,entities,start_tokens,end_tokens,start_chars,end_chars,text,pmid,lf_cytokine_distsv,lf_transcription_factor_distsv,lf_t_lymphocyte_distsv,olabel,orig_index,label,prob_0,prob_1,prob_2
12,CTL immunity,9,11,55,67,"The presence of T-helper cells favors the induction of CTL immunity, whereas the absence of T-helper cells can result in CTL tolerance.",10395322_1,-1,-1,-1,-1,12,-1,0.02074099,0.0013349488,0.97792405
15,CTL tolerance,21,23,121,134,"The presence of T-helper cells favors the induction of CTL immunity, whereas the absence of T-helper cells can result in CTL tolerance.",10395322_1,-1,-1,-1,-1,15,-1,0.0018901664,0.013074186,0.98503566
19,that triggering,3,5,20,35,We demonstrate here that triggering of CD40 in vivo can considerably enhance the efficacy of peptide-based anti-tumor vaccines.,10395322_3,-1,-1,-1,-1,19,-1,2.1787866e-05,0.9999677,1.0569102e-05
21,peptide-based,15,16,93,106,We demonstrate here that triggering of CD40 in vivo can considerably enhance the efficacy of peptide-based anti-tumor vaccines.,10395322_3,0,-1,2,-1,21,-1,5.0002545e-05,0.9999218,2.8155686e-05
23,tolerogenic peptide,4,6,21,40,The combination of a tolerogenic peptide vaccine containing a minimal essential CTL epitope with an activating antibody against CD40 converts tolerization into strong CTL priming.,10395322_4,-1,-1,-1,-1,23,-1,8.203586e-05,0.99986994,4.7993773e-05
27,tumor-specific peptide,9,11,58,80,"Moreover, CD40 ligation can provide an already protective tumor-specific peptide vaccine with the capacity to induce therapeutic CTL immunity in tumor-bearing mice.",10395322_5,-1,-1,-1,-1,27,-1,0.00012093278,0.9998363,4.2732518e-05
30,therapeutic CTL immunity,17,20,117,141,"Moreover, CD40 ligation can provide an already protective tumor-specific peptide vaccine with the capacity to induce therapeutic CTL immunity in tumor-bearing mice.",10395322_5,-1,-1,-1,-1,30,-1,0.1234994,0.83436507,0.042135548
33,that the,3,5,24,32,"These findings indicate that the CD40-CD40 ligand pair can act as a 'switch', determining whether naive peripheral CTLs are primed or tolerized, and support the clinical use of CD40-stimulating agents as components of anti-cancer vaccines.",10395322_6,-1,-1,-1,-1,33,-1,1.7727223e-05,0.9999739,8.43845e-06
41,therapy,14,15,91,98,"The E6 and E7 oncoproteins of human papillomavirus are potentially ideal targets of immune therapy for cervical cancer, because their expression is necessary for cellular transformation.",10419051_1,0,1,-1,-1,41,-1,2.5515466e-05,0.9999604,1.4051513e-05
43,cellular transformation,25,27,162,185,"The E6 and E7 oncoproteins of human papillomavirus are potentially ideal targets of immune therapy for cervical cancer, because their expression is necessary for cellular transformation.",10419051_1,-1,-1,-1,-1,43,-1,0.0013681828,0.04049327,0.9581385
44,proteins,5,6,24,32,"Although both E6 and E7 proteins contain numerous predicted cytotoxic T lymphocyte (CTL) epitopes that are capable of binding to human leukocyte antigens, the majority of earlier in vivo tumor rejection studies have focused on E7.",10419051_2,0,1,-1,-1,44,-1,3.4898152e-05,0.9999286,3.647956e-05
52,that gene,3,5,13,22,"We show here that gene gun-mediated skin transfection of plasmid vector encoding the nontransforming, amino-terminal half of E6 resulted in the induction of E6-specific CTL activity and tumor rejection in a murine model.",10419051_3,-1,-1,-1,-1,52,-1,2.1409509e-05,0.99996686,1.169718e-05
70,that transfection,3,5,21,38,Our results indicate that transfection of the mIL-12 gene at the vaccination site may represent an attractive adjuvant for cancer gene immunotherapy.,10419051_6,-1,-1,-1,-1,70,-1,2.0908004e-05,0.9999702,8.84952e-06
75,the transcription factor nuclear factor-kappaB,2,7,14,60,Activation of the transcription factor nuclear factor-kappaB (NFkappaB) is impaired in T cells from patients with renal cell carcinomas (RCCs).,10491412_0,-1,-1,-1,-1,75,-1,2.7264652e-05,0.99996054,1.2154381e-05
83,factor IkappaBalpha,27,29,176,195,"In circulating T cells from a subset of patients with RCCs, the suppression of NFkappaB binding activity is downstream from the stimulus-induced degradation of the cytoplasmic factor IkappaBalpha.",10491412_1,-1,-1,-1,-1,83,-1,6.4097905e-05,0.99989223,4.3622065e-05
87,these cells,26,28,191,202,"Tumor-derived soluble products from cultured RCC explants inhibit NFkappaB activity in T cells from healthy volunteers, despite a normal level of stimulus-induced IkappaBalpha degradation in these cells.",10491412_2,-1,-1,-1,-1,87,-1,0.0021170182,0.09983851,0.89804447
92,kidney tissue,15,17,96,109,"Indeed, we detected gangliosides in supernatants from RCC explants and not from adjacent normal kidney tissue.",10491412_4,-1,-1,-1,-1,92,-1,0.00024148928,0.9976151,0.002143481
95,the cytokines,30,32,181,194,"Gangliosides prepared from RCC supernatants, as well as the purified bovine gangliosides G(m1) and G(d1a), suppressed NFkappaB binding activity in T cells and reduced expression of the cytokines IL-2 and IFN-gamma.",10491412_5,-1,-1,-1,-1,95,-1,0.38431558,0.6108937,0.004790702
97,Taken together,0,2,0,14,"Taken together, our findings suggest that tumor-derived gangliosides may blunt antitumor immune responses in patients with RCCs.",10491412_6,-1,-1,-1,-1,97,-1,4.05863e-05,0.9999443,1.5043492e-05
98,that tumor-derived,6,8,37,55,"Taken together, our findings suggest that tumor-derived gangliosides may blunt antitumor immune responses in patients with RCCs.",10491412_6,-1,-1,-1,-1,98,-1,2.4473049e-05,0.9999627,1.28246165e-05
102,immune responses to the,1,5,16,39,"Vaccine-induced immune responses to the HPV early antigens E6 and E7, which contribute to cell transformation and are thus expressed in these cervical cancers, could potentially eradicate malignant cells.",10772987_1,-1,-1,-1,-1,102,-1,0.4091212,0.5872145,0.0036643043
104,to cell transformation,14,17,87,109,"Vaccine-induced immune responses to the HPV early antigens E6 and E7, which contribute to cell transformation and are thus expressed in these cervical cancers, could potentially eradicate malignant cells.",10772987_1,-1,-1,-1,-1,104,-1,0.0011377763,0.91220015,0.08666206
116,to tumor cell,19,22,111,124,"Data presented here demonstrate that depending on the model either CD4(+) or CD8(+) T cells provide protection to tumor cell challenge, resulting in striking differences in the efficacy of the four vaccines under investigation.",10772987_4,-1,-1,-1,-1,116,-1,0.003783503,0.820088,0.1761285
125,function,19,20,108,116,"Thymoma is known to contain CD4+CD8+ T cells, indicating that neoplastic epithelial cells of thymoma have a function as thymic cortical epithelium.",10886240_0,0,1,2,-1,125,-1,0.0002133221,0.99962044,0.00016624476
127,that there,6,8,27,37,"However, it has been shown that there is an impairment of CD4+ T cell development in thymoma and that IFN-gamma-induced HLA-DR expression on cultured thymic epithelial cells (TEC) derived from thymoma is decreased when compared with the normal thymus.",10886240_1,-1,-1,-1,-1,127,-1,1.9264919e-05,0.99997103,9.723847e-06
130,that IFN-gamma-induced,20,22,97,119,"However, it has been shown that there is an impairment of CD4+ T cell development in thymoma and that IFN-gamma-induced HLA-DR expression on cultured thymic epithelial cells (TEC) derived from thymoma is decreased when compared with the normal thymus.",10886240_1,-1,-1,-1,-1,130,-1,0.013912197,0.98540455,0.0006833073
136,thymus,42,43,244,250,"However, it has been shown that there is an impairment of CD4+ T cell development in thymoma and that IFN-gamma-induced HLA-DR expression on cultured thymic epithelial cells (TEC) derived from thymoma is decreased when compared with the normal thymus.",10886240_1,-1,1,2,-1,136,-1,8.9126836e-05,0.9997739,0.00013701696
138,to play,9,11,45,52,MHC class II transactivator (CIITA) is known to play a critical role in IFN-gamma-induced MHC II expression.,10886240_2,-1,-1,-1,-1,138,-1,2.6767248e-05,0.99996305,1.0210073e-05
143,to IFN-gamma,22,24,133,145,"In this study, we attempted to elucidate whether CIITA is responsible for the impaired up-regulation of MHC II molecules in response to IFN-gamma in thymoma TEC.",10886240_3,-1,-1,-1,-1,143,-1,0.9337934,0.063669115,0.0025374505
144,thymoma TEC,25,27,149,160,"In this study, we attempted to elucidate whether CIITA is responsible for the impaired up-regulation of MHC II molecules in response to IFN-gamma in thymoma TEC.",10886240_3,-1,-1,-1,-1,144,-1,2.2734597e-05,0.99996674,1.049844e-05
146,that the,8,10,83,91,A quantitative reverse transriptase-polymerase chain reaction examination revealed that the induced level of CIITA was significantly lower in thymoma TEC than in normal TEC.,10886240_4,-1,-1,-1,-1,146,-1,1.6586211e-05,0.9999753,8.144054e-06
147,thymoma TEC than,18,21,142,158,A quantitative reverse transriptase-polymerase chain reaction examination revealed that the induced level of CIITA was significantly lower in thymoma TEC than in normal TEC.,10886240_4,-1,-1,-1,-1,147,-1,2.3257764e-05,0.999964,1.2720754e-05
150,thymoma TEC,12,14,57,68,The induced levels of invariant chain (Ii) and HLA-DR in thymoma TEC were correlated with CIITA expression.,10886240_5,-1,-1,-1,-1,150,-1,2.858806e-05,0.9999572,1.4221387e-05
157,STAT1 to the,10,13,62,74,"A gel mobility shift assay however, revealed translocation of STAT1 to the nucleus in thymoma as well as normal TEC.",10886240_7,-1,-1,-1,-1,157,-1,1.9785664e-05,0.9999658,1.4374499e-05
161,the thymoma TEC to,6,10,54,72,Intercellular adhesion molecule-1 was up-regulated in the thymoma TEC to a level similar to normal TEC in response to IFN-gamma.,10886240_8,-1,-1,-1,-1,161,-1,1.9788962e-05,0.9999703,9.925001e-06
164,to IFN-gamma,18,20,115,127,Intercellular adhesion molecule-1 was up-regulated in the thymoma TEC to a level similar to normal TEC in response to IFN-gamma.,10886240_8,-1,-1,-1,-1,164,-1,0.9202704,0.076728925,0.0030006215
167,to IFN-gamma,10,12,73,85,"These results indicate that impaired up-regulation of HLA-DR in response to IFN-gamma results from insufficient induction of CIITA, but not from the signal from IFN-gamma receptor to the nucleus.",10886240_9,-1,-1,-1,-1,167,-1,0.902916,0.094386704,0.002697287
169,IFN-gamma receptor to the,25,29,161,186,"These results indicate that impaired up-regulation of HLA-DR in response to IFN-gamma results from insufficient induction of CIITA, but not from the signal from IFN-gamma receptor to the nucleus.",10886240_9,-1,-1,-1,-1,169,-1,0.9738149,0.021849072,0.0043359855
180,the immune response,17,20,112,131,The E6 and E7 oncoproteins are constitutively expressed in these lesions and are therefore putative targets for the immune response against HPV.,10962445_1,-1,-1,-1,-1,180,-1,0.26900068,0.72959137,0.0014080082
181,The relation,0,2,0,12,The relation between HPV 16-specific memory cytotoxic T-cell precursor (mCTLp) activity to both oncoproteins and the natural course of cervical dysplasia was analyzed in 38 patients participating in a nonintervention cohort study of women with CIN and 11 HPV 16-positive cervical carcinoma patients.,10962445_2,-1,-1,-1,-1,181,-1,1.8192259e-05,0.9999716,1.0225489e-05
184,the natural,17,19,113,124,The relation between HPV 16-specific memory cytotoxic T-cell precursor (mCTLp) activity to both oncoproteins and the natural course of cervical dysplasia was analyzed in 38 patients participating in a nonintervention cohort study of women with CIN and 11 HPV 16-positive cervical carcinoma patients.,10962445_2,-1,-1,-1,-1,184,-1,2.2411967e-05,0.9999684,9.177777e-06
187,the two,31,33,163,170,"In a cross-sectional study at the end of follow-up prior to biopsy, 8 of 20 patients with a persistent HPV 16 infection had specific mCTLp against at least one of the two oncoproteins.",10962445_3,-1,-1,-1,-1,187,-1,3.517302e-05,0.9999453,1.9569827e-05
190,protein,14,15,82,89,"However, 5 of 11 cervical carcinoma patients showed mCTLp activity against the E7 protein only.",10962445_5,0,1,-1,-1,190,-1,9.525728e-05,0.9997465,0.00015827436
204,to interferon alfa,32,35,186,204,"We wanted to study the expression of interferon regulatory factor 4 (IRF4) in various hematologic disorders, especially chronic myeloid leukemia (CML), and its association with response to interferon alfa (IFN-alpha) treatment in CML.MATERIALS AND METHODS: Blood samples from various hematopoietic cell lines, different leukemia patients (70 CML, 29 acute myeloid leukemia [AML], 10 chronic myelomonocytic leukemia [CMMoL], 10 acute lymphoblastic leukemia, and 10 chronic lymphoid leukemia patients), and 33 healthy volunteers were monitored for IRF4 expression by reverse transcriptase polymerase chain reaction.",11013272_1,-1,-1,-1,-1,204,-1,0.37961283,0.61807317,0.0023140316
207,Blood,44,45,257,262,"We wanted to study the expression of interferon regulatory factor 4 (IRF4) in various hematologic disorders, especially chronic myeloid leukemia (CML), and its association with response to interferon alfa (IFN-alpha) treatment in CML.MATERIALS AND METHODS: Blood samples from various hematopoietic cell lines, different leukemia patients (70 CML, 29 acute myeloid leukemia [AML], 10 chronic myelomonocytic leukemia [CMMoL], 10 acute lymphoblastic leukemia, and 10 chronic lymphoid leukemia patients), and 33 healthy volunteers were monitored for IRF4 expression by reverse transcriptase polymerase chain reaction.",11013272_1,0,1,-1,-1,207,-1,4.216763e-05,0.99988425,7.355982e-05
212,the IRF4,8,10,27,35,"Then, with a focus on CML, the IRF4 level was determined in sorted cell subpopulations from CML patients and healthy volunteers and in in vitro-stimulated CML cells.",11013272_2,-1,-1,-1,-1,212,-1,2.047377e-05,0.9999635,1.6061987e-05
218,IFN-alpha therapy,12,14,74,91,"Furthermore, IRF4 expression was compared in the CML samples taken before IFN-alpha therapy and in 47 additional CML samples taken during IFN-alpha therapy.",11013272_3,-1,-1,-1,-1,218,-1,0.99416983,0.0037970007,0.0020332546
220,IFN-alpha therapy,22,24,138,155,"Furthermore, IRF4 expression was compared in the CML samples taken before IFN-alpha therapy and in 47 additional CML samples taken during IFN-alpha therapy.",11013272_3,-1,-1,-1,-1,220,-1,0.99425006,0.0038165746,0.0019333806
223,to IFN-alpha,8,10,62,74,IRF4 expression was then correlated with cytogenetic response to IFN-alpha.,11013272_4,-1,-1,-1,-1,223,-1,0.9082702,0.08889901,0.002830829
228,IFN-alpha therapy,4,6,23,40,"In CML patients during IFN-alpha therapy, a significant increase in IRF4 levels was detected, and this was also observed in sorted T cells from CML patients.",11013272_7,-1,-1,-1,-1,228,-1,0.9944989,0.0038288983,0.0016721986
233,IFN-alpha therapy,4,6,25,42,The increase seen during IFN-alpha therapy was not due to different blood counts.,11013272_8,-1,-1,-1,-1,233,-1,0.99328905,0.005008862,0.0017021116
235,blood,11,12,68,73,The increase seen during IFN-alpha therapy was not due to different blood counts.,11013272_8,0,1,-1,-1,235,-1,0.0032027673,0.7926219,0.20417531
236,to the,2,4,10,16,"In regard to the cytogenetic response with IFN-alpha, a good response was associated with high IRF4 expression.",11013272_9,-1,-1,-1,-1,236,-1,2.0886471e-05,0.9999697,9.389648e-06
241,to IFN-alpha therapy,22,25,125,145,"CONCLUSION: IRF4 expression is downregulated in T cells of CML patients, and its increase is associated with a good response to IFN-alpha therapy.",11013272_10,-1,-1,-1,-1,241,-1,0.0029624929,0.99674773,0.00028976196
245,to IFN-alpha,17,19,91,103,"These data suggest IRF4 expression as a useful marker to monitor, if not predict, response to IFN-alpha in CML.",11013272_11,-1,-1,-1,-1,245,-1,0.901165,0.096097246,0.0027377468
246,immunology,2,3,12,22,Advances in immunology during the past three decades have facilitated our understanding of the biology of specific lymphoid neoplasms including chronic lymphocytic leukemia (CLL).,11042507_0,0,1,2,-1,246,-1,0.156354,0.83100885,0.012637152
271,the complex,41,43,213,224,"Here, we include an update on our studies regarding CD154 expression in CLL, a review of the data regarding the consequences of CD40 engagement in CLL B cells, and a discussion of these findings in the context of the complex and potentially opposite outcomes that have been reported for CD40-mediated signals in CLL.",11042507_3,-1,-1,-1,-1,271,-1,3.4413828e-05,0.9999511,1.445148e-05
274,therapy,3,4,21,28,"The implications for therapy, such as by impedance to CD154-CD40 interaction using antibody to CD154, or by selective inhibitors of NF-kappa B, are considered.",11042507_4,0,1,-1,-1,274,-1,2.5229097e-05,0.9999622,1.2555899e-05
276,to CD154,14,16,92,100,"The implications for therapy, such as by impedance to CD154-CD40 interaction using antibody to CD154, or by selective inhibitors of NF-kappa B, are considered.",11042507_4,-1,-1,-1,-1,276,-1,0.0079794675,0.41610736,0.57591313
280,transforms cytokine-dependent T lymphocytes,10,14,44,87,Human T cell leukemia virus type 1 (HTLV-1) transforms cytokine-dependent T lymphocytes and causes adult T cell leukemia.,11046040_0,-1,-1,-1,-1,280,-1,0.01344929,0.23924358,0.7473072
283,transcription factors Stat5a,5,8,33,61,"Janus tyrosine kinase (Jak)3 and transcription factors Stat5a and Stat5b are essential for the proliferation of normal T cells and are constitutively hyperactivated in both HTLV-1-transformed human T cell lines and lymphocytes isolated from HTLV-1-infected patients; therefore, a critical role for the Jak3-Stat5 pathway in the progression of this disease has been postulated.",11046040_1,-1,-1,-1,-1,283,-1,3.6764748e-05,0.99993587,2.7340217e-05
293,that tyrphostin,3,5,21,36,We recently reported that tyrphostin AG-490 selectively blocked IL-2 activation of Jak3/Stat5 and growth of murine T cell lines.,11046040_2,-1,-1,-1,-1,293,-1,5.9179085e-05,0.99991226,2.8556693e-05
310,DNA binding to the Stat5-responsive,54,59,280,315,"Disruption of constitutive Jak3/Stat5 activation by AG-490 was demonstrated by inhibition of 1) tyrosine phosphorylation of Jak3, Stat5a (Tyr(694)), and Stat5b (Tyr(699)); 2) serine phosphorylation of Stat5a (Ser(726)) as determined by a novel phosphospecific Ab; and 3) Stat5a/b DNA binding to the Stat5-responsive beta-casein promoter.",11046040_5,-1,-1,-1,-1,310,-1,5.3410015e-05,0.99991477,3.1842308e-05
317,that the,5,7,33,41,"Collectively, these data suggest that the Jak3-Stat5 pathway in HTLV-1-transformed T cells has become functionally redundant for proliferation.",11046040_7,-1,-1,-1,-1,317,-1,1.7996956e-05,0.99997365,8.309634e-06
319,functionally,15,16,102,114,"Collectively, these data suggest that the Jak3-Stat5 pathway in HTLV-1-transformed T cells has become functionally redundant for proliferation.",11046040_7,0,1,2,-1,319,-1,4.5849647e-05,0.9999387,1.5418524e-05
320,this functional,2,4,12,27,Reversal of this functional uncoupling may be required before Jak3/Stat5 inhibitors will be useful in the treatment of this malignancy.,11046040_8,-1,-1,-1,-1,320,-1,3.992493e-05,0.9999436,1.6434784e-05
321,the treatment,15,17,102,115,Reversal of this functional uncoupling may be required before Jak3/Stat5 inhibitors will be useful in the treatment of this malignancy.,11046040_8,-1,-1,-1,-1,321,-1,3.1246516e-05,0.9999573,1.1386456e-05
328,cytokines that,7,9,40,54,This phenotype is determined in part by cytokines that influence T cell differentiation.,11086033_1,-1,-1,-1,-1,328,-1,0.932209,0.06391109,0.0038798726
330,transplantable tumor,1,3,3,23,"In transplantable tumor models such as P1.HTR, tumors grow progressively despite expression of defined tumor Ags.",11086033_2,-1,-1,-1,-1,330,-1,2.3965265e-05,0.9999614,1.4636378e-05
333,that this,2,4,16,25,"We hypothesized that this failure to reject may be due to poor generation of a type 1 phenotype, through a dominant influence of the type 2-promoting cytokines IL-4 and/or IL-13.",11086033_3,-1,-1,-1,-1,333,-1,1.8276447e-05,0.9999738,7.997244e-06
339,the type,24,26,129,137,"We hypothesized that this failure to reject may be due to poor generation of a type 1 phenotype, through a dominant influence of the type 2-promoting cytokines IL-4 and/or IL-13.",11086033_3,-1,-1,-1,-1,339,-1,2.887379e-05,0.99995744,1.37105435e-05
349,tumor-specific IFN-gamma,5,7,39,63,Rejection was accompanied by augmented tumor-specific IFN-gamma production and CTL activity.,11086033_6,-1,-1,-1,-1,349,-1,0.5735918,0.42210832,0.004299914
354,immunity,12,13,99,107,These results suggest that pharmacologic inhibition of Stat6 signaling could potentiate anti-tumor immunity in vivo.,11086033_7,0,-1,2,-1,354,-1,0.99920446,0.00055394636,0.00024154298
355,cell functions,1,3,9,23,Effector cell functions are regulated by a number of positive signals for the mediation of antitumor immunity.,11129327_0,-1,-1,-1,-1,355,-1,4.6268553e-05,8.3795756e-05,0.99986994
357,immunity,16,17,101,109,Effector cell functions are regulated by a number of positive signals for the mediation of antitumor immunity.,11129327_0,0,-1,2,-1,357,-1,0.997239,0.0023474642,0.0004135812
361,the generation,13,15,68,82,"The CD40 and CD40 ligand (CD40L) interaction has been implicated in the generation of effective cell-mediated and humoral immune responses, where cytokines have been shown to play a significant role in the expression of these molecules.",11129327_1,-1,-1,-1,-1,361,-1,1.9861202e-05,0.99996924,1.0926656e-05
365,to play,28,30,172,179,"The CD40 and CD40 ligand (CD40L) interaction has been implicated in the generation of effective cell-mediated and humoral immune responses, where cytokines have been shown to play a significant role in the expression of these molecules.",11129327_1,-1,-1,-1,-1,365,-1,3.541532e-05,0.9999497,1.4880169e-05
377,to cells,19,21,113,121,"Tumor-transplanted animals showed enhanced expression of CD40L on natural killer (NK) and T cells, when compared to cells from normal animals.",11129327_4,-1,-1,-1,-1,377,-1,0.0052055027,0.3741089,0.6206856
378,tumor cells,4,6,24,35,CD40 expression on AK-5 tumor cells was also induced after s.c. transplantation.,11129327_5,-1,-1,-1,-1,378,-1,0.0039856276,0.4284406,0.5675737
379,transplantation,12,13,64,79,CD40 expression on AK-5 tumor cells was also induced after s.c. transplantation.,11129327_5,-1,1,2,-1,379,-1,2.6819682e-05,0.9999621,1.1049222e-05
385,cytokine release,40,42,266,282,"Administration of anti-(interleukin-12) (anti-IL-12) and anti-(interferon gamma) (anti-IFNgamma) antibodies in tumor-bearing animals showed down-regulation of the expression of CD40L on NK and T cells with simultaneous inhibition of cytotoxic acitivity of NK cells, cytokine release and the production of antitumor antibody.",11129327_6,-1,-1,-1,-1,385,-1,0.964259,0.03171599,0.0040250937
393,the immune response,3,6,27,46,"CD40L expression modulated the immune response exerted by NK cells, in part by the activation of nuclear factor kB (NF-kB).",11129327_8,-1,-1,-1,-1,393,-1,0.09601341,0.9033063,0.0006803427
399,CD40L through the,5,8,31,48,"Furthermore, the signaling via CD40L through the use of anti-CD40L antibody promoted the in vitro activation of cytotoxic as well as NF-kappaB binding activity in NK cells from tumor-transplanted animals.",11129327_9,-1,-1,-1,-1,399,-1,0.0027776426,0.05549105,0.9417314
405,that the,3,5,31,39,"These observations demonstrate that the expression of CD40L by the effector cells is regulated by IL-12 and IFNgamma, and could effectively modulate the NK-cell-mediated immune response during the regression of AK-5 tumor.",11129327_10,-1,-1,-1,-1,405,-1,1.6498074e-05,0.9999753,8.20972e-06
419,that IL-15Ralpha,6,8,31,47,"In this study, we demonstrated that IL-15Ralpha, the IL-15-specific binding receptor, mRNA and protein levels were also elevated in HTLV-I-infected cells.",11160322_1,-1,-1,-1,-1,419,-1,0.0045638634,0.9943975,0.0010385815
420,the IL-15-specific,9,11,49,67,"In this study, we demonstrated that IL-15Ralpha, the IL-15-specific binding receptor, mRNA and protein levels were also elevated in HTLV-I-infected cells.",11160322_1,-1,-1,-1,-1,420,-1,0.012217627,0.98663914,0.0011432739
421,receptor,12,13,76,84,"In this study, we demonstrated that IL-15Ralpha, the IL-15-specific binding receptor, mRNA and protein levels were also elevated in HTLV-I-infected cells.",11160322_1,0,1,2,-1,421,-1,0.0009542008,0.12393193,0.8751139
422,protein,16,17,95,102,"In this study, we demonstrated that IL-15Ralpha, the IL-15-specific binding receptor, mRNA and protein levels were also elevated in HTLV-I-infected cells.",11160322_1,0,1,-1,-1,422,-1,2.6540538e-05,0.9999536,1.98297e-05
424,that transient,2,4,10,24,We showed that transient HTLV-I Tax expression lead to increased IL-15Ralpha mRNA levels.,11160322_2,-1,-1,-1,-1,424,-1,1.9609492e-05,0.99997115,9.194904e-06
431,that Tax,17,19,102,110,"In addition, by using a reporter construct that bears the human IL-15Ralpha promoter, we demonstrated that Tax expression increased promoter activity by at least 4-fold.",11160322_3,-1,-1,-1,-1,431,-1,2.1150436e-05,0.9999696,9.194408e-06
432,analysis,9,10,62,70,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,0,1,-1,-1,432,-1,2.7561604e-05,0.9999536,1.8807898e-05
433,functional NF-kappaB-binding,14,16,85,113,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,-1,-1,-1,-1,433,-1,2.7033679e-05,0.99995875,1.4235873e-05
436,that Tax,24,26,166,174,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,-1,-1,-1,-1,436,-1,2.3475743e-05,0.99996674,9.780854e-06
438,to the,35,37,218,224,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,-1,-1,-1,-1,438,-1,2.124881e-05,0.9999685,1.0265381e-05
440,that IL-15Ralpha,43,45,269,285,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,-1,-1,-1,-1,440,-1,0.043003906,0.9551902,0.0018059796
443,Tax protein through the,51,55,331,354,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,-1,-1,-1,-1,443,-1,1.862691e-05,0.9999696,1.1727829e-05
447,through the,7,9,48,59,"In early CD4(-)CD8(-) pro-thymocytes, signaling through the pre-TCR is crucial for survival and differentiation into CD4(+)CD8(+) cells.",11290785_0,-1,-1,-1,-1,447,-1,2.6502317e-05,0.9999583,1.5257584e-05
452,to cell,16,18,107,114,"At this more mature stage, interactions between alphabetaTCR and self-Ag/MHC complexes in turn lead either to cell survival and differentiation (positive selection) or to cell death (negative selection).",11290785_1,-1,-1,-1,-1,452,-1,0.0044090743,0.3460176,0.6495733
453,to cell,26,28,168,175,"At this more mature stage, interactions between alphabetaTCR and self-Ag/MHC complexes in turn lead either to cell survival and differentiation (positive selection) or to cell death (negative selection).",11290785_1,-1,-1,-1,-1,453,-1,0.00451363,0.34177512,0.65371126
455,thymocytes,11,12,83,93,"Intrinsic differences must therefore exist between pre-TCR signals in CD4(-)CD8(-) thymocytes and alphabetaTCR signals in CD4(+)CD8(+) cells, since only the latter can mediate a death signal.",11290785_2,-1,1,2,-1,455,-1,0.0012925208,0.03982956,0.958878
461,thymoma cell,20,22,116,128,"In this work, we directly compared the capability of pre-TCR and alphabetaTCR to induce apoptosis in a CD4(-)CD8(-) thymoma cell line following receptor cross-linking with mAbs.",11290785_3,-1,-1,-1,-1,461,-1,0.003785774,0.70766705,0.2885472
462,receptor,24,25,144,152,"In this work, we directly compared the capability of pre-TCR and alphabetaTCR to induce apoptosis in a CD4(-)CD8(-) thymoma cell line following receptor cross-linking with mAbs.",11290785_3,0,1,2,-1,462,-1,0.0006149994,0.00037901086,0.999006
466,thymocytes,21,22,150,160,"Cross-linking of alphabetaTCR triggered high levels of programmed cell death, mimicking the negative selection signal usually induced in CD4(+)CD8(+) thymocytes.",11290785_4,-1,1,2,-1,466,-1,0.0008026949,0.012805425,0.9863919
467,receptor,18,19,118,126,"In contrast, pre-TCR was very inefficient at inducing apoptosis upon cross-linking, despite similar levels of surface receptor expression.",11290785_5,0,1,2,-1,467,-1,0.00042232053,0.0011683229,0.99840945
469,TCRzeta,16,17,106,113,"Importantly, inefficient apoptosis induction by the pre-TCR did not result from its weak association with TCRzeta chain, since TCRs containing alpha-pTalpha chimeric chains, binding weakly to TCRzeta, were still able to induce apoptosis.",11290785_6,-1,1,2,-1,469,-1,3.0112285e-05,0.99994135,2.856259e-05
470,TCRs,20,21,127,131,"Importantly, inefficient apoptosis induction by the pre-TCR did not result from its weak association with TCRzeta chain, since TCRs containing alpha-pTalpha chimeric chains, binding weakly to TCRzeta, were still able to induce apoptosis.",11290785_6,-1,1,2,-1,470,-1,3.480667e-05,0.9999397,2.5531417e-05
471,to TCRzeta,28,30,189,199,"Importantly, inefficient apoptosis induction by the pre-TCR did not result from its weak association with TCRzeta chain, since TCRs containing alpha-pTalpha chimeric chains, binding weakly to TCRzeta, were still able to induce apoptosis.",11290785_6,-1,-1,-1,-1,471,-1,3.9245784e-05,0.9999366,2.4130895e-05
474,the two,16,18,126,133,"Although similar tyrosine phosphorylation and calcium influx were induced after either pre-TCR or alphabetaTCR cross-linking, the two pathways diverged at the level of Fas ligand induction.",11290785_7,-1,-1,-1,-1,474,-1,3.0639938e-05,0.9999573,1.2007162e-05
481,that the,7,9,41,49,"Together, these results support the view that the structure of the pre-TCR and alphabetaTCR directly influences their apoptosis-inducing capabilities by activating distinct signaling pathways.",11290785_9,-1,-1,-1,-1,481,-1,1.867058e-05,0.99997306,8.259885e-06
484,the interferon,3,5,18,32,"Mice deficient in the interferon consensus sequence binding protein (ICSBP) develop a disease resembling chronic myeloid leukemia (CML), which in humans is caused by the BCR/ABL oncoprotein.",11369642_0,-1,-1,-1,-1,484,-1,0.0013080824,0.9985776,0.00011431629
491,therapy,11,12,74,81,Interferon-alpha (IFN-alpha) induces ICSBP expression and is an effective therapy for CML.,11369642_1,0,1,-1,-1,491,-1,3.3210465e-05,0.9999527,1.41546425e-05
494,that ICSBP-modified cells generated,15,19,121,156,This study examined whether enforced expression of ICSBP might antagonize BCR/ABL-induced leukemia; results demonstrated that ICSBP-modified cells generated a protective CD8(+) cytotoxic T-cell response against BCR/ABL-transformed BaF3 cells in a murine leukemia model.,11369642_2,-1,-1,-1,-1,494,-1,5.00539e-05,0.9998983,5.1563205e-05
495,T-cell,24,25,187,193,This study examined whether enforced expression of ICSBP might antagonize BCR/ABL-induced leukemia; results demonstrated that ICSBP-modified cells generated a protective CD8(+) cytotoxic T-cell response against BCR/ABL-transformed BaF3 cells in a murine leukemia model.,11369642_2,-1,1,2,-1,495,-1,3.867523e-05,4.866873e-05,0.99991274
498,immune response to,10,13,64,82,ICSBP expression represents a novel means of stimulating a host immune response to BCR/ABL(+) leukemia cells and a potential strategy for immunotherapy of CML.,11369642_3,-1,-1,-1,-1,498,-1,0.7638812,0.23374808,0.0023707405
500,Blood,1,2,1,6,(Blood. 2001;97:3491-3497),11369642_4,0,1,-1,-1,500,-1,0.00010041745,0.999617,0.0002826216
504,to generate,5,7,28,39,We used the Cre-loxP system to generate a T cell-specific deletion of the Pten gene (Pten(flox/-) mice).,11371355_1,-1,-1,-1,-1,504,-1,1.6817412e-05,0.9999728,1.035105e-05
509,thymic cellularity,5,7,33,51,Pten(flox/-) mice show increased thymic cellularity due in part to a defect in thymic negative selection.,11371355_3,-1,-1,-1,-1,509,-1,0.0068341796,0.38598815,0.6071777
518,tolerance to,1,3,11,23,Peripheral tolerance to SEB is also impaired in Pten(flox/-) mice.,11371355_6,-1,-1,-1,-1,518,-1,2.538694e-05,0.9999602,1.4444309e-05
522,TGFbeta,7,8,49,56,"IL-2 responses are susceptible to suppression by TGFbeta, a cytokine widely implicated in suppression of inflammatory responses and secreted by many different tumor cell types.",11418694_0,0,1,-1,-1,522,-1,3.1273976e-05,0.9999583,1.0405662e-05
524,tumor cell types,23,26,159,175,"IL-2 responses are susceptible to suppression by TGFbeta, a cytokine widely implicated in suppression of inflammatory responses and secreted by many different tumor cell types.",11418694_0,-1,-1,-1,-1,524,-1,0.0032870704,0.15535375,0.8413592
528,TGFbeta,14,15,108,115,There have been conflicting reports regarding inhibition of IL-2-induced STAT3 and STAT5 phosphorylation by TGFbeta and subsequent suppression of immune responses.,11418694_1,0,1,-1,-1,528,-1,3.3949844e-05,0.99995446,1.1549157e-05
530,TGFbeta-producing,1,2,6,23,Using TGFbeta-producing multiple myeloma tumor cells we demonstrate that tumor-derived TGFbeta can block IL-2-induced proliferation and STAT3 and STAT5 phosphorylation in T cells.,11418694_2,0,1,-1,-1,530,-1,4.8555088e-05,0.99992585,2.5605066e-05
531,tumor cells,4,6,41,52,Using TGFbeta-producing multiple myeloma tumor cells we demonstrate that tumor-derived TGFbeta can block IL-2-induced proliferation and STAT3 and STAT5 phosphorylation in T cells.,11418694_2,-1,-1,-1,-1,531,-1,0.0037962382,0.38485995,0.6113438
532,that tumor-derived TGFbeta,8,11,68,94,Using TGFbeta-producing multiple myeloma tumor cells we demonstrate that tumor-derived TGFbeta can block IL-2-induced proliferation and STAT3 and STAT5 phosphorylation in T cells.,11418694_2,-1,-1,-1,-1,532,-1,3.187671e-05,0.99995685,1.1231793e-05
539,tumor cells,27,29,170,181,High affinity IL-2R expression was required for the suppression of IL-2 responses as a novel CD25(-) T cell line proliferated and phosphorylated STAT3 when cultured with tumor cells or rTGFbeta1.,11418694_3,-1,-1,-1,-1,539,-1,0.0044014985,0.42403296,0.57156557
544,T cells to,20,23,110,120,"Activating T cells with IL-15, which does not use the high affinity IL-2R, completely restored the ability of T cells to phosphorylate STAT3 and STAT5 when cultured with tumor cells.",11418694_4,-1,-1,-1,-1,544,-1,0.0017045473,0.03700532,0.9612901
547,tumor cells,30,32,170,181,"Activating T cells with IL-15, which does not use the high affinity IL-2R, completely restored the ability of T cells to phosphorylate STAT3 and STAT5 when cultured with tumor cells.",11418694_4,-1,-1,-1,-1,547,-1,0.004425161,0.5012347,0.49434015
548,IL-15-treated T cells,0,3,0,21,"IL-15-treated T cells proliferated normally when cocultured with tumor cells or rTGFbeta1, whereas IL-2 responses were consistently inhibited.",11418694_5,-1,-1,-1,-1,548,-1,0.46635288,0.0034724036,0.5301747
549,tumor cells,8,10,65,76,"IL-15-treated T cells proliferated normally when cocultured with tumor cells or rTGFbeta1, whereas IL-2 responses were consistently inhibited.",11418694_5,-1,-1,-1,-1,549,-1,0.0045933933,0.36653942,0.6288672
552,T cells to,8,11,54,64,"Preincubation with IL-15 also restored the ability of T cells to respond to IL-2 by phosphorylating STAT3 and STAT5, and proliferating normally in the presence of tumor cells.",11418694_6,-1,-1,-1,-1,552,-1,0.0014750492,0.034111246,0.96441376
557,tumor cells,27,29,163,174,"Preincubation with IL-15 also restored the ability of T cells to respond to IL-2 by phosphorylating STAT3 and STAT5, and proliferating normally in the presence of tumor cells.",11418694_6,-1,-1,-1,-1,557,-1,0.0038821634,0.35656208,0.6395557
558,T cell function,5,8,34,49,IL-2 pretreatment did not restore T cell function.,11418694_7,-1,-1,-1,-1,558,-1,4.772594e-05,8.5353495e-05,0.99986696
568,TGFbeta1-producing tumor cells,15,18,81,111,"Thus, activation of T cells by IL-15 renders T cells resistant to suppression by TGFbeta1-producing tumor cells and rTGFbeta1.",11418694_9,-1,-1,-1,-1,568,-1,0.0027151254,0.86519533,0.13208948
580,CD8+ T cell activation,10,15,67,89,"KS initiates in a context of immune dysregulation characterised by CD8+ T cell activation and the production of Th1-type cytokines that induce a generalised activation of endothelial cells leading to adhesion and tissue extravasation of lympho-monocytes, spindle cell formation and angiogenesis.",11423257_1,-1,-1,-1,-1,580,-1,5.7621983e-05,6.561842e-05,0.99987674
582,Th1-type cytokines that,19,22,112,135,"KS initiates in a context of immune dysregulation characterised by CD8+ T cell activation and the production of Th1-type cytokines that induce a generalised activation of endothelial cells leading to adhesion and tissue extravasation of lympho-monocytes, spindle cell formation and angiogenesis.",11423257_1,-1,-1,-1,-1,582,-1,8.807747e-05,0.99984336,6.8492234e-05
586,tissue,33,34,213,219,"KS initiates in a context of immune dysregulation characterised by CD8+ T cell activation and the production of Th1-type cytokines that induce a generalised activation of endothelial cells leading to adhesion and tissue extravasation of lympho-monocytes, spindle cell formation and angiogenesis.",11423257_1,-1,1,2,-1,586,-1,3.512839e-05,0.99994206,2.284658e-05
595,tissue,9,10,71,77,"Productively-infected circulating cells are recruited into 'activated' tissue sites where HHV8 finds an optimal environment for establishing a persistent, latent infection of KS spindle cells (KSC).",11423257_3,-1,1,2,-1,595,-1,6.33286e-05,0.99971,0.00022665094
598,to immune responses that,14,18,94,118,"HHV8 dissemination is favoured by virus escape mechanisms and immune dysregulation, and leads to immune responses that are not effective against the virus but, paradoxically, exacerbates the reactive process.",11423257_4,-1,-1,-1,-1,598,-1,0.00041161376,0.99951315,7.526237e-05
601,nature that,9,11,54,65,"Although early KS is a reactive process of polyclonal nature that can regress, in time it can progress in to a true sarcoma.",11423257_5,-1,-1,-1,-1,601,-1,7.7846606e-05,0.99981254,0.000109605564
607,to the,8,10,40,46,"The progression of KS appears to be due to the deregulated expression of oncogenes and oncosuppressor genes, to the long-lasting expression of the HHV8 latency genes and, for AIDS-KS, is promoted by the proliferative and angiogenic effects of the HIV-1 Tat protein.",11423257_6,-1,-1,-1,-1,607,-1,1.899104e-05,0.999972,9.030319e-06
609,to the,18,20,109,115,"The progression of KS appears to be due to the deregulated expression of oncogenes and oncosuppressor genes, to the long-lasting expression of the HHV8 latency genes and, for AIDS-KS, is promoted by the proliferative and angiogenic effects of the HIV-1 Tat protein.",11423257_6,-1,-1,-1,-1,609,-1,2.464973e-05,0.99996364,1.16921565e-05
615,The transcription factor GATA-3,0,4,0,31,The transcription factor GATA-3 is essential for early T cell development and differentiation of naive CD4(+) T cells into Th2 effector cells.,11441076_0,-1,-1,-1,-1,615,-1,2.5347874e-05,0.9999603,1.4314475e-05
622,the function,2,4,9,21,"To study the function of GATA-3 during T cell-mediated immune responses in vivo, we investigated CD2-GATA3-transgenic mice in which GATA-3 expression is driven by the CD2 locus control region.",11441076_1,-1,-1,-1,-1,622,-1,1.9346622e-05,0.9999697,1.0935794e-05
624,T cell-mediated immune responses,7,11,39,71,"To study the function of GATA-3 during T cell-mediated immune responses in vivo, we investigated CD2-GATA3-transgenic mice in which GATA-3 expression is driven by the CD2 locus control region.",11441076_1,-1,-1,-1,-1,624,-1,0.07039976,0.002807644,0.92679256
633,the IL-1 receptor,13,16,85,102,"In CD2-GATA3-transgenic mice, large fractions of peripheral CD4(+) T cells expressed the IL-1 receptor family member T1/ST2, indicative of advanced Th2 commitment.",11441076_3,-1,-1,-1,-1,633,-1,0.008872008,0.9515408,0.03958716
640,the Th2 cytokines,10,13,55,72,"Moreover, CD4(+) T cells manifested rapid secretion of the Th2 cytokines IL-4, IL-5, and IL-10, reminiscent of Th2 memory cells.",11441076_5,-1,-1,-1,-1,640,-1,0.052530173,0.9444279,0.0030418998
654,Th2 cytokine,20,22,144,156,"Under Th1 conditions, cellular proliferation of CD2-GATA3-transgenic CD4(+) cells was severely hampered, IFN-gamma production was decreased and Th2 cytokine production was increased.",11441076_7,-1,-1,-1,-1,654,-1,0.13321868,0.861249,0.0055323136
664,functional,2,3,14,24,"The increased functional capacity to secrete Th2 cytokines, along with the increased expression of surface markers for Ag-experienced Th2-committed cells, would argue for a role of GATA-3 in Th2 memory formation.",11441076_10,0,1,2,-1,664,-1,8.9409885e-05,0.99984133,6.923466e-05
666,Th2 cytokines,6,8,45,58,"The increased functional capacity to secrete Th2 cytokines, along with the increased expression of surface markers for Ag-experienced Th2-committed cells, would argue for a role of GATA-3 in Th2 memory formation.",11441076_10,-1,-1,-1,-1,666,-1,0.28537467,0.7040736,0.010551776
668,Th2-committed cells,19,21,134,153,"The increased functional capacity to secrete Th2 cytokines, along with the increased expression of surface markers for Ag-experienced Th2-committed cells, would argue for a role of GATA-3 in Th2 memory formation.",11441076_10,-1,-1,-1,-1,668,-1,0.002164612,0.096863896,0.9009714
676,functional,6,7,31,41,"In this study, we investigated functional consequences and molecular events in T cells exposed to low levels of oxidative stress.",11509600_2,0,1,2,-1,676,-1,3.7718644e-05,0.9999429,1.9421597e-05
679,that cytokine,2,4,12,25,"We observed that cytokine production of human PBMC, upon stimulation with an HLA-A*0201-restricted influenza peptide and nonspecific receptor cross-linking, was reduced after exposure to micromolar levels of H2O2.",11509600_3,-1,-1,-1,-1,679,-1,0.18480368,0.81135106,0.0038452381
680,peptide,15,16,109,116,"We observed that cytokine production of human PBMC, upon stimulation with an HLA-A*0201-restricted influenza peptide and nonspecific receptor cross-linking, was reduced after exposure to micromolar levels of H2O2.",11509600_3,0,-1,2,-1,680,-1,0.0016516668,0.9967359,0.0016124545
681,receptor,18,19,133,141,"We observed that cytokine production of human PBMC, upon stimulation with an HLA-A*0201-restricted influenza peptide and nonspecific receptor cross-linking, was reduced after exposure to micromolar levels of H2O2.",11509600_3,0,1,2,-1,681,-1,0.00055563834,0.0008649161,0.9985794
683,Functional,0,1,0,10,Functional impairment as measured by IFN-gamma release occurred earlier and at lower doses of exogenously added H2O2 than required to induce apoptosis.,11509600_4,0,1,2,-1,683,-1,8.356808e-05,0.9998642,5.2231964e-05
684,IFN-gamma release,5,7,37,54,Functional impairment as measured by IFN-gamma release occurred earlier and at lower doses of exogenously added H2O2 than required to induce apoptosis.,11509600_4,-1,-1,-1,-1,684,-1,0.9961133,0.0025014917,0.0013851185
688,that there,2,4,14,24,This suggests that there is a dose window of oxidative stress leading to T cell unresponsiveness in the absence of apoptosis.,11509600_5,-1,-1,-1,-1,688,-1,2.23382e-05,0.99996936,8.339003e-06
689,to T cell,12,15,70,79,This suggests that there is a dose window of oxidative stress leading to T cell unresponsiveness in the absence of apoptosis.,11509600_5,-1,-1,-1,-1,689,-1,0.003795937,0.1674173,0.82878673
692,Th1 cytokines,3,5,17,30,"The reduction of Th1 cytokines, induced by H2O2, was predominantly observed in memory/effector (CD45RO(+)) T cells and correlated with a block in NF-kappaB activation.",11509600_6,-1,-1,-1,-1,692,-1,0.23677091,0.739117,0.024112038
696,than IFN-gamma,11,13,69,83,"IL-10 production was more profoundly influenced by low doses of H2O2 than IFN-gamma, TNF-alpha, and IL-2.",11509600_7,-1,-1,-1,-1,696,-1,0.91673154,0.07722578,0.006042669
697,TNF-alpha,14,15,85,94,"IL-10 production was more profoundly influenced by low doses of H2O2 than IFN-gamma, TNF-alpha, and IL-2.",11509600_7,0,1,-1,-1,697,-1,0.0024010336,0.9973572,0.00024179526
700,naive T cells,15,18,106,119,The influence of H2O2 on production of IL-10 was not significantly different between memory/activated and naive T cells.,11509600_8,-1,-1,-1,-1,700,-1,0.0025420263,0.061560232,0.93589765
702,that Th1,3,5,27,35,These observations suggest that Th1 and Th2 cytokines are differently regulated under conditions of oxidative stress.,11509600_9,-1,-1,-1,-1,702,-1,2.4736375e-05,0.99996006,1.5147237e-05
703,Th2 cytokines,6,8,40,53,These observations suggest that Th1 and Th2 cytokines are differently regulated under conditions of oxidative stress.,11509600_9,-1,-1,-1,-1,703,-1,0.12535588,0.8648638,0.009780341
704,Taken together,0,2,0,14,"Taken together, these findings may explain why Ag-experienced, CD45RO(+), T cells found in the tumor milieu are functionally suppressed.",11509600_10,-1,-1,-1,-1,704,-1,5.3629745e-05,0.9999273,1.9036574e-05
707,the tumor,17,19,91,100,"Taken together, these findings may explain why Ag-experienced, CD45RO(+), T cells found in the tumor milieu are functionally suppressed.",11509600_10,-1,-1,-1,-1,707,-1,2.273662e-05,0.99996793,9.322872e-06
708,functionally,21,22,112,124,"Taken together, these findings may explain why Ag-experienced, CD45RO(+), T cells found in the tumor milieu are functionally suppressed.",11509600_10,0,1,2,-1,708,-1,6.0468334e-05,0.9999205,1.9041638e-05
712,proteins,4,5,14,22,The E6 and E7 proteins of HPV are constitutively expressed in cervical carcinoma cells making them attractive targets for CTL-based immunotherapy.,11673561_1,0,1,-1,-1,712,-1,0.00017982809,0.99967885,0.00014134024
723,These CTL,0,2,0,9,These CTL were unable to recognize HLA-A*0201(+) HPV16 E6(+) cervical carcinoma cell lines even when the level of endogenous HPV16 E6 in these cells was increased by transfection.,11673561_4,-1,-1,-1,-1,723,-1,0.0029861187,0.14306246,0.8539515
727,these cells,24,26,137,148,These CTL were unable to recognize HLA-A*0201(+) HPV16 E6(+) cervical carcinoma cell lines even when the level of endogenous HPV16 E6 in these cells was increased by transfection.,11673561_4,-1,-1,-1,-1,727,-1,0.0022668745,0.13753213,0.860201
731,protein,25,26,139,146,"This defect in presentation of HPV16 E6(29-38) correlated with low level expression of HLA class I, proteasome subunits low molecular mass protein 2 and 7, and the transporter proteins TAP1 and TAP2 in the cervical carcinoma cell lines.",11673561_5,0,1,-1,-1,731,-1,0.0006731995,0.99786586,0.0014609196
732,the transporter proteins TAP1,31,35,160,189,"This defect in presentation of HPV16 E6(29-38) correlated with low level expression of HLA class I, proteasome subunits low molecular mass protein 2 and 7, and the transporter proteins TAP1 and TAP2 in the cervical carcinoma cell lines.",11673561_5,-1,-1,-1,-1,732,-1,3.185574e-05,0.9999293,3.8886643e-05
737,these proteins,5,7,25,39,"The expression of all of these proteins could be up-regulated by IFN-gamma, but this was insufficient for CTL recognition unless the level of HPV16 E6 Ag was also increased by transfection.",11673561_6,-1,-1,-1,-1,737,-1,3.5192374e-05,0.99993837,2.6460802e-05
762,factors,6,7,46,53,Tumors produce a variety of immunosuppressive factors which can prevent the proliferation and maturation of a number of normal hemopoietic cell types.,11698483_0,0,1,-1,-1,762,-1,0.9982615,0.0009948851,0.00074361364
764,cell types,20,22,139,149,Tumors produce a variety of immunosuppressive factors which can prevent the proliferation and maturation of a number of normal hemopoietic cell types.,11698483_0,-1,-1,-1,-1,764,-1,4.059499e-05,5.3616775e-05,0.9999057
766,T cell function,17,20,97,112,We have investigated whether primary acute myeloid leukemia (AML) cells have an effect on normal T cell function and signaling.,11698483_1,-1,-1,-1,-1,766,-1,4.6581903e-05,7.545005e-05,0.9998779
767,Tumor cell,0,2,0,10,Tumor cell supernatant (TSN) from AML cells inhibited T cell activation and Th1 cytokine production and also prevented activated T cells from entering the cell cycle.,11698483_2,-1,-1,-1,-1,767,-1,0.0025262975,0.110449165,0.8870245
771,Th1 cytokine,14,16,76,88,Tumor cell supernatant (TSN) from AML cells inhibited T cell activation and Th1 cytokine production and also prevented activated T cells from entering the cell cycle.,11698483_2,-1,-1,-1,-1,771,-1,0.36098838,0.53175986,0.10725177
773,the cell,25,27,151,159,Tumor cell supernatant (TSN) from AML cells inhibited T cell activation and Th1 cytokine production and also prevented activated T cells from entering the cell cycle.,11698483_2,-1,-1,-1,-1,773,-1,0.0036538972,0.18795252,0.8083936
776,cell-T cell,8,10,45,56,These effects occurred in the absence of AML cell-T cell contact.,11698483_3,-1,-1,-1,-1,776,-1,4.7769212e-05,6.2933286e-05,0.99988925
782,TGF-beta,21,22,128,136,"We have demonstrated that AML TSN contained none of the immunosuppressors described to date, namely gangliosides, nitric oxide, TGF-beta, IL-10, vascular endothelial growth factor, or PGs.",11698483_4,0,1,-1,-1,782,-1,7.104522e-05,0.99990237,2.6620879e-05
787,protein,11,12,69,76,"However, the effect was overcome by preincubation with inhibitors of protein secretion and abolished by trypsinization, indicating that the active substance includes one or more proteins.",11698483_6,0,1,-1,-1,787,-1,0.0004134579,0.99869686,0.00088971114
789,that the,19,21,131,139,"However, the effect was overcome by preincubation with inhibitors of protein secretion and abolished by trypsinization, indicating that the active substance includes one or more proteins.",11698483_6,-1,-1,-1,-1,789,-1,2.1588945e-05,0.9999684,9.975428e-06
790,proteins,27,28,178,186,"However, the effect was overcome by preincubation with inhibitors of protein secretion and abolished by trypsinization, indicating that the active substance includes one or more proteins.",11698483_6,0,1,-1,-1,790,-1,0.0049201977,0.93323547,0.061844386
806,the transition,33,35,189,203,"Phosphorylation of pRb by cyclin-dependent kinase 6/4-cyclin D and of p130 did not occur and c-Myc, cyclin D3, and p107 were not induced, consistent with cell cycle inhibition early during the transition from G(0) to G(1).",11698483_10,-1,-1,-1,-1,806,-1,2.0682028e-05,0.99996746,1.1849672e-05
808,that TSN generated,3,6,18,36,Our data indicate that TSN generated by AML cells induces T cell immunosuppression and provides a mechanism by which the leukemic clone could evade T cell-mediated killing.,11698483_11,-1,-1,-1,-1,808,-1,1.9796222e-05,0.999969,1.1204734e-05
817,that they,13,15,80,89,"Although MHC class II molecules are frequently detected on MG cells, suggesting that they may be capable of antigen (Ag) presentation to CD4(+) T cells, deficiencies in CD4(+) T-cell activation are associated with these nonimmunogenic tumors.",11746775_1,-1,-1,-1,-1,817,-1,2.2436217e-05,0.9999665,1.10618175e-05
841,antigen-presenting cells,31,33,202,226,"IFN-gamma-inducible CIITA expression in MG cells, as well as primary human astrocytes, was directed by two CIITA promoters, pIV, the promoter for IFN-gamma-inducible CIITA expression in nonprofessional antigen-presenting cells (APC), and pIII, the promoter that directs constitutive CIITA expression in B cells.",11746775_4,-1,-1,-1,-1,841,-1,0.3021207,0.0027137145,0.6951656
848,time that,6,8,34,43,"We also demonstrate for the first time that MG cells can process native Ag for presentation to CD4(+) MHC class II-restricted Th1 cells, indicating that MG cells can serve as nonprofessional APC.",11746775_6,-1,-1,-1,-1,848,-1,2.1526857e-05,0.99996364,1.4817982e-05
855,target to,5,7,19,28,"CIITA may be a key target to modulate MHC class II expression, which could augment immunogenicity, Ag presentation, and CD4(+) T-cell activation in MG therapy.",11746775_7,-1,-1,-1,-1,855,-1,2.1190937e-05,0.9999678,1.096561e-05
857,therapy,28,29,151,158,"CIITA may be a key target to modulate MHC class II expression, which could augment immunogenicity, Ag presentation, and CD4(+) T-cell activation in MG therapy.",11746775_7,0,1,-1,-1,857,-1,2.8012451e-05,0.99995804,1.3981208e-05
865,TNF-alpha,20,21,114,123,"The 15-d-PGJ(2) has been shown to both inhibit as well as induce the production of inflammatory mediators such as TNF-alpha, IL-1beta, and cyclooxygenase, mostly occurring via a nuclear receptor called peroxisome proliferator-activated receptor-gamma (PPAR-gamma).",11801678_2,0,1,-1,-1,865,-1,0.00014234996,0.9998155,4.2197076e-05
868,receptor-gamma,36,37,236,250,"The 15-d-PGJ(2) has been shown to both inhibit as well as induce the production of inflammatory mediators such as TNF-alpha, IL-1beta, and cyclooxygenase, mostly occurring via a nuclear receptor called peroxisome proliferator-activated receptor-gamma (PPAR-gamma).",11801678_2,0,1,2,-1,868,-1,0.0001442894,0.99920064,0.00065512024
890,protein,18,19,95,102,"In this study, we report that 15-d-PGJ(2) induced a significant increase in both IL-8 mRNA and protein from activated human T lymphocytes.",11801678_8,0,1,-1,-1,890,-1,6.0321774e-05,0.99987984,5.9820275e-05
894,through the nuclear receptor PPAR-gamma,10,15,51,90,"The induction of IL-8 by 15-d-PGJ(2) did not occur through the nuclear receptor PPAR-gamma, as synthetic PPAR-gamma agonists did not mimic the IL-8-inducing effects of 15-d-PGJ(2).",11801678_9,-1,-1,-1,-1,894,-1,4.228946e-05,0.9999273,3.0384144e-05
895,PPAR-gamma agonists,18,20,105,124,"The induction of IL-8 by 15-d-PGJ(2) did not occur through the nuclear receptor PPAR-gamma, as synthetic PPAR-gamma agonists did not mimic the IL-8-inducing effects of 15-d-PGJ(2).",11801678_9,-1,-1,-1,-1,895,-1,6.037815e-05,0.99990606,3.3502558e-05
896,the IL-8-inducing,23,25,139,156,"The induction of IL-8 by 15-d-PGJ(2) did not occur through the nuclear receptor PPAR-gamma, as synthetic PPAR-gamma agonists did not mimic the IL-8-inducing effects of 15-d-PGJ(2).",11801678_9,-1,-1,-1,-1,896,-1,0.0010343373,0.99877375,0.00019188592
900,protein,9,10,64,71,"The mechanism of IL-8 induction was through a mitogen-activated protein kinase and NF-kappaB pathway, as inhibitors of both systems abrogated IL-8 protein induction.",11801678_10,0,1,-1,-1,900,-1,6.358321e-05,0.99984956,8.687572e-05
902,IL-8 protein,21,23,142,154,"The mechanism of IL-8 induction was through a mitogen-activated protein kinase and NF-kappaB pathway, as inhibitors of both systems abrogated IL-8 protein induction.",11801678_10,-1,-1,-1,-1,902,-1,0.9900997,0.0038581023,0.006042173
908,the complexity,3,5,20,34,These findings show the complexity with which 15-d-PGJ(2) regulates T cells by possessing both pro- and anti-inflammatory properties depending on the activation state of the cell.,11801678_12,-1,-1,-1,-1,908,-1,2.5872843e-05,0.9999554,1.8662098e-05
912,the cell,25,27,170,178,These findings show the complexity with which 15-d-PGJ(2) regulates T cells by possessing both pro- and anti-inflammatory properties depending on the activation state of the cell.,11801678_12,-1,-1,-1,-1,912,-1,0.001805581,0.108722016,0.8894725
917,T-cell,6,7,43,49,Mycosis fungoides is a low-grade cutaneous T-cell lymphoma (CTCL) of unknown etiology.,11807001_0,-1,1,2,-1,917,-1,4.134273e-05,5.055297e-05,0.9999081
919,T(H)1 to T(H)2,12,15,61,75,"In advanced stages of CTCL, a shift in cytokine profile from T(H)1 to T(H)2 is observed, which coincides with eosinophilia, high levels of immunoglobulin E, and increased susceptibility to bacterial infections.",11807001_1,-1,-1,-1,-1,919,-1,3.976793e-05,0.9999336,2.6582515e-05
921,T(H)2 cytokines,7,9,28,43,"It is, however, unknown why T(H)2 cytokines predominate in advanced CTCL, and the cellular source of these cytokines also remains to be identified.",11807001_2,-1,-1,-1,-1,921,-1,0.024568424,0.9734157,0.0020159688
922,the cellular,15,17,78,90,"It is, however, unknown why T(H)2 cytokines predominate in advanced CTCL, and the cellular source of these cytokines also remains to be identified.",11807001_2,-1,-1,-1,-1,922,-1,0.0060900664,0.51196647,0.48194352
923,these cytokines,19,21,101,116,"It is, however, unknown why T(H)2 cytokines predominate in advanced CTCL, and the cellular source of these cytokines also remains to be identified.",11807001_2,-1,-1,-1,-1,923,-1,0.5473492,0.44622445,0.006426302
928,tumor cells,12,14,67,78,"In a previous study, constitutive activation of Stat3 was found in tumor cells isolated from affected skin and blood from CTCL patients.",11807001_4,-1,-1,-1,-1,928,-1,0.004215409,0.41162977,0.58415484
929,blood,19,20,111,116,"In a previous study, constitutive activation of Stat3 was found in tumor cells isolated from affected skin and blood from CTCL patients.",11807001_4,0,1,-1,-1,929,-1,0.00016674235,0.99894077,0.0008925182
931,tumor cell,7,9,28,38,"Here, it is shown that CTCL tumor cell lines, but not nonmalignant cell lines, spontaneously produce interleukin-5 (IL-5), IL-6, and IL-13.",11807001_5,-1,-1,-1,-1,931,-1,0.00318252,0.24537477,0.7514427
937,tumor cells,2,4,16,27,"Transfection of tumor cells with dominant-negative Stat3 almost completely blocks IL-5 production and strongly inhibits IL-13 production, whereas IL-6 production is unaffected.",11807001_6,-1,-1,-1,-1,937,-1,0.0035620613,0.46985775,0.52658015
944,cells themselves,8,10,40,56,"Thus, the data show that malignant CTCL cells themselves might contribute to the change in cytokine pattern accompanying progression of CTCL.",11807001_7,-1,-1,-1,-1,944,-1,0.0021328502,0.035614427,0.9622528
945,to the,12,14,74,80,"Thus, the data show that malignant CTCL cells themselves might contribute to the change in cytokine pattern accompanying progression of CTCL.",11807001_7,-1,-1,-1,-1,945,-1,2.0959316e-05,0.9999685,1.05085865e-05
955,the relative,6,8,45,57,"We systematically investigated the impact of the relative maturation levels of dendritic cells (DCs) on their cell surface phenotype, expression of cytokines and chemokines/chemokine receptors (by DNA array and RNase protection analyses), biological activities, and abilities to induce tumor immunity.",11902830_0,-1,-1,-1,-1,955,-1,2.0589057e-05,0.99996626,1.3165778e-05
957,their cell,17,19,104,114,"We systematically investigated the impact of the relative maturation levels of dendritic cells (DCs) on their cell surface phenotype, expression of cytokines and chemokines/chemokine receptors (by DNA array and RNase protection analyses), biological activities, and abilities to induce tumor immunity.",11902830_0,-1,-1,-1,-1,957,-1,0.0043212827,0.5039559,0.49172282
959,receptors,27,28,183,192,"We systematically investigated the impact of the relative maturation levels of dendritic cells (DCs) on their cell surface phenotype, expression of cytokines and chemokines/chemokine receptors (by DNA array and RNase protection analyses), biological activities, and abilities to induce tumor immunity.",11902830_0,0,1,2,-1,959,-1,0.0027421308,0.0015609646,0.9956969
961,tumor immunity,45,47,286,300,"We systematically investigated the impact of the relative maturation levels of dendritic cells (DCs) on their cell surface phenotype, expression of cytokines and chemokines/chemokine receptors (by DNA array and RNase protection analyses), biological activities, and abilities to induce tumor immunity.",11902830_0,-1,-1,-1,-1,961,-1,0.005648069,0.9940935,0.00025849996
962,their antigen-presenting,7,9,56,80,"Mature DCs expressed significantly heightened levels of their antigen-presenting machinery (e.g., CD54, CD80, CD86) and numerous cytokines and chemokines/chemokine receptors (i.e., Flt-3L, G-CSF, IL-1alpha and -1beta, IL-6, IL-12, CCL-2, -3, -4, -5, -17, and -22, MIP-2, and CCR7) and were significantly better at inducing effector T cell responses in vitro.",11902830_1,-1,-1,-1,-1,962,-1,0.05171277,0.9454405,0.0028466932
966,receptors,24,25,164,173,"Mature DCs expressed significantly heightened levels of their antigen-presenting machinery (e.g., CD54, CD80, CD86) and numerous cytokines and chemokines/chemokine receptors (i.e., Flt-3L, G-CSF, IL-1alpha and -1beta, IL-6, IL-12, CCL-2, -3, -4, -5, -17, and -22, MIP-2, and CCR7) and were significantly better at inducing effector T cell responses in vitro.",11902830_1,0,1,2,-1,966,-1,0.0015653705,0.004573453,0.9938612
973,tumor peptide-pulsed,5,7,34,54,"Furthermore, mice vaccinated with tumor peptide-pulsed mature DCs better survived challenge with a weakly immunogenic tumor (8 of 8 survivors) than did mice vaccinated with less mature (3 of 8 survived) or immature (0 of 8 survivors) DCs.",11902830_2,-1,-1,-1,-1,973,-1,8.565989e-05,0.9998796,3.4681485e-05
980,Taken together,0,2,0,14,"Taken together, our data clearly underscore the critical nature of employing DCs of full maturity for DC-based antitumor vaccination strategies.",11902830_4,-1,-1,-1,-1,980,-1,4.8640115e-05,0.999933,1.8308272e-05
990,to the,2,4,12,18,A corollary to the latter is that survival of melanoma in the host is due to the development of anti-apoptotic mechanisms in melanoma cells.,11905805_2,-1,-1,-1,-1,990,-1,2.815395e-05,0.9999584,1.3445076e-05
993,to the,15,17,74,80,A corollary to the latter is that survival of melanoma in the host is due to the development of anti-apoptotic mechanisms in melanoma cells.,11905805_2,-1,-1,-1,-1,993,-1,2.0434947e-05,0.9999709,8.606277e-06
996,them to,10,12,51,58,What are these mechanisms? And how might we bypass them to improve the treatment of melanoma?,11905805_3,-1,-1,-1,-1,996,-1,3.2388438e-05,0.99995553,1.2016373e-05
997,the treatment,13,15,67,80,What are these mechanisms? And how might we bypass them to improve the treatment of melanoma?,11905805_3,-1,-1,-1,-1,997,-1,3.608306e-05,0.99995196,1.19098395e-05
998,receptor,10,11,41,49,"CD30 ligand (CD30L), but not its cognate receptor CD30, is frequently expressed on acute myeloid leukaemia (AML) blasts.",11918534_0,0,1,2,-1,998,-1,0.00030583673,0.0008630853,0.998831
1005,those cytokines,24,26,165,180,"In the present study, we found that leukaemic blasts presenting surface CD30L displayed a characteristic cytokine-receptor pattern that makes them ideal targets for those cytokines usually produced by Th2-type cell subsets.",11918534_1,-1,-1,-1,-1,1005,-1,0.41314742,0.5796465,0.007206048
1006,Th2-type cell subsets,29,32,201,222,"In the present study, we found that leukaemic blasts presenting surface CD30L displayed a characteristic cytokine-receptor pattern that makes them ideal targets for those cytokines usually produced by Th2-type cell subsets.",11918534_1,-1,-1,-1,-1,1006,-1,0.0038333682,0.4599888,0.5361778
1008,Th2 cytokine receptors,9,12,51,73,"In particular, even though a broad distribution of Th2 cytokine receptors by AML blasts was shown, we demonstrated the almost exclusive expression of interleukin 4 (IL-4) receptor (R), in the absence of its cognate cytokine, by CD30L+ AML.",11918534_2,-1,-1,-1,-1,1008,-1,0.0016248979,0.9772978,0.02107738
1011,receptor,30,31,171,179,"In particular, even though a broad distribution of Th2 cytokine receptors by AML blasts was shown, we demonstrated the almost exclusive expression of interleukin 4 (IL-4) receptor (R), in the absence of its cognate cytokine, by CD30L+ AML.",11918534_2,0,1,2,-1,1011,-1,0.0007373115,0.09144319,0.9078195
1018,the Th1-associated,36,38,191,209,"Furthermore, a number of Th2-associated markers, including CD30, IL-4 and GATA-3, were expressed by residual T cells derived from CD30L+ AML but not from CD30L- AML, in which the presence of the Th1-associated marker LAG-3 was documented in some cases.",11918534_3,-1,-1,-1,-1,1018,-1,2.7645521e-05,0.9999478,2.4614032e-05
1027,T-cell,10,11,67,73,"These results, along with the shift toward IL-4-producing specific T-cell clones observed in CD30L+ AML samples by enzyme-linked Immunospot (ELISpot) assay, were consistent with the hypothesis of a Th2 polarization taking place in T cells from CD30L+ AML.",11918534_5,-1,1,2,-1,1027,-1,3.4830155e-05,4.9156442e-05,0.9999161
1030,taking place,34,36,215,227,"These results, along with the shift toward IL-4-producing specific T-cell clones observed in CD30L+ AML samples by enzyme-linked Immunospot (ELISpot) assay, were consistent with the hypothesis of a Th2 polarization taking place in T cells from CD30L+ AML.",11918534_5,-1,-1,-1,-1,1030,-1,3.014397e-05,0.9999554,1.448702e-05
1035,that the,17,19,116,124,The notion that IL-4 was able to enhance in vitro proliferation of CD30L+/IL-4R+ purified leukaemic blasts suggests that the selective interaction of IL-4-producing CD30+ T cells with CD30L+ leukaemic progenitors may have a role in the progression of this particular AML subset.,11918534_6,-1,-1,-1,-1,1035,-1,1.9268773e-05,0.9999727,8.084255e-06
1040,receptors,5,6,34,43,"Activation of apoptosis via death receptors is a tightly regulated event, and the death pathway itself is open to interference on the part of soluble or membrane-bound decoy receptors.",11924906_0,0,1,2,-1,1040,-1,0.00044543398,0.0015632425,0.9979913
1045,receptors,29,30,174,183,"Activation of apoptosis via death receptors is a tightly regulated event, and the death pathway itself is open to interference on the part of soluble or membrane-bound decoy receptors.",11924906_0,0,1,2,-1,1045,-1,0.00024479415,0.0005072789,0.99924785
1049,factor,10,11,64,70,"The aggregation state of the death-inducing ligand is a crucial factor, particularly when these molecules are used as recombinant drugs against tumors.",11924906_1,0,1,-1,-1,1049,-1,0.0006098356,0.99921894,0.00017125893
1055,receptors,16,17,94,103,Whether tumors are sensitive to such ligands is determined by both the net abundance of death receptors versus decoy receptors and the balance between intracellular apoptotic and antiapoptotic mechanisms.,11924906_2,0,1,2,-1,1055,-1,0.00029127882,0.0005467184,0.9991621
1056,receptors,19,20,117,126,Whether tumors are sensitive to such ligands is determined by both the net abundance of death receptors versus decoy receptors and the balance between intracellular apoptotic and antiapoptotic mechanisms.,11924906_2,0,1,2,-1,1056,-1,0.0002215548,0.00046856122,0.9993099
1060,tumor cells,7,9,39,50,"This means that in vivo elimination of tumor cells by effector arms such as T lymphocytes, natural killer cells, macrophages, and dendritic cells is dependent on both the function of activated lymphoid cells and the genetic properties of tumor cells.",11924906_3,-1,-1,-1,-1,1060,-1,0.0045343894,0.349689,0.64577657
1065,the function,30,32,167,179,"This means that in vivo elimination of tumor cells by effector arms such as T lymphocytes, natural killer cells, macrophages, and dendritic cells is dependent on both the function of activated lymphoid cells and the genetic properties of tumor cells.",11924906_3,-1,-1,-1,-1,1065,-1,5.5506138e-05,0.9999113,3.3138986e-05
1067,the genetic,37,39,212,223,"This means that in vivo elimination of tumor cells by effector arms such as T lymphocytes, natural killer cells, macrophages, and dendritic cells is dependent on both the function of activated lymphoid cells and the genetic properties of tumor cells.",11924906_3,-1,-1,-1,-1,1067,-1,4.0736504e-05,0.99993145,2.7788072e-05
1068,tumor cells,41,43,238,249,"This means that in vivo elimination of tumor cells by effector arms such as T lymphocytes, natural killer cells, macrophages, and dendritic cells is dependent on both the function of activated lymphoid cells and the genetic properties of tumor cells.",11924906_3,-1,-1,-1,-1,1068,-1,0.004397597,0.3323843,0.6632181
1076,tumor cells,23,25,131,142,"When expressed on cytotoxic T lymphocytes, natural killer cells, monocytes, and dendritic cells, they induce the apoptosis of many tumor cells, whereas their expression on tumor cells induces the apoptosis of killer cells.",11924906_5,-1,-1,-1,-1,1076,-1,0.0038085282,0.25207993,0.74411154
1078,tumor cells,30,32,172,183,"When expressed on cytotoxic T lymphocytes, natural killer cells, monocytes, and dendritic cells, they induce the apoptosis of many tumor cells, whereas their expression on tumor cells induces the apoptosis of killer cells.",11924906_5,-1,-1,-1,-1,1078,-1,0.004285766,0.3402875,0.6554268
1084,their state,13,15,70,81,"The in vivo result is influenced by the number of infiltrating cells, their state of activation, the cytokine repertoire in the tumor microenvironment, and the ability of the tumor to produce soluble factors inhibiting their cytolytic functions.",11924906_6,-1,-1,-1,-1,1084,-1,3.3517743e-05,0.99994147,2.4993982e-05
1085,the cytokine,18,20,97,109,"The in vivo result is influenced by the number of infiltrating cells, their state of activation, the cytokine repertoire in the tumor microenvironment, and the ability of the tumor to produce soluble factors inhibiting their cytolytic functions.",11924906_6,-1,-1,-1,-1,1085,-1,0.2705548,0.724448,0.0049971463
1086,the tumor,22,24,124,133,"The in vivo result is influenced by the number of infiltrating cells, their state of activation, the cytokine repertoire in the tumor microenvironment, and the ability of the tumor to produce soluble factors inhibiting their cytolytic functions.",11924906_6,-1,-1,-1,-1,1086,-1,2.0399559e-05,0.9999695,1.0128161e-05
1088,the tumor to,30,33,171,183,"The in vivo result is influenced by the number of infiltrating cells, their state of activation, the cytokine repertoire in the tumor microenvironment, and the ability of the tumor to produce soluble factors inhibiting their cytolytic functions.",11924906_6,-1,-1,-1,-1,1088,-1,1.9947263e-05,0.9999691,1.0962666e-05
1089,factors,35,36,200,207,"The in vivo result is influenced by the number of infiltrating cells, their state of activation, the cytokine repertoire in the tumor microenvironment, and the ability of the tumor to produce soluble factors inhibiting their cytolytic functions.",11924906_6,0,1,-1,-1,1089,-1,0.99929297,0.000320845,0.00038616976
1091,functions,39,40,235,244,"The in vivo result is influenced by the number of infiltrating cells, their state of activation, the cytokine repertoire in the tumor microenvironment, and the ability of the tumor to produce soluble factors inhibiting their cytolytic functions.",11924906_6,0,1,2,-1,1091,-1,0.0059634442,0.95308024,0.04095634
1093,TGF-beta,5,6,33,41,"Transforming growth factor beta (TGF-beta), a pleiotropic cytokine that regulates cell growth and differentiation, is secreted by many human tumors and markedly inhibits tumor-specific cellular immunity.",11964281_0,0,1,-1,-1,1093,-1,6.040345e-05,0.99991786,2.1692405e-05
1094,pleiotropic cytokine that,9,12,46,71,"Transforming growth factor beta (TGF-beta), a pleiotropic cytokine that regulates cell growth and differentiation, is secreted by many human tumors and markedly inhibits tumor-specific cellular immunity.",11964281_0,-1,-1,-1,-1,1094,-1,0.00017031784,0.99975675,7.2886745e-05
1097,tumor-specific cellular immunity,27,30,170,202,"Transforming growth factor beta (TGF-beta), a pleiotropic cytokine that regulates cell growth and differentiation, is secreted by many human tumors and markedly inhibits tumor-specific cellular immunity.",11964281_0,-1,-1,-1,-1,1097,-1,0.04061641,0.9478997,0.011483865
1100,TGF-beta,9,10,62,70,Tumors can avoid the differentiating and apoptotic effects of TGF-beta by expressing a nonfunctional TGF-beta receptor.,11964281_1,0,1,-1,-1,1100,-1,4.5229004e-05,0.99993396,2.078098e-05
1101,TGF-beta receptor,14,16,101,118,Tumors can avoid the differentiating and apoptotic effects of TGF-beta by expressing a nonfunctional TGF-beta receptor.,11964281_1,-1,-1,-1,-1,1101,-1,0.0003185643,0.99628675,0.0033947253
1104,tumor-specific cytotoxic T lymphocytes,13,17,85,123,We have determined whether this immune evasion strategy can be manipulated to shield tumor-specific cytotoxic T lymphocytes (CTLs) from the inhibitory effects of tumor-derived TGF-beta.,11964281_2,-1,-1,-1,-1,1104,-1,0.004978301,0.57661474,0.41840696
1107,tumor-derived TGF-beta,25,27,162,184,We have determined whether this immune evasion strategy can be manipulated to shield tumor-specific cytotoxic T lymphocytes (CTLs) from the inhibitory effects of tumor-derived TGF-beta.,11964281_2,-1,-1,-1,-1,1107,-1,4.8845e-05,0.9999355,1.567359e-05
1108,CTLs that,8,10,55,64,As our model we used Epstein-Barr virus (EBV)-specific CTLs that are infused as treatment for EBV-positive Hodgkin disease but that are vulnerable to the TGF-beta produced by this tumor.,11964281_3,-1,-1,-1,-1,1108,-1,0.0015738417,0.028331798,0.9700944
1111,to the TGF-beta,22,25,147,162,As our model we used Epstein-Barr virus (EBV)-specific CTLs that are infused as treatment for EBV-positive Hodgkin disease but that are vulnerable to the TGF-beta produced by this tumor.,11964281_3,-1,-1,-1,-1,1111,-1,7.31711e-05,0.99990535,2.149018e-05
1112,this tumor,27,29,175,185,As our model we used Epstein-Barr virus (EBV)-specific CTLs that are infused as treatment for EBV-positive Hodgkin disease but that are vulnerable to the TGF-beta produced by this tumor.,11964281_3,-1,-1,-1,-1,1112,-1,2.3606412e-05,0.99996316,1.3235127e-05
1116,TGF-beta type,10,12,79,92,CTLs were transduced with a retrovirus vector expressing the dominant-negative TGF-beta type II receptor HATGF-betaRII-Deltacyt.,11964281_4,-1,-1,-1,-1,1116,-1,2.9048142e-05,0.9999523,1.8602992e-05
1117,receptor,13,14,96,104,CTLs were transduced with a retrovirus vector expressing the dominant-negative TGF-beta type II receptor HATGF-betaRII-Deltacyt.,11964281_4,0,1,2,-1,1117,-1,0.00017153838,0.000406721,0.9994217
1118,protein,5,6,51,58,HATGF-betaRII-Deltacyt- but not green fluorescence protein (eGFP)-transduced CTLs was resistant to the antiproliferative and anticytotoxic effects of exogenous TGF-beta.,11964281_5,0,1,-1,-1,1118,-1,0.0002809904,0.99933904,0.00037997047
1120,to the,10,12,96,102,HATGF-betaRII-Deltacyt- but not green fluorescence protein (eGFP)-transduced CTLs was resistant to the antiproliferative and anticytotoxic effects of exogenous TGF-beta.,11964281_5,-1,-1,-1,-1,1120,-1,2.4105619e-05,0.99996626,9.589083e-06
1121,TGF-beta,18,19,160,168,HATGF-betaRII-Deltacyt- but not green fluorescence protein (eGFP)-transduced CTLs was resistant to the antiproliferative and anticytotoxic effects of exogenous TGF-beta.,11964281_5,0,1,-1,-1,1121,-1,6.431524e-05,0.9999174,1.8258503e-05
1122,receptor-transduced cells,2,4,14,39,"Additionally, receptor-transduced cells continued to secrete cytokines in response to antigenic stimulation.",11964281_6,-1,-1,-1,-1,1122,-1,8.1455146e-05,0.00025918483,0.9996593
1125,to antigenic,10,12,83,95,"Additionally, receptor-transduced cells continued to secrete cytokines in response to antigenic stimulation.",11964281_6,-1,-1,-1,-1,1125,-1,0.11630698,0.88143915,0.0022538246
1126,TGF-beta receptor,0,2,0,17,"TGF-beta receptor ligation results in phosphorylation of Smad2, and this pathway was disrupted in HATGF-betaRII-Deltacyt-transduced CTLs, confirming blockade of the signal transduction pathway.",11964281_7,-1,-1,-1,-1,1126,-1,0.00094102044,0.98648864,0.012570384
1132,TGF-betaRII-Deltacyt,3,4,24,44,"Long-term expression of TGF-betaRII-Deltacyt did not affect CTL function, phenotype, or growth characteristics.",11964281_8,0,1,-1,-1,1132,-1,0.0012595018,0.9816914,0.01704909
1133,CTL function,7,9,60,72,"Long-term expression of TGF-betaRII-Deltacyt did not affect CTL function, phenotype, or growth characteristics.",11964281_8,-1,-1,-1,-1,1133,-1,0.00023275806,0.0006995269,0.9990677
1134,Tumor-specific CTLs,0,2,0,19,Tumor-specific CTLs expressing HATGF-betaRII-Deltacyt should have a selective functional and survival advantage over unmodified CTLs in the presence of TGF-beta-secreting tumors and may be of value in treatment of these diseases.,11964281_9,-1,-1,-1,-1,1134,-1,0.004272112,0.73114,0.26458785
1135,functional,8,9,78,88,Tumor-specific CTLs expressing HATGF-betaRII-Deltacyt should have a selective functional and survival advantage over unmodified CTLs in the presence of TGF-beta-secreting tumors and may be of value in treatment of these diseases.,11964281_9,0,1,2,-1,1135,-1,8.978651e-05,0.99987626,3.3937027e-05
1138,TGF-beta-secreting tumors,19,21,152,177,Tumor-specific CTLs expressing HATGF-betaRII-Deltacyt should have a selective functional and survival advantage over unmodified CTLs in the presence of TGF-beta-secreting tumors and may be of value in treatment of these diseases.,11964281_9,-1,-1,-1,-1,1138,-1,3.5363282e-05,0.999946,1.861544e-05
1143,nuclear factor of activated T cells,9,15,90,125,The calcium-dependent phosphatase calcineurin and its downstream transcriptional effector nuclear factor of activated T cells (NFAT) are important regulators of inducible gene expression in multiple cell types.,12091710_0,-1,1,2,-1,1143,-1,0.0034627174,0.7058139,0.29072335
1145,cell types,27,29,199,209,The calcium-dependent phosphatase calcineurin and its downstream transcriptional effector nuclear factor of activated T cells (NFAT) are important regulators of inducible gene expression in multiple cell types.,12091710_0,-1,-1,-1,-1,1145,-1,3.9740604e-05,6.933655e-05,0.9998909
1148,the immune response,15,18,105,124,"In T cells, calcineurin-NFAT signaling represents a critical event for mediating cellular activation and the immune response.",12091710_1,-1,-1,-1,-1,1148,-1,0.46025178,0.53781545,0.0019327861
1150,thought to,9,11,67,77,The widely used immunosuppressant agents cyclosporin and FK506 are thought to antagonize the immune response by directly inhibiting calcineurin-NFAT signal transduction in lymphocytes.,12091710_2,-1,-1,-1,-1,1150,-1,3.1244595e-05,0.99995494,1.3856774e-05
1151,the immune response,12,15,89,108,The widely used immunosuppressant agents cyclosporin and FK506 are thought to antagonize the immune response by directly inhibiting calcineurin-NFAT signal transduction in lymphocytes.,12091710_2,-1,-1,-1,-1,1151,-1,0.15378417,0.8451496,0.0010662433
1156,the immune response,12,15,84,103,"To unequivocally establish the importance of calcineurin signaling as a mediator of the immune response, we deleted the gene encoding the predominant calcineurin isoform expressed in lymphocytes, calcineurin A beta (CnA beta).",12091710_3,-1,-1,-1,-1,1156,-1,0.06675023,0.9326454,0.00060438266
1157,the gene,18,20,116,124,"To unequivocally establish the importance of calcineurin signaling as a mediator of the immune response, we deleted the gene encoding the predominant calcineurin isoform expressed in lymphocytes, calcineurin A beta (CnA beta).",12091710_3,-1,-1,-1,-1,1157,-1,2.1021946e-05,0.9999691,9.867383e-06
1169,tumor-cell transplantation,9,11,54,80,"CnA beta(-/-) mice also were permissive to allogeneic tumor-cell transplantation in vivo, similar to cyclosporin-treated wild-type mice.",12091710_6,-1,-1,-1,-1,1169,-1,7.443014e-05,0.9998474,7.817325e-05
1182,the retinoic acid receptor,4,8,26,52,Rexinoids binding to both the retinoic acid receptor (RAR) and retinoid X receptor (RXR) families of rexinoid receptors have demonstrated clinical activity in hematologic malignancies and have been shown to mediate genes associated with both growth and differentiation.,12149223_0,-1,-1,-1,-1,1182,-1,0.00027537343,0.9979522,0.0017723251
1183,receptor,14,15,74,82,Rexinoids binding to both the retinoic acid receptor (RAR) and retinoid X receptor (RXR) families of rexinoid receptors have demonstrated clinical activity in hematologic malignancies and have been shown to mediate genes associated with both growth and differentiation.,12149223_0,0,1,2,-1,1183,-1,0.0016181169,0.24264148,0.7557404
1184,receptors,21,22,110,119,Rexinoids binding to both the retinoic acid receptor (RAR) and retinoid X receptor (RXR) families of rexinoid receptors have demonstrated clinical activity in hematologic malignancies and have been shown to mediate genes associated with both growth and differentiation.,12149223_0,0,1,2,-1,1184,-1,0.0011129476,0.29053265,0.70835435
1187,the treatment,6,8,44,57,"RXR rexinoids have demonstrated efficacy in the treatment of cutaneous T-cell lymphomas, but the mechanism of action is unclear.",12149223_1,-1,-1,-1,-1,1187,-1,2.4198012e-05,0.99996567,1.0140107e-05
1188,T-cell,10,11,71,77,"RXR rexinoids have demonstrated efficacy in the treatment of cutaneous T-cell lymphomas, but the mechanism of action is unclear.",12149223_1,-1,1,2,-1,1188,-1,5.0276143e-05,9.8684046e-05,0.999851
1189,the mechanism of action,14,18,93,116,"RXR rexinoids have demonstrated efficacy in the treatment of cutaneous T-cell lymphomas, but the mechanism of action is unclear.",12149223_1,-1,-1,-1,-1,1189,-1,3.6757323e-05,0.9999504,1.2859315e-05
1194,interleukin-2 receptor,27,29,183,205,We explored the immunomodulatory effects of RAR and RXR rexinoids in human T- and B-cell leukemia cells and demonstrated that RXR rexinoids are capable of up-regulating high-affinity interleukin-2 receptor (IL-2R) expression.,12149223_2,-1,-1,-1,-1,1194,-1,0.9436258,0.00590807,0.050466157
1197,the p55,21,23,117,124,Exposure to 10(-6) to 10(-10) M bexarotene or Panretin for 48 hours was associated with increased expression of both the p55 and p75 subunits of the IL-2R in T-cell leukemias and p75 in B-cell leukemias.,12149223_3,-1,-1,-1,-1,1197,-1,3.6130277e-05,0.9999312,3.260135e-05
1198,p75 subunits,24,26,129,141,Exposure to 10(-6) to 10(-10) M bexarotene or Panretin for 48 hours was associated with increased expression of both the p55 and p75 subunits of the IL-2R in T-cell leukemias and p75 in B-cell leukemias.,12149223_3,-1,-1,-1,-1,1198,-1,4.7803132e-05,0.99987817,7.400316e-05
1200,T-cell,30,31,158,164,Exposure to 10(-6) to 10(-10) M bexarotene or Panretin for 48 hours was associated with increased expression of both the p55 and p75 subunits of the IL-2R in T-cell leukemias and p75 in B-cell leukemias.,12149223_3,-1,1,2,-1,1200,-1,3.665284e-05,6.335997e-05,0.9999
1202,the cells to,7,10,58,70,"Furthermore, rexinoid exposure enhanced susceptibility of the cells to denileukin diftitox fusion toxin-targeting and -intoxicating cells expressing high-affinity IL-2R.",12149223_4,-1,-1,-1,-1,1202,-1,0.00011092657,0.99961925,0.0002697487
1207,the STAT6 gene,3,6,19,33,Mice deficient for the STAT6 gene (STAT6(-/-) mice) have enhanced immunosurveillance against primary and metastatic tumors.,12421960_0,-1,-1,-1,-1,1207,-1,2.4881945e-05,0.9999598,1.5324062e-05
1212,to the type,13,16,69,80,"Because STAT6 is a downstream effector of the IL-4R, and IL-13 binds to the type 2 IL-4R, IL-13 has been proposed as an inhibitor that blocks differentiation of tumor-specific CD8(+) T cells.",12421960_1,-1,-1,-1,-1,1212,-1,3.6896283e-05,0.9999443,1.8786783e-05
1217,Immunity,0,1,0,8,"Immunity in STAT6(-/-) mice is unusually effective in that 45-80% of STAT6(-/-) mice with established, spontaneous metastatic 4T1 mammary carcinoma, whose primary tumors are surgically excised, survive indefinitely, as compared with <10% of STAT(+/+) (BALB/c) mice.",12421960_2,0,-1,2,-1,1217,-1,0.6451403,0.351853,0.00300678
1220,that immunity,17,19,124,137,"Surprisingly, STAT6(-/-) and BALB/c reciprocal bone marrow chimeras do not have increased immunosurveillance, demonstrating that immunity requires STAT6(-/-) hemopoietic and nonhemopoietic components.",12421960_3,-1,-1,-1,-1,1220,-1,0.013137559,0.9865328,0.00032956005
1222,therefore IL-13,10,12,51,66,"Likewise, CD1(-/-) mice that are NKT deficient and therefore IL-13 deficient also have heightened tumor immunity.",12421960_4,-1,-1,-1,-1,1222,-1,0.83504564,0.15667924,0.008275049
1223,tumor immunity,16,18,98,112,"Likewise, CD1(-/-) mice that are NKT deficient and therefore IL-13 deficient also have heightened tumor immunity.",12421960_4,-1,-1,-1,-1,1223,-1,0.042277053,0.95664406,0.0010789026
1224,that immunity,18,20,108,121,"However, STAT6(-/-) and CD1(-/-) reciprocal bone marrow chimeras do not have increased survival, suggesting that immunity in STAT6(-/-) and CD1(-/-) mice is via noncomplementing mechanisms.",12421960_5,-1,-1,-1,-1,1224,-1,0.008753108,0.99087954,0.00036729648
1227,that IL-13,15,17,93,103,"Metastatic disease is not reduced in BALB/c mice treated with an IL-13 inhibitor, indicating that IL-13 alone is insufficient for negative regulation of 4T1 immunity.",12421960_6,-1,-1,-1,-1,1227,-1,0.75756127,0.23480657,0.0076321755
1229,immunity,25,26,157,165,"Metastatic disease is not reduced in BALB/c mice treated with an IL-13 inhibitor, indicating that IL-13 alone is insufficient for negative regulation of 4T1 immunity.",12421960_6,0,-1,2,-1,1229,-1,0.9977258,0.0015759689,0.00069831894
1233,immunity,26,27,151,159,"Likewise, in vivo depletion of CD4(+)CD25(+) T cells in BALB/c mice does not increase survival, demonstrating that CD4(+)CD25(+) cells do not regulate immunity.",12421960_7,0,-1,2,-1,1233,-1,0.86122406,0.1373932,0.0013827698
1236,that IFN-gamma,10,12,85,99,Cytokine production and tumor challenges into STAT6(-/-)IFN-gamma(-/-) mice indicate that IFN-gamma is essential for immunity.,12421960_8,-1,-1,-1,-1,1236,-1,0.90905875,0.08606704,0.0048741912
1237,immunity,15,16,117,125,Cytokine production and tumor challenges into STAT6(-/-)IFN-gamma(-/-) mice indicate that IFN-gamma is essential for immunity.,12421960_8,0,-1,2,-1,1237,-1,0.9735286,0.0254256,0.0010457408
1245,tumor-derived factors,14,16,84,105,"Using a mammary tumor model syngeneic to BALB/c mice, we have characterized several tumor-derived factors.",12527946_0,-1,-1,-1,-1,1245,-1,0.0025871403,0.99690706,0.0005057912
1246,that the,3,5,14,22,"We now report that the DA-3 cell line derived from this tumor, as well as the in vivo tumor itself, express IL-11.",12527946_1,-1,-1,-1,-1,1246,-1,1.7926977e-05,0.99997246,9.639719e-06
1248,this tumor,10,12,51,61,"We now report that the DA-3 cell line derived from this tumor, as well as the in vivo tumor itself, express IL-11.",12527946_1,-1,-1,-1,-1,1248,-1,2.2518114e-05,0.9999651,1.2403408e-05
1254,the tumor,5,7,27,36,"The expression of IL-11 in the tumor is detectable at the transcriptional and translational levels, as evidenced by RT-PCR and Western blots.",12527946_2,-1,-1,-1,-1,1254,-1,1.7945335e-05,0.99997175,1.0299647e-05
1255,the transcriptional,10,12,54,73,"The expression of IL-11 in the tumor is detectable at the transcriptional and translational levels, as evidenced by RT-PCR and Western blots.",12527946_2,-1,-1,-1,-1,1255,-1,2.0961977e-05,0.9999677,1.1396721e-05
1266,the tumor,28,30,162,171,"Interestingly, elevated levels of IL-11 were found in the sera of tumor-bearers, when compared to normal animals and even higher levels of IL-11 were detected in the tumor cystic fluid.",12527946_4,-1,-1,-1,-1,1266,-1,1.9551599e-05,0.99996996,1.0509644e-05
1278,the transcription factor,7,10,57,81,"Electromobility shift assays showed decreased binding of the transcription factor C/EBP to the IL-12p40 promoter of LPS-activated macrophages from normal animals, upon pretreatment with IL-11.",12527946_8,-1,-1,-1,-1,1278,-1,1.9979145e-05,0.99996686,1.3161769e-05
1279,to the,11,13,88,94,"Electromobility shift assays showed decreased binding of the transcription factor C/EBP to the IL-12p40 promoter of LPS-activated macrophages from normal animals, upon pretreatment with IL-11.",12527946_8,-1,-1,-1,-1,1279,-1,1.7583832e-05,0.9999728,9.54537e-06
1284,that tumor-derived IL-11,3,6,20,44,"Our results suggest that tumor-derived IL-11 may play a role in the depressed IL-12 production by macrophages, leading to the impaired immune functions observed during mammary tumorigenesis.",12527946_10,-1,-1,-1,-1,1284,-1,0.106853426,0.8880986,0.0050479686
1288,to the,19,21,119,125,"Our results suggest that tumor-derived IL-11 may play a role in the depressed IL-12 production by macrophages, leading to the impaired immune functions observed during mammary tumorigenesis.",12527946_10,-1,-1,-1,-1,1288,-1,2.0424997e-05,0.9999703,9.284635e-06
1289,functions,23,24,142,151,"Our results suggest that tumor-derived IL-11 may play a role in the depressed IL-12 production by macrophages, leading to the impaired immune functions observed during mammary tumorigenesis.",12527946_10,0,1,2,-1,1289,-1,0.0060054315,0.98930955,0.0046849614
1299,the target cells,5,8,24,40,"The effects of IL-16 on the target cells are dependent on the cell type, the presence of co-activators etc.",12528894_2,-1,-1,-1,-1,1299,-1,0.0036495016,0.7777477,0.21860278
1300,the cell type,11,14,58,71,"The effects of IL-16 on the target cells are dependent on the cell type, the presence of co-activators etc.",12528894_2,-1,-1,-1,-1,1300,-1,0.001274111,0.9437788,0.054947037
1303,the regulation function,2,5,14,37,"To understand the regulation function and mechanism of IL-16 on target cells, we used a 130 a.a. recombinant IL-16 to study its effects on the growth of Jurkat T leukemia cells in vitro.",12528894_3,-1,-1,-1,-1,1303,-1,2.5113688e-05,0.9999635,1.1407634e-05
1305,target cells,10,12,64,76,"To understand the regulation function and mechanism of IL-16 on target cells, we used a 130 a.a. recombinant IL-16 to study its effects on the growth of Jurkat T leukemia cells in vitro.",12528894_3,-1,-1,-1,-1,1305,-1,0.004101704,0.47661218,0.51928616
1306,IL-16 to,20,22,109,117,"To understand the regulation function and mechanism of IL-16 on target cells, we used a 130 a.a. recombinant IL-16 to study its effects on the growth of Jurkat T leukemia cells in vitro.",12528894_3,-1,-1,-1,-1,1306,-1,0.98372585,0.006489591,0.009784632
1310,that the,2,4,9,17,"We found that the rIL-16 stimulated the proliferation of Jurkat cells at low dose (10(-9)M), but inhibited the growth of the cells at higher concentration (10(-5)M).",12528894_4,-1,-1,-1,-1,1310,-1,1.9567047e-05,0.99996924,1.1147873e-05
1314,the cells,23,25,121,130,"We found that the rIL-16 stimulated the proliferation of Jurkat cells at low dose (10(-9)M), but inhibited the growth of the cells at higher concentration (10(-5)M).",12528894_4,-1,-1,-1,-1,1314,-1,0.0028193707,0.23400493,0.76317567
1318,The treatment,0,2,0,13,"The treatment blocked the expression of FasL, but up-regulated the c-myc and Bid expression in the cells.",12528894_6,-1,-1,-1,-1,1318,-1,2.2989983e-05,0.999967,9.995192e-06
1321,the cells,16,18,95,104,"The treatment blocked the expression of FasL, but up-regulated the c-myc and Bid expression in the cells.",12528894_6,-1,-1,-1,-1,1321,-1,0.002672037,0.32253736,0.6747906
1325,that the,3,5,22,30,The results suggested that the rIL-16 might be a regulator for the growth or apoptosis of Jurkat cells at a dose-dependent manner.,12528894_8,-1,-1,-1,-1,1325,-1,1.96461e-05,0.9999709,9.447776e-06
1333,the generation,7,9,56,70,Currently most attempts at cancer immunotherapy involve the generation of CD8(+) cytotoxic T lymphocytes (CTLs) against tumor-associated antigens.,12566422_0,-1,-1,-1,-1,1333,-1,1.7495673e-05,0.99996865,1.3904196e-05
1336,tumor-associated antigens,19,21,120,145,Currently most attempts at cancer immunotherapy involve the generation of CD8(+) cytotoxic T lymphocytes (CTLs) against tumor-associated antigens.,12566422_0,-1,-1,-1,-1,1336,-1,0.04713357,0.9487577,0.004108742
1343,T cells that,6,9,32,44,"Here we demonstrate that CD4(+) T cells that recognize a secreted tumor-specific antigen and exhibit a cytokine secretion profile characteristic of Th2 cells, are capable of clearing established lung and visceral metastases of a CTL-resistant melanoma.",12566422_2,-1,-1,-1,-1,1343,-1,0.0013769881,0.03194258,0.9666804
1344,tumor-specific antigen,12,14,66,88,"Here we demonstrate that CD4(+) T cells that recognize a secreted tumor-specific antigen and exhibit a cytokine secretion profile characteristic of Th2 cells, are capable of clearing established lung and visceral metastases of a CTL-resistant melanoma.",12566422_2,-1,-1,-1,-1,1344,-1,0.07992124,0.91498476,0.005093964
1348,the Th2 cells,5,8,32,45,"Clearance of lung metastases by the Th2 cells was found to be totally dependent on the eosinophil chemokine, eotaxin, and partially dependent on the transcription activator signal transducer and activator of transcription 6 (STAT6), with degranulating eosinophils within the tumors inducing tumor regression.",12566422_3,-1,-1,-1,-1,1348,-1,0.0022822246,0.15796162,0.83975613
1354,the transcription activator signal transducer and activator of transcription 6,25,35,145,223,"Clearance of lung metastases by the Th2 cells was found to be totally dependent on the eosinophil chemokine, eotaxin, and partially dependent on the transcription activator signal transducer and activator of transcription 6 (STAT6), with degranulating eosinophils within the tumors inducing tumor regression.",12566422_3,-1,-1,-1,-1,1354,-1,2.9297145e-05,0.9999516,1.910586e-05
1356,the tumors,43,45,271,281,"Clearance of lung metastases by the Th2 cells was found to be totally dependent on the eosinophil chemokine, eotaxin, and partially dependent on the transcription activator signal transducer and activator of transcription 6 (STAT6), with degranulating eosinophils within the tumors inducing tumor regression.",12566422_3,-1,-1,-1,-1,1356,-1,1.8889114e-05,0.99997103,1.0040028e-05
1361,the tumors,13,15,78,88,"In contrast, tumor-specific CD4(+) Th1 cells, that recruited macrophages into the tumors, had no effect on tumor growth.",12566422_4,-1,-1,-1,-1,1361,-1,2.0889298e-05,0.99996865,1.0464913e-05
1370,Analysis,0,1,0,8,Analysis of truncated S35 constructs and overlapping peptides revealed that the peptide epitope was LGAEAIFRL.,12707369_1,0,1,-1,-1,1370,-1,2.8196477e-05,0.99995327,1.8479817e-05
1372,peptides,7,8,53,61,Analysis of truncated S35 constructs and overlapping peptides revealed that the peptide epitope was LGAEAIFRL.,12707369_1,0,-1,2,-1,1372,-1,9.697823e-05,0.9997739,0.0001290555
1373,that the peptide,9,12,71,87,Analysis of truncated S35 constructs and overlapping peptides revealed that the peptide epitope was LGAEAIFRL.,12707369_1,-1,-1,-1,-1,1373,-1,0.00010066739,0.9998293,7.0043454e-05
1375,peptide-pulsed,3,4,15,29,"AT-1 CTL lysed peptide-pulsed CMS8 cells at a nanomolar concentration, and the peptide strongly stimulated IFN-gamma production in AT-1 CTL.",12707369_2,0,-1,2,-1,1375,-1,8.698269e-05,0.99988043,3.261658e-05
1378,the peptide,12,14,75,86,"AT-1 CTL lysed peptide-pulsed CMS8 cells at a nanomolar concentration, and the peptide strongly stimulated IFN-gamma production in AT-1 CTL.",12707369_2,-1,-1,-1,-1,1378,-1,3.1858533e-05,0.99995303,1.5127902e-05
1381,that the,3,5,28,36,Sequence homology indicated that the S35 was derived from a mouse homologue of human retinoic acid-regulated nuclear matrix-associated protein (ramp).,12707369_3,-1,-1,-1,-1,1381,-1,1.7040233e-05,0.99997365,9.264773e-06
1382,protein,18,19,135,142,Sequence homology indicated that the S35 was derived from a mouse homologue of human retinoic acid-regulated nuclear matrix-associated protein (ramp).,12707369_3,0,1,-1,-1,1382,-1,5.261738e-05,0.9998499,9.742733e-05
1387,the transcript,7,9,34,48,"The majority of the ramp mRNA was the transcript normally spliced between exons 14 and 15, but a minor population of mRNA with an extended exon 14 was also present in Meth A cells.",12707369_5,-1,-1,-1,-1,1387,-1,2.6284357e-05,0.99995875,1.4958104e-05
1394,antigen-presenting cells,13,15,74,98,Our goal was to convert murine RM-9 prostate carcinoma cells in vivo into antigen-presenting cells capable of presenting endogenous tumor antigens and triggering a potent T-helper cell-mediated immune response essential for the generation of a specific antitumor response.,12804139_0,-1,-1,-1,-1,1394,-1,0.3185288,0.0031783292,0.6782929
1395,tumor antigens,19,21,132,146,Our goal was to convert murine RM-9 prostate carcinoma cells in vivo into antigen-presenting cells capable of presenting endogenous tumor antigens and triggering a potent T-helper cell-mediated immune response essential for the generation of a specific antitumor response.,12804139_0,-1,-1,-1,-1,1395,-1,0.32071197,0.6710383,0.00824973
1397,T-helper cell-mediated immune response,25,29,171,209,Our goal was to convert murine RM-9 prostate carcinoma cells in vivo into antigen-presenting cells capable of presenting endogenous tumor antigens and triggering a potent T-helper cell-mediated immune response essential for the generation of a specific antitumor response.,12804139_0,-1,-1,-1,-1,1397,-1,0.14167984,0.08167664,0.7766435
1398,the generation,31,33,224,238,Our goal was to convert murine RM-9 prostate carcinoma cells in vivo into antigen-presenting cells capable of presenting endogenous tumor antigens and triggering a potent T-helper cell-mediated immune response essential for the generation of a specific antitumor response.,12804139_0,-1,-1,-1,-1,1398,-1,1.9643498e-05,0.99996996,1.0454633e-05
1399,that generating the,2,5,10,29,"We showed that generating the major histocompatibility complex (MHC) class I+/class II+/Ii- phenotype, within an established subcutaneous RM-9 tumor nodule, led to an effective immune response limiting tumor growth.",12804139_1,-1,-1,-1,-1,1399,-1,1.848478e-05,0.99997187,9.653292e-06
1403,immune response limiting tumor,28,32,177,207,"We showed that generating the major histocompatibility complex (MHC) class I+/class II+/Ii- phenotype, within an established subcutaneous RM-9 tumor nodule, led to an effective immune response limiting tumor growth.",12804139_1,-1,-1,-1,-1,1403,-1,0.8930131,0.104061306,0.0029255832
1409,the gene,33,35,191,199,"This phenotype was created by intratumoral injection of plasmid cDNAs coding for interferon gamma, MHC class II transactivator, and an antisense reverse gene construct (RGC) for a segment of the gene for Ii protein (-92,97).",12804139_2,-1,-1,-1,-1,1409,-1,2.8371378e-05,0.9999554,1.6214068e-05
1410,protein,37,38,207,214,"This phenotype was created by intratumoral injection of plasmid cDNAs coding for interferon gamma, MHC class II transactivator, and an antisense reverse gene construct (RGC) for a segment of the gene for Ii protein (-92,97).",12804139_2,0,1,-1,-1,1410,-1,0.00022334901,0.99908066,0.00069596706
1415,the tumor,4,6,29,38,"Nevertheless, irradiation of the tumor nodule on the day preceding initiation of gene therapy yielded 7 of 16 mice that were disease-free in a long-term follow up of 57 days compared to 1 of 7 mice receiving radiotherapy alone.",12804139_4,-1,-1,-1,-1,1415,-1,1.934549e-05,0.9999685,1.20737e-05
1417,gene therapy,13,15,81,93,"Nevertheless, irradiation of the tumor nodule on the day preceding initiation of gene therapy yielded 7 of 16 mice that were disease-free in a long-term follow up of 57 days compared to 1 of 7 mice receiving radiotherapy alone.",12804139_4,-1,-1,-1,-1,1417,-1,2.8409568e-05,0.999954,1.7553444e-05
1420,gene therapy,4,6,32,44,Mice receiving radiotherapy and gene therapy rejected challenge with parental RM-9 cells and demonstrated specific cytotoxic T-cell activity in their splenocytes but not the mouse cured by radiation alone.,12804139_5,-1,-1,-1,-1,1420,-1,3.635206e-05,0.9999465,1.711506e-05
1422,T-cell,16,17,125,131,Mice receiving radiotherapy and gene therapy rejected challenge with parental RM-9 cells and demonstrated specific cytotoxic T-cell activity in their splenocytes but not the mouse cured by radiation alone.,12804139_5,-1,1,2,-1,1422,-1,3.9503426e-05,4.7565507e-05,0.999913
1426,that tumor,9,11,67,77,These data were reproduced in additional experiments and confirmed that tumor irradiation prior to gene therapy resulted in complete tumor regression and specific tumor immunity in more than 50% of the mice.,12804139_6,-1,-1,-1,-1,1426,-1,1.9432098e-05,0.9999713,9.327367e-06
1427,to gene therapy,13,16,96,111,These data were reproduced in additional experiments and confirmed that tumor irradiation prior to gene therapy resulted in complete tumor regression and specific tumor immunity in more than 50% of the mice.,12804139_6,-1,-1,-1,-1,1427,-1,2.461697e-05,0.99996316,1.2167111e-05
1429,tumor immunity,23,25,163,177,These data were reproduced in additional experiments and confirmed that tumor irradiation prior to gene therapy resulted in complete tumor regression and specific tumor immunity in more than 50% of the mice.,12804139_6,-1,-1,-1,-1,1429,-1,0.040279333,0.9585114,0.0012092234
1438,gene therapy,5,7,42,54,"Administering radiation before this novel gene therapy approach, that creates an in situ tumor vaccine, holds promise for the treatment of human prostate carcinoma.",12804139_8,-1,-1,-1,-1,1438,-1,3.9864743e-05,0.99993896,2.117241e-05
1441,the treatment,20,22,122,135,"Administering radiation before this novel gene therapy approach, that creates an in situ tumor vaccine, holds promise for the treatment of human prostate carcinoma.",12804139_8,-1,-1,-1,-1,1441,-1,2.5028941e-05,0.99996495,9.965979e-06
1442,T-helper cell immune response,5,9,26,55,A potent antitumor CD4(+) T-helper cell immune response is created by inducing tumor cells in vivo to a MHC class II(+)/Ii(- )phenotype.,12827305_0,-1,-1,-1,-1,1442,-1,0.419336,0.51336646,0.067297556
1443,tumor cells,13,15,79,90,A potent antitumor CD4(+) T-helper cell immune response is created by inducing tumor cells in vivo to a MHC class II(+)/Ii(- )phenotype.,12827305_0,-1,-1,-1,-1,1443,-1,0.004380488,0.3685249,0.62709457
1445,tumor cells,9,11,46,57,MHC class II and Ii molecules were induced in tumor cells in situ following tumor injection of a plasmid containing the gene for the MHC class II transactivator (CIITA).,12827305_1,-1,-1,-1,-1,1445,-1,0.003373906,0.4218012,0.5748248
1448,the gene,20,22,116,124,MHC class II and Ii molecules were induced in tumor cells in situ following tumor injection of a plasmid containing the gene for the MHC class II transactivator (CIITA).,12827305_1,-1,-1,-1,-1,1448,-1,2.3739232e-05,0.99996436,1.1920431e-05
1451,protein,1,2,3,10,Ii protein was suppressed by the antisense effect of an Ii-reverse gene construct (Ii-RGC) in the same or another co-injected plasmid.,12827305_2,0,1,-1,-1,1451,-1,9.0196416e-05,0.99975353,0.00015630088
1457,the tumor cells,7,10,39,54,The MHC class II(+)/Ii(- )phenotype of the tumor cells was confirmed by FACS analysis of cells transfected in vitro and by immunostaining of tumor nodules transfected by injections in vivo.,12827305_3,-1,-1,-1,-1,1457,-1,0.0028990505,0.79043794,0.20666297
1458,analysis,14,15,77,85,The MHC class II(+)/Ii(- )phenotype of the tumor cells was confirmed by FACS analysis of cells transfected in vitro and by immunostaining of tumor nodules transfected by injections in vivo.,12827305_3,0,1,-1,-1,1458,-1,3.803321e-05,0.9999149,4.707627e-05
1459,cells transfected,16,18,89,106,The MHC class II(+)/Ii(- )phenotype of the tumor cells was confirmed by FACS analysis of cells transfected in vitro and by immunostaining of tumor nodules transfected by injections in vivo.,12827305_3,-1,-1,-1,-1,1459,-1,0.001462239,0.042194977,0.9563428
1472,transcription factor Fos-related antigen 1,12,17,80,122,"Protection against breast cancer was achieved with a DNA vaccine against murine transcription factor Fos-related antigen 1, which is overexpressed in aggressively proliferating D2F2 murine breast carcinoma.",12857959_0,-1,-1,-1,-1,1472,-1,0.00046286275,0.99815506,0.0013821218
1476,Fos-related antigen,23,25,160,179,"tumor and dissemination of pulmonary metastases was markedly suppressed by this oral DNA vaccine, carried by attenuated Salmonella typhimurium, encoding murine Fos-related antigen 1, fused with mutant polyubiquitin, and cotransformed with secretory murine IL-18.",12857959_2,-1,-1,-1,-1,1476,-1,0.038507532,0.94537467,0.016117813
1478,The life,0,2,0,8,The life span of 60% of vaccinated mice was tripled in the absence of detectable tumor growth after lethal tumor cell challenge.,12857959_3,-1,-1,-1,-1,1478,-1,2.2970793e-05,0.9999664,1.0601938e-05
1482,tumor cell,20,22,107,117,The life span of 60% of vaccinated mice was tripled in the absence of detectable tumor growth after lethal tumor cell challenge.,12857959_3,-1,-1,-1,-1,1482,-1,0.0035789749,0.38978678,0.60663426
1487,target cell,3,5,28,39,"Markedly increased specific target cell lysis was mediated by both MHC class I-restricted CD8+ T cells and natural killer cells isolated from splenocytes of vaccinated mice, including a significant release of proinflammatory cytokines IFN-gamma and IL-2.",12857959_5,-1,-1,-1,-1,1487,-1,0.0014362064,0.05010414,0.9484597
1492,cytokines IFN-gamma,34,36,225,244,"Markedly increased specific target cell lysis was mediated by both MHC class I-restricted CD8+ T cells and natural killer cells isolated from splenocytes of vaccinated mice, including a significant release of proinflammatory cytokines IFN-gamma and IL-2.",12857959_5,-1,-1,-1,-1,1492,-1,0.9998789,3.8194823e-05,8.29498e-05
1493,analysis,3,4,26,34,"Importantly, fluorescence analysis of fibroblast growth factor 2 and tumor cell-induced vessel growth in Matrigel plugs demonstrated marked suppression of angiogenesis only in vaccinated animals.",12857959_6,0,1,-1,-1,1493,-1,4.255127e-05,0.99992514,3.225328e-05
1495,tumor cell-induced,10,12,69,87,"Importantly, fluorescence analysis of fibroblast growth factor 2 and tumor cell-induced vessel growth in Matrigel plugs demonstrated marked suppression of angiogenesis only in vaccinated animals.",12857959_6,-1,-1,-1,-1,1495,-1,0.0018599419,0.12620074,0.8719393
1497,Taken together,0,2,0,14,"Taken together, this multifunctional DNA vaccine proved effective in protecting against growth and metastases of breast cancer by combining the action of immune effector cells with suppression of tumor angiogenesis.",12857959_7,-1,-1,-1,-1,1497,-1,3.6995913e-05,0.9999486,1.4428998e-05
1507,that the,24,26,132,140,"Many tumor immunologists favor the hypothesis that optimal anti-tumor activity is mediated by type 1 CD4(+) and CD8(+) T cells, and that the production of type 2 CD4(+) T cells may be counterproductive for effective anti-tumor immunity.",14593499_0,-1,-1,-1,-1,1507,-1,1.9492838e-05,0.99997175,8.7016315e-06
1510,immunity,40,41,227,235,"Many tumor immunologists favor the hypothesis that optimal anti-tumor activity is mediated by type 1 CD4(+) and CD8(+) T cells, and that the production of type 2 CD4(+) T cells may be counterproductive for effective anti-tumor immunity.",14593499_0,0,-1,2,-1,1510,-1,0.99863654,0.0010229895,0.00034042165
1515,transcription-6 protein,14,16,85,108,"Since Stat6-deficient or ""knockout"" mice lack the signal transducer and activator of transcription-6 protein and are unable to transmit signals initiated by the type 2 cytokines, IL-4 and IL-13, they have been studied to confirm the T(h)1 vs T(h)2 paradigm.",14593499_1,-1,-1,-1,-1,1515,-1,3.2760574e-05,0.99994814,1.908194e-05
1516,to transmit,19,21,124,135,"Since Stat6-deficient or ""knockout"" mice lack the signal transducer and activator of transcription-6 protein and are unable to transmit signals initiated by the type 2 cytokines, IL-4 and IL-13, they have been studied to confirm the T(h)1 vs T(h)2 paradigm.",14593499_1,-1,-1,-1,-1,1516,-1,2.4678884e-05,0.99996495,1.0396159e-05
1517,the type,24,26,157,165,"Since Stat6-deficient or ""knockout"" mice lack the signal transducer and activator of transcription-6 protein and are unable to transmit signals initiated by the type 2 cytokines, IL-4 and IL-13, they have been studied to confirm the T(h)1 vs T(h)2 paradigm.",14593499_1,-1,-1,-1,-1,1517,-1,3.3629825e-05,0.99995065,1.574307e-05
1522,the T(h)1,39,41,229,238,"Since Stat6-deficient or ""knockout"" mice lack the signal transducer and activator of transcription-6 protein and are unable to transmit signals initiated by the type 2 cytokines, IL-4 and IL-13, they have been studied to confirm the T(h)1 vs T(h)2 paradigm.",14593499_1,-1,-1,-1,-1,1522,-1,2.7868608e-05,0.99994826,2.3894936e-05
1524,transplantable tumor cells that,1,5,6,37,"Using transplantable tumor cells that cause primary solid tumors and metastatic disease, as well as a spontaneous transgenic tumor model, multiple studies have demonstrated that Stat6(-/-) mice are able to reject or delay primary tumor growth, prevent recurrence of primary tumors, and/or reject established, spontaneous metastatic disease.",14593499_2,-1,-1,-1,-1,1524,-1,5.722465e-05,0.99987435,6.843638e-05
1526,transgenic tumor,18,20,114,130,"Using transplantable tumor cells that cause primary solid tumors and metastatic disease, as well as a spontaneous transgenic tumor model, multiple studies have demonstrated that Stat6(-/-) mice are able to reject or delay primary tumor growth, prevent recurrence of primary tumors, and/or reject established, spontaneous metastatic disease.",14593499_2,-1,-1,-1,-1,1526,-1,2.4872106e-05,0.99995816,1.7003946e-05
1531,the Stat6 gene,2,5,12,26,"Deletion of the Stat6 gene, therefore, provides significantly enhanced immunosurveillance.",14593499_3,-1,-1,-1,-1,1531,-1,2.376001e-05,0.99996006,1.6194825e-05
1537,immunity,1,2,8,16,"Because immunity is enhanced in the absence of Stat6 or CD1, it has been hypothesized that these deletions result in the removal of an inhibitor that blocks constitutive immunosurveillance.",14593499_5,0,-1,2,-1,1537,-1,0.9308532,0.06835445,0.000792334
1540,that these,16,18,86,96,"Because immunity is enhanced in the absence of Stat6 or CD1, it has been hypothesized that these deletions result in the removal of an inhibitor that blocks constitutive immunosurveillance.",14593499_5,-1,-1,-1,-1,1540,-1,1.8691275e-05,0.99997365,7.698389e-06
1557,immunity,14,15,106,114,"Although additional studies are clearly needed to clarify the mechanism(s) underlying improved anti-tumor immunity in Stat6(-/-) and CD1(-/-) mice, deletion of these genes results in a potent anti-tumor immunity and may be a basis for an immunotherapy strategy.",14593499_8,0,-1,2,-1,1557,-1,0.99881077,0.0008520315,0.00033720586
1558,these genes,25,27,160,171,"Although additional studies are clearly needed to clarify the mechanism(s) underlying improved anti-tumor immunity in Stat6(-/-) and CD1(-/-) mice, deletion of these genes results in a potent anti-tumor immunity and may be a basis for an immunotherapy strategy.",14593499_8,-1,-1,-1,-1,1558,-1,2.3047942e-05,0.99996436,1.2597113e-05
1559,immunity,32,33,203,211,"Although additional studies are clearly needed to clarify the mechanism(s) underlying improved anti-tumor immunity in Stat6(-/-) and CD1(-/-) mice, deletion of these genes results in a potent anti-tumor immunity and may be a basis for an immunotherapy strategy.",14593499_8,0,-1,2,-1,1559,-1,0.9992192,0.0005116807,0.00026910513
1560,the two,1,3,7,14,"During the two least decades, the field of tumor immunology has met an expansion of knowledge about the molecular and cellular bases of immune regulation.",14609757_0,-1,-1,-1,-1,1560,-1,2.9332943e-05,0.99995863,1.2022875e-05
1562,tumor immunology,9,11,43,59,"During the two least decades, the field of tumor immunology has met an expansion of knowledge about the molecular and cellular bases of immune regulation.",14609757_0,-1,-1,-1,-1,1562,-1,0.00012906322,0.9998023,6.869954e-05
1570,to the,4,6,19,25,This is mainly due to the capacity of tumor cells to escape from immunological detection and to resist to cell mediated cytotoxicity.,14609757_3,-1,-1,-1,-1,1570,-1,2.0980946e-05,0.99996996,9.105328e-06
1571,tumor cells to,8,11,38,52,This is mainly due to the capacity of tumor cells to escape from immunological detection and to resist to cell mediated cytotoxicity.,14609757_3,-1,-1,-1,-1,1571,-1,9.779718e-05,0.9997508,0.00015145911
1573,to cell,18,20,103,110,This is mainly due to the capacity of tumor cells to escape from immunological detection and to resist to cell mediated cytotoxicity.,14609757_3,-1,-1,-1,-1,1573,-1,0.0055990545,0.47751543,0.5168855
1575,this tumor,10,12,67,77,We will discuss some mechanisms associated with the acquisition of this tumor resistance and the alteration of T cell function and how cancer profiling through genomics approaches may help to reconceptualize immunotherapy strategies.,14609757_4,-1,-1,-1,-1,1575,-1,2.4360179e-05,0.99996436,1.1316883e-05
1577,T cell function,17,20,111,126,We will discuss some mechanisms associated with the acquisition of this tumor resistance and the alteration of T cell function and how cancer profiling through genomics approaches may help to reconceptualize immunotherapy strategies.,14609757_4,-1,-1,-1,-1,1577,-1,4.2912925e-05,6.112311e-05,0.99989593
1580,Regulatory T cells play,0,4,0,23,Regulatory T cells play an important role in the maintenance of immunological self-tolerance by suppressing immune responses against autoimmune diseases and cancer.,14738769_0,-1,-1,-1,-1,1580,-1,0.0016920001,0.33206365,0.6662443
1583,the nature,7,9,32,42,"Little is known, however, about the nature of the physiological target antigens for CD4(+) regulatory T (Treg) cells.",14738769_1,-1,-1,-1,-1,1583,-1,2.2304685e-05,0.99996424,1.3457444e-05
1585,target antigens,12,14,64,79,"Little is known, however, about the nature of the physiological target antigens for CD4(+) regulatory T (Treg) cells.",14738769_1,-1,-1,-1,-1,1585,-1,0.22100294,0.7658704,0.013126672
1591,protein,8,9,47,54,Here we report the identification of the LAGE1 protein as a ligand for tumor-specific CD4(+) Treg cell clones generated from the tumor-infiltrating lymphocytes (TILs) of cancer patients.,14738769_2,0,1,-1,-1,1591,-1,2.7952796e-05,0.9999491,2.2938106e-05
1595,the tumor-infiltrating lymphocytes,21,24,125,159,Here we report the identification of the LAGE1 protein as a ligand for tumor-specific CD4(+) Treg cell clones generated from the tumor-infiltrating lymphocytes (TILs) of cancer patients.,14738769_2,-1,-1,-1,-1,1595,-1,0.0025367374,0.93187463,0.065588616
1597,functional,2,3,15,25,Phenotypic and functional analyses demonstrated that they were antigen-specific CD4(+) Treg cells expressing CD25 and GITR molecules and possessing suppressive activity on the proliferative response of naive CD4(+) T cells to anti-CD3 antibody stimulation.,14738769_3,0,1,2,-1,1597,-1,7.339089e-05,0.9998815,4.5080997e-05
1598,that they,5,7,48,57,Phenotypic and functional analyses demonstrated that they were antigen-specific CD4(+) Treg cells expressing CD25 and GITR molecules and possessing suppressive activity on the proliferative response of naive CD4(+) T cells to anti-CD3 antibody stimulation.,14738769_3,-1,-1,-1,-1,1598,-1,1.8191366e-05,0.99996924,1.2573674e-05
1603,T cells to,30,33,215,225,Phenotypic and functional analyses demonstrated that they were antigen-specific CD4(+) Treg cells expressing CD25 and GITR molecules and possessing suppressive activity on the proliferative response of naive CD4(+) T cells to anti-CD3 antibody stimulation.,14738769_3,-1,-1,-1,-1,1603,-1,0.001755052,0.028822668,0.9694223
1605,Treg cells to,9,12,74,87,Ligand-specific activation and cell-cell contact were required for TIL102 Treg cells to exert suppressive activity on CD4(+) effector cells.,14738769_4,-1,-1,-1,-1,1605,-1,0.002227949,0.41958004,0.578192
1608,that the,3,5,23,31,These findings suggest that the presence of tumor-specific CD4(+) Treg cells at tumor sites may have a profound effect on the inhibition of T cell responses against cancer.,14738769_5,-1,-1,-1,-1,1608,-1,1.7482445e-05,0.9999751,7.3972114e-06
1615,function,4,5,24,32,Deficient T cell immune function and intracellular signaling in cancer patients may result from effects of tumors or their products on lymphocytes.,14741732_0,0,1,2,-1,1615,-1,0.0018740051,0.03221467,0.9659114
1621,factors that,14,16,94,106,"Recently, it was demonstrated that several ovarian carcinoma cell lines could produce soluble factors that inhibited T cell proliferation.",14741732_1,-1,-1,-1,-1,1621,-1,0.28910366,0.7061267,0.0047696424
1630,to the,32,34,169,175,"The aim of this study is to assess the effect of supernatants from 3 ovarian carcinoma cell lines (OVCAR3, CAOV3, SKOV3) on signal transduction elements that are linked to the IL-2R and its JAK-STAT pathway.",14741732_2,-1,-1,-1,-1,1630,-1,2.2082779e-05,0.9999677,1.0174148e-05
1632,IL-10 gene,14,16,85,95,"A profound inhibition of proliferation, lower level of IFN-gamma and higher level of IL-10 gene expression were observed when CD8+ T cells were co-cultured with supernatants from 3 ovarian carcinoma cell lines.",14741732_3,-1,-1,-1,-1,1632,-1,0.9944963,0.0035451706,0.0019585388
1638,analysis,2,3,13,21,Western blot analysis showed that tumor supernatants suppressed expression of JAK3 and tyrosine phosphorylation of STAT5.,14741732_5,0,1,-1,-1,1638,-1,2.2531234e-05,0.99996305,1.44331425e-05
1639,that tumor,4,6,29,39,Western blot analysis showed that tumor supernatants suppressed expression of JAK3 and tyrosine phosphorylation of STAT5.,14741732_5,-1,-1,-1,-1,1639,-1,1.8707005e-05,0.9999728,8.448667e-06
1649,T cell proliferation through,9,13,65,93,"These findings suggest that ovarian carcinoma cells may suppress T cell proliferation through inhibition IL-2 dependent signaling pathways, which may be a mechanism of ovarian carcinoma induced immunosuppression.",14741732_8,-1,-1,-1,-1,1649,-1,0.0012289779,0.018717712,0.98005337
1654,the cytokine IFN-gamma,17,20,113,135,"The local progression of primary tumors is extrinsically controlled by type 1 immune responses, particularly via the cytokine IFN-gamma, whose secretion is highly dependent on helper T cells.",14744755_0,-1,-1,-1,-1,1654,-1,0.95382774,0.04331764,0.0028545123
1656,The T-box transcription factor T-bet,0,5,0,36,The T-box transcription factor T-bet (Tbx21) plays a critical role in the development of type 1 helper T cells and is essential for the production of IFN-gamma.,14744755_1,-1,-1,-1,-1,1656,-1,2.1177091e-05,0.99996746,1.1335151e-05
1657,Tbx21,6,7,38,43,The T-box transcription factor T-bet (Tbx21) plays a critical role in the development of type 1 helper T cells and is essential for the production of IFN-gamma.,14744755_1,-1,1,2,-1,1657,-1,4.098289e-05,0.99992955,2.9444029e-05
1664,the T-bet,2,4,6,15,"Here, the T-bet pathway in the autochthonous transgenic adenocarcinoma mouse prostate model is demonstrated to have only a modest effect on the characteristics of primary prostate cancers but rather exerts a significant suppressor function in the development of metastatic disease.",14744755_2,-1,-1,-1,-1,1664,-1,1.9832552e-05,0.99996877,1.1366309e-05
1669,function,34,35,231,239,"Here, the T-bet pathway in the autochthonous transgenic adenocarcinoma mouse prostate model is demonstrated to have only a modest effect on the characteristics of primary prostate cancers but rather exerts a significant suppressor function in the development of metastatic disease.",14744755_2,0,1,2,-1,1669,-1,4.270055e-05,0.9999291,2.8208166e-05
1678,peptides,2,3,22,30,"Overlapping synthetic peptides covering the entire primary sequences of the HPV16 E6, E7 and E4 proteins were used to screen for CD8+ T cell responses using an ELISPOT assay of interferon (IFN)-gamma release.",14751153_2,0,-1,2,-1,1678,-1,4.9448998e-05,0.9999057,4.486241e-05
1681,proteins,16,17,96,104,"Overlapping synthetic peptides covering the entire primary sequences of the HPV16 E6, E7 and E4 proteins were used to screen for CD8+ T cell responses using an ELISPOT assay of interferon (IFN)-gamma release.",14751153_2,0,1,-1,-1,1681,-1,7.010047e-05,0.99978477,0.00014515503
1686,to the proteins,3,6,20,35,RESULTS: Reactivity to the proteins was detected in all patients on at least one occasion.,14751153_3,-1,-1,-1,-1,1686,-1,3.4285855e-05,0.9999392,2.6540538e-05
1692,the treatment,8,10,58,71,The magnitude and specificities of responses changed over the treatment period.,14751153_5,-1,-1,-1,-1,1692,-1,2.4089468e-05,0.9999664,9.550717e-06
1694,to peptides,6,8,45,56,This was particularly noticeable in response to peptides derived from the E4 protein.,14751153_6,-1,-1,-1,-1,1694,-1,3.609982e-05,0.9999453,1.8643268e-05
1696,protein,12,13,77,84,This was particularly noticeable in response to peptides derived from the E4 protein.,14751153_6,0,1,-1,-1,1696,-1,8.154943e-05,0.999767,0.00015140508
1715,that interleukin,4,6,29,45,"Although much promising data that interleukin (IL)-12 could be a powerful therapeutic agent against cancer were reported in animal models, its excessive toxicity has become a problem for its clinical application.",14871851_0,-1,-1,-1,-1,1715,-1,0.25666884,0.7338247,0.009506545
1717,toxicity,23,24,153,161,"Although much promising data that interleukin (IL)-12 could be a powerful therapeutic agent against cancer were reported in animal models, its excessive toxicity has become a problem for its clinical application.",14871851_0,0,1,-1,-1,1717,-1,4.3711665e-05,0.9999243,3.1932443e-05
1719,that plays,7,9,37,47,"IL-27 is a novel IL-12 family member that plays a role in the early regulation of T helper cell 1 initiation, including induction of T-bet and IL-12 receptor beta 2 expression.",14871851_1,-1,-1,-1,-1,1719,-1,2.3160053e-05,0.9999654,1.14574605e-05
1724,IL-12 receptor,27,29,143,157,"IL-27 is a novel IL-12 family member that plays a role in the early regulation of T helper cell 1 initiation, including induction of T-bet and IL-12 receptor beta 2 expression.",14871851_1,-1,-1,-1,-1,1724,-1,0.9484747,0.003463962,0.04806143
1733,these cells,33,35,182,193,"C26 cells, which were transduced with the single-chain IL-27 cDNA and became secreting IL-27 (C26-IL-27), exhibited minimal tumor growth in vivo, and all of the mice inoculated with these cells survived healthily with complete tumor remission.",14871851_3,-1,-1,-1,-1,1733,-1,0.002129508,0.118704826,0.87916565
1741,immunity to the,9,12,71,86,Recovered mice from the inoculation showed a tumor-specific protective immunity to the following challenge with parental C26 tumor.,14871851_5,-1,-1,-1,-1,1741,-1,0.0012046627,0.9986468,0.0001485437
1755,immunity,15,16,113,121,"These results suggest that IL-27 has potent abilities to induce tumor-specific antitumor activity and protective immunity and that the antitumor activity is mediated mainly through CD8(+) T cells, IFN-gamma, and T-bet but not through STAT4.",14871851_8,0,-1,2,-1,1755,-1,0.9967264,0.0026324294,0.00064112776
1756,that the,17,19,126,134,"These results suggest that IL-27 has potent abilities to induce tumor-specific antitumor activity and protective immunity and that the antitumor activity is mediated mainly through CD8(+) T cells, IFN-gamma, and T-bet but not through STAT4.",14871851_8,-1,-1,-1,-1,1756,-1,1.9599269e-05,0.99997044,9.994836e-06
1761,through STAT4,36,38,226,239,"These results suggest that IL-27 has potent abilities to induce tumor-specific antitumor activity and protective immunity and that the antitumor activity is mediated mainly through CD8(+) T cells, IFN-gamma, and T-bet but not through STAT4.",14871851_8,-1,-1,-1,-1,1761,-1,2.4313758e-05,0.99994814,2.7573073e-05
1762,Tumor cells,0,2,0,11,Tumor cells engineered to secrete TNF were used as a model to examine how persistently high local concentrations of TNF suppress tumor growth.,14978132_0,-1,-1,-1,-1,1762,-1,0.004139044,0.4639917,0.5318692
1764,TNF,5,6,34,37,Tumor cells engineered to secrete TNF were used as a model to examine how persistently high local concentrations of TNF suppress tumor growth.,14978132_0,0,1,-1,-1,1764,-1,0.0001565129,0.9998035,4.0004048e-05
1766,TNF,19,20,116,119,Tumor cells engineered to secrete TNF were used as a model to examine how persistently high local concentrations of TNF suppress tumor growth.,14978132_0,0,1,-1,-1,1766,-1,0.0003173912,0.99961925,6.33765e-05
1768,TNF,0,1,0,3,TNF secretion had no effect on tumor cell proliferation in vitro but caused a very impressive growth arrest in vivo that was dependent on both bone marrow- and non-bone marrow-derived host cells expressing TNFR.,14978132_1,0,1,-1,-1,1768,-1,9.9626566e-05,0.999879,2.1338368e-05
1769,tumor cell,6,8,31,41,TNF secretion had no effect on tumor cell proliferation in vitro but caused a very impressive growth arrest in vivo that was dependent on both bone marrow- and non-bone marrow-derived host cells expressing TNFR.,14978132_1,-1,-1,-1,-1,1769,-1,0.0038205893,0.2834108,0.7127686
1772,TNFR,33,34,206,210,TNF secretion had no effect on tumor cell proliferation in vitro but caused a very impressive growth arrest in vivo that was dependent on both bone marrow- and non-bone marrow-derived host cells expressing TNFR.,14978132_1,0,1,-1,-1,1772,-1,4.068414e-05,0.99994314,1.6154985e-05
1775,IFN-gamma receptor,12,14,93,111,"Suppression also required an endogenous IFN-gamma pathway consisting minimally of IFN-gamma, IFN-gamma receptor, Stat1, and IFN regulatory factor 1 since mice with targeted disruption of any of the four genes failed to arrest tumor growth.",14978132_2,-1,-1,-1,-1,1775,-1,0.9936488,0.0007363917,0.0056147124
1777,IFN regulatory factor,18,21,124,145,"Suppression also required an endogenous IFN-gamma pathway consisting minimally of IFN-gamma, IFN-gamma receptor, Stat1, and IFN regulatory factor 1 since mice with targeted disruption of any of the four genes failed to arrest tumor growth.",14978132_2,-1,-1,-1,-1,1777,-1,0.97863925,0.016711868,0.0046488573
1790,IFN-gamma-inducing cytokines IL-12,6,9,38,72,"Interestingly, mice lacking the major IFN-gamma-inducing cytokines IL-12 and IL-18 or T cells, B cells, and the majority of NK cells that are potential sources of IFN-gamma nevertheless inhibited tumor development.",14978132_4,-1,-1,-1,-1,1790,-1,0.99983823,4.9970957e-05,0.00011174944
1795,cells that,23,25,127,137,"Interestingly, mice lacking the major IFN-gamma-inducing cytokines IL-12 and IL-18 or T cells, B cells, and the majority of NK cells that are potential sources of IFN-gamma nevertheless inhibited tumor development.",14978132_4,-1,-1,-1,-1,1795,-1,0.0024340637,0.05403479,0.94353116
1804,function,6,7,39,47,These results strongly suggest a novel function for the endogenous IFN-gamma pathway that without measurable IFN-gamma production or activity affects the ability of TNF to suppress tumor development.,14978132_6,0,1,2,-1,1804,-1,5.8874077e-05,0.99990535,3.57997e-05
1810,TNF to,23,25,165,171,These results strongly suggest a novel function for the endogenous IFN-gamma pathway that without measurable IFN-gamma production or activity affects the ability of TNF to suppress tumor development.,14978132_6,-1,-1,-1,-1,1810,-1,2.0894253e-05,0.99996936,9.783912e-06
1813,thought to,3,5,17,27,Cancer cells are thought to possess mechanisms for evading the host's immune surveillance system.,15004200_0,-1,-1,-1,-1,1813,-1,3.2691678e-05,0.9999505,1.6764032e-05
1825,protein,8,9,73,80,Quantitative immunostaining showed correlation between survivin and FasL protein expression in colon cancer tissues (r=0.79).,15004200_5,0,1,-1,-1,1825,-1,3.8461985e-05,0.9999008,6.0661736e-05
1826,tissues,13,14,108,115,Quantitative immunostaining showed correlation between survivin and FasL protein expression in colon cancer tissues (r=0.79).,15004200_5,-1,1,2,-1,1826,-1,6.1020044e-05,0.9995036,0.00043541324
1827,cells transfected,8,10,55,72,FasL expression was up-regulated in LS180 colon cancer cells transfected with the survivin gene.,15004200_6,-1,-1,-1,-1,1827,-1,0.0022205045,0.11146278,0.88631666
1833,cells transfected,9,11,57,74,"In contrast, FasL expression was down-regulated in SW480 cells transfected with a small inhibitory RNA to prevent survivin expression.",15004200_8,-1,-1,-1,-1,1833,-1,0.0019757736,0.08646835,0.91155595
1835,gene transfectants,1,3,9,27,"Survivin gene transfectants showed increased DNA binding of transcription factor specificity protein 1 (Sp1) to the FasL promoter, and up-regulation of Sp1 phosphorylation at serine and threonine residues; the total amount of Sp1 was unchanged.",15004200_9,-1,-1,-1,-1,1835,-1,2.3169747e-05,0.99995184,2.4936575e-05
1837,transcription factor specificity protein 1,8,13,60,102,"Survivin gene transfectants showed increased DNA binding of transcription factor specificity protein 1 (Sp1) to the FasL promoter, and up-regulation of Sp1 phosphorylation at serine and threonine residues; the total amount of Sp1 was unchanged.",15004200_9,-1,-1,-1,-1,1837,-1,2.7493777e-05,0.9999387,3.3788616e-05
1839,to the,16,18,109,115,"Survivin gene transfectants showed increased DNA binding of transcription factor specificity protein 1 (Sp1) to the FasL promoter, and up-regulation of Sp1 phosphorylation at serine and threonine residues; the total amount of Sp1 was unchanged.",15004200_9,-1,-1,-1,-1,1839,-1,1.7955597e-05,0.99997115,1.0937792e-05
1842,the total,32,34,206,215,"Survivin gene transfectants showed increased DNA binding of transcription factor specificity protein 1 (Sp1) to the FasL promoter, and up-regulation of Sp1 phosphorylation at serine and threonine residues; the total amount of Sp1 was unchanged.",15004200_9,-1,-1,-1,-1,1842,-1,2.7685277e-05,0.9999571,1.5225952e-05
1853,that T cells,8,11,48,60,"In this article, we provide evidence suggesting that T cells may also play a protective role in liver disease by releasing interleukin-22 (IL-22), a recently identified T cell-derived cytokine whose biological significance is unclear.",15122762_1,-1,-1,-1,-1,1853,-1,0.0035403853,0.21021667,0.78624296
1855,releasing interleukin-22,21,23,113,137,"In this article, we provide evidence suggesting that T cells may also play a protective role in liver disease by releasing interleukin-22 (IL-22), a recently identified T cell-derived cytokine whose biological significance is unclear.",15122762_1,-1,-1,-1,-1,1855,-1,0.19967571,0.7962848,0.0040395046
1856,T cell-derived cytokine,30,33,169,192,"In this article, we provide evidence suggesting that T cells may also play a protective role in liver disease by releasing interleukin-22 (IL-22), a recently identified T cell-derived cytokine whose biological significance is unclear.",15122762_1,-1,-1,-1,-1,1856,-1,0.018767519,0.0010816308,0.9801508
1857,protein,4,5,24,31,IL-22 messenger RNA and protein expression are significantly elevated in T cell-mediated hepatitis induced by concanavalin A (ConA) but are less extensively elevated in the carbon tetrachloride-induced liver injury model.,15122762_2,0,1,-1,-1,1857,-1,3.9167557e-05,0.99993646,2.4400677e-05
1865,receptor,22,23,124,132,Activated CD3(+) T cells are likely responsible for the production of IL-22 in the liver after injection of ConA. The IL-22 receptor is normally expressed at high levels by hepatocytes and further induced after ConA injection.,15122762_3,0,1,2,-1,1865,-1,0.0016648377,0.6610074,0.33732772
1866,signal transducer and activator of transcription factor 3,7,15,52,109,"IL-22 blockade with a neutralizing antibody reduces signal transducer and activator of transcription factor 3 (STAT3) activation and worsens liver injury in T cell-mediated hepatitis, whereas injection of recombinant IL-22 attenuates such injury.",15122762_4,-1,-1,-1,-1,1866,-1,2.894134e-05,0.9999529,1.8160614e-05
1874,proteins,41,42,209,217,"Stable overexpression of IL-22 in HepG2 cells constitutively activates STAT3 and induces expression of a variety of antiapoptotic (e.g., Bcl-2, Bcl-xL, Mcl-1) and mitogenic (e.g., c-myc, cyclin D1, Rb2, CDK4) proteins.",15122762_6,0,1,-1,-1,1874,-1,8.102563e-05,0.9997625,0.00015644396
1878,the T cell-derived cytokine,3,7,15,42,"In conclusion, the T cell-derived cytokine IL-22 is a survival factor for hepatocytes; this suggests that T cell activation may also prevent and repair liver injury by releasing hepatoprotective cytokine IL-22 in addition to its previously documented central role in hepatocellular injury.",15122762_8,-1,-1,-1,-1,1878,-1,0.23879269,0.58147854,0.17972876
1879,factor,11,12,63,69,"In conclusion, the T cell-derived cytokine IL-22 is a survival factor for hepatocytes; this suggests that T cell activation may also prevent and repair liver injury by releasing hepatoprotective cytokine IL-22 in addition to its previously documented central role in hepatocellular injury.",15122762_8,0,1,-1,-1,1879,-1,0.42502683,0.572411,0.002562153
1881,that T cell activation,17,21,101,123,"In conclusion, the T cell-derived cytokine IL-22 is a survival factor for hepatocytes; this suggests that T cell activation may also prevent and repair liver injury by releasing hepatoprotective cytokine IL-22 in addition to its previously documented central role in hepatocellular injury.",15122762_8,-1,-1,-1,-1,1881,-1,0.003019902,0.15908451,0.8378956
1891,protein,6,7,33,40,doses of TA-CIN (HPV-16 L2/E6/E7 protein) at four weekly intervals followed by a single dermal scarification of vaccinia HPV-16/18 E6/E7 and were followed up for 12 weeks.,15131030_1,0,1,-1,-1,1891,-1,0.0055872044,0.9880685,0.0063442234
1892,Immunity to,0,2,0,11,"Immunity to HPV-16 was assessed by lymphoproliferation, IFN-gamma enzyme-linked immunospot (ELISPOT), and ELISA.RESULTS: The patient group significantly responded to TA-CIN and not to the control antigen HPV-6 L2/E7 at all postvaccination time points when compared with baseline responses (P < or = 0.05).",15131030_2,-1,-1,-1,-1,1892,-1,8.843139e-05,0.99987495,3.6656642e-05
1895,to TA-CIN,23,25,163,172,"Immunity to HPV-16 was assessed by lymphoproliferation, IFN-gamma enzyme-linked immunospot (ELISPOT), and ELISA.RESULTS: The patient group significantly responded to TA-CIN and not to the control antigen HPV-6 L2/E7 at all postvaccination time points when compared with baseline responses (P < or = 0.05).",15131030_2,-1,-1,-1,-1,1895,-1,2.9627812e-05,0.99995506,1.5292877e-05
1896,to the,27,29,181,187,"Immunity to HPV-16 was assessed by lymphoproliferation, IFN-gamma enzyme-linked immunospot (ELISPOT), and ELISA.RESULTS: The patient group significantly responded to TA-CIN and not to the control antigen HPV-6 L2/E7 at all postvaccination time points when compared with baseline responses (P < or = 0.05).",15131030_2,-1,-1,-1,-1,1896,-1,3.1130163e-05,0.9999516,1.7215514e-05
1903,proteins,9,10,59,67,Comparison of stimulation with HPV-16 E6- or E7-GST fusion proteins showed that proliferative responses were biased to HPV-16 E6.,15131030_4,0,1,-1,-1,1903,-1,2.791123e-05,0.9999505,2.1525282e-05
1908,peptides,10,11,63,71,"This bias was also seen by IFN-gamma ELISPOT using overlapping peptides, with HPV-16 E6- or E7-specific T cells being detected in 9 and 2 patients, respectively.",15131030_5,0,-1,2,-1,1908,-1,0.000287463,0.99942183,0.0002906854
1916,T-cell,18,19,124,130,"Stable disease was recorded in 19 patients, 8 of whom showed a concomitant TA-CIN-specific proliferative and/or E6-specific T-cell response.",15131030_8,-1,1,2,-1,1916,-1,4.884306e-05,6.498997e-05,0.99988616
1919,T-cell,10,11,41,47,"Of the 4 progressors, 2 failed to make a T-cell response and 2 responded by either proliferation or E6 ELISPOT alone.",15131030_9,-1,1,2,-1,1919,-1,3.8866398e-05,5.5843546e-05,0.99990535
1924,immunity,28,29,184,192,"CONCLUSIONS: The prime-boost regimen is immunogenic in AGIN patients (humoral and cellular immunity), but there is no simple relationship between induction of systemic HPV-16-specific immunity and clinical outcome.",15131030_10,0,-1,2,-1,1924,-1,0.99923766,0.00031061406,0.0004516556
1925,factors that,1,3,6,18,Other factors that may play a role in the eradication of long-term established AGIN lesions need to be determined to identify the patient group that would benefit from immunotherapy with the vaccines used in this study.,15131030_11,-1,-1,-1,-1,1925,-1,8.9573645e-05,0.99987257,3.787531e-05
1936,blood,5,6,36,41,We describe responses of peripheral blood mononuclear cells (PBMC) and T cells from RRP patients and controls to the HPV-11 early proteins E6 and E7.,15138179_1,0,1,-1,-1,1936,-1,0.00016014521,0.9990295,0.00081029534
1939,to the,19,21,110,116,We describe responses of peripheral blood mononuclear cells (PBMC) and T cells from RRP patients and controls to the HPV-11 early proteins E6 and E7.,15138179_1,-1,-1,-1,-1,1939,-1,2.2002743e-05,0.99996555,1.2441383e-05
1940,proteins,23,24,130,138,We describe responses of peripheral blood mononuclear cells (PBMC) and T cells from RRP patients and controls to the HPV-11 early proteins E6 and E7.,15138179_1,0,1,-1,-1,1940,-1,9.972882e-05,0.9998062,9.410545e-05
1942,proteins,10,11,48,56,PBMC were exposed in vitro to purified E6 or E7 proteins or transduced with fusion proteins containing the first 11 amino acids of the human immunodeficiency virus type 1 protein tat fused to E6 or E7 (tat-E6/tat-E7).,15138179_2,0,1,-1,-1,1942,-1,0.0001675776,0.99954057,0.00029193738
1944,proteins,15,16,83,91,PBMC were exposed in vitro to purified E6 or E7 proteins or transduced with fusion proteins containing the first 11 amino acids of the human immunodeficiency virus type 1 protein tat fused to E6 or E7 (tat-E6/tat-E7).,15138179_2,0,1,-1,-1,1944,-1,3.729733e-05,0.99993,3.27071e-05
1961,IL-10 cytokine-producing cells,37,40,194,224,"T(H)1-like (interleukin-2 [IL-2], gamma interferon [IFN-gamma], IL-12, and IL-18), and T(H)2-like (IL-4 and IL-10) cytokine mRNAs were identified by reverse transcription-PCR, and IFN-gamma and IL-10 cytokine-producing cells were identified by enzyme-linked immunospot assay.",15138179_3,-1,-1,-1,-1,1961,-1,0.8285761,0.0015560312,0.16986796
1966,IL-10 than,17,19,117,127,These studies show that HPV-11 E6 skews IL-10-IFN-gamma expression by patients with RRP toward greater expression of IL-10 than of IFN-gamma.,15138179_4,-1,-1,-1,-1,1966,-1,0.99363273,0.0035813611,0.0027860075
1969,general cytokine,6,8,24,40,"In addition, there is a general cytokine hyporesponsiveness to E6 that is more prominent for T(H)1-like cytokine expression by patients with severe disease.",15138179_5,-1,-1,-1,-1,1969,-1,0.4113677,0.58342576,0.005206458
1972,T(H)1-like cytokine,16,18,93,112,"In addition, there is a general cytokine hyporesponsiveness to E6 that is more prominent for T(H)1-like cytokine expression by patients with severe disease.",15138179_5,-1,-1,-1,-1,1972,-1,0.022918133,0.9748917,0.0021901587
1973,IL-10 cytokine,3,5,27,41,"Patients showed persistent IL-10 cytokine expression by the nonadherent fraction of PBMC when challenged with E6 and tat-E6, and, in contrast to controls, both T cells and non-T cells from patients expressed IL-10.",15138179_6,-1,-1,-1,-1,1973,-1,0.99989665,3.0885676e-05,7.244992e-05
1981,to those,11,13,72,80,"However, E7/tat-E7 cytokine responses in patients with RRP were similar to those of the controls.",15138179_7,-1,-1,-1,-1,1981,-1,2.3191385e-05,0.99996316,1.3671465e-05
1988,T-cell,22,23,147,153,"In contrast, E6 inhibited IL-2 and IL-18 mRNA expression that would further contribute to a cytokine microenvironment unfavorable to HPV-specific, T-cell responses that should control persistent HPV infection.",15138179_8,-1,1,2,-1,1988,-1,6.275182e-05,8.329684e-05,0.99985397
1993,to the,23,25,123,129,"In summary, E6 is the dominant inducer of cytokine expression in RRP, and it induces a skewed expression of IL-10 compared to the expression of IFN-gamma.",15138179_9,-1,-1,-1,-1,1993,-1,2.3732942e-05,0.9999654,1.0894712e-05
2008,protein AML1-eight-twenty-one,37,39,232,261,"In this study, three leukemic cell lines were investigated: Kasumi-1 and SKNO-1 (two acute myeloid leukemia (AML) cell lines carrying the (8;21)-chromosomal translocation, resulting in the expression of the leukemia-specific fusion protein AML1-eight-twenty-one) and REH, an acute lymphoblastic leukemia cell line with the (12;21)-chromosomal translocation and expression of translocation ETS-like leukemia-AML1.",15197237_1,-1,-1,-1,-1,2008,-1,8.833991e-05,0.9997812,0.00013049356
2014,proteins,2,3,13,21,"These fusion proteins are implicated in the pathogenesis of the leukemic state by recruiting corepressors and histone deacetylases (HDAC), which interfere with normal cell differentiation.",15197237_2,0,1,-1,-1,2014,-1,2.472044e-05,0.99995184,2.3445122e-05
2022,stimulating factor,19,21,135,153,"In vitro generation of DC was achieved using a cytokine cocktail containing tumor necrosis factor alpha, granulocyte macrophage-colony stimulating factor, c-kit ligand, and soluble CD40 ligand; yet, addition of the HDAC inhibitor (Hdi) trichostatin A enhanced DC differentiation with retention of the fusion transcripts.",15197237_3,-1,-1,-1,-1,2022,-1,0.999607,8.599303e-05,0.0003069498
2031,these cell,4,6,23,33,"Only DC generated from these cell lines after Hdi induced blast-specific cytotoxic T cell responses in HLA-A-matched T cells with a cytotoxicity of 42% in parental Kasumi-1 and 83% in parental REH cells, respectively.",15197237_5,-1,-1,-1,-1,2031,-1,0.003817194,0.3026199,0.69356287
2036,that the,4,6,27,35,This model system suggests that the Hdi supports the in vitro differentiation of DC from leukemic blasts with AML1-containing fusion proteins.,15197237_6,-1,-1,-1,-1,2036,-1,2.1137397e-05,0.9999701,8.726099e-06
2039,proteins,20,21,133,141,This model system suggests that the Hdi supports the in vitro differentiation of DC from leukemic blasts with AML1-containing fusion proteins.,15197237_6,0,1,-1,-1,2039,-1,3.7969294e-05,0.99993813,2.3847e-05
2053,These cells,0,2,0,11,"These cells express the Foxp3 transcription factor, display an activated phenotype, and display a polyclonal TCR Vbeta chain repertoire.",15240741_3,-1,-1,-1,-1,2053,-1,0.0031072074,0.2681717,0.7287211
2054,the Foxp3 transcription factor,3,7,20,50,"These cells express the Foxp3 transcription factor, display an activated phenotype, and display a polyclonal TCR Vbeta chain repertoire.",15240741_3,-1,-1,-1,-1,2054,-1,2.4187393e-05,0.9999596,1.6275731e-05
2055,TCR,17,18,109,112,"These cells express the Foxp3 transcription factor, display an activated phenotype, and display a polyclonal TCR Vbeta chain repertoire.",15240741_3,-1,1,2,-1,2055,-1,4.7459584e-05,0.99986374,8.8834095e-05
2083,Analysis,0,1,0,8,"Analysis of CD4+ T-helper (Th) immunity against the E2, E6, and E7 antigens of HPV16 in healthy women revealed strong proliferative E2- and E6-specific responses associated with prominent IFN-gamma and interleukin 5 secretion.",15289354_2,0,1,-1,-1,2083,-1,2.1840293e-05,0.999964,1.4125782e-05
2086,immunity,8,9,31,39,"Analysis of CD4+ T-helper (Th) immunity against the E2, E6, and E7 antigens of HPV16 in healthy women revealed strong proliferative E2- and E6-specific responses associated with prominent IFN-gamma and interleukin 5 secretion.",15289354_2,0,-1,2,-1,2086,-1,0.9684299,0.029593948,0.0019760348
2092,that the naturally,2,5,15,33,This indicates that the naturally arising virus-induced immune response displays a mixed Th1/Th2 cytokine profile.,15289354_3,-1,-1,-1,-1,2092,-1,2.5161846e-05,0.99996614,8.703624e-06
2098,peptides,20,21,130,138,"Of all HPV16+ cervical cancer patients, approximately half failed to mount a detectable immune response against the HPV16-derived peptides.",15289354_4,0,-1,2,-1,2098,-1,0.004579363,0.9791516,0.016269041
2105,that the,2,4,15,23,"This indicates that the HPV16-specific CD4+ T-cell response in cervical cancer patients is either absent or severely impaired, despite a relatively good immune status of the patients, as indicated by intact responses against recall antigens.",15289354_6,-1,-1,-1,-1,2105,-1,1.8959046e-05,0.99997294,8.075534e-06
2106,T-cell,7,8,44,50,"This indicates that the HPV16-specific CD4+ T-cell response in cervical cancer patients is either absent or severely impaired, despite a relatively good immune status of the patients, as indicated by intact responses against recall antigens.",15289354_6,-1,1,2,-1,2106,-1,5.191858e-05,0.00012792088,0.9998202
2113,T-cell,8,9,42,48,"It is highly conceivable that proper CD4+ T-cell help is important for launching an effective immune attack against HPV because infection of cervical epithelia by this virus is, at least initially, not accompanied by gross disturbance of this tissue and/or strong proinflammatory stimuli.",15289354_7,-1,1,2,-1,2113,-1,3.2929045e-05,5.086365e-05,0.9999162
2115,this tissue,40,42,238,249,"It is highly conceivable that proper CD4+ T-cell help is important for launching an effective immune attack against HPV because infection of cervical epithelia by this virus is, at least initially, not accompanied by gross disturbance of this tissue and/or strong proinflammatory stimuli.",15289354_7,-1,-1,-1,-1,2115,-1,0.00019766527,0.9983199,0.001482443
2118,functional,8,9,51,61,"Therefore, our observations concerning the lack of functional HPV16-specific CD4+ T-cell immunity in patients with cervical cancer offer a possible explanation for the development of this disease.",15289354_8,0,1,2,-1,2118,-1,3.3935685e-05,0.99995303,1.3078706e-05
2119,T-cell immunity,12,14,82,97,"Therefore, our observations concerning the lack of functional HPV16-specific CD4+ T-cell immunity in patients with cervical cancer offer a possible explanation for the development of this disease.",15289354_8,-1,-1,-1,-1,2119,-1,0.009018947,0.00072777446,0.99025327
2122,that immune responses,4,7,17,38,"It is well known that immune responses in the intestine remain in a state of controlled inflammation, suggesting that not only active suppression by regulatory T cells plays an important role in the normal intestinal homeostasis, but also its dysregulation leads to the development of inflammatory bowel disease.",15322172_0,-1,-1,-1,-1,2122,-1,0.29335648,0.704998,0.0016455136
2126,regulatory T cells plays,25,29,149,173,"It is well known that immune responses in the intestine remain in a state of controlled inflammation, suggesting that not only active suppression by regulatory T cells plays an important role in the normal intestinal homeostasis, but also its dysregulation leads to the development of inflammatory bowel disease.",15322172_0,-1,-1,-1,-1,2126,-1,0.0018758051,0.109745376,0.88837886
2128,to the,43,45,263,269,"It is well known that immune responses in the intestine remain in a state of controlled inflammation, suggesting that not only active suppression by regulatory T cells plays an important role in the normal intestinal homeostasis, but also its dysregulation leads to the development of inflammatory bowel disease.",15322172_0,-1,-1,-1,-1,2128,-1,2.0901076e-05,0.9999697,9.410932e-06
2130,that the,6,8,30,38,"In this study, we demonstrate that the CD4(+)CD25(bright) T cells reside in the human intestinal lamina propria (LP) and functionally retain regulatory activities.",15322172_1,-1,-1,-1,-1,2130,-1,1.6359969e-05,0.9999739,9.72663e-06
2133,functionally,23,24,121,133,"In this study, we demonstrate that the CD4(+)CD25(bright) T cells reside in the human intestinal lamina propria (LP) and functionally retain regulatory activities.",15322172_1,0,1,2,-1,2133,-1,2.68334e-05,0.9999614,1.1731134e-05
2136,TNFR,16,17,114,118,"All human LP CD4(+) T cells regardless of CD25 expression constitutively expressed CTLA-4, glucocorticoid-induced TNFR family-related protein, and Foxp3 and proliferate poorly.",15322172_2,0,1,-1,-1,2136,-1,4.4432392e-05,0.99993205,2.347999e-05
2137,protein,18,19,134,141,"All human LP CD4(+) T cells regardless of CD25 expression constitutively expressed CTLA-4, glucocorticoid-induced TNFR family-related protein, and Foxp3 and proliferate poorly.",15322172_2,0,1,-1,-1,2137,-1,6.7501554e-05,0.9998745,5.8019203e-05
2159,to the,26,28,179,185,These results suggest that CD4(+)CD25(bright) T cells found in the normal and inflamed intestinal mucosa selectively inhibit the host immune response and therefore may contribute to the intestinal immune homeostasis.,15322172_7,-1,-1,-1,-1,2159,-1,2.3366169e-05,0.9999651,1.1556065e-05
2163,tissues,19,20,116,123,BACKGROUND: Regulation of gene expression by signal transducer and activator of transcription 1 (STAT1) within host tissues mediates the antitumor effects of interferon alfa (IFN alpha).,15339971_0,-1,1,2,-1,2163,-1,4.838609e-05,0.9997913,0.00016030754
2165,interferon alfa,25,27,158,173,BACKGROUND: Regulation of gene expression by signal transducer and activator of transcription 1 (STAT1) within host tissues mediates the antitumor effects of interferon alfa (IFN alpha).,15339971_0,-1,-1,-1,-1,2165,-1,0.999747,8.633164e-05,0.00016679069
2169,cell subsets,16,18,117,129,We used a novel flow cytometric assay to examine phosphorylation-mediated activation of STAT1 within immune effector cell subsets following in vitro or in vivo IFN alpha treatments.,15339971_1,-1,-1,-1,-1,2169,-1,3.655209e-05,4.557892e-05,0.99991786
2172,blood,3,4,20,25,METHODS: Peripheral blood mononuclear cells (PBMCs) isolated from healthy donors (n = 17) or melanoma patients (n = 19) were treated in vitro with interferon alfa-2b (IFN alpha-2b) or phosphate-buffered saline (PBS) and subjected to multiparametric flow cytometry to measure the levels of phosphorylated STAT1 (P-STAT1) within immune cell subsets.,15339971_2,0,1,-1,-1,2172,-1,0.00012238394,0.9993585,0.00051917846
2175,interferon alfa-2b,31,33,147,165,METHODS: Peripheral blood mononuclear cells (PBMCs) isolated from healthy donors (n = 17) or melanoma patients (n = 19) were treated in vitro with interferon alfa-2b (IFN alpha-2b) or phosphate-buffered saline (PBS) and subjected to multiparametric flow cytometry to measure the levels of phosphorylated STAT1 (P-STAT1) within immune cell subsets.,15339971_2,-1,-1,-1,-1,2175,-1,0.9996958,0.00014072782,0.00016350466
2181,cell subsets,61,63,334,346,METHODS: Peripheral blood mononuclear cells (PBMCs) isolated from healthy donors (n = 17) or melanoma patients (n = 19) were treated in vitro with interferon alfa-2b (IFN alpha-2b) or phosphate-buffered saline (PBS) and subjected to multiparametric flow cytometry to measure the levels of phosphorylated STAT1 (P-STAT1) within immune cell subsets.,15339971_2,-1,-1,-1,-1,2181,-1,3.4977922e-05,4.29936e-05,0.99992204
2183,statistical tests,1,3,4,21,All statistical tests were two-sided.,15339971_4,-1,-1,-1,-1,2183,-1,9.8399294e-05,0.9998357,6.582256e-05
2185,cell subsets,8,10,44,56,RESULTS: P-STAT1 levels in all major immune cell subsets increased within 15 minutes of in vitro IFN alpha-2b treatment of PBMCs; the increase was most pronounced in T lymphocytes and monocytes.,15339971_5,-1,-1,-1,-1,2185,-1,3.600188e-05,4.5195764e-05,0.9999188
2192,maximal STAT1,14,16,71,84,"Relatively low doses of IFN alpha-2b (i.e., 10(2)-10(3) IU/mL) induced maximal STAT1 activation in vitro.",15339971_6,-1,-1,-1,-1,2192,-1,3.485385e-05,0.9999409,2.4321465e-05
2212,to treatments,28,30,169,182,P-STAT1 levels in the PBMCs of a patient treated sequentially with 5 MU/m2 and 10 MU/m2 IFN alpha-2b (administered by subcutaneous injection) also increased in response to treatments with IFN alpha-2b but did not increase further with the increased dosage of IFN alpha-2b.,15339971_9,-1,-1,-1,-1,2212,-1,2.5580477e-05,0.9999645,9.983288e-06
2222,TGF-beta,2,3,15,23,"Alterations of TGF-beta signaling have been described in colorectal cancer, although the molecular consequences are largely unknown.",15485627_0,0,1,-1,-1,2222,-1,5.8625017e-05,0.99991655,2.4760056e-05
2225,TGF-beta,5,6,40,48,"By using transgenic mice overexpressing TGF-beta or a dominant-negative TGF-betaRII, we demonstrate that TGF-beta signaling in tumor infiltrating T lymphocytes controls the growth of dysplastic epithelial cells in experimental colorectal cancer, as determined by histology and a novel system for high-resolution chromoendoscopy.",15485627_1,0,1,-1,-1,2225,-1,4.0485316e-05,0.99994123,1.8257788e-05
2226,TGF-betaRII,9,10,72,83,"By using transgenic mice overexpressing TGF-beta or a dominant-negative TGF-betaRII, we demonstrate that TGF-beta signaling in tumor infiltrating T lymphocytes controls the growth of dysplastic epithelial cells in experimental colorectal cancer, as determined by histology and a novel system for high-resolution chromoendoscopy.",15485627_1,0,1,-1,-1,2226,-1,0.00015073571,0.9996049,0.00024446065
2227,that TGF-beta,13,15,100,113,"By using transgenic mice overexpressing TGF-beta or a dominant-negative TGF-betaRII, we demonstrate that TGF-beta signaling in tumor infiltrating T lymphocytes controls the growth of dysplastic epithelial cells in experimental colorectal cancer, as determined by histology and a novel system for high-resolution chromoendoscopy.",15485627_1,-1,-1,-1,-1,2227,-1,4.502377e-05,0.9999379,1.7026043e-05
2233,TGF-beta,5,6,24,32,"At the molecular level, TGF-beta signaling in T cells regulated STAT-3 activation in tumor cells via IL-6.",15485627_2,0,1,-1,-1,2233,-1,4.4956203e-05,0.999938,1.7086377e-05
2236,tumor cells,14,16,85,96,"At the molecular level, TGF-beta signaling in T cells regulated STAT-3 activation in tumor cells via IL-6.",15485627_2,-1,-1,-1,-1,2236,-1,0.0038832242,0.45394158,0.5421752
2239,tumor cell-derived,3,5,24,42,IL-6 signaling required tumor cell-derived soluble IL-6R rather than membrane bound IL-6R and suppression of such TGF-beta-dependent IL-6 trans-signaling prevented tumor progression in vivo.,15485627_3,-1,-1,-1,-1,2239,-1,0.0023364108,0.44264004,0.55502355
2243,TGF-beta-dependent IL-6 trans-signaling,16,19,114,153,IL-6 signaling required tumor cell-derived soluble IL-6R rather than membrane bound IL-6R and suppression of such TGF-beta-dependent IL-6 trans-signaling prevented tumor progression in vivo.,15485627_3,-1,-1,-1,-1,2243,-1,0.00014341314,0.999796,6.0613795e-05
2245,Taken together,0,2,0,14,"Taken together, our data provide novel insights into TGF-beta signaling in colorectal cancer and suggest novel therapeutic approaches for colorectal cancer based on inhibition of TGF-beta-dependent IL-6 trans-signaling.",15485627_4,-1,-1,-1,-1,2245,-1,5.0309893e-05,0.99993086,1.886801e-05
2246,TGF-beta,9,10,53,61,"Taken together, our data provide novel insights into TGF-beta signaling in colorectal cancer and suggest novel therapeutic approaches for colorectal cancer based on inhibition of TGF-beta-dependent IL-6 trans-signaling.",15485627_4,0,1,-1,-1,2246,-1,3.608364e-05,0.99994993,1.3971405e-05
2248,TGF-beta-dependent IL-6 trans-signaling,26,29,179,218,"Taken together, our data provide novel insights into TGF-beta signaling in colorectal cancer and suggest novel therapeutic approaches for colorectal cancer based on inhibition of TGF-beta-dependent IL-6 trans-signaling.",15485627_4,-1,-1,-1,-1,2248,-1,0.00013636482,0.99980575,5.7850735e-05
2251,receptor,4,5,28,36,The killer cell lectin-like receptor G1 (KLRG1) is expressed in natural killer (NK) cells and effector memory alphabeta T cells.,15498816_0,0,1,2,-1,2251,-1,8.0785474e-05,0.000115361836,0.99980384
2264,to the,14,16,97,103,Vgamma9/Vdelta2 T cells comprise the majority of peripheral human gammadelta T cells and respond to the microbial metabolite (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP).,15498816_2,-1,-1,-1,-1,2264,-1,2.134082e-05,0.9999683,1.0387928e-05
2267,blood,18,19,108,113,"Here, we demonstrate that KLRG1 is expressed in a significant proportion of Vgamma9/Vdelta2 T cells in cord blood and in the majority of peripheral Vgamma9/Vdelta2 T cells from adult donors.",15498816_3,0,1,-1,-1,2267,-1,0.00021176733,0.99710363,0.0026845383
2272,chemokine receptor,29,31,164,182,"KLRG1+ Vgamma9/Vdelta2 T cells displayed an effector memory phenotype, as KLRG1 was expressed mainly in Vgamma9/Vdelta2 T cells lacking CD27, CD45RA, CD62L, and CC chemokine receptor 7 (CCR7).",15498816_4,-1,-1,-1,-1,2272,-1,0.24639297,0.0019624732,0.75164455
2282,tumor antigens,5,7,39,53,"BACKGROUND: Although immunization with tumor antigens can eliminate many transplantable tumors in animal models, immune effector mechanisms associated with successful immunotherapy of epithelial cancers remain undefined.",15523090_0,-1,-1,-1,-1,2282,-1,0.29122558,0.6965336,0.012240749
2283,transplantable tumors,10,12,73,94,"BACKGROUND: Although immunization with tumor antigens can eliminate many transplantable tumors in animal models, immune effector mechanisms associated with successful immunotherapy of epithelial cancers remain undefined.",15523090_0,-1,-1,-1,-1,2283,-1,3.22909e-05,0.9999502,1.7518625e-05
2286,tumor antigen,10,12,77,90,"METHODS: Skin from transgenic mice expressing the cervical cancer-associated tumor antigen human papillomavirus type 16 (HPV16) E6 or E7 proteins from a keratin 14 promoter was grafted onto syngeneic, non-transgenic mice.",15523090_1,-1,-1,-1,-1,2286,-1,0.23922542,0.73938817,0.021386415
2288,proteins,22,23,137,145,"METHODS: Skin from transgenic mice expressing the cervical cancer-associated tumor antigen human papillomavirus type 16 (HPV16) E6 or E7 proteins from a keratin 14 promoter was grafted onto syngeneic, non-transgenic mice.",15523090_1,0,1,-1,-1,2288,-1,0.0012585067,0.9970483,0.0016931959
2290,antigen-specific T cells,15,18,99,123,Skin graft rejection was measured after active immunization with HPV16 E7 and adoptive transfer of antigen-specific T cells.,15523090_2,-1,-1,-1,-1,2290,-1,0.34756792,0.003063871,0.6493683
2294,protein,50,51,359,366,"Cytokine secretion of lymphocytes from mice receiving skin grafts and immunotherapy was detected by enzyme-linked immunosorbent assay, and HPV16 E7-specific memory CD8+ T cells were detected by flow cytometry and ELISPOT.RESULTS: Skin grafts containing HPV16 E6-or E7-expressing keratinocytes were not rejected spontaneously or following immunization with E7 protein and adjuvant.",15523090_3,0,1,-1,-1,2294,-1,0.0011147206,0.9972,0.0016853124
2296,T-cell receptor transgenic,4,7,33,59,Adoptive transfer of E7-specific T-cell receptor transgenic CD8+ T cells combined with immunization resulted in induction of antigen-specific interferon gamma-secreting CD8+ T cells and rejection of HPV16 E7-expressing grafts.,15523090_4,-1,-1,-1,-1,2296,-1,0.00088068156,0.009776322,0.98934305
2298,antigen-specific interferon,18,20,125,152,Adoptive transfer of E7-specific T-cell receptor transgenic CD8+ T cells combined with immunization resulted in induction of antigen-specific interferon gamma-secreting CD8+ T cells and rejection of HPV16 E7-expressing grafts.,15523090_4,-1,-1,-1,-1,2298,-1,0.99978465,7.67172e-05,0.00013863541
2305,tumor antigen,13,15,86,99,"CONCLUSIONS: Antigen-specific CD8+ T cells can destroy epithelium expressing HPV16 E7 tumor antigen, but presentation of E7 antigen from skin is insufficient to reactivate memory CD8+ T cells induced by immunotherapy.",15523090_7,-1,-1,-1,-1,2305,-1,0.59598964,0.38781667,0.016193712
2314,function,9,10,46,54,"In this study, we describe the expression and function of CD40, a TNF receptor family member, in cervical carcinomas.",15611226_0,0,1,2,-1,2314,-1,3.9174698e-05,0.9999356,2.524874e-05
2315,TNF receptor,14,16,66,78,"In this study, we describe the expression and function of CD40, a TNF receptor family member, in cervical carcinomas.",15611226_0,-1,-1,-1,-1,2315,-1,0.00033078413,0.9970796,0.0025896914
2321,the NF-kappaB,18,20,116,129,The stimulation of CD40-positive cervical carcinoma cell lines with soluble CD40L (CD154) resulted in activation of the NF-kappaB and MAPK signaling pathways and up-regulation of cell surface markers and intracellular molecules associated with Ag processing and presentation.,15611226_2,-1,-1,-1,-1,2321,-1,3.0411724e-05,0.99995613,1.3482513e-05
2323,the CD154-induced,2,4,15,32,"Concomitantly, the CD154-induced activation of CD40 in carcinoma cells was found to directly influence susceptibility to CTL-mediated killing.",15611226_3,-1,-1,-1,-1,2323,-1,0.00019733049,0.9995036,0.00029909977
2326,to CTL-mediated,16,18,118,133,"Concomitantly, the CD154-induced activation of CD40 in carcinoma cells was found to directly influence susceptibility to CTL-mediated killing.",15611226_3,-1,-1,-1,-1,2326,-1,0.0021542276,0.0919237,0.90592206
2332,CD154 treatment,2,4,9,24,"However, CD154 treatment of carcinoma cells expressing proteasome-dependent but TAP-independent Ags from the EBV-encoded BRLF1 and BMLF1 failed to increase tumor cell lysis by specific CTLs.",15611226_5,-1,-1,-1,-1,2332,-1,0.0027799427,0.025994321,0.97122574
2337,tumor cell,21,23,156,166,"However, CD154 treatment of carcinoma cells expressing proteasome-dependent but TAP-independent Ags from the EBV-encoded BRLF1 and BMLF1 failed to increase tumor cell lysis by specific CTLs.",15611226_5,-1,-1,-1,-1,2337,-1,0.0040545207,0.32162786,0.6743176
2339,that chemotherapeutic,4,6,25,46,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,-1,-1,-1,-1,2339,-1,0.0016937838,0.99816245,0.00014378417
2341,protein,9,10,68,75,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,0,1,-1,-1,2341,-1,0.00026566343,0.99945253,0.0002817603
2343,the translational,17,19,132,149,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,-1,-1,-1,-1,2343,-1,1.9912011e-05,0.99996936,1.0770529e-05
2345,protein,24,25,200,207,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,0,1,-1,-1,2345,-1,2.4030896e-05,0.9999553,2.0692034e-05
2346,the initiation factor,26,29,213,234,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,-1,-1,-1,-1,2346,-1,2.068849e-05,0.99996614,1.3197305e-05
2349,cells to CD40L-induced,50,53,381,403,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,-1,-1,-1,-1,2349,-1,0.00063944043,0.004989177,0.9943715
2350,Taken together,0,2,0,14,"Taken together, these observations demonstrate the functional expression of CD40 in epithelial tumors of the cervix and support the clinical exploitation of the CD40 pathway for the treatment of cervical cancer through its multiple effects on tumor cell growth, apoptosis, and immune recognition.",15611226_7,-1,-1,-1,-1,2350,-1,4.6624806e-05,0.99993455,1.880768e-05
2352,the functional,6,8,47,61,"Taken together, these observations demonstrate the functional expression of CD40 in epithelial tumors of the cervix and support the clinical exploitation of the CD40 pathway for the treatment of cervical cancer through its multiple effects on tumor cell growth, apoptosis, and immune recognition.",15611226_7,-1,-1,-1,-1,2352,-1,1.8994178e-05,0.9999722,8.796947e-06
2357,the treatment,27,29,178,191,"Taken together, these observations demonstrate the functional expression of CD40 in epithelial tumors of the cervix and support the clinical exploitation of the CD40 pathway for the treatment of cervical cancer through its multiple effects on tumor cell growth, apoptosis, and immune recognition.",15611226_7,-1,-1,-1,-1,2357,-1,2.2451452e-05,0.9999672,1.0294809e-05
2359,tumor cell,37,39,243,253,"Taken together, these observations demonstrate the functional expression of CD40 in epithelial tumors of the cervix and support the clinical exploitation of the CD40 pathway for the treatment of cervical cancer through its multiple effects on tumor cell growth, apoptosis, and immune recognition.",15611226_7,-1,-1,-1,-1,2359,-1,0.0032827884,0.34465727,0.65206
2363,factor,17,18,103,109,"Since the intrinsically poor immunogenicity of chronic lymphocytic leukemia (CLL) cells might be a key factor in allowing them to avoid immune control mechanisms, the development of methods to enhance CLL cell immunogenicity might lead to improved disease control.",15614042_0,0,1,-1,-1,2363,-1,0.0010149349,0.9988201,0.00016489194
2364,them to,20,22,122,129,"Since the intrinsically poor immunogenicity of chronic lymphocytic leukemia (CLL) cells might be a key factor in allowing them to avoid immune control mechanisms, the development of methods to enhance CLL cell immunogenicity might lead to improved disease control.",15614042_0,-1,-1,-1,-1,2364,-1,2.9253708e-05,0.9999603,1.0446569e-05
2370,cells to,4,6,19,27,The ability of CLL cells to stimulate T cells was increased significantly by the protein kinase C (PKC) agonist phorbol myristic acetate (PMA).,15614042_1,-1,-1,-1,-1,2370,-1,0.0031308923,0.14513847,0.85173064
2372,the protein,13,15,77,88,The ability of CLL cells to stimulate T cells was increased significantly by the protein kinase C (PKC) agonist phorbol myristic acetate (PMA).,15614042_1,-1,-1,-1,-1,2372,-1,2.3870445e-05,0.9999604,1.5724241e-05
2375,these cells,18,20,95,106,"Antioxidants, such as 2-mercaptoethanol (2-ME), or fetal calf serum could prevent the death of these cells but caused them to enter distinct states of differentiation.",15614042_3,-1,-1,-1,-1,2375,-1,0.000878527,0.023470273,0.9756512
2376,them to,22,24,118,125,"Antioxidants, such as 2-mercaptoethanol (2-ME), or fetal calf serum could prevent the death of these cells but caused them to enter distinct states of differentiation.",15614042_3,-1,-1,-1,-1,2376,-1,3.01792e-05,0.9999542,1.5630028e-05
2380,T-cell,15,16,109,115,"In the presence of 2-ME, PMA-activated CLL cells extended dendritic-like protrusions and exhibited increased T-cell stimulatory capacity.",15614042_4,-1,1,2,-1,2380,-1,4.1408082e-05,5.1236326e-05,0.9999074
2385,IL-12 p40,18,20,102,111,"In the presence of serum, PMA-activated CLL cells developed fewer dendrites, made less IL-10 and more IL-12 p40 mRNA transcripts, and showed an increased capacity to induce IFN-gamma production by T cells.",15614042_5,-1,-1,-1,-1,2385,-1,0.9914653,0.0007751291,0.0077596516
2395,the NF-kappaB,24,26,150,163,The effects of serum on the promotion of type 1 immune responses by phorbol ester-activated CLL cells were dominant and correlated with activation of the NF-kappaB signaling pathway.,15614042_6,-1,-1,-1,-1,2395,-1,2.693353e-05,0.99996185,1.1223529e-05
2396,agonists,2,3,10,18,"Other PKC agonists, such as Bryostatin-1 and a synthetic Bryostatin analog (Picolog), had similar effects on CLL cells.",15614042_7,0,1,-1,-1,2396,-1,0.10650402,0.87577087,0.017725078
2401,cells that,10,12,65,75,The observation that CLL cells can acquire features of dendritic cells that promote type 1 immunity may find clinical application in immunotherapeutic strategies for this disease.,15614042_8,-1,-1,-1,-1,2401,-1,0.0043980656,0.12577173,0.86983025
2403,immunity,15,16,91,99,The observation that CLL cells can acquire features of dendritic cells that promote type 1 immunity may find clinical application in immunotherapeutic strategies for this disease.,15614042_8,0,-1,2,-1,2403,-1,0.99906975,0.00065271155,0.0002776657
2408,tumor-specific antigen,25,27,117,139,PURPOSE: The idiotype (Id) of the immunoglobulin on a given B-cell malignancy is a clonal marker that can serve as a tumor-specific antigen.,15623607_0,-1,-1,-1,-1,2408,-1,0.07547278,0.917183,0.0073442194
2409,protein,10,11,61,68,"We developed a novel vaccine formulation by incorporating Id protein with liposomal lymphokine that was more potent than a prototype, carrier-conjugated Id protein vaccine in preclinical studies.",15623607_1,0,1,-1,-1,2409,-1,0.0013807128,0.9968561,0.0017631316
2410,lymphokine that,13,15,84,99,"We developed a novel vaccine formulation by incorporating Id protein with liposomal lymphokine that was more potent than a prototype, carrier-conjugated Id protein vaccine in preclinical studies.",15623607_1,-1,-1,-1,-1,2410,-1,0.7342363,0.07944838,0.18631537
2412,protein,25,26,156,163,"We developed a novel vaccine formulation by incorporating Id protein with liposomal lymphokine that was more potent than a prototype, carrier-conjugated Id protein vaccine in preclinical studies.",15623607_1,0,1,-1,-1,2412,-1,0.001410356,0.99719465,0.0013949223
2428,lymphocyte antigen,17,19,83,101,"Antitumor immune responses were mediated by both CD4+ and CD8+ T cells, were human lymphocyte antigen class I and II associated, and persisted 18 months beyond the completion of vaccination.",15623607_6,-1,-1,-1,-1,2428,-1,0.06407477,0.0010850846,0.9348401
2434,T-cell,26,27,163,169,"CONCLUSIONS: This first clinical report of a liposomal cancer vaccine demonstrates that liposomal delivery is safe, induces sustained tumor-specific CD4+ and CD8+ T-cell responses in lymphoma patients, and may serve as a model for vaccine development against other human cancers and infectious pathogens.",15623607_9,-1,1,2,-1,2434,-1,4.839544e-05,7.957273e-05,0.99987197
2452,STAT6-deficient MSCs,3,5,19,39,"Neither BALB/c nor STAT6-deficient MSCs produce inducible NO synthase; however, both produce arginase and reactive oxygen species.",15634881_4,-1,-1,-1,-1,2452,-1,5.753178e-05,0.9999094,3.3096505e-05
2456,Immunity,0,1,0,8,"Immunity in STAT6-deficient mice requires the activation of NO-producing M1 macrophages that are tumoricidal, the reduction in MSC levels to baseline after surgical removal of primary tumor, and the activation of tumor-specific T cells.",15634881_6,0,-1,2,-1,2456,-1,0.9377113,0.0605893,0.0016993211
2466,tumor-specific T cells,33,36,213,235,"Immunity in STAT6-deficient mice requires the activation of NO-producing M1 macrophages that are tumoricidal, the reduction in MSC levels to baseline after surgical removal of primary tumor, and the activation of tumor-specific T cells.",15634881_6,-1,-1,-1,-1,2466,-1,0.0054699043,0.6980643,0.29646578
2468,STAT6 deficiency,8,10,50,66,"These mechanisms occur in STAT6(-/-) mice because STAT6 deficiency prevents signaling through the type 2 IL-4Ralpha, thereby blocking the production of arginase and promoting the synthesis of NO.",15634881_7,-1,-1,-1,-1,2468,-1,2.6625034e-05,0.99995065,2.2767734e-05
2469,through the type,12,15,86,102,"These mechanisms occur in STAT6(-/-) mice because STAT6 deficiency prevents signaling through the type 2 IL-4Ralpha, thereby blocking the production of arginase and promoting the synthesis of NO.",15634881_7,-1,-1,-1,-1,2469,-1,2.9987294e-05,0.99994934,2.0684356e-05
2478,immunity,5,6,47,55,"Strategies to stimulate CTL-mediated antitumor immunity have included in vitro stimulation and/or genetic engineering of T cells, followed by adoptive transfer into tumor-bearing hosts.",15661898_1,0,-1,2,-1,2478,-1,0.9987097,0.00087287545,0.00041738412
2487,Th1 cells to,17,20,74,86,"In this model of B cell lymphoma in SJL/J mice, we used Tim-3(+) T-bet(+) Th1 cells to facilitate the development of tumor-specific CTL.",15661898_2,-1,-1,-1,-1,2487,-1,0.0014790476,0.06500447,0.9335165
2489,tumor-specific CTL,24,26,117,135,"In this model of B cell lymphoma in SJL/J mice, we used Tim-3(+) T-bet(+) Th1 cells to facilitate the development of tumor-specific CTL.",15661898_2,-1,-1,-1,-1,2489,-1,0.0041190735,0.7009213,0.29495963
2490,Tumor-specific Th1 cell,0,3,0,23,Tumor-specific Th1 cell lines were polarized with IL-12 during in vitro stimulation and long term maintenance.,15661898_3,-1,-1,-1,-1,2490,-1,0.0034593607,0.71778136,0.27875927
2497,transplantable cells,18,20,97,117,As few as 5 million Tim-3(+) T-bet(+) Th1 cells enabled recipients to resist growth of malignant transplantable cells.,15661898_4,-1,-1,-1,-1,2497,-1,0.0047994847,0.36476457,0.6304359
2502,tumor cells,7,9,44,55,"CFSE(+) Th1 cells colocalized with injected tumor cells in vivo and formed conjugates with the tumor cells within follicles, whereas in nontumor-challenged recipients the CFSE(+) Th1 cells localized only within the T cell zones of the spleen.",15661898_6,-1,-1,-1,-1,2502,-1,0.0041464707,0.28315055,0.712703
2503,the tumor cells,15,18,91,106,"CFSE(+) Th1 cells colocalized with injected tumor cells in vivo and formed conjugates with the tumor cells within follicles, whereas in nontumor-challenged recipients the CFSE(+) Th1 cells localized only within the T cell zones of the spleen.",15661898_6,-1,-1,-1,-1,2503,-1,0.0035601454,0.7329019,0.26353794
2506,the T cell,33,36,211,221,"CFSE(+) Th1 cells colocalized with injected tumor cells in vivo and formed conjugates with the tumor cells within follicles, whereas in nontumor-challenged recipients the CFSE(+) Th1 cells localized only within the T cell zones of the spleen.",15661898_6,-1,-1,-1,-1,2506,-1,0.0023949938,0.09749081,0.9001142
2512,tumor-specific Th1 cells,12,15,82,106,These results provide evidence that adoptive immunotherapy with Tim-3(+) T-bet(+) tumor-specific Th1 cells can be used to induce host cytotoxic responses that inhibit the development and growth of neoplastic cells.,15661898_7,-1,-1,-1,-1,2512,-1,0.003842505,0.61182135,0.3843361
2520,immunity,19,20,118,126,NKT cells are a regulatory subset of T lymphocytes with immune modulatory effects and an important role in anti-tumor immunity.,15688366_0,0,-1,2,-1,2520,-1,0.9993461,0.00043686287,0.00021709225
2532,NKT cell transplantation,6,9,29,53,Group D mice did not undergo NKT cell transplantation.,15688366_5,-1,-1,-1,-1,2532,-1,0.0011791546,0.12577686,0.87304395
2553,the transcription factor STAT4,2,6,14,44,"Expression of the transcription factor STAT4 was evident in group A, but not in groups B-D. Serum IFNgamma, IL12 and IL4 levels were increased in groups A and E. Adoptive transfer of NKT lymphocytes exposed ex vivo by HCC-derived antigens loaded on dendritic cells and NKT cells from immunized donors led to suppression of HCC in mice.",15688366_12,-1,-1,-1,-1,2553,-1,1.9233792e-05,0.99996674,1.4059214e-05
2566,cytokines IFNgamma,31,33,201,219,"NKT-mediated anti-tumor activity was associated increased NKT and CD8+ T lymphocyte numbers, increased expression of STAT4, a marker for IL-12 activity and elevated serum levels of the proinflammatory cytokines IFNgamma and IL12, and of IL4.",15688366_13,-1,-1,-1,-1,2566,-1,0.9998012,4.973553e-05,0.00014912755
2569,therapy,13,14,78,85,Ex-vivo modulation of NKT lymphocytes holds promise as a novel mode of immune therapy for HCC.,15688366_14,0,1,-1,-1,2569,-1,2.5310213e-05,0.9999621,1.2550488e-05
2570,Transfecting genes,0,2,0,18,"Transfecting genes into tumors, to upregulate major histocompatibility complex (MHC) class I and class II molecules and inhibit MHC class II associated invariant chain (Ii), induces a potent anti-tumor immune response when preceded by tumor irradiation, in murine RM-9 prostate carcinoma.",15761259_0,-1,-1,-1,-1,2570,-1,2.1487622e-05,0.99996567,1.2837234e-05
2576,The transfected genes,0,3,0,21,"The transfected genes are cDNA plasmids for interferon-gamma (pIFN-gamma), MHC class II transactivator (pCIITA), an Ii reverse gene construct (pIi-RGC), and a subtherapeutic dose of adjuvant IL-2 (pIL-2).",15761259_1,-1,-1,-1,-1,2576,-1,2.2614142e-05,0.9999614,1.6012369e-05
2582,tumor-specific cytotoxic T lymphocytes,9,13,72,110,Responding mice rejected challenge with parental tumor and demonstrated tumor-specific cytotoxic T lymphocytes (CTLs).,15761259_2,-1,-1,-1,-1,2582,-1,0.0049737436,0.506709,0.48831725
2585,the relative,7,9,48,60,"We have extended our investigation to determine the relative roles of each one of the four plasmids pIFN-gamma, pCIITA, pIi-RGC, and pIL-2 in conjunction with radiation for the induction of a curative immune response.",15761259_3,-1,-1,-1,-1,2585,-1,2.210754e-05,0.99996495,1.2915274e-05
2594,tumor cells,22,24,115,126,"An optimal and specific antitumor response is achieved in more than 50% of the mice when, after tumor irradiation, tumor cells are converted in situ to a MHC class I+/class II+/Ii- phenotype with pIFN-gamma, pCIITA, pIi-RGC, and pIL-2.",15761259_5,-1,-1,-1,-1,2594,-1,0.0040436015,0.4902451,0.5057113
2602,to the gene therapy,3,7,26,45,The radiation contributes to the gene therapy by causing tumor debulking and increasing the permeability of tumors to infiltration of inflammatory cells.,15761259_7,-1,-1,-1,-1,2602,-1,3.837189e-05,0.99994457,1.7115648e-05
2605,tumors to,16,18,108,117,The radiation contributes to the gene therapy by causing tumor debulking and increasing the permeability of tumors to infiltration of inflammatory cells.,15761259_7,-1,-1,-1,-1,2605,-1,2.3761728e-05,0.99996555,1.0711761e-05
2608,cytokine interferon-gamma,3,5,29,54,"Although the proinflammatory cytokine interferon-gamma (IFN-gamma) has been generally thought to enhance antitumor immune responses and be involved in antitumor mechanisms of many other immunotherapy molecules, it has also been reported that IFN-gamma could promote tumor immune evasion.",15776283_0,-1,-1,-1,-1,2608,-1,0.9998828,3.427964e-05,8.280121e-05
2610,generally thought to,10,13,76,96,"Although the proinflammatory cytokine interferon-gamma (IFN-gamma) has been generally thought to enhance antitumor immune responses and be involved in antitumor mechanisms of many other immunotherapy molecules, it has also been reported that IFN-gamma could promote tumor immune evasion.",15776283_0,-1,-1,-1,-1,2610,-1,3.146454e-05,0.99995637,1.2178557e-05
2612,that IFN-gamma,34,36,237,251,"Although the proinflammatory cytokine interferon-gamma (IFN-gamma) has been generally thought to enhance antitumor immune responses and be involved in antitumor mechanisms of many other immunotherapy molecules, it has also been reported that IFN-gamma could promote tumor immune evasion.",15776283_0,-1,-1,-1,-1,2612,-1,0.88795125,0.108466275,0.0035824622
2629,the tumor,20,22,110,119,"Low level of IFN-gamma upregulates expression of PD-L1, PD-L2, CTLA-4 and Foxp3, which may partly account for the tumor immune evasion promoted by IFN-gamma.",15776283_4,-1,-1,-1,-1,2629,-1,2.1469712e-05,0.9999701,8.431845e-06
2637,that regulatory T cells,5,9,37,60,"Experimental tumor models have shown that regulatory T cells, a functionally unique subset of T cells, can suppress effective antitumor immune responses.",15781662_1,-1,-1,-1,-1,2637,-1,0.002359562,0.09146142,0.906179
2638,functionally,11,12,64,76,"Experimental tumor models have shown that regulatory T cells, a functionally unique subset of T cells, can suppress effective antitumor immune responses.",15781662_1,0,1,2,-1,2638,-1,0.00010588897,0.999845,4.9100523e-05
2650,analysis,18,19,123,131,Regulatory T cells were identified by fluorescence-activated cell sorting using a panel of antibodies and by real-time PCR analysis for Foxp3 expression.,15781662_5,0,1,-1,-1,2650,-1,4.1370615e-05,0.99991477,4.3913602e-05
2652,Functional,0,1,0,10,Functional studies were done to analyze their inhibitory role.,15781662_6,0,1,2,-1,2652,-1,3.4242454e-05,0.99994767,1.8083474e-05
2659,blood,15,16,93,98,"Patients with HCC have increased numbers of CD4+CD25+ regulatory T cells in their peripheral blood, which express high levels of HLA-DR, GITR, and low or no CD45RA.",15781662_8,0,1,-1,-1,2659,-1,0.00038516964,0.9905556,0.009059204
2660,These cells,0,2,0,11,"These cells were anergic toward T-cell receptor stimulation and, when cocultured with activated CD4+CD25- cells, potently suppressed their proliferation and cytokine secretion.",15781662_9,-1,-1,-1,-1,2660,-1,0.0036330046,0.27898997,0.717377
2661,toward T-cell receptor,4,7,25,47,"These cells were anergic toward T-cell receptor stimulation and, when cocultured with activated CD4+CD25- cells, potently suppressed their proliferation and cytokine secretion.",15781662_9,-1,-1,-1,-1,2661,-1,0.0019621437,0.042659223,0.9553787
2667,tumor-infiltrating lymphocytes,10,12,54,84,There were also high numbers of regulatory T cells in tumor-infiltrating lymphocytes of HCC patients comparable with the increase in their peripheral blood.,15781662_10,-1,-1,-1,-1,2667,-1,0.003280313,0.8935032,0.103216544
2670,blood,22,23,150,155,There were also high numbers of regulatory T cells in tumor-infiltrating lymphocytes of HCC patients comparable with the increase in their peripheral blood.,15781662_10,0,1,-1,-1,2670,-1,0.00055794884,0.9829448,0.016497308
2671,that the,3,5,17,25,Our data suggest that the increase in frequency of regulatory T cells might play a role in modulation of the immune response against HCC and could be important in design of immunotherapeutic approaches.,15781662_11,-1,-1,-1,-1,2671,-1,1.837387e-05,0.9999734,8.237656e-06
2674,the immune response,19,22,105,124,Our data suggest that the increase in frequency of regulatory T cells might play a role in modulation of the immune response against HCC and could be important in design of immunotherapeutic approaches.,15781662_11,-1,-1,-1,-1,2674,-1,0.1889196,0.8100123,0.0010680996
2675,T cell-mediated immunity that,8,12,53,82,A novel vaccination strategy induced specific CD8(+) T cell-mediated immunity that eradicated spontaneous and experimental pulmonary cancer metastases in syngeneic mice and was also effective in a therapeutic setting of established breast cancer metastases.,15833877_0,-1,-1,-1,-1,2675,-1,0.0029652198,0.021193853,0.975841
2678,targeting transcription factor Fos-related antigen,4,9,21,71,"This was achieved by targeting transcription factor Fos-related antigen 1(Fra-1), overexpressed by many tumor cells, with an ubiquitinated DNA vaccine against Fra-1, coexpressing secretory IL-18.",15833877_1,-1,-1,-1,-1,2678,-1,0.0056617833,0.9897222,0.0046160906
2679,tumor cells,15,17,104,115,"This was achieved by targeting transcription factor Fos-related antigen 1(Fra-1), overexpressed by many tumor cells, with an ubiquitinated DNA vaccine against Fra-1, coexpressing secretory IL-18.",15833877_1,-1,-1,-1,-1,2679,-1,0.003960089,0.48910958,0.50693035
2688,tissues,11,12,79,86,"Specifically, long-lived T memory cells were maintained dormant in nonlymphoid tissues by IL-18 in the absence of tumor antigen.",15833877_3,-1,1,2,-1,2688,-1,0.00024377726,0.99760085,0.0021553386
2691,tumor antigen,18,20,114,127,"Specifically, long-lived T memory cells were maintained dormant in nonlymphoid tissues by IL-18 in the absence of tumor antigen.",15833877_3,-1,-1,-1,-1,2691,-1,0.41552505,0.5712117,0.0132632535
2692,tumor cell,4,6,22,32,"Importantly, a second tumor cell challenge of these SCID mice restored both, robust tumor-specific cytotoxicity and long-lived T-cell memory, capable of eradicating established pulmonary cancer metastases, suggesting that this vaccine could be effective against tumor recurrence.",15833877_4,-1,-1,-1,-1,2692,-1,0.0032032062,0.28409624,0.71270055
2695,T-cell,19,20,127,133,"Importantly, a second tumor cell challenge of these SCID mice restored both, robust tumor-specific cytotoxicity and long-lived T-cell memory, capable of eradicating established pulmonary cancer metastases, suggesting that this vaccine could be effective against tumor recurrence.",15833877_4,-1,1,2,-1,2695,-1,4.0003437e-05,5.5592267e-05,0.9999044
2696,that this,31,33,217,226,"Importantly, a second tumor cell challenge of these SCID mice restored both, robust tumor-specific cytotoxicity and long-lived T-cell memory, capable of eradicating established pulmonary cancer metastases, suggesting that this vaccine could be effective against tumor recurrence.",15833877_4,-1,-1,-1,-1,2696,-1,2.2411876e-05,0.9999691,8.478929e-06
2699,tumor that,8,10,52,62,The mouse 4T1 mammary carcinoma is a BALB/c-derived tumor that spontaneously metastasizes and induces immune suppression.,15877228_0,-1,-1,-1,-1,2699,-1,2.2059974e-05,0.9999645,1.34796555e-05
2704,Transducer Activator,34,36,168,188,"Although >95% of wild type BALB/c mice die from metastatic 4T1 tumor even if the primary mammary tumor is surgically removed, >65% of BALB/c mice with a deleted Signal Transducer Activator of Transcription 6 (STAT6) gene survive post-surgery.",15877228_1,-1,-1,-1,-1,2704,-1,3.0365258e-05,0.9999511,1.8531295e-05
2709,immunity,4,5,39,47,STAT6-deficiency also confers enhanced immunity against spontaneously developing breast cancer since NeuT+/- mice that are STAT6-deficient develop mammary tumors later and survive longer than NeuT+/- mice that are STAT6-competent.,15877228_2,0,-1,2,-1,2709,-1,0.99515057,0.0043636695,0.0004858149
2719,The generation,21,23,131,145,Rejection of metastastic disease and survival of STAT6-deficient mice after removal of primary tumor involve three mechanisms: (1) The generation of M1 type macrophages that produce nitric oxide and are tumoricidal; (2) A decrease to normal in the elevated levels of myeloid suppressor cells that accumulate during primary tumor growth; and (3) CD8+ tumor-specific T lymphocytes.,15877228_3,-1,-1,-1,-1,2719,-1,1.6654478e-05,0.99997044,1.2878127e-05
2725,suppressor cells that,48,51,275,296,Rejection of metastastic disease and survival of STAT6-deficient mice after removal of primary tumor involve three mechanisms: (1) The generation of M1 type macrophages that produce nitric oxide and are tumoricidal; (2) A decrease to normal in the elevated levels of myeloid suppressor cells that accumulate during primary tumor growth; and (3) CD8+ tumor-specific T lymphocytes.,15877228_3,-1,-1,-1,-1,2725,-1,0.0019821043,0.04868955,0.94932836
2727,tumor-specific T lymphocytes,63,66,350,378,Rejection of metastastic disease and survival of STAT6-deficient mice after removal of primary tumor involve three mechanisms: (1) The generation of M1 type macrophages that produce nitric oxide and are tumoricidal; (2) A decrease to normal in the elevated levels of myeloid suppressor cells that accumulate during primary tumor growth; and (3) CD8+ tumor-specific T lymphocytes.,15877228_3,-1,-1,-1,-1,2727,-1,0.004480144,0.6865635,0.30895633
2732,the STAT6 transcription factor,17,21,110,140,"STAT6-deficient, but not wild type BALB/c, mice generate nitric oxide producing macrophages because they lack the STAT6 transcription factor which is necessary for signaling through the type 2 IL-4Ralpha complex, and which induces the production of arginase instead of nitric oxide.",15877228_4,-1,-1,-1,-1,2732,-1,2.6885684e-05,0.9999596,1.3548037e-05
2733,through the type,26,29,174,190,"STAT6-deficient, but not wild type BALB/c, mice generate nitric oxide producing macrophages because they lack the STAT6 transcription factor which is necessary for signaling through the type 2 IL-4Ralpha complex, and which induces the production of arginase instead of nitric oxide.",15877228_4,-1,-1,-1,-1,2733,-1,2.7312795e-05,0.99995756,1.5150175e-05
2738,tumor immunology,3,5,16,32,"This paradox in tumor immunology led us to address two questions: (a) Does an antitumor response, which is intended to destroy the aberrant target population, also at the same time select for aggressive tumor variants (ATV) in vivo? (b) If this process does occur, what is the contribution of the perforin- or Fas-mediated effector mechanism in the immune selection of such ATV? Here, in an experimental mouse lung metastasis model, we showed that ATV generated either naturally in vivo or in vitro by anti-Fas selection resembled each other biologically and genetically as judged by enhanced tumor growth and genome-scale gene expression profiling, respectively.",15899830_1,-1,-1,-1,-1,2738,-1,0.00037484887,0.9994974,0.00012776926
2759,function,18,19,117,125,"Furthermore, ATV that survived CTL adoptive immunotherapy displayed an even more profound loss of Fas expression and function as well as enhanced malignant proficiency in vivo.",15899830_2,0,1,2,-1,2759,-1,9.01096e-05,0.9998424,6.744869e-05
2762,IFN-gamma-regulated genes,12,14,78,103,"Lastly, such ATV displayed a diminished responsiveness in their expression of IFN-gamma-regulated genes, including those mechanistically linked to Fas-mediated death (i.e., Fas and caspase-1).",15899830_4,-1,-1,-1,-1,2762,-1,0.9915326,0.0061119297,0.0023554433
2768,IFN-gamma-regulated gene,50,52,252,276,"Overall, we showed that (a) immune selection did occur in vivo and played an important role in the emergence of ATV, (b) ATV bearing a Fas-resistant phenotype was a chief consequence of immune selection, and (c) an overall diminished responsiveness of IFN-gamma-regulated gene expression was characteristic of ATV.",15899830_5,-1,-1,-1,-1,2768,-1,0.9909204,0.0067819743,0.0022975595
2771,IFN-gamma-regulated gene,12,14,64,88,"Thus, in this model, Fas-mediated cytotoxicity, in concert with IFN-gamma-regulated gene expression, mechanistically constituted significant determinants of immune selection of ATV in vivo.",15899830_6,-1,-1,-1,-1,2771,-1,0.99157387,0.0056427093,0.002783347
2775,therapeutic immunity,11,13,92,112,"We previously demonstrated that IL-4 gene-transfected glioma cell vaccines induce effective therapeutic immunity in preclinical glioma models, and have initiated phase I trials of these vaccines in patients with malignant gliomas.",15905564_0,-1,-1,-1,-1,2775,-1,0.023595573,0.9757869,0.0006175408
2787,tumor cells,33,35,200,211,"IL-12/23 p40(-/-) and IFN-gamma(-/-) mice, which were able to reject the initial inoculation of IL-4 expressing tumors, failed to mount a sustained systemic response against parental (nontransfected) tumor cells.",15905564_2,-1,-1,-1,-1,2787,-1,0.0035661687,0.47462732,0.52180654
2789,IL-12p70-secreting tumor-infiltrating,13,15,90,127,Paracrine production of IL-4 in vaccine sites promoted the accumulation and maturation of IL-12p70-secreting tumor-infiltrating dendritic cells (TIDCs).,15905564_3,-1,-1,-1,-1,2789,-1,0.96522343,0.017381396,0.017395243
2794,tumor-specific CTL,20,22,121,139,"Adoptive transfer of TIDCs isolated from vaccinated wild-type, but not IL-12/23 p40(-/-), mice were capable of promoting tumor-specific CTL responses in syngeneic recipient animals.",15905564_4,-1,-1,-1,-1,2794,-1,0.0049012206,0.7168577,0.27824107
2798,TIDCs to,21,23,132,140,"Interestingly, both STAT4(-/-) and STAT6(-/-) mice failed to reject IL-4-transfected tumors in concert with the reduced capacity of TIDCs to produce IL-12p70 and to promote specific antitumor CTL reactivity.",15905564_5,-1,-1,-1,-1,2798,-1,1.9849665e-05,0.99996424,1.587793e-05
2804,tumor cells,7,9,50,61,"These results suggest that vaccines consisting of tumor cells engineered to produce the type 2 cytokine, IL-4, critically depend on type 1 immunity for their observed therapeutic efficacy.",15905564_6,-1,-1,-1,-1,2804,-1,0.004444741,0.43900746,0.55654776
2806,the type,12,14,84,92,"These results suggest that vaccines consisting of tumor cells engineered to produce the type 2 cytokine, IL-4, critically depend on type 1 immunity for their observed therapeutic efficacy.",15905564_6,-1,-1,-1,-1,2806,-1,3.171463e-05,0.9999511,1.7179227e-05
2809,immunity,24,25,139,147,"These results suggest that vaccines consisting of tumor cells engineered to produce the type 2 cytokine, IL-4, critically depend on type 1 immunity for their observed therapeutic efficacy.",15905564_6,0,-1,2,-1,2809,-1,0.9986993,0.00086286047,0.0004377736
2813,that plays,7,9,37,47,IL-27 is a novel IL-12 family member that plays a role in the early regulation of Th1 initiation.,16034109_0,-1,-1,-1,-1,2813,-1,2.7373717e-05,0.9999597,1.2883344e-05
2842,the generation,19,21,128,142,"Moreover, IL-27 enhanced proliferation of CD4+ T cell-depleted spleen cells stimulated by allogeneic spleen cells and augmented the generation of CTL.",16034109_5,-1,-1,-1,-1,2842,-1,2.1622454e-05,0.99996006,1.8320523e-05
2844,STAT1-deficient naive,1,3,3,24,"In STAT1-deficient naive CD8+ T cells, IL-27-induced proliferation was not reduced, but synergistic IFN-gamma production with IL-12 was diminished with decreased expression of T-bet, IL-12Rbeta2, granzyme B, and perforin.",16034109_6,-1,-1,-1,-1,2844,-1,3.6619524e-05,0.99993575,2.7596458e-05
2850,T-bet-deficient naive,1,3,3,24,"In T-bet-deficient naive CD8+ T cells, IL-27-induced proliferation was hardly reduced, but synergistic IFN-gamma production with IL-12 was diminished with decreased expression of IL-12Rbeta2, granzyme B, and perforin.",16034109_7,-1,-1,-1,-1,2850,-1,2.6400954e-05,0.99995327,2.0385382e-05
2855,the generation,5,7,31,45,"However, IL-27 still augmented the generation of CTL from T-bet-deficient CD4+ T cell-depleted spleen cells stimulated by allogeneic spleen cells with increased granzyme B expression.",16034109_8,-1,-1,-1,-1,2855,-1,2.1851736e-05,0.9999604,1.7672479e-05
2872,to IFN-gamma,36,38,227,239,"PURPOSE: Previously we have reported that RT4, a well differentiated human bladder cancer line, increases the expression of macrophage derived chemokine (MDC) and interferon (IFN)-gamma-inducible protein-10 (IP-10) in response to IFN-gamma and tumor necrosis factor (TNF)-alpha.",16094077_0,-1,-1,-1,-1,2872,-1,0.9383394,0.05920272,0.0024578725
2881,TNF-alpha,24,25,137,146,"In this study we examined the signal mechanisms for inducting these 2 chemokines in RT4 cells by lipopolysaccharide (LPS), IFN-gamma and TNF-alpha.",16094077_1,0,1,-1,-1,2881,-1,0.109545834,0.8884833,0.0019708562
2883,toll-like receptor,3,5,18,36,The expression of toll-like receptor (TLR)-4 was analyzed by reverse transcriptase-polymerase chain reaction and flow cytometry.,16094077_4,-1,-1,-1,-1,2883,-1,0.0011772132,0.9720711,0.026751677
2886,cells to,7,9,32,40,RESULTS: LPS did not induce RT4 cells to produce IP-10 and MDC.,16094077_5,-1,-1,-1,-1,2886,-1,0.003697996,0.11736979,0.8789322
2887,LPS plus IFN-gamma,2,5,9,27,"However, LPS plus IFN-gamma synergized the productions of the 2 chemokines.",16094077_6,-1,-1,-1,-1,2887,-1,0.5914594,0.40129098,0.007249632
2895,receptor,12,13,72,80,"IFN-gamma up-regulated the expression of TLR-4, which is an LPS binding receptor.",16094077_7,0,1,2,-1,2895,-1,0.0019080685,0.38922107,0.6088709
2900,LPS plus IFN-gamma,14,17,95,113,"Although LPS and IFN-gamma alone marginally activated nuclear factor (NF)-kappaB but not AP-1, LPS plus IFN-gamma augmented NF-kappaB and AP-1.",16094077_8,-1,-1,-1,-1,2900,-1,0.68634313,0.30597305,0.0076838206
2907,to LPS,14,16,89,95,"Extracellular regulated kinase (ERK)1/2, an upstream signal of AP-1, was also responsive to LPS and/or IFN-gamma.",16094077_10,-1,-1,-1,-1,2907,-1,3.0557232e-05,0.99995625,1.314798e-05
2909,TNF-alpha,0,1,0,9,"TNF-alpha also activated NF-kappaB, AP-1 and ERK1/2.",16094077_11,0,1,-1,-1,2909,-1,0.00014330758,0.9998246,3.2159925e-05
2912,TNF-alpha plus IFN- gamma,2,6,9,34,"However, TNF-alpha plus IFN- gamma was associated with the activation of NF-kappaB but not of AP-1/ERK1/2 for the induction of MDC and IP-10.CONCLUSIONS: IFN-gamma enhances LPS for the induction of MDC and IP-10 through up-regulation of TLR-4, and the signal pathways of NF-kappaB and AP-1/ERK1/2.",16094077_12,-1,-1,-1,-1,2912,-1,0.28194523,0.7137022,0.004352538
2932,that the,7,9,44,52,"Recent observations by us and others showed that the prevalence of Treg is increased in cancer patients, particularly in the tumor environment.",16106066_2,-1,-1,-1,-1,2932,-1,1.8006855e-05,0.99997413,7.823517e-06
2934,the tumor,20,22,121,130,"Recent observations by us and others showed that the prevalence of Treg is increased in cancer patients, particularly in the tumor environment.",16106066_2,-1,-1,-1,-1,2934,-1,2.1118547e-05,0.9999695,9.381913e-06
2935,that the tumor,9,12,53,67,Our studies in a mouse pancreas cancer model suggest that the tumor actively promotes the accrual of Treg through several mechanisms involving activation of naturally occurring Treg as well as conversion of non-Treg into Treg.,16106066_3,-1,-1,-1,-1,2935,-1,1.8496736e-05,0.9999728,8.644569e-06
2937,Treg through,17,19,101,113,Our studies in a mouse pancreas cancer model suggest that the tumor actively promotes the accrual of Treg through several mechanisms involving activation of naturally occurring Treg as well as conversion of non-Treg into Treg.,16106066_3,-1,-1,-1,-1,2937,-1,1.8834919e-05,0.9999684,1.2738876e-05
2953,T-cell immunity,14,16,76,91,Our previous work showed that failure is reflected by the absence of type 1 T-cell immunity against HPV16 early antigens E2 and E6 in patients with HPV16+ cervical lesions.,16108057_1,-1,-1,-1,-1,2953,-1,0.0013510678,0.0003192285,0.9983297
2956,peptide-specific type,18,20,105,126,We now show that a majority of both patients with cervical lesions and healthy subjects display HPV16 L1 peptide-specific type 1 T-cell responses with similar magnitude.,16108057_2,-1,-1,-1,-1,2956,-1,0.00028873724,0.9994875,0.00022368644
2957,T-cell,21,22,129,135,We now show that a majority of both patients with cervical lesions and healthy subjects display HPV16 L1 peptide-specific type 1 T-cell responses with similar magnitude.,16108057_2,-1,1,2,-1,2957,-1,4.4137134e-05,6.220553e-05,0.99989367
2958,The T-cell,0,2,0,10,"The T-cell response in patients was directed at a broad range of peptides within L1, suggesting that during persistent or repeated exposure to HPV16 L1, the immune system maximizes its efforts to counter the viral challenge.",16108057_3,-1,-1,-1,-1,2958,-1,0.0030455785,0.2004517,0.79650277
2959,peptides,12,13,65,73,"The T-cell response in patients was directed at a broad range of peptides within L1, suggesting that during persistent or repeated exposure to HPV16 L1, the immune system maximizes its efforts to counter the viral challenge.",16108057_3,0,-1,2,-1,2959,-1,0.0014935795,0.99633574,0.0021707052
2966,the type,1,3,7,15,"Unlike the type 1 T-cell responses against HPV16 early antigens E2 and E6, type 1 T-cell immunity against L1 does not correlate with health or disease.",16108057_4,-1,-1,-1,-1,2966,-1,3.129806e-05,0.99994993,1.8772918e-05
2967,T-cell,4,5,18,24,"Unlike the type 1 T-cell responses against HPV16 early antigens E2 and E6, type 1 T-cell immunity against L1 does not correlate with health or disease.",16108057_4,-1,1,2,-1,2967,-1,3.8401417e-05,6.327605e-05,0.9998983
2970,T-cell immunity,16,18,82,97,"Unlike the type 1 T-cell responses against HPV16 early antigens E2 and E6, type 1 T-cell immunity against L1 does not correlate with health or disease.",16108057_4,-1,-1,-1,-1,2970,-1,0.0074562435,0.0009085556,0.9916352
2972,that T-cell,2,4,12,23,"This argues that T-cell responses against early and late HPV16 antigens essentially differ in the manner in which they are induced and regulated, as well as in their impact on the subsequent stages of HPV16-induced cervical disease.",16108057_5,-1,-1,-1,-1,2972,-1,0.003681751,0.23332964,0.7629886
2990,cells transiently transfected,13,16,82,111,"Formononetin, daidzein and equol also enhanced IL-4 gene promoter activity in EL4 cells transiently transfected with IL-4 gene promoter constructs, but this effect was impaired in EL4 cells transfected with an IL-4 promoter construct deleted of P4 site carrying nuclear factor of activated T cells (NF-AT) and activator protein-1 (AP-1) binding sites.",16108819_5,-1,-1,-1,-1,2990,-1,0.0034390914,0.41336852,0.58319235
2993,cells transfected,29,31,184,201,"Formononetin, daidzein and equol also enhanced IL-4 gene promoter activity in EL4 cells transiently transfected with IL-4 gene promoter constructs, but this effect was impaired in EL4 cells transfected with an IL-4 promoter construct deleted of P4 site carrying nuclear factor of activated T cells (NF-AT) and activator protein-1 (AP-1) binding sites.",16108819_5,-1,-1,-1,-1,2993,-1,0.0023596173,0.12669286,0.87094754
2994,nuclear factor of activated T cells,41,47,262,297,"Formononetin, daidzein and equol also enhanced IL-4 gene promoter activity in EL4 cells transiently transfected with IL-4 gene promoter constructs, but this effect was impaired in EL4 cells transfected with an IL-4 promoter construct deleted of P4 site carrying nuclear factor of activated T cells (NF-AT) and activator protein-1 (AP-1) binding sites.",16108819_5,-1,1,2,-1,2994,-1,0.0035037089,0.53305155,0.4634447
2995,NF-AT,48,49,299,304,"Formononetin, daidzein and equol also enhanced IL-4 gene promoter activity in EL4 cells transiently transfected with IL-4 gene promoter constructs, but this effect was impaired in EL4 cells transfected with an IL-4 promoter construct deleted of P4 site carrying nuclear factor of activated T cells (NF-AT) and activator protein-1 (AP-1) binding sites.",16108819_5,-1,1,2,-1,2995,-1,3.653043e-05,0.9999411,2.2301403e-05
2998,AP-1 DNA binding,9,12,56,72,"In addition, formononetin, daidzein and equol increased AP-1 DNA binding activities while did not affect NF-AT DNA binding activities.",16108819_6,-1,-1,-1,-1,2998,-1,5.8707e-05,0.9998977,4.354354e-05
2999,NF-AT DNA binding,17,20,105,122,"In addition, formononetin, daidzein and equol increased AP-1 DNA binding activities while did not affect NF-AT DNA binding activities.",16108819_6,-1,-1,-1,-1,2999,-1,4.8094822e-05,0.99991894,3.3000848e-05
3001,AP-1 DNA binding,7,10,45,61,"The enhancing effects on IL-4 production and AP-1 DNA binding activities were abrogated by specific inhibitors for phosphatidylinositol-3-kinase (PI3K), protein kinase C (PKC) and p38 mitogen-activated protein kinase (MAPK), indicating that formononetin, daidzein and equol might enhance IL-4 production by increased activation of AP-1 through the PI3-K/PKC/p38 MAPK signalling pathway.",16108819_7,-1,-1,-1,-1,3001,-1,3.919017e-05,0.9999329,2.7934142e-05
3002,protein,23,24,153,160,"The enhancing effects on IL-4 production and AP-1 DNA binding activities were abrogated by specific inhibitors for phosphatidylinositol-3-kinase (PI3K), protein kinase C (PKC) and p38 mitogen-activated protein kinase (MAPK), indicating that formononetin, daidzein and equol might enhance IL-4 production by increased activation of AP-1 through the PI3-K/PKC/p38 MAPK signalling pathway.",16108819_7,0,1,-1,-1,3002,-1,3.891511e-05,0.9999219,3.9180024e-05
3003,protein,32,33,202,209,"The enhancing effects on IL-4 production and AP-1 DNA binding activities were abrogated by specific inhibitors for phosphatidylinositol-3-kinase (PI3K), protein kinase C (PKC) and p38 mitogen-activated protein kinase (MAPK), indicating that formononetin, daidzein and equol might enhance IL-4 production by increased activation of AP-1 through the PI3-K/PKC/p38 MAPK signalling pathway.",16108819_7,0,1,-1,-1,3003,-1,7.244709e-05,0.9998394,8.8132234e-05
3005,AP-1 through the,53,56,331,347,"The enhancing effects on IL-4 production and AP-1 DNA binding activities were abrogated by specific inhibitors for phosphatidylinositol-3-kinase (PI3K), protein kinase C (PKC) and p38 mitogen-activated protein kinase (MAPK), indicating that formononetin, daidzein and equol might enhance IL-4 production by increased activation of AP-1 through the PI3-K/PKC/p38 MAPK signalling pathway.",16108819_7,-1,-1,-1,-1,3005,-1,2.7069467e-05,0.99995613,1.6845477e-05
3012,TGF-beta,4,5,33,41,Transforming growth factor-beta (TGF-beta) plays an essential role in regulating the homeostasis of cells in the lymphoid lineage.,16123803_0,0,1,-1,-1,3012,-1,4.2910797e-05,0.99993885,1.8249857e-05
3017,TGF-beta,0,1,0,8,"TGF-beta signaling is not required for normal thymopoiesis, but is essential for regulating the expansion, activation, and effector function of the mature CD4+ and CD8+ T cells in the peripheral lymphoid organs and target tissues.",16123803_1,0,1,-1,-1,3017,-1,5.160172e-05,0.9999317,1.6759803e-05
3020,function,21,22,132,140,"TGF-beta signaling is not required for normal thymopoiesis, but is essential for regulating the expansion, activation, and effector function of the mature CD4+ and CD8+ T cells in the peripheral lymphoid organs and target tissues.",16123803_1,0,1,2,-1,3020,-1,0.0004126168,0.9989962,0.00059121964
3024,target tissues,38,40,215,229,"TGF-beta signaling is not required for normal thymopoiesis, but is essential for regulating the expansion, activation, and effector function of the mature CD4+ and CD8+ T cells in the peripheral lymphoid organs and target tissues.",16123803_1,-1,-1,-1,-1,3024,-1,6.2770945e-05,0.99982125,0.00011604279
3026,TGF-beta,15,16,89,97,Recent studies in both mice and humans have elucidated an important and complex role for TGF-beta in regulatory T-cell biology.,16123803_2,0,1,-1,-1,3026,-1,3.309243e-05,0.99995327,1.3677381e-05
3028,TGF-beta,2,3,14,22,"Disruption of TGF-beta signaling in T cells impairs the maintenance of regulatory T cells, results in the expansion of activated effector T cells, and is associated with the production of cytokines that have major effects on cells in their environment.",16123803_3,0,1,-1,-1,3028,-1,5.409243e-05,0.9999231,2.2838785e-05
3035,cytokines that,32,34,188,202,"Disruption of TGF-beta signaling in T cells impairs the maintenance of regulatory T cells, results in the expansion of activated effector T cells, and is associated with the production of cytokines that have major effects on cells in their environment.",16123803_3,-1,-1,-1,-1,3035,-1,0.93637604,0.060176615,0.003447252
3040,TGF-beta,13,14,99,107,"While autoimmunity and inflammation are the principal phenotypes associated with the abrogation of TGF-beta signaling in T cells in mice, emerging evidence now also directly links Smad-dependent TGF-beta signaling in T cells to the suppression of epithelial neoplasia.",16123803_4,0,1,-1,-1,3040,-1,6.033817e-05,0.999918,2.1660117e-05
3042,Smad-dependent TGF-beta,27,29,180,203,"While autoimmunity and inflammation are the principal phenotypes associated with the abrogation of TGF-beta signaling in T cells in mice, emerging evidence now also directly links Smad-dependent TGF-beta signaling in T cells to the suppression of epithelial neoplasia.",16123803_4,-1,-1,-1,-1,3042,-1,7.498624e-05,0.9999038,2.1264603e-05
3043,T cells to the,31,35,217,231,"While autoimmunity and inflammation are the principal phenotypes associated with the abrogation of TGF-beta signaling in T cells in mice, emerging evidence now also directly links Smad-dependent TGF-beta signaling in T cells to the suppression of epithelial neoplasia.",16123803_4,-1,-1,-1,-1,3043,-1,0.0031162142,0.18340792,0.8134758
3044,The TGF-beta receptor-activated Smad3 plays,0,5,0,43,"The TGF-beta receptor-activated Smad3 plays a critical role in mediating many of the inhibitory effects of TGF-beta signaling in T cells, and has now been established as an important suppressor of leukemogenesis.",16123803_5,-1,-1,-1,-1,3044,-1,3.29211e-05,0.99994564,2.140887e-05
3046,TGF-beta,16,17,107,115,"The TGF-beta receptor-activated Smad3 plays a critical role in mediating many of the inhibitory effects of TGF-beta signaling in T cells, and has now been established as an important suppressor of leukemogenesis.",16123803_5,0,1,-1,-1,3046,-1,6.5914566e-05,0.9999107,2.333368e-05
3052,TGF-beta,13,14,88,96,These studies are increasing our awareness of the many complex mechanisms through which TGF-beta signaling controls the pathogenesis of cancer.,16123803_6,0,1,-1,-1,3052,-1,5.0070972e-05,0.9999323,1.757779e-05
3055,antigen-presenting cells,4,6,33,57,Dendritic cells are professional antigen-presenting cells associated with efficient antigen processing and presentation to T cells.,16166326_0,-1,-1,-1,-1,3055,-1,0.23519108,0.0027163518,0.76209253
3057,to T cells,13,16,120,130,Dendritic cells are professional antigen-presenting cells associated with efficient antigen processing and presentation to T cells.,16166326_0,-1,-1,-1,-1,3057,-1,0.0026998874,0.07425858,0.92304146
3060,tumoricidal functions,12,14,79,100,"However, recent evidence also suggests that dendritic cells may mediate direct tumoricidal functions.",16166326_1,-1,-1,-1,-1,3060,-1,0.00010443632,0.99983215,6.335772e-05
3067,function,28,29,172,180,"In this study, we investigated the mechanism by which murine dendritic cells mediate the apoptotic death of murine lymphoma cell lines, and whether dendritic cell effector function could be enhanced by preconditioning tumor cells with the protein phosphatase inhibitor nitric oxide (NO) by altering the balance of proapoptotic/antiapoptotic proteins in the treated cells.",16166326_2,0,1,2,-1,3067,-1,0.00014663537,0.0003959114,0.9994574
3068,tumor cells,34,36,218,229,"In this study, we investigated the mechanism by which murine dendritic cells mediate the apoptotic death of murine lymphoma cell lines, and whether dendritic cell effector function could be enhanced by preconditioning tumor cells with the protein phosphatase inhibitor nitric oxide (NO) by altering the balance of proapoptotic/antiapoptotic proteins in the treated cells.",16166326_2,-1,-1,-1,-1,3068,-1,0.0039884252,0.46742997,0.5285816
3069,the protein,37,39,235,246,"In this study, we investigated the mechanism by which murine dendritic cells mediate the apoptotic death of murine lymphoma cell lines, and whether dendritic cell effector function could be enhanced by preconditioning tumor cells with the protein phosphatase inhibitor nitric oxide (NO) by altering the balance of proapoptotic/antiapoptotic proteins in the treated cells.",16166326_2,-1,-1,-1,-1,3069,-1,2.4034169e-05,0.9999608,1.5132665e-05
3071,proteins,52,53,341,349,"In this study, we investigated the mechanism by which murine dendritic cells mediate the apoptotic death of murine lymphoma cell lines, and whether dendritic cell effector function could be enhanced by preconditioning tumor cells with the protein phosphatase inhibitor nitric oxide (NO) by altering the balance of proapoptotic/antiapoptotic proteins in the treated cells.",16166326_2,0,1,-1,-1,3071,-1,5.1286344e-05,0.9998989,4.9826038e-05
3072,the treated cells,54,57,353,370,"In this study, we investigated the mechanism by which murine dendritic cells mediate the apoptotic death of murine lymphoma cell lines, and whether dendritic cell effector function could be enhanced by preconditioning tumor cells with the protein phosphatase inhibitor nitric oxide (NO) by altering the balance of proapoptotic/antiapoptotic proteins in the treated cells.",16166326_2,-1,-1,-1,-1,3072,-1,0.0030452788,0.7910258,0.20592895
3077,tumor cell,16,18,109,119,"Both immature and spontaneously matured bone marrow-derived dendritic cells (SM-DC) were capable of inducing tumor cell apoptosis, with SM-DCs serving as comparatively better killers.",16166326_4,-1,-1,-1,-1,3077,-1,0.0044320375,0.29453942,0.7010286
3080,tumor cells than,33,36,238,254,"Fas ligand (FasL)-Fas engagement proved important in this activity because elevated expression of membrane-bound FasL was detected on SM-DCs, and dendritic cells derived from FasL-deficient mice were less capable of killing NO-sensitized tumor cells than wild-type dendritic cells.",16166326_5,-1,-1,-1,-1,3080,-1,7.704086e-05,0.99981266,0.000110282075
3086,cell-mediated tumor,28,30,193,212,"As FasL-deficient dendritic cells were still capable of mediating a residual degree of tumor killing, this suggests that FasL-independent mechanisms of apoptosis are also involved in dendritic cell-mediated tumor killing.",16166326_6,-1,-1,-1,-1,3086,-1,0.0023216305,0.029278586,0.96839976
3087,tumor cells,2,4,19,30,"Because NO-treated tumor cells displayed a preferential loss of survivin protein expression via a proteasome-dependent pathway, enhanced tumor sensitivity to dendritic cell-mediated killing may be associated with the accelerated turnover of this critical antiapoptotic gene product.",16166326_7,-1,-1,-1,-1,3087,-1,0.004329803,0.44425705,0.5514132
3088,protein,10,11,73,80,"Because NO-treated tumor cells displayed a preferential loss of survivin protein expression via a proteasome-dependent pathway, enhanced tumor sensitivity to dendritic cell-mediated killing may be associated with the accelerated turnover of this critical antiapoptotic gene product.",16166326_7,0,1,-1,-1,3088,-1,2.9717394e-05,0.9999471,2.3220977e-05
3095,gene product,35,37,269,281,"Because NO-treated tumor cells displayed a preferential loss of survivin protein expression via a proteasome-dependent pathway, enhanced tumor sensitivity to dendritic cell-mediated killing may be associated with the accelerated turnover of this critical antiapoptotic gene product.",16166326_7,0,1,-1,-1,3095,-1,7.207299e-05,0.9998265,0.000101495745
3096,tumor cells,3,5,24,35,"Importantly, NO-treated tumor cells were also engulfed more readily than control tumor cells and this resulted in enhanced cross-presentation of tumor-associated antigens to specific T cells in vitro.",16166326_8,-1,-1,-1,-1,3096,-1,0.0029272526,0.2496653,0.7474075
3098,tumor cells,12,14,81,92,"Importantly, NO-treated tumor cells were also engulfed more readily than control tumor cells and this resulted in enhanced cross-presentation of tumor-associated antigens to specific T cells in vitro.",16166326_8,-1,-1,-1,-1,3098,-1,0.003133114,0.29215875,0.70470804
3100,tumor-associated antigens to,21,24,145,173,"Importantly, NO-treated tumor cells were also engulfed more readily than control tumor cells and this resulted in enhanced cross-presentation of tumor-associated antigens to specific T cells in vitro.",16166326_8,-1,-1,-1,-1,3100,-1,7.6485965e-05,0.9998882,3.5342964e-05
3106,that the,3,5,25,33,Our experiments indicate that the accumulation of CD4+CD25+ regulatory T cells (T reg cells) expressing FoxP3 and exhibiting immunosuppressive function originates from the proliferation of naturally occurring CD25+ T cells and requires signaling through transforming growth factor (TGF)-beta receptor II.,16186184_1,-1,-1,-1,-1,3106,-1,1.6642814e-05,0.9999746,8.698254e-06
3111,function,22,23,143,151,Our experiments indicate that the accumulation of CD4+CD25+ regulatory T cells (T reg cells) expressing FoxP3 and exhibiting immunosuppressive function originates from the proliferation of naturally occurring CD25+ T cells and requires signaling through transforming growth factor (TGF)-beta receptor II.,16186184_1,0,1,2,-1,3111,-1,6.6504195e-05,0.9998795,5.400157e-05
3115,through transforming growth factor,37,41,246,280,Our experiments indicate that the accumulation of CD4+CD25+ regulatory T cells (T reg cells) expressing FoxP3 and exhibiting immunosuppressive function originates from the proliferation of naturally occurring CD25+ T cells and requires signaling through transforming growth factor (TGF)-beta receptor II.,16186184_1,-1,-1,-1,-1,3115,-1,0.15927386,0.83779275,0.002933348
3116,receptor,42,43,292,300,Our experiments indicate that the accumulation of CD4+CD25+ regulatory T cells (T reg cells) expressing FoxP3 and exhibiting immunosuppressive function originates from the proliferation of naturally occurring CD25+ T cells and requires signaling through transforming growth factor (TGF)-beta receptor II.,16186184_1,0,1,2,-1,3116,-1,0.00023359519,0.001080332,0.99868613
3126,TGF-beta-dependent,13,14,74,92,This DC subset selectively promotes the proliferation of T reg cells in a TGF-beta-dependent manner in mice and rats.,16186184_3,0,1,-1,-1,3126,-1,5.5212004e-05,0.9999014,4.3365835e-05
3127,Tumor cells,0,2,0,11,Tumor cells are necessary and sufficient to convert DCs into regulatory cells that secrete bioactive TGF-beta and stimulate T reg cell proliferation.,16186184_4,-1,-1,-1,-1,3127,-1,0.0051789014,0.403986,0.59083515
3129,cells that,11,13,72,82,Tumor cells are necessary and sufficient to convert DCs into regulatory cells that secrete bioactive TGF-beta and stimulate T reg cell proliferation.,16186184_4,-1,-1,-1,-1,3129,-1,0.0034088537,0.101741016,0.8948501
3130,TGF-beta,15,16,101,109,Tumor cells are necessary and sufficient to convert DCs into regulatory cells that secrete bioactive TGF-beta and stimulate T reg cell proliferation.,16186184_4,0,1,-1,-1,3130,-1,0.00015996986,0.9998047,3.53203e-05
3132,cell proliferation,20,22,130,148,Tumor cells are necessary and sufficient to convert DCs into regulatory cells that secrete bioactive TGF-beta and stimulate T reg cell proliferation.,16186184_4,-1,-1,-1,-1,3132,-1,5.0845116e-05,4.265107e-05,0.9999064
3139,immunity,7,8,64,72,"The peripheral tolerance mechanism prevents effective antitumor immunity, even though tumor cells possess recognizable tumor-associated Ags.",16210609_0,0,-1,2,-1,3139,-1,0.9989598,0.0007653927,0.00027487337
3140,though tumor cells,10,13,79,97,"The peripheral tolerance mechanism prevents effective antitumor immunity, even though tumor cells possess recognizable tumor-associated Ags.",16210609_0,-1,-1,-1,-1,3140,-1,0.005883633,0.51174325,0.48237306
3142,that regulatory T cells,6,10,33,56,"Recently, it has been elucidated that regulatory T cells (Treg) play a critical role in maintaining not only self-tolerance, but also tolerance of tumor cells.",16210609_1,-1,-1,-1,-1,3142,-1,0.002370615,0.12910064,0.8685288
3146,tumor cells,27,29,147,158,"Recently, it has been elucidated that regulatory T cells (Treg) play a critical role in maintaining not only self-tolerance, but also tolerance of tumor cells.",16210609_1,-1,-1,-1,-1,3146,-1,0.0041272356,0.52933383,0.4665389
3147,the Treg that,3,6,17,30,"However, because the Treg that maintain self-tolerance arise naturally in the thymus and are thought to be anergic in peripheral, it is still unclear where and when Treg for tumor cells are generated.",16210609_2,-1,-1,-1,-1,3147,-1,2.4231002e-05,0.99996233,1.3397796e-05
3149,the thymus,11,13,74,84,"However, because the Treg that maintain self-tolerance arise naturally in the thymus and are thought to be anergic in peripheral, it is still unclear where and when Treg for tumor cells are generated.",16210609_2,-1,-1,-1,-1,3149,-1,3.068733e-05,0.9999484,2.0964251e-05
3150,thought to,15,17,93,103,"However, because the Treg that maintain self-tolerance arise naturally in the thymus and are thought to be anergic in peripheral, it is still unclear where and when Treg for tumor cells are generated.",16210609_2,-1,-1,-1,-1,3150,-1,3.55279e-05,0.9999497,1.4811432e-05
3152,tumor cells,31,33,174,185,"However, because the Treg that maintain self-tolerance arise naturally in the thymus and are thought to be anergic in peripheral, it is still unclear where and when Treg for tumor cells are generated.",16210609_2,-1,-1,-1,-1,3152,-1,0.004453476,0.46608284,0.52946365
3167,to the,9,11,77,83,The regulatory activity generated in tumor-draining LNs exclusively belonged to the CD4(+) T cell subpopulation that expresses both CD25 and a high level of CD62L.,16210609_4,-1,-1,-1,-1,3167,-1,1.8814253e-05,0.9999702,1.1035684e-05
3175,T cell functions,12,15,90,106,"CD62L(high)CD4(+)CD25(+) Treg and CD62L(low)CD4(+)CD25(+) T cells, which possess effector T cell functions, had comparable expression of LFA-1, VLA-4, CTLA-4, lymphocyte activation gene-3, and glucocorticoid-induced TNFR.",16210609_6,-1,-1,-1,-1,3175,-1,5.949982e-05,8.088025e-05,0.9998596
3179,TNFR,32,33,216,220,"CD62L(high)CD4(+)CD25(+) Treg and CD62L(low)CD4(+)CD25(+) T cells, which possess effector T cell functions, had comparable expression of LFA-1, VLA-4, CTLA-4, lymphocyte activation gene-3, and glucocorticoid-induced TNFR.",16210609_6,0,1,-1,-1,3179,-1,4.30874e-05,0.9999385,1.8385901e-05
3183,The Treg generated,0,3,0,18,The Treg generated in tumor-draining LNs possess the same functional properties as the Treg that arise naturally in the thymus but recognize tumor-associated Ag.,16210609_8,-1,-1,-1,-1,3183,-1,1.9590761e-05,0.9999683,1.2129047e-05
3186,functional,9,10,58,68,The Treg generated in tumor-draining LNs possess the same functional properties as the Treg that arise naturally in the thymus but recognize tumor-associated Ag.,16210609_8,0,1,2,-1,3186,-1,0.00017246914,0.9997002,0.00012733447
3187,the Treg that,12,15,83,96,The Treg generated in tumor-draining LNs possess the same functional properties as the Treg that arise naturally in the thymus but recognize tumor-associated Ag.,16210609_8,-1,-1,-1,-1,3187,-1,2.1677359e-05,0.999967,1.1329785e-05
3189,the thymus,18,20,116,126,The Treg generated in tumor-draining LNs possess the same functional properties as the Treg that arise naturally in the thymus but recognize tumor-associated Ag.,16210609_8,-1,-1,-1,-1,3189,-1,3.231679e-05,0.999944,2.3757431e-05
3196,Treg plays,14,16,85,95,Blocking experiments revealed that ligation of CTLA-4 on effector T cells by CD86 on Treg plays a pivotal role in regulating CD4(+) effector T cells.,16210609_10,-1,-1,-1,-1,3196,-1,2.3054765e-05,0.9999609,1.6014774e-05
3198,that tumor cells,4,7,28,44,Previous studies have shown that tumor cells predominantly express Th2 type cytokines and transcription factors.,16212886_0,-1,-1,-1,-1,3198,-1,0.0028089553,0.82754886,0.1696422
3199,Th2 type cytokines,9,12,67,85,Previous studies have shown that tumor cells predominantly express Th2 type cytokines and transcription factors.,16212886_0,-1,-1,-1,-1,3199,-1,0.04262226,0.9523371,0.0050406815
3202,Th2-specific transcription factor,4,7,13,46,"GATA-3, as a Th2-specific transcription factor, plays a central role in positive-regulating Th2 development.",16212886_1,-1,-1,-1,-1,3202,-1,3.987022e-05,0.99992,4.01328e-05
3207,tumor cells,7,9,39,50,So whether the expression of GATA-3 in tumor cells has any effect on tumor development is a question of interest.,16212886_2,-1,-1,-1,-1,3207,-1,0.0033096434,0.42255735,0.574133
3212,tumor cells through,12,15,63,82,"In the present study, we inhibited the expression of GATA-3 in tumor cells through antisense RNA blockade technique, and observed its effects on tumor in vitro and in vivo.",16212886_3,-1,-1,-1,-1,3212,-1,6.08078e-05,0.9998405,9.871313e-05
3216,GATA-3 treatment,5,7,34,50,"Our results showed that antisense GATA-3 treatment could inhibit the expression of TNF-alpha and Th2 cytokines in tumor cells, and antisense-induced blockade of GATA-3 could also depress tumor growth in tumor-bearing mice.",16212886_4,-1,-1,-1,-1,3216,-1,2.7693291e-05,0.99995184,2.0440757e-05
3218,TNF-alpha,12,13,83,92,"Our results showed that antisense GATA-3 treatment could inhibit the expression of TNF-alpha and Th2 cytokines in tumor cells, and antisense-induced blockade of GATA-3 could also depress tumor growth in tumor-bearing mice.",16212886_4,0,1,-1,-1,3218,-1,0.000235284,0.9996977,6.7105386e-05
3219,Th2 cytokines,14,16,97,110,"Our results showed that antisense GATA-3 treatment could inhibit the expression of TNF-alpha and Th2 cytokines in tumor cells, and antisense-induced blockade of GATA-3 could also depress tumor growth in tumor-bearing mice.",16212886_4,-1,-1,-1,-1,3219,-1,0.331846,0.6440853,0.024068711
3220,tumor cells,17,19,114,125,"Our results showed that antisense GATA-3 treatment could inhibit the expression of TNF-alpha and Th2 cytokines in tumor cells, and antisense-induced blockade of GATA-3 could also depress tumor growth in tumor-bearing mice.",16212886_4,-1,-1,-1,-1,3220,-1,0.004565001,0.5506206,0.44481435
3224,that the,2,4,11,19,We suggest that the ratio of T-bet/GATA-3 can be evaluated as a more important marker of the status of Th1/Th2 type.,16212886_5,-1,-1,-1,-1,3224,-1,1.7017997e-05,0.9999745,8.455517e-06
3225,the status,16,18,89,99,We suggest that the ratio of T-bet/GATA-3 can be evaluated as a more important marker of the status of Th1/Th2 type.,16212886_5,-1,-1,-1,-1,3225,-1,2.0646356e-05,0.9999683,1.1020308e-05
3228,tumor cell,13,15,89,99,And our results might provide some evidence about the molecular regulatory mechanisms in tumor cell development.,16212886_6,-1,-1,-1,-1,3228,-1,0.0038947153,0.4604199,0.53568536
3234,proteins,4,5,18,26,"The use of fusion proteins, which link cytotoxic molecules to receptor targets, provides one approach to this problem.",16224276_1,0,1,-1,-1,3234,-1,3.2349737e-05,0.99994147,2.6151707e-05
3235,to receptor targets,10,13,59,78,"The use of fusion proteins, which link cytotoxic molecules to receptor targets, provides one approach to this problem.",16224276_1,-1,-1,-1,-1,3235,-1,8.4521314e-05,0.999811,0.0001045495
3236,to this,17,19,102,109,"The use of fusion proteins, which link cytotoxic molecules to receptor targets, provides one approach to this problem.",16224276_1,-1,-1,-1,-1,3236,-1,2.5562687e-05,0.999964,1.0443231e-05
3239,protein,8,9,44,51,"This study examined the ability of a fusion protein of interleukin-2 (IL-2) and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes based on their expression of high-affinity IL-2 receptors.",16224276_2,0,1,-1,-1,3239,-1,2.951677e-05,0.9999471,2.3440783e-05
3245,receptors,37,38,224,233,"This study examined the ability of a fusion protein of interleukin-2 (IL-2) and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes based on their expression of high-affinity IL-2 receptors.",16224276_2,0,1,2,-1,3245,-1,0.0001813995,0.0022549897,0.9975637
3249,the two,20,22,111,118,"Thirteen patients (12 with metastatic melanoma, 1 with metastatic renal cell carcinoma) were treated at one of the two Food and Drug Administration-approved doses of Denileukin Diftitox (seven patients at 9 microg/kg, six patients at 18 microg/kg).",16224276_3,-1,-1,-1,-1,3249,-1,4.6414134e-05,0.999931,2.2563627e-05
3261,functions,8,9,52,61,JNK1 has divergent roles in regulating the effector functions of CD4+ and CD8+ T cells.,16237070_0,0,1,2,-1,3261,-1,9.67931e-05,0.99978,0.000123254
3263,the function,2,4,9,21,"However, the function of JNK1 in tumor immune surveillance is unknown.",16237070_1,-1,-1,-1,-1,3263,-1,3.17235e-05,0.99995613,1.2142926e-05
3268,to tumor,17,19,94,102,"In this study, we show that similar to IFN-gamma-/- mice, JNK1-/- mice are highly susceptible to tumor development after inoculation of both melanoma cell line B16 and lymphoma cell line EL-4.",16237070_2,-1,-1,-1,-1,3268,-1,2.1397766e-05,0.9999684,1.0173805e-05
3277,IFN-gamma gene transcription,11,14,55,83,JNK1-/- CD8+ T cells have an intrinsic defect in early IFN-gamma gene transcription and production after activation by either anti-CD3/anti-CD28 Abs or dendritic cells loaded with specific Ag in vitro.,16237070_4,-1,-1,-1,-1,3277,-1,0.9904923,0.0067887385,0.0027189252
3284,the transcription,25,27,159,176,"The impaired IFN-gamma production in JNK1-/- CD8+ T cells is associated with reduced expression of both T-bet and Eomesodermin, indicating that JNK1 regulates the transcription program of CD8+ T cells.",16237070_5,-1,-1,-1,-1,3284,-1,2.1854778e-05,0.9999671,1.1032093e-05
3287,CTL function,13,15,78,90,"Finally, JNK1-/- CD8+ T cells showed reduced perforin expression and impaired CTL function.",16237070_6,-1,-1,-1,-1,3287,-1,0.00012364006,0.00021697748,0.9996593
3288,Taken together,0,2,0,14,"Taken together, our results demonstrate that JNK1 plays an important role in tumor immune surveillance through regulating the effector functions of CD8+ T cells.",16237070_7,-1,-1,-1,-1,3288,-1,4.1712545e-05,0.99994135,1.692032e-05
3294,functions,20,21,135,144,"Taken together, our results demonstrate that JNK1 plays an important role in tumor immune surveillance through regulating the effector functions of CD8+ T cells.",16237070_7,0,1,2,-1,3294,-1,0.00070968614,0.9935387,0.0057515833
3297,T-cell growth factor,9,12,48,68,Interleukin-2 (IL-2) is historically known as a T-cell growth factor.,16304057_0,-1,-1,-1,-1,3297,-1,0.015025464,0.0013194261,0.98365515
3300,function,14,15,95,103,Accumulating evidence from knockout mice suggests that IL-2 is crucial for the homeostasis and function of CD4+ CD25+ regulatory T cells in vivo.,16304057_1,0,1,2,-1,3300,-1,6.100991e-05,0.9999057,3.3298085e-05
3305,function,13,14,72,80,"Here, we studied the impact of IL-2 administration on the frequency and function of human CD4+ CD25(hi) T cells in immune intact patients with melanoma or renal cancer.",16304057_3,0,1,2,-1,3305,-1,6.45669e-05,0.9998925,4.2941723e-05
3307,that the,2,4,9,17,"We found that the frequency of CD4+ CD25(hi) T cells was significantly increased after IL-2 treatment, and these cells expressed phenotypic markers associated with regulatory T cells.",16304057_4,-1,-1,-1,-1,3307,-1,1.7421906e-05,0.9999738,8.7615535e-06
3310,these cells,20,22,107,118,"We found that the frequency of CD4+ CD25(hi) T cells was significantly increased after IL-2 treatment, and these cells expressed phenotypic markers associated with regulatory T cells.",16304057_4,-1,-1,-1,-1,3310,-1,0.002732027,0.2022171,0.79505086
3313,protein,6,7,33,40,"In addition, both transcript and protein levels of Foxp3, a transcription factor exclusively expressed on regulatory T cells, were consistently increased in CD4 T cells following IL-2 treatment.",16304057_5,0,1,-1,-1,3313,-1,3.0816052e-05,0.99994767,2.1565904e-05
3319,Functional analysis,0,2,0,19,Functional analysis of the increased number of CD4+ CD25(hi) T cells revealed that this population exhibited potent suppressive activity in vitro.,16304057_6,-1,-1,-1,-1,3319,-1,2.5144715e-05,0.9999565,1.835027e-05
3322,that this,14,16,78,87,Functional analysis of the increased number of CD4+ CD25(hi) T cells revealed that this population exhibited potent suppressive activity in vitro.,16304057_6,-1,-1,-1,-1,3322,-1,1.702141e-05,0.99997187,1.1078567e-05
3329,the therapeutic,15,17,110,125,Our findings suggest that selective inhibition of IL-2-mediated enhancement of regulatory T cells may improve the therapeutic effectiveness of IL-2 administration.,16304057_8,-1,-1,-1,-1,3329,-1,2.3903947e-05,0.99996674,9.405134e-06
3332,peptide,14,15,85,92,Our previous study showed that DNA vaccination with a plasmid vector encoding a core peptide of mucin1 (PDTRP) provided modest protection against challenge with tumor cells that expressed mucin1 protein.,16341143_0,0,-1,2,-1,3332,-1,0.06606212,0.8000799,0.13385798
3333,tumor cells that,26,29,161,177,Our previous study showed that DNA vaccination with a plasmid vector encoding a core peptide of mucin1 (PDTRP) provided modest protection against challenge with tumor cells that expressed mucin1 protein.,16341143_0,-1,-1,-1,-1,3333,-1,8.559565e-05,0.9997675,0.00014687824
3334,protein,31,32,195,202,Our previous study showed that DNA vaccination with a plasmid vector encoding a core peptide of mucin1 (PDTRP) provided modest protection against challenge with tumor cells that expressed mucin1 protein.,16341143_0,0,1,-1,-1,3334,-1,0.00015712727,0.99968815,0.00015468845
3342,the GM-CSF,14,16,107,117,The increased protection was directly correlated with a stronger PDTRP-specific immune response induced by the GM-CSF fusion plasmid.,16341143_2,-1,-1,-1,-1,3342,-1,0.6530909,0.33994296,0.006966093
3344,The plasmid,0,2,0,11,"The plasmid encoding GM-CSF and the target PDTRP antigen induced a greater PDTRP-specific Th proliferation, antibodies, and cytotoxicity.",16341143_3,-1,-1,-1,-1,3344,-1,2.5686906e-05,0.99996126,1.30486505e-05
3346,the target,5,7,32,42,"The plasmid encoding GM-CSF and the target PDTRP antigen induced a greater PDTRP-specific Th proliferation, antibodies, and cytotoxicity.",16341143_3,-1,-1,-1,-1,3346,-1,2.5637028e-05,0.9999602,1.4225227e-05
3351,the type,8,10,67,75,"Interestingly, the modified plasmid vaccine predominantly enhanced the type 2 immune responses manifested by an increased IgG1 to IgG2a antibody ratio and a greater induction of GATA-3 and IL-4 mRNA than that of T-bet and IFN-gamma mRNA in spleen cells from vaccinated mice.",16341143_4,-1,-1,-1,-1,3351,-1,1.8654724e-05,0.9999702,1.118216e-05
3355,than that,31,33,199,208,"Interestingly, the modified plasmid vaccine predominantly enhanced the type 2 immune responses manifested by an increased IgG1 to IgG2a antibody ratio and a greater induction of GATA-3 and IL-4 mRNA than that of T-bet and IFN-gamma mRNA in spleen cells from vaccinated mice.",16341143_4,-1,-1,-1,-1,3355,-1,2.2917433e-05,0.99996006,1.6964363e-05
3360,that there,11,13,74,84,"In addition, protection against tumor challenge in vaccinated mice showed that there was no significant change in mice survival after in vivo CD8+CTL depletion, indicating that antitumor immunity augmented by plasmid encoding GM-CSF and target PDTRP gene vaccine was dominated by Th2 immune response.",16341143_5,-1,-1,-1,-1,3360,-1,2.2146942e-05,0.99996793,9.950188e-06
3362,immunity,29,30,187,195,"In addition, protection against tumor challenge in vaccinated mice showed that there was no significant change in mice survival after in vivo CD8+CTL depletion, indicating that antitumor immunity augmented by plasmid encoding GM-CSF and target PDTRP gene vaccine was dominated by Th2 immune response.",16341143_5,0,-1,2,-1,3362,-1,0.9965848,0.0029609902,0.0004542084
3367,Th2 immune response,43,46,280,299,"In addition, protection against tumor challenge in vaccinated mice showed that there was no significant change in mice survival after in vivo CD8+CTL depletion, indicating that antitumor immunity augmented by plasmid encoding GM-CSF and target PDTRP gene vaccine was dominated by Th2 immune response.",16341143_5,-1,-1,-1,-1,3367,-1,0.14523877,0.85218304,0.0025781782
3371,to three,7,9,49,57,This highly effective immune surveillance is due to three interacting mechanisms: (a) the generation of inducible nitric oxide synthase (iNOS)-producing M1 macrophages that are tumoricidal for 4T1 tumor cells; (b) a rapid decrease in myeloid-derived Gr1(+)CD11b(+) suppressor cells that are elevated and down-regulate the CD3zeta chain when primary tumor is present and that suppress T cells by producing arginase; and (c) production of activated lymphocytes.,16357187_1,-1,-1,-1,-1,3371,-1,2.212038e-05,0.9999677,1.0157452e-05
3372,the generation,15,17,86,100,This highly effective immune surveillance is due to three interacting mechanisms: (a) the generation of inducible nitric oxide synthase (iNOS)-producing M1 macrophages that are tumoricidal for 4T1 tumor cells; (b) a rapid decrease in myeloid-derived Gr1(+)CD11b(+) suppressor cells that are elevated and down-regulate the CD3zeta chain when primary tumor is present and that suppress T cells by producing arginase; and (c) production of activated lymphocytes.,16357187_1,-1,-1,-1,-1,3372,-1,1.7301498e-05,0.99997175,1.0899022e-05
3375,tumor cells,30,32,197,208,This highly effective immune surveillance is due to three interacting mechanisms: (a) the generation of inducible nitric oxide synthase (iNOS)-producing M1 macrophages that are tumoricidal for 4T1 tumor cells; (b) a rapid decrease in myeloid-derived Gr1(+)CD11b(+) suppressor cells that are elevated and down-regulate the CD3zeta chain when primary tumor is present and that suppress T cells by producing arginase; and (c) production of activated lymphocytes.,16357187_1,-1,-1,-1,-1,3375,-1,0.003769948,0.2927307,0.70349944
3376,suppressor cells that,43,46,265,286,This highly effective immune surveillance is due to three interacting mechanisms: (a) the generation of inducible nitric oxide synthase (iNOS)-producing M1 macrophages that are tumoricidal for 4T1 tumor cells; (b) a rapid decrease in myeloid-derived Gr1(+)CD11b(+) suppressor cells that are elevated and down-regulate the CD3zeta chain when primary tumor is present and that suppress T cells by producing arginase; and (c) production of activated lymphocytes.,16357187_1,-1,-1,-1,-1,3376,-1,0.0018835721,0.027413806,0.9707027
3387,the generation,20,22,138,152,"Macrophages from wild-type BALB/c mice are polarized by interleukin-13 (IL-13) towards a tumor-promoting M2 phenotype, thereby inhibiting the generation of tumoricidal M1 macrophages.",16357187_2,-1,-1,-1,-1,3387,-1,2.051125e-05,0.9999671,1.2372975e-05
3391,IL-13-producting NKT cells,15,18,76,102,"In contrast, CD1(-/-) mice, which are deficient for IL-13 because they lack IL-13-producting NKT cells, generate M1 macrophages that are cytotoxic for 4T1 via the production of nitric oxide.",16357187_3,-1,-1,-1,-1,3391,-1,0.5874127,0.0031349508,0.40945232
3412,gene therapy,12,14,67,79,PURPOSE: The aim of this study was to develop an immunostimulating gene therapy for the treatment of orthotopic bladder carcinoma by transferring the gene for CD40L into the tumor site.,16361570_0,-1,-1,-1,-1,3412,-1,2.7684227e-05,0.99995637,1.5969557e-05
3413,the treatment,15,17,84,97,PURPOSE: The aim of this study was to develop an immunostimulating gene therapy for the treatment of orthotopic bladder carcinoma by transferring the gene for CD40L into the tumor site.,16361570_0,-1,-1,-1,-1,3413,-1,2.0877702e-05,0.99996936,9.766015e-06
3414,transferring the gene,22,25,133,154,PURPOSE: The aim of this study was to develop an immunostimulating gene therapy for the treatment of orthotopic bladder carcinoma by transferring the gene for CD40L into the tumor site.,16361570_0,-1,-1,-1,-1,3414,-1,2.2989037e-05,0.99996495,1.2002089e-05
3416,the tumor,28,30,170,179,PURPOSE: The aim of this study was to develop an immunostimulating gene therapy for the treatment of orthotopic bladder carcinoma by transferring the gene for CD40L into the tumor site.,16361570_0,-1,-1,-1,-1,3416,-1,1.8929728e-05,0.9999721,8.928621e-06
3421,Th1 type,10,12,83,91,CD40L stimulation of dendritic cells induces interleukin-12 expression that drives Th1 type of immune responses with activation of cytotoxic T cells.,16361570_1,-1,-1,-1,-1,3421,-1,3.853952e-05,0.99992335,3.807407e-05
3424,The gene,3,5,21,29,EXPERIMENTAL DESIGN: The gene for murine CD40L was transferred into bladders of tumor-bearing mice using an adenoviral vector construct.,16361570_2,-1,-1,-1,-1,3424,-1,2.2539942e-05,0.999966,1.144265e-05
3431,to tumor,15,17,92,100,"Survival of mice as well as transgene expression and immunologic effect, such as resistance to tumor challenge and presence of T regulatory cells, were monitored.",16361570_4,-1,-1,-1,-1,3431,-1,2.95109e-05,0.999959,1.1484363e-05
3436,transgene function,4,6,13,31,"As a sign of transgene function, interleukin-12 (IL-12) expression was significantly increased.",16361570_6,-1,-1,-1,-1,3436,-1,2.9616234e-05,0.99995613,1.42762965e-05
3439,gene therapy,1,3,8,20,AdCD40L gene therapy cured 60% of mice with preestablished tumors.,16361570_7,-1,-1,-1,-1,3439,-1,3.0260499e-05,0.99995124,1.8510294e-05
3443,tumor cells,11,13,77,88,"The cured mice were completely resistant to subcutaneous challenge with MB49 tumor cells, whereas the growth of a syngeneic irrelevant tumor was unaltered.",16361570_8,-1,-1,-1,-1,3443,-1,0.003891883,0.3234939,0.6726142
3447,the T,7,9,42,47,"Furthermore, the mRNA expression level of the T regulatory cell transcription factor Foxp3 was evaluated both in tumor biopsies and lymph nodes.",16361570_9,-1,-1,-1,-1,3447,-1,2.7322378e-05,0.99994695,2.574304e-05
3448,cell transcription factor Foxp3,10,14,59,90,"Furthermore, the mRNA expression level of the T regulatory cell transcription factor Foxp3 was evaluated both in tumor biopsies and lymph nodes.",16361570_9,-1,-1,-1,-1,3448,-1,0.0040228176,0.70416725,0.29180992
3451,the tumors,5,7,33,43,There were no differences within the tumors of the different treatment groups.,16361570_10,-1,-1,-1,-1,3451,-1,2.0137997e-05,0.9999678,1.2080625e-05
3458,naive T cells,14,17,93,106,"Correspondingly, T cells from AdCD40L-treated mice were not able to inhibit proliferation of naive T cells as opposed to T cells from control-treated, tumor-bearing mice.",16361570_12,-1,-1,-1,-1,3458,-1,0.0026324056,0.05746106,0.9399066
3459,to T cells,19,22,118,128,"Correspondingly, T cells from AdCD40L-treated mice were not able to inhibit proliferation of naive T cells as opposed to T cells from control-treated, tumor-bearing mice.",16361570_12,-1,-1,-1,-1,3459,-1,0.0031168642,0.090653494,0.9062296
3461,gene therapy,3,5,21,33,CONCLUSIONS: AdCD40L gene therapy evokes Th1 cytokine responses and counteracts T regulatory cell development and/or function.,16361570_13,-1,-1,-1,-1,3461,-1,2.714447e-05,0.99995553,1.7317394e-05
3462,Th1 cytokine,6,8,41,53,CONCLUSIONS: AdCD40L gene therapy evokes Th1 cytokine responses and counteracts T regulatory cell development and/or function.,16361570_13,-1,-1,-1,-1,3462,-1,0.20074028,0.7835001,0.015759684
3465,function,16,17,117,125,CONCLUSIONS: AdCD40L gene therapy evokes Th1 cytokine responses and counteracts T regulatory cell development and/or function.,16361570_13,0,1,2,-1,3465,-1,0.00014615653,0.99968636,0.00016750392
3469,functions,11,12,67,76,STAT5 belongs to a small family of transcription factors with dual functions.,16375697_0,0,1,2,-1,3469,-1,0.00011407646,0.99983144,5.4446737e-05
3475,the plasma,16,18,104,114,"The seven signal transducers and activators of transcription (STAT) act as signaling components between the plasma membrane and the nucleus, and as transcription factors with specific DNA binding ability in the nucleus.",16375697_1,-1,-1,-1,-1,3475,-1,2.9844769e-05,0.99993634,3.3821194e-05
3484,the regulation,13,15,76,90,"It can promote proliferation and inhibit apoptosis, but is also involved in the regulation of differentiation between specific gene expression.",16375697_3,-1,-1,-1,-1,3484,-1,2.3284787e-05,0.9999646,1.2111687e-05
3487,to the transformed,4,7,26,44,STAT5 can also contribute to the transformed phenotype.,16375697_4,-1,-1,-1,-1,3487,-1,4.3472974e-05,0.99992955,2.701691e-05
3490,through receptors,12,14,75,92,"In many leukemias and some solid tumors, STAT5 is constitutively activated through receptors or receptor associated tyrosine kinases and contributes to the survival and the proliferation of malignant cells.",16375697_5,-1,-1,-1,-1,3490,-1,0.00013357055,0.9991264,0.00074006565
3491,receptor,15,16,96,104,"In many leukemias and some solid tumors, STAT5 is constitutively activated through receptors or receptor associated tyrosine kinases and contributes to the survival and the proliferation of malignant cells.",16375697_5,0,1,2,-1,3491,-1,0.00027431853,0.9977489,0.0019767326
3493,to the,21,23,149,155,"In many leukemias and some solid tumors, STAT5 is constitutively activated through receptors or receptor associated tyrosine kinases and contributes to the survival and the proliferation of malignant cells.",16375697_5,-1,-1,-1,-1,3493,-1,3.0717845e-05,0.9999535,1.5761396e-05
3501,these tumor cells,4,7,23,40,Inhibition of STAT5 in these tumor cells results in growth arrest and apoptosis.,16375697_7,-1,-1,-1,-1,3501,-1,0.0036011604,0.65576535,0.34063345
3506,tumor therapy,16,18,114,127,"Targeting of STATs and other downstream mediators of oncogenic tyrosine kinases provides a promising strategy for tumor therapy, which might be refractory to resistance mechanisms incapacitating tyrosine kinase inhibitors.",16375697_8,-1,-1,-1,-1,3506,-1,2.366677e-05,0.9999666,9.716508e-06
3513,function,27,28,179,187,"The well-studied steps in the activation of STAT5 and its roles in different subcellular compartments suggest original interference strategies, which could be used to inhibit its function.",16375697_9,0,1,2,-1,3513,-1,7.989804e-05,0.9998778,4.229503e-05
3516,protein-protein,11,12,70,85,The challenge for drug developers will be the exploitation of defined protein-protein or protein-DNA interactions as targets of inhibition.,16375697_10,0,1,-1,-1,3516,-1,4.216637e-05,0.99992776,3.0039912e-05
3517,protein-DNA,13,14,89,100,The challenge for drug developers will be the exploitation of defined protein-protein or protein-DNA interactions as targets of inhibition.,16375697_10,0,1,-1,-1,3517,-1,5.865687e-05,0.99991035,3.1009025e-05
3523,tumor relapse,18,20,88,101,"Over an observation period of 3 years, 18% of the patients in our collective suffered a tumor relapse with local or distinct metastases after initial R0-resection.",16391798_1,-1,-1,-1,-1,3523,-1,2.6955155e-05,0.9999548,1.821487e-05
3524,that this,3,5,23,32,"Some evidence suggests that this may be due to suppression of anti-tumor responses, a phenomenon that might be attributed to regulatory T cells.",16391798_2,-1,-1,-1,-1,3524,-1,2.2193273e-05,0.9999683,9.51144e-06
3527,to regulatory T cells,20,24,122,143,"Some evidence suggests that this may be due to suppression of anti-tumor responses, a phenomenon that might be attributed to regulatory T cells.",16391798_2,-1,-1,-1,-1,3527,-1,0.0029266507,0.12408064,0.8729927
3530,the tumor-specific immune response,8,12,40,74,The aim of our study was to investigate the tumor-specific immune response depending on the UICC stage of patients with colorectal cancer.,16391798_3,-1,-1,-1,-1,3530,-1,0.008307099,0.99144405,0.00024889625
3532,The cellular immune responses,0,4,0,29,The cellular immune responses against defined antigens that are overexpressed in most of the patients with colorectal cancer were characterized.,16391798_4,-1,-1,-1,-1,3532,-1,0.18836586,0.80270064,0.00893344
3533,antigens that,6,8,46,59,The cellular immune responses against defined antigens that are overexpressed in most of the patients with colorectal cancer were characterized.,16391798_4,-1,-1,-1,-1,3533,-1,0.9182106,0.07172385,0.0100655025
3536,the tumor,4,6,18,27,"For this purpose, the tumor suppressor gene, p53, was chosen as the tumor-associated antigen that exhibits mutations and overexpression in up to 60% of colorectal carcinoma.",16391798_5,-1,-1,-1,-1,3536,-1,2.2351387e-05,0.9999654,1.2164518e-05
3538,the tumor-associated antigen that,14,18,64,97,"For this purpose, the tumor suppressor gene, p53, was chosen as the tumor-associated antigen that exhibits mutations and overexpression in up to 60% of colorectal carcinoma.",16391798_5,-1,-1,-1,-1,3538,-1,8.31201e-05,0.99987376,4.3115233e-05
3545,that regulatory T cells,6,10,47,70,The predominance of IL-10 production indicated that regulatory T cells directly participate in modulating the anti-tumor immune response.,16391798_7,-1,-1,-1,-1,3545,-1,0.002161726,0.131844,0.86599433
3549,the blood,3,5,16,25,IL-10 levels in the blood as well as the expression of regulatory T-cell specific genes at the tumor site correlate with the UICC stage of the disease.,16391798_8,-1,-1,-1,-1,3549,-1,3.154294e-05,0.9999311,3.7381727e-05
3553,the tumor,16,18,91,100,IL-10 levels in the blood as well as the expression of regulatory T-cell specific genes at the tumor site correlate with the UICC stage of the disease.,16391798_8,-1,-1,-1,-1,3553,-1,2.003847e-05,0.9999697,1.0246692e-05
3564,blood,25,26,150,155,"Sezary syndrome (SS) is a leukemic variant of CTCL that presents with erythroderma, lymphadenopathies and presence of malignant T cells in peripheral blood.",16457762_1,0,1,-1,-1,3564,-1,0.0018407914,0.79502666,0.20313255
3572,cells that,8,10,49,59,KIR3DL2 is the first phenotypic marker of Sezary cells that can be used for the diagnostic and follow-up of Sezary syndrome.,16457762_5,-1,-1,-1,-1,3572,-1,0.0039065266,0.14431334,0.8517801
3578,Th2 cytokines,7,9,44,57,CTCL are characterized by a predominance of Th2 cytokines.,16457762_7,-1,-1,-1,-1,3578,-1,0.40887088,0.5592336,0.031895544
3592,tumor cells,5,7,32,43,"Future challenges are to render tumor cells sensitive to apoptosis by inhibiting specific signalling pathways such as the constitutively activated NF-KB pathway, to identify specific surface kinase receptors and to develop specific inhibitors, to develop humanized monoclonal antibodies directed against tumor specific antigens, able to kill tumor cells via complement-dependent and antibody-dependent cytotoxicity, and to stimulate innate immunity.",16457762_10,-1,-1,-1,-1,3592,-1,0.0035898825,0.3890453,0.6073648
3597,receptors,28,29,198,207,"Future challenges are to render tumor cells sensitive to apoptosis by inhibiting specific signalling pathways such as the constitutively activated NF-KB pathway, to identify specific surface kinase receptors and to develop specific inhibitors, to develop humanized monoclonal antibodies directed against tumor specific antigens, able to kill tumor cells via complement-dependent and antibody-dependent cytotoxicity, and to stimulate innate immunity.",16457762_10,0,1,2,-1,3597,-1,0.00018643065,0.0010013934,0.9988122
3603,tumor cells,49,51,342,353,"Future challenges are to render tumor cells sensitive to apoptosis by inhibiting specific signalling pathways such as the constitutively activated NF-KB pathway, to identify specific surface kinase receptors and to develop specific inhibitors, to develop humanized monoclonal antibodies directed against tumor specific antigens, able to kill tumor cells via complement-dependent and antibody-dependent cytotoxicity, and to stimulate innate immunity.",16457762_10,-1,-1,-1,-1,3603,-1,0.003686634,0.3436422,0.6526712
3619,the cells,25,27,172,181,We induced rat peritoneal macrophages with rat breast cancer cell-conditioned medium and analyzed signal transducer and activators of transcription 3 (Stat3) activities of the cells.,16530087_2,-1,-1,-1,-1,3619,-1,0.0031765536,0.21996285,0.7768606
3620,Then these cells,0,3,0,16,Then these cells were transfected with Stat3 decoy oligonucleotides (ODNs) and were stimulated by lipopolysaccharide (LPS).,16530087_3,-1,-1,-1,-1,3620,-1,0.002590014,0.8279679,0.16944207
3626,antigen-presenting function,12,14,91,118,The results demonstrate that induced macrophages displayed a reduction of cytotoxicity and antigen-presenting function in comparison with control but transfection with Stat3 decoy ODNs enhanced cytotoxicity and antigen-presenting function of the macrophages.,16530087_4,-1,-1,-1,-1,3626,-1,0.97206455,0.0091964165,0.018739065
3629,antigen-presenting function,27,29,211,238,The results demonstrate that induced macrophages displayed a reduction of cytotoxicity and antigen-presenting function in comparison with control but transfection with Stat3 decoy ODNs enhanced cytotoxicity and antigen-presenting function of the macrophages.,16530087_4,-1,-1,-1,-1,3629,-1,0.9721367,0.009802164,0.018061204
3642,the cells,14,16,108,117,The data suggest that immunosuppressive activities of TAMs correlate with over-activated Stat3 signaling of the cells and disruption of Stat3 activity of TAMs can enhance rat immune response to breast cancer.,16530087_6,-1,-1,-1,-1,3642,-1,0.0028225244,0.20722033,0.7899571
3645,immune response to,26,29,175,193,The data suggest that immunosuppressive activities of TAMs correlate with over-activated Stat3 signaling of the cells and disruption of Stat3 activity of TAMs can enhance rat immune response to breast cancer.,16530087_6,-1,-1,-1,-1,3645,-1,0.86471635,0.13227668,0.0030069917
3660,protein-78,13,14,114,124,"Angiogenin, vascular endothelial growth factor, transforming growth factor-beta, epithelial neutrophil-activating protein-78 and several other proteins involved in immune suppression, angiogenesis and plasma extravasation could be detected in both supernatant and pleural effusion.",16540497_4,0,1,-1,-1,3660,-1,0.00033282768,0.99877554,0.00089163653
3661,proteins,17,18,143,151,"Angiogenin, vascular endothelial growth factor, transforming growth factor-beta, epithelial neutrophil-activating protein-78 and several other proteins involved in immune suppression, angiogenesis and plasma extravasation could be detected in both supernatant and pleural effusion.",16540497_4,0,1,-1,-1,3661,-1,0.00078651955,0.9973803,0.0018331837
3669,peptide-2,23,24,182,191,"Surrounding stroma and/or infiltrating cells were the most likely source of hepatocyte growth factor, macrophage inflammatory protein (MIP)-1delta, MIP-3alpha, neutrophil-activating peptide-2, and pulmonary and activation-regulated chemokine that can cause leukocyte infiltration and activation.",16540497_5,0,-1,2,-1,3669,-1,0.94879556,0.049783368,0.0014210268
3670,pulmonary and activation-regulated chemokine that,26,31,197,246,"Surrounding stroma and/or infiltrating cells were the most likely source of hepatocyte growth factor, macrophage inflammatory protein (MIP)-1delta, MIP-3alpha, neutrophil-activating peptide-2, and pulmonary and activation-regulated chemokine that can cause leukocyte infiltration and activation.",16540497_5,-1,-1,-1,-1,3670,-1,0.00017042631,0.99976593,6.358772e-05
3672,T-lymphocytes,11,12,44,57,"There was a massive influx of CD4+ and CD8+ T-lymphocytes and macrophages, but not of dendritic cells, in human mesothelioma biopsies.",16540497_6,-1,1,2,-1,3672,-1,0.0001511088,0.0012730082,0.9985759
3675,tissue,7,8,52,58,It was further demonstrated that human mesothelioma tissue contained significant amounts of Foxp3+CD4+CD25+ regulatory T-cells.,16540497_7,-1,1,2,-1,3675,-1,2.6367e-05,0.9999329,4.0715357e-05
3682,regulatory T-cells that,12,15,85,108,Mesothelioma is infiltrated by immune effector cells but also contains cytokines and regulatory T-cells that suppress an efficient immune response.,16540497_9,-1,-1,-1,-1,3682,-1,0.002421507,0.36281285,0.6347656
3686,that the,5,7,29,37,It has been shown previously that the suppression of tumor immunosurveillance may be a mechanism by which tumors resist immune detection and elimination.,16585215_0,-1,-1,-1,-1,3686,-1,2.0242573e-05,0.99997175,8.050979e-06
3702,the cells,15,17,73,82,"Further, we examined the role of CD4(+) and/or CD8(+) cells by depleting the cells in vivo and measuring CTL activity in vitro.",16585215_3,-1,-1,-1,-1,3702,-1,0.0028436193,0.17968087,0.81747556
3706,receptor,8,9,45,53,"We also asked the role of interleukin (IL)-4 receptor alpha (IL-4Ralpha)-signal transducer and activator of transcription 6 (STAT6) signaling, including IL-13, and transforming growth factor beta (TGF-beta) by using gene-disrupted mice or treating mice with cytokine antagonists.",16585215_4,0,1,2,-1,3706,-1,0.0025142352,0.8016277,0.19585806
3713,TGF-beta,31,32,197,205,"We also asked the role of interleukin (IL)-4 receptor alpha (IL-4Ralpha)-signal transducer and activator of transcription 6 (STAT6) signaling, including IL-13, and transforming growth factor beta (TGF-beta) by using gene-disrupted mice or treating mice with cytokine antagonists.",16585215_4,0,1,-1,-1,3713,-1,3.711342e-05,0.99994695,1.588335e-05
3721,that the,3,5,26,34,Further studies suggested that the rejection of tumor in CD1d KO mice was dependent on CD8(+) lymphocytes.,16585215_6,-1,-1,-1,-1,3721,-1,1.7828432e-05,0.99997437,7.761644e-06
3729,TGF-beta,27,28,174,182,"Distinct from other murine tumor models, the negative regulation induced by CD1d-restricted NKT cells was not dependent on IL-4Ralpha-STAT6 signaling, including IL-13, or on TGF-beta.",16585215_7,0,1,-1,-1,3729,-1,5.9109912e-05,0.9999224,1.847923e-05
3735,that NKT cells,21,24,149,163,These data suggest that a novel CD1d-restricted NKT cell-mediated mechanism for tumor immunosuppression is active in the K7M2 osteosarcoma model and that NKT cells can regulate immunosurveillance through more than one pathway.,16585215_8,-1,-1,-1,-1,3735,-1,0.0025878293,0.17861411,0.8187981
3740,They play,0,2,0,9,They play a crucial role in cancer progression by inhibiting the effector function of CD4(+) or CD8(+) T lymphocytes.,16612596_1,-1,-1,-1,-1,3740,-1,2.2930832e-05,0.9999628,1.4285545e-05
3742,function,12,13,74,82,They play a crucial role in cancer progression by inhibiting the effector function of CD4(+) or CD8(+) T lymphocytes.,16612596_1,0,1,2,-1,3742,-1,0.00018462975,0.99930537,0.00051004556
3744,regulatory T lymphocytes that,3,7,17,46,"However, whether regulatory T lymphocytes that expand during tumor progression can modulate dendritic cell function is unclear.",16612596_2,-1,-1,-1,-1,3744,-1,0.0015442397,0.08425443,0.9142013
3746,cell function,14,16,102,115,"However, whether regulatory T lymphocytes that expand during tumor progression can modulate dendritic cell function is unclear.",16612596_2,-1,-1,-1,-1,3746,-1,0.00012539812,0.0002050082,0.9996697
3755,cell function,15,17,120,133,"We present data demonstrating that CD4(+)CD25(+)FoxP3(+) regulatory T cells from tumor-bearing animals impede dendritic cell function by down-regulating the activation of the transcription factor NF-kappaB. The expression of the co-stimulatory molecules CD80, CD86 and CD40, the production of TNF-alpha, IL-12, and CCL5/RANTES by the suppressed DC is strongly down-regulated.",16612596_4,-1,-1,-1,-1,3755,-1,7.045772e-05,0.00011690419,0.99981266
3757,the transcription factor,22,25,171,195,"We present data demonstrating that CD4(+)CD25(+)FoxP3(+) regulatory T cells from tumor-bearing animals impede dendritic cell function by down-regulating the activation of the transcription factor NF-kappaB. The expression of the co-stimulatory molecules CD80, CD86 and CD40, the production of TNF-alpha, IL-12, and CCL5/RANTES by the suppressed DC is strongly down-regulated.",16612596_4,-1,-1,-1,-1,3757,-1,2.0043759e-05,0.9999684,1.15122475e-05
3762,TNF-alpha,41,42,293,302,"We present data demonstrating that CD4(+)CD25(+)FoxP3(+) regulatory T cells from tumor-bearing animals impede dendritic cell function by down-regulating the activation of the transcription factor NF-kappaB. The expression of the co-stimulatory molecules CD80, CD86 and CD40, the production of TNF-alpha, IL-12, and CCL5/RANTES by the suppressed DC is strongly down-regulated.",16612596_4,0,1,-1,-1,3762,-1,0.0009203182,0.9989479,0.00013174686
3766,TGF-beta,4,5,35,43,The suppression mechanism requires TGF-beta and IL-10 and is associated with induction of the Smad signaling pathway and activation of the STAT3 transcription factor.,16612596_5,0,1,-1,-1,3766,-1,4.8032132e-05,0.99993455,1.7422948e-05
3768,the Smad,13,15,90,98,The suppression mechanism requires TGF-beta and IL-10 and is associated with induction of the Smad signaling pathway and activation of the STAT3 transcription factor.,16612596_5,-1,-1,-1,-1,3768,-1,3.98292e-05,0.9999424,1.778161e-05
3769,the STAT3 transcription factor,20,24,135,165,The suppression mechanism requires TGF-beta and IL-10 and is associated with induction of the Smad signaling pathway and activation of the STAT3 transcription factor.,16612596_5,-1,-1,-1,-1,3769,-1,2.2692828e-05,0.9999635,1.3746068e-05
3781,Stat1 deficiency,0,2,0,16,"Stat1 deficiency in the host significantly enhances IL-12-mediated tumor regression, resulting in tumor eradication from 60% of SCCVII tumor-bearing mice and significant inhibition of tumor growth when compared with control treatment (P < 0.01).",16618773_2,-1,-1,-1,-1,3781,-1,2.847419e-05,0.999941,3.0545318e-05
3783,IL-12-mediated tumor,7,9,52,72,"Stat1 deficiency in the host significantly enhances IL-12-mediated tumor regression, resulting in tumor eradication from 60% of SCCVII tumor-bearing mice and significant inhibition of tumor growth when compared with control treatment (P < 0.01).",16618773_2,-1,-1,-1,-1,3783,-1,0.9904129,0.0064276387,0.003159445
3789,Stat1-activating cytokine IFN-gamma,6,9,35,70,This effect is independent of both Stat1-activating cytokine IFN-gamma and Stat1-downstream effector molecule FasL because neither neutralization of IFN-gamma nor knocking out of FasL enhances or inhibits IL-12-mediated tumor regression.,16618773_3,-1,-1,-1,-1,3789,-1,0.5442228,0.44941273,0.0063645504
3792,IL-12-mediated tumor,27,29,205,225,This effect is independent of both Stat1-activating cytokine IFN-gamma and Stat1-downstream effector molecule FasL because neither neutralization of IFN-gamma nor knocking out of FasL enhances or inhibits IL-12-mediated tumor regression.,16618773_3,-1,-1,-1,-1,3792,-1,0.992035,0.00570835,0.0022566554
3794,tumor-specific CTL,6,8,34,52,"IL-12 induces a high intensity of tumor-specific CTL activity in Stat1-deficient mice (P < 0.01), increases the CD8 T-cell density in tumor bearing Stat1-/- mice, and induces a T-cell-dependent tumor regression.",16618773_4,-1,-1,-1,-1,3794,-1,0.0041796733,0.7222187,0.27360165
3797,T-cell,21,22,116,122,"IL-12 induces a high intensity of tumor-specific CTL activity in Stat1-deficient mice (P < 0.01), increases the CD8 T-cell density in tumor bearing Stat1-/- mice, and induces a T-cell-dependent tumor regression.",16618773_4,-1,1,2,-1,3797,-1,3.2862343e-05,5.119549e-05,0.99991596
3799,T-cell-dependent tumor,32,34,177,199,"IL-12 induces a high intensity of tumor-specific CTL activity in Stat1-deficient mice (P < 0.01), increases the CD8 T-cell density in tumor bearing Stat1-/- mice, and induces a T-cell-dependent tumor regression.",16618773_4,-1,-1,-1,-1,3799,-1,0.0010677854,0.020864552,0.9780677
3804,the tumors,12,14,79,89,The increased CTL activity and the high-intensity infiltration of T cells into the tumors in IL-12-treated Stat1-/- mice are likely due to the longer survival than the same cells from wild-type mice.,16618773_5,-1,-1,-1,-1,3804,-1,2.1006746e-05,0.99996686,1.2075086e-05
3806,to the,21,23,136,142,The increased CTL activity and the high-intensity infiltration of T cells into the tumors in IL-12-treated Stat1-/- mice are likely due to the longer survival than the same cells from wild-type mice.,16618773_5,-1,-1,-1,-1,3806,-1,2.8291422e-05,0.99995995,1.1777502e-05
3807,than the,25,27,159,167,The increased CTL activity and the high-intensity infiltration of T cells into the tumors in IL-12-treated Stat1-/- mice are likely due to the longer survival than the same cells from wild-type mice.,16618773_5,-1,-1,-1,-1,3807,-1,2.4010104e-05,0.99996126,1.4752241e-05
3814,tumor-local IL-12 gene therapy,14,18,81,111,"Together, the data show that inhibition of Stat1 expression in the host enhances tumor-local IL-12 gene therapy for regressing tumors.",16618773_6,-1,-1,-1,-1,3814,-1,0.00022635961,0.99970275,7.0866816e-05
3829,This regulation,0,2,0,15,This regulation involved the binding of STAT3 and STAT5 proteins to a highly conserved STAT-binding site located in the first intron of the FOXP3 gene.,16645171_3,-1,-1,-1,-1,3829,-1,2.0410798e-05,0.9999672,1.2402583e-05
3832,STAT5 proteins to,8,11,50,67,This regulation involved the binding of STAT3 and STAT5 proteins to a highly conserved STAT-binding site located in the first intron of the FOXP3 gene.,16645171_3,-1,-1,-1,-1,3832,-1,2.680907e-05,0.9999535,1.963673e-05
3835,the FOXP3 gene,22,25,136,150,This regulation involved the binding of STAT3 and STAT5 proteins to a highly conserved STAT-binding site located in the first intron of the FOXP3 gene.,16645171_3,-1,-1,-1,-1,3835,-1,2.231182e-05,0.9999646,1.3058903e-05
3838,cell transplantation,26,28,179,199,We also examined the effects of low-dose IL-2 treatment in 12 patients with metastatic cancer and 9 patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation.,16645171_4,-1,-1,-1,-1,3838,-1,0.0034193979,0.08166969,0.91491085
3842,blood,20,21,113,118,"Overall, IL-2 treatment resulted in a 1.9 median fold increase in the frequency of CD4+CD25+ cells in peripheral blood as well as a 9.7 median fold increase in FOXP3 expression in CD3+ T cells.",16645171_5,0,1,-1,-1,3842,-1,0.00012141719,0.9995111,0.00036751252
3847,therapy,11,12,62,69,CD56+CD3- natural killer (NK) cells also expanded during IL-2 therapy but did not express FOXP3.,16645171_6,0,1,-1,-1,3847,-1,2.6275698e-05,0.99995935,1.4401864e-05
3852,to FOXP3,14,16,103,111,"In vitro treatment of NK cells with 5-aza-2'-deoxycytidine restored the IL-2 signaling pathway leading to FOXP3 expression, suggesting that this gene was constitutively repressed by DNA methylation in these cells.",16645171_7,-1,-1,-1,-1,3852,-1,2.332881e-05,0.9999652,1.1481435e-05
3853,that this gene,19,22,135,149,"In vitro treatment of NK cells with 5-aza-2'-deoxycytidine restored the IL-2 signaling pathway leading to FOXP3 expression, suggesting that this gene was constitutively repressed by DNA methylation in these cells.",16645171_7,-1,-1,-1,-1,3853,-1,2.5534548e-05,0.99995935,1.5061605e-05
3854,these cells,29,31,201,212,"In vitro treatment of NK cells with 5-aza-2'-deoxycytidine restored the IL-2 signaling pathway leading to FOXP3 expression, suggesting that this gene was constitutively repressed by DNA methylation in these cells.",16645171_7,-1,-1,-1,-1,3854,-1,0.00083300105,0.028289525,0.9708775
3860,tumor cells,15,17,76,87,"Hodgkin lymphoma (HL) is characterized by the presence of a small number of tumor cells in a rich background of inflammatory cells, but the contribution of the abundant nontumor cells to HL pathogenesis is poorly understood.",16740709_0,-1,-1,-1,-1,3860,-1,0.0042790095,0.26851553,0.7272055
3864,cells to,32,34,178,186,"Hodgkin lymphoma (HL) is characterized by the presence of a small number of tumor cells in a rich background of inflammatory cells, but the contribution of the abundant nontumor cells to HL pathogenesis is poorly understood.",16740709_0,-1,-1,-1,-1,3864,-1,0.003230937,0.062012576,0.93475646
3868,to T-cell receptor,13,16,78,96,We showed that migratory CD4(+) cells induced by HL cells were hyporesponsive to T-cell receptor stimulation and suppressed the activation/proliferation of the effector CD4(+) T cells in an autologous setting.,16740709_1,-1,-1,-1,-1,3868,-1,0.0033501203,0.05151078,0.94513917
3876,chemokine receptor,22,24,128,146,We further showed that HL cells in the affected lymph nodes were surrounded by a large number of lymphocytes expressing both CC chemokine receptor 4 (CCR4) and FOXP3.,16740709_2,-1,-1,-1,-1,3876,-1,0.18419111,0.0019098703,0.8138991
3879,that the,3,5,24,32,These findings indicate that the migratory cells induced by HL cells function as regulatory T (Treg) cells so that these cells create a favorable environment for the tumor cells to escape from host immune system.,16740709_3,-1,-1,-1,-1,3879,-1,1.737008e-05,0.9999739,8.703617e-06
3881,cells function,10,12,63,77,These findings indicate that the migratory cells induced by HL cells function as regulatory T (Treg) cells so that these cells create a favorable environment for the tumor cells to escape from host immune system.,16740709_3,-1,-1,-1,-1,3881,-1,0.0039456757,0.04145062,0.9546036
3885,that these cells,20,23,110,126,These findings indicate that the migratory cells induced by HL cells function as regulatory T (Treg) cells so that these cells create a favorable environment for the tumor cells to escape from host immune system.,16740709_3,-1,-1,-1,-1,3885,-1,0.0046153744,0.69294363,0.302441
3886,the tumor cells to,28,32,162,180,These findings indicate that the migratory cells induced by HL cells function as regulatory T (Treg) cells so that these cells create a favorable environment for the tumor cells to escape from host immune system.,16740709_3,-1,-1,-1,-1,3886,-1,6.54824e-05,0.99987304,6.1428844e-05
3899,immune response to tumor cells,44,49,237,267,"Recognition of the importance of CCR4(+) Treg cells in the pathogenesis of HL will allow rational design of more effective treatments, such as use of an anti-CCR4 mAb, to overcome the suppressive effect of CCR4(+) Treg cells on the host immune response to tumor cells.",16740709_5,-1,-1,-1,-1,3899,-1,0.53878736,0.02316374,0.43804893
3909,analysis,2,3,22,30,"Posttherapy molecular analysis of immune activation/suppression markers within the tumor microenvironment demonstrated a dramatic up-regulation of IFN-gamma and a concomitant down-regulation of Forkhead/winged-helix protein 3 (Foxp3), TGFbeta, and IL-10 expression.",16751376_2,0,1,-1,-1,3909,-1,3.278163e-05,0.9999374,2.9812909e-05
3910,the tumor,8,10,79,88,"Posttherapy molecular analysis of immune activation/suppression markers within the tumor microenvironment demonstrated a dramatic up-regulation of IFN-gamma and a concomitant down-regulation of Forkhead/winged-helix protein 3 (Foxp3), TGFbeta, and IL-10 expression.",16751376_2,-1,-1,-1,-1,3910,-1,1.7903452e-05,0.9999726,9.508388e-06
3912,protein,23,24,216,223,"Posttherapy molecular analysis of immune activation/suppression markers within the tumor microenvironment demonstrated a dramatic up-regulation of IFN-gamma and a concomitant down-regulation of Forkhead/winged-helix protein 3 (Foxp3), TGFbeta, and IL-10 expression.",16751376_2,0,1,-1,-1,3912,-1,4.6343954e-05,0.9999008,5.287243e-05
3914,TGFbeta,29,30,235,242,"Posttherapy molecular analysis of immune activation/suppression markers within the tumor microenvironment demonstrated a dramatic up-regulation of IFN-gamma and a concomitant down-regulation of Forkhead/winged-helix protein 3 (Foxp3), TGFbeta, and IL-10 expression.",16751376_2,0,1,-1,-1,3914,-1,3.3286007e-05,0.9999541,1.2650316e-05
3916,Therapy-induced,0,1,0,15,"Therapy-induced reversion of immune suppression was transient since all three markers of suppression recovered rapidly and surpassed pretherapy levels by day 7 after treatment, resulting in tumor resurgence.",16751376_3,0,1,-1,-1,3916,-1,2.4396242e-05,0.99996555,1.0063077e-05
3923,analysis,2,3,17,25,"Serial long-term analysis demonstrated that although chronic stimulation enhanced the IFN-gamma response, this was countered by a parallel increase in Foxp3, TGFbeta, and IL-10 expression.",16751376_5,0,1,-1,-1,3923,-1,3.1577834e-05,0.9999448,2.358298e-05
3925,the IFN-gamma,9,11,82,95,"Serial long-term analysis demonstrated that although chronic stimulation enhanced the IFN-gamma response, this was countered by a parallel increase in Foxp3, TGFbeta, and IL-10 expression.",16751376_5,-1,-1,-1,-1,3925,-1,0.9036485,0.09323929,0.0031122074
3928,TGFbeta,23,24,158,165,"Serial long-term analysis demonstrated that although chronic stimulation enhanced the IFN-gamma response, this was countered by a parallel increase in Foxp3, TGFbeta, and IL-10 expression.",16751376_5,0,1,-1,-1,3928,-1,3.6290847e-05,0.99995196,1.1776071e-05
3930,Analysis,0,1,0,8,Analysis of tumor-infiltrating T lymphocyte populations showed that the expression of Foxp3 and IL-10 was associated with CD4(+)CD25(+) T cells.,16751376_6,0,1,-1,-1,3930,-1,2.5097603e-05,0.9999579,1.6930415e-05
3931,tumor-infiltrating T lymphocyte,2,5,12,43,Analysis of tumor-infiltrating T lymphocyte populations showed that the expression of Foxp3 and IL-10 was associated with CD4(+)CD25(+) T cells.,16751376_6,-1,-1,-1,-1,3931,-1,0.0035443818,0.80603045,0.19042519
3932,that the,7,9,63,71,Analysis of tumor-infiltrating T lymphocyte populations showed that the expression of Foxp3 and IL-10 was associated with CD4(+)CD25(+) T cells.,16751376_6,-1,-1,-1,-1,3932,-1,1.811766e-05,0.99997294,8.889977e-06
3938,T suppressor cells,11,14,98,116,Repeated treatment resulted in a progressive increase in tumor-infiltrating CD4(+)CD25(+)Foxp3(+) T suppressor cells establishing their role in long-term neutralization of antitumor activity.,16751376_7,-1,-1,-1,-1,3938,-1,0.0006318052,0.009449202,0.98991895
3940,Analysis,0,1,0,8,"Analysis of tumor-infiltrating CD8(+) T cells demonstrated that although treatment enhanced IFN-gamma production, antitumor cytotoxicity was diminished.",16751376_8,0,1,-1,-1,3940,-1,2.4904188e-05,0.99995685,1.8279363e-05
3946,T cells that,4,7,21,33,"Monitoring of CD8(+) T cells that specifically recognized a dominant MHC class I her-2/neu peptide showed a dramatic increase in tetramer-specific CD8(+) T cells after the first treatment; however, continuous therapy resulted in the loss of this population.",16751376_9,-1,-1,-1,-1,3946,-1,0.0016401132,0.031320788,0.9670391
3947,peptide,15,16,91,98,"Monitoring of CD8(+) T cells that specifically recognized a dominant MHC class I her-2/neu peptide showed a dramatic increase in tetramer-specific CD8(+) T cells after the first treatment; however, continuous therapy resulted in the loss of this population.",16751376_9,0,-1,2,-1,3947,-1,3.8366845e-05,0.9999409,2.0798909e-05
3952,therapy,34,35,209,216,"Monitoring of CD8(+) T cells that specifically recognized a dominant MHC class I her-2/neu peptide showed a dramatic increase in tetramer-specific CD8(+) T cells after the first treatment; however, continuous therapy resulted in the loss of this population.",16751376_9,0,1,-1,-1,3952,-1,2.2424896e-05,0.99996626,1.1360678e-05
3957,tumor-specific T cells,11,14,81,103,These results demonstrate that both enhanced suppressor activity and deletion of tumor-specific T cells are responsible for the progressive loss of efficacy that is associated with chronic immune therapy.,16751376_10,-1,-1,-1,-1,3957,-1,0.0042781774,0.7230943,0.2726276
3960,therapy,28,29,196,203,These results demonstrate that both enhanced suppressor activity and deletion of tumor-specific T cells are responsible for the progressive loss of efficacy that is associated with chronic immune therapy.,16751376_10,0,1,-1,-1,3960,-1,2.4353645e-05,0.9999641,1.1536081e-05
3983,FOXP3 protein,25,27,121,134,"Coculture of DCs with autologous T cells leads to an increase in both the number of Treg's, as well as the expression of FOXP3 protein per cell both in healthy donors and myeloma patients.",16763205_3,-1,-1,-1,-1,3983,-1,2.5015752e-05,0.99996054,1.4414756e-05
3994,the nature,11,13,54,64,"The efficacy of induction of Treg's by DCs depends on the nature of the DC maturation stimulus, with inflammatory cytokine-treated DCs (Cyt-DCs) being the most effective Treg inducers.",16763205_6,-1,-1,-1,-1,3994,-1,4.254486e-05,0.9999347,2.2780447e-05
4000,functional,12,13,73,83,DC-induced Treg's from both healthy donors and patients with myeloma are functional and effectively suppress T-cell responses.,16763205_7,0,1,2,-1,4000,-1,5.386896e-05,0.99992514,2.0952451e-05
4001,T-cell,16,17,109,115,DC-induced Treg's from both healthy donors and patients with myeloma are functional and effectively suppress T-cell responses.,16763205_7,-1,1,2,-1,4001,-1,5.167317e-05,6.631209e-05,0.999882
4008,functional FOXP3(high,12,14,61,82,These data reveal a role for DCs in increasing the number of functional FOXP3(high) Treg's in humans.,16763205_9,-1,-1,-1,-1,4008,-1,4.1971394e-05,0.99993086,2.720167e-05
4010,CTL-associated antigen,0,2,0,22,"CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell activation and proliferation, inducing antitumor immunity in both preclinical and early clinical trials.",16778987_0,-1,-1,-1,-1,4010,-1,0.0018500733,0.00023382367,0.99791604
4014,immunity,19,20,130,138,"CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell activation and proliferation, inducing antitumor immunity in both preclinical and early clinical trials.",16778987_0,0,-1,2,-1,4014,-1,0.99886936,0.0007449805,0.00038571167
4017,GM-CSF-transduced tumor cell,10,13,57,85,We examined the mechanisms of action of anti-CTLA4 and a GM-CSF-transduced tumor cell vaccine (Gvax) and their impact on the balance of effector T cells (Teffs) and Tregs in an in vivo model of B16/BL6 melanoma.,16778987_1,-1,-1,-1,-1,4017,-1,0.82201445,0.004314071,0.17367145
4030,their function,8,10,55,69,"Anti-CTLA4 did not deplete Tregs or permanently impair their function but acted in a cell-intrinsic manner on both Tregs and Teffs, allowing them to expand, most likely in response to self antigen.",16778987_3,-1,-1,-1,-1,4030,-1,6.1130595e-05,0.9999021,3.667624e-05
4034,them to,23,25,141,148,"Anti-CTLA4 did not deplete Tregs or permanently impair their function but acted in a cell-intrinsic manner on both Tregs and Teffs, allowing them to expand, most likely in response to self antigen.",16778987_3,-1,-1,-1,-1,4034,-1,2.54266e-05,0.999962,1.2607251e-05
4037,the tumor-reactive Teff,3,6,18,41,"While Gvax primed the tumor-reactive Teff compartment, inducing activation, tumor infiltration, and a delay in tumor growth, the combination with CTLA4 blockade induced greater infiltration and a striking change in the intratumor balance of Tregs and Teffs that directly correlated with tumor rejection.",16778987_4,-1,-1,-1,-1,4037,-1,5.470215e-05,0.9999052,4.00946e-05
4044,Teffs that,40,42,251,261,"While Gvax primed the tumor-reactive Teff compartment, inducing activation, tumor infiltration, and a delay in tumor growth, the combination with CTLA4 blockade induced greater infiltration and a striking change in the intratumor balance of Tregs and Teffs that directly correlated with tumor rejection.",16778987_4,-1,-1,-1,-1,4044,-1,2.8512115e-05,0.9999474,2.4086437e-05
4047,that Tregs,3,5,17,27,"The data suggest that Tregs control both CD4+ and CD8+ T cell activity within the tumor, highlight the importance of the intratumor ratio of effectors to regulators, and demonstrate inversion of the ratio and correlation with tumor rejection during Gvax/anti-CTLA4 immunotherapy.",16778987_5,-1,-1,-1,-1,4047,-1,1.8552475e-05,0.99997294,8.524681e-06
4049,the tumor,16,18,78,87,"The data suggest that Tregs control both CD4+ and CD8+ T cell activity within the tumor, highlight the importance of the intratumor ratio of effectors to regulators, and demonstrate inversion of the ratio and correlation with tumor rejection during Gvax/anti-CTLA4 immunotherapy.",16778987_5,-1,-1,-1,-1,4049,-1,1.9437326e-05,0.99997044,1.0086531e-05
4059,the tumor,17,19,101,110,Studies in cancer patients have suggested that breast tumors recruit regulatory T cells (Tregs) into the tumor microenvironment.,16785502_0,-1,-1,-1,-1,4059,-1,1.8317116e-05,0.9999715,1.0226229e-05
4063,immunity,8,9,51,59,The extent to which local Tregs suppress antitumor immunity in breast cancer is unknown.,16785502_1,0,-1,2,-1,4063,-1,0.9919036,0.007575582,0.0005208182
4069,the tumor,15,17,81,90,"As in human breast cancer, cancers that develop in these mice attract Tregs into the tumor microenvironment to levels of approximately 10-25% of the total CD4+ T cells.",16785502_3,-1,-1,-1,-1,4069,-1,1.9444713e-05,0.9999707,9.9198005e-06
4071,the total,27,29,145,154,"As in human breast cancer, cancers that develop in these mice attract Tregs into the tumor microenvironment to levels of approximately 10-25% of the total CD4+ T cells.",16785502_3,-1,-1,-1,-1,4071,-1,2.477851e-05,0.99996066,1.4527425e-05
4078,The treatment,0,2,0,13,The treatment depleted Tregs without concomitant lymphopenia and markedly inhibited tumor growth.,16785502_5,-1,-1,-1,-1,4078,-1,2.3618893e-05,0.9999654,1.0985755e-05
4089,the therapeutic,16,18,109,124,The clinical response was immune-mediated because adoptive transfer of Tregs led to a complete abrogation of the therapeutic effects of immunotoxin treatment.,16785502_7,-1,-1,-1,-1,4089,-1,2.8161616e-05,0.9999608,1.1086149e-05
4092,immunity,9,10,71,79,"Further, Treg down-modulation was accompanied by increased Ag-specific immunity against the neu protein, a self Ag.",16785502_8,0,-1,2,-1,4092,-1,0.99899226,0.00066906866,0.00033872714
4094,protein,13,14,96,103,"Further, Treg down-modulation was accompanied by increased Ag-specific immunity against the neu protein, a self Ag.",16785502_8,0,1,-1,-1,4094,-1,0.000117253214,0.9997439,0.00013889019
4096,that Tregs play,3,6,22,37,"These results suggest that Tregs play a major role in preventing an effective endogenous immune response against breast cancer and that depletion of Tregs, without any additional immunotherapy, may mediate a significant antitumor response.",16785502_9,-1,-1,-1,-1,4096,-1,1.9687477e-05,0.9999701,1.0244331e-05
4103,the treatment,19,21,117,130,Here we show that a widely used neutralizing anti-murine IL-2 mAb (S4B6) exhibits unexpected activities that enhance the treatment effects of IL-2 in vivo.,16785526_1,-1,-1,-1,-1,4103,-1,2.4825238e-05,0.9999651,1.0073278e-05
4116,that the,27,29,168,176,"A 5-day treatment with the anti-IL-2 mAb alone gradually increased the CD44(high)CD8+ population, and the increased population was maintained for >300 days, suggesting that the mAb can gradually maintain and potentially enhance the bioactivity of endogenous IL-2 for extended periods.",16785526_4,-1,-1,-1,-1,4116,-1,1.983988e-05,0.99997187,8.344282e-06
4120,plus the,8,10,55,63,"Furthermore, combined treatment with the anti-IL-2 mAb plus the IL-2 plasmid markedly enhanced Ag-specific CTL activity in vivo and partially protected mice from tumor metastasis to the lungs, compared with the anti-IL-2 mAb or IL-2 plasmid alone.",16785526_5,-1,-1,-1,-1,4120,-1,2.682339e-05,0.99995923,1.3939354e-05
4124,to the,26,28,179,185,"Furthermore, combined treatment with the anti-IL-2 mAb plus the IL-2 plasmid markedly enhanced Ag-specific CTL activity in vivo and partially protected mice from tumor metastasis to the lungs, compared with the anti-IL-2 mAb or IL-2 plasmid alone.",16785526_5,-1,-1,-1,-1,4124,-1,2.3057131e-05,0.99996436,1.2575292e-05
4132,functions,30,31,200,209,These results demonstrated IL-2-enhancing effects of the anti-IL-2 mAb in vivo and suggest that combining a neutralizing anti-IL-2 Ab with IL-2 gene delivery might be used effectively to enhance IL-2 functions in clinical applications.,16785526_6,0,1,2,-1,4132,-1,0.00013435578,0.99971956,0.00014611761
4136,the blood,22,24,126,135,We reported earlier that patients with breast or pancreas cancer have an increased prevalence of regulatory T cells (Treg) in the blood and tumor draining lymph nodes (TDLNs) compared with healthy individuals.,16799337_0,-1,-1,-1,-1,4136,-1,3.0087564e-05,0.99993443,3.5427955e-05
4140,tested the,6,8,25,35,"In the current study, we tested the hypothesis that tumor cells promote the prevalence of Treg.",16799337_1,-1,-1,-1,-1,4140,-1,2.3315231e-05,0.9999647,1.2017228e-05
4141,that tumor cells,9,12,47,63,"In the current study, we tested the hypothesis that tumor cells promote the prevalence of Treg.",16799337_1,-1,-1,-1,-1,4141,-1,0.0036254758,0.773941,0.22243349
4144,The transforming growth factor-beta,0,4,0,35,"The transforming growth factor-beta (TGF-beta) secreting murine pancreas adenocarcinoma, Pan02 cell line was injected into syngeneic C57BL/6 mice and the prevalence of Treg in the TDLNs and tumor spleen was measured weekly.",16799337_2,-1,-1,-1,-1,4144,-1,0.6355189,0.35966846,0.0048126616
4145,TGF-beta,5,6,37,45,"The transforming growth factor-beta (TGF-beta) secreting murine pancreas adenocarcinoma, Pan02 cell line was injected into syngeneic C57BL/6 mice and the prevalence of Treg in the TDLNs and tumor spleen was measured weekly.",16799337_2,0,1,-1,-1,4145,-1,4.1330233e-05,0.9999405,1.8190618e-05
4149,the TDLNs,27,29,176,185,"The transforming growth factor-beta (TGF-beta) secreting murine pancreas adenocarcinoma, Pan02 cell line was injected into syngeneic C57BL/6 mice and the prevalence of Treg in the TDLNs and tumor spleen was measured weekly.",16799337_2,-1,-1,-1,-1,4149,-1,2.298932e-05,0.999961,1.5949405e-05
4156,Analysis,0,1,0,8,"Analysis of these CD25+ CD4+ T cells in vitro confirmed expression of the Treg marker, Foxp3.",16799337_4,0,1,-1,-1,4156,-1,2.7663233e-05,0.9999473,2.4968136e-05
4159,the Treg,14,16,70,78,"Analysis of these CD25+ CD4+ T cells in vitro confirmed expression of the Treg marker, Foxp3.",16799337_4,-1,-1,-1,-1,4159,-1,2.6706215e-05,0.9999567,1.6566128e-05
4161,their functional,3,5,13,29,"In addition, their functional activity resembled that of Treg, as evidenced by a poor proliferative capacity; suppression of proliferation of CD25- CD4 or CD8T cells and inhibition of interferon-gamma release by CD25- CD4+ T cells.",16799337_5,-1,-1,-1,-1,4161,-1,4.1210606e-05,0.9999362,2.2518707e-05
4165,interferon-gamma release,32,34,184,208,"In addition, their functional activity resembled that of Treg, as evidenced by a poor proliferative capacity; suppression of proliferation of CD25- CD4 or CD8T cells and inhibition of interferon-gamma release by CD25- CD4+ T cells.",16799337_5,-1,-1,-1,-1,4165,-1,0.99211603,0.0062843747,0.0015995426
4174,TGF-beta-negative,18,19,114,131,"In contrast, Foxp3 was not detected in unreconstituted Pan02-bearing Rag-/- mice, or reconstituted mice bearing a TGF-beta-negative esophageal tumor.",16799337_7,0,1,-1,-1,4174,-1,8.8687026e-05,0.9998672,4.4092205e-05
4179,Foxp3 through,10,12,66,79,These results mimic earlier in vitro studies showing induction of Foxp3 through CD3 plus CD28 stimulation in the presence of TGF-beta.,16799337_9,-1,-1,-1,-1,4179,-1,1.7817754e-05,0.99997234,9.873636e-06
4180,plus CD28,13,15,84,93,These results mimic earlier in vitro studies showing induction of Foxp3 through CD3 plus CD28 stimulation in the presence of TGF-beta.,16799337_9,-1,-1,-1,-1,4180,-1,0.006138343,0.19494109,0.79892063
4182,TGF-beta,20,21,125,133,These results mimic earlier in vitro studies showing induction of Foxp3 through CD3 plus CD28 stimulation in the presence of TGF-beta.,16799337_9,0,1,-1,-1,4182,-1,5.5158416e-05,0.999928,1.6833987e-05
4187,through the,13,15,70,81,"We conclude that Pan02 tumor promotes the prevalence of Treg, in part through the secretion of TGF-beta, which may result in immune evasion.",16799337_10,-1,-1,-1,-1,4187,-1,2.19749e-05,0.99996674,1.1246321e-05
4188,TGF-beta,17,18,95,103,"We conclude that Pan02 tumor promotes the prevalence of Treg, in part through the secretion of TGF-beta, which may result in immune evasion.",16799337_10,0,1,-1,-1,4188,-1,5.1161034e-05,0.9999293,1.9493555e-05
4194,to the,16,18,90,96,"We examined the hypothesis that a failure of the immune system to eradicate tumors is due to the immunosuppressive environment created by the growing tumor, which is influenced by the site of tumor growth.",16818744_0,-1,-1,-1,-1,4194,-1,2.1445137e-05,0.99996924,9.262797e-06
4199,that T cell,2,5,16,27,We demonstrated that T cell responses to a bystander Ag in mice were suppressed by a growing CT26 tumor.,16818744_1,-1,-1,-1,-1,4199,-1,0.003950747,0.25064296,0.7454062
4206,TGF-beta,12,13,66,74,"T cells purified from the growing tumor expressed mRNA for IL-10, TGF-beta, and Foxp3.",16818744_2,0,1,-1,-1,4206,-1,0.00010078672,0.9998609,3.8283993e-05
4212,the tumor,23,25,146,155,"Intracellular cytokine staining revealed a high frequency of IL-10-secreting macrophages, dendritic cells, and CD4+ and CD8+ T cells infiltrating the tumor.",16818744_3,-1,-1,-1,-1,4212,-1,1.9892823e-05,0.9999684,1.1736026e-05
4213,T cell IFN-gamma,3,6,13,29,"In contrast, T cell IFN-gamma production was weak and CD8+ CTL responses were undetectable in mice with CT26 lung metastases and weak and transient following s.c. injection of CT26 cells, but were enhanced in the presence of anti-IL-10 and anti-TGF-beta.",16818744_4,-1,-1,-1,-1,4213,-1,0.5190178,0.002166583,0.47881562
4225,the tumor,15,17,76,85,"However, in the lung model, depletion of CD8+ T cells significantly reduced the tumor burden.",16818744_6,-1,-1,-1,-1,4225,-1,1.9967476e-05,0.9999691,1.0923644e-05
4232,that tumor,3,5,23,33,These findings suggest that tumor growth facilitates the induction or recruitment of CD4+ regulatory T cells that secrete IL-10 and TGF-beta and suppress effector CD8+ T cell responses.,16818744_8,-1,-1,-1,-1,4232,-1,1.8491768e-05,0.9999732,8.362257e-06
4234,regulatory T cells that,14,18,90,113,These findings suggest that tumor growth facilitates the induction or recruitment of CD4+ regulatory T cells that secrete IL-10 and TGF-beta and suppress effector CD8+ T cell responses.,16818744_8,-1,-1,-1,-1,4234,-1,0.0017930213,0.06656105,0.93164593
4236,TGF-beta,21,22,132,140,These findings suggest that tumor growth facilitates the induction or recruitment of CD4+ regulatory T cells that secrete IL-10 and TGF-beta and suppress effector CD8+ T cell responses.,16818744_8,0,1,-1,-1,4236,-1,6.162512e-05,0.99991393,2.4415769e-05
4241,TGF-beta,10,11,54,62,"However, CD8+ T regulatory cells expressing IL-10 and TGF-beta are also recruited or activated by the immunosuppressive environment of the lung, where they may suppress the induction of antitumor immunity.",16818744_9,0,1,-1,-1,4241,-1,7.986409e-05,0.99989533,2.4823345e-05
4246,immunity,32,33,196,204,"However, CD8+ T regulatory cells expressing IL-10 and TGF-beta are also recruited or activated by the immunosuppressive environment of the lung, where they may suppress the induction of antitumor immunity.",16818744_9,0,-1,2,-1,4246,-1,0.99932027,0.00043359378,0.00024608782
4247,targeting tumor antigens,4,7,39,63,Cancer immunotherapy utilizes vaccines targeting tumor antigens or tumor endothelium to prevent or regress tumors.,16916758_0,-1,-1,-1,-1,4247,-1,0.06698361,0.9271854,0.005831029
4253,T cells that,9,12,70,82,Many cancer vaccines are designed to induce antigen-specific effector T cells that migrate to the tumor site.,16916758_1,-1,-1,-1,-1,4253,-1,0.001310862,0.038031172,0.9606579
4254,to the tumor,13,16,91,103,Many cancer vaccines are designed to induce antigen-specific effector T cells that migrate to the tumor site.,16916758_1,-1,-1,-1,-1,4254,-1,2.3768343e-05,0.9999654,1.0776333e-05
4257,the tumor,10,12,56,65,"In an optimal situation, the effector T cells penetrate the tumor, release their effector molecules, induce tumor cell death and tumor regression.",16916758_2,-1,-1,-1,-1,4257,-1,2.4542525e-05,0.9999633,1.2178421e-05
4258,release their,13,15,67,80,"In an optimal situation, the effector T cells penetrate the tumor, release their effector molecules, induce tumor cell death and tumor regression.",16916758_2,-1,-1,-1,-1,4258,-1,3.3052424e-05,0.9999471,1.9877853e-05
4259,tumor cell,19,21,108,118,"In an optimal situation, the effector T cells penetrate the tumor, release their effector molecules, induce tumor cell death and tumor regression.",16916758_2,-1,-1,-1,-1,4259,-1,0.0039641676,0.26626888,0.7297669
4261,the tumor,2,4,9,18,"However, the tumor microenvironment is frequently immunosuppressive and contributes to a state of immune ignorance, impacting on the vaccine's ability to break tolerance to tumor antigen/s.",16916758_3,-1,-1,-1,-1,4261,-1,1.9990677e-05,0.9999707,9.374724e-06
4266,tolerance to tumor,25,28,160,178,"However, the tumor microenvironment is frequently immunosuppressive and contributes to a state of immune ignorance, impacting on the vaccine's ability to break tolerance to tumor antigen/s.",16916758_3,-1,-1,-1,-1,4266,-1,2.7645012e-05,0.9999579,1.443695e-05
4268,the factors,3,5,22,33,This review discusses the factors in the tumor microenvironment that can affect the efficacy of cancer vaccines.,16916758_4,-1,-1,-1,-1,4268,-1,3.5375582e-05,0.99994946,1.5225051e-05
4269,the tumor,6,8,37,46,This review discusses the factors in the tumor microenvironment that can affect the efficacy of cancer vaccines.,16916758_4,-1,-1,-1,-1,4269,-1,2.0212754e-05,0.9999701,9.6515805e-06
4286,to test,7,9,34,41,The first goal of this article is to test if the injection of autologous dendritic cells infected ex vivo with the Ad-sig-TAA/ecdCD40L can increase the immune response induced against TAA.,16928818_2,-1,-1,-1,-1,4286,-1,1.9246769e-05,0.9999716,9.136954e-06
4290,the immune response,24,27,148,167,The first goal of this article is to test if the injection of autologous dendritic cells infected ex vivo with the Ad-sig-TAA/ecdCD40L can increase the immune response induced against TAA.,16928818_2,-1,-1,-1,-1,4290,-1,0.29156092,0.70703495,0.0014041403
4293,to test the,4,7,19,30,The second goal is to test the effect of adding local chemotherapy in the form of i.t.,16928818_3,-1,-1,-1,-1,4293,-1,2.0210451e-05,0.9999716,8.118945e-06
4298,the immune response,7,10,61,80,injection of the AdCDIRESE1A vector-directed chemotherapy on the immune response induced by i.t.,16928818_4,-1,-1,-1,-1,4298,-1,0.35525614,0.6424785,0.002265414
4301,that the,3,5,17,25,"The results show that the i.t. injection of the AdCDIRESE1A chemotherapy sensitization vector, which encodes the cytosine deaminase chemotherapy sensitization transcription unit, to the i.t. injection of Ad-sig-ecdCD40L vector-infected dendritic cells increased the level of suppression of the growth of the CCL-51 breast cancer cells.",16928818_6,-1,-1,-1,-1,4301,-1,1.7821976e-05,0.9999727,9.472278e-06
4307,to the,25,27,179,185,"The results show that the i.t. injection of the AdCDIRESE1A chemotherapy sensitization vector, which encodes the cytosine deaminase chemotherapy sensitization transcription unit, to the i.t. injection of Ad-sig-ecdCD40L vector-infected dendritic cells increased the level of suppression of the growth of the CCL-51 breast cancer cells.",16928818_6,-1,-1,-1,-1,4307,-1,2.174427e-05,0.99996746,1.0760478e-05
4323,to the,7,9,63,69,injection of the AdCDIRESE1A chemotherapy sensitization vector to the i.t.,16928818_11,-1,-1,-1,-1,4323,-1,2.5050054e-05,0.9999604,1.4543696e-05
4325,to the,15,17,116,122,administration of dendritic cells infected with a rat HER-2/neu (rH2N)-expressing vector (Ad-sig-rH2N/ecdCD40L) led to the induction of rH2N-specific antitumoral immunity in rH2N transgenic mice (which are anergic to the rH2N antigen).,16928818_12,-1,-1,-1,-1,4325,-1,1.8684786e-05,0.9999726,8.782324e-06
4326,immunity,21,22,162,170,administration of dendritic cells infected with a rat HER-2/neu (rH2N)-expressing vector (Ad-sig-rH2N/ecdCD40L) led to the induction of rH2N-specific antitumoral immunity in rH2N transgenic mice (which are anergic to the rH2N antigen).,16928818_12,0,-1,2,-1,4326,-1,0.9913867,0.0077178646,0.00089536223
4328,to the,30,32,214,220,administration of dendritic cells infected with a rat HER-2/neu (rH2N)-expressing vector (Ad-sig-rH2N/ecdCD40L) led to the induction of rH2N-specific antitumoral immunity in rH2N transgenic mice (which are anergic to the rH2N antigen).,16928818_12,-1,-1,-1,-1,4328,-1,3.1668318e-05,0.9999509,1.7403421e-05
4337,FOXP3-expressing regulatory T cells,2,6,17,52,"CD4(+)CD25(high) FOXP3-expressing regulatory T cells (Treg) can suppress immune responses to infections and tumors, thereby promoting microbial persistence and tumor progression.",16934529_0,-1,-1,-1,-1,4337,-1,0.0033704678,0.7924888,0.20414078
4339,immune responses to,11,14,73,92,"CD4(+)CD25(high) FOXP3-expressing regulatory T cells (Treg) can suppress immune responses to infections and tumors, thereby promoting microbial persistence and tumor progression.",16934529_0,-1,-1,-1,-1,4339,-1,0.8774218,0.12062449,0.0019536426
4344,function,9,10,49,57,"However, little is known about the phenotype and function of human mucosal Treg.",16934529_1,0,1,2,-1,4344,-1,3.0018791e-05,0.9999511,1.8883551e-05
4350,the tumor,9,11,53,62,We found increased numbers of CD4(+)FOXP3(+) Treg in the tumor compared to tumor-free gastric mucosa.,16934529_3,-1,-1,-1,-1,4350,-1,1.8874372e-05,0.99997044,1.0715329e-05
4351,to tumor-free,12,14,72,85,We found increased numbers of CD4(+)FOXP3(+) Treg in the tumor compared to tumor-free gastric mucosa.,16934529_3,-1,-1,-1,-1,4351,-1,2.7320273e-05,0.9999585,1.420048e-05
4359,that these receptors,18,21,116,136,"Furthermore, gastric Treg expressed increased levels of l-selectin and CCR4, compared to non-Treg cells, suggesting that these receptors contribute to Treg recruitment.",16934529_5,-1,-1,-1,-1,4359,-1,0.0017226512,0.9505621,0.047715228
4360,to Treg,22,24,148,155,"Furthermore, gastric Treg expressed increased levels of l-selectin and CCR4, compared to non-Treg cells, suggesting that these receptors contribute to Treg recruitment.",16934529_5,-1,-1,-1,-1,4360,-1,2.877226e-05,0.9999567,1.4530666e-05
4362,functional antigen-specific Treg,3,6,16,48,"The presence of functional antigen-specific Treg in H. pylori-infected gastric mucosa supports an important role for these cells in suppression of mucosal effector T cell responses, which probably contribute to bacterial persistence and possibly also to gastric tumor progression.",16934529_6,-1,-1,-1,-1,4362,-1,0.00070204126,0.99910164,0.00019631708
4363,these cells,16,18,117,128,"The presence of functional antigen-specific Treg in H. pylori-infected gastric mucosa supports an important role for these cells in suppression of mucosal effector T cell responses, which probably contribute to bacterial persistence and possibly also to gastric tumor progression.",16934529_6,-1,-1,-1,-1,4363,-1,0.0031177714,0.16024053,0.83664167
4369,receptor-ligand,12,13,91,106,BACKGROUND & OBJECTIVE: Accumulative evidences have indicated the importance of CD40-CD40L receptor-ligand pair in the initiation and regulation of human immune response.,16965650_0,0,1,2,-1,4369,-1,0.0015765588,0.0012803789,0.9971431
4399,than that,38,40,283,292,The production of IFN-gamma secreted by the spleen cells from CD40L/OVHM and OVHM cell-inoculated mice co-cultured with 20 Gy-irridiated OVHM cells were measured with enzyme-linked immunosorbent assay (ELISA).RESULTS: Expression of CD40L in OVHM/CD40L cells was significantly higher than that in OVHM cells (P<0.05).,16965650_7,-1,-1,-1,-1,4399,-1,2.5785344e-05,0.999959,1.5211379e-05
4410,the tumor,20,22,142,151,"Although, delayed tumor growth was observed when CD40L-expressing OVHM cells and OVHM cells were injected simultaneously and contralaterally, the tumor growth of OVHM and CD40L/OVHM in BALB/c nude mice was not different.",16965650_10,-1,-1,-1,-1,4410,-1,2.0887666e-05,0.9999697,9.381503e-06
4416,than those,23,25,147,157,The amounts of IFN-gamma secreted by the co-culture of irradiated OVHM cells with spleen cells from mice injected with CD40L/OVHM were much higher than those from OVHM/parental cell inoculated and naive mice.,16965650_11,-1,-1,-1,-1,4416,-1,2.486271e-05,0.99996173,1.3431677e-05
4424,the generation,9,11,70,84,In vivo immunization of immunocompetent mice with CD40L/OVHM improves the generation of cytotoxic lymphocytes against parent ovarian cancer cells.,16965650_13,-1,-1,-1,-1,4424,-1,2.5941223e-05,0.99996173,1.2322439e-05
4432,transforming growth factor,14,17,78,104,"These CD8+ T cells selectively express CD103, which is upregulated locally by transforming growth factor (TGF)-beta, and adhere to E-cadherin expressed by mucosal epithelia.",16978200_1,-1,-1,-1,-1,4432,-1,0.87699044,0.11962767,0.0033819084
4435,the type,9,11,61,69,Many of these cancers also possess inactivating mutations in the type II TGF-beta receptor and are believed to be insensitive to TGF-beta.,16978200_2,-1,-1,-1,-1,4435,-1,2.1474547e-05,0.9999654,1.3043964e-05
4436,TGF-beta receptor,12,14,73,90,Many of these cancers also possess inactivating mutations in the type II TGF-beta receptor and are believed to be insensitive to TGF-beta.,16978200_2,-1,-1,-1,-1,4436,-1,0.00033537147,0.9950086,0.0046560653
4438,to TGF-beta,20,22,126,137,Many of these cancers also possess inactivating mutations in the type II TGF-beta receptor and are believed to be insensitive to TGF-beta.,16978200_2,-1,-1,-1,-1,4438,-1,4.9171773e-05,0.99993324,1.759003e-05
4441,to TGF-beta,9,11,63,74,The present study aimed to explore whether such refractoriness to TGF-beta is an independently contributing factor to IEL retention.,16978200_3,-1,-1,-1,-1,4441,-1,4.0995787e-05,0.99994373,1.5283618e-05
4442,factor to,15,17,108,117,The present study aimed to explore whether such refractoriness to TGF-beta is an independently contributing factor to IEL retention.,16978200_3,-1,-1,-1,-1,4442,-1,0.00016392827,0.9997578,7.825702e-05
4443,deficiency,13,14,72,82,METHODS AND RESULTS: A panel of colorectal cancers enriched for DNA MMR deficiency was examined by immunohistochemistry to explore the expression levels and localization of various components in the TGF-beta signalling pathway.,16978200_4,0,1,-1,-1,4443,-1,9.445918e-05,0.99960226,0.0003032456
4446,the TGF-beta,29,31,195,207,METHODS AND RESULTS: A panel of colorectal cancers enriched for DNA MMR deficiency was examined by immunohistochemistry to explore the expression levels and localization of various components in the TGF-beta signalling pathway.,16978200_4,-1,-1,-1,-1,4446,-1,5.2735788e-05,0.99993193,1.5360796e-05
4452,tumour cell,5,7,31,42,"Increases in Smad4 expression, tumour cell proliferation and TGF-beta secretion each emerged as independent predictors of marked lymphocyte infiltration.",16978200_6,-1,-1,-1,-1,4452,-1,0.003229922,0.14088467,0.8558854
4453,TGF-beta,9,10,61,69,"Increases in Smad4 expression, tumour cell proliferation and TGF-beta secretion each emerged as independent predictors of marked lymphocyte infiltration.",16978200_6,0,1,-1,-1,4453,-1,0.00013761465,0.9998265,3.5886365e-05
4459,TGF-beta,12,13,89,97,CONCLUSIONS: These results strongly support the hypothesis that refractoriness to normal TGF-beta signalling in colorectal cancers plays a role in the retention of lymphocytes within tumour epithelium.,16978200_7,0,1,-1,-1,4459,-1,5.999795e-05,0.9999206,1.9362467e-05
4464,the TGF-beta,11,13,76,88,"Since IEL infiltration is an independent predictor of favourable prognosis, the TGF-beta pathway may represent an important therapeutic target.",16978200_8,-1,-1,-1,-1,4464,-1,4.8674458e-05,0.99993885,1.2506275e-05
4465,therapeutic target,18,20,124,142,"Since IEL infiltration is an independent predictor of favourable prognosis, the TGF-beta pathway may represent an important therapeutic target.",16978200_8,-1,-1,-1,-1,4465,-1,2.7879118e-05,0.99996006,1.2037244e-05
4480,therapy,21,22,133,140,We examined the phosphorylation of STAT5 (P-STAT5) in IL-2-stimulated immune cells of normal subjects and in patients receiving IL-2 therapy using a novel flow cytometric assay to characterize the pattern and level of activation within immune subsets.,17020993_2,0,1,-1,-1,4480,-1,2.575886e-05,0.9999614,1.2871602e-05
4484,blood,5,6,39,44,EXPERIMENTAL DESIGN: Normal peripheral blood mononuclear cells (PBMC) were treated in vitro with IL-2 and analyzed for P-STAT5 using an intracellular flow cytometric assay.,17020993_3,0,1,-1,-1,4484,-1,0.00034023685,0.9940368,0.0056230067
4488,STAT5-regulated genes,8,10,56,77,PBMC were simultaneously evaluated for the induction of STAT5-regulated genes at the transcript level.,17020993_4,-1,-1,-1,-1,4488,-1,3.1298903e-05,0.99994636,2.2366654e-05
4489,the transcript,11,13,81,95,PBMC were simultaneously evaluated for the induction of STAT5-regulated genes at the transcript level.,17020993_4,-1,-1,-1,-1,4489,-1,2.4153405e-05,0.9999629,1.2939992e-05
4492,cell subsets,25,27,159,171,PBMC were also obtained from patients immediately before and 1 hour after treatment with high-dose IL-2 and analyzed for the presence of P-STAT5 within immune cell subsets by dual-variable intracellular flow cytometry.,17020993_5,-1,-1,-1,-1,4492,-1,3.7906382e-05,4.755193e-05,0.9999145
4507,The generation,0,2,0,14,The generation of P-STAT5 within immune cell subsets after the therapeutic administration of IL-2 varied significantly between individuals.,17020993_9,-1,-1,-1,-1,4507,-1,1.8347315e-05,0.99996996,1.166915e-05
4508,cell subsets,6,8,40,52,The generation of P-STAT5 within immune cell subsets after the therapeutic administration of IL-2 varied significantly between individuals.,17020993_9,-1,-1,-1,-1,4508,-1,3.6919697e-05,4.9013477e-05,0.99991405
4509,the therapeutic,9,11,59,74,The generation of P-STAT5 within immune cell subsets after the therapeutic administration of IL-2 varied significantly between individuals.,17020993_9,-1,-1,-1,-1,4509,-1,2.16851e-05,0.99996924,9.10414e-06
4520,to therapy,37,39,199,209,"Surprisingly, activated STAT5 persisted within CD4(+) and CD8(+) T lymphocytes, as well as CD56(+) NK cells, for up to 3 weeks post-IL-2 treatment in three patients who exhibited a clinical response to therapy and in a fourth who exhibited a significant inflammatory response after 11 doses of therapy (first cycle).CONCLUSIONS: The flow cytometric assay described herein is a highly efficient and reliable method by which to assess the cellular response to IL-2 within PBMC and specific immune effector subsets, both in vitro and in the clinical setting.",17020993_11,-1,-1,-1,-1,4520,-1,2.6248206e-05,0.99996054,1.3237972e-05
4521,therapy,53,54,294,301,"Surprisingly, activated STAT5 persisted within CD4(+) and CD8(+) T lymphocytes, as well as CD56(+) NK cells, for up to 3 weeks post-IL-2 treatment in three patients who exhibited a clinical response to therapy and in a fourth who exhibited a significant inflammatory response after 11 doses of therapy (first cycle).CONCLUSIONS: The flow cytometric assay described herein is a highly efficient and reliable method by which to assess the cellular response to IL-2 within PBMC and specific immune effector subsets, both in vitro and in the clinical setting.",17020993_11,0,1,-1,-1,4521,-1,3.069488e-05,0.9999484,2.0904537e-05
4525,the cellular,75,77,433,445,"Surprisingly, activated STAT5 persisted within CD4(+) and CD8(+) T lymphocytes, as well as CD56(+) NK cells, for up to 3 weeks post-IL-2 treatment in three patients who exhibited a clinical response to therapy and in a fourth who exhibited a significant inflammatory response after 11 doses of therapy (first cycle).CONCLUSIONS: The flow cytometric assay described herein is a highly efficient and reliable method by which to assess the cellular response to IL-2 within PBMC and specific immune effector subsets, both in vitro and in the clinical setting.",17020993_11,-1,-1,-1,-1,4525,-1,0.0045109233,0.45893806,0.536551
4529,to therapeutic,8,10,50,64,Assessment of P-STAT5 in patient PBMC in response to therapeutic IL-2 administration reveals disparate responses between immune cell subsets as well as interpatient variation.,17020993_12,-1,-1,-1,-1,4529,-1,2.5397989e-05,0.9999652,9.422761e-06
4530,cell subsets,17,19,128,140,Assessment of P-STAT5 in patient PBMC in response to therapeutic IL-2 administration reveals disparate responses between immune cell subsets as well as interpatient variation.,17020993_12,-1,-1,-1,-1,4530,-1,3.972207e-05,4.8587197e-05,0.99991167
4538,tumor-infiltrating lymphocytes,6,8,47,77,"Alternatively, adoptive transfer of autologous tumor-infiltrating lymphocytes (TIL) can mediate tumor regression in 50% of lymphodepleted patients, but are logistically and technically difficult to generate.",17056585_1,-1,-1,-1,-1,4538,-1,0.004206954,0.84516376,0.15062927
4542,to generate,28,30,195,206,"Alternatively, adoptive transfer of autologous tumor-infiltrating lymphocytes (TIL) can mediate tumor regression in 50% of lymphodepleted patients, but are logistically and technically difficult to generate.",17056585_1,-1,-1,-1,-1,4542,-1,2.7097081e-05,0.99995625,1.6598602e-05
4547,transfer to,16,18,101,112,"In this study, we evaluated the capability of vaccine-induced PBMC to mediate tumor regression after transfer to patients receiving the same chemotherapy-induced lymphodepletion used for TIL transfer therapy.",17056585_2,-1,-1,-1,-1,4547,-1,2.0188678e-05,0.9999695,1.032611e-05
4550,TIL transfer therapy,26,29,187,207,"In this study, we evaluated the capability of vaccine-induced PBMC to mediate tumor regression after transfer to patients receiving the same chemotherapy-induced lymphodepletion used for TIL transfer therapy.",17056585_2,-1,-1,-1,-1,4550,-1,2.5436348e-05,0.9999628,1.1750553e-05
4552,peptide,20,21,130,137,Autologous PBMC from nine gp100-vaccinated patients with metastatic melanoma were stimulated ex vivo with the gp100:209-217(210M) peptide and transferred in combination with high-dose IL-2 and cancer vaccine.,17056585_3,0,-1,2,-1,4552,-1,0.0008177016,0.99721634,0.0019659465
4555,peptide-reactive,9,10,54,70,"Transferred PBMC contained highly avid, gp100:209-217 peptide-reactive CD8(+) T cells.",17056585_4,0,-1,2,-1,4555,-1,0.0006635519,0.9991393,0.00019716697
4559,peptide-specific,3,4,14,30,gp100:209-217 peptide-specific CD8(+) T cells persisted at high levels in the blood of all patients and demonstrated significant tumor-specific IFN-gamma secretion in vitro.,17056585_6,0,-1,2,-1,4559,-1,8.442908e-05,0.9998778,3.7718528e-05
4561,the blood,13,15,74,83,gp100:209-217 peptide-specific CD8(+) T cells persisted at high levels in the blood of all patients and demonstrated significant tumor-specific IFN-gamma secretion in vitro.,17056585_6,-1,-1,-1,-1,4561,-1,2.496796e-05,0.9999527,2.2374734e-05
4562,tumor-specific IFN-gamma,21,23,129,153,gp100:209-217 peptide-specific CD8(+) T cells persisted at high levels in the blood of all patients and demonstrated significant tumor-specific IFN-gamma secretion in vitro.,17056585_6,-1,-1,-1,-1,4562,-1,0.57493544,0.41926923,0.005795345
4566,cell transfer,12,14,87,100,"These studies demonstrate the feasibility and safety of using vaccine-induced PBMC for cell transfer, but suggests that they are not as effective as TIL in adoptive immunotherapy even when transferred into lymphodepleted hosts.",17056585_8,-1,-1,-1,-1,4566,-1,0.0026090723,0.058761027,0.9386299
4567,that they,17,19,115,124,"These studies demonstrate the feasibility and safety of using vaccine-induced PBMC for cell transfer, but suggests that they are not as effective as TIL in adoptive immunotherapy even when transferred into lymphodepleted hosts.",17056585_8,-1,-1,-1,-1,4567,-1,1.9601106e-05,0.9999707,9.716261e-06
4571,tumor tissue,4,6,28,40,Cell lines established from tumor tissue of cutaneous melanoma biopsies often display constitutive and IFNgamma-inducible expression of MHC class II molecules.,17067677_0,-1,-1,-1,-1,4571,-1,2.4638302e-05,0.99995387,2.1488371e-05
4575,transcription factors that,8,11,50,76,"We have analyzed the DNA elements and interacting transcription factors that control the constitutive and IFNgamma-inducible expression of the class II transactivator (CIITA), a co-activator essential for transcription of all MHC class II genes.",17067677_2,-1,-1,-1,-1,4575,-1,2.1342965e-05,0.9999628,1.583055e-05
4590,the IFNgamma,17,19,117,129,"Similarly constitutive activation in melanoma of CIITA-PII, CIITA-PIII, and CIITA-PIV does not require components of the IFNgamma signaling pathway.",17067677_5,-1,-1,-1,-1,4590,-1,0.83317006,0.16112372,0.005706227
4592,to the,7,9,48,54,"However, these components are readily recruited to the PURR and CIITA-PIV after exposure of cells to IFNgamma and account for the IFNgamma-induced expression of CIITA.",17067677_6,-1,-1,-1,-1,4592,-1,2.3547012e-05,0.99996257,1.3931148e-05
4593,cells to IFNgamma,15,18,92,109,"However, these components are readily recruited to the PURR and CIITA-PIV after exposure of cells to IFNgamma and account for the IFNgamma-induced expression of CIITA.",17067677_6,-1,-1,-1,-1,4593,-1,0.53470063,0.0052246526,0.4600747
4594,the IFNgamma-induced,21,23,126,146,"However, these components are readily recruited to the PURR and CIITA-PIV after exposure of cells to IFNgamma and account for the IFNgamma-induced expression of CIITA.",17067677_6,-1,-1,-1,-1,4594,-1,0.0028069192,0.9969023,0.00029071735
4597,factors,11,12,68,75,"Together, our data reveal the contribution of distinct elements and factors in the constitutive and IFNgamma-inducible expression of CIITA in melanoma cell lines of the skin.",17067677_7,0,1,-1,-1,4597,-1,4.909809e-05,0.99991655,3.4384033e-05
4609,T-cell,22,23,143,149,Naturally arising CD4(+)CD25(+) regulatory T cells (Tregs) have the potential to suppress aberrant immune responses and to regulate peripheral T-cell homeostasis.,17084366_0,-1,1,2,-1,4609,-1,3.1761556e-05,3.983905e-05,0.9999285
4610,transplantation,6,7,32,47,"In murine models of bone marrow transplantation, Tregs promote donor bone marrow engraftment and decrease the incidence and severity of graft-versus-host-disease without abrogating the beneficial graft-versus-tumor immunologic effect.",17084366_1,-1,1,2,-1,4610,-1,3.007378e-05,0.99995303,1.6843545e-05
4615,that Tregs,7,9,45,55,"These findings, in concert with observations that Tregs in mice and humans share phenotypic and functional characteristics, have led to active investigations into the use of these cells to decrease complications associated with human hematopoietic cell transplantation.",17084366_2,-1,-1,-1,-1,4615,-1,2.2709735e-05,0.9999672,1.0067048e-05
4616,functional,16,17,96,106,"These findings, in concert with observations that Tregs in mice and humans share phenotypic and functional characteristics, have led to active investigations into the use of these cells to decrease complications associated with human hematopoietic cell transplantation.",17084366_2,0,1,2,-1,4616,-1,7.908555e-05,0.9998896,3.12419e-05
4619,these cells to,28,31,174,188,"These findings, in concert with observations that Tregs in mice and humans share phenotypic and functional characteristics, have led to active investigations into the use of these cells to decrease complications associated with human hematopoietic cell transplantation.",17084366_2,-1,-1,-1,-1,4619,-1,8.791305e-05,0.99974304,0.0001690936
4620,cell transplantation,37,39,248,268,"These findings, in concert with observations that Tregs in mice and humans share phenotypic and functional characteristics, have led to active investigations into the use of these cells to decrease complications associated with human hematopoietic cell transplantation.",17084366_2,-1,-1,-1,-1,4620,-1,0.0027508696,0.08044289,0.9168062
4624,to the,15,17,91,97,Early human studies suggest that an imbalance of Tregs and effector T cells may contribute to the development of graft-versus-host-disease.,17084366_3,-1,-1,-1,-1,4624,-1,2.2938482e-05,0.9999664,1.0619798e-05
4637,cell transplantation,25,27,164,184,"In this review, we discuss the current knowledge of Treg biology and the potential therapeutic strategies and barriers of Treg immunotherapy in human hematopoietic cell transplantation.",17084366_5,-1,-1,-1,-1,4637,-1,0.003154169,0.10592375,0.890922
4640,the tumor cells,29,32,165,180,"About 50% of cervical cancers are associated with human papillomavirus type 16 (HPV-16), and since the HPV-16 E6 and E7 oncoproteins are constitutively expressed in the tumor cells, they are attractive targets for cytotoxic T lymphocyte (CTL)-mediated immunotherapy.",17096336_0,-1,-1,-1,-1,4640,-1,0.0030048196,0.7979018,0.1990934
4650,T cells transduced,40,43,227,245,"Using reverse immunological methods, we have generated a CTL clone against the HPV-16 E6(49-57) epitope restricted by HLA-A*2402, which is the most common allele in Japan and relatively frequent worldwide, capable of lysing 293T cells transduced with HLA-A*2402 and HPV-16 E6.",17096336_2,-1,-1,-1,-1,4650,-1,0.0011000962,0.057980366,0.9409195
4654,the cells,18,20,107,116,"Although it was unable to recognize the SiHa cervical cancer cell line positive for HPV-16 and HLA-A*2402, the cells became susceptible to lysis when transduced with E6-E7 genes, which was unexpectedly offset by pretreatment with interferon (IFN)-gamma alone.",17096336_3,-1,-1,-1,-1,4654,-1,0.0033266814,0.35197195,0.6447013
4667,Tetramer analysis,0,2,0,17,Tetramer analysis further revealed that induction of E6(49-57)-specific T cells was possible in 5 of 7 patients with HPV-16-positive high grade cervical intraepithelial neoplasia or cervical cancer by in vitro stimulation with E6(49-57) peptide.,17096336_6,-1,-1,-1,-1,4667,-1,2.0943797e-05,0.99996114,1.796984e-05
4670,peptide,38,39,237,244,Tetramer analysis further revealed that induction of E6(49-57)-specific T cells was possible in 5 of 7 patients with HPV-16-positive high grade cervical intraepithelial neoplasia or cervical cancer by in vitro stimulation with E6(49-57) peptide.,17096336_6,0,-1,2,-1,4670,-1,9.8937824e-05,0.99978715,0.00011397865
4680,function,9,10,62,70,"AIM: To determine whether beta-glucosylceramide can alter NKT function in opposite directions, colitis was induced by intracolonic installation of trinitrobenzenesulphonic acid, and hepatocellular carcinoma (HCC) was induced by transplantation of Hep3B cells.",17172586_1,0,1,2,-1,4680,-1,9.513658e-05,0.99973553,0.00016934861
4682,transplantation,33,34,228,243,"AIM: To determine whether beta-glucosylceramide can alter NKT function in opposite directions, colitis was induced by intracolonic installation of trinitrobenzenesulphonic acid, and hepatocellular carcinoma (HCC) was induced by transplantation of Hep3B cells.",17172586_1,-1,1,2,-1,4682,-1,2.2923428e-05,0.999966,1.100411e-05
4685,analysis,10,11,75,83,"METHODS: The immunological effect of beta-glucosylceramide was assessed by analysis of intrahepatic and intrasplenic lymphocyte populations, serum cytokines and STAT protein expression.",17172586_2,0,1,-1,-1,4685,-1,2.7636755e-05,0.99995863,1.3785464e-05
4693,the two,11,13,80,87,The beneficial effects were associated with an opposite immunological effect in the two models: the peripheral:intrahepatic CD4:CD8 lymphocyte ratio increased in the colitis model and decreased in the HCC group.,17172586_4,-1,-1,-1,-1,4693,-1,2.380747e-05,0.99996614,1.0086949e-05
4711,Proteins,0,1,0,8,Proteins encoded by genes of the SSX family are specifically expressed in tumors and are therefore relevant targets for cancer immunotherapy.,17186289_0,0,1,-1,-1,4711,-1,3.0086836e-05,0.9999465,2.3438022e-05
4715,therefore relevant targets,15,18,89,115,Proteins encoded by genes of the SSX family are specifically expressed in tumors and are therefore relevant targets for cancer immunotherapy.,17186289_0,-1,-1,-1,-1,4715,-1,2.7518265e-05,0.99995923,1.32753e-05
4733,peptides,10,11,51,59,After a single in vitro stimulation with a pool of peptides spanning the entire SSX-1 protein we could detect and isolate SSX-1-specific CD4(+) T cells from 5/5 donors analyzed.,17186289_5,0,-1,2,-1,4733,-1,4.045947e-05,0.9999225,3.69754e-05
4735,protein,15,16,86,93,After a single in vitro stimulation with a pool of peptides spanning the entire SSX-1 protein we could detect and isolate SSX-1-specific CD4(+) T cells from 5/5 donors analyzed.,17186289_5,0,1,-1,-1,4735,-1,5.0063285e-05,0.99990165,4.82767e-05
4738,peptides,8,9,78,86,SSX-1-specific polyclonal populations isolated from these cultures recognized peptides located in three distinct regions of the protein containing clusters of sequences with significant predicted binding to frequently expressed MHC class II alleles.,17186289_6,0,-1,2,-1,4738,-1,0.00019619286,0.999158,0.00064576254
4740,the protein,15,17,124,135,SSX-1-specific polyclonal populations isolated from these cultures recognized peptides located in three distinct regions of the protein containing clusters of sequences with significant predicted binding to frequently expressed MHC class II alleles.,17186289_6,-1,-1,-1,-1,4740,-1,2.8473365e-05,0.9999473,2.4186747e-05
4755,tumor-specific antigen targets,12,15,74,104,The E6 and E7 oncoproteins expressed in ESCC are considered as attractive tumor-specific antigen targets for immunotherapy.,17202676_1,-1,-1,-1,-1,4755,-1,9.2300834e-05,0.9998573,5.036985e-05
4756,that the,3,5,17,25,We have reported that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccination induced powerful anti-tumor immunity against TC-1 tumor cells in a C57BL/6 mouse model.,17202676_2,-1,-1,-1,-1,4756,-1,1.9099492e-05,0.99997115,9.763937e-06
4757,protein,8,9,65,72,We have reported that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccination induced powerful anti-tumor immunity against TC-1 tumor cells in a C57BL/6 mouse model.,17202676_2,0,1,-1,-1,4757,-1,4.146361e-05,0.99993336,2.5136676e-05
4758,immunity,13,14,113,121,We have reported that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccination induced powerful anti-tumor immunity against TC-1 tumor cells in a C57BL/6 mouse model.,17202676_2,0,-1,2,-1,4758,-1,0.99918324,0.00061744446,0.00019922208
4759,TC-1 tumor cells,15,18,130,146,We have reported that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccination induced powerful anti-tumor immunity against TC-1 tumor cells in a C57BL/6 mouse model.,17202676_2,-1,-1,-1,-1,4759,-1,0.0020048143,0.8866653,0.11132991
4763,protein,14,15,81,88,"In the present study, we further evaluate the protective efficacy of this fusion protein vaccine using an HPV E7-expressing human ESCC cell line (EC9706) and a Hu-PBL-SCID mouse model.",17202676_3,0,1,-1,-1,4763,-1,4.061508e-05,0.99993217,2.7223192e-05
4767,protein,7,8,50,57,"We demonstrated that immunization with the fusion protein vaccine caused significant inhibition of tumor growth with the delay time to tumor detection (tests vs. controls, 16 d vs. 9 d, p<0.01) and much smaller tumor size (p<0.01) in vivo.",17202676_4,0,1,-1,-1,4767,-1,8.293436e-05,0.9998635,5.3551557e-05
4770,time to tumor,18,21,127,140,"We demonstrated that immunization with the fusion protein vaccine caused significant inhibition of tumor growth with the delay time to tumor detection (tests vs. controls, 16 d vs. 9 d, p<0.01) and much smaller tumor size (p<0.01) in vivo.",17202676_4,-1,-1,-1,-1,4770,-1,2.7153817e-05,0.9999546,1.8320108e-05
4775,protein,15,16,57,64,"The inhibitory rate was ca. 69.6%, and 25% of the fusion protein vaccinated-mice remained tumor free by the end of the experiment (42 d).",17202676_5,0,1,-1,-1,4775,-1,0.00019468257,0.9996259,0.00017935016
4781,the tumor,14,16,80,89,"Furthermore, the activated lymphocytes (CD8+) were capable of infiltrating into the tumor site, and much more apoptotic cells along with activation of caspase-3 were observed in the tumors from vaccinated-mice.",17202676_6,-1,-1,-1,-1,4781,-1,1.9555104e-05,0.9999689,1.1524964e-05
4783,the tumors,31,33,178,188,"Furthermore, the activated lymphocytes (CD8+) were capable of infiltrating into the tumor site, and much more apoptotic cells along with activation of caspase-3 were observed in the tumors from vaccinated-mice.",17202676_6,-1,-1,-1,-1,4783,-1,1.8496832e-05,0.9999695,1.1963176e-05
4785,TNF-alpha,9,10,49,58,"Also, high expression levels of human IFN-gamma, TNF-alpha, granzyme B and perforin were detected in the tumors from vaccinated-mice.",17202676_7,0,1,-1,-1,4785,-1,0.02868196,0.97021985,0.0010982242
4786,the tumors,18,20,101,111,"Also, high expression levels of human IFN-gamma, TNF-alpha, granzyme B and perforin were detected in the tumors from vaccinated-mice.",17202676_7,-1,-1,-1,-1,4786,-1,1.927078e-05,0.99997103,9.664292e-06
4788,that the,4,6,24,32,"Therefore, we concluded that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccine is able to stimulate cellular-mediated immune response against E7-containing ESCC cells through CD8+-dependent CTL-induced apoptosis in Hu-PBL-SCID mice.",17202676_8,-1,-1,-1,-1,4788,-1,1.7507402e-05,0.999974,8.507335e-06
4789,protein,9,10,72,79,"Therefore, we concluded that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccine is able to stimulate cellular-mediated immune response against E7-containing ESCC cells through CD8+-dependent CTL-induced apoptosis in Hu-PBL-SCID mice.",17202676_8,0,1,-1,-1,4789,-1,3.4630848e-05,0.9999423,2.3035964e-05
4791,cellular-mediated immune response,15,18,109,142,"Therefore, we concluded that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccine is able to stimulate cellular-mediated immune response against E7-containing ESCC cells through CD8+-dependent CTL-induced apoptosis in Hu-PBL-SCID mice.",17202676_8,-1,-1,-1,-1,4791,-1,0.23144239,0.004635815,0.76392174
4792,cells through,21,23,170,183,"Therefore, we concluded that the HPV16 mE6delta/mE7/TBhsp70delta fusion protein vaccine is able to stimulate cellular-mediated immune response against E7-containing ESCC cells through CD8+-dependent CTL-induced apoptosis in Hu-PBL-SCID mice.",17202676_8,-1,-1,-1,-1,4792,-1,0.003201752,0.11063024,0.88616806
4798,tolerance to,22,24,144,156,BACKGROUND: A wealth of evidence obtained using mouse models indicates that CD4(+)CD25(+)FOXP3(+) regulatory T cells (Treg) maintain peripheral tolerance to self-antigens and also inhibit anti-tumor immune responses.,17205133_0,-1,-1,-1,-1,4798,-1,2.4605348e-05,0.999962,1.3421014e-05
4806,tumor-associated antigen,10,12,44,68,We set out to measure T cell responses to a tumor-associated antigen and examine whether Treg impinge on those anti-tumor immune responses in CRC patients.,17205133_2,-1,-1,-1,-1,4806,-1,0.039448686,0.95631075,0.004240542
4812,blood,10,11,67,72,An increased frequency of Treg was demonstrated in both peripheral blood and mesenteric lymph nodes of patients with colorectal cancer (CRC) compared with either healthy controls or patients with inflammatory bowel disease (IBD).,17205133_4,0,1,-1,-1,4812,-1,0.0001574485,0.99834335,0.0014991947
4814,blood,5,6,34,39,"Depletion of Treg from peripheral blood mononuclear cells (PBMC) of CRC patients unmasked CD4(+) T cell responses, as observed by IFNgamma release, to the tumor associated antigen 5T4, whereas no effect was observed in a healthy age-matched control group.",17205133_5,0,1,-1,-1,4814,-1,0.00011884091,0.9993199,0.00056125177
4817,IFNgamma release,24,26,130,146,"Depletion of Treg from peripheral blood mononuclear cells (PBMC) of CRC patients unmasked CD4(+) T cell responses, as observed by IFNgamma release, to the tumor associated antigen 5T4, whereas no effect was observed in a healthy age-matched control group.",17205133_5,-1,-1,-1,-1,4817,-1,0.994311,0.0037393132,0.0019497735
4818,to the tumor,27,30,148,160,"Depletion of Treg from peripheral blood mononuclear cells (PBMC) of CRC patients unmasked CD4(+) T cell responses, as observed by IFNgamma release, to the tumor associated antigen 5T4, whereas no effect was observed in a healthy age-matched control group.",17205133_5,-1,-1,-1,-1,4818,-1,3.1601183e-05,0.99995446,1.3943835e-05
4821,that Treg,7,9,63,72,"CONCLUSIONS/SIGNIFICANCE: Collectively, these data demonstrate that Treg capable of inhibiting tumor associated antigen-specific immune responses are enriched in patients with CRC.",17205133_6,-1,-1,-1,-1,4821,-1,2.1673513e-05,0.99996793,1.0392681e-05
4823,antigen-specific immune responses,14,17,112,145,"CONCLUSIONS/SIGNIFICANCE: Collectively, these data demonstrate that Treg capable of inhibiting tumor associated antigen-specific immune responses are enriched in patients with CRC.",17205133_6,-1,-1,-1,-1,4823,-1,0.99977463,9.628713e-05,0.00012906348
4825,Treg to,7,9,51,58,These results support a rationale for manipulating Treg to enhance cancer immunotherapy.,17205133_7,-1,-1,-1,-1,4825,-1,2.5818756e-05,0.9999608,1.3429731e-05
4827,T-cell,12,13,89,95,Cancer patients often exhibit loss of proper cell-mediated immunity and reduced effector T-cell population in the circulation.,17210719_0,-1,1,2,-1,4827,-1,3.1617492e-05,5.3038693e-05,0.99991536
4829,Thymus,0,1,0,6,"Thymus is a major site of T-cell maturation, and tumors induce thymic atrophy to evade cellular immune response.",17210719_1,-1,1,2,-1,4829,-1,4.209318e-05,0.99993384,2.4083125e-05
4830,T-cell,6,7,26,32,"Thymus is a major site of T-cell maturation, and tumors induce thymic atrophy to evade cellular immune response.",17210719_1,-1,1,2,-1,4830,-1,3.8575028e-05,5.1787185e-05,0.99990964
4834,cellular immune response,16,19,87,111,"Thymus is a major site of T-cell maturation, and tumors induce thymic atrophy to evade cellular immune response.",17210719_1,-1,-1,-1,-1,4834,-1,0.87677664,0.0010714973,0.12215177
4841,that tumor-induced,14,16,81,99,"In an effort to delineate the mechanisms behind such thymic atrophy, we observed that tumor-induced oxidative stress played a critical role, as it perturbed nuclear factor-kappaB (NF-kappaB) activity.",17210719_3,-1,-1,-1,-1,4841,-1,2.2327571e-05,0.99996746,1.0263471e-05
4849,thymic T cells,13,16,123,137,Tumor-induced oxidative stress increased cytosolic IkappaBalpha retention and inhibited NF-kappaB nuclear translocation in thymic T cells.,17210719_4,-1,-1,-1,-1,4849,-1,0.0048683314,0.3018276,0.69330406
4850,These NF-kappaB-perturbed cells,0,3,0,31,These NF-kappaB-perturbed cells became vulnerable to tumor-secreted tumor necrosis factor (TNF)-alpha (TNF-alpha)-mediated apoptosis through the activation of TNF receptor-associated protein death domain-associated Fas-associated protein death domain and caspase-8.,17210719_5,-1,-1,-1,-1,4850,-1,0.001728731,0.9351637,0.06310755
4851,to tumor-secreted tumor necrosis factor,5,10,50,89,These NF-kappaB-perturbed cells became vulnerable to tumor-secreted tumor necrosis factor (TNF)-alpha (TNF-alpha)-mediated apoptosis through the activation of TNF receptor-associated protein death domain-associated Fas-associated protein death domain and caspase-8.,17210719_5,-1,-1,-1,-1,4851,-1,0.099227294,0.898246,0.0025266698
4852,through the,13,15,133,144,These NF-kappaB-perturbed cells became vulnerable to tumor-secreted tumor necrosis factor (TNF)-alpha (TNF-alpha)-mediated apoptosis through the activation of TNF receptor-associated protein death domain-associated Fas-associated protein death domain and caspase-8.,17210719_5,-1,-1,-1,-1,4852,-1,1.9927857e-05,0.9999684,1.1658719e-05
4853,TNF receptor-associated protein,17,20,159,190,These NF-kappaB-perturbed cells became vulnerable to tumor-secreted tumor necrosis factor (TNF)-alpha (TNF-alpha)-mediated apoptosis through the activation of TNF receptor-associated protein death domain-associated Fas-associated protein death domain and caspase-8.,17210719_5,-1,-1,-1,-1,4853,-1,5.1164814e-05,0.99989164,5.7232737e-05
4854,protein,23,24,230,237,These NF-kappaB-perturbed cells became vulnerable to tumor-secreted tumor necrosis factor (TNF)-alpha (TNF-alpha)-mediated apoptosis through the activation of TNF receptor-associated protein death domain-associated Fas-associated protein death domain and caspase-8.,17210719_5,0,1,-1,-1,4854,-1,6.197544e-05,0.99985874,7.930704e-05
4855,TNF-alpha-depleted tumor,2,4,15,39,"Interestingly, TNF-alpha-depleted tumor supernatants, either by antibody neutralization or by TNF-alpha-small interfering RNA transfection of tumor cells, were unable to kill T cell effectively.",17210719_6,-1,-1,-1,-1,4855,-1,3.518807e-05,0.9999449,1.98405e-05
4856,TNF-alpha-small,12,13,94,109,"Interestingly, TNF-alpha-depleted tumor supernatants, either by antibody neutralization or by TNF-alpha-small interfering RNA transfection of tumor cells, were unable to kill T cell effectively.",17210719_6,0,1,-1,-1,4856,-1,7.1509334e-05,0.99988115,4.733335e-05
4858,tumor cells,17,19,142,153,"Interestingly, TNF-alpha-depleted tumor supernatants, either by antibody neutralization or by TNF-alpha-small interfering RNA transfection of tumor cells, were unable to kill T cell effectively.",17210719_6,-1,-1,-1,-1,4858,-1,0.003873974,0.41835645,0.5777696
4863,the cells,8,10,48,57,"When T cells were overexpressed with NF-kappaB, the cells became resistant to tumor-induced apoptosis.",17210719_7,-1,-1,-1,-1,4863,-1,0.0023069135,0.16553007,0.832163
4864,to tumor-induced,12,14,75,91,"When T cells were overexpressed with NF-kappaB, the cells became resistant to tumor-induced apoptosis.",17210719_7,-1,-1,-1,-1,4864,-1,3.1064596e-05,0.9999547,1.4243543e-05
4868,the cells,16,18,113,122,"In contrast, when degradation-defective IkappaBalpha (IkappaBalpha super-repressor) was introduced into T cells, the cells became more vulnerable, indicating that inhibition of NF-kappaB is the reason behind such tumor/TNF-alpha-mediated apoptosis.",17210719_8,-1,-1,-1,-1,4868,-1,0.0028136664,0.20365545,0.7935308
4872,tumor-induced thymic,3,5,23,43,Curcumin could prevent tumor-induced thymic atrophy by restoring the activity of NF-kappaB. Further investigations suggest that neutralization of tumor-induced oxidative stress and restoration of NF-kappaB activity along with the reeducation of the TNF-alpha signaling pathway can be the mechanism behind curcumin-mediated thymic protection.,17210719_9,-1,-1,-1,-1,4872,-1,2.7645357e-05,0.99995995,1.2423374e-05
4878,the TNF-alpha,31,33,245,258,Curcumin could prevent tumor-induced thymic atrophy by restoring the activity of NF-kappaB. Further investigations suggest that neutralization of tumor-induced oxidative stress and restoration of NF-kappaB activity along with the reeducation of the TNF-alpha signaling pathway can be the mechanism behind curcumin-mediated thymic protection.,17210719_9,-1,-1,-1,-1,4878,-1,0.00010577478,0.9998677,2.6526517e-05
4891,immunity,15,16,101,109,"However, Tregs can also interfere with beneficial immune responses such as anti-tumor and anti-viral immunity in humans and rodents.",17224188_1,0,-1,2,-1,4891,-1,0.99945813,0.00033851864,0.00020336645
4894,that they play,10,13,52,66,"Given the overall importance of Tregs, it is likely that they play an important role in diseases of dogs as well.",17224188_2,-1,-1,-1,-1,4894,-1,2.6952232e-05,0.9999608,1.2284573e-05
4905,T cells in blood,13,17,76,92,We found that a cross-reactive FoxP3 antibody identified a subset of CD4(+) T cells in blood and lymph nodes of dogs.,17224188_5,-1,-1,-1,-1,4905,-1,0.0011165391,0.02316095,0.97572255
4909,in blood,17,19,88,96,By flow cytometry the mean percentage of FoxP3(+)CD4(+) T cells in normal dogs was 4.3% in blood and 9.8% in the lymph nodes.,17224188_6,0,1,-1,-1,4909,-1,7.348375e-05,0.99977,0.0001564993
4912,Treg in blood,13,16,68,81,"In dogs with cancer, there was a significant increase in numbers of Treg in blood (7.5%) and tumor-draining lymph nodes (17.1%) compared to age-matched healthy control dogs.",17224188_7,-1,-1,-1,-1,4912,-1,4.1766416e-05,0.99985874,9.94186e-05
4915,that FoxP3(+)CD4(+,3,5,14,32,We also found that FoxP3(+)CD4(+) T cells in dogs could be significantly expanded in vitro by TCR activation together with addition of TGF-beta and IL-2.,17224188_8,-1,-1,-1,-1,4915,-1,0.00038114813,0.99890065,0.00071816734
4917,TCR,17,18,94,97,We also found that FoxP3(+)CD4(+) T cells in dogs could be significantly expanded in vitro by TCR activation together with addition of TGF-beta and IL-2.,17224188_8,-1,1,2,-1,4917,-1,2.5745248e-05,0.9999535,2.0767991e-05
4919,TGF-beta,23,24,135,143,We also found that FoxP3(+)CD4(+) T cells in dogs could be significantly expanded in vitro by TCR activation together with addition of TGF-beta and IL-2.,17224188_8,0,1,-1,-1,4919,-1,4.40157e-05,0.99993765,1.8318295e-05
4920,Treated cells,0,2,0,13,Treated cells also significantly increased expression of TGF-beta and IL-10mRNA.,17224188_9,-1,-1,-1,-1,4920,-1,0.0020824638,0.16178575,0.83613175
4921,TGF-beta,7,8,57,65,Treated cells also significantly increased expression of TGF-beta and IL-10mRNA.,17224188_9,0,1,-1,-1,4921,-1,4.2881988e-05,0.9999367,2.0412628e-05
4928,that this,19,21,110,119,We conclude from these studies that a cross-reactive FoxP3 antibody can be used to identify Tregs in dogs and that this reagent may serve as a useful tool for investigating the role of Treg in a variety of diseases of dogs.,17224188_10,-1,-1,-1,-1,4928,-1,2.2245675e-05,0.9999672,1.0499548e-05
4943,transfer to naive,2,5,15,32,"After adoptive transfer to naive recipients, CD11b(+)Gr-1(+) MSCs freshly isolated from spleens of tumor-bearing mice but not naive mice were able to inhibit NK cell cytotoxicity.",17244679_2,-1,-1,-1,-1,4943,-1,2.4681583e-05,0.99996173,1.3622953e-05
4949,analysis,4,5,19,27,An in vivo imaging analysis indicates that the removal of tumors resulted in a significant increased ability (P < .05) in NK cell cytotoxicity to eliminate injected YAC-1 cells from the lungs.,17244679_3,0,1,-1,-1,4949,-1,2.9731826e-05,0.99994624,2.3985549e-05
4950,that the,6,8,38,46,An in vivo imaging analysis indicates that the removal of tumors resulted in a significant increased ability (P < .05) in NK cell cytotoxicity to eliminate injected YAC-1 cells from the lungs.,17244679_3,-1,-1,-1,-1,4950,-1,1.8709976e-05,0.9999733,7.973679e-06
4957,analysis,6,7,42,50,Fluorescence-activated cell sorter (FACS) analysis of the composition of lung leukocytes further indicates that the removal of tumors also leads to the reduction of MSCs accumulated in the lung.,17244679_4,0,1,-1,-1,4957,-1,2.824358e-05,0.9999497,2.2072676e-05
4959,that the,15,17,107,115,Fluorescence-activated cell sorter (FACS) analysis of the composition of lung leukocytes further indicates that the removal of tumors also leads to the reduction of MSCs accumulated in the lung.,17244679_4,-1,-1,-1,-1,4959,-1,1.9941503e-05,0.9999721,7.947705e-06
4961,to the,22,24,145,151,Fluorescence-activated cell sorter (FACS) analysis of the composition of lung leukocytes further indicates that the removal of tumors also leads to the reduction of MSCs accumulated in the lung.,17244679_4,-1,-1,-1,-1,4961,-1,2.095973e-05,0.9999701,8.943858e-06
4965,that MSCs,3,5,19,28,These data suggest that MSCs suppress NK cell cytotoxicity.,17244679_5,-1,-1,-1,-1,4965,-1,3.2593853e-05,0.9999559,1.1466949e-05
4971,that MSCs,5,7,39,48,Western blot analyses further suggests that MSCs suppress IL-2-mediated NK cell cytotoxicity by affecting the activity of Stat5.,17244679_8,-1,-1,-1,-1,4971,-1,2.4911962e-05,0.9999647,1.0348034e-05
4975,T-cell,1,2,6,12,"Adult T-cell leukemia/lymphoma (ATLL) patients are highly immunocompromised, but the underlying mechanism responsible for this state remains obscure.",17278106_0,-1,1,2,-1,4975,-1,8.5394364e-05,0.00015068438,0.9997639
4977,this state,17,19,122,132,"Adult T-cell leukemia/lymphoma (ATLL) patients are highly immunocompromised, but the underlying mechanism responsible for this state remains obscure.",17278106_0,-1,-1,-1,-1,4977,-1,2.5814048e-05,0.99996054,1.3678707e-05
4978,that FOXP3,3,5,28,38,"Recent studies demonstrated that FOXP3, which is a master control gene of naturally occurring regulatory T (Treg) cells, is expressed in the tumor cells from a subset of patients with ATLL.",17278106_1,-1,-1,-1,-1,4978,-1,1.8478348e-05,0.9999709,1.065458e-05
4984,the tumor cells,25,28,137,152,"Recent studies demonstrated that FOXP3, which is a master control gene of naturally occurring regulatory T (Treg) cells, is expressed in the tumor cells from a subset of patients with ATLL.",17278106_1,-1,-1,-1,-1,4984,-1,0.0032362817,0.7979332,0.19883052
4987,these tumors,10,12,49,61,"Since most ATLL cells express both CD4 and CD25, these tumors might originate from CD4(+)CD25(+)FOXP3(+) Treg cells, based on their phenotypic characteristics.",17278106_2,-1,-1,-1,-1,4987,-1,2.3672748e-05,0.99996364,1.2628559e-05
4991,function,6,7,37,45,"However, whether ATLL cells actually function as Treg cells has not yet been clearly demonstrated.",17278106_3,0,1,2,-1,4991,-1,0.00010520589,0.999824,7.089298e-05
4996,to T-cell receptor-mediated,16,19,85,112,"Here, we show that ATLL cells from a subset of patients are not only hypo-responsive to T-cell receptor-mediated activation, but also suppress the proliferation of autologous CD4(+) non-ATLL cells.",17278106_4,-1,-1,-1,-1,4996,-1,0.0033564474,0.19326846,0.80337507
5000,this subset,5,7,29,40,"Furthermore, ATLL cells from this subset of patients secrete only small amounts of IFN-gamma, and suppress IFN-gamma production by autologous CD4(+) non-ATLL cells.",17278106_5,-1,-1,-1,-1,5000,-1,0.0036601864,0.23622061,0.76011926
5009,function,14,15,75,83,These are the first data showing that ATLL cells from a subset of patients function as Treg cells in an autologous setting.,17278106_6,0,1,2,-1,5009,-1,6.316735e-05,0.9998975,3.931591e-05
5025,chemokine release,23,25,147,164,In the present study we investigated the effects of various chemokines on proliferation of acute myelogenous leukemia (AML) cells and constitutive chemokine release by primary AML cells.,17339182_1,-1,-1,-1,-1,5025,-1,0.92329174,0.07006475,0.0066434727
5030,chemokine receptor,13,15,87,105,"We investigated AML cell proliferation (3H-thymidine incorporation, colony formation), chemokine receptor expression, constitutive chemokine release and chemotaxis of normal peripheral blood mononuclear cells.",17339182_3,-1,-1,-1,-1,5030,-1,0.7282662,0.004591463,0.2671424
5031,chemokine release,18,20,131,148,"We investigated AML cell proliferation (3H-thymidine incorporation, colony formation), chemokine receptor expression, constitutive chemokine release and chemotaxis of normal peripheral blood mononuclear cells.",17339182_3,-1,-1,-1,-1,5031,-1,0.9597316,0.034436025,0.0058323047
5033,blood,25,26,185,190,"We investigated AML cell proliferation (3H-thymidine incorporation, colony formation), chemokine receptor expression, constitutive chemokine release and chemotaxis of normal peripheral blood mononuclear cells.",17339182_3,0,1,-1,-1,5033,-1,0.00037535845,0.99773043,0.001894231
5038,factor-dependent,26,27,167,183,"RESULTS: Exogenous chemokines usually did not have any effect on AML blast proliferation in the absence of hematopoietic growth factors, but when investigating growth factor-dependent (interleukin 3 + granulocyte-macrophage colony-stimulating factor + stem cell factor) proliferation in suspension cultures the following patient subsets were identified: (i) patients whose cells showed chemokine-induced growth enhancement (8 patients); (ii) divergent effects on proliferation (15 patients); and (iii) no effect (most patients).",17339182_4,0,1,-1,-1,5038,-1,0.99949944,0.00025008118,0.00025040668
5048,chemokine receptor,7,9,40,58,"These patient subsets did not differ in chemokine receptor expression, but, compared to CD34- AML cells, CD34+ cells showed higher expression of several receptors.",17339182_5,-1,-1,-1,-1,5048,-1,0.6446364,0.007867701,0.3474959
5052,receptors,27,28,153,162,"These patient subsets did not differ in chemokine receptor expression, but, compared to CD34- AML cells, CD34+ cells showed higher expression of several receptors.",17339182_5,0,1,2,-1,5052,-1,0.0006303978,0.0036631527,0.9957065
5058,chemokine release,5,7,34,51,"Furthermore, a broad constitutive chemokine release profile was detected for most patients, and the following chemokine clusters could be identified: CCL2-4/CXCL1/8, CCL5/CXCL9-11 (possibly also CCL23) and CCL13/17/22/24/CXCL5 (possibly also CXCL6).",17339182_7,-1,-1,-1,-1,5058,-1,0.9582851,0.035583917,0.0061310646
5062,CXCL6,40,41,242,247,"Furthermore, a broad constitutive chemokine release profile was detected for most patients, and the following chemokine clusters could be identified: CCL2-4/CXCL1/8, CCL5/CXCL9-11 (possibly also CCL23) and CCL13/17/22/24/CXCL5 (possibly also CXCL6).",17339182_7,-1,-1,-1,-1,5062,-1,0.9987797,8.5171945e-05,0.0011351642
5063,the CCL2,1,3,5,13,Only the CCL2-4/CXCL1/8 cluster showed significant correlations between corresponding mRNA levels and NFkB levels/activation.,17339182_8,-1,-1,-1,-1,5063,-1,0.116970815,0.85883105,0.024198199
5065,The chemotaxis,0,2,0,14,The chemotaxis of normal immunocompetent cells for patients without constitutive chemokine release was observed to be decreased.,17339182_9,-1,-1,-1,-1,5065,-1,0.041905083,0.95653486,0.0015600579
5067,chemokine release,10,12,81,98,The chemotaxis of normal immunocompetent cells for patients without constitutive chemokine release was observed to be decreased.,17339182_9,-1,-1,-1,-1,5067,-1,0.94143856,0.05149315,0.0070683244
5070,chemokine release,11,13,83,100,INTERPRETATION AND CONCLUSIONS: Differences in chemokine responsiveness as well as chemokine release contribute to patient heterogeneity in AML.,17339182_10,-1,-1,-1,-1,5070,-1,0.92593366,0.06771585,0.0063505345
5073,to their chemokine,10,13,68,86,Patients with AML can be classified into distinct subsets according to their chemokine responsiveness and chemokine release profile.,17339182_11,-1,-1,-1,-1,5073,-1,0.057686724,0.94020385,0.0021093937
5074,chemokine release,15,17,106,123,Patients with AML can be classified into distinct subsets according to their chemokine responsiveness and chemokine release profile.,17339182_11,-1,-1,-1,-1,5074,-1,0.9607251,0.035529993,0.0037449065
5079,therapeutic type,23,25,122,138,Regulatory T cells can suppress activated CD4+ and CD8+ T effector cells and may serve as an impediment to spontaneous or therapeutic type 1 antitumor immunity.,17339434_0,-1,-1,-1,-1,5079,-1,3.2179465e-05,0.9999542,1.3607113e-05
5080,immunity,27,28,151,159,Regulatory T cells can suppress activated CD4+ and CD8+ T effector cells and may serve as an impediment to spontaneous or therapeutic type 1 antitumor immunity.,17339434_0,0,-1,2,-1,5080,-1,0.9992003,0.000456925,0.0003427854
5088,that this cytokine,6,9,23,41,"In this study, we show that this cytokine regimen also results in the profound enhancement of CD4+ tumor-infiltrating lymphocytes (TIL) expressing FoxP3, IL-10, and TGF-beta mRNA, with 50 or 90% of CD4+ TIL coexpressing the CD25 and glucocorticoid-induced TNFR family related molecules, respectively.",17339434_2,-1,-1,-1,-1,5088,-1,0.060724635,0.93684745,0.0024278811
5090,tumor-infiltrating lymphocytes,19,21,99,129,"In this study, we show that this cytokine regimen also results in the profound enhancement of CD4+ tumor-infiltrating lymphocytes (TIL) expressing FoxP3, IL-10, and TGF-beta mRNA, with 50 or 90% of CD4+ TIL coexpressing the CD25 and glucocorticoid-induced TNFR family related molecules, respectively.",17339434_2,-1,-1,-1,-1,5090,-1,0.0036773111,0.83878714,0.15753555
5094,TGF-beta,30,31,165,173,"In this study, we show that this cytokine regimen also results in the profound enhancement of CD4+ tumor-infiltrating lymphocytes (TIL) expressing FoxP3, IL-10, and TGF-beta mRNA, with 50 or 90% of CD4+ TIL coexpressing the CD25 and glucocorticoid-induced TNFR family related molecules, respectively.",17339434_2,0,1,-1,-1,5094,-1,0.00011082609,0.9998573,3.190516e-05
5097,TNFR,47,48,256,260,"In this study, we show that this cytokine regimen also results in the profound enhancement of CD4+ tumor-infiltrating lymphocytes (TIL) expressing FoxP3, IL-10, and TGF-beta mRNA, with 50 or 90% of CD4+ TIL coexpressing the CD25 and glucocorticoid-induced TNFR family related molecules, respectively.",17339434_2,0,1,-1,-1,5097,-1,3.6102476e-05,0.9999492,1.4678247e-05
5099,Foxp3 protein,3,5,27,40,"Intracellular staining for Foxp3 protein revealed that combined treatment with rFL plus rGM-CSF results in a significant increase in CD4+Foxp3+ T cells in the spleen of both control and tumor-bearing mice, and that nearly half of CD4+ TIL expressed this marker.",17339434_3,-1,-1,-1,-1,5099,-1,2.1607253e-05,0.9999616,1.6760046e-05
5109,TIL cells,5,7,18,27,"In addition, CD4+ TIL cells were of an activated/memory (ICOS(high)CD62L(low)CD45RB(low)) phenotype and were capable of suppressing allospecific T cell proliferation and IFN-gamma production from (in vivo cross-primed) anti-CMS4 CD8+ T cells in vitro, via a mechanism at least partially dependent on IL-10 and TGF-beta.",17339434_4,-1,-1,-1,-1,5109,-1,0.00019360751,0.0008002378,0.9990061
5114,TGF-beta,52,53,310,318,"In addition, CD4+ TIL cells were of an activated/memory (ICOS(high)CD62L(low)CD45RB(low)) phenotype and were capable of suppressing allospecific T cell proliferation and IFN-gamma production from (in vivo cross-primed) anti-CMS4 CD8+ T cells in vitro, via a mechanism at least partially dependent on IL-10 and TGF-beta.",17339434_4,0,1,-1,-1,5114,-1,6.338261e-05,0.99990916,2.7469376e-05
5118,therapy-induced,21,22,115,130,"Importantly, in vivo depletion of CD4+ T cells resulted in the ability of previously ineffective, rFL plus rGM-CSF therapy-induced CD8+ T cells to now mediate tumor regression.",17339434_5,0,1,-1,-1,5118,-1,2.93474e-05,0.9999536,1.703596e-05
5119,T cells to,24,27,136,146,"Importantly, in vivo depletion of CD4+ T cells resulted in the ability of previously ineffective, rFL plus rGM-CSF therapy-induced CD8+ T cells to now mediate tumor regression.",17339434_5,-1,-1,-1,-1,5119,-1,0.001391667,0.023995917,0.9746124
5126,to TGF-beta,1,3,8,19,"Similar to TGF-beta, the low MWF (<50kDa) of supernatant derived from SKOV3 could convert part of freshly isolated CD4(+)CD25(-) T cells into CD25(+) population with similar characters as natural CD4(+)CD25(+) regulatory T cells.",17353088_2,-1,-1,-1,-1,5126,-1,5.2573694e-05,0.999931,1.6446711e-05
5132,TGF-beta,2,3,11,19,To deplete TGF-beta in the low MWF by neutralizing anti-TGF-beta would eliminate this transformation phenomenon.,17353088_3,0,1,-1,-1,5132,-1,6.640368e-05,0.9999013,3.2241685e-05
5134,this transformation,12,14,81,100,To deplete TGF-beta in the low MWF by neutralizing anti-TGF-beta would eliminate this transformation phenomenon.,17353088_3,-1,-1,-1,-1,5134,-1,2.5901703e-05,0.9999573,1.673616e-05
5136,that TGF-beta,3,5,23,36,"These results indicate that TGF-beta secreted by ovarian carcinoma cells owns vital function in the process of converting peripheral CD4(+)CD25(-) T cells into CD4(+)CD25(+) regulatory T cells, which may provide one immunotherapeutic target for ovarian cancer.",17353088_4,-1,-1,-1,-1,5136,-1,4.651863e-05,0.99994063,1.2819454e-05
5138,function,12,13,84,92,"These results indicate that TGF-beta secreted by ovarian carcinoma cells owns vital function in the process of converting peripheral CD4(+)CD25(-) T cells into CD4(+)CD25(+) regulatory T cells, which may provide one immunotherapeutic target for ovarian cancer.",17353088_4,0,1,2,-1,5138,-1,0.0018899037,0.99656254,0.0015475712
5144,protein,11,12,67,74,Sequence variation in the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) oncogene structure may affect antigen-presenting cell (APC) function of infected B cells and immune escape by EBV-specific T cells and thus contribute to the development of malignancy.,17372611_0,0,1,-1,-1,5144,-1,0.00014665394,0.99936277,0.0004906147
5145,antigen-presenting cell,20,22,114,137,Sequence variation in the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) oncogene structure may affect antigen-presenting cell (APC) function of infected B cells and immune escape by EBV-specific T cells and thus contribute to the development of malignancy.,17372611_0,-1,-1,-1,-1,5145,-1,0.030258724,0.0007177,0.9690235
5146,function,25,26,144,152,Sequence variation in the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) oncogene structure may affect antigen-presenting cell (APC) function of infected B cells and immune escape by EBV-specific T cells and thus contribute to the development of malignancy.,17372611_0,0,1,2,-1,5146,-1,0.002668263,0.3281841,0.6691476
5150,to the,40,42,235,241,Sequence variation in the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) oncogene structure may affect antigen-presenting cell (APC) function of infected B cells and immune escape by EBV-specific T cells and thus contribute to the development of malignancy.,17372611_0,-1,-1,-1,-1,5150,-1,2.2981594e-05,0.99996626,1.0790842e-05
5153,function through,11,13,62,78,"Normal B cell-associated LMP1 (B-LMP1) upregulates B cell APC function through activation of the necrosis factor (NF)-kappaB subunit, RelB. We examined the ability of B-LMP1 and a nasopharyngeal carcinoma-associated LMP1 (NPC-LMP1) to modulate B cell APC function and T-cell responses.",17372611_1,-1,-1,-1,-1,5153,-1,5.3891385e-05,0.99981016,0.0001359136
5155,factor,17,18,106,112,"Normal B cell-associated LMP1 (B-LMP1) upregulates B cell APC function through activation of the necrosis factor (NF)-kappaB subunit, RelB. We examined the ability of B-LMP1 and a nasopharyngeal carcinoma-associated LMP1 (NPC-LMP1) to modulate B cell APC function and T-cell responses.",17372611_1,0,1,-1,-1,5155,-1,0.99967384,0.0001859548,0.00014022517
5161,function,41,42,255,263,"Normal B cell-associated LMP1 (B-LMP1) upregulates B cell APC function through activation of the necrosis factor (NF)-kappaB subunit, RelB. We examined the ability of B-LMP1 and a nasopharyngeal carcinoma-associated LMP1 (NPC-LMP1) to modulate B cell APC function and T-cell responses.",17372611_1,0,1,2,-1,5161,-1,0.0005051031,0.9798415,0.019653419
5162,T-cell,43,44,268,274,"Normal B cell-associated LMP1 (B-LMP1) upregulates B cell APC function through activation of the necrosis factor (NF)-kappaB subunit, RelB. We examined the ability of B-LMP1 and a nasopharyngeal carcinoma-associated LMP1 (NPC-LMP1) to modulate B cell APC function and T-cell responses.",17372611_1,-1,1,2,-1,5162,-1,3.882762e-05,5.3592543e-05,0.9999075
5163,cells transfected,2,4,11,28,B lymphoma cells transfected with NPC-LMP1 stimulated resting T cells in mixed lymphocyte reaction less efficiently than B-LMP1 transfectants.,17372611_2,-1,-1,-1,-1,5163,-1,0.0021029739,0.08977216,0.90812486
5172,regulatory T-cell function,16,19,97,123,"Unexpectedly, antigen presentation to CD4(+) T helper cells was reduced owing to potentiation of regulatory T-cell function by NPC-LMP1 transfectants, which produce increased levels of interleukin-10, rendering CD4(+) T cells hyporesponsive.",17372611_3,-1,-1,-1,-1,5172,-1,5.4489505e-05,9.7595825e-05,0.9998479
5189,the cellular,2,4,9,21,"However, the cellular lineage and mechanism of FOXP3 induction in CD8 T cells remain unclear.",17414320_1,-1,-1,-1,-1,5189,-1,0.0046965075,0.5544385,0.440865
5192,that interleukin-2,4,6,21,39,"Here, we demonstrate that interleukin-2 (IL-2) induces FOXP3 expression in OKT3-stimulated or antigen-stimulated CD8 T cells, indicating that FOXP3 expression is neither limited to a unique subset of CD8 T cells nor dependent on the mode of T-cell receptor stimulation.",17414320_2,-1,-1,-1,-1,5192,-1,0.43801266,0.55920684,0.0027804743
5196,that FOXP3,21,23,137,147,"Here, we demonstrate that interleukin-2 (IL-2) induces FOXP3 expression in OKT3-stimulated or antigen-stimulated CD8 T cells, indicating that FOXP3 expression is neither limited to a unique subset of CD8 T cells nor dependent on the mode of T-cell receptor stimulation.",17414320_2,-1,-1,-1,-1,5196,-1,2.3635039e-05,0.99996495,1.1370417e-05
5205,function,16,17,102,110,"In the absence of IL-2, antigen stimulation resulted in T-cell activation and acquisition of effector function without induction of FOXP3, indicating that acquisition of effector function is independent of induction of FOXP3 expression in CD8 T cells.",17414320_3,0,1,2,-1,5205,-1,0.0007685111,0.9765772,0.022654302
5208,function,27,28,179,187,"In the absence of IL-2, antigen stimulation resulted in T-cell activation and acquisition of effector function without induction of FOXP3, indicating that acquisition of effector function is independent of induction of FOXP3 expression in CD8 T cells.",17414320_3,0,1,2,-1,5208,-1,0.00026635497,0.99807054,0.0016630914
5224,T cells that,11,14,68,80,"These findings indicate that induction of FOXP3 is intrinsic to CD8 T cells that are activated in the presence of IL-2 or IL-15, and in vitro-induced expression of FOXP3 cannot be simply interpreted as an indicator of Treg activity or activation marker.",17414320_5,-1,-1,-1,-1,5224,-1,0.0013857068,0.035677876,0.9629364
5239,the c-MYC protein to this,9,14,46,71,"To study the contribution of EBV genes and of the c-MYC protein to this phenotype, we have generated a conditional B cell system in which the viral proliferation program and expression of c-myc can be regulated independently of each other.",17419945_2,-1,-1,-1,-1,5239,-1,2.5045923e-05,0.9999604,1.4561197e-05
5245,the cell,9,11,62,70,"In cells proliferating due to exogenous c-myc overexpression, the cell surface phenotype, the pattern of proliferation in single cell suspension, and the immunological characteristics of BL cells could be completely recapitulated.",17419945_3,-1,-1,-1,-1,5245,-1,0.003983683,0.5127762,0.48324013
5255,the NF-kappaB,14,16,86,99,We provide evidence also for the latter by showing that c-MYC down-regulates genes of the NF-kappaB and interferon pathway in a dose-dependent fashion.,17419945_5,-1,-1,-1,-1,5255,-1,2.6346393e-05,0.9999616,1.2075989e-05
5266,the interferon,4,6,21,35,"c-MYC does not block the interferon pathway completely, it shifts the balance and increases the threshold of interferon induction and action.",17419945_7,-1,-1,-1,-1,5266,-1,0.18415235,0.8128603,0.002987303
5268,the threshold,15,17,92,105,"c-MYC does not block the interferon pathway completely, it shifts the balance and increases the threshold of interferon induction and action.",17419945_7,-1,-1,-1,-1,5268,-1,3.1551095e-05,0.9999503,1.8198798e-05
5283,tissue,3,4,31,37,Immunofluorescence staining of tissue sections revealed intense IL-13 staining on breast cancer cells.,17438063_2,-1,1,2,-1,5283,-1,1.9866988e-05,0.99996305,1.7083903e-05
5289,that IL-13,16,18,116,126,The expression of phosphorylated signal transducer and activator of transcription 6 in breast cancer cells suggests that IL-13 actually delivers signals to cancer cells.,17438063_3,-1,-1,-1,-1,5289,-1,0.49760494,0.4959592,0.006435959
5316,tumor cells,39,41,242,253,"Fifty milligrams per kilogram body weight dose of CTX was administrated intraperitoneally to mice after B16 melanoma or C26 colon carcinoma tumor models were established, DC vaccine generated from mouse bone marrow and pulsed with B16 or C26 tumor cells lysates were vaccinated 4 days later.",17440723_2,-1,-1,-1,-1,5316,-1,0.002103643,0.08524672,0.91264963
5337,the tryptophan,22,24,121,135,"Indoleamine 2, 3-dioxygenase (IDO), a key enzyme that catalyses the initial and rate-limiting step in the degradation of the tryptophan, is simultaneously expressed in murine dendritic cells and macrophages stimulated with interferon-gamma (IFN-gamma).",17466914_0,-1,-1,-1,-1,5337,-1,4.033646e-05,0.9999436,1.6041002e-05
5343,the functional,24,26,137,151,"In the present study, we investigated whether p-Coumaric acid (CA), which is suggested to exhibit antioxidant properties, could suppress the functional expression of IDO in murine bone marrow-derived dendritic cells (BMDCs) stimulated with IFN-gamma.",17466914_1,-1,-1,-1,-1,5343,-1,2.037043e-05,0.99997103,8.569235e-06
5347,protein,10,11,67,74,Treatment with CA reduced intracellular expression of IDO mRNA and protein levels in IFN-gamma-activated murine BMDCs in vitro and in CD11c(+)CD8alpha(+) DCs of tumor-draining lymph node (TDLN) of tumor-bearing mice in vivo.,17466914_2,0,1,-1,-1,5347,-1,3.084497e-05,0.9999473,2.1872735e-05
5353,the functional,8,10,54,68,"Consequently, we obtained evidence that CA suppresses the functional activity of IDO, which catalyses oxidative catabolism of tryptophan, and significantly recovers the IDO-dependent T cell suppression.",17466914_3,-1,-1,-1,-1,5353,-1,2.5720707e-05,0.99996305,1.1225181e-05
5357,the signal transducer and activator of transcription 1,2,10,14,68,Activation of the signal transducer and activator of transcription 1 (STAT1) is important to be express IDO in IFN-gamma-stimulated murine BMDCs.,17466914_4,-1,-1,-1,-1,5357,-1,2.1633181e-05,0.9999629,1.5496065e-05
5364,the signal transducer and activator of transcription 1,14,22,90,144,"To determine whether these inhibitory effects of CA are associated with the alteration of the signal transducer and activator of transcription 1 (STAT1) and IFN-gamma-inducible, dsRNA-activated serine/threonine protein kinase (PKR), BMDCs were pretreated with various concentrations of CA.",17466914_5,-1,-1,-1,-1,5364,-1,1.9543666e-05,0.99996567,1.4789297e-05
5367,protein,30,31,211,218,"To determine whether these inhibitory effects of CA are associated with the alteration of the signal transducer and activator of transcription 1 (STAT1) and IFN-gamma-inducible, dsRNA-activated serine/threonine protein kinase (PKR), BMDCs were pretreated with various concentrations of CA.",17466914_5,0,1,-1,-1,5367,-1,6.121046e-05,0.99986696,7.1784496e-05
5371,to IFN-gamma,11,13,63,75,We found that CA inhibited the activation of STAT1 in response to IFN-gamma.,17466914_6,-1,-1,-1,-1,5371,-1,0.9227067,0.074677095,0.0026162833
5385,blood lymphocytes,24,26,153,170,"METHODS AND FINDINGS: To gain insights into the molecular mechanisms of immune dysfunction in cancer, gene expression profiles of pure sorted peripheral blood lymphocytes from 12 patients with melanoma were compared to 12 healthy controls.",17488182_2,-1,-1,-1,-1,5385,-1,0.00043089673,0.0037747282,0.9957944
5393,functional,10,11,73,83,These microarray findings were further confirmed by quantitative PCR and functional responses to IFNs.,17488182_4,0,1,2,-1,5393,-1,5.0587045e-05,0.99993145,1.790567e-05
5394,to IFNs,12,14,94,101,These microarray findings were further confirmed by quantitative PCR and functional responses to IFNs.,17488182_4,-1,-1,-1,-1,5394,-1,0.7662609,0.22880334,0.0049356977
5396,lymphocytes that,4,6,25,41,"The median percentage of lymphocytes that phosphorylate STAT1 in response to interferon-alpha was significantly reduced (Delta = 16.8%; 95% confidence interval, 0.98% to 33.35%) in melanoma patients (n = 9) compared to healthy controls (n = 9) in Phosflow analysis.",17488182_5,-1,-1,-1,-1,5396,-1,0.0028273435,0.14689337,0.8502793
5398,to interferon-alpha,10,12,74,93,"The median percentage of lymphocytes that phosphorylate STAT1 in response to interferon-alpha was significantly reduced (Delta = 16.8%; 95% confidence interval, 0.98% to 33.35%) in melanoma patients (n = 9) compared to healthy controls (n = 9) in Phosflow analysis.",17488182_5,-1,-1,-1,-1,5398,-1,0.8810209,0.11728677,0.0016922392
5401,analysis,51,52,256,264,"The median percentage of lymphocytes that phosphorylate STAT1 in response to interferon-alpha was significantly reduced (Delta = 16.8%; 95% confidence interval, 0.98% to 33.35%) in melanoma patients (n = 9) compared to healthy controls (n = 9) in Phosflow analysis.",17488182_5,0,1,-1,-1,5401,-1,3.555937e-05,0.9999291,3.539835e-05
5409,IFN-stimulated genes,22,24,122,142,The defect in IFN signaling in the melanoma patient group as a whole was partially overcome at the level of expression of IFN-stimulated genes by prolonged stimulation with the high concentration of IFN-alpha that is achievable only in IFN therapy used in melanoma.,17488182_7,-1,-1,-1,-1,5409,-1,0.9871732,0.010434773,0.0023919183
5411,IFN-alpha that,32,34,199,213,The defect in IFN signaling in the melanoma patient group as a whole was partially overcome at the level of expression of IFN-stimulated genes by prolonged stimulation with the high concentration of IFN-alpha that is achievable only in IFN therapy used in melanoma.,17488182_7,-1,-1,-1,-1,5411,-1,0.9959699,0.0028518336,0.0011782306
5412,IFN therapy,38,40,236,247,The defect in IFN signaling in the melanoma patient group as a whole was partially overcome at the level of expression of IFN-stimulated genes by prolonged stimulation with the high concentration of IFN-alpha that is achievable only in IFN therapy used in melanoma.,17488182_7,-1,-1,-1,-1,5412,-1,0.990694,0.007072011,0.002233953
5414,to IFN-alpha,3,5,22,34,The lowest responders to IFN-alpha in the Phosflow assay also showed the lowest gene expression in response to IFN-alpha.,17488182_8,-1,-1,-1,-1,5414,-1,0.8897266,0.107128136,0.0031452721
5418,to IFN-alpha,17,19,108,120,The lowest responders to IFN-alpha in the Phosflow assay also showed the lowest gene expression in response to IFN-alpha.,17488182_8,-1,-1,-1,-1,5418,-1,0.87705827,0.11989654,0.0030452264
5420,functional,8,9,58,68,"Finally, T cells from low-IFN-response patients exhibited functional abnormalities, including decreased expression of activation markers CD69, CD25, and CD71; TH1 cytokines interleukin-2, IFN-gamma, and tumor necrosis factor alpha, and reduced survival following stimulation with anti-CD3/CD28 antibodies compared to controls.",17488182_9,0,1,2,-1,5420,-1,9.574828e-05,0.9997826,0.00012161696
5421,TH1 cytokines interleukin-2,24,27,159,186,"Finally, T cells from low-IFN-response patients exhibited functional abnormalities, including decreased expression of activation markers CD69, CD25, and CD71; TH1 cytokines interleukin-2, IFN-gamma, and tumor necrosis factor alpha, and reduced survival following stimulation with anti-CD3/CD28 antibodies compared to controls.",17488182_9,-1,-1,-1,-1,5421,-1,0.8253016,0.16691288,0.007785499
5428,therapies to,7,9,37,49,These findings may be used to design therapies to counteract immune dysfunction in melanoma and to improve cancer immunotherapy.,17488182_11,-1,-1,-1,-1,5428,-1,2.2546968e-05,0.99996877,8.656463e-06
5433,the immune response,2,5,14,33,"To understand the immune response surrounding BCCs, we characterized the genomic, protein, and cellular microenvironment associated with BCC in comparison to normal skin.",17508019_1,-1,-1,-1,-1,5433,-1,0.19961712,0.7991744,0.0012084055
5435,protein,13,14,82,89,"To understand the immune response surrounding BCCs, we characterized the genomic, protein, and cellular microenvironment associated with BCC in comparison to normal skin.",17508019_1,0,1,-1,-1,5435,-1,0.000116591495,0.99981123,7.21796e-05
5442,the tumor,32,34,152,161,"Our results demonstrated the following: (1) CD4+ CD25+ Foxp3+ surround epithelial tumor aggregates; (2) Immature dendritic cells (DCs) were abundant in the tumor microenvironment; (3) BCC showed increased expression of IL-4, IL-10, and CCL22 and increased expression of interferon-associated genes (IFI27, IRF1, IRF7, and G1P2) and IL-12/23, gene indicating a Th2 dominant microenvironment.",17508019_2,-1,-1,-1,-1,5442,-1,1.9446452e-05,0.9999696,1.100054e-05
5445,interferon-associated genes,54,56,270,297,"Our results demonstrated the following: (1) CD4+ CD25+ Foxp3+ surround epithelial tumor aggregates; (2) Immature dendritic cells (DCs) were abundant in the tumor microenvironment; (3) BCC showed increased expression of IL-4, IL-10, and CCL22 and increased expression of interferon-associated genes (IFI27, IRF1, IRF7, and G1P2) and IL-12/23, gene indicating a Th2 dominant microenvironment.",17508019_2,-1,-1,-1,-1,5445,-1,0.3079239,0.68599147,0.0060845925
5454,Th2 cytokines,13,15,71,84,"The finding of phenotypic T regs, in conjunction with immature DCs and Th2 cytokines, suggests an attenuated state of immunity to human BCC.",17508019_4,-1,-1,-1,-1,5454,-1,0.41242403,0.5678838,0.019692147
5456,immunity to,21,23,118,129,"The finding of phenotypic T regs, in conjunction with immature DCs and Th2 cytokines, suggests an attenuated state of immunity to human BCC.",17508019_4,-1,-1,-1,-1,5456,-1,0.03182122,0.967133,0.0010457354
5463,function,6,7,29,37,"Although dendritic cell (DC) function is impaired in pancreatic cancer patients, the underlying mechanisms are unknown.",17545630_0,0,1,2,-1,5463,-1,0.00074305956,0.9625369,0.036720052
5467,factors released,5,7,32,48,This study analyzed the soluble factors released by pancreatic cancer cells responsible for inhibiting DC differentiation and activation.,17545630_1,-1,-1,-1,-1,5467,-1,0.019542964,0.9793785,0.0010785267
5474,Th2 cytokines,24,26,132,145,Allostimulation of CD4+ and CD8+ T cells by BxCM-treated mDCs was inefficient and resulted in production of lower levels of Th1 and Th2 cytokines.,17545630_4,-1,-1,-1,-1,5474,-1,0.23842594,0.74923235,0.012341678
5475,Antigen-specific T-cell activation,0,3,0,34,Antigen-specific T-cell activation capability was also reduced in BxCM-treated mDCs.,17545630_5,-1,-1,-1,-1,5475,-1,0.3440702,0.0032521458,0.65267766
5491,to the,9,11,38,44,"Furthermore, BxCM, IL-6, or G-CSF led to the activation of signal transducer and activator of transcription 3 (STAT3) in CD14+ monocytes to different degrees.",17545630_10,-1,-1,-1,-1,5491,-1,2.092378e-05,0.9999672,1.1824271e-05
5501,factors,10,11,53,60,"Therefore, IL-6 and G-CSF in BxCM represent two main factors responsible for suppression of DC differentiation, maturation, and antigen presentation, and this suppression of DC functions may be due to the aberrant activation of STAT3 by BxCM.",17545630_12,0,1,-1,-1,5501,-1,0.00038485357,0.9993736,0.00024159769
5504,functions,29,30,177,186,"Therefore, IL-6 and G-CSF in BxCM represent two main factors responsible for suppression of DC differentiation, maturation, and antigen presentation, and this suppression of DC functions may be due to the aberrant activation of STAT3 by BxCM.",17545630_12,0,1,2,-1,5504,-1,0.00020742364,0.9993765,0.00041610945
5505,to the,33,35,198,204,"Therefore, IL-6 and G-CSF in BxCM represent two main factors responsible for suppression of DC differentiation, maturation, and antigen presentation, and this suppression of DC functions may be due to the aberrant activation of STAT3 by BxCM.",17545630_12,-1,-1,-1,-1,5505,-1,2.102377e-05,0.99996996,8.980883e-06
5507,T cell function,5,8,40,55,BACKGROUND/AIMS: An efficient cytolytic T cell function is essential for immune mediated rejection of colorectal cancer.,17566017_0,-1,-1,-1,-1,5507,-1,4.6717316e-05,7.271794e-05,0.99988055
5510,the relevance,4,6,18,31,"Here, we assessed the relevance of the T-box transcription factor eomesodermin in colorectal cancer.",17566017_2,-1,-1,-1,-1,5510,-1,2.3397053e-05,0.999967,9.5886335e-06
5511,the T-box transcription factor,7,11,35,65,"Here, we assessed the relevance of the T-box transcription factor eomesodermin in colorectal cancer.",17566017_2,-1,-1,-1,-1,5511,-1,2.1955742e-05,0.9999671,1.0960636e-05
5512,tissue,5,6,31,37,"METHODS/ RESULTS: By analysing tissue probes from 88 different colorectal tumours, a significant (p<0.02) inverse correlation between eomesodermin expression in colorectal cancers and the presence of lymph node metastases could be shown, whereas no such correlation was noted for the master transcription factor of regulatory T cells, FoxP3 and CD8 alpha expression.",17566017_3,-1,1,2,-1,5512,-1,2.7690736e-05,0.9999243,4.7947793e-05
5525,function,26,27,162,170,"To evaluate whether this effect might be due to effects of eomesodermin on tumour infiltrating CD8 T cells, we subsequently analysed the regulated expression and function of this transcription factor in human T cells.",17566017_4,0,1,2,-1,5525,-1,4.226395e-05,0.9999323,2.5469142e-05
5526,this transcription factor,28,31,174,199,"To evaluate whether this effect might be due to effects of eomesodermin on tumour infiltrating CD8 T cells, we subsequently analysed the regulated expression and function of this transcription factor in human T cells.",17566017_4,-1,-1,-1,-1,5526,-1,2.0227724e-05,0.9999676,1.2227501e-05
5528,this factor,3,5,26,37,"Whereas overexpression of this factor induced perforin but not granzyme expression, siRNA mediated suppression of eomesodermin expression led to significantly reduced IFN-gamma production, perforin levels and cytolytic activity of CD8 T cells.",17566017_5,-1,-1,-1,-1,5528,-1,0.00043651552,0.99949086,7.257781e-05
5532,TGF-beta,2,3,13,21,"Furthermore, TGF-beta and IL4 could be identified as important inducer of eomesodermin expression.",17566017_6,0,1,-1,-1,5532,-1,5.593133e-05,0.99992156,2.2552722e-05
5539,functions,18,19,125,134,Our findings are consistent with a model in which eomesodermin expression in tumour infiltrating T cells regulates cytolytic functions of CD8 T cells via perforin expression.,17566017_8,0,1,2,-1,5539,-1,0.0035545125,0.8693161,0.12712936
5542,the functional,9,11,68,82,These data provide novel insights into control mechanisms governing the functional activity of human CD8 T lymphocytes via T-box transcription factors in cancer.,17566017_9,-1,-1,-1,-1,5542,-1,2.3551638e-05,0.99996626,1.0170544e-05
5544,T-box transcription factors,18,21,123,150,These data provide novel insights into control mechanisms governing the functional activity of human CD8 T lymphocytes via T-box transcription factors in cancer.,17566017_9,-1,-1,-1,-1,5544,-1,2.4098235e-05,0.99995553,2.0384145e-05
5545,The immune response to,2,6,12,34,"BACKGROUND: The immune response to melanoma is rarely curative, suggesting the emergence of immunosuppression.",17574040_0,-1,-1,-1,-1,5545,-1,0.00055005366,0.99937445,7.554645e-05
5547,FOXP3-expressing regulatory T cells,0,4,0,35,FOXP3-expressing regulatory T cells (T(reg) cells) function to suppress immune responses.,17574040_1,-1,-1,-1,-1,5547,-1,0.0037275106,0.73605865,0.26021382
5550,function to,9,11,51,62,FOXP3-expressing regulatory T cells (T(reg) cells) function to suppress immune responses.,17574040_1,-1,-1,-1,-1,5550,-1,5.5534332e-05,0.9999013,4.3181026e-05
5557,blood,5,6,33,38,MATERIAL AND METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated and exposed to melanoma-conditioned media (MCM) or control media for 1 week.,17574040_3,0,1,-1,-1,5557,-1,0.0001523167,0.998906,0.0009417019
5571,cells than those,18,21,122,138,"Supernatant cytokines were determined by ELISA.RESULTS: Normal PBMCs exposed to MCM revealed higher proportions of T(reg) cells than those exposed to control media after 6 days (3.4% versus 1.3%, respectively, P < 0.02).",17574040_6,-1,-1,-1,-1,5571,-1,0.0049643954,0.36127827,0.6337574
5579,than those,26,28,146,156,The expression of FOXP3 in T(reg) cells from PBMCs exposed to MCM increased over time by MFI and Western blot but was not significantly different than those exposed to control media.,17574040_7,-1,-1,-1,-1,5579,-1,2.1313565e-05,0.9999672,1.1515913e-05
5583,TGF-beta,5,6,23,31,"The level of IL-10 and TGF-beta in supernatants after 6 days growth was higher in MCM than control media, but this did not reach statistical significance.",17574040_8,0,1,-1,-1,5583,-1,5.8713278e-05,0.9999207,2.0600473e-05
5591,the nature,2,4,11,21,We defined the nature of the cellular immune response in 5 women with human papillomavirus (HPV) 16+cervical carcinoma at a single time point when surgery was performed for treatment.,17589293_0,-1,-1,-1,-1,5591,-1,2.327194e-05,0.99996114,1.5538331e-05
5592,the cellular immune response,5,9,25,53,We defined the nature of the cellular immune response in 5 women with human papillomavirus (HPV) 16+cervical carcinoma at a single time point when surgery was performed for treatment.,17589293_0,-1,-1,-1,-1,5592,-1,0.21763095,0.77508426,0.0072847703
5597,T-cell,5,6,30,36,"To monitor the differences in T-cell recognition, 2 approaches of tetramer-guided technology were employed: (i) the in situ localization of major histocompatibility complex class I peptide complexes in the tumor lesions and (ii) the ex vivo sorting of HLA-A*0201-restricted and HPV16 E6-reactive T cells.",17589293_1,-1,1,2,-1,5597,-1,3.5384437e-05,4.617457e-05,0.99991846
5598,tetramer-guided technology,11,13,66,92,"To monitor the differences in T-cell recognition, 2 approaches of tetramer-guided technology were employed: (i) the in situ localization of major histocompatibility complex class I peptide complexes in the tumor lesions and (ii) the ex vivo sorting of HLA-A*0201-restricted and HPV16 E6-reactive T cells.",17589293_1,-1,-1,-1,-1,5598,-1,3.0889547e-05,0.99994004,2.9059449e-05
5601,peptide complexes,29,31,181,198,"To monitor the differences in T-cell recognition, 2 approaches of tetramer-guided technology were employed: (i) the in situ localization of major histocompatibility complex class I peptide complexes in the tumor lesions and (ii) the ex vivo sorting of HLA-A*0201-restricted and HPV16 E6-reactive T cells.",17589293_1,-1,-1,-1,-1,5601,-1,0.00088205945,0.99843496,0.00068294635
5602,the tumor,32,34,202,211,"To monitor the differences in T-cell recognition, 2 approaches of tetramer-guided technology were employed: (i) the in situ localization of major histocompatibility complex class I peptide complexes in the tumor lesions and (ii) the ex vivo sorting of HLA-A*0201-restricted and HPV16 E6-reactive T cells.",17589293_1,-1,-1,-1,-1,5602,-1,1.720423e-05,0.9999739,8.868063e-06
5607,blood lymphocytes,8,10,43,60,"CD8 T cells from the periphery (peripheral blood lymphocytes), the tumor (tumor-infiltrating lymphocytes), and T cells harvested from draining lymph nodes (T-LN) were analyzed.",17589293_2,-1,-1,-1,-1,5607,-1,0.00032310392,0.00094052596,0.9987363
5608,the tumor,12,14,63,72,"CD8 T cells from the periphery (peripheral blood lymphocytes), the tumor (tumor-infiltrating lymphocytes), and T cells harvested from draining lymph nodes (T-LN) were analyzed.",17589293_2,-1,-1,-1,-1,5608,-1,2.2670878e-05,0.9999647,1.2672438e-05
5609,tumor-infiltrating lymphocytes,15,17,74,104,"CD8 T cells from the periphery (peripheral blood lymphocytes), the tumor (tumor-infiltrating lymphocytes), and T cells harvested from draining lymph nodes (T-LN) were analyzed.",17589293_2,-1,-1,-1,-1,5609,-1,0.004041947,0.8409745,0.1549835
5612,tetramer-sorted lymphocytes,2,4,9,36,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,-1,-1,-1,-1,5612,-1,0.0033991907,0.62360865,0.3729922
5614,peptide,13,14,110,117,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,0,-1,2,-1,5614,-1,0.004762683,0.98976326,0.005474046
5615,the type,16,18,134,142,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,-1,-1,-1,-1,5615,-1,3.0377025e-05,0.99995327,1.630748e-05
5616,antigen-presenting cells,19,21,146,170,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,-1,-1,-1,-1,5616,-1,0.09984849,0.0011390074,0.89901245
5618,tumor cells,31,33,249,260,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,-1,-1,-1,-1,5618,-1,0.0036521736,0.1770345,0.8193133
5619,antigen-presenting cells,36,38,283,307,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,-1,-1,-1,-1,5619,-1,0.114823855,0.0012803872,0.88389575
5621,peptide,42,43,332,339,"HPV16 E6 tetramer-sorted lymphocytes from the different anatomic sites recognized an HLA-A*0201-restricted E6 peptide irrespective of the type of antigen-presenting cells used for stimulation as determined by interferon-gamma production: autologous tumor cells, HLA-A*0201 surrogate antigen-presenting cells pulsed with the nominal peptide, and an HLA-A*0201-matched human dendritic cell line transgenic for HPV16 E6.",17589293_3,0,-1,2,-1,5621,-1,0.015444507,0.96836543,0.01619007
5624,analysis,1,2,8,16,Further analysis showed that the HPV16 E6-reactive CD8 T cells were of high avidity defined by blocking with an anti-CD8-alpha specific monoclonal antibody.,17589293_4,0,1,-1,-1,5624,-1,2.850112e-05,0.99995077,2.0677382e-05
5625,that the,3,5,24,32,Further analysis showed that the HPV16 E6-reactive CD8 T cells were of high avidity defined by blocking with an anti-CD8-alpha specific monoclonal antibody.,17589293_4,-1,-1,-1,-1,5625,-1,1.6962767e-05,0.9999739,9.108517e-06
5630,T-cell,14,15,87,93,"We found that HPV16 E6-reactive T cells reside preferentially within the CD45RA+ CCR7+ T-cell subpopulation of tumor-infiltrating lymphocyte, peripheral blood lymphocyte, and T-LN in cervical cancer patients, suggesting that successful immune surveillance of HPV16+ tumor cells in cervical cancer patients is impaired.",17589293_5,-1,1,2,-1,5630,-1,3.460486e-05,4.1451083e-05,0.99992394
5631,tumor-infiltrating lymphocyte,17,19,111,140,"We found that HPV16 E6-reactive T cells reside preferentially within the CD45RA+ CCR7+ T-cell subpopulation of tumor-infiltrating lymphocyte, peripheral blood lymphocyte, and T-LN in cervical cancer patients, suggesting that successful immune surveillance of HPV16+ tumor cells in cervical cancer patients is impaired.",17589293_5,-1,-1,-1,-1,5631,-1,0.0037564347,0.8817812,0.11446233
5632,blood lymphocyte,21,23,153,169,"We found that HPV16 E6-reactive T cells reside preferentially within the CD45RA+ CCR7+ T-cell subpopulation of tumor-infiltrating lymphocyte, peripheral blood lymphocyte, and T-LN in cervical cancer patients, suggesting that successful immune surveillance of HPV16+ tumor cells in cervical cancer patients is impaired.",17589293_5,-1,-1,-1,-1,5632,-1,0.00063967163,0.0038344264,0.9955259
5635,tumor cells,39,41,266,277,"We found that HPV16 E6-reactive T cells reside preferentially within the CD45RA+ CCR7+ T-cell subpopulation of tumor-infiltrating lymphocyte, peripheral blood lymphocyte, and T-LN in cervical cancer patients, suggesting that successful immune surveillance of HPV16+ tumor cells in cervical cancer patients is impaired.",17589293_5,-1,-1,-1,-1,5635,-1,0.0030021153,0.19757205,0.79942584
5637,antigen-reactive T cells,6,9,35,59,"The CD45RA+/CCR7+ phenotype of HPV antigen-reactive T cells may serve as an indicator of dysfunctional T cells, despite effective interferon-gamma production in response to HPV antigens.",17589293_6,-1,-1,-1,-1,5637,-1,0.35442024,0.004036416,0.6415433
5643,thought to,4,6,31,41,Foxp3 expression was initially thought to be restricted to the CD4(+)CD25(+) regulatory T-cell population.,17615291_0,-1,-1,-1,-1,5643,-1,2.7791315e-05,0.99995565,1.6598828e-05
5644,to the,8,10,56,62,Foxp3 expression was initially thought to be restricted to the CD4(+)CD25(+) regulatory T-cell population.,17615291_0,-1,-1,-1,-1,5644,-1,1.9648709e-05,0.9999683,1.21032335e-05
5646,that forkhead,5,7,32,45,"However, recent studies suggest that forkhead box P3 (Foxp3) is expressed in CD4(+)CD25(-) T cells in aged mice.",17615291_1,-1,-1,-1,-1,5646,-1,2.0544203e-05,0.9999683,1.1123639e-05
5652,blood,22,23,117,122,"In the present study in B-cell non-Hodgkin lymphoma (NHL), we found that a subset of intratumoral but not peripheral blood CD4(+)CD25(-) T cells, comprising about 15% of intratumoral CD4(+) T cells, express Foxp3 and are capable of suppressing the proliferation of autologous infiltrating CD8(+) T cells.",17615291_2,0,1,-1,-1,5652,-1,8.90788e-05,0.9997002,0.00021075271
5663,that the,2,4,9,17,We found that the presence of lymphoma B cells during activation augmented activation-induced Foxp3 expression in CD4(+)CD25(-) T cells.,17615291_4,-1,-1,-1,-1,5663,-1,1.7762812e-05,0.9999739,8.307861e-06
5669,to the,11,13,70,76,We also found that CD70(+) lymphoma B cells significantly contributed to the activation-induced Foxp3 expression in intratumoral CD4(+)CD25(-) T cells.,17615291_5,-1,-1,-1,-1,5669,-1,2.19538e-05,0.99996734,1.0697529e-05
5675,Taken together,0,2,0,14,"Taken together, these studies reveal a novel role for NHL B cells in the development of intratumoral regulatory T cells.",17615291_7,-1,-1,-1,-1,5675,-1,4.0203566e-05,0.9999442,1.5573925e-05
5693,tissue,47,48,286,292,"To determine, whether accumulation and activation of intratumoral Tregs help in the progression of breast carcinoma, we have analyzed the intratumoral expression of FOXP3 in invasive breast carcinoma and compared it with its level in ductal carcinoma in situ (DCIS) and adjacent normal tissue with the main aim of using this factor as marker of tumor progression.",17653902_1,-1,1,2,-1,5693,-1,0.00020818,0.99508977,0.004702011
5695,this factor,54,56,320,331,"To determine, whether accumulation and activation of intratumoral Tregs help in the progression of breast carcinoma, we have analyzed the intratumoral expression of FOXP3 in invasive breast carcinoma and compared it with its level in ductal carcinoma in situ (DCIS) and adjacent normal tissue with the main aim of using this factor as marker of tumor progression.",17653902_1,-1,-1,-1,-1,5695,-1,8.186849e-05,0.9998896,2.8509026e-05
5699,transforming growth factor,9,12,61,87,"Intratumoral FOXP3 levels were correlated with the levels of transforming growth factor beta1 (TGF-beta1), vascular endothelial growth factor (VEGF, an invasogenic and angiogenic growth factor) and intratumoral microvessel density (IMD, a prognostic marker for angiogenesis).",17653902_2,-1,-1,-1,-1,5699,-1,0.88592553,0.1085025,0.0055720326
5700,TGF-beta1,14,15,95,104,"Intratumoral FOXP3 levels were correlated with the levels of transforming growth factor beta1 (TGF-beta1), vascular endothelial growth factor (VEGF, an invasogenic and angiogenic growth factor) and intratumoral microvessel density (IMD, a prognostic marker for angiogenesis).",17653902_2,0,1,-1,-1,5700,-1,5.445045e-05,0.99989104,5.4507967e-05
5703,FOXP3 gene,4,6,25,35,"We also analyzed whether FOXP3 gene expression correlated with other clinicopathological variables like age, tumor stage, histological grade and lymph node metastasis.",17653902_3,-1,-1,-1,-1,5703,-1,2.1416963e-05,0.9999659,1.2689118e-05
5705,FOXP3 transcription,4,6,32,51,"Infiltrating cancers had higher FOXP3 transcription (7.43+/-3.44) than did ductal carcinoma in situ (4.27+/-1.97, p<0.05) and normal tissues (3.51+/-1.22, p<0.001).",17653902_4,-1,-1,-1,-1,5705,-1,2.1876653e-05,0.99996233,1.5850908e-05
5707,tissues,22,23,133,140,"Infiltrating cancers had higher FOXP3 transcription (7.43+/-3.44) than did ductal carcinoma in situ (4.27+/-1.97, p<0.05) and normal tissues (3.51+/-1.22, p<0.001).",17653902_4,-1,1,2,-1,5707,-1,0.00022596549,0.99772614,0.0020478787
5709,TNM classification,13,15,91,109,Intratumoral FOXP3 expression was significantly higher in patients with stage III disease (TNM classification) compared to patients who had stage II disease (p=0.037).,17653902_5,-1,-1,-1,-1,5709,-1,0.00015011545,0.99944216,0.0004076582
5712,TGF-beta1,12,13,91,100,"In infiltrating carcinoma, a significant positive correlation between FOXP3 expression and TGF-beta1 expression was noted (p<0.001).",17653902_6,0,1,-1,-1,5712,-1,3.9873277e-05,0.99991834,4.1821277e-05
5714,statistically that,20,22,125,143,"Furthermore, a positive correlation between FOXP3 expression with VEGF expression and IMD values was also detected, however, statistically that was non-significant.",17653902_7,-1,-1,-1,-1,5714,-1,3.3112792e-05,0.9999485,1.8371626e-05
5721,function,11,12,75,83,Regulation of T cell homeostasis is critical for maintaining normal immune function.,17659375_0,0,1,2,-1,5721,-1,0.00038500805,0.9994949,0.000120085184
5727,cytokines through their receptors,2,6,15,48,"Signaling from cytokines through their receptors is primarily delivered by two molecular families, namely Janus tyrosine kinases (JAKs) and signal transducers and activators of transcription (STATs).",17659375_3,-1,-1,-1,-1,5727,-1,0.8541449,0.022531636,0.123323485
5736,made genetically,12,14,74,90,"Invaluable knowledge about JAKs and STATs has arisen from studies of mice made genetically deficient in these molecules, analyses of tumor models, and studies of expression patterns by proteomics/genomics, which all have begun to define the role of JAKs and STATs in survival versus apoptosis.",17659375_4,-1,-1,-1,-1,5736,-1,2.661098e-05,0.99995863,1.4759857e-05
5750,the lymphocyte life,18,21,107,126,This review seeks to focus on the role of JAK tyrosine kinases and STAT transcription factors in mediating the lymphocyte life cycle and how they might be manipulated for therapeutic applications.,17659375_6,-1,-1,-1,-1,5750,-1,0.00042649743,0.99495983,0.0046136724
5761,the T cell,4,7,21,31,The skewed nature of the T cell infiltrate and the lack of an effective host antitumor immune response suggest that RS cells use potent mechanisms to evade immune attack.,17670934_1,-1,-1,-1,-1,5761,-1,0.0029431626,0.15691052,0.8401463
5771,protein,20,21,137,144,"In a screen for T cell-inhibitory molecules in cHL, we found that RS cells selectively overexpressed the immunoregulatory glycan-binding protein, galectin-1 (Gal1), through an AP1-dependent enhancer.",17670934_2,0,1,-1,-1,5771,-1,4.1404535e-05,0.9999095,4.9126218e-05
5782,Th2 cytokines,13,15,74,87,"In contrast, Gal1 treatment of activated T cells favored the secretion of Th2 cytokines and the expansion of CD4+CD25high FOXP3+ Treg cells.",17670934_4,-1,-1,-1,-1,5782,-1,0.36792332,0.620748,0.011328674
5792,therapeutic target,6,8,34,52,"Thus, Gal1 represents a potential therapeutic target for restoring immune surveillance in cHL.",17670934_6,-1,-1,-1,-1,5792,-1,2.238612e-05,0.9999676,1.009499e-05
5798,tumor-infiltrating lymphocytes,6,8,35,65,Tregs with a distinct phenotype in tumor-infiltrating lymphocytes (TIL) contribute to local immune suppression.,17671115_1,-1,-1,-1,-1,5798,-1,0.003588635,0.8843112,0.11210015
5804,blood,13,14,82,87,EXPERIMENTAL DESIGN: The frequency and phenotype of Treg in TIL and/or peripheral blood mononuclear cells (PBMC) in 15 HNSCC patients and PBMC in 15 normal controls were compared.,17671115_2,0,1,-1,-1,5804,-1,0.00030616857,0.9983664,0.0013273964
5808,function,10,11,71,79,Single-cell sorted CD4(+)CD25(high) T cells were tested for regulatory function by coculture with carboxyfluorescein diacetate succinimidyl ester-labeled and activated autologous CD4(+)CD25(-) responder T cells.,17671115_3,0,1,2,-1,5808,-1,7.0392736e-05,0.999772,0.00015757687
5815,factor-beta1,15,16,113,125,Transwell inserts separating Treg from responders and neutralizing interleukin-10 (IL-10) or transforming growth factor-beta1 (TGF-beta1) antibodies were used to evaluate the mechanisms used by Treg to suppress responder cell proliferation.,17671115_4,0,1,-1,-1,5815,-1,0.9974744,0.00069098437,0.0018346263
5816,TGF-beta1,17,18,127,136,Transwell inserts separating Treg from responders and neutralizing interleukin-10 (IL-10) or transforming growth factor-beta1 (TGF-beta1) antibodies were used to evaluate the mechanisms used by Treg to suppress responder cell proliferation.,17671115_4,0,1,-1,-1,5816,-1,3.9331597e-05,0.99992824,3.244481e-05
5819,Treg to,28,30,194,201,Transwell inserts separating Treg from responders and neutralizing interleukin-10 (IL-10) or transforming growth factor-beta1 (TGF-beta1) antibodies were used to evaluate the mechanisms used by Treg to suppress responder cell proliferation.,17671115_4,-1,-1,-1,-1,5819,-1,1.9420771e-05,0.999969,1.15919065e-05
5825,relative to,22,24,84,95,"RESULTS: In TIL, CD25(+) cells were enriched in the CD3(+)CD4(+) subset (13 +/- 3%) relative to circulating CD3(+)CD4(+) T cells (3 +/- 0.7%) in HNSCC patients (P < or = 0.01) or normal controls (2 +/- 1.5%; P < or = 0.001).",17671115_5,-1,-1,-1,-1,5825,-1,2.4693652e-05,0.9999596,1.5760425e-05
5834,TGF-beta1(+,11,12,41,52,"Tregs in TIL were GITR(+), IL-10(+), and TGF-beta1(+), although circulating Treg up-regulated CD62L and CCR7 but not GITR, IL-10, or TGF-beta1.",17671115_7,0,1,-1,-1,5834,-1,0.00023136644,0.9996214,0.00014722782
5837,TGF-beta1,28,29,133,142,"Tregs in TIL were GITR(+), IL-10(+), and TGF-beta1(+), although circulating Treg up-regulated CD62L and CCR7 but not GITR, IL-10, or TGF-beta1.",17671115_7,0,1,-1,-1,5837,-1,4.9752194e-05,0.99990356,4.6688365e-05
5840,than Treg,13,15,59,68,Treg in TIL mediated stronger suppression (P < or = 0.001) than Treg in PBMC of HNSCC patients.,17671115_8,-1,-1,-1,-1,5840,-1,2.7806449e-05,0.99995553,1.6607979e-05
5843,TGF-beta,6,7,39,47,The addition of neutralizing IL-10 and TGF-beta antibodies almost completely abrogated suppression (5 +/- 2.51%).,17671115_9,0,1,-1,-1,5843,-1,5.754699e-05,0.9999114,3.103024e-05
5845,the tumor,19,21,104,113,"Transwell inserts partly prevented suppression (60 +/- 5% versus 95 +/- 5%).CONCLUSIONS: Suppression in the tumor microenvironment is mediated by a unique subset of Treg, which produce IL-10 and TGF-beta1 and do not require cell-to-cell contact between Treg and responder cells for inhibition.",17671115_10,-1,-1,-1,-1,5845,-1,1.955109e-05,0.9999715,8.972071e-06
5849,TGF-beta1,35,36,195,204,"Transwell inserts partly prevented suppression (60 +/- 5% versus 95 +/- 5%).CONCLUSIONS: Suppression in the tumor microenvironment is mediated by a unique subset of Treg, which produce IL-10 and TGF-beta1 and do not require cell-to-cell contact between Treg and responder cells for inhibition.",17671115_10,0,1,-1,-1,5849,-1,5.235478e-05,0.9999001,4.7574016e-05
5855,treatment reliably,1,3,5,23,"IL-2 treatment reliably results in 16% to 20% objective clinical response rate in cancer patients, with significant durability of responses in selected patients.",17671219_1,-1,-1,-1,-1,5855,-1,2.0150257e-05,0.99996805,1.182481e-05
5872,that Treg cells,18,21,116,131,"The potency of Treg cell proliferation is negatively determined by the initial prevalence of Treg cells, suggesting that Treg cells are a factor for self-controlling Treg cell proliferation.",17671219_6,-1,-1,-1,-1,5872,-1,0.0030096201,0.12950571,0.8674847
5873,factor,23,24,138,144,"The potency of Treg cell proliferation is negatively determined by the initial prevalence of Treg cells, suggesting that Treg cells are a factor for self-controlling Treg cell proliferation.",17671219_6,0,1,-1,-1,5873,-1,0.05612793,0.94217396,0.0016980921
5879,chemokine receptor,5,7,39,57,"Furthermore, IL-2 treatment stimulates chemokine receptor CXCR4 expression on Treg cells, enables Treg cell migration toward chemokine CXCL12 in the tumor microenvironment, and may enforce Treg cell tumor accumulation.",17671219_8,-1,-1,-1,-1,5879,-1,0.1324417,0.0019772113,0.8655811
5882,toward chemokine CXCL12,17,20,118,141,"Furthermore, IL-2 treatment stimulates chemokine receptor CXCR4 expression on Treg cells, enables Treg cell migration toward chemokine CXCL12 in the tumor microenvironment, and may enforce Treg cell tumor accumulation.",17671219_8,-1,-1,-1,-1,5882,-1,0.9510488,0.042458802,0.006492341
5883,the tumor,21,23,145,154,"Furthermore, IL-2 treatment stimulates chemokine receptor CXCR4 expression on Treg cells, enables Treg cell migration toward chemokine CXCL12 in the tumor microenvironment, and may enforce Treg cell tumor accumulation.",17671219_8,-1,-1,-1,-1,5883,-1,2.2270226e-05,0.9999659,1.1807847e-05
5884,Treg cell tumor,28,31,189,204,"Furthermore, IL-2 treatment stimulates chemokine receptor CXCR4 expression on Treg cells, enables Treg cell migration toward chemokine CXCL12 in the tumor microenvironment, and may enforce Treg cell tumor accumulation.",17671219_8,-1,-1,-1,-1,5884,-1,0.0012185932,0.07207412,0.92670727
5887,functionally,11,12,77,89,Our findings support the concept that administration of IL-2 numerically and functionally affects the Treg cell compartment.,17671219_9,0,1,2,-1,5887,-1,5.6662535e-05,0.9999211,2.2216556e-05
5888,the Treg cell,13,16,98,111,Our findings support the concept that administration of IL-2 numerically and functionally affects the Treg cell compartment.,17671219_9,-1,-1,-1,-1,5888,-1,0.0027110453,0.24931112,0.74797773
5896,immunity,19,20,91,99,"Dendritic cells (DCs), as specialized APCs, play a key role in the induction of anti-tumor immunity.",17895399_0,0,-1,2,-1,5896,-1,0.9994166,0.0003722446,0.00021128893
5898,the targets,13,15,71,82,"They originate from bone marrow (BM) progenitors, which are frequently the targets of chromosomal translocations leading to development of leukemia.",17895399_1,-1,-1,-1,-1,5898,-1,3.248398e-05,0.99994934,1.8137218e-05
5901,functions,4,5,32,41,Aberrant DC differentiation and functions have been observed and are widely reported in patients with leukemia.,17895399_2,0,1,2,-1,5901,-1,9.418779e-05,0.99982625,7.963346e-05
5906,time that,9,11,44,53,"In this study, we demonstrate for the first time that knockin of the Mll-Een fusion gene can affect myeloid DC differentiation and functions directly, independent of the leukemic disease activities.",17895399_4,-1,-1,-1,-1,5906,-1,1.8773686e-05,0.99996984,1.1342034e-05
5907,the Mll-Een,13,15,65,76,"In this study, we demonstrate for the first time that knockin of the Mll-Een fusion gene can affect myeloid DC differentiation and functions directly, independent of the leukemic disease activities.",17895399_4,-1,-1,-1,-1,5907,-1,9.691036e-05,0.9998424,6.0672424e-05
5909,functions,23,24,131,140,"In this study, we demonstrate for the first time that knockin of the Mll-Een fusion gene can affect myeloid DC differentiation and functions directly, independent of the leukemic disease activities.",17895399_4,0,1,2,-1,5909,-1,6.958486e-05,0.9998847,4.565162e-05
5911,that the Mll-Een-expressing,2,5,10,37,We showed that the Mll-Een-expressing BM cells [enhanced green fluorescent protein+ (EGFP+)] from leukemic and nonleukemic mice had similarly impaired DC differentiation capacities with functional abnormalities.,17895399_5,-1,-1,-1,-1,5911,-1,7.010822e-05,0.99986947,6.0432852e-05
5913,protein+,11,12,75,83,We showed that the Mll-Een-expressing BM cells [enhanced green fluorescent protein+ (EGFP+)] from leukemic and nonleukemic mice had similarly impaired DC differentiation capacities with functional abnormalities.,17895399_5,0,1,-1,-1,5913,-1,0.0010360559,0.9982469,0.0007170931
5914,functional,28,29,186,196,We showed that the Mll-Een-expressing BM cells [enhanced green fluorescent protein+ (EGFP+)] from leukemic and nonleukemic mice had similarly impaired DC differentiation capacities with functional abnormalities.,17895399_5,0,1,2,-1,5914,-1,0.00029827017,0.99957186,0.000129845
5917,functions,17,18,96,105,"In contrast, BM cells without Mll-Een expression (EGFP(-)) showed normal DC differentiation and functions.",17895399_6,0,1,2,-1,5917,-1,0.00015054093,0.9997346,0.000114865026
5920,these cells,22,24,120,131,"A reduction in the frequency of CD11c+ DCs was also observed within the EGFP+ population in spleen and lymph nodes, and these cells were dysfunctional.",17895399_7,-1,-1,-1,-1,5920,-1,0.0017200148,0.046099693,0.9521803
5921,Taken together,0,2,0,14,"Taken together, our findings suggest that the Mll-Een fusion gene can affect myeloid DC differentiation directly and functions in a cell-autonomous manner, where fully leukemic transformation of the hematopoietic progenitors is not required exclusively.",17895399_8,-1,-1,-1,-1,5921,-1,3.8391183e-05,0.99994564,1.5924037e-05
5922,that the Mll-Een,6,9,37,53,"Taken together, our findings suggest that the Mll-Een fusion gene can affect myeloid DC differentiation directly and functions in a cell-autonomous manner, where fully leukemic transformation of the hematopoietic progenitors is not required exclusively.",17895399_8,-1,-1,-1,-1,5922,-1,9.64674e-05,0.99984837,5.5156503e-05
5924,functions,18,19,117,126,"Taken together, our findings suggest that the Mll-Een fusion gene can affect myeloid DC differentiation directly and functions in a cell-autonomous manner, where fully leukemic transformation of the hematopoietic progenitors is not required exclusively.",17895399_8,0,1,2,-1,5924,-1,5.9449958e-05,0.9999138,2.6720965e-05
5932,to the,22,24,156,162,"Therefore, the study provides evidence for a direct causal relationship between leukemic gene fusion and abnormal DC differentiation, possibly contributing to the development of leukemia.",17895399_9,-1,-1,-1,-1,5932,-1,3.00773e-05,0.99995756,1.2336967e-05
5934,cells types,22,24,136,147,Interleukin-8 (IL-8) is an important mediator in neutrophil-mediated acute inflammation but has also a wide range of actions on various cells types.,17909856_0,-1,-1,-1,-1,5934,-1,5.727026e-05,7.570923e-05,0.9998671
5943,the IL-8 release,18,21,104,120,The inhibition of the VZV replication with a drug interfering with its DNA replication had no effect on the IL-8 release.,17909856_2,-1,-1,-1,-1,5943,-1,0.0013649324,0.9983217,0.00031332218
5944,the IL-8,1,3,6,14,"Since the IL-8 promoter contains binding sites for NF-kappaB and AP-1, melanoma cells and the T cell line were treated with inhibitors of NF-kappaB, JNK/SAPK or p38/MAPK prior to infection.",17909856_3,-1,-1,-1,-1,5944,-1,0.6749432,0.3187822,0.0062745293
5948,the T cell,15,18,90,100,"Since the IL-8 promoter contains binding sites for NF-kappaB and AP-1, melanoma cells and the T cell line were treated with inhibitors of NF-kappaB, JNK/SAPK or p38/MAPK prior to infection.",17909856_3,-1,-1,-1,-1,5948,-1,0.002569372,0.119372614,0.878058
5955,the IL-8,13,15,70,78,"In melanoma cells, the JNK/SAPK pathway was shown to be important for the IL-8 secretion during the VZV replication, whereas in the T cell line, not only the JNK/SAPK but also the p38/MAPK pathways were required for IL-8 secretion.",17909856_4,-1,-1,-1,-1,5955,-1,0.79085374,0.20220369,0.0069425395
5957,the T cell,23,26,128,138,"In melanoma cells, the JNK/SAPK pathway was shown to be important for the IL-8 secretion during the VZV replication, whereas in the T cell line, not only the JNK/SAPK but also the p38/MAPK pathways were required for IL-8 secretion.",17909856_4,-1,-1,-1,-1,5957,-1,0.0031747662,0.24768469,0.7491405
5962,the IL-8,3,5,22,30,"The neutralisation of the IL-8 bioactivity had no significant consequence on the VZV replication, suggesting that IL-8 acts neither as a proviral nor as an antiviral cytokine during the VZV replication in vitro.",17909856_5,-1,-1,-1,-1,5962,-1,0.6332282,0.35013118,0.016640557
5964,that IL-8,16,18,109,118,"The neutralisation of the IL-8 bioactivity had no significant consequence on the VZV replication, suggesting that IL-8 acts neither as a proviral nor as an antiviral cytokine during the VZV replication in vitro.",17909856_5,-1,-1,-1,-1,5964,-1,0.72551316,0.26058936,0.013897488
5968,tumor-associated antigen,19,21,89,113,"Survivin (SVV), a member of the inhibitors of apoptosis, has been considered as an ideal tumor-associated antigen due to its broad expression pattern in many types of human malignancies.",17931768_0,-1,-1,-1,-1,5968,-1,0.065879636,0.9247436,0.009376789
5975,protein,23,24,130,137,"Here, SVV-specific immune responses were evaluated with dendritic cells (DCs) loaded with a recombinant tatPTD fused SVV (tatSVV) protein both in vitro and in vivo system.",17931768_1,0,1,-1,-1,5975,-1,4.6419307e-05,0.99991953,3.409284e-05
5976,The tatPTD,0,2,0,10,The tatPTD fusion allowed for highly efficient and reproducible protein delivery into the DCs even in the presence of a phagocytosis inhibitor.,17931768_2,-1,-1,-1,-1,5976,-1,2.3224076e-05,0.99996316,1.35848295e-05
5977,protein,9,10,64,71,The tatPTD fusion allowed for highly efficient and reproducible protein delivery into the DCs even in the presence of a phagocytosis inhibitor.,17931768_2,0,1,-1,-1,5977,-1,0.00046642357,0.99920446,0.0003292003
5981,T-cell,5,6,36,42,"The level of SVV-specific cytotoxic T-cell response appeared to be significantly higher for the T-cell line that was primed with the tatSVV-pulsed DCs, as compared to the T-cell line produced with naked (n)-SVV-pulsed DCs in vitro.",17931768_3,-1,1,2,-1,5981,-1,3.3109332e-05,5.325538e-05,0.9999136
5983,the T-cell,13,15,92,102,"The level of SVV-specific cytotoxic T-cell response appeared to be significantly higher for the T-cell line that was primed with the tatSVV-pulsed DCs, as compared to the T-cell line produced with naked (n)-SVV-pulsed DCs in vitro.",17931768_3,-1,-1,-1,-1,5983,-1,0.0020236066,0.11192849,0.8860479
5985,the tatSVV-pulsed,20,22,129,146,"The level of SVV-specific cytotoxic T-cell response appeared to be significantly higher for the T-cell line that was primed with the tatSVV-pulsed DCs, as compared to the T-cell line produced with naked (n)-SVV-pulsed DCs in vitro.",17931768_3,-1,-1,-1,-1,5985,-1,3.894011e-05,0.99993944,2.1650214e-05
5986,to the T-cell,26,29,164,177,"The level of SVV-specific cytotoxic T-cell response appeared to be significantly higher for the T-cell line that was primed with the tatSVV-pulsed DCs, as compared to the T-cell line produced with naked (n)-SVV-pulsed DCs in vitro.",17931768_3,-1,-1,-1,-1,5986,-1,0.0040948265,0.35152614,0.6443791
5990,immune response than,11,14,76,96,"Mice that received a xenogeneic tatSVV-pulsed DC vaccine developed a higher immune response than mice vaccinated with the nSVV-pulsed DCs and exhibited prolonged mean survival rate, though mice injected with the DCs alone or the nSVV-pulsed DC also showed anti-tumor effects in the subcutaneous GL26 glioma model.",17931768_4,-1,-1,-1,-1,5990,-1,0.85207564,0.14412142,0.0038029721
6010,blood,14,15,101,106,CIN and cervical cancer patients showed increased CD4(+)/CD25(high) T cell frequencies in peripheral blood and CD4(+) T cell fraction.,17937675_3,0,1,-1,-1,6010,-1,0.0018703336,0.72822255,0.26990715
6021,IFN-gamma T cell,19,22,108,124,"Moreover, in HPV16(+) cervical cancer patients, in-vitro depletion of CD25(+) T cells resulted in increased IFN-gamma T cell responses against HPV16 E6- and E7 peptides.",17937675_5,-1,-1,-1,-1,6021,-1,0.8224882,0.0016939165,0.17581795
6022,peptides,28,29,160,168,"Moreover, in HPV16(+) cervical cancer patients, in-vitro depletion of CD25(+) T cells resulted in increased IFN-gamma T cell responses against HPV16 E6- and E7 peptides.",17937675_5,0,-1,2,-1,6022,-1,9.386712e-05,0.99981195,9.4211595e-05
6025,immunity,15,16,100,108,"Thus, increased frequencies of T(regs) in cervical cancer patients may indeed suppress HPV-specific immunity.",17937675_6,0,-1,2,-1,6025,-1,0.9995161,0.0002760039,0.00020789866
6026,analysis,1,2,13,21,Longitudinal analysis of CD4(+)/CD25(high) T cell frequencies in patients showed a modest decline 1 year after curative surgery or chemoradiation.,17937675_7,0,1,-1,-1,6026,-1,2.4386954e-05,0.9999596,1.599601e-05
6032,that T(regs,3,5,20,31,These results imply that T(regs) may suppress the immune control of cervical neoplasia and furthermore that suppression of immunity by T(regs) will be another hurdle to overcome in therapeutic immunization strategies against cervical neoplasia.,17937675_9,-1,-1,-1,-1,6032,-1,2.1294567e-05,0.99996626,1.2416274e-05
6035,immunity,19,20,123,131,These results imply that T(regs) may suppress the immune control of cervical neoplasia and furthermore that suppression of immunity by T(regs) will be another hurdle to overcome in therapeutic immunization strategies against cervical neoplasia.,17937675_9,0,-1,2,-1,6035,-1,0.9562656,0.042919382,0.00081497733
6040,peptide,3,4,15,22,"A dual altered peptide ligand (APL), composed of the tandemly arranged two single amino acid analogs of two myasthenogenic peptides, p195-212 and p259-271, down-regulated in vitro and in vivo MG-associated T cell responses.",17956982_1,0,-1,2,-1,6040,-1,0.023151716,0.9033736,0.07347468
6041,the tandemly,11,13,49,61,"A dual altered peptide ligand (APL), composed of the tandemly arranged two single amino acid analogs of two myasthenogenic peptides, p195-212 and p259-271, down-regulated in vitro and in vivo MG-associated T cell responses.",17956982_1,-1,-1,-1,-1,6041,-1,2.9934821e-05,0.9999585,1.1519866e-05
6044,peptides,22,23,123,131,"A dual altered peptide ligand (APL), composed of the tandemly arranged two single amino acid analogs of two myasthenogenic peptides, p195-212 and p259-271, down-regulated in vitro and in vivo MG-associated T cell responses.",17956982_1,0,-1,2,-1,6044,-1,0.005719687,0.9885882,0.005692147
6049,the mechanism of action,15,19,84,107,"In the present study, we investigated the role of CD8(+)CD28(-) regulatory cells in the mechanism of action of the dual APL.",17956982_2,-1,-1,-1,-1,6049,-1,2.380515e-05,0.9999641,1.2125088e-05
6051,that treatment,2,4,16,30,We demonstrated that treatment of mice with the dual APL concomitant with immunization with a myasthenogenic peptide resulted in an increased population of CD8(+)CD28(-) cells that express forkhead box P3 (Foxp3).,17956982_3,-1,-1,-1,-1,6051,-1,1.8905042e-05,0.9999709,1.023641e-05
6053,peptide,16,17,109,116,We demonstrated that treatment of mice with the dual APL concomitant with immunization with a myasthenogenic peptide resulted in an increased population of CD8(+)CD28(-) cells that express forkhead box P3 (Foxp3).,17956982_3,0,-1,2,-1,6053,-1,0.1426184,0.8293968,0.027984802
6054,cells that,25,27,170,180,We demonstrated that treatment of mice with the dual APL concomitant with immunization with a myasthenogenic peptide resulted in an increased population of CD8(+)CD28(-) cells that express forkhead box P3 (Foxp3).,17956982_3,-1,-1,-1,-1,6054,-1,0.003271926,0.07929363,0.91743445
6060,the Torpedo,14,16,69,80,"The dual APL inhibited the proliferation of lymph node (LN) cells of the Torpedo acetylcholine receptor-immunized WT C57BL/6 mice, whereas the inhibition was abrogated in CD8(-/-) knockout mice.",17956982_4,-1,-1,-1,-1,6060,-1,3.0186584e-05,0.9999528,1.7039112e-05
6061,receptor-immunized,17,18,95,113,"The dual APL inhibited the proliferation of lymph node (LN) cells of the Torpedo acetylcholine receptor-immunized WT C57BL/6 mice, whereas the inhibition was abrogated in CD8(-/-) knockout mice.",17956982_4,0,1,2,-1,6061,-1,0.0032203158,0.9721619,0.024617815
6068,receptor,23,24,134,142,"Moreover, the dual APL did not inhibit the secretion of IFN-gamma by LN cells from CD8(-/-) mice immunized with Torpedo acetylcholine receptor.",17956982_5,0,1,2,-1,6068,-1,0.0011800032,0.06536553,0.93345445
6071,TGF-beta,8,9,42,50,"However, the mRNA expression of IL-10 and TGF-beta by LN cells from CD8(-/-) mice was up-regulated similarly to that of the WT mice.",17956982_6,0,1,-1,-1,6071,-1,5.3770258e-05,0.9999242,2.2012684e-05
6073,to that,19,21,109,116,"However, the mRNA expression of IL-10 and TGF-beta by LN cells from CD8(-/-) mice was up-regulated similarly to that of the WT mice.",17956982_6,-1,-1,-1,-1,6073,-1,2.4605866e-05,0.99996305,1.2358231e-05
6081,to that,18,20,113,120,"Finally, the dual APL-induced CD4(+)CD25(+)Foxp3(+) cells were up-regulated in CD8(-/-) mice to a similar extent to that observed in the WT mice.",17956982_8,-1,-1,-1,-1,6081,-1,2.7127664e-05,0.9999589,1.3951092e-05
6085,cells play,8,10,47,57,"Thus, we suggest that CD8(+)CD28(-) regulatory cells play a partial role in the mechanism of action by which the dual APL suppresses experimental autoimmune MG-associated T cell responses.",17956982_9,-1,-1,-1,-1,6085,-1,0.0034503143,0.12570164,0.870848
6086,the mechanism of action,14,18,76,99,"Thus, we suggest that CD8(+)CD28(-) regulatory cells play a partial role in the mechanism of action by which the dual APL suppresses experimental autoimmune MG-associated T cell responses.",17956982_9,-1,-1,-1,-1,6086,-1,2.8522196e-05,0.9999585,1.2942367e-05
6093,blood,15,16,99,104,"Mast cells are effector cells of IgE-mediated immune responses frequently found at the vicinity of blood vessels, the margins of diverse tumors and at sites of potential infection and inflammation.",17982078_0,0,1,-1,-1,6093,-1,0.00035545748,0.99712914,0.0025153877
6100,the AP-1 transcription factor,8,12,41,70,"Recent work identified JunB, a member of the AP-1 transcription factor family, as critical regulator of basal and induced expression of inflammatory mediators in fibroblasts and T cells.",17982078_2,-1,-1,-1,-1,6100,-1,2.3307053e-05,0.99996305,1.3673106e-05
6115,these cells,1,3,4,15,"But these cells exhibit impaired IgE-mediated degranulation most likely due to diminished expression of SWAP-70, Synaptotagmin-1, and VAMP-8, and due to impaired influx of extracellular calcium.",17982078_5,-1,-1,-1,-1,6115,-1,0.0024857852,0.1721302,0.825384
6125,cells to,11,13,69,77,"In line with these findings, the contribution of JunB-deficient mast cells to angiogenesis, as analyzed in an in vitro tube formation assay on matrigel, is severely impaired due to limiting amounts of synthesized and secreted vascular endothelial growth factor.",17982078_7,-1,-1,-1,-1,6125,-1,0.003156815,0.10136118,0.89548206
6127,to limiting,31,33,178,189,"In line with these findings, the contribution of JunB-deficient mast cells to angiogenesis, as analyzed in an in vitro tube formation assay on matrigel, is severely impaired due to limiting amounts of synthesized and secreted vascular endothelial growth factor.",17982078_7,-1,-1,-1,-1,6127,-1,0.0036134524,0.99556017,0.00082640845
6131,cell functions,10,12,53,67,"Thus, JunB is a critical regulator of intrinsic mast cell functions including cross-talk with endothelial cells.",17982078_8,-1,-1,-1,-1,6131,-1,9.002748e-05,0.00015910697,0.9997509
6133,functional status,2,4,12,29,"We examined functional status, activation mechanisms, and biologic role of the mTORC1 signaling pathway in malignant CD4(+) T cells derived from the cutaneous T-cell lymphoma (CTCL).",18025151_0,-1,-1,-1,-1,6133,-1,3.0126834e-05,0.9999485,2.1361719e-05
6137,T-cell,26,27,159,165,"We examined functional status, activation mechanisms, and biologic role of the mTORC1 signaling pathway in malignant CD4(+) T cells derived from the cutaneous T-cell lymphoma (CTCL).",18025151_0,-1,1,2,-1,6137,-1,5.231932e-05,8.030398e-05,0.9998673
6140,the TORC1,11,13,93,102,"Whereas the spontaneously growing CTCL-derived cell lines displayed persistent activation of the TORC1 as well as the PI3K/Akt and MEK/ERK pathways, the IL-2-dependent cell lines activated the pathways in response to IL-2 and IL-15 but not IL-21.",18025151_1,-1,-1,-1,-1,6140,-1,2.2911974e-05,0.9999517,2.5385927e-05
6151,tissues,8,9,48,55,mTORC1 activation was also detected in the CTCL tissues in the lymphoma stage-dependent manner with the highest percentage of positive cells present in the cases with a large cell transformation.,18025151_4,-1,1,2,-1,6151,-1,0.0002727158,0.0005626406,0.9991646
6156,cell transformation,28,30,175,194,mTORC1 activation was also detected in the CTCL tissues in the lymphoma stage-dependent manner with the highest percentage of positive cells present in the cases with a large cell transformation.,18025151_4,-1,-1,-1,-1,6156,-1,0.0011781806,0.019422552,0.9793993
6162,through the,7,9,57,68,"Finally, mTORC1 activation was transduced preferentially through the PI3K/Akt pathway.",18025151_7,-1,-1,-1,-1,6162,-1,2.1016702e-05,0.99996376,1.5196806e-05
6169,that the,18,20,136,144,"These findings document the selective gammac-signaling cytokine-mediated activation of the mTORC1 pathway in the CTCL cells and suggest that the pathway represents a therapeutic target in CTCL and, possibly, other T-cell lymphomas.",18025151_8,-1,-1,-1,-1,6169,-1,1.8402083e-05,0.99997234,9.2990085e-06
6170,therapeutic target,23,25,166,184,"These findings document the selective gammac-signaling cytokine-mediated activation of the mTORC1 pathway in the CTCL cells and suggest that the pathway represents a therapeutic target in CTCL and, possibly, other T-cell lymphomas.",18025151_8,-1,-1,-1,-1,6170,-1,2.4404326e-05,0.999964,1.1616605e-05
6171,T-cell,32,33,214,220,"These findings document the selective gammac-signaling cytokine-mediated activation of the mTORC1 pathway in the CTCL cells and suggest that the pathway represents a therapeutic target in CTCL and, possibly, other T-cell lymphomas.",18025151_8,-1,1,2,-1,6171,-1,6.298548e-05,5.2351723e-05,0.9998847
6173,function,5,6,30,38,We examined the phenotype and function of CD4+ T cells expressing the semaphorin III receptor neuropilin-1 (Nrp1) in human lymph nodes and peripheral blood.,18028372_0,0,1,2,-1,6173,-1,8.190354e-05,0.99984074,7.735614e-05
6176,receptor,15,16,85,93,We examined the phenotype and function of CD4+ T cells expressing the semaphorin III receptor neuropilin-1 (Nrp1) in human lymph nodes and peripheral blood.,18028372_0,0,1,2,-1,6176,-1,0.0011528383,0.1361633,0.86268383
6177,blood,26,27,150,155,We examined the phenotype and function of CD4+ T cells expressing the semaphorin III receptor neuropilin-1 (Nrp1) in human lymph nodes and peripheral blood.,18028372_0,0,1,-1,-1,6177,-1,0.00018539754,0.9985247,0.0012898827
6178,T-cell,13,14,67,73,"In lymph nodes, Nrp1 identified a small regulatory CD4+ CD25(high) T-cell subpopulation (Nrp1+ Treg) that expressed higher levels of Forkhead box P3 (Foxp3) message and protein than Nrp1- Treg, and various molecular markers of activated Treg, i.e. CD45RO, human leucocyte antigen (HLA)-DR and glucocorticoid-induced tumour necrosis factor receptor (GITR).",18028372_1,-1,1,2,-1,6178,-1,3.4154982e-05,4.6718895e-05,0.99991906
6187,tumour necrosis factor receptor,55,59,316,347,"In lymph nodes, Nrp1 identified a small regulatory CD4+ CD25(high) T-cell subpopulation (Nrp1+ Treg) that expressed higher levels of Forkhead box P3 (Foxp3) message and protein than Nrp1- Treg, and various molecular markers of activated Treg, i.e. CD45RO, human leucocyte antigen (HLA)-DR and glucocorticoid-induced tumour necrosis factor receptor (GITR).",18028372_1,-1,-1,-1,-1,6187,-1,0.12328517,0.51979333,0.35692146
6196,T cells that,15,18,77,89,"Nrp1 was also expressed on a small subpopulation of CD25(int) and CD25- CD4+ T cells that expressed more Foxp3, CD45RO, HLA-DR and GITR than their Nrp1- counterparts.",18028372_4,-1,-1,-1,-1,6196,-1,0.0014853175,0.028101448,0.9704132
6198,than their,27,29,136,146,"Nrp1 was also expressed on a small subpopulation of CD25(int) and CD25- CD4+ T cells that expressed more Foxp3, CD45RO, HLA-DR and GITR than their Nrp1- counterparts.",18028372_4,-1,-1,-1,-1,6198,-1,2.688265e-05,0.9999554,1.7654636e-05
6199,blood,5,6,27,32,"In contrast, in peripheral blood Nrp1 identified a minor CD4+ T-cell subset that did not display the phenotypic features of Treg lacking Foxp3 expression and marginally expressing CD25.",18028372_5,0,1,-1,-1,6199,-1,3.9530983e-05,0.99991226,4.8244347e-05
6200,T-cell subset that,12,15,62,80,"In contrast, in peripheral blood Nrp1 identified a minor CD4+ T-cell subset that did not display the phenotypic features of Treg lacking Foxp3 expression and marginally expressing CD25.",18028372_5,-1,-1,-1,-1,6200,-1,0.0014668284,0.13213454,0.8663987
6204,marginally,27,28,158,168,"In contrast, in peripheral blood Nrp1 identified a minor CD4+ T-cell subset that did not display the phenotypic features of Treg lacking Foxp3 expression and marginally expressing CD25.",18028372_5,-1,-1,-1,-1,6204,-1,3.0400177e-05,0.9999474,2.2121072e-05
6205,the function,2,4,7,19,"Hence, the function of Nrp1+ CD4+ T cells seemingly depends on their anatomical location.",18028372_6,-1,-1,-1,-1,6205,-1,2.9622719e-05,0.9999529,1.7506465e-05
6208,that Treg,7,9,34,43,"In a previous report, we proposed that Treg may curb the anti-tumour T-cell response in cervical cancer.",18028372_7,-1,-1,-1,-1,6208,-1,2.2125252e-05,0.9999695,8.401283e-06
6210,T-cell,13,14,69,75,"In a previous report, we proposed that Treg may curb the anti-tumour T-cell response in cervical cancer.",18028372_7,-1,1,2,-1,6210,-1,4.808879e-05,7.63509e-05,0.99987555
6211,that Treg,3,5,13,22,"We show here that Treg and Nrp1+ Treg levels dropped in the tumour-draining lymph nodes of patients with cervical cancer following preoperative chemoradiotherapy in a direct relationship with the reduction of tumour mass, suggesting that suppressor cell elimination facilitated the generation of T cells mediating the destruction of the neoplastic cells left behind after cytotoxic therapy.",18028372_8,-1,-1,-1,-1,6211,-1,1.9993775e-05,0.99996924,1.0757131e-05
6213,the tumour-draining,12,14,56,75,"We show here that Treg and Nrp1+ Treg levels dropped in the tumour-draining lymph nodes of patients with cervical cancer following preoperative chemoradiotherapy in a direct relationship with the reduction of tumour mass, suggesting that suppressor cell elimination facilitated the generation of T cells mediating the destruction of the neoplastic cells left behind after cytotoxic therapy.",18028372_8,-1,-1,-1,-1,6213,-1,3.4206252e-05,0.99994457,2.1165059e-05
6218,that suppressor cell,36,39,233,253,"We show here that Treg and Nrp1+ Treg levels dropped in the tumour-draining lymph nodes of patients with cervical cancer following preoperative chemoradiotherapy in a direct relationship with the reduction of tumour mass, suggesting that suppressor cell elimination facilitated the generation of T cells mediating the destruction of the neoplastic cells left behind after cytotoxic therapy.",18028372_8,-1,-1,-1,-1,6218,-1,0.0036480322,0.2269863,0.7693656
6219,the generation,41,43,278,292,"We show here that Treg and Nrp1+ Treg levels dropped in the tumour-draining lymph nodes of patients with cervical cancer following preoperative chemoradiotherapy in a direct relationship with the reduction of tumour mass, suggesting that suppressor cell elimination facilitated the generation of T cells mediating the destruction of the neoplastic cells left behind after cytotoxic therapy.",18028372_8,-1,-1,-1,-1,6219,-1,1.771976e-05,0.9999677,1.4630442e-05
6224,therapy,57,58,382,389,"We show here that Treg and Nrp1+ Treg levels dropped in the tumour-draining lymph nodes of patients with cervical cancer following preoperative chemoradiotherapy in a direct relationship with the reduction of tumour mass, suggesting that suppressor cell elimination facilitated the generation of T cells mediating the destruction of the neoplastic cells left behind after cytotoxic therapy.",18028372_8,0,1,-1,-1,6224,-1,2.9188794e-05,0.99995613,1.4688151e-05
6226,that play,4,6,29,38,Among the several mechanisms that play role in maintaining peripheral self-tolerance is the existence of a unique CD4+CD25+ population of naturally occurring regulatory T (Treg) cells that actively prevent both the activation and the effector function of autoreactive T cells that have escaped different mechanisms of tolerance.,18092144_0,-1,-1,-1,-1,6226,-1,2.5879406e-05,0.999962,1.209328e-05
6231,cells that,28,30,178,188,Among the several mechanisms that play role in maintaining peripheral self-tolerance is the existence of a unique CD4+CD25+ population of naturally occurring regulatory T (Treg) cells that actively prevent both the activation and the effector function of autoreactive T cells that have escaped different mechanisms of tolerance.,18092144_0,-1,-1,-1,-1,6231,-1,0.003260571,0.09097943,0.90576005
6234,function,38,39,243,251,Among the several mechanisms that play role in maintaining peripheral self-tolerance is the existence of a unique CD4+CD25+ population of naturally occurring regulatory T (Treg) cells that actively prevent both the activation and the effector function of autoreactive T cells that have escaped different mechanisms of tolerance.,18092144_0,0,1,2,-1,6234,-1,0.00084377435,0.99491584,0.004240359
6235,T cells that,41,44,268,280,Among the several mechanisms that play role in maintaining peripheral self-tolerance is the existence of a unique CD4+CD25+ population of naturally occurring regulatory T (Treg) cells that actively prevent both the activation and the effector function of autoreactive T cells that have escaped different mechanisms of tolerance.,18092144_0,-1,-1,-1,-1,6235,-1,0.0014866553,0.026281418,0.972232
6238,targeting this cell,7,10,39,58,Many studies have shown the benefit of targeting this cell population by restoring self-tolerance.,18092144_1,-1,-1,-1,-1,6238,-1,0.002580951,0.87207925,0.12533984
6239,Therapies that,0,2,0,14,Therapies that could possibly increase the suppressive ability of T regulatory cells were proven to improve that course of autoimmune diseases.,18092144_2,-1,-1,-1,-1,6239,-1,2.2092496e-05,0.99996805,9.797336e-06
6249,to the generation,17,20,99,116,Activation and expansion of T helper (Th) cells followed by regulation of activation are essential to the generation of immune responses while limiting concomitant autoreactivity.,18156498_0,-1,-1,-1,-1,6249,-1,3.495661e-05,0.99994767,1.7377428e-05
6255,analysis,21,22,145,153,"In order to characterize T cells reactive towards myeloma-derived monoclonal immunoglobulin (mIg), an autologous coculture assay for single-cell analysis of mIg-responding cells was developed.",18156498_1,0,1,-1,-1,6255,-1,0.000101428996,0.99956733,0.00033124755
6258,Th cells,11,13,59,67,"When cultured with dendritic cells loaded with mIg, CD4(+) Th cells from patients with progressing multiple myeloma (MM) showed a proliferative MHC class II-dependent response.",18156498_2,-1,-1,-1,-1,6258,-1,3.0313337e-05,3.9122457e-05,0.9999306
6259,T-cell,2,3,7,13,"CD8(+) T-cell reactivity and Th1 activation were consistently low or absent, and Th2 and regulatory cytokines were expressed.",18156498_3,-1,1,2,-1,6259,-1,3.5746103e-05,4.837112e-05,0.99991584
6266,blood,11,12,58,63,"The presence of such non-Th1 CD4(+) T cells in peripheral blood was independent of treatment status, while the frequencies of responding cells varied between patients and reached the same order of magnitude as those measured for tetanus toxoid-specific Th memory cells.",18156498_4,0,1,-1,-1,6266,-1,0.000104235485,0.9992742,0.0006215528
6267,treatment status,15,17,83,99,"The presence of such non-Th1 CD4(+) T cells in peripheral blood was independent of treatment status, while the frequencies of responding cells varied between patients and reached the same order of magnitude as those measured for tetanus toxoid-specific Th memory cells.",18156498_4,-1,-1,-1,-1,6267,-1,3.135846e-05,0.99995446,1.4212696e-05
6272,tetanus toxoid-specific Th,38,41,229,255,"The presence of such non-Th1 CD4(+) T cells in peripheral blood was independent of treatment status, while the frequencies of responding cells varied between patients and reached the same order of magnitude as those measured for tetanus toxoid-specific Th memory cells.",18156498_4,-1,-1,-1,-1,6272,-1,5.630558e-05,0.9999186,2.5108513e-05
6274,T-cell,4,5,31,37,"Furthermore, investigations of T-cell subpopulations indicated a possible regulatory role on the mIg responsiveness mediated by suppressive CD25(high)FOXP3(+)CD4(+) T cells.",18156498_5,-1,1,2,-1,6274,-1,3.194438e-05,4.289008e-05,0.99992514
6284,the therapeutic,4,6,24,39,"Previously, we reported the therapeutic properties of a vaccine prepared by transfer of a cDNA-expression library from breast cancer cells into a highly immunogenic allogeneic fibroblast cell line where genes specifying an array of breast cancer antigens were expressed.",18157008_1,-1,-1,-1,-1,6284,-1,2.196636e-05,0.999969,9.053332e-06
6291,this cell-based,7,9,35,50,"Here, we report the application of this cell-based vaccination strategy for breast cancer metastatic to the brain.",18157008_2,-1,-1,-1,-1,6291,-1,0.0019425935,0.7191625,0.27889493
6292,to the,15,17,101,107,"Here, we report the application of this cell-based vaccination strategy for breast cancer metastatic to the brain.",18157008_2,-1,-1,-1,-1,6292,-1,2.0347328e-05,0.99996936,1.024576e-05
6302,immunity to the,1,4,9,24,"Enhanced immunity to the neoplasm mediated predominantly by CD4+, CD8+, and NK/LAK cells was generated in the spleens of mice injected intracerebrally into the tumor bed with cells from the enriched vaccine, which translated into prolonged survival.",18157008_4,-1,-1,-1,-1,6302,-1,0.001233349,0.9985751,0.00019157678
6306,the tumor,27,29,156,165,"Enhanced immunity to the neoplasm mediated predominantly by CD4+, CD8+, and NK/LAK cells was generated in the spleens of mice injected intracerebrally into the tumor bed with cells from the enriched vaccine, which translated into prolonged survival.",18157008_4,-1,-1,-1,-1,6306,-1,1.9576151e-05,0.999969,1.1466913e-05
6324,the Toll-like receptor-9,9,12,67,91,"Moreover, we compared standard BCG immunotherapy side-by-side with the Toll-like receptor-9 agonist CpG. MB49 tumor-bearing mice were treated with BCG or CpG and survival as well as tumor progression were observed over time.",18157010_4,-1,-1,-1,-1,6324,-1,0.00072971353,0.9981229,0.0011474269
6329,Urine,0,1,0,5,"Urine, blood, and tumors were collected and analyzed.",18157010_5,0,1,-1,-1,6329,-1,6.5516324e-05,0.999894,4.0440533e-05
6330,blood,2,3,7,12,"Urine, blood, and tumors were collected and analyzed.",18157010_5,0,1,-1,-1,6330,-1,8.1654514e-05,0.99979407,0.00012433076
6332,tumor-specific immunity,6,8,41,64,Mice were rechallenged and evaluated for tumor-specific immunity.,18157010_6,-1,-1,-1,-1,6332,-1,0.003669224,0.996007,0.0003237265
6336,immunity,21,22,137,145,"In this study, CpGs induced a complete response of large aggressive orthotopic MB49 bladder tumors, resulting in tumor-specific systemic immunity.",18157010_7,0,-1,2,-1,6336,-1,0.99950004,0.00030479842,0.00019513723
6337,that this,4,6,24,33,"Further, data indicated that this potent antitumor effect required T cells.",18157010_8,-1,-1,-1,-1,6337,-1,2.124517e-05,0.9999651,1.3638987e-05
6352,immunity,10,11,80,88,"Further, immune cell depletion studies demonstrated that CpG-induced protective immunity was CD4+ T-cell dependent.",18157010_12,0,-1,2,-1,6352,-1,0.98623544,0.013053098,0.000711438
6353,T-cell,14,15,98,104,"Further, immune cell depletion studies demonstrated that CpG-induced protective immunity was CD4+ T-cell dependent.",18157010_12,-1,1,2,-1,6353,-1,3.506289e-05,4.668563e-05,0.9999182
6354,Taken together,0,2,0,14,"Taken together, our data suggest that CpGs are superior to BCG for bladder cancer immunotherapy.",18157010_13,-1,-1,-1,-1,6354,-1,4.402052e-05,0.99993944,1.64777e-05
6364,peptides,23,24,114,122,PURPOSE: The study aims to evaluate the effect of a human papillomavirus type 16 (HPV16) E6 and E7 synthetic long peptides vaccine on the antigen-specific T-cell response in cervical cancer patients.,18172269_0,0,-1,2,-1,6364,-1,0.0026805683,0.99352723,0.0037921192
6365,the antigen-specific T-cell,26,29,134,161,PURPOSE: The study aims to evaluate the effect of a human papillomavirus type 16 (HPV16) E6 and E7 synthetic long peptides vaccine on the antigen-specific T-cell response in cervical cancer patients.,18172269_0,-1,-1,-1,-1,6365,-1,0.015114796,0.40973753,0.5751477
6366,peptides,17,18,123,131,EXPERIMENTAL DESIGN: Patients with resected HPV16-positive cervical cancer were vaccinated with an overlapping set of long peptides comprising the sequences of the HPV16 E6 and E7 oncoproteins emulsified in Montanide ISA-51.,18172269_1,0,-1,2,-1,6366,-1,0.00020166422,0.99952507,0.00027329152
6369,T-cell immune responses,1,4,15,38,"HPV16-specific T-cell immune responses were analyzed by evaluating the magnitude, breadth, type, and polarization by proliferation assays, IFN gamma-ELISPOT, and cytokine production and phenotyped by the T-cell markers CD4, CD8, CD25, and Foxp3.RESULTS: Vaccine-induced T-cell responses against HPV16 E6 and E7 were detected in six of six and five of six patients, respectively.",18172269_2,-1,-1,-1,-1,6369,-1,0.04374423,0.0035516364,0.9527042
6374,the T-cell,30,32,200,210,"HPV16-specific T-cell immune responses were analyzed by evaluating the magnitude, breadth, type, and polarization by proliferation assays, IFN gamma-ELISPOT, and cytokine production and phenotyped by the T-cell markers CD4, CD8, CD25, and Foxp3.RESULTS: Vaccine-induced T-cell responses against HPV16 E6 and E7 were detected in six of six and five of six patients, respectively.",18172269_2,-1,-1,-1,-1,6374,-1,0.0025643317,0.09387355,0.90356207
6375,T-cell,43,44,270,276,"HPV16-specific T-cell immune responses were analyzed by evaluating the magnitude, breadth, type, and polarization by proliferation assays, IFN gamma-ELISPOT, and cytokine production and phenotyped by the T-cell markers CD4, CD8, CD25, and Foxp3.RESULTS: Vaccine-induced T-cell responses against HPV16 E6 and E7 were detected in six of six and five of six patients, respectively.",18172269_2,-1,1,2,-1,6375,-1,3.526672e-05,5.4089072e-05,0.9999106
6383,cytokine IFN,12,14,91,103,The vaccine-induced responses were dominated by effector type CD4(+)CD25(+)Foxp3(-) type 1 cytokine IFN gamma-producing T cells but also included the expansion of T cells with a CD4(+)CD25(+)Foxp3(+) phenotype.,18172269_4,-1,-1,-1,-1,6383,-1,0.9998653,3.9410334e-05,9.524398e-05
6388,peptides,9,10,48,56,"CONCLUSIONS: The HPV16 E6 and E7 synthetic long peptides vaccine is highly immunogenic, in that it increases the number and activity of HPV16-specific CD4(+) and CD8(+) T cells to a broad array of epitopes in all patients.",18172269_5,0,-1,2,-1,6388,-1,0.0002679747,0.9994062,0.00032579433
6391,T cells to,30,33,169,179,"CONCLUSIONS: The HPV16 E6 and E7 synthetic long peptides vaccine is highly immunogenic, in that it increases the number and activity of HPV16-specific CD4(+) and CD8(+) T cells to a broad array of epitopes in all patients.",18172269_5,-1,-1,-1,-1,6391,-1,0.001728507,0.033843298,0.9644282
6393,tumor-specific T cells,8,11,35,57,"The expansion of CD4(+) and CD8(+) tumor-specific T cells, both considered to be important in the antitumor response, indicates the immunotherapeutic potential of this vaccine.",18172269_6,-1,-1,-1,-1,6393,-1,0.005285173,0.66108567,0.33362913
6401,regulatory T-cell function,18,21,122,148,"Notably, part of the vaccine-induced T cells display a CD4(+)CD25(+)Foxp3(+) phenotype that is frequently associated with regulatory T-cell function, suggesting that strategies to disarm this subset of T cells should be considered as components of immunotherapeutic modalities against HPV-induced cancers.",18172269_7,-1,-1,-1,-1,6401,-1,4.633827e-05,7.0600436e-05,0.99988306
6404,this subset,27,29,187,198,"Notably, part of the vaccine-induced T cells display a CD4(+)CD25(+)Foxp3(+) phenotype that is frequently associated with regulatory T-cell function, suggesting that strategies to disarm this subset of T cells should be considered as components of immunotherapeutic modalities against HPV-induced cancers.",18172269_7,-1,-1,-1,-1,6404,-1,0.004050265,0.32492992,0.6710198
6410,immunity,23,24,126,134,It has been reported that an increased population of regulatory T cells (Tregs) is one of the reasons for impaired anti-tumor immunity.,18224687_0,0,-1,2,-1,6410,-1,0.99944776,0.00034106817,0.00021111446
6425,the relationship,14,16,96,112,"Furthermore, to elucidate the mechanisms behind Treg accumulation within tumors, they evaluated the relationship between CCL17 or CCL22 expression and the frequency of Foxp3(+) Tregs in gastric cancer.",18224687_3,-1,-1,-1,-1,6425,-1,1.7592633e-05,0.9999715,1.0862431e-05
6426,CCL17,17,18,121,126,"Furthermore, to elucidate the mechanisms behind Treg accumulation within tumors, they evaluated the relationship between CCL17 or CCL22 expression and the frequency of Foxp3(+) Tregs in gastric cancer.",18224687_3,0,-1,2,-1,6426,-1,0.9840005,0.00050581375,0.015493741
6435,CCL17,19,20,112,117,"Moreover, an in vitro migration assay using Tregs derived from gastric cancers was performed in the presence of CCL17 or CCL22.",18224687_5,0,-1,2,-1,6435,-1,0.963446,0.001365127,0.035188846
6441,than that,15,17,78,87,"As a result, the frequency of Foxp3(+) Tregs in TILs was significantly higher than that in normal gastric mucosa (12.4% +/- 7.5% vs. 4.1% +/- 5.3%, p < 0.01).",18224687_6,-1,-1,-1,-1,6441,-1,2.3121707e-05,0.99996305,1.3851205e-05
6445,to the,9,11,52,58,"Importantly, the increase in Tregs in TILs occurred to the same extent in early and advanced disease.",18224687_7,-1,-1,-1,-1,6445,-1,2.4795012e-05,0.9999645,1.0724006e-05
6447,CCL17(+,5,6,30,37,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal gastric mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) Tregs in TILs.",18224687_8,0,-1,2,-1,6447,-1,0.98861676,0.0010310531,0.010352091
6452,than that,20,22,116,125,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal gastric mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) Tregs in TILs.",18224687_8,-1,-1,-1,-1,6452,-1,2.1813337e-05,0.99996495,1.3276767e-05
6455,CCL17(+,37,38,217,224,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal gastric mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) Tregs in TILs.",18224687_8,0,-1,2,-1,6455,-1,0.98889446,0.0009683576,0.010137206
6462,that Tregs,9,11,52,62,"In addition, the in vitro migration assay indicated that Tregs were significantly induced to migrate by CCL17 or CCL22.",18224687_9,-1,-1,-1,-1,6462,-1,2.152258e-05,0.999969,9.4289635e-06
6464,CCL17,17,18,104,109,"In addition, the in vitro migration assay indicated that Tregs were significantly induced to migrate by CCL17 or CCL22.",18224687_9,0,-1,2,-1,6464,-1,0.9696964,0.0027787671,0.027524866
6466,CCL17,3,4,15,20,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) Tregs, with such an observation occurring in early gastric cancer.",18224687_10,0,-1,2,-1,6466,-1,0.9642536,0.0012241045,0.034522288
6468,the tumor,7,9,38,47,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) Tregs, with such an observation occurring in early gastric cancer.",18224687_10,-1,-1,-1,-1,6468,-1,2.1984157e-05,0.99996436,1.3698497e-05
6469,related to the,10,13,52,66,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) Tregs, with such an observation occurring in early gastric cancer.",18224687_10,-1,-1,-1,-1,6469,-1,2.5630772e-05,0.99995935,1.5020294e-05
6475,therapy,8,9,45,52,Here we report the effects of systemic IL-21 therapy on the immune system in two phase 1 trials with this novel cytokine.,18286285_1,0,1,-1,-1,6475,-1,2.0999636e-05,0.9999677,1.1288658e-05
6482,two planned treatment,20,23,132,153,EXPERIMENTAL DESIGN: Recombinant IL-21 was administered by intravenous bolus injection at dose levels from 1 to 100 microg/kg using two planned treatment regimens: thrice weekly for 6 weeks (3/week); or once daily for five consecutive days followed by nine dose-free days (5 + 9).,18286285_2,-1,-1,-1,-1,6482,-1,3.5150206e-05,0.99994874,1.6105434e-05
6485,blood,7,8,52,57,"The following biomarkers were studied in peripheral blood mononuclear cells (PBMC) during treatment: phosphorylation of STAT3, alterations in the composition of leukocyte subsets, ex vivo cytotoxicity, expression of effector molecules in enriched CD8(+) T cells and CD56(+) NK cells by quantitative RT-PCR, and gene array profiling of CD8(+) T cells.",18286285_3,0,1,-1,-1,6485,-1,0.00014491432,0.9993506,0.00050443015
6501,transcriptome analysis,4,6,18,40,"In addition, full transcriptome analysis of CD8(+) T cells displayed changes in several transcripts associated with increased cell cycle progression, cellular motility, and immune activation.",18286285_7,-1,-1,-1,-1,6501,-1,2.6963962e-05,0.9999534,1.964096e-05
6508,cells to,12,14,74,82,"Finally, cytotoxicity assays showed that IL-21 enhanced the ability of NK cells to kill sensitive targets ex vivo.",18286285_8,-1,-1,-1,-1,6508,-1,0.0027164463,0.1112493,0.8860343
6520,cell function,25,27,167,180,"As CD4+CD25highFoxp3+ naturally occurring T regulatory cells in melanoma patients express ICOS, we investigated the impact of ICOS on naturally occurring T regulatory cell function.",18292519_1,-1,-1,-1,-1,6520,-1,8.143805e-05,0.00012023614,0.99979836
6525,tumor-infiltrating lymphocytes,22,24,116,146,METHODS: Expression of ICOS and T regulatory (Treg) cell markers was determined on CD4+CD25high T cells in PBMC and tumor-infiltrating lymphocytes from melanoma patients (n=10) and PBMC of normal controls (n=10) by multicolor flow cytometry.,18292519_2,-1,-1,-1,-1,6525,-1,0.0034476335,0.8821885,0.11436386
6537,tumor-infiltrating lymphocytes,19,21,116,146,"ICOShigh and ICOS- Treg were also expanded under conditions previously shown to induce Tr1 from RC.RESULTS: Treg in tumor-infiltrating lymphocytes expressed ICOS (mean fluorescence intensity=70+/-10), while Treg in PBMC had low ICOS expression (mean fluorescence intensity=3.5+/-2.5, p<or=0.001).",18292519_6,-1,-1,-1,-1,6537,-1,0.0042907875,0.8352782,0.160431
6541,relative to,19,21,101,112,ICOShigh Treg up-regulated Treg markers (p<or=0.0016) and mediated stronger suppression (p<or=0.001) relative to ICOSlow Treg.,18292519_7,-1,-1,-1,-1,6541,-1,2.4062796e-05,0.999962,1.3952001e-05
6544,Tr1 cells,3,5,22,31,ICOShigh Treg induced Tr1 cells in nonactivated RC and Th2 cells in preactivated RC.,18292519_8,-1,-1,-1,-1,6544,-1,0.0005441061,0.015610125,0.98384583
6547,to Tr1 cytokines,3,6,22,38,"ICOShigh Treg exposed to Tr1 cytokines expressed IL-10 and suppressed RC (92+/-12%) in contrast to ICOSlow Treg, which mediated low suppression (21+/-15%; p<or=0.0028).CONCLUSION: ICOShigh Treg can induce diverse immune responses in RC, depending on activation signals and cytokines present.",18292519_9,-1,-1,-1,-1,6547,-1,0.04916837,0.9482235,0.0026081281
6561,Treg transit to Tr1,9,13,37,56,"In a ""Tr1"" cytokine milieu, ICOShigh Treg transit to Tr1.",18292519_11,-1,-1,-1,-1,6561,-1,2.7877351e-05,0.9999472,2.4927185e-05
6562,T-cell,1,2,6,12,Adult T-cell leukemia/lymphoma is an aggressive lymphoproliferative disorder of CD4+ T lymphocytes associated with human T-cell leukemia virus type 1 (HTLV-I) infection.,18300056_0,-1,1,2,-1,6562,-1,3.9388142e-05,6.7221714e-05,0.9998934
6564,T-cell,16,17,121,127,Adult T-cell leukemia/lymphoma is an aggressive lymphoproliferative disorder of CD4+ T lymphocytes associated with human T-cell leukemia virus type 1 (HTLV-I) infection.,18300056_0,-1,1,2,-1,6564,-1,5.1746996e-05,9.6812204e-05,0.99985147
6572,to the,4,6,25,31,Recent advances have led to the identification of key molecules and cellular pathways involved in HTLV-1 mediated cellular transformation and tumor progression.,18300056_3,-1,-1,-1,-1,6572,-1,2.1172858e-05,0.9999678,1.1048358e-05
6574,cellular transformation,17,19,114,137,Recent advances have led to the identification of key molecules and cellular pathways involved in HTLV-1 mediated cellular transformation and tumor progression.,18300056_3,-1,-1,-1,-1,6574,-1,0.00038135232,0.0074468646,0.99217176
6579,targets that,21,23,130,142,"We describe within a few key elements that contribute to neoplastic development of ATL, in addition to interesting molecular drug targets that may lead to more effective therapeutic strategies.",18300056_4,-1,-1,-1,-1,6579,-1,2.5171115e-05,0.9999616,1.3192878e-05
6588,therapeutic tumor-infiltrating lymphocytes,36,39,199,241,"The exact role of CD4+CD25(high) regulatory T cells (Treg) in adoptive immunotherapy of melanoma is still to be determined, and an association between an expansion of Treg cells and the expansion of therapeutic tumor-infiltrating lymphocytes (TIL) remains unelucidated.",18312383_0,-1,-1,-1,-1,6588,-1,0.0029251692,0.92522734,0.07184747
6593,functional Treg cells,13,16,63,84,"In this context, the aim of our study was to determine whether functional Treg cells were detectable and amplified among in vitro-expanded TIL from 10 metastatic melanoma lymph nodes (LNs).",18312383_1,-1,-1,-1,-1,6593,-1,0.0017606365,0.053028442,0.94521093
6599,functionality,24,25,156,169,"In this study, we investigated the expression of forkhead/winged helix transcription factor 3 (Foxp3) in melanoma-invaded LNs and determined proportion and functionality of Treg cells among TIL extracted from these 10 metastatic melanoma LNs at different steps of their in vitro expansion.",18312383_2,0,1,2,-1,6599,-1,5.1264098e-05,0.99987996,6.8794114e-05
6612,functional,3,4,13,23,"In addition, functional assays demonstrated that these CD4+CD25(high) T cells were capable of suppressing autologous CD8+ and CD4+CD25- T cell proliferation.",18312383_4,0,1,2,-1,6612,-1,4.8577986e-05,0.9999194,3.1943557e-05
6613,that these,6,8,44,54,"In addition, functional assays demonstrated that these CD4+CD25(high) T cells were capable of suppressing autologous CD8+ and CD4+CD25- T cell proliferation.",18312383_4,-1,-1,-1,-1,6613,-1,1.825104e-05,0.9999721,9.670673e-06
6616,These cells,0,2,0,11,These cells were indeed Treg cells as they expressed Foxp3.,18312383_5,-1,-1,-1,-1,6616,-1,0.0022675886,0.122600146,0.8751322
6627,the therapeutic,3,5,16,31,Here we studied the therapeutic efficacy of IL-21-gene-modified cells (Neuro2a/IL-21) in a syngeneic metastatic neuroblastoma (NB) model.,18324400_1,-1,-1,-1,-1,6627,-1,1.8890247e-05,0.999972,9.123557e-06
6650,time to,16,18,107,114,"The administration of two or three doses of Neuro2a/IL-21 cell vaccine further increased the mean survival time to 54 and 75 days, and the cure rate to 27 and 33%, respectively, whereas the use of unmodified Neuro2a or mock-transfected cells had no effect.",18324400_6,-1,-1,-1,-1,6650,-1,3.253319e-05,0.9999449,2.2587408e-05
6655,cell subset,2,4,8,19,In vivo cell subset depletion and a Winn-assay indicated the involvement of CD8 + CTLs.,18324400_7,-1,-1,-1,-1,6655,-1,3.8751048e-05,4.6041143e-05,0.99991524
6658,analysis,1,2,20,28,Immunohistochemical analysis indicated a reduction of CD31+ and VEGFR2+ microvessels in late metastases from therapeutically vaccinated mice.,18324400_8,0,1,-1,-1,6658,-1,3.060429e-05,0.9999434,2.6058151e-05
6668,therapy,41,42,261,268,"CONCLUSIONS: Our present data indicate that IL-21-secreting NB cells are effective as therapeutic vaccine in mice bearing metastatic NB, through a specific CTL response involving survivin as antigen, and suggest a potential interest for IL-21 in NB immuno-gene therapy.",18324400_10,0,1,-1,-1,6668,-1,2.11294e-05,0.9999654,1.338296e-05
6690,analysis,19,20,136,144,FoxP3+ expressing cells among CD4+CD25+ population were significantly reduced after resveratrol treatment ex vivo in intracellular FACS analysis.,18328445_4,0,1,-1,-1,6690,-1,5.8454596e-05,0.9998186,0.00012298729
6694,TGF-beta,21,22,150,158,"Single intraperitoneal administration of 4 mg/kg resveratrol suppressed the CD4+CD25+ cell population among CD4+ cells and downregulated secretion of TGF-beta, an immunosuppressive cytokine, measured from the spleens of tumor-bearing mice.",18328445_5,0,1,-1,-1,6694,-1,6.219655e-05,0.99991715,2.0621905e-05
6701,Taken together,0,2,0,14,"Taken together, these results suggest that resveratrol has a suppressive role on CD4+CD25+ cell population and makes peritumoral microenvironment unfavorable to tumor in tumor-bearing mice.",18328445_7,-1,-1,-1,-1,6701,-1,4.052931e-05,0.999944,1.546999e-05
6705,to tumor,22,24,158,166,"Taken together, these results suggest that resveratrol has a suppressive role on CD4+CD25+ cell population and makes peritumoral microenvironment unfavorable to tumor in tumor-bearing mice.",18328445_7,-1,-1,-1,-1,6705,-1,3.6168058e-05,0.99994934,1.4510562e-05
6708,therapy,13,14,95,102,"Thus, resveratrol can be considered as possible adjuvant material for vaccination-based cancer therapy.",18328445_8,0,1,-1,-1,6708,-1,2.9162216e-05,0.99995494,1.591295e-05
6713,tumor-specific TGF-beta-producing,14,16,82,115,There is limited information on the influence of tumor growth on the expansion of tumor-specific TGF-beta-producing CD4(+) T cells in humans.,18354237_0,-1,-1,-1,-1,6713,-1,8.258002e-05,0.99988186,3.5572037e-05
6718,T cells that,15,18,86,98,"In this study, we report the identification and characterization of subsets of CD4(+) T cells that recognize an epitope within the AFP sequence (AFP(46-55)) and develop into TGF-beta-producing CD4(+) T cells.",18354237_2,-1,-1,-1,-1,6718,-1,0.0014298845,0.030743899,0.96782625
6720,TGF-beta-producing,34,35,174,192,"In this study, we report the identification and characterization of subsets of CD4(+) T cells that recognize an epitope within the AFP sequence (AFP(46-55)) and develop into TGF-beta-producing CD4(+) T cells.",18354237_2,0,1,-1,-1,6720,-1,5.4492262e-05,0.9999138,3.1647432e-05
6722,peptide-specific,2,3,5,21,"In a peptide-specific and dose-dependent manner, AFP(46-55) CD4(+) T cells produce TGF-beta, GM-CSF, and IL-2 but not Th1-, Th2-, Th17-, or Tr1-type cytokines.",18354237_3,0,-1,2,-1,6722,-1,7.942484e-05,0.99988294,3.7641283e-05
6724,TGF-beta,16,17,83,91,"In a peptide-specific and dose-dependent manner, AFP(46-55) CD4(+) T cells produce TGF-beta, GM-CSF, and IL-2 but not Th1-, Th2-, Th17-, or Tr1-type cytokines.",18354237_3,0,1,-1,-1,6724,-1,7.347521e-05,0.9998902,3.6362602e-05
6729,Tr1-type cytokines,31,33,140,158,"In a peptide-specific and dose-dependent manner, AFP(46-55) CD4(+) T cells produce TGF-beta, GM-CSF, and IL-2 but not Th1-, Th2-, Th17-, or Tr1-type cytokines.",18354237_3,-1,-1,-1,-1,6729,-1,0.036074527,0.95939296,0.0045324564
6730,These cells,0,2,0,11,These cells express CTLA-4 and glucocorticoid-induced TNR receptor and inhibit T cell proliferation in a contact-dependent manner.,18354237_4,-1,-1,-1,-1,6730,-1,0.0029940172,0.16910328,0.82790273
6732,TNR receptor,6,8,54,66,These cells express CTLA-4 and glucocorticoid-induced TNR receptor and inhibit T cell proliferation in a contact-dependent manner.,18354237_4,-1,-1,-1,-1,6732,-1,0.0006355255,0.98346126,0.015903175
6735,that the,6,8,23,31,"In this study, we show that the frequency of AFP(46-55) CD4(+) T cells is significantly higher (p = 001) in patients with hepatocellular carcinoma than in healthy donors, suggesting that these cells are expanded in response to tumor Ag.",18354237_5,-1,-1,-1,-1,6735,-1,1.6474612e-05,0.9999752,8.379414e-06
6738,that these cells,37,40,182,198,"In this study, we show that the frequency of AFP(46-55) CD4(+) T cells is significantly higher (p = 001) in patients with hepatocellular carcinoma than in healthy donors, suggesting that these cells are expanded in response to tumor Ag.",18354237_5,-1,-1,-1,-1,6738,-1,0.0029716038,0.83533895,0.16168949
6739,to tumor,44,46,224,232,"In this study, we show that the frequency of AFP(46-55) CD4(+) T cells is significantly higher (p = 001) in patients with hepatocellular carcinoma than in healthy donors, suggesting that these cells are expanded in response to tumor Ag.",18354237_5,-1,-1,-1,-1,6739,-1,2.1207186e-05,0.99996936,9.397188e-06
6741,treatments that,5,7,37,52,"In contrast, tumor necrosis-inducing treatments that are shown to improve survival rate can shift the Th1/TGF-beta-producing CD4(+) T cell balance in favor of Th1 responses.",18354237_6,-1,-1,-1,-1,6741,-1,2.2056647e-05,0.99996805,9.909138e-06
6746,that tumor,3,5,21,31,"Our data demonstrate that tumor Ags may contain epitopes which activate the expansion of inducible regulatory T cells, leading to evasion of tumor control.",18354237_7,-1,-1,-1,-1,6746,-1,2.0399848e-05,0.9999703,9.301118e-06
6751,typhimurium to,6,8,48,62,"Vaccines are delivered by attenuated Salmonella typhimurium to secondary lymphoid organs and respectively target vascular endothelial growth factor receptor-2, transcription factor Fos-related antigen-1, anti-apoptosis protein survivin and Legumain, an asparaginyl endopeptidase specifically overexpressed on tumor-associated macrophages (TAMs) in the tumor microenvironment (TME).",18363997_1,-1,-1,-1,-1,6751,-1,4.143777e-05,0.9999355,2.3000071e-05
6753,growth factor receptor-2,16,19,134,158,"Vaccines are delivered by attenuated Salmonella typhimurium to secondary lymphoid organs and respectively target vascular endothelial growth factor receptor-2, transcription factor Fos-related antigen-1, anti-apoptosis protein survivin and Legumain, an asparaginyl endopeptidase specifically overexpressed on tumor-associated macrophages (TAMs) in the tumor microenvironment (TME).",18363997_1,-1,-1,-1,-1,6753,-1,0.13231306,0.33036563,0.5373213
6754,transcription factor Fos-related antigen-1,20,24,160,202,"Vaccines are delivered by attenuated Salmonella typhimurium to secondary lymphoid organs and respectively target vascular endothelial growth factor receptor-2, transcription factor Fos-related antigen-1, anti-apoptosis protein survivin and Legumain, an asparaginyl endopeptidase specifically overexpressed on tumor-associated macrophages (TAMs) in the tumor microenvironment (TME).",18363997_1,-1,-1,-1,-1,6754,-1,0.00042230447,0.9986505,0.000927246
6755,protein,26,27,219,226,"Vaccines are delivered by attenuated Salmonella typhimurium to secondary lymphoid organs and respectively target vascular endothelial growth factor receptor-2, transcription factor Fos-related antigen-1, anti-apoptosis protein survivin and Legumain, an asparaginyl endopeptidase specifically overexpressed on tumor-associated macrophages (TAMs) in the tumor microenvironment (TME).",18363997_1,0,1,-1,-1,6755,-1,0.00046645294,0.99936694,0.00016662318
6758,the tumor,43,45,348,357,"Vaccines are delivered by attenuated Salmonella typhimurium to secondary lymphoid organs and respectively target vascular endothelial growth factor receptor-2, transcription factor Fos-related antigen-1, anti-apoptosis protein survivin and Legumain, an asparaginyl endopeptidase specifically overexpressed on tumor-associated macrophages (TAMs) in the tumor microenvironment (TME).",18363997_1,-1,-1,-1,-1,6758,-1,1.9308962e-05,0.9999715,9.219344e-06
6762,immunity,10,11,75,83,"These vaccines are all capable of inducing potent cell-mediated protective immunity against self-antigens, resulting in marked suppression of tumor growth and dissemination.",18363997_2,0,-1,2,-1,6762,-1,0.998692,0.0009454374,0.00036268804
6765,the tumor,13,15,94,103,"Key mechanisms induced by these DNA vaccines include efficient suppression of angiogenesis in the tumor vasculature and marked activation of cytotoxic T cells, natural killer cells, and antigen-presenting dendritic cells.",18363997_3,-1,-1,-1,-1,6765,-1,2.055991e-05,0.99996865,1.073587e-05
6776,the TME,17,19,106,113,The vaccine targeting Legumain establishes the new paradigm whereby a reduction in the density of TAMs in the TME decreases the release of factors potentiating tumor growth and angiogenesis.,18363997_4,-1,-1,-1,-1,6776,-1,2.5277355e-05,0.999962,1.2734638e-05
6777,the release,20,22,124,135,The vaccine targeting Legumain establishes the new paradigm whereby a reduction in the density of TAMs in the TME decreases the release of factors potentiating tumor growth and angiogenesis.,18363997_4,-1,-1,-1,-1,6777,-1,3.0705593e-05,0.9999578,1.152289e-05
6778,factors,23,24,139,146,The vaccine targeting Legumain establishes the new paradigm whereby a reduction in the density of TAMs in the TME decreases the release of factors potentiating tumor growth and angiogenesis.,18363997_4,0,1,-1,-1,6778,-1,0.999186,0.00045171063,0.00036232645
6782,the TME,6,8,24,31,"This, in turn, remodels the TME and decreases its immunosuppressive milieu and thereby potentiates the DNA vaccine's ability to effectively suppress tumor cell proliferation, vascularization, and metastasis.",18363997_5,-1,-1,-1,-1,6782,-1,2.9002511e-05,0.99995387,1.7127597e-05
6786,tumor cell,24,26,149,159,"This, in turn, remodels the TME and decreases its immunosuppressive milieu and thereby potentiates the DNA vaccine's ability to effectively suppress tumor cell proliferation, vascularization, and metastasis.",18363997_5,-1,-1,-1,-1,6786,-1,0.0045537986,0.3344051,0.66104114
6790,the treatment,18,20,110,123,It is anticipated that such research efforts will lead to novel DNA-based vaccines that will be effective for the treatment of cancer.,18363997_6,-1,-1,-1,-1,6790,-1,2.7182748e-05,0.9999608,1.2007958e-05
6791,analysis,2,3,14,22,"A comparative analysis of vaccination with irradiated, murine tumor cells engineered to express a large number of immunostimulatory molecules established the superior ability of granulocyte-macrophage colony-stimulating factor (GM-CSF) to evoke potent, specific, and long-lasting anti-tumor immunity.",18364009_0,0,1,-1,-1,6791,-1,3.6609254e-05,0.9999404,2.3039634e-05
6792,tumor cells,9,11,62,73,"A comparative analysis of vaccination with irradiated, murine tumor cells engineered to express a large number of immunostimulatory molecules established the superior ability of granulocyte-macrophage colony-stimulating factor (GM-CSF) to evoke potent, specific, and long-lasting anti-tumor immunity.",18364009_0,-1,-1,-1,-1,6792,-1,0.0040471894,0.34714168,0.6488111
6798,immunity,40,41,291,299,"A comparative analysis of vaccination with irradiated, murine tumor cells engineered to express a large number of immunostimulatory molecules established the superior ability of granulocyte-macrophage colony-stimulating factor (GM-CSF) to evoke potent, specific, and long-lasting anti-tumor immunity.",18364009_0,0,-1,2,-1,6798,-1,0.99719006,0.0022691048,0.00054085546
6809,immunity,8,9,69,77,More detailed investigations of the mechanisms underlying protective immunity in murine systems together with the characterization of the anti-tumor reactions of patients who achieved durable clinical benefits in response to immunotherapy uncovered several pathways that restrain the efficacy of GM-CSF-secreting tumor cell vaccines.,18364009_3,0,-1,2,-1,6809,-1,0.5615939,0.43646786,0.0019382536
6816,GM-CSF-secreting tumor cell,39,42,296,323,More detailed investigations of the mechanisms underlying protective immunity in murine systems together with the characterization of the anti-tumor reactions of patients who achieved durable clinical benefits in response to immunotherapy uncovered several pathways that restrain the efficacy of GM-CSF-secreting tumor cell vaccines.,18364009_3,-1,-1,-1,-1,6816,-1,0.80446345,0.0055125062,0.19002403
6818,growth factor protein-8,6,9,41,64,"These include milk fat globule epidermal growth factor protein-8 expansion of forkhead box protein 3+ regulatory T cells, cytotoxic T-lymphocyte antigen-4-mediated negative costimulation, and soluble major histocompatibility complex class I chain-related protein A suppression of NKG2D-dependent innate and adaptive anti-tumor cytotoxicity.",18364009_4,-1,-1,-1,-1,6818,-1,0.9991702,0.0003485546,0.00048127444
6820,protein,13,14,91,98,"These include milk fat globule epidermal growth factor protein-8 expansion of forkhead box protein 3+ regulatory T cells, cytotoxic T-lymphocyte antigen-4-mediated negative costimulation, and soluble major histocompatibility complex class I chain-related protein A suppression of NKG2D-dependent innate and adaptive anti-tumor cytotoxicity.",18364009_4,0,1,-1,-1,6820,-1,6.1377104e-05,0.9998847,5.3833606e-05
6822,cytotoxic T-lymphocyte antigen-4-mediated,20,23,122,163,"These include milk fat globule epidermal growth factor protein-8 expansion of forkhead box protein 3+ regulatory T cells, cytotoxic T-lymphocyte antigen-4-mediated negative costimulation, and soluble major histocompatibility complex class I chain-related protein A suppression of NKG2D-dependent innate and adaptive anti-tumor cytotoxicity.",18364009_4,-1,-1,-1,-1,6822,-1,0.017162228,0.0011277451,0.98171014
6824,protein,34,35,255,262,"These include milk fat globule epidermal growth factor protein-8 expansion of forkhead box protein 3+ regulatory T cells, cytotoxic T-lymphocyte antigen-4-mediated negative costimulation, and soluble major histocompatibility complex class I chain-related protein A suppression of NKG2D-dependent innate and adaptive anti-tumor cytotoxicity.",18364009_4,0,1,-1,-1,6824,-1,9.368149e-05,0.99981886,8.75034e-05
6829,therapies that,17,19,136,150,"Together, these results define key regulatory circuits that attenuate immune-mediated tumor destruction and suggest novel combinatorial therapies that might enhance the clinical activity of GM-CSF-secreting tumor cell vaccines.",18364009_5,-1,-1,-1,-1,6829,-1,2.0950385e-05,0.9999695,9.558474e-06
6831,GM-CSF-secreting tumor cell,25,28,190,217,"Together, these results define key regulatory circuits that attenuate immune-mediated tumor destruction and suggest novel combinatorial therapies that might enhance the clinical activity of GM-CSF-secreting tumor cell vaccines.",18364009_5,-1,-1,-1,-1,6831,-1,0.7747349,0.00544325,0.2198218
6836,that interleukin,2,4,15,31,We demonstrate that interleukin (IL)-9 has an important role in this process.,18378796_2,-1,-1,-1,-1,6836,-1,0.16529566,0.82828426,0.0064200773
6850,that IL-9-mediated,42,44,304,322,"In addition, intestinal IL-9 overexpression predisposes to oral antigen sensitization, which requires mast cells and increased intestinal permeability. These observations demonstrate a central role for IL-9 and mast cells in experimental intestinal permeability in oral antigen sensitization and suggest that IL-9-mediated mast cell responses have an important role in food allergy.",18378796_4,-1,-1,-1,-1,6850,-1,0.008339617,0.9889008,0.002759559
6853,related to the,9,12,57,71,"One of the major limitations for cancer immunotherapy is related to the frequent existence of an intra-tumoral immunosuppressive environment, to which STAT3 (Signal transducer and activator of transcription-3) activation in tumor and dendritic cells (DCs) are believed to contribute.",18392040_0,-1,-1,-1,-1,6853,-1,2.1652313e-05,0.99996674,1.1553298e-05
6863,tested the,5,7,18,28,"In this study, we tested the hypothesis that the combination of CpG (a DC activator) and JSI-124 (a STAT3 inhibitor) may generate synergistic antitumor effects compared to CpG or JSI-124 alone.",18392040_1,-1,-1,-1,-1,6863,-1,1.9628427e-05,0.99997115,9.161031e-06
6864,that the,8,10,40,48,"In this study, we tested the hypothesis that the combination of CpG (a DC activator) and JSI-124 (a STAT3 inhibitor) may generate synergistic antitumor effects compared to CpG or JSI-124 alone.",18392040_1,-1,-1,-1,-1,6864,-1,1.6822449e-05,0.9999758,7.389736e-06
6872,then tumor-bearing,19,21,106,124,"B16-F10, a mouse melanoma cell line that has constitutively active STAT3, was grafted in C57BL/6 mice and then tumor-bearing mice treated intra-tumorally with (a) phosphate buffered saline, (b) 10 microg CpG, (c) 1 mg kg(-1) JSI-124 or (d) 10 microg CpG+1 mg kg(-1) JSI-124.",18392040_2,-1,-1,-1,-1,6872,-1,2.3304903e-05,0.99996614,1.0516543e-05
6885,therapy,7,8,49,56,"Correlating with these findings, the combination therapy resulted in significantly higher intra-tumoral levels of several proinflammatory, TH1-related cytokines (including IL-12, IFN-gamma, TNF-alpha and IL-2), increases in intra-tumoral CD8+ and CD4+ T cells expressing activation/memory markers and NK cells and increases in activated DCs in the tumors and regional lymph nodes (LNs).",18392040_5,0,1,-1,-1,6885,-1,2.0051366e-05,0.99996924,1.0717228e-05
6886,TH1-related cytokines,18,20,139,160,"Correlating with these findings, the combination therapy resulted in significantly higher intra-tumoral levels of several proinflammatory, TH1-related cytokines (including IL-12, IFN-gamma, TNF-alpha and IL-2), increases in intra-tumoral CD8+ and CD4+ T cells expressing activation/memory markers and NK cells and increases in activated DCs in the tumors and regional lymph nodes (LNs).",18392040_5,-1,-1,-1,-1,6886,-1,0.050457396,0.94279575,0.0067468714
6889,TNF-alpha,26,27,190,199,"Correlating with these findings, the combination therapy resulted in significantly higher intra-tumoral levels of several proinflammatory, TH1-related cytokines (including IL-12, IFN-gamma, TNF-alpha and IL-2), increases in intra-tumoral CD8+ and CD4+ T cells expressing activation/memory markers and NK cells and increases in activated DCs in the tumors and regional lymph nodes (LNs).",18392040_5,0,1,-1,-1,6889,-1,0.1692367,0.82802707,0.0027361973
6892,the tumors,53,55,344,354,"Correlating with these findings, the combination therapy resulted in significantly higher intra-tumoral levels of several proinflammatory, TH1-related cytokines (including IL-12, IFN-gamma, TNF-alpha and IL-2), increases in intra-tumoral CD8+ and CD4+ T cells expressing activation/memory markers and NK cells and increases in activated DCs in the tumors and regional lymph nodes (LNs).",18392040_5,-1,-1,-1,-1,6892,-1,1.9439138e-05,0.9999691,1.1469114e-05
6894,therapy,4,5,31,38,"Concomitantly, the combination therapy led to a significantly decreased level of immunosuppression, as evidenced by lower intra-tumoral level of VEGF and TGF-beta, and decreased number of CD4+CD25+Foxp3+ regulatory T cells in the regional LNs.",18392040_6,0,1,-1,-1,6894,-1,2.2038323e-05,0.99996376,1.423877e-05
6896,TGF-beta,23,24,154,162,"Concomitantly, the combination therapy led to a significantly decreased level of immunosuppression, as evidenced by lower intra-tumoral level of VEGF and TGF-beta, and decreased number of CD4+CD25+Foxp3+ regulatory T cells in the regional LNs.",18392040_6,0,1,-1,-1,6896,-1,0.00013814493,0.9998253,3.6636087e-05
6904,immunity,14,15,101,109,Oncolytic viruses can exert their antitumor activity via direct oncolysis or activation of antitumor immunity.,18424722_0,0,-1,2,-1,6904,-1,0.999343,0.0003910034,0.0002659839
6905,the treatment,8,10,64,77,"Although reovirus is currently under clinical investigation for the treatment of localized or disseminated cancer, any potential immune contribution to its efficacy has not been addressed.",18424722_1,-1,-1,-1,-1,6905,-1,2.3834604e-05,0.9999665,9.621137e-06
6916,cytokines IFN-alpha,11,13,84,103,"Reovirus induced DC maturation and stimulated the production of the proinflammatory cytokines IFN-alpha, TNF-alpha, IL-12p70, and IL-6.",18424722_3,-1,-1,-1,-1,6916,-1,0.99986756,3.9259845e-05,9.321052e-05
6917,TNF-alpha,14,15,105,114,"Reovirus induced DC maturation and stimulated the production of the proinflammatory cytokines IFN-alpha, TNF-alpha, IL-12p70, and IL-6.",18424722_3,0,1,-1,-1,6917,-1,0.04537801,0.9533455,0.0012764673
6925,T cell cytokine,13,16,94,109,"Moreover, short-term coculture of reovirus-activated DC with autologous T cells also enhanced T cell cytokine secretion (IL-2 and IFN-gamma) and induced non-Ag restricted tumor cell killing.",18424722_6,-1,-1,-1,-1,6925,-1,0.05074842,0.0012462204,0.94800544
6927,tumor cell,26,28,171,181,"Moreover, short-term coculture of reovirus-activated DC with autologous T cells also enhanced T cell cytokine secretion (IL-2 and IFN-gamma) and induced non-Ag restricted tumor cell killing.",18424722_6,-1,-1,-1,-1,6927,-1,0.0034206468,0.274044,0.7225354
6930,time that,6,8,37,46,"These data demonstrate for the first time that reovirus directly activates human DC and that reovirus-activated DC stimulate innate killing by not only NK cells, but also T cells, suggesting a novel potential role for T cells in oncolytic virus-induced local tumor cell death.",18424722_7,-1,-1,-1,-1,6930,-1,2.1790465e-05,0.99996495,1.3269604e-05
6935,tumor cell,43,45,259,269,"These data demonstrate for the first time that reovirus directly activates human DC and that reovirus-activated DC stimulate innate killing by not only NK cells, but also T cells, suggesting a novel potential role for T cells in oncolytic virus-induced local tumor cell death.",18424722_7,-1,-1,-1,-1,6935,-1,0.003943522,0.365243,0.6308135
6949,tissues,14,15,82,89,"However, the identification of Tregs in an ongoing immune response or in inflamed tissues remains elusive.",18424726_1,-1,1,2,-1,6949,-1,0.0005096172,0.9747379,0.02475245
6950,that TIRC7,3,5,25,35,"Our experiments indicate that TIRC7, T cell immune response cDNA 7, a novel membrane molecule involved in the regulation of T lymphocyte activation, identifies two Treg subsets (CD25(low)TIRC7(+) and CD25(high)TIRC7(-)) that are characterized by the expression of Foxp3 and a suppressive activity in vitro and in vivo.",18424726_2,-1,-1,-1,-1,6950,-1,5.1082363e-05,0.9998828,6.606351e-05
6951,T cell immune response,6,10,37,59,"Our experiments indicate that TIRC7, T cell immune response cDNA 7, a novel membrane molecule involved in the regulation of T lymphocyte activation, identifies two Treg subsets (CD25(low)TIRC7(+) and CD25(high)TIRC7(-)) that are characterized by the expression of Foxp3 and a suppressive activity in vitro and in vivo.",18424726_2,-1,-1,-1,-1,6951,-1,0.11647299,0.0029126974,0.88061434
6952,the regulation,19,21,106,120,"Our experiments indicate that TIRC7, T cell immune response cDNA 7, a novel membrane molecule involved in the regulation of T lymphocyte activation, identifies two Treg subsets (CD25(low)TIRC7(+) and CD25(high)TIRC7(-)) that are characterized by the expression of Foxp3 and a suppressive activity in vitro and in vivo.",18424726_2,-1,-1,-1,-1,6952,-1,2.2110813e-05,0.99996424,1.36391445e-05
6954,two Treg subsets,27,30,160,176,"Our experiments indicate that TIRC7, T cell immune response cDNA 7, a novel membrane molecule involved in the regulation of T lymphocyte activation, identifies two Treg subsets (CD25(low)TIRC7(+) and CD25(high)TIRC7(-)) that are characterized by the expression of Foxp3 and a suppressive activity in vitro and in vivo.",18424726_2,-1,-1,-1,-1,6954,-1,0.0041366904,0.43698362,0.55887973
6958,that the,3,5,15,23,"We also showed that the CD25(low)TIRC7(+) subset represents IL-10-secreting Tregs in steady state, which is accumulated intratumorally in a tumor-bearing mice model.",18424726_3,-1,-1,-1,-1,6958,-1,1.6654358e-05,0.99997365,9.70019e-06
6960,IL-10-secreting Tregs,9,11,60,81,"We also showed that the CD25(low)TIRC7(+) subset represents IL-10-secreting Tregs in steady state, which is accumulated intratumorally in a tumor-bearing mice model.",18424726_3,-1,-1,-1,-1,6960,-1,0.9792484,0.016942265,0.003809275
6968,these IL-10-secreting cells,2,5,15,42,"Interestingly, these IL-10-secreting cells derived from the CD25(high)TIRC7(-) subset, both in vitro and in vivo, in response to tumoral Ags.",18424726_5,-1,-1,-1,-1,6968,-1,0.029868579,0.23291817,0.73721325
6971,to tumoral,21,23,126,136,"Interestingly, these IL-10-secreting cells derived from the CD25(high)TIRC7(-) subset, both in vitro and in vivo, in response to tumoral Ags.",18424726_5,-1,-1,-1,-1,6971,-1,2.7873435e-05,0.99995935,1.2788727e-05
6975,natural Tregs,13,15,69,82,"Our present results strongly support the notion that, in the pool of natural Tregs, some cells can recognize foreign Ags and that this recognition is an essential step in their expansion and suppressive activity in vivo.",18424726_6,-1,-1,-1,-1,6975,-1,2.9635858e-05,0.99995756,1.282658e-05
6977,that this,23,25,125,134,"Our present results strongly support the notion that, in the pool of natural Tregs, some cells can recognize foreign Ags and that this recognition is an essential step in their expansion and suppressive activity in vivo.",18424726_6,-1,-1,-1,-1,6977,-1,2.2291428e-05,0.9999677,1.0041394e-05
6979,life-threatening,4,5,31,47,Colorectal cancer represents a life-threatening complication of inflammatory bowel diseases.,18473765_0,0,-1,2,-1,6979,-1,0.00016335488,0.99976915,6.755878e-05
6981,that the,2,4,20,28,Statistics indicate that the risk to develop colorectal cancer is higher in patients affected by ulcerative colitis and to a lesser extent by Crohn's disease and that such a risk is directly proportional to the number of years of active disease.,18473765_1,-1,-1,-1,-1,6981,-1,1.7692775e-05,0.9999733,8.998008e-06
6985,to the,34,36,204,210,Statistics indicate that the risk to develop colorectal cancer is higher in patients affected by ulcerative colitis and to a lesser extent by Crohn's disease and that such a risk is directly proportional to the number of years of active disease.,18473765_1,-1,-1,-1,-1,6985,-1,2.4055898e-05,0.99996233,1.361026e-05
6993,that the release,5,8,32,48,"Indeed from the initial concept that the release of free radicals during inflammation might induce the accumulation of genetic mutations thus leading to the onset of dysplastic cells, it is now becoming clear that the large amount of cytokines and growth factors released during inflammation by immune and non immune cells may influence the carcinogenesis process.",18473765_4,-1,-1,-1,-1,6993,-1,2.463739e-05,0.9999645,1.0863888e-05
6997,to the,22,24,150,156,"Indeed from the initial concept that the release of free radicals during inflammation might induce the accumulation of genetic mutations thus leading to the onset of dysplastic cells, it is now becoming clear that the large amount of cytokines and growth factors released during inflammation by immune and non immune cells may influence the carcinogenesis process.",18473765_4,-1,-1,-1,-1,6997,-1,2.1139707e-05,0.9999696,9.23417e-06
6999,that the,34,36,209,217,"Indeed from the initial concept that the release of free radicals during inflammation might induce the accumulation of genetic mutations thus leading to the onset of dysplastic cells, it is now becoming clear that the large amount of cytokines and growth factors released during inflammation by immune and non immune cells may influence the carcinogenesis process.",18473765_4,-1,-1,-1,-1,6999,-1,2.15165e-05,0.99996877,9.661182e-06
7001,factors released,42,44,255,271,"Indeed from the initial concept that the release of free radicals during inflammation might induce the accumulation of genetic mutations thus leading to the onset of dysplastic cells, it is now becoming clear that the large amount of cytokines and growth factors released during inflammation by immune and non immune cells may influence the carcinogenesis process.",18473765_4,-1,-1,-1,-1,7001,-1,0.911548,0.08462746,0.0038246193
7011,the nuclear factor kappa B,5,10,28,54,"Moreover, the activation of the nuclear factor kappa B (NF kappa B), a transcription factor activated by several cytokines released during inflammation and responsible for many of their proinflammatory effects, have been shown to promote the growth of the colon tumors in experimental models.",18473765_6,-1,-1,-1,-1,7011,-1,2.3712917e-05,0.9999615,1.4803317e-05
7013,cytokines released,22,24,113,131,"Moreover, the activation of the nuclear factor kappa B (NF kappa B), a transcription factor activated by several cytokines released during inflammation and responsible for many of their proinflammatory effects, have been shown to promote the growth of the colon tumors in experimental models.",18473765_6,-1,-1,-1,-1,7013,-1,0.98029923,0.018111914,0.0015887883
7026,factors,23,24,160,167,"Activated Stat3 not only upregulates genes crucial for survival, proliferation, angiogenesis, and metastasis but also promotes expression of immune suppressive factors while inhibiting Th1 immunostimulatory molecules.",18479894_2,0,1,-1,-1,7026,-1,0.9363985,0.03814749,0.025454083
7029,factors that,10,12,55,67,"By virtue of its ability to promote expression of many factors that activate Stat3 in diverse cells, Stat3 allows malignant and immune cells resonate, forming close partnership for tumor immune evasion, tumor progression, and resistance to therapies.",18479894_3,-1,-1,-1,-1,7029,-1,0.00013756624,0.999818,4.445373e-05
7036,to therapies,39,41,237,249,"By virtue of its ability to promote expression of many factors that activate Stat3 in diverse cells, Stat3 allows malignant and immune cells resonate, forming close partnership for tumor immune evasion, tumor progression, and resistance to therapies.",18479894_3,-1,-1,-1,-1,7036,-1,4.078433e-05,0.99994314,1.6058153e-05
7038,T-cell,11,12,57,63,"Szary syndrome (SzS), the leukemic variant of cutaneous T-cell lymphomas, is incurable.",18480841_0,-1,1,2,-1,7038,-1,4.9133425e-05,8.35457e-05,0.9998673
7042,immunity,12,13,74,82,Dendritic cells (DCs) transfected with tumor mRNA can stimulate antitumor immunity in certain cancer patients.,18480841_1,0,-1,2,-1,7042,-1,0.9990864,0.0006635715,0.00024996544
7045,immunity,20,21,117,125,"In this study, we determined whether mRNAs from Szary cells could be used for loading DCs and stimulating antitumor immunity.",18480841_2,0,-1,2,-1,7045,-1,0.99945885,0.00034254254,0.0001986721
7048,blood,9,10,63,68,Autologous DCs were generated from monocytes of the peripheral blood from 10 patients with SzS. Total RNA was extracted from Szary cells and amplified by T7 in vitro transcription.,18480841_3,0,1,-1,-1,7048,-1,9.1826e-05,0.99962914,0.00027900835
7057,that IFN-gamma,2,4,9,23,We found that IFN-gamma was required for IL-12p70 production by monocyte-derived DCs from SzS. The oncogenic transcription factor Twist and the tyrosine kinase receptor EphA4 were expressed in total RNA from Szary cells and the paired amplified mRNAs.,18480841_5,-1,-1,-1,-1,7057,-1,0.8892077,0.106583685,0.0042085475
7061,the tyrosine,20,22,140,152,We found that IFN-gamma was required for IL-12p70 production by monocyte-derived DCs from SzS. The oncogenic transcription factor Twist and the tyrosine kinase receptor EphA4 were expressed in total RNA from Szary cells and the paired amplified mRNAs.,18480841_5,-1,-1,-1,-1,7061,-1,2.2569231e-05,0.999961,1.6436732e-05
7062,receptor,23,24,160,168,We found that IFN-gamma was required for IL-12p70 production by monocyte-derived DCs from SzS. The oncogenic transcription factor Twist and the tyrosine kinase receptor EphA4 were expressed in total RNA from Szary cells and the paired amplified mRNAs.,18480841_5,0,1,2,-1,7062,-1,0.0004858396,0.9835195,0.015994659
7066,IFN-gamma-producing CTLs,4,6,38,62,RNA-transfected DCs induced antitumor IFN-gamma-producing CTLs in 7 of 10 subjects and GrB-producing CTLs in 6 of 9 subjects.,18480841_6,-1,-1,-1,-1,7066,-1,0.8174587,0.0024669557,0.18007444
7075,tumor cells,18,20,105,116,These data support the concept of using tumor mRNA for a vaccine strategy that requires small amounts of tumor cells without need for specific antigens in patients with SzS.,18480841_8,-1,-1,-1,-1,7075,-1,0.0042495904,0.43896115,0.55678934
7078,immune responses to tumor,4,8,27,52,The induction of effective immune responses to tumor vaccines requires the preferential activation of effector T cells relative to regulatory or suppressive T cells.,18481381_0,-1,-1,-1,-1,7078,-1,0.5543291,0.44239733,0.003273595
7080,T cells relative to,15,19,111,130,The induction of effective immune responses to tumor vaccines requires the preferential activation of effector T cells relative to regulatory or suppressive T cells.,18481381_0,-1,-1,-1,-1,7080,-1,0.002816145,0.12731828,0.8698656
7084,growth factor receptor,6,9,48,70,"Glial tumors commonly overexpress the epidermal growth factor receptor (EGFR), which can be targeted by monoclonal antibodies.",18481381_1,-1,-1,-1,-1,7084,-1,0.23083672,0.036523465,0.73263973
7086,that the,3,5,13,21,"Here we show that the coating of glial tumor cells with a clinical grade anti-EGFR antibody, cetuximab, leads to enhanced tumor-specific, interferon-gamma producing CD8+ T cells by dendritic cells (DCs).",18481381_2,-1,-1,-1,-1,7086,-1,1.7543862e-05,0.99997437,8.031368e-06
7087,tumor cells,8,10,39,50,"Here we show that the coating of glial tumor cells with a clinical grade anti-EGFR antibody, cetuximab, leads to enhanced tumor-specific, interferon-gamma producing CD8+ T cells by dendritic cells (DCs).",18481381_2,-1,-1,-1,-1,7087,-1,0.0039066197,0.36894163,0.6271517
7095,cells to,8,10,61,69,"The selective targeting of monoclonal antibody coated glioma cells to activating Fcgamma receptors (FcgammaRs) on DCs, which is achieved with a blocking antibody to the inhibitory form of FcgammaR, leads to the induction of antitumor immunity without the need for an exogenous maturation stimulus.",18481381_3,-1,-1,-1,-1,7095,-1,0.0030872645,0.1412287,0.855684
7096,receptors,12,13,89,98,"The selective targeting of monoclonal antibody coated glioma cells to activating Fcgamma receptors (FcgammaRs) on DCs, which is achieved with a blocking antibody to the inhibitory form of FcgammaR, leads to the induction of antitumor immunity without the need for an exogenous maturation stimulus.",18481381_3,0,1,2,-1,7096,-1,6.6801236e-05,0.00018340467,0.9997497
7097,to the,26,28,162,168,"The selective targeting of monoclonal antibody coated glioma cells to activating Fcgamma receptors (FcgammaRs) on DCs, which is achieved with a blocking antibody to the inhibitory form of FcgammaR, leads to the induction of antitumor immunity without the need for an exogenous maturation stimulus.",18481381_3,-1,-1,-1,-1,7097,-1,3.6216516e-05,0.9999473,1.6518488e-05
7098,to the,34,36,204,210,"The selective targeting of monoclonal antibody coated glioma cells to activating Fcgamma receptors (FcgammaRs) on DCs, which is achieved with a blocking antibody to the inhibitory form of FcgammaR, leads to the induction of antitumor immunity without the need for an exogenous maturation stimulus.",18481381_3,-1,-1,-1,-1,7098,-1,2.1633276e-05,0.9999702,8.1363805e-06
7099,immunity,39,40,234,242,"The selective targeting of monoclonal antibody coated glioma cells to activating Fcgamma receptors (FcgammaRs) on DCs, which is achieved with a blocking antibody to the inhibitory form of FcgammaR, leads to the induction of antitumor immunity without the need for an exogenous maturation stimulus.",18481381_3,0,-1,2,-1,7099,-1,0.9987336,0.0009773864,0.00028912156
7105,immunity,21,22,129,137,"Importantly, this approach reduces the concurrent induction of regulatory T cells, which can also be depleted to further enhance immunity.",18481381_4,0,-1,2,-1,7105,-1,0.9984723,0.001167265,0.0003604068
7107,that immunity to,3,6,19,35,"These data suggest that immunity to EGFR expressing tumors, including glioma, can be enhanced through the concerted function of antitumor monoclonal antibodies, activating FcgammaR, and DCs.",18481381_5,-1,-1,-1,-1,7107,-1,4.1668183e-05,0.9999436,1.4691245e-05
7109,through the,16,18,94,105,"These data suggest that immunity to EGFR expressing tumors, including glioma, can be enhanced through the concerted function of antitumor monoclonal antibodies, activating FcgammaR, and DCs.",18481381_5,-1,-1,-1,-1,7109,-1,2.0503077e-05,0.9999701,9.4286315e-06
7110,function,19,20,116,124,"These data suggest that immunity to EGFR expressing tumors, including glioma, can be enhanced through the concerted function of antitumor monoclonal antibodies, activating FcgammaR, and DCs.",18481381_5,0,1,2,-1,7110,-1,7.510002e-05,0.9998846,4.024517e-05
7114,TNF receptor+,12,14,69,82,"Regulatory T cells (Treg) enriched in FoxP3+, glucocorticoid-induced TNF receptor+, and cytotoxic T-lymphocyte-associated antigen-4+ exert a potential to suppress effector T cells in the periphery.",18512029_0,-1,-1,-1,-1,7114,-1,0.0005365665,0.99683315,0.0026303348
7115,T-lymphocyte-associated antigen-4,17,19,98,131,"Regulatory T cells (Treg) enriched in FoxP3+, glucocorticoid-induced TNF receptor+, and cytotoxic T-lymphocyte-associated antigen-4+ exert a potential to suppress effector T cells in the periphery.",18512029_0,-1,-1,-1,-1,7115,-1,0.0035552527,0.00072772556,0.995717
7119,These cells,0,2,0,11,"These cells exist in markedly higher proportions within tumor-infiltrating lymphocytes, peripheral blood lymphocytes, and/or regional lymph node lymphocytes of patients with cancer and their frequencies are suggested to be strongly related to tumor progression and inversely correlated with the efficacy of treatment.",18512029_1,-1,-1,-1,-1,7119,-1,0.003366602,0.21135673,0.78527665
7120,tumor-infiltrating lymphocytes,8,10,56,86,"These cells exist in markedly higher proportions within tumor-infiltrating lymphocytes, peripheral blood lymphocytes, and/or regional lymph node lymphocytes of patients with cancer and their frequencies are suggested to be strongly related to tumor progression and inversely correlated with the efficacy of treatment.",18512029_1,-1,-1,-1,-1,7120,-1,0.0034315563,0.8911279,0.10544059
7121,blood lymphocytes,12,14,99,116,"These cells exist in markedly higher proportions within tumor-infiltrating lymphocytes, peripheral blood lymphocytes, and/or regional lymph node lymphocytes of patients with cancer and their frequencies are suggested to be strongly related to tumor progression and inversely correlated with the efficacy of treatment.",18512029_1,-1,-1,-1,-1,7121,-1,0.0004298589,0.0017338943,0.9978363
7125,related to tumor,32,35,232,248,"These cells exist in markedly higher proportions within tumor-infiltrating lymphocytes, peripheral blood lymphocytes, and/or regional lymph node lymphocytes of patients with cancer and their frequencies are suggested to be strongly related to tumor progression and inversely correlated with the efficacy of treatment.",18512029_1,-1,-1,-1,-1,7125,-1,2.5896514e-05,0.99996006,1.4081637e-05
7128,Tumor-specific Treg cells,0,3,0,25,"Tumor-specific Treg cells require ligand-specific activation and cell-to-cell contact to exert their suppressive activity on tumor-specific effector cells (CD8+ cytotoxic T lymphocytes and CD4+ Th cells), which includes decreased cytotoxity, proliferation, and Th1 cytokine secrection.",18512029_2,-1,-1,-1,-1,7128,-1,0.0041159005,0.51493233,0.48095173
7135,Th cells,27,29,194,202,"Tumor-specific Treg cells require ligand-specific activation and cell-to-cell contact to exert their suppressive activity on tumor-specific effector cells (CD8+ cytotoxic T lymphocytes and CD4+ Th cells), which includes decreased cytotoxity, proliferation, and Th1 cytokine secrection.",18512029_2,-1,-1,-1,-1,7135,-1,3.2531727e-05,3.9829523e-05,0.99992764
7136,Th1 cytokine,39,41,261,273,"Tumor-specific Treg cells require ligand-specific activation and cell-to-cell contact to exert their suppressive activity on tumor-specific effector cells (CD8+ cytotoxic T lymphocytes and CD4+ Th cells), which includes decreased cytotoxity, proliferation, and Th1 cytokine secrection.",18512029_2,-1,-1,-1,-1,7136,-1,0.18857393,0.79204184,0.019384237
7138,tumor-associated antigens that,11,14,71,101,Depletion or blockade of Treg cells can enhance immune protection from tumor-associated antigens that are expressed as self antigens.,18512029_3,-1,-1,-1,-1,7138,-1,9.02809e-05,0.99987435,3.532374e-05
7154,that tumor-infiltrating,4,6,16,39,"Here, we report that tumor-infiltrating mast cells remodel tumor microenvironment and promote tumor growth.",18524989_1,-1,-1,-1,-1,7154,-1,3.0936742e-05,0.99994946,1.9612638e-05
7160,tumor-derived stem cell factor (SCF,11,17,72,107,Mast cell infiltration and activation in tumors were mainly mediated by tumor-derived stem cell factor (SCF) and its receptor c-Kit on mast cells.,18524989_2,-1,-1,-1,-1,7160,-1,0.07844939,0.9177144,0.0038361994
7161,receptor,20,21,117,125,Mast cell infiltration and activation in tumors were mainly mediated by tumor-derived stem cell factor (SCF) and its receptor c-Kit on mast cells.,18524989_2,0,1,2,-1,7161,-1,0.0005541772,0.009137774,0.9903081
7164,the chemotactic,6,8,46,61,Low concentrations of SCF efficiently induced the chemotactic migration of mast cells.,18524989_3,-1,-1,-1,-1,7164,-1,0.111899845,0.8854639,0.0026362196
7169,factors,14,15,109,116,"Tumor-infiltrating mast cells, activated by higher concentrations of SCF, expressed multiple proinflammatory factors and increased IL-17 expression in tumors.",18524989_4,0,1,-1,-1,7169,-1,0.9069804,0.09126656,0.0017530872
7175,tumor cells,7,9,38,49,The activity of NF-kappaB and AP-1 in tumor cells was intensified in the mast cell-remodeled inflammatory microenvironment.,18524989_5,-1,-1,-1,-1,7175,-1,0.004189799,0.43680918,0.55900097
7190,that the,3,5,25,33,These findings emphasize that the remodeling of the tumor microenvironment can actually be initiated by tumor cell-released SCF and suggest that mast cells are not only a participator but also a critical regulator of inflammation and immunosuppression in the tumor microenvironment.,18524989_7,-1,-1,-1,-1,7190,-1,1.8240318e-05,0.9999739,7.915541e-06
7191,the tumor,7,9,48,57,These findings emphasize that the remodeling of the tumor microenvironment can actually be initiated by tumor cell-released SCF and suggest that mast cells are not only a participator but also a critical regulator of inflammation and immunosuppression in the tumor microenvironment.,18524989_7,-1,-1,-1,-1,7191,-1,1.9324829e-05,0.9999708,9.8372375e-06
7192,tumor cell-released SCF,15,18,104,127,These findings emphasize that the remodeling of the tumor microenvironment can actually be initiated by tumor cell-released SCF and suggest that mast cells are not only a participator but also a critical regulator of inflammation and immunosuppression in the tumor microenvironment.,18524989_7,-1,-1,-1,-1,7192,-1,0.41160107,0.46264994,0.1257489
7195,the tumor,38,40,255,264,These findings emphasize that the remodeling of the tumor microenvironment can actually be initiated by tumor cell-released SCF and suggest that mast cells are not only a participator but also a critical regulator of inflammation and immunosuppression in the tumor microenvironment.,18524989_7,-1,-1,-1,-1,7195,-1,1.9405225e-05,0.99997115,9.39681e-06
7217,than that,18,20,115,124,"By interferon-gamma secretion assay, the capacity of hybrids to stimulate cytotoxic T-lymphocytes (CTLs) is higher than that of other antigen-loading methods showing stronger tumor antigen-specific CTL cytotoxicity to A673.",18563501_3,-1,-1,-1,-1,7217,-1,2.7121987e-05,0.99995935,1.3534964e-05
7219,tumor antigen-specific CTL,26,29,175,201,"By interferon-gamma secretion assay, the capacity of hybrids to stimulate cytotoxic T-lymphocytes (CTLs) is higher than that of other antigen-loading methods showing stronger tumor antigen-specific CTL cytotoxicity to A673.",18563501_3,-1,-1,-1,-1,7219,-1,0.020093814,0.2942251,0.68568116
7222,immune responses to,14,17,89,108,"By in vivo experiment in SCID mice, all dendritic cell-based strategies induced specific immune responses to Ewing's sarcoma after mice-human immune system reconstitution by inoculating human peripheral blood mononuclear cells into the peritoneal cavity of SCID mice.",18563501_4,-1,-1,-1,-1,7222,-1,0.74289584,0.25395116,0.003152989
7223,blood,29,30,203,208,"By in vivo experiment in SCID mice, all dendritic cell-based strategies induced specific immune responses to Ewing's sarcoma after mice-human immune system reconstitution by inoculating human peripheral blood mononuclear cells into the peritoneal cavity of SCID mice.",18563501_4,0,1,-1,-1,7223,-1,0.00021690862,0.99886465,0.00091844104
7236,cell function,9,11,49,62,Down-regulation of CD4+CD25+ regulatory T (Treg) cell function might be beneficial to enhance the immunogenicity of viral and tumor vaccines or to induce breakdown of immunotolerance.,18566377_0,-1,-1,-1,-1,7236,-1,5.3496755e-05,8.07251e-05,0.9998658
7243,that TGF-beta1,16,18,103,117,"Although the mechanism of suppression used by Treg cells remains controversial, it has been postulated that TGF-beta1 mediates their immunosuppressive activity.",18566377_1,-1,-1,-1,-1,7243,-1,3.5922098e-05,0.9999348,2.9254552e-05
7247,peptide that,12,14,51,63,"In this study, we show that P17, a short synthetic peptide that inhibits TGF-beta1 and TGF-beta2 developed in our laboratory, is able to inhibit Treg activity in vitro and in vivo.",18566377_2,-1,-1,-1,-1,7247,-1,3.081614e-05,0.9999486,2.0618385e-05
7248,TGF-beta1,15,16,73,82,"In this study, we show that P17, a short synthetic peptide that inhibits TGF-beta1 and TGF-beta2 developed in our laboratory, is able to inhibit Treg activity in vitro and in vivo.",18566377_2,0,1,-1,-1,7248,-1,3.4535253e-05,0.9999248,4.0709085e-05
7249,TGF-beta2,17,18,87,96,"In this study, we show that P17, a short synthetic peptide that inhibits TGF-beta1 and TGF-beta2 developed in our laboratory, is able to inhibit Treg activity in vitro and in vivo.",18566377_2,0,1,-1,-1,7249,-1,4.480839e-05,0.9999348,2.0361844e-05
7254,T cells to,14,17,106,116,"In vitro studies demonstrate that P17 inhibits murine and human Treg-induced unresponsiveness of effector T cells to anti-CD3 stimulation, in an MLR or to a specific Ag.",18566377_3,-1,-1,-1,-1,7254,-1,0.0016561417,0.031843357,0.9665005
7257,peptide,9,10,55,62,"Moreover, administration of P17 to mice immunized with peptide vaccines containing tumor or viral Ags enhanced anti-vaccine immune responses and improved protective immunogenicity against tumor growth or viral infection or replication.",18566377_4,0,-1,2,-1,7257,-1,9.722166e-05,0.99985194,5.0835122e-05
7272,that peptide,3,5,27,39,These findings demonstrate that peptide inhibitors of TGF-beta may be a valuable tool to enhance vaccination efficacy and to break tolerance against pathogens or tumor Ags.,18566377_9,-1,-1,-1,-1,7272,-1,4.074967e-05,0.99993694,2.230612e-05
7273,TGF-beta,7,8,54,62,These findings demonstrate that peptide inhibitors of TGF-beta may be a valuable tool to enhance vaccination efficacy and to break tolerance against pathogens or tumor Ags.,18566377_9,0,1,-1,-1,7273,-1,3.8887058e-05,0.9999466,1.4516157e-05
7274,tool to,12,14,81,88,These findings demonstrate that peptide inhibitors of TGF-beta may be a valuable tool to enhance vaccination efficacy and to break tolerance against pathogens or tumor Ags.,18566377_9,-1,-1,-1,-1,7274,-1,3.2299627e-05,0.99995625,1.1424524e-05
7285,TGFbeta,28,29,182,189,"Regulatory T cells were enumerated and phenotypically characterized using antibodies to FOXP3.RESULTS: SCCs had higher numbers of CD4 and CD8 cells; infiltrates expressed more CD25, TGFbeta, and IL10 but had significantly lower IL2 compared with cervicitis and CIN III.",18593438_2,0,1,-1,-1,7285,-1,8.97545e-05,0.9998889,2.1286505e-05
7297,TGFbeta(+,13,14,57,66,The proportion of FOXP3(+) CD25(+); FOXP3(+) CD25(-) and TGFbeta(+) CD25(+) in invasive tumors was 17; 19 and 22 respectively.,18593438_6,0,1,-1,-1,7297,-1,0.00021217414,0.99970526,8.251585e-05
7304,TGFbeta,33,34,186,193,"CONCLUSION: Cervical tumors are marked by the presence of an immunoregulatory environment, and harbor equal proportions of 'inactive' n Tregs; activated n Tregs; and Tregs operating via TGFbeta.",18593438_7,0,1,-1,-1,7304,-1,0.00011566238,0.999864,2.0324242e-05
7311,T cells to,20,23,99,109,"In this study, we show that ex vivo splenic DCs are capable of inducing conversion of nave CD4(+) T cells to adaptive Foxp3(+)CD4(+) regulatory T cells (aTreg) in the presence of TGF-beta.",18599457_1,-1,-1,-1,-1,7311,-1,0.0016613831,0.040636055,0.9577026
7315,TGF-beta,36,37,180,188,"In this study, we show that ex vivo splenic DCs are capable of inducing conversion of nave CD4(+) T cells to adaptive Foxp3(+)CD4(+) regulatory T cells (aTreg) in the presence of TGF-beta.",18599457_1,0,1,-1,-1,7315,-1,4.5072204e-05,0.99994016,1.4730786e-05
7319,to the,4,6,26,32,"This was not attributable to the difference in basal level of costimulation, because deficiency of CD40 or CD80/86 signaling did not diminish the differential induction of Foxp3.",18599457_3,-1,-1,-1,-1,7319,-1,2.5169262e-05,0.9999652,9.652629e-06
7320,deficiency,14,15,85,95,"This was not attributable to the difference in basal level of costimulation, because deficiency of CD40 or CD80/86 signaling did not diminish the differential induction of Foxp3.",18599457_3,0,1,-1,-1,7320,-1,0.00011776499,0.99980944,7.284993e-05
7326,receptors,19,20,145,154,Further insights into the molecular mechanisms of conversion were gained by analyzing the contribution of several costimulatory and coinhibitory receptors.,18599457_5,0,1,2,-1,7326,-1,0.000120735036,0.0007225494,0.9991567
7331,TGF-beta,14,15,76,84,Ex vivo PD-L1(-/-) DCs failed to support Foxp3 induction in the presence of TGF-beta.,18599457_7,0,1,-1,-1,7331,-1,7.3126175e-05,0.99990547,2.1384629e-05
7334,the cellular,5,7,36,48,"Collectively, this study highlights the cellular and molecular parameters that might be exploited to control the de novo generation of aTregs and peripheral tolerance.",18599457_9,-1,-1,-1,-1,7334,-1,0.0036019175,0.73705775,0.25934038
7340,The TNF,0,2,0,7,The TNF family member TRAIL is emerging as a promising cytotoxic molecule for antitumor therapy.,18606651_0,-1,-1,-1,-1,7340,-1,3.8894188e-05,0.9999478,1.3359707e-05
7342,therapy,14,15,88,95,The TNF family member TRAIL is emerging as a promising cytotoxic molecule for antitumor therapy.,18606651_0,0,1,-1,-1,7342,-1,2.9232666e-05,0.999956,1.4787716e-05
7343,mechanism of action,3,6,13,32,"However, its mechanism of action and the possible modulation of its effect by the microenvironment in follicular lymphomas (FL) remain unknown.",18606651_1,0,1,-1,-1,7343,-1,5.2758212e-05,0.9999193,2.7907323e-05
7346,that TRAIL,3,5,13,23,"We show here that TRAIL is cytotoxic only against FL B cells and not against normal B cells, and that DR4 is the main receptor involved in the initiation of the apoptotic cascade.",18606651_2,-1,-1,-1,-1,7346,-1,2.2542114e-05,0.999967,1.0530933e-05
7351,receptor,25,26,118,126,"We show here that TRAIL is cytotoxic only against FL B cells and not against normal B cells, and that DR4 is the main receptor involved in the initiation of the apoptotic cascade.",18606651_2,0,1,2,-1,7351,-1,0.00029336716,0.0009836466,0.998723
7358,protein,6,7,29,36,CD40 induces a rapid RNA and protein up-regulation of c-FLIP and Bcl-x(L).,18606651_4,0,1,-1,-1,7358,-1,4.892378e-05,0.9999143,3.674909e-05
7373,therapy,26,27,153,160,These findings suggest that a cotreatment with TRAIL and an inhibitor of NF-kappaB signaling or a blocking anti-CD40 Ab could be of great interest in FL therapy.,18606651_7,0,1,-1,-1,7373,-1,2.3005547e-05,0.99996567,1.1325028e-05
7377,tissue,11,12,71,77,Preferential activation of regulatory T (Treg) cells limits autoimmune tissue damage during chronic immune responses but can also facilitate tumor growth.,18632653_0,-1,1,2,-1,7377,-1,0.0001699801,0.9995552,0.00027480937
7380,that tissue-produced,4,6,14,34,"Here, we show that tissue-produced inflammatory mediators prime maturing dendritic cells (DC) for the differential ability of attracting anti-inflammatory Treg cells.",18632653_1,-1,-1,-1,-1,7380,-1,6.3618e-05,0.99990904,2.7367396e-05
7386,factor,13,14,50,56,"Our data show that prostaglandin E(2) (PGE(2)), a factor overproduced in chronic inflammation and cancer, induces stable Treg-attracting properties in maturing DC, mediated by CCL22.",18632653_2,0,1,-1,-1,7386,-1,0.5411831,0.456019,0.0027978623
7401,the Th1-attracting chemokines,36,39,224,253,"This PGE(2)-induced overproduction of CCL22 and the resulting attraction of FOXP3(+) Tregs are counteracted by IFN alpha, a mediator of acute inflammation, which also restores the ability of the PGE(2)-exposed DC to secrete the Th1-attracting chemokines: CXCL9, CXCL10, CXCL11, and CCL5.",18632653_4,-1,-1,-1,-1,7401,-1,0.028745508,0.9683446,0.0029098527
7414,that the,5,7,26,34,"The current data, showing that the ability of mature DC to interact with Treg cells is predetermined at the stage of DC maturation, pave the way to preferentially target the regulatory versus proinflammatory T cells in autoimmunity and transplantation, as opposed to intracellular infections and cancer.",18632653_6,-1,-1,-1,-1,7414,-1,1.7277145e-05,0.9999747,7.9604015e-06
7420,target the,30,32,163,173,"The current data, showing that the ability of mature DC to interact with Treg cells is predetermined at the stage of DC maturation, pave the way to preferentially target the regulatory versus proinflammatory T cells in autoimmunity and transplantation, as opposed to intracellular infections and cancer.",18632653_6,-1,-1,-1,-1,7420,-1,2.0281259e-05,0.999969,1.0661727e-05
7422,transplantation,40,41,236,251,"The current data, showing that the ability of mature DC to interact with Treg cells is predetermined at the stage of DC maturation, pave the way to preferentially target the regulatory versus proinflammatory T cells in autoimmunity and transplantation, as opposed to intracellular infections and cancer.",18632653_6,-1,1,2,-1,7422,-1,2.8522174e-05,0.9999578,1.3724743e-05
7428,the T,27,29,153,158,"In this study, we demonstrate that malignant mature CD4(+) T lymphocytes derived from cutaneous T cell lymphomas (CTCL) variably display some aspects of the T regulatory phenotype.",18684941_0,-1,-1,-1,-1,7428,-1,2.428088e-05,0.9999597,1.5993923e-05
7431,TGF-beta,17,18,126,134,"Whereas seven cell lines representing a spectrum of primary cutaneous T cell lymphoproliferative disorders expressed CD25 and TGF-beta, the expression of FOXP3 and, to a lesser degree, IL-10 was restricted to two CTCL cell lines that are dependent on exogenous IL-2.",18684941_1,0,1,-1,-1,7431,-1,4.9195463e-05,0.9999286,2.2191736e-05
7436,to two,33,35,206,212,"Whereas seven cell lines representing a spectrum of primary cutaneous T cell lymphoproliferative disorders expressed CD25 and TGF-beta, the expression of FOXP3 and, to a lesser degree, IL-10 was restricted to two CTCL cell lines that are dependent on exogenous IL-2.",18684941_1,-1,-1,-1,-1,7436,-1,3.0256848e-05,0.99994886,2.0828908e-05
7440,through receptors,11,13,45,62,"IL-2, IL-15, and IL-21, all of which signals through receptors containing the common gamma chain, induced expression of IL-10 in the IL-2-dependent cell lines as well as primary leukemic CTCL cells.",18684941_2,-1,-1,-1,-1,7440,-1,0.0014937634,0.9064244,0.09208184
7451,through STAT3,11,13,81,94,"The IL-2-triggered induction of IL-10 and FOXP3 expression occurred by signaling through STAT3 and STAT5, respectively.",18684941_4,-1,-1,-1,-1,7451,-1,2.8259536e-05,0.99995184,1.9898867e-05
7453,analysis,1,2,20,28,Immunohistochemical analysis of the CTCL tissues revealed that FOXP3-expressing cells were common among the CD7-negative enlarged atypical and small lymphocytes at the early skin patch and plaque stages.,18684941_5,0,1,-1,-1,7453,-1,2.6285887e-05,0.9999503,2.3378127e-05
7455,tissues,5,6,41,48,Immunohistochemical analysis of the CTCL tissues revealed that FOXP3-expressing cells were common among the CD7-negative enlarged atypical and small lymphocytes at the early skin patch and plaque stages.,18684941_5,-1,1,2,-1,7455,-1,0.0006429032,0.016236937,0.9831201
7456,that FOXP3-expressing cells,7,10,58,85,Immunohistochemical analysis of the CTCL tissues revealed that FOXP3-expressing cells were common among the CD7-negative enlarged atypical and small lymphocytes at the early skin patch and plaque stages.,18684941_5,-1,-1,-1,-1,7456,-1,0.0021410726,0.933824,0.06403496
7462,the tumor,6,8,45,54,Their frequency was profoundly diminished at the tumor stage and in the CTCL lymph node lesions with or without large cell transformation.,18684941_6,-1,-1,-1,-1,7462,-1,2.1318961e-05,0.99996674,1.1986749e-05
7464,cell transformation,20,22,118,137,Their frequency was profoundly diminished at the tumor stage and in the CTCL lymph node lesions with or without large cell transformation.,18684941_6,-1,-1,-1,-1,7464,-1,0.00036763042,0.0033835887,0.9962488
7466,that the T,3,6,23,33,"These results indicate that the T regulatory cell features are induced in CTCL T cells by common gamma chain signaling cytokines such as IL-2 and do not represent a fully predetermined, constitutive phenotype independent of the local environmental stimuli to which these malignant mature CD4(+) T cells become exposed.",18684941_7,-1,-1,-1,-1,7466,-1,2.1176435e-05,0.999966,1.2855811e-05
7474,The FOXP3,2,4,12,21,BACKGROUND: The FOXP3 mRNA expression and the other regulatory T cell-related molecules were investigated and compared with clinicopathological parameters in human primary breast cancer.,18685848_0,-1,-1,-1,-1,7474,-1,2.1406178e-05,0.9999658,1.2749938e-05
7480,tissues,11,12,68,75,"Total RNA was extracted from frozen normal breast and breast cancer tissues, and the expression of FOXP3, IL-10, TGFbeta1 and CCL22 mRNA was evaluated using quantitative real-time RT-PCR.RESULT: FOXP3, IL-10, TGFbeta1 and CCL22 mRNA expressions were significantly higher in cancer tissue than in normal tissue, not only at pT1, 2, and 3 stages but also at the DCIS stage.",18685848_2,-1,1,2,-1,7480,-1,8.7019325e-05,0.9992499,0.0006630538
7484,TGFbeta1,21,22,113,121,"Total RNA was extracted from frozen normal breast and breast cancer tissues, and the expression of FOXP3, IL-10, TGFbeta1 and CCL22 mRNA was evaluated using quantitative real-time RT-PCR.RESULT: FOXP3, IL-10, TGFbeta1 and CCL22 mRNA expressions were significantly higher in cancer tissue than in normal tissue, not only at pT1, 2, and 3 stages but also at the DCIS stage.",18685848_2,0,1,-1,-1,7484,-1,7.25722e-05,0.9998178,0.000109622764
7488,TGFbeta1,36,37,209,217,"Total RNA was extracted from frozen normal breast and breast cancer tissues, and the expression of FOXP3, IL-10, TGFbeta1 and CCL22 mRNA was evaluated using quantitative real-time RT-PCR.RESULT: FOXP3, IL-10, TGFbeta1 and CCL22 mRNA expressions were significantly higher in cancer tissue than in normal tissue, not only at pT1, 2, and 3 stages but also at the DCIS stage.",18685848_2,0,1,-1,-1,7488,-1,8.394696e-05,0.99976164,0.00015441947
7490,tissue than,46,48,281,292,"Total RNA was extracted from frozen normal breast and breast cancer tissues, and the expression of FOXP3, IL-10, TGFbeta1 and CCL22 mRNA was evaluated using quantitative real-time RT-PCR.RESULT: FOXP3, IL-10, TGFbeta1 and CCL22 mRNA expressions were significantly higher in cancer tissue than in normal tissue, not only at pT1, 2, and 3 stages but also at the DCIS stage.",18685848_2,-1,-1,-1,-1,7490,-1,4.2041695e-05,0.9998802,7.780526e-05
7491,tissue,50,51,303,309,"Total RNA was extracted from frozen normal breast and breast cancer tissues, and the expression of FOXP3, IL-10, TGFbeta1 and CCL22 mRNA was evaluated using quantitative real-time RT-PCR.RESULT: FOXP3, IL-10, TGFbeta1 and CCL22 mRNA expressions were significantly higher in cancer tissue than in normal tissue, not only at pT1, 2, and 3 stages but also at the DCIS stage.",18685848_2,-1,1,2,-1,7491,-1,9.316241e-05,0.9991743,0.00073254225
7497,TGFbeta1,11,12,68,76,"There were positive correlations between FOXP3 and IL-10, FOXP3 and TGFbeta1, as well as FOXP3 and CCL22 mRNA expressions, respectively.",18685848_3,0,1,-1,-1,7497,-1,4.8212387e-05,0.99990094,5.081953e-05
7504,that regulatory T cells,5,9,34,57,"CONCLUSION: These results suggest that regulatory T cells are involved in tumor onset and progression in human primary breast cancer, possibly contributing to poor prognosis of patients with breast cancer.",18685848_5,-1,-1,-1,-1,7504,-1,0.0028384277,0.22772492,0.76943666
7515,To test,2,4,6,13,AIMS: To test if HCV NS3/4A affects innate and adaptive immune responses in vivo.,18689426_3,-1,-1,-1,-1,7515,-1,2.4068935e-05,0.9999653,1.0652042e-05
7517,transfected cells,11,13,66,83,"METHODS: NS3 levels were semi-quantified in human liver biopsies, transfected cells, and in transgenic (Tg) mouse livers by western blot.",18689426_4,-1,-1,-1,-1,7517,-1,0.0005115892,0.009886183,0.98960215
7523,transfected cells,20,22,121,138,"The effect of NS3/4A on dsRNA-mediated signalling and on the integrity of IPS-1 was analysed using in vitro translation, transfected cells and Tg mice.",18689426_5,-1,-1,-1,-1,7523,-1,0.0009021188,0.025222307,0.97387546
7527,protein,3,4,13,20,RESULTS: NS3 protein levels were in a comparable range (0.1-49 microg/g tissue) in infected human livers and Tg mouse livers.,18689426_7,0,1,-1,-1,7527,-1,4.1989686e-05,0.9999012,5.6872108e-05
7528,tissue,15,16,72,78,RESULTS: NS3 protein levels were in a comparable range (0.1-49 microg/g tissue) in infected human livers and Tg mouse livers.,18689426_7,-1,1,2,-1,7528,-1,4.0895226e-05,0.9998709,8.815973e-05
7533,that this,19,21,123,132,"Importantly, these levels of NS3/4A reduced murine innate responses to synthetic dsRNA in vivo, supporting the possibility that this occurs also in infected humans.",18689426_8,-1,-1,-1,-1,7533,-1,2.4616633e-05,0.9999647,1.0720164e-05
7543,the innate immunity,38,41,260,279,"Despite this, FLuc- and/or NS3/4A-expressing murine hepatocytes were effectively eliminated by hepatic CTLs, utilising the classical molecules for virus-infected cell lysis, including CD8, IFN gamma, perforin and FasL.CONCLUSIONS: Although HCV NS3/4A inhibits the innate immunity, this does not prevent CTL-mediated clearance of NS3/4A-expressing hepatocytes in vivo.",18689426_10,-1,-1,-1,-1,7543,-1,0.567962,0.42817995,0.0038580531
7547,proteins,4,5,16,24,"Thus, other HCV proteins are most likely responsible for interfering with the adaptive immunity.",18689426_11,0,1,-1,-1,7547,-1,0.0005383566,0.99802643,0.0014352261
7548,the adaptive immunity,12,15,74,95,"Thus, other HCV proteins are most likely responsible for interfering with the adaptive immunity.",18689426_11,-1,-1,-1,-1,7548,-1,0.13583368,0.86273867,0.0014276245
7549,The status,0,2,0,10,The status of the immune system of patients with B-cell chronic lymphocytic leukemia (B-CLL) is not yet sufficiently characterized.,18695923_0,-1,-1,-1,-1,7549,-1,2.6960251e-05,0.9999627,1.0319326e-05
7562,the complex,31,33,180,191,"In the current study, we evaluated the expression of FOXP3 in CD4+CD25hi T regulatory lymphocytes (Treg) and their influence on immune response against tumor and viral antigens in the complex system of peripheral blood mononuclear cells.",18695923_2,-1,-1,-1,-1,7562,-1,3.9599065e-05,0.9999393,2.1073429e-05
7563,blood,36,37,213,218,"In the current study, we evaluated the expression of FOXP3 in CD4+CD25hi T regulatory lymphocytes (Treg) and their influence on immune response against tumor and viral antigens in the complex system of peripheral blood mononuclear cells.",18695923_2,0,1,-1,-1,7563,-1,0.00015461698,0.99923,0.00061531336
7571,to the,58,60,281,287,"In 80 B-CLL patients, the frequency of Treg (CD4+CD25hi FOXP3+) cells was significantly higher in B-CLL patients when compared to healthy volunteers (HV) and increased with the progression of the disease (median: 8.24% in stage A, 11.24% in stage B and 12.57% in stage C according to the Binet classification).",18695923_3,-1,-1,-1,-1,7571,-1,2.0316842e-05,0.9999691,1.0514347e-05
7572,classification,61,62,294,308,"In 80 B-CLL patients, the frequency of Treg (CD4+CD25hi FOXP3+) cells was significantly higher in B-CLL patients when compared to healthy volunteers (HV) and increased with the progression of the disease (median: 8.24% in stage A, 11.24% in stage B and 12.57% in stage C according to the Binet classification).",18695923_3,0,1,2,-1,7572,-1,8.616926e-05,0.9995334,0.00038048316
7577,TNF,26,27,156,159,"The frequency of Treg showed no correlation with prognostic markers such as ZAP-70, CD38 and HLA-G. Notably, Treg frequency correlated with serum levels of TNF (r(2)=0.45, p=0.001).",18695923_4,0,1,-1,-1,7577,-1,4.1339237e-05,0.9999429,1.5755231e-05
7578,T-cell immune responses,0,3,0,23,"T-cell immune responses against epitopes derived from the tumor-associated antigens survivin, fibromodulin and RHAMM as well as from the influenza matrix protein were evaluated.",18695923_5,-1,-1,-1,-1,7578,-1,0.027268264,0.0020204617,0.97071135
7579,the tumor-associated antigens,7,10,54,83,"T-cell immune responses against epitopes derived from the tumor-associated antigens survivin, fibromodulin and RHAMM as well as from the influenza matrix protein were evaluated.",18695923_5,-1,-1,-1,-1,7579,-1,0.011992349,0.9834856,0.0045220084
7581,protein,22,23,154,161,"T-cell immune responses against epitopes derived from the tumor-associated antigens survivin, fibromodulin and RHAMM as well as from the influenza matrix protein were evaluated.",18695923_5,0,1,-1,-1,7581,-1,0.040359657,0.87728775,0.082352534
7582,Functionally,0,1,0,12,"Functionally, higher frequencies of Treg correlated with decreased T-cell responses against viral and tumor antigens.",18695923_6,0,1,2,-1,7582,-1,4.2447064e-05,0.9999392,1.8315493e-05
7584,T-cell,9,10,67,73,"Functionally, higher frequencies of Treg correlated with decreased T-cell responses against viral and tumor antigens.",18695923_6,-1,1,2,-1,7584,-1,3.820907e-05,6.0908507e-05,0.9999008
7585,tumor antigens,14,16,102,116,"Functionally, higher frequencies of Treg correlated with decreased T-cell responses against viral and tumor antigens.",18695923_6,-1,-1,-1,-1,7585,-1,0.37818357,0.61175686,0.010059607
7590,T-cell,11,12,59,65,Szary syndrome (SS) is an aggressive variant of cutaneous T-cell lymphoma.,18769452_0,-1,1,2,-1,7590,-1,4.6428417e-05,8.3002444e-05,0.99987054
7593,the regulatory T cell,4,8,15,36,"Here, we study the regulatory T cell (Treg) function and the expression of FOXP3 in SS.",18769452_2,-1,-1,-1,-1,7593,-1,0.002573857,0.13383575,0.8635903
7595,function,11,12,44,52,"Here, we study the regulatory T cell (Treg) function and the expression of FOXP3 in SS.",18769452_2,0,1,2,-1,7595,-1,8.3888175e-05,0.99962103,0.00029504206
7600,analysis,2,3,17,25,"Western blotting analysis shows expression of two low molecular splice forms of FOXP3, but not of wild-type (wt) FOXP3.",18769452_4,0,1,-1,-1,7600,-1,2.2611257e-05,0.9999645,1.2882338e-05
7607,TGF-beta,7,8,49,57,The malignant T cells produce interleukin-10 and TGF-beta and suppress the growth of non-malignant T cells.,18769452_5,0,1,-1,-1,7607,-1,6.0173348e-05,0.99991775,2.2127038e-05
7610,The Treg,0,2,0,8,The Treg phenotype and the production of suppressive cytokines are driven by aberrant activation of Jak3 independent of the FOXP3 splice forms.,18769452_6,-1,-1,-1,-1,7610,-1,2.2024024e-05,0.9999671,1.0916571e-05
7613,the FOXP3,18,20,120,129,The Treg phenotype and the production of suppressive cytokines are driven by aberrant activation of Jak3 independent of the FOXP3 splice forms.,18769452_6,-1,-1,-1,-1,7613,-1,2.5165733e-05,0.9999614,1.3451067e-05
7623,that the,5,7,23,31,"In conclusion, we show that the malignant T cells express low molecular splice forms of FOXP3 and function as Tregs.",18769452_8,-1,-1,-1,-1,7623,-1,1.6873899e-05,0.99997306,1.0111868e-05
7626,function,18,19,98,106,"In conclusion, we show that the malignant T cells express low molecular splice forms of FOXP3 and function as Tregs.",18769452_8,0,1,2,-1,7626,-1,4.204011e-05,0.99993396,2.3942497e-05
7628,that FOXP3,5,7,33,43,"Furthermore, we provide evidence that FOXP3 splice forms are functionally different from wt FOXP3 and not involved in the execution of the suppressive function.",18769452_9,-1,-1,-1,-1,7628,-1,2.1700995e-05,0.9999666,1.16983265e-05
7629,functionally,10,11,61,73,"Furthermore, we provide evidence that FOXP3 splice forms are functionally different from wt FOXP3 and not involved in the execution of the suppressive function.",18769452_9,0,1,2,-1,7629,-1,2.9269626e-05,0.99995685,1.3863396e-05
7633,function,24,25,151,159,"Furthermore, we provide evidence that FOXP3 splice forms are functionally different from wt FOXP3 and not involved in the execution of the suppressive function.",18769452_9,0,1,2,-1,7633,-1,5.9046837e-05,0.99988854,5.242222e-05
7647,to therapies,28,30,165,177,"We hypothesized that WP1066, a novel STAT3 blockade agent, has marked antitumor activity, even against the melanoma metastasis to brain, a site typically refractory to therapies.",18794085_1,-1,-1,-1,-1,7647,-1,4.328917e-05,0.999943,1.3741723e-05
7655,these cells,14,16,88,99,WP1066 suppressed the phosphorylation of Janus-activated kinase 2 and STAT3 (Tyr705) in these cells.,18794085_4,-1,-1,-1,-1,7655,-1,0.001962262,0.11812807,0.87990975
7675,that this,17,19,116,125,CONCLUSIONS: The antitumor cytotoxic effects of WP1066 and its ability to induce antitumor immune responses suggest that this compound has potential for the effective treatment of melanoma metastatic to brain.,18794085_8,-1,-1,-1,-1,7675,-1,2.0874075e-05,0.99996924,9.822533e-06
7683,that blood,2,4,9,19,"We found that blood vessels in SCCs did not express E-selectin, and tumors contained few cutaneous lymphocyte antigen (CLA)(+) T cells, the cell type thought to provide cutaneous immunosurveillance.",18794336_1,-1,-1,-1,-1,7683,-1,4.9990336e-05,0.9998846,6.538706e-05
7685,lymphocyte antigen,17,19,99,117,"We found that blood vessels in SCCs did not express E-selectin, and tumors contained few cutaneous lymphocyte antigen (CLA)(+) T cells, the cell type thought to provide cutaneous immunosurveillance.",18794336_1,-1,-1,-1,-1,7685,-1,0.015098459,0.00045451132,0.984447
7687,the cell type thought to,24,29,136,160,"We found that blood vessels in SCCs did not express E-selectin, and tumors contained few cutaneous lymphocyte antigen (CLA)(+) T cells, the cell type thought to provide cutaneous immunosurveillance.",18794336_1,-1,-1,-1,-1,7687,-1,0.00012629092,0.999705,0.00016872185
7688,Tumors treated,0,2,0,14,"Tumors treated with the Toll-like receptor (TLR)7 agonist imiquimod before excision showed induction of E-selectin on tumor vessels, recruitment of CLA(+) CD8(+) T cells, and histological evidence of tumor regression.",18794336_2,-1,-1,-1,-1,7688,-1,1.915163e-05,0.9999697,1.1111991e-05
7689,the Toll-like receptor,3,6,20,42,"Tumors treated with the Toll-like receptor (TLR)7 agonist imiquimod before excision showed induction of E-selectin on tumor vessels, recruitment of CLA(+) CD8(+) T cells, and histological evidence of tumor regression.",18794336_2,-1,-1,-1,-1,7689,-1,0.0018032211,0.9475057,0.050691094
7694,the T cells,4,7,21,32,Approximately 50% of the T cells infiltrating untreated SCCs were FOXP3(+) regulatory T (T reg) cells.,18794336_4,-1,-1,-1,-1,7694,-1,0.0021555652,0.07054787,0.9272965
7702,these cells,12,14,78,89,"Imiquimod-treated tumors contained a decreased percentage of T reg cells, and these cells produced less FOXP3, interleukin (IL)-10, and transforming growth factor (TGF)-beta.",18794336_5,-1,-1,-1,-1,7702,-1,0.0016670541,0.061499417,0.93683356
7705,transforming growth factor,22,25,136,162,"Imiquimod-treated tumors contained a decreased percentage of T reg cells, and these cells produced less FOXP3, interleukin (IL)-10, and transforming growth factor (TGF)-beta.",18794336_5,-1,-1,-1,-1,7705,-1,0.95199925,0.045020726,0.0029800748
7712,TGF-beta,24,25,128,136,"Treatment of T reg cells in vitro with imiquimod inhibited their suppressive activity and reduced FOXP3, CD39, CD73, IL-10, and TGF-beta by indirect mechanisms.",18794336_6,0,1,-1,-1,7712,-1,4.683002e-05,0.9999317,2.1464526e-05
7717,the immune response,8,11,36,55,"In summary, we find that SCCs evade the immune response at least in part by down-regulating vascular E-selectin and recruiting T reg cells.",18794336_8,-1,-1,-1,-1,7717,-1,0.2965492,0.70199895,0.001451853
7720,TLR7 agonists,0,2,0,13,"TLR7 agonists neutralized both of these strategies, supporting their use in SCCs and other tumors with similar immune defects.",18794336_9,-1,-1,-1,-1,7720,-1,0.0015679315,0.9916014,0.006830604
7728,their functional,16,18,70,86,"Regulatory T (T(reg)) cells are often found in human tumors; however, their functional characteristics have been difficult to evaluate due to low cell numbers and the inability to adequately distinguish between activated and T(reg) cell populations.",18820132_0,-1,-1,-1,-1,7728,-1,3.1704116e-05,0.9999505,1.7732575e-05
7738,tumor-infiltrating T cells,13,16,86,112,"Using a novel approach, we examined the intracellular cytokine production capacity of tumor-infiltrating T cells in the single-cell suspensions of enzymatically digested tumors to differentiate T(reg) cells from effector T cells.",18820132_1,-1,-1,-1,-1,7738,-1,0.0038806451,0.8328424,0.16327688
7740,tumors to,23,25,170,179,"Using a novel approach, we examined the intracellular cytokine production capacity of tumor-infiltrating T cells in the single-cell suspensions of enzymatically digested tumors to differentiate T(reg) cells from effector T cells.",18820132_1,-1,-1,-1,-1,7740,-1,1.790975e-05,0.99997234,9.780873e-06
7744,to T(reg,1,3,8,16,"Similar to T(reg) cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3(+)CD4 T cells, unlike FOXP3(-) T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T(reg) cells even in the tumor microenvironment.",18820132_2,-1,-1,-1,-1,7744,-1,2.4338557e-05,0.9999596,1.6036824e-05
7747,blood,8,9,42,47,"Similar to T(reg) cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3(+)CD4 T cells, unlike FOXP3(-) T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T(reg) cells even in the tumor microenvironment.",18820132_2,0,1,-1,-1,7747,-1,5.9443973e-05,0.99981123,0.00012936098
7748,tumor-infiltrating FOXP3(+)CD4 T cells,13,17,72,110,"Similar to T(reg) cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3(+)CD4 T cells, unlike FOXP3(-) T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T(reg) cells even in the tumor microenvironment.",18820132_2,-1,-1,-1,-1,7748,-1,0.0039102803,0.83164173,0.16444795
7753,that FOXP3,37,39,216,226,"Similar to T(reg) cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3(+)CD4 T cells, unlike FOXP3(-) T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T(reg) cells even in the tumor microenvironment.",18820132_2,-1,-1,-1,-1,7753,-1,2.3417339e-05,0.9999658,1.0831522e-05
7756,the tumor,52,54,298,307,"Similar to T(reg) cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3(+)CD4 T cells, unlike FOXP3(-) T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T(reg) cells even in the tumor microenvironment.",18820132_2,-1,-1,-1,-1,7756,-1,1.9552808e-05,0.9999708,9.69994e-06
7757,FOXP3(+)CD4 T(reg,4,6,27,44,"Accordingly, we enumerated FOXP3(+)CD4 T(reg) cells in intratumoral and peritumoral sections of metastatic melanoma tumors and found a significant increase in proportion of FOXP3(+)CD4 T(reg) cells in the intratumoral compared with peritumoral areas.",18820132_3,-1,-1,-1,-1,7757,-1,4.0110925e-05,0.9999232,3.666946e-05
7760,FOXP3(+)CD4 T(reg,25,27,173,190,"Accordingly, we enumerated FOXP3(+)CD4 T(reg) cells in intratumoral and peritumoral sections of metastatic melanoma tumors and found a significant increase in proportion of FOXP3(+)CD4 T(reg) cells in the intratumoral compared with peritumoral areas.",18820132_3,-1,-1,-1,-1,7760,-1,4.209545e-05,0.99991906,3.8896076e-05
7765,tumors than,10,12,56,67,"Moreover, their frequencies were 3- to 5-fold higher in tumors than in peripheral blood from the same patients or healthy donors, respectively.",18820132_4,-1,-1,-1,-1,7765,-1,2.142316e-05,0.9999653,1.3324874e-05
7766,blood,14,15,82,87,"Moreover, their frequencies were 3- to 5-fold higher in tumors than in peripheral blood from the same patients or healthy donors, respectively.",18820132_4,0,1,-1,-1,7766,-1,0.00030038893,0.9931704,0.0065292506
7769,that the tumor-infiltrating,3,6,27,54,"These findings demonstrate that the tumor-infiltrating CD4 T(reg) cell population is accurately depicted by FOXP3 expression, they selectively accumulate in tumors, and their frequency in peripheral blood does not properly reflect tumor microenvironment.",18820132_5,-1,-1,-1,-1,7769,-1,3.091228e-05,0.999949,2.015391e-05
7776,blood,29,30,199,204,"These findings demonstrate that the tumor-infiltrating CD4 T(reg) cell population is accurately depicted by FOXP3 expression, they selectively accumulate in tumors, and their frequency in peripheral blood does not properly reflect tumor microenvironment.",18820132_5,0,1,-1,-1,7776,-1,0.00015248398,0.99861443,0.0012330789
7784,functional,4,5,24,34,A better phenotypic and functional characterization of this regulatory T-cell subset could help in identifying modulators of their activity with therapeutic finalities.,18832002_1,0,1,2,-1,7784,-1,7.336934e-05,0.99989104,3.557233e-05
7785,this regulatory T-cell subset,7,11,55,84,A better phenotypic and functional characterization of this regulatory T-cell subset could help in identifying modulators of their activity with therapeutic finalities.,18832002_1,-1,-1,-1,-1,7785,-1,0.0019931118,0.07975444,0.91825247
7786,modulators,15,16,111,121,A better phenotypic and functional characterization of this regulatory T-cell subset could help in identifying modulators of their activity with therapeutic finalities.,18832002_1,-1,-1,-1,-1,7786,-1,0.018409401,0.6180233,0.36356735
7791,that Foxp3,7,9,37,47,"The results of the present work show that Foxp3, a transcriptional marker of natural CD4+CD25+ Treg, is not expressed by CD8+CD28- Treg, thus indicating different origin and pathways of function for the latter with respect to the former regulatory cell type.",18832002_2,-1,-1,-1,-1,7791,-1,1.8750228e-05,0.9999708,1.0499424e-05
7797,function,33,34,186,194,"The results of the present work show that Foxp3, a transcriptional marker of natural CD4+CD25+ Treg, is not expressed by CD8+CD28- Treg, thus indicating different origin and pathways of function for the latter with respect to the former regulatory cell type.",18832002_2,0,1,2,-1,7797,-1,6.915533e-05,0.9998851,4.57425e-05
7799,to the,39,41,223,229,"The results of the present work show that Foxp3, a transcriptional marker of natural CD4+CD25+ Treg, is not expressed by CD8+CD28- Treg, thus indicating different origin and pathways of function for the latter with respect to the former regulatory cell type.",18832002_2,-1,-1,-1,-1,7799,-1,2.1970473e-05,0.9999683,9.708237e-06
7800,cell type,43,45,248,257,"The results of the present work show that Foxp3, a transcriptional marker of natural CD4+CD25+ Treg, is not expressed by CD8+CD28- Treg, thus indicating different origin and pathways of function for the latter with respect to the former regulatory cell type.",18832002_2,-1,-1,-1,-1,7800,-1,8.923827e-05,0.00035694079,0.99955374
7802,that the,5,7,32,40,"Moreover, the results underline that the glucocorticoid induced TNF receptor is involved in generation processes but not in suppressor function of CD8+CD28- Treg.",18832002_3,-1,-1,-1,-1,7802,-1,1.7640044e-05,0.99997354,8.878638e-06
7803,TNF receptor,9,11,64,76,"Moreover, the results underline that the glucocorticoid induced TNF receptor is involved in generation processes but not in suppressor function of CD8+CD28- Treg.",18832002_3,-1,-1,-1,-1,7803,-1,6.4441e-05,0.9998196,0.00011603452
7805,function,20,21,135,143,"Moreover, the results underline that the glucocorticoid induced TNF receptor is involved in generation processes but not in suppressor function of CD8+CD28- Treg.",18832002_3,0,1,2,-1,7805,-1,5.153314e-05,0.9999025,4.602585e-05
7809,T lymphocytes to Treg,12,16,103,124,"Phenotypic analyses demonstrate that, during their commitment from circulating nonregulatory CD8+CD28- T lymphocytes to Treg (an interleukin-10-dependent process), these cells downmodulate the IL7-receptor, thus differentiating them from long-lived, memory CD8+ T lymphocytes.",18832002_4,-1,-1,-1,-1,7809,-1,0.0027601903,0.33696035,0.6602795
7811,these cells,22,24,164,175,"Phenotypic analyses demonstrate that, during their commitment from circulating nonregulatory CD8+CD28- T lymphocytes to Treg (an interleukin-10-dependent process), these cells downmodulate the IL7-receptor, thus differentiating them from long-lived, memory CD8+ T lymphocytes.",18832002_4,-1,-1,-1,-1,7811,-1,0.0025240628,0.18847077,0.8090052
7812,the IL7-receptor,25,27,189,205,"Phenotypic analyses demonstrate that, during their commitment from circulating nonregulatory CD8+CD28- T lymphocytes to Treg (an interleukin-10-dependent process), these cells downmodulate the IL7-receptor, thus differentiating them from long-lived, memory CD8+ T lymphocytes.",18832002_4,-1,-1,-1,-1,7812,-1,0.025888212,0.64575094,0.32836083
7818,to the,10,12,62,68,"Interestingly, CD8+CD28- Treg have been found to be resistant to the inhibitory effects of methylprednisolone, one of the most frequently administered corticosteroid drug used in therapy for immunosuppressive purposes.",18832002_5,-1,-1,-1,-1,7818,-1,2.279154e-05,0.9999677,9.562458e-06
7820,therapy,27,28,179,186,"Interestingly, CD8+CD28- Treg have been found to be resistant to the inhibitory effects of methylprednisolone, one of the most frequently administered corticosteroid drug used in therapy for immunosuppressive purposes.",18832002_5,0,1,-1,-1,7820,-1,2.713844e-05,0.9999583,1.4634994e-05
7832,analysis,8,9,55,63,"The forestomach of mice was dissected for histological analysis, and tunnel test was performed for apoptosis of tumor cells.",18855977_4,0,1,-1,-1,7832,-1,6.980562e-05,0.9998603,6.984211e-05
7833,tunnel test,11,13,69,80,"The forestomach of mice was dissected for histological analysis, and tunnel test was performed for apoptosis of tumor cells.",18855977_4,-1,-1,-1,-1,7833,-1,3.846424e-05,0.9999403,2.1208369e-05
7834,tumor cells,18,20,112,123,"The forestomach of mice was dissected for histological analysis, and tunnel test was performed for apoptosis of tumor cells.",18855977_4,-1,-1,-1,-1,7834,-1,0.0035574697,0.4186049,0.5778376
7839,chemokine receptors,17,19,100,119,"CD4(+)CD25(+) Tregs were sorted from different lymphoid tissues and expression of Foxp3, IL-10, and chemokine receptors was analyzed by flow cytometry, semi-quantitative and real-time polymerase chain reaction.",18855977_5,-1,-1,-1,-1,7839,-1,0.5318763,0.0040363017,0.4640874
7850,CCR5 chemokine receptors,24,27,137,161,"These CD4(+)CD25(+) Tregs in regional lymph nodes expressed higher levels of Foxp3 and IL-10, enriched in the CD62L-subset, and CCR1 and CCR5 chemokine receptors.",18855977_8,-1,-1,-1,-1,7850,-1,0.0053682346,0.0014927158,0.9931391
7855,tumor cells,25,27,151,162,"In mice gavaged with BaP + PC61, the number of tumor nodules and tumor volume decreased significantly with massive infiltrating cells and apoptosis of tumor cells.",18855977_9,-1,-1,-1,-1,7855,-1,0.004322376,0.4323105,0.5633672
7861,immunity,17,18,113,121,CONCLUSION: Inducible and activated CD4(+)CD25(+) Tregs in the draining regional lymph nodes suppress host local immunity during tumor growth.,18855977_11,0,-1,2,-1,7861,-1,0.99943024,0.0003730741,0.00019665247
7864,immunity to,9,11,56,67,Depletion of CD4(+)CD25(+) Tregs can promote host local immunity to suppress tumor growth.,18855977_12,-1,-1,-1,-1,7864,-1,0.099796884,0.8987611,0.0014419918
7873,to the,2,4,12,18,"In contrast to the increasing number of CD4(+) T cells, CD8(+), CD3(-)CD56(+), CD3(+)CD56(+), and gammadeltaT cells were all found to be under-represented in tumor infiltrating lymphocytes.",18941744_2,-1,-1,-1,-1,7873,-1,2.3864026e-05,0.9999652,1.0927394e-05
7879,the relative,2,4,9,21,"Notably, the relative abundance of CD3(+)CD56(+) cells appeared to be correlated with patient survival.",18941744_3,-1,-1,-1,-1,7879,-1,2.0457855e-05,0.9999659,1.362332e-05
7882,Functional analysis,0,2,0,19,"Functional analysis demonstrated that CD4(+) cells in the tumor tended to produce more IL-10 but less IFN-gamma, whereas CD8(+) cells showed impaired capacity for the production of both IFN-gamma and perforin.",18941744_4,-1,-1,-1,-1,7882,-1,2.7670812e-05,0.9999523,1.996025e-05
7885,the tumor tended to,8,12,54,73,"Functional analysis demonstrated that CD4(+) cells in the tumor tended to produce more IL-10 but less IFN-gamma, whereas CD8(+) cells showed impaired capacity for the production of both IFN-gamma and perforin.",18941744_4,-1,-1,-1,-1,7885,-1,1.9096597e-05,0.9999702,1.071268e-05
7893,the tumor tissue,15,18,90,106,"Consistent with previous reports, we observed a significant increase of Foxp3(+) cells in the tumor tissue.",18941744_5,-1,-1,-1,-1,7893,-1,1.8698966e-05,0.99996626,1.5000686e-05
7906,tissues,24,25,146,153,"In support of its role as a negative regulator, CD4(+)CD25(high) cells suppressed the proliferation of CD4(+)CD25(-) cells isolated from the same tissues in an APC dependent manner.",18941744_7,-1,1,2,-1,7906,-1,7.883908e-05,0.9997352,0.00018600542
7907,the tumor,3,5,15,24,"In conclusion, the tumor microenvironment of hepatocellular carcinoma is featured by the presence of multiple immunosuppressive factors.",18941744_8,-1,-1,-1,-1,7907,-1,2.0319436e-05,0.9999708,8.868484e-06
7909,factors,17,18,128,135,"In conclusion, the tumor microenvironment of hepatocellular carcinoma is featured by the presence of multiple immunosuppressive factors.",18941744_8,0,1,-1,-1,7909,-1,0.8225017,0.17459643,0.0029018498
7914,the therapeutic use,2,5,9,28,"However, the therapeutic use of cytokines has been hampered by their pleiotropic effects on target-cells.",18947877_1,-1,-1,-1,-1,7914,-1,2.8673445e-05,0.9999602,1.1097017e-05
7916,their pleiotropic,11,13,63,80,"However, the therapeutic use of cytokines has been hampered by their pleiotropic effects on target-cells.",18947877_1,-1,-1,-1,-1,7916,-1,5.9706294e-05,0.99992,2.0274385e-05
7921,side effects,12,14,68,80,"Thus, cytokines such as IFN-alpha and IL-2 have multiple and severe side effects.",18947877_2,0,1,-1,-1,7921,-1,0.0004063949,0.9994311,0.00016248347
7931,that the,2,4,8,16,We show that the combined stimulation of target-cells with IFN-alpha and IL-21 triggers an increased STAT3 activation whereas the activation of other STATs including STAT1/2 is unaffected.,18947877_5,-1,-1,-1,-1,7931,-1,1.7194776e-05,0.99997556,7.2596067e-06
7941,T-cell-mediated,24,25,138,153,"In parallel, the combined stimulation with IFN-alpha and IL-21 triggers a selective increase in MHC class I expression and NK- and CD8(+) T-cell-mediated cytotoxicity.",18947877_6,-1,1,2,-1,7941,-1,3.7628844e-05,8.5708096e-05,0.9998766
7946,Taken together,0,2,0,14,"Taken together our data show that the combined use of IFN-alpha and IL-21 boosts STAT3 signaling, cytotoxicity, and anti-tumor efficacy, suggesting that a combinatorial therapeutic use of these cytokines may benefit cancer patients.",18947877_8,-1,-1,-1,-1,7946,-1,4.1931384e-05,0.9999422,1.5839301e-05
7947,that the,5,7,29,37,"Taken together our data show that the combined use of IFN-alpha and IL-21 boosts STAT3 signaling, cytotoxicity, and anti-tumor efficacy, suggesting that a combinatorial therapeutic use of these cytokines may benefit cancer patients.",18947877_8,-1,-1,-1,-1,7947,-1,1.9178644e-05,0.9999726,8.216936e-06
7951,therapeutic use,27,29,169,184,"Taken together our data show that the combined use of IFN-alpha and IL-21 boosts STAT3 signaling, cytotoxicity, and anti-tumor efficacy, suggesting that a combinatorial therapeutic use of these cytokines may benefit cancer patients.",18947877_8,0,1,-1,-1,7951,-1,3.2822543e-05,0.9999505,1.6627137e-05
7952,these cytokines,30,32,188,203,"Taken together our data show that the combined use of IFN-alpha and IL-21 boosts STAT3 signaling, cytotoxicity, and anti-tumor efficacy, suggesting that a combinatorial therapeutic use of these cytokines may benefit cancer patients.",18947877_8,-1,-1,-1,-1,7952,-1,0.44441912,0.5465517,0.009029153
7956,tumour-infiltrating lymphocytes,12,14,66,97,"However, a group of cancers are characterized by the abundance of tumour-infiltrating lymphocytes (TILs).",18980207_1,-1,-1,-1,-1,7956,-1,0.0037203098,0.87690955,0.11937008
7974,The T-cell,0,2,0,10,The T-cell zone of the regional lymph nodes of lymphocyte-rich GCs also abounded with CXCR3(+) T cells and CXCL9(+) stromal cells.,18980207_6,-1,-1,-1,-1,7974,-1,0.0025739886,0.096646965,0.900779
7993,tertiary lymphoid tissue,18,21,111,135,"Given similar findings in the regional lymph nodes, the lymphoid stroma of lymphocyte-rich GCs may represent a tertiary lymphoid tissue with predominantly Th1-shifted immune responses.",18980207_11,-1,-1,-1,-1,7993,-1,0.0001554474,0.0010530036,0.9987915
7994,Th1-shifted immune responses,23,26,155,183,"Given similar findings in the regional lymph nodes, the lymphoid stroma of lymphocyte-rich GCs may represent a tertiary lymphoid tissue with predominantly Th1-shifted immune responses.",18980207_11,-1,-1,-1,-1,7994,-1,0.0476627,0.9503252,0.002012081
7995,T-cell,4,5,45,51,"Cutaneous CD4 small/medium-sized pleomorphic T-cell lymphoma (CSTCL) is a cutaneous T-cell lymphoma defined by a predominance of small-to-medium-sized CD4 pleomorphic T cells, with a favorable clinical course.",18987541_0,-1,1,2,-1,7995,-1,3.8074308e-05,5.4211254e-05,0.99990773
7996,T-cell,12,13,84,90,"Cutaneous CD4 small/medium-sized pleomorphic T-cell lymphoma (CSTCL) is a cutaneous T-cell lymphoma defined by a predominance of small-to-medium-sized CD4 pleomorphic T cells, with a favorable clinical course.",18987541_0,-1,1,2,-1,7996,-1,3.9231436e-05,5.8826954e-05,0.9999019
8002,TFH cells,12,14,63,72,"Recently, it has been reported that follicular helper T cells (TFH cells) display a distinct gene expression profile, positive for PD-1, CXCL13, and BCL-6.",18987541_2,-1,-1,-1,-1,8002,-1,0.0030266158,0.3517859,0.64518744
8007,time the,5,7,24,32,We report for the first time the expression of PD-1 and other TFH cell markers in CSTCLs and discuss its biologic significance.,18987541_3,-1,-1,-1,-1,8007,-1,2.1015441e-05,0.99996674,1.2262969e-05
8008,TFH cell,12,14,62,70,We report for the first time the expression of PD-1 and other TFH cell markers in CSTCLs and discuss its biologic significance.,18987541_3,-1,-1,-1,-1,8008,-1,0.00019517676,0.0009152009,0.9988896
8014,RNA,9,10,76,79,Clonal Ig and T-cell receptor rearrangements and Epstein-Barr virus-encoded RNA expression were also evaluated.,18987541_7,-1,-1,-1,-1,8014,-1,0.00015803025,0.9997135,0.00012844142
8015,throughout the,8,10,70,84,Histologic examination showed a dense polymorphic lymphoid infiltrate throughout the dermis.,18987541_9,-1,-1,-1,-1,8015,-1,3.4539713e-05,0.9999424,2.3069384e-05
8021,T-cell,2,3,11,17,"A dominant T-cell clone was identified in 14 cases, whereas polymerase chain reaction IgH gene rearrangement studies showed that all cases were polyclonal.",18987541_12,-1,1,2,-1,8021,-1,3.7368947e-05,6.4523054e-05,0.9998981
8026,history,20,21,116,123,"None of the patients had lymphadenopathy or showed any evidence of systemic disease, nor did they have any previous history of mycosis fungoides or drug reactions.",18987541_13,0,1,-1,-1,8026,-1,0.00023027882,0.99963963,0.00013011674
8033,take place,12,14,75,85,"Moreover, these findings suggest that B-cell stimulation by FTH could also take place in some cutaneous T-cell lymphomas.",18987541_15,-1,-1,-1,-1,8033,-1,3.2521868e-05,0.9999536,1.3804062e-05
8034,T-cell,17,18,104,110,"Moreover, these findings suggest that B-cell stimulation by FTH could also take place in some cutaneous T-cell lymphomas.",18987541_15,-1,1,2,-1,8034,-1,4.4967415e-05,8.424013e-05,0.9998708
8042,cellular target(s,20,22,160,177,"These drugs exhibit a range of interesting clinical properties, including anti-angiogenic, anti-proliferative, and pro-erythropoietic activities although exact cellular target(s) remain unclear.",19009291_1,-1,-1,-1,-1,8042,-1,0.0058735814,0.36243945,0.6316869
8044,TNF-alpha,8,9,61,70,"Also, anti-inflammatory effects on LPS-stimulated monocytes (TNF-alpha is decreased) and costimulatory effects on anti-CD3 stimulated T cells, (enhanced T cell proliferation and proinflammatory cytokine production) are observed.",19009291_2,0,1,-1,-1,8044,-1,0.00031489527,0.9996377,4.7375743e-05
8049,tumour-cell targets,10,12,74,93,These drugs also cause augmentation of NK-cell cytotoxic activity against tumour-cell targets.,19009291_3,-1,-1,-1,-1,8049,-1,7.662635e-05,0.99984026,8.303025e-05
8054,T-regulatory cell,25,27,195,212,"Having shown that pomalidomide confers T cell-dependent adjuvant-like protection in a preclinical whole tumour-cell vaccine-model, we now show that lenalidomide and pomalidomide strongly inhibit T-regulatory cell proliferation and suppressor-function.",19009291_4,-1,-1,-1,-1,8054,-1,0.0026922042,0.21608639,0.78122145
8060,function,3,4,24,32,"Furthermore, suppressor function of pre-treated T regulatory cells against autologous responder-cells is abolished or markedly inhibited without drug related cytotoxicity.",19009291_6,0,1,2,-1,8060,-1,0.00011975145,0.99969685,0.00018340477
8068,cell function,4,6,27,40,Inhibition of T regulatory cell function was not due to changes in TGF-beta or IL-10 production but was associated with decreased T regulatory cell FOXP3 expression.,19009291_8,-1,-1,-1,-1,8068,-1,4.4393815e-05,7.392554e-05,0.99988174
8070,TGF-beta,12,13,67,75,Inhibition of T regulatory cell function was not due to changes in TGF-beta or IL-10 production but was associated with decreased T regulatory cell FOXP3 expression.,19009291_8,0,1,-1,-1,8070,-1,5.4380533e-05,0.999926,1.9634017e-05
8073,cell FOXP3,23,25,143,153,Inhibition of T regulatory cell function was not due to changes in TGF-beta or IL-10 production but was associated with decreased T regulatory cell FOXP3 expression.,19009291_8,-1,-1,-1,-1,8073,-1,0.0057665957,0.58443105,0.40980235
8074,that they,17,19,117,126,"In conclusion, our data provide one explanation for adjuvant properties of lenalidomide and pomalidomide and suggest that they may help overcome an important barrier to tumour-specific immunity in cancer patients.",19009291_9,-1,-1,-1,-1,8074,-1,2.0854122e-05,0.99996936,9.753858e-06
8075,to tumour-specific immunity,25,28,166,193,"In conclusion, our data provide one explanation for adjuvant properties of lenalidomide and pomalidomide and suggest that they may help overcome an important barrier to tumour-specific immunity in cancer patients.",19009291_9,-1,-1,-1,-1,8075,-1,0.010230384,0.9891149,0.00065479474
8082,to the,30,32,150,156,"The New Zealand Black (NZB) mouse is a murine model for both autoimmune diseases, since high levels of autoantibodies are present, and human CLL, due to the expansion of malignant B-1 cells.",19022624_1,-1,-1,-1,-1,8082,-1,2.558647e-05,0.9999641,1.0290448e-05
8085,the functional,6,8,27,41,"In this study, we examined the functional role of CD4(+)CD25(+) Foxp3(+) Tregs in these different manifestations.",19022624_2,-1,-1,-1,-1,8085,-1,1.9522118e-05,0.9999715,8.977369e-06
8089,analysis,2,3,16,24,Flow cytometric analysis showed increased levels of Tregs in NZB mice compared to healthy C57Bl/6 controls.,19022624_3,0,1,-1,-1,8089,-1,3.1352673e-05,0.9999386,3.00303e-05
8111,to the,25,27,147,153,"These results indicate that while high levels of Tregs found in NZB mice might suppress a more severe autoimmune disease, they may also contribute to the development of the B cell malignancy.",19022624_7,-1,-1,-1,-1,8111,-1,2.2982806e-05,0.9999665,1.0455634e-05
8114,antigens to,3,5,27,38,"Lentiviral vectors deliver antigens to dendritic cells (DCs) in vivo, but they do not trigger DC maturation.",19036811_0,-1,-1,-1,-1,8114,-1,0.8990887,0.086867675,0.01404366
8130,immune response to,17,20,87,105,"When we coexpressed vFLIP in a lentivector with ovalbumin (Ova), we found an increased immune response to Ova; up to 10 times more Ova-specific CD8(+) T cells secreting gamma interferon were detected in the spleens of vFLIP_Ova-immunized mice than in the spleens of mice immunized with GFP_Ova.",19036811_4,-1,-1,-1,-1,8130,-1,0.29983816,0.6981046,0.0020572247
8139,T-cell,6,7,35,41,"Furthermore, this increased CD8(+) T-cell response correlated with improved tumor-free survival in a tumor therapy model.",19036811_5,-1,1,2,-1,8139,-1,3.6345446e-05,4.658595e-05,0.99991703
8141,tumor therapy,15,17,101,114,"Furthermore, this increased CD8(+) T-cell response correlated with improved tumor-free survival in a tumor therapy model.",19036811_5,-1,-1,-1,-1,8141,-1,2.346253e-05,0.9999645,1.201922e-05
8145,that NF-kappaB,2,4,18,32,This demonstrates that NF-kappaB activation is sufficient to induce many aspects of DC maturation and that expression of a constitutive NF-kappaB activator can improve the efficacy of a vaccine vector.,19036811_8,-1,-1,-1,-1,8145,-1,3.1660737e-05,0.9999546,1.3714441e-05
8148,NF-kappaB activator,20,22,136,155,This demonstrates that NF-kappaB activation is sufficient to induce many aspects of DC maturation and that expression of a constitutive NF-kappaB activator can improve the efficacy of a vaccine vector.,19036811_8,-1,-1,-1,-1,8148,-1,4.6712135e-05,0.99992704,2.6195887e-05
8151,to chemo-,8,10,38,47,Cancer stem cells (CSC) are resistant to chemo- and radiotherapy.,19048252_0,-1,-1,-1,-1,8151,-1,0.06557588,0.9321103,0.0023138353
8154,receptors,25,26,127,136,"To eliminate cells with phenotypic markers of CSC-like we characterized: (1) expression of CD44, CD24, CD133 and MIC-A/B (NKG2 receptors) in breast (MCF7) and ovarian (SK-OV-3) cells resistant to gemcitabine (GEM), paclitaxel (PTX) and 5-fluorouracil (5-FU) and (2) their elimination by Numb- and Notch-peptide activated CTL.",19048252_1,0,1,2,-1,8154,-1,0.003125273,0.7934297,0.20344512
8169,tumor cells,14,16,90,101,"Similarly, the number of cells with expressed MIC-A/B increased 4 times in drug-resistant tumor cells compared with drug-sensitive cells.",19048252_3,-1,-1,-1,-1,8169,-1,0.0037903276,0.45263973,0.5435699
8171,MCF7 cells,2,4,9,19,GEM(Res) MCF7 cells had lower levels of the Notch-1-extracellular domain (NECD) and Notch trans-membrane intracellular domain (TMIC) than GEM(Sens) MCF7.,19048252_4,-1,-1,-1,-1,8171,-1,0.06772624,0.001308167,0.9309656
8178,MCF7 cells,16,18,83,93,"The levels of Numb, and Numb-L-[P]-Ser(265) were similar in GEM(Res) and GEM(Sens) MCF7 cells.",19048252_5,-1,-1,-1,-1,8178,-1,0.051028356,0.0017805904,0.9471911
8182,to TMIC,6,8,44,51,This finding suggests that Notch-1 cleavage to TMIC is inhibited in GEM(Res) MCF7 cells.,19048252_7,-1,-1,-1,-1,8182,-1,4.439883e-05,0.99993277,2.2874514e-05
8183,MCF7 cells,13,15,77,87,This finding suggests that Notch-1 cleavage to TMIC is inhibited in GEM(Res) MCF7 cells.,19048252_7,-1,-1,-1,-1,8183,-1,0.020018885,0.0012625273,0.97871864
8185,peptides,5,6,38,46,"PBMC activated by natural immunogenic peptides Notch-1 (2112-2120) and Numb-1 (87-95) eliminated NICD(positive), CD24(hi) CD24(lo) MCF7 cells.",19048252_8,0,-1,2,-1,8185,-1,0.00012155268,0.9997613,0.00011720159
8186,MCF7 cells,27,29,131,141,"PBMC activated by natural immunogenic peptides Notch-1 (2112-2120) and Numb-1 (87-95) eliminated NICD(positive), CD24(hi) CD24(lo) MCF7 cells.",19048252_8,-1,-1,-1,-1,8186,-1,0.55898625,0.0026318359,0.43838194
8187,that the,3,5,13,21,"It is likely that the immunogenic Numb-1 peptide in MCF7 cells originated from Numb, [P]-lated by an unknown kinase, because staurosporine but not wortmannin and MAPK-inhibitors decreased peptide presentation.",19048252_9,-1,-1,-1,-1,8187,-1,2.1740074e-05,0.999969,9.260612e-06
8188,peptide,7,8,41,48,"It is likely that the immunogenic Numb-1 peptide in MCF7 cells originated from Numb, [P]-lated by an unknown kinase, because staurosporine but not wortmannin and MAPK-inhibitors decreased peptide presentation.",19048252_9,0,-1,2,-1,8188,-1,0.00031955275,0.9994856,0.00019481237
8189,MCF7 cells,9,11,52,62,"It is likely that the immunogenic Numb-1 peptide in MCF7 cells originated from Numb, [P]-lated by an unknown kinase, because staurosporine but not wortmannin and MAPK-inhibitors decreased peptide presentation.",19048252_9,-1,-1,-1,-1,8189,-1,0.015584247,0.0014381931,0.9829776
8190,peptide,29,30,188,195,"It is likely that the immunogenic Numb-1 peptide in MCF7 cells originated from Numb, [P]-lated by an unknown kinase, because staurosporine but not wortmannin and MAPK-inhibitors decreased peptide presentation.",19048252_9,0,-1,2,-1,8190,-1,0.0004301013,0.99947745,9.2522525e-05
8191,proteins,5,6,32,40,"Numb and Notch are antagonistic proteins which degrade each other to stop and activate cell proliferation, respectively.",19048252_10,0,1,-1,-1,8191,-1,0.000120864315,0.9997632,0.000115970564
8194,Their peptides,0,2,0,14,Their peptides are presented alternatively.,19048252_11,-1,-1,-1,-1,8194,-1,9.703131e-05,0.9998367,6.630719e-05
8196,proteins,3,4,28,36,Targeting both antagonistic proteins should be useful to prevent metastases in patients whose tumors are resistant to conventional treatments.,19048252_12,0,1,-1,-1,8196,-1,5.638606e-05,0.999884,5.9570317e-05
8206,T-cell,10,11,53,59,IDO has recently been established as a key enzyme in T-cell suppression-mediated immune tolerance to tumors.,19075017_1,-1,1,2,-1,8206,-1,3.759452e-05,5.137503e-05,0.99991107
8207,tolerance to tumors,13,16,88,107,IDO has recently been established as a key enzyme in T-cell suppression-mediated immune tolerance to tumors.,19075017_1,-1,-1,-1,-1,8207,-1,2.2742188e-05,0.99996483,1.23990285e-05
8209,to play,3,5,30,37,"STAT1 phosphorylation appears to play an important role in the control of IDO expression by IFNgamma, but the precise regulatory mechanism remains obscure.",19075017_2,-1,-1,-1,-1,8209,-1,2.656527e-05,0.9999628,1.0680947e-05
8221,protein,14,15,105,112,"We found that curcumin suppressed STAT1 activation by directly inhibiting Janus-activated kinase 1/2 and protein kinase Cdelta phosphorylation in bone marrow-derived DCs, suppressing the subsequent translocation and binding of STAT1 to the GAS element of the IRF-1 promoter.",19075017_5,0,1,-1,-1,8221,-1,3.9630213e-05,0.9998988,6.154096e-05
8224,STAT1 to the,30,33,227,239,"We found that curcumin suppressed STAT1 activation by directly inhibiting Janus-activated kinase 1/2 and protein kinase Cdelta phosphorylation in bone marrow-derived DCs, suppressing the subsequent translocation and binding of STAT1 to the GAS element of the IRF-1 promoter.",19075017_5,-1,-1,-1,-1,8224,-1,1.7927376e-05,0.9999709,1.1187511e-05
8225,the IRF-1,36,38,255,264,"We found that curcumin suppressed STAT1 activation by directly inhibiting Janus-activated kinase 1/2 and protein kinase Cdelta phosphorylation in bone marrow-derived DCs, suppressing the subsequent translocation and binding of STAT1 to the GAS element of the IRF-1 promoter.",19075017_5,-1,-1,-1,-1,8225,-1,1.9663454e-05,0.9999678,1.2551169e-05
8228,T-cell,15,16,123,129,"Coincident with these inhibitory effects on IFNgamma-induced IDO expression, curcumin reversed IDO-mediated suppression of T-cell responses.",19075017_6,-1,1,2,-1,8228,-1,5.181078e-05,7.514213e-05,0.99987304
8236,factor-beta-signaling,6,7,50,71,Alterations in genes encoding transforming growth factor-beta-signaling components contribute to colon cancer in humans.,19119184_0,0,1,-1,-1,8236,-1,0.99370474,0.0050179926,0.0012772782
8238,the transforming growth factor-beta,5,9,29,64,"Similarly, mice deficient in the transforming growth factor-beta signaling molecule, Smad3, develop colon cancer, but only after a bacterial trigger occurs, resulting in chronic inflammation.",19119184_1,-1,-1,-1,-1,8238,-1,0.5671195,0.4293316,0.0035488855
8242,Smad3-null lymphocytes,3,5,21,43,"To determine whether Smad3-null lymphocytes contribute to increased cancer susceptibility, we crossed Smad3-null mice with mice deficient in both B and T lymphocytes (Rag2(-/-) mice).",19119184_2,-1,-1,-1,-1,8242,-1,0.0026625649,0.9082092,0.089128286
8247,T-regulatory cells,6,8,38,56,"Adoptive transfer of WT CD4(+)CD25(+) T-regulatory cells provided significant protection of Smad3/Rag2-DKO from bacterial-induced typhlocolitis, dysplasia, and tumor development, whereas Smad3(-/-) T-regulatory cells provided no protection.",19119184_4,-1,-1,-1,-1,8247,-1,0.0019947307,0.11274879,0.88525647
8250,T-regulatory cells,26,28,198,216,"Adoptive transfer of WT CD4(+)CD25(+) T-regulatory cells provided significant protection of Smad3/Rag2-DKO from bacterial-induced typhlocolitis, dysplasia, and tumor development, whereas Smad3(-/-) T-regulatory cells provided no protection.",19119184_4,-1,-1,-1,-1,8250,-1,0.0017480843,0.08700856,0.91124344
8252,tissues,14,15,118,125,"Immunohistochemistry, real-time reverse transcriptase-polymerase chain reaction, and Western blot analyses of colonic tissues from Smad3/Rag2-DKO mice 1 week after Helicobacter infection revealed an influx of macrophages, enhanced nuclear factor-kappaB activation, increased Bcl(XL)/Bcl-2 expression, increased c-Myc expression, accentuated epithelial cell proliferation, and up-regulated IFN-gamma, IL-1alpha, TNF-alpha, IL-1beta, and IL-6 transcription levels.",19119184_5,-1,1,2,-1,8252,-1,4.8592425e-05,0.9997837,0.00016772533
8257,TNF-alpha,53,54,411,420,"Immunohistochemistry, real-time reverse transcriptase-polymerase chain reaction, and Western blot analyses of colonic tissues from Smad3/Rag2-DKO mice 1 week after Helicobacter infection revealed an influx of macrophages, enhanced nuclear factor-kappaB activation, increased Bcl(XL)/Bcl-2 expression, increased c-Myc expression, accentuated epithelial cell proliferation, and up-regulated IFN-gamma, IL-1alpha, TNF-alpha, IL-1beta, and IL-6 transcription levels.",19119184_5,0,1,-1,-1,8257,-1,0.0015258896,0.9982504,0.00022362891
8259,IL-6 transcription,58,60,436,454,"Immunohistochemistry, real-time reverse transcriptase-polymerase chain reaction, and Western blot analyses of colonic tissues from Smad3/Rag2-DKO mice 1 week after Helicobacter infection revealed an influx of macrophages, enhanced nuclear factor-kappaB activation, increased Bcl(XL)/Bcl-2 expression, increased c-Myc expression, accentuated epithelial cell proliferation, and up-regulated IFN-gamma, IL-1alpha, TNF-alpha, IL-1beta, and IL-6 transcription levels.",19119184_5,-1,-1,-1,-1,8259,-1,0.9926111,0.0042778477,0.0031111278
8261,that the,3,5,22,30,"These results suggest that the loss of Smad3 increases susceptibility to colon cancer by at least two mechanisms: deficient T-regulatory cell function, which leads to excessive inflammation after a bacterial trigger; and increased expression of proinflammatory cytokines, enhanced nuclear factor-kappaB activation, and increased expression of both pro-oncogenic and anti-apoptotic proteins that result in increased cell proliferation/survival of epithelial cells in colonic tissues.",19119184_6,-1,-1,-1,-1,8261,-1,1.6502276e-05,0.9999763,7.269339e-06
8265,T-regulatory cell function,20,23,124,150,"These results suggest that the loss of Smad3 increases susceptibility to colon cancer by at least two mechanisms: deficient T-regulatory cell function, which leads to excessive inflammation after a bacterial trigger; and increased expression of proinflammatory cytokines, enhanced nuclear factor-kappaB activation, and increased expression of both pro-oncogenic and anti-apoptotic proteins that result in increased cell proliferation/survival of epithelial cells in colonic tissues.",19119184_6,-1,-1,-1,-1,8265,-1,0.002240993,0.5028875,0.4948715
8270,proteins that,54,56,381,394,"These results suggest that the loss of Smad3 increases susceptibility to colon cancer by at least two mechanisms: deficient T-regulatory cell function, which leads to excessive inflammation after a bacterial trigger; and increased expression of proinflammatory cytokines, enhanced nuclear factor-kappaB activation, and increased expression of both pro-oncogenic and anti-apoptotic proteins that result in increased cell proliferation/survival of epithelial cells in colonic tissues.",19119184_6,-1,-1,-1,-1,8270,-1,3.6145728e-05,0.999944,1.9886646e-05
8273,tissues,66,67,474,481,"These results suggest that the loss of Smad3 increases susceptibility to colon cancer by at least two mechanisms: deficient T-regulatory cell function, which leads to excessive inflammation after a bacterial trigger; and increased expression of proinflammatory cytokines, enhanced nuclear factor-kappaB activation, and increased expression of both pro-oncogenic and anti-apoptotic proteins that result in increased cell proliferation/survival of epithelial cells in colonic tissues.",19119184_6,-1,1,2,-1,8273,-1,0.00010508144,0.9993587,0.000536154
8274,the immune response,9,12,73,92,INTRODUCTION: Periapical chronic lesion formation involves activation of the immune response and alveolar bone resorption around the tooth apex.,19121066_0,-1,-1,-1,-1,8274,-1,0.13582869,0.8630213,0.0011499753
8275,the tooth,17,19,129,138,INTRODUCTION: Periapical chronic lesion formation involves activation of the immune response and alveolar bone resorption around the tooth apex.,19121066_0,-1,-1,-1,-1,8275,-1,3.2599983e-05,0.9999436,2.384215e-05
8281,T-regulatory cell,17,19,62,79,"However, the overall roles of T helper type 1 (Th1), Th2, and T-regulatory cell (Treg) responses and osteoclast regulatory factors in periapical cysts and granulomas have not been fully determined.",19121066_1,-1,-1,-1,-1,8281,-1,0.0035799998,0.28335726,0.7130627
8283,factors,26,27,123,130,"However, the overall roles of T helper type 1 (Th1), Th2, and T-regulatory cell (Treg) responses and osteoclast regulatory factors in periapical cysts and granulomas have not been fully determined.",19121066_1,0,1,-1,-1,8283,-1,0.0001533895,0.9997613,8.5301515e-05
8290,factors,30,31,176,183,"This study aimed to investigate whether different forms of apical periodontitis, namely cysts and granulomas, show different balances of Th1, Th2 regulators, Treg markers, and factors involved in osteoclast chemotaxis and activation.",19121066_2,0,1,-1,-1,8290,-1,0.04457334,0.9537413,0.0016853714
8293,these factors,5,7,28,41,"METHODS: Gene expression of these factors was assessed using quantitative real-time polymerase chain reaction, in samples obtained from healthy gingiva (n = 8), periapical granulomas (n = 20), and cysts (n = 10).RESULTS: Periapical cysts exhibited a greater expression of GATA-3, while a greater expression of T-bet, Foxp3, and interleukin-10 (IL-10) was seen in granulomas.",19121066_3,-1,-1,-1,-1,8293,-1,0.00020790381,0.9997154,7.673656e-05
8302,factors,2,3,23,30,"Regarding osteoclastic factors, while the expression of SDF-1alpha/CXCL12 and CCR1 was higher in cysts, the expression of RANKL was significantly higher in granulomas.",19121066_5,0,1,-1,-1,8302,-1,0.6876232,0.30003044,0.012346301
8307,the Th1,16,18,108,115,CONCLUSION: Our results showed a predominance of osteoclast activity in granulomas that was correlated with the Th1 response.,19121066_7,-1,-1,-1,-1,8307,-1,2.693229e-05,0.99994826,2.479487e-05
8310,the Th1,12,14,83,90,The concomitant expression of Treg cell markers suggests a possible suppression of the Th1 response in granulomas.,19121066_8,-1,-1,-1,-1,8310,-1,2.5204172e-05,0.99995315,2.1639036e-05
8312,the Th2,7,9,28,35,"On the other hand, in cysts the Th2 activity is augmented.",19121066_9,-1,-1,-1,-1,8312,-1,3.9818075e-05,0.99994254,1.7621742e-05
8323,that T(Reg,9,11,44,54,"In multiple myeloma (MM), evidence suggests that T(Reg) cells are increased though controversy exists with regards to their function and no relationship to disease stage and treatment has been demonstrated.",19133978_1,-1,-1,-1,-1,8323,-1,2.0926716e-05,0.99996734,1.1788624e-05
8326,to their function,20,23,115,132,"In multiple myeloma (MM), evidence suggests that T(Reg) cells are increased though controversy exists with regards to their function and no relationship to disease stage and treatment has been demonstrated.",19133978_1,-1,-1,-1,-1,8326,-1,4.9080027e-05,0.9999224,2.85327e-05
8327,relationship to,25,27,140,155,"In multiple myeloma (MM), evidence suggests that T(Reg) cells are increased though controversy exists with regards to their function and no relationship to disease stage and treatment has been demonstrated.",19133978_1,-1,-1,-1,-1,8327,-1,3.0582316e-05,0.99995005,1.9370407e-05
8329,functional,8,9,54,64,"Here, we demonstrate significantly elevated levels of functional CD4(+)CD25(+)FoxP3(+) T(Reg) cells in a large cohort of patients with MM as well as monoclonal gammopathy of uncertain significance (MGUS) in comparison to age-matched, healthy controls.",19133978_2,0,1,2,-1,8329,-1,3.542862e-05,0.9999342,3.03369e-05
8336,that these cells,13,16,80,96,"The frequency of Double Negative T(Reg) cells was also evaluated, demonstrating that these cells were reduced in patients with MM.",19133978_3,-1,-1,-1,-1,8336,-1,0.0036708035,0.77305263,0.22327656
8339,blood,11,12,86,91,"Furthermore, a characteristic profile of immunomodulatory cytokines in the peripheral blood and bone marrow of patients with MM and MGUS was demonstrated, compared with healthy controls.",19133978_4,0,1,-1,-1,8339,-1,0.0001052951,0.9994148,0.0004798723
8341,to the,5,7,32,38,This data adds further evidence to the understanding of the role of T(Reg) cell subsets in tumour immunology and the fundamentals of the host/tumour immune conflict.,19133978_5,-1,-1,-1,-1,8341,-1,2.519442e-05,0.9999639,1.0946184e-05
8344,cell subsets,14,16,75,87,This data adds further evidence to the understanding of the role of T(Reg) cell subsets in tumour immunology and the fundamentals of the host/tumour immune conflict.,19133978_5,-1,-1,-1,-1,8344,-1,4.2633103e-05,4.8823327e-05,0.99990845
8345,tumour immunology,17,19,91,108,This data adds further evidence to the understanding of the role of T(Reg) cell subsets in tumour immunology and the fundamentals of the host/tumour immune conflict.,19133978_5,-1,-1,-1,-1,8345,-1,0.00071483746,0.9991026,0.00018254212
8351,to their,13,15,74,82,Regulatory T-cells (Treg) have been the focus of immunologic research due to their role in establishing tolerance for harmless antigens versus allowing immune responses against foes.,19147574_0,-1,-1,-1,-1,8351,-1,2.1325364e-05,0.9999695,9.227813e-06
8356,protein,8,9,58,65,"Increased Treg frequencies measured by mRNA expression or protein synthesis of the Treg marker FOXP3 were found in various cancers, indicating that dysregulation of Treg levels contributes to tumor establishment.",19147574_1,0,1,-1,-1,8356,-1,0.00027873873,0.99952173,0.00019959315
8357,the Treg,11,13,79,87,"Increased Treg frequencies measured by mRNA expression or protein synthesis of the Treg marker FOXP3 were found in various cancers, indicating that dysregulation of Treg levels contributes to tumor establishment.",19147574_1,-1,-1,-1,-1,8357,-1,2.998087e-05,0.9999546,1.5455718e-05
8361,to tumor,28,30,189,197,"Increased Treg frequencies measured by mRNA expression or protein synthesis of the Treg marker FOXP3 were found in various cancers, indicating that dysregulation of Treg levels contributes to tumor establishment.",19147574_1,-1,-1,-1,-1,8361,-1,2.251217e-05,0.9999672,1.0242602e-05
8365,transplantation,15,16,93,108,"Furthermore, they constitute a key target of immunomodulatory therapies in cancer as well as transplantation settings.",19147574_2,-1,1,2,-1,8365,-1,4.217182e-05,0.9999387,1.9042747e-05
8371,protein,20,21,98,105,"One core obstacle for understanding the role of Treg, thus far, is the inability of FOXP3 mRNA or protein detection methods to differentiate between Treg and activated T cells.",19147574_3,0,1,-1,-1,8371,-1,0.00037601378,0.99947995,0.00014409704
8376,the technical,5,7,37,50,These difficulties are aggravated by the technical demands of sample logistics and processing.,19147574_4,-1,-1,-1,-1,8376,-1,2.6943568e-05,0.99996066,1.2434026e-05
8378,the FOXP3,6,8,48,57,"Based on Treg-specific DNA demethylation within the FOXP3 locus, we present a novel method for monitoring Treg in human peripheral blood and solid tissues.",19147574_5,-1,-1,-1,-1,8378,-1,1.958848e-05,0.9999691,1.1262501e-05
8380,blood,21,22,131,136,"Based on Treg-specific DNA demethylation within the FOXP3 locus, we present a novel method for monitoring Treg in human peripheral blood and solid tissues.",19147574_5,0,1,-1,-1,8380,-1,0.00020278925,0.99725276,0.0025444727
8381,tissues,24,25,147,154,"Based on Treg-specific DNA demethylation within the FOXP3 locus, we present a novel method for monitoring Treg in human peripheral blood and solid tissues.",19147574_5,-1,1,2,-1,8381,-1,0.00043647774,0.9813967,0.018166779
8382,that Treg,2,4,9,18,We found that Treg numbers are significantly increased in the peripheral blood of patients with interleukin 2-treated melanoma and in formalin-fixed tissue from patients with lung and colon carcinomas.,19147574_6,-1,-1,-1,-1,8382,-1,2.5507587e-05,0.9999596,1.4940693e-05
8384,blood,11,12,73,78,We found that Treg numbers are significantly increased in the peripheral blood of patients with interleukin 2-treated melanoma and in formalin-fixed tissue from patients with lung and colon carcinomas.,19147574_6,0,1,-1,-1,8384,-1,0.00012054394,0.9990767,0.0008027186
8386,tissue,21,22,149,155,We found that Treg numbers are significantly increased in the peripheral blood of patients with interleukin 2-treated melanoma and in formalin-fixed tissue from patients with lung and colon carcinomas.,19147574_6,-1,1,2,-1,8386,-1,4.9071135e-05,0.9998072,0.00014375393
8388,therapy,6,7,43,50,"Conversely, we show that immunosuppressive therapy including therapeutic antibodies leads to a significant reduction of Treg from the peripheral blood of transplantation patients.",19147574_7,0,1,-1,-1,8388,-1,2.15941e-05,0.99996674,1.16454985e-05
8393,blood,20,21,145,150,"Conversely, we show that immunosuppressive therapy including therapeutic antibodies leads to a significant reduction of Treg from the peripheral blood of transplantation patients.",19147574_7,0,1,-1,-1,8393,-1,7.451226e-05,0.99956447,0.00036096538
8394,transplantation,22,23,154,169,"Conversely, we show that immunosuppressive therapy including therapeutic antibodies leads to a significant reduction of Treg from the peripheral blood of transplantation patients.",19147574_7,-1,1,2,-1,8394,-1,2.1698705e-05,0.99996686,1.1461816e-05
8397,blood,11,12,70,75,"In addition, Treg numbers are predictively elevated in the peripheral blood of patients with various solid tumors.",19147574_8,0,1,-1,-1,8397,-1,0.00016275446,0.99748033,0.002356976
8402,protein-based,12,13,81,94,"Although our data generally correspond to data obtained with gene expression and protein-based methods, the results are less fluctuating and more specific to Treg.",19147574_9,0,1,-1,-1,8402,-1,9.417957e-05,0.9998305,7.526078e-05
8404,to Treg,23,25,155,162,"Although our data generally correspond to data obtained with gene expression and protein-based methods, the results are less fluctuating and more specific to Treg.",19147574_9,-1,-1,-1,-1,8404,-1,2.5772155e-05,0.9999633,1.0898867e-05
8407,in blood,7,9,48,56,"The assay presented here measures Treg robustly in blood and solid tissues regardless of conservation levels, promising fast screening of Treg in various clinical settings.",19147574_10,0,1,-1,-1,8407,-1,3.432303e-05,0.99994147,2.415952e-05
8408,tissues,11,12,67,74,"The assay presented here measures Treg robustly in blood and solid tissues regardless of conservation levels, promising fast screening of Treg in various clinical settings.",19147574_10,-1,1,2,-1,8408,-1,7.921991e-05,0.99948347,0.00043723598
8419,blood,1,2,11,16,Peripheral blood mononuclear cells (PBMCs) from cancer patients were cultivated in vitro in the presence of a high-affinity chimeric anti-CD25 Ab (basiliximab).,19148493_2,0,1,-1,-1,8419,-1,0.00011736175,0.999419,0.0004636969
8427,analysis,32,33,227,235,"The CD4+CD25high population, interferon-gamma (IFN-gamma) production and FOXP3 expression were analyzed using flow cytometry (FCM), enzyme-linked immunosorbent assay and reverse transcriptase-polymerase chain reaction (RT-PCR) analysis, respectively.",19148493_3,0,1,-1,-1,8427,-1,3.6180198e-05,0.9999281,3.5713012e-05
8429,the treatment,25,27,146,159,"During in vivo studies, basiliximab was administered intravenously on day 1, followed by AIT using autologous activated lymphocytes on day 8, and the treatment cycle was repeated.",19148493_4,-1,-1,-1,-1,8429,-1,2.7652082e-05,0.99995995,1.2438038e-05
8431,analysis,17,18,101,109,"Subjective and objective effects were observed, and patients' PBMCs were subjected to FCM and RT-PCR analysis.",19148493_5,0,1,-1,-1,8431,-1,3.3448225e-05,0.99992526,4.129241e-05
8432,analysis,2,3,9,17,"In vitro analysis revealed that a low concentration of 0.01 microg/ml basiliximab reduced almost all of CD4+CD25high cells, but less of the CD4+ CD25low cells, and augmented IFN-gamma production of activated PBMCs.",19148493_6,0,1,-1,-1,8432,-1,3.4086657e-05,0.99993646,2.9455634e-05
8439,adverse effects,21,23,121,136,"An in vivo study of 9 metastatic cancer patients (7 colorectal and 2 esophageal) demonstrated no subjective or objective adverse effects, even under repeated administration of basiliximab.",19148493_8,0,1,-1,-1,8439,-1,0.0002885164,0.99951196,0.0001995754
8453,that the,4,6,32,40,We investigated the possibility that the mechanism of Treg suppression depends on Fas/FasL-mediated apoptosis of responder cells (RC).,19155494_1,-1,-1,-1,-1,8453,-1,1.6993923e-05,0.9999751,7.97923e-06
8458,blood,16,17,110,115,CD4(+)CD25(high)Foxp3(+) Treg and autologous CD4(+)CD25(-) and CD8(+)CD25(-) subsets of RC were isolated from blood of 25 cancer patients and 15 normal controls and cocultured in the presence of OKT3 and IL-2 (150 or 1000 IU/ml).,19155494_2,0,1,-1,-1,8458,-1,4.3206233e-05,0.99988306,7.3700445e-05
8463,These Treg,0,2,0,10,"These Treg, when activated via TCR plus IL-2, up-regulated CD95 and CD95L expression (p < 0.001) and suppressed CD8(+) RC proliferation (p < 0.001) by inducing Fas-mediated apoptosis.",19155494_6,-1,-1,-1,-1,8463,-1,2.4781033e-05,0.99995947,1.5772046e-05
8464,TCR plus,6,8,31,39,"These Treg, when activated via TCR plus IL-2, up-regulated CD95 and CD95L expression (p < 0.001) and suppressed CD8(+) RC proliferation (p < 0.001) by inducing Fas-mediated apoptosis.",19155494_6,-1,-1,-1,-1,8464,-1,2.6701851e-05,0.9999554,1.7913342e-05
8480,the CTL,9,11,52,59,"OBJECTIVE: To study the mechanism of enhancement of the CTL activity in mice co-expressing of CD80, CD86 and CD137L genes.",19173904_0,-1,-1,-1,-1,8480,-1,0.0036948838,0.20779257,0.7885125
8490,tumor cells,15,17,68,79,"On the 14th, 35th, 56th and 84th day after the first inoculation of tumor cells, TUNEL staining and DNA ladder examination were used to detect apoptosis of splenic T lymphocytes in all groups at each post-inoculation time point.",19173904_3,-1,-1,-1,-1,8490,-1,0.0037680066,0.34062117,0.65561086
8503,than that,21,23,97,106,"RESULTS: Apoptosis was found in a great number of T lymphocytes in CG on the 14th day, much more than that in group C and E. The number of apoptotic T cells in group C had a significant difference compared with that in the group E from 14th to 84th day (P = 0.003).",19173904_5,-1,-1,-1,-1,8503,-1,3.0272844e-05,0.99994814,2.1592565e-05
8509,analysis,2,3,11,19,"DNA ladder analysis showed typical positive results in group C and E. The significant apoptosis fragments were found in group C on 21st, 35th and 84th days.",19173904_6,0,1,-1,-1,8509,-1,7.0044e-05,0.99981517,0.00011485642
8514,than that,13,15,70,79,"NF-kappaB activity of T cells in groups C and E was remarkably higher than that of groups CG and D, with higher in group D than that of CG (P = 0.002), and with no significant difference between group C and E on 14th day.",19173904_7,-1,-1,-1,-1,8514,-1,2.54561e-05,0.9999571,1.7443857e-05
8515,than that,26,28,123,132,"NF-kappaB activity of T cells in groups C and E was remarkably higher than that of groups CG and D, with higher in group D than that of CG (P = 0.002), and with no significant difference between group C and E on 14th day.",19173904_7,-1,-1,-1,-1,8515,-1,2.9793915e-05,0.9999467,2.3467706e-05
8517,than that,10,12,57,66,The activity in group E was stable and remarkably higher than that of group C on 56th and 84th days after the first inoculation.,19173904_8,-1,-1,-1,-1,8517,-1,2.494665e-05,0.9999591,1.5981548e-05
8534,this treatment,24,26,177,191,"PURPOSE: The administration of interleukin-2 (IL-2) may increase the frequency of peripherally circulating FOXP3-positive regulatory immune cells, thus potentially compromising this treatment option for patients with metastatic renal cell carcinoma.",19188179_0,-1,-1,-1,-1,8534,-1,3.007752e-05,0.99995816,1.1736332e-05
8537,therapy,4,5,25,32,The impact of IL-2-based therapy on the accumulation of FOXP3-positive immune cells in the tumor microenvironment in metastatic renal cell carcinoma is unknown.,19188179_1,0,1,-1,-1,8537,-1,2.3463097e-05,0.9999658,1.075814e-05
8541,the tumor,13,15,87,96,The impact of IL-2-based therapy on the accumulation of FOXP3-positive immune cells in the tumor microenvironment in metastatic renal cell carcinoma is unknown.,19188179_1,-1,-1,-1,-1,8541,-1,2.1129596e-05,0.99996984,8.988491e-06
8548,cell subsets,15,17,123,135,Immunohistochemical expression of FOXP3 was estimated by stereological counting technique and correlated with other immune cell subsets and overall survival.,19188179_3,-1,-1,-1,-1,8548,-1,4.196796e-05,4.8047626e-05,0.99991
8551,The relative,0,2,0,12,"The relative increase in individual patients was median 4.7-fold, range 0.3 to 230.",19188179_5,-1,-1,-1,-1,8551,-1,3.0101683e-05,0.9999496,2.0318925e-05
8553,FOXP3-positive cells,0,2,0,20,"FOXP3-positive cells were positively correlated with CD3-positive, CD4-positive, and CD8-positive tumor-infiltrating immune cells at baseline and during treatment (P < 0.05 in all comparisons).",19188179_6,-1,-1,-1,-1,8553,-1,0.0019926247,0.9200044,0.07800287
8559,FOXP3-positive cells,39,41,214,234,"All patients achieving high numbers (>180 cells/mm2) of on-treatment FOXP3-positive intratumoral immune cells were dead within 22 months (n = 11), whereas patients with low numbers (<180 cells/mm2) of on-treatment FOXP3-positive cells (n = 31) had a 5-year survival rate of 19% (hazard ratio, 2.2; confidence interval, 1.03-4.5; P = 0.043).",19188179_7,-1,-1,-1,-1,8559,-1,0.00221462,0.9099082,0.087877244
8560,FOXP3-positive cells,7,9,59,79,All long-term survivors were characterized by low-baseline FOXP3-positive cells and a modest absolute rise in FOXP3-positive cells.,19188179_8,-1,-1,-1,-1,8560,-1,0.0020789816,0.9097479,0.08817308
8561,FOXP3-positive cells,15,17,110,130,All long-term survivors were characterized by low-baseline FOXP3-positive cells and a modest absolute rise in FOXP3-positive cells.,19188179_8,-1,-1,-1,-1,8561,-1,0.0023520237,0.8630637,0.13458432
8564,FOXP3-positive cells,18,20,154,174,"CONCLUSION: Intratumoral FOXP3-positive regulatory immune cells significantly increased during IL-2-based immunotherapy, and high numbers of on-treatment FOXP3-positive cells were correlated with poor prognosis in patients with metastatic renal cell carcinoma.",19188179_9,-1,-1,-1,-1,8564,-1,0.0022377563,0.92491275,0.07284949
8568,to interleukin 6,20,23,112,128,"Suppressor of cytokine signaling 3 (SOCS3) expression in bone marrow cells (BMC) was up-regulated upon exposure to interleukin 6, lipopolysaccharide, or tumor-associated factors.",19190337_0,-1,-1,-1,-1,8568,-1,0.62911946,0.36661485,0.00426569
8569,tumor-associated factors,27,29,153,177,"Suppressor of cytokine signaling 3 (SOCS3) expression in bone marrow cells (BMC) was up-regulated upon exposure to interleukin 6, lipopolysaccharide, or tumor-associated factors.",19190337_0,-1,-1,-1,-1,8569,-1,0.0033518842,0.9962985,0.0003496044
8574,tissue,8,9,40,46,"Importantly, lung can be as one athymus tissue for the BMCs to differentiate into CD8(+) T cells.",19190337_3,-1,1,2,-1,8574,-1,0.00024764976,0.99618053,0.0035718798
8582,that the,2,4,12,20,"We conclude that the up-regulated SOCS3 in some pathologic conditions, such as tumor and inflammation, might promote BMCs to differentiate into CD8(+) T lymphocytes in lung tissue via up-regulating Notch1 expression.",19190337_5,-1,-1,-1,-1,8582,-1,1.9138006e-05,0.9999714,9.499767e-06
8586,tissue,29,30,173,179,"We conclude that the up-regulated SOCS3 in some pathologic conditions, such as tumor and inflammation, might promote BMCs to differentiate into CD8(+) T lymphocytes in lung tissue via up-regulating Notch1 expression.",19190337_5,-1,1,2,-1,8586,-1,4.8697675e-05,0.99985206,9.926976e-05
8593,to tumor,21,23,162,170,"Established tumors suppress antitumor immune responses and induce tolerance by incompletely characterized mechanisms, and this phenomenon is an important barrier to tumor immunotherapy.",19223534_0,-1,-1,-1,-1,8593,-1,4.4950146e-05,0.9999378,1.725441e-05
8594,tumor cells,3,5,24,35,Single vaccination with tumor cells expressing gp96-Ig stimulates robust expansion of tumor-specific CTLs in tumor-nave mice and this expansion is inhibited by established tumors.,19223534_1,-1,-1,-1,-1,8594,-1,0.0041510616,0.29762354,0.6982254
8595,tumor-specific CTLs,11,13,86,105,Single vaccination with tumor cells expressing gp96-Ig stimulates robust expansion of tumor-specific CTLs in tumor-nave mice and this expansion is inhibited by established tumors.,19223534_1,-1,-1,-1,-1,8595,-1,0.0045401687,0.736391,0.25906882
8604,tumor-specific CTL,10,12,82,100,Comparison of responders to nonresponders revealed an inverse correlation between tumor-specific CTL expansion in the peripheral blood and tumor size.,19223534_4,-1,-1,-1,-1,8604,-1,0.0043502366,0.7267955,0.26885423
8606,blood,16,17,129,134,Comparison of responders to nonresponders revealed an inverse correlation between tumor-specific CTL expansion in the peripheral blood and tumor size.,19223534_4,0,1,-1,-1,8606,-1,0.00059200876,0.9462416,0.05316638
8624,immunity,27,28,160,168,"These data show that up-regulation of T-bet, RORgammat, IFNgamma, CCL8, CXCL9, and CXCL10 at the vaccination site are associated with vaccine-induced antitumor immunity.",19223534_7,0,-1,2,-1,8624,-1,0.99900776,0.0006987336,0.00029352275
8628,blood,10,11,68,73,"These data correlate with increased CTL expansion in the peripheral blood of responders, increased infiltration of responder tumors by CD8+ cells and interleukin-17+ cells, and decreased infiltration of responder tumors by CD11b+Gr-1+ cells and FoxP3+ cells.",19223534_8,0,1,-1,-1,8628,-1,7.464036e-05,0.99971527,0.00021002015
8639,Taken together,0,2,0,14,"Taken together, our data suggest that established tumors may escape immunosurveillance by preventing clonal expansion of tumor-specific CTL without inducing anergy.",19223534_11,-1,-1,-1,-1,8639,-1,4.3060278e-05,0.9999411,1.5799591e-05
8642,tumor-specific CTL,17,19,121,139,"Taken together, our data suggest that established tumors may escape immunosurveillance by preventing clonal expansion of tumor-specific CTL without inducing anergy.",19223534_11,-1,-1,-1,-1,8642,-1,0.0051724785,0.73866504,0.25616252
8654,protein,21,22,125,132,"In our panel of human clones, this stable epigenetic mark correlated better with suppressive activity than did FOXP3 mRNA or protein expression.",19224638_2,0,1,-1,-1,8654,-1,6.700113e-05,0.999889,4.3926295e-05
8658,function,18,19,113,121,"We used expression microarrays to compare Treg and Th clones after activation, which is required for suppressive function.",19224638_3,0,1,2,-1,8658,-1,5.5644723e-05,0.9999044,3.991461e-05
8659,The transcriptional,0,2,0,19,The transcriptional profile that is specific of activated Treg clones includes a TGF-beta signature.,19224638_4,-1,-1,-1,-1,8659,-1,2.2167475e-05,0.9999677,1.0154924e-05
8662,TGF-beta,12,13,81,89,The transcriptional profile that is specific of activated Treg clones includes a TGF-beta signature.,19224638_4,0,1,-1,-1,8662,-1,6.561623e-05,0.9999119,2.2508779e-05
8666,TGF-beta,11,12,62,70,Both activated Treg and Th clones produced the latent form of TGF-beta.,19224638_5,0,1,-1,-1,8666,-1,6.326846e-05,0.9999119,2.4820321e-05
8668,the Treg,9,11,64,72,"However, SMAD2 phosphorylation was observed after activation in the Treg but not in the Th clones, indicating that only activated Treg clones produced the bioactive form of TGF-beta.",19224638_6,-1,-1,-1,-1,8668,-1,1.9460484e-05,0.99996793,1.2650733e-05
8669,the Th,14,16,84,90,"However, SMAD2 phosphorylation was observed after activation in the Treg but not in the Th clones, indicating that only activated Treg clones produced the bioactive form of TGF-beta.",19224638_6,-1,-1,-1,-1,8669,-1,2.0401263e-05,0.9999634,1.6163018e-05
8673,TGF-beta,29,30,173,181,"However, SMAD2 phosphorylation was observed after activation in the Treg but not in the Th clones, indicating that only activated Treg clones produced the bioactive form of TGF-beta.",19224638_6,0,1,-1,-1,8673,-1,7.389865e-05,0.99990225,2.3826686e-05
8674,TGF-beta,1,2,2,10,"A TGF-beta signature was also displayed by a Th clone ""suppressed"" by a Treg clone.",19224638_7,0,1,-1,-1,8674,-1,9.401982e-05,0.9998772,2.87576e-05
8680,TGF-beta,17,18,96,104,"In conclusion, the hallmark of our panel of activated human Treg clones is to produce bioactive TGF-beta which has autocrine actions on Tregs and can have paracrine actions on other T cells.",19224638_8,0,1,-1,-1,8680,-1,3.546821e-05,0.9999485,1.6072809e-05
8683,to tumor,6,8,53,61,BACKGROUND: Immunosuppression by gliomas contributes to tumor progression and treatment resistance.,19226468_0,-1,-1,-1,-1,8683,-1,3.3451783e-05,0.99995244,1.4117917e-05
8686,tumor cells,16,18,111,122,"It is not known when immunosuppression occurs during tumor development but it likely involves cross-talk among tumor cells, tumor-associated macrophages and microglia (TAMs), and peripheral as well as tumor-infiltrating lymphocytes (TILs).RESULTS: We have performed a kinetic study of this immunomodulation, assessing the dynamics of immune infiltration and function, within the central nervous system (CNS) and peripherally.",19226468_1,-1,-1,-1,-1,8686,-1,0.0040637874,0.33118996,0.6647463
8689,tumor-infiltrating lymphocytes,32,34,201,231,"It is not known when immunosuppression occurs during tumor development but it likely involves cross-talk among tumor cells, tumor-associated macrophages and microglia (TAMs), and peripheral as well as tumor-infiltrating lymphocytes (TILs).RESULTS: We have performed a kinetic study of this immunomodulation, assessing the dynamics of immune infiltration and function, within the central nervous system (CNS) and peripherally.",19226468_1,-1,-1,-1,-1,8689,-1,0.0035248245,0.8981456,0.09832958
8692,function,53,54,358,366,"It is not known when immunosuppression occurs during tumor development but it likely involves cross-talk among tumor cells, tumor-associated macrophages and microglia (TAMs), and peripheral as well as tumor-infiltrating lymphocytes (TILs).RESULTS: We have performed a kinetic study of this immunomodulation, assessing the dynamics of immune infiltration and function, within the central nervous system (CNS) and peripherally.",19226468_1,0,1,2,-1,8692,-1,0.00011969474,0.9997954,8.498611e-05
8706,TNF-alpha,49,50,288,297,"Using multiparameter flow cytometry, splenic T cells were assessed for FoxP3 expression to identify regulatory T cells (Tregs) and production of IFN-gamma and IL-10 after stimulation with PMA/ionomycin; within the CNS, CD4+ TILs were quantified, and TAMs were quantified and assessed for TNF-alpha and IL-10 production after stimulation with LPS.",19226468_4,0,1,-1,-1,8706,-1,0.00014644068,0.9998091,4.4555236e-05
8716,throughout the,19,21,99,113,"The percentage of FoxP3+ regulatory T cells (Tregs) increased by day 26, with elevated frequencies throughout the duration of the study.",19226468_6,-1,-1,-1,-1,8716,-1,4.3169326e-05,0.99993646,2.0392194e-05
8729,TNF-alpha,28,29,145,154,"At the final time points examined (tumor morbidity or 40 dpi), there was an increase in the frequency of TAMs with decreased capacity to secrete TNF-alpha.",19226468_8,0,1,-1,-1,8729,-1,9.9354285e-05,0.9998659,3.476416e-05
8738,Functional,0,1,0,10,"Functional impairment of TAMs occurs relatively late in the course of GBM tumor growth, potentially providing a window of opportunity for therapeutic strategies directed towards preventing their functional impairment.",19226468_11,0,1,2,-1,8738,-1,8.36167e-05,0.99987864,3.7769638e-05
8745,their functional,27,29,189,205,"Functional impairment of TAMs occurs relatively late in the course of GBM tumor growth, potentially providing a window of opportunity for therapeutic strategies directed towards preventing their functional impairment.",19226468_11,-1,-1,-1,-1,8745,-1,5.6030785e-05,0.99992144,2.2545986e-05
8748,adaptive immune responses,13,16,64,89,"Dendritic cells (DCs) have a central role in the development of adaptive immune responses, including antitumor immunity.",19234174_0,-1,-1,-1,-1,8748,-1,0.9992925,0.0005067093,0.00020078091
8749,immunity,19,20,111,119,"Dendritic cells (DCs) have a central role in the development of adaptive immune responses, including antitumor immunity.",19234174_0,0,-1,2,-1,8749,-1,0.99943954,0.00034845094,0.00021200671
8750,Factors,0,1,0,7,Factors present in the tumor milieu can alter the maturation of DCs and inhibit their capacity to activate T cells.,19234174_1,0,1,-1,-1,8750,-1,0.01331644,0.98641807,0.0002654259
8751,the tumor,3,5,19,28,Factors present in the tumor milieu can alter the maturation of DCs and inhibit their capacity to activate T cells.,19234174_1,-1,-1,-1,-1,8751,-1,2.3119894e-05,0.9999676,9.327475e-06
8757,analysis,3,4,22,30,"Using gene expression analysis, we found that human DCs increased the expression of TGF-beta1 transcripts following culture with human lung carcinoma cells (LCCs).",19234174_2,0,1,-1,-1,8757,-1,3.089411e-05,0.99994075,2.8297438e-05
8760,TGF-beta1 transcripts,14,16,84,105,"Using gene expression analysis, we found that human DCs increased the expression of TGF-beta1 transcripts following culture with human lung carcinoma cells (LCCs).",19234174_2,-1,-1,-1,-1,8760,-1,2.6475613e-05,0.9999552,1.8310338e-05
8763,TGF-beta1 protein,6,8,40,57,These DCs produced increased amounts of TGF-beta1 protein compared with DCs not exposed to tumor cells.,19234174_3,-1,-1,-1,-1,8763,-1,3.7098536e-05,0.9999331,2.9820118e-05
8764,to tumor cells,13,16,88,102,These DCs produced increased amounts of TGF-beta1 protein compared with DCs not exposed to tumor cells.,19234174_3,-1,-1,-1,-1,8764,-1,0.0039295787,0.81462926,0.18144116
8767,TNF-alpha,10,11,66,75,"Furthermore, LCCs decreased CD86 expression and the production of TNF-alpha and IL-12 p70 by mature DCs.",19234174_5,0,1,-1,-1,8767,-1,0.00018840797,0.99975735,5.428939e-05
8770,TGF-beta1,10,11,62,71,"Moreover, LCCs also converted mature DCs into cells producing TGF-beta1.",19234174_6,0,1,-1,-1,8770,-1,9.552258e-05,0.9997296,0.00017492537
8771,These TGF-beta1-producing,0,2,0,25,These TGF-beta1-producing DCs were poor at eliciting the activation of naive CD4(+) T cells and sustaining their proliferation and differentiation into Th1 (IFN-gamma(+)) effectors.,19234174_7,-1,-1,-1,-1,8771,-1,5.8642654e-05,0.99990547,3.593684e-05
8778,TGF-beta1-producing,2,3,9,28,"Instead, TGF-beta1-producing DCs demonstrated an increased ability to generate CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress the proliferation of T lymphocytes.",19234174_8,0,1,-1,-1,8778,-1,5.705788e-05,0.9999037,3.92201e-05
8779,to generate,8,10,67,78,"Instead, TGF-beta1-producing DCs demonstrated an increased ability to generate CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress the proliferation of T lymphocytes.",19234174_8,-1,-1,-1,-1,8779,-1,1.9420153e-05,0.99996865,1.1948446e-05
8780,regulatory T cells that,12,16,101,124,"Instead, TGF-beta1-producing DCs demonstrated an increased ability to generate CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress the proliferation of T lymphocytes.",19234174_8,-1,-1,-1,-1,8780,-1,0.0012197129,0.021780184,0.977
8784,the function,8,10,50,62,These results identify a novel mechanism by which the function of human DCs is altered by tumor cells and contributes to the evasion of the immune response.,19234174_9,-1,-1,-1,-1,8784,-1,2.5271242e-05,0.9999633,1.14059785e-05
8785,tumor cells,16,18,90,101,These results identify a novel mechanism by which the function of human DCs is altered by tumor cells and contributes to the evasion of the immune response.,19234174_9,-1,-1,-1,-1,8785,-1,0.004366082,0.5149742,0.48065972
8786,to the,20,22,118,124,These results identify a novel mechanism by which the function of human DCs is altered by tumor cells and contributes to the evasion of the immune response.,19234174_9,-1,-1,-1,-1,8786,-1,2.3727056e-05,0.99996436,1.1901971e-05
8787,the immune response,24,27,136,155,These results identify a novel mechanism by which the function of human DCs is altered by tumor cells and contributes to the evasion of the immune response.,19234174_9,-1,-1,-1,-1,8787,-1,0.5129533,0.48494777,0.0020989254
8789,the tumor,18,20,103,112,"Epithelial ovarian cancer (EOC) is a highly inflammatory malignancy, characterized by the presence, at the tumor site, of regulatory T cells (Treg) that suppress antitumor immunity.",19238008_0,-1,-1,-1,-1,8789,-1,1.9535166e-05,0.9999702,1.0302844e-05
8793,immunity,32,33,172,180,"Epithelial ovarian cancer (EOC) is a highly inflammatory malignancy, characterized by the presence, at the tumor site, of regulatory T cells (Treg) that suppress antitumor immunity.",19238008_0,0,-1,2,-1,8793,-1,0.99931455,0.00044156626,0.00024389349
8796,cytokine interleukin,13,15,70,90,"Recently, a new lineage of CD4+ T cells producing the proinflammatory cytokine interleukin (IL)-17 [T helper (TH) 17] has been identified as a major player in some autoimmune diseases.",19238008_1,-1,-1,-1,-1,8796,-1,0.9998429,4.449708e-05,0.00011267842
8801,TH17 cells,3,5,12,22,"The role of TH17 cells in cancer, however, and their relationship with coexisting Treg populations, whose differentiation is partially controlled by the same mediators (ie, transforming growth factor-beta), are yet unclear.",19238008_2,-1,-1,-1,-1,8801,-1,0.0001739116,0.001136584,0.9986895
8802,their relationship,11,13,47,65,"The role of TH17 cells in cancer, however, and their relationship with coexisting Treg populations, whose differentiation is partially controlled by the same mediators (ie, transforming growth factor-beta), are yet unclear.",19238008_2,-1,-1,-1,-1,8802,-1,3.1843712e-05,0.9999503,1.7866825e-05
8811,TH17 cells,21,23,153,163,"Here, we show that EOC-associated/infiltrating lymphocytes derived by culturing tumor samples in the presence of IL-2 contain significant frequencies of TH17 cells, coproducing interferon-gamma (IFN)-gamma and tumor necrosis factor (TNF)-alpha, which represent, in some cases, up to 40% of total CD4+ T cells.",19238008_3,-1,-1,-1,-1,8811,-1,0.0016152537,0.092472434,0.90591234
8817,TH17 cells,0,2,0,10,"TH17 cells were also detected ex vivo, but at lower proportions than in cultured tumor-infiltrating lymphocytes/tumor-associated lymphocytes, and were confined to the CD4+CD25- fraction.",19238008_4,-1,-1,-1,-1,8817,-1,0.00030438838,0.0014803648,0.9982153
8821,to the,22,24,160,166,"TH17 cells were also detected ex vivo, but at lower proportions than in cultured tumor-infiltrating lymphocytes/tumor-associated lymphocytes, and were confined to the CD4+CD25- fraction.",19238008_4,-1,-1,-1,-1,8821,-1,2.4070381e-05,0.99995863,1.7246906e-05
8822,analysis,2,3,12,20,"Remarkably, analysis of EOC-associated conventional CD4CD25 T cell and Treg populations isolated ex vivo from tumor samples by cell sorting and cultured with tumor-associated CD3- cells in the presence of IL-2 revealed that EOC Treg stimulated under these conditions were rapidly converted into TH17 cells, down-regulated FOXP3 expression, and lost their suppressive capacity.",19238008_5,0,1,-1,-1,8822,-1,1.9161092e-05,0.99996674,1.4085653e-05
8833,TH17 cells,44,46,295,305,"Remarkably, analysis of EOC-associated conventional CD4CD25 T cell and Treg populations isolated ex vivo from tumor samples by cell sorting and cultured with tumor-associated CD3- cells in the presence of IL-2 revealed that EOC Treg stimulated under these conditions were rapidly converted into TH17 cells, down-regulated FOXP3 expression, and lost their suppressive capacity.",19238008_5,-1,-1,-1,-1,8833,-1,0.00024627987,0.0011223011,0.9986314
8838,TH17 cells,6,8,29,39,"Thus, although the impact of TH17 cells on the evolution of EOC remains to be established, our data suggest that local IL-2 treatment in ovarian cancer may result in the conversion of tumor-associated Treg into TH17 cells, relieve Treg-mediated suppression, and contribute to enhance antitumor immunity.",19238008_6,-1,-1,-1,-1,8838,-1,0.00034632202,0.0037432448,0.9959104
8844,tumor-associated Treg,34,36,184,205,"Thus, although the impact of TH17 cells on the evolution of EOC remains to be established, our data suggest that local IL-2 treatment in ovarian cancer may result in the conversion of tumor-associated Treg into TH17 cells, relieve Treg-mediated suppression, and contribute to enhance antitumor immunity.",19238008_6,-1,-1,-1,-1,8844,-1,2.1923439e-05,0.9999682,9.910783e-06
8845,TH17 cells,37,39,211,221,"Thus, although the impact of TH17 cells on the evolution of EOC remains to be established, our data suggest that local IL-2 treatment in ovarian cancer may result in the conversion of tumor-associated Treg into TH17 cells, relieve Treg-mediated suppression, and contribute to enhance antitumor immunity.",19238008_6,-1,-1,-1,-1,8845,-1,0.00033234296,0.0023334527,0.99733424
8846,relieve Treg-mediated,40,42,223,244,"Thus, although the impact of TH17 cells on the evolution of EOC remains to be established, our data suggest that local IL-2 treatment in ovarian cancer may result in the conversion of tumor-associated Treg into TH17 cells, relieve Treg-mediated suppression, and contribute to enhance antitumor immunity.",19238008_6,-1,-1,-1,-1,8846,-1,4.9479895e-05,0.9999162,3.4347933e-05
8848,immunity,49,50,294,302,"Thus, although the impact of TH17 cells on the evolution of EOC remains to be established, our data suggest that local IL-2 treatment in ovarian cancer may result in the conversion of tumor-associated Treg into TH17 cells, relieve Treg-mediated suppression, and contribute to enhance antitumor immunity.",19238008_6,0,-1,2,-1,8848,-1,0.99939525,0.00038550535,0.00021923054
8852,the treatment,16,18,123,136,Immune-cell-based approaches using cytotoxic and dendritic cells are under constant scrutiny to design novel therapies for the treatment of tumors.,19240181_0,-1,-1,-1,-1,8852,-1,2.5897567e-05,0.9999635,1.0570852e-05
8856,economical,10,11,59,69,These strategies are hampered by the lack of efficient and economical large-scale production methods for effector cells.,19240181_1,0,1,-1,-1,8856,-1,4.7788842e-05,0.99993205,2.015303e-05
8860,termed tumor killer T cells,21,26,111,138,"Here we describe the propagation of large amounts of a unique population of CD4(+) cytotoxic T cells, which we termed tumor killer T cells (TKTC), because of their potent and broad antitumor cell activity.",19240181_2,-1,-1,-1,-1,8860,-1,0.0052342997,0.44133323,0.5534325
8866,blood,8,9,54,59,"With this cultivation strategy, TKTCs from peripheral blood mononuclear cells are generated within a short period of time using a pulse with a stimulating cell line followed by continuous growth in serum-free medium supplemented with a mixture of interleukin-2 and cyclosporin A. Expression and functional profiling did not allow a classification of TKTCs to any thus far defined subtype of T cells.",19240181_3,0,1,-1,-1,8866,-1,5.684027e-05,0.99984086,0.0001022959
8872,functional,45,46,295,305,"With this cultivation strategy, TKTCs from peripheral blood mononuclear cells are generated within a short period of time using a pulse with a stimulating cell line followed by continuous growth in serum-free medium supplemented with a mixture of interleukin-2 and cyclosporin A. Expression and functional profiling did not allow a classification of TKTCs to any thus far defined subtype of T cells.",19240181_3,0,1,2,-1,8872,-1,5.560632e-05,0.9999198,2.4595065e-05
8873,classification,51,52,332,346,"With this cultivation strategy, TKTCs from peripheral blood mononuclear cells are generated within a short period of time using a pulse with a stimulating cell line followed by continuous growth in serum-free medium supplemented with a mixture of interleukin-2 and cyclosporin A. Expression and functional profiling did not allow a classification of TKTCs to any thus far defined subtype of T cells.",19240181_3,0,1,2,-1,8873,-1,6.71447e-05,0.99986374,6.903537e-05
8874,TKTCs to,53,55,350,358,"With this cultivation strategy, TKTCs from peripheral blood mononuclear cells are generated within a short period of time using a pulse with a stimulating cell line followed by continuous growth in serum-free medium supplemented with a mixture of interleukin-2 and cyclosporin A. Expression and functional profiling did not allow a classification of TKTCs to any thus far defined subtype of T cells.",19240181_3,-1,-1,-1,-1,8874,-1,2.3287597e-05,0.9999614,1.5298909e-05
8877,that TKTCs,3,5,24,34,Cytotoxic assays showed that TKTCs kill a panel of tumor targets of diverse tissue origin while leaving normal cells unaffected.,19240181_4,-1,-1,-1,-1,8877,-1,2.3758985e-05,0.9999635,1.2750627e-05
8878,tumor targets,9,11,51,64,Cytotoxic assays showed that TKTCs kill a panel of tumor targets of diverse tissue origin while leaving normal cells unaffected.,19240181_4,-1,-1,-1,-1,8878,-1,2.0271435e-05,0.99996805,1.1657669e-05
8879,tissue,13,14,76,82,Cytotoxic assays showed that TKTCs kill a panel of tumor targets of diverse tissue origin while leaving normal cells unaffected.,19240181_4,-1,1,2,-1,8879,-1,5.7478188e-05,0.99986434,7.817503e-05
8881,that TKTC,3,5,30,39,"Blocking experiments revealed that TKTC killing was, to a significant extent, mediated by tumor necrosis factor-related apoptosis-inducing ligand and was independent of MHC restriction.",19240181_5,-1,-1,-1,-1,8881,-1,2.1752687e-05,0.9999664,1.1906365e-05
8884,factor-related,17,18,105,119,"Blocking experiments revealed that TKTC killing was, to a significant extent, mediated by tumor necrosis factor-related apoptosis-inducing ligand and was independent of MHC restriction.",19240181_5,0,1,-1,-1,8884,-1,0.99815935,0.0010055245,0.000835057
8886,that TKTCs,3,5,22,32,These results suggest that TKTCs have a high potential as a novel tool in the adoptive immunotherapy of cancer.,19240181_6,-1,-1,-1,-1,8886,-1,2.1755086e-05,0.999967,1.1288024e-05
8889,analysis,1,2,20,28,"Immunohistochemical analysis of FOXP3 in primary breast tumors showed that a high number of tumor-infiltrating regulatory T cells (Ti-Treg) within lymphoid infiltrates surrounding the tumor was predictive of relapse and death, in contrast to those present within the tumor bed.",19244125_0,0,1,-1,-1,8889,-1,2.3867262e-05,0.9999577,1.846554e-05
8893,tumor-infiltrating regulatory T cells,14,18,92,129,"Immunohistochemical analysis of FOXP3 in primary breast tumors showed that a high number of tumor-infiltrating regulatory T cells (Ti-Treg) within lymphoid infiltrates surrounding the tumor was predictive of relapse and death, in contrast to those present within the tumor bed.",19244125_0,-1,-1,-1,-1,8893,-1,0.0042194193,0.6533003,0.34248027
8895,the tumor,25,27,180,189,"Immunohistochemical analysis of FOXP3 in primary breast tumors showed that a high number of tumor-infiltrating regulatory T cells (Ti-Treg) within lymphoid infiltrates surrounding the tumor was predictive of relapse and death, in contrast to those present within the tumor bed.",19244125_0,-1,-1,-1,-1,8895,-1,1.9674948e-05,0.9999695,1.0898477e-05
8897,to those,36,38,239,247,"Immunohistochemical analysis of FOXP3 in primary breast tumors showed that a high number of tumor-infiltrating regulatory T cells (Ti-Treg) within lymphoid infiltrates surrounding the tumor was predictive of relapse and death, in contrast to those present within the tumor bed.",19244125_0,-1,-1,-1,-1,8897,-1,2.0608493e-05,0.9999676,1.1865755e-05
8898,the tumor,40,42,263,272,"Immunohistochemical analysis of FOXP3 in primary breast tumors showed that a high number of tumor-infiltrating regulatory T cells (Ti-Treg) within lymphoid infiltrates surrounding the tumor was predictive of relapse and death, in contrast to those present within the tumor bed.",19244125_0,-1,-1,-1,-1,8898,-1,1.7985436e-05,0.9999713,1.07821625e-05
8899,analysis,2,3,8,16,"Ex vivo analysis showed that these tumor-infiltrating FOXP3(+) T cells are typical Treg based on their CD4(+)CD25(high)CD127(low)FOXP3(+) phenotype, their anergic state on in vitro stimulation, and their suppressive functions.",19244125_1,0,1,-1,-1,8899,-1,3.1276315e-05,0.99994063,2.8048185e-05
8900,that these tumor-infiltrating FOXP3(+,4,8,24,61,"Ex vivo analysis showed that these tumor-infiltrating FOXP3(+) T cells are typical Treg based on their CD4(+)CD25(high)CD127(low)FOXP3(+) phenotype, their anergic state on in vitro stimulation, and their suppressive functions.",19244125_1,-1,-1,-1,-1,8900,-1,0.00012966114,0.9997609,0.00010940097
8902,typical Treg,12,14,75,87,"Ex vivo analysis showed that these tumor-infiltrating FOXP3(+) T cells are typical Treg based on their CD4(+)CD25(high)CD127(low)FOXP3(+) phenotype, their anergic state on in vitro stimulation, and their suppressive functions.",19244125_1,-1,-1,-1,-1,8902,-1,5.147812e-05,0.99991965,2.8861275e-05
8907,functions,32,33,216,225,"Ex vivo analysis showed that these tumor-infiltrating FOXP3(+) T cells are typical Treg based on their CD4(+)CD25(high)CD127(low)FOXP3(+) phenotype, their anergic state on in vitro stimulation, and their suppressive functions.",19244125_1,0,1,2,-1,8907,-1,0.00033288842,0.99921024,0.0004568603
8908,These Ti-Treg,0,2,0,13,"These Ti-Treg could be selectively recruited through CCR4 as illustrated by (a) selective blood Treg CCR4 expression and migration to CCR4 ligands, (b) CCR4 down-regulation on Ti-Treg, and (c) correlation between Ti-Treg in lymphoid infiltrates and intratumoral CCL22 expression.",19244125_2,-1,-1,-1,-1,8908,-1,2.2445212e-05,0.99996483,1.2667884e-05
8910,blood Treg,15,17,90,100,"These Ti-Treg could be selectively recruited through CCR4 as illustrated by (a) selective blood Treg CCR4 expression and migration to CCR4 ligands, (b) CCR4 down-regulation on Ti-Treg, and (c) correlation between Ti-Treg in lymphoid infiltrates and intratumoral CCL22 expression.",19244125_2,-1,-1,-1,-1,8910,-1,5.9101334e-05,0.9998946,4.6323516e-05
8919,tumor-associated antigens,28,30,184,209,"Importantly, in contrast to other T cells, Ti-Treg are selectively activated locally and proliferate in situ, showing T-cell receptor engagement and suggesting specific recognition of tumor-associated antigens (TAA).",19244125_3,-1,-1,-1,-1,8919,-1,0.041590102,0.95403063,0.0043792278
8921,that Ti-Treg,10,12,63,75,"Immunohistochemical stainings for ICOS, Ki67, and DC-LAMP show that Ti-Treg were close to mature DC-LAMP(+) dendritic cells (DC) in lymphoid infiltrates but not in tumor bed and were activated and proliferating.",19244125_4,-1,-1,-1,-1,8921,-1,2.6194602e-05,0.99996006,1.3705154e-05
8928,that Treg,5,7,31,40,"Altogether, these results show that Treg are selectively recruited within lymphoid infiltrates and activated by mature DC likely through TAA presentation, resulting in the prevention of effector T-cell activation, immune escape, and ultimately tumor progression.",19244125_6,-1,-1,-1,-1,8928,-1,2.049166e-05,0.99996805,1.1489287e-05
8929,through TAA,19,21,129,140,"Altogether, these results show that Treg are selectively recruited within lymphoid infiltrates and activated by mature DC likely through TAA presentation, resulting in the prevention of effector T-cell activation, immune escape, and ultimately tumor progression.",19244125_6,-1,-1,-1,-1,8929,-1,4.8765858e-05,0.9999161,3.520394e-05
8934,Treg physiology,6,8,30,45,"This study sheds new light on Treg physiology and validates CCR4/CCL22 and ICOS as therapeutic targets in breast tumors, which represent a major health problem.",19244125_7,-1,-1,-1,-1,8934,-1,3.123505e-05,0.999946,2.2748225e-05
8935,therapeutic targets,14,16,83,102,"This study sheds new light on Treg physiology and validates CCR4/CCL22 and ICOS as therapeutic targets in breast tumors, which represent a major health problem.",19244125_7,-1,-1,-1,-1,8935,-1,2.1219877e-05,0.9999678,1.097242e-05
8939,transcription factor Foxp3,8,11,60,86,Regulatory T cells (Tregs) expressing forkhead/winged-helix transcription factor Foxp3 represent a distinct lineage of lymphocytes which play a central role in protecting the host from autoimmune diseases.,19254475_0,-1,-1,-1,-1,8939,-1,2.4466159e-05,0.9999596,1.5962483e-05
8945,immunity,10,11,55,63,"However, Tregs also pose a major problem to anti-tumor immunity.",19254475_1,0,-1,2,-1,8945,-1,0.99807703,0.0015173575,0.00040561403
8951,function,6,7,53,61,How tumor development subverts normal self-tolerance function of Tregs thereby thwarts host anti-tumor immunity remains elusive.,19254475_3,0,1,2,-1,8951,-1,0.00013373772,0.999775,9.1284644e-05
8952,Tregs thereby thwarts,8,11,65,86,How tumor development subverts normal self-tolerance function of Tregs thereby thwarts host anti-tumor immunity remains elusive.,19254475_3,-1,-1,-1,-1,8952,-1,3.0706895e-05,0.9999554,1.392976e-05
8953,immunity,13,14,103,111,How tumor development subverts normal self-tolerance function of Tregs thereby thwarts host anti-tumor immunity remains elusive.,19254475_3,0,-1,2,-1,8953,-1,0.9996195,0.00022568271,0.00015475145
8964,to the,39,41,256,262,This review will discuss our current knowledge in understanding the dynamics and plasticity of Foxp3+ Treg activation and induction in tumor bearing hosts and their interaction with various antigen presenting cells (APCs) in tumor microenvironment leading to the establishment of active local and systemic immune suppression.,19254475_4,-1,-1,-1,-1,8964,-1,1.9440602e-05,0.999972,8.5931315e-06
8965,toll-like receptor,1,3,9,27,"Although toll-like receptor (TLR) agonists, such as CpG, are used as immunotherapeutic agents in clinical trials for cancer and infectious diseases, their effects are limited and the underlying mechanism(s) that restrains CpG efficacy remains obscure.",19258507_0,-1,-1,-1,-1,8965,-1,0.0021616113,0.91184735,0.085991
8967,agonists,6,7,34,42,"Although toll-like receptor (TLR) agonists, such as CpG, are used as immunotherapeutic agents in clinical trials for cancer and infectious diseases, their effects are limited and the underlying mechanism(s) that restrains CpG efficacy remains obscure.",19258507_0,0,1,-1,-1,8967,-1,0.001932052,0.9897395,0.00832853
8972,that signal transducer and activator of transcription 3,4,12,14,69,"Here, we show that signal transducer and activator of transcription 3 (Stat3) plays a key role in down-modulating immunostimulatory effects of CpG. In the absence of interleukin-6 (IL-6) and IL-10 induction, CpG directly activates Stat3 within minutes through TLR9.",19258507_1,-1,-1,-1,-1,8972,-1,1.6485625e-05,0.99997294,1.0587519e-05
8980,through TLR9,43,45,252,264,"Here, we show that signal transducer and activator of transcription 3 (Stat3) plays a key role in down-modulating immunostimulatory effects of CpG. In the absence of interleukin-6 (IL-6) and IL-10 induction, CpG directly activates Stat3 within minutes through TLR9.",19258507_1,-1,-1,-1,-1,8980,-1,2.670767e-05,0.9999521,2.1157066e-05
8999,tumor antigen-specific T cells,52,56,318,348,"Innate immune responses induced by CpG in mice with a Stat3-ablated hematopoietic system cause potent antitumor effects, leading to eradication of large (>1 cm) B16 melanoma tumors within 72 h. Moreover, ablating Stat3 in myeloid cells increases CpG-induced dendritic cell maturation, T-cell activation, generation of tumor antigen-specific T cells, and long-lasting antitumor immunity.",19258507_3,-1,-1,-1,-1,8999,-1,0.023796964,0.21056947,0.7656335
9000,immunity,60,61,377,385,"Innate immune responses induced by CpG in mice with a Stat3-ablated hematopoietic system cause potent antitumor effects, leading to eradication of large (>1 cm) B16 melanoma tumors within 72 h. Moreover, ablating Stat3 in myeloid cells increases CpG-induced dendritic cell maturation, T-cell activation, generation of tumor antigen-specific T cells, and long-lasting antitumor immunity.",19258507_3,0,-1,2,-1,9000,-1,0.9992786,0.00041804387,0.00030336634
9003,factors,13,14,88,95,A critical role of Stat3 in mediating immunosuppression by certain cytokines and growth factors in the tumor microenvironment has been recently documented.,19258507_4,0,1,-1,-1,9003,-1,0.999718,8.98301e-05,0.00019212723
9004,the tumor,15,17,99,108,A critical role of Stat3 in mediating immunosuppression by certain cytokines and growth factors in the tumor microenvironment has been recently documented.,19258507_4,-1,-1,-1,-1,9004,-1,2.1138692e-05,0.99996924,9.5943815e-06
9006,TLR agonists,9,11,57,69,"By demonstrating direct and rapid activation of Stat3 by TLR agonists, we identify a second level of Stat3-mediated immunosuppression.",19258507_5,-1,-1,-1,-1,9006,-1,0.0003274713,0.99954575,0.00012679887
9008,that targeting Stat3,4,7,28,48,Our results further suggest that targeting Stat3 can drastically improve CpG-based immunotherapeutic approaches.,19258507_6,-1,-1,-1,-1,9008,-1,2.1325377e-05,0.9999682,1.0500669e-05
9009,T cell therapy,3,6,21,35,BACKGROUND: Adoptive T cell therapy involving the use of ex vivo generated antigen-specific cytotoxic T lymphocytes provides a promising approach to immunotherapy.,19270751_0,-1,-1,-1,-1,9009,-1,0.0011495901,0.016355637,0.9824948
9011,generated antigen-specific cytotoxic T lymphocytes,12,17,65,115,BACKGROUND: Adoptive T cell therapy involving the use of ex vivo generated antigen-specific cytotoxic T lymphocytes provides a promising approach to immunotherapy.,19270751_0,-1,-1,-1,-1,9011,-1,0.017017331,0.085244976,0.8977377
9014,transferred T cells,10,13,78,97,It has become increasingly apparent that anti-tumor efficacy using adoptively transferred T cells is linked to their duration of in vivo persistence and can only be achieved when combined with some form of pre-infusion patient conditioning regimen.,19270751_1,-1,-1,-1,-1,9014,-1,0.0025577762,0.08833122,0.9091111
9015,to their,15,17,108,116,It has become increasingly apparent that anti-tumor efficacy using adoptively transferred T cells is linked to their duration of in vivo persistence and can only be achieved when combined with some form of pre-infusion patient conditioning regimen.,19270751_1,-1,-1,-1,-1,9015,-1,2.6779742e-05,0.9999615,1.1765003e-05
9020,transferred T cells,18,21,117,136,We have established a unique clinical model that allows for evaluation of a given conditioning regimen on adoptively transferred T cells in humans.,19270751_3,-1,-1,-1,-1,9020,-1,0.0019940587,0.077041626,0.9209643
9028,tumor-reactive antigen-specific CTL,7,10,44,79,"Patients received two infusions of a single tumor-reactive antigen-specific CTL clone expanded to 10(10)/m(2); the first infusion was given without fludarabine conditioning, and the second CTL infusion was given after a course of fludarabine (25 mg/m(2)/dayx5 days).",19270751_6,-1,-1,-1,-1,9028,-1,0.011507317,0.62358946,0.36490315
9036,to ten,5,7,41,47,Nineteen CTL infusions were administered to ten patients.,19270751_8,-1,-1,-1,-1,9036,-1,2.8160171e-05,0.99995613,1.566686e-05
9044,transferred CTL,13,15,72,87,Fludarabine led to a 2.9 fold improvement in the in vivo persistence of transferred CTL clones from a median of 4.5 days (range 0-38+) to 13.0 days (range 2-63+) (p<0.05).,19270751_12,-1,-1,-1,-1,9044,-1,0.002235866,0.1503536,0.84741056
9048,cytokines IL-7,8,10,71,85,Fludarabine lymphodepletion increased plasma levels of the homeostatic cytokines IL-7 and IL-15.,19270751_13,-1,-1,-1,-1,9048,-1,0.99953437,5.1194453e-05,0.00041440155
9050,the relative,5,7,41,53,"Surprisingly, fludarabine also increased the relative percentage of CD4+ T cells expressing the regulatory protein Foxp3.CONCLUSIONS/SIGNIFICANCE: Lymphodepletion with fludarabine enhances transferred T cell persistence but suggest that additional improvements to optimize T cell survival and address regulatory T cells are critical in providing anti-tumor efficacy.",19270751_14,-1,-1,-1,-1,9050,-1,2.3661309e-05,0.99995816,1.8179251e-05
9052,the regulatory protein,14,17,92,114,"Surprisingly, fludarabine also increased the relative percentage of CD4+ T cells expressing the regulatory protein Foxp3.CONCLUSIONS/SIGNIFICANCE: Lymphodepletion with fludarabine enhances transferred T cell persistence but suggest that additional improvements to optimize T cell survival and address regulatory T cells are critical in providing anti-tumor efficacy.",19270751_14,-1,-1,-1,-1,9052,-1,2.7035152e-05,0.9999503,2.2686101e-05
9053,transferred T cell,23,26,189,207,"Surprisingly, fludarabine also increased the relative percentage of CD4+ T cells expressing the regulatory protein Foxp3.CONCLUSIONS/SIGNIFICANCE: Lymphodepletion with fludarabine enhances transferred T cell persistence but suggest that additional improvements to optimize T cell survival and address regulatory T cells are critical in providing anti-tumor efficacy.",19270751_14,-1,-1,-1,-1,9053,-1,0.00070660043,0.008235141,0.99105823
9067,T-cell,20,21,118,124,They are traditionally viewed as the immunologic centerpiece that is able to prime CD4(+) helper and CD8(+) cytotoxic T-cell effector populations.,19275918_1,-1,1,2,-1,9067,-1,3.4684414e-05,5.1956555e-05,0.99991333
9068,the functional plasticity,5,8,41,66,"However, accumulated evidence highlights the functional plasticity of DC, which are shown to also be able to display a tolerogenic function eliciting the differentiation of T suppressor (Ts) and regulatory (Treg) cells.",19275918_2,-1,-1,-1,-1,9068,-1,2.4086125e-05,0.999964,1.195393e-05
9071,tolerogenic function,21,23,119,139,"However, accumulated evidence highlights the functional plasticity of DC, which are shown to also be able to display a tolerogenic function eliciting the differentiation of T suppressor (Ts) and regulatory (Treg) cells.",19275918_2,-1,-1,-1,-1,9071,-1,8.5120904e-05,0.99986374,5.115685e-05
9077,This tolerogenic state,0,3,0,22,This tolerogenic state of DC is characterized by low costimulatory potential and high expression of inhibitory receptors.,19275918_3,-1,-1,-1,-1,9077,-1,2.4690748e-05,0.99996114,1.4154088e-05
9078,receptors,16,17,111,120,This tolerogenic state of DC is characterized by low costimulatory potential and high expression of inhibitory receptors.,19275918_3,0,1,2,-1,9078,-1,8.346818e-05,0.00025185573,0.9996648
9093,to trigger,15,17,91,101,"In contrast, ILT3-knockdown DC have robust cytokine and chemokine production, and are able to trigger stronger T-cell responses to viral antigens or alloantigens.",19275918_6,-1,-1,-1,-1,9093,-1,2.094581e-05,0.9999685,1.0569625e-05
9094,T-cell,18,19,111,117,"In contrast, ILT3-knockdown DC have robust cytokine and chemokine production, and are able to trigger stronger T-cell responses to viral antigens or alloantigens.",19275918_6,-1,1,2,-1,9094,-1,3.713959e-05,6.038627e-05,0.99990237
9097,the functional,3,5,31,45,"Understanding and manipulating the functional immunogenic/tolerogenic dichotomy of DC has important clinical applications for achieving tolerance in organ transplantation, stemming autoimmune diseases or, conversely, generating efficient immunogenic vaccines for immunotherapy in cancer and chronic viral diseases.",19275918_7,-1,-1,-1,-1,9097,-1,2.3881421e-05,0.99996614,9.913532e-06
9099,transplantation,18,19,155,170,"Understanding and manipulating the functional immunogenic/tolerogenic dichotomy of DC has important clinical applications for achieving tolerance in organ transplantation, stemming autoimmune diseases or, conversely, generating efficient immunogenic vaccines for immunotherapy in cancer and chronic viral diseases.",19275918_7,-1,1,2,-1,9099,-1,3.5168385e-05,0.9999461,1.8686858e-05
9101,to the,2,4,12,18,"In addition to the direct targeting effects on HER2-positive cells, trastuzumab may have a therapeutic role modulating the activity of the cellular immune system in patients with breast cancer.",19277040_0,-1,-1,-1,-1,9101,-1,2.1812173e-05,0.9999689,9.3383105e-06
9107,the cellular,21,23,135,147,"In addition to the direct targeting effects on HER2-positive cells, trastuzumab may have a therapeutic role modulating the activity of the cellular immune system in patients with breast cancer.",19277040_0,-1,-1,-1,-1,9107,-1,0.0052031637,0.49003804,0.5047588
9117,trastuzumab therapy,33,35,139,158,"To investigate this further, the balance of T-regulatory (T(reg)), Th17, natural killer (NK) and NK T (NKT) cells before, during and after trastuzumab therapy was investigated.",19277040_1,-1,-1,-1,-1,9117,-1,4.4220447e-05,0.99993706,1.8693712e-05
9120,Th17 cells,8,10,52,62,"Sequential frequencies of circulating T(reg) cells, Th17 cells, NK and NKT cells were measured in peripheral blood of breast cancer patients and normal controls throughout therapy.",19277040_2,-1,-1,-1,-1,9120,-1,0.00052808254,0.009136043,0.9903358
9122,blood,19,20,109,114,"Sequential frequencies of circulating T(reg) cells, Th17 cells, NK and NKT cells were measured in peripheral blood of breast cancer patients and normal controls throughout therapy.",19277040_2,0,1,-1,-1,9122,-1,7.407282e-05,0.9996605,0.0002653925
9123,throughout therapy,27,29,161,179,"Sequential frequencies of circulating T(reg) cells, Th17 cells, NK and NKT cells were measured in peripheral blood of breast cancer patients and normal controls throughout therapy.",19277040_2,-1,-1,-1,-1,9123,-1,3.5058838e-05,0.99994946,1.544895e-05
9125,blood,12,13,89,94,"Individuals with breast cancer had significantly higher T(reg) frequencies of peripheral blood compared with healthy controls (9.2 or 8.6 vs 6%; P<0.05), and no significant differences in T(reg) frequencies were observed between HER2-positive and HER2-negative individuals.",19277040_3,0,1,-1,-1,9125,-1,0.0002513399,0.9940095,0.0057392046
9128,Th17 cells,3,5,14,24,The number of Th17 cells was lowest in HER2-positive patients compared with both healthy controls and HER2-negative patients (0.31 vs 0.75% or 0.84%; P=0.01).,19277040_4,-1,-1,-1,-1,9128,-1,0.00022335476,0.0011923126,0.9985844
9139,that T(reg,5,7,33,43,This study supports earlier data that T(reg) cells are present at higher frequencies in breast cancer patients compared with healthy individuals.,19277040_6,-1,-1,-1,-1,9139,-1,2.035559e-05,0.9999671,1.2569415e-05
9144,Th17 cells,18,20,118,128,"For the first time, we show that HER2-positive individuals with breast carcinomas have reduced numbers of circulating Th17 cells, which appear, in turn to have an inverse relationship with T(reg) frequency in MBC.",19277040_7,-1,-1,-1,-1,9144,-1,0.0003753281,0.0030295548,0.9965951
9145,turn to,25,27,147,154,"For the first time, we show that HER2-positive individuals with breast carcinomas have reduced numbers of circulating Th17 cells, which appear, in turn to have an inverse relationship with T(reg) frequency in MBC.",19277040_7,-1,-1,-1,-1,9145,-1,2.7860327e-05,0.9999591,1.303432e-05
9149,the T(reg,5,7,25,34,"The change in balance of the T(reg) : Th17 ratio appears to characterise the cancer state, and furthermore, is disrupted by trastuzumab therapy.",19277040_8,-1,-1,-1,-1,9149,-1,2.1433762e-05,0.999966,1.256704e-05
9154,trastuzumab therapy,24,26,124,143,"The change in balance of the T(reg) : Th17 ratio appears to characterise the cancer state, and furthermore, is disrupted by trastuzumab therapy.",19277040_8,-1,-1,-1,-1,9154,-1,5.793211e-05,0.9999181,2.3991806e-05
9157,Th subset,7,9,47,56,The recent discovery of IL-17-producing CD4(+) Th subset significantly revised the Th1/Th2 dichotomy model proposed by Mosmann and Coffman almost two decades ago.,19283720_0,-1,-1,-1,-1,9157,-1,0.00062302826,0.0065668137,0.99281025
9160,Th17 cells,0,2,0,10,Th17 cells are involved in the pathogenesis of many human autoimmune diseases.,19283720_1,-1,-1,-1,-1,9160,-1,0.00058742345,0.007260504,0.99215204
9162,Th17 cells,0,2,0,10,"Th17 cells, their developmental pathways and their effector functions, therefore, provide novel therapeutic targets.",19283720_2,-1,-1,-1,-1,9162,-1,0.0004538327,0.0034422916,0.9961039
9165,functions,9,10,60,69,"Th17 cells, their developmental pathways and their effector functions, therefore, provide novel therapeutic targets.",19283720_2,0,1,2,-1,9165,-1,0.0008603371,0.99517256,0.0039670845
9167,therapeutic targets,15,17,96,115,"Th17 cells, their developmental pathways and their effector functions, therefore, provide novel therapeutic targets.",19283720_2,-1,-1,-1,-1,9167,-1,2.6636086e-05,0.9999604,1.2938775e-05
9169,protein,4,5,27,34,The inhibitor of apoptosis protein survivin is highly expressed in neuroblastoma (NB) and survivin-specific T cells were identified in Stage 4 patients.,19291796_0,0,1,-1,-1,9169,-1,5.3303276e-05,0.99991703,2.967453e-05
9173,peptides,17,18,115,123,"Therefore, we generated a novel survivin minigene DNA vaccine (pUS-high) encoding exclusively for survivin-derived peptides with superior MHC class I (H2-K(k)) binding affinities and tested its efficacy to suppress tumor growth and metastases in a syngeneic NB mouse model.",19291796_1,0,-1,2,-1,9173,-1,0.0013968073,0.99601424,0.0025889706
9183,target cell,16,18,102,113,"This response was as effective as a survivin full-length vaccine and was associated with an increased target cell lysis, increased presence of CD8(+) T-cells at the primary tumor site and enhanced production of proinflammatory cytokines by systemic CD8(+) T cells.",19291796_5,-1,-1,-1,-1,9183,-1,0.0014519319,0.04472329,0.9538248
9184,T-cells,25,26,150,157,"This response was as effective as a survivin full-length vaccine and was associated with an increased target cell lysis, increased presence of CD8(+) T-cells at the primary tumor site and enhanced production of proinflammatory cytokines by systemic CD8(+) T cells.",19291796_5,-1,1,2,-1,9184,-1,5.846525e-05,0.00015981872,0.99978167
9189,T-cells,10,11,48,55,"Furthermore, depletion of CD8(+) but not CD4(+) T-cells completely abrogated the pUS-high mediated primary tumor growth suppression, demonstrating a CD8(+) T-cell mediated effect.",19291796_6,-1,1,2,-1,9189,-1,8.085822e-05,0.00030038462,0.99961865
9192,T-cell,25,26,156,162,"Furthermore, depletion of CD8(+) but not CD4(+) T-cells completely abrogated the pUS-high mediated primary tumor growth suppression, demonstrating a CD8(+) T-cell mediated effect.",19291796_6,-1,1,2,-1,9192,-1,3.4501998e-05,4.3861088e-05,0.9999217
9200,T-cell,4,5,25,31,"Rare cases of peripheral T-cell lymphomas with follicular growth pattern (PTCL-F) have been recently reported, and their association with t(5;9)(q33;q22) involving ITK and SYK has been suggested.",19295409_0,-1,1,2,-1,9200,-1,4.4794273e-05,8.452925e-05,0.99987066
9212,cells that,5,7,41,51,"Neoplastic cells were medium-sized clear cells that were CD4+ (24/27, 89%), CD10+ (21/29, 72%), BCL-6+ (14/19, 74%), and expressed programed death-1 (27/27, 100%), CXCL13 (23/27, 85%), and ICOS (11/11, 100%), markers of follicular helper T cells (TFH).",19295409_3,-1,-1,-1,-1,9212,-1,0.0022145426,0.08037756,0.917408
9219,T-cell,12,13,110,116,Three patients with sequential biopsies disclosed clinical and histopathologic features of angioimmunoblastic T-cell lymphoma at initial presentation.,19295409_6,-1,1,2,-1,9219,-1,3.916761e-05,7.250468e-05,0.9998883
9220,that this,3,5,17,26,"Our results show that this rare form of PTCL-F (1) has an immunophenotype indicative of derivation from TFH cells, (2) is associated with t(5;9) in a proportion of cases, and (3) shows some overlapping features with angioimmunoblastic T-cell lymphoma, raising the question of a possible relationship.",19295409_7,-1,-1,-1,-1,9220,-1,1.7405617e-05,0.99997306,9.539419e-06
9221,TFH cells,19,21,104,113,"Our results show that this rare form of PTCL-F (1) has an immunophenotype indicative of derivation from TFH cells, (2) is associated with t(5;9) in a proportion of cases, and (3) shows some overlapping features with angioimmunoblastic T-cell lymphoma, raising the question of a possible relationship.",19295409_7,-1,-1,-1,-1,9221,-1,0.00033202436,0.0035444787,0.9961235
9222,T-cell,46,47,235,241,"Our results show that this rare form of PTCL-F (1) has an immunophenotype indicative of derivation from TFH cells, (2) is associated with t(5;9) in a proportion of cases, and (3) shows some overlapping features with angioimmunoblastic T-cell lymphoma, raising the question of a possible relationship.",19295409_7,-1,1,2,-1,9222,-1,4.1468502e-05,6.73282e-05,0.99989116
9229,tolerance to tumor-associated antigens,18,22,81,119,CD4+25+Foxp3+ regulatory T cells (Treg) play a critical role in the induction of tolerance to tumor-associated antigens and suppression of antitumor immunity.,19307989_0,-1,-1,-1,-1,9229,-1,0.021855073,0.9752484,0.0028964947
9230,immunity,26,27,149,157,CD4+25+Foxp3+ regulatory T cells (Treg) play a critical role in the induction of tolerance to tumor-associated antigens and suppression of antitumor immunity.,19307989_0,0,-1,2,-1,9230,-1,0.9992955,0.00046422493,0.00024028934
9232,that Treg,3,5,23,32,We reported previously that Treg are significantly elevated in the peripheral blood of patients with pancreas cancer and that in a murine pancreas cancer model induction of Treg seems to be transforming growth factor (TGF)-beta dependent.,19307989_2,-1,-1,-1,-1,9232,-1,2.1020536e-05,0.99996877,1.0171975e-05
9234,blood,11,12,78,83,We reported previously that Treg are significantly elevated in the peripheral blood of patients with pancreas cancer and that in a murine pancreas cancer model induction of Treg seems to be transforming growth factor (TGF)-beta dependent.,19307989_2,0,1,-1,-1,9234,-1,6.386955e-05,0.9998109,0.00012531075
9238,transforming growth factor,31,34,190,216,We reported previously that Treg are significantly elevated in the peripheral blood of patients with pancreas cancer and that in a murine pancreas cancer model induction of Treg seems to be transforming growth factor (TGF)-beta dependent.,19307989_2,-1,-1,-1,-1,9238,-1,0.8484957,0.14786626,0.0036380442
9239,that Treg,5,7,36,45,Here we provide additional evidence that Treg are increased locally within the tumor microenvironment by a mechanism that seems dependent on TGF-beta receptor expression and the presence of tumor derived TGF-beta.,19307989_3,-1,-1,-1,-1,9239,-1,2.0563386e-05,0.99996996,9.506215e-06
9240,the tumor,11,13,75,84,Here we provide additional evidence that Treg are increased locally within the tumor microenvironment by a mechanism that seems dependent on TGF-beta receptor expression and the presence of tumor derived TGF-beta.,19307989_3,-1,-1,-1,-1,9240,-1,1.8313634e-05,0.99997306,8.659257e-06
9242,TGF-beta receptor,21,23,141,158,Here we provide additional evidence that Treg are increased locally within the tumor microenvironment by a mechanism that seems dependent on TGF-beta receptor expression and the presence of tumor derived TGF-beta.,19307989_3,-1,-1,-1,-1,9242,-1,0.00011994273,0.99939895,0.00048113705
9245,TGF-beta,30,31,204,212,Here we provide additional evidence that Treg are increased locally within the tumor microenvironment by a mechanism that seems dependent on TGF-beta receptor expression and the presence of tumor derived TGF-beta.,19307989_3,0,1,-1,-1,9245,-1,3.630799e-05,0.9999465,1.7270992e-05
9248,TGF-beta,11,12,67,75,The murine pancreas cancer cell line Pan02 produces high levels of TGF-beta both in vitro and in vivo.,19307989_4,0,1,-1,-1,9248,-1,4.3752778e-05,0.99994123,1.4977397e-05
9255,TGF-beta,17,18,113,121,Immunohistochemical staining of Foxp3 in explanted tumors shows an identifiable population of Treg in the Pan02 (TGF-beta positive) tumors but not Eso2 (TGF-beta negative).,19307989_6,0,1,-1,-1,9255,-1,9.520229e-05,0.999869,3.5768848e-05
9257,TGF-beta,25,26,153,161,Immunohistochemical staining of Foxp3 in explanted tumors shows an identifiable population of Treg in the Pan02 (TGF-beta positive) tumors but not Eso2 (TGF-beta negative).,19307989_6,0,1,-1,-1,9257,-1,9.126988e-05,0.99987066,3.8074533e-05
9268,TGF-beta receptor,16,18,89,106,"If Rag-/- mice are instead reconstituted with naive CD4+25- T cells expressing a mutated TGF-beta receptor, induction of Foxp3+ Treg in Pan02 bearing mice is blocked.",19307989_9,-1,-1,-1,-1,9268,-1,0.00033896297,0.997447,0.0022140408
9273,TGF-beta,9,10,61,69,"Collectively, these observations further support the role of TGF-beta in the induction of Treg in pancreas adenocarcinoma.",19307989_10,0,1,-1,-1,9273,-1,3.667068e-05,0.9999479,1.5394478e-05
9287,naringenin treatment,12,14,71,91,We used bleomycin to induce pulmonary fibrosis in mice with or without naringenin treatment and measured the immune-associated lymphocytes and their secreted cytokines using flow cytometry and ELISA from lung tissue.,19318568_3,-1,-1,-1,-1,9287,-1,0.000111248926,0.9998287,5.9984704e-05
9292,tissue,30,31,209,215,We used bleomycin to induce pulmonary fibrosis in mice with or without naringenin treatment and measured the immune-associated lymphocytes and their secreted cytokines using flow cytometry and ELISA from lung tissue.,19318568_3,-1,1,2,-1,9292,-1,5.7707926e-05,0.9997726,0.00016967837
9293,to test the,14,17,102,113,Both passive and spontaneous metastatic models in bleomycin-treated C57BL/6 and BALB/c mice were used to test the hypothesis that mice with pulmonary fibrosis could have an increased risk of lung cancer and associated cancer progression.,19318568_4,-1,-1,-1,-1,9293,-1,1.8064815e-05,0.9999739,8.081814e-06
9297,life,21,22,126,130,"Here, we show that mice with lung fibrosis challenged using tumors show an increased incidence of lung metastasis and shorter life spans compared with the mice without lung fibrosis.",19318568_5,0,-1,2,-1,9297,-1,8.778273e-05,0.99985504,5.7113735e-05
9301,factor-beta1,13,14,89,101,A fibrotic environment in the lung results in increased abundance of transforming growth factor-beta1 and CD4(+)CD25(+)Foxp3(+) regulatory T cells and a decreased proportion of activated effector T cells.,19318568_6,0,1,-1,-1,9301,-1,0.99942774,0.00019030702,0.00038193451
9311,factor-beta1,23,24,201,213,Naringenin significantly reduces lung metastases in mice with pulmonary fibrosis and increases their survival by improving the immunosuppressive environment through down-regulating transforming growth factor-beta1 and reducing regulatory T cells.,19318568_8,0,1,-1,-1,9311,-1,0.9989505,0.00036989994,0.00067963544
9315,the treatment,8,10,50,63,Naringenin could be an ideal therapeutic agent in the treatment of both cancer and fibrosis.,19318568_9,-1,-1,-1,-1,9315,-1,2.367433e-05,0.9999666,9.65733e-06
9317,factor,3,4,41,47,The Ca(2+)-regulated calcineurin/nuclear factor of activated T cells (NFAT) cascade controls alternative pathways of T-cell activation and peripheral tolerance.,19318584_0,0,1,-1,-1,9317,-1,3.232652e-05,0.99994457,2.3111803e-05
9324,tumors than,16,18,105,116,"In a murine model of bronchoalveolar adenocarcinoma, mice lacking NFATc2 developed more and larger solid tumors than wild-type littermates.",19318584_2,-1,-1,-1,-1,9324,-1,2.1027303e-05,0.9999635,1.547456e-05
9327,the tumors,9,11,54,64,"The extent of central tumor necrosis was decreased in the tumors in NFATc2((-/-)) mice, and this finding was associated with reduced tumor necrosis factor-alpha and interleukin-2 (IL-2) production by CD8(+) T cells.",19318584_3,-1,-1,-1,-1,9327,-1,1.802212e-05,0.99997187,1.01219675e-05
9337,tumor necrosis factor receptor,27,31,196,226,"Adoptive transfer of CD8(+) T cells of NFATc2((-/-)) mice induced transforming growth factor-beta(1) in the airways of recipient mice, thus supporting CD4(+)CD25(+)Foxp-3(+)glucocorticoid-induced tumor necrosis factor receptor (GITR)(+) regulatory T (T(reg)) cell survival.",19318584_4,-1,-1,-1,-1,9337,-1,0.3487547,0.36507773,0.28616756
9352,the treatment,19,21,106,119,"Agonistic signaling through GITR, in the absence of NFATc2, thus emerges as a novel possible strategy for the treatment of human bronchial adenocarcinoma in the absence of NFATc2 by enhancing IL-2Ralpha(+) effector and IL-7Ralpha(+) memory-expressing T cells.",19318584_6,-1,-1,-1,-1,9352,-1,2.3796822e-05,0.999967,9.221932e-06
9360,the tumor,9,11,45,54,This study demonstrates that CD8+ T cells in the tumor microenvironment display reduced functionality and hyporesponsiveness.,19319531_0,-1,-1,-1,-1,9360,-1,1.85622e-05,0.99997246,9.033285e-06
9361,functionality,14,15,88,101,This study demonstrates that CD8+ T cells in the tumor microenvironment display reduced functionality and hyporesponsiveness.,19319531_0,0,1,2,-1,9361,-1,5.32327e-05,0.9999101,3.666314e-05
9362,to the tumor-infiltrating,3,6,30,55,"TGF-beta contributed markedly to the tumor-infiltrating CD8+ T cells' (TILs) reduced functionality, which could be reversed using a small molecule TGF-beta inhibitor.",19319531_1,-1,-1,-1,-1,9362,-1,3.4840064e-05,0.9999479,1.7208096e-05
9365,functionality,15,16,85,98,"TGF-beta contributed markedly to the tumor-infiltrating CD8+ T cells' (TILs) reduced functionality, which could be reversed using a small molecule TGF-beta inhibitor.",19319531_1,0,1,2,-1,9365,-1,0.0001170019,0.99971634,0.00016668763
9366,TGF-beta,25,26,147,155,"TGF-beta contributed markedly to the tumor-infiltrating CD8+ T cells' (TILs) reduced functionality, which could be reversed using a small molecule TGF-beta inhibitor.",19319531_1,0,1,-1,-1,9366,-1,5.6159104e-05,0.9999155,2.8360128e-05
9372,TGF-beta,31,32,141,149,"Upon T-cell receptor (TCR) activation, the activation of ITK and ERK kinases were reduced in CD8+ TILs, as compared to splenic CD8+ T cells: TGF-beta inhibitor could reverse this phenomenon.",19319531_2,0,1,-1,-1,9372,-1,5.2170508e-05,0.9999268,2.1077909e-05
9376,time the,6,8,38,46,"This study demonstrates for the first time the association of the Spred-1 gene, an inhibitor of the Ras/MAPK pathway, with CD8+ TILs and TGF-beta activity.",19319531_3,-1,-1,-1,-1,9376,-1,1.8514007e-05,0.99997056,1.0939778e-05
9381,TGF-beta,26,27,137,145,"This study demonstrates for the first time the association of the Spred-1 gene, an inhibitor of the Ras/MAPK pathway, with CD8+ TILs and TGF-beta activity.",19319531_3,0,1,-1,-1,9381,-1,3.8855138e-05,0.9999447,1.6505168e-05
9383,TGF-beta,8,9,41,49,Spred-1 was upregulated in CD8+ TILs and TGF-beta enhanced the expression of Spred-1 in effector/memory CD8+ T cells and not in rested/memory CD8+ T cells.,19319531_4,0,1,-1,-1,9383,-1,4.691225e-05,0.99993706,1.59933e-05
9390,that TGF-beta,10,12,60,73,"Based on these findings, this study supports the hypothesis that TGF-beta mediates an inhibitory mechanism on CD8+ TILs involving TCR-signaling blockade and the upregulation of Spred-1, thus implicating Spred-1 as a potential new target for future anti-tumor immune studies.",19319531_5,-1,-1,-1,-1,9390,-1,4.0972296e-05,0.99994564,1.3400677e-05
9392,TCR-signaling,21,22,130,143,"Based on these findings, this study supports the hypothesis that TGF-beta mediates an inhibitory mechanism on CD8+ TILs involving TCR-signaling blockade and the upregulation of Spred-1, thus implicating Spred-1 as a potential new target for future anti-tumor immune studies.",19319531_5,-1,1,2,-1,9392,-1,5.447502e-05,0.9999149,3.061165e-05
9404,the relative,2,4,9,21,"However, the relative contribution of tumor location to the glioma-mediated immunosuppression, as well as the immune mechanisms involved in the failure of glioma rejection are not fully defined.",19337997_2,-1,-1,-1,-1,9404,-1,2.5544006e-05,0.9999597,1.4737593e-05
9406,to the,8,10,53,59,"However, the relative contribution of tumor location to the glioma-mediated immunosuppression, as well as the immune mechanisms involved in the failure of glioma rejection are not fully defined.",19337997_2,-1,-1,-1,-1,9406,-1,2.3286684e-05,0.999966,1.0635869e-05
9414,antigen-dependent T-cell proliferation,18,21,131,169,"In contrast to DC infiltrating subcutaneously grown GL261 gliomas, tumor-infiltrating DC from intracranial gliomas do not activate antigen-dependent T-cell proliferation in vitro.",19337997_5,-1,-1,-1,-1,9414,-1,0.11929164,0.0021190867,0.8785893
9417,TGF-beta1,20,21,131,140,"In addition, brain-localized GL261 gliomas are characterized by significantly higher numbers of Foxp3(+) Treg and higher levels of TGF-beta1 mRNA and protein expression when compared with GL261 gliomas in the skin.",19337997_6,0,1,-1,-1,9417,-1,3.4555167e-05,0.9999385,2.6933772e-05
9418,protein,23,24,150,157,"In addition, brain-localized GL261 gliomas are characterized by significantly higher numbers of Foxp3(+) Treg and higher levels of TGF-beta1 mRNA and protein expression when compared with GL261 gliomas in the skin.",19337997_6,0,1,-1,-1,9418,-1,3.3667257e-05,0.99994254,2.3786302e-05
9423,to TGF-beta,17,19,70,81,"Our data show that gliomas in the CNS, but not in the skin, give rise to TGF-beta production and accumulation of both Treg and functionally impaired DC.",19337997_7,-1,-1,-1,-1,9423,-1,7.375373e-05,0.99990654,1.9671945e-05
9425,functionally,26,27,127,139,"Our data show that gliomas in the CNS, but not in the skin, give rise to TGF-beta production and accumulation of both Treg and functionally impaired DC.",19337997_7,0,1,2,-1,9425,-1,6.250014e-05,0.999918,1.9564273e-05
9427,the tumor,3,5,10,19,"Thus, not the tumor itself, but its location dictates the efficiency of the anti-tumor immune response.",19337997_8,-1,-1,-1,-1,9427,-1,2.3692186e-05,0.9999615,1.4833333e-05
9432,tumor-associated antigens,16,18,126,151,"Previous reports have suggested that autoimmune sequelae may be an unavoidable consequence of successful immunization against tumor-associated antigens, which are typically non-mutated self-antigens.",19338001_0,-1,-1,-1,-1,9432,-1,0.03904598,0.9566544,0.004299652
9435,T-cell-mediated,10,11,52,67,"Using a melanoma model, we demonstrated that CD4(+) T-cell-mediated anti-tumor immunity and autoimmunity could be separated by modulating the STAT4/STAT6 signaling axis.",19338001_1,-1,1,2,-1,9435,-1,3.4327633e-05,6.367745e-05,0.999902
9436,immunity,12,13,79,87,"Using a melanoma model, we demonstrated that CD4(+) T-cell-mediated anti-tumor immunity and autoimmunity could be separated by modulating the STAT4/STAT6 signaling axis.",19338001_1,0,-1,2,-1,9436,-1,0.9994091,0.00036559475,0.00022528021
9439,immunity,16,17,118,126,"Our results have revealed an unexpected dichotomy in the effector phase following cancer vaccination where anti-tumor immunity is mediated via a STAT6 and IL-4-dependent pathway, whereas autoimmune pathology is mediated via STAT4 through a mechanism that relies partially on IFN-gamma.",19338001_2,0,-1,2,-1,9439,-1,0.99847156,0.0009211962,0.00060725614
9442,STAT4 through,32,34,224,237,"Our results have revealed an unexpected dichotomy in the effector phase following cancer vaccination where anti-tumor immunity is mediated via a STAT6 and IL-4-dependent pathway, whereas autoimmune pathology is mediated via STAT4 through a mechanism that relies partially on IFN-gamma.",19338001_2,-1,-1,-1,-1,9442,-1,2.140381e-05,0.99996483,1.3720887e-05
9443,that relies,36,38,250,261,"Our results have revealed an unexpected dichotomy in the effector phase following cancer vaccination where anti-tumor immunity is mediated via a STAT6 and IL-4-dependent pathway, whereas autoimmune pathology is mediated via STAT4 through a mechanism that relies partially on IFN-gamma.",19338001_2,-1,-1,-1,-1,9443,-1,2.657314e-05,0.9999604,1.3011001e-05
9447,tissue,13,14,100,106,Our results offer a possibility to elicit specific anti-tumor responses without triggering unwanted tissue autoimmune diseases.,19338001_3,-1,1,2,-1,9447,-1,5.652059e-05,0.9999057,3.7736743e-05
9456,factor-1-null,6,7,46,59,METHODS: We established interferon regulatory factor-1-null (irf-1(-/-)) mice with inducible and persistent expression of HCV structural proteins (irf-1/CN2 mice).,19362089_2,0,1,-1,-1,9456,-1,3.2728785e-05,0.9999434,2.3864393e-05
9457,proteins,20,21,137,145,METHODS: We established interferon regulatory factor-1-null (irf-1(-/-)) mice with inducible and persistent expression of HCV structural proteins (irf-1/CN2 mice).,19362089_2,0,1,-1,-1,9457,-1,0.00013214353,0.999542,0.00032586002
9461,Proteins,0,1,0,8,Proteins associated with these processes were also assessed.,19362089_5,0,1,-1,-1,9461,-1,0.00019190932,0.99950933,0.00029876083
9474,protein,9,10,44,51,IL-2 and IL-10 were induced by the HCV core protein in splenocytes.,19362089_9,0,1,-1,-1,9474,-1,0.00010353609,0.9997894,0.00010702519
9484,that target the,29,32,184,199,"This mouse model, in which HCV expression and disruption of IFN signaling synergize to promote lymphoproliferation, will be an important tool for the development of therapeutic agents that target the lymphoproliferative pathway.",19362089_11,-1,-1,-1,-1,9484,-1,2.1195094e-05,0.99996746,1.13086535e-05
9494,functions,5,6,21,30,"We now show that IDO functions as a molecular switch in TDLNs, maintaining Tregs in their normal suppressive phenotype when IDO was active, but allowing inflammation-induced conversion of Tregs to a polyfunctional T-helper phenotype similar to proinflammatory T-helper-17 (TH17) cells when IDO was blocked.",19366986_1,0,1,2,-1,9494,-1,3.133071e-05,0.999956,1.2693677e-05
9498,Tregs to,30,32,188,196,"We now show that IDO functions as a molecular switch in TDLNs, maintaining Tregs in their normal suppressive phenotype when IDO was active, but allowing inflammation-induced conversion of Tregs to a polyfunctional T-helper phenotype similar to proinflammatory T-helper-17 (TH17) cells when IDO was blocked.",19366986_1,-1,-1,-1,-1,9498,-1,2.0441861e-05,0.9999678,1.1767985e-05
9504,Tregs to the TH17-like,5,9,24,46,"In vitro, conversion of Tregs to the TH17-like phenotype was driven by antigen-activated effector T cells and required interleukin-6 (IL-6) produced by activated pDCs.",19366986_2,-1,-1,-1,-1,9504,-1,2.678008e-05,0.999956,1.7157256e-05
9514,Tregs to the TH17,34,38,193,210,"In vivo, using a model of established B16 melanoma, the combination of an IDO-inhibitor drug plus antitumor vaccine caused up-regulation of IL-6 in pDCs and in situ conversion of a majority of Tregs to the TH17 phenotype, with marked enhancement of CD8+ T-cell activation and antitumor efficacy.",19366986_4,-1,-1,-1,-1,9514,-1,2.9630233e-05,0.99994135,2.8990202e-05
9523,tumor cell,8,10,67,77,"Methylglyoxal profoundly stimulates host's immune response against tumor cell by producing reactive oxygen intermediates (ROI's) and reactive nitrogen intermediates (RNI's) [Bhattacharyya, N., Pal, A., Patra, S., Haldar, A.K., Roy, S., Ray, M., 2008.",19375802_0,-1,-1,-1,-1,9523,-1,0.0036515894,0.23945083,0.75689757
9525,tumor cells,8,10,67,78,Activation of macrophages and lymphocytes by methylglyoxal against tumor cells in the host.,19375802_1,-1,-1,-1,-1,9525,-1,0.0041342666,0.35212868,0.643737
9534,through the,10,12,42,53,"Production of TLR 4 and TLR 9, which acts through the same signaling pathway, were also upregulated.",19375802_6,-1,-1,-1,-1,9534,-1,3.3590804e-05,0.9999474,1.8925126e-05
9536,the IL-6,6,8,46,54,"Hence, concluded that methylglyoxal augmented the IL-6 and IL-1 beta, expression of TLR 4 and TLR 9 and produced MAPKs, important regulators of ROIs and RNIs.",19375802_7,-1,-1,-1,-1,9536,-1,0.5999837,0.38834265,0.011673647
9550,thought that FOXP3,2,5,6,24,It is thought that FOXP3 is not a specific marker to determine regulatory T cells (Treg) in humans.,19383912_1,-1,-1,-1,-1,9550,-1,2.8649329e-05,0.99995804,1.3304638e-05
9554,the functional,4,6,18,32,"Here, we examined the functional phenotype and cytokine profile of the in vitro induced FOXP3(+) T cells, primary FOXP3(+) and FOXP3(-) T cells in patients with ulcerative colitis and tumors including colon carcinoma, melanoma, hepatic carcinoma, ovarian carcinoma, pancreatic cancer, and renal cell carcinoma.",19383912_2,-1,-1,-1,-1,9554,-1,2.1365275e-05,0.99996805,1.0534641e-05
9565,T cells in blood,11,15,71,87,"We observed similar levels of suppressive capacity of primary FOXP3(+) T cells in blood, tumors, and colitic tissues.",19383912_3,-1,-1,-1,-1,9565,-1,0.0012453971,0.04555135,0.95320326
9567,tissues,20,21,109,116,"We observed similar levels of suppressive capacity of primary FOXP3(+) T cells in blood, tumors, and colitic tissues.",19383912_3,-1,1,2,-1,9567,-1,0.0004958947,0.98037785,0.019126236
9583,functionally,26,27,154,166,"Although the in vitro activated T cells expressed FOXP3, these induced FOXP3(+) T cells expressed high levels of multiple effector cytokines and were not functionally suppressive.",19383912_5,0,1,2,-1,9583,-1,0.00011416769,0.9998479,3.795602e-05
9586,that FOXP3,5,7,28,38,The data reinforce the fact that FOXP3 remains an accurate marker to define primary Tregs in patients with cancer and autoimmune disease.,19383912_6,-1,-1,-1,-1,9586,-1,2.1317142e-05,0.9999682,1.0530322e-05
9589,that the,2,4,11,19,We suggest that the combination of FOXP3 and cytokine profile is useful for further functionally distinguishing primary Tregs from activated conventional T cells.,19383912_7,-1,-1,-1,-1,9589,-1,1.9720648e-05,0.9999721,8.22576e-06
9592,functionally,14,15,84,96,We suggest that the combination of FOXP3 and cytokine profile is useful for further functionally distinguishing primary Tregs from activated conventional T cells.,19383912_7,0,1,2,-1,9592,-1,6.2603096e-05,0.99991786,1.9494744e-05
9598,transcriptional activator,16,18,98,123,"In the present study, we investigated the possibility to use irradiated, non-replicating class II transcriptional activator (CIITA)-transfected tumor TS/A cells as a cell-based vaccine.",19395374_0,-1,-1,-1,-1,9598,-1,2.6780295e-05,0.9999535,1.970947e-05
9608,Immunity generated,0,2,0,18,"Immunity generated in the TS/A-CIITA-vaccinated mice correlated with an efficient priming of CD4(+) T cells and consequent triggering and maintenance of CD8(+) CTL effectors, as assessed by adoptive transfer assays.",19395374_3,-1,-1,-1,-1,9608,-1,0.017069537,0.9823782,0.0005522408
9614,the two cell-based,6,9,56,74,"Important qualitative differences were observed between the two cell-based vaccines, as TS/A-CIITA-vaccinated mice developed a CTL response containing a large proportion of anti-gp70 AH1 epitope-specific cells, completely absent in TS/A-vaccinated mice, and a mixed T(h)1/T(h)2 type of response as opposed to a T(h)2 type of response in TS/A-vaccinated mice.",19395374_4,-1,-1,-1,-1,9614,-1,0.002731489,0.7735858,0.22368276
9620,T(h)2 type,45,47,311,321,"Important qualitative differences were observed between the two cell-based vaccines, as TS/A-CIITA-vaccinated mice developed a CTL response containing a large proportion of anti-gp70 AH1 epitope-specific cells, completely absent in TS/A-vaccinated mice, and a mixed T(h)1/T(h)2 type of response as opposed to a T(h)2 type of response in TS/A-vaccinated mice.",19395374_4,-1,-1,-1,-1,9620,-1,5.3442545e-05,0.9998838,6.2773855e-05
9631,tumor cells,10,12,75,86,"These results let to envisage the use of CIITA-transfected non-replicating tumor cells as a vaccination strategy for prevention and, possibly, adjuvant immunotherapy in human settings.",19395374_6,-1,-1,-1,-1,9631,-1,0.0039878157,0.4057901,0.5902221
9632,peptide,10,11,75,82,Melanoma patients were injected with various vaccines containing a MAGE-A3 peptide presented by HLA-DP4.,19435913_0,0,-1,2,-1,9632,-1,0.06544654,0.86627984,0.06827361
9634,the blood,7,9,48,57,"Anti-MAGE-A3.DP4 T cells were not detectable in the blood before vaccination, but their frequencies after vaccination ranged from 2 x 10(-6) to 2 x 10(-3) among the CD4(+) blood T lymphocytes of the patients.",19435913_1,-1,-1,-1,-1,9634,-1,3.5091685e-05,0.99992275,4.2172916e-05
9638,blood T lymphocytes,32,35,172,191,"Anti-MAGE-A3.DP4 T cells were not detectable in the blood before vaccination, but their frequencies after vaccination ranged from 2 x 10(-6) to 2 x 10(-3) among the CD4(+) blood T lymphocytes of the patients.",19435913_1,-1,-1,-1,-1,9638,-1,0.0009871878,0.00962847,0.98938435
9641,blood T lymphocytes that,3,7,11,35,The CD4(+) blood T lymphocytes that stained ex vivo with HLA-DP4 tetramers folded with the MAGE-A3 peptide were selected by flow cytometry and amplified under clonal conditions.,19435913_2,-1,-1,-1,-1,9641,-1,0.0010622011,0.9674819,0.03145592
9644,peptide,17,18,99,106,The CD4(+) blood T lymphocytes that stained ex vivo with HLA-DP4 tetramers folded with the MAGE-A3 peptide were selected by flow cytometry and amplified under clonal conditions.,19435913_2,0,-1,2,-1,9644,-1,0.007433487,0.985735,0.0068315165
9646,T-cell,7,8,23,29,About 5% of the CD4(+) T-cell clones that recognized the MAGE-A3.DP4 antigen had a CD25(+) phenotype in the resting state.,19435913_3,-1,1,2,-1,9646,-1,3.2515887e-05,5.0050225e-05,0.9999174
9655,T-cell,14,15,82,88,These CD25(+) clones had a high capacity to suppress the proliferation of another T-cell clone after peptide stimulation in vitro.,19435913_4,-1,1,2,-1,9655,-1,3.098741e-05,4.8349495e-05,0.9999206
9656,peptide,17,18,101,108,These CD25(+) clones had a high capacity to suppress the proliferation of another T-cell clone after peptide stimulation in vitro.,19435913_4,0,-1,2,-1,9656,-1,0.0022494441,0.9975515,0.00019910911
9664,cytokines IFN-gamma,9,11,65,84,"They produced active transforming growth factor-beta but none of cytokines IFN-gamma, interleukin-2 (IL-2), IL-4, IL-5, and IL-10.",19435913_6,-1,-1,-1,-1,9664,-1,0.9998555,3.4202683e-05,0.000110218774
9668,cells that,8,10,49,59,"Most of the CD25(-) clonal populations contained cells that expressed FOXP3 in the resting state, but FOXP3 demethylation was not observed.",19435913_8,-1,-1,-1,-1,9668,-1,0.0022164762,0.055508476,0.9422751
9674,T cells that,9,12,60,72,We conclude that MAGE-A3.DP4 vaccination can produce CD4(+) T cells that may exert regulatory T-cell function in vivo.,19435913_9,-1,-1,-1,-1,9674,-1,0.0017359972,0.041673705,0.9565904
9675,regulatory T-cell function,14,17,83,109,We conclude that MAGE-A3.DP4 vaccination can produce CD4(+) T cells that may exert regulatory T-cell function in vivo.,19435913_9,-1,-1,-1,-1,9675,-1,8.9295514e-05,0.00013054135,0.99978024
9687,immunity,13,14,91,99,"Costimulatory molecules play critical roles in modulating innate, adaptive, and regulatory immunity and have potential to serve as effective immunomodulatory components of therapeutic vaccines.",19435920_2,0,-1,2,-1,9687,-1,0.99933976,0.00036635154,0.00029384272
9691,tested the function,5,8,18,37,"In this study, we tested the function of a novel soluble form of 4-1BB ligand (4-1BBL) costimulatory molecule in modulating innate, adaptive, and regulatory immunity and assessed its therapeutic efficacy in the HPV-16 E7-expressing TC-1 cervical cancer and survivin-expressing 3LL lung carcinoma mouse models.",19435920_3,-1,-1,-1,-1,9691,-1,2.1694066e-05,0.9999677,1.06349535e-05
9692,immunity,33,34,157,165,"In this study, we tested the function of a novel soluble form of 4-1BB ligand (4-1BBL) costimulatory molecule in modulating innate, adaptive, and regulatory immunity and assessed its therapeutic efficacy in the HPV-16 E7-expressing TC-1 cervical cancer and survivin-expressing 3LL lung carcinoma mouse models.",19435920_3,0,-1,2,-1,9692,-1,0.9992036,0.00021217082,0.00058423454
9699,T-cell,16,17,96,102,"Vaccination with 4-1BBL activated dendritic cells and enhanced antigen uptake, generated CD8(+) T-cell effector/memory responses, and endowed T effector cells refractory to suppression by CD4(+)CD25(+)FoxP3(+) T regulatory cells.",19435920_4,-1,1,2,-1,9699,-1,3.3445587e-05,4.563229e-05,0.99992085
9705,peptide,10,11,51,58,"Immunization with 4-1BBL in combination with an E7 peptide or survivin protein resulted in eradication of TC-1 and 3LL tumors, respectively.",19435920_5,0,-1,2,-1,9705,-1,0.0011657858,0.9920998,0.0067343246
9706,protein,13,14,71,78,"Immunization with 4-1BBL in combination with an E7 peptide or survivin protein resulted in eradication of TC-1 and 3LL tumors, respectively.",19435920_5,0,1,-1,-1,9706,-1,0.00040796958,0.99914205,0.0004499972
9709,than TLR agonists LPS,6,10,26,47,"4-1BBL was more effective than TLR agonists LPS, MPL, and CpG and an agonistic 4-1BB antibody as a component of E7 peptide-based therapeutic vaccine for the generation of immune responses and eradication of TC-1 established tumors in the absence of detectable toxicity.",19435920_6,-1,-1,-1,-1,9709,-1,5.9696307e-05,0.99989676,4.3578726e-05
9710,peptide-based therapeutic,27,29,115,140,"4-1BBL was more effective than TLR agonists LPS, MPL, and CpG and an agonistic 4-1BB antibody as a component of E7 peptide-based therapeutic vaccine for the generation of immune responses and eradication of TC-1 established tumors in the absence of detectable toxicity.",19435920_6,-1,-1,-1,-1,9710,-1,7.906047e-05,0.9998499,7.1017654e-05
9711,the generation,31,33,153,167,"4-1BBL was more effective than TLR agonists LPS, MPL, and CpG and an agonistic 4-1BB antibody as a component of E7 peptide-based therapeutic vaccine for the generation of immune responses and eradication of TC-1 established tumors in the absence of detectable toxicity.",19435920_6,-1,-1,-1,-1,9711,-1,2.0041434e-05,0.99996877,1.12401995e-05
9716,toxicity,47,48,260,268,"4-1BBL was more effective than TLR agonists LPS, MPL, and CpG and an agonistic 4-1BB antibody as a component of E7 peptide-based therapeutic vaccine for the generation of immune responses and eradication of TC-1 established tumors in the absence of detectable toxicity.",19435920_6,0,1,-1,-1,9716,-1,7.298337e-05,0.9998504,7.656693e-05
9719,T-cell,17,18,138,144,Therapeutic efficacy was associated with reversal of tumor-mediated nonresponsiveness/anergy as well as establishment of long-term CD8(+) T-cell memory.,19435920_7,-1,1,2,-1,9719,-1,3.599501e-05,4.6240286e-05,0.99991775
9721,toxicity,8,9,69,77,Potent pleiotropic immunomodulatory activities combined with lack of toxicity highlight the potential of 4-1BBL molecule as an effective component of therapeutic cancer vaccines.,19435920_8,0,1,-1,-1,9721,-1,5.899893e-05,0.9999037,3.7318725e-05
9727,tolerance that,13,15,79,93,Regulatory T cells (Tregs) play an important role in maintaining immunological tolerance that is one of the main obstacles to overcome for improving antitumor immunity.,19455675_0,-1,-1,-1,-1,9727,-1,2.9189758e-05,0.9999567,1.40558695e-05
9730,immunity,26,27,159,167,Regulatory T cells (Tregs) play an important role in maintaining immunological tolerance that is one of the main obstacles to overcome for improving antitumor immunity.,19455675_0,0,-1,2,-1,9730,-1,0.9994461,0.00031530394,0.00023862274
9731,the Treg,2,4,10,18,"Recently, the Treg has been shown to constitutively express OX40 (CD134), which is a member of the TNF-receptor family that is transiently expressed on effector T cells after TCR triggering, and through which the signal enhances effector T-cell proliferation and memory T-cell development.",19455675_1,-1,-1,-1,-1,9731,-1,1.860854e-05,0.999972,9.3808985e-06
9733,the TNF-receptor,20,22,95,111,"Recently, the Treg has been shown to constitutively express OX40 (CD134), which is a member of the TNF-receptor family that is transiently expressed on effector T cells after TCR triggering, and through which the signal enhances effector T-cell proliferation and memory T-cell development.",19455675_1,-1,-1,-1,-1,9733,-1,0.00042038606,0.9958162,0.0037635055
9737,TCR triggering,32,34,175,189,"Recently, the Treg has been shown to constitutively express OX40 (CD134), which is a member of the TNF-receptor family that is transiently expressed on effector T cells after TCR triggering, and through which the signal enhances effector T-cell proliferation and memory T-cell development.",19455675_1,-1,-1,-1,-1,9737,-1,2.3676894e-05,0.9999604,1.5857047e-05
9743,to Tregs,11,13,62,70,"However, little is known about the role of OX40 costimulation to Tregs in tumor immunology.",19455675_2,-1,-1,-1,-1,9743,-1,2.650456e-05,0.99996185,1.1611419e-05
9744,tumor immunology,14,16,74,90,"However, little is known about the role of OX40 costimulation to Tregs in tumor immunology.",19455675_2,-1,-1,-1,-1,9744,-1,0.0005395953,0.99931693,0.0001435328
9746,the function,7,9,43,55,Here we show that OX40 signaling modulates the function of naturally occurring Tregs in vitro and in vivo.,19455675_3,-1,-1,-1,-1,9746,-1,2.422506e-05,0.9999651,1.0727613e-05
9754,TCR triggering,13,15,73,87,"Tregs suppressed the proliferation of nave CD4(+) CD25(-) T cells after TCR triggering, in contrast, OX40 costimulated Tregs that reduced Foxp3 expression reversed the suppressive function.",19455675_5,-1,-1,-1,-1,9754,-1,2.8894641e-05,0.9999497,2.144157e-05
9755,Tregs that,21,23,120,130,"Tregs suppressed the proliferation of nave CD4(+) CD25(-) T cells after TCR triggering, in contrast, OX40 costimulated Tregs that reduced Foxp3 expression reversed the suppressive function.",19455675_5,-1,-1,-1,-1,9755,-1,2.0937508e-05,0.9999641,1.4993317e-05
9758,function,29,30,181,189,"Tregs suppressed the proliferation of nave CD4(+) CD25(-) T cells after TCR triggering, in contrast, OX40 costimulated Tregs that reduced Foxp3 expression reversed the suppressive function.",19455675_5,0,1,2,-1,9758,-1,7.743793e-05,0.99984753,7.504289e-05
9761,TCR-stimulated,8,9,50,64,"In addition, Tregs inhibited the proliferation of TCR-stimulated (primed) CD4(+) T cells and nave CD8(+) T cells after TCR-mediated activation, however, Tregs with OX40 costimulation lost their suppressive function.",19455675_6,-1,1,2,-1,9761,-1,3.161782e-05,0.9999466,2.1819844e-05
9764,TCR-mediated,23,24,120,132,"In addition, Tregs inhibited the proliferation of TCR-stimulated (primed) CD4(+) T cells and nave CD8(+) T cells after TCR-mediated activation, however, Tregs with OX40 costimulation lost their suppressive function.",19455675_6,-1,1,2,-1,9764,-1,3.0148e-05,0.99993074,3.9151833e-05
9767,function,35,36,207,215,"In addition, Tregs inhibited the proliferation of TCR-stimulated (primed) CD4(+) T cells and nave CD8(+) T cells after TCR-mediated activation, however, Tregs with OX40 costimulation lost their suppressive function.",19455675_6,0,1,2,-1,9767,-1,7.34798e-05,0.9998497,7.6826385e-05
9770,the cytokine,8,10,63,75,"Interestingly, Tregs minimally suppressed the proliferation or the cytokine secretion of Ag-specific CD8(+) T cells after Ag-restimulation.",19455675_7,-1,-1,-1,-1,9770,-1,0.290383,0.7063804,0.003236538
9773,function to the,4,7,31,46,"Furthermore, Tregs suppressive function to the antitumor effect was reversed by OX40 costimulation in vivo.",19455675_8,-1,-1,-1,-1,9773,-1,6.702529e-05,0.99988425,4.8761052e-05
9776,T-cell function,10,12,60,75,"Our data indicate that, in addition to controlling effector T-cell function, OX40 costimulation directly controls Treg-mediated suppression in tumor immunity.",19455675_9,-1,-1,-1,-1,9776,-1,5.102798e-05,9.179309e-05,0.9998572
9778,tumor immunity,20,22,143,157,"Our data indicate that, in addition to controlling effector T-cell function, OX40 costimulation directly controls Treg-mediated suppression in tumor immunity.",19455675_9,-1,-1,-1,-1,9778,-1,0.03299313,0.9661946,0.0008122665
9782,the thymus,11,13,67,77,"Adaptive Foxp3(+)CD4(+) regulatory T (iTreg) cells develop outside the thymus under subimmunogenic antigen presentation, during chronic inflammation, and during normal homeostasis of the gut.",19464985_0,-1,-1,-1,-1,9782,-1,4.424292e-05,0.9999082,4.750503e-05
9789,to the,27,29,159,165,"iTreg cells are essential in mucosal immune tolerance and in the control of severe chronic allergic inflammation, and most likely are one of the main barriers to the eradication of tumors.",19464985_1,-1,-1,-1,-1,9789,-1,3.0590647e-05,0.9999553,1.4129042e-05
9791,The Foxp3(+,0,2,0,11,"The Foxp3(+) iTreg cell repertoire is drawn from naive conventional CD4(+) T cells, whereas natural Treg (nTreg) cells are selected by high-avidity interactions in the thymus.",19464985_2,-1,-1,-1,-1,9791,-1,0.0001765049,0.99968004,0.00014346134
9795,natural Treg,17,19,92,104,"The Foxp3(+) iTreg cell repertoire is drawn from naive conventional CD4(+) T cells, whereas natural Treg (nTreg) cells are selected by high-avidity interactions in the thymus.",19464985_2,-1,-1,-1,-1,9795,-1,3.5019308e-05,0.99994767,1.7332077e-05
9797,the thymus,29,31,164,174,"The Foxp3(+) iTreg cell repertoire is drawn from naive conventional CD4(+) T cells, whereas natural Treg (nTreg) cells are selected by high-avidity interactions in the thymus.",19464985_2,-1,-1,-1,-1,9797,-1,3.1338688e-05,0.99994457,2.4082556e-05
9807,immune responses to,22,25,129,148,"We speculate that iTreg cell development is driven by the need to maintain a noninflammatory environment in the gut, to suppress immune responses to environmental and food allergens, and to decrease chronic inflammation, whereas nTreg cells prevent autoimmunity and raise the activation threshold for all immune responses.",19464985_4,-1,-1,-1,-1,9807,-1,0.8916331,0.10699767,0.001369287
9816,T-cell,12,13,74,80,"Although T central memory cells have been described as the most effective T-cell subtype against tumor growth, little is known about the requirements needed for their optimal ex vivo generation.",19501956_0,-1,1,2,-1,9816,-1,3.3287048e-05,4.818433e-05,0.9999186
9827,Antigen-specific T-cell,0,2,0,23,Antigen-specific T-cell lines were generated by ex vivo stimulation with Class-I and Class-II melanoma peptide pulsed dendritic cells in the presence of either IL-2 or IL-15 plus IL-21.,19501956_2,-1,-1,-1,-1,9827,-1,0.1991291,0.003192641,0.7976783
9829,peptide,14,15,103,110,Antigen-specific T-cell lines were generated by ex vivo stimulation with Class-I and Class-II melanoma peptide pulsed dendritic cells in the presence of either IL-2 or IL-15 plus IL-21.,19501956_2,0,-1,2,-1,9829,-1,0.012293826,0.98666734,0.0010388027
9832,IL-15 plus,25,27,168,178,Antigen-specific T-cell lines were generated by ex vivo stimulation with Class-I and Class-II melanoma peptide pulsed dendritic cells in the presence of either IL-2 or IL-15 plus IL-21.,19501956_2,-1,-1,-1,-1,9832,-1,0.99669576,0.0010779522,0.0022263117
9846,to interleukin,19,21,112,126,"PURPOSE: To assess the extent of signal transducer and activator of transcription (STAT) activation in response to interleukin 2 (IL-2) in melanoma patients' T cells, along with clinical stage of tumor progression.",19509154_0,-1,-1,-1,-1,9846,-1,0.331345,0.6612332,0.007421821
9850,blood,7,8,51,56,"EXPERIMENTAL DESIGN: T lymphocytes from peripheral blood of healthy donors and of American Joint Committee on Cancer stage I to IV melanoma patients, as well as from metastatic lymph nodes of patients, were evaluated for responsiveness to IL-2.",19509154_1,0,1,-1,-1,9850,-1,0.00064693025,0.9462251,0.05312802
9867,blood,22,23,143,148,"By phospho-specific flow cytometry, defective STAT1 and STAT5 activation in response to IL-2 was found mainly in T lymphocytes from peripheral blood and/or tumor site of American Joint Committee on Cancer stage III and IV patients, compared with stage I and II patients and to donors, and in melanoma antigen-specific T cells isolated from metastatic lymph nodes.",19509154_6,0,1,-1,-1,9867,-1,0.0012724837,0.8023843,0.19634317
9870,antigen-specific T cells,52,55,301,325,"By phospho-specific flow cytometry, defective STAT1 and STAT5 activation in response to IL-2 was found mainly in T lymphocytes from peripheral blood and/or tumor site of American Joint Committee on Cancer stage III and IV patients, compared with stage I and II patients and to donors, and in melanoma antigen-specific T cells isolated from metastatic lymph nodes.",19509154_6,-1,-1,-1,-1,9870,-1,0.28668278,0.0026246828,0.7106925
9878,to transforming growth factor,19,23,137,166,Serum from advanced melanoma patients inhibited IL-2-dependent STAT activation in donors' T cells and a neutralizing monoclonal antibody to transforming growth factor beta1 counteracted such inhibition.,19509154_8,-1,-1,-1,-1,9878,-1,0.4505726,0.5413655,0.008061831
9884,T(H)17 cells,18,20,118,130,"Using biopsy specimens from patients with B-cell non-Hodgkin's lymphoma, we observed a significantly low frequency of T(H)17 cells, including several samples with no detectable amount of interleukin (IL)-17-producing cells present in the tumor microenvironment.",19509224_0,-1,-1,-1,-1,9884,-1,0.0029132578,0.7260011,0.27108565
9887,the tumor,34,36,234,243,"Using biopsy specimens from patients with B-cell non-Hodgkin's lymphoma, we observed a significantly low frequency of T(H)17 cells, including several samples with no detectable amount of interleukin (IL)-17-producing cells present in the tumor microenvironment.",19509224_0,-1,-1,-1,-1,9887,-1,1.8808309e-05,0.99997175,9.431904e-06
9909,tested the,30,32,158,168,"Because a subset of lymphoma B cells express IL-2 and given that IL-2 signaling is critically important in the development of regulatory T (T(reg)) cells, we tested the role of IL-2 signaling in T(H)17 cell development.",19509224_3,-1,-1,-1,-1,9909,-1,2.1168787e-05,0.9999701,8.717373e-06
9910,T(H)17 cell,37,39,195,206,"Because a subset of lymphoma B cells express IL-2 and given that IL-2 signaling is critically important in the development of regulatory T (T(reg)) cells, we tested the role of IL-2 signaling in T(H)17 cell development.",19509224_3,-1,-1,-1,-1,9910,-1,0.002732818,0.8255207,0.17174642
9911,that treatment,2,4,9,23,We found that treatment with anti-IL-2 antibody to interrupt IL-2 signaling significantly inhibited Foxp3 expression in CD4(+) T cells.,19509224_4,-1,-1,-1,-1,9911,-1,1.979946e-05,0.9999695,1.07139895e-05
9917,IL-17-producing cells,20,22,142,163,"In contrast, interruption of IL-2 signaling up-regulated IL-17 expression in CD4(+) T cells and restored lymphoma-mediated down-regulation of IL-17-producing cells.",19509224_5,-1,-1,-1,-1,9917,-1,0.74400824,0.0021273352,0.25386444
9922,IL-17-producing cells,18,20,96,117,"Furthermore, the reversal of T(reg) cell activity by LPS or CpG-A resulted in an enhancement of IL-17-producing cells.",19509224_6,-1,-1,-1,-1,9922,-1,0.7826456,0.0016901734,0.2156642
9923,Taken together,0,2,0,14,"Taken together, our study indicated that lymphoma B cells play an important role in skewing the balance between T(reg) and T(H)17 cells resulting in the establishment of a profoundly inhibitory tumor microenvironment.",19509224_7,-1,-1,-1,-1,9923,-1,3.961483e-05,0.9999435,1.6866741e-05
9925,cells play,9,11,52,62,"Taken together, our study indicated that lymphoma B cells play an important role in skewing the balance between T(reg) and T(H)17 cells resulting in the establishment of a profoundly inhibitory tumor microenvironment.",19509224_7,-1,-1,-1,-1,9925,-1,0.0032981029,0.108197376,0.88850456
9928,T(H)17 cells,22,24,123,135,"Taken together, our study indicated that lymphoma B cells play an important role in skewing the balance between T(reg) and T(H)17 cells resulting in the establishment of a profoundly inhibitory tumor microenvironment.",19509224_7,-1,-1,-1,-1,9928,-1,0.0033348864,0.73575646,0.26090866
9936,analysis,21,22,160,168,Regulatory T-cells were identified by fluorescence-activated cell sorting by using a panel of antibodies and by reverse transcriptase polymerase chain reaction analysis for FOXP3 expression.,19538059_1,0,1,-1,-1,9936,-1,3.9710972e-05,0.9999347,2.5631558e-05
9938,Functional,0,1,0,10,Functional studies were done to analyze their inhibitory role.,19538059_2,0,1,2,-1,9938,-1,3.4242454e-05,0.99994767,1.8083474e-05
9946,blood,16,17,100,105,"Patients with NSCLC have increased numbers of CD4(+)CD25(high) FOXP3(+) T(regs) in their peripheral blood and pleura effusion (PE), which express high levels of CTLA-4, GITR.",19538059_4,0,1,-1,-1,9946,-1,0.00021583284,0.99661,0.0031741518
9949,These cells,0,2,0,11,"These cells were anergic toward T-cell receptor stimulation and, when cocultured with activated CD4(+)CD25(-) cells, potently suppressed their proliferation and cytokine secretion.",19538059_5,-1,-1,-1,-1,9949,-1,0.0035855127,0.2391419,0.75727254
9950,toward T-cell receptor,4,7,25,47,"These cells were anergic toward T-cell receptor stimulation and, when cocultured with activated CD4(+)CD25(-) cells, potently suppressed their proliferation and cytokine secretion.",19538059_5,-1,-1,-1,-1,9950,-1,0.0020540247,0.03886947,0.9590764
9958,blood,20,21,127,132,"Our data suggest that in NSCLC patients, there is an increase of CD4(+)CD25(high)FOXP3(+) regulatory T-cells in the peripheral blood and tumor microenvironment.",19538059_6,0,1,-1,-1,9958,-1,0.00017860338,0.99789315,0.001928293
9960,These T-cells,0,2,0,13,"These T-cells might prevent effective antitumor immune responses, and the increase in frequency of CD4(+)CD25(high)FOXP3(+) Tregs might play a role in the modulation of the immune response against NSCLC and could be important in the design of immunotherapeutic approaches.",19538059_7,-1,-1,-1,-1,9960,-1,0.0025278665,0.12551993,0.87195224
9966,the immune response,26,29,169,188,"These T-cells might prevent effective antitumor immune responses, and the increase in frequency of CD4(+)CD25(high)FOXP3(+) Tregs might play a role in the modulation of the immune response against NSCLC and could be important in the design of immunotherapeutic approaches.",19538059_7,-1,-1,-1,-1,9966,-1,0.23810281,0.7606422,0.0012550176
9973,related to,7,9,31,41,"In many cases, this process is related to an inappropriate T cell response to environmental allergens, and other T cell-dependent pathways may also be involved (such as Th17).",19538496_1,-1,-1,-1,-1,9973,-1,3.0508392e-05,0.9999541,1.5409645e-05
9980,T cells that,7,10,31,43,Regulatory T cells (Tregs) are T cells that suppress potentially harmful immune responses.,19538496_2,-1,-1,-1,-1,9980,-1,0.0013669955,0.029279504,0.96935344
9987,IL-10-producing Tregs,11,13,58,79,"Two major subsets of Treg are CD25(hi), Foxp3(+)Tregs and IL-10-producing Tregs. There is evidence that the numbers or function of both subsets may be deficient in patients with atopic allergic disease.",19538496_3,-1,-1,-1,-1,9987,-1,0.9840073,0.012133348,0.0038594115
9989,that the,17,19,99,107,"Two major subsets of Treg are CD25(hi), Foxp3(+)Tregs and IL-10-producing Tregs. There is evidence that the numbers or function of both subsets may be deficient in patients with atopic allergic disease.",19538496_3,-1,-1,-1,-1,9989,-1,2.0411599e-05,0.99997115,8.399583e-06
9990,function,21,22,119,127,"Two major subsets of Treg are CD25(hi), Foxp3(+)Tregs and IL-10-producing Tregs. There is evidence that the numbers or function of both subsets may be deficient in patients with atopic allergic disease.",19538496_3,0,1,2,-1,9990,-1,8.920943e-05,0.99984956,6.116925e-05
9995,Treg-suppressive function,19,21,114,139,Recent work has extended these findings into the airway in asthma where Foxp3 expression was reduced and CD25(hi) Treg-suppressive function was deficient.,19538496_4,-1,-1,-1,-1,9995,-1,6.208171e-05,0.9998857,5.2171155e-05
9999,function,27,28,187,195,"In animal models of allergic airways disease, Tregs can suppress established airway inflammation and airway hyperresponsiveness, and protocols to enhance the development, recruitment and function of Tregs have been described.",19538496_5,0,1,2,-1,9999,-1,7.04822e-05,0.9998834,4.6074598e-05
10005,Treg function,22,24,142,155,"Together with studies of patients and in vitro studies of human T cells, these investigations are defining potential interventions to enhance Treg function in the airway in asthma.",19538496_6,-1,-1,-1,-1,10005,-1,4.0178944e-05,0.99992955,3.0303852e-05
10011,IL-10 Treg function,25,28,179,198,"Existing therapies including corticosteroids and allergen immunotherapy act on Tregs, in part to increase IL-10 production, while vitamin D3 and long-acting beta-agonists enhance IL-10 Treg function.",19538496_7,-1,-1,-1,-1,10011,-1,0.97230744,0.020494929,0.007197487
10012,Treg function,6,8,42,55,"Other possibilities may be enhancement of Treg function via histamine or prostanoid receptors, or by blocking pro-inflammatory pathways that prevent suppression by Tregs (activation of Toll-like receptors, or production of cytokines such as IL-6 and TNF-alpha).",19538496_8,-1,-1,-1,-1,10012,-1,3.4042874e-05,0.9999416,2.4389425e-05
10013,receptors,12,13,84,93,"Other possibilities may be enhancement of Treg function via histamine or prostanoid receptors, or by blocking pro-inflammatory pathways that prevent suppression by Tregs (activation of Toll-like receptors, or production of cytokines such as IL-6 and TNF-alpha).",19538496_8,0,1,2,-1,10013,-1,0.0010201683,0.0695885,0.9293913
10016,Toll-like receptors,27,29,185,204,"Other possibilities may be enhancement of Treg function via histamine or prostanoid receptors, or by blocking pro-inflammatory pathways that prevent suppression by Tregs (activation of Toll-like receptors, or production of cytokines such as IL-6 and TNF-alpha).",19538496_8,-1,-1,-1,-1,10016,-1,0.0021637778,0.95742244,0.040413734
10019,TNF-alpha,38,39,250,259,"Other possibilities may be enhancement of Treg function via histamine or prostanoid receptors, or by blocking pro-inflammatory pathways that prevent suppression by Tregs (activation of Toll-like receptors, or production of cytokines such as IL-6 and TNF-alpha).",19538496_8,0,1,-1,-1,10019,-1,0.0042208727,0.99554056,0.00023855822
10028,TCRalphabeta play,7,9,38,55,Regulatory T cells (Tregs) expressing TCRalphabeta play a critical role in the maintenance of the immune system homeostasis.,19539651_0,-1,-1,-1,-1,10028,-1,2.5342657e-05,0.99995756,1.7037262e-05
10032,the cell,2,4,14,22,Tregs express the cell surface markers CD4 and CD25 as well as the transcription factor Foxp3.,19539651_1,-1,-1,-1,-1,10032,-1,0.004114399,0.59211314,0.4037725
10033,the transcription factor Foxp3,12,16,63,93,Tregs express the cell surface markers CD4 and CD25 as well as the transcription factor Foxp3.,19539651_1,-1,-1,-1,-1,10033,-1,2.3351617e-05,0.99996483,1.1769891e-05
10038,TGF-beta,17,18,116,124,Foxp3(+)CD4(+)CD25(+)TCRalphabeta(+) Tregs can be generated from mouse and human CD4(+)CD25(-) T cells in vitro via TGF-beta induction.,19539651_2,0,1,-1,-1,10038,-1,5.2924457e-05,0.9999279,1.9204967e-05
10041,function,11,12,80,88,"As growing evidences suggest that gammadelta T cells also have immunoregulatory function, we have attempted to identify and characterize Foxp3(+) cells in mouse and human gammadelta T cells.",19539651_3,0,1,2,-1,10041,-1,6.343918e-05,0.9998858,5.070887e-05
10050,TGF-beta,11,12,82,90,"When mouse splenocytes were stimulated with anti-TCRgammadelta in the presence of TGF-beta, a population of Foxp3(+) gammadelta T cells appeared, in most of which expressed CD25 as well.",19539651_5,0,1,-1,-1,10050,-1,5.827707e-05,0.9999194,2.2318407e-05
10054,TGF-beta,8,9,42,50,"Compared with CD25(-) gammadelta T cells, TGF-beta induced CD25(+) gammadelta T cells not only expressed Foxp3, but also had increased TGF-beta and GITR expression.",19539651_6,0,1,-1,-1,10054,-1,7.185397e-05,0.9999044,2.376227e-05
10057,TGF-beta,24,25,135,143,"Compared with CD25(-) gammadelta T cells, TGF-beta induced CD25(+) gammadelta T cells not only expressed Foxp3, but also had increased TGF-beta and GITR expression.",19539651_6,0,1,-1,-1,10057,-1,7.87586e-05,0.99989736,2.3898048e-05
10058,the TGF-beta,2,4,13,25,"Furthermore, the TGF-beta induced gammadelta T cells mediated a potent immunosuppressive effect on anti-CD3 stimulated T cell activation and proliferation.",19539651_7,-1,-1,-1,-1,10058,-1,4.966256e-05,0.99993134,1.8979586e-05
10061,blood,10,11,59,64,"In contrast, although a small fraction of human peripheral blood and tumor infiltrating gammadelta T cells expressed Foxp3, similar culture condition with anti-TCRgammadelta plus TGF-beta failed to generate functional human Foxp3(+) gammadelta T cells.",19539651_8,0,1,-1,-1,10061,-1,0.00021565563,0.99626106,0.0035232326
10065,plus TGF-beta,25,27,174,187,"In contrast, although a small fraction of human peripheral blood and tumor infiltrating gammadelta T cells expressed Foxp3, similar culture condition with anti-TCRgammadelta plus TGF-beta failed to generate functional human Foxp3(+) gammadelta T cells.",19539651_8,-1,-1,-1,-1,10065,-1,0.00010385466,0.99987185,2.4236251e-05
10066,to generate functional,28,31,195,217,"In contrast, although a small fraction of human peripheral blood and tumor infiltrating gammadelta T cells expressed Foxp3, similar culture condition with anti-TCRgammadelta plus TGF-beta failed to generate functional human Foxp3(+) gammadelta T cells.",19539651_8,-1,-1,-1,-1,10066,-1,2.6023765e-05,0.9999628,1.1151097e-05
10072,function,16,17,99,107,"In conclusion, our results suggest that mouse splenic Foxp3(+) gammadelta T cells with suppressive function can be induced by TCR and TGF-beta costimulation, whereas functional human Foxp3(+) gammadelta T cells in peripheral blood could not be generated under the same condition.",19539651_9,0,1,2,-1,10072,-1,8.940237e-05,0.99984026,7.035129e-05
10073,TCR,21,22,126,129,"In conclusion, our results suggest that mouse splenic Foxp3(+) gammadelta T cells with suppressive function can be induced by TCR and TGF-beta costimulation, whereas functional human Foxp3(+) gammadelta T cells in peripheral blood could not be generated under the same condition.",19539651_9,-1,1,2,-1,10073,-1,2.6356902e-05,0.99995506,1.852981e-05
10074,TGF-beta,23,24,134,142,"In conclusion, our results suggest that mouse splenic Foxp3(+) gammadelta T cells with suppressive function can be induced by TCR and TGF-beta costimulation, whereas functional human Foxp3(+) gammadelta T cells in peripheral blood could not be generated under the same condition.",19539651_9,0,1,-1,-1,10074,-1,0.00011014528,0.99986374,2.608544e-05
10075,functional,27,28,166,176,"In conclusion, our results suggest that mouse splenic Foxp3(+) gammadelta T cells with suppressive function can be induced by TCR and TGF-beta costimulation, whereas functional human Foxp3(+) gammadelta T cells in peripheral blood could not be generated under the same condition.",19539651_9,0,1,2,-1,10075,-1,3.0650168e-05,0.99995553,1.3796075e-05
10078,blood,36,37,225,230,"In conclusion, our results suggest that mouse splenic Foxp3(+) gammadelta T cells with suppressive function can be induced by TCR and TGF-beta costimulation, whereas functional human Foxp3(+) gammadelta T cells in peripheral blood could not be generated under the same condition.",19539651_9,0,1,-1,-1,10078,-1,0.00020932617,0.99767464,0.0021160266
10084,the generated immune response,4,8,37,66,"Immune tolerance consistently blunts the generated immune response, and the largely solitary focus on CD8+ T cell immunity has proven ineffective in the absence of CD4+ T cell help.",19561540_1,-1,-1,-1,-1,10084,-1,0.15465675,0.84416646,0.001176747
10086,CD8+ T cell immunity,15,20,102,122,"Immune tolerance consistently blunts the generated immune response, and the largely solitary focus on CD8+ T cell immunity has proven ineffective in the absence of CD4+ T cell help.",19561540_1,-1,-1,-1,-1,10086,-1,0.0022118015,0.00033419905,0.997454
10090,these twin-tier,2,4,11,26,"To address these twin-tier deficiencies, we developed a translational model of melanoma immunotherapy focused on the exploitation of high-avidity CD4+ T cells that become generated in germline antigen-deficient mice.",19561540_2,-1,-1,-1,-1,10090,-1,2.208067e-05,0.99996567,1.2211851e-05
10093,T cells that,22,25,151,163,"To address these twin-tier deficiencies, we developed a translational model of melanoma immunotherapy focused on the exploitation of high-avidity CD4+ T cells that become generated in germline antigen-deficient mice.",19561540_2,-1,-1,-1,-1,10093,-1,0.001514776,0.028637398,0.96984774
10096,tyrosinase-related protein-1,5,7,31,59,We had previously identified a tyrosinase-related protein-1 specific HLA-DRB1*0401-restricted epitope.,19561540_3,-1,-1,-1,-1,10096,-1,4.1525003e-05,0.9998965,6.1925195e-05
10098,tyrosinase-related protein-1,9,11,57,85,"Using this epitope in conjunction with a newly described tyrosinase-related protein-1 germline-knockout, we demonstrate that endogenous tyrosinase-related protein-1 expression alters the functionality of the autoreactive T cell repertoire.",19561540_4,-1,-1,-1,-1,10098,-1,4.422685e-05,0.999874,8.171527e-05
10100,tyrosinase-related protein-1,17,19,136,164,"Using this epitope in conjunction with a newly described tyrosinase-related protein-1 germline-knockout, we demonstrate that endogenous tyrosinase-related protein-1 expression alters the functionality of the autoreactive T cell repertoire.",19561540_4,-1,-1,-1,-1,10100,-1,3.9211674e-05,0.9998969,6.395069e-05
10101,the functionality,21,23,183,200,"Using this epitope in conjunction with a newly described tyrosinase-related protein-1 germline-knockout, we demonstrate that endogenous tyrosinase-related protein-1 expression alters the functionality of the autoreactive T cell repertoire.",19561540_4,-1,-1,-1,-1,10101,-1,2.2197542e-05,0.99996614,1.1714397e-05
10108,triggers the,25,27,168,180,"More importantly, we show, by using major histocompatibility complex-mismatched combinations, that CD4+ T cells derived from the self-antigen deficient host indirectly triggers the eradication of established B16 lung metastases.",19561540_5,-1,-1,-1,-1,10108,-1,2.5283725e-05,0.99996316,1.15445e-05
10109,that the treatment,2,5,15,33,We demonstrate that the treatment effect is mediated entirely by endogenous CD8+ T cells and is not affected by the depletion of host regulatory T cells.,19561540_6,-1,-1,-1,-1,10109,-1,2.0957868e-05,0.9999691,9.906512e-06
10117,through the,19,21,137,148,These findings suggest that high-avidity CD4+ T cells can overcome endogenous conditions and mediate their antitumor effects exclusively through the elicitation of CD8+ T cell immunity.,19561540_7,-1,-1,-1,-1,10117,-1,2.2568911e-05,0.999964,1.3480985e-05
10118,CD8+ T cell immunity,23,28,164,184,These findings suggest that high-avidity CD4+ T cells can overcome endogenous conditions and mediate their antitumor effects exclusively through the elicitation of CD8+ T cell immunity.,19561540_7,-1,-1,-1,-1,10118,-1,0.0043372028,0.00043279328,0.9952301
10119,the Th17 subset,1,4,9,24,"Although the Th17 subset and its signature cytokine, interleukin (IL)-17A (IL-17), are implicated in certain autoimmune diseases, their role in cancer remains to be further explored.",19564351_0,-1,-1,-1,-1,10119,-1,0.0025928176,0.79811347,0.1992937
10128,to tumor,18,20,92,100,"IL-17 has been shown to be elevated in several types of cancer, but how it might contribute to tumor growth is still unclear.",19564351_1,-1,-1,-1,-1,10128,-1,3.064779e-05,0.9999589,1.0471759e-05
10135,analysis,4,5,30,38,Adoptive transfer studies and analysis of the tumor microenvironment suggest that CD4(+) T cells are the predominant source of IL-17.,19564351_3,0,1,-1,-1,10135,-1,3.021912e-05,0.9999505,1.9229336e-05
10136,the tumor,6,8,42,51,Adoptive transfer studies and analysis of the tumor microenvironment suggest that CD4(+) T cells are the predominant source of IL-17.,19564351_3,-1,-1,-1,-1,10136,-1,1.9122497e-05,0.9999713,9.644286e-06
10143,tumor cells,10,12,64,75,"Enhancement of tumor growth by IL-17 involves direct effects on tumor cells and tumor-associated stromal cells, which bear IL-17 receptors.",19564351_4,-1,-1,-1,-1,10143,-1,0.0039990996,0.3612245,0.6347764
10146,IL-17 receptors,19,21,123,138,"Enhancement of tumor growth by IL-17 involves direct effects on tumor cells and tumor-associated stromal cells, which bear IL-17 receptors.",19564351_4,-1,-1,-1,-1,10146,-1,0.93700916,0.0055820365,0.05740884
10153,The Th17,0,2,0,8,"The Th17 response can thus promote tumor growth, in part via an IL-6-Stat3 pathway.",19564351_6,-1,-1,-1,-1,10153,-1,3.2610005e-05,0.9999554,1.1977198e-05
10161,chemokine receptors,6,8,27,46,"In particular, the role of chemokine receptors in metastasis remains controversial.",19567680_2,-1,-1,-1,-1,10161,-1,0.09930704,0.0045405542,0.8961524
10163,the tumor cells that,26,30,125,145,"Here, using a highly metastatic breast cancer (4T1) model, we show that lung metastasis is a feature of only a proportion of the tumor cells that express CCR4.",19567680_3,-1,-1,-1,-1,10163,-1,6.220328e-05,0.999848,8.974399e-05
10168,These chemokines,0,2,0,16,These chemokines acting through CCR4 attract both tumor and immune cells.,19567680_5,-1,-1,-1,-1,10168,-1,0.44553882,0.54746133,0.0069997967
10174,tumor cells,12,14,79,90,"However, CCR4-mediated chemotaxis was not sufficient to produce metastasis, as tumor cells in the lung were efficiently eliminated by natural killer (NK) cells.",19567680_6,-1,-1,-1,-1,10174,-1,0.0030920967,0.20573482,0.791173
10181,protein,19,20,122,129,"Lung metastasis required CCR4(+) regulatory T cells (Treg), which directly killed NK cells using beta-galactoside-binding protein.",19567680_7,0,1,-1,-1,10181,-1,9.885973e-05,0.9997776,0.0001234811
10188,tumor cell,22,24,138,148,"Thus, strategies that abrogate any part of this process should improve the outcome through activation of effector cells and prevention of tumor cell migration.",19567680_8,-1,-1,-1,-1,10188,-1,0.0040216465,0.29525825,0.7007201
10190,cells through,8,10,46,59,We confirm this prediction by killing CCR4(+) cells through delivery of TARC-fused toxins or depleting Tregs and preventing lung metastasis.,19567680_9,-1,-1,-1,-1,10190,-1,0.0038097089,0.12739572,0.8687946
10191,TARC-fused toxins,12,14,72,89,We confirm this prediction by killing CCR4(+) cells through delivery of TARC-fused toxins or depleting Tregs and preventing lung metastasis.,19567680_9,-1,-1,-1,-1,10191,-1,3.79607e-05,0.99994063,2.139915e-05
10197,protein,2,3,7,14,"The E7 protein is found predominantly in the nucleus and, to a lesser extent, in the cytoplasm in cervical cancer cell lines.",19574175_2,0,1,-1,-1,10197,-1,7.607261e-05,0.999683,0.00024091173
10203,functionally,7,8,28,40,HPV E7 has been shown to be functionally associated with the tumor suppressor interferon regulatory factor (IRF)-1 in cervical carcinogenesis.,19574175_3,0,1,2,-1,10203,-1,2.8468525e-05,0.9999604,1.1132625e-05
10204,the tumor,10,12,57,66,HPV E7 has been shown to be functionally associated with the tumor suppressor interferon regulatory factor (IRF)-1 in cervical carcinogenesis.,19574175_3,-1,-1,-1,-1,10204,-1,1.9929195e-05,0.9999708,9.259403e-06
10211,function,20,21,112,120,"MATERIALS AND METHODS: In this study, new gene ontology technology was used to predict changes in the molecular function and biologic processes caused by the interaction between IRF-1 and HPV E7.RESULTS: The molecular function and biologic processes of IRF-1 and the combined IRF-1 and HPV E7 (IRF-1-E7) were derived using the GoFigure server.",19574175_4,0,1,2,-1,10211,-1,6.024606e-05,0.9998971,4.2606727e-05
10215,function,36,37,218,226,"MATERIALS AND METHODS: In this study, new gene ontology technology was used to predict changes in the molecular function and biologic processes caused by the interaction between IRF-1 and HPV E7.RESULTS: The molecular function and biologic processes of IRF-1 and the combined IRF-1 and HPV E7 (IRF-1-E7) were derived using the GoFigure server.",19574175_4,0,1,2,-1,10215,-1,7.148258e-05,0.999877,5.1521503e-05
10223,functions,5,6,40,49,The combined IRF-1-E7 demonstrated more functions and biologic processes compared with IRF-1 alone.,19574175_5,0,1,2,-1,10223,-1,9.036223e-05,0.9998078,0.000101846585
10235,tumor cells,17,19,101,112,Invariant NKT (iNKT) cells recognize lipid antigens presented by CD1d and respond rapidly by killing tumor cells and release cytokines that activate and regulate adaptive immune responses.,19585513_0,-1,-1,-1,-1,10235,-1,0.0046952623,0.35820806,0.6370967
10236,release cytokines that,20,23,117,139,Invariant NKT (iNKT) cells recognize lipid antigens presented by CD1d and respond rapidly by killing tumor cells and release cytokines that activate and regulate adaptive immune responses.,19585513_0,-1,-1,-1,-1,10236,-1,0.00019537857,0.9997298,7.4748874e-05
10242,to their,26,28,153,161,"They are essential for tumor rejection in various mouse models, but clinical trials in humans involving iNKT cells have been less successful, partly due to their rarity in humans compared with mice.",19585513_1,-1,-1,-1,-1,10242,-1,2.6852738e-05,0.99996173,1.1408713e-05
10243,functional,6,7,36,46,"Here we describe an accumulation of functional iNKT cells in human omentum, a migratory organ with healing properties.",19585513_2,0,1,2,-1,10243,-1,7.1205824e-05,0.9998678,6.097851e-05
10245,Analysis,0,1,0,8,"Analysis of 39 omental samples revealed that T cells are the predominant lymphoid cell type and of these, 10% expressed the invariant Valpha24Jalpha18 TCR chain, found on iNKT cells, higher than in any other human organ tested to date.",19585513_3,0,1,-1,-1,10245,-1,2.6185488e-05,0.99995244,2.1427115e-05
10246,that T cells,6,9,40,52,"Analysis of 39 omental samples revealed that T cells are the predominant lymphoid cell type and of these, 10% expressed the invariant Valpha24Jalpha18 TCR chain, found on iNKT cells, higher than in any other human organ tested to date.",19585513_3,-1,-1,-1,-1,10246,-1,0.0024863856,0.11897662,0.87853694
10248,cell type,13,15,82,91,"Analysis of 39 omental samples revealed that T cells are the predominant lymphoid cell type and of these, 10% expressed the invariant Valpha24Jalpha18 TCR chain, found on iNKT cells, higher than in any other human organ tested to date.",19585513_3,-1,-1,-1,-1,10248,-1,6.0687635e-05,0.00013435612,0.99980503
10251,TCR,25,26,151,154,"Analysis of 39 omental samples revealed that T cells are the predominant lymphoid cell type and of these, 10% expressed the invariant Valpha24Jalpha18 TCR chain, found on iNKT cells, higher than in any other human organ tested to date.",19585513_3,-1,1,2,-1,10251,-1,9.934695e-05,0.99965477,0.0002459386
10254,tested to,40,42,220,229,"Analysis of 39 omental samples revealed that T cells are the predominant lymphoid cell type and of these, 10% expressed the invariant Valpha24Jalpha18 TCR chain, found on iNKT cells, higher than in any other human organ tested to date.",19585513_3,-1,-1,-1,-1,10254,-1,4.0282874e-05,0.99993885,2.0824331e-05
10256,in blood,14,16,74,82,"About 15% of omental hematopoietic cells expressed CD1d, compared with 1% in blood (p<0.001).",19585513_4,0,1,-1,-1,10256,-1,6.116968e-05,0.9998566,8.2169594e-05
10259,released IFN-gamma,9,11,55,73,Enriched omental iNKT cells killed CD1d(+) targets and released IFN-gamma and IL-4 upon activation.,19585513_5,-1,-1,-1,-1,10259,-1,0.94606245,0.04781986,0.006117688
10263,tumor immunity,13,15,73,87,These data suggest a novel role for the omentum in immune regulation and tumor immunity and identify it as a potential source of iNKT cells for therapeutic use.,19585513_7,-1,-1,-1,-1,10263,-1,0.004527654,0.99530387,0.00016847238
10265,therapeutic use,26,28,144,159,These data suggest a novel role for the omentum in immune regulation and tumor immunity and identify it as a potential source of iNKT cells for therapeutic use.,19585513_7,0,1,-1,-1,10265,-1,2.909103e-05,0.99995625,1.46021885e-05
10266,tumor-associated antigens,12,14,54,79,"In mice, injection of messenger RNA (mRNA) coding for tumor-associated antigens can induce antitumor immune responses and therefore offers a broadly applicable immunotherapy approach.",19609242_0,-1,-1,-1,-1,10266,-1,0.036768,0.9597875,0.0034445107
10270,to the,11,13,57,63,In 10 patients keyhole limpet hemocyanin (KLH) was added to the vaccine.,19609242_2,-1,-1,-1,-1,10270,-1,3.676297e-05,0.99994946,1.3730363e-05
10272,toxicity,2,3,15,23,Endpoints were toxicity and immune responses.,19609242_4,0,1,-1,-1,10272,-1,5.506888e-05,0.99988735,5.762584e-05
10275,treatment the,1,3,7,20,"During treatment the frequency of Foxp3+/CD4+ regulatory T cells was significantly decreased upon mRNA vaccination in peripheral blood of the patients in the KLH arm, whereas myeloid suppressor cells (CD11b+HLA-DR lo monocytes) were reduced in the patients not receiving KLH.",19609242_6,-1,-1,-1,-1,10275,-1,1.8058474e-05,0.9999728,9.074787e-06
10277,blood,18,19,129,134,"During treatment the frequency of Foxp3+/CD4+ regulatory T cells was significantly decreased upon mRNA vaccination in peripheral blood of the patients in the KLH arm, whereas myeloid suppressor cells (CD11b+HLA-DR lo monocytes) were reduced in the patients not receiving KLH.",19609242_6,0,1,-1,-1,10277,-1,5.6823577e-05,0.99983907,0.00010409538
10285,the treatment,4,6,29,42,"The significant influence of the treatment on the frequency of immunosuppressive cells, the increase of vaccine-directed T cells upon treatment in a subset of patients together with the demonstration of a complete clinical response encourage further clinical investigation of the protamine-mRNA vaccine.",19609242_10,-1,-1,-1,-1,10285,-1,2.5619049e-05,0.9999634,1.0974433e-05
10301,blood,18,19,107,112,OBJECTIVE: To investigate the expression of transcription factors (TF) T-bet and GATA-3 mRNA in peripheral blood mononuclear cells and its correlation with immune status in esophageal cancer patients.,19615257_0,0,1,-1,-1,10301,-1,0.00015396616,0.999091,0.0007549856
10305,to the,10,12,63,69,"METHODS: Sixty patients were divided into two groups according to the clinical data: group A consisting of stage I and II, group B including stage III and IV.",19615257_1,-1,-1,-1,-1,10305,-1,2.1772801e-05,0.9999684,9.779425e-06
10306,The gene,0,2,0,8,The gene expression of T-bet and GATA-3 in 60 esophageal cancer patients and 30 healthy controls was detected by reverse transcription-polymerase chain reaction (RT-PCR).,19615257_2,-1,-1,-1,-1,10306,-1,1.9933845e-05,0.99997044,9.6338545e-06
10313,than that,49,51,258,267,"The expression of IFN-gamma and IL-4 was measured by enzyme linked immunosorbent assay (ELISA).RESULTS: Expression of T-bet mRNA in esophageal cancer patients (stage I and II: 0.27 +/- 0.05 ng/L, stage III and IV: 0.12 +/- 0.02 ng/L) was significantly lower than that in the healthy controls (1.35 +/- 0.14 ng/L), but the expression of GATA-3 mRNA in esophageal cancer patients (stage I and II: 0.45 +/- 0.06, stage III and IV: 0.55 +/- 0.03) was significantly higher than that in the healthy controls (0.09 +/- 0.10).",19615257_3,-1,-1,-1,-1,10313,-1,2.4920271e-05,0.9999578,1.7270511e-05
10317,than that,97,99,468,477,"The expression of IFN-gamma and IL-4 was measured by enzyme linked immunosorbent assay (ELISA).RESULTS: Expression of T-bet mRNA in esophageal cancer patients (stage I and II: 0.27 +/- 0.05 ng/L, stage III and IV: 0.12 +/- 0.02 ng/L) was significantly lower than that in the healthy controls (1.35 +/- 0.14 ng/L), but the expression of GATA-3 mRNA in esophageal cancer patients (stage I and II: 0.45 +/- 0.06, stage III and IV: 0.55 +/- 0.03) was significantly higher than that in the healthy controls (0.09 +/- 0.10).",19615257_3,-1,-1,-1,-1,10317,-1,2.4964384e-05,0.9999583,1.6729122e-05
10319,The plasma,0,2,0,10,"The plasma level of Th1 cytokine IFN-gamma in the patients [stage I and II: (12.12 +/- 1.48) ng/L, stage III and IV: (8.44 +/- 0.90) ng/L] was significantly lower than that in the healthy controls, while the level of Th2 cytokine IL-4 in the patients [stage I and II: (18.64 +/- 0.77) ng/L, stage III and IV: (25.28 +/- 2.02) ng/L] was significantly higher than that in the healthy controls.",19615257_4,-1,-1,-1,-1,10319,-1,1.895059e-05,0.9999684,1.2623839e-05
10320,Th1 cytokine IFN-gamma,4,7,20,42,"The plasma level of Th1 cytokine IFN-gamma in the patients [stage I and II: (12.12 +/- 1.48) ng/L, stage III and IV: (8.44 +/- 0.90) ng/L] was significantly lower than that in the healthy controls, while the level of Th2 cytokine IL-4 in the patients [stage I and II: (18.64 +/- 0.77) ng/L, stage III and IV: (25.28 +/- 2.02) ng/L] was significantly higher than that in the healthy controls.",19615257_4,-1,-1,-1,-1,10320,-1,0.88197637,0.10165637,0.01636724
10322,than that,40,42,163,172,"The plasma level of Th1 cytokine IFN-gamma in the patients [stage I and II: (12.12 +/- 1.48) ng/L, stage III and IV: (8.44 +/- 0.90) ng/L] was significantly lower than that in the healthy controls, while the level of Th2 cytokine IL-4 in the patients [stage I and II: (18.64 +/- 0.77) ng/L, stage III and IV: (25.28 +/- 2.02) ng/L] was significantly higher than that in the healthy controls.",19615257_4,-1,-1,-1,-1,10322,-1,2.4127852e-05,0.9999602,1.5652466e-05
10325,Th2 cytokine,51,53,217,229,"The plasma level of Th1 cytokine IFN-gamma in the patients [stage I and II: (12.12 +/- 1.48) ng/L, stage III and IV: (8.44 +/- 0.90) ng/L] was significantly lower than that in the healthy controls, while the level of Th2 cytokine IL-4 in the patients [stage I and II: (18.64 +/- 0.77) ng/L, stage III and IV: (25.28 +/- 2.02) ng/L] was significantly higher than that in the healthy controls.",19615257_4,-1,-1,-1,-1,10325,-1,0.16429758,0.8141464,0.021555956
10327,than that,87,89,357,366,"The plasma level of Th1 cytokine IFN-gamma in the patients [stage I and II: (12.12 +/- 1.48) ng/L, stage III and IV: (8.44 +/- 0.90) ng/L] was significantly lower than that in the healthy controls, while the level of Th2 cytokine IL-4 in the patients [stage I and II: (18.64 +/- 0.77) ng/L, stage III and IV: (25.28 +/- 2.02) ng/L] was significantly higher than that in the healthy controls.",19615257_4,-1,-1,-1,-1,10327,-1,2.4157811e-05,0.9999603,1.5507749e-05
10332,the plasma,13,15,63,73,"However, neither in the expression of T-bet and GATA-3, nor in the plasma level of IFN-gamma and IL-4, showed a significant difference between group A and B.CONCLUSION: In the peripheral blood of esophageal cancer patients, the expression of T-bet decreased, while GATA-3 increased, Th1/Th2 balance is broken, and the Th2 is dominant.",19615257_5,-1,-1,-1,-1,10332,-1,2.0824365e-05,0.99996626,1.28994625e-05
10335,blood,34,35,187,192,"However, neither in the expression of T-bet and GATA-3, nor in the plasma level of IFN-gamma and IL-4, showed a significant difference between group A and B.CONCLUSION: In the peripheral blood of esophageal cancer patients, the expression of T-bet decreased, while GATA-3 increased, Th1/Th2 balance is broken, and the Th2 is dominant.",19615257_5,0,1,-1,-1,10335,-1,7.191489e-05,0.9996753,0.0002528603
10339,the Th2,56,58,314,321,"However, neither in the expression of T-bet and GATA-3, nor in the plasma level of IFN-gamma and IL-4, showed a significant difference between group A and B.CONCLUSION: In the peripheral blood of esophageal cancer patients, the expression of T-bet decreased, while GATA-3 increased, Th1/Th2 balance is broken, and the Th2 is dominant.",19615257_5,-1,-1,-1,-1,10339,-1,3.11371e-05,0.99995124,1.76549e-05
10341,GATA-3 play,2,4,10,21,T-bet and GATA-3 play a part role in the regulation of Th1/Th2 balance.,19615257_6,-1,-1,-1,-1,10341,-1,4.0015348e-05,0.99992645,3.3493943e-05
10342,the regulation,8,10,37,51,T-bet and GATA-3 play a part role in the regulation of Th1/Th2 balance.,19615257_6,-1,-1,-1,-1,10342,-1,1.9701141e-05,0.9999696,1.0728765e-05
10343,tumor antigens,11,13,57,71,"Since human papillomavirus (HPV) E6 and E7 are promising tumor antigens, we engineered E6 and E7 antigens to generate an optimal HPV DNA vaccine by codon optimization (Co), fusion of E6 and E7, addition of a tissue plasminogen activator (tpa) signal sequence, addition of CD40 ligand (CD40L) or Fms-like tyrosine kinase-3 ligand (Flt3L).",19651174_0,-1,-1,-1,-1,10343,-1,0.3306936,0.65989566,0.009410753
10344,antigens to generate,19,22,97,117,"Since human papillomavirus (HPV) E6 and E7 are promising tumor antigens, we engineered E6 and E7 antigens to generate an optimal HPV DNA vaccine by codon optimization (Co), fusion of E6 and E7, addition of a tissue plasminogen activator (tpa) signal sequence, addition of CD40 ligand (CD40L) or Fms-like tyrosine kinase-3 ligand (Flt3L).",19651174_0,-1,-1,-1,-1,10344,-1,0.5071587,0.47808728,0.014754002
10345,tissue plasminogen activator,43,46,208,236,"Since human papillomavirus (HPV) E6 and E7 are promising tumor antigens, we engineered E6 and E7 antigens to generate an optimal HPV DNA vaccine by codon optimization (Co), fusion of E6 and E7, addition of a tissue plasminogen activator (tpa) signal sequence, addition of CD40 ligand (CD40L) or Fms-like tyrosine kinase-3 ligand (Flt3L).",19651174_0,-1,-1,-1,-1,10345,-1,0.0055149486,0.99404836,0.00043669142
10358,immunity,39,40,201,209,"When E6(Co) and E7(Co) were fused (E67(Co)), CD8(+) T cell responses specific for E6 or E7 antigen decreased, but the preventive antitumor effect rather improved, demonstrating the importance of broad immunity.",19651174_2,0,-1,2,-1,10358,-1,0.9966186,0.0027467692,0.0006345962
10361,than that,22,24,146,155,"Interestingly, Flt3L-fused HPV DNA vaccine exhibited stronger E6- and E7-specific CD8(+) T cell responses as well as therapeutic antitumor effect than that of CD40L linked HPV DNA vaccine.",19651174_3,-1,-1,-1,-1,10361,-1,2.6150903e-05,0.99995923,1.4563638e-05
10369,than those,44,46,226,236,"Finally, the optimal construct, tFE67(Co), was generated by including tpa signal sequence, Flt3L, fusion of E6 and E7, and codon optimization, which induces 23 and 25 times stronger E6- and E7-specific CD8(+) T cell responses than those of initial E67 fusion construct.",19651174_4,-1,-1,-1,-1,10369,-1,2.4728524e-05,0.9999583,1.697728e-05
10376,that tFE67(Co,15,17,91,104,"Thus, our results provide valuable insight on effective HPV DNA vaccine design and suggest that tFE67(Co) delivered with electroporation may be a promising therapeutic HPV DNA vaccine against cervical cancer.",19651174_6,-1,-1,-1,-1,10376,-1,3.9435712e-05,0.99994266,1.7924356e-05
10380,the target,15,17,92,102,"Carcinoembryonic antigen (CEA) is over-expressed on various human cancer cells and has been the target of immunotherapies using dendritic cells (DCs) pulsed with CEA-specific RNA or peptides, or transduced by CEA-expressing adenovirus or vaccinia virus.",19659778_0,-1,-1,-1,-1,10380,-1,2.2884618e-05,0.9999672,9.941075e-06
10382,peptides,30,31,182,190,"Carcinoembryonic antigen (CEA) is over-expressed on various human cancer cells and has been the target of immunotherapies using dendritic cells (DCs) pulsed with CEA-specific RNA or peptides, or transduced by CEA-expressing adenovirus or vaccinia virus.",19659778_0,0,-1,2,-1,10382,-1,0.0822153,0.90651846,0.0112662455
10384,protein antigens,7,9,49,65,"Because activated DCs do not phagocytose soluble protein antigens efficiently and pure immature DCs are not obtained easily ex vivo, an efficacious whole CEA protein-loaded DC vaccine has not been reported.",19659778_1,-1,-1,-1,-1,10384,-1,0.9893365,0.0058122356,0.00485125
10385,protein-loaded,25,26,158,172,"Because activated DCs do not phagocytose soluble protein antigens efficiently and pure immature DCs are not obtained easily ex vivo, an efficacious whole CEA protein-loaded DC vaccine has not been reported.",19659778_1,0,1,-1,-1,10385,-1,0.0006558136,0.9989103,0.00043393992
10387,the antigen,2,4,11,22,"To improve the antigen delivery into DCs, we utilized CEA conjugated to a protein-transduction domain, human immunodeficiency virus transactivating Tat.",19659778_2,-1,-1,-1,-1,10387,-1,0.23810507,0.75182414,0.010070751
10389,protein-transduction,14,15,74,94,"To improve the antigen delivery into DCs, we utilized CEA conjugated to a protein-transduction domain, human immunodeficiency virus transactivating Tat.",19659778_2,0,1,-1,-1,10389,-1,8.255187e-05,0.9998652,5.224402e-05
10390,transactivating Tat,20,22,132,151,"To improve the antigen delivery into DCs, we utilized CEA conjugated to a protein-transduction domain, human immunodeficiency virus transactivating Tat.",19659778_2,-1,-1,-1,-1,10390,-1,3.222476e-05,0.9999484,1.935717e-05
10391,the truncated,4,6,25,38,"Furthermore, we purified the truncated non-glycosylated CEA from Escherichia coli to overcome the safety concerns and immunosuppressive functions associated with the native CEA protein.",19659778_3,-1,-1,-1,-1,10391,-1,2.0054817e-05,0.9999678,1.2112696e-05
10394,functions,18,19,136,145,"Furthermore, we purified the truncated non-glycosylated CEA from Escherichia coli to overcome the safety concerns and immunosuppressive functions associated with the native CEA protein.",19659778_3,0,1,2,-1,10394,-1,0.000671182,0.99866164,0.00066716626
10395,the native,21,23,162,172,"Furthermore, we purified the truncated non-glycosylated CEA from Escherichia coli to overcome the safety concerns and immunosuppressive functions associated with the native CEA protein.",19659778_3,-1,-1,-1,-1,10395,-1,2.2742535e-05,0.9999666,1.0689598e-05
10396,protein,24,25,177,184,"Furthermore, we purified the truncated non-glycosylated CEA from Escherichia coli to overcome the safety concerns and immunosuppressive functions associated with the native CEA protein.",19659778_3,0,1,-1,-1,10396,-1,0.00027856338,0.9991949,0.0005264739
10398,analysis,8,9,66,74,"Using confocal microscopy and fluorescence activating cell sorter analysis, we demonstrated that the Tat-CEA protein entered the cytoplasm of DCs efficiently within 10 min of co-culture, compared with the negligible amount of CEA into DCs 30 min later.",19659778_4,0,1,-1,-1,10398,-1,4.1370928e-05,0.9999081,5.05402e-05
10399,that the Tat-CEA protein,12,16,92,116,"Using confocal microscopy and fluorescence activating cell sorter analysis, we demonstrated that the Tat-CEA protein entered the cytoplasm of DCs efficiently within 10 min of co-culture, compared with the negligible amount of CEA into DCs 30 min later.",19659778_4,-1,-1,-1,-1,10399,-1,3.3240885e-05,0.99993837,2.8346934e-05
10412,interleukin-4 than those,23,26,139,163,T helper type 1 responses were more prominent in the DC (Tat-CEA) immunized mice whose splenocytes secreted more interferon-gamma and less interleukin-4 than those from DC (CEA) immunized mice.,19659778_6,-1,-1,-1,-1,10412,-1,0.96515924,0.030524874,0.004315872
10425,proteins,9,10,47,55,"The genome of Epstein-Barr virus (EBV) encodes proteins essential for malignant transformation, for example, latent membrane protein 1(LMP1).",19664329_0,0,1,-1,-1,10425,-1,0.0010310606,0.9966601,0.0023087924
10427,protein,20,21,125,132,"The genome of Epstein-Barr virus (EBV) encodes proteins essential for malignant transformation, for example, latent membrane protein 1(LMP1).",19664329_0,0,1,-1,-1,10427,-1,0.0005709501,0.99327224,0.0061568827
10428,proteins to,5,7,42,53,"Whereas, LMP1 up-regulates anti-apoptotic proteins to support viral replication, it also potentiates apoptosis, suggesting that a viral protein contributes to the survival of the virus, and it also elicit host defense leading to the destruction of the infected cells.",19664329_1,-1,-1,-1,-1,10428,-1,0.00015446448,0.9997651,8.044577e-05
10430,protein,20,21,136,143,"Whereas, LMP1 up-regulates anti-apoptotic proteins to support viral replication, it also potentiates apoptosis, suggesting that a viral protein contributes to the survival of the virus, and it also elicit host defense leading to the destruction of the infected cells.",19664329_1,0,1,-1,-1,10430,-1,0.00032062863,0.9994261,0.00025324777
10431,to the,22,24,156,162,"Whereas, LMP1 up-regulates anti-apoptotic proteins to support viral replication, it also potentiates apoptosis, suggesting that a viral protein contributes to the survival of the virus, and it also elicit host defense leading to the destruction of the infected cells.",19664329_1,-1,-1,-1,-1,10431,-1,3.3665143e-05,0.9999521,1.42855e-05
10433,to the,36,38,226,232,"Whereas, LMP1 up-regulates anti-apoptotic proteins to support viral replication, it also potentiates apoptosis, suggesting that a viral protein contributes to the survival of the virus, and it also elicit host defense leading to the destruction of the infected cells.",19664329_1,-1,-1,-1,-1,10433,-1,2.6405529e-05,0.9999634,1.0198166e-05
10437,immunity,2,3,14,22,"The antitumor immunity is exerted by infiltrated CD8+ T cells elaborating cytotoxic effectors, like Fas ligand (FasL, CD95L or CD178).",19664329_2,0,-1,2,-1,10437,-1,0.9946344,0.0044040848,0.0009615732
10448,cytokine-targeting therapy,18,20,134,160,"Recent reports suggest that mutations affecting the Fas-mediated apoptotic pathway reduce individuals' susceptibility to cancers, but cytokine-targeting therapy which precisely regulates the Fas level on tumor cells could still contribute to enhancement of antitumor immunity in cancer patients.",19664329_5,-1,-1,-1,-1,10448,-1,0.7267353,0.2676129,0.005651767
10450,tumor cells,27,29,204,215,"Recent reports suggest that mutations affecting the Fas-mediated apoptotic pathway reduce individuals' susceptibility to cancers, but cytokine-targeting therapy which precisely regulates the Fas level on tumor cells could still contribute to enhancement of antitumor immunity in cancer patients.",19664329_5,-1,-1,-1,-1,10450,-1,0.0040951734,0.4218314,0.57407343
10452,immunity,36,37,267,275,"Recent reports suggest that mutations affecting the Fas-mediated apoptotic pathway reduce individuals' susceptibility to cancers, but cytokine-targeting therapy which precisely regulates the Fas level on tumor cells could still contribute to enhancement of antitumor immunity in cancer patients.",19664329_5,0,-1,2,-1,10452,-1,0.9994585,0.00034631044,0.00019512503
10453,Regulatory T cells play,0,4,0,23,Regulatory T cells play an important role in tumor escape from host antitumor immunity.,19673890_0,-1,-1,-1,-1,10453,-1,0.0015418777,0.1270632,0.87139493
10455,immunity,13,14,78,86,Regulatory T cells play an important role in tumor escape from host antitumor immunity.,19673890_0,0,-1,2,-1,10455,-1,0.9986129,0.0011039998,0.0002831326
10457,the tumor,12,14,82,91,"Increased frequencies of CD4(+)CD25(+) regulatory T cells have been documented in the tumor sites, malignant effusions, and peripheral blood of patients with ovarian carcinoma.",19673890_1,-1,-1,-1,-1,10457,-1,2.183187e-05,0.9999654,1.2703073e-05
10458,blood,21,22,135,140,"Increased frequencies of CD4(+)CD25(+) regulatory T cells have been documented in the tumor sites, malignant effusions, and peripheral blood of patients with ovarian carcinoma.",19673890_1,0,1,-1,-1,10458,-1,0.00054154353,0.9884901,0.010968312
10463,These cells,0,2,0,11,"These cells did not express FOXP3 by single-cell analysis, and few cells expressed FOXP3 when they were activated with anti-CD3/CD28 dual signal.",19673890_4,-1,-1,-1,-1,10463,-1,0.0017563669,0.07750822,0.92073536
10465,analysis,8,9,49,57,"These cells did not express FOXP3 by single-cell analysis, and few cells expressed FOXP3 when they were activated with anti-CD3/CD28 dual signal.",19673890_4,0,1,-1,-1,10465,-1,0.002247023,0.7016174,0.29613551
10477,TGF-beta,12,13,99,107,"Neutralization assays revealed that neutralizing antibody against transforming growth factor beta (TGF-beta), interleukin-10, and interleukin-4 did not abrogate elevated FOXP3 expression induced by carcinoma cell culture supernatant, whereas neutralizing leukemia inhibitory factor (LIF) partially abrogated FOXP3 expression, but LIF alone could not increase FOXP3 expression in activated nave T cells.",19673890_6,0,1,-1,-1,10477,-1,8.29584e-05,0.9998901,2.6890995e-05
10484,LIF,46,47,330,333,"Neutralization assays revealed that neutralizing antibody against transforming growth factor beta (TGF-beta), interleukin-10, and interleukin-4 did not abrogate elevated FOXP3 expression induced by carcinoma cell culture supernatant, whereas neutralizing leukemia inhibitory factor (LIF) partially abrogated FOXP3 expression, but LIF alone could not increase FOXP3 expression in activated nave T cells.",19673890_6,0,-1,2,-1,10484,-1,0.0007324904,0.9991111,0.00015633905
10486,nave T cells,55,58,389,402,"Neutralization assays revealed that neutralizing antibody against transforming growth factor beta (TGF-beta), interleukin-10, and interleukin-4 did not abrogate elevated FOXP3 expression induced by carcinoma cell culture supernatant, whereas neutralizing leukemia inhibitory factor (LIF) partially abrogated FOXP3 expression, but LIF alone could not increase FOXP3 expression in activated nave T cells.",19673890_6,-1,-1,-1,-1,10486,-1,0.0016093799,0.024923166,0.9734675
10487,that these cells,9,12,56,72,"Further, an in vitro coculture suppression assay showed that these cells could suppress the proliferation of autologous CD4(+)CD25(-)CD45RA(-) T cells.",19673890_7,-1,-1,-1,-1,10487,-1,0.0041195666,0.7388059,0.25707453
10508,immunity,10,11,52,60,The aim of this study was to enhance the anti-tumor immunity of gp96 vaccine through naloxone administration.,19706340_1,0,-1,2,-1,10508,-1,0.997618,0.0019645153,0.00041742602
10509,through naloxone,14,16,77,93,The aim of this study was to enhance the anti-tumor immunity of gp96 vaccine through naloxone administration.,19706340_1,-1,-1,-1,-1,10509,-1,3.205864e-05,0.99995184,1.6122387e-05
10512,the tumor,12,14,73,82,"Therefore, we used BALB/c mouse model of fibrosarcoma tumor and analyzed the tumor size, splenocyte proliferation, spleen and tumor-infiltrated lymphocytes.",19706340_2,-1,-1,-1,-1,10512,-1,1.948089e-05,0.9999709,9.55969e-06
10513,tumor-infiltrated lymphocytes,21,23,126,155,"Therefore, we used BALB/c mouse model of fibrosarcoma tumor and analyzed the tumor size, splenocyte proliferation, spleen and tumor-infiltrated lymphocytes.",19706340_2,-1,-1,-1,-1,10513,-1,0.0048701153,0.75705117,0.23807871
10527,the tumors,9,11,45,55,The results indicated that on days 27 and 32 the tumors in the gp96+Nal group grew significantly slower.,19706340_5,-1,-1,-1,-1,10527,-1,1.899748e-05,0.9999658,1.5232169e-05
10535,that naloxone,3,5,24,37,Our results demonstrate that naloxone is an effective immunoadjuvant in cancer immunotherapy.,19706340_8,-1,-1,-1,-1,10535,-1,3.61247e-05,0.99994946,1.4430964e-05
10539,to play,23,25,127,134,"The negative signal provided by interactions of programmed death-1 (PD-1) and its ligands, B7-H1 and B7-DC, has been suggested to play an important role in tumor evasion from host immunity.",19724910_0,-1,-1,-1,-1,10539,-1,2.4580702e-05,0.999966,9.33611e-06
10541,immunity,33,34,180,188,"The negative signal provided by interactions of programmed death-1 (PD-1) and its ligands, B7-H1 and B7-DC, has been suggested to play an important role in tumor evasion from host immunity.",19724910_0,0,-1,2,-1,10541,-1,0.99938273,0.00041622043,0.00020094769
10562,the tumors,2,4,19,29,Cells infiltrating the tumors were characterized by immunohistochemistry.,19724910_7,-1,-1,-1,-1,10562,-1,2.2366785e-05,0.9999646,1.3022228e-05
10579,the tumor,18,20,115,124,"B7-DC blockade decreased the levels of IL-10 and FoxP3, suggesting that regulatory systems are mainly inhibited at the tumor site.",19724910_12,-1,-1,-1,-1,10579,-1,1.974956e-05,0.9999703,9.976864e-06
10588,the tumor,23,25,188,197,"Collectively, blocking of B7-H1 or B7-DC efficiently induced regression of pre-established pancreatic cancers by up-regulating IFN-gamma production and down-regulating IL-10 production at the tumor site.",19724910_14,-1,-1,-1,-1,10588,-1,1.9811047e-05,0.99996996,1.0213124e-05
10596,immunity,8,9,51,59,It augments initiation of T helper type 1-mediated immunity by enhancing the proliferation and cytokine production of T cells.,19740343_1,0,-1,2,-1,10596,-1,0.99864703,0.000880952,0.00047202848
10602,cells transduced,1,3,6,22,"COS-7 cells transduced with the mouse (m) p28 gene secreted a monomeric mp28 protein; however, those transduced with the mEBI3 gene did not detect a mEBI3 protein in the culture supernatants.",19740343_3,-1,-1,-1,-1,10602,-1,0.002292469,0.106623456,0.89108413
10605,protein,15,16,77,84,"COS-7 cells transduced with the mouse (m) p28 gene secreted a monomeric mp28 protein; however, those transduced with the mEBI3 gene did not detect a mEBI3 protein in the culture supernatants.",19740343_3,0,1,-1,-1,10605,-1,9.806705e-05,0.9997638,0.00013818912
10606,those transduced,19,21,95,111,"COS-7 cells transduced with the mouse (m) p28 gene secreted a monomeric mp28 protein; however, those transduced with the mEBI3 gene did not detect a mEBI3 protein in the culture supernatants.",19740343_3,-1,-1,-1,-1,10606,-1,2.063474e-05,0.9999653,1.40563525e-05
10609,protein,30,31,155,162,"COS-7 cells transduced with the mouse (m) p28 gene secreted a monomeric mp28 protein; however, those transduced with the mEBI3 gene did not detect a mEBI3 protein in the culture supernatants.",19740343_3,0,1,-1,-1,10609,-1,0.000106497086,0.9997743,0.00011917488
10630,the functions,11,13,62,75,"Furthermore, production of both mp28 and mp40, which inhibits the functions of IL-12 and IL-23, prolonged the graft survival longer than the grafts expressing either mp28 or mp40.",19740343_9,-1,-1,-1,-1,10630,-1,9.369539e-05,0.99984217,6.409934e-05
10633,than the,23,25,132,140,"Furthermore, production of both mp28 and mp40, which inhibits the functions of IL-12 and IL-23, prolonged the graft survival longer than the grafts expressing either mp28 or mp40.",19740343_9,-1,-1,-1,-1,10633,-1,2.4881807e-05,0.99995995,1.52290295e-05
10636,cellular immune responses,11,14,67,92,We propose that p28 can be a regulatory subunit for IL-27-mediated cellular immune responses and a possible therapeutic agent to suppress unfavourable immune responses.,19740343_10,-1,-1,-1,-1,10636,-1,0.733315,0.0031486691,0.26353633
10642,T-cell,8,9,41,47,"Based on their role for the induction of T-cell responses, dendritic cells (DCs) are popular candidates in cancer vaccine development.",19758325_0,-1,1,2,-1,10642,-1,4.1033913e-05,5.1878502e-05,0.99990714
10646,Toll-like receptor-3,17,19,113,133,We established a novel single-step intracellular delivery of peptide/poly(I:C) complexes for antigen loading and Toll-like receptor-3 (TLR3)-mediated maturation of human DCs using a cell-penetrating peptide (tat(49-57): RKKRRQRRR) as delivery vector.,19758325_1,-1,-1,-1,-1,10646,-1,0.0015615833,0.98507315,0.013365275
10647,cell-penetrating peptide,26,28,182,206,We established a novel single-step intracellular delivery of peptide/poly(I:C) complexes for antigen loading and Toll-like receptor-3 (TLR3)-mediated maturation of human DCs using a cell-penetrating peptide (tat(49-57): RKKRRQRRR) as delivery vector.,19758325_1,-1,-1,-1,-1,10647,-1,0.0046145385,0.013154394,0.9822311
10649,Towards this,0,2,0,12,"Towards this end, a cationic tat-sequence was fused with an antigenic, major histocompatibility complex (MHC) class I-binding melanoma epitope (Melan-A/Mart-1 sequence: ELAGIGILTV) and then mixed with negatively charged poly(I:C) dsRNA to form peptide/nucleic acid complexes.",19758325_2,-1,-1,-1,-1,10649,-1,2.701473e-05,0.99995375,1.9191511e-05
10664,to peptide-loaded,23,25,173,190,"When peptide/poly(I:C) complex-loaded DCs were used for autologous T cell stimulation, epitope-specific interferon-gamma secretion was quantitatively superior in comparison to peptide-loaded DCs matured by a cytokine cocktail, as detected by enzyme-linked immunospot assays.",19758325_6,-1,-1,-1,-1,10664,-1,3.1400294e-05,0.9999485,2.01446e-05
10668,antigenic peptides,5,7,28,46,"Thus, complexes of cationic antigenic peptides and poly(I:C) might be of great utility for a TLR3-mediated DC maturation and intracellular peptide targeting in a single step.",19758325_7,-1,-1,-1,-1,10668,-1,0.78098047,0.01575911,0.2032604
10670,peptide targeting,24,26,139,156,"Thus, complexes of cationic antigenic peptides and poly(I:C) might be of great utility for a TLR3-mediated DC maturation and intracellular peptide targeting in a single step.",19758325_7,-1,-1,-1,-1,10670,-1,0.006295535,0.9890514,0.0046530366
10671,antigen-specific T cells,7,10,54,78,Resulting DCs induce a strong expansion/activation of antigen-specific T cells in the context of an IL-12p70 secretion.,19758325_8,-1,-1,-1,-1,10671,-1,0.35725784,0.0032606835,0.63948154
10679,peptide-stimulated,10,11,67,85,"Here, we assessed the immunotherapeutic effects of autologous MUC1 peptide-stimulated CD4(+) effector cells following adoptive transfer in patients with ovarian cancer.",19762283_1,0,-1,2,-1,10679,-1,0.00029479506,0.99963605,6.9100526e-05
10682,peptide,2,3,11,18,"Using MUC1 peptide and IL-2 for ex vivo CD4(+)/Th1 effector cell generation, we show that three monthly treatment cycles of peripheral blood T cell restimulation and intraperitoneal re-infusion selectively modulated endogenous T cell-mediated immune responses that correlated with diminished serum CA125 tumor marker levels and enhanced patient survival.",19762283_2,0,-1,2,-1,10682,-1,0.00045764446,0.99904186,0.00050042395
10683,cell generation,10,12,60,75,"Using MUC1 peptide and IL-2 for ex vivo CD4(+)/Th1 effector cell generation, we show that three monthly treatment cycles of peripheral blood T cell restimulation and intraperitoneal re-infusion selectively modulated endogenous T cell-mediated immune responses that correlated with diminished serum CA125 tumor marker levels and enhanced patient survival.",19762283_2,-1,-1,-1,-1,10683,-1,0.0005626763,0.0077566616,0.9916807
10684,that three,15,17,85,95,"Using MUC1 peptide and IL-2 for ex vivo CD4(+)/Th1 effector cell generation, we show that three monthly treatment cycles of peripheral blood T cell restimulation and intraperitoneal re-infusion selectively modulated endogenous T cell-mediated immune responses that correlated with diminished serum CA125 tumor marker levels and enhanced patient survival.",19762283_2,-1,-1,-1,-1,10684,-1,1.8038918e-05,0.9999716,1.0290073e-05
10686,blood T cell,22,25,135,147,"Using MUC1 peptide and IL-2 for ex vivo CD4(+)/Th1 effector cell generation, we show that three monthly treatment cycles of peripheral blood T cell restimulation and intraperitoneal re-infusion selectively modulated endogenous T cell-mediated immune responses that correlated with diminished serum CA125 tumor marker levels and enhanced patient survival.",19762283_2,-1,-1,-1,-1,10686,-1,0.00016988105,0.00043251755,0.99939764
10687,T cell-mediated immune responses that,32,37,227,264,"Using MUC1 peptide and IL-2 for ex vivo CD4(+)/Th1 effector cell generation, we show that three monthly treatment cycles of peripheral blood T cell restimulation and intraperitoneal re-infusion selectively modulated endogenous T cell-mediated immune responses that correlated with diminished serum CA125 tumor marker levels and enhanced patient survival.",19762283_2,-1,-1,-1,-1,10687,-1,0.0049546915,0.026035864,0.9690094
10690,therapy,11,12,81,88,"Although PBL from all patients showed elevated MUC1 cytolytic activity following therapy, such responses did not correlate with therapeutic efficacy.",19762283_4,0,1,-1,-1,10690,-1,2.3233222e-05,0.99996686,9.954087e-06
10693,to that,22,24,128,135,Long-term survivors showed elevated levels of systemic memory (CD45RO) and nave (CD45RA) CD3/CD4/CD25(+) T cells when compared to that of pre-treatment levels and similarly treated short-term survivors.,19762283_5,-1,-1,-1,-1,10693,-1,2.4922037e-05,0.9999628,1.2229986e-05
10697,CTLA-4 that,8,10,54,65,Such cells co-expressed different levels of Foxp3 and CTLA-4 that resulted in progressively lower systemic Foxp3/CTLA-4 memory T cell ratios that further correlated with disease-free survival.,19762283_6,-1,-1,-1,-1,10697,-1,0.0012235473,0.012781913,0.98599446
10702,the CCR5,12,14,82,90,"Lastly, these patients showed elevated levels of MUC1-specific T cells expressing the CCR5 and CCR1 chemokine receptors and the chemokine CCL4 associated with Th1 cell differentiation/memory.",19762283_7,-1,-1,-1,-1,10702,-1,0.003867908,0.6715541,0.324578
10703,chemokine receptors,16,18,100,119,"Lastly, these patients showed elevated levels of MUC1-specific T cells expressing the CCR5 and CCR1 chemokine receptors and the chemokine CCL4 associated with Th1 cell differentiation/memory.",19762283_7,-1,-1,-1,-1,10703,-1,0.43864867,0.002759707,0.5585916
10704,the chemokine CCL4,19,22,124,142,"Lastly, these patients showed elevated levels of MUC1-specific T cells expressing the CCR5 and CCR1 chemokine receptors and the chemokine CCL4 associated with Th1 cell differentiation/memory.",19762283_7,-1,-1,-1,-1,10704,-1,0.6678627,0.21777247,0.11436479
10710,tumor immunity,32,34,236,250,"We suggest that effective immunotherapy with autologous MUC1-stimulated CD4(+) effector cells induces differential levels of systemic ""Ag-experienced"" and ""Ag-inexperienced"" CD4/CD25(+) TReg cell subpopulations that influence long-term tumor immunity in ovarian cancer patients.",19762283_8,-1,-1,-1,-1,10710,-1,0.011263821,0.9882911,0.00044511774
10713,the general,2,4,9,20,"However, the general effector mechanism is not fully settled.",19773201_1,-1,-1,-1,-1,10713,-1,4.12313e-05,0.9999385,2.0331996e-05
10716,the relative,13,15,81,93,Twenty-four patients with CTCL and 14 patients with GVHD were included to assess the relative numbers of regulatory T cells (Treg) and any change in the serum cytokine profile during 6 months of ECP therapy.,19773201_2,-1,-1,-1,-1,10716,-1,2.4517183e-05,0.99995244,2.3024073e-05
10721,therapy,36,37,199,206,Twenty-four patients with CTCL and 14 patients with GVHD were included to assess the relative numbers of regulatory T cells (Treg) and any change in the serum cytokine profile during 6 months of ECP therapy.,19773201_2,0,1,-1,-1,10721,-1,2.1265461e-05,0.999966,1.2749625e-05
10722,The relative,0,2,0,12,The relative amount of Treg cells was twice as high in CTCL compared to GVHD and healthy controls.,19773201_3,-1,-1,-1,-1,10722,-1,2.4837385e-05,0.99995637,1.8762943e-05
10726,TGF-beta,0,1,0,8,TGF-beta was on average three times higher in GVHD than in CTCL.,19773201_4,0,1,-1,-1,10726,-1,3.8517293e-05,0.99994636,1.5106939e-05
10727,three times,4,6,24,35,TGF-beta was on average three times higher in GVHD than in CTCL.,19773201_4,-1,-1,-1,-1,10727,-1,6.1251914e-05,0.9999107,2.8001616e-05
10729,TGF-beta,10,11,60,68,Both patient groups had a small but significant increase in TGF-beta after treatment.,19773201_5,0,1,-1,-1,10729,-1,3.173526e-05,0.99995196,1.6313183e-05
10731,Treg function,5,7,36,49,Our results indicate a strengthened Treg function as a result of ECP.,19773201_6,-1,-1,-1,-1,10731,-1,4.8500733e-05,0.9999119,3.955631e-05
10732,TGF-beta,1,2,9,17,"Elevated TGF-beta may indicate high Treg activation in GVHD, whereas an increased number of Treg cells in CTCL could be interpreted as a response that is involved in down-regulating the lymphoma cells.",19773201_7,0,1,-1,-1,10732,-1,4.6150133e-05,0.9999374,1.643929e-05
10738,T cell function plays,2,6,17,38,"Although altered T cell function plays a part in immunosenescence, the mechanisms remain uncertain.",19805226_0,-1,-1,-1,-1,10738,-1,0.0017867169,0.025521582,0.9726917
10742,to T cell receptor,24,28,138,156,Here we identify a bona fide age-dependent PD-1(+) memory phenotype (MP) CD4(+) T cell subpopulation that hardly proliferates in response to T cell receptor (TCR) stimulation and produces abundant osteopontin at the cost of typical T cell lymphokines.,19805226_1,-1,-1,-1,-1,10742,-1,0.003682481,0.085552424,0.91076505
10743,TCR,29,30,158,161,Here we identify a bona fide age-dependent PD-1(+) memory phenotype (MP) CD4(+) T cell subpopulation that hardly proliferates in response to T cell receptor (TCR) stimulation and produces abundant osteopontin at the cost of typical T cell lymphokines.,19805226_1,-1,1,2,-1,10743,-1,3.116948e-05,0.9999454,2.3374445e-05
10746,typical T cell lymphokines,40,44,224,250,Here we identify a bona fide age-dependent PD-1(+) memory phenotype (MP) CD4(+) T cell subpopulation that hardly proliferates in response to T cell receptor (TCR) stimulation and produces abundant osteopontin at the cost of typical T cell lymphokines.,19805226_1,-1,-1,-1,-1,10746,-1,0.68408984,0.1626212,0.15328896
10747,These T cells,0,3,0,13,"These T cells demonstrate impaired repopulation in Rag2(-/-) mice, but a homeostatic proliferation in gamma-ray-irradiated mice.",19805226_2,-1,-1,-1,-1,10747,-1,0.0026734609,0.12161722,0.87570924
10748,These T cells,0,3,0,13,"These T cells also reveal a unique molecular signature, including a strong expression of C/EBPalpha normally expressed in myeloid-lineage cells, with diminished c-Myc and cyclin D1.",19805226_3,-1,-1,-1,-1,10748,-1,0.002585805,0.13542905,0.8619852
10753,the TCR-mediated,10,12,58,74,Transduction of Cebpa in regular CD4(+) T cells inhibited the TCR-mediated proliferation with c-Myc and cyclin D1 repression and caused a striking activation of Spp1 encoding osteopontin along with concomitant repression of T cell lymphokine genes.,19805226_4,-1,-1,-1,-1,10753,-1,2.2647222e-05,0.99995637,2.096346e-05
10755,T cell lymphokine genes,33,37,224,247,Transduction of Cebpa in regular CD4(+) T cells inhibited the TCR-mediated proliferation with c-Myc and cyclin D1 repression and caused a striking activation of Spp1 encoding osteopontin along with concomitant repression of T cell lymphokine genes.,19805226_4,-1,-1,-1,-1,10755,-1,0.006902874,0.0076337997,0.98546326
10756,these T cells,1,4,9,22,"Although these T cells gradually increase in number with age and become predominant at the senescent stage in normal mice, the generation is robustly accelerated during leukemia.",19805226_5,-1,-1,-1,-1,10756,-1,0.0021797975,0.09195374,0.9058664
10758,the generation,21,23,123,137,"Although these T cells gradually increase in number with age and become predominant at the senescent stage in normal mice, the generation is robustly accelerated during leukemia.",19805226_5,-1,-1,-1,-1,10758,-1,2.0009018e-05,0.99996746,1.2479598e-05
10765,to the,14,16,99,105,The results suggest that global T cell immunodepression in senescence and leukemia is attributable to the increase in PD-1(+) MP CD4(+) T cells expressing C/EBPalpha.,19805226_7,-1,-1,-1,-1,10765,-1,2.173398e-05,0.9999691,9.145798e-06
10767,Though TGF-beta,0,2,0,15,"Though TGF-beta inhibition enhances antitumor immunity mediated by CD8(+) T cells in several tumor models, it is not always sufficient for rejection of tumors.",19830696_0,-1,-1,-1,-1,10767,-1,7.8208766e-05,0.9998982,2.362163e-05
10768,immunity,5,6,46,54,"Though TGF-beta inhibition enhances antitumor immunity mediated by CD8(+) T cells in several tumor models, it is not always sufficient for rejection of tumors.",19830696_0,0,-1,2,-1,10768,-1,0.997799,0.0018064892,0.0003945193
10773,to maximize the,4,7,15,30,"In this study, to maximize the antitumor effect of TGF-beta blockade, we tested the effect of anti-TGF-beta combined with an irradiated tumor vaccine in a subcutaneous CT26 colon carcinoma tumor model.",19830696_1,-1,-1,-1,-1,10773,-1,1.8468965e-05,0.9999733,8.195014e-06
10774,TGF-beta,10,11,51,59,"In this study, to maximize the antitumor effect of TGF-beta blockade, we tested the effect of anti-TGF-beta combined with an irradiated tumor vaccine in a subcutaneous CT26 colon carcinoma tumor model.",19830696_1,0,1,-1,-1,10774,-1,5.841631e-05,0.99991584,2.5704121e-05
10775,tested the,14,16,73,83,"In this study, to maximize the antitumor effect of TGF-beta blockade, we tested the effect of anti-TGF-beta combined with an irradiated tumor vaccine in a subcutaneous CT26 colon carcinoma tumor model.",19830696_1,-1,-1,-1,-1,10775,-1,2.0362757e-05,0.9999702,9.409016e-06
10779,tumor cell,2,4,15,25,"The irradiated tumor cell vaccine alone in prophylactic setting significantly delayed tumor growth, whereas anti-TGF-beta antibodies alone did not show any antitumor effect.",19830696_2,-1,-1,-1,-1,10779,-1,0.0034973684,0.21881208,0.77769053
10786,T-cell,2,3,7,13,"CD8(+) T-cell depletion completely abrogated the vaccine efficacy, and so protection required CD8(+) T cells.",19830696_4,-1,1,2,-1,10786,-1,3.15544e-05,4.1216677e-05,0.99992716
10791,to the,8,10,44,50,"Depletion of CD25(+) T regulatory cells led to the almost complete rejection of tumors without the vaccine, whereas anti-TGF-beta did not change the number of CD25(+) T regulatory cells in unvaccinated and vaccinated mice.",19830696_5,-1,-1,-1,-1,10791,-1,2.1099033e-05,0.9999701,8.847485e-06
10797,Though the,0,2,0,10,"Though the abrogation of CD1d-restricted NKT cells, which have been reported to induce TGF-beta production by MDSC through an IL-13-IL-4R-STAT6 pathway, partially enhanced antitumor immunity regardless of vaccination, abrogation of the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway did not enhance vaccine efficacy.",19830696_6,-1,-1,-1,-1,10797,-1,2.8957369e-05,0.99995446,1.6553915e-05
10800,TGF-beta,14,15,87,95,"Though the abrogation of CD1d-restricted NKT cells, which have been reported to induce TGF-beta production by MDSC through an IL-13-IL-4R-STAT6 pathway, partially enhanced antitumor immunity regardless of vaccination, abrogation of the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway did not enhance vaccine efficacy.",19830696_6,0,1,-1,-1,10800,-1,6.526781e-05,0.99991226,2.2500717e-05
10803,immunity,26,27,182,190,"Though the abrogation of CD1d-restricted NKT cells, which have been reported to induce TGF-beta production by MDSC through an IL-13-IL-4R-STAT6 pathway, partially enhanced antitumor immunity regardless of vaccination, abrogation of the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway did not enhance vaccine efficacy.",19830696_6,0,-1,2,-1,10803,-1,0.9879005,0.011514983,0.0005845031
10806,Taken together,0,2,0,14,"Taken together, these data indicated that anti-TGF-beta enhances efficacy of a prophylactic vaccine in normal individuals despite their not having the elevated TGF-beta levels found in patients with cancer and that the effect is not dependent on TGF-beta solely from CD4(+)CD25(+) T regulatory cells or the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway.",19830696_7,-1,-1,-1,-1,10806,-1,3.1105228e-05,0.99995613,1.2776094e-05
10811,TGF-beta,23,24,160,168,"Taken together, these data indicated that anti-TGF-beta enhances efficacy of a prophylactic vaccine in normal individuals despite their not having the elevated TGF-beta levels found in patients with cancer and that the effect is not dependent on TGF-beta solely from CD4(+)CD25(+) T regulatory cells or the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway.",19830696_7,0,1,-1,-1,10811,-1,3.638223e-05,0.9999473,1.6329948e-05
10812,that the,31,33,210,218,"Taken together, these data indicated that anti-TGF-beta enhances efficacy of a prophylactic vaccine in normal individuals despite their not having the elevated TGF-beta levels found in patients with cancer and that the effect is not dependent on TGF-beta solely from CD4(+)CD25(+) T regulatory cells or the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway.",19830696_7,-1,-1,-1,-1,10812,-1,1.9934278e-05,0.99997115,8.906501e-06
10813,TGF-beta,38,39,246,254,"Taken together, these data indicated that anti-TGF-beta enhances efficacy of a prophylactic vaccine in normal individuals despite their not having the elevated TGF-beta levels found in patients with cancer and that the effect is not dependent on TGF-beta solely from CD4(+)CD25(+) T regulatory cells or the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway.",19830696_7,0,1,-1,-1,10813,-1,3.3098335e-05,0.99995244,1.4452699e-05
10822,to tumor,17,19,110,118,CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg) known to mediate self-tolerance were also shown to contribute to tumor progression.,19841169_0,-1,-1,-1,-1,10822,-1,2.1889624e-05,0.9999676,1.0516396e-05
10823,transplantation,3,4,18,33,"In mouse melanoma transplantation models, Treg depletion resulted in the stimulation of antitumor immune responses and tumor eradication.",19841169_1,-1,1,2,-1,10823,-1,2.757064e-05,0.99995816,1.4254708e-05
10830,to the,6,8,34,40,"To study Treg in conditions close to the clinical situation, we used a ret transgenic mouse spontaneous melanoma model, which, in contrast to transplantation models, resembles human melanoma regarding clinical development.",19841169_2,-1,-1,-1,-1,10830,-1,3.2465192e-05,0.99995637,1.12160105e-05
10832,to transplantation,25,27,139,157,"To study Treg in conditions close to the clinical situation, we used a ret transgenic mouse spontaneous melanoma model, which, in contrast to transplantation models, resembles human melanoma regarding clinical development.",19841169_2,-1,-1,-1,-1,10832,-1,3.100094e-05,0.9999558,1.3260867e-05
10847,function,2,3,22,30,The immunosuppressive function of Treg from transgenic tumor-bearing mice was similar to that from transgenic tumor-free mice or nontransgenic littermates.,19841169_5,0,1,2,-1,10847,-1,0.0001501635,0.99967146,0.00017838515
10849,transgenic tumor-bearing,6,8,44,68,The immunosuppressive function of Treg from transgenic tumor-bearing mice was similar to that from transgenic tumor-free mice or nontransgenic littermates.,19841169_5,-1,-1,-1,-1,10849,-1,2.3462246e-05,0.999961,1.5517464e-05
10850,to that,11,13,86,93,The immunosuppressive function of Treg from transgenic tumor-bearing mice was similar to that from transgenic tumor-free mice or nontransgenic littermates.,19841169_5,-1,-1,-1,-1,10850,-1,2.3366478e-05,0.99996495,1.1671073e-05
10851,transgenic tumor-free,14,16,99,120,The immunosuppressive function of Treg from transgenic tumor-bearing mice was similar to that from transgenic tumor-free mice or nontransgenic littermates.,19841169_5,-1,-1,-1,-1,10851,-1,2.9359135e-05,0.99994993,2.0711865e-05
10855,the treatment,2,4,13,26,"Furthermore, the treatment of mice with macroscopical tumors also failed to inhibit tumor progression, which correlated with the inability to deplete intratumoral Treg.",19841169_7,-1,-1,-1,-1,10855,-1,2.0901689e-05,0.9999695,9.662111e-06
10867,tumor-promoting functions,21,23,145,170,"We suggest that in the autochthonous melanoma genesis, other immunosuppressive cells could play an important role and replace immunosuppressive, tumor-promoting functions of Treg.",19841169_8,-1,-1,-1,-1,10867,-1,5.0465274e-05,0.9999199,2.9588851e-05
10872,the tumor,13,15,97,106,"Therefore, effective melanoma immunotherapy should include the inhibition of Treg migration into the tumor combined with neutralization of other immunosuppressive cells and factors in the tumor microenvironment.",19841169_9,-1,-1,-1,-1,10872,-1,2.1679902e-05,0.999967,1.1363883e-05
10874,factors,23,24,173,180,"Therefore, effective melanoma immunotherapy should include the inhibition of Treg migration into the tumor combined with neutralization of other immunosuppressive cells and factors in the tumor microenvironment.",19841169_9,0,1,-1,-1,10874,-1,0.9932987,0.0049989177,0.0017023912
10875,the tumor,25,27,184,193,"Therefore, effective melanoma immunotherapy should include the inhibition of Treg migration into the tumor combined with neutralization of other immunosuppressive cells and factors in the tumor microenvironment.",19841169_9,-1,-1,-1,-1,10875,-1,2.2972137e-05,0.9999658,1.1275402e-05
10879,blood lymphocyte,3,5,17,33,"Ten patients had blood lymphocyte proliferative T cell responses directed against E6/2 (14-34) and/or E6/4 (45-68) peptides, which were identified in the present study as immunodominant among HPV-16 E6 and E7 large peptides.",19843089_1,-1,-1,-1,-1,10879,-1,0.000102400365,0.00038919746,0.9995085
10881,peptides,24,25,115,123,"Ten patients had blood lymphocyte proliferative T cell responses directed against E6/2 (14-34) and/or E6/4 (45-68) peptides, which were identified in the present study as immunodominant among HPV-16 E6 and E7 large peptides.",19843089_1,0,-1,2,-1,10881,-1,6.277314e-05,0.99973804,0.00019913776
10883,peptides,41,42,215,223,"Ten patients had blood lymphocyte proliferative T cell responses directed against E6/2 (14-34) and/or E6/4 (45-68) peptides, which were identified in the present study as immunodominant among HPV-16 E6 and E7 large peptides.",19843089_1,0,-1,2,-1,10883,-1,0.00012353242,0.9991642,0.00071223377
10890,peptides,33,34,165,173,"Twelve months later, proliferative T cell responses remained detectable in only six women and the immunodominant antigens remained the E6/2 (14-34) and E6/4 (45-68) peptides.",19843089_3,0,-1,2,-1,10890,-1,7.636314e-05,0.9997775,0.00014610795
10892,peptides,5,6,30,38,The latter large fragments of peptides contained many epitopes able to bind to at least seven human leucocyte antigen (HLA) class I molecules and were strong binders to seven HLA-DR class II molecules.,19843089_4,0,-1,2,-1,10892,-1,6.971391e-05,0.9998085,0.000121830686
10912,the Treg,21,23,142,150,"Although therapeutic strategies have been proposed to deplete Tregs in patients with breast cancer and other malignancies, dynamic changes in the Treg compartment as a function of stage and treatment of breast cancer remain poorly understood.",19855964_1,-1,-1,-1,-1,10912,-1,2.5225321e-05,0.9999622,1.2504813e-05
10913,function,26,27,168,176,"Although therapeutic strategies have been proposed to deplete Tregs in patients with breast cancer and other malignancies, dynamic changes in the Treg compartment as a function of stage and treatment of breast cancer remain poorly understood.",19855964_1,0,1,2,-1,10913,-1,7.3386684e-05,0.99988425,4.2386157e-05
10915,blood,5,6,30,35,"Here, we evaluated peripheral blood CD4(+) T cells and FoxP3(+) CD4(+) T cells from 45 patients with early or late stage breast cancer and compared percentages, absolute counts, and Treg function to those from healthy volunteers (HV) of comparable age.",19855964_2,0,1,-1,-1,10915,-1,5.3707747e-05,0.9997805,0.00016583811
10919,Treg function to those,35,39,182,204,"Here, we evaluated peripheral blood CD4(+) T cells and FoxP3(+) CD4(+) T cells from 45 patients with early or late stage breast cancer and compared percentages, absolute counts, and Treg function to those from healthy volunteers (HV) of comparable age.",19855964_2,-1,-1,-1,-1,10919,-1,2.595931e-05,0.9999511,2.2865315e-05
10926,Functionally,0,1,0,12,"Functionally, FoxP3(+) CD4(+) T cells from all donor groups similarly expressed CTLA-4 and failed to secrete IFN-gamma in response to stimulation.",19855964_5,0,1,2,-1,10926,-1,3.0046438e-05,0.9999552,1.4769099e-05
10941,treatment status,49,51,311,327,"Thus, although Tregs comprise an increased percentage of circulating CD4(+) T cells in patients with metastatic breast cancer and patients in remission after completing the adjuvant chemotherapy, the systemic Treg pool, as measured by absolute counts, appears relatively constant regardless of disease stage or treatment status.",19855964_6,-1,-1,-1,-1,10941,-1,3.1119966e-05,0.99995494,1.3913158e-05
10950,to play,12,14,53,60,CD25+ FOXP3+CD4+ T cells (Treg) have been considered to play an important role in immune tolerance against several tumor antigens.,19902430_0,-1,-1,-1,-1,10950,-1,2.7056372e-05,0.9999615,1.1489738e-05
10952,tumor antigens,22,24,115,129,CD25+ FOXP3+CD4+ T cells (Treg) have been considered to play an important role in immune tolerance against several tumor antigens.,19902430_0,-1,-1,-1,-1,10952,-1,0.2665777,0.726513,0.006909249
10959,time that,7,9,30,39,"Here, we showed for the first time that vascular endothelial growth factor receptor 2 (VEGFR2) is selectively expressed by FOXP3high but not FOXP3low Treg.",19902430_2,-1,-1,-1,-1,10959,-1,1.9045536e-05,0.99996877,1.2226794e-05
10960,growth factor receptor,11,14,61,83,"Here, we showed for the first time that vascular endothelial growth factor receptor 2 (VEGFR2) is selectively expressed by FOXP3high but not FOXP3low Treg.",19902430_2,-1,-1,-1,-1,10960,-1,0.58555716,0.03052451,0.38391826
10962,FOXP3low Treg,25,27,141,154,"Here, we showed for the first time that vascular endothelial growth factor receptor 2 (VEGFR2) is selectively expressed by FOXP3high but not FOXP3low Treg.",19902430_2,-1,-1,-1,-1,10962,-1,2.1630593e-05,0.9999654,1.2906908e-05
10964,tissues,7,8,35,42,Such VEGFR2+ Treg exist in several tissues including PBMC and malignant effusion-derived lymphocytes.,19902430_3,-1,1,2,-1,10964,-1,0.00016889963,0.99826294,0.0015681854
10968,function,15,16,89,97,"In conclusion, VEGFR2 may be a novel target for controlling Treg with highly suppressive function.",19902430_4,0,1,2,-1,10968,-1,5.2816373e-05,0.9999081,3.909938e-05
10973,T-suppressor cells,23,25,143,161,Tumor-resident CD8(+) T cells display a quiescent effector/memory phenotype that is maintained in part by infiltrating CD4(+) CD25(+) Foxp3(+) T-suppressor cells.,19923444_0,-1,-1,-1,-1,10973,-1,0.0013960938,0.046865158,0.9517387
10975,function to tumor-associated,11,14,67,95,"Intratumoral delivery of IL-12, in contrast, can restore cytotoxic function to tumor-associated CD8(+) T cells and induce the apoptotic death of T-suppressor cells.",19923444_1,-1,-1,-1,-1,10975,-1,0.00010389853,0.9998041,9.207736e-05
10978,T-suppressor cells,24,26,145,163,"Intratumoral delivery of IL-12, in contrast, can restore cytotoxic function to tumor-associated CD8(+) T cells and induce the apoptotic death of T-suppressor cells.",19923444_1,-1,-1,-1,-1,10978,-1,0.0013197089,0.04478583,0.95389444
10981,IL-12 treatment,9,11,47,62,Depletion of CD8(+) T cells from tumors before IL-12 treatment resulted in the abrogation of treatment-mediated T-suppressor cell apoptosis revealing a link between CD8(+) T cell activation and T-suppressor elimination.,19923444_2,-1,-1,-1,-1,10981,-1,0.9931212,0.0038978776,0.0029809452
10983,treatment-mediated T-suppressor cell,16,19,93,129,Depletion of CD8(+) T cells from tumors before IL-12 treatment resulted in the abrogation of treatment-mediated T-suppressor cell apoptosis revealing a link between CD8(+) T cell activation and T-suppressor elimination.,19923444_2,-1,-1,-1,-1,10983,-1,0.004140098,0.71355736,0.28230256
10988,T-suppressor cell,6,8,36,53,"Furthermore, IL-12 failed to induce T-suppressor cell loss in IFN-gamma- or FasL-deficient mice demonstrating a requirement for IFN-gamma and FasL in this process.",19923444_3,-1,-1,-1,-1,10988,-1,0.0007925208,0.026992587,0.97221494
10993,T cells to,6,9,38,48,Adoptive transfer of wild-type CD8(+) T cells to FasL-knockout mice restored posttherapy T-suppressor cell elimination from tumors establishing that expression of FasL on CD8(+) T cells was sufficient to promote T-suppressor cell death.,19923444_4,-1,-1,-1,-1,10993,-1,0.0018023421,0.031003118,0.96719456
10994,T-suppressor cell,13,15,89,106,Adoptive transfer of wild-type CD8(+) T cells to FasL-knockout mice restored posttherapy T-suppressor cell elimination from tumors establishing that expression of FasL on CD8(+) T cells was sufficient to promote T-suppressor cell death.,19923444_4,-1,-1,-1,-1,10994,-1,0.0016815399,0.06271581,0.93560255
10999,T-suppressor cell,32,34,212,229,Adoptive transfer of wild-type CD8(+) T cells to FasL-knockout mice restored posttherapy T-suppressor cell elimination from tumors establishing that expression of FasL on CD8(+) T cells was sufficient to promote T-suppressor cell death.,19923444_4,-1,-1,-1,-1,10999,-1,0.0023585071,0.12825698,0.8693845
11007,T-suppressor cell,9,11,54,71,Adoptive transfer of wild-type CD8(+) T cells induced T-suppressor cell death in IFN-gamma-knockout mice confirming that autocrine IFN-gamma was sufficient for CD8(+) T cell FasL expression.,19923444_6,-1,-1,-1,-1,11007,-1,0.0022730702,0.13514158,0.86258525
11037,their Treg cell,8,11,56,71,Patients treated with both IFN-alpha and IL-2 increased their Treg cell levels during the first 2 weeks after initiation of treatment.,19929575_3,-1,-1,-1,-1,11037,-1,0.0026238938,0.16922083,0.82815534
11042,treatment than,30,32,152,166,"Patients who derived complete response (CR), partial response (PR), or stable disease (SD) from IFN-alpha monotherapy had lower Treg cell levels before treatment than did patients whose disease progressed.",19929575_4,-1,-1,-1,-1,11042,-1,2.2841434e-05,0.9999629,1.4278259e-05
11049,T-cell,2,3,15,21,"Involvement of T-cell responses has been suggested, but pancreatitis-specific T cells have not been described.",19931255_1,-1,1,2,-1,11049,-1,4.028936e-05,5.3414395e-05,0.9999063
11051,T-cell,4,5,26,32,"METHODS: We characterized T-cell responses against pancreatitis, pancreatic carcinoma-associated antigens, and tetanus toxoid in the bone marrow, blood, and/or pancreatitis lesions of patients with pancreatitis, pancreatic cancer, and healthy individuals.",19931255_2,-1,1,2,-1,11051,-1,3.5557146e-05,6.369166e-05,0.9999008
11053,tetanus toxoid,14,16,111,125,"METHODS: We characterized T-cell responses against pancreatitis, pancreatic carcinoma-associated antigens, and tetanus toxoid in the bone marrow, blood, and/or pancreatitis lesions of patients with pancreatitis, pancreatic cancer, and healthy individuals.",19931255_2,-1,-1,-1,-1,11053,-1,0.00032149247,0.9995235,0.00015498708
11055,blood,21,22,146,151,"METHODS: We characterized T-cell responses against pancreatitis, pancreatic carcinoma-associated antigens, and tetanus toxoid in the bone marrow, blood, and/or pancreatitis lesions of patients with pancreatitis, pancreatic cancer, and healthy individuals.",19931255_2,0,1,-1,-1,11055,-1,7.780593e-05,0.9997838,0.00013835463
11057,functionally,3,4,13,25,"T cells were functionally characterized by antigen-dependent secretion of interferon (IFN)-gamma, interleukin (Il)-4, and IL-10, which indicate type 1, type 2, or regulatory T-cell responses, respectively.",19931255_3,0,1,2,-1,11057,-1,3.2683572e-05,0.9999467,2.0578347e-05
11074,T cell-derived cytokines,0,3,0,24,T cell-derived cytokines in tissue lesions were quantified by enzyme-linked immunosorbent assay.,19931255_6,-1,-1,-1,-1,11074,-1,0.026426835,0.0011972827,0.97237587
11075,tissue,4,5,28,34,T cell-derived cytokines in tissue lesions were quantified by enzyme-linked immunosorbent assay.,19931255_6,-1,1,2,-1,11075,-1,2.4128965e-05,0.99995196,2.3861687e-05
11078,T-cell,16,17,115,121,"RESULTS: Chronic pancreatitis patients showed similar to pancreatic cancer patients and healthy individuals type 1 T-cell responses against tetanus toxoid; however, they exhibited strong IL-10-based T-cell responses against pancreatitis-associated but not pancreatic carcinoma-associated antigens.",19931255_7,-1,1,2,-1,11078,-1,3.4888937e-05,6.3038606e-05,0.999902
11079,tetanus toxoid,19,21,140,154,"RESULTS: Chronic pancreatitis patients showed similar to pancreatic cancer patients and healthy individuals type 1 T-cell responses against tetanus toxoid; however, they exhibited strong IL-10-based T-cell responses against pancreatitis-associated but not pancreatic carcinoma-associated antigens.",19931255_7,-1,-1,-1,-1,11079,-1,0.0005625647,0.99924517,0.00019231567
11081,IL-10-based T-cell,27,29,187,205,"RESULTS: Chronic pancreatitis patients showed similar to pancreatic cancer patients and healthy individuals type 1 T-cell responses against tetanus toxoid; however, they exhibited strong IL-10-based T-cell responses against pancreatitis-associated but not pancreatic carcinoma-associated antigens.",19931255_7,-1,-1,-1,-1,11081,-1,0.5492609,0.003166775,0.44757226
11090,the blood,16,18,127,136,"Pancreatitis-specific IL-10 responses were mediated by IL-10(+)IFN-gamma(-)FoxP3(+) regulatory T cells, which were expanded in the blood, bone marrow, and pancreatitis lesions and possessed the potential to suppress the proliferation of autologous conventional T cells in an antigen-specific manner.",19931255_9,-1,-1,-1,-1,11090,-1,3.1129242e-05,0.9999325,3.6302536e-05
11101,tumor cell,10,12,90,100,Mitigation of regulatory T cell-mediated immunosuppression and elicitation of immunogenic tumor cell death are crucial events for optimal anti-tumor immune activity in vivo.,19940990_0,-1,-1,-1,-1,11101,-1,0.004229458,0.28743303,0.7083375
11107,these two,32,34,176,185,"This study was designed to investigate the potential synergistic activity of the combined use of cyclophosphamide (CP) and doxorubicin (DR), both of which are known to resolve these two issues.",19940990_1,-1,-1,-1,-1,11107,-1,3.8209208e-05,0.99994826,1.3560473e-05
11111,the tumor,36,38,220,229,BALB/c mice were inoculated subcutaneously with CT-26 carcinoma cells in the bilateral flank and treated with an intraperitoneal injection of a low dose of CP followed by an intratumoral injection of DR into one side of the tumor.,19940990_2,-1,-1,-1,-1,11111,-1,2.3196175e-05,0.9999646,1.22199235e-05
11115,the tumor,17,19,92,101,"We found that, in addition to a significant suppression of growth on the DR-treated side of the tumor, combination therapy suppressed the growth of DR-untreated remote tumors in both tumor-specific and T cell-dependent manners.",19940990_3,-1,-1,-1,-1,11115,-1,2.2668077e-05,0.9999652,1.2161812e-05
11116,therapy,21,22,115,122,"We found that, in addition to a significant suppression of growth on the DR-treated side of the tumor, combination therapy suppressed the growth of DR-untreated remote tumors in both tumor-specific and T cell-dependent manners.",19940990_3,0,1,-1,-1,11116,-1,2.0820124e-05,0.9999676,1.1563117e-05
11122,therapy,1,2,12,19,Combination therapy increased the frequency of interferon (IFN)-gamma-producing T lymphocytes specific to a CT-26-associated class I-binding tumor peptide in the tumor-draining lymph nodes.,19940990_5,0,1,-1,-1,11122,-1,2.331238e-05,0.9999645,1.222498e-05
11127,tumor peptide,16,18,141,154,Combination therapy increased the frequency of interferon (IFN)-gamma-producing T lymphocytes specific to a CT-26-associated class I-binding tumor peptide in the tumor-draining lymph nodes.,19940990_5,-1,-1,-1,-1,11127,-1,0.00025600678,0.99960905,0.00013494921
11128,the tumor-draining,19,21,158,176,Combination therapy increased the frequency of interferon (IFN)-gamma-producing T lymphocytes specific to a CT-26-associated class I-binding tumor peptide in the tumor-draining lymph nodes.,19940990_5,-1,-1,-1,-1,11128,-1,4.7719826e-05,0.9999192,3.3100427e-05
11129,analysis,2,3,14,22,"Real-time PCR analysis revealed that combination therapy led to an increase in IFN-gamma and tumor necrosis factor-alpha mRNA expression; however, levels of Foxp3 and transforming growth factor-beta within the remote tumor tissues were decreased.",19940990_6,0,1,-1,-1,11129,-1,2.652957e-05,0.9999417,3.17797e-05
11131,therapy,6,7,49,56,"Real-time PCR analysis revealed that combination therapy led to an increase in IFN-gamma and tumor necrosis factor-alpha mRNA expression; however, levels of Foxp3 and transforming growth factor-beta within the remote tumor tissues were decreased.",19940990_6,0,1,-1,-1,11131,-1,1.9405992e-05,0.99996877,1.1785538e-05
11138,tumor tissues,32,34,217,230,"Real-time PCR analysis revealed that combination therapy led to an increase in IFN-gamma and tumor necrosis factor-alpha mRNA expression; however, levels of Foxp3 and transforming growth factor-beta within the remote tumor tissues were decreased.",19940990_6,-1,-1,-1,-1,11138,-1,2.3392377e-05,0.9999416,3.5038167e-05
11149,immunity,23,24,127,135,It has been reported that an increased population of regulatory T cells (T-regs) is one of the reasons for impaired anti-tumor immunity.,20002703_0,0,-1,2,-1,11149,-1,0.9994789,0.00030942526,0.00021166957
11153,tumor-infiltrating lymphocytes,9,11,52,82,We investigated the frequency of Foxp3(+) T-regs in tumor-infiltrating lymphocytes (TILs) and peripheral blood lymphocytes (PBLs) of patients with esophageal squamous cell carcinoma (ESCC).,20002703_1,-1,-1,-1,-1,11153,-1,0.0032076284,0.8823924,0.11439996
11155,blood lymphocytes,16,18,105,122,We investigated the frequency of Foxp3(+) T-regs in tumor-infiltrating lymphocytes (TILs) and peripheral blood lymphocytes (PBLs) of patients with esophageal squamous cell carcinoma (ESCC).,20002703_1,-1,-1,-1,-1,11155,-1,0.0001940047,0.00061984867,0.9991861
11161,the relationship,16,18,105,121,"Furthermore, in order to elucidate the mechanisms behind T-regs accumulation within tumors, we evaluated the relationship between CCL17 or CCL22 expression and the frequency of Foxp3(+) T-regs.",20002703_2,-1,-1,-1,-1,11161,-1,1.8080444e-05,0.9999708,1.1163114e-05
11162,CCL17,19,20,130,135,"Furthermore, in order to elucidate the mechanisms behind T-regs accumulation within tumors, we evaluated the relationship between CCL17 or CCL22 expression and the frequency of Foxp3(+) T-regs.",20002703_2,0,-1,2,-1,11162,-1,0.99156344,0.00038705635,0.0080495
11170,CCL17(+,3,4,17,24,The frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells in tumors was also evaluated by flow cytometry.,20002703_4,0,-1,2,-1,11170,-1,0.97565866,0.0016899728,0.022651311
11177,CCL17,18,19,102,107,"Moreover, an in vitro migration assay using T-regs derived from ESCC was performed in the presence of CCL17 or CCL22.",20002703_5,0,-1,2,-1,11177,-1,0.9849975,0.0009064616,0.014096068
11183,than that,11,13,66,75,"The frequency of Foxp3(+) T-regs in TILs was significantly higher than that in the normal esophageal mucosa (24.6 +/- 10.0 vs 7.1 +/- 5.9%, P < 0.01).",20002703_6,-1,-1,-1,-1,11183,-1,2.3683398e-05,0.99996233,1.3950915e-05
11188,than that,14,16,83,92,"The frequency of Foxp3(+) T-regs in PBLs of ESCC patients was significantly higher than that in normal healthy donors (7.0 +/- 4.2 vs 2.5 +/- 1.0%, P < 0.01).",20002703_7,-1,-1,-1,-1,11188,-1,2.4400817e-05,0.9999614,1.4168947e-05
11190,CCL17(+,5,6,30,37,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal esophageal mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) T-regs in TILs.",20002703_8,0,-1,2,-1,11190,-1,0.98948294,0.00096776837,0.009549155
11195,than that,20,22,116,125,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal esophageal mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) T-regs in TILs.",20002703_8,-1,-1,-1,-1,11195,-1,2.2019596e-05,0.99996436,1.361448e-05
11198,CCL17(+,37,38,220,227,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal esophageal mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) T-regs in TILs.",20002703_8,0,-1,2,-1,11198,-1,0.9897585,0.0009231728,0.009318319
11205,that T-regs,9,11,52,63,"In addition, the in vitro migration assay indicated that T-regs were significantly induced to migrate by CCL17 or CCL22.",20002703_9,-1,-1,-1,-1,11205,-1,2.040433e-05,0.999964,1.557688e-05
11207,CCL17,17,18,105,110,"In addition, the in vitro migration assay indicated that T-regs were significantly induced to migrate by CCL17 or CCL22.",20002703_9,0,-1,2,-1,11207,-1,0.9786164,0.0017732683,0.019610282
11209,CCL17,3,4,15,20,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) T-regs in ESCC.",20002703_10,0,-1,2,-1,11209,-1,0.9731897,0.0011829415,0.02562729
11211,the tumor,7,9,38,47,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) T-regs in ESCC.",20002703_10,-1,-1,-1,-1,11211,-1,2.0670319e-05,0.9999658,1.35531345e-05
11212,related to the,10,13,52,66,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) T-regs in ESCC.",20002703_10,-1,-1,-1,-1,11212,-1,2.3474076e-05,0.99996054,1.5957721e-05
11219,that regulatory T cells,3,7,18,41,Our hypothesis is that regulatory T cells (Tregs) are important to obstruct antitumor immune responses in patients with OSCC.,20012605_2,-1,-1,-1,-1,11219,-1,0.002402463,0.11480468,0.8827929
11226,blood,17,18,91,96,"In the present study, we investigated the frequency, phenotype, and activity of Tregs from blood and lesions of patients with OSCC.",20012605_3,0,1,-1,-1,11226,-1,4.6273228e-05,0.99986315,9.0581816e-05
11231,these cells,2,4,6,17,"Also, these cells express surface Treg markers, such as GITR, CD45RO, CD69, LAP, CTLA-4, CCR4, and IL-10.",20012605_5,-1,-1,-1,-1,11231,-1,0.0011501781,0.02779161,0.97105825
11241,these cells,20,22,115,126,"Interestingly, approximately 25% of CD4(+)CD25(-) T cells of PBMC from patients also expressed FoxP3 and, although these cells weakly suppress allogeneic T cells proliferative response, they inhibited IFN-gamma and induced IL-10 and TGF-beta secretion in these co-cultures.",20012605_7,-1,-1,-1,-1,11241,-1,0.003415209,0.19847746,0.79810727
11246,TGF-beta,37,38,233,241,"Interestingly, approximately 25% of CD4(+)CD25(-) T cells of PBMC from patients also expressed FoxP3 and, although these cells weakly suppress allogeneic T cells proliferative response, they inhibited IFN-gamma and induced IL-10 and TGF-beta secretion in these co-cultures.",20012605_7,0,1,-1,-1,11246,-1,8.919249e-05,0.99986935,4.140414e-05
11249,that Treg cells,5,8,20,35,"Thus, our data show that Treg cells are present in OSCC lesions and PBMC, and these cells appear to suppress immune responses both systemically and in the tumor microenvironment.",20012605_8,-1,-1,-1,-1,11249,-1,0.0027629202,0.1601937,0.8370434
11250,these cells,17,19,78,89,"Thus, our data show that Treg cells are present in OSCC lesions and PBMC, and these cells appear to suppress immune responses both systemically and in the tumor microenvironment.",20012605_8,-1,-1,-1,-1,11250,-1,0.0022130175,0.10339505,0.894392
11253,the tumor,28,30,151,160,"Thus, our data show that Treg cells are present in OSCC lesions and PBMC, and these cells appear to suppress immune responses both systemically and in the tumor microenvironment.",20012605_8,-1,-1,-1,-1,11253,-1,2.1457223e-05,0.9999671,1.1481303e-05
11263,the functional,1,3,11,25,"Dissecting the functional subtypes of T cells with multicolor fluorescent microscopy revealed substantial populations of cytotoxic T cells, helper T cells and FoxP3(+) regulatory T cells.",20013807_2,-1,-1,-1,-1,11263,-1,3.4783687e-05,0.99994767,1.7497145e-05
11274,Analysis,0,1,0,8,"Analysis of the macrophage population also showed a dominance of anti-inflammatory cells, as the M2 type scavenger receptor CD163 was abundantly present.",20013807_4,0,1,-1,-1,11274,-1,3.5616526e-05,0.9999387,2.5703946e-05
11278,type scavenger receptor,16,19,100,123,"Analysis of the macrophage population also showed a dominance of anti-inflammatory cells, as the M2 type scavenger receptor CD163 was abundantly present.",20013807_4,-1,-1,-1,-1,11278,-1,0.0042185644,0.693286,0.3024954
11287,the tyrosine,7,9,44,56,"Most metastatic GISTs had been treated with the tyrosine kinase inhibitors imatinib and sunitinib, but the high macrophage infiltrate was not related to this treatment.",20013807_7,-1,-1,-1,-1,11287,-1,2.6597909e-05,0.9999585,1.485628e-05
11289,related to this treatment,22,26,142,167,"Most metastatic GISTs had been treated with the tyrosine kinase inhibitors imatinib and sunitinib, but the high macrophage infiltrate was not related to this treatment.",20013807_7,-1,-1,-1,-1,11289,-1,5.1858813e-05,0.99991953,2.8591534e-05
11291,that treatment,16,18,115,129,"However, imatinib and sunitinib did induce secretion of anti-inflammatory IL-10 in macrophage cultures, indicating that treatment with these inhibitors might contribute to an immune suppressive microenvironment in GIST.",20013807_8,-1,-1,-1,-1,11291,-1,2.5189476e-05,0.9999641,1.0715649e-05
11304,the therapeutic,12,14,68,83,"Here, we studied whether the removal of Treg cells could potentiate the therapeutic efficacy of Neuro2a/IL-21 vaccine.",20039320_2,-1,-1,-1,-1,11304,-1,2.1049735e-05,0.99997115,7.817521e-06
11306,targets Treg cells,7,10,43,61,"The administration of anti-CD25 mAb, which targets Treg cells, slightly potentiated the effect of vaccine IT (50% cure rate), but anti-CD4 mAb had a more potent effect leading to 80% cure rate.",20039320_3,-1,-1,-1,-1,11306,-1,0.002297342,0.11369019,0.88401246
11313,immunity to,9,11,65,76,"In mice receiving vaccine+anti-CD4 mAb, which developed systemic immunity to NB, CD4+ T cells counts completely recovered in 90 days.",20039320_5,-1,-1,-1,-1,11313,-1,0.007838429,0.9917041,0.00045740843
11318,these cells,19,21,100,111,"Depletion of CD8+ T cells abrogated the effect of the combined IT, indicating a predominant role of these cells in driving the immune response.",20039320_6,-1,-1,-1,-1,11318,-1,0.00076326163,0.017317707,0.98191905
11319,the immune response,23,26,123,142,"Depletion of CD8+ T cells abrogated the effect of the combined IT, indicating a predominant role of these cells in driving the immune response.",20039320_6,-1,-1,-1,-1,11319,-1,0.3020895,0.69630724,0.0016033006
11325,therapy,5,6,33,40,"Moreover, mice receiving vaccine therapy alone or vaccine+anti-CD4 mAb showed increased IFN-gamma serum levels and IFN-gamma-producing CD8+ T cells were found in spleen cells.",20039320_9,0,1,-1,-1,11325,-1,3.231986e-05,0.9999541,1.3624784e-05
11331,their precursors,13,15,85,101,"In conclusion, anti-CD4 mAb potentiated IL-21-based IT by removing Treg cells and/or their precursors and other potentially immune-suppressive CD4+ cell subsets, thus allowing the development of an IL-21-driven CD8+ T cell response, which mediates NB rejection.",20039320_10,-1,-1,-1,-1,11331,-1,0.0066348785,0.3182339,0.6751312
11332,cell subsets,21,23,148,160,"In conclusion, anti-CD4 mAb potentiated IL-21-based IT by removing Treg cells and/or their precursors and other potentially immune-suppressive CD4+ cell subsets, thus allowing the development of an IL-21-driven CD8+ T cell response, which mediates NB rejection.",20039320_10,-1,-1,-1,-1,11332,-1,4.0284187e-05,3.783714e-05,0.9999219
11345,tumor-infiltrating lymphocytes,8,10,22,52,"CD8+, CD4+ and Foxp3+ tumor-infiltrating lymphocytes, tryptase and chymase mast cells (MCs), CD34, number of microvessels and vascular endothelial growth factor were determined by immunohistochemistry.",20053697_2,-1,-1,-1,-1,11345,-1,0.004080937,0.85134053,0.14457853
11355,the interleukin,13,15,73,88,"Tryptase MCs, CD8+ and Foxp3+ lymphocytes had significantly increased in the interleukin 2 (IL-2) treated group.",20053697_6,-1,-1,-1,-1,11355,-1,0.1853064,0.8083772,0.0063163443
11365,the tumoral,22,24,129,140,This study indicates that immunotherapy leads to an increase in cytotoxic CD8+ lymphocytes and tryptase MCs and to a decrease of the tumoral neoangiogenesis.,20053697_8,-1,-1,-1,-1,11365,-1,2.065656e-05,0.99996936,9.95341e-06
11375,cytokine interleukin,14,16,81,101,We and others have shown direct cytotoxic effect of the novel common gamma chain cytokine interleukin (IL)-21 on primary B cells from CLL patients.,20081380_2,-1,-1,-1,-1,11375,-1,0.999767,5.0360788e-05,0.0001825385
11389,receptor,7,8,44,52,We demonstrate here the expression of IL-21 receptor in CD4(+)CD25(High) regulatory cells from CLL patients.,20081380_4,0,1,2,-1,11389,-1,0.0010263813,0.12016935,0.8788043
11398,blood,31,32,187,192,"In contrast to IL-2, the IL-21 cytokine failed to mediate expansion of regulatory T cells or induced expression of Foxp3 in CD4(+)CD25(Intermediate) or CD4(+)CD25(Dim/-) T cells in whole blood derived from CLL patients.",20081380_5,0,1,-1,-1,11398,-1,0.00090075354,0.17994843,0.8191508
11399,to their,4,6,27,35,"Interestingly, in contrast to their differential effects on expansion of the CD4(+)CD25(+)Foxp3(+)T cells, IL-2 and IL-21 exhibited a redundant role in Treg mediated suppression of NK cell mediated antibody dependent cytotoxicity function.",20081380_6,-1,-1,-1,-1,11399,-1,2.1524433e-05,0.99996924,9.260475e-06
11401,CD4(+)CD25(+)Foxp3(+)T cells,12,14,77,105,"Interestingly, in contrast to their differential effects on expansion of the CD4(+)CD25(+)Foxp3(+)T cells, IL-2 and IL-21 exhibited a redundant role in Treg mediated suppression of NK cell mediated antibody dependent cytotoxicity function.",20081380_6,-1,-1,-1,-1,11401,-1,0.00030810395,0.00036579717,0.9993261
11404,function,33,34,230,238,"Interestingly, in contrast to their differential effects on expansion of the CD4(+)CD25(+)Foxp3(+)T cells, IL-2 and IL-21 exhibited a redundant role in Treg mediated suppression of NK cell mediated antibody dependent cytotoxicity function.",20081380_6,0,1,2,-1,11404,-1,0.0077221473,0.6156635,0.37661427
11406,related toxicities,3,5,19,37,"Given the infusion related toxicities and pro-survival effect of IL-2 in CLL, these studies provide a rationale to explore IL-21 as an alternate gamma chain cytokine in CLL therapy.",20081380_7,-1,-1,-1,-1,11406,-1,5.861743e-05,0.99989295,4.843501e-05
11410,therapy,29,30,173,180,"Given the infusion related toxicities and pro-survival effect of IL-2 in CLL, these studies provide a rationale to explore IL-21 as an alternate gamma chain cytokine in CLL therapy.",20081380_7,0,1,-1,-1,11410,-1,2.5998905e-05,0.9999608,1.3226668e-05
11413,the interleukin-1 receptor,7,10,46,72,We report that melanoma cell lines expressing the interleukin-1 receptor exhibit 4- to 10-fold lower levels of mRNA of microphthalmia-associated transcription factor (MITF-M) when treated with interleukin-1beta.,20099279_0,-1,-1,-1,-1,11413,-1,0.0045185965,0.9743745,0.021106984
11444,IL-1 cytokines,14,16,90,104,We estimate that approximately 13% of melanoma cell lines are MITF-M-negative and secrete IL-1 cytokines.,20099279_5,-1,-1,-1,-1,11444,-1,0.99968886,5.2868632e-05,0.0002582556
11446,that the,3,5,23,31,These results indicate that the repression of melanocyte-differentiation genes by IL-1 produced by stromal cells or by tumor cells themselves may represent an additional mechanism of melanoma immune escape.,20099279_6,-1,-1,-1,-1,11446,-1,1.8142451e-05,0.9999745,7.324817e-06
11450,tumor cells themselves,17,20,119,141,These results indicate that the repression of melanocyte-differentiation genes by IL-1 produced by stromal cells or by tumor cells themselves may represent an additional mechanism of melanoma immune escape.,20099279_6,-1,-1,-1,-1,11450,-1,0.00013416326,0.9995283,0.00033755862
11451,The functional,0,2,0,14,The functional development of tumor-specific CD4(+) T cells has a critical impact on the outcome of antitumor immune responses.,20118405_0,-1,-1,-1,-1,11451,-1,2.4367624e-05,0.9999658,9.796509e-06
11459,immunity,5,6,32,40,"To mount an effective antitumor immunity, it is desirable to elicit activated type 1 T helper cells.",20118405_2,0,-1,2,-1,11459,-1,0.99921453,0.00049927074,0.0002861797
11463,that type,4,6,16,25,"Here, we report that type 1 T helper cell-like effector cells that arose in tumor-bearing hosts progressively expressed programmed death 1 during tumor growth.",20118405_3,-1,-1,-1,-1,11463,-1,1.818799e-05,0.9999696,1.2184875e-05
11466,cells that,11,13,56,66,"Here, we report that type 1 T helper cell-like effector cells that arose in tumor-bearing hosts progressively expressed programmed death 1 during tumor growth.",20118405_3,-1,-1,-1,-1,11466,-1,0.003741641,0.14117713,0.8550812
11471,interleukin-7 receptor,17,19,125,147,"The programmed death 1(hi) effector cells displayed a dysfunctional phenotype, characterized by selective down-regulation of interleukin-7 receptor, heightened apoptosis, and poor antitumor efficacy.",20118405_4,-1,-1,-1,-1,11471,-1,0.91043484,0.0019288891,0.08763634
11472,This tumor-driven,0,2,0,17,This tumor-driven aberrant T-cell response could be prevented by a single dose of the widely used chemotherapy agent cyclophosphamide.,20118405_5,-1,-1,-1,-1,11472,-1,2.5028567e-05,0.9999634,1.1557005e-05
11473,T-cell,3,4,27,33,This tumor-driven aberrant T-cell response could be prevented by a single dose of the widely used chemotherapy agent cyclophosphamide.,20118405_5,-1,1,2,-1,11473,-1,3.9628838e-05,5.8183225e-05,0.99990225
11476,that chemotherapy,2,4,8,25,"We show that chemotherapy conditioned the host environment, creating a transient window for optimal effector differentiation for adoptively transferred CD4(+) T cells.",20118405_6,-1,-1,-1,-1,11476,-1,0.029655136,0.96978486,0.0005599737
11483,to type,16,18,120,127,"This robust effector differentiation, which was antigen-driven and mechanistically dependent on an intact host response to type I interferon, gave rise to activated polyfunctional T helper cells with high interleukin-7 receptor, rapid clonal expansion, and potent antitumor activity against established B-cell lymphomas.",20118405_7,-1,-1,-1,-1,11483,-1,4.959494e-05,0.9999306,1.9807923e-05
11487,interleukin-7 receptor,31,33,205,227,"This robust effector differentiation, which was antigen-driven and mechanistically dependent on an intact host response to type I interferon, gave rise to activated polyfunctional T helper cells with high interleukin-7 receptor, rapid clonal expansion, and potent antitumor activity against established B-cell lymphomas.",20118405_7,-1,-1,-1,-1,11487,-1,0.9568549,0.00082875916,0.042316288
11491,to the,14,16,108,114,We hypothesize that prevention of tumor-induced effector cell dysfunction is a major mechanism contributing to the efficacy of combined chemoimmunotherapy.,20118405_8,-1,-1,-1,-1,11491,-1,2.9336697e-05,0.9999589,1.18192565e-05
11497,TCR,23,24,142,145,"In a basic study of immunotolerance, injection of an endogenous superantigen, i.e. the minor lymphocyte stimulatory (Mls)-1(a), into specific TCR Vbeta8.1-Tg mice enabled generation of anergic CD25(-) iTreg, the immunosuppressive function of which was maintained by IL-10 production via p38-MAPK activation.",20127675_1,-1,1,2,-1,11497,-1,2.3440129e-05,0.99995434,2.226264e-05
11500,function,36,37,230,238,"In a basic study of immunotolerance, injection of an endogenous superantigen, i.e. the minor lymphocyte stimulatory (Mls)-1(a), into specific TCR Vbeta8.1-Tg mice enabled generation of anergic CD25(-) iTreg, the immunosuppressive function of which was maintained by IL-10 production via p38-MAPK activation.",20127675_1,0,1,2,-1,11500,-1,0.00042534067,0.99916387,0.00041080534
11507,Peptide,0,1,0,7,Peptide OVA(323-339) iv.-injection into its specific TCR-Tg (OT-II) mice also induced adaptive tolerance by iTreg.,20127675_3,0,-1,2,-1,11507,-1,7.557781e-05,0.99985313,7.132017e-05
11508,TCR-Tg,9,10,53,59,Peptide OVA(323-339) iv.-injection into its specific TCR-Tg (OT-II) mice also induced adaptive tolerance by iTreg.,20127675_3,-1,1,2,-1,11508,-1,3.299717e-05,0.99994004,2.6923286e-05
11510,Peptide,0,1,0,7,"Peptide immunotherapy with p38-inhibitor after CD25(+) Treg-depletion was performed in an OVA-expressing lymphoma E.G7-bearing tolerant model established by adoptive transfer of OT-II CD25(-) iTreg, which resulted in suppression of tumor growth.",20127675_4,0,-1,2,-1,11510,-1,5.326983e-05,0.99992454,2.2204516e-05
11516,immunity,4,5,25,33,"Similarly, the antitumor immunity induced by peptide immunotherapy in colon carcinoma CT26-bearing mice, in which the number of IL-10-secreting iTreg is increased, was augmented by treatment with p38-inhibitor after CD25(+) Treg-depletion and resulted in inhibition of tumor progression.",20127675_5,0,-1,2,-1,11516,-1,0.99776745,0.0017026735,0.00052992563
11517,peptide,7,8,45,52,"Similarly, the antitumor immunity induced by peptide immunotherapy in colon carcinoma CT26-bearing mice, in which the number of IL-10-secreting iTreg is increased, was augmented by treatment with p38-inhibitor after CD25(+) Treg-depletion and resulted in inhibition of tumor progression.",20127675_5,0,-1,2,-1,11517,-1,5.7782145e-05,0.9999163,2.5924119e-05
11527,to the,13,15,99,105,These results suggest that simultaneous inhibition of two distinct Treg-functions may be important to the success of cancer immunotherapy.,20127675_6,-1,-1,-1,-1,11527,-1,3.4087192e-05,0.999954,1.18659555e-05
11528,Tehranolide named,0,2,0,17,Tehranolide named as new type of a sesquiterpene lactone with an endoperoxide group which purified from Artemisia diffusa and having similar structure to Artemisinin.,20138670_0,-1,-1,-1,-1,11528,-1,4.1717598e-05,0.9999386,1.9674038e-05
11537,the tumor,11,13,72,81,"In the present research we emphasized on the direct correlation between the tumor sizes, immune response; including cytokin network, T regulatory cells and Tehranolide intraperitoneally injected Tehranolide.",20138670_2,-1,-1,-1,-1,11537,-1,1.9473113e-05,0.9999702,1.0340346e-05
11548,the immune responses,21,24,120,140,"First we evaluated the effects of Tehranolide on cell growth inhibition (in vitro) by MTT assay and second investigated the immune responses, these include measuring tumor growth in the female Balb/c mice transplanted with spontaneous mouse mammary tumor and treated with Tehranolide, splenocyte proliferation detected by using the BrdU kit, measurement of cytokine profile by ELISA and analysis of T-lymphocytes subpopulation in spleen by Flow cytometry.",20138670_4,-1,-1,-1,-1,11548,-1,0.23018405,0.76828575,0.0015302115
11558,analysis,62,63,387,395,"First we evaluated the effects of Tehranolide on cell growth inhibition (in vitro) by MTT assay and second investigated the immune responses, these include measuring tumor growth in the female Balb/c mice transplanted with spontaneous mouse mammary tumor and treated with Tehranolide, splenocyte proliferation detected by using the BrdU kit, measurement of cytokine profile by ELISA and analysis of T-lymphocytes subpopulation in spleen by Flow cytometry.",20138670_4,0,1,-1,-1,11558,-1,2.9134055e-05,0.99994445,2.640208e-05
11559,T-lymphocytes,64,65,399,412,"First we evaluated the effects of Tehranolide on cell growth inhibition (in vitro) by MTT assay and second investigated the immune responses, these include measuring tumor growth in the female Balb/c mice transplanted with spontaneous mouse mammary tumor and treated with Tehranolide, splenocyte proliferation detected by using the BrdU kit, measurement of cytokine profile by ELISA and analysis of T-lymphocytes subpopulation in spleen by Flow cytometry.",20138670_4,-1,1,2,-1,11559,-1,3.4465775e-05,5.3755903e-05,0.9999118
11560,the tumor,10,12,54,63,"Our results showed a significant (p<0.05) decrease in the tumor volume and the level of IL-4 in the animals treated with Tehranolide, compared to untreated group.",20138670_5,-1,-1,-1,-1,11560,-1,2.0551655e-05,0.99996674,1.27057065e-05
11566,the lymphocytes,10,12,48,63,"In addition, a significant (p<0.05) increase in the lymphocytes proliferation and the level of IFN-gamma in the animals treated with Tehranolide in comparison with control group.",20138670_6,-1,-1,-1,-1,11566,-1,0.0029502213,0.49536794,0.50168186
11572,the regulatory T cells,4,8,25,47,"Furthermore, we regulate the regulatory T cells in order to improve the outcome of cancer immunotherapy.",20138670_7,-1,-1,-1,-1,11572,-1,0.0022100823,0.110546075,0.8872438
11577,that Tehranolide,9,11,73,89,The measurement of splenic CD4(+)CD25(+)Foxp3(+) T lymphocytes indicated that Tehranolide significantly (p<0.05) decreased the number of these lymphocytes.,20138670_8,-1,-1,-1,-1,11577,-1,4.6858157e-05,0.9999335,1.9699886e-05
11579,these lymphocytes,19,21,137,154,The measurement of splenic CD4(+)CD25(+)Foxp3(+) T lymphocytes indicated that Tehranolide significantly (p<0.05) decreased the number of these lymphocytes.,20138670_8,-1,-1,-1,-1,11579,-1,0.0024276995,0.1446446,0.8529276
11581,that the,3,5,20,28,These findings show that the use of Tehranolide molecule represents a novel strategy with major suggestions for cancer therapy approaches.,20138670_9,-1,-1,-1,-1,11581,-1,1.9007917e-05,0.9999734,7.534375e-06
11583,therapy,18,19,119,126,These findings show that the use of Tehranolide molecule represents a novel strategy with major suggestions for cancer therapy approaches.,20138670_9,0,1,-1,-1,11583,-1,2.8193856e-05,0.9999567,1.503906e-05
11584,to treat,4,6,35,43,"Antiestrogens are universally used to treat estrogen receptor--positive breast cancer, but relapses occur commonly due to the development of drug resistance.",20145137_0,-1,-1,-1,-1,11584,-1,2.8588074e-05,0.9999596,1.17836535e-05
11585,receptor,7,8,53,61,"Antiestrogens are universally used to treat estrogen receptor--positive breast cancer, but relapses occur commonly due to the development of drug resistance.",20145137_0,0,1,2,-1,11585,-1,0.00024356986,0.9982817,0.0014747279
11587,to the,18,20,119,125,"Antiestrogens are universally used to treat estrogen receptor--positive breast cancer, but relapses occur commonly due to the development of drug resistance.",20145137_0,-1,-1,-1,-1,11587,-1,2.655844e-05,0.99996316,1.0288799e-05
11591,TGFbeta,11,12,71,78,"The ability of antiestrogen to induce transforming growth factor beta (TGFbeta) in breast cancer cells may be relevant to the emergence of resistance, not only at the level of cell autonomous effects of TGFbeta on cancer progression but also at the level of its effects on the host immune system.",20145137_1,0,1,-1,-1,11591,-1,3.6612077e-05,0.9999516,1.1738897e-05
11593,relevant to the,19,22,110,125,"The ability of antiestrogen to induce transforming growth factor beta (TGFbeta) in breast cancer cells may be relevant to the emergence of resistance, not only at the level of cell autonomous effects of TGFbeta on cancer progression but also at the level of its effects on the host immune system.",20145137_1,-1,-1,-1,-1,11593,-1,2.412984e-05,0.9999653,1.0526858e-05
11596,TGFbeta,36,37,203,210,"The ability of antiestrogen to induce transforming growth factor beta (TGFbeta) in breast cancer cells may be relevant to the emergence of resistance, not only at the level of cell autonomous effects of TGFbeta on cancer progression but also at the level of its effects on the host immune system.",20145137_1,0,1,-1,-1,11596,-1,3.1973264e-05,0.9999573,1.0686554e-05
11602,TGFbeta,9,10,70,77,"To evaluate the potential role of tumor-derived, antiestrogen-induced TGFbeta as an immune suppressor, we established in vitro mixed lymphocyte tumor reactions (MLTR) using MCF-7 cells and peripheral blood mononuclear cells (PBMC), as well as tumor tissue and autologous tumor infiltrating lymphocytes (TIL) obtained from primary breast cancer biopsies.",20145137_2,0,1,-1,-1,11602,-1,2.7375181e-05,0.99996173,1.0911579e-05
11603,lymphocyte tumor,20,22,133,149,"To evaluate the potential role of tumor-derived, antiestrogen-induced TGFbeta as an immune suppressor, we established in vitro mixed lymphocyte tumor reactions (MLTR) using MCF-7 cells and peripheral blood mononuclear cells (PBMC), as well as tumor tissue and autologous tumor infiltrating lymphocytes (TIL) obtained from primary breast cancer biopsies.",20145137_2,-1,-1,-1,-1,11603,-1,0.0040048957,0.12997845,0.8660167
11604,MCF-7 cells,27,29,173,184,"To evaluate the potential role of tumor-derived, antiestrogen-induced TGFbeta as an immune suppressor, we established in vitro mixed lymphocyte tumor reactions (MLTR) using MCF-7 cells and peripheral blood mononuclear cells (PBMC), as well as tumor tissue and autologous tumor infiltrating lymphocytes (TIL) obtained from primary breast cancer biopsies.",20145137_2,-1,-1,-1,-1,11604,-1,0.54846144,0.0026985637,0.44884
11605,blood,31,32,200,205,"To evaluate the potential role of tumor-derived, antiestrogen-induced TGFbeta as an immune suppressor, we established in vitro mixed lymphocyte tumor reactions (MLTR) using MCF-7 cells and peripheral blood mononuclear cells (PBMC), as well as tumor tissue and autologous tumor infiltrating lymphocytes (TIL) obtained from primary breast cancer biopsies.",20145137_2,0,1,-1,-1,11605,-1,0.00017529786,0.99920684,0.00061786047
11607,tumor tissue,41,43,243,255,"To evaluate the potential role of tumor-derived, antiestrogen-induced TGFbeta as an immune suppressor, we established in vitro mixed lymphocyte tumor reactions (MLTR) using MCF-7 cells and peripheral blood mononuclear cells (PBMC), as well as tumor tissue and autologous tumor infiltrating lymphocytes (TIL) obtained from primary breast cancer biopsies.",20145137_2,-1,-1,-1,-1,11607,-1,2.36738e-05,0.9999566,1.9747575e-05
11611,MCF-7 cells,5,7,41,52,"In allogeneic MLTR, antiestrogen-treated MCF-7 cells caused downregulation of the effector molecules granzyme B, perforin, and Fas ligand in CD8(+) T cells, and suppressed the generation of cytotoxic effector cells in a TGFbeta-dependent manner.",20145137_3,-1,-1,-1,-1,11611,-1,0.2857327,0.0037974494,0.71046984
11614,the generation,29,31,172,186,"In allogeneic MLTR, antiestrogen-treated MCF-7 cells caused downregulation of the effector molecules granzyme B, perforin, and Fas ligand in CD8(+) T cells, and suppressed the generation of cytotoxic effector cells in a TGFbeta-dependent manner.",20145137_3,-1,-1,-1,-1,11614,-1,2.134545e-05,0.9999628,1.5833963e-05
11616,TGFbeta-dependent,37,38,220,237,"In allogeneic MLTR, antiestrogen-treated MCF-7 cells caused downregulation of the effector molecules granzyme B, perforin, and Fas ligand in CD8(+) T cells, and suppressed the generation of cytotoxic effector cells in a TGFbeta-dependent manner.",20145137_3,0,1,-1,-1,11616,-1,3.7215166e-05,0.9999286,3.4236185e-05
11625,tumor cells,20,22,132,143,"In autologous MLTR, antiestrogen treatment gave rise to enhanced Foxp3 expression of TIL/PBMC and decreased the number of apoptotic tumor cells.",20145137_5,-1,-1,-1,-1,11625,-1,0.003743321,0.41582444,0.58043224
11627,TGFbeta,8,9,45,52,These effects were reversed by addition of a TGFbeta neutralizing antibody.,20145137_6,0,1,-1,-1,11627,-1,3.8934133e-05,0.9999491,1.1974026e-05
11629,the tumor,9,11,75,84,"Our findings offer evidence that antiestrogen induces immunosuppression in the tumor microenvironment, through a TGFbeta-dependent mechanism that may contribute to the development of antiestrogen resistance in breast cancer.",20145137_7,-1,-1,-1,-1,11629,-1,1.8706483e-05,0.99997246,8.808417e-06
11631,TGFbeta-dependent,15,16,113,130,"Our findings offer evidence that antiestrogen induces immunosuppression in the tumor microenvironment, through a TGFbeta-dependent mechanism that may contribute to the development of antiestrogen resistance in breast cancer.",20145137_7,0,1,-1,-1,11631,-1,2.7549642e-05,0.99995255,1.9940657e-05
11633,to the,20,22,161,167,"Our findings offer evidence that antiestrogen induces immunosuppression in the tumor microenvironment, through a TGFbeta-dependent mechanism that may contribute to the development of antiestrogen resistance in breast cancer.",20145137_7,-1,-1,-1,-1,11633,-1,2.240504e-05,0.9999683,9.321604e-06
11635,T-cell,4,5,33,39,We generated an adenovirus-based T-cell vaccine (Ad-p14) that reliably elicits T-cell responses to human papillomavirus (HPV) oncogenes of the 2 most common high-risk HPV serotypes.,20145549_0,-1,1,2,-1,11635,-1,3.5723027e-05,5.8159756e-05,0.99990606
11636,that reliably,9,11,57,70,We generated an adenovirus-based T-cell vaccine (Ad-p14) that reliably elicits T-cell responses to human papillomavirus (HPV) oncogenes of the 2 most common high-risk HPV serotypes.,20145549_0,-1,-1,-1,-1,11636,-1,2.0155394e-05,0.9999683,1.1510633e-05
11637,T-cell,12,13,79,85,We generated an adenovirus-based T-cell vaccine (Ad-p14) that reliably elicits T-cell responses to human papillomavirus (HPV) oncogenes of the 2 most common high-risk HPV serotypes.,20145549_0,-1,1,2,-1,11637,-1,3.6757665e-05,5.6963483e-05,0.9999063
11647,the relevant T-cell,13,16,87,106,"Although ensuring maximal biologic safety, the construct includes approximately 70% of the relevant T-cell epitopes.",20145549_2,-1,-1,-1,-1,11647,-1,0.004335868,0.26945212,0.726212
11657,the therapeutic,3,5,19,34,"To further improve the therapeutic effect, vaccination was combined with systemic application of imiquimod, anti-CD4, alpha-interferon, or anti-GITR.",20145549_5,-1,-1,-1,-1,11657,-1,2.4646697e-05,0.9999664,8.933118e-06
11658,the therapeutic,4,6,42,57,"Although adding alpha-interferon improved the therapeutic potential of Ad-p14 by 40%, the combination with anti-GITR resulted in complete and permanent eradication of all TC1 tumors.",20145549_6,-1,-1,-1,-1,11658,-1,2.1820808e-05,0.9999689,9.264737e-06
11660,TC1 tumors,25,27,171,181,"Although adding alpha-interferon improved the therapeutic potential of Ad-p14 by 40%, the combination with anti-GITR resulted in complete and permanent eradication of all TC1 tumors.",20145549_6,-1,-1,-1,-1,11660,-1,2.1245425e-05,0.99995995,1.8831273e-05
11663,immune response modifiers,14,17,88,113,"Ad-p14 has clinical potential for treating HPV-induced lesions, and the added effect of immune response modifiers stresses the importance of combined protocols for immunotherapy of malignant tumors.",20145549_7,-1,-1,-1,-1,11663,-1,0.9904323,0.0050606593,0.004507014
11681,the analysis,6,8,25,37,The aim of this study is the analysis of tumor immune escape mechanisms in a colorectal liver metastases mouse model at different points in time during tumor growth.,20205946_2,-1,-1,-1,-1,11681,-1,1.9360972e-05,0.99997115,9.4318075e-06
11683,in time,23,25,137,144,The aim of this study is the analysis of tumor immune escape mechanisms in a colorectal liver metastases mouse model at different points in time during tumor growth.,20205946_2,-1,-1,-1,-1,11683,-1,5.056053e-05,0.99992025,2.9129655e-05
11689,in time,15,17,104,111,Metastatic tumor growth in the liver was examined by standard histological procedures at defined points in time during metastatic growth.,20205946_4,-1,-1,-1,-1,11689,-1,8.8370856e-05,0.9998492,6.236611e-05
11690,tissue,1,2,6,12,"Liver tissue with metastases was additionally analyzed for cytokines, T cell markers and Fas/Fas-L expression using immunohistochemistry, immunofluorescence and RT-PCR.",20205946_5,-1,1,2,-1,11690,-1,3.4080796e-05,0.9999229,4.308258e-05
11693,analysis,4,5,30,38,Comparisons were performed by analysis of variance or paired and unpaired t test when appropriate.,20205946_6,0,1,-1,-1,11693,-1,4.6537327e-05,0.9999181,3.5375382e-05
11694,t test,11,13,74,80,Comparisons were performed by analysis of variance or paired and unpaired t test when appropriate.,20205946_6,-1,-1,-1,-1,11694,-1,4.8809357e-05,0.9999026,4.860553e-05
11701,tissue,23,24,141,147,T cells of regulatory phenotype (CD4+CD25+Foxp3+) which might play a role in protumoral immune response were found to infiltrate peritumoral tissue increasingly during carcinogenesis.,20205946_8,-1,1,2,-1,11701,-1,8.002697e-05,0.9996201,0.0002999159
11702,cytokines IL-10,2,4,14,29,"Expression of cytokines IL-10, TGF-beta and TNF-alpha were increased during tumor growth whereas IFN-gamma showed a decrease of the expression from day 10 on following an initial increase.",20205946_9,-1,-1,-1,-1,11702,-1,0.99987936,3.4530523e-05,8.601302e-05
11703,TGF-beta,5,6,31,39,"Expression of cytokines IL-10, TGF-beta and TNF-alpha were increased during tumor growth whereas IFN-gamma showed a decrease of the expression from day 10 on following an initial increase.",20205946_9,0,1,-1,-1,11703,-1,4.7163077e-05,0.99993086,2.2007038e-05
11704,TNF-alpha,7,8,44,53,"Expression of cytokines IL-10, TGF-beta and TNF-alpha were increased during tumor growth whereas IFN-gamma showed a decrease of the expression from day 10 on following an initial increase.",20205946_9,0,1,-1,-1,11704,-1,6.2452054e-05,0.99991214,2.5391919e-05
11708,tumor cell,14,16,87,97,"Moreover, liver metastases of murine colon carcinoma show an up-regulation of FAS-L on tumor cell surface with a decreased expression of FAS from day 10 on.",20205946_10,-1,-1,-1,-1,11708,-1,0.0034200023,0.6710769,0.3255031
11714,Thymic function,0,2,0,15,"Thymic function decreases in line with tumor progression in patients with cancer, resulting in immunodeficiency and a poor prognosis.",20229083_0,-1,-1,-1,-1,11714,-1,9.234364e-05,0.99982125,8.643271e-05
11718,thymic function,9,11,46,61,"In the present study, we attempted to restore thymic function by BALB/c (H-2(d)) syngeneic (Syn), or B6 (H-2(b)) allogeneic (Allo) bone marrow transplantation (BMT) using intra-bone marrow-bone marrow transplantation (IBM-BMT) plus Syn-, Allo- or C3H (H-2(k)) 3rd-party fetal thymus transplantation (TT).",20229083_1,-1,-1,-1,-1,11718,-1,3.357277e-05,0.9999416,2.4846233e-05
11719,transplantation,34,35,143,158,"In the present study, we attempted to restore thymic function by BALB/c (H-2(d)) syngeneic (Syn), or B6 (H-2(b)) allogeneic (Allo) bone marrow transplantation (BMT) using intra-bone marrow-bone marrow transplantation (IBM-BMT) plus Syn-, Allo- or C3H (H-2(k)) 3rd-party fetal thymus transplantation (TT).",20229083_1,-1,1,2,-1,11719,-1,2.5199217e-05,0.9999559,1.8918103e-05
11720,transplantation,42,43,201,216,"In the present study, we attempted to restore thymic function by BALB/c (H-2(d)) syngeneic (Syn), or B6 (H-2(b)) allogeneic (Allo) bone marrow transplantation (BMT) using intra-bone marrow-bone marrow transplantation (IBM-BMT) plus Syn-, Allo- or C3H (H-2(k)) 3rd-party fetal thymus transplantation (TT).",20229083_1,-1,1,2,-1,11720,-1,2.6074928e-05,0.9999547,1.9268387e-05
11722,thymus transplantation,58,60,276,298,"In the present study, we attempted to restore thymic function by BALB/c (H-2(d)) syngeneic (Syn), or B6 (H-2(b)) allogeneic (Allo) bone marrow transplantation (BMT) using intra-bone marrow-bone marrow transplantation (IBM-BMT) plus Syn-, Allo- or C3H (H-2(k)) 3rd-party fetal thymus transplantation (TT).",20229083_1,-1,-1,-1,-1,11722,-1,0.000103467,0.9997695,0.0001270041
11749,T cell function,17,20,97,112,"Furthermore, there was a positive correlation between survival days and the number of T cells or T cell function, while there was a negative correlation between survival days and lung metastasis, the number of Gr-1(+)/CD11b(+) cells, or the percentage of FoxP3(+) cells.",20229083_6,-1,-1,-1,-1,11749,-1,4.037225e-05,5.225405e-05,0.9999074
11761,T cell function,29,32,161,176,"These results suggest that BMT + TT, particularly Allo-BMT + Allo-TT or 3rd-party TT, is most effective in prolonging survival as a result of the restoration of T cell function in hosts with advanced tumors.",20229083_7,-1,-1,-1,-1,11761,-1,4.6814766e-05,7.074045e-05,0.99988246
11765,tumor-specific T-cell,7,9,38,59,The diversity and extent of the local tumor-specific T-cell response in a given individual is largely unknown.,20233872_0,-1,-1,-1,-1,11765,-1,0.0051796176,0.6850763,0.3097441
11767,T-cell,9,10,49,55,"We have performed an in-depth study of the local T-cell repertoire in a selected group of patients with cervical cancer, by systematic analyses of the proportion, breadth, and polarization of human papillomavirus (HPV) E6/E7-specific T cells within the total population of tumor-infiltrating lymphocytes (TIL) and tumor-draining lymph node cells (TDLNC).",20233872_1,-1,1,2,-1,11767,-1,3.6678142e-05,4.3595563e-05,0.99991965
11770,the total,42,44,249,258,"We have performed an in-depth study of the local T-cell repertoire in a selected group of patients with cervical cancer, by systematic analyses of the proportion, breadth, and polarization of human papillomavirus (HPV) E6/E7-specific T cells within the total population of tumor-infiltrating lymphocytes (TIL) and tumor-draining lymph node cells (TDLNC).",20233872_1,-1,-1,-1,-1,11770,-1,2.1995542e-05,0.99996614,1.1820514e-05
11771,tumor-infiltrating lymphocytes,46,48,273,303,"We have performed an in-depth study of the local T-cell repertoire in a selected group of patients with cervical cancer, by systematic analyses of the proportion, breadth, and polarization of human papillomavirus (HPV) E6/E7-specific T cells within the total population of tumor-infiltrating lymphocytes (TIL) and tumor-draining lymph node cells (TDLNC).",20233872_1,-1,-1,-1,-1,11771,-1,0.00381612,0.85871726,0.13746656
11777,peptides,12,13,68,76,"Isolated T cells were stimulated with sets of overlapping E6 and E7 peptides and analyzed by multiparameter flow cytometry with respect to activation, cytokine production, and T-cell receptor Vbeta usage.",20233872_2,0,-1,2,-1,11777,-1,0.00012807621,0.9996642,0.00020773202
11781,T-cell,6,7,27,33,HPV-specific CD4+ and CD8+ T-cell responses were detected in TIL and TDLNC and their relative contribution varied between <1% and 66% of all T cells.,20233872_3,-1,1,2,-1,11781,-1,3.2626172e-05,4.6468806e-05,0.99992085
11784,their relative,15,17,79,93,HPV-specific CD4+ and CD8+ T-cell responses were detected in TIL and TDLNC and their relative contribution varied between <1% and 66% of all T cells.,20233872_3,-1,-1,-1,-1,11784,-1,4.3269374e-05,0.999931,2.5740419e-05
11789,peptide-epitope,28,29,184,199,"In general, these HPV-specific responses were surprisingly broad, aimed at multiple E6 and E7 epitopes and involved multiple dominant and subdominant T-cell receptor Vbetas per single peptide-epitope.",20233872_4,0,-1,2,-1,11789,-1,0.00093216286,0.99812204,0.0009458085
11790,IFNgamma-producing T cells,6,9,27,53,"In most patients, only few IFNgamma-producing T cells were found and the amount of IFNgamma produced was low, suggesting that these are poised T cells, rendered functionally inactive within the tumor environment.",20233872_5,-1,-1,-1,-1,11790,-1,0.69592506,0.0031749343,0.30090007
11793,that these,21,23,121,131,"In most patients, only few IFNgamma-producing T cells were found and the amount of IFNgamma produced was low, suggesting that these are poised T cells, rendered functionally inactive within the tumor environment.",20233872_5,-1,-1,-1,-1,11793,-1,1.8415056e-05,0.99996936,1.22625925e-05
11795,functionally,29,30,161,173,"In most patients, only few IFNgamma-producing T cells were found and the amount of IFNgamma produced was low, suggesting that these are poised T cells, rendered functionally inactive within the tumor environment.",20233872_5,0,1,2,-1,11795,-1,4.5736353e-05,0.9999347,1.9586387e-05
11796,the tumor,32,34,190,199,"In most patients, only few IFNgamma-producing T cells were found and the amount of IFNgamma produced was low, suggesting that these are poised T cells, rendered functionally inactive within the tumor environment.",20233872_5,-1,-1,-1,-1,11796,-1,1.8738237e-05,0.999972,9.296558e-06
11797,the TIL,4,6,28,35,"Importantly, stimulation of the TIL and TDLNC with cognate antigen in the presence of commonly used Toll-like receptor ligands significantly enhanced the effector T-cell function.",20233872_6,-1,-1,-1,-1,11797,-1,2.0678786e-05,0.99996805,1.1255434e-05
11801,Toll-like receptor ligands,17,20,100,126,"Importantly, stimulation of the TIL and TDLNC with cognate antigen in the presence of commonly used Toll-like receptor ligands significantly enhanced the effector T-cell function.",20233872_6,-1,-1,-1,-1,11801,-1,0.13951609,0.5401183,0.3203656
11803,T-cell function,24,26,163,178,"Importantly, stimulation of the TIL and TDLNC with cognate antigen in the presence of commonly used Toll-like receptor ligands significantly enhanced the effector T-cell function.",20233872_6,-1,-1,-1,-1,11803,-1,4.9817867e-05,8.1758386e-05,0.9998684
11805,immunity,13,14,80,88,"In conclusion, our study suggests that within a given patient with HPV-specific immunity many different tumor-specific CD4+ and CD8+ T cells are locally present and poised for action.",20233872_7,0,-1,2,-1,11805,-1,0.9890243,0.010246787,0.00072903786
11809,T-cell,4,5,25,31,This vast existing local T-cell population is awaiting proper stimulation and can be exploited for the immunotherapy of cancer.,20233872_8,-1,1,2,-1,11809,-1,3.176882e-05,5.0345716e-05,0.99991786
11812,to tumor,11,13,86,94,Immune dysfunction is well documented during tumor progression and likely contributes to tumor immune evasion.,20305684_0,-1,-1,-1,-1,11812,-1,3.0027853e-05,0.9999573,1.2702607e-05
11815,antigen-specific tumor,11,13,54,76,CD8(+) cytotoxic T lymphocytes (CTLs) are involved in antigen-specific tumor destruction and CD4(+) T cells are essential for helping this CD8(+) T cell-dependent tumor eradication.,20305684_1,-1,-1,-1,-1,11815,-1,0.9635857,0.03134528,0.0050689843
11818,T cell-dependent tumor,26,29,146,168,CD8(+) cytotoxic T lymphocytes (CTLs) are involved in antigen-specific tumor destruction and CD4(+) T cells are essential for helping this CD8(+) T cell-dependent tumor eradication.,20305684_1,-1,-1,-1,-1,11818,-1,0.0012319925,0.014632101,0.98413587
11821,T-cell function to,5,8,32,50,Tumors often target and inhibit T-cell function to escape from immune surveillance.,20305684_2,-1,-1,-1,-1,11821,-1,0.0011778519,0.022808073,0.97601414
11824,towards type,12,14,68,80,"This dysfunction includes loss of effector and memory T cells, bias towards type 2 cytokines and expansion of T regulatory (Treg) cells.",20305684_3,-1,-1,-1,-1,11824,-1,5.513179e-05,0.99990284,4.200622e-05
11831,this plant-derived,18,20,128,146,Curcumin has previously been shown to have antitumor activity and some research has addressed the immunoprotective potential of this plant-derived polyphenol in tumor-bearing hosts.,20305684_4,-1,-1,-1,-1,11831,-1,3.0240926e-05,0.99994993,1.9767056e-05
11836,T cell-based immune responses,14,18,88,117,Here we examined the role of curcumin in the prevention of tumor-induced dysfunction of T cell-based immune responses.,20305684_5,-1,-1,-1,-1,11836,-1,0.09374616,0.0032294733,0.9030244
11837,T-cell,9,10,52,58,"We observed severe loss of both effector and memory T-cell populations, downregulation of type 1 and upregulation of type 2 immune responses and decreased proliferation of effector T cells in the presence of tumors.",20305684_6,-1,1,2,-1,11837,-1,3.0690626e-05,4.315213e-05,0.9999262
11850,the type,29,31,143,151,"Curcumin, in turn, prevented this loss of T cells, expanded central memory T cell (T(CM))/effector memory T cell (T(EM)) populations, reversed the type 2 immune bias and attenuated the tumor-induced inhibition of T-cell proliferation in tumor-bearing hosts.",20305684_7,-1,-1,-1,-1,11850,-1,2.2246539e-05,0.999967,1.0730098e-05
11851,the tumor-induced,36,38,181,198,"Curcumin, in turn, prevented this loss of T cells, expanded central memory T cell (T(CM))/effector memory T cell (T(EM)) populations, reversed the type 2 immune bias and attenuated the tumor-induced inhibition of T-cell proliferation in tumor-bearing hosts.",20305684_7,-1,-1,-1,-1,11851,-1,2.1986538e-05,0.99996877,9.277185e-06
11854,that tumor,3,5,31,41,Further investigation revealed that tumor burden upregulated Treg cell populations and stimulated the production of the immunosuppressive cytokines transforming growth factor (TGF)-beta and IL-10 in these cells.,20305684_8,-1,-1,-1,-1,11854,-1,1.9215062e-05,0.99997175,9.08205e-06
11858,cytokines transforming growth factor,17,21,138,174,Further investigation revealed that tumor burden upregulated Treg cell populations and stimulated the production of the immunosuppressive cytokines transforming growth factor (TGF)-beta and IL-10 in these cells.,20305684_8,-1,-1,-1,-1,11858,-1,0.9996207,0.00014103096,0.00023820194
11860,these cells,25,27,199,210,Further investigation revealed that tumor burden upregulated Treg cell populations and stimulated the production of the immunosuppressive cytokines transforming growth factor (TGF)-beta and IL-10 in these cells.,20305684_8,-1,-1,-1,-1,11860,-1,0.0016766017,0.08629646,0.9120269
11864,TGF-beta,16,17,104,112,"Curcumin, however, inhibited the suppressive activity of Treg cells by downregulating the production of TGF-beta and IL-10 in these cells.",20305684_9,0,1,-1,-1,11864,-1,4.5841036e-05,0.99993205,2.2161019e-05
11866,these cells,20,22,126,137,"Curcumin, however, inhibited the suppressive activity of Treg cells by downregulating the production of TGF-beta and IL-10 in these cells.",20305684_9,-1,-1,-1,-1,11866,-1,0.00031043918,0.0042512715,0.9954383
11869,T cells to,10,13,70,80,"More importantly, curcumin treatment enhanced the ability of effector T cells to kill cancer cells.",20305684_10,-1,-1,-1,-1,11869,-1,0.0012355977,0.029062869,0.96970147
11871,that the,5,7,34,42,"Overall, our observations suggest that the unique properties of curcumin may be exploited for successful attenuation of tumor-induced suppression of cell-mediated immune responses.",20305684_11,-1,-1,-1,-1,11871,-1,1.9389501e-05,0.99997306,7.530622e-06
11873,cell-mediated immune responses,21,24,149,179,"Overall, our observations suggest that the unique properties of curcumin may be exploited for successful attenuation of tumor-induced suppression of cell-mediated immune responses.",20305684_11,-1,-1,-1,-1,11873,-1,0.29043257,0.004772091,0.70479536
11890,the cellular,22,24,123,135,"Herein, using prophylactic depletion of FoxP3(+) Tregs with either anti-CD4, anti-CD25, or anti-FR4 mAbs, we have compared the cellular and effector requirements for elimination of the renal carcinoma RENCA and prevention of methylcholanthrene-induced fibrosarcoma.",20332236_3,-1,-1,-1,-1,11890,-1,0.0046101953,0.6291968,0.366193
11892,these two,2,4,18,27,"Collectively from these two models, it was clear that CD8(+) T cells and natural killer cells played an important role downstream of Treg depletion.",20332236_4,-1,-1,-1,-1,11892,-1,2.8629967e-05,0.9999572,1.41403525e-05
11896,cells played,17,19,88,100,"Collectively from these two models, it was clear that CD8(+) T cells and natural killer cells played an important role downstream of Treg depletion.",20332236_4,-1,-1,-1,-1,11896,-1,0.0035501698,0.07376933,0.92268044
11900,T cells to,10,13,65,75,"However, whereas all three mAbs quantitatively depleted FoxP3(+) T cells to a similar extent, subtle differences in the downstream mechanisms of tumor control existed for all three approaches.",20332236_5,-1,-1,-1,-1,11900,-1,0.0019197286,0.041994985,0.95608526
11905,lymphocyte subset,6,8,34,51,"In general, neutralization of any lymphocyte subset or effector mechanism was insufficient to alter tumor suppression initiated by Treg depletion, and in some settings, the neutralization of multiple effector mechanisms failed to prevent tumor rejection.",20332236_6,-1,-1,-1,-1,11905,-1,4.0430557e-05,5.099095e-05,0.99990857
11913,that Tregs,3,5,21,31,These studies reveal that Tregs control multiple redundant elements of the immune effector response capable of inhibiting tumor initiation and underscore the importance of effectively targeting these cells in any cancer immunotherapy.,20332236_7,-1,-1,-1,-1,11913,-1,2.0423786e-05,0.99997103,8.599018e-06
11917,targeting these cells,25,28,184,205,These studies reveal that Tregs control multiple redundant elements of the immune effector response capable of inhibiting tumor initiation and underscore the importance of effectively targeting these cells in any cancer immunotherapy.,20332236_7,-1,-1,-1,-1,11917,-1,0.004232067,0.72749764,0.26827028
11918,protein,1,2,5,12,CagA protein is the most assessed effecter molecule of Helicobacter pylori.,20363211_0,0,1,-1,-1,11918,-1,0.00026664528,0.9979918,0.0017415197
11921,protein,8,9,40,47,"In this report, we demonstrate how CagA protein regulates the functions of dendritic cells (DC) against H. pylori infection.",20363211_1,0,1,-1,-1,11921,-1,2.2389278e-05,0.9999646,1.3066153e-05
11922,the functions,10,12,58,71,"In this report, we demonstrate how CagA protein regulates the functions of dendritic cells (DC) against H. pylori infection.",20363211_1,-1,-1,-1,-1,11922,-1,2.9152947e-05,0.9999565,1.4377656e-05
11925,protein,7,8,32,39,"In addition, we found that CagA protein was tyrosine-phosphorylated in DC.",20363211_2,0,1,-1,-1,11925,-1,3.2678097e-05,0.9999299,3.7405505e-05
11929,to those,12,14,74,82,The responses to cagA-positive H. pylori in DC were reduced in comparison to those induced by cagA-negative H. pylori.,20363211_3,-1,-1,-1,-1,11929,-1,2.1836095e-05,0.9999664,1.1722558e-05
11933,T cells toward Th1 type cells,18,24,123,152,CagA-overexpressing DC also exhibited a decline in the responses against LPS stimulation and the differentiation of CD4(+) T cells toward Th1 type cells compared to wild type DC.,20363211_4,-1,-1,-1,-1,11933,-1,0.00014790044,0.00026933916,0.9995828
11945,protein,5,6,29,36,These data suggest that CagA protein negatively regulates the functions of DC via CagA phosphorylation and that cagA-positive H. pylori strains suppress host immune responses resulting in their chronic colonization of the stomach.,20363211_6,0,1,-1,-1,11945,-1,3.7058082e-05,0.99991584,4.7097463e-05
11946,the functions,8,10,58,71,These data suggest that CagA protein negatively regulates the functions of DC via CagA phosphorylation and that cagA-positive H. pylori strains suppress host immune responses resulting in their chronic colonization of the stomach.,20363211_6,-1,-1,-1,-1,11946,-1,2.916196e-05,0.9999567,1.4053202e-05
11952,tumor antigens,3,5,31,45,"Tumor-derived exosomes express tumor antigens, leading to their promising utility as tumor vaccines, but they also can suppress T-cell signaling molecules and reduce cytotoxic effects.",20372811_0,-1,-1,-1,-1,11952,-1,0.28321472,0.70737416,0.0094110975
11953,to their,7,9,55,63,"Tumor-derived exosomes express tumor antigens, leading to their promising utility as tumor vaccines, but they also can suppress T-cell signaling molecules and reduce cytotoxic effects.",20372811_0,-1,-1,-1,-1,11953,-1,2.1172482e-05,0.9999701,8.761522e-06
11956,T-cell,20,21,128,134,"Tumor-derived exosomes express tumor antigens, leading to their promising utility as tumor vaccines, but they also can suppress T-cell signaling molecules and reduce cytotoxic effects.",20372811_0,-1,1,2,-1,11956,-1,6.00115e-05,6.9143265e-05,0.9998709
11963,T-cells,17,18,131,138,"EXO/IL-12 was identified by transmission electron microscopy and Western blotting, which induced proliferation and cytotoxicity of T-cells and were analyzed by CFSE-based flow cytometry.",20372811_3,-1,1,2,-1,11963,-1,4.0994448e-05,0.00011956836,0.9998394
11968,T lymphocytes than,22,25,138,156,"Our results showed that EXO/IL-12 was much more efficient in induction of the proliferation, release of IFN-gamma and cytotoxic effect of T lymphocytes than conventional exosomes in vitro.",20372811_5,-1,-1,-1,-1,11968,-1,0.0018184524,0.20173647,0.7964451
11971,T-cells,14,15,88,95,"Exosomes inhibited the expression of JAK3 and phosphorylation of STAT5 in high doses in T-cells, but not JAK2, while EXO/IL-12 had much less attenuated reduction of the expression of p-STAT5.",20372811_6,-1,1,2,-1,11971,-1,3.625621e-05,9.501551e-05,0.99986875
11985,immunity,3,4,23,31,"Antitumor activity and immunity feedback to GOLFIG were strictly correlated with the best outcome observed in patients with autoimmunity signs, increase of central memory T cells, and decrease of regulatory T cells (Treg) in the peripheral blood.",20386463_1,0,-1,2,-1,11985,-1,0.99212086,0.0054583745,0.0024207754
11992,blood,40,41,240,245,"Antitumor activity and immunity feedback to GOLFIG were strictly correlated with the best outcome observed in patients with autoimmunity signs, increase of central memory T cells, and decrease of regulatory T cells (Treg) in the peripheral blood.",20386463_1,0,1,-1,-1,11992,-1,0.00017339806,0.9988305,0.0009960922
11994,the Treg tumor,7,10,53,67,We thus investigated a potential correlation between the Treg tumor infiltration at diagnosis and the clinical outcome in a current randomized phase 3 trial aimed to compare the GOLFIG regimen with the standard FOLFOX chemotherapy (GOLFIG-2).,20386463_2,-1,-1,-1,-1,11994,-1,1.7864284e-05,0.99997103,1.1063103e-05
12007,Treg tumor,0,2,0,10,"Treg tumor infiltration scores were correlated with overall survival, treatment-relative survival, and progression-free survival (PFS).",20386463_4,-1,-1,-1,-1,12007,-1,2.575439e-05,0.99995565,1.861585e-05
12009,Treg tumor,1,3,7,17,"Higher Treg tumor infiltration scores were associated with a better prognosis in the whole series (Treg high score vs. low score: overall survival=mean 43.2 mo vs. 28.6 mo, P=0.0005) and a better outcome after treatment (Treg high score vs. low score: PFS=mean 15.8 mo vs. 8.8 mo, P=0.0009; treatment-relative survival=mean 23.1 mo vs. 18.2 mo, P=0.004).",20386463_5,-1,-1,-1,-1,12009,-1,2.6257347e-05,0.9999511,2.2666203e-05
12017,T-lymphocyte tumor,8,10,41,59,Our results suggest that a higher FoxP3+ T-lymphocyte tumor infiltration score is a favorable prognostic factor in colon cancer patients undergoing chemo or chemoimmunotherapy.,20386463_7,-1,-1,-1,-1,12017,-1,0.0014690523,0.06341712,0.93511385
12018,factor,16,17,105,111,Our results suggest that a higher FoxP3+ T-lymphocyte tumor infiltration score is a favorable prognostic factor in colon cancer patients undergoing chemo or chemoimmunotherapy.,20386463_7,0,1,-1,-1,12018,-1,0.0017759051,0.99787223,0.00035188667
12035,blood,40,41,252,257,"In this study, we analyzed the impact of administration of dendritic cell (DC) vaccination in combination with low-dose interleukin (IL)-2 in patients with metastatic renal cell carcinoma on the frequency of CD4+CD25highFoxp3+ Treg cells in peripheral blood.",20386464_1,0,1,-1,-1,12035,-1,0.00032236724,0.9839544,0.015723156
12036,that the treatment,2,5,9,27,We found that the treatment increased the frequency of Treg cells more than 7-fold compared with pretreatment levels (P<0.0001).,20386464_2,-1,-1,-1,-1,12036,-1,2.1829424e-05,0.99996793,1.0244426e-05
12044,functional,1,2,2,12,A functional assay showed that isolated Treg cells were capable of inhibiting proliferation of responder cells.,20386464_4,0,1,2,-1,12044,-1,8.442702e-05,0.99980956,0.00010600757
12061,that the,5,7,30,38,"Further, the results indicate that the IL-2-induced effect on Treg cells is reversible and declines shortly after termination of IL-2 treatment.",20386464_7,-1,-1,-1,-1,12061,-1,1.8304143e-05,0.9999726,9.13319e-06
12069,therapy to,22,24,152,162,Our data suggest that approaches combining DC-mediated immunotherapy and depletion of Treg cells may be necessary to enhance the ability of vaccination therapy to elicit effective antitumor responses in cancer patients.,20386464_8,-1,-1,-1,-1,12069,-1,2.3081886e-05,0.99996734,9.555427e-06
12081,cell function,28,30,198,211,"Because of their role in mitosis chemotherapeutic agents targeting microtubules are widely used, and this study determined the outcome of disturbing tubulin cytoskeleton dynamics on human dendritic cell function.",20386470_1,-1,-1,-1,-1,12081,-1,0.00012117146,0.00024210488,0.99963665
12084,the generation,10,12,43,57,Dendritic cells (DCs) play a major role in the generation of the adaptive immune response owing to their capacity for antigen presentation leading to T lymphocyte activation and differentiation and there is compelling evidence for their contribution to the antitumoral immune response.,20386470_2,-1,-1,-1,-1,12084,-1,1.8590385e-05,0.99997056,1.0800813e-05
12087,to their,18,20,96,104,Dendritic cells (DCs) play a major role in the generation of the adaptive immune response owing to their capacity for antigen presentation leading to T lymphocyte activation and differentiation and there is compelling evidence for their contribution to the antitumoral immune response.,20386470_2,-1,-1,-1,-1,12087,-1,2.3637407e-05,0.99996495,1.1371394e-05
12089,to T lymphocyte activation,25,29,147,173,Dendritic cells (DCs) play a major role in the generation of the adaptive immune response owing to their capacity for antigen presentation leading to T lymphocyte activation and differentiation and there is compelling evidence for their contribution to the antitumoral immune response.,20386470_2,-1,-1,-1,-1,12089,-1,0.0028160897,0.14089106,0.85629284
12092,to the,39,41,250,256,Dendritic cells (DCs) play a major role in the generation of the adaptive immune response owing to their capacity for antigen presentation leading to T lymphocyte activation and differentiation and there is compelling evidence for their contribution to the antitumoral immune response.,20386470_2,-1,-1,-1,-1,12092,-1,2.472968e-05,0.999964,1.1247791e-05
12095,that target the tubulin,2,6,11,34,"Two agents that target the tubulin cytoskeleton were used, taxol and colchicine, and a brief pretreatment with either increased antigen presentation by DCs independently of significant phenotypic change, cell death, or cytokine production.",20386470_3,-1,-1,-1,-1,12095,-1,3.415712e-05,0.99994636,1.9478093e-05
12104,the cytokine,4,6,32,44,We therefore determined whether the cytokine secretion profile in response to lipopolysaccharide (LPS) was modified.,20386470_5,-1,-1,-1,-1,12104,-1,0.18928474,0.8066609,0.0040543317
12110,TNFalpha,9,10,48,56,"LPS stimulation of DCs induced IL-10, IL-12p70, TNFalpha and IL-1beta secretion, and taxol pretreatment modified this response by down-regulating IL-1beta secretion whereas colchicine induced a proinflammatory cytokine profile with reduced IL-10 and increased IL-12p70 and TNFalpha secretion.",20386470_6,0,1,-1,-1,12110,-1,8.309957e-05,0.99988127,3.5583995e-05
12118,TNFalpha,38,39,273,281,"LPS stimulation of DCs induced IL-10, IL-12p70, TNFalpha and IL-1beta secretion, and taxol pretreatment modified this response by down-regulating IL-1beta secretion whereas colchicine induced a proinflammatory cytokine profile with reduced IL-10 and increased IL-12p70 and TNFalpha secretion.",20386470_6,0,1,-1,-1,12118,-1,9.934077e-05,0.99985754,4.3092998e-05
12119,Taken together,0,2,0,14,"Taken together, these data reveal new immunomodulatory strategies of microtubule disrupting agents in dendritic cells, that of modifying the cytokine response to LPS and that of increasing T lymphocyte activation without induction of inflammatory cytokine secretion by dendritic cells.",20386470_7,-1,-1,-1,-1,12119,-1,4.4463828e-05,0.9999374,1.81127e-05
12123,the cytokine,20,22,137,149,"Taken together, these data reveal new immunomodulatory strategies of microtubule disrupting agents in dendritic cells, that of modifying the cytokine response to LPS and that of increasing T lymphocyte activation without induction of inflammatory cytokine secretion by dendritic cells.",20386470_7,-1,-1,-1,-1,12123,-1,0.293834,0.70238405,0.0037819096
12124,to LPS,23,25,159,165,"Taken together, these data reveal new immunomodulatory strategies of microtubule disrupting agents in dendritic cells, that of modifying the cytokine response to LPS and that of increasing T lymphocyte activation without induction of inflammatory cytokine secretion by dendritic cells.",20386470_7,-1,-1,-1,-1,12124,-1,3.2301592e-05,0.9999523,1.5422262e-05
12130,immunity factors,8,10,44,60,AIM: We analysed local cellular and humoral immunity factors in the anal mucosa in an attempt to explain how HIV infection increases the risk of anal cancer in HPV-infected patients.,20394639_0,-1,-1,-1,-1,12130,-1,0.94491726,0.05224721,0.0028355927
12140,Tissue,0,1,0,6,"Tissue CD1a(+), CD3(+), CD4(+), CD8(+) cells and mRNAs of selected cytokines and chemokines were quantified and compared in patients with or without AIN3 or cancer using morphometric or immunohistochemistry analysis and qRT-PCR.RESULTS: Sixty-six individuals (22 patients and 44 controls) were included.",20394639_3,-1,1,2,-1,12140,-1,2.354284e-05,0.9999541,2.233939e-05
12144,analysis,36,37,207,215,"Tissue CD1a(+), CD3(+), CD4(+), CD8(+) cells and mRNAs of selected cytokines and chemokines were quantified and compared in patients with or without AIN3 or cancer using morphometric or immunohistochemistry analysis and qRT-PCR.RESULTS: Sixty-six individuals (22 patients and 44 controls) were included.",20394639_3,0,1,-1,-1,12144,-1,2.9087112e-05,0.99994445,2.6451678e-05
12150,tissues,12,13,76,83,IL-8 and IL23 levels were significantly higher in cancer than in non-cancer tissues regardless of HIV status (P = 0.02).,20394639_6,-1,1,2,-1,12150,-1,5.2543e-05,0.99971133,0.00023611734
12158,to the,38,40,234,240,FoxP3 expression was significantly higher in HIV-infected cases than in controls with AIN3/cancer (P < 0.04).CONCLUSION: Depletion of CD1a(+) and CD3(+) cells and overexpression of FoxP3 in the anal mucosa appear likely to contribute to the risk of HPV-related anal cancer in HIV-infected patients.,20394639_7,-1,-1,-1,-1,12158,-1,2.082386e-05,0.99996877,1.0453912e-05
12164,Therapeutic subunit,0,2,0,19,Therapeutic subunit vaccines based on tumor-associated antigens (TAA) represent an attractive approach for the treatment of cancer.,20406989_0,-1,-1,-1,-1,12164,-1,3.2266613e-05,0.99995315,1.4551526e-05
12165,tumor-associated antigens,5,7,38,63,Therapeutic subunit vaccines based on tumor-associated antigens (TAA) represent an attractive approach for the treatment of cancer.,20406989_0,-1,-1,-1,-1,12165,-1,0.02987227,0.9648775,0.005250214
12167,the treatment,15,17,107,120,Therapeutic subunit vaccines based on tumor-associated antigens (TAA) represent an attractive approach for the treatment of cancer.,20406989_0,-1,-1,-1,-1,12167,-1,2.4572702e-05,0.99996567,9.7130805e-06
12170,the tumor necrosis factor,3,7,21,46,"We recently proposed the tumor necrosis factor family costimulatory ligands as potential adjuvants for therapeutic vaccines and, hence, generated a soluble form of 4-1BBL chimeric with streptavidin (SA-4-1BBL) that has pleiotropic effects on cells of innate, adaptive, and regulatory immunity.",20406989_2,-1,-1,-1,-1,12170,-1,0.15508708,0.8425838,0.0023291598
12176,immunity,49,50,284,292,"We recently proposed the tumor necrosis factor family costimulatory ligands as potential adjuvants for therapeutic vaccines and, hence, generated a soluble form of 4-1BBL chimeric with streptavidin (SA-4-1BBL) that has pleiotropic effects on cells of innate, adaptive, and regulatory immunity.",20406989_2,0,-1,2,-1,12176,-1,0.9985362,0.0006492231,0.0008145871
12185,receptor,39,40,216,224,We herein tested whether these effects can translate into effective cancer immunotherapy when SA-4-1BBL was also used as a vehicle to deliver TAAs in vivo to dendritic cells (DCs) constitutively expressing the 4-1BB receptor.,20406989_3,0,1,2,-1,12185,-1,0.00069095456,0.0073742624,0.9919348
12186,receptor,8,9,39,47,"SA-4-1BBL was internalized by DCs upon receptor binding and immunization with biotinylated antigens conjugated to SA-4-1BBL resulted in increased antigen uptake and cross-presentation by DCs, leading to the generation of effective T-cell immune responses.",20406989_4,0,1,2,-1,12186,-1,0.00062473014,0.0022885418,0.9970867
12190,to the generation,31,34,200,217,"SA-4-1BBL was internalized by DCs upon receptor binding and immunization with biotinylated antigens conjugated to SA-4-1BBL resulted in increased antigen uptake and cross-presentation by DCs, leading to the generation of effective T-cell immune responses.",20406989_4,-1,-1,-1,-1,12190,-1,2.1182559e-05,0.99996805,1.07801125e-05
12191,T-cell immune responses,36,39,231,254,"SA-4-1BBL was internalized by DCs upon receptor binding and immunization with biotinylated antigens conjugated to SA-4-1BBL resulted in increased antigen uptake and cross-presentation by DCs, leading to the generation of effective T-cell immune responses.",20406989_4,-1,-1,-1,-1,12191,-1,0.10524837,0.0027899598,0.8919617
12198,T-cell,15,16,87,93,Therapeutic efficacy of the vaccines was associated with increased CD4(+) T and CD8(+) T-cell effector and memory responses and higher intratumoral CD8(+) T effector/CD4(+)CD25(+)Foxp3(+) T regulatory cell ratio.,20406989_6,-1,1,2,-1,12198,-1,3.4477984e-05,4.4888715e-05,0.9999206
12204,functions,5,6,32,41,"Thus, potent pleiotropic immune functions of SA-4-1BBL combined with its ability to serve as a vehicle to increase the delivery of antigens to DCs in vivo endow this molecule with the potential to serve as an effective immunomodulatory component of therapeutic vaccines against cancer and chronic infections.",20406989_7,0,1,2,-1,12204,-1,0.00020857019,0.9996358,0.00015554942
12208,antigens to,24,26,131,142,"Thus, potent pleiotropic immune functions of SA-4-1BBL combined with its ability to serve as a vehicle to increase the delivery of antigens to DCs in vivo endow this molecule with the potential to serve as an effective immunomodulatory component of therapeutic vaccines against cancer and chronic infections.",20406989_7,-1,-1,-1,-1,12208,-1,0.8489907,0.1388059,0.012203438
12226,tissues,14,15,80,87,Foxp3(+) regulatory T cells (Tregs) suppress immune responses in the peripheral tissues and play a role in the immunosuppression of cancer tissues.,20422211_2,-1,1,2,-1,12226,-1,0.0002487606,0.9917802,0.007971055
12229,tissues,24,25,139,146,Foxp3(+) regulatory T cells (Tregs) suppress immune responses in the peripheral tissues and play a role in the immunosuppression of cancer tissues.,20422211_2,-1,1,2,-1,12229,-1,0.0005819046,0.97139156,0.02802652
12250,T-helper type,5,7,32,45,This suggests the occurrence of T-helper type 1 (Th1)-shifted immune responses in Ly-rich GCs.,20422211_6,-1,-1,-1,-1,12250,-1,3.1570904e-05,0.9999218,4.6571644e-05
12261,the tissue,11,13,56,66,"Since Tregs are known to express CCR4, we also examined the tissue distribution of cells expressing its ligand CCL22.",20422211_9,-1,-1,-1,-1,12261,-1,2.114776e-05,0.99996805,1.0815258e-05
12282,the tumor,38,40,216,225,"Like the normal components of this lymphoid structure, FL cells interact with various immune cells, such as the follicular helper T cells, suppressor regulatory T cells, dendritic cells, and histiocytes, that define the tumor microenvironment.",20425464_1,-1,-1,-1,-1,12282,-1,2.4409628e-05,0.99996376,1.180162e-05
12284,that the nature,5,8,35,50,Gene expression studies have shown that the nature of the tumor microenvironment predicts survival in patients with FL and may influence the response to immunotherapy and risk of transformation.,20425464_2,-1,-1,-1,-1,12284,-1,2.7365322e-05,0.9999554,1.7193512e-05
12285,the tumor,9,11,54,63,Gene expression studies have shown that the nature of the tumor microenvironment predicts survival in patients with FL and may influence the response to immunotherapy and risk of transformation.,20425464_2,-1,-1,-1,-1,12285,-1,2.0408495e-05,0.99996877,1.0837836e-05
12290,tumor cell,8,10,50,60,"The immune system may either promote or constrain tumor cell development, depending on the relative distribution and activation status of various cell subpopulations.",20425464_3,-1,-1,-1,-1,12290,-1,0.0026534325,0.16458543,0.83276117
12291,the relative,14,16,87,99,"The immune system may either promote or constrain tumor cell development, depending on the relative distribution and activation status of various cell subpopulations.",20425464_3,-1,-1,-1,-1,12291,-1,3.3409255e-05,0.99994683,1.9775856e-05
12297,that the,12,14,80,88,The prognostic value of germline genetic variants of some immune genes suggests that the host genetic background may also influence the biology of FL.,20425464_4,-1,-1,-1,-1,12297,-1,2.7386348e-05,0.99996424,8.317341e-06
12302,tools that,13,15,83,93,Some efforts have been carried out to validate those findings and provide clinical tools that may be used at the time of diagnosis.,20425464_5,-1,-1,-1,-1,12302,-1,3.6237776e-05,0.9999486,1.51017875e-05
12303,the time,19,21,109,117,Some efforts have been carried out to validate those findings and provide clinical tools that may be used at the time of diagnosis.,20425464_5,-1,-1,-1,-1,12303,-1,2.2427435e-05,0.9999651,1.2558403e-05
12313,to Th1,15,17,91,97,RNA expression profile of SCC patients was analyzed for 8 different sets of genes relating to Th1 versus Th2 response using Gene Set Enrichment Analysis.,20463594_3,-1,-1,-1,-1,12313,-1,2.9718853e-05,0.99994755,2.2735983e-05
12316,Analysis,24,25,144,152,RNA expression profile of SCC patients was analyzed for 8 different sets of genes relating to Th1 versus Th2 response using Gene Set Enrichment Analysis.,20463594_3,0,1,-1,-1,12316,-1,4.406019e-05,0.9999151,4.085376e-05
12321,TGF-beta,30,31,155,163,"SCC from immunocompetent patients and OTRs were analyzed by real-time polymerase chain reactions for CD4, CD8, TBET, GATA-3, FOXP3, RORC, IFN-gamma, IL-4, TGF-beta, IL-10, and IL-17A mRNA expression.",20463594_4,0,1,-1,-1,12321,-1,8.200171e-05,0.99988747,3.052292e-05
12326,Th2 gene,13,15,77,85,SCC in immunocompetent patients and OTRs was associated with a mixed Th1 and Th2 gene expression signature.,20463594_7,-1,-1,-1,-1,12326,-1,3.07626e-05,0.9999378,3.148893e-05
12335,TGF-beta,8,9,48,56,"Regulatory T cells, characterized by FOX-P3 and TGF-beta mRNA level, were decreased in OTRs.",20463594_12,0,1,-1,-1,12335,-1,0.00010263735,0.99987066,2.663987e-05
12339,that the,18,20,117,125,Our findings support the hypothesis that nontumor-bearing skin adjacent to SCC in OTRs is not necessarily normal and that the local microenvironment may contribute to a field effect contributing to higher recurrence rates and more aggressive behavior observed in these patients.,20463594_13,-1,-1,-1,-1,12339,-1,2.056511e-05,0.9999697,9.722843e-06
12343,mediators that,15,17,100,114,INTRODUCTION: Cysts and granulomas are chronic periapical lesions mediated by a set of inflammatory mediators that develop to contain a periapical infection.,20478453_0,-1,-1,-1,-1,12343,-1,0.9112761,0.08195312,0.0067708464
12346,the nature,3,5,20,30,"This study analyzed the nature of the inflammatory infiltrate, presence of mast cells, and in situ expression of cytokines (interleukin [IL]-17 and transforming growth factor [TGF]-beta), chemokines (macrophage inflammatory protein [MIP]-1beta and monocyte chemotactic protein [MCP]-1), and nuclear transcription factor (FoxP3) in human periapical granulomas and cysts compared with a control group.",20478453_1,-1,-1,-1,-1,12346,-1,1.9521794e-05,0.9999665,1.39214935e-05
12351,transforming growth factor,25,28,148,174,"This study analyzed the nature of the inflammatory infiltrate, presence of mast cells, and in situ expression of cytokines (interleukin [IL]-17 and transforming growth factor [TGF]-beta), chemokines (macrophage inflammatory protein [MIP]-1beta and monocyte chemotactic protein [MCP]-1), and nuclear transcription factor (FoxP3) in human periapical granulomas and cysts compared with a control group.",20478453_1,-1,-1,-1,-1,12351,-1,0.938071,0.05866103,0.0032678642
12354,chemotactic protein,39,41,257,276,"This study analyzed the nature of the inflammatory infiltrate, presence of mast cells, and in situ expression of cytokines (interleukin [IL]-17 and transforming growth factor [TGF]-beta), chemokines (macrophage inflammatory protein [MIP]-1beta and monocyte chemotactic protein [MCP]-1), and nuclear transcription factor (FoxP3) in human periapical granulomas and cysts compared with a control group.",20478453_1,-1,-1,-1,-1,12354,-1,0.99947006,8.552002e-05,0.00044438156
12357,The type,0,2,0,8,"The type of inflammatory infiltrate was evaluated by hematoxylin-eosin staining, and the presence of mast cells was analyzed by toluidine blue staining.",20478453_3,-1,-1,-1,-1,12357,-1,2.4810912e-05,0.99995995,1.5274834e-05
12374,TGF-beta,14,15,67,75,A significant difference in the expression of IL-17 (P = .001) and TGF-beta (P = .003) was observed between cysts and granulomas and the control group.,20478453_8,0,1,-1,-1,12374,-1,3.5962592e-05,0.99994946,1.4616453e-05
12391,to the,1,3,9,15,"Contrary to the common notion that MDSC are a heterogeneous population of exclusively immature cells, we find the coexpression of markers associated with mature phenotype.",20484028_3,-1,-1,-1,-1,12391,-1,2.2202128e-05,0.99996865,9.148628e-06
12396,time the,5,7,22,30,"We show for the first time the overexpression of CD80, CD83, and DC-Sign in human MDSC.",20484028_4,-1,-1,-1,-1,12396,-1,2.2204908e-05,0.9999659,1.1870216e-05
12400,function,23,24,136,144,"Further, increased levels of signal transducer and activator of transcription 3 (Stat3), an important regulator in MDSC development and function, were noted in MM-MDSC.",20484028_5,0,1,2,-1,12400,-1,9.9392244e-05,0.9998368,6.3748164e-05
12413,T-cell,19,20,139,145,Several observations suggest a redox imbalance in MDSC and indicate an important role of Stat3-dependent oxidative stress in MDSC-mediated T-cell suppression.,20484028_9,-1,1,2,-1,12413,-1,3.338927e-05,4.8800975e-05,0.99991786
12419,that statins,6,8,44,56,"In particular, compelling evidence suggests that statins have a wide range of immunomodulatory properties.",20491794_1,-1,-1,-1,-1,12419,-1,2.727535e-05,0.9999627,1.0014662e-05
12428,transforming growth factor,15,18,109,135,"Tumour immune tolerance involves the production of immunosuppressive molecules, such as interleukin (IL)-10, transforming growth factor (TGF)-beta and indoleamine-2,3-dioxygenase (IDO) by tumours, which induce a regulatory T cell (T(reg)) response.",20491794_3,-1,-1,-1,-1,12428,-1,0.9682539,0.028677186,0.003068916
12436,TGF-beta,16,17,85,93,"In this study, we investigated the effect of simvastatin on the production of IL-10, TGF-beta and IDO production and the proliferation of T(regs) using several cancer cell lines, and Lewis lung cancer (3LL) cells-inoculated mouse tumour model.",20491794_4,0,1,-1,-1,12436,-1,5.2453168e-05,0.99992657,2.0921252e-05
12448,TGF-beta,9,10,55,63,"The production of the immune regulatory markers IL-10, TGF-beta in 3LL and NCI-H292 cells increased after treatment with simvastatin.",20491794_6,0,1,-1,-1,12448,-1,6.0351464e-05,0.9999218,1.7823228e-05
12462,to these,3,5,10,18,"Thus, due to these opposing actions, simvastatin had no net effect on tumour growth.",20491794_10,-1,-1,-1,-1,12462,-1,3.1799776e-05,0.99995625,1.196902e-05
12474,the FoxP3(+,9,11,42,53,"In adult T cell leukemia/lymphoma (ATLL), the FoxP3(+) population was distinct from the leukemic T cell clones.",20525891_2,-1,-1,-1,-1,12474,-1,0.00032063993,0.99933547,0.00034390215
12482,that the plasma,6,9,25,40,"In this study, we report that the plasma concentration of the chemokine CCL22 is abnormally high in HTLV-1-infected subjects and that the concentration is strongly correlated with the frequency of FoxP3(+) cells, which express the CCL22 receptor CCR4.",20525891_4,-1,-1,-1,-1,12482,-1,1.8870734e-05,0.99997044,1.0668821e-05
12483,the chemokine CCL22,11,14,58,77,"In this study, we report that the plasma concentration of the chemokine CCL22 is abnormally high in HTLV-1-infected subjects and that the concentration is strongly correlated with the frequency of FoxP3(+) cells, which express the CCL22 receptor CCR4.",20525891_4,-1,-1,-1,-1,12483,-1,0.78792983,0.20206703,0.010003222
12484,that the,21,23,129,137,"In this study, we report that the plasma concentration of the chemokine CCL22 is abnormally high in HTLV-1-infected subjects and that the concentration is strongly correlated with the frequency of FoxP3(+) cells, which express the CCL22 receptor CCR4.",20525891_4,-1,-1,-1,-1,12484,-1,1.8368626e-05,0.9999721,9.479121e-06
12488,the CCL22 receptor,37,40,227,245,"In this study, we report that the plasma concentration of the chemokine CCL22 is abnormally high in HTLV-1-infected subjects and that the concentration is strongly correlated with the frequency of FoxP3(+) cells, which express the CCL22 receptor CCR4.",20525891_4,-1,-1,-1,-1,12488,-1,0.0122630475,0.83952504,0.14821194
12489,that CCL22,4,6,17,27,"Further, we show that CCL22 is produced by cells that express the HTLV-1 transactivator protein Tax, and that the increased CCL22 enhances the migration and survival of FoxP3(+) cells in vitro.",20525891_5,-1,-1,-1,-1,12489,-1,0.5372943,0.44807962,0.014626069
12490,cells that,9,11,43,53,"Further, we show that CCL22 is produced by cells that express the HTLV-1 transactivator protein Tax, and that the increased CCL22 enhances the migration and survival of FoxP3(+) cells in vitro.",20525891_5,-1,-1,-1,-1,12490,-1,0.0028606183,0.083356865,0.9137825
12492,transactivator protein Tax,14,17,73,99,"Further, we show that CCL22 is produced by cells that express the HTLV-1 transactivator protein Tax, and that the increased CCL22 enhances the migration and survival of FoxP3(+) cells in vitro.",20525891_5,-1,-1,-1,-1,12492,-1,2.4775441e-05,0.9999598,1.5353377e-05
12493,that the,19,21,105,113,"Further, we show that CCL22 is produced by cells that express the HTLV-1 transactivator protein Tax, and that the increased CCL22 enhances the migration and survival of FoxP3(+) cells in vitro.",20525891_5,-1,-1,-1,-1,12493,-1,2.0955591e-05,0.9999672,1.1856249e-05
12498,that FoxP3(+,4,6,17,29,"Finally, we show that FoxP3(+) cells inhibit the proliferation of ex vivo, autologous leukemic clones from patients with ATLL.",20525891_6,-1,-1,-1,-1,12498,-1,0.00018072026,0.99964786,0.00017143344
12506,these FoxP3(+,18,20,112,125,"We conclude that HTLV-1-induced CCL22 causes the high frequency of FoxP3(+) cells observed in HTLV-1 infection; these FoxP3(+) cells may both retard the progression of ATLL and HTLV-1-associated inflammatory diseases and contribute to the immune suppression seen in HTLV-1 infection, especially in ATLL.",20525891_7,-1,-1,-1,-1,12506,-1,0.00017131728,0.9996902,0.00013857485
12509,to the,35,37,232,238,"We conclude that HTLV-1-induced CCL22 causes the high frequency of FoxP3(+) cells observed in HTLV-1 infection; these FoxP3(+) cells may both retard the progression of ATLL and HTLV-1-associated inflammatory diseases and contribute to the immune suppression seen in HTLV-1 infection, especially in ATLL.",20525891_7,-1,-1,-1,-1,12509,-1,2.2447515e-05,0.99996734,1.0185841e-05
12511,T cells played,5,8,43,57,We previously demonstrated that gammadelta T cells played an important role in tumor immune surveillance by providing an early source of IFN-gamma.,20525896_0,-1,-1,-1,-1,12511,-1,0.0015984139,0.045550108,0.9528515
12525,tumor immunity,23,25,145,159,Vgamma1 and Vgamma4 gammadelta T cells are the principal subsets of peripheral lymphoid gammadelta T cells and they might play distinct roles in tumor immunity.,20525896_2,-1,-1,-1,-1,12525,-1,0.032704554,0.96657616,0.00071927067
12530,that these,3,5,14,24,We also found that these effects were exerted by the activated (CD44(high)) portion of Vgamma4 gammadelta T cells.,20525896_4,-1,-1,-1,-1,12530,-1,1.8190505e-05,0.9999733,8.456635e-06
12533,that IFN-gamma,3,5,22,36,We further determined that IFN-gamma and perforin are critical elements in the Vgamma4-mediated antitumor immune response.,20525896_5,-1,-1,-1,-1,12533,-1,0.88288283,0.11216107,0.0049561453
12540,to the,33,35,213,219,"Indeed, CD44(high) Vgamma4 gammadelta T cells produced significantly more IFN-gamma and perforin on activation, and showed greater cytolytic activity than did CD44(high) Vgamma1 gammadelta T cells, apparently due to the high level of eomesodermin (Eomes) in these activated Vgamma4 gammadelta T cells.",20525896_6,-1,-1,-1,-1,12540,-1,2.4421082e-05,0.99996567,9.941837e-06
12548,function,27,28,181,189,"Consistently, transfection of dominant-negative Eomes in Vgamma4 gammadelta T cells diminished the level of IFN-gamma secretion, indicating a critical role of Eomes in the effector function of these gammadelta T cells.",20525896_7,0,1,2,-1,12548,-1,0.00045936368,0.996933,0.0026076448
12552,functions,5,6,33,42,"Our results thus reveal distinct functions of Vgamma4 and Vgamma1 gammadelta T cells in antitumor immune response, and identify a protective role of activated Vgamma4 gammadelta T cells, with possible implications for tumor immune therapy.",20525896_8,0,1,2,-1,12552,-1,7.379772e-05,0.9998801,4.6163022e-05
12557,therapy,36,37,231,238,"Our results thus reveal distinct functions of Vgamma4 and Vgamma1 gammadelta T cells in antitumor immune response, and identify a protective role of activated Vgamma4 gammadelta T cells, with possible implications for tumor immune therapy.",20525896_8,0,1,-1,-1,12557,-1,2.9312496e-05,0.99995756,1.30962635e-05
12558,proteins,1,2,11,19,"Heat-shock proteins have biochemical and immunological roles in chaperoning/signaling and activation of innate and adaptive immune responses, respectively.",20544406_0,0,1,-1,-1,12558,-1,7.683864e-05,0.9997603,0.00016280833
12561,the immune response,3,6,16,35,"Their effect on the immune response is due to a phenomenon known as cross-priming of antigen, in which exogenous antigens are presented via MHC class I by antigen presenting cells.",20544406_1,-1,-1,-1,-1,12561,-1,0.041519757,0.95804155,0.0004386478
12571,the immune response,2,5,12,31,"Analyses of the immune response, 2weeks after the last immunization revealed decreased CD4+ CD25+ Foxp3+ naturally occurring regulatory T cells (Tregs) at the tumor site and increased IFN-/IL-4 level.",20544406_4,-1,-1,-1,-1,12571,-1,0.15872958,0.8399332,0.0013372144
12577,the tumor,30,32,156,165,"Analyses of the immune response, 2weeks after the last immunization revealed decreased CD4+ CD25+ Foxp3+ naturally occurring regulatory T cells (Tregs) at the tumor site and increased IFN-/IL-4 level.",20544406_4,-1,-1,-1,-1,12577,-1,1.979406e-05,0.9999695,1.0756416e-05
12582,that tumor-associated,4,6,24,45,Many studies have shown that tumor-associated macrophages (TAMs) contribute to tumor development and poor prognosis in various cancers.,20545696_0,-1,-1,-1,-1,12582,-1,2.7503153e-05,0.9999573,1.5178026e-05
12584,to tumor,11,13,76,84,Many studies have shown that tumor-associated macrophages (TAMs) contribute to tumor development and poor prognosis in various cancers.,20545696_0,-1,-1,-1,-1,12584,-1,2.3656212e-05,0.99996495,1.1344293e-05
12589,tissue,15,16,81,87,CD68 (+) and CD163 (+) macrophage infiltration was analyzed in paraffin-embedded tissue samples from 39 patients.,20545696_2,-1,1,2,-1,12589,-1,6.1789135e-05,0.99957377,0.0003644087
12601,tumor cell,21,23,88,98,"In an in vitro study using ICC cell lines (HuCCT1, RBE, and MEC) and human macrophages, tumor cell supernatant (TCS) from cell lines induced an activation of signal transducers and activators of transcription-3 (Stat3) and macrophage polarization toward the M2 phenotype.",20545696_9,-1,-1,-1,-1,12601,-1,0.0026659889,0.1258584,0.8714756
12608,toward the,46,48,247,257,"In an in vitro study using ICC cell lines (HuCCT1, RBE, and MEC) and human macrophages, tumor cell supernatant (TCS) from cell lines induced an activation of signal transducers and activators of transcription-3 (Stat3) and macrophage polarization toward the M2 phenotype.",20545696_9,-1,-1,-1,-1,12608,-1,2.6487276e-05,0.99995506,1.8457042e-05
12609,Tumor cell,0,2,0,10,"Tumor cell supernatant (TCS) from HuCCT1 most strongly induced Stat3 activation and production of cytokines and other bioactive molecules such as interleukin (IL)-10, vascular endothelial growth factor (VEGF)-A, transforming growth factor (TGF)-beta, and matrix metalloproteinase (MMP)-2.",20545696_10,-1,-1,-1,-1,12609,-1,0.003140358,0.26558882,0.73127085
12615,transforming growth factor,32,35,212,238,"Tumor cell supernatant (TCS) from HuCCT1 most strongly induced Stat3 activation and production of cytokines and other bioactive molecules such as interleukin (IL)-10, vascular endothelial growth factor (VEGF)-A, transforming growth factor (TGF)-beta, and matrix metalloproteinase (MMP)-2.",20545696_10,-1,-1,-1,-1,12615,-1,0.974999,0.022754973,0.0022460353
12620,that TAMs,18,20,137,146,"Down-regulation of Stat3 by siRNA significantly suppressed the production of IL-10 and VEGF-A. These results provide suggestive evidence that TAMs contribute to cancer progression via Stat3 activation, and CD163 is useful for evaluating M2 TAMs and predicting the clinical prognosis of ICC patients.",20545696_11,-1,-1,-1,-1,12620,-1,2.11127e-05,0.9999682,1.0677255e-05
12627,peptides,34,35,225,233,One half of a group of 20 patients with human papillomavirus type 16 (HPV16)-induced vulvar intraepithelial neoplasia grade 3 displayed a complete regression (CR) after therapeutic vaccination with HPV16 E6/E7 synthetic long peptides.,20547850_0,0,-1,2,-1,12627,-1,0.0013826068,0.99556524,0.0030521157
12633,immunity,22,23,144,152,"To investigate immune correlates of treatment failure, patients were grouped according to median lesion size at study entry, and HPV16-specific immunity was analyzed at different time points by complementary immunological assays.",20547850_2,0,-1,2,-1,12633,-1,0.99924076,0.00039529326,0.00036401104
12639,in cytokine,10,12,69,80,"Characteristically, this response was accompanied by a distinct peak in cytokine levels after the first vaccination.",20547850_4,-1,-1,-1,-1,12639,-1,0.39746663,0.59620905,0.006324341
12644,immunity to,5,7,25,36,"No disparity in T memory immunity to control antigens was found, indicating that the differences in HPV-specific immunity did not reflect general immune failure.",20547850_6,-1,-1,-1,-1,12644,-1,0.09417042,0.90292066,0.0029088806
12646,that the,13,15,76,84,"No disparity in T memory immunity to control antigens was found, indicating that the differences in HPV-specific immunity did not reflect general immune failure.",20547850_6,-1,-1,-1,-1,12646,-1,2.0280222e-05,0.9999713,8.41981e-06
12647,immunity,18,19,113,121,"No disparity in T memory immunity to control antigens was found, indicating that the differences in HPV-specific immunity did not reflect general immune failure.",20547850_6,0,-1,2,-1,12647,-1,0.99846625,0.0009553639,0.00057849893
12652,T cells to,9,12,66,76,"Notably, a high ratio of HPV16-specific vaccine-prompted effector T cells to HPV16-specific CD4(+)CD25(+)Foxp3(+) T cells was predictive of clinical success.",20547850_8,-1,-1,-1,-1,12652,-1,0.0009710849,0.015114445,0.9839145
12656,immunity,10,11,63,71,Foxp3(+) T cells have been associated previously with impaired immunity in malignancies.,20547850_9,0,-1,2,-1,12656,-1,0.9990189,0.0006144288,0.00036671307
12657,that the,3,5,20,28,Here we demonstrate that the vaccine-prompted level of this population is associated with early treatment failure.,20547850_10,-1,-1,-1,-1,12657,-1,1.779924e-05,0.999974,8.197686e-06
12660,Th17 cells,1,3,9,19,"Although Th17 cells reportedly play critical roles in the development of autoimmunity and allergic reactions, information on Th17 cells in cancer-bearing hosts is still limited.",20550524_0,-1,-1,-1,-1,12660,-1,0.00013941179,0.00070908276,0.9991516
12663,Th17 cells,18,20,125,135,"Although Th17 cells reportedly play critical roles in the development of autoimmunity and allergic reactions, information on Th17 cells in cancer-bearing hosts is still limited.",20550524_0,-1,-1,-1,-1,12663,-1,0.00016768825,0.0010797489,0.9987526
12666,Th17 cells,10,12,58,68,"In the present study, we investigated the distribution of Th17 cells in relation to regulatory T cells (Treg) in the tumor-infiltrating lymphocytes (TILs), regional lymph node lymphocytes, and peripheral blood lymphocytes of gastric cancer patients.",20550524_1,-1,-1,-1,-1,12666,-1,0.00024984754,0.0021448068,0.9976053
12667,relation to regulatory T cells,13,18,72,102,"In the present study, we investigated the distribution of Th17 cells in relation to regulatory T cells (Treg) in the tumor-infiltrating lymphocytes (TILs), regional lymph node lymphocytes, and peripheral blood lymphocytes of gastric cancer patients.",20550524_1,-1,-1,-1,-1,12667,-1,0.0038117184,0.26348004,0.7327082
12669,the tumor-infiltrating lymphocytes,22,25,113,147,"In the present study, we investigated the distribution of Th17 cells in relation to regulatory T cells (Treg) in the tumor-infiltrating lymphocytes (TILs), regional lymph node lymphocytes, and peripheral blood lymphocytes of gastric cancer patients.",20550524_1,-1,-1,-1,-1,12669,-1,0.002534031,0.9117619,0.085704066
12672,blood lymphocytes,36,38,204,221,"In the present study, we investigated the distribution of Th17 cells in relation to regulatory T cells (Treg) in the tumor-infiltrating lymphocytes (TILs), regional lymph node lymphocytes, and peripheral blood lymphocytes of gastric cancer patients.",20550524_1,-1,-1,-1,-1,12672,-1,0.00030020246,0.0011074834,0.9985923
12675,Th17 cells,6,8,46,56,"Interleukin (IL)-17-producing CD4(+) cells as Th17 cells and CD4(+)CD25(+)FoxP3(+) cells as Treg were evaluated by flow cytometry and expressed as a percentage of the total CD4(+) cells, in addition to performing a Th1/Th2 balance assay.",20550524_2,-1,-1,-1,-1,12675,-1,0.004118975,0.4545314,0.5413496
12678,the total,25,27,163,172,"Interleukin (IL)-17-producing CD4(+) cells as Th17 cells and CD4(+)CD25(+)FoxP3(+) cells as Treg were evaluated by flow cytometry and expressed as a percentage of the total CD4(+) cells, in addition to performing a Th1/Th2 balance assay.",20550524_2,-1,-1,-1,-1,12678,-1,2.7121103e-05,0.99995446,1.8447265e-05
12685,Th17 cells,16,18,68,78,"In TILs from patients with early disease (n = 27), the frequency of Th17 cells was significantly higher than that in the normal gastric mucosa (23.7  8.9 vs 4.5  3.1%).",20550524_4,-1,-1,-1,-1,12685,-1,0.0004024128,0.005281353,0.9943163
12686,than that,21,23,104,113,"In TILs from patients with early disease (n = 27), the frequency of Th17 cells was significantly higher than that in the normal gastric mucosa (23.7  8.9 vs 4.5  3.1%).",20550524_4,-1,-1,-1,-1,12686,-1,2.3488376e-05,0.99996305,1.3475073e-05
12690,Th17 cells,16,18,71,81,"In TILs from patients with advanced disease (n = 28), the frequency of Th17 cells was also significantly higher, but lower compared to early disease, than that in the normal gastric mucosa (15.1  6.2 vs 4.0  2.0%).",20550524_5,-1,-1,-1,-1,12690,-1,0.00034616748,0.0035905126,0.9960634
12692,than that,30,32,150,159,"In TILs from patients with advanced disease (n = 28), the frequency of Th17 cells was also significantly higher, but lower compared to early disease, than that in the normal gastric mucosa (15.1  6.2 vs 4.0  2.0%).",20550524_5,-1,-1,-1,-1,12692,-1,2.5724523e-05,0.99996066,1.364512e-05
12695,Th17 cell-distribution,3,5,21,43,This observation for Th17 cell-distribution was also confirmed by immunohistochemistry.,20550524_6,-1,-1,-1,-1,12695,-1,0.0003619001,0.01226446,0.98737365
12700,Th17 cells,6,8,35,45,"In conclusion, the accumulation of Th17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.",20550524_8,-1,-1,-1,-1,12700,-1,0.0004757576,0.0071829413,0.9923413
12702,the tumor,13,15,65,74,"In conclusion, the accumulation of Th17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.",20550524_8,-1,-1,-1,-1,12702,-1,1.8535902e-05,0.99997187,9.556098e-06
12703,then the,24,26,140,148,"In conclusion, the accumulation of Th17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.",20550524_8,-1,-1,-1,-1,12703,-1,1.9701689e-05,0.9999716,8.714369e-06
12704,Th17 cells,28,30,165,175,"In conclusion, the accumulation of Th17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.",20550524_8,-1,-1,-1,-1,12704,-1,0.00087614654,0.023009846,0.97611403
12705,to the,33,35,206,212,"In conclusion, the accumulation of Th17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.",20550524_8,-1,-1,-1,-1,12705,-1,2.3027336e-05,0.9999672,9.7268985e-06
12734,tumor cells,28,30,181,192,"To address these questions, wild-type or IFN-gamma-deficient OVA-specific CD8(+) T cells were activated in RAG-2(-/-) gamma c(-/-) recipients with control or IL-4-expressing OVA(+) tumor cells, and then transferred to secondary recipients for tumor challenge.",20562261_4,-1,-1,-1,-1,12734,-1,0.0036475307,0.314069,0.68228346
12735,then transferred to,32,35,198,217,"To address these questions, wild-type or IFN-gamma-deficient OVA-specific CD8(+) T cells were activated in RAG-2(-/-) gamma c(-/-) recipients with control or IL-4-expressing OVA(+) tumor cells, and then transferred to secondary recipients for tumor challenge.",20562261_4,-1,-1,-1,-1,12735,-1,2.035948e-05,0.99996936,1.0225037e-05
12741,the transcription factor GATA-3,10,14,66,97,Tumor-derived IL-4 induced the expression of type 2 cytokines and the transcription factor GATA-3 by responding CD8 T cells while reducing their CD8 coreceptor expression and ability to eliminate a secondary tumor challenge.,20562261_5,-1,-1,-1,-1,12741,-1,2.3479977e-05,0.9999583,1.8244975e-05
12762,functional,9,10,57,67,These findings may explain the anomalies in the reported functional phenotype of type 2 polarized CD8 T cells.,20562261_8,0,1,2,-1,12762,-1,5.1133607e-05,0.9999243,2.4563205e-05
12767,immunity,18,19,120,128,OBJECTIVES: Costimulatory signals are essential for T-cell activation and hence play a very important role in antitumor immunity.,20563597_0,0,-1,2,-1,12767,-1,0.99423414,0.005128354,0.00063752616
12769,to tumor necrosis factor (TNF,7,13,28,57,B7 and 4-1BBL which belongs to tumor necrosis factor (TNF) family provide costimulatory interaction for T-cell activation and function.,20563597_1,-1,-1,-1,-1,12769,-1,0.0011243877,0.99877685,9.87894e-05
12771,function,22,23,126,134,B7 and 4-1BBL which belongs to tumor necrosis factor (TNF) family provide costimulatory interaction for T-cell activation and function.,20563597_1,0,1,2,-1,12771,-1,0.0002305091,0.9994423,0.00032722167
12776,tumor immunity,15,17,74,88,"This study investigated the role of B7 and 4-1BBL in the amplification of tumor immunity by transduction of the B7-1, B7-2 and 4-1BBL into mouse hepatocellular carcinoma cell line H22.METHODS: The tumorigenicity of H22 variants expressing either B7-1, B7-2 (H22/B7-1/B7-2) or 4-1BBL was compared with an H22 variant expressing B7-1, B7-2 and 4-1BBL (H22/B7-1/B7-2/4-1BBL).",20563597_2,-1,-1,-1,-1,12776,-1,0.004070886,0.99570507,0.00022399772
12778,the B7-1,20,24,108,116,"This study investigated the role of B7 and 4-1BBL in the amplification of tumor immunity by transduction of the B7-1, B7-2 and 4-1BBL into mouse hepatocellular carcinoma cell line H22.METHODS: The tumorigenicity of H22 variants expressing either B7-1, B7-2 (H22/B7-1/B7-2) or 4-1BBL was compared with an H22 variant expressing B7-1, B7-2 and 4-1BBL (H22/B7-1/B7-2/4-1BBL).",20563597_2,-1,-1,-1,-1,12778,-1,0.0021500292,0.45295152,0.54489845
12781,The tumorigenicity,40,42,193,211,"This study investigated the role of B7 and 4-1BBL in the amplification of tumor immunity by transduction of the B7-1, B7-2 and 4-1BBL into mouse hepatocellular carcinoma cell line H22.METHODS: The tumorigenicity of H22 variants expressing either B7-1, B7-2 (H22/B7-1/B7-2) or 4-1BBL was compared with an H22 variant expressing B7-1, B7-2 and 4-1BBL (H22/B7-1/B7-2/4-1BBL).",20563597_2,-1,-1,-1,-1,12781,-1,2.1690686e-05,0.99996734,1.0988583e-05
12795,cells that,14,16,66,76,"RESULTS: Syngeneic BALB/c mice injected with H22/B7-1/B7-2/4-1BBL cells that expressed elevated levels of B7-1, B7-2 and 4-1BBL showed a tumor development frequency of 50% compared with 100% in mice injected with the H22 parental line, H22/neo, H22/B7-1/B7-2 and H22/4-1BBL.",20563597_5,-1,-1,-1,-1,12795,-1,0.003920828,0.1198005,0.8762787
12800,tumor cells,4,6,25,36,"Mice inoculated with H22 tumor cells expressing B7-1, B7-2 and 4-1BBL developed a strong cytotoxic T lymphocyte response and long-term immunity against wild-type tumor, suggesting a synergistic effect between the B7 and 4-1BBL costimulatory pathways.",20563597_6,-1,-1,-1,-1,12800,-1,0.0041548437,0.39893883,0.5969063
12804,immunity,27,28,135,143,"Mice inoculated with H22 tumor cells expressing B7-1, B7-2 and 4-1BBL developed a strong cytotoxic T lymphocyte response and long-term immunity against wild-type tumor, suggesting a synergistic effect between the B7 and 4-1BBL costimulatory pathways.",20563597_6,0,-1,2,-1,12804,-1,0.995609,0.004014624,0.00037639553
12806,the B7,37,39,209,215,"Mice inoculated with H22 tumor cells expressing B7-1, B7-2 and 4-1BBL developed a strong cytotoxic T lymphocyte response and long-term immunity against wild-type tumor, suggesting a synergistic effect between the B7 and 4-1BBL costimulatory pathways.",20563597_6,-1,-1,-1,-1,12806,-1,0.004051949,0.31654668,0.67940134
12812,T-cell-mediated,25,26,156,171,Results showed that H22/B7-1/B7-2/4-1BBL tumor vaccines probably protect the infiltrating lymphocytes from apoptosis and induce NF-B activation to improve T-cell-mediated antitumor response.,20563597_7,-1,1,2,-1,12812,-1,3.3545497e-05,5.6539324e-05,0.99991
12817,gene transfer,22,24,86,99,"CONCLUSIONS: In this study, the antitumor consequences of using B7-1, B7-2 and 4-1BBL gene transfer have demonstrated the therapeutic potential of gene therapy approach for hepatocellular carcinoma.",20563597_8,-1,-1,-1,-1,12817,-1,3.3359884e-05,0.9999453,2.1330503e-05
12818,the therapeutic,26,28,118,133,"CONCLUSIONS: In this study, the antitumor consequences of using B7-1, B7-2 and 4-1BBL gene transfer have demonstrated the therapeutic potential of gene therapy approach for hepatocellular carcinoma.",20563597_8,-1,-1,-1,-1,12818,-1,2.1663986e-05,0.9999697,8.638641e-06
12819,gene therapy,30,32,147,159,"CONCLUSIONS: In this study, the antitumor consequences of using B7-1, B7-2 and 4-1BBL gene transfer have demonstrated the therapeutic potential of gene therapy approach for hepatocellular carcinoma.",20563597_8,-1,-1,-1,-1,12819,-1,3.099245e-05,0.9999517,1.7244156e-05
12821,T-cell,8,9,69,75,Reports focusing on the immunological microenvironment of peripheral T-cell lymphomas (PTCL) are rare.,20595635_0,-1,1,2,-1,12821,-1,4.0514118e-05,7.381791e-05,0.9998857
12826,T-cells to the,16,19,101,115,Here we studied the reciprocal contribution of regulatory (Treg) and interleukin-17-producing (Th17) T-cells to the composition of the lymphoma-associated microenvironment of angioimmunoblastic T-cell lymphoma (AITL) and PTCL not otherwise specified on tissue microarrays from 30 PTCLs not otherwise specified and 37 AITLs.,20595635_1,-1,-1,-1,-1,12826,-1,0.00064775103,0.96434,0.03501234
12828,T-cell,26,27,194,200,Here we studied the reciprocal contribution of regulatory (Treg) and interleukin-17-producing (Th17) T-cells to the composition of the lymphoma-associated microenvironment of angioimmunoblastic T-cell lymphoma (AITL) and PTCL not otherwise specified on tissue microarrays from 30 PTCLs not otherwise specified and 37 AITLs.,20595635_1,-1,1,2,-1,12828,-1,4.121471e-05,6.5893146e-05,0.99989283
12829,tissue,37,38,253,259,Here we studied the reciprocal contribution of regulatory (Treg) and interleukin-17-producing (Th17) T-cells to the composition of the lymphoma-associated microenvironment of angioimmunoblastic T-cell lymphoma (AITL) and PTCL not otherwise specified on tissue microarrays from 30 PTCLs not otherwise specified and 37 AITLs.,20595635_1,-1,1,2,-1,12829,-1,2.474806e-05,0.99994886,2.6334981e-05
12830,that Th17,2,4,9,18,"We found that Th17 but not Treg cells were differently represented in the two lymphomas and correlated with the amount of mast cells (MCs) and granulocytes, which preferentially occurred in the cellular milieu of AITL cases.",20595635_2,-1,-1,-1,-1,12830,-1,4.938457e-05,0.9999075,4.308101e-05
12832,the two,12,14,70,77,"We found that Th17 but not Treg cells were differently represented in the two lymphomas and correlated with the amount of mast cells (MCs) and granulocytes, which preferentially occurred in the cellular milieu of AITL cases.",20595635_2,-1,-1,-1,-1,12832,-1,2.6660706e-05,0.9999602,1.3182233e-05
12835,the cellular,33,35,190,202,"We found that Th17 but not Treg cells were differently represented in the two lymphomas and correlated with the amount of mast cells (MCs) and granulocytes, which preferentially occurred in the cellular milieu of AITL cases.",20595635_2,-1,-1,-1,-1,12835,-1,0.005490287,0.44811198,0.54639775
12839,to the,10,12,76,82,"We observed that MCs directly synthesized interleukin-6 and thus contribute to the establishment of a pro-inflammatory, Th17 permissive environment in AITL.",20595635_3,-1,-1,-1,-1,12839,-1,2.1656342e-05,0.99996877,9.5597425e-06
12841,that the,3,5,24,32,We further hypothesized that the AITL clone itself could be responsible for the preferential accumulation of MCs at sites of infiltration through the synthesis of CXCL-13 and its interaction with the CXCR3 and CXCR5 receptors expressed on MCs.,20595635_4,-1,-1,-1,-1,12841,-1,1.6219814e-05,0.99997413,9.695699e-06
12843,through the,21,23,138,149,We further hypothesized that the AITL clone itself could be responsible for the preferential accumulation of MCs at sites of infiltration through the synthesis of CXCL-13 and its interaction with the CXCR3 and CXCR5 receptors expressed on MCs.,20595635_4,-1,-1,-1,-1,12843,-1,1.9235033e-05,0.9999701,1.0665806e-05
12845,receptors,34,35,216,225,We further hypothesized that the AITL clone itself could be responsible for the preferential accumulation of MCs at sites of infiltration through the synthesis of CXCL-13 and its interaction with the CXCR3 and CXCR5 receptors expressed on MCs.,20595635_4,0,1,2,-1,12845,-1,0.001690784,0.22997324,0.76833594
12851,toward the,18,20,103,113,"On these bases, we conclude that MCs have a role in molding the immunological microenvironment of AITL toward the maintenance of pro-inflammatory conditions prone to Th17 generation and autoimmunity.",20595635_6,-1,-1,-1,-1,12851,-1,2.5010697e-05,0.9999615,1.3475065e-05
12852,to Th17 generation,25,28,163,181,"On these bases, we conclude that MCs have a role in molding the immunological microenvironment of AITL toward the maintenance of pro-inflammatory conditions prone to Th17 generation and autoimmunity.",20595635_6,-1,-1,-1,-1,12852,-1,2.7306465e-05,0.99995375,1.8988954e-05
12864,CTLA-4-blocking therapy,11,13,54,77,"Here, we used this model to investigate the effect of CTLA-4-blocking therapy on the kinetics of T(reg) frequency and function.",20600326_3,-1,-1,-1,-1,12864,-1,0.0016049652,0.028747201,0.9696479
12867,function,21,22,118,126,"Here, we used this model to investigate the effect of CTLA-4-blocking therapy on the kinetics of T(reg) frequency and function.",20600326_3,0,1,2,-1,12867,-1,8.394373e-05,0.9997794,0.00013666718
12868,CTLA-4-blocking treatment,4,6,25,50,"As previously published, CTLA-4-blocking treatment, initiated on day 20 after bone marrow transplantation, led to overt autoimmunity by day 35.",20600326_4,-1,-1,-1,-1,12868,-1,0.0017985633,0.026553163,0.97164816
12869,transplantation,14,15,90,105,"As previously published, CTLA-4-blocking treatment, initiated on day 20 after bone marrow transplantation, led to overt autoimmunity by day 35.",20600326_4,-1,1,2,-1,12869,-1,3.6006077e-05,0.9999486,1.5365815e-05
12874,The T(reg,0,2,0,9,The T(reg) expansion occurred selectively in the recipient-derived CD4+ T-cell compartment.,20600326_6,-1,-1,-1,-1,12874,-1,2.1593694e-05,0.9999652,1.3200149e-05
12876,T-cell,11,12,72,78,The T(reg) expansion occurred selectively in the recipient-derived CD4+ T-cell compartment.,20600326_6,-1,1,2,-1,12876,-1,3.7128306e-05,5.3504962e-05,0.9999094
12884,relative to,21,23,135,146,Purified CD4(+)CD25(high)FR4(high) T(reg) from 'day 35' treated chimeras showed increased IL-10 and IFN-gamma mRNA-expression (RT-PCR) relative to control chimeras.,20600326_8,-1,-1,-1,-1,12884,-1,2.4502951e-05,0.9999622,1.3320513e-05
12887,transplantation,10,11,83,98,"In this model of CTLA-4-blockade-induced autoimmunity after allogeneic bone marrow transplantation, anti-CTLA-4-mAb gives rise to a progressive expansion - without a prior transient reduction - of T(reg) cells.",20600326_9,-1,1,2,-1,12887,-1,3.2771106e-05,0.9999521,1.5117214e-05
12893,function,14,15,74,82,"T(reg) of autoimmune animals do not show a defect in in vitro suppressive function but show an in vivo activated cytokine profile, suggesting that the expansion occurs as a compensatory phenomenon to control autoimmunity.",20600326_10,0,1,2,-1,12893,-1,7.04485e-05,0.99984276,8.6755244e-05
12895,that the,25,27,142,150,"T(reg) of autoimmune animals do not show a defect in in vitro suppressive function but show an in vivo activated cytokine profile, suggesting that the expansion occurs as a compensatory phenomenon to control autoimmunity.",20600326_10,-1,-1,-1,-1,12895,-1,1.9710069e-05,0.9999715,8.839081e-06
12898,tumor antigen genes to,3,7,21,43,Targeted delivery of tumor antigen genes to dendritic cells (DCs) using adenoviral (Ad) vectors holds great potential for cancer immunotherapy.,20664356_0,-1,-1,-1,-1,12898,-1,0.00010969192,0.9998429,4.7384245e-05
12904,T-cell,27,28,185,191,"We previously showed that CD40 targeting of Ad vectors enhanced specific transduction of DC in human skin, while simultaneously ensuring their stable maturation and superior allogeneic T-cell stimulatory capacity.",20664356_1,-1,1,2,-1,12904,-1,5.6109457e-05,5.459928e-05,0.99988925
12913,T-effector cells,38,40,258,274,"In this study, we evaluated whether CD40-targeted Ad encoding the full-length melanoma antigen recognized by T cells-1 (CD40-Ad-MART-1) could be used to efficiently and selectively transduce conventional and plasmacytoid DC to prime melanoma-specific CD8(+) T-effector cells in human melanoma-draining sentinel lymph nodes (SLNs).",20664356_2,-1,-1,-1,-1,12913,-1,0.00077384507,0.027231688,0.9719944
12915,protein,10,11,60,67,"CD40 targeting of Ad was achieved using a bispecific fusion protein, binding and neutralizing the Ad fiber knob through soluble coxsackie and adenovirus receptor while retargeting the virus to hCD40 through the tumor necrosis factor-like domain of mCD40L.",20664356_3,0,1,-1,-1,12915,-1,4.6776404e-05,0.9999106,4.2674725e-05
12918,receptor,24,25,153,161,"CD40 targeting of Ad was achieved using a bispecific fusion protein, binding and neutralizing the Ad fiber knob through soluble coxsackie and adenovirus receptor while retargeting the virus to hCD40 through the tumor necrosis factor-like domain of mCD40L.",20664356_3,0,1,2,-1,12918,-1,0.0015981196,0.00063186965,0.9977701
12921,through the tumor,31,34,199,216,"CD40 targeting of Ad was achieved using a bispecific fusion protein, binding and neutralizing the Ad fiber knob through soluble coxsackie and adenovirus receptor while retargeting the virus to hCD40 through the tumor necrosis factor-like domain of mCD40L.",20664356_3,-1,-1,-1,-1,12921,-1,4.1665982e-05,0.99993455,2.371861e-05
12922,factor-like,35,36,226,237,"CD40 targeting of Ad was achieved using a bispecific fusion protein, binding and neutralizing the Ad fiber knob through soluble coxsackie and adenovirus receptor while retargeting the virus to hCD40 through the tumor necrosis factor-like domain of mCD40L.",20664356_3,0,1,-1,-1,12922,-1,0.99808323,0.0011139228,0.00080286124
12927,functional,7,8,51,61,"Moreover, CD40-Ad-MART-1 enhanced the expansion of functional MART-1-specific CD8(+) T cells from SLN with concomitant decreases in CD4:CD8 T-cell ratios and CD4(+)CD25(hi)FoxP3(+) regulatory T-cell rates.",20664356_5,0,1,2,-1,12927,-1,3.2863652e-05,0.99995005,1.7120217e-05
12929,T-cell,20,21,140,146,"Moreover, CD40-Ad-MART-1 enhanced the expansion of functional MART-1-specific CD8(+) T cells from SLN with concomitant decreases in CD4:CD8 T-cell ratios and CD4(+)CD25(hi)FoxP3(+) regulatory T-cell rates.",20664356_5,-1,1,2,-1,12929,-1,3.498497e-05,3.999717e-05,0.999925
12931,that transduction,3,5,28,45,Additional studies revealed that transduction and activation of monocyte-derived DCs with CD40-Ad-MART-1 significantly enhanced their priming efficiency of functional CD8(+) effector T cells with high avidity.,20664356_6,-1,-1,-1,-1,12931,-1,2.2712047e-05,0.9999651,1.2250723e-05
12933,functional,18,19,156,166,Additional studies revealed that transduction and activation of monocyte-derived DCs with CD40-Ad-MART-1 significantly enhanced their priming efficiency of functional CD8(+) effector T cells with high avidity.,20664356_6,0,1,2,-1,12933,-1,3.346285e-05,0.99994266,2.3823583e-05
12943,therapy,23,24,146,153,"Unfortunately, the need for multiple administrations of antigens often limits the use of one of the most effective vaccine approaches, immunogene therapy using viral vectors, because neutralizing antibodies are rapidly produced.",20683443_1,0,1,-1,-1,12943,-1,2.9911602e-05,0.99995506,1.4985704e-05
12945,therapy,6,7,44,51,"We hypothesized that after viral immunogene therapy ""primed"" an initial strong antitumor immune response, subsequent ""boosts"" could be provided by sequential courses of chemotherapy.",20683443_2,0,1,-1,-1,12945,-1,2.6259824e-05,0.9999615,1.2204023e-05
12949,therapy,4,5,39,46,Three adenoviral (Ad)-based immunogene therapy regimens were administered to animals with large malignant mesothelioma and lung cancer tumors followed by three weekly administrations of a drug regimen commonly used to treat these tumors (Cisplatin/Gemcitabine).,20683443_3,0,1,-1,-1,12949,-1,2.5450645e-05,0.9999573,1.7234783e-05
12953,to treat these tumors,29,33,215,236,Three adenoviral (Ad)-based immunogene therapy regimens were administered to animals with large malignant mesothelioma and lung cancer tumors followed by three weekly administrations of a drug regimen commonly used to treat these tumors (Cisplatin/Gemcitabine).,20683443_3,-1,-1,-1,-1,12953,-1,2.760085e-05,0.9999604,1.2014323e-05
12954,therapy,1,2,11,18,"Immunogene therapy followed by chemotherapy resulted in markedly increased antitumor efficacy associated with increased numbers of antigen-specific, activated CD8(+) T-cells systemically and within the tumors.",20683443_4,0,1,-1,-1,12954,-1,2.5691112e-05,0.99995995,1.4367631e-05
12957,T-cells,21,22,166,173,"Immunogene therapy followed by chemotherapy resulted in markedly increased antitumor efficacy associated with increased numbers of antigen-specific, activated CD8(+) T-cells systemically and within the tumors.",20683443_4,-1,1,2,-1,12957,-1,3.32596e-05,5.1944393e-05,0.99991477
12958,the tumors,25,27,198,208,"Immunogene therapy followed by chemotherapy resulted in markedly increased antitumor efficacy associated with increased numbers of antigen-specific, activated CD8(+) T-cells systemically and within the tumors.",20683443_4,-1,-1,-1,-1,12958,-1,1.9918612e-05,0.99996984,1.0251052e-05
12961,T-regulatory cells,20,22,120,138,"Possible mechanisms included: (i) decreases in immunosuppressive cells such as myeloid-derived suppressor cells (MDSC), T-regulatory cells (T-regs), and B-cells, (ii) stimulation of memory cells by intratumoral antigen release leading to efficient cross-priming, (iii) alteration of the tumor microenvironment with production of ""danger signals"" and immunostimulatory cytokines, and (iv) augmented trafficking of T-cells into the tumors.",20683443_5,-1,-1,-1,-1,12961,-1,0.0026430332,0.17170995,0.82564706
12964,antigen release,38,40,211,226,"Possible mechanisms included: (i) decreases in immunosuppressive cells such as myeloid-derived suppressor cells (MDSC), T-regulatory cells (T-regs), and B-cells, (ii) stimulation of memory cells by intratumoral antigen release leading to efficient cross-priming, (iii) alteration of the tumor microenvironment with production of ""danger signals"" and immunostimulatory cytokines, and (iv) augmented trafficking of T-cells into the tumors.",20683443_5,-1,-1,-1,-1,12964,-1,0.97812414,0.017675497,0.004200355
12966,the tumor,50,52,283,292,"Possible mechanisms included: (i) decreases in immunosuppressive cells such as myeloid-derived suppressor cells (MDSC), T-regulatory cells (T-regs), and B-cells, (ii) stimulation of memory cells by intratumoral antigen release leading to efficient cross-priming, (iii) alteration of the tumor microenvironment with production of ""danger signals"" and immunostimulatory cytokines, and (iv) augmented trafficking of T-cells into the tumors.",20683443_5,-1,-1,-1,-1,12966,-1,1.8917854e-05,0.9999713,9.832975e-06
12969,T-cells,71,72,413,420,"Possible mechanisms included: (i) decreases in immunosuppressive cells such as myeloid-derived suppressor cells (MDSC), T-regulatory cells (T-regs), and B-cells, (ii) stimulation of memory cells by intratumoral antigen release leading to efficient cross-priming, (iii) alteration of the tumor microenvironment with production of ""danger signals"" and immunostimulatory cytokines, and (iv) augmented trafficking of T-cells into the tumors.",20683443_5,-1,1,2,-1,12969,-1,3.3884568e-05,5.5652596e-05,0.9999105
12970,the tumors,73,75,426,436,"Possible mechanisms included: (i) decreases in immunosuppressive cells such as myeloid-derived suppressor cells (MDSC), T-regulatory cells (T-regs), and B-cells, (ii) stimulation of memory cells by intratumoral antigen release leading to efficient cross-priming, (iii) alteration of the tumor microenvironment with production of ""danger signals"" and immunostimulatory cytokines, and (iv) augmented trafficking of T-cells into the tumors.",20683443_5,-1,-1,-1,-1,12970,-1,1.9674364e-05,0.99996936,1.0927763e-05
12976,therapy,20,21,117,124,This approach is currently being tested in a clinical trial and could be applied to other trials of viral immunogene therapy.,20683443_6,0,1,-1,-1,12976,-1,2.5617557e-05,0.9999596,1.4799521e-05
12981,protein,19,20,101,108,"Given that local cell-mediated immunity (CMI) against the human papillomavirus type 16 E6 (HPV16 E6) protein is important for eradication of HPV16 E6-expressing cancer cells in the cervical mucosa, the HPV16 E6 protein may be a target for the mucosal immunotherapy of cervical cancer.",20706715_0,0,1,-1,-1,12981,-1,5.165115e-05,0.9999182,3.0102346e-05
12985,protein,37,38,211,218,"Given that local cell-mediated immunity (CMI) against the human papillomavirus type 16 E6 (HPV16 E6) protein is important for eradication of HPV16 E6-expressing cancer cells in the cervical mucosa, the HPV16 E6 protein may be a target for the mucosal immunotherapy of cervical cancer.",20706715_0,0,1,-1,-1,12985,-1,4.857058e-05,0.9999167,3.4694287e-05
12995,to the,1,3,9,15,"Compared to the L. casei-PgsA-treated mice, significantly higher levels of serum IgG and mucosal IgA were observed in L. casei-PgsA-E6-immunized mice; these differences were significantly enhanced after boost.",20706715_3,-1,-1,-1,-1,12995,-1,2.0270749e-05,0.9999695,1.0222201e-05
12999,IFN-gamma-secreting cells,21,23,123,148,"Consistent with this, systemic and local CMI were significantly increased after the boost, as shown by increased counts of IFN-gamma-secreting cells in splenocytes, mesenteric lymph nodes (MLN), and vaginal samples.",20706715_4,-1,-1,-1,-1,12999,-1,0.89208263,0.0015951629,0.106322244
13000,the TC-1 tumor,3,6,16,30,"Furthermore, in the TC-1 tumor model, animals receiving the orally administered L. casei-PgsA-E6 showed reduced tumor size and increased survival rate versus mice receiving control (L. casei-PgsA) immunization.",20706715_5,-1,-1,-1,-1,13000,-1,1.9537241e-05,0.99996674,1.3736363e-05
13006,that the,5,7,37,45,"Collectively, these results indicate that the oral administration of lactobacilli bearing the surface-displayed E6 protein induces T cell-mediated cellular immunity and antitumor effects in mice.",20706715_7,-1,-1,-1,-1,13006,-1,1.9204877e-05,0.9999728,8.0234395e-06
13008,protein,15,16,115,122,"Collectively, these results indicate that the oral administration of lactobacilli bearing the surface-displayed E6 protein induces T cell-mediated cellular immunity and antitumor effects in mice.",20706715_7,0,1,-1,-1,13008,-1,6.471115e-05,0.99985635,7.886586e-05
13009,T cell-mediated cellular immunity,17,21,131,164,"Collectively, these results indicate that the oral administration of lactobacilli bearing the surface-displayed E6 protein induces T cell-mediated cellular immunity and antitumor effects in mice.",20706715_7,-1,-1,-1,-1,13009,-1,0.0002219078,0.000103752085,0.9996743
13013,therapy,14,15,87,94,BACKGROUND: High-dose interferon-alpha 2b (IFN-alpha 2b) is the only approved systemic therapy in the United States for the adjuvant treatment of melanoma.,20712892_0,0,1,-1,-1,13013,-1,3.2458953e-05,0.9999522,1.5285788e-05
13021,mechanism of action,8,11,56,75,"The study objective was to explore the immunomodulatory mechanism of action for IFN-alpha 2b by measuring serum regulatory T cell (Treg), serum transforming growth factor-beta (TGF-beta), interleukin (IL)-10, and autoantibody levels in patients with melanoma treated with the induction phase of the high-dose IFN-alpha 2b regimen.",20712892_1,0,1,-1,-1,13021,-1,4.258134e-05,0.99993336,2.4028444e-05
13026,TGF-beta,29,30,177,185,"The study objective was to explore the immunomodulatory mechanism of action for IFN-alpha 2b by measuring serum regulatory T cell (Treg), serum transforming growth factor-beta (TGF-beta), interleukin (IL)-10, and autoantibody levels in patients with melanoma treated with the induction phase of the high-dose IFN-alpha 2b regimen.",20712892_1,0,1,-1,-1,13026,-1,4.476912e-05,0.9999393,1.5864367e-05
13037,TGF-beta,16,17,94,102,"Serum Treg levels were measured as whole lymphocytes in CD4+ cells using flow cytometry while TGF-beta, IL-10, and autoantibody levels were measured using enzyme-linked immunosorbent assays.",20712892_3,0,1,-1,-1,13037,-1,5.328516e-05,0.9999242,2.2493476e-05
13054,TGF-beta,9,10,54,62,"No significant effects were observed on the levels of TGF-beta, IL-10, and autoantibodies in patients with melanoma treated with IFN-alpha 2b.",20712892_8,0,1,-1,-1,13054,-1,3.2290558e-05,0.99995196,1.5742698e-05
13059,Treg that,13,15,83,92,CONCLUSIONS: Patients with melanoma in this study showed increased basal levels of Treg that may be relevant to their disease and its progression.,20712892_9,-1,-1,-1,-1,13059,-1,2.1015625e-05,0.9999659,1.3115145e-05
13060,relevant to their,17,20,100,117,CONCLUSIONS: Patients with melanoma in this study showed increased basal levels of Treg that may be relevant to their disease and its progression.,20712892_9,-1,-1,-1,-1,13060,-1,3.12832e-05,0.99995565,1.3060168e-05
13075,T-cell,4,5,17,23,"Among the CD4(+) T-cell population in the skin, at least one-fifth express Foxp3.",20722759_1,-1,1,2,-1,13075,-1,3.065493e-05,5.0166534e-05,0.9999192
13079,to antigenic,6,8,34,46,"As the skin is constantly exposed to antigenic challenge and is a common site of vaccination, understanding the role of these skin-resident Treg cells is important.",20722759_2,-1,-1,-1,-1,13079,-1,0.14982888,0.84764314,0.002527979
13086,the types,18,20,97,106,"Although the suppressive effect of Treg cells on T cells is well documented, less is known about the types of innate immune cells influenced by Treg cells and whether the Treg cells suppress acute innate immune responses in vivo.",20722759_3,-1,-1,-1,-1,13086,-1,2.8829305e-05,0.9999491,2.2066852e-05
13089,the Treg cells,30,33,167,181,"Although the suppressive effect of Treg cells on T cells is well documented, less is known about the types of innate immune cells influenced by Treg cells and whether the Treg cells suppress acute innate immune responses in vivo.",20722759_3,-1,-1,-1,-1,13089,-1,0.0025913597,0.15842591,0.8389827
13094,that Treg cells,2,5,15,30,We demonstrate that Treg cells limit this response by inhibiting neutrophil accumulation and survival within hours of tumour cell inoculation.,20722759_5,-1,-1,-1,-1,13094,-1,0.0025475924,0.13289057,0.8645618
13096,tumour cell,17,19,118,129,We demonstrate that Treg cells limit this response by inhibiting neutrophil accumulation and survival within hours of tumour cell inoculation.,20722759_5,-1,-1,-1,-1,13096,-1,0.0028495311,0.18309976,0.8140507
13099,chemoattractants CXCL1,12,14,78,100,"This effect, which was associated with decreased expression of the neutrophil chemoattractants CXCL1 and CXCL2, promoted survival of the inoculated tumour cells.",20722759_6,-1,-1,-1,-1,13099,-1,0.99808973,0.00024334146,0.0016669687
13102,tumour cells,22,24,148,160,"This effect, which was associated with decreased expression of the neutrophil chemoattractants CXCL1 and CXCL2, promoted survival of the inoculated tumour cells.",20722759_6,-1,-1,-1,-1,13102,-1,0.004261535,0.30020577,0.6955327
13104,that Treg cells,5,8,26,41,"Overall, these data imply that Treg cells in the skin are rapidly mobilized and that this activity serves to limit the amplification of inflammatory responses at this site.",20722759_7,-1,-1,-1,-1,13104,-1,0.0026761708,0.21729432,0.7800296
13106,that this,15,17,80,89,"Overall, these data imply that Treg cells in the skin are rapidly mobilized and that this activity serves to limit the amplification of inflammatory responses at this site.",20722759_7,-1,-1,-1,-1,13106,-1,2.25776e-05,0.99996555,1.1905948e-05
13112,cellular targets,37,39,253,269,"BACKGROUND: Anti-CD20 monoclonal antibody treatment has not only increased survival and cure rates in many non-Hodgkin lymphomas, but also has prompted an explosion in the development of novel antibodies and biologically active substances with specific cellular targets in the field of malignancies treatment.",20815894_0,-1,-1,-1,-1,13112,-1,0.0030245036,0.068515874,0.92845964
13117,the gene-modified T cells,8,12,50,75,"Since the robust immune responses are elicited by the gene-modified T cells, gene based T cell therapy may also provide a powerful tool for cancer immunotherapy.",20815894_1,-1,-1,-1,-1,13117,-1,0.0038035852,0.8214139,0.17478256
13119,T cell therapy,15,18,88,102,"Since the robust immune responses are elicited by the gene-modified T cells, gene based T cell therapy may also provide a powerful tool for cancer immunotherapy.",20815894_1,-1,-1,-1,-1,13119,-1,0.001629555,0.03079529,0.9675751
13122,T cell receptor that,14,18,79,99,"METHODS: In this study, we developed a vector construction encoding a chimeric T cell receptor that recognizes the CD20 antigen and delivers co-stimulatory signals to achieve T cell activation.",20815894_2,-1,-1,-1,-1,13122,-1,0.001325335,0.018218426,0.98045623
13129,blood-derived T cells,10,13,74,95,One non-Hodgkin lymphoma cell line Raji cells co-cultured with peripheral blood-derived T cells were stably transfected with anti-CD20scFvFc/CD28/CD3zeta gene or anti-CD20scFvFc gene.,20815894_3,-1,-1,-1,-1,13129,-1,0.0036924735,0.16312006,0.83318746
13146,blood-derived T cells,13,16,94,115,"Activity of AP-1 was analyzed by EMSA.RESULTS: Following efficient transduction of peripheral blood-derived T cells with anti-CD20scFvFc/CD28/CD3zeta gene, an obvious cell lysis of Raji cells was observed in co-culture.",20815894_8,-1,-1,-1,-1,13146,-1,0.0040740874,0.28101212,0.71491385
13150,T cells transduced,0,3,0,18,T cells transduced anti-CD20scFvFc/CD28/CD3zeta gene had superior secretion of IFN-gamma and IL-2 compared to T cells transduced anti-CD20scFvFc gene.,20815894_9,-1,-1,-1,-1,13150,-1,0.0008454808,0.019653933,0.97950053
13153,to T cells transduced,13,17,107,128,T cells transduced anti-CD20scFvFc/CD28/CD3zeta gene had superior secretion of IFN-gamma and IL-2 compared to T cells transduced anti-CD20scFvFc gene.,20815894_9,-1,-1,-1,-1,13153,-1,0.00021379151,0.9988475,0.0009387089
13159,T cells transduced,4,7,26,44,"CONCLUSION: So adoptively T cells transduced anti-CD20scFvFc/CD28/CD3zeta gene mediates enhanced anti-tumor activities against CD20 positive tumor cells, suggesting a potential of gene-based immunotherapy for non-Hodgkin lymphoma.",20815894_11,-1,-1,-1,-1,13159,-1,0.0012015918,0.02104011,0.9777583
13161,tumor cells,16,18,141,152,"CONCLUSION: So adoptively T cells transduced anti-CD20scFvFc/CD28/CD3zeta gene mediates enhanced anti-tumor activities against CD20 positive tumor cells, suggesting a potential of gene-based immunotherapy for non-Hodgkin lymphoma.",20815894_11,-1,-1,-1,-1,13161,-1,0.0041625476,0.40745568,0.58838177
13163,function,4,5,28,36,OBJECTIVE: Defective immune function is an important cause of tumor development.,20822377_0,0,1,2,-1,13163,-1,0.0003638687,0.9992859,0.00035030258
13167,function,17,18,105,113,Accumulation of myeloid-derived suppressor cell (MDSC) associated with inhibition of dendritic cell (DC) function is one of the major immunological abnormalities in cancer.,20822377_1,0,1,2,-1,13167,-1,0.0007870235,0.96187365,0.03733929
13175,blood,11,12,61,66,"Then we detected the frequency of MDSC in spleen, peripheral blood (PB), lymph node (LN) and tumor tissue of HCC mice and its potential mechanisms.",20822377_4,0,1,-1,-1,13175,-1,0.0003084119,0.99661607,0.0030755512
13176,tumor tissue,22,24,93,105,"Then we detected the frequency of MDSC in spleen, peripheral blood (PB), lymph node (LN) and tumor tissue of HCC mice and its potential mechanisms.",20822377_4,-1,-1,-1,-1,13176,-1,3.106661e-05,0.9999337,3.520839e-05
13178,function,14,15,82,90,We also evaluated IL-10 production of MDSC and mechanism by which MDSC inhibit DC function.,20822377_5,0,1,2,-1,13178,-1,7.571495e-05,0.9998492,7.500982e-05
13179,Toll-like receptor,2,4,9,27,"RESULTS: Toll-like receptor (TLR)-ligand (LPS, CpG, poly(I:C))-induced IL-12 production of DC was decreased in HCC mice compared with control.",20822377_6,-1,-1,-1,-1,13179,-1,0.001709926,0.95339,0.04490007
13182,The T cell,0,3,0,10,The T cell stimulatory activity of DC was lower in HCC mice than in controls.,20822377_7,-1,-1,-1,-1,13182,-1,0.004937787,0.24620879,0.7488534
13187,the IL-10,24,26,115,124,"Meanwhile, an increase in the frequency of MDSC in tumor development was detected in spleen, PB, LN and tumor, and the IL-10 levels were higher in HCC mice derived MDSC than in control.",20822377_8,-1,-1,-1,-1,13187,-1,0.82152593,0.17336808,0.0051059737
13190,TLR-ligand-induced IL-12,5,7,32,56,"Furthermore, the MDSC inhibited TLR-ligand-induced IL-12 production of DC by IL-10 production and suppressed T cell stimulatory activity of DC.",20822377_9,-1,-1,-1,-1,13190,-1,0.18628016,0.8073525,0.0063673714
13193,that the,4,6,25,33,"Finally, we demonstrated that the increase in the frequency of MDSC was mediated by MyD88-NF-kB pathway.",20822377_10,-1,-1,-1,-1,13193,-1,1.7348366e-05,0.9999734,9.197372e-06
13198,antigen-specific cytotoxic T lymphocytes,3,7,21,61,Adoptive transfer of antigen-specific cytotoxic T lymphocytes has shown promise for the therapy of cancer.,20842106_0,-1,-1,-1,-1,13198,-1,0.17089845,0.0025273478,0.8265742
13199,the therapy,11,13,84,95,Adoptive transfer of antigen-specific cytotoxic T lymphocytes has shown promise for the therapy of cancer.,20842106_0,-1,-1,-1,-1,13199,-1,2.5352014e-05,0.9999634,1.1209203e-05
13200,tumor-specific T cells,2,5,9,31,"However, tumor-specific T cells are susceptible to diverse inhibitory signals from the tumor microenvironment.",20842106_1,-1,-1,-1,-1,13200,-1,0.003662126,0.7492642,0.24707372
13202,the tumor,12,14,83,92,"However, tumor-specific T cells are susceptible to diverse inhibitory signals from the tumor microenvironment.",20842106_1,-1,-1,-1,-1,13202,-1,2.1032982e-05,0.99996936,9.55131e-06
13206,function,12,13,71,79,"The Akt/protein kinase B plays a central role in T-cell proliferation, function, and survival and we hypothesized that expression of constitutively active Akt (caAkt) in T cells could provide resistance to many of these tumor-associated inhibitory mechanisms.",20842106_2,0,1,2,-1,13206,-1,0.00024363528,0.99892706,0.00082934607
13210,these tumor-associated,37,39,214,236,"The Akt/protein kinase B plays a central role in T-cell proliferation, function, and survival and we hypothesized that expression of constitutively active Akt (caAkt) in T cells could provide resistance to many of these tumor-associated inhibitory mechanisms.",20842106_2,-1,-1,-1,-1,13210,-1,2.8242446e-05,0.9999572,1.4559748e-05
13221,to T cells,6,9,52,62,"These characteristics provided a survival advantage to T cells cocultured with tumor cells in vitro; CD3/28-stimulated T cells expressing a chimeric antigen receptor (CAR) specific for disialoganglioside (GD2) that redirected their activity to the immunosuppressive, GD2-expressing neuroblastoma cell line, LAN-1, resisted tumor-induced apoptosis when co-expressing transgenic caAkt.",20842106_5,-1,-1,-1,-1,13221,-1,0.0034596343,0.11279892,0.88374144
13222,tumor cells,11,13,79,90,"These characteristics provided a survival advantage to T cells cocultured with tumor cells in vitro; CD3/28-stimulated T cells expressing a chimeric antigen receptor (CAR) specific for disialoganglioside (GD2) that redirected their activity to the immunosuppressive, GD2-expressing neuroblastoma cell line, LAN-1, resisted tumor-induced apoptosis when co-expressing transgenic caAkt.",20842106_5,-1,-1,-1,-1,13222,-1,0.004249634,0.39950037,0.59625
13227,to the,37,39,241,247,"These characteristics provided a survival advantage to T cells cocultured with tumor cells in vitro; CD3/28-stimulated T cells expressing a chimeric antigen receptor (CAR) specific for disialoganglioside (GD2) that redirected their activity to the immunosuppressive, GD2-expressing neuroblastoma cell line, LAN-1, resisted tumor-induced apoptosis when co-expressing transgenic caAkt.",20842106_5,-1,-1,-1,-1,13227,-1,2.1928703e-05,0.999966,1.2101729e-05
13236,transferred T lymphocytes,24,27,170,195,"In conclusion, caAkt-transduced T cells showed resistance to several evasion strategies employed by tumors and may therefore enhance the antitumor activity of adoptively transferred T lymphocytes.",20842106_6,-1,-1,-1,-1,13236,-1,0.002234937,0.052824233,0.9449409
13240,the tumor,2,4,13,22,We evaluated the tumor response and in vivo expansion of allogeneic NK cells in recurrent ovarian and breast cancer.,20849361_1,-1,-1,-1,-1,13240,-1,2.0221845e-05,0.99997056,9.163367e-06
13252,blood,29,30,163,168,"Subcutaneous IL-2 (10 MU) was given three times/week  6 doses after NK cell infusion to promote expansion, defined as detection of 100 donor-derived NK cells/L blood 14 days after infusion, based on molecular chimerism and flow cytometry.",20849361_4,0,1,-1,-1,13252,-1,0.0024842492,0.9593344,0.0381814
13259,T-regulatory cells,0,2,0,18,T-regulatory cells (Treg) were elevated at day +14 compared with pre-chemotherapy (P = 0.03).,20849361_9,-1,-1,-1,-1,13259,-1,0.0022270514,0.12104324,0.87672967
13277,the tumor,9,11,52,61,"In addition, the ratio of various subpopulations in the tumor microenvironment is highly dependent on the nature of the host's immune response.",20857491_1,-1,-1,-1,-1,13277,-1,2.0158139e-05,0.9999701,9.751197e-06
13278,the nature,16,18,102,112,"In addition, the ratio of various subpopulations in the tumor microenvironment is highly dependent on the nature of the host's immune response.",20857491_1,-1,-1,-1,-1,13278,-1,3.4668727e-05,0.9999417,2.3590645e-05
13283,the tumor that,10,13,57,71,"Here, we characterize Foxp3-expressing CD8(+) T cells in the tumor that demonstrate effector function and accumulate in the context of an effective anti-tumor response.",20857491_2,-1,-1,-1,-1,13283,-1,1.6802118e-05,0.9999738,9.436098e-06
13284,function,15,16,93,101,"Here, we characterize Foxp3-expressing CD8(+) T cells in the tumor that demonstrate effector function and accumulate in the context of an effective anti-tumor response.",20857491_2,0,1,2,-1,13284,-1,0.00017187049,0.99902725,0.0008009289
13295,tumor antigen-specific,3,5,20,42,Foxp3 expression in tumor antigen-specific CD8 T cells is restricted to the tumor microenvironment and influenced by cues in the tumor.,20857491_4,-1,-1,-1,-1,13295,-1,0.24208678,0.75350666,0.0044065956
13297,to the tumor,10,13,69,81,Foxp3 expression in tumor antigen-specific CD8 T cells is restricted to the tumor microenvironment and influenced by cues in the tumor.,20857491_4,-1,-1,-1,-1,13297,-1,2.6909689e-05,0.9999584,1.4680229e-05
13298,the tumor,19,21,125,134,Foxp3 expression in tumor antigen-specific CD8 T cells is restricted to the tumor microenvironment and influenced by cues in the tumor.,20857491_4,-1,-1,-1,-1,13298,-1,2.0251435e-05,0.99996984,9.905159e-06
13309,tolerance to,24,26,124,136,"Adoptive transfer studies, using RNEU((420-429)) -specific effector T cells into neu-N mice (a model that results in immune tolerance to neu), confirm that CD8(+) Foxp3(+) T cells are present in tumors only if there is an existing pool of tumor-rejecting effector T cells.",20857491_6,-1,-1,-1,-1,13309,-1,2.5638448e-05,0.9999622,1.2125677e-05
13320,tumor-rejecting antigen-specific T cells,9,13,42,82,CD8(+) Foxp3(+) TILs mark the presence of tumor-rejecting antigen-specific T cells and their accumulation serves as a marker for an effective T cell response.,20857491_7,-1,-1,-1,-1,13320,-1,0.015967445,0.64841443,0.33561814
13328,the antigen-induced,23,25,131,150,"Such early effectors, if present, should be characterized by a specific phenotype, distinct from that expressed at later stages of the antigen-induced differentiation program, by short-lived effector cells, memory precursors, and terminal effectors.",20861189_1,-1,-1,-1,-1,13328,-1,0.04219509,0.95690715,0.0008977004
13333,tissues,6,7,30,37,"Here, we show that neoplastic tissues from primary and metastatic lesions of melanoma patients contain a subset of CD8(+) T cells expressing FOXP3.",20861189_2,-1,1,2,-1,13333,-1,3.533618e-05,0.9998573,0.00010733635
13344,blood,15,16,105,110,Their frequency was significantly higher in TILN compared with tumor-free lymph nodes or with peripheral blood and in primary tumors compared with TILN.,20861189_4,0,1,-1,-1,13344,-1,0.0021822206,0.7471416,0.25067618
13354,factor-1,24,25,121,130,"CD8(+) FOXP3(+) T cells did not express markers of regulatory [CTLA-4, CCL4, interleukin-10 (IL-10), transforming growth factor-1], exhausted (PD-1), or senescent (CD57) CD8(+) T lymphocytes.",20861189_5,0,1,-1,-1,13354,-1,0.99592304,0.0016117367,0.0024651375
13356,this subset,2,4,9,20,"Instead, this subset showed an antigen-experienced ""EM1"" phenotype (CCR7(-) CD45RA(-) CD28(+) CD27(+)) and exhibited a CD127(-), KLRG1(-), HLA-DR(+), CD38(+), T-bet(+), perforin(+) ""early effector"" profile predicted by current models.",20861189_6,-1,-1,-1,-1,13356,-1,0.0038010438,0.3099153,0.68628365
13364,analysis,27,28,152,160,"CD8(+) FOXP3(+) T cells produced IFN- on short in vitro activation, recognized autologous tumor by CD107a mobilization, and expressed Ki-67 on ex vivo analysis.",20861189_7,0,1,-1,-1,13364,-1,5.498361e-05,0.9998828,6.216399e-05
13366,tumor plus,4,6,26,36,"In response to autologous tumor plus IL-2/IL-15, the CD8(+) FOXP3(+) T cells proliferated promptly and showed competence for differentiation (downregulation of CD27 and upregulation of T-bet).",20861189_8,-1,-1,-1,-1,13366,-1,3.5738452e-05,0.9999497,1.450805e-05
13372,immunity,9,10,63,71,These results suggest development of early phases of antitumor immunity even in advanced melanoma.,20861189_9,0,-1,2,-1,13372,-1,0.9968844,0.0025815754,0.0005339333
13377,immunity,19,20,95,103,"Moreover, the CD8(+) FOXP3(+) ""early effector"" subset may be an invaluable tool for monitoring immunity at tumor site.",20861189_10,0,-1,2,-1,13377,-1,0.97376096,0.02545177,0.0007872993
13380,the function,6,8,32,44,"In cancer, the phenotype and/or the function of T cells may differ according to their distribution through immune-associated tissues, namely immune compartments.",20883319_0,-1,-1,-1,-1,13380,-1,6.719976e-05,0.99988616,4.6585305e-05
13382,to their,14,16,77,85,"In cancer, the phenotype and/or the function of T cells may differ according to their distribution through immune-associated tissues, namely immune compartments.",20883319_0,-1,-1,-1,-1,13382,-1,2.3369937e-05,0.99996614,1.047657e-05
13384,tissues,19,20,125,132,"In cancer, the phenotype and/or the function of T cells may differ according to their distribution through immune-associated tissues, namely immune compartments.",20883319_0,-1,1,2,-1,13384,-1,0.0016573659,0.724857,0.27348566
13390,the T cell subsets,24,28,147,165,"Here, in N-methyl-N-nitrosourea (MNU)-induced mammary carcinomas of rat as a relevant model for human breast tumors, the impact of tumor burden on the T cell subsets populating the tumor microenvironment, the tumor-adjacent and -opposite mammary lymph nodes, and the spleen was assessed.",20883319_1,-1,-1,-1,-1,13390,-1,0.0028362938,0.10424881,0.89291495
13391,the tumor,29,31,177,186,"Here, in N-methyl-N-nitrosourea (MNU)-induced mammary carcinomas of rat as a relevant model for human breast tumors, the impact of tumor burden on the T cell subsets populating the tumor microenvironment, the tumor-adjacent and -opposite mammary lymph nodes, and the spleen was assessed.",20883319_1,-1,-1,-1,-1,13391,-1,1.99829e-05,0.99997056,9.423675e-06
13392,the tumor-adjacent,33,35,205,223,"Here, in N-methyl-N-nitrosourea (MNU)-induced mammary carcinomas of rat as a relevant model for human breast tumors, the impact of tumor burden on the T cell subsets populating the tumor microenvironment, the tumor-adjacent and -opposite mammary lymph nodes, and the spleen was assessed.",20883319_1,-1,-1,-1,-1,13392,-1,3.1393232e-05,0.9999534,1.5272579e-05
13394,the tumors,1,3,3,13,"In the tumors, ratio of CD8(+) cytotoxic and CD4(+) helper T cells were not significantly different than other immune compartments.",20883319_2,-1,-1,-1,-1,13394,-1,1.9545609e-05,0.9999696,1.0824468e-05
13398,these cells,7,9,27,38,"On the other hand, most of these cells were further identified with CD4(+) CD25(hi) or CD4(+) Foxp3(+) , CD8(+) Foxp3(+) regulatory phenotype.",20883319_3,-1,-1,-1,-1,13398,-1,0.0023312182,0.13827215,0.8593967
13405,tissue,13,14,85,91,The selective presence of Tregs in the mammary tumors but not in neighboring-mammary tissue was also confirmed by the expression of Treg-associated genes.,20883319_4,-1,1,2,-1,13405,-1,0.0010472006,0.63610286,0.36284995
13407,Treg-associated genes,21,23,132,153,The selective presence of Tregs in the mammary tumors but not in neighboring-mammary tissue was also confirmed by the expression of Treg-associated genes.,20883319_4,-1,-1,-1,-1,13407,-1,2.7065555e-05,0.99995184,2.1063344e-05
13411,the tumors,13,15,84,94,The percentage of CD161(+) NKT cells was also significantly increased especially in the tumors and mammary lymph nodes.,20883319_5,-1,-1,-1,-1,13411,-1,2.1013031e-05,0.9999684,1.0548539e-05
13414,to the,10,12,57,63,"In the lymph nodes of tumor-bearing animals, in contrast to the spleen, total amount of CD8(+) cells and CD4(+) cells were increased but both of these compartments harbored high numbers of CD4(+) CD25(hi) Treg cells.",20883319_6,-1,-1,-1,-1,13414,-1,1.9949523e-05,0.99996984,1.01712685e-05
13426,the T cells,23,26,149,160,"TGF- was determined as the major suppressive cytokine secreted by the immune cells of tumor-bearing animals, in addition, proliferation capacity of the T cells was diminished.",20883319_7,-1,-1,-1,-1,13426,-1,0.0022206265,0.09537011,0.90240926
13428,T cell subsets through the,6,11,40,66,"Hence, the differential distribution of T cell subsets through the spleen, the mammary lymph nodes and the tumor mass in MNU-induced mammary tumor-bearing animals may contribute to a tumor-associated immunosuppression.",20883319_8,-1,-1,-1,-1,13428,-1,0.002439914,0.069778964,0.9277811
13430,the tumor,18,20,103,112,"Hence, the differential distribution of T cell subsets through the spleen, the mammary lymph nodes and the tumor mass in MNU-induced mammary tumor-bearing animals may contribute to a tumor-associated immunosuppression.",20883319_8,-1,-1,-1,-1,13430,-1,2.1577433e-05,0.9999671,1.13257565e-05
13439,immune response gene,3,6,17,37,"Indeed, specific immune response gene signatures, obtained from whole biopsy samples, have been associated with patient survival.",20944673_1,-1,-1,-1,-1,13439,-1,0.66165346,0.331346,0.00700055
13446,functional,13,14,93,103,We identified 677 non-redundant genes defining the FL interface and involving 26 FL-specific functional networks.,20944673_3,0,1,2,-1,13446,-1,0.00015045014,0.9997551,9.444372e-05
13454,through transcriptomic,23,25,128,150,"In addition, FL microenvironment was characterized by a strong enrichment in follicular helper T cells (T(FH)), as demonstrated through transcriptomic and flow cytometry analyses.",20944673_5,-1,-1,-1,-1,13454,-1,3.3995577e-05,0.99994445,2.156131e-05
13462,tonsil-derived T(FH,16,18,94,113,"Moreover, purified FL-derived T(FH), expressed IL4 at very high levels compared with purified tonsil-derived T(FH) or non-T(FH) microenvironment.",20944673_7,-1,-1,-1,-1,13462,-1,9.961672e-05,0.99977833,0.00012208278
13463,that tumor-infiltrating T(FH,5,8,35,63,"Altogether, our study demonstrated that tumor-infiltrating T(FH) specifically express functional IL-4 in FL, creating an IL-4-dependent T(FH)-B cell axis.",20944673_8,-1,-1,-1,-1,13463,-1,2.6911192e-05,0.9999552,1.7890135e-05
13464,functional,11,12,86,96,"Altogether, our study demonstrated that tumor-infiltrating T(FH) specifically express functional IL-4 in FL, creating an IL-4-dependent T(FH)-B cell axis.",20944673_8,0,1,2,-1,13464,-1,4.1708794e-05,0.99993634,2.2002248e-05
13465,T(FH)-B cell,19,21,136,148,"Altogether, our study demonstrated that tumor-infiltrating T(FH) specifically express functional IL-4 in FL, creating an IL-4-dependent T(FH)-B cell axis.",20944673_8,-1,-1,-1,-1,13465,-1,0.0023896918,0.8604183,0.137192
13468,therapeutic target,12,14,76,94,This cross talk could sustain FL pathogenesis and represent a new potential therapeutic target.,20944673_9,-1,-1,-1,-1,13468,-1,2.581646e-05,0.9999634,1.0784803e-05
13477,tissue,3,4,23,29,Surgically removed CRC tissue was collected from 12 patients with CRC.,20952660_2,-1,1,2,-1,13477,-1,0.00015059982,0.9880235,0.0118258875
13483,tissue,6,7,37,43,Chemokine CXCL11 was examined in CRC tissue by Western blotting.,20952660_4,-1,1,2,-1,13483,-1,3.3251297e-05,0.99988735,7.943368e-05
13484,Treg chemotaxis,0,2,0,15,Treg chemotaxis was examined in a transwell system.,20952660_5,-1,-1,-1,-1,13484,-1,0.0039263787,0.99553853,0.00053501944
13493,tissue that,9,11,51,62,"Abundant Foxp3+IL-17+ T cells were detected in CRC tissue that expresses high levels of TGF-, CXCR3, CCR6, and RORt.",20952660_7,-1,-1,-1,-1,13493,-1,3.515503e-05,0.9998971,6.768397e-05
13497,tissue-derived,8,9,43,57,"High levels of CXCL11 were detected in CRC tissue-derived CD68+ cells, which had a strong chemotactic effect on Foxp3+ Tregs.",20952660_8,-1,1,2,-1,13497,-1,4.19207e-05,0.9998971,6.098123e-05
13509,the cells to,26,29,149,161,Hypoxia induced the expression of IL-17 in Foxp3+ Tregs; Foxp3+IL-17+ T cells were capable of inducing CRC-associated cell markers in BMMo and drove the cells to be cancer-initiating cells.,20952660_9,-1,-1,-1,-1,13509,-1,0.00010204065,0.9996438,0.00025417336
13516,tissue-derived Foxp3+IL-17,1,3,4,30,CRC tissue-derived Foxp3+IL-17+ cells have the capacity to induce cancer-initiating cells.,20952660_11,-1,-1,-1,-1,13516,-1,0.026521394,0.9717448,0.0017338346
13521,to chemotherapy,17,19,93,108,"Survivin is overexpressed by 70-80% of pancreatic cancers, and is associated with resistance to chemotherapy and a poor prognosis.",20960189_0,-1,-1,-1,-1,13521,-1,0.31923807,0.67600745,0.004754501
13525,the tumor-suppressive,8,10,71,92,Recent reports have demonstrated that gemcitabine treatment attenuates the tumor-suppressive environment by eliminating CD11b(+)/Gr-1(+) myeloid-derived suppressor cells (MDSCs).,20960189_2,-1,-1,-1,-1,13525,-1,3.3757e-05,0.9999496,1.6638778e-05
13530,tested this,5,7,18,29,"In this study, we tested this hypothesis using modified vaccinia Ankara (MVA) expressing full-length murine survivin.",20960189_4,-1,-1,-1,-1,13530,-1,2.0430049e-05,0.9999696,1.0013059e-05
13541,immune response to,4,7,33,51,"To analyze the survivin-specific immune response to MVA-survivin immunization, we utilized a peptide library of 15mers with 11 residues overlapping from full-length murine survivin.",20960189_9,-1,-1,-1,-1,13541,-1,0.51606053,0.4812017,0.0027378076
13542,peptide,13,14,93,100,"To analyze the survivin-specific immune response to MVA-survivin immunization, we utilized a peptide library of 15mers with 11 residues overlapping from full-length murine survivin.",20960189_9,0,-1,2,-1,13542,-1,0.0001199443,0.9997466,0.00013346026
13545,peptide,18,19,143,150,Splenocytes from mice immunized with MVA-survivin produced intracellular -interferon in response to in vitro stimulation with the overlapping peptide library.,20960189_10,0,-1,2,-1,13545,-1,0.005165853,0.98819554,0.0066386135
13546,T cells that,4,7,35,47,Increased survivin-specific CD8(+) T cells that specifically recognized the Pan02 tumor line were seen in mice treated with MVA-survivin and gemcitabine.,20960189_11,-1,-1,-1,-1,13546,-1,0.0015962507,0.033471067,0.96493274
13556,function,1,2,17,25,Immunomodulatory function of bone marrow derived mesenchymal stem cells in cancer has recently been investigated.,20970781_0,0,1,2,-1,13556,-1,4.3987387e-05,0.99992466,3.132749e-05
13561,tissue,15,16,84,90,But the resident mesenchymal stem cells as whole in cancer and in the breast cancer tissue have not been studied well.,20970781_1,-1,1,2,-1,13561,-1,4.2472027e-05,0.9998902,6.7319466e-05
13564,tissues to,19,21,103,113,"In the present work we isolated adipose derived stem cells (ASCs) from breast cancer and normal breast tissues to investigate the expressions of IL-4, IL-10 and transforming growth factor (TGF)-1 in ASCs and to see if ASCs isolated from patients can modulate the regulatory molecules on peripheral blood lymphocytes.",20970781_2,-1,-1,-1,-1,13564,-1,4.3180615e-05,0.99990606,5.0788785e-05
13567,transforming growth factor,29,32,161,187,"In the present work we isolated adipose derived stem cells (ASCs) from breast cancer and normal breast tissues to investigate the expressions of IL-4, IL-10 and transforming growth factor (TGF)-1 in ASCs and to see if ASCs isolated from patients can modulate the regulatory molecules on peripheral blood lymphocytes.",20970781_2,-1,-1,-1,-1,13567,-1,0.88633895,0.109793894,0.003867164
13570,blood lymphocytes,50,52,299,316,"In the present work we isolated adipose derived stem cells (ASCs) from breast cancer and normal breast tissues to investigate the expressions of IL-4, IL-10 and transforming growth factor (TGF)-1 in ASCs and to see if ASCs isolated from patients can modulate the regulatory molecules on peripheral blood lymphocytes.",20970781_2,-1,-1,-1,-1,13570,-1,0.0005603311,0.004117863,0.9953219
13571,that IL-10,3,5,19,29,Our results showed that IL-10 and TGF-1 have significantly higher mRNA expressions in ASCs isolated from breast cancer patients than those from normal individuals (P value <0.05).,20970781_3,-1,-1,-1,-1,13571,-1,0.72578883,0.26898146,0.00522974
13573,than those,19,21,129,139,Our results showed that IL-10 and TGF-1 have significantly higher mRNA expressions in ASCs isolated from breast cancer patients than those from normal individuals (P value <0.05).,20970781_3,-1,-1,-1,-1,13573,-1,2.2118484e-05,0.999964,1.3827184e-05
13589,tissue,10,11,69,75,These data collectively conclude that resident ASCs in breast cancer tissue may have crucial roles in breast tumor growth and progression by inducing regulatory molecules and promoting anti-inflammatory reaction within the tumor microenvironment.,20970781_7,-1,1,2,-1,13589,-1,6.27843e-05,0.99968016,0.00025704224
13591,the tumor,30,32,219,228,These data collectively conclude that resident ASCs in breast cancer tissue may have crucial roles in breast tumor growth and progression by inducing regulatory molecules and promoting anti-inflammatory reaction within the tumor microenvironment.,20970781_7,-1,-1,-1,-1,13591,-1,1.8740799e-05,0.9999722,9.044861e-06
13594,tumor cells,18,20,115,126,Further investigation is required to see if the immune suppression induced by ASCs is an independent property from tumor cells or ASCs gain their immunosuppressive potential from malignant cells.,20970781_8,-1,-1,-1,-1,13594,-1,0.0045340727,0.38306308,0.6124029
13597,tumor-associated antigen,4,6,20,44,"HBx is an oncogenic tumor-associated antigen and is dominantly expressed in hepatitis and hepatoma tissues, the induction of active cellular responses against HBx should be a promising approach for the treatment of hepatitis B virus-related hepatocellular carcinoma.",21042781_0,-1,-1,-1,-1,13597,-1,0.043945223,0.94957113,0.006483629
13598,tissues,14,15,99,106,"HBx is an oncogenic tumor-associated antigen and is dominantly expressed in hepatitis and hepatoma tissues, the induction of active cellular responses against HBx should be a promising approach for the treatment of hepatitis B virus-related hepatocellular carcinoma.",21042781_0,-1,1,2,-1,13598,-1,0.00014036815,0.99748224,0.002377428
13601,the treatment,30,32,198,211,"HBx is an oncogenic tumor-associated antigen and is dominantly expressed in hepatitis and hepatoma tissues, the induction of active cellular responses against HBx should be a promising approach for the treatment of hepatitis B virus-related hepatocellular carcinoma.",21042781_0,-1,-1,-1,-1,13601,-1,2.3516266e-05,0.9999671,9.359853e-06
13603,to test,5,7,31,38,The present study was designed to test whether a replication-defective adenovirus vaccine expressing HBx antigen could be effectively used in the immunotherapy of hepatocellular carcinoma.,21042781_1,-1,-1,-1,-1,13603,-1,1.8462766e-05,0.99997234,9.250961e-06
13614,immunity,14,15,99,107,We found that immunotherapy with Ad-HBx was effective at both protective and therapeutic antitumor immunity in the hepatoma models in immune-competent mice.,21042781_3,0,-1,2,-1,13614,-1,0.9986941,0.00090578606,0.0004001601
13622,the CTL,7,9,39,46,"In addition, the induction efficacy of the CTL response is dramatically enhanced by immunotherapy.",21042781_5,-1,-1,-1,-1,13622,-1,0.0035569572,0.2189967,0.77744645
13623,Cytokine analysis,0,2,0,17,Cytokine analysis confirmed that the antitumor efficacy of Ad-HBx may mostly result from cellular immunity.,21042781_6,-1,-1,-1,-1,13623,-1,0.8591968,0.13310878,0.0076943855
13624,that the,3,5,28,36,Cytokine analysis confirmed that the antitumor efficacy of Ad-HBx may mostly result from cellular immunity.,21042781_6,-1,-1,-1,-1,13624,-1,2.0880294e-05,0.9999714,7.683738e-06
13626,antigen to the treatment,13,17,80,104,Our findings may prove useful in development of adenovirus vaccine based on HBx antigen to the treatment of HBV-associated hepatocellular carcinoma.,21042781_7,-1,-1,-1,-1,13626,-1,0.39522576,0.58487797,0.019896235
13627,Analysis,0,1,0,8,"Analysis of cytokine and chemokine production by tumor cell lines including five lung cancers, a malignant mesothelioma, and a malignant melanoma recently established in our laboratory showed rather high production of IL-8 in all tumors and IL-6 in one lung cancer, the malignant mesothelioma, and the malignant melanoma.",21048114_0,0,1,-1,-1,13627,-1,2.4550043e-05,0.9999596,1.5875978e-05
13630,tumor cell,7,9,49,59,"Analysis of cytokine and chemokine production by tumor cell lines including five lung cancers, a malignant mesothelioma, and a malignant melanoma recently established in our laboratory showed rather high production of IL-8 in all tumors and IL-6 in one lung cancer, the malignant mesothelioma, and the malignant melanoma.",21048114_0,-1,-1,-1,-1,13630,-1,0.004233129,0.5396748,0.45609203
13637,to these tumor cells,6,10,39,59,We investigated the migration of PBMCs to these tumor cells using Transwell plates and showed enrichment of Foxp3(+) CD4 regulatory T cells (Tregs) in migrated T cells to both IL-6- and IL-8-producing tumors.,21048114_1,-1,-1,-1,-1,13637,-1,0.0024665736,0.88959783,0.10793559
13638,Transwell plates,11,13,66,82,We investigated the migration of PBMCs to these tumor cells using Transwell plates and showed enrichment of Foxp3(+) CD4 regulatory T cells (Tregs) in migrated T cells to both IL-6- and IL-8-producing tumors.,21048114_1,-1,-1,-1,-1,13638,-1,3.8541104e-05,0.9999291,3.2349795e-05
13642,T cells to,28,31,160,170,We investigated the migration of PBMCs to these tumor cells using Transwell plates and showed enrichment of Foxp3(+) CD4 regulatory T cells (Tregs) in migrated T cells to both IL-6- and IL-8-producing tumors.,21048114_1,-1,-1,-1,-1,13642,-1,0.0017777703,0.02423545,0.97398686
13644,IL-8-producing tumors,34,36,186,207,We investigated the migration of PBMCs to these tumor cells using Transwell plates and showed enrichment of Foxp3(+) CD4 regulatory T cells (Tregs) in migrated T cells to both IL-6- and IL-8-producing tumors.,21048114_1,-1,-1,-1,-1,13644,-1,0.98931956,0.007515465,0.0031649664
13651,the tumors,5,7,31,41,Frequent production of IL-8 by the tumors and Treg migration to those tumors through induction of IL-8R expression by IL-6 is one of the mechanisms for tumor escape.,21048114_3,-1,-1,-1,-1,13651,-1,2.3150033e-05,0.99996376,1.310659e-05
13653,to those tumors through,10,14,61,84,Frequent production of IL-8 by the tumors and Treg migration to those tumors through induction of IL-8R expression by IL-6 is one of the mechanisms for tumor escape.,21048114_3,-1,-1,-1,-1,13653,-1,2.5773263e-05,0.99996054,1.3742096e-05
13658,Cytotoxic T Lymphocyte Antigen,0,4,0,30,Cytotoxic T Lymphocyte Antigen 4 (CTLA4) blockade has shown antitumor activity against common cancers.,21056008_0,-1,-1,-1,-1,13658,-1,0.0009112509,0.00012479752,0.99896395
13665,that tremelimumab,3,5,17,34,"Our results show that tremelimumab enhanced the proliferative response of T effector cells (Teff) upon TCR stimulation, and abrogated Treg suppressive ability.",21056008_3,-1,-1,-1,-1,13665,-1,3.300756e-05,0.9999479,1.9119187e-05
13670,TCR,17,18,103,106,"Our results show that tremelimumab enhanced the proliferative response of T effector cells (Teff) upon TCR stimulation, and abrogated Treg suppressive ability.",21056008_3,-1,1,2,-1,13670,-1,3.0302957e-05,0.99994385,2.57896e-05
13678,tumor antigens,30,32,180,194,"In the presence of tremelimumab, frequencies of IL-2-secreting CD4(+) T cells and IFN--secreting CD4(+) and CD8(+) T cells were increased in response to polyclonal activation and tumor antigens.",21056008_4,-1,-1,-1,-1,13678,-1,0.2877896,0.7027423,0.009468126
13689,Taken together,0,2,0,14,"Taken together, this data indicates that tremelimumab induces immune responses mainly by direct activation of Teff rather than by affecting Tregs.",21056008_6,-1,-1,-1,-1,13689,-1,4.1701893e-05,0.9999416,1.6720358e-05
13691,that tremelimumab,6,8,36,53,"Taken together, this data indicates that tremelimumab induces immune responses mainly by direct activation of Teff rather than by affecting Tregs.",21056008_6,-1,-1,-1,-1,13691,-1,3.3915414e-05,0.99994874,1.7314502e-05
13700,the thymus-derived TH17 lymphocyte subset,3,8,28,69,Molecular studies implicate the thymus-derived TH17 lymphocyte subset in a remarkable immunotherapeutic regression.,21061759_1,-1,-1,-1,-1,13700,-1,0.0033138788,0.77066237,0.22602381
13703,tissue,9,10,65,71,The authors performed RT-PCR of total RNA from paraffin-embedded tissue before and after treatment with DPCP.,21061759_2,-1,1,2,-1,13703,-1,4.7769416e-05,0.9997533,0.00019894491
13707,treatment there,15,17,89,104,"Before treatment with DPCP, the authors found elevated expression of IL 17C/D/E/F; after treatment there was no detectable expression.",21061759_3,-1,-1,-1,-1,13707,-1,2.2194183e-05,0.9999664,1.146157e-05
13714,the time,5,7,32,40,Conclusions are limited to only the time samples were obtained.,21061759_6,-1,-1,-1,-1,13714,-1,3.744499e-05,0.99992824,3.4325392e-05
13716,the immunomodulatory agent,9,12,72,98,Remarkable regression of an in-transit metastatic melanoma treated with the immunomodulatory agent DPCP showed gain and loss of gene expression of the TH17 pathway.,21061759_7,-1,-1,-1,-1,13716,-1,0.0054150317,0.99357796,0.0010070045
13718,the TH17,21,23,147,155,Remarkable regression of an in-transit metastatic melanoma treated with the immunomodulatory agent DPCP showed gain and loss of gene expression of the TH17 pathway.,21061759_7,-1,-1,-1,-1,13718,-1,3.309945e-05,0.9999528,1.4051512e-05
13721,to TH7,9,11,46,52,Further study of this pathway from NK to NK-T to TH7 and TH1 cells both with and without accessory or dendritic cells will improve understanding of contact sensitizers as topical immunomodulators.,21061759_8,-1,-1,-1,-1,13721,-1,5.1750078e-05,0.9998785,6.9748006e-05
13724,topical immunomodulators,29,31,171,195,Further study of this pathway from NK to NK-T to TH7 and TH1 cells both with and without accessory or dendritic cells will improve understanding of contact sensitizers as topical immunomodulators.,21061759_8,-1,-1,-1,-1,13724,-1,0.020609355,0.97883624,0.0005543464
13727,immunity,8,9,70,78,Therapeutic strategies combining the induction of effective antitumor immunity with the inhibition of the mechanisms of tumor-induced immunosuppression represent a key objective in cancer immunotherapy.,21123824_0,0,-1,2,-1,13727,-1,0.9987531,0.0008789014,0.00036801177
13741,function,34,35,234,242,"Herein we demonstrate that effector/memory CD4(+) T helper-1 (Th-1) lymphocytes, in addition to polarizing type-1 antitumor immune responses, impair tumor-induced CD4(+)CD25(+)FoxP3(+) regulatory T lymphocyte (Treg) immunosuppressive function in vitro and in vivo.",21123824_1,0,1,2,-1,13741,-1,0.00018811184,0.9994367,0.00037519587
13743,the generation,4,6,24,38,Th-1 cells also inhibit the generation of FoxP3(+) Tregs from naive CD4(+)CD25(-)FoxP3(-) T cells by an interferon--dependent mechanism.,21123824_2,-1,-1,-1,-1,13743,-1,1.9009665e-05,0.99996805,1.2890606e-05
13749,Th-1 lymphocytes,13,15,59,75,"In addition, in an aggressive mouse leukemia model (12B1), Th-1 lymphocytes act synergistically with a chaperone-rich cell lysate (CRCL) vaccine, leading to improved survival and long-lasting protection against leukemia.",21123824_3,-1,-1,-1,-1,13749,-1,0.0023666418,0.14997736,0.847656
13753,tumor-specific antigens,8,10,39,62,The combination of CRCL as a source of tumor-specific antigens and Th-1 lymphocytes as an adjuvant has the potential to stimulate efficient specific antitumor immunity while restraining Treg-induced suppression.,21123824_4,-1,-1,-1,-1,13753,-1,0.059921622,0.93513364,0.004944682
13754,Th-1 lymphocytes,11,13,67,83,The combination of CRCL as a source of tumor-specific antigens and Th-1 lymphocytes as an adjuvant has the potential to stimulate efficient specific antitumor immunity while restraining Treg-induced suppression.,21123824_4,-1,-1,-1,-1,13754,-1,0.0014822396,0.06906923,0.9294485
13757,immunity,24,25,159,167,The combination of CRCL as a source of tumor-specific antigens and Th-1 lymphocytes as an adjuvant has the potential to stimulate efficient specific antitumor immunity while restraining Treg-induced suppression.,21123824_4,0,-1,2,-1,13757,-1,0.9993824,0.00033435822,0.00028317922
13760,immunity,9,10,50,58,Renal cell carcinoma (RCC) can inhibit protective immunity by induction of immunosuppressive cells that produce inhibitory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-.,21150720_0,0,-1,2,-1,13760,-1,0.9885361,0.010753359,0.00071044493
13761,cells that,14,16,93,103,Renal cell carcinoma (RCC) can inhibit protective immunity by induction of immunosuppressive cells that produce inhibitory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-.,21150720_0,-1,-1,-1,-1,13761,-1,0.0031442996,0.094480544,0.9023751
13764,transforming growth factor,24,27,165,191,Renal cell carcinoma (RCC) can inhibit protective immunity by induction of immunosuppressive cells that produce inhibitory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-.,21150720_0,-1,-1,-1,-1,13764,-1,0.9519688,0.044378314,0.0036529058
13770,blood,15,16,106,111,"Therefore, we asked for the prognostic influence of cells with immunosuppressive properties in peripheral blood (pB) in a cohort of metastatic clear cell renal cell carcinoma (mRCC) patients uniformly receiving sorafenib treatment.",21150720_2,0,1,-1,-1,13770,-1,7.449572e-05,0.99964476,0.00028068258
13778,cell subsets,19,21,115,127,"IL-10 and TGF- mRNA levels, regulatory T-cell (Treg) counts, and frequencies of IL-10/TGF- producing mononuclear cell subsets were determined in pB from 46 patients with mRCC before receiving sorafenib treatment.",21150720_3,-1,-1,-1,-1,13778,-1,3.5802273e-05,4.041745e-05,0.9999238
13781,factors,7,8,68,75,Relationship between established clinical and laboratory prognostic factors and outcome were examined by univariate and multivariate Cox regression analysis.,21150720_4,0,1,-1,-1,13781,-1,0.0011864632,0.99812657,0.00068702066
13782,analysis,18,19,148,156,Relationship between established clinical and laboratory prognostic factors and outcome were examined by univariate and multivariate Cox regression analysis.,21150720_4,0,1,-1,-1,13782,-1,3.880565e-05,0.9999318,2.9357592e-05
13788,analysis,3,4,18,26,"In a multivariate analysis low ECOG score and-surprisingly-high TGF-1 mRNA levels were independently associated with favorable progression-free survival (P=0.005 and P=0.003, respectively) and overall survival (P=0.001 and P=0.039, respectively).",21150720_7,0,1,-1,-1,13788,-1,3.8169743e-05,0.9999411,2.0683572e-05
13790,blood,12,13,84,89,"In conclusion, mRCC is associated with an immunosuppressive phenotype in peripheral blood.",21150720_8,0,1,-1,-1,13790,-1,9.247362e-05,0.9995838,0.00032375424
13793,functions,14,15,101,110,The positive prognostic influence of high TGF-1 mRNA expression levels may reflect immune promoting functions of TGF- in combined activity with inflammatory cytokines.,21150720_9,0,1,2,-1,13793,-1,0.00029080146,0.9994777,0.00023158106
13798,thought to,9,11,40,50,"PURPOSE: Regulatory T cells (Tregs) are thought to inhibit antitumor immune responses, and their depletion could therefore have a synergistic effect with therapeutic cancer vaccines.",21177412_0,-1,-1,-1,-1,13798,-1,3.093589e-05,0.99995613,1.2987007e-05
13805,blood Treg,8,10,51,61,We investigated the impact of three medications on blood Treg frequency in vaccinated cancer patients.,21177412_1,-1,-1,-1,-1,13805,-1,3.16045e-05,0.9999478,2.0587402e-05
13811,the transcription factor FOXP3,20,24,112,142,"EXPERIMENTAL DESIGN: To date, the most specific marker for human Tregs is demethylation in the DNA that encodes the transcription factor FOXP3.",21177412_2,-1,-1,-1,-1,13811,-1,2.0704407e-05,0.99996746,1.1806548e-05
13817,blood,20,21,122,127,"Thus, we used a FOXP3 methylation-specific quantitative PCR assay (MS-qPCR) to measure Treg frequencies in the peripheral blood mononuclear cells (PBMCs) of melanoma patients.",21177412_3,0,1,-1,-1,13817,-1,0.0010536744,0.9366245,0.062321793
13821,trials that,6,8,44,55,"The patients participated in three clinical trials that combined tumor vaccines with potential Treg-depleting agents: low-dose cyclophosphamide, anti-CD25 monoclonal antibody daclizumab, and the IL-2/diphtheria toxin fusion protein denileukin diftitox.",21177412_4,-1,-1,-1,-1,13821,-1,2.299174e-05,0.99996233,1.4721141e-05
13826,protein,29,30,224,231,"The patients participated in three clinical trials that combined tumor vaccines with potential Treg-depleting agents: low-dose cyclophosphamide, anti-CD25 monoclonal antibody daclizumab, and the IL-2/diphtheria toxin fusion protein denileukin diftitox.",21177412_4,0,1,-1,-1,13826,-1,0.00014078128,0.99975234,0.000106857944
13828,blood Treg,8,10,39,49,"RESULTS: In the nine control patients, blood Treg frequencies varied over time; there was a 46% reduction in one patient.",21177412_5,-1,-1,-1,-1,13828,-1,4.306492e-05,0.9999182,3.8762624e-05
13833,in Tregs,9,11,49,57,"In treated patients, a more than 2-fold decrease in Tregs was observed in one out of 11 patients receiving cyclophosphamide and in four out of 13 receiving daclizumab, but there was no such Treg decrease in any of the six patients who received denileukin diftitox.",21177412_6,-1,-1,-1,-1,13833,-1,3.0938885e-05,0.99995375,1.528587e-05
13838,in blood Tregs,10,13,51,65,"As a positive control, a more than 2-fold increase in blood Tregs was detected in four out of nine patients who were treated with interleukin-2.CONCLUSIONS: We used a MS-qPCR method that detects Tregs but not other activated T lymphocytes; however, none of the Treg-depleting strategies that we tested led, in the majority of patients, to a conservative 50% reduction in blood Tregs.",21177412_7,-1,-1,-1,-1,13838,-1,3.0885454e-05,0.99995244,1.6629925e-05
13843,the Treg-depleting,46,48,257,275,"As a positive control, a more than 2-fold increase in blood Tregs was detected in four out of nine patients who were treated with interleukin-2.CONCLUSIONS: We used a MS-qPCR method that detects Tregs but not other activated T lymphocytes; however, none of the Treg-depleting strategies that we tested led, in the majority of patients, to a conservative 50% reduction in blood Tregs.",21177412_7,-1,-1,-1,-1,13843,-1,3.7733593e-05,0.9999348,2.7526568e-05
13848,in blood Tregs,66,69,368,382,"As a positive control, a more than 2-fold increase in blood Tregs was detected in four out of nine patients who were treated with interleukin-2.CONCLUSIONS: We used a MS-qPCR method that detects Tregs but not other activated T lymphocytes; however, none of the Treg-depleting strategies that we tested led, in the majority of patients, to a conservative 50% reduction in blood Tregs.",21177412_7,-1,-1,-1,-1,13848,-1,3.4190973e-05,0.99994504,2.0815603e-05
13854,to tumour,26,28,143,152,"BACKGROUND: 'FOXP3+ regulatory T cells' (Tregs) are reported to be increased in tumour-bearing hosts including patients with melanoma, leading to tumour immune suppression.",21198537_0,-1,-1,-1,-1,13854,-1,2.1918793e-05,0.99996793,1.01096375e-05
13856,that the,9,11,52,60,"However, this idea is challenged by recent evidence that the 'FOXP3+ Treg' fraction in fact contains activated 'nonregulatory' T cells.",21198537_1,-1,-1,-1,-1,13856,-1,1.653542e-05,0.9999752,8.301901e-06
13863,functionally,10,11,42,54,"Also, FOXP3+ T cells are reported to have functionally and kinetically distinct subsets.",21198537_2,0,1,2,-1,13863,-1,8.964085e-05,0.99987686,3.3464377e-05
13870,three subsets,9,11,45,58,"METHODS: FOXP3+ T cells were classified into three subsets, namely CD45RO+FOXP3(low) nonregulatory T cells, CD45RO+FOXP3(high) effector Tregs, and CD45RO-FOXP3(low) nave Tregs, according to their expression levels of FOXP3 and CD45RO.",21198537_4,-1,-1,-1,-1,13870,-1,0.0031689934,0.06712921,0.92970175
13875,to their,31,33,188,196,"METHODS: FOXP3+ T cells were classified into three subsets, namely CD45RO+FOXP3(low) nonregulatory T cells, CD45RO+FOXP3(high) effector Tregs, and CD45RO-FOXP3(low) nave Tregs, according to their expression levels of FOXP3 and CD45RO.",21198537_4,-1,-1,-1,-1,13875,-1,2.2710834e-05,0.999966,1.1209542e-05
13879,these FOXP3,6,8,42,53,The percentage and cytokine production of these FOXP3+ T-cell subsets were assessed by flow cytometry.,21198537_5,-1,-1,-1,-1,13879,-1,2.8882518e-05,0.9999535,1.7575077e-05
13890,interferon-+ cells,48,50,280,299,"Moreover, we found three unexpected perturbations in FOXP3+ T-cell subsets: (i) patients with melanoma showed higher frequencies of FOXP3(low) nonregulatory T cells, which decreased and normalized after tumour removal; (ii) FOXP3(low) nave Tregs containing higher frequencies of interferon-+ cells increased with tumour progression; and (iii) CD45RO+FOXP3(high) effector Tregs were pronouncedly infiltrated around tumour tissues.",21198537_7,-1,-1,-1,-1,13890,-1,0.8678494,0.0020916434,0.13005894
13893,tumour tissues,67,69,416,430,"Moreover, we found three unexpected perturbations in FOXP3+ T-cell subsets: (i) patients with melanoma showed higher frequencies of FOXP3(low) nonregulatory T cells, which decreased and normalized after tumour removal; (ii) FOXP3(low) nave Tregs containing higher frequencies of interferon-+ cells increased with tumour progression; and (iii) CD45RO+FOXP3(high) effector Tregs were pronouncedly infiltrated around tumour tissues.",21198537_7,-1,-1,-1,-1,13893,-1,3.979104e-05,0.9999175,4.269e-05
13900,that the,13,15,88,96,"The degree of perturbation is associated with tumour burden and progression, suggesting that the perturbation reflects fundamental pathophysiological processes in patients with melanoma.",21198537_9,-1,-1,-1,-1,13900,-1,1.8659157e-05,0.9999732,8.104986e-06
13902,analysis,2,3,14,22,The presented analysis provides a practical approach to investigate the immunological environment of cancer patients.,21198537_10,0,1,-1,-1,13902,-1,3.7205853e-05,0.9999368,2.5962157e-05
13921,LPS to trigger the toll-like receptor,10,16,50,87,"As PTX has been reported to mimic the activity of LPS to trigger the toll-like receptor 4 (TLR4) signalling pathway in macrophages, we investigated the possible role of TLR4 in the effect of PTX.",21223350_3,-1,-1,-1,-1,13921,-1,0.0007662501,0.9916415,0.0075922306
13928,than that,10,12,59,68,"However, although TLR4 expression on Treg cells was higher than that on Teff cells, the expression level remained unaltered in both Treg and Teff cells after PTX treatment.",21223350_4,-1,-1,-1,-1,13928,-1,2.7023607e-05,0.99995804,1.4945102e-05
13929,Teff cells,13,15,72,82,"However, although TLR4 expression on Treg cells was higher than that on Teff cells, the expression level remained unaltered in both Treg and Teff cells after PTX treatment.",21223350_4,-1,-1,-1,-1,13929,-1,0.0026639865,0.23341997,0.7639161
13932,Teff cells,25,27,141,151,"However, although TLR4 expression on Treg cells was higher than that on Teff cells, the expression level remained unaltered in both Treg and Teff cells after PTX treatment.",21223350_4,-1,-1,-1,-1,13932,-1,0.0036606397,0.40040305,0.59593636
13935,Teff cells,8,10,53,63,"Surface molecules and activation markers in Treg and Teff cells did not change, either.",21223350_5,-1,-1,-1,-1,13935,-1,0.0041659675,0.44428557,0.5515485
13936,that the,3,5,21,29,Further study showed that the effect of PTX on TLR4-/- mice deficient in TLR4 signalling was similar to that on C57BL/6 mice both in vivo and in vitro.,21223350_6,-1,-1,-1,-1,13936,-1,1.7020131e-05,0.99997485,8.133517e-06
13938,to that,17,19,101,108,Further study showed that the effect of PTX on TLR4-/- mice deficient in TLR4 signalling was similar to that on C57BL/6 mice both in vivo and in vitro.,21223350_6,-1,-1,-1,-1,13938,-1,2.4265546e-05,0.999964,1.1748315e-05
13940,that the,3,5,20,28,These data indicate that the selective impairment of Treg cells by PTX is independent of TLR4.,21223350_7,-1,-1,-1,-1,13940,-1,1.8661667e-05,0.9999733,8.048243e-06
13943,to release Th2-dominated,6,9,39,63,It is very important for immunotherapy to release Th2-dominated and Treg-dominated immunological conditions in patients with malignant diseases.,21224532_0,-1,-1,-1,-1,13943,-1,3.7129896e-05,0.99994075,2.2128857e-05
13947,blood,15,16,106,111,"In the present study, we assessed the population of CD4+IL-10+T-cells and CD4+Foxp3+T-cells in peripheral blood in patients with colorectal cancer using a flow cytometric analysis, and we investigated whether Th2-dominated and Treg-dominated condition could be modulated by PSK.",21224532_1,0,1,-1,-1,13947,-1,7.219391e-05,0.9996346,0.00029311038
13948,analysis,25,26,171,179,"In the present study, we assessed the population of CD4+IL-10+T-cells and CD4+Foxp3+T-cells in peripheral blood in patients with colorectal cancer using a flow cytometric analysis, and we investigated whether Th2-dominated and Treg-dominated condition could be modulated by PSK.",21224532_1,0,1,-1,-1,13948,-1,2.9380222e-05,0.999946,2.462843e-05
13951,blood,1,2,11,16,Peripheral blood samples were collected preoperatively from 40 patients with colorectal cancer before and after oral administration of PSK (3 g/day  1 week).,21224532_2,0,1,-1,-1,13951,-1,0.00011123022,0.99898297,0.0009058062
13958,release Th2-dominated,6,8,37,58,These results suggest that PSK could release Th2-dominated and Treg-dominated immunological condition in patients with colorectal cancer.,21224532_5,-1,-1,-1,-1,13958,-1,3.6712936e-05,0.999938,2.5245865e-05
13963,the nuclear factor,2,5,11,29,Members of the nuclear factor of activated T cell (NFAT) family of transcription factors were originally described in T lymphocytes but later shown to be expressed in several immune and non-immune cell types.,21225259_0,-1,-1,-1,-1,13963,-1,2.028547e-05,0.99996686,1.2883893e-05
13968,cell types,33,35,197,207,Members of the nuclear factor of activated T cell (NFAT) family of transcription factors were originally described in T lymphocytes but later shown to be expressed in several immune and non-immune cell types.,21225259_0,-1,-1,-1,-1,13968,-1,3.4599878e-05,5.2765055e-05,0.9999126
13970,cellular transformation,4,6,27,50,"NFAT proteins can modulate cellular transformation intrinsically, and NFAT-deficient (NFAT1-/-) mice are indeed more susceptible to transformation than wild-type counterparts.",21225259_1,-1,-1,-1,-1,13970,-1,0.0014733729,0.048834063,0.9496926
13971,to transformation than,18,21,129,151,"NFAT proteins can modulate cellular transformation intrinsically, and NFAT-deficient (NFAT1-/-) mice are indeed more susceptible to transformation than wild-type counterparts.",21225259_1,-1,-1,-1,-1,13971,-1,2.3514845e-05,0.99996305,1.3416421e-05
13973,to tumor,8,10,58,66,"However, the contribution of an NFAT1-/- microenvironment to tumor progression has not been studied.",21225259_2,-1,-1,-1,-1,13973,-1,2.2440596e-05,0.99996805,9.555962e-06
13988,the cytokine,23,25,159,171,A massive mononuclear perivascular infiltrate and reduced expression of TGF- in the absence of NFAT1 suggested a role for tumor-infiltrating immune cells and the cytokine milieu.,21225259_6,-1,-1,-1,-1,13988,-1,0.28954205,0.7064711,0.003986825
13991,this cytokine,16,18,109,122,"However, these processes are independent of an IL-4-induced regulatory tumor microenvironment, since lack of this cytokine does not alter the phenotype in NFAT1-/- animals.",21225259_7,-1,-1,-1,-1,13991,-1,0.63834625,0.352528,0.009125785
13995,cells to tumor,13,16,101,115,Bone marrow chimera experiments meant to differentiate the contributions of stromal and infiltrating cells to tumor progression demonstrated that NFAT1-induced susceptibility to pulmonary tumor growth depends on NFAT1-expressing parenchyma rather than on bone marrow-derived cells.,21225259_8,-1,-1,-1,-1,13995,-1,0.0058218646,0.38295823,0.6112199
14006,Th2 cytokine,24,26,168,180,"These results suggest an important role for NFAT1 in radio-resistant tumor-associated parenchyma, which is independent of the anti-tumor immune response and Th1 versus Th2 cytokine milieu established by the cancer cells, but able to promote site-specific tumor growth.",21225259_9,-1,-1,-1,-1,14006,-1,0.13708308,0.8576949,0.005222038
14014,function,10,11,65,73,Tumor growth occurs by the imbalance between cells with effector function and cells with suppressor/regulatory functions.,21238620_0,0,1,2,-1,14014,-1,0.0010732504,0.98381823,0.015108442
14016,functions,15,16,111,120,Tumor growth occurs by the imbalance between cells with effector function and cells with suppressor/regulatory functions.,21238620_0,0,1,2,-1,14016,-1,0.00021231266,0.99926335,0.0005243838
14019,the chemical,6,8,45,57,To investigate this scenario we administered the chemical carcinogen Urethane in BALB/c mice and followed these animals during 120 days to observe lung tumor development.,21238620_1,-1,-1,-1,-1,14019,-1,0.010182931,0.98793775,0.0018793149
14025,blood,18,19,99,104,"In another set of experiments the same protocol was performed with the harvest of spleen, lung and blood at 20 and 30 days after Urethane injection.",21238620_2,0,1,-1,-1,14025,-1,0.0001453916,0.9993736,0.0004809732
14035,the time,10,12,60,68,Urethane led to lung nodules development after 120 days and the time point evaluation showed that splenocytes stimulated ex vivo expressed higher levels of IFN- 20 days after the chemical injection.,21238620_5,-1,-1,-1,-1,14035,-1,2.6045162e-05,0.9999608,1.3164939e-05
14038,the chemical,28,30,176,188,Urethane led to lung nodules development after 120 days and the time point evaluation showed that splenocytes stimulated ex vivo expressed higher levels of IFN- 20 days after the chemical injection.,21238620_5,-1,-1,-1,-1,14038,-1,0.028572166,0.9698259,0.001601899
14052,IFN--producing cells,15,17,83,104,In periphery there was an increase at the effector immune response (as depicted by IFN--producing cells) and in tumor development site there was an increase at the suppressor cell (CD11b+Gr-1+) phenotype.,21238620_10,-1,-1,-1,-1,14052,-1,0.9271448,0.0010758935,0.07177932
14055,the suppressor cell,28,31,161,180,In periphery there was an increase at the effector immune response (as depicted by IFN--producing cells) and in tumor development site there was an increase at the suppressor cell (CD11b+Gr-1+) phenotype.,21238620_10,-1,-1,-1,-1,14055,-1,0.0032117316,0.202771,0.79401726
14058,therapy,6,7,51,58,Suppressor/regulatory cells are targets for cancer therapy.,21238620_11,0,1,-1,-1,14058,-1,2.7399508e-05,0.9999584,1.414374e-05
14060,gene therapy,2,4,25,37,"Targeted cancer-specific gene therapy is a promising strategy for treating metastatic lung cancer, which is a leading cause of lung cancer-related deaths.",21282355_0,-1,-1,-1,-1,14060,-1,3.5424913e-05,0.99994016,2.4463932e-05
14062,gene therapy,6,8,43,55,"Previously, we developed a cancer-targeted gene therapy expression system with high tumor specificity and strong activity that selectively induced lung cancer cell killing without affecting normal cells in immunocompromised mice.",21282355_1,-1,-1,-1,-1,14062,-1,2.5902062e-05,0.9999616,1.2444169e-05
14068,gene therapy,6,8,36,48,"Here, we found this cancer-targeted gene therapy, SV-BikDD, composed of the survivin promoter in the VP16-GAL4-WPRE integrated systemic amplifier system to drive the apoptotic gene BikDD, not only caused cytotoxic effects in cancer cells but also elicited a cancer-specific cytotoxic T lymphocyte response to synergistically increase the therapeutic effect and further develop an effective systemic antitumoral immunity against rechallenges of tumorigenic dose of parental tumor cells inoculated at distant sites in immunocompetent mice.",21282355_2,-1,-1,-1,-1,14068,-1,2.8985864e-05,0.9999528,1.8211984e-05
14077,the therapeutic,50,52,334,349,"Here, we found this cancer-targeted gene therapy, SV-BikDD, composed of the survivin promoter in the VP16-GAL4-WPRE integrated systemic amplifier system to drive the apoptotic gene BikDD, not only caused cytotoxic effects in cancer cells but also elicited a cancer-specific cytotoxic T lymphocyte response to synergistically increase the therapeutic effect and further develop an effective systemic antitumoral immunity against rechallenges of tumorigenic dose of parental tumor cells inoculated at distant sites in immunocompetent mice.",21282355_2,-1,-1,-1,-1,14077,-1,2.5010571e-05,0.9999651,9.940683e-06
14078,immunity,60,61,411,419,"Here, we found this cancer-targeted gene therapy, SV-BikDD, composed of the survivin promoter in the VP16-GAL4-WPRE integrated systemic amplifier system to drive the apoptotic gene BikDD, not only caused cytotoxic effects in cancer cells but also elicited a cancer-specific cytotoxic T lymphocyte response to synergistically increase the therapeutic effect and further develop an effective systemic antitumoral immunity against rechallenges of tumorigenic dose of parental tumor cells inoculated at distant sites in immunocompetent mice.",21282355_2,0,-1,2,-1,14078,-1,0.99892515,0.00060641655,0.00046851597
14080,tumor cells,68,70,473,484,"Here, we found this cancer-targeted gene therapy, SV-BikDD, composed of the survivin promoter in the VP16-GAL4-WPRE integrated systemic amplifier system to drive the apoptotic gene BikDD, not only caused cytotoxic effects in cancer cells but also elicited a cancer-specific cytotoxic T lymphocyte response to synergistically increase the therapeutic effect and further develop an effective systemic antitumoral immunity against rechallenges of tumorigenic dose of parental tumor cells inoculated at distant sites in immunocompetent mice.",21282355_2,-1,-1,-1,-1,14080,-1,0.0035792338,0.27924564,0.7171751
14082,gene therapy,5,7,34,46,"In addition, this cancer-targeted gene therapy does not elicit an immune response against normal tissues, but CMV-BikDD treatment does.",21282355_3,-1,-1,-1,-1,14082,-1,2.8907094e-05,0.99995434,1.6697117e-05
14084,tissues,15,16,97,104,"In addition, this cancer-targeted gene therapy does not elicit an immune response against normal tissues, but CMV-BikDD treatment does.",21282355_3,-1,1,2,-1,14084,-1,4.7363086e-05,0.99985874,9.3893184e-05
14086,The therapeutic,0,2,0,15,The therapeutic vector could also induce proinflammatory cytokines to activate innate immunity and provide some benefits in antitumor gene therapy.,21282355_4,-1,-1,-1,-1,14086,-1,2.343881e-05,0.9999677,8.814182e-06
14087,cytokines to,7,9,57,69,The therapeutic vector could also induce proinflammatory cytokines to activate innate immunity and provide some benefits in antitumor gene therapy.,21282355_4,-1,-1,-1,-1,14087,-1,0.90177745,0.09448622,0.0037362364
14089,gene therapy,18,20,134,146,The therapeutic vector could also induce proinflammatory cytokines to activate innate immunity and provide some benefits in antitumor gene therapy.,21282355_4,-1,-1,-1,-1,14089,-1,3.041347e-05,0.99995446,1.5103475e-05
14095,gene therapy,27,29,185,197,"Thus, this study provides a promising strategy with benefit of antitumoral immune response worthy of further development in clinical trials for treating lung cancer via cancer-targeted gene therapy.",21282355_5,-1,-1,-1,-1,14095,-1,3.015845e-05,0.9999502,1.961181e-05
14106,to tumour,19,21,135,144,"Most cancers are accompanied by leukocyte infiltration which, contrary to an anticipated immuno-protective role, could be contributing to tumour development and cancer progression.",21291541_1,-1,-1,-1,-1,14106,-1,3.6722344e-05,0.9999453,1.800091e-05
14112,these cells play,34,37,222,238,"Epstein-Barr virus (EBV) associated cancers, including nasopharyngeal carcinoma and Hodgkin's Disease, show a considerable leukocyte infiltration which surrounds the neoplastic cells, raising the questions as to what role these cells play in either restricting or supporting the tumour and what draws the cells into the tumour.",21291541_2,-1,-1,-1,-1,14112,-1,0.00022929758,0.9980015,0.0017692259
14113,the tumour,42,44,275,285,"Epstein-Barr virus (EBV) associated cancers, including nasopharyngeal carcinoma and Hodgkin's Disease, show a considerable leukocyte infiltration which surrounds the neoplastic cells, raising the questions as to what role these cells play in either restricting or supporting the tumour and what draws the cells into the tumour.",21291541_2,-1,-1,-1,-1,14113,-1,2.4254723e-05,0.9999585,1.7203307e-05
14114,the cells,47,49,301,310,"Epstein-Barr virus (EBV) associated cancers, including nasopharyngeal carcinoma and Hodgkin's Disease, show a considerable leukocyte infiltration which surrounds the neoplastic cells, raising the questions as to what role these cells play in either restricting or supporting the tumour and what draws the cells into the tumour.",21291541_2,-1,-1,-1,-1,14114,-1,0.001933284,0.10396828,0.89409846
14115,the tumour,50,52,316,326,"Epstein-Barr virus (EBV) associated cancers, including nasopharyngeal carcinoma and Hodgkin's Disease, show a considerable leukocyte infiltration which surrounds the neoplastic cells, raising the questions as to what role these cells play in either restricting or supporting the tumour and what draws the cells into the tumour.",21291541_2,-1,-1,-1,-1,14115,-1,2.421649e-05,0.9999602,1.5558677e-05
14121,protein,27,28,173,180,"In order to begin to address this we have studied a transgenic model of multistage carcinogenesis with epithelial expression of the EBV primary oncoprotein, latent membrane protein 1 (LMP1).",21291541_3,0,1,-1,-1,14121,-1,0.00025712125,0.9978582,0.0018846759
14124,The pathology,2,4,9,22,"RESULTS: The pathology advances with time leading to erosive dermatitis which is inflamed with a mixed infiltrate involving activated CD8+ T-cells, CD4+ T-cells including CD4+/CD25+/FoxP3+ Treg cells, mast cells and neutrophils.",21291541_5,-1,-1,-1,-1,14124,-1,0.0012323316,0.9799239,0.01884374
14127,T-cells,22,23,139,146,"RESULTS: The pathology advances with time leading to erosive dermatitis which is inflamed with a mixed infiltrate involving activated CD8+ T-cells, CD4+ T-cells including CD4+/CD25+/FoxP3+ Treg cells, mast cells and neutrophils.",21291541_5,-1,1,2,-1,14127,-1,3.408853e-05,3.9318962e-05,0.99992657
14128,T-cells,26,27,153,160,"RESULTS: The pathology advances with time leading to erosive dermatitis which is inflamed with a mixed infiltrate involving activated CD8+ T-cells, CD4+ T-cells including CD4+/CD25+/FoxP3+ Treg cells, mast cells and neutrophils.",21291541_5,-1,1,2,-1,14128,-1,6.138066e-05,0.00013508699,0.9998036
14131,the pathology,12,14,76,89,Also significant dermal deposition of immunoglobulin-G (IgG) is observed as the pathology advances.,21291541_6,-1,-1,-1,-1,14131,-1,0.0010582977,0.9904412,0.008500511
14134,factor,9,10,50,56,"Along with NF-kappaB activation, STAT3, a central factor in inflammation regulation, is activated in the transgenic tissue.",21291541_7,0,1,-1,-1,14134,-1,0.00015576447,0.9997737,7.050942e-05
14136,the transgenic tissue,17,20,101,122,"Along with NF-kappaB activation, STAT3, a central factor in inflammation regulation, is activated in the transgenic tissue.",21291541_7,-1,-1,-1,-1,14136,-1,3.764568e-05,0.99989676,6.562431e-05
14137,factors,2,3,21,28,"Several inflammatory factors are subsequently upregulated, notably CD30 and its ligand CD153, also leukocyte trafficking factors including CXCL10, CXCL13, L-selectin and TGF1, and inflammatory cytokines including IL-1, IL-3 and the murine IL-8 analogues CXCL1, CXCL2 and CXCL5-6, amongst others.",21291541_8,0,1,-1,-1,14137,-1,0.17331688,0.8229399,0.0037432993
14138,trafficking factors,16,18,109,128,"Several inflammatory factors are subsequently upregulated, notably CD30 and its ligand CD153, also leukocyte trafficking factors including CXCL10, CXCL13, L-selectin and TGF1, and inflammatory cytokines including IL-1, IL-3 and the murine IL-8 analogues CXCL1, CXCL2 and CXCL5-6, amongst others.",21291541_8,-1,-1,-1,-1,14138,-1,0.00036277878,0.99912614,0.00051113724
14154,the pathology to,25,28,166,182,"The crucial role of mature T- and/or B-lymphocytes in the advancing pathology is demonstrated by their elimination, which precludes mast cell infiltration and limits the pathology to an early, benign stage.",21291541_9,-1,-1,-1,-1,14154,-1,9.760422e-05,0.99979573,0.000106703614
14155,to the,5,7,27,33,"CONCLUSIONS: LMP1 can lead to the activation of several key factors mediating proliferation, angiogenesis and inflammation in vivo.",21291541_10,-1,-1,-1,-1,14155,-1,2.3337889e-05,0.9999671,9.578854e-06
14156,factors,11,12,60,67,"CONCLUSIONS: LMP1 can lead to the activation of several key factors mediating proliferation, angiogenesis and inflammation in vivo.",21291541_10,0,1,-1,-1,14156,-1,0.0049347305,0.9911752,0.003890099
14159,to the,15,17,110,116,"With the initiation of an inflammatory programme, leukocyte recruitment follows which then itself contributes to the progressing pathology in these transgenic mice, with a pivotal role for B-and/or T-cells in the process.",21291541_11,-1,-1,-1,-1,14159,-1,2.900267e-05,0.99995255,1.8496468e-05
14161,these transgenic,20,22,142,158,"With the initiation of an inflammatory programme, leukocyte recruitment follows which then itself contributes to the progressing pathology in these transgenic mice, with a pivotal role for B-and/or T-cells in the process.",21291541_11,-1,-1,-1,-1,14161,-1,2.0091875e-05,0.99996567,1.421077e-05
14162,T-cells,30,31,198,205,"With the initiation of an inflammatory programme, leukocyte recruitment follows which then itself contributes to the progressing pathology in these transgenic mice, with a pivotal role for B-and/or T-cells in the process.",21291541_11,-1,1,2,-1,14162,-1,5.131773e-05,0.0001379536,0.99981076
14183,tissue,4,5,27,33,The surgically removed Eca tissue was collected.,21314287_4,-1,1,2,-1,14183,-1,0.0004335657,0.9458619,0.05370456
14185,tissue,4,5,24,30,Cells isolated from Eca tissue were analyzed by flow cytometry.,21314287_5,-1,1,2,-1,14185,-1,4.640993e-05,0.99966025,0.00029331754
14188,tissue-derived,9,10,34,48,The results showed that 2-10% Eca tissue-derived CD4(+) T cells expressed Foxp3; only 0.2-0.8% non-ca tissue-derived CD4(+) T cells expressed Foxp3.,21314287_6,-1,1,2,-1,14188,-1,3.5655943e-05,0.99991,5.429157e-05
14191,tissue-derived,23,24,102,116,The results showed that 2-10% Eca tissue-derived CD4(+) T cells expressed Foxp3; only 0.2-0.8% non-ca tissue-derived CD4(+) T cells expressed Foxp3.,21314287_6,-1,1,2,-1,14191,-1,3.9786803e-05,0.999894,6.6170185e-05
14194,analysis,1,2,8,16,Further analysis showed that 3-15% Eca-isolated CD4(+) T cells were also IL-17 positive whereas only 0.4-1.5% non-ca tissue-isolated CD4(+) T cells were IL-17 positive.,21314287_7,0,1,-1,-1,14194,-1,2.9728059e-05,0.9999492,2.1031114e-05
14198,tissue-isolated,24,25,117,132,Further analysis showed that 3-15% Eca-isolated CD4(+) T cells were also IL-17 positive whereas only 0.4-1.5% non-ca tissue-isolated CD4(+) T cells were IL-17 positive.,21314287_7,-1,1,2,-1,14198,-1,7.121121e-05,0.99985576,7.302324e-05
14206,tissue that,23,25,97,108,We also found that about 4.8-11.2% Foxp3(+) IL-17(+) T cells in isolated CD4(+) T cells from Eca tissue that were significantly less than in non-ca tissue derived CD4(+) T cells.,21314287_8,-1,-1,-1,-1,14206,-1,2.5854786e-05,0.9999467,2.7450662e-05
14208,tissue,31,32,148,154,We also found that about 4.8-11.2% Foxp3(+) IL-17(+) T cells in isolated CD4(+) T cells from Eca tissue that were significantly less than in non-ca tissue derived CD4(+) T cells.,21314287_8,-1,1,2,-1,14208,-1,2.9128183e-05,0.99993265,3.8236165e-05
14224,T cells that,21,24,120,132,Coculturing CD68+ cells and Foxp3+ T cells under hypoxic environment resulted in abundant expression of IL-17 in Foxp3+ T cells that could be blocked by pretreatment with either anti-IL-17 or anti-transforming growth factor beta antibodies.,21314287_11,-1,-1,-1,-1,14224,-1,0.0017968788,0.03585452,0.9623486
14226,that IL-17+Foxp3,2,4,12,28,We conclude that IL-17+Foxp3+ T cells may contribute to the development of Eca.,21314287_12,-1,-1,-1,-1,14226,-1,0.0004255331,0.9994685,0.0001059227
14228,to the,9,11,53,59,We conclude that IL-17+Foxp3+ T cells may contribute to the development of Eca.,21314287_12,-1,-1,-1,-1,14228,-1,2.3376488e-05,0.9999651,1.1595919e-05
14230,that IL-10,5,7,30,40,"Our previous works have shown that IL-10 and IFN co-regulate indoleamine-2,3-dioxygenase (IDO)-expressing immunosuppressive dendritic cells (DCs) in melanoma SLNs.",21327637_1,-1,-1,-1,-1,14230,-1,0.7600278,0.23548919,0.004483035
14236,the relationship,8,10,37,53,The goal of this study is to examine the relationship between melanoma SLN tumor burden and the degree of SLN immune dysfunction as a model to study tumor-induced immune dysfunction.,21327637_2,-1,-1,-1,-1,14236,-1,1.8082828e-05,0.999972,9.9028e-06
14255,Foxp3-expressing T-regs,34,36,195,218,"By using quantitative real-time PCR, gene expressions of cytokines (IL-4, IL-10, IFN, TGF, GM-CSF) and the surrogates of immunosuppressive regulatory and effector cells (IDO-expressing DCs and Foxp3-expressing T-regs, respectively) were measured and correlated against the SLN tumor burden (MART1) and against each other.",21327637_6,-1,-1,-1,-1,14255,-1,2.4260862e-05,0.9999503,2.5401292e-05
14260,Statistical test,0,2,0,16,Statistical test used Student's t-test and stepwise multivariate regression analysis.,21327637_8,-1,-1,-1,-1,14260,-1,7.460395e-05,0.99988914,3.627601e-05
14262,analysis,10,11,76,84,Statistical test used Student's t-test and stepwise multivariate regression analysis.,21327637_8,0,1,-1,-1,14262,-1,6.9679736e-05,0.9998683,6.198863e-05
14264,this analysis,18,20,98,111,Statistical significance was determined at P<0.05.RESULTS: SLNs of 74 patients were analyzed in this analysis.,21327637_9,-1,-1,-1,-1,14264,-1,2.8177614e-05,0.9999479,2.3967596e-05
14271,analysis,6,7,42,50,"Among the various cytokines, multivariate analysis showed that only IFN gene expression correlated independently with MART1 gene expression (P<0.0001, r=0.91).",21327637_12,0,1,-1,-1,14271,-1,3.513626e-05,0.9999429,2.1952092e-05
14273,IFN gene,10,12,68,77,"Among the various cytokines, multivariate analysis showed that only IFN gene expression correlated independently with MART1 gene expression (P<0.0001, r=0.91).",21327637_12,-1,-1,-1,-1,14273,-1,0.99412537,0.0034032788,0.0024713674
14275,that IFN,4,6,35,44,"Similar multivariate analyses show that IFN (P<0.0001, r=0.78), IL-10 (P=0.0037, r=0.60), and TGF (P<0.0001, r=0.95) gene expressions correlated independently with IDO gene expression.",21327637_13,-1,-1,-1,-1,14275,-1,0.71650785,0.27730012,0.0061919997
14283,Foxp3 gene,34,36,108,118,"IFN (P<0.0001, r=0.87) and GM-CSF (P=0.042, r=0.76) gene expressions correlated independently with Foxp3 gene expression.",21327637_14,-1,-1,-1,-1,14283,-1,2.1814945e-05,0.9999633,1.485315e-05
14290,theory that,6,8,33,44,"Our data are consistent with our theory that melanoma induces expressions of specific cytokines, which in turn, stimulate immune suppressors within the SLN.",21327637_17,-1,-1,-1,-1,14290,-1,2.2279173e-05,0.99996614,1.1531638e-05
14295,that IL-10,7,9,46,56,This study also supports our previous finding that IL-10 and IFN co-regulate IDO within the SLN.,21327637_18,-1,-1,-1,-1,14295,-1,0.75345486,0.24180529,0.004739859
14300,cytokine that,8,10,30,43,"In our data, IFN is the sole cytokine that correlates with the SLN tumor burden and seems to play a central role in tumor-induced immunological changes in the SLN immune microenvironment.",21327637_19,-1,-1,-1,-1,14300,-1,0.9453555,0.05029853,0.004345946
14303,to play,18,20,91,98,"In our data, IFN is the sole cytokine that correlates with the SLN tumor burden and seems to play a central role in tumor-induced immunological changes in the SLN immune microenvironment.",21327637_19,-1,-1,-1,-1,14303,-1,2.3841267e-05,0.99996567,1.0497318e-05
14313,therapy,36,37,208,215,"RESULTS: Here we characterise the effects of conditioned media from reovirus-infected, dying human melanoma cells (reoTCM), in the absence of live virus, to address the immune bystander potential of reovirus therapy.",21338484_1,0,1,-1,-1,14313,-1,2.1836902e-05,0.99996805,1.0069283e-05
14320,the type,19,21,109,117,"In addition to RANTES, IL-8, MIP-1 and MIP-1, reovirus-infected melanoma cells secreted eotaxin, IP-10 and the type 1 interferon IFN-.",21338484_2,-1,-1,-1,-1,14320,-1,7.613417e-05,0.9998853,3.8473165e-05
14321,interferon IFN-,22,24,120,136,"In addition to RANTES, IL-8, MIP-1 and MIP-1, reovirus-infected melanoma cells secreted eotaxin, IP-10 and the type 1 interferon IFN-.",21338484_2,-1,-1,-1,-1,14321,-1,0.9997478,0.00012903885,0.00012309027
14325,that IL-8,14,16,90,99,"To address the mechanisms responsible for the inflammatory composition of reoTCM, we show that IL-8 and IFN- secretion by reovirus-infected melanoma cells was associated with activation of NF-B and decreased by pre-treatment with small molecule inhibitors of NF-B and PKR; specific siRNA-mediated knockdown further confirmed a role for PKR.",21338484_3,-1,-1,-1,-1,14325,-1,0.77732676,0.21774657,0.0049266685
14336,tumour targets,16,18,111,125,"Following culture in reoTCM, NK cells upregulated CD69 expression and acquired greater lytic potential against tumour targets.",21338484_5,-1,-1,-1,-1,14336,-1,2.628497e-05,0.9999602,1.3586201e-05
14338,immunity,15,16,108,116,"Furthermore, melanoma cell-loaded DC cultured in reoTCM were more effective at priming adaptive anti-tumour immunity.",21338484_6,0,-1,2,-1,14338,-1,0.99953246,0.0002845079,0.00018298608
14340,that the,5,7,36,44,"CONCLUSIONS: These data demonstrate that the PKR- and NF-B-dependent induction of pro-inflammatory molecules that accompanies reovirus-mediated killing can recruit and activate innate and adaptive effector cells, thus potentially altering the tumour microenvironment to support bystander immune-mediated therapy as well as direct viral oncolysis.",21338484_7,-1,-1,-1,-1,14340,-1,1.7310882e-05,0.99997425,8.421956e-06
14344,the tumour,31,33,240,250,"CONCLUSIONS: These data demonstrate that the PKR- and NF-B-dependent induction of pro-inflammatory molecules that accompanies reovirus-mediated killing can recruit and activate innate and adaptive effector cells, thus potentially altering the tumour microenvironment to support bystander immune-mediated therapy as well as direct viral oncolysis.",21338484_7,-1,-1,-1,-1,14344,-1,1.9869058e-05,0.9999709,9.179043e-06
14346,therapy,38,39,305,312,"CONCLUSIONS: These data demonstrate that the PKR- and NF-B-dependent induction of pro-inflammatory molecules that accompanies reovirus-mediated killing can recruit and activate innate and adaptive effector cells, thus potentially altering the tumour microenvironment to support bystander immune-mediated therapy as well as direct viral oncolysis.",21338484_7,0,1,-1,-1,14346,-1,3.2994354e-05,0.9999424,2.459717e-05
14357,tissue,5,6,24,30,Colorectal cancer (CRC) tissue was collected from surgically removed cancer tissue of 22 patients with CRC.,21352252_2,-1,1,2,-1,14357,-1,4.2473195e-05,0.9996946,0.000262966
14358,tissue,12,13,76,82,Colorectal cancer (CRC) tissue was collected from surgically removed cancer tissue of 22 patients with CRC.,21352252_2,-1,1,2,-1,14358,-1,8.352175e-05,0.9985222,0.0013943171
14362,tissue,8,9,36,42,Foxp3(+) IL-17(+) T cells in cancer tissue were examined by flow cytometry.,21352252_3,-1,1,2,-1,14362,-1,4.2115917e-05,0.9998454,0.000112493064
14378,tissue,17,18,80,86,The results showed that a number of Foxp3(+) IL-17(+) T cells were found in CRC tissue (22.8  2.6 cells/mm(2) tissue) that was significantly more than in non-cancer colonic mucosa (5.6  1.04 cells/mm(2) tissue).,21352252_6,-1,1,2,-1,14378,-1,6.953623e-05,0.9988821,0.0010483694
14379,tissue,24,25,111,117,The results showed that a number of Foxp3(+) IL-17(+) T cells were found in CRC tissue (22.8  2.6 cells/mm(2) tissue) that was significantly more than in non-cancer colonic mucosa (5.6  1.04 cells/mm(2) tissue).,21352252_6,-1,1,2,-1,14379,-1,5.731576e-05,0.999537,0.00040573112
14382,tissue,41,42,205,211,The results showed that a number of Foxp3(+) IL-17(+) T cells were found in CRC tissue (22.8  2.6 cells/mm(2) tissue) that was significantly more than in non-cancer colonic mucosa (5.6  1.04 cells/mm(2) tissue).,21352252_6,-1,1,2,-1,14382,-1,4.904829e-05,0.99961615,0.00033474978
14383,The Foxp3(+,0,2,0,11,"The Foxp3(+) IL-17(+) cells also CD4(+), CCR6(+), transforming growth factor (TGF)-beta(+) and IL-6(+) .",21352252_7,-1,-1,-1,-1,14383,-1,0.00018729501,0.9996568,0.00015593084
14387,transforming growth factor,13,16,50,76,"The Foxp3(+) IL-17(+) cells also CD4(+), CCR6(+), transforming growth factor (TGF)-beta(+) and IL-6(+) .",21352252_7,-1,-1,-1,-1,14387,-1,0.9440112,0.05340033,0.0025884882
14391,to tumour protein,9,12,56,73,The CD8(+) T cells proliferated markedly after exposure to tumour protein in culture that was suppressed in the presence of CRC-derived Foxp3(+) IL-17(+) T cells; the suppression was attenuated by pretreatment with anti-IL-17 antibody.,21352252_8,-1,-1,-1,-1,14391,-1,3.1184827e-05,0.9999552,1.3578607e-05
14406,This subset,0,2,0,11,This subset of T cells may be a novel therapeutic target in the treatment of CRC.,21352252_10,-1,-1,-1,-1,14406,-1,0.005009214,0.47588852,0.5191023
14408,therapeutic target,9,11,38,56,This subset of T cells may be a novel therapeutic target in the treatment of CRC.,21352252_10,-1,-1,-1,-1,14408,-1,2.3583383e-05,0.99996567,1.0696878e-05
14409,the treatment,12,14,60,73,This subset of T cells may be a novel therapeutic target in the treatment of CRC.,21352252_10,-1,-1,-1,-1,14409,-1,2.251845e-05,0.9999677,9.805512e-06
14417,T (Th17,2,5,15,22,IL-17(+)CD4(+) T (Th17) cells mediate inflammation of autoimmune diseases.,21357259_1,-1,-1,-1,-1,14417,-1,4.197744e-05,0.9999356,2.242156e-05
14421,blood,13,14,85,90,A small population of IL-17(+)Foxp3(+)CD4(+) T cells has been observed in peripheral blood in healthy human beings.,21357259_2,0,1,-1,-1,14421,-1,7.962261e-05,0.99964046,0.0002798923
14445,T cells functionally,2,5,23,43,IL-17(+)Foxp3(+)CD4(+) T cells functionally suppressed T cell activation and stimulated inflammatory cytokine production in the colitic tissues.,21357259_8,-1,-1,-1,-1,14445,-1,0.001829097,0.034491867,0.963679
14449,tissues,17,18,136,143,IL-17(+)Foxp3(+)CD4(+) T cells functionally suppressed T cell activation and stimulated inflammatory cytokine production in the colitic tissues.,21357259_8,-1,1,2,-1,14449,-1,0.00047322354,0.9907526,0.008774203
14450,that IL-17(+)Foxp3(+,3,5,18,38,"Our data indicate that IL-17(+)Foxp3(+) cells may be ""inflammatory"" Treg cells in the pathological microenvironments.",21357259_9,-1,-1,-1,-1,14450,-1,0.009023686,0.9895466,0.0014297698
14454,These cells,0,2,0,11,"These cells may contribute to the pathogenesis of ulcerative colitis through inducing inflammatory cytokines and inhibiting local T cell immunity, and in turn may mechanistically link human chronic inflammation to tumor development.",21357259_10,-1,-1,-1,-1,14454,-1,0.0036720566,0.25014925,0.7461787
14455,to the,4,6,27,33,"These cells may contribute to the pathogenesis of ulcerative colitis through inducing inflammatory cytokines and inhibiting local T cell immunity, and in turn may mechanistically link human chronic inflammation to tumor development.",21357259_10,-1,-1,-1,-1,14455,-1,2.5971342e-05,0.9999615,1.2548923e-05
14458,T cell immunity,17,20,130,145,"These cells may contribute to the pathogenesis of ulcerative colitis through inducing inflammatory cytokines and inhibiting local T cell immunity, and in turn may mechanistically link human chronic inflammation to tumor development.",21357259_10,-1,-1,-1,-1,14458,-1,0.00781967,0.0005560262,0.9916243
14460,to tumor,30,32,211,219,"These cells may contribute to the pathogenesis of ulcerative colitis through inducing inflammatory cytokines and inhibiting local T cell immunity, and in turn may mechanistically link human chronic inflammation to tumor development.",21357259_10,-1,-1,-1,-1,14460,-1,2.6708482e-05,0.9999604,1.2899263e-05
14465,complex Treg cell,18,21,114,131,"Our data therefore challenge commonly held beliefs of the anti-inflammatory role of Treg cells and suggest a more complex Treg cell biology, at least in the context of human chronic inflammation and associated carcinoma.",21357259_11,-1,-1,-1,-1,14465,-1,0.0018323946,0.032609895,0.9655577
14470,receptor,3,4,18,26,"Expression of its receptor, TIE2, defines a highly proangiogenic subpopulation of myeloid cells in circulation and tumors called TIE2-expressing monocytes/macrophages (TEMs).",21368233_1,0,1,2,-1,14470,-1,0.0003310336,0.001052917,0.998616
14491,CCL17,32,33,190,195,"Previously, we demonstrated that ANGPT2 augments the expression of various proangiogenic genes, the potent immunosuppressive cytokine, IL-10, and a chemokine for regulatory T cells (Tregs), CCL17 by TEMs in vitro.",21368233_3,0,-1,2,-1,14491,-1,0.9836067,0.0005341326,0.015859202
14493,that TEMs,3,5,12,21,"We now show that TEMs also express higher levels of IL-10 than TIE2(-) macrophages in tumors and that ANGPT2-stimulated release of IL-10 by TEMs suppresses T cell proliferation, increases the ratio of CD4(+) T cells to CD8(+) T cells, and promotes the expansion of CD4(+)CD25(high)FOXP3(+) Tregs.",21368233_4,-1,-1,-1,-1,14493,-1,1.8771265e-05,0.9999716,9.610191e-06
14494,IL-10 than TIE2(-,10,13,52,69,"We now show that TEMs also express higher levels of IL-10 than TIE2(-) macrophages in tumors and that ANGPT2-stimulated release of IL-10 by TEMs suppresses T cell proliferation, increases the ratio of CD4(+) T cells to CD8(+) T cells, and promotes the expansion of CD4(+)CD25(high)FOXP3(+) Tregs.",21368233_4,-1,-1,-1,-1,14494,-1,0.9829117,0.013367903,0.0037203124
14502,T cells to,36,39,208,218,"We now show that TEMs also express higher levels of IL-10 than TIE2(-) macrophages in tumors and that ANGPT2-stimulated release of IL-10 by TEMs suppresses T cell proliferation, increases the ratio of CD4(+) T cells to CD8(+) T cells, and promotes the expansion of CD4(+)CD25(high)FOXP3(+) Tregs.",21368233_4,-1,-1,-1,-1,14502,-1,0.0012024612,0.016906876,0.9818907
14510,tumor TEMs,28,30,176,186,"Furthermore, syngeneic murine tumors expressing high levels of ANGPT2 contained not only high numbers of TEMs but also increased numbers of Tregs, whereas genetic depletion of tumor TEMs resulted in a marked reduction in the frequency of Tregs in tumors.",21368233_5,-1,-1,-1,-1,14510,-1,2.0117834e-05,0.99996746,1.2437124e-05
14514,Taken together,0,2,0,14,"Taken together, our data suggest that ANGPT2-stimulated TEMs represent a novel, potent immunosuppressive force in tumors.",21368233_6,-1,-1,-1,-1,14514,-1,3.9523184e-05,0.9999448,1.567012e-05
14525,antigen-presenting cells,14,16,94,118,"Colonic CD90+ mesenchymal myofibroblasts and fibroblasts (CMFs) are abundant, nonprofessional antigen-presenting cells in the normal human colonic mucosa that suppress proliferation of activated CD4+ effector T cells.",21376048_1,-1,-1,-1,-1,14525,-1,0.32830715,0.002024447,0.66966844
14533,tissues,26,27,154,161,"METHODS: Allogeneic cocultures of CD4+ T cells and CMFs, derived from normal mucosa of patients undergoing colectomy for colon cancer or inflamed colonic tissues from patients with ulcerative colitis or Crohn's disease, were used to assess activation of the Treg cells.",21376048_3,-1,1,2,-1,14533,-1,0.0050634365,0.43969247,0.5552441
14535,the Treg cells,43,46,254,268,"METHODS: Allogeneic cocultures of CD4+ T cells and CMFs, derived from normal mucosa of patients undergoing colectomy for colon cancer or inflamed colonic tissues from patients with ulcerative colitis or Crohn's disease, were used to assess activation of the Treg cells.",21376048_3,-1,-1,-1,-1,14535,-1,0.0028448277,0.18549223,0.81166285
14545,factor-,47,48,247,255,"RESULTS: Coculture of normal CMF with resting or nave CD4+ T cells led to development of cells with a Treg phenotype; it also induced proliferation of a CD25+ CD127- FoxP3+ T cells, which expressed CTLA-4, interleukin-10, and transforming growth factor- and had suppressive activities.",21376048_4,0,1,-1,-1,14545,-1,0.99981827,7.498247e-05,0.00010674948
14548,interleukin-2 to,10,12,63,79,"In contrast to dendritic cells, normal CMFs required exogenous interleukin-2 to induce proliferation of naturally occurring Treg cells.",21376048_5,-1,-1,-1,-1,14548,-1,0.9909582,0.007380582,0.0016612061
14555,to transiently generate,18,21,124,147,CMFs from patients with inflammatory bowel diseases had reduced capacity to induce active Treg cells and increased capacity to transiently generate CD4+CD25+/- CD127+ T cells that express low levels of FoxP3.CONCLUSIONS: CMFs suppress the immune response in normal colon tissue and might therefore help maintain colonic mucosal tolerance.,21376048_7,-1,-1,-1,-1,14555,-1,2.2671495e-05,0.9999614,1.5950916e-05
14556,T cells that,24,27,167,179,CMFs from patients with inflammatory bowel diseases had reduced capacity to induce active Treg cells and increased capacity to transiently generate CD4+CD25+/- CD127+ T cells that express low levels of FoxP3.CONCLUSIONS: CMFs suppress the immune response in normal colon tissue and might therefore help maintain colonic mucosal tolerance.,21376048_7,-1,-1,-1,-1,14556,-1,0.0013731032,0.020303836,0.978323
14557,the immune response,35,38,235,254,CMFs from patients with inflammatory bowel diseases had reduced capacity to induce active Treg cells and increased capacity to transiently generate CD4+CD25+/- CD127+ T cells that express low levels of FoxP3.CONCLUSIONS: CMFs suppress the immune response in normal colon tissue and might therefore help maintain colonic mucosal tolerance.,21376048_7,-1,-1,-1,-1,14557,-1,0.36688122,0.63150454,0.0016142896
14558,tissue,41,42,271,277,CMFs from patients with inflammatory bowel diseases had reduced capacity to induce active Treg cells and increased capacity to transiently generate CD4+CD25+/- CD127+ T cells that express low levels of FoxP3.CONCLUSIONS: CMFs suppress the immune response in normal colon tissue and might therefore help maintain colonic mucosal tolerance.,21376048_7,-1,1,2,-1,14558,-1,0.00016447867,0.9981446,0.0016909187
14570,the plasticity,11,13,79,93,"Mounting data implicates chromatin regulation, namely promoter methylation, in the plasticity of nave human T cells.",21377729_2,-1,-1,-1,-1,14570,-1,2.4319037e-05,0.99996495,1.06860625e-05
14571,nave,14,15,97,102,"Mounting data implicates chromatin regulation, namely promoter methylation, in the plasticity of nave human T cells.",21377729_2,-1,-1,-1,-1,14571,-1,3.2981643e-05,0.9999529,1.4139212e-05
14573,that this plasticity,5,8,35,55,Recent in vitro evidence indicates that this plasticity may be phenotypically altered by using methylation inhibitors which are approved for clinical use in certain types of cancer.,21377729_3,-1,-1,-1,-1,14573,-1,2.3587805e-05,0.99996626,1.0167886e-05
14592,Th2 cells to,8,11,53,65,"Our data indicates that 5A2 treatment can depolarize Th2 cells to effectively secrete interferon gamma, signal via T-bet, and achieve demethylation of critical Th1 specific promoters.",21377729_6,-1,-1,-1,-1,14592,-1,0.0022815263,0.27458137,0.72313714
14603,proteins,5,6,47,55,Cytoplasmic delivery and cross-presentation of proteins and peptides is necessary for processing and presentation of antigens for the generation of cytotoxic T cells.,21383765_0,0,1,-1,-1,14603,-1,0.00042742922,0.9993155,0.00025711814
14604,peptides,7,8,60,68,Cytoplasmic delivery and cross-presentation of proteins and peptides is necessary for processing and presentation of antigens for the generation of cytotoxic T cells.,21383765_0,0,-1,2,-1,14604,-1,0.00068157807,0.99871707,0.0006014324
14606,the generation,17,19,130,144,Cytoplasmic delivery and cross-presentation of proteins and peptides is necessary for processing and presentation of antigens for the generation of cytotoxic T cells.,21383765_0,-1,-1,-1,-1,14606,-1,2.4954461e-05,0.9999584,1.6694159e-05
14610,peptide,10,11,53,60,"We previously described the use of the 16 amino acid peptide penetratin from the Drosophila Antennapedia homeodomain (penetratin, Antp) to transport cytotoxic T lymphocyte epitopes derived from ovalbumin (OVA) or the Mucin-1 tumor-associated antigen into cells.",21383765_1,0,-1,2,-1,14610,-1,0.00012225973,0.9997162,0.00016150434
14612,to transport cytotoxic T lymphocyte,22,27,136,171,"We previously described the use of the 16 amino acid peptide penetratin from the Drosophila Antennapedia homeodomain (penetratin, Antp) to transport cytotoxic T lymphocyte epitopes derived from ovalbumin (OVA) or the Mucin-1 tumor-associated antigen into cells.",21383765_1,-1,-1,-1,-1,14612,-1,0.005525424,0.35714692,0.6373276
14614,tumor-associated antigen,37,39,225,249,"We previously described the use of the 16 amino acid peptide penetratin from the Drosophila Antennapedia homeodomain (penetratin, Antp) to transport cytotoxic T lymphocyte epitopes derived from ovalbumin (OVA) or the Mucin-1 tumor-associated antigen into cells.",21383765_1,-1,-1,-1,-1,14614,-1,0.06468611,0.9231105,0.012203328
14618,protein,10,11,63,70,We have now shown that penetratin covalently conjugated to OVA protein and linked in tandem to CD4(+) and/or CD8(+) T-cell epitopes from OVA-stimulated T cells in vitro (B3Z T-cell hybridoma and OT-I and OT-II T cells).,21383765_2,0,1,-1,-1,14618,-1,0.00030554287,0.999519,0.00017542171
14619,tandem to,14,16,85,94,We have now shown that penetratin covalently conjugated to OVA protein and linked in tandem to CD4(+) and/or CD8(+) T-cell epitopes from OVA-stimulated T cells in vitro (B3Z T-cell hybridoma and OT-I and OT-II T cells).,21383765_2,-1,-1,-1,-1,14619,-1,2.2420087e-05,0.9999645,1.3129267e-05
14620,T-cell,21,22,116,122,We have now shown that penetratin covalently conjugated to OVA protein and linked in tandem to CD4(+) and/or CD8(+) T-cell epitopes from OVA-stimulated T cells in vitro (B3Z T-cell hybridoma and OT-I and OT-II T cells).,21383765_2,-1,1,2,-1,14620,-1,3.2596527e-05,4.400899e-05,0.99992347
14622,T-cell,31,32,174,180,We have now shown that penetratin covalently conjugated to OVA protein and linked in tandem to CD4(+) and/or CD8(+) T-cell epitopes from OVA-stimulated T cells in vitro (B3Z T-cell hybridoma and OT-I and OT-II T cells).,21383765_2,-1,1,2,-1,14622,-1,3.6656536e-05,6.0680824e-05,0.9999026
14627,peptide,11,12,73,80,The induction of these responses was directly mediated by the penetratin peptide as linking a nonspecific 16-mer peptide to OVA or mixing did not induce CD8(+) or CD4(+) T-cell responses in vitro.,21383765_3,0,-1,2,-1,14627,-1,0.00013317702,0.9997125,0.00015428837
14628,peptide to,17,19,113,123,The induction of these responses was directly mediated by the penetratin peptide as linking a nonspecific 16-mer peptide to OVA or mixing did not induce CD8(+) or CD4(+) T-cell responses in vitro.,21383765_3,-1,-1,-1,-1,14628,-1,0.0001274522,0.9997353,0.0001372786
14629,T-cell,30,31,170,176,The induction of these responses was directly mediated by the penetratin peptide as linking a nonspecific 16-mer peptide to OVA or mixing did not induce CD8(+) or CD4(+) T-cell responses in vitro.,21383765_3,-1,1,2,-1,14629,-1,3.8895356e-05,5.4815686e-05,0.9999063
14634,T-cell-dependent,8,9,42,58,Tumor protection was mediated by a CD8(+) T-cell-dependent mechanism and did not require CD4(+) help to protect mice 7 days after a boost immunization.,21383765_5,-1,1,2,-1,14634,-1,4.1009796e-05,5.884346e-05,0.9999001
14637,antigen-specific IFN--secreting,16,18,88,120,"Alternatively, 40 days after a boost immunization, the presence of CD4(+) help enhanced antigen-specific IFN--secreting CD8(+) T cells and tumor protection in mice challenged with B16.OVA.",21383765_6,-1,-1,-1,-1,14637,-1,0.99766517,0.0010669329,0.0012679172
14642,tumor therapy,16,18,99,112,"In addition, immunization with AntpOVA significantly delayed growth of B16.OVA tumors in mice in a tumor therapy model.",21383765_8,-1,-1,-1,-1,14642,-1,2.3843215e-05,0.99996436,1.1770188e-05
14650,the tumor,36,38,215,224,"Although polyclonal regulatory T cells (Tregs) that once expressed Foxp3 (ex-Tregs) derived from Foxp3(+) Tregs have been described in homeostatic and autoimmune settings, little is known regarding the influence of the tumor environment on ex-Treg development.",21389255_0,-1,-1,-1,-1,14650,-1,2.3501418e-05,0.999967,9.534869e-06
14658,transfer to,3,5,14,25,"On the second transfer to a Rag2(-/-) B6 male environment, these ex-Tregs expanded strongly, whereas Tregs that maintained expression of Foxp3 expression did not.",21389255_2,-1,-1,-1,-1,14658,-1,1.9916202e-05,0.9999671,1.3028645e-05
14660,Tregs that,18,20,101,111,"On the second transfer to a Rag2(-/-) B6 male environment, these ex-Tregs expanded strongly, whereas Tregs that maintained expression of Foxp3 expression did not.",21389255_2,-1,-1,-1,-1,14660,-1,2.0049822e-05,0.99996567,1.4323263e-05
14662,analysis,5,6,41,49,Both FACS and quantitative real-time-PCR analysis revealed that ex-Tregs upregulated genes characteristic of a Th1 effector-memory phenotype including IFN- and downregulated a panel of Treg-specific genes.,21389255_3,0,1,-1,-1,14662,-1,2.6953347e-05,0.9999497,2.3349236e-05
14667,Treg-specific genes,24,26,186,205,Both FACS and quantitative real-time-PCR analysis revealed that ex-Tregs upregulated genes characteristic of a Th1 effector-memory phenotype including IFN- and downregulated a panel of Treg-specific genes.,21389255_3,-1,-1,-1,-1,14667,-1,3.089561e-05,0.9999398,2.9355226e-05
14669,transferred to,6,8,51,65,"Peripheral HY-specific green Tregs were adoptively transferred to Rag2(-/-) B6 male mice, to dissect the factors regulating ex-Treg differentiation.",21389255_4,-1,-1,-1,-1,14669,-1,2.0297612e-05,0.9999682,1.155554e-05
14671,the factors,16,18,101,112,"Peripheral HY-specific green Tregs were adoptively transferred to Rag2(-/-) B6 male mice, to dissect the factors regulating ex-Treg differentiation.",21389255_4,-1,-1,-1,-1,14671,-1,4.4839206e-05,0.999931,2.4136581e-05
14678,the plasticity,7,9,46,60,"Collectively, our study not only demonstrates the plasticity of Ag-specific Tregs in the context of the tumor environment, but also defines key molecular and cellular events that modulate ex-Treg differentiation.",21389255_7,-1,-1,-1,-1,14678,-1,1.9212383e-05,0.9999707,1.01373535e-05
14681,the tumor,16,18,100,109,"Collectively, our study not only demonstrates the plasticity of Ag-specific Tregs in the context of the tumor environment, but also defines key molecular and cellular events that modulate ex-Treg differentiation.",21389255_7,-1,-1,-1,-1,14681,-1,2.1308784e-05,0.9999689,9.79046e-06
14684,functions,5,6,41,50,"Several studies have shown physiological functions of interleukin (IL)-32, a novel cytokine.",21423208_0,0,1,2,-1,14684,-1,4.1779153e-05,0.99993575,2.2529803e-05
14690,that IL-32,6,8,25,36,"In this study, we showed that IL-32 inhibited tumor growth in IL-32-overexpressing transgenic mice inoculated with melanoma as well as colon tumor growth in xenograft nude mice inoculated with IL-32-transfected colon cancer cells (SW620).",21423208_2,-1,-1,-1,-1,14690,-1,0.0010991618,0.96061844,0.03828244
14692,IL-32-overexpressing transgenic,12,14,63,95,"In this study, we showed that IL-32 inhibited tumor growth in IL-32-overexpressing transgenic mice inoculated with melanoma as well as colon tumor growth in xenograft nude mice inoculated with IL-32-transfected colon cancer cells (SW620).",21423208_2,-1,-1,-1,-1,14692,-1,0.008237881,0.2150937,0.7766684
14705,tumor-promoting genes,8,10,56,77,"The expression of antiapoptotic, cell proliferation and tumor-promoting genes (bcl-2, X-chromosome inhibitor of apoptosis protein (IAP), cellular IAP and cellular FADD-like IL-1-converting enzyme-inhibitory protein, cyclin D), cyclin-dependent kinase 4, cycolooxygenase-2 and inducible nitric oxide synthase was decreased, whereas the expression of apoptotic target genes (caspase-3 and -9, bax) increased.",21423208_4,-1,-1,-1,-1,14705,-1,2.8237459e-05,0.9999542,1.7493721e-05
14706,protein,17,18,122,129,"The expression of antiapoptotic, cell proliferation and tumor-promoting genes (bcl-2, X-chromosome inhibitor of apoptosis protein (IAP), cellular IAP and cellular FADD-like IL-1-converting enzyme-inhibitory protein, cyclin D), cyclin-dependent kinase 4, cycolooxygenase-2 and inducible nitric oxide synthase was decreased, whereas the expression of apoptotic target genes (caspase-3 and -9, bax) increased.",21423208_4,0,1,-1,-1,14706,-1,0.00014927235,0.99964535,0.00020531547
14710,protein,29,30,208,215,"The expression of antiapoptotic, cell proliferation and tumor-promoting genes (bcl-2, X-chromosome inhibitor of apoptosis protein (IAP), cellular IAP and cellular FADD-like IL-1-converting enzyme-inhibitory protein, cyclin D), cyclin-dependent kinase 4, cycolooxygenase-2 and inducible nitric oxide synthase was decreased, whereas the expression of apoptotic target genes (caspase-3 and -9, bax) increased.",21423208_4,0,1,-1,-1,14710,-1,0.00022273386,0.99929976,0.00047750844
14712,target genes,53,55,360,372,"The expression of antiapoptotic, cell proliferation and tumor-promoting genes (bcl-2, X-chromosome inhibitor of apoptosis protein (IAP), cellular IAP and cellular FADD-like IL-1-converting enzyme-inhibitory protein, cyclin D), cyclin-dependent kinase 4, cycolooxygenase-2 and inducible nitric oxide synthase was decreased, whereas the expression of apoptotic target genes (caspase-3 and -9, bax) increased.",21423208_4,-1,-1,-1,-1,14712,-1,3.0481178e-05,0.99994004,2.9504123e-05
14714,blood,5,6,21,26,"In tumor, spleen and blood, the number of cytotoxic CD8(+) T cells and CD57(+) natural killer cells and the levels of IL-10 increased, but that of tumor necrosis factor- (TNF-), IL-1 and IL-6 decreased.",21423208_5,0,1,-1,-1,14714,-1,5.5318247e-05,0.99986315,8.148745e-05
14723,factor-,33,34,162,170,"In tumor, spleen and blood, the number of cytotoxic CD8(+) T cells and CD57(+) natural killer cells and the levels of IL-10 increased, but that of tumor necrosis factor- (TNF-), IL-1 and IL-6 decreased.",21423208_5,0,1,-1,-1,14723,-1,0.99986994,4.6982837e-05,8.3072395e-05
14724,TNF-,35,36,172,177,"In tumor, spleen and blood, the number of cytotoxic CD8(+) T cells and CD57(+) natural killer cells and the levels of IL-10 increased, but that of tumor necrosis factor- (TNF-), IL-1 and IL-6 decreased.",21423208_5,0,1,-1,-1,14724,-1,8.440767e-05,0.9998932,2.240543e-05
14735,the IL-32-induced,29,31,172,190,"In addition, when IL-32 was knocked down by small interfering RNA (siRNA) or neutralized with an anti-IL-32 antibody, IL-32-induced colon cancer cell growth inhibition, the IL-32-induced decrease of TNF-, IL-1 and IL-6 production, and the increase of IL-10 production were abolished.",21423208_7,-1,-1,-1,-1,14735,-1,0.00014700588,0.9993555,0.0004975092
14736,TNF-,33,34,203,208,"In addition, when IL-32 was knocked down by small interfering RNA (siRNA) or neutralized with an anti-IL-32 antibody, IL-32-induced colon cancer cell growth inhibition, the IL-32-induced decrease of TNF-, IL-1 and IL-6 production, and the increase of IL-10 production were abolished.",21423208_7,0,1,-1,-1,14736,-1,8.8315e-05,0.9998702,4.147594e-05
14749,the functional tolerance,5,8,24,48,One such setting may be the functional tolerance displayed by tumor-bearing hosts toward tumor-associated antigens.,21517755_1,-1,-1,-1,-1,14749,-1,2.3999353e-05,0.9999646,1.1414633e-05
14751,toward tumor-associated antigens,12,15,82,114,One such setting may be the functional tolerance displayed by tumor-bearing hosts toward tumor-associated antigens.,21517755_1,-1,-1,-1,-1,14751,-1,0.020197932,0.97552085,0.0042811865
14754,to tumor-induced,10,12,57,73,Foxp3(+) Tregs are now recognized as a major contributor to tumor-induced immune suppression and functional tolerance.,21517755_2,-1,-1,-1,-1,14754,-1,2.9669958e-05,0.99995744,1.2914808e-05
14755,functional tolerance,15,17,97,117,Foxp3(+) Tregs are now recognized as a major contributor to tumor-induced immune suppression and functional tolerance.,21517755_2,-1,-1,-1,-1,14755,-1,8.0153426e-05,0.999882,3.779077e-05
14763,T cells toward,16,19,92,106,The first is the ability of IDO-expressing DCs to drive the differentiation of naive CD4(+) T cells toward a Foxp3+ (inducible Treg) phenotype.,21517755_4,-1,-1,-1,-1,14763,-1,0.0014487526,0.026485741,0.97206557
14770,target cells,21,23,138,150,"The second link is the ability of IDO-expressing DCs to directly activate mature, pre-existing Tregs for markedly enhanced suppression of target cells.",21517755_5,-1,-1,-1,-1,14770,-1,0.003888642,0.369007,0.62710446
14771,the third,1,3,4,13,"And the third link is the ability of IDO to prevent the inflammation-induced conversion (""reprogramming"") of Tregs into pro-inflammatory T-helper-like cells in vivo.",21517755_6,-1,-1,-1,-1,14771,-1,3.0242127e-05,0.99995625,1.3489163e-05
14776,T-helper-like cells,23,25,137,156,"And the third link is the ability of IDO to prevent the inflammation-induced conversion (""reprogramming"") of Tregs into pro-inflammatory T-helper-like cells in vivo.",21517755_6,-1,-1,-1,-1,14776,-1,0.00085217564,0.0154898325,0.983658
14777,Taken together,0,2,0,14,"Taken together, these findings suggest that IDO may represent an important regulatory checkpoint influencing Treg activity: both by stabilizing and augmenting the suppressive phenotype, and by preventing Treg reprogramming into non-suppressive helper-like cells.",21517755_7,-1,-1,-1,-1,14777,-1,4.3115782e-05,0.9999399,1.6916489e-05
14787,to T,11,13,67,71,We hypothesised that immune suppression in this subtype may be due to T regulatory cells (Treg) recruitment driven by hypoxia-induced up-regulation of CXCR4 in Treg.,21521526_1,-1,-1,-1,-1,14787,-1,2.123125e-05,0.9999676,1.1217644e-05
14793,tissue,11,12,73,79,METHODS: Immunoperoxidase staining for FOXP3 and CXCL12 was performed on tissue microarrays from 491 breast cancers.,21521526_2,-1,1,2,-1,14793,-1,3.5727007e-05,0.99987924,8.50127e-05
14799,tumour CXCL12,7,9,48,61,"RESULTS: High Treg infiltration correlated with tumour CXCL12 positivity (OR 1.89, 95% CI 1.22 to 2.94, P = 0.004) and basal phenotype (OR 3.14, 95% CI 1.08 to 9.17, P = 0.004) in univariate and multivariate analyses.",21521526_4,-1,-1,-1,-1,14799,-1,0.8897085,0.100121714,0.010169714
14805,analysis,50,51,253,261,"CXCL12 positivity correlated with improved survival (P = 0.005), whereas high Treg correlated with shorter survival for all breast cancers (P = 0.001), luminal cancers (P < 0.001) and basal-like cancers (P = 0.040) that were confirmed in a multivariate analysis (OR 1.61, 95% CI 1.02 to 2.53, P = 0.042).",21521526_5,0,1,-1,-1,14805,-1,5.653063e-05,0.9999012,4.2286578e-05
14808,therapy,5,6,33,40,"In patients treated with hormone therapy, high Treg were associated with a shorter survival in a multivariate analysis (OR 1.78, 95% CI 1.01 to 3.15, P = 0.040).",21521526_6,0,1,-1,-1,14808,-1,4.0152067e-05,0.99993837,2.1449321e-05
14810,analysis,18,19,110,118,"In patients treated with hormone therapy, high Treg were associated with a shorter survival in a multivariate analysis (OR 1.78, 95% CI 1.01 to 3.15, P = 0.040).",21521526_6,0,1,-1,-1,14810,-1,8.1967926e-05,0.99985695,6.109479e-05
14839,factor-1,14,15,86,95,METHODS: The frequencies of CD4(+)Foxp3(+) Tregs and the level of transforming growth factor-1 (TGF-1) were analyzed from 56 patients with gastric cancer by flow cytometry and enzyme-linked immunosorbent assay respectively.,21528082_1,0,1,-1,-1,14839,-1,0.99505335,0.0023972515,0.0025494127
14841,Foxp3 gene,0,2,0,10,Foxp3 gene expression was analyzed by real-time polymerase chain reaction.,21528082_2,-1,-1,-1,-1,14841,-1,2.13873e-05,0.9999647,1.39174335e-05
14855,to the,5,7,44,50,Neutralizing anti-TGF-1 antibody was added to the co-culture system for neutralization experiments.,21528082_7,-1,-1,-1,-1,14855,-1,2.1017331e-05,0.9999689,1.0154036e-05
14858,than that,20,22,106,115,RESULTS: The level of serum TGF-1 in gastric cancer patients (15.1  5.5 ng/mL) was significantly higher than that of the gender- and age-matched healthy controls (10.3  3.4 ng/mL) (P < 0.05).,21528082_8,-1,-1,-1,-1,14858,-1,2.363728e-05,0.9999615,1.4913106e-05
14869,that the,12,14,65,73,"Moreover, using the purified CD4(+)CD25(-) T cells, we confirmed that the increased Tregs were mainly induced from the conversation of CD4(+)CD25(-) naive T cells, and induced Tregs were functional and able to suppress the proliferation of effector T cells.",21528082_11,-1,-1,-1,-1,14869,-1,1.7724626e-05,0.9999714,1.0873851e-05
14872,naive T cells,25,28,149,162,"Moreover, using the purified CD4(+)CD25(-) T cells, we confirmed that the increased Tregs were mainly induced from the conversation of CD4(+)CD25(-) naive T cells, and induced Tregs were functional and able to suppress the proliferation of effector T cells.",21528082_11,-1,-1,-1,-1,14872,-1,0.0022265124,0.035388336,0.9623851
14874,functional,33,34,187,197,"Moreover, using the purified CD4(+)CD25(-) T cells, we confirmed that the increased Tregs were mainly induced from the conversation of CD4(+)CD25(-) naive T cells, and induced Tregs were functional and able to suppress the proliferation of effector T cells.",21528082_11,0,1,2,-1,14874,-1,3.5963843e-05,0.999948,1.6023672e-05
14892,the tumor,20,22,128,137,"CONCLUSION: Gastric cancer cell can induce Tregs development via producing TGF-1, by which the existence of cross-talk between the tumor and immune cells might regulate anti-tumor immune responses.",21528082_14,-1,-1,-1,-1,14892,-1,2.1684995e-05,0.9999672,1.1148222e-05
14895,The forkhead transcription factor Foxp3,0,5,0,39,The forkhead transcription factor Foxp3 is the only definitive marker of CD4(+)CD25(+) regulatory T cells (Tregs) and has been identified as a key regulator in the development and function of Tregs.,21547596_0,-1,-1,-1,-1,14895,-1,1.8482287e-05,0.9999715,9.961351e-06
14900,function,31,32,180,188,The forkhead transcription factor Foxp3 is the only definitive marker of CD4(+)CD25(+) regulatory T cells (Tregs) and has been identified as a key regulator in the development and function of Tregs.,21547596_0,0,1,2,-1,14900,-1,6.7121655e-05,0.9998981,3.4743407e-05
14906,tumor-infiltrating Tregs,10,12,53,77,"In this study, we validated Foxp3 expression in both tumor-infiltrating Tregs and melanoma cells by performing immunohistochemical analysis of human melanoma tissue sections.",21547596_2,-1,-1,-1,-1,14906,-1,2.5263618e-05,0.9999621,1.2594021e-05
14908,analysis,18,19,131,139,"In this study, we validated Foxp3 expression in both tumor-infiltrating Tregs and melanoma cells by performing immunohistochemical analysis of human melanoma tissue sections.",21547596_2,0,1,-1,-1,14908,-1,3.2021773e-05,0.9999436,2.4385032e-05
14909,tissue,22,23,158,164,"In this study, we validated Foxp3 expression in both tumor-infiltrating Tregs and melanoma cells by performing immunohistochemical analysis of human melanoma tissue sections.",21547596_2,-1,1,2,-1,14909,-1,4.6415786e-05,0.9998541,9.9459285e-05
14912,analysis,17,18,112,120,"Further, we assessed Foxp3 expression in melanoma cell lines by performing flow cytometry, confocal microscopic analysis, reverse transcription-polymerase chain reaction (RT-PCR), and Western blotting.",21547596_3,0,1,-1,-1,14912,-1,5.089153e-05,0.9998938,5.5255936e-05
14917,transforming growth factor,20,23,125,151,"Inhibition of Foxp3 expression in melanoma cells using small interfering RNA (siRNA) resulted in downregulation of B7-H1 and transforming growth factor (TGF)- expression; in contrast, Foxp3 overexpression resulted in the upregulation of the expression of these proteins.",21547596_4,-1,-1,-1,-1,14917,-1,0.8446485,0.15087137,0.0044801333
14921,these proteins,39,41,256,270,"Inhibition of Foxp3 expression in melanoma cells using small interfering RNA (siRNA) resulted in downregulation of B7-H1 and transforming growth factor (TGF)- expression; in contrast, Foxp3 overexpression resulted in the upregulation of the expression of these proteins.",21547596_4,-1,-1,-1,-1,14921,-1,2.6777749e-05,0.999948,2.521991e-05
14937,Foxp3-dependent Treg-like,8,10,56,81,These findings indicated that melanoma cells could have Foxp3-dependent Treg-like suppressive effects on T cells and suggested that the mimicking of Treg function by melanoma cells may represent a possible mechanism of tumor resistance to immune destruction in the melanoma tumor microenvironment.,21547596_8,-1,-1,-1,-1,14937,-1,2.6446987e-05,0.9999578,1.5781723e-05
14939,that the,17,19,127,135,These findings indicated that melanoma cells could have Foxp3-dependent Treg-like suppressive effects on T cells and suggested that the mimicking of Treg function by melanoma cells may represent a possible mechanism of tumor resistance to immune destruction in the melanoma tumor microenvironment.,21547596_8,-1,-1,-1,-1,14939,-1,1.912798e-05,0.9999728,8.0158825e-06
14940,Treg function,21,23,149,162,These findings indicated that melanoma cells could have Foxp3-dependent Treg-like suppressive effects on T cells and suggested that the mimicking of Treg function by melanoma cells may represent a possible mechanism of tumor resistance to immune destruction in the melanoma tumor microenvironment.,21547596_8,-1,-1,-1,-1,14940,-1,4.5954323e-05,0.99992466,2.9386349e-05
14953,tumor-infiltrating Tregs,30,32,162,186,"However, this evidence is supported by in vitro or mouse model studies with no data from in vivo or human studies to support its role in enriching peripheral and tumor-infiltrating Tregs.",21570917_1,-1,-1,-1,-1,14953,-1,2.5017283e-05,0.99996257,1.2376626e-05
14958,blood,3,4,23,28,We analyzed peripheral blood samples from untreated renal cell carcinoma (RCC) patients and following interleukin (IL)-2 treatment for the expression of FoxP3 and Helios.,21570917_3,0,1,-1,-1,14958,-1,5.7199864e-05,0.99974924,0.00019354452
14968,natural Tregs,11,13,74,87,"Interestingly, IL-2 administration results in expansion of FoxP3+ Helios+ natural Tregs (nTregs) significantly more than FoxP3+ Helios- iTregs.",21570917_5,-1,-1,-1,-1,14968,-1,4.939931e-05,0.9999207,2.9876823e-05
14969,than FoxP3,18,20,116,126,"Interestingly, IL-2 administration results in expansion of FoxP3+ Helios+ natural Tregs (nTregs) significantly more than FoxP3+ Helios- iTregs.",21570917_5,-1,-1,-1,-1,14969,-1,3.2064654e-05,0.99994767,2.0220456e-05
14970,that the,3,5,15,23,"Our work shows that the increased FoxP3+ Treg subpopulation in RCC patients co-express Helios, indicating that they could be derived from natural but not induced Tregs.",21570917_6,-1,-1,-1,-1,14970,-1,1.765085e-05,0.9999726,9.777303e-06
14973,that they,17,19,106,115,"Our work shows that the increased FoxP3+ Treg subpopulation in RCC patients co-express Helios, indicating that they could be derived from natural but not induced Tregs.",21570917_6,-1,-1,-1,-1,14973,-1,2.130167e-05,0.9999678,1.0902929e-05
14979,the autoimmune regulator,29,32,208,232,Much has been learnt about the mechanisms of thymic self-tolerance induction from work on both the rare autosomal recessive disease autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) and the autoimmune regulator (AIRE) protein mutated in this disease.,21574164_0,-1,-1,-1,-1,14979,-1,4.2306576e-05,0.9999143,4.3438704e-05
14981,protein,35,36,240,247,Much has been learnt about the mechanisms of thymic self-tolerance induction from work on both the rare autosomal recessive disease autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) and the autoimmune regulator (AIRE) protein mutated in this disease.,21574164_0,0,1,-1,-1,14981,-1,0.000114717484,0.9996767,0.00020862347
14984,tissue-specific antigens,11,13,73,97,"Normally, AIRE drives low-level expression of huge numbers of peripheral tissue-specific antigens (TSAgs) in medullary thymic epithelial cells (mTECs), leading to the deletion of TSAg-reactive thymocytes maturing nearby.",21574164_1,-1,-1,-1,-1,14984,-1,0.1387615,0.83191186,0.029326634
14988,to the,26,28,160,166,"Normally, AIRE drives low-level expression of huge numbers of peripheral tissue-specific antigens (TSAgs) in medullary thymic epithelial cells (mTECs), leading to the deletion of TSAg-reactive thymocytes maturing nearby.",21574164_1,-1,-1,-1,-1,14988,-1,2.1142861e-05,0.9999701,8.803726e-06
14989,TSAg-reactive thymocytes,30,32,179,203,"Normally, AIRE drives low-level expression of huge numbers of peripheral tissue-specific antigens (TSAgs) in medullary thymic epithelial cells (mTECs), leading to the deletion of TSAg-reactive thymocytes maturing nearby.",21574164_1,-1,-1,-1,-1,14989,-1,0.0027828042,0.77577037,0.22144689
14991,Th17-related cells,10,12,75,93,The very recently discovered neutralizing autoantibodies (autoAbs) against Th17-related cells and cytokines in two autoimmunity-related syndromes associated with AIRE-mutant thymi or AIRE-deficient thymomas help to explain the chronic mucocutaneous candidiasis (CMC) seen in both syndromes.,21574164_2,-1,-1,-1,-1,14991,-1,0.0031252946,0.7863167,0.21055803
14994,AIRE-mutant thymi,20,22,162,179,The very recently discovered neutralizing autoantibodies (autoAbs) against Th17-related cells and cytokines in two autoimmunity-related syndromes associated with AIRE-mutant thymi or AIRE-deficient thymomas help to explain the chronic mucocutaneous candidiasis (CMC) seen in both syndromes.,21574164_2,-1,-1,-1,-1,14994,-1,0.0002190885,0.9995215,0.0002593721
14995,AIRE-deficient thymomas,23,25,183,206,The very recently discovered neutralizing autoantibodies (autoAbs) against Th17-related cells and cytokines in two autoimmunity-related syndromes associated with AIRE-mutant thymi or AIRE-deficient thymomas help to explain the chronic mucocutaneous candidiasis (CMC) seen in both syndromes.,21574164_2,-1,-1,-1,-1,14995,-1,0.00015695921,0.99971086,0.00013212352
15001,AIRE deficiency,16,18,114,129,"The surprising parallels between these syndromes also demand new hypotheses and research into the consequences of AIRE deficiency and the ensuing autoimmunizing pathways, and suggest more appropriate treatment regimens as discussed in this review.",21574164_3,-1,-1,-1,-1,15001,-1,0.00072863855,0.99811065,0.0011607545
15007,immunity through,6,8,45,61,Interferon-alpha (IFN-) promotes anti-tumor immunity through its actions on immune cells.,21604071_0,-1,-1,-1,-1,15007,-1,0.036734812,0.9622318,0.0010334187
15012,blood,18,19,140,145,We hypothesized that elevated percentages of myeloid-derived suppressor cells (MDSC) and increased pro-inflammatory cytokines in peripheral blood would be associated with impaired response to IFN- in patients with gastrointestinal (GI) malignancies.,21604071_1,0,1,-1,-1,15012,-1,6.0028833e-05,0.9998611,7.882646e-05
15013,to IFN-,25,27,189,197,We hypothesized that elevated percentages of myeloid-derived suppressor cells (MDSC) and increased pro-inflammatory cytokines in peripheral blood would be associated with impaired response to IFN- in patients with gastrointestinal (GI) malignancies.,21604071_1,-1,-1,-1,-1,15013,-1,0.90977633,0.088066556,0.0021570956
15016,plasma IL-6,5,7,43,54,"This study evaluated relationships between plasma IL-6, IL-10, circulating MDSC subsets, and IFN--induced signal transduction in 40 patients with GI malignancies.",21604071_2,-1,-1,-1,-1,15016,-1,0.65676683,0.33706552,0.0061676814
15021,Plasma IL-6,0,2,0,11,Plasma IL-6 and IL-10 were significantly higher in patients versus normal donors.,21604071_3,-1,-1,-1,-1,15021,-1,0.36970416,0.61441714,0.015878715
15024,Plasma IL-6,0,2,0,11,Plasma IL-6 was correlated with CD33(+)HLADR(-)CD15(+) MDSC (P = 0.008) and IL-10 with CD33(+)HLADR(-)CD15(-) MDSC (P = 0.002).,21604071_5,-1,-1,-1,-1,15024,-1,0.78091884,0.2112992,0.0077820076
15028,IFN--induced STAT1,18,20,98,117,"The percentage of CD15(+) and CD15(-) but not CD14(+) MDSC subsets were inversely correlated with IFN--induced STAT1 phosphorylation in CD4(+) T cells, while co-culture with in vitro generated MDSC led to reduced IFN- responsiveness in both PBMC and the CD4(+) subset of T cells from normal donors.",21604071_6,-1,-1,-1,-1,15028,-1,0.974108,0.021855773,0.0040362426
15051,blood,18,19,99,104,The aim of the study was to observe the variation of CD4(+)CD25(+) regulatory T cells in periphery blood and tumor microenvironment of non-small cell lung cancer (NSCLC) patients and the effects of CpG ODN.,21611754_0,0,1,-1,-1,15051,-1,4.8849408e-05,0.99984837,0.0001027814
15057,Foxp3 gene,9,11,52,62,"The proportion of CD4(+)CD25(+) regulatory T cells, Foxp3 gene expression, levels of tumor growth factor- (TGF-) and immunoreactive fibronectin- (IFN-) in the periphery blood of 30 NSCLC patients and 30 healthy volunteers were compared.",21611754_1,-1,-1,-1,-1,15057,-1,1.9447843e-05,0.9999696,1.0994123e-05
15059,factor-,17,18,98,106,"The proportion of CD4(+)CD25(+) regulatory T cells, Foxp3 gene expression, levels of tumor growth factor- (TGF-) and immunoreactive fibronectin- (IFN-) in the periphery blood of 30 NSCLC patients and 30 healthy volunteers were compared.",21611754_1,0,1,-1,-1,15059,-1,0.99974436,9.557173e-05,0.00016008901
15063,blood,30,31,173,178,"The proportion of CD4(+)CD25(+) regulatory T cells, Foxp3 gene expression, levels of tumor growth factor- (TGF-) and immunoreactive fibronectin- (IFN-) in the periphery blood of 30 NSCLC patients and 30 healthy volunteers were compared.",21611754_1,0,1,-1,-1,15063,-1,0.00012207165,0.9987753,0.0011026078
15066,Foxp3 gene,0,2,0,10,Foxp3 gene expression in the tumor microenvironment of NSCLC patients was also observed.,21611754_3,-1,-1,-1,-1,15066,-1,2.2305361e-05,0.999966,1.167683e-05
15067,the tumor,4,6,25,34,Foxp3 gene expression in the tumor microenvironment of NSCLC patients was also observed.,21611754_3,-1,-1,-1,-1,15067,-1,1.8591025e-05,0.99997246,8.999828e-06
15073,blood,18,19,114,119,"The results showed CD4(+)CD25(+) regulatory T cell proportion, Foxp3 expression and TGF- levels in the periphery blood of NSCLC patients were higher than those of healthy volunteers (p<0.05), and these indicators of patients were significantly decreased after CpG ODN 2006 treatment (p<0.05).",21611754_4,0,1,-1,-1,15073,-1,0.00038224872,0.9934669,0.0061508385
15074,than those,24,26,150,160,"The results showed CD4(+)CD25(+) regulatory T cell proportion, Foxp3 expression and TGF- levels in the periphery blood of NSCLC patients were higher than those of healthy volunteers (p<0.05), and these indicators of patients were significantly decreased after CpG ODN 2006 treatment (p<0.05).",21611754_4,-1,-1,-1,-1,15074,-1,2.1528602e-05,0.9999646,1.3821854e-05
15079,than that,9,11,58,67,Foxp3 expression in the metastatic lymph nodes was higher than that in the non-metastatic ones of NSCLC patients (p=0.000).,21611754_5,-1,-1,-1,-1,15079,-1,2.4498464e-05,0.99996114,1.43736925e-05
15084,blood,19,20,118,123,"In conclusion, a rise in the proportion of CD4(+)CD25(+)Foxp3(+) regulatory T cells was demonstrated in the periphery blood and tumor microenvironments of NSCLC patients.",21611754_6,0,1,-1,-1,15084,-1,0.00014031644,0.9989907,0.00086896063
15090,blood,17,18,117,122,CpG ODN 2006 downregulated the CD4(+)CD25(+)Foxp3(+) regulatory T cells proportion and TGF- levels in the periphery blood of these patients.,21611754_7,0,1,-1,-1,15090,-1,0.00024057824,0.9963456,0.0034138798
15096,that the,4,6,15,23,"Here, we found that the E6 oncogene from HPV16, but not HPV18, suppressed MHC I expression.",21621523_1,-1,-1,-1,-1,15096,-1,1.8371818e-05,0.99997234,9.277378e-06
15103,to cytotoxic T lymphocytes,8,12,64,90,"The expression of HPV16E6 strongly enhanced cellular resistance to cytotoxic T lymphocytes (CTLs)-mediated lytic activity, and knockdown of HPV16E6 by antisense had the opposite effect.",21621523_3,-1,-1,-1,-1,15103,-1,0.0019292485,0.06276233,0.9353084
15105,The regulation,0,2,0,14,"The regulation of HPV16E6-mediated MHC I suppression might be through the regulation of lymphotoxin (LT) and its receptor, LTR. In addition, cells from the spleen and liver of LT- or LTR-deficient mice showed increased MHC I expression.",21621523_4,-1,-1,-1,-1,15105,-1,1.9927162e-05,0.99996984,1.0182915e-05
15106,through the regulation,9,12,62,84,"The regulation of HPV16E6-mediated MHC I suppression might be through the regulation of lymphotoxin (LT) and its receptor, LTR. In addition, cells from the spleen and liver of LT- or LTR-deficient mice showed increased MHC I expression.",21621523_4,-1,-1,-1,-1,15106,-1,2.2591787e-05,0.9999633,1.4098668e-05
15107,receptor,19,20,113,121,"The regulation of HPV16E6-mediated MHC I suppression might be through the regulation of lymphotoxin (LT) and its receptor, LTR. In addition, cells from the spleen and liver of LT- or LTR-deficient mice showed increased MHC I expression.",21621523_4,0,1,2,-1,15107,-1,0.00055082835,0.0013441446,0.99810505
15111,that the,5,7,36,44,"Overall, these results demonstrated that the E6 oncogene of HPV16 might play an important role in cell transformation and cancer development through LT-mediated MHC I downregulation in humans.",21621523_5,-1,-1,-1,-1,15111,-1,1.815668e-05,0.99997365,8.196964e-06
15113,cell transformation,17,19,98,117,"Overall, these results demonstrated that the E6 oncogene of HPV16 might play an important role in cell transformation and cancer development through LT-mediated MHC I downregulation in humans.",21621523_5,-1,-1,-1,-1,15113,-1,0.00015978004,0.0014847467,0.99835545
15116,therapy,6,7,41,48,Recombinant human interleukin-2 (rhIL-2) therapy is approved for treating patients with advanced melanoma yet significant responses are observed in only 10-15% of patients.,21638127_0,0,1,-1,-1,15116,-1,1.9968014e-05,0.99996936,1.0613188e-05
15133,cell subset,20,22,119,130,"In tumor-free mice and subcutaneous tumor-bearing mouse models, CD8 Foxp3+ T cells were a rare but naturally occurring cell subset.",21638127_3,-1,-1,-1,-1,15133,-1,3.7369307e-05,4.3395317e-05,0.9999192
15158,Functionally,0,1,0,12,Functionally polarized helper T cells (Th cells) play crucial roles in the induction of tumor immunity.,21646476_0,0,1,2,-1,15158,-1,3.7880807e-05,0.99994516,1.6908514e-05
15160,Th cells,6,8,39,47,Functionally polarized helper T cells (Th cells) play crucial roles in the induction of tumor immunity.,21646476_0,-1,-1,-1,-1,15160,-1,4.1811512e-05,6.738098e-05,0.9998908
15163,tumor immunity,16,18,88,102,Functionally polarized helper T cells (Th cells) play crucial roles in the induction of tumor immunity.,21646476_0,-1,-1,-1,-1,15163,-1,0.013708559,0.9858483,0.00044315876
15166,IFN-producing Th1 cells that,8,12,59,87,"There is considerable knowledge about the contributions of IFN-producing Th1 cells that supports the role of cytotoxic cluster of differentiation (CD8) T cells and natural killer (NK) cells, but much less is known about how IL-4-producing Th2 cells contribute to tumor immunity.",21646476_1,-1,-1,-1,-1,15166,-1,0.97778785,0.012120643,0.010091509
15172,to tumor immunity,44,47,260,277,"There is considerable knowledge about the contributions of IFN-producing Th1 cells that supports the role of cytotoxic cluster of differentiation (CD8) T cells and natural killer (NK) cells, but much less is known about how IL-4-producing Th2 cells contribute to tumor immunity.",21646476_1,-1,-1,-1,-1,15172,-1,0.0030634562,0.99670273,0.00023383867
15174,the cellular,6,8,31,43,"In this study, we investigated the cellular and molecular mechanisms employed by memory Th2 cells in sustaining tumor immunity by using a mouse model system wherein ovalbumin (OVA) is used as a specific tumor antigen.",21646476_2,-1,-1,-1,-1,15174,-1,0.0043479265,0.5973829,0.39826918
15176,tumor immunity,18,20,112,126,"In this study, we investigated the cellular and molecular mechanisms employed by memory Th2 cells in sustaining tumor immunity by using a mouse model system wherein ovalbumin (OVA) is used as a specific tumor antigen.",21646476_2,-1,-1,-1,-1,15176,-1,0.014878586,0.9846044,0.00051702955
15177,tumor antigen,36,38,203,216,"In this study, we investigated the cellular and molecular mechanisms employed by memory Th2 cells in sustaining tumor immunity by using a mouse model system wherein ovalbumin (OVA) is used as a specific tumor antigen.",21646476_2,-1,-1,-1,-1,15177,-1,0.33157852,0.656183,0.012238419
15181,tumor cells,20,22,145,156,"In this model, we found that OVA-specific memory Th2 cells exerted potent and long-lasting antitumor effects against NK-sensitive OVA-expressing tumor cells, wherein antitumor effects were mediated by NK cells.",21646476_3,-1,-1,-1,-1,15181,-1,0.004050414,0.39092913,0.6050204
15195,immunity through,11,13,68,84,"Our findings show that memory Th2 cells can induce potent antitumor immunity through IL-4-induced activation of NK cells, suggesting potential applications in cellular therapy for cancer patients.",21646476_6,-1,-1,-1,-1,15195,-1,0.10546944,0.8925565,0.0019741466
15197,cellular therapy,23,25,159,175,"Our findings show that memory Th2 cells can induce potent antitumor immunity through IL-4-induced activation of NK cells, suggesting potential applications in cellular therapy for cancer patients.",21646476_6,-1,-1,-1,-1,15197,-1,0.0029761617,0.09031504,0.9067087
15206,blood,28,29,142,147,"BACKGROUND: The purpose of this study was to investigate the presence of CD4(+) CD25(+) FOXP3(+) regulatory T (Treg) cells both in peripheral blood and local tumors in patients with nasal inverted papilloma (NIP).METHODS: By using flow cytometry, the frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in both peripheral blood and tissues from 18 patients with NIP and 8 control subjects were determined.",21674673_0,0,1,-1,-1,15206,-1,0.00013659407,0.99903023,0.0008332046
15212,blood,59,60,320,325,"BACKGROUND: The purpose of this study was to investigate the presence of CD4(+) CD25(+) FOXP3(+) regulatory T (Treg) cells both in peripheral blood and local tumors in patients with nasal inverted papilloma (NIP).METHODS: By using flow cytometry, the frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in both peripheral blood and tissues from 18 patients with NIP and 8 control subjects were determined.",21674673_0,0,1,-1,-1,15212,-1,0.00018868993,0.99747366,0.002337666
15213,tissues,61,62,330,337,"BACKGROUND: The purpose of this study was to investigate the presence of CD4(+) CD25(+) FOXP3(+) regulatory T (Treg) cells both in peripheral blood and local tumors in patients with nasal inverted papilloma (NIP).METHODS: By using flow cytometry, the frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in both peripheral blood and tissues from 18 patients with NIP and 8 control subjects were determined.",21674673_0,-1,1,2,-1,15213,-1,5.1768573e-05,0.9998221,0.00012618123
15215,CCL17 proteins,2,4,10,24,CCL22 and CCL17 proteins in NIP tumors were analyzed by using enzyme-linked immunosorbent assay.,21674673_1,-1,-1,-1,-1,15215,-1,0.8359289,0.040393114,0.12367791
15222,analysis,27,28,159,167,The suppressive capacity of Treg cells was estimated by WST-8 and enzyme-linked immunosorbent assay (ELISA; interferon-gamma [IFN-] and interleukin-4 [IL-4]) analysis.,21674673_2,0,1,-1,-1,15222,-1,2.7831582e-05,0.9999434,2.8769871e-05
15225,tumor tissues,17,19,93,106,RESULTS: Patients with NIP showed increased CD4(+) CD25(+) FOXP3(+) Treg cell frequencies in tumor tissues and CD4(+) T cell fraction rather than in peripheral blood.,21674673_3,-1,-1,-1,-1,15225,-1,4.7263726e-05,0.9998673,8.537885e-05
15228,blood,29,30,160,165,RESULTS: Patients with NIP showed increased CD4(+) CD25(+) FOXP3(+) Treg cell frequencies in tumor tissues and CD4(+) T cell fraction rather than in peripheral blood.,21674673_3,0,1,-1,-1,15228,-1,0.0015955042,0.28010455,0.7182999
15242,immune response thus,6,9,40,60,Regulatory T cells can affect antiviral immune response thus influencing the outcome of the disease.,21684822_1,-1,-1,-1,-1,15242,-1,0.89450186,0.10261257,0.0028855973
15246,functional,6,7,30,40,AIM: To determine numeric and functional distribution of regulatory T cells expressing CD4+CD25hiFoxp3+ (T-regs) during the different stages of hepatitis C virus-related liver disease.,21684822_2,0,1,2,-1,15246,-1,4.188552e-05,0.9999398,1.832459e-05
15252,Target cell,0,2,0,11,Target cell proliferation and interferon-gamma production were evaluated in 37 HCV patients.,21684822_5,-1,-1,-1,-1,15252,-1,0.003325276,0.31668812,0.6799866
15269,tissue,13,14,85,91,This study aimed to investigate whether Treg are accumulated in human gastric cancer tissue and the mechanism of Treg induction by gastric cancer cells.,21695703_1,-1,1,2,-1,15269,-1,3.1834752e-05,0.99991024,5.7937614e-05
15273,Tissue,2,3,9,15,METHODS: Tissue infiltrated leukocytes from gastric adenocarcinomas were subjected to flow cytometry and immunohistochemistry.,21695703_2,-1,1,2,-1,15273,-1,2.9599178e-05,0.99994564,2.4791208e-05
15275,function,4,5,23,31,"Percentage, phenotype, function, and clinical relevance of Treg were analyzed.",21695703_3,0,1,2,-1,15275,-1,7.38691e-05,0.99987996,4.6147037e-05
15285,tissues,14,15,70,77,RESULTS: The percentages of CD4(+) Foxp3(+) T cells in gastric cancer tissues were significantly higher than those from adjacent non-tumor gastric tissues (P<0.05).,21695703_5,-1,1,2,-1,15285,-1,4.8769944e-05,0.99973863,0.00021258286
15286,than those,18,20,104,114,RESULTS: The percentages of CD4(+) Foxp3(+) T cells in gastric cancer tissues were significantly higher than those from adjacent non-tumor gastric tissues (P<0.05).,21695703_5,-1,-1,-1,-1,15286,-1,2.196812e-05,0.99996233,1.5665284e-05
15287,tissues,24,25,147,154,RESULTS: The percentages of CD4(+) Foxp3(+) T cells in gastric cancer tissues were significantly higher than those from adjacent non-tumor gastric tissues (P<0.05).,21695703_5,-1,1,2,-1,15287,-1,5.5499437e-05,0.99957126,0.00037320287
15290,that the,10,12,74,82,The results of classical Treg phenotype and proliferation assay supported that the elevated CD4(+) Foxp3(+) T cells represents a suppressive Treg population.,21695703_6,-1,-1,-1,-1,15290,-1,1.695791e-05,0.9999727,1.0338124e-05
15301,functional Treg,5,7,30,45,CONCLUSION: The proportion of functional Treg is elevated in human gastric cancer and related to poor prognosis.,21695703_9,-1,-1,-1,-1,15301,-1,4.3113432e-05,0.9999349,2.2008553e-05
15302,related to,14,16,86,96,CONCLUSION: The proportion of functional Treg is elevated in human gastric cancer and related to poor prognosis.,21695703_9,-1,-1,-1,-1,15302,-1,2.8997409e-05,0.9999572,1.3847584e-05
15304,naive T cells to Treg,7,12,45,66,"Gastric cancer cells directly convert CD4(+) naive T cells to Treg by TGF-1, suggesting a possible mechanism through which tumor cells evade the immune system.",21695703_10,-1,-1,-1,-1,15304,-1,0.0002366415,0.9988682,0.00089514995
15307,tumor cells,21,23,124,135,"Gastric cancer cells directly convert CD4(+) naive T cells to Treg by TGF-1, suggesting a possible mechanism through which tumor cells evade the immune system.",21695703_10,-1,-1,-1,-1,15307,-1,0.0041243164,0.36029628,0.6355794
15310,the immunomodulatory agent IFN-2,18,22,134,167,Recent reports have described complete or major molecular remission in patients with polycythemia vera after long-term treatment with the immunomodulatory agent IFN-2.,21708889_0,-1,-1,-1,-1,15310,-1,0.47183156,0.5256765,0.0024919247
15313,that the,7,9,42,50,"Accordingly, there are reasons to believe that the immune system is a key player in eradicating the JAK2 mutated clone in these patients.",21708889_1,-1,-1,-1,-1,15313,-1,1.8357843e-05,0.99997234,9.284194e-06
15318,regulatory T cells play,2,6,9,32,"Foxp3(+) regulatory T cells play a pivotal role in maintaining immune homeostasis and, importantly, preventing immune reactivity to self-antigens; however, their suppressive activity can compromise an effective antitumor immune response, and high frequencies of regulatory T cells in peripheral blood have been reported in both hematologic and solid cancers.",21708889_2,-1,-1,-1,-1,15318,-1,0.001143756,0.050022643,0.9488335
15323,blood,45,46,295,300,"Foxp3(+) regulatory T cells play a pivotal role in maintaining immune homeostasis and, importantly, preventing immune reactivity to self-antigens; however, their suppressive activity can compromise an effective antitumor immune response, and high frequencies of regulatory T cells in peripheral blood have been reported in both hematologic and solid cancers.",21708889_2,0,1,-1,-1,15323,-1,5.69351e-05,0.9997894,0.00015371978
15325,function,9,10,44,52,"We have analyzed the number, phenotype, and function of circulating CD4(+)CD25(+)Foxp3(+) T cells in patients with chronic myeloproliferative neoplasms.",21708889_3,0,1,2,-1,15325,-1,9.611002e-05,0.99981517,8.878574e-05
15327,this subset,8,10,45,56,"Surprisingly, we found a marked expansion of this subset of lymphocytes in patients treated with IFN-2 (13.0%; 95% confidence interval [CI] 10.8% to 15.2%) compared with healthy donors (6.1%; 95% CI 4.9% to 7.2%), patients with untreated chronic myeloproliferative neoplasms (6.9%; 95% CI 5.8% to 7.4%), or patients treated with hydroxyurea (5.8%; 95% CI 4.3% to 7.4%; P < .0001).",21708889_4,-1,-1,-1,-1,15327,-1,0.00360824,0.35293254,0.6434592
15339,Th2 immune responses,13,16,89,109,"We previously showed that exposure to UV radiation after immunization suppresses Th1 and Th2 immune responses, leading to impaired Ab and allo-immune responses, but the impact of UV radiation after immunization on anti-tumor immune responses mediated by tumor-specific CD8(+) T cell responses remains less clear.",21710495_0,-1,-1,-1,-1,15339,-1,0.117639884,0.87972564,0.0026345246
15346,functional,6,7,38,48,"Furthermore, the exact phenotypic and functional characteristics of regulatory T cell population responsible for the UV-induced immunosuppression still remain elusive.",21710495_1,0,1,2,-1,15346,-1,6.25911e-05,0.99989307,4.4292698e-05
15366,tumor cells,32,34,183,194,"This suppression was mediated by interleukin (IL)-10 released from CD4(+) CD25(+) T cells, by which impaired the induction of cytotoxic T lymphocytes (CTL) able to kill Ag-expressing tumor cells.",21710495_3,-1,-1,-1,-1,15366,-1,0.0041627064,0.336106,0.6597312
15370,Tr1-type regulatory T cell,28,32,155,181,"In addition, we generated a panel of T cell clones from UV-irradiated and non-irradiated mice, and all of the clones derived from UV-irradiated mice had a Tr1-type regulatory T cell phenotype with expression of IL-10 and c-Maf, but not Foxp3.",21710495_4,-1,-1,-1,-1,15370,-1,0.002653414,0.64306575,0.35428086
15373,These Tr1-type regulatory T cell,0,5,0,32,These Tr1-type regulatory T cell clones suppressed tumor rejection in vivo as well as Th cell activation in vitro in an IL-10 dependent manner.,21710495_5,-1,-1,-1,-1,15373,-1,0.003906141,0.7236866,0.27240726
15375,Th cell,14,16,86,93,These Tr1-type regulatory T cell clones suppressed tumor rejection in vivo as well as Th cell activation in vitro in an IL-10 dependent manner.,21710495_5,-1,-1,-1,-1,15375,-1,3.7512003e-05,4.4745702e-05,0.99991775
15382,Tr1 cells that,32,35,212,226,"Given that suppression of Ag-specific CTL responses can be induced in Ag-sensitized mice by UV irradiation, our results may imply that exposure to UV radiation during premalignant stage induces tumor-Ag specific Tr1 cells that mediate tumor-Ag specific immune suppression resulting in the promotion of tumor progression.",21710495_6,-1,-1,-1,-1,15382,-1,0.00019260035,0.99702734,0.002780112
15398,these Th17 cells,5,8,21,37,"However, the role of these Th17 cells in the pathogenesis of gastric cancer is less clear.",21710691_2,-1,-1,-1,-1,15398,-1,0.00397265,0.4662772,0.5297501
15405,these tumours,5,7,24,37,"At the molecular level, these tumours demonstrate hyper-activation of the latent transcription factor signal transducer and activator of transcription (STAT)3 via the IL-6 cytokine family member, IL-11.",21710691_4,-1,-1,-1,-1,15405,-1,1.8978291e-05,0.99996805,1.2919502e-05
15407,transcription factor signal transducer and activator of transcription,12,20,81,150,"At the molecular level, these tumours demonstrate hyper-activation of the latent transcription factor signal transducer and activator of transcription (STAT)3 via the IL-6 cytokine family member, IL-11.",21710691_4,-1,-1,-1,-1,15407,-1,2.3999763e-05,0.99995875,1.7192815e-05
15408,the IL-6 cytokine,22,25,163,180,"At the molecular level, these tumours demonstrate hyper-activation of the latent transcription factor signal transducer and activator of transcription (STAT)3 via the IL-6 cytokine family member, IL-11.",21710691_4,-1,-1,-1,-1,15408,-1,0.8441922,0.14859441,0.0072133797
15410,the generation,5,7,20,34,"In gp130(F/F) mice, the generation of Th17 cells, as well as the gastric expression of IL-17a and other Th17-related factors (Rort, IL-23), were augmented compared to wild-type gp130(+/+) mice.",21710691_5,-1,-1,-1,-1,15410,-1,1.9646372e-05,0.9999666,1.3685366e-05
15411,Th17 cells,8,10,38,48,"In gp130(F/F) mice, the generation of Th17 cells, as well as the gastric expression of IL-17a and other Th17-related factors (Rort, IL-23), were augmented compared to wild-type gp130(+/+) mice.",21710691_5,-1,-1,-1,-1,15411,-1,0.0008794479,0.024662746,0.97445774
15414,Th17-related factors,21,23,104,124,"In gp130(F/F) mice, the generation of Th17 cells, as well as the gastric expression of IL-17a and other Th17-related factors (Rort, IL-23), were augmented compared to wild-type gp130(+/+) mice.",21710691_5,-1,-1,-1,-1,15414,-1,0.00029653404,0.9994791,0.0002243911
15419,Th17 generation,13,15,74,89,"Consistent with a role for IL-6 and STAT3 in regulating IL-17A, increased Th17 generation and gastric expression of Th17-related factors in gp130(F/F) mice were reduced to wild-type levels in gp130(F/F) :Stat3(-/+) mice displaying normalized STAT3 activity, and also in gp130(F/F) :IL-6(-/-) mice.",21710691_6,-1,-1,-1,-1,15419,-1,2.605309e-05,0.9999466,2.7304968e-05
15420,Th17-related factors,19,21,116,136,"Consistent with a role for IL-6 and STAT3 in regulating IL-17A, increased Th17 generation and gastric expression of Th17-related factors in gp130(F/F) mice were reduced to wild-type levels in gp130(F/F) :Stat3(-/+) mice displaying normalized STAT3 activity, and also in gp130(F/F) :IL-6(-/-) mice.",21710691_6,-1,-1,-1,-1,15420,-1,5.9456226e-05,0.9998895,5.10436e-05
15430,Th17-related factors,9,11,60,80,"Collectively, our data suggest that increased expression of Th17-related factors does not correlate with the molecular pathogenesis of gastric tumourigenesis.",21710691_9,-1,-1,-1,-1,15430,-1,6.717858e-05,0.99987614,5.661818e-05
15440,receptors,15,16,110,119,Their development and maturation involve a complex variety of interactions with nonlymphoid cell products and receptors.,21740230_1,0,1,2,-1,15440,-1,0.0002322243,0.0006213678,0.99914634
15443,tumor cells,17,19,118,129,"Highly specialized to defend against bacterial and viral infections, T cells also mediate immune surveillance against tumor cells and react to foreign tissues.",21740230_2,-1,-1,-1,-1,15443,-1,0.0038218899,0.36232847,0.63384974
15445,tissues,23,24,151,158,"Highly specialized to defend against bacterial and viral infections, T cells also mediate immune surveillance against tumor cells and react to foreign tissues.",21740230_2,-1,1,2,-1,15445,-1,0.0002487429,0.9978885,0.0018627922
15449,the thymus,21,23,125,135,"T cell progenitors originate in the bone marrow and, through a series of defined and coordinated developmental stages, enter the thymus, differentiate, undergo selection, and eventually mature into functional T cells.",21740230_3,-1,-1,-1,-1,15449,-1,3.92091e-05,0.9999256,3.5112942e-05
15450,functional T cells,33,36,198,216,"T cell progenitors originate in the bone marrow and, through a series of defined and coordinated developmental stages, enter the thymus, differentiate, undergo selection, and eventually mature into functional T cells.",21740230_3,-1,-1,-1,-1,15450,-1,0.0019490885,0.01676661,0.9812843
15454,complex transcriptional,9,11,50,73,"The steps in this process are regulated through a complex transcriptional network, specific receptor-ligand pair interactions, and sensitization to trophic factors, which mediate the homing, proliferation, survival, and differentiation of developing T cells.",21740230_4,-1,-1,-1,-1,15454,-1,2.6371506e-05,0.99995494,1.869615e-05
15455,receptor-ligand,14,15,92,107,"The steps in this process are regulated through a complex transcriptional network, specific receptor-ligand pair interactions, and sensitization to trophic factors, which mediate the homing, proliferation, survival, and differentiation of developing T cells.",21740230_4,0,1,2,-1,15455,-1,0.0044936715,0.021562394,0.9739439
15456,to trophic factors,20,23,145,163,"The steps in this process are regulated through a complex transcriptional network, specific receptor-ligand pair interactions, and sensitization to trophic factors, which mediate the homing, proliferation, survival, and differentiation of developing T cells.",21740230_4,-1,-1,-1,-1,15456,-1,0.0009956155,0.9988757,0.00012870943
15465,antigen-specific T cells,9,12,54,78,"PURPOSE: To predict the potential antitumor effect of antigen-specific T cells in melanoma patients, we investigated T-cell effector function in relation to tumor-escape mechanisms.",21750202_0,-1,-1,-1,-1,15465,-1,0.335659,0.0034656113,0.6608753
15466,T-cell,18,19,117,123,"PURPOSE: To predict the potential antitumor effect of antigen-specific T cells in melanoma patients, we investigated T-cell effector function in relation to tumor-escape mechanisms.",21750202_0,-1,1,2,-1,15466,-1,3.474374e-05,5.285394e-05,0.9999125
15467,function,20,21,133,141,"PURPOSE: To predict the potential antitumor effect of antigen-specific T cells in melanoma patients, we investigated T-cell effector function in relation to tumor-escape mechanisms.",21750202_0,0,1,2,-1,15467,-1,0.00015874664,0.00137804,0.99846315
15468,relation to tumor-escape,22,25,145,169,"PURPOSE: To predict the potential antitumor effect of antigen-specific T cells in melanoma patients, we investigated T-cell effector function in relation to tumor-escape mechanisms.",21750202_0,-1,-1,-1,-1,15468,-1,3.156384e-05,0.99995446,1.3941548e-05
15471,blood,17,18,94,99,"EXPERIMENTAL DESIGN: CD8(+) T cells isolated from tumor, adjacent normal skin, and peripheral blood of 17 HLA-A2(+) patients with advanced-stage melanoma were analyzed for their antigen specificity and effector function against melanocyte differentiation antigens MART-1, gp100, and tyrosinase by using HLA-A2/peptide tetramers and functional assays.",21750202_1,0,1,-1,-1,15471,-1,0.00011611013,0.99929345,0.000590379
15472,their antigen,29,31,172,185,"EXPERIMENTAL DESIGN: CD8(+) T cells isolated from tumor, adjacent normal skin, and peripheral blood of 17 HLA-A2(+) patients with advanced-stage melanoma were analyzed for their antigen specificity and effector function against melanocyte differentiation antigens MART-1, gp100, and tyrosinase by using HLA-A2/peptide tetramers and functional assays.",21750202_1,-1,-1,-1,-1,15472,-1,0.18516015,0.79058945,0.024250405
15473,function,34,35,211,219,"EXPERIMENTAL DESIGN: CD8(+) T cells isolated from tumor, adjacent normal skin, and peripheral blood of 17 HLA-A2(+) patients with advanced-stage melanoma were analyzed for their antigen specificity and effector function against melanocyte differentiation antigens MART-1, gp100, and tyrosinase by using HLA-A2/peptide tetramers and functional assays.",21750202_1,0,1,2,-1,15473,-1,0.0001022386,0.99971646,0.00018125675
15477,functional,50,51,332,342,"EXPERIMENTAL DESIGN: CD8(+) T cells isolated from tumor, adjacent normal skin, and peripheral blood of 17 HLA-A2(+) patients with advanced-stage melanoma were analyzed for their antigen specificity and effector function against melanocyte differentiation antigens MART-1, gp100, and tyrosinase by using HLA-A2/peptide tetramers and functional assays.",21750202_1,0,1,2,-1,15477,-1,6.664303e-05,0.99987817,5.5201977e-05
15482,tumor cell,24,26,153,163,"In addition, the presence of tumor-escape mechanisms PD-L1/PD-1 pathway, FoxP3 and loss of HLA or melanocyte differentiation antigens, both required for tumor cell recognition and killing, were studied.",21750202_2,-1,-1,-1,-1,15482,-1,0.004117304,0.38163698,0.6142458
15486,tissues,16,17,101,108,RESULTS: Higher percentages of melanocyte antigen-specific CD8(+) T cells were found in the melanoma tissues as compared with adjacent normal skin and peripheral blood.,21750202_3,-1,1,2,-1,15486,-1,0.00041322407,0.989833,0.009753833
15487,blood,25,26,162,167,RESULTS: Higher percentages of melanocyte antigen-specific CD8(+) T cells were found in the melanoma tissues as compared with adjacent normal skin and peripheral blood.,21750202_3,0,1,-1,-1,15487,-1,0.0007824817,0.9767096,0.022507895
15488,Functional analysis,0,2,0,19,"Functional analysis revealed 2 important findings: (i) in 5 of 17 patients, we found cytokine production after specific peptide stimulation by tumor-infiltrating lymphocytes (TIL), not by autologous peripheral blood lymphocytes (PBL); (ii) CD8(+) T cells from 7 of 17 patients did not produce cytokines after specific stimulation, which corresponded with significant loss of tumor HLA-A2 expression.",21750202_4,-1,-1,-1,-1,15488,-1,2.7575217e-05,0.99995434,1.809241e-05
15490,peptide,22,23,120,127,"Functional analysis revealed 2 important findings: (i) in 5 of 17 patients, we found cytokine production after specific peptide stimulation by tumor-infiltrating lymphocytes (TIL), not by autologous peripheral blood lymphocytes (PBL); (ii) CD8(+) T cells from 7 of 17 patients did not produce cytokines after specific stimulation, which corresponded with significant loss of tumor HLA-A2 expression.",21750202_4,0,-1,2,-1,15490,-1,0.014266173,0.9849585,0.0007753263
15491,tumor-infiltrating lymphocytes,25,27,143,173,"Functional analysis revealed 2 important findings: (i) in 5 of 17 patients, we found cytokine production after specific peptide stimulation by tumor-infiltrating lymphocytes (TIL), not by autologous peripheral blood lymphocytes (PBL); (ii) CD8(+) T cells from 7 of 17 patients did not produce cytokines after specific stimulation, which corresponded with significant loss of tumor HLA-A2 expression.",21750202_4,-1,-1,-1,-1,15491,-1,0.0036581217,0.8639419,0.13239995
15493,blood lymphocytes,35,37,210,227,"Functional analysis revealed 2 important findings: (i) in 5 of 17 patients, we found cytokine production after specific peptide stimulation by tumor-infiltrating lymphocytes (TIL), not by autologous peripheral blood lymphocytes (PBL); (ii) CD8(+) T cells from 7 of 17 patients did not produce cytokines after specific stimulation, which corresponded with significant loss of tumor HLA-A2 expression.",21750202_4,-1,-1,-1,-1,15493,-1,0.00047254437,0.0028577214,0.9966698
15499,to T-cell function,9,12,64,82,The presence of other tumor-escape mechanisms did not correlate to T-cell function.,21750202_5,-1,-1,-1,-1,15499,-1,0.0031679212,0.14354223,0.8532898
15500,that functional T-cell,5,8,27,49,"CONCLUSIONS: Our data show that functional T-cell responses could be missed when only PBL and not TIL are evaluated, emphasizing the importance of TIL analysis for immunomonitoring.",21750202_6,-1,-1,-1,-1,15500,-1,0.00513959,0.43430933,0.56055105
15504,TIL analysis,25,27,147,159,"CONCLUSIONS: Our data show that functional T-cell responses could be missed when only PBL and not TIL are evaluated, emphasizing the importance of TIL analysis for immunomonitoring.",21750202_6,-1,-1,-1,-1,15504,-1,2.902399e-05,0.999956,1.5017093e-05
15507,T-cell functionality,11,13,58,78,"Furthermore, loss of tumor HLA-A2 may explain the lack of T-cell functionality.",21750202_7,-1,-1,-1,-1,15507,-1,9.702802e-05,0.00023848467,0.99966455
15518,peptides together,38,40,242,259,EXPERIMENTAL DESIGN: HLA-A2.1(+) melanoma patients scheduled for regional lymph node dissection were vaccinated four times biweekly via intradermal or intranodal injection with 12  10 to 17  10 mature DCs loaded with tyrosinase and gp100 peptides together with keyhole limpet hemocyanin (KLH).,21771874_2,-1,-1,-1,-1,15518,-1,0.000107788,0.999801,9.1220965e-05
15520,T-cell,3,4,20,26,KLH-specific B- and T-cell responses were monitored in blood.,21771874_4,-1,1,2,-1,15520,-1,0.00010294688,0.00037776795,0.99951935
15521,in blood,7,9,52,60,KLH-specific B- and T-cell responses were monitored in blood.,21771874_4,0,1,-1,-1,15521,-1,3.2063945e-05,0.9999418,2.6141048e-05
15522,tyrosinase-specific T-cell,2,4,11,37,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,-1,-1,-1,-1,15522,-1,0.0044179317,0.51898724,0.47659478
15523,in blood,7,9,63,71,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,0,1,-1,-1,15523,-1,3.0671617e-05,0.9999417,2.7562772e-05
15524,tetramer analysis,10,12,75,92,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,-1,-1,-1,-1,15524,-1,3.4007593e-05,0.9999336,3.244198e-05
15527,functional,26,27,177,187,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,0,1,2,-1,15527,-1,4.805596e-05,0.999926,2.5945887e-05
15529,IFN release,33,35,227,239,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,-1,-1,-1,-1,15529,-1,0.9941221,0.0037714143,0.0021064489
15530,peptide-pulsed T2 cells,39,42,266,289,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,-1,-1,-1,-1,15530,-1,0.007534263,0.31917012,0.6732956
15531,tyrosinase-expressing tumor cells,45,48,303,336,"gp100- and tyrosinase-specific T-cell responses were monitored in blood by tetramer analysis and in biopsies from delayed-type hypersensitivity (DTH) skin tests by tetramer and functional analyses with (51)Cr release assays or IFN release, following coculture with peptide-pulsed T2 cells or gp100- or tyrosinase-expressing tumor cells.",21771874_5,-1,-1,-1,-1,15531,-1,0.0031356493,0.84616125,0.1507031
15532,functional tumor antigen-specific T cells,9,14,42,83,"RESULTS: In 19 of 43 vaccinated patients, functional tumor antigen-specific T cells could be detected.",21771874_6,-1,-1,-1,-1,15532,-1,0.013573308,0.36611727,0.6203095
15535,functional tumor antigen-specific T cells,6,11,53,94,Intradermal vaccinations proved superior in inducing functional tumor antigen-specific T cells.,21771874_8,-1,-1,-1,-1,15535,-1,0.015448664,0.3904199,0.5941315
15536,the antigen-specific T-cell,7,10,49,76,Coadministration of IL-2 did not further augment the antigen-specific T-cell response but did result in higher regulatory T-cell frequencies.,21771874_9,-1,-1,-1,-1,15536,-1,0.016354628,0.29142642,0.692219
15538,T-cell,8,9,67,73,CONCLUSION: Intradermal vaccination resulted in superior antitumor T-cell induction when compared with intranodal vaccination.,21771874_10,-1,1,2,-1,15538,-1,3.620983e-05,4.855231e-05,0.99991524
15540,T-cell,3,4,19,25,Spontaneous CD4(+) T-cell responses to the tumor-specific antigen NY-ESO-1 (ESO) are frequently found in patients with epithelial ovarian cancer (EOC).,21829534_0,-1,1,2,-1,15540,-1,3.4925743e-05,5.775804e-05,0.99990726
15541,to the tumor-specific antigen,5,9,36,65,Spontaneous CD4(+) T-cell responses to the tumor-specific antigen NY-ESO-1 (ESO) are frequently found in patients with epithelial ovarian cancer (EOC).,21829534_0,-1,-1,-1,-1,15541,-1,0.02699104,0.9702195,0.0027895193
15543,Treg type,7,9,42,51,"If these responses are of effector or/and Treg type, however, has remained unclear.",21829534_1,-1,-1,-1,-1,15543,-1,3.668873e-05,0.99993837,2.490178e-05
15544,functional,5,6,19,29,"Here, we have used functional approaches together with recently developed MHC class II/ESO tetramers to assess the frequency, phenotype and function of ESO-specific cells in circulating lymphocytes from EOC patients.",21829534_2,0,1,2,-1,15544,-1,3.6067424e-05,0.9999449,1.9041301e-05
15546,tetramers to,14,16,91,103,"Here, we have used functional approaches together with recently developed MHC class II/ESO tetramers to assess the frequency, phenotype and function of ESO-specific cells in circulating lymphocytes from EOC patients.",21829534_2,-1,-1,-1,-1,15546,-1,2.2794755e-05,0.9999609,1.6268305e-05
15548,function,22,23,140,148,"Here, we have used functional approaches together with recently developed MHC class II/ESO tetramers to assess the frequency, phenotype and function of ESO-specific cells in circulating lymphocytes from EOC patients.",21829534_2,0,1,2,-1,15548,-1,8.278163e-05,0.9998609,5.6338158e-05
15553,immune responses to the antigen,14,19,87,118,We found that circulating ESO-specific CD4(+) T cells in EOC patients with spontaneous immune responses to the antigen are prevalently T(H)1 type cells secreting IFN- but no IL-17 or IL-10 and are not suppressive.,21829534_3,-1,-1,-1,-1,15553,-1,0.9970451,0.0018773063,0.0010775725
15554,T(H)1 type cells,21,24,135,151,We found that circulating ESO-specific CD4(+) T cells in EOC patients with spontaneous immune responses to the antigen are prevalently T(H)1 type cells secreting IFN- but no IL-17 or IL-10 and are not suppressive.,21829534_3,-1,-1,-1,-1,15554,-1,0.0025290456,0.7844162,0.21305479
15567,T-cell,5,6,25,31,"Thus, spontaneous CD4(+) T-cell responses to ESO in cancer patients are prevalently of T(H)1 type and not Treg.",21829534_6,-1,1,2,-1,15567,-1,3.882132e-05,5.9466187e-05,0.99990165
15569,T(H)1 type,15,17,87,97,"Thus, spontaneous CD4(+) T-cell responses to ESO in cancer patients are prevalently of T(H)1 type and not Treg.",21829534_6,-1,-1,-1,-1,15569,-1,3.081399e-05,0.9999447,2.4501753e-05
15571,Their relatively,0,2,0,16,"Their relatively low frequency and advanced differentiation stage, however, may limit their efficacy, that may be boosted by immunogenic ESO vaccines.",21829534_7,-1,-1,-1,-1,15571,-1,3.0000598e-05,0.9999542,1.57141e-05
15585,The cytokine,0,2,0,12,"The cytokine milieu was analyzed by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR).RESULTS: Oral squamous cell carcinoma expresses high levels of IL-1, IL-6, and transforming growth factor (TGF)-.",21837700_2,-1,-1,-1,-1,15585,-1,0.2833304,0.7121229,0.0045466525
15590,transforming growth factor,26,29,186,212,"The cytokine milieu was analyzed by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR).RESULTS: Oral squamous cell carcinoma expresses high levels of IL-1, IL-6, and transforming growth factor (TGF)-.",21837700_2,-1,-1,-1,-1,15590,-1,0.9493866,0.046772253,0.0038411831
15595,tumor-infiltrating lymphocytes,15,17,90,120,"A unique subset of FOXP3(+) IL-17-producing CD4(+) T cells was consistently identified in tumor-infiltrating lymphocytes from advanced stages of cancer, but not in the circulation, at a frequency of 0.5% to 5.5 % of total CD4(+) T and positively correlated with the frequency of IL-17(+)FOXP3(-) T cells.",21837700_3,-1,-1,-1,-1,15595,-1,0.003814029,0.8394151,0.15677088
15603,The IL-17(+)FOXP3(+,0,2,0,19,The IL-17(+)FOXP3(+) T cells express CCR6 and suppress the proliferation of autologous CD4(+) CD25(-) responder T-cells in vitro.,21837700_4,-1,-1,-1,-1,15603,-1,0.016042816,0.98172957,0.0022276673
15607,T-cells,18,19,112,119,The IL-17(+)FOXP3(+) T cells express CCR6 and suppress the proliferation of autologous CD4(+) CD25(-) responder T-cells in vitro.,21837700_4,-1,1,2,-1,15607,-1,4.067041e-05,8.3971325e-05,0.9998754
15609,IL-17-producing FOXP3(+,5,7,31,54,CONCLUSIONS: The prevalence of IL-17-producing FOXP3(+) CD4(+) tumor infiltrating lymphocytes is increased in oral squamous cell carcinoma.,21837700_5,-1,-1,-1,-1,15609,-1,0.99553865,0.0019027822,0.0025585645
15616,tumor-specific immune responses,12,15,75,106,BACKGROUND: The presence of Tregs in tumors is associated with compromised tumor-specific immune responses and has a clear negative impact on survival of cancer patients.,21843083_0,-1,-1,-1,-1,15616,-1,0.07250301,0.92650133,0.0009956373
15628,the tumor,13,15,93,102,NLGP-mediated downregulation of CCR4 along with its ligand CCL22 restricts Treg migration at the tumor site.,21843083_5,-1,-1,-1,-1,15628,-1,2.0506472e-05,0.99996865,1.0812613e-05
15629,to Tregs,4,6,22,30,"NLGP is not apoptotic to Tregs but significantly downregulates the expression of Foxp3, CTLA4 and GITR.",21843083_6,-1,-1,-1,-1,15629,-1,3.4558583e-05,0.99994874,1.6646909e-05
15633,the functional,3,5,17,31,"It also reverses the functional impairment of T-effector cells by Tregs, in terms of IFN- secretion, cellular proliferation and tumor cell cytotoxicity.",21843083_7,-1,-1,-1,-1,15633,-1,3.6341455e-05,0.9999484,1.5230248e-05
15634,T-effector cells,7,9,46,62,"It also reverses the functional impairment of T-effector cells by Tregs, in terms of IFN- secretion, cellular proliferation and tumor cell cytotoxicity.",21843083_7,-1,-1,-1,-1,15634,-1,0.0019822705,0.124407634,0.87361014
15639,tumor cell,21,23,129,139,"It also reverses the functional impairment of T-effector cells by Tregs, in terms of IFN- secretion, cellular proliferation and tumor cell cytotoxicity.",21843083_7,-1,-1,-1,-1,15639,-1,0.0044949376,0.34562287,0.6498822
15646,Treg function,11,13,73,86,"Interaction between Foxp3, p-NFATc3 and p-Smad2/3, needed for successful Treg function, is also inhibited by NLGP.CONCLUSION: All of these coordinated events might result in inhibition of Treg associated-tumor growth and therefore increased survivability of mice having NLGP treatment before or/and after tumor inoculation.",21843083_9,-1,-1,-1,-1,15646,-1,3.5423727e-05,0.9999392,2.5388537e-05
15655,T-cell,12,13,59,65,"Thus, the possibility of NLGP being an excellent tool as a T-cell anergy breaker by abrogating the suppressor functions of Tregs in cancer needs to be explored further in the clinic.",21843083_10,-1,1,2,-1,15655,-1,4.0213235e-05,6.125865e-05,0.99989855
15657,functions,19,20,110,119,"Thus, the possibility of NLGP being an excellent tool as a T-cell anergy breaker by abrogating the suppressor functions of Tregs in cancer needs to be explored further in the clinic.",21843083_10,0,1,2,-1,15657,-1,8.991184e-05,0.99983776,7.2247014e-05
15664,functions,18,19,116,125,Signal transducer and activator of transcription 3 (Stat3) is a potent transcription factor with diverse biological functions.,21864492_0,0,1,2,-1,15664,-1,0.00010635995,0.9998437,4.98508e-05
15671,blood,22,23,137,142,"In the present study, the population of CD11b(+)Gr-1(+) myeloid-derived suppressor cells (MDSCs) was significantly increased in lung and blood of doxycycline-treated bitransgenic mice, but CD4(+) and CD8(+) T cells were decreased.",21864492_2,0,1,-1,-1,15671,-1,6.2768006e-05,0.99984777,8.943204e-05
15674,cytokines IL-1,14,16,121,136,"In bronchioalveolar lavage fluid and plasma of doxycycline-treated bitransgenic mice, concentrations of MDSC-stimulating cytokines IL-1, IL-6, IL-10, IL-13, INF-, TNF-, and GM-CSF were significantly increased, which stimulated alveolar monocytes/macrophages to CD11b(+)Gr-1(+) cell conversion in vitro.",21864492_3,-1,-1,-1,-1,15674,-1,0.9998178,5.5629665e-05,0.000126541
15678,TNF-,25,26,165,170,"In bronchioalveolar lavage fluid and plasma of doxycycline-treated bitransgenic mice, concentrations of MDSC-stimulating cytokines IL-1, IL-6, IL-10, IL-13, INF-, TNF-, and GM-CSF were significantly increased, which stimulated alveolar monocytes/macrophages to CD11b(+)Gr-1(+) cell conversion in vitro.",21864492_3,0,1,-1,-1,15678,-1,0.00044736484,0.99948525,6.7412446e-05
15684,blood,22,23,159,164,"Phosphorylation of proto-oncogenic intracellular signaling molecules Stat3, Erk1/2, and P38 was significantly increased in CD11b(+)Gr-1(+) cells from lung and blood of doxycycline-treated bitransgenic mice.",21864492_4,0,1,-1,-1,15684,-1,0.000112023816,0.99967945,0.00020856436
15686,function,13,14,110,118,CD11b(+)Gr-1(+) cells from lung of doxycycline-treated bitransgenic mice strongly inhibited proliferation and function of wild-type CD4(+) T cells in vitro.,21864492_5,0,1,2,-1,15686,-1,0.0001121954,0.999726,0.0001618394
15701,the TGF-,10,12,64,73,"Here, we employed two conditional mutagenesis systems to delete the TGF- signaling pathway component Smad4 in T cells and observed the spontaneous development of massive polyps within the gastroduodenal regions of mice.",21881210_1,-1,-1,-1,-1,15701,-1,3.2236774e-05,0.9999578,9.936962e-06
15712,TNF-,18,19,105,110,"The epithelial lesions contained increased levels of transcripts encoding IL-11, IL-6, TGF-, IL-1, and TNF-, and lamina propria cells isolated from lesions contained abundant IL-17A+CD4+ T cells.",21881210_2,0,1,-1,-1,15712,-1,7.111857e-05,0.9998995,2.9401644e-05
15716,that Smad4 deficiency,4,7,22,43,"Furthermore, we found that Smad4 deficiency attenuated TGF--mediated in vitro polarization of FoxP3+CD4+ T cells, but not IL-17A+CD4+ T cells, suggesting that the epithelial lesions may have arisen as a consequence of unchecked Th17 cell activity.",21881210_3,-1,-1,-1,-1,15716,-1,3.5894365e-05,0.9999349,2.9203906e-05
15722,that the,26,28,155,163,"Furthermore, we found that Smad4 deficiency attenuated TGF--mediated in vitro polarization of FoxP3+CD4+ T cells, but not IL-17A+CD4+ T cells, suggesting that the epithelial lesions may have arisen as a consequence of unchecked Th17 cell activity.",21881210_3,-1,-1,-1,-1,15722,-1,1.8794191e-05,0.99997246,8.718233e-06
15723,Th17 cell,38,40,229,238,"Furthermore, we found that Smad4 deficiency attenuated TGF--mediated in vitro polarization of FoxP3+CD4+ T cells, but not IL-17A+CD4+ T cells, suggesting that the epithelial lesions may have arisen as a consequence of unchecked Th17 cell activity.",21881210_3,-1,-1,-1,-1,15723,-1,0.00012432138,0.000290602,0.9995851
15736,Th17 cell,11,13,55,64,"Thus, our data indicate that a chronic increase in gut Th17 cell activity can be associated with the development of premalignant lesions of the gastroduodenal region.",21881210_6,-1,-1,-1,-1,15736,-1,0.00045733116,0.0056809597,0.9938617
15744,tumor immunity regulation,20,23,86,111,"It has been known that regulatory T (Treg) cells and mast cells (MCs) are involved in tumor immunity regulation, but the exact roles and mechanisms of Treg cells and MCs in B-cell non-Hodgkin's lymphoma (NHL) are incompletely defined.",21898141_0,-1,-1,-1,-1,15744,-1,8.476984e-05,0.9998833,3.1879223e-05
15748,that the,7,9,31,39,"In the present study, we found that the number of Foxp3(+) Treg cells and CD117(+) MCs increased in B-cell NHL patients.",21898141_1,-1,-1,-1,-1,15748,-1,1.6928567e-05,0.99997365,9.399953e-06
15763,that Treg cell,5,8,35,49,"Collectively, our results indicate that Treg cell and MCs are involved in immunosuppression in B-cell NHL, and IL-9 is a key mediator of Treg cells and MCs in that process.",21898141_5,-1,-1,-1,-1,15763,-1,0.0027245863,0.18844199,0.8088334
15775,T cell immunity,18,21,108,123,"Identification of molecular adjuvants to in vivo ""modulate "" DC to coordinately render improved Th1 and CD8 T cell immunity, and attenuated deleterious Treg effects, is a critical challenge.",21934655_1,-1,-1,-1,-1,15775,-1,0.010629873,0.0005387738,0.9888313
15778,genetic targeting,7,9,29,46,"Here, we report that in vivo genetic targeting of the active transcription factor XBP1s to DC (XBP1s/DC) potentiated vaccine-induced prophylactic and therapeutic antitumor immunity in multiple tumor models.",21934655_2,-1,-1,-1,-1,15778,-1,2.2986467e-05,0.99996376,1.3285746e-05
15780,transcription factor XBP1s to,12,16,61,90,"Here, we report that in vivo genetic targeting of the active transcription factor XBP1s to DC (XBP1s/DC) potentiated vaccine-induced prophylactic and therapeutic antitumor immunity in multiple tumor models.",21934655_2,-1,-1,-1,-1,15780,-1,2.86152e-05,0.9999515,1.9930256e-05
15782,immunity,26,27,172,180,"Here, we report that in vivo genetic targeting of the active transcription factor XBP1s to DC (XBP1s/DC) potentiated vaccine-induced prophylactic and therapeutic antitumor immunity in multiple tumor models.",21934655_2,0,-1,2,-1,15782,-1,0.998944,0.0007826013,0.00027345426
15793,tumor-associated Treg,22,24,133,154,The novel targeted vaccine induced durable Th1 and CD8 T cell responses to poorly immunogenic self/tumor antigen (Ag) and attenuated tumor-associated Treg suppressive function.,21934655_4,-1,-1,-1,-1,15793,-1,2.6096159e-05,0.9999646,9.265086e-06
15794,function,25,26,167,175,The novel targeted vaccine induced durable Th1 and CD8 T cell responses to poorly immunogenic self/tumor antigen (Ag) and attenuated tumor-associated Treg suppressive function.,21934655_4,0,1,2,-1,15794,-1,0.00026012707,0.9991667,0.0005731895
15803,functional,2,3,18,28,XBP1s/DC elevated functional DEC205(+)CD8(+)DC in the draining lymph nodes (DLN).,21934655_6,0,1,2,-1,15803,-1,5.038735e-05,0.9999224,2.7249185e-05
15810,to tumor,21,23,129,137,"The data suggest a novel role for XBP1s in modulating DC to potentiate tumor vaccine efficacy via overcoming two major obstacles to tumor vaccines (i.e., T cell hyporesponsiveness against poorly immunologic self/tumor Ag and tumor-associated Treg-mediated suppression) and improving DEC205(+)CD8(+)DC.",21934655_7,-1,-1,-1,-1,15810,-1,2.8734414e-05,0.99995947,1.1771578e-05
15812,tumor-associated Treg-mediated,36,38,225,255,"The data suggest a novel role for XBP1s in modulating DC to potentiate tumor vaccine efficacy via overcoming two major obstacles to tumor vaccines (i.e., T cell hyporesponsiveness against poorly immunologic self/tumor Ag and tumor-associated Treg-mediated suppression) and improving DEC205(+)CD8(+)DC.",21934655_7,-1,-1,-1,-1,15812,-1,4.0055038e-05,0.9999299,3.0001756e-05
15815,tumor tissue,12,14,63,75,BACKGROUND: Regulatory T cells (Tregs) are highly prevalent in tumor tissue and can suppress effective anti-tumor immune responses.,21935436_0,-1,-1,-1,-1,15815,-1,2.3245651e-05,0.9999629,1.3781685e-05
15819,tumor-infiltrating Tregs,7,9,37,61,"However, the source of the increased tumor-infiltrating Tregs and their contribution to cancer progression remain poorly understood.",21935436_1,-1,-1,-1,-1,15819,-1,2.7278244e-05,0.9999602,1.25895185e-05
15826,that FoxP3(+,3,5,19,31,"Our results showed that FoxP3(+) Tregs highly aggregated and were in an activated phenotype (CD69(+)HLA-DR(high)) in the tumor site, where they can suppress the proliferation and INF- secretion of CD4(+)CD25(-) T cells.",21935436_3,-1,-1,-1,-1,15826,-1,0.0001295173,0.9997638,0.000106727784
15828,the tumor,20,22,117,126,"Our results showed that FoxP3(+) Tregs highly aggregated and were in an activated phenotype (CD69(+)HLA-DR(high)) in the tumor site, where they can suppress the proliferation and INF- secretion of CD4(+)CD25(-) T cells.",21935436_3,-1,-1,-1,-1,15828,-1,1.9132984e-05,0.99997115,9.666329e-06
15832,These tumor-infiltrating Tregs,0,3,0,30,"These tumor-infiltrating Tregs could be selectively recruited though CCR6-CCL20 axis as illustrated by (a) high expression of CCR6 on circulating Tregs and their selective migration to CCR6 ligand CCL20, and (b) correlation of distribution and expression between tumor-infiltrating Tregs and intratumoral CCL20.",21935436_4,-1,-1,-1,-1,15832,-1,2.2593103e-05,0.99996424,1.3203423e-05
15837,to CCR6,27,29,182,189,"These tumor-infiltrating Tregs could be selectively recruited though CCR6-CCL20 axis as illustrated by (a) high expression of CCR6 on circulating Tregs and their selective migration to CCR6 ligand CCL20, and (b) correlation of distribution and expression between tumor-infiltrating Tregs and intratumoral CCL20.",21935436_4,-1,-1,-1,-1,15837,-1,0.00921377,0.71593004,0.2748562
15838,tumor-infiltrating Tregs,42,44,263,287,"These tumor-infiltrating Tregs could be selectively recruited though CCR6-CCL20 axis as illustrated by (a) high expression of CCR6 on circulating Tregs and their selective migration to CCR6 ligand CCL20, and (b) correlation of distribution and expression between tumor-infiltrating Tregs and intratumoral CCL20.",21935436_4,-1,-1,-1,-1,15838,-1,2.2690043e-05,0.9999639,1.3439816e-05
15839,that the,5,7,22,30,"In addition, we found that the number of tumor-infiltrating Tregs was associated with cirrhosis background (P=0.011) and tumor differentiation (P=0.003), and was an independent prognostic factor for overall survival (HR=2.408, P=0.013) and disease-free survival (HR=2.204, P=0.041).",21935436_5,-1,-1,-1,-1,15839,-1,1.7434839e-05,0.999974,8.540575e-06
15840,tumor-infiltrating Tregs,9,11,41,65,"In addition, we found that the number of tumor-infiltrating Tregs was associated with cirrhosis background (P=0.011) and tumor differentiation (P=0.003), and was an independent prognostic factor for overall survival (HR=2.408, P=0.013) and disease-free survival (HR=2.204, P=0.041).",21935436_5,-1,-1,-1,-1,15840,-1,2.8555181e-05,0.9999547,1.6683083e-05
15842,factor,39,40,192,198,"In addition, we found that the number of tumor-infiltrating Tregs was associated with cirrhosis background (P=0.011) and tumor differentiation (P=0.003), and was an independent prognostic factor for overall survival (HR=2.408, P=0.013) and disease-free survival (HR=2.204, P=0.041).",21935436_5,0,1,-1,-1,15842,-1,0.00021377052,0.9997328,5.3446147e-05
15844,tumor-infiltrating Tregs,2,4,14,38,The increased tumor-infiltrating Tregs predicted poorer prognosis in HCC patients.,21935436_6,-1,-1,-1,-1,15844,-1,3.0481815e-05,0.9999523,1.7153561e-05
15853,therapeutic target,11,13,70,88,"Thus, blocking CCL20-CCR6 axis-mediated Treg migration may be a novel therapeutic target for HCC.",21935436_8,-1,-1,-1,-1,15853,-1,2.6242347e-05,0.99996245,1.1329907e-05
15855,transcription factor peroxisome proliferator-activated receptor,2,7,21,84,"The ligand-activated transcription factor peroxisome proliferator-activated receptor (PPAR)- is highly expressed in colonic epithelial cells; however, the role of PPAR ligands, such as fatty acids, in mucosal inflammation and malignant transformation has not been clarified.",21940900_0,-1,-1,-1,-1,15855,-1,5.63618e-05,0.9998485,9.513e-05
15859,that the,3,5,25,33,Recent evidence suggests that the anti-inflammatory/chemoprotective properties of fish oil (FO)-derived n-3 polyunsaturated fatty acids (PUFAs) may be partly mediated by PPAR.,21940900_1,-1,-1,-1,-1,15859,-1,1.9273231e-05,0.9999733,7.4146506e-06
15878,T cell activation status,7,11,46,70,Dietary FO independently modulated MLN CD4(+) T cell activation status by decreasing CD44 expression.,21940900_9,-1,-1,-1,-1,15878,-1,0.0010052687,0.007696362,0.9912984
15887,Protein,0,1,0,7,Protein vaccines may be a useful strategy for cancer immunotherapy because recombinant tumor antigen proteins can be produced on a large scale at relatively low cost and have been shown to be safe for clinical application.,21945963_0,0,1,-1,-1,15887,-1,5.0973576e-05,0.99990726,4.1720905e-05
15888,tumor antigen proteins,12,15,87,109,Protein vaccines may be a useful strategy for cancer immunotherapy because recombinant tumor antigen proteins can be produced on a large scale at relatively low cost and have been shown to be safe for clinical application.,21945963_0,-1,-1,-1,-1,15888,-1,0.00038585818,0.99938786,0.00022625056
15891,protein,2,3,9,16,"However, protein vaccines have historically exhibited poor immunogenicity; thus, an improved strategy is needed for successful induction of immune responses.",21945963_1,0,1,-1,-1,15891,-1,0.00039964356,0.9994165,0.00018389917
15894,TAT peptide,0,2,0,11,TAT peptide is a protein transduction domain composed of an 11-amino acid peptide (TAT(47-57): YGRKKRRQRRR).,21945963_2,-1,-1,-1,-1,15894,-1,3.246336e-05,0.99993813,2.9366123e-05
15896,peptide,12,13,74,81,TAT peptide is a protein transduction domain composed of an 11-amino acid peptide (TAT(47-57): YGRKKRRQRRR).,21945963_2,0,-1,2,-1,15896,-1,0.0003645662,0.99864477,0.0009906751
15899,this peptide,4,6,23,35,The positive charge of this peptide allows protein antigen fused with it to improve cell penetration.,21945963_3,-1,-1,-1,-1,15899,-1,5.171179e-05,0.9999186,2.9655652e-05
15900,protein antigen,7,9,43,58,The positive charge of this peptide allows protein antigen fused with it to improve cell penetration.,21945963_3,-1,-1,-1,-1,15900,-1,0.84191465,0.09015311,0.0679322
15905,TAT peptide,19,21,113,124,Poly(I:C) is a synthetic double-stranded RNA that is negatively charged and favors interaction with the cationic TAT peptide.,21945963_4,-1,-1,-1,-1,15905,-1,9.842756e-05,0.99978536,0.00011626903
15912,protein,12,13,73,80,"Therefore, we demonstrated that vaccine with a mixture of TAT-CEA fusion protein and poly(I:C) can induce anti-tumor immunity in a murine colorectal tumor model.",21945963_6,0,1,-1,-1,15912,-1,8.688633e-05,0.99984,7.300768e-05
15913,immunity,21,22,117,125,"Therefore, we demonstrated that vaccine with a mixture of TAT-CEA fusion protein and poly(I:C) can induce anti-tumor immunity in a murine colorectal tumor model.",21945963_6,0,-1,2,-1,15913,-1,0.9992669,0.0005142652,0.00021882057
15916,protein,10,11,66,73,Splenocytes from mice vaccinated with a mixture of TAT-CEA fusion protein and poly(I:C) effectively induced CEA-specific IFN--producing T cells and showed cytotoxic activity specific for MC-38-cea2 tumor cells expressing CEA.,21945963_7,0,1,-1,-1,15916,-1,5.2990257e-05,0.99991536,3.165382e-05
15917,IFN--producing T cells,19,22,121,144,Splenocytes from mice vaccinated with a mixture of TAT-CEA fusion protein and poly(I:C) effectively induced CEA-specific IFN--producing T cells and showed cytotoxic activity specific for MC-38-cea2 tumor cells expressing CEA.,21945963_7,-1,-1,-1,-1,15917,-1,0.8130294,0.0018035521,0.18516701
15918,tumor cells,29,31,199,210,Splenocytes from mice vaccinated with a mixture of TAT-CEA fusion protein and poly(I:C) effectively induced CEA-specific IFN--producing T cells and showed cytotoxic activity specific for MC-38-cea2 tumor cells expressing CEA.,21945963_7,-1,-1,-1,-1,15918,-1,0.003605176,0.3007698,0.69562507
15920,protein,7,8,41,48,Vaccine with a mixture of TAT-CEA fusion protein and poly(I:C) delayed tumor growth in MC-38-cea-2 tumor-bearing mice.,21945963_8,0,1,-1,-1,15920,-1,0.00015298408,0.99968207,0.00016492659
15930,immunity,33,34,187,195,"Depletion of CD8(+) T cells and NK cells reversed the inhibition of tumor growth in an MC-38-cea2-bearing mice, indicating that CD8(+) T cells and NK cells are responsible for anti-tumor immunity by vaccine with a mixture of TAT-CEA fusion protein and poly(I:C).",21945963_9,0,-1,2,-1,15930,-1,0.9752237,0.024155239,0.00062105706
15932,protein,42,43,240,247,"Depletion of CD8(+) T cells and NK cells reversed the inhibition of tumor growth in an MC-38-cea2-bearing mice, indicating that CD8(+) T cells and NK cells are responsible for anti-tumor immunity by vaccine with a mixture of TAT-CEA fusion protein and poly(I:C).",21945963_9,0,1,-1,-1,15932,-1,0.000115812574,0.9998276,5.648783e-05
15933,Taken together,0,2,0,14,"Taken together, these results suggest that poly(I:C) could be used as a potent adjuvant to induce the anti-tumor immunity of a TAT-CEA fusion protein vaccine in a murine colorectal tumor model.",21945963_10,-1,-1,-1,-1,15933,-1,4.0289397e-05,0.99994445,1.5268743e-05
15938,immunity,22,23,113,121,"Taken together, these results suggest that poly(I:C) could be used as a potent adjuvant to induce the anti-tumor immunity of a TAT-CEA fusion protein vaccine in a murine colorectal tumor model.",21945963_10,0,-1,2,-1,15938,-1,0.99883133,0.0008849505,0.0002837701
15940,protein,27,28,142,149,"Taken together, these results suggest that poly(I:C) could be used as a potent adjuvant to induce the anti-tumor immunity of a TAT-CEA fusion protein vaccine in a murine colorectal tumor model.",21945963_10,0,1,-1,-1,15940,-1,0.00012322041,0.9997936,8.316331e-05
15956,the tumor,5,7,22,31,"In the lymph nodes of the tumor microenvironment and spleen, the proportion of Treg cells was significantly higher in the tumor-bearing mice.",21963624_4,-1,-1,-1,-1,15956,-1,2.0069734e-05,0.99996936,1.0620235e-05
15959,the tumor-bearing,20,22,118,135,"In the lymph nodes of the tumor microenvironment and spleen, the proportion of Treg cells was significantly higher in the tumor-bearing mice.",21963624_4,-1,-1,-1,-1,15959,-1,1.9806994e-05,0.9999695,1.0698287e-05
15973,the tumor,26,28,151,160,"In conclusion, GP reduced the proportion of Treg cells and Foxp3 lowered expression in Treg cells, and up-regulated Th1/Th2 cytokine ratio in serum in the tumor bearing mice, which might partially cause the inhibition of tumor growth.",21963624_7,-1,-1,-1,-1,15973,-1,2.234869e-05,0.9999658,1.185345e-05
15979,the T-cell antigen,3,6,16,34,"However, during the T-cell antigen response, the physiologic function of endogenous miR-17-92 and the roles of the individual miRNAs remain elusive.",21972292_1,-1,-1,-1,-1,15979,-1,0.1385262,0.5561906,0.30528322
15981,function,10,11,61,69,"However, during the T-cell antigen response, the physiologic function of endogenous miR-17-92 and the roles of the individual miRNAs remain elusive.",21972292_1,0,1,2,-1,15981,-1,3.9418726e-05,0.99993527,2.5355774e-05
15985,functionally,6,7,25,37,"In the present study, we functionally dissected the miR-17-92 cluster and revealed that miR-17 and miR-19b are the key players controlling Th1 responses through multiple coordinated biologic processes.",21972292_2,0,1,2,-1,15985,-1,2.4688652e-05,0.999964,1.1281879e-05
15998,the functionally,12,14,72,88,"Mechanistically, we identified Pten (phosphatase and tensin homolog) as the functionally important target of miR-19b, whereas the function of miR-17 is mediated by TGFRII and the novel target CREB1.",21972292_4,-1,-1,-1,-1,15998,-1,2.8710441e-05,0.9999603,1.0940948e-05
16000,the function,20,22,126,138,"Mechanistically, we identified Pten (phosphatase and tensin homolog) as the functionally important target of miR-19b, whereas the function of miR-17 is mediated by TGFRII and the novel target CREB1.",21972292_4,-1,-1,-1,-1,16000,-1,2.4336128e-05,0.99996364,1.1999441e-05
16003,target CREB1,31,33,186,198,"Mechanistically, we identified Pten (phosphatase and tensin homolog) as the functionally important target of miR-19b, whereas the function of miR-17 is mediated by TGFRII and the novel target CREB1.",21972292_4,-1,-1,-1,-1,16003,-1,3.130331e-05,0.9999201,4.8504324e-05
16004,the Th1 cell-inducible regulatory T cell,6,12,37,77,"Because of its vigorous control over the Th1 cell-inducible regulatory T cell balance, the loss of miR-17-92 in CD4 T cells results in tumor evasion.",21972292_5,-1,-1,-1,-1,16004,-1,0.0022243871,0.064441934,0.9333337
16011,T cell-based tumor therapy,15,19,90,116,Our results suggest that miR-19b and miR-17 could be harnessed to enhance the efficacy of T cell-based tumor therapy.,21972292_6,-1,-1,-1,-1,16011,-1,0.0020105212,0.077407844,0.92058164
16014,T-box transcription factor 21 gene,16,21,98,132,Large granular lymphocyte (LGL) leukemia is a chronic lymphoproliferative disease in which T-bet [T-box transcription factor 21 gene (tbx21)] overexpression may play a pathogenic role.,21983879_0,-1,-1,-1,-1,16014,-1,2.6295002e-05,0.9999546,1.908501e-05
16015,tbx21,22,23,134,139,Large granular lymphocyte (LGL) leukemia is a chronic lymphoproliferative disease in which T-bet [T-box transcription factor 21 gene (tbx21)] overexpression may play a pathogenic role.,21983879_0,-1,1,2,-1,16015,-1,4.4696084e-05,0.9999201,3.514514e-05
16019,T-cells,7,8,60,67,T-bet orchestrates the differentiation of mature peripheral T-cells into interferon- (IFN-) and tumor necrosis factor- producing CD4+ T-helper type I (Th1) and CD8+ T cytotoxic cells that are necessary for antiviral responses.,21983879_1,-1,1,2,-1,16019,-1,0.00042956084,0.010568063,0.98900247
16023,factor-,16,17,113,121,T-bet orchestrates the differentiation of mature peripheral T-cells into interferon- (IFN-) and tumor necrosis factor- producing CD4+ T-helper type I (Th1) and CD8+ T cytotoxic cells that are necessary for antiviral responses.,21983879_1,0,1,-1,-1,16023,-1,0.99987924,4.669672e-05,7.404708e-05
16024,T-helper type,20,22,137,150,T-bet orchestrates the differentiation of mature peripheral T-cells into interferon- (IFN-) and tumor necrosis factor- producing CD4+ T-helper type I (Th1) and CD8+ T cytotoxic cells that are necessary for antiviral responses.,21983879_1,-1,-1,-1,-1,16024,-1,4.6830184e-05,0.9998951,5.804403e-05
16027,cells that,31,33,180,190,T-bet orchestrates the differentiation of mature peripheral T-cells into interferon- (IFN-) and tumor necrosis factor- producing CD4+ T-helper type I (Th1) and CD8+ T cytotoxic cells that are necessary for antiviral responses.,21983879_1,-1,-1,-1,-1,16027,-1,0.003615945,0.09129822,0.90508574
16029,antigen-presenting cells,5,7,26,50,"When IL-12 is produced by antigen-presenting cells, T-bet expression is induced, causing direct stimulation of ifng gene transcription while simultaneously acting as a transcriptional repressor of the IL4 gene, which then leads to Th1 dominance and T-helper type 2 differentiation blockade.",21983879_2,-1,-1,-1,-1,16029,-1,0.29969898,0.0025760732,0.69772494
16031,ifng gene transcription,17,20,111,134,"When IL-12 is produced by antigen-presenting cells, T-bet expression is induced, causing direct stimulation of ifng gene transcription while simultaneously acting as a transcriptional repressor of the IL4 gene, which then leads to Th1 dominance and T-helper type 2 differentiation blockade.",21983879_2,-1,-1,-1,-1,16031,-1,0.9551396,0.039473414,0.0053870566
16036,to Th1,35,37,228,234,"When IL-12 is produced by antigen-presenting cells, T-bet expression is induced, causing direct stimulation of ifng gene transcription while simultaneously acting as a transcriptional repressor of the IL4 gene, which then leads to Th1 dominance and T-helper type 2 differentiation blockade.",21983879_2,-1,-1,-1,-1,16036,-1,2.3301815e-05,0.99995756,1.9121742e-05
16037,T-helper type,39,41,249,262,"When IL-12 is produced by antigen-presenting cells, T-bet expression is induced, causing direct stimulation of ifng gene transcription while simultaneously acting as a transcriptional repressor of the IL4 gene, which then leads to Th1 dominance and T-helper type 2 differentiation blockade.",21983879_2,-1,-1,-1,-1,16037,-1,3.4440516e-05,0.9999225,4.2981283e-05
16040,the ifng,11,13,70,78,"Additionally, T-bet has been shown to regulate histone acetylation of the ifng promoter and enhancer to loosen condensed DNA, creating greater accessibility for other transcription factor binding, which further amplifies IFN production.",21983879_3,-1,-1,-1,-1,16040,-1,0.5620123,0.4326245,0.005363204
16044,that treatment,2,4,9,23,We found that treatment with a farnesyltransferase inhibitor tipifarnib reduced Th1 cytokines in LGL leukemia patient T-cells and blocked T-bet protein expression and IL-12 responsiveness in T-cells from healthy donors.,21983879_4,-1,-1,-1,-1,16044,-1,2.1843583e-05,0.9999678,1.0311883e-05
16046,Th1 cytokines,10,12,80,93,We found that treatment with a farnesyltransferase inhibitor tipifarnib reduced Th1 cytokines in LGL leukemia patient T-cells and blocked T-bet protein expression and IL-12 responsiveness in T-cells from healthy donors.,21983879_4,-1,-1,-1,-1,16046,-1,0.17901768,0.80457,0.016412303
16047,T-cells,16,17,118,125,We found that treatment with a farnesyltransferase inhibitor tipifarnib reduced Th1 cytokines in LGL leukemia patient T-cells and blocked T-bet protein expression and IL-12 responsiveness in T-cells from healthy donors.,21983879_4,-1,1,2,-1,16047,-1,4.7158355e-05,0.000113470065,0.9998393
16048,T-bet protein,19,21,138,151,We found that treatment with a farnesyltransferase inhibitor tipifarnib reduced Th1 cytokines in LGL leukemia patient T-cells and blocked T-bet protein expression and IL-12 responsiveness in T-cells from healthy donors.,21983879_4,-1,-1,-1,-1,16048,-1,2.3931807e-05,0.99995947,1.6616521e-05
16050,T-cells,26,27,191,198,We found that treatment with a farnesyltransferase inhibitor tipifarnib reduced Th1 cytokines in LGL leukemia patient T-cells and blocked T-bet protein expression and IL-12 responsiveness in T-cells from healthy donors.,21983879_4,-1,1,2,-1,16050,-1,4.3591914e-05,9.465488e-05,0.9998617
16052,the ifng gene,12,15,79,92,"The mechanism of suppression was based on modulation of histone acetylation of the ifng gene, which culminated in Th1 blockade.",21983879_5,-1,-1,-1,-1,16052,-1,0.0006304627,0.9991341,0.00023545182
16054,Tumour cells,0,2,0,12,Tumour cells often express deregulated profiles of chemokine receptors that regulate cancer cell migration and proliferation.,21984373_0,-1,-1,-1,-1,16054,-1,0.0037417538,0.2725127,0.7237455
16055,chemokine receptors that,7,10,51,75,Tumour cells often express deregulated profiles of chemokine receptors that regulate cancer cell migration and proliferation.,21984373_0,-1,-1,-1,-1,16055,-1,0.76239365,0.13270618,0.104900144
16059,to the,15,17,86,92,"Notch1 pathway activation is seen in T cell acute lymphoblastic leukaemia (T-ALL) due to the high frequency of Notch1 mutations affecting approximately 60% of patients, causing ligand-independent signalling and/or prolonging Notch1 half-life.",21984373_1,-1,-1,-1,-1,16059,-1,2.1167074e-05,0.9999702,8.6177115e-06
16062,function,13,14,82,90,"We have investigated the possible regulative role of Notch1 on the expression and function of chemokine receptors CCR5, CCR9 and CXCR4 that play a role in determining blast malignant properties and localization of extramedullary infiltrations in leukaemia.",21984373_2,0,1,2,-1,16062,-1,4.3124022e-05,0.9999298,2.7142814e-05
16063,chemokine receptors CCR5,15,18,94,118,"We have investigated the possible regulative role of Notch1 on the expression and function of chemokine receptors CCR5, CCR9 and CXCR4 that play a role in determining blast malignant properties and localization of extramedullary infiltrations in leukaemia.",21984373_2,-1,-1,-1,-1,16063,-1,0.0528484,0.0018211912,0.94533044
16064,that play,22,24,135,144,"We have investigated the possible regulative role of Notch1 on the expression and function of chemokine receptors CCR5, CCR9 and CXCR4 that play a role in determining blast malignant properties and localization of extramedullary infiltrations in leukaemia.",21984373_2,-1,-1,-1,-1,16064,-1,2.1109881e-05,0.9999682,1.0669398e-05
16069,function,19,20,129,137,We inhibited the pathway through -Secretase inhibitor and Notch1 RNA interference and analysed the effect on the expression and function of chemokine receptors.,21984373_3,0,1,2,-1,16069,-1,7.1628914e-05,0.9998764,5.2013038e-05
16070,chemokine receptors,21,23,141,160,We inhibited the pathway through -Secretase inhibitor and Notch1 RNA interference and analysed the effect on the expression and function of chemokine receptors.,21984373_3,-1,-1,-1,-1,16070,-1,0.4053909,0.0039593205,0.5906497
16072,the transcription,8,10,69,86,"Our results indicate that -Secretase inhibitor negatively regulates the transcription level of the CC chemokine receptors 5 and 9 in T-ALL cell lines and patients' primary leukaemia cells, leaving CXCR4 expression unaltered.",21984373_4,-1,-1,-1,-1,16072,-1,2.1597278e-05,0.99996805,1.0406687e-05
16074,chemokine receptors,14,16,103,122,"Our results indicate that -Secretase inhibitor negatively regulates the transcription level of the CC chemokine receptors 5 and 9 in T-ALL cell lines and patients' primary leukaemia cells, leaving CXCR4 expression unaltered.",21984373_4,-1,-1,-1,-1,16074,-1,0.46875745,0.0036311971,0.5276113
16075,T-ALL cell,20,22,134,144,"Our results indicate that -Secretase inhibitor negatively regulates the transcription level of the CC chemokine receptors 5 and 9 in T-ALL cell lines and patients' primary leukaemia cells, leaving CXCR4 expression unaltered.",21984373_4,-1,-1,-1,-1,16075,-1,0.0021963338,0.2158033,0.7820005
16080,through CCL25,4,6,27,40,"Furthermore, engaging CCR9 through CCL25 administration rescues proliferation inhibition associated with abrogation of Notch activity.",21984373_6,-1,-1,-1,-1,16080,-1,0.35440147,0.58010864,0.0654899
16082,that the,7,9,50,58,"Finally, through RNA interference we demonstrated that the oncogenic isoform in T-ALL, Notch1, plays a role in controlling CCR5 and CCR9 expression and functions.",21984373_7,-1,-1,-1,-1,16082,-1,1.6075615e-05,0.9999752,8.707215e-06
16086,functions,26,27,152,161,"Finally, through RNA interference we demonstrated that the oncogenic isoform in T-ALL, Notch1, plays a role in controlling CCR5 and CCR9 expression and functions.",21984373_7,0,1,2,-1,16086,-1,0.00014321906,0.99975973,9.706345e-05
16089,chemokine receptors,10,12,59,78,"These findings suggest that Notch1, acting in concert with chemokine receptors pathways, may provide leukaemia cells with proliferative advantage and specific chemotactic abilities, therefore influencing tumour cell progression and localization.",21984373_8,-1,-1,-1,-1,16089,-1,0.90628517,0.0011627175,0.09255218
16093,tumour cell,28,30,204,215,"These findings suggest that Notch1, acting in concert with chemokine receptors pathways, may provide leukaemia cells with proliferative advantage and specific chemotactic abilities, therefore influencing tumour cell progression and localization.",21984373_8,-1,-1,-1,-1,16093,-1,0.001704259,0.03693857,0.9613571
16095,tissues,14,15,83,90,"Chronic inflammation is a major driving force in the development of cancer in many tissues, but the array of factors involved in this neoplastic transformation are not well understood.",21987656_0,-1,1,2,-1,16095,-1,0.0006654305,0.9574312,0.041903358
16097,factors,20,21,109,116,"Chronic inflammation is a major driving force in the development of cancer in many tissues, but the array of factors involved in this neoplastic transformation are not well understood.",21987656_0,0,1,-1,-1,16097,-1,0.0020935882,0.9973175,0.00058888487
16102,this cytokine,17,19,98,111,"We have investigated the role of interleukin (IL)-21 in colitis-associated colon cancer (CAC), as this cytokine is overexpressed in the gut mucosa of patients with ulcerative colitis (UC), a chronic inflammatory disease associated with colon cancer.",21987656_1,-1,-1,-1,-1,16102,-1,0.44131842,0.54994607,0.008735534
16128,the tumor,2,4,14,23,"Expression of the tumor suppressor, promyelocytic leukemia (PML) protein, is reduced or abolished in gastric carcinomas, in association with an increased level of lymphatic invasion, development of higher pTNM staging, and unfavorable prognosis.",22022583_1,-1,-1,-1,-1,16128,-1,2.7046652e-05,0.9999589,1.4119985e-05
16129,protein,11,12,65,72,"Expression of the tumor suppressor, promyelocytic leukemia (PML) protein, is reduced or abolished in gastric carcinomas, in association with an increased level of lymphatic invasion, development of higher pTNM staging, and unfavorable prognosis.",22022583_1,0,1,-1,-1,16129,-1,5.3296422e-05,0.99989235,5.4360917e-05
16130,the relationship,4,6,24,40,"Herein, we investigated the relationship between the extent of tumor-infiltrating lymphocytes and the status of PML protein expression in advanced gastric carcinoma.",22022583_2,-1,-1,-1,-1,16130,-1,1.7929502e-05,0.99997115,1.0864125e-05
16132,tumor-infiltrating lymphocytes,10,12,63,93,"Herein, we investigated the relationship between the extent of tumor-infiltrating lymphocytes and the status of PML protein expression in advanced gastric carcinoma.",22022583_2,-1,-1,-1,-1,16132,-1,0.0029819733,0.866872,0.13014595
16133,the status,13,15,98,108,"Herein, we investigated the relationship between the extent of tumor-infiltrating lymphocytes and the status of PML protein expression in advanced gastric carcinoma.",22022583_2,-1,-1,-1,-1,16133,-1,1.909155e-05,0.99997103,9.877748e-06
16134,protein,17,18,116,123,"Herein, we investigated the relationship between the extent of tumor-infiltrating lymphocytes and the status of PML protein expression in advanced gastric carcinoma.",22022583_2,0,1,-1,-1,16134,-1,4.622966e-05,0.9999168,3.6962818e-05
16135,T-cells,6,7,43,50,"We observed higher numbers of infiltrating T-cells in gastric carcinoma tissues in which PML expression was reduced or abolished, compared to tissues positive for PML.",22022583_3,-1,1,2,-1,16135,-1,3.5385976e-05,7.61567e-05,0.9998884
16136,tissues,10,11,72,79,"We observed higher numbers of infiltrating T-cells in gastric carcinoma tissues in which PML expression was reduced or abolished, compared to tissues positive for PML.",22022583_3,-1,1,2,-1,16136,-1,3.244592e-05,0.9998996,6.7901434e-05
16137,to tissues,21,23,139,149,"We observed higher numbers of infiltrating T-cells in gastric carcinoma tissues in which PML expression was reduced or abolished, compared to tissues positive for PML.",22022583_3,-1,-1,-1,-1,16137,-1,2.6679816e-05,0.9999472,2.6140488e-05
16139,T-cell,3,4,14,20,The extent of T-cell migration toward culture supernatants obtained from interferon-gamma (IFN--stimulated gastric carcinoma cell lines was additionally affected by expression of PML in vitro.,22022583_4,-1,1,2,-1,16139,-1,2.8222868e-05,4.5016484e-05,0.9999267
16144,Interferon-gamma-inducible protein,0,2,0,34,Interferon-gamma-inducible protein 10 (IP-10/CXCL10) expression was increased in gastric carcinoma tissues displaying reduced PML levels.,22022583_5,-1,-1,-1,-1,16144,-1,0.33151677,0.66459215,0.0038910639
16145,tissues,12,13,99,106,Interferon-gamma-inducible protein 10 (IP-10/CXCL10) expression was increased in gastric carcinoma tissues displaying reduced PML levels.,22022583_5,-1,1,2,-1,16145,-1,4.249449e-05,0.99983037,0.00012705314
16147,protein,13,14,82,89,"Moreover, both Pml knockout and knockdown cells displayed enhanced IP-10 mRNA and protein expression in the presence of IFN-.",22022583_6,0,1,-1,-1,16147,-1,2.7354676e-05,0.99995434,1.833449e-05
16155,to the,14,16,107,113,"PML knockdown increased IFN--mediated Signal Transducer and Activator of Transcription-1 (STAT-1) binding to the IP-10 promoter, resulting in elevated transcription of the IP-10 gene.",22022583_7,-1,-1,-1,-1,16155,-1,1.8419041e-05,0.99997115,1.0373485e-05
16159,protein,4,5,19,26,"Conversely, PML IV protein expression suppressed IP-10 promoter activation.",22022583_8,0,1,-1,-1,16159,-1,8.483778e-05,0.999811,0.00010415303
16162,protein,11,12,52,59,"Based on these results, we propose that loss of PML protein expression in gastric cancer cells contributes to increased IP-10 transcription via enhancement of STAT-1 activity, which, in turn, promotes lymphocyte trafficking within tumor regions.",22022583_9,0,1,-1,-1,16162,-1,3.0798135e-05,0.99995077,1.8392493e-05
16168,lymphocyte trafficking,34,36,201,223,"Based on these results, we propose that loss of PML protein expression in gastric cancer cells contributes to increased IP-10 transcription via enhancement of STAT-1 activity, which, in turn, promotes lymphocyte trafficking within tumor regions.",22022583_9,-1,-1,-1,-1,16168,-1,0.001777885,0.03889505,0.95932716
16176,cellular immune responses,27,30,136,161,"Regulatory T cells (T(reg)) are CD4(+) T lymphocytes with constitutive expression of CD25 and FOXP3, as well as the ability to modulate cellular immune responses.",22041284_0,-1,-1,-1,-1,16176,-1,0.7415821,0.0027465213,0.25567144
16179,function,8,9,47,55,"In this study, the phenotypic characteristics, function and feasibility of enrichment and expansion of canine T(reg) were examined.",22041284_1,0,1,2,-1,16179,-1,4.5510744e-05,0.9999211,3.3377408e-05
16181,blood,2,3,18,23,"Canine peripheral blood mononuclear cells were isolated and enriched by labelling of CD25, and expansion of T(reg) was achieved by adding interleukin (IL)-2 for 1 week.",22041284_2,0,1,-1,-1,16181,-1,0.00013658292,0.99923074,0.00063268066
16185,functional,2,3,15,25,Phenotypic and functional analyses of T(reg) were performed prior to and after expansion.,22041284_3,0,1,2,-1,16185,-1,6.089886e-05,0.9999131,2.601329e-05
16194,factors,13,14,76,83,Expansion of canine T(reg) was possible by adding IL-2 without other growth factors.,22041284_6,0,1,-1,-1,16194,-1,0.99909437,0.00029603174,0.0006096194
16207,to T(reg,17,19,101,109,"Enrichment and expansion of canine T(reg) is feasible, and canine T(reg) had similar characteristics to T(reg) from other species.",22041284_10,-1,-1,-1,-1,16207,-1,3.057977e-05,0.99995065,1.8713836e-05
16217,therapeutic targets,34,36,251,270,"Many transformed lymphoma cells show immune-phenotypes resembling the corresponding normal lymphocytes; thus, they provide a guide for proper diagnosis and present promising routes to improve their pathophysiologic understanding and to identify novel therapeutic targets.",22042699_0,-1,-1,-1,-1,16217,-1,2.423816e-05,0.999964,1.1723905e-05
16242,to the,36,38,246,252,"Interestingly, miR-135b suppressed T-helper (Th) 2 master regulators STAT6 and GATA3, and miR-135b blockade attenuated IL-17 production and paracrine inflammatory response by ALCL cells, indicating that miR-135b-mediated Th2 suppression may lead to the skewing to ALCL immunophenotype overlapping with Th17 cells.",22042699_6,-1,-1,-1,-1,16242,-1,2.1052925e-05,0.9999702,8.804525e-06
16244,Th17 cells,44,46,302,312,"Interestingly, miR-135b suppressed T-helper (Th) 2 master regulators STAT6 and GATA3, and miR-135b blockade attenuated IL-17 production and paracrine inflammatory response by ALCL cells, indicating that miR-135b-mediated Th2 suppression may lead to the skewing to ALCL immunophenotype overlapping with Th17 cells.",22042699_6,-1,-1,-1,-1,16244,-1,0.001488536,0.022854691,0.97565675
16248,therapeutic target,24,26,157,175,"Furthermore, antisense-based miR-135b inhibition reduced tumor angiogenesis and growth in vivo, demonstrating significance of this ""Th17 mimic"" pathway as a therapeutic target.",22042699_7,-1,-1,-1,-1,16248,-1,2.311551e-05,0.9999639,1.305064e-05
16250,to tumorigenesis through,10,13,95,119,These results collectively illuminated unique contribution of oncogenic kinase-linked microRNA to tumorigenesis through modulation of tumor immune-phenotype and microenvironment.,22042699_8,-1,-1,-1,-1,16250,-1,2.2030366e-05,0.99996614,1.1800971e-05
16253,tissues,15,16,86,93,"Dickkopf-1 (DKK1), broadly expressed in myeloma cells but highly restricted in normal tissues, together with its functional roles as an osteoblast formation inhibitor, may be an ideal target for immunotherapy in myeloma.",22049519_0,-1,1,2,-1,16253,-1,0.00016448385,0.99898654,0.0008489729
16255,functional,20,21,113,123,"Dickkopf-1 (DKK1), broadly expressed in myeloma cells but highly restricted in normal tissues, together with its functional roles as an osteoblast formation inhibitor, may be an ideal target for immunotherapy in myeloma.",22049519_0,0,1,2,-1,16255,-1,7.67052e-05,0.99989605,2.7254107e-05
16265,immunity that,20,22,106,119,The goal of this study was to examine whether DKK1 can be used as a tumor vaccine to elicit DKK1-specific immunity that can control myeloma growth or even eradicate established myeloma in vivo.,22049519_2,-1,-1,-1,-1,16265,-1,0.36973238,0.6267789,0.0034887695
16274,the therapeutic,20,22,117,132,"Furthermore, the addition of CpG as an adjuvant, or injection of B7H1-blocking or OX40-agonist Abs, further enhanced the therapeutic effects of the vaccine.",22049519_4,-1,-1,-1,-1,16274,-1,2.3634213e-05,0.99996626,1.0110796e-05
16288,function,10,11,56,64,BACKGROUND: CD8+ effector cells often have an antitumor function in patients with cancer.,22051182_0,0,1,2,-1,16288,-1,0.00014414765,0.9997538,0.00010208176
16290,Tcregs,8,9,40,46,"However, CD8+Foxp3+ regulatory T cells (Tcregs) and interleukin (IL)-17-producing CD8+ T cells (Tc17 cells) also derive from the CD8+ T cell lineage.",22051182_1,-1,1,2,-1,16290,-1,2.3859757e-05,0.9999522,2.3960154e-05
16293,Tc17 cells,18,20,96,106,"However, CD8+Foxp3+ regulatory T cells (Tcregs) and interleukin (IL)-17-producing CD8+ T cells (Tc17 cells) also derive from the CD8+ T cell lineage.",22051182_1,-1,-1,-1,-1,16293,-1,0.003988623,0.44651023,0.5495012
16294,the CD8+ T cell,24,29,125,140,"However, CD8+Foxp3+ regulatory T cells (Tcregs) and interleukin (IL)-17-producing CD8+ T cells (Tc17 cells) also derive from the CD8+ T cell lineage.",22051182_1,-1,-1,-1,-1,16294,-1,0.0030593467,0.106141314,0.8907993
16301,Tcregs,19,20,105,111,"In the present study, we aimed to investigate the distribution, characterization, and generation of CD8+ Tcregs and Tc17 cells in NPC patients.",22051182_3,-1,1,2,-1,16301,-1,2.9552992e-05,0.9999366,3.381195e-05
16302,Tc17 cells,21,23,116,126,"In the present study, we aimed to investigate the distribution, characterization, and generation of CD8+ Tcregs and Tc17 cells in NPC patients.",22051182_3,-1,-1,-1,-1,16302,-1,0.0022147463,0.12436685,0.87341845
16303,blood,3,4,20,25,"METHODS: Peripheral blood and tumor biopsy tissues from 21 newly diagnosed patients with nasopharyngeal carcinoma (NPC) were collected, along with peripheral blood from 21 healthy donors.",22051182_4,0,1,-1,-1,16303,-1,0.00025051794,0.99502736,0.004722086
16305,tissues,7,8,43,50,"METHODS: Peripheral blood and tumor biopsy tissues from 21 newly diagnosed patients with nasopharyngeal carcinoma (NPC) were collected, along with peripheral blood from 21 healthy donors.",22051182_4,-1,1,2,-1,16305,-1,0.000107624845,0.9987627,0.0011296232
16307,blood,25,26,158,163,"METHODS: Peripheral blood and tumor biopsy tissues from 21 newly diagnosed patients with nasopharyngeal carcinoma (NPC) were collected, along with peripheral blood from 21 healthy donors.",22051182_4,0,1,-1,-1,16307,-1,0.00046758115,0.9765361,0.022996299
16309,Tcregs,4,5,34,40,"The biological characteristics of Tcregs and Tc17 cells from blood and tumor tissues were examined by intracellular staining, tetramer staining and fluorescence-activated cell sorting (FACS) analysis.",22051182_5,-1,1,2,-1,16309,-1,2.4699308e-05,0.99995005,2.5293644e-05
16310,Tc17 cells,6,8,45,55,"The biological characteristics of Tcregs and Tc17 cells from blood and tumor tissues were examined by intracellular staining, tetramer staining and fluorescence-activated cell sorting (FACS) analysis.",22051182_5,-1,-1,-1,-1,16310,-1,0.002493989,0.19600096,0.801505
16311,blood,9,10,61,66,"The biological characteristics of Tcregs and Tc17 cells from blood and tumor tissues were examined by intracellular staining, tetramer staining and fluorescence-activated cell sorting (FACS) analysis.",22051182_5,0,1,-1,-1,16311,-1,5.499725e-05,0.999858,8.696125e-05
16312,tumor tissues,11,13,71,84,"The biological characteristics of Tcregs and Tc17 cells from blood and tumor tissues were examined by intracellular staining, tetramer staining and fluorescence-activated cell sorting (FACS) analysis.",22051182_5,-1,-1,-1,-1,16312,-1,2.7019145e-05,0.9999455,2.7456781e-05
16315,analysis,28,29,191,199,"The biological characteristics of Tcregs and Tc17 cells from blood and tumor tissues were examined by intracellular staining, tetramer staining and fluorescence-activated cell sorting (FACS) analysis.",22051182_5,0,1,-1,-1,16315,-1,4.6491616e-05,0.9998871,6.632742e-05
16317,function,2,3,16,24,The suppressive function of Tcregs was investigated using a proliferation assay that involved co-culture of sorted CD8+CD25+ T cells with nave CD4+ T cells in vitro.,22051182_6,0,1,2,-1,16317,-1,4.1328098e-05,0.9999213,3.7343732e-05
16318,Tcregs,4,5,28,34,The suppressive function of Tcregs was investigated using a proliferation assay that involved co-culture of sorted CD8+CD25+ T cells with nave CD4+ T cells in vitro.,22051182_6,-1,1,2,-1,16318,-1,1.8466815e-05,0.9999646,1.6976835e-05
16322,Tcregs,8,9,48,54,RESULTS: We observed an increased prevalence of Tcregs and Tc17 cells among tumor-infiltrating lymphocytes (TILs) and different distribution among peripheral blood mononuclear cells (PBMCs) in NPC patients.,22051182_7,-1,1,2,-1,16322,-1,2.5515821e-05,0.99995625,1.8282002e-05
16323,Tc17 cells,10,12,59,69,RESULTS: We observed an increased prevalence of Tcregs and Tc17 cells among tumor-infiltrating lymphocytes (TILs) and different distribution among peripheral blood mononuclear cells (PBMCs) in NPC patients.,22051182_7,-1,-1,-1,-1,16323,-1,0.003804666,0.5254306,0.4707647
16324,tumor-infiltrating lymphocytes,13,15,76,106,RESULTS: We observed an increased prevalence of Tcregs and Tc17 cells among tumor-infiltrating lymphocytes (TILs) and different distribution among peripheral blood mononuclear cells (PBMCs) in NPC patients.,22051182_7,-1,-1,-1,-1,16324,-1,0.003986984,0.8656689,0.13034412
16326,blood,23,24,158,163,RESULTS: We observed an increased prevalence of Tcregs and Tc17 cells among tumor-infiltrating lymphocytes (TILs) and different distribution among peripheral blood mononuclear cells (PBMCs) in NPC patients.,22051182_7,0,1,-1,-1,16326,-1,0.00057632267,0.99218607,0.007237618
16329,that the Tcregs,3,6,25,40,"Cytokine profiles showed that the Tcregs expressed a high level of IL-10 and low level of transforming growth factor , whereas Tc17 cells expressed a high level of tumor necrosis factor .",22051182_8,-1,-1,-1,-1,16329,-1,2.2496264e-05,0.99996233,1.52094135e-05
16331,transforming growth factor,16,19,90,116,"Cytokine profiles showed that the Tcregs expressed a high level of IL-10 and low level of transforming growth factor , whereas Tc17 cells expressed a high level of tumor necrosis factor .",22051182_8,-1,-1,-1,-1,16331,-1,0.8380815,0.15634036,0.005578233
16332,Tc17 cells,22,24,128,138,"Cytokine profiles showed that the Tcregs expressed a high level of IL-10 and low level of transforming growth factor , whereas Tc17 cells expressed a high level of tumor necrosis factor .",22051182_8,-1,-1,-1,-1,16332,-1,0.0025234665,0.2370585,0.760418
16337,the Tcregs,15,17,80,90,"Interestingly, both subsets expressed a high level of interferon  in TILs, and the Tcregs suppressed nave CD4+ T cell proliferation by a cell contact-dependent mechanism in vitro.",22051182_9,-1,-1,-1,-1,16337,-1,2.3134124e-05,0.99995923,1.7598726e-05
16341,protein,11,12,78,85,"Moreover, we demonstrated the existence of Epstein-Barr virus latent membrane protein (LMP) 1 and LMP2 antigen-specific Tcregs in NPC.CONCLUSIONS: Our data provide new insights into the composition and function of CD8+ T-cell subsets in NPC, which may have an important influence on NPC immunotherapy.",22051182_10,0,1,-1,-1,16341,-1,0.0004074581,0.9983602,0.0012323577
16342,antigen-specific Tcregs,18,20,103,126,"Moreover, we demonstrated the existence of Epstein-Barr virus latent membrane protein (LMP) 1 and LMP2 antigen-specific Tcregs in NPC.CONCLUSIONS: Our data provide new insights into the composition and function of CD8+ T-cell subsets in NPC, which may have an important influence on NPC immunotherapy.",22051182_10,-1,-1,-1,-1,16342,-1,0.9012984,0.08325494,0.015446692
16344,function,32,33,202,210,"Moreover, we demonstrated the existence of Epstein-Barr virus latent membrane protein (LMP) 1 and LMP2 antigen-specific Tcregs in NPC.CONCLUSIONS: Our data provide new insights into the composition and function of CD8+ T-cell subsets in NPC, which may have an important influence on NPC immunotherapy.",22051182_10,0,1,2,-1,16344,-1,5.9095346e-05,0.9998944,4.6473957e-05
16346,tumor-induced T(reg,6,8,36,55,A number of studies have implicated tumor-induced T(reg) cell activity in the sub-optimal response to therapeutic vaccines.,22057676_0,-1,-1,-1,-1,16346,-1,2.0485293e-05,0.9999683,1.1246263e-05
16349,to therapeutic,15,17,99,113,A number of studies have implicated tumor-induced T(reg) cell activity in the sub-optimal response to therapeutic vaccines.,22057676_0,-1,-1,-1,-1,16349,-1,3.0463601e-05,0.9999573,1.22396505e-05
16350,targeting T(reg,4,6,39,54,Development of neo-adjuvant strategies targeting T(reg) cells is therefore imperative.,22057676_1,-1,-1,-1,-1,16350,-1,2.614401e-05,0.9999589,1.5020803e-05
16357,TGF-1-induced T(reg,22,24,118,138,"We report here, for the first time, that Scutellaria ocmulgee leaf extract (SocL) and flavonoid wogonin could inhibit TGF-1-induced T(reg) activity in malignant gliomas.",22057676_3,-1,-1,-1,-1,16357,-1,2.0904823e-05,0.99996483,1.42597255e-05
16364,blood TGF-1,30,32,188,200,"F344 rats, subcutaneously transplanted with F98 gliomas, were treated with SocL. There was a significant inhibition of intra-tumoral TGF-1 and T(reg) cell frequency as well as peripheral blood TGF-1 levels in SocL-treated animals compared to the controls.",22057676_4,-1,-1,-1,-1,16364,-1,6.4005e-05,0.9998456,9.035402e-05
16365,to the,37,39,241,247,"F344 rats, subcutaneously transplanted with F98 gliomas, were treated with SocL. There was a significant inhibition of intra-tumoral TGF-1 and T(reg) cell frequency as well as peripheral blood TGF-1 levels in SocL-treated animals compared to the controls.",22057676_4,-1,-1,-1,-1,16365,-1,2.475435e-05,0.99996173,1.3497821e-05
16366,TGF-1-mediated T(reg,8,10,56,77,"SocL extract and wogonin also inhibited glioma-induced, TGF-1-mediated T(reg) activity in vitro.",22057676_5,-1,-1,-1,-1,16366,-1,3.0012627e-05,0.99994504,2.4956198e-05
16375,the T cells,37,40,214,225,"We also observed an inhibition of Smad-3, GSK-3 and ERK1/2 signaling by SocL and wogonin in T(reg) cells, while phosphorylation of P38 MAPK was considerably enhanced, indicating that SocL or wogonin could inhibit the T cells' response to TGF-1 via modulation of both Smad and non-Smad signaling pathways.",22057676_7,-1,-1,-1,-1,16375,-1,0.00244912,0.12353497,0.8740159
16376,to TGF-1,42,44,236,245,"We also observed an inhibition of Smad-3, GSK-3 and ERK1/2 signaling by SocL and wogonin in T(reg) cells, while phosphorylation of P38 MAPK was considerably enhanced, indicating that SocL or wogonin could inhibit the T cells' response to TGF-1 via modulation of both Smad and non-Smad signaling pathways.",22057676_7,-1,-1,-1,-1,16376,-1,3.4100747e-05,0.9999436,2.222971e-05
16383,to TGF-1,28,30,186,195,"Overall, this study suggests that Scutellaria can potentially reverse tumor-mediated immune suppression via inhibition of TGF-1 secretion as well as via inhibition of T cells' response to TGF-1.",22057676_8,-1,-1,-1,-1,16383,-1,3.912571e-05,0.99993646,2.4437562e-05
16401,plus granulocyte-macrophage colony stimulating factor,26,31,129,182,"In 1 study (Mel38), patients received 1 injection with an adjuvant mixture alone, composed of incomplete Freund's adjuvant (IFA) plus granulocyte-macrophage colony stimulating factor (GM-CSF).",22130163_5,-1,-1,-1,-1,16401,-1,0.9856016,0.009156295,0.0052420534
16403,peptide antigens plus IFA,11,15,73,98,"In a second study, patients received multiple vaccinations with melanoma peptide antigens plus IFA.",22130163_6,-1,-1,-1,-1,16403,-1,0.9766243,0.015282575,0.008093173
16404,"cells, T cells",12,16,94,108,"Single injections with adjuvant alone induced dermal inflammatory infiltrates consisting of B cells, T cells, mature DCs, and vessels resembling high endothelial venules (HEVs).",22130163_7,-1,-1,-1,-1,16404,-1,8.007781e-05,8.536547e-05,0.99983454
16405,These cellular,0,2,0,14,These cellular aggregates usually lacked organization and were transient.,22130163_8,-1,-1,-1,-1,16405,-1,0.0034456912,0.6460447,0.35050964
16407,peptides,7,8,49,57,"In contrast, multiple repeated vaccinations with peptides in adjuvant induced more organized and persistent lymphoid aggregates containing separate B and T cell areas, mature DCs, HEV-like vessels, and lymphoid chemokines.",22130163_9,0,-1,2,-1,16407,-1,0.0002960987,0.9993013,0.000402526
16413,FoxP3CD4 lymphocytes,15,17,86,106,"Within these structures, there are proliferating CD4and CD8 T lymphocytes, as well as FoxP3CD4 lymphocytes, suggesting a complex interplay of lymphoid expansion and regulation within the dermal immunization microenvironment.",22130163_10,-1,-1,-1,-1,16413,-1,0.003938404,0.7284047,0.26765692
16417,the physiology,3,5,17,31,Further study of the physiology of the vaccine site microenvironment promises to identify opportunities for enhancing cancer vaccine efficacy by modulating immune activation and regulation at the site of vaccination.,22130163_11,-1,-1,-1,-1,16417,-1,2.0038115e-05,0.99997103,8.912787e-06
16423,The cytokine interleukin-17A,0,3,0,28,"The cytokine interleukin-17A supports tumour vascularization and growth, however, its role in lung cancer is unknown.",22186896_1,-1,-1,-1,-1,16423,-1,0.9169354,0.080736764,0.00232792
16426,interleukin-17A that,16,18,80,100,"Here we show, in the lungs of patients with lung adenocarcinoma, an increase in interleukin-17A that is inversely correlated with the expression of T-bet and correlated with the T regulatory cell transcription factor Foxp3.",22186896_2,-1,-1,-1,-1,16426,-1,0.99324507,0.005332121,0.0014229036
16429,the T,29,31,174,179,"Here we show, in the lungs of patients with lung adenocarcinoma, an increase in interleukin-17A that is inversely correlated with the expression of T-bet and correlated with the T regulatory cell transcription factor Foxp3.",22186896_2,-1,-1,-1,-1,16429,-1,2.1739279e-05,0.99996495,1.3308676e-05
16430,cell transcription factor Foxp3,32,36,191,222,"Here we show, in the lungs of patients with lung adenocarcinoma, an increase in interleukin-17A that is inversely correlated with the expression of T-bet and correlated with the T regulatory cell transcription factor Foxp3.",22186896_2,-1,-1,-1,-1,16430,-1,0.0038795609,0.7574549,0.2386656
16442,the tumour,16,18,146,156,This is associated with the local upregulation of interleukin-23 and induction of interleukin-17A/interleukin-17R-expressing T cells infiltrating the tumour.,22186896_5,-1,-1,-1,-1,16442,-1,2.2695373e-05,0.99996495,1.2339247e-05
16447,therapy,7,8,63,70,These results suggest that local anti-interleukin-17A antibody therapy could be considered for the treatment of lung tumours.,22186896_7,0,1,-1,-1,16447,-1,2.244877e-05,0.999966,1.1565106e-05
16448,the treatment,12,14,95,108,These results suggest that local anti-interleukin-17A antibody therapy could be considered for the treatment of lung tumours.,22186896_7,-1,-1,-1,-1,16448,-1,2.3305916e-05,0.9999676,9.1312195e-06
16453,the transcription factor Tbet,21,25,111,140,We have recently shown that intratumor (i.t.) injection of syngenic dendritic cells (DC) engineered to express the transcription factor Tbet (TBX21) promotes protective type-1 T cell-mediated immunity via a mechanism that is largely interleukin (IL)-12p70-independent.,22215017_0,-1,-1,-1,-1,16453,-1,1.7568475e-05,0.99997354,8.935636e-06
16454,TBX21,26,27,142,147,We have recently shown that intratumor (i.t.) injection of syngenic dendritic cells (DC) engineered to express the transcription factor Tbet (TBX21) promotes protective type-1 T cell-mediated immunity via a mechanism that is largely interleukin (IL)-12p70-independent.,22215017_0,-1,1,2,-1,16454,-1,4.5401106e-05,0.99992096,3.3603275e-05
16455,type-1 T cell-mediated immunity,30,34,169,200,We have recently shown that intratumor (i.t.) injection of syngenic dendritic cells (DC) engineered to express the transcription factor Tbet (TBX21) promotes protective type-1 T cell-mediated immunity via a mechanism that is largely interleukin (IL)-12p70-independent.,22215017_0,-1,-1,-1,-1,16455,-1,0.026545197,0.95091426,0.022540538
16459,type-1 immunity,7,9,39,54,"Since IL-12 is a classical promoter of type-1 immunity, the current study was undertaken to determine whether gene therapy using combined Tbet and IL-12 complementary DNA (cDNA) would yield improved antitumor efficacy based on the complementary/synergistic action of these biologic modifiers.",22215017_1,-1,-1,-1,-1,16459,-1,0.0031656756,0.99642676,0.00040760209
16462,gene therapy,18,20,110,122,"Since IL-12 is a classical promoter of type-1 immunity, the current study was undertaken to determine whether gene therapy using combined Tbet and IL-12 complementary DNA (cDNA) would yield improved antitumor efficacy based on the complementary/synergistic action of these biologic modifiers.",22215017_1,-1,-1,-1,-1,16462,-1,2.2607102e-05,0.99996376,1.3609241e-05
16474,the tumor,48,50,285,294,"Mice bearing established subcutaneous (s.c.) tumors injected with DC concomitantly expressing ectopic Tbet and IL12 (i.e., DC.Tbet/IL12) displayed superior (i) rates of tumor rejection and extended overall survival, (ii) cross-priming of Tc1 reactive against antigens expressed within the tumor microenvironment, and (iii) infiltration of CD8(+) T cells into treated tumors in association with elevated locoregional production of CXCR3 ligand chemokines.",22215017_2,-1,-1,-1,-1,16474,-1,2.2901439e-05,0.9999658,1.1292653e-05
16476,treated tumors,63,65,359,373,"Mice bearing established subcutaneous (s.c.) tumors injected with DC concomitantly expressing ectopic Tbet and IL12 (i.e., DC.Tbet/IL12) displayed superior (i) rates of tumor rejection and extended overall survival, (ii) cross-priming of Tc1 reactive against antigens expressed within the tumor microenvironment, and (iii) infiltration of CD8(+) T cells into treated tumors in association with elevated locoregional production of CXCR3 ligand chemokines.",22215017_2,-1,-1,-1,-1,16476,-1,2.3900175e-05,0.9999615,1.4595566e-05
16481,tumor antigen-derived peptides,5,8,38,68,"Furthermore, DC.Tbet/IL12 pulsed with tumor antigen-derived peptides and injected as a therapy distal to the tumor site prevented tumor growth and activated robust antigen-specific Tc1 responses.",22215017_5,-1,-1,-1,-1,16481,-1,0.0036367665,0.9942192,0.002144099
16482,therapy,12,13,87,94,"Furthermore, DC.Tbet/IL12 pulsed with tumor antigen-derived peptides and injected as a therapy distal to the tumor site prevented tumor growth and activated robust antigen-specific Tc1 responses.",22215017_5,0,1,-1,-1,16482,-1,2.5619087e-05,0.99995923,1.5119573e-05
16483,to the tumor,14,17,102,114,"Furthermore, DC.Tbet/IL12 pulsed with tumor antigen-derived peptides and injected as a therapy distal to the tumor site prevented tumor growth and activated robust antigen-specific Tc1 responses.",22215017_5,-1,-1,-1,-1,16483,-1,2.897597e-05,0.9999558,1.5274552e-05
16485,antigen-specific Tc1,24,26,164,184,"Furthermore, DC.Tbet/IL12 pulsed with tumor antigen-derived peptides and injected as a therapy distal to the tumor site prevented tumor growth and activated robust antigen-specific Tc1 responses.",22215017_5,-1,-1,-1,-1,16485,-1,0.9210177,0.04396088,0.035021435
16487,the translation,3,5,19,34,These data support the translation use of combined Tbet and IL-12p70 gene therapy in the cancer setting.,22215017_6,-1,-1,-1,-1,16487,-1,2.6614e-05,0.9999634,1.0019894e-05
16489,IL-12p70 gene therapy,10,13,60,81,These data support the translation use of combined Tbet and IL-12p70 gene therapy in the cancer setting.,22215017_6,-1,-1,-1,-1,16489,-1,0.9686651,0.01691705,0.014417797
16492,plasma cells,17,19,119,131,"BACKGROUND: Multiple myeloma (MM) is an immunoproliferative disease characterised by the uncontrolled proliferation of plasma cells, which is accompanied by defects in the immune system.",22223085_0,-1,-1,-1,-1,16492,-1,8.1411476e-05,0.0002901729,0.9996284
16507,therapy,5,6,31,38,"Subsequently, the influence of therapy on those components of immune system was assessed.",22223085_2,0,1,-1,-1,16507,-1,2.4423356e-05,0.9999653,1.02163785e-05
16516,therapy,41,42,263,270,"We found that patients with higher percentages of Treg live shorter (median overall survival 21 months vs not-reached, P=0.013).CONCLUSION: This study identifies several abnormalities of immune system in MM, which only partly could be normalised after successful therapy.",22223085_5,0,1,-1,-1,16516,-1,2.39955e-05,0.9999652,1.0770885e-05
16528,T-cell growth factor,11,14,49,69,"Initially, interleukin 2 (IL-2) has been used as T-cell growth factor in clinical vaccination trials.",22276195_1,-1,-1,-1,-1,16528,-1,0.02221254,0.001152179,0.97663534
16530,function,18,19,92,100,"In murine models, however, a role of IL-2 in development, differentiation, homeostasis, and function of T(reg) cells was established.",22276195_2,0,1,2,-1,16530,-1,7.4454314e-05,0.9998727,5.2832584e-05
16534,T(reg)-cell,7,8,42,53,"In IL-2 treated cancer patients a further T(reg)-cell expansion was described, yet, the mechanism of expansion is still elusive.",22276195_3,-1,1,2,-1,16534,-1,0.0027693715,0.85786396,0.13936672
16536,that functional T(reg,3,6,15,36,Here we report that functional T(reg) cells of a nave phenotype--as determined by CCR7 and CD45RA expression--are significantly expanded in colorectal cancer patients.,22276195_4,-1,-1,-1,-1,16536,-1,2.0016776e-05,0.99996793,1.2001404e-05
16539,peptide,15,16,83,90,Treatment of 15 UICC stage IV colorectal cancer patients with IL-2 in a phase I/II peptide vaccination trial further enlarges the already increased nave T(reg)-cell pool.,22276195_5,0,-1,2,-1,16539,-1,0.00042671364,0.99934846,0.00022484566
16542,T(reg)-cell,24,25,154,165,Treatment of 15 UICC stage IV colorectal cancer patients with IL-2 in a phase I/II peptide vaccination trial further enlarges the already increased nave T(reg)-cell pool.,22276195_5,-1,1,2,-1,16542,-1,0.0026675982,0.8478625,0.14946991
16546,thymic generation,15,17,101,118,Higher frequencies of T-cell receptor excision circles in nave T(reg) cells indicate IL-2 dependent thymic generation of nave T(reg) cells as a mechanism leading to increased frequencies of T(reg) cells post IL-2 treatment in cancer patients.,22276195_6,-1,-1,-1,-1,16546,-1,3.344141e-05,0.99993896,2.7617398e-05
16547,nave T(reg,18,20,122,133,Higher frequencies of T-cell receptor excision circles in nave T(reg) cells indicate IL-2 dependent thymic generation of nave T(reg) cells as a mechanism leading to increased frequencies of T(reg) cells post IL-2 treatment in cancer patients.,22276195_6,-1,-1,-1,-1,16547,-1,3.1310123e-05,0.99994814,2.0536914e-05
16558,complex regulation,6,8,30,48,These results point to a more complex regulation of T(reg) cells in context of IL-2 administration.,22276195_8,-1,-1,-1,-1,16558,-1,4.6297853e-05,0.99991643,3.7253558e-05
16562,therapy,8,9,56,63,Future strategies therefore might aim at combining IL-2 therapy with novel strategies to circumvent expansion and differentiation of nave T(reg) cells.,22276195_9,0,1,-1,-1,16562,-1,2.4280253e-05,0.9999615,1.4276837e-05
16566,factors,3,4,30,37,BACKGROUND: Immunosuppressive factors such as regulatory T cells (Tregs) limit the efficacy of immunotherapies.,22303460_0,0,1,-1,-1,16566,-1,0.0020526054,0.9965341,0.0014133118
16571,the Tregs-targeting,4,6,18,37,"Herein, we report the Tregs-targeting and immune-promoting effect of a class I specific HDAC inhibitor, entinostat, in combination with either IL-2 in a murine renal cell carcinoma (RENCA) model or a survivin-based vaccine therapy (SurVaxM) in a castration resistant prostate cancer (CR Myc-CaP) model.",22303460_2,-1,-1,-1,-1,16571,-1,2.0704161e-05,0.99996805,1.1198527e-05
16573,therapy,38,39,223,230,"Herein, we report the Tregs-targeting and immune-promoting effect of a class I specific HDAC inhibitor, entinostat, in combination with either IL-2 in a murine renal cell carcinoma (RENCA) model or a survivin-based vaccine therapy (SurVaxM) in a castration resistant prostate cancer (CR Myc-CaP) model.",22303460_2,0,1,-1,-1,16573,-1,2.634867e-05,0.99995744,1.6218044e-05
16575,Myc-CaP tumors,7,9,33,47,"METHODS AND RESULTS: RENCA or CR Myc-CaP tumors were implanted orthotopically or subcutaneously, respectively.",22303460_3,-1,-1,-1,-1,16575,-1,5.5840283e-05,0.9999126,3.1493302e-05
16579,the blood,2,4,9,18,Tregs in the blood were assessed by FACS analysis.,22303460_5,-1,-1,-1,-1,16579,-1,6.442312e-05,0.99983764,9.78892e-05
16580,analysis,8,9,41,49,Tregs in the blood were assessed by FACS analysis.,22303460_5,0,1,-1,-1,16580,-1,4.2850537e-05,0.9999049,5.2265474e-05
16582,analysis,7,8,44,52,Real time quantitative PCR and Western blot analysis of isolated T cell subpopulations from spleen were performed to determine Foxp3 gene and protein expression.,22303460_6,0,1,-1,-1,16582,-1,2.503784e-05,0.99995613,1.8837956e-05
16585,Foxp3 gene,19,21,127,137,Real time quantitative PCR and Western blot analysis of isolated T cell subpopulations from spleen were performed to determine Foxp3 gene and protein expression.,22303460_6,-1,-1,-1,-1,16585,-1,2.1918464e-05,0.9999634,1.4636353e-05
16586,protein,22,23,142,149,Real time quantitative PCR and Western blot analysis of isolated T cell subpopulations from spleen were performed to determine Foxp3 gene and protein expression.,22303460_6,0,1,-1,-1,16586,-1,3.512656e-05,0.99993765,2.7190752e-05
16588,function,2,3,16,24,The suppressive function of Tregs was tested by T cell proliferation assay.,22303460_7,0,1,2,-1,16588,-1,9.112871e-05,0.99980193,0.00010694256
16599,function,9,10,91,99,Entinostat down-regulated Foxp3 expression transcriptionally and blocked Tregs suppressive function without affecting T effector cells (Teffs).,22303460_9,0,1,2,-1,16599,-1,7.729898e-05,0.9998511,7.152123e-05
16606,that STAT3,26,28,172,182,"In vitro low dose entinostat (0.5 M) induced STAT3 acetylation and a specific inhibitor of STAT3 partially rescued entinostat-induced down-regulation of Foxp3, suggesting that STAT3 signaling is involved in Foxp3 down-regulation by entinostat.",22303460_10,-1,-1,-1,-1,16606,-1,2.4148023e-05,0.9999652,1.0705365e-05
16613,The cytokine,0,2,0,12,The cytokine and chemokine micromilieu of papillomas is T(H)2-like with a marked absence of IFN- expression.,22322668_1,-1,-1,-1,-1,16613,-1,0.23968132,0.75604284,0.004275852
16626,function,2,3,17,25,Their suppressor function was measured by inhibition of peripheral blood mononuclear cell (PBMC) proliferation.,22322668_4,0,1,2,-1,16626,-1,0.00010217032,0.9998037,9.417067e-05
16627,blood,9,10,67,72,Their suppressor function was measured by inhibition of peripheral blood mononuclear cell (PBMC) proliferation.,22322668_4,0,1,-1,-1,16627,-1,0.00012062181,0.99966204,0.0002173853
16629,these T cells,11,14,55,68,"Expression of PD-1, CD69, and Helios was identified on these T cells.",22322668_5,-1,-1,-1,-1,16629,-1,0.0024335114,0.101284824,0.8962816
16630,CCL17,4,5,14,19,"PD-L1, PD-L2, CCL17, and CCL22 mRNA was also identified in papillomas by quantitative PCR.RESULTS: Functional Tregs were markedly enriched in papillomas and strongly inhibited anti-CD3 and anti-CD28 antibody activated PBMC proliferation.",22322668_6,0,-1,2,-1,16630,-1,0.9925015,0.00038731654,0.007111057
16632,Functional Tregs,18,20,99,115,"PD-L1, PD-L2, CCL17, and CCL22 mRNA was also identified in papillomas by quantitative PCR.RESULTS: Functional Tregs were markedly enriched in papillomas and strongly inhibited anti-CD3 and anti-CD28 antibody activated PBMC proliferation.",22322668_6,-1,-1,-1,-1,16632,-1,2.8468046e-05,0.99995506,1.652963e-05
16633,The natural Treg,0,3,0,16,"The natural Treg marker Helios was reduced on Tregs from papillomas, indicating that the majority of Tregs in papillomas are adaptive.",22322668_7,-1,-1,-1,-1,16633,-1,2.6542133e-05,0.999964,9.426093e-06
16635,that the,13,15,80,88,"The natural Treg marker Helios was reduced on Tregs from papillomas, indicating that the majority of Tregs in papillomas are adaptive.",22322668_7,-1,-1,-1,-1,16635,-1,2.0787882e-05,0.99997044,8.756311e-06
16642,that they,22,24,178,187,"The majority of the papilloma-derived CD4(+) T cells expressed the CD4(+)CD25(-)CD127(low/-)Foxp3(-)PD1(+)CD69(+) phenotype and failed to suppress PBMC proliferation, suggesting that they are chronically activated and exhausted.",22322668_8,-1,-1,-1,-1,16642,-1,1.9045023e-05,0.9999676,1.33941985e-05
16643,The Treg-attracting chemokine CCL22,0,4,0,35,The Treg-attracting chemokine CCL22 was equally expressed by all laryngeal tissues examined.,22322668_9,-1,-1,-1,-1,16643,-1,0.078906246,0.91721076,0.0038830258
16644,tissues,10,11,75,82,The Treg-attracting chemokine CCL22 was equally expressed by all laryngeal tissues examined.,22322668_9,-1,1,2,-1,16644,-1,0.0014018617,0.49037626,0.50822186
16645,CCL17,2,3,9,14,"However, CCL17 was robustly expressed by papillomas compared with unaffected laryngeal tissues from RRP patients and individuals without RRP.",22322668_10,0,-1,2,-1,16645,-1,0.97049785,0.00053306617,0.028968975
16646,tissues,12,13,87,94,"However, CCL17 was robustly expressed by papillomas compared with unaffected laryngeal tissues from RRP patients and individuals without RRP.",22322668_10,-1,1,2,-1,16646,-1,0.0006518004,0.9509624,0.048385732
16647,tissues,9,10,65,72,PD-L1 was elevated in papillomas compared with control laryngeal tissues.,22322668_11,-1,1,2,-1,16647,-1,0.0010916545,0.7226294,0.2762789
16649,functional Tregs,10,12,56,72,"CONCLUSIONS: Papilloma CD4(+) T cells are enriched with functional Tregs, and the adaptive Helios(-) Treg fraction was increased within the T(H)2-like papilloma micromilieu.",22322668_12,-1,-1,-1,-1,16649,-1,6.8627836e-05,0.9998957,3.564092e-05
16652,the T(H)2-like,23,25,136,150,"CONCLUSIONS: Papilloma CD4(+) T cells are enriched with functional Tregs, and the adaptive Helios(-) Treg fraction was increased within the T(H)2-like papilloma micromilieu.",22322668_12,-1,-1,-1,-1,16652,-1,4.317557e-05,0.9999275,2.9294484e-05
16653,T-cells,2,3,34,41,CD4(+)CD25(-)CD127(low/-)Foxp3(-) T-cells failed to suppress PBMC proliferation and may be exhausted.,22322668_13,-1,1,2,-1,16653,-1,8.419194e-05,0.0003451619,0.99957055
16659,therapy,6,7,33,40,"A major concern in targeted drug therapy is that the inhibition of receptors and signaling molecules in tumor cells may also affect similar components in the tumor microenvironment or in the immune system, with undefined consequences for inhibition of tumor growth.",22323550_0,0,1,-1,-1,16659,-1,2.5921294e-05,0.99995995,1.4154705e-05
16660,that the,8,10,44,52,"A major concern in targeted drug therapy is that the inhibition of receptors and signaling molecules in tumor cells may also affect similar components in the tumor microenvironment or in the immune system, with undefined consequences for inhibition of tumor growth.",22323550_0,-1,-1,-1,-1,16660,-1,2.173836e-05,0.9999703,7.95233e-06
16661,receptors,12,13,67,76,"A major concern in targeted drug therapy is that the inhibition of receptors and signaling molecules in tumor cells may also affect similar components in the tumor microenvironment or in the immune system, with undefined consequences for inhibition of tumor growth.",22323550_0,0,1,2,-1,16661,-1,0.0013971999,0.062285274,0.9363175
16662,tumor cells,17,19,104,115,"A major concern in targeted drug therapy is that the inhibition of receptors and signaling molecules in tumor cells may also affect similar components in the tumor microenvironment or in the immune system, with undefined consequences for inhibition of tumor growth.",22323550_0,-1,-1,-1,-1,16662,-1,0.004032008,0.42505515,0.5709128
16663,the tumor,25,27,154,163,"A major concern in targeted drug therapy is that the inhibition of receptors and signaling molecules in tumor cells may also affect similar components in the tumor microenvironment or in the immune system, with undefined consequences for inhibition of tumor growth.",22323550_0,-1,-1,-1,-1,16663,-1,2.272859e-05,0.99996746,9.795835e-06
16673,relative to tumor-bearing,15,18,121,146,"First, FTS exhibited antitumor activity in intracranial immune-competent tumor-bearing mice and increased their survival relative to tumor-bearing immune-compromised mice.",22323550_3,-1,-1,-1,-1,16673,-1,3.0459778e-05,0.99995387,1.5657906e-05
16677,the tumor,24,26,123,132,"Second, FTS induced an increase in regulatory T cells in mouse splenocytes, in which Foxp3+ T cells did not interfere with the tumor growth inhibitory effects of FTS.",22323550_4,-1,-1,-1,-1,16677,-1,2.3839066e-05,0.99996674,9.411819e-06
16679,T-cell,9,10,54,60,"Third, FTS induced an increase in antitumor cytotoxic T-cell reactivity in glioma cells by downregulating their own expression of Foxp3.",22323550_5,-1,1,2,-1,16679,-1,3.7937003e-05,4.987253e-05,0.99991226
16686,the tumor,10,12,82,91,This downregulation induced a TGF--associated mechanism in glioma cells altering the tumor microenvironment and causing reduced resistance of the tumor to the immune system.,22323550_6,-1,-1,-1,-1,16686,-1,2.0628613e-05,0.99996877,1.0627199e-05
16687,the tumor to the,18,22,143,159,This downregulation induced a TGF--associated mechanism in glioma cells altering the tumor microenvironment and causing reduced resistance of the tumor to the immune system.,22323550_6,-1,-1,-1,-1,16687,-1,2.0717025e-05,0.9999683,1.1031601e-05
16694,protein,7,8,44,51,"Galectin-1 (Gal-1), a -galactoside-binding protein, can alter fate and effector function of Th cells; however, little is known about how Gal-1 induces Th cell differentiation.",22345665_0,0,1,-1,-1,16694,-1,4.4902157e-05,0.9999025,5.255039e-05
16695,function,14,15,81,89,"Galectin-1 (Gal-1), a -galactoside-binding protein, can alter fate and effector function of Th cells; however, little is known about how Gal-1 induces Th cell differentiation.",22345665_0,0,1,2,-1,16695,-1,0.0005365023,0.99866545,0.00079803413
16696,Th cells,16,18,93,101,"Galectin-1 (Gal-1), a -galactoside-binding protein, can alter fate and effector function of Th cells; however, little is known about how Gal-1 induces Th cell differentiation.",22345665_0,-1,-1,-1,-1,16696,-1,3.1299915e-05,4.8101687e-05,0.9999205
16697,Th cell,28,30,152,159,"Galectin-1 (Gal-1), a -galactoside-binding protein, can alter fate and effector function of Th cells; however, little is known about how Gal-1 induces Th cell differentiation.",22345665_0,-1,-1,-1,-1,16697,-1,3.3662873e-05,5.113734e-05,0.99991524
16700,Th cells,11,13,61,69,"In this article, we show that both uncommitted and polarized Th cells bound by Gal-1 expressed an immunoregulatory signature defined by IL-10.",22345665_1,-1,-1,-1,-1,16700,-1,2.9465555e-05,5.0165396e-05,0.99992037
16703,to cell,8,10,58,65,"IL-10 synthesis was stimulated by direct Gal-1 engagement to cell surface glycoproteins, principally CD45, on activated Th cells and enhanced by IL-21 expression through the c-Maf/aryl hydrocarbon receptor pathway, independent of APCs.",22345665_2,-1,-1,-1,-1,16703,-1,0.0046426454,0.36524573,0.63011163
16704,Th cells,18,20,120,128,"IL-10 synthesis was stimulated by direct Gal-1 engagement to cell surface glycoproteins, principally CD45, on activated Th cells and enhanced by IL-21 expression through the c-Maf/aryl hydrocarbon receptor pathway, independent of APCs.",22345665_2,-1,-1,-1,-1,16704,-1,3.257841e-05,4.689904e-05,0.9999206
16705,through the,25,27,162,173,"IL-10 synthesis was stimulated by direct Gal-1 engagement to cell surface glycoproteins, principally CD45, on activated Th cells and enhanced by IL-21 expression through the c-Maf/aryl hydrocarbon receptor pathway, independent of APCs.",22345665_2,-1,-1,-1,-1,16705,-1,2.079538e-05,0.9999658,1.3433512e-05
16706,receptor,29,30,197,205,"IL-10 synthesis was stimulated by direct Gal-1 engagement to cell surface glycoproteins, principally CD45, on activated Th cells and enhanced by IL-21 expression through the c-Maf/aryl hydrocarbon receptor pathway, independent of APCs.",22345665_2,0,1,2,-1,16706,-1,0.0054776426,0.41943416,0.57508826
16713,functions,7,8,44,53,"Collectively, these findings show how Gal-1 functions as a major glycome determinant regulating Th cell development, inflammation, and tumor immunity.",22345665_4,0,1,2,-1,16713,-1,4.285503e-05,0.9999373,1.978929e-05
16714,Th cell,14,16,96,103,"Collectively, these findings show how Gal-1 functions as a major glycome determinant regulating Th cell development, inflammation, and tumor immunity.",22345665_4,-1,-1,-1,-1,16714,-1,3.319626e-05,5.2024316e-05,0.9999149
16715,tumor immunity,21,23,135,149,"Collectively, these findings show how Gal-1 functions as a major glycome determinant regulating Th cell development, inflammation, and tumor immunity.",22345665_4,-1,-1,-1,-1,16715,-1,0.06661776,0.93202674,0.0013554774
16721,immunity,32,33,192,200,"CD4(+)CD25(hi)Foxp3(+) regulatory T cells (T(regs)) are critical mediators of self-tolerance, which is crucial for the prevention of autoimmune disease, but T(regs) can also inhibit antitumor immunity.",22375050_0,0,-1,2,-1,16721,-1,0.9981165,0.0013979092,0.0004855849
16727,these cells to,22,25,109,123,"T(regs) inhibit the proliferation of CD4(+)CD25(-) conventional T cells (T(cons)), as well as the ability of these cells to produce effector cytokines; however, the molecular mechanism of suppression remains unclear.",22375050_1,-1,-1,-1,-1,16727,-1,0.00015679533,0.9991339,0.00070930354
16732,the release,10,12,54,65,"Here, we showed that human T(regs) rapidly suppressed the release of calcium ions (Ca(2+)) from intracellular stores in response to T cell receptor (TCR) activation in T(cons).",22375050_2,-1,-1,-1,-1,16732,-1,2.088847e-05,0.9999682,1.0895116e-05
16733,to T cell receptor,25,29,129,147,"Here, we showed that human T(regs) rapidly suppressed the release of calcium ions (Ca(2+)) from intracellular stores in response to T cell receptor (TCR) activation in T(cons).",22375050_2,-1,-1,-1,-1,16733,-1,0.0031163304,0.22472708,0.77215666
16734,TCR,30,31,149,152,"Here, we showed that human T(regs) rapidly suppressed the release of calcium ions (Ca(2+)) from intracellular stores in response to T cell receptor (TCR) activation in T(cons).",22375050_2,-1,1,2,-1,16734,-1,2.4653176e-05,0.99994993,2.5434081e-05
16738,the transcription factor nuclear factor of activated T cells,18,27,110,170,"The inhibition of Ca(2+) signaling resulted in decreased dephosphorylation, and thus decreased activation, of the transcription factor nuclear factor of activated T cells 1 (NFAT1) and reduced the activation of nuclear factor B (NF-B).",22375050_3,-1,-1,-1,-1,16738,-1,0.0026668364,0.87451667,0.122816525
16742,TCR-proximal,11,12,59,71,"In contrast, Ca(2+)-independent events in T(cons), such as TCR-proximal signaling and activation of the transcription factor activator protein 1 (AP-1), were not affected during coculture with T(regs).",22375050_4,-1,1,2,-1,16742,-1,2.6287698e-05,0.9999505,2.3240955e-05
16743,the transcription factor activator protein 1 (AP-1,16,24,100,150,"In contrast, Ca(2+)-independent events in T(cons), such as TCR-proximal signaling and activation of the transcription factor activator protein 1 (AP-1), were not affected during coculture with T(regs).",22375050_4,-1,-1,-1,-1,16743,-1,2.4609402e-05,0.9999571,1.836089e-05
16746,the generation,15,17,92,106,"Despite suppressing intracellular Ca(2+) mobilization, coculture with T(regs) did not block the generation of inositol 1,4,5-trisphosphate in TCR-stimulated T(cons).",22375050_5,-1,-1,-1,-1,16746,-1,2.1806307e-05,0.99996495,1.3217719e-05
16747,TCR-stimulated T(cons,21,23,142,163,"Despite suppressing intracellular Ca(2+) mobilization, coculture with T(regs) did not block the generation of inositol 1,4,5-trisphosphate in TCR-stimulated T(cons).",22375050_5,-1,-1,-1,-1,16747,-1,3.0491756e-05,0.99995124,1.8277447e-05
16748,The T(reg)-induced,0,2,0,18,The T(reg)-induced suppression of the activity of NFAT and NF-B and of the expression of the gene encoding the cytokine interleukin-2 was reversed in T(cons) by increasing the concentration of intracellular Ca(2+).,22375050_6,-1,-1,-1,-1,16748,-1,2.0549607e-05,0.999969,1.042738e-05
16751,the gene,15,17,90,98,The T(reg)-induced suppression of the activity of NFAT and NF-B and of the expression of the gene encoding the cytokine interleukin-2 was reversed in T(cons) by increasing the concentration of intracellular Ca(2+).,22375050_6,-1,-1,-1,-1,16751,-1,2.3836046e-05,0.9999651,1.1082339e-05
16752,the cytokine interleukin-2,18,21,108,134,The T(reg)-induced suppression of the activity of NFAT and NF-B and of the expression of the gene encoding the cytokine interleukin-2 was reversed in T(cons) by increasing the concentration of intracellular Ca(2+).,22375050_6,-1,-1,-1,-1,16752,-1,0.895394,0.10263405,0.0019718683
16758,function,6,7,39,47,This increased understanding of T(reg) function may be exploited to generate possible therapies for the treatment of autoimmune diseases and cancer.,22375050_8,0,1,2,-1,16758,-1,4.6954396e-05,0.99991286,4.0154333e-05
16759,to generate,10,12,65,76,This increased understanding of T(reg) function may be exploited to generate possible therapies for the treatment of autoimmune diseases and cancer.,22375050_8,-1,-1,-1,-1,16759,-1,2.0641646e-05,0.9999709,8.485909e-06
16761,the treatment,15,17,100,113,This increased understanding of T(reg) function may be exploited to generate possible therapies for the treatment of autoimmune diseases and cancer.,22375050_8,-1,-1,-1,-1,16761,-1,2.421585e-05,0.99996626,9.509798e-06
16763,the IL-1,8,10,36,44,"Interleukin-33 (IL-33), a member of the IL-1 family of cytokines, binds to its plasma membrane receptor, heterodimeric complex consisted of membrane-bound ST2L and IL-1R accessory protein, inducing NFkB and MAPK activation.",22392053_0,-1,-1,-1,-1,16763,-1,0.23842333,0.7204656,0.04111107
16767,receptor,19,20,95,103,"Interleukin-33 (IL-33), a member of the IL-1 family of cytokines, binds to its plasma membrane receptor, heterodimeric complex consisted of membrane-bound ST2L and IL-1R accessory protein, inducing NFkB and MAPK activation.",22392053_0,0,1,2,-1,16767,-1,0.0021004938,0.33891806,0.6589814
16770,protein,30,31,180,187,"Interleukin-33 (IL-33), a member of the IL-1 family of cytokines, binds to its plasma membrane receptor, heterodimeric complex consisted of membrane-bound ST2L and IL-1R accessory protein, inducing NFkB and MAPK activation.",22392053_0,0,1,-1,-1,16770,-1,0.00018685691,0.99953425,0.00027889857
16777,Th2 lymphocytes,8,10,43,58,"ST2L is expressed on several immune cells: Th2 lymphocytes, NK, NKT and mast cells and on cells of myeloid lineage: monocytes, dendritic cells and granulocytes.",22392053_2,-1,-1,-1,-1,16777,-1,0.00011914648,0.0004038862,0.99947697
16782,Th2 immune responses,7,10,40,60,IL-33/ST2 axis can promote both Th1 and Th2 immune responses depending on the type of activated cell and microenvironment and cytokine network in damaged tissue.,22392053_3,-1,-1,-1,-1,16782,-1,0.1518635,0.84548014,0.0026563674
16783,the type,12,14,74,82,IL-33/ST2 axis can promote both Th1 and Th2 immune responses depending on the type of activated cell and microenvironment and cytokine network in damaged tissue.,22392053_3,-1,-1,-1,-1,16783,-1,2.9761157e-05,0.99995184,1.8407078e-05
16786,tissue,24,25,154,160,IL-33/ST2 axis can promote both Th1 and Th2 immune responses depending on the type of activated cell and microenvironment and cytokine network in damaged tissue.,22392053_3,-1,1,2,-1,16786,-1,0.00012844539,0.9995795,0.00029204873
16795,receptor,40,41,263,271,"We found that ST2 deletion enhance the development of T cell-mediated autoimmune disorders, EAE and diabetes mellitus type I. Disease development was accompanied by dominantly Th1/Th17 immune response but also higher IL-33 production, which suggest that IL-33 in receptor independent manner could promote the development of inflammatory autoreactive T cells.",22392053_5,0,1,2,-1,16795,-1,0.0040837238,0.0184921,0.97742414
16803,these cells,14,16,85,96,"Deletion of IL-33/ST2 axis enhances cytotoxicity of NK cells, production of IFN- in these cells and systemic production of IFN-, IL-17 and TNF-, which leads to attenuated tumor growth.",22392053_9,-1,-1,-1,-1,16803,-1,0.00058513315,0.009589861,0.98982495
16806,TNF-,24,25,141,146,"Deletion of IL-33/ST2 axis enhances cytotoxicity of NK cells, production of IFN- in these cells and systemic production of IFN-, IL-17 and TNF-, which leads to attenuated tumor growth.",22392053_9,0,1,-1,-1,16806,-1,0.00039475417,0.99953616,6.906095e-05
16816,therapeutic targets,27,29,175,194,"In conclusion, we observed that IL-33 has attenuated anti-inflammatory effects in T cell-mediated responses and that both IL-33 and ST2 could be further explored as potential therapeutic targets in treatment of immune-mediated diseases.",22392053_11,-1,-1,-1,-1,16816,-1,2.4120047e-05,0.9999647,1.1133299e-05
16822,the related peptide,2,5,11,30,"Therefore, the related peptide epitopes derived from Pokemon is essential for the development of specific immunotherapy of malignant tumors.",22405859_1,-1,-1,-1,-1,16822,-1,0.00027137468,0.9989328,0.00079583965
16830,peptide-binding,24,25,166,181,"In this study, we predicted and identified HLA-A(*)0201-restricted cytotoxic T lymphocyte (CTL) epitopes derived from Pokemon with computer-based epitope prediction, peptide-binding assay and testing of the induced CTLs toward different kinds of carcinoma cells.",22405859_2,0,-1,2,-1,16830,-1,6.6843066e-05,0.99988556,4.7526206e-05
16833,CTLs toward,31,33,215,226,"In this study, we predicted and identified HLA-A(*)0201-restricted cytotoxic T lymphocyte (CTL) epitopes derived from Pokemon with computer-based epitope prediction, peptide-binding assay and testing of the induced CTLs toward different kinds of carcinoma cells.",22405859_2,-1,-1,-1,-1,16833,-1,0.0015008481,0.02073747,0.97776175
16837,peptides,7,8,51,59,"The results demonstrated that effectors induced by peptides of Pokemon containing residues 32-40, 61-69, 87-95, and 319-327 could specifically secrete IFN- and lyse tumor cell lines of Pokemon-positive and HLA-A2-matched.",22405859_3,0,-1,2,-1,16837,-1,3.7388992e-05,0.99993277,2.9803816e-05
16840,tumor cell,34,36,166,176,"The results demonstrated that effectors induced by peptides of Pokemon containing residues 32-40, 61-69, 87-95, and 319-327 could specifically secrete IFN- and lyse tumor cell lines of Pokemon-positive and HLA-A2-matched.",22405859_3,-1,-1,-1,-1,16840,-1,0.0038549015,0.51362795,0.48251712
16843,that Pokemon32,3,5,20,34,"The results suggest that Pokemon32, Pokemon61, Pokemon87, and Pokemon319 peptides are novel HLA-A(*)0201-restricted restricted CTL epitopes, and could be utilized in the cancer immunotherapy against a broad spectrum of tumors.",22405859_4,-1,-1,-1,-1,16843,-1,9.038343e-05,0.9997725,0.00013718072
16846,Pokemon319 peptides,11,13,62,81,"The results suggest that Pokemon32, Pokemon61, Pokemon87, and Pokemon319 peptides are novel HLA-A(*)0201-restricted restricted CTL epitopes, and could be utilized in the cancer immunotherapy against a broad spectrum of tumors.",22405859_4,-1,-1,-1,-1,16846,-1,8.427347e-05,0.99983454,8.117503e-05
16854,natural Tregs,6,8,32,45,"Increment of CD25(high+) FOXP3+ natural Tregs has been reported in patients with hepatocellular carcinoma (HCC); however, the involvement of other type of Tregs remain elusive.",22419479_1,-1,-1,-1,-1,16854,-1,4.2057345e-05,0.99993944,1.84485e-05
16859,FOXP3- Tregs,5,7,28,40,We aimed to clarify whether FOXP3- Tregs are increased and functionally suppressive or not in patients with HCC.,22419479_2,-1,-1,-1,-1,16859,-1,1.9272362e-05,0.9999701,1.0598165e-05
16860,functionally,10,11,59,71,We aimed to clarify whether FOXP3- Tregs are increased and functionally suppressive or not in patients with HCC.,22419479_2,0,1,2,-1,16860,-1,5.5872013e-05,0.9999267,1.7489336e-05
16861,Treg subsets,1,3,9,21,"Distinct Treg subsets were phenotypically identified by the expression of CD4, CD25, CD127 and forkhead/winged helix transcription factor (FOXP3).",22419479_4,-1,-1,-1,-1,16861,-1,0.00019428693,0.0022740648,0.99753165
16865,Their gene,0,2,0,10,"Their gene profiles, frequency and suppressor functions against T cell proliferation were compared among the subjects.",22419479_5,-1,-1,-1,-1,16865,-1,2.7666154e-05,0.99995565,1.6736549e-05
16866,functions,7,8,46,55,"Their gene profiles, frequency and suppressor functions against T cell proliferation were compared among the subjects.",22419479_5,0,1,2,-1,16866,-1,0.00021268215,0.99962866,0.00015864451
16877,two types,2,4,14,23,We determined two types of CD4+ CD127- T cells with comparable regulatory ability; one is CD25(high+) cells expressing FOXP3 (CD25(high+) FOXP3+ Tregs) and the other is CD25- cells without FOXP3- expression (CD25- FOXP3- cells).,22419479_7,-1,-1,-1,-1,16877,-1,3.2183583e-05,0.99992764,4.0155577e-05
16886,FOXP3- cells,40,42,214,226,We determined two types of CD4+ CD127- T cells with comparable regulatory ability; one is CD25(high+) cells expressing FOXP3 (CD25(high+) FOXP3+ Tregs) and the other is CD25- cells without FOXP3- expression (CD25- FOXP3- cells).,22419479_7,-1,-1,-1,-1,16886,-1,0.0028374856,0.89832884,0.0988337
16888,FOXP3- Tregs,7,9,50,62,"The peripheral or intrahepatic frequency of CD25- FOXP3- Tregs in HCC patients is higher than those in other groups, of which significance is more than CD25(high+) FOXP3+ cells.",22419479_8,-1,-1,-1,-1,16888,-1,2.6205944e-05,0.99995804,1.5733489e-05
16889,than those,14,16,89,99,"The peripheral or intrahepatic frequency of CD25- FOXP3- Tregs in HCC patients is higher than those in other groups, of which significance is more than CD25(high+) FOXP3+ cells.",22419479_8,-1,-1,-1,-1,16889,-1,2.2658527e-05,0.99996424,1.30746375e-05
16893,FOXP3- Tregs,4,6,21,33,"Of importance, CD25- FOXP3- Tregs, but not CD25(high+) FOXP3+ cells, dynamically change in patients accompanied by the ablation or the recurrence of HCC.",22419479_9,-1,-1,-1,-1,16893,-1,2.5794072e-05,0.9999589,1.5296639e-05
16898,FOXP3- T cells,1,4,6,20,"CD25- FOXP3- T cells with CD127- IL-10+ phenoype are inducible in vitro from naive CD4(+) T cells, in which programmed cell death 1 ligand 1, immunoglobulin-like transcript 4 and human leukocyte antigen G are involved.. In conclusion, CD25- FOXP3- Tregs with suppressive capacity are increased in patients with HCC, suggesting their distinct roles from CD25+ FOXP3+ Tregs.",22419479_10,-1,-1,-1,-1,16898,-1,0.0036869321,0.76263905,0.23367397
16905,FOXP3- Tregs,44,46,241,253,"CD25- FOXP3- T cells with CD127- IL-10+ phenoype are inducible in vitro from naive CD4(+) T cells, in which programmed cell death 1 ligand 1, immunoglobulin-like transcript 4 and human leukocyte antigen G are involved.. In conclusion, CD25- FOXP3- Tregs with suppressive capacity are increased in patients with HCC, suggesting their distinct roles from CD25+ FOXP3+ Tregs.",22419479_10,-1,-1,-1,-1,16905,-1,2.3853201e-05,0.99996066,1.55053e-05
16909,The cytokine IL-12,0,3,0,18,The cytokine IL-12 induces IFN- production by T and NK cells.,22426209_0,-1,-1,-1,-1,16909,-1,0.8890111,0.10685492,0.004134015
16914,immunity,8,9,51,59,"In preclinical models, it contributes to antitumor immunity.",22426209_1,0,-1,2,-1,16914,-1,0.9958597,0.003498177,0.0006421918
16916,trial testing,5,7,24,37,"Moreover, in a clinical trial testing a combination of IL-12 and rituximab in patients with follicular B cell non-Hodgkin lymphoma (FL), those treated with IL-12 showed a lower response rate, suggesting that IL-12 actually plays a detrimental role.",22426209_3,-1,-1,-1,-1,16916,-1,2.2185986e-05,0.9999641,1.3635306e-05
16919,those treated,25,27,137,150,"Moreover, in a clinical trial testing a combination of IL-12 and rituximab in patients with follicular B cell non-Hodgkin lymphoma (FL), those treated with IL-12 showed a lower response rate, suggesting that IL-12 actually plays a detrimental role.",22426209_3,-1,-1,-1,-1,16919,-1,2.1090418e-05,0.99996614,1.2730928e-05
16921,that IL-12,36,38,203,213,"Moreover, in a clinical trial testing a combination of IL-12 and rituximab in patients with follicular B cell non-Hodgkin lymphoma (FL), those treated with IL-12 showed a lower response rate, suggesting that IL-12 actually plays a detrimental role.",22426209_3,-1,-1,-1,-1,16921,-1,0.6094593,0.37728179,0.013258938
16924,IL-12 treatment,8,10,45,60,"Here, we investigated whether the failure of IL-12 treatment for FL was due to T cell exhaustion, a condition characterized by reduced T cell differentiation, proliferation, and function, which has been observed in chronic viral infection.",22426209_4,-1,-1,-1,-1,16924,-1,0.99233294,0.004312648,0.0033543995
16925,to T cell,14,17,76,85,"Here, we investigated whether the failure of IL-12 treatment for FL was due to T cell exhaustion, a condition characterized by reduced T cell differentiation, proliferation, and function, which has been observed in chronic viral infection.",22426209_4,-1,-1,-1,-1,16925,-1,0.0036156306,0.13553242,0.86085194
16927,function,31,32,178,186,"Here, we investigated whether the failure of IL-12 treatment for FL was due to T cell exhaustion, a condition characterized by reduced T cell differentiation, proliferation, and function, which has been observed in chronic viral infection.",22426209_4,0,1,2,-1,16927,-1,0.00021183501,0.9995353,0.0002528379
16929,to IL-12,5,7,32,40,We found that extended exposure to IL-12 induced T cell exhaustion and contributed to the poor prognosis in FL patients.,22426209_5,-1,-1,-1,-1,16929,-1,0.7552993,0.23980415,0.004896517
16931,to the,13,15,83,89,We found that extended exposure to IL-12 induced T cell exhaustion and contributed to the poor prognosis in FL patients.,22426209_5,-1,-1,-1,-1,16931,-1,2.6171727e-05,0.99996185,1.193298e-05
16932,T cells to IL-12,8,12,50,66,"Long-term exposure of freshly isolated human CD4+ T cells to IL-12 in vitro caused T cell dysfunction and induced expression of TIM-3, a T cell immunoglobulin and mucin domain protein with a known role in T cell exhaustion, via an IFN--independent mechanism.",22426209_6,-1,-1,-1,-1,16932,-1,0.3498502,0.004966395,0.6451834
16942,T cell function,10,13,55,70,TIM-3 was required for the negative effect of IL-12 on T cell function.,22426209_7,-1,-1,-1,-1,16942,-1,3.8426453e-05,6.3833686e-05,0.9998977
16944,T cells that,9,12,61,73,"Importantly, TIM-3 also was highly expressed on intratumoral T cells that displayed marked functional impairment.",22426209_8,-1,-1,-1,-1,16944,-1,0.0013952807,0.03717208,0.9614326
16945,functional,14,15,91,101,"Importantly, TIM-3 also was highly expressed on intratumoral T cells that displayed marked functional impairment.",22426209_8,0,1,2,-1,16945,-1,0.00059853966,0.99878854,0.0006129049
16951,IL-15 plays,0,2,0,11,IL-15 plays many important roles within the immune system.,22447977_0,-1,-1,-1,-1,16951,-1,0.98611546,0.0076416284,0.006242953
16959,to IL-15R,20,22,135,145,"IL-15 signals in lymphocytes via trans presentation, where accessory cells such as macrophages and dendritic cells present IL-15 bound to IL-15R in trans to NK cells and CD8(+) memory T cells expressing IL-15/IL-2R and common  chain ((c)).",22447977_1,-1,-1,-1,-1,16959,-1,0.018218292,0.98047626,0.0013053868
16960,trans to,23,25,149,157,"IL-15 signals in lymphocytes via trans presentation, where accessory cells such as macrophages and dendritic cells present IL-15 bound to IL-15R in trans to NK cells and CD8(+) memory T cells expressing IL-15/IL-2R and common  chain ((c)).",22447977_1,-1,-1,-1,-1,16960,-1,2.5442943e-05,0.9999598,1.4684087e-05
16963,that the,4,6,22,30,"Previously, we showed that the prophylactic delivery of IL-15 to Rag2(-/-)(c)(-/-) mice (mature T, B, and NK cell negative) afforded protection against a lethal HSV-2 challenge and metastasis of B16/F10 melanoma cells.",22447977_2,-1,-1,-1,-1,16963,-1,1.7805793e-05,0.999974,8.226969e-06
16964,IL-15 to,9,11,56,64,"Previously, we showed that the prophylactic delivery of IL-15 to Rag2(-/-)(c)(-/-) mice (mature T, B, and NK cell negative) afforded protection against a lethal HSV-2 challenge and metastasis of B16/F10 melanoma cells.",22447977_2,-1,-1,-1,-1,16964,-1,0.99354964,0.0039035475,0.0025468473
16971,IL-15 to,20,22,117,125,"In this study, we demonstrated that in vivo delivery of an adenoviral construct optimized for the secretion of human IL-15 to Rag2(-/-)(c)(-/-) mice resulted in significant increases in spleen size and cell number, leading us to hypothesize that IL-15 signals differently in myeloid immune cells compared with lymphocytes, for which IL-15/IL-2R and (c) expression are essential.",22447977_3,-1,-1,-1,-1,16971,-1,0.993321,0.0040144953,0.0026645516
16974,that IL-15,40,42,242,252,"In this study, we demonstrated that in vivo delivery of an adenoviral construct optimized for the secretion of human IL-15 to Rag2(-/-)(c)(-/-) mice resulted in significant increases in spleen size and cell number, leading us to hypothesize that IL-15 signals differently in myeloid immune cells compared with lymphocytes, for which IL-15/IL-2R and (c) expression are essential.",22447977_3,-1,-1,-1,-1,16974,-1,0.7477757,0.24515234,0.0070719724
16982,to IL-15,28,30,172,180,"Furthermore, treatment with IL-15 induced RANTES production by Rag2(-/-)(c)(-/-) bone marrow cells, but the presence of (c) did not increase bone marrow cell sensitivity to IL-15.",22447977_4,-1,-1,-1,-1,16982,-1,0.8009589,0.1936405,0.0054006
16983,This IL-15-mediated,0,2,0,19,"This IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) bone marrow cells occurred independently of the IL-15/IL-2R and Jak/STAT pathways and instead required IL-15R signaling as well as activation of JNK and NF-B. Importantly, we also showed that the trans presentation of IL-15 by IL-15R boosts IL-15-mediated IFN- production by NK cells but reduces IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) myeloid bone marrow cells.",22447977_5,-1,-1,-1,-1,16983,-1,0.0058152378,0.993123,0.0010617443
16987,that the trans,36,39,250,264,"This IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) bone marrow cells occurred independently of the IL-15/IL-2R and Jak/STAT pathways and instead required IL-15R signaling as well as activation of JNK and NF-B. Importantly, we also showed that the trans presentation of IL-15 by IL-15R boosts IL-15-mediated IFN- production by NK cells but reduces IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) myeloid bone marrow cells.",22447977_5,-1,-1,-1,-1,16987,-1,2.2564229e-05,0.99996626,1.1133762e-05
16990,IL-15-mediated IFN-,45,47,305,325,"This IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) bone marrow cells occurred independently of the IL-15/IL-2R and Jak/STAT pathways and instead required IL-15R signaling as well as activation of JNK and NF-B. Importantly, we also showed that the trans presentation of IL-15 by IL-15R boosts IL-15-mediated IFN- production by NK cells but reduces IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) myeloid bone marrow cells.",22447977_5,-1,-1,-1,-1,16990,-1,0.9998286,4.3161832e-05,0.0001282085
16994,that IL-15,4,6,22,32,Our data clearly show that IL-15 signaling in NK cells is different from that of myeloid immune cells.,22447977_6,-1,-1,-1,-1,16994,-1,0.702154,0.28973138,0.008114603
17001,targeted immune responses,13,16,87,112,Additional insights into IL-15 biology may lead to novel therapies aimed at bolstering targeted immune responses against cancer and infectious disease.,22447977_7,-1,-1,-1,-1,17001,-1,0.18371087,0.8151495,0.0011396342
17009,receptor,1,2,6,14,"IL-22 receptor (IL-22R) expression is limited to epithelial cells of the digestive organs, respiratory tract and skin.",22471280_1,0,1,2,-1,17009,-1,0.00083063135,0.15453756,0.84463173
17019,blood,12,13,76,81,"Interestingly, there is an increase in Th17 frequency within the peripheral blood and tumour microenvironment of advanced cancer patients.",22471280_3,0,1,-1,-1,17019,-1,0.00031079503,0.9933048,0.0063843536
17023,functions,12,13,78,87,"Subsequently, IL-17 has been shown to display both pro-tumour and anti-tumour functions.",22471280_4,0,1,2,-1,17023,-1,0.00012212315,0.9997782,9.9730496e-05
17025,the IL-17 receptor,6,9,40,58,"Because many tumours lack expression of the IL-17 receptor, the effects of IL-17 on tumour growth are generated by cells that surround the tumour cells.",22471280_5,-1,-1,-1,-1,17025,-1,0.001985178,0.99336654,0.0046483213
17030,cells that,20,22,115,125,"Because many tumours lack expression of the IL-17 receptor, the effects of IL-17 on tumour growth are generated by cells that surround the tumour cells.",22471280_5,-1,-1,-1,-1,17030,-1,0.002514612,0.044826455,0.95265895
17031,the tumour cells,23,26,135,151,"Because many tumours lack expression of the IL-17 receptor, the effects of IL-17 on tumour growth are generated by cells that surround the tumour cells.",22471280_5,-1,-1,-1,-1,17031,-1,0.0044394364,0.7127122,0.28284833
17033,tumour tissues,11,13,55,69,"Like IL-17, high levels of IL-22 have been detected in tumour tissues and the peripheral blood of cancer patients; however, the direct effect of IL-22 on tumour cells has remained largely unknown.",22471280_6,-1,-1,-1,-1,17033,-1,3.2974654e-05,0.99993074,3.622987e-05
17035,blood,16,17,89,94,"Like IL-17, high levels of IL-22 have been detected in tumour tissues and the peripheral blood of cancer patients; however, the direct effect of IL-22 on tumour cells has remained largely unknown.",22471280_6,0,1,-1,-1,17035,-1,0.00019881852,0.99800974,0.0017915114
17037,tumour cells,29,31,154,166,"Like IL-17, high levels of IL-22 have been detected in tumour tissues and the peripheral blood of cancer patients; however, the direct effect of IL-22 on tumour cells has remained largely unknown.",22471280_6,-1,-1,-1,-1,17037,-1,0.0035989312,0.39281797,0.6035831
17042,factor,21,22,125,131,"In this report, we show that IL-22 stimulated production of vascular endothelial growth factor (VEGF) and the anti-apoptotic factor Bcl-X(L) in IL-22R-positive HPAFII human pancreatic cancer cells.",22471280_7,0,1,-1,-1,17042,-1,0.104011804,0.89208645,0.0039017922
17050,through the,16,18,105,116,We show further that IL-22 activation of HPAFII cells diminished T cell production of interferon (IFN)- through the action of IL-10.,22471280_9,-1,-1,-1,-1,17050,-1,2.1455291e-05,0.9999658,1.2760181e-05
17053,time that,7,9,34,43,"Strikingly, we show for the first time that IL-22 can fully protect cancer cells from natural killer (NK) cell-mediated cytotoxicity by stimulating tumour production of IL-10 and transforming growth factor (TGF)-1.",22471280_10,-1,-1,-1,-1,17053,-1,2.1630625e-05,0.999967,1.1423078e-05
17059,transforming growth factor,30,33,179,205,"Strikingly, we show for the first time that IL-22 can fully protect cancer cells from natural killer (NK) cell-mediated cytotoxicity by stimulating tumour production of IL-10 and transforming growth factor (TGF)-1.",22471280_10,-1,-1,-1,-1,17059,-1,0.91070354,0.0853022,0.003994141
17064,than function,16,18,91,104,Our data support the idea that IL-22 may act to promote the pathogenesis of cancers rather than function in anti-tumour immunity.,22471280_11,-1,-1,-1,-1,17064,-1,3.938651e-05,0.9999416,1.9020457e-05
17065,immunity,20,21,120,128,Our data support the idea that IL-22 may act to promote the pathogenesis of cancers rather than function in anti-tumour immunity.,22471280_11,0,-1,2,-1,17065,-1,0.9995245,0.00029491002,0.0001806213
17070,the tumor,26,28,154,163,"The development of multiple myeloma (MM) involves a series of genetic alterations and changes in the bone marrow microenvironment, favoring the growth of the tumor and failure of local immune control.",22489248_0,-1,-1,-1,-1,17070,-1,2.1995966e-05,0.9999654,1.2557018e-05
17071,functional,2,3,17,27,Quantitative and functional alterations in CD4(+) and CD8(+) T cells have been described in MM.,22489248_1,0,1,2,-1,17071,-1,0.00010807354,0.99979156,0.000100359444
17080,immunity,24,25,138,146,The balance between T regulatory cells (Treg) and T helper (Th) 17 cells represents one essential prerequisite for maintaining anti-tumor immunity in MM.,22489248_2,0,-1,2,-1,17080,-1,0.999385,0.00038309497,0.00023182586
17081,Tregs play,0,2,0,10,Tregs play an important role in the preservation of self-tolerance and modulation of overall immune responses against infections and tumor cells.,22489248_3,-1,-1,-1,-1,17081,-1,1.8291406e-05,0.9999708,1.0948014e-05
17084,tumor cells,19,21,133,144,Tregs play an important role in the preservation of self-tolerance and modulation of overall immune responses against infections and tumor cells.,22489248_3,-1,-1,-1,-1,17084,-1,0.00453508,0.526071,0.46939394
17088,targeting them,13,15,83,97,"In MM patients, Tregs seem to contribute to myeloma-related immune dysfunction and targeting them could, therefore, help to restore and enhance vital immune responses.",22489248_4,-1,-1,-1,-1,17088,-1,2.0264686e-05,0.9999689,1.0802e-05
17092,Th17 cells,0,2,0,10,Th17 cells protect against fungal and parasitic infections and participate in inflammatory reactions and autoimmunity.,22489248_5,-1,-1,-1,-1,17092,-1,0.0003480656,0.0029549694,0.99669707
17098,Th17 cells,23,25,123,133,"The interplay of TGF- and IL-6, expressed at high levels in the bone marrow of myeloma patients, may affect generation of Th17 cells both directly or via other pro-inflammatory cytokines and thereby modulate antitumor immune responses.",22489248_6,-1,-1,-1,-1,17098,-1,0.00085021404,0.020030098,0.9791197
17102,analysis,2,3,11,19,A detailed analysis of the balance between Tregs and Th17 cells seems necessary in order to design more effective and less toxic modes of immunotherapy myeloma which still is an uncurable malignancy.,22489248_7,0,1,-1,-1,17102,-1,3.404783e-05,0.9999449,2.105097e-05
17105,Th17 cells,9,11,53,63,A detailed analysis of the balance between Tregs and Th17 cells seems necessary in order to design more effective and less toxic modes of immunotherapy myeloma which still is an uncurable malignancy.,22489248_7,-1,-1,-1,-1,17105,-1,0.0011031956,0.026640508,0.9722563
17115,tumor cells,14,16,95,106,Our previous studies indicate that hMSH2 is ectopically expressed on the surface of epithelial tumor cells and recognized by both T cell receptor  (TCR) and natural killer group 2 member D (NKG2D) on V2 T cells.,22493490_1,-1,-1,-1,-1,17115,-1,0.0027482586,0.2301617,0.76709
17124,protein,7,8,51,58,"Under oxidative stress, both p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) pathways have been confirmed to mediate the ectopic expression of hMSH2 through the apoptosis-signaling kinase 1 (ASK1) upstream and activating transcription factor 3 (ATF3) downstream of both pathways.",22493490_4,0,1,-1,-1,17124,-1,5.0178296e-05,0.99989045,5.9389353e-05
17127,through the,30,32,179,190,"Under oxidative stress, both p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) pathways have been confirmed to mediate the ectopic expression of hMSH2 through the apoptosis-signaling kinase 1 (ASK1) upstream and activating transcription factor 3 (ATF3) downstream of both pathways.",22493490_4,-1,-1,-1,-1,17127,-1,1.8450064e-05,0.9999708,1.0787392e-05
17129,cell-derived interleukin,4,6,26,50,"Moreover, renal carcinoma cell-derived interleukin (IL)-18 in oxidative stress was a prominent stimulator for ectopically induced expression of hMSH2, which was promoted by interferon (IFN)- as well.",22493490_5,-1,-1,-1,-1,17129,-1,0.037070934,0.0019696152,0.96095943
17135,tumor cells,12,14,74,85,Our results not only establish a mechanism of ectopic hMSH2 expression in tumor cells but also find a biological linkage between ectopic expression of hMSH2 and activation of  T cells in stressful conditions.,22493490_7,-1,-1,-1,-1,17135,-1,0.004276662,0.51026744,0.4854559
17137,T cells play,2,5,11,23,"Because  T cells play an important role in the early stage of innate anti-tumor response,  T cell activation triggered by ectopically expressed hMSH2 may be an important event in immunosurveillance for carcinogenesis.",22493490_8,-1,-1,-1,-1,17137,-1,0.0014236436,0.03650508,0.96207136
17139,T cell activation triggered,18,22,95,122,"Because  T cells play an important role in the early stage of innate anti-tumor response,  T cell activation triggered by ectopically expressed hMSH2 may be an important event in immunosurveillance for carcinogenesis.",22493490_8,-1,-1,-1,-1,17139,-1,0.001437532,0.022435205,0.9761272
17142,the TNFR,9,11,54,62,"The provision of T cell co-stimulation via members of the TNFR super-family, including OX40 (CD134) and 4-1BB (CD137), provides critical signals that promote T cell survival and differentiation.",22496812_0,-1,-1,-1,-1,17142,-1,2.4561861e-05,0.9999641,1.1327116e-05
17147,immunity,13,14,94,102,"Recent studies have demonstrated that ligation of OX40 can augment T cell-mediated anti-tumor immunity in pre-clinical models and more importantly, OX40 agonists are under clinical development for cancer immunotherapy.",22496812_1,0,-1,2,-1,17147,-1,0.99944144,0.00031526698,0.00024331597
17148,agonists,22,23,153,161,"Recent studies have demonstrated that ligation of OX40 can augment T cell-mediated anti-tumor immunity in pre-clinical models and more importantly, OX40 agonists are under clinical development for cancer immunotherapy.",22496812_1,0,1,-1,-1,17148,-1,0.5322372,0.21419306,0.25356975
17149,therapeutic target,7,9,36,54,"OX40 is of particular interest as a therapeutic target as it is not expressed on nave T cells but rather, is transiently up-regulated following TCR stimulation.",22496812_2,-1,-1,-1,-1,17149,-1,2.2420634e-05,0.999967,1.063228e-05
17152,TCR,25,26,145,148,"OX40 is of particular interest as a therapeutic target as it is not expressed on nave T cells but rather, is transiently up-regulated following TCR stimulation.",22496812_2,-1,1,2,-1,17152,-1,2.3531073e-05,0.9999615,1.4947834e-05
17153,TCR,1,2,9,12,"Although TCR engagement is necessary for inducing OX40 expression, the downstream signals that regulate OX40 itself remain unclear.",22496812_3,-1,1,2,-1,17153,-1,3.5925656e-05,0.9999356,2.8428643e-05
17159,TCR,13,14,74,77,"In this study, we demonstrate that OX40 expression is regulated through a TCR and common gamma chain cytokine-dependent signaling cascade that requires JAK3-mediated activation of the downstream transcription factors STAT3 and STAT5.",22496812_4,-1,1,2,-1,17159,-1,2.8052704e-05,0.9999378,3.417869e-05
17163,transcription factors STAT3,28,31,195,222,"In this study, we demonstrate that OX40 expression is regulated through a TCR and common gamma chain cytokine-dependent signaling cascade that requires JAK3-mediated activation of the downstream transcription factors STAT3 and STAT5.",22496812_4,-1,-1,-1,-1,17163,-1,1.9350868e-05,0.99996316,1.754236e-05
17167,tumor types,16,18,118,129,"Furthermore, combined treatment with an agonist anti-OX40 mAb and IL-2 augmented tumor immunotherapy against multiple tumor types.",22496812_5,-1,-1,-1,-1,17167,-1,2.9005823e-05,0.9999498,2.116208e-05
17168,therapy,1,2,5,12,"Dual therapy was also able to restore the function of anergic tumor-reactive CD8 T cells in mice with long-term well-established (>5 wks) tumors, leading to increased survival of the tumor-bearing hosts.",22496812_6,0,1,-1,-1,17168,-1,2.0952426e-05,0.9999677,1.1371273e-05
17170,the function,7,9,38,50,"Dual therapy was also able to restore the function of anergic tumor-reactive CD8 T cells in mice with long-term well-established (>5 wks) tumors, leading to increased survival of the tumor-bearing hosts.",22496812_6,-1,-1,-1,-1,17170,-1,3.222012e-05,0.99995124,1.6590717e-05
17175,the tumor-bearing,32,34,179,196,"Dual therapy was also able to restore the function of anergic tumor-reactive CD8 T cells in mice with long-term well-established (>5 wks) tumors, leading to increased survival of the tumor-bearing hosts.",22496812_6,-1,-1,-1,-1,17175,-1,2.308117e-05,0.99996674,1.01593805e-05
17179,cytokine signaling to,11,14,66,87,"Together, these data reveal the ability of TCR/common gamma chain cytokine signaling to regulate OX40 expression and demonstrate a novel means of augmenting cancer immunotherapy by providing dual anti-OX40/common gamma chain cytokine-directed therapy.",22496812_7,-1,-1,-1,-1,17179,-1,0.87178844,0.12241468,0.005796904
17180,cytokine-directed therapy,32,34,225,250,"Together, these data reveal the ability of TCR/common gamma chain cytokine signaling to regulate OX40 expression and demonstrate a novel means of augmenting cancer immunotherapy by providing dual anti-OX40/common gamma chain cytokine-directed therapy.",22496812_7,-1,-1,-1,-1,17180,-1,0.9581813,0.035846908,0.0059716976
17182,T-cell immunity,15,17,102,117,Human CD34(+) progenitor-derived Langerhans-type dendritic cells (LCs) are more potent stimulators of T-cell immunity against tumor and viral antigens in vitro than are monocyte-derived DCs (moDCs).,22510877_0,-1,-1,-1,-1,17182,-1,0.011261593,0.0008067393,0.98793167
17189,protein,9,10,56,63,"LCs synthesize the highest amounts of IL-15R- mRNA and protein, which binds IL-15 for presentation to responder lymphocytes, thereby signaling the phosphorylation of signal transducer and activator of transcription 5 (pSTAT5).",22510877_2,0,1,-1,-1,17189,-1,5.2810865e-05,0.99988973,5.741982e-05
17198,antigenic peptides,15,17,96,114,"LCs electroporated with Wilms tumor 1 (WT1) mRNA achieve sufficiently sustained presentation of antigenic peptides, which together with IL-15R-/IL-15, break tolerance against WT1 by stimulating robust autologous, WT1-specific cytolytic T-lymphocytes (CTLs).",22510877_3,-1,-1,-1,-1,17198,-1,0.97686565,0.0070741843,0.016060114
17203,T-lymphocytes,34,35,237,250,"LCs electroporated with Wilms tumor 1 (WT1) mRNA achieve sufficiently sustained presentation of antigenic peptides, which together with IL-15R-/IL-15, break tolerance against WT1 by stimulating robust autologous, WT1-specific cytolytic T-lymphocytes (CTLs).",22510877_3,-1,1,2,-1,17203,-1,3.3349348e-05,6.255485e-05,0.99990404
17205,These CTLs,0,2,0,10,"These CTLs develop from healthy persons after only 7 days' stimulation without exogenous cytokines and lyse MHC-restricted tumor targets, which include primary WT1(+) leukemic blasts.",22510877_4,-1,-1,-1,-1,17205,-1,0.0030266359,0.15493399,0.8420394
17207,tumor targets,18,20,123,136,"These CTLs develop from healthy persons after only 7 days' stimulation without exogenous cytokines and lyse MHC-restricted tumor targets, which include primary WT1(+) leukemic blasts.",22510877_4,-1,-1,-1,-1,17207,-1,2.4078967e-05,0.99996245,1.3431212e-05
17214,T-cell activation than,10,13,70,92,"LCs therefore provide a more potent costimulatory cytokine milieu for T-cell activation than do moDCs, thus accounting for their superior stimulation of MHC-restricted Ag-specific CTLs without need for exogenous cytokines.",22510877_6,-1,-1,-1,-1,17214,-1,0.0010013104,0.014868589,0.98413014
17226,the therapeutic,2,4,15,30,"To investigate the therapeutic efficacy of lipoteichoic acid of Bifidobacterium (BLTA) in combination with 5-fluorouracil (5-FU) treatment on the mice bearing inoculated hepatoma-22 (H(22)) cells and the effects of BLTA on immunological regulation of organism, and explore its mechanisms.",22522606_0,-1,-1,-1,-1,17226,-1,1.8355217e-05,0.99997234,9.261289e-06
17234,The tumor,0,2,0,9,The tumor size were observed and measured regularly.,22522606_2,-1,-1,-1,-1,17234,-1,2.3453273e-05,0.99996376,1.2765595e-05
17249,proteins,5,6,30,38,Expression change of mRNA and proteins of Foxp3 and TIM-3 were detected by Real-Time-PCR and Western blot in tumor-bearing mice tumor tissue.,22522606_7,0,1,-1,-1,17249,-1,3.8156104e-05,0.99992704,3.4762543e-05
17253,tumor tissue,20,22,128,140,Expression change of mRNA and proteins of Foxp3 and TIM-3 were detected by Real-Time-PCR and Western blot in tumor-bearing mice tumor tissue.,22522606_7,-1,-1,-1,-1,17253,-1,2.534025e-05,0.99994946,2.5172394e-05
17264,proteins,19,20,121,129,"Spleen cells of tumor-bearing mice had high CD4(+)CD25(+)regulatory T cell (CD4(+)CD25(+)T(reg)) ratio and high mRNA and proteins expression of Foxp3 and TIM-3, but in the BLTA and 5-FU group, CD4(+)CD25(+)T(reg) ratio degraded, with down regulation mRNA and proteins expression of Foxp3 and TIM-3.",22522606_10,0,1,-1,-1,17264,-1,6.930794e-05,0.9998827,4.7993926e-05
17269,proteins,44,45,259,267,"Spleen cells of tumor-bearing mice had high CD4(+)CD25(+)regulatory T cell (CD4(+)CD25(+)T(reg)) ratio and high mRNA and proteins expression of Foxp3 and TIM-3, but in the BLTA and 5-FU group, CD4(+)CD25(+)T(reg) ratio degraded, with down regulation mRNA and proteins expression of Foxp3 and TIM-3.",22522606_10,0,1,-1,-1,17269,-1,7.739963e-05,0.9998629,5.9663158e-05
17299,immunity,8,9,48,56,"As CD4(+) T lymphocytes coordinate and regulate immunity, a better understanding of interactions between SCLC tumour cells and CD4(+) T cells may lead to effective molecular immunotherapy.",22532287_4,0,-1,2,-1,17299,-1,0.9757996,0.02340668,0.00079368986
17300,SCLC tumour cells,16,19,105,122,"As CD4(+) T lymphocytes coordinate and regulate immunity, a better understanding of interactions between SCLC tumour cells and CD4(+) T cells may lead to effective molecular immunotherapy.",22532287_4,-1,-1,-1,-1,17300,-1,0.0050223917,0.8427279,0.15224965
17304,SCLC tumour cell,9,12,32,48,"We show that some, but not all, SCLC tumour cell lines secrete molecules that induce IL-10 secretion by and de novo differentiation of functional CD4(+)CD25(+)FOXP3(+)CD127(lo)Helios(-) regulatory T (Treg) cells in healthy blood lymphocytes.",22532287_5,-1,-1,-1,-1,17304,-1,0.005842853,0.5499697,0.4441875
17307,functional,25,26,135,145,"We show that some, but not all, SCLC tumour cell lines secrete molecules that induce IL-10 secretion by and de novo differentiation of functional CD4(+)CD25(+)FOXP3(+)CD127(lo)Helios(-) regulatory T (Treg) cells in healthy blood lymphocytes.",22532287_5,0,1,2,-1,17307,-1,3.9161154e-05,0.99993503,2.5838708e-05
17311,blood lymphocytes,36,38,223,240,"We show that some, but not all, SCLC tumour cell lines secrete molecules that induce IL-10 secretion by and de novo differentiation of functional CD4(+)CD25(+)FOXP3(+)CD127(lo)Helios(-) regulatory T (Treg) cells in healthy blood lymphocytes.",22532287_5,-1,-1,-1,-1,17311,-1,0.0014096304,0.009014045,0.98957634
17314,SCLC tumour,7,9,31,42,"FOXP3(+) T cells were found in SCLC tumour biopsies, and patients with higher ratios of FOXP3(+) cells in tumour infiltrates have a worse survival rate.",22532287_6,-1,-1,-1,-1,17314,-1,4.8342277e-05,0.9999125,3.920698e-05
17319,SCLC tumour cells,4,7,25,42,"The inhibitory effect of SCLC tumour cells was not affected by blocking IL-10 receptor or TGF- signalling but was partially reversed by blocking IL-15, which is reported to be involved in human Treg cells induction.",22532287_7,-1,-1,-1,-1,17319,-1,0.0046063894,0.74241054,0.2529831
17320,IL-10 receptor,12,14,72,86,"The inhibitory effect of SCLC tumour cells was not affected by blocking IL-10 receptor or TGF- signalling but was partially reversed by blocking IL-15, which is reported to be involved in human Treg cells induction.",22532287_7,-1,-1,-1,-1,17320,-1,0.93890464,0.0025245815,0.058570694
17326,SCLC cells that,4,7,22,37,IL-15 was secreted by SCLC cells that inhibited CD4(+) T-cell proliferation and was present in SCLC biopsy tumour cells.,22532287_8,-1,-1,-1,-1,17326,-1,0.00027396038,0.99939084,0.00033516175
17329,tumour cells,18,20,107,119,IL-15 was secreted by SCLC cells that inhibited CD4(+) T-cell proliferation and was present in SCLC biopsy tumour cells.,22532287_8,-1,-1,-1,-1,17329,-1,0.0029867047,0.13286392,0.86414933
17331,that SCLC tumour cells,4,8,33,55,These novel findings demonstrate that SCLC tumour cells can induce CD4(+) T-cell-mediated immunosuppression.,22532287_9,-1,-1,-1,-1,17331,-1,0.0030054792,0.9292928,0.06770172
17332,T-cell-mediated,12,13,74,89,These novel findings demonstrate that SCLC tumour cells can induce CD4(+) T-cell-mediated immunosuppression.,22532287_9,-1,1,2,-1,17332,-1,3.414588e-05,5.5942255e-05,0.99991
17334,SCLC tumour cells,7,10,42,59,This gives a potential mechanism by which SCLC tumour cells may downregulate local and systemic immune responses and contribute to poor patient survival.,22532287_10,-1,-1,-1,-1,17334,-1,0.0048623877,0.78237444,0.2127631
17337,that IL-15,3,5,17,27,Our data suggest that IL-15 and Treg cells are potential new therapeutic targets to improve immune response and patient survival in SCLC.,22532287_11,-1,-1,-1,-1,17337,-1,0.71231526,0.27744177,0.010242877
17339,therapeutic targets to,11,14,61,83,Our data suggest that IL-15 and Treg cells are potential new therapeutic targets to improve immune response and patient survival in SCLC.,22532287_11,-1,-1,-1,-1,17339,-1,2.124162e-05,0.9999696,9.183059e-06
17353,the factors that,7,10,34,50,"In the present study, we explored the factors that influence CD4(+) Treg reconstitution in patients receiving adoptive immunotherapy following conditioning regimens designed to enhance T-cell function and evaluated potential associations between CD4(+) Treg levels and clinical responses to therapy.",22555974_1,-1,-1,-1,-1,17353,-1,1.9690477e-05,0.9999707,9.667118e-06
17356,T-cell function,26,28,185,200,"In the present study, we explored the factors that influence CD4(+) Treg reconstitution in patients receiving adoptive immunotherapy following conditioning regimens designed to enhance T-cell function and evaluated potential associations between CD4(+) Treg levels and clinical responses to therapy.",22555974_1,-1,-1,-1,-1,17356,-1,3.1811316e-05,4.8583082e-05,0.99991953
17358,to therapy,40,42,288,298,"In the present study, we explored the factors that influence CD4(+) Treg reconstitution in patients receiving adoptive immunotherapy following conditioning regimens designed to enhance T-cell function and evaluated potential associations between CD4(+) Treg levels and clinical responses to therapy.",22555974_1,-1,-1,-1,-1,17358,-1,2.8422051e-05,0.9999584,1.3181919e-05
17359,The analysis,0,2,0,12,The analysis of 4 trials employing nonmyeloablative chemotherapy with or without total body irradiation (TBI) before adoptive T-cell transfer revealed that the percentage and number of reconstituting CD4(+)FoxP3(+) Tregs observed in the peripheral blood was higher in nonresponders than in responders.,22555974_2,-1,-1,-1,-1,17359,-1,2.0528387e-05,0.99996674,1.269902e-05
17364,T-cell transfer,19,21,126,141,The analysis of 4 trials employing nonmyeloablative chemotherapy with or without total body irradiation (TBI) before adoptive T-cell transfer revealed that the percentage and number of reconstituting CD4(+)FoxP3(+) Tregs observed in the peripheral blood was higher in nonresponders than in responders.,22555974_2,-1,-1,-1,-1,17364,-1,0.00063146284,0.009877505,0.98949105
17365,that the,22,24,151,159,The analysis of 4 trials employing nonmyeloablative chemotherapy with or without total body irradiation (TBI) before adoptive T-cell transfer revealed that the percentage and number of reconstituting CD4(+)FoxP3(+) Tregs observed in the peripheral blood was higher in nonresponders than in responders.,22555974_2,-1,-1,-1,-1,17365,-1,1.6599333e-05,0.9999746,8.738263e-06
17368,blood,36,37,248,253,The analysis of 4 trials employing nonmyeloablative chemotherapy with or without total body irradiation (TBI) before adoptive T-cell transfer revealed that the percentage and number of reconstituting CD4(+)FoxP3(+) Tregs observed in the peripheral blood was higher in nonresponders than in responders.,22555974_2,0,1,-1,-1,17368,-1,0.00013331174,0.9974292,0.0024374893
17374,the TBI,22,24,114,121,"The addition of TBI resulted in a further depletion of CD4(+) Tregs, and the degree of depletion was dependent on the TBI dose.",22555974_3,-1,-1,-1,-1,17374,-1,2.5433968e-05,0.9999608,1.37486395e-05
17381,therapy,16,17,105,112,"These observations provide strong evidence that endogenous CD4(+) Tregs have a negative impact on cancer therapy, and suggest that strategies reducing Treg levels may provide clinical benefit to cancer patients.",22555974_5,0,1,-1,-1,17381,-1,2.4899027e-05,0.99996424,1.0821015e-05
17395,that the,4,6,16,24,"Here, we showed that the expression of perforin, CD95L, and promyelocytic leukemia zinc finger, a transcription factor required for maintenance of iNKT cell functions, was reduced or suppressed in CML patients at diagnosis, as compared with healthy individuals.",22585600_2,-1,-1,-1,-1,17395,-1,1.69184e-05,0.9999746,8.4971e-06
17398,cell functions,26,28,152,166,"Here, we showed that the expression of perforin, CD95L, and promyelocytic leukemia zinc finger, a transcription factor required for maintenance of iNKT cell functions, was reduced or suppressed in CML patients at diagnosis, as compared with healthy individuals.",22585600_2,-1,-1,-1,-1,17398,-1,0.000136294,0.00022549568,0.9996382
17400,blood,4,5,26,31,The proliferation rate of blood iNKT cells in response to their cognate ligand was likewise diminished.,22585600_3,0,1,-1,-1,17400,-1,5.4596294e-05,0.99983835,0.000107027256
17402,to their,9,11,55,63,The proliferation rate of blood iNKT cells in response to their cognate ligand was likewise diminished.,22585600_3,-1,-1,-1,-1,17402,-1,2.7394302e-05,0.999962,1.06112475e-05
17403,These functional,0,2,0,16,These functional deficiencies were corrected in patients having achieved complete cytogenetic remission following TK inhibitor or IFN- therapy.,22585600_4,-1,-1,-1,-1,17403,-1,3.3320925e-05,0.9999497,1.6959331e-05
17405,IFN- therapy,16,18,130,143,These functional deficiencies were corrected in patients having achieved complete cytogenetic remission following TK inhibitor or IFN- therapy.,22585600_4,-1,-1,-1,-1,17405,-1,0.99512935,0.0030936992,0.0017769552
17409,that their,4,6,18,28,"Instead, we found that their anergic status originated from both intrinsic and APC-dependent dysfunctions.",22585600_6,-1,-1,-1,-1,17409,-1,1.8565683e-05,0.9999732,8.304568e-06
17412,functional,10,11,63,73,Our data demonstrate that chronic phase CML is associated with functional deficiencies of iNKT cells that are restored upon remission.,22585600_7,0,1,2,-1,17412,-1,6.930365e-05,0.9998865,4.413538e-05
17413,cells that,14,16,95,105,Our data demonstrate that chronic phase CML is associated with functional deficiencies of iNKT cells that are restored upon remission.,22585600_7,-1,-1,-1,-1,17413,-1,0.0031462028,0.12196859,0.87488514
17419,receptor,5,6,31,39,Surface expression of the IL-2 receptor -chain (CD25) has been used to discriminate between CD4(+) CD25(HI) FOXP3(+) regulatory T (Treg) cells and CD4(+) CD25(NEG) FOXP3(-) non-Treg cells.,22585674_0,0,1,2,-1,17419,-1,0.00047263328,0.0031566229,0.9963708
17428,that the,5,7,28,36,"However, this study reports that the majority of resting human memory CD4(+) FOXP3(-) T cells expresses intermediate levels of CD25 and that CD25 expression can be used to delineate a functionally distinct memory subpopulation.",22585674_1,-1,-1,-1,-1,17428,-1,1.5652702e-05,0.9999733,1.0996868e-05
17433,functionally,33,34,184,196,"However, this study reports that the majority of resting human memory CD4(+) FOXP3(-) T cells expresses intermediate levels of CD25 and that CD25 expression can be used to delineate a functionally distinct memory subpopulation.",22585674_1,0,1,2,-1,17433,-1,4.9734914e-05,0.9999261,2.4177589e-05
17435,T-cell,4,5,21,27,The CD25(NEG) memory T-cell population contains the vast majority of late differentiated cells that respond to antigens associated with chronic immune responses and are increased in patients with systemic lupus erythematosus (SLE).,22585674_2,-1,1,2,-1,17435,-1,2.9453677e-05,4.713004e-05,0.99992347
17437,cells that,13,15,89,99,The CD25(NEG) memory T-cell population contains the vast majority of late differentiated cells that respond to antigens associated with chronic immune responses and are increased in patients with systemic lupus erythematosus (SLE).,22585674_2,-1,-1,-1,-1,17437,-1,0.0024002113,0.07104152,0.9265583
17438,to antigens,16,18,108,119,The CD25(NEG) memory T-cell population contains the vast majority of late differentiated cells that respond to antigens associated with chronic immune responses and are increased in patients with systemic lupus erythematosus (SLE).,22585674_2,-1,-1,-1,-1,17438,-1,0.46690318,0.52689433,0.0062024263
17442,to antigens,10,12,50,61,"In contrast, the CD25(INT) memory T cells respond to antigens associated with recall responses, produce a greater array of cytokines, and are less dependent on costimulation for effector responses due to their expression of CD25.",22585674_3,-1,-1,-1,-1,17442,-1,0.31168327,0.6801126,0.008204185
17444,to their,34,36,201,209,"In contrast, the CD25(INT) memory T cells respond to antigens associated with recall responses, produce a greater array of cytokines, and are less dependent on costimulation for effector responses due to their expression of CD25.",22585674_3,-1,-1,-1,-1,17444,-1,2.5156009e-05,0.99996305,1.1801498e-05
17445,to the,3,5,17,23,"Lastly, compared to the CD25(NEG) and Treg-cell populations, the CD25(INT) memory population is lost to a greater degree from the blood of cancer patients treated with IL-2.",22585674_4,-1,-1,-1,-1,17445,-1,1.9570534e-05,0.99996996,1.0442556e-05
17446,Treg-cell,8,9,38,47,"Lastly, compared to the CD25(NEG) and Treg-cell populations, the CD25(INT) memory population is lost to a greater degree from the blood of cancer patients treated with IL-2.",22585674_4,-1,1,2,-1,17446,-1,0.0032890174,0.49217296,0.50453806
17449,the blood,23,25,126,135,"Lastly, compared to the CD25(NEG) and Treg-cell populations, the CD25(INT) memory population is lost to a greater degree from the blood of cancer patients treated with IL-2.",22585674_4,-1,-1,-1,-1,17449,-1,4.14446e-05,0.9998925,6.606736e-05
17457,functionally,33,34,170,182,"Collectively, these results show that in humans, a large proportion of CD4(+) memory T cells express intermediate levels of CD25, and this CD25(INT) FOXP3(-) subset is a functionally distinct memory population that is uniquely affected by IL-2.",22585674_5,0,1,2,-1,17457,-1,4.4715474e-05,0.9999362,1.906945e-05
17467,T(eff)-attracting chemokines,12,14,76,104,Colorectal tumors with reduced accumulation of T(eff) express low levels of T(eff)-attracting chemokines such as CXCL10/IP10 and CCL5/RANTES.,22593190_1,-1,-1,-1,-1,17467,-1,0.01963201,0.9778642,0.0025037488
17471,T(eff)-attracting chemokines,13,15,80,108,"In this study, we investigated the feasibility of enhancing tumor production of T(eff)-attracting chemokines as a cancer therapeutic strategy using a tissue explant culture system to analyze chemokine induction in intact tumor tissues.",22593190_2,-1,-1,-1,-1,17471,-1,0.0114742555,0.9869862,0.0015395533
17473,tissue,22,23,150,156,"In this study, we investigated the feasibility of enhancing tumor production of T(eff)-attracting chemokines as a cancer therapeutic strategy using a tissue explant culture system to analyze chemokine induction in intact tumor tissues.",22593190_2,-1,1,2,-1,17473,-1,1.8811983e-05,0.9999621,1.9073364e-05
17476,tumor tissues,32,34,221,234,"In this study, we investigated the feasibility of enhancing tumor production of T(eff)-attracting chemokines as a cancer therapeutic strategy using a tissue explant culture system to analyze chemokine induction in intact tumor tissues.",22593190_2,-1,-1,-1,-1,17476,-1,2.0428191e-05,0.99996257,1.6994036e-05
17478,to IFN,10,12,72,79,"In different tumor explants, we observed highly heterogeneous responses to IFN or poly-I:C (a TLR3 ligand) when they were applied individually.",22593190_3,-1,-1,-1,-1,17478,-1,0.84936893,0.14759956,0.0030314957
17487,this triple,1,3,9,20,"Applying this triple combination also uniformly suppressed the production of CCL22/MDC, a chemokine associated with infiltration of T regulatory cells (T(reg)).",22593190_6,-1,-1,-1,-1,17487,-1,3.697128e-05,0.9999484,1.4697089e-05
17493,The T(eff)-enhancing,0,2,0,20,"The T(eff)-enhancing effects of this treatment occurred selectively in tumor tissues, as compared with tissues derived from tumor margins.",22593190_7,-1,-1,-1,-1,17493,-1,4.6400823e-05,0.9999293,2.4285053e-05
17494,this treatment,4,6,32,46,"The T(eff)-enhancing effects of this treatment occurred selectively in tumor tissues, as compared with tissues derived from tumor margins.",22593190_7,-1,-1,-1,-1,17494,-1,2.417807e-05,0.9999633,1.2559625e-05
17495,tumor tissues,9,11,71,84,"The T(eff)-enhancing effects of this treatment occurred selectively in tumor tissues, as compared with tissues derived from tumor margins.",22593190_7,-1,-1,-1,-1,17495,-1,2.5996085e-05,0.9999362,3.7750888e-05
17496,tissues,15,16,103,110,"The T(eff)-enhancing effects of this treatment occurred selectively in tumor tissues, as compared with tissues derived from tumor margins.",22593190_7,-1,1,2,-1,17496,-1,2.9175004e-05,0.9998832,8.7654116e-05
17501,tumor-associated cells,8,10,52,74,"These effects relied on the increased propensity of tumor-associated cells (mostly fibroblasts and infiltrating inflammatory cells) to hyperactivate NF-B and produce T(eff)-attracting chemokines in response to treatment, resulting in an enhanced ability of the treated tumors to attract T(eff) cells and reduced ability to attract T(reg) cells.",22593190_8,-1,-1,-1,-1,17501,-1,0.0034900259,0.85435176,0.14215818
17504,T(eff)-attracting chemokines,23,25,167,195,"These effects relied on the increased propensity of tumor-associated cells (mostly fibroblasts and infiltrating inflammatory cells) to hyperactivate NF-B and produce T(eff)-attracting chemokines in response to treatment, resulting in an enhanced ability of the treated tumors to attract T(eff) cells and reduced ability to attract T(reg) cells.",22593190_8,-1,-1,-1,-1,17504,-1,0.017751884,0.98052084,0.0017272892
17505,to treatment,27,29,208,220,"These effects relied on the increased propensity of tumor-associated cells (mostly fibroblasts and infiltrating inflammatory cells) to hyperactivate NF-B and produce T(eff)-attracting chemokines in response to treatment, resulting in an enhanced ability of the treated tumors to attract T(eff) cells and reduced ability to attract T(reg) cells.",22593190_8,-1,-1,-1,-1,17505,-1,2.4330036e-05,0.9999652,1.0526726e-05
17506,the treated tumors to,36,40,258,279,"These effects relied on the increased propensity of tumor-associated cells (mostly fibroblasts and infiltrating inflammatory cells) to hyperactivate NF-B and produce T(eff)-attracting chemokines in response to treatment, resulting in an enhanced ability of the treated tumors to attract T(eff) cells and reduced ability to attract T(reg) cells.",22593190_8,-1,-1,-1,-1,17506,-1,1.718656e-05,0.9999726,1.0249253e-05
17514,the tumor,12,14,86,95,"Together, our findings suggest the feasibility of exploiting NF-B hyperactivation in the tumor microenvironment to selectively enhance T(eff) entry into colon tumors.",22593190_9,-1,-1,-1,-1,17514,-1,1.9331077e-05,0.99997175,8.945732e-06
17520,pleiotropic cytokine,6,8,26,46,"Interleukin-6 (IL-6) is a pleiotropic cytokine involved in the regulation of the cross talk between haematopoietic/immune cells and stromal cells, including the onset and resolution of inflammation, responses to infection, tissue remodelling and cancer.",22652781_0,-1,-1,-1,-1,17520,-1,0.08330242,0.9100704,0.006627087
17521,the regulation,10,12,59,73,"Interleukin-6 (IL-6) is a pleiotropic cytokine involved in the regulation of the cross talk between haematopoietic/immune cells and stromal cells, including the onset and resolution of inflammation, responses to infection, tissue remodelling and cancer.",22652781_0,-1,-1,-1,-1,17521,-1,2.2926562e-05,0.9999654,1.1588207e-05
17528,tissue,35,36,223,229,"Interleukin-6 (IL-6) is a pleiotropic cytokine involved in the regulation of the cross talk between haematopoietic/immune cells and stromal cells, including the onset and resolution of inflammation, responses to infection, tissue remodelling and cancer.",22652781_0,-1,1,2,-1,17528,-1,4.418595e-05,0.99992347,3.233762e-05
17532,receptor,12,13,83,91,"IL-6 can interact with both membrane-bound and soluble forms of its ligand-binding receptor, the IL-6Ralpha, triggering signalling via dimerization of gp130, the signalling subunit of the IL-6 receptor complex.",22652781_2,0,1,2,-1,17532,-1,0.0015458132,0.49237022,0.50608397
17533,the IL-6Ralpha,14,16,93,107,"IL-6 can interact with both membrane-bound and soluble forms of its ligand-binding receptor, the IL-6Ralpha, triggering signalling via dimerization of gp130, the signalling subunit of the IL-6 receptor complex.",22652781_2,-1,-1,-1,-1,17533,-1,0.004052054,0.99486405,0.0010839097
17537,the IL-6 receptor complex,28,32,184,209,"IL-6 can interact with both membrane-bound and soluble forms of its ligand-binding receptor, the IL-6Ralpha, triggering signalling via dimerization of gp130, the signalling subunit of the IL-6 receptor complex.",22652781_2,-1,-1,-1,-1,17537,-1,0.000428745,0.99933356,0.0002376521
17539,to the,2,4,11,17,This leads to the activation of the JAK/STAT pathway and mainly culminates in the activation of the STAT3 transcription factor.,22652781_3,-1,-1,-1,-1,17539,-1,2.2473392e-05,0.9999665,1.0972239e-05
17542,the STAT3 transcription factor,16,20,96,126,This leads to the activation of the JAK/STAT pathway and mainly culminates in the activation of the STAT3 transcription factor.,22652781_3,-1,-1,-1,-1,17542,-1,2.4489833e-05,0.9999578,1.7704586e-05
17546,function,14,15,88,96,"Both IL-6 and STAT3 have recently emerged as main regulators of the differentiation and function of Th17 cells, via a positive feedback loop enhancing expression and/or activation of IL-6 itself, IL-17 and STAT3.",22652781_4,0,1,2,-1,17546,-1,0.00013593826,0.9997607,0.000103436105
17547,Th17 cells,16,18,100,110,"Both IL-6 and STAT3 have recently emerged as main regulators of the differentiation and function of Th17 cells, via a positive feedback loop enhancing expression and/or activation of IL-6 itself, IL-17 and STAT3.",22652781_4,-1,-1,-1,-1,17547,-1,0.0012855077,0.04579524,0.95291936
17554,therapeutic targets,26,28,187,206,"Dysregulated IL-6 production and signalling are associated with chronic inflammatory diseases, auto-immunity and cancer, and are the object of intense translational research as promising therapeutic targets.",22652781_5,-1,-1,-1,-1,17554,-1,2.420763e-05,0.9999634,1.2414132e-05
17557,that TGF-beta,3,5,13,26,"Here we show that TGF-beta regulates proliferation, migration, and tumorigenicity of mesenchymal GBM cancer stem cells (CSCs) in vivo and in vitro.",22676416_2,-1,-1,-1,-1,17557,-1,4.2792894e-05,0.9999417,1.5519032e-05
17560,TGF-beta,7,8,41,49,"In contrast, proneural GBM CSCs resisted TGF-beta due to TGFR2 deficiency.",22676416_3,0,1,-1,-1,17560,-1,0.00012014864,0.9998456,3.418539e-05
17561,to TGFR2 deficiency,9,12,54,73,"In contrast, proneural GBM CSCs resisted TGF-beta due to TGFR2 deficiency.",22676416_3,-1,-1,-1,-1,17561,-1,6.46894e-05,0.99990153,3.381518e-05
17563,functional,2,3,5,15,"On a functional level, proneural CSC lines caused a significantly stronger TGF-beta-dependent suppression of NKG2D expression on CD8(+) T and NK cells in vitro providing a mechanistic explanation for the reduced immune infiltration of proneural GBMs.",22676416_5,0,1,2,-1,17563,-1,6.9910035e-05,0.9998939,3.6233512e-05
17564,TGF-beta-dependent,12,13,75,93,"On a functional level, proneural CSC lines caused a significantly stronger TGF-beta-dependent suppression of NKG2D expression on CD8(+) T and NK cells in vitro providing a mechanistic explanation for the reduced immune infiltration of proneural GBMs.",22676416_5,0,1,-1,-1,17564,-1,3.9221184e-05,0.999941,1.9819014e-05
17570,TGF-beta-dependently,7,8,36,56,"Thus, the molecular subtype of CSCs TGF-beta-dependently contributes to the degree of immune infiltration.",22676416_6,0,1,-1,-1,17570,-1,3.6580004e-05,0.99993837,2.4996812e-05
17571,to the,9,11,69,75,"Thus, the molecular subtype of CSCs TGF-beta-dependently contributes to the degree of immune infiltration.",22676416_6,-1,-1,-1,-1,17571,-1,2.342765e-05,0.9999635,1.3055763e-05
17585,analysis,10,11,61,69,"At 6 months following the first vaccination, flow cytometric analysis demonstrated a significant increase in the frequency of CD4+ICOS(hi) T cells from 52% pre-vaccination to 234% (p<0.001), with a concomitant decrease in the frequency of CD4+FoxP3+ T cells (regulatory T cells [Treg]) from 196 to 105% (p<0.05).",22678162_5,0,1,-1,-1,17585,-1,3.31679e-05,0.99993384,3.300918e-05
17594,analysis,1,2,8,16,ELISpot analysis of CD4+ICOS(hi) sorted T cells demonstrated that following vaccination the cytokines produced by Mam-A-specific T cells switched from IL-10 (7821 spm pre-vaccination to 3214 spm 5months post-vaccine p<0.001) to IFN- (126 spm pre-vaccination to 12431 spm 5months post-vaccine p<0.001).,22678162_6,0,1,-1,-1,17594,-1,2.445968e-05,0.9999542,2.1270322e-05
17597,the cytokines,12,14,88,101,ELISpot analysis of CD4+ICOS(hi) sorted T cells demonstrated that following vaccination the cytokines produced by Mam-A-specific T cells switched from IL-10 (7821 spm pre-vaccination to 3214 spm 5months post-vaccine p<0.001) to IFN- (126 spm pre-vaccination to 12431 spm 5months post-vaccine p<0.001).,22678162_6,-1,-1,-1,-1,17597,-1,0.34615338,0.6480387,0.0058079013
17601,to IFN-,47,49,234,242,ELISpot analysis of CD4+ICOS(hi) sorted T cells demonstrated that following vaccination the cytokines produced by Mam-A-specific T cells switched from IL-10 (7821 spm pre-vaccination to 3214 spm 5months post-vaccine p<0.001) to IFN- (126 spm pre-vaccination to 12431 spm 5months post-vaccine p<0.001).,22678162_6,-1,-1,-1,-1,17601,-1,0.91713655,0.07854877,0.004314616
17604,T cells to,5,8,26,36,The ratio of CD4+ICOS(hi) T cells to CD4+FoxP3+ T cells increased from 0.370.12 before vaccination to 2.30.72 (p=0.021) following vaccination.,22678162_7,-1,-1,-1,-1,17604,-1,0.0011766431,0.023648586,0.9751747
17610,protein,18,19,119,126,"Further, these activated CD4+ICOS(hi) T cells induced preferential lysis of human breast cancer cells expressing Mam-A protein.",22678162_8,0,1,-1,-1,17610,-1,0.0001078422,0.9998393,5.2770192e-05
17616,immunity,12,13,92,100,These encouraging results strongly suggest that Mam-A cDNA vaccination can induce antitumor immunity in breast cancer patients.,22678162_10,0,-1,2,-1,17616,-1,0.9992274,0.0005531376,0.00021937565
17617,therapy,9,10,70,77,Intrinsic immunosuppression is a major obstacle for successful cancer therapy.,22678911_0,0,1,-1,-1,17617,-1,3.1302003e-05,0.99995387,1.4795978e-05
17622,immunity,7,8,60,68,"A microenvironmental component that might prevent antitumor immunity is the presence of dying tumor cells, which are abundant following conventional cancer ablation methods such as chemo- or radiotherapy.",22678911_2,0,-1,2,-1,17622,-1,0.98565626,0.013712921,0.00063085306
17624,tumor cells,13,15,94,105,"A microenvironmental component that might prevent antitumor immunity is the presence of dying tumor cells, which are abundant following conventional cancer ablation methods such as chemo- or radiotherapy.",22678911_2,-1,-1,-1,-1,17624,-1,0.004614453,0.3176868,0.67769873
17626,factors to the tumor,7,11,49,69,"Shedding of apoptotic debris and/or secretion of factors to the tumor bed or draining lymph nodes thus might have a profound impact on professional phagocytes, such as DCs, and subsequent priming of lymphocytes.",22678911_3,-1,-1,-1,-1,17626,-1,0.15806234,0.8377094,0.00422825
17634,tumor cells,12,14,93,104,"Priming with apoptotic debris prevented DCs from establishing cytotoxicity toward live human tumor cells by inducing a Treg-cell population, defined by coexpression of CD39 and CD69.",22678911_5,-1,-1,-1,-1,17634,-1,0.0046941163,0.39593562,0.5993703
17635,Treg-cell,17,18,119,128,"Priming with apoptotic debris prevented DCs from establishing cytotoxicity toward live human tumor cells by inducing a Treg-cell population, defined by coexpression of CD39 and CD69.",22678911_5,-1,1,2,-1,17635,-1,0.0004700169,0.008844003,0.990686
17638,the release,8,10,63,74,"Immunosuppression via Treg cells was transferable and required the release of sphingosine-1-phosphate (S1P) from apoptotic cells, acting via S1P receptor 4 on DCs to induce IL-27 secretion.",22678911_6,-1,-1,-1,-1,17638,-1,2.1843965e-05,0.9999653,1.2874697e-05
17640,receptor,22,23,145,153,"Immunosuppression via Treg cells was transferable and required the release of sphingosine-1-phosphate (S1P) from apoptotic cells, acting via S1P receptor 4 on DCs to induce IL-27 secretion.",22678911_6,0,1,2,-1,17640,-1,0.00027306235,0.001571482,0.9981554
17644,them to,11,13,62,69,"We propose that CD69 expression on CD39(+) Treg cells enables them to interact with CD73-expressing CD8(+) T cells to generate adenosine, thereby suppressing cytotoxicity.",22678911_7,-1,-1,-1,-1,17644,-1,2.0918518e-05,0.9999684,1.0626547e-05
17645,T cells to generate,18,22,107,126,"We propose that CD69 expression on CD39(+) Treg cells enables them to interact with CD73-expressing CD8(+) T cells to generate adenosine, thereby suppressing cytotoxicity.",22678911_7,-1,-1,-1,-1,17645,-1,0.0033442122,0.16782293,0.8288328
17649,tumor cells,8,10,50,61,These findings aid the understanding of how dying tumor cells limit antitumor immunity.,22678911_8,-1,-1,-1,-1,17649,-1,0.003670545,0.27307427,0.7232553
17650,immunity,12,13,78,86,These findings aid the understanding of how dying tumor cells limit antitumor immunity.,22678911_8,0,-1,2,-1,17650,-1,0.99663687,0.0028859014,0.00047728105
17652,to Th1,8,10,63,69,"Autocrine IFN- signaling is important for CD4 differentiation to Th1 effector cells, but it has been unclear whether it contributes to CD8 T cell differentiation.",22706089_0,-1,-1,-1,-1,17652,-1,4.3968517e-05,0.99991703,3.8990296e-05
17657,that naive,5,7,22,32,"We show in this paper that naive murine CD8 T cells rapidly and transiently produce low levels of IFN- upon stimulation with Ag and B7-1, with production peaking at 8 h and declining by 24 h. The autocrine IFN- signals for upregulation of expression of T-bet and granzyme B and induces weak cytolytic activity and effector IFN- production.",22706089_1,-1,-1,-1,-1,17657,-1,1.9917492e-05,0.9999708,9.306499e-06
17667,IFN- to,4,6,32,40,"IFN- acts synergistically with IFN- to support development of strong effector functions, whereas IL-12 induces high T-bet expression and strong function in the absence of IFN- signaling.",22706089_2,-1,-1,-1,-1,17667,-1,0.99569005,0.002881619,0.0014283624
17668,functions,11,12,80,89,"IFN- acts synergistically with IFN- to support development of strong effector functions, whereas IL-12 induces high T-bet expression and strong function in the absence of IFN- signaling.",22706089_2,0,1,2,-1,17668,-1,0.00021962418,0.9993401,0.0004401959
17671,function,21,22,146,154,"IFN- acts synergistically with IFN- to support development of strong effector functions, whereas IL-12 induces high T-bet expression and strong function in the absence of IFN- signaling.",22706089_2,0,1,2,-1,17671,-1,6.272361e-05,0.99989355,4.368261e-05
17678,factor,18,19,96,102,"Thus, IFN- is not only an important CD8 T cell effector cytokine, it is an autocrine/paracrine factor whose contributions to differentiation vary depending on whether the response is supported by IL-12 or type I IFN.",22706089_3,0,1,-1,-1,17678,-1,0.00054174796,0.9993368,0.00012141894
17687,protein,10,11,64,71,Our previous studies have demonstrated that hepatitis B virus X protein (HBx) was able to inhibit the growth of HCC cells via inducing apoptosis and inhibiting tumor angiogenesis.,22710287_1,0,1,-1,-1,17687,-1,0.00034010762,0.9993771,0.0002828371
17700,IL-12 named,36,38,264,275,"In this study, to further investigate the regulatory effect of IL-12 on HBx-mediated intervention of hepatoma microenvironment especially on intervention of neovessels and immune microenvironment, we constructed the recombinant adenovirus expressing HBx and mouse IL-12 named Ad-HBx-mIL-12.",22710287_3,-1,-1,-1,-1,17700,-1,0.99483454,0.0031745401,0.0019909102
17708,blood,37,38,218,223,"Moreover, treatment with Ad-HBx-mIL-12 not only induced a massive accumulation of immune cells (CD8(+) T leukocytes, macrophages and dendritic cells) in tumors in situ, also apparently reduced the number of angiogenic blood vessels within tumor tissues.",22710287_5,0,1,-1,-1,17708,-1,0.00087972457,0.9870962,0.012024071
17709,tumor tissues,40,42,239,252,"Moreover, treatment with Ad-HBx-mIL-12 not only induced a massive accumulation of immune cells (CD8(+) T leukocytes, macrophages and dendritic cells) in tumors in situ, also apparently reduced the number of angiogenic blood vessels within tumor tissues.",22710287_5,-1,-1,-1,-1,17709,-1,2.1661413e-05,0.999954,2.4322459e-05
17714,the tumor,22,24,131,140,"These results suggest that HBx-mIL-12 can not only induce cell cycle arrest and apoptosis in HCC cells, but also effectively shift the tumor microenvironment from pro-oncogenic to antitumor through recruitment of immune cells and inhibiting stromal cell growth, such as vascular endothelial cells.",22710287_6,-1,-1,-1,-1,17714,-1,1.9589359e-05,0.99997115,9.304906e-06
17724,these cells,11,13,66,77,"However, the distribution, phenotypic features, and regulation of these cells in gastric cancer remain unknown.",22729557_1,-1,-1,-1,-1,17724,-1,0.00053500506,0.011322424,0.98814255
17728,blood,12,13,70,75,"METHODS: The levels of CD8(+)Foxp3(+) T lymphocytes in the peripheral blood, tumor-draining lymph nodes, non-tumor tissues, and tumor tissues of patients with gastric cancer were detected by flow cytometry.",22729557_2,0,1,-1,-1,17728,-1,0.0012712341,0.86076,0.13796878
17730,tissues,19,20,115,122,"METHODS: The levels of CD8(+)Foxp3(+) T lymphocytes in the peripheral blood, tumor-draining lymph nodes, non-tumor tissues, and tumor tissues of patients with gastric cancer were detected by flow cytometry.",22729557_2,-1,1,2,-1,17730,-1,0.00012413447,0.99914324,0.0007325862
17731,tumor tissues,22,24,128,141,"METHODS: The levels of CD8(+)Foxp3(+) T lymphocytes in the peripheral blood, tumor-draining lymph nodes, non-tumor tissues, and tumor tissues of patients with gastric cancer were detected by flow cytometry.",22729557_2,-1,-1,-1,-1,17731,-1,3.6105495e-05,0.9999137,5.024804e-05
17735,function,2,3,16,24,The suppressive function of CD8(+)Foxp3(+) T lymphocytes was analyzed by their effect on CD4(+) T-cell proliferation and IFN- production.,22729557_4,0,1,2,-1,17735,-1,5.6292458e-05,0.9998753,6.836573e-05
17746,tumor tissues,10,12,58,71,"RESULTS: The frequency of CD8(+)Foxp3(+) T lymphocytes in tumor tissues was significantly higher than that in non-tumor tissues, and similar results were also observed in tumor-draining lymph nodes compared with peripheral blood.",22729557_6,-1,-1,-1,-1,17746,-1,2.4648014e-05,0.99994934,2.6005999e-05
17747,than that,15,17,97,106,"RESULTS: The frequency of CD8(+)Foxp3(+) T lymphocytes in tumor tissues was significantly higher than that in non-tumor tissues, and similar results were also observed in tumor-draining lymph nodes compared with peripheral blood.",22729557_6,-1,-1,-1,-1,17747,-1,2.4741146e-05,0.9999622,1.3098597e-05
17748,tissues,19,20,120,127,"RESULTS: The frequency of CD8(+)Foxp3(+) T lymphocytes in tumor tissues was significantly higher than that in non-tumor tissues, and similar results were also observed in tumor-draining lymph nodes compared with peripheral blood.",22729557_6,-1,1,2,-1,17748,-1,4.864917e-05,0.999814,0.0001373803
17750,blood,34,35,223,228,"RESULTS: The frequency of CD8(+)Foxp3(+) T lymphocytes in tumor tissues was significantly higher than that in non-tumor tissues, and similar results were also observed in tumor-draining lymph nodes compared with peripheral blood.",22729557_6,0,1,-1,-1,17750,-1,0.0017437248,0.8723623,0.12589392
17756,tumor tissues,14,16,95,108,"TGF-1 levels were positively correlated with the frequency of CD8(+)Foxp3(+) T lymphocytes in tumor tissues, and in vitro TGF-1 could induce the generation of CD8(+)Foxp3(+) T lymphocytes in a dose-dependent manner.",22729557_8,-1,-1,-1,-1,17756,-1,2.326038e-05,0.9999573,1.9419858e-05
17758,the generation,23,25,143,157,"TGF-1 levels were positively correlated with the frequency of CD8(+)Foxp3(+) T lymphocytes in tumor tissues, and in vitro TGF-1 could induce the generation of CD8(+)Foxp3(+) T lymphocytes in a dose-dependent manner.",22729557_8,-1,-1,-1,-1,17758,-1,2.0535892e-05,0.9999633,1.613457e-05
17772,T-cell functions,23,25,155,171,"CONCLUSIONS: Our data have shown that increased intratumoral CD8(+)Foxp3(+) T lymphocytes are associated with tumor stage and potentially influence CD4(+) T-cell functions, which may provide insights for developing novel immunotherapy protocols against gastric cancer.",22729557_11,-1,-1,-1,-1,17772,-1,4.6477144e-05,6.688695e-05,0.99988663
17773,functional cell,2,4,15,30,Phenotypic and functional cell properties are usually analyzed at the level of defined cell populations but not single cells.,22735807_0,-1,-1,-1,-1,17773,-1,0.00064297346,0.0019561609,0.9974009
17778,functional,10,11,67,77,"Yet, large differences between individual cells may have important functional consequences.",22735807_1,0,1,2,-1,17778,-1,8.642063e-05,0.9998808,3.280514e-05
17779,that T-cell-mediated immunity,3,6,13,42,"It is likely that T-cell-mediated immunity depends on the polyfunctionality of individual T cells, rather than the sum of functions of responding T-cell subpopulations.",22735807_2,-1,-1,-1,-1,17779,-1,0.070082285,0.78243417,0.14748359
17782,than the,16,18,106,114,"It is likely that T-cell-mediated immunity depends on the polyfunctionality of individual T cells, rather than the sum of functions of responding T-cell subpopulations.",22735807_2,-1,-1,-1,-1,17782,-1,2.5129713e-05,0.99996245,1.2472457e-05
17783,functions,20,21,122,131,"It is likely that T-cell-mediated immunity depends on the polyfunctionality of individual T cells, rather than the sum of functions of responding T-cell subpopulations.",22735807_2,0,1,2,-1,17783,-1,0.0014688009,0.9949287,0.003602539
17784,T-cell,23,24,146,152,"It is likely that T-cell-mediated immunity depends on the polyfunctionality of individual T cells, rather than the sum of functions of responding T-cell subpopulations.",22735807_2,-1,1,2,-1,17784,-1,3.1790103e-05,4.341116e-05,0.9999248
17787,tumor-specific T cells,19,22,147,169,"We performed highly sensitive single-cell gene expression profiling, allowing the direct ex vivo characterization of individual virus-specific and tumor-specific T cells from healthy donors and melanoma patients.",22735807_3,-1,-1,-1,-1,17787,-1,0.004405332,0.72824395,0.26735073
17789,the natural tumor peptide,7,11,47,72,We have previously shown that vaccination with the natural tumor peptide Melan-A-induced T cells with superior effector functions as compared with vaccination with the analog peptide optimized for enhanced HLA-A*0201 binding.,22735807_4,-1,-1,-1,-1,17789,-1,5.789824e-05,0.99991894,2.3101338e-05
17791,functions,17,18,120,129,We have previously shown that vaccination with the natural tumor peptide Melan-A-induced T cells with superior effector functions as compared with vaccination with the analog peptide optimized for enhanced HLA-A*0201 binding.,22735807_4,0,1,2,-1,17791,-1,0.00044830257,0.0007900226,0.9987618
17793,peptide,25,26,175,182,We have previously shown that vaccination with the natural tumor peptide Melan-A-induced T cells with superior effector functions as compared with vaccination with the analog peptide optimized for enhanced HLA-A*0201 binding.,22735807_4,0,-1,2,-1,17793,-1,0.005546134,0.9918663,0.0025875461
17794,that natural peptide,3,6,14,34,"Here we found that natural peptide vaccination induced tumor-reactive CD8 T cells with frequent coexpression of both memory/homing-associated genes (CD27, IL7R, EOMES, CXCR3, and CCR5) and effector-related genes (IFNG, KLRD1, PRF1, and GZMB), comparable with protective Epstein-Barr virus-specific and cytomegalovirus-specific T cells.",22735807_5,-1,-1,-1,-1,17794,-1,0.00027632105,0.9996393,8.4392595e-05
17805,peptide,16,17,135,142,"In contrast, memory/homing-associated and effector-associated genes were less frequently coexpressed after vaccination with the analog peptide.",22735807_6,0,-1,2,-1,17805,-1,0.52273464,0.1422976,0.3349677
17813,functional gene,2,4,11,26,Such broad functional gene expression signatures within antigen-specific T cells may be critical for mounting efficient responses to pathogens or tumors.,22735807_8,-1,-1,-1,-1,17813,-1,3.2958258e-05,0.9999474,1.95561e-05
17814,antigen-specific T cells,7,10,56,80,Such broad functional gene expression signatures within antigen-specific T cells may be critical for mounting efficient responses to pathogens or tumors.,22735807_8,-1,-1,-1,-1,17814,-1,0.31000718,0.0034083757,0.6865845
17819,the functional,20,22,141,155,"In summary, direct ex vivo high-resolution molecular characterization of individual T cells provides key insights into the processes shaping the functional properties of tumor-specific and virus-specific T cells.",22735807_9,-1,-1,-1,-1,17819,-1,2.7322883e-05,0.99995875,1.3869348e-05
17824,toll-like receptor,7,9,45,63,AIM: To investigated the interaction between toll-like receptor 4 (TLR4)-activated hepatoma cells and macrophages in the induction of tumor-immune suppression mediated by CD4+CD25(high) family of transcription factor P3 (FOXP3) regulatory T cells (Tregs).METHODS: The proportion of FOXP3+ Tregs was identified in peripheral blood and tumor tissues of 60 hepatocellular carcinoma (HCC) patients.,22736917_0,-1,-1,-1,-1,17824,-1,0.0010052836,0.98521185,0.013782897
17834,blood,48,49,324,329,AIM: To investigated the interaction between toll-like receptor 4 (TLR4)-activated hepatoma cells and macrophages in the induction of tumor-immune suppression mediated by CD4+CD25(high) family of transcription factor P3 (FOXP3) regulatory T cells (Tregs).METHODS: The proportion of FOXP3+ Tregs was identified in peripheral blood and tumor tissues of 60 hepatocellular carcinoma (HCC) patients.,22736917_0,0,1,-1,-1,17834,-1,9.600477e-05,0.99949396,0.00041001936
17835,tumor tissues,50,52,334,347,AIM: To investigated the interaction between toll-like receptor 4 (TLR4)-activated hepatoma cells and macrophages in the induction of tumor-immune suppression mediated by CD4+CD25(high) family of transcription factor P3 (FOXP3) regulatory T cells (Tregs).METHODS: The proportion of FOXP3+ Tregs was identified in peripheral blood and tumor tissues of 60 hepatocellular carcinoma (HCC) patients.,22736917_0,-1,-1,-1,-1,17835,-1,2.940262e-05,0.99993753,3.3085125e-05
17837,tumor tissues,5,7,32,45,TLR4 expression was examined in tumor tissues and cell lines.,22736917_1,-1,-1,-1,-1,17837,-1,2.3933177e-05,0.9999509,2.5135103e-05
17842,blood,10,11,64,69,The correlation was examined between FOXP3+ Tregs in peripheral blood and TLR4 expression of HCC tissues.,22736917_2,0,1,-1,-1,17842,-1,0.00012651781,0.9985208,0.0013527175
17844,tissues,16,17,97,104,The correlation was examined between FOXP3+ Tregs in peripheral blood and TLR4 expression of HCC tissues.,22736917_2,-1,1,2,-1,17844,-1,0.0015440423,0.27137467,0.7270813
17850,cytokines tumor,26,28,171,186,"Following activation of TLR4 in H22 murine hepatoma cells pre-incubated with lipopolysaccharide (LPS) and co-cultured with macrophage cell line RAW246.7, the synthesis of cytokines tumor necrosis factor-, CCL22, and interleukin (IL)-10 by the two cell lines was detected and analyzed.",22736917_3,-1,-1,-1,-1,17850,-1,0.98419964,0.013728509,0.0020718293
17851,factor-,29,30,196,204,"Following activation of TLR4 in H22 murine hepatoma cells pre-incubated with lipopolysaccharide (LPS) and co-cultured with macrophage cell line RAW246.7, the synthesis of cytokines tumor necrosis factor-, CCL22, and interleukin (IL)-10 by the two cell lines was detected and analyzed.",22736917_3,0,1,-1,-1,17851,-1,0.9998592,5.36505e-05,8.707397e-05
17854,the two cell,37,40,240,252,"Following activation of TLR4 in H22 murine hepatoma cells pre-incubated with lipopolysaccharide (LPS) and co-cultured with macrophage cell line RAW246.7, the synthesis of cytokines tumor necrosis factor-, CCL22, and interleukin (IL)-10 by the two cell lines was detected and analyzed.",22736917_3,-1,-1,-1,-1,17854,-1,0.0033700012,0.7461389,0.25049108
17862,tissues,33,34,192,199,"RESULTS: FOXP3+ Tregs were enriched in tumor sites, and circulating FOXP3+ Tregs were increased in HCC patients in correlation with multiple tumor foci and up-regulated TLR4 expression in HCC tissues.",22736917_4,-1,1,2,-1,17862,-1,0.00018392637,0.9933541,0.006462004
17863,analysis,1,2,18,26,Semi-quantitative analysis indicated that TLR4 was over-expressed in HCC compared with the matched normal tissues.,22736917_5,0,1,-1,-1,17863,-1,2.8063541e-05,0.9999502,2.181453e-05
17864,that TLR4,3,5,37,46,Semi-quantitative analysis indicated that TLR4 was over-expressed in HCC compared with the matched normal tissues.,22736917_5,-1,-1,-1,-1,17864,-1,2.5838248e-05,0.999944,3.0189169e-05
17866,tissues,14,15,106,113,Semi-quantitative analysis indicated that TLR4 was over-expressed in HCC compared with the matched normal tissues.,22736917_5,-1,1,2,-1,17866,-1,0.0016977696,0.62720597,0.3710962
17868,that the,4,6,39,47,Cell cultivation experiments indicated that the mRNAs of IL-10 and CCL22 were significantly up-regulated in the RAW246.7 cell line when co-cultured with LPS pre-incubated H22 cells.,22736917_6,-1,-1,-1,-1,17868,-1,1.7936745e-05,0.99997175,1.0263573e-05
17878,Tregs to the tumor,14,18,86,104,"CONCLUSION: In hepatoma cell lines, TLR4 may indirectly facilitate the recruitment of Tregs to the tumor site and promote intrahepatic metastasis through its interaction with macrophages.",22736917_7,-1,-1,-1,-1,17878,-1,2.2823457e-05,0.9999633,1.3877918e-05
17882,function,7,8,57,65,NFAT transcription factors control T-cell activation and function.,22738913_0,0,1,2,-1,17882,-1,0.00031868296,0.9989644,0.00071693416
17883,the transcription factor NFATc2,2,6,14,45,"Specifically, the transcription factor NFATc2 affects the regulation of cell differentiation and growth and plays a critical role in the development of colonic inflammation.",22738913_1,-1,-1,-1,-1,17883,-1,4.6189904e-05,0.999933,2.0853622e-05
17884,the regulation,7,9,54,68,"Specifically, the transcription factor NFATc2 affects the regulation of cell differentiation and growth and plays a critical role in the development of colonic inflammation.",22738913_1,-1,-1,-1,-1,17884,-1,2.1280584e-05,0.9999654,1.3265789e-05
17890,NFATc2 to the,16,19,114,127,"Here, we used an experimental model of colitis-associated colorectal carcinoma to investigate the contribution of NFATc2 to the promotion of colonic tumors.",22738913_2,-1,-1,-1,-1,17890,-1,3.7846672e-05,0.9999411,2.1093974e-05
17900,cytokines interleukin,30,32,223,244,"This observed decrease in colonic tumor progression was associated with reduced endoscopic inflammation, increased apoptosis of lamina propria T lymphocytes, and significantly reduced levels of the critical proinflammatory cytokines interleukin (IL)-21 and IL-6.",22738913_4,-1,-1,-1,-1,17900,-1,0.9997913,4.799682e-05,0.00016061097
17907,Taken together,0,2,0,14,"Taken together, our findings highlight a pivotal role for NFATc2 in the establishment of inflammation-associated colorectal tumors mediated by control of IL-6 expression.",22738913_6,-1,-1,-1,-1,17907,-1,3.9879375e-05,0.9999435,1.6608145e-05
17918,tumor cells,3,5,20,31,"Stat3 inhibition in tumor cells induces the expression of chemokines and proinflammatory cytokines, so we proposed to apply Stat3-inhibited breast cancer cells as a source of immunogens to induce an antitumor immune response.",22753933_1,-1,-1,-1,-1,17918,-1,0.0038528154,0.47591558,0.5202316
17935,cells transfected,5,7,45,62,Prophylactic administration of breast cancer cells transfected with Stat3Y705F (Stat3Y705F-breast cancer cells) inhibited primary tumor growth compared with administration of empty vector-transfected cells in both models.,22753933_4,-1,-1,-1,-1,17935,-1,0.0015048545,0.04609209,0.95240307
17944,that the,7,9,37,45,In vivo assays of C4HD tumors showed that the antitumor immune response involves the participation of CD4(+) T cells and cytotoxic NK cells.,22753933_6,-1,-1,-1,-1,17944,-1,1.7663391e-05,0.99997425,8.072957e-06
17952,tumor cell,11,13,94,104,"Therapeutic immunization with Stat3Y705F-breast cancer cells inhibited tumor growth, promoted tumor cell differentiation, and decreased metastasis.",22753933_7,-1,-1,-1,-1,17952,-1,0.0031227216,0.16652863,0.83034873
17956,to their,15,17,109,117,"Furthermore, inhibition of Stat3 activation in breast cancer cells induced cellular senescence, contributing to their immunogenic phenotype.",22753933_8,-1,-1,-1,-1,17956,-1,3.3051267e-05,0.9999503,1.6679827e-05
17961,that Stat3,5,7,31,41,"Moreover, our findings showing that Stat3 inactivation results in induction of a cellular senescence program disclose a potential mechanism for immunotherapy research.",22753933_10,-1,-1,-1,-1,17961,-1,2.3563993e-05,0.99996424,1.2153023e-05
17965,immunity,6,7,42,50,Interleukin-12 (IL12) enhances anti-tumor immunity when delivered to the tumor microenvironment.,22777646_0,0,-1,2,-1,17965,-1,0.9929987,0.0063233124,0.00067797874
17966,to the tumor,9,12,66,78,Interleukin-12 (IL12) enhances anti-tumor immunity when delivered to the tumor microenvironment.,22777646_0,-1,-1,-1,-1,17966,-1,2.458841e-05,0.99996567,9.743985e-06
17971,tumors to,8,10,47,56,The identity of these local mechanisms used by tumors to suppress immunosurveillance represents a key knowledge gap for improving tumor immunotherapy.,22777646_2,-1,-1,-1,-1,17971,-1,2.160323e-05,0.99996984,8.610677e-06
17973,immunity,9,10,60,68,"From a systems perspective, local suppression of anti-tumor immunity is a closed-loop system - where system response is determined by an unknown combination of external inputs and local cellular cross-talk.",22777646_3,0,-1,2,-1,17973,-1,0.99874926,0.0008363425,0.0004142899
17983,to IL12,28,30,167,174,"Following an induction period, the B16 melanoma cell model, a transplantable model for spontaneous malignant melanoma, inhibited the response of a T helper cell model to IL12.",22777646_5,-1,-1,-1,-1,17983,-1,0.76459813,0.22939377,0.0060081794
17988,protein-1,3,4,38,47,Tumor-derived Wnt-inducible signaling protein-1 (WISP-1) was identified to exert paracrine action on immune cells by inhibiting their response to IL12.,22777646_7,0,1,-1,-1,17988,-1,4.0437168e-05,0.9999033,5.6189012e-05
17992,to IL12,20,22,143,150,Tumor-derived Wnt-inducible signaling protein-1 (WISP-1) was identified to exert paracrine action on immune cells by inhibiting their response to IL12.,22777646_7,-1,-1,-1,-1,17992,-1,0.8812335,0.1141253,0.0046411175
17995,the tumor,20,22,125,134,"Moreover, WISP-1 was expressed in vivo following intradermal challenge with B16F10 cells and was inferred to be expressed at the tumor periphery.",22777646_8,-1,-1,-1,-1,17995,-1,1.9605628e-05,0.9999696,1.0793615e-05
17999,immunity through,18,20,131,147,"Collectively, the data suggest that (1) biochemical cues associated with epithelial-to-mesenchymal transition can shape anti-tumor immunity through paracrine action and (2) remnants of the immunoselective pressure associated with evolution in cancer include both sculpting of tumor antigens and expression of proteins that proactively shape anti-tumor immunity.",22777646_9,-1,-1,-1,-1,17999,-1,0.3831061,0.6127419,0.0041520232
18001,tumor antigens,40,42,276,290,"Collectively, the data suggest that (1) biochemical cues associated with epithelial-to-mesenchymal transition can shape anti-tumor immunity through paracrine action and (2) remnants of the immunoselective pressure associated with evolution in cancer include both sculpting of tumor antigens and expression of proteins that proactively shape anti-tumor immunity.",22777646_9,-1,-1,-1,-1,18001,-1,0.2938837,0.6958096,0.010306747
18002,proteins that,45,47,309,322,"Collectively, the data suggest that (1) biochemical cues associated with epithelial-to-mesenchymal transition can shape anti-tumor immunity through paracrine action and (2) remnants of the immunoselective pressure associated with evolution in cancer include both sculpting of tumor antigens and expression of proteins that proactively shape anti-tumor immunity.",22777646_9,-1,-1,-1,-1,18002,-1,9.9652396e-05,0.9998235,7.680869e-05
18003,immunity,50,51,352,360,"Collectively, the data suggest that (1) biochemical cues associated with epithelial-to-mesenchymal transition can shape anti-tumor immunity through paracrine action and (2) remnants of the immunoselective pressure associated with evolution in cancer include both sculpting of tumor antigens and expression of proteins that proactively shape anti-tumor immunity.",22777646_9,0,-1,2,-1,18003,-1,0.9994667,0.00031435295,0.00021901926
18005,T-cell,3,4,17,23,"Antitumor type I T-cell responses involving IFN- production are critical to control cancer, but the efficacy of this response is limited by a variety of immunosuppressive mechanisms that promote tumoral immune escape.",22798340_0,-1,1,2,-1,18005,-1,7.5436954e-05,0.00018109556,0.9997434
18017,T cells that,20,23,111,123,"One critical mechanism involves the accumulation of FOXP3(+) T regulatory cells (Treg), a class of suppressive T cells that prevent excessive tissue destruction caused by unchecked immune responses.",22798340_1,-1,-1,-1,-1,18017,-1,0.0012919144,0.023945302,0.9747628
18018,tissue,25,26,142,148,"One critical mechanism involves the accumulation of FOXP3(+) T regulatory cells (Treg), a class of suppressive T cells that prevent excessive tissue destruction caused by unchecked immune responses.",22798340_1,-1,1,2,-1,18018,-1,0.00012049346,0.9996455,0.00023401901
18020,that FOXP3(+,4,6,29,41,Recent studies have revealed that FOXP3(+) Treg include distinct subsets specifically controlling over the corresponding effector subset.,22798340_2,-1,-1,-1,-1,18020,-1,0.0001909103,0.9996239,0.00018513564
18029,T-cell,19,20,98,104,"In particular, CXCR3(+) Treg have been described as a subset specialized in the control of type I T-cell responses in vivo.",22798340_3,-1,1,2,-1,18029,-1,8.8175526e-05,0.00015729605,0.9997545
18043,that they,8,10,47,56,"In addition, they coexpress Helios, suggesting that they originate from natural Treg.",22798340_6,-1,-1,-1,-1,18043,-1,2.0897769e-05,0.99996877,1.0331687e-05
18044,natural Treg,12,14,72,84,"In addition, they coexpress Helios, suggesting that they originate from natural Treg.",22798340_6,-1,-1,-1,-1,18044,-1,3.7553265e-05,0.99994993,1.2546768e-05
18045,that the,4,6,17,25,"Finally, we show that the proportion of CXCR3(+) Treg at tumor sites is directly correlated with that of CXCR3(+) T effectors, consistent with expression of CXCR3 ligands.",22798340_7,-1,-1,-1,-1,18045,-1,1.678155e-05,0.99997354,9.667404e-06
18052,that natural,7,9,43,55,"Together, our findings support the concept that natural CXCR3(+) T-bet(+) Treg selectively accumulate in ovarian tumors to control type I T-cell responses, resulting in the collateral limitation of efficient antitumor immunity.",22798340_8,-1,-1,-1,-1,18052,-1,2.0831645e-05,0.9999715,7.6226643e-06
18055,tumors to,18,20,113,122,"Together, our findings support the concept that natural CXCR3(+) T-bet(+) Treg selectively accumulate in ovarian tumors to control type I T-cell responses, resulting in the collateral limitation of efficient antitumor immunity.",22798340_8,-1,-1,-1,-1,18055,-1,1.8814642e-05,0.9999728,8.410128e-06
18057,T-cell,23,24,138,144,"Together, our findings support the concept that natural CXCR3(+) T-bet(+) Treg selectively accumulate in ovarian tumors to control type I T-cell responses, resulting in the collateral limitation of efficient antitumor immunity.",22798340_8,-1,1,2,-1,18057,-1,5.4176267e-05,9.0523165e-05,0.9998553
18059,immunity,34,35,218,226,"Together, our findings support the concept that natural CXCR3(+) T-bet(+) Treg selectively accumulate in ovarian tumors to control type I T-cell responses, resulting in the collateral limitation of efficient antitumor immunity.",22798340_8,0,-1,2,-1,18059,-1,0.99945074,0.0002931381,0.00025619115
18061,T-cell transfer,6,8,36,51,We examined the effects of adoptive T-cell transfer (ACT) on the population of regulatory T cells (Tregs) in a mouse colorectal cancer transplant model.,22812187_0,-1,-1,-1,-1,18061,-1,0.0007207,0.0085492125,0.9907301
18068,blood,20,21,116,121,"In an in vivo study, Treg populations in Balb/c mice colon26 transplant model after ACT were analyzed in peripheral blood, local lymph node, and tumor.",22812187_1,0,1,-1,-1,18068,-1,0.0008128087,0.97957796,0.019609246
18071,TGF-beta to,13,15,67,78,In an in vitro study CD4+ cells were cultured in medium containing TGF-beta to induce Tregs.,22812187_2,-1,-1,-1,-1,18071,-1,3.0314206e-05,0.99995553,1.4205774e-05
18074,this Treg,7,9,31,40,LAK cells were added or not in this Treg induction system.,22812187_3,-1,-1,-1,-1,18074,-1,3.3714718e-05,0.99995315,1.3157685e-05
18099,Th17 cells,9,11,57,67,BACKGROUND: Recent studies suggest a potential impact of Th17 cells on tumor.,22820395_0,-1,-1,-1,-1,18099,-1,0.00028047737,0.0021591557,0.99756026
18103,Th17 cells,10,12,58,68,"In the present study, we investigated the distribution of Th17 cells in relation to Foxp3-expressing T cells in the tumor-infiltrating lymphocytes (TILs) from patients with uterine cervical cancer (UCC), cervical tissues from patients with cervical intraepithelial neoplasia (CIN) and healthy cervical tissues.",22820395_1,-1,-1,-1,-1,18103,-1,0.0002296726,0.0019290167,0.99784124
18104,relation to Foxp3-expressing T cells,13,18,72,108,"In the present study, we investigated the distribution of Th17 cells in relation to Foxp3-expressing T cells in the tumor-infiltrating lymphocytes (TILs) from patients with uterine cervical cancer (UCC), cervical tissues from patients with cervical intraepithelial neoplasia (CIN) and healthy cervical tissues.",22820395_1,-1,-1,-1,-1,18104,-1,0.0024317948,0.91746676,0.08010147
18105,the tumor-infiltrating lymphocytes,19,22,112,146,"In the present study, we investigated the distribution of Th17 cells in relation to Foxp3-expressing T cells in the tumor-infiltrating lymphocytes (TILs) from patients with uterine cervical cancer (UCC), cervical tissues from patients with cervical intraepithelial neoplasia (CIN) and healthy cervical tissues.",22820395_1,-1,-1,-1,-1,18105,-1,0.0021908353,0.91800636,0.07980281
18107,tissues,36,37,213,220,"In the present study, we investigated the distribution of Th17 cells in relation to Foxp3-expressing T cells in the tumor-infiltrating lymphocytes (TILs) from patients with uterine cervical cancer (UCC), cervical tissues from patients with cervical intraepithelial neoplasia (CIN) and healthy cervical tissues.",22820395_1,-1,1,2,-1,18107,-1,0.0007485986,0.95226985,0.04698157
18108,tissues,49,50,302,309,"In the present study, we investigated the distribution of Th17 cells in relation to Foxp3-expressing T cells in the tumor-infiltrating lymphocytes (TILs) from patients with uterine cervical cancer (UCC), cervical tissues from patients with cervical intraepithelial neoplasia (CIN) and healthy cervical tissues.",22820395_1,-1,1,2,-1,18108,-1,0.0013128393,0.8603987,0.13828844
18109,Th17 cells,2,4,9,19,METHODS: Th17 cells and Foxp3-expressing T cells were evaluated by immunohistochemical staining.,22820395_2,-1,-1,-1,-1,18109,-1,0.00021472925,0.0012318452,0.99855345
18110,Foxp3-expressing T cells,5,8,24,48,METHODS: Th17 cells and Foxp3-expressing T cells were evaluated by immunohistochemical staining.,22820395_2,-1,-1,-1,-1,18110,-1,0.0030780616,0.8564314,0.14049053
18118,Th17 cells,16,18,85,95,"RESULTS: Compared with controls, patients with UCC or CIN had a higher proportion of Th17 cells and Foxp3-expressing T cells, when the ratio of Th17/Foxp3-expressing T cells in TILs was decreased in individual cases, it was more markedly decreased in TILs than normal cervical tissues.",22820395_5,-1,-1,-1,-1,18118,-1,0.00011943424,0.00037761283,0.999503
18119,Foxp3-expressing T cells,19,22,100,124,"RESULTS: Compared with controls, patients with UCC or CIN had a higher proportion of Th17 cells and Foxp3-expressing T cells, when the ratio of Th17/Foxp3-expressing T cells in TILs was decreased in individual cases, it was more markedly decreased in TILs than normal cervical tissues.",22820395_5,-1,-1,-1,-1,18119,-1,0.0031774573,0.8329422,0.16388041
18123,TILs than,44,46,251,260,"RESULTS: Compared with controls, patients with UCC or CIN had a higher proportion of Th17 cells and Foxp3-expressing T cells, when the ratio of Th17/Foxp3-expressing T cells in TILs was decreased in individual cases, it was more markedly decreased in TILs than normal cervical tissues.",22820395_5,-1,-1,-1,-1,18123,-1,2.1377782e-05,0.99996483,1.3841114e-05
18124,tissues,48,49,277,284,"RESULTS: Compared with controls, patients with UCC or CIN had a higher proportion of Th17 cells and Foxp3-expressing T cells, when the ratio of Th17/Foxp3-expressing T cells in TILs was decreased in individual cases, it was more markedly decreased in TILs than normal cervical tissues.",22820395_5,-1,1,2,-1,18124,-1,0.0015366364,0.086957306,0.911506
18125,the cytokine(IL-6,2,4,11,28,"Meanwhile, the cytokine(IL-6, TGF- and IL-10) concentrations were significantly higher in UCC patients than those in healthy controls.",22820395_6,-1,-1,-1,-1,18125,-1,0.6366907,0.35579884,0.0075105075
18128,than those,16,18,104,114,"Meanwhile, the cytokine(IL-6, TGF- and IL-10) concentrations were significantly higher in UCC patients than those in healthy controls.",22820395_6,-1,-1,-1,-1,18128,-1,2.5527892e-05,0.99995613,1.8390907e-05
18130,Th17 cells,6,8,42,52,"Interestingly, the levels of intratumoral Th17 cells were positively correlated with MVD in tumors.",22820395_7,-1,-1,-1,-1,18130,-1,0.0002412342,0.0011034826,0.9986553
18136,Th17 cells,20,22,130,140,CONCLUSIONS: The imbalance of Th17/Foxp3-expressing T cells may play critical roles in the development and progression of UCC and Th17 cells may promote tumor progression by fostering angiogenesis.,22820395_8,-1,-1,-1,-1,18136,-1,0.0005167847,0.005473039,0.9940102
18139,the transcriptomes,2,4,13,31,"By comparing the transcriptomes of primary and metastatic tumor cells in a mouse model of spontaneous bone metastasis, we found that a substantial number of genes suppressed in bone metastases are targets of the interferon regulatory factor Irf7.",22820642_1,-1,-1,-1,-1,18139,-1,1.9822633e-05,0.9999701,1.0140307e-05
18140,tumor cells,8,10,58,69,"By comparing the transcriptomes of primary and metastatic tumor cells in a mouse model of spontaneous bone metastasis, we found that a substantial number of genes suppressed in bone metastases are targets of the interferon regulatory factor Irf7.",22820642_1,-1,-1,-1,-1,18140,-1,0.0025505873,0.20584397,0.79160553
18144,the interferon regulatory factor Irf7,34,39,208,245,"By comparing the transcriptomes of primary and metastatic tumor cells in a mouse model of spontaneous bone metastasis, we found that a substantial number of genes suppressed in bone metastases are targets of the interferon regulatory factor Irf7.",22820642_1,-1,-1,-1,-1,18144,-1,2.2959877e-05,0.99996316,1.3868124e-05
18146,tumor cells,4,6,23,34,Restoration of Irf7 in tumor cells or administration of interferon led to reduced bone metastases and prolonged survival time.,22820642_2,-1,-1,-1,-1,18146,-1,0.0038129354,0.39580497,0.6003821
18150,the interferon,4,6,21,35,"In mice deficient in the interferon (IFN) receptor or in natural killer (NK) and CD8(+) T cell responses, metastasis was accelerated, indicating that Irf7-driven suppression of metastasis was reliant on IFN signaling to host immune cells.",22820642_3,-1,-1,-1,-1,18150,-1,0.25509408,0.73964,0.005265943
18152,receptor,9,10,42,50,"In mice deficient in the interferon (IFN) receptor or in natural killer (NK) and CD8(+) T cell responses, metastasis was accelerated, indicating that Irf7-driven suppression of metastasis was reliant on IFN signaling to host immune cells.",22820642_3,0,1,2,-1,18152,-1,0.00051060156,0.008747709,0.9907417
18155,that Irf7-driven,29,31,145,161,"In mice deficient in the interferon (IFN) receptor or in natural killer (NK) and CD8(+) T cell responses, metastasis was accelerated, indicating that Irf7-driven suppression of metastasis was reliant on IFN signaling to host immune cells.",22820642_3,-1,-1,-1,-1,18155,-1,2.2988768e-05,0.9999647,1.2307817e-05
18163,Irf7-regulated genes,17,19,103,123,We confirmed the clinical relevance of these findings in over 800 patients in which high expression of Irf7-regulated genes in primary tumors was associated with prolonged bone metastasis-free survival.,22820642_4,-1,-1,-1,-1,18163,-1,1.9892816e-05,0.99996233,1.774679e-05
18165,This gene,0,2,0,9,This gene signature may identify patients that could benefit from IFN-based therapies.,22820642_5,-1,-1,-1,-1,18165,-1,2.9216435e-05,0.99995375,1.6991715e-05
18167,IFN-based therapies,10,12,66,85,This gene signature may identify patients that could benefit from IFN-based therapies.,22820642_5,-1,-1,-1,-1,18167,-1,0.9770462,0.01960793,0.0033459393
18177,cell transplantation,4,6,33,53,In allogeneic hematopoietic stem cell transplantation (allo-HSCT) therapy-related toxicity and alloreactivity increase inflammatory cytokines that might favor an MDSC accumulation.,22828446_2,-1,-1,-1,-1,18177,-1,0.0033727628,0.06451742,0.93210983
18178,therapy-related toxicity,9,11,66,90,In allogeneic hematopoietic stem cell transplantation (allo-HSCT) therapy-related toxicity and alloreactivity increase inflammatory cytokines that might favor an MDSC accumulation.,22828446_2,-1,-1,-1,-1,18178,-1,4.6468285e-05,0.99992776,2.5811822e-05
18179,cytokines that,15,17,132,146,In allogeneic hematopoietic stem cell transplantation (allo-HSCT) therapy-related toxicity and alloreactivity increase inflammatory cytokines that might favor an MDSC accumulation.,22828446_2,-1,-1,-1,-1,18179,-1,0.9268199,0.068417616,0.004762509
18183,These cells,0,2,0,11,These cells represent one of the few well-described human MDSC subsets under physiological and pathological conditions.,22828446_4,-1,-1,-1,-1,18183,-1,0.0032111867,0.18056831,0.81622046
18189,cells they,4,6,26,36,"Compared to healthy donor cells they were pSTAT1(low) (phosphorylated signal transducer and activator of transcription) and indoleamine 2,3-dioxygenase (IDO)(high).",22828446_6,-1,-1,-1,-1,18189,-1,0.0027256794,0.122425154,0.87484914
18199,T-cell-suppressive,5,6,25,43,"Overall, we identified a T-cell-suppressive monocytic population that expands after allo-HSCT.",22828446_9,-1,1,2,-1,18199,-1,0.00042305115,0.0027516626,0.99682534
18205,these cells,12,14,75,86,It will be of great interest to prospectively investigate the influence of these cells on the graft-versus-tumor and -host reaction.,22828446_11,-1,-1,-1,-1,18205,-1,0.00040925885,0.0063995174,0.9931912
18214,T-cell,8,9,40,46,"In addition, there is an association of T-cell large granular lymphocytic leukemia with rheumatoid arthritis.",22830400_2,-1,1,2,-1,18214,-1,3.4423494e-05,6.4464446e-05,0.99990106
18217,antigen-driven immune response,9,12,46,76,It is believed that LGL leukemia begins as an antigen-driven immune response with subsequent constitutive activation of cytotoxic T lymphocytes or natural killer cells through PDGF and IL-15 contributing to their survival.,22830400_3,-1,-1,-1,-1,18217,-1,0.99962723,0.0002061853,0.00016660096
18220,cells through,23,25,162,175,It is believed that LGL leukemia begins as an antigen-driven immune response with subsequent constitutive activation of cytotoxic T lymphocytes or natural killer cells through PDGF and IL-15 contributing to their survival.,22830400_3,-1,-1,-1,-1,18220,-1,0.003054331,0.0958066,0.9011391
18222,to their,29,31,204,212,It is believed that LGL leukemia begins as an antigen-driven immune response with subsequent constitutive activation of cytotoxic T lymphocytes or natural killer cells through PDGF and IL-15 contributing to their survival.,22830400_3,-1,-1,-1,-1,18222,-1,3.806357e-05,0.99994314,1.8815952e-05
18228,therapy,5,6,24,31,"However, no standard of therapy has been established, as large prospective trials have not been conducted.",22830400_6,0,1,-1,-1,18228,-1,2.4929177e-05,0.99995935,1.568509e-05
18230,to treatment,7,9,42,54,"In addition, some patients are refractory to treatment.",22830400_7,-1,-1,-1,-1,18230,-1,3.502804e-05,0.99994993,1.50304695e-05
18232,therapy,5,6,23,30,The lack of a curative therapy for LGL leukemia means that new treatment options are needed.,22830400_8,0,1,-1,-1,18232,-1,3.1919597e-05,0.999954,1.4139632e-05
18236,therapeutic treatment,13,15,91,112,Insight into the various dysregulated signaling pathways in LGL leukemia may provide novel therapeutic treatment modalities.,22830400_9,-1,-1,-1,-1,18236,-1,2.9295927e-05,0.9999577,1.3001029e-05
18238,cytokine TGF-1,5,7,40,55,Elevated levels of the immunoregulatory cytokine TGF-1 in cancer and HIV infection have been linked to the suppression of protective immune responses.,22859956_0,-1,-1,-1,-1,18238,-1,0.3213598,0.6676835,0.010956676
18239,to the,15,17,101,107,Elevated levels of the immunoregulatory cytokine TGF-1 in cancer and HIV infection have been linked to the suppression of protective immune responses.,22859956_0,-1,-1,-1,-1,18239,-1,2.4818726e-05,0.99996495,1.0231927e-05
18241,The transcriptional regulation,0,3,0,30,The transcriptional regulation of TGF-1 is complex and still not completely understood.,22859956_1,-1,-1,-1,-1,18241,-1,2.3961129e-05,0.99996614,9.928917e-06
18245,time that the transcription factor GLI2,6,12,29,68,We report here for the first time that the transcription factor GLI2 regulates the expression of TGF-1 in human CD4(+) T cells.,22859956_2,-1,-1,-1,-1,18245,-1,2.7232572e-05,0.99995816,1.4650297e-05
18255,the GLI2 activator,14,17,78,96,"At least two of these sites within the human TGF-1 promoter are regulated by the GLI2 activator as knockdown of GLI2 in regulatory CD4(+)CD25(hi) T cells, high producers of TGF-1, significantly decreased TGF-1 transcription.",22859956_4,-1,-1,-1,-1,18255,-1,2.606663e-05,0.9999578,1.6134712e-05
18259,TGF-1 transcription,35,37,206,226,"At least two of these sites within the human TGF-1 promoter are regulated by the GLI2 activator as knockdown of GLI2 in regulatory CD4(+)CD25(hi) T cells, high producers of TGF-1, significantly decreased TGF-1 transcription.",22859956_4,-1,-1,-1,-1,18259,-1,2.8865514e-05,0.9999511,1.9984682e-05
18260,nave,2,3,14,19,"Additionally, nave CD4(+) T cells, low producers of TGF-1, increased their basal level of TGF-1 mRNA following lentiviral infection with GLI2.",22859956_5,-1,-1,-1,-1,18260,-1,3.451571e-05,0.99995005,1.5430347e-05
18265,The transcriptional regulation,0,3,0,30,The transcriptional regulation of TGF-1 by GLI2 is a new extension to Sonic Hedgehog (SHH) and TGF-1 cross-regulation and may provide insight into the detrimental elevation of TGF-1 leading to pathogenesis in cancer and HIV infection.,22859956_6,-1,-1,-1,-1,18265,-1,2.2435263e-05,0.99996686,1.0662446e-05
18273,Tregs play,2,4,10,20,MDSCs and Tregs play an essential role in the immunosuppressive networks that contribute to tumor-immune evasion.,22891289_0,-1,-1,-1,-1,18273,-1,2.454106e-05,0.9999579,1.752172e-05
18276,to tumor-immune,13,15,89,104,MDSCs and Tregs play an essential role in the immunosuppressive networks that contribute to tumor-immune evasion.,22891289_0,-1,-1,-1,-1,18276,-1,0.00044523773,0.99947995,7.488157e-05
18280,function,9,10,60,68,The mechanisms by which tumors promote the expansion and/or function of these suppressive cells and the cross-talk between MDSC and Treg remain incompletely defined.,22891289_1,0,1,2,-1,18280,-1,0.00015693787,0.99974936,9.3696246e-05
18286,to Treg,8,10,57,64,Previous reports have suggested that MDSC may contribute to Treg induction in cancer.,22891289_2,-1,-1,-1,-1,18286,-1,3.3008084e-05,0.999956,1.0997171e-05
18287,that tumor-induced,5,7,28,46,"Herein, we provide evidence that tumor-induced gr-MDSCs, endowed with the potential of suppressing conventional T Lc, surprisingly impair TGF-1-mediated generation of CD4(+)CD25(+)FoxP3(+) iTregs.",22891289_3,-1,-1,-1,-1,18287,-1,2.0249008e-05,0.99996924,1.0478822e-05
18290,TGF-1-mediated generation,21,23,138,164,"Herein, we provide evidence that tumor-induced gr-MDSCs, endowed with the potential of suppressing conventional T Lc, surprisingly impair TGF-1-mediated generation of CD4(+)CD25(+)FoxP3(+) iTregs.",22891289_3,-1,-1,-1,-1,18290,-1,2.4916599e-05,0.9999572,1.7884047e-05
18313,the cytokine,32,34,210,222,"We tested how mcd-exosomes influence CD4+ T cell proliferation induced by bone marrow derived dendritic cells; we quantified NF-B activation in mature macrophages stimulated with mcd-exosomes, and we compared the cytokine profile of LPS-stimulated, IL-4 induced, and mcd-exosome treated macrophages.",22898052_1,-1,-1,-1,-1,18313,-1,0.23631091,0.7595337,0.0041553257
18320,the treated,17,19,114,125,"We observed that mcd-exosomes helped the maturation of dendritic cells, enhancing T cell proliferation induced by the treated dendritic cells.",22898052_2,-1,-1,-1,-1,18320,-1,2.5241547e-05,0.9999616,1.3150107e-05
18323,The cytokine,0,2,0,12,"The cytokine and chemokine profile of macrophages treated with tumor cell derived exosomes showed marked differences from those induced by either LPS or IL-4, and it suggested that exosomes may play a role in the tumor progression and metastasis formation through supporting tumor immune escape mechanisms.",22898052_4,-1,-1,-1,-1,18323,-1,0.20899571,0.7868005,0.0042038234
18326,tumor cell,9,11,63,73,"The cytokine and chemokine profile of macrophages treated with tumor cell derived exosomes showed marked differences from those induced by either LPS or IL-4, and it suggested that exosomes may play a role in the tumor progression and metastasis formation through supporting tumor immune escape mechanisms.",22898052_4,-1,-1,-1,-1,18326,-1,0.002753533,0.1679186,0.8293278
18331,the tumor,35,37,209,218,"The cytokine and chemokine profile of macrophages treated with tumor cell derived exosomes showed marked differences from those induced by either LPS or IL-4, and it suggested that exosomes may play a role in the tumor progression and metastasis formation through supporting tumor immune escape mechanisms.",22898052_4,-1,-1,-1,-1,18331,-1,1.9470002e-05,0.9999715,9.066177e-06
18336,therapy,18,19,129,136,"INTRODUCTION: In this study we describe a patient with a prolonged myasthenic crisis refractory to conventional immunomodulatory therapy who was treated with GM-CSF (granulocyte macrophage colony-stimulating factor, sargramostim).METHODS: T-regulatory cell (Treg) suppressive function and Foxp3 expression were evaluated before and after treatment with GM-CSF.RESULTS: Treatment with GM-CSF was associated with clinical improvement, expansion in the circulating numbers of Foxp3(+) cells, increase in Foxp3 expression levels in Tregs, early improvement in Treg suppressive capacity for AChR--induced T-cell proliferation, and subsequent enhancement in Treg suppression of polyclonal T-cell proliferation.",22907239_0,0,1,-1,-1,18336,-1,2.9446586e-05,0.99995446,1.607315e-05
18340,T-regulatory cell,32,34,239,256,"INTRODUCTION: In this study we describe a patient with a prolonged myasthenic crisis refractory to conventional immunomodulatory therapy who was treated with GM-CSF (granulocyte macrophage colony-stimulating factor, sargramostim).METHODS: T-regulatory cell (Treg) suppressive function and Foxp3 expression were evaluated before and after treatment with GM-CSF.RESULTS: Treatment with GM-CSF was associated with clinical improvement, expansion in the circulating numbers of Foxp3(+) cells, increase in Foxp3 expression levels in Tregs, early improvement in Treg suppressive capacity for AChR--induced T-cell proliferation, and subsequent enhancement in Treg suppression of polyclonal T-cell proliferation.",22907239_0,-1,-1,-1,-1,18340,-1,0.002356109,0.18654144,0.8111025
18342,function,38,39,276,284,"INTRODUCTION: In this study we describe a patient with a prolonged myasthenic crisis refractory to conventional immunomodulatory therapy who was treated with GM-CSF (granulocyte macrophage colony-stimulating factor, sargramostim).METHODS: T-regulatory cell (Treg) suppressive function and Foxp3 expression were evaluated before and after treatment with GM-CSF.RESULTS: Treatment with GM-CSF was associated with clinical improvement, expansion in the circulating numbers of Foxp3(+) cells, increase in Foxp3 expression levels in Tregs, early improvement in Treg suppressive capacity for AChR--induced T-cell proliferation, and subsequent enhancement in Treg suppression of polyclonal T-cell proliferation.",22907239_0,0,1,2,-1,18342,-1,5.871297e-05,0.99983823,0.00010300615
18365,the type,24,26,143,151,BACKGROUND: Several studies have documented modulation of Th17 and T regulatory (Treg) cells in various human malignancies which may vary with the type and extent of the disease.,22956260_0,-1,-1,-1,-1,18365,-1,2.6924035e-05,0.9999603,1.27617905e-05
18370,these two T cell subsets,24,29,146,170,"However, such data in patients with oral cancer is scarce and hence the current study was designed to elaborate the immunological balance between these two T cell subsets in oral cancer.",22956260_1,-1,-1,-1,-1,18370,-1,0.0035821842,0.1884969,0.80792093
18373,blood,13,14,74,79,METHODS AND RESULTS: We analyzed various T cell subsets in the peripheral blood of 45 oral squamous cell carcinoma (OSCC) patients and 40 healthy volunteers.,22956260_2,0,1,-1,-1,18373,-1,0.00011000035,0.998911,0.0009790079
18380,relation to,43,45,226,237,"We found that, compared with the healthy controls, patients had a significantly (p < 0.0001) higher proportion of both Th17 (CD4(+)IL17A(+)) and Treg (CD4(+)CD25(+)FOXP3(+)) cells, which further showed a reciprocal balance in relation to clinico-pathological parameters in patients.",22956260_3,-1,-1,-1,-1,18380,-1,2.1739548e-05,0.99996674,1.1563912e-05
18382,these cells,9,11,48,59,"We also detected a circulating CD8(+) subset of these cells in both patients and healthy controls, although the difference between the two groups was statistically insignificant.",22956260_4,-1,-1,-1,-1,18382,-1,0.0017936716,0.06496698,0.9332393
18384,the two,22,24,131,138,"We also detected a circulating CD8(+) subset of these cells in both patients and healthy controls, although the difference between the two groups was statistically insignificant.",22956260_4,-1,-1,-1,-1,18384,-1,2.7489894e-05,0.9999615,1.0983344e-05
18386,Th17 cells,3,5,22,32,"Higher frequencies of Th17 cells were found in patients with early stages and without lymph node involvement, while an increased prevalence of Tregs was associated with higher clinical stages and lymph node involvement.",22956260_5,-1,-1,-1,-1,18386,-1,0.00017558772,0.0006057586,0.9992187
18388,Th17 cells,2,4,10,20,"Moreover, Th17 cells were quantitatively and positively correlated to CD4(+)T and CD8(+)T cells and inversely correlated with Tregs.",22956260_6,-1,-1,-1,-1,18388,-1,0.00036970538,0.0025953222,0.9970349
18393,CD4(+)T,8,9,53,60,"Contrarily, Tregs showed a negative association with CD4(+)T and CD8(+)T cells.",22956260_7,-1,-1,-1,-1,18393,-1,0.0069869584,0.1303243,0.8626887
18394,CD8(+)T cells,10,12,65,78,"Contrarily, Tregs showed a negative association with CD4(+)T and CD8(+)T cells.",22956260_7,-1,-1,-1,-1,18394,-1,0.00017921608,0.0001722538,0.9996486
18399,factor,12,13,74,80,Such counter regulation of Th17 and Tregs may be a significant prognostic factor in oral cancer patients.,22956260_9,0,1,-1,-1,18399,-1,0.00048034635,0.99939024,0.0001294204
18401,histologically,11,12,85,99,"Using xMAP technology and RT-PCR, we investigated cytokine/chemokine profiles during histologically defined phases of disease: (i) no/mild, (ii) moderate, (iii) severe colitis without dysplasia/cancer and (iv) severe colitis with dysplasia/cancer, compared with age-matched wild-type (WT) littermates.",22962436_1,-1,-1,-1,-1,18401,-1,5.339258e-05,0.9999155,3.1096548e-05
18403,thymus,15,16,104,110,"The histology correlated with progressive increases in colon weight/cm and spleen weight, and decreased thymus weight, all more advanced in mice with dysplasia/cancer.",22962436_3,-1,1,2,-1,18403,-1,0.0006417209,0.99860233,0.00075594056
18407,TNF-,8,9,30,35,"IL-1, IL-6, IL-12p40, IL-17, TNF-, CCL2 and CXCL1 protein levels in colons, but not small intestines increased with colitis progression and were significantly increased in mice with moderate and severe colitis compared with WT mice, irrespective of the absence/presence of dysplasia/cancer.",22962436_4,0,1,-1,-1,18407,-1,0.00012480702,0.9998273,4.7922484e-05
18409,CXCL1 protein,12,14,46,59,"IL-1, IL-6, IL-12p40, IL-17, TNF-, CCL2 and CXCL1 protein levels in colons, but not small intestines increased with colitis progression and were significantly increased in mice with moderate and severe colitis compared with WT mice, irrespective of the absence/presence of dysplasia/cancer.",22962436_4,-1,-1,-1,-1,18409,-1,0.96696943,0.00993284,0.023097733
18411,IL-17 transcription,1,3,8,27,"Colonic IL-17 transcription increased 40- to 70-fold in all stages of colitis, whereas IFN- mRNA was gradually up-regulated 12- to 55-fold with colitis progression, and further to 62-fold in mice with dysplasia/cancer.",22962436_6,-1,-1,-1,-1,18411,-1,0.9916876,0.0052315784,0.0030807422
18420,FoxP3 transcription,0,2,0,19,"FoxP3 transcription was significantly enhanced (3.5-fold) in mice with moderate and severe colitis, but not in mice with dysplasia/cancer, compared with WT mice.",22962436_8,-1,-1,-1,-1,18420,-1,1.9128838e-05,0.9999691,1.1760796e-05
18421,analysis,2,3,27,35,"Constrained correspondence analysis demonstrated an association between increased protein levels of TNF-, CCL2, IL-1, IL-6 and CXCL1 and dysplasia/cancer.",22962436_9,0,1,-1,-1,18421,-1,4.1272968e-05,0.99991393,4.481006e-05
18422,protein,8,9,82,89,"Constrained correspondence analysis demonstrated an association between increased protein levels of TNF-, CCL2, IL-1, IL-6 and CXCL1 and dysplasia/cancer.",22962436_9,0,1,-1,-1,18422,-1,3.9775536e-05,0.9999198,4.047761e-05
18423,TNF-,11,12,100,105,"Constrained correspondence analysis demonstrated an association between increased protein levels of TNF-, CCL2, IL-1, IL-6 and CXCL1 and dysplasia/cancer.",22962436_9,0,1,-1,-1,18423,-1,5.0670904e-05,0.99992645,2.290067e-05
18428,T(h)1 cytokine transcription,15,18,98,126,"In conclusion, colonic responses are dominated by a mixed T(h)1/T(h)17 phenotype, with increasing T(h)1 cytokine transcription with progression of colitis in Gi2(-/-) mice.",22962436_10,-1,-1,-1,-1,18428,-1,9.840195e-05,0.99983215,6.939856e-05
18429,immunity,1,2,11,19,Anti-tumor immunity is thought to play a significant role in chemotherapeutic response of breast tumors.,22986814_0,0,-1,2,-1,18429,-1,0.9939672,0.005458739,0.0005740586
18430,thought to play,3,6,23,38,Anti-tumor immunity is thought to play a significant role in chemotherapeutic response of breast tumors.,22986814_0,-1,-1,-1,-1,18430,-1,3.3934823e-05,0.99995244,1.3579943e-05
18438,IL17F+ helper T cells,23,27,120,141,"In the present study, we investigated whether tumor infiltrating FOXP3+ regulatory T cells, CD8+ cytotoxic T cells, and IL17F+ helper T cells were associated with a pathological complete response (pCR) to neoadjuvant chemotherapy (NAC).",22986814_1,-1,-1,-1,-1,18438,-1,0.685457,0.0021111243,0.31243193
18450,IL17F+ T cells,10,13,47,61,"Intratumoral infiltration of FOXP3+, CD8+, and IL17F+ T cells was observed in 62.2, 80.0, and 62.2% of tumors, respectively.",22986814_4,-1,-1,-1,-1,18450,-1,0.7082648,0.0019816323,0.2897536
18457,analysis,1,2,13,21,Multivariate analysis indicated that only FOXP3 infiltrates (P=0.014) and the conventional predictive factor Ki67 (P=0.031) were statistically significant and independent predictors of pCR.,22986814_6,0,1,-1,-1,18457,-1,2.8507413e-05,0.9999503,2.1184767e-05
18461,factor,18,19,104,110,Multivariate analysis indicated that only FOXP3 infiltrates (P=0.014) and the conventional predictive factor Ki67 (P=0.031) were statistically significant and independent predictors of pCR.,22986814_6,0,1,-1,-1,18461,-1,0.0013004594,0.9982058,0.0004937371
18468,to NAC,19,21,108,114,"FOXP3 infiltrate, in combination with Ki67, could thus be used as a clinically useful predictor of response to NAC.",22986814_8,-1,-1,-1,-1,18468,-1,4.7309746e-05,0.999926,2.6675358e-05
18472,immunity,16,17,118,126,"The possible indirect mechanism through which chemotherapy exerts its anti-tumor activity, i.e., enhancing anti-tumor immunity by inhibiting FOXP3, was also suggested.",22986814_9,0,-1,2,-1,18472,-1,0.99933404,0.00039640503,0.00026951462
18474,The AP1 transcription factor,0,4,0,28,The AP1 transcription factor Batf3 is required for homeostatic development of CD8(+) classical dendritic cells that prime CD8 T-cell responses against intracellular pathogens.,22992524_0,-1,-1,-1,-1,18474,-1,2.432172e-05,0.9999647,1.0913173e-05
18475,cells that,15,17,106,116,The AP1 transcription factor Batf3 is required for homeostatic development of CD8(+) classical dendritic cells that prime CD8 T-cell responses against intracellular pathogens.,22992524_0,-1,-1,-1,-1,18475,-1,0.0044612307,0.12845953,0.8670793
18476,T-cell,19,20,127,133,The AP1 transcription factor Batf3 is required for homeostatic development of CD8(+) classical dendritic cells that prime CD8 T-cell responses against intracellular pathogens.,22992524_0,-1,1,2,-1,18476,-1,3.7386773e-05,4.333758e-05,0.9999192
18478,the cytokines interleukin,25,28,178,203,"Here we identify an alternative, Batf3-independent pathway in mice for CD8(+) dendritic cell development operating during infection with intracellular pathogens and mediated by the cytokines interleukin (IL)-12 and interferon-.",22992524_1,-1,-1,-1,-1,18478,-1,0.79645014,0.19801019,0.0055397144
18481,the related AP1 factors,11,15,83,106,"This alternative pathway results from molecular compensation for Batf3 provided by the related AP1 factors Batf, which also functions in T and B cells, and Batf2 induced by cytokines in response to infection.",22992524_2,-1,-1,-1,-1,18481,-1,7.308652e-05,0.99988854,3.8386686e-05
18482,functions,19,20,124,133,"This alternative pathway results from molecular compensation for Batf3 provided by the related AP1 factors Batf, which also functions in T and B cells, and Batf2 induced by cytokines in response to infection.",22992524_2,0,1,2,-1,18482,-1,0.00023819978,0.99968505,7.675354e-05
18490,factors,3,4,24,31,Compensation among BATF factors is based on the shared capacity of their leucine zipper domains to interact with non-AP1 factors such as IRF4 and IRF8 to mediate cooperative gene activation.,22992524_4,0,1,-1,-1,18490,-1,3.4250214e-05,0.9999281,3.763006e-05
18494,factors,19,20,121,128,Compensation among BATF factors is based on the shared capacity of their leucine zipper domains to interact with non-AP1 factors such as IRF4 and IRF8 to mediate cooperative gene activation.,22992524_4,0,1,-1,-1,18494,-1,3.871941e-05,0.9999186,4.2700427e-05
18496,IRF8 to,24,26,146,153,Compensation among BATF factors is based on the shared capacity of their leucine zipper domains to interact with non-AP1 factors such as IRF4 and IRF8 to mediate cooperative gene activation.,22992524_4,-1,-1,-1,-1,18496,-1,2.2287768e-05,0.99996364,1.4123057e-05
18500,immune responses to,16,19,113,132,"Conceivably, manipulating this alternative pathway of dendritic cell development could be of value in augmenting immune responses to vaccines.",22992524_5,-1,-1,-1,-1,18500,-1,0.9254067,0.07265726,0.001936028
18501,gene therapy,1,3,16,28,Immune-mediated gene therapy using adenovirus expressing Flt3 ligand and thymidine kinase followed by ganciclovir administration (Flt3/TK) effectively elicits tumor regression in preclinical glioma models.,22996231_0,-1,-1,-1,-1,18501,-1,3.0143423e-05,0.9999497,2.0178271e-05
18507,the therapeutic,6,8,35,50,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18507,-1,1.8698674e-05,0.9999727,8.569871e-06
18517,CD40L to,54,56,298,306,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18517,-1,0.0017135335,0.009961557,0.9883249
18518,T helper cell type,62,66,335,353,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18518,-1,0.0010968548,0.913871,0.08503217
18519,cell cytokines interleukin-12,69,72,377,406,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18519,-1,0.8332215,0.0015124426,0.16526611
18527,the tumor,105,107,574,583,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18527,-1,2.1805485e-05,0.9999683,9.946661e-06
18528,T helper cell type,111,115,605,623,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18528,-1,0.0019103682,0.6476359,0.35045373
18529,cytokines interferon-,116,118,626,648,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18529,-1,0.99986804,3.687433e-05,9.505841e-05
18530,interleukin-2 to,119,121,652,668,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18530,-1,0.9933795,0.0045014885,0.0021189607
18531,T-cell functions,123,125,686,702,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18531,-1,6.674771e-05,8.862026e-05,0.99984455
18534,the function,143,145,782,794,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18534,-1,3.3097553e-05,0.9999516,1.525127e-05
18537,T-cell functions,152,154,833,849,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,-1,-1,-1,18537,-1,7.600659e-05,0.00010593448,0.999818
18538,immunity,1,2,11,19,Anti-tumor immunity and tumor specific effector T-cell functions were assessed by cytotoxic T lymphocyte assay and intracellular IFN- staining.,22996231_3,0,-1,2,-1,18538,-1,0.9901467,0.009246004,0.0006072395
18540,T-cell functions,6,8,48,64,Anti-tumor immunity and tumor specific effector T-cell functions were assessed by cytotoxic T lymphocyte assay and intracellular IFN- staining.,22996231_3,-1,-1,-1,-1,18540,-1,4.246189e-05,8.671722e-05,0.9998708
18546,the nuclear factor kappa-B,13,17,87,113,"Our data showed that overexpression of interferon- or interleukin-2, or inhibition of the nuclear factor kappa-B within the tumor microenvironment, enhanced cytotoxic T lymphocyte-mediated immune responses and successfully extended the median survival of rats bearing intracranial RG2 when combined with Flt3L/TK.",22996231_4,-1,-1,-1,-1,18546,-1,3.0419047e-05,0.99995375,1.5854173e-05
18547,the tumor,18,20,121,130,"Our data showed that overexpression of interferon- or interleukin-2, or inhibition of the nuclear factor kappa-B within the tumor microenvironment, enhanced cytotoxic T lymphocyte-mediated immune responses and successfully extended the median survival of rats bearing intracranial RG2 when combined with Flt3L/TK.",22996231_4,-1,-1,-1,-1,18547,-1,1.8619909e-05,0.99997234,9.011911e-06
18548,T lymphocyte-mediated immune responses,24,28,168,206,"Our data showed that overexpression of interferon- or interleukin-2, or inhibition of the nuclear factor kappa-B within the tumor microenvironment, enhanced cytotoxic T lymphocyte-mediated immune responses and successfully extended the median survival of rats bearing intracranial RG2 when combined with Flt3L/TK.",22996231_4,-1,-1,-1,-1,18548,-1,0.1109416,0.0029880852,0.88607025
18552,T-cell functions,6,8,44,60,These findings indicate that enhancement of T-cell functions constitutes a critical therapeutic target to overcome immune evasion and enhance therapeutic efficacy for brain cancer.,22996231_5,-1,-1,-1,-1,18552,-1,4.1297542e-05,8.091451e-05,0.9998778
18553,therapeutic target to,11,14,84,105,These findings indicate that enhancement of T-cell functions constitutes a critical therapeutic target to overcome immune evasion and enhance therapeutic efficacy for brain cancer.,22996231_5,-1,-1,-1,-1,18553,-1,2.3579069e-05,0.99996686,9.542563e-06
18555,targets to,7,9,38,48,"In addition, our study provides novel targets to be used in combination with immune-therapeutic strategies for glioblastoma, which are currently being tested in the clinic.",22996231_6,-1,-1,-1,-1,18555,-1,2.2819766e-05,0.9999665,1.0638076e-05
18558,cell functions,7,9,46,60,Baseline levels of innate and adaptive immune cell functions were studied in patients with pancreatic cancer.,22996369_0,-1,-1,-1,-1,18558,-1,9.987049e-05,0.00013635428,0.9997638
18560,therapy then,13,15,71,83,The effects of pemetrexed were measured at 7 and 14 days after initial therapy then 14 days after combination therapy with gemcitabine.,22996369_1,-1,-1,-1,-1,18560,-1,2.3724222e-05,0.9999633,1.29764285e-05
18561,therapy,19,20,110,117,The effects of pemetrexed were measured at 7 and 14 days after initial therapy then 14 days after combination therapy with gemcitabine.,22996369_1,0,1,-1,-1,18561,-1,2.8991375e-05,0.9999541,1.6856467e-05
18568,cells that,12,14,81,91,Pemetrexed increased intracellular accumulation of interferon gamma (IFN) in NK cells that correlated negatively with survival.,22996369_5,-1,-1,-1,-1,18568,-1,0.003014785,0.13716787,0.8598174
18570,cells to,6,8,52,60,Addition of gemcitabine decreased IFN-producing NK cells to baseline.,22996369_6,-1,-1,-1,-1,18570,-1,0.0029975516,0.1207781,0.8762244
18572,therapy,19,20,117,124,Memory (CD45RO*) T cells enumerated at baseline correlated negatively with survival but were decreased by pemetrexed therapy.,22996369_7,0,1,-1,-1,18572,-1,2.8837123e-05,0.99995697,1.41614555e-05
18575,tumor tissue,12,14,75,87,"Memory T cells were increased in subjects with greater B7-H3 expression in tumor tissue, whereas OX40*-activated total T cells and helper T-cell subset were decreased.",22996369_8,-1,-1,-1,-1,18575,-1,2.1123784e-05,0.99996567,1.3172037e-05
18576,total T cells,19,22,113,126,"Memory T cells were increased in subjects with greater B7-H3 expression in tumor tissue, whereas OX40*-activated total T cells and helper T-cell subset were decreased.",22996369_8,-1,-1,-1,-1,18576,-1,0.0016961319,0.04199636,0.95630753
18577,helper T-cell subset,23,26,131,151,"Memory T cells were increased in subjects with greater B7-H3 expression in tumor tissue, whereas OX40*-activated total T cells and helper T-cell subset were decreased.",22996369_8,-1,-1,-1,-1,18577,-1,5.4888467e-05,5.861348e-05,0.9998865
18580,immunity,5,6,30,38,"In conclusion, innate NK-cell immunity and FoxP3*, CD8* T cells seemed beneficial to pancreatic cancer patients.",22996369_10,0,-1,2,-1,18580,-1,0.99796677,0.00021536148,0.0018179481
18587,immunity,12,13,85,93,Higher levels of B7-H3 expression in pancreatic tumors were detrimental to effective immunity.,22996369_11,0,-1,2,-1,18587,-1,0.99855024,0.0011155978,0.00033414993
18588,therapy,2,3,20,27,"Although pemetrexed therapy increased activation of a subset of NK cells to produce IFN, addition of gemcitabine abated those responses, decreasing IFN-producing NK cells, whereas NK cells producing interleukin-2 without IFN at this timepoint positively correlated with survival.",22996369_12,0,1,-1,-1,18588,-1,2.7058533e-05,0.99995935,1.3575607e-05
18590,cells to,10,12,67,75,"Although pemetrexed therapy increased activation of a subset of NK cells to produce IFN, addition of gemcitabine abated those responses, decreasing IFN-producing NK cells, whereas NK cells producing interleukin-2 without IFN at this timepoint positively correlated with survival.",22996369_12,-1,-1,-1,-1,18590,-1,0.002856628,0.067911364,0.92923206
18598,this timepoint,35,37,231,245,"Although pemetrexed therapy increased activation of a subset of NK cells to produce IFN, addition of gemcitabine abated those responses, decreasing IFN-producing NK cells, whereas NK cells producing interleukin-2 without IFN at this timepoint positively correlated with survival.",22996369_12,-1,-1,-1,-1,18598,-1,3.1231444e-05,0.99994874,2.0048508e-05
18600,adaptive immunity thus,3,6,20,42,Innate immunity and adaptive immunity thus are important in defense against pancreatic cancer.,22996369_13,-1,-1,-1,-1,18600,-1,0.673041,0.32235682,0.0046022106
18612,the tumor,8,10,60,69,"Tregs can prevent anti-tumor-specific T cells from clearing the tumor, making Tregs a significant barrier for effective immunotherapy.",23000301_1,-1,-1,-1,-1,18612,-1,2.4528985e-05,0.9999654,1.0055362e-05
18617,blood,13,14,71,76,An increase in the number of Tregs has been detected in the peripheral blood and tumor infiltrating lymphocytes of patients with hepatocellular carcinoma.,23000301_2,0,1,-1,-1,18617,-1,0.000112694164,0.9991714,0.00071598386
18621,antigen-presenting cells that play,6,10,26,60,Dendritic cells (DCs) are antigen-presenting cells that play a pivotal role in the initiation of immune responses.,23000301_3,-1,-1,-1,-1,18621,-1,0.83745646,0.13840334,0.02414019
18632,immunity,28,29,186,194,The evidence for their ability to act as natural adjuvant in the stimulation of specific anti-tumor cytotoxic T lymphocytes and in the induction of protective and therapeutic anti-tumor immunity is now overwhelming.,23000301_4,0,-1,2,-1,18632,-1,0.9990023,0.0006304736,0.00036733362
18638,the tumor,21,23,123,132,The aim of our study was to investigate the variation of Tregs in hepatocellular carcinoma mice and how Tregs derived from the tumor mice affect DCs' function.,23000301_5,-1,-1,-1,-1,18638,-1,2.0872789e-05,0.99996865,1.0446048e-05
18639,function,27,28,150,158,The aim of our study was to investigate the variation of Tregs in hepatocellular carcinoma mice and how Tregs derived from the tumor mice affect DCs' function.,23000301_5,0,1,2,-1,18639,-1,7.767315e-05,0.99984956,7.2727e-05
18640,that Tregs,2,4,9,19,We found that Tregs derived from the tumor mice down-regulated the expression of costimulatory molecules CD80/CD86 on DCs and inhibited the production of TNF- and IL-12 from DCs.,23000301_6,-1,-1,-1,-1,18640,-1,1.8844112e-05,0.99997187,9.238931e-06
18641,the tumor,6,8,33,42,We found that Tregs derived from the tumor mice down-regulated the expression of costimulatory molecules CD80/CD86 on DCs and inhibited the production of TNF- and IL-12 from DCs.,23000301_6,-1,-1,-1,-1,18641,-1,1.8645014e-05,0.9999713,1.0111021e-05
18644,TNF-,23,24,154,159,We found that Tregs derived from the tumor mice down-regulated the expression of costimulatory molecules CD80/CD86 on DCs and inhibited the production of TNF- and IL-12 from DCs.,23000301_6,0,1,-1,-1,18644,-1,4.876616e-05,0.9999337,1.7468788e-05
18647,function,2,3,16,24,"The suppressive function of Tregs was mediated by cell-to-cell contact, CTLA-4 expression and IL-10 secretion.",23000301_7,0,1,2,-1,18647,-1,7.231006e-05,0.99984694,8.0772166e-05
18656,to the tumor,21,24,148,160,"In conclusion, these mechanisms acting in hepatocellular carcinoma may be necessary to better understand the immunosuppression of Tregs and helpful to the tumor immunotherapy.",23000301_8,-1,-1,-1,-1,18656,-1,4.597117e-05,0.99993825,1.5785103e-05
18678,The tumor-bearing,0,2,0,17,"The tumor-bearing mice had longer survival times and slower tumor growth rates following treatment with CY, but its effects were temporary.",23000689_4,-1,-1,-1,-1,18678,-1,2.2103302e-05,0.9999659,1.2036787e-05
18701,therapy,33,34,214,221,"The changes in intracellular cAMP concentrations correlated with the upregulation of effector T cells and the downregulation of Tregs, indicating the close association of cAMP analogs and low-dose CY in the immune therapy of B-cell lymphoma.",23000689_7,0,1,-1,-1,18701,-1,2.944886e-05,0.9999554,1.5095109e-05
18715,tumor cell,22,24,138,148,"CSC-enriched spheroid culture-derived cells (SDC) exhibited higher expression of ALDH, ICAM1 and of stem/progenitor cell markers on all 3 tumor cell lines investigated and lower MHC class I on the cervical cancer cell line as compared to their monolayer-derived cells (MDC).RESULTS: The expression of ICAM1 and MHCI was upregulated by IFN- treatment.",23001491_2,-1,-1,-1,-1,18715,-1,0.002896193,0.23116337,0.7659404
18718,to their,39,41,235,243,"CSC-enriched spheroid culture-derived cells (SDC) exhibited higher expression of ALDH, ICAM1 and of stem/progenitor cell markers on all 3 tumor cell lines investigated and lower MHC class I on the cervical cancer cell line as compared to their monolayer-derived cells (MDC).RESULTS: The expression of ICAM1 and MHCI was upregulated by IFN- treatment.",23001491_2,-1,-1,-1,-1,18718,-1,2.322309e-05,0.99996364,1.3179248e-05
18722,IFN- treatment,54,56,335,350,"CSC-enriched spheroid culture-derived cells (SDC) exhibited higher expression of ALDH, ICAM1 and of stem/progenitor cell markers on all 3 tumor cell lines investigated and lower MHC class I on the cervical cancer cell line as compared to their monolayer-derived cells (MDC).RESULTS: The expression of ICAM1 and MHCI was upregulated by IFN- treatment.",23001491_2,-1,-1,-1,-1,18722,-1,0.99530655,0.0027857483,0.0019076698
18727,the subset,2,4,9,19,"Finally, the subset of ALDH(high) expressing SDC presented more sensitivity toward CD8(+) CTL killing than the ALDH(low) SDC.CONCLUSIONS: Tumor therapy resistance has been attributed to cancer stem cells (CSC).",23001491_5,-1,-1,-1,-1,18727,-1,0.0040115695,0.35978445,0.636204
18730,than the,17,19,102,110,"Finally, the subset of ALDH(high) expressing SDC presented more sensitivity toward CD8(+) CTL killing than the ALDH(low) SDC.CONCLUSIONS: Tumor therapy resistance has been attributed to cancer stem cells (CSC).",23001491_5,-1,-1,-1,-1,18730,-1,2.5753017e-05,0.9999567,1.753977e-05
18731,Tumor therapy,23,25,138,151,"Finally, the subset of ALDH(high) expressing SDC presented more sensitivity toward CD8(+) CTL killing than the ALDH(low) SDC.CONCLUSIONS: Tumor therapy resistance has been attributed to cancer stem cells (CSC).",23001491_5,-1,-1,-1,-1,18731,-1,2.4383435e-05,0.999964,1.1638638e-05
18734,to CTL-mediated,7,9,39,54,We show in vitro susceptibility of CSC to CTL-mediated lysis.,23001491_6,-1,-1,-1,-1,18734,-1,0.0024718868,0.16537036,0.8321578
18741,immune response to treat,3,7,24,48,Harnessing the adaptive immune response to treat malignancy is now a clinical reality.,23008334_0,-1,-1,-1,-1,18741,-1,0.54361326,0.4519141,0.004472611
18742,to treat,4,6,28,36,"Several strategies are used to treat melanoma; however, very few result in a complete response.",23008334_1,-1,-1,-1,-1,18742,-1,2.4498575e-05,0.99996376,1.17261725e-05
18745,immunity,11,12,64,72,CD4(+) T cells are important and potent mediators of anti-tumor immunity and adoptive transfer of specific CD4(+) T cells can promote tumor regression in mice and patients.,23008334_2,0,-1,2,-1,18745,-1,0.9996716,0.000175977,0.00015244565
18750,immunity,18,19,113,121,"OX40, a costimulatory molecule expressed primarily on activated CD4(+) T cells, promotes and enhances anti-tumor immunity with limited success on large tumors in mice.",23008334_3,0,-1,2,-1,18750,-1,0.99903727,0.00062700163,0.0003357249
18762,Th2 cytokines,47,49,304,317,"We show that OX40 engagement, in the context of chemotherapy-induced lymphopenia, induces a novel CD4(+) T cell population characterized by the expression of the master regulator eomesodermin that leads to both terminal differentiation and central memory phenotype, with concomitant secretion of Th1 and Th2 cytokines.",23008334_4,-1,-1,-1,-1,18762,-1,0.27429414,0.7122936,0.013412205
18768,the therapy,3,5,15,26,The potency of the therapy extends to support a bystander killing effect of antigen loss variants.,23008334_6,-1,-1,-1,-1,18768,-1,2.4821611e-05,0.9999658,9.442755e-06
18771,that these,3,5,17,27,Our results show that these uniquely programmed effector CD4(+) T cells have a distinctive phenotype with increased tumoricidal capability and support the use of immune modulation in reprogramming the phenotype of CD4(+) T cells.,23008334_7,-1,-1,-1,-1,18771,-1,1.6555538e-05,0.9999734,1.0085358e-05
18777,The receptor tyrosine,0,3,0,21,"The receptor tyrosine kinase inhibitor, sunitinib, is astonishingly effective in its capacity to reduce MDSCs in peripheral tissues such as blood (human) and spleen (mouse), restoring responsiveness of bystander T lymphocytes to TcR stimulation.",23017141_0,-1,-1,-1,-1,18777,-1,3.118711e-05,0.9999435,2.5281226e-05
18779,tissues,19,20,124,131,"The receptor tyrosine kinase inhibitor, sunitinib, is astonishingly effective in its capacity to reduce MDSCs in peripheral tissues such as blood (human) and spleen (mouse), restoring responsiveness of bystander T lymphocytes to TcR stimulation.",23017141_0,-1,1,2,-1,18779,-1,0.00022382774,0.996102,0.0036742033
18780,blood,22,23,140,145,"The receptor tyrosine kinase inhibitor, sunitinib, is astonishingly effective in its capacity to reduce MDSCs in peripheral tissues such as blood (human) and spleen (mouse), restoring responsiveness of bystander T lymphocytes to TcR stimulation.",23017141_0,0,1,-1,-1,18780,-1,4.805059e-05,0.9998915,6.0417413e-05
18781,T lymphocytes to TcR,36,40,212,232,"The receptor tyrosine kinase inhibitor, sunitinib, is astonishingly effective in its capacity to reduce MDSCs in peripheral tissues such as blood (human) and spleen (mouse), restoring responsiveness of bystander T lymphocytes to TcR stimulation.",23017141_0,-1,-1,-1,-1,18781,-1,0.0040262686,0.2640859,0.73188794
18792,that GM-CSF,16,18,93,104,"The presence or absence of GM-CSF is likely the major determinant in each compartment, given that GM-CSF's capacity to preempt STAT3-dependent with dominant STAT5-dependent hematopoietic programming confers sunitinib resistance and redirects differentiation from the n-MDSC lineage to the more versatile monocytoid (m-MDSC) lineage.",23017141_4,-1,-1,-1,-1,18792,-1,0.8780073,0.114568345,0.0074243755
18797,to the,38,40,282,288,"The presence or absence of GM-CSF is likely the major determinant in each compartment, given that GM-CSF's capacity to preempt STAT3-dependent with dominant STAT5-dependent hematopoietic programming confers sunitinib resistance and redirects differentiation from the n-MDSC lineage to the more versatile monocytoid (m-MDSC) lineage.",23017141_4,-1,-1,-1,-1,18797,-1,2.2489205e-05,0.9999622,1.5258911e-05
18809,to T cell-secreted IFN-,26,30,179,203,"Ironically, m-MDSCs manifesting resistance to sunitinib also have the greatest potential to differentiate into tumoricidal accessory cells, by virtue of their capacity to respond to T cell-secreted IFN- or to TLR agonists with nitric oxide and peroxynitrate production.",23017141_6,-1,-1,-1,-1,18809,-1,0.7809189,0.17471601,0.044365108
18810,to TLR agonists,31,34,207,222,"Ironically, m-MDSCs manifesting resistance to sunitinib also have the greatest potential to differentiate into tumoricidal accessory cells, by virtue of their capacity to respond to T cell-secreted IFN- or to TLR agonists with nitric oxide and peroxynitrate production.",23017141_6,-1,-1,-1,-1,18810,-1,0.0016307238,0.9980129,0.0003563088
18811,cells play,1,3,10,20,Dendritic cells play a central role in keeping the balance between immunity and immune tolerance.,23049782_0,-1,-1,-1,-1,18811,-1,0.0019175116,0.0716057,0.9264768
18813,immunity,11,12,67,75,Dendritic cells play a central role in keeping the balance between immunity and immune tolerance.,23049782_0,0,-1,2,-1,18813,-1,0.2935386,0.7048466,0.0016147435
18815,factor,2,3,6,12,"A key factor in this equilibrium is the lifespan of DC, as its reduction restrains antigen availability leading to termination of immune responses.",23049782_1,0,1,-1,-1,18815,-1,0.0003806345,0.9994838,0.00013546301
18817,the lifespan,7,9,36,48,"A key factor in this equilibrium is the lifespan of DC, as its reduction restrains antigen availability leading to termination of immune responses.",23049782_1,-1,-1,-1,-1,18817,-1,2.6036483e-05,0.99996316,1.0769702e-05
18819,to termination,19,21,112,126,"A key factor in this equilibrium is the lifespan of DC, as its reduction restrains antigen availability leading to termination of immune responses.",23049782_1,-1,-1,-1,-1,18819,-1,3.3400185e-05,0.9999471,1.9482286e-05
18822,lifespan,8,9,44,52,"Lack of p50 in murine DC promoted increased lifespan, enhanced level of maturation associated with increased expression of the proinflammatory cytokines IL-1, IL-18 and IFN-, enhanced capacity of activating and expanding CD4(+) and CD8(+) T cells in vivo and decreased ability to induce differentiation of FoxP3(+) regulatory T cells.",23049782_3,0,-1,2,-1,18822,-1,2.7602066e-05,0.9999596,1.2785731e-05
18824,cytokines IL-1,21,23,143,157,"Lack of p50 in murine DC promoted increased lifespan, enhanced level of maturation associated with increased expression of the proinflammatory cytokines IL-1, IL-18 and IFN-, enhanced capacity of activating and expanding CD4(+) and CD8(+) T cells in vivo and decreased ability to induce differentiation of FoxP3(+) regulatory T cells.",23049782_3,-1,-1,-1,-1,18824,-1,0.99978083,5.803673e-05,0.00016112755
18831,antigen-pulsed LPS-treated,8,10,56,82,"In agreement, vaccination of melanoma-bearing mice with antigen-pulsed LPS-treated p50(-/-) BM-DC boosted antitumor immunity and inhibition of tumor growth.",23049782_4,-1,-1,-1,-1,18831,-1,0.5912857,0.39208892,0.01662545
18832,immunity,15,16,116,124,"In agreement, vaccination of melanoma-bearing mice with antigen-pulsed LPS-treated p50(-/-) BM-DC boosted antitumor immunity and inhibition of tumor growth.",23049782_4,0,-1,2,-1,18832,-1,0.9983546,0.0012103408,0.00043499752
18837,tuning the,23,25,154,164,"We propose that nuclear accumulation of the p50 NF-B subunit in DC, as occurring during lipopolysaccharide-driven maturation, is a homeostatic mechanism tuning the balance between uncontrolled activation of adaptive immunity and immune tolerance.",23049782_5,-1,-1,-1,-1,18837,-1,3.3886372e-05,0.99995315,1.3018886e-05
18841,cytokine that plays,5,8,42,61,Interleukin (IL)-17 is a pro-inflammatory cytokine that plays critical roles in host defense against extracellular bacteria and fungi and also in the pathogenesis of autoimmune diseases.,23052209_0,-1,-1,-1,-1,18841,-1,0.7773223,0.21728668,0.0053909793
18843,TCR+ T,3,5,11,19,"While CD4+ TCR+ T helper (Th) 17 cells are the best-described cellular source of IL-17, many innate-like T cells are in fact potent producers of IL-17.",23052209_1,-1,-1,-1,-1,18843,-1,3.9755134e-05,0.99992263,3.754798e-05
18853,the IL-17,8,10,59,68,"Given the increasing interest in therapeutic modulation of the IL-17 axis, it is crucial to better understand the cellular origins of IL-17 in various infection and diseases settings.",23052209_2,-1,-1,-1,-1,18853,-1,0.08909195,0.9085949,0.0023131722
18855,the cellular,18,20,110,122,"Given the increasing interest in therapeutic modulation of the IL-17 axis, it is crucial to better understand the cellular origins of IL-17 in various infection and diseases settings.",23052209_2,-1,-1,-1,-1,18855,-1,0.0042699096,0.6386162,0.3571139
18858,IL-17-producing T cells,5,8,32,55,"While the diverse population of IL-17-producing T cells share many common characteristics, notable differences also exist.",23052209_3,-1,-1,-1,-1,18858,-1,0.6101876,0.0025633187,0.38724917
18861,IL-17-producing T cell types,9,13,48,76,"In this review, we discuss the heterogeneity of IL-17-producing T cell types focusing on their development, regulation, and function.",23052209_4,-1,-1,-1,-1,18861,-1,0.5064095,0.0042082816,0.48938218
18864,function,21,22,124,132,"In this review, we discuss the heterogeneity of IL-17-producing T cell types focusing on their development, regulation, and function.",23052209_4,0,1,2,-1,18864,-1,7.0405e-05,0.9998901,3.949446e-05
18865,T-cell,0,1,0,6,"T-cell immunodeficiency is a common feature in patients with chronic myeloid leukemia (CML), and deficiency in CD3 levels was detected in T cells from these patients, which may represent a characteristic that is related to a lower T cell activation.",23057733_0,-1,1,2,-1,18865,-1,3.1688305e-05,4.649757e-05,0.9999218
18866,deficiency,17,18,97,107,"T-cell immunodeficiency is a common feature in patients with chronic myeloid leukemia (CML), and deficiency in CD3 levels was detected in T cells from these patients, which may represent a characteristic that is related to a lower T cell activation.",23057733_0,0,1,-1,-1,18866,-1,7.239141e-05,0.99978596,0.00014170374
18870,related to,37,39,212,222,"T-cell immunodeficiency is a common feature in patients with chronic myeloid leukemia (CML), and deficiency in CD3 levels was detected in T cells from these patients, which may represent a characteristic that is related to a lower T cell activation.",23057733_0,-1,-1,-1,-1,18870,-1,2.9888604e-05,0.9999498,2.0245812e-05
18877,TCR,19,20,110,113,"In this study, we explored the possibility that forced TCR gene expression may upreg-u-late T cell receptor (TCR) signaling activation and reverse interleukin-2 (IL-2) production in T cells from patients with CML.",23057733_1,-1,1,2,-1,18877,-1,2.5344245e-05,0.99995553,1.9161736e-05
18883,cells that,13,15,88,98,"Phosphorylated TCR, phosphorylated NF-B, and the IL-2 level in TCR-transfected CD3+T cells that were activated with anti-CD3 and anti-CD28 antibodies were measured by Western blot and enzyme-linked immunosorbent assay (ELISA).",23057733_3,-1,-1,-1,-1,18883,-1,0.0029920528,0.108055286,0.88895255
18889,gene transfection,40,42,269,286,"After CD3 and CD28 antibody stimulation, a significantly higher phosphorylated TCR chain level was demonstrated, and an increased IL-2 production in TCR-upregulated T cells was associated with the increased expression of the phosphorylated NF-B. In conclusion, TCR gene transfection could restore TCR chain deficiency and enhance IL-2 production in T cells from patients with CML.",23057733_5,-1,-1,-1,-1,18889,-1,2.2636938e-05,0.99996185,1.5535468e-05
18890,deficiency,46,47,312,322,"After CD3 and CD28 antibody stimulation, a significantly higher phosphorylated TCR chain level was demonstrated, and an increased IL-2 production in TCR-upregulated T cells was associated with the increased expression of the phosphorylated NF-B. In conclusion, TCR gene transfection could restore TCR chain deficiency and enhance IL-2 production in T cells from patients with CML.",23057733_5,0,1,-1,-1,18890,-1,0.00013230905,0.9993654,0.00050229125
18898,tumor antigens to Cytotoxic T Lymphocytes,48,54,289,330,"Neuroblastoma (NB), the most common solid extracranial cancer of childhood, displays a remarkable low expression of Major Histocompatibility Complex class I (MHC-I) and Antigen Processing Machinery (APM) molecules, including Endoplasmic Reticulum (ER) Aminopeptidases, and poorly presents tumor antigens to Cytotoxic T Lymphocytes (CTL).",23071666_0,-1,-1,-1,-1,18898,-1,0.008009594,0.21088508,0.7811054
18900,that this,4,6,25,34,We have previously shown that this is due to low expression of the transcription factor NF-kB p65.,23071666_1,-1,-1,-1,-1,18900,-1,2.160551e-05,0.99996865,9.715843e-06
18902,the transcription factor NF-kB,12,16,63,93,We have previously shown that this is due to low expression of the transcription factor NF-kB p65.,23071666_1,-1,-1,-1,-1,18902,-1,2.4211653e-05,0.99996364,1.21005105e-05
18905,the Interferon Regulatory Factor 1,12,17,50,84,"Herein, we show that not only NF-kB p65, but also the Interferon Regulatory Factor 1 (IRF1) and certain APM components are low in a subset of NB cell lines with aggressive features.",23071666_2,-1,-1,-1,-1,18905,-1,2.461668e-05,0.99995327,2.2117572e-05
18918,the three,4,6,24,33,"Absence and presence of the three molecules neatly segregated between high-grade and low-grade NB, respectively.",23071666_5,-1,-1,-1,-1,18918,-1,0.00020916556,0.99951184,0.0002789639
18923,to those,24,26,157,165,"Finally, APM reconstitution by double IRF1/p65 transfection rendered a NB cell line susceptible to killing by anti MAGE-A3 CTLs, lytic efficiency comparable to those seen upon IFN- treatment.",23071666_6,-1,-1,-1,-1,18923,-1,2.6579295e-05,0.99995744,1.592307e-05
18924,IFN- treatment,28,30,176,191,"Finally, APM reconstitution by double IRF1/p65 transfection rendered a NB cell line susceptible to killing by anti MAGE-A3 CTLs, lytic efficiency comparable to those seen upon IFN- treatment.",23071666_6,-1,-1,-1,-1,18924,-1,0.9948068,0.0029985178,0.002194657
18935,therapy,26,27,183,190,These findings provide molecular insight into defective MHC-I expression in NB cells and provide the rational for T cell-based immunotherapy in NB variants refractory to conventional therapy.,23071666_8,0,1,-1,-1,18935,-1,3.2237484e-05,0.99995303,1.472561e-05
18936,The natural,0,2,0,11,"The natural killer T (NKT) cell ligand, alpha-galactosylceramide (-GalCer), represents a potential adjuvant to boost immunotherapeutic vaccination strategies against poorly immunogenic cancers.",23090488_0,-1,-1,-1,-1,18936,-1,3.2277585e-05,0.9999565,1.1245905e-05
18943,the therapeutic,8,10,42,57,The objective of this study was to assess the therapeutic potential of an -GalCer-loaded tumor-cell vaccine against solid tumors in mice and to enhance the effectiveness of this approach by removing immune suppression associated with the activity of Foxp3(+) regulatory T cells (Tregs).,23090488_1,-1,-1,-1,-1,18943,-1,2.0059351e-05,0.9999716,8.36652e-06
18955,tumor cells,15,17,95,106,"In the B16F10 melanoma model, we show that single vaccination with irradiated, -GalCer-loaded tumor cells resulted in suppression of established subcutaneous (s.c.) B16F10 tumor growth, which was mediated by NKT cell-dependent IFN- production and enhanced in the absence of IL-17A. Selective depletion of Foxp3(+) Tregs in transgenic DEpletion of REGulatory T cells (DEREG) mice led to significant inhibition of B16F10 tumor growth and enhanced survival of mice receiving vaccination.",23090488_2,-1,-1,-1,-1,18955,-1,0.004234076,0.4604823,0.53528357
18957,cell-dependent IFN-,36,38,213,233,"In the B16F10 melanoma model, we show that single vaccination with irradiated, -GalCer-loaded tumor cells resulted in suppression of established subcutaneous (s.c.) B16F10 tumor growth, which was mediated by NKT cell-dependent IFN- production and enhanced in the absence of IL-17A. Selective depletion of Foxp3(+) Tregs in transgenic DEpletion of REGulatory T cells (DEREG) mice led to significant inhibition of B16F10 tumor growth and enhanced survival of mice receiving vaccination.",23090488_2,-1,-1,-1,-1,18957,-1,0.39351892,0.0025053243,0.60397583
18969,immunity,16,17,91,99,Short-term elimination of Foxp3(+) Tregs (<7 days) was sufficient to boost vaccine-induced immunity.,23090488_3,0,-1,2,-1,18969,-1,0.99832064,0.0012719134,0.00040732406
18970,therapy,5,6,45,52,"Enhanced antitumor activity with combination therapy was associated with an increase in systemic NK cell and effector CD8(+) T-cell activation and IFN- production, as well as infiltration of effector CD8(+) T cells into the tumor.",23090488_4,0,1,-1,-1,18970,-1,2.4852454e-05,0.9999621,1.3003753e-05
18975,the tumor,36,38,221,230,"Enhanced antitumor activity with combination therapy was associated with an increase in systemic NK cell and effector CD8(+) T-cell activation and IFN- production, as well as infiltration of effector CD8(+) T cells into the tumor.",23090488_4,-1,-1,-1,-1,18975,-1,2.0492133e-05,0.99996924,1.0281985e-05
18977,that transient,5,7,36,50,"Overall, these findings demonstrate that transient depletion of Foxp3(+) Tregs constitutes a highly effective strategy to improve the therapeutic efficacy of anticancer vaccination with NKT cell adjuvants.",23090488_5,-1,-1,-1,-1,18977,-1,1.9471934e-05,0.9999716,8.858872e-06
18981,the therapeutic,19,21,130,145,"Overall, these findings demonstrate that transient depletion of Foxp3(+) Tregs constitutes a highly effective strategy to improve the therapeutic efficacy of anticancer vaccination with NKT cell adjuvants.",23090488_5,-1,-1,-1,-1,18981,-1,2.3112781e-05,0.99996793,8.9326295e-06
18983,protein,1,2,14,21,Water-soluble protein signals (pheromones) of the ciliate Euplotes have been supposed to be functional precursors of growth factors and cytokines that regulate cell-cell interaction in multi-cellular eukaryotes.,23103669_0,0,1,-1,-1,18983,-1,0.006098902,0.9930188,0.0008822121
18986,functional precursors,15,17,92,113,Water-soluble protein signals (pheromones) of the ciliate Euplotes have been supposed to be functional precursors of growth factors and cytokines that regulate cell-cell interaction in multi-cellular eukaryotes.,23103669_0,-1,-1,-1,-1,18986,-1,0.0065594,0.36381716,0.6296235
18987,factors,19,20,124,131,Water-soluble protein signals (pheromones) of the ciliate Euplotes have been supposed to be functional precursors of growth factors and cytokines that regulate cell-cell interaction in multi-cellular eukaryotes.,23103669_0,0,1,-1,-1,18987,-1,0.99971396,0.00011577082,0.00017027419
18988,cytokines that,21,23,136,150,Water-soluble protein signals (pheromones) of the ciliate Euplotes have been supposed to be functional precursors of growth factors and cytokines that regulate cell-cell interaction in multi-cellular eukaryotes.,23103669_0,-1,-1,-1,-1,18988,-1,0.90515107,0.090773165,0.0040757833
18991,that native,4,6,28,39,"This work provides evidence that native preparations of the Euplotes raikovi pheromone Er-1 (a helical protein of 40 amino acids) specifically increases viability, DNA synthesis, proliferation, and the production of interferon-, tumor necrosis factor-, interleukin (IL)-1, IL-2, and IL-13 in human Jurkat T-cells.",23103669_1,-1,-1,-1,-1,18991,-1,1.9825917e-05,0.9999707,9.4467005e-06
18993,helical protein,15,17,95,110,"This work provides evidence that native preparations of the Euplotes raikovi pheromone Er-1 (a helical protein of 40 amino acids) specifically increases viability, DNA synthesis, proliferation, and the production of interferon-, tumor necrosis factor-, interleukin (IL)-1, IL-2, and IL-13 in human Jurkat T-cells.",23103669_1,-1,-1,-1,-1,18993,-1,0.000110644214,0.99965215,0.00023715314
18997,factor-,39,40,245,253,"This work provides evidence that native preparations of the Euplotes raikovi pheromone Er-1 (a helical protein of 40 amino acids) specifically increases viability, DNA synthesis, proliferation, and the production of interferon-, tumor necrosis factor-, interleukin (IL)-1, IL-2, and IL-13 in human Jurkat T-cells.",23103669_1,0,1,-1,-1,18997,-1,0.99987817,4.5852204e-05,7.593913e-05
19000,Jurkat T-cells,50,52,301,315,"This work provides evidence that native preparations of the Euplotes raikovi pheromone Er-1 (a helical protein of 40 amino acids) specifically increases viability, DNA synthesis, proliferation, and the production of interferon-, tumor necrosis factor-, interleukin (IL)-1, IL-2, and IL-13 in human Jurkat T-cells.",23103669_1,-1,-1,-1,-1,19000,-1,9.1435635e-05,0.0003644223,0.9995442
19004,receptor,16,17,83,91,"Also, Er-1 significantly decreases the mRNA levels of the  and  subunits of IL-2 receptor (IL-2R), while the mRNA levels of the  subunit appeared to be not affected.",23103669_2,0,1,2,-1,19004,-1,0.0010170322,0.92814606,0.07083699
19009,T-cell treatments,1,3,7,24,"Jurkat T-cell treatments with Er-1 induced the down-regulation of the IL-2R subunit by a reversible and time-dependent endocytosis, and increased the levels of phosphorylation of the extracellular signal-regulated kinases (ERK).",23103669_3,-1,-1,-1,-1,19009,-1,0.0010852929,0.05098868,0.94792604
19016,The cell-type,0,2,0,13,"The cell-type specificity of these effects was supported by the finding that Er-1, although unable to directly influence the growth of human glioma U-373 cells, induced Jurkat cells to synthesize and release factors that, in turn, inhibited the U-373 cell proliferation.",23103669_4,-1,-1,-1,-1,19016,-1,0.0015696866,0.7877491,0.21068123
19023,Jurkat cells to,28,31,169,184,"The cell-type specificity of these effects was supported by the finding that Er-1, although unable to directly influence the growth of human glioma U-373 cells, induced Jurkat cells to synthesize and release factors that, in turn, inhibited the U-373 cell proliferation.",23103669_4,-1,-1,-1,-1,19023,-1,0.0016691649,0.11418899,0.88414174
19024,release factors that,33,36,200,220,"The cell-type specificity of these effects was supported by the finding that Er-1, although unable to directly influence the growth of human glioma U-373 cells, induced Jurkat cells to synthesize and release factors that, in turn, inhibited the U-373 cell proliferation.",23103669_4,-1,-1,-1,-1,19024,-1,0.0001435082,0.99981195,4.452898e-05
19031,T-cell,13,14,82,88,"Overall, these findings imply that Er-1 coupling to IL-2R and ERK immuno-enhances T-cell activity, and that this effect likely translates to an inhibition of glioma cell growth.",23103669_5,-1,1,2,-1,19031,-1,3.3550234e-05,5.5550867e-05,0.99991095
19032,that this,17,19,103,112,"Overall, these findings imply that Er-1 coupling to IL-2R and ERK immuno-enhances T-cell activity, and that this effect likely translates to an inhibition of glioma cell growth.",23103669_5,-1,-1,-1,-1,19032,-1,2.1357e-05,0.9999689,9.779374e-06
19033,translates to,21,23,127,140,"Overall, these findings imply that Er-1 coupling to IL-2R and ERK immuno-enhances T-cell activity, and that this effect likely translates to an inhibition of glioma cell growth.",23103669_5,-1,-1,-1,-1,19033,-1,2.9108925e-05,0.9999579,1.29890495e-05
19035,function,8,9,57,65,"Previous studies have reported alterations in numbers or function of regulatory T (Treg) cells in myasthenia gravis (MG) patients, but published results have been inconsistent, likely due to the isolation of heterogenous ""Treg"" populations.",23110942_0,0,1,2,-1,19035,-1,7.108035e-05,0.9998808,4.8103906e-05
19039,to the,33,35,188,194,"Previous studies have reported alterations in numbers or function of regulatory T (Treg) cells in myasthenia gravis (MG) patients, but published results have been inconsistent, likely due to the isolation of heterogenous ""Treg"" populations.",23110942_0,-1,-1,-1,-1,19039,-1,2.2170703e-05,0.99996936,8.461652e-06
19045,that there,27,29,142,152,"In this study, we used surface CD4, CD25(high), and CD127(low/-) expression to isolate a relatively pure population of Tregs, and established that there was no alteration in the relative numbers of Tregs within the peripheral T cell pool in MG patients.",23110942_1,-1,-1,-1,-1,19045,-1,2.0372589e-05,0.99996924,1.0366937e-05
19046,the relative,33,35,174,186,"In this study, we used surface CD4, CD25(high), and CD127(low/-) expression to isolate a relatively pure population of Tregs, and established that there was no alteration in the relative numbers of Tregs within the peripheral T cell pool in MG patients.",23110942_1,-1,-1,-1,-1,19046,-1,2.3475874e-05,0.9999541,2.246628e-05
19050,that Treg-mediated,8,10,53,71,"In vitro proliferation assays, however, demonstrated that Treg-mediated suppression of responder T (Tresp) cells was impaired in MG patients and was associated with a reduced expression of FOXP3 in isolated Tregs.",23110942_2,-1,-1,-1,-1,19050,-1,2.2370457e-05,0.99996376,1.3852087e-05
19056,Tresp cells,6,8,50,61,"Suppression of both polyclonal and AChR-activated Tresp cells from MG patients could be restored using Tregs isolated from healthy controls, indicating that the defect in immune regulation in MG is primarily localized to isolated Treg cells, and revealing a potential novel therapeutic target.",23110942_3,-1,-1,-1,-1,19056,-1,0.00024230903,0.0022733433,0.9974843
19058,that the,22,24,152,160,"Suppression of both polyclonal and AChR-activated Tresp cells from MG patients could be restored using Tregs isolated from healthy controls, indicating that the defect in immune regulation in MG is primarily localized to isolated Treg cells, and revealing a potential novel therapeutic target.",23110942_3,-1,-1,-1,-1,19058,-1,1.8037204e-05,0.999974,7.962361e-06
19062,therapeutic target,43,45,274,292,"Suppression of both polyclonal and AChR-activated Tresp cells from MG patients could be restored using Tregs isolated from healthy controls, indicating that the defect in immune regulation in MG is primarily localized to isolated Treg cells, and revealing a potential novel therapeutic target.",23110942_3,-1,-1,-1,-1,19062,-1,2.3303743e-05,0.9999659,1.0814471e-05
19067,blood lymphocytes,19,21,127,144,PURPOSE: To evaluate CD4(+)CD25(+)FOXP3(+) T regulatory cells (T(REG)) and associated immune-regulatory pathways in peripheral blood lymphocytes (PBL) of metastatic renal cell carcinoma (mRCC) patients and healthy volunteers.,23118856_0,-1,-1,-1,-1,19067,-1,0.00054306176,0.0062466487,0.99321026
19071,analysis,19,20,142,150,"We subsequently investigated the effects of immunotherapy on circulating T(REG) combining an extensive phenotype examination, DNA methylation analysis and global transcriptome analysis.",23118856_1,0,1,-1,-1,19071,-1,3.8256952e-05,0.99991727,4.4457716e-05
19072,transcriptome analysis,22,24,162,184,"We subsequently investigated the effects of immunotherapy on circulating T(REG) combining an extensive phenotype examination, DNA methylation analysis and global transcriptome analysis.",23118856_1,-1,-1,-1,-1,19072,-1,3.4077108e-05,0.9999366,2.9283912e-05
19074,analysis,15,16,88,96,DESIGN: Eighteen patients with mRCC and twelve volunteers (controls) were available for analysis.,23118856_2,0,1,-1,-1,19074,-1,3.523106e-05,0.9999423,2.241324e-05
19078,the FOXP3,11,13,66,75,T(REG) were also quantified by analyzing the epigenetic status of the FOXP3 locus using methylation specific PCR.,23118856_5,-1,-1,-1,-1,19078,-1,1.8212577e-05,0.9999701,1.1732041e-05
19084,the gene,20,22,103,111,"As a third approach, RNA of the PBL was hybridized to Affymetrix GeneChip Human Gene 1.0 ST Arrays and the gene signatures were explored using pathway analysis.",23118856_6,-1,-1,-1,-1,19084,-1,2.9133642e-05,0.9999522,1.870737e-05
19085,analysis,27,28,151,159,"As a third approach, RNA of the PBL was hybridized to Affymetrix GeneChip Human Gene 1.0 ST Arrays and the gene signatures were explored using pathway analysis.",23118856_6,0,1,-1,-1,19085,-1,3.40799e-05,0.9999337,3.2229513e-05
19089,the two,13,15,73,80,A significant increase in T(REG) was detected in all mRCC patients after the two cycles of immunotherapy.,23118856_8,-1,-1,-1,-1,19089,-1,2.6404e-05,0.9999628,1.081419e-05
19097,Analysis,3,4,20,28,"Gene Set Enrichment Analysis (GSEA) of the microarray data showed significant enrichment of FOXP3 target genes, CTLA-4 and TGF- associated pathways in the patient cohort.",23118856_11,0,1,-1,-1,19097,-1,4.783162e-05,0.9999064,4.5708417e-05
19099,FOXP3 target genes,15,18,92,110,"Gene Set Enrichment Analysis (GSEA) of the microarray data showed significant enrichment of FOXP3 target genes, CTLA-4 and TGF- associated pathways in the patient cohort.",23118856_11,-1,-1,-1,-1,19099,-1,2.3728198e-05,0.9999572,1.903914e-05
19103,blood,7,8,48,53,CONCLUSION: Immune monitoring of the peripheral blood and tumor tissue is important for a wide range of diseases and treatment strategies.,23118856_12,0,1,-1,-1,19103,-1,0.00012579311,0.9991899,0.00068430015
19104,tumor tissue,9,11,58,70,CONCLUSION: Immune monitoring of the peripheral blood and tumor tissue is important for a wide range of diseases and treatment strategies.,23118856_12,-1,-1,-1,-1,19104,-1,2.6136127e-05,0.99995303,2.0836069e-05
19113,that CCL2,4,6,21,30,"Here, we demonstrate that CCL2 is a critical determinant for both tumor metastasis and immunosuppression induced by Snail(+) tumor cells.",23143679_2,-1,-1,-1,-1,19113,-1,0.074102,0.9172509,0.008647137
19115,tumor cells,20,22,125,136,"Here, we demonstrate that CCL2 is a critical determinant for both tumor metastasis and immunosuppression induced by Snail(+) tumor cells.",23143679_2,-1,-1,-1,-1,19115,-1,0.004456178,0.3631791,0.63236475
19117,tumor cells,7,9,51,62,CCL2 is significantly upregulated in various human tumor cells accompanied by Snail expression induced by snail transduction or TGF treatment.,23143679_3,-1,-1,-1,-1,19117,-1,0.0040112375,0.35136253,0.6446262
19119,TGF treatment,18,20,128,142,CCL2 is significantly upregulated in various human tumor cells accompanied by Snail expression induced by snail transduction or TGF treatment.,23143679_3,-1,-1,-1,-1,19119,-1,3.0158219e-05,0.99995494,1.49424195e-05
19121,tumor-derived CCL2,3,5,13,31,The Snail(+) tumor-derived CCL2 amplifies EMT events in other cells including Snail(-) tumor cells and epithelial cells within tumor microenvironment.,23143679_4,-1,-1,-1,-1,19121,-1,0.03391198,0.9587942,0.007293891
19123,tumor cells,14,16,87,98,The Snail(+) tumor-derived CCL2 amplifies EMT events in other cells including Snail(-) tumor cells and epithelial cells within tumor microenvironment.,23143679_4,-1,-1,-1,-1,19123,-1,0.0035745143,0.24622732,0.7501981
19128,tumor cells,12,14,60,71,CCL2 secondarily induces Lipocalin 2 (LCN2) in the Snail(+) tumor cells in an autocrine manner.,23143679_5,-1,-1,-1,-1,19128,-1,0.0040559103,0.44263035,0.55331373
19135,tumor-specific CTL,15,17,118,136,"The CCL2/LCN2-induced DCreg cells subsequently induce immunosuppressive CD4(+)FOXP3(+) Treg cells, and finally impair tumor-specific CTL induction.",23143679_7,-1,-1,-1,-1,19135,-1,0.0056760516,0.53423804,0.46008587
19142,that CCL2,3,5,22,31,These results suggest that CCL2 is more than a chemoattractant factor that is the significant effector molecule responsible for immune evasion of Snail(+) tumor cells.,23143679_9,-1,-1,-1,-1,19142,-1,0.13801298,0.8524838,0.009503145
19144,chemoattractant factor that,9,12,47,74,These results suggest that CCL2 is more than a chemoattractant factor that is the significant effector molecule responsible for immune evasion of Snail(+) tumor cells.,23143679_9,-1,-1,-1,-1,19144,-1,0.96060675,0.035423853,0.0039693257
19146,tumor cells,24,26,155,166,These results suggest that CCL2 is more than a chemoattractant factor that is the significant effector molecule responsible for immune evasion of Snail(+) tumor cells.,23143679_9,-1,-1,-1,-1,19146,-1,0.004040157,0.4301259,0.5658339
19149,treatment to,7,9,39,51,CCL2 would be an attractive target for treatment to eliminate cancer cells via amelioration of tumor metastasis and immunosuppression.,23143679_10,-1,-1,-1,-1,19149,-1,2.055199e-05,0.99997056,8.900722e-06
19157,to their,19,21,137,145,Subunit vaccines containing universal tumor associated antigens (TAAs) present an attractive treatment modality for cancer primarily due to their safety and potential to generate long-term immunological responses that can safeguard against recurrences.,23144888_0,-1,-1,-1,-1,19157,-1,2.0605994e-05,0.9999703,9.036351e-06
19158,to generate,24,26,167,178,Subunit vaccines containing universal tumor associated antigens (TAAs) present an attractive treatment modality for cancer primarily due to their safety and potential to generate long-term immunological responses that can safeguard against recurrences.,23144888_0,-1,-1,-1,-1,19158,-1,1.9725057e-05,0.9999707,9.62159e-06
19160,TAA-based subunit,2,4,9,26,"However, TAA-based subunit vaccines require potent adjuvants for therapeutic efficacy.",23144888_1,-1,-1,-1,-1,19160,-1,5.2611416e-05,0.99991107,3.6351084e-05
19169,the therapeutic,9,11,44,59,The present study was designed to i) assess the therapeutic efficacy of a prime-boost vaccination and ii) investigate the mechanistic basis of vaccine efficacy.,23144888_3,-1,-1,-1,-1,19169,-1,1.8794199e-05,0.9999728,8.366594e-06
19183,Taken together,0,2,0,14,"Taken together, these results shed light on the mechanistic basis of the SA-4-1BBL/SVN subunit vaccine formulation in a lung carcinoma model and demonstrate the robust therapeutic efficacy of the prime-boost immunization strategy with important clinical implications.",23144888_8,-1,-1,-1,-1,19183,-1,4.1022835e-05,0.9999405,1.8491359e-05
19191,plasma cell,9,11,39,50,BACKGROUND: Multiple myeloma (MM) is a plasma cell malignancy frequently associated with impaired immune cell numbers and functions.,23152910_0,-1,-1,-1,-1,19191,-1,8.761963e-05,0.00026907815,0.9996433
19193,functions,20,21,122,131,BACKGROUND: Multiple myeloma (MM) is a plasma cell malignancy frequently associated with impaired immune cell numbers and functions.,23152910_0,0,1,2,-1,19193,-1,0.0058088517,0.808133,0.18605812
19198,T cell functions,18,21,96,112,"In MM, several studies have previously shown that CD4 regulatory T (Treg) cells hamper effector T cell functions and enhance immune dysfunction.",23152910_1,-1,-1,-1,-1,19198,-1,5.3080756e-05,7.422638e-05,0.9998727
19202,functionally,11,12,49,61,"In this study, we aimed to prove the presence of functionally suppressive Treg cells expressing CD8 phenotype (CD8 Treg cells) in MM.",23152910_2,0,1,2,-1,19202,-1,4.534802e-05,0.9999355,1.9166086e-05
19205,To the,0,2,0,6,"To the best of our knowledge, this has not been reported previously in MM.METHODS: We analyzed CD8 Treg cells and their transcription factor FoxP3 from 64 newly diagnosed MM patients using flow cytometry and real time-polymerase chain reaction (RT-PCR).",23152910_3,-1,-1,-1,-1,19205,-1,3.1039446e-05,0.9999553,1.3617267e-05
19208,their transcription factor FoxP3,22,26,114,146,"To the best of our knowledge, this has not been reported previously in MM.METHODS: We analyzed CD8 Treg cells and their transcription factor FoxP3 from 64 newly diagnosed MM patients using flow cytometry and real time-polymerase chain reaction (RT-PCR).",23152910_3,-1,-1,-1,-1,19208,-1,2.4137391e-05,0.9999635,1.2397144e-05
19213,functionally,12,13,60,72,CD8 Treg cells from 5 MM patients and 5 healthy donors were functionally evaluated using proliferation assays.,23152910_5,0,1,2,-1,19213,-1,5.8859096e-05,0.9999198,2.135416e-05
19215,their transcription factor FoxP3,19,23,97,129,"RESULTS: CD8 Treg cells (CD8+CD25hi+) were significantly elevated in MM patients (P<0.0001), and their transcription factor FoxP3 expression was also higher in MM (P<0.0001) compared to healthy donors which was evidenced by flow cytometry and RT-PCR analyses.",23152910_6,-1,-1,-1,-1,19215,-1,2.165535e-05,0.99996686,1.1502935e-05
19218,total lymphocyte,6,8,42,58,CD8 Treg cells negatively correlated with total lymphocyte count (P=0.016).,23152910_7,-1,-1,-1,-1,19218,-1,0.0021094647,0.060582552,0.93730795
19219,Functional,0,1,0,10,Functional studies revealed that CD8 Treg cells isolated from MM patients and healthy donors inhibited proliferation of CD4 T cells in a concentration dependent manner.,23152910_8,0,1,2,-1,19219,-1,2.9688757e-05,0.9999472,2.3076842e-05
19235,functionally,11,12,69,81,CONCLUSIONS: These findings show the presence of increased number of functionally suppressive CD8 Treg cells in MM patients.,23152910_12,0,1,2,-1,19235,-1,5.9585866e-05,0.999918,2.2412012e-05
19237,that these,2,4,11,21,We believe that these suppressive CD8 Treg cells might enhance immune impairment and disease progression in MM.,23152910_13,-1,-1,-1,-1,19237,-1,2.002507e-05,0.99996924,1.0745514e-05
19248,that tumor,26,28,165,175,"Whereas enhanced Th17 response and related molecules such as interleukin (IL)-17, IL-21, IL-22, IL-23 and STAT3 accompanied tumor induction and progression, finding that tumor growth/stage was negatively correlated with increased infiltration of Th17 cells in the tumor mass has prompted elucidation of various antitumor mechanisms elicited by Th17 and their related molecules.",23159638_1,-1,-1,-1,-1,19248,-1,1.9412315e-05,0.99997115,9.419546e-06
19249,Th17 cells,36,38,246,256,"Whereas enhanced Th17 response and related molecules such as interleukin (IL)-17, IL-21, IL-22, IL-23 and STAT3 accompanied tumor induction and progression, finding that tumor growth/stage was negatively correlated with increased infiltration of Th17 cells in the tumor mass has prompted elucidation of various antitumor mechanisms elicited by Th17 and their related molecules.",23159638_1,-1,-1,-1,-1,19249,-1,0.0023763564,0.11625968,0.88136387
19250,the tumor,39,41,260,269,"Whereas enhanced Th17 response and related molecules such as interleukin (IL)-17, IL-21, IL-22, IL-23 and STAT3 accompanied tumor induction and progression, finding that tumor growth/stage was negatively correlated with increased infiltration of Th17 cells in the tumor mass has prompted elucidation of various antitumor mechanisms elicited by Th17 and their related molecules.",23159638_1,-1,-1,-1,-1,19250,-1,1.8207962e-05,0.9999713,1.0476584e-05
19252,their related,53,55,353,366,"Whereas enhanced Th17 response and related molecules such as interleukin (IL)-17, IL-21, IL-22, IL-23 and STAT3 accompanied tumor induction and progression, finding that tumor growth/stage was negatively correlated with increased infiltration of Th17 cells in the tumor mass has prompted elucidation of various antitumor mechanisms elicited by Th17 and their related molecules.",23159638_1,-1,-1,-1,-1,19252,-1,7.1227485e-05,0.99987435,5.4437445e-05
19255,factors,24,25,149,156,"The pro-tumor efficacy of Th17 response included promotion of neutrophilia and induction of angiogenic (e.g. VEGF, MMP2 and MMP9) and anti-apoptotic factors (e.g. Bcl-XL), as well as expansion and activation of myeloid-derived suppressor cells, which facilitate generation of tumor-specific regulatory T cells.",23159638_2,0,1,-1,-1,19255,-1,0.9975127,0.001922621,0.00056473067
19258,tumor-specific regulatory T cells,45,49,276,309,"The pro-tumor efficacy of Th17 response included promotion of neutrophilia and induction of angiogenic (e.g. VEGF, MMP2 and MMP9) and anti-apoptotic factors (e.g. Bcl-XL), as well as expansion and activation of myeloid-derived suppressor cells, which facilitate generation of tumor-specific regulatory T cells.",23159638_2,-1,-1,-1,-1,19258,-1,0.0041882885,0.5284158,0.4673959
19262,Th17 cells to,20,23,145,158,"Other tumor immunogenic settings revealed anti-tumor pathways including induction of cytotoxic activity, expression of MHC antigens, the ability Th17 cells to reside within the tumor, and to convert into IFN- producers.",23159638_3,-1,-1,-1,-1,19262,-1,0.0004953005,0.98811483,0.011389847
19263,the tumor,25,27,173,182,"Other tumor immunogenic settings revealed anti-tumor pathways including induction of cytotoxic activity, expression of MHC antigens, the ability Th17 cells to reside within the tumor, and to convert into IFN- producers.",23159638_3,-1,-1,-1,-1,19263,-1,2.191933e-05,0.9999666,1.1424871e-05
19266,Th17 cell related,2,5,9,26,"Notably, Th17 cell related molecules exert indirect pro- or anti-tumor effects via inducing viral persistence or mediating protective mechanisms against bacterial and viral infection.",23159638_4,-1,-1,-1,-1,19266,-1,6.505906e-05,0.00019730364,0.99973756
19268,Th17 cells,11,13,78,88,"Herein, the recent literature revealing such immunoediting events mediated by Th17 cells and their associated molecules as delivered by various experimental regimens and observed in cancer patient are revised, with a focus on some proposed anti-cancer therapies.",23159638_5,-1,-1,-1,-1,19268,-1,0.0010200449,0.027274475,0.9717055
19277,analysis,26,27,153,161,"In a previous study, we screened Y Box protein 1 (YB-1) as a potential neuroblastoma-associated antigen from sera of AGN2a-immunized mice by serological analysis of recombinant cDNA expression libraries technique.",23169344_2,0,1,-1,-1,19277,-1,2.7111977e-05,0.9999565,1.6447602e-05
19290,T-cell,7,8,42,48,"It was demonstrated that anti-YB-1 CD8(+) T-cell responses could be induced by AGN2a immunization, and the strongest CD8(+) T-cell responses against AGN2a were induced by YB-1-immunized mice in the context of Treg depletion compared with YB-1 only immunization group and control group.",23169344_5,-1,1,2,-1,19290,-1,3.6271143e-05,6.6513945e-05,0.99989724
19292,T-cell,21,22,124,130,"It was demonstrated that anti-YB-1 CD8(+) T-cell responses could be induced by AGN2a immunization, and the strongest CD8(+) T-cell responses against AGN2a were induced by YB-1-immunized mice in the context of Treg depletion compared with YB-1 only immunization group and control group.",23169344_5,-1,1,2,-1,19292,-1,3.665298e-05,5.7697667e-05,0.9999057
19302,than that,30,32,170,179,"Importantly, the survival rate of mice treated with YB-1 immunization combined with Treg depletion was 80% when challenged by 1  10(4) AGN2a cells, significantly higher than that of mice immunized with YB-1 alone (P < 0.01).",23169344_6,-1,-1,-1,-1,19302,-1,2.472908e-05,0.9999608,1.4513067e-05
19304,T-cell,2,3,13,19,"Furthermore, T-cell adoptive therapy showed that the neuroblastoma growth was inhibited when T cells or splenic cells from YB-1-immunized mice with Treg depletion were transferred to AGN2a bearing mice.",23169344_7,-1,1,2,-1,19304,-1,3.4944125e-05,4.4697073e-05,0.99992037
19305,therapy,4,5,29,36,"Furthermore, T-cell adoptive therapy showed that the neuroblastoma growth was inhibited when T cells or splenic cells from YB-1-immunized mice with Treg depletion were transferred to AGN2a bearing mice.",23169344_7,0,1,-1,-1,19305,-1,2.2705593e-05,0.99995565,2.1594313e-05
19306,that the,6,8,44,52,"Furthermore, T-cell adoptive therapy showed that the neuroblastoma growth was inhibited when T cells or splenic cells from YB-1-immunized mice with Treg depletion were transferred to AGN2a bearing mice.",23169344_7,-1,-1,-1,-1,19306,-1,1.7649849e-05,0.99997306,9.294086e-06
19311,transferred to,25,27,168,182,"Furthermore, T-cell adoptive therapy showed that the neuroblastoma growth was inhibited when T cells or splenic cells from YB-1-immunized mice with Treg depletion were transferred to AGN2a bearing mice.",23169344_7,-1,-1,-1,-1,19311,-1,2.1510925e-05,0.99996614,1.2389589e-05
19317,that YB-1,3,5,24,33,These results indicated that YB-1 immunization combined with Treg depletion could induce specific T-cell responses against neuroblastoma and could be a potential strategy for the prevention and treatment of neuroblastoma in the early stage.,23169344_9,-1,-1,-1,-1,19317,-1,2.3710892e-05,0.99995816,1.8174605e-05
19319,T-cell,13,14,98,104,These results indicated that YB-1 immunization combined with Treg depletion could induce specific T-cell responses against neuroblastoma and could be a potential strategy for the prevention and treatment of neuroblastoma in the early stage.,23169344_9,-1,1,2,-1,19319,-1,4.0628045e-05,6.0854018e-05,0.99989843
19331,that Treg cells play,7,11,40,60,"This work will discuss the central role that Treg cells play in the development of uterine cancer, which makes these cells a key missing component in current cancer immunotherapy.",23178746_3,-1,-1,-1,-1,19331,-1,0.00016987299,0.9994885,0.0003416557
19333,these cells,20,22,111,122,"This work will discuss the central role that Treg cells play in the development of uterine cancer, which makes these cells a key missing component in current cancer immunotherapy.",23178746_3,-1,-1,-1,-1,19333,-1,0.0022537734,0.110507816,0.8872384
19337,factor,24,25,152,158,"CD200, as an immunosuppressive molecule, is overexpressed in some hematological malignancies and it has also been shown to be an independent prognostic factor in AML.",23179394_1,0,1,-1,-1,19337,-1,0.00044077466,0.9994499,0.000109294684
19343,T-reg cytokine,11,13,64,78,We also assessed the effect of CD200-CD200R blockade on Th1 and T-reg cytokine production and T cell proliferation in autologous AML- and monocyte-DC mixed lymphocyte reactions (MLRs).,23179394_3,-1,-1,-1,-1,19343,-1,0.030129863,0.96729696,0.0025731523
19367,immune response through,11,14,74,97,These data present a significant role for CD200 in suppressing anti-tumor immune response through stimulation of regulatory mechanisms in AML patients and suggest that CD200 may have a prognostic value in this malignancy and its blockade may be used as a target for AML immunotherapy.,23179394_10,-1,-1,-1,-1,19367,-1,0.79545945,0.20181653,0.0027240445
19377,therapies targeted,3,5,24,42,"Development of specific therapies targeted at CSCs holds hope for the improvement of survival and quality of life of cancer patients, especially for sufferers of metastatic disease.",23180012_1,-1,-1,-1,-1,19377,-1,2.0627158e-05,0.99996877,1.0549508e-05
19379,life,17,18,109,113,"Development of specific therapies targeted at CSCs holds hope for the improvement of survival and quality of life of cancer patients, especially for sufferers of metastatic disease.",23180012_1,0,-1,2,-1,19379,-1,0.000109781184,0.9998342,5.606983e-05
19390,function,9,10,70,78,We examined their biological characteristics as well as immunological function and further detected the possible molecular mechanism involved in the leukemia genesis.,23180012_3,0,1,2,-1,19390,-1,8.323927e-05,0.9998559,6.090049e-05
19396,function,21,22,157,165,"RESULTS: We showed that CML patient-derived Flk1(+)CD31(-)CD34(-) MSCs had normal morphology, phenotype and karyotype but appeared impaired immunomodulatory function.",23180012_4,0,1,2,-1,19396,-1,0.0009680627,0.9982577,0.00077422085
19402,functions,6,7,57,66,"CML patient-derived MSCs have dampening immunomodulatory functions, suggesting that the dysregulation of hematopoiesis and immune response might originate from MSCs rather than HSCs.",23180012_6,0,1,2,-1,19402,-1,0.00023357866,0.9995664,0.00020008443
19403,that the,9,11,79,87,"CML patient-derived MSCs have dampening immunomodulatory functions, suggesting that the dysregulation of hematopoiesis and immune response might originate from MSCs rather than HSCs.",23180012_6,-1,-1,-1,-1,19403,-1,1.9651308e-05,0.9999728,7.565684e-06
19411,state to,31,33,210,218,"These Ph(+) putative CML hemangioblast upregulated TGF-1 and resultantly activated matrix metalloproteinase-9 (MMP-9) to enhance s-KitL and s-ICAM-1 secretion, which activated c-kit(+) HSCs from the quiescent state to proliferative state.",23180012_7,-1,-1,-1,-1,19411,-1,2.7909186e-05,0.99994886,2.3239385e-05
19414,MSCs that,4,6,35,44,CONCLUSIONS: Flk1(+)CD31(-)CD34(-) MSCs that express BCR/ABL leukemia oncogene are CSCs of CML and they play a critical role in the progression of CML through PI3K/Akt/NF-B/MMP-9/s-ICAM-1/s-KitL signaling pathway beyond HSCs.,23180012_9,-1,-1,-1,-1,19414,-1,4.2065774e-05,0.9999263,3.1564276e-05
19415,they play,15,17,99,108,CONCLUSIONS: Flk1(+)CD31(-)CD34(-) MSCs that express BCR/ABL leukemia oncogene are CSCs of CML and they play a critical role in the progression of CML through PI3K/Akt/NF-B/MMP-9/s-ICAM-1/s-KitL signaling pathway beyond HSCs.,23180012_9,-1,-1,-1,-1,19415,-1,2.1983664e-05,0.9999658,1.2221348e-05
19424,two cell types that,19,23,113,132,CD4(+)CD25(+)Foxp3(+) T regulatory cells (Tregs) and CD1d-restricted invariant natural killer T (iNKT) cells are two cell types that are known to regulate immune reactions.,23182710_0,-1,-1,-1,-1,19424,-1,0.00028038918,0.9988979,0.00082167133
19432,to their,15,17,104,112,"Therefore, the modulatory effects of the specific anti-CD25 antibodies can also be partially attributed to their interactions with the effector cells.",23182710_3,-1,-1,-1,-1,19432,-1,2.5914225e-05,0.99996376,1.029383e-05
19436,functions,4,5,19,28,"Here, the effector functions of iNKT cells were analysed in combination with anti-CD25 mAb PC61.",23182710_4,0,1,2,-1,19436,-1,0.0005297894,0.9922537,0.0072164587
19442,cells take place,11,14,73,89,"In order to determine whether mutual interactions between Tregs and iNKT cells take place, we compared IFN production after -GalCer administration in anti-CD25-treated and ""depletion of regulatory T cell"" (DEREG) mice.",23182710_6,-1,-1,-1,-1,19442,-1,0.0061825635,0.40611282,0.58770466
19448,that the,22,24,123,131,"Since no profound effects on IFN induction were observed in DEREG mice, deficient in FoxP3(+) Tregs, our results indicate that the anti-CD25 antibody acts directly on CD25(+) effector cells.",23182710_7,-1,-1,-1,-1,19448,-1,1.8706198e-05,0.9999734,7.877846e-06
19451,TC-1 tumour,12,14,95,106,"In vivo experiments demonstrated that although both -GalCer and PC61 administration inhibited TC-1 tumour growth in mice, no additive/synergic effects were observed when these substances were used in combination therapy.",23182710_8,-1,-1,-1,-1,19451,-1,1.9662795e-05,0.9999659,1.4469568e-05
19453,therapy,30,31,213,220,"In vivo experiments demonstrated that although both -GalCer and PC61 administration inhibited TC-1 tumour growth in mice, no additive/synergic effects were observed when these substances were used in combination therapy.",23182710_8,0,1,-1,-1,19453,-1,2.7273172e-05,0.9999583,1.4445108e-05
19456,tumor cells,2,4,16,27,Conditioning of tumor cells with chemotherapeutic drug has been shown to enhance the anti-tumor effects of cancer vaccines and adoptive cell therapy.,23185240_1,-1,-1,-1,-1,19456,-1,0.004206935,0.44967028,0.5461228
19460,cell therapy,20,22,136,148,Conditioning of tumor cells with chemotherapeutic drug has been shown to enhance the anti-tumor effects of cancer vaccines and adoptive cell therapy.,23185240_1,-1,-1,-1,-1,19460,-1,0.003291627,0.10784028,0.88886815
19469,tumor cells,5,7,30,41,"We found that pretreatment of tumor cells with AT-101 enhanced susceptibility of L3.6pl and MiaPaCa-2 tumor cells to ATC and aATC-mediated cytotoxicity, which was in part mediated via enhanced release of cytolytic granule GrzB from ATC and aATC.",23185240_4,-1,-1,-1,-1,19469,-1,0.003848657,0.40994856,0.58620274
19470,tumor cells to,15,18,102,116,"We found that pretreatment of tumor cells with AT-101 enhanced susceptibility of L3.6pl and MiaPaCa-2 tumor cells to ATC and aATC-mediated cytotoxicity, which was in part mediated via enhanced release of cytolytic granule GrzB from ATC and aATC.",23185240_4,-1,-1,-1,-1,19470,-1,9.257206e-05,0.9997427,0.00016477154
19481,proteins,41,42,294,302,"Priming (conditioning) of PC cells with AT-101 can significantly enhance the anti-tumor activity of EGFRBi armed ATC through increased IFN- induced activation of pS(727)-Stat1 and inhibition of pY(705)-Stat3 phosphorylation, and resulting in increased ratio of pro-apoptotic to anti-apoptotic proteins.",23185240_6,0,1,-1,-1,19481,-1,9.416993e-05,0.99973196,0.00017388523
19484,tumoral lymphocytic,16,18,97,116,"PURPOSE: Breast carcinomas, including basal and hereditary cases, often present with a prominent tumoral lymphocytic infiltrate.",23213058_0,-1,-1,-1,-1,19484,-1,0.0050665303,0.49426568,0.5006678
19487,these cells,7,9,43,54,Chemokines could play a role in attracting these cells and contribute to tumor progression.,23213058_1,-1,-1,-1,-1,19487,-1,0.0006996389,0.008053958,0.9912464
19488,to tumor,11,13,70,78,Chemokines could play a role in attracting these cells and contribute to tumor progression.,23213058_1,-1,-1,-1,-1,19488,-1,3.413303e-05,0.9999503,1.556547e-05
19491,the relationship,8,10,56,72,We explored tumoral expression of CXCL10 and determined the relationship between CXCL10 and lymphocytic infiltrate in a cohort of breast cancers.,23213058_2,-1,-1,-1,-1,19491,-1,2.2205442e-05,0.9999633,1.4480048e-05
19494,tissue,4,5,27,33,"EXPERIMENTAL DESIGN: Using tissue microarrays of 364 breast tumors, we evaluated expression of CXCL10 and its receptor, CXCR3, in relation to histopathologic features, biomarkers, and lymphocyte markers.",23213058_3,-1,1,2,-1,19494,-1,3.025796e-05,0.999915,5.474214e-05
19497,receptor,18,19,110,118,"EXPERIMENTAL DESIGN: Using tissue microarrays of 364 breast tumors, we evaluated expression of CXCL10 and its receptor, CXCR3, in relation to histopathologic features, biomarkers, and lymphocyte markers.",23213058_3,0,1,2,-1,19497,-1,0.0028783374,0.44896376,0.54815793
19498,relation to,23,25,130,141,"EXPERIMENTAL DESIGN: Using tissue microarrays of 364 breast tumors, we evaluated expression of CXCL10 and its receptor, CXCR3, in relation to histopathologic features, biomarkers, and lymphocyte markers.",23213058_3,-1,-1,-1,-1,19498,-1,2.5990248e-05,0.99995863,1.5363259e-05
19503,T-lymphocyte,15,16,89,101,"In addition, we overexpressed CXCL10 and CXCR3 in MCF7 breast cancer cells and monitored T-lymphocyte migration and invasion.",23213058_4,-1,1,2,-1,19503,-1,3.2486896e-05,5.0325998e-05,0.99991715
19507,the lymphocytic,3,5,28,43,Further characterization of the lymphocytic infiltrate revealed an association with CXCL10 expression for peritumoral CD4+ and CD8+ lymphocytes.,23213058_6,-1,-1,-1,-1,19507,-1,0.003257468,0.21634272,0.7803998
19514,T-BET+ T(H)1 cells,15,18,70,88,"CD8+ intratumoral lymphocytes, FOXP3+ regulatory T cells (Tregs), and T-BET+ T(H)1 cells were associated with BRCA1 and basal tumors.",23213058_7,-1,-1,-1,-1,19514,-1,0.0037249087,0.8075237,0.18875137
19516,MCF7 cells,3,5,23,33,Conditioned media from MCF7 cells overexpressing both CXCL10 and CXCR3 increased T-lymphocyte migration and invasion.,23213058_8,-1,-1,-1,-1,19516,-1,0.0036013965,0.00067647785,0.9957222
19518,T-lymphocyte,11,12,81,93,Conditioned media from MCF7 cells overexpressing both CXCL10 and CXCR3 increased T-lymphocyte migration and invasion.,23213058_8,-1,1,2,-1,19518,-1,3.364756e-05,4.938961e-05,0.99991703
19519,that CXCL10,5,7,34,45,"CONCLUSIONS: Our findings suggest that CXCL10 may act in a paracrine manner, affecting the tumor microenvironment, and in an autocrine manner, acting on the tumor cells themselves and may play a role in tumor invasiveness and progression.",23213058_9,-1,-1,-1,-1,19519,-1,0.8594797,0.1323932,0.00812706
19520,the tumor,15,17,87,96,"CONCLUSIONS: Our findings suggest that CXCL10 may act in a paracrine manner, affecting the tumor microenvironment, and in an autocrine manner, acting on the tumor cells themselves and may play a role in tumor invasiveness and progression.",23213058_9,-1,-1,-1,-1,19520,-1,1.9420817e-05,0.99997044,1.0200513e-05
19521,the tumor cells themselves,27,31,153,179,"CONCLUSIONS: Our findings suggest that CXCL10 may act in a paracrine manner, affecting the tumor microenvironment, and in an autocrine manner, acting on the tumor cells themselves and may play a role in tumor invasiveness and progression.",23213058_9,-1,-1,-1,-1,19521,-1,0.00010153431,0.9994874,0.00041101305
19524,The CXCL10-CXCR3,0,2,0,16,"The CXCL10-CXCR3 axis can serve as a potential target in BRCA1 and basal breast cancers, which present with a prominent lymphocytic infiltrate and a poor prognosis.",23213058_10,-1,-1,-1,-1,19524,-1,0.020062419,0.97824645,0.0016911722
19529,transcription factors T-bet,10,13,90,117,"Besides controlling tumor-sensitive proliferative and angiogenic effects, mTOR influences transcription factors T-bet and Eomesodermin (Eomes) in CD8 cytotoxic T cells (Tc), which are key in rejecting tumors, and allografts.",23222894_1,-1,-1,-1,-1,19529,-1,2.5730125e-05,0.99995434,1.9921723e-05
19536,transplant immunity,11,13,48,67,"METHODS: To study the role of mTOR in tumor and transplant immunity in an antigen-specific way, we used T-cell receptor transgenic B6.OTI recipients, B6.OVA.TG donors, and OVA-B16F10 melanoma cells.",23222894_2,-1,-1,-1,-1,19536,-1,0.0052495548,0.9944648,0.00028559534
19538,T-cell receptor transgenic,20,23,104,130,"METHODS: To study the role of mTOR in tumor and transplant immunity in an antigen-specific way, we used T-cell receptor transgenic B6.OTI recipients, B6.OVA.TG donors, and OVA-B16F10 melanoma cells.",23222894_2,-1,-1,-1,-1,19538,-1,0.0009929643,0.014794096,0.984213
19545,function,11,12,64,72,RESULTS: The role of mTOR in regulating the differentiation and function of alloreactive Tc cells in vitro was explored by stimulating OTI-Tc cells with ovalbumin-transgenic antigen-presenting cells in the presence of rapamycin or tacrolimus.,23222894_4,0,1,2,-1,19545,-1,9.306655e-05,0.999841,6.590136e-05
19546,Tc cells,14,16,89,97,RESULTS: The role of mTOR in regulating the differentiation and function of alloreactive Tc cells in vitro was explored by stimulating OTI-Tc cells with ovalbumin-transgenic antigen-presenting cells in the presence of rapamycin or tacrolimus.,23222894_4,-1,-1,-1,-1,19546,-1,0.00012404274,0.00073284365,0.9991431
19548,antigen-presenting cells,26,28,174,198,RESULTS: The role of mTOR in regulating the differentiation and function of alloreactive Tc cells in vitro was explored by stimulating OTI-Tc cells with ovalbumin-transgenic antigen-presenting cells in the presence of rapamycin or tacrolimus.,23222894_4,-1,-1,-1,-1,19548,-1,0.27706727,0.0021802576,0.7207525
19552,Tc cells to,15,18,103,114,"Rapamycin, but not tacrolimus, induced a pro-antitumor phenotypic shift from CD62LCD44 effector memory Tc cells to CD62LCD44 central memory Tc cells, which featured up-regulated levels of T-bet and Eomes and preserved levels of interferon- and perforin.",23222894_5,-1,-1,-1,-1,19552,-1,0.0016201022,0.42912754,0.5692523
19553,Tc cells,21,23,140,148,"Rapamycin, but not tacrolimus, induced a pro-antitumor phenotypic shift from CD62LCD44 effector memory Tc cells to CD62LCD44 central memory Tc cells, which featured up-regulated levels of T-bet and Eomes and preserved levels of interferon- and perforin.",23222894_5,-1,-1,-1,-1,19553,-1,9.004549e-05,0.00057687616,0.9993331
19562,analysis,35,36,257,265,"For future investigations, an in vivo model was established whereby DsRedOTI-Tc cells adoptively transferred into B6 mice bearing either a ovalbumin-transgenic mouse skin transplant or OVA-B16F10 tumor could be traced by fluorescence-activated cell sorting analysis as effector or memory Tc cells in transplant and tumor tissues.",23222894_6,0,1,-1,-1,19562,-1,2.681182e-05,0.99995697,1.618585e-05
19563,Tc cells,40,42,288,296,"For future investigations, an in vivo model was established whereby DsRedOTI-Tc cells adoptively transferred into B6 mice bearing either a ovalbumin-transgenic mouse skin transplant or OVA-B16F10 tumor could be traced by fluorescence-activated cell sorting analysis as effector or memory Tc cells in transplant and tumor tissues.",23222894_6,-1,-1,-1,-1,19563,-1,7.140742e-05,0.00020435372,0.9997242
19565,tumor tissues,45,47,315,328,"For future investigations, an in vivo model was established whereby DsRedOTI-Tc cells adoptively transferred into B6 mice bearing either a ovalbumin-transgenic mouse skin transplant or OVA-B16F10 tumor could be traced by fluorescence-activated cell sorting analysis as effector or memory Tc cells in transplant and tumor tissues.",23222894_6,-1,-1,-1,-1,19565,-1,2.4730927e-05,0.9999535,2.1715097e-05
19566,Tc cells,12,14,76,84,"CONCLUSION: mTOR, but not calcineurin, inhibition spares antitumoral memory Tc cells by distinctively regulating T-bet and Eomes.",23222894_7,-1,-1,-1,-1,19566,-1,4.709436e-05,0.0001410641,0.9998118
19570,tumor transplant,8,10,38,54,"This finding is now testable in a new tumor transplant model, which incorporates DsRedOTI-Tc cell tracing, opening the way to study the differential effects of immunosuppressants in posttransplantation malignancy.",23222894_8,-1,-1,-1,-1,19570,-1,2.0227948e-05,0.99997103,8.785409e-06
19571,cell tracing,15,17,93,105,"This finding is now testable in a new tumor transplant model, which incorporates DsRedOTI-Tc cell tracing, opening the way to study the differential effects of immunosuppressants in posttransplantation malignancy.",23222894_8,-1,-1,-1,-1,19571,-1,0.001366601,0.02022016,0.9784132
19575,plasma cell,9,11,39,50,BACKGROUND: Multiple myeloma (MM) is a plasma cell malignancy with a multifaceted immune dysfunction.,23232072_0,-1,-1,-1,-1,19575,-1,8.0443744e-05,0.0002844484,0.9996351
19582,the release,6,8,53,64,IDO1-driven tryptophan breakdown was correlated with the release of hepatocyte growth factor (HGF) and with the frequency of Treg cells and NY-ESO-1-specific CD8(+) T cells.,23232072_4,-1,-1,-1,-1,19582,-1,2.6306412e-05,0.99996316,1.0528784e-05
19603,receptor,6,7,39,47,"Mechanistically, the antagonism of MET receptor for HGF with SU11274, a MET inhibitor, prevented HGF-induced AKT phosphorylation in MM cells and translated into reduced IDO protein levels and functional activity.",23232072_9,0,1,2,-1,19603,-1,0.0017413796,0.06984423,0.92841434
19608,protein,28,29,173,180,"Mechanistically, the antagonism of MET receptor for HGF with SU11274, a MET inhibitor, prevented HGF-induced AKT phosphorylation in MM cells and translated into reduced IDO protein levels and functional activity.",23232072_9,0,1,-1,-1,19608,-1,2.9651801e-05,0.9999299,4.0392377e-05
19609,functional,31,32,192,202,"Mechanistically, the antagonism of MET receptor for HGF with SU11274, a MET inhibitor, prevented HGF-induced AKT phosphorylation in MM cells and translated into reduced IDO protein levels and functional activity.",23232072_9,0,1,2,-1,19609,-1,8.6061125e-05,0.9998673,4.6569414e-05
19620,T-regulatory cells,11,13,59,77,The aim of current study is to evaluate the frequencies of T-regulatory cells (Treg) on the basis of distinct phenotypes in the differential diagnosis between malignant and tuberculous pleural effusion.,23252864_1,-1,-1,-1,-1,19620,-1,0.0024408784,0.25277755,0.7447816
19624,tuberculous pleural,29,31,173,192,The aim of current study is to evaluate the frequencies of T-regulatory cells (Treg) on the basis of distinct phenotypes in the differential diagnosis between malignant and tuberculous pleural effusion.,23252864_1,-1,-1,-1,-1,19624,-1,3.6562087e-05,0.9999473,1.6088065e-05
19627,IFN- ,7,9,43,49,"In addition, to evaluate Interferon-gamma (IFN- ) and interleukin-16 (IL-16) levels and their correlation to Treg cells in malignant and tuberculous pleural effusions.",23252864_2,-1,-1,-1,-1,19627,-1,0.9998481,3.588971e-05,0.00011592346
19631,to Treg cells,19,22,107,120,"In addition, to evaluate Interferon-gamma (IFN- ) and interleukin-16 (IL-16) levels and their correlation to Treg cells in malignant and tuberculous pleural effusions.",23252864_2,-1,-1,-1,-1,19631,-1,0.0025643911,0.11296902,0.8844665
19632,tuberculous pleural,25,27,138,157,"In addition, to evaluate Interferon-gamma (IFN- ) and interleukin-16 (IL-16) levels and their correlation to Treg cells in malignant and tuberculous pleural effusions.",23252864_2,-1,-1,-1,-1,19632,-1,4.6094094e-05,0.99992883,2.505414e-05
19637,blood,4,5,29,34,"Pleural fluid and peripheral blood were assessed for frequencies of T regs, IL-16, and IFN-.",23252864_4,0,1,-1,-1,19637,-1,0.00031726557,0.9919459,0.007736839
19647,blood,24,25,165,170,"Pleural effusions from both tuberculous and malignant groups represented significantly higher levels (more in TB) for the following cell populations than peripheral blood: total lymphocytes, CD3+lymphocyte, CD4+CD25+lymphocyte and Treg (CD4+ CD25+FoxP3+).",23252864_5,0,1,-1,-1,19647,-1,0.0006197791,0.96280885,0.03657133
19648,total lymphocytes,26,28,172,189,"Pleural effusions from both tuberculous and malignant groups represented significantly higher levels (more in TB) for the following cell populations than peripheral blood: total lymphocytes, CD3+lymphocyte, CD4+CD25+lymphocyte and Treg (CD4+ CD25+FoxP3+).",23252864_5,-1,-1,-1,-1,19648,-1,0.0020533882,0.06603093,0.93191564
19653,than that,11,13,73,82,Levels of IL-16 and IFN- in tuberculous group were significantly higher than that in malignant group.,23252864_6,-1,-1,-1,-1,19653,-1,2.5084259e-05,0.9999602,1.4715789e-05
19662,the function,12,14,64,76,Forkhead box P3 (FOXP3) is a transcription factor necessary for the function of regulatory T cells (T(reg) cells).,23252899_0,-1,-1,-1,-1,19662,-1,3.0300069e-05,0.99995446,1.5206611e-05
19677,function,34,35,181,189,"Here, we discuss the role of T(reg) cells in the pathogenesis of myasthenia gravis (MG) and review evidence indicating that a significant defect in T(reg) cell in vitro suppressive function exists in MG patients, without an alteration in circulating frequency.",23252899_2,0,1,2,-1,19677,-1,6.009722e-05,0.999843,9.690033e-05
19678,This functional,0,2,0,15,"This functional defect is associated with a reduced expression of key functional molecules, such as FOXP3 on isolated T(reg) cells, and appears to be more pronounced in immunosuppression-naive MG patients.",23252899_3,-1,-1,-1,-1,19678,-1,2.4465417e-05,0.99996257,1.294837e-05
19679,functional,11,12,70,80,"This functional defect is associated with a reduced expression of key functional molecules, such as FOXP3 on isolated T(reg) cells, and appears to be more pronounced in immunosuppression-naive MG patients.",23252899_3,0,1,2,-1,19679,-1,0.00057749584,0.99789053,0.0015320005
19684,factor,6,7,69,75,In vitro administration of granulocyte macrophage-colony-stimulating factor (GM-CSF) enhanced the suppressive function of T(reg) cells and upregulated FOXP3 expression.,23252899_4,0,1,-1,-1,19684,-1,0.99981433,5.7323894e-05,0.00012835665
19687,function,13,14,110,118,In vitro administration of granulocyte macrophage-colony-stimulating factor (GM-CSF) enhanced the suppressive function of T(reg) cells and upregulated FOXP3 expression.,23252899_4,0,1,2,-1,19687,-1,8.481681e-05,0.9998411,7.4078016e-05
19692,relevant T(reg,5,7,37,51,These findings indicate a clinically relevant T(reg) cell-intrinsic defect in immune regulation in MG that may reveal a novel therapeutic target.,23252899_5,-1,-1,-1,-1,19692,-1,2.7302971e-05,0.9999583,1.4424129e-05
19696,therapeutic target,20,22,126,144,These findings indicate a clinically relevant T(reg) cell-intrinsic defect in immune regulation in MG that may reveal a novel therapeutic target.,23252899_5,-1,-1,-1,-1,19696,-1,2.668665e-05,0.999962,1.135283e-05
19697,The transcription factor interferon,0,4,0,35,The transcription factor interferon regulatory factor-8 (IRF-8) is crucial for myeloid cell development and immune response and also acts as a tumor suppressor gene.,23308054_0,-1,-1,-1,-1,19697,-1,2.6076039e-05,0.9999629,1.1045565e-05
19698,factor-8,5,6,47,55,The transcription factor interferon regulatory factor-8 (IRF-8) is crucial for myeloid cell development and immune response and also acts as a tumor suppressor gene.,23308054_0,0,1,-1,-1,19698,-1,4.9308168e-05,0.99991846,3.2226195e-05
19710,cells transplanted,2,4,17,35,"B16-F10 melanoma cells transplanted into IRF-8-deficient (IRF-8(-/-)) mice grow more rapidly, leading to higher numbers of lung metastasis, with respect to control animals.",23308054_2,-1,-1,-1,-1,19710,-1,0.0027712756,0.107854314,0.88937443
19718,receptor,20,21,152,160,"These events correlated with reduced dendritic cell and T cell infiltration, accumulation of myeloid-derived suppressor cells and a chemokine/chemokine receptor expression profile within the tumor microenvironment supporting tumor growth, angiogenesis, and metastasis.",23308054_3,0,1,2,-1,19718,-1,0.046543818,0.010396122,0.9430601
19719,the tumor,24,26,187,196,"These events correlated with reduced dendritic cell and T cell infiltration, accumulation of myeloid-derived suppressor cells and a chemokine/chemokine receptor expression profile within the tumor microenvironment supporting tumor growth, angiogenesis, and metastasis.",23308054_3,-1,-1,-1,-1,19719,-1,2.0513606e-05,0.9999684,1.1113228e-05
19727,chemokine receptor,23,25,192,210,Injection of the demethylating agent 5-aza-2'-deoxycytidine into melanoma-bearing IRF-8(-/-) animals induced intratumoral IRF-8 expression and resulted in the re-establishment of a chemokine/ chemokine receptor pattern favoring leukocyte infiltration and melanoma growth arrest.,23308054_5,-1,-1,-1,-1,19727,-1,0.7740682,0.005127835,0.22080393
19734,factors,12,13,77,84,"Lastly, IRF-8 expression in melanoma cells was directly modulated by soluble factors, among which interleukin-27 (IL-27), released by immune cells from tumor-bearing mice.",23308054_7,0,1,-1,-1,19734,-1,0.99687505,0.0020950618,0.0010298005
19745,function,24,25,140,148,"Collectively, these results underscore a key role of IRF-8 in the cross talk between melanoma and immune cells, thus revealing its critical function within the tumor microenvironment in regulating melanoma progression and invasiveness.",23308054_8,0,1,2,-1,19745,-1,5.794915e-05,0.99991,3.200332e-05
19746,the tumor,26,28,156,165,"Collectively, these results underscore a key role of IRF-8 in the cross talk between melanoma and immune cells, thus revealing its critical function within the tumor microenvironment in regulating melanoma progression and invasiveness.",23308054_8,-1,-1,-1,-1,19746,-1,1.9353409e-05,0.9999714,9.275202e-06
19749,blood,15,16,81,86,A higher frequency of regulatory T cells (Tregs) has been observed in peripheral blood mononuclear cells (PBMC) of patients with different types of solid tumors and hematological malignancies as compared to healthy donors.,23319273_0,0,1,-1,-1,19749,-1,0.00023634612,0.99839896,0.001364749
19756,function,15,16,89,97,"In prostate cancer patients, Tregs in PBMC have been shown to have increased suppressive function.",23319273_1,0,1,2,-1,19756,-1,5.874318e-05,0.99989676,4.44733e-05
19759,tumor cells to,7,10,53,67,Tumor-induced biological changes in Tregs may enable tumor cells to escape immunosurveillance.,23319273_2,-1,-1,-1,-1,19759,-1,9.853115e-05,0.9997539,0.00014755674
19765,blood,25,26,176,181,"We performed genome-wide expression analyses comparing the expression levels of more than 38,500 genes in Tregs with similar suppressive activity, isolated from the peripheral blood of healthy donors and patients with metastatic castration-resistant prostate cancer (mCRPC).",23319273_3,0,1,-1,-1,19765,-1,6.431479e-05,0.99974734,0.00018836367
19772,function,26,27,178,186,"The differentially expressed genes in mCRPC Tregs are involved in cell cycle processes, cellular growth and proliferation, immune responses, hematological system development and function and the interleukin-2 (IL-2) and transforming growth factor- (TGF-) pathways.",23319273_4,0,1,2,-1,19772,-1,6.302341e-05,0.99989176,4.5197863e-05
19773,the interleukin-2,28,30,191,208,"The differentially expressed genes in mCRPC Tregs are involved in cell cycle processes, cellular growth and proliferation, immune responses, hematological system development and function and the interleukin-2 (IL-2) and transforming growth factor- (TGF-) pathways.",23319273_4,-1,-1,-1,-1,19773,-1,0.6275943,0.36892486,0.0034808174
19775,factor-,36,37,240,248,"The differentially expressed genes in mCRPC Tregs are involved in cell cycle processes, cellular growth and proliferation, immune responses, hematological system development and function and the interleukin-2 (IL-2) and transforming growth factor- (TGF-) pathways.",23319273_4,0,1,-1,-1,19775,-1,0.99982494,7.425434e-05,0.00010088348
19777,that the,2,4,17,25,"Studies revealed that the levels of expression of genes responsible for T-cell proliferation (C-FOS, C-JUN and DUSP1) and cellular migration (RGS1) were greater in Tregs from mCRPC patients as compared to values observed in healthy donors.",23319273_5,-1,-1,-1,-1,19777,-1,1.6083794e-05,0.99997556,8.378162e-06
19784,these Tregs,12,14,78,89,Increased RGS1 expression in Tregs from mCRPC patients suggests a decrease in these Tregs' migratory ability.,23319273_6,-1,-1,-1,-1,19784,-1,2.5299552e-05,0.99996054,1.4109766e-05
19788,blood,17,18,88,93,"In addition, the higher frequency of CD4(+) CD25(high) CD127(-) Tregs in the peripheral blood of mCRPC patients may be the result of an increase in Treg proliferation capacity.",23319273_7,0,1,-1,-1,19788,-1,0.00011974993,0.99901795,0.00086230563
19791,that the,3,5,21,29,Results also suggest that the alterations observed in gene expression profiles of Tregs in mCRPC patients may be part of the mechanism of tumor escape from host immune surveillance.,23319273_8,-1,-1,-1,-1,19791,-1,1.7926e-05,0.99997437,7.681147e-06
19796,protein,1,2,9,16,Survivin protein is an attractive candidate for cancer immunotherapy since it is abundantly expressed in most common human cancers and mostly absent in normal adult tissues.,23335100_0,0,1,-1,-1,19796,-1,4.4118173e-05,0.9999151,4.080182e-05
19798,tissues,25,26,165,172,Survivin protein is an attractive candidate for cancer immunotherapy since it is abundantly expressed in most common human cancers and mostly absent in normal adult tissues.,23335100_0,-1,1,2,-1,19798,-1,0.0009650055,0.8964504,0.102584645
19801,the therapeutic,6,8,28,43,"In this study, we evaluated the therapeutic efficacy of a novel survivin-based vaccine by subcutaneous or intraperitoneum injection of BALB/c mice with murine fiber-induced MM tumor cells followed by vaccination with recombinant Fowlpox virus replicons encoding survivin.",23335100_2,-1,-1,-1,-1,19801,-1,1.9552663e-05,0.99997187,8.559539e-06
19802,tumor cells,26,28,176,187,"In this study, we evaluated the therapeutic efficacy of a novel survivin-based vaccine by subcutaneous or intraperitoneum injection of BALB/c mice with murine fiber-induced MM tumor cells followed by vaccination with recombinant Fowlpox virus replicons encoding survivin.",23335100_2,-1,-1,-1,-1,19802,-1,0.0039120824,0.39064723,0.6054407
19808,T-cell,13,14,92,98,"Flow cytometry and immunofluorescence analyses of tumors from vaccinated mice showed CD8(+) T-cell infiltration, and real-time PCR demonstrated increased mRNA and protein levels of immunostimulatory cytokines.",23335100_4,-1,1,2,-1,19808,-1,3.4008357e-05,4.8996986e-05,0.99991703
19809,protein,23,24,163,170,"Flow cytometry and immunofluorescence analyses of tumors from vaccinated mice showed CD8(+) T-cell infiltration, and real-time PCR demonstrated increased mRNA and protein levels of immunostimulatory cytokines.",23335100_4,0,1,-1,-1,19809,-1,4.512187e-05,0.9999275,2.7305256e-05
19811,peptide-pulsed,3,4,21,35,"Analyses of survivin peptide-pulsed spleen and lymph node cells from vaccinated mice using ELISPOT and intracellular cytokine staining confirmed antigen-specific, interferon--producing CD8(+) T-cell responses.",23335100_5,0,-1,2,-1,19811,-1,0.00022137708,0.99971837,6.0257127e-05
19816,T-cell,24,25,193,199,"Analyses of survivin peptide-pulsed spleen and lymph node cells from vaccinated mice using ELISPOT and intracellular cytokine staining confirmed antigen-specific, interferon--producing CD8(+) T-cell responses.",23335100_5,-1,1,2,-1,19816,-1,4.0750987e-05,4.900661e-05,0.99991024
19821,T-cell,11,12,95,101,Our results demonstrate that vaccination with recombinant Fowlpox expressing survivin improves T-cell responses against aggressive MM tumors and may form the basis for promising clinical applications.,23335100_8,-1,1,2,-1,19821,-1,5.1484225e-05,7.145996e-05,0.999877
19824,that the,4,6,21,29,"It has been reported that the imbalance of T helper IL-17-producing cells (Th17 cells)/regulatory T cells (Tregs) was closely associated with advanced tumor growth and poor prognosis in lung cancer, but little is known about whether this imbalance is existed in the peripheral blood of patients with non-small cell lung cancer (NSCLC).",23335103_0,-1,-1,-1,-1,19824,-1,1.7309629e-05,0.9999753,7.3687884e-06
19826,IL-17-producing cells,10,12,52,73,"It has been reported that the imbalance of T helper IL-17-producing cells (Th17 cells)/regulatory T cells (Tregs) was closely associated with advanced tumor growth and poor prognosis in lung cancer, but little is known about whether this imbalance is existed in the peripheral blood of patients with non-small cell lung cancer (NSCLC).",23335103_0,-1,-1,-1,-1,19826,-1,0.8959148,0.0011592268,0.10292599
19833,blood,47,48,277,282,"It has been reported that the imbalance of T helper IL-17-producing cells (Th17 cells)/regulatory T cells (Tregs) was closely associated with advanced tumor growth and poor prognosis in lung cancer, but little is known about whether this imbalance is existed in the peripheral blood of patients with non-small cell lung cancer (NSCLC).",23335103_0,0,1,-1,-1,19833,-1,7.0298935e-05,0.99964225,0.00028739782
19837,Th17 cells,7,9,33,43,"Here, the percentage of Treg and Th17 cells, and the expression of transcription factors RORt and FoxP3 were studied by flow cytometry, real-time PCR, and Western blotting, respectively.",23335103_1,-1,-1,-1,-1,19837,-1,0.00080442266,0.010691711,0.9885039
19847,that there,3,5,19,29,"The results showed that there was an increase in the percentage of Tregs, the mRNA and protein expression of FoxP3, the level of Treg-related cytokines in patients with NSCLC while compared to that in healthy patients.",23335103_3,-1,-1,-1,-1,19847,-1,1.9105808e-05,0.99996984,1.1012719e-05
19851,protein,17,18,87,94,"The results showed that there was an increase in the percentage of Tregs, the mRNA and protein expression of FoxP3, the level of Treg-related cytokines in patients with NSCLC while compared to that in healthy patients.",23335103_3,0,1,-1,-1,19851,-1,3.9380157e-05,0.99993384,2.6834325e-05
19854,Treg-related cytokines,25,27,129,151,"The results showed that there was an increase in the percentage of Tregs, the mRNA and protein expression of FoxP3, the level of Treg-related cytokines in patients with NSCLC while compared to that in healthy patients.",23335103_3,-1,-1,-1,-1,19854,-1,0.026658477,0.97076327,0.0025782147
19855,to that,33,35,190,197,"The results showed that there was an increase in the percentage of Tregs, the mRNA and protein expression of FoxP3, the level of Treg-related cytokines in patients with NSCLC while compared to that in healthy patients.",23335103_3,-1,-1,-1,-1,19855,-1,2.6563353e-05,0.99995935,1.40322545e-05
19857,Th17 cells,5,7,28,38,"Moreover, the percentage of Th17 cells, RORt mRNA, and protein expression were decreased in peripheral blood of NSCLC patients.",23335103_4,-1,-1,-1,-1,19857,-1,0.0001233533,0.00048608446,0.9993906
19858,protein,12,13,56,63,"Moreover, the percentage of Th17 cells, RORt mRNA, and protein expression were decreased in peripheral blood of NSCLC patients.",23335103_4,0,1,-1,-1,19858,-1,4.57457e-05,0.99992156,3.2738903e-05
19859,blood,18,19,104,109,"Moreover, the percentage of Th17 cells, RORt mRNA, and protein expression were decreased in peripheral blood of NSCLC patients.",23335103_4,0,1,-1,-1,19859,-1,0.00013922778,0.99924695,0.0006138373
19861,that the,3,5,21,29,"Our results indicate that the Th17/Treg balance is abnormal in peripheral blood, which may be important in the development of NSCLC.",23335103_6,-1,-1,-1,-1,19861,-1,1.811994e-05,0.99997365,8.1896105e-06
19862,blood,11,12,74,79,"Our results indicate that the Th17/Treg balance is abnormal in peripheral blood, which may be important in the development of NSCLC.",23335103_6,0,1,-1,-1,19862,-1,0.0002010647,0.99857426,0.0012247115
19878,the TGF-1 gene,4,7,31,46,"The interference efficiency of the TGF-1 gene was tested by real-time PCR and ELISA; the expression of Foxp3, IFN- and CD83 in CD4(+), CD8(+) or dendritic cells was examined via flow cytometry; and the tumorigenic ability of the cancer cells was investigated in the animal experiments.",23361571_3,-1,-1,-1,-1,19878,-1,2.358742e-05,0.99996233,1.4085617e-05
19884,the tumorigenic,39,41,200,215,"The interference efficiency of the TGF-1 gene was tested by real-time PCR and ELISA; the expression of Foxp3, IFN- and CD83 in CD4(+), CD8(+) or dendritic cells was examined via flow cytometry; and the tumorigenic ability of the cancer cells was investigated in the animal experiments.",23361571_3,-1,-1,-1,-1,19884,-1,2.6894855e-05,0.9999573,1.5797406e-05
19902,Foxp3 gene,15,17,98,108,"The supernatant from Hepa1-6 cells and recombinant TGF-1 significantly induced the expression of Foxp3 gene in vitro, while that from sh TGF-1 Hepa1-6 cells restored it.",23361571_6,-1,-1,-1,-1,19902,-1,2.3739372e-05,0.9999627,1.3619613e-05
19911,that the,4,6,33,41,The animal experiments indicated that the knockdown TGF-1 gene impaired the tumorigenic ability of Hepa1-6 cells.,23361571_8,-1,-1,-1,-1,19911,-1,1.7907507e-05,0.99997294,9.143277e-06
19912,TGF-1 gene,7,9,52,63,The animal experiments indicated that the knockdown TGF-1 gene impaired the tumorigenic ability of Hepa1-6 cells.,23361571_8,-1,-1,-1,-1,19912,-1,2.4612136e-05,0.99995935,1.6038395e-05
19913,the tumorigenic,10,12,73,88,The animal experiments indicated that the knockdown TGF-1 gene impaired the tumorigenic ability of Hepa1-6 cells.,23361571_8,-1,-1,-1,-1,19913,-1,3.1118336e-05,0.9999541,1.4788111e-05
19917,therapeutic target,13,15,68,86,"CONCLUSION: TGF-1, expressed in cancer cells, might be a potential therapeutic target for cancer treatment.",23361571_9,-1,-1,-1,-1,19917,-1,2.5231537e-05,0.9999635,1.1197451e-05
19919,The generation,0,2,0,14,The generation of effector CD8(+) T cells with lytic capacity is crucial for tumor control.,23380742_0,-1,-1,-1,-1,19919,-1,2.0851561e-05,0.99996483,1.4274923e-05
19927,that the,4,6,16,24,"Here, we report that the Notch pathway has an important role in both these processes in human CD8(+) T cells.",23380742_2,-1,-1,-1,-1,19927,-1,1.9068999e-05,0.9999716,9.2757255e-06
19934,tumor antigen-specific,20,22,108,130,The role for Notch signaling in CD8(+) T cell priming was determined using an ex-vivo model system in which tumor antigen-specific primary CD8(+) T cell responses were measured.,23380742_4,-1,-1,-1,-1,19934,-1,0.21515797,0.7822127,0.0026294196
19940,factor--,32,33,229,238,"Inhibition of Notch using -secretase inhibitors or soluble Delta-like4-Fc during activation reduced expansion of antigen-specific CD8(+) T cells, which was mirrored by decreased frequencies of interferon (IFN)-, tumor necrosis factor--, and granzymeB-producing CD8(+) T cells.",23380742_5,0,1,-1,-1,19940,-1,0.99957305,0.00015697889,0.00026995986
19943,functionally,11,12,64,76,"Moreover, T cells primed when Notch signaling was prevented are functionally low-avidity T cells.",23380742_6,0,1,2,-1,19943,-1,5.8137764e-05,0.99991417,2.773464e-05
19945,T cell function,8,11,60,75,"In addition, Notch partially regulates established effector T cell function.",23380742_7,-1,-1,-1,-1,19945,-1,6.1495695e-05,8.790775e-05,0.9998505
19946,IFN release,6,8,49,61,Activation-induced Notch signaling is needed for IFN release but not for cytolytic activity.,23380742_8,-1,-1,-1,-1,19946,-1,0.99549377,0.003151229,0.0013549387
19950,T cell functions,17,20,107,123,These data indicate that Notch signaling controls human CD8(+) T cell priming and also influences effector T cell functions.,23380742_9,-1,-1,-1,-1,19950,-1,5.8257916e-05,6.4937994e-05,0.99987674
19956,immunity,21,22,161,169,We evaluated the effectiveness of rhamnogalacturonan II (RG-II)-stimulated bone marrow-derived dendritic cells (BMDCs) vaccination on the induction of antitumor immunity in a mouse lymphoma model using EG7-lymphoma cells expressing ovalbumin (OVA).,23392255_0,0,-1,2,-1,19956,-1,0.9756039,0.023703706,0.00069241825
19962,factor-,9,10,57,65,"RG-II induced interleukin (IL)-12, IL-1, tumor necrosis factor- (TNF-) and interferon- (IFN-) production during dendritic cell (DC) maturation.",23392255_2,0,1,-1,-1,19962,-1,0.99985313,4.9854556e-05,9.7079654e-05
19963,TNF-,11,12,67,72,"RG-II induced interleukin (IL)-12, IL-1, tumor necrosis factor- (TNF-) and interferon- (IFN-) production during dendritic cell (DC) maturation.",23392255_2,0,1,-1,-1,19963,-1,0.00013529981,0.9998167,4.799323e-05
19970,Toll-like receptors,7,9,39,58,"Using BMDCs from the mice deficient in Toll-like receptors (TLRs), we revealed that RG-II activity is dependent on TLR4.",23392255_4,-1,-1,-1,-1,19970,-1,0.0018618092,0.939497,0.05864122
19977,immune response through the TLR4,8,13,58,90,These results suggested that RG-II expedites the DC-based immune response through the TLR4 signaling pathway.,23392255_6,-1,-1,-1,-1,19977,-1,0.31058127,0.6799166,0.009502091
19980,T-cell-mediated,4,5,20,35,"The extent to which T-cell-mediated immune surveillance is impaired in human cancer remains a question of major importance, given its potential impact on the development of generalized treatments of advanced disease where the highest degree of heterogeneity exists.",23423978_0,-1,1,2,-1,19980,-1,3.402117e-05,7.0990514e-05,0.999895
19982,generalized treatments,27,29,173,195,"The extent to which T-cell-mediated immune surveillance is impaired in human cancer remains a question of major importance, given its potential impact on the development of generalized treatments of advanced disease where the highest degree of heterogeneity exists.",23423978_0,-1,-1,-1,-1,19982,-1,4.062354e-05,0.99994314,1.6220054e-05
19985,analysis,7,8,33,41,"Here, we report the first global analysis of immune dysfunction in patients with advanced hepatocellular carcinoma (HCC).",23423978_1,0,1,-1,-1,19985,-1,2.8373215e-05,0.9999553,1.628827e-05
19987,analysis,5,6,58,66,"Using multi-parameter fluorescence-activated cell sorting analysis, we quantified the cumulative frequency of regulatory T cells (Treg), exhausted CD4(+) helper T cells, and myeloid-derived suppressor cells (MDSC) to gain concurrent views on the overall level of immune dysfunction in these inoperable patients.",23423978_2,0,1,-1,-1,19987,-1,2.6044232e-05,0.9999517,2.2201395e-05
20000,T-cell-mediated,2,3,13,28,"In dampening T-cell-mediated antitumor immunity, we hypothesized that these processes may facilitate HCC progression and thwart the efficacy of immunotherapeutic interventions.",23423978_4,-1,1,2,-1,20000,-1,3.8452672e-05,7.015376e-05,0.9998913
20001,immunity,4,5,39,47,"In dampening T-cell-mediated antitumor immunity, we hypothesized that these processes may facilitate HCC progression and thwart the efficacy of immunotherapeutic interventions.",23423978_4,0,-1,2,-1,20001,-1,0.9991697,0.0005302874,0.0003000502
20002,that these,8,10,65,75,"In dampening T-cell-mediated antitumor immunity, we hypothesized that these processes may facilitate HCC progression and thwart the efficacy of immunotherapeutic interventions.",23423978_4,-1,-1,-1,-1,20002,-1,1.8433951e-05,0.99997354,8.012626e-06
20003,thwart the,16,18,121,131,"In dampening T-cell-mediated antitumor immunity, we hypothesized that these processes may facilitate HCC progression and thwart the efficacy of immunotherapeutic interventions.",23423978_4,-1,-1,-1,-1,20003,-1,3.5579866e-05,0.99994934,1.5038504e-05
20004,testing this,1,3,3,15,"In testing this hypothesis, we showed that combined regimens to deplete Tregs, MDSC, and PD-1(+) T cells in patients with advanced HCC restored production of granzyme B by CD8(+) T cells, reaching levels observed in normal controls and also modestly increased the number of IFN- producing CD4(+) T cells.",23423978_5,-1,-1,-1,-1,20004,-1,1.9684358e-05,0.9999708,9.56454e-06
20015,T-cell function,7,9,53,68,These clinical findings encourage efforts to restore T-cell function in patients with advanced stage disease by highlighting combined approaches to deplete endogenous suppressor cell populations that can also expand effector T-cell populations.,23423978_6,-1,-1,-1,-1,20015,-1,3.9130755e-05,6.995724e-05,0.9998909
20019,T-cell,30,31,225,231,These clinical findings encourage efforts to restore T-cell function in patients with advanced stage disease by highlighting combined approaches to deplete endogenous suppressor cell populations that can also expand effector T-cell populations.,23423978_6,-1,1,2,-1,20019,-1,3.6843994e-05,5.0441384e-05,0.99991274
20020,T cells play,1,4,6,18,Donor T cells play pivotal roles in graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effects following bone marrow transplantation (BMT).,23430112_0,-1,-1,-1,-1,20020,-1,0.0015569481,0.041259594,0.9571834
20021,transplantation,21,22,131,146,Donor T cells play pivotal roles in graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effects following bone marrow transplantation (BMT).,23430112_0,-1,1,2,-1,20021,-1,3.4134173e-05,0.99994564,2.021704e-05
20025,state to,27,29,147,155,"DNAX accessory molecule 1 (DNAM-1) is a costimulatory and adhesion molecule, expressed mainly by natural killer cells and CD8(+) T cells at steady state to promote adhesion to ligand-expressing targets and enhance cytolysis.",23430112_1,-1,-1,-1,-1,20025,-1,2.1311507e-05,0.999966,1.2634552e-05
20041,function,9,10,61,69,The absence of DNAM-1 promoted the expansion and suppressive function of Treg after BMT.,23430112_6,0,1,2,-1,20041,-1,0.000135161,0.9997248,0.0001400041
20051,IL-10-driven Th2 immune responses,6,10,40,73,IgG4 subclass antibodies are present in IL-10-driven Th2 immune responses in some inflammatory conditions.,23454746_1,-1,-1,-1,-1,20051,-1,0.9994061,0.0003307453,0.0002632007
20055,functional,15,16,105,115,"Since Th2-biased inflammation is a hallmark of tumor microenvironments, we investigated the presence and functional implications of IgG4 in malignant melanoma.",23454746_2,0,1,2,-1,20055,-1,5.052235e-05,0.9999287,2.0715355e-05
20063,blood,10,11,56,61,"When compared with B cells from patient lymph nodes and blood, tumor-associated B cells were polarized to produce IgG4.",23454746_4,0,1,-1,-1,20063,-1,4.016228e-05,0.9999113,4.857333e-05
20068,tumor cells,9,11,46,57,"Secreted B cells increased VEGF and IgG4, and tumor cells enhanced IL-10 secretion in cocultures.",23454746_5,-1,-1,-1,-1,20068,-1,0.0038725175,0.3519927,0.6441348
20070,tumor antigen-specific,5,7,27,49,"Unlike IgG1, an engineered tumor antigen-specific IgG4 was ineffective in triggering effector cell-mediated tumor killing in vitro.",23454746_6,-1,-1,-1,-1,20070,-1,0.09327492,0.90324897,0.0034760819
20072,cell-mediated tumor,13,15,94,113,"Unlike IgG1, an engineered tumor antigen-specific IgG4 was ineffective in triggering effector cell-mediated tumor killing in vitro.",23454746_6,-1,-1,-1,-1,20072,-1,0.0020456212,0.04616436,0.95179003
20074,tumoricidal functions,6,8,62,83,Antigen-specific and nonspecific IgG4 inhibited IgG1-mediated tumoricidal functions.,23454746_7,-1,-1,-1,-1,20074,-1,0.00011687966,0.9997868,9.6360505e-05
20080,tumor-induced Th2-biased,7,9,45,69,"These findings suggest that IgG4 promoted by tumor-induced Th2-biased inflammation may restrict effector cell functions against tumors, providing a previously unexplored aspect of tumor-induced immune escape and a basis for biomarker development and patient-specific therapeutic approaches.",23454746_11,-1,-1,-1,-1,20080,-1,7.1036266e-05,0.9998907,3.8280206e-05
20081,cell functions,13,15,105,119,"These findings suggest that IgG4 promoted by tumor-induced Th2-biased inflammation may restrict effector cell functions against tumors, providing a previously unexplored aspect of tumor-induced immune escape and a basis for biomarker development and patient-specific therapeutic approaches.",23454746_11,-1,-1,-1,-1,20081,-1,9.80696e-05,0.00012838595,0.99977356
20086,regulation that,7,9,46,61,"IL-33 is a multifunctional cytokine in immune regulation that activates Th1 cells, Th2 cells, CD8(+) T cells and NK cells.",23499895_0,-1,-1,-1,-1,20086,-1,3.4211826e-05,0.9999473,1.8437055e-05
20091,that transgenic,3,5,17,32,Our study showed that transgenic expression of IL-33 attenuated tumor metastasis in the B16 melanoma and Lewis lung carcinoma (LLC) metastatic models.,23499895_1,-1,-1,-1,-1,20091,-1,1.8579653e-05,0.99997187,9.550933e-06
20098,the tumor tissues,16,19,92,109,The percentages and cytotoxicity of CD8(+) T cells and NK cells and their infiltration into the tumor tissues were significantly increased by the transgenic expression of IL-33 in tumor-bearing mice.,23499895_2,-1,-1,-1,-1,20098,-1,2.1753836e-05,0.9999534,2.4913581e-05
20099,the transgenic,23,25,142,156,The percentages and cytotoxicity of CD8(+) T cells and NK cells and their infiltration into the tumor tissues were significantly increased by the transgenic expression of IL-33 in tumor-bearing mice.,23499895_2,-1,-1,-1,-1,20099,-1,1.9736646e-05,0.99997056,9.707212e-06
20110,the two cell subsets,22,26,128,148,"Furthermore, IL-33 stimulated the activation of NF-B and increased CD69 expression, which is a marker of the activated form of the two cell subsets, in CD8(+) T cells and NK cells.",23499895_5,-1,-1,-1,-1,20110,-1,0.0025373993,0.10283512,0.8946275
20120,These cells,0,2,0,11,"These cells provide prosurvival signals to tumors; however, little is known regarding their interactions with immune cells within the tumor microenvironment.",23514705_1,-1,-1,-1,-1,20120,-1,0.0033703942,0.24601525,0.75061435
20121,to tumors,5,7,40,49,"These cells provide prosurvival signals to tumors; however, little is known regarding their interactions with immune cells within the tumor microenvironment.",23514705_1,-1,-1,-1,-1,20121,-1,2.7526821e-05,0.99996114,1.1285409e-05
20124,the tumor,20,22,130,139,"These cells provide prosurvival signals to tumors; however, little is known regarding their interactions with immune cells within the tumor microenvironment.",23514705_1,-1,-1,-1,-1,20124,-1,2.0584945e-05,0.9999697,9.685417e-06
20125,that factors,2,4,16,28,"We hypothesized that factors produced by human PSC could enhance myeloid-derived suppressor cell (MDSC) differentiation and function, which promotes an immunosuppressive microenvironment.",23514705_2,-1,-1,-1,-1,20125,-1,0.000102859456,0.99987316,2.3903898e-05
20127,function,18,19,124,132,"We hypothesized that factors produced by human PSC could enhance myeloid-derived suppressor cell (MDSC) differentiation and function, which promotes an immunosuppressive microenvironment.",23514705_2,0,1,2,-1,20127,-1,0.00025390135,0.999321,0.00042507667
20130,protein,33,34,183,190,"Primary PSC cell lines (n = 7) were generated from human specimens and phenotypically confirmed via expression of vimentin, -smooth muscle actin (-SMA), and glial fibrillary acidic protein (GFAP).",23514705_3,0,1,-1,-1,20130,-1,0.15219562,0.80668855,0.04111587
20131,analysis,1,2,8,16,"Luminex analysis indicated that PSC but not human fetal primary pancreatic fibroblast cells (HPF; negative controls) produced MDSC-promoting cytokines [interleukin (IL-6), VEGF, macrophage colony-stimulating factor (M-CSF) ] and chemokines (SDF-1, MCP-1).",23514705_4,0,1,-1,-1,20131,-1,3.102977e-05,0.999944,2.5005775e-05
20141,blood,3,4,22,27,"Culture of peripheral blood mononuclear cells [peripheral blood mononuclear cell (PBMC), n = 3 donors] with PSC supernatants or IL-6/granulocyte macrophage colony-stimulating factor (GM-CSF; positive control) for 7 days promoted PBMC differentiation into an MDSC (CD11b+CD33+) phenotype and a subpopulation of polymorphonuclear CD11b+CD33+CD15+ cells.",23514705_5,0,1,-1,-1,20141,-1,9.2136965e-05,0.99972457,0.00018322174
20143,blood,8,9,58,63,"Culture of peripheral blood mononuclear cells [peripheral blood mononuclear cell (PBMC), n = 3 donors] with PSC supernatants or IL-6/granulocyte macrophage colony-stimulating factor (GM-CSF; positive control) for 7 days promoted PBMC differentiation into an MDSC (CD11b+CD33+) phenotype and a subpopulation of polymorphonuclear CD11b+CD33+CD15+ cells.",23514705_5,0,1,-1,-1,20143,-1,0.00010207857,0.9996673,0.00023060519
20149,cells functionally,4,6,26,44,The resulting CD11b+CD33+ cells functionally suppressed autologous T-lymphocyte proliferation.,23514705_6,-1,-1,-1,-1,20149,-1,0.0040822695,0.08339823,0.9125196
20151,to STAT3,8,10,50,58,Culture of normal PBMCs with PSC supernatants led to STAT3 but not STAT1 or STAT5 phosphorylation.,23514705_8,-1,-1,-1,-1,20151,-1,2.8012988e-05,0.9999553,1.6692467e-05
20163,that STAT3,19,21,114,124,These results identify a novel role for PSC in driving immune escape in pancreatic cancer and extend the evidence that STAT3 acts as a driver of stromal immunosuppression to enhance its interest as a therapeutic target.,23514705_11,-1,-1,-1,-1,20163,-1,2.0447324e-05,0.99996984,9.662069e-06
20165,therapeutic target,34,36,200,218,These results identify a novel role for PSC in driving immune escape in pancreatic cancer and extend the evidence that STAT3 acts as a driver of stromal immunosuppression to enhance its interest as a therapeutic target.,23514705_11,-1,-1,-1,-1,20165,-1,2.493551e-05,0.9999635,1.1532993e-05
20167,T cells that,12,15,66,78,4-1BB agonist antibody treatment induces a population of KLRG1(+) T cells that infiltrate melanoma tumors.,23547098_0,-1,-1,-1,-1,20167,-1,0.0014660717,0.031339403,0.96719456
20170,function,5,6,31,39,"We investigated the origin and function of these cells, as well as their place within established T cell paradigms.",23547098_1,0,1,2,-1,20170,-1,0.00011351295,0.9997861,0.00010046892
20171,these cells,7,9,43,54,"We investigated the origin and function of these cells, as well as their place within established T cell paradigms.",23547098_1,-1,-1,-1,-1,20171,-1,0.0022979015,0.17568454,0.82201755
20172,their place,13,15,67,78,"We investigated the origin and function of these cells, as well as their place within established T cell paradigms.",23547098_1,-1,-1,-1,-1,20172,-1,3.114111e-05,0.9999485,2.033961e-05
20174,that these T cells,2,6,8,26,"We find that these T cells, particularly the CD4 lineage, represent a novel phenotype characterized by enhanced, multipotent cytotoxicity.",23547098_2,-1,-1,-1,-1,20174,-1,0.0035183916,0.45010355,0.5463781
20176,this T cell,5,8,36,47,"Distinct from described polarities, this T cell phenotype is driven by the T-box transcription factor Eomesodermin.",23547098_3,-1,-1,-1,-1,20176,-1,0.003216032,0.16540788,0.8313761
20177,the T-box transcription factor,12,16,71,101,"Distinct from described polarities, this T cell phenotype is driven by the T-box transcription factor Eomesodermin.",23547098_3,-1,-1,-1,-1,20177,-1,2.593699e-05,0.9999597,1.4297848e-05
20180,antigen-presenting cells,13,15,67,91,"Formation of this phenotype requires 4-1BB signaling on both T and antigen-presenting cells and the resulting production of the cytokines IL-27, IL-15, and IL-10.",23547098_4,-1,-1,-1,-1,20180,-1,0.25235668,0.0033615825,0.74428165
20182,the cytokines,20,22,124,137,"Formation of this phenotype requires 4-1BB signaling on both T and antigen-presenting cells and the resulting production of the cytokines IL-27, IL-15, and IL-10.",23547098_4,-1,-1,-1,-1,20182,-1,0.38471946,0.60719293,0.008087652
20189,these cells,33,35,193,204,"Furthermore, we find CD4(+) T cells bearing the signature features of this phenotype in the livers of mice infected with both bacterial and viral intracellular pathogens, suggesting a role for these cells in infectious immunity.",23547098_5,-1,-1,-1,-1,20189,-1,0.0009295984,0.03353228,0.96553814
20190,immunity,37,38,219,227,"Furthermore, we find CD4(+) T cells bearing the signature features of this phenotype in the livers of mice infected with both bacterial and viral intracellular pathogens, suggesting a role for these cells in infectious immunity.",23547098_5,0,-1,2,-1,20190,-1,0.9992865,0.00041097603,0.00030259986
20191,These T cells,0,3,0,13,"These T cells constitute a novel phenotype that resolves multiple questions associated with 4-1BB activation, including how 4-1BB enhances tumor-specific cytotoxicity and how 4-1BB can promote tumor immunity while repressing autoimmunity.",23547098_6,-1,-1,-1,-1,20191,-1,0.0022599879,0.11276364,0.8849764
20194,tumor immunity,33,35,193,207,"These T cells constitute a novel phenotype that resolves multiple questions associated with 4-1BB activation, including how 4-1BB enhances tumor-specific cytotoxicity and how 4-1BB can promote tumor immunity while repressing autoimmunity.",23547098_6,-1,-1,-1,-1,20194,-1,0.020792022,0.9787684,0.00043954674
20195,cells plays,6,8,55,66,An imbalance of immunosuppressive and immunomodulatory cells plays an important role in inhibiting the anti-tumour immune response in a tumour-bearing host.,23572151_0,-1,-1,-1,-1,20195,-1,0.004593747,0.15315124,0.842255
20199,"cells, regulatory T cells",2,7,11,36,"Among such cells, regulatory T cells (Tregs), together with immunosuppressive macrophages, such as CD163+ M2 macrophages, play roles in maintaining the tumour microenvironment.",23572151_1,-1,-1,-1,-1,20199,-1,7.104576e-05,9.2356066e-05,0.99983656
20203,the tumour,27,29,148,158,"Among such cells, regulatory T cells (Tregs), together with immunosuppressive macrophages, such as CD163+ M2 macrophages, play roles in maintaining the tumour microenvironment.",23572151_1,-1,-1,-1,-1,20203,-1,2.0999907e-05,0.99996924,9.774511e-06
20227,Tregs cells,10,12,45,56,We also examined the presence of CD3+ Foxp3+ Tregs cells in lesional skin from 10 patients with KA and 18 patients with SCC.,23572151_4,-1,-1,-1,-1,20227,-1,0.0008489469,0.024747025,0.974404
20234,tumour cells,8,10,41,53,"In addition, the expression of pSTAT1 on tumour cells was observed only in KA.",23572151_8,-1,-1,-1,-1,20234,-1,0.0031668635,0.2917051,0.705128
20236,that the,3,5,23,31,These findings suggest that the induction of immunosuppressive and immunomodulatory cells differs between KA and SCC.,23572151_9,-1,-1,-1,-1,20236,-1,1.81137e-05,0.9999746,7.2998455e-06
20238,the function,5,7,28,40,"MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8(+) Tcell immunity remains unknown.",23601686_0,-1,-1,-1,-1,20238,-1,3.123353e-05,0.99995553,1.318881e-05
20241,Tcell immunity,19,23,101,116,"MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8(+) Tcell immunity remains unknown.",23601686_0,-1,-1,-1,-1,20241,-1,0.0025765179,0.0002783487,0.9971451
20250,deficiency,1,2,10,20,miRNA-155 deficiency resulted in accumulation of suppressor of cytokine signaling-1 (SOCS-1) causing defective cytokine signaling through STAT5.,23601686_4,0,1,-1,-1,20250,-1,4.2057756e-05,0.99990535,5.2555606e-05
20252,cytokine signaling through STAT5,15,19,111,143,miRNA-155 deficiency resulted in accumulation of suppressor of cytokine signaling-1 (SOCS-1) causing defective cytokine signaling through STAT5.,23601686_4,-1,-1,-1,-1,20252,-1,0.7106631,0.28077313,0.008563779
20255,deficiency,15,16,88,98,"Consistently, enforced expression of SOCS-1 in CD8(+) Tcells phenocopied the miRNA-155 deficiency, whereas SOCS-1 silencing augmented tumor destruction.",23601686_5,0,1,-1,-1,20255,-1,0.00083607074,0.9979468,0.0012171621
20259,Tcells that,15,19,93,105,These findings identify miRNA-155 and its target SOCS-1 as key regulators of effector CD8(+) Tcells that can be modulated to potentiate immunotherapies for infectious diseases and cancer.,23601686_6,-1,-1,-1,-1,20259,-1,0.001772771,0.036931954,0.9612952
20263,gene transfected,15,17,82,98,AIM: To study anti-tumor effects of exosomes from class II transactivator (CIITA) gene transfected CT26 cells.,23621273_0,-1,-1,-1,-1,20263,-1,2.6935475e-05,0.9999521,2.0972688e-05
20274,protein,17,18,91,98,RESULTS: Exosomes from CT26-CIITA cells were found to contain a high level of MHC class II protein.,23621273_3,0,1,-1,-1,20274,-1,0.00011971971,0.99975413,0.00012615485
20286,TNF-,14,15,94,99,"In addition, compared to exosomes from CT26 cells, CT26-CIITA-derived exosomes induced higher TNF- and IL-12 mRNA levels.",23621273_6,0,1,-1,-1,20286,-1,8.019795e-05,0.9998822,3.757032e-05
20299,receptor,8,9,54,62,Immune signatures in breast tumors differ by estrogen receptor (ER) status.,23624818_0,0,1,2,-1,20299,-1,0.00027099368,0.9988544,0.0008746015
20304,cytokines that,16,18,101,115,The purpose of this study was to assess associations between ER phenotypes and circulating levels of cytokines that co-ordinate cell-mediated [T-helper type 1 (Th1)] and humoral [T-helper type 2 (Th2)] immunity.,23624818_1,-1,-1,-1,-1,20304,-1,0.9219761,0.073198035,0.0048258845
20306,T-helper type,21,23,143,156,The purpose of this study was to assess associations between ER phenotypes and circulating levels of cytokines that co-ordinate cell-mediated [T-helper type 1 (Th1)] and humoral [T-helper type 2 (Th2)] immunity.,23624818_1,-1,-1,-1,-1,20306,-1,3.792992e-05,0.99990106,6.0983966e-05
20308,T-helper type,31,33,179,192,The purpose of this study was to assess associations between ER phenotypes and circulating levels of cytokines that co-ordinate cell-mediated [T-helper type 1 (Th1)] and humoral [T-helper type 2 (Th2)] immunity.,23624818_1,-1,-1,-1,-1,20308,-1,3.8745267e-05,0.999913,4.828185e-05
20310,immunity,38,39,202,210,The purpose of this study was to assess associations between ER phenotypes and circulating levels of cytokines that co-ordinate cell-mediated [T-helper type 1 (Th1)] and humoral [T-helper type 2 (Th2)] immunity.,23624818_1,0,-1,2,-1,20310,-1,0.9976774,0.0016397225,0.00068285223
20316,Th1 to Th2 cytokines,2,6,10,30,Ratios of Th1 to Th2 cytokines were also evaluated.,23624818_3,-1,-1,-1,-1,20316,-1,0.044554524,0.94610846,0.009337091
20318,Th-2 cytokine,6,8,32,45,"Levels of interleukin (IL)-5, a Th-2 cytokine, were higher in ER(-) than in ER(+) tumors.",23624818_4,-1,-1,-1,-1,20318,-1,0.1186911,0.87303907,0.008269875
20326,Th1 cytokines,1,3,9,22,"Elevated Th1 cytokines were also detected in women with ER(-) and TNBCs, with women in the highest tertile of interferon 2 (OR = 2.39, 95 % CI 1.31-4.35) or tumor necrosis factor- (OR = 2.27, 95 % CI 1.21-4.26) being twice as likely to have TNBC versus LumA cancer.",23624818_6,-1,-1,-1,-1,20326,-1,0.2950457,0.65475166,0.050202645
20332,factor-,38,39,173,181,"Elevated Th1 cytokines were also detected in women with ER(-) and TNBCs, with women in the highest tertile of interferon 2 (OR = 2.39, 95 % CI 1.31-4.35) or tumor necrosis factor- (OR = 2.27, 95 % CI 1.21-4.26) being twice as likely to have TNBC versus LumA cancer.",23624818_6,0,1,-1,-1,20332,-1,0.99985194,5.6880213e-05,9.115152e-05
20338,Th1 cytokines to,12,15,69,85,"When cytokine ratios were examined, women with the highest ratios of Th1 cytokines to IL-5 levels were least likely to have ER(-) or TNBCs compared to ER(+) or LumA cancers, respectively.",23624818_7,-1,-1,-1,-1,20338,-1,0.0005461798,0.9983535,0.0011003126
20345,TNBC than,18,20,96,105,"The strongest associations were in premenopausal women, who were up to 80 % less likely to have TNBC than LumA cancers (IL-12p40/IL-5, OR = 0.19, 95 % CI 0.07-0.56).",23624818_8,-1,-1,-1,-1,20345,-1,3.282762e-05,0.9999422,2.4957128e-05
20348,function,5,6,36,44,"These findings indicate that immune function is associated with ER(-) and TNBC and may be most relevant among younger women, who are likely to be diagnosed with these aggressive phenotypes.",23624818_9,0,1,2,-1,20348,-1,0.00017821652,0.9997023,0.00011949223
20362,to tumor,22,24,150,158,"In tumors rendered immunogenic by model antigen expression or following administration of antitumor vaccines, we found that high NF-B activity leads to tumor rejection and/or growth suppression in mice.",23635779_2,-1,-1,-1,-1,20362,-1,2.0897161e-05,0.99996924,9.849088e-06
20364,T cell chemokines,15,18,100,117,"Using a global RNA expression microarray, we demonstrated that NF-B enhanced expression of several T cell chemokines, including Ccl2, and decreased CCL2 expression was associated with enhanced tumor growth in a mouse lung cancer model.",23635779_3,-1,-1,-1,-1,20364,-1,0.03635112,0.0010195364,0.9626293
20369,function,3,4,21,29,"To investigate NF-B function in human lung tumors, we identified a gene expression signature in human lung adenocarcinoma cell lines that was associated with NF-B activity level.",23635779_4,0,1,2,-1,20369,-1,3.4483845e-05,0.9999409,2.4676643e-05
20383,gene transcripts,10,12,50,66,"miRNAs (miR) have been shown to modulate critical gene transcripts involved in tumorigenesis, but their role in tumor-mediated immunosuppression is largely unknown.",23636127_0,-1,-1,-1,-1,20383,-1,3.9158134e-05,0.9999219,3.8933224e-05
20389,tissue,10,11,55,61,"On the basis of miRNA gene expression in gliomas using tissue microarrays, in situ hybridization, and molecular modeling, miR-124 was identified as a lead candidate for modulating STAT3 signaling, a key pathway mediating immunosuppression in the tumor microenvironment.",23636127_1,-1,1,2,-1,20389,-1,2.4136345e-05,0.99994874,2.7118853e-05
20391,the tumor,39,41,242,251,"On the basis of miRNA gene expression in gliomas using tissue microarrays, in situ hybridization, and molecular modeling, miR-124 was identified as a lead candidate for modulating STAT3 signaling, a key pathway mediating immunosuppression in the tumor microenvironment.",23636127_1,-1,-1,-1,-1,20391,-1,1.9560746e-05,0.9999703,1.0089069e-05
20395,the STAT3,12,14,62,71,"Upon upregulating miR-124 in glioma cancer stem cells (gCSC), the STAT3 pathway was inhibited, and miR-124 reversed gCSC-mediated immunosuppression of T-cell proliferation and induction of forkhead box P3 (Foxp3)(+) regulatory T cells (Treg).",23636127_3,-1,-1,-1,-1,20395,-1,1.9451902e-05,0.9999685,1.201944e-05
20404,TNF-,23,24,168,173,"Treatment of T cells from immunosuppressed glioblastoma patients with miR-124 induced marked effector response including upregulation of interleukin (IL)-2, IFN-, and TNF-.",23636127_4,0,1,-1,-1,20404,-1,8.34319e-05,0.99988997,2.6594767e-05
20405,T-cell transfers,8,10,72,88,Both systemic administration of miR-124 or adoptive miR-124-transfected T-cell transfers exerted potent anti-glioma therapeutic effects in clonotypic and genetically engineered murine models of glioblastoma and enhanced effector responses in the local tumor microenvironment.,23636127_5,-1,-1,-1,-1,20405,-1,0.0008857616,0.02792169,0.9711925
20410,These therapeutic,0,2,0,17,"These therapeutic effects were ablated in both CD4(+)- and CD8(+)-depleted mice and nude mouse systems, indicating that the therapeutic effect of miR-124 depends on the presence of a T-cell-mediated antitumor immune response.",23636127_6,-1,-1,-1,-1,20410,-1,2.2949911e-05,0.99996674,1.0309984e-05
20411,that the therapeutic,17,20,115,135,"These therapeutic effects were ablated in both CD4(+)- and CD8(+)-depleted mice and nude mouse systems, indicating that the therapeutic effect of miR-124 depends on the presence of a T-cell-mediated antitumor immune response.",23636127_6,-1,-1,-1,-1,20411,-1,2.1727865e-05,0.999969,9.250013e-06
20413,T-cell-mediated,29,30,183,198,"These therapeutic effects were ablated in both CD4(+)- and CD8(+)-depleted mice and nude mouse systems, indicating that the therapeutic effect of miR-124 depends on the presence of a T-cell-mediated antitumor immune response.",23636127_6,-1,1,2,-1,20413,-1,3.6371424e-05,6.454952e-05,0.999899
20420,immune responses to,9,12,63,82,The immune system has evolved regulatory mechanisms to control immune responses to self-antigens.,23657628_0,-1,-1,-1,-1,20420,-1,0.23044872,0.7679308,0.0016204938
20423,cells play,5,7,20,30,"Regulatory T (Treg) cells play a pivotal role in maintaining immune tolerance, but tumour growth is associated with local immunosuppression, which can subvert effector immune responses.",23657628_1,-1,-1,-1,-1,20423,-1,0.0029858958,0.116711296,0.8803028
20437,receptor,8,9,53,61,This study addresses the hypothesis that blocking RA receptor alpha (RAR) may enhance the efficacy of a tumour vaccine by inhibiting the induction of Treg cells.,23657628_4,0,1,2,-1,20437,-1,0.00065670273,0.019759482,0.9795838
20446,that this,19,21,118,127,We found that RA significantly enhanced TGF--induced expression of Foxp3 on nave and committed T cells in vitro and that this was blocked by an antagonist of RAR (RARi).,23657628_5,-1,-1,-1,-1,20446,-1,2.1377266e-05,0.9999665,1.2151416e-05
20452,tumour cells,23,25,135,147,"In addition, RARi significantly suppressed TGF- and IL-10 and enhanced IL-12 production by dendritic cells (DC) in response to killed tumour cells or TLR agonists.",23657628_6,-1,-1,-1,-1,20452,-1,0.0048276205,0.26412997,0.73104244
20453,TLR agonists,26,28,151,163,"In addition, RARi significantly suppressed TGF- and IL-10 and enhanced IL-12 production by dendritic cells (DC) in response to killed tumour cells or TLR agonists.",23657628_6,-1,-1,-1,-1,20453,-1,0.008672623,0.9870331,0.004294279
20459,tumour-infiltrating FoxP3(+,9,11,68,95,This protective effect was associated with significant reduction in tumour-infiltrating FoxP3(+) and IL-10(+) Treg cells and a corresponding increase in tumour-infiltrating CD4(+) and CD8(+) T cells that secreted IFN-.,23657628_8,-1,-1,-1,-1,20459,-1,0.00032377068,0.9994448,0.00023142797
20463,T cells that,28,31,191,203,This protective effect was associated with significant reduction in tumour-infiltrating FoxP3(+) and IL-10(+) Treg cells and a corresponding increase in tumour-infiltrating CD4(+) and CD8(+) T cells that secreted IFN-.,23657628_8,-1,-1,-1,-1,20463,-1,0.0014249063,0.02608297,0.9724921
20493,receptor,7,8,40,48,TSCC showed more diffuse Ki67 and IL-22 receptor (IL-22R) expression by IHC.,23667456_7,0,1,2,-1,20493,-1,0.0018687358,0.61523575,0.38289544
20494,cytotoxic T cell function,1,5,11,36,Diminished cytotoxic T cell function in TSCC due to decreased CD8/T-reg ratio may permit tumor progression.,23667456_9,-1,-1,-1,-1,20494,-1,6.0947743e-05,5.7252426e-05,0.99988186
20500,targeted therapy,7,9,41,57,IL-22 may be an attractive candidate for targeted therapy of SCC without endangering allograft survival.,23667456_11,-1,-1,-1,-1,20500,-1,2.8108949e-05,0.99995995,1.19388305e-05
20511,factor-1,8,9,42,51,"In our study, Tregs and hypoxia inducible factor-1 were found to be positively correlated with each other and were increased with the tumor progression.",23723999_3,0,1,-1,-1,20511,-1,0.00024066359,0.99967194,8.7413064e-05
20513,the tumor,22,24,131,140,"In our study, Tregs and hypoxia inducible factor-1 were found to be positively correlated with each other and were increased with the tumor progression.",23723999_3,-1,-1,-1,-1,20513,-1,1.8928742e-05,0.9999716,9.478593e-06
20522,therapeutic target,10,12,56,74,These findings confirmed the crucial role of Tregs as a therapeutic target in gastric cancer therapy and provided helpful thoughts for the design of immunotherapy for gastric cancer in the future.,23723999_5,-1,-1,-1,-1,20522,-1,2.1878534e-05,0.99996626,1.1893178e-05
20523,therapy,15,16,93,100,These findings confirmed the crucial role of Tregs as a therapeutic target in gastric cancer therapy and provided helpful thoughts for the design of immunotherapy for gastric cancer in the future.,23723999_5,0,1,-1,-1,20523,-1,2.240234e-05,0.9999651,1.2469825e-05
20535,blood,20,21,117,122,"For example, a high number of CD4+CD25++Foxp3+ regulatory T-cells (Foxp3+Tregs) have been observed in the peripheral blood and tumor microenvironment of cancer patients.",23725550_1,0,1,-1,-1,20535,-1,0.00016255605,0.9986463,0.0011911488
20539,temozolomide to,19,21,105,120,"On the basis of this, we conducted a study on DC-based vaccination in advanced melanoma, adding low-dose temozolomide to obtain lymphodepletion.",23725550_2,-1,-1,-1,-1,20539,-1,8.610851e-05,0.99988556,2.8286539e-05
20549,Foxp3+Treg cells,3,5,33,49,Temozolomide reduced circulating Foxp3+Treg cells in all patients.,23725550_7,-1,-1,-1,-1,20549,-1,0.003677408,0.5216333,0.47468928
20555,Foxp3+Treg cell,4,6,27,42,"Conversely, IL-2 increased Foxp3+Treg cell count by 75.4%.",23725550_9,-1,-1,-1,-1,20555,-1,0.0032117215,0.65672135,0.3400669
20557,this cytokine,5,7,22,35,"Of note the effect of this cytokine, albeit not statistically significant, on the DCR subgroup led to a further 33.8% reduction in Foxp3+Treg cells.",23725550_10,-1,-1,-1,-1,20557,-1,0.6482488,0.34544146,0.0063096615
20561,Foxp3+Treg cells,25,27,131,147,"Of note the effect of this cytokine, albeit not statistically significant, on the DCR subgroup led to a further 33.8% reduction in Foxp3+Treg cells.",23725550_10,-1,-1,-1,-1,20561,-1,0.0035625792,0.5517299,0.44470748
20562,that the,5,7,33,41,"CONCLUSIONS: Our results suggest that the combined immunological therapy, at least as far as the DCR subgroup is concerned, effectively reduced the number of Foxp3+Treg cells, which exerted a blunting effect on the growth-stimulating effect of IL-2.",23725550_11,-1,-1,-1,-1,20562,-1,1.7594613e-05,0.9999745,7.951894e-06
20563,therapy,9,10,65,72,"CONCLUSIONS: Our results suggest that the combined immunological therapy, at least as far as the DCR subgroup is concerned, effectively reduced the number of Foxp3+Treg cells, which exerted a blunting effect on the growth-stimulating effect of IL-2.",23725550_11,0,1,-1,-1,20563,-1,2.4472884e-05,0.9999597,1.585315e-05
20566,Foxp3+Treg cells,27,29,158,174,"CONCLUSIONS: Our results suggest that the combined immunological therapy, at least as far as the DCR subgroup is concerned, effectively reduced the number of Foxp3+Treg cells, which exerted a blunting effect on the growth-stimulating effect of IL-2.",23725550_11,-1,-1,-1,-1,20566,-1,0.0034131547,0.6788575,0.31772932
20574,tissue,18,19,114,120,"Study animals were analysed for gastric and adipose pathology, inflammatory markers in serum, stomach and adipose tissue, and immune responses in blood, spleen, stomach and adipose tissue.",23729675_2,-1,1,2,-1,20574,-1,0.002461176,0.6303505,0.3671884
20575,immune responses in blood,21,25,126,151,"Study animals were analysed for gastric and adipose pathology, inflammatory markers in serum, stomach and adipose tissue, and immune responses in blood, spleen, stomach and adipose tissue.",23729675_2,-1,-1,-1,-1,20575,-1,0.7937385,0.19857511,0.007686368
20576,tissue,31,32,181,187,"Study animals were analysed for gastric and adipose pathology, inflammatory markers in serum, stomach and adipose tissue, and immune responses in blood, spleen, stomach and adipose tissue.",23729675_2,-1,1,2,-1,20576,-1,0.0014319741,0.8773955,0.12117254
20577,cells in blood,6,9,55,69,Obesity increased bone marrow-derived immature myeloid cells in blood and gastric tissue of H felis-infected mice.,23729675_4,-1,-1,-1,-1,20577,-1,0.0030927646,0.089076586,0.9078307
20578,tissue,11,12,82,88,Obesity increased bone marrow-derived immature myeloid cells in blood and gastric tissue of H felis-infected mice.,23729675_4,-1,1,2,-1,20578,-1,0.00015913781,0.9989924,0.0008484538
20585,tissue,25,26,169,175,"Obesity also led to elevations in CD4 T cells, IL-17A, granulocyte macrophage colony-stimulating factor, phosphorylated STAT3 and prosurvival gene expression in gastric tissue of H felis-infected mice.",23729675_5,-1,1,2,-1,20585,-1,7.790606e-05,0.99957746,0.00034465807
20586,tissue,4,5,23,29,"Conversely, in adipose tissue of obese mice, H felis infection increased macrophage accumulation and expression of IL-6, C-C motif ligand 7 (CCL7) and leptin.",23729675_6,-1,1,2,-1,20586,-1,0.00012091629,0.99902713,0.0008519682
20594,factors,12,13,117,124,"Interestingly, gastric inflammation augmented obesity-induced adipose inflammation and production of adipose-derived factors in obese, but not lean, mice.",23729675_9,0,1,-1,-1,20594,-1,0.9974879,0.0012916463,0.001220485
20596,through cytokine-mediated,9,11,85,110,"Our findings suggest that obesity accelerates Helicobacter-associated gastric cancer through cytokine-mediated cross-talk between inflamed gastric and adipose tissues, augmenting immune responses at both tissue sites, and thereby contributing to a protumorigenic gastric microenvironment.",23729675_10,-1,-1,-1,-1,20596,-1,0.090339296,0.9078989,0.0017618239
20597,tissues,17,18,159,166,"Our findings suggest that obesity accelerates Helicobacter-associated gastric cancer through cytokine-mediated cross-talk between inflamed gastric and adipose tissues, augmenting immune responses at both tissue sites, and thereby contributing to a protumorigenic gastric microenvironment.",23729675_10,-1,1,2,-1,20597,-1,0.00014784379,0.99838936,0.0014628569
20599,tissue,24,25,204,210,"Our findings suggest that obesity accelerates Helicobacter-associated gastric cancer through cytokine-mediated cross-talk between inflamed gastric and adipose tissues, augmenting immune responses at both tissue sites, and thereby contributing to a protumorigenic gastric microenvironment.",23729675_10,-1,1,2,-1,20599,-1,0.00040478003,0.98237544,0.01721977
20604,cytokine that,9,11,50,63,"AIMS: Interleukin-17 (IL-17) is a proinflammatory cytokine that is most prominently produced by T-helper type 17 (Th17) cells, a distinct CD4+ T-helper cell subset.",23738752_0,-1,-1,-1,-1,20604,-1,0.9512464,0.044734716,0.004018963
20605,T-helper type,16,18,96,109,"AIMS: Interleukin-17 (IL-17) is a proinflammatory cytokine that is most prominently produced by T-helper type 17 (Th17) cells, a distinct CD4+ T-helper cell subset.",23738752_0,-1,-1,-1,-1,20605,-1,7.969864e-05,0.9996995,0.00022081687
20608,T-helper cell subset,28,31,143,163,"AIMS: Interleukin-17 (IL-17) is a proinflammatory cytokine that is most prominently produced by T-helper type 17 (Th17) cells, a distinct CD4+ T-helper cell subset.",23738752_0,-1,-1,-1,-1,20608,-1,0.0016722471,0.051266752,0.947061
20613,IL-17-producing cells,11,13,54,75,The aim of this study was to investigate the level of IL-17-producing cells in the breast cancer tumour microenvironment and its prognostic role.,23738752_1,-1,-1,-1,-1,20613,-1,0.78963816,0.0020628006,0.20829906
20620,IL-17-producing cells,6,8,35,56,"We found that increased numbers of IL-17-producing cells were correlated with high histological grade, negative ER/PR status, and triple-negative molecular subtypes segregated by immunoprofiles.",23738752_3,-1,-1,-1,-1,20620,-1,0.82496077,0.0016721018,0.1733671
20625,nodal status,12,14,57,69,"However, they did not correlate with stage, tumour size, nodal status, HER2 status, or histological type.",23738752_4,-1,-1,-1,-1,20625,-1,0.25517157,0.7153019,0.029526612
20629,IL-17-producing cells,7,9,43,64,Patients with tumours with high numbers of IL-17-producing cells had shorter disease-free survival (DFS) than patients with tumours with low numbers of IL-17-producing cells (P < 0.01).,23738752_5,-1,-1,-1,-1,20629,-1,0.75092655,0.0019940084,0.24707943
20632,IL-17-producing cells,24,26,152,173,Patients with tumours with high numbers of IL-17-producing cells had shorter disease-free survival (DFS) than patients with tumours with low numbers of IL-17-producing cells (P < 0.01).,23738752_5,-1,-1,-1,-1,20632,-1,0.7650196,0.0019418428,0.23303853
20633,analysis,2,3,16,24,"In multivariate analysis, high IL-17 level [hazard ratio (HR) 2.24; 95% CI 1.06-4.75], advanced T stage (HR 2.73; 95% CI 1.30-5.73), positive HER2 status (HR 4.88; 95% CI 1.47-16.18) and triple-negative subtype (HR 7.46; 95% CI 1.38-40.36) were significant prognostic factors for DFS.CONCLUSIONS: Our results indicate that a high level of IL-17-producing cells in the breast cancer tumour microenvironment is a poor prognostic factor.",23738752_6,0,1,-1,-1,20633,-1,4.1426872e-05,0.999931,2.7641341e-05
20638,factors,69,70,268,275,"In multivariate analysis, high IL-17 level [hazard ratio (HR) 2.24; 95% CI 1.06-4.75], advanced T stage (HR 2.73; 95% CI 1.30-5.73), positive HER2 status (HR 4.88; 95% CI 1.47-16.18) and triple-negative subtype (HR 7.46; 95% CI 1.38-40.36) were significant prognostic factors for DFS.CONCLUSIONS: Our results indicate that a high level of IL-17-producing cells in the breast cancer tumour microenvironment is a poor prognostic factor.",23738752_6,0,1,-1,-1,20638,-1,0.0011856464,0.9984701,0.00034425067
20640,IL-17-producing cells,81,83,339,360,"In multivariate analysis, high IL-17 level [hazard ratio (HR) 2.24; 95% CI 1.06-4.75], advanced T stage (HR 2.73; 95% CI 1.30-5.73), positive HER2 status (HR 4.88; 95% CI 1.47-16.18) and triple-negative subtype (HR 7.46; 95% CI 1.38-40.36) were significant prognostic factors for DFS.CONCLUSIONS: Our results indicate that a high level of IL-17-producing cells in the breast cancer tumour microenvironment is a poor prognostic factor.",23738752_6,-1,-1,-1,-1,20640,-1,0.82849073,0.0013146454,0.17019464
20643,factor,93,94,427,433,"In multivariate analysis, high IL-17 level [hazard ratio (HR) 2.24; 95% CI 1.06-4.75], advanced T stage (HR 2.73; 95% CI 1.30-5.73), positive HER2 status (HR 4.88; 95% CI 1.47-16.18) and triple-negative subtype (HR 7.46; 95% CI 1.38-40.36) were significant prognostic factors for DFS.CONCLUSIONS: Our results indicate that a high level of IL-17-producing cells in the breast cancer tumour microenvironment is a poor prognostic factor.",23738752_6,0,1,-1,-1,20643,-1,0.0012642398,0.9984003,0.00033551964
20648,to the,14,16,82,88,"While the mechanism is not well understood, BM-MSCs have been shown to contribute to the immunosuppressive response found in a number of diseases.",23777268_1,-1,-1,-1,-1,20648,-1,2.481095e-05,0.9999634,1.18070975e-05
20652,to the,10,12,69,75,"At day 28 post-transplantation, BM-MSCs migrated from the subserosal to the mucosal layer of the stomach.",23777268_3,-1,-1,-1,-1,20652,-1,2.4551848e-05,0.9999578,1.7634991e-05
20659,functions,19,20,133,142,The grafted BM-MSCs significantly stimulated systemic and local interleukin-10 (IL-10)-secreting T cell and regulatory T cell (Treg) functions.,23777268_4,0,1,2,-1,20659,-1,0.0028235149,0.5070449,0.49013156
20664,cytokines IL-10,3,5,21,36,"Moreover, inhibitory cytokines IL-10 and transforming growth factor-1 increased in the gastric tissue, while there was a decrease in inflammatory interferon- (IFN-).",23777268_6,-1,-1,-1,-1,20664,-1,0.99982387,4.4129418e-05,0.00013209486
20666,factor-1,8,9,61,70,"Moreover, inhibitory cytokines IL-10 and transforming growth factor-1 increased in the gastric tissue, while there was a decrease in inflammatory interferon- (IFN-).",23777268_6,0,1,-1,-1,20666,-1,0.9981735,0.00037976497,0.001446713
20668,tissue,13,14,96,102,"Moreover, inhibitory cytokines IL-10 and transforming growth factor-1 increased in the gastric tissue, while there was a decrease in inflammatory interferon- (IFN-).",23777268_6,-1,1,2,-1,20668,-1,6.970676e-05,0.9995009,0.00042936284
20674,the immune responses,15,18,90,110,A coculture system in the presence or absence of BM-MSCs was also established to evaluate the immune responses in vitro.,23777268_8,-1,-1,-1,-1,20674,-1,0.2287173,0.76995605,0.0013267037
20675,IL-10-secreting T cells,3,6,15,38,"An increase in IL-10-secreting T cells and Tregs, associated with increased expression of Gata-3 and FoxP3, generation of IL-10 in the supernatant, and proliferation of gastric epithelial cells (GECs) was observed.",23777268_9,-1,-1,-1,-1,20675,-1,0.59955263,0.0032591934,0.3971881
20684,that transplantation,3,5,27,47,These findings demonstrate that transplantation of BM-MSCs into a chronic H. pylori-infected mouse model results in the generation of an immunosuppressive environment.,23777268_10,-1,-1,-1,-1,20684,-1,1.9619485e-05,0.9999714,8.972883e-06
20685,the generation,16,18,116,130,These findings demonstrate that transplantation of BM-MSCs into a chronic H. pylori-infected mouse model results in the generation of an immunosuppressive environment.,23777268_10,-1,-1,-1,-1,20685,-1,1.775299e-05,0.99997294,9.3297485e-06
20690,Chemokine receptors CCR6,0,3,0,24,Chemokine receptors CCR6 and CCR7 have been reported to play important roles in T cell migration and organ-specific metastasis of various tumors.,23835793_0,-1,-1,-1,-1,20690,-1,0.028629659,0.0022002112,0.9691701
20691,to play,8,10,53,60,Chemokine receptors CCR6 and CCR7 have been reported to play important roles in T cell migration and organ-specific metastasis of various tumors.,23835793_0,-1,-1,-1,-1,20691,-1,2.6057136e-05,0.99996257,1.1415567e-05
20703,the CCR6,18,20,84,92,"The expression of CCR6, CCR7 and their ligands mRNA (CCL20, CCL19/CCL21) as well as the CCR6 and CCR7 proteins were detected by real-time RT-PCR and immunohistochemistry (IHC), respectively.",23835793_2,-1,-1,-1,-1,20703,-1,0.0028329673,0.83312523,0.16404182
20704,proteins,22,23,102,110,"The expression of CCR6, CCR7 and their ligands mRNA (CCL20, CCL19/CCL21) as well as the CCR6 and CCR7 proteins were detected by real-time RT-PCR and immunohistochemistry (IHC), respectively.",23835793_2,0,1,-1,-1,20704,-1,6.81177e-05,0.9998312,0.00010070657
20709,blood,19,20,114,119,Flow cytometry was used to investigate the percentage of CD4+CD25+Foxp3+ regulatory T cells (Tregs) in peripheral blood mononuclear cells (PBMCs).,23835793_3,0,1,-1,-1,20709,-1,0.00028287224,0.9972951,0.0024220082
20716,transforming growth factor,20,23,112,138,"Furthermore, a number of cytokines, including interleukin (IL)-2, IL-4, IL-10, IL-12p70, interferon (IFN)- and transforming growth factor (TGF)-1 were detected by ELISA.",23835793_4,-1,-1,-1,-1,20716,-1,0.8869368,0.10662865,0.0064346
20718,that CCR6,3,5,19,28,"The results showed that CCR6 and CCR7 were expressed in tumors in situ, metastatic LNs and CD4+CD25+Foxp3+ Tregs.",23835793_5,-1,-1,-1,-1,20718,-1,0.0036327345,0.53177345,0.46459386
20721,that the,3,5,20,28,"It was hypothesized that the expression profile of CCR6, CCR7 and the proliferation of CD4+CD25+Foxp3+ Tregs affected the process of LN metastasis in LSCC patients.",23835793_6,-1,-1,-1,-1,20721,-1,1.717342e-05,0.99997437,8.485428e-06
20728,the Foxp3,6,8,39,48,"Therefore, the increased percentage of the Foxp3+ Tregs and the upregulation of Foxp3 expression on CCR6+ Tregs in LSCC patients may have accounted for the downregulation of antitumor immunity in these patients, which could be valuable for assessment of prognosis in LSCC treatment.",23835793_7,-1,-1,-1,-1,20728,-1,3.0038602e-05,0.99995375,1.6229758e-05
20735,immunity,31,32,184,192,"Therefore, the increased percentage of the Foxp3+ Tregs and the upregulation of Foxp3 expression on CCR6+ Tregs in LSCC patients may have accounted for the downregulation of antitumor immunity in these patients, which could be valuable for assessment of prognosis in LSCC treatment.",23835793_7,0,-1,2,-1,20735,-1,0.9994123,0.00033354337,0.00025413148
20743,tolerance to,20,22,126,138,"Here, we further studied the immunogenicity of chimeric murine MSLN-virus-like particles (mMSLN-VLPs), their ability to break tolerance to mMSLN, a self-antigen, and deciphered the mechanism of immune responses elicited by mMSLN-VLP immunization using a pancreatic cancer (PC) mouse model.",23874581_1,-1,-1,-1,-1,20743,-1,2.5003877e-05,0.9999616,1.3375177e-05
20748,the tolerance to,21,24,119,135,"In addition to what we have found with xenogeneic human MSLN-VLP (hMSLN-VLP), mMSLN-VLP immunization was able to break the tolerance to intrinsic MSLN and mount mMSLN-specific, cytotoxic CD8(+) T cells which led to a significant reduction in tumor volume and prolonged survival in an orthotopic PC mouse model.",23874581_2,-1,-1,-1,-1,20748,-1,2.2444468e-05,0.999967,1.0525531e-05
20754,tumor tissues,17,19,103,116,"Furthermore, CD4(+)foxp3(+) regulatory T cells (Tregs) were progressively decreased in both spleen and tumor tissues following mMSLN-VLP immunization and this was at least partly due to elevated levels of IL-6 production from activated plasmocytoid dendritic cell (pDC)-like cells following mMSLN-VLP immunization.",23874581_3,-1,-1,-1,-1,20754,-1,2.8700559e-05,0.99993646,3.4877066e-05
20764,Treg subset,12,14,88,99,"Moreover, mMSLN-VLP treatment mainly reduced the frequency of the CD4(+)foxp3(+)ICOS(-) Treg subset.",23874581_4,-1,-1,-1,-1,20764,-1,0.001410745,0.07210069,0.9264886
20780,to target,12,14,68,77,"However, combination therapies will likely need to be used in order to target residual CD4(+)foxp3(+)ICOS(+) Treg cells.",23874581_7,-1,-1,-1,-1,20780,-1,1.8941908e-05,0.9999716,9.422543e-06
20807,T-cell,10,11,52,58,"Together, these effects result in an altered CD8(+) T-cell adhesiveness to the extracellular matrix and selectins, sensitivity to FasL-mediated apoptosis, and cytotoxicity.",23878002_6,-1,1,2,-1,20807,-1,3.032638e-05,5.0403054e-05,0.9999193
20808,to the,12,14,72,78,"Together, these effects result in an altered CD8(+) T-cell adhesiveness to the extracellular matrix and selectins, sensitivity to FasL-mediated apoptosis, and cytotoxicity.",23878002_6,-1,-1,-1,-1,20808,-1,5.07405e-05,0.9999238,2.5393767e-05
20811,cell types,3,5,24,34,INTRODUCTION: Different cell types and cytokines have been identified as contributors to the formation of periapical lesions.,23880265_0,-1,-1,-1,-1,20811,-1,4.8203532e-05,5.912315e-05,0.9998927
20813,to the,12,14,86,92,INTRODUCTION: Different cell types and cytokines have been identified as contributors to the formation of periapical lesions.,23880265_0,-1,-1,-1,-1,20813,-1,3.1090432e-05,0.9999553,1.3648013e-05
20819,transforming growth factor,15,18,95,121,"In this perspective, this study aimed to evaluate the immunoexpression of interleukin (IL)-17, transforming growth factor (TGF)-1, and the forkhead box P3 (FoxP3) in periapical lesions, correlating them with the type of lesion, the intensity of the inflammatory infiltrate, and the thickness of the cystic epithelial lining.",23880265_1,-1,-1,-1,-1,20819,-1,0.82901686,0.16592784,0.005055251
20820,the forkhead,21,23,136,148,"In this perspective, this study aimed to evaluate the immunoexpression of interleukin (IL)-17, transforming growth factor (TGF)-1, and the forkhead box P3 (FoxP3) in periapical lesions, correlating them with the type of lesion, the intensity of the inflammatory infiltrate, and the thickness of the cystic epithelial lining.",23880265_1,-1,-1,-1,-1,20820,-1,2.0308873e-05,0.9999678,1.1895896e-05
20823,the type,35,37,209,217,"In this perspective, this study aimed to evaluate the immunoexpression of interleukin (IL)-17, transforming growth factor (TGF)-1, and the forkhead box P3 (FoxP3) in periapical lesions, correlating them with the type of lesion, the intensity of the inflammatory infiltrate, and the thickness of the cystic epithelial lining.",23880265_1,-1,-1,-1,-1,20823,-1,2.100434e-05,0.9999666,1.2334055e-05
20826,the thickness,48,50,279,292,"In this perspective, this study aimed to evaluate the immunoexpression of interleukin (IL)-17, transforming growth factor (TGF)-1, and the forkhead box P3 (FoxP3) in periapical lesions, correlating them with the type of lesion, the intensity of the inflammatory infiltrate, and the thickness of the cystic epithelial lining.",23880265_1,-1,-1,-1,-1,20826,-1,2.3132805e-05,0.99996126,1.5593096e-05
20830,analysis,28,29,148,156,"METHODS: Twenty periapical granulomas (PGs), 20 radicular cysts (RCs), and 20 residual radicular cysts (RRCs) were submitted to immunohistochemical analysis using anti-IL-17, anti-TGF-1, and anti-FoxP3 antibodies.",23880265_2,0,1,-1,-1,20830,-1,3.4190358e-05,0.9999366,2.9169272e-05
20887,to the,21,23,109,115,"As a result, the ratio of antigen-specific CD8+ T cells and MDSCs in tumors increased up to 85-fold compared to the control.",23922012_8,-1,-1,-1,-1,20887,-1,2.416472e-05,0.999964,1.1817547e-05
20905,to this,21,23,156,163,Ovarian cancer is a prevalent gynecological malignancy with potent immune-suppression capabilities; regulatory T cells (Tregs) are significant contributors to this immune-suppression.,23948613_0,-1,-1,-1,-1,20905,-1,4.6465346e-05,0.9999304,2.3115615e-05
20906,TNF,9,10,55,58,"As ovarian cancer patients present with high levels of TNF and Tregs expressing TNFR2 are associated with maximal suppressive capacity, we investigated TNFR2+ Tregs within these patients.",23948613_1,0,1,-1,-1,20906,-1,5.747746e-05,0.99992037,2.22004e-05
20908,TNFR2,13,14,80,85,"As ovarian cancer patients present with high levels of TNF and Tregs expressing TNFR2 are associated with maximal suppressive capacity, we investigated TNFR2+ Tregs within these patients.",23948613_1,0,1,-1,-1,20908,-1,3.552766e-05,0.9999478,1.6650178e-05
20910,TNFR2,23,24,152,157,"As ovarian cancer patients present with high levels of TNF and Tregs expressing TNFR2 are associated with maximal suppressive capacity, we investigated TNFR2+ Tregs within these patients.",23948613_1,0,1,-1,-1,20910,-1,4.028648e-05,0.9999416,1.8106126e-05
20913,TNFR2,2,3,8,13,"Indeed, TNFR2+ Tregs from tumor-associated ascites were the most potent suppressor T cell fraction.",23948613_2,0,1,-1,-1,20913,-1,4.0294108e-05,0.9999449,1.4822624e-05
20917,suppressor T cell,12,15,72,89,"Indeed, TNFR2+ Tregs from tumor-associated ascites were the most potent suppressor T cell fraction.",23948613_2,-1,-1,-1,-1,20917,-1,4.465538e-05,5.941279e-05,0.99989593
20921,blood TNFR2,12,14,85,96,They were abundantly present within the ascites and more suppressive than peripheral blood TNFR2+ Tregs in patients.,23948613_3,-1,-1,-1,-1,20921,-1,0.00010672949,0.99981314,8.021121e-05
20926,TNFR2,6,7,39,44,"Additionally, CD73 expression level on TNFR2+ Tregs was inversely correlated with IFN- production by effector T cells.",23948613_5,0,1,-1,-1,20926,-1,3.916865e-05,0.99994826,1.2526972e-05
20930,This Treg,0,2,0,9,This Treg fraction can be selectively recruited into the ascites from the peripheral blood of patients.,23948613_6,-1,-1,-1,-1,20930,-1,2.6578042e-05,0.9999571,1.6283951e-05
20933,blood,13,14,85,90,This Treg fraction can be selectively recruited into the ascites from the peripheral blood of patients.,23948613_6,0,1,-1,-1,20933,-1,0.00025077257,0.99704427,0.0027049896
20934,Targeting TNFR2,0,2,0,15,Targeting TNFR2+ Tregs may offer new approaches to enhance the poor survival rates of ovarian cancer.,23948613_7,-1,-1,-1,-1,20934,-1,4.335086e-05,0.9999442,1.2437973e-05
20938,the T-cell,2,4,13,23,Signals from the T-cell recognition of antigen program effector functions are necessary to clear infections and tumors.,23963642_0,-1,-1,-1,-1,20938,-1,0.0034827914,0.13192788,0.8645893
20940,functions,9,10,64,73,Signals from the T-cell recognition of antigen program effector functions are necessary to clear infections and tumors.,23963642_0,0,1,2,-1,20940,-1,0.00068176334,0.013225495,0.98609275
20946,functions,9,10,46,55,"In T lymphocytes, JNK1 and JNK2 have distinct functions depending on their maturation state and cell-type.",23963642_2,0,1,2,-1,20946,-1,0.00020196736,0.99958605,0.0002119759
20953,function,10,11,74,82,"However, the mechanisms that regulate their isoform-specific activity and function are still unclear.",23963642_3,0,1,2,-1,20953,-1,5.5171236e-05,0.9999162,2.8619157e-05
20955,protein,12,13,59,66,"Here, we identify plenty of SH3 (POSH) and JNK-interacting protein 1 (JIP-1) as a multiprotein scaffold network for TCR-mediated JNK1 activation in CD8(+) T cells.",23963642_4,0,1,-1,-1,20955,-1,0.00010913831,0.99966216,0.00022873328
20956,TCR-mediated,23,24,116,128,"Here, we identify plenty of SH3 (POSH) and JNK-interacting protein 1 (JIP-1) as a multiprotein scaffold network for TCR-mediated JNK1 activation in CD8(+) T cells.",23963642_4,-1,1,2,-1,20956,-1,2.0219655e-05,0.99996245,1.7310265e-05
20962,the transcription factors,23,26,136,161,"Disruption of the POSH/JIP-1 complex led to profound defects in the activation of JNK1, as well as deficient activation or induction of the transcription factors c-Jun, T-bet, and Eomesodermin.",23963642_5,-1,-1,-1,-1,20962,-1,2.2819182e-05,0.999959,1.8215258e-05
20974,TCR-dependent,12,13,77,90,"Collectively, these data identify a mechanism for the specific regulation of TCR-dependent JNK1 activation and function that is key for CD8(+) T-cell responses.",23963642_7,-1,1,2,-1,20974,-1,2.1833785e-05,0.9999616,1.6579945e-05
20975,function that,16,18,111,124,"Collectively, these data identify a mechanism for the specific regulation of TCR-dependent JNK1 activation and function that is key for CD8(+) T-cell responses.",23963642_7,-1,-1,-1,-1,20975,-1,3.722251e-05,0.99993527,2.7495702e-05
20976,T-cell,23,24,143,149,"Collectively, these data identify a mechanism for the specific regulation of TCR-dependent JNK1 activation and function that is key for CD8(+) T-cell responses.",23963642_7,-1,1,2,-1,20976,-1,3.708166e-05,5.2746556e-05,0.9999101
20977,Regulatory T cells play,0,4,0,23,Regulatory T cells play a key role in suppressing tumor immunity.,23975869_0,-1,-1,-1,-1,20977,-1,0.0014645676,0.12512866,0.8734068
20978,tumor immunity,9,11,50,64,Regulatory T cells play a key role in suppressing tumor immunity.,23975869_0,-1,-1,-1,-1,20978,-1,0.022119263,0.97736174,0.00051896623
20989,factor-,21,22,116,124,"Here, we investigated the effect of triptolide on regulatory T cells and on the level of IL-10, transforming growth factor-, and vascular endothelial growth factor in tumor-bearing mice.",23975869_2,0,1,-1,-1,20989,-1,0.999796,7.701673e-05,0.0001271033
20993,three treatment,22,24,126,141,"Fifty male C57BL/6 mice were randomly grouped as follows: normal control group, model group with B16-F10 cells implanted, and three treatment groups with cyclophosphamide, triptolide-high dose, triptolide-low dose.",23975869_3,-1,-1,-1,-1,20993,-1,6.500554e-05,0.9998901,4.484742e-05
20999,analysis,18,19,109,117,The proportion of regulatory T cells in the spleen and axillary lymph nodes was evaluated by flow cytometric analysis.,23975869_4,0,1,-1,-1,20999,-1,4.2046464e-05,0.9999182,3.9725965e-05
21000,cytokines IL-10,2,4,14,29,"Production of cytokines IL-10, transforming growth factor-, and vascular endothelial growth factor in serum was measured using enzyme-labeled immunosorbent assay kits.",23975869_5,-1,-1,-1,-1,21000,-1,0.99984753,4.5776873e-05,0.00010664841
21002,factor-,7,8,51,59,"Production of cytokines IL-10, transforming growth factor-, and vascular endothelial growth factor in serum was measured using enzyme-labeled immunosorbent assay kits.",23975869_5,0,1,-1,-1,21002,-1,0.9997961,8.664172e-05,0.00011722434
21008,factor-,11,12,57,65,"The mRNA levels of Foxp3, IL-10, and transforming growth factor- in the spleen and vascular endothelial growth factor in tumor tissue were detected by real-time PCR.",23975869_6,0,1,-1,-1,21008,-1,0.9997825,8.409735e-05,0.00013331098
21011,tumor tissue,21,23,122,134,"The mRNA levels of Foxp3, IL-10, and transforming growth factor- in the spleen and vascular endothelial growth factor in tumor tissue were detected by real-time PCR.",23975869_6,-1,-1,-1,-1,21011,-1,2.967349e-05,0.99993634,3.400104e-05
21013,that triptolide,3,5,19,34,The results showed that triptolide significantly decreased the proportion of regulatory T cells and lowered the Foxp3 level in the spleen and axillary lymph nodes of tumor-bearing mice.,23975869_7,-1,-1,-1,-1,21013,-1,2.7371852e-05,0.9999603,1.2287908e-05
21016,the Foxp3,15,17,108,117,The results showed that triptolide significantly decreased the proportion of regulatory T cells and lowered the Foxp3 level in the spleen and axillary lymph nodes of tumor-bearing mice.,23975869_7,-1,-1,-1,-1,21016,-1,2.1212185e-05,0.9999676,1.1226281e-05
21021,factor-,6,7,44,52,"Production of IL-10 and transforming growth factor- in peripheral blood, and the mRNA level of IL-10 and transforming growth factor- in the spleen were also decreased.",23975869_8,0,1,-1,-1,21021,-1,0.997863,0.0013821037,0.0007548451
21022,blood,9,10,67,72,"Production of IL-10 and transforming growth factor- in peripheral blood, and the mRNA level of IL-10 and transforming growth factor- in the spleen were also decreased.",23975869_8,0,1,-1,-1,21022,-1,0.00010616427,0.999635,0.0002588675
21026,factor-,20,21,126,134,"Production of IL-10 and transforming growth factor- in peripheral blood, and the mRNA level of IL-10 and transforming growth factor- in the spleen were also decreased.",23975869_8,0,1,-1,-1,21026,-1,0.9975325,0.0015107555,0.00095679075
21031,that triptolide,6,8,38,53,"In conclusion, our study demonstrated that triptolide might inhibit tumor growth by inhibiting regulatory T cells and some cytokines such as IL-10 and transforming growth factor-, as well as production of vascular endothelial growth factor.",23975869_10,-1,-1,-1,-1,21031,-1,2.320884e-05,0.9999659,1.0888818e-05
21037,factor-,26,27,171,179,"In conclusion, our study demonstrated that triptolide might inhibit tumor growth by inhibiting regulatory T cells and some cytokines such as IL-10 and transforming growth factor-, as well as production of vascular endothelial growth factor.",23975869_10,0,1,-1,-1,21037,-1,0.9998392,5.8174006e-05,0.00010258725
21045,those tumors,25,27,131,143,"Although evidence for an active immune response, including infiltration with CD8(+) T cells, can be found in a subset of patients, those tumors are nonetheless not immunologically rejected.",23986400_1,-1,-1,-1,-1,21045,-1,2.1537518e-05,0.99996674,1.1755296e-05
21048,the subset,10,12,42,52,"In the current report, we show that it is the subset of T cell-inflamed tumors that showed high expression of three defined immunosuppressive mechanisms: indoleamine-2,3-dioxygenase (IDO), PD-L1/B7-H1, and FoxP3(+) regulatory T cells (T(regs)), suggesting that these inhibitory pathways might serve as negative feedback mechanisms that followed, rather than preceded, CD8(+) T cell infiltration.",23986400_2,-1,-1,-1,-1,21048,-1,0.0039302334,0.43116757,0.5649021
21049,T cell-inflamed tumors that,13,17,56,83,"In the current report, we show that it is the subset of T cell-inflamed tumors that showed high expression of three defined immunosuppressive mechanisms: indoleamine-2,3-dioxygenase (IDO), PD-L1/B7-H1, and FoxP3(+) regulatory T cells (T(regs)), suggesting that these inhibitory pathways might serve as negative feedback mechanisms that followed, rather than preceded, CD8(+) T cell infiltration.",23986400_2,-1,-1,-1,-1,21049,-1,0.0032947909,0.13087969,0.8658255
21054,that these,45,47,256,266,"In the current report, we show that it is the subset of T cell-inflamed tumors that showed high expression of three defined immunosuppressive mechanisms: indoleamine-2,3-dioxygenase (IDO), PD-L1/B7-H1, and FoxP3(+) regulatory T cells (T(regs)), suggesting that these inhibitory pathways might serve as negative feedback mechanisms that followed, rather than preceded, CD8(+) T cell infiltration.",23986400_2,-1,-1,-1,-1,21054,-1,1.8911194e-05,0.9999721,8.941113e-06
21060,the tumor,22,24,122,131,"Mechanistic studies in mice revealed that up-regulated expression of IDO and PD-L1, as well as recruitment of T(regs), in the tumor microenvironment depended on the presence of CD8(+) T cells.",23986400_3,-1,-1,-1,-1,21060,-1,1.8583834e-05,0.99997187,9.559699e-06
21067,that these,3,5,18,28,"Our results argue that these major immunosuppressive pathways are intrinsically driven by the immune system rather than being orchestrated by cancer cells, and imply that cancer immunotherapy approaches targeting negative regulatory immune checkpoints might be preferentially beneficial for patients with a preexisting T cell-inflamed tumor microenvironment.",23986400_5,-1,-1,-1,-1,21067,-1,1.802752e-05,0.9999739,8.078885e-06
21073,T cell-inflamed tumor,43,46,319,340,"Our results argue that these major immunosuppressive pathways are intrinsically driven by the immune system rather than being orchestrated by cancer cells, and imply that cancer immunotherapy approaches targeting negative regulatory immune checkpoints might be preferentially beneficial for patients with a preexisting T cell-inflamed tumor microenvironment.",23986400_5,-1,-1,-1,-1,21073,-1,0.0029350654,0.038269423,0.9587956
21074,Tumour-infiltrating lymphocytes,0,2,0,31,Tumour-infiltrating lymphocytes (TILs) have been found to play crucial roles in a series of cancers.,24007242_0,-1,-1,-1,-1,21074,-1,0.0041890466,0.82650894,0.16930203
21076,to play,8,10,55,62,Tumour-infiltrating lymphocytes (TILs) have been found to play crucial roles in a series of cancers.,24007242_0,-1,-1,-1,-1,21076,-1,2.2901035e-05,0.99996626,1.07866545e-05
21078,these cells,5,7,23,34,"However, the impact of these cells on gallbladder carcinoma (GBC) remains poorly understood.",24007242_1,-1,-1,-1,-1,21078,-1,0.0006386544,0.0146970125,0.98466426
21084,these cells,33,35,171,182,"In this study, we examined infiltrating FoxP3+, IL-17+, CD4+ and CD8+ cells by immunohistochemistry in specimens of 104 patients with GBC and evaluated the association of these cells with clinicopathological features and prognosis.",24007242_2,-1,-1,-1,-1,21084,-1,0.002022724,0.11165135,0.88632596
21100,IL-17-producing cells,33,35,147,168,"The group with high FoxP3+ cells showed poor overall survival (OS, P < 0.001) and disease-free survival (DFS, P < 0.001), and high infiltration of IL-17-producing cells was also a predictor of poor OS (P = 0.024).",24007242_6,-1,-1,-1,-1,21100,-1,0.8604284,0.0016285464,0.13794315
21101,analysis,1,2,13,21,Multivariate analysis revealed that the presence of intratumoral FoxP3+ cells was an independent prognostic indicator for poor DFS (P < 0.01).,24007242_7,0,1,-1,-1,21101,-1,3.430196e-05,0.9999443,2.138246e-05
21102,that the,3,5,31,39,Multivariate analysis revealed that the presence of intratumoral FoxP3+ cells was an independent prognostic indicator for poor DFS (P < 0.01).,24007242_7,-1,-1,-1,-1,21102,-1,1.8776916e-05,0.9999732,8.004413e-06
21106,that FoxP3,6,8,36,46,"In summary, these findings indicate that FoxP3+ and IL-17+ cells cooperatively facilitate pathogenesis and progression of GBC and show prognostic significance for OS or DFS.",24007242_8,-1,-1,-1,-1,21106,-1,2.6840884e-05,0.9999608,1.2330573e-05
21109,that tumor-evoked,3,5,23,40,We reported previously that tumor-evoked regulatory B cells (tBregs) play an essential role in breast cancer lung metastasis by inducing TGF--dependent conversion of metastasis-promoting Foxp3(+) regulatory T cells (Tregs).,24043896_0,-1,-1,-1,-1,21109,-1,2.2224322e-05,0.99996924,8.49968e-06
21125,the generation,12,14,72,86,"The mechanism of this process is that RSV inactivates Stat3, preventing the generation and function of tBregs, including expression of TGF-.",24043896_2,-1,-1,-1,-1,21125,-1,2.2700835e-05,0.99996436,1.2925666e-05
21126,function,15,16,91,99,"The mechanism of this process is that RSV inactivates Stat3, preventing the generation and function of tBregs, including expression of TGF-.",24043896_2,0,1,2,-1,21126,-1,6.823474e-05,0.99989533,3.6453446e-05
21138,to play,13,15,77,84,"Since their identification in 2005, T helper (TH)17 cells have been proposed to play important roles in several human diseases, including various autoimmune conditions, inflammations, allergy, and tumors.",24044962_0,-1,-1,-1,-1,21138,-1,2.3957773e-05,0.9999653,1.0749532e-05
21147,to Th17,41,43,222,229,"Focusing on human studies, we review the current understanding of molecular interactions (IL-1, IL-6, IL-23, IL-21 and TGF-), the signaling pathway (STAT3RORt) and the migration (induced by CCR6/CCL20) that contribute to Th17 differentiation and function in tumor microenvironment.",24044962_1,-1,-1,-1,-1,21147,-1,2.865292e-05,0.9999565,1.4898857e-05
21148,function,45,46,250,258,"Focusing on human studies, we review the current understanding of molecular interactions (IL-1, IL-6, IL-23, IL-21 and TGF-), the signaling pathway (STAT3RORt) and the migration (induced by CCR6/CCL20) that contribute to Th17 differentiation and function in tumor microenvironment.",24044962_1,0,1,2,-1,21148,-1,7.3298695e-05,0.9998739,5.2759893e-05
21150,to the,11,13,70,76,"Furthermore, we also make a synthesis of contradictory conclusions as to the roles that these cells are playing in the process of tumourigenesis in order to provide guidance of Th17-targeted therapy in tumors.",24044962_2,-1,-1,-1,-1,21150,-1,2.3277385e-05,0.9999672,9.560922e-06
21151,that these cells,14,17,83,99,"Furthermore, we also make a synthesis of contradictory conclusions as to the roles that these cells are playing in the process of tumourigenesis in order to provide guidance of Th17-targeted therapy in tumors.",24044962_2,-1,-1,-1,-1,21151,-1,0.0036903424,0.78087234,0.21543731
21156,Th17-targeted therapy,30,32,177,198,"Furthermore, we also make a synthesis of contradictory conclusions as to the roles that these cells are playing in the process of tumourigenesis in order to provide guidance of Th17-targeted therapy in tumors.",24044962_2,-1,-1,-1,-1,21156,-1,3.363306e-05,0.99994385,2.2452448e-05
21160,that the thymus,1,4,12,27,"Considering that the thymus is the site of most T-cell development, this phenomenon may be related to thymic involution.",24051497_1,-1,-1,-1,-1,21160,-1,3.4048906e-05,0.99994314,2.2814336e-05
21164,related to thymic,16,19,91,108,"Considering that the thymus is the site of most T-cell development, this phenomenon may be related to thymic involution.",24051497_1,-1,-1,-1,-1,21164,-1,4.037398e-05,0.99994063,1.8988017e-05
21172,The thymuses,2,4,9,21,RESULTS: The thymuses of tumor-bearing mice showed less cellularity than those of healthy mice.,24051497_4,-1,-1,-1,-1,21172,-1,2.8616254e-05,0.99995494,1.6396427e-05
21174,cellularity than those,9,12,56,78,RESULTS: The thymuses of tumor-bearing mice showed less cellularity than those of healthy mice.,24051497_4,-1,-1,-1,-1,21174,-1,0.0055630826,0.21312477,0.78131217
21181,three factors,7,9,22,35,"Foxn1, KGF, and IL-7, three factors known to be involved in thymic development, were also downregulated in the thymuses of tumor bearers.",24051497_6,-1,-1,-1,-1,21181,-1,0.0032289717,0.996342,0.00042895082
21184,the thymuses,21,23,107,119,"Foxn1, KGF, and IL-7, three factors known to be involved in thymic development, were also downregulated in the thymuses of tumor bearers.",24051497_6,-1,-1,-1,-1,21184,-1,3.393699e-05,0.9999505,1.5494383e-05
21187,the thymic,9,11,54,64,"When these mice were intravenously injected with KGF, the thymic microenvironment, thymopoiesis, and T-cell differentiation all returned to near normal status.",24051497_7,-1,-1,-1,-1,21187,-1,3.331738e-05,0.9999502,1.6538379e-05
21196,the thymic,16,18,113,123,CONCLUSIONS: The decreases in thymopoiesis and impaired T-cell differentiation may be attributable to changes in the thymic microenvironment.,24051497_8,-1,-1,-1,-1,21196,-1,3.6746496e-05,0.9999485,1.4750027e-05
21197,the function,1,3,10,22,"Improving the function of TEC, rather than T-cell progenitors, should be the focus of therapy.",24051497_9,-1,-1,-1,-1,21197,-1,4.9312894e-05,0.9999218,2.8874745e-05
21199,than T-cell,7,9,38,49,"Improving the function of TEC, rather than T-cell progenitors, should be the focus of therapy.",24051497_9,-1,-1,-1,-1,21199,-1,0.0018104902,0.05121095,0.94697857
21201,therapy,16,17,86,93,"Improving the function of TEC, rather than T-cell progenitors, should be the focus of therapy.",24051497_9,0,1,-1,-1,21201,-1,2.219792e-05,0.999966,1.1760424e-05
21205,the functional,16,18,101,115,"Although elevated CD4Foxp3 regulatory T cell (Treg) frequencies within tumors are well documented, the functional and phenotypic characteristics of CD4Foxp3 and CD4Foxp3 T cell subsets from matched blood, healthy colon, and colorectal cancer require in-depth investigation.",24064667_0,-1,-1,-1,-1,21205,-1,2.9674657e-05,0.99995553,1.4776516e-05
21207,blood,30,31,204,209,"Although elevated CD4Foxp3 regulatory T cell (Treg) frequencies within tumors are well documented, the functional and phenotypic characteristics of CD4Foxp3 and CD4Foxp3 T cell subsets from matched blood, healthy colon, and colorectal cancer require in-depth investigation.",24064667_0,0,1,-1,-1,21207,-1,0.00037577393,0.9971787,0.0024455634
21208,that the,3,5,24,32,Flow cytometry revealed that the majority of intratumoral CD4Foxp3 T cells (Tregs) were Helios and expressed higher levels of cytotoxic T-lymphocyte antigen 4 (CTLA-4) and CD39 than Tregs from colon and blood.,24064667_1,-1,-1,-1,-1,21208,-1,1.6459928e-05,0.99997044,1.31506495e-05
21211,cytotoxic T-lymphocyte antigen,21,24,129,159,Flow cytometry revealed that the majority of intratumoral CD4Foxp3 T cells (Tregs) were Helios and expressed higher levels of cytotoxic T-lymphocyte antigen 4 (CTLA-4) and CD39 than Tregs from colon and blood.,24064667_1,-1,-1,-1,-1,21211,-1,0.009645439,0.00061031553,0.98974425
21213,than Tregs,30,32,180,190,Flow cytometry revealed that the majority of intratumoral CD4Foxp3 T cells (Tregs) were Helios and expressed higher levels of cytotoxic T-lymphocyte antigen 4 (CTLA-4) and CD39 than Tregs from colon and blood.,24064667_1,-1,-1,-1,-1,21213,-1,2.707186e-05,0.9999529,2.0012716e-05
21214,blood,35,36,206,211,Flow cytometry revealed that the majority of intratumoral CD4Foxp3 T cells (Tregs) were Helios and expressed higher levels of cytotoxic T-lymphocyte antigen 4 (CTLA-4) and CD39 than Tregs from colon and blood.,24064667_1,0,1,-1,-1,21214,-1,0.0001263042,0.9996024,0.00027128376
21216,functions,14,15,95,104,"Moreover, 30% of intratumoral CD4Foxp3 T cells expressed markers associated with regulatory functions, including latency-associated peptide (LAP), lymphocyte activation gene-3 (LAG-3), and CD25.",24064667_2,0,1,2,-1,21216,-1,9.0835405e-05,0.99977773,0.00013139223
21217,peptide,18,19,135,142,"Moreover, 30% of intratumoral CD4Foxp3 T cells expressed markers associated with regulatory functions, including latency-associated peptide (LAP), lymphocyte activation gene-3 (LAG-3), and CD25.",24064667_2,0,-1,2,-1,21217,-1,0.01131284,0.9845004,0.0041867546
21225,factor-,13,14,88,96,"This unique population of cells produced interleukin-10 (IL-10) and transforming growth factor- (TGF-), and was 50-fold more suppressive than Foxp3 Tregs.",24064667_3,0,1,-1,-1,21225,-1,0.99977213,9.21078e-05,0.00013575624
21235,factor,17,18,103,109,It has been reported that dense intratumoral infiltration of Foxp3 (+)Tregs (Tregs) was an independent factor for poor prognosis of breast cancer (BC) patients.,24124553_0,0,1,-1,-1,21235,-1,0.00017165647,0.9997731,5.5253422e-05
21236,the cytokines,2,4,9,22,"However, the cytokines activating the Treg infiltration are not known.",24124553_1,-1,-1,-1,-1,21236,-1,0.41703686,0.57860523,0.0043579508
21237,the Treg,5,7,34,42,"However, the cytokines activating the Treg infiltration are not known.",24124553_1,-1,-1,-1,-1,21237,-1,2.8472668e-05,0.9999591,1.2460717e-05
21249,that tumor,3,5,18,28,"It was identified that tumor secretion of CCL22 was positively correlated with the intratumoral Treg infiltration (P<0.0001), but its association with lymphoid aggregates surrounding the tumor was not proven to be significant (P=0.056).",24124553_4,-1,-1,-1,-1,21249,-1,1.9653535e-05,0.9999716,8.663211e-06
21253,the tumor,27,29,183,192,"It was identified that tumor secretion of CCL22 was positively correlated with the intratumoral Treg infiltration (P<0.0001), but its association with lymphoid aggregates surrounding the tumor was not proven to be significant (P=0.056).",24124553_4,-1,-1,-1,-1,21253,-1,2.056436e-05,0.9999696,9.888856e-06
21257,the tumor,10,12,59,68,"Moreover, CCL22 expression was found to be associated with the tumor histological features known to be related with unfavorable prognosis of patients, including high histological grade (P<0.0001), negative ER (P<0.0001), negative PR (P=0.001), and HER2 amplification (P=0.028).",24124553_5,-1,-1,-1,-1,21257,-1,1.7740265e-05,0.9999721,1.0110682e-05
21262,CCL22 tumor,6,8,42,53,"Similar to intratumoral Treg infiltrates, CCL22 tumor secretion correlated with the prognosis of the molecular subtypes of breast carcinoma (P<0.0001).",24124553_6,-1,-1,-1,-1,21262,-1,0.92601603,0.019961728,0.0540222
21265,analysis,1,2,11,19,"Univariate analysis revealed CCL22 to be an independent prognostic factor for overall survival (OS, P<0.0001) and progression-free survival (PFS, P<0.0001) of BC patients that were confirmed by multivariate analysis (P=0.011 and P=0.010 respectively).",24124553_7,0,1,-1,-1,21265,-1,2.8863846e-05,0.9999505,2.0608084e-05
21266,CCL22 to,3,5,29,37,"Univariate analysis revealed CCL22 to be an independent prognostic factor for overall survival (OS, P<0.0001) and progression-free survival (PFS, P<0.0001) of BC patients that were confirmed by multivariate analysis (P=0.011 and P=0.010 respectively).",24124553_7,-1,-1,-1,-1,21266,-1,0.8990694,0.028067304,0.07286328
21267,factor,9,10,67,73,"Univariate analysis revealed CCL22 to be an independent prognostic factor for overall survival (OS, P<0.0001) and progression-free survival (PFS, P<0.0001) of BC patients that were confirmed by multivariate analysis (P=0.011 and P=0.010 respectively).",24124553_7,0,1,-1,-1,21267,-1,0.0003105388,0.9995597,0.0001297564
21269,analysis,34,35,207,215,"Univariate analysis revealed CCL22 to be an independent prognostic factor for overall survival (OS, P<0.0001) and progression-free survival (PFS, P<0.0001) of BC patients that were confirmed by multivariate analysis (P=0.011 and P=0.010 respectively).",24124553_7,0,1,-1,-1,21269,-1,3.7394555e-05,0.99993944,2.3123588e-05
21272,the tumor,14,16,99,108,"In contrast, although TGF-1 expression was positively correlated with both Tregs infiltrates into the tumor bed and lymphoid aggregates surrounding the tumor (P=0.023; P=0.046, respectively), its expression was not significantly associated with the molecular subtypes of breast carcinoma and the prognosis of the patients.",24124553_8,-1,-1,-1,-1,21272,-1,1.932146e-05,0.9999701,1.0631735e-05
21273,the tumor,21,23,149,158,"In contrast, although TGF-1 expression was positively correlated with both Tregs infiltrates into the tumor bed and lymphoid aggregates surrounding the tumor (P=0.023; P=0.046, respectively), its expression was not significantly associated with the molecular subtypes of breast carcinoma and the prognosis of the patients.",24124553_8,-1,-1,-1,-1,21273,-1,2.1171061e-05,0.99996877,1.005624e-05
21288,the proto-oncogene c-MYC,2,5,19,43,Over-expression of the proto-oncogene c-MYC is frequently observed in a variety of tumors and is a hallmark of Burkitts lymphoma.,24130880_0,-1,-1,-1,-1,21288,-1,2.941425e-05,0.9999553,1.5245497e-05
21295,therapy,17,18,105,112,"The fact that many tumors are oncogene-addicted to c-MYC, renders c-MYC a powerful target for anti-tumor therapy.",24130880_1,0,1,-1,-1,21295,-1,2.2155844e-05,0.99996555,1.2271577e-05
21297,peptides,15,16,109,117,"Using a xenogenic vaccination strategy by immunizing C57BL/6 mice with human c-MYC protein or non-homologous peptides, we show that the human c-MYC protein, despite its high homology between mouse and man, contains several immunogenic epitopes presented in the context of murine H2(b) haplotype.",24130880_2,0,-1,2,-1,21297,-1,0.0003073747,0.9993376,0.00035494947
21298,that the,19,21,127,135,"Using a xenogenic vaccination strategy by immunizing C57BL/6 mice with human c-MYC protein or non-homologous peptides, we show that the human c-MYC protein, despite its high homology between mouse and man, contains several immunogenic epitopes presented in the context of murine H2(b) haplotype.",24130880_2,-1,-1,-1,-1,21298,-1,1.8688885e-05,0.9999726,8.7841745e-06
21301,T-cell,7,8,46,52,"We identified an MHC class II-restricted CD4 T-cell epitope and therein an MHC class I-restricted CD8 T-cell epitope (SSPQGSPEPL) that, after prime/boost immunization, protected up to 25% of mice against a lethal lymphoma challenge.",24130880_3,-1,1,2,-1,21301,-1,3.7329817e-05,5.6492052e-05,0.9999062
21303,T-cell,16,17,104,110,"We identified an MHC class II-restricted CD4 T-cell epitope and therein an MHC class I-restricted CD8 T-cell epitope (SSPQGSPEPL) that, after prime/boost immunization, protected up to 25% of mice against a lethal lymphoma challenge.",24130880_3,-1,1,2,-1,21303,-1,3.706429e-05,5.694315e-05,0.99990594
21308,blood,10,11,90,95,Lymphoma-rejecting animals contained MHC multimer-binding CD8 cell within the peripheral blood and displayed in vivo cytolytic activity with specificity for SSPQGSPEPL.,24130880_4,0,1,-1,-1,21308,-1,0.00025494694,0.996145,0.0036000442
21309,Taken together these,0,3,0,20,Taken together these data suggest that oncogenic c-MYC can be targeted with specific T-cells.,24130880_5,-1,-1,-1,-1,21309,-1,3.741874e-05,0.999948,1.456442e-05
21312,T-cells,13,14,85,92,Taken together these data suggest that oncogenic c-MYC can be targeted with specific T-cells.,24130880_5,-1,1,2,-1,21312,-1,0.00022252394,0.0048828586,0.9948946
21314,cell transplantation,21,23,141,161,Cytomegalovirus (CMV) reactivation may lead to CMV disease associated with high morbidity and mortality in patients after hematopoietic stem cell transplantation (HSCT); the identification of clinically relevant markers may aid in the identification of patients at increased risk for developing CMV-associated complications.,24140122_0,-1,-1,-1,-1,21314,-1,0.0039379233,0.09336161,0.9027005
21326,blood,42,43,217,222,"We evaluated the phosphorylation of signal transducer and activator of transcription 5 (STAT5) in CD4(+) T cells, CD8(+) T cells, and TCR T cells in response to stimulation with IL-7 or IL-2 after HSCT by analyzing blood samples taken monthly 1 to 6 months after HSCT.",24140122_1,0,1,-1,-1,21326,-1,4.7349604e-05,0.999884,6.8629844e-05
21329,the time,9,11,60,68,Patients were monitored weekly with a quantitative PCR from the time of engraftment for CMV viral load in whole blood until at least day 100 after HSCT.,24140122_2,-1,-1,-1,-1,21329,-1,2.5408499e-05,0.99995935,1.5214112e-05
21330,blood,19,20,112,117,Patients were monitored weekly with a quantitative PCR from the time of engraftment for CMV viral load in whole blood until at least day 100 after HSCT.,24140122_2,0,1,-1,-1,21330,-1,0.00049191155,0.98853266,0.010975381
21333,to IL-7,15,17,106,113,We identified a correlation between clinical outcome regarding CMV replication and the ability to respond to IL-7 and IL-2 defined by STAT5 phosphorylation (pSTAT5).,24140122_3,-1,-1,-1,-1,21333,-1,0.7760979,0.21583775,0.008064309
21339,than those,27,29,165,175,Patients with recurrent or prolonged CMV replications had significantly lower pSTAT5 upon stimulation of T cells with either IL-7 or IL-2 at time points 1 through 3 than those without CMV replication (P < .05).,24140122_4,-1,-1,-1,-1,21339,-1,1.9031428e-05,0.9999678,1.3211053e-05
21344,to IL-7,5,7,35,42,"We conclude that reduced responses to IL-7, reflected by pSTAT5, may represent a clinically relevant functional biomarker for individuals at increased risk for CMV reactivation; our data may also aid in designing better strategies to improve anti-CMV immune responses without increasing the risk of developing graft-versus-host disease.",24140122_6,-1,-1,-1,-1,21344,-1,0.86439484,0.128416,0.0071891667
21345,relevant functional,16,18,92,111,"We conclude that reduced responses to IL-7, reflected by pSTAT5, may represent a clinically relevant functional biomarker for individuals at increased risk for CMV reactivation; our data may also aid in designing better strategies to improve anti-CMV immune responses without increasing the risk of developing graft-versus-host disease.",24140122_6,-1,-1,-1,-1,21345,-1,4.806105e-05,0.9999337,1.8162984e-05
21352,blood,11,12,74,79,Cytokine-induced killer (CIK) cells are usually generated from peripheral blood mononuclear cells with the stimulation of IL-2 in vitro.,24145357_0,0,1,-1,-1,21352,-1,0.00011609854,0.9996636,0.00022036045
21361,IL-15-CIK cells,23,25,159,174,"Unlike the conventional IL-2-stimulated CIK cells (IL-2-CIK cells), we investigated the characteristics and potential mechanism of IL-15-stimulated CIK cells (IL-15-CIK cells) in this study.",24145357_1,-1,-1,-1,-1,21361,-1,0.58301544,0.0024004236,0.4145842
21366,IL-15-CIK cells,14,16,93,108,"Compared with IL-2-CIK cells, the percentage of CD3CD56 cells was significantly increased in IL-15-CIK cells, but the expression of regulatory T (Treg) cells and IL-35 was significantly decreased in IL-15-CIK cells.",24145357_2,-1,-1,-1,-1,21366,-1,0.574005,0.00209857,0.4238964
21371,IL-15-CIK cells,33,35,199,214,"Compared with IL-2-CIK cells, the percentage of CD3CD56 cells was significantly increased in IL-15-CIK cells, but the expression of regulatory T (Treg) cells and IL-35 was significantly decreased in IL-15-CIK cells.",24145357_2,-1,-1,-1,-1,21371,-1,0.60874027,0.0022336137,0.38902605
21374,IL-15-CIK cells,13,15,82,97,"Meanwhile, the in vitro cytotoxicity against human myeloid leukemia cells K562 of IL-15-CIK cells was significantly augmented compared with IL-2-CIK cells.",24145357_3,-1,-1,-1,-1,21374,-1,0.65603435,0.001788809,0.34217688
21377,that IL-15,3,5,19,29,These data suggest that IL-15 may improve the cytotoxicity of CIK cells against leukemia cells by upregulating CD3CD56 cells and downregulating Treg cells and IL-35.,24145357_4,-1,-1,-1,-1,21377,-1,0.4974646,0.4932338,0.00930162
21392,therapy,9,10,52,59,"This study aimed to determine the effect of radical therapy on HPV-specific T cells and other immune parameters in 20 OPC patients, as a prelude to future immunotherapy studies.",24146146_1,0,1,-1,-1,21392,-1,2.1783897e-05,0.99996674,1.1446292e-05
21395,tissue,8,9,44,50,HPV DNA could be detected in 9/12 available tissue samples (8/9 HPV(+) samples were also p16(+)).,24146146_2,-1,1,2,-1,21395,-1,4.6215788e-05,0.99980944,0.0001443878
21397,peptides,9,10,54,62,"HPV-specific T cell responses against HPV16 E6 and E7 peptides were detected by enzyme-linked immunoSPOT in 10/13 and 8/13 evaluable patients, respectively, but did not appear to correlate with HPV status.",24146146_3,0,-1,2,-1,21397,-1,0.00017229293,0.99928844,0.0005391872
21405,therapy,26,27,163,170,"These reductions in T cell response could not be explained by a concurrent decrease in memory T cells whose absolute numbers were relatively unaffected by radical therapy (27,975 vs. 25,661/10(5) PBMC) despite a significant decrease in overall lymphocyte counts (1.74 vs. 0.69  10(9)/L).",24146146_5,0,1,-1,-1,21405,-1,2.6566808e-05,0.9999615,1.18993485e-05
21412,to the,6,8,52,58,"This suggests that immunosuppression may contribute to the reduction in HPV-specific T cell responses post-treatment, although study of larger patient cohorts will be required to test whether this affects clinical outcome.",24146146_7,-1,-1,-1,-1,21412,-1,2.290658e-05,0.99996614,1.0890712e-05
21414,to test,25,27,176,183,"This suggests that immunosuppression may contribute to the reduction in HPV-specific T cell responses post-treatment, although study of larger patient cohorts will be required to test whether this affects clinical outcome.",24146146_7,-1,-1,-1,-1,21414,-1,2.2075925e-05,0.9999672,1.0736059e-05
21419,T cell immunity,17,20,134,149,Overall these findings suggest that HPV-targeted immunotherapy in post-therapy OPC patients will require multiple strategies to boost T cell immunity and to overcome the influence of immunosuppressive cells.,24146146_8,-1,-1,-1,-1,21419,-1,0.00035926246,8.771764e-05,0.999553
21423,The thymus,0,2,0,10,The thymus is a central lymphoid organ critical for the development and maintenance of an effective peripheral T-cell repertoire.,24198066_0,-1,-1,-1,-1,21423,-1,2.8459348e-05,0.9999471,2.4481957e-05
21425,T-cell,17,18,111,117,The thymus is a central lymphoid organ critical for the development and maintenance of an effective peripheral T-cell repertoire.,24198066_0,-1,1,2,-1,21425,-1,4.16953e-05,5.2682877e-05,0.9999056
21428,function,16,17,103,111,"Most important, it provides a specialized environment for the selection of rearranged clones that will function appropriately in the adaptive immune response.",24198066_1,0,1,2,-1,21428,-1,0.00010812893,0.9998338,5.8046673e-05
21435,related to the,8,11,36,50,"Here, we review some of our results related to the studies of the cell-mediated immunity in a mammary tumor model; more specifically, those related to the tumor-induced impaired T-cell development and thymic involution.",24198066_3,-1,-1,-1,-1,21435,-1,2.395064e-05,0.9999614,1.467627e-05
21436,the cell-mediated immunity,13,16,62,88,"Here, we review some of our results related to the studies of the cell-mediated immunity in a mammary tumor model; more specifically, those related to the tumor-induced impaired T-cell development and thymic involution.",24198066_3,-1,-1,-1,-1,21436,-1,0.049180057,0.89160633,0.059213568
21438,those related to the tumor-induced,25,30,134,168,"Here, we review some of our results related to the studies of the cell-mediated immunity in a mammary tumor model; more specifically, those related to the tumor-induced impaired T-cell development and thymic involution.",24198066_3,-1,-1,-1,-1,21438,-1,2.4175646e-05,0.99996126,1.4600478e-05
21443,the tumor-induced thymic,11,14,79,103,"Collectively, the understanding of the mechanisms and pathways associated with the tumor-induced thymic involution is essential for the development of innovative and safe therapies to fight against the immune suppression caused by the tumor development.",24198066_4,-1,-1,-1,-1,21443,-1,2.5030771e-05,0.9999627,1.2325388e-05
21445,therapies to,24,26,171,183,"Collectively, the understanding of the mechanisms and pathways associated with the tumor-induced thymic involution is essential for the development of innovative and safe therapies to fight against the immune suppression caused by the tumor development.",24198066_4,-1,-1,-1,-1,21445,-1,2.2284445e-05,0.9999672,1.05302315e-05
21447,the tumor,33,35,231,240,"Collectively, the understanding of the mechanisms and pathways associated with the tumor-induced thymic involution is essential for the development of innovative and safe therapies to fight against the immune suppression caused by the tumor development.",24198066_4,-1,-1,-1,-1,21447,-1,2.0130732e-05,0.99997044,9.392002e-06
21449,nave,4,5,35,40,"Upon antigen-specific stimulation, nave CD4 T cells have the potential to differentiate into various T helper (Th) cell subsets.",24215739_0,-1,-1,-1,-1,21449,-1,3.1832144e-05,0.9999541,1.4023818e-05
21455,cell subsets,20,22,117,129,"Upon antigen-specific stimulation, nave CD4 T cells have the potential to differentiate into various T helper (Th) cell subsets.",24215739_0,-1,-1,-1,-1,21455,-1,3.8047874e-05,4.109737e-05,0.99992085
21456,Th cell,3,5,18,25,Earlier models of Th cell differentiation focused on IFN--producing Th1 cells and IL-4-secreting Th2 cells.,24215739_1,-1,-1,-1,-1,21456,-1,3.3848493e-05,4.9882343e-05,0.9999163
21457,IFN--producing Th1 cells,8,11,53,78,Earlier models of Th cell differentiation focused on IFN--producing Th1 cells and IL-4-secreting Th2 cells.,24215739_1,-1,-1,-1,-1,21457,-1,0.7011395,0.0027957987,0.29606462
21460,Th cell subsets,5,8,33,48,The discovery of additional CD4 Th cell subsets has extended our understanding of Th cell differentiation beyond this dichotomy.,24215739_2,-1,-1,-1,-1,21460,-1,3.6414727e-05,4.571718e-05,0.99991786
21461,Th cell,13,15,83,90,The discovery of additional CD4 Th cell subsets has extended our understanding of Th cell differentiation beyond this dichotomy.,24215739_2,-1,-1,-1,-1,21461,-1,3.9197617e-05,4.867186e-05,0.99991214
21465,Th9 cell subset,6,9,38,53,"Among these is the recently described Th9 cell subset, which preferentially produces interleukin (IL)-9.",24215739_3,-1,-1,-1,-1,21465,-1,0.00011721578,0.00034946308,0.9995333
21468,Th9 cell,8,10,43,51,"Here, we review the latest developments in Th9 cell development and differentiation, focusing on contributing environmental signals, and discuss potential physiological and pathophysiological functions of these cells.",24215739_4,-1,-1,-1,-1,21468,-1,6.0030434e-05,0.00013700109,0.999803
21469,functions,26,27,192,201,"Here, we review the latest developments in Th9 cell development and differentiation, focusing on contributing environmental signals, and discuss potential physiological and pathophysiological functions of these cells.",24215739_4,0,1,2,-1,21469,-1,0.00045461277,0.9988404,0.0007049915
21470,these cells,28,30,205,216,"Here, we review the latest developments in Th9 cell development and differentiation, focusing on contributing environmental signals, and discuss potential physiological and pathophysiological functions of these cells.",24215739_4,-1,-1,-1,-1,21470,-1,0.0018628938,0.11096083,0.88717633
21473,Th9 cells,10,12,72,81,"We describe the challenges inherent to unambiguously defining roles for Th9 cells using the available experimental animal models, and suggest new experimental models to address these concerns.",24215739_5,-1,-1,-1,-1,21473,-1,0.00012898771,0.00044120042,0.99942976
21487,that Nanog,3,5,16,26,We further show that Nanog was selectively induced in hypoxic areas of B16-F10 tumors.,24227785_3,-1,-1,-1,-1,21487,-1,2.382018e-05,0.99996483,1.134546e-05
21490,tyrosinase-related protein-2 peptide-based,13,16,98,140,"Stable short hairpin RNA-mediated depletion of Nanog, combined with melanocyte differentiation Ag tyrosinase-related protein-2 peptide-based vaccination, resulted in complete inhibition of B16-F10 tumor growth.",24227785_4,-1,-1,-1,-1,21490,-1,0.00014300317,0.9996693,0.0001876594
21492,Nanog targeting,0,2,0,15,Nanog targeting significantly reduced immunosuppressive cells (regulatory T cells and macrophages) and increased CD8(+) T effector cells in tumor bed in part by modulating TGF-1 production.,24227785_5,-1,-1,-1,-1,21492,-1,2.5752424e-05,0.99995947,1.47577575e-05
21501,the TGF-1,10,12,71,81,"Additionally, Nanog regulated TGF-1 under hypoxia by directly binding the TGF-1 proximal promoter.",24227785_6,-1,-1,-1,-1,21501,-1,2.9706278e-05,0.999944,2.629585e-05
21502,functional,7,8,41,51,"Collectively, our data establish a novel functional link between hypoxia-induced Nanog and TGF-1 regulation and point to a major role of Nanog in hypoxia-driven immunosuppression.",24227785_7,0,1,2,-1,21502,-1,3.60738e-05,0.999948,1.5910018e-05
21504,TGF-1 regulation,13,15,91,108,"Collectively, our data establish a novel functional link between hypoxia-induced Nanog and TGF-1 regulation and point to a major role of Nanog in hypoxia-driven immunosuppression.",24227785_7,-1,-1,-1,-1,21504,-1,2.3628521e-05,0.99996006,1.6284495e-05
21507,Tumor-infiltrating lymphocytes,0,2,0,30,Tumor-infiltrating lymphocytes (TILs) have been reported as a prognostic factor in various cancers and are a promising target for immunotherapy.,24243586_0,-1,-1,-1,-1,21507,-1,0.0036607524,0.87561417,0.12072507
21509,factor,11,12,73,79,Tumor-infiltrating lymphocytes (TILs) have been reported as a prognostic factor in various cancers and are a promising target for immunotherapy.,24243586_0,0,1,-1,-1,21509,-1,0.0033484409,0.9962717,0.000379808
21525,The total,0,2,0,9,The total number of primary TILs (CD4 plus CD8) and CD8(+) primary TILs of stage 3 patients with distant metastases was positively correlated with their overall survival.,24243586_6,-1,-1,-1,-1,21525,-1,2.2368991e-05,0.9999651,1.2517007e-05
21532,analysis,15,16,93,101,"To evaluate whether CD8(+) effector T cells are activated or differentiated, flow cytometric analysis of peripheral blood mononuclear cells (PBMC) was performed.",24243586_7,0,1,-1,-1,21532,-1,3.3548207e-05,0.99993646,2.9943527e-05
21533,blood,18,19,116,121,"To evaluate whether CD8(+) effector T cells are activated or differentiated, flow cytometric analysis of peripheral blood mononuclear cells (PBMC) was performed.",24243586_7,0,1,-1,-1,21533,-1,0.00015712617,0.9992101,0.0006327787
21541,immunity,5,6,38,46,These results suggest that anti-tumor immunity is clinically relevant in angiosarcoma.,24243586_9,0,-1,2,-1,21541,-1,0.99860257,0.0010988719,0.0002985806
21546,therapy,20,21,138,145,Development of agents that specifically kill cancer cells and simultaneously elicit antitumor immune response is a step forward in cancer therapy.,24270218_0,0,1,-1,-1,21546,-1,2.4993884e-05,0.99996245,1.2595071e-05
21549,the immune response,17,20,116,135,Immunostimulation can result in eliminating of the cancer cells; immunotherapy is a promising approach in balancing the immune response by Treg.,24270218_1,-1,-1,-1,-1,21549,-1,0.4217802,0.5763569,0.001862967
21553,to the,13,15,91,97,"In the present study, we investigated whether the administration of salvigenin contributes to the augmentation of antitumor immunity and the regression of tumor tissues in a mouse model of breast cancer.",24270218_2,-1,-1,-1,-1,21553,-1,2.0477679e-05,0.99996936,1.0175474e-05
21554,immunity,18,19,124,132,"In the present study, we investigated whether the administration of salvigenin contributes to the augmentation of antitumor immunity and the regression of tumor tissues in a mouse model of breast cancer.",24270218_2,0,-1,2,-1,21554,-1,0.99913377,0.00050822715,0.00035803972
21556,tumor tissues,23,25,155,168,"In the present study, we investigated whether the administration of salvigenin contributes to the augmentation of antitumor immunity and the regression of tumor tissues in a mouse model of breast cancer.",24270218_2,-1,-1,-1,-1,21556,-1,3.052167e-05,0.9999238,4.5636647e-05
21558,the tumor,11,13,68,77,"Salvigenin was purified from Tanacetum canescens, and its effect on the tumor volume was investigated.",24270218_3,-1,-1,-1,-1,21558,-1,1.8654937e-05,0.9999702,1.1172288e-05
21569,the IFN-,15,17,90,99,Our results demonstrated that a significant decrease in the level of IL-4 and increase in the IFN- in the animals treated with salvigenin and significant decreased in the level of splenic CD4+CD25+Foxp3+ T regulatory cells.,24270218_5,-1,-1,-1,-1,21569,-1,0.86697525,0.12717617,0.0058485926
21576,that interferon,3,5,17,32,We have reported that interferon (IFN)- can attack cancer cells by multiple antitumor mechanisms including the induction of direct cancer cell death and the enhancement of an immune response in several pancreatic cancer models.,24289533_0,-1,-1,-1,-1,21576,-1,0.23149213,0.764031,0.0044769146
21582,the tumors,6,8,47,57,"However, an immunotolerant microenvironment in the tumors is often responsible for the failure of the cancer immunotherapy.",24289533_1,-1,-1,-1,-1,21582,-1,2.274086e-05,0.9999665,1.07698e-05
21589,immunity,19,20,110,118,Here we examined whether the suppression of regulatory T cells (Tregs) within tumors can enhance an antitumor immunity induced by an intratumoral IFN- gene transfer.,24289533_2,0,-1,2,-1,21589,-1,0.9995252,0.00027364102,0.0002011892
21590,IFN- gene transfer,24,27,146,165,Here we examined whether the suppression of regulatory T cells (Tregs) within tumors can enhance an antitumor immunity induced by an intratumoral IFN- gene transfer.,24289533_2,-1,-1,-1,-1,21590,-1,0.9891046,0.008188309,0.00270716
21592,TNF receptor,12,14,99,111,"First we showed that an intraperitoneal administration of an agonistic anti-glucocorticoid induced TNF receptor (GITR) monoclonal antibody (mAb), which is reported to suppress the function of Tregs, significantly inhibited subcutaneous tumor growth in a murine pancreatic cancer model.",24289533_3,-1,-1,-1,-1,21592,-1,0.00029402264,0.9970482,0.0026578251
21594,the function,28,30,176,188,"First we showed that an intraperitoneal administration of an agonistic anti-glucocorticoid induced TNF receptor (GITR) monoclonal antibody (mAb), which is reported to suppress the function of Tregs, significantly inhibited subcutaneous tumor growth in a murine pancreatic cancer model.",24289533_3,-1,-1,-1,-1,21594,-1,3.260914e-05,0.9999527,1.4735128e-05
21600,the IFN--adenovirus,11,13,71,91,The anti-GITR mAb was then combined with the intratumoral injection of the IFN--adenovirus vector.,24289533_4,-1,-1,-1,-1,21600,-1,0.011600086,0.98753566,0.0008642373
21601,The treatment,0,2,0,13,The treatment with the antibody synergistically augmented the antitumor effect of IFN- gene therapy not only in the vector-injected tumors but also in the vector-uninjected tumors.,24289533_5,-1,-1,-1,-1,21601,-1,2.3429375e-05,0.99996567,1.0845795e-05
21604,IFN- gene therapy,11,14,82,100,The treatment with the antibody synergistically augmented the antitumor effect of IFN- gene therapy not only in the vector-injected tumors but also in the vector-uninjected tumors.,24289533_5,-1,-1,-1,-1,21604,-1,0.9877187,0.009923588,0.0023577658
21609,that the,2,4,22,30,"Immunostaining showed that the anti-GITR mAb decreased Foxp3(+) cells infiltrating in the tumors, while the intratumoral IFN- gene transfer increased CD4(+) and CD8(+) T cells in the tumors.",24289533_6,-1,-1,-1,-1,21609,-1,1.7274737e-05,0.99997354,9.145122e-06
21612,the tumors,12,14,86,96,"Immunostaining showed that the anti-GITR mAb decreased Foxp3(+) cells infiltrating in the tumors, while the intratumoral IFN- gene transfer increased CD4(+) and CD8(+) T cells in the tumors.",24289533_6,-1,-1,-1,-1,21612,-1,1.910071e-05,0.99996996,1.0942182e-05
21614,IFN- gene transfer,18,21,121,140,"Immunostaining showed that the anti-GITR mAb decreased Foxp3(+) cells infiltrating in the tumors, while the intratumoral IFN- gene transfer increased CD4(+) and CD8(+) T cells in the tumors.",24289533_6,-1,-1,-1,-1,21614,-1,0.99036354,0.0069076368,0.0027288697
21616,the tumors,30,32,180,190,"Immunostaining showed that the anti-GITR mAb decreased Foxp3(+) cells infiltrating in the tumors, while the intratumoral IFN- gene transfer increased CD4(+) and CD8(+) T cells in the tumors.",24289533_6,-1,-1,-1,-1,21616,-1,1.8568882e-05,0.99997103,1.036747e-05
21619,therapy,4,5,27,34,"Therefore, the combination therapy strongly inclined the immune balance of the tumor microenvironment in an antitumor direction, leading to a marked systemic antitumor effect.",24289533_7,0,1,-1,-1,21619,-1,2.2819613e-05,0.9999646,1.2568533e-05
21621,the tumor,11,13,75,84,"Therefore, the combination therapy strongly inclined the immune balance of the tumor microenvironment in an antitumor direction, leading to a marked systemic antitumor effect.",24289533_7,-1,-1,-1,-1,21621,-1,1.9579198e-05,0.9999701,1.0378066e-05
21623,The CCR5,0,2,0,8,"The CCR5 expression on Tregs was downregulated in the antibody-treated mice, which may explain the decrease of tumor-infiltrating Tregs.",24289533_8,-1,-1,-1,-1,21623,-1,0.0046533914,0.68069524,0.31465137
21627,tumor-infiltrating Tregs,18,20,111,135,"The CCR5 expression on Tregs was downregulated in the antibody-treated mice, which may explain the decrease of tumor-infiltrating Tregs.",24289533_8,-1,-1,-1,-1,21627,-1,3.0800926e-05,0.99995637,1.2886042e-05
21630,the tumor immunity,8,11,52,70,The combination of Treg-suppression by GITR mAb and the tumor immunity induction by IFN- gene therapy could be a promising therapeutic strategy for pancreatic cancer.,24289533_9,-1,-1,-1,-1,21630,-1,0.0090898145,0.99049336,0.00041687128
21631,IFN- gene therapy,13,16,84,102,The combination of Treg-suppression by GITR mAb and the tumor immunity induction by IFN- gene therapy could be a promising therapeutic strategy for pancreatic cancer.,24289533_9,-1,-1,-1,-1,21631,-1,0.9887877,0.008824364,0.0023878214
21634,functional,2,3,14,24,Generation of functional dendritic cells (DCs) with boosted immunity after the withdrawal of initial activation/maturation conditions remains a significant challenge.,24296809_0,0,1,2,-1,21634,-1,0.00014002506,0.9997106,0.00014935287
21636,immunity,10,11,60,68,Generation of functional dendritic cells (DCs) with boosted immunity after the withdrawal of initial activation/maturation conditions remains a significant challenge.,24296809_0,0,-1,2,-1,21636,-1,0.99850345,0.0010731913,0.00042336463
21642,the function,23,25,136,148,"In this study, we investigated the impact of a newly developed maturation cocktail consisting of OK-432 and interferon-gamma (IFN-) on the function of human monocyte-derived DCs (MoDCs).",24296809_1,-1,-1,-1,-1,21642,-1,2.3905492e-05,0.9999627,1.3404753e-05
21644,plus IFN-,4,6,21,31,"We found that OK-432 plus IFN- stimulation could induce significantly stronger expression of surface molecules, production of cytokines, as well as migration of DCs compared with OK-432 stimulation alone.",24296809_2,-1,-1,-1,-1,21644,-1,0.94554716,0.051318426,0.003134308
21646,plus IFN--induced,7,9,42,60,"Most importantly, DCs matured with OK-432 plus IFN--induced maintained secretion of interleukin-12 (IL-12)p70 in secondary culture after stimulus withdrawal.",24296809_3,-1,-1,-1,-1,21646,-1,0.056177363,0.9425394,0.001283293
21648,Functionally,0,1,0,12,"Functionally, OK-432 plus IFN--conditioned DCs induce remarkable Th1 and Tc1 responses more effectively than OK-432 alone, even more than the use of -type-1 cytokine cocktail.",24296809_4,0,1,2,-1,21648,-1,3.0089586e-05,0.99995685,1.3007815e-05
21649,plus IFN--conditioned,3,5,21,43,"Functionally, OK-432 plus IFN--conditioned DCs induce remarkable Th1 and Tc1 responses more effectively than OK-432 alone, even more than the use of -type-1 cytokine cocktail.",24296809_4,-1,-1,-1,-1,21649,-1,0.6371825,0.3548224,0.007995089
21653,than the,20,22,134,142,"Functionally, OK-432 plus IFN--conditioned DCs induce remarkable Th1 and Tc1 responses more effectively than OK-432 alone, even more than the use of -type-1 cytokine cocktail.",24296809_4,-1,-1,-1,-1,21653,-1,2.586498e-05,0.99996233,1.1831127e-05
21655,plus IFN-,8,10,37,47,"As a result, DCs matured with OK-432 plus IFN- can prime stronger cytotoxic lymphocyte (CTL) and natural killer (NK) cell response against tumor cells in vitro.",24296809_5,-1,-1,-1,-1,21655,-1,0.96411043,0.032433916,0.0034555881
21656,cytotoxic lymphocyte,13,15,67,87,"As a result, DCs matured with OK-432 plus IFN- can prime stronger cytotoxic lymphocyte (CTL) and natural killer (NK) cell response against tumor cells in vitro.",24296809_5,-1,-1,-1,-1,21656,-1,4.0129045e-05,4.264079e-05,0.99991715
21660,tumor cells,27,29,140,151,"As a result, DCs matured with OK-432 plus IFN- can prime stronger cytotoxic lymphocyte (CTL) and natural killer (NK) cell response against tumor cells in vitro.",24296809_5,-1,-1,-1,-1,21660,-1,0.0046385727,0.42830765,0.5670538
21661,blood,1,2,11,16,Peripheral blood mononuclear cells activated by DCs matured with OK-432 plus IFN- also showed greater tumor growth inhibition in vivo in null mice.,24296809_6,0,1,-1,-1,21661,-1,0.00012079168,0.99959594,0.00028328213
21663,plus IFN-,10,12,72,82,Peripheral blood mononuclear cells activated by DCs matured with OK-432 plus IFN- also showed greater tumor growth inhibition in vivo in null mice.,24296809_6,-1,-1,-1,-1,21663,-1,0.95528805,0.041479044,0.0032329292
21665,analysis,2,3,22,30,Molecular mechanistic analysis showed that DC maturation using IFN- in concert with OK-432 involves the activation of p38 and nuclear factor-kappa B (NF-B) pathways.,24296809_7,0,1,-1,-1,21665,-1,2.8073944e-05,0.9999498,2.2083059e-05
21669,factor-kappa,20,21,135,147,Molecular mechanistic analysis showed that DC maturation using IFN- in concert with OK-432 involves the activation of p38 and nuclear factor-kappa B (NF-B) pathways.,24296809_7,0,1,-1,-1,21669,-1,6.942395e-05,0.99988997,4.0549432e-05
21671,to generate,6,8,37,48,This study provided a novel strategy to generate more potent immune segments in DC vaccine.,24296809_8,-1,-1,-1,-1,21671,-1,1.989104e-05,0.9999713,8.882767e-06
21673,tumor-infiltrating interleukin,11,13,69,99,"BACKGROUND AND AIM: Recent studies have shown that imbalance between tumor-infiltrating interleukin (IL)-17(+) T cells and regulatory T cells (Tregs) is an important regulator of progression in various cancers, but little is known regarding this imbalance in hepatocellular carcinoma (HCC).",24303990_0,-1,-1,-1,-1,21673,-1,0.02695561,0.97161084,0.0014336113
21688,tissue,13,14,55,61,"The expressions of IL-17, FoxP3, CD4, and CD8 in liver tissue were measured by immunochemistry for the evaluation of liver-infiltrating lymphocytes.",24303990_3,-1,1,2,-1,21688,-1,4.863551e-05,0.99985933,9.1955386e-05
21703,tumor-infiltrating FoxP3(+,11,13,66,92,"In surgical specimens of less differentiated HCC, the quantity of tumor-infiltrating FoxP3(+) Tregs was significantly lower and IL-17(+) T cells and CD8(+) T cells were significantly higher.",24303990_5,-1,-1,-1,-1,21703,-1,0.00036410693,0.999371,0.000264875
21725,lymphoid tissue chemokine,3,6,22,47,BACKGROUND: Secondary lymphoid tissue chemokine (SLC) is a key CC chemokine for chemotaxis of immune cells and has been an attractive candidate for anti-tumor treatments.,24304581_0,-1,-1,-1,-1,21725,-1,0.09512517,0.0019721312,0.9029028
21732,to tumors,9,11,49,58,"However, among the immune cells recruited by SLC to tumors, the CD25+ Foxp3+ regulatory T cells (Tregs) compromise the anti-tumor effects.",24304581_1,-1,-1,-1,-1,21732,-1,2.405171e-05,0.9999627,1.3272156e-05
21740,therapy,8,9,43,50,"In this study, we proposed the combination therapy of intratumoral co-administration of SLC and anti-CD25 monoclonal antibodies (mAbs).",24304581_2,0,1,-1,-1,21740,-1,2.4175313e-05,0.99996364,1.2161492e-05
21741,that the,2,4,16,24,We hypothesized that the intratumoral injections of SLC and depletion of Tregs would have stronger inhibition effects on the progression of hepatocellular carcinoma (HCC) in mice.,24304581_3,-1,-1,-1,-1,21741,-1,1.7680402e-05,0.9999747,7.6246884e-06
21754,the tumors,18,20,81,91,"The percentages of Tregs, effector CD8+ T cells and CD4+ T cells were checked in the tumors, lymph nodes, spleen and liver at regular intervals.",24304581_5,-1,-1,-1,-1,21754,-1,2.2100037e-05,0.999966,1.1930459e-05
21761,the tumor,7,9,46,55,The final anti-tumor effects were measured by the tumor volume and weight as well as the intratumoral activity of MMP2 and MMP9.,24304581_7,-1,-1,-1,-1,21761,-1,2.2326247e-05,0.9999664,1.13078e-05
21767,therapy,7,8,48,55,"RESULTS: Our experiments showed the combination therapy significantly decreased the frequency of Tregs, and increased CD8+ T cells and CD4+ T cells at tumor sites.",24304581_9,0,1,-1,-1,21767,-1,2.3153361e-05,0.9999635,1.3287516e-05
21783,therapy,33,34,176,183,"Unexpectedly, we observed a significantly decreased percentage of Tregs, and increased CD8+ T cells and CD4+ T cells in the lymph nodes, spleen and liver after the combination therapy.",24304581_11,0,1,-1,-1,21783,-1,2.743131e-05,0.99995863,1.3911935e-05
21786,therapy,13,14,83,90,The growth and invasiveness of HCC was also maximally inhibited in the combination therapy compared with the SLC alone.,24304581_12,0,1,-1,-1,21786,-1,3.0025676e-05,0.99995446,1.5500043e-05
21791,therapy,20,21,124,131,"Furthermore, we confirmed SLC induced the maturation of DCs via NF-B p65 and this maturation would benefit the combination therapy.",24304581_13,0,1,-1,-1,21791,-1,3.316523e-05,0.9999497,1.7197643e-05
21811,TNF-,2,3,7,12,"Foxp3, TNF- and TGF- mRNA expressions were assessed in tumor and lung tissues of LLC mice.",24325354_4,0,1,-1,-1,21811,-1,4.639174e-05,0.99993193,2.1649948e-05
21814,tissues,13,14,72,79,"Foxp3, TNF- and TGF- mRNA expressions were assessed in tumor and lung tissues of LLC mice.",24325354_4,-1,1,2,-1,21814,-1,0.00013797032,0.9983169,0.001545159
21818,tumor cell,23,25,129,139,"In addition, IL-10, IFN- and IL-4 levels were determined in sera and also in splenocyte culture supernatants at the presence of tumor cell lysate (10g/ml) and Con A (3g/ml) after 72h. Results showed the cytotoxic effects of umbelliprenin on LLC cells (IC=51.65.4M) while no adverse effect was seen at this concentration on normal splenocytes.",24325354_5,-1,-1,-1,-1,21818,-1,0.0041096606,0.41698626,0.5789041
21822,TNF-,0,1,0,5,TNF- mRNA expression in both lung and tumor tissues was increased.,24325354_6,0,1,-1,-1,21822,-1,5.186048e-05,0.9999249,2.3271741e-05
21823,tumor tissues,7,9,39,52,TNF- mRNA expression in both lung and tumor tissues was increased.,24325354_6,-1,-1,-1,-1,21823,-1,2.3459093e-05,0.9999535,2.3037474e-05
21826,tumor tissues,9,11,55,68,"However, Foxp3 and TGF- expressions were decreased in tumor tissues.",24325354_7,-1,-1,-1,-1,21826,-1,2.1608479e-05,0.99995625,2.2092932e-05
21830,to the,13,15,87,93,Serum level of IFN- was elevated in the umbelliprenin treated cancerous mice compared to the control group while IL-10 and IL-4 secretions were reduced.,24325354_8,-1,-1,-1,-1,21830,-1,2.1861593e-05,0.99996793,1.022864e-05
21847,tolerance to,20,22,125,137,Regulatory T (Treg) cells act to suppress activation of the immune system and thereby maintain immunological homeostasis and tolerance to self-antigens.,24354800_0,-1,-1,-1,-1,21847,-1,3.029599e-05,0.9999542,1.5455787e-05
21861,factor-,25,26,153,161,"These diagnosed patients demonstrated a lower number of CD4(+) CD25(+) cells co-expressing a higher level of FoxP3, interleukin-10, transforming growth factor- and CD152/CTLA-4 than the normal population.",24354800_4,0,1,-1,-1,21861,-1,0.99982613,7.981988e-05,9.404955e-05
21862,than the,28,30,179,187,"These diagnosed patients demonstrated a lower number of CD4(+) CD25(+) cells co-expressing a higher level of FoxP3, interleukin-10, transforming growth factor- and CD152/CTLA-4 than the normal population.",24354800_4,-1,-1,-1,-1,21862,-1,2.1248652e-05,0.99996495,1.3842437e-05
21866,cells than,20,22,103,113,Treg cells from patients showed a higher suppressive capability on CD4(+) CD25(-) responder T (Tresp) cells than normal.,24354800_5,-1,-1,-1,-1,21866,-1,0.0036588046,0.108285375,0.8880558
21876,that Treg cells,11,14,63,78,"A co-culture study at these definite ex vivo ratios, indicated that Treg cells from B-ALL patients exhibited higher immunosuppression than Treg cells from normal healthy individuals.",24354800_8,-1,-1,-1,-1,21876,-1,0.0025513938,0.1326399,0.8648088
21877,than Treg cells,20,23,134,149,"A co-culture study at these definite ex vivo ratios, indicated that Treg cells from B-ALL patients exhibited higher immunosuppression than Treg cells from normal healthy individuals.",24354800_8,-1,-1,-1,-1,21877,-1,0.0024070796,0.09301238,0.9045806
21885,Taken together,0,2,0,14,"Taken together, our study indicated that the CD4(+) CD25(+) FoxP3(+) Treg cells played an important role in immunosuppression, resulting in a positive disease-correlation in these patients.",24354800_10,-1,-1,-1,-1,21885,-1,3.93284e-05,0.9999423,1.8331924e-05
21886,that the,6,8,36,44,"Taken together, our study indicated that the CD4(+) CD25(+) FoxP3(+) Treg cells played an important role in immunosuppression, resulting in a positive disease-correlation in these patients.",24354800_10,-1,-1,-1,-1,21886,-1,1.6765069e-05,0.9999732,1.0059257e-05
21888,Treg cells played,16,19,71,88,"Taken together, our study indicated that the CD4(+) CD25(+) FoxP3(+) Treg cells played an important role in immunosuppression, resulting in a positive disease-correlation in these patients.",24354800_10,-1,-1,-1,-1,21888,-1,0.0013723888,0.048141647,0.95048594
21890,To the,0,2,0,6,"To the best of our knowledge, this is the first detailed report on the frequency, regulation and functionality of Treg cells in B-ALL.",24354800_11,-1,-1,-1,-1,21890,-1,3.4159024e-05,0.9999496,1.6250382e-05
21895,functionality,19,20,97,110,"To the best of our knowledge, this is the first detailed report on the frequency, regulation and functionality of Treg cells in B-ALL.",24354800_11,0,1,2,-1,21895,-1,4.4944336e-05,0.99992394,3.106554e-05
21899,factor,12,13,60,66,"We document human T lymphotropic virus type 1 (HTLV-1) bZIP factor (HBZ)-specific CD4 T cell responses in an adult T cell leukemia/lymphoma (ATL) patient after allogeneic hematopoietic stem cell transplantation (HCT) and identified a novel HLA-DRB1*15:01-restricted HBZ-derived naturally presented minimum epitope sequence, RRRAEKKAADVA (HBZ114-125).",24363428_0,0,1,-1,-1,21899,-1,0.41264334,0.58305734,0.004299271
21902,cell transplantation,32,34,190,210,"We document human T lymphotropic virus type 1 (HTLV-1) bZIP factor (HBZ)-specific CD4 T cell responses in an adult T cell leukemia/lymphoma (ATL) patient after allogeneic hematopoietic stem cell transplantation (HCT) and identified a novel HLA-DRB1*15:01-restricted HBZ-derived naturally presented minimum epitope sequence, RRRAEKKAADVA (HBZ114-125).",24363428_0,-1,-1,-1,-1,21902,-1,0.003068336,0.049476985,0.94745463
21904,This peptide,0,2,0,12,"This peptide was also presented on HLA-DRB1*15:02, recognized by CD4 T cells.",24363428_1,-1,-1,-1,-1,21904,-1,5.2386942e-05,0.9999249,2.2732695e-05
21914,life,14,15,89,93,We surmise that HTLV-1 transmission from mothers to infants through breast milk in early life induces tolerance to HBZ and results in insufficient HBZ-specific T cell responses in HTLV-1 asymptomatic carriers or ATL patients.,24363428_4,0,-1,2,-1,21914,-1,3.0114923e-05,0.99995065,1.9184024e-05
21915,tolerance to,16,18,102,114,We surmise that HTLV-1 transmission from mothers to infants through breast milk in early life induces tolerance to HBZ and results in insufficient HBZ-specific T cell responses in HTLV-1 asymptomatic carriers or ATL patients.,24363428_4,-1,-1,-1,-1,21915,-1,2.5662359e-05,0.99996066,1.3678891e-05
21919,protein,17,18,112,119,"In contrast, after allogeneic HCT, the reconstituted immune system from donor-derived cells can recognize virus protein HBZ as foreign, and HBZ-specific immune responses are provoked that contribute to the graft-versus-HTLV-1 effect.",24363428_5,0,1,-1,-1,21919,-1,0.072385885,0.92085946,0.0067546503
21922,to the,30,32,199,205,"In contrast, after allogeneic HCT, the reconstituted immune system from donor-derived cells can recognize virus protein HBZ as foreign, and HBZ-specific immune responses are provoked that contribute to the graft-versus-HTLV-1 effect.",24363428_5,-1,-1,-1,-1,21922,-1,2.4042742e-05,0.9999646,1.1403056e-05
21923,that TNFR2,4,6,21,31,"It has been reported that TNFR2 is involved in regulatory T cell induction and myeloid-derived suppressor cell (MDSC) accumulation, two kinds of immunosuppressive cells contributing to tumor immune evasion.",24379122_0,-1,-1,-1,-1,21923,-1,2.8346023e-05,0.9999597,1.1896287e-05
21928,to tumor,28,30,182,190,"It has been reported that TNFR2 is involved in regulatory T cell induction and myeloid-derived suppressor cell (MDSC) accumulation, two kinds of immunosuppressive cells contributing to tumor immune evasion.",24379122_0,-1,-1,-1,-1,21928,-1,2.6920105e-05,0.9999602,1.2879014e-05
21929,transmembrane TNF-,1,3,8,27,"Because transmembrane TNF- (tmTNF-) is the primary ligand for TNFR2, we hypothesized that tmTNF- is mainly responsible for the activation of MDSCs.",24379122_1,-1,-1,-1,-1,21929,-1,5.1722924e-05,0.9999269,2.1344378e-05
21932,TNFR2,11,12,64,69,"Because transmembrane TNF- (tmTNF-) is the primary ligand for TNFR2, we hypothesized that tmTNF- is mainly responsible for the activation of MDSCs.",24379122_1,0,1,-1,-1,21932,-1,5.5633136e-05,0.99992406,2.0305273e-05
21933,that tmTNF-,15,17,87,99,"Because transmembrane TNF- (tmTNF-) is the primary ligand for TNFR2, we hypothesized that tmTNF- is mainly responsible for the activation of MDSCs.",24379122_1,-1,-1,-1,-1,21933,-1,3.97966e-05,0.9999428,1.7386874e-05
21935,that tmTNF-,4,6,17,29,"Indeed, we found that tmTNF-, rather than secretory TNF- (sTNF-), activated MDSCs with enhanced suppressive activities, including upregulating arginase-1 and inducible NO synthase transcription, promoting secretion of NO, reactive oxygen species, IL-10, and TGF-, and enhancing inhibition of lymphocyte proliferation.",24379122_2,-1,-1,-1,-1,21935,-1,3.4273668e-05,0.9999471,1.8674675e-05
21937,TNF-,10,11,53,58,"Indeed, we found that tmTNF-, rather than secretory TNF- (sTNF-), activated MDSCs with enhanced suppressive activities, including upregulating arginase-1 and inducible NO synthase transcription, promoting secretion of NO, reactive oxygen species, IL-10, and TGF-, and enhancing inhibition of lymphocyte proliferation.",24379122_2,0,1,-1,-1,21937,-1,6.969896e-05,0.99989426,3.6033696e-05
21944,TNFR2,7,8,39,44,"This effect of tmTNF- was mediated by TNFR2, as TNFR2 deficiency significantly impaired tmTNF--induced release of IL-10 and NO and inhibition of T cell proliferation by MDSC supernatant.",24379122_3,0,1,-1,-1,21944,-1,3.9603798e-05,0.9999434,1.6958416e-05
21945,TNFR2 deficiency,10,12,49,65,"This effect of tmTNF- was mediated by TNFR2, as TNFR2 deficiency significantly impaired tmTNF--induced release of IL-10 and NO and inhibition of T cell proliferation by MDSC supernatant.",24379122_3,-1,-1,-1,-1,21945,-1,3.8867096e-05,0.99993193,2.9140054e-05
21946,tmTNF--induced release,14,16,89,112,"This effect of tmTNF- was mediated by TNFR2, as TNFR2 deficiency significantly impaired tmTNF--induced release of IL-10 and NO and inhibition of T cell proliferation by MDSC supernatant.",24379122_3,-1,-1,-1,-1,21946,-1,4.0910993e-05,0.999936,2.3142968e-05
21957,the tumor,35,37,235,244,"Consistently, our in vivo study showed that ectopic expression of uncleavable tmTNF- mutant by 4T1 cells significantly promoted tumor progression and angiogenesis, accompanied with more accumulation of MDSCs and regulatory T cells in the tumor site, increased production of NO, IL-10, and TGF-, as well as poor lymphocyte infiltration.",24379122_5,-1,-1,-1,-1,21957,-1,2.0191528e-05,0.9999695,1.0379564e-05
21961,cells that,10,12,57,67,"In contrast, enforced expression of sTNF- mutant by 4T1 cells that only released sTNF- without expression of surface tmTNF- markedly reduced MDSC accumulation and induced more lymphocyte infiltration instead, showing obvious tumor regression.",24379122_6,-1,-1,-1,-1,21961,-1,0.0035726887,0.11026536,0.8861619
21966,that tmTNF-,3,5,17,29,Our data suggest that tmTNF- acts as a potent activator of MDSCs via TNFR2 and reveals another novel immunosuppressive effect of this membrane molecule that promotes tumor immune escape.,24379122_7,-1,-1,-1,-1,21966,-1,3.7611102e-05,0.99994767,1.477275e-05
21968,TNFR2,13,14,70,75,Our data suggest that tmTNF- acts as a potent activator of MDSCs via TNFR2 and reveals another novel immunosuppressive effect of this membrane molecule that promotes tumor immune escape.,24379122_7,0,1,-1,-1,21968,-1,4.4602286e-05,0.9999366,1.8854016e-05
21979,factors,24,25,98,105,"OBJECTIVES: T helper 17 (Th17), T cytotoxic 17 (Tc17) and regulatory T (Treg) cells are important factors in the pathogenesis of inflammatory and autoimmune diseases.",24388919_0,0,1,-1,-1,21979,-1,0.00075779576,0.9991259,0.000116288116
21982,these cells,7,9,45,56,"However, information concerning the roles of these cells in antitumor immunity or endometrial tumorigenesis remains limited.",24388919_1,-1,-1,-1,-1,21982,-1,0.0013908028,0.04777082,0.9508384
21983,immunity,11,12,70,78,"However, information concerning the roles of these cells in antitumor immunity or endometrial tumorigenesis remains limited.",24388919_1,0,-1,2,-1,21983,-1,0.994899,0.0046169665,0.00048414012
21998,blood,14,15,87,92,"METHODS: We assessed the expression of interleukin (IL)-17 and Foxp3 in the peripheral blood of endometrial carcinoma patients and healthy controls by flow cytometry to determine the relative numbers of Th17, Tc17 and Treg cells.",24388919_3,0,1,-1,-1,21998,-1,0.00012237232,0.9990464,0.000831182
22000,the relative,27,29,179,191,"METHODS: We assessed the expression of interleukin (IL)-17 and Foxp3 in the peripheral blood of endometrial carcinoma patients and healthy controls by flow cytometry to determine the relative numbers of Th17, Tc17 and Treg cells.",24388919_3,-1,-1,-1,-1,22000,-1,2.634288e-05,0.99994934,2.4329442e-05
22004,Th17 cells,0,2,0,10,Th17 cells and Tc17 cells were counted as percentages of the total number of CD3(+) T cells; Treg cells were counted as a percentage of the total number of CD4(+) T cells.,24388919_4,-1,-1,-1,-1,22004,-1,0.0005175596,0.005676947,0.9938054
22005,Tc17 cells,3,5,15,25,Th17 cells and Tc17 cells were counted as percentages of the total number of CD3(+) T cells; Treg cells were counted as a percentage of the total number of CD4(+) T cells.,24388919_4,-1,-1,-1,-1,22005,-1,0.000979878,0.033569712,0.96545035
22006,the total,10,12,57,66,Th17 cells and Tc17 cells were counted as percentages of the total number of CD3(+) T cells; Treg cells were counted as a percentage of the total number of CD4(+) T cells.,24388919_4,-1,-1,-1,-1,22006,-1,2.6671212e-05,0.9999527,2.063499e-05
22009,the total,27,29,136,145,Th17 cells and Tc17 cells were counted as percentages of the total number of CD3(+) T cells; Treg cells were counted as a percentage of the total number of CD4(+) T cells.,24388919_4,-1,-1,-1,-1,22009,-1,3.074113e-05,0.9999453,2.392786e-05
22012,Tc17 cells,5,7,27,37,We also evaluated Th17 and Tc17 cells in tumor tissue by immunohistochemical staining.,24388919_5,-1,-1,-1,-1,22012,-1,0.003535456,0.60006475,0.3963998
22013,tumor tissue,8,10,41,53,We also evaluated Th17 and Tc17 cells in tumor tissue by immunohistochemical staining.,24388919_5,-1,-1,-1,-1,22013,-1,2.2531425e-05,0.99996006,1.7442231e-05
22016,these three cell types,7,11,38,60,"IL-17 and IL-10, dominant products of these three cell types, were detected by using enzyme-linked immunosorbent assays.",24388919_6,-1,-1,-1,-1,22016,-1,0.0025652107,0.615194,0.38224077
22027,the IL-17,8,10,48,57,"However, there was no significant difference on the IL-17 levels in the serum.",24388919_9,-1,-1,-1,-1,22027,-1,0.042858277,0.95495224,0.0021895303
22029,tumor tissues,5,7,48,61,"Additionally, immunohistochemistry performed on tumor tissues indicated that the amounts of Th17 and Tc17 increased in the cancer patients.",24388919_10,-1,-1,-1,-1,22029,-1,2.5513647e-05,0.9999435,3.1022384e-05
22030,that the,8,10,72,80,"Additionally, immunohistochemistry performed on tumor tissues indicated that the amounts of Th17 and Tc17 increased in the cancer patients.",24388919_10,-1,-1,-1,-1,22030,-1,1.9091996e-05,0.9999715,9.340427e-06
22039,these cells,4,6,25,36,Restoring the balance of these cells may help with the research and development of immunotherapies for endometrial carcinoma.,24388919_12,-1,-1,-1,-1,22039,-1,0.0018076831,0.07842671,0.9197656
22042,the relationship,4,6,22,38,"OBJECTIVE: To explore the relationship between the presence of HPV-16 DNA and the expression Treg surface marker Foxp3(+), peripheral blood levels of Th17/Treg cell-associated cytokines and explore their roles and significance in cervical cancer progression.",24401583_0,-1,-1,-1,-1,22042,-1,1.8605875e-05,0.9999709,1.0532421e-05
22047,blood,22,23,134,139,"OBJECTIVE: To explore the relationship between the presence of HPV-16 DNA and the expression Treg surface marker Foxp3(+), peripheral blood levels of Th17/Treg cell-associated cytokines and explore their roles and significance in cervical cancer progression.",24401583_0,0,1,-1,-1,22047,-1,7.4317344e-05,0.9997098,0.00021589754
22048,cell-associated cytokines,26,28,160,185,"OBJECTIVE: To explore the relationship between the presence of HPV-16 DNA and the expression Treg surface marker Foxp3(+), peripheral blood levels of Th17/Treg cell-associated cytokines and explore their roles and significance in cervical cancer progression.",24401583_0,-1,-1,-1,-1,22048,-1,0.06991866,0.0020539851,0.92802745
22063,cell-associated cytokines,4,6,32,57,"The concentrations of Th17/Treg cell-associated cytokines were detected by enzyme-linked immunosorbent assay (ELISA).RESULTS: Under the same status of HPV16 DNA in vivo, the levels of Foxp3(+), transforming growth factor- (TGF-) and interleukin-10 (IL-10) were significantly higher than those of the control group (P < 0.01) while the levels of interleukin-17 (IL-17) and interleukin-21 (IL-21)were significantly lower than those of the control group (P < 0.05) .",24401583_5,-1,-1,-1,-1,22063,-1,0.05087848,0.0019759925,0.94714546
22069,factor-,32,33,214,222,"The concentrations of Th17/Treg cell-associated cytokines were detected by enzyme-linked immunosorbent assay (ELISA).RESULTS: Under the same status of HPV16 DNA in vivo, the levels of Foxp3(+), transforming growth factor- (TGF-) and interleukin-10 (IL-10) were significantly higher than those of the control group (P < 0.01) while the levels of interleukin-17 (IL-17) and interleukin-21 (IL-21)were significantly lower than those of the control group (P < 0.05) .",24401583_5,0,1,-1,-1,22069,-1,0.99981004,7.690148e-05,0.000113103735
22073,than those,44,46,284,294,"The concentrations of Th17/Treg cell-associated cytokines were detected by enzyme-linked immunosorbent assay (ELISA).RESULTS: Under the same status of HPV16 DNA in vivo, the levels of Foxp3(+), transforming growth factor- (TGF-) and interleukin-10 (IL-10) were significantly higher than those of the control group (P < 0.01) while the levels of interleukin-17 (IL-17) and interleukin-21 (IL-21)were significantly lower than those of the control group (P < 0.05) .",24401583_5,-1,-1,-1,-1,22073,-1,2.2053333e-05,0.9999609,1.7098895e-05
22079,than those,68,70,421,431,"The concentrations of Th17/Treg cell-associated cytokines were detected by enzyme-linked immunosorbent assay (ELISA).RESULTS: Under the same status of HPV16 DNA in vivo, the levels of Foxp3(+), transforming growth factor- (TGF-) and interleukin-10 (IL-10) were significantly higher than those of the control group (P < 0.01) while the levels of interleukin-17 (IL-17) and interleukin-21 (IL-21)were significantly lower than those of the control group (P < 0.05) .",24401583_5,-1,-1,-1,-1,22079,-1,2.2940494e-05,0.9999597,1.7349372e-05
22092,Treg cytokines,47,49,259,273,"In the different status of HPV16 type DNA, the expression of Foxp3(+) was closely correlated with Federation International of Gynecology and Obstetrics (FIGO) stage, histological grade and lymphnode metastasis (P < 0.05) except for age (P > 0.05).CONCLUSION: Treg cytokines, HPV16 integration rate and severity of cervical lesions are positively correlated while Th17 cytokines show opposite effects.",24401583_7,-1,-1,-1,-1,22092,-1,0.19612113,0.78581375,0.018065117
22093,Th17 cytokines,62,64,363,377,"In the different status of HPV16 type DNA, the expression of Foxp3(+) was closely correlated with Federation International of Gynecology and Obstetrics (FIGO) stage, histological grade and lymphnode metastasis (P < 0.05) except for age (P > 0.05).CONCLUSION: Treg cytokines, HPV16 integration rate and severity of cervical lesions are positively correlated while Th17 cytokines show opposite effects.",24401583_7,-1,-1,-1,-1,22093,-1,0.227007,0.76318777,0.009805279
22094,cell-associated cytokines,1,3,10,35,Th17/Treg cell-associated cytokines may play an important role in the occurrence and development of cervical cancer.,24401583_8,-1,-1,-1,-1,22094,-1,0.046317264,0.0014684207,0.9522143
22097,the thymus,11,13,57,67,Myasthenia gravis (MG) is an autoimmune disease in which the thymus frequently presents follicular hyperplasia and signs of inflammation and T cells display a defect in suppressive regulation.,24405842_0,-1,-1,-1,-1,22097,-1,3.804555e-05,0.99992263,3.9369916e-05
22101,function,10,11,65,73,Defects in a suppressive assay can indicate either the defective function of Treg cells or the resistance of Tconv cells to suppression by Treg cells.,24405842_1,0,1,2,-1,22101,-1,0.0011716936,0.994038,0.004790363
22104,Tconv cells to,18,21,109,123,Defects in a suppressive assay can indicate either the defective function of Treg cells or the resistance of Tconv cells to suppression by Treg cells.,24405842_1,-1,-1,-1,-1,22104,-1,6.9907626e-05,0.99984133,8.87818e-05
22113,thymic Treg cells,7,10,59,76,We first performed cross-experiment studies using purified thymic Treg cells and Tconv cells from controls (CTRL) and MG patients.,24405842_3,-1,-1,-1,-1,22113,-1,0.003370271,0.1440331,0.8525966
22114,Tconv cells,11,13,81,92,We first performed cross-experiment studies using purified thymic Treg cells and Tconv cells from controls (CTRL) and MG patients.,24405842_3,-1,-1,-1,-1,22114,-1,0.0038597533,0.7210666,0.27507368
22119,time that,20,22,122,131,"We confirmed that MG Treg cells were defective in suppressing CTRL Tconv proliferation, and we demonstrated for the first time that MG Tconv cells were resistant to Treg cell suppression.",24405842_4,-1,-1,-1,-1,22119,-1,2.249541e-05,0.9999615,1.5954112e-05
22120,Tconv cells,23,25,135,146,"We confirmed that MG Treg cells were defective in suppressing CTRL Tconv proliferation, and we demonstrated for the first time that MG Tconv cells were resistant to Treg cell suppression.",24405842_4,-1,-1,-1,-1,22120,-1,0.0029243797,0.64210707,0.35496858
22121,to Treg cell,27,30,162,174,"We confirmed that MG Treg cells were defective in suppressing CTRL Tconv proliferation, and we demonstrated for the first time that MG Tconv cells were resistant to Treg cell suppression.",24405842_4,-1,-1,-1,-1,22121,-1,0.002363266,0.080699675,0.91693705
22123,Tconv cells triggered,4,7,21,42,The activation of MG Tconv cells triggered a lower upregulation of FoxP3 and a higher upregulation of CD4 and CD25 than CTRL cells.,24405842_5,-1,-1,-1,-1,22123,-1,6.545871e-05,0.9998487,8.580204e-05
22128,the factors that,2,5,15,31,"To investigate the factors that could explain these differences, we analyzed the transcriptomes of purified thymic Treg and Tconv cells from MG patients in comparison to CTRL cells.",24405842_6,-1,-1,-1,-1,22128,-1,2.6137284e-05,0.9999639,1.0005948e-05
22130,the transcriptomes,12,14,77,95,"To investigate the factors that could explain these differences, we analyzed the transcriptomes of purified thymic Treg and Tconv cells from MG patients in comparison to CTRL cells.",24405842_6,-1,-1,-1,-1,22130,-1,1.9031473e-05,0.9999713,9.699001e-06
22131,thymic Treg,16,18,108,119,"To investigate the factors that could explain these differences, we analyzed the transcriptomes of purified thymic Treg and Tconv cells from MG patients in comparison to CTRL cells.",24405842_6,-1,-1,-1,-1,22131,-1,3.0209865e-05,0.99995506,1.4762959e-05
22132,Tconv cells,19,21,124,135,"To investigate the factors that could explain these differences, we analyzed the transcriptomes of purified thymic Treg and Tconv cells from MG patients in comparison to CTRL cells.",24405842_6,-1,-1,-1,-1,22132,-1,0.0031755702,0.8434203,0.15340415
22136,this analysis,6,8,33,46,"Many of the pathways revealed by this analysis are involved in other autoimmune diseases, and T cells from MG patients exhibit a Th1/Th17/Tfh signature.",24405842_7,-1,-1,-1,-1,22136,-1,2.9614417e-05,0.99995494,1.5470117e-05
22138,IL-17-related genes,3,5,15,34,"An increase in IL-17-related genes was only observed in Treg cells, while increases in IFN-, IL-21, and TNF- were observed in both Treg and Tconv cells.",24405842_8,-1,-1,-1,-1,22138,-1,0.9833234,0.011453138,0.0052235066
22141,TNF-,20,21,105,110,"An increase in IL-17-related genes was only observed in Treg cells, while increases in IFN-, IL-21, and TNF- were observed in both Treg and Tconv cells.",24405842_8,0,1,-1,-1,22141,-1,0.00014701694,0.9998149,3.8067326e-05
22143,Tconv cells,27,29,142,153,"An increase in IL-17-related genes was only observed in Treg cells, while increases in IFN-, IL-21, and TNF- were observed in both Treg and Tconv cells.",24405842_8,-1,-1,-1,-1,22143,-1,0.0034730243,0.64132196,0.355205
22146,TNF-,6,7,25,30,"In addition, the role of TNF- in the defect in Tconv cells from MG patients was further confirmed by functional studies.",24405842_10,0,1,-1,-1,22146,-1,4.5756024e-05,0.9999355,1.8738912e-05
22148,Tconv cells,11,13,48,59,"In addition, the role of TNF- in the defect in Tconv cells from MG patients was further confirmed by functional studies.",24405842_10,-1,-1,-1,-1,22148,-1,0.002996146,0.80252326,0.19448058
22149,functional,20,21,102,112,"In addition, the role of TNF- in the defect in Tconv cells from MG patients was further confirmed by functional studies.",24405842_10,0,1,2,-1,22149,-1,4.448658e-05,0.999933,2.2490329e-05
22150,that the,5,7,33,41,"Altogether, our results indicate that the immunoregulatory defects observed in MG patients are caused by both Treg cell and Tconv cell impairment and involve several pro-inflammatory cytokines, with TNF- playing a key role in this process.",24405842_11,-1,-1,-1,-1,22150,-1,1.8398168e-05,0.99997306,8.50904e-06
22152,Tconv cell,20,22,124,134,"Altogether, our results indicate that the immunoregulatory defects observed in MG patients are caused by both Treg cell and Tconv cell impairment and involve several pro-inflammatory cytokines, with TNF- playing a key role in this process.",24405842_11,-1,-1,-1,-1,22152,-1,0.001782992,0.07496977,0.9232473
22154,TNF- playing,30,32,199,212,"Altogether, our results indicate that the immunoregulatory defects observed in MG patients are caused by both Treg cell and Tconv cell impairment and involve several pro-inflammatory cytokines, with TNF- playing a key role in this process.",24405842_11,-1,-1,-1,-1,22154,-1,3.6211204e-05,0.9999474,1.6298336e-05
22157,the thymus,5,7,36,46,The chronic inflammation present in the thymus of MG patients could provide an explanation for the escape of thymic T cells from regulation in the MG thymus.,24405842_12,-1,-1,-1,-1,22157,-1,4.2236174e-05,0.9999157,4.2028718e-05
22159,thymic T cells,18,21,109,123,The chronic inflammation present in the thymus of MG patients could provide an explanation for the escape of thymic T cells from regulation in the MG thymus.,24405842_12,-1,-1,-1,-1,22159,-1,0.0047485386,0.19835715,0.7968944
22162,thymus,26,27,150,156,The chronic inflammation present in the thymus of MG patients could provide an explanation for the escape of thymic T cells from regulation in the MG thymus.,24405842_12,-1,1,2,-1,22162,-1,0.00023555083,0.9985481,0.0012163854
22167,Th1 immune response,11,14,80,99,"Activated STAT3 promotes survival and proliferation of cancer cells, suppresses Th1 immune response, and induces dysfunction of immune cells.",24407159_1,-1,-1,-1,-1,22167,-1,0.24871053,0.74545485,0.0058346093
22171,function,27,28,170,178,We investigated whether pretreating myeloma cells with a phosphor (p)-STAT3 inhibitor (JSI-124) and/or bortezomib before loading into dendritic cells (DCs) can affect DC function.,24407159_2,0,1,2,-1,22171,-1,5.562733e-05,0.99990547,3.8884238e-05
22175,protein,15,16,103,110,The combination treatment with JSI-124 and bortezomib resulted in the highest expression of heat shock protein (HSP) 90 and the lowest expression of p-STAT3 in dying myeloma cells.,24407159_3,0,1,-1,-1,22175,-1,4.9369704e-05,0.99989533,5.528564e-05
22178,cells treated,5,7,30,43,DCs loaded with dying myeloma cells treated by JSI-124 and bortezomib produced the least amount of p-STAT3 compared to other treatments.,24407159_4,-1,-1,-1,-1,22178,-1,0.0033152984,0.11820756,0.87847716
22195,function through the,15,18,95,115,"The data suggest that pretreatment of myeloma cells with JSI-124 and bortezomib can recover DC function through the up-regulation of HSP90 and the down-regulation of p-STAT3 and inhibitory cytokines, and that these DCs can potently generate myeloma-specific CTLs.",24407159_7,-1,-1,-1,-1,22195,-1,2.840278e-05,0.9999534,1.8247425e-05
22198,that these,31,33,204,214,"The data suggest that pretreatment of myeloma cells with JSI-124 and bortezomib can recover DC function through the up-regulation of HSP90 and the down-regulation of p-STAT3 and inhibitory cytokines, and that these DCs can potently generate myeloma-specific CTLs.",24407159_7,-1,-1,-1,-1,22198,-1,1.8537969e-05,0.99997187,9.647807e-06
22207,The treatment,0,2,0,13,"The treatment delayed tumor growth, but unexpectedly increased the proportion of Tregs in tumor.",24416401_2,-1,-1,-1,-1,22207,-1,2.3280447e-05,0.9999671,9.611274e-06
22220,term tumor-free,5,7,34,49,"This combination resulted in long term tumor-free survival of up to 80% of mice, and the tumor-free mice were more resistant to re-challenge with tumor.",24416401_5,-1,-1,-1,-1,22220,-1,2.7005282e-05,0.9999578,1.5138366e-05
22222,the tumor-free,17,19,85,99,"This combination resulted in long term tumor-free survival of up to 80% of mice, and the tumor-free mice were more resistant to re-challenge with tumor.",24416401_5,-1,-1,-1,-1,22222,-1,2.4930461e-05,0.9999603,1.4803187e-05
22230,This treatment,0,2,0,14,"This treatment markedly inhibited tumor growth, and was accompanied by massive infiltration of IFN-producing T cells.",24416401_7,-1,-1,-1,-1,22230,-1,2.2169896e-05,0.9999653,1.2510113e-05
22232,IFN-producing T cells,14,17,95,117,"This treatment markedly inhibited tumor growth, and was accompanied by massive infiltration of IFN-producing T cells.",24416401_7,-1,-1,-1,-1,22232,-1,0.7567236,0.0027996716,0.24047674
22240,therapy,15,16,93,100,"In a spontaneous 4T1 lung metastasis model with resection of primary tumor, this combination therapy markedly increased the survival of mice, indicating it was effective in reducing lethal metastasis burden.",24416401_9,0,1,-1,-1,22240,-1,2.3642884e-05,0.999964,1.240311e-05
22242,Taken together,0,2,0,14,"Taken together, our data show that anti-TGF antibody and cyclophosphamide represents an effective chemoimmunotherapeutic combination.",24416401_10,-1,-1,-1,-1,22242,-1,5.326764e-05,0.9999273,1.9415147e-05
22252,TNF-,9,10,42,47,"Bcl11b(-/-) CD4(+) T cells, with elevated TNF- levels, but not the Bcl11b(-/-) CD8(+) T cells, were required for the reduced tumor burden, as were NK1.1(+) cells, found in increased numbers in Bcl11b(F/F)/CD4-Cre mice.",24446520_1,0,1,-1,-1,22252,-1,7.615669e-05,0.99990356,2.0305477e-05
22274,TNF-,26,27,156,161,"Finally, the reduced tumor burden, increased numbers of NK cells in the lung, and increased hematopoiesis in Bcl11b(F/F)/CD4-Cre mice were all dependent on TNF-.",24446520_5,0,1,-1,-1,22274,-1,4.5978104e-05,0.9999366,1.746907e-05
22275,TNF- treatment,2,4,10,25,"Moreover, TNF- treatment of wild-type mice also reduced the tumor burden and increased hematopoiesis and the numbers and activity of NK cells in the lung.",24446520_6,-1,-1,-1,-1,22275,-1,2.6084603e-05,0.9999604,1.353645e-05
22276,the tumor,9,11,57,66,"Moreover, TNF- treatment of wild-type mice also reduced the tumor burden and increased hematopoiesis and the numbers and activity of NK cells in the lung.",24446520_6,-1,-1,-1,-1,22276,-1,1.9048131e-05,0.9999715,9.440567e-06
22281,TNF-,4,5,24,29,"In vitro treatment with TNF- of lineage-negative hematopoietic progenitors increased NK and myeloid differentiation, further supporting a role of TNF- in promoting hematopoiesis.",24446520_7,0,1,-1,-1,22281,-1,3.5671605e-05,0.9999486,1.5649286e-05
22282,TNF-,20,21,147,152,"In vitro treatment with TNF- of lineage-negative hematopoietic progenitors increased NK and myeloid differentiation, further supporting a role of TNF- in promoting hematopoiesis.",24446520_7,0,1,-1,-1,22282,-1,3.4852615e-05,0.99994934,1.5812293e-05
22284,TNF-,7,8,38,43,"These studies reveal a novel role for TNF- in the antitumor immune response, specifically in stimulating hematopoiesis and increasing the numbers and activity of NK cells.",24446520_8,0,1,-1,-1,22284,-1,2.9595132e-05,0.99995863,1.1762624e-05
22297,Th17 cells,25,27,171,181,"IL-6 regulates T cell differentiation, activation and resistance against apoptosis and thereby controls the balance between pro-inflammatory T cell subsets such as Th1 or Th17 cells and immunosuppressive regulatory T cells.",24447345_1,-1,-1,-1,-1,22297,-1,0.004465267,0.40315846,0.59237635
22302,tumor cell,6,8,32,42,"In fact, IL-6 directly promotes tumor cell proliferation and survival through STAT3 activation.",24447345_3,-1,-1,-1,-1,22302,-1,0.003291516,0.21482526,0.7818832
22303,through STAT3,11,13,70,83,"In fact, IL-6 directly promotes tumor cell proliferation and survival through STAT3 activation.",24447345_3,-1,-1,-1,-1,22303,-1,3.4413093e-05,0.999946,1.9540488e-05
22309,therapeutics targeting IL-6,5,8,29,56,"During recent years, several therapeutics targeting IL-6 dependent pathways have been developed.",24447345_5,-1,-1,-1,-1,22309,-1,0.08610042,0.9068581,0.00704152
22311,targeting this,13,15,94,108,"Although clinical data about anti-IL-6 treatment in intestinal diseases are currently scarce, targeting this pathway might be a promising strategy in IBD and CRC.",24447345_6,-1,-1,-1,-1,22311,-1,2.172718e-05,0.99996996,8.279735e-06
22312,that the,3,5,12,20,"It is known that the intake of omega-3 fatty acids, such as eicosapentaenoic (EPA) and docosahexaenoic acid (DHA), is beneficial for preventing and/or treating allergic diseases.",24460246_0,-1,-1,-1,-1,22312,-1,1.908955e-05,0.99997306,7.8309295e-06
22315,Th2-skewed immunity,10,12,75,94,The pathogenesis of allergic diseases is associated with overactivation of Th2-skewed immunity.,24460246_1,-1,-1,-1,-1,22315,-1,0.010293649,0.9886635,0.0010428126
22317,Th2 cytokines,5,7,36,49,"Basophils generate large amounts of Th2 cytokines such as interleukin (IL)-4 and IL-13, which are critically involved in allergic inflammation.",24460246_2,-1,-1,-1,-1,22317,-1,0.19592838,0.78536534,0.018706331
22320,Th2 cytokine,7,9,39,51,We investigated how EPA and DHA affect Th2 cytokine expression in phorbol 12-myristate 13-acetate- and ionomycin (PI)-activated RBL-2H3 basophilic leukemia cells.,24460246_3,-1,-1,-1,-1,22320,-1,0.10563179,0.8896088,0.0047594127
22324,their transcription,15,17,80,99,EPA and DHA induced a dramatic decrease in the production of IL-4 and IL-13 and their transcription in a dose-dependent manner.,24460246_4,-1,-1,-1,-1,22324,-1,2.9016534e-05,0.9999547,1.6290807e-05
22328,Analysis,0,1,0,8,Analysis of certain transcription factors revealed that nuclear expression of c-Fos and the mRNA expression were suppressed by EPA and DHA.,24460246_6,0,1,-1,-1,22328,-1,1.926963e-05,0.9999685,1.2198105e-05
22335,nuclear factor of activated T cells,11,17,86,121,"Furthermore, they significantly inhibited the nuclear expression and translocation of nuclear factor of activated T cells (NF-AT)1.",24460246_7,-1,1,2,-1,22335,-1,0.0032573976,0.703818,0.29292455
22338,proteins,15,16,83,91,"In contrast, the expression levels of nuclear factor kappa-B (NF-B), GATA-binding proteins (GATAs), and CCAAT/enhancer binding protein alpha (C/EBP) were not significantly affected by EPA and DHA.",24460246_8,0,1,-1,-1,22338,-1,5.343509e-05,0.9998673,7.926923e-05
22340,protein,17,18,130,137,"Phosphorylation of extracellular signal-related kinase was inhibited by EPA and DHA, and phosphorylation of p38 mitogen-activated protein kinase was decreased by DHA, but not by EPA.",24460246_9,0,1,-1,-1,22340,-1,7.0046524e-05,0.9998503,7.966721e-05
22341,Taken together,0,2,0,14,"Taken together, our data suggest that EPA and DHA may suppress Th2-skewed allergic immune responses by inhibiting the expression of basophilic IL-4 and IL-13.",24460246_10,-1,-1,-1,-1,22341,-1,4.2206113e-05,0.99994195,1.5789843e-05
22348,tumor-infiltrating T lymphocytes,9,12,60,92,"The interaction of integrin E(CD103)7, often expressed on tumor-infiltrating T lymphocytes, with its cognate ligand, the epithelial cell marker E-cadherin on tumor cells, plays a major role in antitumor CTL responses.",24477908_0,-1,-1,-1,-1,22348,-1,0.004267693,0.79246867,0.20326369
22351,tumor cells,24,26,160,171,"The interaction of integrin E(CD103)7, often expressed on tumor-infiltrating T lymphocytes, with its cognate ligand, the epithelial cell marker E-cadherin on tumor cells, plays a major role in antitumor CTL responses.",24477908_0,-1,-1,-1,-1,22351,-1,0.004058306,0.40124255,0.5946991
22355,TCR,8,9,37,40,"CD103 is induced on CD8 T cells upon TCR engagement and exposure to TGF-1, abundant within the tumor microenvironment.",24477908_1,-1,1,2,-1,22355,-1,2.8419701e-05,0.99994063,3.089717e-05
22356,to TGF-1,12,14,65,74,"CD103 is induced on CD8 T cells upon TCR engagement and exposure to TGF-1, abundant within the tumor microenvironment.",24477908_1,-1,-1,-1,-1,22356,-1,5.6038793e-05,0.9998965,4.74306e-05
22357,the tumor,17,19,92,101,"CD103 is induced on CD8 T cells upon TCR engagement and exposure to TGF-1, abundant within the tumor microenvironment.",24477908_1,-1,-1,-1,-1,22357,-1,2.0078387e-05,0.99996924,1.0729407e-05
22358,the transcriptional,2,4,9,28,"However, the transcriptional mechanisms underlying the cooperative role of these two signaling pathways in inducing CD103 expression in CD8 T lymphocytes remain unknown.",24477908_2,-1,-1,-1,-1,22358,-1,2.603305e-05,0.9999629,1.1095153e-05
22360,these two,10,12,75,84,"However, the transcriptional mechanisms underlying the cooperative role of these two signaling pathways in inducing CD103 expression in CD8 T lymphocytes remain unknown.",24477908_2,-1,-1,-1,-1,22360,-1,3.7617265e-05,0.99994564,1.6767437e-05
22365,that the transcription factors,23,27,127,157,"Using a human CTL system model based on a CD8(+)/CD103(-) T cell clone specific of a lung tumor-associated Ag, we demonstrated that the transcription factors Smad2/3 and NFAT-1 are two critical regulators of this process.",24477908_3,-1,-1,-1,-1,22365,-1,1.9342373e-05,0.9999684,1.2263879e-05
22366,NFAT-1,29,30,170,176,"Using a human CTL system model based on a CD8(+)/CD103(-) T cell clone specific of a lung tumor-associated Ag, we demonstrated that the transcription factors Smad2/3 and NFAT-1 are two critical regulators of this process.",24477908_3,-1,1,2,-1,22366,-1,5.0326034e-05,0.9998845,6.517998e-05
22371,these transcriptional,21,23,120,141,"We also identified promoter and enhancer elements of the human ITGAE gene, encoding CD103, involved in its induction by these transcriptional regulators.",24477908_4,-1,-1,-1,-1,22371,-1,2.3609067e-05,0.9999633,1.3156099e-05
22373,TCR-engaged,14,15,87,98,"Overall, our results explain how TGF-1 can participate in CD103 expression on locally TCR-engaged Ag-specific CD8 T cells, thus contributing to antitumor CTL responses and cancer cell destruction.",24477908_5,-1,1,2,-1,22373,-1,6.776213e-05,0.99986386,6.840545e-05
22394,IL-17A+ T cells,6,9,40,55,"The frequency of intratumoral Tregs and IL-17A+ T cells, and the levels of FoxP3 and IL-17 mRNA were analyzed.",24487033_2,-1,-1,-1,-1,22394,-1,0.64309007,0.002228962,0.35468102
22403,tumor tissues,9,11,52,65,The activities of matrix metalloproteases (MMPs) in tumor tissues were analyzed.,24487033_4,-1,-1,-1,-1,22403,-1,2.0737369e-05,0.9999608,1.8538842e-05
22405,blood,6,7,32,37,"Meanwhile, Tregs from patient's blood was co-cultured with human CRC cells in the presence of IL-17.",24487033_5,0,1,-1,-1,22405,-1,9.796406e-05,0.9995809,0.00032108594
22409,protein,1,2,5,12,MMPs protein and mRNA levels were determined after 48 or 24h incubation.,24487033_6,0,1,-1,-1,22409,-1,4.903882e-05,0.9998902,6.071764e-05
22410,that Tregs,2,4,9,19,We found that Tregs and IL-17A+T cells were accumulated in CRC.,24487033_7,-1,-1,-1,-1,22410,-1,2.2033752e-05,0.99996626,1.1653493e-05
22411,IL-17A+T cells,5,7,24,38,We found that Tregs and IL-17A+T cells were accumulated in CRC.,24487033_7,-1,-1,-1,-1,22411,-1,0.5545313,0.0022787715,0.44318992
22413,Tregs/IL-17A+T cells,3,5,13,33,The ratio of Tregs/IL-17A+T cells was decreased in CRC tissues.,24487033_8,-1,-1,-1,-1,22413,-1,0.013001094,0.41700047,0.5699984
22414,tissues,9,10,55,62,The ratio of Tregs/IL-17A+T cells was decreased in CRC tissues.,24487033_8,-1,1,2,-1,22414,-1,6.537203e-05,0.99924684,0.0006877966
22416,IL-17A+T cells,5,7,33,47,More intratumoral Tregs and less IL-17A+T cells were associated with suppressed MMPs activities and decreased metastases score.,24487033_9,-1,-1,-1,-1,22416,-1,0.7003019,0.0017947783,0.29790333
22417,that Tregs,6,8,40,50,"In addition, vitro studies demonstrated that Tregs suppressed MMPs expression in the presence of IL-17.",24487033_10,-1,-1,-1,-1,22417,-1,2.1723665e-05,0.99996936,8.957867e-06
22429,functions,13,14,86,95,Cytotoxicity and IFN- production by human  T cells underlie their potent antitumor functions.,24489097_0,0,1,2,-1,22429,-1,0.00019161277,0.99959165,0.00021673719
22433,the thymus to,9,12,55,68,"Given the recent disclosure of a major contribution of the thymus to murine  T cell functional differentiation, in this study we have analyzed a series of human pediatric thymuses.",24489097_2,-1,-1,-1,-1,22433,-1,2.0875606e-05,0.99996626,1.288692e-05
22434,T cell functional,14,17,79,96,"Given the recent disclosure of a major contribution of the thymus to murine  T cell functional differentiation, in this study we have analyzed a series of human pediatric thymuses.",24489097_2,-1,-1,-1,-1,22434,-1,0.00020506003,0.00060061755,0.9991943
22436,thymuses,30,31,173,181,"Given the recent disclosure of a major contribution of the thymus to murine  T cell functional differentiation, in this study we have analyzed a series of human pediatric thymuses.",24489097_2,-1,1,2,-1,22436,-1,5.966117e-05,0.9998926,4.776796e-05
22438,thymocytes,6,7,34,44,We found that ex vivo-isolated  thymocytes produced negligible IFN- and lacked cytolytic activity against leukemia cells.,24489097_3,-1,1,2,-1,22438,-1,0.0012535135,0.09790554,0.9008409
22444,TCR,2,3,14,17,"Unexpectedly, TCR activation was dispensable for these stages of functional differentiation.",24489097_5,-1,1,2,-1,22444,-1,4.2397925e-05,0.9999168,4.079212e-05
22446,functional,10,11,65,75,"Unexpectedly, TCR activation was dispensable for these stages of functional differentiation.",24489097_5,0,1,2,-1,22446,-1,8.134174e-05,0.9998778,4.084503e-05
22448,the transcription factors T-bet,14,18,91,122,"The effects of IL-2/IL-15 depended on MAPK/ERK signaling and induced de novo expression of the transcription factors T-bet and eomesodermin, as well as the cytolytic enzyme perforin, required for the cytotoxic type 1 program.",24489097_6,-1,-1,-1,-1,22448,-1,2.2413817e-05,0.99996424,1.3307411e-05
22461,functions,28,29,142,151,"Although the role of Notch in CD4(+) and CD8(+)  T cells is well documented, there are no reports on how Notch signaling regulates effector functions of  T cells.",24489102_1,0,1,2,-1,22461,-1,0.00011872344,0.9996669,0.00021431939
22465,blood,10,11,50,55, T cells are a minor fraction in the peripheral blood but are known to play a major role in defense against pathogens and tumors.,24489102_2,0,1,-1,-1,22465,-1,0.00014675953,0.9987556,0.0010977136
22466,to play,14,16,70,77, T cells are a minor fraction in the peripheral blood but are known to play a major role in defense against pathogens and tumors.,24489102_2,-1,-1,-1,-1,22466,-1,2.4317229e-05,0.9999659,9.779811e-06
22469,that Notch receptors,6,9,23,43,"In this study, we show that Notch receptors (mRNA and protein) are expressed in peripheral  T cells.",24489102_3,-1,-1,-1,-1,22469,-1,8.029932e-05,0.99968076,0.00023898625
22470,protein,12,13,54,61,"In this study, we show that Notch receptors (mRNA and protein) are expressed in peripheral  T cells.",24489102_3,0,1,-1,-1,22470,-1,3.5629015e-05,0.99994123,2.316475e-05
22487,functions,24,25,137,146,"Our study describes for the first time, to our knowledge, the role of Notch as an additional signal contributing to Ag-specific effector functions of  T cells.",24489102_7,0,1,2,-1,22487,-1,0.0021801493,0.94794446,0.04987538
22493,tissues,16,17,75,82,"In this article, we report that cutaneous T cell lymphoma (CTCL) cells and tissues ubiquitously express the immunosuppressive cell surface protein CD80 (B7-1).",24523507_0,-1,1,2,-1,22493,-1,4.1963016e-05,0.9998809,7.707338e-05
22496,protein CD80,23,25,139,151,"In this article, we report that cutaneous T cell lymphoma (CTCL) cells and tissues ubiquitously express the immunosuppressive cell surface protein CD80 (B7-1).",24523507_0,-1,-1,-1,-1,22496,-1,0.0029472539,0.081485525,0.9155672
22501,the STAT5,15,17,89,98,"CD80 expression in CTCL cells is strictly dependent on the expression of both members of the STAT5 family, STAT5a and STAT5b, as well as their joint ability to transcriptionally activate the CD80 gene.",24523507_1,-1,-1,-1,-1,22501,-1,2.522156e-05,0.99996006,1.4659129e-05
22505,to transcriptionally,29,31,157,177,"CD80 expression in CTCL cells is strictly dependent on the expression of both members of the STAT5 family, STAT5a and STAT5b, as well as their joint ability to transcriptionally activate the CD80 gene.",24523507_1,-1,-1,-1,-1,22505,-1,2.2882083e-05,0.999966,1.1117526e-05
22506,the CD80 gene,32,35,187,200,"CD80 expression in CTCL cells is strictly dependent on the expression of both members of the STAT5 family, STAT5a and STAT5b, as well as their joint ability to transcriptionally activate the CD80 gene.",24523507_1,-1,-1,-1,-1,22506,-1,0.0001675899,0.9994394,0.00039299848
22509,the cytokine,10,12,60,72,"In IL-2-dependent CTCL cells, CD80 expression is induced by the cytokine in a Jak1/3- and STAT5a/b-dependent manner, whereas in the CTCL cells with constitutive STAT5 activation, CD80 expression is also STAT5a/b dependent but is independent of Jak activity.",24523507_2,-1,-1,-1,-1,22509,-1,0.4975744,0.49873814,0.0036875468
22517,the cell-inhibitory receptor,20,23,128,156,"Although depletion of CD80 expression does not affect the proliferation rate and viability of CTCL cells, induced expression of the cell-inhibitory receptor of CD80, CD152 (CTLA-4), impairs growth of the cells.",24523507_3,-1,-1,-1,-1,22517,-1,0.0034952473,0.13333383,0.863171
22520,the cells,34,36,200,209,"Although depletion of CD80 expression does not affect the proliferation rate and viability of CTCL cells, induced expression of the cell-inhibitory receptor of CD80, CD152 (CTLA-4), impairs growth of the cells.",24523507_3,-1,-1,-1,-1,22520,-1,0.002144464,0.063575,0.9342806
22529,that the CD80-CD152,13,16,74,93,These data identify a new mechanism of immune evasion in CTCL and suggest that the CD80-CD152 axis may become a therapeutic target in this type of lymphoma.,24523507_5,-1,-1,-1,-1,22529,-1,0.0016381592,0.9916821,0.0066797286
22530,therapeutic target,20,22,112,130,These data identify a new mechanism of immune evasion in CTCL and suggest that the CD80-CD152 axis may become a therapeutic target in this type of lymphoma.,24523507_5,-1,-1,-1,-1,22530,-1,2.4944331e-05,0.9999634,1.17082e-05
22531,this type,23,25,134,143,These data identify a new mechanism of immune evasion in CTCL and suggest that the CD80-CD152 axis may become a therapeutic target in this type of lymphoma.,24523507_5,-1,-1,-1,-1,22531,-1,2.5890122e-05,0.9999583,1.58825e-05
22533,Tc17 cells,5,7,29,39,"BACKGROUND: The existence of Tc17 cells was recently shown in several types of infectious and autoimmune diseases, but their distribution and functions in uterine cervical cancer (UCC) have not been fully elucidated.",24523865_0,-1,-1,-1,-1,22533,-1,0.0026660336,0.20415692,0.79317695
22536,functions,23,24,142,151,"BACKGROUND: The existence of Tc17 cells was recently shown in several types of infectious and autoimmune diseases, but their distribution and functions in uterine cervical cancer (UCC) have not been fully elucidated.",24523865_0,0,1,2,-1,22536,-1,4.9693517e-05,0.99992514,2.5199524e-05
22538,Tc17 cells,5,7,26,36,"METHODS: The frequency of Tc17 cells in peripheral blood samples obtained from UCC patients, cervical intraepithelial neoplasia (CIN) patients and healthy controls was determined by flow cytometry.",24523865_1,-1,-1,-1,-1,22538,-1,0.0019511939,0.19723111,0.8008177
22539,blood,9,10,51,56,"METHODS: The frequency of Tc17 cells in peripheral blood samples obtained from UCC patients, cervical intraepithelial neoplasia (CIN) patients and healthy controls was determined by flow cytometry.",24523865_1,0,1,-1,-1,22539,-1,0.00014416811,0.99874914,0.0011066921
22541,Tc17 cells,5,7,27,37,"Besides, the prevalence of Tc17 cells and their relationships to Th17 cells and Foxp3-expressing T cells as well as microvessels in tissue samples of the patients were assessed by immunohistochemistry staining.",24523865_2,-1,-1,-1,-1,22541,-1,0.0013939806,0.077056006,0.92155004
22542,their relationships to Th17 cells,8,13,42,75,"Besides, the prevalence of Tc17 cells and their relationships to Th17 cells and Foxp3-expressing T cells as well as microvessels in tissue samples of the patients were assessed by immunohistochemistry staining.",24523865_2,-1,-1,-1,-1,22542,-1,0.0034743198,0.8257181,0.17080759
22543,Foxp3-expressing T cells,14,17,80,104,"Besides, the prevalence of Tc17 cells and their relationships to Th17 cells and Foxp3-expressing T cells as well as microvessels in tissue samples of the patients were assessed by immunohistochemistry staining.",24523865_2,-1,-1,-1,-1,22543,-1,0.0032671895,0.8708369,0.12589587
22544,tissue,22,23,132,138,"Besides, the prevalence of Tc17 cells and their relationships to Th17 cells and Foxp3-expressing T cells as well as microvessels in tissue samples of the patients were assessed by immunohistochemistry staining.",24523865_2,-1,1,2,-1,22544,-1,4.61552e-05,0.9998479,0.00010589765
22547,Tc17 cells,16,18,83,93,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,-1,-1,-1,-1,22547,-1,0.0014292186,0.075189546,0.9233812
22548,blood,21,22,113,118,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,0,1,-1,-1,22548,-1,0.0002629489,0.99690765,0.0028293757
22549,tissues,24,25,132,139,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,-1,1,2,-1,22549,-1,0.00034946576,0.98581505,0.013835473
22551,Tc17 cells,30,32,158,168,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,-1,-1,-1,-1,22551,-1,0.0023804156,0.1901394,0.80748016
22552,tissues,34,35,176,183,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,-1,1,2,-1,22552,-1,0.00013115181,0.9974233,0.002445552
22553,than that,38,40,209,218,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,-1,-1,-1,-1,22553,-1,2.2994744e-05,0.99996233,1.4663679e-05
22554,tissues,42,43,226,233,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,-1,1,2,-1,22554,-1,7.434259e-05,0.99938965,0.00053594855
22557,the status,13,15,73,83,"Besides, the increased level of Tc17 in UCC patients was associated with the status of pelvic lymph node metastases and increased microvessel density.",24523865_4,-1,-1,-1,-1,22557,-1,2.9606237e-05,0.9999571,1.3312418e-05
22558,Tc17 cells,7,9,58,68,"Finally, significant correlations of infiltration between Tc17 cells and Th17 cells or Foxp3-expressing T cells were observed in UCC and CIN tissues.",24523865_5,-1,-1,-1,-1,22558,-1,0.0017725204,0.08795839,0.910269
22559,Th17 cells,10,12,73,83,"Finally, significant correlations of infiltration between Tc17 cells and Th17 cells or Foxp3-expressing T cells were observed in UCC and CIN tissues.",24523865_5,-1,-1,-1,-1,22559,-1,0.0005361634,0.0067449366,0.9927188
22560,Foxp3-expressing T cells,13,16,87,111,"Finally, significant correlations of infiltration between Tc17 cells and Th17 cells or Foxp3-expressing T cells were observed in UCC and CIN tissues.",24523865_5,-1,-1,-1,-1,22560,-1,0.0035792275,0.8416702,0.15475057
22561,tissues,22,23,141,148,"Finally, significant correlations of infiltration between Tc17 cells and Th17 cells or Foxp3-expressing T cells were observed in UCC and CIN tissues.",24523865_5,-1,1,2,-1,22561,-1,0.0013761164,0.8259035,0.17272042
22563,that Tc17 cell,5,8,34,48,CONCLUSIONS: This study indicates that Tc17 cell infiltration in cervical cancers is associated with cancer progression accompanied by increased infiltrations of Th17 cells and regulatory T cells as well as promoted tumor vasculogenesis.,24523865_6,-1,-1,-1,-1,22563,-1,0.0047536828,0.6504307,0.3448157
22564,Th17 cells,22,24,162,172,CONCLUSIONS: This study indicates that Tc17 cell infiltration in cervical cancers is associated with cancer progression accompanied by increased infiltrations of Th17 cells and regulatory T cells as well as promoted tumor vasculogenesis.,24523865_6,-1,-1,-1,-1,22564,-1,0.0011515113,0.030478863,0.9683696
22579,to the,3,5,25,31,Our hypothesis according to the common dogma is that there is no HPV16 specific immune response in offspring of the CIN mother as she/he has not started the sexual life yet.,24524328_3,-1,-1,-1,-1,22579,-1,2.2088949e-05,0.99996865,9.219309e-06
22580,that there,8,10,48,58,Our hypothesis according to the common dogma is that there is no HPV16 specific immune response in offspring of the CIN mother as she/he has not started the sexual life yet.,24524328_3,-1,-1,-1,-1,22580,-1,2.404233e-05,0.99996555,1.0448308e-05
22584,life,29,30,164,168,Our hypothesis according to the common dogma is that there is no HPV16 specific immune response in offspring of the CIN mother as she/he has not started the sexual life yet.,24524328_3,0,-1,2,-1,22584,-1,7.2094e-05,0.99988437,4.3553966e-05
22585,peptides,9,10,39,47,"METHODS: We used overlapping 30-35 mer peptides covering the entire HPV16 E2, E6 and E7 protein sequences.",24524328_4,0,-1,2,-1,22585,-1,6.477257e-05,0.99985695,7.828725e-05
22587,protein,19,20,88,95,"METHODS: We used overlapping 30-35 mer peptides covering the entire HPV16 E2, E6 and E7 protein sequences.",24524328_4,0,1,-1,-1,22587,-1,0.0003131504,0.99909425,0.00059265934
22590,Foxp3+CD25+,10,17,85,99,"Assays for lymphocyte proliferation capacity, cytokine production and HPV16-specific Foxp3+CD25+CD4+ regulatory T-cells were performed.",24524328_5,-1,-1,-1,-1,22590,-1,0.0004048374,0.9985001,0.0010950257
22591,CD4,18,19,100,103,"Assays for lymphocyte proliferation capacity, cytokine production and HPV16-specific Foxp3+CD25+CD4+ regulatory T-cells were performed.",24524328_5,-1,-1,-1,-1,22591,-1,0.0008124026,0.00091444905,0.99827313
22593,T-cell,4,5,38,44,RESULTS: HPV16-specific proliferative T-cell responses were broader in children than in their mothers.,24524328_6,-1,1,2,-1,22593,-1,3.9918625e-05,5.790544e-05,0.9999021
22596,peptide,9,10,50,57,Nine of 10 children had responses against both E2 peptide pools compared to only 4 of the 10 mothers.,24524328_7,0,-1,2,-1,22596,-1,0.00040504563,0.9943457,0.005249197
22601,The cytokine,0,2,0,12,"The cytokine levels of IL-2 (p=0.023) and IL-5 (p=0.028) induced by all peptide pools, were also higher among children than their mothers.",24524328_9,-1,-1,-1,-1,22601,-1,0.22844918,0.766984,0.0045667966
22602,peptide,24,25,76,83,"The cytokine levels of IL-2 (p=0.023) and IL-5 (p=0.028) induced by all peptide pools, were also higher among children than their mothers.",24524328_9,0,-1,2,-1,22602,-1,0.00013012662,0.99947065,0.0003992582
22603,than their,32,34,123,133,"The cytokine levels of IL-2 (p=0.023) and IL-5 (p=0.028) induced by all peptide pools, were also higher among children than their mothers.",24524328_9,-1,-1,-1,-1,22603,-1,2.906489e-05,0.9999527,1.827831e-05
22607,TNF-,20,21,94,99,The children of the mothers with incident CIN3 had significantly higher IFN- (p=0.032) and TNF- (p=0.008) levels than other children.,24524328_10,0,1,-1,-1,22607,-1,5.6756315e-05,0.99991345,2.9738563e-05
22612,immunity,15,16,87,95,CONCLUSIONS: Our study is the first to show that also children could have HPV-specific immunity.,24524328_11,0,-1,2,-1,22612,-1,0.99888974,0.0007192616,0.00039099084
22614,that the,3,5,20,28,These data indicate that the children have circulating HPV16-specific memory T-cells which might have been induced by previous HPV16 exposure or ongoing HPV 16 infection.,24524328_12,-1,-1,-1,-1,22614,-1,1.7393771e-05,0.99997413,8.4681915e-06
22615,T-cells,10,11,77,84,These data indicate that the children have circulating HPV16-specific memory T-cells which might have been induced by previous HPV16 exposure or ongoing HPV 16 infection.,24524328_12,-1,1,2,-1,22615,-1,0.00017944282,0.0024242706,0.99739635
22618,the generation,15,17,116,130,Development of effective immune therapies for cancer patients requires better understanding of hurdles that prevent the generation of effective antitumor immune responses.,24532578_0,-1,-1,-1,-1,22618,-1,2.2994516e-05,0.9999677,9.348662e-06
22620,immunity,10,11,80,88,Administration of -galactosylceramide (-GalCer) in animals enhances antitumor immunity via activation of the invariant NKT (iNKT) cells.,24532578_1,0,-1,2,-1,22620,-1,0.9893923,0.009916281,0.00069140736
22630,that the tuberous sclerosis,5,9,24,51,"We report in this study that the tuberous sclerosis 1 (TSC1), a negative regulator of mTOR signaling, plays a crucial role in iNKT cell anergy.",24532578_4,-1,-1,-1,-1,22630,-1,2.1584645e-05,0.9999666,1.1773089e-05
22634,Deficiency,0,1,0,10,"Deficiency of TSC1 in iNKT cells results in resistance to -GalCer-induced anergy, manifested by increased expansion of and cytokine production by iNKT cells in response to secondary Ag stimulation.",24532578_5,0,1,-1,-1,22634,-1,4.5063145e-05,0.999907,4.788902e-05
22644,immunity,8,9,63,71,"Moreover, TSC1-deficient iNKT cells display enhanced antitumor immunity in a melanoma lung metastasis model.",24532578_7,0,-1,2,-1,22644,-1,0.9989396,0.0007689959,0.00029139203
22646,therapy,12,13,78,85,Our data suggest targeting TSC1/2 as a strategy for boosting antitumor immune therapy.,24532578_8,0,1,-1,-1,22646,-1,2.8803292e-05,0.9999571,1.4156487e-05
22653,their receptor,37,39,234,248,"Hepatocyte growth factor, produced by stromal and follicular dendritic cells, and present at high concentrations in the sera of patients with chronic lymphocytic leukemia, prolongs the survival of leukemic B cells by interacting with their receptor, c-MET.",24561793_0,-1,-1,-1,-1,22653,-1,0.0017701199,0.9599808,0.03824905
22657,to the,23,25,151,157,"It is, however, unknown whether hepatocyte growth factor influences microenvironmental cells, such as nurse-like cells, which deliver survival signals to the leukemic clone.",24561793_1,-1,-1,-1,-1,22657,-1,2.5443085e-05,0.9999616,1.29689715e-05
22668,hepatocyte growth factor treatment,14,18,109,143,"Indoleamine 2,3-dioxygenase, an enzyme modulating T-cell proliferation and induced on normal monocytes after hepatocyte growth factor treatment, was detected together with interleukin-10 on nurse-like cells, and on freshly-prepared patients' monocytes.",24561793_5,-1,-1,-1,-1,22668,-1,0.1787848,0.81198084,0.009234405
22691,T-cell,24,25,161,167,Hepatocyte growth factor may thus have a dual pathophysiological role: directly through enhancement of survival of the leukemic clone and indirectly by favoring T-cell immunosuppression.,24561793_9,-1,1,2,-1,22691,-1,3.499615e-05,5.1424227e-05,0.9999136
22694,T-cell,13,14,75,81,Transforming growth factor beta (TGF-) has an important role in mediating T-cell suppression in B-cell non-Hodgkin lymphoma (NHL).,24569779_0,-1,1,2,-1,22694,-1,3.5771824e-05,5.212414e-05,0.99991214
22702,Tm cells,16,18,87,95,"As reported here, we show that exhaustion is a major mechanism by which TGF- inhibits Tm cells, and TGF- mediated exhaustion is associated with upregulation of CD70.",24569779_2,-1,-1,-1,-1,22702,-1,7.3829855e-05,0.00021431533,0.9997118
22704,that TGF-,2,4,9,19,We found that TGF- upregulates CD70 expression on effector Tm cells while it preferentially induces Foxp3 expression in naive T cells.,24569779_3,-1,-1,-1,-1,22704,-1,3.0870677e-05,0.9999573,1.1783807e-05
22705,Tm cells,9,11,60,68,We found that TGF- upregulates CD70 expression on effector Tm cells while it preferentially induces Foxp3 expression in naive T cells.,24569779_3,-1,-1,-1,-1,22705,-1,7.5023716e-05,0.00019855857,0.99972636
22707,naive T cells,18,21,121,134,We found that TGF- upregulates CD70 expression on effector Tm cells while it preferentially induces Foxp3 expression in naive T cells.,24569779_3,-1,-1,-1,-1,22707,-1,0.003380247,0.10027301,0.8963466
22712,Tm cells,10,12,63,71,CD70+ T cells account for TGF--induced exhaustion of effector Tm cells.,24569779_5,-1,-1,-1,-1,22712,-1,6.725865e-05,0.00013485645,0.999798
22714,Tm cells,8,10,63,71,Both TGF--induced and preexisting intratumoral CD70+ effector Tm cells from B-cell NHL have an exhausted phenotype and express higher levels of PD-1 and TIM-3 compared with CD70- T cells.,24569779_6,-1,-1,-1,-1,22714,-1,3.7810365e-05,6.2486964e-05,0.99989974
22719,these cells,11,13,90,101,"Signaling transduction, proliferation and cytokine production are profoundly decreased in these cells, and they are highly susceptible to apoptosis.",24569779_7,-1,-1,-1,-1,22719,-1,0.0021926193,0.12175444,0.87605304
22726,Tm cell,5,7,47,54,These findings confirm TGF--mediated effector Tm cell exhaustion as an important mechanism of immune suppression in B-cell NHL.,24569779_9,-1,-1,-1,-1,22726,-1,3.991016e-05,4.7773592e-05,0.99991226
22732,relevant to the,1,4,11,26,"Biomarkers relevant to the antitumor effects of IL-2 that may be altered by sorafenib including the percentages of natural T-regulatory cells (Tregs), myeloid-derived suppressor cells (MDSC), and STAT5 phosphorylation (pSTAT5) in T cells were evaluated.",24598448_1,-1,-1,-1,-1,22732,-1,2.5551204e-05,0.999962,1.2458102e-05
22735,natural T-regulatory cells,18,21,115,141,"Biomarkers relevant to the antitumor effects of IL-2 that may be altered by sorafenib including the percentages of natural T-regulatory cells (Tregs), myeloid-derived suppressor cells (MDSC), and STAT5 phosphorylation (pSTAT5) in T cells were evaluated.",24598448_1,-1,-1,-1,-1,22735,-1,0.0046360157,0.47489902,0.5204649
22740,that the,2,4,16,24,We hypothesized that the proposed treatment schedule is feasible and safe and may lead to enhanced tumor response.,24598448_2,-1,-1,-1,-1,22740,-1,1.7790926e-05,0.9999752,7.028296e-06
22749,blood,16,17,82,87,"The percentage of Tregs, MDSC, and pSTAT5 in T cells were evaluated in peripheral blood by flow cytometry.",24598448_6,0,1,-1,-1,22749,-1,0.0015824965,0.64494556,0.3534719
22752,toxicity,9,10,59,67,Twelve of the 18 patients were evaluable for dose-limiting toxicity.,24598448_7,0,1,-1,-1,22752,-1,7.6771714e-05,0.9997615,0.00016171973
22753,toxicity,2,3,17,25,No dose-limiting toxicity was observed.,24598448_8,0,1,-1,-1,22753,-1,7.678682e-05,0.9997905,0.00013276484
22754,The treatment-related toxicity,0,3,0,30,The treatment-related toxicity was predictable and did not seem to be additive with this schedule of administration.,24598448_9,-1,-1,-1,-1,22754,-1,3.733631e-05,0.99993896,2.3666023e-05
22762,T-cell,20,21,109,115,HD IL-2 followed by sorafenib was safe and feasible in patients with MM and RCC and did not adversely affect T-cell signaling through STAT5 in response to IL-2.,24598448_12,-1,1,2,-1,22762,-1,3.6995898e-05,5.561009e-05,0.9999074
22763,through STAT5,22,24,126,139,HD IL-2 followed by sorafenib was safe and feasible in patients with MM and RCC and did not adversely affect T-cell signaling through STAT5 in response to IL-2.,24598448_12,-1,-1,-1,-1,22763,-1,2.9277702e-05,0.9999486,2.211127e-05
22767,tissues,15,16,104,111,"Kras(G12D/+);Trp53(R172H/+);Pdx-1-Cre (KPC) mice, which express an activated form of Kras in pancreatic tissues, develop pancreatic intraepithelial neoplasms (PanIN) that progress to pancreatic ductal adenocarcinoma (PDA).",24607504_1,-1,1,2,-1,22767,-1,0.0018056603,0.5947963,0.403398
22772,T-cell immunity,30,32,198,213,We used these mice to study immune suppression in PDA.METHODS: We immunized KPC and Kras(G12D/+);Pdx-1-Cre mice with attenuated intracellular Listeria monocytogenes (which induces CD4(+) and CD8(+) T-cell immunity) engineered to express Kras(G12D) (LM-Kras).,24607504_2,-1,-1,-1,-1,22772,-1,0.0050536627,0.0006683121,0.9942781
22780,tissues,8,9,52,59,"Survival times were measured; pancreatic and spleen tissues were collected and analyzed by histologic, flow cytometry, andimmunohistochemical analyses.",24607504_4,-1,1,2,-1,22780,-1,0.0006523982,0.9539243,0.045423284
22782,T-cell,7,8,39,45,"RESULTS: Interferon -mediated, CD8(+) T-cell responses were observed in KPC and Kras(G12D/+);Pdx-1-Cre mice given LM-Kras, but not in unvaccinated mice.",24607504_5,-1,1,2,-1,22782,-1,3.739787e-05,5.946287e-05,0.9999031
22793,T cells that,25,28,148,160,"The combination of LM-Kras and Treg cell depletion reduced numbers of Foxp3(+)CD4(+) T cells in pancreatic lymph nodes, increased numbers of CD4(+) T cells that secrete interleukin 17 and interferon , and caused CD11b(+)Gr1(+) cells in the pancreas to acquire an immunostimulatory phenotype.",24607504_8,-1,-1,-1,-1,22793,-1,0.001449646,0.024846291,0.973704
22812,tumor cell,27,29,167,177,"In this study, we have analyzed the in vitro immunomodulatory potential of a non-toxic neem leaf glycoprotein (NLGP) in reprogramming Stage III supraglottic laryngeal tumor cell lysate (SLTCL) induced M2 TAMs to their classical anti-tumor shape (M1).",24607970_1,-1,-1,-1,-1,22812,-1,0.004212064,0.31730995,0.67847794
22813,TAMs to their,35,38,204,217,"In this study, we have analyzed the in vitro immunomodulatory potential of a non-toxic neem leaf glycoprotein (NLGP) in reprogramming Stage III supraglottic laryngeal tumor cell lysate (SLTCL) induced M2 TAMs to their classical anti-tumor shape (M1).",24607970_1,-1,-1,-1,-1,22813,-1,2.2048362e-05,0.9999653,1.2671178e-05
22821,functions,25,26,172,181,"Data generated from this study support that NLGP is effective in preventing the SLTCL induced generation (CD68(+)CD206(+)IL-10(high) to CD68(+)CD206(-)IL-10(low) TAMs) and functions (NO(low) to NO(high), MHC-I(low) to MHC-I(high), CD80(low) to CD80(high)) of pro-tumorous M2 macrophages, which in turn associated with sustained anti-tumor effector functions by promoting cytotoxic T cell activities and suppressing regulatory T cells.",24607970_2,0,1,2,-1,22821,-1,0.00017360634,0.9996661,0.0001602746
22825,to CD80(high,41,43,241,253,"Data generated from this study support that NLGP is effective in preventing the SLTCL induced generation (CD68(+)CD206(+)IL-10(high) to CD68(+)CD206(-)IL-10(low) TAMs) and functions (NO(low) to NO(high), MHC-I(low) to MHC-I(high), CD80(low) to CD80(high)) of pro-tumorous M2 macrophages, which in turn associated with sustained anti-tumor effector functions by promoting cytotoxic T cell activities and suppressing regulatory T cells.",24607970_2,-1,-1,-1,-1,22825,-1,0.0022980038,0.9734821,0.024219882
22827,functions,58,59,348,357,"Data generated from this study support that NLGP is effective in preventing the SLTCL induced generation (CD68(+)CD206(+)IL-10(high) to CD68(+)CD206(-)IL-10(low) TAMs) and functions (NO(low) to NO(high), MHC-I(low) to MHC-I(high), CD80(low) to CD80(high)) of pro-tumorous M2 macrophages, which in turn associated with sustained anti-tumor effector functions by promoting cytotoxic T cell activities and suppressing regulatory T cells.",24607970_2,0,1,2,-1,22827,-1,0.0011004008,0.9829049,0.01599473
22832,targeted STAT3,17,19,111,125,"Furthermore, our data also suggest that NLGP prevents M2 skewness of TAMs by downregulating phosphorylation of targeted STAT3.",24607970_3,-1,-1,-1,-1,22832,-1,2.372593e-05,0.99996185,1.44288315e-05
22835,Tumor-associated lymphocytes,0,2,0,28,Tumor-associated lymphocytes as well as background lymphocytic thyroiditis are frequently mentioned in pathology reports of patients who have undergone surgery for thyroid cancer.,24623740_1,-1,-1,-1,-1,22835,-1,0.004064564,0.8451454,0.15079002
22836,lymphocytic thyroiditis,6,8,51,74,Tumor-associated lymphocytes as well as background lymphocytic thyroiditis are frequently mentioned in pathology reports of patients who have undergone surgery for thyroid cancer.,24623740_1,-1,-1,-1,-1,22836,-1,0.0020626513,0.014777561,0.98315984
22839,The nature,0,2,0,10,The nature of this lymphocytic reaction is not well understood.,24623740_2,-1,-1,-1,-1,22839,-1,3.4482095e-05,0.9999474,1.8044466e-05
22840,this lymphocytic,3,5,14,30,The nature of this lymphocytic reaction is not well understood.,24623740_2,-1,-1,-1,-1,22840,-1,0.0037458558,0.19519514,0.801059
22845,the lymphocytic,2,4,17,32,We characterized the lymphocytic infiltration that accompanies thyroid cancer and compared it with that present in thyroid autoimmunity.,24623740_4,-1,-1,-1,-1,22845,-1,0.0032083879,0.27028275,0.7265088
22859,cell type,16,18,85,94,"Although FOXP3(+) regulatory T cells were also present, DN T cells were the dominant cell type, associated with thyroid cancer.",24623740_6,-1,-1,-1,-1,22859,-1,6.849581e-05,0.00015608087,0.99977535
22867,that the,13,15,84,92,"CD25 expression on DN T cells remained unchanged after stimulation, which indicates that the increase in the absolute number of DN T cells in thyroid autoimmunity was at the expense of inactivation of single-positive T cells.",24623740_8,-1,-1,-1,-1,22867,-1,1.9538347e-05,0.99997187,8.623744e-06
22878,tumor immunity,16,18,82,96,"We concluded that in the setting of thyroid cancer, DN T cells appear to suppress tumor immunity.",24623740_9,-1,-1,-1,-1,22878,-1,0.021261137,0.9781672,0.00057173875
22885,that thyroid,5,7,34,46,"Together, these findings indicate that thyroid cancer-associated DN T cells might regulate proliferation and effector function of T cells and thereby contribute to tumor tolerance and active avoidance of tumor immunity.",24623740_11,-1,-1,-1,-1,22885,-1,2.1518323e-05,0.9999677,1.0762965e-05
22887,function,16,17,118,126,"Together, these findings indicate that thyroid cancer-associated DN T cells might regulate proliferation and effector function of T cells and thereby contribute to tumor tolerance and active avoidance of tumor immunity.",24623740_11,0,1,2,-1,22887,-1,0.0021214029,0.9627754,0.035103235
22890,to tumor tolerance,23,26,161,179,"Together, these findings indicate that thyroid cancer-associated DN T cells might regulate proliferation and effector function of T cells and thereby contribute to tumor tolerance and active avoidance of tumor immunity.",24623740_11,-1,-1,-1,-1,22890,-1,2.431819e-05,0.9999645,1.1234108e-05
22891,tumor immunity,30,32,204,218,"Together, these findings indicate that thyroid cancer-associated DN T cells might regulate proliferation and effector function of T cells and thereby contribute to tumor tolerance and active avoidance of tumor immunity.",24623740_11,-1,-1,-1,-1,22891,-1,0.049644154,0.9493306,0.0010252135
22898,tumor-related Treg subsets,2,5,16,42,The complicated tumor-related Treg subsets and their functional mechanisms are not fully addressed yet.,24668348_1,-1,-1,-1,-1,22898,-1,0.0033145787,0.85880667,0.13787872
22899,their functional,6,8,47,63,The complicated tumor-related Treg subsets and their functional mechanisms are not fully addressed yet.,24668348_1,-1,-1,-1,-1,22899,-1,4.0214192e-05,0.9999386,2.113379e-05
22900,Treg subset,7,9,54,65,"We have previously identified a novel CD4CD69Foxp3 Treg subset in tumor-bearing mice, which suppresses CD4 T cell response via membrane-bound transforming growth factor beta 1 (mTGF-1) and then promotes tumor progression.",24668348_2,-1,-1,-1,-1,22900,-1,0.0028073357,0.33610108,0.6610916
22909,T cells that,20,23,149,161,"In hepatocellular carcinoma patients, here, we identified tumor-infiltrating human CD4CD69 Tregs which represent ~67.2 % of tumor-infiltrating CD4 T cells that is significantly higher than conventional CD4CD25Foxp3 Tregs.",24668348_3,-1,-1,-1,-1,22909,-1,0.0017468178,0.033453133,0.9648
22922,tumor tissue,9,11,56,68,"Furthermore, the percentage of these CD4CD69 Tregs in tumor tissue was significantly correlated with tumor progression, which is more pronounced at the late stage of cancer patients.",24668348_6,-1,-1,-1,-1,22922,-1,3.0048792e-05,0.9999181,5.183733e-05
22928,these Tregs,22,24,155,166,"Thus, we have identified a tumor-induced new population of human CD4CD69 Tregs in cancer patients with phenotype of CD25Foxp3mTGF-1CTLA-4PD-1, and these Tregs can suppress antitumor immune response via mTGF-1.",24668348_7,-1,-1,-1,-1,22928,-1,2.1388625e-05,0.99996555,1.30301405e-05
22931,Treg subsets,8,10,42,54,"Our results not only enrich the family of Treg subsets, providing new mechanistic insight to tumor-induced immune suppression in human, but also suggest a potential target for cancer immunotherapy.",24668348_8,-1,-1,-1,-1,22931,-1,0.000280991,0.0035844445,0.99613464
22932,to tumor-induced,15,17,90,106,"Our results not only enrich the family of Treg subsets, providing new mechanistic insight to tumor-induced immune suppression in human, but also suggest a potential target for cancer immunotherapy.",24668348_8,-1,-1,-1,-1,22932,-1,3.06944e-05,0.99995744,1.1847453e-05
22935,These Treg cells,0,3,0,16,These Treg cells inhibit T cell response via membrane-bound TGF-.,24668348_10,-1,-1,-1,-1,22935,-1,0.0019891209,0.105641946,0.8923689
22939,these cells,3,5,18,29,The percentage of these cells was significantly correlated with tumor progression.,24668348_11,-1,-1,-1,-1,22939,-1,0.0002479644,0.0019100131,0.99784195
22942,these cells,3,5,18,29,The percentage of these cells was higher than conventional CD4CD25Foxp3 Tregs.,24668348_12,-1,-1,-1,-1,22942,-1,0.00031193695,0.0032736866,0.9964144
22945,These Treg cells,0,3,0,16,"These Treg cells not only exist in tumor-bearing mice, but also in cancer patients.",24668348_13,-1,-1,-1,-1,22945,-1,0.001797497,0.07485016,0.92335236
22950,the tumor,12,14,89,98,Increasing evidence suggests that communication between tumor and immune cells can alter the tumor microenvironment in ways that promote tumor development.,24676671_0,-1,-1,-1,-1,22950,-1,1.965043e-05,0.99997187,8.526396e-06
22956,the immune response,8,11,46,65,"The purpose of this study was to characterize the immune response elicited by TLR-9-activated OSCC cells, to identify the cytokines involved in the signaling pathway and to elucidate the molecular mechanism of this pathway in OSCC cells.",24676671_1,-1,-1,-1,-1,22956,-1,0.042943247,0.95651543,0.0005412996
22960,the cytokines,19,21,118,131,"The purpose of this study was to characterize the immune response elicited by TLR-9-activated OSCC cells, to identify the cytokines involved in the signaling pathway and to elucidate the molecular mechanism of this pathway in OSCC cells.",24676671_1,-1,-1,-1,-1,22960,-1,0.24667726,0.7485039,0.0048187873
22967,T-cell immune responses,11,14,58,81,"MTS, flow cytometry and ELISA assay were used to evaluate T-cell immune responses, cancer cell proliferation and pro-inflammatory cytokine secretion, respectively.",24676671_2,-1,-1,-1,-1,22967,-1,0.050643813,0.0019265829,0.9474296
22970,analysis,2,3,13,21,"Western blot analysis, EMSA and ChIP assay were employed to detect the activity of the NF-B and AP-1 signaling pathways.",24676671_3,0,1,-1,-1,22970,-1,2.79648e-05,0.99994826,2.3763017e-05
22975,T-cells,6,7,36,43,A marked response was observed when T-cells were co-cultured with supernatants from CpG-ODN-treated OSCC cells.,24676671_4,-1,1,2,-1,22975,-1,3.157655e-05,6.7105226e-05,0.9999013
22981,T-cell,23,24,128,134,This response was characterized by increased CD4+ and CD8+ T-cell proliferation and an increase in IFN- production by the CD4+ T-cell population.,24676671_5,-1,1,2,-1,22981,-1,2.9663728e-05,5.302317e-05,0.99991727
22986,to the IL-6,22,25,127,138,Treatment of OSCC cells with CpG-ODN resulted in an increase in IL-6 secretion as well as an increase in AP-1 binding activity to the IL-6 promoter.,24676671_6,-1,-1,-1,-1,22986,-1,0.088151366,0.9061612,0.005687428
22989,T-cell immune response,12,15,89,111,"Moreover, blockage of the TLR-9/AP-1 pathway significantly decreased IL-6 expression and T-cell immune response.",24676671_7,-1,-1,-1,-1,22989,-1,0.14335325,0.0034255297,0.8532212
22990,the TLR-9,4,6,15,24,"In human OSCC, the TLR-9 pathway, when stimulated by CpG-ODNs, promotes a T-cell immune response mediated by AP-1-activated IL-6 secretion.",24676671_8,-1,-1,-1,-1,22990,-1,4.0678002e-05,0.99993336,2.5968508e-05
22991,T-cell immune response,15,18,74,96,"In human OSCC, the TLR-9 pathway, when stimulated by CpG-ODNs, promotes a T-cell immune response mediated by AP-1-activated IL-6 secretion.",24676671_8,-1,-1,-1,-1,22991,-1,0.09358028,0.0028811728,0.9035385
22992,AP-1-activated IL-6,20,22,109,128,"In human OSCC, the TLR-9 pathway, when stimulated by CpG-ODNs, promotes a T-cell immune response mediated by AP-1-activated IL-6 secretion.",24676671_8,-1,-1,-1,-1,22992,-1,0.12738433,0.8663728,0.006242829
22996,tumor cell,16,18,108,118,"Although the complete molecular mechanism has yet to be understood, these findings provide evidence linking tumor cell activities to immune system responses.",24676671_9,-1,-1,-1,-1,22996,-1,0.003426245,0.23484029,0.7617335
22999,therapeutic targets,8,10,54,73,"In addition, the TLR-9/AP-1/IL-6 pathway provides new therapeutic targets for the prevention and treatment of OSCC.",24676671_10,-1,-1,-1,-1,22999,-1,2.2501896e-05,0.9999665,1.1009008e-05
23005,to treat,32,34,208,216,"ETHNOPHARMACOLOGICAL RELEVANCE: The larvae of Musca domestica (Diptera: Muscidae) have been used traditionally for malnutritional stagnation, decubital necrosis, osteomyelitis, ecthyma and lip scald and also to treat coma and gastric cancer in the traditional Chinese medicine.",24690776_0,-1,-1,-1,-1,23005,-1,2.6856998e-05,0.9999621,1.102842e-05
23006,the traditional,39,41,244,259,"ETHNOPHARMACOLOGICAL RELEVANCE: The larvae of Musca domestica (Diptera: Muscidae) have been used traditionally for malnutritional stagnation, decubital necrosis, osteomyelitis, ecthyma and lip scald and also to treat coma and gastric cancer in the traditional Chinese medicine.",24690776_0,-1,-1,-1,-1,23006,-1,2.7745089e-05,0.99995697,1.534632e-05
23007,relation to the traditional,12,16,77,104,Its in vitro antitumor activity and immunomodulatory effect in nave mice in relation to the traditional uses were also reported.,24690776_1,-1,-1,-1,-1,23007,-1,3.4659297e-05,0.9999491,1.6208833e-05
23010,mechanism of action,12,15,61,80,"However, the in vivo antitumor effect of this insect and its mechanism of action have not yet been well studied.",24690776_2,0,1,-1,-1,23010,-1,8.012943e-05,0.999882,3.7829675e-05
23015,the peptide,14,16,81,92,The objectives of this study were to evaluate the in vivo antitumor potential of the peptide fraction from Musca domestica larvae (MDPF) and to elucidate its immunological mechanisms.,24690776_3,-1,-1,-1,-1,23015,-1,5.780743e-05,0.99989796,4.4263015e-05
23039,Th1 transcription factors T-bet,17,21,114,145,MDPF also significantly promoted the production of IFN- and up-regulated the mRNA expression levels of IFN- and Th1 transcription factors T-bet and STAT-4 in splenocytes from the S180-bearing mice.,24690776_7,-1,-1,-1,-1,23039,-1,2.6726106e-05,0.999943,3.0243373e-05
23042,Th2 cytokine IL-10,2,5,9,27,"However, Th2 cytokine IL-10 and transcription factors GATA-3 and STAT-6 were not significantly changed both at transcriptional and protein levels following MDPF treatment.",24690776_8,-1,-1,-1,-1,23042,-1,0.82036036,0.16942386,0.010215772
23043,transcription factors GATA-3,6,9,32,60,"However, Th2 cytokine IL-10 and transcription factors GATA-3 and STAT-6 were not significantly changed both at transcriptional and protein levels following MDPF treatment.",24690776_8,-1,-1,-1,-1,23043,-1,4.3929012e-05,0.99991465,4.139847e-05
23046,protein,19,20,131,138,"However, Th2 cytokine IL-10 and transcription factors GATA-3 and STAT-6 were not significantly changed both at transcriptional and protein levels following MDPF treatment.",24690776_8,0,1,-1,-1,23046,-1,3.7684305e-05,0.99993527,2.7090364e-05
23049,transplantable tumor,8,10,54,74,CONCLUSIONS: MDPF significantly inhibit the growth of transplantable tumor in mice and its in vivo antitumor activity might be achieved by switching-on of Th1-based protective cell-mediated immunity.,24690776_9,-1,-1,-1,-1,23049,-1,2.500441e-05,0.999962,1.29898945e-05
23053,peptide,7,8,37,44,"Here, we sought to determine whether peptide vaccines designed harbor both class I as well as class II restricted antigenic motifs could concurrently induce CD4 and CD8 T cell activation against autologous tumor antigens.",24690990_0,0,-1,2,-1,23053,-1,3.82291e-05,0.9999423,1.9439876e-05
23056,tumor antigens,33,35,206,220,"Here, we sought to determine whether peptide vaccines designed harbor both class I as well as class II restricted antigenic motifs could concurrently induce CD4 and CD8 T cell activation against autologous tumor antigens.",24690990_0,-1,-1,-1,-1,23056,-1,0.32676256,0.6654566,0.007780851
23057,tissues to,10,12,70,80,"Based on our prior genome-wide interrogation of human prostate cancer tissues to identify genes over-expressed in cancer and absent in the periphery, we targeted SIM2 as a prototype autologous tumor antigen for these studies.",24690990_1,-1,-1,-1,-1,23057,-1,3.2503434e-05,0.9999244,4.3035958e-05
23062,tumor antigen,30,32,193,206,"Based on our prior genome-wide interrogation of human prostate cancer tissues to identify genes over-expressed in cancer and absent in the periphery, we targeted SIM2 as a prototype autologous tumor antigen for these studies.",24690990_1,-1,-1,-1,-1,23062,-1,0.46197912,0.5133606,0.024660246
23065,that the,6,8,41,49,"Using humanized transgenic mice we found that the 9aa HLA-A*0201 epitope, SIM2(237-245), was effective at inducing an antigen specific response against SIM2-expressing prostate cancer cell line, PC3.",24690990_2,-1,-1,-1,-1,23065,-1,1.7494784e-05,0.99997294,9.577267e-06
23068,peptide,4,5,34,41,"Immunization with a multi-epitope peptide harboring both MHC-I and MHC-II restricted epitopes induced an IFN- response in CD8 T cells to the HLA-A*0201-restricted SIM2(237-245) epitope, and an IL-2 response by CD4 T cells to the SIM2(240-254) epitope.",24690990_3,0,-1,2,-1,23068,-1,0.000305237,0.9993567,0.0003380538
23070,T cells to the,18,22,127,141,"Immunization with a multi-epitope peptide harboring both MHC-I and MHC-II restricted epitopes induced an IFN- response in CD8 T cells to the HLA-A*0201-restricted SIM2(237-245) epitope, and an IL-2 response by CD4 T cells to the SIM2(240-254) epitope.",24690990_3,-1,-1,-1,-1,23070,-1,0.0027137569,0.13133691,0.86594933
23071,T cells to the,35,39,215,229,"Immunization with a multi-epitope peptide harboring both MHC-I and MHC-II restricted epitopes induced an IFN- response in CD8 T cells to the HLA-A*0201-restricted SIM2(237-245) epitope, and an IL-2 response by CD4 T cells to the SIM2(240-254) epitope.",24690990_3,-1,-1,-1,-1,23071,-1,0.0027179006,0.119667776,0.8776143
23072,This peptide,0,2,0,12,This peptide was also effective at inducing CD8+ T-cells that responded specifically to SIM2-expressing tumor cells.,24690990_4,-1,-1,-1,-1,23072,-1,3.8474234e-05,0.9999465,1.49972275e-05
23073,T-cells that,9,11,49,61,This peptide was also effective at inducing CD8+ T-cells that responded specifically to SIM2-expressing tumor cells.,24690990_4,-1,-1,-1,-1,23073,-1,0.0016836427,0.3412285,0.65708786
23075,tumor cells,15,17,104,115,This peptide was also effective at inducing CD8+ T-cells that responded specifically to SIM2-expressing tumor cells.,24690990_4,-1,-1,-1,-1,23075,-1,0.0047018295,0.47409236,0.52120584
23079,peptide,12,13,69,76,"Collectively, the data presented in this study suggest that a single peptide containing multiple SIM2 epitopes can be used to induce both a CD4 and CD8 T cell response, providing a peptide-based vaccine formulation for potential use in immunotherapy of various cancers.",24690990_5,0,-1,2,-1,23079,-1,0.00012374435,0.9997384,0.00013788101
23082,peptide-based,33,34,181,194,"Collectively, the data presented in this study suggest that a single peptide containing multiple SIM2 epitopes can be used to induce both a CD4 and CD8 T cell response, providing a peptide-based vaccine formulation for potential use in immunotherapy of various cancers.",24690990_5,0,-1,2,-1,23082,-1,8.6168504e-05,0.99981827,9.557834e-05
23085,antigen-presenting cells,9,11,39,63,"Dendritic cells (DCs), the most potent antigen-presenting cells have been extensively applied in clinical trials for evaluation of antitumor immunity.",24690994_0,-1,-1,-1,-1,23085,-1,0.30063066,0.0028827381,0.6964866
23087,immunity,22,23,141,149,"Dendritic cells (DCs), the most potent antigen-presenting cells have been extensively applied in clinical trials for evaluation of antitumor immunity.",24690994_0,0,-1,2,-1,23087,-1,0.9978683,0.0015972516,0.0005345181
23095,generated IL-6 transgene-engineered,17,20,93,128,"In this study, we constructed a recombinant adenoviral vector (AdVIL-6) expressing IL-6, and generated IL-6 transgene-engineered DC vaccine (DCOVA/IL-6) by transfection of murine bone marrow-derived ovalbumin (OVA)-pulsed DCs (DCOVA) with AdVIL-6.",24690994_2,-1,-1,-1,-1,23095,-1,0.00049033813,0.99937963,0.00012994427
23100,immunity,12,13,92,100,We then assessed DCOVA/IL-6-stimulated cytotoxic T-lymphocyte (CTL) responses and antitumor immunity in OVA-specific animal tumor model.,24690994_3,0,-1,2,-1,23100,-1,0.99239606,0.0069095753,0.0006943363
23103,transgene-encoded IL-6,13,15,98,120,"We demonstrate that DCOVA/IL-6 vaccine up-regulates expression of DC maturation markers, secretes transgene-encoded IL-6, and more efficiently stimulates OVA-specific CTL responses and therapeutic immunity against OVA-expressing B16 melanoma BL6-10OVA in vivo than the control DCOVA/Null vaccine.",24690994_4,-1,-1,-1,-1,23103,-1,0.26759422,0.7246936,0.0077122035
23105,therapeutic immunity,24,26,185,205,"We demonstrate that DCOVA/IL-6 vaccine up-regulates expression of DC maturation markers, secretes transgene-encoded IL-6, and more efficiently stimulates OVA-specific CTL responses and therapeutic immunity against OVA-expressing B16 melanoma BL6-10OVA in vivo than the control DCOVA/Null vaccine.",24690994_4,-1,-1,-1,-1,23105,-1,0.013627638,0.9861041,0.00026829483
23106,than the,35,37,260,268,"We demonstrate that DCOVA/IL-6 vaccine up-regulates expression of DC maturation markers, secretes transgene-encoded IL-6, and more efficiently stimulates OVA-specific CTL responses and therapeutic immunity against OVA-expressing B16 melanoma BL6-10OVA in vivo than the control DCOVA/Null vaccine.",24690994_4,-1,-1,-1,-1,23106,-1,2.2082517e-05,0.99996734,1.0617196e-05
23112,that IL-6,5,7,28,37,"In addition, we demonstrate that IL-6 down-regulates Foxp3-expression of CD4+25+Foxp3+ Tr-cells in vitro.",24690994_6,-1,-1,-1,-1,23112,-1,0.6559474,0.33726874,0.0067838966
23115,Taken together,0,2,0,14,"Taken together, our results demonstrate that AdV-mediated IL-6 transgene-engineered DC vaccine stimulates potent CTL responses and antitumor immunity by counteracting CD4+25+ Tr immunosuppression via IL-6-induced Foxp3 down-regulation.",24690994_7,-1,-1,-1,-1,23115,-1,4.4667842e-05,0.99993765,1.7694356e-05
23117,IL-6 transgene-engineered,8,10,58,83,"Taken together, our results demonstrate that AdV-mediated IL-6 transgene-engineered DC vaccine stimulates potent CTL responses and antitumor immunity by counteracting CD4+25+ Tr immunosuppression via IL-6-induced Foxp3 down-regulation.",24690994_7,-1,-1,-1,-1,23117,-1,0.96993554,0.02510964,0.004954728
23119,immunity,18,19,141,149,"Taken together, our results demonstrate that AdV-mediated IL-6 transgene-engineered DC vaccine stimulates potent CTL responses and antitumor immunity by counteracting CD4+25+ Tr immunosuppression via IL-6-induced Foxp3 down-regulation.",24690994_7,0,-1,2,-1,23119,-1,0.9898962,0.009556383,0.00054743607
23121,IL-6-induced Foxp3,28,30,200,218,"Taken together, our results demonstrate that AdV-mediated IL-6 transgene-engineered DC vaccine stimulates potent CTL responses and antitumor immunity by counteracting CD4+25+ Tr immunosuppression via IL-6-induced Foxp3 down-regulation.",24690994_7,-1,-1,-1,-1,23121,-1,0.97173834,0.024442147,0.0038194545
23125,functions,20,21,134,143,"Epstein-Barr virus (EBV) infection has been observed in tumor-infiltrated macrophages, but its infection effects on macrophage immune functions are poorly understood.",24696473_0,0,1,2,-1,23125,-1,0.23375979,0.51678246,0.24945775
23127,the tumor,8,10,41,50,"Here, we showed that some macrophages in the tumor stroma of nasopharyngeal carcinoma (NPC) tissue expressed the immunosuppressive protein indoleamine 2,3-dioxygenase (IDO) more strongly than did tumor cells.",24696473_1,-1,-1,-1,-1,23127,-1,1.8495462e-05,0.9999716,9.921778e-06
23129,tissue,17,18,92,98,"Here, we showed that some macrophages in the tumor stroma of nasopharyngeal carcinoma (NPC) tissue expressed the immunosuppressive protein indoleamine 2,3-dioxygenase (IDO) more strongly than did tumor cells.",24696473_1,-1,1,2,-1,23129,-1,2.9933954e-05,0.99992096,4.913517e-05
23131,protein,21,22,131,138,"Here, we showed that some macrophages in the tumor stroma of nasopharyngeal carcinoma (NPC) tissue expressed the immunosuppressive protein indoleamine 2,3-dioxygenase (IDO) more strongly than did tumor cells.",24696473_1,0,1,-1,-1,23131,-1,9.5316784e-05,0.99981683,8.783347e-05
23133,tumor cells,31,33,196,207,"Here, we showed that some macrophages in the tumor stroma of nasopharyngeal carcinoma (NPC) tissue expressed the immunosuppressive protein indoleamine 2,3-dioxygenase (IDO) more strongly than did tumor cells.",24696473_1,-1,-1,-1,-1,23133,-1,0.0027442717,0.19776319,0.79949254
23134,protein,5,6,28,35,"EBV infection induced mRNA, protein, and enzymatic activity of IDO in human monocyte-derived macrophages (MDMs).",24696473_2,0,1,-1,-1,23134,-1,9.3588846e-05,0.99982697,7.941509e-05
23137,TNF-,10,11,67,72,"Infection increased the production of tumor necrosis factor alpha (TNF-) and interleukin-6 (IL-6), whereas the neutralizing antibodies against TNF- and IL-6 inhibited IDO induction.",24696473_3,0,1,-1,-1,23137,-1,6.1514016e-05,0.9999119,2.6531206e-05
23141,TNF-,23,24,144,149,"Infection increased the production of tumor necrosis factor alpha (TNF-) and interleukin-6 (IL-6), whereas the neutralizing antibodies against TNF- and IL-6 inhibited IDO induction.",24696473_3,0,1,-1,-1,23141,-1,6.811368e-05,0.9999001,3.173316e-05
23144,protein,6,7,51,58,"EBV infection also activated the mitogen-activated protein kinase (MAPK) p38 and NF-B, and the inhibition of these two pathways with SB202190 and SN50 almost abrogated TNF- and IL-6 production and inhibited IDO production.",24696473_4,0,1,-1,-1,23144,-1,5.1611427e-05,0.999889,5.9341597e-05
23146,these two,19,21,110,119,"EBV infection also activated the mitogen-activated protein kinase (MAPK) p38 and NF-B, and the inhibition of these two pathways with SB202190 and SN50 almost abrogated TNF- and IL-6 production and inhibited IDO production.",24696473_4,-1,-1,-1,-1,23146,-1,3.5010282e-05,0.9999473,1.762655e-05
23147,TNF-,28,29,169,174,"EBV infection also activated the mitogen-activated protein kinase (MAPK) p38 and NF-B, and the inhibition of these two pathways with SB202190 and SN50 almost abrogated TNF- and IL-6 production and inhibited IDO production.",24696473_4,0,1,-1,-1,23147,-1,0.000102068036,0.9998673,3.0606338e-05
23157,function,48,49,277,285,"Moreover, the activation of IDO in response to EBV infection of MDMs suppressed the proliferation of T cells and impaired the cytotoxic activity of CD8(+) T cells, whereas the inhibition of IDO activity with 1-methyl-l-tryptophan (1-MT) did not affect T cell proliferation and function.",24696473_5,0,1,2,-1,23157,-1,0.0029437186,0.3023797,0.6946766
23161,TNF--dependent,15,16,103,118,"These findings indicate that EBV-induced IDO expression in MDMs is substantially mediated by IL-6- and TNF--dependent mechanisms via the p38/MAPK and NF-B pathways, suggesting that a possible role of EBV-mediated IDO expression in tumor stroma of NPC may be to create a microenvironment of suppressed T cell immune responses.",24696473_6,0,1,-1,-1,23161,-1,0.00014453419,0.9997948,6.073466e-05
23166,T cell immune responses,46,50,303,326,"These findings indicate that EBV-induced IDO expression in MDMs is substantially mediated by IL-6- and TNF--dependent mechanisms via the p38/MAPK and NF-B pathways, suggesting that a possible role of EBV-mediated IDO expression in tumor stroma of NPC may be to create a microenvironment of suppressed T cell immune responses.",24696473_6,-1,-1,-1,-1,23166,-1,0.2629862,0.0030278119,0.733986
23171,tumor cells,22,24,120,131,IMPORTANCE: CD8(+) cytotoxic T lymphocytes (CTLs) play an important role in the control of viral infections and destroy tumor cells.,24696473_7,-1,-1,-1,-1,23171,-1,0.004240352,0.33005482,0.66570485
23172,the tryptophan-catabolizing,2,4,14,41,"Activation of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO) in cancer tissues facilitates immune escape by the impairment of CTL functions.",24696473_8,-1,-1,-1,-1,23172,-1,7.651204e-05,0.99989533,2.8169014e-05
23173,tissues,12,13,93,100,"Activation of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO) in cancer tissues facilitates immune escape by the impairment of CTL functions.",24696473_8,-1,1,2,-1,23173,-1,3.0198245e-05,0.99993277,3.6987174e-05
23175,CTL functions,20,22,148,161,"Activation of the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO) in cancer tissues facilitates immune escape by the impairment of CTL functions.",24696473_8,-1,-1,-1,-1,23175,-1,0.000103358456,0.00017160224,0.99972504
23176,the tumor,8,10,51,60,"IDO expression was observed in some macrophages of the tumor stroma of nasopharyngeal carcinoma (NPC) tissue, and IDO could be induced in Epstein-Barr virus (EBV)-infected human monocyte-derived macrophages (MDMs).",24696473_9,-1,-1,-1,-1,23176,-1,1.9781053e-05,0.99996924,1.0932744e-05
23178,tissue,17,18,102,108,"IDO expression was observed in some macrophages of the tumor stroma of nasopharyngeal carcinoma (NPC) tissue, and IDO could be induced in Epstein-Barr virus (EBV)-infected human monocyte-derived macrophages (MDMs).",24696473_9,-1,1,2,-1,23178,-1,8.276482e-05,0.9991468,0.000770435
23183,TNF--dependent,13,14,83,98,"Instead, EBV-induced IDO expression in MDMs is substantially mediated by IL-6- and TNF--dependent mechanisms via the p38/MAPK and NF-B pathways, which suppressed the proliferation of T cells and impaired the cytotoxic activity of CD8(+) T cells.",24696473_11,0,1,-1,-1,23183,-1,0.00038418255,0.99949515,0.00012067888
23198,The zinc-finger protein,0,3,0,23,"The zinc-finger protein A20, a negative regulator of the nuclear factor (NF)-B pathway, was found to play a crucial role in controlling the maturation and function of human monocyte-derived DCs.",24713261_1,-1,-1,-1,-1,23198,-1,4.031059e-05,0.9999248,3.4852088e-05
23199,the nuclear factor,9,12,53,71,"The zinc-finger protein A20, a negative regulator of the nuclear factor (NF)-B pathway, was found to play a crucial role in controlling the maturation and function of human monocyte-derived DCs.",24713261_1,-1,-1,-1,-1,23199,-1,2.2767237e-05,0.99996316,1.4114903e-05
23200,to play,17,19,99,106,"The zinc-finger protein A20, a negative regulator of the nuclear factor (NF)-B pathway, was found to play a crucial role in controlling the maturation and function of human monocyte-derived DCs.",24713261_1,-1,-1,-1,-1,23200,-1,1.9667494e-05,0.99997103,9.273925e-06
23202,function,27,28,156,164,"The zinc-finger protein A20, a negative regulator of the nuclear factor (NF)-B pathway, was found to play a crucial role in controlling the maturation and function of human monocyte-derived DCs.",24713261_1,0,1,2,-1,23202,-1,8.042865e-05,0.99986887,5.063668e-05
23213,receptor-interacting protein,2,4,14,42,"Additionally, receptor-interacting protein (RIP) and the NF-Bp65 pathway were elevated in AML-DCs when A20 was reduced.",24713261_6,-1,-1,-1,-1,23213,-1,0.00030177025,0.99813336,0.0015649358
23217,through the,30,32,211,222,"Hence, this study identified A20 as a negative regulator for controlling AML-DC maturation and immunostimulatory potency, as A20 down-regulation resulted in AML-DCs with enhanced autologous CTLs immune capacity through the NF-B pathway.",24713261_7,-1,-1,-1,-1,23217,-1,2.3610313e-05,0.99996257,1.3803594e-05
23227,function,8,9,47,55,"However, cytokine production may saturate as a function of antigen input, or be dominated by the precursor frequency of antigen-specific T cells.",24719192_2,0,1,2,-1,23227,-1,0.00019829968,0.99967,0.00013164635
23229,the precursor,17,19,93,106,"However, cytokine production may saturate as a function of antigen input, or be dominated by the precursor frequency of antigen-specific T cells.",24719192_2,-1,-1,-1,-1,23229,-1,0.0042798882,0.52517736,0.47054273
23230,antigen-specific T cells,21,24,120,144,"However, cytokine production may saturate as a function of antigen input, or be dominated by the precursor frequency of antigen-specific T cells.",24719192_2,-1,-1,-1,-1,23230,-1,0.3456922,0.003340909,0.6509669
23231,that T cells,4,7,23,35,"Surprisingly, we found that T cells scale their collective output of IL-2 to total antigen input over a large dynamic range, independently of population size.",24719192_3,-1,-1,-1,-1,23231,-1,0.0025287278,0.16151555,0.8359558
23233,to total antigen,13,16,74,90,"Surprisingly, we found that T cells scale their collective output of IL-2 to total antigen input over a large dynamic range, independently of population size.",24719192_3,-1,-1,-1,-1,23233,-1,0.080526724,0.91450477,0.0049684304
23235,that this,9,11,77,86,"Through experimental quantitation and computational modeling, we demonstrate that this scaling is enforced by an inhibitory cross-talk between antigen and IL-2 signaling, and a nonlinear acceleration of IL-2 secretion per cell.",24719192_4,-1,-1,-1,-1,23235,-1,1.783112e-05,0.99997354,8.653433e-06
23245,immunity,20,21,111,119,"Newly identified nuocytes or group 2 innate lymphoid cells (ILC2s) play an important role in Th2 cell mediated immunity such as protective immune responses to helminth parasites, allergic asthma, and chronic rhinosinusitis.",24741632_0,0,-1,2,-1,23245,-1,0.99961686,0.00021185612,0.00017122862
23246,immune responses to,24,27,139,158,"Newly identified nuocytes or group 2 innate lymphoid cells (ILC2s) play an important role in Th2 cell mediated immunity such as protective immune responses to helminth parasites, allergic asthma, and chronic rhinosinusitis.",24741632_0,-1,-1,-1,-1,23246,-1,0.94302225,0.055269256,0.0017085463
23249,that there,4,6,25,35,Our previous study found that there was a predominant Th2 phenotype in patients with gastric cancer.,24741632_2,-1,-1,-1,-1,23249,-1,1.9101164e-05,0.9999709,9.947067e-06
23253,related genes,6,8,25,38,"In this study, the ILC2s related genes or molecules in PBMC from patients with gastric cancer were measured, and the potential correlation between them was analyzed.",24741632_3,-1,-1,-1,-1,23253,-1,6.200423e-05,0.9998148,0.00012324183
23262,related factors,54,56,275,290,"The expression levels of ROR, GATA3, T1/ST2, IL-17RB, CRTH2, IL-33, IL-5, and IL-4 mRNA were significantly increased in patients, but no significant changes were found in ICOS, CD45, and IL-13 expression, and there was a positive correlation between ROR or IL-13 and other related factors, such as ICOS and CD45.",24741632_4,-1,-1,-1,-1,23262,-1,0.00059400615,0.998971,0.00043506274
23266,that there,3,5,24,34,These results suggested that there are polarized ILC2s in gastric cancer patients which might contribute to immunosuppressive microenvironment and closely related to the upregulation of MDSCs and M2 macrophages.,24741632_7,-1,-1,-1,-1,23266,-1,1.8891851e-05,0.999972,9.09737e-06
23268,related to the,20,23,155,169,These results suggested that there are polarized ILC2s in gastric cancer patients which might contribute to immunosuppressive microenvironment and closely related to the upregulation of MDSCs and M2 macrophages.,24741632_7,-1,-1,-1,-1,23268,-1,2.7009406e-05,0.9999589,1.4118385e-05
23271,through their,13,15,74,87,Foxp3(+) Tregs have been known as a major regulator of immune homeostasis through their immunosuppressive function.,24744433_0,-1,-1,-1,-1,23271,-1,2.3310557e-05,0.9999635,1.3112663e-05
23272,function,16,17,106,114,Foxp3(+) Tregs have been known as a major regulator of immune homeostasis through their immunosuppressive function.,24744433_0,0,1,2,-1,23272,-1,9.75455e-05,0.9998233,7.918913e-05
23274,T cell subset that,6,10,25,43,Th17 lineage is a CD4(+) T cell subset that exerts its function by secreting proinflammatory cytokines and protecting host against microbial infections.,24744433_1,-1,-1,-1,-1,23274,-1,0.0011075394,0.016788697,0.98210377
23275,function,12,13,55,63,Th17 lineage is a CD4(+) T cell subset that exerts its function by secreting proinflammatory cytokines and protecting host against microbial infections.,24744433_1,0,1,2,-1,23275,-1,8.706015e-05,0.99985886,5.4015753e-05
23280,Th17 cells plays,8,11,45,61,The altered ratio between Foxp3(+) Tregs and Th17 cells plays an important role in the pathogenesis of immune-related diseases.,24744433_2,-1,-1,-1,-1,23280,-1,0.000296675,0.99734855,0.002354812
23282,that Tregs,7,9,48,58,"Recent mice and human studies have demonstrated that Tregs can be reprogrammed into a novel population, IL-17(+)Foxp3(+) T cells, phenotypically and functionally resembling Th17 cells under the complicated cytokine stimulation.",24744433_3,-1,-1,-1,-1,23282,-1,1.8765628e-05,0.9999716,9.5712085e-06
23285,functionally,24,25,149,161,"Recent mice and human studies have demonstrated that Tregs can be reprogrammed into a novel population, IL-17(+)Foxp3(+) T cells, phenotypically and functionally resembling Th17 cells under the complicated cytokine stimulation.",24744433_3,0,1,2,-1,23285,-1,0.00011663773,0.99982905,5.4260418e-05
23286,Th17 cells,26,28,173,183,"Recent mice and human studies have demonstrated that Tregs can be reprogrammed into a novel population, IL-17(+)Foxp3(+) T cells, phenotypically and functionally resembling Th17 cells under the complicated cytokine stimulation.",24744433_3,-1,-1,-1,-1,23286,-1,0.00057338213,0.0067855115,0.99264103
23292,therapy targeting Tregs,13,16,82,105,The identification of IL-17(+)Foxp3(+) T cells may provide a new understanding of therapy targeting Tregs and Th17 cells in autoimmune diseases and cancer.,24744433_4,-1,-1,-1,-1,23292,-1,2.6647926e-05,0.9999614,1.1989063e-05
23293,Th17 cells,17,19,110,120,The identification of IL-17(+)Foxp3(+) T cells may provide a new understanding of therapy targeting Tregs and Th17 cells in autoimmune diseases and cancer.,24744433_4,-1,-1,-1,-1,23293,-1,0.001156488,0.021932289,0.9769111
23295,the pleiotropic functions,16,19,103,128,"Here, we highlight significant data regarding the phenotype profile, origination, differentiation, and the pleiotropic functions of IL-17(+)Foxp3(+) T cells and the reciprocal relationships of these cells to Tregs and Th17 cells.",24744433_5,-1,-1,-1,-1,23295,-1,4.6465713e-05,0.999923,3.0588144e-05
23300,these cells to Tregs,29,33,193,213,"Here, we highlight significant data regarding the phenotype profile, origination, differentiation, and the pleiotropic functions of IL-17(+)Foxp3(+) T cells and the reciprocal relationships of these cells to Tregs and Th17 cells.",24744433_5,-1,-1,-1,-1,23300,-1,0.00010199282,0.99953175,0.00036631146
23301,Th17 cells,34,36,218,228,"Here, we highlight significant data regarding the phenotype profile, origination, differentiation, and the pleiotropic functions of IL-17(+)Foxp3(+) T cells and the reciprocal relationships of these cells to Tregs and Th17 cells.",24744433_5,-1,-1,-1,-1,23301,-1,0.0029911138,0.20316906,0.7938398
23306,therapy,16,17,103,110,"Furthermore, the role of IL-17(+)Foxp3(+) T cells in tumorigenesis and clinical implications in cancer therapy are discussed in this review.",24744433_6,0,1,-1,-1,23306,-1,2.6142636e-05,0.9999616,1.2264754e-05
23311,to the generation,15,18,104,121,Thymic central tolerance is a critical process that prevents autoimmunity but also presents a challenge to the generation of anti-tumor immune responses.,24752296_0,-1,-1,-1,-1,23311,-1,3.3768796e-05,0.9999517,1.4558306e-05
23316,tissue-specific antigens,17,19,112,136,Medullary thymic epithelial cells (mTECs) eliminate self-reactive T cells by displaying a diverse repertoire of tissue-specific antigens (TSAs) that are also shared by tumors.,24752296_1,-1,-1,-1,-1,23316,-1,0.12160779,0.8638516,0.014540598
23321,the generation,10,12,77,91,"Therefore, while protecting against autoimmunity, mTECs simultaneously limit the generation of tumor-specific effector T cells by expressing tumor self-antigens.",24752296_2,-1,-1,-1,-1,23321,-1,1.9129791e-05,0.9999683,1.2593944e-05
23330,therapies to,2,4,6,18,"Thus, therapies to deplete Aire-expressing mTECs represent an attractive strategy to increase the pool of tumor-specific effector T cells.",24752296_4,-1,-1,-1,-1,23330,-1,2.1860988e-05,0.99996793,1.0155034e-05
23336,the TNF,4,6,27,34,Recent work has implicated the TNF family members RANK and RANK-Ligand (RANKL) in the development of Aire-expressing mTECs.,24752296_5,-1,-1,-1,-1,23336,-1,4.7160782e-05,0.9999347,1.8193254e-05
23343,the thymus to,16,19,100,113,We show that in vivo RANKL blockade selectively and transiently depletes Aire and TSA expression in the thymus to create a window of defective negative selection.,24752296_6,-1,-1,-1,-1,23343,-1,2.3275337e-05,0.999966,1.0730191e-05
23348,these tumor-specific,19,21,130,150,"Furthermore, we demonstrate that RANKL blockade can rescue melanoma-specific T cells from thymic deletion and that persistence of these tumor-specific effector T cells promoted increased host survival in response to tumor challenge.",24752296_7,-1,-1,-1,-1,23348,-1,2.688917e-05,0.9999577,1.5444362e-05
23350,to tumor,30,32,213,221,"Furthermore, we demonstrate that RANKL blockade can rescue melanoma-specific T cells from thymic deletion and that persistence of these tumor-specific effector T cells promoted increased host survival in response to tumor challenge.",24752296_7,-1,-1,-1,-1,23350,-1,2.0232634e-05,0.99996996,9.846259e-06
23353,tolerance through,6,8,47,64,These results indicate that modulating central tolerance through RANKL can alter thymic output and potentially provide therapeutic benefit by enhancing anti-tumor immunity.,24752296_8,-1,-1,-1,-1,23353,-1,2.114933e-05,0.9999689,1.0007162e-05
23356,immunity,21,22,163,171,These results indicate that modulating central tolerance through RANKL can alter thymic output and potentially provide therapeutic benefit by enhancing anti-tumor immunity.,24752296_8,0,-1,2,-1,23356,-1,0.99952245,0.00029465952,0.0001829087
23366,MCF7 cells,6,8,29,39,"Using a mouse tumor model of MCF7 cells, we showed that CPT strongly inhibited MCF7 cell growth in vivo with polarization of immune reactions toward Th1-type responses, stimulation of naive CD4+ T cell proliferation, and also increased IFN- and perforin production of CD4+ T cells in response to tumor-activated splenocytes.",24761844_2,-1,-1,-1,-1,23366,-1,0.09109598,0.001847562,0.9070564
23368,MCF7 cell,15,17,79,88,"Using a mouse tumor model of MCF7 cells, we showed that CPT strongly inhibited MCF7 cell growth in vivo with polarization of immune reactions toward Th1-type responses, stimulation of naive CD4+ T cell proliferation, and also increased IFN- and perforin production of CD4+ T cells in response to tumor-activated splenocytes.",24761844_2,-1,-1,-1,-1,23368,-1,0.080477856,0.0019439844,0.91757816
23369,toward Th1-type,25,27,142,157,"Using a mouse tumor model of MCF7 cells, we showed that CPT strongly inhibited MCF7 cell growth in vivo with polarization of immune reactions toward Th1-type responses, stimulation of naive CD4+ T cell proliferation, and also increased IFN- and perforin production of CD4+ T cells in response to tumor-activated splenocytes.",24761844_2,-1,-1,-1,-1,23369,-1,2.9988947e-05,0.9999511,1.8856446e-05
23370,naive CD4+ T cell,31,36,184,201,"Using a mouse tumor model of MCF7 cells, we showed that CPT strongly inhibited MCF7 cell growth in vivo with polarization of immune reactions toward Th1-type responses, stimulation of naive CD4+ T cell proliferation, and also increased IFN- and perforin production of CD4+ T cells in response to tumor-activated splenocytes.",24761844_2,-1,-1,-1,-1,23370,-1,0.0036068927,0.08335292,0.9130401
23373,to tumor-activated,52,54,294,312,"Using a mouse tumor model of MCF7 cells, we showed that CPT strongly inhibited MCF7 cell growth in vivo with polarization of immune reactions toward Th1-type responses, stimulation of naive CD4+ T cell proliferation, and also increased IFN- and perforin production of CD4+ T cells in response to tumor-activated splenocytes.",24761844_2,-1,-1,-1,-1,23373,-1,4.5778717e-05,0.9999298,2.445162e-05
23374,that the,4,6,27,35,"Furthermore, data revealed that the cytotoxic activity of CD4+ T cells induced by CPT was markedly abrogated by concanamycin A(CMA), a perforin inhibitor, but not IFN- Ab.",24761844_3,-1,-1,-1,-1,23374,-1,1.7466902e-05,0.99997354,8.938508e-06
23388,T cells to,17,20,106,116,"Thus, our results suggested that CPT mainly inhibited breast tumor growth through inducing cytotoxic CD4+ T cells to secrete perforin.",24761844_5,-1,-1,-1,-1,23388,-1,0.0012164839,0.020735808,0.97804767
23394,tumor therapy,11,13,69,82,"These findings suggest a novel potential therapeutic role for CPT in tumor therapy, and demonstrate that CPT performs its antitumor functions through cytotoxic CD4+ T cells.",24761844_7,-1,-1,-1,-1,23394,-1,2.05367e-05,0.99996924,1.0165473e-05
23396,functions through,21,23,132,149,"These findings suggest a novel potential therapeutic role for CPT in tumor therapy, and demonstrate that CPT performs its antitumor functions through cytotoxic CD4+ T cells.",24761844_7,-1,-1,-1,-1,23396,-1,6.478056e-05,0.99988794,4.7211946e-05
23400,factors,18,19,89,96,"AIMS: Dysfunction of the host immune system in cancer patients can be due to a number of factors, including lymphocyte apoptosis.",24761872_0,0,1,-1,-1,23400,-1,0.014416179,0.9848801,0.0007037127
23402,that Foxp3+T,3,5,23,35,Several studies showed that Foxp3+T cells take part in inducing this process by expressing FasL in tumor patients.,24761872_1,-1,-1,-1,-1,23402,-1,0.0015120188,0.96782357,0.030664444
23403,Foxp3+T cells take,4,7,28,46,Several studies showed that Foxp3+T cells take part in inducing this process by expressing FasL in tumor patients.,24761872_1,-1,-1,-1,-1,23403,-1,7.648801e-05,0.9998148,0.00010867914
23406,the relationship,2,4,9,25,"However, the relationship between apoptosis, CD8+T cells and Foxp3+T cells in HCC patients is still unclear.",24761872_2,-1,-1,-1,-1,23406,-1,2.380423e-05,0.9999654,1.0763237e-05
23408,Foxp3+T cells,10,12,61,74,"However, the relationship between apoptosis, CD8+T cells and Foxp3+T cells in HCC patients is still unclear.",24761872_2,-1,-1,-1,-1,23408,-1,0.0044215266,0.77147186,0.2241066
23413,Foxp3+T cells,19,21,136,149,The present study was designed to investigate the correlation between apoptosis levels and Fas/FasL expression in CD8+T lymphocytes and Foxp3+T cells in patients with HCC.METHODS: CD8+T cells and CD3+Foxp3+T cells were tested from peripheral blood of HCC patients and normal controls and subjected to multicolor flow cytometry.,24761872_3,-1,-1,-1,-1,23413,-1,0.003645234,0.74312437,0.25323042
23417,blood,35,36,242,247,The present study was designed to investigate the correlation between apoptosis levels and Fas/FasL expression in CD8+T lymphocytes and Foxp3+T cells in patients with HCC.METHODS: CD8+T cells and CD3+Foxp3+T cells were tested from peripheral blood of HCC patients and normal controls and subjected to multicolor flow cytometry.,24761872_3,0,1,-1,-1,23417,-1,0.00016580426,0.9974111,0.0024230976
23421,receptor,13,14,64,72,The expression of an apoptosis marker (annexin V) and the death receptor Fas in CD8+T cells and FasL in CD3+Foxp3+T cells were evaluated.,24761872_4,0,1,2,-1,23421,-1,0.0013167459,0.0030002757,0.99568295
23425,The relationship,0,2,0,16,"The relationship between apoptosis and Fas expression, as well as FasL expression in CD3+Foxp3+T cells was then evaluated.",24761872_6,-1,-1,-1,-1,23425,-1,2.2818402e-05,0.999964,1.3134271e-05
23436,CD3+Foxp3+T cells,6,8,46,63,Serum TGF-1 levels correlated inversely with CD3+Foxp3+T cells.,24761872_8,-1,-1,-1,-1,23436,-1,0.0002616779,0.00041640195,0.99932194
23445,to the,9,11,50,56,BACKGROUND: T regulatory cells (Tregs) contribute to the progression of head and neck squamous cell carcinoma (HNSCC) by suppressing antitumor immunity.,24761979_0,-1,-1,-1,-1,23445,-1,2.4583489e-05,0.999964,1.1411981e-05
23447,immunity,25,26,143,151,BACKGROUND: T regulatory cells (Tregs) contribute to the progression of head and neck squamous cell carcinoma (HNSCC) by suppressing antitumor immunity.,24761979_0,0,-1,2,-1,23447,-1,0.99943846,0.0003440657,0.00021741462
23448,the functional,6,8,35,49,"However, little is known regarding the functional heterogeneity of Tregs in HNSCC patients.",24761979_1,-1,-1,-1,-1,23448,-1,3.028311e-05,0.9999591,1.0616218e-05
23451,three Treg subsets,10,13,59,77,"METHODS: Using multicolor flow cytometry, the frequency of three Treg subsets, separated on the basis of CD45RA and Foxp3, from the peripheral circulation of newly-presenting HNSCC patients (19 oral cavity squamous cell carcinoma, 20 hypopharyngeal squamous cell carcinoma, 18 nasopharyngeal squamous cell carcinoma, 19 oropharyngeal squamous cell carcinoma, and 36 laryngeal squamous cell carcinoma) were assessed with regard to 31 healthy donors and clinicopathological features.",24761979_2,-1,-1,-1,-1,23451,-1,0.004838227,0.33900958,0.6561521
23462,the functional,2,4,10,24,"Moreover, the functional capacity of each Treg subsets was evaluated based on CD45RA and CD25 expression.",24761979_3,-1,-1,-1,-1,23462,-1,3.312633e-05,0.9999442,2.2701763e-05
23463,Treg subsets,7,9,42,54,"Moreover, the functional capacity of each Treg subsets was evaluated based on CD45RA and CD25 expression.",24761979_3,-1,-1,-1,-1,23463,-1,0.0008809271,0.03974997,0.95936906
23472,three subsets,4,6,28,41,"Further dividing Tregs into three subsets based on Foxp3 and CD45RA expression revealed that the frequency of CD45RA-Foxp3high Tregs and CD45RA-Foxp3lowCD4+ T cells in patients with HNSCC developing from different subsites was higher than in healthy donors (P <0.0001, P <0.0001), whereas the frequency of CD45RA+Foxp3low Tregs was lower than in healthy donors (P <0.0001).",24761979_6,-1,-1,-1,-1,23472,-1,0.003367078,0.06217104,0.93446183
23474,that the,13,15,88,96,"Further dividing Tregs into three subsets based on Foxp3 and CD45RA expression revealed that the frequency of CD45RA-Foxp3high Tregs and CD45RA-Foxp3lowCD4+ T cells in patients with HNSCC developing from different subsites was higher than in healthy donors (P <0.0001, P <0.0001), whereas the frequency of CD45RA+Foxp3low Tregs was lower than in healthy donors (P <0.0001).",24761979_6,-1,-1,-1,-1,23474,-1,1.7069582e-05,0.99997413,8.754258e-06
23481,Functionally,0,1,0,12,Functionally study revealed that CD45RA-CD25+++ Tregs significantly inhibit the proliferation of CD4+CD25- T cells (P <0.001) and secrete lower levels of cytokines (P <0.01) compared with CD45RA-CD25++CD4+ T cells.,24761979_7,0,1,2,-1,23481,-1,4.2747663e-05,0.99993706,2.0197056e-05
23491,nodal status,19,21,108,120,"Importantly, the frequency of CD45RA-Foxp3high Tregs positively correlate with tumor stage (P <0.0001) and nodal status (P <0.0001).CONCLUSIONS: CD45RA-Foxp3high Tregs increase in the peripheral circulation of HNSCC patients, and correlate with tumor stage and nodal status; suggesting a role in tumor progression which may be manipulated by future immunotherapy.",24761979_8,-1,-1,-1,-1,23491,-1,0.25164002,0.7238381,0.0245219
23495,nodal status,44,46,263,275,"Importantly, the frequency of CD45RA-Foxp3high Tregs positively correlate with tumor stage (P <0.0001) and nodal status (P <0.0001).CONCLUSIONS: CD45RA-Foxp3high Tregs increase in the peripheral circulation of HNSCC patients, and correlate with tumor stage and nodal status; suggesting a role in tumor progression which may be manipulated by future immunotherapy.",24761979_8,-1,-1,-1,-1,23495,-1,0.3416948,0.6313841,0.026921138
23497,The transcription factor T-bet,0,4,0,30,The transcription factor T-bet controls the Th1 genetic program in T cells for effective antitumor responses.,24778280_0,-1,-1,-1,-1,23497,-1,2.2607352e-05,0.9999645,1.2862316e-05
23498,the Th1 genetic,5,8,40,55,The transcription factor T-bet controls the Th1 genetic program in T cells for effective antitumor responses.,24778280_0,-1,-1,-1,-1,23498,-1,2.4052995e-05,0.999959,1.6998189e-05
23500,factors that,15,17,103,115,"Anti-CTLA-4 immunotherapy elicits dramatic antitumor responses in mice and in human patients; however, factors that regulate T-bet expression during an antitumor response mediated by anti-CTLA-4 remain to be elucidated.",24778280_1,-1,-1,-1,-1,23500,-1,2.8281365e-05,0.9999572,1.446773e-05
23505,that treatment,6,8,28,42,We were the first to report that treatment with anti-CTLA-4 led to an increase in the frequency of T cells expressing inducible costimulator (ICOS).,24778280_2,-1,-1,-1,-1,23505,-1,2.0048183e-05,0.9999707,9.316427e-06
23513,the Th1 cytokine IFN-,24,28,124,146,"In both treated patients and mice, our data revealed that CD4(+)ICOS(hi) T cells can act as effector T cells, which produce the Th1 cytokine IFN-.",24778280_3,-1,-1,-1,-1,23513,-1,0.60871756,0.38548917,0.0057933014
23514,analysis that,7,9,40,53,We also showed in a small retrospective analysis that an increased frequency of CD4(+)ICOS(hi) T cells correlated with better clinical outcome and the absence of ICOS or its ligand (ICOSL) in mouse models led to impaired tumor rejection.,24778280_4,-1,-1,-1,-1,23514,-1,2.4979969e-05,0.99995863,1.6425345e-05
23533,therapy,19,20,129,136,We found that ICOS-mediated PI3K signaling is required for T-bet expression during an antitumor response elicited by anti-CTLA-4 therapy.,24778280_9,0,1,-1,-1,23533,-1,2.3039383e-05,0.9999658,1.119895e-05
23534,the regulation,6,8,34,48,Our data provide new insight into the regulation of T-bet expression and suggest that ICOS can be targeted to improve Th1 antitumor responses.,24778280_10,-1,-1,-1,-1,23534,-1,1.9234525e-05,0.99997234,8.373781e-06
23537,targeted to,17,19,98,109,Our data provide new insight into the regulation of T-bet expression and suggest that ICOS can be targeted to improve Th1 antitumor responses.,24778280_10,-1,-1,-1,-1,23537,-1,2.1383717e-05,0.9999689,9.765414e-06
23541,the TCR,8,10,42,49,"Naive CD4(+) T cells require signals from the TCR and CD28 to produce IL-2, expand, and differentiate.",24778448_0,-1,-1,-1,-1,23541,-1,4.2720796e-05,0.9999224,3.4934234e-05
23542,CD28 to,11,13,54,61,"Naive CD4(+) T cells require signals from the TCR and CD28 to produce IL-2, expand, and differentiate.",24778448_0,-1,-1,-1,-1,23542,-1,0.006861793,0.072397694,0.9207405
23548,cell types to,26,29,150,163,"However, these same signals are not sufficient to induce autocrine IL-2 production by naive CD8(+) T cells, which require cytokines provided by other cell types to drive their differentiation.",24778448_1,-1,-1,-1,-1,23548,-1,0.0027937887,0.033141717,0.9640644
23568,IFN--producing CTLs,24,26,160,180,"Naive murine CD8 T cells haplo-insufficient for Ikzf1 failed to upregulate Ikaros, produced autocrine IL-2, and differentiated in an IL-2-dependent manner into IFN--producing CTLs in response to TCR/CD28 stimulation alone.",24778448_5,-1,-1,-1,-1,23568,-1,0.7679838,0.0023885202,0.22962761
23574,cells to,31,33,203,211,"Furthermore, Ikzf1 haplo-insufficient CD8(+) T cells were more effective at controlling Listeria infection and B16 melanoma growth in vivo, and they could provide help to neighboring, non-IL-2-producing cells to differentiate into IFN--producing effectors.",24778448_6,-1,-1,-1,-1,23574,-1,0.0033084932,0.090324126,0.9063673
23577,that naive,10,12,67,77,"Therefore, by repressing autocrine IL-2 production, Ikaros ensures that naive CD8(+) T cells remain dependent on licensing by APCs and CD4(+) T cells, and it may therefore act as a cell-intrinsic safeguard against inappropriate CTL differentiation and immunopathology.",24778448_7,-1,-1,-1,-1,23577,-1,2.6407344e-05,0.9999616,1.197493e-05
23583,the tumor,6,8,39,48,We describe a new mechanism regulating the tumor endothelial barrier and T cell infiltration into tumors.,24793239_0,-1,-1,-1,-1,23583,-1,1.9236593e-05,0.99997115,9.621411e-06
23589,these tumors,1,3,3,15,"In these tumors, FasL expression was associated with scarce CD8(+) infiltration and a predominance of FoxP3(+) T regulatory (Treg) cells.",24793239_2,-1,-1,-1,-1,23589,-1,1.896324e-05,0.99996996,1.1055401e-05
23612,T cells that,20,23,123,135,Pharmacologic inhibition of VEGF and PGE2 produced a marked increase in the influx of tumor-rejecting CD8(+) over FoxP3(+) T cells that was dependent on attenuation of FasL expression and led to CD8-dependent tumor growth suppression.,24793239_5,-1,-1,-1,-1,23612,-1,0.0016874425,0.035316683,0.9629959
23623,the tumor,14,16,67,76,"High number of regulatory T cells (Tregs), both circulating and at the tumor site, often indicates a poor prognosis in CRC patient's possibly impairing natural killer (NK) cell function.",24797894_0,-1,-1,-1,-1,23623,-1,2.2029852e-05,0.9999676,1.0447432e-05
23625,cell function,34,36,172,185,"High number of regulatory T cells (Tregs), both circulating and at the tumor site, often indicates a poor prognosis in CRC patient's possibly impairing natural killer (NK) cell function.",24797894_0,-1,-1,-1,-1,23625,-1,0.00013893821,0.00027489394,0.99958616
23635,transferred Tregs,35,37,201,218,"To determine the role of Tregs in CRC development and their effects on NK cells, we created novel transgenic Rag-Apc mice that lack T cells and develop spontaneous intestinal tumors, and we adoptively transferred Tregs or transiently depleted NK cells during initial stages of tumorigenesis.",24797894_1,-1,-1,-1,-1,23635,-1,2.1836517e-05,0.9999666,1.1582188e-05
23646,Treg transfer,2,4,13,26,"Importantly, Treg transfer increased small intestinal polyp formation up to 65% (P<0.0005) and increased colon tumors multiplicities by 84% (P<0.0001) with a significant decrease in NK cells as compared to control mice.",24797894_3,-1,-1,-1,-1,23646,-1,2.343441e-05,0.9999621,1.45056e-05
23654,Treg transfer,0,2,0,13,"Treg transfer or NK cell transient depletion markedly increased interleukin (IL)-22 systemically and the inflammatory signaling molecules P2X7R, and STAT3 in the tumors; and impaired production of the tumor suppressor interferon (IFN)- systemically.",24797894_5,-1,-1,-1,-1,23654,-1,2.6238904e-05,0.9999542,1.9512065e-05
23655,cell transient,4,6,20,34,"Treg transfer or NK cell transient depletion markedly increased interleukin (IL)-22 systemically and the inflammatory signaling molecules P2X7R, and STAT3 in the tumors; and impaired production of the tumor suppressor interferon (IFN)- systemically.",24797894_5,-1,-1,-1,-1,23655,-1,0.0013865683,0.042539194,0.9560742
23659,the tumors,22,24,158,168,"Treg transfer or NK cell transient depletion markedly increased interleukin (IL)-22 systemically and the inflammatory signaling molecules P2X7R, and STAT3 in the tumors; and impaired production of the tumor suppressor interferon (IFN)- systemically.",24797894_5,-1,-1,-1,-1,23659,-1,2.0740043e-05,0.9999677,1.1559524e-05
23660,the tumor,29,31,197,206,"Treg transfer or NK cell transient depletion markedly increased interleukin (IL)-22 systemically and the inflammatory signaling molecules P2X7R, and STAT3 in the tumors; and impaired production of the tumor suppressor interferon (IFN)- systemically.",24797894_5,-1,-1,-1,-1,23660,-1,2.4018704e-05,0.9999628,1.3120459e-05
23663,the tumor,20,22,105,114,"Notably, IL-22 binding protein (IL-22 BP) was associated with NKs and a significant decrease was seen at the tumor site in mice adoptively transferred with Tregs or depleted of NK cells.",24797894_6,-1,-1,-1,-1,23663,-1,1.8892955e-05,0.9999703,1.0740137e-05
23685,tissue,13,14,84,90,"In this study, single cells were isolated from surgically removed high-grade glioma tissue and examined by flow cytometry.",24813240_4,-1,1,2,-1,23685,-1,3.1137944e-05,0.9999269,4.1956664e-05
23694,tissue,13,14,80,86,The results showed that abundant IL-17(+) Tregs were found in high-grade glioma tissue.,24813240_6,-1,1,2,-1,23694,-1,0.00011738784,0.99823785,0.001644734
23696,transforming growth factor,5,8,32,58,"The immune suppressor molecule, transforming growth factor (TGF)-beta, was detected in the IL-17(+) Tregs.",24813240_7,-1,-1,-1,-1,23696,-1,0.883777,0.11165174,0.004571235
23697,the IL-17(+,13,15,87,98,"The immune suppressor molecule, transforming growth factor (TGF)-beta, was detected in the IL-17(+) Tregs.",24813240_7,-1,-1,-1,-1,23697,-1,0.5189351,0.47454697,0.0065179416
23701,the IL-17(+,12,14,69,80,"The proliferation of CD8(+) T cells was suppressed by culturing with the IL-17(+) Tregs, which was partially abrogated by neutralizing antibodies of either TGF-beta or IL-17 and completely abrogated by neutralizing antibodies against both TGF-beta and IL-17.",24813240_8,-1,-1,-1,-1,23701,-1,0.43145815,0.5623271,0.006214737
23703,TGF-beta,26,27,156,164,"The proliferation of CD8(+) T cells was suppressed by culturing with the IL-17(+) Tregs, which was partially abrogated by neutralizing antibodies of either TGF-beta or IL-17 and completely abrogated by neutralizing antibodies against both TGF-beta and IL-17.",24813240_8,0,1,-1,-1,23703,-1,4.395367e-05,0.9999341,2.1960985e-05
23705,TGF-beta,37,38,239,247,"The proliferation of CD8(+) T cells was suppressed by culturing with the IL-17(+) Tregs, which was partially abrogated by neutralizing antibodies of either TGF-beta or IL-17 and completely abrogated by neutralizing antibodies against both TGF-beta and IL-17.",24813240_8,0,1,-1,-1,23705,-1,4.819636e-05,0.9999261,2.5759202e-05
23710,tissue,11,12,61,67,"In conclusion, IL-17(+) Tregs exist in the high-grade glioma tissue; this subset of T cells can suppress CD8(+) T cell activities via releasing TGF-beta and IL-17.",24813240_9,-1,1,2,-1,23710,-1,3.4128567e-05,0.9999149,5.0941355e-05
23711,this subset,13,15,69,80,"In conclusion, IL-17(+) Tregs exist in the high-grade glioma tissue; this subset of T cells can suppress CD8(+) T cell activities via releasing TGF-beta and IL-17.",24813240_9,-1,-1,-1,-1,23711,-1,0.0046798703,0.36089608,0.63442403
23714,releasing TGF-beta,26,28,134,152,"In conclusion, IL-17(+) Tregs exist in the high-grade glioma tissue; this subset of T cells can suppress CD8(+) T cell activities via releasing TGF-beta and IL-17.",24813240_9,-1,-1,-1,-1,23714,-1,6.315636e-05,0.9999161,2.0724263e-05
23718,cells to,12,14,76,84,"CD8(+) T cells must detect foreign antigens and differentiate into effector cells to eliminate infections. But, when self-antigen is recognized instead, mechanisms of peripheral tolerance prevent acquisition of effector function to avoid autoimmunity.",24823810_0,-1,-1,-1,-1,23718,-1,0.0039354535,0.118795626,0.87726885
23720,function to,33,35,220,231,"CD8(+) T cells must detect foreign antigens and differentiate into effector cells to eliminate infections. But, when self-antigen is recognized instead, mechanisms of peripheral tolerance prevent acquisition of effector function to avoid autoimmunity.",24823810_0,-1,-1,-1,-1,23720,-1,0.00034028472,0.9961455,0.0035142521
23722,the tissue,11,13,82,92,"These distinct responses are influenced by inflammatory and regulatory clues from the tissue environment, but the mechanism(s) by which naive T cells interpret these signals to generate the appropriate immune response are unclear.",24823810_1,-1,-1,-1,-1,23722,-1,3.968302e-05,0.99994195,1.8310338e-05
23724,naive T cells,21,24,136,149,"These distinct responses are influenced by inflammatory and regulatory clues from the tissue environment, but the mechanism(s) by which naive T cells interpret these signals to generate the appropriate immune response are unclear.",24823810_1,-1,-1,-1,-1,23724,-1,0.0027548946,0.06577381,0.9314713
23726,to generate the,27,30,174,189,"These distinct responses are influenced by inflammatory and regulatory clues from the tissue environment, but the mechanism(s) by which naive T cells interpret these signals to generate the appropriate immune response are unclear.",24823810_1,-1,-1,-1,-1,23726,-1,2.913113e-05,0.9999604,1.0490048e-05
23730,these cell-fate,7,9,49,64,"The identification of the molecules operative in these cell-fate decisions is crucial for developing new treatment options for patients with cancer or autoimmunity, where manipulation of T cell activity is desired to alter the course of disease.",24823810_2,-1,-1,-1,-1,23730,-1,0.0027377452,0.25120273,0.7460595
23740,the T-box transcription factors T-bet,28,33,153,190,"With the use of an in vivo murine model to examine CD8(+) T cell responses to healthy self-tissue, we correlated self-tolerance with a failure to induce the T-box transcription factors T-bet and Eomes.",24823810_3,-1,-1,-1,-1,23740,-1,2.0100539e-05,0.9999676,1.2310623e-05
23746,these functional,8,10,40,56,"In the context of a Listeria infection, these functional responses relied on elevated T-bet expression, independent of Eomes.",24823810_5,-1,-1,-1,-1,23746,-1,2.7463379e-05,0.9999597,1.2839337e-05
23750,T-bet to,17,19,107,115,"Alternatively, infection with LCMV induced higher Eomes expression, which was sufficient in the absence of T-bet to promote effector cytokine production.",24823810_6,-1,-1,-1,-1,23750,-1,2.78969e-05,0.99995875,1.33728045e-05
23752,place T-box transcription factors,2,6,12,45,"Our results place T-box transcription factors at a molecular crossroads between CD8(+) T cell anergy and effector function upon recognition of peripheral self-antigen, and suggest that inflammation during T cell priming directs these distinct cellular responses.",24823810_7,-1,-1,-1,-1,23752,-1,2.1135576e-05,0.99996114,1.7688713e-05
23754,function,18,19,114,122,"Our results place T-box transcription factors at a molecular crossroads between CD8(+) T cell anergy and effector function upon recognition of peripheral self-antigen, and suggest that inflammation during T cell priming directs these distinct cellular responses.",24823810_7,0,1,2,-1,23754,-1,0.00043444018,0.9965479,0.0030177273
23761,cells that,16,18,95,105,The biology of follicular lymphoma (FL) is largely dictated by the immune-effector and stromal cells that comprise its tumor microenvironment.,24836297_0,-1,-1,-1,-1,23761,-1,0.002802338,0.060978882,0.93621874
23763,T-cell,1,2,16,22,"FL-infiltrating T-cell populations that are thought to be fundamental to FL biology are follicular helper T-cells (TFH), follicular regulatory T-cells (TFR), a recently described population that regulates TFH activity, and regulatory T-cells (Treg).",24836297_1,-1,1,2,-1,23763,-1,3.4567252e-05,4.1375573e-05,0.99992406
23765,thought to,5,7,44,54,"FL-infiltrating T-cell populations that are thought to be fundamental to FL biology are follicular helper T-cells (TFH), follicular regulatory T-cells (TFR), a recently described population that regulates TFH activity, and regulatory T-cells (Treg).",24836297_1,-1,-1,-1,-1,23765,-1,3.023435e-05,0.99995565,1.410059e-05
23775,These T-cell,0,2,0,12,These T-cell populations have dynamic interactions with mesenchymal stromal cells (MSCs) in the tumor microenvironment.,24836297_2,-1,-1,-1,-1,23775,-1,0.0024744894,0.09919532,0.89833015
23778,the tumor,14,16,92,101,These T-cell populations have dynamic interactions with mesenchymal stromal cells (MSCs) in the tumor microenvironment.,24836297_2,-1,-1,-1,-1,23778,-1,2.0301566e-05,0.9999703,9.429947e-06
23784,TFR cells,19,21,111,120,"Whereas MSCs have been shown to support FL B-cell and Treg viability, their effects on FL-infiltrating TFH and TFR cells have not been described.",24836297_3,-1,-1,-1,-1,23784,-1,0.0029047807,0.22405675,0.7730385
23785,that MSCs,3,5,15,24,"Herein we show that MSCs support the viability of FL-infiltrating TFH and TFR, as well as Tregs, in part through an IL-6-dependent mechanism.",24836297_4,-1,-1,-1,-1,23785,-1,2.4851613e-05,0.99996257,1.257522e-05
23792,that MSCs,3,5,23,32,"We further demonstrate that MSCs mediate TFH to TFR conversion by inducing the expression of FoxP3 in TFH cells, demonstrating for the first time that human TFR can be derived from TFH cells.",24836297_5,-1,-1,-1,-1,23792,-1,3.2869877e-05,0.99995255,1.4601687e-05
23793,TFH to TFR,6,9,41,51,"We further demonstrate that MSCs mediate TFH to TFR conversion by inducing the expression of FoxP3 in TFH cells, demonstrating for the first time that human TFR can be derived from TFH cells.",24836297_5,-1,-1,-1,-1,23793,-1,2.3739793e-05,0.9999565,1.9770805e-05
23796,TFH cells,17,19,102,111,"We further demonstrate that MSCs mediate TFH to TFR conversion by inducing the expression of FoxP3 in TFH cells, demonstrating for the first time that human TFR can be derived from TFH cells.",24836297_5,-1,-1,-1,-1,23796,-1,0.00074901886,0.022275312,0.9769757
23798,time that,24,26,141,150,"We further demonstrate that MSCs mediate TFH to TFR conversion by inducing the expression of FoxP3 in TFH cells, demonstrating for the first time that human TFR can be derived from TFH cells.",24836297_5,-1,-1,-1,-1,23798,-1,2.3017643e-05,0.9999621,1.4888714e-05
23800,TFH cells,32,34,181,190,"We further demonstrate that MSCs mediate TFH to TFR conversion by inducing the expression of FoxP3 in TFH cells, demonstrating for the first time that human TFR can be derived from TFH cells.",24836297_5,-1,-1,-1,-1,23800,-1,0.0015118241,0.0813415,0.9171466
23801,that the,1,3,6,14,"Given that the balance of TFH and TFR populations likely dictate, in part, the biology of this disease, our data support the potential for targeting MSCs as a therapeutic strategy.",24836297_6,-1,-1,-1,-1,23801,-1,2.1193551e-05,0.9999701,8.677245e-06
23807,targeting MSCs,27,29,139,153,"Given that the balance of TFH and TFR populations likely dictate, in part, the biology of this disease, our data support the potential for targeting MSCs as a therapeutic strategy.",24836297_6,-1,-1,-1,-1,23807,-1,2.4079602e-05,0.99996495,1.096516e-05
23809,to therapy,3,5,25,35,"Despite initial response to therapy, most acute myeloid leukemia (AML) patients relapse.",24855276_0,-1,-1,-1,-1,23809,-1,3.8736063e-05,0.9999442,1.7068129e-05
23817,tumor cells,14,16,89,100,"In vitro cellular engineering may require increasing the ""stemness"" or immunogenicity of tumor cells and activating or restoring cancer-impaired immune-effector and antigen-presenting cells.",24855276_2,-1,-1,-1,-1,23817,-1,0.0048843385,0.42744565,0.56767005
23818,antigen-presenting cells,23,25,165,189,"In vitro cellular engineering may require increasing the ""stemness"" or immunogenicity of tumor cells and activating or restoring cancer-impaired immune-effector and antigen-presenting cells.",24855276_2,-1,-1,-1,-1,23818,-1,0.5744187,0.0028930453,0.42268822
23819,the cells,3,5,30,39,"Leukapheresis samples provide the cells needed to engineer therapies: LPCs to be targeted, normal hematopoietic stem cells to be spared, and cancer-impaired immune cells to be repaired and activated.",24855276_3,-1,-1,-1,-1,23819,-1,0.004862607,0.2907218,0.7044156
23824,cells to,18,20,117,125,"Leukapheresis samples provide the cells needed to engineer therapies: LPCs to be targeted, normal hematopoietic stem cells to be spared, and cancer-impaired immune cells to be repaired and activated.",24855276_3,-1,-1,-1,-1,23824,-1,0.0033086909,0.053041045,0.94365025
23825,cells to,26,28,164,172,"Leukapheresis samples provide the cells needed to engineer therapies: LPCs to be targeted, normal hematopoietic stem cells to be spared, and cancer-impaired immune cells to be repaired and activated.",24855276_3,-1,-1,-1,-1,23825,-1,0.0033633795,0.06501758,0.93161905
23834,cells generally,3,5,12,27,CD34(+) AML cells generally displayed more colony-forming and aldehyde dehydrogenase activity than CD34(-) AML cells.,24855276_5,-1,-1,-1,-1,23834,-1,0.002871799,0.07866501,0.9184632
23841,factor- receptor,28,30,152,169,"Along with exposure to bone marrow stromal cells and low (1%-5%) oxygen, culture with RepSox (a reprogramming tool and inhibitor of transforming growth factor- receptor 1) consistently slowed decline of CD34(+) AML and myelodysplastic syndrome (MDS) cells.",24855276_6,-1,-1,-1,-1,23841,-1,0.9811224,0.0064642853,0.012413341
23849,receptor that,16,18,92,105,"RepSox also accelerated loss of T cell immunoglobulin mucin-3 (Tim-3), an immune checkpoint receptor that impairs antitumor immunity, from the surface of AML and MDS cells.",24855276_8,-1,-1,-1,-1,23849,-1,0.006784412,0.47009826,0.5231173
23850,immunity,20,21,124,132,"RepSox also accelerated loss of T cell immunoglobulin mucin-3 (Tim-3), an immune checkpoint receptor that impairs antitumor immunity, from the surface of AML and MDS cells.",24855276_8,0,-1,2,-1,23850,-1,0.99922013,0.00046065976,0.00031921416
23855,factor-,12,13,89,97,"Our results suggest RepSox may reduce Tim-3 expression by inhibiting transforming growth factor- signaling and slow decay of CD34(+) AML cells by increasing CXCL12 and MYC, two factors that inhibit AML cell differentiation.",24855276_9,0,1,-1,-1,23855,-1,0.99972755,0.00013217184,0.00014022469
23859,two factors that,28,31,174,190,"Our results suggest RepSox may reduce Tim-3 expression by inhibiting transforming growth factor- signaling and slow decay of CD34(+) AML cells by increasing CXCL12 and MYC, two factors that inhibit AML cell differentiation.",24855276_9,-1,-1,-1,-1,23859,-1,6.740649e-05,0.99990404,2.857539e-05
23865,T-cell,4,5,24,30,"An increasing number of T-cell epitopes derived from various tumor-associated antigens have been reported, and they proved to play significant roles for tumor rejection both in vivo and in vitro.",24861249_0,-1,1,2,-1,23865,-1,3.798476e-05,6.402752e-05,0.99989796
23866,tumor-associated antigens,9,11,61,86,"An increasing number of T-cell epitopes derived from various tumor-associated antigens have been reported, and they proved to play significant roles for tumor rejection both in vivo and in vitro.",24861249_0,-1,-1,-1,-1,23866,-1,0.028778985,0.96441066,0.0068103382
23868,to play,18,20,123,130,"An increasing number of T-cell epitopes derived from various tumor-associated antigens have been reported, and they proved to play significant roles for tumor rejection both in vivo and in vitro.",24861249_0,-1,-1,-1,-1,23868,-1,2.2291242e-05,0.999967,1.0787762e-05
23872,protein,16,17,85,92,"Over 85% of Ewing's sarcoma family of tumors (ESFTs) express tumor-specific chimeric protein EWS/FLI-1, making it an attractive target for therapeutic cytotoxic T-lymphocyte responses.",24861249_1,0,1,-1,-1,23872,-1,4.989345e-05,0.99990904,4.1102958e-05
23874,therapeutic cytotoxic T-lymphocyte,25,28,139,173,"Over 85% of Ewing's sarcoma family of tumors (ESFTs) express tumor-specific chimeric protein EWS/FLI-1, making it an attractive target for therapeutic cytotoxic T-lymphocyte responses.",24861249_1,-1,-1,-1,-1,23874,-1,0.003505134,0.13227007,0.86422473
23875,peptide,6,7,28,35,"Here, we identified a novel peptide epitope derived from the EWS/FLI-1 protein and demonstrated that effectors induced by the peptide could specifically secrete IFN- and lyse the tumor cell line of EWS/FLI-1-positive and HLA-matched cells.",24861249_2,0,-1,2,-1,23875,-1,9.251974e-05,0.99985147,5.5991877e-05
23877,protein,12,13,71,78,"Here, we identified a novel peptide epitope derived from the EWS/FLI-1 protein and demonstrated that effectors induced by the peptide could specifically secrete IFN- and lyse the tumor cell line of EWS/FLI-1-positive and HLA-matched cells.",24861249_2,0,1,-1,-1,23877,-1,4.776613e-05,0.9999087,4.3489817e-05
23879,the peptide,19,21,122,133,"Here, we identified a novel peptide epitope derived from the EWS/FLI-1 protein and demonstrated that effectors induced by the peptide could specifically secrete IFN- and lyse the tumor cell line of EWS/FLI-1-positive and HLA-matched cells.",24861249_2,-1,-1,-1,-1,23879,-1,3.8737584e-05,0.99994445,1.679403e-05
23881,the tumor cell,27,30,176,190,"Here, we identified a novel peptide epitope derived from the EWS/FLI-1 protein and demonstrated that effectors induced by the peptide could specifically secrete IFN- and lyse the tumor cell line of EWS/FLI-1-positive and HLA-matched cells.",24861249_2,-1,-1,-1,-1,23881,-1,0.0027665803,0.8493105,0.14792287
23894,peptide,12,13,68,75,"Therefore, these data provide evidence for the use of the EWS/FLI-l peptide epitope in T cell-based immunotherapeutic concepts against Ewing's sarcoma cell in vitro and in vivo.",24861249_4,0,-1,2,-1,23894,-1,0.0009703908,0.9972792,0.001750407
23897,Toll-like receptor,5,7,24,42,PURPOSE: Imiquimod is a Toll-like receptor 7 agonist used topically to treat external genital warts and basal cell carcinoma.,24893628_0,-1,-1,-1,-1,23897,-1,0.0020723508,0.9722778,0.02564983
23898,topically to treat,10,13,58,76,PURPOSE: Imiquimod is a Toll-like receptor 7 agonist used topically to treat external genital warts and basal cell carcinoma.,24893628_0,-1,-1,-1,-1,23898,-1,3.52539e-05,0.9999504,1.4381259e-05
23912,the IFN receptor,22,25,130,147,"Recruitment was not dependent upon the specificity of the activated CD8(+) T cells, but was significantly reduced in mice lacking the IFN receptor.",24893628_3,-1,-1,-1,-1,23912,-1,0.03052347,0.8270568,0.14241976
23916,to IFN receptor,21,24,144,160,"Intravaginal imiquimod deposition induced upregulation of CXCL9 and CXCL10 mRNA expression in the genital tract, which are produced in response to IFN receptor signaling and attract cells expressing their ligand, CXCR3.",24893628_4,-1,-1,-1,-1,23916,-1,0.0538505,0.92559826,0.020551302
23919,The T cells,0,3,0,11,"The T cells attracted by imiquimod to the cervicovaginal tract expressed CXCR3 as well as CD49a, an integrin involved in homing and retention of CD8(+) T cells at mucosal sites.",24893628_5,-1,-1,-1,-1,23919,-1,0.0028837172,0.1306622,0.86645406
23920,to the,6,8,35,41,"The T cells attracted by imiquimod to the cervicovaginal tract expressed CXCR3 as well as CD49a, an integrin involved in homing and retention of CD8(+) T cells at mucosal sites.",24893628_5,-1,-1,-1,-1,23920,-1,2.0844385e-05,0.9999678,1.1349823e-05
23925,T cells to the,19,23,155,169,Our results indicate that intramuscular CRT/E7 vaccination in conjunction with intravaginal imiquimod deposition recruits antigen-specific CXCR3(+) CD8(+) T cells to the genital tract.,24893628_6,-1,-1,-1,-1,23925,-1,0.0028537253,0.14790602,0.8492403
23932,the tumor,8,10,64,73,Our findings support accumulating evidence that manipulation of the tumor microenvironment can enhance the therapeutic efficacy of strategies that induce tumor-specific T cells.,24893628_9,-1,-1,-1,-1,23932,-1,1.852355e-05,0.9999728,8.648493e-06
23933,the therapeutic,13,15,103,118,Our findings support accumulating evidence that manipulation of the tumor microenvironment can enhance the therapeutic efficacy of strategies that induce tumor-specific T cells.,24893628_9,-1,-1,-1,-1,23933,-1,2.1481854e-05,0.99996996,8.522178e-06
23935,tumor-specific T cells,20,23,154,176,Our findings support accumulating evidence that manipulation of the tumor microenvironment can enhance the therapeutic efficacy of strategies that induce tumor-specific T cells.,24893628_9,-1,-1,-1,-1,23935,-1,0.0036034014,0.78517956,0.21121705
23942,IFN-activated STAT2,3,5,16,35,Yet evidence of IFN-activated STAT2 as having tumor suppressor function in vivo and participation in antitumor immunity is lacking.,24895110_1,-1,-1,-1,-1,23942,-1,0.99393773,0.0048668734,0.00119544
23944,function,9,10,63,71,Yet evidence of IFN-activated STAT2 as having tumor suppressor function in vivo and participation in antitumor immunity is lacking.,24895110_1,0,1,2,-1,23944,-1,0.00010153712,0.99983823,6.0183025e-05
23945,immunity,16,17,111,119,Yet evidence of IFN-activated STAT2 as having tumor suppressor function in vivo and participation in antitumor immunity is lacking.,24895110_1,0,-1,2,-1,23945,-1,0.99945885,0.0003299946,0.0002110898
23946,tumor transplantation,6,8,28,49,Here we show in a syngeneic tumor transplantation model that STAT2 reduces tumor growth.,24895110_2,-1,-1,-1,-1,23946,-1,2.0079353e-05,0.9999697,1.01406995e-05
23947,that STAT2,9,11,56,66,Here we show in a syngeneic tumor transplantation model that STAT2 reduces tumor growth.,24895110_2,-1,-1,-1,-1,23947,-1,2.515653e-05,0.99996376,1.102888e-05
23952,IFN- treatment,0,2,0,15,IFN- treatment of Stat2(-/-) mice did not cause tumor regression.,24895110_4,-1,-1,-1,-1,23952,-1,0.9944483,0.0035810242,0.001970577
23955,analysis,2,3,16,24,Gene expression analysis revealed a small subset of immunomodulatory genes to be downregulated in tumors established in Stat2(-/-) mice.,24895110_5,0,1,-1,-1,23955,-1,2.6274674e-05,0.9999528,2.092811e-05
23957,genes to,9,11,69,77,Gene expression analysis revealed a small subset of immunomodulatory genes to be downregulated in tumors established in Stat2(-/-) mice.,24895110_5,-1,-1,-1,-1,23957,-1,2.1622554e-05,0.99996376,1.4556483e-05
23959,tumor antigen,4,6,23,36,"Additionally, we found tumor antigen cross-presentation by Stat2(-/-) dendritic cells to T cells to be impaired.",24895110_6,-1,-1,-1,-1,23959,-1,0.32821983,0.6648067,0.0069734254
23960,cells to T cells to,11,16,80,99,"Additionally, we found tumor antigen cross-presentation by Stat2(-/-) dendritic cells to T cells to be impaired.",24895110_6,-1,-1,-1,-1,23960,-1,0.002925013,0.057889253,0.9391856
23962,tumor antigen,3,5,21,34,Adoptive transfer of tumor antigen specific CD8(+) T cells primed by Stat2(-/-) dendritic cells into tumor-bearing Stat2(-/-) mice did not induce tumor regression with IFN- intervention.,24895110_7,-1,-1,-1,-1,23962,-1,0.26647645,0.7264765,0.007047079
23972,IFN--treated tumor-bearing,22,24,103,130,We observed that an increase in the number of CD4(+) and CD8(+) T cells in the draining lymph nodes of IFN--treated tumor-bearing WT mice was absent in IFN- treated Stat2(-/-) mice.,24895110_8,-1,-1,-1,-1,23972,-1,0.95172143,0.04526921,0.0030093123
23974,IFN- treated,29,31,153,166,We observed that an increase in the number of CD4(+) and CD8(+) T cells in the draining lymph nodes of IFN--treated tumor-bearing WT mice was absent in IFN- treated Stat2(-/-) mice.,24895110_8,-1,-1,-1,-1,23974,-1,0.9952813,0.0034764828,0.0012422396
23976,STAT2 function,9,11,59,73,Thus our study provides evidence for further evaluation of STAT2 function in cancer patients receiving type I IFN based immunotherapy.,24895110_9,-1,-1,-1,-1,23976,-1,2.5087309e-05,0.99996066,1.4213734e-05
23979,the therapeutic,6,8,41,56,BACKGROUND: Recent reports have revealed the therapeutic potential of cell-mediated immunity in neoplasms such as cutaneous squamous cell carcinoma (SCC).OBJECTIVES: To define the antigenic coexpression of regulatory T cells (Tregs) and plasmacytoid dendritic cells (pDCs) and assess the CD8(+) /Foxp3(+) CD25(+) cell ratio at peritumoral and intratumoral levels in order to investigate a correlation with the aggressiveness of SCC tumours.,24910265_0,-1,-1,-1,-1,23979,-1,2.0744645e-05,0.99997115,8.1421795e-06
23983,the antigenic,24,26,176,189,BACKGROUND: Recent reports have revealed the therapeutic potential of cell-mediated immunity in neoplasms such as cutaneous squamous cell carcinoma (SCC).OBJECTIVES: To define the antigenic coexpression of regulatory T cells (Tregs) and plasmacytoid dendritic cells (pDCs) and assess the CD8(+) /Foxp3(+) CD25(+) cell ratio at peritumoral and intratumoral levels in order to investigate a correlation with the aggressiveness of SCC tumours.,24910265_0,-1,-1,-1,-1,23983,-1,0.08354777,0.91333145,0.0031208033
24004,transforming growth factor,22,25,114,140,"We determined the profiles of Tregs and CD123(+) cells; immunostained for CD4, CD8, CD123, interleukin (IL)-1 and transforming growth factor (TGF)-1; and unequivocally double stained for Foxp3CD25.RESULTS: Peritumorally, CD4, CD8 and Foxp3 expression showed no difference between the two groups.",24910265_2,-1,-1,-1,-1,24004,-1,0.8625216,0.13276686,0.004711521
24006,the two,46,48,281,288,"We determined the profiles of Tregs and CD123(+) cells; immunostained for CD4, CD8, CD123, interleukin (IL)-1 and transforming growth factor (TGF)-1; and unequivocally double stained for Foxp3CD25.RESULTS: Peritumorally, CD4, CD8 and Foxp3 expression showed no difference between the two groups.",24910265_2,-1,-1,-1,-1,24006,-1,2.3746265e-05,0.99996495,1.12738235e-05
24010,The Foxp3(+,0,2,0,11,"The Foxp3(+) CD25(+) /Foxp3(+) ratio was higher in G2-G3 cases (P=00005), confirming the trend in this group of activated T lymphocytes towards total Treg Foxp3(+) cells, while the CD8(+) /Foxp3(+) CD25(+) ratio was higher in G1 (P=00005).",24910265_4,-1,-1,-1,-1,24010,-1,0.000119460856,0.999782,9.855742e-05
24011,the trend,22,24,88,97,"The Foxp3(+) CD25(+) /Foxp3(+) ratio was higher in G2-G3 cases (P=00005), confirming the trend in this group of activated T lymphocytes towards total Treg Foxp3(+) cells, while the CD8(+) /Foxp3(+) CD25(+) ratio was higher in G1 (P=00005).",24910265_4,-1,-1,-1,-1,24011,-1,2.7541837e-05,0.999961,1.1491749e-05
24013,T lymphocytes towards total Treg Foxp3(+,29,35,125,165,"The Foxp3(+) CD25(+) /Foxp3(+) ratio was higher in G2-G3 cases (P=00005), confirming the trend in this group of activated T lymphocytes towards total Treg Foxp3(+) cells, while the CD8(+) /Foxp3(+) CD25(+) ratio was higher in G1 (P=00005).",24910265_4,-1,-1,-1,-1,24013,-1,0.0054705804,0.10401558,0.8905138
24025,to that,10,12,47,54,The CD8(+) /Foxp3(+) CD25(+) ratio was similar to that observed in peritumoral infiltration.,24910265_7,-1,-1,-1,-1,24025,-1,2.5836469e-05,0.9999628,1.137112e-05
24030,T-cell,32,33,166,172,"CONCLUSIONS: Our data suggest that intratumoral recruitment of Tregs, high expression of TGF-1 and IL-10, almost negative CD123+, and a low CD8(+) /Foxp3(+) CD25(+) T-cell ratio may contribute to the aggressiveness of cutaneous SCC, as already evidenced for other solid tumours.",24910265_8,-1,1,2,-1,24030,-1,3.4189023e-05,5.099754e-05,0.99991477
24031,to the,36,38,194,200,"CONCLUSIONS: Our data suggest that intratumoral recruitment of Tregs, high expression of TGF-1 and IL-10, almost negative CD123+, and a low CD8(+) /Foxp3(+) CD25(+) T-cell ratio may contribute to the aggressiveness of cutaneous SCC, as already evidenced for other solid tumours.",24910265_8,-1,-1,-1,-1,24031,-1,2.3827306e-05,0.9999664,9.787859e-06
24033,T-cell,3,4,24,30,Patients with cutaneous T-cell lymphoma (CTCL) are frequently colonized with Staphylococcus aureus (SA).,24957145_0,-1,1,2,-1,24033,-1,5.0571656e-05,5.9042442e-05,0.99989045
24040,to Stat3-mediated interleukin-10,26,29,159,191,"Here, we show that SA isolates from involved skin express staphylococcal enterotoxins (SEs) that induce crosstalk between malignant and benign T cells leading to Stat3-mediated interleukin-10 (IL-10) production by the malignant T cells.",24957145_2,-1,-1,-1,-1,24040,-1,0.1131405,0.8844678,0.0023917437
24052,T cells to,25,28,169,179,"Instead, SEs triggered a cascade of events involving cell-cell and asymmetric cytokine interactions between malignant and benign T cells, which stimulated the malignant T cells to express high levels of IL-10.",24957145_4,-1,-1,-1,-1,24052,-1,0.0014704623,0.030617984,0.9679116
24057,the immune dysregulation,16,19,101,125,Much evidence supports that malignant activation of the Stat3/IL-10 axis plays a key role in driving the immune dysregulation and severe immunodeficiency that characteristically develops in CTCL patients.,24957145_5,-1,-1,-1,-1,24057,-1,6.7117995e-05,0.99989986,3.2961627e-05
24083,T-cell,4,5,16,22,The CD4 and CD8 T-cell role was analyzed in vitro and in vivo.,24987872_4,-1,1,2,-1,24083,-1,3.1679872e-05,4.7619884e-05,0.9999207
24094,the tumor,18,20,115,124,In vitro assays and immunohistochemical analyses revealed the recruitment of T effector cells and CD8 T cells into the tumor area.,24987872_7,-1,-1,-1,-1,24094,-1,1.9327515e-05,0.9999707,1.0016843e-05
24100,therapy,1,2,13,20,Photodynamic therapy (PDT) by selective photosensitization of cancer cells and subsequent laser application results in local tumor necrosis.,25005268_0,0,1,-1,-1,24100,-1,2.716709e-05,0.9999559,1.6893446e-05
24104,function,8,9,38,46,"However, the effects of PDT on immune function, which may depend on the type of immune response, are controversial.",25005268_1,0,1,2,-1,24104,-1,0.00011636688,0.9997931,9.048896e-05
24105,the type,14,16,68,76,"However, the effects of PDT on immune function, which may depend on the type of immune response, are controversial.",25005268_1,-1,-1,-1,-1,24105,-1,3.0350067e-05,0.9999571,1.2571028e-05
24109,function,16,17,92,100,We investigated the immunological changes induced by PDT and the effect of PDT on level and function of regulatory T cells (Treg) in patients with invasive esophageal squamous cell carcinoma (ESCC).,25005268_2,0,1,2,-1,24109,-1,5.3400443e-05,0.99990916,3.739638e-05
24113,blood,4,5,22,27,We analyzed patient's blood samples before and after PDT.,25005268_3,0,1,-1,-1,24113,-1,0.0001240852,0.9992422,0.00063372264
24114,Blood,0,1,0,5,"Blood CD4+CD25+CD127-FoxP3+ Treg levels were quantified by FACS, and Treg function was evaluated by coculture proliferation assays with T effector (Teff) cells.",25005268_4,0,1,-1,-1,24114,-1,3.1476247e-05,0.9999403,2.819955e-05
24116,Treg function,11,13,69,82,"Blood CD4+CD25+CD127-FoxP3+ Treg levels were quantified by FACS, and Treg function was evaluated by coculture proliferation assays with T effector (Teff) cells.",25005268_4,-1,-1,-1,-1,24116,-1,4.4690813e-05,0.99991,4.533415e-05
24125,Treg function,5,7,21,34,The effect of PDT on Treg function at Day 7 was accompanied by slight but statistically significant increases in peripheral neutrophil granulocytes (p = 0.035) and monocytes (p = 0.013) and a statistically significant increase (approximately 18-fold) in serum IL-6 levels (p = 0.008).,25005268_6,-1,-1,-1,-1,24125,-1,3.3826054e-05,0.99992645,3.9696635e-05
24129,Treg function,5,7,29,42,"In conclusion, PDT abolished Treg function, possibly due to increased IL-6 levels in treated ESCC patients.",25005268_7,-1,-1,-1,-1,24129,-1,4.4847075e-05,0.9999032,5.194969e-05
24136,functions to,11,13,59,71,STAT3 is highly activated in a wide variety of cancers and functions to promote tumor survival.,25015826_0,-1,-1,-1,-1,24136,-1,4.855757e-05,0.99993014,2.1331198e-05
24140,this treatment,20,22,130,144,"We previously reported that blocking STAT3 activation inhibited human hepatocellular carcinoma (HCC) growth in vitro, but whether this treatment also triggered antitumor immune responses in vivo remained unknown.",25015826_1,-1,-1,-1,-1,24140,-1,2.7447906e-05,0.9999627,9.911277e-06
24145,the STAT3,8,10,38,47,"In this study, we found that blocking the STAT3 pathway in HCC cells dramatically inhibited murine HCC growth in vivo and prolonged survival of tumor-bearing mice.",25015826_2,-1,-1,-1,-1,24145,-1,1.8899547e-05,0.9999702,1.09205e-05
24154,function,11,12,67,75,"In T cell-deficient nude mice, a unique NK cell-mediated antitumor function against STAT3-blocked HCC was suggested.",25015826_4,0,1,2,-1,24154,-1,0.00026384837,0.9994367,0.0002994165
24163,TGF- cytokines,9,11,64,79,"Furthermore, regulatory T cells and immunosuppressive IL-10 and TGF- cytokines were reduced in mice bearing STAT3-blocked HCC cells, suggesting that these factors may be involved in HCC-induced NK cell suppression.",25015826_6,-1,-1,-1,-1,24163,-1,0.030243957,0.9678083,0.0019477713
24166,that these factors,21,24,145,163,"Furthermore, regulatory T cells and immunosuppressive IL-10 and TGF- cytokines were reduced in mice bearing STAT3-blocked HCC cells, suggesting that these factors may be involved in HCC-induced NK cell suppression.",25015826_6,-1,-1,-1,-1,24166,-1,4.613467e-05,0.99993515,1.8730187e-05
24173,The transcription factor,0,3,0,24,The transcription factor NF-B is central to inflammatory signaling and activation of innate and adaptive immune responses.,25024217_0,-1,-1,-1,-1,24173,-1,2.384226e-05,0.9999634,1.2807001e-05
24178,the tnfaip3 gene,22,25,151,167,"Activation of the NF-B pathway is tightly controlled by several negative feedback mechanisms, including A20, an ubiquitin-modifying enzyme encoded by the tnfaip3 gene.",25024217_1,-1,-1,-1,-1,24178,-1,4.1584113e-05,0.9999361,2.2345104e-05
24185,T-cell functions,28,30,158,174,"As we observed high expression of A20 transcripts in dysfunctional CD8 T cells in an autochthonous melanoma, we analyzed the role of A20 in regulation of CD8 T-cell functions, using mice in which A20 was selectively deleted in mature conventional T cells.",25024217_3,-1,-1,-1,-1,24185,-1,4.4265387e-05,6.822933e-05,0.9998876
24191,to antigen,7,9,50,60,"A20-deleted CD8 T cells had increased sensitivity to antigen stimulation with production of large amounts of IL-2 and IFN, correlated with sustained nuclear expression of NF-B components reticuloendotheliosis oncogene c-Rel and p65.",25024217_5,-1,-1,-1,-1,24191,-1,0.26773813,0.72544694,0.00681493
24205,TNF,11,12,79,83,Tumor-infiltrating A20-deleted CD8 T cells had enhanced production of IFN and TNF and reduced expression of the inhibitory receptor programmed cell death 1.,25024217_8,0,1,-1,-1,24205,-1,9.7369404e-05,0.99987984,2.2731647e-05
24207,receptor,18,19,125,133,Tumor-infiltrating A20-deleted CD8 T cells had enhanced production of IFN and TNF and reduced expression of the inhibitory receptor programmed cell death 1.,25024217_8,0,1,2,-1,24207,-1,7.320852e-05,8.046627e-05,0.99984634
24212,targeted to,27,29,141,152,"As manipulation of A20 expression in CD8 T cells did not result in pathologic manifestations in the mice, we propose it as a candidate to be targeted to increase antitumor efficiency of adoptive T-cell immunotherapy.",25024217_9,-1,-1,-1,-1,24212,-1,2.1637221e-05,0.9999685,9.775493e-06
24213,T-cell,34,35,195,201,"As manipulation of A20 expression in CD8 T cells did not result in pathologic manifestations in the mice, we propose it as a candidate to be targeted to increase antitumor efficiency of adoptive T-cell immunotherapy.",25024217_9,-1,1,2,-1,24213,-1,3.337882e-05,4.5143286e-05,0.99992144
24215,immune responses through,6,9,34,58,"Cancer cells may escape from host immune responses through active suppression of the immune response, but the detailed mechanisms in colorectal cancer remain to be elucidated.",25034363_0,-1,-1,-1,-1,24215,-1,0.85511607,0.14222626,0.0026577509
24216,the immune response,12,15,81,100,"Cancer cells may escape from host immune responses through active suppression of the immune response, but the detailed mechanisms in colorectal cancer remain to be elucidated.",25034363_0,-1,-1,-1,-1,24216,-1,0.40269813,0.5955097,0.0017921481
24222,tissues,11,12,66,73,"In this study, 108 colorectal tumor samples and their peritumoral tissues were collected for immunohistochemistry of infiltrating lymphocytes.",25034363_1,-1,1,2,-1,24222,-1,5.218034e-05,0.9997757,0.00017214727
24225,Tregs cells,2,4,8,19,"Th1 and Tregs cells were determined by the positiveexpression of T-bet and FOXP3 proteins, respectively.",25034363_2,-1,-1,-1,-1,24225,-1,0.0005176229,0.011422255,0.98806006
24228,FOXP3 proteins,14,16,76,90,"Th1 and Tregs cells were determined by the positiveexpression of T-bet and FOXP3 proteins, respectively.",25034363_2,-1,-1,-1,-1,24228,-1,2.3224915e-05,0.99995923,1.758009e-05
24229,The Tr1 cells,0,3,0,13,The Tr1 cells were identified by CD49b and LAG-3 protein expression.,25034363_3,-1,-1,-1,-1,24229,-1,0.00329264,0.4548297,0.5418777
24231,IL-17-positive cells,0,2,0,20,IL-17-positive cells were identified by IL-17 expression.,25034363_4,-1,-1,-1,-1,24231,-1,0.4322516,0.0032251969,0.5645232
24233,that the,2,4,15,23,"Results showed that the percentage of T-bet-positive cells was significantly decreased, while the percentages of IL-17-, FOXP3-, CD49b-, and LAG-3-positive cells were significantly increased in tumor tissues compared to that in peritumoral tissues.",25034363_5,-1,-1,-1,-1,24233,-1,1.8020643e-05,0.9999709,1.1016723e-05
24234,T-bet-positive cells,6,8,38,58,"Results showed that the percentage of T-bet-positive cells was significantly decreased, while the percentages of IL-17-, FOXP3-, CD49b-, and LAG-3-positive cells were significantly increased in tumor tissues compared to that in peritumoral tissues.",25034363_5,-1,-1,-1,-1,24234,-1,0.0019669267,0.8863453,0.11168769
24239,tumor tissues,29,31,194,207,"Results showed that the percentage of T-bet-positive cells was significantly decreased, while the percentages of IL-17-, FOXP3-, CD49b-, and LAG-3-positive cells were significantly increased in tumor tissues compared to that in peritumoral tissues.",25034363_5,-1,-1,-1,-1,24239,-1,2.2450984e-05,0.9999559,2.1710492e-05
24240,to that,32,34,217,224,"Results showed that the percentage of T-bet-positive cells was significantly decreased, while the percentages of IL-17-, FOXP3-, CD49b-, and LAG-3-positive cells were significantly increased in tumor tissues compared to that in peritumoral tissues.",25034363_5,-1,-1,-1,-1,24240,-1,2.6358579e-05,0.9999577,1.590465e-05
24241,tissues,36,37,240,247,"Results showed that the percentage of T-bet-positive cells was significantly decreased, while the percentages of IL-17-, FOXP3-, CD49b-, and LAG-3-positive cells were significantly increased in tumor tissues compared to that in peritumoral tissues.",25034363_5,-1,1,2,-1,24241,-1,3.8690312e-05,0.99986005,0.0001012364
24245,cells to T-bet-positive cells,11,15,55,84,"The ratio of IL-17-, FOXP3-, CD49b-, and LAG3-positive cells to T-bet-positive cells was significantly higher in tumor tissues than in peritumoral tissues.",25034363_6,-1,-1,-1,-1,24245,-1,0.00030927896,0.0007598751,0.9989309
24246,tumor tissues than,19,22,113,131,"The ratio of IL-17-, FOXP3-, CD49b-, and LAG3-positive cells to T-bet-positive cells was significantly higher in tumor tissues than in peritumoral tissues.",25034363_6,-1,-1,-1,-1,24246,-1,2.04353e-05,0.9999653,1.4195459e-05
24247,tissues,24,25,147,154,"The ratio of IL-17-, FOXP3-, CD49b-, and LAG3-positive cells to T-bet-positive cells was significantly higher in tumor tissues than in peritumoral tissues.",25034363_6,-1,1,2,-1,24247,-1,3.904395e-05,0.9998579,0.00010301849
24249,IL-17-positive cells,4,6,31,51,"The percentage of infiltrating IL-17-positive cells in tumor tissues was negatively associated with lymph metastasis, invasion, and TNM stage.",25034363_7,-1,-1,-1,-1,24249,-1,0.7196265,0.0019182507,0.27845526
24250,tumor tissues,7,9,55,68,"The percentage of infiltrating IL-17-positive cells in tumor tissues was negatively associated with lymph metastasis, invasion, and TNM stage.",25034363_7,-1,-1,-1,-1,24250,-1,3.550056e-05,0.9999162,4.8278e-05
24257,Tr1 cells,6,8,36,45,The percentage of positive Th17 and Tr1 cells is a marker for poor prognosis in patients with CRC.,25034363_9,-1,-1,-1,-1,24257,-1,0.0008888631,0.040519394,0.9585918
24261,IL-17-positive cells,22,24,134,154,"In conclusion, decreased composition of regulative Th1 cells and increased composition of FOXP(+) Tregs-, CD49b(+)/LAG-3(+) Tr1-, and IL-17-positive cells in tumor tissues may be associated with the progression of colorectal cancer.",25034363_10,-1,-1,-1,-1,24261,-1,0.82639146,0.0015628509,0.17204574
24262,tumor tissues,25,27,158,171,"In conclusion, decreased composition of regulative Th1 cells and increased composition of FOXP(+) Tregs-, CD49b(+)/LAG-3(+) Tr1-, and IL-17-positive cells in tumor tissues may be associated with the progression of colorectal cancer.",25034363_10,-1,-1,-1,-1,24262,-1,2.434128e-05,0.999956,1.9596595e-05
24266,Tr1-positive cells,6,8,34,52,The high percentage of IL-17- and Tr1-positive cells in tumor tissues is a predictive marker for poor prognosis of colorectal cancer.,25034363_11,-1,-1,-1,-1,24266,-1,0.0028587587,0.7662173,0.23092401
24267,tumor tissues,9,11,56,69,The high percentage of IL-17- and Tr1-positive cells in tumor tissues is a predictive marker for poor prognosis of colorectal cancer.,25034363_11,-1,-1,-1,-1,24267,-1,2.947239e-05,0.9999387,3.182388e-05
24269,protein osteopontin,2,4,18,37,"The matricellular protein osteopontin (OPN, Spp-1) is widely associated with cancer aggressiveness when produced by tumor cells, but its impact is uncertain when produced by leukocytes in the context of the tumor stroma.",25035397_0,-1,-1,-1,-1,24269,-1,0.96532214,0.02924008,0.005437762
24270,tumor cells,18,20,116,127,"The matricellular protein osteopontin (OPN, Spp-1) is widely associated with cancer aggressiveness when produced by tumor cells, but its impact is uncertain when produced by leukocytes in the context of the tumor stroma.",25035397_0,-1,-1,-1,-1,24270,-1,0.004489749,0.3930998,0.6024105
24272,the tumor,34,36,203,212,"The matricellular protein osteopontin (OPN, Spp-1) is widely associated with cancer aggressiveness when produced by tumor cells, but its impact is uncertain when produced by leukocytes in the context of the tumor stroma.",25035397_0,-1,-1,-1,-1,24272,-1,2.1759935e-05,0.99996865,9.610071e-06
24274,tumor cells,13,15,67,78,"In a broad study using Spp1(-/-) mice along with gene silencing in tumor cells, we obtained evidence of distinct and common activities of OPN when produced by tumor or host cells in a spontaneously metastatic model of breast cancer.",25035397_1,-1,-1,-1,-1,24274,-1,0.0042433217,0.51756275,0.47819394
24278,tumor cells,16,18,108,119,"Different cellular localization of OPN is associated with its distinct activities, being mainly secreted in tumor cells while intracellular in myeloid cells.",25035397_2,-1,-1,-1,-1,24278,-1,0.0046343673,0.4548316,0.5405341
24280,tumor cells,3,5,16,27,"OPN produced by tumor cells supported their survival in the blood stream, whereas both tumor- and host-derived OPN, particularly from myeloid cells, rendered the metastatic site more immunosuppressive.",25035397_3,-1,-1,-1,-1,24280,-1,0.0039666193,0.3266742,0.66935915
24282,the blood,9,11,56,65,"OPN produced by tumor cells supported their survival in the blood stream, whereas both tumor- and host-derived OPN, particularly from myeloid cells, rendered the metastatic site more immunosuppressive.",25035397_3,-1,-1,-1,-1,24282,-1,4.1685427e-05,0.9999224,3.5967038e-05
24295,than their,11,13,65,75,"Notably, monocytic MDSCs in Spp1(-/-) mice were less suppressive than their wild-type counterparts due to lower expression of arginase-1, IL6, and phospho-Stat3.",25035397_7,-1,-1,-1,-1,24295,-1,2.2705786e-05,0.99996316,1.4069828e-05
24302,functions,6,7,36,45,"Overall, our results unveiled novel functions for OPN in shaping local immunosuppression in the lung metastatic niche.",25035397_10,0,1,2,-1,24302,-1,8.663798e-05,0.99987304,4.0343653e-05
24304,TEL-AML the,2,4,12,23,BACKGROUND: TEL-AML the most common genetic alteration in childhood precursor B acute lymphoblastic leukemia (BCP-ALL) is associated with a favorable prognosis.,25062112_0,-1,-1,-1,-1,24304,-1,2.9554041e-05,0.9999511,1.9332947e-05
24308,factor receptor,13,15,85,100,PATIENTS AND METHOD: We studied the expression of nerve growth factor/tumor necrosis factor receptor (NGFR/TNFR)/ligand family members on 108 primary BCP-ALL samples by flow cytometry and compared both their baseline expression and CD40-induced modulation on TEL-AML positive and negative leukemia samples.,25062112_1,-1,-1,-1,-1,24308,-1,0.82668406,0.0105801225,0.16273573
24311,that TEL-AML,5,7,34,46,"RESULTS: Our findings demonstrate that TEL-AML positive patients exhibit a significantly higher percentage of CD40, CD27 and p75NTR positive blasts at diagnosis.",25062112_2,-1,-1,-1,-1,24311,-1,8.207293e-05,0.99986494,5.293385e-05
24314,to the,4,6,27,33,This might well contribute to the improved relapse-free survival of these patients assessed in Kaplan Meier analysis as CD27 and p75NTR directly mediate apoptotic signals.,25062112_3,-1,-1,-1,-1,24314,-1,2.7105103e-05,0.99996233,1.0591567e-05
24317,analysis,16,17,108,116,This might well contribute to the improved relapse-free survival of these patients assessed in Kaplan Meier analysis as CD27 and p75NTR directly mediate apoptotic signals.,25062112_3,0,1,-1,-1,24317,-1,5.2086478e-05,0.9999007,4.7201298e-05
24336,factors,61,62,408,415,CONCLUSION: These data provide novel insights in immunological control mechanisms preserved in this leukemia subtype and suggest that not only treatment with chemicals such as HDAC inhibitors but also retained in vivo response to CD40 ligation contributes to improved immune surveillance in these patients which may add to a superior relapse-free survival observed particularly in the presence of other risk factors.,25062112_5,0,1,-1,-1,24336,-1,0.010541951,0.9879711,0.001486956
24343,function,7,8,36,44,"Here, we analyzed the phenotype and function of dendritic cells (DCs), and the frequency of IL-10-producing regulatory B cells (Breg) and Foxp3(+) regulatory T cells (Treg) in different stages of N-nitrosodiethylamine (DEN)-induced rat HCC in order to understand their roles in this disease.",25066760_2,0,1,2,-1,24343,-1,3.9054943e-05,0.9999335,2.749547e-05
24359,that the,3,5,14,22,We also found that the frequency of IL-10-producing Breg and CD4(+)CD25(+)Foxp3(+) Treg in HCC rats was obviously increased during all of these three stages.,25066760_4,-1,-1,-1,-1,24359,-1,1.6758868e-05,0.99997413,9.090902e-06
24362,these three,22,24,138,149,We also found that the frequency of IL-10-producing Breg and CD4(+)CD25(+)Foxp3(+) Treg in HCC rats was obviously increased during all of these three stages.,25066760_4,-1,-1,-1,-1,24362,-1,3.3423265e-05,0.9999436,2.296854e-05
24367,that the,3,5,20,28,Our results suggest that the dysfunction of DCs and the increase of IL-10-producing Breg and Foxp3(+) Treg might play important roles in HCC progression.,25066760_7,-1,-1,-1,-1,24367,-1,1.8130073e-05,0.99997306,8.851647e-06
24378,peptide,37,38,246,253,"Here, for the first time, we developed a novel combination adjuvant alum-polysaccharide-HH2 (APH) with potent immunomodulating activities, consisting of alum, polysaccharide of Escherichia coli and the synthetic cationic innate defense regulator peptide HH2.METHODS: The adjuvant effects of APH were examined using NY-ESO-1 protein-based vaccines in prophylactic and therapeutic models.",25070035_2,0,-1,2,-1,24378,-1,0.0005757368,0.99897987,0.00044439835
24380,protein-based,49,50,324,337,"Here, for the first time, we developed a novel combination adjuvant alum-polysaccharide-HH2 (APH) with potent immunomodulating activities, consisting of alum, polysaccharide of Escherichia coli and the synthetic cationic innate defense regulator peptide HH2.METHODS: The adjuvant effects of APH were examined using NY-ESO-1 protein-based vaccines in prophylactic and therapeutic models.",25070035_2,0,1,-1,-1,24380,-1,0.00067554833,0.99838006,0.0009443962
24384,therapy,17,18,124,131,We further determined the immunogenicity and anti-tumor effect of NY-ESO-1-APH (NAPH) vaccine using adoptive cellular/serum therapy in C57/B6 and nude mice.,25070035_3,0,1,-1,-1,24384,-1,2.5230423e-05,0.99995947,1.5265012e-05
24392,TNF-,21,22,147,152,"RESULTS: The APH complex significantly promoted antigen uptake, maturation and cross-presentation of dendritic cells and enhanced the secretion of TNF-, MCP-1 and IFN- by human peripheral blood mononuclear cells compared with individual components.",25070035_5,0,1,-1,-1,24392,-1,8.9796216e-05,0.9998766,3.35132e-05
24395,blood,29,30,190,195,"RESULTS: The APH complex significantly promoted antigen uptake, maturation and cross-presentation of dendritic cells and enhanced the secretion of TNF-, MCP-1 and IFN- by human peripheral blood mononuclear cells compared with individual components.",25070035_5,0,1,-1,-1,24395,-1,0.00014128903,0.9993148,0.000543966
24401,therapy,5,6,36,43,"In addition, passive serum/cellular therapy potently inhibited tumor growth of NY-ESO-1-B16.",25070035_7,0,1,-1,-1,24401,-1,2.187079e-05,0.9999641,1.3965262e-05
24411,cellular immune responses to,18,22,118,146,"Therefore, NAPH vaccination effectively stimulated innate immunity, and boosted both arms of the adaptive humoral and cellular immune responses to suppress tumorigenesis and growth of melanoma.",25070035_9,-1,-1,-1,-1,24411,-1,0.0672853,0.08556251,0.8471521
24429,T-cell,22,23,130,136,"Cytokine-matured DCs are regularly used, but to induce memory-type CTLs, they require additional activation stimuli, such as CD4+ T-cell help or TLR activation.",25100611_1,-1,1,2,-1,24429,-1,3.755597e-05,4.9276037e-05,0.9999132
24454,the tumorigenicity,3,5,30,48,"Embelin substantially reduced the tumorigenicity of pancreatic cancer cells in vivo, which was associated with reduced inflammatory cells and immune suppressive cells, IL-17A(+) Th17, GM-CSF(+) Th, MDSCs and Treg, through inhibition of IL-6 secretion.",25128650_3,-1,-1,-1,-1,24454,-1,2.5083827e-05,0.999962,1.2950905e-05
24465,IL-6-induced STAT3,4,6,27,45,"Moreover, embelin decrease IL-6-induced STAT3 phosphorylation.",25128650_4,-1,-1,-1,-1,24465,-1,0.96044123,0.03390929,0.0056494223
24479,the regulatory T cells,20,24,139,161,"After co-culturing with IDO expressing or control vector-transfected 2LL-EGFP cells, T cell apoptosis was determined and the proportion of the regulatory T cells (Tregs) and CD8+ T cell subset was measured.",25138378_4,-1,-1,-1,-1,24479,-1,0.0019110353,0.066066794,0.9320222
24481,CD8+ T cell subset,28,33,174,192,"After co-culturing with IDO expressing or control vector-transfected 2LL-EGFP cells, T cell apoptosis was determined and the proportion of the regulatory T cells (Tregs) and CD8+ T cell subset was measured.",25138378_4,-1,-1,-1,-1,24481,-1,6.837337e-05,7.427233e-05,0.9998573
24482,The total cellular protein,0,4,0,26,The total cellular protein samples of 2 LL-EGFP-IDO cells were isolated for detecting JAK-STAT1 signalling pathway.,25138378_5,-1,-1,-1,-1,24482,-1,0.00011224388,0.9994591,0.00042863897
24502,analysis,13,14,79,87,"Increased expression of IDO, p-JAK1 and p-STAT1 were confirmed by Western blot analysis.",25138378_10,0,1,-1,-1,24502,-1,2.9242608e-05,0.99995077,1.9939498e-05
24519,therapeutic tool to,7,10,50,69,"Therefore, targeting angiogenesis is an important therapeutic tool to reduce MM progression.",25142285_1,-1,-1,-1,-1,24519,-1,2.2970315e-05,0.9999665,1.056779e-05
24539,to this,25,27,161,168,"Moreover, we observed a reduction in proliferation, migration and network formation and an induction of apoptosis upon exposure of murine endothelial cell lines to this conditioned medium.",25142285_6,-1,-1,-1,-1,24539,-1,2.7491318e-05,0.99995804,1.44524765e-05
24540,that the,3,5,24,32,"We furthermore observed that the JAK-STAT signaling pathway was highly activated in endothelial cells in response to stimulated iNKT cells, indicating the possible role of IFN- in the anti-angiogenic process.",25142285_7,-1,-1,-1,-1,24540,-1,1.7723776e-05,0.9999739,8.348072e-06
24549,cells to target,11,14,74,89,"In conclusion, these results highlight the possibility of recruiting iNKT cells to target MM and angiogenesis.",25142285_8,-1,-1,-1,-1,24549,-1,0.0062556127,0.4376809,0.5560635
24552,their therapeutic,15,17,114,131,This gives a rationale for combining immunotherapy with conventional anti-tumour treatments in view of increasing their therapeutic potential.,25142285_9,-1,-1,-1,-1,24552,-1,3.2921314e-05,0.999956,1.1039065e-05
24565,urine,52,53,324,329,"Although several studies assessing the potential prognostic value of InfBMs in cancer have been published in the past decades, they have had no impact on the management of patients with urothelial bladder carcinoma (UBC).OBJECTIVE: To review and summarise the scientific literature on the prognostic value of tumour, serum, urine, and germline DNA InfBMs on UBC.EVIDENCE ACQUISITION: A systematic review of the literature was performed searching the Medline and Embase databases for original articles published between January 1975 and November 2013.",25151017_2,0,1,-1,-1,24565,-1,6.9235386e-05,0.9998871,4.3686454e-05
24570,analysis,10,11,61,69,The main inclusion criterion was the provision of a survival analysis (Kaplan-Meier and/or Cox) according to the Reporting Recommendations for Tumor Marker Prognostic Studies guidelines for the assessment of prognostic markers.,25151017_3,0,1,-1,-1,24570,-1,7.3316594e-05,0.9998348,9.182947e-05
24571,to the,17,19,106,112,The main inclusion criterion was the provision of a survival analysis (Kaplan-Meier and/or Cox) according to the Reporting Recommendations for Tumor Marker Prognostic Studies guidelines for the assessment of prognostic markers.,25151017_3,-1,-1,-1,-1,24571,-1,2.8847888e-05,0.99995923,1.1884114e-05
24578,missing relevant,6,8,39,55,Main limitations of these studies were missing relevant information about design or analysis and heterogeneous methodology used.,25151017_7,-1,-1,-1,-1,24578,-1,0.00770279,0.9919693,0.00032794775
24579,analysis,12,13,84,92,Main limitations of these studies were missing relevant information about design or analysis and heterogeneous methodology used.,25151017_7,0,1,-1,-1,24579,-1,8.5643616e-05,0.9998098,0.00010460733
24581,tumour cells,6,8,47,59,"Inflammatory cells, costimulatory molecules in tumour cells, and serum cytokines showed prognostic significance, mainly in univariable analyses.",25151017_8,-1,-1,-1,-1,24581,-1,0.0044069337,0.20859085,0.7870022
24583,protein,2,3,16,23,High C-reactive protein values were consistently reported as an independent prognostic factor for mortality in invasive UBC.CONCLUSIONS: There is a dearth of studies on InfBMs in UBC compared with other tumour types.,25151017_9,0,1,-1,-1,24583,-1,0.14104204,0.8318338,0.027124163
24584,factor,11,12,87,93,High C-reactive protein values were consistently reported as an independent prognostic factor for mortality in invasive UBC.CONCLUSIONS: There is a dearth of studies on InfBMs in UBC compared with other tumour types.,25151017_9,0,1,-1,-1,24584,-1,0.0009908949,0.9988462,0.00016286544
24586,tumour types,31,33,203,215,High C-reactive protein values were consistently reported as an independent prognostic factor for mortality in invasive UBC.CONCLUSIONS: There is a dearth of studies on InfBMs in UBC compared with other tumour types.,25151017_9,-1,-1,-1,-1,24586,-1,3.9704937e-05,0.9999143,4.5946574e-05
24590,the translational,8,10,57,74,"Currently, methodological drawbacks of the studies limit the translational potential of results.",25151017_11,-1,-1,-1,-1,24590,-1,3.2238044e-05,0.9999504,1.730882e-05
24611,the tumor,9,11,49,58,"In murine tumor systems, HMGB1 was ubiquitous in the tumor microenvironment, activating the NF-B signal transduction pathway in MDSCs and regulating their quantity and quality.",25164013_6,-1,-1,-1,-1,24611,-1,2.2112254e-05,0.9999683,9.62959e-06
24618,to their,16,18,102,110,"We found that HMGB1 promotes the development of MDSCs from bone marrow progenitor cells, contributing to their ability to suppress antigen-driven activation of CD4(+) and CD8(+) T cells.",25164013_7,-1,-1,-1,-1,24618,-1,2.965844e-05,0.99995637,1.39784515e-05
24625,the T-cell,26,28,181,191,"Furthermore, HMGB1 increased MDSC-mediated production of IL-10, enhanced crosstalk between MDSCs and macrophages, and facilitated the ability of MDSCs to downregulate expression of the T-cell homing receptor L-selectin.",25164013_8,-1,-1,-1,-1,24625,-1,0.0025130224,0.104862705,0.89262426
24626,receptor,29,30,199,207,"Furthermore, HMGB1 increased MDSC-mediated production of IL-10, enhanced crosstalk between MDSCs and macrophages, and facilitated the ability of MDSCs to downregulate expression of the T-cell homing receptor L-selectin.",25164013_8,0,1,2,-1,24626,-1,0.00022172193,0.00045350372,0.9993248
24631,tissues,12,13,86,93,The increased number of CD4(+)CD25(+)Treg cells in tumor local and peripheral splenic tissues is related to the low immune function as well as to tumor recurrence and metastasis.,25168696_0,-1,1,2,-1,24631,-1,0.00014931009,0.99709284,0.0027578084
24632,related to the,14,17,97,111,The increased number of CD4(+)CD25(+)Treg cells in tumor local and peripheral splenic tissues is related to the low immune function as well as to tumor recurrence and metastasis.,25168696_0,-1,-1,-1,-1,24632,-1,2.515207e-05,0.999961,1.3813765e-05
24633,function,19,20,123,131,The increased number of CD4(+)CD25(+)Treg cells in tumor local and peripheral splenic tissues is related to the low immune function as well as to tumor recurrence and metastasis.,25168696_0,0,1,2,-1,24633,-1,0.0007576151,0.99886775,0.00037468737
24634,to tumor,23,25,143,151,The increased number of CD4(+)CD25(+)Treg cells in tumor local and peripheral splenic tissues is related to the low immune function as well as to tumor recurrence and metastasis.,25168696_0,-1,-1,-1,-1,24634,-1,2.2119782e-05,0.99996734,1.0593853e-05
24637,functions,20,21,131,140,Our pre-clinical studies showed that low-dose radiation (LDR) of the spleen in liver cancer patients significantly improves immune functions.,25168696_1,0,1,2,-1,24637,-1,0.0005993317,0.99882525,0.0005754121
24647,the blood,21,23,148,157,"Using the diethylnitrosamine (DEN)-induced rat liver tumor model and in vitro cell experiments, the percentage of CD4(+)CD25(+)Treg/CD4(+) cells in the blood and the expressions of Foxp3(+), IL-10, TGF-, and cytotoxic T lymphocyte-associated antigen-4(CTLA-4) in spleen and liver tumors significantly decreased after LDR of the spleen in rats with liver cancer.",25168696_4,-1,-1,-1,-1,24647,-1,4.0701634e-05,0.99990857,5.0764407e-05
24652,T lymphocyte-associated antigen-4(CTLA-4,36,39,219,259,"Using the diethylnitrosamine (DEN)-induced rat liver tumor model and in vitro cell experiments, the percentage of CD4(+)CD25(+)Treg/CD4(+) cells in the blood and the expressions of Foxp3(+), IL-10, TGF-, and cytotoxic T lymphocyte-associated antigen-4(CTLA-4) in spleen and liver tumors significantly decreased after LDR of the spleen in rats with liver cancer.",25168696_4,-1,-1,-1,-1,24652,-1,0.00011115013,0.000114902854,0.9997739
24655,The tumors,0,2,0,10,"The tumors became smaller than those in the non-radiated group, with both showing a parallel relation.",25168696_5,-1,-1,-1,-1,24655,-1,1.8781975e-05,0.99996686,1.4390769e-05
24656,than those,4,6,26,36,"The tumors became smaller than those in the non-radiated group, with both showing a parallel relation.",25168696_5,-1,-1,-1,-1,24656,-1,2.532508e-05,0.9999523,2.2371227e-05
24667,function,17,18,125,133,"This process also changed CTLA-4 molecule expression on the surfaces of CD4(+)CD25(+)Treg cells and reduced their inhibitory function against CD4(+)CD25(-)T cell proliferation, and the suppression function of CD4(+)CD25(+)Treg cells was further weakened with the introduction of the CTLA-4 inhibitor.",25168696_8,0,1,2,-1,24667,-1,0.0008344762,0.99823546,0.00093003013
24670,function,26,27,197,205,"This process also changed CTLA-4 molecule expression on the surfaces of CD4(+)CD25(+)Treg cells and reduced their inhibitory function against CD4(+)CD25(-)T cell proliferation, and the suppression function of CD4(+)CD25(+)Treg cells was further weakened with the introduction of the CTLA-4 inhibitor.",25168696_8,0,1,2,-1,24670,-1,0.00013031194,0.9997445,0.00012523709
24673,the CTLA-4,37,39,279,289,"This process also changed CTLA-4 molecule expression on the surfaces of CD4(+)CD25(+)Treg cells and reduced their inhibitory function against CD4(+)CD25(-)T cell proliferation, and the suppression function of CD4(+)CD25(+)Treg cells was further weakened with the introduction of the CTLA-4 inhibitor.",25168696_8,-1,-1,-1,-1,24673,-1,0.00225635,0.086742364,0.91100127
24674,that the,2,4,21,29,Findings demonstrate that the reduction of CTLA-4 expression on the CD4(+)CD25(+)Treg cell surface and the further inhibition of cell function may be considered as important regulators of LDR-induced immunomodulatory effects.,25168696_9,-1,-1,-1,-1,24674,-1,1.7636548e-05,0.99997365,8.681341e-06
24679,cell function,18,20,129,142,Findings demonstrate that the reduction of CTLA-4 expression on the CD4(+)CD25(+)Treg cell surface and the further inhibition of cell function may be considered as important regulators of LDR-induced immunomodulatory effects.,25168696_9,-1,-1,-1,-1,24679,-1,4.4760178e-05,6.401872e-05,0.99989116
24695,to that,18,20,116,123,"Herein, we characterize the postpartum murine mammary gland and find an orchestrated influx of immune cells similar to that which occurs during wound healing.",25187059_3,-1,-1,-1,-1,24695,-1,2.9889568e-05,0.9999553,1.4754291e-05
24699,the transient,15,17,89,102,"Further, the normal involuting gland may be in an immunosuppressed state as discerned by the transient presence of Foxp3(+) regulatory T cells and IL-10(+) macrophages with T cell suppressive function.",25187059_4,-1,-1,-1,-1,24699,-1,2.3917231e-05,0.9999654,1.0665442e-05
24704,function,32,33,192,200,"Further, the normal involuting gland may be in an immunosuppressed state as discerned by the transient presence of Foxp3(+) regulatory T cells and IL-10(+) macrophages with T cell suppressive function.",25187059_4,0,1,2,-1,24704,-1,0.0021920265,0.96736586,0.03044214
24720,cytokine IL-10,9,11,80,94,"Targeting involution with a neutralizing antibody against the immunosuppressive cytokine IL-10 reduces tumor growth in involution group mice but not in nulliparous mice, implicating the involution microenvironment as the primary target of IL-10 treatment.",25187059_7,-1,-1,-1,-1,24720,-1,0.9998572,3.984902e-05,0.000102984435
24726,Relevance to,0,2,0,12,"Relevance to women is implicated, as we find postlactational human breast tissue has transient high IL-10(+) and Foxp3(+) immune cell infiltrate.",25187059_8,-1,-1,-1,-1,24726,-1,4.5301596e-05,0.99993455,2.0105646e-05
24727,tissue,12,13,74,80,"Relevance to women is implicated, as we find postlactational human breast tissue has transient high IL-10(+) and Foxp3(+) immune cell infiltrate.",25187059_8,-1,1,2,-1,24727,-1,9.455325e-05,0.99919873,0.0007067553
24749,Then the,0,2,0,8,Then the vaccine was injected into C57BL/6J mice and the effect was examined.,25198660_3,-1,-1,-1,-1,24749,-1,1.8704126e-05,0.99997234,8.981932e-06
24751,that the,3,5,16,24,"Our study found that the vaccine could promote the proliferation of antigen-specific T cells, enhance the killing activity of cytotoxic T lymphocytes (CTLs), promote Th1-type cell-mediated secretion of cytokines IFN- and IL-2 while inhibiting Th2-type cell-mediated secretion of IL-4, and inhibit the secretion of TGF-.",25198660_4,-1,-1,-1,-1,24751,-1,1.8077766e-05,0.9999734,8.49487e-06
24753,antigen-specific T cells,11,14,68,92,"Our study found that the vaccine could promote the proliferation of antigen-specific T cells, enhance the killing activity of cytotoxic T lymphocytes (CTLs), promote Th1-type cell-mediated secretion of cytokines IFN- and IL-2 while inhibiting Th2-type cell-mediated secretion of IL-4, and inhibit the secretion of TGF-.",25198660_4,-1,-1,-1,-1,24753,-1,0.38383737,0.0031759758,0.6129866
24757,Th1-type cell-mediated,28,30,166,188,"Our study found that the vaccine could promote the proliferation of antigen-specific T cells, enhance the killing activity of cytotoxic T lymphocytes (CTLs), promote Th1-type cell-mediated secretion of cytokines IFN- and IL-2 while inhibiting Th2-type cell-mediated secretion of IL-4, and inhibit the secretion of TGF-.",25198660_4,-1,-1,-1,-1,24757,-1,0.0018459577,0.38640562,0.61174834
24758,cytokines IFN-,32,34,202,217,"Our study found that the vaccine could promote the proliferation of antigen-specific T cells, enhance the killing activity of cytotoxic T lymphocytes (CTLs), promote Th1-type cell-mediated secretion of cytokines IFN- and IL-2 while inhibiting Th2-type cell-mediated secretion of IL-4, and inhibit the secretion of TGF-.",25198660_4,-1,-1,-1,-1,24758,-1,0.9998667,3.3362867e-05,9.9876874e-05
24759,Th2-type cell-mediated,38,40,244,266,"Our study found that the vaccine could promote the proliferation of antigen-specific T cells, enhance the killing activity of cytotoxic T lymphocytes (CTLs), promote Th1-type cell-mediated secretion of cytokines IFN- and IL-2 while inhibiting Th2-type cell-mediated secretion of IL-4, and inhibit the secretion of TGF-.",25198660_4,-1,-1,-1,-1,24759,-1,0.0018911101,0.38238883,0.61572003
24766,therapy,22,23,152,159,"Generally, the epigenetically modified vaccine could enhance the body's antitumor immune response, providing feasibility research on cancer vaccine for therapy of pancreatic cancer.",25198660_5,0,1,-1,-1,24766,-1,2.6168855e-05,0.9999598,1.3996697e-05
24769,therapy,9,10,69,76,The long-lasting clinical response by lymphoma patients to anti-CD20 therapy has been attributed to the induction of an anti-tumor adaptive immunity.,25231744_0,0,1,-1,-1,24769,-1,2.4816278e-05,0.99996257,1.265595e-05
24770,to the,13,15,97,103,The long-lasting clinical response by lymphoma patients to anti-CD20 therapy has been attributed to the induction of an anti-tumor adaptive immunity.,25231744_0,-1,-1,-1,-1,24770,-1,2.223131e-05,0.9999689,8.851306e-06
24776,tumor immunity,4,6,17,31,"Here, we compare tumor immunity in tumor-bearing animals that did or did not receive anti-CD20 treatment.",25231744_2,-1,-1,-1,-1,24776,-1,0.0019228369,0.9979305,0.00014666333
24790,therapy,3,4,22,29,"Strikingly, anti-CD20 therapy reversed the initial expansion of Tregs, and was accompanied by a marked increase in the number of Th1 cells, with no detectable change in Th2 and Th17 cell numbers.",25231744_4,0,1,-1,-1,24790,-1,2.1117356e-05,0.99996746,1.14673e-05
24796,Th17 cell,32,34,177,186,"Strikingly, anti-CD20 therapy reversed the initial expansion of Tregs, and was accompanied by a marked increase in the number of Th1 cells, with no detectable change in Th2 and Th17 cell numbers.",25231744_4,-1,-1,-1,-1,24796,-1,0.0026649777,0.12679672,0.8705383
24805,the transfer,15,17,78,90,"Also, CD4(+) effector memory T cells were evidenced in surviving animals, and the transfer of CD4(+) T cells induced long-term protection.",25231744_6,-1,-1,-1,-1,24805,-1,2.1429423e-05,0.99996674,1.179361e-05
24808,therapy,3,4,16,23,"Thus, anti-CD20 therapy promotes strong anti-tumor adaptive immunity, opposes Treg expansion and inhibits tumor cells from maintaining an immunosuppressive environment.",25231744_7,0,1,-1,-1,24808,-1,2.0724221e-05,0.9999685,1.0728233e-05
24811,tumor cells,15,17,106,117,"Thus, anti-CD20 therapy promotes strong anti-tumor adaptive immunity, opposes Treg expansion and inhibits tumor cells from maintaining an immunosuppressive environment.",25231744_7,-1,-1,-1,-1,24811,-1,0.004385144,0.4095252,0.5860897
24813,T cells that,9,12,73,85,"CD1d-restricted NKT cells represent a unique lineage of immunoregulatory T cells that are divided into two groups, type I and type II, based on their TCR usage. Because there are no specific tools to identify type II NKT cells, little is known about their developmental requirements and functional regulation.",25236978_0,-1,-1,-1,-1,24813,-1,0.0013331915,0.028369516,0.9702973
24817,their TCR,26,28,144,153,"CD1d-restricted NKT cells represent a unique lineage of immunoregulatory T cells that are divided into two groups, type I and type II, based on their TCR usage. Because there are no specific tools to identify type II NKT cells, little is known about their developmental requirements and functional regulation.",25236978_0,-1,-1,-1,-1,24817,-1,4.697575e-05,0.999925,2.8001776e-05
24819,tools to,35,37,191,199,"CD1d-restricted NKT cells represent a unique lineage of immunoregulatory T cells that are divided into two groups, type I and type II, based on their TCR usage. Because there are no specific tools to identify type II NKT cells, little is known about their developmental requirements and functional regulation.",25236978_0,-1,-1,-1,-1,24819,-1,3.308399e-05,0.99995387,1.30308335e-05
24823,functional regulation,51,53,287,308,"CD1d-restricted NKT cells represent a unique lineage of immunoregulatory T cells that are divided into two groups, type I and type II, based on their TCR usage. Because there are no specific tools to identify type II NKT cells, little is known about their developmental requirements and functional regulation.",25236978_0,-1,-1,-1,-1,24823,-1,3.4587658e-05,0.99994576,1.9605366e-05
24826,protein,13,14,91,98,"In our previous study, we showed that signaling lymphocytic activation molecule associated protein (SAP) is essential for the development of type II NKT cells.",25236978_1,0,1,-1,-1,24826,-1,4.196117e-05,0.99991226,4.5715307e-05
24831,TCR transgenic,7,9,31,45,"Here, using a type II NKT-cell TCR transgenic mouse model, we demonstrated that CD1d-expressing hematopoietic cells, but not thymic epithelial cells, meditate efficient selection of type II NKT cells.",25236978_2,-1,-1,-1,-1,24831,-1,2.033357e-05,0.99996245,1.7227114e-05
24840,protein,17,18,110,117,"Furthermore, we showed that SAP regulates type II NKT-cell development by controlling early growth response 2 protein and promyelocytic leukemia zinc finger expression.",25236978_3,0,1,-1,-1,24840,-1,6.151922e-05,0.9999002,3.8273887e-05
24842,transgenic T cells,2,5,19,37,SAP-deficient 24 transgenic T cells (24 T cells) exhibited an immature phenotype with reduced Th2 cytokine-producing capacity and diminished cytotoxicity to CD1d-expressing lymphoma cells.,25236978_4,-1,-1,-1,-1,24842,-1,0.0014049758,0.03825946,0.96033555
24844,Th2 cytokine-producing,16,18,98,120,SAP-deficient 24 transgenic T cells (24 T cells) exhibited an immature phenotype with reduced Th2 cytokine-producing capacity and diminished cytotoxicity to CD1d-expressing lymphoma cells.,25236978_4,-1,-1,-1,-1,24844,-1,0.18647078,0.80742615,0.0061030835
24849,IFN regulatory factor,13,16,87,108,The impaired IL-4 production by SAP-deficient 24 T cells was associated with reduced IFN regulatory factor 4 and GATA-3 induction following TCR stimulation.,25236978_5,-1,-1,-1,-1,24849,-1,0.968385,0.023934329,0.007680724
24851,TCR,21,22,142,145,The impaired IL-4 production by SAP-deficient 24 T cells was associated with reduced IFN regulatory factor 4 and GATA-3 induction following TCR stimulation.,25236978_5,-1,1,2,-1,24851,-1,2.4591765e-05,0.99995637,1.909138e-05
24856,these T cells,3,6,22,35,Aberrant responses of these T cells may contribute to the immune dysregulation observed in X-linked lymphoproliferative disease caused by mutations in SAP.,25236978_7,-1,-1,-1,-1,24856,-1,0.0019622303,0.0833834,0.9146544
24857,to the immune dysregulation,8,12,51,78,Aberrant responses of these T cells may contribute to the immune dysregulation observed in X-linked lymphoproliferative disease caused by mutations in SAP.,25236978_7,-1,-1,-1,-1,24857,-1,6.0919294e-05,0.99991286,2.621236e-05
24864,relevant TH-1-polarized immune responses,22,26,155,195,"To further elucidate why an allogeneic gene-modified [interleukin-7 (IL-7)/CD80-cotransfected] renal cell cancer (RCC) vaccine failed to induce clinically relevant TH-1-polarized immune responses, peripheral blood mononuclear cells from enrolled study patients were analyzed by gene expression profiling (GEP) both prior and after vaccination.",25242680_1,-1,-1,-1,-1,24864,-1,0.023758529,0.97548157,0.0007598967
24865,blood,28,29,208,213,"To further elucidate why an allogeneic gene-modified [interleukin-7 (IL-7)/CD80-cotransfected] renal cell cancer (RCC) vaccine failed to induce clinically relevant TH-1-polarized immune responses, peripheral blood mononuclear cells from enrolled study patients were analyzed by gene expression profiling (GEP) both prior and after vaccination.",25242680_1,0,1,-1,-1,24865,-1,5.005984e-05,0.9998368,0.000113124246
24870,factors,23,24,189,196,"At baseline before vaccination, a profound downregulation of gene signatures associated with antigen presentation, immune response/T cells, cytokines/chemokines and signaling/transcription factors was observed in RCC patients as compared to healthy controls.",25242680_2,0,1,-1,-1,24870,-1,2.7444024e-05,0.9999491,2.348478e-05
24875,that the,6,8,40,48,"Most interestingly, our results suggest that the nuclear factor-kappa B signaling pathway might be involved in the impairment of immunological responsiveness and the observed TH-2 deviation.",25242680_4,-1,-1,-1,-1,24875,-1,1.7663284e-05,0.999974,8.280044e-06
24876,factor-kappa,9,10,57,69,"Most interestingly, our results suggest that the nuclear factor-kappa B signaling pathway might be involved in the impairment of immunological responsiveness and the observed TH-2 deviation.",25242680_4,0,1,-1,-1,24876,-1,3.2253723e-05,0.9999504,1.7296376e-05
24887,the cellular,9,11,50,62,"During the past decade, a better understanding of the cellular and molecular mechanisms underlying tumor immunity has provided the appropriate framework for the development of therapeutic strategies for cancer immunotherapy.",25253145_0,-1,-1,-1,-1,24887,-1,0.005550924,0.6972855,0.29716358
24888,tumor immunity,15,17,99,113,"During the past decade, a better understanding of the cellular and molecular mechanisms underlying tumor immunity has provided the appropriate framework for the development of therapeutic strategies for cancer immunotherapy.",25253145_0,-1,-1,-1,-1,24888,-1,0.00028715256,0.99966884,4.401759e-05
24892,this complex,1,3,6,18,"Under this complex scenario, galectins have emerged as promising molecular targets for cancer therapy responsible of creating immunosuppressive microenvironments at sites of tumor growth and metastasis.",25253145_1,-1,-1,-1,-1,24892,-1,3.6278238e-05,0.9999478,1.5978074e-05
24894,therapy,14,15,94,101,"Under this complex scenario, galectins have emerged as promising molecular targets for cancer therapy responsible of creating immunosuppressive microenvironments at sites of tumor growth and metastasis.",25253145_1,0,1,-1,-1,24894,-1,2.462297e-05,0.9999627,1.2733713e-05
24898,to thwart the,13,16,74,87,"Galectins, expressed in tumor, stromal, and endothelial cells, contribute to thwart the development of immune responses by favoring the expansion of T regulatory cells and contributing to their immunosuppressive activity, driving the differentiation of tolerogenic dendritic cells, limiting T cell viability, and maintaining T cell anergy.",25253145_2,-1,-1,-1,-1,24898,-1,2.5558855e-05,0.9999628,1.1627376e-05
24903,to their,30,32,185,193,"Galectins, expressed in tumor, stromal, and endothelial cells, contribute to thwart the development of immune responses by favoring the expansion of T regulatory cells and contributing to their immunosuppressive activity, driving the differentiation of tolerogenic dendritic cells, limiting T cell viability, and maintaining T cell anergy.",25253145_2,-1,-1,-1,-1,24903,-1,2.7531802e-05,0.999959,1.345423e-05
24907,limiting T cell,43,46,282,297,"Galectins, expressed in tumor, stromal, and endothelial cells, contribute to thwart the development of immune responses by favoring the expansion of T regulatory cells and contributing to their immunosuppressive activity, driving the differentiation of tolerogenic dendritic cells, limiting T cell viability, and maintaining T cell anergy.",25253145_2,-1,-1,-1,-1,24907,-1,0.003082704,0.0021975946,0.9947196
24921,The tumor-promoting,0,2,0,19,The tumor-promoting effect of inflammation is now widely recognized and understood.,25258409_1,-1,-1,-1,-1,24921,-1,3.316113e-05,0.99995565,1.1197299e-05
24922,that treatment,4,6,29,43,"Recent studies have revealed that treatment with nicotine ameliorates colitis in humans and experimental murine models, whereas the effect of nicotine on colitis-associated colonic tumorigenesis remains unclear.",25258409_2,-1,-1,-1,-1,24922,-1,2.0751353e-05,0.9999703,8.927055e-06
24933,receptor,9,10,67,75,Nicotine and a selective agonist of the 7-nicotinic acetylcholine receptor (7-nAChR) reduced the severity of DSS-induced acute colonic inflammation.,25258409_5,0,1,2,-1,24933,-1,0.0013175454,0.79166013,0.20702228
24936,the IL-6,22,24,142,150,"In addition, the suppressive effect of nicotine on acute colitis was attenuated by an antagonist of 7-nAChR. Furthermore, nicotine inhibited the IL-6 production of CD4 T cells in the DSS-induced inflamed colonic mucosa.",25258409_6,-1,-1,-1,-1,24936,-1,0.6816336,0.31245592,0.005910461
24943,TNF-,6,7,45,50,Nicotine markedly inhibited the elevation of TNF- and IL-6 mRNA as well as phosphorylated signal transducer and activator of transcription (Stat) 3 expression in the colons of the tumor model mice.,25258409_8,0,1,-1,-1,24943,-1,4.1390376e-05,0.99993646,2.2113321e-05
24948,the tumor,29,31,177,186,Nicotine markedly inhibited the elevation of TNF- and IL-6 mRNA as well as phosphorylated signal transducer and activator of transcription (Stat) 3 expression in the colons of the tumor model mice.,25258409_8,-1,-1,-1,-1,24948,-1,1.787724e-05,0.9999713,1.0883758e-05
24957,TNF-,40,41,290,295,"These results demonstrate that nicotine suppresses acute colitis and colitis-associated tumorigenesis, and this effect may be associated with the activation of 7-nAChR. Furthermore, it is presumed that nicotine downregulates the expression of inflammatory mediators such as IL-6/Stat3 and TNF-, thereby reducing the colonic tumorigenesis associated with chronic colitis.",25258409_9,0,1,-1,-1,24957,-1,6.411214e-05,0.99991596,1.9896162e-05
24964,the cytokines they release,2,6,13,39,"Depending on the cytokines they release and the immune responses they mediate, CD4(+) T cells are classically divided into two major cell populations: Th1 and Th2 cells.",25261206_1,-1,-1,-1,-1,24964,-1,0.00015299211,0.99979085,5.612004e-05
24965,the immune responses they,7,11,44,69,"Depending on the cytokines they release and the immune responses they mediate, CD4(+) T cells are classically divided into two major cell populations: Th1 and Th2 cells.",25261206_1,-1,-1,-1,-1,24965,-1,0.00031149597,0.99960726,8.130857e-05
24972,T-helper cell subsets,11,14,80,101,"However, recent studies challenged this Th1/Th2 paradigm by discovering several T-helper cell subsets with specific differentiation program and functions, including Th17 cells, Treg cells, andTfh cells.",25261206_2,-1,-1,-1,-1,24972,-1,0.0003301063,0.0017130885,0.99795675
24973,functions,19,20,144,153,"However, recent studies challenged this Th1/Th2 paradigm by discovering several T-helper cell subsets with specific differentiation program and functions, including Th17 cells, Treg cells, andTfh cells.",25261206_2,0,1,2,-1,24973,-1,0.00033948553,0.9993249,0.00033566004
24974,"Th17 cells, Treg cells",22,27,165,187,"However, recent studies challenged this Th1/Th2 paradigm by discovering several T-helper cell subsets with specific differentiation program and functions, including Th17 cells, Treg cells, andTfh cells.",25261206_2,-1,-1,-1,-1,24974,-1,0.00017089825,0.0005134388,0.9993156
24975,Tfh cells,30,32,193,202,"However, recent studies challenged this Th1/Th2 paradigm by discovering several T-helper cell subsets with specific differentiation program and functions, including Th17 cells, Treg cells, andTfh cells.",25261206_2,-1,-1,-1,-1,24975,-1,0.00096958294,0.017178152,0.9818523
24978,the Th17,13,15,81,89,"In this chapter, we summarize the current understanding and recent progresses on the Th17 lineage differentiation and its effector impacts on variety of inflammatory responses or disease pathogenesis.",25261206_3,-1,-1,-1,-1,24978,-1,3.162937e-05,0.99994755,2.0855934e-05
24984,tolerance to tumor antigens,18,22,96,123,"Dendritic cells (DC) that interact with T cells represent a crucial site for the development of tolerance to tumor antigens, but there remains incomplete knowledge about how DC-tolerizing signals evolve during tumorigenesis.",25261236_1,-1,-1,-1,-1,24984,-1,0.052537374,0.94445086,0.003011716
24990,receptors,24,25,144,153,"In this study, we show that DCs isolated from patients with metastatic or locally advanced breast cancer express high levels of the adiponectin receptors AdipoR1 and AdipoR2, which are sufficient to blunt antitumor immunity.",25261236_2,0,1,2,-1,24990,-1,0.00051982654,0.984444,0.015036145
24992,immunity,35,36,215,223,"In this study, we show that DCs isolated from patients with metastatic or locally advanced breast cancer express high levels of the adiponectin receptors AdipoR1 and AdipoR2, which are sufficient to blunt antitumor immunity.",25261236_2,0,-1,2,-1,24992,-1,0.9994623,0.0003382301,0.0001994536
24993,receptor,13,14,109,117,Mechanistic investigations of ligand-receptor interactions on DCs revealed novel signaling pathways for each receptor.,25261236_3,0,1,2,-1,24993,-1,0.0011577683,0.07986967,0.9189726
25003,antigen-specific T-cell,20,22,128,151,"Stimulation of these pathways was sufficient to block activation of NF-B in DC, thereby attenuating their ability to stimulate antigen-specific T-cell responses.",25261236_5,-1,-1,-1,-1,25003,-1,0.3346219,0.0038057824,0.66157234
25007,therapy,24,25,160,167,"Furthermore, by defining a critical role for adiponectin signaling in this process, our work suggests new and broadly applicable strategies for immunometabolic therapy in patients with cancer.",25261236_7,0,1,-1,-1,25007,-1,2.3322013e-05,0.99996376,1.2889923e-05
25008,peptide,1,2,19,26,Latency-associated peptide (LAP) - expressing regulatory T cells (Tregs) are important for immunological self-tolerance and immune homeostasis.,25268580_0,0,-1,2,-1,25008,-1,0.0017099449,0.997221,0.0010691045
25018,blood,14,15,101,106,"The phenotypes, cytokine-release patterns, and suppressive ability of Tregs isolated from peripheral blood and tumor tissues were analyzed.",25268580_2,0,1,-1,-1,25018,-1,0.00011111729,0.9992268,0.00066201395
25019,tumor tissues,16,18,111,124,"The phenotypes, cytokine-release patterns, and suppressive ability of Tregs isolated from peripheral blood and tumor tissues were analyzed.",25268580_2,-1,-1,-1,-1,25019,-1,2.8456328e-05,0.99993443,3.7147904e-05
25020,that the,2,4,9,17,We found that the population of LAP-positive CD4Foxp3 Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects.,25268580_3,-1,-1,-1,-1,25020,-1,1.561104e-05,0.99997556,8.810839e-06
25022,blood,13,14,100,105,We found that the population of LAP-positive CD4Foxp3 Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects.,25268580_3,0,1,-1,-1,25022,-1,0.0001427697,0.9988115,0.0010457576
25023,tissues,16,17,117,124,We found that the population of LAP-positive CD4Foxp3 Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects.,25268580_3,-1,1,2,-1,25023,-1,0.0001269476,0.99803823,0.0018347919
25024,to that,22,24,153,160,We found that the population of LAP-positive CD4Foxp3 Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects.,25268580_3,-1,-1,-1,-1,25024,-1,2.1866705e-05,0.99996614,1.1929413e-05
25026,blood,27,28,179,184,We found that the population of LAP-positive CD4Foxp3 Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects.,25268580_3,0,1,-1,-1,25026,-1,0.00014350539,0.9984831,0.0013733641
25027,tissues,29,30,189,196,We found that the population of LAP-positive CD4Foxp3 Tregs significantly increased in peripheral blood and cancer tissues of CRC patients as compared to that in the peripheral blood and tissues of healthy subjects.,25268580_3,-1,1,2,-1,25027,-1,8.3536106e-05,0.99884146,0.0010750575
25030,tumor necrosis factor receptor,10,14,65,95,"However, LAP Tregs expressed more effector molecules, including tumor necrosis factor receptor II, granzyme B, perforin, Ki67, and CCR5, than their LAP negative counterparts.",25268580_5,-1,-1,-1,-1,25030,-1,0.41474637,0.18198879,0.40326485
25032,than their,26,28,138,148,"However, LAP Tregs expressed more effector molecules, including tumor necrosis factor receptor II, granzyme B, perforin, Ki67, and CCR5, than their LAP negative counterparts.",25268580_5,-1,-1,-1,-1,25032,-1,3.070982e-05,0.9999448,2.4495446e-05
25036,factor--mediated,14,15,89,106,"The in vitro immunosuppressive activity of LAP Tregs, exerted via a transforming growth factor--mediated mechanism, was more potent than that of LAP Tregs.",25268580_6,0,1,-1,-1,25036,-1,0.9850545,0.009075544,0.0058699525
25037,than that,20,22,134,143,"The in vitro immunosuppressive activity of LAP Tregs, exerted via a transforming growth factor--mediated mechanism, was more potent than that of LAP Tregs.",25268580_6,-1,-1,-1,-1,25037,-1,2.6123136e-05,0.99995744,1.6445798e-05
25041,blood,10,11,66,71,"Furthermore, the enrichment of LAP Treg population in peripheral blood mononuclear cells (PBMCs) of CRC patients correlated with cancer metastases.",25268580_7,0,1,-1,-1,25041,-1,0.0003528056,0.99529064,0.0043565575
25049,immune response to,17,20,108,126,The increased frequency of LAP Tregs in PBMCs of CRC patients suggests their potential role in controlling immune response to cancer and presents LAP as a marker of tumor-specific Tregs in CRC patients.,25268580_9,-1,-1,-1,-1,25049,-1,0.7482915,0.2491683,0.0025401746
25050,tumor-specific Tregs,28,30,166,186,The increased frequency of LAP Tregs in PBMCs of CRC patients suggests their potential role in controlling immune response to cancer and presents LAP as a marker of tumor-specific Tregs in CRC patients.,25268580_9,-1,-1,-1,-1,25050,-1,2.526249e-05,0.9999622,1.25113265e-05
25052,tumor-suppressor gene,9,11,49,70,"Runt-related transcription factor 3 (Runx3) is a tumor-suppressor gene and plays an important role in immune regulation, whose reduced expression may play an important role in the development and progression of gastric carcinoma.",25270738_0,-1,-1,-1,-1,25052,-1,2.9325523e-05,0.9999517,1.8980696e-05
25063,the relationship,25,27,145,161,The aim of this study was to investigate the role of Runx3 on the levels of transcription factors in patients with gastric carcinoma and analyze the relationship between the expression of Runx3 and Th1-type cytokines in peripheral blood mononuclear cells (PBMCs).,25270738_1,-1,-1,-1,-1,25063,-1,1.8293238e-05,0.99997175,9.931918e-06
25065,Th1-type cytokines,33,35,198,216,The aim of this study was to investigate the role of Runx3 on the levels of transcription factors in patients with gastric carcinoma and analyze the relationship between the expression of Runx3 and Th1-type cytokines in peripheral blood mononuclear cells (PBMCs).,25270738_1,-1,-1,-1,-1,25065,-1,0.02390024,0.9724549,0.003644814
25066,blood,37,38,231,236,The aim of this study was to investigate the role of Runx3 on the levels of transcription factors in patients with gastric carcinoma and analyze the relationship between the expression of Runx3 and Th1-type cytokines in peripheral blood mononuclear cells (PBMCs).,25270738_1,0,1,-1,-1,25066,-1,0.00048969046,0.98928165,0.010228661
25068,that the,3,5,19,27,"Our results showed that the expression levels of Runx3, T-bet, and IFN- in patients with gastric carcinoma were obviously lower than those in control groups, and there was a positive correlation between the expression of Runx3 and T-bet or IFN- in patients (p<0.01).",25270738_2,-1,-1,-1,-1,25068,-1,1.7073538e-05,0.9999732,9.767244e-06
25071,than those,22,24,129,139,"Our results showed that the expression levels of Runx3, T-bet, and IFN- in patients with gastric carcinoma were obviously lower than those in control groups, and there was a positive correlation between the expression of Runx3 and T-bet or IFN- in patients (p<0.01).",25270738_2,-1,-1,-1,-1,25071,-1,2.189448e-05,0.99996436,1.3741571e-05
25087,that the,38,40,242,250,"In order to further confirm this result, the Runx3 gene was constructed into pIRES2-eGFP and the recombined plasmid was transfected into SGC-7901 cells with liposome in vitro, the results obtained from the reverse transcription PCR indicated that the mRNA of Runx3, T-bet, or IFN- was significantly upregulated individually in Runx3 gene-transfected SGC-7901 cells.",25270738_3,-1,-1,-1,-1,25087,-1,1.7580283e-05,0.99997306,9.377554e-06
25092,that the,2,4,13,21,It suggested that the Runx3 and Th1-associated factors including T-bet and IFN- synchronization declines in gastric carcinoma may contribute to the development of cancer.,25270738_4,-1,-1,-1,-1,25092,-1,1.8578627e-05,0.9999721,9.33672e-06
25093,Th1-associated factors,6,8,32,54,It suggested that the Runx3 and Th1-associated factors including T-bet and IFN- synchronization declines in gastric carcinoma may contribute to the development of cancer.,25270738_4,-1,-1,-1,-1,25093,-1,4.9516246e-05,0.999899,5.1482657e-05
25096,to the,19,21,142,148,It suggested that the Runx3 and Th1-associated factors including T-bet and IFN- synchronization declines in gastric carcinoma may contribute to the development of cancer.,25270738_4,-1,-1,-1,-1,25096,-1,2.5533152e-05,0.99996376,1.06803245e-05
25097,immunity,7,8,59,67,Eosinophil granulocytes have been implicated in anticancer immunity but recent data indicate that eosinophils can also promote cancer.,25275020_0,0,-1,2,-1,25097,-1,0.9970241,0.0025403716,0.00043547887
25104,T-cells,16,17,137,144,"Importantly, 72% of patients with positive staining for phospho-signal-transducer-and-activator-of-transcription (pY-STAT3) in malignant T-cells also stained positively for eosinophils, whereas this was only observed in 28% of pY-STAT3-negative patients (p<0.01).",25275020_3,-1,1,2,-1,25104,-1,5.2255586e-05,0.00018068566,0.9997671
25106,T-cells,3,4,19,26,"Notably, malignant T-cells expressed eosinophilic activation and trafficking factors: High-mobility group BOX-1 protein (HMGB1) and interleukin 5 (IL5).",25275020_4,-1,1,2,-1,25106,-1,2.960011e-05,5.814703e-05,0.99991226
25107,trafficking factors,8,10,65,84,"Notably, malignant T-cells expressed eosinophilic activation and trafficking factors: High-mobility group BOX-1 protein (HMGB1) and interleukin 5 (IL5).",25275020_4,-1,-1,-1,-1,25107,-1,3.9918024e-05,0.99992704,3.308172e-05
25108,protein,14,15,112,119,"Notably, malignant T-cells expressed eosinophilic activation and trafficking factors: High-mobility group BOX-1 protein (HMGB1) and interleukin 5 (IL5).",25275020_4,0,1,-1,-1,25108,-1,4.4487606e-05,0.9999064,4.9051167e-05
25113,T-cells,8,9,49,56,"In conclusion, these data suggest that malignant T-cells orchestrate accumulation and activation of eosinophils supporting the notion of STAT3 being a putative target for therapy.",25275020_6,-1,1,2,-1,25113,-1,3.6709138e-05,8.2037644e-05,0.99988127
25117,therapy,25,26,171,178,"In conclusion, these data suggest that malignant T-cells orchestrate accumulation and activation of eosinophils supporting the notion of STAT3 being a putative target for therapy.",25275020_6,0,1,-1,-1,25117,-1,2.241794e-05,0.999967,1.0558981e-05
25121,tumour cells,12,14,98,110,"Tumour progression is associated with immune-suppressive conditions that facilitate the escape of tumour cells from the regimen of immune cells, subsequently paralysing the host defence mechanisms.",25284464_0,-1,-1,-1,-1,25121,-1,0.0040969835,0.2791939,0.7167092
25129,the tumour,20,22,88,98,"Induction of CD4(+) CD25(+) FoxP3(+) T regulatory (Treg) cells has been implicated in the tumour immune escape mechanism, although the novel anti-cancer treatment strategies targeting Treg cells remain unknown.",25284464_1,-1,-1,-1,-1,25129,-1,2.3202994e-05,0.99996865,8.187492e-06
25132,targeting Treg cells,32,35,176,196,"Induction of CD4(+) CD25(+) FoxP3(+) T regulatory (Treg) cells has been implicated in the tumour immune escape mechanism, although the novel anti-cancer treatment strategies targeting Treg cells remain unknown.",25284464_1,-1,-1,-1,-1,25132,-1,0.0027934646,0.11564751,0.881559
25139,to the,24,26,140,146,"The focus of this study is to define the interaction between tumour and immune system, i.e. how immune tolerance starts and gradually leads to the induction of adaptive Treg cells in the tumour microenvironment.",25284464_2,-1,-1,-1,-1,25139,-1,1.9160274e-05,0.9999727,8.190181e-06
25141,the tumour,32,34,183,193,"The focus of this study is to define the interaction between tumour and immune system, i.e. how immune tolerance starts and gradually leads to the induction of adaptive Treg cells in the tumour microenvironment.",25284464_2,-1,-1,-1,-1,25141,-1,2.0063599e-05,0.9999707,9.229883e-06
25142,protein,5,6,54,61,Our study identified hyperactivated mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) -signalling as a potential target for reversing Treg cell augmentation in breast cancer patients.,25284464_3,0,1,-1,-1,25142,-1,4.7147118e-05,0.9998977,5.5091667e-05
25146,factor-,13,14,107,115,"In more mechanistic detail, pharmacological inhibitors of MEK/ERK signalling inhibited transforming growth factor- (TGF-) production in tumour cells that essentially blocked TGF--SMAD3/SMAD4-mediated induction of CD25/interleukin-2 receptor  on CD4(+) T-cell surface.",25284464_4,0,1,-1,-1,25146,-1,0.9997838,7.637091e-05,0.00013982433
25148,tumour cells that,19,22,138,155,"In more mechanistic detail, pharmacological inhibitors of MEK/ERK signalling inhibited transforming growth factor- (TGF-) production in tumour cells that essentially blocked TGF--SMAD3/SMAD4-mediated induction of CD25/interleukin-2 receptor  on CD4(+) T-cell surface.",25284464_4,-1,-1,-1,-1,25148,-1,7.050469e-05,0.9997924,0.00013715023
25149,receptor,28,29,235,243,"In more mechanistic detail, pharmacological inhibitors of MEK/ERK signalling inhibited transforming growth factor- (TGF-) production in tumour cells that essentially blocked TGF--SMAD3/SMAD4-mediated induction of CD25/interleukin-2 receptor  on CD4(+) T-cell surface.",25284464_4,0,1,2,-1,25149,-1,0.0036502338,0.018939268,0.9774105
25150,T-cell,33,34,256,262,"In more mechanistic detail, pharmacological inhibitors of MEK/ERK signalling inhibited transforming growth factor- (TGF-) production in tumour cells that essentially blocked TGF--SMAD3/SMAD4-mediated induction of CD25/interleukin-2 receptor  on CD4(+) T-cell surface.",25284464_4,-1,1,2,-1,25150,-1,3.438303e-05,6.014117e-05,0.99990547
25152,those cells,8,10,54,65,"As a result high-affinity binding of interleukin-2 on those cells was prohibited, causing lack of Janus kinase 1 (JAK1)/JAK3-mediated signal transducer and activator of transcription 3 (STAT3)/STAT5 activation required for FoxP3 expression.",25284464_5,-1,-1,-1,-1,25152,-1,0.0010515829,0.028893722,0.9700547
25157,the nano-curcumin made,23,26,140,162,"Finally, for a more radical approach towards a safe MEK inhibitor, we validate the potential of multi-kinase inhibitor curcumin, especially the nano-curcumin made out of pure curcumin with greater bioavailability; in repealing tumour-shed TGF--induced Treg cell augmentation.",25284464_6,-1,-1,-1,-1,25157,-1,4.0179933e-05,0.999938,2.1794325e-05
25158,tumour-shed TGF--induced Treg cell,36,40,227,262,"Finally, for a more radical approach towards a safe MEK inhibitor, we validate the potential of multi-kinase inhibitor curcumin, especially the nano-curcumin made out of pure curcumin with greater bioavailability; in repealing tumour-shed TGF--induced Treg cell augmentation.",25284464_6,-1,-1,-1,-1,25158,-1,0.003260489,0.91064733,0.08609223
25160,T-cell,15,16,91,97,"Recent studies on acute myelogenous leukemia (AML) patients have revealed the existence of T-cell immunodeficiencies, characterized by peripheral T lymphocytes that are unable to interact with blasts, reduced thymic emigrants and oligoclonal restricted repertoires.",25382729_0,-1,1,2,-1,25160,-1,3.417769e-05,4.973313e-05,0.9999161
25161,T lymphocytes that,21,24,146,164,"Recent studies on acute myelogenous leukemia (AML) patients have revealed the existence of T-cell immunodeficiencies, characterized by peripheral T lymphocytes that are unable to interact with blasts, reduced thymic emigrants and oligoclonal restricted repertoires.",25382729_0,-1,-1,-1,-1,25161,-1,0.00122191,0.032765098,0.96601295
25165,that there,3,5,27,37,"These observations suggest that there is a profound thymic dysregulation, which is difficult to study in AML patients.",25382729_1,-1,-1,-1,-1,25165,-1,2.0208277e-05,0.9999708,8.948386e-06
25170,thymus,15,16,95,101,"Using the C1498 AML mouse model, we demonstrated that leukemia development was associated with thymus atrophy, which was defined by abnormal organ weight and reduced cellularity.",25382729_2,-1,1,2,-1,25170,-1,0.00029178694,0.99904925,0.00065894536
25172,T-cell,15,16,73,79,"In addition, we observed a dramatic loss of peripheral CD4(+) and CD8(+) T-cell numbers with increased frequencies of CD4(+) FoxP3(+) regulatory and activated/memory Tcells.",25382729_3,-1,1,2,-1,25172,-1,3.1667143e-05,4.1231022e-05,0.99992704
25176,to this,4,6,37,44,"Investigating the mechanisms leading to this atrophy, we observed a significant accumulation of the monocyte chemoattractant protein 1 (MCP-1/CCL2) in thymi of leukemic mice.",25382729_4,-1,-1,-1,-1,25176,-1,2.1410606e-05,0.9999666,1.19103215e-05
25177,the monocyte chemoattractant protein 1,14,19,96,134,"Investigating the mechanisms leading to this atrophy, we observed a significant accumulation of the monocyte chemoattractant protein 1 (MCP-1/CCL2) in thymi of leukemic mice.",25382729_4,-1,-1,-1,-1,25177,-1,0.0016630646,0.99466175,0.0036751698
25181,T-cell,17,18,122,128,"Treatment of AML-bearing animals with a blocking anti-CCL2 antibody revealed a lower tumor burden, augmented antileukemic T-cell responses, and improved survival rate compared to nontreated mice.",25382729_5,-1,1,2,-1,25181,-1,5.483211e-05,6.636704e-05,0.99987876
25186,that the CCL2 protein,4,8,20,41,"Altogether, we show that the CCL2 protein participates in thymic atrophy in AML mice, and this could have important implications for future immunotherapeutic strategies.",25382729_7,-1,-1,-1,-1,25186,-1,0.00020702947,0.9996667,0.00012623947
25189,immune responses to,1,4,9,28,"Adaptive immune responses to Ags released by dying cells play a critical role in the development of autoimmunity, allograft rejection, and spontaneous as well as therapy-induced tumor rejection.",25385820_0,-1,-1,-1,-1,25189,-1,0.79695785,0.19918777,0.0038543786
25191,cells play,8,10,51,61,"Adaptive immune responses to Ags released by dying cells play a critical role in the development of autoimmunity, allograft rejection, and spontaneous as well as therapy-induced tumor rejection.",25385820_0,-1,-1,-1,-1,25191,-1,0.0036595606,0.13940509,0.8569354
25193,therapy-induced tumor,27,29,162,183,"Adaptive immune responses to Ags released by dying cells play a critical role in the development of autoimmunity, allograft rejection, and spontaneous as well as therapy-induced tumor rejection.",25385820_0,-1,-1,-1,-1,25193,-1,3.293627e-05,0.9999542,1.287286e-05
25199,immune response to cell-associated,23,27,142,176,"Although cell death in these situations is considered sterile, various reports have implicated type I IFNs as drivers of the ensuing adaptive immune response to cell-associated Ags.",25385820_1,-1,-1,-1,-1,25199,-1,0.44163245,0.01937158,0.538996
25202,this type,6,8,38,47,"However, the mechanisms that underpin this type I IFN production are poorly defined.",25385820_2,-1,-1,-1,-1,25202,-1,3.2475647e-05,0.99995315,1.4345586e-05
25208,cells to,22,24,123,131,"In this article, we show that dendritic cells (DCs) can uptake and sense nuclear DNA-associated entities released by dying cells to induce type I IFN.",25385820_3,-1,-1,-1,-1,25208,-1,0.0045534717,0.12438621,0.87106043
25213,function,13,14,70,78,"Remarkably, this molecular pathway requires STING, but not TLR or NLR function, and results in the activation of IRF3 in a TBK1-dependent manner.",25385820_4,0,1,2,-1,25213,-1,0.00015445525,0.9996872,0.00015838335
25218,function,7,8,33,41,DCs are shown to depend on STING function in vivo to efficiently prime IFN-dependent CD8(+) T cell responses to tumor Ags.,25385820_5,0,1,2,-1,25218,-1,0.00012485098,0.9998172,5.796997e-05
25222,to tumor,19,21,109,117,DCs are shown to depend on STING function in vivo to efficiently prime IFN-dependent CD8(+) T cell responses to tumor Ags.,25385820_5,-1,-1,-1,-1,25222,-1,2.435901e-05,0.9999641,1.1503518e-05
25223,the generation,9,11,51,65,"Furthermore, loss of STING activity in DCs impairs the generation of follicular Th cells and plasma cells, as well as anti-nuclear Abs, in an inducible model of systemic lupus erythematosus.",25385820_6,-1,-1,-1,-1,25223,-1,2.1699869e-05,0.9999634,1.4846807e-05
25224,Th cells,13,15,80,88,"Furthermore, loss of STING activity in DCs impairs the generation of follicular Th cells and plasma cells, as well as anti-nuclear Abs, in an inducible model of systemic lupus erythematosus.",25385820_6,-1,-1,-1,-1,25224,-1,4.0682473e-05,6.194953e-05,0.99989736
25225,plasma cells,16,18,93,105,"Furthermore, loss of STING activity in DCs impairs the generation of follicular Th cells and plasma cells, as well as anti-nuclear Abs, in an inducible model of systemic lupus erythematosus.",25385820_6,-1,-1,-1,-1,25225,-1,4.4018856e-05,8.099597e-05,0.99987495
25227,that the,3,5,23,31,"These findings suggest that the STING pathway could be manipulated to enable the rational design of immunotherapies that enhance or diminish antitumor and autoimmune responses, respectively.",25385820_7,-1,-1,-1,-1,25227,-1,1.874248e-05,0.9999732,8.041943e-06
25235,These cells,0,2,0,11,"These cells constitutively or inducibly express a number of receptors of the TNFR and TLR families, whose signals are transduced by TNFR-associated factor (TRAF) molecules.",25422508_1,-1,-1,-1,-1,25235,-1,0.0026209746,0.32586738,0.67151165
25236,receptors,9,10,60,69,"These cells constitutively or inducibly express a number of receptors of the TNFR and TLR families, whose signals are transduced by TNFR-associated factor (TRAF) molecules.",25422508_1,0,1,2,-1,25236,-1,7.675994e-05,0.00022742155,0.9996959
25237,the TNFR,11,13,73,81,"These cells constitutively or inducibly express a number of receptors of the TNFR and TLR families, whose signals are transduced by TNFR-associated factor (TRAF) molecules.",25422508_1,-1,-1,-1,-1,25237,-1,3.0391342e-05,0.9999505,1.9061068e-05
25240,TNFR-associated factor,22,24,132,154,"These cells constitutively or inducibly express a number of receptors of the TNFR and TLR families, whose signals are transduced by TNFR-associated factor (TRAF) molecules.",25422508_1,-1,-1,-1,-1,25240,-1,4.9221777e-05,0.9999149,3.5846435e-05
25242,that TRAF3,4,6,24,34,"In vitro studies showed that TRAF3 is required for TLR-induced type I IFN production, but the in vivo function of TRAF3 in myeloid cells remains unknown.",25422508_2,-1,-1,-1,-1,25242,-1,2.4794695e-05,0.9999641,1.1133674e-05
25243,TLR-induced type,9,11,51,67,"In vitro studies showed that TRAF3 is required for TLR-induced type I IFN production, but the in vivo function of TRAF3 in myeloid cells remains unknown.",25422508_2,-1,-1,-1,-1,25243,-1,2.5912215e-05,0.99996054,1.35189575e-05
25246,function,19,20,102,110,"In vitro studies showed that TRAF3 is required for TLR-induced type I IFN production, but the in vivo function of TRAF3 in myeloid cells remains unknown.",25422508_2,0,1,2,-1,25246,-1,5.2654374e-05,0.9999232,2.4145376e-05
25250,the generation,6,8,27,41,"In this article, we report the generation and characterization of myeloid cell-specific TRAF3-deficient (M-TRAF3(-/-)) mice, which allowed us to gain insights into the in vivo functions of TRAF3 in myeloid cells.",25422508_3,-1,-1,-1,-1,25250,-1,1.673051e-05,0.99997246,1.077423e-05
25251,cell-specific TRAF3-deficient,12,14,74,103,"In this article, we report the generation and characterization of myeloid cell-specific TRAF3-deficient (M-TRAF3(-/-)) mice, which allowed us to gain insights into the in vivo functions of TRAF3 in myeloid cells.",25422508_3,-1,-1,-1,-1,25251,-1,0.003329865,0.12929644,0.8673737
25254,functions,30,31,176,185,"In this article, we report the generation and characterization of myeloid cell-specific TRAF3-deficient (M-TRAF3(-/-)) mice, which allowed us to gain insights into the in vivo functions of TRAF3 in myeloid cells.",25422508_3,0,1,2,-1,25254,-1,4.2115145e-05,0.99993384,2.4045832e-05
25257,that TRAF3,2,4,9,19,"We found that TRAF3 ablation did not affect the maturation or homeostasis of myeloid cells in young adult mice, even though TRAF3-deficient macrophages and neutrophils exhibited constitutive NF-B2 activation.",25422508_4,-1,-1,-1,-1,25257,-1,2.4737303e-05,0.9999633,1.2025374e-05
25260,though TRAF3-deficient,21,23,117,139,"We found that TRAF3 ablation did not affect the maturation or homeostasis of myeloid cells in young adult mice, even though TRAF3-deficient macrophages and neutrophils exhibited constitutive NF-B2 activation.",25422508_4,-1,-1,-1,-1,25260,-1,0.00010204754,0.9998115,8.647136e-05
25269,Taken together,0,2,0,14,"Taken together, our findings indicate that TRAF3 expressed in myeloid cells regulates immune responses in myeloid cells and acts to inhibit inflammation and tumor development in mice.",25422508_8,-1,-1,-1,-1,25269,-1,4.3917553e-05,0.99993885,1.7286597e-05
25270,that TRAF3,6,8,38,48,"Taken together, our findings indicate that TRAF3 expressed in myeloid cells regulates immune responses in myeloid cells and acts to inhibit inflammation and tumor development in mice.",25422508_8,-1,-1,-1,-1,25270,-1,2.145518e-05,0.9999682,1.0328845e-05
25284,the Tregs,4,6,28,37,"The entire re-evaluation of the Tregs was supported due to the increasingly influential and state of the art immunological techniques, as cell sorting and also the expanding understanding of the immune system and its functions which aided in attaining a greater insight into the mechanisms of regulation and suppression.",25427312_1,-1,-1,-1,-1,25284,-1,1.9118774e-05,0.9999701,1.0769643e-05
25285,to the,9,11,56,62,"The entire re-evaluation of the Tregs was supported due to the increasingly influential and state of the art immunological techniques, as cell sorting and also the expanding understanding of the immune system and its functions which aided in attaining a greater insight into the mechanisms of regulation and suppression.",25427312_1,-1,-1,-1,-1,25285,-1,2.5328669e-05,0.9999634,1.1259966e-05
25292,functions,35,36,217,226,"The entire re-evaluation of the Tregs was supported due to the increasingly influential and state of the art immunological techniques, as cell sorting and also the expanding understanding of the immune system and its functions which aided in attaining a greater insight into the mechanisms of regulation and suppression.",25427312_1,0,1,2,-1,25292,-1,8.977764e-05,0.9998318,7.845763e-05
25295,that Tregs,5,7,44,54,"Many researchers nowadays have demonstrated that Tregs may well have therapeutic possibilities for the treatment of autoimmune diseases if it was a possibility to isolate and infuse these Tregs into patients, preferably without any harmful side effects.",25427312_2,-1,-1,-1,-1,25295,-1,2.2577331e-05,0.999967,1.0493919e-05
25297,the treatment,13,15,99,112,"Many researchers nowadays have demonstrated that Tregs may well have therapeutic possibilities for the treatment of autoimmune diseases if it was a possibility to isolate and infuse these Tregs into patients, preferably without any harmful side effects.",25427312_2,-1,-1,-1,-1,25297,-1,2.5006755e-05,0.9999652,9.804384e-06
25299,these Tregs,27,29,182,193,"Many researchers nowadays have demonstrated that Tregs may well have therapeutic possibilities for the treatment of autoimmune diseases if it was a possibility to isolate and infuse these Tregs into patients, preferably without any harmful side effects.",25427312_2,-1,-1,-1,-1,25299,-1,2.4163877e-05,0.9999635,1.2342501e-05
25300,side effects,36,38,240,252,"Many researchers nowadays have demonstrated that Tregs may well have therapeutic possibilities for the treatment of autoimmune diseases if it was a possibility to isolate and infuse these Tregs into patients, preferably without any harmful side effects.",25427312_2,0,1,-1,-1,25300,-1,0.00059439766,0.9992791,0.00012654449
25303,their generation,8,10,42,58,"Therefore, modulation of Tregs as well as their generation is being researched since they were proposed as therapeutic interventions in several disease sceneries, nonetheless, sometimes with disastrous consequences.",25427312_3,-1,-1,-1,-1,25303,-1,3.929336e-05,0.9999304,3.0289893e-05
25312,the topic,12,14,81,90,"This literature study gives an overview of the current accessible information on the topic of the characterization, the generation, regulation and functions of the Inducible Treg populations and their subsets in the human immune system.",25427312_5,-1,-1,-1,-1,25312,-1,2.3372193e-05,0.9999664,1.0253305e-05
25314,the generation,18,20,116,130,"This literature study gives an overview of the current accessible information on the topic of the characterization, the generation, regulation and functions of the Inducible Treg populations and their subsets in the human immune system.",25427312_5,-1,-1,-1,-1,25314,-1,1.827513e-05,0.99996936,1.2351876e-05
25316,functions,23,24,147,156,"This literature study gives an overview of the current accessible information on the topic of the characterization, the generation, regulation and functions of the Inducible Treg populations and their subsets in the human immune system.",25427312_5,0,1,2,-1,25316,-1,7.4640506e-05,0.9998851,4.0234365e-05
25319,their subsets,30,32,195,208,"This literature study gives an overview of the current accessible information on the topic of the characterization, the generation, regulation and functions of the Inducible Treg populations and their subsets in the human immune system.",25427312_5,-1,-1,-1,-1,25319,-1,0.0040086084,0.3309911,0.6650003
25326,those lymphocytes,20,22,136,153,OBJECTIVE: To investigate B7-H4 expression and its correlation with the number of infiltrating T lymphocytes and cytokine production by those lymphocytes in human cervical cancer and to determine the effect of recombinant B7-H4 on the active peripheral blood T cells of the patients in vitro.,25446402_0,-1,-1,-1,-1,25326,-1,0.0012884992,0.05214107,0.9465704
25331,blood T cells,38,41,253,266,OBJECTIVE: To investigate B7-H4 expression and its correlation with the number of infiltrating T lymphocytes and cytokine production by those lymphocytes in human cervical cancer and to determine the effect of recombinant B7-H4 on the active peripheral blood T cells of the patients in vitro.,25446402_0,-1,-1,-1,-1,25331,-1,0.0006961254,0.009345328,0.9899586
25341,blood T lymphocytes,3,6,21,40,"After the peripheral blood T lymphocytes of patients were co-cultured with B7-H4, proliferation, apoptosis, and cell subtypes were analyzed using flow cytometry.",25446402_3,-1,-1,-1,-1,25341,-1,0.0011928617,0.027563745,0.97124344
25350,their IFN-,7,9,51,62,"The number of infiltrating CD8(+)T lymphocytes and their IFN- production in positive B7-H4 expression cervical cancers was significantly lower than in negative B7-H4 cases (P<0.01, P<0.05), but there was no significant difference between cases positive and negative for B7-H4 with respect to infiltrating FOXP3(+)T and CD4(+)T cells or TGF-1 production.",25446402_5,-1,-1,-1,-1,25350,-1,0.9045117,0.091656014,0.0038322378
25379,the T cells,8,11,48,59,B7-H4 had no significant effect on apoptosis of the T cells.,25446402_10,-1,-1,-1,-1,25379,-1,0.0021890225,0.10146239,0.89634866
25392,B7-H4 plays,0,2,0,11,B7-H4 plays an important role in depressing the anti-tumor immunity of CD8(+)T cell in microenvironments of cervical cancer.,25446402_13,-1,-1,-1,-1,25392,-1,0.0016172732,0.015992228,0.9823905
25394,immunity,9,10,59,67,B7-H4 plays an important role in depressing the anti-tumor immunity of CD8(+)T cell in microenvironments of cervical cancer.,25446402_13,0,-1,2,-1,25394,-1,0.99784625,0.001757858,0.0003958726
25399,receptor,8,9,35,43,"CD25, the alpha subunit of the IL2 receptor, is a canonical marker of regulatory T cells (Treg) and hence has been implicated in immune suppression in cancer.",25480168_0,0,1,2,-1,25399,-1,0.0011974527,0.03839758,0.96040493
25403,tissues,17,18,100,107,"However, CD25 is also required for optimal expansion and activity of effector T cells in peripheral tissues.",25480168_1,-1,1,2,-1,25403,-1,0.00013333846,0.9989467,0.0009199863
25412,tumor-infiltrating lymphocytes,14,16,90,120,"To investigate this possibility, we used multiparameter flow cytometry and IHC to analyze tumor-infiltrating lymphocytes (TIL) in primary high-grade serous carcinomas, the most common and fatal subtype of ovarian cancer.",25480168_3,-1,-1,-1,-1,25412,-1,0.003332969,0.8747904,0.12187668
25420,T cells that,13,16,85,97,"In addition to conventional CD25FoxP3 Tregs, we identified a subset of CD25FoxP3 T cells that comprised up to 13% of CD4 TIL.",25480168_5,-1,-1,-1,-1,25420,-1,0.0015533969,0.028945956,0.9695006
25428,TIL subsets,2,4,11,22,"Among CD4 TIL subsets, CD25FoxP3 cells expressed the highest levels of PD-1.",25480168_7,-1,-1,-1,-1,25428,-1,0.004326935,0.3131682,0.68250483
25433,T-helper cytokines,12,14,68,86,"Moreover, after in vitro stimulation, they failed to produce common T-helper cytokines (IFN, TNF, IL2, IL4, IL10, or IL17A), suggesting that they were functionally exhausted.",25480168_8,-1,-1,-1,-1,25433,-1,0.27131045,0.5943004,0.1343892
25435,TNF,17,18,94,98,"Moreover, after in vitro stimulation, they failed to produce common T-helper cytokines (IFN, TNF, IL2, IL4, IL10, or IL17A), suggesting that they were functionally exhausted.",25480168_8,0,1,-1,-1,25435,-1,0.0004841828,0.99942786,8.797984e-05
25438,that they,30,32,138,147,"Moreover, after in vitro stimulation, they failed to produce common T-helper cytokines (IFN, TNF, IL2, IL4, IL10, or IL17A), suggesting that they were functionally exhausted.",25480168_8,-1,-1,-1,-1,25438,-1,2.2804437e-05,0.9999621,1.5100739e-05
25439,functionally,33,34,153,165,"Moreover, after in vitro stimulation, they failed to produce common T-helper cytokines (IFN, TNF, IL2, IL4, IL10, or IL17A), suggesting that they were functionally exhausted.",25480168_8,0,1,2,-1,25439,-1,7.694728e-05,0.99989045,3.255839e-05
25447,TIL that,8,10,45,53,"Thus, CD25 identifies a subset of CD4FoxP3 TIL that, despite being exhausted at diagnosis, have a strong, positive association with patient survival and warrant consideration as effector T cells for immunotherapy.",25480168_10,-1,-1,-1,-1,25447,-1,2.3624574e-05,0.99996173,1.4635268e-05
25449,The antigenic,0,2,0,13,The antigenic variability of tumor cells leading to dynamic changes in cancer epitope landscape along with escape from immune surveillance by down-regulating tumor antigen expression/presentation and immune tolerance are major obstacles for the design of effective vaccines.,25483665_0,-1,-1,-1,-1,25449,-1,0.07682984,0.9164125,0.0067576882
25450,tumor cells,4,6,29,40,The antigenic variability of tumor cells leading to dynamic changes in cancer epitope landscape along with escape from immune surveillance by down-regulating tumor antigen expression/presentation and immune tolerance are major obstacles for the design of effective vaccines.,25483665_0,-1,-1,-1,-1,25450,-1,0.0040173586,0.3691272,0.62685543
25452,tumor antigen,22,24,158,171,The antigenic variability of tumor cells leading to dynamic changes in cancer epitope landscape along with escape from immune surveillance by down-regulating tumor antigen expression/presentation and immune tolerance are major obstacles for the design of effective vaccines.,25483665_0,-1,-1,-1,-1,25452,-1,0.32364324,0.66547936,0.0108774295
25456,targeting antigenically,18,20,124,147,We have developed a novel concept for immunogen construction based on introduction of massive mutations within the epitopes targeting antigenically variable pathogens and diseases.,25483665_1,-1,-1,-1,-1,25456,-1,0.00016270415,0.9997936,4.377841e-05
25457,that these,4,6,22,32,"Previously, we showed that these immunogens carrying large combinatorial libraries of mutated epitope variants, termed as variable epitope libraries (VELs), induce potent, broad and long lasting CD8+IFN-+ T-cell response as well as HIV-neutralizing antibodies.",25483665_2,-1,-1,-1,-1,25457,-1,1.8246996e-05,0.9999727,9.023688e-06
25459,T-cell,33,34,206,212,"Previously, we showed that these immunogens carrying large combinatorial libraries of mutated epitope variants, termed as variable epitope libraries (VELs), induce potent, broad and long lasting CD8+IFN-+ T-cell response as well as HIV-neutralizing antibodies.",25483665_2,-1,1,2,-1,25459,-1,4.5955905e-05,5.983243e-05,0.99989414
25468,peptide,20,21,137,144,"The constructed VELs had complexities of 10,500 and 8,000 individual members, generated as combinatorial M13 phage display and synthetic peptide libraries, respectively, with structural composition GWXPXDXPI, where X is any of 20 natural amino acids.",25483665_4,0,-1,2,-1,25468,-1,0.002429479,0.99653244,0.0010380205
25475,IFN-+ T-cell,9,11,64,77,"Vaccinated mice developed epitope-specific spleen cell and CD8+ IFN-+ T-cell responses that recognize more than 50% of the panel of 87 mutated epitope variants, as demonstrated in T-cell proliferation assays and FACS analysis.",25483665_6,-1,-1,-1,-1,25475,-1,0.7702682,0.0020871519,0.22764465
25480,analysis,35,36,218,226,"Vaccinated mice developed epitope-specific spleen cell and CD8+ IFN-+ T-cell responses that recognize more than 50% of the panel of 87 mutated epitope variants, as demonstrated in T-cell proliferation assays and FACS analysis.",25483665_6,0,1,-1,-1,25480,-1,4.669701e-05,0.9998816,7.16696e-05
25486,functionality,4,5,27,40,Acquisition of an impaired functionality by plasmacytoid dendritic cells (pDCs) contributing to cancer progression has been documented in different types of cancers.,25492101_0,0,1,2,-1,25486,-1,0.00017970314,0.9994436,0.00037673308
25497,functionality,29,30,179,192,"In the present study, we postulate that molecules secreted by (pre)neoplastic epithelial cells of the genital tract (cervix/vulva) might attract pDCs but also modify their proper functionality, allowing these cells to initiate a tolerogenic response interfering with antitumor immunity.",25492101_1,0,1,2,-1,25497,-1,0.00013302681,0.99974185,0.00012511548
25498,these cells to,32,35,203,217,"In the present study, we postulate that molecules secreted by (pre)neoplastic epithelial cells of the genital tract (cervix/vulva) might attract pDCs but also modify their proper functionality, allowing these cells to initiate a tolerogenic response interfering with antitumor immunity.",25492101_1,-1,-1,-1,-1,25498,-1,0.00011074578,0.99956256,0.0003266742
25500,immunity,42,43,277,285,"In the present study, we postulate that molecules secreted by (pre)neoplastic epithelial cells of the genital tract (cervix/vulva) might attract pDCs but also modify their proper functionality, allowing these cells to initiate a tolerogenic response interfering with antitumor immunity.",25492101_1,0,-1,2,-1,25500,-1,0.9992848,0.00048785825,0.00022744817
25503,through the,12,14,98,109,"We demonstrated that pDCs are recruited during the cervical metaplasia-dysplasia-cancer sequence, through the action of their chemoattractant, chemerin.",25492101_2,-1,-1,-1,-1,25503,-1,2.2287828e-05,0.9999664,1.1274548e-05
25504,their chemoattractant,16,18,120,141,"We demonstrated that pDCs are recruited during the cervical metaplasia-dysplasia-cancer sequence, through the action of their chemoattractant, chemerin.",25492101_2,-1,-1,-1,-1,25504,-1,0.5152827,0.47706157,0.007655761
25511,function,10,11,86,94,We also demonstrated that cervical/vulvar neoplastic keratinocytes inhibit the proper function of pDCs by decreasing their IFN secretion in response to CpG oligonucleotides.,25492101_4,0,1,2,-1,25511,-1,0.000106562606,0.9998228,7.072611e-05
25512,their IFN,15,17,117,127,We also demonstrated that cervical/vulvar neoplastic keratinocytes inhibit the proper function of pDCs by decreasing their IFN secretion in response to CpG oligonucleotides.,25492101_4,-1,-1,-1,-1,25512,-1,0.8336167,0.16345416,0.0029291804
25524,factor,6,7,33,39,We identified HMGB1 as a soluble factor produced by neoplastic keratinocytes from the genital tract involved in pDCs functional alteration.,25492101_7,0,1,-1,-1,25524,-1,0.6600626,0.33651647,0.0034209646
25527,functional,18,19,117,127,We identified HMGB1 as a soluble factor produced by neoplastic keratinocytes from the genital tract involved in pDCs functional alteration.,25492101_7,0,1,2,-1,25527,-1,0.00013023836,0.99976915,0.000100562895
25531,these cells to,16,19,111,125,"Indeed, this molecule inhibited pDC maturation, decreased IFN secretion following TLR9 stimulation and forced these cells to become tolerogenic.",25492101_8,-1,-1,-1,-1,25531,-1,0.00015409055,0.9989812,0.0008647651
25533,that the,3,5,22,30,Our findings indicate that the use of inhibitory molecules notably directed against HMGB1 in cervical/vulvar (pre)neoplastic lesions might prevent alterations of pDCs functionality and represent an attractive therapeutic strategy to overcome immune tolerance in cancers.,25492101_10,-1,-1,-1,-1,25533,-1,1.9606676e-05,0.9999726,7.860263e-06
25534,functionality,22,23,167,180,Our findings indicate that the use of inhibitory molecules notably directed against HMGB1 in cervical/vulvar (pre)neoplastic lesions might prevent alterations of pDCs functionality and represent an attractive therapeutic strategy to overcome immune tolerance in cancers.,25492101_10,0,1,2,-1,25534,-1,5.6302077e-05,0.99986494,7.8778445e-05
25546,protein-coding,5,6,26,40,RESULTS: We identified 12 protein-coding candidate variants that segregated in the 3 affected cousins from whom we had samples.,25492914_4,0,1,-1,-1,25546,-1,3.7636633e-05,0.9999378,2.459619e-05
25562,that STAT4,5,7,30,40,"CONCLUSIONS: Our data suggest that STAT4 is a potential cKS-predisposition gene, but further functional and genetic validation is needed.",25492914_10,-1,-1,-1,-1,25562,-1,2.3413853e-05,0.9999609,1.5698688e-05
25564,functional,15,16,93,103,"CONCLUSIONS: Our data suggest that STAT4 is a potential cKS-predisposition gene, but further functional and genetic validation is needed.",25492914_10,0,1,2,-1,25564,-1,4.3427397e-05,0.9999373,1.9257857e-05
25575,Th cells that,8,11,62,75,We have recently demonstrated that patients have CLL-specific Th cells that support CLL proliferation.,25505279_2,-1,-1,-1,-1,25575,-1,0.0014664658,0.048438102,0.9500954
25579,Th cells,11,13,53,61,"In this article, we show that CLL cells attract such Th cells, thereby establishing an Ag-dependent collaboration.",25505279_3,-1,-1,-1,-1,25579,-1,3.2138974e-05,3.9634102e-05,0.99992824
25583,Th cells,28,30,163,171,"Blocking experiments performed in vitro as wells as in vivo, using a xenograft model, revealed that secretion of IFN- was a major mechanism by which CLL-specific Th cells increased CD38 on CLL cells.",25505279_4,-1,-1,-1,-1,25583,-1,3.1368054e-05,3.740898e-05,0.9999312
25586,the transcription factor T-bet,3,7,18,48,"The expression of the transcription factor T-bet in peripheral blood CLL cells significantly correlated with CD38 expression, and transient transfection of CLL cells with T-bet resulted in T-bet(hi)CD38(hi) cells.",25505279_5,-1,-1,-1,-1,25586,-1,1.9215773e-05,0.9999697,1.1035322e-05
25587,blood,9,10,63,68,"The expression of the transcription factor T-bet in peripheral blood CLL cells significantly correlated with CD38 expression, and transient transfection of CLL cells with T-bet resulted in T-bet(hi)CD38(hi) cells.",25505279_5,0,1,-1,-1,25587,-1,6.647232e-05,0.999796,0.00013761346
25589,transient transfection,19,21,130,152,"The expression of the transcription factor T-bet in peripheral blood CLL cells significantly correlated with CD38 expression, and transient transfection of CLL cells with T-bet resulted in T-bet(hi)CD38(hi) cells.",25505279_5,-1,-1,-1,-1,25589,-1,1.954148e-05,0.9999682,1.2285755e-05
25594,that T-bet,6,8,60,70,"Finally, chromatin immunoprecipitation experiments revealed that T-bet can bind to regulatory regions of the CD38 gene.",25505279_6,-1,-1,-1,-1,25594,-1,1.973767e-05,0.999969,1.12050975e-05
25601,Th cells,8,10,55,63,"These data suggest that CLL cells attract CLL-specific Th cells and initiate a positive feedback loop with upregulation of T-bet, CD38, and type 1 chemokines allowing further recruitment of Th cells and increased type 1 cytokine secretion.",25505279_7,-1,-1,-1,-1,25601,-1,3.2051936e-05,4.2189255e-05,0.99992573
25605,Th cells,31,33,190,198,"These data suggest that CLL cells attract CLL-specific Th cells and initiate a positive feedback loop with upregulation of T-bet, CD38, and type 1 chemokines allowing further recruitment of Th cells and increased type 1 cytokine secretion.",25505279_7,-1,-1,-1,-1,25605,-1,3.4442022e-05,4.70614e-05,0.99991846
25612,that targeting the,25,28,181,199,This insight provides a cellular and molecular mechanism that links the inflammatory signature observed in CLL pathogenesis with CD38 expression and aggressive disease and suggests that targeting the IFN-/IFN-R/JAK/STAT/T-bet/CD38 pathway could play a role in the therapy of CLL.,25505279_8,-1,-1,-1,-1,25612,-1,1.8396024e-05,0.99997294,8.612625e-06
25614,the therapy,35,37,262,273,This insight provides a cellular and molecular mechanism that links the inflammatory signature observed in CLL pathogenesis with CD38 expression and aggressive disease and suggests that targeting the IFN-/IFN-R/JAK/STAT/T-bet/CD38 pathway could play a role in the therapy of CLL.,25505279_8,-1,-1,-1,-1,25614,-1,2.1500153e-05,0.9999689,9.636596e-06
25628,tissue,5,6,19,25,"In this study, NPC tissue was collected from patients with NPC.",25544502_4,-1,1,2,-1,25628,-1,5.8394016e-05,0.9991703,0.0007712717
25631,proteins,6,7,36,44,Western blotting was used to assess proteins of interleukin 10 and nuclear factor I-A (NFI-A).,25544502_6,0,1,-1,-1,25631,-1,3.2908563e-05,0.99994636,2.0720008e-05
25639,tissue,14,15,72,78,"The results showed that NPC cell line C666-1 and surgically removed NPC tissue expressed miR-21, which was upregulated by the presence of the Toll-like receptor 3 ligand, Poly I: C. Exposure to miR-21 increased the expression of NFI-A and interleukin (IL)-10 in naive B cells.",25544502_8,-1,1,2,-1,25639,-1,7.11872e-05,0.9992774,0.00065145065
25641,the Toll-like receptor,25,28,138,160,"The results showed that NPC cell line C666-1 and surgically removed NPC tissue expressed miR-21, which was upregulated by the presence of the Toll-like receptor 3 ligand, Poly I: C. Exposure to miR-21 increased the expression of NFI-A and interleukin (IL)-10 in naive B cells.",25544502_8,-1,-1,-1,-1,25641,-1,0.0008021772,0.99224055,0.0069572204
25651,tissue,12,13,59,65,High frequency of IL-10(+) B cells was detected in the NPC tissue.,25544502_9,-1,1,2,-1,25651,-1,4.106235e-05,0.999736,0.00022294544
25659,T-cell,19,20,106,112,We conclude that NPC-derived miR-21 induces IL-10(+) B cells; the latter is capable of suppressing CD8(+) T-cell activities.,25544502_11,-1,1,2,-1,25659,-1,3.2558135e-05,5.1329647e-05,0.9999161
25661,the treatment,7,9,36,49,miR-21 may be a potential target in the treatment of NPC.,25544502_12,-1,-1,-1,-1,25661,-1,2.2651771e-05,0.9999676,9.75479e-06
25668,tumor cells,27,29,151,162,"However, the regulatory mechanism(s) for p53 expression in B lymphoma cells, and the possible role of p53 in the development of the radioresistance in tumor cells are largely unknown.",25544504_1,-1,-1,-1,-1,25668,-1,0.003928703,0.45325124,0.5428201
25693,The IL-17(+)Foxp3(+,0,2,0,19,The IL-17(+)Foxp3(+) T cells suppressed p53 expression in k1106 cells.,25544504_9,-1,-1,-1,-1,25693,-1,0.014323946,0.98357564,0.0021003354
25701,protein,20,21,122,129,"Collectively, irradiated k1106 cells induce the expression of IL-17 in Tregs, which interferes with the expression of p53 protein in k1106 cells and thereby represses irradiation-triggered apoptosis in k1106 cells.",25544504_10,0,1,-1,-1,25701,-1,2.6614525e-05,0.99995553,1.7801898e-05
25707,transferred T cells,13,16,101,120,"Lymphodepleting regimens are used before adoptive immunotherapy to augment the antitumor efficacy of transferred T cells by removing endogenous homeostatic ""cytokine sinks."" These conditioning modalities, however, are often associated with severe toxicities.",25548153_0,-1,-1,-1,-1,25707,-1,0.0022989379,0.07537194,0.92232907
25713,T cells to,11,14,67,77,We found that microRNA-155 (miR-155) enabled tumor-specific CD8(+) T cells to mediate profound antitumor responses in lymphoreplete hosts that were not potentiated by immune-ablation.,25548153_1,-1,-1,-1,-1,25713,-1,0.001519224,0.028902937,0.96957785
25715,T-cell,2,3,17,23,"miR-155 enhanced T-cell responsiveness to limited amounts of homeostatic c cytokines, resulting in delayed cellular contraction and sustained cytokine production.",25548153_2,-1,1,2,-1,25715,-1,3.059644e-05,4.786788e-05,0.99992144
25723,protein,15,16,108,115,"miR-155 restrained the expression of the inositol 5-phosphatase Ship1, an inhibitor of the serine-threonine protein kinase Akt, and multiple negative regulators of signal transducer and activator of transcription 5 (Stat5), including suppressor of cytokine signaling 1 (Socs1) and the protein tyrosine phosphatase Ptpn2.",25548153_3,0,1,-1,-1,25723,-1,5.957321e-05,0.99988294,5.743476e-05
25727,the protein tyrosine phosphatase,45,49,281,313,"miR-155 restrained the expression of the inositol 5-phosphatase Ship1, an inhibitor of the serine-threonine protein kinase Akt, and multiple negative regulators of signal transducer and activator of transcription 5 (Stat5), including suppressor of cytokine signaling 1 (Socs1) and the protein tyrosine phosphatase Ptpn2.",25548153_3,-1,-1,-1,-1,25727,-1,2.7387627e-05,0.9999509,2.1781101e-05
25730,functions,20,21,167,176,"Expression of constitutively active Stat5a recapitulated the survival advantages conferred by miR-155, whereas constitutive Akt activation promoted sustained effector functions.",25548153_4,0,1,2,-1,25730,-1,0.00045845806,0.9984028,0.0011387967
25732,tumor-specific T cells,8,11,55,77,"Our results indicate that overexpression of miR-155 in tumor-specific T cells can be used to increase the effectiveness of adoptive immunotherapies in a cell-intrinsic manner without the need for life-threatening, lymphodepleting maneuvers.",25548153_5,-1,-1,-1,-1,25732,-1,0.0040535266,0.7512332,0.24471325
25737,life-threatening,29,30,196,212,"Our results indicate that overexpression of miR-155 in tumor-specific T cells can be used to increase the effectiveness of adoptive immunotherapies in a cell-intrinsic manner without the need for life-threatening, lymphodepleting maneuvers.",25548153_5,0,-1,2,-1,25737,-1,0.00021981927,0.999728,5.2161933e-05
25740,the regulation,11,13,34,48,"However, the effect of 14-3-3 in the regulation of interactions between tumor cells and the immune system has not been previously reported.",25556369_1,-1,-1,-1,-1,25740,-1,2.0269254e-05,0.9999701,9.603378e-06
25741,tumor cells,16,18,73,84,"However, the effect of 14-3-3 in the regulation of interactions between tumor cells and the immune system has not been previously reported.",25556369_1,-1,-1,-1,-1,25741,-1,0.003560972,0.38224888,0.6141901
25748,tissues,12,13,61,68,"In oral squamous cell carcinoma (OSCC) cell lines and cancer tissues, we found that 14-3-3 is overexpressed.",25556369_3,-1,1,2,-1,25748,-1,5.9870057e-05,0.99971896,0.00022120331
25760,tumor-specific T cells,23,26,141,163,"Furthermore, supernatants from 14-3-3 knockdown OSCC cells dramatically altered the response of peritoneal macrophages, dendritic cells and tumor-specific T cells.",25556369_6,-1,-1,-1,-1,25760,-1,0.0055688196,0.6607672,0.333664
25763,relieved the,17,19,84,96,"Interestingly, Stat3 was found to directly interact with 14-3-3 and its disruption relieved the inhibition induced by 14-3-3 in tumor inflammation.",25556369_7,-1,-1,-1,-1,25763,-1,4.354057e-05,0.99993813,1.8310688e-05
25765,Taken together,0,2,0,14,"Taken together, our studies provide evidence that 14-3-3 may regulate tumor inflammation and immune response through Stat3 signaling in OSCC.",25556369_8,-1,-1,-1,-1,25765,-1,4.2832784e-05,0.99994063,1.652312e-05
25768,immune response through Stat3,18,22,94,123,"Taken together, our studies provide evidence that 14-3-3 may regulate tumor inflammation and immune response through Stat3 signaling in OSCC.",25556369_8,-1,-1,-1,-1,25768,-1,0.32059163,0.6765267,0.0028816713
25772,antigenic peptides to cytotoxic T lymphocytes,16,22,95,140,Human leukocyte antigen class I antigens (HLA-I) is essential in immune response by presenting antigenic peptides to cytotoxic T lymphocytes.,25618241_0,-1,-1,-1,-1,25772,-1,0.04069336,0.0026394192,0.9566672
25775,factors,7,8,38,45,"In addition, elevated level of growth factors like TGF- or EGF in microenvironment is related to the prostate cancer deterioration.",25618241_2,0,1,-1,-1,25775,-1,0.9994234,0.00023911026,0.0003374772
25777,related to the,15,18,87,101,"In addition, elevated level of growth factors like TGF- or EGF in microenvironment is related to the prostate cancer deterioration.",25618241_2,-1,-1,-1,-1,25777,-1,2.8327493e-05,0.9999571,1.4541984e-05
25780,the regulation,11,13,55,69,"Thus, we wondered whether TGF- or EGF was involved in the regulation of HLA-I during the development of prostate cancer cells.",25618241_3,-1,-1,-1,-1,25780,-1,1.998582e-05,0.99996805,1.1986742e-05
25784,that TGF-,6,8,31,41,"In this study, we demonstrated that TGF- and EGF both downregulated the expression of HLA-I, thereby attenuated the cytotoxic T cell mediated lysis of prostate cancer cells.",25618241_4,-1,-1,-1,-1,25784,-1,2.4680208e-05,0.9999633,1.1988914e-05
25787,the cytotoxic T cell,19,23,113,133,"In this study, we demonstrated that TGF- and EGF both downregulated the expression of HLA-I, thereby attenuated the cytotoxic T cell mediated lysis of prostate cancer cells.",25618241_4,-1,-1,-1,-1,25787,-1,0.00307859,0.110305555,0.8866158
25789,that TGF-,4,6,18,28,"Next, we revealed that TGF- and EGF induced downregulation of HLA-I is associated with classical epithelial-mesenchymal transition (EMT) morphological changes and expression profiles.",25618241_5,-1,-1,-1,-1,25789,-1,2.7542428e-05,0.9999596,1.284933e-05
25793,the plausible target,8,11,40,60,"At last, we discussed that NF-B/p65 is the plausible target for Snail to induce HLA-I downregulation.",25618241_7,-1,-1,-1,-1,25793,-1,3.088172e-05,0.9999565,1.2577135e-05
25795,Taken together,0,2,0,14,"Taken together, this is the first evidence to reveal that both TGF- and EGF can induce HLA-I downregulation which is then proven to be associated with EMT in prostate cancer cells.",25618241_8,-1,-1,-1,-1,25795,-1,5.165151e-05,0.9999281,2.0279636e-05
25805,factors,8,9,59,66,These discoveries provide a deeper understanding of growth factors induced immune escape and introduce potential therapeutic targets for prostate cancers.,25618241_9,0,1,-1,-1,25805,-1,0.99642134,0.0028112766,0.0007674645
25806,therapeutic targets,15,17,113,132,These discoveries provide a deeper understanding of growth factors induced immune escape and introduce potential therapeutic targets for prostate cancers.,25618241_9,-1,-1,-1,-1,25806,-1,2.6364005e-05,0.9999614,1.2218637e-05
25808,T-cell tolerance,21,23,116,132,"Recent studies have demonstrated that -catenin in DCs serves as a key mediator in promoting both CD4(+) and CD8(+) T-cell tolerance, although how -catenin exerts its functions remains incompletely understood.",25730849_0,-1,-1,-1,-1,25808,-1,0.00091160747,0.015235064,0.98385334
25809,functions,29,30,168,177,"Recent studies have demonstrated that -catenin in DCs serves as a key mediator in promoting both CD4(+) and CD8(+) T-cell tolerance, although how -catenin exerts its functions remains incompletely understood.",25730849_0,0,1,2,-1,25809,-1,8.32473e-05,0.99988174,3.4997436e-05
25814,T-cell immunity,33,35,221,236,"Here we report that activation of -catenin in DCs inhibits cross-priming of CD8(+) T cells by up-regulating mTOR-dependent IL-10, suggesting blocking -catenin/mTOR/IL-10 signaling as a viable approach to augment CD8(+) T-cell immunity.",25730849_1,-1,-1,-1,-1,25814,-1,0.0049261483,0.00060540554,0.99446845
25820,T-cell immunity,13,15,89,104,"Further studies revealed that DC--catenin(-/-) mice were deficient in generating CD8(+) T-cell immunity despite normal clonal expansion, likely due to impaired IL-10 production by -catenin(-/-) DCs.",25730849_3,-1,-1,-1,-1,25820,-1,0.0007005484,0.00017551564,0.9991239
25828,T-cell,32,33,176,182,"Deletion of -catenin in DCs or blocking IL-10 after clonal expansion similarly led to reduced CD8(+) T cells, suggesting that -catenin in DCs plays a positive role in CD8(+) T-cell maintenance postclonal expansion through IL-10.",25730849_4,-1,1,2,-1,25828,-1,3.0451443e-05,4.33309e-05,0.9999262
25829,through IL-10,36,38,216,229,"Deletion of -catenin in DCs or blocking IL-10 after clonal expansion similarly led to reduced CD8(+) T cells, suggesting that -catenin in DCs plays a positive role in CD8(+) T-cell maintenance postclonal expansion through IL-10.",25730849_4,-1,-1,-1,-1,25829,-1,0.93461615,0.06197408,0.0034097685
25834,functions,4,5,29,38,"Despite -catenin's opposite functions in regulating CD8(+) T-cell responses, selectively blocking -catenin with a pharmacological inhibitor during priming phase augmented DC vaccine-induced CD8(+) T-cell immunity and improved antitumor efficacy, suggesting manipulating -catenin signaling as a feasible therapeutic strategy to improve DC vaccine efficacy.",25730849_6,0,1,2,-1,25834,-1,6.8819056e-05,0.99989533,3.5885583e-05
25835,T-cell,9,10,60,66,"Despite -catenin's opposite functions in regulating CD8(+) T-cell responses, selectively blocking -catenin with a pharmacological inhibitor during priming phase augmented DC vaccine-induced CD8(+) T-cell immunity and improved antitumor efficacy, suggesting manipulating -catenin signaling as a feasible therapeutic strategy to improve DC vaccine efficacy.",25730849_6,-1,1,2,-1,25835,-1,4.0525454e-05,5.054058e-05,0.9999089
25836,T-cell immunity,27,29,199,214,"Despite -catenin's opposite functions in regulating CD8(+) T-cell responses, selectively blocking -catenin with a pharmacological inhibitor during priming phase augmented DC vaccine-induced CD8(+) T-cell immunity and improved antitumor efficacy, suggesting manipulating -catenin signaling as a feasible therapeutic strategy to improve DC vaccine efficacy.",25730849_6,-1,-1,-1,-1,25836,-1,0.00820539,0.0005366322,0.99125797
25843,T-cell,16,17,105,111,The poor efficacy of the in vivo anti-tumor immune response has been partially attributed to ineffective T-cell responses mounted against the tumor.,25745993_0,-1,1,2,-1,25843,-1,4.087814e-05,5.6849232e-05,0.99990225
25844,the tumor,20,22,138,147,The poor efficacy of the in vivo anti-tumor immune response has been partially attributed to ineffective T-cell responses mounted against the tumor.,25745993_0,-1,-1,-1,-1,25844,-1,2.402905e-05,0.99996626,9.755874e-06
25849,immunity,20,21,131,139,Fas-FasL-dependent activation-induced cell death (AICD) of T cells is believed to be a major contributor to compromised anti-tumor immunity.,25745993_1,0,-1,2,-1,25849,-1,0.9994856,0.00029350357,0.00022086989
25852,therapy,16,17,106,113,"The molecular mechanisms of AICD are well-investigated, yet the possibility of regulating AICD for cancer therapy remains to be explored.",25745993_2,0,1,-1,-1,25852,-1,2.4043762e-05,0.9999641,1.1835989e-05
25857,the tumor,22,24,115,124,"In this study, we show that histone deacetylase inhibitors (HDACIs) can inhibit apoptosis of CD4(+) T cells within the tumor, thereby enhancing anti-tumor immune responses and suppressing melanoma growth.",25745993_3,-1,-1,-1,-1,25857,-1,1.9691703e-05,0.9999701,1.0241644e-05
25868,that the,4,6,22,30,"Importantly, we found that the co-administration of HDACIs and anti-CTLA4 could further enhance the infiltration of CD4(+) T cells and achieve a synergistic therapeutic effect on tumor.",25745993_6,-1,-1,-1,-1,25868,-1,1.7483459e-05,0.99997306,9.404996e-06
25874,that the,5,7,34,42,"Therefore, our study demonstrates that the modulation of AICD of tumor-infiltrating CD4(+) T cells using HDACIs can enhance anti-tumor immune responses, uncovering a novel mechanism underlying the anti-tumor effect of HDACIs.",25745993_7,-1,-1,-1,-1,25874,-1,1.6350255e-05,0.9999751,8.52779e-06
25887,the tumor-infiltrating T cells,23,27,157,187,"To study whether the infiltration of T cell subpopulations was correlated with cervical adenocarcinoma patient survival, similar to squamous cell carcinoma, the tumor-infiltrating T cells, Tregs, Th17 cells and IL-17(+) cell frequencies were analyzed in a cohort of cervical adenocarcinoma patients (n=67).",25795131_2,-1,-1,-1,-1,25887,-1,0.003330119,0.8477764,0.14889348
25889,Th17 cells,30,32,196,206,"To study whether the infiltration of T cell subpopulations was correlated with cervical adenocarcinoma patient survival, similar to squamous cell carcinoma, the tumor-infiltrating T cells, Tregs, Th17 cells and IL-17(+) cell frequencies were analyzed in a cohort of cervical adenocarcinoma patients (n=67).",25795131_2,-1,-1,-1,-1,25889,-1,0.0028508336,0.19992694,0.79722226
25892,total cell,4,6,29,39,"Intraepithelial, stromal and total cell frequencies were scored using triple immunofluorescence.",25795131_3,-1,-1,-1,-1,25892,-1,0.00023710894,0.0008440443,0.9989189
25895,the tumor,7,9,38,47,"The majority of Tregs were present in the tumor stroma, while other T cells and IL-17(+) cells infiltrated the tumor epithelium three times more frequently.",25795131_4,-1,-1,-1,-1,25895,-1,1.9221363e-05,0.9999697,1.10274e-05
25899,the tumor,20,22,107,116,"The majority of Tregs were present in the tumor stroma, while other T cells and IL-17(+) cells infiltrated the tumor epithelium three times more frequently.",25795131_4,-1,-1,-1,-1,25899,-1,1.9928762e-05,0.99996626,1.3811822e-05
25900,three times,23,25,128,139,"The majority of Tregs were present in the tumor stroma, while other T cells and IL-17(+) cells infiltrated the tumor epithelium three times more frequently.",25795131_4,-1,-1,-1,-1,25900,-1,6.153672e-05,0.9998956,4.2912747e-05
25903,the tumor,1,3,7,16,"Within the tumor epithelium, a high T cell frequency was significantly correlated with improved disease-free survival (p=0.034).",25795131_6,-1,-1,-1,-1,25903,-1,1.8263538e-05,0.99997103,1.0646497e-05
25909,Th17 cells,7,9,36,46,A low number of Tregs combined with Th17 cells present were also correlated with poor survival (p=0.018).,25795131_8,-1,-1,-1,-1,25909,-1,0.00057792553,0.005569959,0.99385214
25915,that Tregs,3,5,22,32,"These results suggest that Tregs and IL-17(+) cells represent a beneficial immune response, whereas Th17 cells might represent a poor response in cervical adenocarcinoma.",25795131_10,-1,-1,-1,-1,25915,-1,2.3813287e-05,0.99996626,9.880397e-06
25919,Th17 cells,16,18,100,110,"These results suggest that Tregs and IL-17(+) cells represent a beneficial immune response, whereas Th17 cells might represent a poor response in cervical adenocarcinoma.",25795131_10,-1,-1,-1,-1,25919,-1,0.002253597,0.129439,0.86830735
25923,that the,12,14,86,94,"This contrasts with the correlations described in squamous cell carcinoma, suggesting that the local immune response in cervical adenocarcinoma contributes differently to tumor growth than in squamous cell carcinoma.",25795131_11,-1,-1,-1,-1,25923,-1,1.983917e-05,0.99997234,7.850605e-06
25925,to tumor,22,24,168,176,"This contrasts with the correlations described in squamous cell carcinoma, suggesting that the local immune response in cervical adenocarcinoma contributes differently to tumor growth than in squamous cell carcinoma.",25795131_11,-1,-1,-1,-1,25925,-1,2.9698715e-05,0.9999573,1.3012921e-05
25929,that the transforming growth factor beta,4,10,31,71,There is accumulating evidence that the transforming growth factor beta (TGF-) and nuclear factor kappa-B (NFB) pathways are tightly connected and play a key role in malignant transformation in cancer.,25832000_0,-1,-1,-1,-1,25929,-1,0.2687236,0.72689915,0.004377254
25941,functions,9,10,61,70,"There is a plethora of studies examining the pro-tumorigenic functions of carcinoembryonic antigen (CEA), but its receptor CEAR is far less studied.",25832000_2,0,1,2,-1,25941,-1,6.111768e-05,0.999892,4.6847188e-05
25943,receptor,19,20,114,122,"There is a plethora of studies examining the pro-tumorigenic functions of carcinoembryonic antigen (CEA), but its receptor CEAR is far less studied.",25832000_2,0,1,2,-1,25943,-1,0.0026399791,0.6973531,0.30000687
25945,that TGF-,9,11,44,54,"So far, there is a single connecting report that TGF- also may signal through CEAR.",25832000_3,-1,-1,-1,-1,25945,-1,3.5975325e-05,0.99995065,1.339092e-05
25948,tissues,4,5,29,36,"The crosstalk between cancer tissues is further complicated by the expression of CEAR and TGF- receptors in stromal cells, and implications of TGF- in epithelial-mesenchymal transition.",25832000_4,-1,1,2,-1,25948,-1,3.6633362e-05,0.99985206,0.00011128187
25950,TGF- receptors,14,16,90,105,"The crosstalk between cancer tissues is further complicated by the expression of CEAR and TGF- receptors in stromal cells, and implications of TGF- in epithelial-mesenchymal transition.",25832000_4,-1,-1,-1,-1,25950,-1,0.00019059604,0.9986039,0.0012055298
25954,tumor-infiltrating Tregs,2,4,13,37,"Furthermore, tumor-infiltrating Tregs and Bregs may directly instruct cancer cells by secreting TGF- binding to their CEAR.",25832000_5,-1,-1,-1,-1,25954,-1,2.516148e-05,0.9999621,1.2756422e-05
25957,to their,15,17,110,118,"Furthermore, tumor-infiltrating Tregs and Bregs may directly instruct cancer cells by secreting TGF- binding to their CEAR.",25832000_5,-1,-1,-1,-1,25957,-1,2.6790096e-05,0.9999598,1.3344104e-05
25962,TGF--R types,6,8,16,29,"CEAR, TGF-1-3, TGF--R types I-III and NFB class I and II molecules have an outstanding human-canine sequence identity, and only a canine CEA homolog has not yet been identified.",25832000_7,-1,-1,-1,-1,25962,-1,4.4385968e-05,0.9999205,3.5152836e-05
25973,that regulatory T cells,2,6,16,39,We hypothesized that regulatory T cells (Treg) may exert a functional and clinical impact on antitumor immunity in cetuximab-treated individuals.,25832655_1,-1,-1,-1,-1,25973,-1,0.002373362,0.12688668,0.87074
25975,functional,12,13,59,69,We hypothesized that regulatory T cells (Treg) may exert a functional and clinical impact on antitumor immunity in cetuximab-treated individuals.,25832655_1,0,1,2,-1,25975,-1,6.138077e-05,0.99991405,2.458892e-05
25976,immunity,18,19,103,111,We hypothesized that regulatory T cells (Treg) may exert a functional and clinical impact on antitumor immunity in cetuximab-treated individuals.,25832655_1,0,-1,2,-1,25976,-1,0.99888986,0.0007955349,0.00031465758
25990,These Treg,0,2,0,10,These Treg suppressed cetuximab-mediated antibody-dependent cellular cytotoxicity (ADCC) and their presence correlated with poor clinical outcome in two prospective clinical trial cohorts.,25832655_4,-1,-1,-1,-1,25990,-1,2.669916e-05,0.99995947,1.3837239e-05
25999,T-cell receptor triggering,22,25,129,155,"Cetuximab expanded CTLA-4(+)FOXP3(+) Treg in vitro, in part, by inducing dendritic cell maturation, in combination with TGF and T-cell receptor triggering.",25832655_5,-1,-1,-1,-1,25999,-1,0.0008510541,0.005304438,0.9938446
26003,targeted CTLA-4(+,6,8,30,47,"In ex vivo assays, ipilimumab targeted CTLA-4(+) Treg and restored cytolytic functions of NK cells mediating ADCC.",25832655_7,-1,-1,-1,-1,26003,-1,0.007949853,0.8509891,0.1410611
26005,functions,13,14,77,86,"In ex vivo assays, ipilimumab targeted CTLA-4(+) Treg and restored cytolytic functions of NK cells mediating ADCC.",25832655_7,0,1,2,-1,26005,-1,0.00045939733,0.9975943,0.0019463417
26007,Taken together,0,2,0,14,"Taken together, our results argue that differences in Treg-mediated suppression contribute to the clinical response to cetuximab treatment, suggesting its improvement by adding ipilimumab or other strategies of Treg ablation to promote antitumor immunity.",25832655_8,-1,-1,-1,-1,26007,-1,4.3899643e-05,0.99994016,1.5989963e-05
26010,to the,12,14,91,97,"Taken together, our results argue that differences in Treg-mediated suppression contribute to the clinical response to cetuximab treatment, suggesting its improvement by adding ipilimumab or other strategies of Treg ablation to promote antitumor immunity.",25832655_8,-1,-1,-1,-1,26010,-1,2.4409359e-05,0.99996614,9.502472e-06
26015,immunity,35,36,246,254,"Taken together, our results argue that differences in Treg-mediated suppression contribute to the clinical response to cetuximab treatment, suggesting its improvement by adding ipilimumab or other strategies of Treg ablation to promote antitumor immunity.",25832655_8,0,-1,2,-1,26015,-1,0.99937135,0.00039225,0.0002363614
26016,function,3,4,18,26,Decline in immune function and inflammation concomitantly develop with ageing.,25850032_0,0,1,2,-1,26016,-1,0.00074174406,0.99828714,0.00097106915
26032,IL-6 deficiency,25,27,159,174,The impaired antitumour effect of CD4(+) T cells with their defective Th1 differentiation in an aged environment is restored by interleukin (IL)-6 blockade or IL-6 deficiency.,25850032_2,-1,-1,-1,-1,26032,-1,0.99620545,0.0014861866,0.0023083105
26035,T cells to,10,13,59,69,"IL-6 blockade also restores the impaired ability of CD4(+) T cells to promote CD8(+) T-cell-dependent tumour elimination in aged mice, which requires IFN-.",25850032_3,-1,-1,-1,-1,26035,-1,0.0016710378,0.03832711,0.96000177
26036,T-cell-dependent tumour,16,18,85,108,"IL-6 blockade also restores the impaired ability of CD4(+) T cells to promote CD8(+) T-cell-dependent tumour elimination in aged mice, which requires IFN-.",25850032_3,-1,-1,-1,-1,26036,-1,0.0011138,0.014533807,0.9843524
26042,to IL-10,3,5,22,30,"IL-6 also contributes to IL-10 production from CD4(+) T cells in aged mice, causing attenuated responses of CD8(+) T cells.",25850032_5,-1,-1,-1,-1,26042,-1,0.7946951,0.20166898,0.0036358987
26046,that IL-6,3,5,23,32,These findings suggest that IL-6 serves as an extrinsic factor counteracting CD4(+) T-cell-mediated immunity against tumour in old age.,25850032_6,-1,-1,-1,-1,26046,-1,0.70897454,0.2843657,0.0066596875
26047,factor,9,10,56,62,These findings suggest that IL-6 serves as an extrinsic factor counteracting CD4(+) T-cell-mediated immunity against tumour in old age.,25850032_6,0,1,-1,-1,26047,-1,0.0007649226,0.9990759,0.00015916234
26048,T-cell-mediated immunity,13,15,84,108,These findings suggest that IL-6 serves as an extrinsic factor counteracting CD4(+) T-cell-mediated immunity against tumour in old age.,25850032_6,-1,-1,-1,-1,26048,-1,0.013855339,0.0016872737,0.98445743
26052,Th22 cells,7,9,38,48,"AIM: To investigate the expression of Th22 cells and related cytokines in colorectal cancer (CRC) tissues, and the probably mechanism.",25892871_0,-1,-1,-1,-1,26052,-1,0.002329745,0.11893277,0.87873757
26053,related cytokines,10,12,53,70,"AIM: To investigate the expression of Th22 cells and related cytokines in colorectal cancer (CRC) tissues, and the probably mechanism.",25892871_0,-1,-1,-1,-1,26053,-1,0.8089391,0.18220253,0.008858315
26054,tissues,18,19,98,105,"AIM: To investigate the expression of Th22 cells and related cytokines in colorectal cancer (CRC) tissues, and the probably mechanism.",25892871_0,-1,1,2,-1,26054,-1,6.3449654e-05,0.9995597,0.00037677522
26057,tissues,6,7,33,40,"METHODS: CRC tumor and paratumor tissues were collected to detect the expression levels of Th22 cells and of related cytokines by immunohistochemistry, flow cytometry and real-time quantitative polymerase chain reaction (RT-qPCR).",25892871_1,-1,1,2,-1,26057,-1,5.4926182e-05,0.9997247,0.00022033798
26060,Th22 cells,15,17,91,101,"METHODS: CRC tumor and paratumor tissues were collected to detect the expression levels of Th22 cells and of related cytokines by immunohistochemistry, flow cytometry and real-time quantitative polymerase chain reaction (RT-qPCR).",25892871_1,-1,-1,-1,-1,26060,-1,0.0006985434,0.010496419,0.98880506
26061,related cytokines,19,21,109,126,"METHODS: CRC tumor and paratumor tissues were collected to detect the expression levels of Th22 cells and of related cytokines by immunohistochemistry, flow cytometry and real-time quantitative polymerase chain reaction (RT-qPCR).",25892871_1,-1,-1,-1,-1,26061,-1,0.8295828,0.16036086,0.01005633
26070,cells to,19,21,119,127,IL-22 alone or with a STAT3 inhibitor was injected into a BALB/c nude mouse model with subcutaneously transplanted RKO cells to study the effects of IL-22 on colon cancer growth.,25892871_3,-1,-1,-1,-1,26070,-1,0.0038502647,0.16197927,0.8341705
26073,Th22 cells,5,7,27,37,"RESULTS: The percentage of Th22 cells in the CD4(+) T subset was significantly higher in tumor tissues compared with that in paratumor tissues (1.47%  0.083% vs 1.23%  0.077%, P < 0.05) as determined by flow cytometry.",25892871_4,-1,-1,-1,-1,26073,-1,0.003519652,0.28585917,0.7106212
26075,T subset,11,13,52,60,"RESULTS: The percentage of Th22 cells in the CD4(+) T subset was significantly higher in tumor tissues compared with that in paratumor tissues (1.47%  0.083% vs 1.23%  0.077%, P < 0.05) as determined by flow cytometry.",25892871_4,-1,-1,-1,-1,26075,-1,0.0001432462,0.0010951443,0.99876165
26076,tumor tissues,17,19,89,102,"RESULTS: The percentage of Th22 cells in the CD4(+) T subset was significantly higher in tumor tissues compared with that in paratumor tissues (1.47%  0.083% vs 1.23%  0.077%, P < 0.05) as determined by flow cytometry.",25892871_4,-1,-1,-1,-1,26076,-1,2.2325112e-05,0.99995744,2.0195985e-05
26078,tissues,24,25,135,142,"RESULTS: The percentage of Th22 cells in the CD4(+) T subset was significantly higher in tumor tissues compared with that in paratumor tissues (1.47%  0.083% vs 1.23%  0.077%, P < 0.05) as determined by flow cytometry.",25892871_4,-1,1,2,-1,26078,-1,3.4053774e-05,0.99990296,6.2975334e-05
26079,analysis,1,2,8,16,"RT-qPCR analysis revealed that the mRNA expression levels of IL-22, aryl hydrocarbon receptor, CCL20 and CCL22 were significantly higher in tumor tissues compared with those in paratumor tissues.",25892871_5,0,1,-1,-1,26079,-1,2.7523261e-05,0.9999386,3.388985e-05
26080,that the,3,5,26,34,"RT-qPCR analysis revealed that the mRNA expression levels of IL-22, aryl hydrocarbon receptor, CCL20 and CCL22 were significantly higher in tumor tissues compared with those in paratumor tissues.",25892871_5,-1,-1,-1,-1,26080,-1,1.7394825e-05,0.9999727,9.958484e-06
26083,tumor tissues,22,24,140,153,"RT-qPCR analysis revealed that the mRNA expression levels of IL-22, aryl hydrocarbon receptor, CCL20 and CCL22 were significantly higher in tumor tissues compared with those in paratumor tissues.",25892871_5,-1,-1,-1,-1,26083,-1,2.838953e-05,0.9999293,4.227584e-05
26085,tissues,29,30,187,194,"RT-qPCR analysis revealed that the mRNA expression levels of IL-22, aryl hydrocarbon receptor, CCL20 and CCL22 were significantly higher in tumor tissues compared with those in paratumor tissues.",25892871_5,-1,1,2,-1,26085,-1,5.430345e-05,0.9995958,0.00034992167
26087,tumor tissues,9,11,55,68,"CCL27 mRNA also displayed a higher expression level in tumor tissues compared with that in paratumor tissues; however, these levels were not significantly different (2.58  0.93 vs 2.30  0.78, P > 0.05).",25892871_6,-1,-1,-1,-1,26087,-1,2.2893764e-05,0.99995196,2.5098387e-05
26089,tissues,16,17,101,108,"CCL27 mRNA also displayed a higher expression level in tumor tissues compared with that in paratumor tissues; however, these levels were not significantly different (2.58  0.93 vs 2.30  0.78, P > 0.05).",25892871_6,-1,1,2,-1,26089,-1,3.69241e-05,0.9998473,0.00011581
26097,Th22 cells that,2,5,12,27,CONCLUSION: Th22 cells that accumulate in CRC may be associated with the chemotactic effect of the tumor microenvironment.,25892871_9,-1,-1,-1,-1,26097,-1,0.00041883215,0.99319744,0.006383712
26098,the chemotactic,12,14,69,84,CONCLUSION: Th22 cells that accumulate in CRC may be associated with the chemotactic effect of the tumor microenvironment.,25892871_9,-1,-1,-1,-1,26098,-1,0.5612222,0.43447396,0.0043038744
26099,the tumor,16,18,95,104,CONCLUSION: Th22 cells that accumulate in CRC may be associated with the chemotactic effect of the tumor microenvironment.,25892871_9,-1,-1,-1,-1,26099,-1,2.397384e-05,0.99996626,9.787504e-06
26104,that plays,5,7,37,47,PDAC builds a tumor microenvironment that plays critical roles in tumor progression and metastasis.,25952647_1,-1,-1,-1,-1,26104,-1,2.7276148e-05,0.99996054,1.2183765e-05
26106,the relationship,2,4,9,25,"However, the relationship between chemotherapy and modulation of PDAC-induced tumor microenvironment remains poorly understood.",25952647_2,-1,-1,-1,-1,26106,-1,2.3707502e-05,0.9999658,1.05243635e-05
26119,tumor tissues,12,14,80,93,"GM-CSF production was significantly enhanced in various PDAC cell lines or PDAC tumor tissues from patients after treatment with chemotherapy, which induced the differentiation of monocytes into myeloid-derived suppressor cells (MDSC).",25952647_5,-1,-1,-1,-1,26119,-1,3.639257e-05,0.99990237,6.127297e-05
26135,that the targeting,18,21,128,146,"Together, these results describe a role of GM-CSF in the modification of chemotherapy-treated PDAC microenvironment and suggest that the targeting of GM-CSF may benefit PDAC patients' refractory to current anticancer regimens by defeating MDSC-mediated immune escape.",25952647_8,-1,-1,-1,-1,26135,-1,2.1146547e-05,0.9999689,9.962997e-06
26139,This deficiency,0,2,0,15,This deficiency is in part due to an incomplete understanding of how to best invoke dendritic cells (DC) that are crucial for the induction of tumor-specific CD8(+) T cells capable of mediating durable protective immunity.,25972487_1,-1,-1,-1,-1,26139,-1,4.2831794e-05,0.9999291,2.805203e-05
26147,immunity,37,38,213,221,This deficiency is in part due to an incomplete understanding of how to best invoke dendritic cells (DC) that are crucial for the induction of tumor-specific CD8(+) T cells capable of mediating durable protective immunity.,25972487_1,0,-1,2,-1,26147,-1,0.9990914,0.0006411712,0.0002674824
26149,the transcription factor,7,10,39,63,"In this regard, elevated expression of the transcription factor X box-binding protein 1 (XBP1) in DC appears to play a decisive role in promoting the ability of DC to cross-present Ags to CD8(+) T cells in the therapeutic setting.",25972487_2,-1,-1,-1,-1,26149,-1,1.915533e-05,0.9999702,1.0627053e-05
26150,protein,12,13,78,85,"In this regard, elevated expression of the transcription factor X box-binding protein 1 (XBP1) in DC appears to play a decisive role in promoting the ability of DC to cross-present Ags to CD8(+) T cells in the therapeutic setting.",25972487_2,0,1,-1,-1,26150,-1,2.4365341e-05,0.99995506,2.0522117e-05
26152,to play,20,22,109,116,"In this regard, elevated expression of the transcription factor X box-binding protein 1 (XBP1) in DC appears to play a decisive role in promoting the ability of DC to cross-present Ags to CD8(+) T cells in the therapeutic setting.",25972487_2,-1,-1,-1,-1,26152,-1,2.1897296e-05,0.999969,9.086807e-06
26157,the therapeutic,40,42,206,221,"In this regard, elevated expression of the transcription factor X box-binding protein 1 (XBP1) in DC appears to play a decisive role in promoting the ability of DC to cross-present Ags to CD8(+) T cells in the therapeutic setting.",25972487_2,-1,-1,-1,-1,26157,-1,2.1529602e-05,0.9999691,9.366193e-06
26173,blood-,9,10,53,59,"Similarly, human XBP1 improved the capacity of human blood- and skin-derived DC to activate human T cells.",25972487_6,0,1,-1,-1,26173,-1,6.963315e-05,0.99987555,5.4843338e-05
26179,immunity,30,31,210,218,"These data support an important intrinsic role for XBP1 in DC for effective cross-priming and orchestration of Batf3(+) DC-pDC interactions, thereby enabling effective vaccine induction of protective antitumor immunity.",25972487_7,0,-1,2,-1,26179,-1,0.99935406,0.00042717918,0.0002186911
26186,this tolerogenic,3,5,26,42,The mechanisms underlying this tolerogenic phenomenon remain poorly understood.,25984582_1,-1,-1,-1,-1,26186,-1,3.2384563e-05,0.99995506,1.2516214e-05
26202,T-cells,32,33,183,190,"Among various immune cells in colon, dendritic cells (DCs) are unique not only in their accessibility to luminal contents but also in their ability to induce tolerogenic phenotype in T-cells.",25984582_3,-1,1,2,-1,26202,-1,3.7160262e-05,5.8993137e-05,0.9999038
26207,naive T-cells,28,30,177,190,"We found that DCs exposed to butyrate express the immunosuppressive enzymes indoleamine 2,3-dioxygenase 1 (IDO1) and aldehyde dehydrogenase 1A2 (Aldh1A2), promote conversion of naive T-cells into immunosuppressive forkhead box P3(+) (FoxP3(+)) Tregs (regulatory T-cells) and suppress conversion of naive T-cells into pro-inflammatory interferon (IFN)--producing cells.",25984582_4,-1,-1,-1,-1,26207,-1,0.002006478,0.053190738,0.94480276
26212,naive T-cells,49,51,298,311,"We found that DCs exposed to butyrate express the immunosuppressive enzymes indoleamine 2,3-dioxygenase 1 (IDO1) and aldehyde dehydrogenase 1A2 (Aldh1A2), promote conversion of naive T-cells into immunosuppressive forkhead box P3(+) (FoxP3(+)) Tregs (regulatory T-cells) and suppress conversion of naive T-cells into pro-inflammatory interferon (IFN)--producing cells.",25984582_4,-1,-1,-1,-1,26212,-1,0.002213272,0.07078575,0.927001
26215,generate Tregs,11,13,58,72,Slc5a8-null DCs do not induce IDO1 and Aldh1A2 and do not generate Tregs or suppress IFN--producing T-cells in response to butyrate.,25984582_5,-1,-1,-1,-1,26215,-1,3.4847006e-05,0.9999497,1.54027e-05
26216,IFN--producing T-cells,15,17,85,108,Slc5a8-null DCs do not induce IDO1 and Aldh1A2 and do not generate Tregs or suppress IFN--producing T-cells in response to butyrate.,25984582_5,-1,-1,-1,-1,26216,-1,0.7807031,0.0022810427,0.21701582
26218,IFN--producing T-cells,17,19,85,108,We also provide invivo evidence for an obligatory role for Slc5a8in suppression of IFN--producing T-cells.,25984582_6,-1,-1,-1,-1,26218,-1,0.7419463,0.0027721399,0.2552816
26222,the transporter to,7,10,45,63,This agrees with the high-affinity nature of the transporter to mediate butyrate entry into cells.,25984582_8,-1,-1,-1,-1,26222,-1,2.157066e-05,0.999966,1.2361604e-05
26226,that this transporter,21,24,136,157,We conclude that Slc5a8 is an obligatory link between dietary fibre and mucosal immune system via the bacterial metabolite butyrate and that this transporter is a conditional tumour suppressor in colon linked to dietary fibre content.,25984582_9,-1,-1,-1,-1,26226,-1,3.155614e-05,0.9999443,2.4157745e-05
26236,peptides,7,8,31,39,"METHODS: Overlapping 30-35 mer peptides covering the entire HPV16 E2-, E6- and E7 protein sequences were used for defining the lymphocyte proliferation capacity, cytokine production (IL-2, IL-5, IL-10, IL-17A, IFN- and TNF-) and numbers of HPV16 -specific CD4+ CD25+ Foxp3+ regulatory T-cells in 10 women who developed CIN, and in 22 control women who tested constantly HPV-negative during the follow-up.",25990808_2,0,-1,2,-1,26236,-1,6.5649074e-05,0.99986684,6.7495064e-05
26238,protein,17,18,82,89,"METHODS: Overlapping 30-35 mer peptides covering the entire HPV16 E2-, E6- and E7 protein sequences were used for defining the lymphocyte proliferation capacity, cytokine production (IL-2, IL-5, IL-10, IL-17A, IFN- and TNF-) and numbers of HPV16 -specific CD4+ CD25+ Foxp3+ regulatory T-cells in 10 women who developed CIN, and in 22 control women who tested constantly HPV-negative during the follow-up.",25990808_2,0,1,-1,-1,26238,-1,0.000107866355,0.99973613,0.00015599202
26239,the lymphocyte,23,25,123,137,"METHODS: Overlapping 30-35 mer peptides covering the entire HPV16 E2-, E6- and E7 protein sequences were used for defining the lymphocyte proliferation capacity, cytokine production (IL-2, IL-5, IL-10, IL-17A, IFN- and TNF-) and numbers of HPV16 -specific CD4+ CD25+ Foxp3+ regulatory T-cells in 10 women who developed CIN, and in 22 control women who tested constantly HPV-negative during the follow-up.",25990808_2,-1,-1,-1,-1,26239,-1,0.0048615537,0.55110174,0.4440367
26244,TNF-,41,42,220,225,"METHODS: Overlapping 30-35 mer peptides covering the entire HPV16 E2-, E6- and E7 protein sequences were used for defining the lymphocyte proliferation capacity, cytokine production (IL-2, IL-5, IL-10, IL-17A, IFN- and TNF-) and numbers of HPV16 -specific CD4+ CD25+ Foxp3+ regulatory T-cells in 10 women who developed CIN, and in 22 control women who tested constantly HPV-negative during the follow-up.",25990808_2,0,1,-1,-1,26244,-1,0.00014544948,0.9998228,3.1793923e-05
26249,related to the,3,6,21,35,"HPV-specific CMI was related to the demographic data including sexual behavior, smoking and alcohol consumption.",25990808_3,-1,-1,-1,-1,26249,-1,3.7938713e-05,0.9999411,2.1000398e-05
26251,T-cell,10,11,55,61,"RESULTS: Women with CIN and their controls had similar T-cell mediated immunity against HPV16 E2, E6 and E7 peptide pools.",25990808_4,-1,1,2,-1,26251,-1,3.5768146e-05,6.237945e-05,0.9999019
26252,immunity,12,13,71,79,"RESULTS: Women with CIN and their controls had similar T-cell mediated immunity against HPV16 E2, E6 and E7 peptide pools.",25990808_4,0,-1,2,-1,26252,-1,0.99606067,0.0006031589,0.0033361625
26253,peptide,20,21,108,115,"RESULTS: Women with CIN and their controls had similar T-cell mediated immunity against HPV16 E2, E6 and E7 peptide pools.",25990808_4,0,-1,2,-1,26253,-1,0.006089981,0.96417665,0.029733306
26254,T-cell,5,6,32,38,"However, nearly fourfold higher T-cell reactivity against common antigens was found in the CIN women than in the healthy donors (p=0.001).",25990808_5,-1,1,2,-1,26254,-1,3.4613797e-05,6.2631065e-05,0.99990284
26263,the T-cell,6,8,36,46,"Smoking and use of alcohol affected the T-cell response to common antigens but not to HPV peptides (p=0.032 and 0.045, respectively).CONCLUSION: While both the CIN women and controls exhibited an HPV16-specific CMI, IL-17A might be of importance in HPV induced pathology.",25990808_7,-1,-1,-1,-1,26263,-1,0.002750319,0.17242782,0.8248219
26267,peptides,16,17,90,98,"Smoking and use of alcohol affected the T-cell response to common antigens but not to HPV peptides (p=0.032 and 0.045, respectively).CONCLUSION: While both the CIN women and controls exhibited an HPV16-specific CMI, IL-17A might be of importance in HPV induced pathology.",25990808_7,0,-1,2,-1,26267,-1,0.0041062753,0.9788422,0.0170515
26275,that the,5,7,30,38,It has recently been reported that the CD40-CD40 ligand (CD40L) interaction is important in Th17 development.,25992978_0,-1,-1,-1,-1,26275,-1,1.9984443e-05,0.9999716,8.438076e-06
26283,Th17 cells,22,24,146,156,"In addition, transforming growth factor-beta (TGF-) promotes tumorigenesis as an immunosuppressive cytokine and is crucial in the development of Th17 cells.",25992978_1,-1,-1,-1,-1,26283,-1,0.0003411152,0.0027665477,0.9968924
26287,function,16,17,98,106,This study investigated the role of CD40 in breast cancer cells and its role in immunosuppressive function and tumor progression.,25992978_2,0,1,2,-1,26287,-1,5.5800774e-05,0.9999001,4.410148e-05
26299,cells through the,27,30,194,211,"Direct CD40-CD40L interaction between MDA-MB231 cells and activated T cells also increased TGF- production and induced the production of IL-17, which accelerated the proliferation of MDA-MB231 cells through the activation of STAT3.",25992978_4,-1,-1,-1,-1,26299,-1,0.0052008075,0.42313763,0.57166153
26301,Taken together,0,2,0,14,"Taken together, the direct CD40-CD40L interaction of breast tumor cells and activated T cells increases TGF- production and the differentiation of Th17 cells, which promotes the proliferation of breast cancer cells.",25992978_5,-1,-1,-1,-1,26301,-1,5.7086825e-05,0.99991965,2.3232811e-05
26303,tumor cells,9,11,60,71,"Taken together, the direct CD40-CD40L interaction of breast tumor cells and activated T cells increases TGF- production and the differentiation of Th17 cells, which promotes the proliferation of breast cancer cells.",25992978_5,-1,-1,-1,-1,26303,-1,0.0044838935,0.43051174,0.5650044
26307,Th17 cells,22,24,148,158,"Taken together, the direct CD40-CD40L interaction of breast tumor cells and activated T cells increases TGF- production and the differentiation of Th17 cells, which promotes the proliferation of breast cancer cells.",25992978_5,-1,-1,-1,-1,26307,-1,0.0036497226,0.4055675,0.59078276
26321,their related cytokines,19,22,86,109,"In the present study, we mainly investigated the role of Th22, Th17, and Th1 cell and their related cytokines (IL-22, IL-17, and IFN-r) in the pathophysiology of CML.",26000313_1,-1,-1,-1,-1,26321,-1,0.25312227,0.73704875,0.009829036
26325,blood,7,8,32,37,"Bone marrow (BM) and peripheral blood (PB) were extracted from newly diagnosed (ND), chronic phase- (CP-) CML patients, and controls.",26000313_2,0,1,-1,-1,26325,-1,0.00031169815,0.9951762,0.0045120544
26326,Th subsets,0,2,0,10,Th subsets were examined by flow cytometry.,26000313_3,-1,-1,-1,-1,26326,-1,0.0012113163,0.044940706,0.95384794
26342,Th17 cells,12,14,82,92,"In addition, there existed a significantly positive relationship between Th22 and Th17 cells in PB or BM.",26000313_7,-1,-1,-1,-1,26342,-1,0.0032611238,0.29175374,0.70498514
26344,Th cells,7,9,56,64,"A significantly negative relationship was found between Th cells (Th22, Th17, or Th1) and BCR-ABL (%) IS or the number of PB white blood cells.",26000313_8,-1,-1,-1,-1,26344,-1,3.383579e-05,4.951561e-05,0.9999167
26349,blood cells,29,31,131,142,"A significantly negative relationship was found between Th cells (Th22, Th17, or Th1) and BCR-ABL (%) IS or the number of PB white blood cells.",26000313_8,-1,-1,-1,-1,26349,-1,3.9860613e-05,5.6189216e-05,0.99990404
26351,that Th22,4,6,31,40,"All these results demonstrated that Th22, Th17, and Th1 cells might be important therapeutic targets in CML and could facilitate a better outcome for tumor immunotherapy.",26000313_9,-1,-1,-1,-1,26351,-1,4.3364515e-05,0.9999387,1.788897e-05
26354,therapeutic targets,15,17,81,100,"All these results demonstrated that Th22, Th17, and Th1 cells might be important therapeutic targets in CML and could facilitate a better outcome for tumor immunotherapy.",26000313_9,-1,-1,-1,-1,26354,-1,2.9480994e-05,0.99995685,1.3620807e-05
26358,T-cell,13,14,76,82,One of the obstacles for cancer immunotherapy is the inefficiency of CD8(+) T-cell recruitment to tumors.,26025380_0,-1,1,2,-1,26358,-1,3.1455544e-05,4.2409763e-05,0.9999261
26359,to tumors,15,17,95,104,One of the obstacles for cancer immunotherapy is the inefficiency of CD8(+) T-cell recruitment to tumors.,26025380_0,-1,-1,-1,-1,26359,-1,2.9427873e-05,0.99995863,1.19021415e-05
26362,T-cell,8,9,40,46,"STAT3 has been shown to suppress CD8(+) T-cell antitumor functions in various cancer models, in part by restricting accumulation of CD8(+) T cells.",26025380_1,-1,1,2,-1,26362,-1,3.2607848e-05,4.2901753e-05,0.9999244
26363,functions,10,11,57,66,"STAT3 has been shown to suppress CD8(+) T-cell antitumor functions in various cancer models, in part by restricting accumulation of CD8(+) T cells.",26025380_1,0,1,2,-1,26363,-1,0.0020288979,0.98542815,0.012542916
26371,that STAT3,4,6,14,24,"Here, we show that STAT3 signaling in CD8(+) T cells inhibits chemokine CXCL10 production by tumor-associated myeloid cells by reducing IFN expression by T cells.",26025380_3,-1,-1,-1,-1,26371,-1,2.0622552e-05,0.9999677,1.1699912e-05
26381,the receptor,14,16,82,94,"We further demonstrate that ablating STAT3 in T cells allows expression of CXCR3, the receptor of CXCL10, on CD8(+) T cells, resulting in efficient accumulation of CD8(+) T cells at tumor sites.",26025380_4,-1,-1,-1,-1,26381,-1,0.0024702556,0.9470362,0.05049353
26397,T cells through,20,23,120,135,"Together, our study reveals a negative regulation by STAT3 signaling in T cells on cross-talk between myeloid cells and T cells through IFN/CXCR3/CXCL10, which is important for CD8(+) T cells homing to tumors.",26025380_6,-1,-1,-1,-1,26397,-1,0.001926809,0.04335301,0.9547202
26399,to tumors,34,36,200,209,"Together, our study reveals a negative regulation by STAT3 signaling in T cells on cross-talk between myeloid cells and T cells through IFN/CXCR3/CXCL10, which is important for CD8(+) T cells homing to tumors.",26025380_6,-1,-1,-1,-1,26399,-1,2.4359346e-05,0.9999646,1.109059e-05
26402,T-cell,12,13,86,92,Our results thus provide new insights applicable to cancer immunotherapy and adoptive T-cell strategies.,26025380_7,-1,1,2,-1,26402,-1,3.3781744e-05,5.742217e-05,0.9999088
26404,tumor cells,5,7,27,38,"In order to understand how tumor cells can escape immune surveillance mechanisms and thus develop antitumor therapies, it is critically important to investigate the mechanisms by which the immune system interacts with the tumor microenvironment.",26047948_0,-1,-1,-1,-1,26404,-1,0.0035513788,0.4961657,0.50028294
26410,the tumor,33,35,218,227,"In order to understand how tumor cells can escape immune surveillance mechanisms and thus develop antitumor therapies, it is critically important to investigate the mechanisms by which the immune system interacts with the tumor microenvironment.",26047948_0,-1,-1,-1,-1,26410,-1,1.8975066e-05,0.99997175,9.304308e-06
26411,that chemokine receptor,7,10,31,54,"In our current study, we found that chemokine receptor 5 (CCR5) neutralization resulted in reduced melanoma tumor size, decreased percentage of CD11b+ Gr-1(+) myeloid-derived suppressor cells (MDSCs), and increased proportion of cluster of differentiation (CD)3+ T cells in tumor tissues.",26047948_1,-1,-1,-1,-1,26411,-1,0.003540631,0.9369775,0.05948185
26416,tumor tissues,47,49,274,287,"In our current study, we found that chemokine receptor 5 (CCR5) neutralization resulted in reduced melanoma tumor size, decreased percentage of CD11b+ Gr-1(+) myeloid-derived suppressor cells (MDSCs), and increased proportion of cluster of differentiation (CD)3+ T cells in tumor tissues.",26047948_1,-1,-1,-1,-1,26416,-1,2.1688022e-05,0.9999542,2.4080973e-05
26433,cells transfected,37,39,211,228,"CCR5 blockade also induces suppressor of cytokine signaling 3 (SOCS3) upregulations, and anti-CCR5 antibody fails to suppress expression of phospho-Stat3 (p-Stat3), matrix metallopeptidase 9 (MMP9), and IL-6 in cells transfected with SOCS3 short-interfering RNA (SiRNA).",26047948_5,-1,-1,-1,-1,26433,-1,0.001773663,0.09383209,0.90439427
26435,that CCR5,4,6,23,32,All these data suggest that CCR5 blockade suppresses melanoma development through inhibition of IL-6-Stat3 pathway via upregulation of SOCS3.,26047948_6,-1,-1,-1,-1,26435,-1,0.003773569,0.78919095,0.20703547
26441,translation to,11,13,58,72,The paucity of regulatory T cells (Tregs) limits clinical translation to control aberrant immune reactions including graft-versus-host disease (GVHD).,26063163_0,-1,-1,-1,-1,26441,-1,2.3626744e-05,0.9999659,1.0467839e-05
26442,that the,3,5,22,30,Recent studies showed that the agonistic antibody to DR3 (DR3) expanded CD4(+)FoxP3(+) Tregs in vivo.,26063163_1,-1,-1,-1,-1,26442,-1,1.7927572e-05,0.9999732,8.929875e-06
26446,transplantation,21,22,130,145,We investigated whether treating donor mice with a single dose of DR3 could alleviate acute GVHD in a MHC-mismatched bone marrow transplantation model.,26063163_2,-1,1,2,-1,26446,-1,2.7333479e-05,0.9999565,1.6133014e-05
26447,functional Tregs,5,7,40,56,DR3 induced selective proliferation of functional Tregs. CD4(+) T cells isolated from DR3-treated mice contained higher numbers of Tregs and were less proliferative to allogeneic stimuli.,26063163_3,-1,-1,-1,-1,26447,-1,3.5883535e-05,0.99994123,2.2880096e-05
26451,that Tregs,5,7,31,41,"In vivo GVHD studies confirmed that Tregs from DR3-treated donors expanded robustly and higher frequencies of Tregs within donor CD4(+) T cells were maintained, resulting in improved survival.",26063163_4,-1,-1,-1,-1,26451,-1,2.1632091e-05,0.999967,1.1333633e-05
26458,TNF,11,12,60,64,"Serum levels of proinflammatory cytokines (IFN, IL-1, and TNF) and infiltration of donor T cells into GVHD target tissues (gastrointestinal tract and liver) were decreased.",26063163_6,0,1,-1,-1,26458,-1,0.00011178411,0.99984515,4.298685e-05
26460,target tissues,21,23,110,124,"Serum levels of proinflammatory cytokines (IFN, IL-1, and TNF) and infiltration of donor T cells into GVHD target tissues (gastrointestinal tract and liver) were decreased.",26063163_6,-1,-1,-1,-1,26460,-1,9.6405965e-05,0.99943084,0.00047278678
26466,Treg-based therapies,9,11,64,84,This novel strategy will facilitate the clinical application of Treg-based therapies.,26063163_9,-1,-1,-1,-1,26466,-1,2.6497712e-05,0.9999552,1.8356337e-05
26472,tumor antigen,9,11,48,61,This lack of success is conceivably due to poor tumor antigen presentation combined with immuno-suppressive mechanisms exploited by the tumor itself.,26079374_1,-1,-1,-1,-1,26472,-1,0.23806177,0.75132,0.010618282
26473,the tumor,18,20,132,141,This lack of success is conceivably due to poor tumor antigen presentation combined with immuno-suppressive mechanisms exploited by the tumor itself.,26079374_1,-1,-1,-1,-1,26473,-1,2.2128212e-05,0.99996877,9.1619695e-06
26475,tumor cells,15,17,91,102,Knock down of Inhibitor of differentiation protein 2 (Id2-kd) in mouse neuroblastoma whole tumor cells rendered these cells immunogenic.,26079374_2,-1,-1,-1,-1,26475,-1,0.0043931506,0.44353423,0.5520726
26476,these cells,18,20,112,123,Knock down of Inhibitor of differentiation protein 2 (Id2-kd) in mouse neuroblastoma whole tumor cells rendered these cells immunogenic.,26079374_2,-1,-1,-1,-1,26476,-1,0.0017612859,0.079643235,0.91859543
26480,immunity,23,24,133,141,Id2-kd neuroblastoma (Neuro2a) cells (Id2-kd N2a) failed to grow in most immune competent mice and these mice subsequently developed immunity against further wild-type Neuro2a tumor cell challenge.,26079374_3,0,-1,2,-1,26480,-1,0.9315724,0.06742233,0.0010053682
26481,tumor cell,28,30,176,186,Id2-kd neuroblastoma (Neuro2a) cells (Id2-kd N2a) failed to grow in most immune competent mice and these mice subsequently developed immunity against further wild-type Neuro2a tumor cell challenge.,26079374_3,-1,-1,-1,-1,26481,-1,0.002261687,0.120968014,0.87677026
26485,these cells,14,16,107,118,"Id2-kd N2a cells grew aggressively in immune-compromised hosts, thereby establishing the immunogenicity of these cells.",26079374_4,-1,-1,-1,-1,26485,-1,0.0019806356,0.08138931,0.9166301
26494,immunity,17,18,111,119,"Mechanistically, immune cell depletion studies demonstrated that while CD8+ T cells are critical for antitumor immunity, CD4+ T cells are also required to induce a sustained long-lasting helper effect.",26079374_6,0,-1,2,-1,26494,-1,0.9796966,0.019408986,0.00089437957
26497,T-cells,7,8,30,37,An increase in number of CD8+ T-cells and enhanced production of interferon gamma (IFN) was observed in tumor antigen stimulated splenocytes of vaccinated mice.,26079374_7,-1,1,2,-1,26497,-1,8.8847366e-05,0.0005310601,0.99938
26500,tumor antigen,20,22,105,118,An increase in number of CD8+ T-cells and enhanced production of interferon gamma (IFN) was observed in tumor antigen stimulated splenocytes of vaccinated mice.,26079374_7,-1,-1,-1,-1,26500,-1,0.19093615,0.80429864,0.004765164
26501,T-cells,10,11,53,60,"More importantly, a massive influx of cytotoxic CD8+ T-cells infiltrated the shrinking tumor following combined immunotherapy.",26079374_8,-1,1,2,-1,26501,-1,0.00017142802,0.0012679349,0.9985606
26502,the shrinking tumor,12,15,73,92,"More importantly, a massive influx of cytotoxic CD8+ T-cells infiltrated the shrinking tumor following combined immunotherapy.",26079374_8,-1,-1,-1,-1,26502,-1,2.6099851e-05,0.9999573,1.65198e-05
26506,tumor cell immunity,9,12,56,75,"These findings show that down regulation of Id2 induced tumor cell immunity and in combination with checkpoint blockade produced a novel, potent, T-cell mediated tumor vaccine strategy.",26079374_9,-1,-1,-1,-1,26506,-1,0.09754972,0.2929181,0.60953224
26507,T-cell,24,25,146,152,"These findings show that down regulation of Id2 induced tumor cell immunity and in combination with checkpoint blockade produced a novel, potent, T-cell mediated tumor vaccine strategy.",26079374_9,-1,1,2,-1,26507,-1,3.822319e-05,5.29068e-05,0.9999088
26510,the tumor,9,11,57,66,IL-12 promotes a rapid reversal of immune suppression in the tumor microenvironment.,26085681_0,-1,-1,-1,-1,26510,-1,2.097546e-05,0.99996877,1.0203815e-05
26513,to regulatory T cell,10,14,59,79,"However, the adjuvant activity of IL-12 is short-lived due to regulatory T cell (Treg) reinfiltration.",26085681_1,-1,-1,-1,-1,26513,-1,0.0032705439,0.116802566,0.8799269
26515,analysis,1,2,13,21,Quantitative analysis of Treg kinetics in IL-12-treated tumors and tumor-draining lymph nodes revealed a transient loss followed by a rapid 4-fold expansion of tumor Treg between days 3 and 10.,26085681_2,0,1,-1,-1,26515,-1,2.2884165e-05,0.99996173,1.5364874e-05
26517,IL-12-treated tumors,6,8,42,62,Quantitative analysis of Treg kinetics in IL-12-treated tumors and tumor-draining lymph nodes revealed a transient loss followed by a rapid 4-fold expansion of tumor Treg between days 3 and 10.,26085681_2,-1,-1,-1,-1,26517,-1,0.9666286,0.027777495,0.0055938405
26520,tumor Treg,23,25,160,170,Quantitative analysis of Treg kinetics in IL-12-treated tumors and tumor-draining lymph nodes revealed a transient loss followed by a rapid 4-fold expansion of tumor Treg between days 3 and 10.,26085681_2,-1,-1,-1,-1,26520,-1,1.9263009e-05,0.9999702,1.04888295e-05
26521,Subset-specific analysis,0,2,0,24,"Subset-specific analysis demonstrated that the posttreatment rebound was driven by the CD4(+)CD25(+)Foxp3(+) neuropilin-1(low) peripheral Treg (pTreg), resulting in a 3-5-fold increase in the pTreg to CD4(+)CD25(+)Foxp3(+) neuropilin-1(high) thymic Treg ratio by day 10.",26085681_3,-1,-1,-1,-1,26521,-1,0.0022681882,0.06595118,0.9317806
26522,that the,3,5,38,46,"Subset-specific analysis demonstrated that the posttreatment rebound was driven by the CD4(+)CD25(+)Foxp3(+) neuropilin-1(low) peripheral Treg (pTreg), resulting in a 3-5-fold increase in the pTreg to CD4(+)CD25(+)Foxp3(+) neuropilin-1(high) thymic Treg ratio by day 10.",26085681_3,-1,-1,-1,-1,26522,-1,1.5591142e-05,0.99997604,8.425898e-06
26527,thymic Treg,36,38,242,253,"Subset-specific analysis demonstrated that the posttreatment rebound was driven by the CD4(+)CD25(+)Foxp3(+) neuropilin-1(low) peripheral Treg (pTreg), resulting in a 3-5-fold increase in the pTreg to CD4(+)CD25(+)Foxp3(+) neuropilin-1(high) thymic Treg ratio by day 10.",26085681_3,-1,-1,-1,-1,26527,-1,4.244575e-05,0.99992657,3.1028936e-05
26532,TNFR,20,21,146,150,"The expanding pTreg displayed hypermethylation of the CpG islands in Treg-specific demethylated region, CTLA-4 exon 2, and glucocorticoid-induced TNFR exon 5, were phenotypically unstable, and exhibited diminished suppressive function consistent with an uncommitted in vitro-induced Treg-like phenotype.",26085681_4,0,1,-1,-1,26532,-1,5.0355247e-05,0.999926,2.3662782e-05
26533,function,32,33,226,234,"The expanding pTreg displayed hypermethylation of the CpG islands in Treg-specific demethylated region, CTLA-4 exon 2, and glucocorticoid-induced TNFR exon 5, were phenotypically unstable, and exhibited diminished suppressive function consistent with an uncommitted in vitro-induced Treg-like phenotype.",26085681_4,0,1,2,-1,26533,-1,0.00013499947,0.9997011,0.00016391445
26538,thymic Treg,21,23,149,160,"In vitro culture of posttherapy Treg populations under Th1-promoting conditions resulted in higher levels of IFN- production by pTreg compared with thymic Treg, confirming their transitional state.",26085681_5,-1,-1,-1,-1,26538,-1,3.3590914e-05,0.999946,2.0427618e-05
26539,their transitional state,25,28,173,197,"In vitro culture of posttherapy Treg populations under Th1-promoting conditions resulted in higher levels of IFN- production by pTreg compared with thymic Treg, confirming their transitional state.",26085681_5,-1,-1,-1,-1,26539,-1,2.849789e-05,0.99995387,1.758001e-05
26546,T-cell,0,1,0,6,"T-cell exhaustion was originally identified during chronic infection in mice, and was subsequently observed in humans with cancer.",26086965_0,-1,1,2,-1,26546,-1,3.4387842e-05,5.454999e-05,0.99991107
26549,the tumor,5,7,25,34,"The exhausted T cells in the tumor microenvironment show overexpressed inhibitory receptors, decreased effector cytokine production and cytolytic activity, leading to the failure of cancer elimination.",26086965_1,-1,-1,-1,-1,26549,-1,2.1780499e-05,0.9999672,1.0998983e-05
26550,receptors,11,12,82,91,"The exhausted T cells in the tumor microenvironment show overexpressed inhibitory receptors, decreased effector cytokine production and cytolytic activity, leading to the failure of cancer elimination.",26086965_1,0,1,2,-1,26550,-1,0.00011736106,0.00024656692,0.99963605
26552,to the,22,24,164,170,"The exhausted T cells in the tumor microenvironment show overexpressed inhibitory receptors, decreased effector cytokine production and cytolytic activity, leading to the failure of cancer elimination.",26086965_1,-1,-1,-1,-1,26552,-1,2.3873203e-05,0.9999653,1.0756495e-05
26569,toxicity,13,14,73,81,Mutyh-/- mice were more sensitive than wild-type (WT) animals to AOM/DSS toxicity and accumulated DNA 8-oxoG in their gastrointestinal tract.,26109431_3,0,1,-1,-1,26569,-1,5.4161086e-05,0.999826,0.00011983479
26577,cytokines GM-CSF,12,14,87,103,"The colon of untreated Mutyh-/- mice expressed higher basal levels of pro-inflammatory cytokines GM-CSF and IFN, and treatment with AOM/DSS induced an early decrease in circulating CD4+ and CD8+ T lymphocytes and an increase in myeloid-derived suppressor cells (MDSCs).",26109431_6,-1,-1,-1,-1,26577,-1,0.9997775,5.3987464e-05,0.0001685562
26585,TGF--latency-associated peptide,24,26,141,173,"Adenomas from Mutyh-/- mice had a greater infiltrate of Foxp3+ T regulatory cells, granulocytes, macrophages, MDSCs and strong expression of TGF--latency-associated peptide and IL6.",26109431_7,-1,-1,-1,-1,26585,-1,0.00012771218,0.9997485,0.00012372341
26588,that the,2,4,11,19,We propose that the AOM/DSS initiation/promotion protocol in Mutyh-/- mice provides a good model for MAP.,26109431_9,-1,-1,-1,-1,26588,-1,2.0678757e-05,0.99997056,8.807501e-06
26589,cell transplantation,13,15,104,124,"Acute graft-versus-host disease (aGVHD) remains a major complication following allogeneic hematopoietic cell transplantation, limiting the success of this therapy.",26153763_0,-1,-1,-1,-1,26589,-1,0.0030649104,0.07615048,0.92078465
26590,limiting the,16,18,126,138,"Acute graft-versus-host disease (aGVHD) remains a major complication following allogeneic hematopoietic cell transplantation, limiting the success of this therapy.",26153763_0,-1,-1,-1,-1,26590,-1,0.015475214,0.98302585,0.0014989144
26591,this therapy,20,22,150,162,"Acute graft-versus-host disease (aGVHD) remains a major complication following allogeneic hematopoietic cell transplantation, limiting the success of this therapy.",26153763_0,-1,-1,-1,-1,26591,-1,3.7848808e-05,0.99994695,1.5248233e-05
26592,that interleukin-22,3,5,23,42,"We previously reported that interleukin-22 (IL-22) participates to aGVHD development, but the underlying mechanisms of its contribution remain poorly understood.",26153763_1,-1,-1,-1,-1,26592,-1,0.03868231,0.9574078,0.0039098402
26598,function,11,12,61,69,"In this study, we analyzed the mechanism of the pathological function of IL-22 in intestinal aGVHD.",26153763_2,0,1,2,-1,26598,-1,5.566854e-05,0.99990416,4.0217907e-05
26602,signal transducer and activator of transcription factor-1,14,21,100,157,Ex-vivo colon culture experiments indicated that IL-22 was able to induce Th1-like inflammation via signal transducer and activator of transcription factor-1 (STAT1) and CXCL10 induction in the presence of type I interferon (IFN).,26153763_3,-1,-1,-1,-1,26602,-1,2.9520314e-05,0.99995077,1.9761002e-05
26614,IFN receptor,27,29,135,147,"To evaluate a potential synergy between IL-22 and type I IFN in aGVHD, we transplanted recipient mice, either wild-type (WT) or type I IFN receptor deficient (IFNAR(-/-)), with bone marrow cells and WT or IL-22 deficient (IL-22(-/-)) T cells.",26153763_4,-1,-1,-1,-1,26614,-1,0.96155924,0.0012653103,0.037175372
26624,tissues,20,21,171,178,"Finally, immunohistochemistry staining of STAT1 performed on gastrointestinal biopsies of 20 transplanted patients showed exacerbated STAT1 activation in gastrointestinal tissues of patients with aGVHD as compared with those without aGVHD.",26153763_6,-1,1,2,-1,26624,-1,0.001008431,0.8660992,0.13289236
26638,to tumor,9,11,61,69,"However, the detailed mechanisms by which S100A8 contributes to tumor progression have not been elucidated.",26165843_2,-1,-1,-1,-1,26638,-1,2.2587908e-05,0.9999652,1.2166915e-05
26643,peptide,9,10,28,35,"We found that S100A8 (2-89) peptide stimulated cell migration in a manner dependent on TLR4, MD-2 and MyD88.",26165843_4,0,-1,2,-1,26643,-1,3.73958e-05,0.99994123,2.1401e-05
26647,peptide,7,8,18,25,The S100A8 (2-89) peptide also activated p38 and NF-B in TLR4-dependent manner.,26165843_5,0,-1,2,-1,26647,-1,3.1149175e-05,0.9999461,2.2748422e-05
26649,The peptide,0,2,0,11,"The peptide induced the upregulation of both IL-6 and Ccl2 in peritoneal macrophages obtained from wild-type mice, but not TLR4-deficient mice.",26165843_6,-1,-1,-1,-1,26649,-1,3.2461518e-05,0.9999548,1.2759676e-05
26660,the TLR4,3,5,20,28,"To further evaluate the TLR4 dependency on tumor microenvironment, Lewis lung carcinoma-bearing mice were treated with Eritoran, an antagonist of TLR4/MD-2 complex.",26165843_8,-1,-1,-1,-1,26660,-1,2.5862222e-05,0.99994826,2.5905596e-05
26667,the treatment,16,18,112,125,We found that both tumor volume and pulmonary recruitment of myeloid-derived suppressor cells were reduced with the treatment of Eritoran for five consecutive days.,26165843_9,-1,-1,-1,-1,26667,-1,2.4270628e-05,0.99996555,1.02135555e-05
26671,T-cells,14,15,98,105,"Eritoran reduced the development of tumor vasculature, and increased tumor-infiltration of CD8(+) T-cells.",26165843_10,-1,1,2,-1,26671,-1,3.7296737e-05,6.473026e-05,0.99989796
26672,Taken together,0,2,0,14,"Taken together, S100A8 appears to play a crucial role in the activation of the TLR4/MD-2 pathway and the promotion of a tumor growth-enhancing immune microenvironment.",26165843_11,-1,-1,-1,-1,26672,-1,4.4925146e-05,0.9999374,1.7665585e-05
26673,to play,5,7,31,38,"Taken together, S100A8 appears to play a crucial role in the activation of the TLR4/MD-2 pathway and the promotion of a tumor growth-enhancing immune microenvironment.",26165843_11,-1,-1,-1,-1,26673,-1,2.2742279e-05,0.99996686,1.041278e-05
26684,immune responses to,11,14,66,85,Recent studies show that CD8(+) Treg cells might impede effective immune responses to established tumors.,26166762_1,-1,-1,-1,-1,26684,-1,0.8570935,0.14046675,0.0024397895
26691,tumor-infiltrating lymphocytes,3,5,28,58,The immunohistochemistry of tumor-infiltrating lymphocytes revealed a significant correlation between the intratumoral CD8(+) T cells and the forkhead box p3 (Foxp3)(+) cells in the intraepithelial and stromal areas of advanced OC tissues.,26166762_4,-1,-1,-1,-1,26691,-1,0.0028326665,0.8888717,0.10829557
26694,the forkhead,17,19,138,150,The immunohistochemistry of tumor-infiltrating lymphocytes revealed a significant correlation between the intratumoral CD8(+) T cells and the forkhead box p3 (Foxp3)(+) cells in the intraepithelial and stromal areas of advanced OC tissues.,26166762_4,-1,-1,-1,-1,26694,-1,2.169578e-05,0.9999666,1.1684611e-05
26697,tissues,33,34,231,238,The immunohistochemistry of tumor-infiltrating lymphocytes revealed a significant correlation between the intratumoral CD8(+) T cells and the forkhead box p3 (Foxp3)(+) cells in the intraepithelial and stromal areas of advanced OC tissues.,26166762_4,-1,1,2,-1,26697,-1,0.0014811367,0.16068275,0.83783615
26702,blood,15,16,81,86,We examined the expression of Treg markers in CD8(+) T cells from the peripheral blood and fresh tumor tissues of OC patients using flow cytometry.,26166762_5,0,1,-1,-1,26702,-1,0.0002540822,0.9948021,0.004943831
26703,tumor tissues,18,20,97,110,We examined the expression of Treg markers in CD8(+) T cells from the peripheral blood and fresh tumor tissues of OC patients using flow cytometry.,26166762_5,-1,-1,-1,-1,26703,-1,5.7642006e-05,0.99981326,0.0001291682
26705,Treg cell subsets,9,12,48,65,"Our results indicated an increase in the CD8(+) Treg cell subsets of OC patients compared with those in patients with benign ovarian tumors and healthy controls, including an increased expression of CD25, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), and Foxp3 and decreased CD28 expression.",26166762_6,-1,-1,-1,-1,26705,-1,3.6886402e-05,5.399962e-05,0.99990916
26708,T-lymphocyte-associated protein,36,38,215,246,"Our results indicated an increase in the CD8(+) Treg cell subsets of OC patients compared with those in patients with benign ovarian tumors and healthy controls, including an increased expression of CD25, cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), and Foxp3 and decreased CD28 expression.",26166762_6,-1,-1,-1,-1,26708,-1,0.0016711612,0.042064287,0.95626456
26713,the tumor,3,5,23,32,"To demonstrate whether the tumor microenvironment could convert CD8(+) effector T cells into suppressor cells, we used an in vitro transwell culturing system.",26166762_7,-1,-1,-1,-1,26713,-1,1.9371879e-05,0.9999727,7.946792e-06
26727,through TGF-1,21,23,127,141,"In addition, the in vitro-induced CD8(+) Treg cells inhibited nave CD4(+) T-cell proliferation, which was partially mediated through TGF-1 and IFN-.",26166762_9,-1,-1,-1,-1,26727,-1,4.2816813e-05,0.99991775,3.942868e-05
26732,that tumors,25,27,124,135,"Our study suggests that CD8(+) Treg cells were increased in OC patients and could be induced in vitro, which may be the way that tumors limit antitumor immunity and evade immune surveillance.",26166762_10,-1,-1,-1,-1,26732,-1,2.2920773e-05,0.9999665,1.0565895e-05
26733,immunity,29,30,152,160,"Our study suggests that CD8(+) Treg cells were increased in OC patients and could be induced in vitro, which may be the way that tumors limit antitumor immunity and evade immune surveillance.",26166762_10,0,-1,2,-1,26733,-1,0.9972059,0.0023943738,0.00039967208
26745,Foxp3-positive Tregs,0,2,0,20,Foxp3-positive Tregs in the duodenal mucosa were examined by immunohistochemistry and immunofluorescence.,26173451_3,-1,-1,-1,-1,26745,-1,2.1404981e-05,0.9999652,1.3397042e-05
26760,Foxp3-positive cells,10,12,62,82,"Some large cell intestinal lymphoma cases had high numbers of Foxp3-positive cells, but the increase was not statistically significant.",26173451_7,-1,-1,-1,-1,26760,-1,0.0019236486,0.9340703,0.06400603
26769,than that,20,22,119,128,"In small cell intestinal lymphoma cases, the overall survival of dogs with a high Treg density was significantly worse than that of dogs with a normal Treg density.",26173451_9,-1,-1,-1,-1,26769,-1,2.6634842e-05,0.9999604,1.2946441e-05
26774,Foxp3-positive Tregs,10,12,53,73,"These results suggest that a change in the number of Foxp3-positive Tregs contributes to the pathogenesis of canine IBD and intestinal lymphoma by disrupting mucosal tolerance and suppressing antitumor immunity, respectively.",26173451_10,-1,-1,-1,-1,26774,-1,2.0956371e-05,0.9999653,1.3748939e-05
26775,to the,13,15,86,92,"These results suggest that a change in the number of Foxp3-positive Tregs contributes to the pathogenesis of canine IBD and intestinal lymphoma by disrupting mucosal tolerance and suppressing antitumor immunity, respectively.",26173451_10,-1,-1,-1,-1,26775,-1,2.215443e-05,0.9999676,1.0270032e-05
26777,immunity,29,30,202,210,"These results suggest that a change in the number of Foxp3-positive Tregs contributes to the pathogenesis of canine IBD and intestinal lymphoma by disrupting mucosal tolerance and suppressing antitumor immunity, respectively.",26173451_10,0,-1,2,-1,26777,-1,0.99951756,0.00028158652,0.00020083992
26781,the IL-12,9,11,47,56,Interleukin-12 (IL-12) was the first member of the IL-12 family of cytokines to be identified and has therefore become its eponym.,26182974_0,-1,-1,-1,-1,26781,-1,0.46224993,0.53122866,0.006521458
26782,cytokines to,13,15,67,79,Interleukin-12 (IL-12) was the first member of the IL-12 family of cytokines to be identified and has therefore become its eponym.,26182974_0,-1,-1,-1,-1,26782,-1,0.9179265,0.07628428,0.005789259
26784,protein,4,5,22,29,"It is a heterodimeric protein of two subunits (p35, p40) secreted by phagocytic cells in response to pathogens and mainly acts through STAT4 to induce IFN- production in T and NK cells.",26182974_1,0,1,-1,-1,26784,-1,2.6980175e-05,0.99995077,2.224951e-05
26785,two subunits,6,8,33,45,"It is a heterodimeric protein of two subunits (p35, p40) secreted by phagocytic cells in response to pathogens and mainly acts through STAT4 to induce IFN- production in T and NK cells.",26182974_1,-1,-1,-1,-1,26785,-1,5.1641422e-05,0.9998777,7.0596965e-05
26789,through STAT4 to,24,27,127,143,"It is a heterodimeric protein of two subunits (p35, p40) secreted by phagocytic cells in response to pathogens and mainly acts through STAT4 to induce IFN- production in T and NK cells.",26182974_1,-1,-1,-1,-1,26789,-1,2.2338394e-05,0.99996185,1.577935e-05
26795,functions,5,6,39,48,IFN- in turn mediates proinflammatory functions and activates T-bet.,26182974_2,0,1,2,-1,26795,-1,0.00013289016,0.99978596,8.111475e-05
26802,to TH1,9,11,64,70,"Following its identification and the finding of its association to TH1 commitment, great hopes were placed in IL-12 to become a target for therapeutic applications in multiple settings of autoimmunity and cancer.",26182974_4,-1,-1,-1,-1,26802,-1,2.7229818e-05,0.9999467,2.6101265e-05
26804,IL-12 to,18,20,110,118,"Following its identification and the finding of its association to TH1 commitment, great hopes were placed in IL-12 to become a target for therapeutic applications in multiple settings of autoimmunity and cancer.",26182974_4,-1,-1,-1,-1,26804,-1,0.990629,0.004337168,0.005033797
26809,the related,5,7,25,36,"Though, the discovery of the related members of the IL-12 family and several rather disappointing attempts to translate experimental results into clinical practice, have relativized these hopes.",26182974_5,-1,-1,-1,-1,26809,-1,2.5631532e-05,0.99995565,1.8740095e-05
26810,the IL-12,9,11,48,57,"Though, the discovery of the related members of the IL-12 family and several rather disappointing attempts to translate experimental results into clinical practice, have relativized these hopes.",26182974_5,-1,-1,-1,-1,26810,-1,0.16862223,0.82375413,0.0076236553
26811,to translate,17,19,107,119,"Though, the discovery of the related members of the IL-12 family and several rather disappointing attempts to translate experimental results into clinical practice, have relativized these hopes.",26182974_5,-1,-1,-1,-1,26811,-1,2.2198883e-05,0.9999664,1.1475941e-05
26812,relativized these,26,28,170,187,"Though, the discovery of the related members of the IL-12 family and several rather disappointing attempts to translate experimental results into clinical practice, have relativized these hopes.",26182974_5,-1,-1,-1,-1,26812,-1,3.3508913e-05,0.9999498,1.6704844e-05
26817,the cytokine,12,14,65,77,"In this review, we will first briefly depict the biochemistry of the cytokine, its receptor and the related signal transduction, before summarizing the regulation of IL-12 production and its biological functions.",26182974_7,-1,-1,-1,-1,26817,-1,0.28041974,0.71314317,0.0064371317
26818,receptor,16,17,83,91,"In this review, we will first briefly depict the biochemistry of the cytokine, its receptor and the related signal transduction, before summarizing the regulation of IL-12 production and its biological functions.",26182974_7,0,1,2,-1,26818,-1,0.0027745757,0.92359114,0.07363427
26819,the related,18,20,96,107,"In this review, we will first briefly depict the biochemistry of the cytokine, its receptor and the related signal transduction, before summarizing the regulation of IL-12 production and its biological functions.",26182974_7,-1,-1,-1,-1,26819,-1,3.0753607e-05,0.9999515,1.7796257e-05
26821,the regulation,25,27,148,162,"In this review, we will first briefly depict the biochemistry of the cytokine, its receptor and the related signal transduction, before summarizing the regulation of IL-12 production and its biological functions.",26182974_7,-1,-1,-1,-1,26821,-1,2.1859867e-05,0.99996626,1.1905366e-05
26823,functions,33,34,202,211,"In this review, we will first briefly depict the biochemistry of the cytokine, its receptor and the related signal transduction, before summarizing the regulation of IL-12 production and its biological functions.",26182974_7,0,1,2,-1,26823,-1,7.425918e-05,0.9998766,4.9157035e-05
26831,functions,9,10,73,82,STAT3 is an oncogenic transcription factor with potent immunosuppressive functions.,26208907_0,0,1,2,-1,26831,-1,0.00012396982,0.99980503,7.096348e-05
26835,the tumor,15,17,99,108,We found that pharmacologic inhibition of STAT3 or its selective knockout in cancer cells improved the tumor growth-inhibitory efficacy of anthracycline-based chemotherapies.,26208907_1,-1,-1,-1,-1,26835,-1,2.026245e-05,0.999972,7.7132345e-06
26854,these therapy-relevant,1,3,6,28,"Among these therapy-relevant stress pathways, Stat3(-/-) cancer cells manifested one significant improvement, namely an increase in the expression of multiple type-1 interferon-responsive genes, including that of the chemokines Cxcl9 and Cxcl10.",26208907_5,-1,-1,-1,-1,26854,-1,2.3431827e-05,0.9999635,1.2989369e-05
26858,type-1 interferon-responsive genes,23,26,159,193,"Among these therapy-relevant stress pathways, Stat3(-/-) cancer cells manifested one significant improvement, namely an increase in the expression of multiple type-1 interferon-responsive genes, including that of the chemokines Cxcl9 and Cxcl10.",26208907_5,-1,-1,-1,-1,26858,-1,0.00012181977,0.9998115,6.674912e-05
26860,the chemokines,30,32,213,227,"Among these therapy-relevant stress pathways, Stat3(-/-) cancer cells manifested one significant improvement, namely an increase in the expression of multiple type-1 interferon-responsive genes, including that of the chemokines Cxcl9 and Cxcl10.",26208907_5,-1,-1,-1,-1,26860,-1,0.32825476,0.66590595,0.005839206
26863,type-1 interferon,2,4,14,31,This enhanced type-1 interferon response could be suppressed by reintroducing wild-type Stat3 (but not a transactivation-deficient mutant Stat3(Y705F)) into the tumor cells.,26208907_6,-1,-1,-1,-1,26863,-1,0.12526315,0.8711884,0.0035484568
26866,Stat3(Y705F,18,19,138,149,This enhanced type-1 interferon response could be suppressed by reintroducing wild-type Stat3 (but not a transactivation-deficient mutant Stat3(Y705F)) into the tumor cells.,26208907_6,-1,-1,-1,-1,26866,-1,0.0004063299,0.99937516,0.00021847684
26867,the tumor cells,22,25,157,172,This enhanced type-1 interferon response could be suppressed by reintroducing wild-type Stat3 (but not a transactivation-deficient mutant Stat3(Y705F)) into the tumor cells.,26208907_6,-1,-1,-1,-1,26867,-1,0.0032988575,0.8330639,0.16363719
26873,type-1 interferon receptor,7,10,42,68,"Finally, the neutralization of the common type-1 interferon receptor or that of the chemokine receptor CXCR3 (which binds CXCL9 and CXCL10) abolished the difference in the chemotherapeutic response between Stat3(-/-) and control tumors.",26208907_8,-1,-1,-1,-1,26873,-1,0.0033418646,0.94973797,0.046920232
26875,the chemokine receptor,13,16,80,102,"Finally, the neutralization of the common type-1 interferon receptor or that of the chemokine receptor CXCR3 (which binds CXCL9 and CXCL10) abolished the difference in the chemotherapeutic response between Stat3(-/-) and control tumors.",26208907_8,-1,-1,-1,-1,26875,-1,0.0053096786,0.9139707,0.0807196
26878,the chemotherapeutic,28,30,168,188,"Finally, the neutralization of the common type-1 interferon receptor or that of the chemokine receptor CXCR3 (which binds CXCL9 and CXCL10) abolished the difference in the chemotherapeutic response between Stat3(-/-) and control tumors.",26208907_8,-1,-1,-1,-1,26878,-1,0.043677427,0.95547867,0.00084387546
26881,that STAT3,5,7,34,44,"Altogether, these results suggest that STAT3 inhibitors may improve the outcome of chemotherapy by enhancing the type-1 interferon response of cancer cells.",26208907_9,-1,-1,-1,-1,26881,-1,2.4399802e-05,0.99996364,1.1928495e-05
26884,the type-1 interferon,16,19,109,130,"Altogether, these results suggest that STAT3 inhibitors may improve the outcome of chemotherapy by enhancing the type-1 interferon response of cancer cells.",26208907_9,-1,-1,-1,-1,26884,-1,0.020582588,0.97862524,0.00079222466
26886,The tumor-promoting chemokine,0,3,0,29,"The tumor-promoting chemokine CCL5 has been implicated in malignant transformation of breast epithelial cells, with studies to date focusing mainly on basal-type breast cancers.",26249173_0,-1,-1,-1,-1,26886,-1,0.02291561,0.9752656,0.0018187695
26901,chemokine receptor,11,13,81,99,"Mechanistic investigations revealed that CCL5 activates CCR3, a highly expressed chemokine receptor on CD4 T cells, and also boosts Gfi1 expression to promote the differentiation of Th2 cells, which enhance the prometastatic activity of tumor-associated myeloid cells.",26249173_3,-1,-1,-1,-1,26901,-1,0.64984775,0.0037001863,0.34645203
26910,toward this,3,5,25,36,"Clinically, polarization toward this immunosuppressive Th2 phenotype was also evident in patients with advanced luminal breast cancer.",26249173_4,-1,-1,-1,-1,26910,-1,2.2581145e-05,0.9999652,1.2276102e-05
26927,Th subsets,0,2,0,10,Th subsets were examined by flow cytometry.,26255628_2,-1,-1,-1,-1,26927,-1,0.0012113163,0.044940706,0.95384794
26932,that the,4,6,15,23,"Here, we found that the frequency of Th22 cells was significantly elevated in peripheral blood (PB) and bone marrow (BM) of newly-diagnosed MM patients, and recovered in complete remission patients after chemotherapy.",26255628_5,-1,-1,-1,-1,26932,-1,1.6579901e-05,0.9999753,8.136779e-06
26933,Th22 cells,8,10,37,47,"Here, we found that the frequency of Th22 cells was significantly elevated in peripheral blood (PB) and bone marrow (BM) of newly-diagnosed MM patients, and recovered in complete remission patients after chemotherapy.",26255628_5,-1,-1,-1,-1,26933,-1,0.0007916223,0.013780152,0.98542815
26934,blood,15,16,89,94,"Here, we found that the frequency of Th22 cells was significantly elevated in peripheral blood (PB) and bone marrow (BM) of newly-diagnosed MM patients, and recovered in complete remission patients after chemotherapy.",26255628_5,0,1,-1,-1,26934,-1,0.00019489476,0.99791735,0.0018877045
26937,Th17 cells,2,4,16,26,The circulating Th17 cells accompanied by IL-17A levels were also up-regulated in MM patients and decreased after remission.,26255628_6,-1,-1,-1,-1,26937,-1,0.00021732156,0.0009586903,0.99882394
26939,that there,3,5,14,24,We also found that there was a significantly positive correlation between Th22 and Th17 cells in MM patients.,26255628_7,-1,-1,-1,-1,26939,-1,1.9852216e-05,0.9999707,9.44291e-06
26941,Th17 cells,13,15,83,93,We also found that there was a significantly positive correlation between Th22 and Th17 cells in MM patients.,26255628_7,-1,-1,-1,-1,26941,-1,0.0012675613,0.040759508,0.9579728
26944,Th17 cells,7,9,38,48,"Moreover, the frequencies of Th22 and Th17 cells were higher in stage III than in stage I+II of MM.",26255628_8,-1,-1,-1,-1,26944,-1,0.00086818205,0.013737048,0.9853947
26946,that Th22,3,5,22,31,Our data demonstrated that Th22 and Th17 cells might be important therapeutic targets in multiple myeloma and could facilitate the effect of antitumor immunotherapy.,26255628_9,-1,-1,-1,-1,26946,-1,4.105157e-05,0.99994075,1.820883e-05
26947,Th17 cells,6,8,36,46,Our data demonstrated that Th22 and Th17 cells might be important therapeutic targets in multiple myeloma and could facilitate the effect of antitumor immunotherapy.,26255628_9,-1,-1,-1,-1,26947,-1,0.0033740688,0.2134859,0.78314006
26948,therapeutic targets,11,13,66,85,Our data demonstrated that Th22 and Th17 cells might be important therapeutic targets in multiple myeloma and could facilitate the effect of antitumor immunotherapy.,26255628_9,-1,-1,-1,-1,26948,-1,2.7373348e-05,0.99996054,1.2032247e-05
26968,tumor tissue,11,13,62,74,"Subsequently, there was a significant decrease in the size of tumor tissue and the numbers of heteromorphic tumor cells.",26270121_6,-1,-1,-1,-1,26968,-1,2.168998e-05,0.9999558,2.2537432e-05
26970,tumor cells,18,20,108,119,"Subsequently, there was a significant decrease in the size of tumor tissue and the numbers of heteromorphic tumor cells.",26270121_6,-1,-1,-1,-1,26970,-1,0.0030941495,0.35112342,0.6457825
26971,The tumor,0,2,0,9,The tumor metastasis in the lung and liver of the Ad-mIL-28B group also decreased.,26270121_7,-1,-1,-1,-1,26971,-1,2.2202481e-05,0.9999664,1.1361134e-05
26982,to the,13,15,113,119,BACKGROUND AIMS: Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorders (PTLD) belong to the most dreaded complications of immunosuppression.,26276009_0,-1,-1,-1,-1,26982,-1,2.5605246e-05,0.99996233,1.2079708e-05
26984,T-cell transfer,4,6,29,44,"The efficacy of EBV-specific T-cell transfer for PTLD has been previously shown, yet the optimal choice of EBV-derived antigens inducing polyclonal CD4(+) and CD8(+) T cells that cover a wide range of human leukocyte antigen types and efficiently control PTLD remains unclear.",26276009_1,-1,-1,-1,-1,26984,-1,0.0008283163,0.0135097895,0.9856619
26987,T cells that,27,30,166,178,"The efficacy of EBV-specific T-cell transfer for PTLD has been previously shown, yet the optimal choice of EBV-derived antigens inducing polyclonal CD4(+) and CD8(+) T cells that cover a wide range of human leukocyte antigen types and efficiently control PTLD remains unclear.",26276009_1,-1,-1,-1,-1,26987,-1,0.0017279993,0.032714974,0.9655569
26988,antigen types,37,39,217,230,"The efficacy of EBV-specific T-cell transfer for PTLD has been previously shown, yet the optimal choice of EBV-derived antigens inducing polyclonal CD4(+) and CD8(+) T cells that cover a wide range of human leukocyte antigen types and efficiently control PTLD remains unclear.",26276009_1,-1,-1,-1,-1,26988,-1,0.9932661,0.0018253798,0.0049084965
26989,T-cell,6,7,23,29,"METHODS: A pool of 125 T-cell epitopes from seven latent and nine lytic EBV-derived proteins (EBVmix) and peptide pools of EBNA1, EBNA3c, LMP2a and BZLF1 were used to determine T-cell frequencies and to isolate T cells through the use of the interferon (IFN)- cytokine capture system.",26276009_2,-1,1,2,-1,26989,-1,3.1732867e-05,4.697486e-05,0.9999213
26990,proteins,15,16,84,92,"METHODS: A pool of 125 T-cell epitopes from seven latent and nine lytic EBV-derived proteins (EBVmix) and peptide pools of EBNA1, EBNA3c, LMP2a and BZLF1 were used to determine T-cell frequencies and to isolate T cells through the use of the interferon (IFN)- cytokine capture system.",26276009_2,0,1,-1,-1,26990,-1,0.00018958382,0.99959797,0.00021245201
26991,peptide,20,21,106,113,"METHODS: A pool of 125 T-cell epitopes from seven latent and nine lytic EBV-derived proteins (EBVmix) and peptide pools of EBNA1, EBNA3c, LMP2a and BZLF1 were used to determine T-cell frequencies and to isolate T cells through the use of the interferon (IFN)- cytokine capture system.",26276009_2,0,-1,2,-1,26991,-1,0.00010526548,0.9998171,7.7731675e-05
26993,T-cell,34,35,177,183,"METHODS: A pool of 125 T-cell epitopes from seven latent and nine lytic EBV-derived proteins (EBVmix) and peptide pools of EBNA1, EBNA3c, LMP2a and BZLF1 were used to determine T-cell frequencies and to isolate T cells through the use of the interferon (IFN)- cytokine capture system.",26276009_2,-1,1,2,-1,26993,-1,3.1343512e-05,4.678439e-05,0.9999219
26995,T cells through the,39,43,211,230,"METHODS: A pool of 125 T-cell epitopes from seven latent and nine lytic EBV-derived proteins (EBVmix) and peptide pools of EBNA1, EBNA3c, LMP2a and BZLF1 were used to determine T-cell frequencies and to isolate T cells through the use of the interferon (IFN)- cytokine capture system.",26276009_2,-1,-1,-1,-1,26995,-1,0.0028236883,0.15625663,0.8409196
26996,the interferon,45,47,238,252,"METHODS: A pool of 125 T-cell epitopes from seven latent and nine lytic EBV-derived proteins (EBVmix) and peptide pools of EBNA1, EBNA3c, LMP2a and BZLF1 were used to determine T-cell frequencies and to isolate T cells through the use of the interferon (IFN)- cytokine capture system.",26276009_2,-1,-1,-1,-1,26996,-1,0.25900966,0.73619765,0.004792654
26999,functionality,6,7,39,52,We further evaluated the phenotype and functionality of the generated T-cell lines in vitro.,26276009_3,0,1,2,-1,26999,-1,5.629396e-05,0.999902,4.1628286e-05
27000,the generated T-cell,8,11,56,76,We further evaluated the phenotype and functionality of the generated T-cell lines in vitro.,26276009_3,-1,-1,-1,-1,27000,-1,0.0033710643,0.38050824,0.6161207
27001,T-cell,6,7,45,51,RESULTS: EBVmix induced significantly higher T-cell frequencies and allowed selecting more CD4(+)IFN-(+) and CD8(+)IFN-(+) cells than single peptide pools.,26276009_4,-1,1,2,-1,27001,-1,3.1679338e-05,4.2435648e-05,0.99992585
27002,cells than,17,19,125,135,RESULTS: EBVmix induced significantly higher T-cell frequencies and allowed selecting more CD4(+)IFN-(+) and CD8(+)IFN-(+) cells than single peptide pools.,26276009_4,-1,-1,-1,-1,27002,-1,0.0039634523,0.100698456,0.8953381
27003,peptide,20,21,143,150,RESULTS: EBVmix induced significantly higher T-cell frequencies and allowed selecting more CD4(+)IFN-(+) and CD8(+)IFN-(+) cells than single peptide pools.,26276009_4,0,-1,2,-1,27003,-1,6.1199295e-05,0.99989045,4.8321806e-05
27012,proteins,21,22,137,145,This control was mainly mediated by EBV-specific CD8(+) cells with an oligoclonal epitope signature covering both latent and lytic viral proteins.,26276009_7,0,1,-1,-1,27012,-1,0.061671734,0.93079823,0.0075300015
27015,T-cell,6,7,38,44,"CONCLUSIONS: EBVmix induces a broader T-cell response, probably because of its coverage of latent and lytic EBV-derived proteins that may be important to control EBV-transformed B cells and might offer an improvement of T-cell therapies.",26276009_9,-1,1,2,-1,27015,-1,3.9805396e-05,5.3878117e-05,0.9999063
27016,proteins that,19,21,120,133,"CONCLUSIONS: EBVmix induces a broader T-cell response, probably because of its coverage of latent and lytic EBV-derived proteins that may be important to control EBV-transformed B cells and might offer an improvement of T-cell therapies.",26276009_9,-1,-1,-1,-1,27016,-1,0.00012511692,0.9998392,3.5690635e-05
27019,T-cell therapies,35,37,220,236,"CONCLUSIONS: EBVmix induces a broader T-cell response, probably because of its coverage of latent and lytic EBV-derived proteins that may be important to control EBV-transformed B cells and might offer an improvement of T-cell therapies.",26276009_9,-1,-1,-1,-1,27019,-1,0.0014081888,0.022882616,0.9757092
27021,tumor necrosis factor receptor,5,9,46,76,"T cell stimulation via glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR) elicits antitumor activity in various tumor models; however, the underlying mechanism of action remains unclear.",26280119_0,-1,-1,-1,-1,27021,-1,0.024162598,0.9364104,0.039427
27022,protein,10,11,92,99,"T cell stimulation via glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR) elicits antitumor activity in various tumor models; however, the underlying mechanism of action remains unclear.",26280119_0,0,1,-1,-1,27022,-1,4.486326e-05,0.9998894,6.570824e-05
27025,mechanism of action,26,29,183,202,"T cell stimulation via glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR) elicits antitumor activity in various tumor models; however, the underlying mechanism of action remains unclear.",26280119_0,0,1,-1,-1,27025,-1,4.835835e-05,0.9999293,2.232772e-05
27027,immunity generated,11,13,71,89,Here we demonstrate a crucial role for interleukin (IL)-9 in antitumor immunity generated by the GITR agonistic antibody DTA-1.,26280119_1,-1,-1,-1,-1,27027,-1,0.08164843,0.9166562,0.0016952958
27029,receptor,1,2,5,13,"IL-4 receptor knockout (Il4ra(-/-)) mice, which have reduced expression of IL-9, were resistant to tumor growth inhibition by DTA-1.",26280119_2,0,1,2,-1,27029,-1,0.0026404588,0.56240416,0.4349554
27031,to tumor,18,20,96,104,"IL-4 receptor knockout (Il4ra(-/-)) mice, which have reduced expression of IL-9, were resistant to tumor growth inhibition by DTA-1.",26280119_2,-1,-1,-1,-1,27031,-1,2.1586124e-05,0.9999665,1.1858705e-05
27035,tumor-specific cytotoxic T lymphocyte,6,10,43,80,"In particular, DTA-1-induced IL-9 promoted tumor-specific cytotoxic T lymphocyte (CTL) responses by enhancing the function of dendritic cells in vivo.",26280119_4,-1,-1,-1,-1,27035,-1,0.0052105696,0.56237996,0.43240944
27037,the function,16,18,110,122,"In particular, DTA-1-induced IL-9 promoted tumor-specific cytotoxic T lymphocyte (CTL) responses by enhancing the function of dendritic cells in vivo.",26280119_4,-1,-1,-1,-1,27037,-1,4.393311e-05,0.99992776,2.8274626e-05
27044,TNFR-associated factor,18,20,108,130,"Furthermore, GITR signaling enhanced the differentiation of IL-9-producing CD4(+) T-helper (TH9) cells in a TNFR-associated factor 6 (TRAF6)- and NF-B-dependent manner and inhibited the generation of induced regulatory T cells in vitro.",26280119_5,-1,-1,-1,-1,27044,-1,7.2185e-05,0.9998908,3.6978494e-05
27045,the generation,27,29,183,197,"Furthermore, GITR signaling enhanced the differentiation of IL-9-producing CD4(+) T-helper (TH9) cells in a TNFR-associated factor 6 (TRAF6)- and NF-B-dependent manner and inhibited the generation of induced regulatory T cells in vitro.",26280119_5,-1,-1,-1,-1,27045,-1,1.8782846e-05,0.9999666,1.4560788e-05
27048,immunity,8,9,69,77,Our findings demonstrate that GITR co-stimulation mediates antitumor immunity by promoting TH9 cell differentiation and enhancing CTL responses and thus provide a mechanism of action for GITR agonist-mediated cancer immunotherapies.,26280119_6,0,-1,2,-1,27048,-1,0.982157,0.017172072,0.00067092193
27049,TH9 cell,11,13,91,99,Our findings demonstrate that GITR co-stimulation mediates antitumor immunity by promoting TH9 cell differentiation and enhancing CTL responses and thus provide a mechanism of action for GITR agonist-mediated cancer immunotherapies.,26280119_6,-1,-1,-1,-1,27049,-1,0.00012270425,0.00044079416,0.99943644
27052,mechanism of action,22,25,163,182,Our findings demonstrate that GITR co-stimulation mediates antitumor immunity by promoting TH9 cell differentiation and enhancing CTL responses and thus provide a mechanism of action for GITR agonist-mediated cancer immunotherapies.,26280119_6,0,1,-1,-1,27052,-1,6.570845e-05,0.99990785,2.6476859e-05
27055,cells play,8,10,33,43,"Follicular helper CD4(+) T (TFH) cells play a fundamental role in humoral immunity deriving from their ability to provide help for germinal center (GC) formation, B cell differentiation into plasma cells and memory cells, and antibody production in secondary lymphoid tissues.",26300592_0,-1,-1,-1,-1,27055,-1,0.0027891027,0.082502164,0.9147088
27056,immunity,15,16,74,82,"Follicular helper CD4(+) T (TFH) cells play a fundamental role in humoral immunity deriving from their ability to provide help for germinal center (GC) formation, B cell differentiation into plasma cells and memory cells, and antibody production in secondary lymphoid tissues.",26300592_0,0,-1,2,-1,27056,-1,0.9992679,0.0004299533,0.00030226514
27060,plasma cells,35,37,191,203,"Follicular helper CD4(+) T (TFH) cells play a fundamental role in humoral immunity deriving from their ability to provide help for germinal center (GC) formation, B cell differentiation into plasma cells and memory cells, and antibody production in secondary lymphoid tissues.",26300592_0,-1,-1,-1,-1,27060,-1,0.00022783094,0.001272251,0.9985
27063,TFH cells,0,2,0,9,"TFH cells can be identified by a combination of markers, including the chemokine receptor CXCR5, costimulatory molecules ICOS and PD-1, transcription repressor Bcl-6, and cytokine IL-21.",26300592_1,-1,-1,-1,-1,27063,-1,0.0011777253,0.049135208,0.9496871
27064,the chemokine receptor,12,15,67,89,"TFH cells can be identified by a combination of markers, including the chemokine receptor CXCR5, costimulatory molecules ICOS and PD-1, transcription repressor Bcl-6, and cytokine IL-21.",26300592_1,-1,-1,-1,-1,27064,-1,0.018648284,0.7512611,0.23009059
27071,blood,23,24,141,146,"It is difficult and impossible to get access to secondary lymphoid tissues in humans, so studies are usually performed with human peripheral blood samples as circulating counterparts of tissue TFH cells.",26300592_2,0,1,-1,-1,27071,-1,0.00017347261,0.99784386,0.001982674
27072,tissue TFH cells,29,32,186,202,"It is difficult and impossible to get access to secondary lymphoid tissues in humans, so studies are usually performed with human peripheral blood samples as circulating counterparts of tissue TFH cells.",26300592_2,-1,-1,-1,-1,27072,-1,0.0016216277,0.08117905,0.9171994
27073,TFH cell generation,3,6,13,32,"A balance of TFH cell generation and function is critical for protective antibody response, whereas overactivation of TFH cells or overexpression of TFH-associated molecules may result in autoimmune diseases.",26300592_3,-1,-1,-1,-1,27073,-1,0.00013680036,0.0026107675,0.9972524
27074,function,7,8,37,45,"A balance of TFH cell generation and function is critical for protective antibody response, whereas overactivation of TFH cells or overexpression of TFH-associated molecules may result in autoimmune diseases.",26300592_3,0,1,2,-1,27074,-1,0.0021394351,0.9508528,0.047007732
27075,TFH cells,18,20,118,127,"A balance of TFH cell generation and function is critical for protective antibody response, whereas overactivation of TFH cells or overexpression of TFH-associated molecules may result in autoimmune diseases.",26300592_3,-1,-1,-1,-1,27075,-1,0.0002075801,0.0029311106,0.99686134
27077,that TFH cells,4,7,25,39,"Emerging data have shown that TFH cells and TFH-associated molecules may be involved in the pathogenesis of neuroautoimmune diseases including multiple sclerosis (MS), neuromyelitis optica (NMO)/neuromyelitis optica spectrum disorders (NMOSD), and myasthenia gravis (MG).",26300592_4,-1,-1,-1,-1,27077,-1,0.003576526,0.50168073,0.49474275
27083,TFH cells,6,8,39,48,"This review summarizes the features of TFH cells, including their development, function, and roles as well as TFH-associated molecules in neuroautoimmune diseases and their animal models.",26300592_5,-1,-1,-1,-1,27083,-1,0.0009527599,0.050178748,0.9488685
27085,function,13,14,79,87,"This review summarizes the features of TFH cells, including their development, function, and roles as well as TFH-associated molecules in neuroautoimmune diseases and their animal models.",26300592_5,0,1,2,-1,27085,-1,5.298466e-05,0.9999145,3.249877e-05
27089,the cytokine,2,4,9,21,"However, the cytokine background associated with these disorders and whether it differs between ocular adnexal MZLs with (IgG4-associated MZL) and without (IgG4-negative MZL) numerous IgG4(+) plasma cells are unknown.",26311608_1,-1,-1,-1,-1,27089,-1,0.23634644,0.76025766,0.0033958617
27091,plasma cells,31,33,192,204,"However, the cytokine background associated with these disorders and whether it differs between ocular adnexal MZLs with (IgG4-associated MZL) and without (IgG4-negative MZL) numerous IgG4(+) plasma cells are unknown.",26311608_1,-1,-1,-1,-1,27091,-1,4.5042718e-05,8.369707e-05,0.99987125
27098,analysis,33,34,205,213,"In this study, we identified the mRNA expression pattern of Th2 and regulatory T-cell (Treg) cytokines in IgG4-RD and in IgG4-associated MZL and IgG4-negative MZL using real-time polymerase chain reaction analysis.",26311608_2,0,1,-1,-1,27098,-1,3.4176814e-05,0.9999399,2.5938556e-05
27100,transforming growth factor,18,21,149,175,"Ocular IgG4-RD and IgG4-associated MZL exhibited significantly higher expression ratios of interleukin (IL)-4/-actin, IL-10/-actin, IL-13/-actin, transforming growth factor (TGF) 1/-actin, and FOXP3/-actin than did IgG4-negative MZL (p<0.05).",26311608_3,-1,-1,-1,-1,27100,-1,0.94651216,0.050306384,0.0031814403
27123,blood,9,10,57,62,"CD4(+)CD25(-) T cells were separated from the peripheral blood mononuclear cells of MG patients and HCs, and the CD4(+)CD25(+) Tregs were separated from HCs by Magnetic cell sorting (MACS).",26347149_4,0,1,-1,-1,27123,-1,0.00033915116,0.99658453,0.0030763152
27134,The FoxP3,0,2,0,9,The FoxP3 expression of the induced CD4(+)CD25(+) T cells in MG patients was detected by real-time PCR at mRNA level.,26347149_7,-1,-1,-1,-1,27134,-1,2.0286465e-05,0.9999691,1.05763065e-05
27139,T cells to,12,15,81,91,The induced CD4(+)CD25(+) T cells were co-cultured with autologous CD4(+)CD25(-) T cells to estimate the suppressive ability of the induced CD4(+)CD25(+) T cells to CD4(+)CD25(-) T cells.,26347149_8,-1,-1,-1,-1,27139,-1,0.0017508407,0.033214007,0.9650352
27142,T cells to,24,27,154,164,The induced CD4(+)CD25(+) T cells were co-cultured with autologous CD4(+)CD25(-) T cells to estimate the suppressive ability of the induced CD4(+)CD25(+) T cells to CD4(+)CD25(-) T cells.,26347149_8,-1,-1,-1,-1,27142,-1,0.0013277888,0.020234797,0.9784373
27164,function,27,28,141,149,"The proportion and FoxP3 expression of the induced CD4(+)CD25(+) T cells are the highest at the level of 40ng/ml IFN-, and the suppressive function of the CD4(+)CD25(+) T cells induced by 40ng/ml IFN- is the strongest in MG patients.",26347149_12,0,1,2,-1,27164,-1,6.967124e-05,0.99986064,6.963456e-05
27175,targeted therapy,10,12,59,75,It will also provide the scientific basis for the clinical targeted therapy of MG.,26347149_14,-1,-1,-1,-1,27175,-1,2.8824714e-05,0.9999577,1.3494883e-05
27186,to the,42,44,240,246,"On one hand, the surveillance role of the immune system plays an important role in endogenous tumor prevention, but on the other hand, in some special circumstances such as in chronic inflammation, the immune system can actually contribute to the formation and progression of tumors.",26364615_1,-1,-1,-1,-1,27186,-1,2.6062444e-05,0.99996316,1.07232345e-05
27192,targeting the,23,25,163,176,"In the present manuscript, we explore known and potential various types of cancer prevention strategies and focus on nonvaccine-based cancer preventive strategies targeting the immune system at the early stages of tumorigenesis.",26364615_3,-1,-1,-1,-1,27192,-1,1.8330915e-05,0.9999713,1.0340062e-05
27200,blood,11,12,68,73,We detected an increase in Bregs producing IL-10 both in peripheral blood mononuclear cells (PBMCs) and in gastric tumors.,26378021_2,0,1,-1,-1,27200,-1,0.00092672213,0.97871804,0.020355234
27203,analysis,3,4,26,34,Multicolor flow cytometry analysis revealed that a subset of CD19+CD24hiCD38hi B cells produces IL-10.,26378021_3,0,1,-1,-1,27203,-1,3.5683242e-05,0.9999229,4.1430805e-05
27208,Functional,0,1,0,10,Functional studies indicated that increased Bregs do not inhibit the proliferation of CD3+T cells or CD4+ helper T cells (Th cells).,26378021_4,0,1,2,-1,27208,-1,3.696434e-05,0.999938,2.4974308e-05
27213,Th cells,21,23,122,130,Functional studies indicated that increased Bregs do not inhibit the proliferation of CD3+T cells or CD4+ helper T cells (Th cells).,26378021_4,-1,-1,-1,-1,27213,-1,3.8563845e-05,4.6075274e-05,0.99991524
27216,TNF-,10,11,54,59,"However, Bregs do suppress the secretion of IFN- and TNF- by CD4+Th cells.",26378021_5,0,1,-1,-1,27216,-1,0.00091639144,0.9990055,7.8157944e-05
27222,T cells to,8,11,72,82,Neutralization experiments showed that Bregs convert CD4+CD25- effector T cells to CD4+FoxP3+Tregs via TGF-1.,26378021_7,-1,-1,-1,-1,27222,-1,0.0015574561,0.03355859,0.964884
27227,T cells cytokines,17,20,124,141,"Collectively, these findings demonstrate that increased Bregs play a immunosuppressive role in gastric cancer by inhibiting T cells cytokines as well as conversion to Tregs.",26378021_8,-1,-1,-1,-1,27227,-1,0.09103613,0.0012306209,0.90773326
27228,to Tregs,24,26,164,172,"Collectively, these findings demonstrate that increased Bregs play a immunosuppressive role in gastric cancer by inhibiting T cells cytokines as well as conversion to Tregs.",26378021_8,-1,-1,-1,-1,27228,-1,2.3031242e-05,0.99996424,1.2776539e-05
27232,receptor,10,11,78,86,We have previously shown that a specific promyelocytic leukemia-retinoic acid receptor alpha (PML-RARA) DNA vaccine combined with all-trans retinoic acid (ATRA) increases the number of long term survivors with enhanced immune responses in a mouse model of acute promyelocytic leukemia (APL).,26378812_0,0,1,2,-1,27232,-1,0.0018287757,0.04333677,0.9548344
27239,therapeutic plasmid,12,14,79,98,PVAX14 is comprised of novel immunogenic DNA sequences inserted into the pVAX1 therapeutic plasmid.,26378812_2,-1,-1,-1,-1,27239,-1,3.2957214e-05,0.9999435,2.3543535e-05
27241,to that,12,14,82,89,APL mice treated with pVAX14 combined with ATRA had increased survival comparable to that obtained with a specific PML-RARA vaccine.,26378812_3,-1,-1,-1,-1,27241,-1,2.809689e-05,0.99996006,1.1836799e-05
27247,T-cells,17,18,110,117,"In both preclinical models, pVAX14 vaccine significantly increased interferon gamma (IFN) production, memory T-cells (memT), reduced the number of colony forming units (CFU) and increased expression of the adapter molecule signalling to NF-B, MyD88.",26378812_6,-1,1,2,-1,27247,-1,4.3992808e-05,0.00010177597,0.9998542
27257,the nuclear receptor,18,21,79,99,"Nuclear receptor subfamily 2, group F, member 6 (NR2F6) is an orphan member of the nuclear receptor superfamily.",26387951_0,-1,-1,-1,-1,27257,-1,5.5753506e-05,0.99985564,8.858981e-05
27258,that genetic,4,6,14,26,"Here, we show that genetic ablation of Nr2f6 significantly improves survival in the murine transgenic TRAMP prostate cancer model.",26387951_1,-1,-1,-1,-1,27258,-1,2.0358126e-05,0.9999696,1.0026886e-05
27260,transgenic TRAMP,15,17,91,107,"Here, we show that genetic ablation of Nr2f6 significantly improves survival in the murine transgenic TRAMP prostate cancer model.",26387951_1,-1,-1,-1,-1,27260,-1,2.5555475e-05,0.9999603,1.4125758e-05
27267,the tumor,26,28,144,153,This is paralleled by increased frequencies of both CD4(+) and CD8(+) T cells and higher expression levels of interleukin 2 and interferon  at the tumor site.,26387951_3,-1,-1,-1,-1,27267,-1,1.8145109e-05,0.99997234,9.550227e-06
27271,the interleukin,21,23,118,133,"Mechanistically, CD4(+) and CD8(+) T cell-intrinsic NR2F6 acts as a direct repressor of the NFAT/AP-1 complex on both the interleukin 2 and the interferon  cytokine promoters, attenuating their transcriptional thresholds.",26387951_4,-1,-1,-1,-1,27271,-1,0.2838018,0.7115432,0.004654995
27272,the interferon,25,27,140,154,"Mechanistically, CD4(+) and CD8(+) T cell-intrinsic NR2F6 acts as a direct repressor of the NFAT/AP-1 complex on both the interleukin 2 and the interferon  cytokine promoters, attenuating their transcriptional thresholds.",26387951_4,-1,-1,-1,-1,27272,-1,0.24555121,0.75122535,0.0032234837
27274,their transcriptional thresholds,32,35,189,221,"Mechanistically, CD4(+) and CD8(+) T cell-intrinsic NR2F6 acts as a direct repressor of the NFAT/AP-1 complex on both the interleukin 2 and the interferon  cytokine promoters, attenuating their transcriptional thresholds.",26387951_4,-1,-1,-1,-1,27274,-1,2.8436963e-05,0.9999565,1.5105838e-05
27283,immunity,20,21,129,137,"Altogether, this defines NR2F6 as an intracellular immune checkpoint in effector T cells, governing the amplitude of anti-cancer immunity.",26387951_6,0,-1,2,-1,27283,-1,0.9995024,0.00029751254,0.00020002393
27285,TNFR,2,3,27,31,"The glucocorticoid-induced TNFR family-related protein (GITR, TNFRSF18, CD357) is expressed on effector and regulatory T (Treg) cells.",26423152_0,0,1,-1,-1,27285,-1,4.459923e-05,0.99993396,2.1379119e-05
27286,protein,4,5,47,54,"The glucocorticoid-induced TNFR family-related protein (GITR, TNFRSF18, CD357) is expressed on effector and regulatory T (Treg) cells.",26423152_0,0,1,-1,-1,27286,-1,3.8669e-05,0.9999205,4.0793322e-05
27287,TNFRSF18,8,9,62,70,"The glucocorticoid-induced TNFR family-related protein (GITR, TNFRSF18, CD357) is expressed on effector and regulatory T (Treg) cells.",26423152_0,0,1,-1,-1,27287,-1,0.00222268,0.99755645,0.00022089224
27294,cell-mediated immune responses,13,16,85,115,Previous studies demonstrated that GITR triggering by anti-GITR mAb enhanced T and B cell-mediated immune responses.,26423152_1,-1,-1,-1,-1,27294,-1,0.20913073,0.0034246647,0.7874446
27301,the true,12,14,67,75,"Because the activities of mAbs are controlled by their Fc regions, the true effect of GITR signaling needs to be determined by examining its interaction with authentic ligand.",26423152_3,-1,-1,-1,-1,27301,-1,2.1026744e-05,0.9999703,8.695629e-06
27310,The pGITRL,0,2,0,10,The pGITRL was more effective than anti-GITR mAb in enhancing the proliferation of effector and regulatory cells in vitro and in vivo.,26423152_5,-1,-1,-1,-1,27310,-1,0.46362227,0.5262984,0.010079328
27317,analysis,1,2,9,17,Detailed analysis revealed that pGITRL induced extensive proliferation of Foxp3(+)CD4(+) Treg cells and led to the accumulation of activated Treg cells in tumor tissue and draining lymph nodes.,26423152_7,0,1,-1,-1,27317,-1,4.5275687e-05,0.99990606,4.8674676e-05
27318,that pGITRL,3,5,27,38,Detailed analysis revealed that pGITRL induced extensive proliferation of Foxp3(+)CD4(+) Treg cells and led to the accumulation of activated Treg cells in tumor tissue and draining lymph nodes.,26423152_7,-1,-1,-1,-1,27318,-1,0.32904822,0.66111624,0.009835588
27321,to the,15,17,108,114,Detailed analysis revealed that pGITRL induced extensive proliferation of Foxp3(+)CD4(+) Treg cells and led to the accumulation of activated Treg cells in tumor tissue and draining lymph nodes.,26423152_7,-1,-1,-1,-1,27321,-1,1.7209273e-05,0.99997246,1.0354403e-05
27323,tumor tissue,23,25,155,167,Detailed analysis revealed that pGITRL induced extensive proliferation of Foxp3(+)CD4(+) Treg cells and led to the accumulation of activated Treg cells in tumor tissue and draining lymph nodes.,26423152_7,-1,-1,-1,-1,27323,-1,2.5897652e-05,0.999944,3.0074196e-05
27330,tumor tissue,33,35,212,224,"Because GITR signaling could not neutralize the suppressive activity of activated Treg cells, pGITRL seems to lose its adjuvant effect when sufficient activated Treg cells have accumulated in the lymph nodes and tumor tissue.",26423152_8,-1,-1,-1,-1,27330,-1,2.7274718e-05,0.99995005,2.2698237e-05
27337,through Treg cells,16,19,109,127,These results suggest that GITR signaling has stimulatory effects on effector T cells and inhibitory effects through Treg cells.,26423152_10,-1,-1,-1,-1,27337,-1,0.0022164094,0.082971625,0.91481197
27341,the tumor-infiltrating T cell,13,17,69,98,Foxp3(+) regulatory T cells (Tregs) are often highly enriched within the tumor-infiltrating T cell pool.,26433463_0,-1,-1,-1,-1,27341,-1,0.003863094,0.8503558,0.14578107
27342,that the,9,11,77,85,Using a well-characterised model of carcinogen-induced fibrosarcomas we show that the enriched tumor-infiltrating Treg population comprises largely of CXCR3(+) T-bet(+) 'TH1-like' Tregs which are thymus-derived Helios(+) cells.,26433463_1,-1,-1,-1,-1,27342,-1,1.5220986e-05,0.99997616,8.609138e-06
27343,tumor-infiltrating Treg,12,14,95,118,Using a well-characterised model of carcinogen-induced fibrosarcomas we show that the enriched tumor-infiltrating Treg population comprises largely of CXCR3(+) T-bet(+) 'TH1-like' Tregs which are thymus-derived Helios(+) cells.,26433463_1,-1,-1,-1,-1,27343,-1,2.5074498e-05,0.99996006,1.4910083e-05
27347,thymus-derived,28,29,196,210,Using a well-characterised model of carcinogen-induced fibrosarcomas we show that the enriched tumor-infiltrating Treg population comprises largely of CXCR3(+) T-bet(+) 'TH1-like' Tregs which are thymus-derived Helios(+) cells.,26433463_1,-1,1,2,-1,27347,-1,8.545261e-05,0.9998468,6.775651e-05
27350,that the,13,15,79,87,"Whilst IL-2 maintains homeostatic ratios of Tregs in lymphoid organs, we found that the perturbation in Treg frequencies in tumors is IL-2 independent.",26433463_2,-1,-1,-1,-1,27350,-1,1.8616758e-05,0.99997294,8.452456e-06
27353,that the TH1,4,7,18,30,"Moreover, we show that the TH1 phenotype of tumor-infiltrating Tregs is dispensable for their ability to influence tumor progression.",26433463_3,-1,-1,-1,-1,27353,-1,2.18977e-05,0.99995697,2.1128373e-05
27354,tumor-infiltrating Tregs,9,11,44,68,"Moreover, we show that the TH1 phenotype of tumor-infiltrating Tregs is dispensable for their ability to influence tumor progression.",26433463_3,-1,-1,-1,-1,27354,-1,2.5918012e-05,0.9999602,1.3883527e-05
27364,than Tconvs,31,33,182,193,"We did however find that unlike Tconvs, the majority of intra-tumoral Tregs express the activation markers CD69, CD25, ICOS, CD103 and CTLA4 and are significantly more proliferative than Tconvs.",26433463_4,-1,-1,-1,-1,27364,-1,2.9667464e-05,0.9999516,1.8725603e-05
27367,than their,12,14,64,74,"Moreover, we have found that CD69(+) Tregs are more suppressive than their CD69- counterparts.",26433463_5,-1,-1,-1,-1,27367,-1,2.2022026e-05,0.9999651,1.2935615e-05
27370,the tumor,10,12,66,75,"Collectively, these data indicate superior activation of Tregs in the tumor microenvironment, promoting their suppressive ability and selective proliferation at this site.",26433463_6,-1,-1,-1,-1,27370,-1,1.9863797e-05,0.99996924,1.0898994e-05
27376,natural T cells,20,23,120,135,The liver resident lymphoid population is featured by the presence of a large number of CD3(+)CD56(+) cells referred as natural T cells.,26437631_0,-1,-1,-1,-1,27376,-1,0.0038420497,0.062687226,0.9334708
27377,the natural T cells,9,13,50,69,"In human hepatocellular carcinoma (HCC) patients, the natural T cells were found to be sharply decreased in tumor (5.8713.553%) versus non-tumor (14.026.151%) tissues.",26437631_1,-1,-1,-1,-1,27377,-1,0.003832975,0.57692003,0.41924703
27380,tissues,39,40,165,172,"In human hepatocellular carcinoma (HCC) patients, the natural T cells were found to be sharply decreased in tumor (5.8713.553%) versus non-tumor (14.026.151%) tissues.",26437631_1,-1,1,2,-1,27380,-1,4.20257e-05,0.9998543,0.00010357995
27381,the natural T cells,7,11,45,64,"More intriguingly, a substantial fraction of the natural T cells (22.7618.61%) assumed FOXP3 expression.",26437631_2,-1,-1,-1,-1,27381,-1,0.0038600848,0.41426697,0.581873
27383,These FOXP3-expressing,0,2,0,22,"These FOXP3-expressing CD3(+)CD56(+) cells lost the expression of IFN- and perforin, which are critical for the effector function of natural T cells.",26437631_3,-1,-1,-1,-1,27383,-1,2.7358972e-05,0.999956,1.6593882e-05
27388,function,19,20,122,130,"These FOXP3-expressing CD3(+)CD56(+) cells lost the expression of IFN- and perforin, which are critical for the effector function of natural T cells.",26437631_3,0,1,2,-1,27388,-1,0.00047297665,0.9967571,0.0027699487
27389,natural T cells,21,24,134,149,"These FOXP3-expressing CD3(+)CD56(+) cells lost the expression of IFN- and perforin, which are critical for the effector function of natural T cells.",26437631_3,-1,-1,-1,-1,27389,-1,0.0033145838,0.080261014,0.9164244
27392,CTLA-4 typically,12,14,64,80,"On the other hand, they acquired surface expression of CD25 and CTLA-4 typically found in regulatory T (Treg) cells.",26437631_4,-1,-1,-1,-1,27392,-1,0.0018921279,0.009268351,0.98883957
27398,naive T cells,15,18,114,127,"Consistent with the phenotypic conversion, they imposed an inhibitory effect on anti-CD3-induced proliferation of naive T cells.",26437631_5,-1,-1,-1,-1,27398,-1,0.0029986673,0.0790795,0.9179218
27399,that transforming growth factor,3,7,29,60,Further studies demonstrated that transforming growth factor 1 (TGF-1) could effectively induce FOXP3 expression in CD3(+)CD56(+) cells and the cells were thus endowed with a potent immunosuppressive capacity.,26437631_6,-1,-1,-1,-1,27399,-1,0.11758892,0.87890685,0.0035042462
27403,the cells,21,23,142,151,Further studies demonstrated that transforming growth factor 1 (TGF-1) could effectively induce FOXP3 expression in CD3(+)CD56(+) cells and the cells were thus endowed with a potent immunosuppressive capacity.,26437631_6,-1,-1,-1,-1,27403,-1,0.003425873,0.3122469,0.68432724
27405,analysis,3,4,22,30,"Finally, Kaplan-Meier analysis revealed that the relative abundance of FOXP3-expressing CD3(+)CD56(+) cells in tumor tissues was significantly correlated with the survival of HCC patients.",26437631_7,0,1,-1,-1,27405,-1,3.417861e-05,0.9999316,3.4249744e-05
27406,that the relative,5,8,40,57,"Finally, Kaplan-Meier analysis revealed that the relative abundance of FOXP3-expressing CD3(+)CD56(+) cells in tumor tissues was significantly correlated with the survival of HCC patients.",26437631_7,-1,-1,-1,-1,27406,-1,1.943297e-05,0.99996746,1.3060173e-05
27409,tumor tissues,15,17,111,124,"Finally, Kaplan-Meier analysis revealed that the relative abundance of FOXP3-expressing CD3(+)CD56(+) cells in tumor tissues was significantly correlated with the survival of HCC patients.",26437631_7,-1,-1,-1,-1,27409,-1,2.1954991e-05,0.9999529,2.5148678e-05
27414,tissues,19,20,114,121,"In conclusion, the present study identified a new type of regulatory immune cells whose emergence in liver cancer tissues may contribute to tumor progression.",26437631_8,-1,1,2,-1,27414,-1,5.060468e-05,0.9997956,0.00015373834
27415,to tumor,22,24,137,145,"In conclusion, the present study identified a new type of regulatory immune cells whose emergence in liver cancer tissues may contribute to tumor progression.",26437631_8,-1,-1,-1,-1,27415,-1,2.540729e-05,0.99996424,1.0342928e-05
27422,immunity,14,15,96,104,The present study was aimed at analysing how expression of endogenous galectin-3 regulates host immunity and lung metastasis in B16F10 murine melanoma model.,26442663_3,0,-1,2,-1,27422,-1,0.99783784,0.0019095644,0.00025271176
27426,tumor targets,30,32,167,180,"Transgenic Gal-3(+/-) (hemizygous) and Gal-3(-/-) (null) mice exhibited decreased levels of Natural Killer (NK) cells and lower NK mediated cytotoxicity against YAC-1 tumor targets, compared to Gal-3(+/+) (wild-type) mice.",26442663_4,-1,-1,-1,-1,27426,-1,2.0096024e-05,0.9999671,1.2790156e-05
27428,T cell proliferation than,12,16,76,101,"On stimulation, Gal-3(+/-) and Gal-3(-/-) mice splenocytes showed increased T cell proliferation than Gal-3(+/+) mice.",26442663_5,-1,-1,-1,-1,27428,-1,0.0012288264,0.014120153,0.98465097
27431,to T cells,18,21,101,111,Intracellular calcium flux was found to be lower in activated T cells of Gal-3(-/-) mice as compared to T cells from Gal-3(+/+) and Gal-3(+/-) mice.,26442663_6,-1,-1,-1,-1,27431,-1,0.0031549463,0.13464889,0.86219615
27434,Th17 cytokine,10,12,39,52,"In Gal-3(-/-) mice, serum Th1, Th2 and Th17 cytokine levels were found to be lowest, exhibiting dysregulation of pro-inflammatory and anti-inflammatory cytokines balance.",26442663_7,-1,-1,-1,-1,27434,-1,0.11050728,0.88215977,0.007332937
27439,IFN- Receptor,10,12,59,73,Marked decrease in serum IFN- levels and splenic IFN-R1 (IFN- Receptor 1) expressing T and NK cell percentages were observed in Gal-3(-/-) mice.,26442663_8,-1,-1,-1,-1,27439,-1,0.9763742,0.0021484452,0.021477241
27442,IFN- treatment,2,4,15,30,"On recombinant IFN- treatment of splenocytes in vitro, Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 protein expression was higher in Gal-3(-/-) mice compared to that in Gal-3(+/+) and Gal-3(+/-) mice; suggesting possible attenuation of Signal Transducer and Activator of Transcription (STAT) 1 mediated IFN- signaling in Gal-3(-/-) mice.",26442663_9,-1,-1,-1,-1,27442,-1,0.99542725,0.002873927,0.001698808
27444,protein,19,20,108,115,"On recombinant IFN- treatment of splenocytes in vitro, Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 protein expression was higher in Gal-3(-/-) mice compared to that in Gal-3(+/+) and Gal-3(+/-) mice; suggesting possible attenuation of Signal Transducer and Activator of Transcription (STAT) 1 mediated IFN- signaling in Gal-3(-/-) mice.",26442663_9,0,1,-1,-1,27444,-1,2.3538614e-05,0.9999596,1.6877793e-05
27445,to that,28,30,166,173,"On recombinant IFN- treatment of splenocytes in vitro, Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 protein expression was higher in Gal-3(-/-) mice compared to that in Gal-3(+/+) and Gal-3(+/-) mice; suggesting possible attenuation of Signal Transducer and Activator of Transcription (STAT) 1 mediated IFN- signaling in Gal-3(-/-) mice.",26442663_9,-1,-1,-1,-1,27445,-1,2.225987e-05,0.99996626,1.146311e-05
27450,cells to,5,7,31,39,"The ability of B16F10 melanoma cells to form metastatic colonies in the lungs of Gal-3(+/+) and Gal-3(-/-) mice remained comparable, whereas it was found to be reduced in Gal-3(+/-) mice.",26442663_10,-1,-1,-1,-1,27450,-1,0.0036014095,0.124854,0.8715446
27458,Th17 cytokine,39,41,250,263,"Our data indicates that complete absence of endogenous host galectin-3 facilitates lung metastasis of B16F10 cells in mice, which may be contributed by dysregulated immune responses resulting from decreased NK cytotoxicity, disturbed serum Th1, Th2, Th17 cytokine milieu, reduced serum IFN- levels and attenuation of splenic STAT1 mediated IFN- signalling in Gal-3(-/-) mice.",26442663_11,-1,-1,-1,-1,27458,-1,0.14094599,0.8543272,0.0047268295
27466,functions,14,15,78,87,"Regulatory T cells (Treg cells) are known to exert certain immune suppression functions, in addition to immune mediating effects.",26464657_1,0,1,2,-1,27466,-1,0.00018160611,0.99962616,0.00019221898
27473,the functional,4,6,34,48,This study therefore investigated the functional role and related mechanism of Treg cells in BCL.,26464657_3,-1,-1,-1,-1,27473,-1,2.1595277e-05,0.9999584,1.9986428e-05
27478,blood,1,2,11,16,Peripheral blood mononuclear cells (PBMCs) were separated and analyzed for the ratio of CD4+/CD25+ Treg cells.,26464657_6,0,1,-1,-1,27478,-1,0.00014129524,0.99928635,0.00057234673
27484,transforming growth factor,7,10,37,63,"The mRNA expression levels of Foxp3, transforming growth factor (TGF)-1 and interleukin (IL)-10 genes were quantified by real-time PCR, while their serum levels were determined by enzyme-linked immunosorbent assay (ELISA).",26464657_7,-1,-1,-1,-1,27484,-1,0.70183766,0.2933406,0.0048217047
27493,to protein,11,13,52,62,"mRNA levels of Foxp3, TGF-1 and IL-10, in addition to protein levels of TGF-1 and IL-10 were potentiated in lymphoma patients but decreased in CR patients (P<0.05 in all cases).",26464657_10,-1,-1,-1,-1,27493,-1,3.790151e-05,0.99994135,2.069007e-05
27497,functions,7,8,47,56,"CD4+/CD25+ Treg cells exert immune suppressing functions in BCL via regulating cytokines, thereby facilitating the pathogenesis and progression of lymphoma.",26464657_11,0,1,2,-1,27497,-1,0.00012856237,0.99972206,0.00014938036
27510,factor-,15,16,81,89,"MFE stimulated the production of cytokines, nitric oxide (NO) and tumor necrosis factor- (TNF-) and tumoricidal properties of macrophages.",26473845_4,0,1,-1,-1,27510,-1,0.9998344,6.0002447e-05,0.000105563486
27511,TNF-,17,18,91,96,"MFE stimulated the production of cytokines, nitric oxide (NO) and tumor necrosis factor- (TNF-) and tumoricidal properties of macrophages.",26473845_4,0,1,-1,-1,27511,-1,0.00012420642,0.9998367,3.912188e-05
27513,through the,3,5,26,37,MFE activated macrophages through the mitogen-activated protein kinase (MAPKinase) and nuclear factor-B (NF-B) signaling pathways downstream from toll-like receptor (TLR) 4.,26473845_5,-1,-1,-1,-1,27513,-1,2.1724867e-05,0.9999608,1.7526114e-05
27514,protein,6,7,56,63,MFE activated macrophages through the mitogen-activated protein kinase (MAPKinase) and nuclear factor-B (NF-B) signaling pathways downstream from toll-like receptor (TLR) 4.,26473845_5,0,1,-1,-1,27514,-1,8.141631e-05,0.99978405,0.00013458825
27515,toll-like receptor,21,23,148,166,MFE activated macrophages through the mitogen-activated protein kinase (MAPKinase) and nuclear factor-B (NF-B) signaling pathways downstream from toll-like receptor (TLR) 4.,26473845_5,-1,-1,-1,-1,27515,-1,0.0033318603,0.8785603,0.11810779
27533,T-cell,3,4,21,27,PURPOSE: Inefficient T-cell reconstitution from x-ray-induced immune damage reduces antitumor response.,26475064_0,-1,1,2,-1,27533,-1,3.1271447e-05,5.126754e-05,0.9999175
27536,T-cell,5,6,29,35,To understand the profile of T-cell reconstitution after irradiation will overcome the barrier of antitumor immunity.,26475064_1,-1,1,2,-1,27536,-1,3.1484666e-05,4.9877606e-05,0.9999187
27538,immunity,15,16,108,116,To understand the profile of T-cell reconstitution after irradiation will overcome the barrier of antitumor immunity.,26475064_1,0,-1,2,-1,27538,-1,0.99876666,0.0008398399,0.0003934944
27545,T-cell,23,24,147,153,This study aimed to identify the recovery profile of T-cell subsets following x-ray irradiation and to highlight the role of cinnamon on efficient T-cell restoration postexposure in the antitumor response.,26475064_2,-1,1,2,-1,27545,-1,3.491942e-05,4.4237782e-05,0.99992085
27567,than that,11,13,59,68,RESULTS: Reconstitution of CD4(+) T cells was delayed more than that of CD8(+) T cells in T-cell restoration after SLTBI.,26475064_6,-1,-1,-1,-1,27567,-1,3.162751e-05,0.99994314,2.519303e-05
27569,T-cell,19,20,90,96,RESULTS: Reconstitution of CD4(+) T cells was delayed more than that of CD8(+) T cells in T-cell restoration after SLTBI.,26475064_6,-1,1,2,-1,27569,-1,3.2080938e-05,3.8007165e-05,0.9999299
27573,Tc1 cells,7,9,33,42,"The production of IFN by Th1 or Tc1 cells was sharply decreased and was accompanied by reduced T-bet mRNA, even when total T-cell numbers had recovered; the frequencies of Th17 and Treg cells and their specific transcription factors (RORt and Foxp3, respectively) were obviously increased.",26475064_7,-1,-1,-1,-1,27573,-1,0.0007256193,0.01852637,0.98074806
27575,total T-cell,22,24,118,130,"The production of IFN by Th1 or Tc1 cells was sharply decreased and was accompanied by reduced T-bet mRNA, even when total T-cell numbers had recovered; the frequencies of Th17 and Treg cells and their specific transcription factors (RORt and Foxp3, respectively) were obviously increased.",26475064_7,-1,-1,-1,-1,27575,-1,0.0019491053,0.04826128,0.9497896
27582,T-cell,2,3,32,38,Irradiation-induced inefficient T-cell reconstitution impaired the antitumor capacities in the lung melanoma model.,26475064_8,-1,1,2,-1,27582,-1,3.452039e-05,5.230959e-05,0.9999131
27585,the generation,7,9,58,72,Pretreatment with cinnamon in irradiated mice accelerated the generation of Th1 and reduced the differentiation of Treg cells by activating T-bet and limiting transcriptions of Foxp3.,26475064_9,-1,-1,-1,-1,27585,-1,1.9243304e-05,0.9999671,1.36248045e-05
27590,limiting transcriptions,22,24,150,173,Pretreatment with cinnamon in irradiated mice accelerated the generation of Th1 and reduced the differentiation of Treg cells by activating T-bet and limiting transcriptions of Foxp3.,26475064_9,-1,-1,-1,-1,27590,-1,0.0021226783,0.994142,0.003735296
27593,T-cell,8,9,66,72,Improvement resulting from cinnamon pretreatment on the efficient T-cell recovery profile from SLTBI promoted antitumor immunity in the lung melanoma model.,26475064_10,-1,1,2,-1,27593,-1,3.494638e-05,5.2613097e-05,0.9999125
27594,immunity,15,16,120,128,Improvement resulting from cinnamon pretreatment on the efficient T-cell recovery profile from SLTBI promoted antitumor immunity in the lung melanoma model.,26475064_10,0,-1,2,-1,27594,-1,0.9993007,0.00041564248,0.00028359308
27596,T-cell,2,3,13,19,CONCLUSIONS: T-cell reconstitution from SLTBI was characterized by impaired Th1 and elevated Th17 and Treg cells.,26475064_11,-1,1,2,-1,27596,-1,3.592635e-05,4.6314606e-05,0.99991775
27607,T-cell,6,7,34,40,The role of cinnamon in efficient T-cell reconstitution from SLTBI is effective in antitumor immunity.,26475064_13,-1,1,2,-1,27607,-1,3.38808e-05,5.534922e-05,0.99991083
27608,immunity,14,15,93,101,The role of cinnamon in efficient T-cell reconstitution from SLTBI is effective in antitumor immunity.,26475064_13,0,-1,2,-1,27608,-1,0.9991585,0.00056844746,0.00027313817
27613,function,14,15,83,91,T cell abnormalities are a common feature of CLL and contribute to impaired immune function in these patients.,26478573_1,0,1,2,-1,27613,-1,0.0004047355,0.99941516,0.00018013695
27618,IL-17A-producing Th17 cells,10,13,76,103,Previous work from our laboratory documented elevated circulating levels of IL-17A-producing Th17 cells in CLL patients as compared to healthy age-matched control subjects.,26478573_3,-1,-1,-1,-1,27618,-1,0.6609193,0.004021839,0.3350588
27622,that Th17 cells,3,6,23,38,"Recent studies suggest that Th17 cells are heterogeneous, expressing different profiles of cytokines, and that different subsets of Th17s mediate different biological functions.",26478573_5,-1,-1,-1,-1,27622,-1,0.0041062934,0.5517216,0.44417214
27627,functions,24,25,167,176,"Recent studies suggest that Th17 cells are heterogeneous, expressing different profiles of cytokines, and that different subsets of Th17s mediate different biological functions.",26478573_5,0,1,2,-1,27627,-1,0.0005200085,0.99889165,0.0005883961
27631,blood,21,22,128,133,"In the present study, we found significantly higher levels of IL-17F-expressing CD4(+) T cells in CLL versus healthy peripheral blood mononuclear cells following in vitro stimulation in the presence of Th17-promoting cytokines.",26478573_6,0,1,-1,-1,27631,-1,0.0002541273,0.9982158,0.0015301201
27634,Th17-promoting cytokines,32,34,202,226,"In the present study, we found significantly higher levels of IL-17F-expressing CD4(+) T cells in CLL versus healthy peripheral blood mononuclear cells following in vitro stimulation in the presence of Th17-promoting cytokines.",26478573_6,-1,-1,-1,-1,27634,-1,0.07120661,0.92518103,0.003612331
27636,IL-17F-expressing Th17 cells,5,8,36,64,"Furthermore, the differentiation of IL-17F-expressing Th17 cells was significantly enhanced when purified CD4(+) T cells from CLL patients were cultured in the presence of autologous CLL B cells.",26478573_7,-1,-1,-1,-1,27636,-1,0.77061975,0.004039131,0.22534116
27640,that IL-17F triggers,6,9,47,67,"Lastly, single-cell network profiling revealed that IL-17F triggers NFB phosphorylation in T and B cells from patients with CLL, but not age-matched healthy controls.",26478573_8,-1,-1,-1,-1,27640,-1,0.0018525426,0.9979157,0.000231812
27643,Taken together,0,2,0,14,"Taken together, our data suggest that the phenotype of Th17 cells in CLL patients is distinct from healthy individuals, expressing higher levels of IL-17F, and that B and T cells from CLL patients are particularly responsive to IL-17F, as compared to healthy age-matched control individuals.",26478573_9,-1,-1,-1,-1,27643,-1,3.9134047e-05,0.9999436,1.7278915e-05
27644,that the,6,8,33,41,"Taken together, our data suggest that the phenotype of Th17 cells in CLL patients is distinct from healthy individuals, expressing higher levels of IL-17F, and that B and T cells from CLL patients are particularly responsive to IL-17F, as compared to healthy age-matched control individuals.",26478573_9,-1,-1,-1,-1,27644,-1,1.707488e-05,0.9999745,8.405989e-06
27645,Th17 cells,10,12,55,65,"Taken together, our data suggest that the phenotype of Th17 cells in CLL patients is distinct from healthy individuals, expressing higher levels of IL-17F, and that B and T cells from CLL patients are particularly responsive to IL-17F, as compared to healthy age-matched control individuals.",26478573_9,-1,-1,-1,-1,27645,-1,0.00059336144,0.01209202,0.9873146
27649,to IL-17F,39,41,225,234,"Taken together, our data suggest that the phenotype of Th17 cells in CLL patients is distinct from healthy individuals, expressing higher levels of IL-17F, and that B and T cells from CLL patients are particularly responsive to IL-17F, as compared to healthy age-matched control individuals.",26478573_9,-1,-1,-1,-1,27649,-1,0.8705823,0.1253076,0.004110067
27656,IL12RB2 gene,8,10,53,65,We asked whether specific polymorphisms of the human IL12RB2 gene may confer susceptibility to LAC.,26547104_1,-1,-1,-1,-1,27656,-1,0.9364199,0.05398931,0.009590781
27660,to the,13,15,85,91,We studied IL12RB2 single nucleotide polymorphisms (SNPs) spanning from the promoter to the first untranslated exon of the gene.,26547104_2,-1,-1,-1,-1,27660,-1,2.3797133e-05,0.999962,1.4219704e-05
27661,the gene,19,21,119,127,We studied IL12RB2 single nucleotide polymorphisms (SNPs) spanning from the promoter to the first untranslated exon of the gene.,26547104_2,-1,-1,-1,-1,27661,-1,2.7124575e-05,0.99995565,1.7182434e-05
27672,to the,11,13,83,89,"In conclusion, genetically determined low signaling activity of IL-12R predisposes to the development of LAC.",26547104_7,-1,-1,-1,-1,27672,-1,1.9822464e-05,0.9999702,9.94706e-06
27677,T-cell trafficking to the tumor,6,11,44,75,"However, the mechanisms underlying effector T-cell trafficking to the tumor microenvironment remain poorly understood in patients with colon cancer.",26567139_1,-1,-1,-1,-1,27677,-1,0.0040412727,0.42065924,0.5752995
27680,the regulation,15,17,80,94,"The polycomb repressive complex 2 (PRC2) is involved in cancer progression, but the regulation of tumor immunity by epigenetic mechanisms has yet to be investigated.",26567139_2,-1,-1,-1,-1,27680,-1,2.0423928e-05,0.9999695,1.0077733e-05
27681,tumor immunity,18,20,98,112,"The polycomb repressive complex 2 (PRC2) is involved in cancer progression, but the regulation of tumor immunity by epigenetic mechanisms has yet to be investigated.",26567139_2,-1,-1,-1,-1,27681,-1,0.067166954,0.93159443,0.0012386433
27684,the relationship,6,8,27,43,"In this study, we examined the relationship between the repressive PRC2 machinery and effector T-cell trafficking.",26567139_3,-1,-1,-1,-1,27684,-1,1.8896768e-05,0.99996996,1.115972e-05
27686,T-cell trafficking,15,17,95,113,"In this study, we examined the relationship between the repressive PRC2 machinery and effector T-cell trafficking.",26567139_3,-1,-1,-1,-1,27686,-1,0.00016779819,0.0008687844,0.9989635
27690,Th1-type chemokines,23,25,160,179,"We found that PRC2 components and demethylase JMJD3-mediated histone H3 lysine 27 trimethylation (H3K27me3) repress the expression and subsequent production of Th1-type chemokines CXCL9 and CXCL10, mediators of effector T-cell trafficking.",26567139_4,-1,-1,-1,-1,27690,-1,0.023042599,0.97327536,0.0036819654
27693,T-cell trafficking,32,34,220,238,"We found that PRC2 components and demethylase JMJD3-mediated histone H3 lysine 27 trimethylation (H3K27me3) repress the expression and subsequent production of Th1-type chemokines CXCL9 and CXCL10, mediators of effector T-cell trafficking.",26567139_4,-1,-1,-1,-1,27693,-1,0.00016834827,0.000793033,0.9990386
27696,Th1-type chemokines,28,30,138,157,"Moreover, the expression levels of PRC2 components, including EZH2, SUZ12, and EED, were inversely associated with those of CD4, CD8, and Th1-type chemokines in human colon cancer tissue, and this expression pattern was significantly associated with patient survival.",26567139_5,-1,-1,-1,-1,27696,-1,0.039638538,0.9542772,0.0060842936
27697,tissue,34,35,180,186,"Moreover, the expression levels of PRC2 components, including EZH2, SUZ12, and EED, were inversely associated with those of CD4, CD8, and Th1-type chemokines in human colon cancer tissue, and this expression pattern was significantly associated with patient survival.",26567139_5,-1,1,2,-1,27697,-1,0.00010043186,0.99942774,0.00047178118
27705,T-cell-mediated immunity,20,22,157,181,"Therefore, targeting epigenetic programs may have significant implications for improving the efficacy of current cancer immunotherapies relying on effective T-cell-mediated immunity at the tumor site.",26567139_7,-1,-1,-1,-1,27705,-1,0.010430577,0.0010591041,0.9885103
27706,the tumor,23,25,185,194,"Therefore, targeting epigenetic programs may have significant implications for improving the efficacy of current cancer immunotherapies relying on effective T-cell-mediated immunity at the tumor site.",26567139_7,-1,-1,-1,-1,27706,-1,1.9328343e-05,0.9999715,9.185863e-06
27714,immunity,15,16,84,92,"Because regulatory T cells (Tregs) are regarded as a critical hurdle in anti-tumour immunity, we assessed the distribution of Tregs in 45 cases of EBVaGC and 45 cases of EBV-negative gastric carcinoma (EBVnGC) with matched clinicopathological parameters by immunohistochemistry.",26673957_2,0,-1,2,-1,27714,-1,0.99931157,0.0004476643,0.00024070054
27717,that Tregs,2,4,10,20,"We showed that Tregs were significantly increased in EBVaGC compared to EBVnGC (15.9211.45/HPF vs. 8.456.16/HPF, p=0.001).",26673957_3,-1,-1,-1,-1,27717,-1,2.0704369e-05,0.99996746,1.1826619e-05
27722,blood,2,3,16,21,"When peripheral blood mononuclear cells (PBMCs) were co-cultured with EBV (+) gastric carcinoma cell lines, the Treg frequency increased, and they underwent phenotypic and functional changes.",26673957_5,0,1,-1,-1,27722,-1,0.00046473218,0.9925667,0.0069685825
27725,the Treg,20,22,108,116,"When peripheral blood mononuclear cells (PBMCs) were co-cultured with EBV (+) gastric carcinoma cell lines, the Treg frequency increased, and they underwent phenotypic and functional changes.",26673957_5,-1,-1,-1,-1,27725,-1,2.4602807e-05,0.99996364,1.17444015e-05
27727,functional,30,31,172,182,"When peripheral blood mononuclear cells (PBMCs) were co-cultured with EBV (+) gastric carcinoma cell lines, the Treg frequency increased, and they underwent phenotypic and functional changes.",26673957_5,0,1,2,-1,27727,-1,0.00011911601,0.9998275,5.3312942e-05
27733,the Treg,18,20,115,123,"The enhanced recruitment by CCL22 produced by EBVaGC cells, the decreased emigration due to CCR7 downregulation on the Treg surface, the higher proliferation rate, and the lower apoptosis rate of Tregs at tumour sites may promote the accumulation of Tregs in EBVaGC.",26673957_6,-1,-1,-1,-1,27733,-1,3.2112304e-05,0.9999497,1.8161423e-05
27741,therapeutic targets,15,17,112,131,Histone/protein deacetylases (HDACs) are frequently upregulated in human malignancies and have therefore become therapeutic targets in cancer therapy.,26704363_0,-1,-1,-1,-1,27741,-1,2.4497178e-05,0.9999639,1.1633057e-05
27742,therapy,19,20,142,149,Histone/protein deacetylases (HDACs) are frequently upregulated in human malignancies and have therefore become therapeutic targets in cancer therapy.,26704363_0,0,1,-1,-1,27742,-1,2.4905463e-05,0.99996233,1.2715881e-05
27744,tumor cells to,21,24,127,141,"However, inhibiting certain HDAC isoforms can have protolerogenic effects on the immune system, which could make it easier for tumor cells to evade the host immune system.",26704363_1,-1,-1,-1,-1,27744,-1,0.00010242875,0.9997454,0.00015217728
27749,therapy,19,20,119,126,"Therefore, a better understanding of how each HDAC isoform affects immune biology is needed to develop targeted cancer therapy.",26704363_2,0,1,-1,-1,27749,-1,2.4082103e-05,0.9999629,1.2990055e-05
27751,their T-regulatory,17,19,106,124,"While HDAC5(-/-) mice replicate at expected Mendelian ratios and do not develop overt autoimmune disease, their T-regulatory (Treg) cells show reduced suppressive function in vitro and in vivo.",26704363_4,-1,-1,-1,-1,27751,-1,4.882338e-05,0.9998704,8.0682286e-05
27754,function,26,27,163,171,"While HDAC5(-/-) mice replicate at expected Mendelian ratios and do not develop overt autoimmune disease, their T-regulatory (Treg) cells show reduced suppressive function in vitro and in vivo.",26704363_4,0,1,2,-1,27754,-1,5.7895722e-05,0.99988306,5.8995913e-05
27755,T-cells,4,5,17,24,"Likewise, CD4(+) T-cells lacking HDAC5 convert poorly to Tregs under appropriately polarizing conditions.",26704363_5,-1,1,2,-1,27755,-1,0.00011207952,0.0006675532,0.9992204
27756,to Tregs,9,11,54,62,"Likewise, CD4(+) T-cells lacking HDAC5 convert poorly to Tregs under appropriately polarizing conditions.",26704363_5,-1,-1,-1,-1,27756,-1,2.9154515e-05,0.9999579,1.2944186e-05
27757,To test,0,2,0,7,"To test if this attenuated Treg formation and suppressive function translated into improved anticancer immunity, we inoculated HDAC5(-/-) mice and littermate controls with a lung adenocarcinoma cell line.",26704363_6,-1,-1,-1,-1,27757,-1,2.172035e-05,0.99996936,8.966739e-06
27760,function translated,9,11,58,77,"To test if this attenuated Treg formation and suppressive function translated into improved anticancer immunity, we inoculated HDAC5(-/-) mice and littermate controls with a lung adenocarcinoma cell line.",26704363_6,-1,-1,-1,-1,27760,-1,5.876685e-05,0.9999068,3.4444773e-05
27761,immunity,14,15,103,111,"To test if this attenuated Treg formation and suppressive function translated into improved anticancer immunity, we inoculated HDAC5(-/-) mice and littermate controls with a lung adenocarcinoma cell line.",26704363_6,0,-1,2,-1,27761,-1,0.9993942,0.0003555616,0.00025032993
27764,immunity,11,12,62,70,"Cumulatively, lack of HDAC5 did not lead to better anticancer immunity.",26704363_7,0,-1,2,-1,27764,-1,0.9991929,0.00047071566,0.00033635492
27766,T cells missing,5,8,21,36,"We found that CD8(+) T cells missing HDAC5 had a reduced ability to produce the cytokine, IFN-, in vitro and in vivo, which may offset the benefit of weakened Treg function and formation.",26704363_8,-1,-1,-1,-1,27766,-1,0.005579585,0.0017922947,0.99262804
27768,the cytokine,15,17,76,88,"We found that CD8(+) T cells missing HDAC5 had a reduced ability to produce the cytokine, IFN-, in vitro and in vivo, which may offset the benefit of weakened Treg function and formation.",26704363_8,-1,-1,-1,-1,27768,-1,0.42246047,0.5714642,0.0060754204
27771,Treg function,33,35,160,173,"We found that CD8(+) T cells missing HDAC5 had a reduced ability to produce the cytokine, IFN-, in vitro and in vivo, which may offset the benefit of weakened Treg function and formation.",26704363_8,-1,-1,-1,-1,27771,-1,4.6835175e-05,0.99991965,3.3535423e-05
27772,Taken together,0,2,0,14,"Taken together, targeting HDAC5 weakens suppressive function and de-novo induction of Tregs, but also reduces the ability of CD8(+) T cells to produce IFN-.",26704363_9,-1,-1,-1,-1,27772,-1,5.1960233e-05,0.9999287,1.9295785e-05
27774,function,7,8,52,60,"Taken together, targeting HDAC5 weakens suppressive function and de-novo induction of Tregs, but also reduces the ability of CD8(+) T cells to produce IFN-.",26704363_9,0,1,2,-1,27774,-1,5.7753343e-05,0.9998927,4.9506016e-05
27777,T cells to,22,25,132,142,"Taken together, targeting HDAC5 weakens suppressive function and de-novo induction of Tregs, but also reduces the ability of CD8(+) T cells to produce IFN-.",26704363_9,-1,-1,-1,-1,27777,-1,0.0016907777,0.03194425,0.9663649
27794,tissues,28,29,163,170,"MATERIALS AND METHODS: FoxP3+ Tregs in human colorectal adenomas were evaluated with immunohistochemistry (IHC) and real-time PCR, and compared to CRCs and normal tissues.",26724144_2,-1,1,2,-1,27794,-1,0.00012674555,0.9984863,0.0013869782
27797,cytokine interleukin,8,10,50,70,"In addition, the change of Treg immunosuppressive cytokine interleukin (IL)-10 was examined with IHC and real-time PCR.RESULTS: increased FoxP3+Tregs were observed in the adenomatous stroma/epithelium and the density in colorectal adenomas, which was similar to that in the CRCs, significantly increased as compared to normal tissues.",26724144_3,-1,-1,-1,-1,27797,-1,0.9998603,4.1318086e-05,9.836287e-05
27801,to that,37,39,259,266,"In addition, the change of Treg immunosuppressive cytokine interleukin (IL)-10 was examined with IHC and real-time PCR.RESULTS: increased FoxP3+Tregs were observed in the adenomatous stroma/epithelium and the density in colorectal adenomas, which was similar to that in the CRCs, significantly increased as compared to normal tissues.",26724144_3,-1,-1,-1,-1,27801,-1,2.4937044e-05,0.9999621,1.2972081e-05
27804,tissues,49,50,326,333,"In addition, the change of Treg immunosuppressive cytokine interleukin (IL)-10 was examined with IHC and real-time PCR.RESULTS: increased FoxP3+Tregs were observed in the adenomatous stroma/epithelium and the density in colorectal adenomas, which was similar to that in the CRCs, significantly increased as compared to normal tissues.",26724144_3,-1,1,2,-1,27804,-1,0.0002084942,0.9945958,0.005195643
27814,that IL-10,12,14,95,105,Double IHCs with CD4/CD25 and IL-10/FoxP3 antibodies confirmed above observations and revealed that IL-10 was at least partially released from increased Tregs.,26724144_6,-1,-1,-1,-1,27814,-1,0.80373156,0.19163498,0.004633482
27817,that the,5,7,45,53,"Quantitative real-time PCR results confirmed that the expression levels of FoxP3 and IL-10 mRNAs in the adenomas were increased, which equivalent to that in the CRCs.",26724144_7,-1,-1,-1,-1,27817,-1,1.6166114e-05,0.99997485,8.982418e-06
27821,to that,22,24,146,153,"Quantitative real-time PCR results confirmed that the expression levels of FoxP3 and IL-10 mRNAs in the adenomas were increased, which equivalent to that in the CRCs.",26724144_7,-1,-1,-1,-1,27821,-1,2.7175172e-05,0.9999577,1.5174181e-05
27825,the tumor,8,10,44,53,"CONCLUSION: accumulation of FoxP3+ Tregs in the tumor microenvironment is an early event along the adenoma-carcinoma sequence, and might play a role in the regulation of host immune response to the initiation of CRC.",26724144_8,-1,-1,-1,-1,27825,-1,2.0364418e-05,0.99996865,1.0989058e-05
27828,the regulation,26,28,152,166,"CONCLUSION: accumulation of FoxP3+ Tregs in the tumor microenvironment is an early event along the adenoma-carcinoma sequence, and might play a role in the regulation of host immune response to the initiation of CRC.",26724144_8,-1,-1,-1,-1,27828,-1,1.989051e-05,0.99997044,9.665843e-06
27829,immune response to the,30,34,175,197,"CONCLUSION: accumulation of FoxP3+ Tregs in the tumor microenvironment is an early event along the adenoma-carcinoma sequence, and might play a role in the regulation of host immune response to the initiation of CRC.",26724144_8,-1,-1,-1,-1,27829,-1,0.44799733,0.54811144,0.0038912573
27833,tumor cells to,19,22,142,156,"Indoleamine 2,3-dioxygenase (IDO), a tryptophan-catabolizing intracellular enzyme of the L-kynurenine pathway, causes preneoplastic cells and tumor cells to escape the immune system by inducing immune tolerance; this mechanism might be associated with the development and progression of human malignancies.",26727596_0,-1,-1,-1,-1,27833,-1,9.1067894e-05,0.99977237,0.00013662712
27840,diethylnitrosamine,12,13,57,75,"In the present study, we investigated the role of IDO in diethylnitrosamine (DEN)-induced hepatocarcinogenesis by using IDO-knockout (KO) mice.",26727596_1,-1,-1,-1,-1,27840,-1,9.8597084e-05,0.9998524,4.8987422e-05
27848,tissue,9,10,70,76,HCC overexpressed IDO and L-kynurenine compared to surrounding normal tissue in the DEN-treated IDO-WT mice.,26727596_4,-1,1,2,-1,27848,-1,0.0014358825,0.8182134,0.18035069
27858,protein,6,7,33,40,"The expression levels of the IDO protein, of L-kynurenine, and of IFN-, COX-2, TNF-, and Foxp3 mRNA were also significantly increased in the DEN-induced hepatic tumors that developed in the IDO-WT mice.",26727596_6,0,1,-1,-1,27858,-1,3.5056324e-05,0.9999293,3.5679117e-05
27860,TNF-,17,18,80,85,"The expression levels of the IDO protein, of L-kynurenine, and of IFN-, COX-2, TNF-, and Foxp3 mRNA were also significantly increased in the DEN-induced hepatic tumors that developed in the IDO-WT mice.",26727596_6,0,1,-1,-1,27860,-1,0.00010184342,0.999871,2.7092241e-05
27863,tumors that,30,32,163,174,"The expression levels of the IDO protein, of L-kynurenine, and of IFN-, COX-2, TNF-, and Foxp3 mRNA were also significantly increased in the DEN-induced hepatic tumors that developed in the IDO-WT mice.",26727596_6,-1,-1,-1,-1,27863,-1,1.9769082e-05,0.9999685,1.1698438e-05
27880,immunity,7,8,46,54,"As melanoma progression is controlled by host immunity, here we present a novel approach interrogating immunoregulatory pathways using the genome-wide maps of expression quantitative trait loci (eQTL) to reveal biologically relevant germline variants modulating cutaneous melanoma outcomes.",26733611_1,0,-1,2,-1,27880,-1,0.9991923,0.00047690189,0.00033080796
27893,that their,4,6,21,31,"Furthermore, we show that their combined effect on melanoma OS is substantially enhanced reaching the level of clinical applicability (HR, 1.92; 95% CI, 1.43-2.60; P = 2.38e-5).CONCLUSIONS: Our unique approach of interrogating lymphocyte-specific eQTLs reveals novel and biologically relevant immunomodulatory eQTL predictors of cutaneous melanoma prognosis that are independent of current histopathologic markers.",26733611_6,-1,-1,-1,-1,27893,-1,1.9777586e-05,0.9999713,8.993734e-06
27906,through regulation,13,15,94,112,Nuclear Factor (NF)-B is positioned to provide the interface between COPD and carcinogenesis through regulation of chronic inflammation in the lungs.,26756215_0,-1,-1,-1,-1,27906,-1,2.201393e-05,0.9999654,1.2603255e-05
27908,tetracycline-inducible transgenic,2,4,8,41,"Using a tetracycline-inducible transgenic mouse model that conditionally expresses activated IB kinase  (IKK) in airway epithelium (IKTA), we found that sustained NF-B signaling results in chronic inflammation and emphysema by 4 months.",26756215_1,-1,-1,-1,-1,27908,-1,2.6590678e-05,0.99995935,1.4091998e-05
27934,through generation,14,16,93,111,These studies indicate that sustained activation of NF-B pathway links COPD and lung cancer through generation and maintenance of a pro-tumorigenic inflammatory environment consisting of alternatively activated macrophages and regulatory T cells.,26756215_7,-1,-1,-1,-1,27934,-1,2.1046852e-05,0.9999639,1.5013947e-05
27955,cell transplantation,44,46,177,197,"CD4(+)CD25(+)Tregs or CD4(+)CD25(+)CD127(lo)Tregs expanded ex vivo with rapamycin could be used to suppress regrowth of residual lymphoma after autologous hematopoietic cell transplantation (HCT), and to counteract both graft-versus-host disease and lymphoma re-growth after allogeneic HCT in select patients with lymphoma susceptible to the regulation by Tregs.",26758248_5,-1,-1,-1,-1,27955,-1,0.0033745687,0.054846425,0.94177896
27957,to the regulation,68,71,343,360,"CD4(+)CD25(+)Tregs or CD4(+)CD25(+)CD127(lo)Tregs expanded ex vivo with rapamycin could be used to suppress regrowth of residual lymphoma after autologous hematopoietic cell transplantation (HCT), and to counteract both graft-versus-host disease and lymphoma re-growth after allogeneic HCT in select patients with lymphoma susceptible to the regulation by Tregs.",26758248_5,-1,-1,-1,-1,27957,-1,2.5945921e-05,0.99996066,1.3382475e-05
27978,blood,17,18,130,135,Human leukocyte antigen (HLA)-DR and CD86 expression was significantly reduced in CD11b(+)CD11c(+) cells obtained from peripheral blood mononuclear cells (PBMCs) of healthy donors by IL-6 treatment and was STAT3 dependent.,26759006_4,0,1,-1,-1,27978,-1,0.00016096399,0.99938333,0.00045562876
27980,IL-6 treatment,27,29,183,197,Human leukocyte antigen (HLA)-DR and CD86 expression was significantly reduced in CD11b(+)CD11c(+) cells obtained from peripheral blood mononuclear cells (PBMCs) of healthy donors by IL-6 treatment and was STAT3 dependent.,26759006_4,-1,-1,-1,-1,27980,-1,0.9927072,0.004301713,0.0029911306
27994,tumor tissues,9,11,61,74,There was a relationship between HLA-DR expression levels in tumor tissues and the size of CD4(+) T and CD8(+) T cell compartments.,26759006_8,-1,-1,-1,-1,27994,-1,1.8139319e-05,0.9999659,1.5894833e-05
27998,that IL-6,3,5,22,31,"Our findings indicate that IL-6 causes a dysfunction in human DCs that activates cancer antigen-specific Th cells, suggesting that blocking the IL-6/STAT3 signaling pathway might be a promising strategy to improve cancer immunotherapy.",26759006_9,-1,-1,-1,-1,27998,-1,0.65003693,0.34069952,0.0092635825
28000,antigen-specific Th cells,14,17,88,113,"Our findings indicate that IL-6 causes a dysfunction in human DCs that activates cancer antigen-specific Th cells, suggesting that blocking the IL-6/STAT3 signaling pathway might be a promising strategy to improve cancer immunotherapy.",26759006_9,-1,-1,-1,-1,28000,-1,0.34723017,0.0035864983,0.64918333
28013,T-cell-mediated tumor cell,15,18,101,127,"Tregs promote tumor growth by modulating the antitumor immune response, mainly through inhibition of T-cell-mediated tumor cell killing: this has been suggested to be dependent on IL-10 and/or TGF-.",26782287_1,-1,-1,-1,-1,28013,-1,5.1300376e-05,0.00011102121,0.99983776
28021,tumor tissue,12,14,70,82,"In stomach cancer, the mechanisms behind the accumulation of Tregs in tumor tissue has not been fully elucidated, and neither has Treg gene expression in situ.",26782287_2,-1,-1,-1,-1,28021,-1,2.5537214e-05,0.99995124,2.3264942e-05
28022,Treg gene,23,25,130,139,"In stomach cancer, the mechanisms behind the accumulation of Tregs in tumor tissue has not been fully elucidated, and neither has Treg gene expression in situ.",26782287_2,-1,-1,-1,-1,28022,-1,2.6683947e-05,0.9999522,2.1151236e-05
28023,tissue,5,6,31,37,"MATERIALS AND METHODS: Stomach tissue from gastric cancer patients undergoing gastric resection was analyzed using flow cytometry and cell sorting, followed by RT-PCR.RESULTS: We observed that stomach CD4+ FOXP3+ T cells proliferated to a higher degree than CD4+ FOXP3- T cells, which may contribute to Treg accumulation in the mucosa.",26782287_3,-1,1,2,-1,28023,-1,3.7205195e-05,0.99989724,6.5528286e-05
28030,FOXP3- T cells,44,47,263,277,"MATERIALS AND METHODS: Stomach tissue from gastric cancer patients undergoing gastric resection was analyzed using flow cytometry and cell sorting, followed by RT-PCR.RESULTS: We observed that stomach CD4+ FOXP3+ T cells proliferated to a higher degree than CD4+ FOXP3- T cells, which may contribute to Treg accumulation in the mucosa.",26782287_3,-1,-1,-1,-1,28030,-1,0.003680155,0.7562467,0.24007317
28031,to Treg,51,53,300,307,"MATERIALS AND METHODS: Stomach tissue from gastric cancer patients undergoing gastric resection was analyzed using flow cytometry and cell sorting, followed by RT-PCR.RESULTS: We observed that stomach CD4+ FOXP3+ T cells proliferated to a higher degree than CD4+ FOXP3- T cells, which may contribute to Treg accumulation in the mucosa.",26782287_3,-1,-1,-1,-1,28031,-1,2.4007943e-05,0.9999658,1.023259e-05
28036,the FOXP3 gene,20,23,142,156,"By analyzing DNA methylation, we demonstrated that both proliferating and nonproliferating FOXP3+ T cells exhibited complete demethylation of the FOXP3 gene, indicating a stable FOXP3 expression in both cell populations.",26782287_4,-1,-1,-1,-1,28036,-1,2.4935312e-05,0.9999604,1.4682444e-05
28039,analysis,2,3,13,21,"Furthermore, analysis of T-cell populations isolated directly from the tumor and tumor-free mucosa demonstrated that CD4+ CD25high T cells have a higher IL-10/IFN- gene expression ratio but express lower levels of TGF- than CD4+ CD25low/- T cells.",26782287_5,0,1,-1,-1,28039,-1,1.9868e-05,0.99996626,1.3839129e-05
28040,T-cell,4,5,25,31,"Furthermore, analysis of T-cell populations isolated directly from the tumor and tumor-free mucosa demonstrated that CD4+ CD25high T cells have a higher IL-10/IFN- gene expression ratio but express lower levels of TGF- than CD4+ CD25low/- T cells.",26782287_5,-1,1,2,-1,28040,-1,2.9672463e-05,4.2969525e-05,0.9999274
28041,the tumor,9,11,67,76,"Furthermore, analysis of T-cell populations isolated directly from the tumor and tumor-free mucosa demonstrated that CD4+ CD25high T cells have a higher IL-10/IFN- gene expression ratio but express lower levels of TGF- than CD4+ CD25low/- T cells.",26782287_5,-1,-1,-1,-1,28041,-1,1.8230361e-05,0.9999714,1.034614e-05
28046,TGF- than,33,35,215,225,"Furthermore, analysis of T-cell populations isolated directly from the tumor and tumor-free mucosa demonstrated that CD4+ CD25high T cells have a higher IL-10/IFN- gene expression ratio but express lower levels of TGF- than CD4+ CD25low/- T cells.",26782287_5,-1,-1,-1,-1,28046,-1,2.050569e-05,0.99996686,1.2640517e-05
28059,the tumor,4,6,21,30,"The immune status of the tumor microenvironment influences tumor progression, and hepatocellular carcinoma (HCC) with an immunosuppressive signature often is associated with a poor prognosis.",26786094_0,-1,-1,-1,-1,28059,-1,2.1797496e-05,0.9999671,1.1135853e-05
28064,tumor cell,18,20,107,117,This study examined the impact of a bone marrow-derived dendritic cell (DC) vaccine loaded with autologous tumor cell lysate on tumor progression and the tumor microenvironment using an orthotopic murine HCC model.,26786094_1,-1,-1,-1,-1,28064,-1,0.0048307353,0.46722296,0.52794635
28066,the tumor,25,27,150,159,This study examined the impact of a bone marrow-derived dendritic cell (DC) vaccine loaded with autologous tumor cell lysate on tumor progression and the tumor microenvironment using an orthotopic murine HCC model.,26786094_1,-1,-1,-1,-1,28066,-1,1.943463e-05,0.9999709,9.672018e-06
28072,tumor-infiltrating lymphocytes,19,21,93,123,"The impact of DC vaccine loaded with Hepa1-6 cell lysate on tumor progression, survival, and tumor-infiltrating lymphocytes and cytokines was examined.",26786094_3,-1,-1,-1,-1,28072,-1,0.0036775696,0.8872335,0.10908894
28077,generated through,18,20,102,119,Treating mice with DC vaccine loaded with Hepa1-6 cell lysate inhibited the progression of murine HCC generated through orthotopic implantation of Hepa1-6 cells and resulted in a 90% survival rate by day 60 compared with a survival rate lower than 5% for untreated mice.,26786094_4,-1,-1,-1,-1,28077,-1,2.6582022e-05,0.9999571,1.6307713e-05
28082,the tumor,11,13,88,97,This anti-tumor response was associated with inhibition of STAT3 phosphorylation within the tumor.,26786094_5,-1,-1,-1,-1,28082,-1,1.966345e-05,0.99997056,9.765523e-06
28086,the tumor,12,14,76,85,The DC vaccine reduced accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and prevented TGF- production from the tumor tissue.,26786094_6,-1,-1,-1,-1,28086,-1,1.810898e-05,0.99997234,9.542543e-06
28088,the tumor tissue,20,23,139,155,The DC vaccine reduced accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and prevented TGF- production from the tumor tissue.,26786094_6,-1,-1,-1,-1,28088,-1,2.514509e-05,0.99995327,2.1611815e-05
28089,Tumor cell,0,2,0,10,Tumor cell lysate-loaded DC vaccine prevented HCC progression in a clinically relevant orthotopic murine HCC model.,26786094_7,-1,-1,-1,-1,28089,-1,0.004751455,0.4829534,0.5122951
28095,the tumor,15,17,85,94,The effect of DC vaccine on the accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and on the production of TGF- suggests that tumor regression by DC vaccination may be associated with an altered immunosuppressive tumor microenvironment.,26786094_8,-1,-1,-1,-1,28095,-1,1.9231402e-05,0.99997115,9.5687765e-06
28098,that tumor,25,27,152,162,The effect of DC vaccine on the accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and on the production of TGF- suggests that tumor regression by DC vaccination may be associated with an altered immunosuppressive tumor microenvironment.,26786094_8,-1,-1,-1,-1,28098,-1,2.0419968e-05,0.99997103,8.514964e-06
28107,the tumor,3,5,23,32,"The latter inactivates the tumor suppressor protein retinoblastoma (Rb), which leads to the overexpression of p16(INK4) protein, providing unique Ags for therapeutic HPV-specific cancer vaccination.",26851223_2,-1,-1,-1,-1,28107,-1,2.0911462e-05,0.9999677,1.1359167e-05
28108,protein,6,7,44,51,"The latter inactivates the tumor suppressor protein retinoblastoma (Rb), which leads to the overexpression of p16(INK4) protein, providing unique Ags for therapeutic HPV-specific cancer vaccination.",26851223_2,0,1,-1,-1,28108,-1,3.608255e-05,0.9999198,4.4185203e-05
28109,to the,14,16,85,91,"The latter inactivates the tumor suppressor protein retinoblastoma (Rb), which leads to the overexpression of p16(INK4) protein, providing unique Ags for therapeutic HPV-specific cancer vaccination.",26851223_2,-1,-1,-1,-1,28109,-1,2.2137448e-05,0.9999684,9.442312e-06
28110,protein,20,21,120,127,"The latter inactivates the tumor suppressor protein retinoblastoma (Rb), which leads to the overexpression of p16(INK4) protein, providing unique Ags for therapeutic HPV-specific cancer vaccination.",26851223_2,0,1,-1,-1,28110,-1,3.975131e-05,0.9999162,4.4032095e-05
28113,protein,9,10,65,72,We developed potential adenoviral vaccines that express a fusion protein of HPV-16 E6 and E7 (Ad.,26851223_3,0,1,-1,-1,28113,-1,8.296323e-05,0.99985194,6.512076e-05
28132,immunity,6,7,46,54,"E6E7.p16 with Ad.PD1 could improve antitumor immunity against HPV-related tumors and that p16 may enhance the immunogenicity of DC, through cyclin-dependent pathways, Th1 cytokine secretion, and by adding a nonviral Ag highly overexpressed in HPV-induced cancers.",26851223_15,0,-1,2,-1,28132,-1,0.9925128,0.0068983417,0.0005889134
28137,Th1 cytokine,24,26,168,180,"E6E7.p16 with Ad.PD1 could improve antitumor immunity against HPV-related tumors and that p16 may enhance the immunogenicity of DC, through cyclin-dependent pathways, Th1 cytokine secretion, and by adding a nonviral Ag highly overexpressed in HPV-induced cancers.",26851223_15,-1,-1,-1,-1,28137,-1,0.17803629,0.8122699,0.0096937865
28143,tissue,6,7,43,49,"MATERIALS AND METHODS: Surgically obtained tissue and blood samples of 100 Dupuytren patients were processed by immunohistochemistry, flow cytometry, as well as immunoscope analysis.",26852784_2,-1,1,2,-1,28143,-1,4.0101542e-05,0.99987996,7.995599e-05
28144,blood,8,9,54,59,"MATERIALS AND METHODS: Surgically obtained tissue and blood samples of 100 Dupuytren patients were processed by immunohistochemistry, flow cytometry, as well as immunoscope analysis.",26852784_2,0,1,-1,-1,28144,-1,0.00012348015,0.9995142,0.000362291
28145,analysis,26,27,173,181,"MATERIALS AND METHODS: Surgically obtained tissue and blood samples of 100 Dupuytren patients were processed by immunohistochemistry, flow cytometry, as well as immunoscope analysis.",26852784_2,0,1,-1,-1,28145,-1,7.972239e-05,0.9998313,8.8965586e-05
28146,tissue,3,4,35,41,Macroscopically normal aponeurotic tissue served as control.,26852784_3,-1,1,2,-1,28146,-1,0.00020200424,0.9879231,0.011874901
28148,protein,29,30,130,137,"RESULTS: Locally, microvascular alterations and massive infiltration by mononuclear cells (CD3+, CD4>CD8, CD45RO>CD45RA, S100 protein, CD56, CD68, scarce CD19 and mast cells) forming perivascular clusters were found in DD tissue.",26852784_4,0,1,-1,-1,28148,-1,0.0009791118,0.99879396,0.00022695975
28150,tissue,48,49,226,232,"RESULTS: Locally, microvascular alterations and massive infiltration by mononuclear cells (CD3+, CD4>CD8, CD45RO>CD45RA, S100 protein, CD56, CD68, scarce CD19 and mast cells) forming perivascular clusters were found in DD tissue.",26852784_4,-1,1,2,-1,28150,-1,0.00011290085,0.9990069,0.0008802368
28152,tissue-derived T-cells,4,6,35,57,Cytokine profiling of fibromatosis tissue-derived T-cells showed a Th1/TH17-weighted immune response.,26852784_5,-1,-1,-1,-1,28152,-1,0.0036585517,0.38476664,0.61157477
28154,analysis,1,2,12,20,Immunoscope analysis revealed a restricted T-cell receptor / repertoire pointing to an (auto)antigen-driven process.,26852784_6,0,1,-1,-1,28154,-1,2.4850306e-05,0.99995863,1.6553937e-05
28161,the theory that the,27,31,194,213,"CONCLUSION: The striking accumulation of immune cells, expression of leukocyte adhesion molecules, as well as pro-inflammatory and pro-fibrotic cytokines near markedly narrowed vessels supports the theory that the abnormal proliferation of fibroblasts and production of extracellular matrix proteins in DD seems to be related to immune-mediated microvascular damage.",26852784_7,-1,-1,-1,-1,28161,-1,1.937251e-05,0.99997187,8.780986e-06
28162,proteins,40,41,291,299,"CONCLUSION: The striking accumulation of immune cells, expression of leukocyte adhesion molecules, as well as pro-inflammatory and pro-fibrotic cytokines near markedly narrowed vessels supports the theory that the abnormal proliferation of fibroblasts and production of extracellular matrix proteins in DD seems to be related to immune-mediated microvascular damage.",26852784_7,0,1,-1,-1,28162,-1,0.9906674,0.0062564677,0.0030762174
28164,related to,46,48,318,328,"CONCLUSION: The striking accumulation of immune cells, expression of leukocyte adhesion molecules, as well as pro-inflammatory and pro-fibrotic cytokines near markedly narrowed vessels supports the theory that the abnormal proliferation of fibroblasts and production of extracellular matrix proteins in DD seems to be related to immune-mediated microvascular damage.",26852784_7,-1,-1,-1,-1,28164,-1,2.5288093e-05,0.9999604,1.4326441e-05
28167,T-cells,7,8,60,67,The restricted T-cell receptor repertoire of intra-lesional T-cells points to an antigen-driven process.,26852784_8,-1,1,2,-1,28167,-1,4.068116e-05,6.94556e-05,0.99988985
28170,T-cells,0,1,0,7,T-cells seem to play an important role in the development of Dupuytren's disease.,26852784_9,-1,1,2,-1,28170,-1,3.688514e-05,7.670139e-05,0.9998865
28171,to play,2,4,13,20,T-cells seem to play an important role in the development of Dupuytren's disease.,26852784_9,-1,-1,-1,-1,28171,-1,2.5271858e-05,0.999962,1.2782214e-05
28181,to tumor,15,17,102,110,"However, we describe here a different, cell-extrinsic mechanism through which mutant KRAS contributes to tumor development.",26880715_2,-1,-1,-1,-1,28181,-1,2.4370978e-05,0.9999622,1.3406435e-05
28182,Tumor cells,0,2,0,11,"Tumor cells carrying mutated KRAS induced highly suppressive T cells, and silencing KRAS reversed this effect.",26880715_3,-1,-1,-1,-1,28182,-1,0.0045153257,0.41121212,0.58427256
28186,tumor cells,8,10,62,73,Overexpression of the mutant KRAS(G12V)gene in wild-type KRAS tumor cells led to regulatory T-cell (Treg) induction.,26880715_4,-1,-1,-1,-1,28186,-1,0.0033371956,0.3400737,0.6565891
28187,to regulatory T-cell,11,14,78,98,Overexpression of the mutant KRAS(G12V)gene in wild-type KRAS tumor cells led to regulatory T-cell (Treg) induction.,26880715_4,-1,-1,-1,-1,28187,-1,0.0025876244,0.09373391,0.9036785
28193,factor-1,14,15,91,100,We also demonstrate that mutant KRAS induces the secretion of IL10 and transforming growth factor-1 (both required for Treg induction) by tumor cells through the activation of the MEK-ERK-AP1 pathway.,26880715_5,0,1,-1,-1,28193,-1,0.9960008,0.0006292047,0.0033700108
28195,tumor cells through the,23,27,139,162,We also demonstrate that mutant KRAS induces the secretion of IL10 and transforming growth factor-1 (both required for Treg induction) by tumor cells through the activation of the MEK-ERK-AP1 pathway.,26880715_5,-1,-1,-1,-1,28195,-1,4.7185735e-05,0.9999038,4.8972655e-05
28202,This cell-extrinsic,0,2,0,19,This cell-extrinsic mechanism allows tumor cells harboring a mutant KRAS oncogene to escape immune recognition.,26880715_7,-1,-1,-1,-1,28202,-1,0.0046863053,0.19120339,0.80411035
28203,tumor cells,4,6,37,48,This cell-extrinsic mechanism allows tumor cells harboring a mutant KRAS oncogene to escape immune recognition.,26880715_7,-1,-1,-1,-1,28203,-1,0.0037444578,0.4274157,0.56883985
28209,function,18,19,118,126,"Thus, an oncogene can promote tumor progression independent of its transforming activity by increasing the number and function of Tregs.",26880715_8,0,1,2,-1,28209,-1,0.00012956037,0.99978834,8.2140556e-05
28217,functional,14,15,96,106,Regulatory T cells (Tregs) comprise numerous heterogeneous subsets with distinct phenotypic and functional features.,26885615_0,0,1,2,-1,28217,-1,0.00016797251,0.99975234,7.962764e-05
28221,Treg subsets,14,16,92,104,"Identifying Treg markers is critical to investigate the role and clinical impact of various Treg subsets in pathological settings, and also for developing more effective immunotherapies.",26885615_1,-1,-1,-1,-1,28221,-1,0.00025798936,0.0034212032,0.99632084
28227,blood,10,11,63,68,In this study we report similar observations in the peripheral blood of patients with pancreatic cancer (PC) and liver metastases from colorectal cancer (LICRC).,26885615_3,0,1,-1,-1,28227,-1,5.9421593e-05,0.9997274,0.00021319462
28234,that FoxP3-LAP+ Tregs,9,12,60,81,"However, defining Tregs based on GARP/LAP expression showed that FoxP3-LAP+ Tregs in non-activated and activated settings, and FoxP3+Helios+GARP+LAP+ activated Tregs were significantly increased in both groups of patients, compared with controls.",26885615_5,-1,-1,-1,-1,28234,-1,2.5264268e-05,0.99996006,1.47140345e-05
28241,Treg subsets,17,19,114,126,This work implies that a combination of Treg-specific markers could be used to more accurately determine expanded Treg subsets and to understand their contribution in cancer settings.,26885615_6,-1,-1,-1,-1,28241,-1,0.00043136292,0.010248827,0.9893197
28244,T cells made IL-10,5,9,31,49,"Additionally, GARP-/+LAP+ CD4+ T cells made IL-10, and not IFN-, and levels of IL-10-secreting CD4+ T cells were elevated in LICRC patients, especially with higher tumor staging.",26885615_7,-1,-1,-1,-1,28244,-1,0.4104873,0.0044833175,0.58502936
28249,Taken together,0,2,0,14,"Taken together, our results indicate that investigations of Treg levels in different cancers should consider diverse Treg-related markers such as GARP, LAP, Helios, and others and not only FoxP3 as a sole Treg-specific marker.",26885615_8,-1,-1,-1,-1,28249,-1,4.7812326e-05,0.9999331,1.9041388e-05
28258,the immune response,3,6,12,31,The role of the immune response in this phenomenon is yet unclear.,26899388_1,-1,-1,-1,-1,28258,-1,0.24028692,0.7581911,0.0015219396
28272,tumor-infiltrating T cells,9,12,50,76,"Furthermore, the production of IFN- and IL-17 by tumor-infiltrating T cells was analyzed.",26899388_3,-1,-1,-1,-1,28272,-1,0.0033156339,0.82233554,0.17434882
28274,tumor-infiltrating T cells,3,6,14,40,The number of tumor-infiltrating T cells and Tregs was higher in HPV-positive than HPV-negative OPSCC (p < 0.0001).,26899388_4,-1,-1,-1,-1,28274,-1,0.0039627026,0.7580371,0.23800017
28280,trend toward,10,12,57,69,"Although a high number of intra-tumoral T cells showed a trend toward improved survival of all OPSCC patients, their prognostic effect in patients with a low number of intra-tumoral IL-17(+) non-T cells was significant with regard to disease-specific (p = 0.033) and disease-free survival (p = 0.012).",26899388_6,-1,-1,-1,-1,28280,-1,2.4889316e-05,0.9999641,1.0991849e-05
28289,related to,12,14,64,74,"This suggests that a high frequency of IL-17(+) non-T cells was related to a poor immune response, which was further supported by the observation that a high number of T cells was correlated with improved disease-free survival in the HPV-positive OPSCC (p = 0.008).",26899388_7,-1,-1,-1,-1,28289,-1,2.50792e-05,0.9999616,1.3257239e-05
28295,Th17 cell,7,9,33,42,"In addition, we detected a minor Th17 cell population.",26899388_8,-1,-1,-1,-1,28295,-1,0.00032583767,0.0026027604,0.9970714
28297,IL-17 than those,11,14,78,94,"However, T cells obtained from HPV-positive OPSCC produced significantly more IL-17 than those from HPV-negative tumors (p = 0.006).",26899388_9,-1,-1,-1,-1,28297,-1,0.9757691,0.0190388,0.0051920502
28301,tumor-infiltrating T cells,13,16,87,113,"The improved prognosis of HPV-positive OPSCC is thus correlated with higher numbers of tumor-infiltrating T cells, more active Th17 cells and lower numbers of IL-17(+) non-T cells.",26899388_10,-1,-1,-1,-1,28301,-1,0.005377616,0.7331949,0.2614275
28302,Th17 cells,19,21,127,137,"The improved prognosis of HPV-positive OPSCC is thus correlated with higher numbers of tumor-infiltrating T cells, more active Th17 cells and lower numbers of IL-17(+) non-T cells.",26899388_10,-1,-1,-1,-1,28302,-1,0.00017616061,0.0006463752,0.9991774
28305,tumor-reactive T cells,3,6,24,46,Acquired dysfunction of tumor-reactive T cells is one mechanism by which tumors can evade the immune system.,26903482_0,-1,-1,-1,-1,28305,-1,0.0050925384,0.7061934,0.28871405
28310,therapy,13,14,103,110,Identifying and correcting pathways that contribute to such dysfunction should enable novel anticancer therapy design.,26903482_1,0,1,-1,-1,28310,-1,2.6782634e-05,0.9999598,1.3378126e-05
28314,to tumor,10,12,69,77,Impaired T cell-intrinsic NF-B may create a vicious cycle conducive to tumor progression and further T cell dysfunction.,26903482_3,-1,-1,-1,-1,28314,-1,3.0259065e-05,0.9999583,1.144434e-05
28326,functional tumor-specific,9,11,72,97,T cell-restricted constitutively active IKK augmented the frequency of functional tumor-specific CD8(+) T cells and improved tumor control.,26903482_6,-1,-1,-1,-1,28326,-1,3.6302135e-05,0.9999474,1.6259275e-05
28343,transplantation,12,13,56,71,"In this study, a LC mouse model was created by adoptive transplantation with LC cells.",26910585_2,-1,1,2,-1,28343,-1,2.4509076e-05,0.99996126,1.4224781e-05
28345,The tumor-bearing,0,2,0,17,The tumor-bearing mice were vaccinated with LC cell extracts plus adjuvant TNBS or adoptive transplantation with specific CD8(+) CD196(+) T cells.,26910585_3,-1,-1,-1,-1,28345,-1,2.9478537e-05,0.9999565,1.40809025e-05
28349,transplantation,14,15,92,107,The tumor-bearing mice were vaccinated with LC cell extracts plus adjuvant TNBS or adoptive transplantation with specific CD8(+) CD196(+) T cells.,26910585_3,-1,1,2,-1,28349,-1,2.8968985e-05,0.99995494,1.6129296e-05
28352,that the,3,5,19,27,The results showed that the vaccination with LC extracts (LCE)/TNBS markedly inhibited the LC growth and induced CD8(+) CD196(+) T cells in LC tissue and the spleen.,26910585_4,-1,-1,-1,-1,28352,-1,1.9186158e-05,0.99997234,8.496287e-06
28355,tissue,25,26,143,149,The results showed that the vaccination with LC extracts (LCE)/TNBS markedly inhibited the LC growth and induced CD8(+) CD196(+) T cells in LC tissue and the spleen.,26910585_4,-1,1,2,-1,28355,-1,0.0010864246,0.23575553,0.763158
28361,to TNBS,1,3,9,16,Exposure to TNBS induced RAW264.7 cells to produce macrophage inflammatory protein-3; the latter activated signal transducer and activator of transcription 3 and further induced perforin expression in the CD8(+) CD196(+) T cells.,26910585_6,-1,-1,-1,-1,28361,-1,2.4600693e-05,0.9999645,1.0900419e-05
28362,cells to,5,7,34,42,Exposure to TNBS induced RAW264.7 cells to produce macrophage inflammatory protein-3; the latter activated signal transducer and activator of transcription 3 and further induced perforin expression in the CD8(+) CD196(+) T cells.,26910585_6,-1,-1,-1,-1,28362,-1,0.0028796971,0.09692686,0.9001934
28363,protein-3,10,11,75,85,Exposure to TNBS induced RAW264.7 cells to produce macrophage inflammatory protein-3; the latter activated signal transducer and activator of transcription 3 and further induced perforin expression in the CD8(+) CD196(+) T cells.,26910585_6,0,1,-1,-1,28363,-1,0.91196364,0.086892635,0.0011437827
28381,blood,13,14,70,75,Our study found a higher percentage of CD4(+) Tregs in the peripheral blood of NSCLC compared with healthy donors.,27000869_3,0,1,-1,-1,28381,-1,0.00028235905,0.9930962,0.006621458
28382,the Foxp3,9,11,62,71,NSCLC patients showed demethylation of eight CpG sites within the Foxp3 promoter with methylation ratios negatively correlated with CD4(+)CD25(+)Foxp3(+) T levels.,27000869_4,-1,-1,-1,-1,28382,-1,2.3848062e-05,0.99996364,1.245545e-05
28389,tumor cells,5,7,24,35,"To verify the effect of tumor cells on the phenotype and function of CD4(+) Tregs, we established a coculture system using NSCLC cell line and healthy CD4(+) T cells and showed that SPC-A1 induced IL-10 and TGF-1 secretion by affecting the function of CD4(+) Tregs.",27000869_6,-1,-1,-1,-1,28389,-1,0.0038679324,0.41266677,0.58346534
28391,function,11,12,57,65,"To verify the effect of tumor cells on the phenotype and function of CD4(+) Tregs, we established a coculture system using NSCLC cell line and healthy CD4(+) T cells and showed that SPC-A1 induced IL-10 and TGF-1 secretion by affecting the function of CD4(+) Tregs.",27000869_6,0,1,2,-1,28391,-1,5.8978083e-05,0.99989176,4.92739e-05
28398,the function,43,45,237,249,"To verify the effect of tumor cells on the phenotype and function of CD4(+) Tregs, we established a coculture system using NSCLC cell line and healthy CD4(+) T cells and showed that SPC-A1 induced IL-10 and TGF-1 secretion by affecting the function of CD4(+) Tregs.",27000869_6,-1,-1,-1,-1,28398,-1,3.3832534e-05,0.9999454,2.0731177e-05
28403,the Foxp3,6,8,36,45,"Furthermore, eight CpG sites within the Foxp3 promoter also appeared to have undergone demethylation.",27000869_8,-1,-1,-1,-1,28403,-1,2.2082406e-05,0.999966,1.1893652e-05
28415,to tumor,19,21,153,161,Our study provides one possible mechanism describing Foxp3 promoter demethylation changes by which NSCLC down-regulates immune responses and contributes to tumor progression.,27000869_11,-1,-1,-1,-1,28415,-1,2.372606e-05,0.9999653,1.0962111e-05
28418,tumor cells,3,5,25,36,"Radiation modulates both tumor cells and immune cells in the tumor microenvironment to exert its anti-tumor activity; however, the molecular connection between tumor cells and immune cells that mediates radiation-exerted tumor suppression activity in the tumor microenvironment is largely unknown.",27014915_0,-1,-1,-1,-1,28418,-1,0.004336034,0.32946652,0.6661975
28420,the tumor,9,11,57,66,"Radiation modulates both tumor cells and immune cells in the tumor microenvironment to exert its anti-tumor activity; however, the molecular connection between tumor cells and immune cells that mediates radiation-exerted tumor suppression activity in the tumor microenvironment is largely unknown.",27014915_0,-1,-1,-1,-1,28420,-1,2.139474e-05,0.9999691,9.455483e-06
28423,tumor cells,24,26,160,171,"Radiation modulates both tumor cells and immune cells in the tumor microenvironment to exert its anti-tumor activity; however, the molecular connection between tumor cells and immune cells that mediates radiation-exerted tumor suppression activity in the tumor microenvironment is largely unknown.",27014915_0,-1,-1,-1,-1,28423,-1,0.0041707307,0.33382195,0.6620074
28424,cells that,28,30,183,193,"Radiation modulates both tumor cells and immune cells in the tumor microenvironment to exert its anti-tumor activity; however, the molecular connection between tumor cells and immune cells that mediates radiation-exerted tumor suppression activity in the tumor microenvironment is largely unknown.",27014915_0,-1,-1,-1,-1,28424,-1,0.004312316,0.11325954,0.8824281
28426,the tumor,36,38,251,260,"Radiation modulates both tumor cells and immune cells in the tumor microenvironment to exert its anti-tumor activity; however, the molecular connection between tumor cells and immune cells that mediates radiation-exerted tumor suppression activity in the tumor microenvironment is largely unknown.",27014915_0,-1,-1,-1,-1,28426,-1,2.0972464e-05,0.99996996,9.050406e-06
28430,tissue,18,19,112,118,We report here that radiation induces rapid activation of the p65/p50 and p50/p50 NF-B complexes in human soft tissue sarcoma (STS) cells.,27014915_1,-1,1,2,-1,28430,-1,4.2311476e-05,0.999908,4.9740036e-05
28432,to the TNF,5,8,45,56,Radiation-activated p65/p50 and p50/p50 bind to the TNF promoter to activate its transcription in STS cells.,27014915_2,-1,-1,-1,-1,28432,-1,3.340217e-05,0.99995315,1.3483733e-05
28436,TNF,1,2,18,22,Radiation-induced TNF induces tumor cell death in an autocrine manner.,27014915_3,0,1,-1,-1,28436,-1,4.5119497e-05,0.9999379,1.7043474e-05
28437,tumor cell,3,5,31,41,Radiation-induced TNF induces tumor cell death in an autocrine manner.,27014915_3,-1,-1,-1,-1,28437,-1,0.003800916,0.36649656,0.6297025
28439,tumor cell,14,16,85,95,A sublethal dose of Smac mimetic BV6 induces cIAP1 and cIAP2 degradation to increase tumor cell sensitivity to radiation-induced cell death in vitro and to enhance radiation-mediated suppression of STS xenografts in vivo.,27014915_4,-1,-1,-1,-1,28439,-1,0.0028200583,0.18060768,0.8165723
28444,TNF-induced,18,19,114,126,"Inhibition of caspases, RIP1, or RIP3 blocks radiation/TNF-induced cell death, whereas inhibition of RIP1 blocks TNF-induced caspase activation, suggesting that caspases and RIP1 act sequentially to mediate the non-compensatory cell death pathways.",27014915_5,0,1,-1,-1,28444,-1,6.74051e-05,0.9999063,2.6285434e-05
28452,the T cell chemokines CCL2,18,23,106,132,"Furthermore, we determined in a syngeneic sarcoma mouse model that radiation up-regulates IRF3, IFN, and the T cell chemokines CCL2 and CCL5 in the tumor microenvironment, which are associated with activation and increased infiltration of Th1/Tc1 T cells in the tumor microenvironment.",27014915_6,-1,-1,-1,-1,28452,-1,0.31034574,0.5959353,0.09371903
28453,the tumor,26,28,145,154,"Furthermore, we determined in a syngeneic sarcoma mouse model that radiation up-regulates IRF3, IFN, and the T cell chemokines CCL2 and CCL5 in the tumor microenvironment, which are associated with activation and increased infiltration of Th1/Tc1 T cells in the tumor microenvironment.",27014915_6,-1,-1,-1,-1,28453,-1,1.955922e-05,0.99996865,1.1746847e-05
28455,the tumor,43,45,259,268,"Furthermore, we determined in a syngeneic sarcoma mouse model that radiation up-regulates IRF3, IFN, and the T cell chemokines CCL2 and CCL5 in the tumor microenvironment, which are associated with activation and increased infiltration of Th1/Tc1 T cells in the tumor microenvironment.",27014915_6,-1,-1,-1,-1,28455,-1,2.0094272e-05,0.9999677,1.2162352e-05
28456,tumor-infiltrating T cells,2,5,10,36,"Moreover, tumor-infiltrating T cells are in their active form since both the perforin and FasL pathways are activated in irradiated tumor tissues.",27014915_7,-1,-1,-1,-1,28456,-1,0.0042616962,0.7528226,0.24291572
28459,tumor tissues,21,23,132,145,"Moreover, tumor-infiltrating T cells are in their active form since both the perforin and FasL pathways are activated in irradiated tumor tissues.",27014915_7,-1,-1,-1,-1,28459,-1,3.9297178e-05,0.99991024,5.045006e-05
28462,functions,4,5,35,44,"Therefore, radiation-induced NF-B functions as a molecular link between tumor cells and immune cells in the tumor microenvironment for radiation-mediated tumor suppression.",27014915_9,0,1,2,-1,28462,-1,5.1949788e-05,0.9999213,2.6684498e-05
28463,tumor cells,10,12,73,84,"Therefore, radiation-induced NF-B functions as a molecular link between tumor cells and immune cells in the tumor microenvironment for radiation-mediated tumor suppression.",27014915_9,-1,-1,-1,-1,28463,-1,0.0042948998,0.4025498,0.5931553
28465,the tumor,16,18,105,114,"Therefore, radiation-induced NF-B functions as a molecular link between tumor cells and immune cells in the tumor microenvironment for radiation-mediated tumor suppression.",27014915_9,-1,-1,-1,-1,28465,-1,2.2432372e-05,0.99996674,1.0843852e-05
28468,tumor immunity,3,5,25,39,"Recent studies implicate tumor immunity in the development of various tumors, including malignant mesothelioma.",27042963_1,-1,-1,-1,-1,28468,-1,0.03015698,0.9688775,0.00096559955
28472,T-cell,7,8,34,40,"In order to establish an in vitro T-cell model to clarify the effects of long-term exposure of asbestos on tumor immunity, in this study, human T-cell line MT-2 cells were cultured with asbestos for longer than 8 months and the resultant cells (MT-2Rst) were assessed for the expression of forkhead transcription factor FoxO1.",27042963_2,-1,1,2,-1,28472,-1,3.0484038e-05,5.7849582e-05,0.99991167
28475,tumor immunity,19,21,107,121,"In order to establish an in vitro T-cell model to clarify the effects of long-term exposure of asbestos on tumor immunity, in this study, human T-cell line MT-2 cells were cultured with asbestos for longer than 8 months and the resultant cells (MT-2Rst) were assessed for the expression of forkhead transcription factor FoxO1.",27042963_2,-1,-1,-1,-1,28475,-1,0.011549935,0.98803097,0.00041911134
28477,T-cell,27,28,144,150,"In order to establish an in vitro T-cell model to clarify the effects of long-term exposure of asbestos on tumor immunity, in this study, human T-cell line MT-2 cells were cultured with asbestos for longer than 8 months and the resultant cells (MT-2Rst) were assessed for the expression of forkhead transcription factor FoxO1.",27042963_2,-1,1,2,-1,28477,-1,2.9470722e-05,5.5048426e-05,0.9999155
28483,forkhead transcription factor,53,56,290,319,"In order to establish an in vitro T-cell model to clarify the effects of long-term exposure of asbestos on tumor immunity, in this study, human T-cell line MT-2 cells were cultured with asbestos for longer than 8 months and the resultant cells (MT-2Rst) were assessed for the expression of forkhead transcription factor FoxO1.",27042963_2,-1,-1,-1,-1,28483,-1,2.458591e-05,0.9999614,1.4024188e-05
28485,analysis,2,3,16,24,Gene expression analysis revealed that the amount of FoxO1 mRNA decreased after long-term exposure of the MT-2 cells to asbestos.,27042963_3,0,1,-1,-1,28485,-1,2.6600314e-05,0.99995255,2.0895955e-05
28486,that the,4,6,34,42,Gene expression analysis revealed that the amount of FoxO1 mRNA decreased after long-term exposure of the MT-2 cells to asbestos.,27042963_3,-1,-1,-1,-1,28486,-1,1.8084407e-05,0.9999734,8.46171e-06
28488,cells to,17,19,111,119,Gene expression analysis revealed that the amount of FoxO1 mRNA decreased after long-term exposure of the MT-2 cells to asbestos.,27042963_3,-1,-1,-1,-1,28488,-1,0.0040833587,0.13472895,0.8611877
28490,target genes,10,12,64,76,"In accordance with this reduction in FoxO1, pro-apoptotic Foxo1 target genes Puma, Fas ligand and Bim were also seen to be down-regulated in MT-2Rst cells.",27042963_4,-1,-1,-1,-1,28490,-1,2.5359996e-05,0.99995303,2.1558059e-05
28505,therapy,6,7,56,63,Successful immunogenic apoptosis in experimental cancer therapy depends on the induction of strong host anti-tumor responses.,27050509_0,0,1,-1,-1,28505,-1,2.3667302e-05,0.99996436,1.2023139e-05
28507,that tumors,1,3,6,17,"Given that tumors are often resistant to apoptosis, it is important to identify alternative molecular mechanisms that elicit immunogenic cell death.",27050509_1,-1,-1,-1,-1,28507,-1,2.7185923e-05,0.9999622,1.0611888e-05
28514,cells release,5,7,34,47,"We report that necroptotic cancer cells release damage-associated molecular patterns and promote maturation of dendritic cells, the cross-priming of cytotoxic Tcells, and the production of IFN- in response to tumor antigen stimulation.",27050509_3,-1,-1,-1,-1,28514,-1,0.003622792,0.14188738,0.85448986
28520,to tumor antigen,32,35,208,224,"We report that necroptotic cancer cells release damage-associated molecular patterns and promote maturation of dendritic cells, the cross-priming of cytotoxic Tcells, and the production of IFN- in response to tumor antigen stimulation.",27050509_3,-1,-1,-1,-1,28520,-1,0.079593085,0.9172582,0.003148736
28526,therapy,21,22,129,136,Our study broadens the current concept of immunogenic cell death and opens doors for the development of new strategies in cancer therapy.,27050509_5,0,1,-1,-1,28526,-1,2.6347967e-05,0.9999622,1.1397039e-05
28531,functionally,14,15,83,95,There are many molecules that define regulatory T cells (Tregs) phenotypically and functionally.,27095576_0,0,1,2,-1,28531,-1,7.279072e-05,0.9998946,3.2519765e-05
28532,transmembrane protein,9,11,51,72,Glycoprotein A repetitions predominant (GARP) is a transmembrane protein containing leucine rich repeats.,27095576_1,-1,-1,-1,-1,28532,-1,9.134849e-05,0.99979705,0.00011162192
28539,Tregs that,9,11,44,54,"Besides, GARP is a cell surface molecule of Tregs that maintains their regulatory function and homeosatsis.",27095576_4,-1,-1,-1,-1,28539,-1,2.8974815e-05,0.99995303,1.8012366e-05
28541,function,14,15,82,90,"Besides, GARP is a cell surface molecule of Tregs that maintains their regulatory function and homeosatsis.",27095576_4,0,1,2,-1,28541,-1,9.9218676e-05,0.9998418,5.8910944e-05
28544,transforming growth factor,12,15,69,95,GARP has also been proved to promote the activation and secretion of transforming growth factor  (TGF-).,27095576_5,-1,-1,-1,-1,28544,-1,0.85252154,0.14181952,0.005659017
28547,T cells that,2,5,7,19,CD4(+) T cells that express the forkhead box P3 (FOXP3) transcription factor function as regulatory T (Treg) cells and hinder effective immune responses against cancer cells.,27111280_0,-1,-1,-1,-1,28547,-1,0.0014972636,0.03294149,0.9655613
28548,the forkhead,6,8,28,40,CD4(+) T cells that express the forkhead box P3 (FOXP3) transcription factor function as regulatory T (Treg) cells and hinder effective immune responses against cancer cells.,27111280_0,-1,-1,-1,-1,28548,-1,2.2683222e-05,0.99996555,1.1750821e-05
28550,transcription factor function,13,16,56,85,CD4(+) T cells that express the forkhead box P3 (FOXP3) transcription factor function as regulatory T (Treg) cells and hinder effective immune responses against cancer cells.,27111280_0,-1,-1,-1,-1,28550,-1,2.8605878e-05,0.9999528,1.8564579e-05
28566,two types,21,23,125,134,"Here we show that CRCs, which are commonly infiltrated by suppression-competent FOXP3(hi) Treg cells, can be classified into two types by the degree of additional infiltration of FOXP3(lo) nonsuppressive T cells.",27111280_3,-1,-1,-1,-1,28566,-1,3.7063088e-05,0.9999269,3.602652e-05
28573,the naive T cell,14,18,82,98,"The latter, which are distinguished from FOXP3(+) Treg cells by non-expression of the naive T cell marker CD45RA and instability of FOXP3, secreted inflammatory cytokines.",27111280_4,-1,-1,-1,-1,28573,-1,0.005091413,0.43245795,0.56245065
28578,than those,15,17,99,109,"Indeed, CRCs with abundant infiltration of FOXP3(lo) T cells showed significantly better prognosis than those with predominantly FOXP3(hi) Treg cell infiltration.",27111280_5,-1,-1,-1,-1,28578,-1,2.1010252e-05,0.9999658,1.319964e-05
28584,transforming growth factor,16,19,109,135,"Development of such inflammatory FOXP3(lo) non-Treg cells may depend on secretion of interleukin (IL)-12 and transforming growth factor (TGF)- by tissues and their presence was correlated with tumor invasion by intestinal bacteria, especially Fusobacterium nucleatum.",27111280_6,-1,-1,-1,-1,28584,-1,0.8830162,0.11323729,0.0037465892
28585,tissues,21,22,147,154,"Development of such inflammatory FOXP3(lo) non-Treg cells may depend on secretion of interleukin (IL)-12 and transforming growth factor (TGF)- by tissues and their presence was correlated with tumor invasion by intestinal bacteria, especially Fusobacterium nucleatum.",27111280_6,-1,1,2,-1,28585,-1,3.2076943e-05,0.9999285,3.9388284e-05
28589,functionally,2,3,6,18,"Thus, functionally distinct subpopulations of tumor-infiltrating FOXP3(+) T cells contribute in opposing ways to determining CRC prognosis.",27111280_7,0,1,2,-1,28589,-1,4.440326e-05,0.99993515,2.0449814e-05
28590,tumor-infiltrating FOXP3(+,6,8,46,72,"Thus, functionally distinct subpopulations of tumor-infiltrating FOXP3(+) T cells contribute in opposing ways to determining CRC prognosis.",27111280_7,-1,-1,-1,-1,28590,-1,0.00021555093,0.9996222,0.00016214888
28595,tumor tissues,7,9,39,52,"Depletion of FOXP3(hi) Treg cells from tumor tissues, which would augment antitumor immunity, could thus be used as an effective treatment strategy for CRCs and other cancers, whereas strategies that locally increase the population of FOXP3(lo) non-Treg cells could be used to suppress or prevent tumor formation.",27111280_8,-1,-1,-1,-1,28595,-1,2.447823e-05,0.99995124,2.433369e-05
28596,immunity,14,15,84,92,"Depletion of FOXP3(hi) Treg cells from tumor tissues, which would augment antitumor immunity, could thus be used as an effective treatment strategy for CRCs and other cancers, whereas strategies that locally increase the population of FOXP3(lo) non-Treg cells could be used to suppress or prevent tumor formation.",27111280_8,0,-1,2,-1,28596,-1,0.99915576,0.0005182556,0.0003260359
28610,to tumour,7,9,39,48,"Regulatory T cells (T-regs) contribute to tumour immune escape, but their role in basal cell carcinoma (BCC) is not understood.",27117439_1,-1,-1,-1,-1,28610,-1,2.8882801e-05,0.9999604,1.0700271e-05
28616,analysis,15,16,102,110,"The fraction of T-regs among T cells was analysed by immunohistochemistry followed by automated image analysis in facial BCC, peritumoural skin and normal, buttock skin.",27117439_2,0,1,-1,-1,28616,-1,4.1063657e-05,0.9999242,3.476801e-05
28627,Transforming growth factor,0,3,0,26,"Transforming growth factor (TGF)- and T-reg chemokine expression was increased in BCC and peritumoural skin, but not in buttock skin, with expression levels correlating with Foxp3.",27117439_7,-1,-1,-1,-1,28627,-1,0.8698451,0.12552042,0.0046344465
28628,T-reg chemokine,5,7,39,54,"Transforming growth factor (TGF)- and T-reg chemokine expression was increased in BCC and peritumoural skin, but not in buttock skin, with expression levels correlating with Foxp3.",27117439_7,-1,-1,-1,-1,28628,-1,0.026491301,0.971238,0.0022706487
28649,T-cell proliferation to,57,60,344,367,"METHODS: The expression and activation of NF-B, Akt and IDO1 by MyD88(+) EOC SKOV3 cells was determined using western blot; the TLR4/MD-2 complex on SKOV3 cells and the phenotype of T lymphocytes were determined using flow cytometry; IDO activity was evaluated by measuring L-kynurenine; Immunesuppressive cytokines were detected using ELISA; T-cell proliferation to mitogen stimulation was assessed by MTT assay; the cytotoxicity of lymphocytes and NK cells was measured using LDH-cytotoxicity assay.",27118139_3,-1,-1,-1,-1,28649,-1,0.0010408539,0.0046563516,0.99430287
28667,therapy,12,13,79,86,"BACKGROUND: Chronic lymphocytic leukemia (CLL) remains incurable with standard therapy, and is characterized by excessive expansion of monoclonal abnormal mature B cells and more regulatory immune properties of T cell compartment.",27118475_0,0,1,-1,-1,28667,-1,3.2554686e-05,0.9999542,1.3211856e-05
28672,function,8,9,52,60,"Thus, developing novel strategies to enhance immune function merits further investigation as a possible therapy for CLL.METHODS: We generated a fusion cytokine (fusokine) arising from the combination of human GM-CSF and IL-4 (named GIFT4).",27118475_1,0,1,2,-1,28672,-1,0.00011541607,0.99982554,5.907454e-05
28673,therapy,15,16,104,111,"Thus, developing novel strategies to enhance immune function merits further investigation as a possible therapy for CLL.METHODS: We generated a fusion cytokine (fusokine) arising from the combination of human GM-CSF and IL-4 (named GIFT4).",27118475_1,0,1,-1,-1,28673,-1,2.7663658e-05,0.9999589,1.3505404e-05
28687,function,17,18,101,109,"The phenotype and secretome of GIFT4-treated CLL cells (GIFT4-CLL cells), and the immune stimulatory function of GIFT4-CLL cells on autologous T cells were analyzed by flow cytometry and luminex assay.",27118475_4,0,1,2,-1,28687,-1,0.00041822708,0.99897647,0.0006053735
28697,relative to,11,13,66,77,"GIFT4-CLL cells secreted IL-1, IL-6, ICAM-1 and substantial IL-2 relative to unstimulated CLL cells.",27118475_6,-1,-1,-1,-1,28697,-1,5.159697e-05,0.999913,3.5389236e-05
28708,that these,18,20,120,130,"GIFT4-CLL cells directly propelled the expansion of autologous IFN--producing CD314(+) cytotoxic T cells in vitro, and that these could lyse autologous CLL cells.",27118475_8,-1,-1,-1,-1,28708,-1,2.3696719e-05,0.99996006,1.624584e-05
28710,protein,5,6,37,44,"Furthermore, administration of GIFT4 protein promoted the expansion of human T cells in NOD-scid IL2R(null) immune deficient mice adoptively pre-transferred with peripheral blood mononuclear cells from subjects with CLL.CONCLUSION: GIFT4 has potent capability to converts primary CLL cells into APC-like immune helper cells that initiate a T cell driven anti-CLL immune response.",27118475_9,0,1,-1,-1,28710,-1,3.4901837e-05,0.9999473,1.7794793e-05
28713,blood,24,25,174,179,"Furthermore, administration of GIFT4 protein promoted the expansion of human T cells in NOD-scid IL2R(null) immune deficient mice adoptively pre-transferred with peripheral blood mononuclear cells from subjects with CLL.CONCLUSION: GIFT4 has potent capability to converts primary CLL cells into APC-like immune helper cells that initiate a T cell driven anti-CLL immune response.",27118475_9,0,1,-1,-1,28713,-1,6.879841e-05,0.99979645,0.00013472604
28717,helper cells that,44,47,312,329,"Furthermore, administration of GIFT4 protein promoted the expansion of human T cells in NOD-scid IL2R(null) immune deficient mice adoptively pre-transferred with peripheral blood mononuclear cells from subjects with CLL.CONCLUSION: GIFT4 has potent capability to converts primary CLL cells into APC-like immune helper cells that initiate a T cell driven anti-CLL immune response.",27118475_9,-1,-1,-1,-1,28717,-1,0.0016459179,0.023374835,0.97497934
28721,T-helper-cell,4,5,28,41,We propose that deregulated T-helper-cell (Th) signaling underlies evolving Th17 cytokine expression seen during progression of cutaneous T-cell lymphoma (CTCL).,27144517_0,-1,1,2,-1,28721,-1,0.000961458,0.0145664485,0.984472
28723,Th17 cytokine,11,13,76,89,We propose that deregulated T-helper-cell (Th) signaling underlies evolving Th17 cytokine expression seen during progression of cutaneous T-cell lymphoma (CTCL).,27144517_0,-1,-1,-1,-1,28723,-1,0.10788265,0.88720506,0.0049122768
28724,T-cell,19,20,138,144,We propose that deregulated T-helper-cell (Th) signaling underlies evolving Th17 cytokine expression seen during progression of cutaneous T-cell lymphoma (CTCL).,27144517_0,-1,1,2,-1,28724,-1,6.199726e-05,6.299178e-05,0.99987507
28729,Th17 related cytokines,16,19,118,140,"Though isogenic, indolent and aggressive-stage cell lines had diverged phenotypically, the latter expressing multiple Th17 related cytokines, the former a narrower profile.",27144517_3,-1,-1,-1,-1,28729,-1,0.16294415,0.8241717,0.012884071
28733,Th17 cytokine,8,10,54,67,"Importantly, indolent stage cells remained poised for Th17 cytokine expression, readily inducible by treatment with IL-2 - a cytokine which mitigates Th17 differentiation in mice.",27144517_4,-1,-1,-1,-1,28733,-1,0.102958895,0.89221185,0.0048291935
28744,cells to,9,11,58,66,"Like IL-2 treatment, SOCS1 knockdown drove indolent stage cells to mimic key aggressive stage properties, notably IL17F upregulation.",27144517_7,-1,-1,-1,-1,28744,-1,0.0031259372,0.11839807,0.87847596
28751,therapeutic target,25,27,182,200,"Collectively, our results show how JAK/STAT pathway mutations contribute to disease progression in CTCL cells by potentiating inflammatory cytokine signaling, widening the potential therapeutic target range for this intractable entity.",27144517_9,-1,-1,-1,-1,28751,-1,3.0788582e-05,0.99995613,1.3037487e-05
28756,testing their,19,21,134,147,MAC-1/2A cells also provide a candidate human Th17 laboratory model for identifying potentally actionable CTCL markers or targets and testing their druggability in vitro.,27144517_10,-1,-1,-1,-1,28756,-1,2.1816772e-05,0.99996793,1.0297163e-05
28764,these tumours,21,23,144,157,"Within the lesions, all of the early papillomavirus genes are expressed and promote the excessive replication of fibroblasts which characterise these tumours.",27160146_1,-1,-1,-1,-1,28764,-1,2.6223373e-05,0.9999534,2.044414e-05
28765,the natural,10,12,68,79,"Equine sarcoids differ from BPV induced fibro-papillomas of cattle (the natural host of BPV), in that they do not produce high amounts of virus particles, do not usually regress spontaneously and do not sero-convert to BPV; features which suggest that affected horses lack an effective anti-viral immune response to BPV.",27160146_2,-1,-1,-1,-1,28765,-1,3.6160513e-05,0.9999504,1.3409908e-05
28766,that they,18,20,97,106,"Equine sarcoids differ from BPV induced fibro-papillomas of cattle (the natural host of BPV), in that they do not produce high amounts of virus particles, do not usually regress spontaneously and do not sero-convert to BPV; features which suggest that affected horses lack an effective anti-viral immune response to BPV.",27160146_2,-1,-1,-1,-1,28766,-1,2.5600992e-05,0.9999583,1.6147822e-05
28769,immune response to,51,54,297,315,"Equine sarcoids differ from BPV induced fibro-papillomas of cattle (the natural host of BPV), in that they do not produce high amounts of virus particles, do not usually regress spontaneously and do not sero-convert to BPV; features which suggest that affected horses lack an effective anti-viral immune response to BPV.",27160146_2,-1,-1,-1,-1,28769,-1,0.82094467,0.1755716,0.003483806
28770,T-cells,14,15,65,72,"Equine sarcoids contain large numbers of CD4+CD8+dual positive T-cells which uniformly express FOXP3, the key transcription factor of regulatory T-cells, and FOXP3 is also expressed within the BPV infected fibroblasts.",27160146_3,-1,1,2,-1,28770,-1,3.3778848e-05,6.404856e-05,0.99990225
28781,cytokine TGF,15,17,100,113,"Compared to healthy skin, sarcoids showed increased mRNA transcription for FOXP3 and the regulatory cytokine TGF.",27160146_4,-1,-1,-1,-1,28781,-1,0.861874,0.1348334,0.0032925687
28785,function,12,13,65,73,"Transcription of IL17, which has been shown to have a regulatory function in human papillomavirus-associated tumours, was also elevated in equine sarcoids compared to spleen.",27160146_5,0,1,2,-1,28785,-1,4.4664022e-05,0.99993026,2.5102008e-05
28790,T cell cytokines,10,13,57,73,"In contrast, the levels of mRNA transcripts for effector T cell cytokines IL2, IL4 and interferon-gamma (IFN) were not elevated in sarcoids compared to healthy skin or spleen.",27160146_6,-1,-1,-1,-1,28790,-1,0.044746518,0.0010221392,0.95423126
28800,that the,2,4,11,19,We suggest that the regulatory cytokine micro-environment within sarcoids enables the persistence of the lesions by preventing an effective anti-viral immune response.,27160146_8,-1,-1,-1,-1,28800,-1,1.7590673e-05,0.9999746,7.7906425e-06
28807,that Th17 cells,4,7,21,36,It has been reported that Th17 cells as a newly identified subset of CD4(+) T cells are involved in the pathogenesis of several hematological disorders.,27176825_1,-1,-1,-1,-1,28807,-1,0.0041667065,0.67462456,0.32120878
28812,Th17 cells,5,7,21,31,"However, the role of Th17 cells in the pathophysiology of B-ALL is still unclear.",27176825_2,-1,-1,-1,-1,28812,-1,0.000587906,0.011374981,0.9880371
28817,blood,15,16,88,93,METHODS: The frequencies of T cells were determined by flow cytometry in the peripheral blood and bone marrow of 44 newly diagnosed B-ALL patients and 25 age-matched healthy donors.,27176825_3,0,1,-1,-1,28817,-1,0.00017622799,0.9974903,0.0023334997
28818,The cell,0,2,0,8,"The cell viability and apoptosis were determined by CCK-8 assay and Annexin V staining, respectively.",27176825_4,-1,-1,-1,-1,28818,-1,0.0042988663,0.41994125,0.5757598
28822,Th17 cells,11,13,73,83,RESULTS: We assessed and observed a significantly increased frequency of Th17 cells and a drastically decreased frequency of Th1 cells in peripheral blood mononuclear cells and bone marrow mononuclear cells from newly diagnosed B-ALL patients compared with healthy donors.,27176825_6,-1,-1,-1,-1,28822,-1,0.00074340764,0.015274436,0.98398215
28824,blood,23,24,149,154,RESULTS: We assessed and observed a significantly increased frequency of Th17 cells and a drastically decreased frequency of Th1 cells in peripheral blood mononuclear cells and bone marrow mononuclear cells from newly diagnosed B-ALL patients compared with healthy donors.,27176825_6,0,1,-1,-1,28824,-1,0.00019479568,0.99934286,0.0004623786
28827,Th17-related cytokines,5,7,33,55,"Furthermore, increased levels of Th17-related cytokines including IL-17, IL-21, IL-23, IL-1, and IL-6 were presented in between blood and marrow in B-ALL patients.",27176825_7,-1,-1,-1,-1,28827,-1,0.03998279,0.95383066,0.0061865486
28831,blood,22,23,129,134,"Furthermore, increased levels of Th17-related cytokines including IL-17, IL-21, IL-23, IL-1, and IL-6 were presented in between blood and marrow in B-ALL patients.",27176825_7,0,1,-1,-1,28831,-1,6.350501e-05,0.9997899,0.00014662597
28833,two Th17-secreted cytokines,5,8,23,50,"Both IL-17A and IL-21, two Th17-secreted cytokines, induced the proliferation of B-ALL cell line Nalm-6 and patient B-ALL cells isolated from B-ALL patients, herein either cytokine led to the phosphorylation of Akt and Stat3.",27176825_8,-1,-1,-1,-1,28833,-1,0.1571337,0.8365373,0.006328978
28839,to the,30,32,185,191,"Both IL-17A and IL-21, two Th17-secreted cytokines, induced the proliferation of B-ALL cell line Nalm-6 and patient B-ALL cells isolated from B-ALL patients, herein either cytokine led to the phosphorylation of Akt and Stat3.",27176825_8,-1,-1,-1,-1,28839,-1,2.0503105e-05,0.9999695,1.0036835e-05
28847,Th17 cells,7,9,48,58,CONCLUSIONS: Our findings suggest that elevated Th17 cells secrete IL-17A by which promotes the proliferation and resistance to daunorubicin in B-ALL cells through activation of Akt signaling.,27176825_10,-1,-1,-1,-1,28847,-1,0.0009516649,0.0315216,0.9675268
28851,cells through,22,24,150,163,CONCLUSIONS: Our findings suggest that elevated Th17 cells secrete IL-17A by which promotes the proliferation and resistance to daunorubicin in B-ALL cells through activation of Akt signaling.,27176825_10,-1,-1,-1,-1,28851,-1,0.003480964,0.12862067,0.8678984
28852,Th17 cells,0,2,0,10,Th17 cells may represent a novel target to improve B-ALL immunotherapy.,27176825_11,-1,-1,-1,-1,28852,-1,0.0005844168,0.008342362,0.9910732
28853,target to,6,8,33,42,Th17 cells may represent a novel target to improve B-ALL immunotherapy.,27176825_11,-1,-1,-1,-1,28853,-1,2.604425e-05,0.9999639,1.0041835e-05
28858,functions,10,11,46,55,FoxP3+ regulatory T (Treg) cells have diverse functions in the suppression of antitumor immunity.,27177223_0,0,1,2,-1,28858,-1,0.00011101463,0.99981385,7.518183e-05
28860,immunity,16,17,88,96,FoxP3+ regulatory T (Treg) cells have diverse functions in the suppression of antitumor immunity.,27177223_0,0,-1,2,-1,28860,-1,0.99884915,0.00081955036,0.0003313156
28861,that FoxP3hiCD45RA-CD4,2,4,8,30,"We show that FoxP3hiCD45RA-CD4+ Treg cells [activated Treg (aTreg) cells] are the predominant cell population among tumor-infiltrating FoxP3+ T cells, and that high aTreg cell-infiltrating content is associated with reduced survival in patients with head and neck squamous cell carcinoma (HNSCC).",27177223_1,-1,-1,-1,-1,28861,-1,0.000885109,0.9881684,0.010946484
28867,tumor-infiltrating FoxP3,21,23,116,140,"We show that FoxP3hiCD45RA-CD4+ Treg cells [activated Treg (aTreg) cells] are the predominant cell population among tumor-infiltrating FoxP3+ T cells, and that high aTreg cell-infiltrating content is associated with reduced survival in patients with head and neck squamous cell carcinoma (HNSCC).",27177223_1,-1,-1,-1,-1,28867,-1,3.027338e-05,0.9999554,1.4292838e-05
28874,tumor-associated antigen,10,12,65,89,In vitro studies have demonstrated that aTreg cells can suppress tumor-associated antigen (TAA) effector T cell immune responses in HNSCC.,27177223_2,-1,-1,-1,-1,28874,-1,0.041956272,0.9546176,0.0034260338
28876,T cell immune responses,16,20,105,128,In vitro studies have demonstrated that aTreg cells can suppress tumor-associated antigen (TAA) effector T cell immune responses in HNSCC.,27177223_2,-1,-1,-1,-1,28876,-1,0.27541897,0.0038023698,0.72077864
28877,chemokine receptor,3,5,14,32,"Moreover, C-C chemokine receptor 4 (CCR4) was specifically expressed by aTreg cells in the peripheral blood of HNSCC patients.",27177223_3,-1,-1,-1,-1,28877,-1,0.48169443,0.0032272644,0.51507837
28880,blood,18,19,102,107,"Moreover, C-C chemokine receptor 4 (CCR4) was specifically expressed by aTreg cells in the peripheral blood of HNSCC patients.",27177223_3,0,1,-1,-1,28880,-1,0.00022919479,0.9980538,0.0017170818
28882,that monocyte chemoattractant protein-1,10,14,61,100,"Using a RayBiotech human chemokine antibody array, we showed that monocyte chemoattractant protein-1 (MCP-1), an endogenous CCR4-binding ligand, was specifically upregulated in the HNSCC microenvironment compared to the other four CCR4-binding ligands.",27177223_4,-1,-1,-1,-1,28882,-1,0.006404499,0.97996736,0.013628166
28885,to the,31,33,213,219,"Using a RayBiotech human chemokine antibody array, we showed that monocyte chemoattractant protein-1 (MCP-1), an endogenous CCR4-binding ligand, was specifically upregulated in the HNSCC microenvironment compared to the other four CCR4-binding ligands.",27177223_4,-1,-1,-1,-1,28885,-1,2.4572038e-05,0.9999645,1.1002457e-05
28887,immunity,12,13,102,110,"Blocking MCP-1/CCR4 signaling-induced aTreg cell recruitment using a CCR4 antagonist evoked antitumor immunity in mice, and lead to inhibition of tumor growth and prolonged survival.",27177223_5,0,-1,2,-1,28887,-1,0.99638176,0.003053335,0.00056486233
28891,cell trafficking,4,6,26,42,"Therefore, blocking aTreg cell trafficking in tumors using CCR4-binding agents may be an effective immunotherapy for HNSCC.",27177223_6,-1,-1,-1,-1,28891,-1,0.0012232526,0.021742547,0.97703415
28893,The tumor,0,2,0,9,"The tumor microenvironment impacts tumor progression and individual cells, including CD4(+) T cells, which have been detected in bladder cancer tissues.",27196763_0,-1,-1,-1,-1,28893,-1,2.254491e-05,0.9999671,1.0332291e-05
28897,tissues,23,24,144,151,"The tumor microenvironment impacts tumor progression and individual cells, including CD4(+) T cells, which have been detected in bladder cancer tissues.",27196763_0,-1,1,2,-1,28897,-1,0.00042332552,0.98900175,0.010574915
28899,these T cells,5,8,30,43,"The detailed mechanism of how these T cells were recruited to the bladder cancer tumor and their impact on bladder cancer progression, however, remains unclear.",27196763_1,-1,-1,-1,-1,28899,-1,0.0024295044,0.13144727,0.86612326
28900,to the,10,12,59,65,"The detailed mechanism of how these T cells were recruited to the bladder cancer tumor and their impact on bladder cancer progression, however, remains unclear.",27196763_1,-1,-1,-1,-1,28900,-1,2.0649826e-05,0.99996746,1.19368715e-05
28905,T cells than,25,28,146,158,"Using a human clinical bladder cancer sample survey and in vitro coculture system, we found that bladder cancer has a greater capacity to recruit T cells than surrounding normal bladder tissues.",27196763_2,-1,-1,-1,-1,28905,-1,0.0016415755,0.036438104,0.9619203
28906,tissues,31,32,186,193,"Using a human clinical bladder cancer sample survey and in vitro coculture system, we found that bladder cancer has a greater capacity to recruit T cells than surrounding normal bladder tissues.",27196763_2,-1,1,2,-1,28906,-1,0.00012211403,0.99904484,0.0008330325
28911,function through,8,10,62,78,"Mechanism dissection revealed that infiltrating T cells might function through secreting the cytokine IL1, which increases the recruitment of T cells to bladder cancer and enhances the bladder cancer androgen receptor (AR) signaling that results in increased bladder cancer cell invasion via upregulation of hypoxia-inducible factor-1 (HIF1)/VEGFa expression.",27196763_4,-1,-1,-1,-1,28911,-1,3.137487e-05,0.9999473,2.1299486e-05
28912,the cytokine IL1,11,14,89,105,"Mechanism dissection revealed that infiltrating T cells might function through secreting the cytokine IL1, which increases the recruitment of T cells to bladder cancer and enhances the bladder cancer androgen receptor (AR) signaling that results in increased bladder cancer cell invasion via upregulation of hypoxia-inducible factor-1 (HIF1)/VEGFa expression.",27196763_4,-1,-1,-1,-1,28912,-1,0.7573504,0.227671,0.014978631
28914,T cells to,20,23,142,152,"Mechanism dissection revealed that infiltrating T cells might function through secreting the cytokine IL1, which increases the recruitment of T cells to bladder cancer and enhances the bladder cancer androgen receptor (AR) signaling that results in increased bladder cancer cell invasion via upregulation of hypoxia-inducible factor-1 (HIF1)/VEGFa expression.",27196763_4,-1,-1,-1,-1,28914,-1,0.0011887244,0.02301701,0.9757943
28916,receptor,31,32,209,217,"Mechanism dissection revealed that infiltrating T cells might function through secreting the cytokine IL1, which increases the recruitment of T cells to bladder cancer and enhances the bladder cancer androgen receptor (AR) signaling that results in increased bladder cancer cell invasion via upregulation of hypoxia-inducible factor-1 (HIF1)/VEGFa expression.",27196763_4,0,1,2,-1,28916,-1,0.00030505075,0.9983347,0.0013602953
28919,factor-1,48,49,326,335,"Mechanism dissection revealed that infiltrating T cells might function through secreting the cytokine IL1, which increases the recruitment of T cells to bladder cancer and enhances the bladder cancer androgen receptor (AR) signaling that results in increased bladder cancer cell invasion via upregulation of hypoxia-inducible factor-1 (HIF1)/VEGFa expression.",27196763_4,0,1,-1,-1,28919,-1,0.00058673334,0.99927336,0.0001399055
28924,T24 cells,10,12,60,69,"Finally, in vivo mouse models of xenografted bladder cancer T24 cells with CD4(+) T cells confirmed in vitro coculture studies and concluded that infiltrating CD4(+) T cells can promote bladder cancer metastasis via modulation of the IL1ARHIF1VEGFa signaling.",27196763_6,-1,-1,-1,-1,28924,-1,0.0017354963,0.16296169,0.83530277
28930,to target this,6,9,45,59,Future clinical trials using small molecules to target this newly identified signaling pathway may facilitate the development of new therapeutic approaches to better suppress bladder cancer metastasis.,27196763_7,-1,-1,-1,-1,28930,-1,2.1355749e-05,0.99996936,9.244989e-06
28941,cytokine IL-15,6,8,58,72,"Among immunotherapeutic strategies, the immunostimulatory cytokine IL-15 could represent a serious candidate for the reactivation of antitumor immunity.",27217584_1,-1,-1,-1,-1,28941,-1,0.9996698,5.6374083e-05,0.0002738161
28943,immunity,18,19,143,151,"Among immunotherapeutic strategies, the immunostimulatory cytokine IL-15 could represent a serious candidate for the reactivation of antitumor immunity.",27217584_1,0,-1,2,-1,28943,-1,0.99723744,0.0018829512,0.00087957265
28949,the IL-15,10,12,51,60,"In this work, we studied the antitumor activity of the IL-15 superagonist receptor-linker-IL-15 (RLI), designed to bypass the need of endogenous IL-15R.",27217584_3,-1,-1,-1,-1,28949,-1,0.6765848,0.31335303,0.0100620985
28950,receptor-linker-IL-15,13,14,74,95,"In this work, we studied the antitumor activity of the IL-15 superagonist receptor-linker-IL-15 (RLI), designed to bypass the need of endogenous IL-15R.",27217584_3,0,1,2,-1,28950,-1,0.5505849,0.110787645,0.3386274
28955,to the,7,9,46,52,RLI consists of human IL-15 covalently linked to the human IL-15R sushi(+) domain.,27217584_4,-1,-1,-1,-1,28955,-1,2.3489909e-05,0.9999645,1.20873265e-05
28973,function,16,17,89,97,RLI could induce a greater accumulation of memory CD8(+) T cells and a stronger effector function in comparison with IL-15.,27217584_8,0,1,2,-1,28973,-1,0.004910986,0.8556552,0.13943382
28975,tumor-infiltrated lymphocytes,4,6,23,52,"Ex vivo stimulation of tumor-infiltrated lymphocytes from 16 patients with renal cell carcinoma demonstrated 56% of a strong tumor-infiltrated lymphocyte reactivation with the combination anti-PD-1/RLI compared with 43 and 6% with RLI or anti-PD-1, respectively.",27217584_9,-1,-1,-1,-1,28975,-1,0.0027429154,0.9048648,0.09239228
28977,tumor-infiltrated lymphocyte,19,21,125,153,"Ex vivo stimulation of tumor-infiltrated lymphocytes from 16 patients with renal cell carcinoma demonstrated 56% of a strong tumor-infiltrated lymphocyte reactivation with the combination anti-PD-1/RLI compared with 43 and 6% with RLI or anti-PD-1, respectively.",27217584_9,-1,-1,-1,-1,28977,-1,0.0034772211,0.84114546,0.15537731
28980,that the,6,8,40,48,"Altogether, this work provides evidence that the sushi-IL-15R/IL-15 fusion protein RLI enhances antitumor activity of anti-PD-1 treatment and is a promising approach to stimulate host immunity.",27217584_10,-1,-1,-1,-1,28980,-1,1.8291308e-05,0.99997306,8.60985e-06
28981,protein,10,11,76,83,"Altogether, this work provides evidence that the sushi-IL-15R/IL-15 fusion protein RLI enhances antitumor activity of anti-PD-1 treatment and is a promising approach to stimulate host immunity.",27217584_10,0,1,-1,-1,28981,-1,3.53054e-05,0.9999273,3.7361664e-05
28984,immunity,26,27,185,193,"Altogether, this work provides evidence that the sushi-IL-15R/IL-15 fusion protein RLI enhances antitumor activity of anti-PD-1 treatment and is a promising approach to stimulate host immunity.",27217584_10,0,-1,2,-1,28984,-1,0.99818414,0.0014961121,0.00031975476
28985,T-cell,1,2,6,12,Adult T-cell leukemia/lymphoma (ATL) develops in human T-cell leukemia virus type 1 (HTLV-1) carriers.,27223899_0,-1,1,2,-1,28985,-1,4.58949e-05,7.700961e-05,0.9998771
28986,T-cell,9,10,55,61,Adult T-cell leukemia/lymphoma (ATL) develops in human T-cell leukemia virus type 1 (HTLV-1) carriers.,27223899_0,-1,1,2,-1,28986,-1,5.566466e-05,0.00010987642,0.9998344
28997,T cells that,22,25,117,129,"Here, we present a new mouse model of acute type ATL that can be generated rapidly by transplanting invitro-induced T cells that have been retrovirally transduced with HBZ and two cooperative genes, BCLxL and AKT, into mice.",27223899_3,-1,-1,-1,-1,28997,-1,0.0016642397,0.03523085,0.963105
29001,these T cells to,6,10,45,61,"Co-transduction of HBZ and BCLxL/AKT allowed these T cells to grow invitro in the absence of cytokines (Flt3-ligand and interleukin-7), which did not occur with any two-gene combination.",27223899_4,-1,-1,-1,-1,29001,-1,0.00015904177,0.9993079,0.000533093
29006,transplanted T cells,1,4,9,29,"Although transplanted T cells were a mixture of cells transduced with different combinations of the genes, tumors that developed in mice were composed of HBZ/BCLxL/AKT triply transduced T cells, showing the synergistic effect of the three genes.",27223899_5,-1,-1,-1,-1,29006,-1,0.0029133246,0.089933455,0.9071532
29007,cells transduced,8,10,48,64,"Although transplanted T cells were a mixture of cells transduced with different combinations of the genes, tumors that developed in mice were composed of HBZ/BCLxL/AKT triply transduced T cells, showing the synergistic effect of the three genes.",27223899_5,-1,-1,-1,-1,29007,-1,0.0024927102,0.06016773,0.93733954
29008,the genes,14,16,96,105,"Although transplanted T cells were a mixture of cells transduced with different combinations of the genes, tumors that developed in mice were composed of HBZ/BCLxL/AKT triply transduced T cells, showing the synergistic effect of the three genes.",27223899_5,-1,-1,-1,-1,29008,-1,4.4707325e-05,0.99993324,2.2013766e-05
29009,tumors that,17,19,107,118,"Although transplanted T cells were a mixture of cells transduced with different combinations of the genes, tumors that developed in mice were composed of HBZ/BCLxL/AKT triply transduced T cells, showing the synergistic effect of the three genes.",27223899_5,-1,-1,-1,-1,29009,-1,2.1394946e-05,0.99996924,9.328613e-06
29010,triply transduced T cells,26,30,168,193,"Although transplanted T cells were a mixture of cells transduced with different combinations of the genes, tumors that developed in mice were composed of HBZ/BCLxL/AKT triply transduced T cells, showing the synergistic effect of the three genes.",27223899_5,-1,-1,-1,-1,29010,-1,0.0049445974,0.5685845,0.4264709
29012,the three genes,36,39,229,244,"Although transplanted T cells were a mixture of cells transduced with different combinations of the genes, tumors that developed in mice were composed of HBZ/BCLxL/AKT triply transduced T cells, showing the synergistic effect of the three genes.",27223899_5,-1,-1,-1,-1,29012,-1,4.3949218e-05,0.99993384,2.224771e-05
29016,tool to,5,7,31,38,"Our model provides a versatile tool to examine the roles of these hits, in collaboration with HBZ, in the development of acute ATL.",27223899_7,-1,-1,-1,-1,29016,-1,2.8963419e-05,0.99995923,1.1752372e-05
29024,T cells that,13,16,68,80,Invariant natural killer T (iNKT) cells are a subset of innate-like T cells that act as important mediators of immune responses.,27226296_0,-1,-1,-1,-1,29024,-1,0.0013289988,0.020477982,0.97819304
29036,that basic helix-loop-helix transcription factor,4,9,16,64,"Here, we report that basic helix-loop-helix transcription factor family, member e40 (Bhlhe40), is an important regulator for IFN- production in iNKT cells.",27226296_3,-1,-1,-1,-1,29036,-1,2.2606126e-05,0.99996173,1.5693116e-05
29051,T-box transcription factor Tbx21,14,18,98,130,Bhlhe40 alone shows no significant effects on Ifng promoter activities but contributes to enhance T-box transcription factor Tbx21 (T-bet)-mediated Ifng promoter activation.,27226296_6,-1,1,2,-1,29051,-1,3.7873888e-05,0.9999199,4.2210137e-05
29053,analysis,2,3,30,38,"Chromatin immunoprecipitation analysis revealed that Bhlhe40 accumulates in the T-box region of the Ifng locus and contributes to histone H3-lysine 9 acetylation of the Ifng locus, which is impaired without T-bet conditions.",27226296_7,0,1,-1,-1,29053,-1,2.3744426e-05,0.999959,1.7304512e-05
29055,the T-box,8,10,76,85,"Chromatin immunoprecipitation analysis revealed that Bhlhe40 accumulates in the T-box region of the Ifng locus and contributes to histone H3-lysine 9 acetylation of the Ifng locus, which is impaired without T-bet conditions.",27226296_7,-1,-1,-1,-1,29055,-1,2.8546892e-05,0.9999552,1.6263588e-05
29056,the Ifng,12,14,96,104,"Chromatin immunoprecipitation analysis revealed that Bhlhe40 accumulates in the T-box region of the Ifng locus and contributes to histone H3-lysine 9 acetylation of the Ifng locus, which is impaired without T-bet conditions.",27226296_7,-1,-1,-1,-1,29056,-1,0.1850042,0.8118342,0.0031616243
29058,the Ifng,23,25,165,173,"Chromatin immunoprecipitation analysis revealed that Bhlhe40 accumulates in the T-box region of the Ifng locus and contributes to histone H3-lysine 9 acetylation of the Ifng locus, which is impaired without T-bet conditions.",27226296_7,-1,-1,-1,-1,29058,-1,0.20244849,0.7944204,0.003131104
29065,T cells play,1,4,3,15, T cells play a critical role in early anti-tumor immunity and perform cytotoxicity via NKG2D for recognition and multiple cytotoxic factors for tumor killing.,27256566_0,-1,-1,-1,-1,29065,-1,0.0012869767,0.03791172,0.96080136
29066,immunity,10,11,52,60, T cells play a critical role in early anti-tumor immunity and perform cytotoxicity via NKG2D for recognition and multiple cytotoxic factors for tumor killing.,27256566_0,0,-1,2,-1,29066,-1,0.9992317,0.0004893817,0.0002789812
29067,factors,21,22,135,142, T cells play a critical role in early anti-tumor immunity and perform cytotoxicity via NKG2D for recognition and multiple cytotoxic factors for tumor killing.,27256566_0,0,1,-1,-1,29067,-1,0.99598134,0.0020593337,0.0019592424
29069,metabolism,8,9,64,74,"Recent studies have demonstrated pivotal roles of mTOR-mediated metabolism in the maturation, differentiation, and effector function of diverse immune cells, including DCs, NK cells, CD4+ T cell subsets, and CD8+ T cells, but the role of mTOR signaling in  T cells is barely known.",27256566_1,0,1,2,-1,29069,-1,6.690795e-05,0.9998307,0.00010233614
29071,function,17,18,124,132,"Recent studies have demonstrated pivotal roles of mTOR-mediated metabolism in the maturation, differentiation, and effector function of diverse immune cells, including DCs, NK cells, CD4+ T cell subsets, and CD8+ T cells, but the role of mTOR signaling in  T cells is barely known.",27256566_1,0,1,2,-1,29071,-1,0.0007549804,0.997479,0.0017659739
29074,CD4+ T cell subsets,29,34,183,202,"Recent studies have demonstrated pivotal roles of mTOR-mediated metabolism in the maturation, differentiation, and effector function of diverse immune cells, including DCs, NK cells, CD4+ T cell subsets, and CD8+ T cells, but the role of mTOR signaling in  T cells is barely known.",27256566_1,-1,-1,-1,-1,29074,-1,7.748977e-05,6.948365e-05,0.999853
29082,tumor cell,25,27,169,179,"Here, we showed that suppressing mTOR signaling in in vitro-expanded V4  T cells via the mechanistic inhibitor rapamycin enhanced their cytotoxicity against multiple tumor cell lines, and these cells performed better tumor-suppressing effects upon adoptive therapy.",27256566_2,-1,-1,-1,-1,29082,-1,0.0044033616,0.53319514,0.46240148
29083,these cells,30,32,191,202,"Here, we showed that suppressing mTOR signaling in in vitro-expanded V4  T cells via the mechanistic inhibitor rapamycin enhanced their cytotoxicity against multiple tumor cell lines, and these cells performed better tumor-suppressing effects upon adoptive therapy.",27256566_2,-1,-1,-1,-1,29083,-1,0.0035939817,0.32875463,0.66765136
29085,therapy,38,39,260,267,"Here, we showed that suppressing mTOR signaling in in vitro-expanded V4  T cells via the mechanistic inhibitor rapamycin enhanced their cytotoxicity against multiple tumor cell lines, and these cells performed better tumor-suppressing effects upon adoptive therapy.",27256566_2,0,1,-1,-1,29085,-1,2.189704e-05,0.99996674,1.1303837e-05
29087,TNF-,14,15,101,106,Further investigation revealed that elevated cytotoxicity was a result of up-regulation of NKG2D and TNF-.,27256566_3,0,1,-1,-1,29087,-1,5.6051438e-05,0.99991906,2.48918e-05
29093,TNF-,18,19,122,127,The inhibition of STAT5 pathways via siRNA interference or a specific inhibitor eliminated the up-regulation of NKG2D and TNF- in rapamycin-treated V4  T cells.,27256566_5,0,1,-1,-1,29093,-1,6.0678365e-05,0.99991834,2.1003887e-05
29097,function,13,14,86,94,These results uncovered an important role of mTOR signaling in the cytotoxic effector function of  T cells and provided a potential strategy to improve  T cell-based cancer immunotherapy.,27256566_6,0,1,2,-1,29097,-1,0.0029762546,0.79694134,0.20008236
29103,Toll-like receptor-myeloid differentiation factor,5,9,29,78,The activation of TLR-MyD88 (Toll-like receptor-myeloid differentiation factor 88) signaling within T cells functions as a potent costimulatory signal that boosts antitumor and antiviral responses.,27267778_0,-1,-1,-1,-1,29103,-1,0.30338925,0.6626363,0.03397453
29104,T cells functions,13,16,100,117,The activation of TLR-MyD88 (Toll-like receptor-myeloid differentiation factor 88) signaling within T cells functions as a potent costimulatory signal that boosts antitumor and antiviral responses.,27267778_0,-1,-1,-1,-1,29104,-1,0.0018415203,0.029351132,0.96880734
29108,gene analysis,3,5,23,36,"We compared microarray gene analysis data between TLR1-TLR2-stimulated and unstimulated T-cell receptor transgenic ""pmel"" and MyD88(-/-) pmel CD8(+) T cells and identified changes in the expression of several TNF family members.",27267778_2,-1,-1,-1,-1,29108,-1,3.3501034e-05,0.9999417,2.480923e-05
29110,T-cell receptor transgenic,10,13,88,114,"We compared microarray gene analysis data between TLR1-TLR2-stimulated and unstimulated T-cell receptor transgenic ""pmel"" and MyD88(-/-) pmel CD8(+) T cells and identified changes in the expression of several TNF family members.",27267778_2,-1,-1,-1,-1,29110,-1,0.00093973737,0.013921842,0.98513836
29113,TNF,32,33,209,212,"We compared microarray gene analysis data between TLR1-TLR2-stimulated and unstimulated T-cell receptor transgenic ""pmel"" and MyD88(-/-) pmel CD8(+) T cells and identified changes in the expression of several TNF family members.",27267778_2,0,1,-1,-1,29113,-1,4.8311267e-05,0.99993265,1.9085646e-05
29119,T cells to TLR1-TLR2,25,29,121,141,"A link between 4-1BB and TLR1-TLR2 signaling in CD8(+) T cells was highlighted by the suboptimal responses of 4-1BB(-/-) T cells to TLR1-TLR2 agonist, but their normal response to CD28 or OX40 costimulation.",27267778_4,-1,-1,-1,-1,29119,-1,0.007588434,0.5182704,0.4741412
29121,to CD28,35,37,177,184,"A link between 4-1BB and TLR1-TLR2 signaling in CD8(+) T cells was highlighted by the suboptimal responses of 4-1BB(-/-) T cells to TLR1-TLR2 agonist, but their normal response to CD28 or OX40 costimulation.",27267778_4,-1,-1,-1,-1,29121,-1,0.0058492995,0.3356998,0.65845084
29123,the TLR1-TLR2,13,15,84,97,Blocking 4-1BB signaling with antibodies also hindered the costimulatory effects of the TLR1-TLR2 agonist.,27267778_5,-1,-1,-1,-1,29123,-1,4.3783923e-05,0.99993753,1.8704315e-05
29126,TLR1-TLR2-stimulated cells,9,11,44,70,"The elevated levels of 4-1BB transcripts in TLR1-TLR2-stimulated cells were not due to increased mRNA stability nor increased histone activation, but instead were associated with increased binding of p65 and c-Jun to two distinct 4-1BB promoter sites.",27267778_6,-1,-1,-1,-1,29126,-1,0.0014260678,0.9433459,0.055228014
29128,to two,34,36,214,220,"The elevated levels of 4-1BB transcripts in TLR1-TLR2-stimulated cells were not due to increased mRNA stability nor increased histone activation, but instead were associated with increased binding of p65 and c-Jun to two distinct 4-1BB promoter sites.",27267778_6,-1,-1,-1,-1,29128,-1,2.3800878e-05,0.9999639,1.2365043e-05
29134,that the,3,5,21,29,These studies reveal that the costimulatory effects of TLR1-TLR2 signaling in CD8(+) T cells are in part mediated by 4-1BB and are important for mounting an effective antitumor immune response.,27267778_8,-1,-1,-1,-1,29134,-1,1.6850996e-05,0.9999747,8.43326e-06
29140,T-cell,9,10,45,51,"BACKGROUND: Regulatory T-cells (Tregs) are a T-cell subpopulation with suppressive capacities, which are specifically attracted by C-C motif chemokine 22 (CCL22).",27272839_0,-1,1,2,-1,29140,-1,2.9705976e-05,4.805106e-05,0.9999223
29149,the Treg-specific transcription factor forkhead,16,21,107,154,MATERIALS AND METHODS: Eighty paraffin-embedded human breast cancer samples were stained for CCL22 and for the Treg-specific transcription factor forkhead box P3 (FOXP3).,27272839_3,-1,-1,-1,-1,29149,-1,2.2385073e-05,0.9999627,1.4923395e-05
29156,the tertiary,7,9,34,46,"Moreover, Treg infiltrated 93% of the tertiary lymphoid structures.",27272839_6,-1,-1,-1,-1,29156,-1,0.00013156082,0.99884725,0.0010211894
29160,the tertiary,10,12,76,88,CCL22 expression positively correlated with FOXP3(+) cell infiltration into the tertiary lymphoid structures.,27272839_7,-1,-1,-1,-1,29160,-1,6.471589e-05,0.99973994,0.00019532019
29161,that CCL22,5,7,36,46,CONCLUSION: Our results demonstrate that CCL22 expression correlates with infiltration by FOXP3(+) cells.,27272839_8,-1,-1,-1,-1,29161,-1,0.54631346,0.43682867,0.016857838
29165,nodal status,8,10,65,77,"Interestingly, Treg presence negatively correlated with positive nodal status.",27272839_9,-1,-1,-1,-1,29165,-1,0.38609114,0.5036854,0.110223465
29166,to their,2,4,12,20,"In addition to their unfavorable role as mediators of evasion from antitumor immune response, Tregs might also have a beneficial role by reducing inflammation thereby limiting early tumor growth and spreading.",27272839_10,-1,-1,-1,-1,29166,-1,2.4665655e-05,0.99996567,9.658499e-06
29170,thereby limiting,25,27,159,175,"In addition to their unfavorable role as mediators of evasion from antitumor immune response, Tregs might also have a beneficial role by reducing inflammation thereby limiting early tumor growth and spreading.",27272839_10,-1,-1,-1,-1,29170,-1,0.00058669166,0.99923956,0.0001738087
29172,Gfi1 plays,0,2,0,10,Gfi1 plays an important role in the development and maintenance of many hematopoietic linage cells.,27284976_0,-1,-1,-1,-1,29172,-1,0.0001676952,0.99960786,0.00022449536
29181,cell subsets,14,16,84,96,We herein demonstrate a critical role of Gfi1 in regulating the development of iNKT cell subsets.,27284976_2,-1,-1,-1,-1,29181,-1,3.5210407e-05,4.147245e-05,0.99992335
29182,the thymus,1,3,3,13,"In the thymus of T cell-specific Gfi1-deficient mice, iNKT cells normally developed up to stage 2, while the number of stage 3 NK1.1pos iNKT cells was significantly reduced.",27284976_3,-1,-1,-1,-1,29182,-1,2.9583012e-05,0.9999362,3.4213077e-05
29183,T cell-specific Gfi1-deficient,4,7,17,47,"In the thymus of T cell-specific Gfi1-deficient mice, iNKT cells normally developed up to stage 2, while the number of stage 3 NK1.1pos iNKT cells was significantly reduced.",27284976_3,-1,-1,-1,-1,29183,-1,0.0014690034,0.006421559,0.9921095
29190,T cell-specific Gfi1-deficient,13,16,84,114,"Furthermore, CD4pos iNKT cells were selectively reduced in the peripheral organs of T cell-specific Gfi1-deficient mice.",27284976_4,-1,-1,-1,-1,29190,-1,0.00064270623,0.0024137194,0.99694353
29192,IFN-and Th2 cytokines,4,7,37,59,"The -GalCer-dependent production of IFN-and Th2 cytokines, but not IL-17A, was severely reduced in T cell-specific Gfi1-deficient mice.",27284976_5,-1,-1,-1,-1,29192,-1,0.9994567,0.00018133964,0.00036191824
29194,T cell-specific Gfi1-deficient,16,19,101,131,"The -GalCer-dependent production of IFN-and Th2 cytokines, but not IL-17A, was severely reduced in T cell-specific Gfi1-deficient mice.",27284976_5,-1,-1,-1,-1,29194,-1,0.00067334424,0.0062123206,0.9931143
29201,function,13,14,88,96,These findings demonstrate the important role of Gfi1 in regulating the development and function of NKT1- and NKT2-type iNKT cell subsets.,27284976_7,0,1,2,-1,29201,-1,6.9529124e-05,0.9998903,4.0132298e-05
29202,cell subsets,19,21,125,137,These findings demonstrate the important role of Gfi1 in regulating the development and function of NKT1- and NKT2-type iNKT cell subsets.,27284976_7,-1,-1,-1,-1,29202,-1,3.474788e-05,3.9501178e-05,0.99992573
29210,plasma IL18,3,5,16,27,"RESULTS: Higher plasma IL18 was associated with longer overall survival (OS), but higher IL18 in pancreatic cancer tissues was associated with shorter OS and increased invasion and metastasis.",27297583_3,-1,-1,-1,-1,29210,-1,0.55081934,0.44136992,0.007810808
29212,tissues,21,22,115,122,"RESULTS: Higher plasma IL18 was associated with longer overall survival (OS), but higher IL18 in pancreatic cancer tissues was associated with shorter OS and increased invasion and metastasis.",27297583_3,-1,1,2,-1,29212,-1,0.00024237928,0.992494,0.007263651
29215,transplanted tumors,13,15,89,108,Recombinant IL18 alone had no antitumor effect in the syngeneic mice with orthotopically transplanted tumors and promoted tumors in immunocompromised mice; it also facilitated immune responses in vitro and in vivo by augmenting the activity of cytotoxic T cells and NK cells in peripheral blood and lymph nodes.,27297583_4,-1,-1,-1,-1,29215,-1,2.6345497e-05,0.9999609,1.2738135e-05
29221,blood,45,46,289,294,Recombinant IL18 alone had no antitumor effect in the syngeneic mice with orthotopically transplanted tumors and promoted tumors in immunocompromised mice; it also facilitated immune responses in vitro and in vivo by augmenting the activity of cytotoxic T cells and NK cells in peripheral blood and lymph nodes.,27297583_4,0,1,-1,-1,29221,-1,0.00026927423,0.99686134,0.0028694056
29225,through the,19,21,104,115,"However, IL18 promoted the proliferation and invasion of pancreatic cancer cells, in vitro and in vivo, through the NF-B pathway.",27297583_5,-1,-1,-1,-1,29225,-1,2.6347603e-05,0.99995697,1.673507e-05
29234,functions,8,9,67,76,CONCLUSIONS: IL18 has both cancer-promoting and cancer-suppressing functions.,27297583_7,0,1,2,-1,29234,-1,5.4775166e-05,0.99990404,4.1146486e-05
29246,functionality,28,29,175,188,"Despite of the potential implications for cancer immunotherapy, conventional approaches using in vitro expanded CD8(+) T cells have suboptimal outcomes, mostly due to loss of functionality from cellular exhaustion.",27306834_0,0,1,2,-1,29246,-1,0.00012127786,0.9997695,0.00010921188
29250,functional,6,7,45,55,"We therefore investigated the phenotypic and functional differences among in vitro activated CD8(+) T cells of three different sources, namely nave (NTeff), memory (MTeff) and tumor-infiltrating lymphocytes (TILeff) from human and mice, to better understand mechanisms behind potent effector functions and potential for overcoming current limitations.",27306834_1,0,1,2,-1,29250,-1,5.2177915e-05,0.9999237,2.4054303e-05
29254,tumor-infiltrating lymphocytes,32,34,177,207,"We therefore investigated the phenotypic and functional differences among in vitro activated CD8(+) T cells of three different sources, namely nave (NTeff), memory (MTeff) and tumor-infiltrating lymphocytes (TILeff) from human and mice, to better understand mechanisms behind potent effector functions and potential for overcoming current limitations.",27306834_1,-1,-1,-1,-1,29254,-1,0.0042995494,0.87478656,0.12091393
29257,functions,49,50,293,302,"We therefore investigated the phenotypic and functional differences among in vitro activated CD8(+) T cells of three different sources, namely nave (NTeff), memory (MTeff) and tumor-infiltrating lymphocytes (TILeff) from human and mice, to better understand mechanisms behind potent effector functions and potential for overcoming current limitations.",27306834_1,0,1,2,-1,29257,-1,0.00020839223,0.9993088,0.00048275533
29262,than those,28,30,186,196,"In line with the greater proliferation activity and longer telomere lengths of NTeff populations, cells of nave origin exhibited significantly less amounts of T cell exhaustion markers than those of MTeff and TILeff, and moreover, acquired distinct expression patterns of memory-promoting transcription factors, T-bet and Eomes, induced in a rapid and sustainable manner.",27306834_2,-1,-1,-1,-1,29262,-1,2.1339487e-05,0.9999629,1.5689662e-05
29271,to tumor-induced,24,26,163,179,"NTeff cells appeared to have lower expression of Foxp1 and were refractory to apoptosis upon TGF- conditioning, implying better survival potential and resistance to tumor-induced immune suppression.",27306834_3,-1,-1,-1,-1,29271,-1,2.9513789e-05,0.9999567,1.3728708e-05
29273,to tumor-specific CTLs,7,10,33,55,"Of CD8(+) T cell pools activated to tumor-specific CTLs, nave cell generated effectors possessed the most potent cytotoxic activity, validating implications for use in rational design of adoptive immunotherapy.",27306834_4,-1,-1,-1,-1,29273,-1,0.0055791414,0.6927596,0.30166125
29274,cell generated,12,14,63,77,"Of CD8(+) T cell pools activated to tumor-specific CTLs, nave cell generated effectors possessed the most potent cytotoxic activity, validating implications for use in rational design of adoptive immunotherapy.",27306834_4,-1,-1,-1,-1,29274,-1,0.00025147953,0.0007932744,0.99895525
29278,functional subsets,14,16,88,106,Distinct metabolic programs support the differentiation of CD4(+) Tcells into separate functional subsets.,27317260_0,-1,-1,-1,-1,29278,-1,0.0020984693,0.027609672,0.97029185
29286,Th9 cell,8,10,61,69,We found that histone deacetylase SIRT1 negatively regulated Th9 cell differentiation.,27317260_2,-1,-1,-1,-1,29286,-1,8.995877e-05,0.00022931809,0.99968076
29287,deficiency,1,2,2,12,"A deficiency of SIRT1 induced by either conditional deletion in mouse CD4(+) Tcells or the use of small interfering RNA (siRNA) in mouse or human Tcells increased IL-9 production, whereas ectopic SIRT1 expression inhibited it.",27317260_3,0,1,-1,-1,29287,-1,0.00013841387,0.9996055,0.00025619075
29292,Th9 cell,4,6,25,33,"Notably, SIRT1 inhibited Th9 cell differentiation that regulated anti-tumor immunity and allergic pulmonary inflammation.",27317260_4,-1,-1,-1,-1,29292,-1,5.3946653e-05,0.00010548844,0.9998405
29294,immunity,10,11,76,84,"Notably, SIRT1 inhibited Th9 cell differentiation that regulated anti-tumor immunity and allergic pulmonary inflammation.",27317260_4,0,-1,2,-1,29294,-1,0.99950075,0.00029563403,0.00020363947
29295,through the,2,4,22,33,Glycolytic activation through the mTOR-hypoxia-inducible factor-1 (HIF1) was required for the differentiation of Th9 cells that conferred protection against tumors and is involved in allergic airway inflammation.,27317260_5,-1,-1,-1,-1,29295,-1,2.135355e-05,0.99996555,1.3095618e-05
29296,factor-1,5,6,57,66,Glycolytic activation through the mTOR-hypoxia-inducible factor-1 (HIF1) was required for the differentiation of Th9 cells that conferred protection against tumors and is involved in allergic airway inflammation.,27317260_5,0,1,-1,-1,29296,-1,0.00017991719,0.9997584,6.166244e-05
29299,Th9 cells that,15,18,115,129,Glycolytic activation through the mTOR-hypoxia-inducible factor-1 (HIF1) was required for the differentiation of Th9 cells that conferred protection against tumors and is involved in allergic airway inflammation.,27317260_5,-1,-1,-1,-1,29299,-1,0.0023881998,0.28474465,0.71286714
29302,Th9 cell,13,15,111,119,"Our results define the essential features of SIRT1-mTOR-HIF1 signaling-coupled glycolytic pathway in inducing Th9 cell differentiation, with implications for metabolic reprogramming as an immunotherapeutic approach.",27317260_6,-1,-1,-1,-1,29302,-1,5.1995805e-05,9.109923e-05,0.99985695
29304,antigen-specific T cells,10,13,69,93,MHC-multimers are reagents used for the detection and enumeration of antigen-specific T cells (ASTs).,27327144_0,-1,-1,-1,-1,29304,-1,0.30587858,0.0033737484,0.6907477
29308,TCR,11,12,64,67,These reagents exploit the mechanism by which T cell receptors (TCR) on cytotoxic CD8 T cells recognize specific antigens in the context of a major histocompatibility complex (MHC) molecule during antigen presentation.,27327144_1,-1,1,2,-1,29308,-1,2.6265963e-05,0.99994445,2.923902e-05
29315,peptide,12,13,94,101,MHC-multimers are fluorescently-labeled dextran polymers that carry MHC Class I molecules and peptide sequences that can be modified to represent specific cognate sequences of the antigen of interest with dextramers having a 10-fold multiplicity of the MHC/peptide combination within a single multimer.,27327144_2,0,-1,2,-1,29315,-1,0.0010716935,0.9976497,0.0012785292
29318,the antigen,24,26,176,187,MHC-multimers are fluorescently-labeled dextran polymers that carry MHC Class I molecules and peptide sequences that can be modified to represent specific cognate sequences of the antigen of interest with dextramers having a 10-fold multiplicity of the MHC/peptide combination within a single multimer.,27327144_2,-1,-1,-1,-1,29318,-1,0.36508226,0.6149057,0.020012032
29323,to the TCR,9,12,77,87,"Since the binding of antigen-specific dextramers mimics antigen presentation to the TCR, the present study sought to determine whether this TCR engagement on the AST was sufficient to elicit a functional T cell response.",27327144_3,-1,-1,-1,-1,29323,-1,3.0535157e-05,0.99994683,2.2662454e-05
29326,this TCR,20,22,135,143,"Since the binding of antigen-specific dextramers mimics antigen presentation to the TCR, the present study sought to determine whether this TCR engagement on the AST was sufficient to elicit a functional T cell response.",27327144_3,-1,-1,-1,-1,29326,-1,2.55161e-05,0.99995375,2.077505e-05
29329,functional T cell,31,34,193,210,"Since the binding of antigen-specific dextramers mimics antigen presentation to the TCR, the present study sought to determine whether this TCR engagement on the AST was sufficient to elicit a functional T cell response.",27327144_3,-1,-1,-1,-1,29329,-1,0.0027486307,0.031160656,0.9660908
29334,blood,21,22,134,139,The effect of binding of CMV specific dextramers on the activation of the NFAT signal transduction cascade was assessed in peripheral blood from bone marrow transplant recipients previously determined to be positive for CMV-ASTs (CASTs).,27327144_4,0,1,-1,-1,29334,-1,5.543147e-05,0.9997954,0.00014923155
29343,functional,7,8,50,60,The NFAT1 activation correlated with a downstream functional response in the form of interferon gamma production.,27327144_7,0,1,2,-1,29343,-1,6.294967e-05,0.99991107,2.5979967e-05
29348,blood,23,24,168,173,"Sample preparation, temperature, and duration of dextramer exposure were important parameters affecting the dextramer-induced NFAT activation with 2h exposure in whole blood at room temperature being the optimal of the conditions tested.",27327144_8,0,1,-1,-1,29348,-1,0.00022965399,0.99814785,0.0016225736
29353,to the,8,10,68,74,Intra- and inter-individual heterogeneity was observed with regards to the NFAT activation in the CASTs.,27327144_9,-1,-1,-1,-1,29353,-1,2.3908138e-05,0.9999676,8.505602e-06
29367,that the,19,21,123,131,"Thus, the data demonstrate that binding of antigen-specific dextramers to ASTs specifically results in activation of NFAT, that the NFAT activation correlates with a downstream functional response and that the response can be heterogeneous.",27327144_12,-1,-1,-1,-1,29367,-1,2.1747548e-05,0.99996567,1.2547157e-05
29368,functional,27,28,177,187,"Thus, the data demonstrate that binding of antigen-specific dextramers to ASTs specifically results in activation of NFAT, that the NFAT activation correlates with a downstream functional response and that the response can be heterogeneous.",27327144_12,0,1,2,-1,29368,-1,0.000113256385,0.9998474,3.935798e-05
29369,that the,30,32,201,209,"Thus, the data demonstrate that binding of antigen-specific dextramers to ASTs specifically results in activation of NFAT, that the NFAT activation correlates with a downstream functional response and that the response can be heterogeneous.",27327144_12,-1,-1,-1,-1,29369,-1,2.159656e-05,0.9999682,1.023853e-05
29370,This functional,0,2,0,15,This functional parameter may provide insight to the issue whether enumeration alone of ASTs is a sufficient parameter to assess an individual's immune status against a specific antigen.,27327144_13,-1,-1,-1,-1,29370,-1,3.5461897e-05,0.9999498,1.4668964e-05
29371,to the,6,8,46,52,This functional parameter may provide insight to the issue whether enumeration alone of ASTs is a sufficient parameter to assess an individual's immune status against a specific antigen.,27327144_13,-1,-1,-1,-1,29371,-1,2.9798683e-05,0.9999608,9.420275e-06
29387,The forkhead,0,2,0,12,The forkhead lineage-transcription factor (FoxP3) was considered for many years to be a highly specific intracellular regulatory marker of CD4+CD25+ T regulatory cells.,27339600_3,-1,-1,-1,-1,29387,-1,2.1307196e-05,0.99996686,1.1800642e-05
29388,factor,3,4,35,41,The forkhead lineage-transcription factor (FoxP3) was considered for many years to be a highly specific intracellular regulatory marker of CD4+CD25+ T regulatory cells.,27339600_3,0,1,-1,-1,29388,-1,2.6611473e-05,0.9999515,2.1856416e-05
29407,that FoxP3,8,10,37,47,"In addition, most studies' report on that FoxP3 expression in all abovementioned cells is related to their status of activation since nave (non-activated cells) were found poorly FoxP3 expressing.",27339600_7,-1,-1,-1,-1,29407,-1,2.1518497e-05,0.9999672,1.128947e-05
29409,related to their status,16,20,90,113,"In addition, most studies' report on that FoxP3 expression in all abovementioned cells is related to their status of activation since nave (non-activated cells) were found poorly FoxP3 expressing.",27339600_7,-1,-1,-1,-1,29409,-1,3.990506e-05,0.9999293,3.0733954e-05
29410,nave,23,24,134,139,"In addition, most studies' report on that FoxP3 expression in all abovementioned cells is related to their status of activation since nave (non-activated cells) were found poorly FoxP3 expressing.",27339600_7,-1,-1,-1,-1,29410,-1,3.1323485e-05,0.9999552,1.3518859e-05
29424,immunity,17,18,100,108,"BACKGROUND: Regulatory T cells (Tregs), particularly the CD4(+)CD25(+)Foxp3(+) Tregs, down regulate immunity and promote tumor cell growth by directly suppressing CD8(+) and CD4(+) T cells.",27389040_0,0,-1,2,-1,29424,-1,0.96483576,0.03405334,0.0011109009
29425,tumor cell,20,22,121,131,"BACKGROUND: Regulatory T cells (Tregs), particularly the CD4(+)CD25(+)Foxp3(+) Tregs, down regulate immunity and promote tumor cell growth by directly suppressing CD8(+) and CD4(+) T cells.",27389040_0,-1,-1,-1,-1,29425,-1,0.003356092,0.29429662,0.7023473
29429,generating interleukin-10,7,9,47,72,"Alternatively they can promote tumor growth by generating interleukin-10 (IL-10) and transforming growth factor  (TGF) in situ, which help tumor cells to evade the immune system.",27389040_1,-1,-1,-1,-1,29429,-1,0.8518917,0.14427683,0.0038315277
29431,transforming growth factor,13,16,85,111,"Alternatively they can promote tumor growth by generating interleukin-10 (IL-10) and transforming growth factor  (TGF) in situ, which help tumor cells to evade the immune system.",27389040_1,-1,-1,-1,-1,29431,-1,0.8412912,0.15218347,0.006525355
29433,tumor cells to,25,28,141,155,"Alternatively they can promote tumor growth by generating interleukin-10 (IL-10) and transforming growth factor  (TGF) in situ, which help tumor cells to evade the immune system.",27389040_1,-1,-1,-1,-1,29433,-1,0.00010241606,0.9997408,0.00015680846
29441,the Tregs,6,8,37,46,"Flow cytometry was used to determine the Tregs levels in the spleen and peripheral blood, and immunohistochemistry was performed to determine the expression levels of TGF and IL-10 in the tumor microenvironment.",27389040_4,-1,-1,-1,-1,29441,-1,1.815518e-05,0.9999721,9.725407e-06
29443,blood,14,15,83,88,"Flow cytometry was used to determine the Tregs levels in the spleen and peripheral blood, and immunohistochemistry was performed to determine the expression levels of TGF and IL-10 in the tumor microenvironment.",27389040_4,0,1,-1,-1,29443,-1,0.0005067855,0.98827785,0.01121536
29448,the tumor,30,32,185,194,"Flow cytometry was used to determine the Tregs levels in the spleen and peripheral blood, and immunohistochemistry was performed to determine the expression levels of TGF and IL-10 in the tumor microenvironment.",27389040_4,-1,-1,-1,-1,29448,-1,1.8476021e-05,0.9999709,1.0587244e-05
29457,that the,5,7,34,42,The flow cytometry results showed that the ratios of CD4(+)CD25(+)Foxp3(+) Tregs to lymphocytes and CD4(+) cells in the spleen and in peripheral blood were significantly decreased after treatment with IFN (P<0.05).,27389040_6,-1,-1,-1,-1,29457,-1,1.7869015e-05,0.9999727,9.403908e-06
29458,Tregs to lymphocytes,11,14,75,95,The flow cytometry results showed that the ratios of CD4(+)CD25(+)Foxp3(+) Tregs to lymphocytes and CD4(+) cells in the spleen and in peripheral blood were significantly decreased after treatment with IFN (P<0.05).,27389040_6,-1,-1,-1,-1,29458,-1,0.002800882,0.7439688,0.2532303
29461,blood,24,25,145,150,The flow cytometry results showed that the ratios of CD4(+)CD25(+)Foxp3(+) Tregs to lymphocytes and CD4(+) cells in the spleen and in peripheral blood were significantly decreased after treatment with IFN (P<0.05).,27389040_6,0,1,-1,-1,29461,-1,0.00018350803,0.9991148,0.0007016178
29466,the tumor,6,8,32,41,"Expression of TGF and IL-10 in the tumor microenvironment in the CT and RT groups was higher compared with the control group (P<0.01), while the expression of TGF and IL-10 in the INF group was not significantly different (P>0.05).CONCLUSIONS: The results show that INF-2b inhibits cancer cell immune evasion by decreasing the levels of CD4(+)CD25(+)Foxp3(+) Tregs and suppressing the expression of TGF and IL-10 in the tumor microenvironment.",27389040_7,-1,-1,-1,-1,29466,-1,1.8784713e-05,0.9999696,1.163158e-05
29481,the tumor,79,81,425,434,"Expression of TGF and IL-10 in the tumor microenvironment in the CT and RT groups was higher compared with the control group (P<0.01), while the expression of TGF and IL-10 in the INF group was not significantly different (P>0.05).CONCLUSIONS: The results show that INF-2b inhibits cancer cell immune evasion by decreasing the levels of CD4(+)CD25(+)Foxp3(+) Tregs and suppressing the expression of TGF and IL-10 in the tumor microenvironment.",27389040_7,-1,-1,-1,-1,29481,-1,1.9229568e-05,0.99996924,1.15412895e-05
29486,that T cell,23,26,121,132,"In the last 15 years, it has become apparent that ovarian cancer is recognized by the immune system, taking into account that T cell infiltration can be associated with increased overall survival.",27420920_0,-1,-1,-1,-1,29486,-1,0.0038301458,0.19175684,0.80441296
29491,that the,26,28,163,171,Several studies indicate that a correct combination of cluster of differentiation 8 and cluster of differentiation 4 T cells is key to fight tumor progression and that the presence of regulatory T cells (Tregs) infiltrating ovarian solid tumors (or present in ascites) is deleterious.,27420920_1,-1,-1,-1,-1,29491,-1,1.9578447e-05,0.99997175,8.702943e-06
29497,tumor necrosis factor receptor,7,11,71,101,"Several markers that characterize Tregs include glucocorticoid-induced tumor necrosis factor receptor, cytotoxic T lymphocyte antigen-4, and forkhead box protein 3 (Foxp3).",27420920_2,-1,-1,-1,-1,29497,-1,0.07611877,0.82918096,0.094700284
29498,cytotoxic T lymphocyte antigen-4,12,16,103,135,"Several markers that characterize Tregs include glucocorticoid-induced tumor necrosis factor receptor, cytotoxic T lymphocyte antigen-4, and forkhead box protein 3 (Foxp3).",27420920_2,-1,-1,-1,-1,29498,-1,0.0014573089,0.00019461886,0.9983481
29500,protein,20,21,154,161,"Several markers that characterize Tregs include glucocorticoid-induced tumor necrosis factor receptor, cytotoxic T lymphocyte antigen-4, and forkhead box protein 3 (Foxp3).",27420920_2,0,1,-1,-1,29500,-1,3.9237842e-05,0.9999174,4.336363e-05
29502,that Tregs,3,5,19,29,Research has shown that Tregs can infiltrate cancerous tissue and contribute to tumor growth by secreting immunosuppressive cytokines such as transforming growth factor beta and interleukin (IL)-10.,27420920_3,-1,-1,-1,-1,29502,-1,1.9955565e-05,0.99996936,1.0651009e-05
29503,tissue,8,9,55,61,Research has shown that Tregs can infiltrate cancerous tissue and contribute to tumor growth by secreting immunosuppressive cytokines such as transforming growth factor beta and interleukin (IL)-10.,27420920_3,-1,1,2,-1,29503,-1,7.571106e-05,0.99928516,0.00063920853
29504,to tumor,11,13,77,85,Research has shown that Tregs can infiltrate cancerous tissue and contribute to tumor growth by secreting immunosuppressive cytokines such as transforming growth factor beta and interleukin (IL)-10.,27420920_3,-1,-1,-1,-1,29504,-1,2.4593804e-05,0.999962,1.3373906e-05
29508,these cells,2,4,13,24,"Importantly, these cells might hamper the efficacy of immunotherapeutic approaches, thus strategies involving depletion or regulation of this population have been proposed and tested in experimental models.",27420920_4,-1,-1,-1,-1,29508,-1,0.00079515687,0.01571643,0.9834885
29515,the relevance,7,9,36,49,"In this Minireview, we will discuss the relevance of Tregs in ovarian cancer and the experimental approaches destined to impair their immunosuppressive effects.",27420920_5,-1,-1,-1,-1,29515,-1,2.109792e-05,0.99996877,1.011385e-05
29524,Th9 cells,9,11,58,67,"However, whether dectin-1 directs DCs to prime antitumour Th9 cells remains unclear.",27492902_1,-1,-1,-1,-1,29524,-1,0.00013625505,0.00039003455,0.99947363
29526,agonists,9,10,45,53,"Here, we show that DCs activated by dectin-1 agonists potently promote naive CD4(+) T cells to differentiate into Th9 cells.",27492902_2,0,1,-1,-1,29526,-1,0.012614674,0.98673844,0.0006468328
29528,T cells to,15,18,84,94,"Here, we show that DCs activated by dectin-1 agonists potently promote naive CD4(+) T cells to differentiate into Th9 cells.",27492902_2,-1,-1,-1,-1,29528,-1,0.0014011683,0.02379955,0.9747993
29529,Th9 cells,20,22,114,123,"Here, we show that DCs activated by dectin-1 agonists potently promote naive CD4(+) T cells to differentiate into Th9 cells.",27492902_2,-1,-1,-1,-1,29529,-1,0.00016110892,0.000557735,0.9992812
29530,their Th9-polarizing,7,9,51,71,Abrogation of dectin-1 in DCs completely abolishes their Th9-polarizing capability in response to dectin-1 agonist curdlan.,27492902_3,-1,-1,-1,-1,29530,-1,5.914994e-05,0.9999118,2.9029683e-05
29532,TNFSF15,7,8,49,56,"Notably, dectin-1 stimulation of DCs upregulates TNFSF15 and OX40L, which are essential for dectin-1-activated DC-induced Th9 cell priming.",27492902_4,0,1,-1,-1,29532,-1,0.00029452352,0.99958235,0.00012315456
29534,Th9 cell,17,19,122,130,"Notably, dectin-1 stimulation of DCs upregulates TNFSF15 and OX40L, which are essential for dectin-1-activated DC-induced Th9 cell priming.",27492902_4,-1,-1,-1,-1,29534,-1,4.184695e-05,7.172916e-05,0.9998864
29537,TNFSF15,21,22,139,146,"Mechanistically, dectin-1 activates Syk, Raf1 and NF-B signalling pathways, resulting in increased p50 and RelB nuclear translocation and TNFSF15 and OX40L expression.",27492902_5,0,1,-1,-1,29537,-1,0.00011218519,0.9998286,5.9191123e-05
29541,Th9 cells,16,18,128,137,"Furthermore, immunization of tumour-bearing mice with dectin-1-activated DCs induces potent antitumour response that depends on Th9 cells and IL-9 induced by dectin-1-activated DCs in vivo.",27492902_6,-1,-1,-1,-1,29541,-1,6.0436665e-05,0.00010336029,0.9998362
29543,Th9 cells,10,12,69,78,Our results identify dectin-1-activated DCs as a powerful inducer of Th9 cells and antitumour immunity and may have important clinical implications.,27492902_7,-1,-1,-1,-1,29543,-1,8.616883e-05,0.00018709121,0.9997267
29544,immunity,14,15,94,102,Our results identify dectin-1-activated DCs as a powerful inducer of Th9 cells and antitumour immunity and may have important clinical implications.,27492902_7,0,-1,2,-1,29544,-1,0.99953973,0.00026638838,0.00019387875
29551,the Treg,9,11,78,86,"Recent studies have revealed considerable heterogeneity and plasticity within the Treg compartment, depending on the immunological context, which may result in Tregs losing their suppressive function in inflammatory environments.",27497235_1,-1,-1,-1,-1,29551,-1,2.2795997e-05,0.99996483,1.2352915e-05
29555,function,27,28,191,199,"Recent studies have revealed considerable heterogeneity and plasticity within the Treg compartment, depending on the immunological context, which may result in Tregs losing their suppressive function in inflammatory environments.",27497235_1,0,1,2,-1,29555,-1,0.0004625342,0.99893624,0.0006012377
29558,immunity,20,21,161,169,We review how dysfunctional Tregs contribute to disease pathogenesis in inflammatory conditions and how inappropriate regulatory responses may hamper protective immunity in the context of infection and cancer.,27497235_2,0,-1,2,-1,29558,-1,0.9995276,0.00027733186,0.0001950399
29561,targeted therapeutically to,7,10,35,62,"We also discuss how Tregs might be targeted therapeutically to re-establish a proper balance between regulatory and effector responses in autoimmunity, infections, and cancer.",27497235_3,-1,-1,-1,-1,29561,-1,2.0192387e-05,0.9999709,8.935484e-06
29563,Th9 cells,2,4,9,18,Th17 and Th9 cells have been demonstrated to possess immune regulatory functions in malignant pleural effusion (MPE).,27535421_0,-1,-1,-1,-1,29563,-1,8.9405665e-05,0.00018124557,0.99972934
29565,functions,11,12,71,80,Th17 and Th9 cells have been demonstrated to possess immune regulatory functions in malignant pleural effusion (MPE).,27535421_0,0,1,2,-1,29565,-1,5.818785e-05,0.9998883,5.352021e-05
29568,function,8,9,54,62,"However, whether IL-17 can affect differentiation and function of Th9 cells in MPE remains unknown.",27535421_1,0,1,2,-1,29568,-1,8.911305e-05,0.99984133,6.958005e-05
29569,Th9 cells,10,12,66,75,"However, whether IL-17 can affect differentiation and function of Th9 cells in MPE remains unknown.",27535421_1,-1,-1,-1,-1,29569,-1,0.0002453281,0.0016594521,0.9980952
29576,Th9 cells,19,21,104,113,"The objective of the present study was to explore the impact of IL-17 on the in vivo differentiation of Th9 cells in relation to Th2 cells in a murine model of MPE, and to explore whether IL-17 inhibits MPE formation via IL-9dependent mechanism.",27535421_2,-1,-1,-1,-1,29576,-1,0.0001458145,0.00050203013,0.99935216
29577,relation to Th2 cells,22,26,117,138,"The objective of the present study was to explore the impact of IL-17 on the in vivo differentiation of Th9 cells in relation to Th2 cells in a murine model of MPE, and to explore whether IL-17 inhibits MPE formation via IL-9dependent mechanism.",27535421_2,-1,-1,-1,-1,29577,-1,0.004224332,0.4071026,0.5886731
29580,that Th9,3,5,13,21,It was found that Th9 and Th2 cells were decreased in MPE from IL-17 -/- mice as compared with wild type mice.,27535421_3,-1,-1,-1,-1,29580,-1,3.415248e-05,0.99993825,2.7571827e-05
29584,IL-17 deficiency,0,2,0,16,"IL-17 deficiency inhibited Th9 and Th2 cell differentiation via suppressing transcription factors IRF4 and GATA-3, respectively.",27535421_4,-1,-1,-1,-1,29584,-1,0.99535525,0.0022107689,0.0024340327
29587,transcription factors IRF4,10,13,76,102,"IL-17 deficiency inhibited Th9 and Th2 cell differentiation via suppressing transcription factors IRF4 and GATA-3, respectively.",27535421_4,-1,-1,-1,-1,29587,-1,2.8474304e-05,0.99993646,3.5024525e-05
29589,IL-17 deficiency,0,2,0,16,"IL-17 deficiency enhanced MPE formation by promoting angiogenesis and proliferation of pleural tumors, and thus accelerated the death of mice bearing MPE.",27535421_5,-1,-1,-1,-1,29589,-1,0.99298406,0.003914256,0.003101702
29590,pleural tumors,11,13,87,101,"IL-17 deficiency enhanced MPE formation by promoting angiogenesis and proliferation of pleural tumors, and thus accelerated the death of mice bearing MPE.",27535421_5,-1,-1,-1,-1,29590,-1,4.7422927e-05,0.99993217,2.035519e-05
29599,that IL-17,7,9,47,57,Our data provide the first definitive evidence that IL-17 promotes the differentiation of Th9 and Th2 cells in MPE.,27535421_7,-1,-1,-1,-1,29599,-1,0.6015188,0.39335686,0.0051243193
29603,that IL-17,4,6,30,40,Our findings also demonstrate that IL-17 inhibits the formation of MPE and improves the survival of mice bearing MPE via an IL-9-dependent mechanism.,27535421_8,-1,-1,-1,-1,29603,-1,0.37729546,0.6183907,0.0043138093
29612,tumor cells,2,4,16,27,HPV 16-positive tumor cells exclusively carry the HPV 16 oncogenes E6 and E7.,27548034_2,-1,-1,-1,-1,29612,-1,0.002944438,0.28352943,0.7135261
29629,blood,4,5,28,33,The frequency of peripheral blood mononuclear cells secreting IFN- and perforin was significantly (P<0.05) increased in HPV-vaccinated versus nonvaccinated volunteers.,27548034_7,0,1,-1,-1,29629,-1,9.914372e-05,0.99960786,0.0002929818
29643,Function,0,1,0,8,Function of dendritic cells (DCs) is impaired by some cancer cells.,27556503_0,0,1,2,-1,29643,-1,6.288996e-05,0.99989104,4.6078556e-05
29648,function,14,15,66,74,"However, the effect of bladder cancer cell (BCC) on phenotype and function of DCs remains unclear.",27556503_1,0,1,2,-1,29648,-1,8.061808e-05,0.9998678,5.153538e-05
29650,blood,7,8,40,45,"In this study, healthy human peripheral blood mononuclear cells (PBMCs) derived DCs were co-cultured with BCC pumc-91 and adriamycin-resistant pumc-91/ADM.",27556503_2,0,1,-1,-1,29650,-1,0.00011298938,0.9994137,0.00047332703
29656,T cell-derived cytokine,11,14,81,104,"Furthermore, co-cultured DCs showed impaired allogeneic T cell proliferation and T cell-derived cytokine secretion.",27556503_5,-1,-1,-1,-1,29656,-1,0.036204595,0.0014625154,0.96233284
29658,Taken together,0,2,0,14,"Taken together, these results suggest BCC may inhibit maturation and function of DCs involving of Jak2/STAT3 pathway, and there may be different mechanisms by which adriamycin-resistant BCC restrains DC function in antitumor immune response.",27556503_8,-1,-1,-1,-1,29658,-1,5.02517e-05,0.9999293,2.0375213e-05
29660,function,11,12,69,77,"Taken together, these results suggest BCC may inhibit maturation and function of DCs involving of Jak2/STAT3 pathway, and there may be different mechanisms by which adriamycin-resistant BCC restrains DC function in antitumor immune response.",27556503_8,0,1,2,-1,29660,-1,5.4145574e-05,0.9999095,3.631773e-05
29662,function,31,32,203,211,"Taken together, these results suggest BCC may inhibit maturation and function of DCs involving of Jak2/STAT3 pathway, and there may be different mechanisms by which adriamycin-resistant BCC restrains DC function in antitumor immune response.",27556503_8,0,1,2,-1,29662,-1,4.303555e-05,0.9999255,3.152129e-05
29665,receptor,3,4,24,32,Killer cell lectin-like receptor subfamily G member 1 (KLRG1) has been found on human memory T lymphocytes.,27557510_0,0,1,2,-1,29665,-1,0.000100865596,0.00020297251,0.99969625
29678,to the,6,8,45,51,Our results indicated KLRG1 might contribute to the impaired antitumor immunity of memory T cells in tumor microenvironment.,27557510_6,-1,-1,-1,-1,29678,-1,2.5710511e-05,0.9999633,1.0959205e-05
29679,immunity,10,11,71,79,Our results indicated KLRG1 might contribute to the impaired antitumor immunity of memory T cells in tumor microenvironment.,27557510_6,0,-1,2,-1,29679,-1,0.9984484,0.0012116376,0.0003399499
29696,the cell subset,7,10,30,45,Regulatory T (Treg) cells and the cell subset secreting IL-17 (Th17) in peripheral blood were detected with flow cytometry.,27584054_1,-1,-1,-1,-1,29696,-1,0.0022050946,0.08614679,0.91164815
29699,blood,17,18,83,88,Regulatory T (Treg) cells and the cell subset secreting IL-17 (Th17) in peripheral blood were detected with flow cytometry.,27584054_1,0,1,-1,-1,29699,-1,0.00011193536,0.9993247,0.000563384
29704,Th17 cell,26,28,157,166,"Serum levels of IL-10 and IL-17 were determined with ELISA, and expression of Foxp3 and RORt was assessed with quantitative real-time PCR.RESULTS: Treg and Th17 cell proportions in peripheral blood in the CLL patients were significantly higher than control.",27584054_2,-1,-1,-1,-1,29704,-1,0.00020704407,0.0010859057,0.99870706
29705,blood,31,32,193,198,"Serum levels of IL-10 and IL-17 were determined with ELISA, and expression of Foxp3 and RORt was assessed with quantitative real-time PCR.RESULTS: Treg and Th17 cell proportions in peripheral blood in the CLL patients were significantly higher than control.",27584054_2,0,1,-1,-1,29705,-1,7.558391e-05,0.9995858,0.00033861373
29718,Th17 cells,13,15,86,96,"Compared with the non-remission group, Treg cells were significantly decreased, while Th17 cells were significantly increased, resulting in decreased Treg/Th17 ratio, in the remission group.",27584054_6,-1,-1,-1,-1,29718,-1,8.876917e-05,0.0002226561,0.9996886
29725,analysis,1,2,12,20,"Correlation analysis showed that, Treg and Th17 cell counts were significantly associated with CD38 and ZAP-70 expression in the CLL patients.",27584054_8,0,1,-1,-1,29725,-1,3.2835993e-05,0.99994063,2.6542728e-05
29728,Th17 cell,7,9,43,52,"Correlation analysis showed that, Treg and Th17 cell counts were significantly associated with CD38 and ZAP-70 expression in the CLL patients.",27584054_8,-1,-1,-1,-1,29728,-1,0.002384837,0.11603403,0.88158107
29732,factors,12,13,86,93,"Moreover, the IL-10/IL-17 ratio was also significantly associated with CLL prognostic factors.",27584054_9,0,1,-1,-1,29732,-1,0.08578367,0.90516007,0.009056315
29740,the cells,7,9,35,44,"However, how MDSCs are induced and the cells from which they arise remains unknown.",27593937_2,-1,-1,-1,-1,29740,-1,0.0038716428,0.31300336,0.68312496
29742,that tumor-derived cytokines,4,7,35,63,"Although studies have demonstrated that tumor-derived cytokines promote MDSC accumulation and activation, little is known regarding the role of the tumor stroma in MDSC accumulation and activation.",27593937_3,-1,-1,-1,-1,29742,-1,0.022022372,0.9765663,0.001411276
29744,the tumor,20,22,144,153,"Although studies have demonstrated that tumor-derived cytokines promote MDSC accumulation and activation, little is known regarding the role of the tumor stroma in MDSC accumulation and activation.",27593937_3,-1,-1,-1,-1,29744,-1,1.9106188e-05,0.9999716,9.241925e-06
29749,cell-derived factor,10,12,71,90,Tumor-associated fibroblasts (TAFs) attracted monocytes by the stromal cell-derived factor (SDF)-1a/CXCR4 pathway and induced their differentiation into MDSCs through interleukin (IL)-6-mediated STAT3 activation.,27593937_5,-1,-1,-1,-1,29749,-1,0.22179991,0.0029529943,0.77524704
29751,through interleukin,20,22,159,178,Tumor-associated fibroblasts (TAFs) attracted monocytes by the stromal cell-derived factor (SDF)-1a/CXCR4 pathway and induced their differentiation into MDSCs through interleukin (IL)-6-mediated STAT3 activation.,27593937_5,-1,-1,-1,-1,29751,-1,0.3257305,0.66540647,0.008862957
29758,function,14,15,100,108,TAF-treated monocytes (T-MDSCs) then impaired T-cell proliferation and altered the phenotype and/or function of T-cells in an STAT3-dependent manner.,27593937_6,0,1,2,-1,29758,-1,0.00035199488,0.99917245,0.0004756147
29759,T-cells,16,17,112,119,TAF-treated monocytes (T-MDSCs) then impaired T-cell proliferation and altered the phenotype and/or function of T-cells in an STAT3-dependent manner.,27593937_6,-1,1,2,-1,29759,-1,3.4286677e-05,4.2543637e-05,0.9999231
29763,functionally,10,11,70,82,"CD11b+ myeloid cells, which resembled T-MDSCs both phenotypically and functionally, were primarily in the peritumoral stroma and a positive association with TAFs in vivo.",27593937_7,0,1,2,-1,29763,-1,9.707723e-05,0.9998616,4.1250976e-05
29771,that TAF-derived cytokines,9,12,44,70,"Together, our results are the first to show that TAF-derived cytokines, such as IL-6 and SDF-1a, can induce MDSC generation and activation and then impair human anti-tumor immune responses, which create favorable conditions for HCC progression.",27593937_10,-1,-1,-1,-1,29771,-1,0.019545984,0.9784556,0.0019984597
29787,cells that,8,10,54,64,Myeloid-derived suppressor cells (MDSCs) are immature cells that do not differentiate into mature myeloid cells.,27601624_0,-1,-1,-1,-1,29787,-1,0.0036046228,0.08165273,0.91474265
29790,function,17,18,135,143,Two major populations of PMN-MDSCs (Ly6GhighLy6ClowGr1highCD11b+) and MO-MDSCs (Ly6G-Ly6ChighGr-1intCD11b+) have an immune suppressive function.,27601624_1,0,1,2,-1,29790,-1,0.00011543683,0.99975556,0.00012900526
29801,that IRF4,6,8,24,33,"In this study, we found that IRF4 expression was remarkably suppressed during the development of MDSCs in the tumor microenvironment.",27601624_4,-1,-1,-1,-1,29801,-1,1.9448862e-05,0.99996674,1.3796519e-05
29803,the tumor,18,20,106,115,"In this study, we found that IRF4 expression was remarkably suppressed during the development of MDSCs in the tumor microenvironment.",27601624_4,-1,-1,-1,-1,29803,-1,1.847713e-05,0.99997187,9.673475e-06
29805,protein,4,5,18,25,"Both the mRNA and protein levels of IRF4 in MDSCs were gradually reduced, depending on the development of tumors in the 4T1 model.",27601624_5,0,1,-1,-1,29805,-1,2.9966632e-05,0.9999448,2.5175086e-05
29819,the total,10,12,64,73,"In contrast, IRF4 overexpression in bone marrow cells inhibited the total numbers of MDSCs, especially PMN-MDSCs.",27601624_8,-1,-1,-1,-1,29819,-1,2.3072686e-05,0.9999634,1.3566033e-05
29826,that IRF4,4,6,22,31,"Finally, we confirmed that IRF4 expression in MDSCs can modulate their activity to inhibit T cell proliferation through IL-10 production and ROS generation, and myeloid-specific deletion of IRF4 leads to the increase of MDSC differentiation.",27601624_10,-1,-1,-1,-1,29826,-1,2.2066926e-05,0.9999591,1.8831079e-05
29829,T cell proliferation through IL-10,15,20,91,125,"Finally, we confirmed that IRF4 expression in MDSCs can modulate their activity to inhibit T cell proliferation through IL-10 production and ROS generation, and myeloid-specific deletion of IRF4 leads to the increase of MDSC differentiation.",27601624_10,-1,-1,-1,-1,29829,-1,0.24409544,0.004061958,0.7518426
29832,to the,31,33,201,207,"Finally, we confirmed that IRF4 expression in MDSCs can modulate their activity to inhibit T cell proliferation through IL-10 production and ROS generation, and myeloid-specific deletion of IRF4 leads to the increase of MDSC differentiation.",27601624_10,-1,-1,-1,-1,29832,-1,1.8784396e-05,0.99996996,1.1208549e-05
29833,that IRF4,4,6,30,39,"Our present findings indicate that IRF4 reduction induced by tumor formation can increase the number of MDSCs, and increases in the IRF4 expression in MDSCs may infringe on the immune-suppressive function of MDSCs.",27601624_11,-1,-1,-1,-1,29833,-1,2.3667273e-05,0.99995744,1.8939832e-05
29836,the IRF4,21,23,128,136,"Our present findings indicate that IRF4 reduction induced by tumor formation can increase the number of MDSCs, and increases in the IRF4 expression in MDSCs may infringe on the immune-suppressive function of MDSCs.",27601624_11,-1,-1,-1,-1,29836,-1,2.5224184e-05,0.99995434,2.0475438e-05
29838,function,31,32,196,204,"Our present findings indicate that IRF4 reduction induced by tumor formation can increase the number of MDSCs, and increases in the IRF4 expression in MDSCs may infringe on the immune-suppressive function of MDSCs.",27601624_11,0,1,2,-1,29838,-1,0.00010892513,0.9997745,0.00011652152
29841,transplantation,27,28,178,193,"The immunogenic tumor dormancy has been demonstrated in animal models of cancer, which can explain clinical observations such as an increased incidence of cancer following organ transplantation.",27603507_0,-1,1,2,-1,29841,-1,2.7926191e-05,0.9999591,1.2901756e-05
29846,related to the,8,11,40,54,"Here, we provide a review of literature related to the contribution of Tregs in tumor dormancy or recurrence.",27603507_2,-1,-1,-1,-1,29846,-1,2.156188e-05,0.999969,9.42668e-06
29855,factors,12,13,70,77,This could be due to a disparity among patients in harboring multiple factors associated with tumor immunoediting and immune evasion mechanisms.,27603507_4,0,1,-1,-1,29855,-1,0.0007813579,0.99902046,0.00019820807
29857,The nature,0,2,0,10,The nature of gut intraepithelial lymphocytes (IELs) lacking antigen receptors remains controversial.,27612641_0,-1,-1,-1,-1,29857,-1,2.4942192e-05,0.9999567,1.838601e-05
29862,to TF,32,34,193,198,"Herein we showed that, in humans and in mice, innate intestinal IELs expressing intracellular CD3 (iCD3(+)) differentiate along an Id2 transcription factor (TF)-independentpathway in response to TF NOTCH1, interleukin-15 (IL-15), and Granzyme B signals.",27612641_1,-1,-1,-1,-1,29862,-1,2.5444691e-05,0.9999646,9.912572e-06
29867,peptide,16,17,106,113,"In NOTCH1-activated human hematopoietic precursors, IL-15 induced Granzyme B, which cleaved NOTCH1 into a peptide lacking transcriptional activity.",27612641_2,0,-1,2,-1,29867,-1,0.00078718277,0.9979639,0.0012488975
29869,target genes,5,7,20,32,"As a result, NOTCH1 target genes indispensable for Tcell differentiation were silenced and precursors were reprogrammed into innate cells with Tcell marks including intracellular CD3 and Tcell rearrangements.",27612641_3,-1,-1,-1,-1,29869,-1,2.4475736e-05,0.99995804,1.7478613e-05
29878,to IL-15,32,34,220,228,"In the intraepithelial lymphoma complicating celiac disease, iCD3(+) innate IELs acquired gain-of-function mutations in Janus kinase 1 or Signal transducer and activator of transcription 3, which enhanced their response to IL-15.",27612641_4,-1,-1,-1,-1,29878,-1,0.9058107,0.09022506,0.0039642192
29879,Tcell-like,4,7,29,40,"Overall we characterized gut Tcell-like innate IELs, deciphered their pathway of differentiation and showed their malignant transformation in celiac disease.",27612641_5,-1,-1,-1,-1,29879,-1,5.2052135e-05,7.728302e-05,0.99987066
29902,factor-,15,16,79,87,"The expression of Forkhead box P3 (Foxp3), interleukin 10, transforming growth factor-, chemokine CC motif ligands 17, 20, and CC chemokine receptor 4 was determined using real-time quantitative polymerase chain reaction.",27614428_2,0,1,-1,-1,29902,-1,0.9997942,0.000104242485,0.00010148956
29904,chemokine receptor,27,29,131,149,"The expression of Forkhead box P3 (Foxp3), interleukin 10, transforming growth factor-, chemokine CC motif ligands 17, 20, and CC chemokine receptor 4 was determined using real-time quantitative polymerase chain reaction.",27614428_2,-1,-1,-1,-1,29904,-1,0.28148985,0.0039207344,0.7145894
29920,the total,14,16,81,90,COX-2 inhibitor did not prevent the progression of tongue SCC and did not reduce the total amount of Tregs.,27614428_7,-1,-1,-1,-1,29920,-1,2.907444e-05,0.99995124,1.9690093e-05
29922,Tregs function,0,2,0,14,"Tregs function at the early stage of the development of tongue SCC, and it may be effective to suppress Tregs at the early stage of tumor progression for the treatment and/or prevention of tongue SCC.",27614428_8,-1,-1,-1,-1,29922,-1,3.0155192e-05,0.99994993,1.9925285e-05
29930,the treatment,29,31,154,167,"Tregs function at the early stage of the development of tongue SCC, and it may be effective to suppress Tregs at the early stage of tumor progression for the treatment and/or prevention of tongue SCC.",27614428_8,-1,-1,-1,-1,29930,-1,3.025181e-05,0.999954,1.5719746e-05
29932,enzymes that,9,11,45,57,"Histone deacetylases (HDACs) are a family of enzymes that influence expression of genes implicated in tumor initiation, progression, and anti-tumor responses.",27614429_0,-1,-1,-1,-1,29932,-1,0.00086796144,0.9770692,0.022062797
29935,to their,2,4,12,20,"In addition to their canonical role in deacetylation of histones, HDACs regulate many non-canonical targets, such as Signal Transducer and Activator of Transcription 3 (STAT3).",27614429_1,-1,-1,-1,-1,29935,-1,2.2692822e-05,0.99996805,9.274596e-06
29939,that tumors,2,4,15,26,"We hypothesize that tumors use epigenetic mechanisms to dysregulate CD1d-mediated antigen presentation, thereby impairing the ability of natural killer T (NKT) cells to recognize and destroy malignant cells.",27614429_2,-1,-1,-1,-1,29939,-1,1.8034058e-05,0.99997306,8.9198975e-06
29946,cells to,24,26,160,168,"We hypothesize that tumors use epigenetic mechanisms to dysregulate CD1d-mediated antigen presentation, thereby impairing the ability of natural killer T (NKT) cells to recognize and destroy malignant cells.",27614429_2,-1,-1,-1,-1,29946,-1,0.0034706062,0.09738867,0.8991407
29949,tumor cells,7,9,46,57,"In this study, we pre-treated CD1d-expressing tumor cells with HDAC inhibitors (HDACi) and assessed CD1d-dependent NKT cell responses to mantle cell lymphoma (MCL).",27614429_3,-1,-1,-1,-1,29949,-1,0.003956363,0.3389273,0.65711635
29962,to the,7,9,43,49,"Mechanistically, we found that HDAC2 binds to the CD1D promoter.",27614429_7,-1,-1,-1,-1,29962,-1,1.8560937e-05,0.99997115,1.0319807e-05
29963,tumor cells,4,6,22,33,Knockdown of HDAC2 in tumor cells resulted in a significant increase in CD1d-mediated antigen presentation.,27614429_8,-1,-1,-1,-1,29963,-1,0.004363809,0.4278682,0.56776804
29975,Taken together,0,2,0,14,"Taken together, our studies demonstrate the efficacy of HDACi in restoring anti-tumor responses to MCL through both cell-intrinsic and cell-extrinsic mechanisms and strongly implicate a role for HDACi in enhancing immune responses to cancer.",27614429_11,-1,-1,-1,-1,29975,-1,3.741995e-05,0.999946,1.6624856e-05
29981,immune responses to,31,34,214,233,"Taken together, our studies demonstrate the efficacy of HDACi in restoring anti-tumor responses to MCL through both cell-intrinsic and cell-extrinsic mechanisms and strongly implicate a role for HDACi in enhancing immune responses to cancer.",27614429_11,-1,-1,-1,-1,29981,-1,0.6604007,0.33686754,0.0027316946
29985,this subset,5,7,23,34,"In our previous study, this subset was detected in tumor-draining lymph nodes (TDLNs) of patients with breast cancer.",27619682_1,-1,-1,-1,-1,29985,-1,0.004233736,0.46641698,0.5293493
29988,their function,5,7,25,39,"As little is known about their function in TDLNs of cancer patients, in this study, their frequency as well as their ability to produce interleukin (IL)-2, IL-10, or interferon (IFN)- were investigated in TDLNs of colorectal cancer (CRC) patients.",27619682_2,-1,-1,-1,-1,29988,-1,2.2142463e-05,0.999967,1.0874767e-05
30013,IFN--producing cells than,11,14,74,100,"Moreover, CD4+CD25-FoxP3+ cells contained higher percentages of IL-2- and IFN--producing cells than CD4+CD25+FoxP3+ subpopulation.",27619682_7,-1,-1,-1,-1,30013,-1,0.9898756,0.0045423517,0.0055819643
30014,two subsets,7,9,36,47,"But, no difference was seen between two subsets in terms of IL-10 production.",27619682_8,-1,-1,-1,-1,30014,-1,0.005805201,0.4054437,0.5887511
30021,TSLP,4,5,30,34,Thymic stromal lymphopoietin (TSLP) activates dendritic cells to induce Th2-mediated inflammation.,27634769_0,0,1,-1,-1,30021,-1,0.00018034202,0.99969554,0.00012409652
30022,cells to,8,10,56,64,Thymic stromal lymphopoietin (TSLP) activates dendritic cells to induce Th2-mediated inflammation.,27634769_0,-1,-1,-1,-1,30022,-1,0.004245793,0.10954502,0.8862092
30024,protein,5,6,35,42,"Periostin, an extracellular matrix protein produced by fibroblasts, induces chronic inflammation by stimulating TSLP production.",27634769_1,0,1,-1,-1,30024,-1,0.6528811,0.26035625,0.08676265
30025,TSLP,15,16,112,116,"Periostin, an extracellular matrix protein produced by fibroblasts, induces chronic inflammation by stimulating TSLP production.",27634769_1,0,1,-1,-1,30025,-1,8.511659e-05,0.9998598,5.5102086e-05
30026,Th2-type immune responses,6,9,38,63,"Recently, a reinforcing cycle linking Th2-type immune responses with periostin-induced keratinocyte activation has been proposed in atopic dermatitis pathogenesis.",27634769_2,-1,-1,-1,-1,30026,-1,0.037745073,0.96094215,0.0013128165
30029,TSLP,9,10,43,47,"In this study, we investigated the role of TSLP and periostin in the development of cutaneous T-cell lymphoma (CTCL), where Th2 cytokines and chemokines are also dominant.",27634769_3,0,1,-1,-1,30029,-1,4.1900315e-05,0.99992585,3.221973e-05
30031,T-cell,17,18,94,100,"In this study, we investigated the role of TSLP and periostin in the development of cutaneous T-cell lymphoma (CTCL), where Th2 cytokines and chemokines are also dominant.",27634769_3,-1,1,2,-1,30031,-1,4.940518e-05,5.989337e-05,0.9998908
30032,Th2 cytokines,24,26,124,137,"In this study, we investigated the role of TSLP and periostin in the development of cutaneous T-cell lymphoma (CTCL), where Th2 cytokines and chemokines are also dominant.",27634769_3,-1,-1,-1,-1,30032,-1,0.17334414,0.81752497,0.009130872
30034,TSLP,0,1,0,4,"TSLP and periostin mRNA expression levels were elevated in CTCL lesional skin, both of which correlated with IL4 expression levels.",27634769_4,0,1,-1,-1,30034,-1,7.8734345e-05,0.9998362,8.4990235e-05
30036,than those,27,29,166,176,"In vitro and ex vivo, IL4 or IL13 stimulated periostin expression by dermal fibroblasts, and fibroblasts from CTCL lesional skin expressed higher levels of periostin than those from control skin.",27634769_5,-1,-1,-1,-1,30036,-1,2.4146688e-05,0.99995947,1.6336986e-05
30037,than those,10,12,71,81,Serum periostin levels of CTCL patients were also significantly higher than those of healthy individuals.,27634769_6,-1,-1,-1,-1,30037,-1,2.4446867e-05,0.9999604,1.5143343e-05
30039,blood,10,11,46,51,"Hut78 and MJ, CTCL cell lines, and peripheral blood mononuclear cells from leukemic CTCL patients expressed the TSLP receptor.",27634769_7,0,1,-1,-1,30039,-1,0.0004515253,0.99527115,0.004277347
30041,the TSLP receptor,18,21,108,125,"Hut78 and MJ, CTCL cell lines, and peripheral blood mononuclear cells from leukemic CTCL patients expressed the TSLP receptor.",27634769_7,-1,-1,-1,-1,30041,-1,0.00073829794,0.9870548,0.012206915
30042,TSLP,0,1,0,4,TSLP induced production of IL4 and IL13 by Hut78 and MJ cells through the activation of STAT5.,27634769_8,0,1,-1,-1,30042,-1,7.9778445e-05,0.9998456,7.455789e-05
30044,cells through the,11,14,56,73,TSLP induced production of IL4 and IL13 by Hut78 and MJ cells through the activation of STAT5.,27634769_8,-1,-1,-1,-1,30044,-1,0.004866501,0.37911054,0.616023
30046,TSLP,2,3,10,14,"Moreover, TSLP induced proliferation of CTCL cells both in vitro and in vivo These data suggest that periostin-mediated TSLP production by keratinocytes directly stimulates CTCL tumor cell growth in addition to inducing a Th2-dominant tumor environment in CTCL.",27634769_9,0,1,-1,-1,30046,-1,8.81845e-05,0.9998448,6.69447e-05
30050,TSLP,19,20,120,124,"Moreover, TSLP induced proliferation of CTCL cells both in vitro and in vivo These data suggest that periostin-mediated TSLP production by keratinocytes directly stimulates CTCL tumor cell growth in addition to inducing a Th2-dominant tumor environment in CTCL.",27634769_9,0,1,-1,-1,30050,-1,8.3108e-05,0.99985313,6.3753396e-05
30051,tumor cell,26,28,178,188,"Moreover, TSLP induced proliferation of CTCL cells both in vitro and in vivo These data suggest that periostin-mediated TSLP production by keratinocytes directly stimulates CTCL tumor cell growth in addition to inducing a Th2-dominant tumor environment in CTCL.",27634769_9,-1,-1,-1,-1,30051,-1,0.004306768,0.18933691,0.8063563
30053,Th2-dominant tumor,34,36,222,240,"Moreover, TSLP induced proliferation of CTCL cells both in vitro and in vivo These data suggest that periostin-mediated TSLP production by keratinocytes directly stimulates CTCL tumor cell growth in addition to inducing a Th2-dominant tumor environment in CTCL.",27634769_9,-1,-1,-1,-1,30053,-1,3.3029064e-05,0.9999411,2.586056e-05
30066,function,13,14,69,77,"Here, we examined the frequency, phenotype, induction mechanism, and function of Tr1 cells in GBM patients.",27644153_2,0,1,2,-1,30066,-1,6.824603e-05,0.9998834,4.8269696e-05
30067,Tr1 cells,15,17,81,90,"Here, we examined the frequency, phenotype, induction mechanism, and function of Tr1 cells in GBM patients.",27644153_2,-1,-1,-1,-1,30067,-1,0.0021029548,0.2463446,0.75155234
30069,Tr1 cells,12,14,87,96,"Compared to healthy controls, GBM patients presented significantly higher frequency of Tr1 cells in peripheral blood.",27644153_3,-1,-1,-1,-1,30069,-1,0.0019226654,0.26076522,0.73731214
30070,blood,16,17,111,116,"Compared to healthy controls, GBM patients presented significantly higher frequency of Tr1 cells in peripheral blood.",27644153_3,0,1,-1,-1,30070,-1,0.00033856803,0.9883008,0.011360647
30071,The Tr1,0,2,0,7,The Tr1 frequency was further elevated in the tumor.,27644153_4,-1,-1,-1,-1,30071,-1,2.4190509e-05,0.9999559,1.9941446e-05
30072,the tumor,7,9,42,51,The Tr1 frequency was further elevated in the tumor.,27644153_4,-1,-1,-1,-1,30072,-1,2.0629672e-05,0.99996865,1.0674635e-05
30073,the Tr1 cells,5,8,30,43,"By surface marker expression, the Tr1 cells were enriched in the antigen-experienced effector/memory cell compartment.",27644153_5,-1,-1,-1,-1,30073,-1,0.0031892299,0.58794487,0.40886587
30074,the antigen-experienced,11,13,61,84,"By surface marker expression, the Tr1 cells were enriched in the antigen-experienced effector/memory cell compartment.",27644153_5,-1,-1,-1,-1,30074,-1,0.062312253,0.9362104,0.0014773757
30076,Tr1 cells,3,5,14,23,A minority of Tr1 cells presented IL-10+TGF-+ double expression.,27644153_6,-1,-1,-1,-1,30076,-1,0.00016964482,0.0026035015,0.9972269
30081,TGF--expressing cells,11,13,77,99,"Interestingly, naive CD4+CD45RA+ T cells could differentiate into IL-10- and TGF--expressing cells, if incubated with tumor-associated macrophages (TAMs) or with macrophages conditioned with primary glioma cells, suggesting that tumor cells and TAMs had a role in inducing Tr1 cells in GBM patients.",27644153_7,-1,-1,-1,-1,30081,-1,0.0046167052,0.8329179,0.16246538
30085,that tumor cells,32,35,225,241,"Interestingly, naive CD4+CD45RA+ T cells could differentiate into IL-10- and TGF--expressing cells, if incubated with tumor-associated macrophages (TAMs) or with macrophages conditioned with primary glioma cells, suggesting that tumor cells and TAMs had a role in inducing Tr1 cells in GBM patients.",27644153_7,-1,-1,-1,-1,30085,-1,0.0048814034,0.774681,0.22043765
30087,Tr1 cells,42,44,274,283,"Interestingly, naive CD4+CD45RA+ T cells could differentiate into IL-10- and TGF--expressing cells, if incubated with tumor-associated macrophages (TAMs) or with macrophages conditioned with primary glioma cells, suggesting that tumor cells and TAMs had a role in inducing Tr1 cells in GBM patients.",27644153_7,-1,-1,-1,-1,30087,-1,0.0017673636,0.0958683,0.9023643
30088,Tr1 cells,2,4,13,22,"Coculture of Tr1 cells with proinflammatory CD4+ T cells resulted in TGF--dependent reduction of interferon gamma (IFN-) and IL-10-dependent reduction of tumor necrosis factor alpha (TNF-), while coculture of Tr1 cells with CD8+ T cells resulted in lower tumor-specific cytotoxicity.",27644153_8,-1,-1,-1,-1,30088,-1,0.00031781514,0.0067996373,0.9928826
30095,TNF-,29,30,185,190,"Coculture of Tr1 cells with proinflammatory CD4+ T cells resulted in TGF--dependent reduction of interferon gamma (IFN-) and IL-10-dependent reduction of tumor necrosis factor alpha (TNF-), while coculture of Tr1 cells with CD8+ T cells resulted in lower tumor-specific cytotoxicity.",27644153_8,0,1,-1,-1,30095,-1,0.00010875919,0.99986637,2.4866338e-05
30096,Tr1 cells,35,37,212,221,"Coculture of Tr1 cells with proinflammatory CD4+ T cells resulted in TGF--dependent reduction of interferon gamma (IFN-) and IL-10-dependent reduction of tumor necrosis factor alpha (TNF-), while coculture of Tr1 cells with CD8+ T cells resulted in lower tumor-specific cytotoxicity.",27644153_8,-1,-1,-1,-1,30096,-1,0.0012744173,0.0915009,0.9072246
30101,Tr1 cells,8,10,56,65,"Together, these results demonstrated an upregulation of Tr1 cells in GBM with anti-inflammatory functions.",27644153_9,-1,-1,-1,-1,30101,-1,0.001112411,0.08291897,0.9159686
30102,functions,14,15,96,105,"Together, these results demonstrated an upregulation of Tr1 cells in GBM with anti-inflammatory functions.",27644153_9,0,1,2,-1,30102,-1,0.00087415654,0.9983358,0.00079009734
30110,treatment targets,17,19,126,143,"Thus, immunosuppression-related signaling, especially that involving immune checkpoint and inflammation, has emerged as novel treatment targets for PAC.",27672267_2,-1,-1,-1,-1,30110,-1,2.7277429e-05,0.9999589,1.3844334e-05
30118,interleukin-12 subunit,11,13,68,90,"IL-35 is a novel heterodimeric and inhibitory cytokine, composed of interleukin-12 subunit alpha (P35) and Epstein-Barr virus -induced gene 3 (EBI3).",27682874_0,-1,-1,-1,-1,30118,-1,0.9941983,0.0032966114,0.0025051415
30121,cell types,11,13,53,63,"IL-35 has been reported to be produced by a range of cell types, especially regulatory T cells, and to exert immunosuppressive effects via the STATx signaling pathway.",27682874_1,-1,-1,-1,-1,30121,-1,4.5115517e-05,7.0677444e-05,0.9998841
30124,the STATx,25,27,139,148,"IL-35 has been reported to be produced by a range of cell types, especially regulatory T cells, and to exert immunosuppressive effects via the STATx signaling pathway.",27682874_1,-1,-1,-1,-1,30124,-1,2.59244e-05,0.99996245,1.1584802e-05
30130,tissues,15,16,86,93,IL-35 mainly expressed in CD4+ T cells in human colorectal cancer tumors and adjacent tissues.,27682874_3,-1,1,2,-1,30130,-1,0.00015205747,0.9981079,0.0017400612
30131,tumor-adjacent tissues,4,6,30,52,Increased IL-35 expression in tumor-adjacent tissues was significantly associated with tumor metastasis.,27682874_4,-1,-1,-1,-1,30131,-1,2.6329742e-05,0.99994457,2.9127808e-05
30142,that Tregs,2,4,12,22,We observed that Tregs obtained from colorectal cancer patients were capable of inducing more IL-35 production.,27682874_8,-1,-1,-1,-1,30142,-1,2.1540658e-05,0.9999685,9.897979e-06
30143,than that,9,11,65,74,"In addition, EBI3 promoter-driven luciferase activity was higher than that of the mock plasmid after IL-35stimulation.",27682874_9,-1,-1,-1,-1,30143,-1,2.4382587e-05,0.99996173,1.3918321e-05
30147,that the,5,7,26,34,"Thus, our study indicates that the high level of IL-35 in colorectal cancer promotes the production of IL-35 via STAT1 and STAT3, which suppresses T cell proliferation and may participate in tumor immunotolerance.",27682874_10,-1,-1,-1,-1,30147,-1,1.7456754e-05,0.99997413,8.415765e-06
30153,receptor that,8,10,44,57,Programmed death-1 (PD-1) is a coinhibitory receptor that downregulates the activity of tumor-infiltrating lymphocytes (TIL) in cancer and of virus-specific T cells in chronic infection.,27683557_0,-1,-1,-1,-1,30153,-1,0.0032042284,0.7312315,0.26556426
30155,tumor-infiltrating lymphocytes,14,16,88,118,Programmed death-1 (PD-1) is a coinhibitory receptor that downregulates the activity of tumor-infiltrating lymphocytes (TIL) in cancer and of virus-specific T cells in chronic infection.,27683557_0,-1,-1,-1,-1,30155,-1,0.003502868,0.87449026,0.12200693
30160,that TGF1,2,4,15,25,"We demonstrate that TGF1 enhances antigen-induced PD-1 expression through SMAD3-dependent, SMAD2-independent transcriptional activation in T cells in vitro and in TILs in vivo The PD-1hi subset seen in CD8+ TILs is absent in Smad3-deficient tumor-specific CD8+ TILs, resulting in enhanced cytokine production by TILs and in draining lymph nodes and antitumor activity.",27683557_2,-1,-1,-1,-1,30160,-1,2.2420398e-05,0.999964,1.3533632e-05
30162,through SMAD3-dependent,8,10,67,90,"We demonstrate that TGF1 enhances antigen-induced PD-1 expression through SMAD3-dependent, SMAD2-independent transcriptional activation in T cells in vitro and in TILs in vivo The PD-1hi subset seen in CD8+ TILs is absent in Smad3-deficient tumor-specific CD8+ TILs, resulting in enhanced cytokine production by TILs and in draining lymph nodes and antitumor activity.",27683557_2,-1,-1,-1,-1,30162,-1,3.2927815e-05,0.9999379,2.9140061e-05
30163,SMAD2-independent transcriptional,11,13,92,125,"We demonstrate that TGF1 enhances antigen-induced PD-1 expression through SMAD3-dependent, SMAD2-independent transcriptional activation in T cells in vitro and in TILs in vivo The PD-1hi subset seen in CD8+ TILs is absent in Smad3-deficient tumor-specific CD8+ TILs, resulting in enhanced cytokine production by TILs and in draining lymph nodes and antitumor activity.",27683557_2,-1,-1,-1,-1,30163,-1,4.2182743e-05,0.9999373,2.0541293e-05
30170,Smad3-deficient tumor-specific,35,37,226,256,"We demonstrate that TGF1 enhances antigen-induced PD-1 expression through SMAD3-dependent, SMAD2-independent transcriptional activation in T cells in vitro and in TILs in vivo The PD-1hi subset seen in CD8+ TILs is absent in Smad3-deficient tumor-specific CD8+ TILs, resulting in enhanced cytokine production by TILs and in draining lymph nodes and antitumor activity.",27683557_2,-1,-1,-1,-1,30170,-1,4.3630254e-05,0.9999379,1.847312e-05
30174,to TGF1,2,4,12,20,"In addition to TGF1's previously known effects on T-cell function, our findings suggest that TGF1 mediates T-cell suppression via PD-1 upregulation in the tumor microenvironment (TME).",27683557_3,-1,-1,-1,-1,30174,-1,2.9687799e-05,0.9999473,2.2946357e-05
30175,T-cell function,9,11,51,66,"In addition to TGF1's previously known effects on T-cell function, our findings suggest that TGF1 mediates T-cell suppression via PD-1 upregulation in the tumor microenvironment (TME).",27683557_3,-1,-1,-1,-1,30175,-1,4.1033036e-05,7.8851415e-05,0.9998801
30176,that TGF1,15,17,89,99,"In addition to TGF1's previously known effects on T-cell function, our findings suggest that TGF1 mediates T-cell suppression via PD-1 upregulation in the tumor microenvironment (TME).",27683557_3,-1,-1,-1,-1,30176,-1,2.6621365e-05,0.9999521,2.1317532e-05
30177,T-cell,18,19,109,115,"In addition to TGF1's previously known effects on T-cell function, our findings suggest that TGF1 mediates T-cell suppression via PD-1 upregulation in the tumor microenvironment (TME).",27683557_3,-1,1,2,-1,30177,-1,3.3434695e-05,4.7371417e-05,0.9999193
30178,the tumor,24,26,153,162,"In addition to TGF1's previously known effects on T-cell function, our findings suggest that TGF1 mediates T-cell suppression via PD-1 upregulation in the tumor microenvironment (TME).",27683557_3,-1,-1,-1,-1,30178,-1,1.8238896e-05,0.9999732,8.559804e-06
30182,TGF-producing cells that,8,11,66,91,They highlight bidirectional cross-talk between effector TILs and TGF-producing cells that upregulates multiple components of the PD-1 signaling pathway to inhibit antitumor immunity.,27683557_4,-1,-1,-1,-1,30182,-1,4.639378e-05,0.9999062,4.7421603e-05
30185,immunity,22,23,175,183,They highlight bidirectional cross-talk between effector TILs and TGF-producing cells that upregulates multiple components of the PD-1 signaling pathway to inhibit antitumor immunity.,27683557_4,0,-1,2,-1,30185,-1,0.99872154,0.0009588791,0.0003196055
30187,receptor,6,7,45,53,"SIGNIFICANCE: Engagement of the coinhibitory receptor PD-1 or its ligand, PD-L1, dramatically inhibits the antitumor function of TILs within the TME.",27683557_5,0,1,2,-1,30187,-1,0.00037150635,0.009459166,0.99016935
30189,function,18,19,117,125,"SIGNIFICANCE: Engagement of the coinhibitory receptor PD-1 or its ligand, PD-L1, dramatically inhibits the antitumor function of TILs within the TME.",27683557_5,0,1,2,-1,30189,-1,0.0001031769,0.999777,0.00011985543
30191,the TME,22,24,141,148,"SIGNIFICANCE: Engagement of the coinhibitory receptor PD-1 or its ligand, PD-L1, dramatically inhibits the antitumor function of TILs within the TME.",27683557_5,-1,-1,-1,-1,30191,-1,2.0208035e-05,0.9999684,1.1360723e-05
30192,function,6,7,49,57,Our findings represent a novel immunosuppressive function of TGF and demonstrate that TGF1 allows tumors to evade host immune responses in part through enhanced SMAD3-mediated PD-1 expression on TILs.,27683557_6,0,1,2,-1,30192,-1,7.9983205e-05,0.99986076,5.9215385e-05
30194,that TGF1,11,13,82,92,Our findings represent a novel immunosuppressive function of TGF and demonstrate that TGF1 allows tumors to evade host immune responses in part through enhanced SMAD3-mediated PD-1 expression on TILs.,27683557_6,-1,-1,-1,-1,30194,-1,2.2894495e-05,0.999961,1.6101056e-05
30195,tumors to,14,16,100,109,Our findings represent a novel immunosuppressive function of TGF and demonstrate that TGF1 allows tumors to evade host immune responses in part through enhanced SMAD3-mediated PD-1 expression on TILs.,27683557_6,-1,-1,-1,-1,30195,-1,1.6246959e-05,0.9999753,8.469671e-06
30216,Tr1 cells,10,12,53,62,"In this study, we investigated the potential role of Tr1 cells in DLBCL.",27704876_4,-1,-1,-1,-1,30216,-1,0.0012726766,0.1093729,0.8893544
30218,to that,4,6,23,30,"We found that compared to that in healthy controls, the frequency of Tr1 cells was significantly increased in DLBCL patients, even during complete remission.",27704876_5,-1,-1,-1,-1,30218,-1,2.3060176e-05,0.9999647,1.2178566e-05
30220,Tr1 cells,13,15,69,78,"We found that compared to that in healthy controls, the frequency of Tr1 cells was significantly increased in DLBCL patients, even during complete remission.",27704876_5,-1,-1,-1,-1,30220,-1,0.0020757343,0.3295653,0.668359
30221,that these Tr1 cells,3,7,21,41,Further study showed that these Tr1 cells were enriched in the CD25low/-Foxp3-CD49b+LAG-3+ fraction and could be developed in vitro from naive CD45RA+ CD4+ T cells.,27704876_6,-1,-1,-1,-1,30221,-1,0.003220063,0.7102665,0.28651345
30229,Tr1 cells,14,16,87,96,"To examine the effect of Tr1 upregulation, we cocultured the enriched in vitro-induced Tr1 cells (iTr1) with autologous primary DLBCL cells and CD3+ T cells and found that iTr1 cells both enhanced the survival of CD20+ DLBCL tumor cells and suppressed the antitumor response of CD3+ T cells through the production of IL-10.",27704876_7,-1,-1,-1,-1,30229,-1,0.0018750386,0.1729048,0.82522017
30235,tumor cells,42,44,225,236,"To examine the effect of Tr1 upregulation, we cocultured the enriched in vitro-induced Tr1 cells (iTr1) with autologous primary DLBCL cells and CD3+ T cells and found that iTr1 cells both enhanced the survival of CD20+ DLBCL tumor cells and suppressed the antitumor response of CD3+ T cells through the production of IL-10.",27704876_7,-1,-1,-1,-1,30235,-1,0.0035949252,0.22587942,0.77052575
30237,T cells through the,52,56,283,302,"To examine the effect of Tr1 upregulation, we cocultured the enriched in vitro-induced Tr1 cells (iTr1) with autologous primary DLBCL cells and CD3+ T cells and found that iTr1 cells both enhanced the survival of CD20+ DLBCL tumor cells and suppressed the antitumor response of CD3+ T cells through the production of IL-10.",27704876_7,-1,-1,-1,-1,30237,-1,0.0034806468,0.12276323,0.8737562
30240,Tr1 cells,7,9,47,56,"Furthermore, the frequency of CD4+Foxp3-IL-10+ Tr1 cells in DLBCL patients during complete remission is directly associated with the risk of relapse.",27704876_8,-1,-1,-1,-1,30240,-1,0.003194842,0.28836134,0.7084438
30245,that Tr1 cells,5,8,34,48,"Together, these results suggested that Tr1 cells contributed to tumor cell maintenance and may serve as a prognostic marker and therapeutic target.",27704876_9,-1,-1,-1,-1,30245,-1,0.0034754763,0.69724244,0.2992821
30246,to tumor cell,9,12,61,74,"Together, these results suggested that Tr1 cells contributed to tumor cell maintenance and may serve as a prognostic marker and therapeutic target.",27704876_9,-1,-1,-1,-1,30246,-1,0.004792787,0.64902896,0.34617823
30247,therapeutic target,21,23,128,146,"Together, these results suggested that Tr1 cells contributed to tumor cell maintenance and may serve as a prognostic marker and therapeutic target.",27704876_9,-1,-1,-1,-1,30247,-1,2.7992646e-05,0.9999584,1.35730825e-05
30254,this immune response,9,12,43,63,"In this study, we address the mechanism of this immune response and its possible clinical significance.",27707838_3,-1,-1,-1,-1,30254,-1,0.09857131,0.9006341,0.0007945419
30260,chemokine release,17,19,100,117,"Isogenic cell lines, which represent DDRD-positive and -negative, were used to study the effects of chemokine release on peripheral blood mononuclear cell (PBMC) migration and the mechanism of immune signaling activation.",27707838_5,-1,-1,-1,-1,30260,-1,0.93260586,0.062927924,0.0044662887
30261,blood,21,22,132,137,"Isogenic cell lines, which represent DDRD-positive and -negative, were used to study the effects of chemokine release on peripheral blood mononuclear cell (PBMC) migration and the mechanism of immune signaling activation.",27707838_5,0,1,-1,-1,30261,-1,0.00021722524,0.9988366,0.0009462725
30267,protein,15,16,101,108,"Finally, we studied the association between the DDRD subtype and expression of the immune-checkpoint protein PD-L1 as detected by IHC.",27707838_6,0,1,-1,-1,30267,-1,7.8933466e-05,0.9997366,0.00018447037
30268,statistical tests,1,3,4,21,All statistical tests were two-sided.,27707838_7,-1,-1,-1,-1,30268,-1,9.8399294e-05,0.9998357,6.582256e-05
30276,the chemokines CXCL10,32,35,163,184,RESULTS: We found that DDRD breast tumors were associated with CD4+ and CD8+ lymphocytic infiltration (Fisher's exact test P < .001) and that DDRD cells expressed the chemokines CXCL10 and CCL5 3.5- to 11.9-fold more than DNA damage response-proficient cells (P < .01).,27707838_8,-1,-1,-1,-1,30276,-1,0.9243899,0.070443854,0.005166304
30280,cells statistically,4,6,29,48,"Conditioned medium from DDRD cells statistically significantly attracted PBMCs when compared with medium from DNA damage response-proficient cells (P < .05), and this was dependent on CXCL10 and CCL5.",27707838_9,-1,-1,-1,-1,30280,-1,0.0032566856,0.082752764,0.91399056
30292,T-cell-mediated,14,15,95,110,Activation of this pathway and associated PD-L1 expression may explain the paradoxical lack of T-cell-mediated cytotoxicity observed in DDRD tumors.,27707838_14,-1,1,2,-1,30292,-1,4.1816704e-05,8.3394116e-05,0.9998747
30300,to therapy,15,17,124,134,"Tumor-associated neutrophils are increasingly recognized for their ability to promote tumor progression, mediate resistance to therapy, and regulate immunosuppression.",27737879_0,-1,-1,-1,-1,30300,-1,4.1099658e-05,0.9999403,1.8648829e-05
30301,that the chemokine receptor,7,11,46,73,"Evidence from various murine models has shown that the chemokine receptor CXCR2 attracts neutrophil into tumors and, therefore, represents a tractable therapeutic target.",27737879_1,-1,-1,-1,-1,30301,-1,0.0014445755,0.9878913,0.010664083
30304,tractable therapeutic target,22,25,141,169,"Evidence from various murine models has shown that the chemokine receptor CXCR2 attracts neutrophil into tumors and, therefore, represents a tractable therapeutic target.",27737879_1,-1,-1,-1,-1,30304,-1,3.0053088e-05,0.9999515,1.846423e-05
30312,that tumor,11,13,60,70,"Using a genetically engineered mouse model of PDA, we found that tumor and stromal cells differentially expressed CXCR2 ligands, with Cxcl5 high in tumor and Cxcl2 high in stroma.",27737879_4,-1,-1,-1,-1,30312,-1,2.106131e-05,0.9999678,1.1074202e-05
30322,functional T cells,8,11,45,63,"In the absence of neutrophils, activated and functional T cells infiltrated pancreatic tumors otherwise devoid of effector T cells.",27737879_7,-1,-1,-1,-1,30322,-1,0.001554181,0.006508572,0.9919373
30328,targeting this,18,20,128,142,"Thus, the CXCR2-ligand axis helps establish an immunosuppressive microenvironment in PDA, highlighting the potential utility of targeting this axis as a novel therapy for this deadly disease.",27737879_8,-1,-1,-1,-1,30328,-1,2.0064783e-05,0.99997056,9.425544e-06
30329,therapy,24,25,159,166,"Thus, the CXCR2-ligand axis helps establish an immunosuppressive microenvironment in PDA, highlighting the potential utility of targeting this axis as a novel therapy for this deadly disease.",27737879_8,0,1,-1,-1,30329,-1,2.75157e-05,0.99995756,1.4906746e-05
30331,Th17 cells,0,2,0,10,"Th17 cells represent a distinct subset of CD4 effector T cells with potent pathogenic qualities, capable of directly mediating tumor cell destruction.",27741090_0,-1,-1,-1,-1,30331,-1,0.0020071384,0.07224741,0.9257454
30334,tumor cell,20,22,127,137,"Th17 cells represent a distinct subset of CD4 effector T cells with potent pathogenic qualities, capable of directly mediating tumor cell destruction.",27741090_0,-1,-1,-1,-1,30334,-1,0.0032511794,0.20017295,0.79657584
30341,the Th17,10,12,51,59,We investigated the effect of in vivo IL-2 on both the Th17 and FoxP3CD4 T-cell compartments in a human model of cancer.,27741090_2,-1,-1,-1,-1,30341,-1,2.669952e-05,0.99996054,1.272588e-05
30342,FoxP3CD4 T-cell,13,15,64,79,We investigated the effect of in vivo IL-2 on both the Th17 and FoxP3CD4 T-cell compartments in a human model of cancer.,27741090_2,-1,-1,-1,-1,30342,-1,0.0029734315,0.79661304,0.20041355
30344,blood,22,23,115,120,"High-dose IL-2 (HDIL-2) was administered at a dose of 720,000 IU/kg to patients with melanoma (n=7) and peripheral blood was collected at baseline and at 24, 48, 72, and 96 hours posttreatment.",27741090_3,0,1,-1,-1,30344,-1,0.00018564031,0.99620783,0.003606505
30345,blood,1,2,11,16,Peripheral blood mononuclear cells (PBMCs) were isolated and subjected to intracellular cytokine and extracellular receptor staining for flow cytometry.,27741090_4,0,1,-1,-1,30345,-1,0.0001315922,0.9993724,0.00049595576
30349,receptor,16,17,115,123,Peripheral blood mononuclear cells (PBMCs) were isolated and subjected to intracellular cytokine and extracellular receptor staining for flow cytometry.,27741090_4,0,1,2,-1,30349,-1,0.000193117,0.0003290766,0.9994778
30351,Th17 cells,11,13,73,83,We report that HDIL-2 increased both frequencies and absolute numbers of Th17 cells on day 4 of treatment.,27741090_5,-1,-1,-1,-1,30351,-1,0.0008011893,0.01715333,0.9820455
30360,the Th17-cell,28,30,185,198,"The administration of HDIL-2 to patients with melanoma increased IL-6 production by peripheral immune cells, a cytokine vital in the downregulation of FoxP3 expression and expansion of the Th17-cell population.",27741090_6,-1,-1,-1,-1,30360,-1,0.002972957,0.85456586,0.14246117
30361,that FoxP3CD4 T cells,4,8,29,50,"Furthermore, we demonstrated that FoxP3CD4 T cells express IL-17 in patients with melanoma undergoing HDIL-2 therapy.",27741090_7,-1,-1,-1,-1,30361,-1,0.003039187,0.8123647,0.18459612
30363,therapy,16,17,109,116,"Furthermore, we demonstrated that FoxP3CD4 T cells express IL-17 in patients with melanoma undergoing HDIL-2 therapy.",27741090_7,0,1,-1,-1,30363,-1,2.5660087e-05,0.99995995,1.4384577e-05
30364,Taken together,0,2,0,14,"Taken together, our findings indicate that HDIL-2 combined with the conditions of malignancy create an immune environment supportive of Th17 differentiation and that expansion of this compartment may occur through the transdifferentiation of IL-17-secreting FoxP3CD4 T cells.",27741090_8,-1,-1,-1,-1,30364,-1,4.2426524e-05,0.99994075,1.685261e-05
30370,through the transdifferentiation,30,33,206,238,"Taken together, our findings indicate that HDIL-2 combined with the conditions of malignancy create an immune environment supportive of Th17 differentiation and that expansion of this compartment may occur through the transdifferentiation of IL-17-secreting FoxP3CD4 T cells.",27741090_8,-1,-1,-1,-1,30370,-1,3.980747e-05,0.9999317,2.8535902e-05
30371,IL-17-secreting FoxP3CD4 T cells,34,38,242,274,"Taken together, our findings indicate that HDIL-2 combined with the conditions of malignancy create an immune environment supportive of Th17 differentiation and that expansion of this compartment may occur through the transdifferentiation of IL-17-secreting FoxP3CD4 T cells.",27741090_8,-1,-1,-1,-1,30371,-1,0.5919987,0.006919476,0.40108177
30377,tissues,17,18,103,110,"Forty-eight cases of colorectal carcinomas, 22 cases of colon polyps and 21 cases of normal colorectal tissues were collected.",27752897_1,-1,1,2,-1,30377,-1,0.00062704866,0.94135517,0.058017764
30384,these three,14,16,76,87,"The correlation among Foxp3, IL-10 and Stat3, and the clinical relevance of these three indexes were analyzed.",27752897_2,-1,-1,-1,-1,30384,-1,4.2486357e-05,0.99993086,2.6595271e-05
30386,that the,3,5,19,27,"The results showed that the levels of Foxp3 expressed in infiltrating CD4+CD25+Foxp3+Tregs, and IL-10 and Stat3 in CRC tissues were all significantly higher than those in polypus tissues and normal colon tissues (P< 0.01).",27752897_3,-1,-1,-1,-1,30386,-1,1.693923e-05,0.99997294,1.011833e-05
30390,tissues,19,20,119,126,"The results showed that the levels of Foxp3 expressed in infiltrating CD4+CD25+Foxp3+Tregs, and IL-10 and Stat3 in CRC tissues were all significantly higher than those in polypus tissues and normal colon tissues (P< 0.01).",27752897_3,-1,1,2,-1,30390,-1,0.0009434796,0.79771435,0.20134217
30391,than those,24,26,157,167,"The results showed that the levels of Foxp3 expressed in infiltrating CD4+CD25+Foxp3+Tregs, and IL-10 and Stat3 in CRC tissues were all significantly higher than those in polypus tissues and normal colon tissues (P< 0.01).",27752897_3,-1,-1,-1,-1,30391,-1,2.260507e-05,0.9999627,1.4672482e-05
30392,tissues,28,29,179,186,"The results showed that the levels of Foxp3 expressed in infiltrating CD4+CD25+Foxp3+Tregs, and IL-10 and Stat3 in CRC tissues were all significantly higher than those in polypus tissues and normal colon tissues (P< 0.01).",27752897_3,-1,1,2,-1,30392,-1,0.00019875327,0.9946791,0.0051221885
30393,tissues,32,33,204,211,"The results showed that the levels of Foxp3 expressed in infiltrating CD4+CD25+Foxp3+Tregs, and IL-10 and Stat3 in CRC tissues were all significantly higher than those in polypus tissues and normal colon tissues (P< 0.01).",27752897_3,-1,1,2,-1,30393,-1,0.0005542799,0.9676032,0.031842556
30394,analysis,2,3,20,28,"Pearson correlation analysis indicated that the expression level of Foxp3 was positively correlated with Stat3 at mRNA level (r=0.526, P=0.036), and was positively correlated with IL-10 at protein level (r=0.314, P=0.030).",27752897_4,0,1,-1,-1,30394,-1,3.8916438e-05,0.99992836,3.2671007e-05
30395,that the,4,6,39,47,"Pearson correlation analysis indicated that the expression level of Foxp3 was positively correlated with Stat3 at mRNA level (r=0.526, P=0.036), and was positively correlated with IL-10 at protein level (r=0.314, P=0.030).",27752897_4,-1,-1,-1,-1,30395,-1,1.777445e-05,0.9999727,9.522746e-06
30399,protein,31,32,189,196,"Pearson correlation analysis indicated that the expression level of Foxp3 was positively correlated with Stat3 at mRNA level (r=0.526, P=0.036), and was positively correlated with IL-10 at protein level (r=0.314, P=0.030).",27752897_4,0,1,-1,-1,30399,-1,6.387546e-05,0.99988234,5.371261e-05
30400,The Foxp3,0,2,0,9,"The Foxp3 expressed in CD4+CD25+Foxp3+Tregs was correlated with the histological grade, lymph node metastasis and TNM stage of CRC (P<0.05 for all).",27752897_5,-1,-1,-1,-1,30400,-1,2.5060686e-05,0.99996126,1.3660779e-05
30403,The IL-10,0,2,0,9,The IL-10 expression was correlated with the histological grade and TNM stage (both P<0.05).,27752897_6,-1,-1,-1,-1,30403,-1,0.81236833,0.18192211,0.0057096286
30406,The Stat3,0,2,0,9,The Stat3 expression was correlated with the lymph node metastasis and TNM stage (both P<0.05).,27752897_7,-1,-1,-1,-1,30406,-1,2.4738758e-05,0.999961,1.43000225e-05
30410,CD4+CD25+Foxp3+Tregs,4,5,22,42,It was concluded that CD4+CD25+Foxp3+Tregs can inhibit tumor immunity in combination with some other related inhibitory cytokines and that Foxp3 expression in CD4+CD25+Foxp3+Tregs correlates with CRC progression.,27752897_8,-1,-1,-1,-1,30410,-1,0.0088401595,0.26228327,0.7288766
30411,tumor immunity,7,9,55,69,It was concluded that CD4+CD25+Foxp3+Tregs can inhibit tumor immunity in combination with some other related inhibitory cytokines and that Foxp3 expression in CD4+CD25+Foxp3+Tregs correlates with CRC progression.,27752897_8,-1,-1,-1,-1,30411,-1,0.0072732707,0.992393,0.0003337414
30414,that Foxp3,18,20,134,144,It was concluded that CD4+CD25+Foxp3+Tregs can inhibit tumor immunity in combination with some other related inhibitory cytokines and that Foxp3 expression in CD4+CD25+Foxp3+Tregs correlates with CRC progression.,27752897_8,-1,-1,-1,-1,30414,-1,2.5705087e-05,0.9999621,1.2257768e-05
30415,CD4+CD25+Foxp3+Tregs,22,23,159,179,It was concluded that CD4+CD25+Foxp3+Tregs can inhibit tumor immunity in combination with some other related inhibitory cytokines and that Foxp3 expression in CD4+CD25+Foxp3+Tregs correlates with CRC progression.,27752897_8,-1,-1,-1,-1,30415,-1,0.009662599,0.25991914,0.7304182
30418,the tumor,11,13,61,70,Regulatory T cells (Tregs) have an immunosuppressive role in the tumor microenvironment.,27756099_0,-1,-1,-1,-1,30418,-1,2.0655312e-05,0.99996996,9.38265e-06
30420,functions,11,12,61,70,"Since effector Tregs (eTregs), which have highly suppressive functions, are located in a subpopulation of Foxp3+ CD4+ Tregs, the TCR-inducible costimulatory receptor (ICOS) was applied as a marker of eTregs that infiltrated gastric cancer tissue and the induction pathway of ICOS+ Foxp3+ cells was analyzed by flow cytometry and immunohistochemistry.",27756099_1,0,1,2,-1,30420,-1,6.146474e-05,0.99989355,4.5005076e-05
30423,the TCR-inducible,25,27,125,142,"Since effector Tregs (eTregs), which have highly suppressive functions, are located in a subpopulation of Foxp3+ CD4+ Tregs, the TCR-inducible costimulatory receptor (ICOS) was applied as a marker of eTregs that infiltrated gastric cancer tissue and the induction pathway of ICOS+ Foxp3+ cells was analyzed by flow cytometry and immunohistochemistry.",27756099_1,-1,-1,-1,-1,30423,-1,2.3726134e-05,0.99996555,1.0735713e-05
30424,receptor,28,29,157,165,"Since effector Tregs (eTregs), which have highly suppressive functions, are located in a subpopulation of Foxp3+ CD4+ Tregs, the TCR-inducible costimulatory receptor (ICOS) was applied as a marker of eTregs that infiltrated gastric cancer tissue and the induction pathway of ICOS+ Foxp3+ cells was analyzed by flow cytometry and immunohistochemistry.",27756099_1,0,1,2,-1,30424,-1,0.00020264655,0.00058170885,0.9992156
30426,tissue,43,44,239,245,"Since effector Tregs (eTregs), which have highly suppressive functions, are located in a subpopulation of Foxp3+ CD4+ Tregs, the TCR-inducible costimulatory receptor (ICOS) was applied as a marker of eTregs that infiltrated gastric cancer tissue and the induction pathway of ICOS+ Foxp3+ cells was analyzed by flow cytometry and immunohistochemistry.",27756099_1,-1,1,2,-1,30426,-1,6.167345e-05,0.99971086,0.00022748395
30430,tumor-infiltrating lymphocytes,1,3,3,33,"In tumor-infiltrating lymphocytes (TILs), ICOS+ Foxp3+ CD4+ T cells were abundantly observed in the late stages of gastric cancer.",27756099_2,-1,-1,-1,-1,30430,-1,0.0036347038,0.8369435,0.15942179
30440,TNF,15,16,71,74,"ICOS+ CD4+ TILs exhibited the ability to produce IL-10, but not IFN-, TNF, or IL-17 and also to suppress the proliferation of CFSE-labeled responder CD8+ T cells.",27756099_3,0,1,-1,-1,30440,-1,0.00010846477,0.999863,2.8429642e-05
30446,protein,4,5,26,33,"With the agonistic ICOS-L protein (rICOS-L Ig), ICOS+ Foxp3+ cells were efficiently induced from naive CD4+ T cells under a stimulation with TGF- and CD3/CD28 mAbs.",27756099_4,0,1,-1,-1,30446,-1,5.8157017e-05,0.9998971,4.4735094e-05
30453,antigenic peptide,12,14,69,86,"Furthermore, when A*0201 PBMCs were cultured with the CMV or Melan-A antigenic peptide and rICOS-L Ig, the induction of CMV or Melan-A tetramer-binding CD8+ T cells, respectively, was inhibited.",27756099_5,-1,-1,-1,-1,30453,-1,0.9771926,0.0025107607,0.020296754
30460,related to plasmacytoid,10,13,51,74,The expression of ICOS in Foxp3+ cells was closely related to plasmacytoid dendritic cells (pDCs) and their expression of ICOS-L and TLR9 as well as Helicobacter pylori infection.,27756099_6,-1,-1,-1,-1,30460,-1,4.087114e-05,0.9999331,2.598376e-05
30466,Treg-targeting therapeutic,15,17,93,119,"Collectively, our results demonstrate the potential of ICOS as a promising target for direct Treg-targeting therapeutic agents for gastric cancer, and that of eradicating therapy for H. pylori as an indirect immune therapy for gastric cancer.",27756099_7,-1,-1,-1,-1,30466,-1,2.6551987e-05,0.9999528,2.0679436e-05
30468,therapy,26,27,171,178,"Collectively, our results demonstrate the potential of ICOS as a promising target for direct Treg-targeting therapeutic agents for gastric cancer, and that of eradicating therapy for H. pylori as an indirect immune therapy for gastric cancer.",27756099_7,0,1,-1,-1,30468,-1,2.7288668e-05,0.9999541,1.8618804e-05
30469,therapy,34,35,215,222,"Collectively, our results demonstrate the potential of ICOS as a promising target for direct Treg-targeting therapeutic agents for gastric cancer, and that of eradicating therapy for H. pylori as an indirect immune therapy for gastric cancer.",27756099_7,0,1,-1,-1,30469,-1,2.663894e-05,0.9999559,1.7424318e-05
30470,the functions,10,12,62,75,An imperative demand is present for a better understanding of the functions and regulations of the immune system and how they affect HCC pathogenesis.,27797409_1,-1,-1,-1,-1,30470,-1,2.7953845e-05,0.99995995,1.2145637e-05
30476,termed Th9 cells,13,16,66,82,"Recently, a group of interleukin 9 (IL-9)-producing CD4+ T cells, termed Th9 cells, has been described in mice and humans with both tumour-inhibiting as well as tumour-promoting effects.",27797409_2,-1,-1,-1,-1,30476,-1,0.0035960744,0.21418798,0.78221595
30480,Th9 cells,4,6,22,31,The specific roles of Th9 cells in human HCC are not entirely understood.,27797409_3,-1,-1,-1,-1,30480,-1,8.341258e-05,0.0002448347,0.9996718
30482,functions,7,8,38,47,"Here, we examined the frequencies and functions of IL-9-producing Th9 cells in HCC patients.",27797409_4,0,1,2,-1,30482,-1,6.8237845e-05,0.9998845,4.7253947e-05
30483,IL-9-producing Th9 cells,9,12,51,75,"Here, we examined the frequencies and functions of IL-9-producing Th9 cells in HCC patients.",27797409_4,-1,-1,-1,-1,30483,-1,0.58901215,0.0037235946,0.40726423
30484,that the,2,4,9,17,We found that the frequencies of circulating IL-9-producing Th9 cells were significantly higher in HCC patients compared to in healthy individuals.,27797409_5,-1,-1,-1,-1,30484,-1,1.7407487e-05,0.99997365,8.904382e-06
30485,IL-9-producing Th9 cells,7,10,45,69,We found that the frequencies of circulating IL-9-producing Th9 cells were significantly higher in HCC patients compared to in healthy individuals.,27797409_5,-1,-1,-1,-1,30485,-1,0.6234189,0.0037309101,0.37285015
30488,IL-9-producing Th9 cells,7,10,36,60,"In HCC patients, the frequencies of IL-9-producing Th9 cells were significantly higher in peritumour and tumour tissues than in unaffected liver tissues.",27797409_6,-1,-1,-1,-1,30488,-1,0.62049186,0.002745557,0.3767626
30489,tumour tissues than,16,19,105,124,"In HCC patients, the frequencies of IL-9-producing Th9 cells were significantly higher in peritumour and tumour tissues than in unaffected liver tissues.",27797409_6,-1,-1,-1,-1,30489,-1,3.118621e-05,0.9999404,2.843352e-05
30490,tissues,22,23,145,152,"In HCC patients, the frequencies of IL-9-producing Th9 cells were significantly higher in peritumour and tumour tissues than in unaffected liver tissues.",27797409_6,-1,1,2,-1,30490,-1,0.00019314443,0.996418,0.0033888677
30491,tumour-infiltrating Th9,6,8,40,63,"Interestingly, HCC patients with higher tumour-infiltrating Th9 frequency had significantly shorter disease-free survival period after resection.",27797409_7,-1,-1,-1,-1,30491,-1,8.096672e-05,0.99986184,5.7130797e-05
30498,tumour cells,17,19,115,127,"We found that incubation of primary HCC cells with autologous Th9 significantly elevated the CCL20 production from tumour cells, which could be partially inhibited by suppressing STAT3.",27797409_10,-1,-1,-1,-1,30498,-1,0.0039294795,0.34257936,0.65349114
30503,Th9 cells,9,11,58,67,"Together, this study suggested a tumour-promoting role of Th9 cells in HCC.",27797409_11,-1,-1,-1,-1,30503,-1,8.099729e-05,0.00022199938,0.99969697
30504,therapy,20,21,147,154,OBJECTIVE: Limited efficacy of immune checkpoint inhibitors in pancreatic ductal adenocarcinoma (PDAC) has prompted investigation into combination therapy.,27797936_0,0,1,-1,-1,30504,-1,2.794141e-05,0.99995756,1.4471461e-05
30505,that interleukin 6,2,5,16,34,We hypothesised that interleukin 6 (IL-6) blockade would modulate immunological features of PDAC and enhance the efficacy of anti-programmed death-1-ligand 1 (PD-L1) checkpoint inhibitor therapy.,27797936_1,-1,-1,-1,-1,30505,-1,0.35230154,0.6416275,0.006070984
30508,therapy,28,29,187,194,We hypothesised that interleukin 6 (IL-6) blockade would modulate immunological features of PDAC and enhance the efficacy of anti-programmed death-1-ligand 1 (PD-L1) checkpoint inhibitor therapy.,27797936_1,0,1,-1,-1,30508,-1,2.1467264e-05,0.99996674,1.1742825e-05
30513,targeting IL-6,13,15,78,92,"In vivo efficacy and mechanistic studies were conducted with antibodies (Abs) targeting IL-6, PD-L1, CD4 or CD8 in subcutaneous or orthotopic models using Panc02, MT5 or KPC-luc cell lines; and the aggressive, genetically engineered PDAC model (KrasLSL-G12D, Trp53LSL-R270H, Pdx1-cre, Brca2F/F (KPC-Brca2 mice)).",27797936_3,-1,-1,-1,-1,30513,-1,0.7696526,0.22231066,0.008036739
30517,analysis,13,14,101,109,Systemic and local changes in immunophenotype were measured by flow cytometry or immunohistochemical analysis.,27797936_4,0,1,-1,-1,30517,-1,4.792342e-05,0.99990404,4.7996647e-05
30527,This treatment,0,2,0,14,This treatment combination also elicited significant antitumour activity in mice bearing orthotopic KPC-luc tumours and limited tumour progression in KPC-Brca2 mice (p<0.001).,27797936_8,-1,-1,-1,-1,30527,-1,2.8501305e-05,0.99995923,1.2312681e-05
30530,analysis,1,2,13,21,Histological analysis revealed increased T-cell infiltration and reduced -smooth muscle actin cells in tumours from multiple models.,27797936_9,0,1,-1,-1,30530,-1,3.6136455e-05,0.99993527,2.8607179e-05
30531,T-cell,4,5,41,47,Histological analysis revealed increased T-cell infiltration and reduced -smooth muscle actin cells in tumours from multiple models.,27797936_9,-1,1,2,-1,30531,-1,3.2453452e-05,4.751216e-05,0.99992
30536,that targeted,22,24,168,181,"Finally, IL-6 and PD-L1 blockade increased overall survival in KPC-Brca2 mice compared with isotype controls (p=0.0012).CONCLUSIONS: These preclinical results indicate that targeted inhibition of IL-6 may enhance the efficacy of anti-PD-L1 in PDAC.",27797936_10,-1,-1,-1,-1,30536,-1,2.1313968e-05,0.999969,9.69075e-06
30541,thought to,9,11,61,71,"Natural polyphenolic compounds of grapes and their seeds are thought to be therapeutic adjuvants in a variety of diseases, including cancer prevention.",27833081_0,-1,-1,-1,-1,30541,-1,3.2249078e-05,0.99995315,1.4643519e-05
30546,the regulation,14,16,84,98,This study was carried out to investigate the effect of grape phenolic compounds on the regulation of cancer-mediated immune suppression.,27833081_1,-1,-1,-1,-1,30546,-1,1.7411026e-05,0.9999728,9.787288e-06
30551,function,25,26,155,163,"Laricitrin exhibits the greatest potential to ameliorate the suppressive effects of lung cancer on dendritic cells' (DCs') differentiation, maturation and function.",27833081_2,0,1,2,-1,30551,-1,0.000113368704,0.999783,0.00010366564
30557,T cells towards,23,26,114,129,Human lung cancer A549 and CL1-5 cells change the phenotype of DCs that express to high levels of IL-10 and prime T cells towards an immune suppression type-2 response (Th2).,27833081_3,-1,-1,-1,-1,30557,-1,0.0010335785,0.017646683,0.9813198
30565,Th2 to Th1,18,21,120,130,"Laricitrin decreases expression of IL-10 in cancer-conditioned DCs, and subsequently switches CD4+ T cell response from Th2 to Th1 in vitro and in vivo.",27833081_5,-1,-1,-1,-1,30565,-1,2.979457e-05,0.9999372,3.3053893e-05
30572,protein,1,2,17,24,Follistatin-like protein 1 (FSTL1) is a newly characterized protein that can regulate the immune response in various ways.,27859422_0,0,1,-1,-1,30572,-1,5.9685244e-05,0.9998173,0.00012304707
30574,the immune response,14,17,86,105,Follistatin-like protein 1 (FSTL1) is a newly characterized protein that can regulate the immune response in various ways.,27859422_0,-1,-1,-1,-1,30574,-1,0.22846101,0.7703657,0.0011732068
30589,protein nuclear factor,11,14,66,88,"In the experimental groups, the expression of the critical immune protein nuclear factor (NF)-b was upregulated, whereas Jun N-terminal kinase (JNK) was downregulated.",27859422_5,-1,-1,-1,-1,30589,-1,2.5831374e-05,0.99995255,2.1576829e-05
30594,the antigen,14,16,90,101,"Our findings demonstrate that FSTL1 plays a critical role in immune regulation, enhancing the antigen presentation ability of DCs by up-regulating NF-b expression and down-regulating JNK expression.",27859422_6,-1,-1,-1,-1,30594,-1,0.2012426,0.7936781,0.005079299
30598,immunity,17,18,110,118,"Based on our hypothesis in which continuous exposure to asbestos of immune cells cause reduction of antitumor immunity, the decrease of natural killer cell killing activity with reduction of NKp46 activating receptor expression, inhibition of cytotoxic Tcell clonal expansion, reduced CXCR3 chemokine receptor expression and production of interferon- production in CD4+ Tcells were reported using cell line models, freshly isolated peripheral blood immune cells from health donors as well as asbestos exposed patients such as pleural plaque and mesothelioma.",27878235_1,0,-1,2,-1,30598,-1,0.9973321,0.0020484445,0.00061940815
30602,receptor,32,33,208,216,"Based on our hypothesis in which continuous exposure to asbestos of immune cells cause reduction of antitumor immunity, the decrease of natural killer cell killing activity with reduction of NKp46 activating receptor expression, inhibition of cytotoxic Tcell clonal expansion, reduced CXCR3 chemokine receptor expression and production of interferon- production in CD4+ Tcells were reported using cell line models, freshly isolated peripheral blood immune cells from health donors as well as asbestos exposed patients such as pleural plaque and mesothelioma.",27878235_1,0,1,2,-1,30602,-1,0.0006067847,0.0046838475,0.9947094
30604,chemokine receptor,46,48,292,310,"Based on our hypothesis in which continuous exposure to asbestos of immune cells cause reduction of antitumor immunity, the decrease of natural killer cell killing activity with reduction of NKp46 activating receptor expression, inhibition of cytotoxic Tcell clonal expansion, reduced CXCR3 chemokine receptor expression and production of interferon- production in CD4+ Tcells were reported using cell line models, freshly isolated peripheral blood immune cells from health donors as well as asbestos exposed patients such as pleural plaque and mesothelioma.",27878235_1,-1,-1,-1,-1,30604,-1,0.8047212,0.0030674734,0.1922114
30608,blood,70,71,446,451,"Based on our hypothesis in which continuous exposure to asbestos of immune cells cause reduction of antitumor immunity, the decrease of natural killer cell killing activity with reduction of NKp46 activating receptor expression, inhibition of cytotoxic Tcell clonal expansion, reduced CXCR3 chemokine receptor expression and production of interferon- production in CD4+ Tcells were reported using cell line models, freshly isolated peripheral blood immune cells from health donors as well as asbestos exposed patients such as pleural plaque and mesothelioma.",27878235_1,0,1,-1,-1,30608,-1,0.00069038506,0.97692966,0.022379914
30610,pleural plaque,84,86,529,543,"Based on our hypothesis in which continuous exposure to asbestos of immune cells cause reduction of antitumor immunity, the decrease of natural killer cell killing activity with reduction of NKp46 activating receptor expression, inhibition of cytotoxic Tcell clonal expansion, reduced CXCR3 chemokine receptor expression and production of interferon- production in CD4+ Tcells were reported using cell line models, freshly isolated peripheral blood immune cells from health donors as well as asbestos exposed patients such as pleural plaque and mesothelioma.",27878235_1,-1,-1,-1,-1,30610,-1,6.140088e-05,0.99991345,2.5147636e-05
30611,to these,2,4,12,20,"In addition to these findings, regulatory Tcells (Treg) showed enhanced function through cell-cell contact and increased secretion of typical soluble factors, interleukin (IL)-10 and transforming growth factor (TGF)-, in a cell line model using the MT-2 human polyclonal Tcells and its sublines exposed continuously to asbestos fibers.",27878235_2,-1,-1,-1,-1,30611,-1,1.9573568e-05,0.99997044,9.93343e-06
30614,function through cell-cell,15,18,73,99,"In addition to these findings, regulatory Tcells (Treg) showed enhanced function through cell-cell contact and increased secretion of typical soluble factors, interleukin (IL)-10 and transforming growth factor (TGF)-, in a cell line model using the MT-2 human polyclonal Tcells and its sublines exposed continuously to asbestos fibers.",27878235_2,-1,-1,-1,-1,30614,-1,0.003002988,0.27876955,0.71822745
30616,factors,25,26,151,158,"In addition to these findings, regulatory Tcells (Treg) showed enhanced function through cell-cell contact and increased secretion of typical soluble factors, interleukin (IL)-10 and transforming growth factor (TGF)-, in a cell line model using the MT-2 human polyclonal Tcells and its sublines exposed continuously to asbestos fibers.",27878235_2,0,1,-1,-1,30616,-1,0.99978584,6.759729e-05,0.0001465928
30618,transforming growth factor,30,33,184,210,"In addition to these findings, regulatory Tcells (Treg) showed enhanced function through cell-cell contact and increased secretion of typical soluble factors, interleukin (IL)-10 and transforming growth factor (TGF)-, in a cell line model using the MT-2 human polyclonal Tcells and its sublines exposed continuously to asbestos fibers.",27878235_2,-1,-1,-1,-1,30618,-1,0.8716238,0.124049105,0.0043270644
30626,the cell,22,24,158,166,"Since these sublines showed a remarkable reduction of FoxO1 transcription factor, which regulates various cell cycle regulators in asbestos-exposed sublines, the cell cycle progression in these sublines was examined and compared with that of the original MT-2 cells.",27878235_3,-1,-1,-1,-1,30626,-1,0.004938804,0.6039432,0.39111805
30636,immunity,6,7,45,53,The overall findings indicate that antitumor immunity in asbestos-exposed individuals may be reduced in Treg through changes in the function and volume of Treg.,27878235_6,0,-1,2,-1,30636,-1,0.9969304,0.0024970009,0.00057260273
30637,Treg through,14,16,104,116,The overall findings indicate that antitumor immunity in asbestos-exposed individuals may be reduced in Treg through changes in the function and volume of Treg.,27878235_6,-1,-1,-1,-1,30637,-1,1.8721677e-05,0.999969,1.2293184e-05
30638,the function,18,20,128,140,The overall findings indicate that antitumor immunity in asbestos-exposed individuals may be reduced in Treg through changes in the function and volume of Treg.,27878235_6,-1,-1,-1,-1,30638,-1,4.6262336e-05,0.9999273,2.6427348e-05
30643,tumor immunity,11,13,57,71,BACKGROUND: CD4+CD25+ regulatory T (Treg) cells suppress tumor immunity by inhibiting immune cells.,27887569_0,-1,-1,-1,-1,30643,-1,0.013182456,0.9864032,0.00041423985
30648,receptor activator,14,16,87,105,"Zoledronic acid (ZA), a nitrogen-containing bisphosphonate, inhibits the expression of receptor activator of nuclear factor kappa-B ligand (RANKL) on osteoblasts to inhibit osteoclastogenesis.",27887569_2,-1,-1,-1,-1,30648,-1,3.254181e-05,0.99992764,3.9821545e-05
30652,Treg-cell,15,16,101,110,"In a mouse model of bisphosphonate-related osteonecrosis of the jaw, administration of ZA suppressed Treg-cell activity and activated inflammatory Th17 cells.",27887569_3,-1,1,2,-1,30652,-1,0.0003638361,0.005323886,0.9943123
30653,Th17 cells,20,22,147,157,"In a mouse model of bisphosphonate-related osteonecrosis of the jaw, administration of ZA suppressed Treg-cell activity and activated inflammatory Th17 cells.",27887569_3,-1,-1,-1,-1,30653,-1,0.00024171438,0.0010713794,0.99868697
30661,Treg cells treated,24,27,166,184,This study investigated the immune modulation of Treg cells by ZA.METHODS: Flow cytometry was used to analyze the phenotypic and immunosuppressive characteristics of Treg cells treated with ZA.,27887569_5,-1,-1,-1,-1,30661,-1,0.0012565475,0.06667992,0.9320635
30674,functions,4,5,44,53,"Chemotactic migration and immunosuppressive functions were also significantly attenuated in Treg cells pretreated with ZA, and these effects were dose-dependent.",27887569_10,0,1,2,-1,30674,-1,0.00063061406,0.99761754,0.0017518578
30684,function,21,22,148,156,"CONCLUSIONS: Our findings demonstrated that ZA acted as an immune modulator by significantly inhibiting the expansion, migration, immunosuppressive function and pro-metastatic ability of Treg cells.",27887569_12,0,1,2,-1,30684,-1,0.00030914796,0.99939287,0.00029801662
30687,therapy,12,13,74,81,Immunomodulation of Treg cells by ZA represents a new strategy for cancer therapy.,27887569_13,0,1,-1,-1,30687,-1,3.2106727e-05,0.99995327,1.4571206e-05
30688,to the,12,14,85,91,Cigarette smoking is associated with numerous diseases and poses a serious challenge to the current healthcare system worldwide.,27902485_0,-1,-1,-1,-1,30688,-1,2.8533612e-05,0.999961,1.0472002e-05
30691,immunity,13,14,85,93,Smoking impacts both innate and adaptive immunity and plays dual roles in regulating immunity by either exacerbation of pathogenic immune responses or attenuation of defensive immunity.,27902485_1,0,-1,2,-1,30691,-1,0.9992286,0.0005123293,0.00025909787
30693,immunity,25,26,176,184,Smoking impacts both innate and adaptive immunity and plays dual roles in regulating immunity by either exacerbation of pathogenic immune responses or attenuation of defensive immunity.,27902485_1,0,-1,2,-1,30693,-1,0.9996704,0.00017655219,0.0001530255
30705,immunity,14,15,97,105,"Although previous reviews have described the effects of smoking on various diseases and regional immunity associated with specific diseases, a comprehensive and updated review is rarely seen to demonstrate impacts of smoking on general immunity and, especially on major components of immune cells.",27902485_4,0,-1,2,-1,30705,-1,0.99763906,0.00092554395,0.0014354025
30707,general immunity,34,36,228,244,"Although previous reviews have described the effects of smoking on various diseases and regional immunity associated with specific diseases, a comprehensive and updated review is rarely seen to demonstrate impacts of smoking on general immunity and, especially on major components of immune cells.",27902485_4,-1,-1,-1,-1,30707,-1,0.07039825,0.92736286,0.0022388652
30722,the the,4,6,22,29,OBJECTIVE: To observe the the potential benefit of sunitinib in combination with cyclooxygenase-2(COX-2) inhibitor in renal cell carcinoma therapy.,27926489_0,-1,-1,-1,-1,30722,-1,2.0413378e-05,0.99997246,7.168107e-06
30724,therapy,20,21,139,146,OBJECTIVE: To observe the the potential benefit of sunitinib in combination with cyclooxygenase-2(COX-2) inhibitor in renal cell carcinoma therapy.,27926489_0,0,1,-1,-1,30724,-1,2.4782392e-05,0.9999628,1.2383216e-05
30737,blood,16,17,90,95,The myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) in peripheral blood and spleen were determined by flow cytometry.,27926489_5,0,1,-1,-1,30737,-1,0.00012869705,0.998809,0.0010623924
30739,protein,2,3,10,17,The MDSCs protein was extracted for STAT3 analysis by western blot.,27926489_6,0,1,-1,-1,30739,-1,4.734841e-05,0.99985504,9.754999e-05
30740,STAT3 analysis,6,8,36,50,The MDSCs protein was extracted for STAT3 analysis by western blot.,27926489_6,-1,-1,-1,-1,30740,-1,2.881795e-05,0.999948,2.3183118e-05
30746,than those,12,14,82,92,Combination of sunitinib and celecoxib in vivo could effectively reduce the MDSCs than those in control group.,27926489_9,-1,-1,-1,-1,30746,-1,2.198205e-05,0.99996305,1.4947273e-05
30752,therapy,3,4,24,31,CONCLUSION: Combination therapy with sunitinib and celecoxib intensified the curative effects to renal cell carcinoma by suppressing immune regulatory cells.,27926489_11,0,1,-1,-1,30752,-1,2.8669643e-05,0.9999573,1.39930835e-05
30763,deficiency,1,2,5,15,SHP2 deficiency in T cells aggravated colitis with increased level of pro-inflammatory cytokines including IFN- and IL-17A.,27935860_3,0,1,-1,-1,30763,-1,6.3565254e-05,0.9998398,9.661554e-05
30769,tumors than,11,13,66,77,"In contrast, the SHP2CD4-/- mice developed much fewer and smaller tumors than wild type mice with higher level of IFN- and enhanced cytotoxicity of CD8+ T cells in the tumor and peritumoral areas.",27935860_4,-1,-1,-1,-1,30769,-1,2.0905252e-05,0.9999645,1.45677e-05
30773,the tumor,30,32,165,174,"In contrast, the SHP2CD4-/- mice developed much fewer and smaller tumors than wild type mice with higher level of IFN- and enhanced cytotoxicity of CD8+ T cells in the tumor and peritumoral areas.",27935860_4,-1,-1,-1,-1,30773,-1,1.9391191e-05,0.99996865,1.199369e-05
30781,IFN- receptor,3,5,24,38,"IFN- neutralization or IFN- receptor knockout but not IL-17A neutralization, abrogated the anti-tumor effect of SHP2 knockout with lowered levels of perforin 1, FasL and granzyme B. Finally, the expression of granzyme B was negatively correlated with the malignancy of colon cancer in human patients.",27935860_6,-1,-1,-1,-1,30781,-1,0.9802964,0.0012023787,0.0185012
30787,to treat,9,11,53,61,"In conclusion, these findings suggest a new strategy to treat colitis-associated cancer via targeting SHP2.",27935860_7,-1,-1,-1,-1,30787,-1,2.0304258e-05,0.9999695,1.0197927e-05
30791,receptor-negative,16,17,87,104,The expression of IL-17A and programmed death ligand 1 (PDL1) is increased in estrogen receptor-negative breast cancer.,27935862_0,0,1,2,-1,30791,-1,0.00016628021,0.9995913,0.00024239653
30793,tumor cell,2,4,16,26,IL-17A promotes tumor cell survival and invasiveness and inhibits the antitumor immune response.,27935862_1,-1,-1,-1,-1,30793,-1,0.0028237086,0.17085291,0.82632333
30797,protein,5,6,31,38,The PDL1-PD1 (programmed death protein 1) signaling pathway promotes escape from immune surveillance in tumor cells.,27935862_2,0,1,-1,-1,30797,-1,0.00022303879,0.99908876,0.0006882124
30798,tumor cells,16,18,104,115,The PDL1-PD1 (programmed death protein 1) signaling pathway promotes escape from immune surveillance in tumor cells.,27935862_2,-1,-1,-1,-1,30798,-1,0.004259959,0.48439714,0.5113428
30801,the relationship,17,19,103,119,"The pro-tumor properties of IL-17A and PDL1 in various cancers have been previously examined; however, the relationship and roles of IL-17A and PDL1 in ER-negative breast cancer have not been evaluated.",27935862_3,-1,-1,-1,-1,30801,-1,2.5993742e-05,0.99995863,1.5398331e-05
30805,tumor cells,10,12,66,77,"Therefore, we assessed whether IL-17A promotes PDL1 expression in tumor cells and whether targeting of IL-17A could inhibit ER-negative breast cancer progression in a murine model.",27935862_4,-1,-1,-1,-1,30805,-1,0.0035771916,0.49015546,0.5062674
30808,that IL-17A,3,5,19,30,Our study revealed that IL-17A promoted PDL1 expression in human and mouse cells.,27935862_5,-1,-1,-1,-1,30808,-1,0.675643,0.31870356,0.005653397
30813,the tumor,13,15,77,86,"In the murine cancer model, targeting of IL-17A inhibited PDL1 expression in the tumor microenvironment, decreased the percentage of Treg cells in tumor-infiltrating lymphocytes, and promoted CD4+ and CD8+ T cells to secrete interferon gamma.",27935862_6,-1,-1,-1,-1,30813,-1,1.9083682e-05,0.9999708,1.0079754e-05
30816,tumor-infiltrating lymphocytes,24,26,147,177,"In the murine cancer model, targeting of IL-17A inhibited PDL1 expression in the tumor microenvironment, decreased the percentage of Treg cells in tumor-infiltrating lymphocytes, and promoted CD4+ and CD8+ T cells to secrete interferon gamma.",27935862_6,-1,-1,-1,-1,30816,-1,0.0036584048,0.8654635,0.13087808
30817,T cells to,34,37,206,216,"In the murine cancer model, targeting of IL-17A inhibited PDL1 expression in the tumor microenvironment, decreased the percentage of Treg cells in tumor-infiltrating lymphocytes, and promoted CD4+ and CD8+ T cells to secrete interferon gamma.",27935862_6,-1,-1,-1,-1,30817,-1,0.0013093908,0.022350831,0.9763398
30826,targeting relies,4,6,32,48,Clinical efficacy of PD-1/PD-L1 targeting relies upon the reactivation of tumor-specific but functionally impaired PD-1+ T cells present before therapy.,27979840_0,-1,-1,-1,-1,30826,-1,2.0558602e-05,0.99996614,1.335361e-05
30829,functionally,12,13,93,105,Clinical efficacy of PD-1/PD-L1 targeting relies upon the reactivation of tumor-specific but functionally impaired PD-1+ T cells present before therapy.,27979840_0,0,1,2,-1,30829,-1,9.369984e-05,0.99987257,3.367871e-05
30831,therapy,20,21,144,151,Clinical efficacy of PD-1/PD-L1 targeting relies upon the reactivation of tumor-specific but functionally impaired PD-1+ T cells present before therapy.,27979840_0,0,1,-1,-1,30831,-1,2.2754748e-05,0.9999666,1.065732e-05
30835,T cells that,11,14,70,82,"Thus, analyzing early-stage primary tumors may reveal the presence of T cells that are not yet functionally impaired.",27979840_1,-1,-1,-1,-1,30835,-1,0.0015837451,0.040704373,0.9577119
30836,functionally,17,18,95,107,"Thus, analyzing early-stage primary tumors may reveal the presence of T cells that are not yet functionally impaired.",27979840_1,0,1,2,-1,30836,-1,0.00022165338,0.9997297,4.8625123e-05
30841,Tumor-infiltrating lymphocytes,0,2,0,30,"Tumor-infiltrating lymphocytes coexpressed PD-1 with the inhibitory receptors TIM-3, CTLA-4, LAG-3, and TIGIT, but also displayed a recently activated, nonexhausted phenotype.",27979840_3,-1,-1,-1,-1,30841,-1,0.0035515178,0.8361184,0.1603301
30843,receptors TIM-3,7,9,68,83,"Tumor-infiltrating lymphocytes coexpressed PD-1 with the inhibitory receptors TIM-3, CTLA-4, LAG-3, and TIGIT, but also displayed a recently activated, nonexhausted phenotype.",27979840_3,-1,-1,-1,-1,30843,-1,0.003217424,0.87350124,0.12328138
30849,functional,15,16,86,96,"We also identified a subset of CD8+PD-1+FOXP3+ T lymphocytes at the earliest phase of functional differentiation after priming, termed ""early effector cells"" (EEC), which also exhibited an activated nonexhausted phenotype, but was less differentiated and associated with coexpression of multiple inhibitory receptors.",27979840_4,0,1,2,-1,30849,-1,8.673095e-05,0.99984026,7.303402e-05
30852,receptors,49,50,307,316,"We also identified a subset of CD8+PD-1+FOXP3+ T lymphocytes at the earliest phase of functional differentiation after priming, termed ""early effector cells"" (EEC), which also exhibited an activated nonexhausted phenotype, but was less differentiated and associated with coexpression of multiple inhibitory receptors.",27979840_4,0,1,2,-1,30852,-1,0.00011507283,0.00020724372,0.99967766
30857,receptor,7,8,48,56,"The identification of EECs marked by inhibitory receptor expression at tumor sites will enable investigations of early stages of adaptive antitumor immunity, as well as support the rationale for administering immunotherapy in early-stage non-small cell lung cancer.",27979840_6,0,1,2,-1,30857,-1,0.00041250285,0.00091522123,0.99867225
30859,immunity,21,22,148,156,"The identification of EECs marked by inhibitory receptor expression at tumor sites will enable investigations of early stages of adaptive antitumor immunity, as well as support the rationale for administering immunotherapy in early-stage non-small cell lung cancer.",27979840_6,0,-1,2,-1,30859,-1,0.9994093,0.0003476398,0.00024309546
30862,Forkheadbox protein,0,2,0,19,"Forkheadbox protein 3 (FOXP3), initially identified as a key transcription factor for regulatory T cells (Treg cells), was also expressed in many tumors including pancreatic ductal adenocarcinoma (PDAC).",27991933_0,-1,-1,-1,-1,30862,-1,3.273088e-05,0.9999465,2.0839012e-05
30869,tissues,8,9,36,43,"In this study, we utilized 120 PDAC tissues after radical resection to detect cancer-FOXP3 and Treg cells by immunohistochemistry and evaluated clinical and pathological features of these patients.",27991933_2,-1,1,2,-1,30869,-1,0.00011872272,0.9982346,0.0016466286
30874,tumor tissues,9,11,71,84,Cancer-FOXP3 was positively correlated with Treg cells accumulation in tumor tissues derived from PDAC patients.,27991933_3,-1,-1,-1,-1,30874,-1,2.6276166e-05,0.99993896,3.4805948e-05
30877,the tumor,4,6,40,49,Overexpression of cancer-FOXP3 promoted the tumor growth in immunocompetent syngeneic mice but not in immunocompromised or Treg cell-depleted mice.,27991933_5,-1,-1,-1,-1,30877,-1,1.8888635e-05,0.99997246,8.624407e-06
30882,blood to the tumor,17,21,122,140,"Furthermore, CCL5 was directly trans-activated by cancer-FOXP3 and promoted the recruitment of Treg cells from peripheral blood to the tumor site in vitro and in vivo.",27991933_6,-1,-1,-1,-1,30882,-1,0.0008628065,0.98706263,0.012074573
30885,that Treg cells,9,12,57,72,"This finding has been further reinforced by the evidence that Treg cells recruitment by cancer-FOXP3 was impaired by neutralization of CCL5, thereby inhibiting the growth of PDAC.",27991933_7,-1,-1,-1,-1,30885,-1,0.0025422089,0.1447708,0.85268694
30898,the immune response,20,23,117,136,Foxp3+ T regulatory cells (Tregs) play critical roles in immune homeostasis primarily by suppressing many aspects of the immune response.,28001437_0,-1,-1,-1,-1,30898,-1,0.44589567,0.55233335,0.0017709449
30900,their cell,5,7,31,41,Tregs uniquely express GARP on their cell surface and GARP functions as a delivery system for latent TGF-.,28001437_1,-1,-1,-1,-1,30900,-1,0.0037329139,0.4823887,0.5138784
30901,functions,10,11,59,68,Tregs uniquely express GARP on their cell surface and GARP functions as a delivery system for latent TGF-.,28001437_1,0,1,2,-1,30901,-1,4.940973e-05,0.9999248,2.57837e-05
30903,Treg-derived TGF-,1,3,3,21,"As Treg-derived TGF- may mediate the suppressive functions of Tregs, GARP may represent a target to inhibit Treg suppression in cancer or augment suppression in autoimmunity.",28001437_2,-1,-1,-1,-1,30903,-1,3.4691864e-05,0.999948,1.731439e-05
30905,functions,7,8,50,59,"As Treg-derived TGF- may mediate the suppressive functions of Tregs, GARP may represent a target to inhibit Treg suppression in cancer or augment suppression in autoimmunity.",28001437_2,0,1,2,-1,30905,-1,0.00013104563,0.9997646,0.00010439222
30907,target to,15,17,91,100,"As Treg-derived TGF- may mediate the suppressive functions of Tregs, GARP may represent a target to inhibit Treg suppression in cancer or augment suppression in autoimmunity.",28001437_2,-1,-1,-1,-1,30907,-1,2.3994544e-05,0.9999645,1.1493334e-05
30911,Treg-derived TGF-,13,15,57,75,"Areas covered: This article will focus on 1) the role of Treg-derived TGF- in the suppressive activity of Treg, 2) the cellular and molecular regulation of expression of GARP on mouse and human Tregs, 3) the role of integrins in the activation of latent-TGF-/GARP complex, 4) an overview of our present understanding of the function of the latent-TGF-/GARP complex.",28001437_3,-1,-1,-1,-1,30911,-1,2.8360128e-05,0.9999517,1.9943911e-05
30914,the cellular,24,26,116,128,"Areas covered: This article will focus on 1) the role of Treg-derived TGF- in the suppressive activity of Treg, 2) the cellular and molecular regulation of expression of GARP on mouse and human Tregs, 3) the role of integrins in the activation of latent-TGF-/GARP complex, 4) an overview of our present understanding of the function of the latent-TGF-/GARP complex.",28001437_3,-1,-1,-1,-1,30914,-1,0.0026573397,0.840959,0.15638371
30920,the function,61,63,322,334,"Areas covered: This article will focus on 1) the role of Treg-derived TGF- in the suppressive activity of Treg, 2) the cellular and molecular regulation of expression of GARP on mouse and human Tregs, 3) the role of integrins in the activation of latent-TGF-/GARP complex, 4) an overview of our present understanding of the function of the latent-TGF-/GARP complex.",28001437_3,-1,-1,-1,-1,30920,-1,2.2466498e-05,0.9999658,1.1730323e-05
30924,targeting the,8,10,48,61,Expert opinion: Two approaches are outlined for targeting the L-TGF-1/GARP complex for therapeutic purposes.,28001437_4,-1,-1,-1,-1,30924,-1,1.7978684e-05,0.99997354,8.537444e-06
30927,Tregs play,0,2,0,10,Tregs play a major role in suppressive effector T cell responses to tumors and TGF-1 may be a major contributor to this process.,28001437_5,-1,-1,-1,-1,30927,-1,1.8796767e-05,0.99997115,9.991717e-06
30929,to tumors,11,13,65,74,Tregs play a major role in suppressive effector T cell responses to tumors and TGF-1 may be a major contributor to this process.,28001437_5,-1,-1,-1,-1,30929,-1,2.4670799e-05,0.99996436,1.0988969e-05
30931,to this,20,22,113,120,Tregs play a major role in suppressive effector T cell responses to tumors and TGF-1 may be a major contributor to this process.,28001437_5,-1,-1,-1,-1,30931,-1,3.944631e-05,0.9999434,1.7232473e-05
30936,to tumor,16,18,95,103,One approach is to specifically block the production of active TGF-1 from Tregs as an adjunct to tumor immunotherapy.,28001437_6,-1,-1,-1,-1,30936,-1,3.9421495e-05,0.99994636,1.418554e-05
30942,Th1-type immunity,0,2,0,17,"Th1-type immunity is considered to be required for efficient response to BCG in bladder cancer, although Th2 predisposition of BCG responders has recently been reported.",28005163_0,-1,-1,-1,-1,30942,-1,0.0028906183,0.99655837,0.00055099087
30948,the relationship,5,7,24,40,The aim was to evaluate the relationship of Th1 and Th2 components in 23 patients undergoing BCG treatment.,28005163_1,-1,-1,-1,-1,30948,-1,2.0631964e-05,0.99996614,1.31860825e-05
30952,blood,1,2,11,16,"Peripheral blood, serum and urine samples were prospectively collected at baseline, during and after BCG.",28005163_2,0,1,-1,-1,30952,-1,8.173758e-05,0.9995034,0.00041493162
30953,urine,5,6,28,33,"Peripheral blood, serum and urine samples were prospectively collected at baseline, during and after BCG.",28005163_2,0,1,-1,-1,30953,-1,7.086197e-05,0.9998784,5.06848e-05
30958,TNF-R75,19,20,100,107,"Th1 (neopterin, tryptophan, kynurenine, kynurenine-to-tryptophan ratio (KTR), IL-12, IFN-, soluble TNF-R75 and IL-2R) and Th2 (IL-4, IL-10) biomarkers as well as CD4 expression in T helper (Th), effector and regulatory T cells were determined.",28005163_3,0,1,-1,-1,30958,-1,0.00028841713,0.99954635,0.00016520676
30964,cell subsets,2,4,13,25,"Local immune cell subsets were measured on formalin-fixed, paraffin-embedded cancer tissue by immunohistochemistry to examine expression of transcription factors that control Th1 (T-bet) and Th2-type (GATA3) immunity.",28005163_4,-1,-1,-1,-1,30964,-1,4.5988163e-05,5.2469415e-05,0.99990153
30965,tissue,11,12,84,90,"Local immune cell subsets were measured on formalin-fixed, paraffin-embedded cancer tissue by immunohistochemistry to examine expression of transcription factors that control Th1 (T-bet) and Th2-type (GATA3) immunity.",28005163_4,-1,1,2,-1,30965,-1,4.419888e-05,0.9998584,9.741626e-05
30967,transcription factors that,18,21,140,166,"Local immune cell subsets were measured on formalin-fixed, paraffin-embedded cancer tissue by immunohistochemistry to examine expression of transcription factors that control Th1 (T-bet) and Th2-type (GATA3) immunity.",28005163_4,-1,-1,-1,-1,30967,-1,1.873381e-05,0.99996936,1.1941767e-05
30972,immunity,31,32,208,216,"Local immune cell subsets were measured on formalin-fixed, paraffin-embedded cancer tissue by immunohistochemistry to examine expression of transcription factors that control Th1 (T-bet) and Th2-type (GATA3) immunity.",28005163_4,0,-1,2,-1,30972,-1,0.9945167,0.0046776463,0.0008057391
30976,therapy,62,63,194,201,"BCG responders showed significantly higher levels of urinary (p=0.003) and serum neopterin (p=0.012), kynurenine (p=0.015), KTR (p=0.005), IFN- (p=0.005) and IL-12 (p=0.003) during therapy, whereas levels of IL-10 decreased significantly (p<0.001) compared to non-responders.",28005163_6,0,1,-1,-1,30976,-1,2.0816713e-05,0.9999678,1.1358084e-05
30981,the Th cell,9,12,56,67,"We observed a significant increase in CD4 expression in the Th cell population (p<0.05), with only a modest tendency toward higher frequency in responders compared to non-responders (p=0.303).",28005163_8,-1,-1,-1,-1,30981,-1,0.002756542,0.21364659,0.7835969
30982,tendency toward,25,27,110,125,"We observed a significant increase in CD4 expression in the Th cell population (p<0.05), with only a modest tendency toward higher frequency in responders compared to non-responders (p=0.303).",28005163_8,-1,-1,-1,-1,30982,-1,2.4145376e-05,0.99996054,1.5301961e-05
30985,Th2-promoting factors,0,2,0,21,Th2-promoting factors such as GATA3 may trigger Th1-type immune responses and thus contribute to the BCG success.,28005163_10,-1,-1,-1,-1,30985,-1,6.8441805e-05,0.9998765,5.498599e-05
30987,trigger Th1-type immune responses,6,10,40,73,Th2-promoting factors such as GATA3 may trigger Th1-type immune responses and thus contribute to the BCG success.,28005163_10,-1,-1,-1,-1,30987,-1,0.031035,0.9681696,0.00079535355
30989,to the,13,15,94,100,Th2-promoting factors such as GATA3 may trigger Th1-type immune responses and thus contribute to the BCG success.,28005163_10,-1,-1,-1,-1,30989,-1,3.0200312e-05,0.9999554,1.4328159e-05
30992,tumor immunity,10,12,52,66,"The role of IL-33, particularly in tumor growth and tumor immunity, remains ill-defined.",28011934_0,-1,-1,-1,-1,30992,-1,0.010466646,0.98912305,0.00041034265
31003,therapy,19,20,94,101,"Notably, in addition to a direct action on CD8+ T cell expansion and IFN- production, rIL-33 therapy activated myeloid dendritic cells (mDCs) in tumor-bearing mice, restored antitumor T cell activity, and increased Ag cross-presentation within the tumor microenvironment.",28011934_3,0,1,-1,-1,31003,-1,2.152897e-05,0.99996734,1.11294e-05
31007,the tumor,42,44,245,254,"Notably, in addition to a direct action on CD8+ T cell expansion and IFN- production, rIL-33 therapy activated myeloid dendritic cells (mDCs) in tumor-bearing mice, restored antitumor T cell activity, and increased Ag cross-presentation within the tumor microenvironment.",28011934_3,-1,-1,-1,-1,31007,-1,1.8685318e-05,0.9999715,9.803847e-06
31008,therapy,3,4,25,32,"Furthermore, combination therapy consisting of rIL-33 and agonistic anti-CD40 Abs demonstrated synergistic antitumor activity.",28011934_4,0,1,-1,-1,31008,-1,2.2831317e-05,0.9999633,1.390151e-05
31011,that the,4,6,27,35,"Importantly, we identified that the IL-33 receptor ST2, MyD88, and STAT1 cooperate to induce costimulatory molecule expression on mDCs in response to rIL-33.",28011934_6,-1,-1,-1,-1,31011,-1,1.7610671e-05,0.9999702,1.2163983e-05
31012,receptor,7,8,42,50,"Importantly, we identified that the IL-33 receptor ST2, MyD88, and STAT1 cooperate to induce costimulatory molecule expression on mDCs in response to rIL-33.",28011934_6,0,1,2,-1,31012,-1,0.00071523205,0.029469255,0.9698155
31021,to treat,40,42,252,260,"Thus, our study revealed a novel IL-33-ST2-MyD88-STAT1 axis that restores mDC activation and maturation in established cancer and, thereby, the magnitude of antitumor immune responses, suggesting a potential use of rIL-33 as a new immunotherapy option to treat established cancer.",28011934_7,-1,-1,-1,-1,31021,-1,2.2760916e-05,0.9999659,1.1381473e-05
31026,TCR gene,8,10,54,62,METHODS: Immunophenotyping of circulating T cells and TCR gene restriction analysis using Biomed-2 protocol.,28018996_2,-1,-1,-1,-1,31026,-1,3.1364336e-05,0.99993575,3.292316e-05
31027,analysis,11,12,75,83,METHODS: Immunophenotyping of circulating T cells and TCR gene restriction analysis using Biomed-2 protocol.,28018996_2,0,1,-1,-1,31027,-1,3.7651782e-05,0.99992156,4.0729774e-05
31031,blood,18,19,130,135,NF-B staining and mRNA quantification of inflammatory genes in HK-2 epithelial renal cells exposed to supernatants of peripheral blood mononuclear cells with clonal T-cell population.,28018996_3,0,1,-1,-1,31031,-1,0.00045447698,0.9961927,0.0033528006
31033,T-cell,23,24,166,172,NF-B staining and mRNA quantification of inflammatory genes in HK-2 epithelial renal cells exposed to supernatants of peripheral blood mononuclear cells with clonal T-cell population.,28018996_3,-1,1,2,-1,31033,-1,3.428829e-05,4.993948e-05,0.9999157
31034,T-cell,10,11,53,59,"RESULTS: Here, we could identify a persistent clonal T-cell population, only characterized by in-depth immunophenotyping of circulating lymphocytes and using multiplex PCR analysis of TCR gene rearrangements, in two patients with polymorphic inflammatory renal fibrosis of unknown origin.",28018996_4,-1,1,2,-1,31034,-1,2.9919722e-05,4.304202e-05,0.99992704
31036,analysis,25,26,172,180,"RESULTS: Here, we could identify a persistent clonal T-cell population, only characterized by in-depth immunophenotyping of circulating lymphocytes and using multiplex PCR analysis of TCR gene rearrangements, in two patients with polymorphic inflammatory renal fibrosis of unknown origin.",28018996_4,0,1,-1,-1,31036,-1,4.3259228e-05,0.9999082,4.8499856e-05
31037,TCR gene,27,29,184,192,"RESULTS: Here, we could identify a persistent clonal T-cell population, only characterized by in-depth immunophenotyping of circulating lymphocytes and using multiplex PCR analysis of TCR gene rearrangements, in two patients with polymorphic inflammatory renal fibrosis of unknown origin.",28018996_4,-1,-1,-1,-1,31037,-1,3.0499486e-05,0.99994147,2.7997672e-05
31040,blood,11,12,65,70,"Using an in vitro approach, we could demonstrate that peripheral blood mononuclear cells including the clonal population can trigger a phenotype switch of epithelial renal cells from a quiescent state to a pro-inflammatory state characterized by NF-B nuclear translocation and overexpression of inflammatory cytokine or chemokine.",28018996_5,0,1,-1,-1,31040,-1,8.0866615e-05,0.9997588,0.00016032954
31045,state to,30,32,195,203,"Using an in vitro approach, we could demonstrate that peripheral blood mononuclear cells including the clonal population can trigger a phenotype switch of epithelial renal cells from a quiescent state to a pro-inflammatory state characterized by NF-B nuclear translocation and overexpression of inflammatory cytokine or chemokine.",28018996_5,-1,-1,-1,-1,31045,-1,2.418123e-05,0.99995935,1.6469246e-05
31052,T-cell,8,9,60,66,"CONCLUSION: These preliminary data suggest that circulating T-cell clones may directly activate epithelial renal cells or promote a T-/B-cell population with autoimmune reactive properties against kidney cells, which, in the absence of overt renal lymphoma infiltration, lead to the subsequent inflammatory renal fibrotic phenotype.",28018996_6,-1,1,2,-1,31052,-1,3.3582197e-05,4.9253817e-05,0.99991715
31054,kidney cells,26,28,197,209,"CONCLUSION: These preliminary data suggest that circulating T-cell clones may directly activate epithelial renal cells or promote a T-/B-cell population with autoimmune reactive properties against kidney cells, which, in the absence of overt renal lymphoma infiltration, lead to the subsequent inflammatory renal fibrotic phenotype.",28018996_6,-1,-1,-1,-1,31054,-1,0.000650655,0.0024191535,0.9969302
31056,to the,41,43,276,282,"CONCLUSION: These preliminary data suggest that circulating T-cell clones may directly activate epithelial renal cells or promote a T-/B-cell population with autoimmune reactive properties against kidney cells, which, in the absence of overt renal lymphoma infiltration, lead to the subsequent inflammatory renal fibrotic phenotype.",28018996_6,-1,-1,-1,-1,31056,-1,1.9113817e-05,0.9999713,9.588501e-06
31062,T-cell,5,6,35,41,"We explored approaches to overcome T-cell suppression in murine breast and kidney adenocarcinomas, and lung fibrosarcoma expressing immunogenic antigens.",28052005_1,-1,1,2,-1,31062,-1,3.3633944e-05,5.258668e-05,0.9999138
31065,that treatment,2,4,12,26,"We observed that treatment with a reversible proteasome inhibitor bortezomib (1 mg/kg body weight) in tumor-bearing mice significantly enhanced the expression of lymphocyte-stimulatory cytokines IL-2, IL-12, and IL-15.",28052005_2,-1,-1,-1,-1,31065,-1,1.9776524e-05,0.9999701,1.0151724e-05
31068,lymphocyte-stimulatory cytokines,24,26,162,194,"We observed that treatment with a reversible proteasome inhibitor bortezomib (1 mg/kg body weight) in tumor-bearing mice significantly enhanced the expression of lymphocyte-stimulatory cytokines IL-2, IL-12, and IL-15.",28052005_2,-1,-1,-1,-1,31068,-1,0.11212412,0.0024724905,0.88540334
31073,IL-15 cytokines,4,6,28,43,Neutralization of IL-12 and IL-15 cytokines with a regimen of blocking antibodies pre- and post-adoptive transfer of low-avidity HA518-526-specific CD8+T-cells following intravenous injection of 4T1HA cells increased the number of pulmonary tumor nodules.,28052005_4,-1,-1,-1,-1,31073,-1,0.99986243,2.874067e-05,0.00010879207
31079,the tumor,6,8,47,56,This neutralization effect was counteracted by the tumor metastasis-suppressing action of bortezomib treatments.,28052005_5,-1,-1,-1,-1,31079,-1,2.0509118e-05,0.99997187,7.611183e-06
31089,IL-15 receptors,13,15,65,80,"We also noted a trend of increased expression of IL-2, IL-12 and IL-15 receptors as well as increased phosphorylation of STAT5 in tumor-infiltrating CD8+T-cells following bortezomib treatment.",28052005_7,-1,-1,-1,-1,31089,-1,0.8985387,0.0040982678,0.09736303
31093,protein,9,10,98,105,"Furthermore, bortezomib-treated CD8+T-cells showed increased phosphorylation of mitogen-activated protein kinase p38, and Akt, which was abrogated by phosphatidylinositide 3-kinase (PI3K) inhibitor.",28052005_8,0,1,-1,-1,31093,-1,6.398602e-05,0.99987614,5.9827642e-05
31095,the therapeutic,3,5,19,34,"These data support the therapeutic potential of bortezomib in conjunction with other immunotherapies to augment the strength of convergent signals from CD8+T-cell signaling molecules including TCR, cytokine receptors and downstream PI3K/Akt/STAT5 pathways to sustain CD8+T-cell effector function in the tumor microenvironment.",28052005_9,-1,-1,-1,-1,31095,-1,2.0334706e-05,0.9999707,8.951013e-06
31098,TCR,25,26,193,196,"These data support the therapeutic potential of bortezomib in conjunction with other immunotherapies to augment the strength of convergent signals from CD8+T-cell signaling molecules including TCR, cytokine receptors and downstream PI3K/Akt/STAT5 pathways to sustain CD8+T-cell effector function in the tumor microenvironment.",28052005_9,-1,1,2,-1,31098,-1,3.0479388e-05,0.9999442,2.5275145e-05
31099,cytokine receptors,27,29,198,216,"These data support the therapeutic potential of bortezomib in conjunction with other immunotherapies to augment the strength of convergent signals from CD8+T-cell signaling molecules including TCR, cytokine receptors and downstream PI3K/Akt/STAT5 pathways to sustain CD8+T-cell effector function in the tumor microenvironment.",28052005_9,-1,-1,-1,-1,31099,-1,0.9613935,0.00054613553,0.038060438
31101,function,37,38,287,295,"These data support the therapeutic potential of bortezomib in conjunction with other immunotherapies to augment the strength of convergent signals from CD8+T-cell signaling molecules including TCR, cytokine receptors and downstream PI3K/Akt/STAT5 pathways to sustain CD8+T-cell effector function in the tumor microenvironment.",28052005_9,0,1,2,-1,31101,-1,0.0011400061,0.0363814,0.9624786
31102,the tumor,39,41,299,308,"These data support the therapeutic potential of bortezomib in conjunction with other immunotherapies to augment the strength of convergent signals from CD8+T-cell signaling molecules including TCR, cytokine receptors and downstream PI3K/Akt/STAT5 pathways to sustain CD8+T-cell effector function in the tumor microenvironment.",28052005_9,-1,-1,-1,-1,31102,-1,1.9326026e-05,0.9999716,8.986159e-06
31103,T cells that,2,5,5,17,CD8+ T cells that express retinoic acid-related orphan receptor (ROR)t (TC17 cells) have been shown to promote procarcinogenic inflammation and contribute to a tolerogenic microenvironment in tumors.,28053236_0,-1,-1,-1,-1,31103,-1,0.001506587,0.032351177,0.96614224
31104,receptor,9,10,55,63,CD8+ T cells that express retinoic acid-related orphan receptor (ROR)t (TC17 cells) have been shown to promote procarcinogenic inflammation and contribute to a tolerogenic microenvironment in tumors.,28053236_0,0,1,2,-1,31104,-1,0.000767817,0.037855346,0.96137685
31105,TC17 cells,12,14,73,83,CD8+ T cells that express retinoic acid-related orphan receptor (ROR)t (TC17 cells) have been shown to promote procarcinogenic inflammation and contribute to a tolerogenic microenvironment in tumors.,28053236_0,-1,-1,-1,-1,31105,-1,0.0042097745,0.49435535,0.50143486
31111,functional,5,6,36,46,We investigated their phenotype and functional properties in relationship to the pathogenesis of human distal bile duct cancer (DBDC).,28053236_1,0,1,2,-1,31111,-1,4.332192e-05,0.99993634,2.038589e-05
31112,relationship to the,8,11,61,80,We investigated their phenotype and functional properties in relationship to the pathogenesis of human distal bile duct cancer (DBDC).,28053236_1,-1,-1,-1,-1,31112,-1,2.1904105e-05,0.99996614,1.1892065e-05
31117,TC17 cells,19,21,105,115,DBDC patients had an elevated level of type 17 immune responses and the frequency of CD8+RORt+ T cells (TC17 cells) was increased in peripheral blood.,28053236_2,-1,-1,-1,-1,31117,-1,0.002912552,0.22396736,0.7731201
31118,blood,26,27,145,150,DBDC patients had an elevated level of type 17 immune responses and the frequency of CD8+RORt+ T cells (TC17 cells) was increased in peripheral blood.,28053236_2,0,1,-1,-1,31118,-1,5.6711684e-05,0.99985635,8.692943e-05
31124,TH17 cells,20,22,120,130,The CD8+RORt+ T cells represented a highly activated subset and produced IL-17A in equal amount as CD4+RORt+ T cells (TH17 cells).,28053236_3,-1,-1,-1,-1,31124,-1,0.00090705755,0.015601892,0.983491
31132,plasticity toward,23,25,146,163,"Most CD8+RORt+ T cells coexpressed T-bet, a lineage transcription factor for TH1 and TC1 development, suggesting that CD8+RORt+ T cells undergo plasticity toward a TC17/1-like phenotype with coproduction of IL-17A and INF-.",28053236_4,-1,-1,-1,-1,31132,-1,2.4136869e-05,0.9999571,1.876752e-05
31137,TCR,16,17,84,87,"In comparison with CD8+RORt- T cells, the CD8+RORt+ T cells had a higher level of TCR signaling and were terminally differentiated and exhausted.",28053236_5,-1,1,2,-1,31137,-1,3.374306e-05,0.99993515,3.1076583e-05
31139,These cells,0,2,0,11,These cells also had impaired ability to re-express perforin after degranulation and reduced cytotoxic immune function.,28053236_6,-1,-1,-1,-1,31139,-1,0.0036479265,0.32039508,0.67595696
31141,function,15,16,110,118,These cells also had impaired ability to re-express perforin after degranulation and reduced cytotoxic immune function.,28053236_6,0,1,2,-1,31141,-1,0.021509081,0.93987733,0.03861357
31145,protein,14,15,79,86,A subset of CD8+RORt+ T cells expressing a low level of programmed cell death protein 1 and a high level of OX40 were associated with reduced patient survival.,28053236_7,0,1,-1,-1,31145,-1,0.00014564783,0.99965024,0.00020406168
31147,functionally,9,10,58,70,"In conclusion, CD8+RORt+ T cells are proinflammatory and functionally impaired and may contribute to the pathogenesis of DBDC.",28053236_8,0,1,2,-1,31147,-1,0.00012494388,0.99984086,3.415997e-05
31148,to the,14,16,99,105,"In conclusion, CD8+RORt+ T cells are proinflammatory and functionally impaired and may contribute to the pathogenesis of DBDC.",28053236_8,-1,-1,-1,-1,31148,-1,2.7576298e-05,0.9999602,1.228875e-05
31160,targets that,1,3,5,17,Drug targets that are in use to interfere with inflammation in cancer are discussed.,28067176_4,-1,-1,-1,-1,31160,-1,2.8692739e-05,0.9999577,1.3630253e-05
31162,tumor-induced tolerance,4,6,34,57,CONCLUSION: Inflammation mediates tumor-induced tolerance.,28067176_5,-1,-1,-1,-1,31162,-1,3.180353e-05,0.99995124,1.6893095e-05
31167,peptide,5,6,27,34,"MENK, an endogenous opioid peptide has been reported to have many immunological and antitumor activities.",28088065_0,0,-1,2,-1,31167,-1,0.008318406,0.95560366,0.036077924
31179,TLR4 through,36,38,235,247,"We found bone marrow derived dendritic cells (BMDCs) in 36 female C57BL/6 mice treated with MENK enhanced expression of key surface molecules, increased production of critical cytokines reduced endocytosis of FITC-dextran, upregulated TLR4 through MyD88/NF-B signaling pathway and mounted higher antitumor activity.",28088065_4,-1,-1,-1,-1,31179,-1,2.7742963e-05,0.9999471,2.512681e-05
31185,receptors,3,4,24,33,"Surprisingly, mu-opioid receptors were the main participants of this kind of activation, not delta-opioid receptors nor kappa-opioid receptors, and these interactions could be partly blocked by Naltrexone (a kind of opioid antagonist).",28088065_6,0,1,2,-1,31185,-1,0.00047041086,0.055185363,0.9443442
31188,receptors,16,17,106,115,"Surprisingly, mu-opioid receptors were the main participants of this kind of activation, not delta-opioid receptors nor kappa-opioid receptors, and these interactions could be partly blocked by Naltrexone (a kind of opioid antagonist).",28088065_6,0,1,2,-1,31188,-1,0.000823668,0.23615196,0.7630244
31189,receptors,19,20,133,142,"Surprisingly, mu-opioid receptors were the main participants of this kind of activation, not delta-opioid receptors nor kappa-opioid receptors, and these interactions could be partly blocked by Naltrexone (a kind of opioid antagonist).",28088065_6,0,1,2,-1,31189,-1,0.000786067,0.14354639,0.8556676
31201,receptor,15,16,97,105,"Thus, it is concluded that MENK could exert antitumor effect through precisely regulating opioid receptor mediated functions of DCs.",28088065_8,0,1,2,-1,31201,-1,0.0020463464,0.9725946,0.025359109
31202,functions,17,18,115,124,"Thus, it is concluded that MENK could exert antitumor effect through precisely regulating opioid receptor mediated functions of DCs.",28088065_8,0,1,2,-1,31202,-1,0.000121413585,0.99967873,0.00019986318
31205,The c-Rel transcription factor,0,4,0,30,"The c-Rel transcription factor is a unique member of the nuclear factor (NF)-B family that has a role in curtailing the proliferation, differentiation, cytokine production, and overall activity of B- and T-cells.",28090796_0,-1,-1,-1,-1,31205,-1,2.2565686e-05,0.99996126,1.6211086e-05
31206,the nuclear factor,9,12,53,71,"The c-Rel transcription factor is a unique member of the nuclear factor (NF)-B family that has a role in curtailing the proliferation, differentiation, cytokine production, and overall activity of B- and T-cells.",28090796_0,-1,-1,-1,-1,31206,-1,2.3014081e-05,0.99996173,1.5301717e-05
31210,T-cells,34,35,205,212,"The c-Rel transcription factor is a unique member of the nuclear factor (NF)-B family that has a role in curtailing the proliferation, differentiation, cytokine production, and overall activity of B- and T-cells.",28090796_0,-1,1,2,-1,31210,-1,0.00032889485,0.006804693,0.9928664
31218,the relationship,3,5,21,37,"To better understand the relationship between c-Rel expression and effects on B- and T-cell expansion, the current study evaluated c-Rel expression in cord blood mononuclear cells.",28090796_2,-1,-1,-1,-1,31218,-1,1.9990826e-05,0.99997056,9.4587085e-06
31220,T-cell,13,14,85,91,"To better understand the relationship between c-Rel expression and effects on B- and T-cell expansion, the current study evaluated c-Rel expression in cord blood mononuclear cells.",28090796_2,-1,1,2,-1,31220,-1,8.9799185e-05,0.00035124258,0.99955887
31223,blood,24,25,156,161,"To better understand the relationship between c-Rel expression and effects on B- and T-cell expansion, the current study evaluated c-Rel expression in cord blood mononuclear cells.",28090796_2,0,1,-1,-1,31223,-1,6.9674395e-05,0.9998098,0.000120554876
31226,blood,7,8,44,49,"This particular source was selected as cord blood is an important source of cells used for transplantation and immunotherapy, primarily in treating leukemias.",28090796_3,0,1,-1,-1,31226,-1,0.00017085637,0.99865156,0.0011776466
31228,transplantation,16,17,91,106,"This particular source was selected as cord blood is an important source of cells used for transplantation and immunotherapy, primarily in treating leukemias.",28090796_3,-1,1,2,-1,31228,-1,4.0914412e-05,0.9999337,2.5396754e-05
31238,blood,52,53,277,282,"As stem cell factor (SCF) and FLT3 are important agents for hematopoietic stem cell expansion, and cytokines like interleukin (IL)-2, -7, and -15 are essential for T- and B- (and also NK) cell development and proliferation, the current study evaluated c-Rel expression in cord blood mononuclear cells and CD34+cells, as well as effects on B-, T-, and NK cells associated with alterations in c-Rel expression, using flow cytometry and PCR.",28090796_4,0,1,-1,-1,31238,-1,6.2947875e-05,0.9998549,8.21577e-05
31253,blood-derived,10,11,62,75,"Further, inhibition of c-Rel expression by siRNA reduced cord blood-derived B-, T-, and NK cell differentiation and expansion.",28090796_6,0,1,-1,-1,31253,-1,0.000154374,0.99938345,0.00046211592
31259,blood,9,10,59,64,"These results indicated that with cells isolated from cord blood, c-Rel has an important role in B-, T-, and NK cell differentiation and, further, that agents (select cytokines/growth factors) that could impact on its expression might not only affect immune cell profiles in a host but could potentially also limit apoptotic activities in (non-)immune cells in that host.",28090796_7,0,1,-1,-1,31259,-1,9.014811e-05,0.9996766,0.0002333272
31264,factors,34,35,184,191,"These results indicated that with cells isolated from cord blood, c-Rel has an important role in B-, T-, and NK cell differentiation and, further, that agents (select cytokines/growth factors) that could impact on its expression might not only affect immune cell profiles in a host but could potentially also limit apoptotic activities in (non-)immune cells in that host.",28090796_7,0,1,-1,-1,31264,-1,0.9996251,0.00014850103,0.00022643033
31270,blood,12,13,67,72,"In the context of cancer (immuno)therapy, in particular, when cord blood is used an important source in stem cell transplantation in leukemia patients, such down-regulating changes in c-Rel levels could be counter-productive.",28090796_8,0,1,-1,-1,31270,-1,0.0023818049,0.7639051,0.23371305
31271,cell transplantation,20,22,109,129,"In the context of cancer (immuno)therapy, in particular, when cord blood is used an important source in stem cell transplantation in leukemia patients, such down-regulating changes in c-Rel levels could be counter-productive.",28090796_8,-1,-1,-1,-1,31271,-1,0.0031807176,0.08296149,0.9138578
31280,antigen-specific targeting,9,11,57,83,We previously showed that polyclonal T cells can acquire antigen-specific targeting activity through arming with exosomal peptide-MHC (pMHC).,28096300_1,-1,-1,-1,-1,31280,-1,0.9565175,0.033098742,0.010383764
31282,peptide-MHC,16,17,122,133,We previously showed that polyclonal T cells can acquire antigen-specific targeting activity through arming with exosomal peptide-MHC (pMHC).,28096300_1,0,-1,2,-1,31282,-1,0.35455894,0.61682767,0.028613402
31289,immunity,36,37,212,220,"In this study, we assessed the suppressive effect of CD8+25+ Tregs or CD8+25+ Tregs armed with ovalbumin (OVA)-specific exosomes on other immune cells and OVA-specific dendritic cell (DCOVA)-stimulated antitumor immunity.",28096300_2,0,-1,2,-1,31289,-1,0.9990741,0.00061324326,0.0003125859
31303,through the,8,10,52,63,"Tregs also anergize DCs by preventing DC maturation through the down-regulation of Iab, CD80, CD86, and inflammatory cytokines, leading to defects in T cell stimulation.",28096300_5,-1,-1,-1,-1,31303,-1,2.279627e-05,0.9999653,1.1938895e-05
31309,CTLs through,8,10,32,44,"Moreover, CD8+25+ Tregs inhibit CTLs through inducing CTL death via perforin-mediated apoptosis and through reducing effector CTL cytotoxic activity via down-regulating CTL perforin-production and degranulation.",28096300_6,-1,-1,-1,-1,31309,-1,0.0018091918,0.030201446,0.96798944
31317,immunity,22,23,123,131,"In addition, we show that CD8+25+ Tregs suppress DCOVA-stimulated CTL responses in priming and effector phases and inhibit immunity against OVA-expressing CCLOVA lung cancer.",28096300_7,0,-1,2,-1,31317,-1,0.98722816,0.012231539,0.0005402905
31324,Taken together,0,2,0,14,"Taken together, our investigation reveals that assigning antigen specificity to nonspecific polyclonal CD8+25+ Tregs for enhanced immune suppression can be achieved through exosomal pMHC arming.",28096300_9,-1,-1,-1,-1,31324,-1,4.2536623e-05,0.9999393,1.8082857e-05
31335,therapy,6,7,33,40,"In mouse models of PD-1 blockade therapy, we found that tumor-reactive cytotoxic T lymphocytes (CTLs) in draining lymph nodes (DLNs) carry increased mitochondrial mass and more reactive oxygen species (ROS).",28096382_1,0,1,-1,-1,31335,-1,2.0630212e-05,0.9999671,1.228484e-05
31336,that tumor-reactive cytotoxic T lymphocytes,10,15,51,94,"In mouse models of PD-1 blockade therapy, we found that tumor-reactive cytotoxic T lymphocytes (CTLs) in draining lymph nodes (DLNs) carry increased mitochondrial mass and more reactive oxygen species (ROS).",28096382_1,-1,-1,-1,-1,31336,-1,0.0041033705,0.6532947,0.342602
31341,the tumoricidal,14,16,99,114,We show that ROS generation by ROS precursors or indirectly by mitochondrial uncouplers synergized the tumoricidal activity of PD-1 blockade by expansion of effector/memory CTLs in DLNs and within the tumor.,28096382_2,-1,-1,-1,-1,31341,-1,4.841673e-05,0.9999331,1.8468698e-05
31343,the tumor,29,31,197,206,We show that ROS generation by ROS precursors or indirectly by mitochondrial uncouplers synergized the tumoricidal activity of PD-1 blockade by expansion of effector/memory CTLs in DLNs and within the tumor.,28096382_2,-1,-1,-1,-1,31343,-1,2.2528362e-05,0.9999671,1.0429509e-05
31344,These CTLs,0,2,0,10,These CTLs carry not only the activation of mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) but also an increment of their downstream transcription factors such as PPAR-gamma coactivator 1 (PGC-1) and T-bet.,28096382_3,-1,-1,-1,-1,31344,-1,0.0025257466,0.18871401,0.8087602
31347,protein,17,18,101,108,These CTLs carry not only the activation of mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) but also an increment of their downstream transcription factors such as PPAR-gamma coactivator 1 (PGC-1) and T-bet.,28096382_3,0,1,-1,-1,31347,-1,7.515952e-05,0.9998203,0.00010458229
31350,PPAR-gamma coactivator,33,35,195,217,These CTLs carry not only the activation of mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) but also an increment of their downstream transcription factors such as PPAR-gamma coactivator 1 (PGC-1) and T-bet.,28096382_3,-1,-1,-1,-1,31350,-1,4.1269217e-05,0.99991465,4.4059623e-05
31354,therapy,16,17,90,97,"Furthermore, direct activators of mTOR, AMPK, or PGC-1 also synergized the PD-1 blockade therapy whereas none of above-mentioned chemicals alone had any effects on tumor growth.",28096382_4,0,1,-1,-1,31354,-1,2.471516e-05,0.99996233,1.3011038e-05
31362,functions,8,9,48,57,AIM: To investigate the abundance and potential functions of LAP+CD4+ T cells in colorectal cancer (CRC).METHODS: Proportions of LAP+CD4+ T cells were examined in peripheral blood and tumor/paratumor tissues of CRC patients and healthy controls using flow cytometry.,28210081_0,0,1,2,-1,31362,-1,4.7759648e-05,0.9999293,2.293632e-05
31365,blood,29,30,174,179,AIM: To investigate the abundance and potential functions of LAP+CD4+ T cells in colorectal cancer (CRC).METHODS: Proportions of LAP+CD4+ T cells were examined in peripheral blood and tumor/paratumor tissues of CRC patients and healthy controls using flow cytometry.,28210081_0,0,1,-1,-1,31365,-1,0.000101965896,0.9993861,0.00051197875
31366,tissues,32,33,200,207,AIM: To investigate the abundance and potential functions of LAP+CD4+ T cells in colorectal cancer (CRC).METHODS: Proportions of LAP+CD4+ T cells were examined in peripheral blood and tumor/paratumor tissues of CRC patients and healthy controls using flow cytometry.,28210081_0,-1,1,2,-1,31366,-1,4.4069333e-05,0.99988127,7.464364e-05
31368,T-lymphocyte-associated protein,11,13,73,104,"Expression of phenotypic markers such as forkhead box (Fox)p3, cytotoxic T-lymphocyte-associated protein (CTLA)-4, chemokine CC receptor (CCR)4 and CCR5 was measured using flow cytometry.",28210081_1,-1,-1,-1,-1,31368,-1,0.00037329234,0.0070890854,0.99253756
31370,receptor,17,18,128,136,"Expression of phenotypic markers such as forkhead box (Fox)p3, cytotoxic T-lymphocyte-associated protein (CTLA)-4, chemokine CC receptor (CCR)4 and CCR5 was measured using flow cytometry.",28210081_1,0,1,2,-1,31370,-1,0.00030305912,0.00029389973,0.999403
31376,cytokines interleukin,11,13,83,104,Real-time quantitative polymerase chain reaction was used to measure expression of cytokines interleukin (IL)-10 and transforming growth factor (TGF)-.,28210081_3,-1,-1,-1,-1,31376,-1,0.99984777,4.108434e-05,0.000111117224
31377,transforming growth factor,15,18,117,143,Real-time quantitative polymerase chain reaction was used to measure expression of cytokines interleukin (IL)-10 and transforming growth factor (TGF)-.,28210081_3,-1,-1,-1,-1,31377,-1,0.85674906,0.137394,0.0058570364
31380,blood,14,15,83,88,"RESULTS: The proportion of LAP+CD4+ T cells was significantly higher in peripheral blood from patients (9.44%  3.18%) than healthy controls (1.49%  1.00%, P < 0.001).",28210081_4,0,1,-1,-1,31380,-1,7.862839e-05,0.99958175,0.00033959353
31384,tumor tissues,14,16,79,92,"Among patients, the proportion of LAP+CD4+ T cells was significantly higher in tumor tissues (11.76%  3.74%) compared with paratumor tissues (3.87%  1.64%, P < 0.001).",28210081_5,-1,-1,-1,-1,31384,-1,2.4267862e-05,0.9999479,2.7801463e-05
31385,tissues,26,27,134,141,"Among patients, the proportion of LAP+CD4+ T cells was significantly higher in tumor tissues (11.76%  3.74%) compared with paratumor tissues (3.87%  1.64%, P < 0.001).",28210081_5,-1,1,2,-1,31385,-1,4.528376e-05,0.9998078,0.00014696935
31406,the tumor,8,10,44,53,CONCLUSION: LAP+CD4+ T cells accumulated in the tumor microenvironment of CRC patients and were involved in immune evasion mediated by IL-10 and TGF-.,28210081_10,-1,-1,-1,-1,31406,-1,1.92223e-05,0.9999708,9.926123e-06
31410,immunity,6,7,38,46,IL-21 is known to promote anti-tumour immunity due to its ability to promote T cell responses and counteract Treg-mediated suppression.,28239749_0,0,-1,2,-1,31410,-1,0.99864954,0.0010209437,0.00032948912
31421,natural Treg,18,20,110,122,"However, whether this represents inhibition of FOXP3 induction in nave CD4 T cells or curtailed expansion of natural Treg remains unclear.",28239749_2,-1,-1,-1,-1,31421,-1,4.2203457e-05,0.9999429,1.4933578e-05
31424,factors,13,14,98,105,"Moreover, whether this effect is maintained in an environment of tumour-derived immunosuppressive factors is not known.",28239749_3,0,1,-1,-1,31424,-1,0.9990683,0.0005485623,0.00038309046
31430,that FOXP3,29,31,133,143,"Here, we show that in the context of a number of cancers, nave CD45RA+ CD4 T cells are induced to express high levels of FOXP3, and that FOXP3 expression correlates with inhibition of T cell proliferation.",28239749_4,-1,-1,-1,-1,31430,-1,2.4190307e-05,0.9999628,1.3029434e-05
31438,that Treg,2,4,12,21,We conclude that Treg induction in nave T cells is a common phenomenon amongst a number of different cancers and that the ability of IL-21 to counteract this effect is further evidence of its promise in cancer therapy.,28239749_6,-1,-1,-1,-1,31438,-1,2.3702998e-05,0.9999666,9.678905e-06
31440,that the,20,22,114,122,We conclude that Treg induction in nave T cells is a common phenomenon amongst a number of different cancers and that the ability of IL-21 to counteract this effect is further evidence of its promise in cancer therapy.,28239749_6,-1,-1,-1,-1,31440,-1,2.0485912e-05,0.99996984,9.649894e-06
31443,therapy,37,38,211,218,We conclude that Treg induction in nave T cells is a common phenomenon amongst a number of different cancers and that the ability of IL-21 to counteract this effect is further evidence of its promise in cancer therapy.,28239749_6,0,1,-1,-1,31443,-1,2.5495201e-05,0.9999622,1.2247346e-05
31445,to treat,10,12,77,85,Immunotherapy is being increasingly recognized as a key therapeutic modality to treat cancer and represents one of the most exciting treatments for the disease.,28258697_0,-1,-1,-1,-1,31445,-1,2.3591032e-05,0.9999658,1.0564236e-05
31450,therapies targeting the,11,14,86,109,"Fighting cancer with immunotherapy has revolutionized treatment for some patients and therapies targeting the immune checkpoint molecules such as CTLA-4 and PD-1 have achieved durable responses in melanoma, renal cancer, Hodgkin's diseases and lung cancer.",28258697_1,-1,-1,-1,-1,31450,-1,1.9332952e-05,0.99997056,1.0059557e-05
31453,these treatments,6,8,29,45,"However, the success rate of these treatments has been low and a large number of cancers, including colorectal cancer remain largely refractory to CTLA-4 and PD-1 blockade.",28258697_2,-1,-1,-1,-1,31453,-1,2.5534237e-05,0.99996233,1.2112652e-05
31454,to CTLA-4,24,26,144,153,"However, the success rate of these treatments has been low and a large number of cancers, including colorectal cancer remain largely refractory to CTLA-4 and PD-1 blockade.",28258697_2,-1,-1,-1,-1,31454,-1,0.0024660577,0.083679594,0.91385436
31457,receptors that,8,10,58,72,This has provided impetus to identify other co-inhibitory receptors that could be exploited to enhance response rates of current immunotherapeutic agents and achieve responses to the cancers that are refectory to immunotherapy.,28258697_3,-1,-1,-1,-1,31457,-1,0.0013813622,0.9298999,0.0687188
31459,to the,24,26,176,182,This has provided impetus to identify other co-inhibitory receptors that could be exploited to enhance response rates of current immunotherapeutic agents and achieve responses to the cancers that are refectory to immunotherapy.,28258697_3,-1,-1,-1,-1,31459,-1,2.2229364e-05,0.9999672,1.0588912e-05
31463,receptor that,4,6,25,38,"Tim-3 is a co-inhibitory receptor that is expressed on IFN-g-producing T cells, FoxP3+ Treg cells and innate immune cells (macrophages and dendritic cells) where it has been shown to suppress their responses upon interaction with their ligand(s).",28258697_4,-1,-1,-1,-1,31463,-1,0.0020494002,0.8473084,0.15064222
31464,IFN-g-producing T cells,9,12,55,78,"Tim-3 is a co-inhibitory receptor that is expressed on IFN-g-producing T cells, FoxP3+ Treg cells and innate immune cells (macrophages and dendritic cells) where it has been shown to suppress their responses upon interaction with their ligand(s).",28258697_4,-1,-1,-1,-1,31464,-1,0.8609424,0.0015948319,0.13746278
31475,immunity,29,30,188,196,"Tim-3 has gained prominence as a potential candidate for cancer immunotherapy, where it has been shown that in vivo blockade of Tim-3 with other check-point inhibitors enhances anti-tumor immunity and suppresses tumor growth in several preclinical tumor models.",28258697_5,0,-1,2,-1,31475,-1,0.99924195,0.00054421567,0.00021381109
31484,cell types,19,21,114,124,"This review discusses the recent findings on Tim-3, the role it plays in regulating immune responses in different cell types and the rationale for targeting Tim-3 for effective cancer immunotherapy.",28258697_6,-1,-1,-1,-1,31484,-1,4.007203e-05,6.46621e-05,0.99989533
31486,targeting Tim-3,25,27,147,162,"This review discusses the recent findings on Tim-3, the role it plays in regulating immune responses in different cell types and the rationale for targeting Tim-3 for effective cancer immunotherapy.",28258697_6,-1,-1,-1,-1,31486,-1,2.1229584e-05,0.9999683,1.04649e-05
31490,to tumor-infiltrating lymphocytes,11,14,69,102,Triple-negative breast cancer (TNBC) cells are modulated in reaction to tumor-infiltrating lymphocytes.,28264810_0,-1,-1,-1,-1,31490,-1,0.0031089406,0.92596644,0.07092454
31492,to this,5,7,34,41,"However, their specific responses to this immune pressure are unknown.",28264810_1,-1,-1,-1,-1,31492,-1,4.137006e-05,0.9999434,1.5270067e-05
31497,the TNBC cell,17,20,99,112,"In order to address this question, we first used mRNA sequencing to compare the immunophenotype of the TNBC cell line MDA-MB-231 and the luminal breast cancer cell line MCF7 after both were cocultured with activated human T cells.",28264810_2,-1,-1,-1,-1,31497,-1,0.0027784395,0.88227844,0.114943154
31502,the cytokine-induced,3,5,24,44,"Despite similarities in the cytokine-induced immune signatures of the two cell lines, MDA-MD-231 cells were able to transcribe more IDO1 than MCF7 cells.",28264810_3,-1,-1,-1,-1,31502,-1,0.014262439,0.9854301,0.0003074488
31503,the two cell,8,11,66,78,"Despite similarities in the cytokine-induced immune signatures of the two cell lines, MDA-MD-231 cells were able to transcribe more IDO1 than MCF7 cells.",28264810_3,-1,-1,-1,-1,31503,-1,0.0039269524,0.7820887,0.21398434
31505,to transcribe,17,19,113,126,"Despite similarities in the cytokine-induced immune signatures of the two cell lines, MDA-MD-231 cells were able to transcribe more IDO1 than MCF7 cells.",28264810_3,-1,-1,-1,-1,31505,-1,2.1476038e-05,0.9999671,1.1419061e-05
31506,than MCF7 cells,21,24,137,152,"Despite similarities in the cytokine-induced immune signatures of the two cell lines, MDA-MD-231 cells were able to transcribe more IDO1 than MCF7 cells.",28264810_3,-1,-1,-1,-1,31506,-1,0.010745456,0.13246794,0.85678667
31507,The two cell,0,3,0,12,The two cell lines had similar upstream JAK/STAT1 signaling and IDO1 mRNA stability.,28264810_4,-1,-1,-1,-1,31507,-1,0.0027715599,0.872365,0.12486345
31510,protein,14,15,74,81,"However, using a series of breast cancer cell lines, IFN stimulated IDO1 protein expression and enzymatic activity only in ER-, not ER+, cell lines.",28264810_5,0,1,-1,-1,31510,-1,2.4471432e-05,0.9999548,2.0746898e-05
31514,MCF7 cells,10,12,82,92,"Treatment with 5-aza-deoxycytidine reversed the suppression of IDO1 expression in MCF7 cells, suggesting that DNA methylation was potentially involved in IDO1 induction.",28264810_6,-1,-1,-1,-1,31514,-1,0.0031656749,0.00080963946,0.9960246
31516,this trend,2,4,13,23,We confirmed this trend of IDO1 methylation by bisulfite pyrosequencing breast cancer cell lines and an independent cohort of primary breast tumors.,28264810_8,-1,-1,-1,-1,31516,-1,2.7031894e-05,0.9999604,1.25365295e-05
31519,Taken together,0,2,0,14,"Taken together, these findings suggest that IDO1 promoter methylation regulates anti-immune responses in breast cancer subtypes and could be used as a predictive biomarker for IDO1 inhibitor-based immunotherapy.",28264810_9,-1,-1,-1,-1,31519,-1,4.2449155e-05,0.9999428,1.4718888e-05
31526,to this,1,3,4,11,"Due to this controversial function, we aimed to explore whether an insufficient anti-tumour response during colitis-associated colon cancer could be ascribed to a hypoxic microenvironment.",28278498_2,-1,-1,-1,-1,31526,-1,2.282732e-05,0.9999684,8.810212e-06
31527,function,4,5,26,34,"Due to this controversial function, we aimed to explore whether an insufficient anti-tumour response during colitis-associated colon cancer could be ascribed to a hypoxic microenvironment.",28278498_2,0,1,2,-1,31527,-1,6.9574235e-05,0.9998895,4.093438e-05
31530,T cell immunity,16,19,94,109,"METHODS: Colitis-associated colon cancer was induced in wildtype mice, and hypoxia as well as T cell immunity were analysed in the colonic tumour tissues.",28278498_3,-1,-1,-1,-1,31530,-1,0.0027557756,0.00030565346,0.9969386
31532,tumour tissues,24,26,139,153,"METHODS: Colitis-associated colon cancer was induced in wildtype mice, and hypoxia as well as T cell immunity were analysed in the colonic tumour tissues.",28278498_3,-1,-1,-1,-1,31532,-1,0.00014995257,0.9987281,0.0011218977
31536,function,25,26,153,161,"In addition, CD4+ effector T cells and regulatory T cells were cultured under normoxic and hypoxic conditions and examined regarding their phenotype and function.",28278498_4,0,1,2,-1,31536,-1,0.00012987066,0.9997619,0.00010822813
31541,that T cell,8,11,52,63,"Complementary ex vivo and in vitro studies revealed that T cell stimulation under hypoxic conditions inhibited the differentiation, proliferation and IFN- production of TH1 cells and enhanced the suppressive capacity of regulatory T cells.",28278498_6,-1,-1,-1,-1,31541,-1,0.0036249757,0.15770577,0.83866924
31549,CD4+ T cell functions,13,18,71,92,"Moreover, we identified an active role for HIF-1 in the modulation of CD4+ T cell functions under hypoxic conditions.",28278498_7,-1,-1,-1,-1,31549,-1,7.524575e-05,0.00010798076,0.99981683
31551,function,9,10,59,67,CONCLUSION: Our data indicate that oxygen availability can function as a local modulator of CD4+ T cell responses and thus influences tumour immune surveillance in inflammation-associated colon cancer.,28278498_8,0,1,2,-1,31551,-1,3.883716e-05,0.9999453,1.5905454e-05
31560,that Th17 cells,3,6,13,28,Here we show that Th17 cells are a source of tumour-induced Foxp3+ cells.,28290453_1,-1,-1,-1,-1,31560,-1,0.004148271,0.56463146,0.43122023
31561,tumour-induced Foxp3,10,12,45,65,Here we show that Th17 cells are a source of tumour-induced Foxp3+ cells.,28290453_1,-1,-1,-1,-1,31561,-1,4.146763e-05,0.99994254,1.6014877e-05
31563,to natural,2,4,12,22,"In addition to natural (n)Treg and induced (i)Treg cells that develop from naive precursors, suppressive IL-17A+Foxp3+ and ex-Th17 Foxp3+ cells are converted from IL-17A+Foxp3neg cells in tumour-bearing mice.",28290453_2,-1,-1,-1,-1,31563,-1,2.7711338e-05,0.9999615,1.0824391e-05
31564,cells that,8,10,51,61,"In addition to natural (n)Treg and induced (i)Treg cells that develop from naive precursors, suppressive IL-17A+Foxp3+ and ex-Th17 Foxp3+ cells are converted from IL-17A+Foxp3neg cells in tumour-bearing mice.",28290453_2,-1,-1,-1,-1,31564,-1,0.0036487903,0.09213271,0.90421844
31565,naive precursors,12,14,75,91,"In addition to natural (n)Treg and induced (i)Treg cells that develop from naive precursors, suppressive IL-17A+Foxp3+ and ex-Th17 Foxp3+ cells are converted from IL-17A+Foxp3neg cells in tumour-bearing mice.",28290453_2,-1,-1,-1,-1,31565,-1,0.0056720343,0.22925918,0.7650688
31569,IL-17A+Foxp3neg cells,26,28,163,184,"In addition to natural (n)Treg and induced (i)Treg cells that develop from naive precursors, suppressive IL-17A+Foxp3+ and ex-Th17 Foxp3+ cells are converted from IL-17A+Foxp3neg cells in tumour-bearing mice.",28290453_2,-1,-1,-1,-1,31569,-1,0.7838072,0.003946586,0.21224622
31571,Foxp3-expressing IL-17A+,3,5,25,49,"Metabolic phenotyping of Foxp3-expressing IL-17A+, ex-Th17 and iTreg cells demonstrates the dissociation between the metabolic fitness and the suppressive function of Foxp3-expressing Treg cell subsets.",28290453_3,-1,-1,-1,-1,31571,-1,0.036656205,0.96089184,0.0024519535
31576,function,20,21,155,163,"Metabolic phenotyping of Foxp3-expressing IL-17A+, ex-Th17 and iTreg cells demonstrates the dissociation between the metabolic fitness and the suppressive function of Foxp3-expressing Treg cell subsets.",28290453_3,0,1,2,-1,31576,-1,6.8407295e-05,0.9998679,6.371379e-05
31577,Foxp3-expressing Treg cell subsets,22,26,167,201,"Metabolic phenotyping of Foxp3-expressing IL-17A+, ex-Th17 and iTreg cells demonstrates the dissociation between the metabolic fitness and the suppressive function of Foxp3-expressing Treg cell subsets.",28290453_3,-1,-1,-1,-1,31577,-1,0.0038762218,0.6563505,0.33977333
31578,Foxp3-expressing subsets,2,4,13,37,"Although all Foxp3-expressing subsets are immunosuppressive, glycolysis is a prominent metabolic pathway exerted only by IL-17A+Foxp3+ cells.",28290453_4,-1,-1,-1,-1,31578,-1,0.0018434485,0.9431082,0.055048365
31581,Transcriptome analysis,0,2,0,22,"Transcriptome analysis and flow cytometry of IL-17A+Foxp3+ cells indicate that Folr4, GARP, Itgb8, Pglyrp1, Il1rl1, Itgae, TIGIT and ICOS are Th17-to-Treg cell transdifferentiation-associated markers.",28290453_5,-1,-1,-1,-1,31581,-1,2.4407384e-05,0.9999577,1.7942875e-05
31587,Th17-to-Treg cell transdifferentiation-associated,27,30,142,191,"Transcriptome analysis and flow cytometry of IL-17A+Foxp3+ cells indicate that Folr4, GARP, Itgb8, Pglyrp1, Il1rl1, Itgae, TIGIT and ICOS are Th17-to-Treg cell transdifferentiation-associated markers.",28290453_5,-1,-1,-1,-1,31587,-1,0.0002716099,0.9979686,0.0017597487
31588,Tumour-associated Th17-to-Treg cell,0,3,0,35,Tumour-associated Th17-to-Treg cell conversion identified here provides insights for targeting the dynamism of Th17-Treg cells in cancer immunotherapy.,28290453_6,-1,-1,-1,-1,31588,-1,0.0035863866,0.8554892,0.14092444
31589,targeting the,9,11,85,98,Tumour-associated Th17-to-Treg cell conversion identified here provides insights for targeting the dynamism of Th17-Treg cells in cancer immunotherapy.,28290453_6,-1,-1,-1,-1,31589,-1,2.1266227e-05,0.9999715,7.2302823e-06
31590,Th17-Treg cells,13,15,111,126,Tumour-associated Th17-to-Treg cell conversion identified here provides insights for targeting the dynamism of Th17-Treg cells in cancer immunotherapy.,28290453_6,-1,-1,-1,-1,31590,-1,0.0003788785,0.0041645393,0.9954566
31605,tumor cells,4,6,23,34,"Moreover, grafted D2F2 tumor cells grew faster and intratumoral Foxp3+ cell accumulation was observed in these mice compared to sham-treated controls.",28332605_4,-1,-1,-1,-1,31605,-1,0.0033448082,0.32311898,0.67353624
31613,receptor,12,13,87,95,Results from reporter cell lines suggested that acrolein acts via the aryl-hydrocarbon receptor which could be inhibited by resveratrol and 3'-methoxy-4'-nitroflavone Acrolein- stimulation of human PBMCs increased Foxp3+ expression by T cells which could be antagonized by resveratrol.,28332605_5,0,1,2,-1,31613,-1,0.0010951229,0.80736405,0.19154081
31627,the regulation,5,7,33,47,"Besides the established roles in the regulation of inflammation and autoimmune disease, studies have shown that iNKT cells have important roles in tumor surveillance and the control of tumor metastasis.",28401935_1,-1,-1,-1,-1,31627,-1,2.0450865e-05,0.9999685,1.1029058e-05
31633,that the,3,5,14,22,"Here we found that the absence of iNKT cells markedly decreased the total number of intestinal polyps in APCMin/+ mice, a model for colorectal cancer.",28401935_2,-1,-1,-1,-1,31633,-1,1.8404218e-05,0.9999739,7.664005e-06
31635,the total,11,13,64,73,"Here we found that the absence of iNKT cells markedly decreased the total number of intestinal polyps in APCMin/+ mice, a model for colorectal cancer.",28401935_2,-1,-1,-1,-1,31635,-1,2.2953001e-05,0.9999659,1.1090478e-05
31638,IL-17-producing cells,9,11,63,84,"Polyp iNKT cells were enriched for interleukin-10 (IL-10)- and IL-17-producing cells, showed a distinct phenotype being CD4+, NK1.1- CD44int, and PD-1lo, and they were negative for the NKT cell transcription factor promyelocytic leukemia zinc-finger.",28401935_3,-1,-1,-1,-1,31638,-1,0.8166662,0.001600313,0.18173352
31640,the NKT cell transcription factor,31,36,181,214,"Polyp iNKT cells were enriched for interleukin-10 (IL-10)- and IL-17-producing cells, showed a distinct phenotype being CD4+, NK1.1- CD44int, and PD-1lo, and they were negative for the NKT cell transcription factor promyelocytic leukemia zinc-finger.",28401935_3,-1,-1,-1,-1,31640,-1,0.00010532572,0.99961674,0.00027790415
31646,FoxP3 protein,23,25,127,140,"The absence of iNKT cells was associated with a reduced frequency of regulatory T (Tregs) cells and lower expression levels of FoxP3 protein and transcript uniquely in the polyps, and a switch to an inflammatory macrophage phenotype.",28401935_4,-1,-1,-1,-1,31646,-1,2.2096387e-05,0.9999639,1.40553e-05
31656,this tissue,42,44,226,237,"Moreover, in iNKT cell-deficient APCMin/+ mice, expression of T-helper (TH) 1-associated genes, such as IFN- and Nos2, was increased in polyps, concomitantly with elevated frequencies of conventional CD4+ and CD8+ T cells in this tissue.",28401935_5,-1,-1,-1,-1,31656,-1,5.101815e-05,0.99980384,0.00014520556
31661,TH1 immunity,23,25,165,177,The results suggest that a population of regulatory iNKT cells locally promote intestinal polyp formation by enhancing Treg cells and immunosuppression of antitumor TH1 immunity.,28401935_6,-1,-1,-1,-1,31661,-1,0.07261879,0.9148124,0.012568849
31665,to the,12,14,70,76,Memory cytotoxic T lymphocytes (CTLs) are able to provide protections to the host against repeated insults from intracellular pathogens.,28405920_0,-1,-1,-1,-1,31665,-1,2.8821705e-05,0.9999591,1.2011455e-05
31667,functions,11,12,64,73,"However, it has not been completely understood how the effector functions of memory CTLs are induced upon antigen challenge, which is directly related to the efficacy of their protection.",28405920_1,0,1,2,-1,31667,-1,0.00018374523,0.99857223,0.0012440517
31670,related to the,24,27,143,157,"However, it has not been completely understood how the effector functions of memory CTLs are induced upon antigen challenge, which is directly related to the efficacy of their protection.",28405920_1,-1,-1,-1,-1,31670,-1,2.9361208e-05,0.9999558,1.4822501e-05
31679,function,21,22,114,122,"Third signal cytokines, such as IL-12 and type I interferon, have been suggested to be involved in the protective function of memory CTLs, but direct evidence is warranted.",28405920_2,0,1,2,-1,31679,-1,0.00015431106,0.9997193,0.00012636356
31686,functions,16,17,83,92,"In this report, we found that memory CTLs need to be reactivated to exert effector functions.",28405920_3,0,1,2,-1,31686,-1,0.00076000515,0.99384767,0.0053923004
31695,to antigen,12,14,78,88,This reactivation of memory CTLs requires cytokines such as IL-12 in addition to antigen but was less dependent upon costimulation and IL-2 compared to naive CTLs.,28405920_5,-1,-1,-1,-1,31695,-1,0.6817772,0.30577898,0.012443811
31696,to naive CTLs,23,26,149,162,This reactivation of memory CTLs requires cytokines such as IL-12 in addition to antigen but was less dependent upon costimulation and IL-2 compared to naive CTLs.,28405920_5,-1,-1,-1,-1,31696,-1,0.0054325797,0.45100522,0.5435622
31698,than their naive,9,12,61,77,"Memory CTLs responded more quickly and with greater strength than their naive counterparts upon stimulation, which is associated with higher upregulation of important transcription factors such as T-bet and phosphorylated STAT4.",28405920_6,-1,-1,-1,-1,31698,-1,2.3401144e-05,0.9999645,1.2109168e-05
31703,than naive CTLs,8,11,50,65,"In addition, memory CTLs underwent less expansion than naive CTLs upon pathogen challenge.",28405920_7,-1,-1,-1,-1,31703,-1,0.0047383117,0.37232783,0.62293386
31704,functions,4,5,24,33,"In conclusion, effector functions of established memory CTLs may be affected by certain cytokines such as IL-12 and type I IFN.",28405920_8,0,1,2,-1,31704,-1,0.0002318589,0.99902046,0.00074773206
31713,to the,11,13,64,70,"Thus, a pathogen's ability to induce cytokines could contribute to the efficacy of protection of an established memory CTL population.",28405920_9,-1,-1,-1,-1,31713,-1,2.3861634e-05,0.999966,1.0098508e-05
31718,that the,4,6,26,34,"Recent studies have shown that the CXCR5+CD8+ T cells present more potent proinflammatory function than CXCR5-CD8+ T cells in chronic virus infections and in follicular lymphoma, but the role of CXCR5+CD8+ T cells in colorectal cancer is yet unclear.",28412245_1,-1,-1,-1,-1,31718,-1,1.8505732e-05,0.99997175,9.793944e-06
31720,function than,14,16,90,103,"Recent studies have shown that the CXCR5+CD8+ T cells present more potent proinflammatory function than CXCR5-CD8+ T cells in chronic virus infections and in follicular lymphoma, but the role of CXCR5+CD8+ T cells in colorectal cancer is yet unclear.",28412245_1,-1,-1,-1,-1,31720,-1,0.0001399053,0.9997447,0.00011538242
31727,blood,16,17,84,89,"In this study, we demonstrated that CXCR5+CD8+ T cells were very rare in peripheral blood mononuclear cells from healthy and colorectal cancer individuals, but were significantly enriched in resected tumors and tumor-associated lymph nodes.",28412245_2,0,1,-1,-1,31727,-1,0.00021179613,0.998563,0.0012252156
31739,CD8+ T cell subset,32,37,195,213,"Compared to CXCR5-CD8+ T cells, the CXCR5+CD8+ T cells demonstrated significantly higher Bcl-6 expression and lower Blimp1 expression, suggesting that CXCR5+CD8+ T cells might represent a memory CD8+ T cell subset.",28412245_3,-1,-1,-1,-1,31739,-1,7.6252574e-05,7.507626e-05,0.9998486
31745,TNF,14,15,82,86,"Under ex vivo condition, the CXCR5+CD8+ T cells demonstrated lower degranulation, TNF expression and IFN expression than CXCR5-CD8+ T cells.",28412245_5,0,1,-1,-1,31745,-1,4.4639233e-05,0.99993587,1.9539357e-05
31750,TNF,11,12,66,70,"However, after PMA + ionomycin stimulation, the degranulation and TNF expression by CXCR5+CD8+ T cells were significantly elevated to a level comparable with CXCR5-CD8+ T cells, whereas the IFN expression by PMA + ionomycin-stimulated CXCR5+CD8+ T cells were significantly higher than that by CXCR5-CD8+ T cells.",28412245_6,0,1,-1,-1,31750,-1,3.412356e-05,0.9999523,1.3545432e-05
31754,the IFN,32,34,187,195,"However, after PMA + ionomycin stimulation, the degranulation and TNF expression by CXCR5+CD8+ T cells were significantly elevated to a level comparable with CXCR5-CD8+ T cells, whereas the IFN expression by PMA + ionomycin-stimulated CXCR5+CD8+ T cells were significantly higher than that by CXCR5-CD8+ T cells.",28412245_6,-1,-1,-1,-1,31754,-1,0.7428293,0.25356463,0.0036061415
31756,than that,46,48,282,291,"However, after PMA + ionomycin stimulation, the degranulation and TNF expression by CXCR5+CD8+ T cells were significantly elevated to a level comparable with CXCR5-CD8+ T cells, whereas the IFN expression by PMA + ionomycin-stimulated CXCR5+CD8+ T cells were significantly higher than that by CXCR5-CD8+ T cells.",28412245_6,-1,-1,-1,-1,31756,-1,2.579788e-05,0.99995875,1.545375e-05
31758,TCR-stimulation,2,3,20,35,"Following long-term TCR-stimulation, CXCR5+CD8+ T cells demonstrated significantly more potent proliferation capacity and higher IFN expression than CXCR5-CD8+ T cells.",28412245_7,-1,1,2,-1,31758,-1,2.7645183e-05,0.9999546,1.7779772e-05
31763,TCR-stimulated,0,1,0,14,TCR-stimulated CXCR5+CD8+ T cells also showed a gradual downregulation in CXCR5 expression.,28412245_8,-1,1,2,-1,31763,-1,3.1132764e-05,0.99995124,1.7664232e-05
31765,that TCR-stimulated,3,5,17,36,We further found that TCR-stimulated CXCR5+CD8+ T cells demonstrated higher granzyme B production and induced more specific lysis of autologous tumor cells than CXCR5-CD8+ T cells.,28412245_9,-1,-1,-1,-1,31765,-1,2.672731e-05,0.9999604,1.2901921e-05
31767,tumor cells than,21,24,144,160,We further found that TCR-stimulated CXCR5+CD8+ T cells demonstrated higher granzyme B production and induced more specific lysis of autologous tumor cells than CXCR5-CD8+ T cells.,28412245_9,-1,-1,-1,-1,31767,-1,8.763215e-05,0.99977845,0.00013398047
31773,CD8+ T cell subset,13,18,81,99,"Together, these data demonstrate that CXCR5+CD8+ T cells represent a significant CD8+ T cell subset in colorectal tumors and have the potential to contribute to antitumor immunity, but their specific roles require further studies in vivo.",28412245_10,-1,-1,-1,-1,31773,-1,7.9450525e-05,8.5381886e-05,0.99983513
31778,immunity,29,30,171,179,"Together, these data demonstrate that CXCR5+CD8+ T cells represent a significant CD8+ T cell subset in colorectal tumors and have the potential to contribute to antitumor immunity, but their specific roles require further studies in vivo.",28412245_10,0,-1,2,-1,31778,-1,0.99815,0.0015325296,0.00031751615
31782,growth factor receptor,7,10,41,63,The mutant Type III variant of epidermal growth factor receptor (EGFRvIII) is present in approximately one-third of glioblastoma (GBM) patients.,28412740_0,-1,-1,-1,-1,31782,-1,0.49214485,0.045624834,0.46223032
31783,tissues,6,7,28,35,"It is never found in normal tissues; therefore, it represents a candidate target for GBM immunotherapy.",28412740_1,-1,1,2,-1,31783,-1,0.000114747134,0.9987381,0.0011471666
31787,peptide,3,4,11,18,"PEPvIII, a peptide sequence from EGFRvIII, was designed to represent a target of glioma and is presented by MHC I/II complexes.",28412740_2,0,-1,2,-1,31787,-1,0.0012178358,0.9972107,0.0015714709
31794,T cells to,16,19,72,82,Dendritic cells (DCs) have great potential to sensitize CD4+ T and CD8+ T cells to precisely target and eradicate GBM.,28412740_3,-1,-1,-1,-1,31794,-1,0.0016748705,0.0345639,0.96376127
31796,that PEPvIII,4,6,14,26,"Here, we show that PEPvIII could be loaded by DCs and presented to T lymphocytes, especially PEPvIII-specific CTLs, to precisely kill U87-EGFRvIII cells.",28412740_4,-1,-1,-1,-1,31796,-1,3.7705504e-05,0.99993014,3.2159118e-05
31797,to T lymphocytes,13,16,64,80,"Here, we show that PEPvIII could be loaded by DCs and presented to T lymphocytes, especially PEPvIII-specific CTLs, to precisely kill U87-EGFRvIII cells.",28412740_4,-1,-1,-1,-1,31797,-1,0.0032039057,0.1338073,0.8629888
31798,PEPvIII-specific CTLs,18,20,93,114,"Here, we show that PEPvIII could be loaded by DCs and presented to T lymphocytes, especially PEPvIII-specific CTLs, to precisely kill U87-EGFRvIII cells.",28412740_4,-1,-1,-1,-1,31798,-1,0.004967355,0.7076713,0.28736132
31806,the tumour,21,23,139,149,"In addition to inhibiting proliferation and inducing the apoptosis of U87-EGFRvIII cells, miR-326 also reduced the expression of TGF-1 in the tumour environment, resulting in improved efficacy of T cell activation and killing via suppressing the SMO/Gli2 axis, which at least partially reversed the immunosuppressive environment.",28412740_5,-1,-1,-1,-1,31806,-1,2.3477924e-05,0.99996614,1.03999e-05
31815,immunity,15,16,106,114,"This finding suggested that a DC-based vaccine combined with miR-326 may induce more powerful anti-tumour immunity against GBM cells that express a relevant antigen, which provides a promising approach for GBM immunotherapy.",28412740_7,0,-1,2,-1,31815,-1,0.9982122,0.0015438996,0.00024395272
31816,cells that,18,20,127,137,"This finding suggested that a DC-based vaccine combined with miR-326 may induce more powerful anti-tumour immunity against GBM cells that express a relevant antigen, which provides a promising approach for GBM immunotherapy.",28412740_7,-1,-1,-1,-1,31816,-1,0.0040553054,0.09968967,0.896255
31817,relevant antigen,22,24,148,164,"This finding suggested that a DC-based vaccine combined with miR-326 may induce more powerful anti-tumour immunity against GBM cells that express a relevant antigen, which provides a promising approach for GBM immunotherapy.",28412740_7,-1,-1,-1,-1,31817,-1,0.9575403,0.031892557,0.010567181
31822,cells that play,5,8,40,55,Neutrophils are important innate immune cells that play key roles in tumor development.,28432279_1,-1,-1,-1,-1,31822,-1,0.008252755,0.37788028,0.613867
31832,function,15,16,120,128,The sustained expression of IL-35 could promote chronic inflammation to augment the proangiogenic and immunosuppressive function of neutrophils.,28432279_4,0,1,2,-1,31832,-1,0.00048671186,0.99854845,0.00096485007
31834,cytokines IL-1,6,8,56,71,IL-35 stimulated macrophages to secrete proinflammatory cytokines IL-1 and IL-6.,28432279_5,-1,-1,-1,-1,31834,-1,0.99909484,0.00038602174,0.0005192173
31837,T cells to,3,6,20,30,"IL-1 stimulated  T cells to produce IL-17, which in turn increased the production of G-CSF.",28432279_6,-1,-1,-1,-1,31837,-1,0.0013263889,0.042986237,0.95568746
31849,function,30,31,190,198,"By increasing the expression of G-CSF and IL-6, IL-35 could up-regulate the expression of MMP-9 and Bv8, and down-regulate TRAIL expression in neutrophils, thus augmenting the proangiogenic function of neutrophils.",28432279_7,0,1,2,-1,31849,-1,0.0002519417,0.9993672,0.00038084204
31858,functioning,10,11,65,76,Our findings suggest that IL-35 can promote tumor progression by functioning as an up-stream cytokine to promote cancer-associated inflammation and control neutrophil polarization.,28432279_9,0,1,2,-1,31858,-1,3.4226927e-05,0.99995184,1.3923601e-05
31859,cytokine to,14,16,93,104,Our findings suggest that IL-35 can promote tumor progression by functioning as an up-stream cytokine to promote cancer-associated inflammation and control neutrophil polarization.,28432279_9,-1,-1,-1,-1,31859,-1,0.9304747,0.0644988,0.0050265617
31861,tumor therapy,12,14,77,90,Targeting IL-35 might be an important approach for designing new strategy of tumor therapy.,28432279_10,-1,-1,-1,-1,31861,-1,2.4892444e-05,0.999964,1.1162144e-05
31870,Treg cells that,12,15,85,100,"Tumours, including intestinal malignancies, often present with local accumulation of Treg cells that can prevent tumour clearance, but how tumour progression leads to Treg cell accumulation is incompletely understood.",28437001_1,-1,-1,-1,-1,31870,-1,0.0016276796,0.06093344,0.93743885
31873,to Treg cell,25,28,164,176,"Tumours, including intestinal malignancies, often present with local accumulation of Treg cells that can prevent tumour clearance, but how tumour progression leads to Treg cell accumulation is incompletely understood.",28437001_1,-1,-1,-1,-1,31873,-1,0.0035921137,0.10830102,0.8881069
31884,Treg subset,42,44,270,281,"Here using genetically modified mouse models we show that ablation of E-cadherin, a process associated with epithelial to mesenchymal transition and tumour progression, promotes the accumulation of intestinal Treg cells by the specific accumulation of the KLRG1+ GATA3+ Treg subset.",28437001_2,-1,-1,-1,-1,31884,-1,9.0246176e-05,0.00037905827,0.9995308
31894,cytokine that,18,20,126,139,"Both E-cadherin ablation and increased -catenin signals resulted in epithelial cells with higher levels of interleukin-33, a cytokine that preferentially expands KLRG1+ GATA3+ Treg cells.",28437001_4,-1,-1,-1,-1,31894,-1,0.9707851,0.026669234,0.002545789
31901,to the,14,16,97,103,"Accordingly, Treg cell accumulation in intestinal tumours from APCmin/+ mice was exclusively due to the increase in KLRG1+ GATA3+ Treg cells.",28437001_6,-1,-1,-1,-1,31901,-1,2.1955022e-05,0.9999677,1.0329361e-05
31906,Treg cell subsets,12,15,76,93,"Our data identify a novel axis through which epithelial cells control local Treg cell subsets, which may be activated during intestinal tumorigenesis.",28437001_7,-1,-1,-1,-1,31906,-1,6.593006e-05,0.00014978852,0.9997843
31915,to the,4,6,28,34,"M2 cell products contribute to the growth-promoting attributes of the tumor microenvironment (TME) and bias immunity toward type 2, away from the type 1 mechanisms with antitumor properties.",28461570_1,-1,-1,-1,-1,31915,-1,2.6944921e-05,0.99995935,1.37213365e-05
31916,the tumor,9,11,66,75,"M2 cell products contribute to the growth-promoting attributes of the tumor microenvironment (TME) and bias immunity toward type 2, away from the type 1 mechanisms with antitumor properties.",28461570_1,-1,-1,-1,-1,31916,-1,2.1679361e-05,0.9999677,1.06325815e-05
31918,immunity toward type,17,20,108,128,"M2 cell products contribute to the growth-promoting attributes of the tumor microenvironment (TME) and bias immunity toward type 2, away from the type 1 mechanisms with antitumor properties.",28461570_1,-1,-1,-1,-1,31918,-1,0.0015624879,0.9979569,0.00048067534
31919,the type,24,26,142,150,"M2 cell products contribute to the growth-promoting attributes of the tumor microenvironment (TME) and bias immunity toward type 2, away from the type 1 mechanisms with antitumor properties.",28461570_1,-1,-1,-1,-1,31919,-1,3.2065564e-05,0.99994946,1.8443794e-05
31922,immunity,4,5,16,24,"To drive type 1 immunity in CNS tissues, we infected GL261 tumor-bearing mice with attenuated rabies virus (RABV).",28461570_2,0,-1,2,-1,31922,-1,0.99625045,0.003126863,0.0006227257
31923,tissues,7,8,32,39,"To drive type 1 immunity in CNS tissues, we infected GL261 tumor-bearing mice with attenuated rabies virus (RABV).",28461570_2,-1,1,2,-1,31923,-1,0.0013517898,0.5306562,0.467992
31927,tissues trans-axonally,6,8,40,62,"These neurotropic viruses spread to CNS tissues trans-axonally, where they induce a strong type 1 immune response that involves Th1, CD8, and B cell entry across the blood-brain barrier and virus clearance in the absence of overt sequelae.",28461570_3,-1,-1,-1,-1,31927,-1,0.00030104656,0.9976949,0.0020040555
31930,immune response that,16,19,98,118,"These neurotropic viruses spread to CNS tissues trans-axonally, where they induce a strong type 1 immune response that involves Th1, CD8, and B cell entry across the blood-brain barrier and virus clearance in the absence of overt sequelae.",28461570_3,-1,-1,-1,-1,31930,-1,0.9160017,0.08052482,0.0034735287
31933,the blood-brain,29,31,162,177,"These neurotropic viruses spread to CNS tissues trans-axonally, where they induce a strong type 1 immune response that involves Th1, CD8, and B cell entry across the blood-brain barrier and virus clearance in the absence of overt sequelae.",28461570_3,-1,-1,-1,-1,31933,-1,7.078274e-05,0.99988794,4.126741e-05
31938,to the tumor,6,9,36,48,"Despite the failure of virus spread to the tumor, infection resulted in significantly enhanced tumor necrosis, extensive CD4 T cell accumulation, and high levels of the proinflammatory factors IFN-, TNF-, and inducible NO synthase in the TME merely 4 d postinfection, before significant virus spread or the appearance of RABV-specific immune mechanisms in CNS tissues.",28461570_5,-1,-1,-1,-1,31938,-1,2.4858165e-05,0.99996114,1.4030178e-05
31942,factors IFN-,30,32,185,198,"Despite the failure of virus spread to the tumor, infection resulted in significantly enhanced tumor necrosis, extensive CD4 T cell accumulation, and high levels of the proinflammatory factors IFN-, TNF-, and inducible NO synthase in the TME merely 4 d postinfection, before significant virus spread or the appearance of RABV-specific immune mechanisms in CNS tissues.",28461570_5,-1,-1,-1,-1,31942,-1,0.9997383,9.301165e-05,0.00016881019
31943,TNF-,33,34,200,205,"Despite the failure of virus spread to the tumor, infection resulted in significantly enhanced tumor necrosis, extensive CD4 T cell accumulation, and high levels of the proinflammatory factors IFN-, TNF-, and inducible NO synthase in the TME merely 4 d postinfection, before significant virus spread or the appearance of RABV-specific immune mechanisms in CNS tissues.",28461570_5,0,1,-1,-1,31943,-1,0.0007737147,0.9991547,7.1585404e-05
31944,the TME,40,42,236,243,"Despite the failure of virus spread to the tumor, infection resulted in significantly enhanced tumor necrosis, extensive CD4 T cell accumulation, and high levels of the proinflammatory factors IFN-, TNF-, and inducible NO synthase in the TME merely 4 d postinfection, before significant virus spread or the appearance of RABV-specific immune mechanisms in CNS tissues.",28461570_5,-1,-1,-1,-1,31944,-1,2.2914379e-05,0.9999641,1.2984077e-05
31946,tissues,60,61,362,369,"Despite the failure of virus spread to the tumor, infection resulted in significantly enhanced tumor necrosis, extensive CD4 T cell accumulation, and high levels of the proinflammatory factors IFN-, TNF-, and inducible NO synthase in the TME merely 4 d postinfection, before significant virus spread or the appearance of RABV-specific immune mechanisms in CNS tissues.",28461570_5,-1,1,2,-1,31946,-1,0.0011005,0.87902874,0.119870834
31949,functionally,8,9,57,69,"Although the majority of infiltrating CD4 cells appeared functionally inactive, the proinflammatory changes in the TME later resulted in the loss of accumulating M2 and increased M1 TAMs.",28461570_6,0,1,2,-1,31949,-1,8.633689e-05,0.99987936,3.4281875e-05
31951,the TME,15,17,111,118,"Although the majority of infiltrating CD4 cells appeared functionally inactive, the proinflammatory changes in the TME later resulted in the loss of accumulating M2 and increased M1 TAMs.",28461570_6,-1,-1,-1,-1,31951,-1,2.4239298e-05,0.99996424,1.1514681e-05
31954,the Th1 transcription factor T-bet,3,8,18,52,"Mice deficient in the Th1 transcription factor T-bet did not gain any survival advantage from RABV infection, exhibiting only limited tumor necrosis and no change in TME cytokines or TAM phenotype and highlighting the importance of type 1 mechanisms in this process.",28461570_7,-1,-1,-1,-1,31954,-1,2.195503e-05,0.99996233,1.57709e-05
31956,TME cytokines,27,29,166,179,"Mice deficient in the Th1 transcription factor T-bet did not gain any survival advantage from RABV infection, exhibiting only limited tumor necrosis and no change in TME cytokines or TAM phenotype and highlighting the importance of type 1 mechanisms in this process.",28461570_7,-1,-1,-1,-1,31956,-1,0.14228609,0.85169023,0.006023636
31971,the Tregs,7,9,34,43,"Here, we explored how OA affected the Tregs in lung cancer environment and the involved underlying mechanism.",28472762_3,-1,-1,-1,-1,31971,-1,2.1099404e-05,0.99996865,1.0232765e-05
31974,the generation,6,8,29,43,It is found that OA reversed the generation of Tregs induced by H460 lung cancer cells co-culture.,28472762_4,-1,-1,-1,-1,31974,-1,2.1055892e-05,0.999969,9.942343e-06
31979,tumor-infiltrating lymphocytes,15,17,89,119,"Furthermore, in vivo, OA reduced tumor formation rate and attenuated Foxp3 expression in tumor-infiltrating lymphocytes.",28472762_5,-1,-1,-1,-1,31979,-1,0.0035154861,0.890141,0.10634346
31980,that transforming,3,5,14,31,We also found that transforming growth factor-1 (TGF-1) neutralizing antibody reversed the enhancement of Treg number and expression of p-Smad3'p-p38'p-JNK'p-ERK1/2 in the co-culture model.,28472762_6,-1,-1,-1,-1,31980,-1,2.2891738e-05,0.9999665,1.0548789e-05
31981,factor-1,6,7,39,48,We also found that transforming growth factor-1 (TGF-1) neutralizing antibody reversed the enhancement of Treg number and expression of p-Smad3'p-p38'p-JNK'p-ERK1/2 in the co-culture model.,28472762_6,0,1,-1,-1,31981,-1,0.9790906,0.016902136,0.004007361
31991,the T cells,10,13,58,69,OA also inhibited Treg activity by a direct inhibition of the T cells' response to TGF-1.,28472762_8,-1,-1,-1,-1,31991,-1,0.00175023,0.073609814,0.92463994
31992,to TGF-1,15,17,80,89,OA also inhibited Treg activity by a direct inhibition of the T cells' response to TGF-1.,28472762_8,-1,-1,-1,-1,31992,-1,4.063194e-05,0.99992955,2.9805598e-05
31994,the generation,9,11,55,69,"In conclusion, our study demonstrated that OA inhibits the generation of Tregs in lung cancer environment by inhibiting the T cells' response to TGF-1 and decreasing the secretion of TGF-1 in lung cancer cells via NF-B signaling.",28472762_9,-1,-1,-1,-1,31994,-1,1.7689264e-05,0.9999713,1.1045551e-05
31996,the T cells,19,22,120,131,"In conclusion, our study demonstrated that OA inhibits the generation of Tregs in lung cancer environment by inhibiting the T cells' response to TGF-1 and decreasing the secretion of TGF-1 in lung cancer cells via NF-B signaling.",28472762_9,-1,-1,-1,-1,31996,-1,0.0021576537,0.11385716,0.8839852
31997,to TGF-1,24,26,142,151,"In conclusion, our study demonstrated that OA inhibits the generation of Tregs in lung cancer environment by inhibiting the T cells' response to TGF-1 and decreasing the secretion of TGF-1 in lung cancer cells via NF-B signaling.",28472762_9,-1,-1,-1,-1,31997,-1,4.222925e-05,0.9999273,3.052748e-05
32019,blood,8,9,49,54,"The frequencies of ILC2s and MDSCs in peripheral blood mononuclear cells were determined, and the mRNA expression levels of ILC2s or Th2related transcription factors and cytokines, and MDSCsrelated products were assessed.",28487978_4,0,1,-1,-1,32019,-1,0.00018542538,0.99886703,0.000947605
32025,that the,3,5,25,33,"The results demonstrated that the frequencies of the circulatory ILC2s and MDSCs were enhanced in lung cancer patients, as were ILC2related transcription factors and cytokines in peripheral blood.",28487978_5,-1,-1,-1,-1,32025,-1,1.7089815e-05,0.99997425,8.630898e-06
32029,blood,28,29,191,196,"The results demonstrated that the frequencies of the circulatory ILC2s and MDSCs were enhanced in lung cancer patients, as were ILC2related transcription factors and cytokines in peripheral blood.",28487978_5,0,1,-1,-1,32029,-1,0.00012332958,0.9994537,0.0004229522
32046,function,7,8,36,44,Increased CD8+ T cell frequency and function is associated with better prognosis in cancer patients.,28488547_1,0,1,2,-1,32046,-1,0.0007416013,0.9865731,0.01268536
32050,immunity,14,15,89,97,Interleukin 10 is a cytokine with controversial roles in CD8+ T cell-mediated anti-tumor immunity.,28488547_2,0,-1,2,-1,32050,-1,0.99882764,0.0008153348,0.00035702233
32052,the interleukin 10,3,6,22,40,We therefore examined the interleukin 10 expression and consumption in CD8+ T cells harvested from the peripheral blood and resected tumors of gastric cancer patients of stages II-IV.,28488547_3,-1,-1,-1,-1,32052,-1,0.45076638,0.5459811,0.0032524583
32055,blood,18,19,114,119,We therefore examined the interleukin 10 expression and consumption in CD8+ T cells harvested from the peripheral blood and resected tumors of gastric cancer patients of stages II-IV.,28488547_3,0,1,-1,-1,32055,-1,0.00021637077,0.99606955,0.0037140795
32057,that the,2,4,9,17,We found that the gastric cancer patients presented significantly elevated frequencies of interleukin 10-expressing cells in both CD4+ and CD8+ T cells compared to healthy controls.,28488547_4,-1,-1,-1,-1,32057,-1,1.7831186e-05,0.99997246,9.707155e-06
32062,the interleukin,3,5,21,36,"But distinctive from the interleukin 10-expressing CD4+ T cells, which increased in frequency in advanced cancer, the interleukin 10-expressing CD8+ T cells did not increase with cancer stage in the peripheral blood and actually decreased with cancer stage in resected tumor.",28488547_5,-1,-1,-1,-1,32062,-1,0.21452425,0.780677,0.004798721
32064,the interleukin,19,21,114,129,"But distinctive from the interleukin 10-expressing CD4+ T cells, which increased in frequency in advanced cancer, the interleukin 10-expressing CD8+ T cells did not increase with cancer stage in the peripheral blood and actually decreased with cancer stage in resected tumor.",28488547_5,-1,-1,-1,-1,32064,-1,0.23888399,0.7562376,0.004878396
32067,blood,35,36,210,215,"But distinctive from the interleukin 10-expressing CD4+ T cells, which increased in frequency in advanced cancer, the interleukin 10-expressing CD8+ T cells did not increase with cancer stage in the peripheral blood and actually decreased with cancer stage in resected tumor.",28488547_5,0,1,-1,-1,32067,-1,0.0001788165,0.9987457,0.0010754385
32070,interleukin 10 receptor,3,6,19,42,Interleukin 10 and interleukin 10 receptor expression was also enriched in interferon gamma-expressing activated CD8+ T cells.,28488547_6,-1,-1,-1,-1,32070,-1,0.93860775,0.004564301,0.056828
32073,to interleukin,1,3,9,23,"Compared to interleukin 10-nonexpressing CD8+ T cells, interleukin 10 receptor-expressing CD8+ T cells secreted significantly elevated interferon gamma levels.",28488547_7,-1,-1,-1,-1,32073,-1,0.28281787,0.71108204,0.0061000516
32075,interleukin 10 receptor-expressing,9,12,55,89,"Compared to interleukin 10-nonexpressing CD8+ T cells, interleukin 10 receptor-expressing CD8+ T cells secreted significantly elevated interferon gamma levels.",28488547_7,-1,-1,-1,-1,32075,-1,0.9230724,0.017189661,0.05973782
32082,interleukin 10 receptor,26,29,160,183,"Treatment of anti-CD3/CD28-stimulated, purified CD8+ T cells with interleukin 10 alone could significantly enhance CD8+ T cell survival, an effect dependent on interleukin 10 receptor expression.",28488547_8,-1,-1,-1,-1,32082,-1,0.91948754,0.0043377792,0.07617474
32086,Analysis,0,1,0,8,Analysis of downstream signal transducer and activator of transcription molecules showed that interleukin 10 treatment significantly increased the phosphorylation of signal transducer and activator of transcription 3 and signal transducer and activator of transcription 1 to lesser extent.,28488547_10,0,1,-1,-1,32086,-1,2.0848986e-05,0.99996245,1.6729928e-05
32088,that interleukin 10 treatment,11,15,89,118,Analysis of downstream signal transducer and activator of transcription molecules showed that interleukin 10 treatment significantly increased the phosphorylation of signal transducer and activator of transcription 3 and signal transducer and activator of transcription 1 to lesser extent.,28488547_10,-1,-1,-1,-1,32088,-1,0.0002891287,0.9996301,8.0742786e-05
32091,signal transducer and activator of transcription 1 to,28,36,221,274,Analysis of downstream signal transducer and activator of transcription molecules showed that interleukin 10 treatment significantly increased the phosphorylation of signal transducer and activator of transcription 3 and signal transducer and activator of transcription 1 to lesser extent.,28488547_10,-1,-1,-1,-1,32091,-1,3.5758167e-05,0.9999366,2.7673172e-05
32094,that interleukin 10,5,8,36,55,"Together, these results demonstrate that interleukin 10 possessed stimulatory roles in activated CD8+ T cells from gastric cancer patients.",28488547_11,-1,-1,-1,-1,32094,-1,0.1999125,0.79830015,0.0017873273
32101,peptide,23,24,124,131,"Here, we describe a novel combination of aluminum salts (alum), CpG oligodeoxynucleotide (CpG) and innate defense regulator peptide HH2 for improving anti-tumor immune responses.",28515346_2,0,-1,2,-1,32101,-1,0.17982306,0.70283675,0.11734023
32107,TNF-,10,11,68,73,"The CpG-HH2 complex significantly enhanced the production of IFN-, TNF- and IL-1, promoted the uptake of antigen and strengthened the activation of p38, Erk1/2 and NF-B in vitro, compared to CpG or HH2 alone.",28515346_3,0,1,-1,-1,32107,-1,0.00057335297,0.999332,9.4623865e-05
32113,antigen plus,3,5,27,39,Immunization with NY-ESO-1 antigen plus alum-CpG-HH2 combinatorial adjuvant effectively inhibited tumor growth and reduced tumor burden in prophylactic and therapeutic tumor models and even in passive serum or cellular therapy.,28515346_4,-1,-1,-1,-1,32113,-1,0.92683035,0.059073355,0.014096307
32116,therapeutic tumor,19,21,156,173,Immunization with NY-ESO-1 antigen plus alum-CpG-HH2 combinatorial adjuvant effectively inhibited tumor growth and reduced tumor burden in prophylactic and therapeutic tumor models and even in passive serum or cellular therapy.,28515346_4,-1,-1,-1,-1,32116,-1,2.741223e-05,0.999959,1.3598512e-05
32117,cellular therapy,28,30,210,226,Immunization with NY-ESO-1 antigen plus alum-CpG-HH2 combinatorial adjuvant effectively inhibited tumor growth and reduced tumor burden in prophylactic and therapeutic tumor models and even in passive serum or cellular therapy.,28515346_4,-1,-1,-1,-1,32117,-1,0.004159627,0.07399393,0.92184645
32136,therapy,14,15,101,108,The identification of mechanisms leading to local immune dysregulation is critical to improve cancer therapy.,28533483_1,0,1,-1,-1,32136,-1,2.7428892e-05,0.9999621,1.0451699e-05
32137,that Interleukin-1 receptor,3,6,20,47,"We here demonstrate that Interleukin-1 receptor 8 (IL-1R8 - previously known as SIGIRR/TIR8), a negative regulator of Toll-Like and Interleukin-1 Receptor family signaling, is up-regulated during breast epithelial cell transformation and in primary breast tumors.",28533483_2,-1,-1,-1,-1,32137,-1,0.0061870706,0.9644573,0.029355677
32138,IL-1R8 -,8,10,51,59,"We here demonstrate that Interleukin-1 receptor 8 (IL-1R8 - previously known as SIGIRR/TIR8), a negative regulator of Toll-Like and Interleukin-1 Receptor family signaling, is up-regulated during breast epithelial cell transformation and in primary breast tumors.",28533483_2,-1,-1,-1,-1,32138,-1,0.9904242,0.0021118836,0.007463854
32140,Interleukin-1 Receptor,22,24,132,154,"We here demonstrate that Interleukin-1 receptor 8 (IL-1R8 - previously known as SIGIRR/TIR8), a negative regulator of Toll-Like and Interleukin-1 Receptor family signaling, is up-regulated during breast epithelial cell transformation and in primary breast tumors.",28533483_2,-1,-1,-1,-1,32140,-1,0.9787717,0.004214714,0.017013619
32141,cell transformation,32,34,214,233,"We here demonstrate that Interleukin-1 receptor 8 (IL-1R8 - previously known as SIGIRR/TIR8), a negative regulator of Toll-Like and Interleukin-1 Receptor family signaling, is up-regulated during breast epithelial cell transformation and in primary breast tumors.",28533483_2,-1,-1,-1,-1,32141,-1,0.0013089142,0.056602187,0.94208884
32154,analysis,4,5,31,39,"Finally, immune-gene signature analysis in clinical specimens revealed that high IL-1R8 expression is associated with impaired innate immune sensing and T-cell exclusion from the tumor microenvironment.",28533483_5,0,1,-1,-1,32154,-1,2.6345671e-05,0.9999504,2.3286142e-05
32157,T-cell,21,22,153,159,"Finally, immune-gene signature analysis in clinical specimens revealed that high IL-1R8 expression is associated with impaired innate immune sensing and T-cell exclusion from the tumor microenvironment.",28533483_5,-1,1,2,-1,32157,-1,3.457474e-05,5.003108e-05,0.99991536
32158,the tumor,24,26,175,184,"Finally, immune-gene signature analysis in clinical specimens revealed that high IL-1R8 expression is associated with impaired innate immune sensing and T-cell exclusion from the tumor microenvironment.",28533483_5,-1,-1,-1,-1,32158,-1,1.8567778e-05,0.9999716,9.75057e-06
32162,immunity,16,17,116,124,Our results indicate that high IL-1R8 expression acts as a novel immunomodulatory mechanism leading to dysregulated immunity with important implications for breast cancer immunotherapy.,28533483_6,0,-1,2,-1,32162,-1,0.99903893,0.0006169959,0.0003440144
32163,therapy,1,2,12,19,Anti-CTL4-A therapy is associated with development of colitis.,28548891_0,0,1,-1,-1,32163,-1,2.500966e-05,0.99996305,1.1968622e-05
32165,T-cells,15,16,123,130,Endoscopic characteristics resembled inflammatory bowel disease and histology revealed predominance of plasmacytes or CD4+ T-cells.,28548891_3,-1,1,2,-1,32165,-1,7.065751e-05,0.00021389955,0.9997154
32177,T-cell,18,19,134,140,Histone acetylation and the families of enzymes responsible for controlling these epigenetic marks have been implicated in regulating T-cell maturation and phenotype.,28550044_0,-1,1,2,-1,32177,-1,3.585402e-05,4.943619e-05,0.99991465
32178,T-cell,17,18,98,104,"Here, we demonstrate a previously undefined role of histone deacetylase 11 (HDAC11) in regulating T-cell effector functions.",28550044_1,-1,1,2,-1,32178,-1,4.0970073e-05,6.376843e-05,0.9998952
32179,functions,19,20,114,123,"Here, we demonstrate a previously undefined role of histone deacetylase 11 (HDAC11) in regulating T-cell effector functions.",28550044_1,0,1,2,-1,32179,-1,0.003960772,0.39624125,0.599798
32182,relative to naive,15,18,98,115,"Using EGFP-HDAC11 transgenic reporter mice, we found that HDAC11 expression was lower in effector relative to naive and central memory T-cell populations, and activation of resting T cells resulted in its decreased expression.",28550044_2,-1,-1,-1,-1,32182,-1,3.1407988e-05,0.99995136,1.7276428e-05
32183,T-cell,21,22,135,141,"Using EGFP-HDAC11 transgenic reporter mice, we found that HDAC11 expression was lower in effector relative to naive and central memory T-cell populations, and activation of resting T cells resulted in its decreased expression.",28550044_2,-1,1,2,-1,32183,-1,3.398986e-05,5.2414984e-05,0.9999136
32185,that T cells,9,12,53,65,"Experiments using HDAC11 knockout (KO) mice revealed that T cells from these mice displayed enhanced proliferation, proinflammatory cytokine production, and effector molecule expression.",28550044_3,-1,-1,-1,-1,32185,-1,0.0025580928,0.15638065,0.8410613
32189,TBX21,15,16,83,88,"In addition, HDAC11KO T cells had increased expression of Eomesodermin (Eomes) and TBX21 (Tbet), transcription factors previously shown to regulate inflammatory cytokine and effector molecule production.",28550044_4,-1,1,2,-1,32189,-1,0.000109179935,0.99979454,9.62458e-05
32194,these genes,10,12,73,84,"Conversely, overexpression of HDAC11 resulted in decreased expression of these genes.",28550044_5,-1,-1,-1,-1,32194,-1,3.0629537e-05,0.999946,2.3330762e-05
32197,Tbet gene,11,13,77,86,"Chromatin immunoprecipitation showed the presence of HDAC11 at the Eomes and Tbet gene promoters in resting T cells, where it rapidly disassociated following T-cell activation.",28550044_6,-1,-1,-1,-1,32197,-1,2.5615771e-05,0.99995756,1.6762904e-05
32201,to tolerance,8,10,42,54,"In vivo, HDAC11KO T cells were refractory to tolerance induction.",28550044_7,-1,-1,-1,-1,32201,-1,3.8644797e-05,0.9999466,1.478109e-05
32209,Taken together,0,2,0,14,"Taken together, these data demonstrate a previously unknown role of HDAC11 as a negative epigenetic regulator of T-cell effector phenotype and function.",28550044_10,-1,-1,-1,-1,32209,-1,4.4142347e-05,0.9999393,1.6489348e-05
32211,T-cell,18,19,113,119,"Taken together, these data demonstrate a previously unknown role of HDAC11 as a negative epigenetic regulator of T-cell effector phenotype and function.",28550044_10,-1,1,2,-1,32211,-1,3.8865317e-05,6.256715e-05,0.99989855
32212,function,22,23,143,151,"Taken together, these data demonstrate a previously unknown role of HDAC11 as a negative epigenetic regulator of T-cell effector phenotype and function.",28550044_10,0,1,2,-1,32212,-1,9.669672e-05,0.9998223,8.102848e-05
32216,immunity,18,19,116,124,Inflammation plays a critical role in the initiation of colorectal cancer but is also required to mediate antitumor immunity in established tumors.,28558303_0,0,-1,2,-1,32216,-1,0.999223,0.00053688174,0.00024019675
32219,the cellular,3,5,23,35,"Therefore, identifying the cellular and molecular components in colorectal tumors is necessary for the understanding of tumor progression and the development of novel treatment strategies.",28558303_1,-1,-1,-1,-1,32219,-1,0.003829258,0.6930949,0.30307588
32233,plasmablast subset,2,4,18,36,This CD19loCD27hi plasmablast subset presented high interleukin 10 (IL-10) expression but not transforming growth factor- (TGF-) secretion.,28558303_3,-1,-1,-1,-1,32233,-1,0.003244308,0.74823,0.2485258
32237,factor-,16,17,114,122,This CD19loCD27hi plasmablast subset presented high interleukin 10 (IL-10) expression but not transforming growth factor- (TGF-) secretion.,28558303_3,0,1,-1,-1,32237,-1,0.99974996,0.00011609384,0.00013392184
32239,the tumor-infiltrating IL-10,2,5,16,44,"Phenotypically, the tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts presented lower CD24, CD38, and IgA, and higher Tim-1 and IgG expression compared to the IL-10- CD19loCD27hi plasmablasts.",28558303_4,-1,-1,-1,-1,32239,-1,0.09742678,0.8997382,0.0028350207
32242,to the IL-10-,24,27,154,167,"Phenotypically, the tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts presented lower CD24, CD38, and IgA, and higher Tim-1 and IgG expression compared to the IL-10- CD19loCD27hi plasmablasts.",28558303_4,-1,-1,-1,-1,32242,-1,0.19163099,0.80353636,0.004832595
32244,The tumor-infiltrating IL-10,0,3,0,28,The tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts were found to be gut-homing due to their higher expression of 47 while peripheral blood B cells did not show the same characteristic.,28558303_5,-1,-1,-1,-1,32244,-1,0.09386511,0.9038504,0.0022845038
32247,to their,12,14,88,96,The tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts were found to be gut-homing due to their higher expression of 47 while peripheral blood B cells did not show the same characteristic.,28558303_5,-1,-1,-1,-1,32247,-1,2.401127e-05,0.999966,1.0003984e-05
32248,blood,20,21,140,145,The tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts were found to be gut-homing due to their higher expression of 47 while peripheral blood B cells did not show the same characteristic.,28558303_5,0,1,-1,-1,32248,-1,9.8193064e-05,0.99950016,0.00040169468
32256,factor-,21,22,151,159,"When cocultured with autologous T cells, CD19loCD27hi plasmablasts demonstrated potent activity in suppressing interferon- (IFN-) and tumor necrosis factor- (TNF-) expression but did not promote Foxp3 expression.",28558303_6,0,1,-1,-1,32256,-1,0.99987364,4.8835274e-05,7.7511184e-05
32257,TNF-,23,24,161,166,"When cocultured with autologous T cells, CD19loCD27hi plasmablasts demonstrated potent activity in suppressing interferon- (IFN-) and tumor necrosis factor- (TNF-) expression but did not promote Foxp3 expression.",28558303_6,0,1,-1,-1,32257,-1,0.00013237524,0.9998385,2.9121164e-05
32262,tumor-infiltrating lymphocytes,18,20,115,145,"Overall, this study demonstrate that in colorectal cancer, CD19loCD27hi plasmablasts make up a large percentage in tumor-infiltrating lymphocytes and possess potent immunoregulatory functions, and thus could be utilized in future therapeutic strategies.",28558303_7,-1,-1,-1,-1,32262,-1,0.00410455,0.8581631,0.13773237
32263,functions,24,25,182,191,"Overall, this study demonstrate that in colorectal cancer, CD19loCD27hi plasmablasts make up a large percentage in tumor-infiltrating lymphocytes and possess potent immunoregulatory functions, and thus could be utilized in future therapeutic strategies.",28558303_7,0,1,2,-1,32263,-1,6.383713e-05,0.9998896,4.652193e-05
32269,cytokines to,12,14,76,88,Immune cells constantly survey the host for pathogens or tumors and secrete cytokines to alert surrounding cells of these threats.,28575659_0,-1,-1,-1,-1,32269,-1,0.92744905,0.06875103,0.0037998455
32271,these threats,18,20,116,129,Immune cells constantly survey the host for pathogens or tumors and secrete cytokines to alert surrounding cells of these threats.,28575659_0,-1,-1,-1,-1,32271,-1,8.208362e-05,0.99987686,4.1009742e-05
32276,cytokine-responsive cells translate,8,11,51,86,"Given these divergent timescales, we addressed how cytokine-responsive cells translate brief cytokine exposure into phenotypic changes that persist over long timescales.",28575659_2,-1,-1,-1,-1,32276,-1,0.8701285,0.12175486,0.008116567
32281,to transient,5,7,35,47,We studied melanoma cell responses to transient exposure to the cytokine interferon  (IFN) by combining a systems-scale analysis of gene expression dynamics with computational modeling and experiments.,28575659_3,-1,-1,-1,-1,32281,-1,2.4798195e-05,0.9999641,1.1093674e-05
32282,to the cytokine interferon,8,12,57,83,We studied melanoma cell responses to transient exposure to the cytokine interferon  (IFN) by combining a systems-scale analysis of gene expression dynamics with computational modeling and experiments.,28575659_3,-1,-1,-1,-1,32282,-1,0.35599303,0.6379973,0.00600961
32284,analysis,20,21,122,130,We studied melanoma cell responses to transient exposure to the cytokine interferon  (IFN) by combining a systems-scale analysis of gene expression dynamics with computational modeling and experiments.,28575659_3,0,1,-1,-1,32284,-1,3.5202058e-05,0.99993896,2.5871308e-05
32286,that IFN,2,4,14,23,We discovered that IFN is captured by phosphatidylserine (PS) on the surface of viable cells both invitro and invivo then slowly released to drive long-term transcription of cytokine-response genes.,28575659_4,-1,-1,-1,-1,32286,-1,0.79130906,0.20362355,0.0050673825
32290,released to,27,29,132,143,We discovered that IFN is captured by phosphatidylserine (PS) on the surface of viable cells both invitro and invivo then slowly released to drive long-term transcription of cytokine-response genes.,28575659_4,-1,-1,-1,-1,32290,-1,2.5276986e-05,0.9999646,1.012171e-05
32292,cytokine-response genes,33,35,177,200,We discovered that IFN is captured by phosphatidylserine (PS) on the surface of viable cells both invitro and invivo then slowly released to drive long-term transcription of cytokine-response genes.,28575659_4,-1,-1,-1,-1,32292,-1,0.9494894,0.047793698,0.002716817
32294,function,5,6,40,48,This mechanism introduces an additional function for PS in dynamically regulating inflammation across diverse cancer and primary cell types and has potential to usher in new immunotherapies targeting PS and inflammatory pathways.,28575659_5,0,1,2,-1,32294,-1,0.00024092117,0.99960774,0.00015135008
32295,cell types,17,19,129,139,This mechanism introduces an additional function for PS in dynamically regulating inflammation across diverse cancer and primary cell types and has potential to usher in new immunotherapies targeting PS and inflammatory pathways.,28575659_5,-1,-1,-1,-1,32295,-1,3.7677935e-05,6.456107e-05,0.9998977
32300,receptor,3,4,18,26,The adenosine A2A receptor (A2AR) could protect cancerous tissues from immune clearance via inhibiting T cells response.,28592285_1,0,1,2,-1,32300,-1,0.000248219,0.0039145923,0.9958372
32301,tissues,10,11,58,65,The adenosine A2A receptor (A2AR) could protect cancerous tissues from immune clearance via inhibiting T cells response.,28592285_1,-1,1,2,-1,32301,-1,6.6165965e-05,0.9996358,0.00029800524
32309,tissues,36,37,217,224,"Here, we sought to explore the expression and immunotherapeutic value of A2AR blockade in HNSCC.METHODS: The expression of A2AR was evaluated by immunostaining in 43 normal mucosae, 48 dysplasia and 165 primary HNSCC tissues.",28592285_3,-1,1,2,-1,32309,-1,0.0012290857,0.60549706,0.39327386
32312,tissue,5,6,33,39,"RESULTS: Immunostaining of HNSCC tissue samples revealed that increased expression of A2AR on tumor infiltrating immune cells correlated with advanced pathological grade, larger tumor size and positive lymph node status.",28592285_5,-1,1,2,-1,32312,-1,3.8264745e-05,0.9998253,0.00013642602
32318,tissues,11,12,72,79,Elevated A2AR expression was also detected in recurrent HNSCC and HNSCC tissues with induction chemotherapy.,28592285_6,-1,1,2,-1,32318,-1,9.6701835e-05,0.9981527,0.0017506458
32328,the tumor,7,9,53,62,Pharmacological blockade of A2AR by SCH58261 delayed the tumor growth in the HNSCC mouse model.,28592285_9,-1,-1,-1,-1,32328,-1,2.0716665e-05,0.99996996,9.3051085e-06
32337,therapy,17,18,123,130,CONCLUSIONS: These results offer a preclinical proof for the administration of A2AR inhibitor on prophylactic experimental therapy of HNSCC and suggest that A2AR blockade can be a potential novel strategy for HNSCC immunotherapy.,28592285_11,0,1,-1,-1,32337,-1,2.88158e-05,0.99995637,1.4852876e-05
32343,that the,2,4,8,16,"We show that the DNA exonuclease Trex1 is induced by radiation doses above 12-18 Gy in different cancer cells, and attenuates their immunogenicity by degrading DNA that accumulates in the cytosol upon radiation.",28598415_2,-1,-1,-1,-1,32343,-1,1.6636035e-05,0.9999745,8.864094e-06
32357,T cells that,9,12,45,57,This effect is essential for priming of CD8+ T cells that mediate systemic tumour rejection (abscopal effect) in the context of immune checkpoint blockade.,28598415_5,-1,-1,-1,-1,32357,-1,0.0015870463,0.031808414,0.96660453
32362,immunity,10,11,69,77,"Thus, Trex1 is an upstream regulator of radiation-driven anti-tumour immunity.",28598415_6,0,-1,2,-1,32362,-1,0.9991726,0.0005649033,0.0002624355
32379,cells that,18,20,100,110,"Therefore, we hypothesized that OSCC may favor the recruitment and retention of regulatory T (Treg) cells that express the CCL20 receptor, CCR6.",28600287_2,-1,-1,-1,-1,32379,-1,0.002804863,0.08687539,0.9103197
32381,receptor,23,24,129,137,"Therefore, we hypothesized that OSCC may favor the recruitment and retention of regulatory T (Treg) cells that express the CCL20 receptor, CCR6.",28600287_2,0,1,2,-1,32381,-1,0.0002026517,0.00072777795,0.9990695
32383,blood Treg cells,8,11,38,54,"Interestingly, most (60%) peripheral blood Treg cells express CCR6, and CCR6+ Treg cells exhibit an activated effector/memory phenotype.",28600287_3,-1,-1,-1,-1,32383,-1,0.000169073,0.00057092897,0.99926
32387,CCR6- Treg cells,12,15,45,61,"In contrast, a significant portion (>30%) of CCR6- Treg cells were found to be CD45RA+ naive Treg cells.",28600287_4,-1,-1,-1,-1,32387,-1,0.0001121974,0.00013346689,0.99975437
32389,naive Treg cells,20,23,87,103,"In contrast, a significant portion (>30%) of CCR6- Treg cells were found to be CD45RA+ naive Treg cells.",28600287_4,-1,-1,-1,-1,32389,-1,0.0019123349,0.03499584,0.96309173
32390,to CCR6- naive,1,4,9,23,"Compared to CCR6- naive or memory Treg cells, CCR6+ Treg cells exhibit stronger suppressive activity and display higher FOXP3 expression along with lower methylation at the Treg-specific demethylated region of the FOXP3 gene.",28600287_5,-1,-1,-1,-1,32390,-1,0.0004069608,0.997985,0.0016080721
32395,the Treg-specific,27,29,169,186,"Compared to CCR6- naive or memory Treg cells, CCR6+ Treg cells exhibit stronger suppressive activity and display higher FOXP3 expression along with lower methylation at the Treg-specific demethylated region of the FOXP3 gene.",28600287_5,-1,-1,-1,-1,32395,-1,3.6098263e-05,0.9999422,2.1739614e-05
32396,the FOXP3 gene,32,35,210,224,"Compared to CCR6- naive or memory Treg cells, CCR6+ Treg cells exhibit stronger suppressive activity and display higher FOXP3 expression along with lower methylation at the Treg-specific demethylated region of the FOXP3 gene.",28600287_5,-1,-1,-1,-1,32396,-1,2.1348287e-05,0.9999652,1.34761685e-05
32401,tumor-infiltrating lymphocytes,16,18,85,115,This predominance of CCR6+ Treg cells was also found in the draining lymph nodes and tumor-infiltrating lymphocytes of OSCC patients with early or late clinical staging.,28600287_6,-1,-1,-1,-1,32401,-1,0.0043739784,0.821621,0.17400506
32404,tumor-infiltrating lymphocytes,8,10,41,71,"Moreover, CCR6+ Treg cells isolated from tumor-infiltrating lymphocytes or draining lymph nodes maintained similar phenotypic and suppressive characteristics ex vivo as did their counterparts isolated from peripheral blood.",28600287_7,-1,-1,-1,-1,32404,-1,0.004427002,0.82077897,0.17479406
32406,blood,29,30,217,222,"Moreover, CCR6+ Treg cells isolated from tumor-infiltrating lymphocytes or draining lymph nodes maintained similar phenotypic and suppressive characteristics ex vivo as did their counterparts isolated from peripheral blood.",28600287_7,0,1,-1,-1,32406,-1,0.0002701299,0.99477565,0.0049541774
32408,that CCR6,3,5,22,31,These results suggest that CCR6 marks activated effector or memory Treg phenotypes with superior suppressive activity in humans.,28600287_8,-1,-1,-1,-1,32408,-1,0.0037353446,0.6921779,0.30408674
32411,therapy,10,11,89,96,Tumor migration/metastasis and immunosuppression are major obstacles in effective cancer therapy.,28612394_0,0,1,-1,-1,32411,-1,2.6988742e-05,0.9999603,1.2710339e-05
32415,therapy,12,13,78,85,"Incidentally, these 2 hurdles usually coexist inside tumors, therefore making therapy significantly more complicated, as both oncogenic mechanisms must be addressed for successful therapeutic intervention.",28612394_1,0,1,-1,-1,32415,-1,2.4683266e-05,0.9999633,1.2039717e-05
32417,that the tumor,4,7,29,43,"Our recent report highlights that the tumor expression of a TNF family member, CD70, is correlated with poor survival for primary gliomas.",28612394_2,-1,-1,-1,-1,32417,-1,1.9680723e-05,0.99997115,9.18353e-06
32418,TNF,10,11,60,63,"Our recent report highlights that the tumor expression of a TNF family member, CD70, is correlated with poor survival for primary gliomas.",28612394_2,0,1,-1,-1,32418,-1,5.4784196e-05,0.99992573,1.948813e-05
32421,tumor cells,15,17,89,100,"In this study, we investigated how CD70 expression by GBM affects the characteristics of tumor cells and the tumor microenvironment.",28612394_3,-1,-1,-1,-1,32421,-1,0.003321561,0.43690374,0.5597747
32422,the tumor,18,20,105,114,"In this study, we investigated how CD70 expression by GBM affects the characteristics of tumor cells and the tumor microenvironment.",28612394_3,-1,-1,-1,-1,32422,-1,1.9495328e-05,0.9999707,9.838926e-06
32423,that the,2,4,9,17,"We found that the ablation of CD70 in primary GBM decreased CD44 and SOX2 gene expression, and inhibited tumor migration, growth and the ability to attract monocyte-derived M2 macrophages in vitro.",28612394_4,-1,-1,-1,-1,32423,-1,1.842115e-05,0.99997306,8.474703e-06
32424,SOX2 gene,13,15,69,78,"We found that the ablation of CD70 in primary GBM decreased CD44 and SOX2 gene expression, and inhibited tumor migration, growth and the ability to attract monocyte-derived M2 macrophages in vitro.",28612394_4,-1,-1,-1,-1,32424,-1,4.239298e-05,0.99993086,2.6688595e-05
32428,the tumor,1,3,3,12,"In the tumor microenvironment, CD70 was associated with immune cell infiltrates, such as T cells; myeloid-derived suppressor cells; and monocytes/macrophages based on the RNA-sequencing profile.",28612394_5,-1,-1,-1,-1,32428,-1,2.0632446e-05,0.9999685,1.0849872e-05
32434,than T cells,8,11,46,58,The CD163+ macrophages were far more abundant than T cells were.,28612394_6,-1,-1,-1,-1,32434,-1,0.0023345677,0.044279378,0.9533861
32436,their tumor,21,23,132,143,"This overwhelming level of macrophages was identified only in GBM and not in low-grade gliomas and normal brain specimens, implying their tumor association.",28612394_7,-1,-1,-1,-1,32436,-1,2.737399e-05,0.99996114,1.1449405e-05
32437,tumor cells,5,7,26,37,"CD70 was detected only on tumor cells, not on macrophages, and was highly correlated with CD163 gene expression in primary GBM.",28612394_8,-1,-1,-1,-1,32437,-1,0.00365974,0.30867907,0.68766123
32448,to target this,3,6,20,34,Our current efforts to target this molecule using chimeric antigen receptor T cells hold great potential for treating patients with GBM.,28612394_11,-1,-1,-1,-1,32448,-1,1.8425273e-05,0.9999709,1.0625054e-05
32449,antigen receptor T cells,9,13,59,83,Our current efforts to target this molecule using chimeric antigen receptor T cells hold great potential for treating patients with GBM.,28612394_11,-1,-1,-1,-1,32449,-1,0.000338337,9.8035365e-05,0.99956363
32454,cell therapy,21,23,128,140,Systemic high dose interleukin-2 (IL-2) postconditioning has long been utilized in boosting the efficacy of T cells in adoptive cell therapy (ACT) of solid tumors.,28614908_0,-1,-1,-1,-1,32454,-1,0.0026639071,0.050678983,0.9466571
32457,toxicity,4,5,32,40,The resulting severe off-target toxicity of these regimens renders local production at the tumor an attractive concept with possible safety gains.,28614908_1,0,1,-1,-1,32457,-1,5.1548977e-05,0.99989414,5.4256805e-05
32459,the tumor,12,14,87,96,The resulting severe off-target toxicity of these regimens renders local production at the tumor an attractive concept with possible safety gains.,28614908_1,-1,-1,-1,-1,32459,-1,2.328025e-05,0.9999653,1.1363798e-05
32461,tumor-infiltrating lymphocyte therapy,14,17,113,150,We evaluated the efficacy and safety of intratumorally administered IL-2-coding adenoviruses in combination with tumor-infiltrating lymphocyte therapy in syngeneic Syrian hamsters bearing HapT1 pancreatic tumors and with T cell receptor transgenic ACT in B16.OVA melanoma bearing C57BL/6 mice.,28614908_2,-1,-1,-1,-1,32461,-1,6.32936e-05,0.9998838,5.2877833e-05
32463,T cell receptor transgenic,27,31,221,247,We evaluated the efficacy and safety of intratumorally administered IL-2-coding adenoviruses in combination with tumor-infiltrating lymphocyte therapy in syngeneic Syrian hamsters bearing HapT1 pancreatic tumors and with T cell receptor transgenic ACT in B16.OVA melanoma bearing C57BL/6 mice.,28614908_2,-1,-1,-1,-1,32463,-1,0.0013135306,0.017542902,0.9811436
32467,the cell therapy,25,28,155,171,"In both models, local production of IL-2 successfully replaced the need for systemic recombinant IL-2 (rIL-2) administration and increased the efficacy of the cell therapy.",28614908_4,-1,-1,-1,-1,32467,-1,9.3239374e-05,0.99975854,0.00014817368
32472,the tumor,34,36,185,194,"Furthermore, vectored delivery of IL-2 significantly enhanced the infiltration of CD8+ T cells, M1-like macrophages, and B-cells while systemic rIL-2 increased CD25+FoxP3+ T cells at the tumor.",28614908_5,-1,-1,-1,-1,32472,-1,2.1002808e-05,0.99996626,1.2685614e-05
32473,analysis,7,8,54,62,"In contrast with vectored delivery, histopathological analysis of systemic rIL-2-treated animals revealed significant changes in lungs, livers, hearts, spleens, and kidneys.",28614908_6,0,1,-1,-1,32473,-1,2.7141286e-05,0.99995077,2.2041522e-05
32479,Therapies targeting,0,2,0,19,Therapies targeting immune checkpoints are effective in tumors with a high mutation burden that express multiple neo-antigens.,28620836_0,-1,-1,-1,-1,32479,-1,2.115218e-05,0.9999691,9.698777e-06
32486,antigenic targets,21,23,120,137,"However, glial tumors including those seen in children carry fewer mutations and there is an unmet need to identify new antigenic targets of anti-tumor immunity.",28620836_1,-1,-1,-1,-1,32486,-1,0.87475187,0.10519515,0.020052966
32487,immunity,25,26,152,160,"However, glial tumors including those seen in children carry fewer mutations and there is an unmet need to identify new antigenic targets of anti-tumor immunity.",28620836_1,0,-1,2,-1,32487,-1,0.9994074,0.00031411165,0.00027838966
32489,cell antigen,5,7,26,38,SOX2 is an embryonal stem cell antigen implicated in the biology of glioma initiating cells.,28620836_2,-1,-1,-1,-1,32489,-1,0.020569423,0.00040409865,0.97902656
32501,tissue,9,10,65,71,We examined the expression of SOX2 on archived paraffin-embedded tissue from pediatric glial tumors.,28620836_4,-1,1,2,-1,32501,-1,6.142873e-05,0.9996203,0.0003182645
32504,T-cell immunity to SOX2,3,7,16,39,The presence of T-cell immunity to SOX2 was examined in both blood and tumor-infiltrating T-cells in children and young adults with glioma.,28620836_5,-1,-1,-1,-1,32504,-1,0.007040324,0.20124221,0.7917175
32505,blood,11,12,61,66,The presence of T-cell immunity to SOX2 was examined in both blood and tumor-infiltrating T-cells in children and young adults with glioma.,28620836_5,0,1,-1,-1,32505,-1,6.687716e-05,0.9997757,0.00015737471
32506,tumor-infiltrating T-cells,13,15,71,97,The presence of T-cell immunity to SOX2 was examined in both blood and tumor-infiltrating T-cells in children and young adults with glioma.,28620836_5,-1,-1,-1,-1,32506,-1,0.004715365,0.7293417,0.265943
32507,The nature,0,2,0,10,The nature of tumor-infiltrating immune cells was analyzed with a 37-marker panel using single-cell mass cytometry.,28620836_6,-1,-1,-1,-1,32507,-1,2.3169727e-05,0.99996245,1.4395372e-05
32511,tumor cells,4,6,21,32,SOX2 is expressed by tumor cells but not surrounding normal tissue in pediatric gliomas of all grades.,28620836_7,-1,-1,-1,-1,32511,-1,0.0031192005,0.21999747,0.77688336
32512,tissue,10,11,60,66,SOX2 is expressed by tumor cells but not surrounding normal tissue in pediatric gliomas of all grades.,28620836_7,-1,1,2,-1,32512,-1,0.00046996382,0.9920678,0.007462189
32513,T-cells,0,1,0,7,T-cells against this antigen can be detected in blood and tumor tissue in glioma patients.,28620836_8,-1,1,2,-1,32513,-1,3.5329555e-05,7.844163e-05,0.9998863
32514,this antigen,2,4,16,28,T-cells against this antigen can be detected in blood and tumor tissue in glioma patients.,28620836_8,-1,-1,-1,-1,32514,-1,0.3578468,0.6029253,0.039227895
32515,in blood,7,9,45,53,T-cells against this antigen can be detected in blood and tumor tissue in glioma patients.,28620836_8,0,1,-1,-1,32515,-1,3.8478775e-05,0.9999347,2.686323e-05
32516,tumor tissue,10,12,58,70,T-cells against this antigen can be detected in blood and tumor tissue in glioma patients.,28620836_8,-1,-1,-1,-1,32516,-1,2.4656212e-05,0.99995947,1.5830483e-05
32518,T-cells,6,7,38,45,"Glial tumors are enriched for CD8/CD4 T-cells with tissue resident memory (TRM; CD45RO+, CD69+, CCR7-) phenotype, which co-express multiple inhibitory checkpoints including PD-1, PD-L1 and TIGIT.",28620836_9,-1,1,2,-1,32518,-1,3.535598e-05,5.7166268e-05,0.9999074
32519,tissue,8,9,51,57,"Glial tumors are enriched for CD8/CD4 T-cells with tissue resident memory (TRM; CD45RO+, CD69+, CCR7-) phenotype, which co-express multiple inhibitory checkpoints including PD-1, PD-L1 and TIGIT.",28620836_9,-1,1,2,-1,32519,-1,3.3047905e-05,0.99992967,3.7305676e-05
32526,tumor cells,14,16,100,111,"Our data demonstrate immunogenicity of SOX2, which is specifically overexpressed on pediatric glial tumor cells.",28620836_11,-1,-1,-1,-1,32526,-1,0.0032371832,0.26961452,0.7271483
32527,tumor immunity,1,3,11,25,Harnessing tumor immunity in glioma will likely require the combined targeting of multiple inhibitory checkpoints.,28620836_12,-1,-1,-1,-1,32527,-1,0.021812249,0.97757643,0.0006112498
32534,protein,21,22,133,140,BACKGROUND: T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif (ITIM) domain (TIGIT) and programmed cell death protein 1 (PD-1) are important inhibitory receptors that associate with T cell exhaustion in acute myeloid leukemia (AML).,28629373_0,0,1,-1,-1,32534,-1,0.00090798596,0.99605465,0.0030373994
32535,receptors that,29,31,175,189,BACKGROUND: T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif (ITIM) domain (TIGIT) and programmed cell death protein 1 (PD-1) are important inhibitory receptors that associate with T cell exhaustion in acute myeloid leukemia (AML).,28629373_0,-1,-1,-1,-1,32535,-1,0.0045333756,0.5821952,0.4132714
32543,transcription factor B lymphocyte-induced maturation protein 1,7,14,42,104,"Specifically, we investigated the role of transcription factor B lymphocyte-induced maturation protein 1 (Blimp-1) in T cell response and transcriptional regulation of TIGIT and PD-1 in AML.METHODS: Peripheral blood samples collected from patients with AML were used in this study.",28629373_2,-1,-1,-1,-1,32543,-1,8.024677e-05,0.99964106,0.00027870954
32548,blood,32,33,210,215,"Specifically, we investigated the role of transcription factor B lymphocyte-induced maturation protein 1 (Blimp-1) in T cell response and transcriptional regulation of TIGIT and PD-1 in AML.METHODS: Peripheral blood samples collected from patients with AML were used in this study.",28629373_2,0,1,-1,-1,32548,-1,0.00010787539,0.9993413,0.0005508131
32554,functional,2,3,15,25,Phenotypic and functional studies of Blimp-1-expressing T cells were performed using flow cytometry-based assays.,28629373_5,0,1,2,-1,32554,-1,5.862839e-05,0.9999063,3.502504e-05
32555,Blimp-1-expressing T cells,5,8,37,63,Phenotypic and functional studies of Blimp-1-expressing T cells were performed using flow cytometry-based assays.,28629373_5,-1,-1,-1,-1,32555,-1,0.0028098929,0.85163903,0.14555106
32563,the TIGIT,15,17,88,97,"Using siRNA to silence Blimp-1, we further elucidated the regulatory role of Blimp-1 in the TIGIT and PD-1 expression and T cell immune response.",28629373_7,-1,-1,-1,-1,32563,-1,2.8049297e-05,0.9999546,1.7325687e-05
32564,T cell immune response,21,25,122,144,"Using siRNA to silence Blimp-1, we further elucidated the regulatory role of Blimp-1 in the TIGIT and PD-1 expression and T cell immune response.",28629373_7,-1,-1,-1,-1,32564,-1,0.1793978,0.0022961586,0.8183061
32569,receptors,11,12,76,85,"Consistent with exhaustion, Blimp-1+ T cells upregulate multiple inhibitory receptors including PD-1 and TIGIT.",28629373_9,0,1,2,-1,32569,-1,0.00012270278,0.00031650972,0.9995608
32572,functionally,5,6,22,34,"In addition, they are functionally impaired manifested by low cytokine production and decreased cytotoxicity capacity.",28629373_10,0,1,2,-1,32572,-1,6.509849e-05,0.99990857,2.6314938e-05
32574,the functional,2,4,13,27,"Importantly, the functional defect is reversed by inhibition of Blimp-1 via siRNA knockdown.",28629373_11,-1,-1,-1,-1,32574,-1,2.8434117e-05,0.99995947,1.2057896e-05
32577,to the,4,6,27,33,"Furthermore, Blimp-1 binds to the promoters of PD-1 and TIGIT and positively regulates their expression.",28629373_12,-1,-1,-1,-1,32577,-1,1.8530805e-05,0.9999715,9.960904e-06
32583,targeting Blimp-1,20,22,111,128,"CONCLUSIONS: Our study demonstrates an important inhibitory effect of Blimp-1 on T cell response in AML; thus, targeting Blimp-1 and its regulated molecules to improve the immune response may provide effective leukemia therapeutics.",28629373_13,-1,-1,-1,-1,32583,-1,2.497894e-05,0.9999517,2.33475e-05
32585,the immune response,28,31,168,187,"CONCLUSIONS: Our study demonstrates an important inhibitory effect of Blimp-1 on T cell response in AML; thus, targeting Blimp-1 and its regulated molecules to improve the immune response may provide effective leukemia therapeutics.",28629373_13,-1,-1,-1,-1,32585,-1,0.2484718,0.75030327,0.0012248901
32588,FOXP3-dependent regulatory T cell function,4,9,31,73,"Although strategies that block FOXP3-dependent regulatory T cell function (CTLA4 blockade) and the inhibitory receptor PD1 have shown great promise in promoting antitumor immune responses in humans, their widespread implementation for cancer immunotherapy has been hampered by significant off-target autoimmune side effects that can be lethal.",28646041_0,-1,-1,-1,-1,32588,-1,0.0021030596,0.87622094,0.121676065
32591,receptor,16,17,110,118,"Although strategies that block FOXP3-dependent regulatory T cell function (CTLA4 blockade) and the inhibitory receptor PD1 have shown great promise in promoting antitumor immune responses in humans, their widespread implementation for cancer immunotherapy has been hampered by significant off-target autoimmune side effects that can be lethal.",28646041_0,0,1,2,-1,32591,-1,0.00018578034,0.00045525806,0.9993591
32594,side effects that,43,46,311,328,"Although strategies that block FOXP3-dependent regulatory T cell function (CTLA4 blockade) and the inhibitory receptor PD1 have shown great promise in promoting antitumor immune responses in humans, their widespread implementation for cancer immunotherapy has been hampered by significant off-target autoimmune side effects that can be lethal.",28646041_0,-1,-1,-1,-1,32594,-1,0.00021893227,0.99969506,8.608939e-05
32599,these side effects,27,30,168,186,"Our work has shown that absence of OX40 and CD30 costimulatory signals prevents CD4 T cell-driven autoimmunity in Foxp3-deficient mice, suggesting a novel way to block these side effects.",28646041_1,-1,-1,-1,-1,32599,-1,6.7570814e-05,0.99990416,2.8233513e-05
32609,side effects,3,5,27,39,"By dissociating autoimmune side effects from anticancer immune responses, this potentially shifts this antitumor approach to patients with far less advanced disease.",28646041_4,0,1,-1,-1,32609,-1,0.0009227718,0.9986934,0.0003838663
32616,tissue,7,8,53,59,Increased IL-4 expression in human colorectal cancer tissue and growth of colon cancer cell lines implied that IL-4-induced Stat6-mediated tumorigenic signaling likely contributes to intestinal tumor progression in ApcMin/+ mice.,28654863_1,-1,1,2,-1,32616,-1,4.487125e-05,0.9998547,0.00010046786
32619,Stat6-mediated tumorigenic,18,20,124,150,Increased IL-4 expression in human colorectal cancer tissue and growth of colon cancer cell lines implied that IL-4-induced Stat6-mediated tumorigenic signaling likely contributes to intestinal tumor progression in ApcMin/+ mice.,28654863_1,-1,-1,-1,-1,32619,-1,4.0025934e-05,0.9999325,2.7445927e-05
32633,factor-BB,15,16,127,136,"We found that IL-4-induced Stat6-mediated proliferation of intestinal epithelial cells is augmented by platelet-derived growth factor-BB, a tumor-promoting growth factor.",28654863_5,0,1,-1,-1,32633,-1,0.9989247,0.00028199254,0.000793283
32634,tumor-promoting growth factor,18,21,140,169,"We found that IL-4-induced Stat6-mediated proliferation of intestinal epithelial cells is augmented by platelet-derived growth factor-BB, a tumor-promoting growth factor.",28654863_5,-1,-1,-1,-1,32634,-1,0.26597187,0.72837085,0.0056572063
32643,that Stat6,11,13,77,87,"Furthermore, proliferation of polyp epithelial cells was reduced, indicating that Stat6 in part controlled polyp formation.",28654863_8,-1,-1,-1,-1,32643,-1,4.2541717e-05,0.99993026,2.716453e-05
32647,T-cell,20,21,123,129,"Stat6 also promoted expansion of MDSCs in the spleen and lamina propria of ApcMin/+ mice, implying regulation of antitumor T-cell response.",28654863_9,-1,1,2,-1,32647,-1,5.801081e-05,6.714647e-05,0.99987483
32651,tumor cells,12,14,72,83,"In addition, a strong CD8-mediated cytotoxic response led to killing of tumor cells in Stat6-deficient ApcMin/+ mice.",28654863_11,-1,-1,-1,-1,32651,-1,0.004371937,0.4106345,0.5849936
32655,that Stat6,5,7,31,41,"Therefore, these findings show that Stat6 has an oncogenic role in intestinal tumorigenesis by promoting polyp cell proliferation and immunosuppressive mediators, and preventing an active cytotoxic process.",28654863_12,-1,-1,-1,-1,32655,-1,2.2463917e-05,0.9999634,1.4114207e-05
32663,the tumor,16,18,103,112,"BACKGROUND/AIM: Tumor-associated macrophages (TAMs), together with splenic CD11b+ cells, help maintain the tumor microenvironment.",28668835_0,-1,-1,-1,-1,32663,-1,2.1669772e-05,0.99996877,9.502497e-06
32669,the tumor,9,11,44,53,"In order to elucidate the effects of IQM on the tumor microenvironment, we investigated the immunomodulatory effect of IQM during melanoma growth by using the B16F10 melanoma model.",28668835_2,-1,-1,-1,-1,32669,-1,1.7854029e-05,0.9999728,9.266948e-06
32674,the tumor,12,14,75,84,"MATERIALS AND METHODS: To elucidate the immunomodulatory effects of IQM on the tumor microenvironment, we isolated CD11b+ TAMs and splenic CD11b+ cells and evaluated the immunomodulatory effects of IQM, using the B16F10 melanoma model.",28668835_3,-1,-1,-1,-1,32674,-1,1.8686005e-05,0.999972,9.355651e-06
32682,the tumor,21,23,114,123,"RESULTS: IQM suppressed B16F10 melanoma growth in parallel with reduction of Foxp3+ regulatory T cells (Tregs) at the tumor site, caused by the down-regulation of CCL22 production by tumor-derived and splenic CD11b+ cells.",28668835_4,-1,-1,-1,-1,32682,-1,2.0581985e-05,0.9999689,1.0589486e-05
32699,the tumor,16,18,131,140,"Furthermore, intratumoral administration of anti-CCL22 antibody inhibited B16F10 melanoma growth by decreasing Treg recruitment at the tumor site.",28668835_8,-1,-1,-1,-1,32699,-1,2.0049783e-05,0.99996865,1.1290962e-05
32702,through tumor-associated,16,18,102,126,CONCLUSION: Our results suggest a possible mechanism for the antitumor immune response induced by IQM through tumor-associated macrophages.,28668835_9,-1,-1,-1,-1,32702,-1,2.6849953e-05,0.99995625,1.6918766e-05
32703,functions,1,2,18,27,"Immunosuppressive functions of glucocorticoids (GC) can be mediated via various mechanisms, including the modulation of dendritic cells (DC).",28675711_0,0,1,2,-1,32703,-1,0.00011137046,0.99980575,8.294816e-05
32709,transgenic TCR,22,24,137,151,"Our study investigates the effects of tolerogenic GC-treated DCs on NK and T cell anti-tumor responses in OT-1/Rag-/- mice, expressing a transgenic TCR in CD8+ T cells.",28675711_1,-1,-1,-1,-1,32709,-1,3.191194e-05,0.9999361,3.1934098e-05
32712,to the,8,10,51,57,"The effects caused by GC-treated DCs were compared to the responses to immunogenic, CpG-activated DCs.",28675711_2,-1,-1,-1,-1,32712,-1,2.1039208e-05,0.9999697,9.289385e-06
32718,the tumor cells,17,20,97,112,"The effects of DCs on anti-tumor immune responses were analyzed using the EG7 tumor model, where the tumor cells express the peptide epitope recognized by OT-1 T cells.",28675711_3,-1,-1,-1,-1,32718,-1,0.003284031,0.80269814,0.19401787
32719,the peptide,21,23,121,132,"The effects of DCs on anti-tumor immune responses were analyzed using the EG7 tumor model, where the tumor cells express the peptide epitope recognized by OT-1 T cells.",28675711_3,-1,-1,-1,-1,32719,-1,0.00026877577,0.9996184,0.00011278631
32722,peptide-treated,7,8,43,58,We observed that immunization with CpG and peptide-treated DCs protected against tumor growth by activation of NK cell response.,28675711_4,0,-1,2,-1,32722,-1,9.907155e-05,0.9998599,4.0993214e-05
32728,the peptide,3,5,13,24,"In contrast, the peptide and GC-treated DCs in OT-1 mice increased the numbers of immature Mac-1+CD27- NK cells as well as Foxp3+ and IL-10 secreting CD8+OT-1 cells with suppressive properties.",28675711_6,-1,-1,-1,-1,32728,-1,3.360843e-05,0.9999504,1.60107e-05
32734,that the generation,2,5,12,31,We conclude that the generation of tolerogenic DCs is one of many immunosuppressive mechanisms that can be induced by GC.,28675711_7,-1,-1,-1,-1,32734,-1,1.8557266e-05,0.9999708,1.0698382e-05
32737,that tolerogenic,3,5,23,39,Our study demonstrated that tolerogenic DCs modify anti-tumor immune response by suppressing NK cell activity and stimulating the formation of IL-10-secreting CD8+ Tregs.,28675711_8,-1,-1,-1,-1,32737,-1,2.3483886e-05,0.9999664,1.0171981e-05
32744,their natural,12,14,77,90,Cytokines are potent immune modulating agents but are not ideal medicines in their natural form due to their short half-life and pleiotropic systemic effects.,28678791_0,-1,-1,-1,-1,32744,-1,4.2401734e-05,0.9999428,1.4864465e-05
32745,to their,16,18,100,108,Cytokines are potent immune modulating agents but are not ideal medicines in their natural form due to their short half-life and pleiotropic systemic effects.,28678791_0,-1,-1,-1,-1,32745,-1,2.8715109e-05,0.99996066,1.0564604e-05
32749,protein,11,12,73,80,NKTR-214 is a clinical-stage biologic that comprises interleukin-2 (IL2) protein bound by multiple releasable polyethylene glycol (PEG) chains.,28678791_1,0,1,-1,-1,32749,-1,0.00045163717,0.998094,0.0014543815
32756,protein,18,19,104,111,"When administered in vivo, the PEG chains slowly release, creating a cascade of increasingly active IL2 protein conjugates bound by fewer PEG chains.",28678791_3,0,1,-1,-1,32756,-1,0.0047471584,0.969422,0.025830919
32759,protein,1,2,9,16,Free-IL2 protein is undetectable in vivo as it is eliminated faster than formed.,28678791_5,0,1,-1,-1,32759,-1,4.763615e-05,0.99991035,4.2003812e-05
32767,receptor complex,24,26,122,138,"The PEG chains on NKTR-214 are located at the region of IL2 that contacts the alpha () subunit of the heterotrimeric IL2 receptor complex, IL2R, reducing its ability to bind and activate the heterotrimer.",28678791_6,-1,-1,-1,-1,32767,-1,0.00045749178,0.9965403,0.0030021719
32779,the receptor complex,22,25,122,142,"Therefore, without the use of mutations, PEGylation reduces the affinity for IL2R to a greater extent than for IL2R, the receptor complex predominant on CD8 T cells.",28678791_8,-1,-1,-1,-1,32779,-1,5.881511e-05,0.9998436,9.760006e-05
32784,the tumor,13,15,74,83,NKTR-214 treatment in vivo favors activation of CD8 T cells over Tregs in the tumor microenvironment to provide anti-tumor efficacy in multiple syngeneic models.,28678791_9,-1,-1,-1,-1,32784,-1,2.0743053e-05,0.99996984,9.4305e-06
32787,pharmacology,18,19,112,124,Mechanistic modeling based on in vitro and in vivo kinetic data provides insight into the mechanism of NKTR-214 pharmacology.,28678791_10,0,1,-1,-1,32787,-1,8.2917984e-05,0.9998586,5.8459387e-05
32790,protein,5,6,38,45,The model reveals that conjugated-IL2 protein derived from NKTR-214 occupy IL-2R to a greater extent compared to free-IL2 protein.,28678791_11,0,1,-1,-1,32790,-1,0.00013711372,0.9993605,0.00050238083
32793,protein,18,19,124,131,The model reveals that conjugated-IL2 protein derived from NKTR-214 occupy IL-2R to a greater extent compared to free-IL2 protein.,28678791_11,0,1,-1,-1,32793,-1,8.126966e-05,0.999716,0.00020277685
32797,mechanism of action,28,31,201,220,The model accurately describes the sustained in vivo signaling observed after a single dose of NKTR-214 and explains how the properties of NKTR-214 impart a unique kinetically-controlled immunological mechanism of action.,28678791_12,0,1,-1,-1,32797,-1,0.00012431559,0.99979514,8.0609614e-05
32799,proteins that,15,17,96,109,Reed-Sternberg (RS) cells of classical Hodgkin lymphoma (cHL) express multiple immunoregulatory proteins that shape the cHL microenvironment and allow tumor cells to evade immune surveillance.,28698206_0,-1,-1,-1,-1,32799,-1,4.6461326e-05,0.99992967,2.38255e-05
32801,tumor cells to,23,26,151,165,Reed-Sternberg (RS) cells of classical Hodgkin lymphoma (cHL) express multiple immunoregulatory proteins that shape the cHL microenvironment and allow tumor cells to evade immune surveillance.,28698206_0,-1,-1,-1,-1,32801,-1,8.7333916e-05,0.99972266,0.0001900019
32802,proteins,4,5,39,47,"Expression of certain immunoregulatory proteins is modulated by prosurvival transcription factors, such as NFB and STATs.",28698206_1,0,1,-1,-1,32802,-1,6.354081e-05,0.9998585,7.7890145e-05
32805,these factors,1,3,8,21,"Because these factors also induce expression of the oncogenic PIM1/2/3 serine/threonine kinases, and as PIMs modulate transcriptional activity of NFB and STATs, we hypothesized that these kinases support RS cell survival and foster their immune privilege.",28698206_2,-1,-1,-1,-1,32805,-1,6.835169e-05,0.9999074,2.42336e-05
32809,that these,26,28,178,188,"Because these factors also induce expression of the oncogenic PIM1/2/3 serine/threonine kinases, and as PIMs modulate transcriptional activity of NFB and STATs, we hypothesized that these kinases support RS cell survival and foster their immune privilege.",28698206_2,-1,-1,-1,-1,32809,-1,1.868246e-05,0.9999721,9.2238615e-06
32811,foster their,34,36,226,238,"Because these factors also induce expression of the oncogenic PIM1/2/3 serine/threonine kinases, and as PIMs modulate transcriptional activity of NFB and STATs, we hypothesized that these kinases support RS cell survival and foster their immune privilege.",28698206_2,-1,-1,-1,-1,32811,-1,2.9431261e-05,0.9999584,1.2215163e-05
32826,than T cells,17,20,127,139,"In coculture experiments, T cells incubated with SEL24-B489-treated RS cells exhibited higher expression of activation markers than T cells coincubated with control RS cells.",28698206_9,-1,-1,-1,-1,32826,-1,0.0025032402,0.0861453,0.9113515
32828,Taken together,0,2,0,14,"Taken together, our data indicate that PIM kinases in cHL exhibit pleiotropic effects, orchestrating tumor immune escape and supporting RS cell survival.",28698206_10,-1,-1,-1,-1,32828,-1,5.733542e-05,0.9999218,2.0855017e-05
32835,these cells,14,16,96,107,Inhibition of PIM kinases decreases RS cell viability and disrupts signaling circuits that link these cells with their niches.,28698206_11,-1,-1,-1,-1,32835,-1,0.0007567869,0.013902713,0.98534054
32838,therapeutic targets,6,8,32,51,"Thus, PIM kinases are promising therapeutic targets in cHL.",28698206_12,-1,-1,-1,-1,32838,-1,2.3227336e-05,0.9999653,1.1431964e-05
32842,functions,11,12,56,65,Regulatory T cells (Tregs) have been proposed to dampen functions of anti-neoplastic immune cells and thus promote cancer progression.,28721449_0,0,1,2,-1,32842,-1,0.0001086587,0.9998393,5.1980907e-05
32846,Mission Trial,8,10,24,37,"In a phase IV trial (Re:Mission Trial, NCT01347996, http://www.clinicaltrials.gov ) 84 patients (age 18-79) with acute myeloid leukemia (AML) in first complete remission (CR) received ten consecutive 3-week cycles of immunotherapy with histamine dihydrochloride (HDC) and low-dose interleukin-2 (IL-2) to prevent relapse of leukemia in the post-consolidation phase.",28721449_1,-1,-1,-1,-1,32846,-1,6.0224083e-05,0.99990225,3.747238e-05
32854,function,8,9,43,51,"This study aimed at defining the features, function and dynamics of Foxp3+CD25highCD4+ Tregs during immunotherapy and to determine the potential impact of Tregs on relapse risk and survival.",28721449_2,0,1,2,-1,32854,-1,3.8736445e-05,0.9999398,2.1518359e-05
32862,blood,10,11,63,68,We observed a pronounced increase in Treg counts in peripheral blood during initial cycles of HDC/IL-2.,28721449_3,0,1,-1,-1,32862,-1,9.781138e-05,0.9987685,0.0011335947
32865,thymic-derived natural Tregs,4,7,33,61,"The accumulating Tregs resembled thymic-derived natural Tregs (nTregs), showed augmented expression of CTLA-4 and suppressed the cell cycle proliferation of conventional T cells ex vivo.",28721449_4,-1,-1,-1,-1,32865,-1,3.1364176e-05,0.9999467,2.1894657e-05
32867,the cell,18,20,125,133,"The accumulating Tregs resembled thymic-derived natural Tregs (nTregs), showed augmented expression of CTLA-4 and suppressed the cell cycle proliferation of conventional T cells ex vivo.",28721449_4,-1,-1,-1,-1,32867,-1,0.004808005,0.47808084,0.5171111
32879,Treg telomere,16,18,101,114,Exploratory analyses implied that a reduced expansion of Tregs in later treatment cycles and a short Treg telomere length were significantly associated with a favorable clinical outcome.,28721449_7,-1,-1,-1,-1,32879,-1,5.928228e-05,0.99985504,8.561573e-05
32881,Tregs that,13,15,99,109,Our results suggest that immunotherapy with HDC/IL-2 in AML entails induction of immunosuppressive Tregs that may be targeted for improved anti-leukemic efficiency.,28721449_8,-1,-1,-1,-1,32881,-1,1.9303383e-05,0.99996865,1.2035959e-05
32883,The regulatory T cells,0,4,0,22,The regulatory T cells (Treg) play an important role in the tumor tolerance.,28731226_0,-1,-1,-1,-1,32883,-1,0.002405601,0.11561538,0.881979
32886,the tumor tolerance,12,15,56,75,The regulatory T cells (Treg) play an important role in the tumor tolerance.,28731226_0,-1,-1,-1,-1,32886,-1,2.1502101e-05,0.9999678,1.0678758e-05
32889,the Treg,4,6,24,32,The methods to regulate the Treg population in cancer-bearing hosts are limited currently.,28731226_1,-1,-1,-1,-1,32889,-1,2.5013343e-05,0.9999596,1.5439266e-05
32904,the Tregs,6,8,42,51,The mechanism by which curcumin regulated the Tregs was observed by cell culture approaches.,28731226_6,-1,-1,-1,-1,32904,-1,2.1822421e-05,0.99996746,1.0679875e-05
32907,that the,3,5,19,27,"The results showed that the frequency of peripheral Treg was markedly higher in LC patients than that in healthy subjects, which was suppressed after treating with curcumin for 2 weeks.",28731226_7,-1,-1,-1,-1,32907,-1,1.7183303e-05,0.9999738,9.086764e-06
32909,than that,15,17,92,101,"The results showed that the frequency of peripheral Treg was markedly higher in LC patients than that in healthy subjects, which was suppressed after treating with curcumin for 2 weeks.",28731226_7,-1,-1,-1,-1,32909,-1,2.4052339e-05,0.9999622,1.37358675e-05
32914,therapy,12,13,74,81,The peripheral Th1 cells were increased in LC patients after the curcumin therapy.,28731226_8,0,1,-1,-1,32914,-1,2.7791019e-05,0.9999584,1.3818472e-05
32919,Tregs to Th1 cells,14,18,92,110,The data of the in vitro experiments showed that curcumin converted the LC patient-isolated Tregs to Th1 cells via repressing the gene transcription of forkhead protein-3 and increasing the expression of interferon-.,28731226_9,-1,-1,-1,-1,32919,-1,0.0028883277,0.58518016,0.41193154
32920,the gene transcription,20,23,126,148,The data of the in vitro experiments showed that curcumin converted the LC patient-isolated Tregs to Th1 cells via repressing the gene transcription of forkhead protein-3 and increasing the expression of interferon-.,28731226_9,-1,-1,-1,-1,32920,-1,2.0900792e-05,0.9999676,1.1479426e-05
32921,forkhead protein-3,24,26,152,170,The data of the in vitro experiments showed that curcumin converted the LC patient-isolated Tregs to Th1 cells via repressing the gene transcription of forkhead protein-3 and increasing the expression of interferon-.,28731226_9,-1,-1,-1,-1,32921,-1,3.5693927e-05,0.999938,2.6315312e-05
32924,Tregs to Th1 cells,8,12,56,74,"In conclusion, curcumin can convert LC patient-isolated Tregs to Th1 cells.",28731226_10,-1,-1,-1,-1,32924,-1,0.0033302016,0.54217887,0.45449087
32928,immunity,9,10,60,68,The results suggest that curcumin may improve the antitumor immunity by regulating the tumor specific immune tolerance.,28731226_11,0,-1,2,-1,32928,-1,0.998387,0.0013026892,0.00031045504
32929,the tumor,12,14,83,92,The results suggest that curcumin may improve the antitumor immunity by regulating the tumor specific immune tolerance.,28731226_11,-1,-1,-1,-1,32929,-1,1.9711464e-05,0.9999716,8.648384e-06
32931,T-cell therapy,3,5,18,32,Purpose: Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes (TIL) has shown an overall clinical response rate 40%-50% in metastatic melanoma patients.,28754817_0,-1,-1,-1,-1,32931,-1,0.001026873,0.020597463,0.97837573
32932,tumor-infiltrating lymphocytes,7,9,50,80,Purpose: Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes (TIL) has shown an overall clinical response rate 40%-50% in metastatic melanoma patients.,28754817_0,-1,-1,-1,-1,32932,-1,0.003200283,0.9102311,0.08656865
32938,function,2,3,16,24,The suppressive function of the ITIM and ITSM motifs of BTLA is well described.,28754817_2,0,1,2,-1,32938,-1,5.9091333e-05,0.999897,4.393888e-05
32941,the functional,6,8,29,43,"Here, we sought to determine the functional characteristics of the CD8+BTLA+TIL subset and define the contribution of the Grb2 motif of BTLA in T-cell costimulation.",28754817_3,-1,-1,-1,-1,32941,-1,2.014939e-05,0.9999689,1.0986441e-05
32946,T-cell,24,25,144,150,"Here, we sought to determine the functional characteristics of the CD8+BTLA+TIL subset and define the contribution of the Grb2 motif of BTLA in T-cell costimulation.",28754817_3,-1,1,2,-1,32946,-1,5.0209004e-05,4.9317536e-05,0.99990046
32947,the functional,5,7,35,49,Experimental Design: We determined the functional role and downstream signal of BTLA in both human CD8+ TILs and mouse CD8+ T cells.,28754817_4,-1,-1,-1,-1,32947,-1,2.0816253e-05,0.9999695,9.6907925e-06
32950,Functional,0,1,0,10,"Functional assays were used including single-cell analysis, reverse-phase protein array (RPPA), antigen-specific vaccination models with adoptively transferred TCR-transgenic T cells as well as patient-derived xenograft (PDX) model using immunodeficient NOD-scid IL2Rgammanull (NSG) tumor-bearing mice treated with autologous TILs.",28754817_5,0,1,2,-1,32950,-1,3.205343e-05,0.9999429,2.504988e-05
32951,analysis,6,7,50,58,"Functional assays were used including single-cell analysis, reverse-phase protein array (RPPA), antigen-specific vaccination models with adoptively transferred TCR-transgenic T cells as well as patient-derived xenograft (PDX) model using immunodeficient NOD-scid IL2Rgammanull (NSG) tumor-bearing mice treated with autologous TILs.",28754817_5,0,1,-1,-1,32951,-1,0.0001726989,0.9981178,0.0017094731
32952,protein,9,10,74,81,"Functional assays were used including single-cell analysis, reverse-phase protein array (RPPA), antigen-specific vaccination models with adoptively transferred TCR-transgenic T cells as well as patient-derived xenograft (PDX) model using immunodeficient NOD-scid IL2Rgammanull (NSG) tumor-bearing mice treated with autologous TILs.",28754817_5,0,1,-1,-1,32952,-1,8.125983e-05,0.9998419,7.675892e-05
32954,transferred TCR-transgenic T cells,20,24,148,182,"Functional assays were used including single-cell analysis, reverse-phase protein array (RPPA), antigen-specific vaccination models with adoptively transferred TCR-transgenic T cells as well as patient-derived xenograft (PDX) model using immunodeficient NOD-scid IL2Rgammanull (NSG) tumor-bearing mice treated with autologous TILs.",28754817_5,-1,-1,-1,-1,32954,-1,0.0036948458,0.7366968,0.25960833
32966,tumor target,12,14,79,91,"However, CD8+BTLA+ TILs displayed improved survival following the killing of a tumor target and heightened ""serial killing"" capacity.",28754817_7,-1,-1,-1,-1,32966,-1,2.1617681e-05,0.9999653,1.3057007e-05
32967,function,11,12,69,77,"Using mutants of BTLA signaling motifs, we uncovered a costimulatory function mediated by Grb2 through enhancing the secretion of IL-2 and the activation of Src after TCR stimulation.",28754817_8,0,1,2,-1,32967,-1,6.227851e-05,0.9998913,4.6475892e-05
32971,TCR,27,28,167,170,"Using mutants of BTLA signaling motifs, we uncovered a costimulatory function mediated by Grb2 through enhancing the secretion of IL-2 and the activation of Src after TCR stimulation.",28754817_8,-1,1,2,-1,32971,-1,2.5520476e-05,0.99995744,1.7021506e-05
32978,functional,41,42,239,249,"Conclusions: Our data portrays BTLA as a molecule with the singular ability to provide both costimulatory and coinhibitory signals to activated CD8+ T cells, resulting in extended survival, improved tumor control, and the development of a functional recall response.",28754817_9,0,1,2,-1,32978,-1,0.00015342908,0.9998142,3.233655e-05
32981,to treat this,3,6,25,38,"More therapeutic options to treat this disease are needed, for the current standard of care is ineffective.",28775207_1,-1,-1,-1,-1,32981,-1,2.3274939e-05,0.999967,9.792272e-06
33005,analysis,1,2,6,14,"Human analysis of human datasets from The Cancer Genome Atlas and tissue microarrays correlated with observations from our mouse model experiments, especially in patients with grade 1, stage II disease.",28775207_6,0,1,-1,-1,33005,-1,4.0119292e-05,0.99992776,3.2112333e-05
33007,tissue,11,12,66,72,"Human analysis of human datasets from The Cancer Genome Atlas and tissue microarrays correlated with observations from our mouse model experiments, especially in patients with grade 1, stage II disease.",28775207_6,-1,1,2,-1,33007,-1,3.6601483e-05,0.99991596,4.7435682e-05
33010,to tumor,10,12,63,71,"We propose that in aggressive PDAC, elevated G-CSF contributes to tumor progression through promoting increases in infiltration of neutrophil-like cells with high immunosuppressive activity.",28775207_7,-1,-1,-1,-1,33010,-1,2.1788956e-05,0.9999682,1.002474e-05
33016,the release,16,18,114,125,"Glutamine-synthetase (GS), the glutamine-synthesizing enzyme from glutamate, controls important events, including the release of inflammatory mediators, mammalian target of rapamycin (mTOR) activation, and autophagy.",28813676_0,-1,-1,-1,-1,33016,-1,2.7982273e-05,0.99995685,1.51969625e-05
33020,toward the,10,12,77,87,"We report that pharmacologic inhibition of GS skews M2-polarized macrophages toward the M1-like phenotype, characterized by reduced intracellular glutamine and increased succinate with enhanced glucose flux through glycolysis, which could be partly related to HIF1 activation.",28813676_2,-1,-1,-1,-1,33020,-1,2.335295e-05,0.9999609,1.5705964e-05
33022,related to HIF1,34,37,249,265,"We report that pharmacologic inhibition of GS skews M2-polarized macrophages toward the M1-like phenotype, characterized by reduced intracellular glutamine and increased succinate with enhanced glucose flux through glycolysis, which could be partly related to HIF1 activation.",28813676_2,-1,-1,-1,-1,33022,-1,3.894955e-05,0.9999454,1.5682986e-05
33028,to foster,35,37,210,219,"As a result of these metabolic changes and HIF1 accumulation, GS-inhibited macrophages display an increased capacity to induce Tcell recruitment, reduced Tcell suppressive potential, and an impaired ability to foster endothelial cell branching or cancer cell motility.",28813676_3,-1,-1,-1,-1,33028,-1,2.8789835e-05,0.99995804,1.311084e-05
33037,function,15,16,104,112,"These data identify GS activity as mediator of the proangiogenic, immunosuppressive, and pro-metastatic function of M2-like macrophages and highlight the possibility of targeting this enzyme in the treatment of cancer metastasis.",28813676_5,0,1,2,-1,33037,-1,0.00017989718,0.9995776,0.00024256688
33039,targeting this,24,26,169,183,"These data identify GS activity as mediator of the proangiogenic, immunosuppressive, and pro-metastatic function of M2-like macrophages and highlight the possibility of targeting this enzyme in the treatment of cancer metastasis.",28813676_5,-1,-1,-1,-1,33039,-1,1.829508e-05,0.9999722,9.4373245e-06
33040,the treatment,28,30,194,207,"These data identify GS activity as mediator of the proangiogenic, immunosuppressive, and pro-metastatic function of M2-like macrophages and highlight the possibility of targeting this enzyme in the treatment of cancer metastasis.",28813676_5,-1,-1,-1,-1,33040,-1,2.0954338e-05,0.9999695,9.542498e-06
33046,the Tregs,5,7,30,39,"However, different subsets of the Tregs and their relevance to GC are unknown.",28817117_1,-1,-1,-1,-1,33046,-1,2.1065427e-05,0.9999678,1.1150356e-05
33047,their relevance to,8,11,44,62,"However, different subsets of the Tregs and their relevance to GC are unknown.",28817117_1,-1,-1,-1,-1,33047,-1,3.1624022e-05,0.99995494,1.338102e-05
33051,Treg subset,19,21,114,125,"Here, we found that patients with GC showed a significantly higher Tregs infiltration in tumors, and CD45RA-CCR7- Treg subset constituted most tumor-infiltrating Tregs.",28817117_2,-1,-1,-1,-1,33051,-1,0.0003185199,0.00347295,0.99620855
33052,tumor-infiltrating Tregs,23,25,143,167,"Here, we found that patients with GC showed a significantly higher Tregs infiltration in tumors, and CD45RA-CCR7- Treg subset constituted most tumor-infiltrating Tregs.",28817117_2,-1,-1,-1,-1,33052,-1,2.6607317e-05,0.9999583,1.5162212e-05
33054,Treg subset,2,4,32,43,Tumor-infiltrating CD45RA-CCR7- Treg subset with an effector/memory phenotype accumulated in tumors and expressed low level of HLA-DR.,28817117_3,-1,-1,-1,-1,33054,-1,0.0015986069,0.06674966,0.9316517
33056,tumor-derived TNF-,1,3,8,27,Gastric tumor-derived TNF- induced CD45RA-CCR7- Treg subset with similar phenotype to their status in tumors and inhibited their HLA-DR expression via activating STAT3 phosphorylation.,28817117_4,-1,-1,-1,-1,33056,-1,3.8529553e-05,0.9999461,1.5299363e-05
33057,Treg subset,5,7,49,60,Gastric tumor-derived TNF- induced CD45RA-CCR7- Treg subset with similar phenotype to their status in tumors and inhibited their HLA-DR expression via activating STAT3 phosphorylation.,28817117_4,-1,-1,-1,-1,33057,-1,0.0010878171,0.027049508,0.97186273
33058,to their status,10,13,84,99,Gastric tumor-derived TNF- induced CD45RA-CCR7- Treg subset with similar phenotype to their status in tumors and inhibited their HLA-DR expression via activating STAT3 phosphorylation.,28817117_4,-1,-1,-1,-1,33058,-1,3.1194857e-05,0.99995434,1.4466806e-05
33062,These tumor-associated,0,2,0,22,"These tumor-associated CD45RA-CCR7- Treg subset exerted superior immunosuppressive properties to effectively suppress CD8+ T cells' anti-tumor function including CD8+ T-cell IFN- and granzyme B (GrB) production as well as CD8+ T-cell proliferation in vitro, and also contributed to the growth and progression of human gastric tumors in vivo, via IL-10 secretion and cell-cell contact mechanisms.",28817117_5,-1,-1,-1,-1,33062,-1,2.3086297e-05,0.999962,1.488373e-05
33063,Treg subset,3,5,36,47,"These tumor-associated CD45RA-CCR7- Treg subset exerted superior immunosuppressive properties to effectively suppress CD8+ T cells' anti-tumor function including CD8+ T-cell IFN- and granzyme B (GrB) production as well as CD8+ T-cell proliferation in vitro, and also contributed to the growth and progression of human gastric tumors in vivo, via IL-10 secretion and cell-cell contact mechanisms.",28817117_5,-1,-1,-1,-1,33063,-1,0.0024956518,0.20351365,0.7939907
33066,function,18,19,143,151,"These tumor-associated CD45RA-CCR7- Treg subset exerted superior immunosuppressive properties to effectively suppress CD8+ T cells' anti-tumor function including CD8+ T-cell IFN- and granzyme B (GrB) production as well as CD8+ T-cell proliferation in vitro, and also contributed to the growth and progression of human gastric tumors in vivo, via IL-10 secretion and cell-cell contact mechanisms.",28817117_5,0,1,2,-1,33066,-1,0.0002495101,0.9993906,0.00035983737
33067,T-cell IFN-,22,24,167,179,"These tumor-associated CD45RA-CCR7- Treg subset exerted superior immunosuppressive properties to effectively suppress CD8+ T cells' anti-tumor function including CD8+ T-cell IFN- and granzyme B (GrB) production as well as CD8+ T-cell proliferation in vitro, and also contributed to the growth and progression of human gastric tumors in vivo, via IL-10 secretion and cell-cell contact mechanisms.",28817117_5,-1,-1,-1,-1,33067,-1,0.36909327,0.0025525284,0.6283542
33069,to the,44,46,280,286,"These tumor-associated CD45RA-CCR7- Treg subset exerted superior immunosuppressive properties to effectively suppress CD8+ T cells' anti-tumor function including CD8+ T-cell IFN- and granzyme B (GrB) production as well as CD8+ T-cell proliferation in vitro, and also contributed to the growth and progression of human gastric tumors in vivo, via IL-10 secretion and cell-cell contact mechanisms.",28817117_5,-1,-1,-1,-1,33069,-1,2.3388538e-05,0.9999635,1.314335e-05
33074,Treg subset,5,7,52,63,"Moreover, increased tumor-infiltrating CD45RA-CCR7- Treg subset as well as higher intratumoral CD45RA-CCR7- Treg/CD8+ T-cell ratio was associated with advanced disease progression and reduced GC patient survival.",28817117_6,-1,-1,-1,-1,33074,-1,0.0024291219,0.13440067,0.86317027
33075,T-cell,15,16,118,124,"Moreover, increased tumor-infiltrating CD45RA-CCR7- Treg subset as well as higher intratumoral CD45RA-CCR7- Treg/CD8+ T-cell ratio was associated with advanced disease progression and reduced GC patient survival.",28817117_6,-1,1,2,-1,33075,-1,3.8841605e-05,5.111971e-05,0.99991
33078,Treg subset,10,12,89,100,This study therefore identifies a novel immunosuppressive pathway involving CD45RA-CCR7- Treg subset development within the GC microenvironment.,28817117_7,-1,-1,-1,-1,33078,-1,0.00024865576,0.001967787,0.9977835
33084,to treat this,15,18,88,101,"Efforts to inhibit this pathway may therefore prove a valuable strategy to prevent, and to treat this immune suppressive of GC.",28817117_8,-1,-1,-1,-1,33084,-1,2.1038439e-05,0.9999684,1.0579871e-05
33090,immune responses through,26,29,128,152,"B cells give rise to polarized subsets, including B effector 1 (Be1) cells and regulatory B cells, which can promote or inhibit immune responses through expression of IFN- and IL-10, respectively.",28848066_0,-1,-1,-1,-1,33090,-1,0.65035236,0.34695882,0.0026887238
33095,these cells,18,20,117,128,"Such subsets likely explain why B cell depletion can either ameliorate or exacerbate inflammatory diseases; however, these cells remain poorly understood because of the absence of specific markers.",28848066_1,-1,-1,-1,-1,33095,-1,0.0041391235,0.23402092,0.7618399
33101,that TIM-4,3,5,12,22,We now show that TIM-4 is expressed by a subset of B cells distinct from those expressing TIM-1.,28848066_3,-1,-1,-1,-1,33101,-1,2.1090244e-05,0.9999616,1.7243538e-05
33131,T cells-effects that,27,30,154,174,"Moreover, TIM-4+ B cells promoted proinflammatory Th differentiation in vivo, increasing IFN- while decreasing IL-4, IL-10, and Foxp3 expression by CD4+ T cells-effects that are opposite from those of TIM-1+ B cells.",28848066_9,-1,-1,-1,-1,33131,-1,0.0037043896,0.20415904,0.79213655
33150,cells that,12,14,74,84,"Thus, TIM-4+ B cells are enriched for IFN--producing proinflammatory Be1 cells that enhance immune responsiveness and can be specifically targeted with anti-TIM-4.",28848066_12,-1,-1,-1,-1,33150,-1,0.0028561067,0.10237115,0.8947728
33158,tumor cells,28,30,164,175,"Natural killer (NK) cells are large granular lymphocytes of the innate immune system and play a pivotal role against virus-infected cells, microbial pathogens, and tumor cells.",28891726_0,-1,-1,-1,-1,33158,-1,0.0048482358,0.39797333,0.5971784
33162,cells play,12,14,61,71,"NK cells secrete several cytokine,s but IFN- secreted by NK cells play a vital role in the activation of the innate and adaptive immune systems.",28891726_1,-1,-1,-1,-1,33162,-1,0.0026753186,0.10319627,0.8941284
33166,functional,8,9,42,52,"But during any infection or tumor burden, functional activity of NK cells is downregulated significantly by nTreg cells.",28891726_2,0,1,2,-1,33166,-1,4.4035787e-05,0.9999267,2.9309886e-05
33184,cell functional,2,4,7,22,The NK cell functional activity was govern by high level of IFN- measurement during tumor progression.,28891726_6,-1,-1,-1,-1,33184,-1,0.00010887854,0.00027445357,0.9996166
33187,The FoxP3,0,2,0,9,The FoxP3+ CD25+ CD4+ T regulatory cell population was found to be continuously increased with high-level expression of FoxP3 during DL growth.,28891726_7,-1,-1,-1,-1,33187,-1,2.4933865e-05,0.99996424,1.0875775e-05
33196,the FoxP3 transcription factor,19,23,97,127,The rapid increase in the number of Treg cells during DL progression may be due to high level of the FoxP3 transcription factor.,28891726_8,-1,-1,-1,-1,33196,-1,2.3248553e-05,0.9999647,1.20785135e-05
33197,The tumor,0,2,0,9,The tumor microenvironment of DL cell progression has highly deleterious effect on NK cells after massive growth of tumor burden in BALB/c mice.,28891726_9,-1,-1,-1,-1,33197,-1,2.075279e-05,0.99996984,9.382256e-06
33211,factors,7,8,58,65,Emerging evidence suggests a role for micro-environmental factors such as CD25+ cells modulating response to PD-1 inhibition.,28940183_1,0,1,-1,-1,33211,-1,0.00011744595,0.99984026,4.2272313e-05
33224,Treg function,6,8,36,49,There was no difference in systemic Treg function or numbers between ApcMin/+ and wild-type mice.,28940183_4,-1,-1,-1,-1,33224,-1,4.985071e-05,0.9999038,4.6308083e-05
33229,Tslp,28,29,166,170,"However, increased numbers of small intestinal CD25+ Tregs were observed with increased Cox-2 activity in the absence of any difference in the expression of Tgf- or Tslp between ApcMin/+ and wild-type mice.",28940183_5,0,1,-1,-1,33229,-1,6.165175e-05,0.9998988,3.95659e-05
33230,therapy,2,3,16,23,"Cox-2 inhibitor therapy (Celecoxib) reversed the increase in ApcMin/+ intestinal CD25+ Treg numbers, without decreasing numbers of CD25+ systemic Tregs .",28940183_6,0,1,-1,-1,33230,-1,2.3742743e-05,0.9999645,1.1736742e-05
33234,Forkhead box protein,0,3,0,20,Forkhead box protein 3 (FoxP3+ ) and Cox-2+ cells were co-localized to the interstitium of adenomas of Apcmin/+ mice.,28940183_7,-1,-1,-1,-1,33234,-1,3.340712e-05,0.999944,2.2570806e-05
33237,to the,14,16,68,74,Forkhead box protein 3 (FoxP3+ ) and Cox-2+ cells were co-localized to the interstitium of adenomas of Apcmin/+ mice.,28940183_7,-1,-1,-1,-1,33237,-1,1.9802861e-05,0.99996865,1.1563691e-05
33242,the relevance,10,12,68,81,"For therapeutic potential, further studies are required to evaluate the relevance of these findings to human cancer as well as the functional significance of CD25+ intestinal Tregs in cancer.",28940183_9,-1,-1,-1,-1,33242,-1,1.9611654e-05,0.9999708,9.584629e-06
33245,the functional,21,23,127,141,"For therapeutic potential, further studies are required to evaluate the relevance of these findings to human cancer as well as the functional significance of CD25+ intestinal Tregs in cancer.",28940183_9,-1,-1,-1,-1,33245,-1,2.597085e-05,0.9999645,9.578062e-06
33249,to rely,13,15,92,99,"The antitumor effectiveness of cyclophosphamide (CTX) and other chemotherapeutics was shown to rely not only on direct cytotoxicity but also on immunogenic tumor cell death and systemic immunomodulatory mechanisms, including regulatory T cell (Treg) depletion, Th1 cell polarization, type I interferon (IFN) and proinflammatory cytokine production.",28975621_0,-1,-1,-1,-1,33249,-1,2.1782762e-05,0.999969,9.208012e-06
33250,tumor cell,24,26,156,166,"The antitumor effectiveness of cyclophosphamide (CTX) and other chemotherapeutics was shown to rely not only on direct cytotoxicity but also on immunogenic tumor cell death and systemic immunomodulatory mechanisms, including regulatory T cell (Treg) depletion, Th1 cell polarization, type I interferon (IFN) and proinflammatory cytokine production.",28975621_0,-1,-1,-1,-1,33250,-1,0.003930094,0.27937418,0.7166957
33258,IFN regulatory factor,0,3,0,21,"IFN regulatory factor (IRF)-1 is a transcriptional regulator of IFNs and IFN-inducible genes, involved in the control of Th1 and Treg differentiation and in sterile inflammation.",28975621_1,-1,-1,-1,-1,33258,-1,0.94680905,0.04700569,0.0061852913
33261,IFN-inducible genes,11,13,73,92,"IFN regulatory factor (IRF)-1 is a transcriptional regulator of IFNs and IFN-inducible genes, involved in the control of Th1 and Treg differentiation and in sterile inflammation.",28975621_1,-1,-1,-1,-1,33261,-1,0.98803806,0.00894085,0.0030211392
33272,time that IRF-1,6,9,31,46,This study shows for the first time that IRF-1 is important for the antitumor efficacy of CTX in mice.,28975621_3,-1,-1,-1,-1,33272,-1,2.2814194e-05,0.9999598,1.7375833e-05
33275,that Irf1 gene,8,11,59,73,"Moreover, experiments in tumor-bearing C57BL/6 mice showed that Irf1 gene expression in the spleen was transiently increased following CTX administration and correlated with the induction of Th1 cell expansion and of Il12p40 gene expression, which is the main Th1-driving cytokine.",28975621_4,-1,-1,-1,-1,33275,-1,2.1078793e-05,0.99996686,1.2078771e-05
33282,Th1-driving cytokine,40,42,260,280,"Moreover, experiments in tumor-bearing C57BL/6 mice showed that Irf1 gene expression in the spleen was transiently increased following CTX administration and correlated with the induction of Th1 cell expansion and of Il12p40 gene expression, which is the main Th1-driving cytokine.",28975621_4,-1,-1,-1,-1,33282,-1,0.044560753,0.94694513,0.008494086
33288,that the gene,3,6,27,40,"Further experiments showed that the gene and/or protein expression of caspase-1, iNOS, IL-1, IL-6 and CXCL10 and the levels of nitric oxide were modulated following CTX in an IRF-1-direct- or -indirect-dependent manner, and highlighted the importance of caspase-1 in driving the sterile inflammatory response to CTX.",28975621_7,-1,-1,-1,-1,33288,-1,2.208674e-05,0.9999659,1.200027e-05
33289,protein,7,8,48,55,"Further experiments showed that the gene and/or protein expression of caspase-1, iNOS, IL-1, IL-6 and CXCL10 and the levels of nitric oxide were modulated following CTX in an IRF-1-direct- or -indirect-dependent manner, and highlighted the importance of caspase-1 in driving the sterile inflammatory response to CTX.",28975621_7,0,1,-1,-1,33289,-1,3.222494e-05,0.99994445,2.3379327e-05
33300,the regulation,14,16,79,93,"Our data identify IRF-1 as important for the antitumor efficacy of CTX and for the regulation of many immunomodulatory activities of CTX, such as Th1 polarization, Treg depletion and inflammation.",28975621_8,-1,-1,-1,-1,33300,-1,2.0308815e-05,0.9999697,1.00267725e-05
33303,Antigen-independent tonic,0,2,0,25,"Antigen-independent tonic signaling by chimeric antigen receptors (CARs) can increase differentiation and exhaustion of Tcells, limiting their potency.",28978471_0,-1,-1,-1,-1,33303,-1,0.9571737,0.0331253,0.009700954
33306,limiting their,20,22,129,143,"Antigen-independent tonic signaling by chimeric antigen receptors (CARs) can increase differentiation and exhaustion of Tcells, limiting their potency.",28978471_0,-1,-1,-1,-1,33306,-1,0.027857544,0.96393615,0.00820632
33307,Tcells to,9,13,53,63,"Incorporating 4-1BB costimulation in CARs may enable Tcells to resist this functional exhaustion; however, the potential ramifications of tonic 4-1BB signaling in CAR Tcells remain unclear.",28978471_1,-1,-1,-1,-1,33307,-1,0.0017011254,0.03400364,0.96429527
33308,this functional,14,16,71,86,"Incorporating 4-1BB costimulation in CARs may enable Tcells to resist this functional exhaustion; however, the potential ramifications of tonic 4-1BB signaling in CAR Tcells remain unclear.",28978471_1,-1,-1,-1,-1,33308,-1,3.8363552e-05,0.9999465,1.5099091e-05
33312,that tonic,4,6,15,25,"Here, we found that tonic CAR-derived 4-1BB signaling can produce toxicity in Tcells via continuous TRAF2-dependent activation of the nuclear factor B (NF-B) pathway and augmented FAS-dependent cell death.",28978471_2,-1,-1,-1,-1,33312,-1,2.052349e-05,0.9999695,1.0020395e-05
33313,toxicity,13,14,66,74,"Here, we found that tonic CAR-derived 4-1BB signaling can produce toxicity in Tcells via continuous TRAF2-dependent activation of the nuclear factor B (NF-B) pathway and augmented FAS-dependent cell death.",28978471_2,0,1,-1,-1,33313,-1,4.156535e-05,0.999912,4.6418518e-05
33316,the nuclear factor,23,26,131,149,"Here, we found that tonic CAR-derived 4-1BB signaling can produce toxicity in Tcells via continuous TRAF2-dependent activation of the nuclear factor B (NF-B) pathway and augmented FAS-dependent cell death.",28978471_2,-1,-1,-1,-1,33316,-1,2.2418344e-05,0.99996483,1.2804028e-05
33325,function,21,22,157,165,Attenuating CAR expression by substitution with a self-inactivating lentiviral vector minimized tonic signaling and improved Tcell expansion and anti-tumor function.,28978471_4,0,1,2,-1,33325,-1,0.00025056006,0.9995147,0.0002347902
33338,Tcell receptor-triggered,5,9,26,51,"We found that APC ensures Tcell receptor-triggered activation through Nuclear Factor of Activated Tcells (NFAT), since APC is necessary for NFAT's nuclear localization in a microtubule-dependent fashion and for NFAT-driven transcription leading to cytokine gene expression.",28978472_2,-1,-1,-1,-1,33338,-1,0.0006270552,0.0066028726,0.99277014
33339,through Nuclear Factor,10,13,63,85,"We found that APC ensures Tcell receptor-triggered activation through Nuclear Factor of Activated Tcells (NFAT), since APC is necessary for NFAT's nuclear localization in a microtubule-dependent fashion and for NFAT-driven transcription leading to cytokine gene expression.",28978472_2,-1,-1,-1,-1,33339,-1,2.610872e-05,0.9999567,1.719268e-05
33342,to cytokine gene,40,43,247,263,"We found that APC ensures Tcell receptor-triggered activation through Nuclear Factor of Activated Tcells (NFAT), since APC is necessary for NFAT's nuclear localization in a microtubule-dependent fashion and for NFAT-driven transcription leading to cytokine gene expression.",28978472_2,-1,-1,-1,-1,33342,-1,0.00035932282,0.9995608,7.988124e-05
33343,deficiency,4,5,22,32,"Ultimately, mouse Apc deficiency reduces the presence of NFAT in the nucleus of intestinal regulatory Tcells (Tregs) and impairs Treg differentiation and the acquisition of a suppressive phenotype, which is characterized by the production of the anti-inflammatory cytokine IL-10.",28978472_4,0,1,-1,-1,33343,-1,3.434707e-05,0.9998882,7.746147e-05
33352,cytokine IL-10,43,45,265,279,"Ultimately, mouse Apc deficiency reduces the presence of NFAT in the nucleus of intestinal regulatory Tcells (Tregs) and impairs Treg differentiation and the acquisition of a suppressive phenotype, which is characterized by the production of the anti-inflammatory cytokine IL-10.",28978472_4,-1,-1,-1,-1,33352,-1,0.9998679,3.9750154e-05,9.240469e-05
33367,Tr1 cells,10,12,55,64,"Thus, this study aimed to investigate whether Treg and Tr1 cells participate in immunological status against cancer.",28982868_1,-1,-1,-1,-1,33367,-1,0.0024736375,0.31855533,0.678971
33369,blood,5,6,33,38,"PATIENTS AND METHODS: Peripheral blood was withdrawn from patients (n=78), and healthy volunteers as controls (n=23).",28982868_2,0,1,-1,-1,33369,-1,0.00014133062,0.9981229,0.0017358343
33371,blood,2,3,15,20,"The peripheral blood mononuclear cells were subjected to FACScan analysis after labeling with anti-CD4, -CD25, - Foxp3, -CD49b and -LAG3 antibodies.",28982868_3,0,1,-1,-1,33371,-1,0.00020686352,0.99871016,0.0010829987
33374,analysis,9,10,65,73,"The peripheral blood mononuclear cells were subjected to FACScan analysis after labeling with anti-CD4, -CD25, - Foxp3, -CD49b and -LAG3 antibodies.",28982868_3,0,1,-1,-1,33374,-1,2.9878443e-05,0.9999416,2.8521166e-05
33377,factors,6,7,50,57,Patients' clinical course and clinicopathological factors were compared.,28982868_5,0,1,-1,-1,33377,-1,0.00012482227,0.9997799,9.532179e-05
33388,the tumor,9,11,46,55,Ligation of programmed cell death-1 (PD-1) in the tumor microenvironment is known to inhibit effective adaptive antitumor immunity.,28993412_0,-1,-1,-1,-1,33388,-1,2.2256765e-05,0.99996877,8.991413e-06
33390,immunity,19,20,122,130,Ligation of programmed cell death-1 (PD-1) in the tumor microenvironment is known to inhibit effective adaptive antitumor immunity.,28993412_0,0,-1,2,-1,33390,-1,0.999303,0.00042943016,0.0002676077
33391,tumor types,15,17,94,105,"Blockade of PD-1 in humans has resulted in impressive, durable regression responses in select tumor types.",28993412_1,-1,-1,-1,-1,33391,-1,3.0294956e-05,0.9999392,3.0492349e-05
33394,the functions,11,13,62,75,PD-1 was recently shown to be expressed on and thereby impair the functions of tumor-infiltrating murine and human myeloid dendritic cells (TIDC) in ovarian cancer.,28993412_3,-1,-1,-1,-1,33394,-1,3.7256614e-05,0.99994695,1.5804053e-05
33399,the regulation,7,9,37,51,"In the present work, we characterize the regulation of PD-1 expression and the effects of PD-1 blockade on TIDC.",28993412_4,-1,-1,-1,-1,33399,-1,1.7734605e-05,0.9999716,1.0627371e-05
33413,these two,13,15,93,102,"While PD-1 blockade or IL10 neutralization as monotherapies were inefficient, combination of these two led to improved survival and delayed tumor growth; this was accompanied by augmented antitumor T- and B-cell responses and decreased infiltration of immunosuppressive MDSC.",28993412_8,-1,-1,-1,-1,33413,-1,3.5990593e-05,0.9999429,2.1075955e-05
33418,Taken together,0,2,0,14,"Taken together, our findings implicate compensatory release of IL10 as one of the adaptive resistance mechanisms that undermine the efficacy of anti-PD-1 (or anti-PD-L1) monotherapies and prompt further studies aimed at identifying such resistance mechanisms.",28993412_9,-1,-1,-1,-1,33418,-1,3.4975965e-05,0.99995184,1.3175825e-05
33429,the cytokine interleukin-9 (IL-9,17,22,85,117,"Tumor-specific CD4+ T helper 9 (TH9) cells, so-called because of their production of the cytokine interleukin-9 (IL-9), are a powerful effector T cell subset for cancer immunotherapy.",29018172_0,-1,-1,-1,-1,33429,-1,0.89710593,0.100286335,0.0026076576
33435,TH9 cells,17,19,103,112,We found that pretreatment of nave CD4+ T cells with IL-7 further enhanced their differentiation into TH9 cells and augmented their antitumor activity.,29018172_1,-1,-1,-1,-1,33435,-1,0.00017685506,0.00058138324,0.9992417
33440,the STAT5,12,14,90,99,IL-7 markedly increased the abundance of the histone acetyltransferase p300 by activating the STAT5 and PI3K-AKT-mTOR signaling pathways and promoting the acetylation of histones at the Il9 promoter.,29018172_2,-1,-1,-1,-1,33440,-1,2.8590894e-05,0.9999534,1.800995e-05
33442,the Il9,25,27,182,189,IL-7 markedly increased the abundance of the histone acetyltransferase p300 by activating the STAT5 and PI3K-AKT-mTOR signaling pathways and promoting the acetylation of histones at the Il9 promoter.,29018172_2,-1,-1,-1,-1,33442,-1,0.009437131,0.98944956,0.0011132761
33443,the transcriptional,4,6,13,32,"As a result, the transcriptional regulator Foxo1 was dephosphorylated and translocated to the nucleus, bound to the Il9 promoter, and induced the production of IL-9 protein.",29018172_3,-1,-1,-1,-1,33443,-1,2.0339516e-05,0.9999677,1.19784645e-05
33444,translocated to the,11,14,74,93,"As a result, the transcriptional regulator Foxo1 was dephosphorylated and translocated to the nucleus, bound to the Il9 promoter, and induced the production of IL-9 protein.",29018172_3,-1,-1,-1,-1,33444,-1,2.1873784e-05,0.9999647,1.3402863e-05
33445,to the Il9,17,20,109,119,"As a result, the transcriptional regulator Foxo1 was dephosphorylated and translocated to the nucleus, bound to the Il9 promoter, and induced the production of IL-9 protein.",29018172_3,-1,-1,-1,-1,33445,-1,0.043065827,0.95452887,0.0024053066
33447,IL-9 protein,27,29,160,172,"As a result, the transcriptional regulator Foxo1 was dephosphorylated and translocated to the nucleus, bound to the Il9 promoter, and induced the production of IL-9 protein.",29018172_3,-1,-1,-1,-1,33447,-1,0.9949884,0.0024085839,0.0026030485
33449,to the Il9,7,10,32,42,"In contrast, Foxp1, which bound to the Il9 promoter in nave CD4+ T cells and inhibited Il9 expression, was outcompeted for binding to the Il9 promoter by Foxo1 and translocated to the cytoplasm.",29018172_4,-1,-1,-1,-1,33449,-1,0.071244985,0.92646974,0.0022852526
33452,to the Il9,26,29,132,142,"In contrast, Foxp1, which bound to the Il9 promoter in nave CD4+ T cells and inhibited Il9 expression, was outcompeted for binding to the Il9 promoter by Foxo1 and translocated to the cytoplasm.",29018172_4,-1,-1,-1,-1,33452,-1,0.07721208,0.92036533,0.0024225893
33453,translocated to the,33,36,165,184,"In contrast, Foxp1, which bound to the Il9 promoter in nave CD4+ T cells and inhibited Il9 expression, was outcompeted for binding to the Il9 promoter by Foxo1 and translocated to the cytoplasm.",29018172_4,-1,-1,-1,-1,33453,-1,2.2743106e-05,0.99996126,1.601805e-05
33454,deficiency,8,9,45,55,"Furthermore, forced expression of Foxo1 or a deficiency in Foxp1 in CD4+ T cells markedly increased the production of IL-9, whereas a deficiency in Foxo1 inhibited the ability of IL-7 to enhance the differentiation and antitumor activity of TH9 cells.",29018172_5,0,1,-1,-1,33454,-1,0.0001088516,0.9997286,0.00016256563
33459,deficiency,25,26,134,144,"Furthermore, forced expression of Foxo1 or a deficiency in Foxp1 in CD4+ T cells markedly increased the production of IL-9, whereas a deficiency in Foxo1 inhibited the ability of IL-7 to enhance the differentiation and antitumor activity of TH9 cells.",29018172_5,0,1,-1,-1,33459,-1,0.00013776218,0.99969256,0.00016972289
33461,IL-7 to,32,34,179,186,"Furthermore, forced expression of Foxo1 or a deficiency in Foxp1 in CD4+ T cells markedly increased the production of IL-9, whereas a deficiency in Foxo1 inhibited the ability of IL-7 to enhance the differentiation and antitumor activity of TH9 cells.",29018172_5,-1,-1,-1,-1,33461,-1,0.9942438,0.0034757513,0.002280434
33463,TH9 cells,41,43,241,250,"Furthermore, forced expression of Foxo1 or a deficiency in Foxp1 in CD4+ T cells markedly increased the production of IL-9, whereas a deficiency in Foxo1 inhibited the ability of IL-7 to enhance the differentiation and antitumor activity of TH9 cells.",29018172_5,-1,-1,-1,-1,33463,-1,0.00015001927,0.0006290586,0.99922097
33467,TH9 cell,19,21,100,108,"Thus, we identified the roles of Foxo1 as a positive regulator and Foxp1 as a negative regulator of TH9 cell differentiation and antitumor activity, which may provide potential targets for cancer immunotherapy.",29018172_6,-1,-1,-1,-1,33467,-1,6.08981e-05,0.00010334822,0.9998357
33469,IFN--producing cytotoxic T lymphocytes,0,4,0,39,IFN--producing cytotoxic T lymphocytes are essential for host defense against viral infection and cancer.,29021521_0,-1,-1,-1,-1,33469,-1,0.6362056,0.0028307855,0.36096358
33470,that the,3,5,13,21,"Here we show that the RNA-binding tristetraprolin, encoded by Zfp36, is needed for CD8+ T-cell production of IFN- in vivo.",29021521_1,-1,-1,-1,-1,33470,-1,1.824491e-05,0.9999728,8.880665e-06
33472,T-cell,17,18,88,94,"Here we show that the RNA-binding tristetraprolin, encoded by Zfp36, is needed for CD8+ T-cell production of IFN- in vivo.",29021521_1,-1,1,2,-1,33472,-1,3.0570325e-05,4.5408564e-05,0.99992406
33478,T-cells,17,18,105,112,"When activated in vitro, however, IFN- production by naive wild type and tristetraprolin-deficient CD8+ T-cells is comparable.",29021521_2,-1,1,2,-1,33478,-1,0.00025800517,0.0027611747,0.9969807
33482,receptor,5,6,31,39,"Importantly, deletion of IL-27 receptor WSX-1 in tristetraprolin-deficient mice (WSX-1/tristetraprolin double knockout) leads to a reduction in cytotoxic T lymphocyte numbers.",29021521_5,0,1,2,-1,33482,-1,0.0003339786,0.002467875,0.9971982
33490,tumor cytotoxic T lymphocytes,33,37,222,251,"Moreover, tumor growth is accelerated, not only in tristetraprolin-deficient mice after cytotoxic T lymphocyte depletion, but also in WSX-1/tristetraprolin double knockout mice, with substantial reduction in the number of tumor cytotoxic T lymphocytes.",29021521_6,-1,-1,-1,-1,33490,-1,0.0033573054,0.11039045,0.8862522
33492,cytotoxic T lymphocyte function,10,14,67,98,"This study describes a regulatory pathway for IL-27 expression and cytotoxic T lymphocyte function mediated by tristetraprolin, contributing to regulation of antitumour immunity.",29021521_7,-1,-1,-1,-1,33492,-1,5.8730246e-05,8.244371e-05,0.99985874
33494,to regulation,19,21,141,154,"This study describes a regulatory pathway for IL-27 expression and cytotoxic T lymphocyte function mediated by tristetraprolin, contributing to regulation of antitumour immunity.",29021521_7,-1,-1,-1,-1,33494,-1,2.7117547e-05,0.99995685,1.6057806e-05
33495,immunity,23,24,169,177,"This study describes a regulatory pathway for IL-27 expression and cytotoxic T lymphocyte function mediated by tristetraprolin, contributing to regulation of antitumour immunity.",29021521_7,0,-1,2,-1,33495,-1,0.9991085,0.000593585,0.0002978557
33496,cytokines that,7,9,28,42,IL-27 is one of a number of cytokines that can induce antitumour CD8+ T cell responses.,29021521_8,-1,-1,-1,-1,33496,-1,0.9593591,0.037148837,0.0034921614
33499,that TTP,4,6,22,30,"Here the authors show that TTP, encoded by Zfp36, degrades p28 to inhibit IL-27 production by macrophages and is thereby a negative regulator of the antitumour response.",29021521_9,-1,-1,-1,-1,33499,-1,2.2543814e-05,0.99996805,9.371669e-06
33521,these cells,26,28,162,173,"Allogeneic immune cells, particularly T cells in donor grafts, recognize and eliminate leukemic cells via graft-versus-leukemia (GVL) reactivity, and transfer of these cells is often used for high-risk hematological malignancies, including acute myeloid leukemia.",29038366_0,-1,-1,-1,-1,33521,-1,0.002637664,0.13270259,0.8646597
33522,these cells,2,4,15,26,"Unfortunately, these cells also attack host normal tissues through the often fatal graft-versus-host disease (GVHD).",29038366_1,-1,-1,-1,-1,33522,-1,0.0022089484,0.10253777,0.89525324
33523,tissues through the,8,11,51,70,"Unfortunately, these cells also attack host normal tissues through the often fatal graft-versus-host disease (GVHD).",29038366_1,-1,-1,-1,-1,33523,-1,0.00012827889,0.99959844,0.00027331497
33529,T9IL-33 cells,24,26,132,145,"Here, we show that, in mice and humans, a population of interleukin-9 (IL-9)-producing T cells activated via the ST2-IL-33 pathway (T9IL-33 cells) increases GVL while decreasing GVHD through two opposing mechanisms: protection from fatal immunity by amphiregulin expression and augmentation of antileukemic activity compared with T9, T1, and unmanipulated T cells through CD8 expression.",29038366_3,-1,-1,-1,-1,33529,-1,0.0032204178,0.41840068,0.5783789
33530,through two,32,34,183,194,"Here, we show that, in mice and humans, a population of interleukin-9 (IL-9)-producing T cells activated via the ST2-IL-33 pathway (T9IL-33 cells) increases GVL while decreasing GVHD through two opposing mechanisms: protection from fatal immunity by amphiregulin expression and augmentation of antileukemic activity compared with T9, T1, and unmanipulated T cells through CD8 expression.",29038366_3,-1,-1,-1,-1,33530,-1,2.6464853e-05,0.9999579,1.5668771e-05
33531,immunity,40,41,238,246,"Here, we show that, in mice and humans, a population of interleukin-9 (IL-9)-producing T cells activated via the ST2-IL-33 pathway (T9IL-33 cells) increases GVL while decreasing GVHD through two opposing mechanisms: protection from fatal immunity by amphiregulin expression and augmentation of antileukemic activity compared with T9, T1, and unmanipulated T cells through CD8 expression.",29038366_3,0,-1,2,-1,33531,-1,0.909756,0.086900406,0.0033435097
33534,T cells through,57,60,356,371,"Here, we show that, in mice and humans, a population of interleukin-9 (IL-9)-producing T cells activated via the ST2-IL-33 pathway (T9IL-33 cells) increases GVL while decreasing GVHD through two opposing mechanisms: protection from fatal immunity by amphiregulin expression and augmentation of antileukemic activity compared with T9, T1, and unmanipulated T cells through CD8 expression.",29038366_3,-1,-1,-1,-1,33534,-1,0.00093938445,0.013847838,0.9852128
33537,T9IL-33 cells,6,8,38,51,"Thus, adoptive transfer of allogeneic T9IL-33 cells offers an attractive approach for separating GVL activity from GVHD.",29038366_4,-1,-1,-1,-1,33537,-1,0.003381252,0.45488605,0.5417327
33548,the tumor,6,8,43,52,We found that fucoidan treatment decreased the tumor incidence and mean tumor weight and prolonged the tumor latency.,29043842_3,-1,-1,-1,-1,33548,-1,1.9949812e-05,0.999969,1.09992125e-05
33550,the tumor,15,17,99,108,We found that fucoidan treatment decreased the tumor incidence and mean tumor weight and prolonged the tumor latency.,29043842_3,-1,-1,-1,-1,33550,-1,2.148447e-05,0.99996674,1.17554755e-05
33551,that the,4,6,34,42,Flow cytometric analyses revealed that the number of blood natural killer cells was higher after fucoidan treatment and that the proportions of CD4 and CD8 T cells were also increased.,29043842_4,-1,-1,-1,-1,33551,-1,1.7232038e-05,0.99997354,9.18901e-06
33552,blood natural,8,10,53,66,Flow cytometric analyses revealed that the number of blood natural killer cells was higher after fucoidan treatment and that the proportions of CD4 and CD8 T cells were also increased.,29043842_4,-1,-1,-1,-1,33552,-1,4.6535475e-05,0.9999298,2.3659622e-05
33555,that the,18,20,120,128,Flow cytometric analyses revealed that the number of blood natural killer cells was higher after fucoidan treatment and that the proportions of CD4 and CD8 T cells were also increased.,29043842_4,-1,-1,-1,-1,33555,-1,1.9024226e-05,0.9999708,1.0225091e-05
33562,to those,21,23,128,136,"The serum levels of interleukin (IL)-6, IL-12p40, and interferon (IFN)- were higher in the rats treated with fucoidan compared to those of model rats.",29043842_5,-1,-1,-1,-1,33562,-1,2.3969407e-05,0.99996054,1.5510268e-05
33566,the blood,13,15,62,71,"Moreover, the percentage of CD3+ Foxp3+ regulatory T cells in the blood and the levels of IL-10 and transforming growth factor  in the serum were lower in the rats treated with fucoidan.",29043842_6,-1,-1,-1,-1,33566,-1,3.2153395e-05,0.9999267,4.1195675e-05
33569,transforming growth factor,21,24,100,126,"Moreover, the percentage of CD3+ Foxp3+ regulatory T cells in the blood and the levels of IL-10 and transforming growth factor  in the serum were lower in the rats treated with fucoidan.",29043842_6,-1,-1,-1,-1,33569,-1,0.6693818,0.32515493,0.005463293
33577,tumor tissues,20,22,113,126,"Furthermore, fucoidan treatment decreased the expression of Foxp3 and programmed cell death 1 ligand 1 (PDL1) in tumor tissues.",29043842_7,-1,-1,-1,-1,33577,-1,2.2494301e-05,0.9999523,2.5130752e-05
33579,tumor tissues,10,12,60,73,The levels of p-phosphatidyl inositol kinase 3 and p-AKT in tumor tissues were also lower than those of model rats.,29043842_8,-1,-1,-1,-1,33579,-1,2.3378974e-05,0.9999503,2.6277416e-05
33580,than those,15,17,90,100,The levels of p-phosphatidyl inositol kinase 3 and p-AKT in tumor tissues were also lower than those of model rats.,29043842_8,-1,-1,-1,-1,33580,-1,2.4497662e-05,0.9999608,1.4700341e-05
33587,through the,13,15,104,115,This study provides experimental evidence toward elucidating the immune enhancement induced by fucoidan through the programmed cell death 1/PDL1 signaling pathway.,29043842_10,-1,-1,-1,-1,33587,-1,1.840073e-05,0.9999713,1.0274361e-05
33597,the tumor,17,19,97,106,The clinical significance of regulatory T cells (Treg) and tumor-associated macrophages (TAM) in the tumor microenvironment of human bladder cancer remains unclear.,29048388_0,-1,-1,-1,-1,33597,-1,1.9890944e-05,0.9999713,8.819535e-06
33601,their relevance to,8,11,36,54,The aim of this study is to explore their relevance to oncological features in non-muscle invasive bladder cancer (NMIBC).,29048388_1,-1,-1,-1,-1,33601,-1,2.1692897e-05,0.9999691,9.176043e-06
33602,analysis,4,5,35,43,"We carried out immunohistochemical analysis of forkhead box P3 (FOXP3, Treg maker), CD204 (TAM marker), and interleukin-6 (IL6) using surgical specimens obtained from 154 NMIBC patients.",29048388_2,0,1,-1,-1,33602,-1,2.8604565e-05,0.99994886,2.2502249e-05
33609,The Treg,0,2,0,8,The Treg and TAM counts surrounding the cancer lesion and IL6-positive cancer cell counts were evaluated against clinicopathological variables.,29048388_3,-1,-1,-1,-1,33609,-1,2.7005803e-05,0.999959,1.3987823e-05
33615,the Treg,6,8,29,37,We focused on the ability of the Treg and TAM counts around the cancer lesion to predict outcomes after adjuvant intravesical Bacille Calmette-Gurin (BCG) treatment.,29048388_4,-1,-1,-1,-1,33615,-1,2.096726e-05,0.999966,1.3057949e-05
33627,analysis,2,3,7,15,"In our analysis of 71 patients treated with BCG, high counts of Treg and TAM were associated with shorter recurrence-free survival, and the former was an independent predictor of recurrence.",29048388_7,0,1,-1,-1,33627,-1,3.1947322e-05,0.99994195,2.6163196e-05
33635,the tumor,12,14,70,79,Poor response to intravesical BCG was associated with Treg and TAM in the tumor microenvironment.,29048388_8,-1,-1,-1,-1,33635,-1,2.0318614e-05,0.99997044,9.196757e-06
33641,peptides,8,9,55,63,"Here, we identify and characterize immunogenic HLA-A24 peptides derived from these antigens for potential vaccination therapy of HLA-A24+ patients with MM.",29089645_1,0,-1,2,-1,33641,-1,0.00021051022,0.99666613,0.0031233847
33642,these antigens,11,13,77,91,"Here, we identify and characterize immunogenic HLA-A24 peptides derived from these antigens for potential vaccination therapy of HLA-A24+ patients with MM.",29089645_1,-1,-1,-1,-1,33642,-1,0.15806815,0.80716157,0.03477032
33643,therapy,16,17,118,125,"Here, we identify and characterize immunogenic HLA-A24 peptides derived from these antigens for potential vaccination therapy of HLA-A24+ patients with MM.",29089645_1,0,1,-1,-1,33643,-1,2.3499255e-05,0.9999635,1.2985975e-05
33647,peptides,67,68,206,214,"The identified immunogenic HLA-A24-specific XBP1 unspliced (UN)185-193 (I S P W I L A V L), XBP1 spliced (SP)223-231 (V Y P E G P S S L), CD138265-273 (I F A V C L V G F) and CS1240-248 (L F V L G L F L W) peptides induced antigen-specific CTL with anti-MM activity in an HLA-A24 restricted manner.",29089645_2,0,-1,2,-1,33647,-1,7.36566e-05,0.999841,8.5296764e-05
33648,antigen-specific CTL,69,71,223,243,"The identified immunogenic HLA-A24-specific XBP1 unspliced (UN)185-193 (I S P W I L A V L), XBP1 spliced (SP)223-231 (V Y P E G P S S L), CD138265-273 (I F A V C L V G F) and CS1240-248 (L F V L G L F L W) peptides induced antigen-specific CTL with anti-MM activity in an HLA-A24 restricted manner.",29089645_2,-1,-1,-1,-1,33648,-1,0.22501157,0.002509514,0.7724789
33650,peptides,8,9,52,60,"Furthermore, a cocktail containing the four HLA-A24 peptides evoked MM-specific CTL with distinct phenotypic profiles (CD28, CD40L, 41BB, CD38, CD69) and anti-tumor activities, evidenced by perforin upregulation, CD107a degranulation (cytotoxicity) and Th1-type cytokines (IFN-/IL-2/TNF-) production in response to HLA-A24+ MM cells.",29089645_3,0,-1,2,-1,33650,-1,7.758366e-05,0.99983466,8.7777255e-05
33654,Th1-type cytokines,42,44,253,271,"Furthermore, a cocktail containing the four HLA-A24 peptides evoked MM-specific CTL with distinct phenotypic profiles (CD28, CD40L, 41BB, CD38, CD69) and anti-tumor activities, evidenced by perforin upregulation, CD107a degranulation (cytotoxicity) and Th1-type cytokines (IFN-/IL-2/TNF-) production in response to HLA-A24+ MM cells.",29089645_3,-1,-1,-1,-1,33654,-1,0.03516947,0.95892644,0.00590413
33667,therapy to,9,11,67,77,These results provide the framework for a multipeptide vaccination therapy to induce tumor-specific CTL in HLA-A24-positive patients with myeloma and other cancers expressing these antigens.,29089645_5,-1,-1,-1,-1,33667,-1,2.1403961e-05,0.999969,9.570583e-06
33668,tumor-specific CTL,12,14,85,103,These results provide the framework for a multipeptide vaccination therapy to induce tumor-specific CTL in HLA-A24-positive patients with myeloma and other cancers expressing these antigens.,29089645_5,-1,-1,-1,-1,33668,-1,0.0053092297,0.7320738,0.262617
33669,these antigens,23,25,175,189,These results provide the framework for a multipeptide vaccination therapy to induce tumor-specific CTL in HLA-A24-positive patients with myeloma and other cancers expressing these antigens.,29089645_5,-1,-1,-1,-1,33669,-1,0.39638546,0.5696608,0.033953812
33678,tumour cells,5,7,30,42,METHODS: Exosomes released by tumour cells infected with IRF-1-expressing adenovirus (IRF-1-Exo) or treated with interferon- (IFN-Exo) were isolated via ultracentrifugation.,29112686_2,-1,-1,-1,-1,33678,-1,0.003409292,0.33364567,0.66294503
33684,The IRF-1 target proteins IL-15R,0,5,0,33,The IRF-1 target proteins IL-15R and MHC class I (MHC-I) were analysed by western blot.,29112686_3,-1,-1,-1,-1,33684,-1,0.0025531475,0.9971827,0.0002641577
33690,tumour cells,7,9,59,71,Splenocytes from tumour-bearing mice were co-cultured with tumour cells.,29112686_6,-1,-1,-1,-1,33690,-1,0.0043921946,0.28138986,0.7142179
33691,The IFN-positive,0,2,0,17,The IFN-positive and granzyme B-positive CD8+ splenocyte cells were quantified by flow cytometry.,29112686_7,-1,-1,-1,-1,33691,-1,0.0031059298,0.99624485,0.0006492145
33693,The IRF-1-Exo,2,4,9,22,RESULTS: The IRF-1-Exo or IFN-Exo displayed increased IL-15R and MHC-I expression.,29112686_8,-1,-1,-1,-1,33693,-1,3.0578096e-05,0.9999522,1.7209632e-05
33708,The IRF-1,2,4,13,22,CONCLUSIONS: The IRF-1 priming of TEXs enhances antitumour immune response.,29112686_13,-1,-1,-1,-1,33708,-1,2.2983191e-05,0.99996233,1.4651349e-05
33713,tumor-specific T-cell,24,26,144,165,"BACKGROUND: Whole-cell tumor vaccines have shown much promise; however, only limited success has been achieved for the goal of eliciting robust tumor-specific T-cell responses.",29115974_0,-1,-1,-1,-1,33713,-1,0.005315425,0.60703045,0.3876541
33715,the STAT3,19,21,90,99,"METHODS: Hepatocellular carcinoma (HCC) cells, H22 and Hepa1-6, were modified by blocking the STAT3 signaling pathway with a STAT3 decoy oligodeoxynucleotide, and the immunogenicity and possibility of using these cell lysates as a vaccine were evaluated.",29115974_1,-1,-1,-1,-1,33715,-1,2.8418379e-05,0.9999579,1.3626005e-05
33718,these cell,36,38,207,217,"METHODS: Hepatocellular carcinoma (HCC) cells, H22 and Hepa1-6, were modified by blocking the STAT3 signaling pathway with a STAT3 decoy oligodeoxynucleotide, and the immunogenicity and possibility of using these cell lysates as a vaccine were evaluated.",29115974_1,-1,-1,-1,-1,33718,-1,0.0039920686,0.3869612,0.60904676
33733,the tumor tissues,33,36,177,194,"In addition, STAT3-blocked whole HCC cell lysates stimulated the activation of T cells and natural killer (NK) cells, and enhanced the infiltration of cytotoxic CD8+ T cells in the tumor tissues.",29115974_3,-1,-1,-1,-1,33733,-1,2.4900537e-05,0.99994755,2.753658e-05
33736,the generation,16,18,82,96,"In addition, the maturation of dendritic cells (DCs) was enhanced, which promoted the generation of immunological memory against HCC.",29115974_4,-1,-1,-1,-1,33736,-1,2.0185422e-05,0.99996924,1.0621876e-05
33743,the generation,7,9,55,69,"Additionally, immunization with this vaccine decreased the generation of Tregs and the production of TGF- and IL-10.",29115974_6,-1,-1,-1,-1,33743,-1,2.2051649e-05,0.9999665,1.1409856e-05
33757,generated STAT3-blocked,4,6,23,46,CONCLUSIONS: The newly generated STAT3-blocked whole-cell HCC vaccine has potential for cancer cell vaccination.,29115974_8,-1,-1,-1,-1,33757,-1,0.00014295071,0.9997658,9.118774e-05
33759,tissue,5,6,37,43,Macrophages are exquisite sensors of tissue homeostasis that can rapidly switch between pro- and anti-inflammatory or regulatory modes to respond to perturbations in their microenvironment.,29150563_0,-1,1,2,-1,33759,-1,3.146204e-05,0.9999504,1.8134091e-05
33764,This functional plasticity,0,3,0,26,This functional plasticity involves a precise orchestration of gene expression patterns whose transcriptional regulators have not been fully characterized.,29150563_1,-1,-1,-1,-1,33764,-1,2.7267037e-05,0.9999584,1.4342105e-05
33767,the transcription factor,4,7,29,53,"We had previously identified the transcription factor NFAT5 as an activator of TLR-induced responses, and in this study we explore its contribution to macrophage functions in different polarization settings.",29150563_2,-1,-1,-1,-1,33767,-1,1.9150697e-05,0.99997056,1.02936165e-05
33772,functions,25,26,162,171,"We had previously identified the transcription factor NFAT5 as an activator of TLR-induced responses, and in this study we explore its contribution to macrophage functions in different polarization settings.",29150563_2,0,1,2,-1,33772,-1,0.00052115764,0.998796,0.00068278686
33774,functions,13,14,90,99,"We found that both in classically and alternatively polarized macrophages, NFAT5 enhanced functions associated with a proinflammatory profile such as bactericidal capacity and the ability to promote Th1 polarization over Th2 responses.",29150563_3,0,1,2,-1,33774,-1,0.0002020489,0.9996007,0.00019728753
33780,the Th1-stimulatory cytokine IL-12,6,10,34,68,"In this regard, NFAT5 upregulated the Th1-stimulatory cytokine IL-12 in classically activated macrophages, whereas in alternatively polarized ones it enhanced the expression of the pro-Th1 mediators Fizz-1 and arginase 1, indicating that it could promote proinflammatory readiness by regulating independent genes in differently polarized macrophages.",29150563_4,-1,-1,-1,-1,33780,-1,0.37892082,0.61500275,0.006076436
33791,the tumor,45,47,284,293,"Finally, adoptive transfer assays in vivo revealed a reduced antitumor capacity in NFAT5-deficient macrophages against syngeneic Lewis lung carcinoma and ID8 ovarian carcinoma cells, a defect that in the ID8 model was associated with a reduced accumulation of effector CD8 T cells at the tumor site.",29150563_5,-1,-1,-1,-1,33791,-1,1.9722958e-05,0.9999691,1.1096502e-05
33792,analysis,3,4,21,29,"Altogether, detailed analysis of the effect of NFAT5 in pro- and anti-inflammatory macrophages uncovered its ability to regulate distinct genes under both polarization modes and revealed its predominant role in promoting proinflammatory macrophage functions.",29150563_6,0,1,-1,-1,33792,-1,2.5784548e-05,0.99995875,1.5511867e-05
33796,functions,34,35,248,257,"Altogether, detailed analysis of the effect of NFAT5 in pro- and anti-inflammatory macrophages uncovered its ability to regulate distinct genes under both polarization modes and revealed its predominant role in promoting proinflammatory macrophage functions.",29150563_6,0,1,2,-1,33796,-1,0.0068345787,0.68663853,0.3065269
33799,Toll-like receptor,9,11,62,80,Metabolic shifts in mitochondrial dynamics may be involved in Toll-like receptor agonist-mediated inflammatory responses and immune cell polarization.,29180626_1,-1,-1,-1,-1,33799,-1,0.0031984642,0.98051447,0.016287062
33803,immunity,12,13,89,97,"However, whether the mitochondrial morphology in myeloid immune cells affects anti-tumor immunity is unclear.",29180626_2,0,-1,2,-1,33803,-1,0.9992205,0.0005738688,0.00020558492
33805,protein,10,11,57,64,"Here we show that FAM73b, a mitochondrial outer membrane protein, has a pivotal function in Toll-like receptor-regulated mitochondrial morphology switching from fusion to fission.",29180626_3,0,1,-1,-1,33805,-1,0.0005704953,0.9927537,0.006675796
33806,function,15,16,80,88,"Here we show that FAM73b, a mitochondrial outer membrane protein, has a pivotal function in Toll-like receptor-regulated mitochondrial morphology switching from fusion to fission.",29180626_3,0,1,2,-1,33806,-1,5.862012e-05,0.9999074,3.4041226e-05
33807,Toll-like receptor-regulated,17,19,92,120,"Here we show that FAM73b, a mitochondrial outer membrane protein, has a pivotal function in Toll-like receptor-regulated mitochondrial morphology switching from fusion to fission.",29180626_3,-1,-1,-1,-1,33807,-1,0.00083761645,0.9973258,0.0018365473
33814,immunity,13,14,98,106,"In tumor-associated macrophages, this switch results in T-cell activation and enhances anti-tumor immunity.",29180626_5,0,-1,2,-1,33814,-1,0.9993267,0.00044042978,0.00023293078
33815,that the,3,5,13,21,We also show that the mitochondrial morphology affects Parkin expression and its recruitment to mitochondria.,29180626_6,-1,-1,-1,-1,33815,-1,2.1778778e-05,0.9999683,9.913553e-06
33828,CD4+ T cell subsets,16,21,88,107,"CD8+ T lymphocytes mediate potent immune responses against tumor, but the role of human CD4+ T cell subsets in cancer immunotherapy remains ill-defined.",29213079_0,-1,-1,-1,-1,33828,-1,7.289149e-05,8.21832e-05,0.9998448
33830,three T,7,9,40,47,"Herein, we exhibit that CD26 identifies three T helper subsets with distinct immunological properties in both healthy individuals and cancer patients.",29213079_1,-1,-1,-1,-1,33830,-1,6.779609e-05,0.99985385,7.832308e-05
33839,cell transfer,14,16,96,109,"Paradoxically, CD26high T cells persist in and regress multiple solid tumors following adoptive cell transfer.",29213079_3,-1,-1,-1,-1,33839,-1,0.0024413555,0.040745243,0.9568134
33840,analysis,1,2,8,16,"Further analysis revealed that CD26high cells have a rich chemokine receptor profile (including CCR2 and CCR5), profound cytotoxicity (Granzyme B and CD107A), resistance to apoptosis (c-KIT and Bcl2), and enhanced stemness (-catenin and Lef1).",29213079_4,0,1,-1,-1,33840,-1,3.25473e-05,0.99993706,3.035325e-05
33843,chemokine receptor,9,11,58,76,"Further analysis revealed that CD26high cells have a rich chemokine receptor profile (including CCR2 and CCR5), profound cytotoxicity (Granzyme B and CD107A), resistance to apoptosis (c-KIT and Bcl2), and enhanced stemness (-catenin and Lef1).",29213079_4,-1,-1,-1,-1,33843,-1,0.6661644,0.0026699447,0.33116564
33849,to traffic to,10,13,66,79,"These properties license CD26high T cells with a natural capacity to traffic to, regress and survive in solid tumors.",29213079_5,-1,-1,-1,-1,33849,-1,2.6530273e-05,0.9999597,1.3713439e-05
33852,CD4+ T cell subsets,5,10,38,57,"Collectively, these findings identify CD4+ T cell subsets with properties critical for improving cancer immunotherapy.",29213079_6,-1,-1,-1,-1,33852,-1,7.038209e-05,8.8466695e-05,0.9998411
33854,functions,8,9,50,59,Interferon regulatory factors (IRF) have critical functions in lymphoid development and in immune response regulation.,29233972_0,0,1,2,-1,33854,-1,4.2785887e-05,0.99993336,2.3794275e-05
33855,immune response regulation,14,17,91,117,Interferon regulatory factors (IRF) have critical functions in lymphoid development and in immune response regulation.,29233972_0,-1,-1,-1,-1,33855,-1,0.65488124,0.34235686,0.0027618886
33856,the function,5,7,37,49,"Although many studies have described the function of IRF4 in CD4+ T cells, few have focused on the IRF4 homologue, IRF8.",29233972_1,-1,-1,-1,-1,33856,-1,1.9754221e-05,0.9999689,1.131877e-05
33859,the IRF4,19,21,95,103,"Although many studies have described the function of IRF4 in CD4+ T cells, few have focused on the IRF4 homologue, IRF8.",29233972_1,-1,-1,-1,-1,33859,-1,2.0103242e-05,0.9999609,1.8959016e-05
33861,that IRF8,4,6,14,23,"Here, we show that IRF8 is required for Th9 differentiation in vitro and in vivo.",29233972_2,-1,-1,-1,-1,33861,-1,2.6364236e-05,0.99995863,1.5040438e-05
33863,IRF8 functions through,0,3,0,22,"IRF8 functions through a transcription factor complex consisting of IRF8, IRF4, PU.1 and BATF, which binds to DNA and boosts Il9 transcription.",29233972_3,-1,-1,-1,-1,33863,-1,2.4129415e-05,0.9999553,2.0592955e-05
33864,transcription factor complex,4,7,25,53,"IRF8 functions through a transcription factor complex consisting of IRF8, IRF4, PU.1 and BATF, which binds to DNA and boosts Il9 transcription.",29233972_3,-1,-1,-1,-1,33864,-1,2.5281955e-05,0.9999552,1.9584191e-05
33868,Il9 transcription,23,25,125,142,"IRF8 functions through a transcription factor complex consisting of IRF8, IRF4, PU.1 and BATF, which binds to DNA and boosts Il9 transcription.",29233972_3,-1,-1,-1,-1,33868,-1,0.9829622,0.010557649,0.006480158
33869,IRF8 deficiency,3,5,13,28,"By contrast, IRF8 deficiency promotes the expression of other genes such as Il4, as IRF8 dimerises with the transcriptional repressor ETV6 and inhibits Il4 expression.",29233972_4,-1,-1,-1,-1,33869,-1,2.946089e-05,0.9999471,2.3450557e-05
33873,the transcriptional,19,21,104,123,"By contrast, IRF8 deficiency promotes the expression of other genes such as Il4, as IRF8 dimerises with the transcriptional repressor ETV6 and inhibits Il4 expression.",29233972_4,-1,-1,-1,-1,33873,-1,2.3171582e-05,0.9999653,1.1463176e-05
33876,Th9 cells,11,13,58,67,"In vivo, IRF8 is essential for the anti-tumour effects of Th9 cells in mouse melanoma models.",29233972_5,-1,-1,-1,-1,33876,-1,0.00010312365,0.00032325948,0.99957365
33877,that IRF8 complexes,3,6,17,36,"Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.",29233972_6,-1,-1,-1,-1,33877,-1,2.295005e-05,0.99996316,1.3829996e-05
33878,the Th9,7,9,43,50,"Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.",29233972_6,-1,-1,-1,-1,33878,-1,3.2098786e-05,0.9999491,1.8800743e-05
33880,Th9 cell,16,18,98,106,"Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.",29233972_6,-1,-1,-1,-1,33880,-1,0.00010331644,0.00027677143,0.99961984
33883,therapeutic target to,26,29,164,185,"Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.",29233972_6,-1,-1,-1,-1,33883,-1,1.8889948e-05,0.9999714,9.702203e-06
33885,therapy,34,35,217,224,"Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.",29233972_6,0,1,-1,-1,33885,-1,2.2117363e-05,0.99996567,1.2247038e-05
33887,the IL-17,8,10,47,56,"BACKGROUND: Interleukin (IL)-25 is a member of the IL-17 family, which can promote and augment T-helper (Th) type 2 responses.",29238954_0,-1,-1,-1,-1,33887,-1,0.5669813,0.42591622,0.007102467
33892,receptor,7,8,40,48,"The expression of IL-25 and its cognate receptor, IL-25 receptor (IL-25R), is upregulated and correlated with disease activity in Th2-associated diseases.",29238954_1,0,1,2,-1,33892,-1,0.0010586565,0.7831183,0.21582302
33893,receptor,10,11,56,64,"The expression of IL-25 and its cognate receptor, IL-25 receptor (IL-25R), is upregulated and correlated with disease activity in Th2-associated diseases.",29238954_1,0,1,2,-1,33893,-1,0.0010907489,0.8089375,0.18997173
33897,function,7,8,42,50,OBJECTIVES: To examine the expression and function of IL-25 in cutaneous T-cell lymphoma (CTCL).METHODS: Expression and location of IL-25 in lesional skin was investigated with immunohistochemistry.,29238954_2,0,1,2,-1,33897,-1,4.8832553e-05,0.9999162,3.4950714e-05
33898,T-cell,12,13,73,79,OBJECTIVES: To examine the expression and function of IL-25 in cutaneous T-cell lymphoma (CTCL).METHODS: Expression and location of IL-25 in lesional skin was investigated with immunohistochemistry.,29238954_2,-1,1,2,-1,33898,-1,5.0731865e-05,8.484175e-05,0.99986434
33902,tumour cells,6,8,30,42,The direct effect of IL-25 on tumour cells was also examined using CTCL cell lines and peripheral blood mononuclear cells in patients with Szary syndrome.,29238954_5,-1,-1,-1,-1,33902,-1,0.0036576062,0.24128474,0.7550576
33904,blood,17,18,98,103,The direct effect of IL-25 on tumour cells was also examined using CTCL cell lines and peripheral blood mononuclear cells in patients with Szary syndrome.,29238954_5,0,1,-1,-1,33904,-1,0.00015034479,0.9992932,0.0005564827
33906,Th2 cytokines,0,2,0,13,"Th2 cytokines, IL-4 and IL-13, and periostin induced IL-25 expression by normal human epidermal keratinocytes.",29238954_7,-1,-1,-1,-1,33906,-1,0.2264634,0.7505753,0.022961348
33912,blood,1,2,11,16,"Peripheral blood mononuclear cells from one patient with Szary syndrome expressed IL-25R and showed increase of IL-13 production by IL-25.CONCLUSIONS: Th2 cytokines highly expressed in CTCL lesional skin induce IL-25 production by epidermal keratinocytes, which may, in turn, lead to formation of a Th2-dominant microenvironment through the direct induction of IL-13 by tumour cells.",29238954_11,0,1,-1,-1,33912,-1,0.00017553088,0.9990238,0.00080068485
33915,Th2 cytokines,21,23,152,165,"Peripheral blood mononuclear cells from one patient with Szary syndrome expressed IL-25R and showed increase of IL-13 production by IL-25.CONCLUSIONS: Th2 cytokines highly expressed in CTCL lesional skin induce IL-25 production by epidermal keratinocytes, which may, in turn, lead to formation of a Th2-dominant microenvironment through the direct induction of IL-13 by tumour cells.",29238954_11,-1,-1,-1,-1,33915,-1,0.21534933,0.76941544,0.015235226
33919,through the,49,51,330,341,"Peripheral blood mononuclear cells from one patient with Szary syndrome expressed IL-25R and showed increase of IL-13 production by IL-25.CONCLUSIONS: Th2 cytokines highly expressed in CTCL lesional skin induce IL-25 production by epidermal keratinocytes, which may, in turn, lead to formation of a Th2-dominant microenvironment through the direct induction of IL-13 by tumour cells.",29238954_11,-1,-1,-1,-1,33919,-1,2.1150378e-05,0.99996793,1.0934283e-05
33921,tumour cells,56,58,371,383,"Peripheral blood mononuclear cells from one patient with Szary syndrome expressed IL-25R and showed increase of IL-13 production by IL-25.CONCLUSIONS: Th2 cytokines highly expressed in CTCL lesional skin induce IL-25 production by epidermal keratinocytes, which may, in turn, lead to formation of a Th2-dominant microenvironment through the direct induction of IL-13 by tumour cells.",29238954_11,-1,-1,-1,-1,33921,-1,0.0036643823,0.26211068,0.7342249
33922,therapy,1,2,9,16,Adoptive therapy with chimeric antigen receptor (CAR)-redirected Tcells has achieved remarkable efficacy in the treatment of hematopoietic malignancies.,29241547_0,0,1,-1,-1,33922,-1,2.499218e-05,0.9999609,1.4069313e-05
33925,the treatment,15,17,109,122,Adoptive therapy with chimeric antigen receptor (CAR)-redirected Tcells has achieved remarkable efficacy in the treatment of hematopoietic malignancies.,29241547_0,-1,-1,-1,-1,33925,-1,2.412822e-05,0.99996495,1.0955993e-05
33929,that IL-18,3,5,31,41,Systematic screening indicates that IL-18 polarizes CAR Tcells toward T-bethigh FoxO1low effectors with an acute inflammatory response.,29241547_3,-1,-1,-1,-1,33929,-1,0.6859354,0.30915233,0.0049122903
33930,Tcells toward T-bethigh,7,12,56,80,Systematic screening indicates that IL-18 polarizes CAR Tcells toward T-bethigh FoxO1low effectors with an acute inflammatory response.,29241547_3,-1,-1,-1,-1,33930,-1,0.003057395,0.43492618,0.5620164
33932,IL-18 release,7,9,38,51,CAR Tcells engineered with inducible IL-18 release exhibited superior activity against large pancreatic and lung tumors that were refractory to CAR Tcells without cytokines.,29241547_4,-1,-1,-1,-1,33932,-1,0.99468946,0.0030984555,0.00221215
33933,tumors that,17,19,114,125,CAR Tcells engineered with inducible IL-18 release exhibited superior activity against large pancreatic and lung tumors that were refractory to CAR Tcells without cytokines.,29241547_4,-1,-1,-1,-1,33933,-1,1.850436e-05,0.999972,9.555818e-06
33938,Tcell treatment,2,6,10,26,IL-18 CAR Tcell treatment was accompanied by an overall change in the immune cell landscape associated with the tumor.,29241547_5,-1,-1,-1,-1,33938,-1,0.0017151171,0.059515808,0.938769
33941,the tumor,19,21,109,118,IL-18 CAR Tcell treatment was accompanied by an overall change in the immune cell landscape associated with the tumor.,29241547_5,-1,-1,-1,-1,33941,-1,2.0070122e-05,0.99997056,9.34098e-06
33948,antigen gene,7,9,43,55,"We found a HLA class II histocompatibility antigen gene, DQ alpha 1 chain (HLA-DQA1), that was expressed more than 9-fold higher in high-load hepatitis C virus (HCV) livers than low-load HCV livers using transcriptomics of chronic HCV-infected livers.",29248968_0,-1,-1,-1,-1,33948,-1,0.81075805,0.08057561,0.10866641
33967,the lymphocytic,19,21,110,125,HLA-DQA1-positive cells in the liver sinusoid were positive for CD68 (macrophages or Kupffer cells); those in the lymphocytic infiltrates were positive for CD20 (B cells) or CD3 (T cells).,29248968_4,-1,-1,-1,-1,33967,-1,0.0034886086,0.19925675,0.7972546
33970,antigen-presenting cell,3,5,15,38,mRNA levels of antigen-presenting cell (APC) markers such as CD68 and CD11c were significantly upregulated in the HCV-high group and were correlated with HLA-DQA mRNA levels.,29248968_5,-1,-1,-1,-1,33970,-1,0.017923398,0.0006856363,0.98139095
34015,Taken together,0,2,0,14,"Taken together, our data suggest that constitutive Eomes expression enhances CD8 T-cell proliferation and survival, in part through the enhancement of interleukin-2 responsiveness through CD25 induction.",29271784_5,-1,-1,-1,-1,34015,-1,4.0018836e-05,0.99994314,1.6815082e-05
34018,through the,19,21,124,135,"Taken together, our data suggest that constitutive Eomes expression enhances CD8 T-cell proliferation and survival, in part through the enhancement of interleukin-2 responsiveness through CD25 induction.",29271784_5,-1,-1,-1,-1,34018,-1,2.2136279e-05,0.9999652,1.2676204e-05
34021,The receptors,2,4,12,25,"BACKGROUND: The receptors of Notch family play an important role in controlling the development, differentiation, and function of multiple cell types.",29301578_0,-1,-1,-1,-1,34021,-1,0.00039265578,0.9925897,0.0070176465
34022,Notch family play,5,8,29,46,"BACKGROUND: The receptors of Notch family play an important role in controlling the development, differentiation, and function of multiple cell types.",29301578_0,-1,-1,-1,-1,34022,-1,3.1332565e-05,0.9999474,2.1286167e-05
34024,function,19,20,118,126,"BACKGROUND: The receptors of Notch family play an important role in controlling the development, differentiation, and function of multiple cell types.",29301578_0,0,1,2,-1,34024,-1,0.00023946525,0.99960595,0.00015463
34025,cell types,22,24,139,149,"BACKGROUND: The receptors of Notch family play an important role in controlling the development, differentiation, and function of multiple cell types.",29301578_0,-1,-1,-1,-1,34025,-1,3.7371872e-05,5.2980555e-05,0.99990964
34035,shRNA to generate,17,20,108,125,METHODS: Melanoma cell line B16 cells were transfected by lentivirus containing mouse Notch1 gene or Notch1 shRNA to generate B16 cell line that highly or lowly expressed Notch1.,29301578_2,-1,-1,-1,-1,34035,-1,5.5989516e-05,0.99991035,3.3684963e-05
34063,IFN- release,20,22,124,137,Notch1 expression in B16 melanoma cells inhibited the infiltration of CD8+ cytotoxic T lymphocytes and NK cells and reduced IFN- release in tumor tissue.,29301578_8,-1,-1,-1,-1,34063,-1,0.9963987,0.0020829558,0.0015183914
34064,tumor tissue,23,25,141,153,Notch1 expression in B16 melanoma cells inhibited the infiltration of CD8+ cytotoxic T lymphocytes and NK cells and reduced IFN- release in tumor tissue.,29301578_8,-1,-1,-1,-1,34064,-1,2.2016313e-05,0.99996305,1.4965502e-05
34072,to the,20,22,146,152,"The percentage of CD4+CD25+FoxP3+ Tregs and Gr1+CD11b+MDSCs were significantly increased in tumor microenvironment, and all these were attributed to the upregulation of TGF-1.CONCLUSION: These findings suggested that Notch1 signaling in B16 melanoma cells might inhibit antitumor immunity by upregulation of TGF-1.",29301578_10,-1,-1,-1,-1,34072,-1,2.3369315e-05,0.99996626,1.0346403e-05
34076,immunity,39,40,281,289,"The percentage of CD4+CD25+FoxP3+ Tregs and Gr1+CD11b+MDSCs were significantly increased in tumor microenvironment, and all these were attributed to the upregulation of TGF-1.CONCLUSION: These findings suggested that Notch1 signaling in B16 melanoma cells might inhibit antitumor immunity by upregulation of TGF-1.",29301578_10,0,-1,2,-1,34076,-1,0.9826868,0.01662917,0.0006840155
34082,lifelong,29,30,168,176,"The B-lymphotropic Epstein-Barr virus (EBV), pandemic in humans, is rapidly controlled on initial infection by T cell surveillance; thereafter, the virus establishes a lifelong latent infection in the host.",29311309_0,0,-1,2,-1,34082,-1,3.5848992e-05,0.9999461,1.7994644e-05
34088,to treating,3,5,17,28,A major approach to treating EBV-associated lymphomas is adoptive transfer of autologous or allogeneic T cells that are stimulated/expanded on EBV-transformed B cells.,29311309_3,-1,-1,-1,-1,34088,-1,2.061722e-05,0.9999685,1.086386e-05
34090,T cells that,14,17,103,115,A major approach to treating EBV-associated lymphomas is adoptive transfer of autologous or allogeneic T cells that are stimulated/expanded on EBV-transformed B cells.,29311309_3,-1,-1,-1,-1,34090,-1,0.0013137962,0.020611161,0.978075
34108,immunity,13,14,74,82,The mouse model offers a unique tool for uncovering basic features of EBV immunity.,29311309_7,0,-1,2,-1,34108,-1,0.9933929,0.005805837,0.00080129603
34118,immunity,6,7,41,49,"These findings provide insights into EBV immunity, demonstrating that LMP1 signaling alone is sufficient to induce a prominent cytotoxic CD4 response, and suggest strategies for immunotherapy in EBV-related and other cancers.",29311309_10,0,-1,2,-1,34118,-1,0.9840847,0.014978919,0.0009363986
34139,tissue-resident T cells,1,4,6,29,"Liver tissue-resident T cells were investigated using immunostaining, western blotting, and real-time PCR.RESULTS: OV+NDMA-induced CCA tissues showed significantly higher numbers of inflammatory cells, especially eosinophils, bile duct proliferation and IL-17+ cell infiltration compared to normal livers.",29331794_5,-1,-1,-1,-1,34139,-1,0.0037362946,0.41483042,0.5814333
34140,tissues,18,19,135,142,"Liver tissue-resident T cells were investigated using immunostaining, western blotting, and real-time PCR.RESULTS: OV+NDMA-induced CCA tissues showed significantly higher numbers of inflammatory cells, especially eosinophils, bile duct proliferation and IL-17+ cell infiltration compared to normal livers.",29331794_5,-1,1,2,-1,34140,-1,0.00010217231,0.99923885,0.00065897667
34151,the Foxp3,12,14,62,71,Accumulation of CD4+ and IL-17+ cells and intense staining of the Foxp3+ marker were consistent with their protein levels.,29331794_7,-1,-1,-1,-1,34151,-1,3.458233e-05,0.999948,1.7367807e-05
34152,their protein,19,21,101,114,Accumulation of CD4+ and IL-17+ cells and intense staining of the Foxp3+ marker were consistent with their protein levels.,29331794_7,-1,-1,-1,-1,34152,-1,3.360626e-05,0.9999459,2.0485168e-05
34157,their transcription,16,18,84,103,"Infiltration of IL-17+ inflammatory cells and Foxp3+ cells, as well as increases in their transcription expression levels, were significantly lower in the melatonin-treated group.",29331794_8,-1,-1,-1,-1,34157,-1,2.7529339e-05,0.9999554,1.7079961e-05
34160,TNF-,9,10,50,55,"In contrast, increased CD4+ cell infiltration and TNF- expression were also observed through melatonin treatment.",29331794_9,0,1,-1,-1,34160,-1,4.704792e-05,0.9999372,1.575986e-05
34163,Th17 cells,11,13,85,95,"CONCLUSION: Melatonin exerts an immunomodulatory effect, suppressing eosinophils and Th17 cells and expression of Foxp3, but enhancing CD4+ cells and TNF-.",29331794_10,-1,-1,-1,-1,34163,-1,0.0019109277,0.054092895,0.9439962
34166,TNF-,24,25,150,155,"CONCLUSION: Melatonin exerts an immunomodulatory effect, suppressing eosinophils and Th17 cells and expression of Foxp3, but enhancing CD4+ cells and TNF-.",29331794_10,0,1,-1,-1,34166,-1,7.37167e-05,0.9999032,2.311556e-05
34174,related to,4,6,20,30,High serum CA125 is related to metabolic tumor burden and poor prognosis.,29337110_2,-1,-1,-1,-1,34174,-1,3.547515e-05,0.999946,1.8528177e-05
34177,Treg subset,2,4,16,27,The circulating Treg subset is another independent prognostic factor for pancreatic cancer.,29337110_3,-1,-1,-1,-1,34177,-1,0.00020357226,0.003338505,0.9964579
34178,factor,8,9,62,68,The circulating Treg subset is another independent prognostic factor for pancreatic cancer.,29337110_3,0,1,-1,-1,34178,-1,0.0020311153,0.99769175,0.0002772024
34179,that the,4,6,31,39,Our unpublished data indicated that the circulating Treg proportion might be related to the serum CA125 level.,29337110_4,-1,-1,-1,-1,34179,-1,1.8820943e-05,0.999972,9.1890915e-06
34181,related to the,11,14,77,91,Our unpublished data indicated that the circulating Treg proportion might be related to the serum CA125 level.,29337110_4,-1,-1,-1,-1,34181,-1,2.507476e-05,0.99996006,1.4883659e-05
34185,tissues,15,16,100,107,"However, the potential relationship and underlying mechanism of MUC16 and Treg in pancreatic cancer tissues remain unclear.",29337110_5,-1,1,2,-1,34185,-1,6.233735e-05,0.99956447,0.00037318715
34188,tissues,9,10,47,54,"In this study, we found that pancreatic cancer tissues were positive for both MUC16 C terminal (MUC16c) and Foxp3 expression and that their expression was correlated.",29337110_6,-1,1,2,-1,34188,-1,3.2783915e-05,0.9998716,9.555573e-05
34191,that their,24,26,129,139,"In this study, we found that pancreatic cancer tissues were positive for both MUC16 C terminal (MUC16c) and Foxp3 expression and that their expression was correlated.",29337110_6,-1,-1,-1,-1,34191,-1,1.8966246e-05,0.99997115,9.858495e-06
34196,the regulation,6,8,40,54,The PI3K/AKT pathway may participate in the regulation of IL-6 expression and secretion.,29337110_8,-1,-1,-1,-1,34196,-1,2.1831176e-05,0.9999671,1.1058849e-05
34201,the cells,10,12,51,60,"By treating CD4+ T cells with IL-6 or co-culturing the cells with pancreatic cancer cells, tumor-derived IL-6 was identified to promote Foxp3 expression and Treg differentiation, which was significantly inhibited by the JAK2 inhibitor AG-490.",29337110_9,-1,-1,-1,-1,34201,-1,0.0039599566,0.37161252,0.6244275
34203,tumor-derived IL-6,17,19,91,109,"By treating CD4+ T cells with IL-6 or co-culturing the cells with pancreatic cancer cells, tumor-derived IL-6 was identified to promote Foxp3 expression and Treg differentiation, which was significantly inhibited by the JAK2 inhibitor AG-490.",29337110_9,-1,-1,-1,-1,34203,-1,0.22338402,0.7718368,0.0047791894
34208,that the relationship,6,9,31,52,"In sum, our study demonstrated that the relationship between the MUC16c level and Foxp3 expression in the local tumor environment was consistent with that of the serum CA125 level and circulating Treg proportion in the systemic environment.",29337110_10,-1,-1,-1,-1,34208,-1,2.060124e-05,0.99996746,1.19806655e-05
34218,tumor-associated Treg,5,7,37,58,MUC16c promoted Foxp3 expression and tumor-associated Treg enrichment in tumor tissues through tumor-secreted IL-6 activation of the JAK2/STAT3 pathway.,29337110_11,-1,-1,-1,-1,34218,-1,2.405643e-05,0.9999645,1.1492491e-05
34219,tumor tissues through tumor-secreted IL-6,9,14,73,114,MUC16c promoted Foxp3 expression and tumor-associated Treg enrichment in tumor tissues through tumor-secreted IL-6 activation of the JAK2/STAT3 pathway.,29337110_11,-1,-1,-1,-1,34219,-1,0.07219199,0.92421615,0.0035918683
34222,therapy,10,11,75,82,These findings may provide deeper insight into potential pancreatic cancer therapy approaches.,29337110_12,0,1,-1,-1,34222,-1,2.5714116e-05,0.9999614,1.2890913e-05
34223,The function,2,4,17,29,"BACKGROUND/AIMS: The function of regulatory T cells (Treg) and helper T cells 17 (Th17) related indexes, such as interleukin (IL)-6, IL-17, transforming growth factor (TGF)-1, and forkhead box protein 3(FoxP3) in gastric adenocarcinoma tissues remains undefined.",29391307_0,-1,-1,-1,-1,34223,-1,2.6132555e-05,0.99995935,1.4534835e-05
34231,transforming growth factor,29,32,140,166,"BACKGROUND/AIMS: The function of regulatory T cells (Treg) and helper T cells 17 (Th17) related indexes, such as interleukin (IL)-6, IL-17, transforming growth factor (TGF)-1, and forkhead box protein 3(FoxP3) in gastric adenocarcinoma tissues remains undefined.",29391307_0,-1,-1,-1,-1,34231,-1,0.92662066,0.07035241,0.0030268696
34233,protein,37,38,194,201,"BACKGROUND/AIMS: The function of regulatory T cells (Treg) and helper T cells 17 (Th17) related indexes, such as interleukin (IL)-6, IL-17, transforming growth factor (TGF)-1, and forkhead box protein 3(FoxP3) in gastric adenocarcinoma tissues remains undefined.",29391307_0,0,1,-1,-1,34233,-1,4.513378e-05,0.999912,4.279983e-05
34234,tissues,43,44,237,244,"BACKGROUND/AIMS: The function of regulatory T cells (Treg) and helper T cells 17 (Th17) related indexes, such as interleukin (IL)-6, IL-17, transforming growth factor (TGF)-1, and forkhead box protein 3(FoxP3) in gastric adenocarcinoma tissues remains undefined.",29391307_0,-1,1,2,-1,34234,-1,0.0002367635,0.9957983,0.003964891
34235,the relevance,4,6,29,42,We investigated and analyzed the relevance of the proteins with the clinicopathological characteristics and the interactions among them in gastric cancer.,29391307_1,-1,-1,-1,-1,34235,-1,2.0304806e-05,0.9999678,1.1840853e-05
34236,the proteins,7,9,46,58,We investigated and analyzed the relevance of the proteins with the clinicopathological characteristics and the interactions among them in gastric cancer.,29391307_1,-1,-1,-1,-1,34236,-1,2.8531213e-05,0.99994457,2.6939384e-05
34241,transcription- polymerase,10,12,69,94,"Immunohistochemistry (IHC) as well as quantitative real-time reverse transcription- polymerase chain reaction (RT-PCR) was used to determine the expression levels of IL-6, TGF-1, IL-17, and FoxP3 in the prepared tissues.",29391307_3,-1,-1,-1,-1,34241,-1,3.317806e-05,0.9999397,2.7081132e-05
34249,tissues,36,37,213,220,"Immunohistochemistry (IHC) as well as quantitative real-time reverse transcription- polymerase chain reaction (RT-PCR) was used to determine the expression levels of IL-6, TGF-1, IL-17, and FoxP3 in the prepared tissues.",29391307_3,-1,1,2,-1,34249,-1,0.00019679849,0.99638605,0.003417214
34250,Statistical analysis,0,2,0,20,Statistical analysis included ANOVA and chi-square test.,29391307_4,-1,-1,-1,-1,34250,-1,6.0815237e-05,0.99989605,4.313396e-05
34257,tissues,19,20,103,110,"RESULTS: The expression levels of IL-6, IL-17, FoxP3, and TGF-1 had significantly increased in cancer tissues compared to controls.",29391307_5,-1,1,2,-1,34257,-1,0.00014220252,0.99751294,0.0023448842
34264,tissues,23,24,126,133,"Clinical staging of gastric cancer were correlated with the rise of IL-6, IL-17, FoxP3, and TGF-1 levels expressed in cancer tissues.",29391307_6,-1,1,2,-1,34264,-1,0.000102069826,0.99890506,0.0009928584
34268,related to that,9,12,55,70,"The expression level of TGF-1 and IL-6 was positively related to that of IL-17 and FoxP3, similar to FoxP3 and IL-17 in gastric cancer tissues.",29391307_7,-1,-1,-1,-1,34268,-1,3.7685313e-05,0.99993527,2.7082742e-05
34271,to FoxP3,18,20,99,107,"The expression level of TGF-1 and IL-6 was positively related to that of IL-17 and FoxP3, similar to FoxP3 and IL-17 in gastric cancer tissues.",29391307_7,-1,-1,-1,-1,34271,-1,2.9919578e-05,0.9999546,1.5479793e-05
34273,tissues,25,26,136,143,"The expression level of TGF-1 and IL-6 was positively related to that of IL-17 and FoxP3, similar to FoxP3 and IL-17 in gastric cancer tissues.",29391307_7,-1,1,2,-1,34273,-1,0.00014236254,0.9977349,0.0021227326
34282,the transcription factor forkhead,8,12,44,77,Regulatory T cells (Tregs) characterized by the transcription factor forkhead box P3 (FoxP3) are crucial for maintaining immune tolerance and preventing autoimmunity.,29455107_0,-1,-1,-1,-1,34282,-1,2.2362428e-05,0.9999653,1.2298696e-05
34286,function,5,6,24,32,"However, FoxP3 does not function alone and Helios is considered a potential candidate for defining Treg subsets.",29455107_1,0,1,2,-1,34286,-1,0.00019982687,0.9997173,8.288191e-05
34287,Treg subsets,16,18,99,111,"However, FoxP3 does not function alone and Helios is considered a potential candidate for defining Treg subsets.",29455107_1,-1,-1,-1,-1,34287,-1,0.00021486504,0.0016279354,0.9981572
34290,function,9,10,50,58,"In this study, we investigated the expression and function of Helios for identifying Tregs in childhood precursor B-cell acute lymphoblastic leukemia (pre-B ALL).",29455107_2,0,1,2,-1,34290,-1,4.0675328e-05,0.99994004,1.9237223e-05
34299,function,34,35,198,206,"Our results demonstrated that patients with pre-B ALL had a higher percentage of Helios+ FoxP3+ CD4+ Tregs. And there was a positive correlation between the expression of Helios and the suppressive function of Tregs, the risk gradation of ALL.",29455107_3,0,1,2,-1,34299,-1,8.615199e-05,0.99980396,0.00010986437
34304,functional Tregs,14,16,75,91,Helios in combination with CD4 and FoxP3 may be an effective way to detect functional Tregs in pre-B ALL by promoting the secretion of transforming growth factor (TGF)-1.,29455107_4,-1,-1,-1,-1,34304,-1,3.265858e-05,0.9999552,1.215479e-05
34306,transforming growth factor,24,27,135,161,Helios in combination with CD4 and FoxP3 may be an effective way to detect functional Tregs in pre-B ALL by promoting the secretion of transforming growth factor (TGF)-1.,29455107_4,-1,-1,-1,-1,34306,-1,0.8835854,0.11337666,0.0030378522
34311,nalm-6 cells,9,11,56,68,We also found Helios+ Tregs decreased apoptosis rate of nalm-6 cells by up-regulating the expression of anti-apoptosis protein Bcl-2.,29455107_6,-1,-1,-1,-1,34311,-1,0.0032725432,0.6744461,0.3222814
34313,protein,17,18,119,126,We also found Helios+ Tregs decreased apoptosis rate of nalm-6 cells by up-regulating the expression of anti-apoptosis protein Bcl-2.,29455107_6,0,1,-1,-1,34313,-1,3.385679e-05,0.9999287,3.7484377e-05
34317,that the,18,20,110,118,"In summary, these data strongly imply the physiological importance of Helios expression in Tregs, and suggest that the manipulation of Helios may serve as a novel strategy for cancer immunotherapy.",29455107_7,-1,-1,-1,-1,34317,-1,1.9146275e-05,0.9999733,7.5097328e-06
34319,cytokine released,8,10,41,58,Interleukin 33 (IL33) is an inflammatory cytokine released during necrotic cell death.,29463593_0,-1,-1,-1,-1,34319,-1,0.97400314,0.022868728,0.003128124
34323,receptor,14,15,81,89,The epithelium and stroma of the intestine express large amounts of IL33 and its receptor St2.,29463593_1,0,1,2,-1,34323,-1,0.00091105176,0.023822038,0.9752669
34332,to tumorigenesis,18,20,107,123,"Here, we utilized a mouse model of sporadic colon cancer to investigate the contribution of IL33 signaling to tumorigenesis in the absence of preexisting inflammation.",29463593_4,-1,-1,-1,-1,34332,-1,2.1757925e-05,0.99996686,1.1369496e-05
34334,that genetic,2,4,16,28,We demonstrated that genetic ablation of St2 enhanced colon tumor development.,29463593_5,-1,-1,-1,-1,34334,-1,2.4263727e-05,0.9999635,1.2220575e-05
34343,target genes,23,25,161,173,We detected St2 expression within the radioresistant mesenchymal cell compartment of the colon whose stimulation with IL33 induced expression of bona fide NF-B target genes.,29463593_8,-1,-1,-1,-1,34343,-1,2.1936454e-05,0.9999628,1.5265761e-05
34345,deficiency,6,7,40,50,"Mechanistically, we discovered that St2 deficiency within the nonhematopoietic compartment coincided with increased abundance of regulatory T cells and suppression of an IFN gene expression signature, whereas IL33 administration triggered IFN expression by tumor allograft-infiltrating T cells.",29463593_9,0,1,-1,-1,34345,-1,6.695818e-05,0.99984384,8.920765e-05
34348,IFN gene,23,25,170,179,"Mechanistically, we discovered that St2 deficiency within the nonhematopoietic compartment coincided with increased abundance of regulatory T cells and suppression of an IFN gene expression signature, whereas IL33 administration triggered IFN expression by tumor allograft-infiltrating T cells.",29463593_9,-1,-1,-1,-1,34348,-1,0.9948677,0.0035321307,0.001600096
34349,triggered IFN,31,33,230,244,"Mechanistically, we discovered that St2 deficiency within the nonhematopoietic compartment coincided with increased abundance of regulatory T cells and suppression of an IFN gene expression signature, whereas IL33 administration triggered IFN expression by tumor allograft-infiltrating T cells.",29463593_9,-1,-1,-1,-1,34349,-1,0.8683042,0.12837735,0.0033184486
34353,this IFN gene,3,6,16,30,"The decrease of this IFN gene expression signature was associated with more aggressive disease in human colon cancer patients, suggesting that lack of IL33 signaling impaired the generation of a potent IFN-mediated antitumor immune response.",29463593_10,-1,-1,-1,-1,34353,-1,0.001063101,0.9986873,0.00024963383
34355,the generation,27,29,176,190,"The decrease of this IFN gene expression signature was associated with more aggressive disease in human colon cancer patients, suggesting that lack of IL33 signaling impaired the generation of a potent IFN-mediated antitumor immune response.",29463593_10,-1,-1,-1,-1,34355,-1,2.0313964e-05,0.9999685,1.1126888e-05
34359,functions,7,8,40,49,"Collectively, our data reveal that IL33 functions as a tumor suppressor in sporadic colon cancer.",29463593_11,0,1,2,-1,34359,-1,4.568205e-05,0.999933,2.1362732e-05
34364,cytotoxic T-lymphocyte antigen-4,17,20,109,141,"A majority of cancers fail to respond to immunotherapy with antibodies targeting immune checkpoints, such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) or programmed death-1 (PD-1)/PD-1 ligand (PD-L1).",29467463_0,-1,-1,-1,-1,34364,-1,0.0010801905,0.00027483943,0.9986449
34367,factor-,5,6,47,55,"Cancers frequently express transforming growth factor- (TGF), which drives immune dysfunction in the tumor microenvironment by inducing regulatory T cells (Tregs) and inhibiting CD8+ and TH1 cells.",29467463_1,0,1,-1,-1,34367,-1,0.9997398,9.5138894e-05,0.00016500363
34369,the tumor,15,17,99,108,"Cancers frequently express transforming growth factor- (TGF), which drives immune dysfunction in the tumor microenvironment by inducing regulatory T cells (Tregs) and inhibiting CD8+ and TH1 cells.",29467463_1,-1,-1,-1,-1,34369,-1,1.9440911e-05,0.9999707,9.896216e-06
34374,this therapeutic,2,4,11,27,"To address this therapeutic challenge, we invent bifunctional antibody-ligand traps (Y-traps) comprising an antibody targeting CTLA-4 or PD-L1 fused to a TGF receptor II ectodomain sequence that simultaneously disables autocrine/paracrine TGF in the target cell microenvironment (a-CTLA4-TGFRIIecd and a-PDL1-TGFRIIecd).",29467463_2,-1,-1,-1,-1,34374,-1,2.2188071e-05,0.9999676,1.02063905e-05
34375,traps,10,11,78,83,"To address this therapeutic challenge, we invent bifunctional antibody-ligand traps (Y-traps) comprising an antibody targeting CTLA-4 or PD-L1 fused to a TGF receptor II ectodomain sequence that simultaneously disables autocrine/paracrine TGF in the target cell microenvironment (a-CTLA4-TGFRIIecd and a-PDL1-TGFRIIecd).",29467463_2,-1,1,2,-1,34375,-1,2.741729e-05,0.99995387,1.8692404e-05
34376,targeting CTLA-4,17,19,117,133,"To address this therapeutic challenge, we invent bifunctional antibody-ligand traps (Y-traps) comprising an antibody targeting CTLA-4 or PD-L1 fused to a TGF receptor II ectodomain sequence that simultaneously disables autocrine/paracrine TGF in the target cell microenvironment (a-CTLA4-TGFRIIecd and a-PDL1-TGFRIIecd).",29467463_2,-1,-1,-1,-1,34376,-1,0.0023580883,0.09498037,0.90266156
34378,TGF receptor,24,26,154,167,"To address this therapeutic challenge, we invent bifunctional antibody-ligand traps (Y-traps) comprising an antibody targeting CTLA-4 or PD-L1 fused to a TGF receptor II ectodomain sequence that simultaneously disables autocrine/paracrine TGF in the target cell microenvironment (a-CTLA4-TGFRIIecd and a-PDL1-TGFRIIecd).",29467463_2,-1,-1,-1,-1,34378,-1,0.00026206608,0.9985972,0.0011406664
34381,the target cell,35,38,248,263,"To address this therapeutic challenge, we invent bifunctional antibody-ligand traps (Y-traps) comprising an antibody targeting CTLA-4 or PD-L1 fused to a TGF receptor II ectodomain sequence that simultaneously disables autocrine/paracrine TGF in the target cell microenvironment (a-CTLA4-TGFRIIecd and a-PDL1-TGFRIIecd).",29467463_2,-1,-1,-1,-1,34381,-1,0.0036215961,0.73013073,0.26624766
34382,tumor-infiltrating Tregs,6,8,49,73,a-CTLA4-TGFRIIecd is more effective in reducing tumor-infiltrating Tregs and inhibiting tumor progression compared with CTLA-4 antibody (Ipilimumab).,29467463_3,-1,-1,-1,-1,34382,-1,2.9080742e-05,0.99995434,1.6564429e-05
34392,IFN- plays,0,2,0,11,"IFN- plays a crucial role in anti-tumor responses and also induces expression of PD-L1, a well-established inhibitor of anti-tumor immune function.",29516506_0,-1,-1,-1,-1,34392,-1,0.99558336,0.0029701912,0.0014465253
34393,function,21,22,139,147,"IFN- plays a crucial role in anti-tumor responses and also induces expression of PD-L1, a well-established inhibitor of anti-tumor immune function.",29516506_0,0,1,2,-1,34393,-1,0.00030616188,0.99949634,0.0001974467
34394,the function,5,7,48,60,Understanding how molecular signaling regulates the function of IFN- might improve its anti-tumor efficacy.,29516506_1,-1,-1,-1,-1,34394,-1,3.329826e-05,0.99995303,1.3619742e-05
34396,that the tumor,4,7,14,28,"Here, we show that the tumor expression of IFN- expression alone has no significant prognostic value in patients with locally advanced lung adenocarcinoma.",29516506_2,-1,-1,-1,-1,34396,-1,1.9827909e-05,0.99997103,9.145884e-06
34401,to those,15,17,100,108,"Surprisingly, patients with tumors expressing both IFN- and PD-L1 have the best prognosis compared to those with tumors expressing IFN- or PD-L1 alone.",29516506_3,-1,-1,-1,-1,34401,-1,1.9840207e-05,0.9999683,1.1887374e-05
34404,Transcriptome analysis,0,2,0,22,Transcriptome analysis demonstrated that tumor tissues expressing IFN- display gene expression associated with suppressed cell cycle progression and expansion.,29516506_4,-1,-1,-1,-1,34404,-1,2.1922857e-05,0.99996257,1.5532176e-05
34405,that tumor tissues,3,6,36,54,Transcriptome analysis demonstrated that tumor tissues expressing IFN- display gene expression associated with suppressed cell cycle progression and expansion.,29516506_4,-1,-1,-1,-1,34405,-1,2.0506568e-05,0.9999629,1.6532535e-05
34413,functions,6,7,34,43,The current concept is that PD-L1 functions as a shield protecting tumor cells from cytolytic T cell (CTL)-mediated anti-tumor progression.,29516506_6,0,1,2,-1,34413,-1,4.3122363e-05,0.999938,1.882201e-05
34414,tumor cells,11,13,67,78,The current concept is that PD-L1 functions as a shield protecting tumor cells from cytolytic T cell (CTL)-mediated anti-tumor progression.,29516506_6,-1,-1,-1,-1,34414,-1,0.005037975,0.42953756,0.56542444
34420,tumors to the,21,24,122,135,"However, our data indicate that PD-L1 expression in the presence of IFN- might serve as biomarker for the sensitivity of tumors to the inhibitory effect of IFN-.",29516506_7,-1,-1,-1,-1,34420,-1,1.711083e-05,0.99997485,8.098208e-06
34422,analysis,1,2,12,20,Mechanistic analysis revealed that in lung adenocarcinoma cells IFN--induced activation of JAK2-STAT1 and PI3K-AKT pathways.,29516506_8,0,1,-1,-1,34422,-1,2.7081154e-05,0.99995196,2.1002788e-05
34424,cells IFN--induced,7,9,58,77,Mechanistic analysis revealed that in lung adenocarcinoma cells IFN--induced activation of JAK2-STAT1 and PI3K-AKT pathways.,29516506_8,-1,-1,-1,-1,34424,-1,0.17892449,0.038308013,0.78276753
34431,maximize the IFN--mediated,22,25,142,169,"Inhibition of PI3K downregulated PD-L1 expression and enhanced the anti-proliferative effect of IFN-, suggesting that blockade of PI3K might maximize the IFN--mediated anti-tumor effect.",29516506_10,-1,-1,-1,-1,34431,-1,0.006833186,0.9924489,0.00071793
34432,to IFN-,13,15,97,105,Our findings provide evidence for crosstalk between JAK2-STAT1 and PI3K-AKT pathways in response to IFN- in lung adenocarcinoma and have implications for the design of combinatorial targeted therapy and immunotherapy for the treatment of lung adenocarcinoma.,29516506_11,-1,-1,-1,-1,34432,-1,0.9396233,0.05747873,0.0028979715
34434,targeted therapy,26,28,183,199,Our findings provide evidence for crosstalk between JAK2-STAT1 and PI3K-AKT pathways in response to IFN- in lung adenocarcinoma and have implications for the design of combinatorial targeted therapy and immunotherapy for the treatment of lung adenocarcinoma.,29516506_11,-1,-1,-1,-1,34434,-1,2.7922028e-05,0.9999559,1.6150307e-05
34435,the treatment,31,33,222,235,Our findings provide evidence for crosstalk between JAK2-STAT1 and PI3K-AKT pathways in response to IFN- in lung adenocarcinoma and have implications for the design of combinatorial targeted therapy and immunotherapy for the treatment of lung adenocarcinoma.,29516506_11,-1,-1,-1,-1,34435,-1,2.2891729e-05,0.999967,1.007988e-05
34437,protein,2,3,24,31,The prolactin-inducible protein (PIP) is considered a valuable biomarker that is associated with both benign and malignant pathological conditions of the mammary gland.,29536339_0,0,1,-1,-1,34437,-1,5.570377e-05,0.99980825,0.00013602135
34441,The function,0,2,0,12,"The function of PIP in breast tumorigenesis remains unknown; however, evidence from our laboratory and others suggest that it regulates host immunity.",29536339_1,-1,-1,-1,-1,34441,-1,2.3982773e-05,0.9999659,1.014156e-05
34444,immunity,23,24,141,149,"The function of PIP in breast tumorigenesis remains unknown; however, evidence from our laboratory and others suggest that it regulates host immunity.",29536339_1,0,-1,2,-1,34444,-1,0.99958426,0.00025405036,0.00016172622
34461,protein,8,9,72,79,This was associated with decreased phosphorylation of mitogen-activated protein kinase (MAPK) and signal transducer of activation of transcription (STAT) proteins in macrophages from PIP-/- mice.,29536339_5,0,1,-1,-1,34461,-1,4.2123578e-05,0.99991477,4.308704e-05
34465,proteins,23,24,154,162,This was associated with decreased phosphorylation of mitogen-activated protein kinase (MAPK) and signal transducer of activation of transcription (STAT) proteins in macrophages from PIP-/- mice.,29536339_5,0,1,-1,-1,34465,-1,2.5687892e-05,0.9999491,2.5194335e-05
34468,proteins,15,16,82,90,"Interestingly, the expression of suppressors of cytokine signaling (SOCS) 1 and 3 proteins, known to suppress IFN- and LPS signaling, was higher in PIP-/- macrophages compared to those from WT mice.",29536339_6,0,1,-1,-1,34468,-1,4.0791983e-05,0.9999105,4.875419e-05
34472,to those,31,33,177,185,"Interestingly, the expression of suppressors of cytokine signaling (SOCS) 1 and 3 proteins, known to suppress IFN- and LPS signaling, was higher in PIP-/- macrophages compared to those from WT mice.",29536339_6,-1,-1,-1,-1,34472,-1,2.2161856e-05,0.9999659,1.1924519e-05
34473,that deficiency,5,7,31,46,"Collectively, our studies show that deficiency of PIP significantly affects intracellular signaling events leading to decreased pro-inflammatory cytokine production, and further confirms a role for PIP as an important immunoregulatory protein.",29536339_7,-1,-1,-1,-1,34473,-1,1.9570476e-05,0.9999689,1.149298e-05
34476,protein,32,33,235,242,"Collectively, our studies show that deficiency of PIP significantly affects intracellular signaling events leading to decreased pro-inflammatory cytokine production, and further confirms a role for PIP as an important immunoregulatory protein.",29536339_7,0,1,-1,-1,34476,-1,3.911576e-05,0.9999063,5.4624532e-05
34483,that the,4,6,21,29,"Here, we demonstrate that the pro-inflammatory cytokine interleukin (IL)-18 is critically involved in these hallmarks in multiple myeloma (MM).",29551594_1,-1,-1,-1,-1,34483,-1,1.8415465e-05,0.9999726,9.057173e-06
34484,cytokine interleukin,7,9,47,67,"Here, we demonstrate that the pro-inflammatory cytokine interleukin (IL)-18 is critically involved in these hallmarks in multiple myeloma (MM).",29551594_1,-1,-1,-1,-1,34484,-1,0.9998122,4.8658498e-05,0.00013916299
34487,Tcell-dependent,15,18,88,104,Mice deficient for IL-18 were remarkably protected from VkMYC MM progression in a CD8+ Tcell-dependent manner.,29551594_2,-1,-1,-1,-1,34487,-1,4.1461804e-05,5.6416557e-05,0.9999021
34493,transcriptome analysis,2,4,9,31,A global transcriptome analysis of the immune microenvironment in 73 MM patients strongly supported the negative impact of IL-18-driven MDSCs on Tcell responses.,29551594_4,-1,-1,-1,-1,34493,-1,3.0523395e-05,0.9999498,1.9695137e-05
34498,plasma IL-18,7,9,39,51,"Strikingly, high levels of bone marrow plasma IL-18 were associated with poor overall survival in MM patients.",29551594_5,-1,-1,-1,-1,34498,-1,0.8143236,0.17931883,0.0063575483
34499,that IL-18,6,8,47,57,"Furthermore, our preclinical studies suggested that IL-18 could be a potential therapeutic target in MM.",29551594_6,-1,-1,-1,-1,34499,-1,0.30082887,0.6947569,0.0044142446
34500,therapeutic target,12,14,79,97,"Furthermore, our preclinical studies suggested that IL-18 could be a potential therapeutic target in MM.",29551594_6,-1,-1,-1,-1,34500,-1,2.156199e-05,0.9999665,1.1990667e-05
34506,tumor immunity,15,17,113,127,"One mechanism is tumor-induced myelopoiesis, whereby the expansion of immunosuppressive myeloid cells can impair tumor immunity.",29593283_1,-1,-1,-1,-1,34506,-1,0.04642355,0.95266753,0.00090890337
34513,immunity,20,21,96,104,"The cDC subset, cDC1, which includes human CD141+ DCs and mouse CD103+ DCs, supports anti-tumor immunity by stimulating CD8+ T-cell responses.",29593283_3,0,-1,2,-1,34513,-1,0.9992848,0.000472464,0.00024273878
34514,T-cell,25,26,125,131,"The cDC subset, cDC1, which includes human CD141+ DCs and mouse CD103+ DCs, supports anti-tumor immunity by stimulating CD8+ T-cell responses.",29593283_3,-1,1,2,-1,34514,-1,3.7444977e-05,4.788678e-05,0.99991465
34519,factor,4,5,56,62,"Mechanistically, tumor-produced granulocyte-stimulating factor downregulates interferon regulatory factor-8 in cDC progenitors, and thus results in reduced cDC1 development.",29593283_6,0,1,-1,-1,34519,-1,0.99929714,0.00043426862,0.0002686768
34521,factor-8,8,9,99,107,"Mechanistically, tumor-produced granulocyte-stimulating factor downregulates interferon regulatory factor-8 in cDC progenitors, and thus results in reduced cDC1 development.",29593283_6,0,1,-1,-1,34521,-1,0.00030669756,0.99956983,0.00012350269
34524,T-cell,9,10,68,74,Tumor-induced reductions in cDC1 development impair anti-tumor CD8+ T-cell responses and correlate with poor patient outcomes.,29593283_7,-1,1,2,-1,34524,-1,4.4796416e-05,6.441266e-05,0.9998908
34527,tissue generally,2,4,16,32,"Although cancer tissue generally shows limited immune responses, some cancers abound with lymphocytes, which generally show favorable prognosis.",29594353_0,-1,-1,-1,-1,34527,-1,4.4230022e-05,0.999897,5.8804628e-05
34534,tissue,15,16,91,97,"These cancers, despite their rarity, are important in analyzing immune responses in cancer tissue.",29594353_1,-1,1,2,-1,34534,-1,7.098554e-05,0.9995552,0.00037379758
34535,Transforming growth factor,0,3,0,26,"Transforming growth factor 1 (TFG1) is a multifunctional cytokine, generally having an immunosuppressive function.",29594353_2,-1,-1,-1,-1,34535,-1,0.820298,0.17476706,0.004934915
34539,function,16,17,107,115,"Transforming growth factor 1 (TFG1) is a multifunctional cytokine, generally having an immunosuppressive function.",29594353_2,0,1,2,-1,34539,-1,0.00052666833,0.99905926,0.0004140756
34545,peptide,4,5,54,61,"Immunohistochemistry revealed that latency-associated peptide (LAP) of TGF1 was localized in mainly immune cells in all cases, which was more abundant than in control GCs.",29594353_4,0,-1,2,-1,34545,-1,0.000106447136,0.9996972,0.00019642494
34561,than those,10,12,68,78,Mature dendritic cells in Ly-rich GCs expressed LAP more frequently than those in the secondary lymphoid organs.,29594353_9,-1,-1,-1,-1,34561,-1,2.6857657e-05,0.9999571,1.6065133e-05
34565,to Treg cells,12,15,76,89,"Our data revealed abundant expression of TGF1 in immune cells with contact to Treg cells in lymphoid stroma, which is consistent with the notion that TGF1 is one of the immunosuppressive factors in cancer stroma.",29594353_10,-1,-1,-1,-1,34565,-1,0.0039919494,0.21544984,0.7805582
34567,that TGF1,25,27,146,156,"Our data revealed abundant expression of TGF1 in immune cells with contact to Treg cells in lymphoid stroma, which is consistent with the notion that TGF1 is one of the immunosuppressive factors in cancer stroma.",29594353_10,-1,-1,-1,-1,34567,-1,2.9473238e-05,0.99994934,2.1154445e-05
34569,factors,32,33,189,196,"Our data revealed abundant expression of TGF1 in immune cells with contact to Treg cells in lymphoid stroma, which is consistent with the notion that TGF1 is one of the immunosuppressive factors in cancer stroma.",29594353_10,0,1,-1,-1,34569,-1,0.1994452,0.7982925,0.0022622836
34573,The type,0,2,0,8,The type 1 regulatory T (Tr1) cells have recently emerged as a critical participant in maintaining self-tolerance.,29625086_2,-1,-1,-1,-1,34573,-1,2.0593994e-05,0.9999647,1.4716754e-05
34578,Tr1 cells,6,8,27,36,"In this study, we examined Tr1 cells in H. pylori infection and gastric cancer development.",29625086_3,-1,-1,-1,-1,34578,-1,0.0014831241,0.16281419,0.83570266
34581,blood,14,15,95,100,"While H. pylori-uninfected (uninfected) subjects presented low Tr1 frequency in the peripheral blood, H. pylori-infected asymptomatic (infected) individuals and H. pylori-infected gastric cancer (cancer) individuals both presented elevated Tr1 frequency.",29625086_4,0,1,-1,-1,34581,-1,0.00010731742,0.9991091,0.00078354694
34583,the Tr1 cells,1,4,9,22,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,-1,-1,-1,-1,34583,-1,0.0028870997,0.40884903,0.5882638
34584,functionally,9,10,64,76,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,0,1,2,-1,34584,-1,3.5549998e-05,0.9999459,1.858514e-05
34585,than those,12,14,89,99,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,-1,-1,-1,-1,34585,-1,2.2055041e-05,0.999964,1.3953626e-05
34586,the Tr1 cells,19,22,134,147,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,-1,-1,-1,-1,34586,-1,0.0029950454,0.62141633,0.37558863
34587,functional,27,28,191,201,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,0,1,2,-1,34587,-1,6.266905e-05,0.999897,4.036983e-05
34590,factors,44,45,295,302,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,0,1,-1,-1,34590,-1,0.9994392,0.00023044377,0.0003303253
34595,function,6,7,31,39,"In addition, the frequency and function of Tr1 cells were positively correlated with the disease-free survival of the gastric cancer patients.",29625086_6,0,1,2,-1,34595,-1,6.81318e-05,0.99986374,6.81149e-05
34596,Tr1 cells,8,10,43,52,"In addition, the frequency and function of Tr1 cells were positively correlated with the disease-free survival of the gastric cancer patients.",29625086_6,-1,-1,-1,-1,34596,-1,0.0008340423,0.062003944,0.937162
34600,that Tr1 cells,3,6,22,36,These results suggest that Tr1 cells might be involved in the regulating immune responses in H. pylori infection and gastric cancer development.,29625086_7,-1,-1,-1,-1,34600,-1,0.0027566818,0.73272634,0.264517
34604,that Tr1 cells,2,5,9,23,The fact that Tr1 cells could suppress inflammation and produce cytotoxic molecules at the same time has made them attractive potential candidates for future immunotherapies.,29625086_8,-1,-1,-1,-1,34604,-1,0.0036982226,0.5957071,0.40059468
34607,made them,17,19,105,114,The fact that Tr1 cells could suppress inflammation and produce cytotoxic molecules at the same time has made them attractive potential candidates for future immunotherapies.,29625086_8,-1,-1,-1,-1,34607,-1,3.0127441e-05,0.9999572,1.2710772e-05
34612,the tumor-immune,19,21,148,164,"Increasing evidence indicates that Wnt/-catenin signaling, one of the best-characterized cancer drivers, promotes cancer progression by regulating the tumor-immune cycle in most of the nodes, including dendritic cells, T cells, and tumor cells.",29678298_1,-1,-1,-1,-1,34612,-1,0.00034429893,0.99958104,7.466537e-05
34616,tumor cells,36,38,233,244,"Increasing evidence indicates that Wnt/-catenin signaling, one of the best-characterized cancer drivers, promotes cancer progression by regulating the tumor-immune cycle in most of the nodes, including dendritic cells, T cells, and tumor cells.",29678298_1,-1,-1,-1,-1,34616,-1,0.0043422095,0.33514982,0.6605079
34622,that targeting,2,4,11,25,"We propose that targeting Wnt/-catenin signaling would potentially improve clinical outcomes of cancer patients by overcoming the primary, adaptive, and acquired resistance to immunotherapy.",29678298_3,-1,-1,-1,-1,34622,-1,1.9199928e-05,0.9999726,8.180156e-06
34627,tumor cells termed,22,25,132,150,"BACKGROUND: It has been proposed that cancer establishment, maintenance, and recurrence may be attributed to a unique population of tumor cells termed cancer-initiating cells (CICs) that may include characteristics of putative cancer stem cell-like cells.",29699516_0,-1,-1,-1,-1,34627,-1,0.000113185335,0.9997254,0.00016145578
34630,cell-like cells,38,40,239,254,"BACKGROUND: It has been proposed that cancer establishment, maintenance, and recurrence may be attributed to a unique population of tumor cells termed cancer-initiating cells (CICs) that may include characteristics of putative cancer stem cell-like cells.",29699516_0,-1,-1,-1,-1,34630,-1,5.4439548e-05,5.5473793e-05,0.9998901
34633,tumor cells,18,20,103,114,Studies in lung cancer have shown that such cells can be enriched and propagated in vitro by culturing tumor cells in serum-free suspension as tumorspheres.,29699516_1,-1,-1,-1,-1,34633,-1,0.004093898,0.45649233,0.53941375
34653,TC-1 cells,3,5,9,19,"In vivo, TC-1 cells enriched for CICs were resistant to human papillomavirus 16 E6/E7 peptide vaccine-mediated killing.",29699516_7,-1,-1,-1,-1,34653,-1,0.0017942891,0.17017533,0.82803035
34655,peptide,15,16,86,93,"In vivo, TC-1 cells enriched for CICs were resistant to human papillomavirus 16 E6/E7 peptide vaccine-mediated killing.",29699516_7,0,-1,2,-1,34655,-1,0.01765323,0.980497,0.0018497937
34664,TC-1 cells,17,19,112,122,"Furthermore, cultured cytotoxic T lymphocytes (CTLs) from vaccinated mice demonstrated reduced capacity to lyse TC-1 cells enriched for CICs compared to non-enriched TC-1 cells.",29699516_9,-1,-1,-1,-1,34664,-1,0.0012581723,0.077636935,0.92110497
34666,TC-1 cells,25,27,166,176,"Furthermore, cultured cytotoxic T lymphocytes (CTLs) from vaccinated mice demonstrated reduced capacity to lyse TC-1 cells enriched for CICs compared to non-enriched TC-1 cells.",29699516_9,-1,-1,-1,-1,34666,-1,0.00196592,0.16486101,0.83317316
34669,TC-1 cells,10,12,67,77,"Following treatment with IFN-, both CIC enriched and non-enriched TC-1 cells expressed similar levels of MHC-I, and the increased MHC-I expression on CICs resulted in greater CTL-mediated tumor lysis and improved tumor-free survival in mice.",29699516_10,-1,-1,-1,-1,34669,-1,0.00222265,0.3267753,0.671002
34671,CTL-mediated tumor,28,30,176,194,"Following treatment with IFN-, both CIC enriched and non-enriched TC-1 cells expressed similar levels of MHC-I, and the increased MHC-I expression on CICs resulted in greater CTL-mediated tumor lysis and improved tumor-free survival in mice.",29699516_10,-1,-1,-1,-1,34671,-1,0.0013114213,0.016661964,0.98202664
34674,that the,5,7,35,43,"CONCLUSIONS: These results suggest that the attenuated expression of MHC-I molecules by CICs represents a potential strategy of CICs to escape immune recognition, and that the development of successful immunotherapy strategies targeting CICs may decrease their resistance to T cell-mediated immune detection by enhancing CIC MHC-I expression.",29699516_11,-1,-1,-1,-1,34674,-1,1.743769e-05,0.99997437,8.145327e-06
34676,that the,26,28,167,175,"CONCLUSIONS: These results suggest that the attenuated expression of MHC-I molecules by CICs represents a potential strategy of CICs to escape immune recognition, and that the development of successful immunotherapy strategies targeting CICs may decrease their resistance to T cell-mediated immune detection by enhancing CIC MHC-I expression.",29699516_11,-1,-1,-1,-1,34676,-1,2.008588e-05,0.9999715,8.3534915e-06
34679,to T cell-mediated,39,42,272,290,"CONCLUSIONS: These results suggest that the attenuated expression of MHC-I molecules by CICs represents a potential strategy of CICs to escape immune recognition, and that the development of successful immunotherapy strategies targeting CICs may decrease their resistance to T cell-mediated immune detection by enhancing CIC MHC-I expression.",29699516_11,-1,-1,-1,-1,34679,-1,0.0025539012,0.1565361,0.84090996
34684,receptors,16,17,90,99,"Tyrosine kinase inhibitors (TKIs) target angiogenesis by affecting, for example, the VEGF receptors in tumors and have improved outcomes for patients with metastatic renal cell carcinoma (mRCC).",29700053_0,0,1,2,-1,34684,-1,0.0026992704,0.36001828,0.63728243
34697,the TKI,9,11,48,55,"In this study, we investigated the influence of the TKI pazopanib on dendritic cell (DC) performance and immune priming.",29700053_3,-1,-1,-1,-1,34697,-1,2.1352866e-05,0.99996495,1.3638218e-05
34708,T-cell,11,12,69,75,In treated patients pazopanib appeared to enhance a circulating CD4+ T-cell population that expresses CD137 (4-1BB).,29700053_8,-1,1,2,-1,34708,-1,4.471811e-05,0.000112744485,0.9998425
34728,Treg-like cells,21,23,101,116,"At an early stage of tumor development, we have identified a subset of FOXP3- CD8+ CD25+ KIR+ CD127- Treg-like cells, which are IFN+ .",29768737_2,-1,-1,-1,-1,34728,-1,0.0035972262,0.5408065,0.4555963
34732,the IFN+,15,17,87,96,"However, this early-induced CD8+ CD25+ CD127- T-cell subset is certainly distinct from the IFN+ CD8+ T-effector cells.",29768737_3,-1,-1,-1,-1,34732,-1,0.17624804,0.8198104,0.003941559
34733,T-effector cells,19,21,102,118,"However, this early-induced CD8+ CD25+ CD127- T-cell subset is certainly distinct from the IFN+ CD8+ T-effector cells.",29768737_3,-1,-1,-1,-1,34733,-1,0.0030644622,0.25038105,0.74655443
34738,TFH cells,24,26,136,145,"These CD8+ CD25+ CD127- T cells express other FOXP3- CD8+ Treg cell signature markers, and can selectively suppress autoreactive HLA-E+ TFH cells as well as tumor-induced CD4+ Treg cells.",29768737_4,-1,-1,-1,-1,34738,-1,0.00087350514,0.013453074,0.9856734
34741,to FOXP3,2,4,12,20,"In contrast to FOXP3+ CD8+ Tregs, this subset does not inhibit effector T-cell proliferation or their functions as they are HLA-E- .",29768737_5,-1,-1,-1,-1,34741,-1,3.092124e-05,0.99995553,1.3518504e-05
34743,this subset,9,11,34,45,"In contrast to FOXP3+ CD8+ Tregs, this subset does not inhibit effector T-cell proliferation or their functions as they are HLA-E- .",29768737_5,-1,-1,-1,-1,34743,-1,0.00473077,0.4156216,0.57964766
34745,their functions,18,20,96,111,"In contrast to FOXP3+ CD8+ Tregs, this subset does not inhibit effector T-cell proliferation or their functions as they are HLA-E- .",29768737_5,-1,-1,-1,-1,34745,-1,6.846559e-05,0.99989676,3.4700344e-05
34749,Treg-like subset,6,8,37,53,Adoptive transfer of this early-CD8+ Treg-like subset restrained tumor growth and inhibited CD4+ Treg generation that impedes the immune surveillance and impairs cancer immunotherapy.,29768737_6,-1,-1,-1,-1,34749,-1,0.0029073053,0.75623447,0.24085826
34751,Treg generation that,15,18,97,117,Adoptive transfer of this early-CD8+ Treg-like subset restrained tumor growth and inhibited CD4+ Treg generation that impedes the immune surveillance and impairs cancer immunotherapy.,29768737_6,-1,-1,-1,-1,34751,-1,3.1377996e-05,0.9999335,3.5140518e-05
34756,the tumor-microenvironment,14,16,70,96,"At the late stage of tumor development, when CD4+ Treg cells dominate the tumor-microenvironment, CD4+ Tregs mediate the clonal deletion of these tumor-suppressive FOXP3- IFN+ CD8+ CD25+ CD127- T cells and ensure tumor immune evasion.",29768737_7,-1,-1,-1,-1,34756,-1,0.000121087935,0.99981207,6.685505e-05
34759,these tumor-suppressive FOXP3- IFN+,25,29,140,176,"At the late stage of tumor development, when CD4+ Treg cells dominate the tumor-microenvironment, CD4+ Tregs mediate the clonal deletion of these tumor-suppressive FOXP3- IFN+ CD8+ CD25+ CD127- T cells and ensure tumor immune evasion.",29768737_7,-1,-1,-1,-1,34759,-1,0.0008179771,0.99889743,0.00028452653
34763,the tumor,9,11,47,56,"Our findings suggest that at an early stage of the tumor, this tumor-induced IFN-producing FOXP3- CD8+ CD25+ CD127- T-cell subset can potentiate immune surveillance by targeting HLA-E-restricted CD4+ Treg cells while leaving the effector T-cell population unaffected.",29768737_8,-1,-1,-1,-1,34763,-1,1.9003557e-05,0.99997103,9.932471e-06
34764,this tumor-induced IFN-producing FOXP3-,12,16,58,98,"Our findings suggest that at an early stage of the tumor, this tumor-induced IFN-producing FOXP3- CD8+ CD25+ CD127- T-cell subset can potentiate immune surveillance by targeting HLA-E-restricted CD4+ Treg cells while leaving the effector T-cell population unaffected.",29768737_8,-1,-1,-1,-1,34764,-1,0.00016503005,0.99976176,7.3172865e-05
34769,T-cell,38,39,239,245,"Our findings suggest that at an early stage of the tumor, this tumor-induced IFN-producing FOXP3- CD8+ CD25+ CD127- T-cell subset can potentiate immune surveillance by targeting HLA-E-restricted CD4+ Treg cells while leaving the effector T-cell population unaffected.",29768737_8,-1,1,2,-1,34769,-1,3.176214e-05,3.8334714e-05,0.9999299
34777,the regulation,9,11,37,51,AIMS: To evaluate the roles of PE in the regulation of anti-tumor effects and the cellular immune response in the tumor microenvironment.,29783020_1,-1,-1,-1,-1,34777,-1,1.8091747e-05,0.99997306,8.790556e-06
34778,the cellular immune response,15,19,78,106,AIMS: To evaluate the roles of PE in the regulation of anti-tumor effects and the cellular immune response in the tumor microenvironment.,29783020_1,-1,-1,-1,-1,34778,-1,0.38420564,0.6038081,0.011986304
34779,the tumor,20,22,110,119,AIMS: To evaluate the roles of PE in the regulation of anti-tumor effects and the cellular immune response in the tumor microenvironment.,29783020_1,-1,-1,-1,-1,34779,-1,1.9012954e-05,0.9999722,8.751336e-06
34785,the cell,23,25,147,155,RESULTS: Our study demonstrated that PE in vitro could significantly increase the percentage of apoptosis and necrosis in HPV+TC-1 cells and block the cell cycle phase.,29783020_3,-1,-1,-1,-1,34785,-1,0.0049015703,0.5587284,0.43637002
34793,factors,2,3,8,15,"The key factors in the canonical Wnt signaling pathway in the experimental group (PE+mDC+naive CD4+T cells) were challenged, and the levels of beta-catenin, C-myc, cyclin D1 and PPAR1 were significantly enhanced at the 5th day.",29783020_5,0,1,-1,-1,34793,-1,0.00011214011,0.9998024,8.545477e-05
34801,the subset,3,5,15,25,"In particular, the subset proportion of Th1 cells (characterized by IFN production and the transcription factor Tbet) increased significantly, and both Th2 cells (characterized by IL-4 production and the transcription factor GATA3) and Th17 cells (characterized by IL-17 production and the transcription factor RoRt) decreased profoundly.",29783020_6,-1,-1,-1,-1,34801,-1,0.0034471508,0.44515178,0.5514011
34804,the transcription factor Tbet,15,19,88,117,"In particular, the subset proportion of Th1 cells (characterized by IFN production and the transcription factor Tbet) increased significantly, and both Th2 cells (characterized by IL-4 production and the transcription factor GATA3) and Th17 cells (characterized by IL-17 production and the transcription factor RoRt) decreased profoundly.",29783020_6,-1,-1,-1,-1,34804,-1,2.1139133e-05,0.99996626,1.2622078e-05
34806,the transcription factor GATA3,33,37,201,231,"In particular, the subset proportion of Th1 cells (characterized by IFN production and the transcription factor Tbet) increased significantly, and both Th2 cells (characterized by IL-4 production and the transcription factor GATA3) and Th17 cells (characterized by IL-17 production and the transcription factor RoRt) decreased profoundly.",29783020_6,-1,-1,-1,-1,34806,-1,2.659203e-05,0.99995387,1.9529278e-05
34807,Th17 cells,39,41,237,247,"In particular, the subset proportion of Th1 cells (characterized by IFN production and the transcription factor Tbet) increased significantly, and both Th2 cells (characterized by IL-4 production and the transcription factor GATA3) and Th17 cells (characterized by IL-17 production and the transcription factor RoRt) decreased profoundly.",29783020_6,-1,-1,-1,-1,34807,-1,0.0013146516,0.055686947,0.94299835
34809,the transcription factor,47,50,287,311,"In particular, the subset proportion of Th1 cells (characterized by IFN production and the transcription factor Tbet) increased significantly, and both Th2 cells (characterized by IL-4 production and the transcription factor GATA3) and Th17 cells (characterized by IL-17 production and the transcription factor RoRt) decreased profoundly.",29783020_6,-1,-1,-1,-1,34809,-1,2.4030414e-05,0.9999591,1.68278e-05
34829,analysis,26,27,141,149,HCC cell lines HCCLM3 and Hepa1-6 were used to evaluate the efficacy of FM targeting NF-B and STAT3 signaling with western blot and qRT-PCR analysis.,29784005_5,0,1,-1,-1,34829,-1,3.537137e-05,0.9999268,3.7844115e-05
34831,blood,7,8,52,57,CD8+NKG2D+ cells were derived from human peripheral blood and were used for evaluation of immune cells-mediated inflammation and oncolysis on HCCLM3 cells.,29784005_6,0,1,-1,-1,34831,-1,5.941785e-05,0.9998723,6.8250934e-05
34843,TNF-,19,20,115,120,RESULTS: FM significantly inhibited the activation of NF-B and STAT3 signaling in HCC cells induced by cytokines (TNF- or IL-6) and in co-culture system with CD8+NKG2D+ cells.,29784005_11,0,1,-1,-1,34843,-1,0.00054990215,0.9993923,5.780542e-05
34846,cells to,5,7,31,39,"Furthermore, FM sensitized HCC cells to CD8+NKG2D+ cells-mediated oncolysis.",29784005_12,-1,-1,-1,-1,34846,-1,0.0037269886,0.09938391,0.8968891
34851,life,27,28,164,168,"In HCC-bearing mice, FM at a non-toxic dose failed to reduce tumor growth in immune compromised mice, whereas it significantly inhibited tumor growth and prolonged life span in immune competent mice.",29784005_13,0,-1,2,-1,34851,-1,5.366519e-05,0.99991083,3.5522724e-05
34853,IFN--producing cells,4,6,20,41,"While the number of IFN--producing cells within TME was increased in mice treated with FM, the infiltration of CD8+ T cells and NK cells was not increased.",29784005_14,-1,-1,-1,-1,34853,-1,0.84623694,0.0016926078,0.15207037
34865,time that,28,30,158,167,"Finally, we identified that depletion of CD8+ T cells rather than NK cells abrogated the antitumor activity of FM.CONCLUSIONS: Our results show for the first time that CD8+ T cells mediate the antitumor activity of FM at a non-toxic dose.",29784005_15,-1,-1,-1,-1,34865,-1,2.0939533e-05,0.99996364,1.5449255e-05
34869,to this,5,7,30,37,"This may provide new insights to this ancient mysterious prescription in cancer therapy, which offers a novel and practical therapeutic strategy and the possibilities of combined immunotherapy for HCC as well as other inflammation-related cancers in clinic.",29784005_16,-1,-1,-1,-1,34869,-1,2.9292663e-05,0.9999597,1.10498695e-05
34870,therapy,12,13,80,87,"This may provide new insights to this ancient mysterious prescription in cancer therapy, which offers a novel and practical therapeutic strategy and the possibilities of combined immunotherapy for HCC as well as other inflammation-related cancers in clinic.",29784005_16,0,1,-1,-1,34870,-1,3.2035176e-05,0.999951,1.698619e-05
34880,the relationship,9,11,50,66,"Thus, we investigated the prevalence of Tregs and the relationship between them and TGF- and IL-10 concentrations and measured expression of FOXP3, CTLA-4, CD28, and GITR genes, as well as protein expression of selected genes in benign effusions and MPEs.",29785404_2,-1,-1,-1,-1,34880,-1,1.8979508e-05,0.9999702,1.0806053e-05
34888,protein,35,36,190,197,"Thus, we investigated the prevalence of Tregs and the relationship between them and TGF- and IL-10 concentrations and measured expression of FOXP3, CTLA-4, CD28, and GITR genes, as well as protein expression of selected genes in benign effusions and MPEs.",29785404_2,0,1,-1,-1,34888,-1,4.230924e-05,0.9999372,2.048956e-05
34908,the genes,5,7,32,41,Relative mRNA expression of all the genes was higher in CD4+CD25+ compared to CD4+CD25- cells.,29785404_7,-1,-1,-1,-1,34908,-1,3.8317114e-05,0.99994075,2.096701e-05
34915,CD28 genes,16,18,77,87,"In CD4+CD25+ cells from MPEs, relative mRNA expression of FOXP3, CTLA-4, and CD28 genes was significantly higher than in benign effusions; however, the level of CD4+CD25+CTLA-4+ cells in analyzed groups showed no significant differences.",29785404_8,-1,-1,-1,-1,34915,-1,0.0030409398,0.023101622,0.9738574
34920,cell subset,10,12,60,71,We found numerous genes correlations in an entire CD4+CD25+ cell subset and CD4+CD25+ cells from MPEs.,29785404_9,-1,-1,-1,-1,34920,-1,3.8719245e-05,4.1268144e-05,0.99992
34927,factors,8,9,75,82,Understanding of relations between cellular and cytokine immunosuppressive factors in tumor microenvironment may determine success of anticancer response.,29785404_11,0,1,-1,-1,34927,-1,0.0005865692,0.9992835,0.0001299335
34937,blood,11,12,63,68,The number of Tregs is increased in tumor sites and peripheral blood of breast cancer patients.,29797233_1,0,1,-1,-1,34937,-1,0.00021951646,0.99808335,0.0016971097
34939,functional,7,8,43,53,"However, the data regarding phenotypic and functional heterogeneity of Treg subpopulations in breast cancer are limited.",29797233_2,0,1,2,-1,34939,-1,5.6304438e-05,0.99992025,2.3473063e-05
34944,Tregs that,12,14,79,89,"The present study aimed to investigate the number and suppressive potential of Tregs that possess natural nave-(N nTregs), effector/memory-like (EM nTregs), and Tr1-like phenotypes in breast cancer patients and healthy women.",29797233_3,-1,-1,-1,-1,34944,-1,1.7058277e-05,0.99997056,1.2378659e-05
34948,Tr1 subsets,13,15,98,109,"Numbers of CD4+CD25+FoxP3+CD45RA+ N nTregs, CD4+CD25+FoxP3+CD45RA- EM nTregs, and CD4+IL-4-IL-10+ Tr1 subsets and the expression of CTLA-4, CD39, GITR, LAP, and IL-35 by these Treg subsets were measured in freshly obtained peripheral blood by flow cytometry.",29797233_5,-1,-1,-1,-1,34948,-1,0.003327296,0.61229813,0.38437462
34951,these Treg subsets,30,33,170,188,"Numbers of CD4+CD25+FoxP3+CD45RA+ N nTregs, CD4+CD25+FoxP3+CD45RA- EM nTregs, and CD4+IL-4-IL-10+ Tr1 subsets and the expression of CTLA-4, CD39, GITR, LAP, and IL-35 by these Treg subsets were measured in freshly obtained peripheral blood by flow cytometry.",29797233_5,-1,-1,-1,-1,34951,-1,0.003629827,0.38617477,0.6101954
34952,blood,39,40,234,239,"Numbers of CD4+CD25+FoxP3+CD45RA+ N nTregs, CD4+CD25+FoxP3+CD45RA- EM nTregs, and CD4+IL-4-IL-10+ Tr1 subsets and the expression of CTLA-4, CD39, GITR, LAP, and IL-35 by these Treg subsets were measured in freshly obtained peripheral blood by flow cytometry.",29797233_5,0,1,-1,-1,34952,-1,0.001494422,0.5809875,0.41751802
34953,that the,6,8,32,40,"RESULTS: Herein, we demonstrate that the percentages of N nTregs, EM nTregs, CD25+ and FoxP3+ Tr1 cells are elevated in the peripheral blood of breast cancer patients, but do not correlate with cancer stages.",29797233_6,-1,-1,-1,-1,34953,-1,1.6454971e-05,0.99997437,9.150817e-06
34955,Tr1 cells,21,23,94,103,"RESULTS: Herein, we demonstrate that the percentages of N nTregs, EM nTregs, CD25+ and FoxP3+ Tr1 cells are elevated in the peripheral blood of breast cancer patients, but do not correlate with cancer stages.",29797233_6,-1,-1,-1,-1,34955,-1,0.003990594,0.43887964,0.55712974
34957,blood,28,29,135,140,"RESULTS: Herein, we demonstrate that the percentages of N nTregs, EM nTregs, CD25+ and FoxP3+ Tr1 cells are elevated in the peripheral blood of breast cancer patients, but do not correlate with cancer stages.",29797233_6,0,1,-1,-1,34957,-1,8.874414e-05,0.9995307,0.00038059207
34959,Tr1 cells,7,9,37,46,"Nevertheless, the frequency of CD25+ Tr1 cells was associated with nodal involvement, while the number of EM nTregs correlated with clinical outcome.",29797233_7,-1,-1,-1,-1,34959,-1,0.00065363327,0.019451953,0.97989434
34964,Treg subsets,9,11,51,63,"The expression of CTLA-4 and IL-35 by all assessed Treg subsets was increased throughout all tumor stages (I-III).CONCLUSIONS: Collectively, the current study shows phenotypic alterations in suppressive receptors of Treg subsets, suggesting that breast cancer patients have increased activity of N nTregs, EM nTregs and Tr1 cells; and EM nTregs and CD25+ Tr1 cells represent prospective markers for assessing disease prognosis.",29797233_8,-1,-1,-1,-1,34964,-1,0.00016801653,0.0016746377,0.9981573
34968,receptors,29,30,203,212,"The expression of CTLA-4 and IL-35 by all assessed Treg subsets was increased throughout all tumor stages (I-III).CONCLUSIONS: Collectively, the current study shows phenotypic alterations in suppressive receptors of Treg subsets, suggesting that breast cancer patients have increased activity of N nTregs, EM nTregs and Tr1 cells; and EM nTregs and CD25+ Tr1 cells represent prospective markers for assessing disease prognosis.",29797233_8,0,1,2,-1,34968,-1,0.0019219778,0.8862853,0.11179271
34969,Treg subsets,31,33,216,228,"The expression of CTLA-4 and IL-35 by all assessed Treg subsets was increased throughout all tumor stages (I-III).CONCLUSIONS: Collectively, the current study shows phenotypic alterations in suppressive receptors of Treg subsets, suggesting that breast cancer patients have increased activity of N nTregs, EM nTregs and Tr1 cells; and EM nTregs and CD25+ Tr1 cells represent prospective markers for assessing disease prognosis.",29797233_8,-1,-1,-1,-1,34969,-1,0.00023295962,0.0034401088,0.996327
34971,Tr1 cells,49,51,320,329,"The expression of CTLA-4 and IL-35 by all assessed Treg subsets was increased throughout all tumor stages (I-III).CONCLUSIONS: Collectively, the current study shows phenotypic alterations in suppressive receptors of Treg subsets, suggesting that breast cancer patients have increased activity of N nTregs, EM nTregs and Tr1 cells; and EM nTregs and CD25+ Tr1 cells represent prospective markers for assessing disease prognosis.",29797233_8,-1,-1,-1,-1,34971,-1,0.0011917397,0.037595775,0.9612126
34972,Tr1 cells,58,60,355,364,"The expression of CTLA-4 and IL-35 by all assessed Treg subsets was increased throughout all tumor stages (I-III).CONCLUSIONS: Collectively, the current study shows phenotypic alterations in suppressive receptors of Treg subsets, suggesting that breast cancer patients have increased activity of N nTregs, EM nTregs and Tr1 cells; and EM nTregs and CD25+ Tr1 cells represent prospective markers for assessing disease prognosis.",29797233_8,-1,-1,-1,-1,34972,-1,0.0021087355,0.10458456,0.8933067
34981,Toll-like receptor-3,10,12,71,91,"Immune adjuvants, including double-stranded (ds)RNAs, which signal via Toll-like receptor-3 (TLR3) and helicase (RIG-I/MDA5) pathways, all induce intratumoral production of CTL-attractants, but also Treg attractants and suppressive factors, raising the question of whether induction of these opposing groups of immune mediators can be separated.",29853604_1,-1,-1,-1,-1,34981,-1,0.0010018676,0.9962364,0.0027617405
34985,factors,35,36,232,239,"Immune adjuvants, including double-stranded (ds)RNAs, which signal via Toll-like receptor-3 (TLR3) and helicase (RIG-I/MDA5) pathways, all induce intratumoral production of CTL-attractants, but also Treg attractants and suppressive factors, raising the question of whether induction of these opposing groups of immune mediators can be separated.",29853604_1,0,1,-1,-1,34985,-1,0.8539141,0.1334421,0.012643764
34992,that the,14,16,74,82,"Here, we use human tumor explant cultures and cell culture models to show that the (ds) RNA Sendai Virus (SeV), poly-I:C, and rintatolimod (poly-I:C12U) all activate the TLR3 pathway involving TRAF3 and IRF3, and induce IFN, ISG-60, and CXCL10 to promote CTL chemotaxis to ex vivo-treated tumors.",29853604_2,-1,-1,-1,-1,34992,-1,1.9602265e-05,0.9999697,1.0640982e-05
34993,the TLR3,39,41,166,174,"Here, we use human tumor explant cultures and cell culture models to show that the (ds) RNA Sendai Virus (SeV), poly-I:C, and rintatolimod (poly-I:C12U) all activate the TLR3 pathway involving TRAF3 and IRF3, and induce IFN, ISG-60, and CXCL10 to promote CTL chemotaxis to ex vivo-treated tumors.",29853604_2,-1,-1,-1,-1,34993,-1,2.4252384e-05,0.99995935,1.6450786e-05
34997,CXCL10 to,54,56,238,247,"Here, we use human tumor explant cultures and cell culture models to show that the (ds) RNA Sendai Virus (SeV), poly-I:C, and rintatolimod (poly-I:C12U) all activate the TLR3 pathway involving TRAF3 and IRF3, and induce IFN, ISG-60, and CXCL10 to promote CTL chemotaxis to ex vivo-treated tumors.",29853604_2,-1,-1,-1,-1,34997,-1,0.98860675,0.006605108,0.004788194
34998,CTL chemotaxis to,57,60,256,273,"Here, we use human tumor explant cultures and cell culture models to show that the (ds) RNA Sendai Virus (SeV), poly-I:C, and rintatolimod (poly-I:C12U) all activate the TLR3 pathway involving TRAF3 and IRF3, and induce IFN, ISG-60, and CXCL10 to promote CTL chemotaxis to ex vivo-treated tumors.",29853604_2,-1,-1,-1,-1,34998,-1,0.0075603896,0.032439906,0.9599997
35002,TNF-dependent,24,25,125,139,"However, in contrast with SeV and poly I:C, rintatolimod did not activate the MAVS/helicase pathway, thus avoiding NFB- and TNF-dependent induction of COX2, COX2/PGE2-dependent induction of IDO, IL10, CCL22, and CXCL12, and eliminating Treg attraction.",29853604_3,0,1,-1,-1,35002,-1,3.692691e-05,0.99994254,2.0536818e-05
35018,type-1 immunity,35,37,250,265,Our data identify the helicase/NFB/TNF/COX2 axis as the key suppressive pathway of dsRNA signaling in human TME and suggest that selective targeting of TLR3 or elimination of NFB/TNF/COX2-driven suppression may allow for selective enhancement of type-1 immunity.,29853604_5,-1,-1,-1,-1,35018,-1,0.008534643,0.9907452,0.0007201785
35022,factors,19,20,145,152,Significance: This study characterizes two different poly-I:C-induced signaling pathways in their induction of immunostimulatory and suppressive factors and suggests improved ways to reprogram the TME to enhance the antitumor efficacy of immunotherapies.,29853604_6,0,1,-1,-1,35022,-1,0.007987738,0.99124473,0.0007675515
35024,the TME to,26,29,193,203,Significance: This study characterizes two different poly-I:C-induced signaling pathways in their induction of immunostimulatory and suppressive factors and suggests improved ways to reprogram the TME to enhance the antitumor efficacy of immunotherapies.,29853604_6,-1,-1,-1,-1,35024,-1,1.9241028e-05,0.9999709,9.90142e-06
35031,cellular therapy,29,31,159,175,"Memory stem T (TSCM) cells, a new subset of memory T cells with self-renewal and multipotent capacities, are considered as a promising candidates for adoptive cellular therapy.",29864078_0,-1,-1,-1,-1,35031,-1,0.004308919,0.071570545,0.92412055
35033,TSCM cells,7,9,37,47,"However, the low proportion of human TSCM cells in total CD8 T cells limits their utility.",29864078_1,-1,-1,-1,-1,35033,-1,0.0023251413,0.104690276,0.89298457
35038,TSCM cells,8,10,35,45,"Here, we aimed to induce human CD8 TSCM cells by stimulating naive precursors with interleukin-21 (IL-21).",29864078_2,-1,-1,-1,-1,35038,-1,0.0022206523,0.12839928,0.86938006
35039,naive precursors,12,14,61,77,"Here, we aimed to induce human CD8 TSCM cells by stimulating naive precursors with interleukin-21 (IL-21).",29864078_2,-1,-1,-1,-1,35039,-1,0.0073822774,0.2833494,0.70926833
35042,the generation,5,7,29,43,"We found that IL-21 promoted the generation of TSCM cells, described as CD45RACD45ROCD62LCCR7CD122CD95 cells, with a higher efficiency than that observed with other common -chain cytokines.",29864078_3,-1,-1,-1,-1,35042,-1,2.0951267e-05,0.99996495,1.4141054e-05
35043,TSCM cells,8,10,47,57,"We found that IL-21 promoted the generation of TSCM cells, described as CD45RACD45ROCD62LCCR7CD122CD95 cells, with a higher efficiency than that observed with other common -chain cytokines.",29864078_3,-1,-1,-1,-1,35043,-1,0.002674226,0.18799295,0.8093328
35045,than that,20,22,135,144,"We found that IL-21 promoted the generation of TSCM cells, described as CD45RACD45ROCD62LCCR7CD122CD95 cells, with a higher efficiency than that observed with other common -chain cytokines.",29864078_3,-1,-1,-1,-1,35045,-1,2.8418102e-05,0.9999577,1.3929792e-05
35048,these lymphocytes,10,12,58,75,"Upon adoptive transfer into an A375 melanoma mouse model, these lymphocytes mediated much stronger antitumor responses.",29864078_4,-1,-1,-1,-1,35048,-1,0.0036051848,0.32306525,0.67332953
35049,analysis,2,3,20,28,"Further mechanistic analysis revealed that IL-21 activated the Janus kinase signal transducer and activator of transcription 3 pathway by upregulating signal transducer and activator of transcription 3 phosphorylation and consequently promoting the expression of T-bet and suppressor of cytokine signaling 1, but decreasing the expression of eomesodermin and GATA binding protein 3.",29864078_5,0,1,-1,-1,35049,-1,2.1202115e-05,0.9999629,1.586701e-05
35059,the generation,6,8,41,55,Our findings provide novel insights into the generation of human CD8 TSCM cells and reveal a novel potential clinical application of IL-21.,29864078_6,-1,-1,-1,-1,35059,-1,1.8966892e-05,0.9999709,1.0124294e-05
35060,TSCM cells,11,13,69,79,Our findings provide novel insights into the generation of human CD8 TSCM cells and reveal a novel potential clinical application of IL-21.,29864078_6,-1,-1,-1,-1,35060,-1,0.0029099681,0.24622172,0.7508683
35066,the chemotherapy,26,28,177,193,"Hypoxia is reported to participate in tumor progression, promote drug resistance, and immune escape within tumor microenvironment, and thus impair therapeutic effects including the chemotherapy and advanced immunotherapy.",29882235_0,-1,-1,-1,-1,35066,-1,0.2268331,0.7671104,0.0060564554
35070,functionalities,8,9,60,75,"Based on the properties including good biodegradability and functionalities, the pH-sensitive zeolitic imidazolate framework 8 embedded with catalase and doxorubicin constructs the core and serves as an oxygen generator and drug reservoir.",29882235_2,0,1,2,-1,35070,-1,0.00022314917,0.9995976,0.00017931651
35076,tumor targeting,9,11,59,74,Murine melanoma cell membrane coating on the core provides tumor targeting ability and elicits an immune response due to abundance of antigens.,29882235_3,-1,-1,-1,-1,35076,-1,2.787824e-05,0.999961,1.10739265e-05
35080,that this,3,5,19,28,"It is demonstrated that this biomimetic core-shell nanoplatform with oxygen generation can be partial to accumulate in tumor and downregulate the expression of hypoxia-inducible factor 1, which can further enhance the therapeutic effects of chemotherapy and reduce the expression of programmed death ligand 1 (PD-L1).",29882235_4,-1,-1,-1,-1,35080,-1,1.6587177e-05,0.9999753,8.082441e-06
35087,the therapeutic,31,33,215,230,"It is demonstrated that this biomimetic core-shell nanoplatform with oxygen generation can be partial to accumulate in tumor and downregulate the expression of hypoxia-inducible factor 1, which can further enhance the therapeutic effects of chemotherapy and reduce the expression of programmed death ligand 1 (PD-L1).",29882235_4,-1,-1,-1,-1,35087,-1,2.320744e-05,0.9999676,9.214306e-06
35090,therapy,5,6,42,49,"Combined with immune checkpoints blockade therapy by programmed death 1 (PD-1) antibody, the dual inhibition of the PD-1/PD-L1 axis elicits significant immune response and presents a robust effect in lengthening tumor recurrent time and inhibiting tumor metastasis.",29882235_5,0,1,-1,-1,35090,-1,2.1238746e-05,0.9999659,1.2877652e-05
35103,tumor tissues,18,20,98,111,"Regulatory Tcells (Tregs) are critical for maintaining immune homeostasis, but their presence in tumor tissues impairs anti-tumor immunity and portends poor prognoses in cancer patients.",29898397_0,-1,-1,-1,-1,35103,-1,2.22383e-05,0.9999609,1.6830045e-05
35104,immunity,22,23,131,139,"Regulatory Tcells (Tregs) are critical for maintaining immune homeostasis, but their presence in tumor tissues impairs anti-tumor immunity and portends poor prognoses in cancer patients.",29898397_0,0,-1,2,-1,35104,-1,0.99955183,0.00027073946,0.0001774153
35107,the function,11,13,64,76,"Here, we reveal a mechanism to selectively target and reprogram the function of tumor-infiltrating Tregs (TI-Tregs) by exploiting their dependency on the histone H3K27 methyltransferase enhancer of zeste homolog 2 (EZH2) in tumors.",29898397_1,-1,-1,-1,-1,35107,-1,2.560474e-05,0.99996173,1.2631463e-05
35108,tumor-infiltrating Tregs,14,16,80,104,"Here, we reveal a mechanism to selectively target and reprogram the function of tumor-infiltrating Tregs (TI-Tregs) by exploiting their dependency on the histone H3K27 methyltransferase enhancer of zeste homolog 2 (EZH2) in tumors.",29898397_1,-1,-1,-1,-1,35108,-1,2.1754298e-05,0.99996614,1.2114201e-05
35116,functions,17,18,121,130,"Disruption of EZH2 activity in Tregs, either pharmacologically or genetically, drove the acquisition of pro-inflammatory functions in TI-Tregs,remodeling the tumor microenvironment and enhancing the recruitment and function of CD8+ and CD4+ effector Tcells that eliminate tumors.",29898397_2,0,1,2,-1,35116,-1,0.00051252823,0.9989115,0.0005759502
35118,the tumor,23,25,155,164,"Disruption of EZH2 activity in Tregs, either pharmacologically or genetically, drove the acquisition of pro-inflammatory functions in TI-Tregs,remodeling the tumor microenvironment and enhancing the recruitment and function of CD8+ and CD4+ effector Tcells that eliminate tumors.",29898397_2,-1,-1,-1,-1,35118,-1,2.108648e-05,0.9999691,9.757085e-06
35120,function,31,32,216,224,"Disruption of EZH2 activity in Tregs, either pharmacologically or genetically, drove the acquisition of pro-inflammatory functions in TI-Tregs,remodeling the tumor microenvironment and enhancing the recruitment and function of CD8+ and CD4+ effector Tcells that eliminate tumors.",29898397_2,0,1,2,-1,35120,-1,7.751483e-05,0.99986064,6.180652e-05
35121,Tcells that,39,43,251,263,"Disruption of EZH2 activity in Tregs, either pharmacologically or genetically, drove the acquisition of pro-inflammatory functions in TI-Tregs,remodeling the tumor microenvironment and enhancing the recruitment and function of CD8+ and CD4+ effector Tcells that eliminate tumors.",29898397_2,-1,-1,-1,-1,35121,-1,0.0013258033,0.025003755,0.9736704
35123,function,4,5,26,34,"Moreover, abolishing EZH2 function in Tregs was mechanistically distinct from, more potent than, and less toxic than a generalized Treg depletion approach.",29898397_3,0,1,2,-1,35123,-1,6.409594e-05,0.9998683,6.7652785e-05
35126,toxic than,18,20,106,116,"Moreover, abolishing EZH2 function in Tregs was mechanistically distinct from, more potent than, and less toxic than a generalized Treg depletion approach.",29898397_3,-1,-1,-1,-1,35126,-1,9.5524934e-05,0.99981433,9.014367e-05
35127,generalized Treg,21,23,119,135,"Moreover, abolishing EZH2 function in Tregs was mechanistically distinct from, more potent than, and less toxic than a generalized Treg depletion approach.",29898397_3,-1,-1,-1,-1,35127,-1,5.687142e-05,0.9999138,2.9364317e-05
35129,to target Tregs,5,8,30,45,This study reveals a strategy to target Tregs in cancer that mitigates autoimmunity by reprogramming their function in tumors to enhance anti-cancer immunity.,29898397_4,-1,-1,-1,-1,35129,-1,1.9365354e-05,0.99997234,8.237209e-06
35131,their function,15,17,101,115,This study reveals a strategy to target Tregs in cancer that mitigates autoimmunity by reprogramming their function in tumors to enhance anti-cancer immunity.,29898397_4,-1,-1,-1,-1,35131,-1,5.4470704e-05,0.9999224,2.3126633e-05
35132,tumors to,18,20,119,128,This study reveals a strategy to target Tregs in cancer that mitigates autoimmunity by reprogramming their function in tumors to enhance anti-cancer immunity.,29898397_4,-1,-1,-1,-1,35132,-1,1.8148083e-05,0.999974,7.8873745e-06
35133,immunity,22,23,149,157,This study reveals a strategy to target Tregs in cancer that mitigates autoimmunity by reprogramming their function in tumors to enhance anti-cancer immunity.,29898397_4,0,-1,2,-1,35133,-1,0.999508,0.00031510164,0.00017678582
35135,receptors,4,5,32,41,"The expression of co-inhibitory receptors, such as CTLA-4 and PD-1, on effector T cells is a key mechanism for ensuring immune homeostasis.",29899446_0,0,1,2,-1,35135,-1,7.0572125e-05,0.00016815946,0.9997613
35138,receptors,4,5,41,50,"Dysregulated expression of co-inhibitory receptors on CD4+ T cells promotes autoimmunity, whereas sustained overexpression on CD8+ T cells promotes T cell dysfunction or exhaustion, leading to impaired ability to clear chronic viral infections and diseases such as cancer1,2.",29899446_1,0,1,2,-1,35138,-1,0.00017455376,0.00051509717,0.9993104
35144,protein,5,6,20,27,"Here, using RNA and protein expression profiling at single-cell resolution in mouse cells, we identify a module of co-inhibitory receptors that includes not only several known co-inhibitory receptors (PD-1, TIM-3, LAG-3 and TIGIT) but also many new surface receptors.",29899446_2,0,1,-1,-1,35144,-1,4.140809e-05,0.9999294,2.9124702e-05
35146,receptors that,21,23,129,143,"Here, using RNA and protein expression profiling at single-cell resolution in mouse cells, we identify a module of co-inhibitory receptors that includes not only several known co-inhibitory receptors (PD-1, TIM-3, LAG-3 and TIGIT) but also many new surface receptors.",29899446_2,-1,-1,-1,-1,35146,-1,0.0020976893,0.9044177,0.09348456
35147,receptors,29,30,190,199,"Here, using RNA and protein expression profiling at single-cell resolution in mouse cells, we identify a module of co-inhibitory receptors that includes not only several known co-inhibitory receptors (PD-1, TIM-3, LAG-3 and TIGIT) but also many new surface receptors.",29899446_2,0,1,2,-1,35147,-1,0.0001998302,0.0011428692,0.9986572
35150,receptors,44,45,257,266,"Here, using RNA and protein expression profiling at single-cell resolution in mouse cells, we identify a module of co-inhibitory receptors that includes not only several known co-inhibitory receptors (PD-1, TIM-3, LAG-3 and TIGIT) but also many new surface receptors.",29899446_2,0,1,2,-1,35150,-1,0.00021764632,0.0012299517,0.9985524
35151,functionally,1,2,3,15,"We functionally validated two new co-inhibitory receptors, activated protein C receptor (PROCR) and podoplanin (PDPN).",29899446_3,0,1,2,-1,35151,-1,3.0036012e-05,0.9999572,1.2814301e-05
35153,receptors,6,7,48,57,"We functionally validated two new co-inhibitory receptors, activated protein C receptor (PROCR) and podoplanin (PDPN).",29899446_3,0,1,2,-1,35153,-1,0.0003142861,0.00860962,0.9910761
35154,protein,9,10,69,76,"We functionally validated two new co-inhibitory receptors, activated protein C receptor (PROCR) and podoplanin (PDPN).",29899446_3,0,1,-1,-1,35154,-1,4.785647e-05,0.9999051,4.7007932e-05
35155,receptor,11,12,79,87,"We functionally validated two new co-inhibitory receptors, activated protein C receptor (PROCR) and podoplanin (PDPN).",29899446_3,0,1,2,-1,35155,-1,0.0005075981,0.03141887,0.96807355
35157,receptors,4,5,28,37,The module of co-inhibitory receptors is co-expressed in both CD4+ and CD8+ T cells and is part of a larger co-inhibitory gene program that is shared by non-responsive T cells in several physiological contexts and is driven by the immunoregulatory cytokine IL-27.,29899446_4,0,1,2,-1,35157,-1,0.00010169138,0.00034340765,0.99955493
35164,analysis,1,2,14,22,"Computational analysis identified the transcription factors PRDM1 and c-MAF as cooperative regulators of the co-inhibitory module, and this was validated experimentally.",29899446_5,0,1,-1,-1,35164,-1,2.8969951e-05,0.999954,1.7078715e-05
35165,the transcription factors PRDM1,3,7,34,65,"Computational analysis identified the transcription factors PRDM1 and c-MAF as cooperative regulators of the co-inhibitory module, and this was validated experimentally.",29899446_5,-1,-1,-1,-1,35165,-1,2.8970366e-05,0.99993396,3.7035046e-05
35170,receptors,8,9,68,77,This molecular circuit underlies the co-expression of co-inhibitory receptors in T cells and identifies regulators of T cell function with the potential to control autoimmunity and tumour immunity.,29899446_6,0,1,2,-1,35170,-1,0.00012399223,0.00029351996,0.99958247
35172,T cell function,16,19,118,133,This molecular circuit underlies the co-expression of co-inhibitory receptors in T cells and identifies regulators of T cell function with the potential to control autoimmunity and tumour immunity.,29899446_6,-1,-1,-1,-1,35172,-1,3.868005e-05,5.455365e-05,0.99990666
35175,tumour immunity,26,28,181,196,This molecular circuit underlies the co-expression of co-inhibitory receptors in T cells and identifies regulators of T cell function with the potential to control autoimmunity and tumour immunity.,29899446_6,-1,-1,-1,-1,35175,-1,0.034782574,0.9644699,0.0007475339
35186,the gene,46,48,262,270,METHODS: Pancreata of C57BL/6 or Rag1-/- mice were given pancreatic injections of a combination of KrasG12D/+; Trp53 R172H/+; Pdx-1cre (KPC) pancreatic cancer cells and pancreatic stellate cells (PSCs) extracted from C57BL/6 (control) or mice with disruption of the gene encoding the NFB p50 subunit (Nfkb1 or p50-/- mice).,29909021_2,-1,-1,-1,-1,35186,-1,2.3403532e-05,0.9999635,1.3024337e-05
35198,T-cell,0,1,0,6,T-cell migration toward cancer cells was measured using the Boyden chamber assay.,29909021_7,-1,1,2,-1,35198,-1,2.865148e-05,4.6051224e-05,0.9999254
35204,tumors than,20,22,108,119,RESULTS: C57BL/6 mice coinjected with KPC cells (or LLC or B16-F10 cells) and p50-/- PSCs developed smaller tumors than mice given injections of the cancer cells along with control PSCs.,29909021_8,-1,-1,-1,-1,35204,-1,1.89826e-05,0.99996805,1.2983409e-05
35207,Tumors that,0,2,0,11,"Tumors that formed when KPC cells were injected along with p50-/- PSCs had increased infiltration by activated cytotoxic T cells along with decreased levels of CXCL12, compared with tumors grown from KPC cells injected along with control PSCs.",29909021_9,-1,-1,-1,-1,35207,-1,2.015275e-05,0.9999696,1.0228872e-05
35217,The CXCL12,0,2,0,10,The CXCL12 inhibitor slowed tumor growth and increased tumor infiltration by cytotoxic T cells.,29909021_11,-1,-1,-1,-1,35217,-1,0.8622677,0.1312316,0.006500747
35221,T-cell,9,10,43,49,Invitro expression of p50 by PSCs reduced T-cell migration toward and killing of cancer cells.,29909021_12,-1,1,2,-1,35221,-1,3.0968265e-05,4.164109e-05,0.9999274
35225,CXCL12 than,13,15,81,92,"When cultured with cancer cells, control PSCs expressed 10-fold higher levels of CXCL12 than p50-/- PSCs.",29909021_13,-1,-1,-1,-1,35225,-1,0.9894051,0.006461204,0.0041337
35226,The CXCL12,0,2,0,10,The CXCL12 inhibitor increased migration of T cells toward KPC cells in culture.,29909021_14,-1,-1,-1,-1,35226,-1,0.8510634,0.14137958,0.0075570135
35227,T cells toward,6,9,44,58,The CXCL12 inhibitor increased migration of T cells toward KPC cells in culture.,29909021_14,-1,-1,-1,-1,35227,-1,0.0012792593,0.024779387,0.9739414
35234,the tumor,34,36,193,202,"CONCLUSIONS: In studies of mice and cell lines, we found that NFB activity in PSCs promotes tumor growth by increasing expression of CXCL12, which prevents cytotoxic Tcells from infiltrating the tumor and killing cancer cells.",29909021_15,-1,-1,-1,-1,35234,-1,2.3121158e-05,0.9999659,1.0919048e-05
35238,tumor cells,6,8,41,52,Strategies to block CXCL12 in pancreatic tumor cells might increase antitumor immunity.,29909021_16,-1,-1,-1,-1,35238,-1,0.0038057687,0.315346,0.68084824
35239,immunity,11,12,78,86,Strategies to block CXCL12 in pancreatic tumor cells might increase antitumor immunity.,29909021_16,0,-1,2,-1,35239,-1,0.99852484,0.0011863842,0.00028876908
35245,T-cell,22,23,116,122,"In this study, the inhibitory effect of Brucea javanica (BJ) on cell growth and inflammation was confirmed in human T-cell acute lymphocytic leukemia (T-ALL) cells, and its efficacy as an antileukemic agent was verified.",29966986_1,-1,1,2,-1,35245,-1,3.6404603e-05,5.0036717e-05,0.9999136
35250,T-ALL Jurkat cells through,10,14,74,100,"Our results showed that BJ extract induced caspase-dependent apoptosis of T-ALL Jurkat cells through inhibition of the CK2-mediated signaling pathway, while exerting no significant cytotoxicity in normal peripheral blood mononuclear cells.",29966986_2,-1,-1,-1,-1,35250,-1,0.0001112203,0.9993437,0.0005450528
35252,blood,29,30,215,220,"Our results showed that BJ extract induced caspase-dependent apoptosis of T-ALL Jurkat cells through inhibition of the CK2-mediated signaling pathway, while exerting no significant cytotoxicity in normal peripheral blood mononuclear cells.",29966986_2,0,1,-1,-1,35252,-1,0.00014131132,0.999337,0.0005216309
35256,the interleukin,13,15,78,93,"Moreover, BJ extract suppressed the NF-B signaling pathway, thus, inhibiting the interleukin (IL)-2 expression induced by phorbol 12-myristate 13-acetate (PMA) and phytohemagglutinin (PHA).",29966986_3,-1,-1,-1,-1,35256,-1,0.23813534,0.7563437,0.005520933
35259,T-ALL cell,16,18,108,118,"Notably, combined treatment with BJ extract plus CX-4945 or imatinib exerted enhanced inhibitory effects on T-ALL cell growth and IL-2 production.",29966986_4,-1,-1,-1,-1,35259,-1,0.0007506561,0.029434515,0.9698148
35263,T-ALL treatment,16,18,92,107,"Overall, these results suggest that BJ extract can be a potent therapeutic herbal agent for T-ALL treatment and prevention of IL-2 mediated inflammatory immune responses.",29966986_5,-1,-1,-1,-1,35263,-1,3.8375667e-05,0.9999342,2.7370746e-05
35268,the Th17-related transcription factor,9,13,46,83,"FoxP3+ regulatory T cells (Treg) coexpressing the Th17-related transcription factor RORt accumulate in the lamina propria of IBD patients, where they are thought to represent an intermediate stage of development toward a Th17 proinflammatory phenotype.",29991500_1,-1,-1,-1,-1,35268,-1,2.7608821e-05,0.99995637,1.5990985e-05
35271,thought to,26,28,155,165,"FoxP3+ regulatory T cells (Treg) coexpressing the Th17-related transcription factor RORt accumulate in the lamina propria of IBD patients, where they are thought to represent an intermediate stage of development toward a Th17 proinflammatory phenotype.",29991500_1,-1,-1,-1,-1,35271,-1,3.394887e-05,0.9999505,1.554927e-05
35275,these cells,5,7,21,32,"However, the role of these cells in CAC is unknown.",29991500_2,-1,-1,-1,-1,35275,-1,0.00025133818,0.0029618095,0.99678683
35278,function,16,17,97,105,"RORt+FoxP3+ cells were investigated in human samples of CAC, and their phenotypic stability and function were investigated in an azoxymethane/dextran sulfate sodium model of CAC using Treg fate-mapping reporter and Treg-specific RORt conditional knockout mice.",29991500_3,0,1,2,-1,35278,-1,5.4212655e-05,0.9999106,3.51437e-05
35284,The functional,0,2,0,14,The functional role of CTLA-4 expressed by Tregs and FoxO3 in dendritic cells (DC) was studied in vitro and in vivo by siRNA-silencing experiments.,29991500_5,-1,-1,-1,-1,35284,-1,2.182862e-05,0.99996924,8.925139e-06
35288,tumor-infiltrating Tregs,8,10,66,90,RORt expression identified a phenotypically stable population of tumor-infiltrating Tregs in humans and mice.,29991500_6,-1,-1,-1,-1,35288,-1,2.9039276e-05,0.99995613,1.4782134e-05
35294,cytokine that triggers STAT3-dependent,7,11,44,82,"Tumor-infiltrating DCs produced less IL6, a cytokine that triggers STAT3-dependent proliferative signals in neoplastic cells.",29991500_8,-1,-1,-1,-1,35294,-1,0.6177155,0.37174624,0.010538332
35300,the transcription factor,15,18,111,135,"RORt-deficient Tregs isolated from tumors overexpressed CTLA-4 and induced DCs to have elevated expression of the transcription factor FoxO3, thus reducing IL6 expression.",29991500_9,-1,-1,-1,-1,35300,-1,2.1556567e-05,0.99996674,1.173095e-05
35303,the tumors,12,14,72,82,"Finally, in vivo silencing of FoxO3 obtained by siRNA microinjection in the tumors of RORt-deficient mice restored IL6 expression and tumor growth.",29991500_10,-1,-1,-1,-1,35303,-1,1.9846995e-05,0.999969,1.1115905e-05
35308,tumor-infiltrating Tregs,7,9,47,71,These data demonstrate that RORt expressed by tumor-infiltrating Tregs sustains tumor growth by leaving IL6 expression in DCs unchecked.,29991500_11,-1,-1,-1,-1,35308,-1,2.4820603e-05,0.99996233,1.2826006e-05
35312,cell function,9,11,61,74,Mucosa-associated lymphoid tissue 1 (Malt1) regulates immune cell function by mediating the activation of nuclear factor B (NF-B) signaling through both its adaptor and proteolytic function.,30025160_0,-1,-1,-1,-1,35312,-1,5.4774882e-05,8.6364176e-05,0.99985874
35316,function,29,30,183,191,Mucosa-associated lymphoid tissue 1 (Malt1) regulates immune cell function by mediating the activation of nuclear factor B (NF-B) signaling through both its adaptor and proteolytic function.,30025160_0,0,1,2,-1,35316,-1,4.5706314e-05,0.9999224,3.1932475e-05
35320,the functional,3,5,11,25,"Until now, the functional distinction between Malt1 self-cleavage and its general protease function in regulating NF-B signaling and immune activation remained unclear.",30025160_2,-1,-1,-1,-1,35320,-1,2.9826422e-05,0.9999604,9.755046e-06
35322,function,13,14,91,99,"Until now, the functional distinction between Malt1 self-cleavage and its general protease function in regulating NF-B signaling and immune activation remained unclear.",30025160_2,0,1,2,-1,35322,-1,5.9718135e-05,0.9999018,3.846078e-05
35324,target genes,20,22,118,130,"Here we demonstrate, using a new mouse model, the importance of Malt1 self-cleavage in regulating expression of NF-B target genes and subsequent Tcell activation.",30025160_3,-1,-1,-1,-1,35324,-1,2.200216e-05,0.99996185,1.6084556e-05
35326,that Treg,5,7,36,45,"Significantly, we further establish that Treg homeostasis is critically linked to Malt1 function via a Treg intrinsic and extrinsic mechanism.",30025160_4,-1,-1,-1,-1,35326,-1,2.4068891e-05,0.9999664,9.50561e-06
35328,function,13,14,88,96,"Significantly, we further establish that Treg homeostasis is critically linked to Malt1 function via a Treg intrinsic and extrinsic mechanism.",30025160_4,0,1,2,-1,35328,-1,6.091777e-05,0.9998859,5.3136362e-05
35330,TCR-mediated,0,1,0,12,"TCR-mediated Malt1 proteolytic activity and self-cleavage was found to drive Il2 expression in conventional CD4+ Tcells, thereby regulating Il2 availability for Treg homeostasis.",30025160_5,-1,1,2,-1,35330,-1,2.4375197e-05,0.9999541,2.149211e-05
35340,time that,6,8,38,47,These results establish for the first time that inhibition of MALT1 proteolytic activity could be a viable therapeutic strategy to augment anti-tumor immunity.,30025160_7,-1,-1,-1,-1,35340,-1,2.1000224e-05,0.999969,1.00451325e-05
35343,immunity,22,23,150,158,These results establish for the first time that inhibition of MALT1 proteolytic activity could be a viable therapeutic strategy to augment anti-tumor immunity.,30025160_7,0,-1,2,-1,35343,-1,0.999332,0.00042581314,0.0002421641
35346,tumor cell,13,15,82,92,We have previously shown that Notch1 plays a critical role in modulating melanoma tumor cell growth and survival.,30036609_0,-1,-1,-1,-1,35346,-1,0.004014355,0.46529523,0.53069043
35354,functional,17,18,108,118,"Notch1 inhibition reduces immune suppressive cells (i.e. MDSCs and Tregs) while allowing the recruitment of functional CD8(+) T cells, leading to a decrease in the Tregs/CD8(+) ratio, a key parameter in assessing positive responses to immune-checkpoint inhibitors.",30036609_2,0,1,2,-1,35354,-1,5.1762534e-05,0.9999094,3.88134e-05
35369,the transcription,2,4,16,33,"Notch1 controls the transcription of IL8 and IL6; and the secretion of CCL5 likely by inhibiting the expression of SNAP23, a member of the SNAREs family of proteins involved in cell exocytosis.",30036609_6,-1,-1,-1,-1,35369,-1,2.4018296e-05,0.99996305,1.29501295e-05
35375,proteins,29,30,156,164,"Notch1 controls the transcription of IL8 and IL6; and the secretion of CCL5 likely by inhibiting the expression of SNAP23, a member of the SNAREs family of proteins involved in cell exocytosis.",30036609_6,0,1,-1,-1,35375,-1,0.00010374725,0.999703,0.00019325652
35381,therapy,21,22,149,156,"Hence, targeting Notch1 would affect both melanoma intrinsic growth/survival properties, and provide an immune-responsive TME, thus improving immune therapy efficacy.",30036609_8,0,1,-1,-1,35381,-1,3.9970677e-05,0.99994445,1.5586382e-05
35383,tissue,20,21,145,151,"M1 macrophages are involved in inflammation by producing proinflammatory cytokines, whereas M2 macrophages are associated with wound healing and tissue regeneration by producing anti-inflammatory cytokines.",30047999_0,-1,1,2,-1,35383,-1,9.2968396e-05,0.99983966,6.7317356e-05
35395,tumour tissues,9,11,50,64,"Meanwhile, the M1 cell frequencies were higher in tumour tissues and inflamed colons of KO mice than of littermate controls.",30047999_4,-1,-1,-1,-1,35395,-1,7.7280536e-05,0.99973077,0.00019189493
35407,deficiency,4,5,34,44,Results indicated that miR-15a/16 deficiency in the macrophages directs M1 polarization for tumour suppression and proinflammation.,30047999_8,0,1,-1,-1,35407,-1,7.109955e-05,0.99986374,6.5138855e-05
35413,deficiency,16,17,108,118,"Thus, miR-15a/16 deletion in macrophages holds a distinct biological significance from that of the microRNA deficiency in tumour cells.",30047999_9,0,1,-1,-1,35413,-1,0.00044111404,0.9987263,0.0008325866
35414,tumour cells,18,20,122,134,"Thus, miR-15a/16 deletion in macrophages holds a distinct biological significance from that of the microRNA deficiency in tumour cells.",30047999_9,-1,-1,-1,-1,35414,-1,0.0042855456,0.3478578,0.6478567
35419,T cell-mediated immunity,16,19,96,120,Dendritic cells (DCs) are the most potent professional antigen presenting cells and inducers of T cell-mediated immunity.,30068989_0,-1,-1,-1,-1,35419,-1,0.0070533482,0.0007350472,0.9922117
35420,analysis,3,4,22,30,A previous microarray analysis revealed expression of mDC-specific genes and identified Rsad2 (radical S-adenosyl methionine domain containing 2) as a candidate specific marker for DC maturation.,30068989_2,0,1,-1,-1,35420,-1,2.6886975e-05,0.99995613,1.6959926e-05
35423,cells to,5,7,43,51,C57BL/6 mice received intravenously B16F10 cells to establish a pulmonary metastasis model.,30068989_4,-1,-1,-1,-1,35423,-1,0.0037199422,0.113695584,0.8825844
35427,The cytotoxic T lymphocyte,0,4,0,26,The cytotoxic T lymphocyte (CTL) population was examined from splenocytes of DC-vaccinated mice by flow cytometry.,30068989_6,-1,-1,-1,-1,35427,-1,0.0026530996,0.11939882,0.8779481
35430,function,11,12,64,72,Rsad2 was induced at high levels in LPS-stimulated mDCs and mDC function was markedly attenuated under conditions of Rsad2 knockdown.,30068989_7,0,1,2,-1,35430,-1,6.0322636e-05,0.9998598,7.983613e-05
35431,the IRF7-mediated,9,11,53,70,"Moreover, Rsad2 was necessary for mDC maturation via the IRF7-mediated signaling pathway.",30068989_8,-1,-1,-1,-1,35431,-1,3.1187228e-05,0.99994063,2.8230155e-05
35434,the CTL,2,4,8,15,Data on the CTL population further supported the results as above.,30068989_10,-1,-1,-1,-1,35434,-1,0.002814198,0.17576116,0.82142466
35436,Taken together,0,2,0,14,"Taken together, Rsad2 was an obvious and specific marker necessary for DC maturation and these findings will be clearly helpful for further understanding of DC biology.",30068989_11,-1,-1,-1,-1,35436,-1,5.9883678e-05,0.99991775,2.2359829e-05
35438,factors,1,2,14,21,Environmental factors and chronic inflammation are correlated with the disease risk.,30075815_1,0,1,-1,-1,35438,-1,0.00022222745,0.9996804,9.734487e-05
35447,the tumour,10,12,59,69,"The anti-tumour immune responses, known to be initiated in the tumour and draining lymph nodes, may play a major role in future treatment strategies.",30075815_3,-1,-1,-1,-1,35447,-1,2.2480139e-05,0.9999672,1.02758195e-05
35463,the transcription factor Foxp3,35,39,174,204,"Activated CD4+ T cells differentiate into four main separate lineages: Th1, Th2, Th17 and Treg, and they are recognized by their effector molecules IFN-, IL-13, IL-17A, and the transcription factor Foxp3, respectively.",30075815_5,-1,-1,-1,-1,35463,-1,2.2560129e-05,0.9999639,1.351248e-05
35468,blood,14,15,84,89,"Here, we investigate the lineage commitment specifically in tumour, lymph nodes and blood and relate them to the disease stage and response to neoadjuvant chemotherapy.",30075815_7,0,1,-1,-1,35468,-1,0.0001491962,0.99921167,0.0006390823
35469,them to the,17,20,101,112,"Here, we investigate the lineage commitment specifically in tumour, lymph nodes and blood and relate them to the disease stage and response to neoadjuvant chemotherapy.",30075815_7,-1,-1,-1,-1,35469,-1,2.0669762e-05,0.99996746,1.1910672e-05
35472,Blood,2,3,9,14,"RESULTS: Blood, tumour and regional lymph nodes were obtained from patients at time of transurethral resection of the bladder and at radical cystectomy.",30075815_8,0,1,-1,-1,35472,-1,0.000120396406,0.9992643,0.000615318
35481,blood,22,23,157,162,"Tumour-infiltrating CD4+ lymphocytes were significantly hypomethylated in all four investigated lineage loci compared to CD4+ lymphocytes in lymph nodes and blood (lymph nodes vs tumour-infiltrating lymphocytes: IFNG -4229bp p<0.0001, IL13 -11bp p<0.05, IL17A -122bp p<0.01 and FOXP3 -77bp p>0.05).",30075815_9,0,1,-1,-1,35481,-1,0.00018089583,0.99926573,0.0005533633
35482,tumour-infiltrating lymphocytes,27,29,179,210,"Tumour-infiltrating CD4+ lymphocytes were significantly hypomethylated in all four investigated lineage loci compared to CD4+ lymphocytes in lymph nodes and blood (lymph nodes vs tumour-infiltrating lymphocytes: IFNG -4229bp p<0.0001, IL13 -11bp p<0.05, IL17A -122bp p<0.01 and FOXP3 -77bp p>0.05).",30075815_9,-1,-1,-1,-1,35482,-1,0.00372852,0.8427188,0.15355273
35488,the IFNG -4229,11,14,99,113,More advanced post-cystectomy tumour stages correlated significantly with increased methylation at the IFNG -4229bp locus.,30075815_11,-1,-1,-1,-1,35488,-1,0.004528911,0.9942946,0.0011765371
35498,blood,15,16,93,98,"Neoadjuvant chemotherapy seemed to result in a relocation of Th1-committed CD4+ T cells from blood, presumably to the tumour, indicated by shifts in the methylation patterns, whereas no such shifts were seen for lineages corresponding to IL13, IL17A and FOXP3.CONCLUSION: Increased lineage commitment in CD4+ T cells, as determined by demethylation in predictive CpG sites, is associated with lower post-cystectomy tumour stage, complete response to neoadjuvant chemotherapy and overall better outcome, suggesting epigenetic profiling of CD4+ T cell lineages as a useful readout for clinical staging.",30075815_13,0,1,-1,-1,35498,-1,0.0005726277,0.9724803,0.02694709
35499,to the tumour,18,21,111,124,"Neoadjuvant chemotherapy seemed to result in a relocation of Th1-committed CD4+ T cells from blood, presumably to the tumour, indicated by shifts in the methylation patterns, whereas no such shifts were seen for lineages corresponding to IL13, IL17A and FOXP3.CONCLUSION: Increased lineage commitment in CD4+ T cells, as determined by demethylation in predictive CpG sites, is associated with lower post-cystectomy tumour stage, complete response to neoadjuvant chemotherapy and overall better outcome, suggesting epigenetic profiling of CD4+ T cell lineages as a useful readout for clinical staging.",30075815_13,-1,-1,-1,-1,35499,-1,3.8731363e-05,0.99994504,1.6249502e-05
35501,to IL13,39,41,235,242,"Neoadjuvant chemotherapy seemed to result in a relocation of Th1-committed CD4+ T cells from blood, presumably to the tumour, indicated by shifts in the methylation patterns, whereas no such shifts were seen for lineages corresponding to IL13, IL17A and FOXP3.CONCLUSION: Increased lineage commitment in CD4+ T cells, as determined by demethylation in predictive CpG sites, is associated with lower post-cystectomy tumour stage, complete response to neoadjuvant chemotherapy and overall better outcome, suggesting epigenetic profiling of CD4+ T cell lineages as a useful readout for clinical staging.",30075815_13,-1,-1,-1,-1,35501,-1,0.75854087,0.23461679,0.006842302
35510,to the,3,5,23,29,Controversy remains as to the role of Notch signaling pathway in CD8+ T cells regulation in tumorigenesis.,30086535_1,-1,-1,-1,-1,35510,-1,2.4589866e-05,0.9999659,9.443575e-06
35511,T cells regulation,13,16,70,88,Controversy remains as to the role of Notch signaling pathway in CD8+ T cells regulation in tumorigenesis.,30086535_1,-1,-1,-1,-1,35511,-1,0.0008006343,0.011465309,0.9877341
35523,bloods,25,26,160,166,"Forty-eight lung adenocarcinoma patients and twenty healthy individuals were enrolled in the current study, and CD8+ T cells were purified from both peripheral bloods and bronchoalveolar lavage fluids.",30086535_3,0,1,-1,-1,35523,-1,0.00043841192,0.9967809,0.0027807094
35532,growth factor receptor,29,32,178,200,"Notch2 mRNA expression was elevated in both peripheral and lung-resident CD8+ T cells in lung adenocarcinoma patients, however, did not correlated with tumor stages or epidermal growth factor receptor mutation.",30086535_7,-1,-1,-1,-1,35532,-1,0.44823816,0.19680801,0.3549538
35544,therapy,10,11,55,62,"In this study, we investigated the impact of nivolumab therapy on peripheral blood regulatory T cells (Treg) and its relation to patient outcomes.",30131384_1,0,1,-1,-1,35544,-1,1.9126912e-05,0.9999695,1.1353836e-05
35545,blood regulatory T cells,13,17,77,101,"In this study, we investigated the impact of nivolumab therapy on peripheral blood regulatory T cells (Treg) and its relation to patient outcomes.",30131384_1,-1,-1,-1,-1,35545,-1,0.001333927,0.035306837,0.9633593
35547,relation to,22,24,117,128,"In this study, we investigated the impact of nivolumab therapy on peripheral blood regulatory T cells (Treg) and its relation to patient outcomes.",30131384_1,-1,-1,-1,-1,35547,-1,2.2129649e-05,0.9999641,1.3769458e-05
35548,blood Tregs,4,6,32,43,EXPERIMENTAL DESIGN: Peripheral blood Tregs and conventional CD4+ T cells from patients with resected high-risk melanoma treated with adjuvant nivolumab were assessed for gene expression changes by RNA-seq.,30131384_2,-1,-1,-1,-1,35548,-1,4.8594593e-05,0.99987984,7.160266e-05
35553,function,1,2,12,20,Suppressive function of Tregs was assessed in allogeneic mixed lymphocyte reactions.,30131384_4,0,1,2,-1,35553,-1,6.567883e-05,0.99987555,5.880224e-05
35564,Treg-suppressive function,14,16,88,113,"In vitro blockade of PD-1 increased Treg percentages and pSTAT3 expression, and reduced Treg-suppressive function.",30131384_7,-1,-1,-1,-1,35564,-1,6.250559e-05,0.9998754,6.199729e-05
35565,to IL10,4,6,23,30,"PD-1 blockade also led to IL10 production by T cells, resulting in higher Treg proliferation.",30131384_8,-1,-1,-1,-1,35565,-1,0.6863528,0.30927488,0.0043723783
35572,function,14,15,90,98,"The addition of a STAT3 inhibitor ameliorated the increase in Tregs, enhanced suppressive function, and decreased T-cell IL10 production in vitro.",30131384_9,0,1,2,-1,35572,-1,0.00012869014,0.9996997,0.00017167645
35573,T-cell IL10,18,20,114,125,"The addition of a STAT3 inhibitor ameliorated the increase in Tregs, enhanced suppressive function, and decreased T-cell IL10 production in vitro.",30131384_9,-1,-1,-1,-1,35573,-1,0.11730934,0.002539907,0.8801507
35576,function,12,13,85,93,"CONCLUSIONS: These results demonstrate that induction of pSTAT3, reduced suppressive function, and a paradoxical increase in Treg proliferation are novel correlates of patient benefit from PD-1 blockade.",30131384_10,0,1,2,-1,35576,-1,6.74368e-05,0.9998435,8.906337e-05
35578,the relationship,2,4,16,32,"We investigated the relationship between Neutrophil-to-lymphocyte ratio (NLR) and the quantities of neutrophil elastase, CD3, Foxp3, and CD204 in tumor-infiltrating cells and circulating cytokines (IL-2, -6, -8, 17a, and TGF-) in muscle-invasive bladder cancer.",30199269_0,-1,-1,-1,-1,35578,-1,1.7258619e-05,0.99997187,1.08637505e-05
35581,tumor-infiltrating cells,24,26,146,170,"We investigated the relationship between Neutrophil-to-lymphocyte ratio (NLR) and the quantities of neutrophil elastase, CD3, Foxp3, and CD204 in tumor-infiltrating cells and circulating cytokines (IL-2, -6, -8, 17a, and TGF-) in muscle-invasive bladder cancer.",30199269_0,-1,-1,-1,-1,35581,-1,0.0033330987,0.86432576,0.13234119
35586,in blood,10,12,63,71,IL-6 and IL-8 levels showed a significant correlation with NLR in blood and Foxp3+ cells around the tumor.,30199269_1,0,1,-1,-1,35586,-1,5.5389322e-05,0.99984443,0.00010010274
35589,the tumor,17,19,96,105,IL-6 and IL-8 levels showed a significant correlation with NLR in blood and Foxp3+ cells around the tumor.,30199269_1,-1,-1,-1,-1,35589,-1,2.0785832e-05,0.999969,1.0205744e-05
35590,blood cells,4,6,31,42,"After co-culture of peripheral blood cells with bladder cancer cell lines, the induction of regulatory T cell (Treg) was higher in T24 whose IL-6 and IL-8 levels were higher.",30199269_2,-1,-1,-1,-1,35590,-1,9.472267e-05,0.00026126346,0.99964404
35607,the genetic,13,15,71,82,"To investigate the role of the NLRP3 inflammasome in MM, we determined the genetic polymorphisms and expression of NLRP3 inflammasome-related genes (IL-1, IL-18, CARD8, and NF-B) in MM patients, and explored their clinical relevance.",30211233_1,-1,-1,-1,-1,35607,-1,1.922841e-05,0.99996626,1.4463475e-05
35613,the relationship,4,6,29,45,"Furthermore, we investigated the relationship of the NLRP3 inflammasome with Th cells in MM.",30211233_2,-1,-1,-1,-1,35613,-1,2.0662408e-05,0.9999615,1.7860468e-05
35615,Th cells,11,13,77,85,"Furthermore, we investigated the relationship of the NLRP3 inflammasome with Th cells in MM.",30211233_2,-1,-1,-1,-1,35615,-1,3.7256803e-05,6.4089196e-05,0.99989855
35616,that the,3,5,17,25,Our study showed that the CARD8-C10X (rs2043211) AT genotype contributed to the susceptibility of MM.,30211233_3,-1,-1,-1,-1,35616,-1,1.9211737e-05,0.9999685,1.2297609e-05
35617,to the,12,14,73,79,Our study showed that the CARD8-C10X (rs2043211) AT genotype contributed to the susceptibility of MM.,30211233_3,-1,-1,-1,-1,35617,-1,2.2840162e-05,0.9999645,1.2683596e-05
35620,the three,4,6,17,26,The WBC count in the three CARD8 genotypes showed an increasing trend (AA<AT<TT).,30211233_5,-1,-1,-1,-1,35620,-1,3.521546e-05,0.99994576,1.903293e-05
35629,that the,4,6,22,30,"Furthermore, we found that the genotype of CARD8-C10X (rs2043211) or NF-B-94 ins/del ATTG was closely related to the frequency of Th1.",30211233_8,-1,-1,-1,-1,35629,-1,1.7045648e-05,0.99997294,1.0048007e-05
35630,related to the,18,21,103,117,"Furthermore, we found that the genotype of CARD8-C10X (rs2043211) or NF-B-94 ins/del ATTG was closely related to the frequency of Th1.",30211233_8,-1,-1,-1,-1,35630,-1,2.3151571e-05,0.99996054,1.6287982e-05
35633,the genetic,2,4,11,22,"Therefore, the genetic polymorphisms of the NLRP3 inflammasome associated with Th cells might be involved in the pathogenesis of multiple myeloma.",30211233_9,-1,-1,-1,-1,35633,-1,2.29097e-05,0.99996305,1.4012099e-05
35635,Th cells,11,13,79,87,"Therefore, the genetic polymorphisms of the NLRP3 inflammasome associated with Th cells might be involved in the pathogenesis of multiple myeloma.",30211233_9,-1,-1,-1,-1,35635,-1,3.498182e-05,6.0407663e-05,0.99990463
35637,receptor-directed,10,11,57,74,PURPOSE: Clinical responses with programmed death (PD-1) receptor-directed antibodies occur in about 20% of patients with advanced head and neck squamous cell cancer (HNSCCa).,30242022_0,0,1,2,-1,35637,-1,0.0011630277,0.05857998,0.940257
35640,proteins,7,8,37,45,"Viral neoantigens, such as the E6/E7 proteins of HPV16/18, are attractive targets for therapeutic immunization and offer an immune activation strategy that may be complementary to PD-1 inhibition.",30242022_1,0,1,-1,-1,35640,-1,0.0008093173,0.99754,0.0016507489
35652,antigen-specific T-cell,7,9,50,73,"Eighteen of 21 evaluable patients showed elevated antigen-specific T-cell activity by IFN ELISpot, and persistent cellular responses surpassing 100 spot-forming units (SFUs)/106 peripheral blood mononuclear cells (PBMCs) were noted out to 1 year.",30242022_4,-1,-1,-1,-1,35652,-1,0.24339065,0.003066519,0.75354284
35655,blood,24,25,190,195,"Eighteen of 21 evaluable patients showed elevated antigen-specific T-cell activity by IFN ELISpot, and persistent cellular responses surpassing 100 spot-forming units (SFUs)/106 peripheral blood mononuclear cells (PBMCs) were noted out to 1 year.",30242022_4,0,1,-1,-1,35655,-1,0.0005928029,0.9869211,0.012486141
35663,therapy,10,11,72,79,One patient developed metastatic disease and was treated with anti-PD-1 therapy with a rapid and durable complete response.,30242022_7,0,1,-1,-1,35663,-1,2.255811e-05,0.99996305,1.4449944e-05
35664,T cells that,10,13,73,85,Flow-cytometric analyses revealed induction of HPV16-specific PD-1+ CD8+ T cells that were not found prior to MEDI0547 (0% vs. 1.8%).CONCLUSIONS: These data demonstrate that MEDI0457 can generate durable HPV16/18 antigen-specific peripheral and tumor immune responses.,30242022_8,-1,-1,-1,-1,35664,-1,0.0014453032,0.0355185,0.96303624
35670,tumor immune responses,37,40,245,267,Flow-cytometric analyses revealed induction of HPV16-specific PD-1+ CD8+ T cells that were not found prior to MEDI0547 (0% vs. 1.8%).CONCLUSIONS: These data demonstrate that MEDI0457 can generate durable HPV16/18 antigen-specific peripheral and tumor immune responses.,30242022_8,-1,-1,-1,-1,35670,-1,0.39737225,0.59993225,0.00269553
35681,the T helper cells type,4,9,26,49,OBJECTIVE: To investigate the T helper cells type 1 (Th1) /Th2/Th17/Treg paradigms in peripheral blood of infertile PCOS compared with normal fertile women.,30246693_2,-1,-1,-1,-1,35681,-1,0.00015245988,0.9989453,0.0009022192
35683,blood,17,18,97,102,OBJECTIVE: To investigate the T helper cells type 1 (Th1) /Th2/Th17/Treg paradigms in peripheral blood of infertile PCOS compared with normal fertile women.,30246693_2,0,1,-1,-1,35683,-1,5.7841648e-05,0.99975353,0.00018857783
35684,blood,3,4,20,25,METHODS: Peripheral blood mononuclear cells (PBMCs) were isolated at the late follicular phase from 10 PCOS and 10 fertile women.,30246693_3,0,1,-1,-1,35684,-1,0.00026801325,0.9971885,0.0025434452
35695,cells subsets,40,42,223,236,"PBMCs were stimulated with PMA and ionomycin in the presence of Berefeldin A as Golgi stop agent to detect intracellular cytokine production (IFN-, IL-17, and IL-4) from CD3+CD4+T cells population indicating T helper (Th) cells subsets by flowcytometry.",30246693_4,-1,-1,-1,-1,35695,-1,3.5812172e-05,4.054407e-05,0.9999237
35699,that the,8,10,34,42,"RESULTS: In this study, we report that the frequency of Th1 cells was increased compared to Th2 cells in infertile PCOS when considering Th1/Th2 ratio (P=0.05).",30246693_6,-1,-1,-1,-1,35699,-1,1.739329e-05,0.999974,8.575532e-06
35701,to Th2 cells,17,20,89,101,"RESULTS: In this study, we report that the frequency of Th1 cells was increased compared to Th2 cells in infertile PCOS when considering Th1/Th2 ratio (P=0.05).",30246693_6,-1,-1,-1,-1,35701,-1,0.0029908859,0.19849505,0.7985141
35702,Analysis,0,1,0,8,Analysis of Th17/Th2 ratio showed a significant difference with a bias toward Th17 dominancy in PCOS (P=0.02).,30246693_7,0,1,-1,-1,35702,-1,2.8082048e-05,0.99994755,2.431205e-05
35703,toward Th17,11,13,71,82,Analysis of Th17/Th2 ratio showed a significant difference with a bias toward Th17 dominancy in PCOS (P=0.02).,30246693_7,-1,-1,-1,-1,35703,-1,3.8862345e-05,0.99994314,1.8010365e-05
35706,than that,14,16,94,103,"The proportion of CD4+CD25+Foxp3+ regulatory T cells was significantly lower in PCOS patients than that of healthy fertile women (P=0.02).CONCLUSION: In summary, Th1 and Th17 bias and reduction of Treg and Th2 cells as regulators of immune responses might be involved in the pathogenesis of PCOS.",30246693_8,-1,-1,-1,-1,35706,-1,2.3923569e-05,0.9999614,1.4648108e-05
35714,immune response to,7,10,43,61,"These results are suggestive of an altered immune response to inflammatory status in PCOS patients, likely causing some complications such as infertility in these patients.",30246693_9,-1,-1,-1,-1,35714,-1,0.7267064,0.26955613,0.003737526
35744,that the IL-10,3,6,17,31,We further found that the IL-10 expression level and the STAT3 activation level were significantly higher in MYD88 L265P mutant lymphomas than in MYD88 WT lymphomas.,30253331_5,-1,-1,-1,-1,35744,-1,0.4433689,0.5512156,0.0054154787
35745,the STAT3,9,11,53,62,We further found that the IL-10 expression level and the STAT3 activation level were significantly higher in MYD88 L265P mutant lymphomas than in MYD88 WT lymphomas.,30253331_5,-1,-1,-1,-1,35745,-1,2.2501396e-05,0.99996436,1.3108547e-05
35769,factor,39,40,232,238,"In this study, we demonstrated that breast cancer cells (BCCs) also expressed and secreted IL-35 and higher level of IL-35 in BCCs was closely associated with poor prognosis of patients and was an independent unfavorable prognostic factor for breast cancer.",30321288_3,0,1,-1,-1,35769,-1,0.0004952598,0.9993679,0.00013682684
35774,Tconv cells,18,20,132,143,Subsequent study revealed that BCC-derived IL-35 inhibited conventional T (Tconv) cell proliferation and further induced suppressed Tconv cells into IL-35-producing induced regulatory T (iTr35) cells.,30321288_4,-1,-1,-1,-1,35774,-1,0.003538465,0.6767828,0.31967875
35778,cytokine IL-10,9,11,68,82,"Furthermore, BCC-derived IL-35 promoted the secretion of inhibitory cytokine IL-10 and obviously decreased the secretion of Th1-type cytokine IFN- and Th17-type cytokine IL-17 in Tconv cells.",30321288_5,-1,-1,-1,-1,35778,-1,0.99985254,3.8156642e-05,0.00010934455
35780,Th1-type cytokine IFN-,17,20,124,147,"Furthermore, BCC-derived IL-35 promoted the secretion of inhibitory cytokine IL-10 and obviously decreased the secretion of Th1-type cytokine IFN- and Th17-type cytokine IL-17 in Tconv cells.",30321288_5,-1,-1,-1,-1,35780,-1,0.5656226,0.41573194,0.018645415
35781,Th17-type cytokine IL-17,21,24,152,176,"Furthermore, BCC-derived IL-35 promoted the secretion of inhibitory cytokine IL-10 and obviously decreased the secretion of Th1-type cytokine IFN- and Th17-type cytokine IL-17 in Tconv cells.",30321288_5,-1,-1,-1,-1,35781,-1,0.2842068,0.70709425,0.008698918
35782,Tconv cells,25,27,180,191,"Furthermore, BCC-derived IL-35 promoted the secretion of inhibitory cytokine IL-10 and obviously decreased the secretion of Th1-type cytokine IFN- and Th17-type cytokine IL-17 in Tconv cells.",30321288_5,-1,-1,-1,-1,35782,-1,0.0028943361,0.57438356,0.42272213
35784,receptor,6,7,40,48,"Meanwhile, the expression of inhibitory receptor CD73 was also elevated on the surface of Tconv cells following the BCCs' supernatant treatment.",30321288_6,0,1,2,-1,35784,-1,6.958898e-05,0.00013138575,0.9997991
35786,Tconv cells,15,17,90,101,"Meanwhile, the expression of inhibitory receptor CD73 was also elevated on the surface of Tconv cells following the BCCs' supernatant treatment.",30321288_6,-1,-1,-1,-1,35786,-1,0.0031275128,0.70126665,0.29560584
35789,Tconv cells,5,7,45,56,"Mechanistically, BCC-derived IL-35 exhausted Tconv cells and induced iTr35 by activating transcription factor STAT1/STAT3.",30321288_7,-1,-1,-1,-1,35789,-1,0.003496446,0.68430424,0.31219932
35791,functions,5,6,28,37,"Hence, our results indicate functions of BCC-derived IL-35 in promoting tumor progression through proliferation inhibition of tumor-infiltrating Tconv cells and induction of iTr35 cells in tumor microenvironment.",30321288_8,0,1,2,-1,35791,-1,3.254329e-05,0.9999502,1.7327178e-05
35794,tumor-infiltrating Tconv cells,17,20,126,156,"Hence, our results indicate functions of BCC-derived IL-35 in promoting tumor progression through proliferation inhibition of tumor-infiltrating Tconv cells and induction of iTr35 cells in tumor microenvironment.",30321288_8,-1,-1,-1,-1,35794,-1,0.0027059342,0.92931247,0.06798165
35799,therapeutic target,11,13,66,84,This study highlights that IL-35 produced by BCCs are a potential therapeutic target for breast cancer.,30321288_9,-1,-1,-1,-1,35799,-1,2.2587355e-05,0.9999664,1.1024566e-05
35803,to the,12,14,81,87,Regulatory T cells (Tregs) mediate immunosuppressive signals that can contribute to the progression of head and neck squamous cell carcinoma (HNSCC).,30357458_0,-1,-1,-1,-1,35803,-1,2.6283327e-05,0.9999616,1.2093611e-05
35806,factor that,14,16,65,76,"Interleukin-33 (IL-33) is defined as an 'alarmin', an endogenous factor that is expressed during tissue and cell damage, which has been shown to promote Treg proliferation in non-lymphoid organs.",30357458_1,-1,-1,-1,-1,35806,-1,0.00013918173,0.99982375,3.7047175e-05
35807,tissue,19,20,97,103,"Interleukin-33 (IL-33) is defined as an 'alarmin', an endogenous factor that is expressed during tissue and cell damage, which has been shown to promote Treg proliferation in non-lymphoid organs.",30357458_1,-1,1,2,-1,35807,-1,4.663385e-05,0.9998977,5.569521e-05
35819,functional analysis,24,26,134,153,"In this study, we examined IL-33+ and Foxp3+ cells by immunohistochemistry in 68 laryngeal squamous cell cancer patients, followed by functional analysis of IL-33 in Tregs.",30357458_3,-1,-1,-1,-1,35819,-1,3.5924957e-05,0.9999399,2.4152432e-05
35822,function,5,6,29,37,"In addition, the suppressive function of Tregs was assessed by cell proliferation assays.",30357458_4,0,1,2,-1,35822,-1,5.860183e-05,0.99989283,4.860315e-05
35829,receptor,6,7,28,36,ST2 is regarded as the only receptor of IL-33.,30357458_6,0,1,2,-1,35829,-1,0.0029578246,0.5875063,0.40953588
35834,Functional,0,1,0,10,Functional investigation demonstrated that IL-33 increased the proportion of Foxp3+GATA3+ Tregs and improved the suppressive functions of Tregs by inducing IL-10 and TGF-1 as well as decreasing the proliferation of responder T cells.,30357458_8,0,1,2,-1,35834,-1,3.0145084e-05,0.99995315,1.6703085e-05
35840,functions,16,17,125,134,Functional investigation demonstrated that IL-33 increased the proportion of Foxp3+GATA3+ Tregs and improved the suppressive functions of Tregs by inducing IL-10 and TGF-1 as well as decreasing the proliferation of responder T cells.,30357458_8,0,1,2,-1,35840,-1,0.00011334895,0.99973935,0.00014734859
35848,the Treg,8,10,53,61,Our data demonstrate that stromal IL-33 both expands the Treg population and enhances their functions in the tumor microenvironment.,30357458_10,-1,-1,-1,-1,35848,-1,2.630163e-05,0.9999559,1.7862087e-05
35849,their functions,13,15,86,101,Our data demonstrate that stromal IL-33 both expands the Treg population and enhances their functions in the tumor microenvironment.,30357458_10,-1,-1,-1,-1,35849,-1,7.734674e-05,0.9998822,4.0396386e-05
35850,the tumor,16,18,105,114,Our data demonstrate that stromal IL-33 both expands the Treg population and enhances their functions in the tumor microenvironment.,30357458_10,-1,-1,-1,-1,35850,-1,1.8654244e-05,0.9999721,9.209095e-06
35855,to the,14,16,86,92,BACKGROUND: The prognosis of pancreatic ductal adenocarcinoma (PDAC) remains poor due to the difficulty of disease diagnosis and therapy.,30359281_0,-1,-1,-1,-1,35855,-1,2.7861715e-05,0.99996316,9.027449e-06
35856,therapy,21,22,129,136,BACKGROUND: The prognosis of pancreatic ductal adenocarcinoma (PDAC) remains poor due to the difficulty of disease diagnosis and therapy.,30359281_0,0,1,-1,-1,35856,-1,3.4729743e-05,0.9999502,1.5112588e-05
35863,tumor tissues,22,24,106,119,"In this study, we aim to analyze the expression of CD8 and FoxP3 on T lymphocytes and TGF- expressionin tumor tissues, andthen analyze the possible clinical significance of these finding in order to find a novel effective immunotherapy target in PDAC using a murine model.",30359281_2,-1,-1,-1,-1,35863,-1,1.9774487e-05,0.9999653,1.4886619e-05
35869,tissue,3,4,11,17,METHODS: A tissue microarray using patient PDAC samples was stained and analyzed for associations with clinicopathological characteristics.,30359281_3,-1,1,2,-1,35869,-1,3.678515e-05,0.99987364,8.9569636e-05
35874,tumor tissues,13,15,63,76,"RESULTS: The infiltrating FoxP3+ regulatory T cells (Tregs) in tumor tissues were associated with survival, while CD8+ tumor infiltrating lymphocytes (TILs) were not.",30359281_5,-1,-1,-1,-1,35874,-1,2.8500754e-05,0.99992657,4.4973098e-05
35884,factor,8,9,54,60,IIR was further verified as an independent prognostic factor according to multivariate analysis as well as TGF- expression.,30359281_7,0,1,-1,-1,35884,-1,0.0003960402,0.99939704,0.00020694146
35886,analysis,12,13,87,95,IIR was further verified as an independent prognostic factor according to multivariate analysis as well as TGF- expression.,30359281_7,0,1,-1,-1,35886,-1,4.3777633e-05,0.9999293,2.6922819e-05
35894,therapy,2,3,17,24,This combination therapy significantly depleted periphery and intra-tumor FoxP3+ Tregs while increasing intra-tumor CD8+ TILs levels compared to controls or anti-TGF- monotherapy (p<0.05).,30359281_10,0,1,-1,-1,35894,-1,2.0442125e-05,0.99996734,1.2163333e-05
35916,cell transplantation,15,17,108,128,Graft-versus host disease (GVHD) remains the most significant complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT).,30445020_0,-1,-1,-1,-1,35916,-1,0.0032910162,0.06720107,0.9295079
35921,CD11c+CD80,3,4,14,24,We found that CD11c+CD80+ dendritic cells (DCs) were up-regulated but did not enhance GVHD.,30445020_3,-1,-1,-1,-1,35921,-1,0.00070449646,0.00033319037,0.9989623
35925,T cells that,9,12,46,58,Regulatory T cells (Tregs) and central memory T cells that express high levels of CD62L and CD44 had an expansion after Notch inhibition.,30445020_4,-1,-1,-1,-1,35925,-1,0.0014701613,0.030081514,0.9684484
35927,Factor-,3,4,23,31,"Reduced Tumor Necrosis Factor- and increased Interferon- production were found, which might be ascribed to the expansion of Tregs and central memory T cells, and result in increased sensitivity of tumor cells to cytotoxic T lymphocyte activity.",30445020_5,0,1,-1,-1,35927,-1,0.99981695,9.1057096e-05,9.201938e-05
35929,to the,15,17,106,112,"Reduced Tumor Necrosis Factor- and increased Interferon- production were found, which might be ascribed to the expansion of Tregs and central memory T cells, and result in increased sensitivity of tumor cells to cytotoxic T lymphocyte activity.",30445020_5,-1,-1,-1,-1,35929,-1,2.1807968e-05,0.99996865,9.589838e-06
35932,tumor cells to cytotoxic T lymphocyte,32,38,199,236,"Reduced Tumor Necrosis Factor- and increased Interferon- production were found, which might be ascribed to the expansion of Tregs and central memory T cells, and result in increased sensitivity of tumor cells to cytotoxic T lymphocyte activity.",30445020_5,-1,-1,-1,-1,35932,-1,0.0033663742,0.12516962,0.871464
35933,Receptor-Fas,1,2,4,16,Fas Receptor-Fas Ligand interaction plays a critical role in GVL instead of aGVHD.,30445020_6,0,1,2,-1,35933,-1,0.0019418156,0.97492176,0.023136478
35955,bloods,8,9,43,49,"CD4+ T cells were purified from peripheral bloods and bronchoalveolar lavage fluids (BALF), and were stimulated with -secretase inhibitor (GSI).",30473538_4,0,1,-1,-1,35955,-1,0.00011157428,0.9996687,0.00021972258
35956,to Notch receptors,2,5,19,37,mRNA corresponding to Notch receptors and transcriptional factors were measured by real-time PCR.,30473538_5,-1,-1,-1,-1,35956,-1,9.290142e-05,0.9997379,0.00016921792
35957,transcriptional factors,6,8,42,65,mRNA corresponding to Notch receptors and transcriptional factors were measured by real-time PCR.,30473538_5,-1,-1,-1,-1,35957,-1,2.9831066e-05,0.9999492,2.092053e-05
35964,bloods,14,15,91,97,Notch1 mRNA expression was significantly elevated in CD4+ T cells purified from peripheral bloods and tumor site BALF in lung adenocarcinoma patients.,30473538_8,0,1,-1,-1,35964,-1,0.00033545814,0.99798584,0.0016786988
35984,to the tumor,10,13,78,90,Prevention of intratumoral Treg accumulation by inhibition of their migration to the tumor microenvironment is a promising therapeutic strategy.,30572845_1,-1,-1,-1,-1,35984,-1,3.0310634e-05,0.9999559,1.378945e-05
35990,the two,11,13,50,57,The aim of this study was to identify the role of the two major Treg-attracting chemokines CCL1 and CCL22 in human breast cancer.,30572845_2,-1,-1,-1,-1,35990,-1,2.258188e-05,0.9999671,1.0376055e-05
35991,Treg-attracting chemokines CCL1,14,17,64,95,The aim of this study was to identify the role of the two major Treg-attracting chemokines CCL1 and CCL22 in human breast cancer.,30572845_2,-1,-1,-1,-1,35991,-1,0.0018479739,0.9390354,0.059116665
35993,tissue,5,6,33,39,METHODS: One hundred ninety-nine tissue samples of patients with invasive breast cancer were stained for CCL1 and CCL22 by immunohistochemistry.,30572845_3,-1,1,2,-1,35993,-1,6.465115e-05,0.9995105,0.0004248205
35999,the transcription factor FoxP3,14,18,95,125,"Chemokine expression and tumor infiltration by regulatory T cells, determined by expression of the transcription factor FoxP3, were quantified and their correlation to clinical features was statistically analyzed.",30572845_4,-1,-1,-1,-1,35999,-1,1.935447e-05,0.9999691,1.1519307e-05
36005,tissues,12,13,66,73,RESULTS: Both CCL1 and CCL22 were expressed in most breast cancer tissues.,30572845_5,-1,1,2,-1,36005,-1,0.0001776856,0.9957331,0.0040892144
36008,tissue,13,14,93,99,CCL1 was significantly over-expressed in invasive breast cancer as compared to normal breast tissue.,30572845_6,-1,1,2,-1,36008,-1,6.233636e-05,0.9995962,0.000341525
36012,tumor-infiltrating FoxP3,15,17,86,110,"CCL1, but surprisingly not CCL22, showed a significant correlation with the number of tumor-infiltrating FoxP3+ Treg (p<0.001).",30572845_7,-1,-1,-1,-1,36012,-1,3.5193094e-05,0.99994564,1.9114677e-05
36016,related to,8,10,56,66,High numbers of intratumoral CCL1 expressing cells were related to high grade tumors (G4) and a positive estrogen receptor (ER) status whereas high CCL22 expression was generally seen in lower grade tumors.,30572845_8,-1,-1,-1,-1,36016,-1,3.83743e-05,0.99993587,2.5779116e-05
36018,receptor,20,21,114,122,High numbers of intratumoral CCL1 expressing cells were related to high grade tumors (G4) and a positive estrogen receptor (ER) status whereas high CCL22 expression was generally seen in lower grade tumors.,30572845_8,0,1,2,-1,36018,-1,0.00017573494,0.99949586,0.00032844106
36028,this trend,29,31,152,162,"The median survival of 88 patients with high intratumoral CCL1 expression was 37months compared to 50months for the 87 patients with low CCL1 levels, this trend was however not statistically significant.",30572845_9,-1,-1,-1,-1,36028,-1,2.7495433e-05,0.9999589,1.36626995e-05
36039,therapeutic target,10,12,52,70,"Thus, CCL1 may serve as prognostic marker and novel therapeutic target in breast cancer.",30572845_12,-1,-1,-1,-1,36039,-1,2.7725691e-05,0.9999585,1.3780808e-05
36040,protein,4,5,39,46,"High mobility group nucleosome-binding protein 1 (HMGN1 or N1) is a Th1-polarizing alarmin, but alone is insufficient to induce antitumor immunity.",30619338_0,0,1,-1,-1,36040,-1,9.250191e-05,0.99961686,0.000290578
36043,immunity,23,24,138,146,"High mobility group nucleosome-binding protein 1 (HMGN1 or N1) is a Th1-polarizing alarmin, but alone is insufficient to induce antitumor immunity.",30619338_0,0,-1,2,-1,36043,-1,0.99899274,0.00074400683,0.00026327407
36047,immunity,26,27,164,172,"We previously showed that combination of N1 and R848, a synthetic TLR7/8 agonist, synergistically activates dendritic cells (DCs) and induces therapeutic antitumor immunity, however, it remained unclear how N1 and R848 synergistically activate DCs.",30619338_1,0,-1,2,-1,36047,-1,0.9961947,0.0033911986,0.00041411948
36053,TNF-,47,48,262,267,"Here, we show that co-stimulation with N1 and R848 of human monocyte-derived DCs (MoDCs) markedly upregulated DC's surface expression of CD80, CD83, CD86, and HLA-DR, as well as synergistic production of pro-inflammatory cytokines including IL-12p70, IL-1, and TNF-.",30619338_2,0,1,-1,-1,36053,-1,0.00013146066,0.9998273,4.1246727e-05
36068,analysis,1,2,8,16,"RNA-seq analysis in human MoDCs revealed that N1 plus R848 synergistically upregulated the expression of genes predominantly involved in DC maturation pathway, particularly genes critical for the polarization of Th1 immune responses (e.g., IL12A, IL12B, and IFNB1, etc.).",30619338_6,0,1,-1,-1,36068,-1,2.6367614e-05,0.99994946,2.4209809e-05
36075,Th1 immune responses,30,33,212,232,"RNA-seq analysis in human MoDCs revealed that N1 plus R848 synergistically upregulated the expression of genes predominantly involved in DC maturation pathway, particularly genes critical for the polarization of Th1 immune responses (e.g., IL12A, IL12B, and IFNB1, etc.).",30619338_6,-1,-1,-1,-1,36075,-1,0.20985752,0.7841564,0.005986071
36082,transcriptional factors,38,40,214,237,"Overall, our findings show that (1) N1 synergizes with R848 in activating human and mouse DCs and (2) the synergistic effect based on various intracellular signaling events culminated in the activation of multiple transcriptional factors.",30619338_7,-1,-1,-1,-1,36082,-1,3.1785796e-05,0.99993527,3.295613e-05
36088,Interleukin-32,0,1,0,14,Interleukin-32 (IL-32) was originally identified in natural killer (NK) cells activated by IL-2 in 1992.,30638183_0,0,-1,2,-1,36088,-1,0.00042474005,0.00044737765,0.9991279
36094,cell transcript,6,8,22,37,"Thus, it was named NK cell transcript 4 (NK4) because of its unknown function at that time.",30638183_1,-1,-1,-1,-1,36094,-1,0.0008564437,0.019787863,0.97935563
36095,function,16,17,69,77,"Thus, it was named NK cell transcript 4 (NK4) because of its unknown function at that time.",30638183_1,0,1,2,-1,36095,-1,0.0001719642,0.99976164,6.634819e-05
36096,that time,18,20,81,90,"Thus, it was named NK cell transcript 4 (NK4) because of its unknown function at that time.",30638183_1,-1,-1,-1,-1,36096,-1,3.5981717e-05,0.99994326,2.0752674e-05
36097,The function,0,2,0,12,The function of IL-32 has been elucidated over the last decade.,30638183_2,-1,-1,-1,-1,36097,-1,2.4884133e-05,0.99996185,1.3218939e-05
36104,those cytokines,23,25,156,171,IL-32 is primarily considered to be a booster of inflammatory reactions because it is induced by proinflammatory cytokines and stimulates the production of those cytokines and vice versa.,30638183_3,-1,-1,-1,-1,36104,-1,0.571327,0.41644493,0.012228097
36112,IL-32 fosters the tumor,2,6,14,37,"Collectively, IL-32 fosters the tumor progression by nuclear factor-B (NF-B)-mediated cytokines and metalloproteinase production, as well as stimulation of differentiation into immunosuppressive cell types in some cancer types.",30638183_6,-1,-1,-1,-1,36112,-1,0.034872796,0.30981004,0.6553171
36114,cell types,24,26,197,207,"Collectively, IL-32 fosters the tumor progression by nuclear factor-B (NF-B)-mediated cytokines and metalloproteinase production, as well as stimulation of differentiation into immunosuppressive cell types in some cancer types.",30638183_6,-1,-1,-1,-1,36114,-1,5.0476454e-05,7.992184e-05,0.9998696
36117,tumor cell,8,10,35,45,"However, it is also able to induce tumor cell apoptosis and enhance NK and cytotoxic T cell sensitivity in other cancer types.",30638183_7,-1,-1,-1,-1,36117,-1,0.001158481,0.017257703,0.9815839
36121,the function,7,9,32,44,"In this review, we will address the function of each IL-32 isoform in different cancer types studied to date, and suggest further strategies to comprehensively elucidate the roles of IL-32 in a contextdependent manner. [BMB Reports 2019; 52(3): 165-174].",30638183_8,-1,-1,-1,-1,36121,-1,2.336377e-05,0.9999635,1.316303e-05
36130,protein,10,11,60,67,"The IRE1/XBP1s signaling pathway is an arm of the unfolded protein response (UPR) that safeguards the fidelity of the cellular proteome during endoplasmic reticulum (ER) stress, and that has also emerged as a key regulator of dendritic cell (DC) homeostasis.",30687308_0,0,1,-1,-1,36130,-1,0.0006192112,0.99924195,0.0001388631
36133,the cellular,20,22,115,127,"The IRE1/XBP1s signaling pathway is an arm of the unfolded protein response (UPR) that safeguards the fidelity of the cellular proteome during endoplasmic reticulum (ER) stress, and that has also emerged as a key regulator of dendritic cell (DC) homeostasis.",30687308_0,-1,-1,-1,-1,36133,-1,0.0028150326,0.830864,0.166321
36137,the regulation,9,11,42,56,"However, in the context of DC activation, the regulation of the IRE1/XBP1s axis is not fully understood.",30687308_1,-1,-1,-1,-1,36137,-1,2.2146178e-05,0.99996877,9.116943e-06
36140,that cell,6,8,24,33,"In this work, we report that cell lysates generated from melanoma cell lines markedly induce XBP1s and certain members of the UPR such as the chaperone BiP in bone marrow derived DCs (BMDCs).",30687308_2,-1,-1,-1,-1,36140,-1,0.0036836585,0.59071285,0.40560347
36155,tumor antigens,24,26,158,172,"Altogether, this work provides evidence indicating that ex-vivo activation of the IRE1/XBP1 pathway in BMDCs enhances CD8+ T cell specific responses against tumor antigens.",30687308_4,-1,-1,-1,-1,36155,-1,0.21845877,0.7753847,0.006156527
36158,T subset,7,9,31,39,V9V2 T cells are the main  T subset in the peripheral blood and lymphoid organs.,30708194_0,-1,-1,-1,-1,36158,-1,9.0306174e-05,0.0003123618,0.9995974
36160,blood,12,13,58,63,V9V2 T cells are the main  T subset in the peripheral blood and lymphoid organs.,30708194_0,0,1,-1,-1,36160,-1,0.0002546369,0.99756444,0.0021809943
36164,functions,20,21,125,134,Previous studies have shown that V9V2 T cells could expand in the presence of phosphoantigens and IL-2 and exert antitumor functions.,30708194_1,0,1,2,-1,36164,-1,0.0003835604,0.9991893,0.00042717555
36170,T cells to,11,14,64,74,"In this study, we examined the proliferative response of V9V2 T cells to IL-21, a cytokine previously shown to promote NK cell and CD8 T cell cytotoxicity.",30708194_3,-1,-1,-1,-1,36170,-1,0.0015501908,0.03631676,0.96213305
36192,the STAT,6,8,47,55,Blocking Tim-3 increased the proliferation and the STAT phosphorylation in V9V2 T cells in response to IL-21.,30708194_10,-1,-1,-1,-1,36192,-1,2.2829863e-05,0.99996734,9.856492e-06
36203,lifespan,17,18,115,123,"Despite having favorable prognosis, patients with differentiated thyroid carcinoma (DTC) still suffer from reduced lifespan due to recurrences, metastasis, and dedifferentiation.",30711567_0,0,-1,2,-1,36203,-1,6.4202875e-05,0.9999169,1.8891333e-05
36206,to the,8,10,40,46,"Regulatory B (Breg) cells are essential to the maintenance of peripheral tolerance, but upregulated Breg response may impede the clearance of pathogens and tumor cells.",30711567_1,-1,-1,-1,-1,36206,-1,2.969773e-05,0.99995947,1.0859482e-05
36209,tumor cells,26,28,156,167,"Regulatory B (Breg) cells are essential to the maintenance of peripheral tolerance, but upregulated Breg response may impede the clearance of pathogens and tumor cells.",30711567_1,-1,-1,-1,-1,36209,-1,0.005015797,0.49459788,0.5003863
36227,IL-10 than the,11,14,68,82,"Moreover, each IL-10-producing B cell in DTC patients produced more IL-10 than the counterparts in healthy controls.",30711567_5,-1,-1,-1,-1,36227,-1,0.97648126,0.017607097,0.00591166
36228,This IL-10,0,2,0,10,This IL-10+ subset was enriched in the CD27+ fraction.,30711567_6,-1,-1,-1,-1,36228,-1,0.7579676,0.23782903,0.0042033135
36252,the two,24,26,153,160,"Unstimulated CD27+ B cells presented low STAT3 and Erk phosphorylation in both healthy controls and DTC patients, with no significant difference between the two groups.",30711567_12,-1,-1,-1,-1,36252,-1,2.9702182e-05,0.99995863,1.1637678e-05
36255,cell-mediated IL-10,7,9,36,55,"Overall, this study suggests that B cell-mediated IL-10 production can exert complex effects toward autologous T cells.",30711567_13,-1,-1,-1,-1,36255,-1,0.29475158,0.0034335647,0.7018149
36260,Th9 cells,2,4,15,24,Tumor specific Th9 cells are potential effector cells for adoptive therapy of human cancers.,30717817_0,-1,-1,-1,-1,36260,-1,6.186782e-05,0.00011802508,0.9998202
36262,therapy,10,11,67,74,Tumor specific Th9 cells are potential effector cells for adoptive therapy of human cancers.,30717817_0,0,1,-1,-1,36262,-1,2.8073746e-05,0.99995613,1.5771075e-05
36263,TNF,0,1,0,3,"TNF family members OX40L, TL1A and GITRL have been shown to promote the induction of Th9 cells and antitumor immunity.",30717817_1,0,1,-1,-1,36263,-1,5.6407047e-05,0.9999194,2.4163965e-05
36268,Th9 cells,16,18,85,94,"TNF family members OX40L, TL1A and GITRL have been shown to promote the induction of Th9 cells and antitumor immunity.",30717817_1,-1,-1,-1,-1,36268,-1,8.487581e-05,0.00014808805,0.999767
36269,immunity,20,21,109,117,"TNF family members OX40L, TL1A and GITRL have been shown to promote the induction of Th9 cells and antitumor immunity.",30717817_1,0,-1,2,-1,36269,-1,0.9992454,0.00043884103,0.00031573194
36271,TNF-,5,6,21,26,"However, the role of TNF-, the prototype of the TNF superfamily cytokines, in Th9 cell differentiation and their antitumor efficacy is not defined.",30717817_2,0,1,-1,-1,36271,-1,5.876742e-05,0.9999174,2.3808625e-05
36273,the TNF superfamily cytokines,10,14,45,74,"However, the role of TNF-, the prototype of the TNF superfamily cytokines, in Th9 cell differentiation and their antitumor efficacy is not defined.",30717817_2,-1,-1,-1,-1,36273,-1,0.03125706,0.9669055,0.0018374942
36274,Th9 cell,16,18,79,87,"However, the role of TNF-, the prototype of the TNF superfamily cytokines, in Th9 cell differentiation and their antitumor efficacy is not defined.",30717817_2,-1,-1,-1,-1,36274,-1,6.825363e-05,0.00014682366,0.9997849
36276,that TNF-,4,6,16,26,"Here, we showed that TNF- potently promoted nave CD4+ T cells to differentiate into Th9 cells in vitro.",30717817_3,-1,-1,-1,-1,36276,-1,3.465192e-05,0.9999528,1.2554033e-05
36277,T cells to,11,14,56,66,"Here, we showed that TNF- potently promoted nave CD4+ T cells to differentiate into Th9 cells in vitro.",30717817_3,-1,-1,-1,-1,36277,-1,0.0014463572,0.02737216,0.97118145
36278,Th9 cells,16,18,86,95,"Here, we showed that TNF- potently promoted nave CD4+ T cells to differentiate into Th9 cells in vitro.",30717817_3,-1,-1,-1,-1,36278,-1,0.00014304019,0.00045975356,0.99939716
36280,TNF-,5,6,29,34,"Furthermore, the addition of TNF- during Th9 cell differentiation increased T cell survival and proliferation.",30717817_4,0,1,-1,-1,36280,-1,7.9578196e-05,0.9998883,3.2083364e-05
36281,Th9 cell,7,9,42,50,"Furthermore, the addition of TNF- during Th9 cell differentiation increased T cell survival and proliferation.",30717817_4,-1,-1,-1,-1,36281,-1,5.7469715e-05,0.00012159542,0.999821
36285,TNF--treated Th9 cells,7,10,43,66,"More importantly, the adoptive transfer of TNF--treated Th9 cells induced more potent antitumor effects than regular Th9 cells in mouse tumor model.",30717817_5,-1,-1,-1,-1,36285,-1,0.0030360294,0.86534554,0.13161841
36287,Th9 cells,17,19,118,127,"More importantly, the adoptive transfer of TNF--treated Th9 cells induced more potent antitumor effects than regular Th9 cells in mouse tumor model.",30717817_5,-1,-1,-1,-1,36287,-1,4.563667e-05,7.20557e-05,0.9998822
36289,TNF-,0,1,0,5,"TNF- signals via two cell surface receptors, TNFR1 and TNFR2.",30717817_6,0,1,-1,-1,36289,-1,0.00012353856,0.999846,3.0429317e-05
36290,two cell,3,5,18,26,"TNF- signals via two cell surface receptors, TNFR1 and TNFR2.",30717817_6,-1,-1,-1,-1,36290,-1,0.006063857,0.3707214,0.6232147
36291,receptors,6,7,35,44,"TNF- signals via two cell surface receptors, TNFR1 and TNFR2.",30717817_6,0,1,2,-1,36291,-1,0.00013829785,0.00021350017,0.9996481
36292,TNFR1,8,9,46,51,"TNF- signals via two cell surface receptors, TNFR1 and TNFR2.",30717817_6,0,1,-1,-1,36292,-1,6.235966e-05,0.99986005,7.7610275e-05
36293,TNFR2,10,11,56,61,"TNF- signals via two cell surface receptors, TNFR1 and TNFR2.",30717817_6,0,1,-1,-1,36293,-1,7.365487e-05,0.9998938,3.2587977e-05
36294,that TNF-,3,5,29,39,Mechanistic studies revealed that TNF- drove Th9 cell differentiation through TNFR2 but not TNFR1.,30717817_7,-1,-1,-1,-1,36294,-1,5.4518652e-05,0.99992585,1.9589332e-05
36295,Th9 cell,6,8,46,54,Mechanistic studies revealed that TNF- drove Th9 cell differentiation through TNFR2 but not TNFR1.,30717817_7,-1,-1,-1,-1,36295,-1,5.9833525e-05,0.00013067348,0.99980956
36296,through TNFR2,9,11,71,84,Mechanistic studies revealed that TNF- drove Th9 cell differentiation through TNFR2 but not TNFR1.,30717817_7,-1,-1,-1,-1,36296,-1,4.4778782e-05,0.99993,2.5209814e-05
36297,TNFR1,13,14,93,98,Mechanistic studies revealed that TNF- drove Th9 cell differentiation through TNFR2 but not TNFR1.,30717817_7,0,1,-1,-1,36297,-1,3.7393685e-05,0.99991333,4.923386e-05
36299,TNF-,8,9,45,50,"In addition, under Th9 polarizing condition, TNF- activated STAT5 and NF-B pathways in T cells in a TNFR2-dependent manner.",30717817_8,0,1,-1,-1,36299,-1,5.086948e-05,0.9999287,2.0411413e-05
36302,TNFR2-dependent,19,20,102,117,"In addition, under Th9 polarizing condition, TNF- activated STAT5 and NF-B pathways in T cells in a TNFR2-dependent manner.",30717817_8,0,1,-1,-1,36302,-1,4.313375e-05,0.99991596,4.0865914e-05
36305,TNF--induced Th9 cell,11,14,77,99,Inhibition of STAT5 and NF-B pathways by their specific inhibitors impaired TNF--induced Th9 cell differentiation.,30717817_9,-1,-1,-1,-1,36305,-1,0.0040130154,0.8524081,0.14357881
36306,TNF-,3,4,23,28,Our results identified TNF- as a new powerful inducer of Th9 cells and clarified the molecular mechanisms underlying TNF--induced Th9 cell differentiation.,30717817_10,0,1,-1,-1,36306,-1,3.743409e-05,0.999949,1.3552157e-05
36307,Th9 cells,10,12,58,67,Our results identified TNF- as a new powerful inducer of Th9 cells and clarified the molecular mechanisms underlying TNF--induced Th9 cell differentiation.,30717817_10,-1,-1,-1,-1,36307,-1,0.00018620296,0.0009247366,0.998889
36309,TNF--induced Th9 cell,18,21,118,140,Our results identified TNF- as a new powerful inducer of Th9 cells and clarified the molecular mechanisms underlying TNF--induced Th9 cell differentiation.,30717817_10,-1,-1,-1,-1,36309,-1,0.0032337396,0.87664783,0.12011848
36317,tumor types,48,50,299,310,"However, resistance to PARP inhibitors may preexist or evolve during treatment in many cancer types and may be overcome by combining PARP inhibitors with other therapies, such as immune checkpoint inhibitors, which confer durable responses and are rapidly becoming the standard of care for multiple tumor types.",30755715_1,-1,-1,-1,-1,36317,-1,2.790226e-05,0.9999496,2.248161e-05
36319,the therapeutic,3,5,24,39,"This study investigated the therapeutic potential of combining niraparib, a highly selective PARP1/2 inhibitor, with anti-PD-1 immune checkpoint inhibitors in preclinical tumor models.",30755715_2,-1,-1,-1,-1,36319,-1,1.8850298e-05,0.9999721,9.099184e-06
36324,the type,10,12,72,80,Our results indicate that niraparib treatment increases the activity of the type I (alpha) and type II (gamma) interferon pathways and enhances the infiltration of CD8+ cells and CD4+ cells in tumors.,30755715_3,-1,-1,-1,-1,36324,-1,2.200362e-05,0.99996626,1.1730832e-05
36336,tumor cell,18,20,127,137,"Interestingly, mice with tumors cured by niraparib monotherapy completely rejected tumor growth upon rechallenge with the same tumor cell line, suggesting the potential establishment of immune memory in animals treated with niraparib monotherapy.",30755715_5,-1,-1,-1,-1,36336,-1,0.0039595696,0.51005304,0.4859874
36339,Taken together,0,2,0,14,"Taken together, our findings uncovered immunomodulatory effects of niraparib that may sensitize tumors to immune checkpoint blockade therapies.",30755715_6,-1,-1,-1,-1,36339,-1,4.5476605e-05,0.99993837,1.6185088e-05
36341,tumors to,13,15,96,105,"Taken together, our findings uncovered immunomodulatory effects of niraparib that may sensitize tumors to immune checkpoint blockade therapies.",30755715_6,-1,-1,-1,-1,36341,-1,2.059243e-05,0.9999708,8.651677e-06
36347,T-helper cells that,13,16,53,72,IL-9-producing CD4+ (Th9) cells are a subset of CD4+ T-helper cells that are endowed with powerful antitumor capacity.,30914642_0,-1,-1,-1,-1,36347,-1,0.00022938258,0.9988944,0.0008762611
36350,Th9 cell-priming,11,13,63,79,Both IL-4 and TGF- have been reported to be indispensable for Th9 cell-priming and differentiation.,30914642_1,-1,-1,-1,-1,36350,-1,8.071562e-05,0.00013275114,0.99978656
36351,that Th9 cell,7,10,27,40,"Here we show, by contrast, that Th9 cell development can occur in the absence of TGF- signaling.",30914642_2,-1,-1,-1,-1,36351,-1,0.0029770874,0.24413651,0.7528864
36358,IL-9-producing T cells,15,18,89,111,"When TGF- was replaced by IL-1, the combination of IL-1 and IL-4 efficiently promoted IL-9-producing T cells (Th9IL-4+IL-1).",30914642_3,-1,-1,-1,-1,36358,-1,0.4259297,0.002845638,0.57122463
36361,IL-1 cells,2,4,9,20,"Th9IL-4+ IL-1 cells are phenotypically distinct T cells compared to classic Th9 cells (Th9IL-4+TGF-) and other Th cells, and are enriched for IL-1 and NF-B gene signatures.",30914642_4,-1,-1,-1,-1,36361,-1,0.7307713,0.0018307504,0.2673979
36364,Th9 cells,12,14,77,86,"Th9IL-4+ IL-1 cells are phenotypically distinct T cells compared to classic Th9 cells (Th9IL-4+TGF-) and other Th cells, and are enriched for IL-1 and NF-B gene signatures.",30914642_4,-1,-1,-1,-1,36364,-1,5.544591e-05,0.00010796108,0.99983656
36366,Th cells,19,21,113,121,"Th9IL-4+ IL-1 cells are phenotypically distinct T cells compared to classic Th9 cells (Th9IL-4+TGF-) and other Th cells, and are enriched for IL-1 and NF-B gene signatures.",30914642_4,-1,-1,-1,-1,36366,-1,3.131095e-05,4.1937612e-05,0.9999267
36371,Th9IL-4+IL-1 cells,10,12,71,90,Inhibition of NF-B but not TGF--signaling negates IL-9 production by Th9IL-4+IL-1 cells.,30914642_5,-1,-1,-1,-1,36371,-1,0.010663423,0.36858314,0.62075347
36372,Th9IL-4+TGF- cells,6,8,40,59,"Furthermore, when compared with classic Th9IL-4+TGF- cells, Th9IL-4+IL-1 cells are less exhausted, exhibit cytotoxic T effector gene signature and tumor killing function, and exert a superior antitumor response in a mouse melanoma model.",30914642_6,-1,-1,-1,-1,36372,-1,0.00302018,0.827441,0.1695389
36373,Th9IL-4+IL-1 cells,9,11,61,80,"Furthermore, when compared with classic Th9IL-4+TGF- cells, Th9IL-4+IL-1 cells are less exhausted, exhibit cytotoxic T effector gene signature and tumor killing function, and exert a superior antitumor response in a mouse melanoma model.",30914642_6,-1,-1,-1,-1,36373,-1,0.0094086565,0.3485066,0.6420847
36377,function,24,25,163,171,"Furthermore, when compared with classic Th9IL-4+TGF- cells, Th9IL-4+IL-1 cells are less exhausted, exhibit cytotoxic T effector gene signature and tumor killing function, and exert a superior antitumor response in a mouse melanoma model.",30914642_6,0,1,2,-1,36377,-1,0.00035473143,0.99931204,0.00033321805
36379,Th9 cell,8,10,52,60,Our study thus describes an alternative pathway for Th9 cell differentiation and provides a potential avenue for antitumor therapies.,30914642_7,-1,-1,-1,-1,36379,-1,6.075248e-05,0.00011808992,0.9998211
36399,Th17 cells,36,38,181,191,"The aim of this study was to investigate the frequency of circulating CD4+CD25-Foxp3+ Treg cells and their role in NSCLC. Methods: The frequencies of Treg, T helper (Th)1, Th2, and Th17 cells in peripheral blood were separately measured in 36 NSCLC patients and 20 healthy controls (HCs) using flow cytometry.",30925076_2,-1,-1,-1,-1,36399,-1,0.0012875127,0.030194877,0.9685176
36400,blood,40,41,206,211,"The aim of this study was to investigate the frequency of circulating CD4+CD25-Foxp3+ Treg cells and their role in NSCLC. Methods: The frequencies of Treg, T helper (Th)1, Th2, and Th17 cells in peripheral blood were separately measured in 36 NSCLC patients and 20 healthy controls (HCs) using flow cytometry.",30925076_2,0,1,-1,-1,36400,-1,0.00014626354,0.9978904,0.0019633817
36417,the tumor,12,14,68,77,The drivers and the specification of CD4+ T cell differentiation in the tumor microenvironment and their contributions to tumor immunity or tolerance are incompletely understood.,30926808_0,-1,-1,-1,-1,36417,-1,2.4009358e-05,0.9999665,9.468913e-06
36419,to tumor immunity,18,21,119,136,The drivers and the specification of CD4+ T cell differentiation in the tumor microenvironment and their contributions to tumor immunity or tolerance are incompletely understood.,30926808_0,-1,-1,-1,-1,36419,-1,0.009919782,0.9897227,0.00035750607
36427,FoxP3neg tumor-promoting IL-10+IL-17+IFN+,16,19,91,133,"Specifically, CD11b+CD103- DC predominate in PDA, express high IL-23 and TGF-, and induce FoxP3neg tumor-promoting IL-10+IL-17+IFN+regulatory CD4+ T cells.",30926808_2,-1,-1,-1,-1,36427,-1,0.008518634,0.99080515,0.0006762747
36434,receptor,18,19,112,120,The balance between this distinctive TH program and canonical FoxP3+TREGS is unaffected by pattern recognition receptor ligation and is modulated by DC expression of retinoic acid.,30926808_3,0,1,2,-1,36434,-1,0.00076620764,0.0015546809,0.9976792
36435,This TH-signature,0,2,0,17,This TH-signature is mimicked in human PDA where it is associated with immune-tolerance and diminished patient survival.,30926808_4,-1,-1,-1,-1,36435,-1,2.5893094e-05,0.9999615,1.266533e-05
36437,CD4+ T cell tolerance,7,12,46,67,Our data suggest that CD11b+CD103- DC promote CD4+ T cell tolerance in PDA which may underscore its resistance to immunotherapy.,30926808_5,-1,-1,-1,-1,36437,-1,0.0013975597,0.008863991,0.9897385
36445,the tumor,32,34,215,224,"Here, we examined the association of programmed cell death ligand 1 (PD-L1) expression with epithelial-mesenchymal transition (EMT)-associated markers in pancreatic ductal adenocarcinoma (PDA) within the context of the tumor microenvironment.",30927618_1,-1,-1,-1,-1,36445,-1,1.9075627e-05,0.9999721,8.790816e-06
36451,them to,17,19,135,142,"RESULTS: Immunohistochemistry revealed a significant correlation between vimentin and PD-L1 expression, whereas double staining showed them to be simultaneously expressed by PDA cells.",30927618_4,-1,-1,-1,-1,36451,-1,2.4058982e-05,0.9999646,1.139687e-05
36457,tumor cells,1,3,4,15,"PDA tumor cells promoted PD-L1 expression and EMT under the presence of IFN-, which was inhibited by the signal transducer and activator of transcription (STAT)1 small interfering RNA.CONCLUSIONS: Strong correlations were observed between PD-L1 expression, EMT, and the immunosuppressive tumor microenvironment.",30927618_6,-1,-1,-1,-1,36457,-1,0.0020494724,0.12676278,0.8711878
36460,the signal transducer and activator of transcription,18,25,102,154,"PDA tumor cells promoted PD-L1 expression and EMT under the presence of IFN-, which was inhibited by the signal transducer and activator of transcription (STAT)1 small interfering RNA.CONCLUSIONS: Strong correlations were observed between PD-L1 expression, EMT, and the immunosuppressive tumor microenvironment.",30927618_6,-1,-1,-1,-1,36460,-1,2.3990371e-05,0.99996316,1.2886633e-05
36463,Targeting STAT1,0,2,0,15,Targeting STAT1 combined with PD-1/PD-L1 immunotherapy may improve outcomes for patients with PDA.,30927618_7,-1,-1,-1,-1,36463,-1,2.3426439e-05,0.99995947,1.7076318e-05
36471,tissues,12,13,73,80,Tregs are decisive not only in the protection against destruction of own tissues by autoimmune immunocompetent cells but also in the immunological answer to developing cancers.,30944830_1,-1,1,2,-1,36471,-1,0.00026752,0.99801093,0.0017215399
36481,blood,7,8,57,62,The percentage of regulatory T-lymphocytes in peripheral blood and bone marrow was elevated compared to those in healthy individuals and correlated with progressive disease.,30944830_4,0,1,-1,-1,36481,-1,0.00011019776,0.99912256,0.0007671951
36482,to those,14,16,101,109,The percentage of regulatory T-lymphocytes in peripheral blood and bone marrow was elevated compared to those in healthy individuals and correlated with progressive disease.,30944830_4,-1,-1,-1,-1,36482,-1,2.2004824e-05,0.9999666,1.1347223e-05
36483,Regulatory T-cells taken,0,3,0,24,"Regulatory T-cells taken from children diagnosed with leukemia showed a higher suppressive capability, which was confirmed by detecting elevated levels of secreted IL-10 and TGF-beta.",30944830_5,-1,-1,-1,-1,36483,-1,0.000985947,0.069159165,0.9298548
36485,TGF-beta,25,26,174,182,"Regulatory T-cells taken from children diagnosed with leukemia showed a higher suppressive capability, which was confirmed by detecting elevated levels of secreted IL-10 and TGF-beta.",30944830_5,0,1,-1,-1,36485,-1,4.5936744e-05,0.9999349,1.9126031e-05
36490,targeted therapies,10,12,48,66,"Presumably, Treg cells could be a vital part of targeted therapies.",30944830_7,-1,-1,-1,-1,36490,-1,3.0089122e-05,0.9999558,1.4186648e-05
36498,blood,18,19,107,112,"This proposition results from the fact that in some studies, higher percentage of Treg cells in peripheral blood was demonstrated.",30944830_9,0,1,-1,-1,36498,-1,0.00053157343,0.95427895,0.045189478
36501,them to the,12,15,77,88,"However, observations confirming these facts are scarce; thus, extrapolating them to the population of children with hematological malignancies needs to be verified in additional studies.",30944830_10,-1,-1,-1,-1,36501,-1,2.2904049e-05,0.9999672,9.83346e-06
36509,two subsets,17,19,107,118,"We comprehensively characterized myeloid cells in tumor draining lymph nodes (tdLN) of mice and identified two subsets of conventional type-2 dendritic cells (cDC2) that traffic from tumor to tdLN and present tumor-derived antigens to CD4+ Tconv, but then fail to support antitumor CD4+ Tconv differentiation.",30955881_1,-1,-1,-1,-1,36509,-1,0.004740949,0.2173538,0.7779053
36512,that traffic,27,29,165,177,"We comprehensively characterized myeloid cells in tumor draining lymph nodes (tdLN) of mice and identified two subsets of conventional type-2 dendritic cells (cDC2) that traffic from tumor to tdLN and present tumor-derived antigens to CD4+ Tconv, but then fail to support antitumor CD4+ Tconv differentiation.",30955881_1,-1,-1,-1,-1,36512,-1,2.0521262e-05,0.99996686,1.2592364e-05
36513,tumor to tdLN,30,33,183,196,"We comprehensively characterized myeloid cells in tumor draining lymph nodes (tdLN) of mice and identified two subsets of conventional type-2 dendritic cells (cDC2) that traffic from tumor to tdLN and present tumor-derived antigens to CD4+ Tconv, but then fail to support antitumor CD4+ Tconv differentiation.",30955881_1,-1,-1,-1,-1,36513,-1,2.4506884e-05,0.9999634,1.2136555e-05
36514,tumor-derived antigens to,35,38,209,234,"We comprehensively characterized myeloid cells in tumor draining lymph nodes (tdLN) of mice and identified two subsets of conventional type-2 dendritic cells (cDC2) that traffic from tumor to tdLN and present tumor-derived antigens to CD4+ Tconv, but then fail to support antitumor CD4+ Tconv differentiation.",30955881_1,-1,-1,-1,-1,36514,-1,0.00010667722,0.9998487,4.457345e-05
36525,relative to Treg,15,18,88,104,"Analogous cDC2 populations were identified in patients, and as in mice, their abundance relative to Treg predicts protective ICOS+ PD-1lo CD4+ Tconv phenotypes and survival.",30955881_3,-1,-1,-1,-1,36525,-1,3.0799205e-05,0.9999541,1.5148419e-05
36530,therapy,27,28,160,167,"Further, in melanoma patients with lowTreg abundance, intratumoral cDC2 density alonecorrelates with abundant CD4+ Tconv and with responsiveness to anti-PD-1 therapy.",30955881_4,0,1,-1,-1,36530,-1,2.4603494e-05,0.999962,1.3424906e-05
36537,the cytokine,6,8,42,54,BACKGROUND: The immunosuppressive role of the cytokine IL-35 in patients with non-small cell lung cancer (NSCLC) is poorly understood.,30956278_0,-1,-1,-1,-1,36537,-1,0.45926988,0.5329947,0.0077354964
36548,analysis,3,4,27,35,"Immunohistochemistry, FACS analysis, real-time PCR, as well as western blot from samples of the control (CTR), peri-tumoural (PT) and the tumoural (TU) region of the lung derived from patients with NSCLC and 10 controls were performed.",30956278_3,0,1,-1,-1,36548,-1,4.8364014e-05,0.99988616,6.544549e-05
36550,the tumoural,27,29,134,146,"Immunohistochemistry, FACS analysis, real-time PCR, as well as western blot from samples of the control (CTR), peri-tumoural (PT) and the tumoural (TU) region of the lung derived from patients with NSCLC and 10 controls were performed.",30956278_3,-1,-1,-1,-1,36550,-1,3.0236928e-05,0.99994934,2.0404927e-05
36553,the TU,10,12,51,57,RESULTS: Here we found elevated levels of IL-35 in the TU region as well as postoperative serum from patients with lung adenocarcinoma.,30956278_4,-1,-1,-1,-1,36553,-1,2.254387e-05,0.9999658,1.1629407e-05
36555,TNFA,20,21,128,132,"Consistently, we found an increased expression of IL-35+Foxp-3+ cells, which associated with ARG1 mRNA expression and decreased TNFA in the TU region of the lung of patients with NSCLC as compared to their CTR region.",30956278_5,0,1,-1,-1,36555,-1,5.76131e-05,0.99992096,2.1433636e-05
36556,the TU,22,24,136,142,"Consistently, we found an increased expression of IL-35+Foxp-3+ cells, which associated with ARG1 mRNA expression and decreased TNFA in the TU region of the lung of patients with NSCLC as compared to their CTR region.",30956278_5,-1,-1,-1,-1,36556,-1,2.1887356e-05,0.9999651,1.3032507e-05
36558,to their,34,36,197,205,"Consistently, we found an increased expression of IL-35+Foxp-3+ cells, which associated with ARG1 mRNA expression and decreased TNFA in the TU region of the lung of patients with NSCLC as compared to their CTR region.",30956278_5,-1,-1,-1,-1,36558,-1,2.2039867e-05,0.99996805,9.946375e-06
36564,the TU,10,12,64,70,"Finally, IL-35 positively correlated with TTF-1+PD-L1+ cells in the TU region of NSCLC patients.",30956278_7,-1,-1,-1,-1,36564,-1,2.487438e-05,0.99995613,1.8975477e-05
36566,the TU,8,10,50,56,CONCLUSIONS: Induced IL-35+Foxp3+ cell numbers in the TU region of the lung of patients with NSCLC associated with ARG1 mRNA expression and with TTF-1+PD-L1+ cells.,30956278_8,-1,-1,-1,-1,36566,-1,2.3702096e-05,0.999962,1.4341089e-05
36570,the tumour-free,1,3,3,18,"In the tumour-free CTR area, IL-35 correlated with CD68+ macrophages.",30956278_9,-1,-1,-1,-1,36570,-1,3.1012147e-05,0.999951,1.8034674e-05
36579,the TU,45,47,333,339,Thus inhibitors to IL-35 would probably succeed in combination with antibodies against immune checkpoints like PD-L1 and PD-1 currently used against NSCLC because they would inhibit immunosuppressive macrophages and T regulatory cells while promoting T cell-mediated anti-tumoural immune responses in the microenvironment as well as the TU region of NSCLC patients.,30956278_10,-1,-1,-1,-1,36579,-1,2.3433597e-05,0.99996555,1.1033591e-05
36585,Tissue,0,1,0,6,"Tissue expression of Forkhead box P3 (FOXP3), one of the transcription factors of Treg cells, and transforming growth factor-beta (TGF-) were examined by immunohistochemistry.",30981619_3,-1,1,2,-1,36585,-1,2.2489554e-05,0.9999616,1.5840395e-05
36588,the transcription factors,12,15,53,78,"Tissue expression of Forkhead box P3 (FOXP3), one of the transcription factors of Treg cells, and transforming growth factor-beta (TGF-) were examined by immunohistochemistry.",30981619_3,-1,-1,-1,-1,36588,-1,2.9890669e-05,0.9999473,2.279599e-05
36605,related to,10,12,75,85,"CONCLUSIONS: This study confirms current speculation that endometriosis is related to alteration in Treg cells, causing survival and implantation of ectopic endometrial lesions in women with endometrioma and dermoid cysts.",30981619_8,-1,-1,-1,-1,36605,-1,2.6538364e-05,0.99995935,1.4063938e-05
36608,the general,11,13,50,61,The findings may clarify why only 10% of women in the general population develop endometriosis despite cyclic menstruation with retrograde flow occurring in >90% of women.,30981619_9,-1,-1,-1,-1,36608,-1,2.3794699e-05,0.9999635,1.2738472e-05
36618,therapy,10,11,51,58,"However, in both mice and humans, chronic imatinib therapy decreases intratumoral DCs and effector CD8+ T cells.",31000683_3,0,1,-1,-1,36618,-1,2.1630973e-05,0.9999677,1.0714583e-05
36622,to the,17,19,103,109,"The mechanism in our mouse model depends on Kit inhibition, which reduces intratumoral GM-CSF, leading to the accumulation of Batf3-lineage DC progenitors.",31000683_4,-1,-1,-1,-1,36622,-1,2.0803325e-05,0.99996924,1.0005037e-05
36628,immunity,11,12,82,90,Stimulants that expand and mature DCs during imatinib treatment improve antitumor immunity.,31000683_6,0,-1,2,-1,36628,-1,0.9992494,0.0004971623,0.00025331168
36630,tumor cell,6,8,40,50,Our findings identify the importance of tumor cell oncogene activity in modulating the Batf3-dependent DC lineage and reveal therapeutic limitations for combined checkpoint blockade and tyrosine kinase inhibition.,31000683_7,-1,-1,-1,-1,36630,-1,0.00080759346,0.020620743,0.97857165
36637,The tumor,0,2,0,9,The tumor immune microenvironment and secreted cytokines play a substantial role in development of resistance to chemotherapy.,31018021_1,-1,-1,-1,-1,36637,-1,2.2206701e-05,0.9999676,1.020027e-05
36638,cytokines play,6,8,47,61,The tumor immune microenvironment and secreted cytokines play a substantial role in development of resistance to chemotherapy.,31018021_1,-1,-1,-1,-1,36638,-1,0.9014899,0.09279179,0.005718244
36639,to chemotherapy,15,17,110,125,The tumor immune microenvironment and secreted cytokines play a substantial role in development of resistance to chemotherapy.,31018021_1,-1,-1,-1,-1,36639,-1,0.11092266,0.88630944,0.0027679147
36644,T-cell,26,27,155,161,"Our previous study has demonstrated that CD4+ T cells in prostate tumor microenvironment contribute to PCa progression; meanwhile, we found increased CD4+ T-cell infiltration in tumor area after Doc treatment; however, their effects on PCa chemosensitivity remain unclear.",31018021_2,-1,1,2,-1,36644,-1,3.253432e-05,4.8735998e-05,0.9999187
36653,T-cell,4,5,14,20,"METHODS: CD4+ T-cell infiltration in Doc-treated paraffin-embedded specimens from transurethral resection of prostate, radical prostatectomy, or bone metastasis was detected by immunohistochemistry.",31018021_4,-1,1,2,-1,36653,-1,3.3804194e-05,5.102855e-05,0.9999151
36657,T-cell,13,14,68,74,"The castration-resistant PCa cell lines-C4-2 and CWR22RV1, and CD4+ T-cell lines-HH and Molt-3 were used in the coculture system.",31018021_5,-1,1,2,-1,36657,-1,3.2978623e-05,5.130858e-05,0.9999157
36659,the lymphocytes,3,5,21,36,"After coculture with the lymphocytes, PCa cell chemosensitivity was detected by cell counting kit-8, terminal deoxynucleotidyl transferase dUTP nick-end labeling assays, and Western blot analysis.",31018021_6,-1,-1,-1,-1,36659,-1,0.0040180576,0.34295243,0.6530295
36660,cell chemosensitivity,7,9,42,63,"After coculture with the lymphocytes, PCa cell chemosensitivity was detected by cell counting kit-8, terminal deoxynucleotidyl transferase dUTP nick-end labeling assays, and Western blot analysis.",31018021_6,-1,-1,-1,-1,36660,-1,0.085021295,0.029661715,0.885317
36664,analysis,27,28,187,195,"After coculture with the lymphocytes, PCa cell chemosensitivity was detected by cell counting kit-8, terminal deoxynucleotidyl transferase dUTP nick-end labeling assays, and Western blot analysis.",31018021_6,0,1,-1,-1,36664,-1,3.5348992e-05,0.9999348,2.9888586e-05
36665,cell cytokines,1,3,8,22,Various cell cytokines were determined by cytokine arrays and reverse-transcription polymerase chain reaction.,31018021_7,-1,-1,-1,-1,36665,-1,0.29745197,0.0011967507,0.7013513
36673,to the,17,19,91,97,"S3I-201, a signal transducer and activator of transcription 3 (STAT3) inhibitor, was added to the coculture system to detect STAT3 role in chemosensitivity.",31018021_9,-1,-1,-1,-1,36673,-1,2.0658206e-05,0.999969,1.0286916e-05
36682,tissues,19,20,103,110,RESULTS: We found more infiltrated CD4+ T cells in human PCa lesions than in the adjacent noncancerous tissues after Doc treatment.,31018021_11,-1,1,2,-1,36682,-1,0.0005424064,0.9659693,0.033488296
36696,the chemoresistance,21,23,120,139,We found that CD4+ T cells could activate P-STAT3 signaling via secreting CCL5 and adding a STAT3 inhibitor can reverse the chemoresistance.,31018021_15,-1,-1,-1,-1,36696,-1,0.0007279084,0.99918133,9.072436e-05
36716,that these,10,12,71,81,We hypothesized that a mechanism for IL-6-associated poor prognosis is that these patients would have altered T-cell populations and impaired T-cell signaling.,31027698_2,-1,-1,-1,-1,36716,-1,1.8372477e-05,0.99997187,9.731843e-06
36717,T-cell,16,17,110,116,We hypothesized that a mechanism for IL-6-associated poor prognosis is that these patients would have altered T-cell populations and impaired T-cell signaling.,31027698_2,-1,1,2,-1,36717,-1,3.523547e-05,4.901211e-05,0.9999157
36718,T-cell,20,21,142,148,We hypothesized that a mechanism for IL-6-associated poor prognosis is that these patients would have altered T-cell populations and impaired T-cell signaling.,31027698_2,-1,1,2,-1,36718,-1,4.3541513e-05,5.579612e-05,0.9999007
36721,T-cell,0,1,0,6,"T-cell populations from Non-small cell lung cancer patients were characterized using surface markers by flow cytometry, and signaling in the T-cell populations were measured by PhosFlow cytometry.",31027698_4,-1,1,2,-1,36721,-1,3.1150455e-05,4.8342015e-05,0.9999205
36723,the T-cell,20,22,137,147,"T-cell populations from Non-small cell lung cancer patients were characterized using surface markers by flow cytometry, and signaling in the T-cell populations were measured by PhosFlow cytometry.",31027698_4,-1,-1,-1,-1,36723,-1,0.0023113554,0.11410588,0.8835827
36727,relative to those,16,19,106,123,RESULTS: We determine that patients with high circulating IL-6 levels had distinct T cell characteristics relative to those with low levels.,31027698_5,-1,-1,-1,-1,36727,-1,2.1731916e-05,0.99996376,1.4511298e-05
36731,protein-1,16,17,103,112,"Patients with high levels of IL-6 had significantly more Treg cells and elevated Programmed cell death protein-1 (PD-1) expression on CD4+, CD8+, Treg, and Th17 cells.",31027698_6,0,1,-1,-1,36731,-1,0.00018759147,0.99902534,0.00078707223
36733,Th17 cells,31,33,156,166,"Patients with high levels of IL-6 had significantly more Treg cells and elevated Programmed cell death protein-1 (PD-1) expression on CD4+, CD8+, Treg, and Th17 cells.",31027698_6,-1,-1,-1,-1,36733,-1,0.00048078893,0.0032727853,0.9962464
36740,T-Cells,28,29,179,186,"These patients also showed impaired signal transducer and activator of transcription-1 (STAT1) signaling upon stimulation with IL-6 and phorbol 12-myristate 13-acetate (PMA), and T-Cells from a healthy donor that were treated for four days with IL-6 displayed a similar muting of STAT signaling, which verified the effect seen in patient samples.",31027698_7,-1,1,2,-1,36740,-1,3.412018e-05,7.546791e-05,0.99989045
36754,function,10,11,59,67,Our data suggest that alteration in T cell populations and function may be a mechanism underlying the poor prognosis seen in NSCLC patients with high IL-6 levels.,31027698_9,0,1,2,-1,36754,-1,0.0003210041,0.99777114,0.0019079023
36759,the tumor,11,13,58,67,INTRODUCTION: Regulatory T cells (Tregs) are important in the tumor microenvironment.,31036318_0,-1,-1,-1,-1,36759,-1,2.1691725e-05,0.9999685,9.826508e-06
36761,immunity,9,10,72,80,Many subpopulations of Tregs have participated in suppressing antitumor immunity.,31036318_1,0,-1,2,-1,36761,-1,0.9983014,0.001290813,0.00040773363
36765,Tregs that,12,14,58,68,"Recently, FOXA1+ Tregs were reported as a novel subset of Tregs that control autoimmune diseases.",31036318_2,-1,-1,-1,-1,36765,-1,2.0339901e-05,0.9999658,1.384604e-05
36768,blood,1,2,11,16,Peripheral blood samples were collected from 15 lung cancer patients.,31036318_5,0,1,-1,-1,36768,-1,0.00014121327,0.99870074,0.0011580861
36770,the analysis,14,16,97,109,Another 45 advanced stage lung cancer patients with malignant pleural effusion were enrolled for the analysis of FOXA1+ Tregs in pleural effusions.,31036318_6,-1,-1,-1,-1,36770,-1,2.1981476e-05,0.9999646,1.33900085e-05
36774,tissues,2,3,12,19,Lung cancer tissues were collected from 3 patients.,31036318_7,-1,1,2,-1,36774,-1,0.00014989461,0.9961034,0.0037466614
36787,that FOXA1,5,7,31,41,RESULTS: Our data demonstrated that FOXA1+ Tregs were increased in lung cancer.,31036318_10,-1,-1,-1,-1,36787,-1,4.4311397e-05,0.99990225,5.3424523e-05
36792,that FOXA1,5,7,25,35,"Invitro assays revealed that FOXA1+ Tregs inhibited the proliferation of T cells, the production of IFN- and IL-2 by T cells.",31036318_12,-1,-1,-1,-1,36792,-1,5.1101495e-05,0.99988353,6.533606e-05
36806,function,13,14,80,88,"DISCUSSION: Collectively, our study is the first to investigate the suppressive function of FOXA1+ Tregs against T cells in lung cancer, and the results showed that FOXA1+ Tregs are markers of poor treatment responses in lung cancer patients.",31036318_14,0,1,2,-1,36806,-1,2.990234e-05,0.9999515,1.8577695e-05
36811,that FOXA1,29,31,160,170,"DISCUSSION: Collectively, our study is the first to investigate the suppressive function of FOXA1+ Tregs against T cells in lung cancer, and the results showed that FOXA1+ Tregs are markers of poor treatment responses in lung cancer patients.",31036318_14,-1,-1,-1,-1,36811,-1,4.3288128e-05,0.9999056,5.1170016e-05
36818,immunity,14,15,88,96,The inhibition of FOXA1+ Tregs represents a promising new strategy to enhance antitumor immunity.,31036318_15,0,-1,2,-1,36818,-1,0.9983181,0.0013009841,0.0003809071
36819,the tumor,4,6,28,37,Macrophages are presents in the tumor microenvironment and acquire different phenotypic and functional characteristics in response to microenvironmental signals.,31099286_0,-1,-1,-1,-1,36819,-1,2.1931455e-05,0.9999684,9.701498e-06
36820,functional,12,13,92,102,Macrophages are presents in the tumor microenvironment and acquire different phenotypic and functional characteristics in response to microenvironmental signals.,31099286_0,0,1,2,-1,36820,-1,0.00014900308,0.99974424,0.00010676357
36823,to the,2,4,12,18,"In response to the microenvironment, macrophages activate transcription factors as STAT1 and NF-B-p65 for M1 macrophages or STAT3 and STAT6 for M2 macrophages; activation impacts on the profile of cytokine, chemokines and growth factors secreted by macrophages.",31099286_2,-1,-1,-1,-1,36823,-1,2.2399365e-05,0.9999677,9.850538e-06
36831,factors,36,37,230,237,"In response to the microenvironment, macrophages activate transcription factors as STAT1 and NF-B-p65 for M1 macrophages or STAT3 and STAT6 for M2 macrophages; activation impacts on the profile of cytokine, chemokines and growth factors secreted by macrophages.",31099286_2,0,1,-1,-1,36831,-1,0.9997141,0.000110598114,0.00017526915
36836,transcriptional factors STAT1,22,25,132,161,"We evaluated the effect of the supernatant of cervical-derived carcinoma cell lines HeLa, SiHa, and C-33A on the phosphorylation of transcriptional factors STAT1, NF-B-p65, and STAT6, and their impact in the profile of secretion of cytokines and growth factors by macrophages derived from the U937 cell line.",31099286_3,-1,-1,-1,-1,36836,-1,2.2300637e-05,0.99995637,2.128096e-05
36841,factors,43,44,254,261,"We evaluated the effect of the supernatant of cervical-derived carcinoma cell lines HeLa, SiHa, and C-33A on the phosphorylation of transcriptional factors STAT1, NF-B-p65, and STAT6, and their impact in the profile of secretion of cytokines and growth factors by macrophages derived from the U937 cell line.",31099286_3,0,1,-1,-1,36841,-1,0.99971133,0.00012829863,0.00016029364
36862,factors that,32,34,192,204,"Our results suggest that HeLa, SiHa, and C-33A cell lines down-regulate the activation of transcription factors characteristic of M1 macrophages (STAT1, NF-B-p65) and induce the secretion of factors that favor tumor growth.",31099286_5,-1,-1,-1,-1,36862,-1,0.0022979935,0.9974336,0.00026840784
36864,functional,6,7,36,46,BACKGROUND: Helios is important for functional and phenotype stability of regulatory T cells (Tregs).,31118027_0,0,1,2,-1,36864,-1,4.908115e-05,0.999931,1.9928364e-05
36873,tumor necrosis factor receptor,18,22,111,141,This study aimed to investigate the role of Helios+ Tregs in myasthenia gravis (MG) and glucocorticoid-induced tumor necrosis factor receptor (GITR) and its ligand (GITRL) in the modulation of Helios.,31118027_2,-1,-1,-1,-1,36873,-1,0.0123048695,0.96931654,0.018378535
36877,blood,13,14,87,92,METHOD: Multicolor flow cytometry was performed to analyze Helios+ Tregs in peripheral blood from MG patients and healthy donors (HDs).,31118027_3,0,1,-1,-1,36877,-1,0.00031374072,0.99205655,0.0076297577
36884,other,9,10,53,58,"Membrane GITRL on Tregs and expression of Helios and other markers (FOXP3, CD25, CD39, CTLA-4, PD-L1 and IL-10) involved in immunosuppressive activity were determined by flow cytometry.",31118027_6,-1,-1,-1,-1,36884,-1,0.00014795395,0.9997738,7.8233126e-05
36893,analysis,1,2,8,16,"Further analysis indicates soluble GITR was negatively correlated with quantitative MG score and promoted Helios expression and enhanced function of Tregs independently of membrane GITRL.CONCLUSION: This work demonstrates abnormal changes in Helios+ Tregs and soluble GITR in MG, as well as direct regulation of Helios by GITR in the context of Tregs.",31118027_9,0,1,-1,-1,36893,-1,3.270598e-05,0.9999473,2.0023734e-05
36894,function,18,19,137,145,"Further analysis indicates soluble GITR was negatively correlated with quantitative MG score and promoted Helios expression and enhanced function of Tregs independently of membrane GITRL.CONCLUSION: This work demonstrates abnormal changes in Helios+ Tregs and soluble GITR in MG, as well as direct regulation of Helios by GITR in the context of Tregs.",31118027_9,0,1,2,-1,36894,-1,7.31921e-05,0.9998872,3.9590206e-05
36908,cell types,6,8,36,46,"Itch is expressed in most mammalian cell types, and, based on published data, it regulates many cellular pathways ranging from T cell differentiation to liver tumorigenesis.",31126634_1,-1,-1,-1,-1,36908,-1,3.9891824e-05,7.4340765e-05,0.9998857
36917,cell function,24,26,137,150,"However, while autoimmunity is the primary clinical feature that occurs in both mice and humans lacking Itch, and Itch control of immune cell function has been well-studied, it remains unclear how Itch prevents the emergence of autoimmune disease.",31126634_4,-1,-1,-1,-1,36917,-1,7.312382e-05,8.601716e-05,0.99984074
36928,to therapeutically target,24,27,138,163,"Additionally, we discuss how molecular regulators of Itch impact its ability to control these processes, as this may provide clues on how to therapeutically target Itch to treat patients with autoimmune disease.",31126634_6,-1,-1,-1,-1,36928,-1,2.1302492e-05,0.9999701,8.628977e-06
36929,to treat,28,30,169,177,"Additionally, we discuss how molecular regulators of Itch impact its ability to control these processes, as this may provide clues on how to therapeutically target Itch to treat patients with autoimmune disease.",31126634_6,-1,-1,-1,-1,36929,-1,2.1119657e-05,0.9999696,9.293903e-06
36935,that the,3,5,15,23,We showed here that the spatial distribution of interleukin-4 (IL4) in invariant natural killer T (iNKT) cells regulated crosstalk between iNKT cells and dendritic cells (DCs) and controlled iNKT cell-mediated T-helper type 1 (Th1) responses.,31160756_1,-1,-1,-1,-1,36935,-1,1.6598797e-05,0.99997556,7.8625135e-06
36942,cell-mediated T-helper type,35,38,196,223,We showed here that the spatial distribution of interleukin-4 (IL4) in invariant natural killer T (iNKT) cells regulated crosstalk between iNKT cells and dendritic cells (DCs) and controlled iNKT cell-mediated T-helper type 1 (Th1) responses.,31160756_1,-1,-1,-1,-1,36942,-1,0.0023787722,0.06834987,0.9292714
36961,the immune response to,29,33,182,204,"Conversely, the nonpolarized secretion of IL4 induced by Th2 lipid antigens with a short or unsaturated chain was incapable of enhancing this iNKT cell-DC crosstalk and thus shifted the immune response to a Th2-type response.",31160756_3,-1,-1,-1,-1,36961,-1,0.000280209,0.999665,5.476766e-05
36964,to Th2,7,9,46,52,The nonpolarized secretion of IL4 in response to Th2 lipid antigens was caused by the degradation of Cdc42 in iNKT cells.,31160756_4,-1,-1,-1,-1,36964,-1,4.5178902e-05,0.9999404,1.4399681e-05
36974,T cells through,14,17,70,85,BACKGROUND: B cells can increase the expression of granzyme B in CD8+ T cells through 4-1BBL/4-1BB interaction and promote anti-tumor immunity.,31182685_0,-1,-1,-1,-1,36974,-1,0.0014618029,0.031982273,0.9665559
36975,immunity,26,27,134,142,BACKGROUND: B cells can increase the expression of granzyme B in CD8+ T cells through 4-1BBL/4-1BB interaction and promote anti-tumor immunity.,31182685_0,0,-1,2,-1,36975,-1,0.99931884,0.00045241698,0.0002286713
36997,the TDLNs,48,50,257,266,"However, in patients with invasive ductal carcinoma, the percentage of 4-1BBL expressing B cells in stimulated condition had a decreasing trend in grade III, compared to grade II+I. In addition, significantly higher frequency of 4-1BBL+ B cells was seen in the TDLNs of ER+ or PR+ compared with ER or PR patients (p=0.021 and p=0.015, respectively).",31182685_7,-1,-1,-1,-1,36997,-1,2.3057139e-05,0.9999598,1.7171842e-05
37006,receptor status,29,31,184,199,"CONCLUSIONS: The frequency of 4-1BBL+ B cells significantly increased following a short time activation, and showed relative and significant associations with tumor grade and estrogen receptor status, respectively.",31182685_9,-1,-1,-1,-1,37006,-1,0.00010154093,0.999767,0.00013146602
37018,transformed TC-1 tumour,6,9,38,61,METHOD: Human papillomavirus 16 E6/E7 transformed TC-1 tumour bearing mice were intravenously administered with low (1  108 CFU/kg) or high dosage (3  108 CFU/kg) of Derivative Clostridial spore (DCG).RESULTS: Intravenous administration of the derivative of Clostridial ghonii (DCG) spores leads to both tumour and systemic inflammatory responses characterized by increased IFN/IL-9 secreting T cells in the spleen and the tumour.,31183361_2,-1,-1,-1,-1,37018,-1,2.4514775e-05,0.9999486,2.6853408e-05
37024,the tumour,68,70,422,432,METHOD: Human papillomavirus 16 E6/E7 transformed TC-1 tumour bearing mice were intravenously administered with low (1  108 CFU/kg) or high dosage (3  108 CFU/kg) of Derivative Clostridial spore (DCG).RESULTS: Intravenous administration of the derivative of Clostridial ghonii (DCG) spores leads to both tumour and systemic inflammatory responses characterized by increased IFN/IL-9 secreting T cells in the spleen and the tumour.,31183361_2,-1,-1,-1,-1,37024,-1,2.2983924e-05,0.99996376,1.3268259e-05
37029,the tumour,17,19,80,90,Low numbers of antigen specific T cells (<20/106 spleen cells) in the spleen of the tumour bearing mice are also detected after intravenous DCG delivery.,31183361_3,-1,-1,-1,-1,37029,-1,2.2392416e-05,0.9999664,1.1189796e-05
37032,the tumour,16,18,100,110,"Interestingly, our results showed that a mixed IL-9/IFN secreting T cell response was induced when the tumour bearing mice received a low dose of DCG spore (1  108 CFU/kg), while a strong IFN response was elicited with a high dosage of DCG spore (3  108 CFU/kg).CONCLUSION: The dosage of DCG spore will determine the types of the DCG induced immune responses.",31183361_4,-1,-1,-1,-1,37032,-1,2.033268e-05,0.9999701,9.536862e-06
37035,the types,61,63,317,326,"Interestingly, our results showed that a mixed IL-9/IFN secreting T cell response was induced when the tumour bearing mice received a low dose of DCG spore (1  108 CFU/kg), while a strong IFN response was elicited with a high dosage of DCG spore (3  108 CFU/kg).CONCLUSION: The dosage of DCG spore will determine the types of the DCG induced immune responses.",31183361_4,-1,-1,-1,-1,37035,-1,2.5612051e-05,0.9999573,1.7071541e-05
37043,function,14,15,81,89,"In this study, we investigated the distribution, prognostic value, and potential function of pDCs in HCC patients undergoing curative resection.",31201473_1,0,1,2,-1,37043,-1,6.712436e-05,0.9998994,3.349128e-05
37050,tissue,5,6,34,40,The findings were validated using tissue microarrays from another two independent cohorts totaling 841 HCC patients undergoing curative resection.,31201473_3,-1,1,2,-1,37050,-1,2.2773924e-05,0.99994016,3.707418e-05
37056,tissues,14,15,91,98,"However, patient outcomes were not associated with pDCs in peritumoral stromal or nontumor tissues.",31201473_5,-1,1,2,-1,37056,-1,0.0012170466,0.789886,0.20889701
37059,IL-17-producing cells,20,22,135,156,"Furthermore, an increase in intratumoral pDCs was associated with increased intratumoral infiltration of Foxp3+ regulatory T cells and IL-17-producing cells and correlated with tumor vascular density.",31201473_6,-1,-1,-1,-1,37059,-1,0.8808168,0.0011816613,0.118001506
37061,that the,5,7,46,54,Univariate and multivariate analyses revealed that the presence of intratumoral pDCs alone or in combination with regulatory T and/or IL-17-producing cells was an independent predictor of time to recurrence and overall survival.,31201473_7,-1,-1,-1,-1,37061,-1,1.7624881e-05,0.99997365,8.662253e-06
37063,IL-17-producing cells,19,21,134,155,Univariate and multivariate analyses revealed that the presence of intratumoral pDCs alone or in combination with regulatory T and/or IL-17-producing cells was an independent predictor of time to recurrence and overall survival.,31201473_7,-1,-1,-1,-1,37063,-1,0.840938,0.0011945334,0.15786742
37064,time to,26,28,188,195,Univariate and multivariate analyses revealed that the presence of intratumoral pDCs alone or in combination with regulatory T and/or IL-17-producing cells was an independent predictor of time to recurrence and overall survival.,31201473_7,-1,-1,-1,-1,37064,-1,2.508259e-05,0.99995565,1.9264384e-05
37066,through the,24,26,148,159,"In conclusion, our study demonstrated that intratumoral infiltration by pDCs is a novel indicator for poor prognosis in patients with HCC, possibly through the induction of an immune tolerogenic and inflammatory tumor microenvironment comprising regulatory T and IL-17-producing cells.",31201473_8,-1,-1,-1,-1,37066,-1,2.0547357e-05,0.9999702,9.203581e-06
37070,IL-17-producing cells,39,41,263,284,"In conclusion, our study demonstrated that intratumoral infiltration by pDCs is a novel indicator for poor prognosis in patients with HCC, possibly through the induction of an immune tolerogenic and inflammatory tumor microenvironment comprising regulatory T and IL-17-producing cells.",31201473_8,-1,-1,-1,-1,37070,-1,0.8709772,0.001450902,0.12757193
37072,these cells,6,8,36,47,An assessment of the combination of these cells represents a superior predictor of patient outcome.,31201473_9,-1,-1,-1,-1,37072,-1,0.0010293993,0.03236198,0.9666086
37077,to chemotherapy,17,19,97,112,BACKGROUND: Type I interferons (IFN-I) have recently emerged as key regulators of tumor response to chemotherapy and immunotherapy.,31228946_0,-1,-1,-1,-1,37077,-1,0.26181212,0.7322755,0.0059123645
37078,IFN-I function,2,4,9,23,"However, IFN-I function in cytotoxic T lymphocytes (CTLs) in the tumor microenvironment is largely unknown.",31228946_1,-1,-1,-1,-1,37078,-1,0.99593496,0.002031772,0.0020332744
37081,the tumor,12,14,61,70,"However, IFN-I function in cytotoxic T lymphocytes (CTLs) in the tumor microenvironment is largely unknown.",31228946_1,-1,-1,-1,-1,37081,-1,2.3552388e-05,0.9999676,8.906247e-06
37082,Tumor tissues,2,4,9,22,METHODS: Tumor tissues and CTLs of human colorectal cancer patients were analyzed for interferon (alpha and beta) receptor 1 (IFNAR1) expression.,31228946_2,-1,-1,-1,-1,37082,-1,2.3653909e-05,0.9999553,2.1042015e-05
37085,receptor,20,21,114,122,METHODS: Tumor tissues and CTLs of human colorectal cancer patients were analyzed for interferon (alpha and beta) receptor 1 (IFNAR1) expression.,31228946_2,0,1,2,-1,37085,-1,0.00063818303,0.1157456,0.88361615
37091,IFNAR1 deficiency,23,25,104,121,"IFNAR1 knock out (IFNAR-KO), mixed wild type (WT) and IFNAR1-KO bone marrow chimera mice, and mice with IFNAR1 deficiency only in T cells (IFNAR1-TKO) were used to determine IFN-I function in T cells in tumor suppression.",31228946_3,-1,-1,-1,-1,37091,-1,0.99576217,0.0018305796,0.002407298
37095,IFN-I function,36,38,174,188,"IFNAR1 knock out (IFNAR-KO), mixed wild type (WT) and IFNAR1-KO bone marrow chimera mice, and mice with IFNAR1 deficiency only in T cells (IFNAR1-TKO) were used to determine IFN-I function in T cells in tumor suppression.",31228946_3,-1,-1,-1,-1,37095,-1,0.9961175,0.0018687536,0.002013872
37098,IFN-I target genes,0,3,0,18,IFN-I target genes in tumor-infiltrating and antigen-specific CTLs were identified and functionally analyzed.,31228946_4,-1,-1,-1,-1,37098,-1,0.98065233,0.016032858,0.0033147288
37100,antigen-specific CTLs,6,8,45,66,IFN-I target genes in tumor-infiltrating and antigen-specific CTLs were identified and functionally analyzed.,31228946_4,-1,-1,-1,-1,37100,-1,0.24991544,0.0029920742,0.7470925
37101,functionally,11,12,87,99,IFN-I target genes in tumor-infiltrating and antigen-specific CTLs were identified and functionally analyzed.,31228946_4,0,1,2,-1,37101,-1,5.3958527e-05,0.99992514,2.095381e-05
37103,tissue than,12,14,86,97,RESULTS: IFNAR1 expression level is significantly lower in human colorectal carcinoma tissue than in normal colon tissue.,31228946_5,-1,-1,-1,-1,37103,-1,3.649608e-05,0.999915,4.8477203e-05
37104,tissue,17,18,114,120,RESULTS: IFNAR1 expression level is significantly lower in human colorectal carcinoma tissue than in normal colon tissue.,31228946_5,-1,1,2,-1,37104,-1,6.697484e-05,0.9995254,0.00040759225
37105,IFNAR1 protein,0,2,0,14,IFNAR1 protein is also significantly lower on CTLs from colorectal cancer patients than those from healthy donors.,31228946_6,-1,-1,-1,-1,37105,-1,0.9743705,0.014333871,0.011295578
37107,than those,12,14,83,93,IFNAR1 protein is also significantly lower on CTLs from colorectal cancer patients than those from healthy donors.,31228946_6,-1,-1,-1,-1,37107,-1,2.5000349e-05,0.9999597,1.5286225e-05
37110,IFNAR1-sufficient tumors,10,12,98,122,"Although IFNAR1-KO mice exhibited increased susceptibility to methylcholanthrene-induced sarcoma, IFNAR1-sufficient tumors also grow significantly faster in IFNAR1-KO mice and in mice with IFNAR1 deficiency only in T cells (IFNAR1-TKO), suggesting that IFN-I functions in T cells to enhance host cancer immunosurveillance.",31228946_7,-1,-1,-1,-1,37110,-1,0.98517346,0.011345665,0.0034808833
37112,IFNAR1 deficiency,23,25,189,206,"Although IFNAR1-KO mice exhibited increased susceptibility to methylcholanthrene-induced sarcoma, IFNAR1-sufficient tumors also grow significantly faster in IFNAR1-KO mice and in mice with IFNAR1 deficiency only in T cells (IFNAR1-TKO), suggesting that IFN-I functions in T cells to enhance host cancer immunosurveillance.",31228946_7,-1,-1,-1,-1,37112,-1,0.9961397,0.0018121131,0.0020481634
37115,that IFN-I functions,34,37,248,268,"Although IFNAR1-KO mice exhibited increased susceptibility to methylcholanthrene-induced sarcoma, IFNAR1-sufficient tumors also grow significantly faster in IFNAR1-KO mice and in mice with IFNAR1 deficiency only in T cells (IFNAR1-TKO), suggesting that IFN-I functions in T cells to enhance host cancer immunosurveillance.",31228946_7,-1,-1,-1,-1,37115,-1,0.005530138,0.99383706,0.00063278154
37116,T cells to,38,41,272,282,"Although IFNAR1-KO mice exhibited increased susceptibility to methylcholanthrene-induced sarcoma, IFNAR1-sufficient tumors also grow significantly faster in IFNAR1-KO mice and in mice with IFNAR1 deficiency only in T cells (IFNAR1-TKO), suggesting that IFN-I functions in T cells to enhance host cancer immunosurveillance.",31228946_7,-1,-1,-1,-1,37116,-1,0.00172452,0.035034876,0.9632407
37117,tumor-infiltrating CTL,2,4,12,34,"Strikingly, tumor-infiltrating CTL levels are similar between tumor-bearing WT and IFNAR1-KO mice.",31228946_8,-1,-1,-1,-1,37117,-1,0.004498445,0.76002795,0.23547359
37121,that IFNAR1-deficient,13,15,97,118,Competitive reconstitution of mixed WT and IFNAR1-KO bone marrow chimera mice further determined that IFNAR1-deficient nave CTLs exhibit no deficiency in response to vaccination to generate antigen-specific CTLs as compared to WT CTLs.,31228946_9,-1,-1,-1,-1,37121,-1,0.007732771,0.9906956,0.0015716633
37123,deficiency,19,20,141,151,Competitive reconstitution of mixed WT and IFNAR1-KO bone marrow chimera mice further determined that IFNAR1-deficient nave CTLs exhibit no deficiency in response to vaccination to generate antigen-specific CTLs as compared to WT CTLs.,31228946_9,0,1,-1,-1,37123,-1,0.00024343262,0.99930286,0.0004536432
37125,to generate antigen-specific CTLs,24,28,179,212,Competitive reconstitution of mixed WT and IFNAR1-KO bone marrow chimera mice further determined that IFNAR1-deficient nave CTLs exhibit no deficiency in response to vaccination to generate antigen-specific CTLs as compared to WT CTLs.,31228946_9,-1,-1,-1,-1,37125,-1,0.018700529,0.41177464,0.56952477
37130,tumor-infiltrating CTLs,10,12,79,102,"Gene expression profiling determined that Gzmb expression is down-regulated in tumor-infiltrating CTLs of IFNAR1-KO mice as compared to WT mice, and in antigen-specific IFNAR1-KO CTLs as compared to WT CTLs in vivo.",31228946_10,-1,-1,-1,-1,37130,-1,0.004384172,0.72813654,0.2674792
37133,antigen-specific IFNAR1-KO CTLs,23,26,152,183,"Gene expression profiling determined that Gzmb expression is down-regulated in tumor-infiltrating CTLs of IFNAR1-KO mice as compared to WT mice, and in antigen-specific IFNAR1-KO CTLs as compared to WT CTLs in vivo.",31228946_10,-1,-1,-1,-1,37133,-1,0.55547535,0.0031587055,0.44136587
37136,that IFN-I,4,6,31,41,"Mechanistically, we determined that IFN-I activates STAT3 that binds to the Gzmb promoter to activate Gzmb transcription in CTLs.",31228946_11,-1,-1,-1,-1,37136,-1,0.51895136,0.47401753,0.0070311343
37137,STAT3 that,7,9,52,62,"Mechanistically, we determined that IFN-I activates STAT3 that binds to the Gzmb promoter to activate Gzmb transcription in CTLs.",31228946_11,-1,-1,-1,-1,37137,-1,1.9855499e-05,0.99996626,1.3871924e-05
37138,to the,10,12,69,75,"Mechanistically, we determined that IFN-I activates STAT3 that binds to the Gzmb promoter to activate Gzmb transcription in CTLs.",31228946_11,-1,-1,-1,-1,37138,-1,1.8656856e-05,0.9999701,1.1256369e-05
37147,function to,14,16,95,106,CONCLUSION: IFN-I induces STAT3 activation to activate Gzmb expression to enhance CTL effector function to suppress tumor development.,31228946_12,-1,-1,-1,-1,37147,-1,0.00031465673,0.9978465,0.0018388919
37150,CTLs to,9,11,64,71,Human colorectal carcinoma may use down-regulation of IFNAR1 on CTLs to suppress CTL effector function to evade host cancer immunosurveillance.,31228946_13,-1,-1,-1,-1,37150,-1,0.0023006639,0.038721636,0.95897764
37152,function to,14,16,94,105,Human colorectal carcinoma may use down-regulation of IFNAR1 on CTLs to suppress CTL effector function to evade host cancer immunosurveillance.,31228946_13,-1,-1,-1,-1,37152,-1,0.00014640758,0.99942005,0.00043358104
37153,IFN- therapy,0,2,0,13,IFN- therapy has been approved by the Food and Drug Administration (FDA) for the treatment of chronic granulomatous disease and severe malignant osteopetrosis.,31233057_0,-1,-1,-1,-1,37153,-1,0.99493307,0.0029909355,0.00207598
37155,the treatment,15,17,78,91,IFN- therapy has been approved by the Food and Drug Administration (FDA) for the treatment of chronic granulomatous disease and severe malignant osteopetrosis.,31233057_0,-1,-1,-1,-1,37155,-1,2.3046061e-05,0.9999666,1.0377019e-05
37157,IFN--based therapeutic,3,5,22,45,"Despite the promising IFN--based therapeutic applications, its limited success in clinical trials is related with limitations inherent to its molecular properties and with the difficulties to deliver it locally or with adequate periodicity to achieve a therapeutic effect.",31233057_1,-1,-1,-1,-1,37157,-1,0.9874796,0.009027042,0.00349332
37178,These IFN--NPs,0,2,0,15,"These IFN--NPs induced an immunostimulatory profile on dendritic cells (DCs) with increased cell surface costimulatory molecules and secretion of pro-inflammatory cytokines, including IL-6, IL-12p40 and TNF-.",31233057_6,-1,-1,-1,-1,37178,-1,0.0025924263,0.9970651,0.00034247516
37183,TNF-,29,30,204,209,"These IFN--NPs induced an immunostimulatory profile on dendritic cells (DCs) with increased cell surface costimulatory molecules and secretion of pro-inflammatory cytokines, including IL-6, IL-12p40 and TNF-.",31233057_6,0,1,-1,-1,37183,-1,0.00023416021,0.9997203,4.558347e-05
37185,the IL-10-stimulated,3,5,25,45,"IFN--NPs also modulated the IL-10-stimulated macrophage profile, increasing their ability to secrete the pro-inflammatory cytokines IL-6, IL-12p40 and TNF-.",31233057_7,-1,-1,-1,-1,37185,-1,0.0054248422,0.99414825,0.00042691306
37189,cytokines IL-6,15,17,123,137,"IFN--NPs also modulated the IL-10-stimulated macrophage profile, increasing their ability to secrete the pro-inflammatory cytokines IL-6, IL-12p40 and TNF-.",31233057_7,-1,-1,-1,-1,37189,-1,0.9997942,5.0719987e-05,0.00015502844
37190,TNF-,20,21,152,157,"IFN--NPs also modulated the IL-10-stimulated macrophage profile, increasing their ability to secrete the pro-inflammatory cytokines IL-6, IL-12p40 and TNF-.",31233057_7,0,1,-1,-1,37190,-1,9.0783346e-05,0.99987674,3.240668e-05
37213,to their,1,3,4,12,"Due to their ease of synthesis, good biocompatibility and designable bioactivity, peptide derivatives-based supramolecular nanomaterials have attracted increasing interest in improving the immunogenicity of cancer vaccines.",31244959_1,-1,-1,-1,-1,37213,-1,2.5443169e-05,0.9999639,1.0716097e-05
37214,peptide,13,14,82,89,"Due to their ease of synthesis, good biocompatibility and designable bioactivity, peptide derivatives-based supramolecular nanomaterials have attracted increasing interest in improving the immunogenicity of cancer vaccines.",31244959_1,0,-1,2,-1,37214,-1,9.708771e-05,0.9998331,6.978588e-05
37219,peptide,24,25,178,185,"Methods: Herein, we synthesized an NF-B-activating supramolecular nanoadjuvant (3DSNA) that is prepared by pH-triggering self-assembly of a positively charged D-configurational peptide derivative.",31244959_2,0,-1,2,-1,37219,-1,0.0003538543,0.99901855,0.00062762556
37225,factors,13,14,92,99,"Then, 3DSNA promotes ingestion and cross-presentation of OVA, upregulation of costimulatory factors (CD80 and CD86) and secretion of proinflammatory cytokines (IL-6 and IL-12) by dendritic cells (DCs), accompanied by activation of the innate immune response (NF-B signaling), resulting in long-term antigen-specific memory and effector CD8+ T cells response.",31244959_5,0,1,-1,-1,37225,-1,0.014437709,0.98408324,0.0014790989
37231,the innate immune response,40,44,231,257,"Then, 3DSNA promotes ingestion and cross-presentation of OVA, upregulation of costimulatory factors (CD80 and CD86) and secretion of proinflammatory cytokines (IL-6 and IL-12) by dendritic cells (DCs), accompanied by activation of the innate immune response (NF-B signaling), resulting in long-term antigen-specific memory and effector CD8+ T cells response.",31244959_5,-1,-1,-1,-1,37231,-1,0.24396256,0.7545244,0.0015129618
37236,the tumor,38,40,268,277,"When compared with conventional aluminum hydroxide adjuvant and the corresponding L-configurational supramolecular nanoadjuvant (3LSNA), 3DSNA-adjuvanted OVA (3DSNA+OVA) significantly prevents oncogenesis in nave mice with a complete response rate of 60 %, restrains the tumor growth and prolongs the survival of melanoma-bearing mice.",31244959_6,-1,-1,-1,-1,37236,-1,2.0004036e-05,0.99996924,1.06948155e-05
37244,the tumor,7,9,49,58,Macrophages play an important role in regulating the tumor microenvironment (TME).,31249575_0,-1,-1,-1,-1,37244,-1,2.0204081e-05,0.9999691,1.0636065e-05
37247,the zinc finger protein,24,28,126,149,"Here we show that classical (M1) macrophage polarization reduced expression of LSD1, nuclear REST corepressor 1 (CoREST), and the zinc finger protein SNAIL.",31249575_1,-1,-1,-1,-1,37247,-1,2.9250257e-05,0.9999492,2.1572396e-05
37252,targeted the,28,30,167,179,"The LSD1 inhibitor phenelzine targeted both the flavin adenine dinucleotide (FAD) and CoREST binding domains of LSD1, unlike the LSD1 inhibitor GSK2879552, which only targeted the FAD domain.",31249575_2,-1,-1,-1,-1,37252,-1,2.616361e-05,0.9999578,1.5986387e-05
37260,complex to,23,25,161,171,"Overall, the LSD1 inhibitors phenelzine and GSK2879552 are useful tools for dissecting the contribution of LSD1 demethylase activity and the nuclear LSD1-CoREST complex to switching macrophage polarization programs.",31249575_4,-1,-1,-1,-1,37260,-1,3.2022686e-05,0.99994826,1.9656674e-05
37267,T cell to,5,8,35,44,"Fas induces apoptosis in activated T cell to maintain immune homeostasis, but the effects of non-apoptotic Fas signaling on T cells remain unclear.",31266950_0,-1,-1,-1,-1,37267,-1,0.0014676723,0.030761456,0.9677709
37271,TH9 cell,6,8,31,39,Here we show that Fas promotes TH9 cell differentiation by activating NF-B via Ca2+-dependent PKC- activation.,31266950_1,-1,-1,-1,-1,37271,-1,7.5852826e-05,0.00018007736,0.9997441
37275,TH9 transcription,18,20,121,138,"In addition, PKC- also phosphorylates p38 to inactivate NFAT1 and reduce NFAT1-NF-B synergy to promote the Fas-induced TH9 transcription program.",31266950_2,-1,-1,-1,-1,37275,-1,4.3273783e-05,0.9999118,4.4992677e-05
37276,TH9 cell,8,10,66,74,"Fas ligation exacerbates inflammatory bowel disease by increasing TH9 cell differentiation, and promotes antitumor activity in p38 inhibitor-treated TH9 cells.",31266950_3,-1,-1,-1,-1,37276,-1,5.4450476e-05,8.45877e-05,0.9998609
37277,TH9 cells,19,21,149,158,"Fas ligation exacerbates inflammatory bowel disease by increasing TH9 cell differentiation, and promotes antitumor activity in p38 inhibitor-treated TH9 cells.",31266950_3,-1,-1,-1,-1,37277,-1,5.1478397e-05,7.891438e-05,0.9998696
37279,adverse effects,11,13,86,101,"Furthermore, low-dose p38 inhibitor suppresses tumor growth without inducing systemic adverse effects.",31266950_4,0,1,-1,-1,37279,-1,0.0008953224,0.9988335,0.00027123909
37282,TH9 cell,7,9,40,48,"In patients with tumor, relatively high TH9 cell numbers are associated with good prognosis.",31266950_5,-1,-1,-1,-1,37282,-1,9.481546e-05,0.0002004324,0.99970466
37286,therapy,17,18,89,96,Our study thus implicates Fas in CD4+ T cells as a target for inflammatory bowel disease therapy.,31266950_6,0,1,-1,-1,37286,-1,2.272197e-05,0.99996424,1.30705475e-05
37287,TH9 cell,15,17,100,108,"Furthermore, simultaneous Fas ligation and low-dose p38 inhibition may be an effective approach for TH9 cell induction and cancer therapy.",31266950_7,-1,-1,-1,-1,37287,-1,5.2129722e-05,9.559063e-05,0.9998523
37288,therapy,20,21,130,137,"Furthermore, simultaneous Fas ligation and low-dose p38 inhibition may be an effective approach for TH9 cell induction and cancer therapy.",31266950_7,0,1,-1,-1,37288,-1,2.929372e-05,0.9999567,1.3979071e-05
37295,that TET2,3,5,13,22,"Here we show that TET2 mediates interferon  (IFN)-JAK-STAT signaling pathway to control chemokine and PD-L1 expression, lymphocyte infiltration and cancer immunity.",31310587_2,-1,-1,-1,-1,37295,-1,2.185717e-05,0.9999678,1.0344859e-05
37300,immunity,22,23,157,165,"Here we show that TET2 mediates interferon  (IFN)-JAK-STAT signaling pathway to control chemokine and PD-L1 expression, lymphocyte infiltration and cancer immunity.",31310587_2,0,-1,2,-1,37300,-1,0.9988288,0.00071608246,0.00045507774
37302,STAT1 to,2,4,16,24,IFN stimulated STAT1 to bind TET2 and recruit TET2 to hydroxymethylate chemokine and PD-L1 genes.,31310587_3,-1,-1,-1,-1,37302,-1,2.5037913e-05,0.99995816,1.6806196e-05
37304,TET2 to,8,10,47,54,IFN stimulated STAT1 to bind TET2 and recruit TET2 to hydroxymethylate chemokine and PD-L1 genes.,31310587_3,-1,-1,-1,-1,37304,-1,2.3780145e-05,0.99996114,1.5133825e-05
37308,TH1-type chemokines,7,9,51,70,Reduced TET activity was associated with decreased TH1-type chemokines and tumor-infiltrating lymphocytes (TILs) and the progression of human colon cancer.,31310587_4,-1,-1,-1,-1,37308,-1,0.0349591,0.95960104,0.0054398184
37309,tumor-infiltrating lymphocytes,10,12,75,105,Reduced TET activity was associated with decreased TH1-type chemokines and tumor-infiltrating lymphocytes (TILs) and the progression of human colon cancer.,31310587_4,-1,-1,-1,-1,37309,-1,0.0051779225,0.86163485,0.1331872
37313,tumor cells,8,10,46,57,"Deletion of Tet2 in murine melanoma and colon tumor cells reduced chemokine expression and TILs, enabling tumors to evade anti-tumor immunity and to resist anti-PD-L1 therapy.",31310587_5,-1,-1,-1,-1,37313,-1,0.0033598726,0.17608711,0.820553
37316,tumors to,17,19,106,115,"Deletion of Tet2 in murine melanoma and colon tumor cells reduced chemokine expression and TILs, enabling tumors to evade anti-tumor immunity and to resist anti-PD-L1 therapy.",31310587_5,-1,-1,-1,-1,37316,-1,2.005703e-05,0.9999703,9.571325e-06
37317,immunity,21,22,133,141,"Deletion of Tet2 in murine melanoma and colon tumor cells reduced chemokine expression and TILs, enabling tumors to evade anti-tumor immunity and to resist anti-PD-L1 therapy.",31310587_5,0,-1,2,-1,37317,-1,0.9989692,0.0007752284,0.00025561464
37319,therapy,26,27,167,174,"Deletion of Tet2 in murine melanoma and colon tumor cells reduced chemokine expression and TILs, enabling tumors to evade anti-tumor immunity and to resist anti-PD-L1 therapy.",31310587_5,0,1,-1,-1,37319,-1,2.437202e-05,0.99996316,1.2441079e-05
37324,immunity,24,25,161,169,"Conversely, stimulating TET activity by systematic injection of its co-factor, ascorbate/vitamin C, increased chemokine and TILs, leading to enhanced anti-tumor immunity and anti-PD-L1 efficacy and extended lifespan of tumor-bearing mice.",31310587_6,0,-1,2,-1,37324,-1,0.99873334,0.0009248637,0.00034175685
37325,lifespan,30,31,207,215,"Conversely, stimulating TET activity by systematic injection of its co-factor, ascorbate/vitamin C, increased chemokine and TILs, leading to enhanced anti-tumor immunity and anti-PD-L1 efficacy and extended lifespan of tumor-bearing mice.",31310587_6,0,-1,2,-1,37325,-1,3.5777204e-05,0.9999491,1.5125765e-05
37332,therapy,13,14,109,116,These results suggest an IFN-JAK-STAT-TET signaling pathway that mediates tumor response to anti-PD-L1/PD-1 therapy and is frequently disrupted in solid tumors.,31310587_7,0,1,-1,-1,37332,-1,2.5604848e-05,0.9999621,1.2313021e-05
37337,therapy,18,19,122,129,"Our findings also suggest TET activity as a biomarker for predicting the efficacy and patient response to anti-PD-1/PD-L1 therapy, and stimulating TET activity as an adjuvant immunotherapy of solid tumors.",31310587_8,0,1,-1,-1,37337,-1,2.9381523e-05,0.99995697,1.3683929e-05
37342,through the,24,26,165,176,"Caloric restriction mimetics (CRMs), compounds that mimic the biochemical effects of nutrient deprivation, administered via systemic route promote antitumor effects through the induction of autophagy and the modulation of the immune microenvironment; however, collateral effects due to metabolic changes and the possible weight loss might potentially limit their administration at long term.",31321243_0,-1,-1,-1,-1,37342,-1,2.3752504e-05,0.9999645,1.1771795e-05
37353,that target,9,11,56,67,"Hydroxycitrate, spermidine, and alpha-lipoic acid, CRMs that target different metabolic enzymes, administered by aerosol, strongly reduced implantation of intravenously injected B16 melanoma cells without overt signs of toxicity, such as weight loss and changes in lung structure.",31321243_2,-1,-1,-1,-1,37353,-1,2.7799084e-05,0.99995387,1.836279e-05
37356,toxicity,32,33,220,228,"Hydroxycitrate, spermidine, and alpha-lipoic acid, CRMs that target different metabolic enzymes, administered by aerosol, strongly reduced implantation of intravenously injected B16 melanoma cells without overt signs of toxicity, such as weight loss and changes in lung structure.",31321243_2,0,1,-1,-1,37356,-1,5.792841e-05,0.99988675,5.5269717e-05
37357,analysis,1,2,17,25,Cytofluorimetric analysis of lung immune infiltrates revealed a significant increase of alveolar macrophages and CD103+ dendritic cells in mice treated with CRMs that paralleled an increased recruitment and activation of both CD3 T lymphocytes and NK cells.,31321243_3,0,1,-1,-1,37357,-1,2.7962673e-05,0.9999505,2.1484879e-05
37365,genes related to,8,11,55,71,"These effects were associated with the upregulation of genes related to M1 phenotype, as IL-12 and STAT-1, and to the decrease of M2 genes, as IL-10 and STAT-6, in adherent fraction of lung immune infiltrate, as revealed by real-time PCR analysis.",31321243_4,-1,-1,-1,-1,37365,-1,2.6861357e-05,0.9999527,2.0504714e-05
37368,to the,20,22,111,117,"These effects were associated with the upregulation of genes related to M1 phenotype, as IL-12 and STAT-1, and to the decrease of M2 genes, as IL-10 and STAT-6, in adherent fraction of lung immune infiltrate, as revealed by real-time PCR analysis.",31321243_4,-1,-1,-1,-1,37368,-1,2.104604e-05,0.9999683,1.06212165e-05
37372,analysis,45,46,238,246,"These effects were associated with the upregulation of genes related to M1 phenotype, as IL-12 and STAT-1, and to the decrease of M2 genes, as IL-10 and STAT-6, in adherent fraction of lung immune infiltrate, as revealed by real-time PCR analysis.",31321243_4,0,1,-1,-1,37372,-1,3.363735e-05,0.9999254,4.0997264e-05
37378,the tumor,28,30,186,195,"Thus, in this proof-of-principle study, we highlight the antitumor effect of CRM aerosol delivery as a new and noninvasive therapeutic approach to locally modulate immunosurveillance at the tumor site in the lung.",31321243_5,-1,-1,-1,-1,37378,-1,1.8618863e-05,0.9999715,9.832086e-06
37405,functions,28,29,176,185,"The increase was not only associated with reduced disease-free survival but also strongly correlated with an increase in FOXP3 mRNA, a master regulator of Treg development and functions.",31325403_5,0,1,2,-1,37405,-1,0.00011417968,0.99982893,5.6827936e-05
37417,transcription factor nuclear factor kappa B,23,29,140,183,Release of interleukin 1 (IL-1) from cancer-associated fibroblasts (CAF) induces CCL22 mRNA expression in oral cancer cells by activating transcription factor nuclear factor kappa B (NF-B).,31325403_8,-1,-1,-1,-1,37417,-1,2.8846882e-05,0.9999558,1.536377e-05
37420,receptor,14,15,68,76,"Our data support a model in which CAF-derived IL-1, CCL22, and its receptor CCR4 foster a protumor environment by promoting cell transformation and Treg infiltration.",31325403_9,0,1,2,-1,37420,-1,0.00091108604,0.009848709,0.98924017
37422,cell transformation,22,24,125,144,"Our data support a model in which CAF-derived IL-1, CCL22, and its receptor CCR4 foster a protumor environment by promoting cell transformation and Treg infiltration.",31325403_9,-1,-1,-1,-1,37422,-1,0.00043023055,0.0048904857,0.99467933
37424,the IL-1-CCL22-CCR4,2,4,16,36,Intervention of the IL-1-CCL22-CCR4 signaling axis may offer a novel therapeutic strategy for oral cancer treatment.,31325403_10,-1,-1,-1,-1,37424,-1,0.019039016,0.88529944,0.09566154
37431,to tumor,16,18,87,95,"Regulatory T (Treg) cells are crucial for immune homeostasis, but they also contribute to tumor immune evasion by promoting a suppressive tumor microenvironment (TME).",31350177_0,-1,-1,-1,-1,37431,-1,2.5427304e-05,0.9999629,1.1638461e-05
37435,deficiency,5,6,44,54,"Mice with Treg cell-restricted Neuropilin-1 deficiency show tumor resistance while maintaining peripheral immune homeostasis, thereby providing a controlled system to interrogate the impact of intratumoral Treg cells on the TME.",31350177_1,0,1,-1,-1,37435,-1,3.5417645e-05,0.99992096,4.3650118e-05
37441,the TME,29,31,220,227,"Mice with Treg cell-restricted Neuropilin-1 deficiency show tumor resistance while maintaining peripheral immune homeostasis, thereby providing a controlled system to interrogate the impact of intratumoral Treg cells on the TME.",31350177_1,-1,-1,-1,-1,37441,-1,2.218052e-05,0.99996674,1.1097195e-05
37444,that Treg cells,9,12,47,62,"Using this and other genetic models, we showed that Treg cells shaped the transcriptional landscape across multiple tumor-infiltrating immune cell types.",31350177_2,-1,-1,-1,-1,37444,-1,0.0031297451,0.26601884,0.73085135
37445,the transcriptional,13,15,70,89,"Using this and other genetic models, we showed that Treg cells shaped the transcriptional landscape across multiple tumor-infiltrating immune cell types.",31350177_2,-1,-1,-1,-1,37445,-1,2.263275e-05,0.9999666,1.0732592e-05
37447,cell types,20,22,142,152,"Using this and other genetic models, we showed that Treg cells shaped the transcriptional landscape across multiple tumor-infiltrating immune cell types.",31350177_2,-1,-1,-1,-1,37447,-1,5.45044e-05,5.6178265e-05,0.9998894
37453,protein,25,26,148,155,"Treg cells suppressed CD8+ Tcell secretion of interferon- (IFN), which would otherwise block the activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated fatty acid synthesis in immunosuppressive (M2-like) tumor-associated macrophages (TAMs).",31350177_3,0,1,-1,-1,37453,-1,2.7969358e-05,0.99994826,2.3761251e-05
37460,that targeting Treg cells,11,15,83,108,"SREBP1 inhibition augmented the efficacy of immune checkpoint blockade, suggesting that targeting Treg cells or their modulation of lipid metabolism in M2-like TAMs could improve cancer immunotherapy.",31350177_5,-1,-1,-1,-1,37460,-1,0.0045511546,0.554169,0.4412799
37462,metabolism,20,21,138,148,"SREBP1 inhibition augmented the efficacy of immune checkpoint blockade, suggesting that targeting Treg cells or their modulation of lipid metabolism in M2-like TAMs could improve cancer immunotherapy.",31350177_5,0,1,2,-1,37462,-1,0.0003209809,0.9991302,0.0005488674
37466,to tumor,25,27,143,151,"BACKGROUND: Interleukin(IL)-30/IL-27p28 production by Prostate Cancer (PC) Stem-Like Cells (SLCs) has proven, in murine models, to be critical to tumor onset and progression.",31366386_0,-1,-1,-1,-1,37466,-1,3.120244e-05,0.99995613,1.2709716e-05
37475,CD4+T,21,22,133,138,"RESULTS: Implantation of PC-SLCs in IL-30KO mice, gave rise to slow growing tumors characterized by apoptotic events associated with CD4+T lymphocyte infiltrates and lack of CD4+Foxp3+ T regulatory cells (Tregs).",31366386_5,-1,-1,-1,-1,37475,-1,0.00012346408,0.00014822008,0.99972826
37494,tumor cells,44,46,329,340,"In patients with high-grade and locally advanced PC, those with IL-30-/-tumors, showed distinct intra-tumoral cytotoxic granule-associated RNA binding protein (TIA-1)+CD4+Tlymphocyte infiltrate, rare Foxp3+Tregs and a lower biochemical recurrence rate compared to patients with IL-30+/+tumors in which IL-30 is expressed in both tumor cells and infiltrating leukocytes.",31366386_9,-1,-1,-1,-1,37494,-1,0.0019252156,0.056257013,0.94181776
37497,CD4+T,16,17,118,123,"CONCLUSION: The lack of host leukocyte-derived IL-30 inhibits Tregs expansion, promotes intra-tumoral infiltration of CD4+T lymphocytes and cancer cell apoptosis.",31366386_10,-1,-1,-1,-1,37497,-1,9.524657e-05,0.0001028535,0.99980193
37500,cytotoxic T lymphocyte activation,14,18,79,112,"Concomitant lack of MDC influx, obtained by IL-30 silencing in PC-SLCs, boosts cytotoxic T lymphocyte activation and cancer cell apoptosis resulting in a synergistic tumor suppression with the prospective benefit of better survival for patients with advanced disease.",31366386_11,-1,-1,-1,-1,37500,-1,7.702429e-05,5.6473218e-05,0.9998665
37506,protein,3,4,27,34,The WD40 repeat-containing protein EED is a core component of PRC2 and enhances PRC2 activity through interaction with H3K27me3.,31395608_1,0,1,-1,-1,37506,-1,5.603149e-05,0.9998683,7.564854e-05
37516,T-cell,32,33,185,191,BR-001 was also efficacious in syngeneic CT26 colon tumor-bearing mice; oral dosing of 30 mg/kg of BR-001 led to 59.3% tumor growth suppression and increased frequency of effector CD8+ T-cell infiltrates in tumors.,31395608_6,-1,1,2,-1,37516,-1,3.6696256e-05,5.441021e-05,0.9999089
37518,analysis,1,2,16,24,"Pharmacodynamic analysis revealed that CXCL10 was highly upregulated, suggesting that CXCL10 triggers the trafficking of CD8+ T cells toward tumor sites.",31395608_7,0,1,-1,-1,37518,-1,2.8472185e-05,0.99995077,2.0788008e-05
37519,that CXCL10,3,5,34,45,"Pharmacodynamic analysis revealed that CXCL10 was highly upregulated, suggesting that CXCL10 triggers the trafficking of CD8+ T cells toward tumor sites.",31395608_7,-1,-1,-1,-1,37519,-1,0.8612148,0.1323107,0.006474446
37520,that CXCL10 triggers the trafficking,10,15,81,117,"Pharmacodynamic analysis revealed that CXCL10 was highly upregulated, suggesting that CXCL10 triggers the trafficking of CD8+ T cells toward tumor sites.",31395608_7,-1,-1,-1,-1,37520,-1,0.0004493564,0.99937916,0.00017150951
37521,T cells toward tumor,18,22,126,146,"Pharmacodynamic analysis revealed that CXCL10 was highly upregulated, suggesting that CXCL10 triggers the trafficking of CD8+ T cells toward tumor sites.",31395608_7,-1,-1,-1,-1,37521,-1,0.0032697686,0.15659365,0.8401365
37523,time that,6,8,38,47,Our results demonstrate for the first time that inhibition of EED modulates the tumor immune microenvironment to induce regression of colon tumors and therefore has the potential to be used in combination with immune-oncology therapy.,31395608_8,-1,-1,-1,-1,37523,-1,1.908195e-05,0.9999697,1.1188618e-05
37524,the tumor,12,14,76,85,Our results demonstrate for the first time that inhibition of EED modulates the tumor immune microenvironment to induce regression of colon tumors and therefore has the potential to be used in combination with immune-oncology therapy.,31395608_8,-1,-1,-1,-1,37524,-1,1.7661712e-05,0.99997365,8.720738e-06
37530,therapy,34,35,226,233,Our results demonstrate for the first time that inhibition of EED modulates the tumor immune microenvironment to induce regression of colon tumors and therefore has the potential to be used in combination with immune-oncology therapy.,31395608_8,0,1,-1,-1,37530,-1,2.5666528e-05,0.99996006,1.4313679e-05
37536,the tumor,21,23,124,133,"SIGNIFICANCE: BR-001, a potent inhibitor of the EED subunit of the PRC2 complex, suppresses tumor progression by modulating the tumor microenvironment.",31395608_9,-1,-1,-1,-1,37536,-1,2.0994803e-05,0.99996936,9.598739e-06
37537,The helper T cell,0,4,0,17,"The helper T cell 9 (Thelper-9, Th9), as a functional subgroup of CD4+T cells, was first discovered in 2008.",31414895_0,-1,-1,-1,-1,37537,-1,0.0029336172,0.08168288,0.91538346
37540,functional,13,14,43,53,"The helper T cell 9 (Thelper-9, Th9), as a functional subgroup of CD4+T cells, was first discovered in 2008.",31414895_0,0,1,2,-1,37540,-1,0.00011161435,0.9998179,7.048034e-05
37541,CD4+T cells,16,18,66,77,"The helper T cell 9 (Thelper-9, Th9), as a functional subgroup of CD4+T cells, was first discovered in 2008.",31414895_0,-1,-1,-1,-1,37541,-1,6.0138795e-05,6.0566785e-05,0.99987924
37542,Th9 cells,0,2,0,9,Th9 cells expressed transcription factor PU.1 and cytokine interleukin-9 (IL-9) characteristically.,31414895_1,-1,-1,-1,-1,37542,-1,9.647285e-05,0.00038953693,0.999514
37544,cytokine interleukin-9,7,9,50,72,Th9 cells expressed transcription factor PU.1 and cytokine interleukin-9 (IL-9) characteristically.,31414895_1,-1,-1,-1,-1,37544,-1,0.99985015,5.1242238e-05,9.8610304e-05
37546,that the,4,6,29,37,"Recent researches have shown that the differentiation of Th9 cells was coregulated by cytokine transforming growth factor , IL-4, and various transcription factors.",31414895_2,-1,-1,-1,-1,37546,-1,1.8378692e-05,0.9999726,9.04734e-06
37547,Th9 cells,8,10,57,66,"Recent researches have shown that the differentiation of Th9 cells was coregulated by cytokine transforming growth factor , IL-4, and various transcription factors.",31414895_2,-1,-1,-1,-1,37547,-1,0.00017332424,0.0010470679,0.9987796
37548,cytokine transforming growth factor,13,17,86,121,"Recent researches have shown that the differentiation of Th9 cells was coregulated by cytokine transforming growth factor , IL-4, and various transcription factors.",31414895_2,-1,-1,-1,-1,37548,-1,0.99938905,0.0003014013,0.00030953737
37550,Th9 cells,0,2,0,9,"Th9 cells, as a new player, played an important role in various immune-related diseases, including tumors, inflammatory diseases, parasite infection, and other diseases.",31414895_3,-1,-1,-1,-1,37550,-1,6.270233e-05,0.00014840544,0.99978894
37555,the related,6,8,30,41,"In this article, we summarize the related research progress and discuss the possible prospect.",31414895_4,-1,-1,-1,-1,37555,-1,2.5866537e-05,0.9999596,1.4528463e-05
37558,the natural,3,5,16,27,The ligands for the natural killer group 2 (NKG2D) protein render tumor cells susceptible to NKG2D-dependent immune cell attack.,31427736_0,-1,-1,-1,-1,37558,-1,3.189313e-05,0.999956,1.205966e-05
37559,protein,11,12,51,58,The ligands for the natural killer group 2 (NKG2D) protein render tumor cells susceptible to NKG2D-dependent immune cell attack.,31427736_0,0,1,-1,-1,37559,-1,0.00012476317,0.99979657,7.864851e-05
37560,tumor cells,13,15,66,77,The ligands for the natural killer group 2 (NKG2D) protein render tumor cells susceptible to NKG2D-dependent immune cell attack.,31427736_0,-1,-1,-1,-1,37560,-1,0.003959214,0.4146836,0.5813571
37566,tumor cells,12,14,71,82,"We previously discovered that engagement of activated CD8+ T cells and tumor cells induces NKG2D ligands on tumor cells, but the underlying mechanism remains to be defined.",31427736_2,-1,-1,-1,-1,37566,-1,0.0043109953,0.36772943,0.6279596
37567,tumor cells,18,20,108,119,"We previously discovered that engagement of activated CD8+ T cells and tumor cells induces NKG2D ligands on tumor cells, but the underlying mechanism remains to be defined.",31427736_2,-1,-1,-1,-1,37567,-1,0.0043730573,0.40994018,0.58568674
37577,receptors,12,13,72,81,"Our results supported the notion that, upon engagement with the cognate receptors, CD137 ligand and CD40 initiates activation of nuclear factor-kappa B (NF-B) signaling in tumor cells even in the absence of CD8+ T cells.",31427736_4,0,1,2,-1,37577,-1,0.0004853436,0.0028161765,0.99669844
37578,factor-kappa,22,23,137,149,"Our results supported the notion that, upon engagement with the cognate receptors, CD137 ligand and CD40 initiates activation of nuclear factor-kappa B (NF-B) signaling in tumor cells even in the absence of CD8+ T cells.",31427736_4,0,1,-1,-1,37578,-1,6.296796e-05,0.99990416,3.2885877e-05
37579,tumor cells,29,31,173,184,"Our results supported the notion that, upon engagement with the cognate receptors, CD137 ligand and CD40 initiates activation of nuclear factor-kappa B (NF-B) signaling in tumor cells even in the absence of CD8+ T cells.",31427736_4,-1,-1,-1,-1,37579,-1,0.0036763027,0.45759395,0.5387298
37585,factor,24,25,193,199,"Like tumor and CD8+ T cell contact-dependent NKG2D ligand induction, this CD137L/CD40-mediated signaling activation was associated with elevated levels of acetyltransferase P300/CBP-associated factor (PCAF), whereas inhibition of phosphorylated NF-B abrogated PCAF induction.",31427736_5,0,1,-1,-1,37585,-1,0.00012389955,0.999795,8.110326e-05
37589,TNF,18,19,127,131,"Although stimulation of CD137L/CD40-mediated signaling is vital, inflammatory cytokines, including interferon gamma (IFN) and TNF, also facilitate NKG2D ligand-induced immune surveillance via both facilitating T-cell chemotaxis and CD137L/CD40 induced NF-B/PCAF activation.",31427736_6,0,1,-1,-1,37589,-1,8.680431e-05,0.9998913,2.1936352e-05
37590,T-cell chemotaxis,29,31,212,229,"Although stimulation of CD137L/CD40-mediated signaling is vital, inflammatory cytokines, including interferon gamma (IFN) and TNF, also facilitate NKG2D ligand-induced immune surveillance via both facilitating T-cell chemotaxis and CD137L/CD40 induced NF-B/PCAF activation.",31427736_6,-1,-1,-1,-1,37590,-1,0.027208436,0.0013379891,0.97145355
37591,tumor cells,20,22,130,141,"Collectively, our results unveil a novel mechanism of NKG2D ligand upregulation involving reverse signaling of CD40 and CD137L on tumor cells which, along with inflammatory cytokines IFN and TNF, stimulate downstream NF-B and PCAF activation.",31427736_7,-1,-1,-1,-1,37591,-1,0.004407132,0.47207776,0.52351516
37592,cytokines IFN,27,29,173,187,"Collectively, our results unveil a novel mechanism of NKG2D ligand upregulation involving reverse signaling of CD40 and CD137L on tumor cells which, along with inflammatory cytokines IFN and TNF, stimulate downstream NF-B and PCAF activation.",31427736_7,-1,-1,-1,-1,37592,-1,0.999866,3.8359696e-05,9.553525e-05
37593,TNF,30,31,192,196,"Collectively, our results unveil a novel mechanism of NKG2D ligand upregulation involving reverse signaling of CD40 and CD137L on tumor cells which, along with inflammatory cytokines IFN and TNF, stimulate downstream NF-B and PCAF activation.",31427736_7,0,1,-1,-1,37593,-1,0.00024054789,0.9997298,2.9594823e-05
37595,T-cell therapy,11,13,87,101,Understanding this mechanism may help in development of induced NKG2D ligand-dependent T-cell therapy against cancers.,31427736_8,-1,-1,-1,-1,37595,-1,0.0011436644,0.03342224,0.96543413
37604,the regulation,7,9,37,51,We investigated the role of IL-17 in the regulation of expression of programmed cell death 1 ligand 1 in ovarian cancer by evaluating changes in the number of IL-17-producing cluster of differentiation 4 helper T cells (Th17) and T cells (T17) in PBMC of 52 gynecological cancer patients (including 30 ovarian cancer patients) and 18 healthy controls.,31432577_2,-1,-1,-1,-1,37604,-1,1.6323671e-05,0.99997485,8.834274e-06
37620,factors,13,14,77,84,We found that programmed cell death 1 ligand 1 expression and its associated factors (IL-6 and phospho-signal transducer and activator of transcription 3) were induced by IL-17 in an ovarian cancer cell line.,31432577_6,0,1,-1,-1,37620,-1,8.277126e-05,0.9998404,7.684765e-05
37636,immunity,33,34,222,230,"Kynurenine pathway (KP) activation by the enzymatic activity of indoleamine 2,3-dioxygenase1 (IDO1) and kynurenine (KYN) production represents an attractive target for reducing tumour progression and improving anti-tumour immunity in multiple cancers.",31434983_0,0,-1,2,-1,37636,-1,0.99937785,0.00036309016,0.00025903946
37639,T-cell status,8,10,57,70,"The association of the kynurenine metabolic pathway with T-cell status in the tumour microenvironment were characterized, using gene expression data of 368 cutaneous skin melanoma (SKCM) patients from the TCGA cohort.",31434983_2,-1,-1,-1,-1,37639,-1,0.00018873982,0.0010303652,0.9987809
37640,the tumour,11,13,74,84,"The association of the kynurenine metabolic pathway with T-cell status in the tumour microenvironment were characterized, using gene expression data of 368 cutaneous skin melanoma (SKCM) patients from the TCGA cohort.",31434983_2,-1,-1,-1,-1,37640,-1,1.9267565e-05,0.9999702,1.058441e-05
37642,the TCGA,31,33,201,209,"The association of the kynurenine metabolic pathway with T-cell status in the tumour microenvironment were characterized, using gene expression data of 368 cutaneous skin melanoma (SKCM) patients from the TCGA cohort.",31434983_2,-1,-1,-1,-1,37642,-1,2.421127e-05,0.9999602,1.5590967e-05
37646,T-cells,28,29,159,166,"Based on the identified correlations, we characterized the production of KYN, 3-HK, and KYNA in vitro using melanoma-derived cell lines and primary CD4+ CD25- T-cells.",31434983_3,-1,1,2,-1,37646,-1,0.0015375683,0.10484449,0.89361787
37648,T-cells,5,6,23,30,"Activation of the CD4+ T-cells produced IFN, which yielded increased levels of KYN and KYNA.",31434983_4,-1,1,2,-1,37648,-1,0.00053006754,0.016754638,0.9827153
37650,T-cells,13,14,84,91,"Concurrently, kynurenine 3-monooxygenase (KMO) expression and proliferation of CD4+ T-cells were reduced, whereas exhaustion markers such as PD-L1, AHR, FOXP3, and CTLA4 were increased.",31434983_5,-1,1,2,-1,37650,-1,5.5714518e-05,0.00016062615,0.9997837
37654,analysis,3,4,17,25,"Additionally, an analysis of the correlation network reconstructed using TCGA-SKCM emphasized KMO and KYNU with high variability among BRAF wild-type compared with V600E, which underscored their role in distinct CD4+ T-cell behavior in tumour immunity.",31434983_6,0,1,-1,-1,37654,-1,3.1120573e-05,0.9999516,1.7297816e-05
37658,T-cell,33,34,217,223,"Additionally, an analysis of the correlation network reconstructed using TCGA-SKCM emphasized KMO and KYNU with high variability among BRAF wild-type compared with V600E, which underscored their role in distinct CD4+ T-cell behavior in tumour immunity.",31434983_6,-1,1,2,-1,37658,-1,3.3807104e-05,4.7878875e-05,0.9999182
37659,tumour immunity,36,38,236,251,"Additionally, an analysis of the correlation network reconstructed using TCGA-SKCM emphasized KMO and KYNU with high variability among BRAF wild-type compared with V600E, which underscored their role in distinct CD4+ T-cell behavior in tumour immunity.",31434983_6,-1,-1,-1,-1,37659,-1,0.022103004,0.9771309,0.0007661681
37666,T-cell,36,37,221,227,"Our results suggest that, in addition to IDO1, there is an alternative immune regulatory mechanism associated with the lower KMO expression and the higher KYNA production, which contributes to dysfunctional effector CD4+ T-cell response.",31434983_7,-1,1,2,-1,37666,-1,4.248954e-05,5.7608595e-05,0.9999
37670,tumor cells,10,12,65,76,"Blocking the PD-L1/PD-1 pathway to prevent the immune evasion of tumor cells is a powerful approach for treating multiple cancers, including hepatocellular carcinoma (HCC).",31437792_0,-1,-1,-1,-1,37670,-1,0.003965763,0.44240704,0.55362713
37677,these two,25,27,156,165,"Previous studies have shown that baicalein and baicalin are directly cytotoxic to some tumors, here we demonstrate that in addition to direct cytotoxicity, these two flavonoids stimulate the T cell mediated immune response against tumors through reduction of PD-L1 expression in cancer cells.",31437792_1,-1,-1,-1,-1,37677,-1,3.105874e-05,0.9999567,1.2205012e-05
37678,the T cell,29,32,187,197,"Previous studies have shown that baicalein and baicalin are directly cytotoxic to some tumors, here we demonstrate that in addition to direct cytotoxicity, these two flavonoids stimulate the T cell mediated immune response against tumors through reduction of PD-L1 expression in cancer cells.",31437792_1,-1,-1,-1,-1,37678,-1,0.0036587422,0.23997186,0.75636935
37680,tumors through,36,38,231,245,"Previous studies have shown that baicalein and baicalin are directly cytotoxic to some tumors, here we demonstrate that in addition to direct cytotoxicity, these two flavonoids stimulate the T cell mediated immune response against tumors through reduction of PD-L1 expression in cancer cells.",31437792_1,-1,-1,-1,-1,37680,-1,1.6896705e-05,0.9999751,8.022195e-06
37687,these two,12,14,82,91,PD-L1 upregulation induced by interferon- (IFN-) was significantly inhibited by these two flavonoids in vitro.,31437792_3,-1,-1,-1,-1,37687,-1,4.1997675e-05,0.9999417,1.6252316e-05
37689,T cells to,8,11,57,67,"Both baicalein and baicalin enhanced the cytotoxicity of T cells to eliminate tumor cells, which was abrogated after HCC cells were transfected with a PD-L1 overexpression plasmid or after T cells were pretreated with an anti-PD-1 blocking antibody.",31437792_4,-1,-1,-1,-1,37689,-1,0.0014183522,0.0251312,0.9734504
37690,tumor cells,12,14,78,89,"Both baicalein and baicalin enhanced the cytotoxicity of T cells to eliminate tumor cells, which was abrogated after HCC cells were transfected with a PD-L1 overexpression plasmid or after T cells were pretreated with an anti-PD-1 blocking antibody.",31437792_4,-1,-1,-1,-1,37690,-1,0.00391575,0.3696249,0.6264593
37695,that the IFN--induced,4,7,39,61,"Further mechanistic research indicated that the IFN--induced expression and promoter activity of PD-L1 were suppressed by these two flavonoids, and these effects were mediated by STAT3 activity inhibition.",31437792_5,-1,-1,-1,-1,37695,-1,0.0013575638,0.9984269,0.00021558184
37696,these two,16,18,123,132,"Further mechanistic research indicated that the IFN--induced expression and promoter activity of PD-L1 were suppressed by these two flavonoids, and these effects were mediated by STAT3 activity inhibition.",31437792_5,-1,-1,-1,-1,37696,-1,4.1125284e-05,0.9999399,1.896294e-05
37704,tumor cells,22,24,166,177,"Therefore, baicalein and baicalin decreased STAT3 activity, further downregulated IFN--induced PD-L1 expression and subsequently restored T cell sensitivity to kill tumor cells.",31437792_6,-1,-1,-1,-1,37704,-1,0.003921195,0.38336828,0.61271054
37708,that these,25,27,176,186,Our findings provide novel insight into the anticancer effects of baicalein and baicalin through which tumor growth is inhibited by PD-L1 expression downregulation and suggest that these flavonoids have great potential for clinical treatment.,31437792_7,-1,-1,-1,-1,37708,-1,1.8291792e-05,0.9999738,7.937916e-06
37711,cells generate,5,7,20,34,Natural killer (NK) cells generate proinflammatory cytokines that are required to contain infections and tumor growth.,31515257_0,-1,-1,-1,-1,37711,-1,0.0037548507,0.1139363,0.88230884
37712,cytokines that,8,10,51,65,Natural killer (NK) cells generate proinflammatory cytokines that are required to contain infections and tumor growth.,31515257_0,-1,-1,-1,-1,37712,-1,0.94630826,0.050987937,0.0027038234
37717,cell functions,8,10,61,75,"However, the posttranscriptional mechanisms that regulate NK cell functions are not fully understood.",31515257_1,-1,-1,-1,-1,37717,-1,0.00017959066,0.00061649136,0.99920386
37725,factors,9,10,62,69,"However, loss of Mirc11 reduced generation of proinflammatory factors in vitro and interferon--dependent clearance of Listeria monocytogenes or B16F10 melanoma in vivo by NK cells.",31515257_4,0,1,-1,-1,37725,-1,0.9992669,0.0004856849,0.00024745066
37728,These functional,0,2,0,16,"These functional changes resulted from Mirc11 silencing ubiquitin modifiers A20, Cbl-b, and Itch, allowing TRAF6-dependent activation of NF-B and AP-1.",31515257_5,-1,-1,-1,-1,37728,-1,3.310253e-05,0.9999485,1.8424244e-05
37733,proteins,13,14,68,76,"Lack of Mirc11 caused increased translation of A20, Cbl-b, and Itch proteins, resulting in deubiquitylation of scaffolding K63 and addition of degradative K48 moieties on TRAF6.",31515257_6,0,1,-1,-1,37733,-1,0.0004297377,0.99828583,0.0012844516
37735,function,6,7,37,45,"Collectively, our results describe a function of Mirc11 that regulates generation of proinflammatory cytokines from effector lymphocytes.",31515257_7,0,1,2,-1,37735,-1,4.1529074e-05,0.9999287,2.9808813e-05
37740,the treatment,7,9,61,74,Immune-checkpoint blockade antibodies have been approved for the treatment of cancer.,31515801_0,-1,-1,-1,-1,37740,-1,2.4056599e-05,0.99996376,1.2162722e-05
37744,receptor,2,3,25,33,"Agonistic anti-Toll-like receptor 4 (TLR4) monoclonal antibodies (mAbs) activate only cell-surface TLR4; in contrast, lipopolysaccharide (LPS) activates both TLR4 and intracellular inflammatory caspases.",31515801_2,0,1,2,-1,37744,-1,0.00015984183,0.00036863558,0.9994715
37746,cell-surface TLR4,14,16,86,103,"Agonistic anti-Toll-like receptor 4 (TLR4) monoclonal antibodies (mAbs) activate only cell-surface TLR4; in contrast, lipopolysaccharide (LPS) activates both TLR4 and intracellular inflammatory caspases.",31515801_2,-1,-1,-1,-1,37746,-1,0.0014401512,0.07530764,0.9232522
37751,T-cell-mediated,14,15,76,91,"In this study, we investigated the adjuvant activity of an anti-TLR4 mAb in T-cell-mediated antitumour immunity.",31515801_3,-1,1,2,-1,37751,-1,4.087091e-05,8.495739e-05,0.9998741
37752,immunity,16,17,103,111,"In this study, we investigated the adjuvant activity of an anti-TLR4 mAb in T-cell-mediated antitumour immunity.",31515801_3,0,-1,2,-1,37752,-1,0.9990219,0.00062851864,0.00034956486
37755,antigen-specific T-cells,7,9,44,68,The anti-TLR4 mAb induced the activation of antigen-specific T-cells in adoptive transfer studies.,31515801_4,-1,-1,-1,-1,37755,-1,0.25468588,0.0038868561,0.7414273
37761,plus the,13,15,82,90,The antitumour effect of anti-PD-1 mAb was enhanced in mice administered with OVA plus the anti-TLR4 mAb.,31515801_6,-1,-1,-1,-1,37761,-1,3.5183704e-05,0.99995136,1.3510714e-05
37764,T-cells,4,5,37,44,The OVA-specific IFN--producing CD8 T-cells were induced by administration of OVA and the anti-TLR4 mAb.,31515801_7,-1,1,2,-1,37764,-1,0.0014492671,0.060618155,0.93793255
37768,T-cells,16,17,82,89,"The suppression of tumour growth was diminished by depletion of CD8, but not CD4, T-cells.",31515801_8,-1,1,2,-1,37768,-1,3.584037e-05,6.783985e-05,0.9998963
37770,to the,3,5,26,32,"The inflammatory response to the anti-TLR4 mAb was of significantly lesser magnitude than that to LPS, as assessed by NF-B activation and production of TNF-, IL-6 and IL-1.",31515801_9,-1,-1,-1,-1,37770,-1,2.2417842e-05,0.9999645,1.3072732e-05
37771,than that to LPS,12,16,85,101,"The inflammatory response to the anti-TLR4 mAb was of significantly lesser magnitude than that to LPS, as assessed by NF-B activation and production of TNF-, IL-6 and IL-1.",31515801_9,-1,-1,-1,-1,37771,-1,3.4767374e-05,0.999943,2.2206408e-05
37772,TNF-,25,26,153,158,"The inflammatory response to the anti-TLR4 mAb was of significantly lesser magnitude than that to LPS, as assessed by NF-B activation and production of TNF-, IL-6 and IL-1.",31515801_9,0,1,-1,-1,37772,-1,0.00016308788,0.99978894,4.7931426e-05
37778,to those,14,16,94,102,Administration of LPS (at a dose that elicited levels of proinflammatory cytokines comparable to those by the anti-TLR4 mAb) plus OVA induced no or less-marked activation of OVA-specific T-cells and failed to suppress tumour growth in mice.,31515801_10,-1,-1,-1,-1,37778,-1,3.19577e-05,0.9999502,1.7846745e-05
37781,T-cells,30,31,187,194,Administration of LPS (at a dose that elicited levels of proinflammatory cytokines comparable to those by the anti-TLR4 mAb) plus OVA induced no or less-marked activation of OVA-specific T-cells and failed to suppress tumour growth in mice.,31515801_10,-1,1,2,-1,37781,-1,4.095624e-05,6.483813e-05,0.99989414
37785,T-cell-dependent,10,11,62,78,"In conclusion, the agonistic anti-TLR4 mAb induces potent CD8 T-cell-dependent antitumour immunity and an inflammatory response of lesser magnitude than does LPS.",31515801_11,-1,1,2,-1,37785,-1,4.1390944e-05,6.09594e-05,0.9998977
37786,immunity,12,13,90,98,"In conclusion, the agonistic anti-TLR4 mAb induces potent CD8 T-cell-dependent antitumour immunity and an inflammatory response of lesser magnitude than does LPS.",31515801_11,0,-1,2,-1,37786,-1,0.99950624,0.00027440678,0.00021940171
37791,factor-,2,3,20,28,"Transforming growth factor- (TGF-) is produced by tumors, and increased amounts of this cytokine in the tumor microenvironment and serum are associated with poor patient survival.",31530731_0,0,1,-1,-1,37791,-1,0.99978286,7.425383e-05,0.00014288511
37794,this cytokine,15,17,85,98,"Transforming growth factor- (TGF-) is produced by tumors, and increased amounts of this cytokine in the tumor microenvironment and serum are associated with poor patient survival.",31530731_0,-1,-1,-1,-1,37794,-1,0.54308265,0.4474556,0.009461764
37795,the tumor,18,20,102,111,"Transforming growth factor- (TGF-) is produced by tumors, and increased amounts of this cytokine in the tumor microenvironment and serum are associated with poor patient survival.",31530731_0,-1,-1,-1,-1,37795,-1,2.0179237e-05,0.999969,1.0811061e-05
37798,to tumor,8,10,69,77,TGF--mediated suppression of antitumor T cell responses contributes to tumor growth and survival.,31530731_1,-1,-1,-1,-1,37798,-1,2.9614896e-05,0.9999558,1.4601095e-05
37802,cell type-specific,11,13,69,87,"However, TGF- also has tumor-suppressive activity; thus, dissecting cell type-specific molecular effects may inform therapeutic strategies targeting this cytokine.",31530731_2,-1,-1,-1,-1,37802,-1,0.0036615105,0.10045615,0.89588225
37804,targeting this cytokine,19,22,140,163,"However, TGF- also has tumor-suppressive activity; thus, dissecting cell type-specific molecular effects may inform therapeutic strategies targeting this cytokine.",31530731_2,-1,-1,-1,-1,37804,-1,0.0908054,0.9066024,0.0025922093
37805,tumor-associated lymphocytes,6,8,33,61,"Here, using human peripheral and tumor-associated lymphocytes, we investigated how tumor-derived TGF- suppresses a key antitumor function of CD4+ T cells, interferon- (IFN-) production.",31530731_3,-1,-1,-1,-1,37805,-1,0.0026673316,0.91330075,0.08403195
37806,tumor-derived TGF-,12,14,83,102,"Here, using human peripheral and tumor-associated lymphocytes, we investigated how tumor-derived TGF- suppresses a key antitumor function of CD4+ T cells, interferon- (IFN-) production.",31530731_3,-1,-1,-1,-1,37806,-1,2.601572e-05,0.99996257,1.1367593e-05
37807,function,18,19,130,138,"Here, using human peripheral and tumor-associated lymphocytes, we investigated how tumor-derived TGF- suppresses a key antitumor function of CD4+ T cells, interferon- (IFN-) production.",31530731_3,0,1,2,-1,37807,-1,0.00014257336,0.99975294,0.00010443044
37813,the TGF-,10,12,76,85,"Suppression required the expression and phosphorylation of Smad proteins in the TGF- signaling pathway, but not their nuclear translocation, and depended on oxygen availability, suggesting a metabolic basis for these effects.",31530731_4,-1,-1,-1,-1,37813,-1,3.4154145e-05,0.9999536,1.2175504e-05
37825,tumor-associated lymphocytes,11,13,80,108,Phosphorylated Smad proteins were also detected in the mitochondria of isolated tumor-associated lymphocytes.,31530731_6,-1,-1,-1,-1,37825,-1,0.0030748611,0.8955204,0.10140472
37834,immunity,9,10,59,67,"These results, which have implications for human antitumor immunity, suggest that TGF- targets T cell metabolism directly, thus diminishing T cell function through metabolic paralysis.",31530731_9,0,-1,2,-1,37834,-1,0.9983853,0.0011923136,0.00042240074
37835,that TGF- targets T cell metabolism,12,18,77,113,"These results, which have implications for human antitumor immunity, suggest that TGF- targets T cell metabolism directly, thus diminishing T cell function through metabolic paralysis.",31530731_9,-1,-1,-1,-1,37835,-1,0.0015336863,0.9597038,0.03876245
37837,T cell function through,22,26,141,164,"These results, which have implications for human antitumor immunity, suggest that TGF- targets T cell metabolism directly, thus diminishing T cell function through metabolic paralysis.",31530731_9,-1,-1,-1,-1,37837,-1,0.0014138077,0.026642438,0.9719438
37842,the tumor,28,30,166,175,We examined whether this ligand is a prognostic marker for high-grade serous ovarian cancer (HGSOC) and whether it is associated with accumulation of immune cells in the tumor.,31537619_1,-1,-1,-1,-1,37842,-1,2.0120731e-05,0.99996936,1.0544565e-05
37851,tumor tissues,15,17,60,73,"Although the intensity of CD3, CD8, CD4, CD20, and CD163 in tumor tissues remained constant regardless of membrane CD95L expression, tumors in patients with HGSOC with s-CD95L levels 516 pg/mL showed increased infiltration by CD3+ T cells (P = 0.001), comprising both cytotoxic CD8+ (P = 0.01) and CD4+ (P = 0.0062) cells including FoxP3+ regulatory T cells (P = 0.0044).",31537619_4,-1,-1,-1,-1,37851,-1,2.1330367e-05,0.9999579,2.0715941e-05
37863,factors,57,58,238,245,"Multivariate analyses revealed that low s-CD95L concentrations [<516 pg/mL, HR, 3.54; 95% confidence interval (CI), 1.13-11.11), and <1,200 activated CD8+ (Granzyme B+) cells (HR, 2.63; 95% CI, 1.16-5.95) were independent poor prognostic factors for recurrence, whereas >6,000 CD3+ cells (HR, 0.34; 95% CI, 0.15-0.79) was a good prognostic factor.",31537619_6,0,1,-1,-1,37863,-1,0.00035543466,0.9994405,0.00020408639
37865,factor,84,85,340,346,"Multivariate analyses revealed that low s-CD95L concentrations [<516 pg/mL, HR, 3.54; 95% confidence interval (CI), 1.13-11.11), and <1,200 activated CD8+ (Granzyme B+) cells (HR, 2.63; 95% CI, 1.16-5.95) were independent poor prognostic factors for recurrence, whereas >6,000 CD3+ cells (HR, 0.34; 95% CI, 0.15-0.79) was a good prognostic factor.",31537619_6,0,1,-1,-1,37865,-1,0.000764923,0.9989697,0.00026540746
37867,tumor-infiltrating lymphocytes,17,19,78,108,"Thus, low levels of s-CD95L (<516 pg/mL) are correlated with lower numbers of tumor-infiltrating lymphocytes (CD3+ and CD8+, and also CD4 and FoxP3 T cells) in advanced HGSOC and are a poor prognostic marker.",31537619_7,-1,-1,-1,-1,37867,-1,0.004708081,0.7864978,0.20879418
37868,FoxP3 T cells,30,33,142,155,"Thus, low levels of s-CD95L (<516 pg/mL) are correlated with lower numbers of tumor-infiltrating lymphocytes (CD3+ and CD8+, and also CD4 and FoxP3 T cells) in advanced HGSOC and are a poor prognostic marker.",31537619_7,-1,-1,-1,-1,37868,-1,0.004685467,0.5610108,0.4343038
37873,trials that,33,35,217,228,IMPLICATIONS: Serum s-CD95L is correlated with a number of tumor-infiltrating immune cells in HGSOC and could be used as a noninvasive marker of tumor immune infiltration to select patients referred for immunotherapy trials that evaluate checkpoint inhibitor treatment.,31537619_8,-1,-1,-1,-1,37873,-1,2.4640553e-05,0.99996316,1.2160071e-05
37877,tumor-infiltrating lymphocytes,20,22,130,160,BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is often accompanied by resistance to immunotherapies despite the presence of tumor-infiltrating lymphocytes.,31539182_0,-1,-1,-1,-1,37877,-1,0.003854387,0.87443465,0.121710986
37892,T cells trigger,3,6,29,44,"Intriguingly, HDAC6-depleted T cells trigger programmed cell death protein 1 (PD-1)-PD-1 ligand 1 expression to achieve a strong synergistic effect to sensitize advanced HCC to an immune checkpoint blocker, while blockade of IL-17A partially suppresses it.",31539182_3,-1,-1,-1,-1,37892,-1,0.0014565606,0.031069553,0.96747386
37894,protein,9,10,67,74,"Intriguingly, HDAC6-depleted T cells trigger programmed cell death protein 1 (PD-1)-PD-1 ligand 1 expression to achieve a strong synergistic effect to sensitize advanced HCC to an immune checkpoint blocker, while blockade of IL-17A partially suppresses it.",31539182_3,0,1,-1,-1,37894,-1,0.00025384148,0.9988777,0.00086838845
37905,receptor,23,24,160,168,"HDAC6 binds and deacetylates cytosolic FoxO1 at K242, which is required for its nuclear translocation and stabilization to repress retinoic acid-related orphan receptor gamma (RoRt), the transcription factor of TH 17 cell.",31539182_5,0,1,2,-1,37905,-1,0.0025697506,0.11635378,0.8810765
37906,the transcription factor,29,32,184,208,"HDAC6 binds and deacetylates cytosolic FoxO1 at K242, which is required for its nuclear translocation and stabilization to repress retinoic acid-related orphan receptor gamma (RoRt), the transcription factor of TH 17 cell.",31539182_5,-1,-1,-1,-1,37906,-1,2.7483527e-05,0.999956,1.6489117e-05
37909,This regulation,0,2,0,15,This regulation of HDAC6 for murine and human TH 17 cell is highly conserved.,31539182_6,-1,-1,-1,-1,37909,-1,2.8940636e-05,0.99995816,1.2881506e-05
37913,that targeting the,5,8,39,57,"CONCLUSIONS: These results demonstrate that targeting the cytosolic HDAC6-FoxO1 axis reprograms the pathogenicity and antitumor response of TH 17 cells in HCC, with a pathogenicity-driven responsiveness to facilitate immunotherapies.",31539182_7,-1,-1,-1,-1,37913,-1,1.7527484e-05,0.999974,8.48774e-06
37922,that chemotherapeutics,8,10,38,60,"A key discovery in the past decade is that chemotherapeutics can alter tumor cell immunogenicity via inducing release of damage-associated molecular patterns (DAMPs), including ecto-calreticulin (ecto-CALR), high mobility group box 1 (HMGB1) and ATP, causing tumor cells to die in a manner known as bona fide immunogenic apoptosis or immunogenic cell death (ICD).",31600692_2,-1,-1,-1,-1,37922,-1,0.00033431847,0.9996039,6.176025e-05
37923,tumor cell,12,14,71,81,"A key discovery in the past decade is that chemotherapeutics can alter tumor cell immunogenicity via inducing release of damage-associated molecular patterns (DAMPs), including ecto-calreticulin (ecto-CALR), high mobility group box 1 (HMGB1) and ATP, causing tumor cells to die in a manner known as bona fide immunogenic apoptosis or immunogenic cell death (ICD).",31600692_2,-1,-1,-1,-1,37923,-1,0.0035365464,0.32776713,0.6686963
37925,tumor cells to,44,47,259,273,"A key discovery in the past decade is that chemotherapeutics can alter tumor cell immunogenicity via inducing release of damage-associated molecular patterns (DAMPs), including ecto-calreticulin (ecto-CALR), high mobility group box 1 (HMGB1) and ATP, causing tumor cells to die in a manner known as bona fide immunogenic apoptosis or immunogenic cell death (ICD).",31600692_2,-1,-1,-1,-1,37925,-1,8.372265e-05,0.9997478,0.00016840901
37950,these cells,7,9,41,52,We aimed to investigate the frequency of these cells and their ability to produce cytokines in tumor-draining lymph nodes from patients with breast cancer (BC).MATERIALS AND METHODS: Mononuclear cells from lymph nodes of 20 patients with BC were activated and stained for appropriate markers.,31630080_1,-1,-1,-1,-1,37950,-1,0.00255712,0.20540363,0.7920392
37956,The cells,0,2,0,9,The cells were assayed with four-color flow cytometry.,31630080_2,-1,-1,-1,-1,37956,-1,0.0031729245,0.30529994,0.6915272
37990,functions through,23,25,145,162,"Since oral delivery of plasmid DNA is intervened by various physical obstacles, here we constructed a nanogel (Alg-Tat-gp100) with multi-faceted functions through blending-by-blending method.",31655203_1,-1,-1,-1,-1,37990,-1,0.00025918472,0.99939966,0.0003412045
37991,to the cooperation,1,4,4,22,"Due to the cooperation of alginate and Tat peptide, Alg-Tat-gp100 demonstrated the significant improvement of stability in the stomach, mucus penetration ability in intestine, and transport across mucus layer and MDCK cells.",31655203_2,-1,-1,-1,-1,37991,-1,3.853342e-05,0.99994624,1.5232409e-05
37992,Tat peptide,7,9,39,50,"Due to the cooperation of alginate and Tat peptide, Alg-Tat-gp100 demonstrated the significant improvement of stability in the stomach, mucus penetration ability in intestine, and transport across mucus layer and MDCK cells.",31655203_2,-1,-1,-1,-1,37992,-1,0.00010580405,0.9997905,0.000103746235
38008,that this,20,22,114,123,"Benefiting from those cases, the B16F10 tumor inhibition rate achieved 42.5% by this oral DNA vaccine, suggesting that this multi-faceted nanogel prepared by simple blending-by-blending method may provide a new strategy for oral DNA vaccine delivery.",31655203_5,-1,-1,-1,-1,38008,-1,1.9238267e-05,0.99997234,8.406797e-06
38013,to the tumor,10,13,53,65,Blocking the migration of regulatory T cells (Tregs) to the tumor microenvironment is a promising strategy for tumor immunotherapy.,31669202_0,-1,-1,-1,-1,38013,-1,2.6405456e-05,0.99996257,1.1030739e-05
38026,to Treg,28,30,175,182,"Here, we studied the distribution and characteristics of Tregs in the LHME, investigated the effects of Treg ablation on leukemia progression, explored the mechanisms leading to Treg accumulation, and studied whether blocking Treg migration to the LHME delayed leukemia progression in MLL-AF9-induced mouse acute myeloid leukemia (AML) models using wildtype (WT) and Foxp3DTR/GFP mice.",31669202_3,-1,-1,-1,-1,38026,-1,2.6112231e-05,0.9999614,1.2493157e-05
38028,to the,38,40,241,247,"Here, we studied the distribution and characteristics of Tregs in the LHME, investigated the effects of Treg ablation on leukemia progression, explored the mechanisms leading to Treg accumulation, and studied whether blocking Treg migration to the LHME delayed leukemia progression in MLL-AF9-induced mouse acute myeloid leukemia (AML) models using wildtype (WT) and Foxp3DTR/GFP mice.",31669202_3,-1,-1,-1,-1,38028,-1,3.1048312e-05,0.99994826,2.070705e-05
38054,that tumor-infiltrating FOXP3,2,5,12,41,"Data showed that tumor-infiltrating FOXP3+ Treg cells expressed granzyme B immediately following resection, indicating that granzyme B-expressing Treg cells were present directly ex vivo.",31669380_3,-1,-1,-1,-1,38054,-1,2.927771e-05,0.9999536,1.704979e-05
38058,the tumor-associated,1,3,3,23,"In the tumor-associated lymph nodes (LNs) and circulating lymphocytes, however, granzyme B-expressing Treg cells were only scarcely found.",31669380_4,-1,-1,-1,-1,38058,-1,2.7468233e-05,0.99994576,2.6709999e-05
38066,TCR,16,17,90,93,"Granzyme B upregulation in Treg cells could not be activated by standard T cell receptor (TCR) activation through anti-CD3/CD28 and IL-2 but required stimulation with bacterial products, such as with heat-killed Staphylococcus aureus.",31669380_6,-1,1,2,-1,38066,-1,2.9487794e-05,0.99994624,2.4233037e-05
38070,Treg subset,15,17,85,96,"Interestingly, granzyme B expression was highly concentrated in TIM-3+ Treg cells, a Treg subset previously shown to be enriched in the tumor microenvironment and presented increased suppressive capacity.",31669380_7,-1,-1,-1,-1,38070,-1,0.000103191946,0.00035832933,0.99953854
38072,the tumor,23,25,132,141,"Interestingly, granzyme B expression was highly concentrated in TIM-3+ Treg cells, a Treg subset previously shown to be enriched in the tumor microenvironment and presented increased suppressive capacity.",31669380_7,-1,-1,-1,-1,38072,-1,2.1123e-05,0.9999695,9.362553e-06
38073,These TIM-3,0,2,0,11,"These TIM-3+ Treg cells presented higher cytolytic capacity toward autologous T conventional cells than the TIM-3- Treg cells, in a manner that was dependent on granzyme B but not TIM-3.",31669380_8,-1,-1,-1,-1,38073,-1,3.0260862e-05,0.99994516,2.4541425e-05
38077,cells than the TIM-3- Treg cells,13,19,93,125,"These TIM-3+ Treg cells presented higher cytolytic capacity toward autologous T conventional cells than the TIM-3- Treg cells, in a manner that was dependent on granzyme B but not TIM-3.",31669380_8,-1,-1,-1,-1,38077,-1,0.00026277153,0.0005009029,0.99923635
38082,the tumors,12,14,73,83,"Overall, we found that granzyme B-expressing Treg cells were enriched in the tumors from CRC patients and had the potential to eliminate autologous T conventional cells.",31669380_9,-1,-1,-1,-1,38082,-1,1.9543466e-05,0.99997056,9.920935e-06
38093,classification,7,8,45,59,"Recently, a new global transcriptomic immune classification of solid tumours has identified six immune subtypes (ISs) (C1-C6).",31678770_1,0,1,2,-1,38093,-1,7.0119546e-05,0.9998574,7.246857e-05
38103,analysis,11,12,78,86,"Immune cell populations, differential gene expression and gene set enrichment analysiswere performed to characterise ISs in the global CRC population by using CMSs.",31678770_3,0,1,-1,-1,38103,-1,4.929975e-05,0.99991274,3.795472e-05
38119,classification,31,32,179,193,"Prognostic relevance of ISs in CRC substantially differed from that reported for the global TCGA, and ISs had a greater ability to stratify the prognosis of CRC patients than CMS classification.",31678770_7,0,1,2,-1,38119,-1,0.0001320165,0.99917847,0.00068954553
38123,related to the,7,10,43,57,"C2 had a heightened activation of pathways related to the immune system, apoptosis and DNA repair, mTOR signalling and oxidative phosphorylation, whereas C1 was more dependent of metabolic pathways.",31678770_9,-1,-1,-1,-1,38123,-1,4.5603778e-05,0.99992335,3.108324e-05
38126,tools to,26,28,166,174,"CONCLUSIONS: The correlation of IS and CMS allows a more precise categorisation of patients with relevant clinical and biological implications, which may be valuable tools to improve tailored therapeutic interventions in CRC patients.",31678770_10,-1,-1,-1,-1,38126,-1,3.5853565e-05,0.9999516,1.2586781e-05
38127,tailored therapeutic,29,31,183,203,"CONCLUSIONS: The correlation of IS and CMS allows a more precise categorisation of patients with relevant clinical and biological implications, which may be valuable tools to improve tailored therapeutic interventions in CRC patients.",31678770_10,-1,-1,-1,-1,38127,-1,4.6879333e-05,0.9999342,1.8862838e-05
38128,therapy,9,10,49,56,"Glucocorticoids (GCs) are a central component of therapy for patients with T cell acute lymphoblastic leukemia (T-ALL), and although resistance to GCs is a strong negative prognostic indicator in T-ALL, the mechanisms of GC resistance remain poorly understood.",31687977_0,0,1,-1,-1,38128,-1,3.090672e-05,0.9999541,1.4950134e-05
38143,cytokine that,43,45,251,264,"Using diagnostic samples from patients enrolled in the frontline Children's Oncology Group (COG) T-ALL clinical trial AALL1231, we demonstrated that one-third of primary T-ALLs were resistant to GCs when cells were cultured in the presence of IL-7, a cytokine that is critical for normal T cell function and that plays a well-established role in leukemogenesis.",31687977_1,-1,-1,-1,-1,38143,-1,0.9660564,0.03055677,0.0033867927
38144,T cell function,49,52,288,303,"Using diagnostic samples from patients enrolled in the frontline Children's Oncology Group (COG) T-ALL clinical trial AALL1231, we demonstrated that one-third of primary T-ALLs were resistant to GCs when cells were cultured in the presence of IL-7, a cytokine that is critical for normal T cell function and that plays a well-established role in leukemogenesis.",31687977_1,-1,-1,-1,-1,38144,-1,5.269304e-05,7.474728e-05,0.99987257
38145,that plays,53,55,308,318,"Using diagnostic samples from patients enrolled in the frontline Children's Oncology Group (COG) T-ALL clinical trial AALL1231, we demonstrated that one-third of primary T-ALLs were resistant to GCs when cells were cultured in the presence of IL-7, a cytokine that is critical for normal T cell function and that plays a well-established role in leukemogenesis.",31687977_1,-1,-1,-1,-1,38145,-1,3.6275895e-05,0.999946,1.7774128e-05
38147,these T-ALLs,4,6,24,36,"We demonstrated that in these T-ALLs and in distinct populations of normal developing thymocytes, GCs paradoxically induced their own resistance by promoting upregulation of IL-7 receptor (IL-7R) expression.",31687977_2,-1,-1,-1,-1,38147,-1,3.1333977e-05,0.9999372,3.1510903e-05
38148,thymocytes,13,14,86,96,"We demonstrated that in these T-ALLs and in distinct populations of normal developing thymocytes, GCs paradoxically induced their own resistance by promoting upregulation of IL-7 receptor (IL-7R) expression.",31687977_2,-1,1,2,-1,38148,-1,0.00038123387,0.007839342,0.9917794
38150,IL-7 receptor,25,27,174,187,"We demonstrated that in these T-ALLs and in distinct populations of normal developing thymocytes, GCs paradoxically induced their own resistance by promoting upregulation of IL-7 receptor (IL-7R) expression.",31687977_2,-1,-1,-1,-1,38150,-1,0.5958437,0.0038445874,0.4003117
38156,STAT5 transcriptional,15,17,95,116,"In the presence of IL-7, this augmented downstream signal transduction, resulting in increased STAT5 transcriptional output and upregulation of the prosurvival protein BCL-2.",31687977_3,-1,-1,-1,-1,38156,-1,2.8806247e-05,0.99995387,1.73494e-05
38158,protein,23,24,160,167,"In the presence of IL-7, this augmented downstream signal transduction, resulting in increased STAT5 transcriptional output and upregulation of the prosurvival protein BCL-2.",31687977_3,0,1,-1,-1,38158,-1,5.208213e-05,0.9998344,0.0001134746
38159,Taken together,0,2,0,14,"Taken together, we showed that IL-7 mediates an intrinsic and physiologic mechanism of GC resistance in normal thymocyte development that is retained during leukemogenesis in a subset of T-ALLs and is reversible with targeted inhibition of the IL-7R/JAK/STAT5/BCL-2 axis.",31687977_4,-1,-1,-1,-1,38159,-1,4.1609852e-05,0.9999417,1.6644315e-05
38160,that IL-7,5,7,26,35,"Taken together, we showed that IL-7 mediates an intrinsic and physiologic mechanism of GC resistance in normal thymocyte development that is retained during leukemogenesis in a subset of T-ALLs and is reversible with targeted inhibition of the IL-7R/JAK/STAT5/BCL-2 axis.",31687977_4,-1,-1,-1,-1,38160,-1,0.6776338,0.31135547,0.011010642
38161,thymocyte development that,18,21,111,137,"Taken together, we showed that IL-7 mediates an intrinsic and physiologic mechanism of GC resistance in normal thymocyte development that is retained during leukemogenesis in a subset of T-ALLs and is reversible with targeted inhibition of the IL-7R/JAK/STAT5/BCL-2 axis.",31687977_4,-1,-1,-1,-1,38161,-1,0.00024324504,0.9976847,0.0020720144
38173,Tcell Stat3,1,5,9,21,"Ablating Tcell Stat3 or treatment with an FAO inhibitor in obese mice spontaneously developing breast tumor reduces FAO, increases glycolysis and CD8+ T effector cell functions, leading to inhibition of breast tumor development.",31761565_2,-1,-1,-1,-1,38173,-1,0.0023493567,0.06286062,0.93478996
38177,cell functions,28,30,163,177,"Ablating Tcell Stat3 or treatment with an FAO inhibitor in obese mice spontaneously developing breast tumor reduces FAO, increases glycolysis and CD8+ T effector cell functions, leading to inhibition of breast tumor development.",31761565_2,-1,-1,-1,-1,38177,-1,8.7264416e-05,8.405826e-05,0.9998287
38181,STAT3 to,11,13,50,58,"Moreover, PD-1 ligation in CD8+ Tcells activates STAT3 to increase FAO, inhibiting CD8+ T effector cell glycolysis and functions.",31761565_3,-1,-1,-1,-1,38181,-1,2.4478239e-05,0.99996114,1.4324456e-05
38184,functions,24,25,120,129,"Moreover, PD-1 ligation in CD8+ Tcells activates STAT3 to increase FAO, inhibiting CD8+ T effector cell glycolysis and functions.",31761565_3,0,1,2,-1,38184,-1,0.005317338,0.9492921,0.045390464
38185,tissues,9,10,55,62,"Finally, leptin enriched in mammary adipocytes and fat tissues downregulates CD8+ Tcell effector functions through activating STAT3-FAO and inhibiting glycolysis.",31761565_4,-1,1,2,-1,38185,-1,0.00010728929,0.9994247,0.0004680284
38187,functions through,17,19,98,115,"Finally, leptin enriched in mammary adipocytes and fat tissues downregulates CD8+ Tcell effector functions through activating STAT3-FAO and inhibiting glycolysis.",31761565_4,-1,-1,-1,-1,38187,-1,0.0005226225,0.99309546,0.0063818824
38189,through STAT3,16,18,92,105,We identify a critical role of increased oxidation of fatty acids driven by leptin and PD-1 through STAT3 in inhibiting CD8+ T effector cell glycolysis and in promoting obesity-associated breast tumorigenesis.,31761565_5,-1,-1,-1,-1,38189,-1,2.6133452e-05,0.9999565,1.7334163e-05
38193,CCL22 played,2,4,12,24,BACKGROUND: CCL22 played critical roles in Tregs recruitment.,31769216_0,-1,-1,-1,-1,38193,-1,0.9612331,0.011040263,0.027726598
38202,tissues,14,15,86,93,Immunofluorescence assay was used to perform the costaining of Foxp3 and CD4 on liver tissues.,31769216_3,-1,1,2,-1,38202,-1,0.000121259676,0.9984534,0.0014253329
38214,the functions,7,9,53,66,Xenograft tumor models were developed to investigate the functions of p65 and miR-23a in vivo.,31769216_7,-1,-1,-1,-1,38214,-1,2.218166e-05,0.9999666,1.1197464e-05
38221,targeted CCL22,2,4,17,31,"MiR-23a directly targeted CCL22 3'UTR, leading to CCL22 reduction and attenuated Tregs recruitment.",31769216_11,-1,-1,-1,-1,38221,-1,0.52490294,0.45672435,0.018372716
38222,to CCL22,7,9,47,55,"MiR-23a directly targeted CCL22 3'UTR, leading to CCL22 reduction and attenuated Tregs recruitment.",31769216_11,-1,-1,-1,-1,38222,-1,0.55083853,0.43321368,0.015947834
38224,functioned,3,4,15,25,"Meanwhile, p65 functioned as a transcription repressor of miR-23a by directly binding to its promoter.",31769216_12,0,1,2,-1,38224,-1,4.3540625e-05,0.99993944,1.7070342e-05
38235,to CCL22,10,12,69,77,"CONCLUSION: Blockage of p65 disinhibited miR-23a expression, leading to CCL22 reduction and repress Tregs recruitment.",31769216_16,-1,-1,-1,-1,38235,-1,0.5373116,0.44340277,0.019285625
38242,the tumor-infiltrating lymphocytes,10,13,48,82,"Low Foxp3+ regulatory T-cell (Treg) presence in the tumor-infiltrating lymphocytes (TILs) is considered favorable in breast cancer, and numerous CD25-targeting agents have been applied in the attempt to remove Foxp3+ Treg cells, which typically present CD4+ CD25+/hi surface phenotype.",31811667_0,-1,-1,-1,-1,38242,-1,0.0027317826,0.92200094,0.07526728
38252,T cells that,10,13,61,73,"Hence, CD25 depletion may cause the elimination of activated T cells that are responding to tumor-specific antigens.",31811667_2,-1,-1,-1,-1,38252,-1,0.0013120191,0.024541939,0.974146
38253,to tumor-specific antigens,15,18,89,115,"Hence, CD25 depletion may cause the elimination of activated T cells that are responding to tumor-specific antigens.",31811667_2,-1,-1,-1,-1,38253,-1,0.057485778,0.93936306,0.0031511746
38256,function,7,8,35,43,"In this study, the composition and function of CD4+ CD25+ cells inside the microenvironment of triple-negative breast carcinoma (TNBC) were investigated.",31811667_3,0,1,2,-1,38256,-1,8.178009e-05,0.99985814,6.0060545e-05
38261,the Foxp3,4,6,18,27,"Directly ex vivo, the Foxp3+ Treg cells represented a minor subset in total CD4+ CD25+ TILs.",31811667_4,-1,-1,-1,-1,38261,-1,2.879903e-05,0.99995506,1.6114416e-05
38270,Foxp3- TILs,23,25,131,142,Significant differences were observed in the expression of Treg-associated molecules between CD4+ CD25+ Foxp3+ TILs and CD4+ CD25+ Foxp3- TILs.,31811667_5,-1,-1,-1,-1,38270,-1,2.2808354e-05,0.99996316,1.4030741e-05
38274,Foxp3- TILs,15,17,52,63,"While both the CD4+ CD25+ Foxp3+ and the CD4+ CD25+ Foxp3- TILs could express CTLA-4 and LAG-3, the expression levels were significantly higher in CD4+ CD25+ Foxp3+ TILs than in CD4+ CD25+ Foxp3- TILs.",31811667_6,-1,-1,-1,-1,38274,-1,2.4225677e-05,0.99995995,1.5832318e-05
38278,TILs than,36,38,165,174,"While both the CD4+ CD25+ Foxp3+ and the CD4+ CD25+ Foxp3- TILs could express CTLA-4 and LAG-3, the expression levels were significantly higher in CD4+ CD25+ Foxp3+ TILs than in CD4+ CD25+ Foxp3- TILs.",31811667_6,-1,-1,-1,-1,38278,-1,2.12228e-05,0.9999645,1.4303017e-05
38279,Foxp3- TILs,43,45,189,200,"While both the CD4+ CD25+ Foxp3+ and the CD4+ CD25+ Foxp3- TILs could express CTLA-4 and LAG-3, the expression levels were significantly higher in CD4+ CD25+ Foxp3+ TILs than in CD4+ CD25+ Foxp3- TILs.",31811667_6,-1,-1,-1,-1,38279,-1,2.4089282e-05,0.9999597,1.6160753e-05
38280,TCR,1,2,5,8,"Upon TCR stimulation, the expression of TGF-beta was significantly higher in CD4+ CD25+ Foxp3+ TILs, while the expression of IL-10 was significantly higher in CD4+ CD25+ Foxp3- TILs.",31811667_7,-1,1,2,-1,38280,-1,2.5251764e-05,0.99995327,2.1486658e-05
38282,TGF-beta,7,8,40,48,"Upon TCR stimulation, the expression of TGF-beta was significantly higher in CD4+ CD25+ Foxp3+ TILs, while the expression of IL-10 was significantly higher in CD4+ CD25+ Foxp3- TILs.",31811667_7,0,1,-1,-1,38282,-1,3.1664436e-05,0.9999522,1.6127684e-05
38287,Foxp3- TILs,33,35,170,181,"Upon TCR stimulation, the expression of TGF-beta was significantly higher in CD4+ CD25+ Foxp3+ TILs, while the expression of IL-10 was significantly higher in CD4+ CD25+ Foxp3- TILs.",31811667_7,-1,-1,-1,-1,38287,-1,2.2689475e-05,0.99996257,1.4753779e-05
38289,the blood,5,7,36,45,These differences were conserved in the blood counterparts of these cells.,31811667_8,-1,-1,-1,-1,38289,-1,5.5584e-05,0.99988544,5.8980808e-05
38290,these cells,9,11,62,73,These differences were conserved in the blood counterparts of these cells.,31811667_8,-1,-1,-1,-1,38290,-1,0.000760824,0.015876219,0.9833629
38300,Foxp3- cells,39,41,175,187,"Interestingly, the level of CD25+ Foxp3+ cells in circulating CD4+ T cells was positively correlated with the level of CD25+ Foxp3+ cells in CD4+ TILs, but the level of CD25+ Foxp3- cells in circulating CD4+ T cells was not associated with the level of CD25+ Foxp3- cells in CD4+ TILs.",31811667_9,-1,-1,-1,-1,38300,-1,0.0027664814,0.8998182,0.097415335
38303,Foxp3- cells,56,58,259,271,"Interestingly, the level of CD25+ Foxp3+ cells in circulating CD4+ T cells was positively correlated with the level of CD25+ Foxp3+ cells in CD4+ TILs, but the level of CD25+ Foxp3- cells in circulating CD4+ T cells was not associated with the level of CD25+ Foxp3- cells in CD4+ TILs.",31811667_9,-1,-1,-1,-1,38303,-1,0.0029015762,0.87773746,0.11936094
38309,IL-17-expressing T cells,25,28,120,144,"Th17-polarizing medium could readily remodel CD4+ CD25+ Foxp3- , but not CD4+ CD25+ Foxp3+ , T cells into RORgammat and IL-17-expressing T cells, demonstrating stronger plasticity of the former subset.",31811667_10,-1,-1,-1,-1,38309,-1,0.7630016,0.0021966107,0.23480172
38315,that the,5,7,34,42,"Together, these data demonstrated that the CD4+ CD25+ TILs were composed of distinctive Foxp3- and Foxp3+ cells, with the former representing the major subset.",31811667_11,-1,-1,-1,-1,38315,-1,1.6017355e-05,0.9999751,8.840681e-06
38323,The antigen,0,2,0,11,The antigen specificity and effector molecule expression of the CD4+ CD25+ Foxp3- thus require further analyses.,31811667_12,-1,-1,-1,-1,38323,-1,0.16350254,0.81946635,0.017031081
38325,Foxp3- thus,13,15,75,86,The antigen specificity and effector molecule expression of the CD4+ CD25+ Foxp3- thus require further analyses.,31811667_12,-1,-1,-1,-1,38325,-1,2.5264952e-05,0.9999585,1.6239483e-05
38331,the immune response,13,16,75,94,OBJECTIVE: The study aimed to review the most potent compounds that affect the immune response and diseases associated with it.,31814545_1,-1,-1,-1,-1,38331,-1,0.033998575,0.96563673,0.0003646548
38334,transcriptional factors,11,13,68,91,"RESULTS: In vitro, flavonoids and their derivatives inhibit various transcriptional factors, which modulate differentiation, proliferation, activation of immune cells and enhance regulatory T cell generation.",31814545_3,-1,-1,-1,-1,38334,-1,3.5144792e-05,0.999933,3.189176e-05
38336,regulatory T cell generation,26,30,179,207,"RESULTS: In vitro, flavonoids and their derivatives inhibit various transcriptional factors, which modulate differentiation, proliferation, activation of immune cells and enhance regulatory T cell generation.",31814545_3,-1,-1,-1,-1,38336,-1,0.000121832934,0.0004983792,0.99937975
38341,TNF-,27,28,171,176,"Some flavonoids exert anti-inflammatory effects through: Blockade of NF-B, and NLRP3 inflammasome, inhibition of pro-inflammatory cytokine production, IL-1, IL-2, IL-6, TNF-, IL-17A, down regulation of chemokines, and reduction of reactive oxygen and nitrogen species.",31814545_4,0,1,-1,-1,38341,-1,0.0018243082,0.99802727,0.00014836904
38348,receptors,30,31,211,220,"Nevertheless, several reports have shown that some flavonoids enhance immune response by enhancing: oxygen and nitrogen radicals, antibody production, cytotoxic activity against tumours by increasing activating receptors and down regulating inhibitory receptors.",31814545_5,0,1,2,-1,38348,-1,0.00011823749,0.00036241865,0.99951935
38349,receptors,35,36,252,261,"Nevertheless, several reports have shown that some flavonoids enhance immune response by enhancing: oxygen and nitrogen radicals, antibody production, cytotoxic activity against tumours by increasing activating receptors and down regulating inhibitory receptors.",31814545_5,0,1,2,-1,38349,-1,0.000112745875,0.00035565053,0.9995316
38361,to the,17,19,108,114,Respiratory diseases compromise the health of millions of people all over the world and are strongly linked to the immune dysfunction.,31827925_0,-1,-1,-1,-1,38361,-1,3.416532e-05,0.9999527,1.31965735e-05
38365,tissue,16,17,84,90,"CD4+FOXP3+ T regulatory cells, also known as Tregs, have a central role maintaining tissue homeostasis during immune responses.",31827925_1,-1,1,2,-1,38365,-1,4.4771168e-05,0.99991345,4.179763e-05
38369,transcription factor forkhead,2,5,14,43,"Tregs express transcription factor forkhead box P3 (FOXP3), which allows regulation of the immune response through anti-inflammatory cytokines such as IL-10 or transforming growth factor beta (TGF-) and direct cell-to-cell interaction.",31827925_3,-1,-1,-1,-1,38369,-1,1.9901858e-05,0.99996567,1.438809e-05
38372,the immune response through,15,19,87,114,"Tregs express transcription factor forkhead box P3 (FOXP3), which allows regulation of the immune response through anti-inflammatory cytokines such as IL-10 or transforming growth factor beta (TGF-) and direct cell-to-cell interaction.",31827925_3,-1,-1,-1,-1,38372,-1,0.00017699842,0.9997857,3.7349215e-05
38390,cells that,1,3,7,17,Cancer cells that succeed in forming metastasis need to be reprogrammed to evade immune surveillance and survive in a new microenvironment.,31848193_0,-1,-1,-1,-1,38390,-1,0.0030021577,0.11115689,0.885841
38396,tumor cells,14,16,105,116,This is facilitated by metastatic niches that are either postformed through reciprocal signaling between tumor cells and local stromal cells or preformed as premetastatic niches before tumor cell arrival.,31848193_1,-1,-1,-1,-1,38396,-1,0.0033124294,0.15691039,0.8397772
38398,tumor cell,26,28,185,195,This is facilitated by metastatic niches that are either postformed through reciprocal signaling between tumor cells and local stromal cells or preformed as premetastatic niches before tumor cell arrival.,31848193_1,-1,-1,-1,-1,38398,-1,0.0021637597,0.054149818,0.9436864
38404,tumor cells,12,14,67,78,"Here, we showed that blockade of intrinsic STAT3 signaling in lung tumor cells suppressed lung metastasis in immune-competent syngeneic mice, but not in immune-deficient nude mice.",31848193_3,-1,-1,-1,-1,38404,-1,0.0038525925,0.4865893,0.5095581
38406,tumor cells made them,7,11,47,68,"Consistently, repression of STAT3 signaling in tumor cells made them susceptible to T-cell-mediated cytotoxicity.",31848193_4,-1,-1,-1,-1,38406,-1,5.8289683e-05,0.99987733,6.440793e-05
38407,to T-cell-mediated,12,14,81,99,"Consistently, repression of STAT3 signaling in tumor cells made them susceptible to T-cell-mediated cytotoxicity.",31848193_4,-1,-1,-1,-1,38407,-1,0.0020973638,0.11323494,0.88466763
38411,the tumor,27,29,158,167,"Noticeably, lung metastasis was greatly increased in Gprc5a-knockout (ko; 5a -/-) mice compared with wild-type mice, which correlated with upregulated IL6 in the tumor microenvironment.",31848193_6,-1,-1,-1,-1,38411,-1,1.9465668e-05,0.9999702,1.0341333e-05
38416,the STAT3,5,7,47,56,"Mechanistically, dysregulated IL6 reprogrammed the STAT3 pathway in metastatic tumor cells, and induced recruitment of myeloid-derived suppressor cells and polarized macrophages to evade host immunity.",31848193_8,-1,-1,-1,-1,38416,-1,2.6396121e-05,0.999959,1.4564606e-05
38417,tumor cells,10,12,79,90,"Mechanistically, dysregulated IL6 reprogrammed the STAT3 pathway in metastatic tumor cells, and induced recruitment of myeloid-derived suppressor cells and polarized macrophages to evade host immunity.",31848193_8,-1,-1,-1,-1,38417,-1,0.0041745408,0.3053661,0.6904593
38420,immunity,26,27,192,200,"Mechanistically, dysregulated IL6 reprogrammed the STAT3 pathway in metastatic tumor cells, and induced recruitment of myeloid-derived suppressor cells and polarized macrophages to evade host immunity.",31848193_8,0,-1,2,-1,38420,-1,0.9994742,0.00032334076,0.00020238897
38426,IL6 plays,2,4,14,23,"Significance: IL6 plays important roles not only in cell autonomous propensity for metastasis, but also in establishing the metastatic niche.",31848193_11,-1,-1,-1,-1,38426,-1,0.97045946,0.019803215,0.009737371
38430,cytokine interleukin-6,7,9,61,83,"BACKGROUND/AIM: We previously demonstrated that inflammatory cytokine interleukin-6 (IL-6) was produced during cancer progression, worked together with transforming growth factor-beta 1 (TGF-1), and induced the epithelial-mesenchymal transition (EMT) with chemo-resistance against gemcitabine (GR) at the invasion front of biliary tract cancers (BTCs).",31853779_0,-1,-1,-1,-1,38430,-1,0.9998292,5.074039e-05,0.000120015306
38441,cytokine-induced T cell,5,8,29,52,"However, the significance of cytokine-induced T cell accumulation at the tumor microenvironment in biliary tract cancer (BTC) is not well understood.",31853779_1,-1,-1,-1,-1,38441,-1,0.46498632,0.0072371946,0.5277765
38442,the tumor,10,12,69,78,"However, the significance of cytokine-induced T cell accumulation at the tumor microenvironment in biliary tract cancer (BTC) is not well understood.",31853779_1,-1,-1,-1,-1,38442,-1,2.0597321e-05,0.99996984,9.548746e-06
38444,these cytokines,1,3,8,23,"Because these cytokines (IL-6 and TGF-1) are able to differentiate nave T cells into Foxp3-expressing T cells (Tregs) and/or IL-17-producing T helper 17 (Th17) cells, we investigated the relationship between heterogeneous, cancer-producing cytokines and T cell differentiation.",31853779_2,-1,-1,-1,-1,38444,-1,0.42810515,0.5651803,0.0067146104
38448,nave T cells,12,15,68,81,"Because these cytokines (IL-6 and TGF-1) are able to differentiate nave T cells into Foxp3-expressing T cells (Tregs) and/or IL-17-producing T helper 17 (Th17) cells, we investigated the relationship between heterogeneous, cancer-producing cytokines and T cell differentiation.",31853779_2,-1,-1,-1,-1,38448,-1,0.0024318341,0.05310024,0.944468
38449,Foxp3-expressing T cells,16,19,87,111,"Because these cytokines (IL-6 and TGF-1) are able to differentiate nave T cells into Foxp3-expressing T cells (Tregs) and/or IL-17-producing T helper 17 (Th17) cells, we investigated the relationship between heterogeneous, cancer-producing cytokines and T cell differentiation.",31853779_2,-1,-1,-1,-1,38449,-1,0.003426492,0.8470797,0.14949387
38451,IL-17-producing T,23,25,127,144,"Because these cytokines (IL-6 and TGF-1) are able to differentiate nave T cells into Foxp3-expressing T cells (Tregs) and/or IL-17-producing T helper 17 (Th17) cells, we investigated the relationship between heterogeneous, cancer-producing cytokines and T cell differentiation.",31853779_2,-1,-1,-1,-1,38451,-1,0.99317086,0.0046353047,0.002193904
38454,the relationship,34,36,185,201,"Because these cytokines (IL-6 and TGF-1) are able to differentiate nave T cells into Foxp3-expressing T cells (Tregs) and/or IL-17-producing T helper 17 (Th17) cells, we investigated the relationship between heterogeneous, cancer-producing cytokines and T cell differentiation.",31853779_2,-1,-1,-1,-1,38454,-1,1.8612227e-05,0.9999708,1.0626451e-05
38462,Th17 cells,31,33,170,180,"METHODS: In total, 127 curative resected specimens from patients with BTCs at Osaka University Hospital between 2000 and 2012 were evaluated for IL-6, TGF-1, Tregs, and Th17 cells by immunohistochemistry.",31853779_3,-1,-1,-1,-1,38462,-1,0.0003428572,0.002494562,0.99716264
38464,cells to,4,6,22,30,The ability of BTC-GR cells to undergo T cell differentiation was investigated in vitro.,31853779_4,-1,-1,-1,-1,38464,-1,0.0033979856,0.12453645,0.87206554
38467,the tumor,5,7,30,39,RESULTS: Tregs accumulated at the tumor center and Th17 cells accumulated at the invasion front during cancer progression and/or metastasis; each signaled poor prognosis.,31853779_5,-1,-1,-1,-1,38467,-1,2.4686564e-05,0.9999585,1.6768421e-05
38468,Th17 cells,9,11,51,61,RESULTS: Tregs accumulated at the tumor center and Th17 cells accumulated at the invasion front during cancer progression and/or metastasis; each signaled poor prognosis.,31853779_5,-1,-1,-1,-1,38468,-1,0.00015026813,0.0005726663,0.9992772
38471,related to TGF-1,3,6,22,39,"Treg accumulation was related to TGF-1 expression by cancer cells, and Th17 cell accumulation was related to IL-6 expression by cancer cells, in resected specimens; this was confirmed in vitro.",31853779_6,-1,-1,-1,-1,38471,-1,3.959076e-05,0.99992406,3.6392663e-05
38473,Th17 cell,12,14,72,81,"Treg accumulation was related to TGF-1 expression by cancer cells, and Th17 cell accumulation was related to IL-6 expression by cancer cells, in resected specimens; this was confirmed in vitro.",31853779_6,-1,-1,-1,-1,38473,-1,0.0002995454,0.002574042,0.9971264
38474,related to IL-6,16,19,99,114,"Treg accumulation was related to TGF-1 expression by cancer cells, and Th17 cell accumulation was related to IL-6 expression by cancer cells, in resected specimens; this was confirmed in vitro.",31853779_6,-1,-1,-1,-1,38474,-1,0.45084664,0.53294617,0.016207187
38483,to Th17 cells,26,29,147,160,"Compared with parent cells, GR cells produced IL-6 but not TGF-1 in a time-dependent manner, had EMT features, and induced T cell differentiation to Th17 cells but not Tregs.",31853779_7,-1,-1,-1,-1,38483,-1,0.0033796213,0.25813052,0.73848987
38490,Th17 cells,17,19,100,110,"CONCLUSION: Cytokines produced by cancer cells (IL-6 and TGF-1) induced heterogeneity of Tregs and Th17 cells in the tumor microenvironment, supporting progression of BTC.",31853779_8,-1,-1,-1,-1,38490,-1,0.0013187282,0.034934316,0.96374696
38491,the tumor,20,22,114,123,"CONCLUSION: Cytokines produced by cancer cells (IL-6 and TGF-1) induced heterogeneity of Tregs and Th17 cells in the tumor microenvironment, supporting progression of BTC.",31853779_8,-1,-1,-1,-1,38491,-1,2.2387261e-05,0.999966,1.155676e-05
38505,tissues,12,13,86,93,METHODS: Whole-exome and transcriptome sequencing were performed on cancer and normal tissues from seven colorectal cancer patients diagnosed with mismatch repair-proficient tumors to detect putative neoantigens.,31888734_3,-1,1,2,-1,38505,-1,0.0001101044,0.99886096,0.0010289659
38507,tumors to,22,24,174,183,METHODS: Whole-exome and transcriptome sequencing were performed on cancer and normal tissues from seven colorectal cancer patients diagnosed with mismatch repair-proficient tumors to detect putative neoantigens.,31888734_3,-1,-1,-1,-1,38507,-1,1.8187766e-05,0.99997246,9.349259e-06
38509,T cells that,12,15,92,104,Corresponding neo-epitopes were synthesized and tested for recognition by in vitro expanded T cells that were isolated from tumor tissues (tumor-infiltrating lymphocytes) and from peripheral mononuclear blood cells stimulated with tumor material.,31888734_4,-1,-1,-1,-1,38509,-1,0.001339905,0.028109174,0.9705509
38510,tumor tissues,18,20,124,137,Corresponding neo-epitopes were synthesized and tested for recognition by in vitro expanded T cells that were isolated from tumor tissues (tumor-infiltrating lymphocytes) and from peripheral mononuclear blood cells stimulated with tumor material.,31888734_4,-1,-1,-1,-1,38510,-1,2.8996748e-05,0.99994206,2.898511e-05
38511,tumor-infiltrating lymphocytes,21,23,139,169,Corresponding neo-epitopes were synthesized and tested for recognition by in vitro expanded T cells that were isolated from tumor tissues (tumor-infiltrating lymphocytes) and from peripheral mononuclear blood cells stimulated with tumor material.,31888734_4,-1,-1,-1,-1,38511,-1,0.0036052621,0.8661203,0.13027446
38512,blood cells,28,30,203,214,Corresponding neo-epitopes were synthesized and tested for recognition by in vitro expanded T cells that were isolated from tumor tissues (tumor-infiltrating lymphocytes) and from peripheral mononuclear blood cells stimulated with tumor material.,31888734_4,-1,-1,-1,-1,38512,-1,3.5838173e-05,4.7030328e-05,0.99991703
38516,the tumor-infiltrating lymphocytes,12,15,87,121,"RESULTS: Neoantigen-specific T cell reactivity was detected to several neo-epitopes in the tumor-infiltrating lymphocytes of three patients while their respective cancers expressed 15, 21, and 30 non-synonymous variants.",31888734_5,-1,-1,-1,-1,38516,-1,0.002652243,0.90262085,0.09472696
38520,tumor-infiltrating lymphocytes,3,5,16,46,Cell sorting of tumor-infiltrating lymphocytes based on the co-expression of CD39 and CD103 pinpointed the presence of neoantigen-specific T cells in the CD39+CD103+ T cell subset.,31888734_6,-1,-1,-1,-1,38520,-1,0.00281074,0.90000564,0.097183645
38526,the tumors,2,4,12,22,"Strikingly, the tumors containing neoantigen-reactive TIL were classified as consensus molecular subtype 4 (CMS4), which is associated with TGF- pathway activation and worse clinical outcome.",31888734_7,-1,-1,-1,-1,38526,-1,1.7684368e-05,0.99997103,1.1244181e-05
38537,target the TGF-,19,22,151,167,These findings warrant the development of specific immunotherapeutic strategies that selectively boost the activity of neoantigen-specific T cells and target the TGF- pathway to reinforce T cell reactivity in this patient group.,31888734_9,-1,-1,-1,-1,38537,-1,3.1378662e-05,0.99995375,1.4842359e-05
38541,the tumor,1,3,14,23,Reprogramming the tumor microenvironment to increase immune-mediated responses is currently of intense interest.,31888983_0,-1,-1,-1,-1,38541,-1,2.0562215e-05,0.99996924,1.0152529e-05
38552,tumors to,21,23,132,141,"Here, we report that unadjuvanted seasonal influenza vaccination via intratumoral, but not intramuscular, injection converts ""cold"" tumors to hot, generates systemic CD8+ T cell-mediated antitumor immunity, and sensitizes resistant tumors to checkpoint blockade.",31888983_5,-1,-1,-1,-1,38552,-1,2.3710536e-05,0.99996316,1.30896315e-05
38555,immunity,32,33,197,205,"Here, we report that unadjuvanted seasonal influenza vaccination via intratumoral, but not intramuscular, injection converts ""cold"" tumors to hot, generates systemic CD8+ T cell-mediated antitumor immunity, and sensitizes resistant tumors to checkpoint blockade.",31888983_5,0,-1,2,-1,38555,-1,0.9993911,0.00032822095,0.00028068363
38556,tumors to,37,39,232,241,"Here, we report that unadjuvanted seasonal influenza vaccination via intratumoral, but not intramuscular, injection converts ""cold"" tumors to hot, generates systemic CD8+ T cell-mediated antitumor immunity, and sensitizes resistant tumors to checkpoint blockade.",31888983_5,-1,-1,-1,-1,38556,-1,2.0371104e-05,0.99996805,1.1609076e-05
38570,the The,5,7,33,40,RNA-seq data were collected from the The Cancer Genome Atlas database.,31898342_2,-1,-1,-1,-1,38570,-1,1.9813155e-05,0.9999695,1.0659159e-05
38571,The relationships,0,2,0,17,The relationships between transcription factors and immune infiltrates were assessed.,31898342_3,-1,-1,-1,-1,38571,-1,2.3586823e-05,0.9999647,1.1703214e-05
38578,analysis,25,26,176,184,"Runt-related transcription factor 3 (RUNX3)-associated immune pathways were investigated by the Kyoto Encyclopedia of Genes and Genomes, Gene Ontology, and Gene set enrichment analysis.",31898342_4,0,1,-1,-1,38578,-1,4.7069272e-05,0.9999074,4.5584784e-05
38582,These chemokines,0,2,0,16,These chemokines were further confirmed in RUNX3-downregulated cell lines.,31898342_6,-1,-1,-1,-1,38582,-1,0.4037115,0.59209526,0.004193294
38589,tissues,26,27,140,147,"Immunochemistry was conducted to determine the expression of RUNX3, CCL3, CCL20, and the numbers of CD8+ T lymphocytes in human lung cancer tissues.",31898342_7,-1,1,2,-1,38589,-1,6.161362e-05,0.999694,0.00024444048
38590,Chemokine receptors,0,2,0,19,Chemokine receptors in CD8+ T cells were explored by flow cytometry and immunofluorescence.,31898342_8,-1,-1,-1,-1,38590,-1,0.52250594,0.006662659,0.4708314
38603,receptors CCR5,10,12,76,90,"Further investigation exhibited RUNX3 could upregulate CCL3 and CCL20 whose receptors CCR5 and CCR6 were upregulated in CD8+ effector T cells, while downregulation of RUNX3 decreased the expression of CCL3 and CCL20 and the infiltration of CD8+ T cells in RUNX3-downregulated lung cancer cell lines.",31898342_13,-1,-1,-1,-1,38603,-1,0.00095166144,0.0048725903,0.9941757
38613,The chemotaxis,0,2,0,14,The chemotaxis assay proved RUNX3 could promote CD8+ T cell recruitment by upregulating CCL3 and CCL20.,31898342_15,-1,-1,-1,-1,38613,-1,0.012015924,0.9874363,0.00054780586
38620,cell therapy,29,31,216,228,This study unearths RUNX3 related molecular mechanisms of tumor immune microenvironment and may reverse the immune-desert condition in lung adenocarcinoma and be combined with immune checkpoint blockade and adoptive cell therapy.,31898342_16,-1,-1,-1,-1,38620,-1,0.003525887,0.1008077,0.89566636
38625,TNBC cells,8,10,51,61,"Here, we report BRCA1-IRIS-overexpressing (IRISOE) TNBC cells secrete high levels of GM-CSF in a hypoxia-inducible factor-1 (HIF1)- and a NF-B-dependent manner to recruit macrophages to IRISOE cells and polarize them to protumor M2 TAMs.",31911557_1,-1,-1,-1,-1,38625,-1,0.0036354023,0.5180622,0.47830245
38627,factor-1,18,19,115,124,"Here, we report BRCA1-IRIS-overexpressing (IRISOE) TNBC cells secrete high levels of GM-CSF in a hypoxia-inducible factor-1 (HIF1)- and a NF-B-dependent manner to recruit macrophages to IRISOE cells and polarize them to protumor M2 TAMs.",31911557_1,0,1,-1,-1,38627,-1,0.0007094399,0.99921966,7.083541e-05
38631,them to,32,34,215,222,"Here, we report BRCA1-IRIS-overexpressing (IRISOE) TNBC cells secrete high levels of GM-CSF in a hypoxia-inducible factor-1 (HIF1)- and a NF-B-dependent manner to recruit macrophages to IRISOE cells and polarize them to protumor M2 TAMs.",31911557_1,-1,-1,-1,-1,38631,-1,2.9959157e-05,0.99994814,2.1916207e-05
38633,GM-CSF triggered TGF1,0,3,0,22,"GM-CSF triggered TGF1 expression by M2 TAMs by activating STAT5, NF-B, and/or ERK signaling.",31911557_2,-1,-1,-1,-1,38633,-1,0.7846551,0.2006763,0.014668561
38636,TGF1 receptors,5,7,34,49,"Despite expressing high levels of TGF1 receptors on their surface, IRISOE TNBC cells channeled TGF1/TRI/II signaling toward AKT, not SMAD, which activated stemness/EMT phenotypes.",31911557_3,-1,-1,-1,-1,38636,-1,0.00035267987,0.9947102,0.004937136
38638,TNBC cells,12,14,75,85,"Despite expressing high levels of TGF1 receptors on their surface, IRISOE TNBC cells channeled TGF1/TRI/II signaling toward AKT, not SMAD, which activated stemness/EMT phenotypes.",31911557_3,-1,-1,-1,-1,38638,-1,0.00364299,0.5639829,0.4323741
38641,TNBC cells,12,14,76,86,"In orthotopic and syngeneic mouse models, silencing or inactivating IRIS in TNBC cells lowered the levels of circulating GM-CSF, suppressed TAM recruitment, and decreased the levels of circulating TGF1.",31911557_4,-1,-1,-1,-1,38641,-1,0.00384389,0.6288875,0.36726862
38647,TNBC cells,4,6,36,46,Coinjecting macrophages with IRISOE TNBC cells induced earlier metastasis in athymic mice accompanied by high levels of circulating GM-CSF and TGF1.,31911557_5,-1,-1,-1,-1,38647,-1,0.00491436,0.6435468,0.35153884
38650,TNBC cells,1,3,7,17,"IRISOE TNBC cells expressed low levels of calreticulin (the ""eat me"" signal for macrophages) and high levels of CD47 (the ""do not eat me"" signal for macrophages) and PD-L1 (a T-cell inactivator) on their surface.",31911557_6,-1,-1,-1,-1,38650,-1,0.003329545,0.43113878,0.5655317
38653,T-cell,39,40,175,181,"IRISOE TNBC cells expressed low levels of calreticulin (the ""eat me"" signal for macrophages) and high levels of CD47 (the ""do not eat me"" signal for macrophages) and PD-L1 (a T-cell inactivator) on their surface.",31911557_6,-1,1,2,-1,38653,-1,3.6149362e-05,5.5781e-05,0.9999081
38655,TNBC tumors,3,5,20,31,"Accordingly, IRISOE TNBC tumors had significantly few CD8+/PD-1+ cytotoxic T cells and more CD25+/FOXP3+ regulatory T cells.",31911557_7,-1,-1,-1,-1,38655,-1,2.3880628e-05,0.9999597,1.6431193e-05
38659,that the,3,5,16,24,These data show that the bidirectional interaction between IRISOE cells and macrophages triggers an immunosuppressive microenvironment within TNBC tumors that is favorable for the generation of immune-evading/stem-like/IRISOE TNBC metastatic precursors.,31911557_8,-1,-1,-1,-1,38659,-1,1.7772618e-05,0.9999745,7.772179e-06
38662,TNBC tumors that,17,20,142,158,These data show that the bidirectional interaction between IRISOE cells and macrophages triggers an immunosuppressive microenvironment within TNBC tumors that is favorable for the generation of immune-evading/stem-like/IRISOE TNBC metastatic precursors.,31911557_8,-1,-1,-1,-1,38662,-1,2.3686633e-05,0.9999635,1.2846441e-05
38663,the generation,23,25,176,190,These data show that the bidirectional interaction between IRISOE cells and macrophages triggers an immunosuppressive microenvironment within TNBC tumors that is favorable for the generation of immune-evading/stem-like/IRISOE TNBC metastatic precursors.,31911557_8,-1,-1,-1,-1,38663,-1,2.0026788e-05,0.99996924,1.07777305e-05
38670,immunity,5,6,51,59,Understanding the mechanisms underlying anti-tumor immunity is pivotal for improving immune-based cancer therapies.,31911617_0,0,-1,2,-1,38670,-1,0.93143255,0.067721516,0.00084593875
38677,Ccl17,14,15,113,118,"Growth-inhibited tumors exhibit increased numbers of intra-tumoral activated T cells and decreased expression of Ccl17, Ccl22, and Foxp3.",31911617_2,0,-1,2,-1,38677,-1,0.98929673,0.0004951736,0.010208054
38686,therapy,3,4,20,27,"Growth of anti-PD-1 therapy resistant melanoma is effectively inhibited in Siah2-/- mice subjected to PD-1 blockade, indicating synergy between PD-1 blockade and Siah2 loss.",31911617_4,0,1,-1,-1,38686,-1,2.9533436e-05,0.9999536,1.678277e-05
38695,therapy,25,26,175,182,"Overall, Siah2 regulation of Treg recruitment and cell cycle progression effectively controls melanoma development and Siah2 loss in the host sensitizes melanoma to anti-PD-1 therapy.",31911617_6,0,1,-1,-1,38695,-1,2.4191802e-05,0.99996364,1.2127185e-05
38696,Chemokines play,0,2,0,15,"Chemokines play essential roles in the progression of various human cancers; however, the expression and role of CXC chemokines in pancreatic adenocarcinoma (PAAD) have not yet been identified.",31913856_0,-1,-1,-1,-1,38696,-1,0.8821968,0.11112243,0.006680794
38709,tissues,17,18,99,106,"Three CXC chemokines, including CXCL5, CXCL9, and CXCL10, were significantly overexpressed in PAAD tissues, which were correlated with the poor survival of the patients.",31913856_2,-1,1,2,-1,38709,-1,0.00093739684,0.10152244,0.8975402
38713,the tumour,10,12,62,72,"CXCL9/10 was associated with change of immune cell pattern in the tumour microenvironment, and supplementation of CXCL9 in the orthotopic murine PAAD model promoted tumour progression.",31913856_3,-1,-1,-1,-1,38713,-1,2.284195e-05,0.9999664,1.0749789e-05
38718,the tumour,12,14,65,75,"In particular, CXCL9 reduced the CD8+ cytotoxic T lymphocytes in the tumour microenvironment of PAAD, which could be attributed to the reduced CD8+ T cell proliferation, activation, and secretion of anti-tumour cytokines.",31913856_4,-1,-1,-1,-1,38718,-1,2.1452586e-05,0.9999665,1.21036155e-05
38719,to the,22,24,128,134,"In particular, CXCL9 reduced the CD8+ cytotoxic T lymphocytes in the tumour microenvironment of PAAD, which could be attributed to the reduced CD8+ T cell proliferation, activation, and secretion of anti-tumour cytokines.",31913856_4,-1,-1,-1,-1,38719,-1,2.3805605e-05,0.9999651,1.1166649e-05
38723,to the,7,9,41,47,"In vitro treatment of CXCL9 directly led to the suppression of the proliferation, activation, and secretion of anti-tumour cytokines of isolated CD8+ T cells.",31913856_5,-1,-1,-1,-1,38723,-1,2.1331378e-05,0.999969,9.687323e-06
38733,the CD8+ T lymphocytes,15,20,97,119,Our study indicates CXCL9 as a potential target of immunotherapy in PAAD treatment by regulating the CD8+ T lymphocytes in the tumour microenvironment.,31913856_7,-1,-1,-1,-1,38733,-1,0.003431168,0.15257764,0.84399116
38734,the tumour,21,23,123,133,Our study indicates CXCL9 as a potential target of immunotherapy in PAAD treatment by regulating the CD8+ T lymphocytes in the tumour microenvironment.,31913856_7,-1,-1,-1,-1,38734,-1,2.2356186e-05,0.99996746,1.0239e-05
38751,Transcriptional analysis,0,2,0,24,Transcriptional analysis revealed a polyfunctional helper and cytotoxic phenotype characterized by the expression of the transcription factors T-bet and Blimp-1.,31924474_3,-1,-1,-1,-1,38751,-1,2.1663154e-05,0.9999647,1.3613109e-05
38753,the transcription factors T-bet,14,18,117,148,Transcriptional analysis revealed a polyfunctional helper and cytotoxic phenotype characterized by the expression of the transcription factors T-bet and Blimp-1.,31924474_3,-1,-1,-1,-1,38753,-1,2.227307e-05,0.99996305,1.4633221e-05
38769,through their,33,35,185,198,"Our findings underscore the role of Treg cells, IL-2, and Blimp-1 in controlling the differentiation of cytotoxic CD4+ Tcells and offer a pathway to enhancement of anti-tumor activity through their manipulation.",31924474_5,-1,-1,-1,-1,38769,-1,2.3436518e-05,0.9999634,1.3182828e-05
38770,tool that,10,12,71,80,"Diffusion-weighted magnetic resonance imaging (DW-MRI) is a diagnostic tool that is increasingly used for the detection and characterization of focal masses in the abdomen, among these, pancreatic ductal adenocarcinoma (PDAC).",31948053_0,-1,-1,-1,-1,38770,-1,3.1402393e-05,0.99995434,1.428943e-05
38775,the tissue,5,7,41,51,"DW-MRI reflects the microarchitecture of the tissue, and changes in diffusion, which are reflected by changes in the apparent diffusion coefficient (ADC), are mainly attributed to variations in cellular density, glandular formation, and fibrosis.",31948053_1,-1,-1,-1,-1,38775,-1,4.7792844e-05,0.9998784,7.3734205e-05
38780,the T cell,2,5,15,25,"When analyzing the T cell infiltrates, we found an association of a tumor-promoting subpopulation, characterized by the expression of interleukin (IL) 21 and IL26, with high ADC values.",31948053_2,-1,-1,-1,-1,38780,-1,0.002890265,0.22865522,0.7684545
38786,tissue-expressed receptors,5,7,46,72,"Pancreatic cancers-but not healthy pancreatic tissue-expressed receptors for IL21 and IL26, a finding that could be confirmed in pancreatic cell lines.",31948053_4,-1,-1,-1,-1,38786,-1,0.00021532552,0.9972512,0.002533407
38789,The functionality,0,2,0,17,"The functionality of these receptors was demonstrated in pancreatic tumor cell lines, which showed phosphorylation of ERK1/2 and STAT3 pathways in response to the respective recombinant interleukins.",31948053_5,-1,-1,-1,-1,38789,-1,2.0716758e-05,0.9999697,9.568982e-06
38790,these receptors,3,5,21,36,"The functionality of these receptors was demonstrated in pancreatic tumor cell lines, which showed phosphorylation of ERK1/2 and STAT3 pathways in response to the respective recombinant interleukins.",31948053_5,-1,-1,-1,-1,38790,-1,0.0016455813,0.8481782,0.15017623
38791,tumor cell,9,11,68,78,"The functionality of these receptors was demonstrated in pancreatic tumor cell lines, which showed phosphorylation of ERK1/2 and STAT3 pathways in response to the respective recombinant interleukins.",31948053_5,-1,-1,-1,-1,38791,-1,0.0028995462,0.52288985,0.47421062
38793,to the,23,25,156,162,"The functionality of these receptors was demonstrated in pancreatic tumor cell lines, which showed phosphorylation of ERK1/2 and STAT3 pathways in response to the respective recombinant interleukins.",31948053_5,-1,-1,-1,-1,38793,-1,2.254503e-05,0.99996865,8.819092e-06
38795,tumor cells,11,13,64,75,"Moreover, in vitro data showed an increased colony formation of tumor cells.",31948053_6,-1,-1,-1,-1,38795,-1,0.004079773,0.4084796,0.58744055
38798,to the,29,31,149,155,"In summary, our data showed an association of IL21+ and IL26+ immune cell infiltration, increased ADC, and aggressive tumor disease, most likely due to the activation of the key cancer signaling pathways ERK1/2 and STAT3 and formation of tumor colonies.",31948053_7,-1,-1,-1,-1,38798,-1,2.0481684e-05,0.99997044,9.073053e-06
38804,the cytokines they,14,17,75,93,CD8+ T cells can be polarized into several different subsets as defined by the cytokines they produce and the transcription factors that govern their differentiation.,31964625_0,-1,-1,-1,-1,38804,-1,0.00019747052,0.9997285,7.403718e-05
38805,the transcription factors that,19,23,106,136,CD8+ T cells can be polarized into several different subsets as defined by the cytokines they produce and the transcription factors that govern their differentiation.,31964625_0,-1,-1,-1,-1,38805,-1,2.3185861e-05,0.99996245,1.4371217e-05
38811,the aryl hydrocarbon receptor transcription factor,22,28,122,172,"Here, we identified the polarizing conditions to induce an IL22-producing CD8+ Tc22 subset, which is dependent on IL6 and the aryl hydrocarbon receptor transcription factor.",31964625_1,-1,-1,-1,-1,38811,-1,3.2713782e-05,0.9999465,2.0842232e-05
38812,that this subset,3,6,32,48,Further characterization showed that this subset was highly cytolytic and expressed a distinct cytokine profile and transcriptome relative to other subsets.,31964625_2,-1,-1,-1,-1,38812,-1,0.0036341466,0.8124533,0.18391259
38814,transcriptome relative to,16,19,116,141,Further characterization showed that this subset was highly cytolytic and expressed a distinct cytokine profile and transcriptome relative to other subsets.,31964625_2,-1,-1,-1,-1,38814,-1,2.9005085e-05,0.999951,1.9939238e-05
38820,the traditional IFN-producing Tc1 subset,20,25,94,135,"In addition, polarized Tc22 were able to control tumor growth as well as, if not better than, the traditional IFN-producing Tc1 subset.",31964625_3,-1,-1,-1,-1,38820,-1,0.01913886,0.59957594,0.38128516
38823,the tumors,6,8,36,46,"Tc22s were also found to infiltrate the tumors of human patients with ovarian cancer, comprising up to approximately 30% of expanded CD8+ tumor-infiltrating lymphocytes (TIL).",31964625_4,-1,-1,-1,-1,38823,-1,1.8687004e-05,0.9999721,9.250377e-06
38825,tumor-infiltrating lymphocytes,25,27,138,168,"Tc22s were also found to infiltrate the tumors of human patients with ovarian cancer, comprising up to approximately 30% of expanded CD8+ tumor-infiltrating lymphocytes (TIL).",31964625_4,-1,-1,-1,-1,38825,-1,0.004284526,0.81515485,0.18056057
38830,Tc22 cells,5,7,34,44,"Given the antitumor properties of Tc22 cells, it may be prudent to polarize T cells to the Tc22 lineage when using chimeric antigen receptor (CAR)-T or T-cell receptor (TCR) transduction-based immunotherapies.",31964625_6,-1,-1,-1,-1,38830,-1,0.0036643988,0.496044,0.5002916
38832,T cells to the Tc22,14,19,76,95,"Given the antitumor properties of Tc22 cells, it may be prudent to polarize T cells to the Tc22 lineage when using chimeric antigen receptor (CAR)-T or T-cell receptor (TCR) transduction-based immunotherapies.",31964625_6,-1,-1,-1,-1,38832,-1,0.006548819,0.26888156,0.7245696
38836,cellular therapy,1,3,9,25,"Adoptive cellular therapy and its derivative, chimeric AgR T cell therapy, have achieved significant progress against cancer.",31969386_0,-1,-1,-1,-1,38836,-1,0.0027878275,0.05725939,0.9399528
38837,T cell therapy,9,12,59,73,"Adoptive cellular therapy and its derivative, chimeric AgR T cell therapy, have achieved significant progress against cancer.",31969386_0,-1,-1,-1,-1,38837,-1,0.001251963,0.02000241,0.9787457
38839,tumor-infiltrating lymphocytes,16,18,105,135,"Major barriers persist, however, including insufficient induction of cytotoxic T cells and exhaustion of tumor-infiltrating lymphocytes.",31969386_1,-1,-1,-1,-1,38839,-1,0.0039383476,0.86863196,0.1274297
38843,tumor cells,26,28,153,164,"In this study, we discovered a new role for 2-deoxy-d-glucose (2DG) in enhancing the antitumor activity of human T cells against NKG2D ligand-expressing tumor cells.",31969386_2,-1,-1,-1,-1,38843,-1,0.004073704,0.4746164,0.5213098
38844,T cells treated,1,4,6,21,"Human T cells treated with 2DG upregulated the NK-specific transcription factors TOX2 and EOMES, thereby acquiring NK cell properties, including high levels of perforin/granzyme and increased sensitivity to IL-2.",31969386_3,-1,-1,-1,-1,38844,-1,0.0014048173,0.04152568,0.9570695
38846,transcription factors TOX2,9,12,59,85,"Human T cells treated with 2DG upregulated the NK-specific transcription factors TOX2 and EOMES, thereby acquiring NK cell properties, including high levels of perforin/granzyme and increased sensitivity to IL-2.",31969386_3,-1,-1,-1,-1,38846,-1,3.702914e-05,0.9999366,2.6354026e-05
38866,IFN-stimulated genes,10,12,46,66,"Type I interferons (IFN), which activate many IFN-stimulated genes (ISG), are known to regulate tumorigenesis.",31974171_0,-1,-1,-1,-1,38866,-1,0.97977763,0.0160018,0.004220625
38869,that the,4,6,16,24,"Here, we report that the ISG UBA7 is a tumor suppressor in breast cancer.",31974171_2,-1,-1,-1,-1,38869,-1,2.1056092e-05,0.9999689,1.0104036e-05
38874,protein,12,13,85,92,"UBA7 encodes an enzyme that catalyzes the covalent conjugation of the ubiquitin-like protein product of another ISG (ISG15) to cellular proteins in a process known as ""ISGylation."" ISGylation of other ISGs, including STAT1 and STAT2, synergistically facilitates production of chemokine-receptor ligands to attract cytotoxic T cells.",31974171_3,0,1,-1,-1,38874,-1,9.8602155e-05,0.99981433,8.712264e-05
38875,to cellular proteins,20,23,124,144,"UBA7 encodes an enzyme that catalyzes the covalent conjugation of the ubiquitin-like protein product of another ISG (ISG15) to cellular proteins in a process known as ""ISGylation."" ISGylation of other ISGs, including STAT1 and STAT2, synergistically facilitates production of chemokine-receptor ligands to attract cytotoxic T cells.",31974171_3,-1,-1,-1,-1,38875,-1,0.0008251427,0.9916924,0.00748251
38881,These gene-activation,0,2,0,21,These gene-activation events are further linked to clustering and nuclear relocalization of STAT1/2 within IFN-induced promyelocytic leukemia (PML) bodies.,31974171_4,-1,-1,-1,-1,38881,-1,3.0078549e-05,0.99995327,1.6626578e-05
38888,IFN-inducible gene,5,7,36,54,These findings reveal a cooperative IFN-inducible gene network in orchestrating a tumor-suppressive microenvironment.,31974171_6,-1,-1,-1,-1,38888,-1,0.99373055,0.0044249,0.001844607
38894,functional,21,22,140,150,"These findings provide mechanistic insights into immune evasion in breast cancer associated with UBA7 loss, emphasizing the importance of a functional ISG-ISGylation network in tumor suppression.",31974171_8,0,1,2,-1,38894,-1,4.2735035e-05,0.999941,1.6244168e-05
38907,biosynthesis,8,9,46,58,"Here we report that iNKT cells increase lipid biosynthesis after activation, and that is promoted by PPAR and PLZF synergically through enhancing transcription of Srebf1.",31974378_1,0,1,-1,-1,38907,-1,7.2905474e-05,0.9998772,4.984321e-05
38936,biosynthesis,18,19,127,139,Our studies provide a strategy to augment the anti-tumor efficacy of iNKT cell-based immunotherapies via promoting their lipid biosynthesis.,31974378_6,0,1,-1,-1,38936,-1,7.399749e-05,0.9998703,5.5660075e-05
38942,analysis,5,6,31,39,"METHODS: By digital microscopy analysis of a muscle-invasive BC (MIBC) cohort, we explored the density and clinical significance of CD66b+ tumor-associated-neutrophils (TAN) and CD3+ T cells.",31991796_2,0,1,-1,-1,38942,-1,3.0019404e-05,0.9999486,2.1330776e-05
38947,analysis,1,2,15,23,Bioinformatics analysis of UBC datasets and gene expression analysis of UBC cell lines were additionally performed.,31991796_3,0,1,-1,-1,38947,-1,2.8380959e-05,0.9999535,1.8130379e-05
38949,analysis,8,9,60,68,Bioinformatics analysis of UBC datasets and gene expression analysis of UBC cell lines were additionally performed.,31991796_3,0,1,-1,-1,38949,-1,3.4417546e-05,0.99993896,2.6599773e-05
38953,to the,14,16,87,93,RESULTS: Basal type BC contained a significantly higher density of CD66b+ TAN compared to the luminal type.,31991796_4,-1,-1,-1,-1,38953,-1,2.1400616e-05,0.9999672,1.1338088e-05
38964,T celsl,9,11,39,46,"In term of survival, a high density of T celsl and TAN was significantly associated to a better outcome, with TAN density showing a more limited statistical power and following a non-linear predicting model.",31991796_8,-1,-1,-1,-1,38964,-1,0.0015703886,0.667364,0.33106565
38973,immunity,12,13,76,84,This finding establishes a groundwork for a better understanding of the UBC immunity and its relevance.,31991796_10,0,-1,2,-1,38973,-1,0.99827003,0.0011929243,0.0005370141
38975,antigen receptor-modified T cell,5,9,26,58,"In recent years, chimeric antigen receptor-modified T cell (CAR T cell) therapy has proven to be a promising approach against cancer.",31999649_0,-1,-1,-1,-1,38975,-1,0.00014340221,9.013275e-05,0.9997665
38977,therapy,14,15,72,79,"In recent years, chimeric antigen receptor-modified T cell (CAR T cell) therapy has proven to be a promising approach against cancer.",31999649_0,0,1,-1,-1,38977,-1,2.198875e-05,0.9999616,1.645004e-05
38986,TGF- receptor,9,11,55,69,"Here, we demonstrated that knocking out the endogenous TGF- receptor II (TGFBR2) in CAR T cells with CRISPR/Cas9 technology could reduce the induced Treg conversion and prevent the exhaustion of CAR T ce lls.",31999649_2,-1,-1,-1,-1,38986,-1,0.0001889571,0.99868983,0.0011211808
38999,the TGFBR2-edited,3,5,13,30,"In addition, the TGFBR2-edited CAR T cells could eliminate contralaterally reinoculated xenografts in mice effectively, with an increased proportion of memory subsets within circulating CAR T cells of central memory and effector memory subsets.",31999649_4,-1,-1,-1,-1,38999,-1,3.483719e-05,0.9999454,1.9784015e-05
39005,function,12,13,60,68,"In conclusion, we greatly improved the in vitro and in vivo function of CAR T cells in TGF--rich tumor environments by knocking out endogenous TGFBR2 and propose a potentially new method to improve the efficacy of CAR T cell therapy for treating solid tumors.",31999649_5,0,1,2,-1,39005,-1,5.2002833e-05,0.9999081,3.99472e-05
39007,TGF--rich tumor,18,20,87,103,"In conclusion, we greatly improved the in vitro and in vivo function of CAR T cells in TGF--rich tumor environments by knocking out endogenous TGFBR2 and propose a potentially new method to improve the efficacy of CAR T cell therapy for treating solid tumors.",31999649_5,-1,-1,-1,-1,39007,-1,3.5139525e-05,0.99994326,2.1597874e-05
39011,T cell therapy,38,41,219,233,"In conclusion, we greatly improved the in vitro and in vivo function of CAR T cells in TGF--rich tumor environments by knocking out endogenous TGFBR2 and propose a potentially new method to improve the efficacy of CAR T cell therapy for treating solid tumors.",31999649_5,-1,-1,-1,-1,39011,-1,0.0015948035,0.05581166,0.9425935
39014,The metabolism-controlled,0,2,0,25,"The metabolism-controlled differentiation of  T cells has been well documented; however, the role of a metabolism program in  T cell differentiation and function has not been clarified.",32001780_0,-1,-1,-1,-1,39014,-1,4.2134852e-05,0.9999306,2.7286986e-05
39017,metabolism,18,19,105,115,"The metabolism-controlled differentiation of  T cells has been well documented; however, the role of a metabolism program in  T cell differentiation and function has not been clarified.",32001780_0,0,1,2,-1,39017,-1,0.00022684206,0.9993173,0.0004558207
39019,function,26,27,157,165,"The metabolism-controlled differentiation of  T cells has been well documented; however, the role of a metabolism program in  T cell differentiation and function has not been clarified.",32001780_0,0,1,2,-1,39019,-1,9.7310396e-05,0.9997782,0.00012445834
39035,their cytokine,2,4,16,30,"Consistent with their cytokine production profiles, the Raptor KO  T cells lost their anti-tumor function both in vitro and in vivo, whereas both Raptor and Rictor KO mice were resistant to imiquimod (IMQ)-induced psoriasis-like skin pathogenesis.",32001780_6,-1,-1,-1,-1,39035,-1,0.26554495,0.7305391,0.003915955
39039,function,16,17,99,107,"Consistent with their cytokine production profiles, the Raptor KO  T cells lost their anti-tumor function both in vitro and in vivo, whereas both Raptor and Rictor KO mice were resistant to imiquimod (IMQ)-induced psoriasis-like skin pathogenesis.",32001780_6,0,1,2,-1,39039,-1,0.00013845987,0.99972695,0.00013458288
39041,functions,7,8,45,54,"In summary, we identified previously unknown functions of mTORC1 and mTORC2 in  T cell differentiation and clarified their divergent roles in mediating the activity of  T cells in tumors and autoimmunity.",32001780_7,0,1,2,-1,39041,-1,4.5035948e-05,0.9999336,2.1315533e-05
39047,Cytokines that,0,2,0,14,"Cytokines that stimulate T cell proliferation, such as interleukin (IL)-15, have been explored as a means of boosting the antitumor activity of chimeric antigen receptor (CAR) T cells.",32015548_0,-1,-1,-1,-1,39047,-1,0.9307645,0.06472396,0.004511549
39056,toxicity,15,16,96,104,"However, constitutive cytokine signaling in T cells and activation of bystander cells may cause toxicity.",32015548_1,0,1,-1,-1,39056,-1,4.407986e-05,0.99991906,3.6870308e-05
39057,two-subunit cytokine,3,5,11,31,IL-23 is a two-subunit cytokine known to promote proliferation of memory T cells and T helper type 17 cells.,32015548_2,-1,-1,-1,-1,39057,-1,0.2018808,0.78936744,0.008751687
39065,TCR,10,11,45,48,"We found that, upon T cell antigen receptor (TCR) stimulation, T cells upregulated the IL-23 receptor and the IL-23 p19 subunit, but not the p40 subunit.",32015548_3,-1,1,2,-1,39065,-1,2.294926e-05,0.9999565,2.0565954e-05
39068,receptor,19,20,93,101,"We found that, upon T cell antigen receptor (TCR) stimulation, T cells upregulated the IL-23 receptor and the IL-23 p19 subunit, but not the p40 subunit.",32015548_3,0,1,2,-1,39068,-1,0.00019956024,0.0014351077,0.99836534
39071,the p40 subunit,28,31,138,153,"We found that, upon T cell antigen receptor (TCR) stimulation, T cells upregulated the IL-23 receptor and the IL-23 p19 subunit, but not the p40 subunit.",32015548_3,-1,-1,-1,-1,39071,-1,5.3711214e-05,0.99985826,8.794902e-05
39072,the p40 subunit,4,7,28,43,We engineered expression of the p40 subunit in T cells (p40-Td cells) and obtained selective proliferative activity in activated T cells via autocrine IL-23 signaling.,32015548_4,-1,-1,-1,-1,39072,-1,3.760791e-05,0.9999182,4.4169035e-05
39074,p40-Td cells,11,13,56,68,We engineered expression of the p40 subunit in T cells (p40-Td cells) and obtained selective proliferative activity in activated T cells via autocrine IL-23 signaling.,32015548_4,-1,-1,-1,-1,39074,-1,0.0010029284,0.02309716,0.9758999
39087,side effects,26,28,149,161,"In two xenograft and two syngeneic solid tumor mouse models, p40-Td CAR T cells showed superior efficacy in comparison to CAR T cells and attenuated side effects in comparison to CAR T cells expressing IL-18 or IL-15.",32015548_6,0,1,-1,-1,39087,-1,0.00054137525,0.9993486,0.00010999051
39096,T-cell,6,7,46,52,Cancer-associated mechanisms that elicit CD8+ T-cell exclusion and resistance to immunotherapy are not well-known.,32024640_1,-1,1,2,-1,39096,-1,3.240792e-05,4.2085285e-05,0.9999255
39098,mechanism of action,14,17,63,82,"Here, using a Kras- and p53-driven model of PDA, we describe a mechanism of action for the protumorigenic cytokine IL35 through STAT3 activation in CD8+ T cells.",32024640_2,0,1,-1,-1,39098,-1,6.104873e-05,0.99990106,3.788253e-05
39101,through STAT3,22,24,120,133,"Here, using a Kras- and p53-driven model of PDA, we describe a mechanism of action for the protumorigenic cytokine IL35 through STAT3 activation in CD8+ T cells.",32024640_2,-1,-1,-1,-1,39101,-1,2.9786732e-05,0.9999516,1.8638762e-05
39105,the transcription factor STAT3,18,22,89,119,"Distinct from its action on CD4+ T cells, IL35 signaling in gp130+CD8+ T cells activated the transcription factor STAT3, which antagonized intratumoral infiltration and effector function of CD8+ T cells via suppression of CXCR3, CCR5, and IFN expression.",32024640_3,-1,-1,-1,-1,39105,-1,2.0013105e-05,0.9999685,1.14883505e-05
39106,function,29,30,178,186,"Distinct from its action on CD4+ T cells, IL35 signaling in gp130+CD8+ T cells activated the transcription factor STAT3, which antagonized intratumoral infiltration and effector function of CD8+ T cells via suppression of CXCR3, CCR5, and IFN expression.",32024640_3,0,1,2,-1,39106,-1,0.0002508466,0.99916255,0.00058660004
39113,transfer to tumor-bearing,16,19,103,128,Inhibition of STAT3 signaling in tumor-educated CD8+ T cells improved PDA growth control upon adoptive transfer to tumor-bearing mice.,32024640_4,-1,-1,-1,-1,39113,-1,3.6650243e-05,0.99994266,2.0721118e-05
39127,that the,16,18,95,103,"Finally, we identified a circulating IL35+ B-cell subset in patients with PDA and demonstrated that the presence of IL35+ cells predicted increased occurrence of phosphorylated (p)Stat3+CXCR3-CD8+ T cells in tumors and inversely correlated with a cytotoxic T-cell signature in patients.",32024640_7,-1,-1,-1,-1,39127,-1,1.7220962e-05,0.99997425,8.505828e-06
39131,T-cell,40,41,257,263,"Finally, we identified a circulating IL35+ B-cell subset in patients with PDA and demonstrated that the presence of IL35+ cells predicted increased occurrence of phosphorylated (p)Stat3+CXCR3-CD8+ T cells in tumors and inversely correlated with a cytotoxic T-cell signature in patients.",32024640_7,-1,1,2,-1,39131,-1,3.4354674e-05,4.594306e-05,0.9999198
39136,T-cell,17,18,111,117,"Together, these data identified B cell-mediated IL35/gp130/STAT3 signaling as an important direct link to CD8+ T-cell exclusion and immunotherapy resistance in PDA.",32024640_8,-1,1,2,-1,39136,-1,3.0443185e-05,4.182893e-05,0.99992776
39146,analysis,1,2,9,17,"Survival analysis showed differential prognosis, while principal component analysis revealed distinctly different immune phenotypes between the two risk groups.",32028264_3,0,1,-1,-1,39146,-1,4.712291e-05,0.9999248,2.8062535e-05
39147,analysis,9,10,75,83,"Survival analysis showed differential prognosis, while principal component analysis revealed distinctly different immune phenotypes between the two risk groups.",32028264_3,0,1,-1,-1,39147,-1,6.717248e-05,0.99985385,7.898301e-05
39148,the two,16,18,140,147,"Survival analysis showed differential prognosis, while principal component analysis revealed distinctly different immune phenotypes between the two risk groups.",32028264_3,-1,-1,-1,-1,39148,-1,2.7761489e-05,0.9999614,1.089016e-05
39149,tended to,2,4,19,28,"High-risk patients tended to have advanced stage, higher grade disease, and poorer prognoses.",32028264_4,-1,-1,-1,-1,39149,-1,3.057888e-05,0.9999387,3.0697393e-05
39150,Functional,0,1,0,10,Functional enrichment analysis showed that the signature genes were mainly involved in the cytokine-cytokine receptor interaction pathway.,32028264_5,0,1,2,-1,39150,-1,3.775019e-05,0.9999424,1.9847492e-05
39151,analysis,2,3,22,30,Functional enrichment analysis showed that the signature genes were mainly involved in the cytokine-cytokine receptor interaction pathway.,32028264_5,0,1,-1,-1,39151,-1,3.856164e-05,0.9999268,3.461268e-05
39152,that the,4,6,38,46,Functional enrichment analysis showed that the signature genes were mainly involved in the cytokine-cytokine receptor interaction pathway.,32028264_5,-1,-1,-1,-1,39152,-1,2.0034979e-05,0.99996805,1.1874511e-05
39154,the cytokine-cytokine receptor,12,15,87,117,Functional enrichment analysis showed that the signature genes were mainly involved in the cytokine-cytokine receptor interaction pathway.,32028264_5,-1,-1,-1,-1,39154,-1,0.008434449,0.9841377,0.007427861
39155,that tumors,4,6,19,30,"Moreover, we found that tumors from high-risk patients had higher relative abundance of T follicular helper cells, regulatory T cells, and M0 macrophages, and higher expression of PD-1, CTLA-4, LAG3, and CD47 than low-risk patients.",32028264_6,-1,-1,-1,-1,39155,-1,1.7577036e-05,0.9999715,1.0911353e-05
39166,tool to,22,24,115,122,"This suggests our gene signature may not only serve as an indicator of tumor immune status, but may be a promising tool to select high-risk patients who may benefit from immune checkpoint inhibitor therapy.",32028264_7,-1,-1,-1,-1,39166,-1,2.655361e-05,0.9999634,1.0007574e-05
39167,therapy,34,35,198,205,"This suggests our gene signature may not only serve as an indicator of tumor immune status, but may be a promising tool to select high-risk patients who may benefit from immune checkpoint inhibitor therapy.",32028264_7,0,1,-1,-1,39167,-1,2.8452872e-05,0.9999589,1.26166415e-05
39168,analysis,3,4,28,36,"Multivariate Cox regression analysis showed that the signature remained an independent prognostic factor after adjusting for clinicopathological variables, while prognostic accuracy was further improved after integrating clinical parameters into the analysis.",32028264_8,0,1,-1,-1,39168,-1,3.392445e-05,0.99994147,2.4568497e-05
39169,that the,5,7,44,52,"Multivariate Cox regression analysis showed that the signature remained an independent prognostic factor after adjusting for clinicopathological variables, while prognostic accuracy was further improved after integrating clinical parameters into the analysis.",32028264_8,-1,-1,-1,-1,39169,-1,1.8145161e-05,0.9999733,8.502219e-06
39170,factor,12,13,98,104,"Multivariate Cox regression analysis showed that the signature remained an independent prognostic factor after adjusting for clinicopathological variables, while prognostic accuracy was further improved after integrating clinical parameters into the analysis.",32028264_8,0,1,-1,-1,39170,-1,0.0024856576,0.99704033,0.00047395847
39171,the analysis,30,32,246,258,"Multivariate Cox regression analysis showed that the signature remained an independent prognostic factor after adjusting for clinicopathological variables, while prognostic accuracy was further improved after integrating clinical parameters into the analysis.",32028264_8,-1,-1,-1,-1,39171,-1,2.841273e-05,0.99995756,1.4049194e-05
39180,T-cells to,18,20,95,105,T Follicular helper (TFH) and T follicular regulatory (TFR) cells are specialized providers of T-cells to help B-cells and shaping germinal centers (GC) response.,32061875_1,-1,-1,-1,-1,39180,-1,0.0010712502,0.030794092,0.96813464
39183,their functional,2,4,9,25,"However, their functional role in human colorectal cancer (CRC) is relatively unknown.",32061875_3,-1,-1,-1,-1,39183,-1,3.321022e-05,0.99995303,1.3726615e-05
39185,that the,5,7,33,41,"Furthermore, recent studies show that the interaction of both TFH cells and TFR cells are essential to promote several diseases.",32061875_4,-1,-1,-1,-1,39185,-1,1.9381238e-05,0.9999721,8.525325e-06
39186,TFH cells,10,12,62,71,"Furthermore, recent studies show that the interaction of both TFH cells and TFR cells are essential to promote several diseases.",32061875_4,-1,-1,-1,-1,39186,-1,0.00014548094,0.0011754333,0.9986791
39187,TFR cells,13,15,76,85,"Furthermore, recent studies show that the interaction of both TFH cells and TFR cells are essential to promote several diseases.",32061875_4,-1,-1,-1,-1,39187,-1,0.0017382893,0.11491787,0.88334376
39195,TFH cells,21,23,126,135,"Under the control of specific cytokines and B-cell lymphoma 6 transcription factor (Bcl-6), the major transcription factor of TFH cells, TFH, can expand to the other distinct CD4+T helper cells (TH1, TH2, and TH17) which exert a different role in the development of CRC.",32061875_5,-1,-1,-1,-1,39195,-1,0.00023067436,0.002967932,0.9968014
39197,to the,28,30,153,159,"Under the control of specific cytokines and B-cell lymphoma 6 transcription factor (Bcl-6), the major transcription factor of TFH cells, TFH, can expand to the other distinct CD4+T helper cells (TH1, TH2, and TH17) which exert a different role in the development of CRC.",32061875_5,-1,-1,-1,-1,39197,-1,2.5192516e-05,0.9999579,1.6844222e-05
39206,the two-opposite subset,9,12,53,76,This review aims to discuss these suggested roles of the two-opposite subset of follicular T cells in colorectal cancer immune pathogenesis.,32061875_6,-1,-1,-1,-1,39206,-1,0.0032755681,0.90288335,0.09384113
39208,TNF,0,1,0,3,TNF is a key proinflammatory and immunoregulatory cytokine whose deregulation is associated with the development of autoimmune diseases and other pathologies.,32083339_0,0,1,-1,-1,39208,-1,3.5979352e-05,0.9999528,1.1237952e-05
39212,functions,5,6,37,46,Recent studies suggest that distinct functions of TNF may be associated with differential engagement of its two receptors: TNFR1 or TNFR2.,32083339_1,0,1,2,-1,39212,-1,6.034909e-05,0.99990916,3.0453422e-05
39213,TNF,7,8,50,53,Recent studies suggest that distinct functions of TNF may be associated with differential engagement of its two receptors: TNFR1 or TNFR2.,32083339_1,0,1,-1,-1,39213,-1,5.0322946e-05,0.9999347,1.5049947e-05
39214,two receptors,16,18,108,121,Recent studies suggest that distinct functions of TNF may be associated with differential engagement of its two receptors: TNFR1 or TNFR2.,32083339_1,-1,-1,-1,-1,39214,-1,0.0021700123,0.88169086,0.116139136
39215,TNFR1,19,20,123,128,Recent studies suggest that distinct functions of TNF may be associated with differential engagement of its two receptors: TNFR1 or TNFR2.,32083339_1,0,1,-1,-1,39215,-1,3.5427587e-05,0.999926,3.856841e-05
39216,TNFR2,21,22,132,137,Recent studies suggest that distinct functions of TNF may be associated with differential engagement of its two receptors: TNFR1 or TNFR2.,32083339_1,0,1,-1,-1,39216,-1,4.5343975e-05,0.99993503,1.9611738e-05
39218,the relative,6,8,27,39,"In this review, we discuss the relative contributions of these receptors to pathogenesis of several diseases, with the focus on autoimmunity and neuroinflammation.",32083339_2,-1,-1,-1,-1,39218,-1,2.642009e-05,0.9999597,1.3897124e-05
39219,these receptors to,10,13,57,75,"In this review, we discuss the relative contributions of these receptors to pathogenesis of several diseases, with the focus on autoimmunity and neuroinflammation.",32083339_2,-1,-1,-1,-1,39219,-1,3.8382113e-05,0.9999267,3.4952413e-05
39222,TNFRs,8,9,38,43,"In particular, we discuss the role of TNFRs in the development of regulatory T cells during neuroinflammation and recent findings concerning targeting TNFR2 with agonistic and antagonistic reagents in various murine models of autoimmune and neuroinflammatory disorders and cancer.",32083339_3,0,1,-1,-1,39222,-1,2.6488195e-05,0.99996114,1.2352434e-05
39225,targeting TNFR2,22,24,141,156,"In particular, we discuss the role of TNFRs in the development of regulatory T cells during neuroinflammation and recent findings concerning targeting TNFR2 with agonistic and antagonistic reagents in various murine models of autoimmune and neuroinflammatory disorders and cancer.",32083339_3,-1,-1,-1,-1,39225,-1,3.0440737e-05,0.99995697,1.2640464e-05
39227,transgenic T cell receptor,5,9,27,53,Mice that express a single transgenic T cell receptor have a low incidence of T cell lymphoma development.,32143838_0,-1,-1,-1,-1,39227,-1,0.0013571221,0.028181937,0.97046095
39229,this tumor,3,5,24,34,We investigated whether this tumor development is restricted by surveillance mechanisms that are exerted by IL-15-dependent cells.,32143838_1,-1,-1,-1,-1,39229,-1,1.9295308e-05,0.9999709,9.773902e-06
39231,IL-15-dependent cells,15,17,108,129,We investigated whether this tumor development is restricted by surveillance mechanisms that are exerted by IL-15-dependent cells.,32143838_1,-1,-1,-1,-1,39231,-1,0.7550029,0.0016816101,0.24331544
39233,TCR transgenes,11,13,60,74,Lymphoma incidence was increased to between 30 and 60% when TCR transgenes were expressed in IL-15-deficient mice.,32143838_2,-1,-1,-1,-1,39233,-1,2.3544999e-05,0.99995995,1.6471455e-05
39244,receptor,17,18,91,99,"The distinct phenotype of the lymphomas involved expression of PD1, CD30, CD24, the stress receptor ligand Mult1 and MHC class I down-regulation.",32143838_5,0,1,2,-1,39244,-1,0.0066209543,0.0017496515,0.9916294
39249,Together these,0,2,0,14,Together these data support an involvement of NK cells in tumor surveillance of nascent T cell lymphomas.,32143838_7,-1,-1,-1,-1,39249,-1,3.7040667e-05,0.99994946,1.3556533e-05
39254,the tumor,2,4,15,24,Elucidation of the tumor immune microenvironment is essential for understanding tumorigenesis and for the development of immunotherapeutic strategies.,32156780_1,-1,-1,-1,-1,39254,-1,2.0660424e-05,0.9999695,9.814193e-06
39257,the tumor,9,11,62,71,"However, it remains unclear how -catenin signaling regulates the tumor immune microenvironment in the stomach.",32156780_2,-1,-1,-1,-1,39257,-1,1.8515415e-05,0.9999722,9.260034e-06
39260,transcriptional target gene,8,11,36,63,"Here, we identify CCL28 as a direct transcriptional target gene of -catenin/T-cell factor (TCF).",32156780_3,-1,-1,-1,-1,39260,-1,2.4123485e-05,0.99996233,1.3571351e-05
39261,factor,13,14,84,90,"Here, we identify CCL28 as a direct transcriptional target gene of -catenin/T-cell factor (TCF).",32156780_3,0,1,-1,-1,39261,-1,0.4650622,0.015533997,0.5194038
39263,Protein,0,1,0,7,Protein levels of -catenin and CCL28 positively correlated in human gastric adenocarcinoma.,32156780_4,0,1,-1,-1,39263,-1,2.7603588e-05,0.99995375,1.864115e-05
39277,toxin-induced Treg cell,1,4,11,34,"Diphtheria toxin-induced Treg cell ablation restrained gastric cancer progression in H. felis/MNU-treated DEREG (Foxp3-DTR) mice, clarifying the tumor-promoting role of Treg cells.",32156780_8,-1,-1,-1,-1,39277,-1,0.0053760805,0.42518538,0.5694385
39279,the tumor-promoting,19,21,141,160,"Diphtheria toxin-induced Treg cell ablation restrained gastric cancer progression in H. felis/MNU-treated DEREG (Foxp3-DTR) mice, clarifying the tumor-promoting role of Treg cells.",32156780_8,-1,-1,-1,-1,39279,-1,4.1831434e-05,0.99993896,1.9216171e-05
39283,-catenin-CCL28-Treg cell,3,5,10,35,"Thus, the -catenin-CCL28-Treg cell axis may serve as an important mechanism for immunosuppression of the stomach tumor microenvironment.",32156780_9,-1,-1,-1,-1,39283,-1,0.0074232244,0.24575734,0.74681944
39287,the therapeutic,14,16,100,115,Our findings reveal an immunoregulatory role of -catenin signaling in stomach tumors and highlight the therapeutic potential of CCL28 blockade for the treatment of gastric cancer.,32156780_10,-1,-1,-1,-1,39287,-1,2.1757452e-05,0.999969,9.285845e-06
39289,the treatment,21,23,148,161,Our findings reveal an immunoregulatory role of -catenin signaling in stomach tumors and highlight the therapeutic potential of CCL28 blockade for the treatment of gastric cancer.,32156780_10,-1,-1,-1,-1,39289,-1,2.1986527e-05,0.99996734,1.0651738e-05
39292,the therapeutic,13,15,110,125,SIGNIFICANCE: These findings demonstrate an immunosuppressive role of tumor-intrinsic -catenin signaling and the therapeutic potential of CCL28 blockade in gastric cancer.,32156780_11,-1,-1,-1,-1,39292,-1,2.3211933e-05,0.9999666,1.01409005e-05
39300,the therapies,8,10,33,46,"However, in HGSOC, the impact of the therapies aiming at these targets remains unsatisfying.",32184777_2,-1,-1,-1,-1,39300,-1,2.7661199e-05,0.9999616,1.0775264e-05
39301,these targets,12,14,57,70,"However, in HGSOC, the impact of the therapies aiming at these targets remains unsatisfying.",32184777_2,-1,-1,-1,-1,39301,-1,2.9260496e-05,0.9999567,1.4034478e-05
39304,the TMEs,13,15,69,77,Tumor-associated macrophages (TAMs) in HGSOC make up a large part of the TMEs and transform between diverse phenotypes under different treatments.,32184777_3,-1,-1,-1,-1,39304,-1,3.1701275e-05,0.9999505,1.7752878e-05
39327,MAF transcripts,4,6,28,43,"This modification occurs on MAF transcripts in TAMs and modified by BRD4, which is the target of AZD5153.",32184777_7,-1,-1,-1,-1,39327,-1,7.562407e-05,0.9998661,5.820987e-05
39330,the target,15,17,83,93,"This modification occurs on MAF transcripts in TAMs and modified by BRD4, which is the target of AZD5153.",32184777_7,-1,-1,-1,-1,39330,-1,2.7935472e-05,0.9999566,1.5475454e-05
39334,therapy,14,15,104,111,"Importantly, the 3-D microfluid model demonstrates that AZD5153 sensitizes ovarian cancer to anti-PD-L1 therapy.",32184777_8,0,1,-1,-1,39334,-1,2.2802882e-05,0.99996257,1.4576066e-05
39336,tumor cells,6,8,45,56,"Our results clarify that besides eliminating tumor cells directly, AZD5153 works as a regulator of the TAM phenotype, providing a novel strategy combining AZD5153 and PD-1/PD-L1 antibody that could benefit HGSOC patients.",32184777_9,-1,-1,-1,-1,39336,-1,0.0037911548,0.43762398,0.55858487
39337,the TAM,16,18,99,106,"Our results clarify that besides eliminating tumor cells directly, AZD5153 works as a regulator of the TAM phenotype, providing a novel strategy combining AZD5153 and PD-1/PD-L1 antibody that could benefit HGSOC patients.",32184777_9,-1,-1,-1,-1,39337,-1,2.2856182e-05,0.99996746,9.738746e-06
39348,blood lymphocytes,32,34,191,208,"A limited number of studies, largely performed on tumor infiltrating lymphocytes (TILs), has provided evidence in support of this hypothesis, but whether similar changes occur in circulating blood lymphocytes has received little attention.",32210968_1,-1,-1,-1,-1,39348,-1,0.0003308738,0.0013533199,0.9983158
39350,analysis,7,8,38,46,"In the present study, a comprehensive analysis of peripheral blood leukocytes from 42 patients taken over the course of treatment with anti-PD-1 was undertaken.",32210968_2,0,1,-1,-1,39350,-1,2.9653807e-05,0.99994516,2.512791e-05
39351,blood,10,11,61,66,"In the present study, a comprehensive analysis of peripheral blood leukocytes from 42 patients taken over the course of treatment with anti-PD-1 was undertaken.",32210968_2,0,1,-1,-1,39351,-1,6.9337686e-05,0.9993679,0.0005627379
39359,Analysis,0,1,0,8,"Analysis included surface markers of exhaustion, production of cytokines following in vitro stimulation, and assessment of transcription factor levels associated with T cell exhaustion.",32210968_4,0,1,-1,-1,39359,-1,2.9704539e-05,0.9999465,2.3766399e-05
39365,throughout therapy,15,17,115,133,There were differences in innate cell populations between responders and non-responders at baseline and maintained throughout therapy.,32210968_5,-1,-1,-1,-1,39365,-1,3.9159884e-05,0.9999399,2.092357e-05
39371,blood,5,6,35,40,"However, differences in peripheral blood expression of exhaustion markers were not evident between the treatment groups.",32210968_7,0,1,-1,-1,39371,-1,0.00015288145,0.99915814,0.0006890168
39372,the treatment,14,16,99,112,"However, differences in peripheral blood expression of exhaustion markers were not evident between the treatment groups.",32210968_7,-1,-1,-1,-1,39372,-1,2.2249029e-05,0.9999683,9.4860125e-06
39385,blood,3,4,17,22,"Thus, peripheral blood expression of T cell exhaustion markers does not distinguish between responders and non-responders to anti-PD-1 therapy.",32210968_10,0,1,-1,-1,39385,-1,4.9702587e-05,0.99988914,6.110433e-05
39388,therapy,19,20,135,142,"Thus, peripheral blood expression of T cell exhaustion markers does not distinguish between responders and non-responders to anti-PD-1 therapy.",32210968_10,0,1,-1,-1,39388,-1,2.30898e-05,0.9999658,1.1171962e-05
39393,blood,25,26,162,167,"CD4 T cell expression of IFN also differed in pre-treatment samples, indicating that predictors of response unrelated to exhaustion may be present in peripheral blood.",32210968_11,0,1,-1,-1,39393,-1,0.00014091255,0.99924743,0.000611709
39400,to the,12,14,74,80,"Though benign in the majority of cases, complications can be excruciating to the affected individual, and recurrences after tumor removal may happen with more aggressive clinical features.",32279926_1,-1,-1,-1,-1,39400,-1,3.3032502e-05,0.9999479,1.9059384e-05
39407,cell type,12,14,76,85,T regulatory (Treg) cells are generally considered a tumor-promoting immune cell type in malignant cancers with currently unclear roles in pituitary adenoma patients.,32279926_2,-1,-1,-1,-1,39407,-1,0.00013238152,0.00028760827,0.99957997
39410,functional,7,8,45,55,"Therefore, we investigated the frequency and functional characteristics of Treg cells in nonfunctioning pituitary adenoma patients before and after tumor removal.",32279926_3,0,1,2,-1,39410,-1,4.378441e-05,0.9999305,2.5742936e-05
39414,functional,16,17,130,140,"Compared to healthy controls, untreated patients with nonfunctioning pituitary adenomas presented an overrepresentation of highly functional circulating FOXP3+ Treg cells.",32279926_4,0,1,2,-1,39414,-1,0.00014212077,0.9997595,9.8433644e-05
39417,the FOXP3,2,4,14,23,"Specifically, the FOXP3+ Treg cells in patients were slightly upregulated in frequency and displayed markedly elevated capacity to co-produce TGF- and IL-10.",32279926_5,-1,-1,-1,-1,39417,-1,2.4396475e-05,0.9999598,1.5802161e-05
39429,cells than TIM-3- Treg cells,22,27,145,173,"In both healthy controls and pituitary adenoma patients, TIM-3+ Treg cells presented significantly higher levels of TGF- and IL-10 co-producing cells than TIM-3- Treg cells but compared to healthy controls, patients with nonfunctioning pituitary adenomas showed significantly higher levels of TIM-3+ FOXP3+ Treg cells.",32279926_7,-1,-1,-1,-1,39429,-1,0.00029227723,0.00064376584,0.999064
39434,the tumor,5,7,35,44,"Interestingly, surgical removal of the tumor significantly reduced the extent of Treg upregulation in patients.",32279926_8,-1,-1,-1,-1,39434,-1,2.2067592e-05,0.9999664,1.1599185e-05
39437,functional FOXP3,7,9,51,67,"Also, resected pituitary adenomas contained highly functional FOXP3+ Treg cells, with high levels of TIM-3 expression and high frequency of TGF- and IL-10 co-producers in the TIM-3+ fraction.",32279926_9,-1,-1,-1,-1,39437,-1,7.243578e-05,0.9998741,5.3463697e-05
39442,the TIM-3,28,30,172,181,"Also, resected pituitary adenomas contained highly functional FOXP3+ Treg cells, with high levels of TIM-3 expression and high frequency of TGF- and IL-10 co-producers in the TIM-3+ fraction.",32279926_9,-1,-1,-1,-1,39442,-1,3.0001785e-05,0.99995184,1.8134566e-05
39445,functional Treg cells,18,21,141,162,"Overall, these results demonstrate that patients with nonfunctioning pituitary adenomas are characterized by an overrepresentation of highly functional Treg cells.",32279926_10,-1,-1,-1,-1,39445,-1,0.0014990483,0.015440697,0.9830602
39450,protein,7,8,46,53,We recently reported that cancer Forkhead box protein 3 (Cancer-FOXP3 or C-FOXP3) promoted immune evasion of PDAC by recruiting Treg cells into PDAC via upregulation of CCL5.,32300119_2,0,1,-1,-1,39450,-1,5.3998272e-05,0.99987555,7.0427224e-05
39456,tumor cells,13,15,81,92,"Moreover, C-FOXP3 was colocalized and correlated with the expression of PD-L1 in tumor cells at the mRNA and protein levels, and this finding was confirmed by the The Cancer Genome Atlas (TCGA) database.",32300119_4,-1,-1,-1,-1,39456,-1,0.0032891887,0.44622198,0.5504889
39458,protein,19,20,109,116,"Moreover, C-FOXP3 was colocalized and correlated with the expression of PD-L1 in tumor cells at the mRNA and protein levels, and this finding was confirmed by the The Cancer Genome Atlas (TCGA) database.",32300119_4,0,1,-1,-1,39458,-1,4.6543417e-05,0.9999192,3.4287816e-05
39460,the The,28,30,159,166,"Moreover, C-FOXP3 was colocalized and correlated with the expression of PD-L1 in tumor cells at the mRNA and protein levels, and this finding was confirmed by the The Cancer Genome Atlas (TCGA) database.",32300119_4,-1,-1,-1,-1,39460,-1,1.8715007e-05,0.9999713,9.954767e-06
39463,to the,10,12,74,80,Chromatin immunoprecipitation (ChIP) revealed that C-FOXP3 directly bound to the promoter region of PD-L1 in pancreatic cancer cells.,32300119_5,-1,-1,-1,-1,39463,-1,1.7992355e-05,0.9999726,9.409567e-06
39473,that the,5,7,28,36,"Based on our recent finding that the CCL-5 antibody achieved a better response to PDAC models with high C-FOXP3 levels, we further demonstrated that the PD-L1 antibody strengthened the antitumor effect of CCL-5 blockade in xenograft and orthotopic mouse models with high C-FOXP3 levels.",32300119_9,-1,-1,-1,-1,39473,-1,1.7022516e-05,0.9999739,9.024043e-06
39475,that the,24,26,144,152,"Based on our recent finding that the CCL-5 antibody achieved a better response to PDAC models with high C-FOXP3 levels, we further demonstrated that the PD-L1 antibody strengthened the antitumor effect of CCL-5 blockade in xenograft and orthotopic mouse models with high C-FOXP3 levels.",32300119_9,-1,-1,-1,-1,39475,-1,1.7199469e-05,0.9999738,8.999754e-06
39479,therapy,10,11,62,69,Combined blockade of PD-L1 and CCL-5 may provide an effective therapy for patients with PDAC that have high C-FOXP3 levels.,32300119_11,0,1,-1,-1,39479,-1,2.7400556e-05,0.9999603,1.2298154e-05
39481,The tumor,0,2,0,9,The tumor microenvironment (TME) is an essential contributor to the development and progression of malignancy.,32300202_0,-1,-1,-1,-1,39481,-1,2.0968091e-05,0.9999684,1.0613299e-05
39483,to the,10,12,61,67,The tumor microenvironment (TME) is an essential contributor to the development and progression of malignancy.,32300202_0,-1,-1,-1,-1,39483,-1,2.6949792e-05,0.9999598,1.3244729e-05
39484,the TME,1,3,7,14,"Within the TME, tumor associated macrophages (TAMs) mediate angiogenesis, metastasis, and immunosuppression, which inhibits infiltration of tumor-specific cytotoxic CD8+ T cells.",32300202_1,-1,-1,-1,-1,39484,-1,2.282406e-05,0.99996305,1.4106007e-05
39489,that the,6,8,34,42,"In previous work, we demonstrated that the synthetic triterpenoid CDDO-methyl ester (CDDO-Me) converts breast TAMs from a tumor-promoting to a tumor-inhibiting activation state in vitro.",32300202_2,-1,-1,-1,-1,39489,-1,1.7070975e-05,0.9999746,8.291508e-06
39492,tumor-promoting to,20,22,122,140,"In previous work, we demonstrated that the synthetic triterpenoid CDDO-methyl ester (CDDO-Me) converts breast TAMs from a tumor-promoting to a tumor-inhibiting activation state in vitro.",32300202_2,-1,-1,-1,-1,39492,-1,2.6908632e-05,0.99995923,1.3913456e-05
39499,T cell tumor,14,17,81,93,"We show now that CDDO-Me remodels the breast TME, redirecting TAM activation and T cell tumor infiltration in vivo.",32300202_3,-1,-1,-1,-1,39499,-1,0.0015219465,0.032499745,0.9659782
39502,TNF,12,13,94,97,"We demonstrate that CDDO-Me significantly attenuates IL-10 and VEGF expression but stimulates TNF production, and reduces surface expression of CD206 and CD115, markers of immunosuppressive TAMs.",32300202_4,0,1,-1,-1,39502,-1,0.00025561606,0.9997048,3.9547438e-05
39505,the TAM transcriptional,3,6,28,51,"CDDO-Me treatment redirects the TAM transcriptional profile, inducing signaling pathways associated with immune stimulation, and inhibits TAM tumor infiltration, consistent with decreased expression of CCL2.",32300202_5,-1,-1,-1,-1,39505,-1,2.1901615e-05,0.9999678,1.0341111e-05
39506,TAM tumor,18,20,138,147,"CDDO-Me treatment redirects the TAM transcriptional profile, inducing signaling pathways associated with immune stimulation, and inhibits TAM tumor infiltration, consistent with decreased expression of CCL2.",32300202_5,-1,-1,-1,-1,39506,-1,2.4078552e-05,0.9999633,1.2674814e-05
39518,time that,6,8,40,49,These results demonstrate for the first time that CDDO-Me relieves immunosuppression in the breast TME and unleashes host adaptive anti-tumor immunity.,32300202_8,-1,-1,-1,-1,39518,-1,2.0423442e-05,0.9999685,1.107683e-05
39522,immunity,20,21,142,150,These results demonstrate for the first time that CDDO-Me relieves immunosuppression in the breast TME and unleashes host adaptive anti-tumor immunity.,32300202_8,0,-1,2,-1,39522,-1,0.999556,0.0002752059,0.00016867305
39532,CCL11,22,23,115,120,"The aim of the present study was to investigate the role and molecular mechanism of CC motif chemokine ligand11 (CCL11) in the regulation of Treg cells from patients with breast cancer (BC) and healthy individuals invitro, and from tumorbearing mice invivo.",32323817_1,0,-1,2,-1,39532,-1,0.947241,0.0008828545,0.05187618
39533,the regulation,25,27,125,139,"The aim of the present study was to investigate the role and molecular mechanism of CC motif chemokine ligand11 (CCL11) in the regulation of Treg cells from patients with breast cancer (BC) and healthy individuals invitro, and from tumorbearing mice invivo.",32323817_1,-1,-1,-1,-1,39533,-1,1.6605829e-05,0.9999738,9.670264e-06
39536,CCL11 protein,22,24,143,156,"CD4+ Tcells isolated from patients with BC or healthy individuals were incubated with antiCCL11 neutralizing antibodies or recombinant human CCL11 protein, in the presence or absence of a STAT5 inhibitor.",32323817_2,-1,-1,-1,-1,39536,-1,0.93684465,0.008949986,0.054205388
39540,CCL11,2,3,10,15,"The serum CCL11 level and proportion of Treg cells characterized as CD4+CD25+forkhead box P3+ (Foxp3) among the CD4+ Tcells in patients with BC and healthy individuals were analyzed by ELISA and flow cytometry, respectively.",32323817_3,0,-1,2,-1,39540,-1,0.9847222,0.00031650672,0.014961282
39542,CD4+CD25+forkhead,11,12,68,85,"The serum CCL11 level and proportion of Treg cells characterized as CD4+CD25+forkhead box P3+ (Foxp3) among the CD4+ Tcells in patients with BC and healthy individuals were analyzed by ELISA and flow cytometry, respectively.",32323817_3,-1,-1,-1,-1,39542,-1,0.004408887,0.053049143,0.942542
39546,CCL11,0,1,0,5,"CCL11, CC motif chemokine receptor3 (CCR3), Foxp3, phosphorylatedSTAT5 and STAT5 expression levels were determined by western blotting.",32323817_4,0,-1,2,-1,39546,-1,0.13942303,0.0010575233,0.8595194
39547,chemokine receptor,4,6,17,35,"CCL11, CC motif chemokine receptor3 (CCR3), Foxp3, phosphorylatedSTAT5 and STAT5 expression levels were determined by western blotting.",32323817_4,-1,-1,-1,-1,39547,-1,0.63706225,0.004026866,0.35891092
39551,CCL11,2,3,10,15,The serum CCL11 level and the proportion of CD4+CD25+Foxp3+ Treg cells were significantly increased in patients with BC compared with healthy individuals.,32323817_5,0,-1,2,-1,39551,-1,0.96315235,0.0004964052,0.036351334
39554,CCL11,0,1,0,5,"CCL11 blockade reduced the proportion of CD4+CD25+Foxp3+ Treg cells, the expression of CCR3 and Foxp3, and the level of STAT5 activation in tumorassociated CD4+ Tcells, in a dosedependent manner.",32323817_6,0,-1,2,-1,39554,-1,0.66584295,0.0014365587,0.33272046
39562,CCL11,0,1,0,5,CCL11 blockade also reduced the proportion of CD4+CD25+Foxp3+ Treg cells and the serum levels of interleukin (IL)2 and transforming growth factor (TGF)1 in tumorbearing mice.,32323817_7,0,-1,2,-1,39562,-1,0.875523,0.0012490116,0.123228066
39567,transforming growth factor,19,22,120,146,CCL11 blockade also reduced the proportion of CD4+CD25+Foxp3+ Treg cells and the serum levels of interleukin (IL)2 and transforming growth factor (TGF)1 in tumorbearing mice.,32323817_7,-1,-1,-1,-1,39567,-1,0.9267933,0.070085004,0.003121684
39569,CCL11 protein,3,5,22,35,"The recombinant human CCL11 protein increased the proportion of CD4+CD25+Foxp3+ Treg cells, the expression of CCR3 and Foxp3, and the release of IL2 and TGF1 in nontumorassociated CD4+ Tcells via the STAT5 signaling pathway.",32323817_8,-1,-1,-1,-1,39569,-1,0.7864108,0.02608971,0.18749948
39574,the release,22,24,130,141,"The recombinant human CCL11 protein increased the proportion of CD4+CD25+Foxp3+ Treg cells, the expression of CCR3 and Foxp3, and the release of IL2 and TGF1 in nontumorassociated CD4+ Tcells via the STAT5 signaling pathway.",32323817_8,-1,-1,-1,-1,39574,-1,2.3247601e-05,0.99996376,1.30433455e-05
39576,the STAT5,36,38,202,211,"The recombinant human CCL11 protein increased the proportion of CD4+CD25+Foxp3+ Treg cells, the expression of CCR3 and Foxp3, and the release of IL2 and TGF1 in nontumorassociated CD4+ Tcells via the STAT5 signaling pathway.",32323817_8,-1,-1,-1,-1,39576,-1,2.9329623e-05,0.9999523,1.8337947e-05
39579,therapeutics that,10,12,56,73,The results of the present study may aid in identifying therapeutics that could further modulate the immune system during BC.,32323817_9,-1,-1,-1,-1,39579,-1,1.9799396e-05,0.99997103,9.131321e-06
39582,T-cell,12,13,86,92,"Although melanoma is considered one of the most immunogenic malignancies, spontaneous T-cell responses to melanoma antigens are ineffective due to tumor cell-intrinsic or microenvironment-driven immune evasion mechanisms.",32330348_0,-1,1,2,-1,39582,-1,3.2550033e-05,5.1412342e-05,0.9999161
39585,to tumor cell-intrinsic,20,23,144,167,"Although melanoma is considered one of the most immunogenic malignancies, spontaneous T-cell responses to melanoma antigens are ineffective due to tumor cell-intrinsic or microenvironment-driven immune evasion mechanisms.",32330348_0,-1,-1,-1,-1,39585,-1,0.0073937066,0.46980885,0.52279747
39586,cells fosters tumor,9,12,55,74,"For example, oncogenic BRAF V600E mutation in melanoma cells fosters tumor immune escape by modulating cell immunogenicity and microenvironment composition.",32330348_1,-1,-1,-1,-1,39586,-1,0.006026683,0.6875708,0.3064025
39605,these cells,24,26,162,173,"In coculture experiments, A375 melanoma cells pretreated with vemurafenib induced apoptosis of interacting Jurkat T cells, whereas genetic inhibition of Gal-1 in these cells restored the viability of cocultured T lymphocytes, indicating that Gal-1 contributes to tumor immune escape.",32330348_6,-1,-1,-1,-1,39605,-1,0.00166961,0.069021724,0.92930865
39609,to tumor,38,40,260,268,"In coculture experiments, A375 melanoma cells pretreated with vemurafenib induced apoptosis of interacting Jurkat T cells, whereas genetic inhibition of Gal-1 in these cells restored the viability of cocultured T lymphocytes, indicating that Gal-1 contributes to tumor immune escape.",32330348_6,-1,-1,-1,-1,39609,-1,2.385787e-05,0.99996567,1.0529413e-05
39612,Taken together,0,2,0,14,"Taken together, these results suggest a two-faceted nature of BRAF inhibition-associated immunomodulatory effects: an early immunostimulatory activity, mediated at least in part by decreased PD-L1 expression, and a delayed immunosuppressive effect associated with Gal-1 induction.",32330348_8,-1,-1,-1,-1,39612,-1,3.8357506e-05,0.99994624,1.5414991e-05
39614,two-faceted nature,7,9,40,58,"Taken together, these results suggest a two-faceted nature of BRAF inhibition-associated immunomodulatory effects: an early immunostimulatory activity, mediated at least in part by decreased PD-L1 expression, and a delayed immunosuppressive effect associated with Gal-1 induction.",32330348_8,-1,-1,-1,-1,39614,-1,4.7801073e-05,0.9999256,2.6534786e-05
39616,therapeutic target,17,19,107,125,"Importantly, our observations suggest that Gal-1 might be utilized as a potential biomarker and a putative therapeutic target in melanoma patients.",32330348_9,-1,-1,-1,-1,39616,-1,2.3404082e-05,0.99996316,1.3422771e-05
39618,therapy,12,13,90,97,The development of immune checkpoint inhibitors represents a major breakthrough in cancer therapy.,32332858_0,0,1,-1,-1,39618,-1,2.6106225e-05,0.9999603,1.3612244e-05
39628,the tumors to,29,32,193,206,"Here we show that a specific small-molecule tankyrase inhibitor, G007-LK, decreases WNT/-catenin and YAP signaling in the syngeneic murine B16-F10 and Clone M-3 melanoma models and sensitizes the tumors to anti-PD-1 immune checkpoint therapy.",32332858_4,-1,-1,-1,-1,39628,-1,1.7589908e-05,0.99997306,9.327687e-06
39629,therapy,35,36,235,242,"Here we show that a specific small-molecule tankyrase inhibitor, G007-LK, decreases WNT/-catenin and YAP signaling in the syngeneic murine B16-F10 and Clone M-3 melanoma models and sensitizes the tumors to anti-PD-1 immune checkpoint therapy.",32332858_4,0,1,-1,-1,39629,-1,2.2059266e-05,0.99996567,1.22219535e-05
39630,that the,4,6,32,40,"Mechanistically, we demonstrate that the synergistic effect of tankyrase and checkpoint inhibitor treatment is dependent on loss of -catenin in the tumor cells, anti-PD-1-stimulated infiltration of T cells into the tumor and induction of an IFN- and CD8+ T cell-mediated anti-tumor immune response.",32332858_5,-1,-1,-1,-1,39630,-1,1.6411706e-05,0.99997556,8.060412e-06
39633,the tumor cells,21,24,145,160,"Mechanistically, we demonstrate that the synergistic effect of tankyrase and checkpoint inhibitor treatment is dependent on loss of -catenin in the tumor cells, anti-PD-1-stimulated infiltration of T cells into the tumor and induction of an IFN- and CD8+ T cell-mediated anti-tumor immune response.",32332858_5,-1,-1,-1,-1,39633,-1,0.0030278827,0.7696957,0.2272764
39635,the tumor,31,33,212,221,"Mechanistically, we demonstrate that the synergistic effect of tankyrase and checkpoint inhibitor treatment is dependent on loss of -catenin in the tumor cells, anti-PD-1-stimulated infiltration of T cells into the tumor and induction of an IFN- and CD8+ T cell-mediated anti-tumor immune response.",32332858_5,-1,-1,-1,-1,39635,-1,1.9458306e-05,0.9999696,1.09098755e-05
39645,functions,8,9,56,65,"T cells have been reported to exert immunosuppressive functions in multiple solid malignant diseases, but their immunosuppressive functional subpopulation in breast cancer (BC) is still undetermined.",32345959_0,0,1,2,-1,39645,-1,5.7177043e-05,0.99991,3.287086e-05
39647,functional,18,19,132,142,"T cells have been reported to exert immunosuppressive functions in multiple solid malignant diseases, but their immunosuppressive functional subpopulation in breast cancer (BC) is still undetermined.",32345959_0,0,1,2,-1,39647,-1,0.00015509815,0.99953055,0.00031442518
39648,tissue,9,10,43,49,"Here, we collected 40 paired BC and normal tissue samples from Chinese patients for analysis.",32345959_1,-1,1,2,-1,39648,-1,0.00016459048,0.9926509,0.007184446
39649,analysis,15,16,84,92,"Here, we collected 40 paired BC and normal tissue samples from Chinese patients for analysis.",32345959_1,0,1,-1,-1,39649,-1,2.7856784e-05,0.99994826,2.3897828e-05
39659,that their,38,40,182,192,"First, we showed that T1 cells comprise the majority of CD3+ T cells in BC; next, we found that CD73+T1 cells were the predominant regulatory T-cell (Treg) population in BC, and that their prevalence in peripheral blood was also related to tumour burden.",32345959_2,-1,-1,-1,-1,39659,-1,1.7991952e-05,0.9999721,9.868597e-06
39660,blood,43,44,218,223,"First, we showed that T1 cells comprise the majority of CD3+ T cells in BC; next, we found that CD73+T1 cells were the predominant regulatory T-cell (Treg) population in BC, and that their prevalence in peripheral blood was also related to tumour burden.",32345959_2,0,1,-1,-1,39660,-1,7.269736e-05,0.99961084,0.00031647997
39661,related to tumour,46,49,233,250,"First, we showed that T1 cells comprise the majority of CD3+ T cells in BC; next, we found that CD73+T1 cells were the predominant regulatory T-cell (Treg) population in BC, and that their prevalence in peripheral blood was also related to tumour burden.",32345959_2,-1,-1,-1,-1,39661,-1,2.7025766e-05,0.99995685,1.61848e-05
39667,analysis,2,3,15,23,"The microarray analysis and functional experiments indicated that breast tumour cell-derived exosomes (TDEs) could transmit lncRNA SNHG16, which upregulates CD73 expression, to V1 T cells.",32345959_5,0,1,-1,-1,39667,-1,3.2729848e-05,0.9999397,2.755541e-05
39668,functional,4,5,28,38,"The microarray analysis and functional experiments indicated that breast tumour cell-derived exosomes (TDEs) could transmit lncRNA SNHG16, which upregulates CD73 expression, to V1 T cells.",32345959_5,0,1,2,-1,39668,-1,5.2331627e-05,0.99991465,3.2983306e-05
39670,tumour cell-derived,9,11,73,92,"The microarray analysis and functional experiments indicated that breast tumour cell-derived exosomes (TDEs) could transmit lncRNA SNHG16, which upregulates CD73 expression, to V1 T cells.",32345959_5,-1,-1,-1,-1,39670,-1,0.0019575257,0.24920735,0.7488351
39676,to the,17,19,83,89,"Regarding the mechanism, SNHG16 served as a ceRNA by sponging miR-16-5p, which led to the derepression of its target gene SMAD5 and resulted in potentiation of the TGF-1/SMAD5 pathway to upregulate CD73 expression in V1 T cells.",32345959_6,-1,-1,-1,-1,39676,-1,1.9613813e-05,0.9999703,1.0100381e-05
39677,target gene SMAD5,22,25,110,127,"Regarding the mechanism, SNHG16 served as a ceRNA by sponging miR-16-5p, which led to the derepression of its target gene SMAD5 and resulted in potentiation of the TGF-1/SMAD5 pathway to upregulate CD73 expression in V1 T cells.",32345959_6,-1,-1,-1,-1,39677,-1,3.4813624e-05,0.9999335,3.1701336e-05
39681,that the,3,5,19,27,"Our results showed that the BC-derived exosomal SNHG16/miR-16-5p/SMAD5-regulatory axis potentiates TGF-1/SMAD5 pathway activation, thus inducing CD73 expression in V1 T cells.",32345959_7,-1,-1,-1,-1,39681,-1,1.6844668e-05,0.9999739,9.312033e-06
39686,therapy targeting this,13,16,73,95,"Our results first identify the significance of CD73+V1 Tregs in BC, and therapy targeting this subpopulation or blocking TDEs might have potential for BC treatment in the future.",32345959_8,-1,-1,-1,-1,39686,-1,1.779492e-05,0.9999726,9.629062e-06
39702,to the,6,8,40,46,"In addition, gut microbiota contributes to the development and progression of CAC.",32357539_4,-1,-1,-1,-1,39702,-1,2.5612908e-05,0.9999602,1.4183802e-05
39711,receptor,3,4,30,38,"Although the estrogen-related receptor alpha (ERR) has been implicated in breast cancer cell dissemination to the bone from the primary tumor, its role after tumor cell anchorage in the bone microenvironment remains elusive.",32366476_1,0,1,2,-1,39711,-1,0.0007913388,0.9441182,0.055090487
39713,to the,16,18,108,114,"Although the estrogen-related receptor alpha (ERR) has been implicated in breast cancer cell dissemination to the bone from the primary tumor, its role after tumor cell anchorage in the bone microenvironment remains elusive.",32366476_1,-1,-1,-1,-1,39713,-1,3.0766918e-05,0.9999541,1.5172028e-05
39716,tumor cell,27,29,159,169,"Although the estrogen-related receptor alpha (ERR) has been implicated in breast cancer cell dissemination to the bone from the primary tumor, its role after tumor cell anchorage in the bone microenvironment remains elusive.",32366476_1,-1,-1,-1,-1,39716,-1,0.0037290663,0.3672951,0.62897587
39723,chemokines CCL17,11,13,78,94,Overexpression of ERR in breast cancer bone metastases induced expression of chemokines CCL17 and CCL20 and repressed production of TGF3.,32366476_3,-1,-1,-1,-1,39723,-1,0.99778557,0.00021636994,0.0019980506
39739,the immune response,10,13,62,81,"SIGNIFICANCE: This study places ERR at the interplay between the immune response and bone metastases of breast cancer, highlighting a potential target for intervention in advanced disease.",32366476_7,-1,-1,-1,-1,39739,-1,0.26479763,0.7334286,0.0017737473
39750,protein,39,40,232,239,"AIM: To compare cytokine patterns of active IBD patients with early and advanced CRC.METHODS: Choosing a panel of cytokines crucial for Th17/Treg differentiation and behavior, in colon specimens, as mRNA biomarkers, and their serum protein levels.",32390702_2,0,1,-1,-1,39750,-1,0.022358822,0.9659629,0.011678291
39760,The protein,0,2,0,11,The protein levels of the cytokines were significantly higher in CRC patients compared to IBD patients.,32390702_5,-1,-1,-1,-1,39760,-1,2.7842185e-05,0.99995613,1.59673e-05
39761,the cytokines,4,6,22,35,The protein levels of the cytokines were significantly higher in CRC patients compared to IBD patients.,32390702_5,-1,-1,-1,-1,39761,-1,0.3865049,0.6080226,0.0054725213
39763,that IL-6,5,7,32,41,"CONCLUSION: Our findings showed that IL-6 upregulation is essential for both IBD and CRC development until the upregulation of other Th17/Treg related genes (TGFb1, IL-10, IL-23, and transcription factor FoxP3) is a crucial primarily for CRC development.",32390702_6,-1,-1,-1,-1,39763,-1,0.73690045,0.2563151,0.006784473
39765,related genes,22,24,143,156,"CONCLUSION: Our findings showed that IL-6 upregulation is essential for both IBD and CRC development until the upregulation of other Th17/Treg related genes (TGFb1, IL-10, IL-23, and transcription factor FoxP3) is a crucial primarily for CRC development.",32390702_6,-1,-1,-1,-1,39765,-1,5.9018974e-05,0.9998667,7.426241e-05
39768,transcription factor FoxP3,32,35,183,209,"CONCLUSION: Our findings showed that IL-6 upregulation is essential for both IBD and CRC development until the upregulation of other Th17/Treg related genes (TGFb1, IL-10, IL-23, and transcription factor FoxP3) is a crucial primarily for CRC development.",32390702_6,-1,-1,-1,-1,39768,-1,2.7054057e-05,0.999956,1.692241e-05
39777,deficiency,30,31,141,151,Background: The role of T cell Ig and ITIM domain (TIGIT) and programmed cell death-1 (PD-1) in colorectal cancer (CRC) with mismatch repair deficiency is unknown.,32397769_0,0,1,-1,-1,39777,-1,0.03124605,0.9668059,0.0019480849
39780,deficiency,13,14,66,76,"Methods: This was a study of 60 CRC patients with mismatch repair deficiency and 30 healthy controls between June 2015 and October 2015.Results: The expression of Foxp3, PD-1, and TIGIT was higher in cancer tissues compared with adjacent mucosa (all P <.05).",32397769_1,0,1,-1,-1,39780,-1,0.009872521,0.98599374,0.004133792
39785,tissues,38,39,207,214,"Methods: This was a study of 60 CRC patients with mismatch repair deficiency and 30 healthy controls between June 2015 and October 2015.Results: The expression of Foxp3, PD-1, and TIGIT was higher in cancer tissues compared with adjacent mucosa (all P <.05).",32397769_1,-1,1,2,-1,39785,-1,0.00016443655,0.9970919,0.0027436556
39793,than those,18,20,89,99,"The overall survival (OS) of the patients with CRC and high expression of PD-1 was worse than those with low expression (HR=4.01, 95%CI:1.26-12.69, P =.019).Conclusion: TIGIT and PD-1 are upregulated in CRC with mismatch repair deficiency and associated with TNM stage and DFS.",32397769_4,-1,-1,-1,-1,39793,-1,2.4414583e-05,0.9999598,1.5749069e-05
39796,deficiency,49,50,231,241,"The overall survival (OS) of the patients with CRC and high expression of PD-1 was worse than those with low expression (HR=4.01, 95%CI:1.26-12.69, P =.019).Conclusion: TIGIT and PD-1 are upregulated in CRC with mismatch repair deficiency and associated with TNM stage and DFS.",32397769_4,0,1,-1,-1,39796,-1,0.018579636,0.97757554,0.0038448556
39798,Tissue-resident,0,1,0,15,Tissue-resident memory (Trm) cells are specialized components of both CD4+ and CD8+ T cell subsets that persist in peripheral nonlymphoid tissues following infections and provide fast response in case of a secondary invasion by the same pathogen.,32441311_0,-1,1,2,-1,39798,-1,2.7731923e-05,0.9999554,1.6832537e-05
39801,CD8+ T cell subsets that,14,20,79,103,Tissue-resident memory (Trm) cells are specialized components of both CD4+ and CD8+ T cell subsets that persist in peripheral nonlymphoid tissues following infections and provide fast response in case of a secondary invasion by the same pathogen.,32441311_0,-1,-1,-1,-1,39801,-1,0.0029892614,0.021098891,0.9759118
39802,tissues,24,25,138,145,Tissue-resident memory (Trm) cells are specialized components of both CD4+ and CD8+ T cell subsets that persist in peripheral nonlymphoid tissues following infections and provide fast response in case of a secondary invasion by the same pathogen.,32441311_0,-1,1,2,-1,39802,-1,0.00033613655,0.99634403,0.0033198085
39804,Trm cells,0,2,0,9,"Trm cells express the surface markers CD69, CD103, and the immune checkpoint molecule PD-1.",32441311_1,-1,-1,-1,-1,39804,-1,0.00030517823,0.006767412,0.9929274
39807,Trm cells,0,2,0,9,"Trm cells develop not only in the context of infections but also in tumors, where they can provide a line of defense as suggested by the positive correlation between the frequency of tumor-infiltrating Trm cells and patients' survival.",32441311_2,-1,-1,-1,-1,39807,-1,0.0002779005,0.0066774334,0.99304456
39813,tumor-infiltrating Trm cells,33,36,183,211,"Trm cells develop not only in the context of infections but also in tumors, where they can provide a line of defense as suggested by the positive correlation between the frequency of tumor-infiltrating Trm cells and patients' survival.",32441311_2,-1,-1,-1,-1,39813,-1,0.002642224,0.9131906,0.0841672
39814,Trm cells,0,2,0,9,"Trm cells persistence in peripheral tissues depends on their adaptation to the local microenvironment and the presence of survival factors, mainly IL-7, IL-15, and Notch ligands.",32441311_3,-1,-1,-1,-1,39814,-1,0.00020742798,0.0030955456,0.99669707
39815,tissues,5,6,36,43,"Trm cells persistence in peripheral tissues depends on their adaptation to the local microenvironment and the presence of survival factors, mainly IL-7, IL-15, and Notch ligands.",32441311_3,-1,1,2,-1,39815,-1,9.572544e-05,0.99946886,0.00043538792
39817,to the,10,12,72,78,"Trm cells persistence in peripheral tissues depends on their adaptation to the local microenvironment and the presence of survival factors, mainly IL-7, IL-15, and Notch ligands.",32441311_3,-1,-1,-1,-1,39817,-1,2.521291e-05,0.99996316,1.1601627e-05
39819,factors,19,20,131,138,"Trm cells persistence in peripheral tissues depends on their adaptation to the local microenvironment and the presence of survival factors, mainly IL-7, IL-15, and Notch ligands.",32441311_3,0,1,-1,-1,39819,-1,0.9991652,0.00023237466,0.0006024328
39822,the cell,2,4,9,17,"However, the cell sources of these factors are largely unknown, especially in the context of tumors.",32441311_4,-1,-1,-1,-1,39822,-1,0.0032640754,0.1905381,0.8061979
39823,these factors,6,8,29,42,"However, the cell sources of these factors are largely unknown, especially in the context of tumors.",32441311_4,-1,-1,-1,-1,39823,-1,0.003704787,0.99603087,0.00026432204
39831,cells that,7,9,43,53,"Moreover, we show that mesenchymal stromal cells that accumulate in HNSCC are a source of survival factors and allow proper expression of Trm-typical markers in a VCAM1-dependent manner.",32441311_6,-1,-1,-1,-1,39831,-1,0.0034074646,0.13024174,0.8663508
39832,factors,17,18,99,106,"Moreover, we show that mesenchymal stromal cells that accumulate in HNSCC are a source of survival factors and allow proper expression of Trm-typical markers in a VCAM1-dependent manner.",32441311_6,0,1,-1,-1,39832,-1,0.9881285,0.010459484,0.0014119678
39839,factor,6,7,26,32,"A viral gene, HTLV-1 bZIP factor (HBZ), induces pathogenic Foxp3-expressing T cells and triggers systemic inflammation and T cell lymphoma in transgenic mice, indicating its significance in HTLV-1-associated diseases.",32471947_1,0,1,-1,-1,39839,-1,0.0011012182,0.99851066,0.0003880747
39840,Foxp3-expressing T cells,13,16,59,83,"A viral gene, HTLV-1 bZIP factor (HBZ), induces pathogenic Foxp3-expressing T cells and triggers systemic inflammation and T cell lymphoma in transgenic mice, indicating its significance in HTLV-1-associated diseases.",32471947_1,-1,-1,-1,-1,39840,-1,0.003016655,0.8410919,0.1558915
39851,that IL-6 functions,9,12,69,88,"IL-6 innately inhibits regulatory T cell differentiation, suggesting that IL-6 functions as a suppressor against HBZ-associated complications.",32471947_4,-1,-1,-1,-1,39851,-1,0.001419353,0.9983516,0.00022914578
39853,cytokine IL-10,6,8,53,67,HBZ up-regulates expression of the immunosuppressive cytokine IL-10.,32471947_5,-1,-1,-1,-1,39853,-1,0.99981374,4.5223653e-05,0.00014112034
39877,transcription factor forkhead box protein P3,19,25,100,144,Regulatory T cells (Tregs) is one of the immunosuppressive subsets of CD4+ T cells characterized by transcription factor forkhead box protein P3 (FOXP3) expression which are involved in tumor development and progression.,32480291_0,-1,-1,-1,-1,39877,-1,2.7222097e-05,0.999951,2.1802092e-05
39880,the factors that,2,5,18,34,Identification of the factors that influence Treg cell function is extremely important.,32480291_1,-1,-1,-1,-1,39880,-1,2.9335375e-05,0.9999567,1.3938004e-05
39881,Treg cell function,6,9,45,63,Identification of the factors that influence Treg cell function is extremely important.,32480291_1,-1,-1,-1,-1,39881,-1,0.00012729503,0.0010635051,0.9988092
39896,TNF-,22,23,102,107,"Plasma levels of IL-10, transcription factor  (TGF-), IL-6, IL-17, IL-23 and tumor necrosis factor (TNF-) were measured by Enzyme-linked immunosorbent assay (ELISA).",32480291_4,0,1,-1,-1,39896,-1,6.759286e-05,0.99990237,2.997762e-05
39902,TNF-,27,28,93,98,"There was a significant elevation in IL-10 (p < 0.05), IL-6 (p < 0.01), IL-23 (p < 0.05) and TNF- (p < 0.01) in ALL patients compared with controls.",32480291_7,0,1,-1,-1,39902,-1,7.396164e-05,0.99989784,2.8187276e-05
39907,related cytokines,13,15,75,92,"In conclusion, the slight change in Treg cells frequency and alteration in related cytokines could possibly involve in the pathogenesis of ALL.",32480291_11,-1,-1,-1,-1,39907,-1,0.8467127,0.14322156,0.010065765
39909,to these,12,14,80,88,"Dysregulated miRNAs, as a regulatory mechanism of epigenetics, might contribute to these observed results.",32480291_12,-1,-1,-1,-1,39909,-1,3.299595e-05,0.9999527,1.4290141e-05
39912,antigen-presenting cells that,7,10,35,64,"Dendritic cells (DCs) are powerful antigen-presenting cells that are often used to evaluate adjuvants, particularly for adjuvant selection for various vaccines.",32486094_0,-1,-1,-1,-1,39912,-1,0.9019643,0.071473666,0.026562013
39921,functional,19,20,117,127,"We first confirmed the phenotypic (surface molecules, cytokines, antigen uptake, and antigen-presenting ability) and functional alterations (T cell proliferation/activation) of DCs in vitro.",32486094_2,0,1,2,-1,39921,-1,8.4503125e-05,0.9998399,7.557011e-05
39924,immunity,11,12,76,84,We also confirmed the adjuvant effect by evaluating anti-tumor activity and immunity using an ALP-treated DC-immunized mouse model.,32486094_3,0,-1,2,-1,39924,-1,0.9912561,0.008001708,0.000742242
39925,functionally,1,2,4,16,"ALP functionally induced DC maturation by up-regulating the secretion of Th1-polarizing pro-inflammatory cytokines, the expression of surface molecules, and antigen-presenting ability.",32486094_4,0,1,2,-1,39925,-1,3.2591783e-05,0.9999534,1.40371085e-05
39935,naive T cells to Th1,8,13,60,80,ALP-activated DCs showed an ample capacity to differentiate naive T cells to Th1 and activated CD8+ T cells effectively.,32486094_6,-1,-1,-1,-1,39935,-1,0.0002706967,0.9982004,0.0015288196
39939,peptides,10,11,64,72,"The systemic administration of DCs that pulse ALP and ovalbumin peptides strongly increased cytotoxic T lymphocyte (CTL) activity (by 9.5% compared to that in the control vaccine groups), the generation of CD107a-producing multifunctional T cells, and Th1-mediated humoral immunity, and caused a significant reduction (increased protection by 29% over that in control vaccine groups) in tumor growth.",32486094_7,0,-1,2,-1,39939,-1,0.00099294,0.9979874,0.001019625
39942,to that,25,27,148,155,"The systemic administration of DCs that pulse ALP and ovalbumin peptides strongly increased cytotoxic T lymphocyte (CTL) activity (by 9.5% compared to that in the control vaccine groups), the generation of CD107a-producing multifunctional T cells, and Th1-mediated humoral immunity, and caused a significant reduction (increased protection by 29% over that in control vaccine groups) in tumor growth.",32486094_7,-1,-1,-1,-1,39942,-1,3.0493933e-05,0.999954,1.5553982e-05
39944,the generation,34,36,188,202,"The systemic administration of DCs that pulse ALP and ovalbumin peptides strongly increased cytotoxic T lymphocyte (CTL) activity (by 9.5% compared to that in the control vaccine groups), the generation of CD107a-producing multifunctional T cells, and Th1-mediated humoral immunity, and caused a significant reduction (increased protection by 29% over that in control vaccine groups) in tumor growth.",32486094_7,-1,-1,-1,-1,39944,-1,2.0397209e-05,0.99996495,1.4626691e-05
39947,immunity,45,46,273,281,"The systemic administration of DCs that pulse ALP and ovalbumin peptides strongly increased cytotoxic T lymphocyte (CTL) activity (by 9.5% compared to that in the control vaccine groups), the generation of CD107a-producing multifunctional T cells, and Th1-mediated humoral immunity, and caused a significant reduction (increased protection by 29% over that in control vaccine groups) in tumor growth.",32486094_7,0,-1,2,-1,39947,-1,0.9993161,0.00037162143,0.00031219143
39950,triggers the Th1,3,6,11,27,"ALP, which triggers the Th1 and CTL response, provides a basis for a new adjuvant for various vaccines.",32486094_8,-1,-1,-1,-1,39950,-1,4.4224234e-05,0.99991393,4.1805066e-05
39952,CD8+ T cell trafficking to the tumor,2,10,12,48,BACKGROUND: CD8+ T cell trafficking to the tumor site is essential for effective colorectal cancer (CRC) immunotherapy.,32503584_0,-1,-1,-1,-1,39952,-1,0.0044951383,0.13676378,0.8587411
39955,tumor tissues,12,14,73,86,"However, the mechanism underlying CD8+ T cell infiltration in colorectal tumor tissues is not fully understood.",32503584_1,-1,-1,-1,-1,39955,-1,2.828254e-05,0.9999397,3.202116e-05
39958,tissues,14,15,70,77,"In the present study, we investigated CD8+ T cell infiltration in CRC tissues and the role of chemokine-chemokine receptor signaling in regulation of T cell recruitment.",32503584_2,-1,1,2,-1,39958,-1,0.00014385447,0.99726474,0.0025914065
39960,chemokine-chemokine receptor,19,21,94,122,"In the present study, we investigated CD8+ T cell infiltration in CRC tissues and the role of chemokine-chemokine receptor signaling in regulation of T cell recruitment.",32503584_2,-1,-1,-1,-1,39960,-1,0.94780266,0.0024640472,0.04973337
39965,tissues,12,13,71,78,METHODS: We screened chemokines and cytokines in healthy donor and CRC tissues from early- and advanced-stage patients using multiplex assays and PCR screening.,32503584_3,-1,1,2,-1,39965,-1,0.0013324621,0.68886757,0.30979997
39967,tumor tissues,4,6,23,36,"RESULTS: Compared with tumor tissues of early-stage CRC patients, CD8+ T cell density was lower in advanced-stage tumor tissues.",32503584_5,-1,-1,-1,-1,39967,-1,3.4670615e-05,0.99989605,6.930246e-05
39969,tumor tissues,20,22,114,127,"RESULTS: Compared with tumor tissues of early-stage CRC patients, CD8+ T cell density was lower in advanced-stage tumor tissues.",32503584_5,-1,-1,-1,-1,39969,-1,3.3900098e-05,0.9998976,6.8432426e-05
39970,that CXCL10,3,5,21,32,PCR screening showed that CXCL10 levels were significantly increased in advanced-stage tumor tissues.,32503584_6,-1,-1,-1,-1,39970,-1,0.8562843,0.13618885,0.0075268447
39971,tumor tissues,11,13,87,100,PCR screening showed that CXCL10 levels were significantly increased in advanced-stage tumor tissues.,32503584_6,-1,-1,-1,-1,39971,-1,2.7571046e-05,0.99993384,3.8591377e-05
39972,the receptor,2,4,7,19,CXCR3 (the receptor of CXCL10) expression on CD8+ T cells was lower in the peripheral blood of advanced-stage patients.,32503584_7,-1,-1,-1,-1,39972,-1,0.0012774376,0.9783891,0.020333542
39976,blood,18,19,86,91,CXCR3 (the receptor of CXCL10) expression on CD8+ T cells was lower in the peripheral blood of advanced-stage patients.,32503584_7,0,1,-1,-1,39976,-1,0.0001242909,0.9991924,0.000683306
39978,T cells to CXCL10,6,10,30,47,The migratory ability of CD8+ T cells to CXCL10 depended on CXCR3 expression.,32503584_8,-1,-1,-1,-1,39978,-1,0.30719024,0.004034986,0.6887748
39979,that IL-17A,3,5,24,35,"Multiplex arrays showed that IL-17A was increased in advanced-stage patient sera, which markedly downregulated CXCR3 expression via activating STAT3 signaling and reduced CD8+ T cell migration.",32503584_9,-1,-1,-1,-1,39979,-1,0.84457767,0.15082051,0.0046018534
39984,Th17 cell,12,14,64,73,Similar results were found after CD8+ T cells were treated with Th17 cell supernatant.,32503584_10,-1,-1,-1,-1,39984,-1,0.0007168914,0.012966366,0.98631674
39985,the STAT3,3,5,22,31,"Adding anti-IL-17A or the STAT3 inhibitor, Stattic, rescued these effects in vitro and in vivo.",32503584_11,-1,-1,-1,-1,39985,-1,3.2733973e-05,0.9999522,1.50818505e-05
39988,analysis,3,4,19,27,"Moreover, survival analysis showed that patients with low CD8 and CXCR3 expression and high IL-17A levels had significantly worse prognosis.",32503584_12,0,1,-1,-1,39988,-1,3.969658e-05,0.9999347,2.5590427e-05
39993,Th17 cells,14,16,94,104,CONCLUSIONS: CD8+ T cell infiltration in advanced-stage tumor was systematically inhibited by Th17 cells via IL-17A/STAT3/CXCR3 axis.,32503584_13,-1,-1,-1,-1,39993,-1,0.0014523969,0.038402,0.96014565
39994,that the T cell,3,7,22,37,Our findings indicate that the T cell infiltration in the tumor microenvironment may be improved by inhibiting STAT3 signaling.,32503584_14,-1,-1,-1,-1,39994,-1,0.0044489573,0.66820306,0.32734793
39995,the tumor,9,11,54,63,Our findings indicate that the T cell infiltration in the tumor microenvironment may be improved by inhibiting STAT3 signaling.,32503584_14,-1,-1,-1,-1,39995,-1,2.0860882e-05,0.9999702,8.929574e-06
40000,functionally,10,11,53,65,Regulatory T (Treg) cell populations are composed of functionally quiescent resting Treg (rTreg) cells which differentiate into activated Treg (aTreg) cells upon antigen stimulation.,32515782_0,0,1,2,-1,40000,-1,4.130033e-05,0.99993575,2.2915172e-05
40009,The transcription factor,0,3,0,24,"The transcription factor BACH2 is critical for early Treg lineage specification, but its function following lineage commitment is unresolved.",32515782_2,-1,-1,-1,-1,40009,-1,2.5981333e-05,0.9999608,1.3193484e-05
40011,function,14,15,89,97,"The transcription factor BACH2 is critical for early Treg lineage specification, but its function following lineage commitment is unresolved.",32515782_2,0,1,2,-1,40011,-1,6.7543435e-05,0.99990714,2.536449e-05
40021,their TCR-driven,16,18,98,114,"In rTreg cells, BACH2 binds to enhancers of genes involved in aTreg differentiation and represses their TCR-driven induction by competing with AP-1 factors for DNA binding.",32515782_5,-1,-1,-1,-1,40021,-1,3.356267e-05,0.9999478,1.8614463e-05
40022,AP-1 factors,22,24,143,155,"In rTreg cells, BACH2 binds to enhancers of genes involved in aTreg differentiation and represses their TCR-driven induction by competing with AP-1 factors for DNA binding.",32515782_5,-1,-1,-1,-1,40022,-1,4.25754e-05,0.9999331,2.4354795e-05
40024,This function,0,2,0,13,This function promotes rTreg cell quiescence and long-term maintenance and is required for immune homeostasis and durable immunosuppression in cancer.,32515782_6,-1,-1,-1,-1,40024,-1,3.130225e-05,0.9999504,1.8265515e-05
40030,function,22,23,125,133,"Thus, BACH2 supports a ""division of labor"" between quiescent rTreg cells and their activated progeny in Treg maintenance and function, respectively.",32515782_7,0,1,2,-1,40030,-1,0.00016348698,0.9997278,0.00010871623
40036,Tfh subset,27,29,150,160,"Based on CD25 expression, T follicular helper cells (Tfh) could be divided into T follicular regulatory (Tfr)-like subset (CD25+CD4+CXCR5+) and CD25- Tfh subset (CD25-CD4+CXCR5+).",32534760_0,-1,-1,-1,-1,40036,-1,0.0033497235,0.35478795,0.64186233
40038,Tfr-like cells in blood,14,18,74,97,Patients with diffuse large B cell lymphoma (DLBCL) display high level of Tfr-like cells in blood and tumor.,32534760_1,-1,-1,-1,-1,40038,-1,6.473088e-05,0.99970347,0.00023172308
40040,This Tfr-like subset,0,3,0,20,This Tfr-like subset could suppress CD8 T cell response while promote tumor cell proliferation.,32534760_2,-1,-1,-1,-1,40040,-1,0.0028326118,0.90837854,0.088788845
40042,tumor cell,11,13,70,80,This Tfr-like subset could suppress CD8 T cell response while promote tumor cell proliferation.,32534760_2,-1,-1,-1,-1,40042,-1,0.004115919,0.20525399,0.7906301
40044,the transcription factors,6,9,31,56,"In this study, we investigated the transcription factors and regulatory elements associated with Tfr-like cells in DLBCL patients.",32534760_3,-1,-1,-1,-1,40044,-1,1.8282359e-05,0.9999701,1.1637489e-05
40045,Tfr-like cells,14,16,97,111,"In this study, we investigated the transcription factors and regulatory elements associated with Tfr-like cells in DLBCL patients.",32534760_3,-1,-1,-1,-1,40045,-1,0.0022071395,0.8551495,0.1426433
40046,tumor-infiltrating Tfr-like cells,3,6,21,54,Both circulating and tumor-infiltrating Tfr-like cells presented slightly higher Blimp-1 expression and significantly higher Foxp3 expression than the CD25- Tfh subset.,32534760_4,-1,-1,-1,-1,40046,-1,0.0025059115,0.93826586,0.05922829
40049,than the,16,18,142,150,Both circulating and tumor-infiltrating Tfr-like cells presented slightly higher Blimp-1 expression and significantly higher Foxp3 expression than the CD25- Tfh subset.,32534760_4,-1,-1,-1,-1,40049,-1,2.0555652e-05,0.9999666,1.2803306e-05
40050,Tfh subset,19,21,157,167,Both circulating and tumor-infiltrating Tfr-like cells presented slightly higher Blimp-1 expression and significantly higher Foxp3 expression than the CD25- Tfh subset.,32534760_4,-1,-1,-1,-1,40050,-1,0.0025194124,0.17173181,0.8257488
40052,receptor,3,4,12,20,"As the IL-2 receptor, CD25 could be moderately upregulated in stimulated CD25- Tfh cells.",32534760_5,0,1,2,-1,40052,-1,0.00017789363,0.00066829927,0.99915373
40053,Tfh cells,13,15,79,88,"As the IL-2 receptor, CD25 could be moderately upregulated in stimulated CD25- Tfh cells.",32534760_5,-1,-1,-1,-1,40053,-1,0.0009049864,0.023885457,0.97520953
40054,Tfh cells,4,6,26,35,"However, stimulated CD25- Tfh cells could not upregulate Foxp3, indicating that the distinction between Foxp3-low CD25-CXCR5+CD4+ T cells and Foxp3-high CD25+CXCR5+CD4+ T cells was not due to differences in stimulation status.",32534760_6,-1,-1,-1,-1,40054,-1,0.0024156452,0.16978271,0.8278017
40056,that the,12,14,75,83,"However, stimulated CD25- Tfh cells could not upregulate Foxp3, indicating that the distinction between Foxp3-low CD25-CXCR5+CD4+ T cells and Foxp3-high CD25+CXCR5+CD4+ T cells was not due to differences in stimulation status.",32534760_6,-1,-1,-1,-1,40056,-1,1.9202971e-05,0.9999727,8.043711e-06
40065,Tfh cells,9,11,61,70,"Regarding cytokine production, while both Tfr-like and CD25- Tfh cells upregulated IL-21 and IL-10 during stimulation, the CD25- Tfh cells presented significantly higher IL-21 and lower IL-10 expression than the Tfr-like cells, and the TGF- expression was only increased in Tfr-like cells.",32534760_7,-1,-1,-1,-1,40065,-1,0.001740232,0.10605226,0.8922075
40068,Tfh cells,20,22,129,138,"Regarding cytokine production, while both Tfr-like and CD25- Tfh cells upregulated IL-21 and IL-10 during stimulation, the CD25- Tfh cells presented significantly higher IL-21 and lower IL-10 expression than the Tfr-like cells, and the TGF- expression was only increased in Tfr-like cells.",32534760_7,-1,-1,-1,-1,40068,-1,0.0016949949,0.09810812,0.9001969
40070,than the Tfr-like cells,30,34,203,226,"Regarding cytokine production, while both Tfr-like and CD25- Tfh cells upregulated IL-21 and IL-10 during stimulation, the CD25- Tfh cells presented significantly higher IL-21 and lower IL-10 expression than the Tfr-like cells, and the TGF- expression was only increased in Tfr-like cells.",32534760_7,-1,-1,-1,-1,40070,-1,0.002760795,0.8980406,0.09919862
40071,the TGF-,36,38,232,241,"Regarding cytokine production, while both Tfr-like and CD25- Tfh cells upregulated IL-21 and IL-10 during stimulation, the CD25- Tfh cells presented significantly higher IL-21 and lower IL-10 expression than the Tfr-like cells, and the TGF- expression was only increased in Tfr-like cells.",32534760_7,-1,-1,-1,-1,40071,-1,3.0574225e-05,0.9999553,1.4152655e-05
40072,Tfr-like cells,43,45,275,289,"Regarding cytokine production, while both Tfr-like and CD25- Tfh cells upregulated IL-21 and IL-10 during stimulation, the CD25- Tfh cells presented significantly higher IL-21 and lower IL-10 expression than the Tfr-like cells, and the TGF- expression was only increased in Tfr-like cells.",32534760_7,-1,-1,-1,-1,40072,-1,0.0029903864,0.6917074,0.30530226
40073,Tfh cells,6,8,41,50,"Interestingly, IL-21 secreted from CD25- Tfh cells negatively regulated the expression of Foxp3 and IL-10 of autologous Tfr-like cells.",32534760_8,-1,-1,-1,-1,40073,-1,0.0012718621,0.051440172,0.9472879
40077,Tfr-like cells,18,20,120,134,"Interestingly, IL-21 secreted from CD25- Tfh cells negatively regulated the expression of Foxp3 and IL-10 of autologous Tfr-like cells.",32534760_8,-1,-1,-1,-1,40077,-1,0.0034153522,0.6669253,0.32965928
40080,that the Tfr-like,5,8,37,54,"Together, these results demonstrated that the Tfr-like and CD25- Tfh subsets of circulating Tfh cells presented different functions and should be investigated separately.",32534760_9,-1,-1,-1,-1,40080,-1,2.7241222e-05,0.9999572,1.5494012e-05
40081,Tfh subsets,10,12,65,76,"Together, these results demonstrated that the Tfr-like and CD25- Tfh subsets of circulating Tfh cells presented different functions and should be investigated separately.",32534760_9,-1,-1,-1,-1,40081,-1,0.0031627468,0.2659581,0.7308791
40082,Tfh cells,14,16,92,101,"Together, these results demonstrated that the Tfr-like and CD25- Tfh subsets of circulating Tfh cells presented different functions and should be investigated separately.",32534760_9,-1,-1,-1,-1,40082,-1,0.0003232315,0.0042609554,0.9954158
40083,functions,18,19,122,131,"Together, these results demonstrated that the Tfr-like and CD25- Tfh subsets of circulating Tfh cells presented different functions and should be investigated separately.",32534760_9,0,1,2,-1,40083,-1,0.0004167107,0.9990496,0.00053366926
40088,peptides that,18,20,139,152,PDS0101 is a liposomal-based HPV therapeutic vaccine consisting of the immune activating cationic lipid R-DOTAP and HLA-unrestricted HPV16 peptides that has shown in vivo CD8+ Tcell induction and safety in a phase I study.,32554612_1,-1,-1,-1,-1,40088,-1,0.00013109224,0.9997627,0.00010621115
40092,two immune modulators,11,14,58,79,"In this report, we have employed the PDS0101 vaccine with two immune modulators previously characterized in preclinical studies and which are currently in phase II clinical trials.",32554612_2,-1,-1,-1,-1,40092,-1,0.37735322,0.57791716,0.044729624
40094,Bintrafusp alfa,0,2,0,15,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,-1,-1,-1,40094,-1,0.23204088,0.7598527,0.008106412
40095,protein,10,11,64,71,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,0,1,-1,-1,40095,-1,2.9017785e-05,0.9999472,2.3781718e-05
40097,the transforming,17,19,113,129,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,-1,-1,-1,40097,-1,3.07711e-05,0.99995375,1.551661e-05
40098,factor- receptor type,20,23,137,159,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,-1,-1,-1,40098,-1,0.9396638,0.05397916,0.0063570947
40102,protein-1,38,39,246,255,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,0,1,-1,-1,40102,-1,0.06020953,0.2767702,0.66302025
40104,the TGFRII,53,55,324,335,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,-1,-1,-1,40104,-1,3.9977163e-05,0.9999293,3.072651e-05
40105,trap,56,57,337,341,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,1,2,-1,40105,-1,2.5807123e-05,0.99995744,1.6737535e-05
40106,to the tumor,58,61,343,355,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,-1,-1,-1,40106,-1,2.1423823e-05,0.99996567,1.285414e-05
40108,tumor targeting,6,8,35,50,NHS-interleukin-12 (NHS-IL12) is a tumor targeting immunocytokine designed to bring IL-12 to the TME and thus enhance the inflammatory Th1 response.,32554612_4,-1,-1,-1,-1,40108,-1,2.4604795e-05,0.9999634,1.1953101e-05
40110,IL-12 to the TME,12,16,84,100,NHS-interleukin-12 (NHS-IL12) is a tumor targeting immunocytokine designed to bring IL-12 to the TME and thus enhance the inflammatory Th1 response.,32554612_4,-1,-1,-1,-1,40110,-1,0.95186704,0.041833248,0.0062996815
40115,therapy,27,28,153,160,"METHODS: We employed TC-1 carcinoma (expressing HPV16 E6 and E7 and devoid of PDL1 expression) in a syngeneic mouse model in monotherapy and combination therapy studies to analyze antitumor effects and changes in immune cell types in the spleen and the TME.RESULTS: As a monotherapy, the PDS0101 vaccine generated HPV-specific T cells and antitumor activity in mice bearing HPV-expressing mEER oropharyngeal and TC-1 lung carcinomas.",32554612_5,0,1,-1,-1,40115,-1,2.9352781e-05,0.9999558,1.4865961e-05
40117,cell types,37,39,220,230,"METHODS: We employed TC-1 carcinoma (expressing HPV16 E6 and E7 and devoid of PDL1 expression) in a syngeneic mouse model in monotherapy and combination therapy studies to analyze antitumor effects and changes in immune cell types in the spleen and the TME.RESULTS: As a monotherapy, the PDS0101 vaccine generated HPV-specific T cells and antitumor activity in mice bearing HPV-expressing mEER oropharyngeal and TC-1 lung carcinomas.",32554612_5,-1,-1,-1,-1,40117,-1,5.5438264e-05,6.662528e-05,0.9998779
40124,the TC-1,6,8,30,38,"When used as a monotherapy in the TC-1 model, NHS-IL12 elicited antitumor effects as well as an increase in CD8+ T cells in the TME.",32554612_6,-1,-1,-1,-1,40124,-1,2.1127447e-05,0.9999608,1.8139433e-05
40126,the TME,25,27,124,131,"When used as a monotherapy in the TC-1 model, NHS-IL12 elicited antitumor effects as well as an increase in CD8+ T cells in the TME.",32554612_6,-1,-1,-1,-1,40126,-1,2.2892467e-05,0.99996495,1.2171068e-05
40127,bintrafusp alfa,6,8,28,43,"When used as a monotherapy, bintrafusp alfa did not elicit antitumor effects or any increase in T cells in the TME.",32554612_7,-1,-1,-1,-1,40127,-1,0.010936757,0.9871057,0.0019575432
40129,the TME,20,22,107,114,"When used as a monotherapy, bintrafusp alfa did not elicit antitumor effects or any increase in T cells in the TME.",32554612_7,-1,-1,-1,-1,40129,-1,2.497337e-05,0.99996245,1.2590412e-05
40133,T-cell,23,24,136,142,"When all three agents were used in combination, maximum antitumor effects were observed, which correlated with increases in T cells and T-cell clonality in the TME.CONCLUSION: These studies provide the rationale for the potential clinical use of combinations of agents that can (1) induce tumor-associated T-cell responses, (2) potentiate immune responses in the TME and (3) reduce immunosuppressive entities in the TME.",32554612_8,-1,1,2,-1,40133,-1,3.6840014e-05,5.546689e-05,0.99990773
40139,tumor-associated T-cell,49,51,289,312,"When all three agents were used in combination, maximum antitumor effects were observed, which correlated with increases in T cells and T-cell clonality in the TME.CONCLUSION: These studies provide the rationale for the potential clinical use of combinations of agents that can (1) induce tumor-associated T-cell responses, (2) potentiate immune responses in the TME and (3) reduce immunosuppressive entities in the TME.",32554612_8,-1,-1,-1,-1,40139,-1,0.004557747,0.64667976,0.34876248
40141,the TME,60,62,359,366,"When all three agents were used in combination, maximum antitumor effects were observed, which correlated with increases in T cells and T-cell clonality in the TME.CONCLUSION: These studies provide the rationale for the potential clinical use of combinations of agents that can (1) induce tumor-associated T-cell responses, (2) potentiate immune responses in the TME and (3) reduce immunosuppressive entities in the TME.",32554612_8,-1,-1,-1,-1,40141,-1,2.1230886e-05,0.9999677,1.1107624e-05
40142,the TME,70,72,412,419,"When all three agents were used in combination, maximum antitumor effects were observed, which correlated with increases in T cells and T-cell clonality in the TME.CONCLUSION: These studies provide the rationale for the potential clinical use of combinations of agents that can (1) induce tumor-associated T-cell responses, (2) potentiate immune responses in the TME and (3) reduce immunosuppressive entities in the TME.",32554612_8,-1,-1,-1,-1,40142,-1,2.1247e-05,0.99996734,1.1437264e-05
40164,functional,9,10,47,57,RESULTS: We found that both the phenotypic and functional maturation of dendritic cells was suppressed by the conditioned medium.,32573300_5,0,1,2,-1,40164,-1,0.000102496604,0.999845,5.24621e-05
40169,TNF-,5,6,28,33,"The expression of IL-12p70, TNF-, CD80, CD83, and CD86 was significantly reduced by conditioned medium from the 786-O and HeLa cell lines, and CD4+ T cells had a weaker TH1 phenotype with significantly decreased expression of IFN- and T-bet following co-culturing.",32573300_6,0,1,-1,-1,40169,-1,9.568185e-05,0.99987435,2.9991621e-05
40184,the tumor,17,19,117,126,"CONCLUSION: This model can be used to screen pharmacological compounds seeking to alleviate the immunosuppression of the tumor microenvironment and can furthermore be used to investigate the immunoregulatory capacities of primary cancer cells, which could be a helpful prognostic tool following tumor resection.",32573300_8,-1,-1,-1,-1,40184,-1,2.0790387e-05,0.9999697,9.491573e-06
40192,T-cell,12,13,81,87,BACKGROUND: Systemic chemotherapy is often the last resort of advanced cutaneous T-cell lymphoma (CTCL).,32573814_0,-1,1,2,-1,40192,-1,4.7989597e-05,6.4131e-05,0.9998878
40194,adverse effects,3,5,21,36,Tumor recurrence and adverse effects of systemic chemotherapy are the main limitations.,32573814_1,0,1,-1,-1,40194,-1,0.00074553414,0.9989712,0.00028328146
40199,tumor cells,10,12,62,73,"OBJECTIVE: We aim to investigate the metabolic alterations in tumor cells after CHOP (cyclophosphamide, hydroxydaunorubicin, oncovin and prednisone) chemotherapy.",32573814_2,-1,-1,-1,-1,40199,-1,0.0035198445,0.38693464,0.6095455
40206,tumor cell,13,15,79,89,HIF-1 is significantly elevated in lesions of advanced MF patients as well as tumor cell line Hut78 and tumor xenograft mice model.,32573814_4,-1,-1,-1,-1,40206,-1,0.0040281652,0.4478701,0.5481017
40208,therapy,1,2,5,12,CHOP therapy also increased glycolytic activities in a HIF-1-dependent manner.,32573814_5,0,1,-1,-1,40208,-1,2.0084371e-05,0.9999697,1.0221161e-05
40228,T-cell,11,12,72,78,"Tumor progression in the host leads to severe impairment of intrathymic T-cell differentiation/maturation, leading to the paralysis of cellular anti-tumor immunity.",32582141_0,-1,1,2,-1,40228,-1,3.5289682e-05,4.6937348e-05,0.99991775
40229,to the,15,17,115,121,"Tumor progression in the host leads to severe impairment of intrathymic T-cell differentiation/maturation, leading to the paralysis of cellular anti-tumor immunity.",32582141_0,-1,-1,-1,-1,40229,-1,2.5182799e-05,0.999964,1.0783534e-05
40231,immunity,21,22,155,163,"Tumor progression in the host leads to severe impairment of intrathymic T-cell differentiation/maturation, leading to the paralysis of cellular anti-tumor immunity.",32582141_0,0,-1,2,-1,40231,-1,0.99937445,0.0002819014,0.00034366472
40233,thymocytes,13,14,81,91,Such suppression manifests the erosion of CD4+CD8+ double-positive (DP) immature thymocytes and a gradual increase in CD4-CD8- double negative (DN) early T-cell progenitors.,32582141_1,-1,1,2,-1,40233,-1,0.0017365692,0.06464701,0.9336164
40234,T-cell,26,27,154,160,Such suppression manifests the erosion of CD4+CD8+ double-positive (DP) immature thymocytes and a gradual increase in CD4-CD8- double negative (DN) early T-cell progenitors.,32582141_1,-1,1,2,-1,40234,-1,3.790301e-05,4.9799008e-05,0.99991226
40236,the T-cell,6,8,30,40,The impact of such changes on the T-cell progenitor pool in the context of cancer remains poorly investigated.,32582141_2,-1,-1,-1,-1,40236,-1,0.0030952992,0.16233982,0.83456486
40238,that tumor,4,6,14,24,"Here, we show that tumor progression blocks the transition of Lin-Thy1.2+CD25+CD44+c-KitlowDN2b to Lin-Thy1.2+CD25+CD44-c-Kit-DN3 in T-cell maturation, instead leading to DN2-T-cell differentiation into dendritic cells (DC).",32582141_3,-1,-1,-1,-1,40238,-1,1.7522176e-05,0.99997354,8.921075e-06
40239,the transition,8,10,44,58,"Here, we show that tumor progression blocks the transition of Lin-Thy1.2+CD25+CD44+c-KitlowDN2b to Lin-Thy1.2+CD25+CD44-c-Kit-DN3 in T-cell maturation, instead leading to DN2-T-cell differentiation into dendritic cells (DC).",32582141_3,-1,-1,-1,-1,40239,-1,1.933522e-05,0.9999696,1.1054934e-05
40241,T-cell,15,16,133,139,"Here, we show that tumor progression blocks the transition of Lin-Thy1.2+CD25+CD44+c-KitlowDN2b to Lin-Thy1.2+CD25+CD44-c-Kit-DN3 in T-cell maturation, instead leading to DN2-T-cell differentiation into dendritic cells (DC).",32582141_3,-1,1,2,-1,40241,-1,3.5223307e-05,3.8653332e-05,0.9999262
40244,that thymic IL-10,2,5,12,29,"We observed that thymic IL-10 expression is upregulated, particularly at cortico-medullary junctions (CMJ), under conditions of progressive disease, resulting in the termination of IL-10Rhigh DN2-T-cell maturation due to dysregulated expression of Notch1 and its target, CCR7 (thus restricting these cells to the CMJ).",32582141_4,-1,-1,-1,-1,40244,-1,0.2382981,0.75852257,0.0031793443
40246,the termination,25,27,162,177,"We observed that thymic IL-10 expression is upregulated, particularly at cortico-medullary junctions (CMJ), under conditions of progressive disease, resulting in the termination of IL-10Rhigh DN2-T-cell maturation due to dysregulated expression of Notch1 and its target, CCR7 (thus restricting these cells to the CMJ).",32582141_4,-1,-1,-1,-1,40246,-1,2.3328008e-05,0.9999652,1.145358e-05
40251,these cells to the,45,49,294,312,"We observed that thymic IL-10 expression is upregulated, particularly at cortico-medullary junctions (CMJ), under conditions of progressive disease, resulting in the termination of IL-10Rhigh DN2-T-cell maturation due to dysregulated expression of Notch1 and its target, CCR7 (thus restricting these cells to the CMJ).",32582141_4,-1,-1,-1,-1,40251,-1,0.00019866439,0.99831223,0.001489081
40254,that IL-10,16,18,116,126,"Intrathymic differentiation of T-cell precursors in IL-10-/- mice and in vitro fetal thymic organ cultures revealed that IL-10 promotes the interaction between thymic stromal cells and Notch1low DN2-T cells, thus facilitating these DN2-T cells to differentiate toward CD45+CD11c+MHC-II+ thymic DCs as a consequence of activating the Ikaros/IRF8 signaling axis.",32582141_5,-1,-1,-1,-1,40254,-1,0.8054889,0.1907481,0.003762977
40261,cells to,34,36,238,246,"Intrathymic differentiation of T-cell precursors in IL-10-/- mice and in vitro fetal thymic organ cultures revealed that IL-10 promotes the interaction between thymic stromal cells and Notch1low DN2-T cells, thus facilitating these DN2-T cells to differentiate toward CD45+CD11c+MHC-II+ thymic DCs as a consequence of activating the Ikaros/IRF8 signaling axis.",32582141_5,-1,-1,-1,-1,40261,-1,0.0027753673,0.07391826,0.9233064
40266,function,5,6,25,33,"We conclude that a novel function of thymically-expressed IL-10 in the tumor-bearing host diverts T-cell differentiation toward a DC pathway, thus limiting the protective adaptive immune repertoire.",32582141_6,0,1,2,-1,40266,-1,0.00012214472,0.99977535,0.00010254823
40267,thymically-expressed IL-10,7,9,37,63,"We conclude that a novel function of thymically-expressed IL-10 in the tumor-bearing host diverts T-cell differentiation toward a DC pathway, thus limiting the protective adaptive immune repertoire.",32582141_6,-1,-1,-1,-1,40267,-1,0.27155498,0.72335076,0.0050942856
40268,the tumor-bearing,10,12,67,84,"We conclude that a novel function of thymically-expressed IL-10 in the tumor-bearing host diverts T-cell differentiation toward a DC pathway, thus limiting the protective adaptive immune repertoire.",32582141_6,-1,-1,-1,-1,40268,-1,2.1802405e-05,0.9999691,9.087831e-06
40269,T-cell differentiation toward,14,17,98,127,"We conclude that a novel function of thymically-expressed IL-10 in the tumor-bearing host diverts T-cell differentiation toward a DC pathway, thus limiting the protective adaptive immune repertoire.",32582141_6,-1,-1,-1,-1,40269,-1,0.00093393325,0.013038031,0.9860281
40270,thus limiting the,21,24,142,159,"We conclude that a novel function of thymically-expressed IL-10 in the tumor-bearing host diverts T-cell differentiation toward a DC pathway, thus limiting the protective adaptive immune repertoire.",32582141_6,-1,-1,-1,-1,40270,-1,7.154574e-05,0.999899,2.945908e-05
40275,therapy,16,17,95,102,"Small molecule targeting of the essential HH effector Smoothened (SMO) has proven an effective therapy of BCC, though the frequent development of drug resistance poses major challenges to anti-HH treatments.",32615027_1,0,1,-1,-1,40275,-1,2.4058127e-05,0.99996245,1.3471839e-05
40276,though the,20,22,111,121,"Small molecule targeting of the essential HH effector Smoothened (SMO) has proven an effective therapy of BCC, though the frequent development of drug resistance poses major challenges to anti-HH treatments.",32615027_1,-1,-1,-1,-1,40276,-1,3.599135e-05,0.9999478,1.6171198e-05
40288,to the,13,15,76,82,"Anti-PD-1 monotherapy, however, did not reduce tumor growth, presumably due to the lack of immunogenic mutations in common BCC mouse models, as shown by whole-exome sequencing.",32615027_5,-1,-1,-1,-1,40288,-1,2.5228199e-05,0.9999658,9.0161675e-06
40300,tumors typically relapse,9,12,60,84,"Although initial treatment of ovarian cancer is successful, tumors typically relapse and become resistant to treatment.",32641415_0,-1,-1,-1,-1,40300,-1,2.3973704e-05,0.9999653,1.07397655e-05
40301,to treatment,15,17,106,118,"Although initial treatment of ovarian cancer is successful, tumors typically relapse and become resistant to treatment.",32641415_0,-1,-1,-1,-1,40301,-1,3.343813e-05,0.9999515,1.5107406e-05
40311,T-cell function,15,17,87,102,"In chemosensitive conditions, secretion of sEV-pGSN was low, allowing for optimal CD8+ T-cell function.",32641415_4,-1,-1,-1,-1,40311,-1,5.395581e-05,8.547913e-05,0.9998605
40313,T-cell,4,5,27,33,"This resulted in increased T-cell secretion of IFN, which reduced intracellular glutathione (GSH) production and sensitized chemosensitive cells to cis-diaminedichloroplatinum (CDDP)-induced apoptosis.",32641415_5,-1,1,2,-1,40313,-1,2.8954764e-05,4.645679e-05,0.99992454
40315,chemosensitive cells to,19,22,125,148,"This resulted in increased T-cell secretion of IFN, which reduced intracellular glutathione (GSH) production and sensitized chemosensitive cells to cis-diaminedichloroplatinum (CDDP)-induced apoptosis.",32641415_5,-1,-1,-1,-1,40315,-1,0.70568067,0.23179513,0.06252428
40325,biosynthesis,12,13,100,112,"These findings support our hypothesis that sEV-pGSN attenuates immunosurveillance and regulates GSH biosynthesis, a phenomenon that contributes to chemoresistance in ovarian cancer.",32641415_8,0,1,-1,-1,40325,-1,0.00031426214,0.9994991,0.00018663272
40327,to chemoresistance,18,20,144,162,"These findings support our hypothesis that sEV-pGSN attenuates immunosurveillance and regulates GSH biosynthesis, a phenomenon that contributes to chemoresistance in ovarian cancer.",32641415_8,-1,-1,-1,-1,40327,-1,0.0028761756,0.99689794,0.00022591015
40337,subunit ARID1A,15,17,90,104,"Approximately half of ovarian clear cell carcinomas (OCCC) carry mutations in the SWI/SNF subunit ARID1A, while small cell carcinoma of the ovary hypercalcemic type (SCCOHT) presents with inactivating mutations of the SWI/SNF ATPase SMARCA4 alongside epigenetic silencing of the ATPase SMARCA2.",32649682_1,-1,-1,-1,-1,40337,-1,0.0003276116,0.998456,0.0012163798
40342,ATPase SMARCA4,37,39,226,240,"Approximately half of ovarian clear cell carcinomas (OCCC) carry mutations in the SWI/SNF subunit ARID1A, while small cell carcinoma of the ovary hypercalcemic type (SCCOHT) presents with inactivating mutations of the SWI/SNF ATPase SMARCA4 alongside epigenetic silencing of the ATPase SMARCA2.",32649682_1,-1,-1,-1,-1,40342,-1,0.00010543595,0.9995022,0.00039235264
40343,the ATPase SMARCA2,43,46,275,293,"Approximately half of ovarian clear cell carcinomas (OCCC) carry mutations in the SWI/SNF subunit ARID1A, while small cell carcinoma of the ovary hypercalcemic type (SCCOHT) presents with inactivating mutations of the SWI/SNF ATPase SMARCA4 alongside epigenetic silencing of the ATPase SMARCA2.",32649682_1,-1,-1,-1,-1,40343,-1,6.327295e-05,0.9998828,5.3849013e-05
40344,these ATPases,2,4,8,21,Loss of these ATPases disrupts SWI/SNF chromatin remodeling activity and may also interfere with the function of other histone-modifying enzymes that associate with or are dependent on SWI/SNF activity.,32649682_2,-1,-1,-1,-1,40344,-1,2.704556e-05,0.9999528,2.0106068e-05
40345,the function,14,16,97,109,Loss of these ATPases disrupts SWI/SNF chromatin remodeling activity and may also interfere with the function of other histone-modifying enzymes that associate with or are dependent on SWI/SNF activity.,32649682_2,-1,-1,-1,-1,40345,-1,3.091605e-05,0.9999546,1.4528681e-05
40346,enzymes that,19,21,137,149,Loss of these ATPases disrupts SWI/SNF chromatin remodeling activity and may also interfere with the function of other histone-modifying enzymes that associate with or are dependent on SWI/SNF activity.,32649682_2,-1,-1,-1,-1,40346,-1,0.0009397443,0.97433907,0.02472117
40349,proteins,22,23,148,156,"One such enzyme is lysine-specific histone demethylase 1 (LSD1/KDM1A), which regulates the chromatin landscape and gene expression by demethylating proteins such as histone H3.",32649682_3,0,1,-1,-1,40349,-1,0.00026206297,0.99887866,0.00085927994
40350,analysis,1,2,13,21,Cross-cancer analysis of the TCGA database shows that LSD1 is highly expressed in SWI/SNF-mutated tumors.,32649682_4,0,1,-1,-1,40350,-1,3.095255e-05,0.999951,1.8006574e-05
40351,the TCGA,3,5,25,33,Cross-cancer analysis of the TCGA database shows that LSD1 is highly expressed in SWI/SNF-mutated tumors.,32649682_4,-1,-1,-1,-1,40351,-1,3.3445365e-05,0.99994755,1.9050254e-05
40355,to the,8,10,50,56,"SCCOHT and OCCC cell lines have shown sensitivity to the reversible LSD1 inhibitor SP-2577 (Seclidemstat), suggesting that SWI/SNF-deficient ovarian cancers are dependent on LSD1 activity.",32649682_5,-1,-1,-1,-1,40355,-1,2.0144109e-05,0.999969,1.0806978e-05
40359,immunity through,14,16,101,117,"Moreover, it has been shown that inhibition of LSD1 stimulates interferon (IFN)-dependent anti-tumor immunity through induction of endogenous retroviral elements and may thereby overcome resistance to checkpoint blockade.",32649682_6,-1,-1,-1,-1,40359,-1,0.2598397,0.7361999,0.003960377
40365,immunity,13,14,76,84,"In this study, we investigated the ability of SP-2577 to promote anti-tumor immunity and T-cell infiltration in SCCOHT and OCCC cell lines.",32649682_7,0,-1,2,-1,40365,-1,0.99852294,0.0011922374,0.00028487996
40366,T-cell,15,16,89,95,"In this study, we investigated the ability of SP-2577 to promote anti-tumor immunity and T-cell infiltration in SCCOHT and OCCC cell lines.",32649682_7,-1,1,2,-1,40366,-1,3.452886e-05,4.8416317e-05,0.99991703
40370,immunity,7,8,58,66,We found that SP-2577 stimulated IFN-dependent anti-tumor immunity in SCCOHT and promoted the expression of PD-L1 in both SCCOHT and OCCC.,32649682_8,0,-1,2,-1,40370,-1,0.99876237,0.0009125483,0.00032513269
40374,that the,5,7,33,41,"Together, these findings suggest that the combination therapy of SP-2577 with checkpoint inhibitors may induce or augment immunogenic responses of SWI/SNF-mutated ovarian cancers and warrants further investigation.",32649682_9,-1,-1,-1,-1,40374,-1,1.8587725e-05,0.99997437,7.022488e-06
40375,therapy,8,9,54,61,"Together, these findings suggest that the combination therapy of SP-2577 with checkpoint inhibitors may induce or augment immunogenic responses of SWI/SNF-mutated ovarian cancers and warrants further investigation.",32649682_9,0,1,-1,-1,40375,-1,2.2152288e-05,0.99996614,1.1725451e-05
40378,tissue,7,8,41,47,The contribution of immune cells in soft tissue sarcomas (STS) is not completely known and understanding their role is very essential for employing immunotherapy strategies.,32661685_0,-1,1,2,-1,40378,-1,4.1199513e-05,0.9999198,3.8981772e-05
40389,to Treg,17,19,104,111,This increased proliferation was found to be in B cells resulting in generation of Breg further leading to Treg population.,32661685_2,-1,-1,-1,-1,40389,-1,2.7432476e-05,0.9999573,1.5210831e-05
40399,These tumor,0,2,0,11,"These tumor evoked Bregs (tBreg), when co-cultured with B depleted T cells, suppressed their proliferation in response to anti-CD3/CD28 stimulation.",32661685_5,-1,-1,-1,-1,40399,-1,2.3112494e-05,0.99996495,1.194135e-05
40409,TGF Receptor type,24,27,148,166,"tBreg-induced suppression of T cell responses wasnot abrogated by the inhibition or neutralization of IL-10 but by the small molecule inhibitor of TGF Receptor type I, SB431542.",32661685_6,-1,-1,-1,-1,40409,-1,5.444137e-05,0.999874,7.149226e-05
40410,to tumor cells,7,10,40,54,"While SB531542 per se was not cytotoxic to tumor cells, administration of SB431542 in tumor-bearing mice (TBM) significantly reduced the tumor burden.",32661685_7,-1,-1,-1,-1,40410,-1,0.003730722,0.56258214,0.43368712
40413,the tumor,22,24,133,142,"While SB531542 per se was not cytotoxic to tumor cells, administration of SB431542 in tumor-bearing mice (TBM) significantly reduced the tumor burden.",32661685_7,-1,-1,-1,-1,40413,-1,1.8421944e-05,0.99997234,9.180983e-06
40414,the treatment,3,5,13,26,"In addition, the treatment significantly reduced Treg cells and rescued proliferation of T cells in response to mitogen and allo-antigen.",32661685_8,-1,-1,-1,-1,40414,-1,2.224804e-05,0.9999677,1.0105393e-05
40418,that tumor,5,7,35,45,"Collectively, our results identify that tumor evoked Breg cells mediate T cell immune suppression through TGF-mediated pathway and that targeting the Breg-Treg axis can be potentially used as an immunotherapy agent.",32661685_9,-1,-1,-1,-1,40418,-1,2.1301514e-05,0.99996805,1.0650975e-05
40421,through TGF-mediated,15,17,98,119,"Collectively, our results identify that tumor evoked Breg cells mediate T cell immune suppression through TGF-mediated pathway and that targeting the Breg-Treg axis can be potentially used as an immunotherapy agent.",32661685_9,-1,-1,-1,-1,40421,-1,3.4552366e-05,0.9999356,2.978262e-05
40422,that targeting the,19,22,132,150,"Collectively, our results identify that tumor evoked Breg cells mediate T cell immune suppression through TGF-mediated pathway and that targeting the Breg-Treg axis can be potentially used as an immunotherapy agent.",32661685_9,-1,-1,-1,-1,40422,-1,2.1142907e-05,0.9999684,1.0402523e-05
40429,functional,35,36,223,233,"The lamina propria of the gastrointestinal tract and other mucosal surfaces of humans and mice host a network of mononuclear phagocytes that differ in their ontogeny, surface marker and transcription factor expression, and functional specialization.",32848032_0,0,1,2,-1,40429,-1,0.00010786878,0.99984634,4.5724333e-05
40439,that the,22,24,131,139,"In this study, we show in various Th1- and/or Th17-polarized settings of acute and chronic bacterial infection and of tumor growth that the conditional ablation of Irf4 in CD11c+ DCs results in more efficient immune control of Helicobacter pylori, Mycobacterium bovis bacillus Calmette-Gurin, and Citrobacter rodentium and of tumor growth in a syngeneic tumor model.",32848032_2,-1,-1,-1,-1,40439,-1,1.725241e-05,0.99997354,9.219793e-06
40447,to IFN--,14,16,91,100,We attribute the phenotype of IRF4DC mice to unrestricted Th1 responses and in particular to IFN-- and TNF--expressing CD4+ T cells.,32848032_3,-1,-1,-1,-1,40447,-1,0.2553473,0.7397435,0.0049092746
40448,TNF--expressing,17,18,105,121,We attribute the phenotype of IRF4DC mice to unrestricted Th1 responses and in particular to IFN-- and TNF--expressing CD4+ T cells.,32848032_3,0,1,-1,-1,40448,-1,5.949183e-05,0.9999045,3.5982077e-05
40464,T cell therapy,17,20,106,120,In vivo expansion of adoptively transferred CD8+ T cells is a critical determinant of successful adoptive T cell therapy.,32848036_0,-1,-1,-1,-1,40464,-1,0.0013028001,0.019271167,0.9794261
40467,the tumor,15,17,108,117,Emerging evidence indicates Batf3-dependent conventional type 1 dendritic cells (cDC1s) rarely found within the tumor myeloid compartment are crucial for effector T cell recruitment to the tumor microenvironment.,32848036_1,-1,-1,-1,-1,40467,-1,2.1061234e-05,0.99996984,9.04975e-06
40469,to the tumor,26,29,182,194,Emerging evidence indicates Batf3-dependent conventional type 1 dendritic cells (cDC1s) rarely found within the tumor myeloid compartment are crucial for effector T cell recruitment to the tumor microenvironment.,32848036_1,-1,-1,-1,-1,40469,-1,2.8540575e-05,0.99995995,1.1454186e-05
40480,transferred tumor-specific,10,12,79,105,We found that TLR/CD40-mediated expansion and antitumor efficacy of adoptively transferred tumor-specific CD8+ T cells were abrogated in Batf3-/- mice.,32848036_4,-1,-1,-1,-1,40480,-1,2.8990087e-05,0.99995637,1.4595798e-05
40487,agonists,20,21,120,128,"Moreover, induction and activation of cDC1s by administration of FMS-like tyrosine kinase 3 ligand (Flt3L) and TLR/CD40 agonists augmented expansion of adoptively transferred CD8+ T cells, delayed tumor growth, and improved survival.",32848036_6,0,1,-1,-1,40487,-1,0.92413735,0.04581012,0.03005256
40493,T cell therapy,26,29,157,171,These findings reveal a key role for CD40 and CD70 signaling in cDC1s and have major implications for the design of new vaccination strategies with adoptive T cell therapy.,32848036_7,-1,-1,-1,-1,40493,-1,0.0014579139,0.02102244,0.97751963
40495,the treatment,14,16,76,89,BACKGROUND: It has been shown that dihydroartemisinin (DHA) is effective in the treatment of malaria.,32859456_0,-1,-1,-1,-1,40495,-1,2.7514927e-05,0.999961,1.1428425e-05
40497,tumor cell,8,10,59,69,"Recently studies have demonstrated that DHA also regulates tumor cell growth, angiogenesis, T cell differentiation and generation.",32859456_1,-1,-1,-1,-1,40497,-1,0.0026477783,0.12663189,0.87072027
40523,the tumor,15,17,86,95,"DHA diminished expression of IL-10 and IL-6, and increased the expression of IFN- in the tumor and spleen.",32859456_10,-1,-1,-1,-1,40523,-1,2.0216214e-05,0.99996865,1.1143052e-05
40525,the STAT3,13,15,106,115,"Moreover, DHA administration significantly promoted the mitochondrial apoptosis of melanoma by regulating the STAT3 pathway.",32859456_11,-1,-1,-1,-1,40525,-1,2.2788989e-05,0.9999635,1.3663624e-05
40529,immunity,3,4,24,32,"DHA improves anti-tumor immunity in mice through controlling CD8+CTL function by counteracting IL-10-dependent Treg cells suppression, which promises to be an alternative drug for melanoma.",32859456_13,0,-1,2,-1,40529,-1,0.9975051,0.0020010923,0.0004938867
40531,function,9,10,69,77,"DHA improves anti-tumor immunity in mice through controlling CD8+CTL function by counteracting IL-10-dependent Treg cells suppression, which promises to be an alternative drug for melanoma.",32859456_13,0,1,2,-1,40531,-1,0.00039050257,0.011806572,0.9878029
40532,IL-10-dependent Treg cells,12,15,95,121,"DHA improves anti-tumor immunity in mice through controlling CD8+CTL function by counteracting IL-10-dependent Treg cells suppression, which promises to be an alternative drug for melanoma.",32859456_13,-1,-1,-1,-1,40532,-1,0.60587233,0.0022522258,0.39187545
40546,functions,27,28,177,186,Recent studies revealed that immunosuppressive TME is directly correlated with heightened activations of T regulatory cells (Tregs) and Myeloid derived suppressor cells (MDSCs) functions.,32890791_2,0,1,2,-1,40546,-1,0.0030361009,0.71829015,0.27867377
40553,the therapeutic,2,4,9,24,"However, the therapeutic efficacy of GA in impressive regression of tumor was found to be directly correlated with induction of apoptosis and modulation of cytokines from Th2 to Th1 type.",32890791_5,-1,-1,-1,-1,40553,-1,1.9449628e-05,0.99997175,8.849121e-06
40557,Th2 to Th1 type,27,31,171,186,"However, the therapeutic efficacy of GA in impressive regression of tumor was found to be directly correlated with induction of apoptosis and modulation of cytokines from Th2 to Th1 type.",32890791_5,-1,-1,-1,-1,40557,-1,3.2983877e-05,0.99993384,3.3198183e-05
40562,function,22,23,135,143,"To unravel the mechanism of anti-melanoma effect of GA, it has been delineated that GA inhibits pSTAT3 to evade anti-tumor suppressive function of Tregs and MDSCs.",32890791_6,0,1,2,-1,40562,-1,7.330805e-05,0.99986887,5.780701e-05
40566,tumor-infiltrating Tregs,8,10,43,67,"Downregulation of FOXP3, GITR and CTLA4 in tumor-infiltrating Tregs and inhibition of Cox2, PGE2 and Arginase 1 in intra-tumoral MDSC were evidenced as some of the key events during therapeutic intervention of GA in melanoma management.",32890791_7,-1,-1,-1,-1,40566,-1,2.6945863e-05,0.9999591,1.39214835e-05
40575,therapy,21,22,110,117,"Thus, our findings may open up a novel insight of GA as a promising agent in cancer immunotherapy or adjuvant therapy in future.",32890791_9,0,1,-1,-1,40575,-1,3.7817386e-05,0.99994326,1.8975903e-05
40577,tumor cells,2,4,21,32,Genetically modified tumor cells harboring immunomodulators may be used as therapeutic vaccines to stimulate antitumor immunity.,32939048_0,-1,-1,-1,-1,40577,-1,0.0034068492,0.27855095,0.71804214
40581,immunity,15,16,119,127,Genetically modified tumor cells harboring immunomodulators may be used as therapeutic vaccines to stimulate antitumor immunity.,32939048_0,0,-1,2,-1,40581,-1,0.99924517,0.0005524181,0.00020243754
40582,The therapeutic,0,2,0,15,The therapeutic benefit of these tumor vaccines is extensively investigated and mechanisms by which they boost antitumor response may be further explored.,32939048_1,-1,-1,-1,-1,40582,-1,2.5844527e-05,0.9999647,9.485942e-06
40583,these tumor,4,6,27,38,The therapeutic benefit of these tumor vaccines is extensively investigated and mechanisms by which they boost antitumor response may be further explored.,32939048_1,-1,-1,-1,-1,40583,-1,2.3432322e-05,0.99996555,1.1043308e-05
40585,Tumor cells,0,2,0,11,Tumor cells are large secretors of extracellular vesicles (EVs).,32939048_2,-1,-1,-1,-1,40585,-1,0.0035542015,0.38546485,0.610981
40588,proteins to target cells,8,12,41,65,"These EVs are able to vehiculate RNA and proteins to target cells, and engineered EVs also vehiculate recombinant proteins.",32939048_3,-1,-1,-1,-1,40588,-1,0.008483165,0.5931129,0.39840397
40589,proteins,19,20,114,122,"These EVs are able to vehiculate RNA and proteins to target cells, and engineered EVs also vehiculate recombinant proteins.",32939048_3,0,1,-1,-1,40589,-1,0.00031557478,0.9994979,0.00018648163
40591,the TNFSF,15,17,104,113,"In this study, we explore immunomodulatory properties of EVs derived from antitumor vaccines expressing the TNFSF ligands 4-1BBL and OX40L, modulating immune response mediated by immune cells and eliminating tumors.",32939048_4,-1,-1,-1,-1,40591,-1,5.0309187e-05,0.99992824,2.1408028e-05
40596,that the,3,5,20,28,"Our results suggest that the EVs secreted by genetically modified tumor cells harboring TNFSF ligands can induce T cell proliferation, inhibit the transcription factor FoxP3, associated with the maintenance of Treg phenotype, and enhance antitumor activity mediated by immune cells.",32939048_5,-1,-1,-1,-1,40596,-1,1.8143899e-05,0.99997246,9.44262e-06
40598,tumor cells,10,12,66,77,"Our results suggest that the EVs secreted by genetically modified tumor cells harboring TNFSF ligands can induce T cell proliferation, inhibit the transcription factor FoxP3, associated with the maintenance of Treg phenotype, and enhance antitumor activity mediated by immune cells.",32939048_5,-1,-1,-1,-1,40598,-1,0.0038968476,0.38352942,0.6125737
40599,TNFSF,13,14,88,93,"Our results suggest that the EVs secreted by genetically modified tumor cells harboring TNFSF ligands can induce T cell proliferation, inhibit the transcription factor FoxP3, associated with the maintenance of Treg phenotype, and enhance antitumor activity mediated by immune cells.",32939048_5,0,1,-1,-1,40599,-1,0.00016573818,0.9997948,3.9539875e-05
40601,the transcription factor FoxP3,22,26,143,173,"Our results suggest that the EVs secreted by genetically modified tumor cells harboring TNFSF ligands can induce T cell proliferation, inhibit the transcription factor FoxP3, associated with the maintenance of Treg phenotype, and enhance antitumor activity mediated by immune cells.",32939048_5,-1,-1,-1,-1,40601,-1,1.8954845e-05,0.9999697,1.132678e-05
40607,therapy,16,17,125,132,The immunomodulatory extracellular vesicles have potential to be further engineered for developing new approaches for cancer therapy.,32939048_6,0,1,-1,-1,40607,-1,2.6191537e-05,0.99996126,1.2536839e-05
40614,that the,6,8,24,32,"In this study, we found that the upregulation of Foxp3+ regulatory T cells (Tregs) in the mesothelioma tumor microenvironment after nonablative oligofractionated irradiation significantly limited the success of irradiation.",32948683_2,-1,-1,-1,-1,40614,-1,1.6379707e-05,0.9999751,8.513927e-06
40624,that transient Foxp3,21,24,125,145,"Using DEREG mice, which allow conditional and efficient depletion of Foxp3+ Tregs by diphtheria toxin injection, we observed that transient Foxp3+ Treg depletion immediately after nonablative oligofractionated irradiation provided synergistic local control and biased the T cell repertoire toward central and effector memory T cells, resulting in long-term cure.",32948683_3,-1,-1,-1,-1,40624,-1,2.7637358e-05,0.9999614,1.1018487e-05
40626,the T cell,38,41,268,278,"Using DEREG mice, which allow conditional and efficient depletion of Foxp3+ Tregs by diphtheria toxin injection, we observed that transient Foxp3+ Treg depletion immediately after nonablative oligofractionated irradiation provided synergistic local control and biased the T cell repertoire toward central and effector memory T cells, resulting in long-term cure.",32948683_3,-1,-1,-1,-1,40626,-1,0.0037451403,0.16904347,0.8272113
40630,therapy,4,5,30,37,"Furthermore, this combination therapy showed significant abscopal effect on the nonirradiated tumors in a concomitant model of mesothelioma through systemic activation of cytotoxic T cells and enhanced production of IFN- and granzyme B. Although local control was preserved with one fraction of nonablative irradiation, three fractions were required to generate the abscopal effect.",32948683_4,0,1,-1,-1,40630,-1,2.0901687e-05,0.9999665,1.26469395e-05
40637,to generate the,50,53,351,366,"Furthermore, this combination therapy showed significant abscopal effect on the nonirradiated tumors in a concomitant model of mesothelioma through systemic activation of cytotoxic T cells and enhanced production of IFN- and granzyme B. Although local control was preserved with one fraction of nonablative irradiation, three fractions were required to generate the abscopal effect.",32948683_4,-1,-1,-1,-1,40637,-1,2.1011349e-05,0.99996936,9.575205e-06
40645,to the,4,6,28,34,Our findings are applicable to the strategy of immuno-radiotherapy for generating optimal antitumor immune responses in the clinical setting.,32948683_6,-1,-1,-1,-1,40645,-1,2.3492204e-05,0.9999677,8.76757e-06
40649,Targeting Tregs,0,2,0,15,Targeting Tregs immediately after a short course of irradiation could have a major impact on the local response to irradiation and its abscopal effect.,32948683_7,-1,-1,-1,-1,40649,-1,2.18058e-05,0.99996746,1.0752107e-05
40670,the Stat1,11,13,96,105,"Mechanistically, Mettl3 or Mettl14 loss promoted IFN--Stat1-Irf1 signaling through stabilizing the Stat1 and Irf1 mRNA via Ythdf2.",32964498_5,-1,-1,-1,-1,40670,-1,2.370196e-05,0.9999542,2.2076436e-05
40674,the function,9,11,52,64,"Altogether, our findings uncover a new awareness of the function of RNA methylation in adaptive immunity and provide METTL3 and METTL14 as potential therapeutic targets in anticancer immunotherapy.",32964498_7,-1,-1,-1,-1,40674,-1,2.8707378e-05,0.9999604,1.0915416e-05
40676,therapeutic targets,24,26,149,168,"Altogether, our findings uncover a new awareness of the function of RNA methylation in adaptive immunity and provide METTL3 and METTL14 as potential therapeutic targets in anticancer immunotherapy.",32964498_7,-1,-1,-1,-1,40676,-1,2.4662097e-05,0.9999645,1.0861547e-05
40680,deficiency,19,20,137,147,"The depletion of eosinophils represents an efficient strategy to alleviate allergic asthma, but the consequences of prolonged eosinophil deficiency for human health remain poorly understood.",32970801_0,0,1,-1,-1,40680,-1,0.00026717916,0.99830914,0.0014237303
40681,that the,3,5,13,21,"We show here that the ablation of eosinophils severely compromises antitumor immunity in syngeneic and genetic models of colorectal cancer (CRC), which can be attributed to defective Th1 and CD8+ T cell responses.",32970801_1,-1,-1,-1,-1,40681,-1,1.7757935e-05,0.9999739,8.340426e-06
40682,immunity,11,12,77,85,"We show here that the ablation of eosinophils severely compromises antitumor immunity in syngeneic and genetic models of colorectal cancer (CRC), which can be attributed to defective Th1 and CD8+ T cell responses.",32970801_1,0,-1,2,-1,40682,-1,0.99740076,0.0021074528,0.0004917651
40696,tumor immunity,15,17,92,106,GM-CSF activates IRF5 in vitro and in vivo and can be administered recombinantly to improve tumor immunity.,32970801_3,-1,-1,-1,-1,40696,-1,0.025038702,0.9742298,0.0007314371
40706,the GM-CSF-IRF5,16,18,102,117,The combined results demonstrate a critical role of eosinophils in tumor control in CRC and introduce the GM-CSF-IRF5 axis as a critical driver of the antitumor activities of this versatile cell type.,32970801_6,-1,-1,-1,-1,40706,-1,0.0004194439,0.9994357,0.00014485452
40709,cell type,30,32,190,199,The combined results demonstrate a critical role of eosinophils in tumor control in CRC and introduce the GM-CSF-IRF5 axis as a critical driver of the antitumor activities of this versatile cell type.,32970801_6,-1,-1,-1,-1,40709,-1,7.563961e-05,0.00014928715,0.999775
40711,that STAT3,3,5,23,33,We previously reported that STAT3 activation in cancer cells and immune cells was involved in immune-resistant mechanisms.,33006786_1,-1,-1,-1,-1,40711,-1,2.7045193e-05,0.99995923,1.3672807e-05
40719,tumor antigen-specific T cells through,14,19,96,134,The curcumin po administration resulted in the significant augmentation of in vivo induction of tumor antigen-specific T cells through restoration of dendritic cells (DCs) by inhibiting directly STAT3 in DCs and indirectly via reduced IL-6 production from STAT3 activated cancer cells in 2 syngeneic MC38 and CT26 murine tumor models.,33006786_3,-1,-1,-1,-1,40719,-1,0.0005230446,0.99912924,0.00034776755
40729,functions,3,4,21,30,Curcumin restored DC functions in xenogeneic nude mouse model implanted with high IL-6-producing human clear cell ovarian cancer cells.,33006786_5,0,1,2,-1,40729,-1,5.907744e-05,0.99989176,4.9117432e-05
40738,tumor antigen-specific T cells,9,13,64,94,These results indicated that curcumin augments the induction of tumor antigen-specific T cells by restoring the T cell stimulatory activity of DCs targeting activated STAT3 in both cancer cells and immune cells.,33006786_7,-1,-1,-1,-1,40738,-1,0.027956469,0.3424669,0.6295766
40739,the T cell,15,18,108,118,These results indicated that curcumin augments the induction of tumor antigen-specific T cells by restoring the T cell stimulatory activity of DCs targeting activated STAT3 in both cancer cells and immune cells.,33006786_7,-1,-1,-1,-1,40739,-1,0.0046170386,0.18425012,0.8111328
40746,regulatory T cells that,10,14,50,73,"NK1.1- CD4+ NKG2D+ T cells are a subpopulation of regulatory T cells that downregulate the functions of CD4+ T, CD8+ T, natural killer (NK) cells, and macrophages through TGF-1 production.",33011290_0,-1,-1,-1,-1,40746,-1,0.0010613871,0.025956605,0.972982
40747,the functions,15,17,87,100,"NK1.1- CD4+ NKG2D+ T cells are a subpopulation of regulatory T cells that downregulate the functions of CD4+ T, CD8+ T, natural killer (NK) cells, and macrophages through TGF-1 production.",33011290_0,-1,-1,-1,-1,40747,-1,5.3751777e-05,0.9999132,3.306464e-05
40752,through TGF-1,35,37,163,177,"NK1.1- CD4+ NKG2D+ T cells are a subpopulation of regulatory T cells that downregulate the functions of CD4+ T, CD8+ T, natural killer (NK) cells, and macrophages through TGF-1 production.",33011290_0,-1,-1,-1,-1,40752,-1,5.723599e-05,0.9998932,4.9610677e-05
40756,T cell function,24,27,138,153,"Early growth response genes 2 (Egr2) and 3 (Egr3) maintain immune homeostasis by modulating T lymphocyte development, inhibiting effector T cell function, and promoting the induction of regulatory T cells.",33011290_1,-1,-1,-1,-1,40756,-1,4.718832e-05,6.278239e-05,0.99988997
40760,TGF-1 transcription,6,8,40,60,Whether Egr2 and Egr3 directly regulate TGF-1 transcription in NK1.1- CD4+ NKG2D+ T cells remains elusive.,33011290_2,-1,-1,-1,-1,40760,-1,2.5114174e-05,0.9999609,1.3981289e-05
40764,T cells than,14,17,73,85,The expression levels of Egr2 and Egr3 were higher in NK1.1- CD4+ NKG2D+ T cells than in NK1.1- CD4+ NKG2D- T cells.,33011290_3,-1,-1,-1,-1,40764,-1,0.0015104281,0.03587216,0.9626175
40773,to the,22,24,125,131,"The ectopic expression of Egr2 or Egr3 resulted in the enhancement of TGF-1 expression, while knockdown of Egr2 or Egr3 led to the decreased expression of TGF-1 in NK1.1- CD4+ NKG2D+ T cells.",33011290_5,-1,-1,-1,-1,40773,-1,1.941915e-05,0.99997044,1.0108717e-05
40777,the TGF-1,6,8,34,44,Egr2 and Egr3 directly bound with the TGF-1 promoter as demonstrated by the electrophoretic mobility shift assay and dual-luciferase gene reporter assay.,33011290_6,-1,-1,-1,-1,40777,-1,3.0832907e-05,0.9999453,2.3918577e-05
40780,the Egr2,2,4,13,21,"Furthermore, the Egr2 and Egr3 expression of NK1.1- CD4+ NKG2D+ T cells could be induced by the AP-1 and NF-B transcriptional factors, but had no involvement with the activation of NF-AT and STAT3.",33011290_7,-1,-1,-1,-1,40780,-1,3.0444158e-05,0.99995303,1.6487766e-05
40782,the AP-1,18,20,92,100,"Furthermore, the Egr2 and Egr3 expression of NK1.1- CD4+ NKG2D+ T cells could be induced by the AP-1 and NF-B transcriptional factors, but had no involvement with the activation of NF-AT and STAT3.",33011290_7,-1,-1,-1,-1,40782,-1,2.7891581e-05,0.9999511,2.0974869e-05
40783,transcriptional factors,22,24,111,134,"Furthermore, the Egr2 and Egr3 expression of NK1.1- CD4+ NKG2D+ T cells could be induced by the AP-1 and NF-B transcriptional factors, but had no involvement with the activation of NF-AT and STAT3.",33011290_7,-1,-1,-1,-1,40783,-1,2.711738e-05,0.99994874,2.4182518e-05
40785,NF-AT,33,34,182,187,"Furthermore, the Egr2 and Egr3 expression of NK1.1- CD4+ NKG2D+ T cells could be induced by the AP-1 and NF-B transcriptional factors, but had no involvement with the activation of NF-AT and STAT3.",33011290_7,-1,1,2,-1,40785,-1,3.846257e-05,0.9999398,2.1683696e-05
40789,TGF-1 transcription,13,15,73,93,"In conclusion, Egr2 and Egr3 induced by AP-1 and NF-B directly initiate TGF-1 transcription in NK1.1- CD4+ NKG2D+ T cells.",33011290_8,-1,-1,-1,-1,40789,-1,2.926591e-05,0.999951,1.9755864e-05
40795,function,15,16,109,117,This study indicates that manipulating Egr2 and Egr3 expression would potentiate or alleviate the regulatory function of NK1.1- CD4+ NKG2D+ T cells and this strategy could be used in the therapy for patients with autoimmune diseases or tumor.,33011290_9,0,1,2,-1,40795,-1,7.1246955e-05,0.9998759,5.2863397e-05
40798,the therapy,30,32,183,194,This study indicates that manipulating Egr2 and Egr3 expression would potentiate or alleviate the regulatory function of NK1.1- CD4+ NKG2D+ T cells and this strategy could be used in the therapy for patients with autoimmune diseases or tumor.,33011290_9,-1,-1,-1,-1,40798,-1,2.3529155e-05,0.99996686,9.6670165e-06
40800,Immunity to,0,2,0,11,Immunity to viruses requires an array of critical cellular proteins that include IFN regulatory factor 3 (IRF3).,33020188_0,-1,-1,-1,-1,40800,-1,0.00015054326,0.9998149,3.459445e-05
40801,cellular proteins that,8,11,50,72,Immunity to viruses requires an array of critical cellular proteins that include IFN regulatory factor 3 (IRF3).,33020188_0,-1,-1,-1,-1,40801,-1,0.0046797125,0.25313377,0.7421865
40802,IFN regulatory factor,12,15,81,102,Immunity to viruses requires an array of critical cellular proteins that include IFN regulatory factor 3 (IRF3).,33020188_0,-1,-1,-1,-1,40802,-1,0.93028903,0.06038747,0.009323513
40805,proteins that,8,10,58,71,"Consequently, most viruses that infect vertebrates encode proteins that interfere with IRF3 activation.",33020188_1,-1,-1,-1,-1,40805,-1,6.627889e-05,0.9998714,6.228957e-05
40808,the cellular,3,5,22,34,This review describes the cellular pathways linked to IRF3 activation and where those pathways are targeted by human viral pathogens.,33020188_2,-1,-1,-1,-1,40808,-1,0.0031231462,0.70354414,0.29333267
40809,to IRF3,7,9,51,58,This review describes the cellular pathways linked to IRF3 activation and where those pathways are targeted by human viral pathogens.,33020188_2,-1,-1,-1,-1,40809,-1,2.3938559e-05,0.99996316,1.2857883e-05
40816,immunity,17,18,106,114,"Besides viral infections, IRF3 is also involved in resistance to some bacterial infections, in anticancer immunity, and in anticancer therapies involving DNA damage agents.",33020188_4,0,-1,2,-1,40816,-1,0.99720544,0.002270208,0.00052440295
40818,that IRF3,4,6,23,32,A recent finding shows that IRF3 is needed for T cell effector functions that are involved in anticancer immunity and also in T cell autoimmune diseases.,33020188_5,-1,-1,-1,-1,40818,-1,2.1378648e-05,0.9999691,9.483416e-06
40820,functions that,12,14,63,77,A recent finding shows that IRF3 is needed for T cell effector functions that are involved in anticancer immunity and also in T cell autoimmune diseases.,33020188_5,-1,-1,-1,-1,40820,-1,0.0009150508,0.9810563,0.018028714
40821,immunity,18,19,105,113,A recent finding shows that IRF3 is needed for T cell effector functions that are involved in anticancer immunity and also in T cell autoimmune diseases.,33020188_5,0,-1,2,-1,40821,-1,0.9992213,0.0004891527,0.00028945733
40826,to IFN--induced,25,27,166,182,"In contrast, unregulated IRF3 activity is clearly not beneficial, considering it is implicated in certain interferonopathies, in which heightened IRF3 activity leads to IFN--induced disease.",33020188_6,-1,-1,-1,-1,40826,-1,0.006476712,0.9931248,0.00039850982
40834,immunity,9,10,69,77,"To identify critical molecules for activation of effective antitumor immunity, we have profiled autologous dendritic cell (DC) vaccines used to treat 35 patients with melanoma.",33051240_1,0,-1,2,-1,40834,-1,0.9992557,0.0004953489,0.00024892058
40836,to treat,22,24,141,149,"To identify critical molecules for activation of effective antitumor immunity, we have profiled autologous dendritic cell (DC) vaccines used to treat 35 patients with melanoma.",33051240_1,-1,-1,-1,-1,40836,-1,2.3709414e-05,0.9999654,1.0851576e-05
40839,T-cell,10,11,70,76,Melanoma patient DCs had reduced expression of cell surface inducible T-cell costimulator ligand (ICOSL) and had defective intrinsic NF-B signaling.,33051240_3,-1,1,2,-1,40839,-1,4.9316233e-05,5.1620267e-05,0.999899
40846,to the,3,5,17,23,"These data point to the critical role of canonical NF-B signaling, the regulation of matrix metalloproteinases, and DC-derived ICOSL in the specific priming of cognate T-cell responses in the cancer setting.",33051240_6,-1,-1,-1,-1,40846,-1,2.0443484e-05,0.99996996,9.58761e-06
40847,the regulation,12,14,68,82,"These data point to the critical role of canonical NF-B signaling, the regulation of matrix metalloproteinases, and DC-derived ICOSL in the specific priming of cognate T-cell responses in the cancer setting.",33051240_6,-1,-1,-1,-1,40847,-1,2.170577e-05,0.9999654,1.2827341e-05
40849,T-cell,27,28,169,175,"These data point to the critical role of canonical NF-B signaling, the regulation of matrix metalloproteinases, and DC-derived ICOSL in the specific priming of cognate T-cell responses in the cancer setting.",33051240_6,-1,1,2,-1,40849,-1,4.078616e-05,5.9999988e-05,0.99989927
40864,Th cells,4,6,25,33,"However, these polarized Th cells can also adapt their function and phenotype depending on the changing cytokine environment, demonstrating functional plasticity.",33064842_1,-1,-1,-1,-1,40864,-1,2.5190357e-05,4.4466695e-05,0.9999304
40865,their function,9,11,49,63,"However, these polarized Th cells can also adapt their function and phenotype depending on the changing cytokine environment, demonstrating functional plasticity.",33064842_1,-1,-1,-1,-1,40865,-1,5.3079722e-05,0.9999161,3.084636e-05
40868,functional plasticity,21,23,140,161,"However, these polarized Th cells can also adapt their function and phenotype depending on the changing cytokine environment, demonstrating functional plasticity.",33064842_1,-1,-1,-1,-1,40868,-1,6.800447e-05,0.99989283,3.91787e-05
40869,Th17 cells,2,4,6,16,"Here, Th17 cells, which play a critical role in host protection from extracellular pathogens and in autoimmune disorders, are of particular interest.",33064842_2,-1,-1,-1,-1,40869,-1,0.00021241362,0.0015228736,0.99826473
40873,Th17 cells,10,12,58,68,"While being able to shift phenotype within their lineage, Th17 cells can also acquire characteristics of Th1, Th2, T follicular helper (Tfh) or regulatory T cells.",33064842_3,-1,-1,-1,-1,40873,-1,0.0006045903,0.0067727272,0.99262273
40879,Th17 cell,0,2,0,9,"Th17 cell identity is determined by a spectrum of extracellular signals, including cytokines, which are critical orchestrators of cellular immune responses.",33064842_4,-1,-1,-1,-1,40879,-1,0.00041592916,0.0045163087,0.99506783
40881,cellular immune responses,20,23,130,155,"Th17 cell identity is determined by a spectrum of extracellular signals, including cytokines, which are critical orchestrators of cellular immune responses.",33064842_4,-1,-1,-1,-1,40881,-1,0.74293983,0.003195242,0.2538649
40887,Th17 plasticity,7,9,46,61,"How these signals are integrated to determine Th17 plasticity is not well defined, yet this is a crucial point of investigation as it represents a potential target to treat autoimmune and inflammatory diseases.",33064842_6,-1,-1,-1,-1,40887,-1,3.407404e-05,0.999943,2.2947923e-05
40889,target to treat,27,30,157,172,"How these signals are integrated to determine Th17 plasticity is not well defined, yet this is a crucial point of investigation as it represents a potential target to treat autoimmune and inflammatory diseases.",33064842_6,-1,-1,-1,-1,40889,-1,2.2286378e-05,0.99996805,9.699838e-06
40894,the regulation,16,18,98,112,"The goal of this review was to discuss how cytokines regulate intracellular networks, focusing on the regulation of lineage-specific transcription factors, chromatin remodelling and metabolism, to control human Th17 cell plasticity.",33064842_7,-1,-1,-1,-1,40894,-1,1.8078304e-05,0.9999726,9.293284e-06
40896,metabolism,26,27,182,192,"The goal of this review was to discuss how cytokines regulate intracellular networks, focusing on the regulation of lineage-specific transcription factors, chromatin remodelling and metabolism, to control human Th17 cell plasticity.",33064842_7,0,1,2,-1,40896,-1,8.995067e-05,0.99974793,0.00016216957
40898,Th17 cell plasticity,31,34,211,231,"The goal of this review was to discuss how cytokines regulate intracellular networks, focusing on the regulation of lineage-specific transcription factors, chromatin remodelling and metabolism, to control human Th17 cell plasticity.",33064842_7,-1,-1,-1,-1,40898,-1,0.0015960683,0.63172734,0.3666766
40900,Th17 plasticity,5,7,29,44,"We discuss the importance of Th17 plasticity in autoimmunity and cancer and present current strategies and challenges in targeting pathogenic Th17 cells with cytokine-based approaches, considering human genetic variants associated with altered Th17 differentiation.",33064842_8,-1,-1,-1,-1,40900,-1,2.7897642e-05,0.99995005,2.207881e-05
40902,Th17 cells,20,22,142,152,"We discuss the importance of Th17 plasticity in autoimmunity and cancer and present current strategies and challenges in targeting pathogenic Th17 cells with cytokine-based approaches, considering human genetic variants associated with altered Th17 differentiation.",33064842_8,-1,-1,-1,-1,40902,-1,0.00020278226,0.00083602034,0.9989612
40906,Th17 plasticity,6,8,35,50,"Finally, we discuss how modulating Th17 plasticity rather than targeting the Th17 lineage as a whole might preserve its essential immune function while purging its adverse effects.",33064842_9,-1,-1,-1,-1,40906,-1,3.261359e-05,0.9999403,2.7107168e-05
40907,than targeting the Th17,9,13,58,81,"Finally, we discuss how modulating Th17 plasticity rather than targeting the Th17 lineage as a whole might preserve its essential immune function while purging its adverse effects.",33064842_9,-1,-1,-1,-1,40907,-1,3.358414e-05,0.9999484,1.8015564e-05
40908,function,22,23,137,145,"Finally, we discuss how modulating Th17 plasticity rather than targeting the Th17 lineage as a whole might preserve its essential immune function while purging its adverse effects.",33064842_9,0,1,2,-1,40908,-1,0.0005036176,0.99925476,0.00024155101
40909,adverse effects,26,28,164,179,"Finally, we discuss how modulating Th17 plasticity rather than targeting the Th17 lineage as a whole might preserve its essential immune function while purging its adverse effects.",33064842_9,0,1,-1,-1,40909,-1,0.009724276,0.98894346,0.0013323172
40914,transplantation,28,29,158,173,"Regulatory B cells (Bregs) and CD4+ regulatory T cells (Tregs) are subgroups of immunoregulatory cells involved in modulating autoimmunity, inflammation, and transplantation reactions.",33083479_1,-1,1,2,-1,40914,-1,3.5280307e-05,0.99994576,1.892293e-05
40916,function,7,8,35,43,"Herein, by studying the number and function of Breg and Treg cell subsets in patients with AML, we explored their potential role in the pathogenesis of AML.",33083479_2,0,1,2,-1,40916,-1,4.8407408e-05,0.9999237,2.7914766e-05
40917,Treg cell subsets,11,14,56,73,"Herein, by studying the number and function of Breg and Treg cell subsets in patients with AML, we explored their potential role in the pathogenesis of AML.",33083479_2,-1,-1,-1,-1,40917,-1,0.00028362518,0.002498873,0.9972174
40929,The relationship,0,2,0,16,The relationship of Bregs and Tregs with the clinicopathological parameters was analyzed.,33083479_7,-1,-1,-1,-1,40929,-1,2.0913623e-05,0.99996424,1.4822456e-05
40937,plasma IL-10,19,21,127,139,"Furthermore, compared with healthy controls and AML patients in complete remission, newly diagnosed AML patients had increased plasma IL-10 but reduced TGF-.",33083479_10,-1,-1,-1,-1,40937,-1,0.844212,0.14585303,0.00993498
40946,that they,11,13,71,80,"Bregs and Tregs have abnormal distribution in AML patients, suggesting that they might play an important role in regulating immune responses in AML.",33083479_13,-1,-1,-1,-1,40946,-1,1.9314597e-05,0.99997056,1.0080752e-05
40949,function,17,18,91,99,"Oxya chinensis sinuosa (Ocs) is consumed as representative edible insects in Asia, but its function in various immune systems remains unclear.",33105813_0,0,1,2,-1,40949,-1,5.596446e-05,0.99992347,2.0554688e-05
40955,protein,20,21,125,132,"This study aimed to demonstrate the immunomodulatory effect, particularly on the innate and adaptive immune response, of Ocs protein (Ocs-P) and to investigate its function as a potent anticancer immunostimulant when administered during the progression stage of colon carcinoma in tumor-bearing mice.",33105813_1,0,1,-1,-1,40955,-1,0.00016586199,0.999585,0.0002492254
40957,function,28,29,164,172,"This study aimed to demonstrate the immunomodulatory effect, particularly on the innate and adaptive immune response, of Ocs protein (Ocs-P) and to investigate its function as a potent anticancer immunostimulant when administered during the progression stage of colon carcinoma in tumor-bearing mice.",33105813_1,0,1,2,-1,40957,-1,2.9085466e-05,0.9999566,1.4357173e-05
40962,Th1-polarizing cytokines,20,22,146,170,Our in vitro results demonstrated that Ocs-P treatment induces phenotypic alteration (increased expression of surface molecules and production of Th1-polarizing cytokines and decreased antigen uptake ability) of dendritic cells (DCs) through the activation of MAPK and NF-B-dependent signaling pathways.,33105813_2,-1,-1,-1,-1,40962,-1,0.06664366,0.92527336,0.008082921
40965,through the,34,36,234,245,Our in vitro results demonstrated that Ocs-P treatment induces phenotypic alteration (increased expression of surface molecules and production of Th1-polarizing cytokines and decreased antigen uptake ability) of dendritic cells (DCs) through the activation of MAPK and NF-B-dependent signaling pathways.,33105813_2,-1,-1,-1,-1,40965,-1,1.796472e-05,0.99997175,1.0317107e-05
40966,naive T cells,7,10,64,77,"Additionally, Ocs-P-stimulated DCs initiated differentiation of naive T cells into IFN--producing Th1-type T cells effectively and activated cytotoxic CD8+ T cell response.",33105813_3,-1,-1,-1,-1,40966,-1,0.0029936978,0.054145,0.9428613
40967,IFN--producing Th1-type T cells,11,15,83,115,"Additionally, Ocs-P-stimulated DCs initiated differentiation of naive T cells into IFN--producing Th1-type T cells effectively and activated cytotoxic CD8+ T cell response.",33105813_3,-1,-1,-1,-1,40967,-1,0.6141488,0.004838893,0.38101232
40971,the generation,5,7,43,57,"Furthermore, Ocs-P administration enhanced the generation of multifunctional CD4+ and CD8+ T cells expressing Th1-type cytokines (TNF-, IFN-, and IL-2) and the degranulation marker (CD107a).",33105813_5,-1,-1,-1,-1,40971,-1,1.8992423e-05,0.9999666,1.4414074e-05
40973,Th1-type cytokines,17,19,110,128,"Furthermore, Ocs-P administration enhanced the generation of multifunctional CD4+ and CD8+ T cells expressing Th1-type cytokines (TNF-, IFN-, and IL-2) and the degranulation marker (CD107a).",33105813_5,-1,-1,-1,-1,40973,-1,0.05564074,0.93487257,0.009486668
40974,TNF-,20,21,130,135,"Furthermore, Ocs-P administration enhanced the generation of multifunctional CD4+ and CD8+ T cells expressing Th1-type cytokines (TNF-, IFN-, and IL-2) and the degranulation marker (CD107a).",33105813_5,0,1,-1,-1,40974,-1,0.00031788572,0.9996244,5.7772162e-05
40979,immunity,16,17,123,131,"Collectively, these results suggest that Ocs-P demonstrates an immunostimulatory effect and may induce powerful anticancer immunity.",33105813_6,0,-1,2,-1,40979,-1,0.999485,0.00029463696,0.00022027592
40982,function,14,15,89,97,Eomesodermin (Eomes) is a T-box transcription factor that drives the differentiation and function of cytotoxic lymphocytes.,33113266_0,0,1,2,-1,40982,-1,0.00021522792,0.9995627,0.00022204283
40985,function,4,5,24,32,"However, the underlying function and mechanism of Eomes in tumor cells remains elusive.",33113266_1,0,1,2,-1,40985,-1,7.7262564e-05,0.9998739,4.8874655e-05
40986,tumor cells,10,12,59,70,"However, the underlying function and mechanism of Eomes in tumor cells remains elusive.",33113266_1,-1,-1,-1,-1,40986,-1,0.0037999211,0.4173592,0.57884085
40992,that the,18,20,110,118,"Using 2 human ESCC cell lines, we found that Eomes knockdown reduced esophageal cancer cell proliferation and that the esophageal cancer cell cycle was blocked in the G2/M phase.",33113266_3,-1,-1,-1,-1,40992,-1,2.0243191e-05,0.999969,1.0778119e-05
40998,chemoregulate regulatory T cells,7,11,39,71,"Furthermore, we found that CCL20 could chemoregulate regulatory T cells (Tregs) through their specific receptor CCR6, then promoting the proliferation of esophageal cancer cells.",33113266_5,-1,-1,-1,-1,40998,-1,0.022053119,0.0026145577,0.9753323
41000,through their,14,16,80,93,"Furthermore, we found that CCL20 could chemoregulate regulatory T cells (Tregs) through their specific receptor CCR6, then promoting the proliferation of esophageal cancer cells.",33113266_5,-1,-1,-1,-1,41000,-1,2.6938327e-05,0.99995303,2.006355e-05
41001,receptor CCR6,17,19,103,116,"Furthermore, we found that CCL20 could chemoregulate regulatory T cells (Tregs) through their specific receptor CCR6, then promoting the proliferation of esophageal cancer cells.",33113266_5,-1,-1,-1,-1,41001,-1,0.00018333063,0.0003723574,0.9994443
41006,tissues,6,7,31,38,"Importantly, in 133 human ESCC tissues, high Eomes levels were associated with poor clinical prognosis.",33113266_7,-1,1,2,-1,41006,-1,7.678549e-05,0.9981364,0.0017867563
41007,that the,5,7,32,40,"Overall, our findings suggested that the Eomes-CCL20-CCR6 pathway plays a vital role in human ESCC progress.",33113266_8,-1,-1,-1,-1,41007,-1,1.810693e-05,0.99997365,8.262017e-06
41010,targeting this,2,4,11,25,"Therefore, targeting this pathway may represent a promising strategy for controlling human ESCC.",33113266_9,-1,-1,-1,-1,41010,-1,1.8381756e-05,0.9999733,8.2941915e-06
41013,receptor,25,26,154,162,"Myasthenia gravis (MG) is a prototypic organ-specific autoimmune disorder that, in most cases, is mainly mediated by antibodies against the acetylcholine receptor.",33136553_0,0,1,2,-1,41013,-1,0.00152251,0.2587655,0.739712
41024,receptor,12,13,75,83,"In the present study, we investigated serum melatonin levels and melatonin receptor expression in MG patients and healthy controls (HCs).",33136553_4,0,1,2,-1,41024,-1,0.00010525756,0.9994368,0.0004579372
41026,Th cells,12,14,76,84,We also evaluated the impact of melatonin administration on peripheral CD4+ Th cells and related cytokine production.,33136553_5,-1,-1,-1,-1,41026,-1,3.3176326e-05,5.4754877e-05,0.99991214
41027,related cytokine,15,17,89,105,We also evaluated the impact of melatonin administration on peripheral CD4+ Th cells and related cytokine production.,33136553_5,-1,-1,-1,-1,41027,-1,0.4065386,0.58673334,0.0067280536
41032,Th17 cell,7,9,60,69,Administration of melatonin significantly decreased Th1 and Th17 cell responses and proinflammatory cytokine production.,33136553_7,-1,-1,-1,-1,41032,-1,0.0007951446,0.013511414,0.98569345
41039,function,25,26,169,177,Further investigation in vitro revealed that melatonin administration increased FoxP3 and IL-10 expression in CD4+ T cells from MG patients and enhanced the suppressive function of Tregs.,33136553_8,0,1,2,-1,41039,-1,0.00012079888,0.9997212,0.00015799078
41043,Th cell,15,17,115,122,These findings indicate that melatonin exerts immunoregulatory activity in MG by balancing effector and regulatory Th cell populations as well as by suppressing proinflammatory cytokine production.,33136553_9,-1,-1,-1,-1,41043,-1,3.3608554e-05,5.8048674e-05,0.9999083
41057,the blood,15,17,63,72,"METHODS: The levels of Treg cells and IL-2, IL-10, and TGF in the blood of patients with liver cancer were detected by flow cytometry and ELISA, respectively.",33204731_1,-1,-1,-1,-1,41057,-1,3.246537e-05,0.99992573,4.1773994e-05
41065,transplanted tumor tissues,7,10,42,68,The proportion of CD4+CD25+Foxp3+ Treg in transplanted tumor tissues was detected by flow cytometry.,33204731_4,-1,-1,-1,-1,41065,-1,2.5017123e-05,0.9999467,2.8234232e-05
41069,transplanted tumor tissues,8,11,43,69,"The expression levels of Foxp3 and TGF in transplanted tumor tissues were detected by quantitative fluorescence PCR.RESULTS: Compared with healthy people, Treg cells and IL-2, IL-10, and TGF contents in peripheral blood of liver cancer patients were increased.",33204731_5,-1,-1,-1,-1,41069,-1,2.531844e-05,0.9999429,3.173924e-05
41073,blood,35,36,216,221,"The expression levels of Foxp3 and TGF in transplanted tumor tissues were detected by quantitative fluorescence PCR.RESULTS: Compared with healthy people, Treg cells and IL-2, IL-10, and TGF contents in peripheral blood of liver cancer patients were increased.",33204731_5,0,1,-1,-1,41073,-1,0.00013060929,0.99922407,0.0006453435
41075,the transplanted tumor,3,6,15,37,The results of the transplanted tumor model in mice showed that the tumor volume of the transplanted mice in the solanine group and the TGF inhibitor mice was reduced compared with the control group.,33204731_6,-1,-1,-1,-1,41075,-1,1.9610145e-05,0.9999683,1.211938e-05
41076,that the tumor,10,13,59,73,The results of the transplanted tumor model in mice showed that the tumor volume of the transplanted mice in the solanine group and the TGF inhibitor mice was reduced compared with the control group.,33204731_6,-1,-1,-1,-1,41076,-1,2.0233438e-05,0.9999677,1.210893e-05
41077,the transplanted,15,17,84,100,The results of the transplanted tumor model in mice showed that the tumor volume of the transplanted mice in the solanine group and the TGF inhibitor mice was reduced compared with the control group.,33204731_6,-1,-1,-1,-1,41077,-1,1.905712e-05,0.9999684,1.25205e-05
41079,the TGF,23,25,132,140,The results of the transplanted tumor model in mice showed that the tumor volume of the transplanted mice in the solanine group and the TGF inhibitor mice was reduced compared with the control group.,33204731_6,-1,-1,-1,-1,41079,-1,3.5338748e-05,0.9999491,1.5534455e-05
41086,the transplanted tumor tissues,7,11,42,72,The proportion of CD4+CD25+Foxp3+ Treg in the transplanted tumor tissues of mice in the solanine treatment group was significantly lower than that in the control group.,33204731_8,-1,-1,-1,-1,41086,-1,2.4128793e-05,0.9999448,3.1090254e-05
41089,than that,21,23,137,146,The proportion of CD4+CD25+Foxp3+ Treg in the transplanted tumor tissues of mice in the solanine treatment group was significantly lower than that in the control group.,33204731_8,-1,-1,-1,-1,41089,-1,2.2905338e-05,0.9999634,1.3653462e-05
41094,the transplanted tumor tissues,7,11,37,67,The expressions of Foxp3 and TGF in the transplanted tumor tissues of mice in the solanine group were significantly lower than those in the control group.,33204731_9,-1,-1,-1,-1,41094,-1,2.952185e-05,0.9999218,4.864518e-05
41096,than those,20,22,123,133,The expressions of Foxp3 and TGF in the transplanted tumor tissues of mice in the solanine group were significantly lower than those in the control group.,33204731_9,-1,-1,-1,-1,41096,-1,2.2539421e-05,0.99996305,1.4447147e-05
41105,tumor tissues,25,27,154,167,CONCLUSION: Solanine may enhance the antitumor immune response by downregulating the proportion of CD4+CD25+ Treg and the expression of Foxp3 and TGF in tumor tissues.,33204731_10,-1,-1,-1,-1,41105,-1,2.4938441e-05,0.9999447,3.0406443e-05
41111,TRM to,5,7,29,35,"However, the contribution of TRM to anti-tumor immunity and to the response to immune checkpoint blockade has not been clearly established.",33205076_1,-1,-1,-1,-1,41111,-1,1.9848145e-05,0.99996877,1.1388954e-05
41112,immunity,8,9,47,55,"However, the contribution of TRM to anti-tumor immunity and to the response to immune checkpoint blockade has not been clearly established.",33205076_1,0,-1,2,-1,41112,-1,0.99873,0.00095561636,0.0003144153
41113,to the,10,12,60,66,"However, the contribution of TRM to anti-tumor immunity and to the response to immune checkpoint blockade has not been clearly established.",33205076_1,-1,-1,-1,-1,41113,-1,2.577176e-05,0.9999633,1.0907695e-05
41124,tumor TRM,2,4,11,20,"CD103+CD8+ tumor TRM, but not CD103-CD8+ tumor-infiltrating counterparts, express Aiolos, phosphorylated STAT-3, and IL-17; demonstrate enhanced proliferation and cytotoxicity toward autologous cancer cells; and frequently display oligoclonal expansion of TCR- clonotypes.",33205076_5,-1,-1,-1,-1,41124,-1,2.1087579e-05,0.99996495,1.3903747e-05
41130,TCR-,37,38,256,261,"CD103+CD8+ tumor TRM, but not CD103-CD8+ tumor-infiltrating counterparts, express Aiolos, phosphorylated STAT-3, and IL-17; demonstrate enhanced proliferation and cytotoxicity toward autologous cancer cells; and frequently display oligoclonal expansion of TCR- clonotypes.",33205076_5,-1,1,2,-1,41130,-1,4.236261e-05,0.9999161,4.1554256e-05
41152,TNFRSF19,16,17,88,96,"A 7 immune-related genes prognostic model for OSCC was obtained, including CGB8, CTLA4, TNFRSF19, CCL26, NRG1, TPM2 and PLAU, which was further proved to be an independent prognostic indicator after adjusting for other clinical factors.",33220636_4,0,1,-1,-1,41152,-1,0.0059069316,0.99318475,0.000908305
41156,factors,41,42,228,235,"A 7 immune-related genes prognostic model for OSCC was obtained, including CGB8, CTLA4, TNFRSF19, CCL26, NRG1, TPM2 and PLAU, which was further proved to be an independent prognostic indicator after adjusting for other clinical factors.",33220636_4,0,1,-1,-1,41156,-1,0.082458265,0.91389805,0.0036436378
41159,to the,9,11,82,88,The immune-related genes prognostic index was significantly negatively correlated to the infiltration abundances of B cells (P<0.05) and CD8+ T cells (P<0.05).,33220636_5,-1,-1,-1,-1,41159,-1,2.1983727e-05,0.9999677,1.0265177e-05
41172,tissue,14,15,80,86,"SKIL expression levels in NSCLC cell line, clinical sample, and adjacent normal tissue were measured by quantitative PCR, western blot, or immunohistochemistry.",33268765_2,-1,1,2,-1,41172,-1,8.7167675e-05,0.99954444,0.00036841613
41181,protein,12,13,77,84,"Quantitative PCR and western blot were applied to evaluate relevant mRNA and protein levels, respectively.",33268765_6,0,1,-1,-1,41181,-1,4.1906267e-05,0.99991524,4.2823565e-05
41185,tissue,6,7,36,42,SKIL expression was higher in NSCLC tissue compared to adjacent normal tissue.,33268765_8,-1,1,2,-1,41185,-1,0.00013877578,0.9965017,0.0033595897
41187,tissue,11,12,71,77,SKIL expression was higher in NSCLC tissue compared to adjacent normal tissue.,33268765_8,-1,1,2,-1,41187,-1,0.00012183094,0.9985946,0.0012836021
41191,cells through,10,12,76,89,SKIL-knockdown inhibited autophagy and activated the STING pathway in NSCLC cells through down-regulation of TAZ.,33268765_10,-1,-1,-1,-1,41191,-1,0.0034374332,0.12216458,0.874398
41199,cells through,11,13,70,83,"In conclusion, SKIL promoted tumorigenesis and immune escape of NSCLC cells through upregulation of TAZ/autophagy axis and inhibition on downstream STING pathway.",33268765_13,-1,-1,-1,-1,41199,-1,0.00397197,0.12883884,0.86718917
41201,T cell therapy,13,16,79,93,"While effective in specific settings, adoptive chimeric antigen receptor (CAR) T cell therapy for cancer requires further improvement and optimization.",33268774_0,-1,-1,-1,-1,41201,-1,0.0013836508,0.027291808,0.9713245
41202,that CD40L-overexpressing,4,6,26,51,"Our previous results show that CD40L-overexpressing CAR T cells mobilize endogenous immune effectors, resulting in improved antitumor immunity.",33268774_1,-1,-1,-1,-1,41202,-1,0.00032407715,0.99714285,0.0025330991
41204,immunity,18,19,134,142,"Our previous results show that CD40L-overexpressing CAR T cells mobilize endogenous immune effectors, resulting in improved antitumor immunity.",33268774_1,0,-1,2,-1,41204,-1,0.99933904,0.00041096675,0.00024999527
41205,the cell,2,4,9,17,"However, the cell populations required for this protective effect remain to be identified.",33268774_2,-1,-1,-1,-1,41205,-1,0.0036618805,0.38496932,0.6113688
41209,cell type,14,16,83,92,"Here we show, by analyzing Batf3-/- mice lacking the CD103+ conventional dendritic cell type 1 (cDC1) subpopulation important for antigen cross-presentation, that CD40L-overexpressing CAR T cells elicit an impaired antitumor response in the absence of cDC1s.",33268774_3,-1,-1,-1,-1,41209,-1,0.000101414385,0.00027499755,0.99962354
41211,that CD40L-overexpressing,26,28,158,183,"Here we show, by analyzing Batf3-/- mice lacking the CD103+ conventional dendritic cell type 1 (cDC1) subpopulation important for antigen cross-presentation, that CD40L-overexpressing CAR T cells elicit an impaired antitumor response in the absence of cDC1s.",33268774_3,-1,-1,-1,-1,41211,-1,0.0011573583,0.9674403,0.031402335
41214,that CD40L-overexpressing,3,5,16,41,We further find that CD40L-overexpressing CAR T cells stimulate tumor-resident CD11b-CD103- double-negative (DN) cDCs to proliferate and differentiate into cDC1s in wild-type mice.,33268774_4,-1,-1,-1,-1,41214,-1,0.0012671343,0.9558856,0.042847347
41227,T cells to,27,30,185,195,"Our findings thus demonstrate the stimulatory effect of CD40L-overexpressing CAR T cells on innate and adaptive immune cells, and provide a rationale for using CD40L-overexpressing CAR T cells to improve immunotherapy responses.",33268774_6,-1,-1,-1,-1,41227,-1,0.0020384728,0.055328526,0.94263303
41228,tumors that,8,10,63,74,"Cancer immunotherapy shows limited efficacy against many solid tumors that originate from epithelial tissues, including triple-negative breast cancer (TNBC).",33385331_0,-1,-1,-1,-1,41228,-1,1.896268e-05,0.99996924,1.1843705e-05
41229,tissues,13,14,101,108,"Cancer immunotherapy shows limited efficacy against many solid tumors that originate from epithelial tissues, including triple-negative breast cancer (TNBC).",33385331_0,-1,1,2,-1,41229,-1,0.0006296961,0.07593031,0.92344
41232,the SOX4 transcription factor,2,6,12,41,We identify the SOX4 transcription factor as an important resistance mechanism to Tcell-mediated cytotoxicity for TNBC cells.,33385331_1,-1,-1,-1,-1,41232,-1,2.4359964e-05,0.9999614,1.42427825e-05
41233,to Tcell-mediated,11,15,79,97,We identify the SOX4 transcription factor as an important resistance mechanism to Tcell-mediated cytotoxicity for TNBC cells.,33385331_1,-1,-1,-1,-1,41233,-1,0.0025950635,0.12407563,0.87332934
41234,TNBC cells,17,19,115,125,We identify the SOX4 transcription factor as an important resistance mechanism to Tcell-mediated cytotoxicity for TNBC cells.,33385331_1,-1,-1,-1,-1,41234,-1,0.003486091,0.6639358,0.33257812
41237,tumor cells,8,10,61,72,Mechanistic studies demonstrate that inactivation of SOX4 in tumor cells increases the expression of genes in a number of innate and adaptive immune pathways important for protective tumor immunity.,33385331_2,-1,-1,-1,-1,41237,-1,0.0028585584,0.2733178,0.7238236
41240,tumor immunity,27,29,183,197,Mechanistic studies demonstrate that inactivation of SOX4 in tumor cells increases the expression of genes in a number of innate and adaptive immune pathways important for protective tumor immunity.,33385331_2,-1,-1,-1,-1,41240,-1,0.05103101,0.9477398,0.0012291565
41243,receptor,9,10,53,61,"Expression of SOX4 is regulated by the integrin v6 receptor on the surface of tumor cells, which activates TGF from a latent precursor.",33385331_3,0,1,2,-1,41243,-1,0.00022805994,0.0012334803,0.9985385
41245,tumor cells,14,16,80,91,"Expression of SOX4 is regulated by the integrin v6 receptor on the surface of tumor cells, which activates TGF from a latent precursor.",33385331_3,-1,-1,-1,-1,41245,-1,0.0038046031,0.4081215,0.58807385
41249,TNBC cells to,13,16,94,107,An integrin v6/8-blocking monoclonal antibody (mAb) inhibits SOX4 expression and sensitizes TNBC cells to cytotoxic Tcells.,33385331_4,-1,-1,-1,-1,41249,-1,8.632896e-05,0.9997303,0.00018334409
41272,analysis,2,3,20,28,Stratified survival analysis showed IRG signature was an effective predictor of survival in patients with different clinical characteristics.,33401247_5,0,1,-1,-1,41272,-1,3.5373778e-05,0.99993575,2.8823835e-05
41273,The protein,0,2,0,11,The protein expression level of six genes was validated by immunohistochemistry analysis.,33401247_6,-1,-1,-1,-1,41273,-1,2.7123042e-05,0.9999602,1.26453515e-05
41275,analysis,11,12,80,88,The protein expression level of six genes was validated by immunohistochemistry analysis.,33401247_6,0,1,-1,-1,41275,-1,3.2467982e-05,0.99994504,2.2451362e-05
41276,analysis,1,2,11,19,"Difference analysis indicated the mutation rate, immune cell of resting NK cells and regulatory T cells infiltration and four immune checkpoints of PD-1, PD-L1, LAG3 and VSIR expression levels in the high-risk group were significantly higher than those in the low-risk group.",33401247_7,0,1,-1,-1,41276,-1,3.799055e-05,0.99993134,3.068912e-05
41282,than those,39,41,242,252,"Difference analysis indicated the mutation rate, immune cell of resting NK cells and regulatory T cells infiltration and four immune checkpoints of PD-1, PD-L1, LAG3 and VSIR expression levels in the high-risk group were significantly higher than those in the low-risk group.",33401247_7,-1,-1,-1,-1,41282,-1,2.3546123e-05,0.9999609,1.5603922e-05
41284,the gene,3,5,25,33,"A nomogram incorporating the gene signatures and clinical factors was demonstrated had a good accuracy (1-, 3-, and 5-year AUC= 0.799, 0.791, 0.738).",33401247_8,-1,-1,-1,-1,41284,-1,3.6362988e-05,0.99993706,2.6555595e-05
41285,factors,8,9,58,65,"A nomogram incorporating the gene signatures and clinical factors was demonstrated had a good accuracy (1-, 3-, and 5-year AUC= 0.799, 0.791, 0.738).",33401247_8,0,1,-1,-1,41285,-1,0.005132268,0.9943954,0.00047232647
41287,that the,4,6,26,34,It is clearly established that the immune system can affect cancer response to therapy.,33419764_0,-1,-1,-1,-1,41287,-1,2.1118349e-05,0.99996877,1.0092902e-05
41288,to therapy,12,14,76,86,It is clearly established that the immune system can affect cancer response to therapy.,33419764_0,-1,-1,-1,-1,41288,-1,3.068504e-05,0.9999559,1.345415e-05
41290,the tumor,5,7,26,35,"However, the influence of the tumor microenvironment (TME) on immune cells is not completely understood.",33419764_1,-1,-1,-1,-1,41290,-1,2.0936384e-05,0.99997056,8.5609e-06
41296,that the TME,4,7,16,28,"Here, we showed that the TME, via a TGF-dependent mechanism, increased alternative splicing events and induced the expression of an alternative isoform of the IRF1 transcription factor (IRF17) in Th1 cells.",33419764_3,-1,-1,-1,-1,41296,-1,2.0211257e-05,0.9999695,1.0342844e-05
41299,the IRF1 transcription factor,26,30,156,185,"Here, we showed that the TME, via a TGF-dependent mechanism, increased alternative splicing events and induced the expression of an alternative isoform of the IRF1 transcription factor (IRF17) in Th1 cells.",33419764_3,-1,-1,-1,-1,41299,-1,2.1442866e-05,0.99996436,1.4171625e-05
41301,that the,2,4,9,17,"We found that the SFPQ splicing factor (splicing factor, proline- and glutamine-rich) was responsible for the IRF17 production.",33419764_4,-1,-1,-1,-1,41301,-1,1.6776434e-05,0.9999747,8.533294e-06
41302,factor,6,7,32,38,"We found that the SFPQ splicing factor (splicing factor, proline- and glutamine-rich) was responsible for the IRF17 production.",33419764_4,0,1,-1,-1,41302,-1,2.7904345e-05,0.9999509,2.1206692e-05
41303,factor,9,10,49,55,"We found that the SFPQ splicing factor (splicing factor, proline- and glutamine-rich) was responsible for the IRF17 production.",33419764_4,0,1,-1,-1,41303,-1,3.3423767e-05,0.99994147,2.515712e-05
41306,that the IRF1,10,13,41,54,"We also showed, in both mice and humans, that the IRF1 alternative isoform altered the full-length IRF1 transcriptional activity on the Il12rb1 promoter, resulting in decreased IFN secretion in Th1 cells.",33419764_5,-1,-1,-1,-1,41306,-1,1.8919165e-05,0.99996805,1.3000557e-05
41308,IRF1 transcriptional,18,20,99,119,"We also showed, in both mice and humans, that the IRF1 alternative isoform altered the full-length IRF1 transcriptional activity on the Il12rb1 promoter, resulting in decreased IFN secretion in Th1 cells.",33419764_5,-1,-1,-1,-1,41308,-1,2.1221587e-05,0.9999635,1.5232121e-05
41309,the Il12rb1,22,24,132,143,"We also showed, in both mice and humans, that the IRF1 alternative isoform altered the full-length IRF1 transcriptional activity on the Il12rb1 promoter, resulting in decreased IFN secretion in Th1 cells.",33419764_5,-1,-1,-1,-1,41309,-1,0.0012417007,0.997982,0.00077629794
41314,the TME,8,10,42,49,"Thus, the IRF17 isoform was increased in the TME, and inhibiting IRF17 expression could potentiate Th1 antitumor responses.",33419764_6,-1,-1,-1,-1,41314,-1,2.1405005e-05,0.9999672,1.142696e-05
41322,life-threatening immune response,22,25,108,140,"Engineered immune cells, such as chimeric antigen receptor (CAR) T cells, are facing the danger of an overt life-threatening immune response due to the ON-target OFF-tumor cytotoxicity and Cytokine Release Syndrome.",33514819_1,-1,-1,-1,-1,41322,-1,0.30231544,0.6946528,0.0030317076
41323,to the,26,28,145,151,"Engineered immune cells, such as chimeric antigen receptor (CAR) T cells, are facing the danger of an overt life-threatening immune response due to the ON-target OFF-tumor cytotoxicity and Cytokine Release Syndrome.",33514819_1,-1,-1,-1,-1,41323,-1,2.335662e-05,0.99996746,9.2182945e-06
41324,Cytokine Release,32,34,189,205,"Engineered immune cells, such as chimeric antigen receptor (CAR) T cells, are facing the danger of an overt life-threatening immune response due to the ON-target OFF-tumor cytotoxicity and Cytokine Release Syndrome.",33514819_1,-1,-1,-1,-1,41324,-1,0.9775418,0.020550556,0.001907577
41329,the tumor,22,24,164,173,We therefore developed synthetic promoters for regulation of gene expression under the control of inflammation and Hypoxia-induced signals that are associated with the tumor microenvironment (TME).,33514819_2,-1,-1,-1,-1,41329,-1,1.8875418e-05,0.9999726,8.587344e-06
41331,termed this,1,3,3,14,We termed this methodology as chimeric-antigen-receptor-tumor-induced-vector (CARTIV).,33514819_3,-1,-1,-1,-1,41331,-1,3.2710588e-05,0.99995375,1.35043565e-05
41333,TNF,19,20,107,111,"For proof of concept, we studied synthetic promoters based on promoter-responsive elements (PREs) of IFN, TNF and hypoxia; triple PRE-based CARTIV promoter manifested a synergistic activity in cell-lines and potent activation in human primary T-cells.",33514819_4,0,1,-1,-1,41333,-1,0.00027247393,0.99969316,3.437035e-05
41336,T-cells,39,40,245,252,"For proof of concept, we studied synthetic promoters based on promoter-responsive elements (PREs) of IFN, TNF and hypoxia; triple PRE-based CARTIV promoter manifested a synergistic activity in cell-lines and potent activation in human primary T-cells.",33514819_4,-1,1,2,-1,41336,-1,5.240358e-05,0.00019429928,0.9997533
41338,T-cells,7,8,42,49,"CARTIV platform can improve safety of CAR T-cells or other engineered immune-cells, providing TME-focused activity and opening a therapeutic window for many tumor-associated antigens that are also expressed by non-tumor healthy tissues.",33514819_5,-1,1,2,-1,41338,-1,0.0001449125,0.0007762286,0.99907887
41341,tumor-associated antigens that,23,26,157,187,"CARTIV platform can improve safety of CAR T-cells or other engineered immune-cells, providing TME-focused activity and opening a therapeutic window for many tumor-associated antigens that are also expressed by non-tumor healthy tissues.",33514819_5,-1,-1,-1,-1,41341,-1,8.826259e-05,0.99988115,3.0570354e-05
41342,tissues,32,33,228,235,"CARTIV platform can improve safety of CAR T-cells or other engineered immune-cells, providing TME-focused activity and opening a therapeutic window for many tumor-associated antigens that are also expressed by non-tumor healthy tissues.",33514819_5,-1,1,2,-1,41342,-1,0.00018574679,0.99819475,0.0016195648
41343,The transcription factor,0,3,0,24,"The transcription factor eomesodermin (EOMES) promotes interleukin (IL)-10 expression in CD4+ T cells, which has been linked to immunosuppressive and cytotoxic activities.",33526861_0,-1,-1,-1,-1,41343,-1,2.2964901e-05,0.9999654,1.1581777e-05
41348,protein-1,7,8,45,54,"We detected cytotoxic, programmed cell death protein-1 (PD-1) and EOMES co-expressing CD4+ T cells in lymph nodes (LNs) of patients with chronic lymphocytic leukemia (CLL) or diffuse large B-cell lymphoma.",33526861_1,0,1,-1,-1,41348,-1,0.00035094493,0.99867755,0.00097146095
41357,genes typical,32,34,192,205,"Transcriptome and flow cytometry analyses revealed that EOMES does not only drive IL-10 expression, but rather controls a unique transcriptional signature in CD4+ T cells, that is enriched in genes typical for T regulatory type 1 (TR1) cells.",33526861_2,-1,-1,-1,-1,41357,-1,3.4239794e-05,0.9999491,1.6692762e-05
41362,The TR1 cell,0,3,0,12,"The TR1 cell identity of these CD4+ T cells was supported by their expression of interferon gamma and IL-10, as well as inhibitory receptors including PD-1.",33526861_3,-1,-1,-1,-1,41362,-1,0.0031630786,0.3705336,0.6263033
41368,receptors,25,26,131,140,"The TR1 cell identity of these CD4+ T cells was supported by their expression of interferon gamma and IL-10, as well as inhibitory receptors including PD-1.",33526861_3,0,1,2,-1,41368,-1,0.000110253786,0.00035357772,0.9995363
41369,TR1 cells,0,2,0,9,TR1 cells with cytotoxic capacity accumulate also in E-TCL1 mice that develop CLL-like disease.,33526861_4,-1,-1,-1,-1,41369,-1,0.0006986759,0.029787017,0.9695143
41376,that TR1 cell-mediated,3,6,16,38,"We further show that TR1 cell-mediated control of TCL1 leukemia requires IL-10 receptor (IL-10R) signaling, as Il10rb-deficient CD4+ T cells showed impaired antileukemia activity.",33526861_6,-1,-1,-1,-1,41376,-1,0.0017953326,0.35642478,0.64177984
41378,IL-10 receptor,11,13,73,87,"We further show that TR1 cell-mediated control of TCL1 leukemia requires IL-10 receptor (IL-10R) signaling, as Il10rb-deficient CD4+ T cells showed impaired antileukemia activity.",33526861_6,-1,-1,-1,-1,41378,-1,0.94084704,0.0016636458,0.057489384
41385,TR1 cells,16,18,112,121,"Altogether, our data demonstrate that EOMES is indispensable for the development of IL-10-expressing, cytotoxic TR1 cells, which accumulate in LNs of CLL patients and control TCL1 leukemia in mice in an IL-10R-dependent manner.",33526861_7,-1,-1,-1,-1,41385,-1,0.0014663733,0.114845164,0.88368845
41389,to the,7,9,36,42,"Glioma stem cells (GSCs) contribute to the malignant growth of glioma, but little is known about the interaction between GSCs and tumor microenvironment.",33576874_0,-1,-1,-1,-1,41389,-1,2.578464e-05,0.99996233,1.19411925e-05
41396,through TGF-,19,21,105,118,"Here, we found that intense infiltration of regulatory T cells (Tregs) facilitated the qualities of GSCs through TGF- secretion that helped coordinately tumor growth.",33576874_1,-1,-1,-1,-1,41396,-1,4.828267e-05,0.9999329,1.8828681e-05
41399,that TGF-,3,5,37,47,"Mechanistic investigations indicated that TGF- acted on cancer cells to induce the core cancer stem cell-related genes CD133, SOX2, NESTIN, MUSASHI1 and ALDH1A expression and spheres formation via NF-B-IL6-STAT3 signaling pathway, resulting in the increased cancer stemness and tumorigenic potential.",33576874_2,-1,-1,-1,-1,41399,-1,2.9595394e-05,0.99995697,1.346397e-05
41400,cells to,8,10,64,72,"Mechanistic investigations indicated that TGF- acted on cancer cells to induce the core cancer stem cell-related genes CD133, SOX2, NESTIN, MUSASHI1 and ALDH1A expression and spheres formation via NF-B-IL6-STAT3 signaling pathway, resulting in the increased cancer stemness and tumorigenic potential.",33576874_2,-1,-1,-1,-1,41400,-1,0.0032188687,0.12118336,0.87559783
41402,cell-related genes,15,17,101,119,"Mechanistic investigations indicated that TGF- acted on cancer cells to induce the core cancer stem cell-related genes CD133, SOX2, NESTIN, MUSASHI1 and ALDH1A expression and spheres formation via NF-B-IL6-STAT3 signaling pathway, resulting in the increased cancer stemness and tumorigenic potential.",33576874_2,-1,-1,-1,-1,41402,-1,0.00093198253,0.009056093,0.990012
41409,IL6 receptor,17,19,101,113,"Furthermore, Tregs promoted glioma tumor growth, and this effect could be abrogated with blockade of IL6 receptor by tocilizumab which also demonstrated certain level of therapeutic efficacy in xenograft model.",33576874_3,-1,-1,-1,-1,41409,-1,0.26806578,0.0063241343,0.7256101
41416,to target this,3,6,18,32,"Moreover, efforts to target this network may be an effective strategy for treating glioma.",33576874_6,-1,-1,-1,-1,41416,-1,2.1845675e-05,0.9999691,9.0856565e-06
41418,tumor-infiltrating lymphocytes,2,4,16,46,Inactivation of tumor-infiltrating lymphocytes (TIL) is one of the mechanisms mitigating antitumor immunity during tumor onset and progression.,33589517_0,-1,-1,-1,-1,41418,-1,0.004032287,0.8533422,0.14262547
41421,immunity,14,15,99,107,Inactivation of tumor-infiltrating lymphocytes (TIL) is one of the mechanisms mitigating antitumor immunity during tumor onset and progression.,33589517_0,0,-1,2,-1,41421,-1,0.999014,0.0006994814,0.0002865879
41423,to the,9,11,70,76,Epigenetic abnormalities are regarded as a major culprit contributing to the dysfunction of TILs within tumor microenvironments.,33589517_1,-1,-1,-1,-1,41423,-1,2.3887902e-05,0.9999666,9.536548e-06
41428,that Tet2,13,15,62,71,"In this study, we used a murine model of melanoma to discover that Tet2 inactivation significantly enhances the antitumor activity of TILs with an efficacy comparable to immune checkpoint inhibition imposed by anti-PD-L1 treatment.",33589517_2,-1,-1,-1,-1,41428,-1,2.788698e-05,0.99996066,1.1406024e-05
41433,analysis,2,3,27,35,Single-cell RNA-sequencing analysis suggested that Tet2-deficient TILs exhibit effector-like features.,33589517_3,0,1,-1,-1,41433,-1,2.6377254e-05,0.99995065,2.3020651e-05
41434,that Tet2-deficient TILs,4,7,46,70,Single-cell RNA-sequencing analysis suggested that Tet2-deficient TILs exhibit effector-like features.,33589517_3,-1,-1,-1,-1,41434,-1,2.4804976e-05,0.999961,1.421843e-05
41436,analysis,3,4,35,43,Transcriptomic and ATAC-sequencing analysis showed that Tet2 ablation reshapes chromatin accessibility and favors binding of transcription factors geared toward CD8+ T-cell activation.,33589517_4,0,1,-1,-1,41436,-1,3.236448e-05,0.99994326,2.4370445e-05
41437,that Tet2,5,7,51,60,Transcriptomic and ATAC-sequencing analysis showed that Tet2 ablation reshapes chromatin accessibility and favors binding of transcription factors geared toward CD8+ T-cell activation.,33589517_4,-1,-1,-1,-1,41437,-1,2.8478546e-05,0.99996054,1.1011167e-05
41444,T-cell function,13,15,83,98,"Furthermore, the ETS family of transcription factors contributed to augmented CD8+ T-cell function following Tet2 depletion.",33589517_5,-1,-1,-1,-1,41444,-1,4.711711e-05,8.623737e-05,0.9998666
41446,that Tet2,5,7,31,40,"Overall, our study establishes that Tet2 constitutes one of the epigenetic barriers that account for dysfunction of TILs and that Tet2 inactivation could promote antitumor immunity to suppress tumor growth.",33589517_6,-1,-1,-1,-1,41446,-1,2.2266604e-05,0.99996734,1.0415704e-05
41450,that Tet2,20,22,125,134,"Overall, our study establishes that Tet2 constitutes one of the epigenetic barriers that account for dysfunction of TILs and that Tet2 inactivation could promote antitumor immunity to suppress tumor growth.",33589517_6,-1,-1,-1,-1,41450,-1,2.7765966e-05,0.9999615,1.077146e-05
41451,immunity to,26,28,172,183,"Overall, our study establishes that Tet2 constitutes one of the epigenetic barriers that account for dysfunction of TILs and that Tet2 inactivation could promote antitumor immunity to suppress tumor growth.",33589517_6,-1,-1,-1,-1,41451,-1,0.26830915,0.7291569,0.0025339806
41458,function,16,17,97,105,SIGNIFICANCE: This study suggests that ablation of TET2+ from TILs could promote their antitumor function by reshaping chromatin accessibility for key transcription factors and enhancing the transcription of genes essential for antitumor activity.,33589517_7,0,1,2,-1,41458,-1,6.112362e-05,0.9999052,3.3597556e-05
41460,the transcription,27,29,187,204,SIGNIFICANCE: This study suggests that ablation of TET2+ from TILs could promote their antitumor function by reshaping chromatin accessibility for key transcription factors and enhancing the transcription of genes essential for antitumor activity.,33589517_7,-1,-1,-1,-1,41460,-1,2.2680026e-05,0.9999666,1.0680946e-05
41464,immunity through,14,16,113,129,"CTLA-4 blockade in combination with an agonist OX40-specific monoclonal antibody synergizes to augment antitumor immunity through enhanced T-cell effector function, leading to increased survival in preclinical cancer models.",33593794_0,-1,-1,-1,-1,41464,-1,0.16030651,0.83714974,0.0025437786
41465,T-cell,17,18,139,145,"CTLA-4 blockade in combination with an agonist OX40-specific monoclonal antibody synergizes to augment antitumor immunity through enhanced T-cell effector function, leading to increased survival in preclinical cancer models.",33593794_0,-1,1,2,-1,41465,-1,3.4006567e-05,5.111938e-05,0.9999149
41466,function,19,20,155,163,"CTLA-4 blockade in combination with an agonist OX40-specific monoclonal antibody synergizes to augment antitumor immunity through enhanced T-cell effector function, leading to increased survival in preclinical cancer models.",33593794_0,0,1,2,-1,41466,-1,0.0003886168,0.002901424,0.99670994
41469,therapy,7,8,64,71,We have shown previously that anti-OX40/anti-CTLA-4 combination therapy synergistically enhances the expression of Eomesodermin (Eomes) in CD8+ T cells.,33593794_1,0,1,-1,-1,41469,-1,2.2829841e-05,0.9999645,1.272332e-05
41474,function,11,12,76,84,Eomes is a critical transcription factor for the differentiation and memory function of CD8+ T cells.,33593794_2,0,1,2,-1,41474,-1,0.00023515226,0.99937624,0.00038860968
41483,therapy,14,15,95,102,"Indeed, CD8+ T cell-specific deletion of Eomes abrogated the efficacy of anti-OX40/anti-CTLA-4 therapy.",33593794_4,0,1,-1,-1,41483,-1,2.3912726e-05,0.9999629,1.3184783e-05
41486,receptors,14,15,106,115,"We also found that anti-OX40/anti-CTLA-4-induced EomeshiCD8+ T cells expressed lower levels of checkpoint receptors (PD1, Tim-3, and Lag-3) and higher levels of effector cytokines (IFN and TNF) than their Eomeslo counterparts.",33593794_5,0,1,2,-1,41486,-1,0.00022094062,0.001912783,0.99786633
41490,TNF,32,33,190,194,"We also found that anti-OX40/anti-CTLA-4-induced EomeshiCD8+ T cells expressed lower levels of checkpoint receptors (PD1, Tim-3, and Lag-3) and higher levels of effector cytokines (IFN and TNF) than their Eomeslo counterparts.",33593794_5,0,1,-1,-1,41490,-1,0.0002232432,0.9997336,4.3159707e-05
41491,than their,34,36,196,206,"We also found that anti-OX40/anti-CTLA-4-induced EomeshiCD8+ T cells expressed lower levels of checkpoint receptors (PD1, Tim-3, and Lag-3) and higher levels of effector cytokines (IFN and TNF) than their Eomeslo counterparts.",33593794_5,-1,-1,-1,-1,41491,-1,2.18573e-05,0.99996424,1.39634e-05
41492,T cells through interleukin-2-inducible T-cell,6,11,44,90,Eomes expression is negatively regulated in T cells through interleukin-2-inducible T-cell kinase (ITK) signaling.,33593794_6,-1,-1,-1,-1,41492,-1,0.00034292892,0.0003233921,0.99933356
41496,therapy,21,22,161,168,"We investigated the impact of modulating ITK signaling with ibrutinib, an FDA-approved tyrosine kinase inhibitor, and found that anti-OX40/anti-CTLA-4/ibrutinib therapy further enhanced CD8+ T cell-specific Eomes expression, leading to enhanced tumor regression and improved survival, both of which were associated with increased T-cell effector function across multiple tumor models.",33593794_7,0,1,-1,-1,41496,-1,2.0603034e-05,0.99996877,1.0595413e-05
41500,T-cell,47,48,330,336,"We investigated the impact of modulating ITK signaling with ibrutinib, an FDA-approved tyrosine kinase inhibitor, and found that anti-OX40/anti-CTLA-4/ibrutinib therapy further enhanced CD8+ T cell-specific Eomes expression, leading to enhanced tumor regression and improved survival, both of which were associated with increased T-cell effector function across multiple tumor models.",33593794_7,-1,1,2,-1,41500,-1,3.394338e-05,4.4707474e-05,0.9999213
41501,function,49,50,346,354,"We investigated the impact of modulating ITK signaling with ibrutinib, an FDA-approved tyrosine kinase inhibitor, and found that anti-OX40/anti-CTLA-4/ibrutinib therapy further enhanced CD8+ T cell-specific Eomes expression, leading to enhanced tumor regression and improved survival, both of which were associated with increased T-cell effector function across multiple tumor models.",33593794_7,0,1,2,-1,41501,-1,0.0012418042,0.023998478,0.97475964
41503,Taken together,0,2,0,14,"Taken together, these data demonstrate the potential of anti-OX40/anti-CTLA-4/ibrutinib as a triple therapy to improve the efficacy of immunotherapy.",33593794_8,-1,-1,-1,-1,41503,-1,4.2108833e-05,0.99994135,1.6497339e-05
41506,triple therapy to,12,15,93,110,"Taken together, these data demonstrate the potential of anti-OX40/anti-CTLA-4/ibrutinib as a triple therapy to improve the efficacy of immunotherapy.",33593794_8,-1,-1,-1,-1,41506,-1,3.4181387e-05,0.99995184,1.3928593e-05
41508,Th17 cells,3,5,16,26,An imbalance in Th17 cells and Tregs may be an important cause of the pathogenesis of thymoma with myasthenia gravis (MG).,33636431_0,-1,-1,-1,-1,41508,-1,0.00020814716,0.00089826324,0.99889356
41515,analysis,2,3,15,23,"Flow cytometry analysis of Th17 and Tregs in peripheral blood revealed that the percentages of Th17 in thymoma were lower than those in thymoma with MG, while the percentages of Tregs were higher than those in simple thymoma.",33636431_2,0,1,-1,-1,41515,-1,2.8762961e-05,0.9999473,2.396815e-05
41518,blood,9,10,56,61,"Flow cytometry analysis of Th17 and Tregs in peripheral blood revealed that the percentages of Th17 in thymoma were lower than those in thymoma with MG, while the percentages of Tregs were higher than those in simple thymoma.",33636431_2,0,1,-1,-1,41518,-1,0.0002439425,0.9955342,0.004221862
41519,that the,11,13,71,79,"Flow cytometry analysis of Th17 and Tregs in peripheral blood revealed that the percentages of Th17 in thymoma were lower than those in thymoma with MG, while the percentages of Tregs were higher than those in simple thymoma.",33636431_2,-1,-1,-1,-1,41519,-1,1.872903e-05,0.9999707,1.0538125e-05
41522,than those,20,22,122,132,"Flow cytometry analysis of Th17 and Tregs in peripheral blood revealed that the percentages of Th17 in thymoma were lower than those in thymoma with MG, while the percentages of Tregs were higher than those in simple thymoma.",33636431_2,-1,-1,-1,-1,41522,-1,2.4734265e-05,0.9999577,1.7526678e-05
41526,than those,34,36,196,206,"Flow cytometry analysis of Th17 and Tregs in peripheral blood revealed that the percentages of Th17 in thymoma were lower than those in thymoma with MG, while the percentages of Tregs were higher than those in simple thymoma.",33636431_2,-1,-1,-1,-1,41526,-1,2.4126939e-05,0.9999596,1.628191e-05
41529,that IL-6,5,7,35,44,Serum cytokine ELISA assays showed that IL-6 levels in simple thymoma were lower than those in MG patients.,33636431_3,-1,-1,-1,-1,41529,-1,0.5422132,0.4447682,0.013018556
41531,than those,13,15,81,91,Serum cytokine ELISA assays showed that IL-6 levels in simple thymoma were lower than those in MG patients.,33636431_3,-1,-1,-1,-1,41531,-1,2.5196738e-05,0.99996054,1.42351655e-05
41534,thymoma tissue,13,15,87,101,"Further, Th17 and Tregs levels were detected by immunohistochemical double staining of thymoma tissue; the number of positive Th17 cells in thymoma with MG was higher than that in simple thymoma, while positive Tregs showed the opposite results.",33636431_4,-1,-1,-1,-1,41534,-1,5.2560557e-05,0.9998785,6.895349e-05
41536,Th17 cells,20,22,126,136,"Further, Th17 and Tregs levels were detected by immunohistochemical double staining of thymoma tissue; the number of positive Th17 cells in thymoma with MG was higher than that in simple thymoma, while positive Tregs showed the opposite results.",33636431_4,-1,-1,-1,-1,41536,-1,0.0004965624,0.0062932875,0.99321014
41538,than that,28,30,167,176,"Further, Th17 and Tregs levels were detected by immunohistochemical double staining of thymoma tissue; the number of positive Th17 cells in thymoma with MG was higher than that in simple thymoma, while positive Tregs showed the opposite results.",33636431_4,-1,-1,-1,-1,41538,-1,2.5920699e-05,0.9999598,1.4287287e-05
41542,protein,1,2,6,13,RORt protein and mRNA expression in thymoma with MG were both higher than those in simple thymoma.,33636431_5,0,1,-1,-1,41542,-1,5.8636193e-05,0.99983335,0.000107953005
41544,than those,12,14,70,80,RORt protein and mRNA expression in thymoma with MG were both higher than those in simple thymoma.,33636431_5,-1,-1,-1,-1,41544,-1,3.1234216e-05,0.99995255,1.6237076e-05
41546,FOXP3 protein,0,2,0,13,FOXP3 protein and mRNA expression in the thymoma with MG group were lower than those in simple thymoma.,33636431_6,-1,-1,-1,-1,41546,-1,2.749233e-05,0.9999528,1.975083e-05
41547,the thymoma,6,8,37,48,FOXP3 protein and mRNA expression in the thymoma with MG group were lower than those in simple thymoma.,33636431_6,-1,-1,-1,-1,41547,-1,3.3579094e-05,0.9999392,2.7259834e-05
41548,than those,13,15,74,84,FOXP3 protein and mRNA expression in the thymoma with MG group were lower than those in simple thymoma.,33636431_6,-1,-1,-1,-1,41548,-1,2.7425753e-05,0.99995637,1.6226257e-05
41551,thymoma cells,5,7,28,41,The results of coculture of thymoma cells and CD4 + T cells showed that thymoma cells could promote the differentiation of Th17 cells and inhibit the Tregs.,33636431_7,-1,-1,-1,-1,41551,-1,0.004646166,0.47458836,0.5207655
41553,that thymoma cells,13,16,67,85,The results of coculture of thymoma cells and CD4 + T cells showed that thymoma cells could promote the differentiation of Th17 cells and inhibit the Tregs.,33636431_7,-1,-1,-1,-1,41553,-1,0.0033617974,0.825751,0.17088717
41555,Th17 cells,21,23,123,133,The results of coculture of thymoma cells and CD4 + T cells showed that thymoma cells could promote the differentiation of Th17 cells and inhibit the Tregs.,33636431_7,-1,-1,-1,-1,41555,-1,0.0012184262,0.031441163,0.96734047
41556,the Tregs,25,27,146,155,The results of coculture of thymoma cells and CD4 + T cells showed that thymoma cells could promote the differentiation of Th17 cells and inhibit the Tregs.,33636431_7,-1,-1,-1,-1,41556,-1,2.2758268e-05,0.9999659,1.1390083e-05
41557,Th17 cells,2,4,9,19,"Overall, Th17 cells and related transcription factors and cytokines in thymoma with MG patients were higher than those in thymoma patients, whereas, Tregs showed the opposite results, the mechanism may be that thymoma can secrete IL6 and IL21.",33636431_8,-1,-1,-1,-1,41557,-1,0.00020789809,0.00095616025,0.998836
41558,related transcription factors,5,8,24,53,"Overall, Th17 cells and related transcription factors and cytokines in thymoma with MG patients were higher than those in thymoma patients, whereas, Tregs showed the opposite results, the mechanism may be that thymoma can secrete IL6 and IL21.",33636431_8,-1,-1,-1,-1,41558,-1,3.338653e-05,0.99994063,2.595795e-05
41561,than those,17,19,108,118,"Overall, Th17 cells and related transcription factors and cytokines in thymoma with MG patients were higher than those in thymoma patients, whereas, Tregs showed the opposite results, the mechanism may be that thymoma can secrete IL6 and IL21.",33636431_8,-1,-1,-1,-1,41561,-1,2.7289443e-05,0.9999577,1.5072385e-05
41566,that thymoma,35,37,205,217,"Overall, Th17 cells and related transcription factors and cytokines in thymoma with MG patients were higher than those in thymoma patients, whereas, Tregs showed the opposite results, the mechanism may be that thymoma can secrete IL6 and IL21.",33636431_8,-1,-1,-1,-1,41566,-1,2.4871491e-05,0.9999629,1.2180518e-05
41578,immunity,28,29,156,164,Outcomes for triple negative breast cancer (TNBC) are poor and may be improved by increasing CD8+ tumor infiltrating lymphocytes (TIL) to augment antitumor immunity.,33647370_0,0,-1,2,-1,41578,-1,0.99936587,0.0003950311,0.00023915946
41585,immunity,36,37,228,236,"Because metabolic alterations affect immune homeostasis and prior studies show caloric restriction (CR) combined with RT improves preclinical TNBC outcomes, we hypothesized that CR augments RT, in part, by altering intratumoral immunity.",33647370_2,0,-1,2,-1,41585,-1,0.9993444,0.0003316285,0.00032394633
41598,the tumor,12,14,56,65,"In addition, PD-1 expression on CD3+CD8+ Tcells within the tumor microenvironment was significantly increased in CR + RT versus AL + RT treated mice as per immunofluorescence.",33647370_6,-1,-1,-1,-1,41598,-1,1.88501e-05,0.9999721,8.989539e-06
41614,gland that,12,14,55,65,"Warthin tumour (WT) is a benign tumour of the salivary gland that proliferates in both glandular epithelial and lymphoid tissue components, and rarely exhibits cystic changes.",33647861_0,-1,-1,-1,-1,41614,-1,0.0016781881,0.9594822,0.03883959
41623,plasma cells,24,26,135,147,"T follicular helper cells (Tfh) are involved in the formation and maintenance of germinal centres, the differentiation of B cells into plasma cells, and the maintenance of helper T cell type 2 (Th2)-dominant humoral immune responses.",33647861_1,-1,-1,-1,-1,41623,-1,6.549284e-05,0.0001310016,0.9998035
41625,helper T cell type,31,35,172,190,"T follicular helper cells (Tfh) are involved in the formation and maintenance of germinal centres, the differentiation of B cells into plasma cells, and the maintenance of helper T cell type 2 (Th2)-dominant humoral immune responses.",33647861_1,-1,-1,-1,-1,41625,-1,4.5567696e-05,8.26445e-05,0.99987185
41628,helper T cell type,4,8,35,53,T-bet induces differentiation into helper T cell type 1 (Th1) by suppressing differentiation into Tfh and enhances cellular immune responses.,33647861_2,-1,-1,-1,-1,41628,-1,5.9910988e-05,0.00012329557,0.99981683
41631,cellular immune responses,19,22,115,140,T-bet induces differentiation into helper T cell type 1 (Th1) by suppressing differentiation into Tfh and enhances cellular immune responses.,33647861_2,-1,-1,-1,-1,41631,-1,0.8978564,0.00162701,0.10051658
41635,the immune responses,11,14,64,84,The objective of this study was to enhance our understanding of the immune responses and relationship between Tfh and Th1 cells in patients with WTs.,33647861_3,-1,-1,-1,-1,41635,-1,0.05521814,0.9443153,0.00046649307
41640,the Tfh,5,7,36,43,"We also performed immunostaining of the Tfh markers CXCR5 and CD40 L, and the Th1 marker T-bet for statistical analysis.",33647861_5,-1,-1,-1,-1,41640,-1,2.1719326e-05,0.9999641,1.41581395e-05
41641,the Th1,14,16,74,81,"We also performed immunostaining of the Tfh markers CXCR5 and CD40 L, and the Th1 marker T-bet for statistical analysis.",33647861_5,-1,-1,-1,-1,41641,-1,3.1914115e-05,0.99991083,5.718729e-05
41643,statistical analysis,19,21,99,119,"We also performed immunostaining of the Tfh markers CXCR5 and CD40 L, and the Th1 marker T-bet for statistical analysis.",33647861_5,-1,-1,-1,-1,41643,-1,7.102923e-05,0.9998919,3.70385e-05
41646,Tfh-positive lymphocytes,18,20,106,130,"The cyst-type exhibited significant atrophy of the germinal centre area (P = 0.0019), significantly fewer Tfh-positive lymphocytes in germinal centres (P < 0.0001), and significantly more T-bet-positive lymphocytes in the epithelium (P = 0.0017).",33647861_6,-1,-1,-1,-1,41646,-1,0.0030954536,0.7419997,0.2549049
41647,T-bet-positive lymphocytes,32,34,188,214,"The cyst-type exhibited significant atrophy of the germinal centre area (P = 0.0019), significantly fewer Tfh-positive lymphocytes in germinal centres (P < 0.0001), and significantly more T-bet-positive lymphocytes in the epithelium (P = 0.0017).",33647861_6,-1,-1,-1,-1,41647,-1,0.0024956777,0.8547041,0.14280021
41649,that Tfh,2,4,12,20,We observed that Tfh were involved in the formation and maintenance of lymphoid follicles in WTs.,33647861_7,-1,-1,-1,-1,41649,-1,2.2298575e-05,0.9999659,1.1795534e-05
41654,Th1-dominant cellular immune responses,12,16,77,115,"In the cyst-type, Th2-dominant humoral immune responses were suppressed, and Th1-dominant cellular immune responses may have caused damage to tumour tissue.",33647861_8,-1,-1,-1,-1,41654,-1,0.117568225,0.86953294,0.012898786
41655,to tumour tissue,20,23,139,155,"In the cyst-type, Th2-dominant humoral immune responses were suppressed, and Th1-dominant cellular immune responses may have caused damage to tumour tissue.",33647861_8,-1,-1,-1,-1,41655,-1,7.7500285e-05,0.99982846,9.3991315e-05
41661,blood,15,16,77,82,We isolated HLA-DR-CD33+ MDSCs and CD3+ T cells from BC patients' peripheral blood and healthy donors through MACS and immunophenotyped by flow cytometry.,33679700_3,0,1,-1,-1,41661,-1,0.0004527494,0.98616123,0.013386031
41667,These cells,0,2,0,11,These cells strongly suppress both autologous and analogous CD3+ T cell proliferation and enter the tumor microenvironment.,33679700_7,-1,-1,-1,-1,41667,-1,0.003104134,0.15967357,0.8372223
41669,the tumor,15,17,96,105,These cells strongly suppress both autologous and analogous CD3+ T cell proliferation and enter the tumor microenvironment.,33679700_7,-1,-1,-1,-1,41669,-1,2.1156982e-05,0.99996924,9.551746e-06
41696,that IRF-1,4,6,22,32,"Here, we investigated that IRF-1 regulates C-X-C motif chemokine 10 (CXCL10) and chemokine receptor 3 (CXCR3) to activate anti-tumor immunity in HCC.",33689775_1,-1,-1,-1,-1,41696,-1,1.773058e-05,0.9999696,1.262796e-05
41699,chemokine receptor,15,17,81,99,"Here, we investigated that IRF-1 regulates C-X-C motif chemokine 10 (CXCL10) and chemokine receptor 3 (CXCR3) to activate anti-tumor immunity in HCC.",33689775_1,-1,-1,-1,-1,41699,-1,0.64132845,0.004493714,0.35417786
41701,immunity,24,25,133,141,"Here, we investigated that IRF-1 regulates C-X-C motif chemokine 10 (CXCL10) and chemokine receptor 3 (CXCR3) to activate anti-tumor immunity in HCC.",33689775_1,0,-1,2,-1,41701,-1,0.9987029,0.0010084929,0.00028862068
41702,that IRF-1,2,4,9,19,We found that IRF-1 mRNA expression was positively correlated with CXCL10 and CXCR3 through qRT-PCR assay in HCC tumors and in analysis of the TCGA database.,33689775_2,-1,-1,-1,-1,41702,-1,1.989269e-05,0.9999665,1.3564187e-05
41706,analysis,21,22,127,135,We found that IRF-1 mRNA expression was positively correlated with CXCL10 and CXCR3 through qRT-PCR assay in HCC tumors and in analysis of the TCGA database.,33689775_2,0,1,-1,-1,41706,-1,3.1170515e-05,0.9999443,2.4555216e-05
41707,the TCGA,23,25,139,147,We found that IRF-1 mRNA expression was positively correlated with CXCL10 and CXCR3 through qRT-PCR assay in HCC tumors and in analysis of the TCGA database.,33689775_2,-1,-1,-1,-1,41707,-1,3.1503914e-05,0.9999443,2.4202274e-05
41709,the CXCL10,6,8,43,53,"IRF-1 response elements were identified in the CXCL10 promoter region, and ChIP-qPCR confirmed IRF-1 binding to promote CXCL10 transcription.",33689775_3,-1,-1,-1,-1,41709,-1,0.819716,0.17386548,0.006418488
41712,CXCL10 transcription,18,20,120,140,"IRF-1 response elements were identified in the CXCL10 promoter region, and ChIP-qPCR confirmed IRF-1 binding to promote CXCL10 transcription.",33689775_3,-1,-1,-1,-1,41712,-1,0.9876038,0.0067207506,0.005675435
41722,that IRF-1,7,9,36,46,"In vitro and in vivo studies showed that IRF-1 increased CD8+ T cells, NK and NKT cells migration, and activated IFN- secretion in NK and NKT cells to induce tumor apoptosis through the CXCL10/CXCR3 paracrine axis.",33689775_6,-1,-1,-1,-1,41722,-1,2.1055312e-05,0.99996626,1.26529085e-05
41726,NKT cells to,28,31,139,151,"In vitro and in vivo studies showed that IRF-1 increased CD8+ T cells, NK and NKT cells migration, and activated IFN- secretion in NK and NKT cells to induce tumor apoptosis through the CXCL10/CXCR3 paracrine axis.",33689775_6,-1,-1,-1,-1,41726,-1,0.00020126897,0.9983436,0.0014551475
41728,through the,34,36,175,186,"In vitro and in vivo studies showed that IRF-1 increased CD8+ T cells, NK and NKT cells migration, and activated IFN- secretion in NK and NKT cells to induce tumor apoptosis through the CXCL10/CXCR3 paracrine axis.",33689775_6,-1,-1,-1,-1,41728,-1,2.182977e-05,0.9999665,1.1628162e-05
41733,to the,6,8,51,57,"Therefore, the IRF-1/CXCL10/CXCR3 axis contributes to the anti-tumor microenvironment in HCC.",33689775_8,-1,-1,-1,-1,41733,-1,2.2091917e-05,0.9999666,1.130377e-05
41735,factors,4,5,23,30,The mechanisms and key factors involved in tumor environments for lung metastasis of CRC are still unclear.,33707428_0,0,1,-1,-1,41735,-1,0.00012746206,0.99980897,6.36032e-05
41745,tumor cells,31,33,151,162,"Erbin deletion in B cells suppressed lung metastasis of CRC in vivo. And, deletion of Erbin in B cells enhanced the killing effects of CD8+ T cells on tumor cells.",33707428_3,-1,-1,-1,-1,41745,-1,0.004181956,0.34021798,0.65560013
41762,cells that,5,7,30,40,"For tumor engraftment, HGC-27 cells that received LINC00152 shRNA, LINC00152 overexpression vectors, enhancer of zeste homolog 2 (EZH2) shRNA or combination transfection were injected into mice.",33709190_2,-1,-1,-1,-1,41762,-1,0.00330868,0.099502176,0.89718914
41771,T-cell,9,10,47,53,Flow cytometry was adopted to measure the CD8+ T-cell infiltration in tumor issue.,33709190_4,-1,1,2,-1,41771,-1,3.2658707e-05,4.353687e-05,0.9999238
41777,to the,7,9,49,55,"ChIP assay verified that LINC00152 recruits EZH2 to the promoters of CXCL9 and CXCL10, thus the silencing of LINC00152 promoted the production of CXCL9 and CXCL10.",33709190_6,-1,-1,-1,-1,41777,-1,1.9221388e-05,0.9999701,1.0738977e-05
41779,thus the,15,17,87,95,"ChIP assay verified that LINC00152 recruits EZH2 to the promoters of CXCL9 and CXCL10, thus the silencing of LINC00152 promoted the production of CXCL9 and CXCL10.",33709190_6,-1,-1,-1,-1,41779,-1,2.2446067e-05,0.9999677,9.874899e-06
41782,tumor cells,4,6,34,45,"Knockdown of LINC00152 suppressed tumor cells growth in vivo and in vitro, increased tumor-infiltrating CD8+ T cells numbers and promoted the expression of CXCL9, CXCL10 and C-X-C Motif Chemokine Receptor 3 (CXCR3) in xenograft tumors.",33709190_7,-1,-1,-1,-1,41782,-1,0.0035965068,0.34330988,0.65309364
41787,Chemokine Receptor,31,33,186,204,"Knockdown of LINC00152 suppressed tumor cells growth in vivo and in vitro, increased tumor-infiltrating CD8+ T cells numbers and promoted the expression of CXCL9, CXCL10 and C-X-C Motif Chemokine Receptor 3 (CXCR3) in xenograft tumors.",33709190_7,-1,-1,-1,-1,41787,-1,0.712668,0.004047331,0.28328463
41790,the tumor,7,9,37,46,While CD8+ T cell depletion reversed the tumor suppression effect of LINC00152 silence.,33709190_8,-1,-1,-1,-1,41790,-1,2.1842963e-05,0.99996996,8.203721e-06
41795,the tumor,7,9,57,66,Our study indicated that LINC00152 inhibition suppressed the tumor progress may through promoting CD8+ T-cell infiltration.,33709190_10,-1,-1,-1,-1,41795,-1,2.0169058e-05,0.99996984,9.970895e-06
41797,T-cell,15,16,103,109,Our study indicated that LINC00152 inhibition suppressed the tumor progress may through promoting CD8+ T-cell infiltration.,33709190_10,-1,1,2,-1,41797,-1,3.651384e-05,4.7488465e-05,0.9999161
41799,factors,14,15,101,108,Immune escape mechanisms employed by neuroblastoma (NB) cells include secretion of immunosuppressive factors disrupting effective antitumor immunity.,33737337_0,0,1,-1,-1,41799,-1,0.8468762,0.14971137,0.0034124309
41800,immunity,18,19,140,148,Immune escape mechanisms employed by neuroblastoma (NB) cells include secretion of immunosuppressive factors disrupting effective antitumor immunity.,33737337_0,0,-1,2,-1,41800,-1,0.9993218,0.00040585312,0.00027228886
41802,cellular therapy to treat,3,7,11,36,The use of cellular therapy to treat solid tumors needs to be implemented.,33737337_1,-1,-1,-1,-1,41802,-1,0.0047235726,0.72086567,0.27441072
41812,analysis,31,32,182,190,Killing activity of anti-GD2 Chimeric Antigen Receptor (CAR) T or natural killer (NK) cells against target NB cells was assessed through coculture experiments and quantified by FACS analysis.,33737337_2,0,1,-1,-1,41812,-1,3.459112e-05,0.99991226,5.3101183e-05
41820,protein,12,13,66,73,Real Time PCR and Western Blot were performed to analyze gene and protein levels modifications.,33737337_4,0,1,-1,-1,41820,-1,4.1812356e-05,0.99991953,3.8600174e-05
41823,tissue,1,2,3,9,NB tissue sample were analyzed by IHC and Real Time PCR to perform correlation study.,33737337_6,-1,1,2,-1,41823,-1,4.4672724e-05,0.999778,0.00017731282
41834,T-cell,20,21,97,103,"In NB, IDO1 is able to inhibit the anti-tumor effect displayed by of both anti-GD2 CAR (GD2.CAR) T-cell and NK cells, mainly by impairing their IFN production.",33737337_8,-1,1,2,-1,41834,-1,3.0384545e-05,5.4912995e-05,0.99991465
41836,their IFN,28,30,138,148,"In NB, IDO1 is able to inhibit the anti-tumor effect displayed by of both anti-GD2 CAR (GD2.CAR) T-cell and NK cells, mainly by impairing their IFN production.",33737337_8,-1,-1,-1,-1,41836,-1,0.88084155,0.115883105,0.0032754098
41846,T-cell,17,18,94,100,The evidence of IDO1 involvement in NB immune escape and its ability to impair NK and GD2.CAR T-cell activity contribute to clarify one of the possible mechanisms responsible for the limited efficacy of these immunotherapeutic approaches.,33737337_12,-1,1,2,-1,41846,-1,4.143956e-05,6.93357e-05,0.99988914
41851,therapy,2,3,11,18,"A combined therapy of NK or GD2.CAR T-cells with IDO1 inhibitors, a class of compounds already in phase I/II clinical studies, could represent a new and still unexplored strategy capable to improve long-term efficacy of these immunotherapeutic approaches.",33737337_13,0,1,-1,-1,41851,-1,2.6340083e-05,0.99995863,1.5066566e-05
41852,T-cells,7,8,36,43,"A combined therapy of NK or GD2.CAR T-cells with IDO1 inhibitors, a class of compounds already in phase I/II clinical studies, could represent a new and still unexplored strategy capable to improve long-term efficacy of these immunotherapeutic approaches.",33737337_13,-1,1,2,-1,41852,-1,0.00021774096,0.0022979996,0.9974842
41858,tumor cell,5,7,35,45,"Virotherapy is proposed to achieve tumor cell killing, while indirectly activating innate immunity.",33767151_1,-1,-1,-1,-1,41858,-1,0.0038802666,0.29419383,0.701926
41861,therapy,7,8,44,51,"Here, we report that recombinant poliovirus therapy primarily mediates antitumor immunotherapy via direct infection of non-malignant tumor microenvironment (TME) cells, independent of malignant cell lysis.",33767151_2,0,1,-1,-1,41861,-1,2.051061e-05,0.9999683,1.1154722e-05
41866,Relative to,0,2,0,11,"Relative to other innate immune agonists, virotherapy provokes selective, TBK1-IRF3 driven innate inflammation that is associated with sustained type-I/III interferon (IFN) release.",33767151_3,-1,-1,-1,-1,41866,-1,3.2557502e-05,0.99995005,1.744653e-05
41867,agonists,5,6,32,40,"Relative to other innate immune agonists, virotherapy provokes selective, TBK1-IRF3 driven innate inflammation that is associated with sustained type-I/III interferon (IFN) release.",33767151_3,0,1,-1,-1,41867,-1,0.9989034,0.00031182062,0.00078471954
41878,type-I IFN,1,3,12,22,"Recombinant type-I IFN increases tumor-localized T cell function, but does not mediate durable antitumor immunotherapy without concomitant pattern recognition receptor (PRR) signaling.",33767151_5,-1,-1,-1,-1,41878,-1,0.36973336,0.6235751,0.006691589
41879,tumor-localized T cell function,4,8,33,64,"Recombinant type-I IFN increases tumor-localized T cell function, but does not mediate durable antitumor immunotherapy without concomitant pattern recognition receptor (PRR) signaling.",33767151_5,-1,-1,-1,-1,41879,-1,0.004262918,0.7733191,0.22241795
41880,receptor,20,21,159,167,"Recombinant type-I IFN increases tumor-localized T cell function, but does not mediate durable antitumor immunotherapy without concomitant pattern recognition receptor (PRR) signaling.",33767151_5,0,1,2,-1,41880,-1,0.00023355987,0.0004986366,0.99926776
41882,the TME,6,8,48,55,"Thus, virus-induced MDA5-TBK1-IRF3 signaling in the TME provides PRR-contextualized IFN responses that elicit functional antitumor T cell immunity.",33767151_6,-1,-1,-1,-1,41882,-1,2.4098885e-05,0.9999634,1.2534786e-05
41885,functional,14,15,110,120,"Thus, virus-induced MDA5-TBK1-IRF3 signaling in the TME provides PRR-contextualized IFN responses that elicit functional antitumor T cell immunity.",33767151_6,0,1,2,-1,41885,-1,9.986195e-05,0.99987185,2.8233895e-05
41886,T cell immunity,16,19,131,146,"Thus, virus-induced MDA5-TBK1-IRF3 signaling in the TME provides PRR-contextualized IFN responses that elicit functional antitumor T cell immunity.",33767151_6,-1,-1,-1,-1,41886,-1,0.02914294,0.0010882807,0.9697687
41889,function,6,7,57,65,TBK1-IRF3 innate signal transduction stimulates eventual function and differentiation of tumor-infiltrating T cells.,33767151_7,0,1,2,-1,41889,-1,8.359447e-05,0.9998596,5.6802746e-05
41890,tumor-infiltrating T cells,10,13,89,115,TBK1-IRF3 innate signal transduction stimulates eventual function and differentiation of tumor-infiltrating T cells.,33767151_7,-1,-1,-1,-1,41890,-1,0.0043355008,0.7731594,0.22250512
41892,factor that,7,9,35,46,"Immune activation in BLBC is a key factor that influences both cancer progression and therapeutic response, although its molecular mechanisms are not well clarified.",33767579_1,-1,-1,-1,-1,41892,-1,4.98108e-05,0.9999306,1.950831e-05
41895,immunity-related,8,9,39,55,"In this study, we examined five cancer immunity-related pathways (IFN, IFN, STAT3, TGF and TNF) in four large independent breast cancer cohorts (n = 6,381) and their associations with the prognosis of breast cancer subtypes.",33767579_2,0,-1,2,-1,41895,-1,0.18991897,0.8031112,0.0069698063
41900,TNF,19,20,94,98,"In this study, we examined five cancer immunity-related pathways (IFN, IFN, STAT3, TGF and TNF) in four large independent breast cancer cohorts (n = 6,381) and their associations with the prognosis of breast cancer subtypes.",33767579_2,0,1,-1,-1,41900,-1,3.554985e-05,0.99994934,1.5079233e-05
41904,analysis,23,24,169,177,Activities of the 5 pathways were calculated based on corresponding pathway signatures and associations between pathways and clinical outcomes were examined by survival analysis.,33767579_3,0,1,-1,-1,41904,-1,7.349477e-05,0.9998721,5.441781e-05
41909,TNF,14,15,70,74,"Among the five PAM50-based subtypes, BLBC had the highest IFN, IFN, TNF pathway activities, and the lowest TGF activity.",33767579_4,0,1,-1,-1,41909,-1,6.1069484e-05,0.99991083,2.8039485e-05
41912,The IFN,0,2,0,8,"The IFN, IFN, TNF pathway activities were negatively correlated with BLBC recurrence.",33767579_5,-1,-1,-1,-1,41912,-1,0.74680835,0.25033674,0.0028549023
41914,TNF,5,6,16,20,"The IFN, IFN, TNF pathway activities were negatively correlated with BLBC recurrence.",33767579_5,0,1,-1,-1,41914,-1,5.447247e-05,0.9999243,2.1268996e-05
41919,cell subset analysis,1,4,7,27,"Immune cell subset analysis in BLBC showed that M0, M1 and M2 macrophage levels were associated with either TNF or TGF pathways, whereas the level of activated memory CD4 T cells were associated with both pathways.",33767579_8,-1,-1,-1,-1,41919,-1,0.0007012677,0.0045765787,0.9947221
41921,TNF,19,20,108,112,"Immune cell subset analysis in BLBC showed that M0, M1 and M2 macrophage levels were associated with either TNF or TGF pathways, whereas the level of activated memory CD4 T cells were associated with both pathways.",33767579_8,0,1,-1,-1,41921,-1,5.01112e-05,0.9999324,1.7449784e-05
41925,this T cell subset,2,6,10,28,"Moreover, this T cell subset was most abundant in BLBCs with low TGF and high TNF pathway activities.",33767579_9,-1,-1,-1,-1,41925,-1,0.0013409372,0.03393476,0.9647243
41927,TNF,16,17,79,83,"Moreover, this T cell subset was most abundant in BLBCs with low TGF and high TNF pathway activities.",33767579_9,0,1,-1,-1,41927,-1,4.6794827e-05,0.9999343,1.8876282e-05
41929,that cooperation,3,5,24,40,These results suggested that cooperation of TNF and TGF signaling may be involved in the regulation of memory T cells and anti-cancer immunity in BLBCs.,33767579_10,-1,-1,-1,-1,41929,-1,2.515495e-05,0.99996483,9.9725385e-06
41930,TNF,6,7,44,48,These results suggested that cooperation of TNF and TGF signaling may be involved in the regulation of memory T cells and anti-cancer immunity in BLBCs.,33767579_10,0,1,-1,-1,41930,-1,3.2477812e-05,0.99995506,1.24132475e-05
41932,the regulation,14,16,87,101,These results suggested that cooperation of TNF and TGF signaling may be involved in the regulation of memory T cells and anti-cancer immunity in BLBCs.,33767579_10,-1,-1,-1,-1,41932,-1,1.894371e-05,0.99997056,1.0457241e-05
41934,immunity,22,23,136,144,These results suggested that cooperation of TNF and TGF signaling may be involved in the regulation of memory T cells and anti-cancer immunity in BLBCs.,33767579_10,0,-1,2,-1,41934,-1,0.99942577,0.00034987731,0.00022435431
41937,growth factor receptor,22,25,157,179,"BACKGROUND: Poly-(ADP-Ribose)-Polymerase inhibitors (PARPi) were reported as radiosensitizers in non-small cell lung cancer (NSCLC) with wide-type epidermal growth factor receptor (EGFR), but the effects of radiation combined with PARPi were not investigated in EGFR-mutated NSCLC.",33774805_0,-1,-1,-1,-1,41937,-1,0.7533633,0.012972992,0.23366368
41959,immunity,6,7,51,59,"Radiation plus niraparib could activate anti-tumor immunity, which appeared as increased CD8+ T lymphocytes and activated STING/TBK1/IRF3 pathway.",33774805_8,0,-1,2,-1,41959,-1,0.9990195,0.00066732836,0.00031325396
41965,tumorigenesis through,13,15,73,94,Programmed death ligand 1 (PD-L1) plays a significant role in colorectal tumorigenesis through induction of regulatory T cells (Tregs) and suppression of antitumor immunity.,33821473_0,-1,-1,-1,-1,41965,-1,2.0082009e-05,0.9999695,1.0417207e-05
41968,immunity,27,28,164,172,Programmed death ligand 1 (PD-L1) plays a significant role in colorectal tumorigenesis through induction of regulatory T cells (Tregs) and suppression of antitumor immunity.,33821473_0,0,-1,2,-1,41968,-1,0.99936587,0.00038925753,0.00024491036
41971,therapeutic target,18,20,120,138,"Furthermore, microRNAs (miRNAs) as the posttranscriptional regulators of gene expression show considerable promise as a therapeutic target for colorectal cancer (CRC) treatment.",33821473_1,-1,-1,-1,-1,41971,-1,2.2112823e-05,0.9999654,1.2464776e-05
41974,cell tumorigenesis,15,17,68,86,"Considering this, in vitro effects of miRNA-124 (miR-124-3p) on CRC cell tumorigenesis and Tregs differentiation via targeting PD-L1were investigated in the current study.",33821473_2,-1,-1,-1,-1,41974,-1,0.0019638888,0.07486921,0.923167
41978,Functional analysis,0,2,0,19,"Functional analysis showed that miR-124 is significantly downregulated in CRC tissues as compared with marginal normal samples (p<.0001), and its downregulation was negatively correlated with PD-L1 expression.",33821473_3,-1,-1,-1,-1,41978,-1,2.7461867e-05,0.9999542,1.8279106e-05
41980,tissues,10,11,78,85,"Functional analysis showed that miR-124 is significantly downregulated in CRC tissues as compared with marginal normal samples (p<.0001), and its downregulation was negatively correlated with PD-L1 expression.",33821473_3,-1,1,2,-1,41980,-1,0.00013760445,0.99647313,0.0033892412
41984,that transfection,3,5,29,46,"Further investigation showed that transfection of HT29 and SW480 cells with miR-124 mimics significantly reduced PD-L1 mRNA, protein, and cell surface expression, and inhibited Tregs in coculture models via modulating interleukin[IL]-10, IL-2, tumor necrosis factor , transforming growth factor beta, and interferon gamma expression levels.",33821473_5,-1,-1,-1,-1,41984,-1,1.8787894e-05,0.9999691,1.2143744e-05
41986,protein,18,19,125,132,"Further investigation showed that transfection of HT29 and SW480 cells with miR-124 mimics significantly reduced PD-L1 mRNA, protein, and cell surface expression, and inhibited Tregs in coculture models via modulating interleukin[IL]-10, IL-2, tumor necrosis factor , transforming growth factor beta, and interferon gamma expression levels.",33821473_5,0,1,-1,-1,41986,-1,4.0325885e-05,0.9999256,3.4056004e-05
42000,that STAT3,3,5,20,30,We also illustrated that STAT3 signaling was repressed by miR-124 in CRC cells.,33821473_9,-1,-1,-1,-1,42000,-1,2.540321e-05,0.9999609,1.3734554e-05
42002,Taken together,0,2,0,14,"Taken together, our findings imply that considering the involvement of miR-124 in the regulation of PD-L1 through colorectal tumorigenesis and its remarkable antitumor effects, this miRNA could be regarded as the promising target for the development of therapeutic approaches for colorectal cancer.",33821473_10,-1,-1,-1,-1,42002,-1,3.358027e-05,0.9999523,1.40998845e-05
42005,the regulation,13,15,82,96,"Taken together, our findings imply that considering the involvement of miR-124 in the regulation of PD-L1 through colorectal tumorigenesis and its remarkable antitumor effects, this miRNA could be regarded as the promising target for the development of therapeutic approaches for colorectal cancer.",33821473_10,-1,-1,-1,-1,42005,-1,1.9706069e-05,0.99996984,1.0473473e-05
42013,factors,6,7,41,48,UVR and immunosuppression are major risk factors for cutaneous squamous cell carcinoma (cSCC).,33848530_0,0,1,-1,-1,42013,-1,0.00023482212,0.9996125,0.00015264394
42025,nucleotides,6,7,47,58,We previously showed that extracellular purine nucleotides influence DNA damage repair.,33848530_2,-1,-1,-1,-1,42025,-1,0.0042417245,0.993129,0.0026292568
42031,blood,19,20,111,116,"We found increased ENTPD1 expression on T cells within cSCCs when compared with the expression on T cells from blood or nonlesional skin, and accordingly, concentrations of derivative extracellular adenosine diphosphate (ADP), adenosine monophosphate (AMP), and ADO are increased in tumors compared with those in normal skin.",33848530_4,0,1,-1,-1,42031,-1,9.656394e-05,0.9996557,0.00024773894
42036,those that,14,16,95,105,"Importantly, ENTPD1 expression is significantly higher in human cSCCs that metastasize than in those that are nonmetastatic.",33848530_5,-1,-1,-1,-1,42036,-1,2.2749333e-05,0.99995744,1.9793217e-05
42041,protein,17,18,110,117,"Finally, increased extracellular ADO is shown to downregulate the expression of NAP1L2, a nucleosome assembly protein we show to be important for DNA damage repair secondary to UVR.",33848530_7,0,1,-1,-1,42041,-1,0.00039251146,0.99911135,0.000496114
42046,T cells to,12,15,75,85,"Together, these data suggest a role for ENTPD1 expression on skin-resident T cells to regulate DNA damage repair through purinergic signaling to promote skin carcinogenesis and metastasis.",33848530_8,-1,-1,-1,-1,42046,-1,0.0018057799,0.037291944,0.96090233
42049,Foxp3+Treg cells,0,2,0,16,"Foxp3+Treg cells display phenotypic and functional heterogeneity, which express high levels of T cell immunoglobulin and mucin-domain containing-3 (Tim-3) in the tumor microenvironment (TME) of colorectal and lung cancer.",33864956_0,-1,-1,-1,-1,42049,-1,0.003067485,0.4456796,0.5512529
42050,functional,5,6,40,50,"Foxp3+Treg cells display phenotypic and functional heterogeneity, which express high levels of T cell immunoglobulin and mucin-domain containing-3 (Tim-3) in the tumor microenvironment (TME) of colorectal and lung cancer.",33864956_0,0,1,2,-1,42050,-1,0.00012429562,0.99981946,5.6323945e-05
42053,the tumor,23,25,158,167,"Foxp3+Treg cells display phenotypic and functional heterogeneity, which express high levels of T cell immunoglobulin and mucin-domain containing-3 (Tim-3) in the tumor microenvironment (TME) of colorectal and lung cancer.",33864956_0,-1,-1,-1,-1,42053,-1,1.813073e-05,0.999972,9.823346e-06
42060,TFT cells,8,10,46,55,"However, the expression patterns and roles of TFT cells in TME of diffuse large B cell lymphoma (DLBCL) remain to be established.",33864956_2,-1,-1,-1,-1,42060,-1,0.0003278157,0.005010852,0.9946613
42065,TFT cell,10,12,83,91,Double immunofluorescence and flow cytometry analyses were employed to investigate TFT cell enrichment in paraffin-embedded fresh tumor tissues from patients with DLBCL.,33864956_3,-1,-1,-1,-1,42065,-1,0.0005060575,0.009338372,0.9901556
42066,tumor tissues,16,18,130,143,Double immunofluorescence and flow cytometry analyses were employed to investigate TFT cell enrichment in paraffin-embedded fresh tumor tissues from patients with DLBCL.,33864956_3,-1,-1,-1,-1,42066,-1,3.926817e-05,0.9998908,6.991022e-05
42069,TFT cell,19,21,126,134,Spearman's or Pearson's correlation and Kaplan-Meier survival analyses were further applied to decide the prognostic value of TFT cell levels in DLBCL.,33864956_4,-1,-1,-1,-1,42069,-1,0.00014012228,0.00075093063,0.99910897
42070,The IL-10-secreting function,0,3,0,28,The IL-10-secreting function of TFT cells in vitro was examined via flow cytometry and ELISA.,33864956_5,-1,-1,-1,-1,42070,-1,0.0010081353,0.99851197,0.0004798899
42071,TFT cells,4,6,32,41,The IL-10-secreting function of TFT cells in vitro was examined via flow cytometry and ELISA.,33864956_5,-1,-1,-1,-1,42071,-1,0.00051456876,0.01142661,0.98805875
42073,time that TFT cells,6,10,33,52,Our results showed for the first time that TFT cells are highly enriched in TME of DLBCL patients and associated with predictions of poor prognoses.,33864956_6,-1,-1,-1,-1,42073,-1,0.0037585606,0.5780347,0.41820672
42075,TFT cell-induced,0,2,0,16,TFT cell-induced secretion of IL-10 in the TME was suppressed by an anti-Tim-3 antibody in vitro.,33864956_7,-1,-1,-1,-1,42075,-1,7.353309e-05,0.00040274288,0.99952376
42077,the TME,6,8,39,46,TFT cell-induced secretion of IL-10 in the TME was suppressed by an anti-Tim-3 antibody in vitro.,33864956_7,-1,-1,-1,-1,42077,-1,2.3911552e-05,0.9999645,1.16614765e-05
42078,TFT cells,6,8,33,42,"In conclusion, high abundance of TFT cells in the TME is predictive of poor outcomes of DLBCL.",33864956_8,-1,-1,-1,-1,42078,-1,0.00046594784,0.007720226,0.9918139
42079,the TME,9,11,46,53,"In conclusion, high abundance of TFT cells in the TME is predictive of poor outcomes of DLBCL.",33864956_8,-1,-1,-1,-1,42079,-1,2.4925417e-05,0.9999602,1.4848317e-05
42080,TFT cells,0,2,0,9,TFT cells promote DLBCL development partly by secreting IL-10 in the TME.,33864956_9,-1,-1,-1,-1,42080,-1,0.00085280254,0.022933615,0.9762136
42082,the TME,10,12,65,72,TFT cells promote DLBCL development partly by secreting IL-10 in the TME.,33864956_9,-1,-1,-1,-1,42082,-1,2.7298753e-05,0.99995923,1.3526834e-05
42098,functions,33,34,198,207,"In this study, we generated a humanized neutralizing antihuman DNAM-1 monoclonal antibody (mAb), named TNAX101A, which contains an engineered Fc portion of human IgG1 to reduce Fc-mediated effector functions.",33900821_2,0,1,2,-1,42098,-1,0.0005465125,0.9971174,0.0023360746
42102,functions,17,18,105,114,"We show that TNAX101A efficiently interfered the binding of DNAM-1 to its ligand CD155 and showed unique functions; it decreased production of the inflammatory cytokines such as interferon-gamma, tumor necrosis factor alpha, interleukin (IL)-6, IL-17A, and IL-17F by anti-CD3 antibody-stimulated or alloantigen-stimulated T cells and increased FOXP3 expression in anti-CD3-stimulated regulatory T (Treg) cells.",33900821_3,0,1,2,-1,42102,-1,0.000118535136,0.99982375,5.7696732e-05
42116,functions,2,3,11,20,These dual functions of TNAX101A may be advantageous for the treatment of T cell-mediated inflammatory diseases through both downregulation of effector T cell function and upregulation of Treg cell function.,33900821_4,0,1,2,-1,42116,-1,0.00015210031,0.99967253,0.00017537203
42117,the treatment,9,11,57,70,These dual functions of TNAX101A may be advantageous for the treatment of T cell-mediated inflammatory diseases through both downregulation of effector T cell function and upregulation of Treg cell function.,33900821_4,-1,-1,-1,-1,42117,-1,2.4003697e-05,0.99996626,9.6776e-06
42120,T cell function,21,24,152,167,These dual functions of TNAX101A may be advantageous for the treatment of T cell-mediated inflammatory diseases through both downregulation of effector T cell function and upregulation of Treg cell function.,33900821_4,-1,-1,-1,-1,42120,-1,3.738391e-05,4.5537432e-05,0.99991703
42121,Treg cell function,27,30,188,206,These dual functions of TNAX101A may be advantageous for the treatment of T cell-mediated inflammatory diseases through both downregulation of effector T cell function and upregulation of Treg cell function.,33900821_4,-1,-1,-1,-1,42121,-1,4.4107728e-05,8.957983e-05,0.99986625
42123,the tumor,6,8,35,44,Inflammation is the main driver of the tumor initiation and progression in colitis-associated colorectal cancer (CAC).,33919941_0,-1,-1,-1,-1,42123,-1,2.3236407e-05,0.9999666,1.01871365e-05
42124,that the signal transducer and activator of transcription 6,4,13,31,90,"Recent findings have indicated that the signal transducer and activator of transcription 6 (STAT6) plays a fundamental role in the early stages of CAC, and STAT6 knockout (STAT6-/-) mice are highly resistant to CAC development.",33919941_1,-1,-1,-1,-1,42124,-1,2.6476338e-05,0.99995315,2.0364916e-05
42132,cells play,5,7,20,30,"Regulatory T (Treg) cells play a major role in coordinating immunomodulation in cancer; however, the role of STAT6 in the induction and function of Treg cells is poorly understood.",33919941_2,-1,-1,-1,-1,42132,-1,0.0032839049,0.11457905,0.88213706
42136,function,26,27,136,144,"Regulatory T (Treg) cells play a major role in coordinating immunomodulation in cancer; however, the role of STAT6 in the induction and function of Treg cells is poorly understood.",33919941_2,0,1,2,-1,42136,-1,9.773627e-05,0.99984777,5.4411397e-05
42140,STAT6 to,5,7,31,39,"To clarify the contribution of STAT6 to CAC, STAT6-/- and wild type (WT) mice were subjected to an AOM/DSS regimen, and the frequency of peripheral and local Treg cells was determined during the progression of CAC.",33919941_3,-1,-1,-1,-1,42140,-1,2.3211935e-05,0.9999591,1.762807e-05
42150,TGF-beta,41,42,246,254,"When STAT6 was lacking, a remarkable reduction in tumor growth was observed, which was associated with decreased inflammation and an increased number of CD4+CD25+Foxp3+ cells in the colon, circulation, and spleen, including an over-expression of TGF-beta, IL-10, and Foxp3, compared to WT mice, during the early stages of CAC development.",33919941_4,0,1,-1,-1,42150,-1,6.7276946e-05,0.99990773,2.4929863e-05
42161,STAT6 deficiency,3,5,11,27,"Thus, with STAT6 deficiency, an increased number of Treg cells induce resistance against tumorigenesis, arresting tumor-promoting inflammation.",33919941_7,-1,-1,-1,-1,42161,-1,5.554047e-05,0.99989355,5.0885308e-05
42167,function,11,12,56,64,We reported a direct role of STAT6 in the induction and function of Treg cells during CAC development and suggest that STAT6 is a potential target for the modulation of immune response in colitis and CAC.,33919941_8,0,1,2,-1,42167,-1,7.747046e-05,0.99986124,6.127004e-05
42169,that STAT6,20,22,114,124,We reported a direct role of STAT6 in the induction and function of Treg cells during CAC development and suggest that STAT6 is a potential target for the modulation of immune response in colitis and CAC.,33919941_8,-1,-1,-1,-1,42169,-1,2.2326647e-05,0.99996424,1.3413444e-05
42175,IL-17-expressing cells,8,10,52,74,"The presence and clinical significance of IL-17 and IL-17-expressing cells have been studied for several cancers, although their correlation with tumor development remains controversial.",33971545_0,-1,-1,-1,-1,42175,-1,0.6263811,0.0029914933,0.3706274
42178,blood,1,2,11,16,Peripheral blood was collected from healthy donors and glioma patients to isolate peripheral blood mononuclear cells (PBMCs).,33971545_1,0,1,-1,-1,42178,-1,7.4729e-05,0.9996691,0.00025615134
42180,blood,13,14,93,98,Peripheral blood was collected from healthy donors and glioma patients to isolate peripheral blood mononuclear cells (PBMCs).,33971545_1,0,1,-1,-1,42180,-1,0.00024380645,0.9980895,0.001666663
42183,IL-17-expressing cells,3,5,18,40,The percentage of IL-17-expressing cells and the production of inflammatory cytokines in PBMCs and tissues were measured.,33971545_2,-1,-1,-1,-1,42183,-1,0.75959665,0.0022291574,0.23817416
42186,tissues,14,15,99,106,The percentage of IL-17-expressing cells and the production of inflammatory cytokines in PBMCs and tissues were measured.,33971545_2,-1,1,2,-1,42186,-1,3.865307e-05,0.9998803,8.105652e-05
42196,the IL-17,28,30,156,165,"Human IL17 cDNA was then inserted into the pEGFPN1 plasmid and transfected into the glioma U87MG cell line, and tumstatin was used to block the effect of the IL-17 overexpression.",33971545_3,-1,-1,-1,-1,42196,-1,0.431978,0.5631651,0.0048568565
42197,cell transcription factors,1,4,5,31,"Stem cell transcription factors were evaluated in each group using qRT-PCR and western blotting, and proliferation and migration were detected using colony formation and wound-healing assays.",33971545_4,-1,-1,-1,-1,42197,-1,0.0037387472,0.29082146,0.70543975
42198,The cells,0,2,0,9,The cells were then subcutaneously inoculated into nude mice to evaluate the growth of glioma.,33971545_5,-1,-1,-1,-1,42198,-1,0.002701365,0.29885092,0.69844776
42203,IL-17-expressing T cells,15,18,98,122,"Compared with healthy donors, the PBMCs from glioma patients showed a significant accumulation of IL-17-expressing T cells.",33971545_6,-1,-1,-1,-1,42203,-1,0.6501958,0.0027518081,0.34705237
42204,Th17 cell,0,2,0,9,"Th17 cell differentiation-related cytokines (IL-23, TGF- and IL-6) were increased in the tumor microenvironment.",33971545_7,-1,-1,-1,-1,42204,-1,0.0002741712,0.00229018,0.9974356
42208,the tumor,14,16,86,95,"Th17 cell differentiation-related cytokines (IL-23, TGF- and IL-6) were increased in the tumor microenvironment.",33971545_7,-1,-1,-1,-1,42208,-1,2.176404e-05,0.9999685,9.705692e-06
42211,protein,6,7,42,49,IL17 transfection increased the mRNA and protein expression of stem cell transcription factors in U87MG cells in vitro.,33971545_8,0,1,-1,-1,42211,-1,3.0613297e-05,0.99995065,1.8716657e-05
42212,cell transcription factors,10,13,69,95,IL17 transfection increased the mRNA and protein expression of stem cell transcription factors in U87MG cells in vitro.,33971545_8,-1,-1,-1,-1,42212,-1,0.0042636096,0.2620784,0.733658
42228,factors,12,13,105,112,Tumstatin effectively suppressed IL-17-derived U87MG cell growth by downregulating stem cell maintenance factors and inducing proliferation and migration.,33971545_12,0,1,-1,-1,42228,-1,0.9987025,0.00042451348,0.000872922
42230,that IL-17,3,5,25,35,"These findings indicated that IL-17 represents a potential prognostic marker for glioma, while tumstatin has potential in the treatment for glioma.",33971545_13,-1,-1,-1,-1,42230,-1,0.47211683,0.5204143,0.0074688755
42232,the treatment,18,20,122,135,"These findings indicated that IL-17 represents a potential prognostic marker for glioma, while tumstatin has potential in the treatment for glioma.",33971545_13,-1,-1,-1,-1,42232,-1,2.8943268e-05,0.99995947,1.155265e-05
42236,immunity,14,15,81,89,BACKGROUND: Conventional type 1 dendritic cells (cDC1s) are central to antitumor immunity and their presence in the tumor microenvironment associates with improved outcomes in patients with cancer.,33980589_0,0,-1,2,-1,42236,-1,0.9981224,0.0015372906,0.00034027576
42238,the tumor,19,21,112,121,BACKGROUND: Conventional type 1 dendritic cells (cDC1s) are central to antitumor immunity and their presence in the tumor microenvironment associates with improved outcomes in patients with cancer.,33980589_0,-1,-1,-1,-1,42238,-1,2.078642e-05,0.9999697,9.504917e-06
42239,cell-sensing receptor,7,9,26,47,DNGR-1 (CLEC9A) is a dead cell-sensing receptor highly restricted to cDC1s.,33980589_1,-1,-1,-1,-1,42239,-1,0.00014433629,0.00015213084,0.99970347
42241,cell-associated antigens,9,11,60,84,"DNGR-1 has been involved in both cross-presentation of dead cell-associated antigens and processes of disease tolerance, but its role in antitumor immunity has not been clarified yet.",33980589_2,-1,-1,-1,-1,42241,-1,0.025323786,0.0012307036,0.9734455
42243,immunity,22,23,147,155,"DNGR-1 has been involved in both cross-presentation of dead cell-associated antigens and processes of disease tolerance, but its role in antitumor immunity has not been clarified yet.",33980589_2,0,-1,2,-1,42243,-1,0.99916613,0.0005340293,0.00029980484
42244,tumor cell,5,7,22,32,METHODS: B16 and MC38 tumor cell lines were inoculated subcutaneously into wild-type (WT) and DNGR-1-deficient mice.,33980589_3,-1,-1,-1,-1,42244,-1,0.0031237055,0.3035703,0.69330597
42246,gene therapy through the,7,11,48,72,"To overexpress Flt3L systemically, we performed gene therapy through the hydrodynamic injection of an Flt3L-encoding plasmid.",33980589_4,-1,-1,-1,-1,42246,-1,2.062813e-05,0.9999683,1.1117296e-05
42249,the immune response,2,5,16,35,"To characterize the immune response, we performed flow cytometry and RNA-Seq of tumor-infiltrating cDC1s.",33980589_5,-1,-1,-1,-1,42249,-1,0.20561914,0.79288787,0.0014929362
42252,tumor antigens,9,11,51,65,"RESULTS: Here, we found that cross-presentation of tumor antigens in the steady state was DNGR-1-independent.",33980589_6,-1,-1,-1,-1,42252,-1,0.23208112,0.75467974,0.013239162
42257,gene therapy,14,16,102,114,"Of note, this protection was recapitulated by anti-DNGR-1-blocking antibodies in mice following Flt3L gene therapy.",33980589_8,-1,-1,-1,-1,42257,-1,2.6677628e-05,0.99995756,1.5750717e-05
42259,immunity,3,4,24,32,This improved antitumor immunity was associated with Batf3-dependent enhanced accumulation of CD8+ T cells and cDC1s within tumors.,33980589_9,0,-1,2,-1,42259,-1,0.9973774,0.0021255407,0.00049711386
42262,the deficiency,2,4,17,31,"Mechanistically, the deficiency in DNGR-1 boosted an Flt3L-induced specific inflammatory gene signature in cDC1s, including Ccl5 expression.",33980589_10,-1,-1,-1,-1,42262,-1,3.5261648e-05,0.99993944,2.5306403e-05
42269,CCR5 gene,6,8,29,38,"Moreover, FLT3LG and CCL5 or CCR5 gene expression signatures correlate with an enhanced cDC1 signature and a favorable overall survival in patients with cancer.",33980589_12,-1,-1,-1,-1,42269,-1,0.017617445,0.047903135,0.9344795
42275,immunity,7,8,44,52,"Thus, DNGR-1 blockade may improve antitumor immunity in tumor therapy settings associated to high Flt3L expression.",33980589_15,0,-1,2,-1,42275,-1,0.99491775,0.0046368283,0.00044552414
42276,tumor therapy,9,11,56,69,"Thus, DNGR-1 blockade may improve antitumor immunity in tumor therapy settings associated to high Flt3L expression.",33980589_15,-1,-1,-1,-1,42276,-1,2.4432524e-05,0.9999658,9.73378e-06
42284,tumors that,8,10,50,61,"Thus, additional treatment options are needed for tumors that lose expression of MHC class I. The cellular inhibitor of apoptosis proteins 1 and 2 (cIAP1/2) regulate classical and alternative nuclear factor B (NF-B) signaling.",34011631_1,-1,-1,-1,-1,42284,-1,1.929998e-05,0.9999716,9.079815e-06
42285,The cellular,16,18,94,106,"Thus, additional treatment options are needed for tumors that lose expression of MHC class I. The cellular inhibitor of apoptosis proteins 1 and 2 (cIAP1/2) regulate classical and alternative nuclear factor B (NF-B) signaling.",34011631_1,-1,-1,-1,-1,42285,-1,0.0043367078,0.56444025,0.431223
42286,proteins,21,22,130,138,"Thus, additional treatment options are needed for tumors that lose expression of MHC class I. The cellular inhibitor of apoptosis proteins 1 and 2 (cIAP1/2) regulate classical and alternative nuclear factor B (NF-B) signaling.",34011631_1,0,1,-1,-1,42286,-1,0.00012101907,0.99972564,0.00015333327
42288,immunity,14,15,120,128,"Induction of noncanonical NF-B signaling with cIAP1/2 antagonists mimics costimulatory signaling, augmenting antitumor immunity.",34011631_2,0,-1,2,-1,42288,-1,0.9988708,0.00081732956,0.00031180572
42290,T cell-dependent immune responses,9,13,63,96,"We show that induction of noncanonical NF-B signaling induces T cell-dependent immune responses, even in 2-microglobulin (2M)-deficient tumors, demonstrating that direct CD8 T cell recognition of tumor cell-expressed MHC class I is not required.",34011631_3,-1,-1,-1,-1,42290,-1,0.10947651,0.0031150354,0.88740844
42294,tumor cell-expressed,28,30,199,219,"We show that induction of noncanonical NF-B signaling induces T cell-dependent immune responses, even in 2-microglobulin (2M)-deficient tumors, demonstrating that direct CD8 T cell recognition of tumor cell-expressed MHC class I is not required.",34011631_3,-1,-1,-1,-1,42294,-1,0.0035840452,0.37346476,0.62295127
42298,antigen-specific T cell,9,12,45,68,"In wild-type mice, but not mice incapable of antigen-specific T cell responses, cIAP1/2 antagonism reduces tumor burden by increasing phagocytosis of live tumor cells.",34011631_5,-1,-1,-1,-1,42298,-1,0.45509025,0.003318904,0.54159087
42300,tumor cells,24,26,155,166,"In wild-type mice, but not mice incapable of antigen-specific T cell responses, cIAP1/2 antagonism reduces tumor burden by increasing phagocytosis of live tumor cells.",34011631_5,-1,-1,-1,-1,42300,-1,0.004546549,0.3450571,0.65039635
42304,tumors that,15,17,99,110,"Thus, activation of noncanonical NF-B stimulates a T cell-macrophage axis that curtails growth of tumors that are resistant to checkpoint blockade because of loss of MHC class I or IFN- sensing.",34011631_7,-1,-1,-1,-1,42304,-1,1.8526182e-05,0.9999708,1.06216685e-05
42309,the MYCN,4,6,29,37,"BACKGROUND: Amplification of the MYCN oncogene is a molecular hallmark of aggressive neuroblastoma (NB), a childhood cancer of the sympathetic nervous system.",34016720_0,-1,-1,-1,-1,42309,-1,2.7740822e-05,0.9999596,1.2690526e-05
42312,that MYCN,3,5,18,27,There is evidence that MYCN promotes a non-inflamed and T-cell infiltration-poor ('cold') tumor microenvironment (TME) by suppressing interferon signaling.,34016720_1,-1,-1,-1,-1,42312,-1,2.8365575e-05,0.99996066,1.0991403e-05
42313,T-cell,9,10,56,62,There is evidence that MYCN promotes a non-inflamed and T-cell infiltration-poor ('cold') tumor microenvironment (TME) by suppressing interferon signaling.,34016720_1,-1,1,2,-1,42313,-1,3.7223825e-05,5.332433e-05,0.9999095
42319,therapy,26,27,136,143,"This may explain, at least in part, why patients with NB seem to have little benefit from single-agent immune checkpoint blockade (ICB) therapy.",34016720_2,0,1,-1,-1,42319,-1,2.5134796e-05,0.9999615,1.3315193e-05
42320,Targeting MYCN,0,2,0,14,Targeting MYCN or its effectors could be a strategy to convert a cold TME into a 'hot' (inflamed) TME and improve the efficacy of ICB therapy.,34016720_3,-1,-1,-1,-1,42320,-1,3.5535242e-05,0.9999466,1.7811079e-05
42325,therapy,29,30,134,141,Targeting MYCN or its effectors could be a strategy to convert a cold TME into a 'hot' (inflamed) TME and improve the efficacy of ICB therapy.,34016720_3,0,1,-1,-1,42325,-1,2.386185e-05,0.99996555,1.0641576e-05
42328,T-cell,13,14,81,87,METHODS: NB transcriptome analyses were used to identify epigenetic drivers of a T-cell infiltration-poor TME.,34016720_4,-1,1,2,-1,42328,-1,3.8864066e-05,4.6254445e-05,0.9999149
42330,cells to,6,8,41,49,"Biological and molecular responses of NB cells to epigenetic drugs and interferon (IFN)- exposure were assessed by proliferation assays, immunoblotting, ELISA, qRT-PCR, RNA-seq and ChIP-qPCR as well as co-culture assays with T cells.",34016720_5,-1,-1,-1,-1,42330,-1,0.0038479557,0.15090086,0.84525114
42333,the MYCN-driven,23,25,145,160,"RESULTS: We identified H3K9 euchromatic histone-lysine methyltransferases EHMT2 and EHMT1, also known as G9a and GLP, as epigenetic effectors of the MYCN-driven malignant phenotype and repressors of IFN- transcriptional responses in NB cells.",34016720_6,-1,-1,-1,-1,42333,-1,2.9841689e-05,0.99995625,1.3862211e-05
42334,IFN- transcriptional,30,32,199,220,"RESULTS: We identified H3K9 euchromatic histone-lysine methyltransferases EHMT2 and EHMT1, also known as G9a and GLP, as epigenetic effectors of the MYCN-driven malignant phenotype and repressors of IFN- transcriptional responses in NB cells.",34016720_6,-1,-1,-1,-1,42334,-1,0.996865,0.0020452125,0.001089879
42337,the Th1-type chemokines,6,9,53,76,"EHMT inhibitors enhanced IFN--induced expression of the Th1-type chemokines CXCL9 and CXCL10, key factors of T-cell recruitment into the TME.",34016720_7,-1,-1,-1,-1,42337,-1,0.016558353,0.9813865,0.002055178
42339,factors,14,15,99,106,"EHMT inhibitors enhanced IFN--induced expression of the Th1-type chemokines CXCL9 and CXCL10, key factors of T-cell recruitment into the TME.",34016720_7,0,1,-1,-1,42339,-1,0.00077854434,0.99875736,0.0004641347
42340,T-cell,16,17,110,116,"EHMT inhibitors enhanced IFN--induced expression of the Th1-type chemokines CXCL9 and CXCL10, key factors of T-cell recruitment into the TME.",34016720_7,-1,1,2,-1,42340,-1,3.414242e-05,4.376705e-05,0.99992216
42341,the TME,19,21,134,141,"EHMT inhibitors enhanced IFN--induced expression of the Th1-type chemokines CXCL9 and CXCL10, key factors of T-cell recruitment into the TME.",34016720_7,-1,-1,-1,-1,42341,-1,2.533421e-05,0.99996185,1.2863091e-05
42345,to IFN-,30,32,189,197,"In MYCN-amplified NB cells, co-inhibition of EZH2 (enhancer of zeste homologue 2), a H3K27 histone methyltransferase cooperating with EHMTs, was needed for strong transcriptional responses to IFN-, in line with histone mark changes at CXCL9 and CXCL10 chemokine gene loci.",34016720_8,-1,-1,-1,-1,42345,-1,0.9490088,0.047722768,0.0032682996
42346,CXCL10 chemokine gene,42,45,246,267,"In MYCN-amplified NB cells, co-inhibition of EZH2 (enhancer of zeste homologue 2), a H3K27 histone methyltransferase cooperating with EHMTs, was needed for strong transcriptional responses to IFN-, in line with histone mark changes at CXCL9 and CXCL10 chemokine gene loci.",34016720_8,-1,-1,-1,-1,42346,-1,0.9915531,0.0032647036,0.0051820725
42352,T-cell-infiltrated TME,35,37,225,247,"CONCLUSION: Our results delineate a strategy for targeted epigenetic immunomodulation of high-risk NBs, whereby EHMT inhibitors alone or in combination with EZH2 inhibitors (in particular, MYCN-amplified NBs) could promote a T-cell-infiltrated TME via enhanced Th1-type chemokine expression.",34016720_10,-1,-1,-1,-1,42352,-1,0.0021406505,0.0805848,0.9172745
42353,Th1-type chemokine,39,41,261,279,"CONCLUSION: Our results delineate a strategy for targeted epigenetic immunomodulation of high-risk NBs, whereby EHMT inhibitors alone or in combination with EZH2 inhibitors (in particular, MYCN-amplified NBs) could promote a T-cell-infiltrated TME via enhanced Th1-type chemokine expression.",34016720_10,-1,-1,-1,-1,42353,-1,0.06563418,0.90359753,0.030768301
42355,the tumor,8,10,41,50,"The immune system is a fine modulator of the tumor biology supporting or inhibiting its progression, growth, invasion and conveys the pharmacological treatment effect.",34070750_0,-1,-1,-1,-1,42355,-1,2.5459272e-05,0.9999634,1.1140347e-05
42363,the cellular,30,32,179,191,"Tumors, on their side, have developed escaping mechanisms from the immune system action ranging from the direct secretion of biochemical signals to an indirect reaction, in which the cellular actors of the tumor microenvironment (TME) collaborate to mechanically condition the extracellular matrix (ECM) making it inhospitable to immune cells.",34070750_1,-1,-1,-1,-1,42363,-1,0.0033354457,0.39543408,0.60123056
42364,the tumor,34,36,202,211,"Tumors, on their side, have developed escaping mechanisms from the immune system action ranging from the direct secretion of biochemical signals to an indirect reaction, in which the cellular actors of the tumor microenvironment (TME) collaborate to mechanically condition the extracellular matrix (ECM) making it inhospitable to immune cells.",34070750_1,-1,-1,-1,-1,42364,-1,2.0812515e-05,0.9999683,1.0905223e-05
42375,innate immunity cells,26,29,162,183,"TME is composed of several cell lines besides cancer cells, including tumor-associated macrophages, cancer-associated fibroblasts, CD4+ and CD8+ lymphocytes, and innate immunity cells.",34070750_2,-1,-1,-1,-1,42375,-1,0.2007134,0.0028940358,0.79639256
42387,therapy,35,36,169,176,"The presence or absence, in particular, of cytotoxic CD8+ cells in the vicinity of the main tumor mass, is able to predict, respectively, the success or failure of drug therapy.",34070750_4,0,1,-1,-1,42387,-1,2.7159811e-05,0.9999597,1.3111588e-05
42393,to the,33,35,184,190,"Among various mechanisms of immunescaping, in this study, we characterized the modulation of the phenotypic profile of CD4+ and CD8+ cells in resting and activated states, in response to the mechanical pressure exerted by a three-dimensional in vitro system, able to recapitulate the rheological and stiffness properties of the tumor ECM.",34070750_5,-1,-1,-1,-1,42393,-1,1.9963445e-05,0.9999713,8.732452e-06
42397,the tumor,54,56,324,333,"Among various mechanisms of immunescaping, in this study, we characterized the modulation of the phenotypic profile of CD4+ and CD8+ cells in resting and activated states, in response to the mechanical pressure exerted by a three-dimensional in vitro system, able to recapitulate the rheological and stiffness properties of the tumor ECM.",34070750_5,-1,-1,-1,-1,42397,-1,1.9405807e-05,0.9999697,1.08845e-05
42402,immunity,14,15,90,98,Interleukin 9 (IL-9)-producing helper T (Th9) cells are essential for inducing anti-tumor immunity and inflammation in allergic and autoimmune diseases.,34075041_0,0,-1,2,-1,42402,-1,0.999014,0.0006672315,0.0003186417
42403,transcription factors that,1,4,9,35,"Although transcription factors that are essential for Th9 cell differentiation have been identified, other signaling pathways that are required for their generation and functions are yet to be explored.",34075041_1,-1,-1,-1,-1,42403,-1,2.3034521e-05,0.9999635,1.3471572e-05
42404,Th9 cell,7,9,54,62,"Although transcription factors that are essential for Th9 cell differentiation have been identified, other signaling pathways that are required for their generation and functions are yet to be explored.",34075041_1,-1,-1,-1,-1,42404,-1,6.490475e-05,0.00013456454,0.9998005
42406,their generation,21,23,148,164,"Although transcription factors that are essential for Th9 cell differentiation have been identified, other signaling pathways that are required for their generation and functions are yet to be explored.",34075041_1,-1,-1,-1,-1,42406,-1,2.5660416e-05,0.99995935,1.5021441e-05
42407,functions,24,25,169,178,"Although transcription factors that are essential for Th9 cell differentiation have been identified, other signaling pathways that are required for their generation and functions are yet to be explored.",34075041_1,0,1,2,-1,42407,-1,5.4107895e-05,0.99991906,2.680265e-05
42410,Growth Factor Receptor,6,9,33,55,"Here, we identify that Epidermal Growth Factor Receptor (EGFR) is essential for IL-9 induction in helper T (Th) cells.",34075041_2,-1,-1,-1,-1,42410,-1,0.10435711,0.28232843,0.61331445
42416,Th9 cells,17,19,84,93,"Moreover, amphiregulin (Areg), an EGFR ligand, is critical for the amplification of Th9 cells induced by TGF-1 and IL-4.",34075041_3,-1,-1,-1,-1,42416,-1,0.00015954394,0.0007958603,0.9990445
42420,transactivates IL-9,14,16,83,102,"Furthermore, our data show that Areg-EGFR signaling induces HIF1, which binds and transactivates IL-9 and NOS2 promoters in Th9 cells.",34075041_4,-1,-1,-1,-1,42420,-1,0.14670174,0.84916544,0.004132857
42421,Th9 cells,20,22,125,134,"Furthermore, our data show that Areg-EGFR signaling induces HIF1, which binds and transactivates IL-9 and NOS2 promoters in Th9 cells.",34075041_4,-1,-1,-1,-1,42421,-1,0.00026552487,0.002260573,0.9974739
42423,Th9 cell,6,8,32,40,Loss of EGFR or HIF1 abrogates Th9 cell differentiation and suppresses their anti-tumor functions.,34075041_5,-1,-1,-1,-1,42423,-1,8.300517e-05,0.00018233426,0.9997347
42425,functions,13,14,89,98,Loss of EGFR or HIF1 abrogates Th9 cell differentiation and suppresses their anti-tumor functions.,34075041_5,0,1,2,-1,42425,-1,0.00023517545,0.99959487,0.00016991746
42428,Th9 cells,14,16,83,92,"Moreover, in line with its reliance on HIF1 expression, metabolomics profiling of Th9 cells revealed that Succinate, a TCA cycle metabolite, promotes Th9 cell differentiation and Th9 cell-mediated tumor regression.",34075041_6,-1,-1,-1,-1,42428,-1,4.7785226e-05,8.818333e-05,0.999864
42431,Th9 cell,26,28,151,159,"Moreover, in line with its reliance on HIF1 expression, metabolomics profiling of Th9 cells revealed that Succinate, a TCA cycle metabolite, promotes Th9 cell differentiation and Th9 cell-mediated tumor regression.",34075041_6,-1,-1,-1,-1,42431,-1,5.008978e-05,7.9804515e-05,0.99987006
42432,Th9 cell-mediated tumor,30,33,180,203,"Moreover, in line with its reliance on HIF1 expression, metabolomics profiling of Th9 cells revealed that Succinate, a TCA cycle metabolite, promotes Th9 cell differentiation and Th9 cell-mediated tumor regression.",34075041_6,-1,-1,-1,-1,42432,-1,0.0016508643,0.08088686,0.9174623
42446,The tumor,2,4,9,18,Methods: The tumor growth of the syngeneic mouse allograft in wild type or Rab37 knockout mice was analyzed.,34093869_3,-1,-1,-1,-1,42446,-1,1.879168e-05,0.9999714,9.829114e-06
42454,the protein,7,9,68,79,"Multiplex fluorescence immunohistochemistry was performed to detect the protein level of Rab37, IL-6 and PD-1 and localization of the tumor-infiltrating immune cells in allografts from mice or tumor specimens from lung cancer patients.",34093869_6,-1,-1,-1,-1,42454,-1,2.058472e-05,0.99996734,1.2133246e-05
42456,the tumor-infiltrating,19,21,130,152,"Multiplex fluorescence immunohistochemistry was performed to detect the protein level of Rab37, IL-6 and PD-1 and localization of the tumor-infiltrating immune cells in allografts from mice or tumor specimens from lung cancer patients.",34093869_6,-1,-1,-1,-1,42456,-1,3.6654445e-05,0.9999343,2.9026018e-05
42462,to trigger,17,19,108,118,Results: We revealed that Rab37 regulates the secretion of IL-6 in a GTPase-dependent manner in macrophages to trigger M2 polarization.,34093869_7,-1,-1,-1,-1,42462,-1,2.2051294e-05,0.9999676,1.0415737e-05
42469,T cells that,18,21,124,136,"Clinically, tumors with high stromal Rab37 and IL-6 expression coincide with tumor infiltrating M2-macrophages and PD1+CD8+ T cells that predicts poor prognosis in lung cancer patients.",34093869_9,-1,-1,-1,-1,42469,-1,0.0018775618,0.034622263,0.96350014
42470,in plasma IL-6,9,12,51,65,"In addition, lung cancer patients with an increase in plasma IL-6 level are found to be associated with immunotherapeutic resistance.",34093869_10,-1,-1,-1,-1,42470,-1,0.1307115,0.85062796,0.018660547
42478,transcription regulation to foster,8,12,71,105,Conclusions: Rab37/IL-6 trafficking pathway links with IL-6/STAT3/PD-1 transcription regulation to foster an immunosuppressive TME and combined IL-6/CTLA-4 blockade therapy exerts potent anti-tumor efficacy.,34093869_12,-1,-1,-1,-1,42478,-1,2.5121803e-05,0.99995947,1.5418562e-05
42480,therapy,19,20,165,172,Conclusions: Rab37/IL-6 trafficking pathway links with IL-6/STAT3/PD-1 transcription regulation to foster an immunosuppressive TME and combined IL-6/CTLA-4 blockade therapy exerts potent anti-tumor efficacy.,34093869_12,0,1,-1,-1,42480,-1,2.2103584e-05,0.99996626,1.1670252e-05
42486,immunity,15,16,89,97,"T regulatory (Treg) cells are crucial to maintain immune tolerance and repress antitumor immunity, but the mechanisms governing their cellular redox homeostasis remain elusive.",34133924_0,0,-1,2,-1,42486,-1,0.996912,0.0026945607,0.00039339165
42488,their cellular,21,23,128,142,"T regulatory (Treg) cells are crucial to maintain immune tolerance and repress antitumor immunity, but the mechanisms governing their cellular redox homeostasis remain elusive.",34133924_0,-1,-1,-1,-1,42488,-1,0.005207297,0.50761694,0.48717576
42491,immunity,23,24,154,162,We report that glutathione peroxidase 4 (Gpx4) prevents Treg cells from lipid peroxidation and ferroptosis in regulating immune homeostasis and antitumor immunity.,34133924_1,0,-1,2,-1,42491,-1,0.99841106,0.0012201183,0.00036879236
42507,immunity,13,14,107,115,"Furthermore, Treg-specific ablation of Gpx4 represses tumor growth and concomitantly potentiates antitumor immunity.",34133924_6,0,-1,2,-1,42507,-1,0.9991115,0.000599376,0.00028920366
42514,The tumor,0,2,0,9,"The tumor microenvironment (TME) of PCa is involved in the emergence of immunosuppressive factors such as myeloid-derived suppressor cells (MDSC), which regulate the immune system by several mechanisms, including interleukin (IL)-10 production.",34184811_1,-1,-1,-1,-1,42514,-1,1.8536703e-05,0.9999721,9.370438e-06
42517,factors,15,16,90,97,"The tumor microenvironment (TME) of PCa is involved in the emergence of immunosuppressive factors such as myeloid-derived suppressor cells (MDSC), which regulate the immune system by several mechanisms, including interleukin (IL)-10 production.",34184811_1,0,1,-1,-1,42517,-1,0.06334854,0.9338719,0.0027795827
42528,that the,3,5,24,32,This study demonstrated that the frequency of CD33+ pSTAT3+ MDSC and IL-17+ lymphocyte as well as IL-10 messenger RNA (mRNA) expression were significantly higher in the PCa patients than in the benign prostatic hyperplasia (BPH) group.,34184811_3,-1,-1,-1,-1,42528,-1,1.5818867e-05,0.9999759,8.242581e-06
42541,that the,2,4,13,21,We suggested that the higher frequency of CD33+ pSTAT3+ MDSC and IL-17+ lymphocyte and the more frequent expression of IL-10 mRNA in PCa patients may play roles in tumor progression from BPH to PCa.,34184811_5,-1,-1,-1,-1,42541,-1,1.7754697e-05,0.9999728,9.449128e-06
42551,to the,4,6,39,45,"SOX11 oncogenic expression contributes to the aggressiveness of these tumors by different mechanisms, including tumor and stromal cell interactions.",34189576_1,-1,-1,-1,-1,42551,-1,2.5986737e-05,0.9999609,1.3144555e-05
42552,these tumors,8,10,64,76,"SOX11 oncogenic expression contributes to the aggressiveness of these tumors by different mechanisms, including tumor and stromal cell interactions.",34189576_1,-1,-1,-1,-1,42552,-1,2.195043e-05,0.99996555,1.2559462e-05
42558,relationship to SOX11,15,18,90,111,"However, the precise composition of the immune cell microenvironment of MCL, its possible relationship to SOX11 expression, and how it may contribute to tumor behavior is not well known.",34189576_2,-1,-1,-1,-1,42558,-1,9.0138e-05,0.99984753,6.234573e-05
42559,to tumor,25,27,150,158,"However, the precise composition of the immune cell microenvironment of MCL, its possible relationship to SOX11 expression, and how it may contribute to tumor behavior is not well known.",34189576_2,-1,-1,-1,-1,42559,-1,2.9988008e-05,0.99995697,1.3046144e-05
42560,transcriptome analysis,6,8,34,56,"Here, we performed an integrative transcriptome analysis of 730 immune-related genes combined with the immune cell phenotype analysis by immunohistochemistry in SOX11+ and SOX11- primary nodal MCL cases and non-neoplastic reactive lymph nodes.",34189576_3,-1,-1,-1,-1,42560,-1,3.0257304e-05,0.9999497,2.0086763e-05
42564,analysis,18,19,125,133,"Here, we performed an integrative transcriptome analysis of 730 immune-related genes combined with the immune cell phenotype analysis by immunohistochemistry in SOX11+ and SOX11- primary nodal MCL cases and non-neoplastic reactive lymph nodes.",34189576_3,0,1,-1,-1,42564,-1,3.872785e-05,0.9999211,4.0215637e-05
42569,T-cell,7,8,35,41,SOX11+ MCL had a significant lower T-cell intratumoral infiltration compared with negative cases.,34189576_4,-1,1,2,-1,42569,-1,3.335948e-05,4.9659528e-05,0.9999169
42570,T-cell,6,7,41,47,A reduced expression of MHCI/II-like and T-cell costimulation and signaling activation related transcripts was significantly associated with poor clinical outcome.,34189576_5,-1,1,2,-1,42570,-1,4.5592566e-05,5.5832632e-05,0.9998987
42571,related transcripts,11,13,87,106,A reduced expression of MHCI/II-like and T-cell costimulation and signaling activation related transcripts was significantly associated with poor clinical outcome.,34189576_5,-1,-1,-1,-1,42571,-1,4.6331716e-05,0.9999056,4.8030648e-05
42573,target gene,9,11,47,58,"Moreover, we identified CD70 as a SOX11 direct target gene, whose overexpression was induced in SOX11+, but not SOX11- tumor cells by CD40L in vitro.",34189576_6,-1,-1,-1,-1,42573,-1,2.5775458e-05,0.99995995,1.42580375e-05
42575,SOX11- tumor cells,22,25,112,130,"Moreover, we identified CD70 as a SOX11 direct target gene, whose overexpression was induced in SOX11+, but not SOX11- tumor cells by CD40L in vitro.",34189576_6,-1,-1,-1,-1,42575,-1,0.002494849,0.9274264,0.07007874
42578,the tumor,17,19,95,104,"CD70 was overexpressed in primary SOX11+ MCL and it was associated with an immune unbalance of the tumor microenvironment characterized by increased number of effector regulatory t (Treg) cell infiltration, higher proliferation, and aggressive clinical course.",34189576_7,-1,-1,-1,-1,42578,-1,2.1499374e-05,0.99996877,9.7903e-06
42583,that SOX11,5,7,29,39,"Overall, our results suggest that SOX11 expression in MCL is associated with an immunosuppressive microenvironment characterized by CD70 overexpression in tumor cells, increased Treg cell infiltration and downmodulation of antigen processing, and presentation and T-cell activation that could promote MCL progression and represent a potential target for tailored therapies.",34189576_9,-1,-1,-1,-1,42583,-1,4.0198745e-05,0.99994254,1.7206707e-05
42584,tumor cells,21,23,155,166,"Overall, our results suggest that SOX11 expression in MCL is associated with an immunosuppressive microenvironment characterized by CD70 overexpression in tumor cells, increased Treg cell infiltration and downmodulation of antigen processing, and presentation and T-cell activation that could promote MCL progression and represent a potential target for tailored therapies.",34189576_9,-1,-1,-1,-1,42584,-1,0.0036862819,0.3164583,0.6798554
42587,T-cell activation that,37,40,264,286,"Overall, our results suggest that SOX11 expression in MCL is associated with an immunosuppressive microenvironment characterized by CD70 overexpression in tumor cells, increased Treg cell infiltration and downmodulation of antigen processing, and presentation and T-cell activation that could promote MCL progression and represent a potential target for tailored therapies.",34189576_9,-1,-1,-1,-1,42587,-1,0.0011703469,0.015724028,0.9831057
42589,tailored therapies,50,52,354,372,"Overall, our results suggest that SOX11 expression in MCL is associated with an immunosuppressive microenvironment characterized by CD70 overexpression in tumor cells, increased Treg cell infiltration and downmodulation of antigen processing, and presentation and T-cell activation that could promote MCL progression and represent a potential target for tailored therapies.",34189576_9,-1,-1,-1,-1,42589,-1,3.5328343e-05,0.99994946,1.5272795e-05
42601,immunity,27,28,175,183,"OBJECTIVES: We aimed to pulsate lymphocytes of breast cancer patients and normal individuals, using Diospyros peregrina fruit preparation (DFP) to study the cancer-protective immunity, and the signal transduction processes involved with it.",34190692_2,0,-1,2,-1,42601,-1,0.9993094,0.00037376324,0.0003167299
42605,the release,8,10,40,51,"We also investigated the role of DFP in the release of lymphocytic nitric oxide (NO), which is a key tumoricidal agent, known to regulate T-cell proliferation, cytokine production, cell signaling, and apoptosis.",34190692_3,-1,-1,-1,-1,42605,-1,1.9389527e-05,0.9999696,1.0993535e-05
42613,the blood,11,13,86,95,"METHODS: Using Ficoll-Hypaque gradient centrifugation, lymphocytes were isolated from the blood of 12 patients and 12 normal individuals.",34190692_4,-1,-1,-1,-1,42613,-1,4.195847e-05,0.99990225,5.5838744e-05
42632,T-Box Transcription Factor 21,26,30,125,154,"DFP also noticeably enhances the expression of T helper (TH) cell 1 specific interferon-gamma (IFNG), interleukin 12 (IL12), T-Box Transcription Factor 21 (TBX21) and signal transducer and activator of transcription 1 (STAT1) genes.",34190692_8,-1,-1,-1,-1,42632,-1,3.08103e-05,0.99993265,3.6483467e-05
42633,TBX21,31,32,156,161,"DFP also noticeably enhances the expression of T helper (TH) cell 1 specific interferon-gamma (IFNG), interleukin 12 (IL12), T-Box Transcription Factor 21 (TBX21) and signal transducer and activator of transcription 1 (STAT1) genes.",34190692_8,-1,1,2,-1,42633,-1,4.7627604e-05,0.9999045,4.7790993e-05
42639,immunity,6,7,55,63,"DFP treatment significantly increases tumor protective immunity by decreasing the expression levels of TH2 network-specific GATA3 and interleukin 4 (IL4) genes but increasing the expression levels of TH1 network-specific IFNG, IL12, TBX21, and STAT1 genes.",34190692_9,0,-1,2,-1,42639,-1,0.9981528,0.0013997938,0.00044738667
42649,TBX21,35,36,233,238,"DFP treatment significantly increases tumor protective immunity by decreasing the expression levels of TH2 network-specific GATA3 and interleukin 4 (IL4) genes but increasing the expression levels of TH1 network-specific IFNG, IL12, TBX21, and STAT1 genes.",34190692_9,-1,1,2,-1,42649,-1,0.00031001857,0.99952424,0.00016573617
42650,STAT1 genes,38,40,244,255,"DFP treatment significantly increases tumor protective immunity by decreasing the expression levels of TH2 network-specific GATA3 and interleukin 4 (IL4) genes but increasing the expression levels of TH1 network-specific IFNG, IL12, TBX21, and STAT1 genes.",34190692_9,-1,-1,-1,-1,42650,-1,2.7124737e-05,0.9999473,2.5587871e-05
42656,immunity,20,21,125,133,CONCLUSION: DFP increases the expression levels of TH1 specific network genes which in turn help in evoking tumor protective immunity.,34190692_10,0,-1,2,-1,42656,-1,0.99948597,0.00033200806,0.00018195543
42658,transforming growth factor,7,10,34,60,"v8 integrin, a key activator of transforming growth factor  (TGF-), inhibits anti-tumor immunity.",34233193_0,-1,-1,-1,-1,42658,-1,0.8844797,0.110641174,0.0048791086
42660,immunity,17,18,92,100,"v8 integrin, a key activator of transforming growth factor  (TGF-), inhibits anti-tumor immunity.",34233193_0,0,-1,2,-1,42660,-1,0.99893945,0.0007655683,0.00029493423
42673,tumor cell,22,24,128,138,"ADWA-11 increases expression of a suite of genes in tumor-infiltrating CD8+ Tcells normally inhibited by TGF- and involved in tumor cell killing, including granzyme B and interferon-.",34233193_3,-1,-1,-1,-1,42673,-1,0.004487841,0.36330158,0.63221055
42688,that the,13,15,66,74,"In this study, in accordance with our previous findings, we found that the expression of NFAT2 and pri-miR-17~92 are lower in peripheral blood CD3+ T cells from chronic myelogenous leukemia (CML) patients by gene expression analysis.",34237654_2,-1,-1,-1,-1,42688,-1,1.7352108e-05,0.99997437,8.235779e-06
42689,blood,28,29,139,144,"In this study, in accordance with our previous findings, we found that the expression of NFAT2 and pri-miR-17~92 are lower in peripheral blood CD3+ T cells from chronic myelogenous leukemia (CML) patients by gene expression analysis.",34237654_2,0,1,-1,-1,42689,-1,4.373999e-05,0.9998969,5.938577e-05
42692,analysis,44,45,226,234,"In this study, in accordance with our previous findings, we found that the expression of NFAT2 and pri-miR-17~92 are lower in peripheral blood CD3+ T cells from chronic myelogenous leukemia (CML) patients by gene expression analysis.",34237654_2,0,1,-1,-1,42692,-1,3.3472665e-05,0.9999366,2.9888068e-05
42693,that the,3,5,23,31,"We further demonstrate that the NFAT2-induced activation, differentiation, and expression of cytokines in human umbilical cord blood CD8+ nave T cells are miR-20a-5p dependent.",34237654_3,-1,-1,-1,-1,42693,-1,1.865375e-05,0.9999715,9.780716e-06
42695,blood,18,19,127,132,"We further demonstrate that the NFAT2-induced activation, differentiation, and expression of cytokines in human umbilical cord blood CD8+ nave T cells are miR-20a-5p dependent.",34237654_3,0,1,-1,-1,42695,-1,6.470071e-05,0.9998704,6.481212e-05
42697,the relationship,4,6,31,47,We also preliminarily explored the relationship between NFAT2 and miR-20a-5p in naive T cells.,34237654_4,-1,-1,-1,-1,42697,-1,2.0524682e-05,0.99996746,1.2068139e-05
42698,naive T cells,11,14,80,93,We also preliminarily explored the relationship between NFAT2 and miR-20a-5p in naive T cells.,34237654_4,-1,-1,-1,-1,42698,-1,0.0032334316,0.11829329,0.8784733
42701,functional,11,12,72,82,These results suggest that NFAT2 and miR-20a are crucial for regulating functional CD8+ T cells.,34237654_5,0,1,2,-1,42701,-1,3.5621073e-05,0.9999453,1.9111973e-05
42704,related to CD8+ T cell,6,12,38,60,"Additionally, their alteration may be related to CD8+ T cell dysfunction in CML patients; thus, NFAT2 and miR-20a-5p may be considered potential targets for revising T cell function in leukemia immunotherapy.",34237654_6,-1,-1,-1,-1,42704,-1,0.0048763747,0.17849462,0.81662905
42707,T cell function,29,32,166,181,"Additionally, their alteration may be related to CD8+ T cell dysfunction in CML patients; thus, NFAT2 and miR-20a-5p may be considered potential targets for revising T cell function in leukemia immunotherapy.",34237654_6,-1,-1,-1,-1,42707,-1,4.007675e-05,5.4741864e-05,0.9999052
42711,deficiency,18,19,134,144,"In this study, we investigate mechanisms leading to inflammation and immunoreactivity in ovarian tumors with homologous recombination deficiency (HRD).",34289354_0,0,1,-1,-1,42711,-1,0.0011504062,0.9976387,0.0012108537
42713,to transcriptional,6,8,28,46,BRCA1 loss is found to lead to transcriptional reprogramming in tumor cells and cell-intrinsic inflammation involving type I interferon (IFN) and stimulator of IFN genes (STING).,34289354_1,-1,-1,-1,-1,42713,-1,2.2402724e-05,0.99996793,9.620646e-06
42714,tumor cells,10,12,64,75,BRCA1 loss is found to lead to transcriptional reprogramming in tumor cells and cell-intrinsic inflammation involving type I interferon (IFN) and stimulator of IFN genes (STING).,34289354_1,-1,-1,-1,-1,42714,-1,0.003756503,0.51210636,0.48413712
42719,IFN genes,25,27,160,169,BRCA1 loss is found to lead to transcriptional reprogramming in tumor cells and cell-intrinsic inflammation involving type I interferon (IFN) and stimulator of IFN genes (STING).,34289354_1,-1,-1,-1,-1,42719,-1,0.9941438,0.0041863574,0.0016698313
42721,thus Tcell,6,10,36,47,BRCA1-mutated (BRCA1mut) tumors are thus Tcell inflamed at baseline.,34289354_2,-1,-1,-1,-1,42721,-1,0.004002492,0.104311705,0.8916858
42742,analysis to,7,9,44,55,"Herein, we carried out flow cytometry-based analysis to readdress issues on NK and T lymphocyte subsets in women with advanced EOC, additionally evaluating phenotypic modulation of their intracellular pathways involved in interleukin (IL)-2 and IL-15 signaling.",34359872_3,-1,-1,-1,-1,42742,-1,2.4905648e-05,0.9999602,1.4929607e-05
42748,IL-10 than,22,24,144,154,"Results depicted ascites as an inflammatory and immunosuppressive environment, presenting significantly (p < 0.0001) higher amounts of IL-6 and IL-10 than in the patients' blood, as well as significantly (p < 0.05) increased expression of checkpoint inhibitory receptors (programmed death protein-1, PD-1) and ectonucleotidase (CD39) on T lymphocytes.",34359872_4,-1,-1,-1,-1,42748,-1,0.993807,0.0036243203,0.0025687413
42750,blood,28,29,172,177,"Results depicted ascites as an inflammatory and immunosuppressive environment, presenting significantly (p < 0.0001) higher amounts of IL-6 and IL-10 than in the patients' blood, as well as significantly (p < 0.05) increased expression of checkpoint inhibitory receptors (programmed death protein-1, PD-1) and ectonucleotidase (CD39) on T lymphocytes.",34359872_4,0,1,-1,-1,42750,-1,0.0001667833,0.99935085,0.0004823996
42751,receptors,44,45,261,270,"Results depicted ascites as an inflammatory and immunosuppressive environment, presenting significantly (p < 0.0001) higher amounts of IL-6 and IL-10 than in the patients' blood, as well as significantly (p < 0.05) increased expression of checkpoint inhibitory receptors (programmed death protein-1, PD-1) and ectonucleotidase (CD39) on T lymphocytes.",34359872_4,0,1,2,-1,42751,-1,0.00012358262,0.0005301299,0.9993463
42752,protein-1,48,49,289,298,"Results depicted ascites as an inflammatory and immunosuppressive environment, presenting significantly (p < 0.0001) higher amounts of IL-6 and IL-10 than in the patients' blood, as well as significantly (p < 0.05) increased expression of checkpoint inhibitory receptors (programmed death protein-1, PD-1) and ectonucleotidase (CD39) on T lymphocytes.",34359872_4,0,1,-1,-1,42752,-1,0.00080992613,0.99555993,0.003630072
42755,blood,20,21,119,124,"However, NK lymphocytes from EOC-associated ascites showed higher (p < 0.05) pS6 phosphorylation compared with NK from blood.",34359872_5,0,1,-1,-1,42755,-1,7.664779e-05,0.9997644,0.00015891744
42759,the STAT5 protein,20,23,121,138,"Additionally, in vitro treatment of lymphocytes with IL-2 or IL-15 elicited significantly (p < 0.001) phosphorylation of the STAT5 protein in NK, CD3 and CD8 lymphocytes, both from blood and ascites.",34359872_6,-1,-1,-1,-1,42759,-1,2.2980286e-05,0.99996376,1.329051e-05
42761,blood,33,34,181,186,"Additionally, in vitro treatment of lymphocytes with IL-2 or IL-15 elicited significantly (p < 0.001) phosphorylation of the STAT5 protein in NK, CD3 and CD8 lymphocytes, both from blood and ascites.",34359872_6,0,1,-1,-1,42761,-1,7.192022e-05,0.9998142,0.00011389567
42762,lymphocytes than blood,15,18,91,113,"EOC-associated ascites had a significantly (p < 0.0001) higher proportion of NK CD56bright lymphocytes than blood, which, in addition, were more responsive (p < 0.05) to stimulation by IL-2 than CD56dim NK.",34359872_7,-1,-1,-1,-1,42762,-1,0.002106265,0.10332509,0.8945686
42766,the tumor,9,11,75,84,"EOC-associated ascites allow studies on lymphocyte phenotype modulation in the tumor environment, where inflammatory profile contrasts with the presence of immunosuppressive elements and development of cellular self-regulating mechanisms.",34359872_8,-1,-1,-1,-1,42766,-1,2.1060427e-05,0.9999697,9.227807e-06
42786,the STAT3,30,32,165,174,"Our results indicate that germline variation in DPF3, a component of the BAF complex, part of the SWI/SNF complexes, can lead to reduced apoptosis and activation of the STAT3 pathway, both critical in RCC carcinogenesis.",34390653_4,-1,-1,-1,-1,42786,-1,2.1509168e-05,0.99996555,1.2959625e-05
42791,tumor cytokine,25,27,156,170,"In addition, we show that altered DPF3 expression in the 14q24 RCC locus could influence the effectiveness of immunotherapy treatment for RCC by regulating tumor cytokine secretion and immune cell activation.",34390653_5,-1,-1,-1,-1,42791,-1,0.26900885,0.72679734,0.004193753
42793,that the,4,6,32,40,Accumulating evidence has shown that the cystathionine -synthase/hydrogen sulfide (CBS/H2S) axis is involved in the regulation of inflammation.,34413167_1,-1,-1,-1,-1,42793,-1,1.721465e-05,0.99997485,7.891836e-06
42794,the regulation,16,18,113,127,Accumulating evidence has shown that the cystathionine -synthase/hydrogen sulfide (CBS/H2S) axis is involved in the regulation of inflammation.,34413167_1,-1,-1,-1,-1,42794,-1,2.0052326e-05,0.99997044,9.502022e-06
42797,tumor cells,9,11,42,53,"Here, we investigated the roles of CBS in tumor cells and tumor microenvironment of HCC.METHODS: 236 HCC samples were collected to detect the expression of CBS, cleaved Caspase-3 and paired related homeobox 2 (PRRX2) and the number of immune cells.",34413167_3,-1,-1,-1,-1,42797,-1,0.0032723674,0.321525,0.67520267
42801,related homeobox,33,35,190,206,"Here, we investigated the roles of CBS in tumor cells and tumor microenvironment of HCC.METHODS: 236 HCC samples were collected to detect the expression of CBS, cleaved Caspase-3 and paired related homeobox 2 (PRRX2) and the number of immune cells.",34413167_3,-1,-1,-1,-1,42801,-1,8.5697175e-05,0.999859,5.5351364e-05
42810,functions,24,25,154,163,"Cbs heterozygous knockout mice, C57BL/6 mice, nude mice and non-obese diabetic severe combined immunodeficiency mice were used to investigate the in vivo functions of CBS.RESULTS: Downregulation of CBS was observed in HCC, and low expression of CBS predicted poor prognosis in HCC patients.",34413167_5,0,1,2,-1,42810,-1,4.7095367e-05,0.9999248,2.811619e-05
42815,tumor-infiltrating Tregs,10,12,61,85,"Activation of the Cbs/H2S axis also reduced the abundance of tumor-infiltrating Tregs, while Cbs deficiency promoted Tregs-mediated immune evasion and boosted tumor growth in Cbs heterozygous knockout mice.",34413167_7,-1,-1,-1,-1,42815,-1,3.068242e-05,0.99995434,1.4934204e-05
42816,deficiency,15,16,97,107,"Activation of the Cbs/H2S axis also reduced the abundance of tumor-infiltrating Tregs, while Cbs deficiency promoted Tregs-mediated immune evasion and boosted tumor growth in Cbs heterozygous knockout mice.",34413167_7,0,1,-1,-1,42816,-1,0.00013860068,0.9997181,0.00014320722
42820,tumor cells,9,11,69,80,"Mechanistically, CBS facilitated the expression cleaved Caspase-3 in tumor cells, and on the other hand, suppressed Foxp3 expression in Tregs via inactivating IL-6/STAT3 pathway.",34413167_8,-1,-1,-1,-1,42820,-1,0.0034991358,0.43172073,0.5647801
42828,function,22,23,126,134,"Additionally, miR-24-3p was proven to be an upstream suppressor of CBS in HCC.CONCLUSIONS: Our results indicate the antitumor function of CBS in HCC by inactivation of the PRRX2/IL-6/STAT3 pathway, which may serve as a potential target for HCC clinical immunotherapy.",34413167_10,0,1,2,-1,42828,-1,3.013971e-05,0.9999523,1.7515122e-05
42848,TCR,7,8,57,60,Single-cell TCR/RNA sequencing revealed the existence of TCR clonotypes shared between the liver and CCA tumor of a PBC host.,34495298_7,-1,1,2,-1,42848,-1,4.5731602e-05,0.9998776,7.666444e-05
42860,that CXCL10,31,33,207,218,We performed immune profiling to compare immune-related gene expression between ductal carcinoma in situ (DCIS) and invasive carcinoma of the breast using nCounter PanCancer immune Profiling Panel and found that CXCL10 was the most significant gene that had the highest difference in expression between them.,34504204_1,-1,-1,-1,-1,42860,-1,0.86558765,0.12598635,0.008425933
42862,gene that,37,39,244,253,We performed immune profiling to compare immune-related gene expression between ductal carcinoma in situ (DCIS) and invasive carcinoma of the breast using nCounter PanCancer immune Profiling Panel and found that CXCL10 was the most significant gene that had the highest difference in expression between them.,34504204_1,-1,-1,-1,-1,42862,-1,2.7120795e-05,0.99995553,1.73242e-05
42875,that CXCL10,2,4,13,24,"We confirmed that CXCL10 mRNA expression was significantly higher in invasive carcinoma than in DCIS, especially in hormone receptor (HR)-negative tumors using a validation set.",34504204_4,-1,-1,-1,-1,42875,-1,0.8592544,0.13024761,0.010497928
42883,CXCL10-positive tumors generally,22,25,139,171,"CXCL10 mRNA expression showed a positive correlation with tumor infiltrating lymphocyte (TIL) density in both DCIS and invasive carcinoma; CXCL10-positive tumors generally showed higher infiltration of CD8+and FOXP3+TILs as well as PD-L1+immune cells compared to CXCL10-negative tumors, albeit with different patterns according to HR status.",34504204_5,-1,-1,-1,-1,42883,-1,0.96590984,0.025789794,0.008300399
42886,to CXCL10-negative tumors,43,46,262,287,"CXCL10 mRNA expression showed a positive correlation with tumor infiltrating lymphocyte (TIL) density in both DCIS and invasive carcinoma; CXCL10-positive tumors generally showed higher infiltration of CD8+and FOXP3+TILs as well as PD-L1+immune cells compared to CXCL10-negative tumors, albeit with different patterns according to HR status.",34504204_5,-1,-1,-1,-1,42886,-1,0.0012646564,0.99842936,0.000305922
42889,that CXCL10,6,8,32,43,"In conclusion, our study showed that CXCL10 promotes tumor cell proliferation, invasion, and immune cell infiltration, implying its contribution in the progression of DCIS to invasive carcinoma of the breast.",34504204_6,-1,-1,-1,-1,42889,-1,0.8537137,0.13761128,0.008674992
42890,tumor cell,9,11,53,63,"In conclusion, our study showed that CXCL10 promotes tumor cell proliferation, invasion, and immune cell infiltration, implying its contribution in the progression of DCIS to invasive carcinoma of the breast.",34504204_6,-1,-1,-1,-1,42890,-1,0.0034498663,0.31650287,0.6800473
42899,their function,19,21,98,112,"Regulatory T (Treg) cells, possess a strategic role in the maintenance of immune homeostasis, and their function has been closely linked to development of diverse pathologies including autoimmunity and cancer.",34539668_0,-1,-1,-1,-1,42899,-1,3.541757e-05,0.99994266,2.1898475e-05
42903,Treg cell plasticity,1,4,9,29,"Although Treg cell plasticity comes in various flavors, the major categories enclose the loss of Foxp3 expression, which is the master regulator of Treg cell lineage, giving rise to ""ex-Treg"" cells and the ""fragile"" Treg cells in which FOXP3 expression is retained but accompanied by the engagement of an inflammatory program and attenuation of the suppressive activity.",34539668_2,-1,-1,-1,-1,42903,-1,4.051387e-05,8.956623e-05,0.99986994
42916,Treg cell plasticity,0,3,0,20,"Treg cell plasticity possess a tremendous therapeutic potential either by inducing Treg cell de-stabilization to promote anti-tumor immunity, or re-enforcing Treg cell stability to attenuate chronic inflammation.",34539668_3,-1,-1,-1,-1,42916,-1,7.091516e-05,0.0003979947,0.99953115
42917,tremendous therapeutic,5,7,31,53,"Treg cell plasticity possess a tremendous therapeutic potential either by inducing Treg cell de-stabilization to promote anti-tumor immunity, or re-enforcing Treg cell stability to attenuate chronic inflammation.",34539668_3,-1,-1,-1,-1,42917,-1,4.9893122e-05,0.99992263,2.7506578e-05
42920,immunity,17,18,132,140,"Treg cell plasticity possess a tremendous therapeutic potential either by inducing Treg cell de-stabilization to promote anti-tumor immunity, or re-enforcing Treg cell stability to attenuate chronic inflammation.",34539668_3,0,-1,2,-1,42920,-1,0.9996891,0.00017281776,0.0001381207
42924,the Treg cell plasticity,7,11,36,60,"Herein, we review the literature on the Treg cell plasticity with lessons learned in autoimmunity and cancer and discuss challenges and open questions with potential therapeutic implications.",34539668_4,-1,-1,-1,-1,42924,-1,0.0010040563,0.92478466,0.0742113
42926,receptor-positive,3,4,22,39,"BACKGROUND: Oestrogen receptor-positive (ER+) breast cancer is commonly treated using endocrine therapies such as aromatase inhibitors which block synthesis of oestradiol, but the influence of this therapy on the immune composition of breast tumours has not been fully explored.",34602068_0,0,1,2,-1,42926,-1,0.0018314293,0.9493365,0.048832096
42930,this therapy,29,31,193,205,"BACKGROUND: Oestrogen receptor-positive (ER+) breast cancer is commonly treated using endocrine therapies such as aromatase inhibitors which block synthesis of oestradiol, but the influence of this therapy on the immune composition of breast tumours has not been fully explored.",34602068_0,-1,-1,-1,-1,42930,-1,3.0459032e-05,0.99995804,1.1531237e-05
42933,that tumour,3,5,26,37,Previous findings suggest that tumour infiltrating lymphocytes and immune-related gene expression may be altered by treatment with aromatase inhibitors.,34602068_1,-1,-1,-1,-1,42933,-1,2.2715736e-05,0.9999683,9.034541e-06
42939,through tumour cells,18,21,100,120,"However, whether these changes are a direct result of impacts on the host immune system or mediated through tumour cells is not known.",34602068_2,-1,-1,-1,-1,42939,-1,0.0036993837,0.70525885,0.2910418
42951,blood,15,16,92,97,"A migration assay and flow cytometry were used to measure the migration of human peripheral blood mononuclear cells (PBMCs) to MCF-7 cells grown without the main biologically active oestrogen, oestradiol.",34602068_5,0,1,-1,-1,42951,-1,0.0001488036,0.9991061,0.0007450633
42953,to MCF-7 cells,21,24,124,138,"A migration assay and flow cytometry were used to measure the migration of human peripheral blood mononuclear cells (PBMCs) to MCF-7 cells grown without the main biologically active oestrogen, oestradiol.",34602068_5,-1,-1,-1,-1,42953,-1,0.018367518,0.15070438,0.8309281
42961,TNF,13,14,97,100,"RESULTS: This study demonstrates that oestrogen deprivation increases breast cancer secretion of TNF, CCL5, IL-6, IL-8, and CCL22 and alters total human peripheral blood mononuclear cell migration in an in vitro assay.",34602068_7,0,1,-1,-1,42961,-1,5.794228e-05,0.99991834,2.3707598e-05
42966,blood,28,29,164,169,"RESULTS: This study demonstrates that oestrogen deprivation increases breast cancer secretion of TNF, CCL5, IL-6, IL-8, and CCL22 and alters total human peripheral blood mononuclear cell migration in an in vitro assay.",34602068_7,0,1,-1,-1,42966,-1,0.0001882129,0.99810046,0.0017113566
42977,therapy,3,4,25,32,Treatment with endocrine therapy using the aromatase inhibitor letrozole increases CD4+ T cell infiltration into ER+ breast cancer tumours in immune competent mice.,34602068_10,0,1,-1,-1,42977,-1,2.7202492e-05,0.9999602,1.2655534e-05
42996,the tumor,7,9,37,46,Little is known about its effects on the tumor immune microenvironment.,34680134_1,-1,-1,-1,-1,42996,-1,2.1185526e-05,0.9999689,9.942162e-06
43006,analysis,6,7,53,61,Tumor immune composition determined by deconvolution analysis revealed significant increases in M0 macrophages and B lymphocytes in both I2 groups.,34680134_4,0,1,-1,-1,43006,-1,3.93026e-05,0.999925,3.5704867e-05
43014,factor-beta,26,27,133,144,"Real-time RT-PCR showed that I2 tumors overexpress T-BET (p = 0.019) and interferon-gamma (IFN; p = 0.020) and silence tumor growth factor-beta (TGF; p = 0.049), whereas in Cht+I2 tumors, GATA3 is silenced (p = 0.014).",34680134_5,0,1,-1,-1,43014,-1,0.9998728,4.6319943e-05,8.0864884e-05
43018,analysis,2,3,24,32,Preliminary methylation analysis shows that I2 activates IFN gene promoter (by increasing its unmethylated form) and silences TGF in Cht+I2.,34680134_6,0,1,-1,-1,43018,-1,2.8475499e-05,0.9999479,2.3673369e-05
43020,IFN gene,7,9,57,66,Preliminary methylation analysis shows that I2 activates IFN gene promoter (by increasing its unmethylated form) and silences TGF in Cht+I2.,34680134_6,-1,-1,-1,-1,43020,-1,0.99399996,0.0037263625,0.002273655
43024,the immune response,13,16,76,95,"In conclusion, our data showed that I2 supplements induce the activation of the immune response and that when combined with Cht, the Th1 pathways are stimulated.",34680134_7,-1,-1,-1,-1,43024,-1,0.2021425,0.79642177,0.0014357147
43026,the Th1,23,25,129,136,"In conclusion, our data showed that I2 supplements induce the activation of the immune response and that when combined with Cht, the Th1 pathways are stimulated.",34680134_7,-1,-1,-1,-1,43026,-1,2.8144477e-05,0.99993753,3.4271972e-05
43037,traps,13,14,92,97,"C3 is found to promote neutrophil recruitment and the formation of neutrophil extracellular traps (NETs), which facilitate cancer cell metastasis to the lungs.",34707103_3,-1,1,2,-1,43037,-1,7.799543e-05,0.9998636,5.840134e-05
43039,to the,23,25,146,152,"C3 is found to promote neutrophil recruitment and the formation of neutrophil extracellular traps (NETs), which facilitate cancer cell metastasis to the lungs.",34707103_3,-1,-1,-1,-1,43039,-1,2.9913812e-05,0.9999546,1.5516005e-05
43040,Th2 cytokines,9,11,51,64,C3 expression in LMSCs is induced and sustained by Th2 cytokines in a STAT6-dependent manner.,34707103_4,-1,-1,-1,-1,43040,-1,0.27811563,0.7122876,0.009596748
43042,Th1-skewing Stat6-deficient,6,8,45,72,LMSCs-driven lung metastasis is abolished in Th1-skewing Stat6-deficient mice.,34707103_5,-1,-1,-1,-1,43042,-1,4.990112e-05,0.99990356,4.6490786e-05
43043,to the,10,12,76,82,Blockade of IL-4 by antibody also attenuates LMSCs-driven cancer metastasis to the lungs.,34707103_6,-1,-1,-1,-1,43043,-1,2.621259e-05,0.9999589,1.4858581e-05
43044,Th2-skewing T-bet-deficient,7,9,48,75,"Consistently, metastasis is greatly enhanced in Th2-skewing T-bet-deficient mice or in nude mice adoptively transferred with T-bet-deficient T cells.",34707103_7,-1,-1,-1,-1,43044,-1,4.2736436e-05,0.99991834,3.89537e-05
43046,T-bet-deficient T cells,17,20,125,148,"Consistently, metastasis is greatly enhanced in Th2-skewing T-bet-deficient mice or in nude mice adoptively transferred with T-bet-deficient T cells.",34707103_7,-1,-1,-1,-1,43046,-1,0.003900879,0.7343602,0.2617389
43047,that targeting the Th2-STAT6-C3-NETs,3,7,20,56,Our results suggest that targeting the Th2-STAT6-C3-NETs cascade may reduce breast cancer metastasis to the lungs.,34707103_9,-1,-1,-1,-1,43047,-1,9.602456e-05,0.9998516,5.2407337e-05
43048,to the,13,15,101,107,Our results suggest that targeting the Th2-STAT6-C3-NETs cascade may reduce breast cancer metastasis to the lungs.,34707103_9,-1,-1,-1,-1,43048,-1,2.270904e-05,0.99996626,1.1004365e-05
43051,that cell-permeable,3,5,13,32,"Here we show that cell-permeable -ketoglutarate (KG) alters the DNA methylation profile of naive CD4 Tcells activated under Treg polarizing conditions, markedly attenuating FoxP3+ Treg differentiation and increasing inflammatory cytokines.",34731632_1,-1,-1,-1,-1,43051,-1,0.00036310396,0.9970469,0.0025900237
43060,these Tcells,3,7,21,34,"Adoptive transfer of these Tcells into tumor-bearing mice results in enhanced tumor infiltration, decreased FoxP3 expression, and delayed tumor growth.",34731632_2,-1,-1,-1,-1,43060,-1,0.0018703456,0.08348586,0.9146438
43066,state that,7,9,43,53,"Mechanistically, KG leads to an energetic state that is reprogrammed toward a mitochondrial metabolism, with increased oxidative phosphorylation and expression of mitochondrial complex enzymes.",34731632_3,-1,-1,-1,-1,43066,-1,2.047117e-05,0.9999652,1.4291083e-05
43068,metabolism,14,15,93,103,"Mechanistically, KG leads to an energetic state that is reprogrammed toward a mitochondrial metabolism, with increased oxidative phosphorylation and expression of mitochondrial complex enzymes.",34731632_3,0,1,2,-1,43068,-1,0.00086739624,0.97396415,0.0251685
43069,complex enzymes,24,26,178,193,"Mechanistically, KG leads to an energetic state that is reprogrammed toward a mitochondrial metabolism, with increased oxidative phosphorylation and expression of mitochondrial complex enzymes.",34731632_3,-1,-1,-1,-1,43069,-1,0.0013635049,0.92175955,0.076876976
43070,the generation,10,12,63,77,"Furthermore, carbons from ectopic KG are directly utilized in the generation of fatty acids, associated with lipidome remodeling and increased triacylglyceride stores.",34731632_4,-1,-1,-1,-1,43070,-1,2.5934232e-05,0.9999573,1.6736703e-05
43077,metabolism,10,11,57,67,"Thus, we identify a crosstalk between KG, mitochondrial metabolism and triacylglyceride synthesis that controls Treg fate.",34731632_6,0,1,2,-1,43077,-1,0.00024150476,0.9987463,0.0010121573
43090,therapeutic target,20,22,130,148,"As inhibition of EZH2 activity could upregulate the expression of tumor suppressor genes, EZH2 has recently become an interesting therapeutic target for cancer therapy.",34737746_2,-1,-1,-1,-1,43090,-1,2.264301e-05,0.99996686,1.0466322e-05
43091,therapy,24,25,160,167,"As inhibition of EZH2 activity could upregulate the expression of tumor suppressor genes, EZH2 has recently become an interesting therapeutic target for cancer therapy.",34737746_2,0,1,-1,-1,43091,-1,2.2928112e-05,0.99996626,1.08408685e-05
43093,to the regulation,10,13,67,84,"Moreover, accumulating evidence has shown that EZH2 may contribute to the regulation of immune cells, especially T cells.",34737746_3,-1,-1,-1,-1,43093,-1,2.3477103e-05,0.99996364,1.2937151e-05
43097,function,9,10,56,64,"EZH2 regulates T cell development, differentiation, and function, suggesting that EZH2 also regulates immune homeostasis in addition to tumor suppressor genes.",34737746_4,0,1,2,-1,43097,-1,0.00015800513,0.9997434,9.860269e-05
43099,to tumor,20,22,133,141,"EZH2 regulates T cell development, differentiation, and function, suggesting that EZH2 also regulates immune homeostasis in addition to tumor suppressor genes.",34737746_4,-1,-1,-1,-1,43099,-1,3.662004e-05,0.99994695,1.6411752e-05
43104,metabolism,15,16,80,90,"Moreover, EZH2 can regulate T cell fate by targeting non-T cell factors such as metabolism, cytokines, and myeloid-derived suppressor cells.",34737746_5,0,1,2,-1,43104,-1,0.00016317671,0.9995809,0.00025591292
43111,function,10,11,87,95,This review discusses up-to-date research on EZH2-mediated regulation of immunological function and the progress of immunological therapeutic strategies based on this regulation.,34737746_7,0,1,2,-1,43111,-1,7.7489254e-05,0.99986255,5.991476e-05
43114,this regulation,20,22,162,177,This review discusses up-to-date research on EZH2-mediated regulation of immunological function and the progress of immunological therapeutic strategies based on this regulation.,34737746_7,-1,-1,-1,-1,43114,-1,2.270277e-05,0.9999628,1.4452614e-05
43116,side effects,6,8,34,46,"While lower gastrointestinal (GI) side effects are more common, upper gastrointestinal adverse events are rarely reported.",34755133_1,0,1,-1,-1,43116,-1,0.00041813383,0.9990652,0.00051668496
43118,the immunology,2,4,13,27,"To elucidate the immunology underlying this condition, we leverage multiplexed ion beam imaging by time-of-flight (MIBI-TOF) to identify the presence and proportion of infiltrating immune cells from a single section of biopsy specimen.",34755133_3,-1,-1,-1,-1,43118,-1,0.00033283106,0.99954885,0.00011826557
43124,tissue,10,11,75,81,"Using MIBI-TOF, we analyze formalin-fixed, paraffin-embedded human gastric tissue with 28 labels simultaneously.",34755133_4,-1,1,2,-1,43124,-1,6.9212336e-05,0.9992588,0.00067195937
43130,tissue,11,12,82,88,"Here, we provide a comprehensive multiplexed histopathological mapping of gastric tissue, which identifies IFN--producing epithelial cells as possible contributors to the nivolumab-associated gastritis.",34755133_6,-1,1,2,-1,43130,-1,3.025089e-05,0.9998951,7.469082e-05
43133,to the,21,23,165,171,"Here, we provide a comprehensive multiplexed histopathological mapping of gastric tissue, which identifies IFN--producing epithelial cells as possible contributors to the nivolumab-associated gastritis.",34755133_6,-1,-1,-1,-1,43133,-1,2.6900563e-05,0.99995875,1.428723e-05
43134,to target the,7,10,57,70,New approaches beyond PD-1/PD-L1 inhibition are required to target the immunologically diverse tumor microenvironment (TME) in high-grade serous ovarian cancer (HGSOC).,34799346_0,-1,-1,-1,-1,43134,-1,1.9356143e-05,0.9999726,8.013955e-06
43140,the CCL2-CCR2-M2,15,17,77,93,"In this study, we explored the immunosuppressive effect of B7-H3 (CD276) via the CCL2-CCR2-M2 macrophage axis and its potential as a therapeutic target.",34799346_1,-1,-1,-1,-1,43140,-1,0.007141756,0.989785,0.0030732881
43141,therapeutic target,24,26,133,151,"In this study, we explored the immunosuppressive effect of B7-H3 (CD276) via the CCL2-CCR2-M2 macrophage axis and its potential as a therapeutic target.",34799346_1,-1,-1,-1,-1,43141,-1,2.4897947e-05,0.9999628,1.2250952e-05
43142,Transcriptome analysis,0,2,0,22,"Transcriptome analysis revealed that B7-H3 is highly expressed in PD-L1-low, nonimmunoreactive HGSOC tumors, and its expression negatively correlated with an IFN signature, which reflects the tumor immune reactivity.",34799346_2,-1,-1,-1,-1,43142,-1,2.2263781e-05,0.9999635,1.4269842e-05
43143,that B7-H3,3,5,32,42,"Transcriptome analysis revealed that B7-H3 is highly expressed in PD-L1-low, nonimmunoreactive HGSOC tumors, and its expression negatively correlated with an IFN signature, which reflects the tumor immune reactivity.",34799346_2,-1,-1,-1,-1,43143,-1,0.0038134994,0.20763788,0.78854865
43146,the tumor,27,29,189,198,"Transcriptome analysis revealed that B7-H3 is highly expressed in PD-L1-low, nonimmunoreactive HGSOC tumors, and its expression negatively correlated with an IFN signature, which reflects the tumor immune reactivity.",34799346_2,-1,-1,-1,-1,43146,-1,2.1100559e-05,0.999969,9.867456e-06
43148,tumor cells,14,16,58,69,"In syngeneic mouse models, B7-H3 (Cd276) knockout (KO) in tumor cells, but not in stromal cells, suppressed tumor progression, with a reduced number of M2 macrophages and an increased number of IFN+CD8+ T cells.",34799346_3,-1,-1,-1,-1,43148,-1,0.004411355,0.43096322,0.56462544
43154,the B7-H3,5,7,37,46,CCL2 expression was downregulated in the B7-H3 KO tumor cell lines.,34799346_4,-1,-1,-1,-1,43154,-1,0.0072351717,0.3554489,0.637316
43155,tumor cell,8,10,50,60,CCL2 expression was downregulated in the B7-H3 KO tumor cell lines.,34799346_4,-1,-1,-1,-1,43155,-1,0.004098582,0.48219034,0.5137111
43156,the CCL2-CCR2,2,4,14,27,"Inhibition of the CCL2-CCR2 axis partly negated the effects of B7-H3 suppression on M2 macrophage migration and differentiation, and tumor progression.",34799346_5,-1,-1,-1,-1,43156,-1,0.012123348,0.98238784,0.0054887515
43162,B7-H3-high tumors,20,22,131,148,"In patients with HGSOC, B7-H3 expression positively correlated with CCL2 expression and M2 macrophage abundance, and patients with B7-H3-high tumors had fewer tumoral IFN+CD8+ T cells and poorer prognosis than patients with B7-H3-low tumors.",34799346_6,-1,-1,-1,-1,43162,-1,0.002725377,0.032804456,0.9644702
43163,tumoral IFN+CD8,24,26,159,175,"In patients with HGSOC, B7-H3 expression positively correlated with CCL2 expression and M2 macrophage abundance, and patients with B7-H3-high tumors had fewer tumoral IFN+CD8+ T cells and poorer prognosis than patients with B7-H3-low tumors.",34799346_6,-1,-1,-1,-1,43163,-1,0.057982594,0.9163058,0.025711594
43166,B7-H3-low tumors,35,37,225,241,"In patients with HGSOC, B7-H3 expression positively correlated with CCL2 expression and M2 macrophage abundance, and patients with B7-H3-high tumors had fewer tumoral IFN+CD8+ T cells and poorer prognosis than patients with B7-H3-low tumors.",34799346_6,-1,-1,-1,-1,43166,-1,0.0024671275,0.032175064,0.96535784
43169,tumor cells,5,7,26,37,"Thus, B7-H3 expression in tumor cells contributes to CCL2-CCR2-M2 macrophage axis-mediated immunosuppression and tumor progression.",34799346_7,-1,-1,-1,-1,43169,-1,0.0029918503,0.22014715,0.7768611
43170,to CCL2-CCR2-M2,8,10,50,65,"Thus, B7-H3 expression in tumor cells contributes to CCL2-CCR2-M2 macrophage axis-mediated immunosuppression and tumor progression.",34799346_7,-1,-1,-1,-1,43170,-1,0.015182396,0.9739259,0.010891674
43179,T-cell therapy,17,19,110,124,"The unprecedented successes of immunotherapies (IOs) including immune checkpoint blockers (ICBs) and adoptive T-cell therapy (ACT) in patients with late-stage cancer provide proof-of-principle evidence that harnessing the immune system, in particular T cells, can be an effective approach to eradicate cancer.",34830176_0,-1,-1,-1,-1,43179,-1,0.0008795513,0.012714952,0.98640543
43191,immunity,27,28,154,162,"With the ""newly"" discovered immunogenic responses from RT, numerous endeavors have been undertaken to combine RT with IOs, in order to bolster anti-tumor immunity.",34830176_2,0,-1,2,-1,43191,-1,0.9993716,0.00038621927,0.00024224528
43195,the IFN-JAK-STAT,19,21,142,158,"We therefore conducted a systematic literature search on the molecular underpinnings of RT-induced immunomodulation and IOs, which identified the IFN-JAK-STAT pathway as a major regulator.",34830176_4,-1,-1,-1,-1,43195,-1,0.0011400846,0.9986981,0.0001617293
43196,analysis,2,3,12,20,Our further analysis of relevant studies revealed that the signaling strength and duration of this pathway in response to RT and IOs may determine eventual immunological outcomes.,34830176_5,0,1,-1,-1,43196,-1,3.1663312e-05,0.9999473,2.1081576e-05
43198,that the,7,9,50,58,Our further analysis of relevant studies revealed that the signaling strength and duration of this pathway in response to RT and IOs may determine eventual immunological outcomes.,34830176_5,-1,-1,-1,-1,43198,-1,1.7405524e-05,0.99997437,8.270285e-06
43207,therapy,27,28,178,185,"We propose that strategic targeting of this axis can boost the immunostimulatory effects of RT and radiosensitizing effects of IOs, thereby promoting the efficacy of combination therapy of RT and IOs.",34830176_6,0,1,-1,-1,43207,-1,2.7410222e-05,0.9999602,1.2437211e-05
43213,IFN- treatment,7,9,61,76,AX-0085 effectively blocks JAK2/STAT1 signaling initiated by IFN- treatment and prevents nuclear localization of STAT1.,35011581_1,-1,-1,-1,-1,43213,-1,0.99565315,0.0027232207,0.0016235852
43216,the IFN--mediated,7,9,50,68,"Importantly, we demonstrate that AX-0085 reverses the IFN--mediated repression of T cell activation in vitro and enhances the anti-tumor activity of anti-PD-1 antibody in vivo when used in combination.",35011581_2,-1,-1,-1,-1,43216,-1,0.01823292,0.98036,0.0014071382
43221,targeting the IFN--pathway,11,14,78,105,"Finally, transcriptomic analyses indicated that AX-0085 is highly specific in targeting the IFN--pathway, thereby raising the possibility of applying this reagent in combination therapy with checkpoint inhibitor antibodies.",35011581_3,-1,-1,-1,-1,43221,-1,0.0034600173,0.9957474,0.0007926107
43225,therapy,25,26,179,186,"Finally, transcriptomic analyses indicated that AX-0085 is highly specific in targeting the IFN--pathway, thereby raising the possibility of applying this reagent in combination therapy with checkpoint inhibitor antibodies.",35011581_3,0,1,-1,-1,43225,-1,2.5962996e-05,0.9999596,1.4490285e-05
43231,tissues,13,14,85,92,The GATA4 transcription factor acts as a master regulator of development of multiple tissues.,35017504_0,-1,1,2,-1,43231,-1,0.00052259397,0.9824609,0.01701649
43239,factors,11,12,68,75,"This secretory pathway is composed of chemokines, cytokines, growth factors, and proteases.",35017504_2,0,1,-1,-1,43239,-1,0.9998004,8.086034e-05,0.000118834796
43250,Analysis,0,1,0,8,"Analysis of transcriptome data in human tumors reveals reduced lymphocyte infiltration in GATA4-deficient tumors, consistent with our murine data.",35017504_6,0,1,-1,-1,43250,-1,2.7234571e-05,0.9999553,1.7484816e-05
43258,receptor,2,3,11,19,"The apelin receptor (APLNR) regulates many biological processes including metabolism, angiogenesis, circulating blood volume and cardiovascular function.",35084016_0,0,1,2,-1,43258,-1,0.0013942982,0.84346527,0.15514044
43259,metabolism,11,12,74,84,"The apelin receptor (APLNR) regulates many biological processes including metabolism, angiogenesis, circulating blood volume and cardiovascular function.",35084016_0,0,1,2,-1,43259,-1,3.0501456e-05,0.99993837,3.1182226e-05
43260,blood,16,17,112,117,"The apelin receptor (APLNR) regulates many biological processes including metabolism, angiogenesis, circulating blood volume and cardiovascular function.",35084016_0,0,1,-1,-1,43260,-1,0.00024460355,0.999212,0.00054331106
43261,function,20,21,144,152,"The apelin receptor (APLNR) regulates many biological processes including metabolism, angiogenesis, circulating blood volume and cardiovascular function.",35084016_0,0,1,2,-1,43261,-1,9.6688585e-05,0.99981076,9.261934e-05
43265,the IFN-,12,14,89,98,APLNR is reported to regulate tumor recognition during immune surveillance by modulating the IFN- response.,35084016_2,-1,-1,-1,-1,43265,-1,0.8955424,0.101157255,0.0033003464
43270,cells through,13,15,80,93,"Here, we show that activation of APLNR up-regulates IFN- signaling in melanoma cells through APLNR mediated -arrestin 1 but not -arrestin 2 recruitment.",35084016_4,-1,-1,-1,-1,43270,-1,0.0032014814,0.18339409,0.81340444
43272,STAT1 to,9,11,60,68,Our data suggests that -arrestin 1 directly interacts with STAT1 to inhibit STAT1 phosphorylation to attenuate IFN- signaling.,35084016_5,-1,-1,-1,-1,43272,-1,1.9857514e-05,0.9999677,1.2456795e-05
43277,receptor,3,4,17,25,"The APLNR mutant receptor, I109A, which is deficient in -arrestins recruitment, is unable to enhance intratumoral IFN- signaling.",35084016_6,0,1,2,-1,43277,-1,0.00044753513,0.013535622,0.9860169
43280,receptor,9,10,50,58,"While APLNR N112G, a constitutively active mutant receptor, increases intratumoral sensitivity to IFN- signaling by enhancing STAT1 phosphorylation upon IFN- exposure.",35084016_7,0,1,2,-1,43280,-1,0.0015095824,0.22172731,0.7767631
43281,to IFN-,14,16,95,103,"While APLNR N112G, a constitutively active mutant receptor, increases intratumoral sensitivity to IFN- signaling by enhancing STAT1 phosphorylation upon IFN- exposure.",35084016_7,-1,-1,-1,-1,43281,-1,0.905767,0.0902716,0.003961392
43286,Taken together,0,2,0,14,"Taken together, our findings reveal that APLNR modulates IFN- signaling in melanoma cells and suggest that APLNR may be a potential target to enhance the efficacy of immunotherapy.",35084016_9,-1,-1,-1,-1,43286,-1,4.1995434e-05,0.9999417,1.6313823e-05
43291,target to,22,24,133,142,"Taken together, our findings reveal that APLNR modulates IFN- signaling in melanoma cells and suggest that APLNR may be a potential target to enhance the efficacy of immunotherapy.",35084016_9,-1,-1,-1,-1,43291,-1,2.1520682e-05,0.9999695,8.962619e-06
43293,tumor types,8,10,57,68,"Despite recent advances in cancer immunotherapy, certain tumor types, such as Glioblastomas, are highly resistant due to their tumor microenvironment disabling the anti-tumor immune response.",35177622_0,-1,-1,-1,-1,43293,-1,2.5608153e-05,0.9999567,1.7624314e-05
43294,to their tumor,19,22,118,132,"Despite recent advances in cancer immunotherapy, certain tumor types, such as Glioblastomas, are highly resistant due to their tumor microenvironment disabling the anti-tumor immune response.",35177622_0,-1,-1,-1,-1,43294,-1,2.772528e-05,0.9999609,1.1350351e-05
43306,T-cell,46,47,302,308,"Here we show, by applying an in-silico multidimensional model integrating spatially resolved and single-cell gene expression data of 45,615 immune cells from 12 tumor samples, that a subset of Interleukin-10-releasing HMOX1+myeloid cells, spatially localizing to mesenchymal-like tumor regions, drive T-cell exhaustion and thus contribute to the immunosuppressive tumor microenvironment.",35177622_1,-1,1,2,-1,43306,-1,3.6590616e-05,4.0125462e-05,0.9999232
43308,to the,51,53,340,346,"Here we show, by applying an in-silico multidimensional model integrating spatially resolved and single-cell gene expression data of 45,615 immune cells from 12 tumor samples, that a subset of Interleukin-10-releasing HMOX1+myeloid cells, spatially localizing to mesenchymal-like tumor regions, drive T-cell exhaustion and thus contribute to the immunosuppressive tumor microenvironment.",35177622_1,-1,-1,-1,-1,43308,-1,2.368293e-05,0.9999654,1.0850925e-05
43311,T-cells to,16,18,125,135,These findings are validated using a human ex-vivo neocortical glioblastoma model inoculated with patient derived peripheral T-cells to simulate the immune compartment.,35177622_2,-1,-1,-1,-1,43311,-1,0.001371455,0.053688444,0.94494003
43317,T-cells,9,10,80,87,This model recapitulates the dysfunctional transformation of tumor infiltrating T-cells.,35177622_3,-1,1,2,-1,43317,-1,9.695377e-05,0.0005012773,0.9994017
43319,T-cell functionality,6,8,43,63,"Inhibition of the JAK/STAT pathway rescues T-cell functionality both in our model and in-vivo, providing further evidence of IL-10 release being an important driving force of tumor immune escape.",35177622_4,-1,-1,-1,-1,43319,-1,4.9913026e-05,8.816086e-05,0.99986184
43320,IL-10 release,19,21,125,138,"Inhibition of the JAK/STAT pathway rescues T-cell functionality both in our model and in-vivo, providing further evidence of IL-10 release being an important driving force of tumor immune escape.",35177622_4,-1,-1,-1,-1,43320,-1,0.9951389,0.002895177,0.001965992
43326,tool to,17,19,111,118,Our results thus show that integrative modelling of single cell and spatial transcriptomics data is a valuable tool to interrogate the tumor immune microenvironment and might contribute to the development of successful immunotherapies.,35177622_5,-1,-1,-1,-1,43326,-1,2.8634582e-05,0.99996006,1.1283341e-05
43327,the tumor,20,22,131,140,Our results thus show that integrative modelling of single cell and spatial transcriptomics data is a valuable tool to interrogate the tumor immune microenvironment and might contribute to the development of successful immunotherapies.,35177622_5,-1,-1,-1,-1,43327,-1,1.914701e-05,0.9999726,8.320648e-06
43328,to the,27,29,186,192,Our results thus show that integrative modelling of single cell and spatial transcriptomics data is a valuable tool to interrogate the tumor immune microenvironment and might contribute to the development of successful immunotherapies.,35177622_5,-1,-1,-1,-1,43328,-1,2.4876475e-05,0.9999659,9.222344e-06
43334,immunity,19,20,122,130,T regulatory (Treg) cells are essential for self-tolerance whereas they are detrimental for dampening the host anti-tumor immunity.,35895684_0,0,-1,2,-1,43334,-1,0.999534,0.00027909488,0.00018697417
43339,functions,12,13,83,92,How Treg cells adapt to environmental signals to orchestrate their homeostasis and functions remains poorly understood.,35895684_1,0,1,2,-1,43339,-1,0.000109598026,0.9998267,6.366015e-05
43340,that transcription factor EB,4,8,20,48,"Here, we identified that transcription factor EB (TFEB) is induced by host nutrition deprivation or interleukin (IL)-2 in CD4+ T cells.",35895684_2,-1,-1,-1,-1,43340,-1,1.9151561e-05,0.99997175,9.041942e-06
43349,Treg function,14,16,79,92,The loss of TFEB in Treg cells leads to reduced Treg accumulation and impaired Treg function in mouse models of cancer and autoimmune disease.,35895684_3,-1,-1,-1,-1,43349,-1,6.362936e-05,0.9998598,7.6558084e-05
43353,function,11,12,90,98,TFEB intrinsically regulates genes involved in Treg cell differentiation and mitochondria function while it suppresses expression of proinflammatory cytokines independently of its established roles in autophagy.,35895684_4,0,1,2,-1,43353,-1,0.00013649851,0.9996575,0.00020599952
43356,metabolism,11,12,85,95,This coordinated action is required for mitochondria integrity and appropriate lipid metabolism in Treg cells.,35895684_5,0,1,2,-1,43356,-1,0.0017234309,0.9926835,0.005593059
43360,Treg generation,10,12,71,86,"These findings identify TFEB as a critical regulator for orchestrating Treg generation and function, which may contribute to the adaptive responses of T cells to local environmental cues.",35895684_6,-1,-1,-1,-1,43360,-1,2.5806527e-05,0.9999542,1.9985697e-05
43361,function,13,14,91,99,"These findings identify TFEB as a critical regulator for orchestrating Treg generation and function, which may contribute to the adaptive responses of T cells to local environmental cues.",35895684_6,0,1,2,-1,43361,-1,9.331835e-05,0.9998584,4.833095e-05
43362,to the,18,20,122,128,"These findings identify TFEB as a critical regulator for orchestrating Treg generation and function, which may contribute to the adaptive responses of T cells to local environmental cues.",35895684_6,-1,-1,-1,-1,43362,-1,2.6581643e-05,0.99996185,1.1568092e-05
43363,T cells to,23,26,151,161,"These findings identify TFEB as a critical regulator for orchestrating Treg generation and function, which may contribute to the adaptive responses of T cells to local environmental cues.",35895684_6,-1,-1,-1,-1,43363,-1,0.0021142995,0.031082153,0.9668035
43366,adaptive immune responses,9,12,50,75,B cells are emerging as key players of anti-tumor adaptive immune responses.,35909944_0,-1,-1,-1,-1,43366,-1,0.99948585,0.00039082443,0.00012326123
43373,TNF-+,14,15,90,96,"We found enhanced circulating regulatory (TGF-+ and PD-L1+) and reduced pro-inflammatory TNF-+ B cell populations in patients compared with healthy volunteers (HVs), including lower IFN-+:IL-4+and higher TGF-+:TNF-+ B cell ratios in patients.",35909944_2,0,1,-1,-1,43373,-1,7.3169314e-05,0.9998791,4.774696e-05
43386,to blood,5,7,33,41,"While reduced in tumors compared to blood, TNF--expressing B cells engaged in crosstalk with Tregs via TNF- signaling and the ICOS/ICOSL axis.",35909944_4,-1,-1,-1,-1,43386,-1,2.9420838e-05,0.9999466,2.3996747e-05
43387,TNF--expressing,8,9,43,59,"While reduced in tumors compared to blood, TNF--expressing B cells engaged in crosstalk with Tregs via TNF- signaling and the ICOS/ICOSL axis.",35909944_4,0,1,-1,-1,43387,-1,4.3492575e-05,0.9999273,2.9251349e-05
43390,TNF-,17,18,104,109,"While reduced in tumors compared to blood, TNF--expressing B cells engaged in crosstalk with Tregs via TNF- signaling and the ICOS/ICOSL axis.",35909944_4,0,1,-1,-1,43390,-1,6.8834415e-05,0.99990773,2.3422032e-05
43397,TNF-,19,20,131,136,"Patient-derived B cells promoted FOXP3+ Treg differentiation in a TGF--dependent manner, while sustaining expression of IFN- and TNF- by autologous T-helper cells and promoting T-helper cell proliferation ex vivo, an effect further enhanced with anti-PD-1 checkpoint blockade.",35909944_5,0,1,-1,-1,43397,-1,7.657669e-05,0.9999025,2.096213e-05
43413,T-cells,16,17,113,120,The mechanisms through which Vascular Endothelial Growth Factor A(VEGF-A) modulates tumor EC response to exclude T-cells are not well understood.,36403190_1,-1,1,2,-1,43413,-1,0.00032678395,0.0044138557,0.99525946
43419,T-cells,26,27,180,187,"EC-specific Rap1B deletion inhibits angiogenesis, but also leads to an altered tumor microenvironment with increased recruitment of leukocytes and increased activity of tumor CD8+ T-cells.",36403190_3,-1,1,2,-1,43419,-1,0.0017306387,0.075816825,0.9224525
43420,T-cells,4,5,18,25,Depletion of CD8+ T-cells restored tumor growth in Rap1BiEC mice.,36403190_4,-1,1,2,-1,43420,-1,0.00014261964,0.000954134,0.99890316
43423,functional,5,6,42,52,"Mechanistically, global transcriptome and functional analyses indicated upregulation of signaling by a tumor cytokine, TNF-, and increased NF-B transcription in Rap1B-deficient ECs.",36403190_5,0,1,2,-1,43423,-1,7.660994e-05,0.9998789,4.444325e-05
43424,tumor cytokine,13,15,103,117,"Mechanistically, global transcriptome and functional analyses indicated upregulation of signaling by a tumor cytokine, TNF-, and increased NF-B transcription in Rap1B-deficient ECs.",36403190_5,-1,-1,-1,-1,43424,-1,0.48484886,0.5072744,0.0078767985
43425,TNF-,16,17,119,124,"Mechanistically, global transcriptome and functional analyses indicated upregulation of signaling by a tumor cytokine, TNF-, and increased NF-B transcription in Rap1B-deficient ECs.",36403190_5,0,1,-1,-1,43425,-1,0.00041484067,0.9995173,6.784033e-05
43430,TNF-,15,16,108,113,Rap1B-deficiency led to elevated proinflammatory chemokine and Cell Adhesion Molecules (CAMs) expression in TNF- stimulated ECs.,36403190_6,0,1,-1,-1,43430,-1,6.992817e-05,0.99990547,2.4562716e-05
43437,the regulation,3,5,17,31,"We have examined the regulation of the AP-1 DNA transcription complex during T cell activation in response to interleukin 1 (IL-1) and phorbol ester (TPA) treatment of the IL-1 responsive murine thymoma T cell line, EL4 6.1 C 10.",7675040_0,-1,-1,-1,-1,43437,-1,1.7708391e-05,0.99997234,9.95268e-06
43438,the AP-1,6,8,35,43,"We have examined the regulation of the AP-1 DNA transcription complex during T cell activation in response to interleukin 1 (IL-1) and phorbol ester (TPA) treatment of the IL-1 responsive murine thymoma T cell line, EL4 6.1 C 10.",7675040_0,-1,-1,-1,-1,43438,-1,1.9002737e-05,0.99996877,1.2233605e-05
43439,transcription complex,9,11,48,69,"We have examined the regulation of the AP-1 DNA transcription complex during T cell activation in response to interleukin 1 (IL-1) and phorbol ester (TPA) treatment of the IL-1 responsive murine thymoma T cell line, EL4 6.1 C 10.",7675040_0,-1,-1,-1,-1,43439,-1,1.9706658e-05,0.99996626,1.4015125e-05
43441,to interleukin 1,17,20,107,123,"We have examined the regulation of the AP-1 DNA transcription complex during T cell activation in response to interleukin 1 (IL-1) and phorbol ester (TPA) treatment of the IL-1 responsive murine thymoma T cell line, EL4 6.1 C 10.",7675040_0,-1,-1,-1,-1,43441,-1,0.2280877,0.76265466,0.009257607
43445,the IL-1,31,33,168,176,"We have examined the regulation of the AP-1 DNA transcription complex during T cell activation in response to interleukin 1 (IL-1) and phorbol ester (TPA) treatment of the IL-1 responsive murine thymoma T cell line, EL4 6.1 C 10.",7675040_0,-1,-1,-1,-1,43445,-1,0.27802292,0.708573,0.013404042
43446,thymoma T cell,35,38,195,209,"We have examined the regulation of the AP-1 DNA transcription complex during T cell activation in response to interleukin 1 (IL-1) and phorbol ester (TPA) treatment of the IL-1 responsive murine thymoma T cell line, EL4 6.1 C 10.",7675040_0,-1,-1,-1,-1,43446,-1,0.0038569798,0.40825403,0.587889
43450,AP-1-mediated gene,9,11,63,81,IL-1 synergistically enhances the stimulatory effect of TPA on AP-1-mediated gene expression in this cell line.,7675040_1,-1,-1,-1,-1,43450,-1,3.512438e-05,0.99994135,2.3577322e-05
43451,this cell,13,15,96,105,IL-1 synergistically enhances the stimulatory effect of TPA on AP-1-mediated gene expression in this cell line.,7675040_1,-1,-1,-1,-1,43451,-1,0.003134473,0.5962582,0.40060732
43455,AP-1-mediated gene,9,11,53,71,"To elucidate the mechanism(s) by which IL-1 enhances AP-1-mediated gene expression, we examined the effect of IL-1 on the synthesis and turnover of Jun B, the member of the jun gene family that is present in AP-1 complexes in EL4 cells.",7675040_2,-1,-1,-1,-1,43455,-1,3.0545478e-05,0.9999492,2.0177646e-05
43462,the jun gene,31,34,169,181,"To elucidate the mechanism(s) by which IL-1 enhances AP-1-mediated gene expression, we examined the effect of IL-1 on the synthesis and turnover of Jun B, the member of the jun gene family that is present in AP-1 complexes in EL4 cells.",7675040_2,-1,-1,-1,-1,43462,-1,2.285436e-05,0.9999659,1.1278909e-05
43466,that IL-1,2,4,9,18,We found that IL-1 + TPA-treated cells contain significantly higher Jun B protein levels than cells treated with TPA alone.,7675040_3,-1,-1,-1,-1,43466,-1,0.44340864,0.53840137,0.018190023
43467,TPA-treated cells,5,7,21,38,We found that IL-1 + TPA-treated cells contain significantly higher Jun B protein levels than cells treated with TPA alone.,7675040_3,-1,-1,-1,-1,43467,-1,0.0018706906,0.89909774,0.09903154
43469,protein,12,13,74,81,We found that IL-1 + TPA-treated cells contain significantly higher Jun B protein levels than cells treated with TPA alone.,7675040_3,0,1,-1,-1,43469,-1,2.7122096e-05,0.999931,4.193315e-05
43470,than cells treated,14,17,89,107,We found that IL-1 + TPA-treated cells contain significantly higher Jun B protein levels than cells treated with TPA alone.,7675040_3,-1,-1,-1,-1,43470,-1,8.635402e-05,0.9997019,0.00021168371
43475,the cellular,10,12,59,71,"IL-1 promotes the prolonged accumulation of Jun B, whereas the cellular content of Jun B decreases dramatically after 6 hr in cells treated with only TPA.",7675040_4,-1,-1,-1,-1,43475,-1,0.0033503096,0.6760177,0.32063195
43477,cells treated,22,24,126,139,"IL-1 promotes the prolonged accumulation of Jun B, whereas the cellular content of Jun B decreases dramatically after 6 hr in cells treated with only TPA.",7675040_4,-1,-1,-1,-1,43477,-1,0.0032317394,0.15128349,0.84548485
43481,protein,5,6,26,33,"IL-1 enhancement of Jun B protein levels is not the result of a change in the turnover rate of the Jun B protein, but rather results from the maintenance of sufficient jun B mRNA to support continued accumulation of newly synthesized protein.",7675040_5,0,1,-1,-1,43481,-1,6.121732e-05,0.9998073,0.0001315201
43483,the turnover,15,17,74,86,"IL-1 enhancement of Jun B protein levels is not the result of a change in the turnover rate of the Jun B protein, but rather results from the maintenance of sufficient jun B mRNA to support continued accumulation of newly synthesized protein.",7675040_5,-1,-1,-1,-1,43483,-1,3.0136871e-05,0.99995637,1.35294e-05
43484,the Jun,19,21,95,102,"IL-1 enhancement of Jun B protein levels is not the result of a change in the turnover rate of the Jun B protein, but rather results from the maintenance of sufficient jun B mRNA to support continued accumulation of newly synthesized protein.",7675040_5,-1,-1,-1,-1,43484,-1,2.5077426e-05,0.99996054,1.4427753e-05
43485,protein,22,23,105,112,"IL-1 enhancement of Jun B protein levels is not the result of a change in the turnover rate of the Jun B protein, but rather results from the maintenance of sufficient jun B mRNA to support continued accumulation of newly synthesized protein.",7675040_5,0,1,-1,-1,43485,-1,8.0384074e-05,0.9997236,0.00019603563
43489,protein,42,43,234,241,"IL-1 enhancement of Jun B protein levels is not the result of a change in the turnover rate of the Jun B protein, but rather results from the maintenance of sufficient jun B mRNA to support continued accumulation of newly synthesized protein.",7675040_5,0,1,-1,-1,43489,-1,0.0006619238,0.99750704,0.0018310297
43490,to Jun,2,4,12,18,"In addition to Jun B, we found that the T cell AP-1 complex contains the Fra-1 protein, a member of the fos gene family.",7675040_6,-1,-1,-1,-1,43490,-1,2.4554794e-05,0.9999604,1.5075374e-05
43491,that the T cell AP-1 complex,8,14,31,59,"In addition to Jun B, we found that the T cell AP-1 complex contains the Fra-1 protein, a member of the fos gene family.",7675040_6,-1,-1,-1,-1,43491,-1,6.863074e-05,0.999796,0.0001354615
43492,the Fra-1 protein,15,18,69,86,"In addition to Jun B, we found that the T cell AP-1 complex contains the Fra-1 protein, a member of the fos gene family.",7675040_6,-1,-1,-1,-1,43492,-1,2.6659161e-05,0.99995184,2.1537466e-05
43493,the fos gene,22,25,100,112,"In addition to Jun B, we found that the T cell AP-1 complex contains the Fra-1 protein, a member of the fos gene family.",7675040_6,-1,-1,-1,-1,43493,-1,2.7878432e-05,0.9999584,1.37193465e-05
43496,TPA-induced Fra-1 protein,12,15,77,102,"Although IL-1 dramatically increases Jun B accumulation, it does not enhance TPA-induced Fra-1 protein levels in EL4 cells.",7675040_7,-1,-1,-1,-1,43496,-1,2.9273797e-05,0.99995255,1.8191116e-05
43500,AP-1-mediated gene,5,7,25,43,"Thus, the stimulation of AP-1-mediated gene expression by IL-1 in EL4 cells is due to the promotion of Jun B protein accumulation that, in turn, facilitates Jun B heterodimerization with TPA-induced Fra-1 protein, thereby forming an active AP-1 complex.",7675040_8,-1,-1,-1,-1,43500,-1,3.086773e-05,0.99995065,1.8471452e-05
43503,to the,15,17,83,89,"Thus, the stimulation of AP-1-mediated gene expression by IL-1 in EL4 cells is due to the promotion of Jun B protein accumulation that, in turn, facilitates Jun B heterodimerization with TPA-induced Fra-1 protein, thereby forming an active AP-1 complex.",7675040_8,-1,-1,-1,-1,43503,-1,1.8203884e-05,0.9999733,8.500071e-06
43505,protein,21,22,109,116,"Thus, the stimulation of AP-1-mediated gene expression by IL-1 in EL4 cells is due to the promotion of Jun B protein accumulation that, in turn, facilitates Jun B heterodimerization with TPA-induced Fra-1 protein, thereby forming an active AP-1 complex.",7675040_8,0,1,-1,-1,43505,-1,2.7375165e-05,0.9999354,3.7288177e-05
43509,TPA-induced Fra-1 protein,33,36,187,212,"Thus, the stimulation of AP-1-mediated gene expression by IL-1 in EL4 cells is due to the promotion of Jun B protein accumulation that, in turn, facilitates Jun B heterodimerization with TPA-induced Fra-1 protein, thereby forming an active AP-1 complex.",7675040_8,-1,-1,-1,-1,43509,-1,2.6892398e-05,0.9999546,1.8512934e-05
43514,TH2 lymphocytes,8,10,38,53,Interleukin 10 (IL-10) is produced by TH2 lymphocytes and regulates both lymphoid and myeloid cells.,8037735_0,-1,-1,-1,-1,43514,-1,0.0001396368,0.00051731244,0.9993431
43517,that IL-10,6,8,36,46,"In the present study we demonstrate that IL-10 is expressed and produced spontaneously in the peripheral blood mononuclear cells (PBMCs) of all HIV-1 infected individuals tested, 3 of 19 cases of HIV-negative lymphoma and none of five healthy controls.",8037735_1,-1,-1,-1,-1,43517,-1,0.75933224,0.23593839,0.004729351
43519,blood,16,17,105,110,"In the present study we demonstrate that IL-10 is expressed and produced spontaneously in the peripheral blood mononuclear cells (PBMCs) of all HIV-1 infected individuals tested, 3 of 19 cases of HIV-negative lymphoma and none of five healthy controls.",8037735_1,0,1,-1,-1,43519,-1,0.00022848393,0.9983229,0.0014485623
43535,Receptor-dependent tumor necrosis factor,0,4,0,40,Receptor-dependent tumor necrosis factor (TNF)-mediated activities against mouse thymoma cells and normal thymocytes syngeneic for C57 mice were examined to determine the specific involvement of TNF receptors R1 and R2.,8258153_0,-1,-1,-1,-1,43535,-1,0.50165397,0.1355343,0.3628117
43536,thymoma cells,8,10,81,94,Receptor-dependent tumor necrosis factor (TNF)-mediated activities against mouse thymoma cells and normal thymocytes syngeneic for C57 mice were examined to determine the specific involvement of TNF receptors R1 and R2.,8258153_0,-1,-1,-1,-1,43536,-1,0.004809009,0.5418467,0.4533443
43537,thymocytes,12,13,106,116,Receptor-dependent tumor necrosis factor (TNF)-mediated activities against mouse thymoma cells and normal thymocytes syngeneic for C57 mice were examined to determine the specific involvement of TNF receptors R1 and R2.,8258153_0,-1,1,2,-1,43537,-1,0.000442932,0.005443589,0.9941134
43540,TNF receptors,25,27,195,208,Receptor-dependent tumor necrosis factor (TNF)-mediated activities against mouse thymoma cells and normal thymocytes syngeneic for C57 mice were examined to determine the specific involvement of TNF receptors R1 and R2.,8258153_0,-1,-1,-1,-1,43540,-1,0.00034480862,0.99336714,0.0062880195
43541,receptors,1,2,5,14,Both receptors are expressed by EL4 thymoma cells and normal C57 thymocytes.,8258153_1,0,1,2,-1,43541,-1,0.00017101351,0.00048187177,0.99934703
43542,thymoma cells,6,8,36,49,Both receptors are expressed by EL4 thymoma cells and normal C57 thymocytes.,8258153_1,-1,-1,-1,-1,43542,-1,0.0031725545,0.22759311,0.7692343
43543,thymocytes,11,12,65,75,Both receptors are expressed by EL4 thymoma cells and normal C57 thymocytes.,8258153_1,-1,1,2,-1,43543,-1,0.0011406073,0.022661196,0.9761982
43544,TNF-mediated,0,1,0,12,"TNF-mediated activities included (a) cytotoxicity, (b) induction of hyposensitivity to TNF-mediated lysis, (c) costimulatory stimulation of thymocyte proliferation, and (d) activation of NF-kB-like transcription factor.",8258153_2,0,1,-1,-1,43544,-1,3.4620745e-05,0.99993384,3.1534728e-05
43545,to TNF-mediated,14,16,84,99,"TNF-mediated activities included (a) cytotoxicity, (b) induction of hyposensitivity to TNF-mediated lysis, (c) costimulatory stimulation of thymocyte proliferation, and (d) activation of NF-kB-like transcription factor.",8258153_2,-1,-1,-1,-1,43545,-1,5.6682933e-05,0.99989665,4.667229e-05
43546,thymocyte,24,25,140,149,"TNF-mediated activities included (a) cytotoxicity, (b) induction of hyposensitivity to TNF-mediated lysis, (c) costimulatory stimulation of thymocyte proliferation, and (d) activation of NF-kB-like transcription factor.",8258153_2,-1,1,2,-1,43546,-1,0.0017608041,0.04790792,0.9503312
43547,NF-kB-like transcription factor,33,36,187,218,"TNF-mediated activities included (a) cytotoxicity, (b) induction of hyposensitivity to TNF-mediated lysis, (c) costimulatory stimulation of thymocyte proliferation, and (d) activation of NF-kB-like transcription factor.",8258153_2,-1,-1,-1,-1,43547,-1,3.4635108e-05,0.99993575,2.9625151e-05
43549,TNF receptors to,6,9,43,59,The ability of polyclonal antisera against TNF receptors to mimic the above TNF-mediated activities was determined.,8258153_3,-1,-1,-1,-1,43549,-1,4.5386045e-05,0.9999106,4.4058856e-05
43551,TNF-mediated,12,13,76,88,The ability of polyclonal antisera against TNF receptors to mimic the above TNF-mediated activities was determined.,8258153_3,0,1,-1,-1,43551,-1,5.864959e-05,0.99987686,6.4426815e-05
43555,to TNF,17,19,122,128,"The results clearly showed that anti-TNF-R1 antibodies were cytotoxic against EL4 cells, induced hyposensitivity of S-EL4 to TNF lysis and activated the NF-kB-like transcription factor in EL 4 cells and syngeneic normal thymocytes.",8258153_4,-1,-1,-1,-1,43555,-1,7.959011e-05,0.99989784,2.2551261e-05
43556,the NF-kB-like transcription factor,22,26,149,184,"The results clearly showed that anti-TNF-R1 antibodies were cytotoxic against EL4 cells, induced hyposensitivity of S-EL4 to TNF lysis and activated the NF-kB-like transcription factor in EL 4 cells and syngeneic normal thymocytes.",8258153_4,-1,-1,-1,-1,43556,-1,2.481617e-05,0.99996114,1.4096877e-05
43558,thymocytes,33,34,220,230,"The results clearly showed that anti-TNF-R1 antibodies were cytotoxic against EL4 cells, induced hyposensitivity of S-EL4 to TNF lysis and activated the NF-kB-like transcription factor in EL 4 cells and syngeneic normal thymocytes.",8258153_4,-1,1,2,-1,43558,-1,0.001959362,0.074984424,0.92305624
43559,TNF-R2,2,3,17,23,Antisera against TNF-R2 only mimicked TNF-mediated costimulation of thymocyte proliferation with IL2.,8258153_5,0,1,-1,-1,43559,-1,8.480652e-05,0.9998714,4.3760614e-05
43560,TNF-mediated,5,6,38,50,Antisera against TNF-R2 only mimicked TNF-mediated costimulation of thymocyte proliferation with IL2.,8258153_5,0,1,-1,-1,43560,-1,4.991349e-05,0.999915,3.5076355e-05
43561,thymocyte,8,9,68,77,Antisera against TNF-R2 only mimicked TNF-mediated costimulation of thymocyte proliferation with IL2.,8258153_5,-1,1,2,-1,43561,-1,0.0015017834,0.057202272,0.9412959
43562,TNF,6,7,40,43,No direct correlation was noted between TNF activation of NF-kB and TNF-mediated lysis.,8258153_6,0,1,-1,-1,43562,-1,4.4390526e-05,0.99994206,1.3494929e-05
43564,TNF-mediated,11,12,68,80,No direct correlation was noted between TNF activation of NF-kB and TNF-mediated lysis.,8258153_6,0,1,-1,-1,43564,-1,5.6062006e-05,0.9998987,4.522335e-05
43567,the T cell,8,11,49,59,"The activation of T cells requires engagement of the T cell receptor/CD3 complex and co-stimulatory molecules, and results in the triggering of several signaling pathways which lead rapidly to the nuclear translocation of several transcription factors, such as nuclear factor (NF)-kappa B and NF-AT.",8605941_0,-1,-1,-1,-1,43567,-1,0.0038695286,0.24190098,0.7542295
43569,the triggering,20,22,126,140,"The activation of T cells requires engagement of the T cell receptor/CD3 complex and co-stimulatory molecules, and results in the triggering of several signaling pathways which lead rapidly to the nuclear translocation of several transcription factors, such as nuclear factor (NF)-kappa B and NF-AT.",8605941_0,-1,-1,-1,-1,43569,-1,2.1875363e-05,0.9999672,1.0933369e-05
43570,to the,29,31,190,196,"The activation of T cells requires engagement of the T cell receptor/CD3 complex and co-stimulatory molecules, and results in the triggering of several signaling pathways which lead rapidly to the nuclear translocation of several transcription factors, such as nuclear factor (NF)-kappa B and NF-AT.",8605941_0,-1,-1,-1,-1,43570,-1,2.0430869e-05,0.9999697,9.825723e-06
43574,NF-AT,45,46,293,298,"The activation of T cells requires engagement of the T cell receptor/CD3 complex and co-stimulatory molecules, and results in the triggering of several signaling pathways which lead rapidly to the nuclear translocation of several transcription factors, such as nuclear factor (NF)-kappa B and NF-AT.",8605941_0,-1,1,2,-1,43574,-1,3.495289e-05,0.9999423,2.2697563e-05
43584,factor,6,7,34,40,"We report here that a DNA-binding factor containing STAT1 also becomes activated in human peripheral blood T lymphocytes or Jurkat cells, although not until 1-2 h after stimulation.",8605941_2,0,1,-1,-1,43584,-1,3.5190737e-05,0.9999405,2.4252113e-05
43586,blood T lymphocytes,15,18,101,120,"We report here that a DNA-binding factor containing STAT1 also becomes activated in human peripheral blood T lymphocytes or Jurkat cells, although not until 1-2 h after stimulation.",8605941_2,-1,-1,-1,-1,43586,-1,0.0015715885,0.03195037,0.96647805
43590,the STAT1 factor,2,5,14,30,"Appearance of the STAT1 factor is significantly reduced in the presence of cyclosporin A, and blocked by cycloheximide, indicating that its activation is dependent upon a protein(s) synthesized in response to initial signaling events.",8605941_4,-1,-1,-1,-1,43590,-1,2.7639895e-05,0.99995303,1.9367195e-05
43593,protein(s,28,29,171,180,"Appearance of the STAT1 factor is significantly reduced in the presence of cyclosporin A, and blocked by cycloheximide, indicating that its activation is dependent upon a protein(s) synthesized in response to initial signaling events.",8605941_4,0,1,-1,-1,43593,-1,9.635278e-05,0.99979633,0.00010730933
43596,cytokines tested,8,10,56,72,"Neutralizing antiserum against IFN-gamma, but not other cytokines tested, blocked activation of the factor almost completely, and IFN-gamma was found in the culture supernatants of stimulated cells at levels at which recombinant IFN-gamma could activate the factor in naive cells.",8605941_5,-1,-1,-1,-1,43596,-1,0.97415596,0.0225213,0.0033228267
43597,the factor,14,16,96,106,"Neutralizing antiserum against IFN-gamma, but not other cytokines tested, blocked activation of the factor almost completely, and IFN-gamma was found in the culture supernatants of stimulated cells at levels at which recombinant IFN-gamma could activate the factor in naive cells.",8605941_5,-1,-1,-1,-1,43597,-1,6.7745e-05,0.99990857,2.3679211e-05
43602,the factor,38,40,254,264,"Neutralizing antiserum against IFN-gamma, but not other cytokines tested, blocked activation of the factor almost completely, and IFN-gamma was found in the culture supernatants of stimulated cells at levels at which recombinant IFN-gamma could activate the factor in naive cells.",8605941_5,-1,-1,-1,-1,43602,-1,0.00010022168,0.9998714,2.8428416e-05
43603,naive cells,41,43,268,279,"Neutralizing antiserum against IFN-gamma, but not other cytokines tested, blocked activation of the factor almost completely, and IFN-gamma was found in the culture supernatants of stimulated cells at levels at which recombinant IFN-gamma could activate the factor in naive cells.",8605941_5,-1,-1,-1,-1,43603,-1,0.0038070008,0.30690682,0.6892862
43605,STAT1 transcription factor,3,6,13,39,"Therefore, a STAT1 transcription factor is activated by IFN-gamma synthesized and released upon stimulation of T lymphocyte populations.",8605941_6,-1,-1,-1,-1,43605,-1,2.2120372e-05,0.9999616,1.6291775e-05
43610,to IFN-gamma,7,9,44,56,"While Jurkat cells both secrete and respond to IFN-gamma in an autocrine loop, it seems likely that the responding cells may differ from those synthesizing this cytokine in the mononuclear cell cultures in the light of the recent report that Th1 cells lack the IFN-gamma receptor chain necessary for activation of STAT1 (Pernis, A., Gupta, S., Gollob, K.J., Garfein, E., Coffman, R.L., Schindler, C., and Rothman, P., Science 1995. 269:245).",8605941_7,-1,-1,-1,-1,43610,-1,0.9093069,0.08771011,0.0029830053
43611,that the,17,19,95,103,"While Jurkat cells both secrete and respond to IFN-gamma in an autocrine loop, it seems likely that the responding cells may differ from those synthesizing this cytokine in the mononuclear cell cultures in the light of the recent report that Th1 cells lack the IFN-gamma receptor chain necessary for activation of STAT1 (Pernis, A., Gupta, S., Gollob, K.J., Garfein, E., Coffman, R.L., Schindler, C., and Rothman, P., Science 1995. 269:245).",8605941_7,-1,-1,-1,-1,43611,-1,1.9275374e-05,0.9999709,9.851171e-06
43614,this cytokine,26,28,156,169,"While Jurkat cells both secrete and respond to IFN-gamma in an autocrine loop, it seems likely that the responding cells may differ from those synthesizing this cytokine in the mononuclear cell cultures in the light of the recent report that Th1 cells lack the IFN-gamma receptor chain necessary for activation of STAT1 (Pernis, A., Gupta, S., Gollob, K.J., Garfein, E., Coffman, R.L., Schindler, C., and Rothman, P., Science 1995. 269:245).",8605941_7,-1,-1,-1,-1,43614,-1,0.44037294,0.55356413,0.006062884
43619,that Th1 cells,40,43,237,251,"While Jurkat cells both secrete and respond to IFN-gamma in an autocrine loop, it seems likely that the responding cells may differ from those synthesizing this cytokine in the mononuclear cell cultures in the light of the recent report that Th1 cells lack the IFN-gamma receptor chain necessary for activation of STAT1 (Pernis, A., Gupta, S., Gollob, K.J., Garfein, E., Coffman, R.L., Schindler, C., and Rothman, P., Science 1995. 269:245).",8605941_7,-1,-1,-1,-1,43619,-1,0.00293339,0.28775498,0.70931166
43620,the IFN-gamma receptor,44,47,257,279,"While Jurkat cells both secrete and respond to IFN-gamma in an autocrine loop, it seems likely that the responding cells may differ from those synthesizing this cytokine in the mononuclear cell cultures in the light of the recent report that Th1 cells lack the IFN-gamma receptor chain necessary for activation of STAT1 (Pernis, A., Gupta, S., Gollob, K.J., Garfein, E., Coffman, R.L., Schindler, C., and Rothman, P., Science 1995. 269:245).",8605941_7,-1,-1,-1,-1,43620,-1,0.07554394,0.7233981,0.20105802
43623,the receptor,4,6,26,38,The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.,8662928_0,-1,-1,-1,-1,43623,-1,0.00010751702,0.9995003,0.0003921839
43629,receptor subunits,25,27,154,171,The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.,8662928_0,-1,-1,-1,-1,43629,-1,0.0005416469,0.9819026,0.017555764
43630,IL-6-type cytokines,28,30,176,195,The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.,8662928_0,-1,-1,-1,-1,43630,-1,0.99969935,8.880475e-05,0.0002118716
43633,transcription through IL-6-responsive,40,43,255,292,The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.,8662928_0,-1,-1,-1,-1,43633,-1,0.0005996795,0.9992581,0.0001422451
43635,the IL-10R,3,5,21,31,"To determine whether the IL-10R has signaling functions similar to IL-6R in cells normally expressing these receptors, leukocytes of the B-, T-, and NK-cell lineages were treated with either cytokine.",8662928_1,-1,-1,-1,-1,43635,-1,0.4438468,0.54926157,0.006891642
43636,functions,7,8,46,55,"To determine whether the IL-10R has signaling functions similar to IL-6R in cells normally expressing these receptors, leukocytes of the B-, T-, and NK-cell lineages were treated with either cytokine.",8662928_1,0,1,2,-1,43636,-1,0.00017562501,0.9997254,9.8987766e-05
43637,to IL-6R,9,11,64,72,"To determine whether the IL-10R has signaling functions similar to IL-6R in cells normally expressing these receptors, leukocytes of the B-, T-, and NK-cell lineages were treated with either cytokine.",8662928_1,-1,-1,-1,-1,43637,-1,0.62773436,0.36571983,0.006545781
43639,these receptors,15,17,102,117,"To determine whether the IL-10R has signaling functions similar to IL-6R in cells normally expressing these receptors, leukocytes of the B-, T-, and NK-cell lineages were treated with either cytokine.",8662928_1,-1,-1,-1,-1,43639,-1,0.0025865224,0.75500184,0.24241164
43645,factors that,3,5,25,37,Both cytokines activated factors that bound to the sis-inducible element and included STAT1 and STAT3.,8662928_2,-1,-1,-1,-1,43645,-1,6.806278e-05,0.9998839,4.7981535e-05
43646,to the,6,8,44,50,Both cytokines activated factors that bound to the sis-inducible element and included STAT1 and STAT3.,8662928_2,-1,-1,-1,-1,43646,-1,2.3478886e-05,0.99996424,1.2271128e-05
43649,The cell,0,2,0,8,"The cell response to IL-10 characteristically differed from that to IL-2/IL-15, IL-4, and interferon gamma.",8662928_3,-1,-1,-1,-1,43649,-1,0.003626085,0.5219912,0.4743828
43650,to IL-10,3,5,18,26,"The cell response to IL-10 characteristically differed from that to IL-2/IL-15, IL-4, and interferon gamma.",8662928_3,-1,-1,-1,-1,43650,-1,0.72665155,0.26309797,0.010250498
43651,that to,8,10,60,67,"The cell response to IL-10 characteristically differed from that to IL-2/IL-15, IL-4, and interferon gamma.",8662928_3,-1,-1,-1,-1,43651,-1,3.9972714e-05,0.99993145,2.8625873e-05
43654,the IL-10R,4,6,30,40,The signaling capabilities of the IL-10R for activating specific STAT proteins and inducing gene transcription were defined by reconstitution of receptor functions in transfected tissue culture cells.,8662928_4,-1,-1,-1,-1,43654,-1,0.22871596,0.7599752,0.011308812
43657,receptor functions,20,22,145,163,The signaling capabilities of the IL-10R for activating specific STAT proteins and inducing gene transcription were defined by reconstitution of receptor functions in transfected tissue culture cells.,8662928_4,-1,-1,-1,-1,43657,-1,0.0028412035,0.4788023,0.51835656
43658,transfected tissue,23,25,167,185,The signaling capabilities of the IL-10R for activating specific STAT proteins and inducing gene transcription were defined by reconstitution of receptor functions in transfected tissue culture cells.,8662928_4,-1,-1,-1,-1,43658,-1,2.8929464e-05,0.99991345,5.7553472e-05
43664,the IL-10R,16,18,100,110,"COS-1 cells, co-expressing the human IL-10R and individual STAT proteins, confirmed a preference of the IL-10R for STAT3 and STAT1.",8662928_5,-1,-1,-1,-1,43664,-1,0.7668303,0.22306702,0.010102606
43667,receptors,3,4,26,35,"Unlike many hematopoietin receptors, the IL-10R did not detectably activate STAT5.",8662928_6,0,1,2,-1,43667,-1,0.00042179486,0.0067877877,0.99279034
43668,the IL-10R,5,7,37,47,"Unlike many hematopoietin receptors, the IL-10R did not detectably activate STAT5.",8662928_6,-1,-1,-1,-1,43668,-1,0.34824902,0.6392967,0.012454246
43670,The IL-10R,0,2,0,10,"The IL-10R, together with reporter gene constructs containing different IL-6-responsive gene elements, reconstituted in hepatoma cells an induction of transcription by IL-10 that was comparable to that by IL-6.",8662928_7,-1,-1,-1,-1,43670,-1,0.0048819827,0.9930228,0.0020951368
43673,IL-6-responsive gene,10,12,72,92,"The IL-10R, together with reporter gene constructs containing different IL-6-responsive gene elements, reconstituted in hepatoma cells an induction of transcription by IL-10 that was comparable to that by IL-6.",8662928_7,-1,-1,-1,-1,43673,-1,0.9745901,0.019213095,0.0061967974
43676,IL-10 that,23,25,168,178,"The IL-10R, together with reporter gene constructs containing different IL-6-responsive gene elements, reconstituted in hepatoma cells an induction of transcription by IL-10 that was comparable to that by IL-6.",8662928_7,-1,-1,-1,-1,43676,-1,0.9921272,0.0048611336,0.0030116267
43677,to that,27,29,194,201,"The IL-10R, together with reporter gene constructs containing different IL-6-responsive gene elements, reconstituted in hepatoma cells an induction of transcription by IL-10 that was comparable to that by IL-6.",8662928_7,-1,-1,-1,-1,43677,-1,3.1183827e-05,0.99995446,1.4389259e-05
43679,This regulation,0,2,0,15,This regulation could not be appreciably modified by enhanced expression of STAT proteins.,8662928_8,-1,-1,-1,-1,43679,-1,2.2932623e-05,0.9999646,1.2493103e-05
43685,IL-6-responsive genes,12,14,71,92,The similar actions of IL-10R and IL-6R on the induction of endogenous IL-6-responsive genes were demonstrated in hepatoma cells stably expressing the IL-10R.,8662928_9,-1,-1,-1,-1,43685,-1,0.97450054,0.01942096,0.0060784393
43687,the IL-10R,21,23,147,157,The similar actions of IL-10R and IL-6R on the induction of endogenous IL-6-responsive genes were demonstrated in hepatoma cells stably expressing the IL-10R.,8662928_9,-1,-1,-1,-1,43687,-1,0.15082201,0.8381127,0.011065303
43688,These receptor functions,0,3,0,24,"These receptor functions required the presence of the box 3 motifs, as shown by the analysis of the mouse IL-10R constructs containing progressively truncated cytoplasmic domains.",8662928_10,-1,-1,-1,-1,43688,-1,7.275946e-05,0.999821,0.00010620943
43691,the analysis,15,17,80,92,"These receptor functions required the presence of the box 3 motifs, as shown by the analysis of the mouse IL-10R constructs containing progressively truncated cytoplasmic domains.",8662928_10,-1,-1,-1,-1,43691,-1,2.1015003e-05,0.9999678,1.1120429e-05
43696,that the IL-10R,3,6,21,36,"The data demonstrate that the IL-10R, unlike other members of the interferon receptor family, is highly effective in recruiting the signaling pathways of IL-6-type cytokine receptors.",8662928_11,-1,-1,-1,-1,43696,-1,0.003111925,0.9953513,0.0015367767
43697,the interferon receptor,11,14,62,85,"The data demonstrate that the IL-10R, unlike other members of the interferon receptor family, is highly effective in recruiting the signaling pathways of IL-6-type cytokine receptors.",8662928_11,-1,-1,-1,-1,43697,-1,0.0013649,0.9897804,0.008854617
43699,IL-6-type cytokine receptors,25,28,154,182,"The data demonstrate that the IL-10R, unlike other members of the interferon receptor family, is highly effective in recruiting the signaling pathways of IL-6-type cytokine receptors.",8662928_11,-1,-1,-1,-1,43699,-1,0.8650881,0.006423178,0.12848872
43700,Analysis,0,1,0,8,Analysis of melanoma cell lines with abnormalities in HLA Class I antigen expression has identified two serological phenotypes caused by distinct molecular defects.,8795138_0,0,1,-1,-1,43700,-1,2.4554294e-05,0.9999583,1.7213904e-05
43720,antigen trimolecular complex,23,26,155,183,"This phenotype reflects abnormalities in TAP heterodimer expression, which cause defects in stable assembly and intracellular transport of the HLA Class I antigen trimolecular complex.",8795138_4,-1,-1,-1,-1,43720,-1,0.59939367,0.33425856,0.06634778
43724,antigen-restricted cytotoxic T cells,16,20,86,122,Loss of HLA Class I antigens renders melanoma cells resistant to lysis by HLA Class I antigen-restricted cytotoxic T cells which specifically recognize melanoma associated antigens.,8795138_5,-1,-1,-1,-1,43724,-1,0.07370144,0.0013941207,0.92490447
43739,interleukin-8 (IL-8) receptor,6,11,44,73,"HHV-8 possesses genes including homologs of interleukin-8 (IL-8) receptor, Bcl-2, and cyclin D, which can potentially transform the host cell.",9446657_1,-1,-1,-1,-1,43739,-1,0.9429542,0.0032323261,0.05381348
43740,transform the,21,23,118,131,"HHV-8 possesses genes including homologs of interleukin-8 (IL-8) receptor, Bcl-2, and cyclin D, which can potentially transform the host cell.",9446657_1,-1,-1,-1,-1,43740,-1,2.4051968e-05,0.9999554,2.0504614e-05
43743,these genes,5,7,27,38,"However, the expression of these genes in KS tissues is very low or undetectable and HHV-8 does not seem to transform human cells in vitro.",9446657_2,-1,-1,-1,-1,43743,-1,2.3722949e-05,0.999961,1.5253102e-05
43744,tissues,9,10,45,52,"However, the expression of these genes in KS tissues is very low or undetectable and HHV-8 does not seem to transform human cells in vitro.",9446657_2,-1,1,2,-1,43744,-1,3.4844263e-05,0.9998814,8.3781604e-05
43745,to transform,20,22,105,117,"However, the expression of these genes in KS tissues is very low or undetectable and HHV-8 does not seem to transform human cells in vitro.",9446657_2,-1,-1,-1,-1,43745,-1,2.3871313e-05,0.99995863,1.7516935e-05
43755,the nature,6,8,28,38,"However, little is known on the nature of the inflammatory cell infiltration present in KS, on the type of cytokines produced and on their role in KS, and whether this correlates with the presence of HHV-8.",9446657_6,-1,-1,-1,-1,43755,-1,2.191062e-05,0.99996316,1.493559e-05
43758,the type,18,20,95,103,"However, little is known on the nature of the inflammatory cell infiltration present in KS, on the type of cytokines produced and on their role in KS, and whether this correlates with the presence of HHV-8.",9446657_6,-1,-1,-1,-1,43758,-1,3.074994e-05,0.9999534,1.5901245e-05
43770,cells to,8,10,40,48,"gamma IFN, in fact, induces endothelial cells to acquire the same features of KS cells, including the spindle morphology and the pattern of cell marker expression.",9446657_8,-1,-1,-1,-1,43770,-1,0.0033184001,0.14362332,0.8530582
43780,factor,15,16,101,107,"These KS-like lesions are accompanied by production of basic fibroblast growth factor, an angiogenic factor highly expressed in primary lesions that mediates angiogenesis and spindle cell growth.",9446657_10,0,1,-1,-1,43780,-1,0.99919397,0.000502639,0.00030339215
43786,factor,20,21,136,142,The formation of KS-like lesions is upregulated by the human immunodeficiency virus Tat protein demonstrating its role as a progression factor in AIDS-KS.,9446657_11,0,1,-1,-1,43786,-1,0.0014477316,0.99836534,0.00018696583
43789,tissues,17,18,105,112,"Finally, gamma IFN and HLA-DR expression correlate with the presence of HHV-8 in lesional and uninvolved tissues from the same patients.",9446657_12,-1,1,2,-1,43789,-1,0.0010049259,0.7209128,0.27808228
43801,the tumour plasma cells,11,15,61,84,The monoclonal immunoglobulin (Ig) (M-component) secreted by the tumour plasma cells in multiple myeloma (MM) has specific antigenic determinants (idiotypes; id) that can serve as tumour-specific antigens.,9531329_0,-1,-1,-1,-1,43801,-1,0.0024431965,0.87493235,0.122624435
43804,tumour-specific antigens,35,37,180,204,The monoclonal immunoglobulin (Ig) (M-component) secreted by the tumour plasma cells in multiple myeloma (MM) has specific antigenic determinants (idiotypes; id) that can serve as tumour-specific antigens.,9531329_0,-1,-1,-1,-1,43804,-1,0.045571905,0.94855976,0.0058683963
43807,protein,15,16,68,75,"The intact Ig molecule is a weak antigen, and small fragments of id protein might be more immunogenic for the induction of id-specific immunity.",9531329_1,0,1,-1,-1,43807,-1,0.000498457,0.9979752,0.0015263841
43809,immunity,25,26,135,143,"The intact Ig molecule is a weak antigen, and small fragments of id protein might be more immunogenic for the induction of id-specific immunity.",9531329_1,0,-1,2,-1,43809,-1,0.99914,0.00052583934,0.00033408304
43812,antigen-presenting cells,12,14,68,92,Dendritic cells (DC) have attracted attention as the most efficient antigen-presenting cells and promising adjuvants for immunotherapy in tumours.,9531329_2,-1,-1,-1,-1,43812,-1,0.40357623,0.0032301473,0.59319365
43816,T-cell,6,7,27,33,"In this study the in vitro T-cell response against F(ab')2 and Fab fragments, heavy and light chains of the M-component was examined in five patients with MM clinical stage I. All fragments were able to stimulate T cells but F(ab')2 or Fab fragments and heavy chains induced a stronger response than light chains.",9531329_3,-1,1,2,-1,43816,-1,3.3730124e-05,4.929803e-05,0.9999169
43821,immune response than,6,9,48,68,DC induced a significantly stronger id-specific immune response than monocytes.,9531329_4,-1,-1,-1,-1,43821,-1,0.90006804,0.096196614,0.0037352634
43822,antigen-presenting cells,5,7,21,45,"Moreover, with DC as antigen-presenting cells, a predominant interferon (IFN)-gamma (type-1 T-cell) response was seen in all patients.",9531329_5,-1,-1,-1,-1,43822,-1,0.16347216,0.0033150108,0.83321285
43824,type-1 T-cell,13,15,85,98,"Moreover, with DC as antigen-presenting cells, a predominant interferon (IFN)-gamma (type-1 T-cell) response was seen in all patients.",9531329_5,-1,-1,-1,-1,43824,-1,0.0023062716,0.20221657,0.79547715
43828,type-2 T-cell,8,10,50,63,Both IFN-gamma and interleukin (IL)-4 (type-1 and type-2 T-cell) responses were noted when monocytes were used.,9531329_6,-1,-1,-1,-1,43828,-1,0.0038338646,0.28727368,0.70889246
43832,T-cell,25,26,155,161,Our study suggests that DC pulsed with idiotypic fragments such as F(ab')2 fragment and heavy chain can be used for the induction of type-1 anti-idiotypic T-cell response for immunotherapy in MM.,9531329_7,-1,1,2,-1,43832,-1,3.5732053e-05,5.432041e-05,0.9999099
43847,factor,25,26,187,193,The efficacy of the activated LN cells is augmented when the sensitizing tumor is a genetically modified variant (designated D5G6) that secretes granulocyte/macrophage-colony-stimulating factor.,9690455_1,0,1,-1,-1,43847,-1,0.99977297,7.6537195e-05,0.00015052574
43856,function,7,8,50,58,"To determine whether the acquisition of antitumor function during ex vivo activation is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were analyzed in tumor-draining LN T cells.",9690455_3,0,1,2,-1,43856,-1,4.9903196e-05,0.99991846,3.166062e-05
43858,the protein tyrosine,21,24,151,171,"To determine whether the acquisition of antitumor function during ex vivo activation is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were analyzed in tumor-draining LN T cells.",9690455_3,-1,-1,-1,-1,43858,-1,2.2017537e-05,0.9999634,1.4588832e-05
43859,proteins,29,30,202,210,"To determine whether the acquisition of antitumor function during ex vivo activation is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were analyzed in tumor-draining LN T cells.",9690455_3,0,1,-1,-1,43859,-1,4.2348835e-05,0.99992275,3.4847297e-05
43860,the NF-kappaB,31,33,214,227,"To determine whether the acquisition of antitumor function during ex vivo activation is associated with modifications in signal transduction capacity, the protein tyrosine kinases p56lck and p59fyn and proteins of the NF-kappaB family were analyzed in tumor-draining LN T cells.",9690455_3,-1,-1,-1,-1,43860,-1,3.4011533e-05,0.99994934,1.6671862e-05
43864,tumor-draining than,9,11,46,65,The levels of p56lck and p59fyn were lower in tumor-draining than in normal LN T cells and production of tyrosine-phosphorylated substrates was markedly depressed following anti-CD3 stimulation.,9690455_4,-1,-1,-1,-1,43864,-1,2.5446805e-05,0.99996185,1.2713826e-05
43872,than they,25,27,141,150,"Interestingly, the levels of p56lck, p59fyn, and tyrosine kinase activity were higher in activated T cells derived from LN that drained D5G6 than they were in those from D5 tumors.",9690455_6,-1,-1,-1,-1,43872,-1,2.616968e-05,0.9999542,1.9604373e-05
43880,tumor cells,7,9,42,53,Stimulation of activated LN cells with D5 tumor cells induced the nuclear translocation of NF-kappaB. These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.,9690455_8,-1,-1,-1,-1,43880,-1,0.0042184317,0.38493124,0.61085033
43884,that the,18,20,126,134,Stimulation of activated LN cells with D5 tumor cells induced the nuclear translocation of NF-kappaB. These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.,9690455_8,-1,-1,-1,-1,43884,-1,1.776887e-05,0.99997437,7.851707e-06
43885,proteins,22,23,147,155,Stimulation of activated LN cells with D5 tumor cells induced the nuclear translocation of NF-kappaB. These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.,9690455_8,0,1,-1,-1,43885,-1,2.9191651e-05,0.999951,1.9822955e-05
43886,transduction through the T cell,25,30,173,204,Stimulation of activated LN cells with D5 tumor cells induced the nuclear translocation of NF-kappaB. These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.,9690455_8,-1,-1,-1,-1,43886,-1,0.004873422,0.68788004,0.30724648
43890,function,46,47,307,315,Stimulation of activated LN cells with D5 tumor cells induced the nuclear translocation of NF-kappaB. These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.,9690455_8,0,1,2,-1,43890,-1,6.85816e-05,0.9998741,5.7268364e-05
43891,blood T lymphocytes,6,9,46,65,We examined signaling molecules of peripheral blood T lymphocytes obtained from women with breast cancer.,9724088_0,-1,-1,-1,-1,43891,-1,0.00071793544,0.0123358285,0.9869463
43893,to translocate,12,14,65,79,"In 6 of 14 patients, T lymphocytes displayed an impaired ability to translocate NFB p65 (Rel-A) following activation by anti-CD3 and IL-2.",9724088_1,-1,-1,-1,-1,43893,-1,2.3226848e-05,0.99996054,1.6258e-05
43897,the Rel-A protein,9,12,63,80,This observation was made despite normal cytoplasmic levels of the Rel-A protein.,9724088_2,-1,-1,-1,-1,43897,-1,3.0915813e-05,0.99994314,2.5950862e-05
43901,T-cell,29,30,164,170,"We also detected abnormally low levels of the signaling molecules T-cell receptor (TCR)-zeta, ZAP-70 and p56lck in 4 of 14 breast cancer patients, i.e., defects in T-cell signaling molecules.",9724088_3,-1,1,2,-1,43901,-1,4.010503e-05,5.4037566e-05,0.99990594
43907,T cells that,21,24,108,120,"Abnormalities of I or more signaling molecules were found in 9 of 14 patients; however, only 3 patients had T cells that exhibited all 5 defects.",9724088_6,-1,-1,-1,-1,43907,-1,0.001147463,0.027104504,0.9717481
43910,the analysis,3,5,13,25,"For example, the analysis of only 1 signaling molecule may allow patients with significant defects in T-cell signaling to go unnoticed.",9724088_8,-1,-1,-1,-1,43910,-1,2.3422785e-05,0.9999647,1.1818806e-05
43911,T-cell,17,18,102,108,"For example, the analysis of only 1 signaling molecule may allow patients with significant defects in T-cell signaling to go unnoticed.",9724088_8,-1,1,2,-1,43911,-1,3.8501246e-05,5.6971803e-05,0.9999045
43913,Rel-A translocation,4,6,26,45,"Finally, despite impaired Rel-A translocation, T cells were capable of transcribing IL-2.",9724088_9,-1,-1,-1,-1,43913,-1,3.1513177e-05,0.99994457,2.392522e-05
43916,the translocation,2,4,15,32,"Impairments in the translocation of Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.",9724088_10,-1,-1,-1,-1,43916,-1,2.1406922e-05,0.9999671,1.144896e-05
43919,that the NFKB,10,13,68,81,"Impairments in the translocation of Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.",9724088_10,-1,-1,-1,-1,43919,-1,2.5916006e-05,0.999962,1.2135149e-05
43923,the transcription,24,26,141,158,"Impairments in the translocation of Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.",9724088_10,-1,-1,-1,-1,43923,-1,2.2473303e-05,0.9999672,1.0355435e-05
10895,antigen,18,19,110,117,The latter large fragments of peptides contained many epitopes able to bind to at least seven human leucocyte antigen (HLA) class I molecules and were strong binders to seven HLA-DR class II molecules.,19843089_4,0,-1,-1,0,10895,-1,0.9500471,0.0003262708,0.049626667
32108,IL-1,12,13,78,83,"The CpG-HH2 complex significantly enhanced the production of IFN-, TNF- and IL-1, promoted the uptake of antigen and strengthened the activation of p38, Erk1/2 and NF-B in vitro, compared to CpG or HH2 alone.",28515346_3,0,-1,-1,0,32108,-1,0.99972254,9.095617e-05,0.0001865527
18339,granulocyte macrophage colony-stimulating factor,25,29,166,214,"INTRODUCTION: In this study we describe a patient with a prolonged myasthenic crisis refractory to conventional immunomodulatory therapy who was treated with GM-CSF (granulocyte macrophage colony-stimulating factor, sargramostim).METHODS: T-regulatory cell (Treg) suppressive function and Foxp3 expression were evaluated before and after treatment with GM-CSF.RESULTS: Treatment with GM-CSF was associated with clinical improvement, expansion in the circulating numbers of Foxp3(+) cells, increase in Foxp3 expression levels in Tregs, early improvement in Treg suppressive capacity for AChR--induced T-cell proliferation, and subsequent enhancement in Treg suppression of polyclonal T-cell proliferation.",22907239_0,0,-1,-1,0,18339,-1,0.9988148,0.0001140457,0.001071086
22408,IL-17,17,18,94,99,"Meanwhile, Tregs from patient's blood was co-cultured with human CRC cells in the presence of IL-17.",24487033_5,0,-1,-1,0,22408,-1,0.9996455,7.360007e-05,0.00028083142
7711,IL-10,21,22,117,122,"Treatment of T reg cells in vitro with imiquimod inhibited their suppressive activity and reduced FOXP3, CD39, CD73, IL-10, and TGF-beta by indirect mechanisms.",18794336_6,0,-1,-1,0,7711,-1,0.9998883,2.7429433e-05,8.42179e-05
29900,interleukin 10,10,12,43,57,"The expression of Forkhead box P3 (Foxp3), interleukin 10, transforming growth factor-, chemokine CC motif ligands 17, 20, and CC chemokine receptor 4 was determined using real-time quantitative polymerase chain reaction.",27614428_2,0,-1,-1,0,29900,-1,0.9998828,3.994851e-05,7.726525e-05
3945,IFN-gamma,12,13,92,101,"Analysis of tumor-infiltrating CD8(+) T cells demonstrated that although treatment enhanced IFN-gamma production, antitumor cytotoxicity was diminished.",16751376_8,0,-1,-1,0,3945,-1,0.99987876,2.937847e-05,9.185909e-05
15593,IL-17-producing,6,7,28,43,"A unique subset of FOXP3(+) IL-17-producing CD4(+) T cells was consistently identified in tumor-infiltrating lymphocytes from advanced stages of cancer, but not in the circulation, at a frequency of 0.5% to 5.5 % of total CD4(+) T and positively correlated with the frequency of IL-17(+)FOXP3(-) T cells.",21837700_3,0,-1,-1,0,15593,-1,0.9997396,9.595751e-05,0.00016450929
37414,IL-1,5,6,27,32,Release of interleukin 1 (IL-1) from cancer-associated fibroblasts (CAF) induces CCL22 mRNA expression in oral cancer cells by activating transcription factor nuclear factor kappa B (NF-B).,31325403_8,0,-1,-1,0,37414,-1,0.99805874,0.00095965934,0.0009815237
12323,IL-17A,35,36,176,182,"SCC from immunocompetent patients and OTRs were analyzed by real-time polymerase chain reactions for CD4, CD8, TBET, GATA-3, FOXP3, RORC, IFN-gamma, IL-4, TGF-beta, IL-10, and IL-17A mRNA expression.",20463594_4,0,-1,-1,0,12323,-1,0.99983263,3.1896525e-05,0.00013534649
12732,IFN-gamma-deficient,7,8,41,60,"To address these questions, wild-type or IFN-gamma-deficient OVA-specific CD8(+) T cells were activated in RAG-2(-/-) gamma c(-/-) recipients with control or IL-4-expressing OVA(+) tumor cells, and then transferred to secondary recipients for tumor challenge.",20562261_4,0,-1,-1,0,12732,-1,0.99924767,0.00034692688,0.00040549284
21757,IFN-,6,7,34,39,"The levels of intratumoral IL-12, IFN-, IL-10 and TGF-1 were evaluated.",24304581_6,0,-1,-1,0,21757,-1,0.999866,3.0522817e-05,0.00010348676
43787,IFN,3,4,15,18,"Finally, gamma IFN and HLA-DR expression correlate with the presence of HHV-8 in lesional and uninvolved tissues from the same patients.",9446657_12,0,-1,-1,0,43787,-1,0.9997167,5.6219367e-05,0.00022701586
11840,immune responses,21,23,124,140,"We observed severe loss of both effector and memory T-cell populations, downregulation of type 1 and upregulation of type 2 immune responses and decreased proliferation of effector T cells in the presence of tumors.",20305684_6,0,-1,-1,0,11840,-1,0.999828,9.7912896e-05,7.408672e-05
11208,CCL22,19,20,114,119,"In addition, the in vitro migration assay indicated that T-regs were significantly induced to migrate by CCL17 or CCL22.",20002703_9,0,-1,-1,0,11208,-1,0.9942636,0.00036052428,0.0053758887
5842,IL-10,4,5,29,34,The addition of neutralizing IL-10 and TGF-beta antibodies almost completely abrogated suppression (5 +/- 2.51%).,17671115_9,0,-1,-1,0,5842,-1,0.99986184,2.9864155e-05,0.00010826198
35099,chemotherapy,11,12,91,103,"Consequently, the multifunctional nanoplatform provides a potential strategy of synergetic chemotherapy and immunotherapy.",29882235_6,0,-1,-1,0,35099,-1,0.9989728,0.00031175427,0.0007154873
8983,innate immunity,10,12,69,84,"Ablating Stat3 in hematopoietic cells results in rapid activation of innate immunity by CpG, with enhanced production of IFN-gamma, tumor necrosis factor-alpha, IL-12, and activation of macrophages, neutrophils, and natural killer cells marked with Stat1 activation.",19258507_2,0,-1,-1,0,8983,-1,0.9996444,0.00017034078,0.0001852574
37086,IFNAR1,23,24,126,132,METHODS: Tumor tissues and CTLs of human colorectal cancer patients were analyzed for interferon (alpha and beta) receptor 1 (IFNAR1) expression.,31228946_2,0,-1,-1,0,37086,-1,0.99310124,0.0010822611,0.0058164587
19701,immune response,16,18,108,123,The transcription factor interferon regulatory factor-8 (IRF-8) is crucial for myeloid cell development and immune response and also acts as a tumor suppressor gene.,23308054_0,0,-1,-1,0,19701,-1,0.99973375,0.00018512915,8.1150436e-05
31827,IL-6,19,20,110,114,"Here, we report that IL-35 can induce N2 neutrophil polarization (protumor phenotype) by increasing G-CSF and IL-6 production, and promote neutrophil infiltration into tumor microenvironment.",28432279_3,0,-1,-1,0,31827,-1,0.9997497,4.565948e-05,0.00020464018
21835,immune response,15,17,88,103,"In summary, umbelliprenin has shown a partially Th1 bias with a reduction of regulatory immune response.",24325354_10,0,-1,-1,0,21835,-1,0.99980575,0.00011364603,8.0616e-05
5853,Interleukin,0,1,0,11,Interleukin (IL)-2 is used in the immunotherapy of patients with certain cancer and HIV infection.,17671219_0,0,-1,-1,0,5853,-1,0.9997421,4.6041907e-05,0.00021191318
17322,IL-15,23,24,146,151,"The inhibitory effect of SCLC tumour cells was not affected by blocking IL-10 receptor or TGF- signalling but was partially reversed by blocking IL-15, which is reported to be involved in human Treg cells induction.",22532287_7,0,-1,-1,0,17322,-1,0.99974364,4.1156956e-05,0.00021521126
5113,IL-10,50,51,300,305,"In addition, CD4+ TIL cells were of an activated/memory (ICOS(high)CD62L(low)CD45RB(low)) phenotype and were capable of suppressing allospecific T cell proliferation and IFN-gamma production from (in vivo cross-primed) anti-CMS4 CD8+ T cells in vitro, via a mechanism at least partially dependent on IL-10 and TGF-beta.",17339434_4,0,-1,-1,0,5113,-1,0.9999033,2.5920592e-05,7.076797e-05
36077,IL12B,38,39,247,252,"RNA-seq analysis in human MoDCs revealed that N1 plus R848 synergistically upregulated the expression of genes predominantly involved in DC maturation pathway, particularly genes critical for the polarization of Th1 immune responses (e.g., IL12A, IL12B, and IFNB1, etc.).",30619338_6,0,-1,-1,0,36077,-1,0.99981755,4.182129e-05,0.00014063051
20184,IL-10,27,28,156,161,"Formation of this phenotype requires 4-1BB signaling on both T and antigen-presenting cells and the resulting production of the cytokines IL-27, IL-15, and IL-10.",23547098_4,0,-1,-1,0,20184,-1,0.99979216,3.456886e-05,0.00017325839
2426,immune responses,1,3,10,26,"Antitumor immune responses were mediated by both CD4+ and CD8+ T cells, were human lymphocyte antigen class I and II associated, and persisted 18 months beyond the completion of vaccination.",15623607_6,0,-1,-1,0,2426,-1,0.9996383,0.00022531189,0.00013634992
16141,interferon-gamma,10,11,73,89,The extent of T-cell migration toward culture supernatants obtained from interferon-gamma (IFN--stimulated gastric carcinoma cell lines was additionally affected by expression of PML in vitro.,22022583_4,0,-1,-1,0,16141,-1,0.9998971,3.3856562e-05,6.898957e-05
43267,IFN-,9,10,61,66,"However, the mechanism of APLNR cross-talk with intratumoral IFN- signaling remains unknown.",35084016_3,0,-1,-1,0,43267,-1,0.99987245,3.4199544e-05,9.3354734e-05
33737,immune responses,3,5,23,39,"Furthermore, secondary immune responses could be primed as soon as these immunized mice were challenged with HCC cells, accompanied by T cell and NK cell activation and infiltration.",29115974_5,0,-1,-1,0,33737,-1,0.99963284,0.00025687693,0.00011027676
34194,IL-6,10,11,77,81,MUC16c released into the cytoplasm via EGF induction significantly increased IL-6 expression and secretion.,29337110_7,0,-1,-1,0,34194,-1,0.9998016,4.9544953e-05,0.00014890506
834,IFN-gamma,3,4,24,33,"After interferon-gamma (IFN-gamma) stimulation, MG cells upregulated CIITA and class II molecules.",11746775_3,0,-1,-1,0,834,-1,0.99990284,3.196777e-05,6.522806e-05
19147,CCL2,0,1,0,4,CCL2 would be an attractive target for treatment to eliminate cancer cells via amelioration of tumor metastasis and immunosuppression.,23143679_10,0,-1,-1,0,19147,-1,0.90885353,0.002810113,0.08833641
9455,interferon,4,5,24,34,METHODS: We established interferon regulatory factor-1-null (irf-1(-/-)) mice with inducible and persistent expression of HCV structural proteins (irf-1/CN2 mice).,19362089_2,0,-1,-1,0,9455,-1,0.00012477426,0.9998338,4.140867e-05
18324,chemokine,3,4,17,26,"The cytokine and chemokine profile of macrophages treated with tumor cell derived exosomes showed marked differences from those induced by either LPS or IL-4, and it suggested that exosomes may play a role in the tumor progression and metastasis formation through supporting tumor immune escape mechanisms.",22898052_4,0,-1,-1,0,18324,-1,0.99977416,6.439643e-05,0.00016153109
32147,cytokines,15,16,132,141,"IL-1R8 expression in transformed breast epithelial cells reduced IL-1-dependent NF-B activation and production of pro-inflammatory cytokines, inhibited NK cell activation and favored M2-like macrophage polarization.",28533483_3,0,-1,-1,0,32147,-1,0.9998599,4.714822e-05,9.288344e-05
2854,IL-12Rbeta2,26,27,179,190,"In T-bet-deficient naive CD8+ T cells, IL-27-induced proliferation was hardly reduced, but synergistic IFN-gamma production with IL-12 was diminished with decreased expression of IL-12Rbeta2, granzyme B, and perforin.",16034109_7,0,-1,-1,0,2854,-1,0.9977519,0.0011957651,0.0010524275
22781,Interferon,2,3,9,19,"RESULTS: Interferon -mediated, CD8(+) T-cell responses were observed in KPC and Kras(G12D/+);Pdx-1-Cre mice given LM-Kras, but not in unvaccinated mice.",24607504_5,0,-1,-1,0,22781,-1,0.9996878,0.00012019807,0.00019194176
26117,GM-CSF,0,1,0,6,"GM-CSF production was significantly enhanced in various PDAC cell lines or PDAC tumor tissues from patients after treatment with chemotherapy, which induced the differentiation of monocytes into myeloid-derived suppressor cells (MDSC).",25952647_5,0,-1,-1,0,26117,-1,0.99977845,6.373842e-05,0.00015780723
1718,IL-12,4,5,17,22,"IL-27 is a novel IL-12 family member that plays a role in the early regulation of T helper cell 1 initiation, including induction of T-bet and IL-12 receptor beta 2 expression.",14871851_1,0,-1,-1,0,1718,-1,0.99961394,8.3138926e-05,0.00030286793
36355,IL-1,5,6,27,32,"When TGF- was replaced by IL-1, the combination of IL-1 and IL-4 efficiently promoted IL-9-producing T cells (Th9IL-4+IL-1).",30914642_3,0,-1,-1,0,36355,-1,0.99242675,0.0026695535,0.004903696
26876,CXCL10,22,23,132,138,"Finally, the neutralization of the common type-1 interferon receptor or that of the chemokine receptor CXCR3 (which binds CXCL9 and CXCL10) abolished the difference in the chemotherapeutic response between Stat3(-/-) and control tumors.",26208907_8,0,-1,-1,0,26876,-1,0.99959046,5.8257676e-05,0.0003513178
35462,IL-17A,32,33,162,168,"Activated CD4+ T cells differentiate into four main separate lineages: Th1, Th2, Th17 and Treg, and they are recognized by their effector molecules IFN-, IL-13, IL-17A, and the transcription factor Foxp3, respectively.",30075815_5,0,-1,-1,0,35462,-1,0.9998541,3.0122756e-05,0.000115718154
12649,immune responses,12,14,84,100,We observed a strong correlation between a defined set of vaccine-prompted specific immune responses and the clinical efficacy of therapeutic vaccination.,20547850_7,0,-1,-1,0,12649,-1,0.99975437,0.00015412219,9.150834e-05
13090,innate immune responses,35,38,197,220,"Although the suppressive effect of Treg cells on T cells is well documented, less is known about the types of innate immune cells influenced by Treg cells and whether the Treg cells suppress acute innate immune responses in vivo.",20722759_3,0,-1,-1,0,13090,-1,0.99980956,0.00010085489,8.96467e-05
8977,IL-6,31,32,181,185,"Here, we show that signal transducer and activator of transcription 3 (Stat3) plays a key role in down-modulating immunostimulatory effects of CpG. In the absence of interleukin-6 (IL-6) and IL-10 induction, CpG directly activates Stat3 within minutes through TLR9.",19258507_1,0,-1,-1,0,8977,-1,0.9998554,3.7313224e-05,0.000107248365
42174,IL-17,6,7,42,47,"The presence and clinical significance of IL-17 and IL-17-expressing cells have been studied for several cancers, although their correlation with tumor development remains controversial.",33971545_0,0,-1,-1,0,42174,-1,0.99972945,6.300652e-05,0.00020749553
13172,interleukin,11,12,67,78,MATERIAL AND METHODS: We evaluated T cell stimulatory activity and interleukin (IL)-12 production of DC in a mouse model of liver cancer (hepatocellular carcinoma [HCC] mice).,20822377_3,0,-1,-1,0,13172,-1,0.9998466,4.1611886e-05,0.000111831505
6844,antigen,9,10,64,71,"In addition, intestinal IL-9 overexpression predisposes to oral antigen sensitization, which requires mast cells and increased intestinal permeability. These observations demonstrate a central role for IL-9 and mast cells in experimental intestinal permeability in oral antigen sensitization and suggest that IL-9-mediated mast cell responses have an important role in food allergy.",18378796_4,0,-1,-1,0,6844,-1,0.9995622,0.00010050517,0.00033737396
20060,IL-10,17,18,106,111,"Consistent with Th2 inflammation, CD22+ B cells and IgG4(+)-infiltrating cells accumulated in tumors, and IL-10, IL-4, and tumor-reactive IgG4 were expressed in situ.",23454746_3,0,-1,-1,0,20060,-1,0.9998468,2.8626808e-05,0.00012450213
12320,IFN-gamma,26,27,138,147,"SCC from immunocompetent patients and OTRs were analyzed by real-time polymerase chain reactions for CD4, CD8, TBET, GATA-3, FOXP3, RORC, IFN-gamma, IL-4, TGF-beta, IL-10, and IL-17A mRNA expression.",20463594_4,0,-1,-1,0,12320,-1,0.9998795,2.6646052e-05,9.385261e-05
15792,antigen,16,17,105,112,The novel targeted vaccine induced durable Th1 and CD8 T cell responses to poorly immunogenic self/tumor antigen (Ag) and attenuated tumor-associated Treg suppressive function.,21934655_4,0,-1,-1,0,15792,-1,0.9992298,7.0866e-05,0.0006993456
22390,IL-17,13,14,76,81,"In this study, we investigated the mix-effect of the intratumoral Tregs and IL-17 producing T cells on metastasis of colorectal carcinoma (CRC) after resection.",24487033_1,0,-1,-1,0,22390,-1,0.9997886,5.1938925e-05,0.00015950936
3668,MIP-3alpha,20,21,148,158,"Surrounding stroma and/or infiltrating cells were the most likely source of hepatocyte growth factor, macrophage inflammatory protein (MIP)-1delta, MIP-3alpha, neutrophil-activating peptide-2, and pulmonary and activation-regulated chemokine that can cause leukocyte infiltration and activation.",16540497_5,0,-1,-1,0,3668,-1,0.9983596,0.00079340156,0.00084704993
7499,CCL22,18,19,99,104,"There were positive correlations between FOXP3 and IL-10, FOXP3 and TGFbeta1, as well as FOXP3 and CCL22 mRNA expressions, respectively.",18685848_3,0,-1,-1,0,7499,-1,0.99729055,0.00016820733,0.002541248
17666,IFN-,0,1,0,5,"IFN- acts synergistically with IFN- to support development of strong effector functions, whereas IL-12 induces high T-bet expression and strong function in the absence of IFN- signaling.",22706089_2,0,-1,-1,0,17666,-1,0.9998901,3.16018e-05,7.8288205e-05
5940,IL-8,31,32,193,197,We demonstrated that infection of melanoma cells and fibroblasts with cell-associated varicella-zoster virus (VZV) and infection of a T cell line with cell-free VZV resulted in an induction of IL-8 secretion in vitro.,17909856_1,0,-1,-1,0,5940,-1,0.9998373,3.0692172e-05,0.00013191685
15967,IL-12p70,19,20,92,100,"In addition, GP treatment decreased IL-10 and TGF- level (P < 0.01) and increased IL-2 and IL-12p70 level in serum (P < 0.01).",21963624_6,0,-1,-1,0,15967,-1,0.9898352,0.0005951152,0.009569733
32741,IL-10-secreting,20,21,143,158,Our study demonstrated that tolerogenic DCs modify anti-tumor immune response by suppressing NK cell activity and stimulating the formation of IL-10-secreting CD8+ Tregs.,28675711_8,0,-1,-1,0,32741,-1,0.9975968,0.0010686602,0.0013344997
24386,immune responses,3,5,36,52,Cell-mediated and antibody-mediated immune responses were evaluated.,25070035_4,0,-1,-1,0,24386,-1,0.9994759,0.00036027943,0.0001638386
27420,immune responses,10,12,57,73,Galectin-3 is also known to be an important regulator of immune responses.,26442663_2,0,-1,-1,0,27420,-1,0.99923134,0.00061929,0.00014942384
31049,chemokine,46,47,321,330,"Using an in vitro approach, we could demonstrate that peripheral blood mononuclear cells including the clonal population can trigger a phenotype switch of epithelial renal cells from a quiescent state to a pro-inflammatory state characterized by NF-B nuclear translocation and overexpression of inflammatory cytokine or chemokine.",28018996_5,0,-1,-1,0,31049,-1,0.9998492,5.616599e-05,9.465974e-05
21141,IL-1,14,15,90,95,"Focusing on human studies, we review the current understanding of molecular interactions (IL-1, IL-6, IL-23, IL-21 and TGF-), the signaling pathway (STAT3RORt) and the migration (induced by CCR6/CCL20) that contribute to Th17 differentiation and function in tumor microenvironment.",24044962_1,0,-1,-1,0,21141,-1,0.9992724,0.00014736856,0.00058021466
20745,immune responses,32,34,194,210,"Here, we further studied the immunogenicity of chimeric murine MSLN-virus-like particles (mMSLN-VLPs), their ability to break tolerance to mMSLN, a self-antigen, and deciphered the mechanism of immune responses elicited by mMSLN-VLP immunization using a pancreatic cancer (PC) mouse model.",23874581_1,0,-1,-1,0,20745,-1,0.99974245,0.00016476521,9.2770715e-05
26578,IFN,15,16,108,112,"The colon of untreated Mutyh-/- mice expressed higher basal levels of pro-inflammatory cytokines GM-CSF and IFN, and treatment with AOM/DSS induced an early decrease in circulating CD4+ and CD8+ T lymphocytes and an increase in myeloid-derived suppressor cells (MDSCs).",26109431_6,0,-1,-1,0,26578,-1,0.9998857,3.414199e-05,8.023617e-05
11475,chemotherapy,16,17,98,110,This tumor-driven aberrant T-cell response could be prevented by a single dose of the widely used chemotherapy agent cyclophosphamide.,20118405_5,0,-1,-1,0,11475,-1,0.9988526,0.00012860278,0.0010188121
21726,chemokine,13,14,66,75,BACKGROUND: Secondary lymphoid tissue chemokine (SLC) is a key CC chemokine for chemotaxis of immune cells and has been an attractive candidate for anti-tumor treatments.,24304581_0,0,-1,-1,0,21726,-1,0.9993315,7.6590266e-05,0.0005919956
27969,IL-6-conditioned,0,1,0,16,IL-6-conditioned monocyte-derived DCs (MoDCs) impaired the presenting ability of cancer-related antigens.,26759006_2,0,-1,-1,0,27969,-1,0.99846256,0.00024546683,0.001291969
21466,interleukin,13,14,85,96,"Among these is the recently described Th9 cell subset, which preferentially produces interleukin (IL)-9.",24215739_3,0,-1,-1,0,21466,-1,0.99978834,4.645573e-05,0.0001651656
6913,immune responses,27,29,146,162,"This is the first study to investigate the ability of reovirus to activate human dendritic cells (DC), key regulators of both innate and adaptive immune responses.",18424722_2,0,-1,-1,0,6913,-1,0.9998266,9.960378e-05,7.375676e-05
11739,IFN-gamma,15,16,58,67,"Numbers of CD4(+) and CD8(+) T cells, Con A response, and IFN-gamma production increased significantly, whereas number of Gr-1(+)/CD11b(+) myeloid suppressor cells and the percentage of FoxP3(+) cells in CD4(+) T cells significantly decreased in these mice.",20229083_5,0,-1,-1,0,11739,-1,0.999894,3.197691e-05,7.397321e-05
593,cytokines,20,21,107,116,"These phenomena are triggered or enhanced by infection with HHV8 that, in turn, is reactivated by the same cytokines.",11423257_2,0,-1,-1,0,593,-1,0.9997981,4.9805523e-05,0.00015212277
23941,IFN,14,15,76,79,The role of STAT2 in mediating the antigrowth effects of type I interferon (IFN) is well-documented in vitro.,24895110_0,0,-1,-1,0,23941,-1,0.9998528,4.470629e-05,0.0001024458
18096,IFN-gamma,8,9,42,51,One of the mechanisms is considered to be IFN-gamma inhibiting the induction of Tregs.,22812187_11,0,-1,-1,0,18096,-1,0.99988186,3.1431064e-05,8.659579e-05
40927,IL-10,4,5,19,24,The mRNA levels of IL-10 and Foxp3 were measured with RT-qPCR.,33083479_6,0,-1,-1,0,40927,-1,0.9998441,3.3093995e-05,0.00012279386
699,IL-10,7,8,39,44,The influence of H2O2 on production of IL-10 was not significantly different between memory/activated and naive T cells.,11509600_8,0,-1,-1,0,699,-1,0.9998696,3.131561e-05,9.901848e-05
16988,IL-15,41,42,281,286,"This IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) bone marrow cells occurred independently of the IL-15/IL-2R and Jak/STAT pathways and instead required IL-15R signaling as well as activation of JNK and NF-B. Importantly, we also showed that the trans presentation of IL-15 by IL-15R boosts IL-15-mediated IFN- production by NK cells but reduces IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) myeloid bone marrow cells.",22447977_5,0,-1,-1,0,16988,-1,0.99979717,3.779279e-05,0.00016505716
30956,IL-12,14,15,78,83,"Th1 (neopterin, tryptophan, kynurenine, kynurenine-to-tryptophan ratio (KTR), IL-12, IFN-, soluble TNF-R75 and IL-2R) and Th2 (IL-4, IL-10) biomarkers as well as CD4 expression in T helper (Th), effector and regulatory T cells were determined.",28005163_3,0,-1,-1,0,30956,-1,0.999864,2.910991e-05,0.0001068923
25184,CCL2,8,9,55,59,These results were not observed when neutralization of CCL2 was performed in thymectomized mice.,25382729_6,0,-1,-1,0,25184,-1,0.9509093,0.0026989463,0.046391774
36725,IL-6,9,10,58,62,RESULTS: We determine that patients with high circulating IL-6 levels had distinct T cell characteristics relative to those with low levels.,31027698_5,0,-1,-1,0,36725,-1,0.99967384,6.595515e-05,0.00026029162
12728,IFN-gamma,24,25,144,153,"Furthermore, disparate results have been reported regarding the anti-tumor ability of type 2 polarized effector CD8 T cells, and the effects of IFN-gamma in this respect remain unknown.",20562261_3,0,-1,-1,0,12728,-1,0.9998914,2.838875e-05,8.0163656e-05
2215,IFN,43,44,259,262,P-STAT1 levels in the PBMCs of a patient treated sequentially with 5 MU/m2 and 10 MU/m2 IFN alpha-2b (administered by subcutaneous injection) also increased in response to treatments with IFN alpha-2b but did not increase further with the increased dosage of IFN alpha-2b.,15339971_9,0,-1,-1,0,2215,-1,0.99980253,5.49193e-05,0.00014250145
29447,IL-10,28,29,176,181,"Flow cytometry was used to determine the Tregs levels in the spleen and peripheral blood, and immunohistochemistry was performed to determine the expression levels of TGF and IL-10 in the tumor microenvironment.",27389040_4,0,-1,-1,0,29447,-1,0.9998574,3.067769e-05,0.00011187549
6427,CCL22,19,20,130,135,"Furthermore, to elucidate the mechanisms behind Treg accumulation within tumors, they evaluated the relationship between CCL17 or CCL22 expression and the frequency of Foxp3(+) Tregs in gastric cancer.",18224687_3,0,-1,-1,0,6427,-1,0.9920631,0.00030565707,0.007631122
1353,eotaxin,19,20,109,116,"Clearance of lung metastases by the Th2 cells was found to be totally dependent on the eosinophil chemokine, eotaxin, and partially dependent on the transcription activator signal transducer and activator of transcription 6 (STAT6), with degranulating eosinophils within the tumors inducing tumor regression.",12566422_3,0,-1,-1,0,1353,-1,0.9996061,0.00013373411,0.0002602092
27438,IFN-R1,8,9,50,57,Marked decrease in serum IFN- levels and splenic IFN-R1 (IFN- Receptor 1) expressing T and NK cell percentages were observed in Gal-3(-/-) mice.,26442663_8,0,-1,-1,0,27438,-1,0.9688287,0.004929513,0.026241804
21719,IL-17(+,40,41,228,235,"High intratumoral FoxP3(+) Tregs with high peritumoral IL-17(+) T cells showed a significantly lower survival rate compared with other groups (OS, P < 0.001 and DFS, P < 0.001).CONCLUSION: Our findings suggest that intrahepatic IL-17(+) T cells and FoxP3(+) Tregs may cooperate to promote the progression of HCC.",24303990_8,0,-1,-1,0,21719,-1,0.9996743,6.4544925e-05,0.00026115155
6698,IFN-gamma,4,5,34,43,"Furthermore, resveratrol enhanced IFN-gamma expression in CD8+ T cells both ex vivo and in vivo,leading to immune stimulation.",18328445_6,0,-1,-1,0,6698,-1,0.99989605,3.1026004e-05,7.2895855e-05
16805,IL-17,22,23,131,136,"Deletion of IL-33/ST2 axis enhances cytotoxicity of NK cells, production of IFN- in these cells and systemic production of IFN-, IL-17 and TNF-, which leads to attenuated tumor growth.",22392053_9,0,-1,-1,0,16805,-1,0.99984586,3.143683e-05,0.00012258967
22619,immune responses,20,22,154,170,Development of effective immune therapies for cancer patients requires better understanding of hurdles that prevent the generation of effective antitumor immune responses.,24532578_0,0,-1,-1,0,22619,-1,0.9998153,0.00010488289,7.984109e-05
38921,IFN-,20,21,153,158,Lactic acid in tumor microenvironment reduces expression of PPAR in intratumoral iNKT cells and consequently diminishes their cholesterol synthesis and IFN- production.,31974378_3,0,-1,-1,0,38921,-1,0.9998803,3.4978366e-05,8.472086e-05
33900,cytokines,4,5,22,31,The effect of various cytokines on IL-25 production from normal human epidermal keratinocytes was assessed by quantitative reverse-transcription real-time polymerase chain reaction.,29238954_3,0,-1,-1,0,33900,-1,0.99981385,5.0183447e-05,0.00013600773
6289,antigens,37,38,246,254,"Previously, we reported the therapeutic properties of a vaccine prepared by transfer of a cDNA-expression library from breast cancer cells into a highly immunogenic allogeneic fibroblast cell line where genes specifying an array of breast cancer antigens were expressed.",18157008_1,0,-1,-1,0,6289,-1,0.99947935,8.048568e-05,0.00044011115
43643,cytokine,32,33,191,199,"To determine whether the IL-10R has signaling functions similar to IL-6R in cells normally expressing these receptors, leukocytes of the B-, T-, and NK-cell lineages were treated with either cytokine.",8662928_1,0,-1,-1,0,43643,-1,0.99985325,4.4415207e-05,0.000102261176
35506,chemotherapy,76,77,462,474,"Neoadjuvant chemotherapy seemed to result in a relocation of Th1-committed CD4+ T cells from blood, presumably to the tumour, indicated by shifts in the methylation patterns, whereas no such shifts were seen for lineages corresponding to IL13, IL17A and FOXP3.CONCLUSION: Increased lineage commitment in CD4+ T cells, as determined by demethylation in predictive CpG sites, is associated with lower post-cystectomy tumour stage, complete response to neoadjuvant chemotherapy and overall better outcome, suggesting epigenetic profiling of CD4+ T cell lineages as a useful readout for clinical staging.",30075815_13,0,-1,-1,0,35506,-1,0.9995981,0.0001373864,0.00026452594
11590,transforming growth factor beta,6,10,38,69,"The ability of antiestrogen to induce transforming growth factor beta (TGFbeta) in breast cancer cells may be relevant to the emergence of resistance, not only at the level of cell autonomous effects of TGFbeta on cancer progression but also at the level of its effects on the host immune system.",20145137_1,0,-1,-1,0,11590,-1,0.97820365,0.01982681,0.001969579
32277,cytokine,12,13,93,101,"Given these divergent timescales, we addressed how cytokine-responsive cells translate brief cytokine exposure into phenotypic changes that persist over long timescales.",28575659_2,0,-1,-1,0,32277,-1,0.9998641,4.9508377e-05,8.641754e-05
11393,cytokine,7,8,31,39,"In contrast to IL-2, the IL-21 cytokine failed to mediate expansion of regulatory T cells or induced expression of Foxp3 in CD4(+)CD25(Intermediate) or CD4(+)CD25(Dim/-) T cells in whole blood derived from CLL patients.",20081380_5,0,-1,-1,0,11393,-1,0.99985254,4.7865502e-05,9.952574e-05
11290,IL-10,10,11,74,79,"However, imatinib and sunitinib did induce secretion of anti-inflammatory IL-10 in macrophage cultures, indicating that treatment with these inhibitors might contribute to an immune suppressive microenvironment in GIST.",20013807_8,0,-1,-1,0,11290,-1,0.99987054,3.3114382e-05,9.630398e-05
38286,IL-10,24,25,125,130,"Upon TCR stimulation, the expression of TGF-beta was significantly higher in CD4+ CD25+ Foxp3+ TILs, while the expression of IL-10 was significantly higher in CD4+ CD25+ Foxp3- TILs.",31811667_7,0,-1,-1,0,38286,-1,0.999884,2.939219e-05,8.6532906e-05
9472,IL-10,2,3,9,14,IL-2 and IL-10 were induced by the HCV core protein in splenocytes.,19362089_9,0,-1,-1,0,9472,-1,0.9998317,3.8857863e-05,0.00012938252
12109,IL-12p70,7,8,38,46,"LPS stimulation of DCs induced IL-10, IL-12p70, TNFalpha and IL-1beta secretion, and taxol pretreatment modified this response by down-regulating IL-1beta secretion whereas colchicine induced a proinflammatory cytokine profile with reduced IL-10 and increased IL-12p70 and TNFalpha secretion.",20386470_6,0,-1,-1,0,12109,-1,0.99868804,9.62591e-05,0.0012156315
38615,CCL3,14,15,88,92,The chemotaxis assay proved RUNX3 could promote CD8+ T cell recruitment by upregulating CCL3 and CCL20.,31898342_15,0,-1,-1,0,38615,-1,0.9832161,0.0011880876,0.015595789
7397,IFN,16,17,111,114,"This PGE(2)-induced overproduction of CCL22 and the resulting attraction of FOXP3(+) Tregs are counteracted by IFN alpha, a mediator of acute inflammation, which also restores the ability of the PGE(2)-exposed DC to secrete the Th1-attracting chemokines: CXCL9, CXCL10, CXCL11, and CCL5.",18632653_4,0,-1,-1,0,7397,-1,0.9998123,4.649461e-05,0.00014121844
30016,IL-10,12,13,60,65,"But, no difference was seen between two subsets in terms of IL-10 production.",27619682_8,0,-1,-1,0,30016,-1,0.99980265,3.3259515e-05,0.0001640911
3712,transforming growth factor beta,26,30,164,195,"We also asked the role of interleukin (IL)-4 receptor alpha (IL-4Ralpha)-signal transducer and activator of transcription 6 (STAT6) signaling, including IL-13, and transforming growth factor beta (TGF-beta) by using gene-disrupted mice or treating mice with cytokine antagonists.",16585215_4,0,-1,-1,0,3712,-1,0.984269,0.0138254315,0.0019054693
12076,chemotherapeutic,6,7,33,49,"Because of their role in mitosis chemotherapeutic agents targeting microtubules are widely used, and this study determined the outcome of disturbing tubulin cytoskeleton dynamics on human dendritic cell function.",20386470_1,0,-1,-1,0,12076,-1,0.9940124,0.0040640375,0.001923596
10271,Granulocyte macrophage colony-stimulating factor,0,4,0,48,Granulocyte macrophage colony-stimulating factor was applied as an adjuvant.,19609242_3,0,-1,-1,0,10271,-1,0.9960841,0.0005300884,0.0033857957
11948,immune responses,23,25,158,174,These data suggest that CagA protein negatively regulates the functions of DC via CagA phosphorylation and that cagA-positive H. pylori strains suppress host immune responses resulting in their chronic colonization of the stomach.,20363211_6,0,-1,-1,0,11948,-1,0.9998265,9.237011e-05,8.121572e-05
14815,CXCL12,9,10,49,55,"There was a tendency for luminal cancers to show CXCL12 expression (102/138, 74%) compared to basal-like cancers (16/27, 59%), which verged on statistical significance (P = 0.050).",21521526_7,0,-1,-1,0,14815,-1,0.9995018,7.166548e-05,0.00042656023
13629,chemokine,4,5,25,34,"Analysis of cytokine and chemokine production by tumor cell lines including five lung cancers, a malignant mesothelioma, and a malignant melanoma recently established in our laboratory showed rather high production of IL-8 in all tumors and IL-6 in one lung cancer, the malignant mesothelioma, and the malignant melanoma.",21048114_0,0,-1,-1,0,13629,-1,0.99979967,6.325135e-05,0.00013711749
29345,interferon,13,14,85,95,The NFAT1 activation correlated with a downstream functional response in the form of interferon gamma production.,27327144_7,0,-1,-1,0,29345,-1,0.99982363,6.946226e-05,0.00010692162
15416,IL-6,5,6,27,31,"Consistent with a role for IL-6 and STAT3 in regulating IL-17A, increased Th17 generation and gastric expression of Th17-related factors in gp130(F/F) mice were reduced to wild-type levels in gp130(F/F) :Stat3(-/+) mice displaying normalized STAT3 activity, and also in gp130(F/F) :IL-6(-/-) mice.",21710691_6,0,-1,-1,0,15416,-1,0.9996921,5.3619482e-05,0.00025437356
19655,IL-16,6,7,30,35,"Regulatory T cells, INF- and IL-16 are new important tools for differentiation between tuberculous and malignant pleural effusion.",23252864_7,0,-1,-1,0,19655,-1,0.99323577,0.00016688813,0.006597467
14004,immune response,19,21,137,152,"These results suggest an important role for NFAT1 in radio-resistant tumor-associated parenchyma, which is independent of the anti-tumor immune response and Th1 versus Th2 cytokine milieu established by the cancer cells, but able to promote site-specific tumor growth.",21225259_9,0,-1,-1,0,14004,-1,0.99982387,0.00010369163,7.2444986e-05
41044,cytokine,24,25,177,185,These findings indicate that melatonin exerts immunoregulatory activity in MG by balancing effector and regulatory Th cell populations as well as by suppressing proinflammatory cytokine production.,33136553_9,0,-1,-1,0,41044,-1,0.9998553,5.7628276e-05,8.7138505e-05
12127,cytokine,36,37,247,255,"Taken together, these data reveal new immunomodulatory strategies of microtubule disrupting agents in dendritic cells, that of modifying the cytokine response to LPS and that of increasing T lymphocyte activation without induction of inflammatory cytokine secretion by dendritic cells.",20386470_7,0,-1,-1,0,12127,-1,0.99986815,5.1842304e-05,7.996404e-05
37630,IL-17,8,9,53,58,"These results suggest that increased Th17 counts and IL-17 level, which correlated with high neutrophil-to-lymphocyte ratio and programmed cell death 1 ligand 1 expression, are potential biomarkers for poor prognosis in ovarian cancer and likely indications for application of programmed cell death 1 ligand 1 pathway inhibitors.",31432577_7,0,-1,-1,0,37630,-1,0.999841,4.6166766e-05,0.00011292445
12565,antigen,28,29,155,162,"Their effect on the immune response is due to a phenomenon known as cross-priming of antigen, in which exogenous antigens are presented via MHC class I by antigen presenting cells.",20544406_1,0,-1,-1,0,12565,-1,0.99924505,0.00013328584,0.0006216313
25708,cytokine,21,22,157,165,"Lymphodepleting regimens are used before adoptive immunotherapy to augment the antitumor efficacy of transferred T cells by removing endogenous homeostatic ""cytokine sinks."" These conditioning modalities, however, are often associated with severe toxicities.",25548153_0,0,-1,-1,0,25708,-1,0.9998292,6.572114e-05,0.00010506647
20145,macrophage colony-stimulating factor,25,28,145,181,"Culture of peripheral blood mononuclear cells [peripheral blood mononuclear cell (PBMC), n = 3 donors] with PSC supernatants or IL-6/granulocyte macrophage colony-stimulating factor (GM-CSF; positive control) for 7 days promoted PBMC differentiation into an MDSC (CD11b+CD33+) phenotype and a subpopulation of polymorphonuclear CD11b+CD33+CD15+ cells.",23514705_5,0,-1,-1,0,20145,-1,0.99891937,0.00014527995,0.00093531946
29146,CCL22,5,6,32,37,We aimed to investigate whether CCL22 is expressed in human breast cancer and whether its presence is associated with Treg infiltration.,27272839_2,0,-1,-1,0,29146,-1,0.9902666,0.0007011556,0.009032134
4372,immune response,21,23,154,169,BACKGROUND & OBJECTIVE: Accumulative evidences have indicated the importance of CD40-CD40L receptor-ligand pair in the initiation and regulation of human immune response.,16965650_0,0,-1,-1,0,4372,-1,0.99958056,0.0003099553,0.00010952653
19349,IL-10,12,13,56,61,"ELISA assay was performed to detect IL-2, IL-12, IFN-, IL-10, and TGF- production in MLR supernatants.",23179394_4,0,-1,-1,0,19349,-1,0.9997905,3.570769e-05,0.00017374042
42450,IL-6,10,11,82,86,Imaging analyses and vesicle isolation were conducted to determine Rab37-mediated IL-6 secretion.,34093869_4,0,-1,-1,0,42450,-1,0.9997633,5.3824555e-05,0.00018278291
11519,IL-10-secreting,20,21,128,143,"Similarly, the antitumor immunity induced by peptide immunotherapy in colon carcinoma CT26-bearing mice, in which the number of IL-10-secreting iTreg is increased, was augmented by treatment with p38-inhibitor after CD25(+) Treg-depletion and resulted in inhibition of tumor progression.",20127675_5,0,-1,-1,0,11519,-1,0.9979134,0.0007289338,0.0013576021
20757,IL-6,33,34,205,209,"Furthermore, CD4(+)foxp3(+) regulatory T cells (Tregs) were progressively decreased in both spleen and tumor tissues following mMSLN-VLP immunization and this was at least partly due to elevated levels of IL-6 production from activated plasmocytoid dendritic cell (pDC)-like cells following mMSLN-VLP immunization.",23874581_3,0,-1,-1,0,20757,-1,0.9998814,3.6946e-05,8.1686885e-05
39390,IFN,5,6,25,29,"CD4 T cell expression of IFN also differed in pre-treatment samples, indicating that predictors of response unrelated to exhaustion may be present in peripheral blood.",32210968_11,0,-1,-1,0,39390,-1,0.99988234,4.1230083e-05,7.646357e-05
1379,IFN-gamma,16,17,107,116,"AT-1 CTL lysed peptide-pulsed CMS8 cells at a nanomolar concentration, and the peptide strongly stimulated IFN-gamma production in AT-1 CTL.",12707369_2,0,-1,-1,0,1379,-1,0.9998926,2.865199e-05,7.884556e-05
14169,cytokines,5,6,34,43,"Recent studies indicate that some cytokines, such as interleukin (IL)-17, and regulatory T cells are involved in the development of cancer.",21314287_1,0,-1,-1,0,14169,-1,0.99980587,4.397973e-05,0.00015012355
12447,IL-10,7,8,48,53,"The production of the immune regulatory markers IL-10, TGF-beta in 3LL and NCI-H292 cells increased after treatment with simvastatin.",20491794_6,0,-1,-1,0,12447,-1,0.99986017,3.3171942e-05,0.00010671069
15043,cytokines,10,11,71,80,"These data provide evidence for a unique relationship between specific cytokines, MDSC subsets, and IFN- responsiveness in patients with GI malignancies.",21604071_8,0,-1,-1,0,15043,-1,0.999775,4.6045265e-05,0.0001790216
2589,immune response,35,37,201,216,"We have extended our investigation to determine the relative roles of each one of the four plasmids pIFN-gamma, pCIITA, pIi-RGC, and pIL-2 in conjunction with radiation for the induction of a curative immune response.",15761259_3,0,-1,-1,0,2589,-1,0.99972767,0.00016252983,0.00010975745
18453,IL17F,7,8,35,40,"FOXP3 and CD8 infiltrates, but not IL17F infiltrate, were significantly (P<0.001 and P=0.007, respectively) associated with a high-pCR rate (31.3 and 25.7%, respectively), and breast tumors with both FOXP3 and CD8 infiltrates showed the highest pCR rate (33.0%).",22986814_5,0,-1,-1,0,18453,-1,0.99984217,4.0457147e-05,0.00011742725
6667,antigen,29,30,191,198,"CONCLUSIONS: Our present data indicate that IL-21-secreting NB cells are effective as therapeutic vaccine in mice bearing metastatic NB, through a specific CTL response involving survivin as antigen, and suggest a potential interest for IL-21 in NB immuno-gene therapy.",18324400_10,0,-1,-1,0,6667,-1,0.99891067,0.00010693183,0.0009824532
13783,IL-10,0,1,0,5,"IL-10 and TGF-1 mRNA levels, and frequencies of CD4(+)CD25high/CD3(+) and CD4(+)CD25highFoxP3(+)/CD3(+)Treg cells were significantly higher in mRCC patients compared with healthy individuals.",21150720_5,0,-1,-1,0,13783,-1,0.9998685,3.223236e-05,9.934707e-05
7704,interleukin,18,19,111,122,"Imiquimod-treated tumors contained a decreased percentage of T reg cells, and these cells produced less FOXP3, interleukin (IL)-10, and transforming growth factor (TGF)-beta.",18794336_5,0,-1,-1,0,7704,-1,0.99985886,3.708241e-05,0.00010408771
26322,IL-17,25,26,118,123,"In the present study, we mainly investigated the role of Th22, Th17, and Th1 cell and their related cytokines (IL-22, IL-17, and IFN-r) in the pathophysiology of CML.",26000313_1,0,-1,-1,0,26322,-1,0.9997813,4.5921806e-05,0.00017286435
17083,immune responses,14,16,93,109,Tregs play an important role in the preservation of self-tolerance and modulation of overall immune responses against infections and tumor cells.,22489248_3,0,-1,-1,0,17083,-1,0.9997768,0.00014687148,7.6425604e-05
16150,IFN--mediated,3,4,24,38,"PML knockdown increased IFN--mediated Signal Transducer and Activator of Transcription-1 (STAT-1) binding to the IP-10 promoter, resulting in elevated transcription of the IP-10 gene.",22022583_7,0,-1,-1,0,16150,-1,0.99798286,0.00094241934,0.0010746289
28796,interferon-beta,7,8,43,58,"Similarly neither interferon-alpha (IFN), interferon-beta (IFN) nor IL12 family members were elevated in sarcoids compared to normal skin.",27160146_7,0,-1,-1,0,28796,-1,0.9998246,8.092332e-05,9.4574854e-05
12353,macrophage inflammatory protein,33,36,200,231,"This study analyzed the nature of the inflammatory infiltrate, presence of mast cells, and in situ expression of cytokines (interleukin [IL]-17 and transforming growth factor [TGF]-beta), chemokines (macrophage inflammatory protein [MIP]-1beta and monocyte chemotactic protein [MCP]-1), and nuclear transcription factor (FoxP3) in human periapical granulomas and cysts compared with a control group.",20478453_1,0,-1,-1,0,12353,-1,0.99966407,7.7882425e-05,0.0002579735
34803,IFN,12,13,68,72,"In particular, the subset proportion of Th1 cells (characterized by IFN production and the transcription factor Tbet) increased significantly, and both Th2 cells (characterized by IL-4 production and the transcription factor GATA3) and Th17 cells (characterized by IL-17 production and the transcription factor RoRt) decreased profoundly.",29783020_6,0,-1,-1,0,34803,-1,0.99988854,3.1826537e-05,7.9585734e-05
15799,IL-15R,23,24,156,163,"Bone marrow (BM)-derived DC genetically modified to simultaneously overexpress XBP1s and express Aghsp70 upregulated CD40, CD70, CD86, interleukin (IL)-15, IL-15R, and CCR7 expression, and increased IL-6, IL-12, and tumor necrosis factor (TNF)- production in vitro.",21934655_5,0,-1,-1,0,15799,-1,0.9996668,9.890629e-05,0.00023427344
29048,IFN-,16,17,127,132,"Although Bhlhe40-deficient mice show normal iNKT cell development, Bhlhe40-deficient iNKT cells show significant impairment of IFN- production and antitumor effects.",27226296_5,0,-1,-1,0,29048,-1,0.99989295,3.5280023e-05,7.181218e-05
38721,cytokines,37,38,211,220,"In particular, CXCL9 reduced the CD8+ cytotoxic T lymphocytes in the tumour microenvironment of PAAD, which could be attributed to the reduced CD8+ T cell proliferation, activation, and secretion of anti-tumour cytokines.",31913856_4,0,-1,-1,0,38721,-1,0.99986017,5.077725e-05,8.909595e-05
6214,chemoradiotherapy,23,24,144,161,"We show here that Treg and Nrp1+ Treg levels dropped in the tumour-draining lymph nodes of patients with cervical cancer following preoperative chemoradiotherapy in a direct relationship with the reduction of tumour mass, suggesting that suppressor cell elimination facilitated the generation of T cells mediating the destruction of the neoplastic cells left behind after cytotoxic therapy.",18028372_8,0,-1,-1,0,6214,-1,0.9932869,0.004423307,0.0022897706
36652,chemotherapy,17,18,71,83,"Here, we aim to explore the role and mechanisms of CD4+ T cells in PCa chemotherapy sensitivity.",31018021_3,0,-1,-1,0,36652,-1,0.99935514,0.00020686016,0.00043805628
27972,Interferon,0,1,0,10,Interferon (IFN)- production attenuated by CD4(+) T cells co-cultured with IL-6-conditioned MoDCs corresponded with decreased DC IL-12p70 production.,26759006_3,0,-1,-1,0,27972,-1,0.9998241,5.4598895e-05,0.0001213097
29321,antigen-specific,4,5,21,37,"Since the binding of antigen-specific dextramers mimics antigen presentation to the TCR, the present study sought to determine whether this TCR engagement on the AST was sufficient to elicit a functional T cell response.",27327144_3,0,-1,-1,0,29321,-1,0.9984817,0.0002866644,0.0012316675
30001,IFN-,14,15,66,71,"Cells were stimulated in vitro and stained with CD25, CD4, FoxP3, IFN-, IL-10, and IL-2 or isotype matched antibodies and subjected to flow cytometry.",27619682_4,0,-1,-1,0,30001,-1,0.9998746,3.0078992e-05,9.539541e-05
3547,immune response,16,18,121,136,The predominance of IL-10 production indicated that regulatory T cells directly participate in modulating the anti-tumor immune response.,16391798_7,0,-1,-1,0,3547,-1,0.99980134,0.0001226675,7.60774e-05
13351,interleukin-10,17,18,77,91,"CD8(+) FOXP3(+) T cells did not express markers of regulatory [CTLA-4, CCL4, interleukin-10 (IL-10), transforming growth factor-1], exhausted (PD-1), or senescent (CD57) CD8(+) T lymphocytes.",20861189_5,0,-1,-1,0,13351,-1,0.9998745,2.7892422e-05,9.757701e-05
14487,IL-10,19,20,135,140,"Previously, we demonstrated that ANGPT2 augments the expression of various proangiogenic genes, the potent immunosuppressive cytokine, IL-10, and a chemokine for regulatory T cells (Tregs), CCL17 by TEMs in vitro.",21368233_3,0,-1,-1,0,14487,-1,0.9998616,2.8169943e-05,0.000110246045
29030,IFN-,14,15,83,88,"In particular, iNKT cells have the ability to immediately produce large amounts of IFN- upon activation and thus initiate immune responses in various pathological conditions.",27226296_1,0,-1,-1,0,29030,-1,0.9998869,3.590743e-05,7.718469e-05
2191,IFN,4,5,24,27,"Relatively low doses of IFN alpha-2b (i.e., 10(2)-10(3) IU/mL) induced maximal STAT1 activation in vitro.",15339971_6,0,-1,-1,0,2191,-1,0.9998055,5.5060325e-05,0.00013949997
20794,IFN-,28,29,174,179,"Here, employing an in vitro coculture system, we demonstrate that splenic MDSC subsets suppress antigen-driven CD8(+) T-cell proliferation, but differ in their dependency on IFN-, STAT-1, IRF-1, and NO to do so.",23878002_2,0,-1,-1,0,20794,-1,0.9999014,3.0138981e-05,6.845233e-05
36050,cytokines,40,41,221,230,"Here, we show that co-stimulation with N1 and R848 of human monocyte-derived DCs (MoDCs) markedly upregulated DC's surface expression of CD80, CD83, CD86, and HLA-DR, as well as synergistic production of pro-inflammatory cytokines including IL-12p70, IL-1, and TNF-.",30619338_2,0,-1,-1,0,36050,-1,0.9998574,4.4600118e-05,9.802267e-05
31693,cytokines,6,7,42,51,This reactivation of memory CTLs requires cytokines such as IL-12 in addition to antigen but was less dependent upon costimulation and IL-2 compared to naive CTLs.,28405920_5,0,-1,-1,0,31693,-1,0.9998233,3.9414615e-05,0.0001372844
41758,immune responses,22,24,113,129,This study aimed to annotate the role of long intergenic non-coding RNA 152 (LINC00152) in CD8+ T cells mediated immune responses in gastric cancer (GC) and the underlying mechanism.,33709190_0,0,-1,-1,0,41758,-1,0.9997242,0.00016003846,0.00011567058
12363,cytokines,9,10,69,78,"Indirect immunohistochemistry was used to evaluate the expression of cytokines, chemokines, and FoxP3.RESULTS: The inflammatory infiltrate mainly consisted of mononuclear cells.",20478453_4,0,-1,-1,0,12363,-1,0.9998708,4.546885e-05,8.378799e-05
437,IL-15Ralpha,28,29,189,200,"Furthermore, using promoter deletion constructs and gel shift analysis, we defined a functional NF-kappaB-binding motif in the human IL-15Ralpha promoter, suggesting that Tax activation of IL-15Ralpha is due, in part, to the induction of NF-kappaB. These data indicate that IL-15Ralpha is transcriptionally regulated by the HTLV-I Tax protein through the action of NF-kappaB. These findings suggest a role for IL-15Ralpha in aberrant T cell proliferation observed in HTLV-I-associated diseases.",11160322_4,0,-1,-1,0,437,-1,0.9976931,0.00091895356,0.001387885
20840,IL-17,28,29,176,181,"Similarly, in comparison with lesions with inflammatory infiltrates grades II and III, lesions with inflammatory infiltrate grade I showed a tendency for a lower expression of IL-17 and TGF-1 (P = .085 and P = .051, respectively).",23880265_6,0,-1,-1,0,20840,-1,0.99974746,4.8161335e-05,0.00020443859
33108,IL-10,8,9,41,46,"Although TIM-1+ B cells are enriched for IL-10, TIM-4+ B cells are enriched for IFN-.",28848066_4,0,-1,-1,0,33108,-1,0.99987555,3.0005504e-05,9.440899e-05
18127,IL-10,7,8,40,45,"Meanwhile, the cytokine(IL-6, TGF- and IL-10) concentrations were significantly higher in UCC patients than those in healthy controls.",22820395_6,0,-1,-1,0,18127,-1,0.9998586,3.080605e-05,0.0001106083
42630,interleukin 12,20,22,102,116,"DFP also noticeably enhances the expression of T helper (TH) cell 1 specific interferon-gamma (IFNG), interleukin 12 (IL12), T-Box Transcription Factor 21 (TBX21) and signal transducer and activator of transcription 1 (STAT1) genes.",34190692_8,0,-1,-1,0,42630,-1,0.9998809,3.811994e-05,8.09783e-05
16184,interleukin,23,24,138,149,"Canine peripheral blood mononuclear cells were isolated and enriched by labelling of CD25, and expansion of T(reg) was achieved by adding interleukin (IL)-2 for 1 week.",22041284_2,0,-1,-1,0,16184,-1,0.99981767,4.2179057e-05,0.00014018077
7930,cytokine,29,30,180,188,"Here we hypothesized that a combination of IFN-alpha and IL-21, a novel cytokine of the IL-2 family with anti-cancer effects, will increase the anti-cancer efficacy at sub-optimal cytokine doses.",18947877_4,0,-1,-1,0,7930,-1,0.9997552,4.8823855e-05,0.00019595193
27495,IL-10,17,18,84,89,"mRNA levels of Foxp3, TGF-1 and IL-10, in addition to protein levels of TGF-1 and IL-10 were potentiated in lymphoma patients but decreased in CR patients (P<0.05 in all cases).",26464657_10,0,-1,-1,0,27495,-1,0.999866,3.1400876e-05,0.00010267388
37831,IFN-,11,12,64,69,"Last, inhibition of ATP synthase alone was sufficient to impair IFN- production by CD4+ T cells.",31530731_8,0,-1,-1,0,37831,-1,0.9998876,3.2914417e-05,7.9510406e-05
19496,CXCL10,15,16,95,101,"EXPERIMENTAL DESIGN: Using tissue microarrays of 364 breast tumors, we evaluated expression of CXCL10 and its receptor, CXCR3, in relation to histopathologic features, biomarkers, and lymphocyte markers.",23213058_3,0,-1,-1,0,19496,-1,0.9993444,8.008299e-05,0.00057556655
43580,interleukin-2,21,22,118,131,"A result of this activation process is the induction of a number of genes, including those encoding cytokines such as interleukin-2, tumor necrosis factor-alpha, and interferon (IFN)-gamma which have important immunoregulatory effects.",8605941_1,0,-1,-1,0,43580,-1,0.9998915,4.1131763e-05,6.7338566e-05
5001,IFN-gamma,14,15,83,92,"Furthermore, ATLL cells from this subset of patients secrete only small amounts of IFN-gamma, and suppress IFN-gamma production by autologous CD4(+) non-ATLL cells.",17278106_5,0,-1,-1,0,5001,-1,0.9999031,2.7833114e-05,6.898149e-05
7000,cytokines,39,40,234,243,"Indeed from the initial concept that the release of free radicals during inflammation might induce the accumulation of genetic mutations thus leading to the onset of dysplastic cells, it is now becoming clear that the large amount of cytokines and growth factors released during inflammation by immune and non immune cells may influence the carcinogenesis process.",18473765_4,0,-1,-1,0,7000,-1,0.99983585,5.3496737e-05,0.00011054873
6146,IL-15,34,35,226,231,"Whereas the spontaneously growing CTCL-derived cell lines displayed persistent activation of the TORC1 as well as the PI3K/Akt and MEK/ERK pathways, the IL-2-dependent cell lines activated the pathways in response to IL-2 and IL-15 but not IL-21.",18025151_1,0,-1,-1,0,6146,-1,0.9994894,6.3977925e-05,0.0004465866
8211,IFNgamma,15,16,92,100,"STAT1 phosphorylation appears to play an important role in the control of IDO expression by IFNgamma, but the precise regulatory mechanism remains obscure.",19075017_2,0,-1,-1,0,8211,-1,0.9997842,5.3055715e-05,0.000162763
40728,antigens,15,16,98,106,Curcumin also showed direct DC enhancing activity and enhanced T cell induction for the immunized antigens in non-tumor-bearing mice and human hosts.,33006786_4,0,-1,-1,0,40728,-1,0.99939716,0.00011308291,0.00048979383
18973,IFN-,22,23,147,152,"Enhanced antitumor activity with combination therapy was associated with an increase in systemic NK cell and effector CD8(+) T-cell activation and IFN- production, as well as infiltration of effector CD8(+) T cells into the tumor.",23090488_4,0,-1,-1,0,18973,-1,0.99989533,3.2240263e-05,7.2438976e-05
17921,cytokines,12,13,89,98,"Stat3 inhibition in tumor cells induces the expression of chemokines and proinflammatory cytokines, so we proposed to apply Stat3-inhibited breast cancer cells as a source of immunogens to induce an antitumor immune response.",22753933_1,0,-1,-1,0,17921,-1,0.9998795,5.0362323e-05,7.0137474e-05
28267,IL-17(+,23,24,91,98,"We studied the number of T cells, regulatory T cells (Tregs), T helper 17 (Th17) cells and IL-17(+) non-T cells (mainly granulocytes) in matched HPV-positive and HPV-negative OPSCC cases (n = 162).",26899388_2,0,-1,-1,0,28267,-1,0.99976486,5.819964e-05,0.0001769306
7178,SCF-activated,0,1,0,13,"SCF-activated mast cells also exacerbated tumor immunosuppression by releasing adenosine and increasing T regulatory cells, which augmented the suppression of T cells and natural killer cells in tumors.",18524989_6,0,-1,-1,0,7178,-1,0.011107811,0.9879218,0.0009703703
28830,IL-6,17,18,98,102,"Furthermore, increased levels of Th17-related cytokines including IL-17, IL-21, IL-23, IL-1, and IL-6 were presented in between blood and marrow in B-ALL patients.",27176825_7,0,-1,-1,0,28830,-1,0.9995579,6.600912e-05,0.0003760471
5477,IL-6,5,6,37,41,"Addition of exogenous interleukin-6 (IL-6) and granulocyte colony-stimulating factor (G-CSF), which were present in high amounts in BxCM, mimicked the inhibitory effect of BxCM on DC differentiation and maturation.",17545630_6,0,-1,-1,0,5477,-1,0.9998394,3.804173e-05,0.00012249972
30002,IL-10,16,17,73,78,"Cells were stimulated in vitro and stained with CD25, CD4, FoxP3, IFN-, IL-10, and IL-2 or isotype matched antibodies and subjected to flow cytometry.",27619682_4,0,-1,-1,0,30002,-1,0.9998574,2.9156425e-05,0.00011339488
9329,tumor necrosis factor-alpha,24,27,133,160,"The extent of central tumor necrosis was decreased in the tumors in NFATc2((-/-)) mice, and this finding was associated with reduced tumor necrosis factor-alpha and interleukin-2 (IL-2) production by CD8(+) T cells.",19318584_3,0,-1,-1,0,9329,-1,0.96694124,0.031542756,0.0015160628
43296,immune response,26,28,175,190,"Despite recent advances in cancer immunotherapy, certain tumor types, such as Glioblastomas, are highly resistant due to their tumor microenvironment disabling the anti-tumor immune response.",35177622_0,0,-1,-1,0,43296,-1,0.99982065,0.000107406966,7.19821e-05
34723,IL10,32,33,175,179,"Previous studies have reported the presence of FOXP3+ CD8+ Treg cells, similar to CD4+ Tregs, in cancer patients which produce high levels of the immunosuppressive cytokines, IL10 and TGF.",29768737_1,0,-1,-1,0,34723,-1,0.9998821,3.0484502e-05,8.733311e-05
5203,antigen,6,7,24,31,"In the absence of IL-2, antigen stimulation resulted in T-cell activation and acquisition of effector function without induction of FOXP3, indicating that acquisition of effector function is independent of induction of FOXP3 expression in CD8 T cells.",17414320_3,0,-1,-1,0,5203,-1,0.9996506,8.711302e-05,0.00026230924
4315,chemotherapy,4,5,29,41,injection of the AdCDIRESE1A chemotherapy sensitization vector and Ad-sig-ecdCD40L vector-infected dendritic cells into s.c.,16928818_8,0,-1,-1,0,4315,-1,0.99902296,0.00025017752,0.0007268757
11557,cytokine,57,58,357,365,"First we evaluated the effects of Tehranolide on cell growth inhibition (in vitro) by MTT assay and second investigated the immune responses, these include measuring tumor growth in the female Balb/c mice transplanted with spontaneous mouse mammary tumor and treated with Tehranolide, splenocyte proliferation detected by using the BrdU kit, measurement of cytokine profile by ELISA and analysis of T-lymphocytes subpopulation in spleen by Flow cytometry.",20138670_4,0,-1,-1,0,11557,-1,0.9998264,5.8638907e-05,0.000114983195
35461,IL-13,30,31,155,160,"Activated CD4+ T cells differentiate into four main separate lineages: Th1, Th2, Th17 and Treg, and they are recognized by their effector molecules IFN-, IL-13, IL-17A, and the transcription factor Foxp3, respectively.",30075815_5,0,-1,-1,0,35461,-1,0.9998498,3.024286e-05,0.00011991973
6165,cytokine-mediated,6,7,55,72,"These findings document the selective gammac-signaling cytokine-mediated activation of the mTORC1 pathway in the CTCL cells and suggest that the pathway represents a therapeutic target in CTCL and, possibly, other T-cell lymphomas.",18025151_8,0,-1,-1,0,6165,-1,0.9971246,0.0018590324,0.0010163069
26376,IFN,22,23,136,140,"Here, we show that STAT3 signaling in CD8(+) T cells inhibits chemokine CXCL10 production by tumor-associated myeloid cells by reducing IFN expression by T cells.",26025380_3,0,-1,-1,0,26376,-1,0.9998919,3.282515e-05,7.5295764e-05
33985,immune responses,5,7,34,50,HCV-high livers had two molecular immune responses: increased APC numbers and adaptive immunity and the induction of immune tolerance.,29248968_8,0,-1,-1,0,33985,-1,0.9997545,0.00014822098,9.728573e-05
36852,MCP-1,33,34,201,206,"The results show that in macrophages, these supernatants induce a decrease in the phosphorylation of NF-B-p65 and STAT1 in U937-macrophages accompanied by an increase in the secretion of IL-10, IL-6, MCP-1, and IL-8, as well as GM-CSF, G-CSF, PDGF-AA, PDGF-BB, and VEGF.",31099286_4,0,-1,-1,0,36852,-1,0.9991466,0.000114019625,0.0007393903
43725,antigens,25,26,172,180,Loss of HLA Class I antigens renders melanoma cells resistant to lysis by HLA Class I antigen-restricted cytotoxic T cells which specifically recognize melanoma associated antigens.,8795138_5,0,-1,-1,0,43725,-1,0.9989286,0.00010727614,0.0009640463
16335,interferon,9,10,54,64,"Interestingly, both subsets expressed a high level of interferon  in TILs, and the Tcregs suppressed nave CD4+ T cell proliferation by a cell contact-dependent mechanism in vitro.",22051182_9,0,-1,-1,0,16335,-1,0.99977785,9.233179e-05,0.0001297742
18488,IL-10,16,17,105,110,"Reciprocally, physiological compensation between Batf and Batf3 also occurs in T cells for expression of IL-10 and CTLA4.",22992524_3,0,-1,-1,0,18488,-1,0.9998461,3.280131e-05,0.00012106551
49,antigens,24,25,145,153,"Although both E6 and E7 proteins contain numerous predicted cytotoxic T lymphocyte (CTL) epitopes that are capable of binding to human leukocyte antigens, the majority of earlier in vivo tumor rejection studies have focused on E7.",10419051_2,0,-1,-1,0,49,-1,0.9990459,8.9169276e-05,0.00086482515
14792,CXCL12,7,8,49,55,METHODS: Immunoperoxidase staining for FOXP3 and CXCL12 was performed on tissue microarrays from 491 breast cancers.,21521526_2,0,-1,-1,0,14792,-1,0.99947137,7.93602e-05,0.00044925362
38878,chemokine-receptor,46,47,276,294,"UBA7 encodes an enzyme that catalyzes the covalent conjugation of the ubiquitin-like protein product of another ISG (ISG15) to cellular proteins in a process known as ""ISGylation."" ISGylation of other ISGs, including STAT1 and STAT2, synergistically facilitates production of chemokine-receptor ligands to attract cytotoxic T cells.",31974171_3,0,-1,-1,0,38878,-1,0.9954561,0.0004299064,0.0041139093
7402,CXCL10,42,43,262,268,"This PGE(2)-induced overproduction of CCL22 and the resulting attraction of FOXP3(+) Tregs are counteracted by IFN alpha, a mediator of acute inflammation, which also restores the ability of the PGE(2)-exposed DC to secrete the Th1-attracting chemokines: CXCL9, CXCL10, CXCL11, and CCL5.",18632653_4,0,-1,-1,0,7402,-1,0.9992781,6.5191656e-05,0.0006567741
20967,cytokine,18,19,112,120,"Furthermore, disruption of the POSH/JIP complex in CD8(+) T cells resulted in impaired proliferation, decreased cytokine expression, and the inability to control tumors.",23963642_6,0,-1,-1,0,20967,-1,0.9998692,5.1233197e-05,7.944694e-05
2567,IL12,34,35,224,228,"NKT-mediated anti-tumor activity was associated increased NKT and CD8+ T lymphocyte numbers, increased expression of STAT4, a marker for IL-12 activity and elevated serum levels of the proinflammatory cytokines IFNgamma and IL12, and of IL4.",15688366_13,0,-1,-1,0,2567,-1,0.99979955,4.163851e-05,0.00015889667
22186,IL-12p70,22,23,133,141,"The DCs were recovered from abnormal cytokine secretions of interleukin (IL)-10, IL-6, and IL-23 without any effect on production of IL-12p70.",24407159_5,0,-1,-1,0,22186,-1,0.99532926,0.00032070046,0.0043500774
2260,adaptive immunity,21,23,142,159,Gammadelta T cells represent an unconventional lymphocyte population that shares characteristics of NK cells and T cells and links innate and adaptive immunity.,15498816_1,0,-1,-1,0,2260,-1,0.99961287,0.00021487428,0.00017228525
11000,IL-12,0,1,0,5,IL-12 failed to induce FasL on T-effectors in IFN-gamma-knockout mice demonstrating a requirement for IFN-gamma in FasL up-regulation.,19923444_5,0,-1,-1,0,11000,-1,0.9998828,3.1824533e-05,8.538938e-05
25604,chemokines,26,27,147,157,"These data suggest that CLL cells attract CLL-specific Th cells and initiate a positive feedback loop with upregulation of T-bet, CD38, and type 1 chemokines allowing further recruitment of Th cells and increased type 1 cytokine secretion.",25505279_7,0,-1,-1,0,25604,-1,0.999861,5.444638e-05,8.4559164e-05
40008,antigens,13,14,87,95,How rTreg cells remain quiescent despite chronic exposure to cognate self- and foreign antigens is unclear.,32515782_1,0,-1,-1,0,40008,-1,0.99936754,0.00010574123,0.0005266399
31654,IFN-,19,20,104,109,"Moreover, in iNKT cell-deficient APCMin/+ mice, expression of T-helper (TH) 1-associated genes, such as IFN- and Nos2, was increased in polyps, concomitantly with elevated frequencies of conventional CD4+ and CD8+ T cells in this tissue.",28401935_5,0,-1,-1,0,31654,-1,0.9998857,3.112054e-05,8.324406e-05
23123,IL-6,2,3,6,10,"Thus, IL-6 may be a good candidate for engineering DCs for cancer immunotherapy.",24690994_8,0,-1,-1,0,23123,-1,0.996218,0.00020279824,0.0035791185
34648,immune responses,29,31,194,210,"METHODS: We established CIC-enriched tumorspheres from murine TC-1 lung cancer cells, expressing human papillomavirus 16 (HPV-16) E6/E7 antigens, and evaluated their susceptibility to antitumor immune responses both in vitro and in vivo.",29699516_4,0,-1,-1,0,34648,-1,0.9998037,0.00011611603,8.024566e-05
7005,cytokines,4,5,16,25,"IL-6 and IL-23, cytokines which play key roles in the induction and maintenance of gut inflammation during IBDs, have been recently shown to influence the development and growth of colitis associated colorectal cancer.",18473765_5,0,-1,-1,0,7005,-1,0.9997136,4.7337067e-05,0.00023908212
11978,immune response,1,3,10,25,"Antitumor immune response and chemotherapy-induced immunomodulation in colon cancer patients represented the rationale to design new strategies, like GOLFIG chemoimmunotherapy (gemcitabine, oxaliplatin, 5-fluorouracil/folinic acid, granulocyte macrophage colony-stimulating factor, and aldesleukine), that resulted a safe and very active regimen.",20386463_0,0,-1,-1,0,11978,-1,0.9987921,0.0010176036,0.00019020957
25220,IFN-dependent,13,14,71,84,DCs are shown to depend on STING function in vivo to efficiently prime IFN-dependent CD8(+) T cell responses to tumor Ags.,25385820_5,0,-1,-1,0,25220,-1,0.99977297,0.00010003126,0.00012702512
3683,immune response,18,20,131,146,Mesothelioma is infiltrated by immune effector cells but also contains cytokines and regulatory T-cells that suppress an efficient immune response.,16540497_9,0,-1,-1,0,3683,-1,0.99981564,0.0001229263,6.153214e-05
35417,antigen,10,11,55,62,Dendritic cells (DCs) are the most potent professional antigen presenting cells and inducers of T cell-mediated immunity.,30068989_0,0,-1,-1,0,35417,-1,0.9992644,0.00011604256,0.000619498
2846,IFN-gamma,16,17,100,109,"In STAT1-deficient naive CD8+ T cells, IL-27-induced proliferation was not reduced, but synergistic IFN-gamma production with IL-12 was diminished with decreased expression of T-bet, IL-12Rbeta2, granzyme B, and perforin.",16034109_6,0,-1,-1,0,2846,-1,0.9998883,2.9803088e-05,8.1930244e-05
26265,antigens,11,12,66,74,"Smoking and use of alcohol affected the T-cell response to common antigens but not to HPV peptides (p=0.032 and 0.045, respectively).CONCLUSION: While both the CIN women and controls exhibited an HPV16-specific CMI, IL-17A might be of importance in HPV induced pathology.",25990808_7,0,-1,-1,0,26265,-1,0.99883145,0.000109745364,0.001058771
20582,granulocyte macrophage colony-stimulating factor,12,16,55,103,"Obesity also led to elevations in CD4 T cells, IL-17A, granulocyte macrophage colony-stimulating factor, phosphorylated STAT3 and prosurvival gene expression in gastric tissue of H felis-infected mice.",23729675_5,0,-1,-1,0,20582,-1,0.9987018,0.00016026285,0.0011379353
18408,CCL2,10,11,37,41,"IL-1, IL-6, IL-12p40, IL-17, TNF-, CCL2 and CXCL1 protein levels in colons, but not small intestines increased with colitis progression and were significantly increased in mice with moderate and severe colitis compared with WT mice, irrespective of the absence/presence of dysplasia/cancer.",22962436_4,0,-1,-1,0,18408,-1,0.9951525,0.00020836711,0.0046392186
29193,IL-17A,10,11,69,75,"The -GalCer-dependent production of IFN-and Th2 cytokines, but not IL-17A, was severely reduced in T cell-specific Gfi1-deficient mice.",27284976_5,0,-1,-1,0,29193,-1,0.9998565,2.9287683e-05,0.000114158436
6926,IFN-gamma,20,21,130,139,"Moreover, short-term coculture of reovirus-activated DC with autologous T cells also enhanced T cell cytokine secretion (IL-2 and IFN-gamma) and induced non-Ag restricted tumor cell killing.",18424722_6,0,-1,-1,0,6926,-1,0.9998989,2.7551581e-05,7.3518124e-05
18427,CXCL1,19,20,129,134,"Constrained correspondence analysis demonstrated an association between increased protein levels of TNF-, CCL2, IL-1, IL-6 and CXCL1 and dysplasia/cancer.",22962436_9,0,-1,-1,0,18427,-1,0.9910648,0.00022696148,0.008708242
5330,immune responses,12,14,70,86,"Thus, a single administration of low dose CTX could augment antitumor immune responses of DC vaccine by reducing the proportion of CD4+CD25+FoxP3+ Treg cells in tumor-bearing mice.",17440723_5,0,-1,-1,0,5330,-1,0.9995881,0.0002989625,0.000112959846
29052,Ifng,19,20,148,152,Bhlhe40 alone shows no significant effects on Ifng promoter activities but contributes to enhance T-box transcription factor Tbx21 (T-bet)-mediated Ifng promoter activation.,27226296_6,0,-1,-1,0,29052,-1,0.99958223,0.00018008839,0.00023772391
19126,CCL2,0,1,0,4,CCL2 secondarily induces Lipocalin 2 (LCN2) in the Snail(+) tumor cells in an autocrine manner.,23143679_5,0,-1,-1,0,19126,-1,0.9887583,0.00071802136,0.010523561
43727,antigen,7,8,40,47,"Therefore, abnormalities in HLA Class I antigen expression may have a negative impact on the outcome of T cell based immunotherapy.",8795138_6,0,-1,-1,0,43727,-1,0.99840957,0.00010351108,0.0014868861
29772,IL-6,15,16,80,84,"Together, our results are the first to show that TAF-derived cytokines, such as IL-6 and SDF-1a, can induce MDSC generation and activation and then impair human anti-tumor immune responses, which create favorable conditions for HCC progression.",27593937_10,0,-1,-1,0,29772,-1,0.99980396,3.8874394e-05,0.00015716781
1234,Cytokine,0,1,0,8,Cytokine production and tumor challenges into STAT6(-/-)IFN-gamma(-/-) mice indicate that IFN-gamma is essential for immunity.,12421960_8,0,-1,-1,0,1234,-1,0.999848,5.9932176e-05,9.202216e-05
20987,IL-10,17,18,89,94,"Here, we investigated the effect of triptolide on regulatory T cells and on the level of IL-10, transforming growth factor-, and vascular endothelial growth factor in tumor-bearing mice.",23975869_2,0,-1,-1,0,20987,-1,0.99985147,3.1365613e-05,0.00011714891
8637,transforming growth factor-beta,9,12,62,93,"Furthermore, serum ELISAs revealed a significant elevation of transforming growth factor-beta in nonresponders as compared with responders.",19223534_9,0,-1,-1,0,8637,-1,0.8836476,0.113392934,0.0029594507
22678,interleukin-10,19,20,163,177,"Furthermore nurse-like cells and chronic lymphocytic monocytes significantly inhibited T-cell proliferation, prevented by anti-transforming growth factor beta and interleukin-10 antibodies and indoleamine 2,3-dioxygenase inhibitors, and supported CD4(+)CD25(high+)/FOXP3(+) T regulatory cell expansion.",24561793_7,0,-1,-1,0,22678,-1,0.9998969,3.3814864e-05,6.930146e-05
18117,IL-17,17,18,111,116,Immunohistochemical staining for microvessel density (MVD) was performed in order to assess the association of IL-17 expression with angiogenesis.,22820395_4,0,-1,-1,0,18117,-1,0.99955446,9.221719e-05,0.00035333814
8256,IL-1alpha,51,52,400,409,"Immunohistochemistry, real-time reverse transcriptase-polymerase chain reaction, and Western blot analyses of colonic tissues from Smad3/Rag2-DKO mice 1 week after Helicobacter infection revealed an influx of macrophages, enhanced nuclear factor-kappaB activation, increased Bcl(XL)/Bcl-2 expression, increased c-Myc expression, accentuated epithelial cell proliferation, and up-regulated IFN-gamma, IL-1alpha, TNF-alpha, IL-1beta, and IL-6 transcription levels.",19119184_5,0,-1,-1,0,8256,-1,0.9999043,2.6882095e-05,6.883332e-05
12349,cytokines,20,21,113,122,"This study analyzed the nature of the inflammatory infiltrate, presence of mast cells, and in situ expression of cytokines (interleukin [IL]-17 and transforming growth factor [TGF]-beta), chemokines (macrophage inflammatory protein [MIP]-1beta and monocyte chemotactic protein [MCP]-1), and nuclear transcription factor (FoxP3) in human periapical granulomas and cysts compared with a control group.",20478453_1,0,-1,-1,0,12349,-1,0.9998648,3.7882062e-05,9.7218086e-05
2111,antigens,37,38,232,240,"This indicates that the HPV16-specific CD4+ T-cell response in cervical cancer patients is either absent or severely impaired, despite a relatively good immune status of the patients, as indicated by intact responses against recall antigens.",15289354_6,0,-1,-1,0,2111,-1,0.99952114,0.00010324616,0.0003755204
25726,cytokine signaling,38,40,248,266,"miR-155 restrained the expression of the inositol 5-phosphatase Ship1, an inhibitor of the serine-threonine protein kinase Akt, and multiple negative regulators of signal transducer and activator of transcription 5 (Stat5), including suppressor of cytokine signaling 1 (Socs1) and the protein tyrosine phosphatase Ptpn2.",25548153_3,0,-1,-1,0,25726,-1,0.99794143,0.0014359964,0.0006225943
550,IL-15,2,3,19,24,"Preincubation with IL-15 also restored the ability of T cells to respond to IL-2 by phosphorylating STAT3 and STAT5, and proliferating normally in the presence of tumor cells.",11418694_6,0,-1,-1,0,550,-1,0.9997147,5.6550336e-05,0.00022872108
16402,GM-CSF,32,33,184,190,"In 1 study (Mel38), patients received 1 injection with an adjuvant mixture alone, composed of incomplete Freund's adjuvant (IFA) plus granulocyte-macrophage colony stimulating factor (GM-CSF).",22130163_5,0,-1,-1,0,16402,-1,0.9997688,5.624632e-05,0.00017500881
3570,antigens,13,14,79,87,"In the past few years, we have identified and reported several CTCL-associated antigens, CD158k/KIR3DL2, CD85j/ILT2, and SC5/vimentin.",16457762_4,0,-1,-1,0,3570,-1,0.9953497,0.00016846086,0.0044818614
40635,IFN-,30,31,216,221,"Furthermore, this combination therapy showed significant abscopal effect on the nonirradiated tumors in a concomitant model of mesothelioma through systemic activation of cytotoxic T cells and enhanced production of IFN- and granzyme B. Although local control was preserved with one fraction of nonablative irradiation, three fractions were required to generate the abscopal effect.",32948683_4,0,-1,-1,0,40635,-1,0.9998766,3.339716e-05,9.0017944e-05
4205,IL-10,10,11,59,64,"T cells purified from the growing tumor expressed mRNA for IL-10, TGF-beta, and Foxp3.",16818744_2,0,-1,-1,0,4205,-1,0.9998822,2.8015109e-05,8.972858e-05
42205,cytokines,3,4,34,43,"Th17 cell differentiation-related cytokines (IL-23, TGF- and IL-6) were increased in the tumor microenvironment.",33971545_7,0,-1,-1,0,42205,-1,0.9998147,4.3593853e-05,0.00014170105
21640,interferon-gamma,18,19,108,124,"In this study, we investigated the impact of a newly developed maturation cocktail consisting of OK-432 and interferon-gamma (IFN-) on the function of human monocyte-derived DCs (MoDCs).",24296809_1,0,-1,-1,0,21640,-1,0.9998839,3.728729e-05,7.877392e-05
14894,immune responses,28,30,181,197,"CONCLUSION: Gastric cancer cell can induce Tregs development via producing TGF-1, by which the existence of cross-talk between the tumor and immune cells might regulate anti-tumor immune responses.",21528082_14,0,-1,-1,0,14894,-1,0.9998234,9.9734716e-05,7.689708e-05
29903,chemokine,17,18,89,98,"The expression of Forkhead box P3 (Foxp3), interleukin 10, transforming growth factor-, chemokine CC motif ligands 17, 20, and CC chemokine receptor 4 was determined using real-time quantitative polymerase chain reaction.",27614428_2,0,-1,-1,0,29903,-1,0.99945515,0.000115693285,0.0004291815
37763,IFN--producing,2,3,17,32,The OVA-specific IFN--producing CD8 T-cells were induced by administration of OVA and the anti-TLR4 mAb.,31515801_7,0,-1,-1,0,37763,-1,0.99926454,0.00030561542,0.00042980924
13913,cytokine,32,33,168,176,"Here, we demonstrated that PTX not only decreased the percentage of CD4+Foxp3+ regulatory T (Treg) cells both in vitro and in vivo but also impaired cell viability and cytokine production of Treg cells rather than CD4+Foxp3- effector T (Teff) cells.",21223350_2,0,-1,-1,0,13913,-1,0.9998604,6.316416e-05,7.64086e-05
7381,mediators,7,8,48,57,"Here, we show that tissue-produced inflammatory mediators prime maturing dendritic cells (DC) for the differential ability of attracting anti-inflammatory Treg cells.",18632653_1,0,-1,-1,0,7381,-1,0.9998204,6.6111636e-05,0.00011351749
26619,CXCL10,28,29,157,163,"We observed a decreased GVHD severity in IFNAR(-/-) recipient of IL-22(-/-) T cells, which was associated with a lower level of STAT1 activation and reduced CXCL10 expression in the large intestine.",26153763_5,0,-1,-1,0,26619,-1,0.9997807,5.057749e-05,0.0001687195
30979,IFN-,15,16,74,79,"GATA3/T-bet ratio correlated positively with serum neopterin (p=0.008), IFN- (p=0.013) and KTR (p=0.018) after the first BCG instillation.",28005163_7,0,-1,-1,0,30979,-1,0.99988246,3.1290576e-05,8.6129185e-05
30855,IFN,13,14,75,79,"In response to autologous tumor, EECs upregulated CD107a, produced IL2 and IFN, and were competent for differentiation.",27979840_5,0,-1,-1,0,30855,-1,0.99986446,3.524566e-05,0.00010019185
12636,IFNgamma,17,18,142,150,The group of patients with smaller lesions displayed stronger and broader vaccine-prompted HPV16-specific proliferative responses with higher IFNgamma (P = 0.0003) and IL-5 (P < 0.0001) levels than patients with large lesions.,20547850_3,0,-1,-1,0,12636,-1,0.9997899,4.7878842e-05,0.00016216756
13031,IFN-alpha,50,51,309,318,"The study objective was to explore the immunomodulatory mechanism of action for IFN-alpha 2b by measuring serum regulatory T cell (Treg), serum transforming growth factor-beta (TGF-beta), interleukin (IL)-10, and autoantibody levels in patients with melanoma treated with the induction phase of the high-dose IFN-alpha 2b regimen.",20712892_1,0,-1,-1,0,13031,-1,0.99989796,2.8713965e-05,7.324708e-05
21686,IL-17,3,4,19,24,"The expressions of IL-17, FoxP3, CD4, and CD8 in liver tissue were measured by immunochemistry for the evaluation of liver-infiltrating lymphocytes.",24303990_3,0,-1,-1,0,21686,-1,0.9997975,4.5882276e-05,0.00015664652
6472,interleukin-21,3,4,15,29,PURPOSE: Human interleukin-21 (IL-21) is a class I cytokine previously reported in clinical studies on immune responsive cancers.,18286285_0,0,-1,-1,0,6472,-1,0.99681586,0.00041859306,0.0027655244
42081,IL-10,8,9,56,61,TFT cells promote DLBCL development partly by secreting IL-10 in the TME.,33864956_9,0,-1,-1,0,42081,-1,0.9998319,3.1295618e-05,0.00013676118
22439,IFN-,9,10,65,70,We found that ex vivo-isolated  thymocytes produced negligible IFN- and lacked cytolytic activity against leukemia cells.,24489097_3,0,-1,-1,0,22439,-1,0.99987125,3.2090713e-05,9.666577e-05
43012,IFN,16,17,91,95,"Real-time RT-PCR showed that I2 tumors overexpress T-BET (p = 0.019) and interferon-gamma (IFN; p = 0.020) and silence tumor growth factor-beta (TGF; p = 0.049), whereas in Cht+I2 tumors, GATA3 is silenced (p = 0.014).",34680134_5,0,-1,-1,0,43012,-1,0.9998995,3.2518376e-05,6.793356e-05
35077,immune response,15,17,98,113,Murine melanoma cell membrane coating on the core provides tumor targeting ability and elicits an immune response due to abundance of antigens.,29882235_3,0,-1,-1,0,35077,-1,0.99976486,0.00014453758,9.0627174e-05
31088,IL-12,11,12,55,60,"We also noted a trend of increased expression of IL-2, IL-12 and IL-15 receptors as well as increased phosphorylation of STAT5 in tumor-infiltrating CD8+T-cells following bortezomib treatment.",28052005_7,0,-1,-1,0,31088,-1,0.99974245,5.008845e-05,0.00020749883
864,mediators,17,18,96,105,"The 15-d-PGJ(2) has been shown to both inhibit as well as induce the production of inflammatory mediators such as TNF-alpha, IL-1beta, and cyclooxygenase, mostly occurring via a nuclear receptor called peroxisome proliferator-activated receptor-gamma (PPAR-gamma).",11801678_2,0,-1,-1,0,864,-1,0.99971133,7.225469e-05,0.00021643842
42331,interferon,11,12,71,81,"Biological and molecular responses of NB cells to epigenetic drugs and interferon (IFN)- exposure were assessed by proliferation assays, immunoblotting, ELISA, qRT-PCR, RNA-seq and ChIP-qPCR as well as co-culture assays with T cells.",34016720_5,0,-1,-1,0,42331,-1,0.9998247,5.909556e-05,0.00011620731
35756,Interleukin,0,1,0,11,"Interleukin 35 (IL-35) is a potent immunosuppressive cytokine, consisting of an Epstein-Barr virus-induced gene 3 (EBI3) subunit and a p35 subunit.",30321288_0,0,-1,-1,0,35756,-1,0.99919635,6.773304e-05,0.00073589076
39754,IL-10,16,17,91,96,"RESULTS: We found a significant difference between higher gene expression of FoxP3, TGFb1, IL-10, and IL-23, and approximately equal level of IL-6 in CRC patients in comparison with IBD patients.",32390702_3,0,-1,-1,0,39754,-1,0.99976534,3.8380495e-05,0.00019625013
26457,IL-1,8,9,49,54,"Serum levels of proinflammatory cytokines (IFN, IL-1, and TNF) and infiltration of donor T cells into GVHD target tissues (gastrointestinal tract and liver) were decreased.",26063163_6,0,-1,-1,0,26457,-1,0.99982196,5.6027824e-05,0.000122040714
3544,IL-10,3,4,20,25,The predominance of IL-10 production indicated that regulatory T cells directly participate in modulating the anti-tumor immune response.,16391798_7,0,-1,-1,0,3544,-1,0.9998784,3.0312765e-05,9.129226e-05
37232,antigen-specific,52,53,300,316,"Then, 3DSNA promotes ingestion and cross-presentation of OVA, upregulation of costimulatory factors (CD80 and CD86) and secretion of proinflammatory cytokines (IL-6 and IL-12) by dendritic cells (DCs), accompanied by activation of the innate immune response (NF-B signaling), resulting in long-term antigen-specific memory and effector CD8+ T cells response.",31244959_5,0,-1,-1,0,37232,-1,0.9994986,0.00016422654,0.000337141
37387,CCL22,6,7,31,36,C-C motif chemokine ligand 22 (CCL22) has been implicated in the recruitment of Tregs.,31325403_1,0,-1,-1,0,37387,-1,0.99477863,0.00045413448,0.0047671907
18077,IFN-gamma,6,7,28,37,We also studied the role of IFN-gamma in the mechanism of Treg induction.,22812187_5,0,-1,-1,0,18077,-1,0.9998832,3.381314e-05,8.295925e-05
41992,interferon,50,51,307,317,"Further investigation showed that transfection of HT29 and SW480 cells with miR-124 mimics significantly reduced PD-L1 mRNA, protein, and cell surface expression, and inhibited Tregs in coculture models via modulating interleukin[IL]-10, IL-2, tumor necrosis factor , transforming growth factor beta, and interferon gamma expression levels.",33821473_5,0,-1,-1,0,41992,-1,0.9998116,5.8044494e-05,0.00013038755
27005,antigen,12,13,77,84,"T cells of all specificities expanded similarly in vitro, recognized cognate antigen, and, to a lower extent, EBV-infected cells, exerted moderate cytotoxicity and showed reduced alloreactivity.",26276009_5,0,-1,-1,0,27005,-1,0.999432,7.589295e-05,0.0004921042
16949,IL-12,18,19,116,121,Our findings identify IL-12- and TIM-3-mediated exhaustion of T cells as a mechanism for poor clinical outcome when IL-12 is administered to FL patients.,22426209_9,0,-1,-1,0,16949,-1,0.9997731,4.659283e-05,0.00018034724
11047,IFN-alpha,14,15,101,110,"Low Treg cell levels before treatment may therefore be advantageous to subsequent immunotherapy with IFN-alpha, and predictive for treatment results in RCC patients.",19929575_5,0,-1,-1,0,11047,-1,0.9999025,3.0251058e-05,6.723938e-05
9049,IL-15,11,12,90,95,Fludarabine lymphodepletion increased plasma levels of the homeostatic cytokines IL-7 and IL-15.,19270751_13,0,-1,-1,0,9049,-1,0.999169,6.261476e-05,0.00076839974
35596,IL-6,26,27,141,145,"After co-culture of peripheral blood cells with bladder cancer cell lines, the induction of regulatory T cell (Treg) was higher in T24 whose IL-6 and IL-8 levels were higher.",30199269_2,0,-1,-1,0,35596,-1,0.9996407,4.688064e-05,0.00031248797
8590,immune responses,4,6,38,54,"Established tumors suppress antitumor immune responses and induce tolerance by incompletely characterized mechanisms, and this phenomenon is an important barrier to tumor immunotherapy.",19223534_0,0,-1,-1,0,8590,-1,0.9998123,9.858682e-05,8.915372e-05
8813,tumor necrosis factor,28,31,210,231,"Here, we show that EOC-associated/infiltrating lymphocytes derived by culturing tumor samples in the presence of IL-2 contain significant frequencies of TH17 cells, coproducing interferon-gamma (IFN)-gamma and tumor necrosis factor (TNF)-alpha, which represent, in some cases, up to 40% of total CD4+ T cells.",19238008_3,0,-1,-1,0,8813,-1,0.9693248,0.028626204,0.0020490324
38339,IL-1,21,22,152,157,"Some flavonoids exert anti-inflammatory effects through: Blockade of NF-B, and NLRP3 inflammasome, inhibition of pro-inflammatory cytokine production, IL-1, IL-2, IL-6, TNF-, IL-17A, down regulation of chemokines, and reduction of reactive oxygen and nitrogen species.",31814545_4,0,-1,-1,0,38339,-1,0.9998,5.2920666e-05,0.0001471076
24192,IFN,18,19,118,122,"A20-deleted CD8 T cells had increased sensitivity to antigen stimulation with production of large amounts of IL-2 and IFN, correlated with sustained nuclear expression of NF-B components reticuloendotheliosis oncogene c-Rel and p65.",25024217_5,0,-1,-1,0,24192,-1,0.99987507,3.516649e-05,8.977356e-05
35995,CCL22,18,19,114,119,METHODS: One hundred ninety-nine tissue samples of patients with invasive breast cancer were stained for CCL1 and CCL22 by immunohistochemistry.,30572845_3,0,-1,-1,0,35995,-1,0.98875755,0.00042390483,0.010818659
28073,cytokines,22,23,128,137,"The impact of DC vaccine loaded with Hepa1-6 cell lysate on tumor progression, survival, and tumor-infiltrating lymphocytes and cytokines was examined.",26786094_3,0,-1,-1,0,28073,-1,0.9998454,5.2364645e-05,0.00010223141
28277,IL-17(+,10,11,74,81,"In contrast, HPV-negative OPSCC contained significantly higher numbers of IL-17(+) non-T cells (p < 0.0001).",26899388_5,0,-1,-1,0,28277,-1,0.9997328,7.074025e-05,0.00019635665
24297,IL6,22,23,138,141,"Notably, monocytic MDSCs in Spp1(-/-) mice were less suppressive than their wild-type counterparts due to lower expression of arginase-1, IL6, and phospho-Stat3.",25035397_7,0,-1,-1,0,24297,-1,0.9995925,5.767948e-05,0.00034990232
29638,IFN-,11,12,63,68,"But some vaccinated volunteers showed up to 0.1% HPV-specific, IFN- or perforin-secreting cells.",27548034_9,0,-1,-1,0,29638,-1,0.9998673,3.5834615e-05,9.682565e-05
43702,antigen,11,12,66,73,Analysis of melanoma cell lines with abnormalities in HLA Class I antigen expression has identified two serological phenotypes caused by distinct molecular defects.,8795138_0,0,-1,-1,0,43702,-1,0.9986829,9.284791e-05,0.001224179
40975,IFN-,22,23,137,142,"Furthermore, Ocs-P administration enhanced the generation of multifunctional CD4+ and CD8+ T cells expressing Th1-type cytokines (TNF-, IFN-, and IL-2) and the degranulation marker (CD107a).",33105813_5,0,-1,-1,0,40975,-1,0.9999039,2.8907043e-05,6.714029e-05
39820,IL-7,22,23,147,151,"Trm cells persistence in peripheral tissues depends on their adaptation to the local microenvironment and the presence of survival factors, mainly IL-7, IL-15, and Notch ligands.",32441311_3,0,-1,-1,0,39820,-1,0.9995598,4.143785e-05,0.000398712
31084,IL-15,19,20,144,149,"In bortezomib-treated 4T1HA tumor-bearing mice, CD4+T-cells showed increased IL-2 production, CD11c+ dendritic cells showed increased IL-12 and IL-15 production, and HA-specific activated CD8+T-cells showed enhanced expression of IFN, granzyme-B and transcription factor eomesodermin.",28052005_6,0,-1,-1,0,31084,-1,0.9998684,3.434996e-05,9.726546e-05
21003,growth factor,12,14,86,99,"Production of cytokines IL-10, transforming growth factor-, and vascular endothelial growth factor in serum was measured using enzyme-labeled immunosorbent assay kits.",23975869_5,0,-1,-1,0,21003,-1,0.9995689,0.0001907824,0.0002403271
8097,IFN-alpha,9,10,52,61,Ex vivo treatment of splenocytes from NZB mice with IFN-alpha resulted in a decrease in the frequency of Tregs and malignant B-1 cells.,19022624_5,0,-1,-1,0,8097,-1,0.99989295,3.9820963e-05,6.720009e-05
21705,IL-17(+,19,20,128,135,"In surgical specimens of less differentiated HCC, the quantity of tumor-infiltrating FoxP3(+) Tregs was significantly lower and IL-17(+) T cells and CD8(+) T cells were significantly higher.",24303990_5,0,-1,-1,0,21705,-1,0.999705,6.150352e-05,0.00023344358
35690,IFN-,23,24,142,147,"PBMCs were stimulated with PMA and ionomycin in the presence of Berefeldin A as Golgi stop agent to detect intracellular cytokine production (IFN-, IL-17, and IL-4) from CD3+CD4+T cells population indicating T helper (Th) cells subsets by flowcytometry.",30246693_4,0,-1,-1,0,35690,-1,0.9998927,3.008648e-05,7.7281555e-05
30605,interferon-,52,53,340,352,"Based on our hypothesis in which continuous exposure to asbestos of immune cells cause reduction of antitumor immunity, the decrease of natural killer cell killing activity with reduction of NKp46 activating receptor expression, inhibition of cytotoxic Tcell clonal expansion, reduced CXCR3 chemokine receptor expression and production of interferon- production in CD4+ Tcells were reported using cell line models, freshly isolated peripheral blood immune cells from health donors as well as asbestos exposed patients such as pleural plaque and mesothelioma.",27878235_1,0,-1,-1,0,30605,-1,0.99983287,7.966452e-05,8.747251e-05
25384,IFN-,24,25,163,168,"CONCLUSION: B7-H4 is overexpressed in human cervical cancers, and it is associated with lower numbers of tumor-infiltrating CD8(+)T lymphocytes and therefore less IFN- production.",25446402_11,0,-1,-1,0,25384,-1,0.9998758,3.2848864e-05,9.1358386e-05
340,cytokines,27,28,150,159,"We hypothesized that this failure to reject may be due to poor generation of a type 1 phenotype, through a dominant influence of the type 2-promoting cytokines IL-4 and/or IL-13.",11086033_3,0,-1,-1,0,340,-1,0.99976975,4.2072905e-05,0.00018821779
364,cytokines,24,25,146,155,"The CD40 and CD40 ligand (CD40L) interaction has been implicated in the generation of effective cell-mediated and humoral immune responses, where cytokines have been shown to play a significant role in the expression of these molecules.",11129327_1,0,-1,-1,0,364,-1,0.99985135,5.1374856e-05,9.728838e-05
18645,IL-12,25,26,164,169,We found that Tregs derived from the tumor mice down-regulated the expression of costimulatory molecules CD80/CD86 on DCs and inhibited the production of TNF- and IL-12 from DCs.,23000301_6,0,-1,-1,0,18645,-1,0.9998536,3.1834894e-05,0.00011458481
34261,IL-17,13,14,74,79,"Clinical staging of gastric cancer were correlated with the rise of IL-6, IL-17, FoxP3, and TGF-1 levels expressed in cancer tissues.",29391307_6,0,-1,-1,0,34261,-1,0.9997938,3.8281203e-05,0.00016788483
96,IFN-gamma,34,35,204,213,"Gangliosides prepared from RCC supernatants, as well as the purified bovine gangliosides G(m1) and G(d1a), suppressed NFkappaB binding activity in T cells and reduced expression of the cytokines IL-2 and IFN-gamma.",10491412_5,0,-1,-1,0,96,-1,0.9998988,2.9913828e-05,7.1278286e-05
2029,antigen,9,10,61,68,These leukemic DC showed high-level CD83 and human leukocyte antigen (HLA)-DR expression and had a high allostimulatory potential.,15197237_4,0,-1,-1,0,2029,-1,0.98389196,0.00016827405,0.015939688
32048,cytokine,4,5,20,28,Interleukin 10 is a cytokine with controversial roles in CD8+ T cell-mediated anti-tumor immunity.,28488547_2,0,-1,-1,0,32048,-1,0.9998227,5.1071296e-05,0.00012630578
29505,cytokines,17,18,124,133,Research has shown that Tregs can infiltrate cancerous tissue and contribute to tumor growth by secreting immunosuppressive cytokines such as transforming growth factor beta and interleukin (IL)-10.,27420920_3,0,-1,-1,0,29505,-1,0.99982786,4.155234e-05,0.00013046432
5015,immune responses,25,27,157,173,"The present study provides novel insights into understanding the immunopathogenesis of ATLL, i.e., how HTLV-1-infected cells can survive in the face of host immune responses.",17278106_7,0,-1,-1,0,5015,-1,0.99983394,9.573584e-05,7.026302e-05
33408,IL10,13,14,79,83,Both groups of DCs also responded to PD-1 blockade by increasing production of IL10.,28993412_6,0,-1,-1,0,33408,-1,0.999811,3.624924e-05,0.00015278684
36222,IL-10,3,4,16,21,The quantity of IL-10 produced by B cells was significantly higher in DTC patients than in controls.,30711567_4,0,-1,-1,0,36222,-1,0.99984765,3.5878737e-05,0.00011643118
16958,IL-15,18,19,123,128,"IL-15 signals in lymphocytes via trans presentation, where accessory cells such as macrophages and dendritic cells present IL-15 bound to IL-15R in trans to NK cells and CD8(+) memory T cells expressing IL-15/IL-2R and common  chain ((c)).",22447977_1,0,-1,-1,0,16958,-1,0.999762,4.7300047e-05,0.0001906801
5489,IL-6,4,5,19,23,"Furthermore, BxCM, IL-6, or G-CSF led to the activation of signal transducer and activator of transcription 3 (STAT3) in CD14+ monocytes to different degrees.",17545630_10,0,-1,-1,0,5489,-1,0.99979144,3.6048034e-05,0.00017263184
30977,IL-10,67,68,221,226,"BCG responders showed significantly higher levels of urinary (p=0.003) and serum neopterin (p=0.012), kynurenine (p=0.015), KTR (p=0.005), IFN- (p=0.005) and IL-12 (p=0.003) during therapy, whereas levels of IL-10 decreased significantly (p<0.001) compared to non-responders.",28005163_6,0,-1,-1,0,30977,-1,0.99979323,3.235796e-05,0.00017453505
8702,IL-10,26,27,159,164,"Using multiparameter flow cytometry, splenic T cells were assessed for FoxP3 expression to identify regulatory T cells (Tregs) and production of IFN-gamma and IL-10 after stimulation with PMA/ionomycin; within the CNS, CD4+ TILs were quantified, and TAMs were quantified and assessed for TNF-alpha and IL-10 production after stimulation with LPS.",19226468_4,0,-1,-1,0,8702,-1,0.999902,2.5920337e-05,7.216971e-05
9507,interleukin-6,19,20,119,132,"In vitro, conversion of Tregs to the TH17-like phenotype was driven by antigen-activated effector T cells and required interleukin-6 (IL-6) produced by activated pDCs.",19366986_2,0,-1,-1,0,9507,-1,0.99982375,4.813934e-05,0.00012818207
27235,immune responses,34,36,219,235,We have previously shown that a specific promyelocytic leukemia-retinoic acid receptor alpha (PML-RARA) DNA vaccine combined with all-trans retinoic acid (ATRA) increases the number of long term survivors with enhanced immune responses in a mouse model of acute promyelocytic leukemia (APL).,26378812_0,0,-1,-1,0,27235,-1,0.99964917,0.00024764283,0.000103242055
12114,IL-1beta,22,23,146,154,"LPS stimulation of DCs induced IL-10, IL-12p70, TNFalpha and IL-1beta secretion, and taxol pretreatment modified this response by down-regulating IL-1beta secretion whereas colchicine induced a proinflammatory cytokine profile with reduced IL-10 and increased IL-12p70 and TNFalpha secretion.",20386470_6,0,-1,-1,0,12114,-1,0.9998416,4.2893043e-05,0.00011548354
16702,IL-10,0,1,0,5,"IL-10 synthesis was stimulated by direct Gal-1 engagement to cell surface glycoproteins, principally CD45, on activated Th cells and enhanced by IL-21 expression through the c-Maf/aryl hydrocarbon receptor pathway, independent of APCs.",22345665_2,0,-1,-1,0,16702,-1,0.9998851,3.2901153e-05,8.197813e-05
5269,interferon,18,19,109,119,"c-MYC does not block the interferon pathway completely, it shifts the balance and increases the threshold of interferon induction and action.",17419945_7,0,-1,-1,0,5269,-1,0.99974114,0.00012578908,0.00013316292
40309,chemoresistance,12,13,73,88,"Here, we report the immunomodulatory roles of sEV-pGSN in ovarian cancer chemoresistance.",32641415_3,0,-1,-1,0,40309,-1,0.9924568,0.0057436004,0.0017996521
28841,IL-17A,2,3,14,20,"Additionally, IL-17A promoted resistance to daunorubicin via activation of Akt signaling and the PI3K/Akt inhibitor LY294002 or perifosine almost completely rescued daunorubicin-induced cell death in B-ALL cells.",27176825_9,0,-1,-1,0,28841,-1,0.9998265,3.6926816e-05,0.00013660455
30172,cytokine,44,45,290,298,"We demonstrate that TGF1 enhances antigen-induced PD-1 expression through SMAD3-dependent, SMAD2-independent transcriptional activation in T cells in vitro and in TILs in vivo The PD-1hi subset seen in CD8+ TILs is absent in Smad3-deficient tumor-specific CD8+ TILs, resulting in enhanced cytokine production by TILs and in draining lymph nodes and antitumor activity.",27683557_2,0,-1,-1,0,30172,-1,0.9998443,5.066655e-05,0.00010497291
19960,IL-1,5,6,35,40,"RG-II induced interleukin (IL)-12, IL-1, tumor necrosis factor- (TNF-) and interferon- (IFN-) production during dendritic cell (DC) maturation.",23392255_2,0,-1,-1,0,19960,-1,0.9997937,5.3249147e-05,0.00015307414
8976,interleukin-6,29,30,166,179,"Here, we show that signal transducer and activator of transcription 3 (Stat3) plays a key role in down-modulating immunostimulatory effects of CpG. In the absence of interleukin-6 (IL-6) and IL-10 induction, CpG directly activates Stat3 within minutes through TLR9.",19258507_1,0,-1,-1,0,8976,-1,0.9998462,4.2683212e-05,0.00011109417
38433,transforming growth factor-beta,21,24,152,183,"BACKGROUND/AIM: We previously demonstrated that inflammatory cytokine interleukin-6 (IL-6) was produced during cancer progression, worked together with transforming growth factor-beta 1 (TGF-1), and induced the epithelial-mesenchymal transition (EMT) with chemo-resistance against gemcitabine (GR) at the invasion front of biliary tract cancers (BTCs).",31853779_0,0,-1,-1,0,38433,-1,0.9774145,0.020034214,0.002551258
32069,Interleukin 10,0,2,0,14,Interleukin 10 and interleukin 10 receptor expression was also enriched in interferon gamma-expressing activated CD8+ T cells.,28488547_6,0,-1,-1,0,32069,-1,0.9998049,8.420678e-05,0.000110898196
3438,IL-12,9,10,49,54,"As a sign of transgene function, interleukin-12 (IL-12) expression was significantly increased.",16361570_6,0,-1,-1,0,3438,-1,0.99983966,3.689932e-05,0.00012336814
26430,cytokine signaling,6,8,41,59,"CCR5 blockade also induces suppressor of cytokine signaling 3 (SOCS3) upregulations, and anti-CCR5 antibody fails to suppress expression of phospho-Stat3 (p-Stat3), matrix metallopeptidase 9 (MMP9), and IL-6 in cells transfected with SOCS3 short-interfering RNA (SiRNA).",26047948_5,0,-1,-1,0,26430,-1,0.9951988,0.003508688,0.001292601
14249,IL-10,13,14,74,79,"By using quantitative real-time PCR, gene expressions of cytokines (IL-4, IL-10, IFN, TGF, GM-CSF) and the surrogates of immunosuppressive regulatory and effector cells (IDO-expressing DCs and Foxp3-expressing T-regs, respectively) were measured and correlated against the SLN tumor burden (MART1) and against each other.",21327637_6,0,-1,-1,0,14249,-1,0.99986875,2.77662e-05,0.00010349553
5639,interferon-gamma,21,22,130,146,"The CD45RA+/CCR7+ phenotype of HPV antigen-reactive T cells may serve as an indicator of dysfunctional T cells, despite effective interferon-gamma production in response to HPV antigens.",17589293_6,0,-1,-1,0,5639,-1,0.99986136,5.671927e-05,8.185244e-05
42316,interferon,23,24,134,144,There is evidence that MYCN promotes a non-inflamed and T-cell infiltration-poor ('cold') tumor microenvironment (TME) by suppressing interferon signaling.,34016720_1,0,-1,-1,0,42316,-1,0.99982506,7.297136e-05,0.00010198111
17549,IL-17,32,33,196,201,"Both IL-6 and STAT3 have recently emerged as main regulators of the differentiation and function of Th17 cells, via a positive feedback loop enhancing expression and/or activation of IL-6 itself, IL-17 and STAT3.",22652781_4,0,-1,-1,0,17549,-1,0.999757,4.1850595e-05,0.00020121188
36945,antigens,9,10,59,67,"The persistent polarization of IL4 induced by strong lipid antigens, that is, -galactosylceramide (GC), caused IL4 accumulation at the immunological synapse (IS), which promoted the activation of the IL4R-STAT6 (signal transducer and activator of transcription 6) pathway and production of IL12 in DCs, which enhanced interferon- (IFN) production in iNKT cells.",31160756_2,0,-1,-1,0,36945,-1,0.99887055,0.0001600666,0.0009694149
21815,IL-10,3,4,13,18,"In addition, IL-10, IFN- and IL-4 levels were determined in sera and also in splenocyte culture supernatants at the presence of tumor cell lysate (10g/ml) and Con A (3g/ml) after 72h. Results showed the cytotoxic effects of umbelliprenin on LLC cells (IC=51.65.4M) while no adverse effect was seen at this concentration on normal splenocytes.",24325354_5,0,-1,-1,0,21815,-1,0.9998615,3.075647e-05,0.00010778774
24994,IL10,2,3,19,23,"AdipoR1 stimulated IL10 production by activating the AMPK and MAPKp38 pathways, whereas AdipoR2 modified inflammatory processes by activating the COX-2 and PPAR pathways.",25261236_4,0,-1,-1,0,24994,-1,0.99985695,3.6779733e-05,0.00010622026
35928,Interferon-,6,7,46,58,"Reduced Tumor Necrosis Factor- and increased Interferon- production were found, which might be ascribed to the expansion of Tregs and central memory T cells, and result in increased sensitivity of tumor cells to cytotoxic T lymphocyte activity.",30445020_5,0,-1,-1,0,35928,-1,0.9997944,9.429696e-05,0.000111303896
15995,IFN-,14,15,104,109,"These include: promoting proliferation, protecting cells from activation-induced cell death, supporting IFN- production, and suppressing inducible regulatory T-cell differentiation.",21972292_3,0,-1,-1,0,15995,-1,0.99988675,3.4709137e-05,7.8568875e-05
24956,mediators,35,36,257,266,"These results demonstrate that nicotine suppresses acute colitis and colitis-associated tumorigenesis, and this effect may be associated with the activation of 7-nAChR. Furthermore, it is presumed that nicotine downregulates the expression of inflammatory mediators such as IL-6/Stat3 and TNF-, thereby reducing the colonic tumorigenesis associated with chronic colitis.",25258409_9,0,-1,-1,0,24956,-1,0.9998271,5.6711917e-05,0.000116183655
38230,CCL22,0,1,0,5,CCL22 was the indispensable effector underlying p65/miR-23a axis and Tregs recruitment.,31769216_14,0,-1,-1,0,38230,-1,0.9790557,0.0007979365,0.020146325
28829,IL-1,14,15,87,92,"Furthermore, increased levels of Th17-related cytokines including IL-17, IL-21, IL-23, IL-1, and IL-6 were presented in between blood and marrow in B-ALL patients.",27176825_7,0,-1,-1,0,28829,-1,0.99915147,0.00019332938,0.0006552648
2545,antigens,8,9,55,63,"Adoptive transfer of NKT cells pulsed with HCC-derived antigens (group A) and NKT cells from immunized donors (group E) resulted in complete disappearance of tumors within 4 weeks and attenuated weight loss (6.5% and 7% in groups A and E, respectively).",15688366_9,0,-1,-1,0,2545,-1,0.9992186,9.549242e-05,0.000685848
2542,cytokine,44,45,243,251,"To determine the mechanism of the anti-tumor effect, intrasplenic lymphocyte populations were analyzed by FACS for NKT, CD4+ and CD8+ lymphocyte subpopulations; STAT 1, 4 and 6 expression in splenocytes was assessed by Western blot, and serum cytokine levels were measured by ELISA.",15688366_8,0,-1,-1,0,2542,-1,0.99984765,5.4901197e-05,9.738549e-05
17945,immune response,10,12,56,71,In vivo assays of C4HD tumors showed that the antitumor immune response involves the participation of CD4(+) T cells and cytotoxic NK cells.,22753933_6,0,-1,-1,0,17945,-1,0.9997398,0.0001685111,9.169177e-05
22291,IL-6,0,1,0,4,"IL-6 regulates T cell differentiation, activation and resistance against apoptosis and thereby controls the balance between pro-inflammatory T cell subsets such as Th1 or Th17 cells and immunosuppressive regulatory T cells.",24447345_1,0,-1,-1,0,22291,-1,0.9997948,5.3655633e-05,0.00015163486
23288,cytokine,31,32,206,214,"Recent mice and human studies have demonstrated that Tregs can be reprogrammed into a novel population, IL-17(+)Foxp3(+) T cells, phenotypically and functionally resembling Th17 cells under the complicated cytokine stimulation.",24744433_3,0,-1,-1,0,23288,-1,0.999858,5.043473e-05,9.148476e-05
35903,IL-10,4,5,29,34,"The excretion of intra-tumor IL-10, TGF- was notably lower but higher IFN- excretion in this combination immunotherapy.",30359281_12,0,-1,-1,0,35903,-1,0.9998481,2.8579845e-05,0.00012320575
2853,IL-12,19,20,129,134,"In T-bet-deficient naive CD8+ T cells, IL-27-induced proliferation was hardly reduced, but synergistic IFN-gamma production with IL-12 was diminished with decreased expression of IL-12Rbeta2, granzyme B, and perforin.",16034109_7,0,-1,-1,0,2853,-1,0.9998492,3.5176115e-05,0.000115622955
10520,immune response,25,27,168,183,"Tumor and spleen CD4+CD25+Foxp3+ regulatory T lymphocytes, cytotoxic activity of the splenocytes, IFN-gamma and IL-4 secretion were assessed to describe the anti-tumor immune response.",19706340_3,0,-1,-1,0,10520,-1,0.9997665,0.00014236117,9.116451e-05
11210,CCL22,5,6,25,30,"In conclusion, CCL17 and CCL22 within the tumor are related to the increased population of Foxp3(+) T-regs in ESCC.",20002703_10,0,-1,-1,0,11210,-1,0.98871094,0.00073091587,0.01055822
29709,IL-17,5,6,26,31,"Serum levels of IL-10 and IL-17, and expression of Foxp3 and RORt, were significantly increased in the CLL patients.",27584054_3,0,-1,-1,0,29709,-1,0.99983335,3.8473554e-05,0.00012807077
37879,interleukin-17,10,11,55,69,"We report that histone deacetylase 6 (HDAC6) represses interleukin-17 (IL-17)-producing helper T (TH 17) cell pathogenicity and the antitumor immune response, dependent on its deacetylase activity.",31539182_1,0,-1,-1,0,37879,-1,0.99987614,3.9414215e-05,8.43829e-05
39990,IL-17A,15,16,92,98,"Moreover, survival analysis showed that patients with low CD8 and CXCR3 expression and high IL-17A levels had significantly worse prognosis.",32503584_12,0,-1,-1,0,39990,-1,0.9997961,4.586086e-05,0.00015804617
31178,cytokines,29,30,176,185,"We found bone marrow derived dendritic cells (BMDCs) in 36 female C57BL/6 mice treated with MENK enhanced expression of key surface molecules, increased production of critical cytokines reduced endocytosis of FITC-dextran, upregulated TLR4 through MyD88/NF-B signaling pathway and mounted higher antitumor activity.",28088065_4,0,-1,-1,0,31178,-1,0.99984586,4.7947513e-05,0.00010616986
15495,cytokines,56,57,293,302,"Functional analysis revealed 2 important findings: (i) in 5 of 17 patients, we found cytokine production after specific peptide stimulation by tumor-infiltrating lymphocytes (TIL), not by autologous peripheral blood lymphocytes (PBL); (ii) CD8(+) T cells from 7 of 17 patients did not produce cytokines after specific stimulation, which corresponded with significant loss of tumor HLA-A2 expression.",21750202_4,0,-1,-1,0,15495,-1,0.9998392,4.7346173e-05,0.00011345945
24003,interleukin,19,20,91,102,"We determined the profiles of Tregs and CD123(+) cells; immunostained for CD4, CD8, CD123, interleukin (IL)-1 and transforming growth factor (TGF)-1; and unequivocally double stained for Foxp3CD25.RESULTS: Peritumorally, CD4, CD8 and Foxp3 expression showed no difference between the two groups.",24910265_2,0,-1,-1,0,24003,-1,0.99984264,3.8794456e-05,0.00011856315
409,IL-12,15,16,98,103,"These observations demonstrate that the expression of CD40L by the effector cells is regulated by IL-12 and IFNgamma, and could effectively modulate the NK-cell-mediated immune response during the regression of AK-5 tumor.",11129327_10,0,-1,-1,0,409,-1,0.999846,3.0789975e-05,0.00012327389
43428,chemokine,5,6,49,58,Rap1B-deficiency led to elevated proinflammatory chemokine and Cell Adhesion Molecules (CAMs) expression in TNF- stimulated ECs.,36403190_6,0,-1,-1,0,43428,-1,0.99973625,8.0899816e-05,0.00018281754
24237,FOXP3-,18,19,121,127,"Results showed that the percentage of T-bet-positive cells was significantly decreased, while the percentages of IL-17-, FOXP3-, CD49b-, and LAG-3-positive cells were significantly increased in tumor tissues compared to that in peritumoral tissues.",25034363_5,-1,1,-1,1,24237,-1,3.4782744e-05,0.9999397,2.5523286e-05
40372,Together,0,1,0,8,"Together, these findings suggest that the combination therapy of SP-2577 with checkpoint inhibitors may induce or augment immunogenic responses of SWI/SNF-mutated ovarian cancers and warrants further investigation.",32649682_9,-1,1,-1,1,40372,-1,3.2927688e-05,0.99995506,1.2069946e-05
40538,TME,7,8,54,57,"In addition, immunosuppresive tumor microenvironment (TME) has been identified as major barrier to evoke anti-tumor response in melanoma.",32890791_1,-1,1,-1,1,40538,-1,2.6942509e-05,0.9999604,1.2618611e-05
953,transformation,32,33,195,209,"In conclusion, constitutively activated Stat3 is found to mediate a spontaneous IL-5 production and regulate IL-13 production in CTCL cell lines, pointing toward a new role of Stat3 in malignant transformation.",11807001_8,-1,1,-1,1,953,-1,2.2037659e-05,0.99995947,1.8519875e-05
40291,the,11,12,69,72,The study provides a comprehensive survey of and novel insights into the immune status of murine BCC and serves as a basis for the design of efficacious rational combination treatments.,32615027_7,-1,1,-1,1,40291,-1,1.8543224e-05,0.9999739,7.5141356e-06
8695,the,7,8,51,54,PDGF-driven murine glioma cells were injected into the white matter of 13 mice.,19226468_2,-1,1,-1,1,8695,-1,1.690173e-05,0.99997294,1.02152e-05
25306,the,8,9,51,54,"Consequently, a full and complete understanding of the exceptional biology of human Tregs is fundamental for the accurate interpretation of found data, before therapeutic interventions can be undertaken.",25427312_4,-1,1,-1,1,25306,-1,1.72282e-05,0.99997485,7.9571455e-06
2748,the,57,58,273,276,"This paradox in tumor immunology led us to address two questions: (a) Does an antitumor response, which is intended to destroy the aberrant target population, also at the same time select for aggressive tumor variants (ATV) in vivo? (b) If this process does occur, what is the contribution of the perforin- or Fas-mediated effector mechanism in the immune selection of such ATV? Here, in an experimental mouse lung metastasis model, we showed that ATV generated either naturally in vivo or in vitro by anti-Fas selection resembled each other biologically and genetically as judged by enhanced tumor growth and genome-scale gene expression profiling, respectively.",15899830_1,-1,1,-1,1,2748,-1,2.0745449e-05,0.99997175,7.558291e-06
3045,the,12,13,81,84,"The TGF-beta receptor-activated Smad3 plays a critical role in mediating many of the inhibitory effects of TGF-beta signaling in T cells, and has now been established as an important suppressor of leukemogenesis.",16123803_5,-1,1,-1,1,3045,-1,2.9875984e-05,0.99995756,1.250652e-05
12407,Stat3,4,5,27,32,"Importantly, inhibition of Stat3 abolished their suppressive activity almost completely.",20484028_7,-1,1,-1,1,12407,-1,2.5846886e-05,0.999954,2.0206242e-05
4564,These,0,1,0,5,"These studies demonstrate the feasibility and safety of using vaccine-induced PBMC for cell transfer, but suggests that they are not as effective as TIL in adoptive immunotherapy even when transferred into lymphodepleted hosts.",17056585_8,-1,1,-1,1,4564,-1,1.8430163e-05,0.9999721,9.404969e-06
9353,the,26,27,157,160,"Agonistic signaling through GITR, in the absence of NFATc2, thus emerges as a novel possible strategy for the treatment of human bronchial adenocarcinoma in the absence of NFATc2 by enhancing IL-2Ralpha(+) effector and IL-7Ralpha(+) memory-expressing T cells.",19318584_6,-1,1,-1,1,9353,-1,2.3670686e-05,0.9999672,9.0551475e-06
16042,transcription factor,26,28,167,187,"Additionally, T-bet has been shown to regulate histone acetylation of the ifng promoter and enhancer to loosen condensed DNA, creating greater accessibility for other transcription factor binding, which further amplifies IFN production.",21983879_3,-1,1,-1,1,16042,-1,4.4212906e-05,0.9999229,3.29271e-05
546,STAT5,26,27,145,150,"Activating T cells with IL-15, which does not use the high affinity IL-2R, completely restored the ability of T cells to phosphorylate STAT3 and STAT5 when cultured with tumor cells.",11418694_4,-1,1,-1,1,546,-1,3.9362305e-05,0.99993336,2.7259543e-05
35980,thereby,16,17,98,105,BACKGROUND: Regulatory T cells (Treg) suppress cytotoxic T cell anti-tumoral immune responses and thereby promote tumor progression.,30572845_0,-1,1,-1,1,35980,-1,2.0611593e-05,0.9999702,9.21862e-06
6539,Treg,1,2,9,13,ICOShigh Treg up-regulated Treg markers (p<or=0.0016) and mediated stronger suppression (p<or=0.001) relative to ICOSlow Treg.,18292519_7,-1,1,-1,1,6539,-1,2.2608938e-05,0.99995923,1.8109984e-05
7681,that,13,14,73,77,Squamous cell carcinomas (SCCs) of the skin are sun-induced skin cancers that are particularly numerous in patients on T cell immunosuppression.,18794336_0,-1,1,-1,1,7681,-1,2.271552e-05,0.9999645,1.2843083e-05
42256,this,3,4,9,13,"Of note, this protection was recapitulated by anti-DNGR-1-blocking antibodies in mice following Flt3L gene therapy.",33980589_8,-1,1,-1,1,42256,-1,2.1475598e-05,0.9999695,9.015255e-06
19881,Foxp3,18,19,104,109,"The interference efficiency of the TGF-1 gene was tested by real-time PCR and ELISA; the expression of Foxp3, IFN- and CD83 in CD4(+), CD8(+) or dendritic cells was examined via flow cytometry; and the tumorigenic ability of the cancer cells was investigated in the animal experiments.",23361571_3,-1,1,-1,1,19881,-1,2.674672e-05,0.99995875,1.4557355e-05
27787,therefore,16,17,88,97,"Most human colorectal cancers (CRCs) develop from the preformed adenomas, this study is therefore designed to evaluate forkhead box P3 (FoxP3)+ Tregs in human colorectal adenomas.",26724144_1,-1,1,-1,1,27787,-1,1.9717394e-05,0.99996924,1.1033433e-05
19495,tumors,9,10,60,66,"EXPERIMENTAL DESIGN: Using tissue microarrays of 364 breast tumors, we evaluated expression of CXCL10 and its receptor, CXCR3, in relation to histopathologic features, biomarkers, and lymphocyte markers.",23213058_3,-1,1,-1,1,19495,-1,2.0711424e-05,0.999964,1.5327663e-05
597,immune dysregulation,9,11,62,82,"HHV8 dissemination is favoured by virus escape mechanisms and immune dysregulation, and leads to immune responses that are not effective against the virus but, paradoxically, exacerbates the reactive process.",11423257_4,-1,1,-1,1,597,-1,0.003773954,0.99567753,0.00054849806
36597,FOXP3,2,3,11,16,"Numbers of FOXP3+ Treg cells were significantly higher in peritoneal lesions of women coexistent with ovarian endometrioma (F=21.52, P<0.001) and dermoid cysts (F=22.01, P<0.001) compared with women without peritoneal lesions.",30981619_6,-1,1,-1,1,36597,-1,3.0207619e-05,0.99994934,2.0417694e-05
34878,the,4,5,22,25,"Thus, we investigated the prevalence of Tregs and the relationship between them and TGF- and IL-10 concentrations and measured expression of FOXP3, CTLA-4, CD28, and GITR genes, as well as protein expression of selected genes in benign effusions and MPEs.",29785404_2,-1,1,-1,1,34878,-1,1.5080939e-05,0.99997663,8.293738e-06
11845,this,6,7,29,33,"Curcumin, in turn, prevented this loss of T cells, expanded central memory T cell (T(CM))/effector memory T cell (T(EM)) populations, reversed the type 2 immune bias and attenuated the tumor-induced inhibition of T-cell proliferation in tumor-bearing hosts.",20305684_7,-1,1,-1,1,11845,-1,2.08513e-05,0.9999685,1.0643334e-05
32538,to,6,7,24,26,"In this study, we aimed to determine the underlying transcriptional mechanisms regulating these inhibitory pathways.",28629373_1,-1,1,-1,1,32538,-1,1.7121969e-05,0.99997234,1.0551929e-05
35457,Treg,18,19,90,94,"Activated CD4+ T cells differentiate into four main separate lineages: Th1, Th2, Th17 and Treg, and they are recognized by their effector molecules IFN-, IL-13, IL-17A, and the transcription factor Foxp3, respectively.",30075815_5,-1,1,-1,1,35457,-1,2.82773e-05,0.99994886,2.2865372e-05
14602,therapeutic,28,29,162,173,In conclusion our data seeks to define a modality in which improper or ineffective T cell polarization can be altered by 5AZA and could be incorporated in future therapeutic interventions.,21377729_8,-1,1,-1,1,14602,-1,2.3846029e-05,0.9999651,1.10867995e-05
35286,Tregs,7,8,43,48,The functional role of CTLA-4 expressed by Tregs and FoxO3 in dendritic cells (DC) was studied in vitro and in vivo by siRNA-silencing experiments.,29991500_5,-1,1,-1,1,35286,-1,2.2291575e-05,0.9999647,1.2938276e-05
7530,these,2,3,13,18,"Importantly, these levels of NS3/4A reduced murine innate responses to synthetic dsRNA in vivo, supporting the possibility that this occurs also in infected humans.",18689426_8,-1,1,-1,1,7530,-1,2.0877646e-05,0.9999658,1.3308432e-05
10069,that,6,7,35,39,"In conclusion, our results suggest that mouse splenic Foxp3(+) gammadelta T cells with suppressive function can be induced by TCR and TGF-beta costimulation, whereas functional human Foxp3(+) gammadelta T cells in peripheral blood could not be generated under the same condition.",19539651_9,-1,1,-1,1,10069,-1,1.7582564e-05,0.99997413,8.231302e-06
40587,to,4,5,19,21,"These EVs are able to vehiculate RNA and proteins to target cells, and engineered EVs also vehiculate recombinant proteins.",32939048_3,-1,1,-1,1,40587,-1,1.9665598e-05,0.99997103,9.344656e-06
8064,T,10,11,54,55,"Also, Balb/C mice exhibit 25% reduction of lymph-node T regulatory cells after pomalidomide treatment.",19009291_7,-1,1,-1,1,8064,-1,4.8496386e-05,0.9998585,9.303197e-05
1923,relationship,22,23,125,137,"CONCLUSIONS: The prime-boost regimen is immunogenic in AGIN patients (humoral and cellular immunity), but there is no simple relationship between induction of systemic HPV-16-specific immunity and clinical outcome.",15131030_10,-1,1,-1,1,1923,-1,3.884247e-05,0.9999372,2.396151e-05
28408,gene,16,17,71,75,"Foxp3 is highly expressed in CD4(+) T cells, and this may be caused by gene promoter demethylation.",27000869_9,-1,1,-1,1,28408,-1,3.8070837e-05,0.9999424,1.9535593e-05
24431,these,4,5,26,31,"One common denominator of these stimuli is the activation of NF-B. Here, we show that human monocyte-derived, cytokine cocktail-matured DCs transfected with constitutively active mutants of IB kinases (caIKKs) by mRNA electroporation, further upregulated maturation markers, and secreted enhanced amounts of cytokines, including IL-12p70, which was produced for more than 48 h after transfection.",25100611_2,-1,1,-1,1,24431,-1,3.5747624e-05,0.99995065,1.3640104e-05
35334,Treg,25,26,162,166,"TCR-mediated Malt1 proteolytic activity and self-cleavage was found to drive Il2 expression in conventional CD4+ Tcells, thereby regulating Il2 availability for Treg homeostasis.",30025160_5,-1,1,-1,1,35334,-1,2.9570578e-05,0.99995637,1.4112453e-05
19132,The,0,1,0,3,"The CCL2/LCN2-induced DCreg cells subsequently induce immunosuppressive CD4(+)FOXP3(+) Treg cells, and finally impair tumor-specific CTL induction.",23143679_7,-1,1,-1,1,19132,-1,1.8015851e-05,0.9999701,1.193672e-05
3954,this,40,41,241,245,"Monitoring of CD8(+) T cells that specifically recognized a dominant MHC class I her-2/neu peptide showed a dramatic increase in tetramer-specific CD8(+) T cells after the first treatment; however, continuous therapy resulted in the loss of this population.",16751376_9,-1,1,-1,1,3954,-1,2.1033338e-05,0.99996257,1.6358315e-05
33147,TIM-4,2,3,6,11,"Thus, TIM-4+ B cells are enriched for IFN--producing proinflammatory Be1 cells that enhance immune responsiveness and can be specifically targeted with anti-TIM-4.",28848066_12,-1,1,-1,1,33147,-1,3.053052e-05,0.9999418,2.764288e-05
28813,the,8,9,35,38,"However, the role of Th17 cells in the pathophysiology of B-ALL is still unclear.",27176825_2,-1,1,-1,1,28813,-1,2.0612451e-05,0.99997175,7.693105e-06
30241,the,19,20,129,132,"Furthermore, the frequency of CD4+Foxp3-IL-10+ Tr1 cells in DLBCL patients during complete remission is directly associated with the risk of relapse.",27704876_8,-1,1,-1,1,30241,-1,1.9956577e-05,0.9999714,8.620994e-06
10439,nuclear factor-kappaB,2,4,5,26,"As a nuclear factor-kappaB (NF-kappaB)-dependent molecule, Fas is induced by LMP1, and LMP1 enhances Fas-mediated apoptosis, according to our finding of stimulus-dependent apoptosis regulation by LMP1.",19664329_3,-1,1,-1,1,10439,-1,4.7974336e-05,0.9999198,3.226929e-05
39144,that,11,12,68,72,"In this study, we identified an immune-related, five-gene signature that improves survival prediction in ccRCC.",32028264_1,-1,1,-1,1,39144,-1,1.9403407e-05,0.9999709,9.632077e-06
33415,tumor,21,22,140,145,"While PD-1 blockade or IL10 neutralization as monotherapies were inefficient, combination of these two led to improved survival and delayed tumor growth; this was accompanied by augmented antitumor T- and B-cell responses and decreased infiltration of immunosuppressive MDSC.",28993412_8,-1,1,-1,1,33415,-1,2.1060472e-05,0.999969,9.948803e-06
3786,tumor,26,27,184,189,"Stat1 deficiency in the host significantly enhances IL-12-mediated tumor regression, resulting in tumor eradication from 60% of SCCVII tumor-bearing mice and significant inhibition of tumor growth when compared with control treatment (P < 0.01).",16618773_2,-1,1,-1,1,3786,-1,1.9162291e-05,0.9999702,1.0586369e-05
28442,to,24,25,153,155,A sublethal dose of Smac mimetic BV6 induces cIAP1 and cIAP2 degradation to increase tumor cell sensitivity to radiation-induced cell death in vitro and to enhance radiation-mediated suppression of STS xenografts in vivo.,27014915_4,-1,1,-1,1,28442,-1,2.2114058e-05,0.99996793,9.913002e-06
81,the,21,22,124,127,"In circulating T cells from a subset of patients with RCCs, the suppression of NFkappaB binding activity is downstream from the stimulus-induced degradation of the cytoplasmic factor IkappaBalpha.",10491412_1,-1,1,-1,1,81,-1,1.9825755e-05,0.999972,8.195269e-06
37814,their,17,18,113,118,"Suppression required the expression and phosphorylation of Smad proteins in the TGF- signaling pathway, but not their nuclear translocation, and depended on oxygen availability, suggesting a metabolic basis for these effects.",31530731_4,-1,1,-1,1,37814,-1,2.7244056e-05,0.9999583,1.4534652e-05
6712,the,11,12,65,68,There is limited information on the influence of tumor growth on the expansion of tumor-specific TGF-beta-producing CD4(+) T cells in humans.,18354237_0,-1,1,-1,1,6712,-1,1.7998143e-05,0.9999738,8.280026e-06
11567,the,14,15,82,85,"In addition, a significant (p<0.05) increase in the lymphocytes proliferation and the level of IFN-gamma in the animals treated with Tehranolide in comparison with control group.",20138670_6,-1,1,-1,1,11567,-1,1.9046789e-05,0.9999708,1.0203212e-05
38409,STAT3-mediated,2,3,6,20,"Thus, STAT3-mediated immunosuppression is crucial for metastasis.",31848193_5,-1,1,-1,1,38409,-1,3.3517397e-05,0.9999293,3.7124268e-05
11477,the,5,6,38,41,"We show that chemotherapy conditioned the host environment, creating a transient window for optimal effector differentiation for adoptively transferred CD4(+) T cells.",20118405_6,-1,1,-1,1,11477,-1,3.766108e-05,0.999951,1.1347987e-05
19967,the,5,6,39,42,BMDCs stimulated with RG-II facilitate the proliferation of CD8+ T cells.,23392255_3,-1,1,-1,1,19967,-1,2.066046e-05,0.9999684,1.0902686e-05
34690,the,12,13,64,67,"A better understanding of the activity of immune cells in mRCC, the immunomodulatory effects of TKIs, and the characteristics defining patients most likely to benefit from various therapies will help optimize immunotherapeutic approaches.",29700053_2,-1,1,-1,1,34690,-1,1.9847055e-05,0.99997103,9.100441e-06
4697,the,30,31,197,200,The beneficial effects were associated with an opposite immunological effect in the two models: the peripheral:intrahepatic CD4:CD8 lymphocyte ratio increased in the colitis model and decreased in the HCC group.,17172586_4,-1,1,-1,1,4697,-1,1.8427601e-05,0.99997234,9.169555e-06
22944,Tregs,10,11,75,80,The percentage of these cells was higher than conventional CD4CD25Foxp3 Tregs.,24668348_12,-1,1,-1,1,22944,-1,2.2522663e-05,0.99996305,1.4436804e-05
6451,tumors,16,17,84,90,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal gastric mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) Tregs in TILs.",18224687_8,-1,1,-1,1,6451,-1,1.8118837e-05,0.9999701,1.1766025e-05
33353,These,0,1,0,5,"These findings suggest a dual role for APC mutations in colorectal cancer development, where mutations drive the initiation of epithelial neoplasms and also reduce Treg-mediated suppression of the detrimental inflammation that enhances cancer growth.",28978472_5,-1,1,-1,1,33353,-1,1.9640616e-05,0.99997115,9.192781e-06
27670,genetically,3,4,15,26,"In conclusion, genetically determined low signaling activity of IL-12R predisposes to the development of LAC.",26547104_7,-1,1,-1,1,27670,-1,2.3980952e-05,0.9999615,1.4575398e-05
10667,complexes,2,3,6,15,"Thus, complexes of cationic antigenic peptides and poly(I:C) might be of great utility for a TLR3-mediated DC maturation and intracellular peptide targeting in a single step.",19758325_7,-1,1,-1,1,10667,-1,6.465159e-05,0.99988925,4.6056903e-05
9241,that,17,18,117,121,Here we provide additional evidence that Treg are increased locally within the tumor microenvironment by a mechanism that seems dependent on TGF-beta receptor expression and the presence of tumor derived TGF-beta.,19307989_3,-1,1,-1,1,9241,-1,1.9558887e-05,0.9999707,9.79838e-06
1941,to,5,6,27,29,PBMC were exposed in vitro to purified E6 or E7 proteins or transduced with fusion proteins containing the first 11 amino acids of the human immunodeficiency virus type 1 protein tat fused to E6 or E7 (tat-E6/tat-E7).,15138179_2,-1,1,-1,1,1941,-1,1.991621e-05,0.99996936,1.0710138e-05
12192,therapeutic,15,16,106,117,"Conjugate vaccines containing human papillomavirus 16 E7 oncoprotein or survivin as a self-TAA had potent therapeutic efficacy against TC-1 cervical and 3LL lung carcinoma tumors, respectively.",20406989_5,-1,1,-1,1,12192,-1,2.327015e-05,0.9999653,1.1432268e-05
2783,to,11,12,59,61,"IL-12/23 p40(-/-) and IFN-gamma(-/-) mice, which were able to reject the initial inoculation of IL-4 expressing tumors, failed to mount a sustained systemic response against parental (nontransfected) tumor cells.",15905564_2,-1,1,-1,1,2783,-1,2.0731432e-05,0.99996924,1.00792295e-05
10189,this,2,3,11,15,We confirm this prediction by killing CCR4(+) cells through delivery of TARC-fused toxins or depleting Tregs and preventing lung metastasis.,19567680_9,-1,1,-1,1,10189,-1,1.9857263e-05,0.9999713,8.838793e-06
14850,TGF-1,3,4,18,24,The production of TGF-1 was detected in supernatant of MGC and GES-1.,21528082_5,-1,1,-1,1,14850,-1,2.874651e-05,0.9999474,2.3860051e-05
122,that,11,12,57,61,"Thymoma is known to contain CD4+CD8+ T cells, indicating that neoplastic epithelial cells of thymoma have a function as thymic cortical epithelium.",10886240_0,-1,1,-1,1,122,-1,2.0967253e-05,0.9999684,1.0670549e-05
19370,target,41,42,255,261,These data present a significant role for CD200 in suppressing anti-tumor immune response through stimulation of regulatory mechanisms in AML patients and suggest that CD200 may have a prognostic value in this malignancy and its blockade may be used as a target for AML immunotherapy.,23179394_10,-1,1,-1,1,19370,-1,2.5029101e-05,0.9999628,1.21481735e-05
1123,to,5,6,50,52,"Additionally, receptor-transduced cells continued to secrete cytokines in response to antigenic stimulation.",11964281_6,-1,1,-1,1,1123,-1,3.4742057e-05,0.99995077,1.4498701e-05
14933,Transwell,19,20,126,135,We observed an attenuated antiproliferative effect even when melanoma cells and T cells in the coculture were separated using Transwell inserts.,21547596_7,-1,1,-1,1,14933,-1,4.0768464e-05,0.9999336,2.558347e-05
36976,To,2,3,11,13,OBJECTIVE: To investigate the expression of 4-1BBL on B cells in the breast tumor draining lymph nodes (TDLNs) and its association with disease parameters.,31182685_1,-1,1,-1,1,36976,-1,1.7242008e-05,0.999974,8.76408e-06
20508,Treg-mediated,7,8,44,57,"Unfortunately, the link between hypoxia and Treg-mediated immune tolerance in gastric cancer remains poorly understood.",23723999_2,-1,1,-1,1,20508,-1,3.476626e-05,0.9999405,2.4720326e-05
6644,them,36,37,213,217,"More importantly, in mice bearing Neuro2a/pc micrometastases, a single sc injection of Neuro2a/IL-21 cells significantly increased the mean tumor-free survival of treated animals (43 vs. 22 days) and cured 14% of them.",18324400_5,-1,1,-1,1,6644,-1,2.2380913e-05,0.99996185,1.5754464e-05
20323,TNBCs,25,26,103,108,"The highest tertile of IL-5 was more strongly associated with ER(-) (OR = 2.33, 95 % CI 1.40-3.90) and TNBCs (OR = 2.78, 95 % CI 1.53-5.06) compared to ER(+) and LumA cancers, respectively, particularly among premenopausal women (OR = 4.17, 95 % CI 1.86-9.34, ER(-) vs. ER(+); OR = 5.60, 95 % CI 2.09-15.01, TNBC vs. LumA).",23624818_5,-1,1,-1,1,20323,-1,4.6012607e-05,0.9998932,6.0750368e-05
35667,that,28,29,169,173,Flow-cytometric analyses revealed induction of HPV16-specific PD-1+ CD8+ T cells that were not found prior to MEDI0547 (0% vs. 1.8%).CONCLUSIONS: These data demonstrate that MEDI0457 can generate durable HPV16/18 antigen-specific peripheral and tumor immune responses.,30242022_8,-1,1,-1,1,35667,-1,1.6884216e-05,0.99997485,8.326136e-06
11827,Treg,22,23,124,128,"This dysfunction includes loss of effector and memory T cells, bias towards type 2 cytokines and expansion of T regulatory (Treg) cells.",20305684_3,-1,1,-1,1,11827,-1,2.4222749e-05,0.9999603,1.5449441e-05
28071,tumor,13,14,60,65,"The impact of DC vaccine loaded with Hepa1-6 cell lysate on tumor progression, survival, and tumor-infiltrating lymphocytes and cytokines was examined.",26786094_3,-1,1,-1,1,28071,-1,1.9640967e-05,0.9999708,9.536597e-06
40145,the,9,10,61,64,"However, a major challenge in cancer immunotherapies remains the heterogeneity of the immunoregulatory capacities of cancers, and not all patients of a given cancer responds to current therapeutic strategies.",32573300_1,-1,1,-1,1,40145,-1,1.9139936e-05,0.9999721,8.807356e-06
40475,their,11,12,52,57,"In this article, we addressed the role of cDC1s and their costimulatory molecules, CD40, CD70, and CD80/CD86, in expansion and antitumor efficacy of adoptively transferred in vitro-primed CD8+ T cells recognizing nonmutated tumor-associated self-antigens.",32848036_3,-1,1,-1,1,40475,-1,2.1654014e-05,0.99996614,1.2216435e-05
12881,treated,10,11,56,63,Purified CD4(+)CD25(high)FR4(high) T(reg) from 'day 35' treated chimeras showed increased IL-10 and IFN-gamma mRNA-expression (RT-PCR) relative to control chimeras.,20600326_8,-1,1,-1,1,12881,-1,2.3822795e-05,0.99996114,1.5043861e-05
24630,tumor,7,8,51,56,The increased number of CD4(+)CD25(+)Treg cells in tumor local and peripheral splenic tissues is related to the low immune function as well as to tumor recurrence and metastasis.,25168696_0,-1,1,-1,1,24630,-1,1.9590703e-05,0.9999701,1.0296281e-05
14076,to,47,48,306,308,"Here, we found this cancer-targeted gene therapy, SV-BikDD, composed of the survivin promoter in the VP16-GAL4-WPRE integrated systemic amplifier system to drive the apoptotic gene BikDD, not only caused cytotoxic effects in cancer cells but also elicited a cancer-specific cytotoxic T lymphocyte response to synergistically increase the therapeutic effect and further develop an effective systemic antitumoral immunity against rechallenges of tumorigenic dose of parental tumor cells inoculated at distant sites in immunocompetent mice.",21282355_2,-1,1,-1,1,14076,-1,2.0713675e-05,0.9999696,9.665494e-06
13097,This,0,1,0,4,"This effect, which was associated with decreased expression of the neutrophil chemoattractants CXCL1 and CXCL2, promoted survival of the inoculated tumour cells.",20722759_6,-1,1,-1,1,13097,-1,2.176707e-05,0.9999684,9.880832e-06
32320,The,0,1,0,3,"The expression of A2AR was found to be significantly correlated with HIF-1, CD73, CD8 and Foxp3.",28592285_7,-1,1,-1,1,32320,-1,1.7776112e-05,0.9999746,7.578913e-06
2828,STAT1,12,13,53,58,"In a manner similar to CD4+ T cells, IL-27 activated STAT1, -2, -3, -4, and -5, and augmented the expression of T-bet, IL-12Rbeta2, and granzyme B, and slightly that of perforin in naive CD8+ T cells stimulated with anti-CD3.",16034109_3,-1,1,-1,1,2828,-1,4.603513e-05,0.999879,7.494984e-05
12456,there,6,7,23,28,"In a murine 3LL model, there were no significant differences in tumour growth rate between untreated and simvastatin-treated mice groups.",20491794_8,-1,1,-1,1,12456,-1,2.2557922e-05,0.9999671,1.032703e-05
33373,to,7,8,54,56,"The peripheral blood mononuclear cells were subjected to FACScan analysis after labeling with anti-CD4, -CD25, - Foxp3, -CD49b and -LAG3 antibodies.",28982868_3,-1,1,-1,1,33373,-1,1.9319523e-05,0.99996984,1.0796934e-05
42237,their,16,17,94,99,BACKGROUND: Conventional type 1 dendritic cells (cDC1s) are central to antitumor immunity and their presence in the tumor microenvironment associates with improved outcomes in patients with cancer.,33980589_0,-1,1,-1,1,42237,-1,2.9844232e-05,0.9999528,1.7347e-05
32890,The,0,1,0,3,"The effect of curcumin on inhibiting cancer has been recognized, but the mechanism remains elusive.",28731226_2,-1,1,-1,1,32890,-1,2.3080622e-05,0.9999689,8.024892e-06
31612,the,10,11,66,69,Results from reporter cell lines suggested that acrolein acts via the aryl-hydrocarbon receptor which could be inhibited by resveratrol and 3'-methoxy-4'-nitroflavone Acrolein- stimulation of human PBMCs increased Foxp3+ expression by T cells which could be antagonized by resveratrol.,28332605_5,-1,1,-1,1,31612,-1,1.5292495e-05,0.9999758,8.895422e-06
14596,that,4,5,25,29,"Moreover, we demonstrate that 5A2 can force Th1 polarization of nave T cells despite a strong IL-4 stimuli and a lack of IL-12.",21377729_7,-1,1,-1,1,14596,-1,1.763271e-05,0.9999734,8.949979e-06
21248,TGF-1,19,20,111,117,417 cases of invasive breast cancer were selected from the prior study cohort and the expressions of CCL22 and TGF-1 were assessed by immunohistochemistry.,24124553_3,-1,1,-1,1,21248,-1,3.7978658e-05,0.99992526,3.6716847e-05
21442,the,5,6,35,38,"Collectively, the understanding of the mechanisms and pathways associated with the tumor-induced thymic involution is essential for the development of innovative and safe therapies to fight against the immune suppression caused by the tumor development.",24198066_4,-1,1,-1,1,21442,-1,1.8129562e-05,0.9999734,8.491776e-06
26596,the,6,7,27,30,"In this study, we analyzed the mechanism of the pathological function of IL-22 in intestinal aGVHD.",26153763_2,-1,1,-1,1,26596,-1,1.681398e-05,0.99997485,8.3500945e-06
12254,relative,19,20,94,102,"On the other hand, conventional GCs were characterized by a paucity of CXCR3(+) T cells and a relative abundance of Tregs.",20422211_7,-1,1,-1,1,12254,-1,6.55804e-05,0.9998797,5.470837e-05
26319,Th17,13,14,63,67,"In the present study, we mainly investigated the role of Th22, Th17, and Th1 cell and their related cytokines (IL-22, IL-17, and IFN-r) in the pathophysiology of CML.",26000313_1,-1,1,-1,1,26319,-1,4.9282604e-05,0.9999225,2.8219929e-05
5064,NFkB,14,15,102,106,Only the CCL2-4/CXCL1/8 cluster showed significant correlations between corresponding mRNA levels and NFkB levels/activation.,17339182_8,-1,1,-1,1,5064,-1,4.079614e-05,0.99993515,2.4048066e-05
13713,to,3,4,24,26,Conclusions are limited to only the time samples were obtained.,21061759_6,-1,1,-1,1,13713,-1,5.554345e-05,0.9999014,4.3087075e-05
26525,the,29,30,188,191,"Subset-specific analysis demonstrated that the posttreatment rebound was driven by the CD4(+)CD25(+)Foxp3(+) neuropilin-1(low) peripheral Treg (pTreg), resulting in a 3-5-fold increase in the pTreg to CD4(+)CD25(+)Foxp3(+) neuropilin-1(high) thymic Treg ratio by day 10.",26085681_3,-1,1,-1,1,26525,-1,1.6673499e-05,0.9999733,1.0032796e-05
11379,to,9,10,52,54,"Since members of this family of cytokines are known to exhibit their effects on diverse immune cells, we have examined the effects of IL-21 on CLL patient derived regulatory T cell (Treg) induction, expansion and the inhibitory effect on natural killer cells in vitro.",20081380_3,-1,1,-1,1,11379,-1,2.3375906e-05,0.9999678,8.773926e-06
12919,the,27,28,180,183,"CD40 targeting of Ad was achieved using a bispecific fusion protein, binding and neutralizing the Ad fiber knob through soluble coxsackie and adenovirus receptor while retargeting the virus to hCD40 through the tumor necrosis factor-like domain of mCD40L.",20664356_3,-1,1,-1,1,12919,-1,2.3325769e-05,0.99996555,1.1157627e-05
614,Tat protein,43,45,253,264,"The progression of KS appears to be due to the deregulated expression of oncogenes and oncosuppressor genes, to the long-lasting expression of the HHV8 latency genes and, for AIDS-KS, is promoted by the proliferative and angiogenic effects of the HIV-1 Tat protein.",11423257_6,-1,1,-1,1,614,-1,3.8537924e-05,0.9999095,5.1989962e-05
41822,the,16,17,133,136,Transcriptional study was performed by chromatin immunoprecipitation and luciferase reporter assays on experiments of mutagenesis on the promoter sequence.,33737337_5,-1,1,-1,1,41822,-1,1.831272e-05,0.9999727,9.025211e-06
33204,the,15,16,94,97,"This result also indicates that NK cell proliferation, activation, and accumulation are under the control of regulatory T cells.",28891726_10,-1,1,-1,1,33204,-1,2.5917578e-05,0.9999634,1.06263515e-05
35763,plays,13,14,69,74,"IL-35 is mainly produced by regulatory T and regulatory B cells, and plays a crucial role in the development and prevention of infectious and autoimmune diseases.",30321288_1,-1,1,-1,1,35763,-1,3.223062e-05,0.9999509,1.6874683e-05
37,the,28,29,157,160,"These findings indicate that the CD40-CD40 ligand pair can act as a 'switch', determining whether naive peripheral CTLs are primed or tolerized, and support the clinical use of CD40-stimulating agents as components of anti-cancer vaccines.",10395322_6,-1,1,-1,1,37,-1,2.194604e-05,0.9999696,8.47384e-06
37779,the,17,18,106,109,Administration of LPS (at a dose that elicited levels of proinflammatory cytokines comparable to those by the anti-TLR4 mAb) plus OVA induced no or less-marked activation of OVA-specific T-cells and failed to suppress tumour growth in mice.,31515801_10,-1,1,-1,1,37779,-1,1.9913728e-05,0.9999697,1.03377e-05
574,tumor-induced,19,20,111,124,This finding may be exploited in the design of new immunotherapy approaches that will rely on T cells avoiding tumor-induced suppression.,11418694_10,-1,1,-1,1,574,-1,3.311815e-05,0.9999547,1.22175525e-05
26065,to,15,16,92,94,Interleukin (IL)-22 alone or with a STAT3 inhibitor was co-cultured with RKO cells in vitro to study the effects of IL-22 on colon cancer cells.,25892871_2,-1,1,-1,1,26065,-1,1.955488e-05,0.9999727,7.7450395e-06
9284,to,28,29,150,152,The objective of this study was to determine whether there is a similar tendency in mice as in human beings and whether these mice models may be used to find new therapeutic agents with antifibrotic properties but not cancer-promoting properties.,19318568_2,-1,1,-1,1,9284,-1,1.9657138e-05,0.99997187,8.432833e-06
20815,this,4,5,21,25,"In this perspective, this study aimed to evaluate the immunoexpression of interleukin (IL)-17, transforming growth factor (TGF)-1, and the forkhead box P3 (FoxP3) in periapical lesions, correlating them with the type of lesion, the intensity of the inflammatory infiltrate, and the thickness of the cystic epithelial lining.",23880265_1,-1,1,-1,1,20815,-1,1.8891136e-05,0.9999703,1.080555e-05
41746,TGF-mediated,5,6,43,56,"Mechanistically, Erbin knockout attenuated TGF-mediated suppression of migration of CXCR5+ IgA+ cells and STAT6-mediated PD1 expression.",33707428_4,-1,1,-1,1,41746,-1,2.434831e-05,0.9999577,1.7935092e-05
5844,Transwell,0,1,0,9,"Transwell inserts partly prevented suppression (60 +/- 5% versus 95 +/- 5%).CONCLUSIONS: Suppression in the tumor microenvironment is mediated by a unique subset of Treg, which produce IL-10 and TGF-beta1 and do not require cell-to-cell contact between Treg and responder cells for inhibition.",17671115_10,-1,1,-1,1,5844,-1,3.331619e-05,0.99994683,1.9874378e-05
38024,Treg,18,19,104,108,"Here, we studied the distribution and characteristics of Tregs in the LHME, investigated the effects of Treg ablation on leukemia progression, explored the mechanisms leading to Treg accumulation, and studied whether blocking Treg migration to the LHME delayed leukemia progression in MLL-AF9-induced mouse acute myeloid leukemia (AML) models using wildtype (WT) and Foxp3DTR/GFP mice.",31669202_3,-1,1,-1,1,38024,-1,2.4430963e-05,0.999962,1.3568033e-05
9775,to,7,8,36,38,"Our data indicate that, in addition to controlling effector T-cell function, OX40 costimulation directly controls Treg-mediated suppression in tumor immunity.",19455675_9,-1,1,-1,1,9775,-1,2.611473e-05,0.9999627,1.1160724e-05
6327,tumor,28,29,182,187,"Moreover, we compared standard BCG immunotherapy side-by-side with the Toll-like receptor-9 agonist CpG. MB49 tumor-bearing mice were treated with BCG or CpG and survival as well as tumor progression were observed over time.",18157010_4,-1,1,-1,1,6327,-1,1.8291656e-05,0.99997294,8.806229e-06
6808,the,4,5,32,35,More detailed investigations of the mechanisms underlying protective immunity in murine systems together with the characterization of the anti-tumor reactions of patients who achieved durable clinical benefits in response to immunotherapy uncovered several pathways that restrain the efficacy of GM-CSF-secreting tumor cell vaccines.,18364009_3,-1,1,-1,1,6808,-1,1.5591713e-05,0.99997544,8.932449e-06
13980,though,1,2,5,11,"Even though melanoma cells equally colonize NFAT1-/- and wild-type lungs, tumors do not progress in the absence of NFAT1 expression.",21225259_5,-1,1,-1,1,13980,-1,4.8661797e-05,0.99992,3.1325013e-05
19092,than,10,11,67,71,The expansion of T(REG) was significantly higher in non-responders than in responding patients.,23118856_9,-1,1,-1,1,19092,-1,2.1564585e-05,0.9999647,1.3757678e-05
36654,transurethral,11,12,82,95,"METHODS: CD4+ T-cell infiltration in Doc-treated paraffin-embedded specimens from transurethral resection of prostate, radical prostatectomy, or bone metastasis was detected by immunohistochemistry.",31018021_4,-1,1,-1,1,36654,-1,4.903272e-05,0.9999242,2.6833504e-05
7425,that,6,7,30,34,"In this study, we demonstrate that malignant mature CD4(+) T lymphocytes derived from cutaneous T cell lymphomas (CTCL) variably display some aspects of the T regulatory phenotype.",18684941_0,-1,1,-1,1,7425,-1,1.632535e-05,0.99997365,1.0027568e-05
14803,Treg,14,15,78,82,"CXCL12 positivity correlated with improved survival (P = 0.005), whereas high Treg correlated with shorter survival for all breast cancers (P = 0.001), luminal cancers (P < 0.001) and basal-like cancers (P = 0.040) that were confirmed in a multivariate analysis (OR 1.61, 95% CI 1.02 to 2.53, P = 0.042).",21521526_5,-1,1,-1,1,14803,-1,3.1330634e-05,0.99995255,1.615224e-05
37251,the,21,22,125,128,"The LSD1 inhibitor phenelzine targeted both the flavin adenine dinucleotide (FAD) and CoREST binding domains of LSD1, unlike the LSD1 inhibitor GSK2879552, which only targeted the FAD domain.",31249575_2,-1,1,-1,1,37251,-1,2.4597555e-05,0.99996185,1.3507145e-05
2317,The,0,1,0,3,The stimulation of CD40-positive cervical carcinoma cell lines with soluble CD40L (CD154) resulted in activation of the NF-kappaB and MAPK signaling pathways and up-regulation of cell surface markers and intracellular molecules associated with Ag processing and presentation.,15611226_2,-1,1,-1,1,2317,-1,1.8591943e-05,0.9999733,8.105149e-06
9010,the,7,8,46,49,BACKGROUND: Adoptive T cell therapy involving the use of ex vivo generated antigen-specific cytotoxic T lymphocytes provides a promising approach to immunotherapy.,19270751_0,-1,1,-1,1,9010,-1,2.2206028e-05,0.9999697,8.043472e-06
38481,time-dependent,14,15,71,85,"Compared with parent cells, GR cells produced IL-6 but not TGF-1 in a time-dependent manner, had EMT features, and induced T cell differentiation to Th17 cells but not Tregs.",31853779_7,-1,1,-1,1,38481,-1,0.00010706365,0.99979776,9.51425e-05
37747,LPS,22,23,138,141,"Agonistic anti-Toll-like receptor 4 (TLR4) monoclonal antibodies (mAbs) activate only cell-surface TLR4; in contrast, lipopolysaccharide (LPS) activates both TLR4 and intracellular inflammatory caspases.",31515801_2,-1,1,-1,1,37747,-1,8.488919e-05,0.9998778,3.7241996e-05
31265,that,36,37,193,197,"These results indicated that with cells isolated from cord blood, c-Rel has an important role in B-, T-, and NK cell differentiation and, further, that agents (select cytokines/growth factors) that could impact on its expression might not only affect immune cell profiles in a host but could potentially also limit apoptotic activities in (non-)immune cells in that host.",28090796_7,-1,1,-1,1,31265,-1,2.7064829e-05,0.99996114,1.175319e-05
2685,to,19,20,140,142,Insight into the immunologic mechanisms involved was provided by adoptive transfer of T lymphocytes from successfully immunized BALB/c mice to syngeneic severe combined immunodeficient (SCID) mice.,15833877_2,-1,1,-1,1,2685,-1,2.120124e-05,0.9999684,1.0422005e-05
24941,tumors,12,13,76,82,We found that nicotine significantly reduced the number and size of colonic tumors in mice with CAC.,25258409_7,-1,1,-1,1,24941,-1,1.9635878e-05,0.9999653,1.5058277e-05
17451,these,2,3,14,19,"Collectively, these results show that in humans, a large proportion of CD4(+) memory T cells express intermediate levels of CD25, and this CD25(INT) FOXP3(-) subset is a functionally distinct memory population that is uniquely affected by IL-2.",22585674_5,-1,1,-1,1,17451,-1,2.1274334e-05,0.99996746,1.1252497e-05
24807,Thus,0,1,0,4,"Thus, anti-CD20 therapy promotes strong anti-tumor adaptive immunity, opposes Treg expansion and inhibits tumor cells from maintaining an immunosuppressive environment.",25231744_7,-1,1,-1,1,24807,-1,2.255322e-05,0.9999676,9.855367e-06
6160,the,14,15,83,86,"Activation of the mTORC1, PI3K/Akt, and MEK/ERK pathways was strictly dependent on the Jak3 and Jak1 kinases.",18025151_6,-1,1,-1,1,6160,-1,2.0684958e-05,0.999966,1.3275744e-05
9402,state,17,18,133,138,This failure of the immune system has been associated both with glioma-derived immunosuppressive molecules and the immune-privileged state of the CNS.,19337997_1,-1,1,-1,1,9402,-1,2.7729033e-05,0.99994946,2.2859564e-05
16103,the,22,23,132,135,"We have investigated the role of interleukin (IL)-21 in colitis-associated colon cancer (CAC), as this cytokine is overexpressed in the gut mucosa of patients with ulcerative colitis (UC), a chronic inflammatory disease associated with colon cancer.",21987656_1,-1,1,-1,1,16103,-1,1.6463242e-05,0.99997425,9.344739e-06
33401,TIDC,19,20,107,111,"In the present work, we characterize the regulation of PD-1 expression and the effects of PD-1 blockade on TIDC.",28993412_4,-1,1,-1,1,33401,-1,1.7257533e-05,0.9999728,9.954527e-06
12825,Th17,14,15,95,99,Here we studied the reciprocal contribution of regulatory (Treg) and interleukin-17-producing (Th17) T-cells to the composition of the lymphoma-associated microenvironment of angioimmunoblastic T-cell lymphoma (AITL) and PTCL not otherwise specified on tissue microarrays from 30 PTCLs not otherwise specified and 37 AITLs.,20595635_1,-1,1,-1,1,12825,-1,3.0135512e-05,0.9999504,1.9466805e-05
27385,the,6,7,48,51,"These FOXP3-expressing CD3(+)CD56(+) cells lost the expression of IFN- and perforin, which are critical for the effector function of natural T cells.",26437631_3,-1,1,-1,1,27385,-1,1.9538245e-05,0.99997234,8.157322e-06
8350,the,7,8,36,39,Regulatory T-cells (Treg) have been the focus of immunologic research due to their role in establishing tolerance for harmless antigens versus allowing immune responses against foes.,19147574_0,-1,1,-1,1,8350,-1,2.208441e-05,0.9999691,8.765825e-06
21075,TILs,3,4,33,37,Tumour-infiltrating lymphocytes (TILs) have been found to play crucial roles in a series of cancers.,24007242_0,-1,1,-1,1,21075,-1,2.6126421e-05,0.9999602,1.3713525e-05
32321,to,6,7,33,35,"The expression of A2AR was found to be significantly correlated with HIF-1, CD73, CD8 and Foxp3.",28592285_7,-1,1,-1,1,32321,-1,2.2677328e-05,0.9999678,9.494878e-06
3267,to,8,9,36,38,"In this study, we show that similar to IFN-gamma-/- mice, JNK1-/- mice are highly susceptible to tumor development after inoculation of both melanoma cell line B16 and lymphoma cell line EL-4.",16237070_2,-1,1,-1,1,3267,-1,1.9058165e-05,0.99997175,9.241556e-06
12605,activators,37,38,181,191,"In an in vitro study using ICC cell lines (HuCCT1, RBE, and MEC) and human macrophages, tumor cell supernatant (TCS) from cell lines induced an activation of signal transducers and activators of transcription-3 (Stat3) and macrophage polarization toward the M2 phenotype.",20545696_9,-1,1,-1,1,12605,-1,4.7217836e-05,0.99992204,3.072857e-05
13768,the,5,6,24,27,"Therefore, we asked for the prognostic influence of cells with immunosuppressive properties in peripheral blood (pB) in a cohort of metastatic clear cell renal cell carcinoma (mRCC) patients uniformly receiving sorafenib treatment.",21150720_2,-1,1,-1,1,13768,-1,1.8486653e-05,0.999974,7.456742e-06
17534,triggering,17,18,109,119,"IL-6 can interact with both membrane-bound and soluble forms of its ligand-binding receptor, the IL-6Ralpha, triggering signalling via dimerization of gp130, the signalling subunit of the IL-6 receptor complex.",22652781_2,-1,1,-1,1,17534,-1,3.7590526e-05,0.99994695,1.5433876e-05
29330,The,0,1,0,3,The effect of binding of CMV specific dextramers on the activation of the NFAT signal transduction cascade was assessed in peripheral blood from bone marrow transplant recipients previously determined to be positive for CMV-ASTs (CASTs).,27327144_4,-1,1,-1,1,29330,-1,1.8692417e-05,0.99997365,7.617746e-06
38075,toward,9,10,60,66,"These TIM-3+ Treg cells presented higher cytolytic capacity toward autologous T conventional cells than the TIM-3- Treg cells, in a manner that was dependent on granzyme B but not TIM-3.",31669380_8,-1,1,-1,1,38075,-1,3.1132626e-05,0.9999459,2.2984412e-05
43480,Jun,3,4,20,23,"IL-1 enhancement of Jun B protein levels is not the result of a change in the turnover rate of the Jun B protein, but rather results from the maintenance of sufficient jun B mRNA to support continued accumulation of newly synthesized protein.",7675040_5,-1,1,-1,1,43480,-1,2.54444e-05,0.999956,1.8496548e-05
10303,status,26,27,163,169,OBJECTIVE: To investigate the expression of transcription factors (TF) T-bet and GATA-3 mRNA in peripheral blood mononuclear cells and its correlation with immune status in esophageal cancer patients.,19615257_0,-1,1,-1,1,10303,-1,3.0534484e-05,0.99995446,1.5001439e-05
28626,those,16,17,109,114,"Unexpectedly, expression of Foxp3 was increased in peritumoural skin, with the FoxP3/CD3 fractions exceeding those of BCC (p=0.0065).",27117439_6,-1,1,-1,1,28626,-1,5.8610913e-05,0.99988854,5.2809242e-05
22951,that,17,18,124,128,Increasing evidence suggests that communication between tumor and immune cells can alter the tumor microenvironment in ways that promote tumor development.,24676671_0,-1,1,-1,1,22951,-1,2.286429e-05,0.9999664,1.0721143e-05
27096,Treg,16,17,87,91,"In this study, we identified the mRNA expression pattern of Th2 and regulatory T-cell (Treg) cytokines in IgG4-RD and in IgG4-associated MZL and IgG4-negative MZL using real-time polymerase chain reaction analysis.",26311608_2,-1,1,-1,1,27096,-1,2.7962209e-05,0.99995494,1.707663e-05
1579,to,29,30,189,191,We will discuss some mechanisms associated with the acquisition of this tumor resistance and the alteration of T cell function and how cancer profiling through genomics approaches may help to reconceptualize immunotherapy strategies.,14609757_4,-1,1,-1,1,1579,-1,2.4875395e-05,0.9999645,1.0590811e-05
40895,transcription factors,20,22,133,154,"The goal of this review was to discuss how cytokines regulate intracellular networks, focusing on the regulation of lineage-specific transcription factors, chromatin remodelling and metabolism, to control human Th17 cell plasticity.",33064842_7,-1,1,-1,1,40895,-1,2.9710032e-05,0.9999416,2.8674442e-05
33589,The,0,1,0,3,The immunomodulatory effect is one of the possible mechanisms of the protective effect of fucoidan against mammary carcinogenesis.,29043842_11,-1,1,-1,1,33589,-1,2.193121e-05,0.9999697,8.394653e-06
15386,the,3,4,22,25,Chronic activation of the gastric mucosal adaptive immune response is a characteristic trait of gastric cancer.,21710691_0,-1,1,-1,1,15386,-1,2.1307267e-05,0.9999664,1.2339735e-05
1876,the,4,5,36,39,Blocking STAT3 activation abolishes the antiapoptotic and mitogenic actions of IL-22 in hepatic cells.,15122762_7,-1,1,-1,1,1876,-1,2.0750917e-05,0.99997115,8.119878e-06
827,the,13,14,68,71,"We evaluated regulation of the MHC class II transactivator (CIITA), the key intermediate that controls class II expression, in MG cells and tested whether MG cells could process native Ag.",11746775_2,-1,1,-1,1,827,-1,2.0128553e-05,0.99996805,1.185505e-05
29522,Th17,16,17,103,107,Dectin-1 signalling in dendritic cells (DCs) has an important role in triggering protective antifungal Th17 responses.,27492902_0,-1,1,-1,1,29522,-1,6.658721e-05,0.9999033,3.0043819e-05
28920,the,2,3,16,19,Interruption of the IL1ARHIF1VEGFa signals with inhibitors of HIF1 or VEGFa partially reversed the enhanced bladder cancer cell invasion.,27196763_5,-1,1,-1,1,28920,-1,2.0631982e-05,0.99996996,9.395491e-06
8994,Stat3,37,38,213,218,"Innate immune responses induced by CpG in mice with a Stat3-ablated hematopoietic system cause potent antitumor effects, leading to eradication of large (>1 cm) B16 melanoma tumors within 72 h. Moreover, ablating Stat3 in myeloid cells increases CpG-induced dendritic cell maturation, T-cell activation, generation of tumor antigen-specific T cells, and long-lasting antitumor immunity.",19258507_3,-1,1,-1,1,8994,-1,2.5841957e-05,0.999954,2.0226484e-05
16693,the,18,19,113,116,They may provide an experimental framework for examination of the impact of other anticancer drugs on cancer and the immune system.,22323550_8,-1,1,-1,1,16693,-1,2.1275677e-05,0.99996936,9.307365e-06
39510,the,20,21,109,112,"In CDDO-Me-treated mice, both the absolute number and proportion of splenic CD4+ T cells were reduced, while the proportion of CD8+ T cells was significantly increased in both tumors and spleen.",32300202_6,-1,1,-1,1,39510,-1,1.6719516e-05,0.99997413,9.106112e-06
15991,through,26,27,153,160,"In the present study, we functionally dissected the miR-17-92 cluster and revealed that miR-17 and miR-19b are the key players controlling Th1 responses through multiple coordinated biologic processes.",21972292_2,-1,1,-1,1,15991,-1,1.9665442e-05,0.99996984,1.0515457e-05
42,their,20,21,128,133,"The E6 and E7 oncoproteins of human papillomavirus are potentially ideal targets of immune therapy for cervical cancer, because their expression is necessary for cellular transformation.",10419051_1,-1,1,-1,1,42,-1,2.384217e-05,0.9999645,1.1629991e-05
267,the,21,22,108,111,"Here, we include an update on our studies regarding CD154 expression in CLL, a review of the data regarding the consequences of CD40 engagement in CLL B cells, and a discussion of these findings in the context of the complex and potentially opposite outcomes that have been reported for CD40-mediated signals in CLL.",11042507_3,-1,1,-1,1,267,-1,1.79526e-05,0.99997306,8.988305e-06
25114,the,16,17,123,126,"In conclusion, these data suggest that malignant T-cells orchestrate accumulation and activation of eosinophils supporting the notion of STAT3 being a putative target for therapy.",25275020_6,-1,1,-1,1,25114,-1,2.0892043e-05,0.99997044,8.623124e-06
22709,Smad3-dependent,5,6,27,42,CD70 induction by TGF- is Smad3-dependent and involves IL-2/Stat5 signaling.,24569779_4,-1,1,-1,1,22709,-1,4.1500418e-05,0.9999261,3.2345168e-05
17440,the,3,4,13,16,"In contrast, the CD25(INT) memory T cells respond to antigens associated with recall responses, produce a greater array of cytokines, and are less dependent on costimulation for effector responses due to their expression of CD25.",22585674_3,-1,1,-1,1,17440,-1,1.7131428e-05,0.99997044,1.2399784e-05
33348,Treg,24,25,130,134,"Ultimately, mouse Apc deficiency reduces the presence of NFAT in the nucleus of intestinal regulatory Tcells (Tregs) and impairs Treg differentiation and the acquisition of a suppressive phenotype, which is characterized by the production of the anti-inflammatory cytokine IL-10.",28978472_4,-1,1,-1,1,33348,-1,2.9642231e-05,0.999938,3.2370484e-05
36499,these,4,5,33,38,"However, observations confirming these facts are scarce; thus, extrapolating them to the population of children with hematological malignancies needs to be verified in additional studies.",30944830_10,-1,1,-1,1,36499,-1,2.3507933e-05,0.99996567,1.0847316e-05
3992,The,0,1,0,3,"The efficacy of induction of Treg's by DCs depends on the nature of the DC maturation stimulus, with inflammatory cytokine-treated DCs (Cyt-DCs) being the most effective Treg inducers.",16763205_6,-1,1,-1,1,3992,-1,1.926225e-05,0.9999727,8.007005e-06
16279,treatment,21,22,126,135,"Mechanistic studies revealed that DKK1 vaccine elicited a strong DKK1- and tumor-specific CD4+ and CD8+ immune responses, and treatment with B7H1 or OX40 Abs significantly reduced the numbers of IL-10-expressing and Foxp3+ regulatory T cells in vaccinated mice.",22049519_5,-1,1,-1,1,16279,-1,1.9213558e-05,0.9999689,1.1888979e-05
21805,Th2,13,14,86,89,The present study investigates the effect of umbelliprenin on predominance of Th1 and Th2 responses in Lewis lung cancer (LLC) mouse model.,24325354_1,-1,1,-1,1,21805,-1,4.628938e-05,0.99991465,3.906814e-05
26650,the,3,4,20,23,"The peptide induced the upregulation of both IL-6 and Ccl2 in peritoneal macrophages obtained from wild-type mice, but not TLR4-deficient mice.",26165843_6,-1,1,-1,1,26650,-1,1.8464012e-05,0.99997306,8.534233e-06
23764,that,3,4,35,39,"FL-infiltrating T-cell populations that are thought to be fundamental to FL biology are follicular helper T-cells (TFH), follicular regulatory T-cells (TFR), a recently described population that regulates TFH activity, and regulatory T-cells (Treg).",24836297_1,-1,1,-1,1,23764,-1,2.4566873e-05,0.9999602,1.5231342e-05
35754,Together,0,1,0,8,"Together, these data revealed a mechanism of immune evasion in MYD88 L265P mutant lymphomas.",30253331_8,-1,1,-1,1,35754,-1,3.894064e-05,0.9999455,1.5578224e-05
24730,Foxp3(+,19,20,113,120,"Relevance to women is implicated, as we find postlactational human breast tissue has transient high IL-10(+) and Foxp3(+) immune cell infiltrate.",25187059_8,-1,1,-1,1,24730,-1,0.00034826345,0.9993333,0.00031844422
12057,to,16,17,99,101,These findings demonstrate that even low doses of IL-2 in combination with DC vaccination are able to expand CD4+CD25+Foxp3+ Treg cells in vivo in metastatic renal cell carcinoma patients.,20386464_6,-1,1,-1,1,12057,-1,1.9841998e-05,0.99997175,8.429374e-06
21684,tumors,5,6,38,44,"METHODS: Fifty-six of patient-matched tumors and peritumoral surgical specimens from 56 patient with HCC and 136 liver biopsies specimens from 46 patients with CHB, 37 with atypical hyperplasia (AH), and 53 with HCC were enrolled.",24303990_2,-1,1,-1,1,21684,-1,2.1710259e-05,0.99996233,1.5902222e-05
24593,they,12,13,100,104,"Despite methodological limitations, some inflammatory biomarkers should be further analysed because they hold promise to improve patient care.",25151017_13,-1,1,-1,1,24593,-1,2.4346633e-05,0.99996424,1.1373273e-05
35363,Tregs,14,15,110,115,"Mechanistically, tumor-associated Notch1 regulates the expression of several chemokines involved in MDSCs and Tregs recruitment.",30036609_4,-1,1,-1,1,35363,-1,3.1966796e-05,0.9999467,2.1264605e-05
16060,the,3,4,21,24,"We have investigated the possible regulative role of Notch1 on the expression and function of chemokine receptors CCR5, CCR9 and CXCR4 that play a role in determining blast malignant properties and localization of extramedullary infiltrations in leukaemia.",21984373_2,-1,1,-1,1,16060,-1,1.7190434e-05,0.9999747,8.09105e-06
23453,Foxp3,21,22,116,121,"METHODS: Using multicolor flow cytometry, the frequency of three Treg subsets, separated on the basis of CD45RA and Foxp3, from the peripheral circulation of newly-presenting HNSCC patients (19 oral cavity squamous cell carcinoma, 20 hypopharyngeal squamous cell carcinoma, 18 nasopharyngeal squamous cell carcinoma, 19 oropharyngeal squamous cell carcinoma, and 36 laryngeal squamous cell carcinoma) were assessed with regard to 31 healthy donors and clinicopathological features.",24761979_2,-1,1,-1,1,23453,-1,2.1961741e-05,0.9999666,1.1426332e-05
17568,Thus,0,1,0,4,"Thus, the molecular subtype of CSCs TGF-beta-dependently contributes to the degree of immune infiltration.",22676416_6,-1,1,-1,1,17568,-1,2.2084907e-05,0.9999658,1.2157319e-05
7019,that,3,4,25,29,Recent evidence suggests that what sustains a tumor's survival and proliferation can also subvert the immune system from its defense role.,18479894_0,-1,1,-1,1,7019,-1,1.8912191e-05,0.9999733,7.7370705e-06
34302,FoxP3,6,7,35,40,Helios in combination with CD4 and FoxP3 may be an effective way to detect functional Tregs in pre-B ALL by promoting the secretion of transforming growth factor (TGF)-1.,29455107_4,-1,1,-1,1,34302,-1,2.2675295e-05,0.99996686,1.0453015e-05
26029,their,10,11,54,59,The impaired antitumour effect of CD4(+) T cells with their defective Th1 differentiation in an aged environment is restored by interleukin (IL)-6 blockade or IL-6 deficiency.,25850032_2,-1,1,-1,1,26029,-1,2.8864732e-05,0.9999583,1.2847329e-05
14422,the,2,3,9,12,"However, the biology of IL-17(+)Foxp3(+)CD4(+) T cells remains poorly understood in humans.",21357259_3,-1,1,-1,1,14422,-1,1.9928859e-05,0.9999721,7.967239e-06
26181,this,10,11,79,83,Mammalian colon harbours trillions of bacteria under physiological conditions; this symbiosis is made possible because of a tolerized response from the mucosal immune system.,25984582_0,-1,1,-1,1,26181,-1,2.1843354e-05,0.9999678,1.03054135e-05
4192,to,11,12,63,65,"We examined the hypothesis that a failure of the immune system to eradicate tumors is due to the immunosuppressive environment created by the growing tumor, which is influenced by the site of tumor growth.",16818744_0,-1,1,-1,1,4192,-1,2.2499895e-05,0.99996626,1.1242369e-05
31211,c-Rel,3,4,13,18,"In addition, c-Rel is a key regulator of apoptosis in that it influences the expression of anti-apoptotic genes such as Bcl-2 and Bcl-xL; conversely, inhibition of c-Rel increases cell apoptosis.",28090796_1,-1,1,-1,1,31211,-1,5.1459327e-05,0.99991214,3.6404137e-05
34321,The,0,1,0,3,The epithelium and stroma of the intestine express large amounts of IL33 and its receptor St2.,29463593_1,-1,1,-1,1,34321,-1,2.196873e-05,0.9999652,1.2845494e-05
872,regulation,13,14,71,81,Data concerning the effects of 15-d-PGJ(2) on human T cells and immune regulation are sparse.,11801678_3,-1,1,-1,1,872,-1,3.4372464e-05,0.9999244,4.1183634e-05
3520,there,12,13,88,93,"Despite the radical surgical resection performed in patients with colorectal carcinoma, there is a high rate of tumor recurrence.",16391798_0,-1,1,-1,1,3520,-1,2.2858016e-05,0.9999666,1.0510661e-05
23668,transfer,5,6,34,42,Our results suggest that adoptive transfer of Tregs aggressively promote intestinal tumorigenesis by decreasing NK cell number and activity by modulating IL-22 BP.,24797894_7,-1,1,-1,1,23668,-1,2.077586e-05,0.99996793,1.1313697e-05
30647,the,11,12,69,72,"Zoledronic acid (ZA), a nitrogen-containing bisphosphonate, inhibits the expression of receptor activator of nuclear factor kappa-B ligand (RANKL) on osteoblasts to inhibit osteoclastogenesis.",27887569_2,-1,1,-1,1,30647,-1,1.7261771e-05,0.9999733,9.411378e-06
25281,the,24,25,131,134,"The idea of regulatory T cells (Tregs) lost its popularity during the 1980s and 1990s, since immunologists failed to elucidate how the innate regulation of immunological reactions worked.",25427312_0,-1,1,-1,1,25281,-1,2.1576514e-05,0.9999703,8.105078e-06
35179,to,14,15,102,104,We investigated whether the activity of nuclear factor (NF)B in pancreatic stromal cells contributes to an environment that suppresses antitumor immune response.,29909021_1,-1,1,-1,1,35179,-1,2.5845413e-05,0.9999627,1.1437778e-05
27158,the,6,7,39,42,"The proportion and FoxP3 expression of the induced CD4(+)CD25(+) T cells are the highest at the level of 40ng/ml IFN-, and the suppressive function of the CD4(+)CD25(+) T cells induced by 40ng/ml IFN- is the strongest in MG patients.",26347149_12,-1,1,-1,1,27158,-1,1.64291e-05,0.9999734,1.0142642e-05
20537,the,1,2,3,6,"On the basis of this, we conducted a study on DC-based vaccination in advanced melanoma, adding low-dose temozolomide to obtain lymphodepletion.",23725550_2,-1,1,-1,1,20537,-1,2.4031278e-05,0.9999646,1.1338643e-05
23918,their,29,30,200,205,"Intravaginal imiquimod deposition induced upregulation of CXCL9 and CXCL10 mRNA expression in the genital tract, which are produced in response to IFN receptor signaling and attract cells expressing their ligand, CXCR3.",24893628_4,-1,1,-1,1,23918,-1,8.621196e-05,0.9998723,4.1483825e-05
2353,tumors,13,14,95,101,"Taken together, these observations demonstrate the functional expression of CD40 in epithelial tumors of the cervix and support the clinical exploitation of the CD40 pathway for the treatment of cervical cancer through its multiple effects on tumor cell growth, apoptosis, and immune recognition.",15611226_7,-1,1,-1,1,2353,-1,1.9637757e-05,0.99996674,1.35634145e-05
8289,Treg,26,27,158,162,"This study aimed to investigate whether different forms of apical periodontitis, namely cysts and granulomas, show different balances of Th1, Th2 regulators, Treg markers, and factors involved in osteoclast chemotaxis and activation.",19121066_2,-1,1,-1,1,8289,-1,5.26668e-05,0.99990654,4.0725896e-05
7093,The,0,1,0,3,"The selective targeting of monoclonal antibody coated glioma cells to activating Fcgamma receptors (FcgammaRs) on DCs, which is achieved with a blocking antibody to the inhibitory form of FcgammaR, leads to the induction of antitumor immunity without the need for an exogenous maturation stimulus.",18481381_3,-1,1,-1,1,7093,-1,1.85619e-05,0.9999734,8.029768e-06
4698,The,0,1,0,3,The peripheral:intrahepatic NKT lymphocyte ratio decreased in beta-glucosylceramide-treated mice solely in the HCC model.,17172586_5,-1,1,-1,1,4698,-1,1.8940704e-05,0.999972,9.125793e-06
8625,These,0,1,0,5,"These data correlate with increased CTL expansion in the peripheral blood of responders, increased infiltration of responder tumors by CD8+ cells and interleukin-17+ cells, and decreased infiltration of responder tumors by CD11b+Gr-1+ cells and FoxP3+ cells.",19223534_8,-1,1,-1,1,8625,-1,2.0018346e-05,0.9999691,1.0869452e-05
18465,to,10,11,62,64,Breast tumors with FOXP3 and CD8 infiltrates were more likely to achieve pCR.,22986814_7,-1,1,-1,1,18465,-1,2.0513831e-05,0.999969,1.0506377e-05
27964,activator,12,13,73,82,"Here, we focused on the role of interleukin (IL)-6/signal transducer and activator of transcription (STAT3) signaling cascade in immune regulation by human dendritic cells (DCs).",26759006_1,-1,1,-1,1,27964,-1,2.8838527e-05,0.9999523,1.8839699e-05
20988,transforming,19,20,96,108,"Here, we investigated the effect of triptolide on regulatory T cells and on the level of IL-10, transforming growth factor-, and vascular endothelial growth factor in tumor-bearing mice.",23975869_2,-1,1,-1,1,20988,-1,4.211854e-05,0.9999362,2.1708303e-05
19981,the,24,25,154,157,"The extent to which T-cell-mediated immune surveillance is impaired in human cancer remains a question of major importance, given its potential impact on the development of generalized treatments of advanced disease where the highest degree of heterogeneity exists.",23423978_0,-1,1,-1,1,19981,-1,1.7916662e-05,0.99997485,7.264893e-06
30810,the,1,2,3,6,"In the murine cancer model, targeting of IL-17A inhibited PDL1 expression in the tumor microenvironment, decreased the percentage of Treg cells in tumor-infiltrating lymphocytes, and promoted CD4+ and CD8+ T cells to secrete interferon gamma.",27935862_6,-1,1,-1,1,30810,-1,1.7581642e-05,0.99997306,9.308136e-06
32900,T,4,5,25,26,The peripheral Tregs and T helper (Th) 1 cells were analyzed by flow cytometry.,28731226_5,-1,1,-1,1,32900,-1,2.651018e-05,0.9999478,2.5730717e-05
38542,to,4,5,41,43,Reprogramming the tumor microenvironment to increase immune-mediated responses is currently of intense interest.,31888983_0,-1,1,-1,1,38542,-1,2.1191065e-05,0.99996805,1.0773176e-05
58,tumor,28,29,186,191,"We show here that gene gun-mediated skin transfection of plasmid vector encoding the nontransforming, amino-terminal half of E6 resulted in the induction of E6-specific CTL activity and tumor rejection in a murine model.",10419051_3,-1,1,-1,1,58,-1,1.9695055e-05,0.99997056,9.806924e-06
21817,the,20,21,113,116,"In addition, IL-10, IFN- and IL-4 levels were determined in sera and also in splenocyte culture supernatants at the presence of tumor cell lysate (10g/ml) and Con A (3g/ml) after 72h. Results showed the cytotoxic effects of umbelliprenin on LLC cells (IC=51.65.4M) while no adverse effect was seen at this concentration on normal splenocytes.",24325354_5,-1,1,-1,1,21817,-1,2.210282e-05,0.99996793,9.973748e-06
32068,tumor,44,45,269,274,"But distinctive from the interleukin 10-expressing CD4+ T cells, which increased in frequency in advanced cancer, the interleukin 10-expressing CD8+ T cells did not increase with cancer stage in the peripheral blood and actually decreased with cancer stage in resected tumor.",28488547_5,-1,1,-1,1,32068,-1,2.3486451e-05,0.99996305,1.3494415e-05
17078,Th,13,14,60,62,The balance between T regulatory cells (Treg) and T helper (Th) 17 cells represents one essential prerequisite for maintaining anti-tumor immunity in MM.,22489248_2,-1,1,-1,1,17078,-1,3.5171885e-05,0.9999454,1.9449431e-05
13845,tested,51,52,295,301,"As a positive control, a more than 2-fold increase in blood Tregs was detected in four out of nine patients who were treated with interleukin-2.CONCLUSIONS: We used a MS-qPCR method that detects Tregs but not other activated T lymphocytes; however, none of the Treg-depleting strategies that we tested led, in the majority of patients, to a conservative 50% reduction in blood Tregs.",21177412_7,-1,1,-1,1,13845,-1,2.379512e-05,0.9999622,1.3992006e-05
1721,regulation,14,15,68,78,"IL-27 is a novel IL-12 family member that plays a role in the early regulation of T helper cell 1 initiation, including induction of T-bet and IL-12 receptor beta 2 expression.",14871851_1,-1,1,-1,1,1721,-1,2.6648542e-05,0.9999473,2.5981699e-05
36784,Treg,12,13,71,75,Tumor-bearing mice model was utilized to explore the effects of Foxa1+ Treg on tumor growth and the prognoses.,31036318_9,-1,1,-1,1,36784,-1,2.188031e-05,0.9999635,1.4629041e-05
22774,The,0,1,0,3,The vaccine was given alone or in sequence with an anti-CD25 antibody (PC61) and cyclophosphamide to deplete T-regulatory (Treg) cells.,24607504_3,-1,1,-1,1,22774,-1,2.1861511e-05,0.99996996,8.139809e-06
31553,thus,21,22,118,122,CONCLUSION: Our data indicate that oxygen availability can function as a local modulator of CD4+ T cell responses and thus influences tumour immune surveillance in inflammation-associated colon cancer.,28278498_8,-1,1,-1,1,31553,-1,2.7867658e-05,0.99995995,1.2225637e-05
2865,T-bet-dependent,14,15,72,87,These results suggest that IL-27 directly acts on naive CD8+ T cells in T-bet-dependent and -independent manners and augments generation of CTL with enhanced granzyme B expression.,16034109_9,-1,1,-1,1,2865,-1,2.6329886e-05,0.99994814,2.5467214e-05
34195,The,0,1,0,3,The PI3K/AKT pathway may participate in the regulation of IL-6 expression and secretion.,29337110_8,-1,1,-1,1,34195,-1,1.8902367e-05,0.99997246,8.580524e-06
32246,to,8,9,67,69,The tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts were found to be gut-homing due to their higher expression of 47 while peripheral blood B cells did not show the same characteristic.,28558303_5,-1,1,-1,1,32246,-1,2.4094223e-05,0.9999645,1.1369882e-05
16589,Tregs,4,5,28,33,The suppressive function of Tregs was tested by T cell proliferation assay.,22303460_7,-1,1,-1,1,16589,-1,1.9417574e-05,0.9999703,1.0305833e-05
2996,activator protein-1,51,53,310,329,"Formononetin, daidzein and equol also enhanced IL-4 gene promoter activity in EL4 cells transiently transfected with IL-4 gene promoter constructs, but this effect was impaired in EL4 cells transfected with an IL-4 promoter construct deleted of P4 site carrying nuclear factor of activated T cells (NF-AT) and activator protein-1 (AP-1) binding sites.",16108819_5,-1,1,-1,1,2996,-1,6.087536e-05,0.9998647,7.4386015e-05
2832,that,38,39,161,165,"In a manner similar to CD4+ T cells, IL-27 activated STAT1, -2, -3, -4, and -5, and augmented the expression of T-bet, IL-12Rbeta2, and granzyme B, and slightly that of perforin in naive CD8+ T cells stimulated with anti-CD3.",16034109_3,-1,1,-1,1,2832,-1,3.4764707e-05,0.9999436,2.1590142e-05
6596,the,6,7,31,34,"In this study, we investigated the expression of forkhead/winged helix transcription factor 3 (Foxp3) in melanoma-invaded LNs and determined proportion and functionality of Treg cells among TIL extracted from these 10 metastatic melanoma LNs at different steps of their in vitro expansion.",18312383_2,-1,1,-1,1,6596,-1,1.4664881e-05,0.99997663,8.683983e-06
5378,The,0,1,0,3,The precise nature and molecular basis of immune dysfunction in the cancer state are not well defined.,17488182_1,-1,1,-1,1,5378,-1,2.0416785e-05,0.9999715,8.065809e-06
40453,transcriptional,11,12,81,96,This activity of IRF4-expressing DCs is linked to a DC-specific immunoregulatory transcriptional program.,32848032_4,-1,1,-1,1,40453,-1,2.8966553e-05,0.99995303,1.8032491e-05
1414,there,11,12,68,73,"While this protocol led to significant suppression of tumor growth, there were no disease-free survivors.",12804139_3,-1,1,-1,1,1414,-1,2.2290238e-05,0.9999658,1.1976602e-05
28611,their,13,14,68,73,"Regulatory T cells (T-regs) contribute to tumour immune escape, but their role in basal cell carcinoma (BCC) is not understood.",27117439_1,-1,1,-1,1,28611,-1,2.7157765e-05,0.9999616,1.1251487e-05
37799,TGF-,2,3,9,14,"However, TGF- also has tumor-suppressive activity; thus, dissecting cell type-specific molecular effects may inform therapeutic strategies targeting this cytokine.",31530731_2,-1,1,-1,1,37799,-1,2.8875062e-05,0.9999604,1.07237065e-05
38807,the,4,5,20,23,"Here, we identified the polarizing conditions to induce an IL22-producing CD8+ Tc22 subset, which is dependent on IL6 and the aryl hydrocarbon receptor transcription factor.",31964625_1,-1,1,-1,1,38807,-1,1.9247173e-05,0.9999727,8.075024e-06
39675,the,1,2,10,13,"Regarding the mechanism, SNHG16 served as a ceRNA by sponging miR-16-5p, which led to the derepression of its target gene SMAD5 and resulted in potentiation of the TGF-1/SMAD5 pathway to upregulate CD73 expression in V1 T cells.",32345959_6,-1,1,-1,1,39675,-1,2.5002819e-05,0.99996126,1.3757184e-05
35740,the,47,48,274,277,"Interestingly, in the absence of autologous lymphomas, the granzyme B and perforin expression levels in CD8+ T cells from patients with MYD88 WT lymphomas and from patients with MYD88 L265P mutant lymphomas were comparable; however, in the presence of autologous lymphomas, the CD8+ T cells from patients with MYD88 L265P mutant lymphomas presented significantly lower granzyme B and perforin expression than CD8+ T cells from patients with MYD88 WT lymphomas.",30253331_4,-1,1,-1,1,35740,-1,1.6471799e-05,0.9999732,1.0402374e-05
15791,to,12,13,72,74,The novel targeted vaccine induced durable Th1 and CD8 T cell responses to poorly immunogenic self/tumor antigen (Ag) and attenuated tumor-associated Treg suppressive function.,21934655_4,-1,1,-1,1,15791,-1,4.9352868e-05,0.99993205,1.8612644e-05
20546,the,14,15,100,103,"Circulating Foxp3+Tregs were evaluated before and after temozolomide, and after IL-2.RESULTS: Among the 17 evaluable patients we observed 1 partial response (PR), 6 stable disease (SD) and 10 progressive disease (PD).",23725550_5,-1,1,-1,1,20546,-1,2.0957592e-05,0.9999664,1.2716976e-05
36197,that,5,6,37,41,"Together, these results demonstrated that IL-21 could significantly expand the V9V2 T cells, but its efficacy was limited since it also increased the expression of checkpoint molecule Tim-3.",30708194_11,-1,1,-1,1,36197,-1,1.8837467e-05,0.99997306,8.050952e-06
36591,TGF-,24,25,131,136,"Tissue expression of Forkhead box P3 (FOXP3), one of the transcription factors of Treg cells, and transforming growth factor-beta (TGF-) were examined by immunohistochemistry.",30981619_3,-1,1,-1,1,36591,-1,4.063022e-05,0.9999387,2.0636948e-05
2899,AP-1,12,13,89,93,"Although LPS and IFN-gamma alone marginally activated nuclear factor (NF)-kappaB but not AP-1, LPS plus IFN-gamma augmented NF-kappaB and AP-1.",16094077_8,-1,1,-1,1,2899,-1,4.356175e-05,0.99992204,3.437048e-05
7240,to,24,25,144,146,Down-regulation of CD4+CD25+ regulatory T (Treg) cell function might be beneficial to enhance the immunogenicity of viral and tumor vaccines or to induce breakdown of immunotolerance.,18566377_0,-1,1,-1,1,7240,-1,2.3151064e-05,0.9999683,8.610335e-06
26021,to,19,20,106,108,"Here we focus on the impact of this inflammatory environment on T cells, and demonstrate that in contrast to successful tumour elimination in young mice, replenishment of tumour-specific CD4(+) T cells fails to induce tumour regression in aged hosts.",25850032_1,-1,1,-1,1,26021,-1,2.1308522e-05,0.9999701,8.648205e-06
16105,treatment,2,3,14,23,"After AOM+DSS treatment, IL-21 KO mice showed reduced mucosal damage, reduced infiltration of T cells, and diminished production of IL-6 and IL-17A.",21987656_3,-1,1,-1,1,16105,-1,2.472076e-05,0.99995816,1.7144275e-05
6862,this,1,2,3,7,"In this study, we tested the hypothesis that the combination of CpG (a DC activator) and JSI-124 (a STAT3 inhibitor) may generate synergistic antitumor effects compared to CpG or JSI-124 alone.",18392040_1,-1,1,-1,1,6862,-1,1.9284429e-05,0.99997044,1.0242733e-05
36172,to,20,21,110,112,"In this study, we examined the proliferative response of V9V2 T cells to IL-21, a cytokine previously shown to promote NK cell and CD8 T cell cytotoxicity.",30708194_3,-1,1,-1,1,36172,-1,3.7817354e-05,0.9999491,1.3051703e-05
42245,To,0,1,0,2,"To overexpress Flt3L systemically, we performed gene therapy through the hydrodynamic injection of an Flt3L-encoding plasmid.",33980589_4,-1,1,-1,1,42245,-1,1.8347439e-05,0.9999728,8.787067e-06
4724,types,16,17,107,112,"In addition, the full-length SSX-1 antigen is frequently expressed in tumors of several other histological types such as sarcoma, melanoma, hepatocellular carcinoma, ovarian cancer and myeloma.",17186289_2,-1,1,-1,1,4724,-1,7.11182e-05,0.9997781,0.00015082741
15047,the,3,4,11,14,The aim of the study was to observe the variation of CD4(+)CD25(+) regulatory T cells in periphery blood and tumor microenvironment of non-small cell lung cancer (NSCLC) patients and the effects of CpG ODN.,21611754_0,-1,1,-1,1,15047,-1,1.8664903e-05,0.99997306,8.241709e-06
16422,the,3,4,15,18,Lung cancer is the leading cause of cancer deaths worldwide.,22186896_0,-1,1,-1,1,16422,-1,2.9280782e-05,0.99995744,1.33097565e-05
24786,the,29,30,184,187,"Splenic CD4(+)FoxP3(+) regulatory T cells (Tregs) expanded substantially in untreated mice that exhibited then a reduced survival, whereas Tregs depletion led to long-term survival of the animals, suggesting the establishment of a Treg-dependent immunosuppressive environment after tumor injection.",25231744_3,-1,1,-1,1,24786,-1,1.8467581e-05,0.99997187,9.6777385e-06
28646,the,31,32,166,169,"METHODS: The expression and activation of NF-B, Akt and IDO1 by MyD88(+) EOC SKOV3 cells was determined using western blot; the TLR4/MD-2 complex on SKOV3 cells and the phenotype of T lymphocytes were determined using flow cytometry; IDO activity was evaluated by measuring L-kynurenine; Immunesuppressive cytokines were detected using ELISA; T-cell proliferation to mitogen stimulation was assessed by MTT assay; the cytotoxicity of lymphocytes and NK cells was measured using LDH-cytotoxicity assay.",27118139_3,-1,1,-1,1,28646,-1,1.8896175e-05,0.9999691,1.19482565e-05
3392,generate,19,20,104,112,"In contrast, CD1(-/-) mice, which are deficient for IL-13 because they lack IL-13-producting NKT cells, generate M1 macrophages that are cytotoxic for 4T1 via the production of nitric oxide.",16357187_3,-1,1,-1,1,3392,-1,2.5544805e-05,0.9999585,1.5945396e-05
21424,the,9,10,52,55,The thymus is a central lymphoid organ critical for the development and maintenance of an effective peripheral T-cell repertoire.,24198066_0,-1,1,-1,1,21424,-1,2.0993391e-05,0.9999697,9.339574e-06
31966,Tregs,6,7,36,41,CD4+CD25+Foxp3+ regulatory T cells (Tregs) play an important role in maintenance of immunologic self-tolerance.,28472762_1,-1,1,-1,1,31966,-1,2.1882832e-05,0.99996626,1.1874185e-05
3379,that,59,60,370,374,This highly effective immune surveillance is due to three interacting mechanisms: (a) the generation of inducible nitric oxide synthase (iNOS)-producing M1 macrophages that are tumoricidal for 4T1 tumor cells; (b) a rapid decrease in myeloid-derived Gr1(+)CD11b(+) suppressor cells that are elevated and down-regulate the CD3zeta chain when primary tumor is present and that suppress T cells by producing arginase; and (c) production of activated lymphocytes.,16357187_1,-1,1,-1,1,3379,-1,2.7445143e-05,0.9999535,1.9061745e-05
25287,the,16,17,101,104,"The entire re-evaluation of the Tregs was supported due to the increasingly influential and state of the art immunological techniques, as cell sorting and also the expanding understanding of the immune system and its functions which aided in attaining a greater insight into the mechanisms of regulation and suppression.",25427312_1,-1,1,-1,1,25287,-1,4.182357e-05,0.99993396,2.424807e-05
43908,the,5,6,31,34,Our data have implications for the detection of potentially dysfunctional T cells in patients with cancer.,9724088_7,-1,1,-1,1,43908,-1,1.8616765e-05,0.99997425,7.151234e-06
5997,that,3,4,22,26,These results suggest that vaccination with DCs pulsed with tatSVV is an effective way for the SVV-targeting cancer vaccine to induce an effective anti-tumor responses.,17931768_5,-1,1,-1,1,5997,-1,1.9491259e-05,0.99997365,6.8215263e-06
34762,that,3,4,21,25,"Our findings suggest that at an early stage of the tumor, this tumor-induced IFN-producing FOXP3- CD8+ CD25+ CD127- T-cell subset can potentiate immune surveillance by targeting HLA-E-restricted CD4+ Treg cells while leaving the effector T-cell population unaffected.",29768737_8,-1,1,-1,1,34762,-1,1.6977636e-05,0.99997365,9.342363e-06
11488,that,2,3,15,19,We hypothesize that prevention of tumor-induced effector cell dysfunction is a major mechanism contributing to the efficacy of combined chemoimmunotherapy.,20118405_8,-1,1,-1,1,11488,-1,1.830323e-05,0.99997425,7.4192267e-06
18049,T,22,23,114,115,"Finally, we show that the proportion of CXCR3(+) Treg at tumor sites is directly correlated with that of CXCR3(+) T effectors, consistent with expression of CXCR3 ligands.",22798340_7,-1,1,-1,1,18049,-1,2.4648867e-05,0.99995244,2.2893599e-05
31973,that,3,4,12,16,It is found that OA reversed the generation of Tregs induced by H460 lung cancer cells co-culture.,28472762_4,-1,1,-1,1,31973,-1,2.1302005e-05,0.9999702,8.441525e-06
20610,this,3,4,11,15,The aim of this study was to investigate the level of IL-17-producing cells in the breast cancer tumour microenvironment and its prognostic role.,23738752_1,-1,1,-1,1,20610,-1,1.9823856e-05,0.9999707,9.5494825e-06
18135,the,13,14,87,90,CONCLUSIONS: The imbalance of Th17/Foxp3-expressing T cells may play critical roles in the development and progression of UCC and Th17 cells may promote tumor progression by fostering angiogenesis.,22820395_8,-1,1,-1,1,18135,-1,1.8844765e-05,0.9999732,7.942925e-06
16268,that,16,17,93,97,"We used DKK1-DNA vaccine in the murine MOPC-21 myeloma model, and the results clearly showed that active vaccination using the DKK1 vaccine not only was able to protect mice from developing myeloma, but it was also therapeutic against established myeloma.",22049519_3,-1,1,-1,1,16268,-1,2.0441217e-05,0.9999716,7.947686e-06
38566,to,3,4,16,18,This study aims to investigate the ability of transcription factors in regulating tumor immune microenvironment in lung adenocarcinoma.,31898342_1,-1,1,-1,1,38566,-1,1.6077249e-05,0.9999747,9.1424035e-06
20971,these,2,3,14,19,"Collectively, these data identify a mechanism for the specific regulation of TCR-dependent JNK1 activation and function that is key for CD8(+) T-cell responses.",23963642_7,-1,1,-1,1,20971,-1,2.1617181e-05,0.999967,1.1416196e-05
25370,the,12,13,79,82,"The proportion of CD4(+)T and CD8(+)T cells decreased, but CD4(+)T/CD8(+)T and the proportion of CD4(+)CD25(+)Foxp3(+)T cells increased.",25446402_8,-1,1,-1,1,25370,-1,1.830329e-05,0.9999708,1.0846254e-05
33865,IRF8,9,10,68,72,"IRF8 functions through a transcription factor complex consisting of IRF8, IRF4, PU.1 and BATF, which binds to DNA and boosts Il9 transcription.",29233972_3,-1,1,-1,1,33865,-1,3.5285768e-05,0.99993086,3.390821e-05
42141,type,12,13,63,67,"To clarify the contribution of STAT6 to CAC, STAT6-/- and wild type (WT) mice were subjected to an AOM/DSS regimen, and the frequency of peripheral and local Treg cells was determined during the progression of CAC.",33919941_3,-1,1,-1,1,42141,-1,2.6775453e-05,0.99995387,1.9309155e-05
25571,the,17,18,100,103,"Similarly, expression of CD38 on CLL cells correlates with CLL cell survival and proliferation, but the mechanisms that regulate CD38 expression and inflammatory cytokines remain unclear.",25505279_1,-1,1,-1,1,25571,-1,2.2216469e-05,0.99996865,9.076983e-06
34482,Tumor-promoting,0,1,0,15,Tumor-promoting inflammation and avoiding immune destruction are hallmarks of cancer.,29551594_0,-1,1,-1,1,34482,-1,5.8523703e-05,0.9999244,1.7079432e-05
30970,Th2-type,27,28,191,199,"Local immune cell subsets were measured on formalin-fixed, paraffin-embedded cancer tissue by immunohistochemistry to examine expression of transcription factors that control Th1 (T-bet) and Th2-type (GATA3) immunity.",28005163_4,-1,1,-1,1,30970,-1,3.067837e-05,0.99994266,2.6655665e-05
24027,Tregs,9,10,63,68,"CONCLUSIONS: Our data suggest that intratumoral recruitment of Tregs, high expression of TGF-1 and IL-10, almost negative CD123+, and a low CD8(+) /Foxp3(+) CD25(+) T-cell ratio may contribute to the aggressiveness of cutaneous SCC, as already evidenced for other solid tumours.",24910265_8,-1,1,-1,1,24027,-1,1.98427e-05,0.9999671,1.3088073e-05
21768,the,10,11,80,83,"RESULTS: Our experiments showed the combination therapy significantly decreased the frequency of Tregs, and increased CD8+ T cells and CD4+ T cells at tumor sites.",24304581_9,-1,1,-1,1,21768,-1,1.8111867e-05,0.99997246,9.395426e-06
35307,that,3,4,23,27,These data demonstrate that RORt expressed by tumor-infiltrating Tregs sustains tumor growth by leaving IL6 expression in DCs unchecked.,29991500_11,-1,1,-1,1,35307,-1,1.7102555e-05,0.9999747,8.2202305e-06
29059,T-bet,31,32,207,212,"Chromatin immunoprecipitation analysis revealed that Bhlhe40 accumulates in the T-box region of the Ifng locus and contributes to histone H3-lysine 9 acetylation of the Ifng locus, which is impaired without T-bet conditions.",27226296_7,-1,1,-1,1,29059,-1,2.839643e-05,0.9999548,1.6809154e-05
37948,to,2,3,9,11,We aimed to investigate the frequency of these cells and their ability to produce cytokines in tumor-draining lymph nodes from patients with breast cancer (BC).MATERIALS AND METHODS: Mononuclear cells from lymph nodes of 20 patients with BC were activated and stained for appropriate markers.,31630080_1,-1,1,-1,1,37948,-1,1.736745e-05,0.9999733,9.357036e-06
42831,the,6,7,38,41,Cholangiocarcinoma (CCA) results from the malignant transformation of cholangiocytes.,34495298_0,-1,1,-1,1,42831,-1,2.0880307e-05,0.9999691,9.948359e-06
31828,tumor,27,28,168,173,"Here, we report that IL-35 can induce N2 neutrophil polarization (protumor phenotype) by increasing G-CSF and IL-6 production, and promote neutrophil infiltration into tumor microenvironment.",28432279_3,-1,1,-1,1,31828,-1,1.8941495e-05,0.9999709,1.0123386e-05
25980,natural,12,13,78,85,"The frequency, immunosuppressive phenotype, and activation status of Treg and natural killer (NK) cells were analyzed in the circulation and tumor microenvironment of cetuximab-treated patients with HNSCC enrolled in a novel neoadjuvant, single-agent cetuximab clinical trial.",25832655_2,-1,1,-1,1,25980,-1,5.5409044e-05,0.99991906,2.5582316e-05
22142,Treg,25,26,133,137,"An increase in IL-17-related genes was only observed in Treg cells, while increases in IFN-, IL-21, and TNF- were observed in both Treg and Tconv cells.",24405842_8,-1,1,-1,1,22142,-1,4.016223e-05,0.99988544,7.434748e-05
21973,Th17,6,7,25,29,"OBJECTIVES: T helper 17 (Th17), T cytotoxic 17 (Tc17) and regulatory T (Treg) cells are important factors in the pathogenesis of inflammatory and autoimmune diseases.",24388919_0,-1,1,-1,1,21973,-1,4.7887417e-05,0.999925,2.709895e-05
25553,Thr446Ile,16,17,87,96,"Among the 12 candidates was a rare heterozygous substitution rs141331848 (c.1337C>T, p.Thr446Ile) in the DNA-binding domain of STAT4.",25492914_6,-1,1,-1,1,25553,-1,8.698845e-05,0.9998455,6.748203e-05
17375,The,0,1,0,3,The number of administered doses of IL-2 was found to be positively associated with peripheral Treg reconstitution.,22555974_4,-1,1,-1,1,17375,-1,1.8587883e-05,0.99997234,9.063004e-06
39741,The,2,3,12,15,"BACKGROUND: The connection between inflammatory bowel disease (IBD) and colorectal cancer (CRC) is well-established, as persistent intestinal inflammation plays a substantial role in both disorders.",32390702_0,-1,1,-1,1,39741,-1,2.206951e-05,0.9999703,7.5921043e-06
12872,treated,20,21,89,96,"CD4(+)Foxp3(+) T(reg) frequency was determined (flowcytometry) on day 21, 23, 25 and 35: treated chimeras showed an expansion of CD4(+)Foxp3(+) T(reg) frequencies on day 25 and 35, without a prior frequency decrease.",20600326_5,-1,1,-1,1,12872,-1,2.2648625e-05,0.9999602,1.7144834e-05
24950,that,3,4,26,30,"These results demonstrate that nicotine suppresses acute colitis and colitis-associated tumorigenesis, and this effect may be associated with the activation of 7-nAChR. Furthermore, it is presumed that nicotine downregulates the expression of inflammatory mediators such as IL-6/Stat3 and TNF-, thereby reducing the colonic tumorigenesis associated with chronic colitis.",25258409_9,-1,1,-1,1,24950,-1,1.7371749e-05,0.9999746,7.97572e-06
22631,TSC1,11,12,55,59,"We report in this study that the tuberous sclerosis 1 (TSC1), a negative regulator of mTOR signaling, plays a crucial role in iNKT cell anergy.",24532578_4,-1,1,-1,1,22631,-1,2.1541317e-05,0.9999523,2.6181164e-05
20474,TSCC,6,7,37,41,We determined T cell polarization in TSCC and SCC by intracellular cytokine staining of T cell crawl outs from human skin explants.,23667456_2,-1,1,-1,1,20474,-1,4.0433046e-05,0.99993384,2.5772624e-05
10526,that,3,4,22,26,The results indicated that on days 27 and 32 the tumors in the gp96+Nal group grew significantly slower.,19706340_5,-1,1,-1,1,10526,-1,1.7883087e-05,0.99996924,1.2848108e-05
22056,status,8,9,46,52,E2/E6 ratio was used to evaluate the physical status of HPV-16 DNA in host cell genome.,24401583_3,-1,1,-1,1,22056,-1,2.5944351e-05,0.99995923,1.4815542e-05
40595,tumors,33,34,208,214,"In this study, we explore immunomodulatory properties of EVs derived from antitumor vaccines expressing the TNFSF ligands 4-1BBL and OX40L, modulating immune response mediated by immune cells and eliminating tumors.",32939048_4,-1,1,-1,1,40595,-1,2.044561e-05,0.99996805,1.1559671e-05
11951,Tumor-derived,0,1,0,13,"Tumor-derived exosomes express tumor antigens, leading to their promising utility as tumor vaccines, but they also can suppress T-cell signaling molecules and reduce cytotoxic effects.",20372811_0,-1,1,-1,1,11951,-1,2.3897555e-05,0.9999635,1.2555748e-05
12858,this,22,23,117,121,Patient and mouse data on the contribution of a quantitative or qualitative defect of regulatory T cells (T(reg)) in this autoimmune phenomenon are conflicting.,20600326_1,-1,1,-1,1,12858,-1,2.3349994e-05,0.9999678,8.8018605e-06
36791,treatment,14,15,82,91,"Moreover, patients with more FOXA1+ Tregs showed more liver metastases and poorer treatment responses.",31036318_11,-1,1,-1,1,36791,-1,5.18859e-05,0.9999163,3.1825082e-05
10573,tumor,6,7,55,60,Treatment with both antibodies significantly decreased tumor growth in vivo.,19724910_11,-1,1,-1,1,10573,-1,1.9851506e-05,0.9999702,1.0003902e-05
21407,there,2,3,9,14,"Instead, there were significant increases in regulatory T cells (3.7 vs. 6.8 %) and a population of myeloid-derived suppressor cells (CD14(-)HLA-DR(-)CD15(hi), 12.38 vs. 21.92 %).",24146146_6,-1,1,-1,1,21407,-1,1.7991224e-05,0.9999726,9.416596e-06
17613,Treg,24,25,149,153,"We conclude that Mam-A cDNA vaccination is associated with specific expansion and activation of CD4+ICOS(hi) T cells, with a concomitant decrease in Treg frequency.",22678162_9,-1,1,-1,1,17613,-1,2.8180773e-05,0.99995315,1.863721e-05
17943,tumors,5,6,23,29,In vivo assays of C4HD tumors showed that the antitumor immune response involves the participation of CD4(+) T cells and cytotoxic NK cells.,22753933_6,-1,1,-1,1,17943,-1,1.9515961e-05,0.9999689,1.1571891e-05
33738,these,11,12,67,72,"Furthermore, secondary immune responses could be primed as soon as these immunized mice were challenged with HCC cells, accompanied by T cell and NK cell activation and infiltration.",29115974_5,-1,1,-1,1,33738,-1,1.9525092e-05,0.9999695,1.0982216e-05
4291,TAA,29,30,184,187,The first goal of this article is to test if the injection of autologous dendritic cells infected ex vivo with the Ad-sig-TAA/ecdCD40L can increase the immune response induced against TAA.,16928818_2,-1,1,-1,1,4291,-1,2.5727371e-05,0.9999608,1.3516834e-05
3476,the,20,21,128,131,"The seven signal transducers and activators of transcription (STAT) act as signaling components between the plasma membrane and the nucleus, and as transcription factors with specific DNA binding ability in the nucleus.",16375697_1,-1,1,-1,1,3476,-1,2.3334747e-05,0.99996126,1.5456146e-05
41093,TGF,5,6,29,33,The expressions of Foxp3 and TGF in the transplanted tumor tissues of mice in the solanine group were significantly lower than those in the control group.,33204731_9,-1,1,-1,1,41093,-1,3.9523355e-05,0.9999405,1.9949777e-05
13611,the,25,26,170,173,"To validate the possibility, we developed a novel HBx-positive hepatocellular carcinoma in mice by inoculated the pcDNA-HBx transfected Hepa1-6 cells subcutaneously into the right flank of mice.",21042781_2,-1,1,-1,1,13611,-1,1.8775476e-05,0.99997175,9.462103e-06
18361,Th17,8,9,58,62,BACKGROUND: Several studies have documented modulation of Th17 and T regulatory (Treg) cells in various human malignancies which may vary with the type and extent of the disease.,22956260_0,-1,1,-1,1,18361,-1,2.464063e-05,0.99996066,1.4710478e-05
2777,these,25,26,180,185,"We previously demonstrated that IL-4 gene-transfected glioma cell vaccines induce effective therapeutic immunity in preclinical glioma models, and have initiated phase I trials of these vaccines in patients with malignant gliomas.",15905564_0,-1,1,-1,1,2777,-1,1.924991e-05,0.9999709,9.823495e-06
27925,Targeting,0,1,0,9,Targeting of TGF and IL-10 reduced the ability of alveolar macrophages from IKTA mice to induce Foxp3 expression on T cells.,26756215_6,-1,1,-1,1,27925,-1,2.2138682e-05,0.999966,1.17999125e-05
1732,the,29,30,157,160,"C26 cells, which were transduced with the single-chain IL-27 cDNA and became secreting IL-27 (C26-IL-27), exhibited minimal tumor growth in vivo, and all of the mice inoculated with these cells survived healthily with complete tumor remission.",14871851_3,-1,1,-1,1,1732,-1,2.3587394e-05,0.99996316,1.3217431e-05
804,STAT5,21,22,146,151,"In contrast, calcium mobilization and activation of other signal transduction pathways, namely extracellular signal-regulated kinase1/2, p38, and STAT5 were unaffected, but activation of c-Jun N-terminal kinase 1/2 was delayed.",11698483_9,-1,1,-1,1,804,-1,3.7925583e-05,0.9999306,3.15024e-05
22193,that,3,4,17,21,"The data suggest that pretreatment of myeloma cells with JSI-124 and bortezomib can recover DC function through the up-regulation of HSP90 and the down-regulation of p-STAT3 and inhibitory cytokines, and that these DCs can potently generate myeloma-specific CTLs.",24407159_7,-1,1,-1,1,22193,-1,1.7646034e-05,0.99997354,8.786554e-06
25801,then,21,22,118,122,"Taken together, this is the first evidence to reveal that both TGF- and EGF can induce HLA-I downregulation which is then proven to be associated with EMT in prostate cancer cells.",25618241_8,-1,1,-1,1,25801,-1,2.622679e-05,0.9999645,9.27889e-06
1780,genes,32,33,203,208,"Suppression also required an endogenous IFN-gamma pathway consisting minimally of IFN-gamma, IFN-gamma receptor, Stat1, and IFN regulatory factor 1 since mice with targeted disruption of any of the four genes failed to arrest tumor growth.",14978132_2,-1,1,-1,1,1780,-1,3.0434947e-05,0.9999461,2.3420918e-05
30376,the,23,24,139,142,The mechanism underlying CD4+CD25+Foxp3+ regulatory T cells (Tregs) promoting the development of colorectal cancer (CRC) was elucidated in the present study.,27752897_0,-1,1,-1,1,30376,-1,2.0276468e-05,0.9999702,9.501069e-06
15101,The,0,1,0,3,"The expression of HPV16E6 strongly enhanced cellular resistance to cytotoxic T lymphocytes (CTLs)-mediated lytic activity, and knockdown of HPV16E6 by antisense had the opposite effect.",21621523_3,-1,1,-1,1,15101,-1,1.8665207e-05,0.9999732,8.212272e-06
14519,Treg,7,8,33,37,BACKGROUND & AIMS: Regulatory T (Treg) cells (CD4+ CD25high FoxP3+) regulate mucosal tolerance; their adoptive transfer prevents or reduces symptoms of colitis in mouse models of inflammatory bowel disease.,21376048_0,-1,1,-1,1,14519,-1,2.4771649e-05,0.99996126,1.4001989e-05
33120,TIM-1,0,1,0,5,"TIM-1+ B cells prolonged islet allograft survival in B-deficient mice, whereas TIM-4+ B cells accelerated rejection in an IFN--dependent manner.",28848066_8,-1,1,-1,1,33120,-1,3.3530207e-05,0.9999243,4.2102773e-05
27556,treatments,48,49,226,236,"METHODS AND MATERIALS: CD3(+), CD8(+), and CD4(+) T cells and Th1, Th2, Th17, and regulatory T (Treg) cells were evaluated at different time points after single low-dose total body irradiation (SLTBI) with or without cinnamon treatments.",26475064_3,-1,1,-1,1,27556,-1,3.3339187e-05,0.9999503,1.632173e-05
8140,tumor-free,11,12,76,86,"Furthermore, this increased CD8(+) T-cell response correlated with improved tumor-free survival in a tumor therapy model.",19036811_5,-1,1,-1,1,8140,-1,6.1206585e-05,0.9999075,3.1281215e-05
35866,these,34,35,176,181,"In this study, we aim to analyze the expression of CD8 and FoxP3 on T lymphocytes and TGF- expressionin tumor tissues, andthen analyze the possible clinical significance of these finding in order to find a novel effective immunotherapy target in PDAC using a murine model.",30359281_2,-1,1,-1,1,35866,-1,1.8576724e-05,0.99997175,9.677468e-06
34849,tumor,12,13,61,66,"In HCC-bearing mice, FM at a non-toxic dose failed to reduce tumor growth in immune compromised mice, whereas it significantly inhibited tumor growth and prolonged life span in immune competent mice.",29784005_13,-1,1,-1,1,34849,-1,1.8017578e-05,0.9999715,1.0495327e-05
13160,gene,8,9,74,78,"CONCLUSION: So adoptively T cells transduced anti-CD20scFvFc/CD28/CD3zeta gene mediates enhanced anti-tumor activities against CD20 positive tumor cells, suggesting a potential of gene-based immunotherapy for non-Hodgkin lymphoma.",20815894_11,-1,1,-1,1,13160,-1,2.6345948e-05,0.9999571,1.6541444e-05
12890,T(reg,27,28,197,202,"In this model of CTLA-4-blockade-induced autoimmunity after allogeneic bone marrow transplantation, anti-CTLA-4-mAb gives rise to a progressive expansion - without a prior transient reduction - of T(reg) cells.",20600326_9,-1,1,-1,1,12890,-1,2.2441383e-05,0.99995923,1.8300303e-05
28096,the,20,21,119,122,The effect of DC vaccine on the accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and on the production of TGF- suggests that tumor regression by DC vaccination may be associated with an altered immunosuppressive tumor microenvironment.,26786094_8,-1,1,-1,1,28096,-1,1.8073642e-05,0.99997413,7.838783e-06
10173,to,7,8,53,55,"However, CCR4-mediated chemotaxis was not sufficient to produce metastasis, as tumor cells in the lung were efficiently eliminated by natural killer (NK) cells.",19567680_6,-1,1,-1,1,10173,-1,3.2257012e-05,0.99995697,1.0776981e-05
264,the,46,47,250,253,"We have established that in some cases of CLL the malignant cells express both CD40 and CD154, and on the basis of those observations, proposed a model for CLL tumor growth due to CD40-CD154 interactions within and among the malignant cells, and for the occurrence of autoimmune syndromes in some cases of CLL.",11042507_2,-1,1,-1,1,264,-1,1.827209e-05,0.9999728,8.852674e-06
16188,T(reg,1,2,7,12,"Canine T(reg) could be phenotypically characterized by CD4, CD25, and FOXP3 expression.",22041284_4,-1,1,-1,1,16188,-1,2.1414698e-05,0.99995744,2.1100617e-05
31357,These,0,1,0,5,These findings will pave a way to developing novel combinatorial therapies with PD-1 blockade.,28096382_5,-1,1,-1,1,31357,-1,2.1532194e-05,0.99996936,9.102682e-06
38249,Treg-exclusive,5,6,21,35,"However, CD25 is not Treg-exclusive and can be upregulated by effector T cells.",31811667_1,-1,1,-1,1,38249,-1,5.763521e-05,0.99989545,4.685687e-05
8936,tumors,18,19,113,119,"This study sheds new light on Treg physiology and validates CCR4/CCL22 and ICOS as therapeutic targets in breast tumors, which represent a major health problem.",19244125_7,-1,1,-1,1,8936,-1,1.7801722e-05,0.9999714,1.0769205e-05
26857,the,19,20,132,135,"Among these therapy-relevant stress pathways, Stat3(-/-) cancer cells manifested one significant improvement, namely an increase in the expression of multiple type-1 interferon-responsive genes, including that of the chemokines Cxcl9 and Cxcl10.",26208907_5,-1,1,-1,1,26857,-1,1.707687e-05,0.99997365,9.235264e-06
22135,the,2,3,8,11,"Many of the pathways revealed by this analysis are involved in other autoimmune diseases, and T cells from MG patients exhibit a Th1/Th17/Tfh signature.",24405842_7,-1,1,-1,1,22135,-1,2.409869e-05,0.99996483,1.1124194e-05
21620,the,7,8,53,56,"Therefore, the combination therapy strongly inclined the immune balance of the tumor microenvironment in an antitumor direction, leading to a marked systemic antitumor effect.",24289533_7,-1,1,-1,1,21620,-1,1.7864963e-05,0.9999738,8.3342065e-06
8498,NF-kappaB,18,19,109,118,Electrophoretic mobility-shift assay (EMSA) method was used to detect the activity of nuclear factor kappaB (NF-kappaB) in splenic T lymphocytes in each group at each time point post-inoculation.,19173904_4,-1,1,-1,1,8498,-1,3.301505e-05,0.9999505,1.6455722e-05
8954,This,0,1,0,4,This review will discuss our current knowledge in understanding the dynamics and plasticity of Foxp3+ Treg activation and induction in tumor bearing hosts and their interaction with various antigen presenting cells (APCs) in tumor microenvironment leading to the establishment of active local and systemic immune suppression.,19254475_4,-1,1,-1,1,8954,-1,2.308212e-05,0.999967,9.9235485e-06
9453,the,12,13,81,84,Lymphomas are extrahepatic manifestations of HCV infection; we sought to clarify the molecular mechanisms of these processes.,19362089_1,-1,1,-1,1,9453,-1,1.980045e-05,0.99997187,8.378243e-06
15479,tumor-escape,6,7,29,41,"In addition, the presence of tumor-escape mechanisms PD-L1/PD-1 pathway, FoxP3 and loss of HLA or melanocyte differentiation antigens, both required for tumor cell recognition and killing, were studied.",21750202_2,-1,1,-1,1,15479,-1,2.557132e-05,0.999964,1.0473092e-05
381,the,21,22,159,162,"Administration of anti-(interleukin-12) (anti-IL-12) and anti-(interferon gamma) (anti-IFNgamma) antibodies in tumor-bearing animals showed down-regulation of the expression of CD40L on NK and T cells with simultaneous inhibition of cytotoxic acitivity of NK cells, cytokine release and the production of antitumor antibody.",11129327_6,-1,1,-1,1,381,-1,1.6663382e-05,0.9999747,8.6525115e-06
3138,tolerance,2,3,15,24,"The peripheral tolerance mechanism prevents effective antitumor immunity, even though tumor cells possess recognizable tumor-associated Ags.",16210609_0,-1,1,-1,1,3138,-1,3.487937e-05,0.9999405,2.460794e-05
9047,the,6,7,55,58,Fludarabine lymphodepletion increased plasma levels of the homeostatic cytokines IL-7 and IL-15.,19270751_13,-1,1,-1,1,9047,-1,1.9943533e-05,0.99996996,1.0052388e-05
31170,through,7,8,44,51,So far the detailed mechanisms of antitumor through regulating DCs by MENK have not been elucidated yet.,28088065_1,-1,1,-1,1,31170,-1,2.4963161e-05,0.9999627,1.2350345e-05
37994,the,18,19,123,126,"Due to the cooperation of alginate and Tat peptide, Alg-Tat-gp100 demonstrated the significant improvement of stability in the stomach, mucus penetration ability in intestine, and transport across mucus layer and MDCK cells.",31655203_2,-1,1,-1,1,37994,-1,2.1864938e-05,0.99996555,1.2530533e-05
6076,the,6,7,35,38,"Furthermore, the dual APL elevated the proapoptotic markers caspases 3 and caspase 8, whereas it down-regulated the antiapoptotic marker Bcl-xL in both CD8(-/-) and WT mice.",17956982_7,-1,1,-1,1,6076,-1,1.666127e-05,0.9999738,9.597398e-06
7788,therapeutic,20,21,145,156,A better phenotypic and functional characterization of this regulatory T-cell subset could help in identifying modulators of their activity with therapeutic finalities.,18832002_1,-1,1,-1,1,7788,-1,2.5638474e-05,0.99996316,1.1223512e-05
41564,the,27,28,162,165,"Overall, Th17 cells and related transcription factors and cytokines in thymoma with MG patients were higher than those in thymoma patients, whereas, Tregs showed the opposite results, the mechanism may be that thymoma can secrete IL6 and IL21.",33636431_8,-1,1,-1,1,41564,-1,2.505238e-05,0.9999645,1.0505438e-05
15258,T-regs,20,21,148,154,"Circulating T-regs did not correlate with intrahepatic distribution of Foxp3.CONCLUSIONS: In chronic hepatitis C, selective expansion of peripheral T-regs in patients with normal aminotransferases and advanced disease suggests that, though a continual low level inflammation does not prevent liver disease progression, once cirrhosis has developed it may represent an attempt to prevent immuno-mediated decompensation.",21684822_9,-1,1,-1,1,15258,-1,3.169559e-05,0.9998989,6.9434434e-05
3595,NF-KB,20,21,147,152,"Future challenges are to render tumor cells sensitive to apoptosis by inhibiting specific signalling pathways such as the constitutively activated NF-KB pathway, to identify specific surface kinase receptors and to develop specific inhibitors, to develop humanized monoclonal antibodies directed against tumor specific antigens, able to kill tumor cells via complement-dependent and antibody-dependent cytotoxicity, and to stimulate innate immunity.",16457762_10,-1,1,-1,1,3595,-1,3.4544577e-05,0.9999448,2.070064e-05
28528,that,4,5,25,29,There are many molecules that define regulatory T cells (Tregs) phenotypically and functionally.,27095576_0,-1,1,-1,1,28528,-1,2.7161248e-05,0.9999573,1.5470523e-05
2100,the,4,5,18,21,"The other half of the patients showed impaired HPV16-specific proliferative responses, which generally lacked both IFN-gamma and interleukin 5.",15289354_5,-1,1,-1,1,2100,-1,1.8711005e-05,0.9999701,1.1171998e-05
26305,TGF-,16,17,104,109,"Taken together, the direct CD40-CD40L interaction of breast tumor cells and activated T cells increases TGF- production and the differentiation of Th17 cells, which promotes the proliferation of breast cancer cells.",25992978_5,-1,1,-1,1,26305,-1,3.5376062e-05,0.9999497,1.4968184e-05
8756,gene,1,2,6,10,"Using gene expression analysis, we found that human DCs increased the expression of TGF-beta1 transcripts following culture with human lung carcinoma cells (LCCs).",19234174_2,-1,1,-1,1,8756,-1,2.8745773e-05,0.9999523,1.8945335e-05
32037,Th2,15,16,99,102,It was demonstrated that ILC2s and MDSCs were clearly upregulated and accompanied by a predominant Th2 phenotype in patients with lung cancer; this may lead to new immunotherapy approaches for lung cancer based on the associated metabolites and cytokines.,28487978_8,-1,1,-1,1,32037,-1,4.1852727e-05,0.9999224,3.570457e-05
42218,than,8,9,59,63,"Moreover, the pEGFPN1IL17U87MG cells grew more rapidly than other cells.",33971545_10,-1,1,-1,1,42218,-1,3.1850544e-05,0.99993587,3.2310887e-05
22995,these,11,12,68,73,"Although the complete molecular mechanism has yet to be understood, these findings provide evidence linking tumor cell activities to immune system responses.",24676671_9,-1,1,-1,1,22995,-1,2.1775895e-05,0.99996936,8.829324e-06
22100,the,8,9,51,54,Defects in a suppressive assay can indicate either the defective function of Treg cells or the resistance of Tconv cells to suppression by Treg cells.,24405842_1,-1,1,-1,1,22100,-1,1.989908e-05,0.99997103,9.010043e-06
20700,The,0,1,0,3,"The expression of CCR6, CCR7 and their ligands mRNA (CCL20, CCL19/CCL21) as well as the CCR6 and CCR7 proteins were detected by real-time RT-PCR and immunohistochemistry (IHC), respectively.",23835793_2,-1,1,-1,1,20700,-1,1.7306294e-05,0.99997425,8.41059e-06
21367,the,18,19,114,117,"Compared with IL-2-CIK cells, the percentage of CD3CD56 cells was significantly increased in IL-15-CIK cells, but the expression of regulatory T (Treg) cells and IL-35 was significantly decreased in IL-15-CIK cells.",24145357_2,-1,1,-1,1,21367,-1,1.7878283e-05,0.9999733,8.808634e-06
23536,that,13,14,81,85,Our data provide new insight into the regulation of T-bet expression and suggest that ICOS can be targeted to improve Th1 antitumor responses.,24778280_10,-1,1,-1,1,23536,-1,1.839841e-05,0.9999739,7.689101e-06
40866,the,15,16,91,94,"However, these polarized Th cells can also adapt their function and phenotype depending on the changing cytokine environment, demonstrating functional plasticity.",33064842_1,-1,1,-1,1,40866,-1,2.812642e-05,0.99996233,9.495632e-06
38236,Tregs,15,16,100,105,"CONCLUSION: Blockage of p65 disinhibited miR-23a expression, leading to CCL22 reduction and repress Tregs recruitment.",31769216_16,-1,1,-1,1,38236,-1,2.824826e-05,0.99995327,1.8445166e-05
35952,the,16,17,93,96,"Thus, the aim of current study was to investigate the involvement of Notch-AhR-IL-22 axis in the pathogenesis of lung adenocarcinoma.",30473538_2,-1,1,-1,1,35952,-1,1.6515858e-05,0.9999751,8.433038e-06
31168,to,9,10,53,55,"MENK, an endogenous opioid peptide has been reported to have many immunological and antitumor activities.",28088065_0,-1,1,-1,1,31168,-1,3.3104814e-05,0.9999554,1.14971e-05
41898,STAT3,15,16,78,83,"In this study, we examined five cancer immunity-related pathways (IFN, IFN, STAT3, TGF and TNF) in four large independent breast cancer cohorts (n = 6,381) and their associations with the prognosis of breast cancer subtypes.",33767579_2,-1,1,-1,1,41898,-1,3.2637334e-05,0.9999472,2.0110769e-05
17220,the,3,4,19,22,"These data support the use of mRNA-electroporated LCs, or moDCs supplemented with exogenous rhuIL-15, as vaccines for cancer immunotherapy to break tolerance against self-differentiation antigens shared by tumors.",22510877_7,-1,1,-1,1,17220,-1,2.0284055e-05,0.9999714,8.30754e-06
41972,treatment,26,27,167,176,"Furthermore, microRNAs (miRNAs) as the posttranscriptional regulators of gene expression show considerable promise as a therapeutic target for colorectal cancer (CRC) treatment.",33821473_1,-1,1,-1,1,41972,-1,2.0208383e-05,0.9999665,1.3292473e-05
39825,tumors,17,18,93,99,"However, the cell sources of these factors are largely unknown, especially in the context of tumors.",32441311_4,-1,1,-1,1,39825,-1,2.1258396e-05,0.9999695,9.211618e-06
17904,NFATc2-knockout,10,11,76,91,Administration of hyper IL-6 abrogated protection from tumor progression in NFATc2-knockout mice and restored tumor incidence to control levels.,22738913_5,-1,1,-1,1,17904,-1,7.070847e-05,0.99987555,5.3676296e-05
10532,the,2,3,12,15,In addition the results indicated a significant increase in the proliferation of splenocytes and IFN-gamma production.,19706340_7,-1,1,-1,1,10532,-1,1.9091167e-05,0.99997187,9.020557e-06
20886,to,18,19,89,91,"As a result, the ratio of antigen-specific CD8+ T cells and MDSCs in tumors increased up to 85-fold compared to the control.",23922012_8,-1,1,-1,1,20886,-1,2.5962676e-05,0.99996054,1.34619895e-05
43284,that,7,8,43,47,We also demonstrate in a co-culture system that APLNR regulates tumor survival rate.,35084016_8,-1,1,-1,1,43284,-1,1.9621297e-05,0.9999713,9.055322e-06
26390,tumor,14,15,85,90,Blocking IFN or CXCR3 impairs the accumulation of STAT3-deficient CD8(+) T cells in tumor and their antitumor effects.,26025380_5,-1,1,-1,1,26390,-1,1.9453591e-05,0.99997044,1.0166406e-05
3131,T,18,19,124,125,Tumor cells are necessary and sufficient to convert DCs into regulatory cells that secrete bioactive TGF-beta and stimulate T reg cell proliferation.,16186184_4,-1,1,-1,1,3131,-1,3.4297427e-05,0.9999238,4.189416e-05
9399,This,0,1,0,4,This failure of the immune system has been associated both with glioma-derived immunosuppressive molecules and the immune-privileged state of the CNS.,19337997_1,-1,1,-1,1,9399,-1,2.1290616e-05,0.9999695,9.253881e-06
42993,therapies,12,13,86,95,These findings may have implications for the combination and timing of anti-oestrogen therapies with other therapies.,34602068_12,-1,1,-1,1,42993,-1,2.5678588e-05,0.9999616,1.270935e-05
14297,the,14,15,89,92,This study also supports our previous finding that IL-10 and IFN co-regulate IDO within the SLN.,21327637_18,-1,1,-1,1,14297,-1,1.7585939e-05,0.99997234,1.0128326e-05
15866,the,9,10,63,66,"Subsequently, we documented changes in colon tumorigenesis and the inflammatory microenvironment, i.e., local [mesenteric lymph node (MLN)] and systemic (spleen) T cell activation.",21940900_3,-1,1,-1,1,15866,-1,1.9899438e-05,0.9999709,9.18499e-06
37241,to,15,16,108,110,Conclusion: These findings demonstrate that 3DSNA is a promising neo-adjuvant that enables various vaccines to be therapeutic for many important diseases including cancer.,31244959_7,-1,1,-1,1,37241,-1,2.6865337e-05,0.9999616,1.1495242e-05
26026,tumour,37,38,218,224,"Here we focus on the impact of this inflammatory environment on T cells, and demonstrate that in contrast to successful tumour elimination in young mice, replenishment of tumour-specific CD4(+) T cells fails to induce tumour regression in aged hosts.",25850032_1,-1,1,-1,1,26026,-1,2.0259575e-05,0.9999702,9.584577e-06
13972,the,2,3,9,12,"However, the contribution of an NFAT1-/- microenvironment to tumor progression has not been studied.",21225259_2,-1,1,-1,1,13972,-1,1.9995852e-05,0.9999721,7.864706e-06
2820,to,28,29,155,157,"We have recently demonstrated that IL-27 has a potent antitumor activity, which is mainly mediated through CD8+ T cells, and also has an adjuvant activity to induce epitope-specific CTL in vivo.",16034109_1,-1,1,-1,1,2820,-1,2.452527e-05,0.99996376,1.1730412e-05
4893,Tregs,5,6,32,37,"Given the overall importance of Tregs, it is likely that they play an important role in diseases of dogs as well.",17224188_2,-1,1,-1,1,4893,-1,2.5836085e-05,0.99995744,1.67145e-05
39496,the,6,7,34,37,"We show now that CDDO-Me remodels the breast TME, redirecting TAM activation and T cell tumor infiltration in vivo.",32300202_3,-1,1,-1,1,39496,-1,1.8725288e-05,0.9999721,9.136122e-06
807,to,38,39,214,216,"Phosphorylation of pRb by cyclin-dependent kinase 6/4-cyclin D and of p130 did not occur and c-Myc, cyclin D3, and p107 were not induced, consistent with cell cycle inhibition early during the transition from G(0) to G(1).",11698483_10,-1,1,-1,1,807,-1,2.2083776e-05,0.9999633,1.4641321e-05
43690,the,7,8,50,53,"These receptor functions required the presence of the box 3 motifs, as shown by the analysis of the mouse IL-10R constructs containing progressively truncated cytoplasmic domains.",8662928_10,-1,1,-1,1,43690,-1,1.9400446e-05,0.9999708,9.806683e-06
3450,There,0,1,0,5,There were no differences within the tumors of the different treatment groups.,16361570_10,-1,1,-1,1,3450,-1,2.3705086e-05,0.9999641,1.2124278e-05
25238,TLR,14,15,86,89,"These cells constitutively or inducibly express a number of receptors of the TNFR and TLR families, whose signals are transduced by TNFR-associated factor (TRAF) molecules.",25422508_1,-1,1,-1,1,25238,-1,3.5294728e-05,0.9999205,4.4165223e-05
11307,the,13,14,84,87,"The administration of anti-CD25 mAb, which targets Treg cells, slightly potentiated the effect of vaccine IT (50% cure rate), but anti-CD4 mAb had a more potent effect leading to 80% cure rate.",20039320_3,-1,1,-1,1,11307,-1,2.1692462e-05,0.9999682,1.0104896e-05
11808,This,0,1,0,4,This vast existing local T-cell population is awaiting proper stimulation and can be exploited for the immunotherapy of cancer.,20233872_8,-1,1,-1,1,11808,-1,2.55816e-05,0.9999635,1.087304e-05
1725,the,1,2,3,6,"In the present study, we have evaluated the antitumor activity of IL-27 against a murine tumor model of colon carcinoma C26.",14871851_2,-1,1,-1,1,1725,-1,2.2890017e-05,0.99996567,1.1486039e-05
27082,the,3,4,23,26,"This review summarizes the features of TFH cells, including their development, function, and roles as well as TFH-associated molecules in neuroautoimmune diseases and their animal models.",26300592_5,-1,1,-1,1,27082,-1,2.0414873e-05,0.9999676,1.1969657e-05
33699,tumours,10,11,57,64,This effect may be a result of increased infiltration of tumours by CD4+ and CD8+ T cells.,29112686_10,-1,1,-1,1,33699,-1,2.268885e-05,0.9999646,1.27158855e-05
8892,that,9,10,70,74,"Immunohistochemical analysis of FOXP3 in primary breast tumors showed that a high number of tumor-infiltrating regulatory T cells (Ti-Treg) within lymphoid infiltrates surrounding the tumor was predictive of relapse and death, in contrast to those present within the tumor bed.",19244125_0,-1,1,-1,1,8892,-1,1.6461205e-05,0.99997354,1.0050372e-05
35065,therapeutic,23,24,147,158,"Hypoxia is reported to participate in tumor progression, promote drug resistance, and immune escape within tumor microenvironment, and thus impair therapeutic effects including the chemotherapy and advanced immunotherapy.",29882235_0,-1,1,-1,1,35065,-1,5.7153702e-05,0.9999223,2.061446e-05
11337,this,3,4,15,19,"The purpose of this study was to investigate immunological effector cells and angiogenesis in malignant pleural mesothelioma (MPM) patients, who underwent multimodality treatments.",20053697_0,-1,1,-1,1,11337,-1,2.106717e-05,0.9999684,1.0571096e-05
32352,that,4,5,30,34,"Repeated irradiation at doses that do not induce Trex1 amplifies interferon- production, resulting in recruitment and activation of Batf3-dependent dendritic cells.",28598415_4,-1,1,-1,1,32352,-1,4.9744933e-05,0.9999254,2.4818195e-05
23973,absent,27,28,143,149,We observed that an increase in the number of CD4(+) and CD8(+) T cells in the draining lymph nodes of IFN--treated tumor-bearing WT mice was absent in IFN- treated Stat2(-/-) mice.,24895110_8,-1,1,-1,1,23973,-1,9.9502824e-05,0.9998721,2.8437165e-05
38227,to,8,9,53,55,"Inhibition of p65 induced miR-23 expression, leading to less CCL22 expression and Tregs recruitment in vitro.",31769216_13,-1,1,-1,1,38227,-1,2.2212402e-05,0.99996674,1.103792e-05
4076,tumor,11,12,70,75,"To examine the role of Tregs in blocking immune-mediated rejection of tumor, we depleted CD4+CD25+ T cells with an IL-2 immunotoxin.",16785502_4,-1,1,-1,1,4076,-1,1.7246557e-05,0.9999738,9.022897e-06
24445,to,26,27,161,163,"We hypothesize that ""designer"" DCs expressing constitutively active IB kinases will prove highly immunogenic also in vivo and possibly emerge as a new strategy to improve the clinical efficacy of therapeutic vaccinations against cancer and other chronic diseases.",25100611_5,-1,1,-1,1,24445,-1,2.1847589e-05,0.99996996,8.159215e-06
9864,STAT5,8,9,56,61,"By phospho-specific flow cytometry, defective STAT1 and STAT5 activation in response to IL-2 was found mainly in T lymphocytes from peripheral blood and/or tumor site of American Joint Committee on Cancer stage III and IV patients, compared with stage I and II patients and to donors, and in melanoma antigen-specific T cells isolated from metastatic lymph nodes.",19509154_6,-1,1,-1,1,9864,-1,3.0572104e-05,0.99994314,2.633144e-05
14389,The,0,1,0,3,The CD8(+) T cells proliferated markedly after exposure to tumour protein in culture that was suppressed in the presence of CRC-derived Foxp3(+) IL-17(+) T cells; the suppression was attenuated by pretreatment with anti-IL-17 antibody.,21352252_8,-1,1,-1,1,14389,-1,1.5935602e-05,0.9999745,9.615334e-06
35000,the,16,17,74,77,"However, in contrast with SeV and poly I:C, rintatolimod did not activate the MAVS/helicase pathway, thus avoiding NFB- and TNF-dependent induction of COX2, COX2/PGE2-dependent induction of IDO, IL10, CCL22, and CXCL12, and eliminating Treg attraction.",29853604_3,-1,1,-1,1,35000,-1,1.856456e-05,0.99997187,9.5398445e-06
15257,T-regs,1,2,12,18,"Circulating T-regs did not correlate with intrahepatic distribution of Foxp3.CONCLUSIONS: In chronic hepatitis C, selective expansion of peripheral T-regs in patients with normal aminotransferases and advanced disease suggests that, though a continual low level inflammation does not prevent liver disease progression, once cirrhosis has developed it may represent an attempt to prevent immuno-mediated decompensation.",21684822_9,-1,1,-1,1,15257,-1,3.0671523e-05,0.9999025,6.684037e-05
16249,These,0,1,0,5,These results collectively illuminated unique contribution of oncogenic kinase-linked microRNA to tumorigenesis through modulation of tumor immune-phenotype and microenvironment.,22042699_8,-1,1,-1,1,16249,-1,1.9987192e-05,0.99996984,1.0154724e-05
22367,two,31,32,181,184,"Using a human CTL system model based on a CD8(+)/CD103(-) T cell clone specific of a lung tumor-associated Ag, we demonstrated that the transcription factors Smad2/3 and NFAT-1 are two critical regulators of this process.",24477908_3,-1,1,-1,1,22367,-1,5.3044936e-05,0.9999205,2.6419104e-05
24217,the,17,18,106,109,"Cancer cells may escape from host immune responses through active suppression of the immune response, but the detailed mechanisms in colorectal cancer remain to be elucidated.",25034363_0,-1,1,-1,1,24217,-1,1.8021243e-05,0.9999727,9.224244e-06
37529,to,27,28,179,181,Our results demonstrate for the first time that inhibition of EED modulates the tumor immune microenvironment to induce regression of colon tumors and therefore has the potential to be used in combination with immune-oncology therapy.,31395608_8,-1,1,-1,1,37529,-1,1.9543948e-05,0.99997234,8.092336e-06
8578,plays,1,2,7,12,Notch1 plays a critical role in the differentiation from SOCS3-transfected BMCs to CD8(+) T cells.,19190337_4,-1,1,-1,1,8578,-1,2.6523476e-05,0.9999609,1.2620842e-05
19130,generate,4,5,28,36,CCL2 and LCN2 cooperatively generate immunoregulatory dendritic cells (DCreg) having suppressive activity accompanied by lowered expression of costimulatory molecules such as HLA-DR but increased expression of immunosuppressive molecules such as PD-L1 in human PBMCs.,23143679_6,-1,1,-1,1,19130,-1,2.3734749e-05,0.9999634,1.285362e-05
8471,to,44,45,257,259,"However, Treg cocultured with CD4(+) RC suppressed proliferation independently of Fas/FasL. In cocultures, Treg were found to be resistant to apoptosis in the presence of 1000 IU/ml IL-2, but at lower IL-2 concentrations (150 IU/ml) they became susceptible to RC-induced death.",19155494_7,-1,1,-1,1,8471,-1,2.09994e-05,0.99996793,1.1110223e-05
6833,the,15,16,108,111,Previous mouse and clinical studies demonstrate a link between Th2 intestinal inflammation and induction of the effector phase of food allergy.,18378796_0,-1,1,-1,1,6833,-1,1.8044684e-05,0.99997365,8.2632705e-06
43079,that,14,15,99,103,"Thus, we identify a crosstalk between KG, mitochondrial metabolism and triacylglyceride synthesis that controls Treg fate.",34731632_6,-1,1,-1,1,43079,-1,2.2207762e-05,0.99996674,1.1094868e-05
40944,Foxp3,10,11,60,65,"However, there were no significant differences in IL-10 and Foxp3 mRNA levels between patients in complete remission and healthy controls.",33083479_12,-1,1,-1,1,40944,-1,2.9763949e-05,0.9999522,1.8055589e-05
14201,that,3,4,14,18,We also found that about 4.8-11.2% Foxp3(+) IL-17(+) T cells in isolated CD4(+) T cells from Eca tissue that were significantly less than in non-ca tissue derived CD4(+) T cells.,21314287_8,-1,1,-1,1,14201,-1,1.7507075e-05,0.99997056,1.1915957e-05
21693,Tregs,9,10,51,56,"RESULTS: The density of liver infiltrated FoxP3(+) Tregs was increased in a stepwise manner from CHB to AH then HCC, while there was a decreasing trend for the density of IL-17(+) T cells and CD8(+) T cells.",24303990_4,-1,1,-1,1,21693,-1,2.1304199e-05,0.9999616,1.7119435e-05
14837,the,9,10,53,56,METHODS: The frequencies of CD4(+)Foxp3(+) Tregs and the level of transforming growth factor-1 (TGF-1) were analyzed from 56 patients with gastric cancer by flow cytometry and enzyme-linked immunosorbent assay respectively.,21528082_1,-1,1,-1,1,14837,-1,1.7377275e-05,0.9999732,9.500582e-06
41619,Tfh,5,6,27,30,"T follicular helper cells (Tfh) are involved in the formation and maintenance of germinal centres, the differentiation of B cells into plasma cells, and the maintenance of helper T cell type 2 (Th2)-dominant humoral immune responses.",33647861_1,-1,1,-1,1,41619,-1,2.2046992e-05,0.9999604,1.7559216e-05
13003,that,3,4,14,18,We also found that L. casei-PgsA-E6-induced antitumor effect was decreased by in vivo depletion of CD4(+) or CD8(+) T cells.,20706715_6,-1,1,-1,1,13003,-1,1.8285702e-05,0.99997354,8.206356e-06
6478,trials,17,18,89,95,Here we report the effects of systemic IL-21 therapy on the immune system in two phase 1 trials with this novel cytokine.,18286285_1,-1,1,-1,1,6478,-1,2.4640349e-05,0.9999597,1.5667752e-05
28336,tumor,11,12,74,79,"Our results demonstrate that driving T cell-intrinsic NF-B can result in tumor control, thus identifying a pathway with potential clinical applicability.",26903482_8,-1,1,-1,1,28336,-1,2.0007043e-05,0.9999708,9.219118e-06
22627,to,3,4,23,25,The mechanisms leading to iNKT cell anergy remain poorly understood.,24532578_3,-1,1,-1,1,22627,-1,2.7288697e-05,0.99995995,1.2732863e-05
31058,tolerance,2,3,21,30,Tumor-induced immune tolerance poses a major challenge for therapeutic interventions aimed to manage cancer.,28052005_0,-1,1,-1,1,31058,-1,2.5946885e-05,0.9999597,1.4386042e-05
11893,that,9,10,49,53,"Collectively from these two models, it was clear that CD8(+) T cells and natural killer cells played an important role downstream of Treg depletion.",20332236_4,-1,1,-1,1,11893,-1,1.931719e-05,0.9999713,9.3651415e-06
42382,the,14,15,67,70,"The presence or absence, in particular, of cytotoxic CD8+ cells in the vicinity of the main tumor mass, is able to predict, respectively, the success or failure of drug therapy.",34070750_4,-1,1,-1,1,42382,-1,2.011697e-05,0.9999703,9.603491e-06
24976,this,1,2,3,7,"In this chapter, we summarize the current understanding and recent progresses on the Th17 lineage differentiation and its effector impacts on variety of inflammatory responses or disease pathogenesis.",25261206_3,-1,1,-1,1,24976,-1,3.24856e-05,0.99995077,1.6733704e-05
6419,TILs,14,15,80,84,"The authors investigated the frequency of Foxp3(+) Tregs within CD4(+) cells in TILs, regional lymph nodes and PBLs of gastric cancer patients (n = 45).",18224687_2,-1,1,-1,1,6419,-1,2.3391107e-05,0.9999627,1.3868872e-05
43236,This,0,1,0,4,"This secretory pathway is composed of chemokines, cytokines, growth factors, and proteases.",35017504_2,-1,1,-1,1,43236,-1,2.464326e-05,0.99996233,1.3080822e-05
2184,two-sided,4,5,27,36,All statistical tests were two-sided.,15339971_4,-1,1,-1,1,2184,-1,0.0002098527,0.9996501,0.0001400003
13461,T(FH,4,5,30,34,"Moreover, purified FL-derived T(FH), expressed IL4 at very high levels compared with purified tonsil-derived T(FH) or non-T(FH) microenvironment.",20944673_7,-1,1,-1,1,13461,-1,4.1619947e-05,0.99990106,5.7346257e-05
30973,Th2,3,4,15,18,We confirmed a Th2 predisposition with a mean GATA3/T-bet ratio of 5.51.,28005163_5,-1,1,-1,1,30973,-1,3.5550558e-05,0.99993885,2.554976e-05
18631,therapeutic,26,27,163,174,The evidence for their ability to act as natural adjuvant in the stimulation of specific anti-tumor cytotoxic T lymphocytes and in the induction of protective and therapeutic anti-tumor immunity is now overwhelming.,23000301_4,-1,1,-1,1,18631,-1,3.2160642e-05,0.9999566,1.1210484e-05
2336,to,19,20,144,146,"However, CD154 treatment of carcinoma cells expressing proteasome-dependent but TAP-independent Ags from the EBV-encoded BRLF1 and BMLF1 failed to increase tumor cell lysis by specific CTLs.",15611226_5,-1,1,-1,1,2336,-1,2.275601e-05,0.99996686,1.0349191e-05
38124,The,2,3,13,16,"CONCLUSIONS: The correlation of IS and CMS allows a more precise categorisation of patients with relevant clinical and biological implications, which may be valuable tools to improve tailored therapeutic interventions in CRC patients.",31678770_10,-1,1,-1,1,38124,-1,1.8486486e-05,0.99997365,7.801863e-06
37393,to,7,8,63,65,"Loss-of-function and gain-of-function studies were carried out to analyze the effects of CCL22 modulations on cell proliferation, migration, invasion, and tumorigenesis and the mechanism involved in the deregulation of CCL22.",31325403_3,-1,1,-1,1,37393,-1,1.7470882e-05,0.9999734,9.120464e-06
28932,therapeutic,19,20,133,144,Future clinical trials using small molecules to target this newly identified signaling pathway may facilitate the development of new therapeutic approaches to better suppress bladder cancer metastasis.,27196763_7,-1,1,-1,1,28932,-1,2.512404e-05,0.99996364,1.1181787e-05
8249,tumor,20,21,160,165,"Adoptive transfer of WT CD4(+)CD25(+) T-regulatory cells provided significant protection of Smad3/Rag2-DKO from bacterial-induced typhlocolitis, dysplasia, and tumor development, whereas Smad3(-/-) T-regulatory cells provided no protection.",19119184_4,-1,1,-1,1,8249,-1,2.5158377e-05,0.9999628,1.201913e-05
11179,The,0,1,0,3,"The frequency of Foxp3(+) T-regs in TILs was significantly higher than that in the normal esophageal mucosa (24.6 +/- 10.0 vs 7.1 +/- 5.9%, P < 0.01).",20002703_6,-1,1,-1,1,11179,-1,1.6032067e-05,0.9999757,8.22885e-06
10338,GATA-3,47,48,265,271,"However, neither in the expression of T-bet and GATA-3, nor in the plasma level of IFN-gamma and IL-4, showed a significant difference between group A and B.CONCLUSION: In the peripheral blood of esophageal cancer patients, the expression of T-bet decreased, while GATA-3 increased, Th1/Th2 balance is broken, and the Th2 is dominant.",19615257_5,-1,1,-1,1,10338,-1,5.0800343e-05,0.99989235,5.680358e-05
37496,Tregs,9,10,62,67,"CONCLUSION: The lack of host leukocyte-derived IL-30 inhibits Tregs expansion, promotes intra-tumoral infiltration of CD4+T lymphocytes and cancer cell apoptosis.",31366386_10,-1,1,-1,1,37496,-1,2.5700449e-05,0.9999571,1.7238459e-05
38861,the,16,17,97,100,"Our results, therefore, suggest that modifying N-glycosylation of T cells with 2DG could improve the efficacy of T cell-based immunotherapies against cancer.",31969386_6,-1,1,-1,1,38861,-1,1.8434168e-05,0.9999739,7.626187e-06
724,to,4,5,22,24,These CTL were unable to recognize HLA-A*0201(+) HPV16 E6(+) cervical carcinoma cell lines even when the level of endogenous HPV16 E6 in these cells was increased by transfection.,11673561_4,-1,1,-1,1,724,-1,2.0416242e-05,0.99996984,9.782976e-06
6296,to,9,10,53,55,"As relatively few cells in the vaccine were expected to have incorporated cDNA fragments specifying breast cancer antigens (most specify normal cellular constituents), an enrichment strategy was employed to increase the proportion of immunotherapeutic cells.",18157008_3,-1,1,-1,1,6296,-1,2.9930157e-05,0.9999591,1.1009324e-05
24732,These,0,1,0,5,"These data show an immune modulated microenvironment within the normal involuting mammary gland suggestive of immunosuppression, that when targeted reduces tumor promotion, revealing possible immune-based strategies for postpartum breast cancer.",25187059_9,-1,1,-1,1,24732,-1,1.9914318e-05,0.9999697,1.0378061e-05
12365,The,16,17,111,114,"Indirect immunohistochemistry was used to evaluate the expression of cytokines, chemokines, and FoxP3.RESULTS: The inflammatory infiltrate mainly consisted of mononuclear cells.",20478453_4,-1,1,-1,1,12365,-1,1.8347173e-05,0.9999708,1.0818465e-05
5793,that,5,6,38,42,"PURPOSE: Immunosuppression, including that mediated by CD4(+)CD25(high)Foxp3(+) regulatory T cells (Treg), is a characteristic feature of head and neck squamous cell carcinoma (HNSCC).",17671115_0,-1,1,-1,1,5793,-1,3.2383683e-05,0.9999461,2.1492038e-05
38207,to,4,5,36,38,Dual-luciferase assay was performed to determine relationship of miR-23a/CCL22 and p65/miR-23a.,31769216_5,-1,1,-1,1,38207,-1,1.7624036e-05,0.99997246,9.890507e-06
37599,targeted,13,14,86,94,The programmed cell death 1/programmed cell death 1 ligand 1 pathway was successfully targeted in cancer immunotherapy.,31432577_0,-1,1,-1,1,37599,-1,2.4142046e-05,0.9999646,1.1242576e-05
3034,the,29,30,170,173,"Disruption of TGF-beta signaling in T cells impairs the maintenance of regulatory T cells, results in the expansion of activated effector T cells, and is associated with the production of cytokines that have major effects on cells in their environment.",16123803_3,-1,1,-1,1,3034,-1,1.950403e-05,0.9999715,8.996095e-06
19410,the,29,30,196,199,"These Ph(+) putative CML hemangioblast upregulated TGF-1 and resultantly activated matrix metalloproteinase-9 (MMP-9) to enhance s-KitL and s-ICAM-1 secretion, which activated c-kit(+) HSCs from the quiescent state to proliferative state.",23180012_7,-1,1,-1,1,19410,-1,1.987345e-05,0.9999678,1.2326169e-05
36655,The,0,1,0,3,"The castration-resistant PCa cell lines-C4-2 and CWR22RV1, and CD4+ T-cell lines-HH and Molt-3 were used in the coculture system.",31018021_5,-1,1,-1,1,36655,-1,1.9114905e-05,0.999969,1.1861336e-05
12875,the,7,8,45,48,The T(reg) expansion occurred selectively in the recipient-derived CD4+ T-cell compartment.,20600326_6,-1,1,-1,1,12875,-1,1.710274e-05,0.999974,8.851538e-06
17517,tumors,23,24,160,166,"Together, our findings suggest the feasibility of exploiting NF-B hyperactivation in the tumor microenvironment to selectively enhance T(eff) entry into colon tumors.",22593190_9,-1,1,-1,1,17517,-1,2.0300968e-05,0.9999695,1.02719805e-05
3265,this,1,2,3,7,"In this study, we show that similar to IFN-gamma-/- mice, JNK1-/- mice are highly susceptible to tumor development after inoculation of both melanoma cell line B16 and lymphoma cell line EL-4.",16237070_2,-1,1,-1,1,3265,-1,2.0156634e-05,0.99996877,1.111198e-05
10655,complexes,44,45,265,274,"Towards this end, a cationic tat-sequence was fused with an antigenic, major histocompatibility complex (MHC) class I-binding melanoma epitope (Melan-A/Mart-1 sequence: ELAGIGILTV) and then mixed with negatively charged poly(I:C) dsRNA to form peptide/nucleic acid complexes.",19758325_2,-1,1,-1,1,10655,-1,0.00011539405,0.9996605,0.00022407917
1662,the,25,26,132,135,The T-box transcription factor T-bet (Tbx21) plays a critical role in the development of type 1 helper T cells and is essential for the production of IFN-gamma.,14744755_1,-1,1,-1,1,1662,-1,2.0985226e-05,0.9999709,8.084826e-06
11292,these,19,20,135,140,"However, imatinib and sunitinib did induce secretion of anti-inflammatory IL-10 in macrophage cultures, indicating that treatment with these inhibitors might contribute to an immune suppressive microenvironment in GIST.",20013807_8,-1,1,-1,1,11292,-1,2.4788116e-05,0.9999621,1.308374e-05
17699,the,29,30,212,215,"In this study, to further investigate the regulatory effect of IL-12 on HBx-mediated intervention of hepatoma microenvironment especially on intervention of neovessels and immune microenvironment, we constructed the recombinant adenovirus expressing HBx and mouse IL-12 named Ad-HBx-mIL-12.",22710287_3,-1,1,-1,1,17699,-1,1.7361683e-05,0.9999739,8.731576e-06
2436,their,18,19,125,130,"More than 60% of STAT6(-/-) mice immunologically reject spontaneous metastatic mammary carcinoma and survive indefinitely if their primary tumors are removed, whereas 95% of STAT6-competent BALB/c mice succumb to metastatic disease.",15634881_0,-1,1,-1,1,2436,-1,3.0941923e-05,0.9999566,1.249081e-05
23829,to,13,14,96,98,This study sought to advance development of LPC-targeted therapies by exploring nongenetic ways to slow the decay and to increase the immunogenicity of primary CD34(+) AML cells.,24855276_4,-1,1,-1,1,23829,-1,1.8752082e-05,0.99997234,8.897665e-06
3710,STAT6,18,19,125,130,"We also asked the role of interleukin (IL)-4 receptor alpha (IL-4Ralpha)-signal transducer and activator of transcription 6 (STAT6) signaling, including IL-13, and transforming growth factor beta (TGF-beta) by using gene-disrupted mice or treating mice with cytokine antagonists.",16585215_4,-1,1,-1,1,3710,-1,2.7053416e-05,0.99995327,1.9628695e-05
18168,Thus,0,1,0,4,"Thus, we have identified an innate immune pathway intrinsic to breast cancer cells, the suppression of which restricts immunosurveillance to enable metastasis.",22820642_6,-1,1,-1,1,18168,-1,2.378904e-05,0.9999651,1.1171027e-05
21089,FoxP3,2,3,18,23,Both intratumoral FoxP3+ and IL-17+ cells correlated with nodal metastasis and TNM stage.,24007242_4,-1,1,-1,1,21089,-1,4.1394007e-05,0.9999374,2.1209398e-05
38938,namely,16,17,91,97,"BACKGROUND: Urothelial bladder cancers (UBCs) are distinct in two main molecular subtypes, namely basal and luminal type.",31991796_0,-1,1,-1,1,38938,-1,2.668514e-05,0.99996066,1.2609327e-05
35708,Th17,27,28,170,174,"The proportion of CD4+CD25+Foxp3+ regulatory T cells was significantly lower in PCOS patients than that of healthy fertile women (P=0.02).CONCLUSION: In summary, Th1 and Th17 bias and reduction of Treg and Th2 cells as regulators of immune responses might be involved in the pathogenesis of PCOS.",30246693_8,-1,1,-1,1,35708,-1,3.6817954e-05,0.999941,2.2203549e-05
26912,Thus,0,1,0,4,"Thus, our findings showed that CCL5/CCR3 signaling promotes metastasis by inducing Th2 polarization of CD4 T cells, with implications for prognosis and immunotherapy of luminal breast cancer.",26249173_5,-1,1,-1,1,26912,-1,2.5105039e-05,0.9999633,1.157133e-05
22025,to,8,9,54,56,The Th17/Tc17 and Th17/Treg ratios were also observed to change significantly.,24388919_8,-1,1,-1,1,22025,-1,2.470753e-05,0.9999654,9.831511e-06
10825,the,10,11,69,72,"In mouse melanoma transplantation models, Treg depletion resulted in the stimulation of antitumor immune responses and tumor eradication.",19841169_1,-1,1,-1,1,10825,-1,1.9743966e-05,0.9999722,7.992262e-06
38917,tumor,3,4,15,20,Lactic acid in tumor microenvironment reduces expression of PPAR in intratumoral iNKT cells and consequently diminishes their cholesterol synthesis and IFN- production.,31974378_3,-1,1,-1,1,38917,-1,1.9089459e-05,0.9999721,8.798482e-06
33636,the,1,2,11,14,Disrupting the immune network can be a supplementary therapeutic approach for NMIBC patients receiving intravesical BCG.,29048388_9,-1,1,-1,1,33636,-1,2.2944647e-05,0.99996626,1.0747891e-05
39619,to,8,9,52,54,"Nevertheless, a substantial number of patients fail to respond to checkpoint pathway blockade.",32332858_1,-1,1,-1,1,39619,-1,2.2410413e-05,0.99996483,1.2709464e-05
15889,relatively,23,24,146,156,Protein vaccines may be a useful strategy for cancer immunotherapy because recombinant tumor antigen proteins can be produced on a large scale at relatively low cost and have been shown to be safe for clinical application.,21945963_0,-1,1,-1,1,15889,-1,2.8478724e-05,0.9999591,1.2453351e-05
37483,tumor,28,29,205,210,"IL-30 knockdown in PC-SLCs reduced cancer cell proliferation, vascularization and intra-tumoral Indoleamine 2,3-Dioxygenase (IDO)+CD11b+Gr-1+ myeloid-derived cells (MDCs) and led to a significant delay in tumor growth and increase in survival.",31366386_6,-1,1,-1,1,37483,-1,1.8165707e-05,0.999972,9.866225e-06
19705,IRF-8,7,8,30,35,"Here, we analyzed the role of IRF-8 in the cross talk between melanoma cells and tumor-infiltrating leukocytes.",23308054_1,-1,1,-1,1,19705,-1,2.8012273e-05,0.9999546,1.7415623e-05
24102,tumor,18,19,125,130,Photodynamic therapy (PDT) by selective photosensitization of cancer cells and subsequent laser application results in local tumor necrosis.,25005268_0,-1,1,-1,1,24102,-1,2.3628438e-05,0.9999651,1.1242152e-05
43246,tumor,6,7,46,51,"Mechanistically, we show that Gata4-dependent tumor suppression requires cytotoxic CD8 T cells and partially requires the secreted chemokine CCL2.",35017504_5,-1,1,-1,1,43246,-1,1.9289395e-05,0.9999714,9.321153e-06
39384,Thus,0,1,0,4,"Thus, peripheral blood expression of T cell exhaustion markers does not distinguish between responders and non-responders to anti-PD-1 therapy.",32210968_10,-1,1,-1,1,39384,-1,2.6089252e-05,0.9999622,1.1643058e-05
31496,the,14,15,76,79,"In order to address this question, we first used mRNA sequencing to compare the immunophenotype of the TNBC cell line MDA-MB-231 and the luminal breast cancer cell line MCF7 after both were cocultured with activated human T cells.",28264810_2,-1,1,-1,1,31496,-1,1.5684263e-05,0.99997723,7.036083e-06
4960,tumors,19,20,127,133,Fluorescence-activated cell sorter (FACS) analysis of the composition of lung leukocytes further indicates that the removal of tumors also leads to the reduction of MSCs accumulated in the lung.,17244679_4,-1,1,-1,1,4960,-1,2.1557418e-05,0.99996805,1.0427887e-05
8308,The,0,1,0,3,The concomitant expression of Treg cell markers suggests a possible suppression of the Th1 response in granulomas.,19121066_8,-1,1,-1,1,8308,-1,1.8393315e-05,0.99997354,8.044961e-06
18652,these,3,4,15,20,"In conclusion, these mechanisms acting in hepatocellular carcinoma may be necessary to better understand the immunosuppression of Tregs and helpful to the tumor immunotherapy.",23000301_8,-1,1,-1,1,18652,-1,2.2590732e-05,0.99996805,9.414434e-06
29754,T-MDSCs,3,4,23,30,TAF-treated monocytes (T-MDSCs) then impaired T-cell proliferation and altered the phenotype and/or function of T-cells in an STAT3-dependent manner.,27593937_6,-1,1,-1,1,29754,-1,4.622452e-05,0.9999114,4.229363e-05
22844,regulation,14,15,90,100,The fact that cancer can survive in this adverse microenvironment is indicative of immune regulation.,24623740_3,-1,1,-1,1,22844,-1,3.386198e-05,0.9999428,2.3354598e-05
40871,to,3,4,17,19,"While being able to shift phenotype within their lineage, Th17 cells can also acquire characteristics of Th1, Th2, T follicular helper (Tfh) or regulatory T cells.",33064842_3,-1,1,-1,1,40871,-1,1.9844127e-05,0.99996936,1.074977e-05
29535,RelB,17,18,108,112,"Mechanistically, dectin-1 activates Syk, Raf1 and NF-B signalling pathways, resulting in increased p50 and RelB nuclear translocation and TNFSF15 and OX40L expression.",27492902_5,-1,1,-1,1,29535,-1,3.41501e-05,0.999943,2.2814203e-05
42251,that,6,7,24,28,"RESULTS: Here, we found that cross-presentation of tumor antigens in the steady state was DNGR-1-independent.",33980589_6,-1,1,-1,1,42251,-1,1.8497438e-05,0.99997365,7.834012e-06
15914,tumor,26,27,149,154,"Therefore, we demonstrated that vaccine with a mixture of TAT-CEA fusion protein and poly(I:C) can induce anti-tumor immunity in a murine colorectal tumor model.",21945963_6,-1,1,-1,1,15914,-1,1.96941e-05,0.99996984,1.0449628e-05
21480,Nanog,10,11,59,64,"In this study, we investigated the role of hypoxia-induced Nanog, a stemness-associated transcription factor, in immune suppression.",24227785_1,-1,1,-1,1,21480,-1,3.5954967e-05,0.99993765,2.634041e-05
13806,To,3,4,21,23,"EXPERIMENTAL DESIGN: To date, the most specific marker for human Tregs is demethylation in the DNA that encodes the transcription factor FOXP3.",21177412_2,-1,1,-1,1,13806,-1,2.4337896e-05,0.9999639,1.1746499e-05
35606,the,5,6,27,30,"To investigate the role of the NLRP3 inflammasome in MM, we determined the genetic polymorphisms and expression of NLRP3 inflammasome-related genes (IL-1, IL-18, CARD8, and NF-B) in MM patients, and explored their clinical relevance.",30211233_1,-1,1,-1,1,35606,-1,1.50144415e-05,0.9999759,9.116087e-06
42052,Tim-3,20,21,148,153,"Foxp3+Treg cells display phenotypic and functional heterogeneity, which express high levels of T cell immunoglobulin and mucin-domain containing-3 (Tim-3) in the tumor microenvironment (TME) of colorectal and lung cancer.",33864956_0,-1,1,-1,1,42052,-1,2.605987e-05,0.99995875,1.5152246e-05
39467,the,11,12,84,87,"Furthermore, overexpression of C-FOXP3 activated the luciferase reporter gene under the control of the PD-L1 promoter.",32300119_6,-1,1,-1,1,39467,-1,1.9137038e-05,0.9999714,9.432952e-06
27785,the,9,10,50,53,"Most human colorectal cancers (CRCs) develop from the preformed adenomas, this study is therefore designed to evaluate forkhead box P3 (FoxP3)+ Tregs in human colorectal adenomas.",26724144_1,-1,1,-1,1,27785,-1,1.7882941e-05,0.9999716,1.0463168e-05
11416,MITF-M,23,24,167,173,We report that melanoma cell lines expressing the interleukin-1 receptor exhibit 4- to 10-fold lower levels of mRNA of microphthalmia-associated transcription factor (MITF-M) when treated with interleukin-1beta.,20099279_0,-1,1,-1,1,11416,-1,3.2816755e-05,0.9999478,1.941399e-05
10718,Treg,21,22,125,129,Twenty-four patients with CTCL and 14 patients with GVHD were included to assess the relative numbers of regulatory T cells (Treg) and any change in the serum cytokine profile during 6 months of ECP therapy.,19773201_2,-1,1,-1,1,10718,-1,2.1091006e-05,0.99996626,1.2651363e-05
34819,this,3,4,15,19,The purpose of this study is to investigate whether extract of frankincense and myrrh (FM) downregulates inflammatory microenvironment of HCC and thereby restores antitumor immune responses.,29784005_3,-1,1,-1,1,34819,-1,1.9511435e-05,0.9999697,1.0767083e-05
34354,that,21,22,139,143,"The decrease of this IFN gene expression signature was associated with more aggressive disease in human colon cancer patients, suggesting that lack of IL33 signaling impaired the generation of a potent IFN-mediated antitumor immune response.",29463593_10,-1,1,-1,1,34354,-1,2.0260877e-05,0.9999716,8.125893e-06
28499,These,0,1,0,5,These results suggested that FoxO1 played an important role in regulating asbestos-induced apoptosis and confirmed the presence of multiple pathways regulating resistance to asbestos in MT-2Rst cells.,27042963_7,-1,1,-1,1,28499,-1,1.9973988e-05,0.99996996,1.006386e-05
221,IRF4,0,1,0,4,IRF4 expression was then correlated with cytogenetic response to IFN-alpha.,11013272_4,-1,1,-1,1,221,-1,2.2274327e-05,0.99995553,2.2243992e-05
13955,treatment,19,20,142,151,"However, no correlation was found between the ratio of CD4+IL-10+T-cell percentages and that of CD4+Foxp3+T-cell percentages after/before PSK treatment.",21224532_4,-1,1,-1,1,13955,-1,2.186243e-05,0.9999653,1.2807929e-05
8722,the,1,2,3,6,"At the final time points examined (tumor morbidity or 40 dpi), there was an increase in the frequency of TAMs with decreased capacity to secrete TNF-alpha.",19226468_8,-1,1,-1,1,8722,-1,1.882474e-05,0.99997056,1.0579833e-05
8077,Tregs,4,5,20,25,Regulatory T cells (Tregs) play an important role in protection against autoimmune disease and are also known to be potent inhibitors of anti-tumor immune responses.,19022624_0,-1,1,-1,1,8077,-1,2.2884287e-05,0.99996614,1.0981237e-05
22091,Foxp3(+,12,13,61,68,"In the different status of HPV16 type DNA, the expression of Foxp3(+) was closely correlated with Federation International of Gynecology and Obstetrics (FIGO) stage, histological grade and lymphnode metastasis (P < 0.05) except for age (P > 0.05).CONCLUSION: Treg cytokines, HPV16 integration rate and severity of cervical lesions are positively correlated while Th17 cytokines show opposite effects.",24401583_7,-1,1,-1,1,22091,-1,0.000108406064,0.999808,8.3584644e-05
11288,the,16,17,103,106,"Most metastatic GISTs had been treated with the tyrosine kinase inhibitors imatinib and sunitinib, but the high macrophage infiltrate was not related to this treatment.",20013807_7,-1,1,-1,1,11288,-1,1.928682e-05,0.99997044,1.0276626e-05
10056,Foxp3,18,19,105,110,"Compared with CD25(-) gammadelta T cells, TGF-beta induced CD25(+) gammadelta T cells not only expressed Foxp3, but also had increased TGF-beta and GITR expression.",19539651_6,-1,1,-1,1,10056,-1,2.3903565e-05,0.9999641,1.1927455e-05
23848,Tim-3,10,11,63,68,"RepSox also accelerated loss of T cell immunoglobulin mucin-3 (Tim-3), an immune checkpoint receptor that impairs antitumor immunity, from the surface of AML and MDS cells.",24855276_8,-1,1,-1,1,23848,-1,3.3589113e-05,0.9999496,1.6836662e-05
33542,to,6,7,49,51,"Sixty Sprague-Dawley rats were randomly assigned to four equal groups: the control group (control group), the cancer model group (model group), and the F1 and F2 groups, which were fed fucoidan at concentrations of 200 and 400mg/kgbody weight, respectively.",29043842_2,-1,1,-1,1,33542,-1,2.1675556e-05,0.9999658,1.257441e-05
20042,Treg,11,12,73,77,The absence of DNAM-1 promoted the expansion and suppressive function of Treg after BMT.,23430112_6,-1,1,-1,1,20042,-1,2.3284923e-05,0.999961,1.5704214e-05
36026,the,21,22,114,117,"The median survival of 88 patients with high intratumoral CCL1 expression was 37months compared to 50months for the 87 patients with low CCL1 levels, this trend was however not statistically significant.",30572845_9,-1,1,-1,1,36026,-1,1.8429633e-05,0.9999691,1.24695425e-05
16712,these,2,3,14,19,"Collectively, these findings show how Gal-1 functions as a major glycome determinant regulating Th cell development, inflammation, and tumor immunity.",22345665_4,-1,1,-1,1,16712,-1,2.3030609e-05,0.99996626,1.069559e-05
4304,the,17,18,109,112,"The results show that the i.t. injection of the AdCDIRESE1A chemotherapy sensitization vector, which encodes the cytosine deaminase chemotherapy sensitization transcription unit, to the i.t. injection of Ad-sig-ecdCD40L vector-infected dendritic cells increased the level of suppression of the growth of the CCL-51 breast cancer cells.",16928818_6,-1,1,-1,1,4304,-1,2.080983e-05,0.99996805,1.1113606e-05
40391,to,3,4,15,17,This was found to be the same in vitro and in vivo.,32661685_3,-1,1,-1,1,40391,-1,2.9294595e-05,0.9999589,1.187054e-05
24885,trials,26,27,163,169,"In summary, our data suggest that GEP might be a powerful tool for the prediction of immunosuppression and the monitoring of immune responses within immunotherapy trials.",25242680_5,-1,1,-1,1,24885,-1,2.8775781e-05,0.99995613,1.5041919e-05
12274,this,5,6,30,34,"Like the normal components of this lymphoid structure, FL cells interact with various immune cells, such as the follicular helper T cells, suppressor regulatory T cells, dendritic cells, and histiocytes, that define the tumor microenvironment.",20425464_1,-1,1,-1,1,12274,-1,2.8536648e-05,0.9999492,2.218703e-05
33524,to,9,10,50,52,Full separation of GVL activity from GVHD has yet to be achieved.,29038366_2,-1,1,-1,1,33524,-1,3.436216e-05,0.9999536,1.198937e-05
22814,generated,1,2,5,14,"Data generated from this study support that NLGP is effective in preventing the SLTCL induced generation (CD68(+)CD206(+)IL-10(high) to CD68(+)CD206(-)IL-10(low) TAMs) and functions (NO(low) to NO(high), MHC-I(low) to MHC-I(high), CD80(low) to CD80(high)) of pro-tumorous M2 macrophages, which in turn associated with sustained anti-tumor effector functions by promoting cytotoxic T cell activities and suppressing regulatory T cells.",24607970_2,-1,1,-1,1,22814,-1,2.4760066e-05,0.9999608,1.4403711e-05
33201,This,0,1,0,4,"This result also indicates that NK cell proliferation, activation, and accumulation are under the control of regulatory T cells.",28891726_10,-1,1,-1,1,33201,-1,2.3259736e-05,0.9999658,1.094581e-05
30199,TILs,28,29,197,201,Our findings represent a novel immunosuppressive function of TGF and demonstrate that TGF1 allows tumors to evade host immune responses in part through enhanced SMAD3-mediated PD-1 expression on TILs.,27683557_6,-1,1,-1,1,30199,-1,2.247728e-05,0.99996686,1.0703279e-05
14812,There,0,1,0,5,"There was a tendency for luminal cancers to show CXCL12 expression (102/138, 74%) compared to basal-like cancers (16/27, 59%), which verged on statistical significance (P = 0.050).",21521526_7,-1,1,-1,1,14812,-1,1.9889847e-05,0.9999685,1.1529796e-05
17255,the,2,3,9,12,"While in the 5-FU+BLTA group, the inhibition of tumor growth was more significant, with increased T lymphocyte proliferation and IFN-production of spleen cells.",22522606_9,-1,1,-1,1,17255,-1,1.7810551e-05,0.9999714,1.085013e-05
20958,the,2,3,14,17,"Disruption of the POSH/JIP-1 complex led to profound defects in the activation of JNK1, as well as deficient activation or induction of the transcription factors c-Jun, T-bet, and Eomesodermin.",23963642_5,-1,1,-1,1,20958,-1,1.5432532e-05,0.9999752,9.338948e-06
28318,this,10,11,75,79,We hypothesized that forcing T cell-intrinsic NF-B activation might break this cycle and induce tumor elimination.,26903482_4,-1,1,-1,1,28318,-1,2.8253839e-05,0.99995816,1.3546881e-05
43516,the,1,2,3,6,"In the present study we demonstrate that IL-10 is expressed and produced spontaneously in the peripheral blood mononuclear cells (PBMCs) of all HIV-1 infected individuals tested, 3 of 19 cases of HIV-negative lymphoma and none of five healthy controls.",8037735_1,-1,1,-1,1,43516,-1,1.8749379e-05,0.9999713,1.0016706e-05
12177,tested,2,3,10,16,We herein tested whether these effects can translate into effective cancer immunotherapy when SA-4-1BBL was also used as a vehicle to deliver TAAs in vivo to dendritic cells (DCs) constitutively expressing the 4-1BB receptor.,20406989_3,-1,1,-1,1,12177,-1,2.0286947e-05,0.9999709,8.784838e-06
4923,these,3,4,17,22,We conclude from these studies that a cross-reactive FoxP3 antibody can be used to identify Tregs in dogs and that this reagent may serve as a useful tool for investigating the role of Treg in a variety of diseases of dogs.,17224188_10,-1,1,-1,1,4923,-1,1.8915667e-05,0.99997115,9.912467e-06
17734,The,0,1,0,3,The suppressive function of CD8(+)Foxp3(+) T lymphocytes was analyzed by their effect on CD4(+) T-cell proliferation and IFN- production.,22729557_4,-1,1,-1,1,17734,-1,1.7501545e-05,0.99997413,8.35466e-06
37907,TH,33,34,212,214,"HDAC6 binds and deacetylates cytosolic FoxO1 at K242, which is required for its nuclear translocation and stabilization to repress retinoic acid-related orphan receptor gamma (RoRt), the transcription factor of TH 17 cell.",31539182_5,-1,1,-1,1,37907,-1,6.266371e-05,0.9997594,0.00017796378
16219,these,8,9,50,55,"However, the underlying molecular mechanism(s) of these aberrant immune-phenotypes is largely unknown.",22042699_1,-1,1,-1,1,16219,-1,2.2120244e-05,0.9999672,1.068189e-05
9695,TC-1,43,44,232,236,"In this study, we tested the function of a novel soluble form of 4-1BB ligand (4-1BBL) costimulatory molecule in modulating innate, adaptive, and regulatory immunity and assessed its therapeutic efficacy in the HPV-16 E7-expressing TC-1 cervical cancer and survivin-expressing 3LL lung carcinoma mouse models.",19435920_3,-1,1,-1,1,9695,-1,2.672747e-05,0.9999368,3.6497466e-05
17452,that,5,6,33,37,"Collectively, these results show that in humans, a large proportion of CD4(+) memory T cells express intermediate levels of CD25, and this CD25(INT) FOXP3(-) subset is a functionally distinct memory population that is uniquely affected by IL-2.",22585674_5,-1,1,-1,1,17452,-1,1.7509588e-05,0.9999721,1.0349621e-05
7460,plaque,26,27,189,195,Immunohistochemical analysis of the CTCL tissues revealed that FOXP3-expressing cells were common among the CD7-negative enlarged atypical and small lymphocytes at the early skin patch and plaque stages.,18684941_5,-1,1,-1,1,7460,-1,3.7948445e-05,0.9999343,2.7675382e-05
37040,their,18,19,108,113,"Plasmacytoid dendritic cells (pDCs) are present in various primary and metastatic human neoplasms; however, their clinical significance in hepatocellular carcinoma (HCC) is unclear.",31201473_0,-1,1,-1,1,37040,-1,2.3617698e-05,0.9999653,1.101374e-05
8645,the,32,33,174,177,"From cancerous and non-cancerous patients, we derived stable clones of CD4(+) Treg, defined as clones that expressed high CD25 at rest, were anergic in vitro, and suppressed the proliferation of co-cultured CD4(+) cells.",19224638_0,-1,1,-1,1,8645,-1,1.7974542e-05,0.9999739,8.142294e-06
16111,tumor,13,14,90,95,Absence of IL-21 reduced signal transducer and activator of transcription 3 activation in tumor and stromal cells.,21987656_5,-1,1,-1,1,16111,-1,2.1343267e-05,0.99996746,1.12193875e-05
34391,to,27,28,215,217,"Our data demonstrate that Y-traps counteract TGF-mediated differentiation of Tregs and immune tolerance, thereby providing a potentially more effective immunotherapeutic strategy against cancers that are resistant to current immune checkpoint inhibitors.",29467463_5,-1,1,-1,1,34391,-1,2.5027945e-05,0.9999634,1.1527802e-05
40571,to,26,27,173,175,"Moreover, GA effectively restricted advanced stage solid tumor while used in combination with Mycobacterium indicus pranii, a known immunomodulator, which alone is reported to be ineffective to restrict advanced stage solid tumor.",32890791_8,-1,1,-1,1,40571,-1,3.9857183e-05,0.9999467,1.3455771e-05
5634,that,32,33,220,224,"We found that HPV16 E6-reactive T cells reside preferentially within the CD45RA+ CCR7+ T-cell subpopulation of tumor-infiltrating lymphocyte, peripheral blood lymphocyte, and T-LN in cervical cancer patients, suggesting that successful immune surveillance of HPV16+ tumor cells in cervical cancer patients is impaired.",17589293_5,-1,1,-1,1,5634,-1,1.9015582e-05,0.9999732,7.784972e-06
42978,the,5,6,39,42,Treatment with endocrine therapy using the aromatase inhibitor letrozole increases CD4+ T cell infiltration into ER+ breast cancer tumours in immune competent mice.,34602068_10,-1,1,-1,1,42978,-1,2.155249e-05,0.9999702,8.278805e-06
18213,there,3,4,13,18,"In addition, there is an association of T-cell large granular lymphocytic leukemia with rheumatoid arthritis.",22830400_2,-1,1,-1,1,18213,-1,2.6888902e-05,0.9999629,1.02159065e-05
11884,Treg,7,8,50,54,"Although different strategies to deplete FoxP3(+) Treg have been used, no study has systematically compared these qualitatively for the effector mechanisms they each liberate.",20332236_2,-1,1,-1,1,11884,-1,2.2484111e-05,0.99996173,1.581199e-05
7865,tumor,12,13,77,82,Depletion of CD4(+)CD25(+) Tregs can promote host local immunity to suppress tumor growth.,18855977_12,-1,1,-1,1,7865,-1,1.8381716e-05,0.99997294,8.719178e-06
26593,to,9,10,64,66,"We previously reported that interleukin-22 (IL-22) participates to aGVHD development, but the underlying mechanisms of its contribution remain poorly understood.",26153763_1,-1,1,-1,1,26593,-1,3.0191692e-05,0.99995697,1.2842804e-05
13998,tumor,23,24,188,193,Bone marrow chimera experiments meant to differentiate the contributions of stromal and infiltrating cells to tumor progression demonstrated that NFAT1-induced susceptibility to pulmonary tumor growth depends on NFAT1-expressing parenchyma rather than on bone marrow-derived cells.,21225259_8,-1,1,-1,1,13998,-1,1.9942088e-05,0.99996805,1.1947971e-05
29054,that,4,5,48,52,"Chromatin immunoprecipitation analysis revealed that Bhlhe40 accumulates in the T-box region of the Ifng locus and contributes to histone H3-lysine 9 acetylation of the Ifng locus, which is impaired without T-bet conditions.",27226296_7,-1,1,-1,1,29054,-1,1.7274295e-05,0.99997187,1.0909401e-05
20944,this,8,9,54,58,The JNK pathway is critically important in regulating this process.,23963642_1,-1,1,-1,1,20944,-1,2.7036147e-05,0.9999585,1.4475781e-05
11456,tumor-specific,3,4,33,47,Adoptive immunotherapy involving tumor-specific CD4(+) T cells has shown encouraging clinical benefits in some cancer patients.,20118405_1,-1,1,-1,1,11456,-1,2.7123893e-05,0.99996006,1.2832291e-05
43532,that,4,5,26,30,We have also demonstrated that rhIL-10 inhibited HIV-1 replication in infected monocytes and PBMCs in a dose dependent manner.,8037735_5,-1,1,-1,1,43532,-1,1.8630579e-05,0.99997306,8.303878e-06
31729,tumors,32,33,200,206,"In this study, we demonstrated that CXCR5+CD8+ T cells were very rare in peripheral blood mononuclear cells from healthy and colorectal cancer individuals, but were significantly enriched in resected tumors and tumor-associated lymph nodes.",28412245_2,-1,1,-1,1,31729,-1,2.27243e-05,0.99996376,1.35633745e-05
25034,Tregs,7,8,48,53,"The in vitro immunosuppressive activity of LAP Tregs, exerted via a transforming growth factor--mediated mechanism, was more potent than that of LAP Tregs.",25268580_6,-1,1,-1,1,25034,-1,1.8931321e-05,0.9999676,1.3551169e-05
11454,the,14,15,85,88,The functional development of tumor-specific CD4(+) T cells has a critical impact on the outcome of antitumor immune responses.,20118405_0,-1,1,-1,1,11454,-1,2.1468586e-05,0.9999701,8.424965e-06
19289,that,3,4,20,24,"It was demonstrated that anti-YB-1 CD8(+) T-cell responses could be induced by AGN2a immunization, and the strongest CD8(+) T-cell responses against AGN2a were induced by YB-1-immunized mice in the context of Treg depletion compared with YB-1 only immunization group and control group.",23169344_5,-1,1,-1,1,19289,-1,1.6222819e-05,0.9999752,8.531833e-06
23930,therapeutic,11,12,73,84,Our study identifies a mechanism by which these strategies could provide therapeutic benefit.,24893628_8,-1,1,-1,1,23930,-1,2.3214434e-05,0.9999666,1.0122474e-05
36742,treated,35,36,218,225,"These patients also showed impaired signal transducer and activator of transcription-1 (STAT1) signaling upon stimulation with IL-6 and phorbol 12-myristate 13-acetate (PMA), and T-Cells from a healthy donor that were treated for four days with IL-6 displayed a similar muting of STAT signaling, which verified the effect seen in patient samples.",31027698_7,-1,1,-1,1,36742,-1,2.8864819e-05,0.99995565,1.5435231e-05
29570,The,0,1,0,3,"The objective of the present study was to explore the impact of IL-17 on the in vivo differentiation of Th9 cells in relation to Th2 cells in a murine model of MPE, and to explore whether IL-17 inhibits MPE formation via IL-9dependent mechanism.",27535421_2,-1,1,-1,1,29570,-1,1.9252362e-05,0.99997234,8.40448e-06
38580,the,3,4,26,29,"Upregulated chemokines in the RUNX3-overexpressed cell line were determined by quantitative real-time polymerase chain reaction, western blot, and enzyme-linked immunosorbent assay.",31898342_5,-1,1,-1,1,38580,-1,1.7789944e-05,0.99997044,1.1761317e-05
27024,the,24,25,168,171,"T cell stimulation via glucocorticoid-induced tumor necrosis factor receptor (TNFR)-related protein (GITR) elicits antitumor activity in various tumor models; however, the underlying mechanism of action remains unclear.",26280119_0,-1,1,-1,1,27024,-1,2.0391162e-05,0.99997175,7.890185e-06
506,the,12,13,70,73,We used the Cre-loxP system to generate a T cell-specific deletion of the Pten gene (Pten(flox/-) mice).,11371355_1,-1,1,-1,1,506,-1,1.7367813e-05,0.9999721,1.0492471e-05
42634,signal transducer and activator of transcription 1,34,41,167,217,"DFP also noticeably enhances the expression of T helper (TH) cell 1 specific interferon-gamma (IFNG), interleukin 12 (IL12), T-Box Transcription Factor 21 (TBX21) and signal transducer and activator of transcription 1 (STAT1) genes.",34190692_8,-1,1,-1,1,42634,-1,3.2383792e-05,0.9999398,2.7758797e-05
2788,the,8,9,55,58,Paracrine production of IL-4 in vaccine sites promoted the accumulation and maturation of IL-12p70-secreting tumor-infiltrating dendritic cells (TIDCs).,15905564_3,-1,1,-1,1,2788,-1,1.6974542e-05,0.9999753,7.684261e-06
21191,status,23,24,152,158,"When these mice were intravenously injected with KGF, the thymic microenvironment, thymopoiesis, and T-cell differentiation all returned to near normal status.",24051497_7,-1,1,-1,1,21191,-1,4.774428e-05,0.99992037,3.1869342e-05
35452,tumour-associated,6,7,34,51,"Thus, increasing the knowledge of tumour-associated immunological processes is important.",30075815_4,-1,1,-1,1,35452,-1,2.721502e-05,0.99996185,1.0907378e-05
23492,Tregs,28,29,164,169,"Importantly, the frequency of CD45RA-Foxp3high Tregs positively correlate with tumor stage (P <0.0001) and nodal status (P <0.0001).CONCLUSIONS: CD45RA-Foxp3high Tregs increase in the peripheral circulation of HNSCC patients, and correlate with tumor stage and nodal status; suggesting a role in tumor progression which may be manipulated by future immunotherapy.",24761979_8,-1,1,-1,1,23492,-1,2.1164644e-05,0.9999622,1.6670994e-05
33254,type,45,46,284,288,"The antitumor effectiveness of cyclophosphamide (CTX) and other chemotherapeutics was shown to rely not only on direct cytotoxicity but also on immunogenic tumor cell death and systemic immunomodulatory mechanisms, including regulatory T cell (Treg) depletion, Th1 cell polarization, type I interferon (IFN) and proinflammatory cytokine production.",28975621_0,-1,1,-1,1,33254,-1,5.0098846e-05,0.9999032,4.6689154e-05
988,natural,3,4,19,26,"Similarly, several natural defence mechanisms kill melanoma by the same pathways.",11905805_1,-1,1,-1,1,988,-1,0.0005706492,0.9993759,5.3468044e-05
1177,NFATc2,24,25,152,158,"A mechanism for the compromised immune response is suggested by the observation that CnA beta(-/-) T cells are defective in stimulation-induced NFATc1, NFATc2, and NFATc3 activation.",12091710_7,-1,1,-1,1,1177,-1,0.00010722057,0.9998385,5.4279717e-05
32622,Stat6,0,1,0,5,Stat6 also appears to promote expansion of myeloid-derived suppressor cells (MDSCs) cells.,28654863_2,-1,1,-1,1,32622,-1,4.0256975e-05,0.9999299,2.9788045e-05
19186,the,12,13,69,72,"Taken together, these results shed light on the mechanistic basis of the SA-4-1BBL/SVN subunit vaccine formulation in a lung carcinoma model and demonstrate the robust therapeutic efficacy of the prime-boost immunization strategy with important clinical implications.",23144888_8,-1,1,-1,1,19186,-1,1.7234346e-05,0.9999739,8.913544e-06
28855,T,3,4,18,19,FoxP3+ regulatory T (Treg) cells have diverse functions in the suppression of antitumor immunity.,27177223_0,-1,1,-1,1,28855,-1,2.5057227e-05,0.999951,2.390633e-05
22380,Tregs,9,10,53,58,"With opposite immune activities, regulatory T cells (Tregs) and IL-17 producing T cells were accumulated in various malignant tumors and played critical roles in pathophysiologic course of these diseases.",24487033_0,-1,1,-1,1,22380,-1,2.0901674e-05,0.9999678,1.12836215e-05
7722,their,9,10,63,68,"TLR7 agonists neutralized both of these strategies, supporting their use in SCCs and other tumors with similar immune defects.",18794336_9,-1,1,-1,1,7722,-1,2.292503e-05,0.99996734,9.742051e-06
27076,TFH-associated,23,24,149,163,"A balance of TFH cell generation and function is critical for protective antibody response, whereas overactivation of TFH cells or overexpression of TFH-associated molecules may result in autoimmune diseases.",26300592_3,-1,1,-1,1,27076,-1,4.0745566e-05,0.9999317,2.750932e-05
20268,the,24,25,137,140,"METHODS: In this study, we established an MHC class II molecule-expressing murine colon cancer cell line (CT26-CIITA) by transduction of the CIITA gene.",23621273_1,-1,1,-1,1,20268,-1,1.8026602e-05,0.9999726,9.407153e-06
22075,the,56,57,333,336,"The concentrations of Th17/Treg cell-associated cytokines were detected by enzyme-linked immunosorbent assay (ELISA).RESULTS: Under the same status of HPV16 DNA in vivo, the levels of Foxp3(+), transforming growth factor- (TGF-) and interleukin-10 (IL-10) were significantly higher than those of the control group (P < 0.01) while the levels of interleukin-17 (IL-17) and interleukin-21 (IL-21)were significantly lower than those of the control group (P < 0.05) .",24401583_5,-1,1,-1,1,22075,-1,1.69499e-05,0.99997234,1.0744359e-05
3637,tumor,31,32,213,218,"Furthermore, injection of induced macrophages promoted tumor growth accompanied by immunosuppression in the rat tumor models, but injection of induced macrophages transfected with Stat3 decoy ODNs led to retarded tumor growth accompanied by immune activation.",16530087_5,-1,1,-1,1,3637,-1,2.0249412e-05,0.99996734,1.2402702e-05
11649,therapeutic,11,12,43,54,"In a tumor model for cervical cancer (C3), therapeutic vaccination led to complete eradication in 100% of the mice.",20145549_3,-1,1,-1,1,11649,-1,2.2858447e-05,0.99996734,9.858335e-06
38355,relevant,2,3,9,17,The most relevant patents concerning the use of flavones and other polyphenols were revised.,31814545_8,-1,1,-1,1,38355,-1,3.8954884e-05,0.9999393,2.1774515e-05
20540,Twenty-one,2,3,9,19,METHODS: Twenty-one patients were entered onto our vaccination protocol using autologous DCs pulsed with autologous tumor lysate and keyhole limpet hemocyanin.,23725550_3,-1,1,-1,1,20540,-1,2.8163837e-05,0.9999509,2.0985808e-05
10691,therapeutic,19,20,128,139,"Although PBL from all patients showed elevated MUC1 cytolytic activity following therapy, such responses did not correlate with therapeutic efficacy.",19762283_4,-1,1,-1,1,10691,-1,2.6459258e-05,0.9999629,1.0619114e-05
27500,the,16,17,111,114,"CD4+/CD25+ Treg cells exert immune suppressing functions in BCL via regulating cytokines, thereby facilitating the pathogenesis and progression of lymphoma.",26464657_11,-1,1,-1,1,27500,-1,1.9686464e-05,0.999969,1.1346676e-05
38337,through,5,6,48,55,"Some flavonoids exert anti-inflammatory effects through: Blockade of NF-B, and NLRP3 inflammasome, inhibition of pro-inflammatory cytokine production, IL-1, IL-2, IL-6, TNF-, IL-17A, down regulation of chemokines, and reduction of reactive oxygen and nitrogen species.",31814545_4,-1,1,-1,1,38337,-1,2.3881168e-05,0.9999604,1.5639072e-05
35574,These,2,3,13,18,"CONCLUSIONS: These results demonstrate that induction of pSTAT3, reduced suppressive function, and a paradoxical increase in Treg proliferation are novel correlates of patient benefit from PD-1 blockade.",30131384_10,-1,1,-1,1,35574,-1,1.9637691e-05,0.9999701,1.0290803e-05
22637,to,9,10,55,57,"Deficiency of TSC1 in iNKT cells results in resistance to -GalCer-induced anergy, manifested by increased expansion of and cytokine production by iNKT cells in response to secondary Ag stimulation.",24532578_5,-1,1,-1,1,22637,-1,2.3872726e-05,0.9999654,1.0647188e-05
6067,Torpedo,21,22,112,119,"Moreover, the dual APL did not inhibit the secretion of IFN-gamma by LN cells from CD8(-/-) mice immunized with Torpedo acetylcholine receptor.",17956982_5,-1,1,-1,1,6067,-1,4.099385e-05,0.9999385,2.056076e-05
3473,transcription,7,8,47,60,"The seven signal transducers and activators of transcription (STAT) act as signaling components between the plasma membrane and the nucleus, and as transcription factors with specific DNA binding ability in the nucleus.",16375697_1,-1,1,-1,1,3473,-1,3.3594217e-05,0.99994504,2.1337293e-05
23926,tract,24,25,178,183,Our results indicate that intramuscular CRT/E7 vaccination in conjunction with intravaginal imiquimod deposition recruits antigen-specific CXCR3(+) CD8(+) T cells to the genital tract.,24893628_6,-1,1,-1,1,23926,-1,3.9910887e-05,0.9999323,2.7748292e-05
19661,transcription factor,8,10,29,49,Forkhead box P3 (FOXP3) is a transcription factor necessary for the function of regulatory T cells (T(reg) cells).,23252899_0,-1,1,-1,1,19661,-1,2.593689e-05,0.9999567,1.7336914e-05
23088,the,2,3,9,12,"However, the efficacy of DC-mediated cancer vaccines is still limited as they are unable to sufficiently break the immune tolerance.",24690994_1,-1,1,-1,1,23088,-1,2.1894548e-05,0.9999703,7.818118e-06
3543,The,0,1,0,3,The predominance of IL-10 production indicated that regulatory T cells directly participate in modulating the anti-tumor immune response.,16391798_7,-1,1,-1,1,3543,-1,1.7975042e-05,0.999974,8.069529e-06
30991,tumor,7,8,35,40,"The role of IL-33, particularly in tumor growth and tumor immunity, remains ill-defined.",28011934_0,-1,1,-1,1,30991,-1,2.2898585e-05,0.999967,1.0072788e-05
7536,the,6,7,36,39,"The likely explanation for this was the NS3/4A-mediated cleavage of mouse IPS-1, albeit less efficiently than human IPS-1.",18689426_9,-1,1,-1,1,7536,-1,2.056404e-05,0.99997115,8.254625e-06
14054,there,23,24,136,141,In periphery there was an increase at the effector immune response (as depicted by IFN--producing cells) and in tumor development site there was an increase at the suppressor cell (CD11b+Gr-1+) phenotype.,21238620_10,-1,1,-1,1,14054,-1,2.5196863e-05,0.99996066,1.418105e-05
37912,These,2,3,13,18,"CONCLUSIONS: These results demonstrate that targeting the cytosolic HDAC6-FoxO1 axis reprograms the pathogenicity and antitumor response of TH 17 cells in HCC, with a pathogenicity-driven responsiveness to facilitate immunotherapies.",31539182_7,-1,1,-1,1,37912,-1,2.0900783e-05,0.99996805,1.1028275e-05
16251,tumor,15,16,134,139,These results collectively illuminated unique contribution of oncogenic kinase-linked microRNA to tumorigenesis through modulation of tumor immune-phenotype and microenvironment.,22042699_8,-1,1,-1,1,16251,-1,1.9847505e-05,0.99996984,1.0265904e-05
4391,The,0,1,0,3,The production of IFN-gamma secreted by the spleen cells from CD40L/OVHM and OVHM cell-inoculated mice co-cultured with 20 Gy-irridiated OVHM cells were measured with enzyme-linked immunosorbent assay (ELISA).RESULTS: Expression of CD40L in OVHM/CD40L cells was significantly higher than that in OVHM cells (P<0.05).,16965650_7,-1,1,-1,1,4391,-1,1.7103835e-05,0.9999751,7.800995e-06
10046,that,2,3,9,13,We found that freshly isolated mouse splenic gammadelta T cells did not express Foxp3.,19539651_4,-1,1,-1,1,10046,-1,1.9794617e-05,0.9999701,1.014283e-05
15320,their,25,26,156,161,"Foxp3(+) regulatory T cells play a pivotal role in maintaining immune homeostasis and, importantly, preventing immune reactivity to self-antigens; however, their suppressive activity can compromise an effective antitumor immune response, and high frequencies of regulatory T cells in peripheral blood have been reported in both hematologic and solid cancers.",21708889_2,-1,1,-1,1,15320,-1,1.940632e-05,0.9999703,1.03017155e-05
4112,treatment,2,3,8,17,"A 5-day treatment with the anti-IL-2 mAb alone gradually increased the CD44(high)CD8+ population, and the increased population was maintained for >300 days, suggesting that the mAb can gradually maintain and potentially enhance the bioactivity of endogenous IL-2 for extended periods.",16785526_4,-1,1,-1,1,4112,-1,2.2564667e-05,0.99996567,1.1800123e-05
16115,the,15,16,94,97,Administration of a neutralizing IL-21 antibody to WT mice after the last DSS cycle decreased the colonic T cell infiltrate and the production of IL-6 and IL-17A and reduced the number of tumors.,21987656_6,-1,1,-1,1,16115,-1,1.677794e-05,0.9999739,9.2854825e-06
23832,the,20,21,130,133,This study sought to advance development of LPC-targeted therapies by exploring nongenetic ways to slow the decay and to increase the immunogenicity of primary CD34(+) AML cells.,24855276_4,-1,1,-1,1,23832,-1,1.7554848e-05,0.99997485,7.651699e-06
33540,to,4,5,24,26,"This study was designed to evaluate the protective and immunomodulatory effects of dietary fucoidan on 7,12-dimethyl benz[a]anthracene (DMBA)-induced experimental mammary carcinogenesis in rats.",29043842_1,-1,1,-1,1,33540,-1,1.7354281e-05,0.9999738,8.846582e-06
32897,treated,10,11,42,49,"In this study, a group of LC patients was treated with curcumin.",28731226_4,-1,1,-1,1,32897,-1,2.2469498e-05,0.9999658,1.1690264e-05
5572,to,22,23,147,149,"Supernatant cytokines were determined by ELISA.RESULTS: Normal PBMCs exposed to MCM revealed higher proportions of T(reg) cells than those exposed to control media after 6 days (3.4% versus 1.3%, respectively, P < 0.02).",17574040_6,-1,1,-1,1,5572,-1,2.4782594e-05,0.9999614,1.3891265e-05
2779,the,6,7,44,47,"To gain additional mechanistic insight into the efficacy of this approach, we have treated mice bearing the MCA205 (H-2(b)) or CMS-4 (H-2(d)) sarcomas.",15905564_1,-1,1,-1,1,2779,-1,1.9030726e-05,0.9999738,7.242251e-06
9765,Tregs,28,29,154,159,"In addition, Tregs inhibited the proliferation of TCR-stimulated (primed) CD4(+) T cells and nave CD8(+) T cells after TCR-mediated activation, however, Tregs with OX40 costimulation lost their suppressive function.",19455675_6,-1,1,-1,1,9765,-1,1.9645979e-05,0.9999685,1.1881233e-05
39495,that,3,4,12,16,"We show now that CDDO-Me remodels the breast TME, redirecting TAM activation and T cell tumor infiltration in vivo.",32300202_3,-1,1,-1,1,39495,-1,1.9866444e-05,0.9999709,9.275417e-06
13548,tumor,11,12,82,87,Increased survivin-specific CD8(+) T cells that specifically recognized the Pan02 tumor line were seen in mice treated with MVA-survivin and gemcitabine.,20960189_11,-1,1,-1,1,13548,-1,1.9245348e-05,0.99996936,1.1402752e-05
38926,tumor-infiltrating,19,20,129,147,"Importantly, PPAR agonist pioglitazone, a thiazolidinedione drug for type 2 diabetes, successfully restores IFN- production in tumor-infiltrating iNKT cells from both human patients and mouse models.",31974378_4,-1,1,-1,1,38926,-1,4.9417555e-05,0.99991906,3.1506726e-05
25537,tolerance,32,33,249,258,Our findings indicate that the use of inhibitory molecules notably directed against HMGB1 in cervical/vulvar (pre)neoplastic lesions might prevent alterations of pDCs functionality and represent an attractive therapeutic strategy to overcome immune tolerance in cancers.,25492101_10,-1,1,-1,1,25537,-1,2.6761843e-05,0.9999614,1.1867423e-05
6558,state,11,12,66,71,ICOShigh Treg induce Tr1 or Th2 cells depending on the activation state of RC.,18292519_10,-1,1,-1,1,6558,-1,3.1335676e-05,0.99994564,2.2966768e-05
27110,Tregs,21,22,115,120,"BACKGROUND: In myasthenia gravis (MG) patients, the dysfunction of CD4(+)CD25(+) regulatory T cells (CD4(+)CD25(+) Tregs) may be one of the important pathogenesis of MG.",26347149_0,-1,1,-1,1,27110,-1,2.6403886e-05,0.9999566,1.6986383e-05
4506,treatment,65,66,245,254,"P-STAT5 was detected within a subset of normal donor CD4(+) T cells (52.2 +/- 15.0%), CD8(+) T cells (57.6 +/- 25.8%), and CD56(+) natural killer (NK) cells (54.2 +/- 27.2%), but not CD14(+) monocytes or CD21(+) B cells, following in vitro IL-2 treatment.",17020993_8,-1,1,-1,1,4506,-1,2.6703798e-05,0.9999567,1.6612974e-05
40347,the,14,15,87,90,"One such enzyme is lysine-specific histone demethylase 1 (LSD1/KDM1A), which regulates the chromatin landscape and gene expression by demethylating proteins such as histone H3.",32649682_3,-1,1,-1,1,40347,-1,1.7481698e-05,0.99997246,1.0079935e-05
20959,complex,4,5,29,36,"Disruption of the POSH/JIP-1 complex led to profound defects in the activation of JNK1, as well as deficient activation or induction of the transcription factors c-Jun, T-bet, and Eomesodermin.",23963642_5,-1,1,-1,1,20959,-1,2.672614e-05,0.9999434,2.994019e-05
16864,FOXP3,21,22,139,144,"Distinct Treg subsets were phenotypically identified by the expression of CD4, CD25, CD127 and forkhead/winged helix transcription factor (FOXP3).",22419479_4,-1,1,-1,1,16864,-1,1.9914605e-05,0.99996984,1.02988515e-05
32646,regulation,17,18,99,109,"Stat6 also promoted expansion of MDSCs in the spleen and lamina propria of ApcMin/+ mice, implying regulation of antitumor T-cell response.",28654863_9,-1,1,-1,1,32646,-1,2.73296e-05,0.999949,2.3725876e-05
34892,TGF-,0,1,0,5,TGF- and IL-10 concentrations were measured using human TGF-1 and IL-10 ELISA kit.,29785404_4,-1,1,-1,1,34892,-1,2.8649896e-05,0.99995303,1.836719e-05
41850,these,33,34,203,208,The evidence of IDO1 involvement in NB immune escape and its ability to impair NK and GD2.CAR T-cell activity contribute to clarify one of the possible mechanisms responsible for the limited efficacy of these immunotherapeutic approaches.,33737337_12,-1,1,-1,1,41850,-1,2.2917247e-05,0.9999672,9.863092e-06
22721,to,19,20,135,137,"Signaling transduction, proliferation and cytokine production are profoundly decreased in these cells, and they are highly susceptible to apoptosis.",24569779_7,-1,1,-1,1,22721,-1,3.167078e-05,0.99995136,1.6928188e-05
31522,this,1,2,7,11,"Within this context, hypoxia was shown to inhibit but also to promote T cell responses.",28278498_1,-1,1,-1,1,31522,-1,2.4039788e-05,0.99996674,9.17722e-06
12939,the,2,3,15,18,"Unfortunately, the need for multiple administrations of antigens often limits the use of one of the most effective vaccine approaches, immunogene therapy using viral vectors, because neutralizing antibodies are rapidly produced.",20683443_1,-1,1,-1,1,12939,-1,2.7805123e-05,0.99996316,8.997857e-06
18094,the,2,3,7,10,One of the mechanisms is considered to be IFN-gamma inhibiting the induction of Tregs.,22812187_11,-1,1,-1,1,18094,-1,3.1682488e-05,0.9999528,1.5484991e-05
5791,Thus,0,1,0,4,"Thus, Gal1 represents a potential therapeutic target for restoring immune surveillance in cHL.",17670934_6,-1,1,-1,1,5791,-1,2.41766e-05,0.99996436,1.1414304e-05
22080,the,71,72,435,438,"The concentrations of Th17/Treg cell-associated cytokines were detected by enzyme-linked immunosorbent assay (ELISA).RESULTS: Under the same status of HPV16 DNA in vivo, the levels of Foxp3(+), transforming growth factor- (TGF-) and interleukin-10 (IL-10) were significantly higher than those of the control group (P < 0.01) while the levels of interleukin-17 (IL-17) and interleukin-21 (IL-21)were significantly lower than those of the control group (P < 0.05) .",24401583_5,-1,1,-1,1,22080,-1,1.8509952e-05,0.99996996,1.1531835e-05
3818,plays,1,2,5,10,IL-2 plays a critical role in the maintenance of CD4+CD25+ FOXP3(+) regulatory T cells (Tregs) in vivo.,16645171_0,-1,1,-1,1,3818,-1,2.8631404e-05,0.99995875,1.2610553e-05
42043,to,28,29,174,176,"Finally, increased extracellular ADO is shown to downregulate the expression of NAP1L2, a nucleosome assembly protein we show to be important for DNA damage repair secondary to UVR.",33848530_7,-1,1,-1,1,42043,-1,2.4767189e-05,0.9999633,1.1976526e-05
13852,to,14,15,61,63,"BACKGROUND: 'FOXP3+ regulatory T cells' (Tregs) are reported to be increased in tumour-bearing hosts including patients with melanoma, leading to tumour immune suppression.",21198537_0,-1,1,-1,1,13852,-1,2.4618426e-05,0.9999651,1.0335345e-05
22389,Tregs,11,12,66,71,"In this study, we investigated the mix-effect of the intratumoral Tregs and IL-17 producing T cells on metastasis of colorectal carcinoma (CRC) after resection.",24487033_1,-1,1,-1,1,22389,-1,2.1676273e-05,0.9999645,1.3796066e-05
25028,Tregs,4,5,19,24,Both LAP and LAP Tregs had a similar effector/memory phenotype.,25268580_4,-1,1,-1,1,25028,-1,1.9960875e-05,0.9999646,1.549587e-05
37187,to,11,12,91,93,"IFN--NPs also modulated the IL-10-stimulated macrophage profile, increasing their ability to secrete the pro-inflammatory cytokines IL-6, IL-12p40 and TNF-.",31233057_7,-1,1,-1,1,37187,-1,2.5459407e-05,0.999961,1.3507006e-05
41307,the,16,17,83,86,"We also showed, in both mice and humans, that the IRF1 alternative isoform altered the full-length IRF1 transcriptional activity on the Il12rb1 promoter, resulting in decreased IFN secretion in Th1 cells.",33419764_5,-1,1,-1,1,41307,-1,1.6065971e-05,0.99997497,8.939305e-06
24707,the,5,6,30,33,"To determine the influence of the postpartum immune microenvironment on mammary tumor promotion, we developed an immune-competent model.",25187059_5,-1,1,-1,1,24707,-1,1.784393e-05,0.99997354,8.663251e-06
38646,TGF1,31,32,197,202,"In orthotopic and syngeneic mouse models, silencing or inactivating IRIS in TNBC cells lowered the levels of circulating GM-CSF, suppressed TAM recruitment, and decreased the levels of circulating TGF1.",31911557_4,-1,1,-1,1,38646,-1,3.072686e-05,0.9999484,2.0930373e-05
10884,three,9,10,78,83,Ex vivo enzyme-linked immunospot-interferon (IFN)-gamma assay was positive in three patients who had proliferative responses.,19843089_2,-1,1,-1,1,10884,-1,4.0924424e-05,0.9999286,3.0479292e-05
22810,this,1,2,3,7,"In this study, we have analyzed the in vitro immunomodulatory potential of a non-toxic neem leaf glycoprotein (NLGP) in reprogramming Stage III supraglottic laryngeal tumor cell lysate (SLTCL) induced M2 TAMs to their classical anti-tumor shape (M1).",24607970_1,-1,1,-1,1,22810,-1,2.2339715e-05,0.9999676,1.0079502e-05
19740,IRF-8,9,10,53,58,"Collectively, these results underscore a key role of IRF-8 in the cross talk between melanoma and immune cells, thus revealing its critical function within the tumor microenvironment in regulating melanoma progression and invasiveness.",23308054_8,-1,1,-1,1,19740,-1,2.6220287e-05,0.99995494,1.8845372e-05
41262,to,8,9,72,74,The heterogeneity and complexity of tumor-immune microenvironments lead to diverse immunotherapy effects among colon cancer patients.,33401247_0,-1,1,-1,1,41262,-1,2.0580177e-05,0.9999697,9.6845215e-06
7003,the,54,55,337,340,"Indeed from the initial concept that the release of free radicals during inflammation might induce the accumulation of genetic mutations thus leading to the onset of dysplastic cells, it is now becoming clear that the large amount of cytokines and growth factors released during inflammation by immune and non immune cells may influence the carcinogenesis process.",18473765_4,-1,1,-1,1,7003,-1,1.9703271e-05,0.99997175,8.499012e-06
36746,This,2,3,13,17,"CONCLUSIONS: This work directly links circulating IL-6 with other poor prognostic indicators, STAT1 and PD-1, and highlights the effects of circulating IL-6 on the immune system.",31027698_8,-1,1,-1,1,36746,-1,2.7255319e-05,0.9999596,1.3102699e-05
28581,FOXP3(lo,4,5,33,41,"Development of such inflammatory FOXP3(lo) non-Treg cells may depend on secretion of interleukin (IL)-12 and transforming growth factor (TGF)- by tissues and their presence was correlated with tumor invasion by intestinal bacteria, especially Fusobacterium nucleatum.",27111280_6,-1,1,-1,1,28581,-1,2.3966897e-05,0.9999627,1.3387992e-05
14876,the,38,39,219,222,"Moreover, using the purified CD4(+)CD25(-) T cells, we confirmed that the increased Tregs were mainly induced from the conversation of CD4(+)CD25(-) naive T cells, and induced Tregs were functional and able to suppress the proliferation of effector T cells.",21528082_11,-1,1,-1,1,14876,-1,1.6226097e-05,0.99997413,9.600642e-06
1612,the,21,22,122,125,These findings suggest that the presence of tumor-specific CD4(+) Treg cells at tumor sites may have a profound effect on the inhibition of T cell responses against cancer.,14738769_5,-1,1,-1,1,1612,-1,1.7282131e-05,0.9999752,7.459546e-06
13892,Tregs,62,63,373,378,"Moreover, we found three unexpected perturbations in FOXP3+ T-cell subsets: (i) patients with melanoma showed higher frequencies of FOXP3(low) nonregulatory T cells, which decreased and normalized after tumour removal; (ii) FOXP3(low) nave Tregs containing higher frequencies of interferon-+ cells increased with tumour progression; and (iii) CD45RO+FOXP3(high) effector Tregs were pronouncedly infiltrated around tumour tissues.",21198537_7,-1,1,-1,1,13892,-1,2.2264952e-05,0.999956,2.1666003e-05
37425,therapeutic,10,11,70,81,Intervention of the IL-1-CCL22-CCR4 signaling axis may offer a novel therapeutic strategy for oral cancer treatment.,31325403_10,-1,1,-1,1,37425,-1,2.5748426e-05,0.9999634,1.0861411e-05
33760,that,7,8,56,60,Macrophages are exquisite sensors of tissue homeostasis that can rapidly switch between pro- and anti-inflammatory or regulatory modes to respond to perturbations in their microenvironment.,29150563_0,-1,1,-1,1,33760,-1,2.039002e-05,0.9999701,9.494601e-06
22125,than,20,21,115,119,The activation of MG Tconv cells triggered a lower upregulation of FoxP3 and a higher upregulation of CD4 and CD25 than CTRL cells.,24405842_5,-1,1,-1,1,22125,-1,3.720279e-05,0.99991834,4.448084e-05
19353,TGF-,7,8,32,37,"Expression of Foxp3, IL-10, and TGF- mRNAs in MLRs were detected by real-time PCR.",23179394_5,-1,1,-1,1,19353,-1,3.8740443e-05,0.9999429,1.835298e-05
41337,platform,1,2,7,15,"CARTIV platform can improve safety of CAR T-cells or other engineered immune-cells, providing TME-focused activity and opening a therapeutic window for many tumor-associated antigens that are also expressed by non-tumor healthy tissues.",33514819_5,-1,1,-1,1,41337,-1,2.1458525e-05,0.99996483,1.376474e-05
8396,the,9,10,55,58,"In addition, Treg numbers are predictively elevated in the peripheral blood of patients with various solid tumors.",19147574_8,-1,1,-1,1,8396,-1,1.7497625e-05,0.9999733,9.240187e-06
19789,the,23,24,119,122,"In addition, the higher frequency of CD4(+) CD25(high) CD127(-) Tregs in the peripheral blood of mCRPC patients may be the result of an increase in Treg proliferation capacity.",23319273_7,-1,1,-1,1,19789,-1,2.4297058e-05,0.99996674,8.915283e-06
38513,tumor,32,33,231,236,Corresponding neo-epitopes were synthesized and tested for recognition by in vitro expanded T cells that were isolated from tumor tissues (tumor-infiltrating lymphocytes) and from peripheral mononuclear blood cells stimulated with tumor material.,31888734_4,-1,1,-1,1,38513,-1,2.1452786e-05,0.9999682,1.0394111e-05
24834,thymic,21,22,125,131,"Here, using a type II NKT-cell TCR transgenic mouse model, we demonstrated that CD1d-expressing hematopoietic cells, but not thymic epithelial cells, meditate efficient selection of type II NKT cells.",25236978_2,-1,1,-1,1,24834,-1,8.54335e-05,0.999874,4.0546693e-05
40398,TGF-,14,15,96,101,The phenotype of these B cells was CD19+CD81+CD27+CD25+PD-L1hi and they secreted both IL-10 and TGF-.,32661685_4,-1,1,-1,1,40398,-1,3.314591e-05,0.9999496,1.730679e-05
25548,the,11,12,79,82,RESULTS: We identified 12 protein-coding candidate variants that segregated in the 3 affected cousins from whom we had samples.,25492914_4,-1,1,-1,1,25548,-1,2.0339887e-05,0.9999659,1.3787405e-05
4114,the,10,11,67,70,"A 5-day treatment with the anti-IL-2 mAb alone gradually increased the CD44(high)CD8+ population, and the increased population was maintained for >300 days, suggesting that the mAb can gradually maintain and potentially enhance the bioactivity of endogenous IL-2 for extended periods.",16785526_4,-1,1,-1,1,4114,-1,1.8608489e-05,0.99997115,1.0256953e-05
10222,IRF-1-E7,2,3,13,21,The combined IRF-1-E7 demonstrated more functions and biologic processes compared with IRF-1 alone.,19574175_5,-1,1,-1,1,10222,-1,4.4963504e-05,0.9998411,0.00011387104
29712,the,9,10,67,70,Ratios of Treg/Th17 and IL-10/IL-17 were significantly elevated in the CLL patients.,27584054_4,-1,1,-1,1,29712,-1,1.678247e-05,0.999972,1.1190756e-05
40850,the,30,31,189,192,"These data point to the critical role of canonical NF-B signaling, the regulation of matrix metalloproteinases, and DC-derived ICOSL in the specific priming of cognate T-cell responses in the cancer setting.",33051240_6,-1,1,-1,1,40850,-1,1.9013969e-05,0.9999713,9.750826e-06
9725,Tregs,4,5,20,25,Regulatory T cells (Tregs) play an important role in maintaining immunological tolerance that is one of the main obstacles to overcome for improving antitumor immunity.,19455675_0,-1,1,-1,1,9725,-1,2.30908e-05,0.99996626,1.0592729e-05
6636,to,17,18,112,114,"RESULTS: When injected sc in syngeneic A/J mice viable Neuro2a/IL-21 cells were rejected and induced resistance to a subsequent iv challenge with Neuro2a parental cells (Neuro2a/pc), suggesting the involvement of an immune response.",18324400_4,-1,1,-1,1,6636,-1,2.2752849e-05,0.99996614,1.1056983e-05
16377,Smad,48,49,269,273,"We also observed an inhibition of Smad-3, GSK-3 and ERK1/2 signaling by SocL and wogonin in T(reg) cells, while phosphorylation of P38 MAPK was considerably enhanced, indicating that SocL or wogonin could inhibit the T cells' response to TGF-1 via modulation of both Smad and non-Smad signaling pathways.",22057676_7,-1,1,-1,1,16377,-1,5.9858918e-05,0.9999143,2.5793366e-05
24542,to,16,17,114,116,"We furthermore observed that the JAK-STAT signaling pathway was highly activated in endothelial cells in response to stimulated iNKT cells, indicating the possible role of IFN- in the anti-angiogenic process.",25142285_7,-1,1,-1,1,24542,-1,2.0272626e-05,0.99997056,9.199187e-06
8783,These,0,1,0,5,These results identify a novel mechanism by which the function of human DCs is altered by tumor cells and contributes to the evasion of the immune response.,19234174_9,-1,1,-1,1,8783,-1,1.8978004e-05,0.999972,8.983745e-06
35580,Foxp3,19,20,126,131,"We investigated the relationship between Neutrophil-to-lymphocyte ratio (NLR) and the quantities of neutrophil elastase, CD3, Foxp3, and CD204 in tumor-infiltrating cells and circulating cytokines (IL-2, -6, -8, 17a, and TGF-) in muscle-invasive bladder cancer.",30199269_0,-1,1,-1,1,35580,-1,2.646276e-05,0.9999579,1.5665946e-05
10434,the,40,41,248,251,"Whereas, LMP1 up-regulates anti-apoptotic proteins to support viral replication, it also potentiates apoptosis, suggesting that a viral protein contributes to the survival of the virus, and it also elicit host defense leading to the destruction of the infected cells.",19664329_1,-1,1,-1,1,10434,-1,2.0431575e-05,0.9999689,1.06598845e-05
16813,that,5,6,27,31,"In conclusion, we observed that IL-33 has attenuated anti-inflammatory effects in T cell-mediated responses and that both IL-33 and ST2 could be further explored as potential therapeutic targets in treatment of immune-mediated diseases.",22392053_11,-1,1,-1,1,16813,-1,2.1651227e-05,0.999969,9.322633e-06
2268,the,21,22,121,124,"Here, we demonstrate that KLRG1 is expressed in a significant proportion of Vgamma9/Vdelta2 T cells in cord blood and in the majority of peripheral Vgamma9/Vdelta2 T cells from adult donors.",15498816_3,-1,1,-1,1,2268,-1,1.9863524e-05,0.999966,1.4081037e-05
40572,to,29,30,191,193,"Moreover, GA effectively restricted advanced stage solid tumor while used in combination with Mycobacterium indicus pranii, a known immunomodulator, which alone is reported to be ineffective to restrict advanced stage solid tumor.",32890791_8,-1,1,-1,1,40572,-1,2.8338047e-05,0.99996054,1.11074605e-05
6814,that,34,35,266,270,More detailed investigations of the mechanisms underlying protective immunity in murine systems together with the characterization of the anti-tumor reactions of patients who achieved durable clinical benefits in response to immunotherapy uncovered several pathways that restrain the efficacy of GM-CSF-secreting tumor cell vaccines.,18364009_3,-1,1,-1,1,6814,-1,1.9081373e-05,0.99996996,1.0970017e-05
28092,the,6,7,28,31,The effect of DC vaccine on the accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and on the production of TGF- suggests that tumor regression by DC vaccination may be associated with an altered immunosuppressive tumor microenvironment.,26786094_8,-1,1,-1,1,28092,-1,1.6010501e-05,0.9999763,7.695971e-06
26663,complex,23,24,156,163,"To further evaluate the TLR4 dependency on tumor microenvironment, Lewis lung carcinoma-bearing mice were treated with Eritoran, an antagonist of TLR4/MD-2 complex.",26165843_8,-1,1,-1,1,26663,-1,2.9920462e-05,0.9999441,2.5961703e-05
23905,tumor,42,43,283,288,"We examined the combination of topical imiquimod with intramuscular administration of CRT/E7, a therapeutic human papillomavirus (HPV) vaccine comprised of a naked DNA vector expressing calreticulin fused to HPV16 E7.EXPERIMENTAL DESIGN: Using an orthotopic HPV16 E6/E7(+) syngeneic tumor, TC-1, as a model of high-grade cervical/vaginal/vulvar intraepithelial neoplasia, we assessed if combining CRT/E7 vaccination with cervicovaginal deposition of imiquimod could result in synergistic activities promoting immune-mediated tumor clearance.",24893628_1,-1,1,-1,1,23905,-1,2.3587707e-05,0.9999602,1.618402e-05
12319,FOXP3,22,23,125,130,"SCC from immunocompetent patients and OTRs were analyzed by real-time polymerase chain reactions for CD4, CD8, TBET, GATA-3, FOXP3, RORC, IFN-gamma, IL-4, TGF-beta, IL-10, and IL-17A mRNA expression.",20463594_4,-1,1,-1,1,12319,-1,3.0708838e-05,0.9999529,1.6333699e-05
25767,tumor,15,16,71,76,"Taken together, our studies provide evidence that 14-3-3 may regulate tumor inflammation and immune response through Stat3 signaling in OSCC.",25556369_8,-1,1,-1,1,25767,-1,1.9434125e-05,0.9999716,8.971986e-06
9932,T(regs,8,9,61,67,We have studied CD4(+)CD25(high)FOXP3(+) regulatory T-cells (T(regs)) from 51 patients with non-small-cell lung cancer (NSCLC) and 33 healthy donors.,19538059_0,-1,1,-1,1,9932,-1,2.4157014e-05,0.99995697,1.8903373e-05
17972,tumor,19,20,130,135,The identity of these local mechanisms used by tumors to suppress immunosurveillance represents a key knowledge gap for improving tumor immunotherapy.,22777646_2,-1,1,-1,1,17972,-1,2.4472341e-05,0.99996626,9.305588e-06
37981,that,4,5,23,27,CONCLUSION: We suggest that CD4+CD25-FoxP3+ cells in patients with BC are exhausted cells with an intermediate phenotype between effector and regulatory cells.,31630080_7,-1,1,-1,1,37981,-1,1.7190709e-05,0.99997354,9.2753535e-06
18008,the,15,16,97,100,"Antitumor type I T-cell responses involving IFN- production are critical to control cancer, but the efficacy of this response is limited by a variety of immunosuppressive mechanisms that promote tumoral immune escape.",22798340_0,-1,1,-1,1,18008,-1,2.1327396e-05,0.99996936,9.318547e-06
41590,to,7,8,36,38,"Invivo CD8 depletion was performed to assess the role of effector T cells in mitigating the effects of CR, and it was found that in mice undergoing CR, depletion of CD8 T cells resulted in increased tumor progression and decreased median survival compared with isotype control-treated mice.",33647370_5,-1,1,-1,1,41590,-1,1.754004e-05,0.999974,8.473757e-06
4633,Treg,10,11,52,56,"In this review, we discuss the current knowledge of Treg biology and the potential therapeutic strategies and barriers of Treg immunotherapy in human hematopoietic cell transplantation.",17084366_5,-1,1,-1,1,4633,-1,2.3935974e-05,0.9999629,1.30919125e-05
10869,Therefore,0,1,0,9,"Therefore, effective melanoma immunotherapy should include the inhibition of Treg migration into the tumor combined with neutralization of other immunosuppressive cells and factors in the tumor microenvironment.",19841169_9,-1,1,-1,1,10869,-1,2.2871098e-05,0.99996567,1.1463606e-05
42405,that,17,18,126,130,"Although transcription factors that are essential for Th9 cell differentiation have been identified, other signaling pathways that are required for their generation and functions are yet to be explored.",34075041_1,-1,1,-1,1,42405,-1,2.4920466e-05,0.99996185,1.3213014e-05
31641,The,0,1,0,3,"The absence of iNKT cells was associated with a reduced frequency of regulatory T (Tregs) cells and lower expression levels of FoxP3 protein and transcript uniquely in the polyps, and a switch to an inflammatory macrophage phenotype.",28401935_4,-1,1,-1,1,31641,-1,1.8357092e-05,0.9999734,8.2386e-06
5696,tumor,59,60,345,350,"To determine, whether accumulation and activation of intratumoral Tregs help in the progression of breast carcinoma, we have analyzed the intratumoral expression of FOXP3 in invasive breast carcinoma and compared it with its level in ductal carcinoma in situ (DCIS) and adjacent normal tissue with the main aim of using this factor as marker of tumor progression.",17653902_1,-1,1,-1,1,5696,-1,1.915268e-05,0.99997115,9.723469e-06
16787,the,6,7,41,44,"We previously described and discuss here the important role of IL-33/ST2 axis in experimental models of type 1 diabetes, experimental autoimmune encephalomyelitis, fulminant hepatitis and breast cancer.",22392053_4,-1,1,-1,1,16787,-1,2.0595251e-05,0.9999714,8.035236e-06
4129,that,13,14,91,95,These results demonstrated IL-2-enhancing effects of the anti-IL-2 mAb in vivo and suggest that combining a neutralizing anti-IL-2 Ab with IL-2 gene delivery might be used effectively to enhance IL-2 functions in clinical applications.,16785526_6,-1,1,-1,1,4129,-1,2.0022542e-05,0.99997175,8.263065e-06
22124,FoxP3,11,12,67,72,The activation of MG Tconv cells triggered a lower upregulation of FoxP3 and a higher upregulation of CD4 and CD25 than CTRL cells.,24405842_5,-1,1,-1,1,22124,-1,2.3191458e-05,0.9999634,1.3346888e-05
40639,tumor-infiltrating,6,7,36,54,"PD-1 and CTLA-4 were upregulated on tumor-infiltrating CD4+ and CD8+ T cells in irradiated and nonirradiated tumors, suggesting that immune checkpoint inhibitors could be beneficial after LRT and Foxp3+ Treg depletion.",32948683_5,-1,1,-1,1,40639,-1,5.1788706e-05,0.9999248,2.3473862e-05
1026,toward,7,8,36,42,"These results, along with the shift toward IL-4-producing specific T-cell clones observed in CD30L+ AML samples by enzyme-linked Immunospot (ELISpot) assay, were consistent with the hypothesis of a Th2 polarization taking place in T cells from CD30L+ AML.",11918534_5,-1,1,-1,1,1026,-1,2.1725225e-05,0.99996495,1.3264365e-05
34706,treated,1,2,3,10,In treated patients pazopanib appeared to enhance a circulating CD4+ T-cell population that expresses CD137 (4-1BB).,29700053_8,-1,1,-1,1,34706,-1,2.1701671e-05,0.99996626,1.2012674e-05
18327,those,17,18,122,127,"The cytokine and chemokine profile of macrophages treated with tumor cell derived exosomes showed marked differences from those induced by either LPS or IL-4, and it suggested that exosomes may play a role in the tumor progression and metastasis formation through supporting tumor immune escape mechanisms.",22898052_4,-1,1,-1,1,18327,-1,2.4199633e-05,0.9999629,1.2837321e-05
8958,Treg,16,17,102,106,This review will discuss our current knowledge in understanding the dynamics and plasticity of Foxp3+ Treg activation and induction in tumor bearing hosts and their interaction with various antigen presenting cells (APCs) in tumor microenvironment leading to the establishment of active local and systemic immune suppression.,19254475_4,-1,1,-1,1,8958,-1,2.1410104e-05,0.9999651,1.3473816e-05
30578,this,1,2,3,7,"In this study, we explored the impact of FSTL1 on DC activity in nasopharyngeal carcinoma (NPC) patients.",27859422_2,-1,1,-1,1,30578,-1,1.8991475e-05,0.99997103,1.0005141e-05
8989,Stat1,40,41,249,254,"Ablating Stat3 in hematopoietic cells results in rapid activation of innate immunity by CpG, with enhanced production of IFN-gamma, tumor necrosis factor-alpha, IL-12, and activation of macrophages, neutrophils, and natural killer cells marked with Stat1 activation.",19258507_2,-1,1,-1,1,8989,-1,2.9951818e-05,0.99992824,4.179406e-05
31078,This,0,1,0,4,This neutralization effect was counteracted by the tumor metastasis-suppressing action of bortezomib treatments.,28052005_5,-1,1,-1,1,31078,-1,2.1711674e-05,0.99996936,8.94705e-06
43138,the,6,7,27,30,"In this study, we explored the immunosuppressive effect of B7-H3 (CD276) via the CCL2-CCR2-M2 macrophage axis and its potential as a therapeutic target.",34799346_1,-1,1,-1,1,43138,-1,1.7201293e-05,0.99997497,7.884584e-06
7616,the,6,7,25,28,"In contrast to wt FOXP3, the low molecular splice forms of FOXP3 have no inhibitory effect on nuclear factor-kappaB (NF-kappaB) activity in reporter assays which is in keeping with a constitutive NF-kappaB activity in the malignant T cells.",18769452_7,-1,1,-1,1,7616,-1,1.6999044e-05,0.999974,9.020645e-06
19876,through,11,12,61,68,Knocked-down TGF-1 of the Hepa1-6 cell line was established through lentivirus-based RNA interference.,23361571_2,-1,1,-1,1,19876,-1,2.1832106e-05,0.999961,1.7143278e-05
43226,relevant,4,5,23,31,It may be particularly relevant in cases in which PD-L1-mediated T cell exhaustion leads to immunoevasive phenotypes.,35011581_4,-1,1,-1,1,43226,-1,3.755285e-05,0.9999455,1.6912632e-05
4223,the,3,4,12,15,"However, in the lung model, depletion of CD8+ T cells significantly reduced the tumor burden.",16818744_6,-1,1,-1,1,4223,-1,1.7672526e-05,0.9999726,9.789684e-06
5711,FOXP3,9,10,70,75,"In infiltrating carcinoma, a significant positive correlation between FOXP3 expression and TGF-beta1 expression was noted (p<0.001).",17653902_6,-1,1,-1,1,5711,-1,2.190977e-05,0.9999652,1.2919319e-05
38470,Treg,0,1,0,4,"Treg accumulation was related to TGF-1 expression by cancer cells, and Th17 cell accumulation was related to IL-6 expression by cancer cells, in resected specimens; this was confirmed in vitro.",31853779_6,-1,1,-1,1,38470,-1,2.4118042e-05,0.9999598,1.603233e-05
38422,STAT3,7,8,49,54,"Consistently, IHC staining showed that activated STAT3 correlated with repressed infiltration of CD8+ T cells in non-small cell lung cancer.",31848193_9,-1,1,-1,1,38422,-1,2.7432663e-05,0.99995553,1.7004031e-05
4444,to,18,19,120,122,METHODS AND RESULTS: A panel of colorectal cancers enriched for DNA MMR deficiency was examined by immunohistochemistry to explore the expression levels and localization of various components in the TGF-beta signalling pathway.,16978200_4,-1,1,-1,1,4444,-1,1.7479559e-05,0.99997413,8.422203e-06
3997,the,27,28,151,154,"The efficacy of induction of Treg's by DCs depends on the nature of the DC maturation stimulus, with inflammatory cytokine-treated DCs (Cyt-DCs) being the most effective Treg inducers.",16763205_6,-1,1,-1,1,3997,-1,2.6003909e-05,0.99996054,1.3461039e-05
5500,two,8,9,44,47,"Therefore, IL-6 and G-CSF in BxCM represent two main factors responsible for suppression of DC differentiation, maturation, and antigen presentation, and this suppression of DC functions may be due to the aberrant activation of STAT3 by BxCM.",17545630_12,-1,1,-1,1,5500,-1,4.7734036e-05,0.99992895,2.3288485e-05
23238,time-integration,4,5,22,38,Our study reveals how time-integration of these regulatory loops within individual cell signaling generates scaled collective responses and can be leveraged for immune monitoring.,24719192_5,-1,1,-1,1,23238,-1,4.135933e-05,0.99993956,1.9134732e-05
4021,Teffs,28,29,154,159,We examined the mechanisms of action of anti-CTLA4 and a GM-CSF-transduced tumor cell vaccine (Gvax) and their impact on the balance of effector T cells (Teffs) and Tregs in an in vivo model of B16/BL6 melanoma.,16778987_1,-1,1,-1,1,4021,-1,3.257366e-05,0.99994636,2.102161e-05
7554,FOXP3,10,11,53,58,"In the current study, we evaluated the expression of FOXP3 in CD4+CD25hi T regulatory lymphocytes (Treg) and their influence on immune response against tumor and viral antigens in the complex system of peripheral blood mononuclear cells.",18695923_2,-1,1,-1,1,7554,-1,1.7347924e-05,0.9999726,1.0072172e-05
35938,the,22,23,126,129,"We showed that Notch inhibition could enhances GVL while reducing GVHD via modulating host DCs and donor T cell activity, and the production of inflammatory cytokines.",30445020_8,-1,1,-1,1,35938,-1,2.070701e-05,0.9999702,9.099375e-06
18432,tumors,14,15,97,103,Anti-tumor immunity is thought to play a significant role in chemotherapeutic response of breast tumors.,22986814_0,-1,1,-1,1,18432,-1,2.1936767e-05,0.9999684,9.705339e-06
6227,the,12,13,88,91,Among the several mechanisms that play role in maintaining peripheral self-tolerance is the existence of a unique CD4+CD25+ population of naturally occurring regulatory T (Treg) cells that actively prevent both the activation and the effector function of autoreactive T cells that have escaped different mechanisms of tolerance.,18092144_0,-1,1,-1,1,6227,-1,1.788575e-05,0.9999733,8.859842e-06
6883,these,2,3,17,22,"Correlating with these findings, the combination therapy resulted in significantly higher intra-tumoral levels of several proinflammatory, TH1-related cytokines (including IL-12, IFN-gamma, TNF-alpha and IL-2), increases in intra-tumoral CD8+ and CD4+ T cells expressing activation/memory markers and NK cells and increases in activated DCs in the tumors and regional lymph nodes (LNs).",18392040_5,-1,1,-1,1,6883,-1,1.9249313e-05,0.9999703,1.04914325e-05
11802,the,22,23,150,153,"Importantly, stimulation of the TIL and TDLNC with cognate antigen in the presence of commonly used Toll-like receptor ligands significantly enhanced the effector T-cell function.",20233872_6,-1,1,-1,1,11802,-1,1.8723234e-05,0.99997103,1.0297194e-05
36647,their,37,38,219,224,"Our previous study has demonstrated that CD4+ T cells in prostate tumor microenvironment contribute to PCa progression; meanwhile, we found increased CD4+ T-cell infiltration in tumor area after Doc treatment; however, their effects on PCa chemosensitivity remain unclear.",31018021_2,-1,1,-1,1,36647,-1,2.384052e-05,0.99996674,9.460576e-06
34546,TGF1,9,10,71,76,"Immunohistochemistry revealed that latency-associated peptide (LAP) of TGF1 was localized in mainly immune cells in all cases, which was more abundant than in control GCs.",29594353_4,-1,1,-1,1,34546,-1,2.2228442e-05,0.99995613,2.1590451e-05
9213,BCL-6,26,27,96,101,"Neoplastic cells were medium-sized clear cells that were CD4+ (24/27, 89%), CD10+ (21/29, 72%), BCL-6+ (14/19, 74%), and expressed programed death-1 (27/27, 100%), CXCL13 (23/27, 85%), and ICOS (11/11, 100%), markers of follicular helper T cells (TFH).",19295409_3,-1,1,-1,1,9213,-1,0.00027253816,0.9994025,0.00032497515
1730,the,7,8,38,41,"C26 cells, which were transduced with the single-chain IL-27 cDNA and became secreting IL-27 (C26-IL-27), exhibited minimal tumor growth in vivo, and all of the mice inoculated with these cells survived healthily with complete tumor remission.",14871851_3,-1,1,-1,1,1730,-1,2.1278573e-05,0.9999635,1.5201123e-05
2232,the,1,2,3,6,"At the molecular level, TGF-beta signaling in T cells regulated STAT-3 activation in tumor cells via IL-6.",15485627_2,-1,1,-1,1,2232,-1,2.2200134e-05,0.99996555,1.2266124e-05
39640,tankyrase,8,9,64,73,Our study uncovers a combinatorial therapeutical strategy using tankyrase inhibition to overcome -catenin-mediated resistance to immune checkpoint blockade in melanoma.,32332858_6,-1,1,-1,1,39640,-1,2.9632894e-05,0.99994826,2.2082308e-05
20875,the,19,20,114,117,"When 14 Gy irradiation was combined with immunization, intratumoral numbers of CD8+ T cells increased 10-fold and the number of CD8+ T cells specific for the E7- epitope increased more than 20-fold.",23922012_5,-1,1,-1,1,20875,-1,1.890198e-05,0.99997103,1.00859015e-05
13427,the,2,3,7,10,"Hence, the differential distribution of T cell subsets through the spleen, the mammary lymph nodes and the tumor mass in MNU-induced mammary tumor-bearing animals may contribute to a tumor-associated immunosuppression.",20883319_8,-1,1,-1,1,13427,-1,1.6425816e-05,0.9999758,7.77081e-06
11565,to,26,27,143,145,"Our results showed a significant (p<0.05) decrease in the tumor volume and the level of IL-4 in the animals treated with Tehranolide, compared to untreated group.",20138670_5,-1,1,-1,1,11565,-1,2.2798284e-05,0.999966,1.119164e-05
454,therefore,3,4,27,36,"Intrinsic differences must therefore exist between pre-TCR signals in CD4(-)CD8(-) thymocytes and alphabetaTCR signals in CD4(+)CD8(+) cells, since only the latter can mediate a death signal.",11290785_2,-1,1,-1,1,454,-1,2.3362136e-05,0.99996793,8.744157e-06
35017,TLR3,23,24,154,158,Our data identify the helicase/NFB/TNF/COX2 axis as the key suppressive pathway of dsRNA signaling in human TME and suggest that selective targeting of TLR3 or elimination of NFB/TNF/COX2-driven suppression may allow for selective enhancement of type-1 immunity.,29853604_5,-1,1,-1,1,35017,-1,2.47878e-05,0.99995685,1.8332628e-05
39691,the,2,3,11,14,"Similarly, the cumulative rate of incidence of developing CAC increases with prolonged colon inflammation.",32357539_2,-1,1,-1,1,39691,-1,2.1815613e-05,0.9999691,8.999583e-06
39550,The,0,1,0,3,The serum CCL11 level and the proportion of CD4+CD25+Foxp3+ Treg cells were significantly increased in patients with BC compared with healthy individuals.,32323817_5,-1,1,-1,1,39550,-1,2.0753409e-05,0.9999691,1.008421e-05
17434,The,0,1,0,3,The CD25(NEG) memory T-cell population contains the vast majority of late differentiated cells that respond to antigens associated with chronic immune responses and are increased in patients with systemic lupus erythematosus (SLE).,22585674_2,-1,1,-1,1,17434,-1,1.807002e-05,0.9999721,9.7979455e-06
40888,this,15,16,87,91,"How these signals are integrated to determine Th17 plasticity is not well defined, yet this is a crucial point of investigation as it represents a potential target to treat autoimmune and inflammatory diseases.",33064842_6,-1,1,-1,1,40888,-1,2.6286949e-05,0.99996305,1.0711654e-05
41644,The,0,1,0,3,"The cyst-type exhibited significant atrophy of the germinal centre area (P = 0.0019), significantly fewer Tfh-positive lymphocytes in germinal centres (P < 0.0001), and significantly more T-bet-positive lymphocytes in the epithelium (P = 0.0017).",33647861_6,-1,1,-1,1,41644,-1,1.7041264e-05,0.9999722,1.0692869e-05
27391,they,5,6,19,23,"On the other hand, they acquired surface expression of CD25 and CTLA-4 typically found in regulatory T (Treg) cells.",26437631_4,-1,1,-1,1,27391,-1,2.1144091e-05,0.99996626,1.2620153e-05
6084,that,4,5,17,21,"Thus, we suggest that CD8(+)CD28(-) regulatory cells play a partial role in the mechanism of action by which the dual APL suppresses experimental autoimmune MG-associated T cell responses.",17956982_9,-1,1,-1,1,6084,-1,1.6825908e-05,0.99997437,8.843153e-06
34608,the,1,2,8,11,"Despite the dramatic antitumor efficiency of certain immune checkpoint inhibitors, immunotherapy has met a bottleneck regarding the response rate and resistance in cancer patients.",29678298_0,-1,1,-1,1,34608,-1,2.2775515e-05,0.9999691,8.127043e-06
37692,transfected,22,23,132,143,"Both baicalein and baicalin enhanced the cytotoxicity of T cells to eliminate tumor cells, which was abrogated after HCC cells were transfected with a PD-L1 overexpression plasmid or after T cells were pretreated with an anti-PD-1 blocking antibody.",31437792_4,-1,1,-1,1,37692,-1,2.650899e-05,0.9999572,1.6246788e-05
9940,their,6,7,40,45,Functional studies were done to analyze their inhibitory role.,19538059_2,-1,1,-1,1,9940,-1,2.344005e-05,0.9999653,1.1218827e-05
27017,to,24,25,151,153,"CONCLUSIONS: EBVmix induces a broader T-cell response, probably because of its coverage of latent and lytic EBV-derived proteins that may be important to control EBV-transformed B cells and might offer an improvement of T-cell therapies.",26276009_9,-1,1,-1,1,27017,-1,3.4560224e-05,0.9999542,1.1193503e-05
38321,the,26,27,142,145,"Together, these data demonstrated that the CD4+ CD25+ TILs were composed of distinctive Foxp3- and Foxp3+ cells, with the former representing the major subset.",31811667_11,-1,1,-1,1,38321,-1,2.02645e-05,0.9999645,1.52283e-05
10669,TLR3-mediated,19,20,93,106,"Thus, complexes of cationic antigenic peptides and poly(I:C) might be of great utility for a TLR3-mediated DC maturation and intracellular peptide targeting in a single step.",19758325_7,-1,1,-1,1,10669,-1,2.8799288e-05,0.99992394,4.726974e-05
3340,The,0,1,0,3,The increased protection was directly correlated with a stronger PDTRP-specific immune response induced by the GM-CSF fusion plasmid.,16341143_2,-1,1,-1,1,3340,-1,1.6971997e-05,0.9999752,7.766197e-06
8112,the,29,30,169,172,"These results indicate that while high levels of Tregs found in NZB mice might suppress a more severe autoimmune disease, they may also contribute to the development of the B cell malignancy.",19022624_7,-1,1,-1,1,8112,-1,1.713125e-05,0.9999734,9.439126e-06
22400,the,6,7,38,41,The ratio of Tregs/IL-17A+T cells and the ratio of FoxP3 mRNA/IL-17 mRNA were calculated.,24487033_3,-1,1,-1,1,22400,-1,1.8280265e-05,0.99997187,9.804056e-06
42955,the,8,9,59,62,"Using flow cytometry and immunohistochemistry, we examined the immune cell infiltrate into tumours created by injecting SSM3 ER+ breast cancer cells into wild-type, immunocompetent 129/SvEv mice.",34602068_6,-1,1,-1,1,42955,-1,1.6000567e-05,0.99997556,8.395975e-06
19846,The,0,1,0,3,"The results showed that there was an increase in the percentage of Tregs, the mRNA and protein expression of FoxP3, the level of Treg-related cytokines in patients with NSCLC while compared to that in healthy patients.",23335103_3,-1,1,-1,1,19846,-1,1.9270356e-05,0.99996996,1.0726796e-05
38296,Foxp3,25,26,125,130,"Interestingly, the level of CD25+ Foxp3+ cells in circulating CD4+ T cells was positively correlated with the level of CD25+ Foxp3+ cells in CD4+ TILs, but the level of CD25+ Foxp3- cells in circulating CD4+ T cells was not associated with the level of CD25+ Foxp3- cells in CD4+ TILs.",31811667_9,-1,1,-1,1,38296,-1,3.3982113e-05,0.999949,1.7003822e-05
31761,than,18,19,145,149,"Following long-term TCR-stimulation, CXCR5+CD8+ T cells demonstrated significantly more potent proliferation capacity and higher IFN expression than CXCR5-CD8+ T cells.",28412245_7,-1,1,-1,1,31761,-1,2.3742674e-05,0.9999596,1.6677883e-05
20102,the,7,8,53,56,Treatment with recombinant IL-33 could also increase the cytotoxicity of CD8(+) T cells and NK cells in vitro.,23499895_3,-1,1,-1,1,20102,-1,1.778914e-05,0.99997485,7.418191e-06
15381,tumor-Ag,30,31,194,202,"Given that suppression of Ag-specific CTL responses can be induced in Ag-sensitized mice by UV irradiation, our results may imply that exposure to UV radiation during premalignant stage induces tumor-Ag specific Tr1 cells that mediate tumor-Ag specific immune suppression resulting in the promotion of tumor progression.",21710495_6,-1,1,-1,1,15381,-1,3.26416e-05,0.9999548,1.2484833e-05
4885,Treg,4,5,20,24,Regulatory T cells (Treg) are a distinct group of T lymphocytes with immunosuppressive properties that serve normally to prevent harmful autoimmune responses.,17224188_0,-1,1,-1,1,4885,-1,2.3313563e-05,0.9999647,1.1955819e-05
24942,the,3,4,28,31,Nicotine markedly inhibited the elevation of TNF- and IL-6 mRNA as well as phosphorylated signal transducer and activator of transcription (Stat) 3 expression in the colons of the tumor model mice.,25258409_8,-1,1,-1,1,24942,-1,1.5432206e-05,0.99997616,8.442155e-06
12314,Th2,18,19,105,108,RNA expression profile of SCC patients was analyzed for 8 different sets of genes relating to Th1 versus Th2 response using Gene Set Enrichment Analysis.,20463594_3,-1,1,-1,1,12314,-1,4.5806475e-05,0.9999207,3.3410328e-05
41197,the,10,11,75,78,Inhibition of autophagy reversed the effects of SKIL/TAZ overexpression on the STING pathway.,33268765_12,-1,1,-1,1,41197,-1,1.9993247e-05,0.9999715,8.493217e-06
14144,the,35,36,230,233,"Several inflammatory factors are subsequently upregulated, notably CD30 and its ligand CD153, also leukocyte trafficking factors including CXCL10, CXCL13, L-selectin and TGF1, and inflammatory cytokines including IL-1, IL-3 and the murine IL-8 analogues CXCL1, CXCL2 and CXCL5-6, amongst others.",21291541_8,-1,1,-1,1,14144,-1,3.5055473e-05,0.9999442,2.071708e-05
24648,the,24,25,162,165,"Using the diethylnitrosamine (DEN)-induced rat liver tumor model and in vitro cell experiments, the percentage of CD4(+)CD25(+)Treg/CD4(+) cells in the blood and the expressions of Foxp3(+), IL-10, TGF-, and cytotoxic T lymphocyte-associated antigen-4(CTLA-4) in spleen and liver tumors significantly decreased after LDR of the spleen in rats with liver cancer.",25168696_4,-1,1,-1,1,24648,-1,1.8529561e-05,0.99997115,1.0361936e-05
31982,TGF-1,8,9,50,56,We also found that transforming growth factor-1 (TGF-1) neutralizing antibody reversed the enhancement of Treg number and expression of p-Smad3'p-p38'p-JNK'p-ERK1/2 in the co-culture model.,28472762_6,-1,1,-1,1,31982,-1,2.8479904e-05,0.9999491,2.245383e-05
6367,the,19,20,143,146,EXPERIMENTAL DESIGN: Patients with resected HPV16-positive cervical cancer were vaccinated with an overlapping set of long peptides comprising the sequences of the HPV16 E6 and E7 oncoproteins emulsified in Montanide ISA-51.,18172269_1,-1,1,-1,1,6367,-1,2.6197873e-05,0.9999628,1.0977243e-05
19321,treatment,27,28,194,203,These results indicated that YB-1 immunization combined with Treg depletion could induce specific T-cell responses against neuroblastoma and could be a potential strategy for the prevention and treatment of neuroblastoma in the early stage.,23169344_9,-1,1,-1,1,19321,-1,2.5906787e-05,0.99995995,1.4195273e-05
20382,to,7,8,29,31,"miRNAs (miR) have been shown to modulate critical gene transcripts involved in tumorigenesis, but their role in tumor-mediated immunosuppression is largely unknown.",23636127_0,-1,1,-1,1,20382,-1,2.0948459e-05,0.9999701,8.970346e-06
41752,the,24,25,150,153,"Targeting Erbin as well as combined use of neutralizing B cells and antibodies neutralizing PD1 suppresses lung metastasis of CRC in mice, suggesting the potential option for treatment of lung metastasis of CRC.",33707428_6,-1,1,-1,1,41752,-1,2.2356668e-05,0.99996996,7.704427e-06
28205,Thus,0,1,0,4,"Thus, an oncogene can promote tumor progression independent of its transforming activity by increasing the number and function of Tregs.",26880715_8,-1,1,-1,1,28205,-1,2.2599603e-05,0.99996686,1.0524607e-05
26600,to,9,10,64,66,Ex-vivo colon culture experiments indicated that IL-22 was able to induce Th1-like inflammation via signal transducer and activator of transcription factor-1 (STAT1) and CXCL10 induction in the presence of type I interferon (IFN).,26153763_3,-1,1,-1,1,26600,-1,1.8590237e-05,0.99997306,8.3488385e-06
36924,these,25,26,144,149,"In this review, we explore recent discoveries that advance our understanding of how Itch regulates immune cell biology, and the extent to which these clarify how Itch prevents autoimmune disease.",31126634_5,-1,1,-1,1,36924,-1,2.2943355e-05,0.9999652,1.1918315e-05
6763,tumor,19,20,142,147,"These vaccines are all capable of inducing potent cell-mediated protective immunity against self-antigens, resulting in marked suppression of tumor growth and dissemination.",18363997_2,-1,1,-1,1,6763,-1,2.1762398e-05,0.99996734,1.0850168e-05
17682,type,34,35,206,210,"Thus, IFN- is not only an important CD8 T cell effector cytokine, it is an autocrine/paracrine factor whose contributions to differentiation vary depending on whether the response is supported by IL-12 or type I IFN.",22706089_3,-1,1,-1,1,17682,-1,3.1140906e-05,0.9999534,1.5421248e-05
20552,the,12,13,79,82,"A statistically significant reduction of 60% was observed in Foxp3+Tregs after the first cycle, whereas the absolute lymphocyte count decreased by only 14%.",23725550_8,-1,1,-1,1,20552,-1,1.9185727e-05,0.99997175,9.064519e-06
30542,therapeutic,12,13,75,86,"Natural polyphenolic compounds of grapes and their seeds are thought to be therapeutic adjuvants in a variety of diseases, including cancer prevention.",27833081_0,-1,1,-1,1,30542,-1,2.9980458e-05,0.99995697,1.3013512e-05
8600,tumors,13,14,103,109,"Interestingly, frequent vaccinations restore antitumor immune responses in the presence of established tumors.",19223534_2,-1,1,-1,1,8600,-1,2.1102964e-05,0.9999684,1.0476694e-05
13909,T,15,16,90,91,"Here, we demonstrated that PTX not only decreased the percentage of CD4+Foxp3+ regulatory T (Treg) cells both in vitro and in vivo but also impaired cell viability and cytokine production of Treg cells rather than CD4+Foxp3- effector T (Teff) cells.",21223350_2,-1,1,-1,1,13909,-1,2.114325e-05,0.9999589,1.9958172e-05
13139,The,0,1,0,3,"The expressions of Fas, Bcl-2 and Caspase-3 of Raji cells were detected by flow cytometric.",20815894_6,-1,1,-1,1,13139,-1,1.8973724e-05,0.9999715,9.568653e-06
27577,Th17,31,32,173,177,"The production of IFN by Th1 or Tc1 cells was sharply decreased and was accompanied by reduced T-bet mRNA, even when total T-cell numbers had recovered; the frequencies of Th17 and Treg cells and their specific transcription factors (RORt and Foxp3, respectively) were obviously increased.",26475064_7,-1,1,-1,1,27577,-1,7.07865e-05,0.99972254,0.00020662344
27331,the,2,3,8,11,"Indeed, the antitumor effects of pGITRL were markedly enhanced by depleting CD4(+) cells.",26423152_9,-1,1,-1,1,27331,-1,1.8480578e-05,0.99997437,7.1755076e-06
1584,the,10,11,46,49,"Little is known, however, about the nature of the physiological target antigens for CD4(+) regulatory T (Treg) cells.",14738769_1,-1,1,-1,1,1584,-1,1.9578636e-05,0.9999709,9.545606e-06
18535,Foxp3,146,147,798,803,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,1,-1,1,18535,-1,3.2233664e-05,0.99995005,1.771205e-05
27047,that,3,4,25,29,Our findings demonstrate that GITR co-stimulation mediates antitumor immunity by promoting TH9 cell differentiation and enhancing CTL responses and thus provide a mechanism of action for GITR agonist-mediated cancer immunotherapies.,26280119_6,-1,1,-1,1,27047,-1,1.7657523e-05,0.99997485,7.5517582e-06
28156,to,10,11,83,85,Immunoscope analysis revealed a restricted T-cell receptor / repertoire pointing to an (auto)antigen-driven process.,26852784_6,-1,1,-1,1,28156,-1,2.4627487e-05,0.99996495,1.03613875e-05
5979,the,16,17,102,105,The tatPTD fusion allowed for highly efficient and reproducible protein delivery into the DCs even in the presence of a phagocytosis inhibitor.,17931768_2,-1,1,-1,1,5979,-1,2.3117933e-05,0.9999695,7.3893298e-06
1401,tumor,21,22,143,148,"We showed that generating the major histocompatibility complex (MHC) class I+/class II+/Ii- phenotype, within an established subcutaneous RM-9 tumor nodule, led to an effective immune response limiting tumor growth.",12804139_1,-1,1,-1,1,1401,-1,2.1325597e-05,0.99996614,1.2473622e-05
11185,The,0,1,0,3,"The frequency of Foxp3(+) T-regs in PBLs of ESCC patients was significantly higher than that in normal healthy donors (7.0 +/- 4.2 vs 2.5 +/- 1.0%, P < 0.01).",20002703_7,-1,1,-1,1,11185,-1,1.6136128e-05,0.9999759,7.934648e-06
18143,targets,32,33,197,204,"By comparing the transcriptomes of primary and metastatic tumor cells in a mouse model of spontaneous bone metastasis, we found that a substantial number of genes suppressed in bone metastases are targets of the interferon regulatory factor Irf7.",22820642_1,-1,1,-1,1,18143,-1,2.3506142e-05,0.99996376,1.2778214e-05
10408,type,2,3,9,13,T helper type 1 responses were more prominent in the DC (Tat-CEA) immunized mice whose splenocytes secreted more interferon-gamma and less interleukin-4 than those from DC (CEA) immunized mice.,19659778_6,-1,1,-1,1,10408,-1,2.7589716e-05,0.9999317,4.0672887e-05
15202,FOXP3(+,17,18,88,95,"BACKGROUND: The purpose of this study was to investigate the presence of CD4(+) CD25(+) FOXP3(+) regulatory T (Treg) cells both in peripheral blood and local tumors in patients with nasal inverted papilloma (NIP).METHODS: By using flow cytometry, the frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in both peripheral blood and tissues from 18 patients with NIP and 8 control subjects were determined.",21674673_0,-1,1,-1,1,15202,-1,9.788124e-05,0.99983454,6.75596e-05
15725,the,6,7,57,60,"Proinflammatory cytokine production likely accounted for the raised levels of IL-11, a cytokine known to promote gastric epithelial cell survival and hyperplasia.",21881210_4,-1,1,-1,1,15725,-1,2.1315236e-05,0.99996924,9.389732e-06
32419,this,1,2,3,7,"In this study, we investigated how CD70 expression by GBM affects the characteristics of tumor cells and the tumor microenvironment.",28612394_3,-1,1,-1,1,32419,-1,1.9377027e-05,0.9999703,1.0306363e-05
37707,tumor,15,16,103,108,Our findings provide novel insight into the anticancer effects of baicalein and baicalin through which tumor growth is inhibited by PD-L1 expression downregulation and suggest that these flavonoids have great potential for clinical treatment.,31437792_7,-1,1,-1,1,37707,-1,1.7487719e-05,0.99997437,8.189366e-06
21429,the,19,20,129,132,"Most important, it provides a specialized environment for the selection of rearranged clones that will function appropriately in the adaptive immune response.",24198066_1,-1,1,-1,1,21429,-1,2.6284613e-05,0.9999628,1.0926816e-05
3471,transducers,3,4,17,28,"The seven signal transducers and activators of transcription (STAT) act as signaling components between the plasma membrane and the nucleus, and as transcription factors with specific DNA binding ability in the nucleus.",16375697_1,-1,1,-1,1,3471,-1,3.9165967e-05,0.99993026,3.0534797e-05
17500,the,4,5,24,27,"These effects relied on the increased propensity of tumor-associated cells (mostly fibroblasts and infiltrating inflammatory cells) to hyperactivate NF-B and produce T(eff)-attracting chemokines in response to treatment, resulting in an enhanced ability of the treated tumors to attract T(eff) cells and reduced ability to attract T(reg) cells.",22593190_8,-1,1,-1,1,17500,-1,1.5641552e-05,0.9999759,8.436584e-06
5548,T(reg,5,6,37,42,FOXP3-expressing regulatory T cells (T(reg) cells) function to suppress immune responses.,17574040_1,-1,1,-1,1,5548,-1,2.6140831e-05,0.9999527,2.1167409e-05
18737,the,8,9,42,45,"Our results and method may be helpful for the development and optimization of adjuvants, as here exemplified for INF-, for CSC-targeted vaccines, independent of the availability of CSC-specific antigens.",23001491_8,-1,1,-1,1,18737,-1,2.179755e-05,0.99997056,7.6685565e-06
1802,tumor,17,18,107,112,"Moreover, multiple lines of evidence indicated that local release of IFN-gamma was not required to inhibit tumor formation.",14978132_5,-1,1,-1,1,1802,-1,1.8233544e-05,0.99997246,9.361564e-06
42037,that,7,8,34,38,We also identify in a mouse model that ENTPD1 expression is induced by UVR in an IL-27-dependent manner.,33848530_6,-1,1,-1,1,42037,-1,1.7613336e-05,0.99997365,8.686375e-06
43426,transcription,21,22,146,159,"Mechanistically, global transcriptome and functional analyses indicated upregulation of signaling by a tumor cytokine, TNF-, and increased NF-B transcription in Rap1B-deficient ECs.",36403190_5,-1,1,-1,1,43426,-1,2.6351025e-05,0.9999542,1.9441888e-05
20524,thoughts,19,20,122,130,These findings confirmed the crucial role of Tregs as a therapeutic target in gastric cancer therapy and provided helpful thoughts for the design of immunotherapy for gastric cancer in the future.,23723999_5,-1,1,-1,1,20524,-1,6.796579e-05,0.9999094,2.260324e-05
14698,tumor,6,7,35,40,The inhibitory effect of IL-32 on tumor growth was associated with the inhibition of constitutive activated nuclear transcription factor-B (NF-B) and of signal transducer and activator of transcription 3 (STAT3).,21423208_3,-1,1,-1,1,14698,-1,1.734211e-05,0.9999733,9.4126435e-06
17362,total,11,12,81,86,The analysis of 4 trials employing nonmyeloablative chemotherapy with or without total body irradiation (TBI) before adoptive T-cell transfer revealed that the percentage and number of reconstituting CD4(+)FoxP3(+) Tregs observed in the peripheral blood was higher in nonresponders than in responders.,22555974_2,-1,1,-1,1,17362,-1,0.00014257013,0.9997904,6.709221e-05
27689,the,17,18,116,119,"We found that PRC2 components and demethylase JMJD3-mediated histone H3 lysine 27 trimethylation (H3K27me3) repress the expression and subsequent production of Th1-type chemokines CXCL9 and CXCL10, mediators of effector T-cell trafficking.",26567139_4,-1,1,-1,1,27689,-1,1.8237846e-05,0.9999728,8.969866e-06
37049,The,0,1,0,3,The findings were validated using tissue microarrays from another two independent cohorts totaling 841 HCC patients undergoing curative resection.,31201473_3,-1,1,-1,1,37049,-1,1.8211831e-05,0.99997306,8.687364e-06
16506,the,2,3,14,17,"Subsequently, the influence of therapy on those components of immune system was assessed.",22223085_2,-1,1,-1,1,16506,-1,1.8934072e-05,0.99997365,7.392208e-06
41067,Foxp3,4,5,25,30,"The expression levels of Foxp3 and TGF in transplanted tumor tissues were detected by quantitative fluorescence PCR.RESULTS: Compared with healthy people, Treg cells and IL-2, IL-10, and TGF contents in peripheral blood of liver cancer patients were increased.",33204731_5,-1,1,-1,1,41067,-1,2.2384398e-05,0.9999621,1.5490217e-05
37896,to,21,22,148,150,"Intriguingly, HDAC6-depleted T cells trigger programmed cell death protein 1 (PD-1)-PD-1 ligand 1 expression to achieve a strong synergistic effect to sensitize advanced HCC to an immune checkpoint blocker, while blockade of IL-17A partially suppresses it.",31539182_3,-1,1,-1,1,37896,-1,1.9795292e-05,0.9999716,8.596383e-06
37099,tumor-infiltrating,4,5,22,40,IFN-I target genes in tumor-infiltrating and antigen-specific CTLs were identified and functionally analyzed.,31228946_4,-1,1,-1,1,37099,-1,3.2362997e-05,0.9999498,1.7791035e-05
14822,the,34,35,182,185,"Up-regulation of CXCR4 in Treg correlated with the basal-like phenotype (P = 0.029) and tumour hypoxia, as indicated by CA9 expression (P = 0.049).CONCLUSIONS: Our data show that in the setting of hypoxia and CXCR4 up-regulation in Treg, CXCL12 expression may have the negative consequence of enhancing Treg recruitment and suppressing the anti-tumour immune response.",21521526_8,-1,1,-1,1,14822,-1,1.8028386e-05,0.99997425,7.760607e-06
11148,the,18,19,91,94,It has been reported that an increased population of regulatory T cells (T-regs) is one of the reasons for impaired anti-tumor immunity.,20002703_0,-1,1,-1,1,11148,-1,3.482833e-05,0.99995136,1.3843146e-05
4622,Tregs,8,9,49,54,Early human studies suggest that an imbalance of Tregs and effector T cells may contribute to the development of graft-versus-host-disease.,17084366_3,-1,1,-1,1,4622,-1,2.2395332e-05,0.999964,1.3604573e-05
35084,tumor,17,18,119,124,"It is demonstrated that this biomimetic core-shell nanoplatform with oxygen generation can be partial to accumulate in tumor and downregulate the expression of hypoxia-inducible factor 1, which can further enhance the therapeutic effects of chemotherapy and reduce the expression of programmed death ligand 1 (PD-L1).",29882235_4,-1,1,-1,1,35084,-1,1.9491385e-05,0.9999696,1.0853691e-05
26352,Th17,7,8,42,46,"All these results demonstrated that Th22, Th17, and Th1 cells might be important therapeutic targets in CML and could facilitate a better outcome for tumor immunotherapy.",26000313_9,-1,1,-1,1,26352,-1,5.3894884e-05,0.999918,2.811407e-05
43350,TFEB,0,1,0,4,TFEB intrinsically regulates genes involved in Treg cell differentiation and mitochondria function while it suppresses expression of proinflammatory cytokines independently of its established roles in autophagy.,35895684_4,-1,1,-1,1,43350,-1,2.836698e-05,0.9999596,1.2054838e-05
12255,Tregs,22,23,116,121,"On the other hand, conventional GCs were characterized by a paucity of CXCR3(+) T cells and a relative abundance of Tregs.",20422211_7,-1,1,-1,1,12255,-1,2.1874706e-05,0.9999658,1.2384504e-05
4025,Tregs,6,7,43,48,"Tumor challenge increased the frequency of Tregs in lymph nodes, and untreated tumors became infiltrated by CD4+Foxp3- and CD4+Foxp3+ T cells but few CD8+ T cells.",16778987_2,-1,1,-1,1,4025,-1,2.458703e-05,0.99996114,1.4321766e-05
42388,this,7,8,46,50,"Among various mechanisms of immunescaping, in this study, we characterized the modulation of the phenotypic profile of CD4+ and CD8+ cells in resting and activated states, in response to the mechanical pressure exerted by a three-dimensional in vitro system, able to recapitulate the rheological and stiffness properties of the tumor ECM.",34070750_5,-1,1,-1,1,42388,-1,2.0505642e-05,0.9999683,1.1204213e-05
19953,the,2,3,13,16,We evaluated the effectiveness of rhamnogalacturonan II (RG-II)-stimulated bone marrow-derived dendritic cells (BMDCs) vaccination on the induction of antitumor immunity in a mouse lymphoma model using EG7-lymphoma cells expressing ovalbumin (OVA).,23392255_0,-1,1,-1,1,19953,-1,1.7837112e-05,0.9999738,8.418289e-06
39405,generally,7,8,30,39,T regulatory (Treg) cells are generally considered a tumor-promoting immune cell type in malignant cancers with currently unclear roles in pituitary adenoma patients.,32279926_2,-1,1,-1,1,39405,-1,3.2148364e-05,0.9999485,1.9404972e-05
29682,Thus,0,1,0,4,"Thus, repressing KLRG1 on human memory T cells might be a novel therapeutics against cancer.",27557510_7,-1,1,-1,1,29682,-1,3.0357263e-05,0.9999577,1.1914554e-05
21624,Tregs,4,5,23,28,"The CCR5 expression on Tregs was downregulated in the antibody-treated mice, which may explain the decrease of tumor-infiltrating Tregs.",24289533_8,-1,1,-1,1,21624,-1,2.111926e-05,0.99996793,1.0906746e-05
27765,that,2,3,9,13,"We found that CD8(+) T cells missing HDAC5 had a reduced ability to produce the cytokine, IFN-, in vitro and in vivo, which may offset the benefit of weakened Treg function and formation.",26704363_8,-1,1,-1,1,27765,-1,1.8166804e-05,0.9999714,1.0474627e-05
39624,targeting,9,10,61,70,"Currently, there are no therapeutic strategies available for targeting WNT/-catenin signaling.",32332858_3,-1,1,-1,1,39624,-1,2.0408423e-05,0.99996996,9.64639e-06
33200,tumor,18,19,116,121,The tumor microenvironment of DL cell progression has highly deleterious effect on NK cells after massive growth of tumor burden in BALB/c mice.,28891726_9,-1,1,-1,1,33200,-1,2.052947e-05,0.999969,1.0410905e-05
20425,tumour,16,17,83,89,"Regulatory T (Treg) cells play a pivotal role in maintaining immune tolerance, but tumour growth is associated with local immunosuppression, which can subvert effector immune responses.",23657628_1,-1,1,-1,1,20425,-1,2.2734816e-05,0.99996674,1.0467469e-05
34942,to,4,5,24,26,"The present study aimed to investigate the number and suppressive potential of Tregs that possess natural nave-(N nTregs), effector/memory-like (EM nTregs), and Tr1-like phenotypes in breast cancer patients and healthy women.",29797233_3,-1,1,-1,1,34942,-1,1.6148224e-05,0.9999746,9.231575e-06
32885,play,7,8,30,34,The regulatory T cells (Treg) play an important role in the tumor tolerance.,28731226_0,-1,1,-1,1,32885,-1,2.555141e-05,0.99995756,1.6911352e-05
10688,tumor,42,43,304,309,"Using MUC1 peptide and IL-2 for ex vivo CD4(+)/Th1 effector cell generation, we show that three monthly treatment cycles of peripheral blood T cell restimulation and intraperitoneal re-infusion selectively modulated endogenous T cell-mediated immune responses that correlated with diminished serum CA125 tumor marker levels and enhanced patient survival.",19762283_2,-1,1,-1,1,10688,-1,2.1454094e-05,0.99996626,1.2285813e-05
24121,the,5,6,28,31,"We found that PDT abrogated the suppressive capacity of peripheral Treg (Days 7 and 14, p = 0.016) but had no effect on Treg levels.",25005268_5,-1,1,-1,1,24121,-1,1.7006434e-05,0.9999747,8.286425e-06
43881,the,10,11,62,65,Stimulation of activated LN cells with D5 tumor cells induced the nuclear translocation of NF-kappaB. These findings indicate that the recovery of proteins mediating signal transduction through the T cell receptor/CD3 complex in LN T cells activated ex vivo was associated with the acquisition of antitumor function.,9690455_8,-1,1,-1,1,43881,-1,1.7556506e-05,0.9999739,8.523746e-06
18078,the,8,9,41,44,We also studied the role of IFN-gamma in the mechanism of Treg induction.,22812187_5,-1,1,-1,1,18078,-1,1.923486e-05,0.9999726,8.186899e-06
6024,T(regs,5,6,31,37,"Thus, increased frequencies of T(regs) in cervical cancer patients may indeed suppress HPV-specific immunity.",17937675_6,-1,1,-1,1,6024,-1,2.3056273e-05,0.99995756,1.9366986e-05
29910,tongue,4,5,34,40,Well to moderately differentiated tongue SCC was induced in all of the experimental mice.,27614428_5,-1,1,-1,1,29910,-1,3.5569476e-05,0.9999424,2.1994641e-05
33752,TIGIT,27,28,173,178,"Importantly, STAT3-blocked whole HCC cell lysates prevented HCC-mediated exhaustion of T cells and NK cells, showing low expression of checkpoint molecules such as PD-1 and TIGIT on T cells and NK cells in the immunized mice.",29115974_7,-1,1,-1,1,33752,-1,4.8549635e-05,0.99990404,4.738728e-05
25183,These,0,1,0,5,These results were not observed when neutralization of CCL2 was performed in thymectomized mice.,25382729_6,-1,1,-1,1,25183,-1,2.0944663e-05,0.9999701,8.968063e-06
41294,to,9,10,64,66,"In this respect, alternative splicing is increasingly described to affect the immune system.",33419764_2,-1,1,-1,1,41294,-1,2.7124177e-05,0.9999629,9.950574e-06
31793,T,12,13,61,62,Dendritic cells (DCs) have great potential to sensitize CD4+ T and CD8+ T cells to precisely target and eradicate GBM.,28412740_3,-1,1,-1,1,31793,-1,2.8936183e-05,0.9999473,2.3721312e-05
1556,the,8,9,58,61,"Although additional studies are clearly needed to clarify the mechanism(s) underlying improved anti-tumor immunity in Stat6(-/-) and CD1(-/-) mice, deletion of these genes results in a potent anti-tumor immunity and may be a basis for an immunotherapy strategy.",14593499_8,-1,1,-1,1,1556,-1,1.844143e-05,0.9999747,6.8688223e-06
33299,the,7,8,41,44,"Our data identify IRF-1 as important for the antitumor efficacy of CTX and for the regulation of many immunomodulatory activities of CTX, such as Th1 polarization, Treg depletion and inflammation.",28975621_8,-1,1,-1,1,33299,-1,1.9047364e-05,0.9999733,7.636306e-06
1270,the,20,21,117,120,"Macrophages from mice bearing large mammary tumors show an impaired production of IL-12 and NO, whereas T cells from the same animals display a deficient production of IFN-gamma.",12527946_5,-1,1,-1,1,1270,-1,2.2018443e-05,0.9999645,1.3549939e-05
32224,treatment,24,25,167,176,"Therefore, identifying the cellular and molecular components in colorectal tumors is necessary for the understanding of tumor progression and the development of novel treatment strategies.",28558303_1,-1,1,-1,1,32224,-1,2.4809211e-05,0.9999629,1.2300227e-05
7264,tumors,1,2,9,15,"EG.7-OVA tumors, administration of P17 improved their proliferation, reduced the number of CD4+Foxp3+ T cells, and inhibited tumor growth.",18566377_6,-1,1,-1,1,7264,-1,1.8671311e-05,0.99996734,1.3952262e-05
29456,The,0,1,0,3,The flow cytometry results showed that the ratios of CD4(+)CD25(+)Foxp3(+) Tregs to lymphocytes and CD4(+) cells in the spleen and in peripheral blood were significantly decreased after treatment with IFN (P<0.05).,27389040_6,-1,1,-1,1,29456,-1,1.81124e-05,0.99997234,9.598218e-06
4824,These,0,1,0,5,These results support a rationale for manipulating Treg to enhance cancer immunotherapy.,17205133_7,-1,1,-1,1,4824,-1,2.2644623e-05,0.9999684,8.992388e-06
28603,to,46,47,274,276,"Depletion of FOXP3(hi) Treg cells from tumor tissues, which would augment antitumor immunity, could thus be used as an effective treatment strategy for CRCs and other cancers, whereas strategies that locally increase the population of FOXP3(lo) non-Treg cells could be used to suppress or prevent tumor formation.",27111280_8,-1,1,-1,1,28603,-1,1.9952766e-05,0.9999721,7.914908e-06
5506,STAT3,38,39,228,233,"Therefore, IL-6 and G-CSF in BxCM represent two main factors responsible for suppression of DC differentiation, maturation, and antigen presentation, and this suppression of DC functions may be due to the aberrant activation of STAT3 by BxCM.",17545630_12,-1,1,-1,1,5506,-1,2.14969e-05,0.99996436,1.4099543e-05
6103,To,0,1,0,2,"To study the impact of JunB on mast cell biology, we analyzed JunB-deficient mast cells.",17982078_3,-1,1,-1,1,6103,-1,1.8895455e-05,0.999972,9.07221e-06
7767,the,16,17,93,96,"Moreover, their frequencies were 3- to 5-fold higher in tumors than in peripheral blood from the same patients or healthy donors, respectively.",18820132_4,-1,1,-1,1,7767,-1,2.0373665e-05,0.9999678,1.1759862e-05
22964,this,33,34,210,214,"The purpose of this study was to characterize the immune response elicited by TLR-9-activated OSCC cells, to identify the cytokines involved in the signaling pathway and to elucidate the molecular mechanism of this pathway in OSCC cells.",24676671_1,-1,1,-1,1,22964,-1,2.2774659e-05,0.99996483,1.2402032e-05
31090,STAT5,21,22,121,126,"We also noted a trend of increased expression of IL-2, IL-12 and IL-15 receptors as well as increased phosphorylation of STAT5 in tumor-infiltrating CD8+T-cells following bortezomib treatment.",28052005_7,-1,1,-1,1,31090,-1,2.8746908e-05,0.9999527,1.8582274e-05
13791,The,0,1,0,3,The positive prognostic influence of high TGF-1 mRNA expression levels may reflect immune promoting functions of TGF- in combined activity with inflammatory cytokines.,21150720_9,-1,1,-1,1,13791,-1,2.0999474e-05,0.9999715,7.4869936e-06
32675,TAMs,19,20,122,126,"MATERIALS AND METHODS: To elucidate the immunomodulatory effects of IQM on the tumor microenvironment, we isolated CD11b+ TAMs and splenic CD11b+ cells and evaluated the immunomodulatory effects of IQM, using the B16F10 melanoma model.",28668835_3,-1,1,-1,1,32675,-1,2.524065e-05,0.9999603,1.4420623e-05
24619,to,19,20,119,121,"We found that HMGB1 promotes the development of MDSCs from bone marrow progenitor cells, contributing to their ability to suppress antigen-driven activation of CD4(+) and CD8(+) T cells.",25164013_7,-1,1,-1,1,24619,-1,2.0377647e-05,0.9999696,1.0058243e-05
9851,to,20,21,125,127,"EXPERIMENTAL DESIGN: T lymphocytes from peripheral blood of healthy donors and of American Joint Committee on Cancer stage I to IV melanoma patients, as well as from metastatic lymph nodes of patients, were evaluated for responsiveness to IL-2.",19509154_1,-1,1,-1,1,9851,-1,6.648743e-05,0.999881,5.245058e-05
37443,genetic,4,5,21,28,"Using this and other genetic models, we showed that Treg cells shaped the transcriptional landscape across multiple tumor-infiltrating immune cell types.",31350177_2,-1,1,-1,1,37443,-1,4.5705994e-05,0.99987054,8.368104e-05
24896,tumor,4,5,24,29,"Galectins, expressed in tumor, stromal, and endothelial cells, contribute to thwart the development of immune responses by favoring the expansion of T regulatory cells and contributing to their immunosuppressive activity, driving the differentiation of tolerogenic dendritic cells, limiting T cell viability, and maintaining T cell anergy.",25253145_2,-1,1,-1,1,24896,-1,2.262523e-05,0.99996436,1.2980675e-05
21459,The,0,1,0,3,The discovery of additional CD4 Th cell subsets has extended our understanding of Th cell differentiation beyond this dichotomy.,24215739_2,-1,1,-1,1,21459,-1,2.2698589e-05,0.9999684,8.945361e-06
10610,the,32,33,166,169,"COS-7 cells transduced with the mouse (m) p28 gene secreted a monomeric mp28 protein; however, those transduced with the mEBI3 gene did not detect a mEBI3 protein in the culture supernatants.",19740343_3,-1,1,-1,1,10610,-1,1.8019458e-05,0.999972,9.973961e-06
18360,trial,44,45,298,303,"CONCLUSION: Although definitive conclusions cannot be drawn from a single case, the correlation with similar findings in GM-CSF-treated animals with experimental autoimmune myasthenia gravis suggests further exploration of the effects of GM-CSF in myasthenia gravis should be studied in a clinical trial setting.",22907239_1,-1,1,-1,1,18360,-1,2.7437538e-05,0.9999578,1.4755045e-05
40912,Tregs,13,14,56,61,"Regulatory B cells (Bregs) and CD4+ regulatory T cells (Tregs) are subgroups of immunoregulatory cells involved in modulating autoimmunity, inflammation, and transplantation reactions.",33083479_1,-1,1,-1,1,40912,-1,2.2731598e-05,0.99996245,1.4785188e-05
19870,The,2,3,9,12,"METHODS: The expression of TGF-1 was investigated in Huh7, Hep 3B, SGC-7901, Eca-109 and Hepa1-6 cell lines using immunofluorescence.",23361571_1,-1,1,-1,1,19870,-1,1.6850423e-05,0.9999751,8.039858e-06
13169,the,2,3,9,12,"However, the molecular mechanism of the phenomenon remains unclear.",20822377_2,-1,1,-1,1,13169,-1,2.2643764e-05,0.99996865,8.728741e-06
9822,that,9,10,43,47,"Hence, our goal is to establish a protocol that will lead to consistent ex vivo generation of lymphocytes skewed toward a central memory phenotype.",19501956_1,-1,1,-1,1,9822,-1,2.0840253e-05,0.99996984,9.3199915e-06
29091,STAT5,3,4,18,23,The inhibition of STAT5 pathways via siRNA interference or a specific inhibitor eliminated the up-regulation of NKG2D and TNF- in rapamycin-treated V4  T cells.,27256566_5,-1,1,-1,1,29091,-1,3.3983433e-05,0.99992955,3.6456953e-05
19172,The,0,1,0,3,The vaccine efficacy was correlated with increased percentages of CD8(+) T cells expressing IFN- as well as potent killing responses of both CD8(+) T and NK cells in the absence of detectable antibodies to ssDNA as a sign of autoimmunity.,23144888_5,-1,1,-1,1,19172,-1,2.0396617e-05,0.9999713,8.3428295e-06
15209,the,45,46,247,250,"BACKGROUND: The purpose of this study was to investigate the presence of CD4(+) CD25(+) FOXP3(+) regulatory T (Treg) cells both in peripheral blood and local tumors in patients with nasal inverted papilloma (NIP).METHODS: By using flow cytometry, the frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in both peripheral blood and tissues from 18 patients with NIP and 8 control subjects were determined.",21674673_0,-1,1,-1,1,15209,-1,1.6979733e-05,0.99997413,8.8682855e-06
24949,These,0,1,0,5,"These results demonstrate that nicotine suppresses acute colitis and colitis-associated tumorigenesis, and this effect may be associated with the activation of 7-nAChR. Furthermore, it is presumed that nicotine downregulates the expression of inflammatory mediators such as IL-6/Stat3 and TNF-, thereby reducing the colonic tumorigenesis associated with chronic colitis.",25258409_9,-1,1,-1,1,24949,-1,1.8511502e-05,0.99997175,9.731796e-06
36788,Tregs,8,9,43,48,RESULTS: Our data demonstrated that FOXA1+ Tregs were increased in lung cancer.,31036318_10,-1,1,-1,1,36788,-1,2.0997037e-05,0.9999651,1.3935342e-05
4042,the,34,35,215,218,"While Gvax primed the tumor-reactive Teff compartment, inducing activation, tumor infiltration, and a delay in tumor growth, the combination with CTLA4 blockade induced greater infiltration and a striking change in the intratumor balance of Tregs and Teffs that directly correlated with tumor rejection.",16778987_4,-1,1,-1,1,4042,-1,1.6490661e-05,0.9999752,8.303596e-06
7790,the,3,4,15,18,"The results of the present work show that Foxp3, a transcriptional marker of natural CD4+CD25+ Treg, is not expressed by CD8+CD28- Treg, thus indicating different origin and pathways of function for the latter with respect to the former regulatory cell type.",18832002_2,-1,1,-1,1,7790,-1,2.06324e-05,0.99996924,1.0066549e-05
40527,the,12,13,94,97,CONCLUSION: DHA induces mitochondrial apoptosis and alters cytokines expression by inhibiting the phosphorylation of STAT3.,32859456_12,-1,1,-1,1,40527,-1,1.8399707e-05,0.9999728,8.77183e-06
35470,to,24,25,140,142,"Here, we investigate the lineage commitment specifically in tumour, lymph nodes and blood and relate them to the disease stage and response to neoadjuvant chemotherapy.",30075815_7,-1,1,-1,1,35470,-1,3.0288766e-05,0.99995804,1.1720157e-05
9998,the,22,23,154,157,"In animal models of allergic airways disease, Tregs can suppress established airway inflammation and airway hyperresponsiveness, and protocols to enhance the development, recruitment and function of Tregs have been described.",19538496_5,-1,1,-1,1,9998,-1,1.902198e-05,0.99997187,9.106266e-06
30010,the,7,8,44,47,The percentage of CD127dim/- cells and also the MFI of FoxP3 expression was significantly lower in CD4+CD25-FoxP3+ in comparison with CD4+CD25+FoxP3+ population.,27619682_6,-1,1,-1,1,30010,-1,1.983331e-05,0.99997056,9.621974e-06
903,Therefore,0,1,0,9,"Therefore, 15-d-PGJ(2) can act as a potent proinflammatory mediator in activated T cells by inducing the production of IL-8.",11801678_11,-1,1,-1,1,903,-1,2.367687e-05,0.9999633,1.30687395e-05
42091,the,5,6,28,31,"Since DNAM-1 is involved in the pathogenesis of various inflammatory diseases and cancers in humans as well as mouse models, it is a potential target for immunotherapy for these diseases.",33900821_1,-1,1,-1,1,42091,-1,1.9575466e-05,0.999972,8.469199e-06
23395,that,16,17,100,104,"These findings suggest a novel potential therapeutic role for CPT in tumor therapy, and demonstrate that CPT performs its antitumor functions through cytotoxic CD4+ T cells.",24761844_7,-1,1,-1,1,23395,-1,1.7878634e-05,0.99997294,9.13167e-06
5179,the,6,7,51,54,These observations have important implications for the establishment of EBV-associated malignancy in the context of infection with tumour-associated EBV LMP1 variants.,17372611_5,-1,1,-1,1,5179,-1,1.7929817e-05,0.9999753,6.700068e-06
24381,therapeutic,54,55,367,378,"Here, for the first time, we developed a novel combination adjuvant alum-polysaccharide-HH2 (APH) with potent immunomodulating activities, consisting of alum, polysaccharide of Escherichia coli and the synthetic cationic innate defense regulator peptide HH2.METHODS: The adjuvant effects of APH were examined using NY-ESO-1 protein-based vaccines in prophylactic and therapeutic models.",25070035_2,-1,1,-1,1,24381,-1,3.084751e-05,0.99995613,1.3036183e-05
9426,Thus,0,1,0,4,"Thus, not the tumor itself, but its location dictates the efficiency of the anti-tumor immune response.",19337997_8,-1,1,-1,1,9426,-1,2.6384556e-05,0.99995947,1.417557e-05
3368,their,14,15,110,115,"CD1-deficient mice reject established, disseminated 4T1 metastatic mammary cancer and survive indefinitely if their primary mammary tumors are surgically removed.",16357187_0,-1,1,-1,1,3368,-1,3.0329125e-05,0.9999573,1.2383242e-05
24592,the,11,12,64,67,"PATIENT SUMMARY: In this review, we analysed studies evaluating the impact of inflammatory response on bladder cancer progression.",25151017_12,-1,1,-1,1,24592,-1,1.8067263e-05,0.99997306,8.822403e-06
28940,the,4,5,36,39,"Among immunotherapeutic strategies, the immunostimulatory cytokine IL-15 could represent a serious candidate for the reactivation of antitumor immunity.",27217584_1,-1,1,-1,1,28940,-1,2.2266768e-05,0.99996805,9.695853e-06
43022,that,6,7,31,35,"In conclusion, our data showed that I2 supplements induce the activation of the immune response and that when combined with Cht, the Th1 pathways are stimulated.",34680134_7,-1,1,-1,1,43022,-1,2.0741318e-05,0.9999691,1.0084248e-05
3338,the,17,18,100,103,We report here that a DNA vaccine comprising a modified PDTRP plasmid and GM-CSF coding sequence at the C-terminus induced better protection against tumor challenge.,16341143_1,-1,1,-1,1,3338,-1,2.0730458e-05,0.99996805,1.1243708e-05
28251,Treg,9,10,60,64,"Taken together, our results indicate that investigations of Treg levels in different cancers should consider diverse Treg-related markers such as GARP, LAP, Helios, and others and not only FoxP3 as a sole Treg-specific marker.",26885615_8,-1,1,-1,1,28251,-1,2.7197573e-05,0.9999577,1.5089141e-05
14816,to,18,19,91,93,"There was a tendency for luminal cancers to show CXCL12 expression (102/138, 74%) compared to basal-like cancers (16/27, 59%), which verged on statistical significance (P = 0.050).",21521526_7,-1,1,-1,1,14816,-1,2.0441286e-05,0.9999683,1.1278905e-05
34601,the,10,11,58,61,These results suggest that Tr1 cells might be involved in the regulating immune responses in H. pylori infection and gastric cancer development.,29625086_7,-1,1,-1,1,34601,-1,2.1301743e-05,0.99996936,9.356465e-06
7292,they,37,38,186,190,"A fraction of cervicitis, CIN I, CIN II and CIN III had natural (n) regulatory T cells (Tregs); their lesional distribution was predominantly intraepithelial in cervicitis, while in CIN they were also present in the stroma.",18593438_5,-1,1,-1,1,7292,-1,2.5617162e-05,0.99995744,1.6948792e-05
11311,to,24,25,140,142,"Anti-CD25 mAb, indeed, only partially depleted CD4+CD25+FoxP3+ Treg cells, whereas anti-CD4 mAb was more effective in this respect, leading to 90% depletion of Treg cells.",20039320_4,-1,1,-1,1,11311,-1,2.3205688e-05,0.9999665,1.0344816e-05
29125,transcripts,7,8,29,40,"The elevated levels of 4-1BB transcripts in TLR1-TLR2-stimulated cells were not due to increased mRNA stability nor increased histone activation, but instead were associated with increased binding of p65 and c-Jun to two distinct 4-1BB promoter sites.",27267778_6,-1,1,-1,1,29125,-1,2.0903684e-05,0.999962,1.717052e-05
14996,to,26,27,212,214,The very recently discovered neutralizing autoantibodies (autoAbs) against Th17-related cells and cytokines in two autoimmunity-related syndromes associated with AIRE-mutant thymi or AIRE-deficient thymomas help to explain the chronic mucocutaneous candidiasis (CMC) seen in both syndromes.,21574164_2,-1,1,-1,1,14996,-1,2.6939635e-05,0.99996245,1.0667912e-05
15769,therapeutic,10,11,71,82,These findings provide novel insight for the pathogenesis and possible therapeutic strategy of B-cell NHL.,21898141_6,-1,1,-1,1,15769,-1,2.6801468e-05,0.9999598,1.33282065e-05
7118,the,29,30,183,186,"Regulatory T cells (Treg) enriched in FoxP3+, glucocorticoid-induced TNF receptor+, and cytotoxic T-lymphocyte-associated antigen-4+ exert a potential to suppress effector T cells in the periphery.",18512029_0,-1,1,-1,1,7118,-1,1.9873192e-05,0.9999691,1.0943946e-05
12029,the,6,7,27,30,"In this study, we analyzed the impact of administration of dendritic cell (DC) vaccination in combination with low-dose interleukin (IL)-2 in patients with metastatic renal cell carcinoma on the frequency of CD4+CD25highFoxp3+ Treg cells in peripheral blood.",20386464_1,-1,1,-1,1,12029,-1,1.6998847e-05,0.99997485,8.15612e-06
11382,the,21,22,119,122,"Since members of this family of cytokines are known to exhibit their effects on diverse immune cells, we have examined the effects of IL-21 on CLL patient derived regulatory T cell (Treg) induction, expansion and the inhibitory effect on natural killer cells in vitro.",20081380_3,-1,1,-1,1,11382,-1,1.7942528e-05,0.99997365,8.39243e-06
27923,TGF,18,19,123,127,Alveolar macrophages from IKTA mice supported increased generation of inducible Foxp3+ Tregs ex vivo through expression of TGF and IL-10.,26756215_5,-1,1,-1,1,27923,-1,2.9678182e-05,0.9999571,1.3218245e-05
12257,the,5,6,31,34,"Furthermore, the stroma inside the cancer was characterized by even less CXCR3(+) cells, suggesting a strongly immunosuppressive microenvironment.",20422211_8,-1,1,-1,1,12257,-1,1.8029792e-05,0.9999702,1.1797958e-05
38565,This,0,1,0,4,This study aims to investigate the ability of transcription factors in regulating tumor immune microenvironment in lung adenocarcinoma.,31898342_1,-1,1,-1,1,38565,-1,1.7643306e-05,0.9999734,8.9175355e-06
14782,Treg,30,31,204,208,"Taken together, these findings suggest that IDO may represent an important regulatory checkpoint influencing Treg activity: both by stabilizing and augmenting the suppressive phenotype, and by preventing Treg reprogramming into non-suppressive helper-like cells.",21517755_7,-1,1,-1,1,14782,-1,2.4190002e-05,0.9999654,1.0403703e-05
38831,to,12,13,64,66,"Given the antitumor properties of Tc22 cells, it may be prudent to polarize T cells to the Tc22 lineage when using chimeric antigen receptor (CAR)-T or T-cell receptor (TCR) transduction-based immunotherapies.",31964625_6,-1,1,-1,1,38831,-1,2.2730686e-05,0.9999682,9.135389e-06
2017,state,11,12,73,78,"These fusion proteins are implicated in the pathogenesis of the leukemic state by recruiting corepressors and histone deacetylases (HDAC), which interfere with normal cell differentiation.",15197237_2,-1,1,-1,1,2017,-1,1.8166858e-05,0.9999647,1.707162e-05
25875,tumor-infiltrating,11,12,65,83,"Therefore, our study demonstrates that the modulation of AICD of tumor-infiltrating CD4(+) T cells using HDACIs can enhance anti-tumor immune responses, uncovering a novel mechanism underlying the anti-tumor effect of HDACIs.",25745993_7,-1,1,-1,1,25875,-1,4.137011e-05,0.9999331,2.553663e-05
40715,the,6,7,28,31,"In this study, we evaluated the effect of highly absorptive forms of curcumin extracts and synthetic curcumin on anti-tumor T cell responses.",33006786_2,-1,1,-1,1,40715,-1,1.7088265e-05,0.9999751,7.85196e-06
20284,to,4,5,22,24,"In addition, compared to exosomes from CT26 cells, CT26-CIITA-derived exosomes induced higher TNF- and IL-12 mRNA levels.",23621273_6,-1,1,-1,1,20284,-1,2.2864244e-05,0.9999654,1.1660552e-05
34917,the,28,29,148,151,"In CD4+CD25+ cells from MPEs, relative mRNA expression of FOXP3, CTLA-4, and CD28 genes was significantly higher than in benign effusions; however, the level of CD4+CD25+CTLA-4+ cells in analyzed groups showed no significant differences.",29785404_8,-1,1,-1,1,34917,-1,1.6865733e-05,0.9999745,8.666127e-06
5354,tryptophan,19,20,126,136,"Consequently, we obtained evidence that CA suppresses the functional activity of IDO, which catalyses oxidative catabolism of tryptophan, and significantly recovers the IDO-dependent T cell suppression.",17466914_3,-1,1,-1,1,5354,-1,0.00017962855,0.9997855,3.4938075e-05
16564,T(reg,19,20,139,144,Future strategies therefore might aim at combining IL-2 therapy with novel strategies to circumvent expansion and differentiation of nave T(reg) cells.,22276195_9,-1,1,-1,1,16564,-1,2.2404154e-05,0.9999602,1.741891e-05
25778,Thus,0,1,0,4,"Thus, we wondered whether TGF- or EGF was involved in the regulation of HLA-I during the development of prostate cancer cells.",25618241_3,-1,1,-1,1,25778,-1,2.1971056e-05,0.9999672,1.0823751e-05
25711,that,2,3,9,13,We found that microRNA-155 (miR-155) enabled tumor-specific CD8(+) T cells to mediate profound antitumor responses in lymphoreplete hosts that were not potentiated by immune-ablation.,25548153_1,-1,1,-1,1,25711,-1,1.7231736e-05,0.99997413,8.61142e-06
4018,their,18,19,105,110,We examined the mechanisms of action of anti-CTLA4 and a GM-CSF-transduced tumor cell vaccine (Gvax) and their impact on the balance of effector T cells (Teffs) and Tregs in an in vivo model of B16/BL6 melanoma.,16778987_1,-1,1,-1,1,4018,-1,2.1368809e-05,0.9999685,1.0145437e-05
30159,TILs,8,9,57,61,The molecular mechanisms driving high PD-1 expression on TILs have not been fully investigated.,27683557_1,-1,1,-1,1,30159,-1,2.4093597e-05,0.9999652,1.0701486e-05
42361,the,17,18,101,104,"Tumors, on their side, have developed escaping mechanisms from the immune system action ranging from the direct secretion of biochemical signals to an indirect reaction, in which the cellular actors of the tumor microenvironment (TME) collaborate to mechanically condition the extracellular matrix (ECM) making it inhospitable to immune cells.",34070750_1,-1,1,-1,1,42361,-1,1.8865367e-05,0.999972,9.170724e-06
20776,the,39,40,277,280,"This study reveals that mMSLN-VLP immunization is capable of controlling PC progression by effectively mounting an immune response against mMSLN, a tumor self-antigen, and altering the immunosuppressive tumor microenvironment via activation of pDCs-like cells and reduction in the frequency of CD4(+)foxp3(+)ICOS(-) Treg cells.",23874581_6,-1,1,-1,1,20776,-1,1.6620894e-05,0.99997365,9.756765e-06
35241,to,19,20,97,99,"Since 1970, the isolated and identified components of Brucea javanica (L.) Merr. have been known to contain anticancer effects, particularly antileukemic effect.",29966986_0,-1,1,-1,1,35241,-1,2.6180802e-05,0.9999633,1.05736435e-05
27732,to,14,15,89,91,"The enhanced recruitment by CCL22 produced by EBVaGC cells, the decreased emigration due to CCR7 downregulation on the Treg surface, the higher proliferation rate, and the lower apoptosis rate of Tregs at tumour sites may promote the accumulation of Tregs in EBVaGC.",26673957_6,-1,1,-1,1,27732,-1,2.6583724e-05,0.999962,1.14008735e-05
39730,Thus,0,1,0,4,"Thus, this study reveals that ERR regulates immune properties in the bone microenvironment that contributes to decreasing metastatic growth.",32366476_6,-1,1,-1,1,39730,-1,2.4750936e-05,0.9999639,1.1329545e-05
32238,TGF-,18,19,124,129,This CD19loCD27hi plasmablast subset presented high interleukin 10 (IL-10) expression but not transforming growth factor- (TGF-) secretion.,28558303_3,-1,1,-1,1,32238,-1,3.835858e-05,0.9999418,1.9818426e-05
41123,the,14,15,92,95,CD103+CD8+ cells co-express CD49a and CD69 and display a molecular profile characterized by the expression of PD-1 and CD39.,33205076_4,-1,1,-1,1,41123,-1,1.8328521e-05,0.9999722,9.4185325e-06
17397,transcription factor,19,21,98,118,"Here, we showed that the expression of perforin, CD95L, and promyelocytic leukemia zinc finger, a transcription factor required for maintenance of iNKT cell functions, was reduced or suppressed in CML patients at diagnosis, as compared with healthy individuals.",22585600_2,-1,1,-1,1,17397,-1,2.8610175e-05,0.99995327,1.8089715e-05
19909,TGF-1,17,18,92,98,Hepa1-6 cells inhibited IFN- and CD83 expression in CD8(+) or dendritic cells by secreting TGF-1.,23361571_7,-1,1,-1,1,19909,-1,4.8771417e-05,0.99990606,4.5178338e-05
22708,TGF-,3,4,18,23,CD70 induction by TGF- is Smad3-dependent and involves IL-2/Stat5 signaling.,24569779_4,-1,1,-1,1,22708,-1,3.1136133e-05,0.9999546,1.4332861e-05
34859,that,4,5,23,27,"Finally, we identified that depletion of CD8+ T cells rather than NK cells abrogated the antitumor activity of FM.CONCLUSIONS: Our results show for the first time that CD8+ T cells mediate the antitumor activity of FM at a non-toxic dose.",29784005_15,-1,1,-1,1,34859,-1,1.897632e-05,0.99997187,9.209408e-06
29349,temperature,26,27,182,193,"Sample preparation, temperature, and duration of dextramer exposure were important parameters affecting the dextramer-induced NFAT activation with 2h exposure in whole blood at room temperature being the optimal of the conditions tested.",27327144_8,-1,1,-1,1,29349,-1,4.1629384e-05,0.99993324,2.5071555e-05
39163,gene,3,4,18,22,"This suggests our gene signature may not only serve as an indicator of tumor immune status, but may be a promising tool to select high-risk patients who may benefit from immune checkpoint inhibitor therapy.",32028264_7,-1,1,-1,1,39163,-1,3.588045e-05,0.99993825,2.5905338e-05
16431,targeting,1,2,6,15,"Local targeting of interleukin-17A in experimental lung adenocarcinoma results in a reduction in tumour load, local expansion of interferon--producing CD4(+) T cells and a reduction in lung CD4(+)CD25(+)Foxp3(+) regulatory T cells.",22186896_3,-1,1,-1,1,16431,-1,2.3002585e-05,0.99996567,1.1385183e-05
6237,the,4,5,24,27,Many studies have shown the benefit of targeting this cell population by restoring self-tolerance.,18092144_1,-1,1,-1,1,6237,-1,2.1596314e-05,0.9999701,8.340409e-06
39577,The,0,1,0,3,The results of the present study may aid in identifying therapeutics that could further modulate the immune system during BC.,32323817_9,-1,1,-1,1,39577,-1,1.8505467e-05,0.9999728,8.650456e-06
12842,the,12,13,76,79,We further hypothesized that the AITL clone itself could be responsible for the preferential accumulation of MCs at sites of infiltration through the synthesis of CXCL-13 and its interaction with the CXCR3 and CXCR5 receptors expressed on MCs.,20595635_4,-1,1,-1,1,12842,-1,1.674714e-05,0.9999751,8.135164e-06
43530,tat,14,15,62,65,"Furthermore, a T cell line (H9) stably transfected with a HIV tat expression-vector secreted higher levels of IL-10.",8037735_4,-1,1,-1,1,43530,-1,2.4855832e-05,0.999954,2.1142077e-05
38132,T-ALL,34,35,196,201,"Glucocorticoids (GCs) are a central component of therapy for patients with T cell acute lymphoblastic leukemia (T-ALL), and although resistance to GCs is a strong negative prognostic indicator in T-ALL, the mechanisms of GC resistance remain poorly understood.",31687977_0,-1,1,-1,1,38132,-1,5.756911e-05,0.99988663,5.5767676e-05
28173,the,3,4,27,30,Constitutive activation of the KRAS oncogene in human malignancies is associated with aggressive tumor growth and poor prognosis.,26880715_0,-1,1,-1,1,28173,-1,1.808085e-05,0.9999722,9.68897e-06
3282,T-bet,17,18,104,109,"The impaired IFN-gamma production in JNK1-/- CD8+ T cells is associated with reduced expression of both T-bet and Eomesodermin, indicating that JNK1 regulates the transcription program of CD8+ T cells.",16237070_5,-1,1,-1,1,3282,-1,2.5174155e-05,0.99995744,1.7428865e-05
43771,the,11,12,57,60,"gamma IFN, in fact, induces endothelial cells to acquire the same features of KS cells, including the spindle morphology and the pattern of cell marker expression.",9446657_8,-1,1,-1,1,43771,-1,2.866422e-05,0.9999589,1.2498155e-05
24979,trait,5,6,31,36,Immune escape is a fundamental trait of cancer.,25261236_0,-1,1,-1,1,24979,-1,5.577111e-05,0.9999062,3.8057915e-05
29351,the,31,32,215,218,"Sample preparation, temperature, and duration of dextramer exposure were important parameters affecting the dextramer-induced NFAT activation with 2h exposure in whole blood at room temperature being the optimal of the conditions tested.",27327144_8,-1,1,-1,1,29351,-1,2.5164847e-05,0.99996436,1.05159015e-05
28051,These,0,1,0,5,These local Treg express a suppressive cytokine profile characterized by high IL-10 and low TGF- and IFN- production.,26782287_7,-1,1,-1,1,28051,-1,2.2445834e-05,0.9999659,1.1597632e-05
40843,released,25,26,155,163,"Blockade of ICOSL on DCs reduced priming of antigen-specific CD8+ and CD4+ T cells from nave donors in vitro Concentration of extracellular/soluble ICOSL released from vaccine DCs positively correlated with patient clinical outcomes, which we showed to be partially regulated by ADAM10/17 sheddase activity.",33051240_5,-1,1,-1,1,40843,-1,2.5476473e-05,0.9999597,1.4855534e-05
6983,to,18,19,120,122,Statistics indicate that the risk to develop colorectal cancer is higher in patients affected by ulcerative colitis and to a lesser extent by Crohn's disease and that such a risk is directly proportional to the number of years of active disease.,18473765_1,-1,1,-1,1,6983,-1,3.081336e-05,0.99995387,1.5287418e-05
22468,this,1,2,3,7,"In this study, we show that Notch receptors (mRNA and protein) are expressed in peripheral  T cells.",24489102_3,-1,1,-1,1,22468,-1,2.0675769e-05,0.99996805,1.1213115e-05
8709,tumor,4,5,35,40,Peripheral changes associated with tumor development were noted prior to effects within the CNS.,19226468_5,-1,1,-1,1,8709,-1,2.019125e-05,0.999969,1.0834253e-05
28115,transduced,7,8,44,54,Human monocyte-derived dendritic cells (DC) transduced with Ad.,26851223_6,-1,1,-1,1,28115,-1,3.8986018e-05,0.9999275,3.3477914e-05
28635,to,12,13,78,80,Atractylenolide I (AO-1) is a naturally occurring sesquiterpene lactone known to change the conformational ensemble of human MD-2 on EOC cells.,27118139_1,-1,1,-1,1,28635,-1,2.6347818e-05,0.9999633,1.0344378e-05
37047,Foxp3,24,25,134,139,"We performed immunohistochemical analyses of whole tumor sections from 224 patients to assess the expression of BDCA2, CD3, CD4, CD8, Foxp3, granzyme B, IL-17, and CD34.",31201473_2,-1,1,-1,1,37047,-1,2.9545867e-05,0.9999548,1.5669619e-05
10459,the,2,3,9,12,"However, the mechanism involved remains unclear.",19673890_2,-1,1,-1,1,10459,-1,2.388533e-05,0.99996674,9.351783e-06
29692,this,32,33,209,213,OBJECTIVE: This study is to investigate the association between the Treg/Th17 cells and prognosis of chronic lymphocytic leukemia (CLL).METHODS: Totally 50 CLL patients and 20 Health controls were included in this study.,27584054_0,-1,1,-1,1,29692,-1,2.0688081e-05,0.99996924,1.0083691e-05
37572,to,13,14,72,74,Both in vivo mouse tumor models and in vitro cell assays were performed to study the downstream signaling.,31427736_3,-1,1,-1,1,37572,-1,2.0348134e-05,0.9999708,8.830051e-06
42913,FOXP3,45,46,236,241,"Although Treg cell plasticity comes in various flavors, the major categories enclose the loss of Foxp3 expression, which is the master regulator of Treg cell lineage, giving rise to ""ex-Treg"" cells and the ""fragile"" Treg cells in which FOXP3 expression is retained but accompanied by the engagement of an inflammatory program and attenuation of the suppressive activity.",34539668_2,-1,1,-1,1,42913,-1,2.2537244e-05,0.99996555,1.19545975e-05
41321,the,17,18,85,88,"Engineered immune cells, such as chimeric antigen receptor (CAR) T cells, are facing the danger of an overt life-threatening immune response due to the ON-target OFF-tumor cytotoxicity and Cytokine Release Syndrome.",33514819_1,-1,1,-1,1,41321,-1,2.4586887e-05,0.99996674,8.687773e-06
28982,treatment,17,18,129,138,"Altogether, this work provides evidence that the sushi-IL-15R/IL-15 fusion protein RLI enhances antitumor activity of anti-PD-1 treatment and is a promising approach to stimulate host immunity.",27217584_10,-1,1,-1,1,28982,-1,2.5301313e-05,0.9999615,1.3257251e-05
34371,Tregs,24,25,158,163,"Cancers frequently express transforming growth factor- (TGF), which drives immune dysfunction in the tumor microenvironment by inducing regulatory T cells (Tregs) and inhibiting CD8+ and TH1 cells.",29467463_1,-1,1,-1,1,34371,-1,2.4201514e-05,0.9999615,1.4332673e-05
6333,this,1,2,3,7,"In this study, CpGs induced a complete response of large aggressive orthotopic MB49 bladder tumors, resulting in tumor-specific systemic immunity.",18157010_7,-1,1,-1,1,6333,-1,1.966472e-05,0.9999703,1.0044552e-05
7472,these,42,43,265,270,"These results indicate that the T regulatory cell features are induced in CTCL T cells by common gamma chain signaling cytokines such as IL-2 and do not represent a fully predetermined, constitutive phenotype independent of the local environmental stimuli to which these malignant mature CD4(+) T cells become exposed.",18684941_7,-1,1,-1,1,7472,-1,2.0166914e-05,0.9999684,1.1423367e-05
6652,to,27,28,149,151,"The administration of two or three doses of Neuro2a/IL-21 cell vaccine further increased the mean survival time to 54 and 75 days, and the cure rate to 27 and 33%, respectively, whereas the use of unmodified Neuro2a or mock-transfected cells had no effect.",18324400_6,-1,1,-1,1,6652,-1,2.7993252e-05,0.9999572,1.4779387e-05
13014,the,16,17,98,101,BACKGROUND: High-dose interferon-alpha 2b (IFN-alpha 2b) is the only approved systemic therapy in the United States for the adjuvant treatment of melanoma.,20712892_0,-1,1,-1,1,13014,-1,2.4333607e-05,0.99996495,1.0676508e-05
5341,the,1,2,3,6,"In the present study, we investigated whether p-Coumaric acid (CA), which is suggested to exhibit antioxidant properties, could suppress the functional expression of IDO in murine bone marrow-derived dendritic cells (BMDCs) stimulated with IFN-gamma.",17466914_1,-1,1,-1,1,5341,-1,2.008007e-05,0.9999701,9.807087e-06
22640,to,26,27,170,172,"Deficiency of TSC1 in iNKT cells results in resistance to -GalCer-induced anergy, manifested by increased expansion of and cytokine production by iNKT cells in response to secondary Ag stimulation.",24532578_5,-1,1,-1,1,22640,-1,2.9391033e-05,0.99995816,1.2495262e-05
39932,the,9,10,51,54,"ALP triggered DC maturation, which is dependent on the activation of the MAPK and NF-B signaling pathways.",32486094_5,-1,1,-1,1,39932,-1,2.0158388e-05,0.9999709,8.922686e-06
25101,this,21,22,140,144,"The presence of eosinophils correlated with disease stage: 78% of patients with advanced disease displayed eosinophil infiltration, whereas this was only seen in 11% of patients with patches (p<0.01), and in 48% of those with plaque disease.",25275020_2,-1,1,-1,1,25101,-1,2.2887041e-05,0.99996436,1.2770743e-05
2620,types,30,31,190,195,"In this report, by using an ideal mouse model that expresses IFN-gamma locally in muscle, we demonstrate that sustained low-level expression of IFN-gamma promotes the development of several types of tumor including H22 hepatoma, MA782/5S mammary adenocarcinoma and B16 melanoma.",15776283_1,-1,1,-1,1,2620,-1,3.1122156e-05,0.9999386,3.0267502e-05
4191,the,8,9,45,48,"We examined the hypothesis that a failure of the immune system to eradicate tumors is due to the immunosuppressive environment created by the growing tumor, which is influenced by the site of tumor growth.",16818744_0,-1,1,-1,1,4191,-1,1.801112e-05,0.9999726,9.430274e-06
38623,triple-negative,6,7,43,58,Tumor-associated macrophages (TAM) promote triple-negative breast cancer (TNBC) progression.,31911557_0,-1,1,-1,1,38623,-1,6.878181e-05,0.99988806,4.317634e-05
15457,the,26,27,179,182,"The steps in this process are regulated through a complex transcriptional network, specific receptor-ligand pair interactions, and sensitization to trophic factors, which mediate the homing, proliferation, survival, and differentiation of developing T cells.",21740230_4,-1,1,-1,1,15457,-1,1.851609e-05,0.9999707,1.08266995e-05
7475,the,7,8,42,45,BACKGROUND: The FOXP3 mRNA expression and the other regulatory T cell-related molecules were investigated and compared with clinicopathological parameters in human primary breast cancer.,18685848_0,-1,1,-1,1,7475,-1,2.007183e-05,0.99996793,1.1941853e-05
1586,T,18,19,102,103,"Little is known, however, about the nature of the physiological target antigens for CD4(+) regulatory T (Treg) cells.",14738769_1,-1,1,-1,1,1586,-1,2.2469707e-05,0.99995315,2.436892e-05
37253,treatment,1,2,11,20,Phenelzine treatment reduced nuclear demethylase activity and increased transcription and expression of M1-like signatures both in vitro and in a murine triple-negative breast cancer model.,31249575_3,-1,1,-1,1,37253,-1,2.1416876e-05,0.9999676,1.0956252e-05
40304,Plasma,0,1,0,6,"Plasma gelsolin (pGSN) is transported by exosomes (small extracellular vesicle, sEV) and plays a key role in ovarian cancer chemoresistance, yet little is known about its role in immunosurveillance.",32641415_2,-1,1,-1,1,40304,-1,2.6572816e-05,0.99996066,1.2760541e-05
10634,that,2,3,11,15,We propose that p28 can be a regulatory subunit for IL-27-mediated cellular immune responses and a possible therapeutic agent to suppress unfavourable immune responses.,19740343_10,-1,1,-1,1,10634,-1,1.7392145e-05,0.999974,8.581774e-06
24845,to,22,23,158,160,SAP-deficient 24 transgenic T cells (24 T cells) exhibited an immature phenotype with reduced Th2 cytokine-producing capacity and diminished cytotoxicity to CD1d-expressing lymphoma cells.,25236978_4,-1,1,-1,1,24845,-1,6.8276124e-05,0.9998779,5.380291e-05
5078,to,20,21,104,106,Regulatory T cells can suppress activated CD4+ and CD8+ T effector cells and may serve as an impediment to spontaneous or therapeutic type 1 antitumor immunity.,17339434_0,-1,1,-1,1,5078,-1,5.9684146e-05,0.9999162,2.4058667e-05
25931,nuclear factor kappa-B,14,17,84,106,There is accumulating evidence that the transforming growth factor beta (TGF-) and nuclear factor kappa-B (NFB) pathways are tightly connected and play a key role in malignant transformation in cancer.,25832000_0,-1,1,-1,1,25931,-1,4.0012397e-05,0.99993765,2.2361064e-05
15124,Foxp3,27,28,145,150,"Employing IL-2 responsive (B16-F1, B16-BL6, JB/MS, MCA-205) and nonresponsive (JB/RH, B16-F10) subcutaneous tumor mouse models, we evaluated CD8 Foxp3+ T cell distribution and changes in response to rhIL-2 (50,000 U, i.p. or s.q., twice daily for 5 days).",21638127_2,-1,1,-1,1,15124,-1,3.1914933e-05,0.99994993,1.817248e-05
3933,Foxp3,11,12,86,91,Analysis of tumor-infiltrating T lymphocyte populations showed that the expression of Foxp3 and IL-10 was associated with CD4(+)CD25(+) T cells.,16751376_6,-1,1,-1,1,3933,-1,2.290091e-05,0.9999645,1.263646e-05
9970,Th2,13,14,81,84,"Airway inflammation in asthma is characterized by activation of T helper type-2 (Th2) T cells, IgE production and eosinophilia.",19538496_0,-1,1,-1,1,9970,-1,6.8615984e-05,0.99987566,5.573931e-05
30944,to,10,11,70,72,"Th1-type immunity is considered to be required for efficient response to BCG in bladder cancer, although Th2 predisposition of BCG responders has recently been reported.",28005163_0,-1,1,-1,1,30944,-1,3.5119218e-05,0.99995077,1.4060398e-05
30628,that,34,35,234,238,"Since these sublines showed a remarkable reduction of FoxO1 transcription factor, which regulates various cell cycle regulators in asbestos-exposed sublines, the cell cycle progression in these sublines was examined and compared with that of the original MT-2 cells.",27878235_3,-1,1,-1,1,30628,-1,2.3535627e-05,0.9999634,1.308201e-05
24159,transferring,20,21,107,119,"NK cells were shown to be necessary and sufficient in NK or T cell depletion experiments, or by adoptively transferring NK cells.",25015826_5,-1,1,-1,1,24159,-1,2.8674116e-05,0.9999521,1.930516e-05
86,IkappaBalpha,23,24,163,175,"Tumor-derived soluble products from cultured RCC explants inhibit NFkappaB activity in T cells from healthy volunteers, despite a normal level of stimulus-induced IkappaBalpha degradation in these cells.",10491412_2,-1,1,-1,1,86,-1,6.40986e-05,0.9999032,3.2706474e-05
43903,the,5,6,24,27,"T lymphocytes from 6 of the 14 patients also exhibited an increased expression of the dual specificity phosphatase, map kinase phosphatase-1 (MKP-1).",9724088_4,-1,1,-1,1,43903,-1,2.4472916e-05,0.999961,1.4528484e-05
786,the,2,3,9,12,"However, the effect was overcome by preincubation with inhibitors of protein secretion and abolished by trypsinization, indicating that the active substance includes one or more proteins.",11698483_6,-1,1,-1,1,786,-1,1.787399e-05,0.9999746,7.5563817e-06
24828,type,23,24,141,145,"In our previous study, we showed that signaling lymphocytic activation molecule associated protein (SAP) is essential for the development of type II NKT cells.",25236978_1,-1,1,-1,1,24828,-1,2.2826258e-05,0.99996006,1.7144095e-05
23605,the,14,15,89,92,"In mice, genetic or pharmacologic suppression of FasL produced a substantial increase in the influx of tumor-rejecting CD8(+) over FoxP3(+) T cells.",24793239_4,-1,1,-1,1,23605,-1,1.7348779e-05,0.9999752,7.4032387e-06
8737,tumor,15,16,104,109,CONCLUSION: These data provide insight into the kinetics of the immunosuppressive state associated with tumor growth in a murine model of human gliomas.,19226468_10,-1,1,-1,1,8737,-1,1.8224462e-05,0.99997294,8.837341e-06
8643,Treg,13,14,78,82,"From cancerous and non-cancerous patients, we derived stable clones of CD4(+) Treg, defined as clones that expressed high CD25 at rest, were anergic in vitro, and suppressed the proliferation of co-cultured CD4(+) cells.",19224638_0,-1,1,-1,1,8643,-1,2.3076165e-05,0.9999578,1.9065354e-05
23909,the,5,6,35,38,"Recruitment was not dependent upon the specificity of the activated CD8(+) T cells, but was significantly reduced in mice lacking the IFN receptor.",24893628_3,-1,1,-1,1,23909,-1,2.0294134e-05,0.99997044,9.323909e-06
30566,the,12,13,80,83,Reversal of laricitrin on lung cancer-induced DCs' paralysis was via inhibiting the phosphorylation of signal transducer and activator of transcription 3 (STAT3).,27833081_6,-1,1,-1,1,30566,-1,1.6466402e-05,0.9999753,8.2648285e-06
27781,Tregs,6,7,32,37,OBJECTIVES: T regulatory cells (Tregs) play a critical important role for the occurrence and development of human tumors.,26724144_0,-1,1,-1,1,27781,-1,2.1567655e-05,0.999967,1.1491379e-05
34256,TGF-1,13,14,58,64,"RESULTS: The expression levels of IL-6, IL-17, FoxP3, and TGF-1 had significantly increased in cancer tissues compared to controls.",29391307_5,-1,1,-1,1,34256,-1,3.1470045e-05,0.9999368,3.1682677e-05
3521,tumor,18,19,112,117,"Despite the radical surgical resection performed in patients with colorectal carcinoma, there is a high rate of tumor recurrence.",16391798_0,-1,1,-1,1,3521,-1,2.0639069e-05,0.9999672,1.2179919e-05
18098,Tregs,13,14,80,85,One of the mechanisms is considered to be IFN-gamma inhibiting the induction of Tregs.,22812187_11,-1,1,-1,1,18098,-1,2.2254819e-05,0.9999653,1.23879245e-05
29338,that,3,4,24,28,Our results demonstrate that an increase in the nuclear localization of NFAT1 was detectable in the CASTs following the CMV-dextramer binding and could be observed as early as 10min post-exposure.,27327144_6,-1,1,-1,1,29338,-1,1.7379463e-05,0.99997425,8.348975e-06
3777,generation,31,32,210,220,"Signal transducer and activator of transcription 1 (Stat1) is considered a key transcription factor that inhibits tumorigenesis, and Stat1 activation in the host is required for interleukin-12 (IL-12)-mediated generation of CTL activity.",16618773_0,-1,1,-1,1,3777,-1,3.7324975e-05,0.9999262,3.6401663e-05
10080,the,42,43,260,263,"In conclusion, our results suggest that mouse splenic Foxp3(+) gammadelta T cells with suppressive function can be induced by TCR and TGF-beta costimulation, whereas functional human Foxp3(+) gammadelta T cells in peripheral blood could not be generated under the same condition.",19539651_9,-1,1,-1,1,10080,-1,2.1301634e-05,0.99996996,8.792851e-06
29970,that,2,3,16,20,We demonstrated that MCL-secreted IL-10 inhibits CD1d-mediated antigen presentation and pre-treatment with TSA abrogates secretion of IL-10 by MCL.,27614429_10,-1,1,-1,1,29970,-1,1.8934243e-05,0.9999722,8.81175e-06
42785,to,24,25,126,128,"Our results indicate that germline variation in DPF3, a component of the BAF complex, part of the SWI/SNF complexes, can lead to reduced apoptosis and activation of the STAT3 pathway, both critical in RCC carcinogenesis.",34390653_4,-1,1,-1,1,42785,-1,2.0144531e-05,0.999969,1.0839761e-05
20108,the,4,5,30,33,"Furthermore, IL-33 stimulated the activation of NF-B and increased CD69 expression, which is a marker of the activated form of the two cell subsets, in CD8(+) T cells and NK cells.",23499895_5,-1,1,-1,1,20108,-1,1.7869954e-05,0.9999727,9.479326e-06
15140,treatment,1,2,10,19,"Following treatment with rhIL-2, a dramatic increase in CD8 Foxp3+ T cell prevalence was observed in the circulation and tumor-draining lymph nodes (TD.LNs) of animals bearing IL-2 nonresponsive tumors, while no significant changes were observed in the circulation and TD.LNs of animals bearing IL-2 responsive tumors.",21638127_5,-1,1,-1,1,15140,-1,2.0077508e-05,0.9999695,1.0438926e-05
18400,technology,2,3,11,21,"Using xMAP technology and RT-PCR, we investigated cytokine/chemokine profiles during histologically defined phases of disease: (i) no/mild, (ii) moderate, (iii) severe colitis without dysplasia/cancer and (iv) severe colitis with dysplasia/cancer, compared with age-matched wild-type (WT) littermates.",22962436_1,-1,1,-1,1,18400,-1,2.0648426e-05,0.9999646,1.47002565e-05
35986,The,0,1,0,3,The aim of this study was to identify the role of the two major Treg-attracting chemokines CCL1 and CCL22 in human breast cancer.,30572845_2,-1,1,-1,1,35986,-1,1.9550474e-05,0.9999726,7.816287e-06
26840,Stat3-sufficient,3,4,17,33,"As compared with Stat3-sufficient control tumors, Stat3(-/-) cancer cells exhibited an increased infiltration by dendritic cells and cytotoxic T lymphocytes after chemotherapy.",26208907_3,-1,1,-1,1,26840,-1,7.461116e-05,0.99989796,2.7367745e-05
16223,the,4,5,35,38,NPM-ALK oncogene strongly promoted the expression of miR-135b and its host gene LEMD1 through activation of signal transducer and activator of transcription (STAT) 3.,22042699_3,-1,1,-1,1,16223,-1,1.66197e-05,0.9999753,8.029323e-06
10696,Foxp3,6,7,44,49,Such cells co-expressed different levels of Foxp3 and CTLA-4 that resulted in progressively lower systemic Foxp3/CTLA-4 memory T cell ratios that further correlated with disease-free survival.,19762283_6,-1,1,-1,1,10696,-1,2.7178869e-05,0.9999583,1.4499958e-05
40177,to,6,7,30,32,"Furthermore, we use our model to characterize the differential immunoregulatory capacities of primary cancers by using conditioned medium of cultured primary cancer cells.",32573300_7,-1,1,-1,1,40177,-1,1.67344e-05,0.99997425,9.0117655e-06
33823,targets,17,18,136,143,Our findings identify mechanisms associated with mitochondrial dynamics that control anti-tumor immune responses and that are potential targets for cancer immunotherapy.,29180626_8,-1,1,-1,1,33823,-1,2.8035995e-05,0.9999609,1.1017631e-05
33301,Th1,25,26,146,149,"Our data identify IRF-1 as important for the antitumor efficacy of CTX and for the regulation of many immunomodulatory activities of CTX, such as Th1 polarization, Treg depletion and inflammation.",28975621_8,-1,1,-1,1,33301,-1,3.0758445e-05,0.9999076,6.164583e-05
3895,to,31,32,168,170,"Recognition of the importance of CCR4(+) Treg cells in the pathogenesis of HL will allow rational design of more effective treatments, such as use of an anti-CCR4 mAb, to overcome the suppressive effect of CCR4(+) Treg cells on the host immune response to tumor cells.",16740709_5,-1,1,-1,1,3895,-1,1.9498337e-05,0.99997234,8.158185e-06
915,that,7,8,47,51,The implications of this research also include that caution is warranted in assigning a solely anti-inflammatory role for 15-d-PGJ(2).,11801678_13,-1,1,-1,1,915,-1,2.6833815e-05,0.9999615,1.1612632e-05
17659,transiently,13,14,64,75,"We show in this paper that naive murine CD8 T cells rapidly and transiently produce low levels of IFN- upon stimulation with Ag and B7-1, with production peaking at 8 h and declining by 24 h. The autocrine IFN- signals for upregulation of expression of T-bet and granzyme B and induces weak cytolytic activity and effector IFN- production.",22706089_1,-1,1,-1,1,17659,-1,2.1165904e-05,0.99996746,1.1338437e-05
21152,playing,18,19,104,111,"Furthermore, we also make a synthesis of contradictory conclusions as to the roles that these cells are playing in the process of tumourigenesis in order to provide guidance of Th17-targeted therapy in tumors.",24044962_2,-1,1,-1,1,21152,-1,4.2356445e-05,0.99994123,1.6352837e-05
37812,Smad proteins,7,9,59,72,"Suppression required the expression and phosphorylation of Smad proteins in the TGF- signaling pathway, but not their nuclear translocation, and depended on oxygen availability, suggesting a metabolic basis for these effects.",31530731_4,-1,1,-1,1,37812,-1,2.9664729e-05,0.99994624,2.4138355e-05
10785,tumor,28,29,229,234,"However, tumor growth was inhibited significantly more in vaccinated mice treated with anti-TGF-beta antibodies compared to vaccinated mice without anti-TGF-beta, suggesting that anti-TGF-beta synergistically enhanced irradiated tumor vaccine efficacy.",19830696_3,-1,1,-1,1,10785,-1,2.5652635e-05,0.9999622,1.2159294e-05
7327,through,2,3,22,29,"Costimulatory signals through GITR suppressed conversion, whereas coinhibitory signaling via programmed death 1 ligand (PD-L1) but not PD-L2 was required for conversion.",18599457_6,-1,1,-1,1,7327,-1,3.7339e-05,0.9999461,1.6543565e-05
24613,transduction,17,18,105,117,"In murine tumor systems, HMGB1 was ubiquitous in the tumor microenvironment, activating the NF-B signal transduction pathway in MDSCs and regulating their quantity and quality.",25164013_6,-1,1,-1,1,24613,-1,3.369984e-05,0.99994457,2.1730339e-05
30134,T,6,7,47,48,"IL-35 inhibited the proliferation of CD4+CD25- T effector cells in vitro in a dose-dependent manner, and its suppression was partially reversed by applying IL-35-neutralizing antibodies.",27682874_5,-1,1,-1,1,30134,-1,3.2151453e-05,0.99993014,3.769407e-05
28210,Tregs,20,21,130,135,"Thus, an oncogene can promote tumor progression independent of its transforming activity by increasing the number and function of Tregs.",26880715_8,-1,1,-1,1,28210,-1,2.2932696e-05,0.9999621,1.4995431e-05
8467,to,19,20,123,125,"However, Treg cocultured with CD4(+) RC suppressed proliferation independently of Fas/FasL. In cocultures, Treg were found to be resistant to apoptosis in the presence of 1000 IU/ml IL-2, but at lower IL-2 concentrations (150 IU/ml) they became susceptible to RC-induced death.",19155494_7,-1,1,-1,1,8467,-1,2.055403e-05,0.99996877,1.0638618e-05
39354,treatment,20,21,120,129,"In the present study, a comprehensive analysis of peripheral blood leukocytes from 42 patients taken over the course of treatment with anti-PD-1 was undertaken.",32210968_2,-1,1,-1,1,39354,-1,2.1937709e-05,0.99996555,1.2459655e-05
18206,the,15,16,90,93,It will be of great interest to prospectively investigate the influence of these cells on the graft-versus-tumor and -host reaction.,22828446_11,-1,1,-1,1,18206,-1,1.7138409e-05,0.9999745,8.422745e-06
5242,the,26,27,138,141,"To study the contribution of EBV genes and of the c-MYC protein to this phenotype, we have generated a conditional B cell system in which the viral proliferation program and expression of c-myc can be regulated independently of each other.",17419945_2,-1,1,-1,1,5242,-1,1.8124649e-05,0.9999732,8.718772e-06
30932,to,3,4,16,18,One approach is to specifically block the production of active TGF-1 from Tregs as an adjunct to tumor immunotherapy.,28001437_6,-1,1,-1,1,30932,-1,2.093896e-05,0.99997044,8.65793e-06
40440,Irf4,27,28,164,168,"In this study, we show in various Th1- and/or Th17-polarized settings of acute and chronic bacterial infection and of tumor growth that the conditional ablation of Irf4 in CD11c+ DCs results in more efficient immune control of Helicobacter pylori, Mycobacterium bovis bacillus Calmette-Gurin, and Citrobacter rodentium and of tumor growth in a syngeneic tumor model.",32848032_2,-1,1,-1,1,40440,-1,2.06202e-05,0.9999614,1.7973683e-05
28340,This,0,1,0,4,This study aimed to inhibit lung cancer (LC) growth in a mouse model by using an LC-specific vaccination.,26910585_1,-1,1,-1,1,28340,-1,2.1726975e-05,0.9999691,9.1129305e-06
832,native,32,33,178,184,"We evaluated regulation of the MHC class II transactivator (CIITA), the key intermediate that controls class II expression, in MG cells and tested whether MG cells could process native Ag.",11746775_2,-1,1,-1,1,832,-1,3.0880048e-05,0.9999585,1.0612324e-05
2861,These,0,1,0,5,These results suggest that IL-27 directly acts on naive CD8+ T cells in T-bet-dependent and -independent manners and augments generation of CTL with enhanced granzyme B expression.,16034109_9,-1,1,-1,1,2861,-1,2.0075695e-05,0.9999697,1.0185799e-05
41011,that,11,12,74,78,"Myasthenia gravis (MG) is a prototypic organ-specific autoimmune disorder that, in most cases, is mainly mediated by antibodies against the acetylcholine receptor.",33136553_0,-1,1,-1,1,41011,-1,2.3594479e-05,0.999964,1.2398746e-05
39061,type,16,17,94,98,IL-23 is a two-subunit cytokine known to promote proliferation of memory T cells and T helper type 17 cells.,32015548_2,-1,1,-1,1,39061,-1,5.110693e-05,0.9998754,7.343476e-05
25134,this,3,4,13,17,"The focus of this study is to define the interaction between tumour and immune system, i.e. how immune tolerance starts and gradually leads to the induction of adaptive Treg cells in the tumour microenvironment.",25284464_2,-1,1,-1,1,25134,-1,2.063258e-05,0.9999703,9.057023e-06
8842,treatment,24,25,124,133,"Thus, although the impact of TH17 cells on the evolution of EOC remains to be established, our data suggest that local IL-2 treatment in ovarian cancer may result in the conversion of tumor-associated Treg into TH17 cells, relieve Treg-mediated suppression, and contribute to enhance antitumor immunity.",19238008_6,-1,1,-1,1,8842,-1,2.2578743e-05,0.9999665,1.0899402e-05
29143,Treg,0,1,0,4,Treg infiltration of tumors is associated with a poor prognosis in many patients.,27272839_1,-1,1,-1,1,29143,-1,3.1138617e-05,0.99994946,1.935876e-05
33881,thereby,20,21,124,131,"Our results show that IRF8 complexes boost the Th9 program and repress Il4 expression to modulate Th9 cell differentiation, thereby implicating IRF8 as a potential therapeutic target to affect Th9 responses in cancer therapy.",29233972_6,-1,1,-1,1,33881,-1,1.9066976e-05,0.99997246,8.45001e-06
39220,the,19,20,115,118,"In this review, we discuss the relative contributions of these receptors to pathogenesis of several diseases, with the focus on autoimmunity and neuroinflammation.",32083339_2,-1,1,-1,1,39220,-1,2.5028568e-05,0.9999654,9.594472e-06
37381,Treg,20,21,111,115,"Oral cancer, a subtype of head and neck cancer, is characterized by increased infiltrating regulatory T cells (Treg); however, the pathological significance of the increase in Tregs in disease prognosis and progression and their underlying mechanism remain unestablished.",31325403_0,-1,1,-1,1,37381,-1,2.3352259e-05,0.99996185,1.4831104e-05
24708,tumor,11,12,80,85,"To determine the influence of the postpartum immune microenvironment on mammary tumor promotion, we developed an immune-competent model.",25187059_5,-1,1,-1,1,24708,-1,1.9991272e-05,0.999969,1.099661e-05
8160,The,0,1,0,3,"The number of cells in all populations with the luminal CSC phenotype [epithelial specific antigen(+) (ESA) CD44(hi) CD24(lo), CD44(hi) CD133(+), and CD133(+) CD24(lo)] increased in drug-resistant MCF7 and SK-OV-3 cells.",19048252_2,-1,1,-1,1,8160,-1,1.886221e-05,0.99997056,1.0572349e-05
29335,transplant,25,26,157,167,The effect of binding of CMV specific dextramers on the activation of the NFAT signal transduction cascade was assessed in peripheral blood from bone marrow transplant recipients previously determined to be positive for CMV-ASTs (CASTs).,27327144_4,-1,1,-1,1,29335,-1,2.6020101e-05,0.99996126,1.2732711e-05
19425,to,25,26,143,145,CD4(+)CD25(+)Foxp3(+) T regulatory cells (Tregs) and CD1d-restricted invariant natural killer T (iNKT) cells are two cell types that are known to regulate immune reactions.,23182710_0,-1,1,-1,1,19425,-1,2.8236009e-05,0.999961,1.0685675e-05
18441,NAC,41,42,231,234,"In the present study, we investigated whether tumor infiltrating FOXP3+ regulatory T cells, CD8+ cytotoxic T cells, and IL17F+ helper T cells were associated with a pathological complete response (pCR) to neoadjuvant chemotherapy (NAC).",22986814_1,-1,1,-1,1,18441,-1,6.214724e-05,0.99990606,3.173556e-05
14263,Statistical,0,1,0,11,Statistical significance was determined at P<0.05.RESULTS: SLNs of 74 patients were analyzed in this analysis.,21327637_9,-1,1,-1,1,14263,-1,2.4692363e-05,0.9999597,1.5553416e-05
34330,to,11,12,57,59,"Here, we utilized a mouse model of sporadic colon cancer to investigate the contribution of IL33 signaling to tumorigenesis in the absence of preexisting inflammation.",29463593_4,-1,1,-1,1,34330,-1,1.7287017e-05,0.9999746,8.114843e-06
9208,to,22,23,114,116,"Therefore, we analyzed the pathologic, phenotypic, and cytogenetic features of a series of 30 patients (range: 33 to 88 y) that showed histopathologic features of PTCL-F in at least 1 biopsy (n=30), either at initial presentation (n=26) or at relapse (n=4).",19295409_2,-1,1,-1,1,9208,-1,3.9725666e-05,0.9999393,2.089524e-05
42296,to,11,12,81,83,"Instead, T cell-produced lymphotoxin reprograms both mouse and human macrophages to be tumoricidal.",34011631_4,-1,1,-1,1,42296,-1,2.9214603e-05,0.9999597,1.111542e-05
40253,thymic,12,13,85,91,"Intrathymic differentiation of T-cell precursors in IL-10-/- mice and in vitro fetal thymic organ cultures revealed that IL-10 promotes the interaction between thymic stromal cells and Notch1low DN2-T cells, thus facilitating these DN2-T cells to differentiate toward CD45+CD11c+MHC-II+ thymic DCs as a consequence of activating the Ikaros/IRF8 signaling axis.",32582141_5,-1,1,-1,1,40253,-1,4.889178e-05,0.9999248,2.631371e-05
15982,the,17,18,98,101,"However, during the T-cell antigen response, the physiologic function of endogenous miR-17-92 and the roles of the individual miRNAs remain elusive.",21972292_1,-1,1,-1,1,15982,-1,2.010589e-05,0.99997056,9.336865e-06
38190,T,22,23,125,126,We identify a critical role of increased oxidation of fatty acids driven by leptin and PD-1 through STAT3 in inhibiting CD8+ T effector cell glycolysis and in promoting obesity-associated breast tumorigenesis.,31761565_5,-1,1,-1,1,38190,-1,6.4313e-05,0.99969196,0.00024380579
2067,type,9,10,38,42,"In some cases, the presence of T(reg) type 1/Th3-like lymphocytes could also be demonstrated.",15240741_5,-1,1,-1,1,2067,-1,1.907427e-05,0.999962,1.9003495e-05
4376,to,3,4,15,17,This study was to investigate the biological and antitumor effects of CD40L on ovarian cancer cell line OVHM (CD40-positive).METHODS: CD40L cDNA was transfected into OVHM cells by lipofectamine 2000.,16965650_2,-1,1,-1,1,4376,-1,1.8656505e-05,0.9999722,9.176833e-06
31518,tumors,21,22,141,147,We confirmed this trend of IDO1 methylation by bisulfite pyrosequencing breast cancer cell lines and an independent cohort of primary breast tumors.,28264810_8,-1,1,-1,1,31518,-1,2.2129074e-05,0.9999629,1.49016405e-05
24623,the,18,19,130,133,"Furthermore, HMGB1 increased MDSC-mediated production of IL-10, enhanced crosstalk between MDSCs and macrophages, and facilitated the ability of MDSCs to downregulate expression of the T-cell homing receptor L-selectin.",25164013_8,-1,1,-1,1,24623,-1,1.6955111e-05,0.9999745,8.611816e-06
19107,the,8,9,52,55,Adoption of methodology for quantifying T(REG) with the least variability and subjectivity will enhance the ability to compare and interpret findings across studies.,23118856_13,-1,1,-1,1,19107,-1,2.7150532e-05,0.9999585,1.429246e-05
38684,to,28,29,185,187,"Marked reduction in Treg proliferation and tumor infiltration coincide with G1 arrest in tumor infiltrated Siah2-/- Tregs in vivo or following T cell stimulation in culture, attributed to elevated expression of the cyclin-dependent kinase inhibitor p27, a Siah2 substrate.",31911617_3,-1,1,-1,1,38684,-1,2.0998792e-05,0.9999695,9.543444e-06
4840,thymic,9,10,53,59,"In an effort to delineate the mechanisms behind such thymic atrophy, we observed that tumor-induced oxidative stress played a critical role, as it perturbed nuclear factor-kappaB (NF-kappaB) activity.",17210719_3,-1,1,-1,1,4840,-1,3.5211087e-05,0.9999465,1.825691e-05
13450,STAT6,20,21,152,157,"This approach highlighted an interleukin-4 (IL-4)-centered pathway associated with an activation of signal transducer and activator of transcription 6 (STAT6), which favors overexpression of IL-4-target genes.",20944673_4,-1,1,-1,1,13450,-1,2.8772341e-05,0.99994814,2.3067798e-05
19233,These,2,3,13,18,CONCLUSIONS: These findings show the presence of increased number of functionally suppressive CD8 Treg cells in MM patients.,23152910_12,-1,1,-1,1,19233,-1,2.0726597e-05,0.99996865,1.0592917e-05
5982,to,8,9,61,63,"The level of SVV-specific cytotoxic T-cell response appeared to be significantly higher for the T-cell line that was primed with the tatSVV-pulsed DCs, as compared to the T-cell line produced with naked (n)-SVV-pulsed DCs in vitro.",17931768_3,-1,1,-1,1,5982,-1,2.1074895e-05,0.9999689,1.0088132e-05
28772,the,20,21,104,107,"Equine sarcoids contain large numbers of CD4+CD8+dual positive T-cells which uniformly express FOXP3, the key transcription factor of regulatory T-cells, and FOXP3 is also expressed within the BPV infected fibroblasts.",27160146_3,-1,1,-1,1,28772,-1,1.9464067e-05,0.999969,1.1563541e-05
20672,the,4,5,22,25,A coculture system in the presence or absence of BM-MSCs was also established to evaluate the immune responses in vitro.,23777268_8,-1,1,-1,1,20672,-1,2.2075723e-05,0.9999695,8.483841e-06
32098,Th1,10,11,67,70,Single-component adjuvant is prone to eliciting a specific type of Th1 or Th2 response.,28515346_0,-1,1,-1,1,32098,-1,3.2465512e-05,0.99993575,3.180998e-05
24711,the,7,8,33,36,"In this model, mammary tumors in the involution group are sixfold larger than nulliparous group tumors, have decreased CD4(+) and CD8(+) T cell infiltrates and contain a greater number of macrophages with the ability to inhibit T cell activation.",25187059_6,-1,1,-1,1,24711,-1,1.9194922e-05,0.9999702,1.0550387e-05
21012,The,0,1,0,3,The results showed that triptolide significantly decreased the proportion of regulatory T cells and lowered the Foxp3 level in the spleen and axillary lymph nodes of tumor-bearing mice.,23975869_7,-1,1,-1,1,21012,-1,1.9172812e-05,0.9999716,9.152242e-06
29598,the,3,4,17,20,Our data provide the first definitive evidence that IL-17 promotes the differentiation of Th9 and Th2 cells in MPE.,27535421_7,-1,1,-1,1,29598,-1,2.2249087e-05,0.9999671,1.0593901e-05
16771,NFkB,33,34,198,202,"Interleukin-33 (IL-33), a member of the IL-1 family of cytokines, binds to its plasma membrane receptor, heterodimeric complex consisted of membrane-bound ST2L and IL-1R accessory protein, inducing NFkB and MAPK activation.",22392053_0,-1,1,-1,1,16771,-1,3.6734862e-05,0.9999409,2.2418553e-05
10367,times,34,35,167,172,"Finally, the optimal construct, tFE67(Co), was generated by including tpa signal sequence, Flt3L, fusion of E6 and E7, and codon optimization, which induces 23 and 25 times stronger E6- and E7-specific CD8(+) T cell responses than those of initial E67 fusion construct.",19651174_4,-1,1,-1,1,10367,-1,2.9923134e-05,0.9999542,1.5870777e-05
3717,to,3,4,18,20,We were surprised to find a high rate of rejection of osteosarcoma primary tumors in 88% (14 of 16) of CD1d KO mice compared with syngeneic wild-type BALB/c mice that showed rejection of tumor in <24% of mice.,16585215_5,-1,1,-1,1,3717,-1,2.026348e-05,0.9999695,1.0220163e-05
21834,Th1,8,9,48,51,"In summary, umbelliprenin has shown a partially Th1 bias with a reduction of regulatory immune response.",24325354_10,-1,1,-1,1,21834,-1,4.0353898e-05,0.9998493,0.00011032693
21718,that,38,39,210,214,"High intratumoral FoxP3(+) Tregs with high peritumoral IL-17(+) T cells showed a significantly lower survival rate compared with other groups (OS, P < 0.001 and DFS, P < 0.001).CONCLUSION: Our findings suggest that intrahepatic IL-17(+) T cells and FoxP3(+) Tregs may cooperate to promote the progression of HCC.",24303990_8,-1,1,-1,1,21718,-1,1.7065395e-05,0.9999739,9.069935e-06
10942,Total,0,1,0,5,"Total CD4(+) T cell counts are not constant, however, suggesting that homeostatic mechanisms, or susceptibility to cytotoxic or malignant insults, fundamentally differ for regulatory and non-regulatory CD4(+) T cells.",19855964_7,-1,1,-1,1,10942,-1,2.5641893e-05,0.99995923,1.5153091e-05
590,that,10,11,65,69,"These phenomena are triggered or enhanced by infection with HHV8 that, in turn, is reactivated by the same cytokines.",11423257_2,-1,1,-1,1,590,-1,2.6867734e-05,0.9999602,1.298805e-05
25921,the,3,4,20,23,"This contrasts with the correlations described in squamous cell carcinoma, suggesting that the local immune response in cervical adenocarcinoma contributes differently to tumor growth than in squamous cell carcinoma.",25795131_11,-1,1,-1,1,25921,-1,2.0969319e-05,0.9999707,8.297612e-06
40043,this,1,2,3,7,"In this study, we investigated the transcription factors and regulatory elements associated with Tfr-like cells in DLBCL patients.",32534760_3,-1,1,-1,1,40043,-1,1.916026e-05,0.99996996,1.08597e-05
37016,the,13,14,79,82,The immune mediated response plays a critical role in the antitumour effect by the anaerobic spore treatment.,31183361_1,-1,1,-1,1,37016,-1,2.0870131e-05,0.9999701,9.012072e-06
5303,Thus,0,1,0,4,"Thus, breast cancer targets DCs to facilitate its development.",17438063_7,-1,1,-1,1,5303,-1,3.1951135e-05,0.9999535,1.4543846e-05
114,the,7,8,50,53,"Data presented here demonstrate that depending on the model either CD4(+) or CD8(+) T cells provide protection to tumor cell challenge, resulting in striking differences in the efficacy of the four vaccines under investigation.",10772987_4,-1,1,-1,1,114,-1,1.7580745e-05,0.9999746,7.840402e-06
13836,the,40,41,214,217,"In treated patients, a more than 2-fold decrease in Tregs was observed in one out of 11 patients receiving cyclophosphamide and in four out of 13 receiving daclizumab, but there was no such Treg decrease in any of the six patients who received denileukin diftitox.",21177412_6,-1,1,-1,1,13836,-1,2.1558595e-05,0.9999654,1.30149865e-05
20784,two,22,23,141,144,"Tumor growth coincides with an accumulation of myeloid-derived suppressor cells (MDSCs), which exert immune suppression and which consist of two main subpopulations, known as monocytic (MO) CD11b(+) CD115(+) Ly6G(-) Ly6C(high) MDSCs and granulocytic CD11b(+) CD115(-) Ly6G(+) Ly6C(int) polymorphonuclear (PMN)-MDSCs.",23878002_0,-1,1,-1,1,20784,-1,3.6933423e-05,0.99993765,2.546289e-05
29499,forkhead,18,19,141,149,"Several markers that characterize Tregs include glucocorticoid-induced tumor necrosis factor receptor, cytotoxic T lymphocyte antigen-4, and forkhead box protein 3 (Foxp3).",27420920_2,-1,1,-1,1,29499,-1,3.6277197e-05,0.9999429,2.0873706e-05
35608,genes,21,22,142,147,"To investigate the role of the NLRP3 inflammasome in MM, we determined the genetic polymorphisms and expression of NLRP3 inflammasome-related genes (IL-1, IL-18, CARD8, and NF-B) in MM patients, and explored their clinical relevance.",30211233_1,-1,1,-1,1,35608,-1,2.5649135e-05,0.9999498,2.4569688e-05
9022,the,12,13,56,59,"In this first-in-human study (FHCRC #1796), we evaluate the use of fludarabine, an FDA-approved reagent with predictable lymphodepleting kinetics and duration of action, as a conditioning regimen that promotes homeostatic upregulation of cytokines and growth signals contributing to in vivo T cell persistence.",19270751_4,-1,1,-1,1,9022,-1,1.6902079e-05,0.9999746,8.503504e-06
35857,this,1,2,3,7,"In this study, we aim to analyze the expression of CD8 and FoxP3 on T lymphocytes and TGF- expressionin tumor tissues, andthen analyze the possible clinical significance of these finding in order to find a novel effective immunotherapy target in PDAC using a murine model.",30359281_2,-1,1,-1,1,35857,-1,1.8555467e-05,0.99997115,1.029163e-05
34704,this,11,12,86,90,"Our results demonstrate that pazopanib inhibits the Erk/-catenin pathway, suggesting this pathway might be involved in increased DC activation.",29700053_6,-1,1,-1,1,34704,-1,1.9996474e-05,0.9999708,9.183123e-06
41583,TNBC,20,21,142,146,"Because metabolic alterations affect immune homeostasis and prior studies show caloric restriction (CR) combined with RT improves preclinical TNBC outcomes, we hypothesized that CR augments RT, in part, by altering intratumoral immunity.",33647370_2,-1,1,-1,1,41583,-1,4.336928e-05,0.99993026,2.6333433e-05
37734,TRAF6,28,29,171,176,"Lack of Mirc11 caused increased translation of A20, Cbl-b, and Itch proteins, resulting in deubiquitylation of scaffolding K63 and addition of degradative K48 moieties on TRAF6.",31515257_6,-1,1,-1,1,37734,-1,3.73792e-05,0.9999378,2.4826219e-05
4822,tumor,12,13,95,100,"CONCLUSIONS/SIGNIFICANCE: Collectively, these data demonstrate that Treg capable of inhibiting tumor associated antigen-specific immune responses are enriched in patients with CRC.",17205133_6,-1,1,-1,1,4822,-1,1.9463903e-05,0.99997103,9.5557e-06
14648,Tregs,19,20,106,111,"Although polyclonal regulatory T cells (Tregs) that once expressed Foxp3 (ex-Tregs) derived from Foxp3(+) Tregs have been described in homeostatic and autoimmune settings, little is known regarding the influence of the tumor environment on ex-Treg development.",21389255_0,-1,1,-1,1,14648,-1,2.0063853e-05,0.9999653,1.4600969e-05
7392,This,0,1,0,4,"This PGE(2)-induced overproduction of CCL22 and the resulting attraction of FOXP3(+) Tregs are counteracted by IFN alpha, a mediator of acute inflammation, which also restores the ability of the PGE(2)-exposed DC to secrete the Th1-attracting chemokines: CXCL9, CXCL10, CXCL11, and CCL5.",18632653_4,-1,1,-1,1,7392,-1,1.8901237e-05,0.9999708,1.0363474e-05
9640,The,0,1,0,3,The CD4(+) blood T lymphocytes that stained ex vivo with HLA-DP4 tetramers folded with the MAGE-A3 peptide were selected by flow cytometry and amplified under clonal conditions.,19435913_2,-1,1,-1,1,9640,-1,1.897725e-05,0.9999685,1.2468977e-05
2045,the,19,20,105,108,Dominant tolerance is mediated by regulatory T cells (T(reg)) that control harmful autoimmune T cells in the periphery.,15240741_0,-1,1,-1,1,2045,-1,2.201285e-05,0.9999651,1.2958803e-05
3574,The,0,1,0,3,The SC5 antibody is the only monoclonal antibody reacting with vimentin on the surface of viable Sezary cells.,16457762_6,-1,1,-1,1,3574,-1,2.1369346e-05,0.99996877,9.890177e-06
23313,thymic,1,2,10,16,Medullary thymic epithelial cells (mTECs) eliminate self-reactive T cells by displaying a diverse repertoire of tissue-specific antigens (TSAs) that are also shared by tumors.,24752296_1,-1,1,-1,1,23313,-1,8.2137885e-05,0.9998398,7.8040524e-05
17266,TIM-3,24,25,154,159,"Spleen cells of tumor-bearing mice had high CD4(+)CD25(+)regulatory T cell (CD4(+)CD25(+)T(reg)) ratio and high mRNA and proteins expression of Foxp3 and TIM-3, but in the BLTA and 5-FU group, CD4(+)CD25(+)T(reg) ratio degraded, with down regulation mRNA and proteins expression of Foxp3 and TIM-3.",22522606_10,-1,1,-1,1,17266,-1,2.1780425e-05,0.99996376,1.4436636e-05
33782,the,25,26,177,180,"In this regard, NFAT5 upregulated the Th1-stimulatory cytokine IL-12 in classically activated macrophages, whereas in alternatively polarized ones it enhanced the expression of the pro-Th1 mediators Fizz-1 and arginase 1, indicating that it could promote proinflammatory readiness by regulating independent genes in differently polarized macrophages.",29150563_4,-1,1,-1,1,33782,-1,1.9377712e-05,0.9999714,9.247275e-06
42840,The,0,1,0,3,"The protective effect of PBC was relying on type 1 and type 2 T cell responses and, to a lesser extent, on B cells.",34495298_6,-1,1,-1,1,42840,-1,1.9423089e-05,0.99997294,7.636479e-06
8754,to,16,17,95,97,Factors present in the tumor milieu can alter the maturation of DCs and inhibit their capacity to activate T cells.,19234174_1,-1,1,-1,1,8754,-1,2.315834e-05,0.9999621,1.4773709e-05
35946,took,7,8,61,65,"Previous studies have demonstrated that Notch-AhR-IL-22 axis took part in the pathogenesis of chronic viral infection, however, its role in cancer has not been fully elucidated.",30473538_1,-1,1,-1,1,35946,-1,4.8437527e-05,0.9999335,1.8034083e-05
8644,that,18,19,102,106,"From cancerous and non-cancerous patients, we derived stable clones of CD4(+) Treg, defined as clones that expressed high CD25 at rest, were anergic in vitro, and suppressed the proliferation of co-cultured CD4(+) cells.",19224638_0,-1,1,-1,1,8644,-1,2.0572596e-05,0.9999666,1.28602705e-05
12583,TAMs,8,9,59,63,Many studies have shown that tumor-associated macrophages (TAMs) contribute to tumor development and poor prognosis in various cancers.,20545696_0,-1,1,-1,1,12583,-1,2.1065833e-05,0.9999689,1.00693405e-05
30803,Therefore,0,1,0,9,"Therefore, we assessed whether IL-17A promotes PDL1 expression in tumor cells and whether targeting of IL-17A could inhibit ER-negative breast cancer progression in a murine model.",27935862_4,-1,1,-1,1,30803,-1,1.921622e-05,0.9999701,1.0706989e-05
37134,to,28,29,196,198,"Gene expression profiling determined that Gzmb expression is down-regulated in tumor-infiltrating CTLs of IFNAR1-KO mice as compared to WT mice, and in antigen-specific IFNAR1-KO CTLs as compared to WT CTLs in vivo.",31228946_10,-1,1,-1,1,37134,-1,2.3458299e-05,0.99996436,1.2238569e-05
10414,Tat-CEA,6,7,17,24,"In vivo, the DC (Tat-CEA) vaccine delayed tumour growth significantly and prolonged survival of tumour-bearing mice.",19659778_7,-1,1,-1,1,10414,-1,4.9835784e-05,0.9999076,4.2601445e-05
36221,The,0,1,0,3,The quantity of IL-10 produced by B cells was significantly higher in DTC patients than in controls.,30711567_4,-1,1,-1,1,36221,-1,1.8047502e-05,0.99997354,8.392284e-06
10406,those,26,27,164,169,CEA-specific T cell proliferation and cytotoxic T cell responses were enhanced significantly in mice immunized with Tat-CEA-pulsed DCs [DC (Tat-CEA)] compared with those immunized with CEA-pulsed DCs [DC (CEA)].,19659778_5,-1,1,-1,1,10406,-1,2.0886639e-05,0.9999682,1.0997808e-05
14105,to,10,11,71,73,"Most cancers are accompanied by leukocyte infiltration which, contrary to an anticipated immuno-protective role, could be contributing to tumour development and cancer progression.",21291541_1,-1,1,-1,1,14105,-1,4.268359e-05,0.99994373,1.3523979e-05
13985,the,11,12,81,84,A massive mononuclear perivascular infiltrate and reduced expression of TGF- in the absence of NFAT1 suggested a role for tumor-infiltrating immune cells and the cytokine milieu.,21225259_6,-1,1,-1,1,13985,-1,2.2675302e-05,0.99996805,9.313524e-06
27654,to,17,18,95,97,"In a previous study, lack of IL-12 signaling in il12rb2 knock-out mice was found to predispose to lung adenocarcinoma (LAC).",26547104_0,-1,1,-1,1,27654,-1,2.0760031e-05,0.99996877,1.0488315e-05
705,these,3,4,16,21,"Taken together, these findings may explain why Ag-experienced, CD45RO(+), T cells found in the tumor milieu are functionally suppressed.",11509600_10,-1,1,-1,1,705,-1,2.565844e-05,0.9999635,1.0833686e-05
4130,gene,21,22,144,148,These results demonstrated IL-2-enhancing effects of the anti-IL-2 mAb in vivo and suggest that combining a neutralizing anti-IL-2 Ab with IL-2 gene delivery might be used effectively to enhance IL-2 functions in clinical applications.,16785526_6,-1,1,-1,1,4130,-1,3.0253994e-05,0.99995375,1.6045662e-05
35909,tumor,13,14,104,109,Such combination immunotherapy was further confirmed to synergize with anti-PD-1 monotherapy to improve tumor growth inhibition and cure rates.,30359281_13,-1,1,-1,1,35909,-1,1.8975592e-05,0.99997175,9.2738865e-06
39119,that,3,4,21,25,We also demonstrated that B cell-specific deletion of IL35 facilitated CD8+ T-cell activation independently of effector or regulatory CD4+ T cells and was sufficient to phenocopy therapeutic anti-IL35 blockade in overcoming resistance to anti-PD-1 immunotherapy.,32024640_6,-1,1,-1,1,39119,-1,1.7368988e-05,0.99997497,7.6067286e-06
37635,tumour,28,29,177,183,"Kynurenine pathway (KP) activation by the enzymatic activity of indoleamine 2,3-dioxygenase1 (IDO1) and kynurenine (KYN) production represents an attractive target for reducing tumour progression and improving anti-tumour immunity in multiple cancers.",31434983_0,-1,1,-1,1,37635,-1,2.2484266e-05,0.99996567,1.1830117e-05
23530,that,16,17,95,99,"We conducted studies in ICOS-deficient and ICOS-YF mice, which have a single amino acid change that abrogates PI3K signaling by ICOS.",24778280_8,-1,1,-1,1,23530,-1,2.274532e-05,0.9999652,1.2046425e-05
4367,tumor,38,39,262,267,"The presence of functional antigen-specific Treg in H. pylori-infected gastric mucosa supports an important role for these cells in suppression of mucosal effector T cell responses, which probably contribute to bacterial persistence and possibly also to gastric tumor progression.",16934529_6,-1,1,-1,1,4367,-1,2.2564542e-05,0.9999658,1.1684223e-05
37054,tumors,11,12,65,71,"Our results demonstrated that high numbers of BDCA2+ pDCs within tumors correlated with high alpha-fetoprotein levels, greater vascular invasion, advanced tumor-node-metastasis stage, shorter overall survival, and a higher recurrence rate.",31201473_4,-1,1,-1,1,37054,-1,1.8608616e-05,0.99996936,1.2070187e-05
7394,the,6,7,48,51,"This PGE(2)-induced overproduction of CCL22 and the resulting attraction of FOXP3(+) Tregs are counteracted by IFN alpha, a mediator of acute inflammation, which also restores the ability of the PGE(2)-exposed DC to secrete the Th1-attracting chemokines: CXCL9, CXCL10, CXCL11, and CCL5.",18632653_4,-1,1,-1,1,7394,-1,1.8566589e-05,0.9999733,8.133799e-06
27899,the,9,10,72,75,"The significantly enhanced combined effect of identified eQTLs suggests the personalized utilization of both SNPs in a clinical setting, strongly indicating the promise of the proposed design for the discovery of prognostic or risk germline markers in other cancers.",26733611_7,-1,1,-1,1,27899,-1,2.0519577e-05,0.9999715,7.948685e-06
35975,the,27,28,166,169,"The current data indicated that elevated Notch1 induced higher IL-22 secretion by CD4+ T cells in lung adenocarcinoma patients, and Notch-AhR-IL-22 axis took part in the pathogenesis of lung adenocarcinoma.",30473538_12,-1,1,-1,1,35975,-1,2.0072994e-05,0.9999707,9.267812e-06
15071,TGF-,13,14,84,89,"The results showed CD4(+)CD25(+) regulatory T cell proportion, Foxp3 expression and TGF- levels in the periphery blood of NSCLC patients were higher than those of healthy volunteers (p<0.05), and these indicators of patients were significantly decreased after CpG ODN 2006 treatment (p<0.05).",21611754_4,-1,1,-1,1,15071,-1,3.494941e-05,0.9999496,1.5498726e-05
25168,the,1,2,6,9,"Using the C1498 AML mouse model, we demonstrated that leukemia development was associated with thymus atrophy, which was defined by abnormal organ weight and reduced cellularity.",25382729_2,-1,1,-1,1,25168,-1,1.7605313e-05,0.99997294,9.473762e-06
9572,FOXP3(+,14,15,83,90,"Compared with primary FOXP3(-) T cells in the same microenvironment, these primary FOXP3(+) T cells expressed minimal levels of effector cytokines, negligible amount of cytotoxic molecule granzyme B, and levels of suppressive molecules interleukin-10 and PD-1.",19383912_4,-1,1,-1,1,9572,-1,0.00014787701,0.9996685,0.00018365527
9066,to,11,12,74,76,They are traditionally viewed as the immunologic centerpiece that is able to prime CD4(+) helper and CD8(+) cytotoxic T-cell effector populations.,19275918_1,-1,1,-1,1,9066,-1,1.9732834e-05,0.99996996,1.0301053e-05
38758,Blimp-1,12,13,73,80,"While T-bet ablation restricted interferon- (IFN-) production, loss of Blimp-1 prevented GzmB expression in response to IL-2, suggesting two independent programs required for polyfunctionality of tumor-reactive CD4+ Tcells.",31924474_4,-1,1,-1,1,38758,-1,4.001678e-05,0.9999223,3.7713875e-05
30407,the,6,7,41,44,The Stat3 expression was correlated with the lymph node metastasis and TNM stage (both P<0.05).,27752897_7,-1,1,-1,1,30407,-1,1.9371162e-05,0.999969,1.1679549e-05
23658,STAT3,20,21,149,154,"Treg transfer or NK cell transient depletion markedly increased interleukin (IL)-22 systemically and the inflammatory signaling molecules P2X7R, and STAT3 in the tumors; and impaired production of the tumor suppressor interferon (IFN)- systemically.",24797894_5,-1,1,-1,1,23658,-1,2.8147007e-05,0.99995494,1.6911936e-05
2644,the,10,11,59,62,This suppression might explain the poor outcome of some of the immunotherapy protocols currently being used.,15781662_2,-1,1,-1,1,2644,-1,2.4920322e-05,0.99996364,1.1393469e-05
11903,three,29,30,175,180,"However, whereas all three mAbs quantitatively depleted FoxP3(+) T cells to a similar extent, subtle differences in the downstream mechanisms of tumor control existed for all three approaches.",20332236_5,-1,1,-1,1,11903,-1,5.5631765e-05,0.99991846,2.5952177e-05
9465,to,6,7,44,46,Disruption of irf-1 reduced the sensitivity to Fas-induced apoptosis and decreased the levels of caspases-3/7 and caspase-9 messenger RNA species and enzymatic activities.,19362089_7,-1,1,-1,1,9465,-1,2.021505e-05,0.9999683,1.15395405e-05
3165,generated,3,4,24,33,The regulatory activity generated in tumor-draining LNs exclusively belonged to the CD4(+) T cell subpopulation that expresses both CD25 and a high level of CD62L.,16210609_4,-1,1,-1,1,3165,-1,2.2162525e-05,0.99996376,1.4088258e-05
13415,total,14,15,72,77,"In the lymph nodes of tumor-bearing animals, in contrast to the spleen, total amount of CD8(+) cells and CD4(+) cells were increased but both of these compartments harbored high numbers of CD4(+) CD25(hi) Treg cells.",20883319_6,-1,1,-1,1,13415,-1,2.5919277e-05,0.99995935,1.467568e-05
20825,the,43,44,246,249,"In this perspective, this study aimed to evaluate the immunoexpression of interleukin (IL)-17, transforming growth factor (TGF)-1, and the forkhead box P3 (FoxP3) in periapical lesions, correlating them with the type of lesion, the intensity of the inflammatory infiltrate, and the thickness of the cystic epithelial lining.",23880265_1,-1,1,-1,1,20825,-1,1.8031913e-05,0.99997044,1.14825025e-05
12441,tumour,41,42,230,236,"In this study, we investigated the effect of simvastatin on the production of IL-10, TGF-beta and IDO production and the proliferation of T(regs) using several cancer cell lines, and Lewis lung cancer (3LL) cells-inoculated mouse tumour model.",20491794_4,-1,1,-1,1,12441,-1,2.3607603e-05,0.9999584,1.79996e-05
30533,tumours,13,14,104,111,Histological analysis revealed increased T-cell infiltration and reduced -smooth muscle actin cells in tumours from multiple models.,27797936_9,-1,1,-1,1,30533,-1,2.5168867e-05,0.9999572,1.763858e-05
17861,TLR4,29,30,169,173,"RESULTS: FOXP3+ Tregs were enriched in tumor sites, and circulating FOXP3+ Tregs were increased in HCC patients in correlation with multiple tumor foci and up-regulated TLR4 expression in HCC tissues.",22736917_4,-1,1,-1,1,17861,-1,2.9209441e-05,0.999928,4.2793945e-05
20371,gene,12,13,68,72,"To investigate NF-B function in human lung tumors, we identified a gene expression signature in human lung adenocarcinoma cell lines that was associated with NF-B activity level.",23635779_4,-1,1,-1,1,20371,-1,2.5406742e-05,0.9999578,1.6733678e-05
42385,to,24,25,112,114,"The presence or absence, in particular, of cytotoxic CD8+ cells in the vicinity of the main tumor mass, is able to predict, respectively, the success or failure of drug therapy.",34070750_4,-1,1,-1,1,42385,-1,2.0360098e-05,0.99997103,8.620374e-06
29179,Gfi1,7,8,41,45,We herein demonstrate a critical role of Gfi1 in regulating the development of iNKT cell subsets.,27284976_2,-1,1,-1,1,29179,-1,0.00026217315,0.999132,0.0006058362
35313,the,13,14,88,91,Mucosa-associated lymphoid tissue 1 (Malt1) regulates immune cell function by mediating the activation of nuclear factor B (NF-B) signaling through both its adaptor and proteolytic function.,30025160_0,-1,1,-1,1,35313,-1,1.7248234e-05,0.9999746,8.155069e-06
37285,target,12,13,51,57,Our study thus implicates Fas in CD4+ T cells as a target for inflammatory bowel disease therapy.,31266950_6,-1,1,-1,1,37285,-1,2.2786275e-05,0.99996555,1.1718592e-05
30904,the,5,6,34,37,"As Treg-derived TGF- may mediate the suppressive functions of Tregs, GARP may represent a target to inhibit Treg suppression in cancer or augment suppression in autoimmunity.",28001437_2,-1,1,-1,1,30904,-1,2.1294203e-05,0.9999701,8.596353e-06
21118,that,6,7,25,29,"In this article, we show that resveratrol (RSV), a plant-derived polyphenol, at low and noncytotoxic doses for immune cells, can efficiently inhibit lung metastasis in mice.",24043896_1,-1,1,-1,1,21118,-1,1.8019457e-05,0.99997187,1.0101813e-05
34390,that,24,25,196,200,"Our data demonstrate that Y-traps counteract TGF-mediated differentiation of Tregs and immune tolerance, thereby providing a potentially more effective immunotherapeutic strategy against cancers that are resistant to current immune checkpoint inhibitors.",29467463_5,-1,1,-1,1,34390,-1,2.1231575e-05,0.9999659,1.2810919e-05
25085,the,33,34,202,205,"In order to further confirm this result, the Runx3 gene was constructed into pIRES2-eGFP and the recombined plasmid was transfected into SGC-7901 cells with liposome in vitro, the results obtained from the reverse transcription PCR indicated that the mRNA of Runx3, T-bet, or IFN- was significantly upregulated individually in Runx3 gene-transfected SGC-7901 cells.",25270738_3,-1,1,-1,1,25085,-1,1.6729035e-05,0.999974,9.238192e-06
15480,FoxP3,11,12,73,78,"In addition, the presence of tumor-escape mechanisms PD-L1/PD-1 pathway, FoxP3 and loss of HLA or melanocyte differentiation antigens, both required for tumor cell recognition and killing, were studied.",21750202_2,-1,1,-1,1,15480,-1,2.2607048e-05,0.9999653,1.2024663e-05
1581,the,8,9,45,48,Regulatory T cells play an important role in the maintenance of immunological self-tolerance by suppressing immune responses against autoimmune diseases and cancer.,14738769_0,-1,1,-1,1,1581,-1,2.0036781e-05,0.9999721,7.798057e-06
43788,the,9,10,56,59,"Finally, gamma IFN and HLA-DR expression correlate with the presence of HHV-8 in lesional and uninvolved tissues from the same patients.",9446657_12,-1,1,-1,1,43788,-1,1.6829099e-05,0.9999752,8.001147e-06
21431,Thymic,0,1,0,6,"Thymic involution has been observed in several model systems; including graft-versus-host disease, aging, viral infection, and tumor development, however, the precise mechanisms involved in this phenomenon remain poorly defined.",24198066_2,-1,1,-1,1,21431,-1,4.418918e-05,0.99993443,2.1402038e-05
11881,therapeutic,12,13,77,88,These same depletion methods do not significantly suppress tumor growth in a therapeutic setting.,20332236_1,-1,1,-1,1,11881,-1,2.6272599e-05,0.99996245,1.1227915e-05
13162,gene-based,23,24,180,190,"CONCLUSION: So adoptively T cells transduced anti-CD20scFvFc/CD28/CD3zeta gene mediates enhanced anti-tumor activities against CD20 positive tumor cells, suggesting a potential of gene-based immunotherapy for non-Hodgkin lymphoma.",20815894_11,-1,1,-1,1,13162,-1,3.3002125e-05,0.9999453,2.1680282e-05
1781,to,34,35,216,218,"Suppression also required an endogenous IFN-gamma pathway consisting minimally of IFN-gamma, IFN-gamma receptor, Stat1, and IFN regulatory factor 1 since mice with targeted disruption of any of the four genes failed to arrest tumor growth.",14978132_2,-1,1,-1,1,1781,-1,1.9707435e-05,0.9999695,1.0773459e-05
42214,The,0,1,0,3,The proliferation and migration of U87MG cells were also increased.,33971545_9,-1,1,-1,1,42214,-1,2.249022e-05,0.9999672,1.0286633e-05
40503,to,22,23,119,121,"OBJECTIVES: To investigate the effects of DHA on the proliferation and migration of melanoma in vivo and in vitro, and to explore its possible mechanism.",32859456_3,-1,1,-1,1,40503,-1,1.8612183e-05,0.9999722,9.2015725e-06
34316,Tregs,14,15,91,96,"In summary, these data strongly imply the physiological importance of Helios expression in Tregs, and suggest that the manipulation of Helios may serve as a novel strategy for cancer immunotherapy.",29455107_7,-1,1,-1,1,34316,-1,2.0085527e-05,0.9999691,1.0781307e-05
40381,total,9,10,67,72,"Here, we show that murine fibrosarcoma-conditioned medium promoted total spleen cell proliferation but inhibited T cell responses to mitogenic and allo-antigen-mediated stimulation.",32661685_1,-1,1,-1,1,40381,-1,2.5088788e-05,0.9999585,1.6378948e-05
27382,FOXP3,20,21,90,95,"More intriguingly, a substantial fraction of the natural T cells (22.7618.61%) assumed FOXP3 expression.",26437631_2,-1,1,-1,1,27382,-1,2.4056873e-05,0.9999628,1.3173494e-05
37732,translation,5,6,32,43,"Lack of Mirc11 caused increased translation of A20, Cbl-b, and Itch proteins, resulting in deubiquitylation of scaffolding K63 and addition of degradative K48 moieties on TRAF6.",31515257_6,-1,1,-1,1,37732,-1,2.8191524e-05,0.99995506,1.6798278e-05
3348,Th,13,14,90,92,"The plasmid encoding GM-CSF and the target PDTRP antigen induced a greater PDTRP-specific Th proliferation, antibodies, and cytotoxicity.",16341143_3,-1,1,-1,1,3348,-1,3.615158e-05,0.99991894,4.4902725e-05
29014,the,12,13,79,82,"The genetic/epigenetic landscape of ATL has only recently been elucidated, and the roles of additional ""hits"" in ATL pathogenesis remain to be explored.",27223899_6,-1,1,-1,1,29014,-1,2.0693784e-05,0.99997115,8.0984255e-06
32888,to,2,3,12,14,The methods to regulate the Treg population in cancer-bearing hosts are limited currently.,28731226_1,-1,1,-1,1,32888,-1,2.4862093e-05,0.9999627,1.2466253e-05
3552,genes,14,15,82,87,IL-10 levels in the blood as well as the expression of regulatory T-cell specific genes at the tumor site correlate with the UICC stage of the disease.,16391798_8,-1,1,-1,1,3552,-1,2.5933152e-05,0.99995375,2.0326472e-05
4531,STAT5,3,4,25,30,Persistent activation of STAT5 within NK and T cells was an unexpected observation and requires further investigation.,17020993_13,-1,1,-1,1,4531,-1,3.4183508e-05,0.99993753,2.826266e-05
16450,that,4,5,23,27,We have recently shown that intratumor (i.t.) injection of syngenic dendritic cells (DC) engineered to express the transcription factor Tbet (TBX21) promotes protective type-1 T cell-mediated immunity via a mechanism that is largely interleukin (IL)-12p70-independent.,22215017_0,-1,1,-1,1,16450,-1,1.652379e-05,0.99997556,7.962268e-06
10607,the,22,23,117,120,"COS-7 cells transduced with the mouse (m) p28 gene secreted a monomeric mp28 protein; however, those transduced with the mEBI3 gene did not detect a mEBI3 protein in the culture supernatants.",19740343_3,-1,1,-1,1,10607,-1,1.8464494e-05,0.99997056,1.09407065e-05
39095,that,2,3,29,33,Cancer-associated mechanisms that elicit CD8+ T-cell exclusion and resistance to immunotherapy are not well-known.,32024640_1,-1,1,-1,1,39095,-1,2.4258075e-05,0.999966,9.7709935e-06
37446,tumor-infiltrating,18,19,116,134,"Using this and other genetic models, we showed that Treg cells shaped the transcriptional landscape across multiple tumor-infiltrating immune cell types.",31350177_2,-1,1,-1,1,37446,-1,5.0030918e-05,0.9999206,2.9343859e-05
20927,Tregs,8,9,46,51,"Additionally, CD73 expression level on TNFR2+ Tregs was inversely correlated with IFN- production by effector T cells.",23948613_5,-1,1,-1,1,20927,-1,2.0660531e-05,0.9999689,1.0393186e-05
42553,tumor,15,16,112,117,"SOX11 oncogenic expression contributes to the aggressiveness of these tumors by different mechanisms, including tumor and stromal cell interactions.",34189576_1,-1,1,-1,1,42553,-1,2.2447652e-05,0.9999647,1.2779445e-05
41748,STAT6-mediated,15,16,107,121,"Mechanistically, Erbin knockout attenuated TGF-mediated suppression of migration of CXCR5+ IgA+ cells and STAT6-mediated PD1 expression.",33707428_4,-1,1,-1,1,41748,-1,3.40491e-05,0.9999317,3.4247885e-05
3704,the,3,4,14,17,"We also asked the role of interleukin (IL)-4 receptor alpha (IL-4Ralpha)-signal transducer and activator of transcription 6 (STAT6) signaling, including IL-13, and transforming growth factor beta (TGF-beta) by using gene-disrupted mice or treating mice with cytokine antagonists.",16585215_4,-1,1,-1,1,3704,-1,1.708167e-05,0.9999753,7.588892e-06
22775,to,17,18,98,100,The vaccine was given alone or in sequence with an anti-CD25 antibody (PC61) and cyclophosphamide to deplete T-regulatory (Treg) cells.,24607504_3,-1,1,-1,1,22775,-1,2.2564232e-05,0.9999665,1.0914264e-05
34987,these,44,45,286,291,"Immune adjuvants, including double-stranded (ds)RNAs, which signal via Toll-like receptor-3 (TLR3) and helicase (RIG-I/MDA5) pathways, all induce intratumoral production of CTL-attractants, but also Treg attractants and suppressive factors, raising the question of whether induction of these opposing groups of immune mediators can be separated.",29853604_1,-1,1,-1,1,34987,-1,2.6320617e-05,0.99996126,1.2476131e-05
25985,treatment,3,4,19,28,"Notably, cetuximab treatment increased the frequency of CD4(+)FOXP3(+) intratumoral Treg expressing CTLA-4, CD39, and TGF.",25832655_3,-1,1,-1,1,25985,-1,2.1320413e-05,0.9999652,1.3435042e-05
31180,These,0,1,0,5,These observations were further supported by an enhancement of nuclear translocation of the p65NF-B subunit involved in this process.,28088065_5,-1,1,-1,1,31180,-1,1.9982823e-05,0.99997056,9.508542e-06
40111,thus,17,18,105,109,NHS-interleukin-12 (NHS-IL12) is a tumor targeting immunocytokine designed to bring IL-12 to the TME and thus enhance the inflammatory Th1 response.,32554612_4,-1,1,-1,1,40111,-1,2.6460752e-05,0.9999621,1.1503648e-05
24554,tumour,9,10,47,53,CONTEXT: Host immune response has an impact on tumour development and progression.,25151017_0,-1,1,-1,1,24554,-1,2.7849179e-05,0.99995935,1.2854267e-05
23822,to,11,12,75,77,"Leukapheresis samples provide the cells needed to engineer therapies: LPCs to be targeted, normal hematopoietic stem cells to be spared, and cancer-impaired immune cells to be repaired and activated.",24855276_3,-1,1,-1,1,23822,-1,3.338433e-05,0.9999473,1.9265619e-05
19329,This,0,1,0,4,"This work will discuss the central role that Treg cells play in the development of uterine cancer, which makes these cells a key missing component in current cancer immunotherapy.",23178746_3,-1,1,-1,1,19329,-1,2.9062661e-05,0.99995816,1.2745793e-05
20572,placed,11,12,57,63,DESIGN: C57BL/6 male mice were infected with H felis and placed on a high-fat diet (45% calories from fat).,23729675_1,-1,1,-1,1,20572,-1,2.2908183e-05,0.9999654,1.1648482e-05
14265,Ten,0,1,0,3,Ten of seventy-four patients (13.5%) had tumor-positive SLNs.,21327637_10,-1,1,-1,1,14265,-1,2.9207966e-05,0.9999509,1.9847128e-05
38924,type,10,11,70,74,"Importantly, PPAR agonist pioglitazone, a thiazolidinedione drug for type 2 diabetes, successfully restores IFN- production in tumor-infiltrating iNKT cells from both human patients and mouse models.",31974378_4,-1,1,-1,1,38924,-1,2.9972272e-05,0.999948,2.194561e-05
18996,tumor,37,38,230,235,"This work provides evidence that native preparations of the Euplotes raikovi pheromone Er-1 (a helical protein of 40 amino acids) specifically increases viability, DNA synthesis, proliferation, and the production of interferon-, tumor necrosis factor-, interleukin (IL)-1, IL-2, and IL-13 in human Jurkat T-cells.",23103669_1,-1,1,-1,1,18996,-1,0.00013160608,0.9998191,4.935784e-05
6955,that,37,38,220,224,"Our experiments indicate that TIRC7, T cell immune response cDNA 7, a novel membrane molecule involved in the regulation of T lymphocyte activation, identifies two Treg subsets (CD25(low)TIRC7(+) and CD25(high)TIRC7(-)) that are characterized by the expression of Foxp3 and a suppressive activity in vitro and in vivo.",18424726_2,-1,1,-1,1,6955,-1,1.9449219e-05,0.99996877,1.1774832e-05
36072,genes,15,16,105,110,"RNA-seq analysis in human MoDCs revealed that N1 plus R848 synergistically upregulated the expression of genes predominantly involved in DC maturation pathway, particularly genes critical for the polarization of Th1 immune responses (e.g., IL12A, IL12B, and IFNB1, etc.).",30619338_6,-1,1,-1,1,36072,-1,2.5583573e-05,0.999951,2.3395429e-05
20911,Tregs,25,26,159,164,"As ovarian cancer patients present with high levels of TNF and Tregs expressing TNFR2 are associated with maximal suppressive capacity, we investigated TNFR2+ Tregs within these patients.",23948613_1,-1,1,-1,1,20911,-1,1.8692943e-05,0.99996746,1.3809718e-05
42074,TME,14,15,76,79,Our results showed for the first time that TFT cells are highly enriched in TME of DLBCL patients and associated with predictions of poor prognoses.,33864956_6,-1,1,-1,1,42074,-1,2.8745577e-05,0.9999559,1.5354779e-05
4578,the,18,19,139,142,"We have analyzed the DNA elements and interacting transcription factors that control the constitutive and IFNgamma-inducible expression of the class II transactivator (CIITA), a co-activator essential for transcription of all MHC class II genes.",17067677_2,-1,1,-1,1,4578,-1,1.7622351e-05,0.9999714,1.09288685e-05
4126,plasmid,37,38,233,240,"Furthermore, combined treatment with the anti-IL-2 mAb plus the IL-2 plasmid markedly enhanced Ag-specific CTL activity in vivo and partially protected mice from tumor metastasis to the lungs, compared with the anti-IL-2 mAb or IL-2 plasmid alone.",16785526_5,-1,1,-1,1,4126,-1,3.939476e-05,0.999926,3.4683526e-05
29955,treatment,2,3,11,20,"Similarly, treatment of MCL cells with other HDACi resulted in enhanced CD1d-dependent NKT cell responses.",27614429_5,-1,1,-1,1,29955,-1,2.5334337e-05,0.99996114,1.3539196e-05
12273,the,1,2,5,8,"Like the normal components of this lymphoid structure, FL cells interact with various immune cells, such as the follicular helper T cells, suppressor regulatory T cells, dendritic cells, and histiocytes, that define the tumor microenvironment.",20425464_1,-1,1,-1,1,12273,-1,2.9283177e-05,0.9999534,1.7293063e-05
16122,These,0,1,0,5,"These observations indicate that IL-21 amplifies an inflammatory milieu that promotes CAC, and suggest that IL-21 blockade may be useful in reducing the risk of UC-associated colon cancer.",21987656_7,-1,1,-1,1,16122,-1,1.9081614e-05,0.99997115,9.808239e-06
20681,the,22,23,131,134,"An increase in IL-10-secreting T cells and Tregs, associated with increased expression of Gata-3 and FoxP3, generation of IL-10 in the supernatant, and proliferation of gastric epithelial cells (GECs) was observed.",23777268_9,-1,1,-1,1,20681,-1,2.0778423e-05,0.9999683,1.0905659e-05
7262,transgenic,8,9,38,48,When CD4+ T cells purified from OT-II transgenic mice were transferred into C57BL/6 mice bearing s.c.,18566377_5,-1,1,-1,1,7262,-1,2.2291442e-05,0.9999578,1.987797e-05
40617,Tregs,16,17,76,81,"In this study, we found that the upregulation of Foxp3+ regulatory T cells (Tregs) in the mesothelioma tumor microenvironment after nonablative oligofractionated irradiation significantly limited the success of irradiation.",32948683_2,-1,1,-1,1,40617,-1,2.1439528e-05,0.99996424,1.4291914e-05
12977,that,1,2,6,10,"Given that local cell-mediated immunity (CMI) against the human papillomavirus type 16 E6 (HPV16 E6) protein is important for eradication of HPV16 E6-expressing cancer cells in the cervical mucosa, the HPV16 E6 protein may be a target for the mucosal immunotherapy of cervical cancer.",20706715_0,-1,1,-1,1,12977,-1,2.372289e-05,0.99996626,9.993554e-06
26425,the,2,3,13,16,"Furthermore, the suppressed B16 tumor growth induced by CCR5 blockade is abolished with additional administration of recombinant IL-6.",26047948_4,-1,1,-1,1,26425,-1,1.759289e-05,0.9999738,8.686559e-06
23265,These,0,1,0,5,These results suggested that there are polarized ILC2s in gastric cancer patients which might contribute to immunosuppressive microenvironment and closely related to the upregulation of MDSCs and M2 macrophages.,24741632_7,-1,1,-1,1,23265,-1,1.9600546e-05,0.9999707,9.693391e-06
16494,This,2,3,9,13,"METHODS: This study aimed to characterise the frequency of T regulatory cells (Tregs), dendritic cells (DCs) as well as sub-populations of T cells bearing regulatory properties like CD4(+)GITR(+), CD4(+)CD62L(+), CD3(+)TCR(+) along with the concentrations of IL-10, TGF, IL-6 in 66 patients with MM.",22223085_1,-1,1,-1,1,16494,-1,1.9694888e-05,0.9999697,1.0626104e-05
43021,TGF,19,20,127,131,Preliminary methylation analysis shows that I2 activates IFN gene promoter (by increasing its unmethylated form) and silences TGF in Cht+I2.,34680134_6,-1,1,-1,1,43021,-1,2.82063e-05,0.9999583,1.3526458e-05
35717,The,0,1,0,3,The myeloid differentiation factor 88 (MYD88) signaling plays critical roles in the developments of B cells.,30253331_0,-1,1,-1,1,35717,-1,2.0951793e-05,0.99996996,9.115414e-06
35602,the,11,12,62,65,The pathogenesis of multiple myeloma (MM) remains unclear and the NLRP3 inflammasome has been more and more recognized in the progression of many diseases.,30211233_0,-1,1,-1,1,35602,-1,1.7979222e-05,0.9999738,8.252789e-06
34207,the,34,35,216,219,"By treating CD4+ T cells with IL-6 or co-culturing the cells with pancreatic cancer cells, tumor-derived IL-6 was identified to promote Foxp3 expression and Treg differentiation, which was significantly inhibited by the JAK2 inhibitor AG-490.",29337110_9,-1,1,-1,1,34207,-1,2.2462647e-05,0.999967,1.0526665e-05
2313,the,6,7,27,30,"In this study, we describe the expression and function of CD40, a TNF receptor family member, in cervical carcinomas.",15611226_0,-1,1,-1,1,2313,-1,1.6286496e-05,0.9999751,8.5822e-06
8010,They,0,1,0,4,They were immunohistochemically analyzed for a large panel of markers.,18987541_5,-1,1,-1,1,8010,-1,2.5350322e-05,0.9999567,1.7932167e-05
6161,transduced,5,6,31,41,"Finally, mTORC1 activation was transduced preferentially through the PI3K/Akt pathway.",18025151_7,-1,1,-1,1,6161,-1,3.033836e-05,0.999948,2.168253e-05
13045,test,26,27,156,160,"Before treatment, Treg levels were significantly higher in patients with melanoma when compared with data from 20 healthy subjects (P = 0.001; Mann-Whitney test).",20712892_5,-1,1,-1,1,13045,-1,2.603511e-05,0.99996006,1.3865595e-05
23526,T-bet,15,16,91,96,An ICOS-specific siRNA transfected into human T cells led to diminished PI3K signaling and T-bet expression.,24778280_6,-1,1,-1,1,23526,-1,2.3304061e-05,0.99995756,1.9099069e-05
20178,this,2,3,13,17,"Formation of this phenotype requires 4-1BB signaling on both T and antigen-presenting cells and the resulting production of the cytokines IL-27, IL-15, and IL-10.",23547098_4,-1,1,-1,1,20178,-1,1.8515799e-05,0.99997115,1.0368519e-05
4857,transfection,15,16,126,138,"Interestingly, TNF-alpha-depleted tumor supernatants, either by antibody neutralization or by TNF-alpha-small interfering RNA transfection of tumor cells, were unable to kill T cell effectively.",17210719_6,-1,1,-1,1,4857,-1,2.5301902e-05,0.9999541,2.0567495e-05
33928,the,4,5,28,31,We explored augmentation of the anti-tumor immune reaction by establishing an acute inflammatory reaction.,29241547_2,-1,1,-1,1,33928,-1,1.7886892e-05,0.99997413,7.9983465e-06
27407,FOXP3-expressing,10,11,71,87,"Finally, Kaplan-Meier analysis revealed that the relative abundance of FOXP3-expressing CD3(+)CD56(+) cells in tumor tissues was significantly correlated with the survival of HCC patients.",26437631_7,-1,1,-1,1,27407,-1,2.392657e-05,0.9999609,1.5161384e-05
37346,the,46,47,308,311,"Caloric restriction mimetics (CRMs), compounds that mimic the biochemical effects of nutrient deprivation, administered via systemic route promote antitumor effects through the induction of autophagy and the modulation of the immune microenvironment; however, collateral effects due to metabolic changes and the possible weight loss might potentially limit their administration at long term.",31321243_0,-1,1,-1,1,37346,-1,2.7503596e-05,0.99996114,1.1363046e-05
9115,T,23,24,100,101,"To investigate this further, the balance of T-regulatory (T(reg)), Th17, natural killer (NK) and NK T (NKT) cells before, during and after trastuzumab therapy was investigated.",19277040_1,-1,1,-1,1,9115,-1,2.3157576e-05,0.99995005,2.6749829e-05
20636,status,40,41,147,153,"In multivariate analysis, high IL-17 level [hazard ratio (HR) 2.24; 95% CI 1.06-4.75], advanced T stage (HR 2.73; 95% CI 1.30-5.73), positive HER2 status (HR 4.88; 95% CI 1.47-16.18) and triple-negative subtype (HR 7.46; 95% CI 1.38-40.36) were significant prognostic factors for DFS.CONCLUSIONS: Our results indicate that a high level of IL-17-producing cells in the breast cancer tumour microenvironment is a poor prognostic factor.",23738752_6,-1,1,-1,1,20636,-1,4.01668e-05,0.9999019,5.7875284e-05
2012,translocation,56,57,375,388,"In this study, three leukemic cell lines were investigated: Kasumi-1 and SKNO-1 (two acute myeloid leukemia (AML) cell lines carrying the (8;21)-chromosomal translocation, resulting in the expression of the leukemia-specific fusion protein AML1-eight-twenty-one) and REH, an acute lymphoblastic leukemia cell line with the (12;21)-chromosomal translocation and expression of translocation ETS-like leukemia-AML1.",15197237_1,-1,1,-1,1,2012,-1,2.26258e-05,0.99995995,1.7478462e-05
21050,three,21,22,110,115,"In the current report, we show that it is the subset of T cell-inflamed tumors that showed high expression of three defined immunosuppressive mechanisms: indoleamine-2,3-dioxygenase (IDO), PD-L1/B7-H1, and FoxP3(+) regulatory T cells (T(regs)), suggesting that these inhibitory pathways might serve as negative feedback mechanisms that followed, rather than preceded, CD8(+) T cell infiltration.",23986400_2,-1,1,-1,1,21050,-1,3.8455597e-05,0.99994445,1.7076352e-05
24555,There,0,1,0,5,There is interest in the use of inflammatory biomarkers (InfBMs) in cancer care.,25151017_1,-1,1,-1,1,24555,-1,2.7299451e-05,0.999961,1.1704822e-05
28789,transcripts,7,8,32,43,"In contrast, the levels of mRNA transcripts for effector T cell cytokines IL2, IL4 and interferon-gamma (IFN) were not elevated in sarcoids compared to healthy skin or spleen.",27160146_6,-1,1,-1,1,28789,-1,2.1013253e-05,0.99996555,1.34529055e-05
35479,to,14,15,118,120,"Tumour-infiltrating CD4+ lymphocytes were significantly hypomethylated in all four investigated lineage loci compared to CD4+ lymphocytes in lymph nodes and blood (lymph nodes vs tumour-infiltrating lymphocytes: IFNG -4229bp p<0.0001, IL13 -11bp p<0.05, IL17A -122bp p<0.01 and FOXP3 -77bp p>0.05).",30075815_9,-1,1,-1,1,35479,-1,2.5073632e-05,0.99996173,1.3163108e-05
25163,thymic,32,33,209,215,"Recent studies on acute myelogenous leukemia (AML) patients have revealed the existence of T-cell immunodeficiencies, characterized by peripheral T lymphocytes that are unable to interact with blasts, reduced thymic emigrants and oligoclonal restricted repertoires.",25382729_0,-1,1,-1,1,25163,-1,7.796415e-05,0.9998869,3.510227e-05
32170,FoxP3,3,4,25,30,Significant elevation of FoxP3 was also detected.,28548891_5,-1,1,-1,1,32170,-1,1.9648689e-05,0.9999683,1.2014429e-05
23494,tumor,41,42,247,252,"Importantly, the frequency of CD45RA-Foxp3high Tregs positively correlate with tumor stage (P <0.0001) and nodal status (P <0.0001).CONCLUSIONS: CD45RA-Foxp3high Tregs increase in the peripheral circulation of HNSCC patients, and correlate with tumor stage and nodal status; suggesting a role in tumor progression which may be manipulated by future immunotherapy.",24761979_8,-1,1,-1,1,23494,-1,2.0877085e-05,0.9999665,1.2661662e-05
17257,tumor,13,14,50,55,"While in the 5-FU+BLTA group, the inhibition of tumor growth was more significant, with increased T lymphocyte proliferation and IFN-production of spleen cells.",22522606_9,-1,1,-1,1,17257,-1,1.8608434e-05,0.99997103,1.0315495e-05
26160,to,9,10,52,54,Delivery of DNA vaccines encoding XBP1 and tumor Ag to skin DC resulted in increased IFN- production by plasmacytoid DC (pDC) from skin/tumor draining lymph nodes and the cross-priming of Ag-specific CD8(+) T cell responses associated with therapeutic benefit.,25972487_3,-1,1,-1,1,26160,-1,3.1072486e-05,0.99995303,1.58796e-05
33507,T-ALL,11,12,76,81,Hepatomegaly is frequently observed in T cell acute lymphoblastic leukemia (T-ALL) patients with poor prognosis.,29030004_1,-1,1,-1,1,33507,-1,9.325622e-05,0.9998104,9.633006e-05
19313,the,11,12,48,51,Both CD4(+) and CD8(+) T cells were involved in the anti-neuroblastoma responses induced by YB-1 immunization combined with Treg depletion.,23169344_8,-1,1,-1,1,19313,-1,1.9335499e-05,0.9999726,8.036487e-06
33953,To,0,1,0,2,"To further investigate this finding, we examined which cells were positive for HLA-DQA1 and what liver immune responses were different between HCV-high and -low livers.",29248968_1,-1,1,-1,1,33953,-1,1.735941e-05,0.99997365,8.998062e-06
6606,that,13,14,87,91,We found that metastatic melanoma LNs expressed very heterogeneous levels of Foxp3 and that CD4+CD25(high) Treg cells extracted from these LNs were detectable at each step of the in vitro culture of TIL but decreasing during the culture.,18312383_3,-1,1,-1,1,6606,-1,1.8279017e-05,0.9999703,1.1361005e-05
41862,tumor,17,18,133,138,"Here, we report that recombinant poliovirus therapy primarily mediates antitumor immunotherapy via direct infection of non-malignant tumor microenvironment (TME) cells, independent of malignant cell lysis.",33767151_2,-1,1,-1,1,41862,-1,1.9578258e-05,0.99996984,1.05868085e-05
4621,that,4,5,28,32,Early human studies suggest that an imbalance of Tregs and effector T cells may contribute to the development of graft-versus-host-disease.,17084366_3,-1,1,-1,1,4621,-1,1.7188633e-05,0.99997497,7.898131e-06
35579,the,11,12,82,85,"We investigated the relationship between Neutrophil-to-lymphocyte ratio (NLR) and the quantities of neutrophil elastase, CD3, Foxp3, and CD204 in tumor-infiltrating cells and circulating cytokines (IL-2, -6, -8, 17a, and TGF-) in muscle-invasive bladder cancer.",30199269_0,-1,1,-1,1,35579,-1,1.6188667e-05,0.9999746,9.199444e-06
28705,the,4,5,35,38,"GIFT4-CLL cells directly propelled the expansion of autologous IFN--producing CD314(+) cytotoxic T cells in vitro, and that these could lyse autologous CLL cells.",27118475_8,-1,1,-1,1,28705,-1,1.901007e-05,0.9999713,9.6791255e-06
36443,transition,18,19,115,125,"Here, we examined the association of programmed cell death ligand 1 (PD-L1) expression with epithelial-mesenchymal transition (EMT)-associated markers in pancreatic ductal adenocarcinoma (PDA) within the context of the tumor microenvironment.",30927618_1,-1,1,-1,1,36443,-1,3.6312482e-05,0.99989474,6.890977e-05
3968,Treg,8,9,60,64,The mechanisms controlling the induction and maintenance of Treg's in humans need to be defined.,16763205_1,-1,1,-1,1,3968,-1,2.8231569e-05,0.9999535,1.8272018e-05
7244,their,19,20,127,132,"Although the mechanism of suppression used by Treg cells remains controversial, it has been postulated that TGF-beta1 mediates their immunosuppressive activity.",18566377_1,-1,1,-1,1,7244,-1,2.3394377e-05,0.99996614,1.0518106e-05
21542,relevant,8,9,61,69,These results suggest that anti-tumor immunity is clinically relevant in angiosarcoma.,24243586_9,-1,1,-1,1,21542,-1,3.8726517e-05,0.9999486,1.2622746e-05
34006,tumor,22,23,136,141,"The increase in tumor rejection was associated with an increased number and persistence of CD8 T cells in lymphoid tissues during acute tumor rejection, tumor regrowth, and in mice that remained tumor-free.",29271784_2,-1,1,-1,1,34006,-1,2.1587663e-05,0.99996614,1.2237307e-05
36115,types,29,30,223,228,"Collectively, IL-32 fosters the tumor progression by nuclear factor-B (NF-B)-mediated cytokines and metalloproteinase production, as well as stimulation of differentiation into immunosuppressive cell types in some cancer types.",30638183_6,-1,1,-1,1,36115,-1,4.050398e-05,0.9999081,5.144155e-05
31685,to,13,14,65,67,"In this report, we found that memory CTLs need to be reactivated to exert effector functions.",28405920_3,-1,1,-1,1,31685,-1,2.1318598e-05,0.99996865,1.0014874e-05
158,thymoma,15,16,86,93,"A gel mobility shift assay however, revealed translocation of STAT1 to the nucleus in thymoma as well as normal TEC.",10886240_7,-1,1,-1,1,158,-1,3.1832453e-05,0.99995327,1.4947482e-05
24446,the,28,29,172,175,"We hypothesize that ""designer"" DCs expressing constitutively active IB kinases will prove highly immunogenic also in vivo and possibly emerge as a new strategy to improve the clinical efficacy of therapeutic vaccinations against cancer and other chronic diseases.",25100611_5,-1,1,-1,1,24446,-1,2.0766967e-05,0.99997187,7.398528e-06
5588,FOXP3(+,11,12,66,73,CONCLUSION: Exposure of PBMCs to melanoma results in induction of FOXP3(+) T(reg) cells.,17574040_9,-1,1,-1,1,5588,-1,0.00018748525,0.99966395,0.00014853216
38492,The,2,3,12,15,BACKGROUND: The efficacy of checkpoint blockade immunotherapies in colorectal cancer is currently restricted to a minority of patients diagnosed with mismatch repair-deficient tumors having high mutation burden.,31888734_0,-1,1,-1,1,38492,-1,1.9887388e-05,0.99997175,8.386924e-06
16880,FOXP3,21,22,119,124,We determined two types of CD4+ CD127- T cells with comparable regulatory ability; one is CD25(high+) cells expressing FOXP3 (CD25(high+) FOXP3+ Tregs) and the other is CD25- cells without FOXP3- expression (CD25- FOXP3- cells).,22419479_7,-1,1,-1,1,16880,-1,2.7063774e-05,0.99995947,1.34872e-05
23352,that,3,4,23,27,These results indicate that modulating central tolerance through RANKL can alter thymic output and potentially provide therapeutic benefit by enhancing anti-tumor immunity.,24752296_8,-1,1,-1,1,23352,-1,1.8180941e-05,0.99997485,6.978981e-06
38564,the,9,10,70,73,"Considering the existence of immune-desert in tumor microenvironment, the clinical efficacy of immunotherapy for lung adenocarcinoma is limited.",31898342_0,-1,1,-1,1,38564,-1,2.2696302e-05,0.99996877,8.5536285e-06
33263,Th1,19,20,121,124,"IFN regulatory factor (IRF)-1 is a transcriptional regulator of IFNs and IFN-inducible genes, involved in the control of Th1 and Treg differentiation and in sterile inflammation.",28975621_1,-1,1,-1,1,33263,-1,2.9965211e-05,0.99991083,5.92406e-05
20621,status,17,18,118,124,"We found that increased numbers of IL-17-producing cells were correlated with high histological grade, negative ER/PR status, and triple-negative molecular subtypes segregated by immunoprofiles.",23738752_3,-1,1,-1,1,20621,-1,3.5075165e-05,0.99993443,3.0449834e-05
9500,to,37,38,241,243,"We now show that IDO functions as a molecular switch in TDLNs, maintaining Tregs in their normal suppressive phenotype when IDO was active, but allowing inflammation-induced conversion of Tregs to a polyfunctional T-helper phenotype similar to proinflammatory T-helper-17 (TH17) cells when IDO was blocked.",19366986_1,-1,1,-1,1,9500,-1,2.3359136e-05,0.99996734,9.250227e-06
34782,that,5,6,32,36,RESULTS: Our study demonstrated that PE in vitro could significantly increase the percentage of apoptosis and necrosis in HPV+TC-1 cells and block the cell cycle phase.,29783020_3,-1,1,-1,1,34782,-1,1.7479459e-05,0.99997413,8.346992e-06
23037,the,10,11,74,77,MDPF also significantly promoted the production of IFN- and up-regulated the mRNA expression levels of IFN- and Th1 transcription factors T-bet and STAT-4 in splenocytes from the S180-bearing mice.,24690776_7,-1,1,-1,1,23037,-1,1.601025e-05,0.99997485,9.140382e-06
25519,to,11,12,93,95,"Accordingly, pDCs cocultured with cervical/vulvar neoplastic keratinocytes have the capacity to induce a Treg cell differentiation from nave CD4(+) T cells, which is in agreement with the development of a tolerogenic response.",25492101_6,-1,1,-1,1,25519,-1,1.9993215e-05,0.99996984,1.0112646e-05
7594,Treg,9,10,38,42,"Here, we study the regulatory T cell (Treg) function and the expression of FOXP3 in SS.",18769452_2,-1,1,-1,1,7594,-1,2.1545695e-05,0.99996674,1.1656232e-05
16208,transformed,1,2,5,16,"Many transformed lymphoma cells show immune-phenotypes resembling the corresponding normal lymphocytes; thus, they provide a guide for proper diagnosis and present promising routes to improve their pathophysiologic understanding and to identify novel therapeutic targets.",22042699_0,-1,1,-1,1,16208,-1,2.5575393e-05,0.99994016,3.425252e-05
43187,than,22,23,143,147,"This instills strong interests in understanding the immunomodulatory effects of radiotherapy (RT), an area that was actually investigated more than a century ago but had been largely ignored for many decades.",34830176_1,-1,1,-1,1,43187,-1,3.6662666e-05,0.99994016,2.3173985e-05
23507,the,15,16,82,85,We were the first to report that treatment with anti-CTLA-4 led to an increase in the frequency of T cells expressing inducible costimulator (ICOS).,24778280_2,-1,1,-1,1,23507,-1,1.6954134e-05,0.99997497,8.052095e-06
42064,to,8,9,68,70,Double immunofluorescence and flow cytometry analyses were employed to investigate TFT cell enrichment in paraffin-embedded fresh tumor tissues from patients with DLBCL.,33864956_3,-1,1,-1,1,42064,-1,1.7958304e-05,0.9999732,8.81102e-06
17066,The,0,1,0,3,"The development of multiple myeloma (MM) involves a series of genetic alterations and changes in the bone marrow microenvironment, favoring the growth of the tumor and failure of local immune control.",22489248_0,-1,1,-1,1,17066,-1,1.7674318e-05,0.9999739,8.452729e-06
37973,than,10,11,68,72,"Conversely, IL-22 expression in Treg cells was significantly higher than in the CD4+CD25-FoxP3+ subpopulation.",31630080_5,-1,1,-1,1,37973,-1,2.2254604e-05,0.9999652,1.2580473e-05
25644,NFI-A,42,43,229,234,"The results showed that NPC cell line C666-1 and surgically removed NPC tissue expressed miR-21, which was upregulated by the presence of the Toll-like receptor 3 ligand, Poly I: C. Exposure to miR-21 increased the expression of NFI-A and interleukin (IL)-10 in naive B cells.",25544502_8,-1,1,-1,1,25644,-1,4.178324e-05,0.9999287,2.9476032e-05
42379,the,20,21,137,140,"These populations interface with each other to prepare a conservative response, capable of evading the defense mechanisms implemented by the host's immune system.",34070750_3,-1,1,-1,1,42379,-1,1.918814e-05,0.9999708,9.98474e-06
40618,the,19,20,86,89,"In this study, we found that the upregulation of Foxp3+ regulatory T cells (Tregs) in the mesothelioma tumor microenvironment after nonablative oligofractionated irradiation significantly limited the success of irradiation.",32948683_2,-1,1,-1,1,40618,-1,1.7617906e-05,0.9999727,9.665902e-06
37437,thereby,15,16,126,133,"Mice with Treg cell-restricted Neuropilin-1 deficiency show tumor resistance while maintaining peripheral immune homeostasis, thereby providing a controlled system to interrogate the impact of intratumoral Treg cells on the TME.",31350177_1,-1,1,-1,1,37437,-1,2.0614443e-05,0.99997103,8.385383e-06
25485,the,23,24,139,142,These data indicate the feasibility of the application of this new class of immunogens based on VEL concept as an alternative approach for the development of molecular vaccines against cancer.,25483665_7,-1,1,-1,1,25485,-1,2.0889052e-05,0.9999713,7.843202e-06
34001,tumor,24,25,162,167,"Using an adoptive transfer model of cancer immunotherapy, we demonstrate that constitutive eomesodermin (Eomes) expression in tumor-specific CD8 T cells improves tumor rejection and survival.",29271784_1,-1,1,-1,1,34001,-1,1.839622e-05,0.99997306,8.5763e-06
34717,FOXP3,7,8,47,52,"Previous studies have reported the presence of FOXP3+ CD8+ Treg cells, similar to CD4+ Tregs, in cancer patients which produce high levels of the immunosuppressive cytokines, IL10 and TGF.",29768737_1,-1,1,-1,1,34717,-1,2.6457501e-05,0.99995947,1.4044116e-05
35006,Treg,43,44,238,242,"However, in contrast with SeV and poly I:C, rintatolimod did not activate the MAVS/helicase pathway, thus avoiding NFB- and TNF-dependent induction of COX2, COX2/PGE2-dependent induction of IDO, IL10, CCL22, and CXCL12, and eliminating Treg attraction.",29853604_3,-1,1,-1,1,35006,-1,6.468427e-05,0.99989665,3.866174e-05
24259,Tregs-,15,16,98,104,"In conclusion, decreased composition of regulative Th1 cells and increased composition of FOXP(+) Tregs-, CD49b(+)/LAG-3(+) Tr1-, and IL-17-positive cells in tumor tissues may be associated with the progression of colorectal cancer.",25034363_10,-1,1,-1,1,24259,-1,4.4923163e-05,0.9999076,4.7448724e-05
26271,The,0,1,0,3,The hyper-responsiveness of the CIN patients to common antigens needs further studies.,25990808_8,-1,1,-1,1,26271,-1,1.9601834e-05,0.9999715,8.93192e-06
32410,Tumor,0,1,0,5,Tumor migration/metastasis and immunosuppression are major obstacles in effective cancer therapy.,28612394_0,-1,1,-1,1,32410,-1,2.2433265e-05,0.99996746,1.0107e-05
30922,complex,66,67,360,367,"Areas covered: This article will focus on 1) the role of Treg-derived TGF- in the suppressive activity of Treg, 2) the cellular and molecular regulation of expression of GARP on mouse and human Tregs, 3) the role of integrins in the activation of latent-TGF-/GARP complex, 4) an overview of our present understanding of the function of the latent-TGF-/GARP complex.",28001437_3,-1,1,-1,1,30922,-1,2.2595608e-05,0.99995697,2.0430844e-05
6043,two,20,21,104,107,"A dual altered peptide ligand (APL), composed of the tandemly arranged two single amino acid analogs of two myasthenogenic peptides, p195-212 and p259-271, down-regulated in vitro and in vivo MG-associated T cell responses.",17956982_1,-1,1,-1,1,6043,-1,0.00010313944,0.99985063,4.6175533e-05
40138,that,43,44,269,273,"When all three agents were used in combination, maximum antitumor effects were observed, which correlated with increases in T cells and T-cell clonality in the TME.CONCLUSION: These studies provide the rationale for the potential clinical use of combinations of agents that can (1) induce tumor-associated T-cell responses, (2) potentiate immune responses in the TME and (3) reduce immunosuppressive entities in the TME.",32554612_8,-1,1,-1,1,40138,-1,2.0383717e-05,0.99996984,9.717264e-06
39927,Th1-polarizing,10,11,73,87,"ALP functionally induced DC maturation by up-regulating the secretion of Th1-polarizing pro-inflammatory cytokines, the expression of surface molecules, and antigen-presenting ability.",32486094_4,-1,1,-1,1,39927,-1,7.952645e-05,0.9998615,5.9006677e-05
29363,the,2,3,6,9,"Thus, the data demonstrate that binding of antigen-specific dextramers to ASTs specifically results in activation of NFAT, that the NFAT activation correlates with a downstream functional response and that the response can be heterogeneous.",27327144_12,-1,1,-1,1,29363,-1,1.6883845e-05,0.9999738,9.354972e-06
1629,that,29,30,153,157,"The aim of this study is to assess the effect of supernatants from 3 ovarian carcinoma cell lines (OVCAR3, CAOV3, SKOV3) on signal transduction elements that are linked to the IL-2R and its JAK-STAT pathway.",14741732_2,-1,1,-1,1,1629,-1,1.8546612e-05,0.9999716,9.77583e-06
1435,tumor,10,11,76,81,Increasing the number of plasmid injections after tumor irradiation induced tumor regression in 70% of the mice.,12804139_7,-1,1,-1,1,1435,-1,2.103631e-05,0.9999684,1.0523578e-05
12296,genes,10,11,65,70,The prognostic value of germline genetic variants of some immune genes suggests that the host genetic background may also influence the biology of FL.,20425464_4,-1,1,-1,1,12296,-1,3.9575258e-05,0.9999274,3.298939e-05
38466,Tregs,2,3,9,14,RESULTS: Tregs accumulated at the tumor center and Th17 cells accumulated at the invasion front during cancer progression and/or metastasis; each signaled poor prognosis.,31853779_5,-1,1,-1,1,38466,-1,2.1602416e-05,0.99996567,1.2761505e-05
31708,type,19,20,116,120,"In conclusion, effector functions of established memory CTLs may be affected by certain cytokines such as IL-12 and type I IFN.",28405920_8,-1,1,-1,1,31708,-1,5.352784e-05,0.9999107,3.57e-05
12356,FoxP3,49,50,321,326,"This study analyzed the nature of the inflammatory infiltrate, presence of mast cells, and in situ expression of cytokines (interleukin [IL]-17 and transforming growth factor [TGF]-beta), chemokines (macrophage inflammatory protein [MIP]-1beta and monocyte chemotactic protein [MCP]-1), and nuclear transcription factor (FoxP3) in human periapical granulomas and cysts compared with a control group.",20478453_1,-1,1,-1,1,12356,-1,1.9858378e-05,0.99996734,1.2772485e-05
17829,FOXP3,31,32,221,226,AIM: To investigated the interaction between toll-like receptor 4 (TLR4)-activated hepatoma cells and macrophages in the induction of tumor-immune suppression mediated by CD4+CD25(high) family of transcription factor P3 (FOXP3) regulatory T cells (Tregs).METHODS: The proportion of FOXP3+ Tregs was identified in peripheral blood and tumor tissues of 60 hepatocellular carcinoma (HCC) patients.,22736917_0,-1,1,-1,1,17829,-1,2.186365e-05,0.99996674,1.143752e-05
36090,natural,8,9,52,59,Interleukin-32 (IL-32) was originally identified in natural killer (NK) cells activated by IL-2 in 1992.,30638183_0,-1,1,-1,1,36090,-1,4.3873533e-05,0.9999355,2.0614181e-05
13077,Foxp3,14,15,75,80,"Among the CD4(+) T-cell population in the skin, at least one-fifth express Foxp3.",20722759_1,-1,1,-1,1,13077,-1,2.3120103e-05,0.99996424,1.2632241e-05
1601,the,23,24,172,175,Phenotypic and functional analyses demonstrated that they were antigen-specific CD4(+) Treg cells expressing CD25 and GITR molecules and possessing suppressive activity on the proliferative response of naive CD4(+) T cells to anti-CD3 antibody stimulation.,14738769_3,-1,1,-1,1,1601,-1,1.601769e-05,0.99997604,7.960867e-06
1931,that,24,25,144,148,Other factors that may play a role in the eradication of long-term established AGIN lesions need to be determined to identify the patient group that would benefit from immunotherapy with the vaccines used in this study.,15131030_11,-1,1,-1,1,1931,-1,2.496056e-05,0.9999615,1.3557343e-05
7553,the,7,8,35,38,"In the current study, we evaluated the expression of FOXP3 in CD4+CD25hi T regulatory lymphocytes (Treg) and their influence on immune response against tumor and viral antigens in the complex system of peripheral blood mononuclear cells.",18695923_2,-1,1,-1,1,7553,-1,1.6118542e-05,0.99997556,8.314613e-06
20741,their,16,17,103,108,"Here, we further studied the immunogenicity of chimeric murine MSLN-virus-like particles (mMSLN-VLPs), their ability to break tolerance to mMSLN, a self-antigen, and deciphered the mechanism of immune responses elicited by mMSLN-VLP immunization using a pancreatic cancer (PC) mouse model.",23874581_1,-1,1,-1,1,20741,-1,1.9961544e-05,0.99997044,9.645695e-06
43121,to,19,20,125,127,"To elucidate the immunology underlying this condition, we leverage multiplexed ion beam imaging by time-of-flight (MIBI-TOF) to identify the presence and proportion of infiltrating immune cells from a single section of biopsy specimen.",34755133_3,-1,1,-1,1,43121,-1,1.6401094e-05,0.9999753,8.256644e-06
14935,that,3,4,25,29,These findings indicated that melanoma cells could have Foxp3-dependent Treg-like suppressive effects on T cells and suggested that the mimicking of Treg function by melanoma cells may represent a possible mechanism of tumor resistance to immune destruction in the melanoma tumor microenvironment.,21547596_8,-1,1,-1,1,14935,-1,1.7787113e-05,0.99997354,8.7283925e-06
1946,the,23,24,131,134,PBMC were exposed in vitro to purified E6 or E7 proteins or transduced with fusion proteins containing the first 11 amino acids of the human immunodeficiency virus type 1 protein tat fused to E6 or E7 (tat-E6/tat-E7).,15138179_2,-1,1,-1,1,1946,-1,2.0628111e-05,0.9999683,1.1128519e-05
42822,Foxp3,19,20,116,121,"Mechanistically, CBS facilitated the expression cleaved Caspase-3 in tumor cells, and on the other hand, suppressed Foxp3 expression in Tregs via inactivating IL-6/STAT3 pathway.",34413167_8,-1,1,-1,1,42822,-1,2.2625534e-05,0.99996436,1.3024038e-05
20152,STAT1,12,13,67,72,Culture of normal PBMCs with PSC supernatants led to STAT3 but not STAT1 or STAT5 phosphorylation.,23514705_8,-1,1,-1,1,20152,-1,3.002139e-05,0.99993753,3.2459193e-05
13803,the,2,3,16,19,We investigated the impact of three medications on blood Treg frequency in vaccinated cancer patients.,21177412_1,-1,1,-1,1,13803,-1,1.7093267e-05,0.99997497,7.899261e-06
39307,BRD4,2,3,19,23,"AZD5153 inhibiting BRD4, as a potential therapeutic strategy for HGSOC, was demonstrated to confer controversial plasticity on TAMs, which shows the need to uncover its impact on TAMs in HGSOC.",32184777_4,-1,1,-1,1,39307,-1,0.0002692664,0.9946919,0.005038844
19145,the,13,14,78,81,These results suggest that CCL2 is more than a chemoattractant factor that is the significant effector molecule responsible for immune evasion of Snail(+) tumor cells.,23143679_9,-1,1,-1,1,19145,-1,2.6463716e-05,0.9999597,1.387104e-05
22823,to,35,36,215,217,"Data generated from this study support that NLGP is effective in preventing the SLTCL induced generation (CD68(+)CD206(+)IL-10(high) to CD68(+)CD206(-)IL-10(low) TAMs) and functions (NO(low) to NO(high), MHC-I(low) to MHC-I(high), CD80(low) to CD80(high)) of pro-tumorous M2 macrophages, which in turn associated with sustained anti-tumor effector functions by promoting cytotoxic T cell activities and suppressing regulatory T cells.",24607970_2,-1,1,-1,1,22823,-1,7.550878e-05,0.9998654,5.9098766e-05
13270,to,1,2,11,13,Strategies to augment in vivo NK cell persistence and expansion are needed.,20849361_14,-1,1,-1,1,13270,-1,2.3639892e-05,0.9999652,1.1134939e-05
11640,The,0,1,0,3,The artificial gene used to create the vaccine comprising 415 aa (1248 bp) was cloned by fusing 14 polymerase chain reaction fragments of HPV16 and HPV18 E6 and E7 oncogenes devoid of sequences with transforming potential.,20145549_1,-1,1,-1,1,11640,-1,1.65639e-05,0.99997485,8.551341e-06
3779,tumors,7,8,49,55,"Using syngeneic Stat1-/- C3H mice bearing SCCVII tumors in this study, we discovered opposite results.",16618773_1,-1,1,-1,1,3779,-1,1.8638586e-05,0.99996793,1.337155e-05
42128,STAT6,28,29,156,161,"Recent findings have indicated that the signal transducer and activator of transcription 6 (STAT6) plays a fundamental role in the early stages of CAC, and STAT6 knockout (STAT6-/-) mice are highly resistant to CAC development.",33919941_1,-1,1,-1,1,42128,-1,3.511151e-05,0.9999335,3.1449752e-05
39742,plays,24,25,155,160,"BACKGROUND: The connection between inflammatory bowel disease (IBD) and colorectal cancer (CRC) is well-established, as persistent intestinal inflammation plays a substantial role in both disorders.",32390702_0,-1,1,-1,1,39742,-1,4.2930988e-05,0.99994385,1.32444675e-05
2577,plasmids,5,6,31,39,"The transfected genes are cDNA plasmids for interferon-gamma (pIFN-gamma), MHC class II transactivator (pCIITA), an Ii reverse gene construct (pIi-RGC), and a subtherapeutic dose of adjuvant IL-2 (pIL-2).",15761259_1,-1,1,-1,1,2577,-1,3.0993757e-05,0.99993956,2.9432895e-05
42845,to,18,19,84,86,"The protective effect of PBC was relying on type 1 and type 2 T cell responses and, to a lesser extent, on B cells.",34495298_6,-1,1,-1,1,42845,-1,3.822648e-05,0.9999435,1.8241608e-05
14899,the,28,29,160,163,The forkhead transcription factor Foxp3 is the only definitive marker of CD4(+)CD25(+) regulatory T cells (Tregs) and has been identified as a key regulator in the development and function of Tregs.,21547596_0,-1,1,-1,1,14899,-1,1.7960203e-05,0.999974,8.026044e-06
42623,release,10,11,65,72,RESULTS: DFP stimulates lymphocytic proliferation (p=0.0118) and release of NO (p=0.01) significantly.,34190692_7,-1,1,-1,1,42623,-1,3.3494187e-05,0.99994516,2.1312078e-05
31386,the,6,7,47,50,"We also observed positive correlations between the proportion of LAP+CD4+ T cells and TNM stage (P < 0.001), distant metastasis (P < 0.001) and serum level of carcinoembryonic antigen (P < 0.05).",28210081_6,-1,1,-1,1,31386,-1,1.6558379e-05,0.99997616,7.2317366e-06
24605,that,12,13,75,79,"Thus, MDSCs may define an element of the pathogenic inflammatory processes that drives immune escape.",25164013_3,-1,1,-1,1,24605,-1,2.4874456e-05,0.999962,1.3162031e-05
4173,Foxp3,3,4,13,18,"In contrast, Foxp3 was not detected in unreconstituted Pan02-bearing Rag-/- mice, or reconstituted mice bearing a TGF-beta-negative esophageal tumor.",16799337_7,-1,1,-1,1,4173,-1,2.0745927e-05,0.9999672,1.20146915e-05
42418,that,5,6,27,31,"Furthermore, our data show that Areg-EGFR signaling induces HIF1, which binds and transactivates IL-9 and NOS2 promoters in Th9 cells.",34075041_4,-1,1,-1,1,42418,-1,1.7792883e-05,0.9999726,9.569759e-06
43917,Rel-B,5,6,36,41,"Impairments in the translocation of Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.",9724088_10,-1,1,-1,1,43917,-1,3.3172546e-05,0.9999422,2.4694658e-05
38333,their,7,8,34,39,"RESULTS: In vitro, flavonoids and their derivatives inhibit various transcriptional factors, which modulate differentiation, proliferation, activation of immune cells and enhance regulatory T cell generation.",31814545_3,-1,1,-1,1,38333,-1,4.7587368e-05,0.9999329,1.9467838e-05
3959,that,22,23,157,161,These results demonstrate that both enhanced suppressor activity and deletion of tumor-specific T cells are responsible for the progressive loss of efficacy that is associated with chronic immune therapy.,16751376_10,-1,1,-1,1,3959,-1,2.299681e-05,0.9999654,1.15362045e-05
19327,treatment,2,3,11,20,"To improve treatment strategies, I will be reviewing recent studies in the field.",23178746_2,-1,1,-1,1,19327,-1,2.8043181e-05,0.99995685,1.5082208e-05
3608,the,6,7,41,44,Tumor-associated macrophages (TAMs) have the potential to induce both immune activation and immune tolerance.,16530087_0,-1,1,-1,1,3608,-1,2.1392156e-05,0.9999695,9.096801e-06
23902,therapeutic,14,15,96,107,"We examined the combination of topical imiquimod with intramuscular administration of CRT/E7, a therapeutic human papillomavirus (HPV) vaccine comprised of a naked DNA vector expressing calreticulin fused to HPV16 E7.EXPERIMENTAL DESIGN: Using an orthotopic HPV16 E6/E7(+) syngeneic tumor, TC-1, as a model of high-grade cervical/vaginal/vulvar intraepithelial neoplasia, we assessed if combining CRT/E7 vaccination with cervicovaginal deposition of imiquimod could result in synergistic activities promoting immune-mediated tumor clearance.",24893628_1,-1,1,-1,1,23902,-1,3.205477e-05,0.99995315,1.4790042e-05
6136,the,24,25,145,148,"We examined functional status, activation mechanisms, and biologic role of the mTORC1 signaling pathway in malignant CD4(+) T cells derived from the cutaneous T-cell lymphoma (CTCL).",18025151_0,-1,1,-1,1,6136,-1,1.992473e-05,0.99996793,1.2139423e-05
7368,NF-kappaB-mediated,19,20,113,131,"Thus, the antiapoptotic signaling of CD40, which interferes with TRAIL-induced apoptosis in FL B cells, involves NF-kappaB-mediated induction of c-FLIP and Bcl-x(L) which can respectively interfere with caspase 8 activation or mitochondrial-mediated apoptosis.",18606651_6,-1,1,-1,1,7368,-1,3.0921787e-05,0.99994934,1.9759807e-05
28015,to,24,25,161,163,"Tregs promote tumor growth by modulating the antitumor immune response, mainly through inhibition of T-cell-mediated tumor cell killing: this has been suggested to be dependent on IL-10 and/or TGF-.",26782287_1,-1,1,-1,1,28015,-1,2.3495415e-05,0.999966,1.0441938e-05
26579,treatment,18,19,118,127,"The colon of untreated Mutyh-/- mice expressed higher basal levels of pro-inflammatory cytokines GM-CSF and IFN, and treatment with AOM/DSS induced an early decrease in circulating CD4+ and CD8+ T lymphocytes and an increase in myeloid-derived suppressor cells (MDSCs).",26109431_6,-1,1,-1,1,26579,-1,1.904457e-05,0.99997056,1.0381644e-05
25103,plaque,43,44,226,232,"The presence of eosinophils correlated with disease stage: 78% of patients with advanced disease displayed eosinophil infiltration, whereas this was only seen in 11% of patients with patches (p<0.01), and in 48% of those with plaque disease.",25275020_2,-1,1,-1,1,25103,-1,4.014604e-05,0.9999256,3.4212877e-05
746,TAP,17,18,83,86,CTL recognition of the HPV16 E6(29-38) epitope in 721.174 B cells was dependent on TAP expression but independent of immunoproteasome expression.,11673561_7,-1,1,-1,1,746,-1,2.2980339e-05,0.9999671,9.951166e-06
9905,the,18,19,107,110,"Because a subset of lymphoma B cells express IL-2 and given that IL-2 signaling is critically important in the development of regulatory T (T(reg)) cells, we tested the role of IL-2 signaling in T(H)17 cell development.",19509224_3,-1,1,-1,1,9905,-1,1.9138808e-05,0.9999732,7.659017e-06
39408,Therefore,0,1,0,9,"Therefore, we investigated the frequency and functional characteristics of Treg cells in nonfunctioning pituitary adenoma patients before and after tumor removal.",32279926_3,-1,1,-1,1,39408,-1,1.779368e-05,0.9999716,1.058164e-05
16369,T(reg,11,12,66,71,SocL extract and wogonin also inhibited the secretion of IL-10 in T(reg) culture; whereas the level of IL-2 was either unchanged or marginally enhanced.,22057676_6,-1,1,-1,1,16369,-1,1.9028312e-05,0.99996805,1.2910168e-05
19162,the,5,6,22,25,"Using a novel form of the 4-1BBL costimulatory molecule, SA-4-1BBL, as the adjuvant of choice, we previously demonstrated that a single vaccination with survivin (SVN) as a bona fide self TAA was effective in eradicating weakly immunogenic 3LL tumors in >70% of C57BL/6 mice.",23144888_2,-1,1,-1,1,19162,-1,2.0402924e-05,0.9999676,1.20716395e-05
33809,to,1,2,10,12,Switching to mitochondrial fission via ablation of Fam73b (also known as Miga2) promotes IL-12 production.,29180626_4,-1,1,-1,1,33809,-1,2.6851068e-05,0.99996054,1.2565821e-05
24287,tumor,8,9,54,59,Myeloid-derived suppressor cells (MDSC) expanded with tumor progression at both primary and lung metastatic sites.,25035397_4,-1,1,-1,1,24287,-1,2.2361557e-05,0.99996734,1.0312183e-05
15036,that,7,8,67,71,"Exploratory multivariable Cox proportional hazards models revealed that an increased percentage of the CD33(+)HLADR(-)CD15(-) MDSC subset was associated with reduced overall survival (P = 0.049), while an increased percentage of the CD33(+)HLADR(-/low)CD14(+) subset was associated with greater overall survival (P = 0.033).",21604071_7,-1,1,-1,1,15036,-1,1.7046359e-05,0.9999726,1.0371551e-05
28174,tumor,13,14,97,102,Constitutive activation of the KRAS oncogene in human malignancies is associated with aggressive tumor growth and poor prognosis.,26880715_0,-1,1,-1,1,28174,-1,2.251614e-05,0.99996424,1.3264761e-05
10676,treatment,10,11,71,80,Adoptive T cell immunotherapy using autologous lymphocytes is a viable treatment for patients with cancer and requires participation of Ag-specific CD4 and CD8 T cells.,19762283_0,-1,1,-1,1,10676,-1,3.0339485e-05,0.9999527,1.7018956e-05
9766,their,33,34,189,194,"In addition, Tregs inhibited the proliferation of TCR-stimulated (primed) CD4(+) T cells and nave CD8(+) T cells after TCR-mediated activation, however, Tregs with OX40 costimulation lost their suppressive function.",19455675_6,-1,1,-1,1,9766,-1,2.0173533e-05,0.99997044,9.445519e-06
37673,to,11,12,79,81,"Previous studies have shown that baicalein and baicalin are directly cytotoxic to some tumors, here we demonstrate that in addition to direct cytotoxicity, these two flavonoids stimulate the T cell mediated immune response against tumors through reduction of PD-L1 expression in cancer cells.",31437792_1,-1,1,-1,1,37673,-1,2.4927425e-05,0.99996257,1.2508766e-05
36711,the,6,7,46,49,"While the inflammatory cytokine can stimulate the immune system and promote tumor growth, it remains unclear how circulating IL-6 can potentiate a poor prognosis.",31027698_1,-1,1,-1,1,36711,-1,2.1940175e-05,0.99996734,1.0670977e-05
42814,the,7,8,44,47,"Activation of the Cbs/H2S axis also reduced the abundance of tumor-infiltrating Tregs, while Cbs deficiency promoted Tregs-mediated immune evasion and boosted tumor growth in Cbs heterozygous knockout mice.",34413167_7,-1,1,-1,1,42814,-1,1.6295819e-05,0.99997616,7.507835e-06
15296,TNM,8,9,49,52,High proportion of Treg is correlated to advance TNM stage and reduced survival.,21695703_7,-1,1,-1,1,15296,-1,4.2127267e-05,0.9999318,2.6104435e-05
21046,the,1,2,3,6,"In the current report, we show that it is the subset of T cell-inflamed tumors that showed high expression of three defined immunosuppressive mechanisms: indoleamine-2,3-dioxygenase (IDO), PD-L1/B7-H1, and FoxP3(+) regulatory T cells (T(regs)), suggesting that these inhibitory pathways might serve as negative feedback mechanisms that followed, rather than preceded, CD8(+) T cell infiltration.",23986400_2,-1,1,-1,1,21046,-1,2.0025416e-05,0.99996936,1.0612157e-05
33397,TIDC,22,23,140,144,PD-1 was recently shown to be expressed on and thereby impair the functions of tumor-infiltrating murine and human myeloid dendritic cells (TIDC) in ovarian cancer.,28993412_3,-1,1,-1,1,33397,-1,2.4894736e-05,0.99996257,1.258962e-05
15728,to,15,16,102,104,"Proinflammatory cytokine production likely accounted for the raised levels of IL-11, a cytokine known to promote gastric epithelial cell survival and hyperplasia.",21881210_4,-1,1,-1,1,15728,-1,5.268395e-05,0.9999336,1.368109e-05
26791,T,31,32,171,172,"It is a heterodimeric protein of two subunits (p35, p40) secreted by phagocytic cells in response to pathogens and mainly acts through STAT4 to induce IFN- production in T and NK cells.",26182974_1,-1,1,-1,1,26791,-1,2.3706723e-05,0.99995303,2.3243672e-05
32215,to,15,16,95,97,Inflammation plays a critical role in the initiation of colorectal cancer but is also required to mediate antitumor immunity in established tumors.,28558303_0,-1,1,-1,1,32215,-1,3.0388688e-05,0.99995947,1.0103499e-05
38716,the,5,6,29,32,"In particular, CXCL9 reduced the CD8+ cytotoxic T lymphocytes in the tumour microenvironment of PAAD, which could be attributed to the reduced CD8+ T cell proliferation, activation, and secretion of anti-tumour cytokines.",31913856_4,-1,1,-1,1,38716,-1,1.7108341e-05,0.9999715,1.13910055e-05
43675,transcription,21,22,151,164,"The IL-10R, together with reporter gene constructs containing different IL-6-responsive gene elements, reconstituted in hepatoma cells an induction of transcription by IL-10 that was comparable to that by IL-6.",8662928_7,-1,1,-1,1,43675,-1,2.6277232e-05,0.9999585,1.5201221e-05
4102,that,17,18,104,108,Here we show that a widely used neutralizing anti-murine IL-2 mAb (S4B6) exhibits unexpected activities that enhance the treatment effects of IL-2 in vivo.,16785526_1,-1,1,-1,1,4102,-1,2.0387166e-05,0.9999702,9.407741e-06
21562,naturally-occurring,13,14,80,99,"The splenocyte proliferation, shifting of cytokine profile, and the presence of naturally-occurring CD4+CD25+Foxp3+ Treg cells were assessed to describe the anti-tumor immune response.",24270218_4,-1,1,-1,1,21562,-1,4.5310666e-05,0.9999411,1.35253495e-05
32757,The,0,1,0,3,The 1-PEG-IL2 and 2-PEG-IL2 species derived from NKTR-214 are the most active conjugated-IL2 species.,28678791_4,-1,1,-1,1,32757,-1,2.0353511e-05,0.999969,1.06226225e-05
32013,to,28,29,159,161,"However, the contributions of ILC2s in the occurrence and development of lung cancer, and the association between ILC2s and Th2 or MDSCs in lung cancer remain to be elucidated.",28487978_2,-1,1,-1,1,32013,-1,2.5228275e-05,0.9999621,1.2630455e-05
7250,to,25,26,134,136,"In this study, we show that P17, a short synthetic peptide that inhibits TGF-beta1 and TGF-beta2 developed in our laboratory, is able to inhibit Treg activity in vitro and in vivo.",18566377_2,-1,1,-1,1,7250,-1,1.7804363e-05,0.9999739,8.338366e-06
28641,The,2,3,9,12,"METHODS: The expression and activation of NF-B, Akt and IDO1 by MyD88(+) EOC SKOV3 cells was determined using western blot; the TLR4/MD-2 complex on SKOV3 cells and the phenotype of T lymphocytes were determined using flow cytometry; IDO activity was evaluated by measuring L-kynurenine; Immunesuppressive cytokines were detected using ELISA; T-cell proliferation to mitogen stimulation was assessed by MTT assay; the cytotoxicity of lymphocytes and NK cells was measured using LDH-cytotoxicity assay.",27118139_3,-1,1,-1,1,28641,-1,1.7205786e-05,0.999972,1.0811413e-05
23951,type,9,10,54,58,Stat2(-/-) mice formed larger tumors compared to wild type (WT) mice.,24895110_3,-1,1,-1,1,23951,-1,3.8749386e-05,0.9999372,2.4063438e-05
37344,the,33,34,222,225,"Caloric restriction mimetics (CRMs), compounds that mimic the biochemical effects of nutrient deprivation, administered via systemic route promote antitumor effects through the induction of autophagy and the modulation of the immune microenvironment; however, collateral effects due to metabolic changes and the possible weight loss might potentially limit their administration at long term.",31321243_0,-1,1,-1,1,37344,-1,2.0238189e-05,0.99996984,9.91896e-06
9275,Treg,14,15,90,94,"Collectively, these observations further support the role of TGF-beta in the induction of Treg in pancreas adenocarcinoma.",19307989_10,-1,1,-1,1,9275,-1,2.3498256e-05,0.999964,1.24729995e-05
39644,to,5,6,29,31,"T cells have been reported to exert immunosuppressive functions in multiple solid malignant diseases, but their immunosuppressive functional subpopulation in breast cancer (BC) is still undetermined.",32345959_0,-1,1,-1,1,39644,-1,2.631548e-05,0.9999645,9.170332e-06
16247,Th17,18,19,132,136,"Furthermore, antisense-based miR-135b inhibition reduced tumor angiogenesis and growth in vivo, demonstrating significance of this ""Th17 mimic"" pathway as a therapeutic target.",22042699_7,-1,1,-1,1,16247,-1,4.357147e-05,0.9999342,2.2234484e-05
10757,the,14,15,87,90,"Although these T cells gradually increase in number with age and become predominant at the senescent stage in normal mice, the generation is robustly accelerated during leukemia.",19805226_5,-1,1,-1,1,10757,-1,1.8344494e-05,0.9999726,9.0521735e-06
12822,the,3,4,16,19,Here we studied the reciprocal contribution of regulatory (Treg) and interleukin-17-producing (Th17) T-cells to the composition of the lymphoma-associated microenvironment of angioimmunoblastic T-cell lymphoma (AITL) and PTCL not otherwise specified on tissue microarrays from 30 PTCLs not otherwise specified and 37 AITLs.,20595635_1,-1,1,-1,1,12822,-1,1.5875661e-05,0.99997675,7.3412407e-06
40112,the,19,20,118,121,NHS-interleukin-12 (NHS-IL12) is a tumor targeting immunocytokine designed to bring IL-12 to the TME and thus enhance the inflammatory Th1 response.,32554612_4,-1,1,-1,1,40112,-1,2.0028456e-05,0.9999715,8.415429e-06
5829,Treg,8,9,42,46,"Among the CD3(+)CD4(+) subset, CD25(high) Treg represented 3 +/- 0.5% in TIL, 1 +/- 0.3% in PBMC, and 0.4 +/- 0.2% in normal controls.",17671115_6,-1,1,-1,1,5829,-1,2.5615775e-05,0.9999529,2.1480342e-05
9177,typhimurium,9,10,66,77,Vaccination was performed by oral gavage of attenuated Salmonella typhimurium SL7207 carrying pUS-high.,19291796_2,-1,1,-1,1,9177,-1,4.566789e-05,0.9999187,3.5600257e-05
22055,the,6,7,33,36,E2/E6 ratio was used to evaluate the physical status of HPV-16 DNA in host cell genome.,24401583_3,-1,1,-1,1,22055,-1,1.7879178e-05,0.9999747,7.421488e-06
7648,The,3,4,21,24,EXPERIMENTAL DESIGN: The antitumor activities and related mechanisms of WP1066 were investigated both in vitro on melanoma cell lines and in vivo on mice with subcutaneously syngeneic melanoma or with intracerebral melanoma tumors.,18794085_2,-1,1,-1,1,7648,-1,1.6805558e-05,0.99997544,7.80792e-06
23921,tract,9,10,57,62,"The T cells attracted by imiquimod to the cervicovaginal tract expressed CXCR3 as well as CD49a, an integrin involved in homing and retention of CD8(+) T cells at mucosal sites.",24893628_5,-1,1,-1,1,23921,-1,3.9031023e-05,0.99991965,4.1277923e-05
26900,that,3,4,36,40,"Mechanistic investigations revealed that CCL5 activates CCR3, a highly expressed chemokine receptor on CD4 T cells, and also boosts Gfi1 expression to promote the differentiation of Th2 cells, which enhance the prometastatic activity of tumor-associated myeloid cells.",26249173_3,-1,1,-1,1,26900,-1,1.8016533e-05,0.99997175,1.0185431e-05
24905,tolerogenic,39,40,253,264,"Galectins, expressed in tumor, stromal, and endothelial cells, contribute to thwart the development of immune responses by favoring the expansion of T regulatory cells and contributing to their immunosuppressive activity, driving the differentiation of tolerogenic dendritic cells, limiting T cell viability, and maintaining T cell anergy.",25253145_2,-1,1,-1,1,24905,-1,8.1269434e-05,0.99987817,4.055715e-05
22769,to,26,27,180,182,"Kras(G12D/+);Trp53(R172H/+);Pdx-1-Cre (KPC) mice, which express an activated form of Kras in pancreatic tissues, develop pancreatic intraepithelial neoplasms (PanIN) that progress to pancreatic ductal adenocarcinoma (PDA).",24607504_1,-1,1,-1,1,22769,-1,2.2372213e-05,0.99996126,1.6398344e-05
4496,transcript,23,24,146,156,"RESULTS: In vitro IL-2 treatment produced a rapid and dose-dependent increase in P-STAT5 within normal PBMC that correlated with the induction of transcript for the IL-2-responsive genes CIS, Pim-1, and SOCS1 (correlation coefficients 0.8628, 0.6667, and 0.7828, respectively).",17020993_6,-1,1,-1,1,4496,-1,2.161825e-05,0.99996305,1.5285868e-05
12212,therapeutic,43,44,249,260,"Thus, potent pleiotropic immune functions of SA-4-1BBL combined with its ability to serve as a vehicle to increase the delivery of antigens to DCs in vivo endow this molecule with the potential to serve as an effective immunomodulatory component of therapeutic vaccines against cancer and chronic infections.",20406989_7,-1,1,-1,1,12212,-1,2.288718e-05,0.9999666,1.04347955e-05
34768,the,36,37,226,229,"Our findings suggest that at an early stage of the tumor, this tumor-induced IFN-producing FOXP3- CD8+ CD25+ CD127- T-cell subset can potentiate immune surveillance by targeting HLA-E-restricted CD4+ Treg cells while leaving the effector T-cell population unaffected.",29768737_8,-1,1,-1,1,34768,-1,1.9680238e-05,0.99996936,1.0988155e-05
8267,trigger,32,33,208,215,"These results suggest that the loss of Smad3 increases susceptibility to colon cancer by at least two mechanisms: deficient T-regulatory cell function, which leads to excessive inflammation after a bacterial trigger; and increased expression of proinflammatory cytokines, enhanced nuclear factor-kappaB activation, and increased expression of both pro-oncogenic and anti-apoptotic proteins that result in increased cell proliferation/survival of epithelial cells in colonic tissues.",19119184_6,-1,1,-1,1,8267,-1,2.9494226e-05,0.99995637,1.4122927e-05
12195,Therapeutic,0,1,0,11,Therapeutic efficacy of the vaccines was associated with increased CD4(+) T and CD8(+) T-cell effector and memory responses and higher intratumoral CD8(+) T effector/CD4(+)CD25(+)Foxp3(+) T regulatory cell ratio.,20406989_6,-1,1,-1,1,12195,-1,2.2690723e-05,0.99996805,9.276762e-06
22343,Th2-skewed,12,13,63,73,"Taken together, our data suggest that EPA and DHA may suppress Th2-skewed allergic immune responses by inhibiting the expression of basophilic IL-4 and IL-13.",24460246_10,-1,1,-1,1,22343,-1,3.454522e-05,0.9999368,2.8575483e-05
16675,Foxp3,16,17,85,90,"Second, FTS induced an increase in regulatory T cells in mouse splenocytes, in which Foxp3+ T cells did not interfere with the tumor growth inhibitory effects of FTS.",22323550_4,-1,1,-1,1,16675,-1,4.2643253e-05,0.9999367,2.0667037e-05
34591,to,54,55,357,359,"Although the Tr1 cells from infected asymptomatic subjects were functionally more potent than those from uninfected healthy subjects, the Tr1 cells in cancer individuals demonstrated several functional impairments, such as reduced interleukin 10 (IL-10) expression, lower secretion of cytolytic factors including granzyme B and perforin, and lower capacity to suppress CD4+CD25- T cell and CD8+ T cell proliferation.",29625086_5,-1,1,-1,1,34591,-1,2.4284804e-05,0.999961,1.4668064e-05
1109,treatment,13,14,80,89,As our model we used Epstein-Barr virus (EBV)-specific CTLs that are infused as treatment for EBV-positive Hodgkin disease but that are vulnerable to the TGF-beta produced by this tumor.,11964281_3,-1,1,-1,1,1109,-1,3.845016e-05,0.9999424,1.9086381e-05
42191,the,13,14,82,85,"Human IL17 cDNA was then inserted into the pEGFPN1 plasmid and transfected into the glioma U87MG cell line, and tumstatin was used to block the effect of the IL-17 overexpression.",33971545_3,-1,1,-1,1,42191,-1,1.7479813e-05,0.99997246,1.0000615e-05
6248,regulation,12,13,60,70,Activation and expansion of T helper (Th) cells followed by regulation of activation are essential to the generation of immune responses while limiting concomitant autoreactivity.,18156498_0,-1,1,-1,1,6248,-1,3.587624e-05,0.9999325,3.156694e-05
34757,Tregs,19,20,103,108,"At the late stage of tumor development, when CD4+ Treg cells dominate the tumor-microenvironment, CD4+ Tregs mediate the clonal deletion of these tumor-suppressive FOXP3- IFN+ CD8+ CD25+ CD127- T cells and ensure tumor immune evasion.",29768737_7,-1,1,-1,1,34757,-1,3.242871e-05,0.99991345,5.416753e-05
37289,genes,3,4,30,35,"Loss-of-function mutations in genes encoding TET DNA dioxygenase occur frequently in hematopoietic malignancy, but rarely in solid tumors which instead commonly have reduced activity.",31310587_0,-1,1,-1,1,37289,-1,2.6518972e-05,0.9999579,1.5542832e-05
41060,Tumor,0,1,0,5,"Tumor volume of each group was recorded, tumor inhibition rate was calculated, and tumor metastasis was counted.",33204731_3,-1,1,-1,1,41060,-1,2.1263295e-05,0.99996436,1.4347115e-05
1852,this,1,2,3,7,"In this article, we provide evidence suggesting that T cells may also play a protective role in liver disease by releasing interleukin-22 (IL-22), a recently identified T cell-derived cytokine whose biological significance is unclear.",15122762_1,-1,1,-1,1,1852,-1,3.040858e-05,0.9999548,1.4812341e-05
25739,the,2,3,9,12,"However, the effect of 14-3-3 in the regulation of interactions between tumor cells and the immune system has not been previously reported.",25556369_1,-1,1,-1,1,25739,-1,1.9638046e-05,0.9999728,7.582283e-06
21724,the,52,53,289,292,"High intratumoral FoxP3(+) Tregs with high peritumoral IL-17(+) T cells showed a significantly lower survival rate compared with other groups (OS, P < 0.001 and DFS, P < 0.001).CONCLUSION: Our findings suggest that intrahepatic IL-17(+) T cells and FoxP3(+) Tregs may cooperate to promote the progression of HCC.",24303990_8,-1,1,-1,1,21724,-1,1.800902e-05,0.99997425,7.770939e-06
19800,this,1,2,3,7,"In this study, we evaluated the therapeutic efficacy of a novel survivin-based vaccine by subcutaneous or intraperitoneum injection of BALB/c mice with murine fiber-induced MM tumor cells followed by vaccination with recombinant Fowlpox virus replicons encoding survivin.",23335100_2,-1,1,-1,1,19800,-1,1.9652016e-05,0.9999707,9.704417e-06
13396,than,19,20,100,104,"In the tumors, ratio of CD8(+) cytotoxic and CD4(+) helper T cells were not significantly different than other immune compartments.",20883319_2,-1,1,-1,1,13396,-1,2.5258638e-05,0.9999604,1.4339563e-05
14657,the,1,2,3,6,"On the second transfer to a Rag2(-/-) B6 male environment, these ex-Tregs expanded strongly, whereas Tregs that maintained expression of Foxp3 expression did not.",21389255_2,-1,1,-1,1,14657,-1,1.7633925e-05,0.99997365,8.701881e-06
28461,Therefore,0,1,0,9,"Therefore, radiation-induced NF-B functions as a molecular link between tumor cells and immune cells in the tumor microenvironment for radiation-mediated tumor suppression.",27014915_9,-1,1,-1,1,28461,-1,2.2180244e-05,0.99996567,1.2165762e-05
11878,tumor,31,32,194,199,Several reports have shown that prophylactic depletion of regulatory T cells (Treg) using various monoclonal antibodies (mAb) in mice can stimulate potent antitumor immune responses and prevent tumor development.,20332236_0,-1,1,-1,1,11878,-1,2.0380436e-05,0.9999701,9.54568e-06
30451,TGF-,27,28,141,146,"With the agonistic ICOS-L protein (rICOS-L Ig), ICOS+ Foxp3+ cells were efficiently induced from naive CD4+ T cells under a stimulation with TGF- and CD3/CD28 mAbs.",27756099_4,-1,1,-1,1,30451,-1,4.3397464e-05,0.99994004,1.6523329e-05
10555,the,9,10,48,51,"Five weeks later, tumor sizes were measured and the mice bearing appropriate size of tumors received the following treatments.",19724910_5,-1,1,-1,1,10555,-1,2.0076648e-05,0.9999696,1.0378575e-05
43833,The,0,1,0,3,The adoptive transfer of tumor-draining lymph node (LN) T cells activated ex vivo with anti-CD3 and interleukin 2 (IL-2) mediates the regression of the poorly immunogenic murine melanoma D5.,9690455_0,-1,1,-1,1,43833,-1,1.7881292e-05,0.9999728,9.241319e-06
10529,naloxone,6,7,40,48,"Moreover, co-administration of gp96 and naloxone significantly increased the intra-tumor CD8+ T cells and cytotoxic activity.",19706340_6,-1,1,-1,1,10529,-1,5.2190913e-05,0.999923,2.4763996e-05
13758,Treg-induced,27,28,186,198,The combination of CRCL as a source of tumor-specific antigens and Th-1 lymphocytes as an adjuvant has the potential to stimulate efficient specific antitumor immunity while restraining Treg-induced suppression.,21123824_4,-1,1,-1,1,13758,-1,2.9170875e-05,0.99995327,1.7518647e-05
13840,that,32,33,182,186,"As a positive control, a more than 2-fold increase in blood Tregs was detected in four out of nine patients who were treated with interleukin-2.CONCLUSIONS: We used a MS-qPCR method that detects Tregs but not other activated T lymphocytes; however, none of the Treg-depleting strategies that we tested led, in the majority of patients, to a conservative 50% reduction in blood Tregs.",21177412_7,-1,1,-1,1,13840,-1,1.9106961e-05,0.99996924,1.1613642e-05
41186,to,8,9,52,54,SKIL expression was higher in NSCLC tissue compared to adjacent normal tissue.,33268765_8,-1,1,-1,1,41186,-1,2.5478083e-05,0.99996185,1.2615813e-05
33748,STAT3-blocked,2,3,13,26,"Importantly, STAT3-blocked whole HCC cell lysates prevented HCC-mediated exhaustion of T cells and NK cells, showing low expression of checkpoint molecules such as PD-1 and TIGIT on T cells and NK cells in the immunized mice.",29115974_7,-1,1,-1,1,33748,-1,9.0691006e-05,0.999767,0.00014226638
24127,statistically,36,37,192,205,The effect of PDT on Treg function at Day 7 was accompanied by slight but statistically significant increases in peripheral neutrophil granulocytes (p = 0.035) and monocytes (p = 0.013) and a statistically significant increase (approximately 18-fold) in serum IL-6 levels (p = 0.008).,25005268_6,-1,1,-1,1,24127,-1,2.883904e-05,0.9999529,1.8217406e-05
1262,the,9,10,54,57,"Interestingly, elevated levels of IL-11 were found in the sera of tumor-bearers, when compared to normal animals and even higher levels of IL-11 were detected in the tumor cystic fluid.",12527946_4,-1,1,-1,1,1262,-1,1.6514514e-05,0.9999747,8.720831e-06
20738,that,5,6,29,33,Our previous study has shown that mesothelin (MSLN) is a potential immunotherapeutic target for pancreatic cancer.,23874581_0,-1,1,-1,1,20738,-1,1.9689096e-05,0.99997115,9.161301e-06
2757,that,3,4,17,21,"Furthermore, ATV that survived CTL adoptive immunotherapy displayed an even more profound loss of Fas expression and function as well as enhanced malignant proficiency in vivo.",15899830_2,-1,1,-1,1,2757,-1,2.0986452e-05,0.99996626,1.27771245e-05
25084,the,29,30,176,179,"In order to further confirm this result, the Runx3 gene was constructed into pIRES2-eGFP and the recombined plasmid was transfected into SGC-7901 cells with liposome in vitro, the results obtained from the reverse transcription PCR indicated that the mRNA of Runx3, T-bet, or IFN- was significantly upregulated individually in Runx3 gene-transfected SGC-7901 cells.",25270738_3,-1,1,-1,1,25084,-1,1.9436007e-05,0.99997115,9.406871e-06
5382,To,4,5,22,24,"METHODS AND FINDINGS: To gain insights into the molecular mechanisms of immune dysfunction in cancer, gene expression profiles of pure sorted peripheral blood lymphocytes from 12 patients with melanoma were compared to 12 healthy controls.",17488182_2,-1,1,-1,1,5382,-1,1.7346876e-05,0.99997425,8.423104e-06
8527,genes,44,45,256,261,"CONCLUSION: H22-CD80/CD86/CD137L(+) induces higher NF-kappaB activity of the host T cells by synergistic action of CD28 and CD137, which may be one of the mechanisms of enhancement of the host CTL activity induced by co-expression of CD80, CD86 and CD137L genes.",19173904_9,-1,1,-1,1,8527,-1,3.6949506e-05,0.9999362,2.6864578e-05
999,the,1,2,3,6,"In the present study, we found that leukaemic blasts presenting surface CD30L displayed a characteristic cytokine-receptor pattern that makes them ideal targets for those cytokines usually produced by Th2-type cell subsets.",11918534_1,-1,1,-1,1,999,-1,2.0645726e-05,0.9999684,1.0978372e-05
19351,Foxp3,2,3,14,19,"Expression of Foxp3, IL-10, and TGF- mRNAs in MLRs were detected by real-time PCR.",23179394_5,-1,1,-1,1,19351,-1,2.2774171e-05,0.9999616,1.562126e-05
16030,T-bet,8,9,52,57,"When IL-12 is produced by antigen-presenting cells, T-bet expression is induced, causing direct stimulation of ifng gene transcription while simultaneously acting as a transcriptional repressor of the IL4 gene, which then leads to Th1 dominance and T-helper type 2 differentiation blockade.",21983879_2,-1,1,-1,1,16030,-1,2.3505843e-05,0.99995875,1.7731842e-05
39184,relatively,13,14,67,77,"However, their functional role in human colorectal cancer (CRC) is relatively unknown.",32061875_3,-1,1,-1,1,39184,-1,5.515742e-05,0.9999261,1.8720659e-05
7291,their,25,26,96,101,"A fraction of cervicitis, CIN I, CIN II and CIN III had natural (n) regulatory T cells (Tregs); their lesional distribution was predominantly intraepithelial in cervicitis, while in CIN they were also present in the stroma.",18593438_5,-1,1,-1,1,7291,-1,2.3095361e-05,0.9999653,1.154011e-05
30290,this,2,3,14,18,Activation of this pathway and associated PD-L1 expression may explain the paradoxical lack of T-cell-mediated cytotoxicity observed in DDRD tumors.,27707838_14,-1,1,-1,1,30290,-1,2.5460216e-05,0.99996233,1.2214816e-05
10027,Tregs,4,5,20,25,Regulatory T cells (Tregs) expressing TCRalphabeta play a critical role in the maintenance of the immune system homeostasis.,19539651_0,-1,1,-1,1,10027,-1,2.2107568e-05,0.9999653,1.2611526e-05
9179,the,5,6,31,34,Mice receiving the pUS-high in the prophylactic setting presented a 48-52% reduction in s.c.,19291796_3,-1,1,-1,1,9179,-1,2.4683712e-05,0.9999641,1.1252814e-05
25549,The,0,1,0,3,The affected mother of the index case was an obligatory carrier.,25492914_5,-1,1,-1,1,25549,-1,2.0071875e-05,0.99996924,1.073864e-05
21969,this,21,22,130,134,Our data suggest that tmTNF- acts as a potent activator of MDSCs via TNFR2 and reveals another novel immunosuppressive effect of this membrane molecule that promotes tumor immune escape.,24379122_7,-1,1,-1,1,21969,-1,2.5385985e-05,0.9999598,1.4794233e-05
19356,TGF-,9,10,76,81,Blocking of CD200-CD200R interaction demonstrated a significant decrease in TGF- and IL-10 expression in AML-DC MLRs and a significant increase in IL-12 and IFN- expression in monocyte-DC MLRs.,23179394_7,-1,1,-1,1,19356,-1,2.7551348e-05,0.99995816,1.433212e-05
43395,TGF--dependent,10,11,66,81,"Patient-derived B cells promoted FOXP3+ Treg differentiation in a TGF--dependent manner, while sustaining expression of IFN- and TNF- by autologous T-helper cells and promoting T-helper cell proliferation ex vivo, an effect further enhanced with anti-PD-1 checkpoint blockade.",35909944_5,-1,1,-1,1,43395,-1,3.4592416e-05,0.9999392,2.6174877e-05
27587,the,13,14,92,95,Pretreatment with cinnamon in irradiated mice accelerated the generation of Th1 and reduced the differentiation of Treg cells by activating T-bet and limiting transcriptions of Foxp3.,26475064_9,-1,1,-1,1,27587,-1,1.6632648e-05,0.99997497,8.425255e-06
27913,Tregs,21,22,156,161,Investigation of lung inflammation in IKTA mice revealed a substantial increase in M2-polarized macrophages and CD4+/CD25+/FoxP3+ regulatory T lymphocytes (Tregs).,26756215_3,-1,1,-1,1,27913,-1,1.8477333e-05,0.9999695,1.2061513e-05
29306,the,3,4,23,26,These reagents exploit the mechanism by which T cell receptors (TCR) on cytotoxic CD8 T cells recognize specific antigens in the context of a major histocompatibility complex (MHC) molecule during antigen presentation.,27327144_1,-1,1,-1,1,29306,-1,1.6824344e-05,0.99997497,8.260421e-06
32327,that,27,28,159,163,"Furthermore, the increased population of CD4+Foxp3+ regulatory T cells (Tregs), which partially expressed A2AR, was observed in an immunocompetent mouse model that spontaneously develops HNSCC.",28592285_8,-1,1,-1,1,32327,-1,1.9126619e-05,0.9999703,1.0592267e-05
31897,Tumours,0,1,0,7,Tumours often present reduced E-cadherin expression and increased -catenin signalling and interleukin-33 production.,28437001_5,-1,1,-1,1,31897,-1,2.3577242e-05,0.9999609,1.546251e-05
29937,Signal Transducer and Activator of Transcription 3,19,26,117,167,"In addition to their canonical role in deacetylation of histones, HDACs regulate many non-canonical targets, such as Signal Transducer and Activator of Transcription 3 (STAT3).",27614429_1,-1,1,-1,1,29937,-1,3.894894e-05,0.9999373,2.3743118e-05
23806,the,24,25,121,124,"Given that the balance of TFH and TFR populations likely dictate, in part, the biology of this disease, our data support the potential for targeting MSCs as a therapeutic strategy.",24836297_6,-1,1,-1,1,23806,-1,1.9528092e-05,0.99997234,8.1392855e-06
22088,status,3,4,17,23,"In the different status of HPV16 type DNA, the expression of Foxp3(+) was closely correlated with Federation International of Gynecology and Obstetrics (FIGO) stage, histological grade and lymphnode metastasis (P < 0.05) except for age (P > 0.05).CONCLUSION: Treg cytokines, HPV16 integration rate and severity of cervical lesions are positively correlated while Th17 cytokines show opposite effects.",24401583_7,-1,1,-1,1,22088,-1,3.2765747e-05,0.9999449,2.2280421e-05
11069,to,9,10,59,61,Isolated regulatory T cells were tested for their capacity to recognize pancreatitis-associated antigens and to suppress conventional T cells in an antigen-dependent manner.,19931255_5,-1,1,-1,1,11069,-1,1.9477911e-05,0.9999714,9.099577e-06
12063,termination,18,19,114,125,"Further, the results indicate that the IL-2-induced effect on Treg cells is reversible and declines shortly after termination of IL-2 treatment.",20386464_7,-1,1,-1,1,12063,-1,4.410011e-05,0.99992824,2.7605727e-05
1551,to,8,9,50,52,"Although the first three mechanisms do not appear to be relevant, regression of myeloid suppressor cells in Stat6-deficient and CD1-deficient mice may be responsible for enhanced immunosurveillance.",14593499_7,-1,1,-1,1,1551,-1,3.8338352e-05,0.99994946,1.2220473e-05
36418,their,16,17,99,104,The drivers and the specification of CD4+ T cell differentiation in the tumor microenvironment and their contributions to tumor immunity or tolerance are incompletely understood.,30926808_0,-1,1,-1,1,36418,-1,3.259957e-05,0.9999558,1.15796765e-05
26084,those,26,27,168,173,"RT-qPCR analysis revealed that the mRNA expression levels of IL-22, aryl hydrocarbon receptor, CCL20 and CCL22 were significantly higher in tumor tissues compared with those in paratumor tissues.",25892871_5,-1,1,-1,1,26084,-1,2.2479211e-05,0.9999621,1.5478889e-05
41612,tumour,8,9,32,38,"Warthin tumour (WT) is a benign tumour of the salivary gland that proliferates in both glandular epithelial and lymphoid tissue components, and rarely exhibits cystic changes.",33647861_0,-1,1,-1,1,41612,-1,3.6631278e-05,0.99991333,5.0064722e-05
4810,Treg,5,6,36,40,METHODOLOGY AND PRINCIPAL FINDINGS: Treg were identified and characterized as CD4(+)CD25(+)FOXP3(+) using flow cytometry.,17205133_3,-1,1,-1,1,4810,-1,2.0792524e-05,0.99996483,1.4341567e-05
18700,the,31,32,203,206,"The changes in intracellular cAMP concentrations correlated with the upregulation of effector T cells and the downregulation of Tregs, indicating the close association of cAMP analogs and low-dose CY in the immune therapy of B-cell lymphoma.",23000689_7,-1,1,-1,1,18700,-1,2.1608746e-05,0.9999696,8.733404e-06
22431,these,13,14,67,72,"However, it remains unclear where and how human  T cells acquire these key effector properties.",24489097_1,-1,1,-1,1,22431,-1,2.2407992e-05,0.99996555,1.20511295e-05
29483,that,10,11,45,49,"In the last 15 years, it has become apparent that ovarian cancer is recognized by the immune system, taking into account that T cell infiltration can be associated with increased overall survival.",27420920_0,-1,1,-1,1,29483,-1,2.0368194e-05,0.9999701,9.500043e-06
38574,the,10,11,92,95,"Runt-related transcription factor 3 (RUNX3)-associated immune pathways were investigated by the Kyoto Encyclopedia of Genes and Genomes, Gene Ontology, and Gene set enrichment analysis.",31898342_4,-1,1,-1,1,38574,-1,1.8998851e-05,0.9999703,1.0673878e-05
10092,the,16,17,113,116,"To address these twin-tier deficiencies, we developed a translational model of melanoma immunotherapy focused on the exploitation of high-avidity CD4+ T cells that become generated in germline antigen-deficient mice.",19561540_2,-1,1,-1,1,10092,-1,1.6704644e-05,0.9999759,7.424838e-06
15508,These,0,1,0,5,These findings have important implications for selecting melanoma patients who may benefit from immunotherapy.,21750202_8,-1,1,-1,1,15508,-1,2.1930226e-05,0.99996865,9.409009e-06
22155,this,36,37,227,231,"Altogether, our results indicate that the immunoregulatory defects observed in MG patients are caused by both Treg cell and Tconv cell impairment and involve several pro-inflammatory cytokines, with TNF- playing a key role in this process.",24405842_11,-1,1,-1,1,22155,-1,2.2872711e-05,0.9999665,1.0646754e-05
23128,nasopharyngeal,12,13,61,75,"Here, we showed that some macrophages in the tumor stroma of nasopharyngeal carcinoma (NPC) tissue expressed the immunosuppressive protein indoleamine 2,3-dioxygenase (IDO) more strongly than did tumor cells.",24696473_1,-1,1,-1,1,23128,-1,6.1187646e-05,0.9998956,4.3187778e-05
16065,the,2,3,13,16,We inhibited the pathway through -Secretase inhibitor and Notch1 RNA interference and analysed the effect on the expression and function of chemokine receptors.,21984373_3,-1,1,-1,1,16065,-1,1.7869434e-05,0.9999713,1.0805725e-05
6611,the,37,38,225,228,We found that metastatic melanoma LNs expressed very heterogeneous levels of Foxp3 and that CD4+CD25(high) Treg cells extracted from these LNs were detectable at each step of the in vitro culture of TIL but decreasing during the culture.,18312383_3,-1,1,-1,1,6611,-1,1.9923751e-05,0.9999703,9.704644e-06
42992,timing,9,10,61,67,These findings may have implications for the combination and timing of anti-oestrogen therapies with other therapies.,34602068_12,-1,1,-1,1,42992,-1,3.324691e-05,0.99995184,1.4865138e-05
1520,they,33,34,195,199,"Since Stat6-deficient or ""knockout"" mice lack the signal transducer and activator of transcription-6 protein and are unable to transmit signals initiated by the type 2 cytokines, IL-4 and IL-13, they have been studied to confirm the T(h)1 vs T(h)2 paradigm.",14593499_1,-1,1,-1,1,1520,-1,1.9080919e-05,0.99997187,9.028372e-06
12070,to,7,8,45,47,"Also, adjuvant IL-21 administration may lead to immune enhancement without simultaneous induction of Treg cells.",20386464_9,-1,1,-1,1,12070,-1,2.6018588e-05,0.99996424,9.753361e-06
38176,T,26,27,152,153,"Ablating Tcell Stat3 or treatment with an FAO inhibitor in obese mice spontaneously developing breast tumor reduces FAO, increases glycolysis and CD8+ T effector cell functions, leading to inhibition of breast tumor development.",31761565_2,-1,1,-1,1,38176,-1,3.554537e-05,0.999933,3.143366e-05
12624,the,38,39,260,263,"Down-regulation of Stat3 by siRNA significantly suppressed the production of IL-10 and VEGF-A. These results provide suggestive evidence that TAMs contribute to cancer progression via Stat3 activation, and CD163 is useful for evaluating M2 TAMs and predicting the clinical prognosis of ICC patients.",20545696_11,-1,1,-1,1,12624,-1,2.0046078e-05,0.9999707,9.332326e-06
43869,tyrosine,10,11,49,57,"Interestingly, the levels of p56lck, p59fyn, and tyrosine kinase activity were higher in activated T cells derived from LN that drained D5G6 than they were in those from D5 tumors.",9690455_6,-1,1,-1,1,43869,-1,2.7052094e-05,0.9999502,2.2750057e-05
28621,T-regs,0,1,0,6,T-regs comprised 45% of CD4-cells surrounding BCC.,27117439_4,-1,1,-1,1,28621,-1,2.7287817e-05,0.99990666,6.6057466e-05
22107,this,3,4,11,15,The aim of this study was to determine which cells were responsible for this defect and to address the mechanisms involved.,24405842_2,-1,1,-1,1,22107,-1,1.9678298e-05,0.9999691,1.1151603e-05
38850,than,3,4,16,20,"Notably, rather than inhibiting glycolysis, 2DG modified N-glycosylation, which augmented antitumor activity and cell surface retention of IL-2R of T cells.",31969386_4,-1,1,-1,1,38850,-1,3.9575825e-05,0.9999368,2.3617904e-05
28180,through,10,11,64,71,"However, we describe here a different, cell-extrinsic mechanism through which mutant KRAS contributes to tumor development.",26880715_2,-1,1,-1,1,28180,-1,2.3175857e-05,0.999962,1.4822282e-05
3646,The,0,1,0,3,"The objective of the present study was to address the role of the immune system, tumour micro-environment and potential immunosuppression in mesothelioma.",16540497_1,-1,1,-1,1,3646,-1,2.0192156e-05,0.99997187,7.911403e-06
1565,regulation,25,26,143,153,"During the two least decades, the field of tumor immunology has met an expansion of knowledge about the molecular and cellular bases of immune regulation.",14609757_0,-1,1,-1,1,1565,-1,3.2906806e-05,0.9999387,2.841732e-05
2530,transferred,34,35,164,175,"NKT cells prepared from immunocompetent Balb/C mice were pulsed ex vivo with HCC-derived antigens (Group A), Hep3B cells (group B) or BSA (group C), and adoptively transferred into HCC harboring mice (1 x 0(6) NKT cells per mouse).",15688366_4,-1,1,-1,1,2530,-1,2.6137106e-05,0.9999552,1.867463e-05
17575,this,1,2,3,7,"In this article, we present our results on a phase I clinical trial of a Mam-A cDNA vaccination in breast cancer patients with stage-IV metastatic disease, including the impact of vaccination on the expression of the inducible co-stimulator molecule (ICOS) on CD4 T cells.",22678162_2,-1,1,-1,1,17575,-1,2.5081305e-05,0.99996257,1.2386118e-05
26595,this,1,2,3,7,"In this study, we analyzed the mechanism of the pathological function of IL-22 in intestinal aGVHD.",26153763_2,-1,1,-1,1,26595,-1,2.0289046e-05,0.9999695,1.0201701e-05
9264,tumors,28,29,144,150,"Naive CD4+25-Foxp3- T cells, when adoptively transferred into Rag-/- mice, are converted into Foxp3+ Treg in the presence of Pan02 but not Eso2 tumors.",19307989_7,-1,1,-1,1,9264,-1,1.9993084e-05,0.9999671,1.2890717e-05
21618,the,2,3,11,14,"Therefore, the combination therapy strongly inclined the immune balance of the tumor microenvironment in an antitumor direction, leading to a marked systemic antitumor effect.",24289533_7,-1,1,-1,1,21618,-1,1.772538e-05,0.99997485,7.4846907e-06
27224,these,2,3,14,19,"Collectively, these findings demonstrate that increased Bregs play a immunosuppressive role in gastric cancer by inhibiting T cells cytokines as well as conversion to Tregs.",26378021_8,-1,1,-1,1,27224,-1,2.1803573e-05,0.99996746,1.07758e-05
36780,Tumor-bearing,0,1,0,13,Tumor-bearing mice model was utilized to explore the effects of Foxa1+ Treg on tumor growth and the prognoses.,31036318_9,-1,1,-1,1,36780,-1,1.975641e-05,0.9999701,1.0180218e-05
23260,there,43,44,210,215,"The expression levels of ROR, GATA3, T1/ST2, IL-17RB, CRTH2, IL-33, IL-5, and IL-4 mRNA were significantly increased in patients, but no significant changes were found in ICOS, CD45, and IL-13 expression, and there was a positive correlation between ROR or IL-13 and other related factors, such as ICOS and CD45.",24741632_4,-1,1,-1,1,23260,-1,2.1176713e-05,0.9999677,1.1130955e-05
13983,the,16,17,100,103,"Even though melanoma cells equally colonize NFAT1-/- and wild-type lungs, tumors do not progress in the absence of NFAT1 expression.",21225259_5,-1,1,-1,1,13983,-1,2.1901586e-05,0.99996936,8.692736e-06
43874,tumors,32,33,173,179,"Interestingly, the levels of p56lck, p59fyn, and tyrosine kinase activity were higher in activated T cells derived from LN that drained D5G6 than they were in those from D5 tumors.",9690455_6,-1,1,-1,1,43874,-1,2.11818e-05,0.9999628,1.6068472e-05
4820,these,4,5,40,45,"CONCLUSIONS/SIGNIFICANCE: Collectively, these data demonstrate that Treg capable of inhibiting tumor associated antigen-specific immune responses are enriched in patients with CRC.",17205133_6,-1,1,-1,1,4820,-1,2.0795625e-05,0.99996805,1.1114178e-05
41447,the,10,11,60,63,"Overall, our study establishes that Tet2 constitutes one of the epigenetic barriers that account for dysfunction of TILs and that Tet2 inactivation could promote antitumor immunity to suppress tumor growth.",33589517_6,-1,1,-1,1,41447,-1,2.8575249e-05,0.9999591,1.2344531e-05
37947,the,7,8,34,37,BACKGROUND: A T cell subtype with the CD4+CD25-FoxP3+ phenotype was recently described.,31630080_0,-1,1,-1,1,37947,-1,2.0228048e-05,0.99996924,1.0518891e-05
11035,treated,1,2,9,16,Patients treated with both IFN-alpha and IL-2 increased their Treg cell levels during the first 2 weeks after initiation of treatment.,19929575_3,-1,1,-1,1,11035,-1,2.4280342e-05,0.99996233,1.3406615e-05
26311,Th-,3,4,11,14,T helper- (Th-) cell immunodeficiency plays important roles in tumor development and their effects in chronic myeloid leukemia (CML) remain unclear.,26000313_0,-1,1,-1,1,26311,-1,5.862012e-05,0.9998988,4.2596355e-05
7591,the,9,10,64,67,"During disease progression, immunodeficiency develops; however, the underlying molecular and cellular mechanisms are not fully understood.",18769452_1,-1,1,-1,1,7591,-1,2.1592059e-05,0.9999696,8.801263e-06
26284,This,0,1,0,4,This study investigated the role of CD40 in breast cancer cells and its role in immunosuppressive function and tumor progression.,25992978_2,-1,1,-1,1,26284,-1,1.9324296e-05,0.9999709,9.73929e-06
38892,These,0,1,0,5,"These findings provide mechanistic insights into immune evasion in breast cancer associated with UBA7 loss, emphasizing the importance of a functional ISG-ISGylation network in tumor suppression.",31974171_8,-1,1,-1,1,38892,-1,2.1438564e-05,0.9999697,8.829932e-06
42261,tumors,18,19,124,130,This improved antitumor immunity was associated with Batf3-dependent enhanced accumulation of CD8+ T cells and cDC1s within tumors.,33980589_9,-1,1,-1,1,42261,-1,1.8800712e-05,0.9999722,8.975783e-06
4973,the,14,15,106,109,Western blot analyses further suggests that MSCs suppress IL-2-mediated NK cell cytotoxicity by affecting the activity of Stat5.,17244679_8,-1,1,-1,1,4973,-1,1.8439014e-05,0.99997246,9.039767e-06
31575,the,18,19,139,142,"Metabolic phenotyping of Foxp3-expressing IL-17A+, ex-Th17 and iTreg cells demonstrates the dissociation between the metabolic fitness and the suppressive function of Foxp3-expressing Treg cell subsets.",28290453_3,-1,1,-1,1,31575,-1,1.7683176e-05,0.99997425,8.008956e-06
42796,the,4,5,22,25,"Here, we investigated the roles of CBS in tumor cells and tumor microenvironment of HCC.METHODS: 236 HCC samples were collected to detect the expression of CBS, cleaved Caspase-3 and paired related homeobox 2 (PRRX2) and the number of immune cells.",34413167_3,-1,1,-1,1,42796,-1,1.6036018e-05,0.99997616,7.863343e-06
8946,that,12,13,91,95,Growing body of evidence from both laboratory and clinical investigations has demonstrated that expansion and accumulation of these immunosuppressive cells correlates with advanced tumor growth and predicts poor disease prognosis.,19254475_2,-1,1,-1,1,8946,-1,1.8374427e-05,0.99997306,8.510784e-06
4648,the,25,26,139,142,"Using reverse immunological methods, we have generated a CTL clone against the HPV-16 E6(49-57) epitope restricted by HLA-A*2402, which is the most common allele in Japan and relatively frequent worldwide, capable of lysing 293T cells transduced with HLA-A*2402 and HPV-16 E6.",17096336_2,-1,1,-1,1,4648,-1,2.6331494e-05,0.9999615,1.2215143e-05
23040,STAT-4,22,23,150,156,MDPF also significantly promoted the production of IFN- and up-regulated the mRNA expression levels of IFN- and Th1 transcription factors T-bet and STAT-4 in splenocytes from the S180-bearing mice.,24690776_7,-1,1,-1,1,23040,-1,2.8007074e-05,0.9999416,3.0432691e-05
27862,the,27,28,139,142,"The expression levels of the IDO protein, of L-kynurenine, and of IFN-, COX-2, TNF-, and Foxp3 mRNA were also significantly increased in the DEN-induced hepatic tumors that developed in the IDO-WT mice.",26727596_6,-1,1,-1,1,27862,-1,1.7811592e-05,0.99997354,8.611316e-06
33480,tristetraprolin-deficient,10,11,93,118,IL-27 is overproduced by tristetraprolin-deficient macrophages and increased systemically in tristetraprolin-deficient mice.,29021521_3,-1,1,-1,1,33480,-1,5.379692e-05,0.9999201,2.6062193e-05
21638,this,1,2,3,7,"In this study, we investigated the impact of a newly developed maturation cocktail consisting of OK-432 and interferon-gamma (IFN-) on the function of human monocyte-derived DCs (MoDCs).",24296809_1,-1,1,-1,1,21638,-1,1.8930983e-05,0.9999708,1.0249909e-05
21204,tumors,11,12,73,79,"Although elevated CD4Foxp3 regulatory T cell (Treg) frequencies within tumors are well documented, the functional and phenotypic characteristics of CD4Foxp3 and CD4Foxp3 T cell subsets from matched blood, healthy colon, and colorectal cancer require in-depth investigation.",24064667_0,-1,1,-1,1,21204,-1,1.9335024e-05,0.9999709,9.781138e-06
38624,TNBC,10,11,74,78,Tumor-associated macrophages (TAM) promote triple-negative breast cancer (TNBC) progression.,31911557_0,-1,1,-1,1,38624,-1,3.4685243e-05,0.9999478,1.7568542e-05
11619,Foxp3,17,18,87,92,"Furthermore, we documented induction of regulatory T cells in CD4(+) T cells, based on Foxp3 expression and T-cell activation in cocultures.",20145137_4,-1,1,-1,1,11619,-1,2.4497163e-05,0.9999615,1.4059114e-05
9652,These,0,1,0,5,These CD25(+) clones had a high capacity to suppress the proliferation of another T-cell clone after peptide stimulation in vitro.,19435913_4,-1,1,-1,1,9652,-1,1.959725e-05,0.9999695,1.08821505e-05
3837,treatment,8,9,46,55,We also examined the effects of low-dose IL-2 treatment in 12 patients with metastatic cancer and 9 patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation.,16645171_4,-1,1,-1,1,3837,-1,2.1647706e-05,0.99996567,1.2640863e-05
18502,thymidine,9,10,73,82,Immune-mediated gene therapy using adenovirus expressing Flt3 ligand and thymidine kinase followed by ganciclovir administration (Flt3/TK) effectively elicits tumor regression in preclinical glioma models.,22996231_0,-1,1,-1,1,18502,-1,0.00026893066,0.9994184,0.00031271836
10985,T-suppressor,30,31,194,206,Depletion of CD8(+) T cells from tumors before IL-12 treatment resulted in the abrogation of treatment-mediated T-suppressor cell apoptosis revealing a link between CD8(+) T cell activation and T-suppressor elimination.,19923444_2,-1,1,-1,1,10985,-1,0.00013838116,0.99933773,0.00052381196
42466,tumors,2,3,12,18,"Clinically, tumors with high stromal Rab37 and IL-6 expression coincide with tumor infiltrating M2-macrophages and PD1+CD8+ T cells that predicts poor prognosis in lung cancer patients.",34093869_9,-1,1,-1,1,42466,-1,1.8674215e-05,0.9999721,9.233753e-06
23544,to,8,9,47,49,"However, these same signals are not sufficient to induce autocrine IL-2 production by naive CD8(+) T cells, which require cytokines provided by other cell types to drive their differentiation.",24778448_1,-1,1,-1,1,23544,-1,2.6328968e-05,0.9999647,8.89904e-06
42511,treatment,27,28,182,191,Our studies establish a crucial role for Gpx4 in protecting activated Treg cells from lipid peroxidation and ferroptosis and offer a potential therapeutic strategy to improve cancer treatment.,34133924_7,-1,1,-1,1,42511,-1,2.6019468e-05,0.99996173,1.22712845e-05
642,Th2,22,23,111,114,"Moreover, CD4(+) T cells manifested rapid secretion of the Th2 cytokines IL-4, IL-5, and IL-10, reminiscent of Th2 memory cells.",11441076_5,-1,1,-1,1,642,-1,7.2300354e-05,0.99985576,7.197872e-05
10652,complex,15,16,96,103,"Towards this end, a cationic tat-sequence was fused with an antigenic, major histocompatibility complex (MHC) class I-binding melanoma epitope (Melan-A/Mart-1 sequence: ELAGIGILTV) and then mixed with negatively charged poly(I:C) dsRNA to form peptide/nucleic acid complexes.",19758325_2,-1,1,-1,1,10652,-1,0.0001229891,0.99967134,0.00020570612
33795,genes,20,21,138,143,"Altogether, detailed analysis of the effect of NFAT5 in pro- and anti-inflammatory macrophages uncovered its ability to regulate distinct genes under both polarization modes and revealed its predominant role in promoting proinflammatory macrophage functions.",29150563_6,-1,1,-1,1,33795,-1,3.3723958e-05,0.9999392,2.7076572e-05
1904,that,11,12,75,79,Comparison of stimulation with HPV-16 E6- or E7-GST fusion proteins showed that proliferative responses were biased to HPV-16 E6.,15131030_4,-1,1,-1,1,1904,-1,1.8642817e-05,0.9999726,8.7326725e-06
42728,Tumor-intrinsic,0,1,0,15,"Tumor-intrinsic STING elimination reduces neoangiogenesis, increases CD8+ Tcell infiltration, and reverts therapeutic resistance to dual immune checkpoint blockade (ICB).",34289354_5,-1,1,-1,1,42728,-1,3.8086833e-05,0.9999448,1.7051478e-05
16197,T(reg,1,2,7,12,Canine T(reg) have the potential to suppress proliferation of effector T cells (T(eff)).,22041284_8,-1,1,-1,1,16197,-1,2.1164511e-05,0.99995875,2.0043432e-05
8651,this,7,8,30,34,"In our panel of human clones, this stable epigenetic mark correlated better with suppressive activity than did FOXP3 mRNA or protein expression.",19224638_2,-1,1,-1,1,8651,-1,2.0358695e-05,0.999969,1.0599085e-05
42324,the,25,26,114,117,Targeting MYCN or its effectors could be a strategy to convert a cold TME into a 'hot' (inflamed) TME and improve the efficacy of ICB therapy.,34016720_3,-1,1,-1,1,42324,-1,2.0697938e-05,0.9999716,7.706586e-06
33136,this,11,12,74,78,"Importantly, a monoclonal anti-TIM-4 Ab promoted allograft tolerance, and this was dependent on B cell expression of TIM-4.",28848066_10,-1,1,-1,1,33136,-1,2.102712e-05,0.9999652,1.3739905e-05
25138,tolerance,19,20,103,112,"The focus of this study is to define the interaction between tumour and immune system, i.e. how immune tolerance starts and gradually leads to the induction of adaptive Treg cells in the tumour microenvironment.",25284464_2,-1,1,-1,1,25138,-1,2.8493392e-05,0.99995804,1.3455384e-05
41426,this,1,2,3,7,"In this study, we used a murine model of melanoma to discover that Tet2 inactivation significantly enhances the antitumor activity of TILs with an efficacy comparable to immune checkpoint inhibition imposed by anti-PD-L1 treatment.",33589517_2,-1,1,-1,1,41426,-1,1.9991407e-05,0.99996996,1.0000972e-05
22550,the,27,28,145,148,"RESULTS: Compared to controls, patients with UCC or CIN had a higher proportion of Tc17 cells in both peripheral blood and cervical tissues, but the level of Tc17 cells in UCC tissues was significantly higher than that in CIN tissues.",24523865_3,-1,1,-1,1,22550,-1,1.6401013e-05,0.99997425,9.3024155e-06
33724,tumor-bearing,18,19,118,131,"RESULTS: STAT3-blocked whole HCC cell lysates inhibited tumor growth and tumorigenesis, and prolonged the survival of tumor-bearing mice.",29115974_2,-1,1,-1,1,33724,-1,2.6901207e-05,0.9999589,1.4250274e-05
36384,tumor,19,20,123,128,Purpose: CD4+CD25+Foxp3+ regulatory T (Treg) cell-mediated immunosuppression has been implicated as a crucial mechanism of tumor immune cell escape in nonsmall cell lung cancer (NSCLC).,30925076_0,-1,1,-1,1,36384,-1,2.0926103e-05,0.99996865,1.0407169e-05
40494,that,6,7,30,34,BACKGROUND: It has been shown that dihydroartemisinin (DHA) is effective in the treatment of malaria.,32859456_0,-1,1,-1,1,40494,-1,2.1508826e-05,0.9999696,8.899016e-06
33163,the,18,19,88,91,"NK cells secrete several cytokine,s but IFN- secreted by NK cells play a vital role in the activation of the innate and adaptive immune systems.",28891726_1,-1,1,-1,1,33163,-1,2.2857865e-05,0.9999676,9.525658e-06
6319,to,10,11,68,70,"However, relapses are frequent and some patients develop resistance to BCG.",18157010_1,-1,1,-1,1,6319,-1,2.7454093e-05,0.99995434,1.815496e-05
28028,to,37,38,234,236,"MATERIALS AND METHODS: Stomach tissue from gastric cancer patients undergoing gastric resection was analyzed using flow cytometry and cell sorting, followed by RT-PCR.RESULTS: We observed that stomach CD4+ FOXP3+ T cells proliferated to a higher degree than CD4+ FOXP3- T cells, which may contribute to Treg accumulation in the mucosa.",26782287_3,-1,1,-1,1,28028,-1,2.4556046e-05,0.9999628,1.2618051e-05
16123,that,3,4,28,32,"These observations indicate that IL-21 amplifies an inflammatory milieu that promotes CAC, and suggest that IL-21 blockade may be useful in reducing the risk of UC-associated colon cancer.",21987656_7,-1,1,-1,1,16123,-1,1.9020043e-05,0.9999721,8.887842e-06
11993,thus,1,2,3,7,We thus investigated a potential correlation between the Treg tumor infiltration at diagnosis and the clinical outcome in a current randomized phase 3 trial aimed to compare the GOLFIG regimen with the standard FOLFOX chemotherapy (GOLFIG-2).,20386463_2,-1,1,-1,1,11993,-1,1.934315e-05,0.99997044,1.0188992e-05
13016,the,20,21,120,123,BACKGROUND: High-dose interferon-alpha 2b (IFN-alpha 2b) is the only approved systemic therapy in the United States for the adjuvant treatment of melanoma.,20712892_0,-1,1,-1,1,13016,-1,2.8264081e-05,0.999962,9.797266e-06
36950,signal transducer and activator of transcription 6,38,45,214,264,"The persistent polarization of IL4 induced by strong lipid antigens, that is, -galactosylceramide (GC), caused IL4 accumulation at the immunological synapse (IS), which promoted the activation of the IL4R-STAT6 (signal transducer and activator of transcription 6) pathway and production of IL12 in DCs, which enhanced interferon- (IFN) production in iNKT cells.",31160756_2,-1,1,-1,1,36950,-1,5.8719364e-05,0.9998976,4.361797e-05
35948,Thus,0,1,0,4,"Thus, the aim of current study was to investigate the involvement of Notch-AhR-IL-22 axis in the pathogenesis of lung adenocarcinoma.",30473538_2,-1,1,-1,1,35948,-1,1.930265e-05,0.9999707,1.000842e-05
17910,tumors,17,18,124,130,"Taken together, our findings highlight a pivotal role for NFATc2 in the establishment of inflammation-associated colorectal tumors mediated by control of IL-6 expression.",22738913_6,-1,1,-1,1,17910,-1,1.8743734e-05,0.9999678,1.3465759e-05
40274,the,4,5,28,31,"Small molecule targeting of the essential HH effector Smoothened (SMO) has proven an effective therapy of BCC, though the frequent development of drug resistance poses major challenges to anti-HH treatments.",32615027_1,-1,1,-1,1,40274,-1,1.6545622e-05,0.9999732,1.0280154e-05
3823,the,2,3,12,15,We examined the effects of IL-2 signaling in human Tregs.,16645171_1,-1,1,-1,1,3823,-1,1.7749659e-05,0.9999732,9.041627e-06
13125,to,26,27,164,166,"METHODS: In this study, we developed a vector construction encoding a chimeric T cell receptor that recognizes the CD20 antigen and delivers co-stimulatory signals to achieve T cell activation.",20815894_2,-1,1,-1,1,13125,-1,2.317011e-05,0.9999676,9.274529e-06
20843,the,10,11,57,60,"For all groups, there was a positive correlation between the immunoexpressions of IL-17 and TGF-1 (P < .05).",23880265_7,-1,1,-1,1,20843,-1,1.690142e-05,0.99997485,8.203972e-06
20878,than,33,34,185,189,"When 14 Gy irradiation was combined with immunization, intratumoral numbers of CD8+ T cells increased 10-fold and the number of CD8+ T cells specific for the E7- epitope increased more than 20-fold.",23922012_5,-1,1,-1,1,20878,-1,3.8239832e-05,0.9999293,3.2412278e-05
9865,to,12,13,85,87,"By phospho-specific flow cytometry, defective STAT1 and STAT5 activation in response to IL-2 was found mainly in T lymphocytes from peripheral blood and/or tumor site of American Joint Committee on Cancer stage III and IV patients, compared with stage I and II patients and to donors, and in melanoma antigen-specific T cells isolated from metastatic lymph nodes.",19509154_6,-1,1,-1,1,9865,-1,2.9448678e-05,0.9999578,1.27512585e-05
18738,the,27,28,162,165,"Our results and method may be helpful for the development and optimization of adjuvants, as here exemplified for INF-, for CSC-targeted vaccines, independent of the availability of CSC-specific antigens.",23001491_8,-1,1,-1,1,18738,-1,2.503506e-05,0.99996626,8.684415e-06
29402,to,22,23,118,120,"Aiming to avoid artifact staining, many researchers required the usage of FoxP3 messenger RNA (mRNA) and PCR in order to prove a true expression of FoxP3 in these different cells.",27339600_6,-1,1,-1,1,29402,-1,1.700967e-05,0.99997437,8.586525e-06
7988,the,10,11,59,62,"Collectively, the CXCL9-CXCR3 axis plays a pivotal role in the formation of lymphoid stroma in lymphocyte-rich GCs.",18980207_10,-1,1,-1,1,7988,-1,1.8825873e-05,0.9999726,8.590605e-06
12807,that,2,3,15,19,Results showed that H22/B7-1/B7-2/4-1BBL tumor vaccines probably protect the infiltrating lymphocytes from apoptosis and induce NF-B activation to improve T-cell-mediated antitumor response.,20563597_7,-1,1,-1,1,12807,-1,2.0039328e-05,0.9999714,8.572017e-06
13062,treated,7,8,46,53,"Treg levels shifted in patients with melanoma treated with IFN-alpha 2b, although no firm conclusions regarding the role of Tregs as a marker of treatment response or outcome can be made at present.",20712892_10,-1,1,-1,1,13062,-1,2.501415e-05,0.9999641,1.0836462e-05
29743,the,17,18,132,135,"Although studies have demonstrated that tumor-derived cytokines promote MDSC accumulation and activation, little is known regarding the role of the tumor stroma in MDSC accumulation and activation.",27593937_3,-1,1,-1,1,29743,-1,1.7791626e-05,0.9999745,7.661934e-06
35422,transfected,5,6,35,46,"Mouse bone marrow-derived DCs were transfected with Rsad2 siRNA and examined by flow cytometry, ELISA, western, and confocal microscopy.",30068989_3,-1,1,-1,1,35422,-1,2.1110927e-05,0.9999615,1.743492e-05
795,that,2,3,8,12,We show that nuclear translocation of NFATc and NF-kappaB are markedly reduced in T cells activated in the presence of primary AML cells.,11698483_8,-1,1,-1,1,795,-1,1.7456798e-05,0.9999738,8.794193e-06
21059,T(regs,18,19,110,116,"Mechanistic studies in mice revealed that up-regulated expression of IDO and PD-L1, as well as recruitment of T(regs), in the tumor microenvironment depended on the presence of CD8(+) T cells.",23986400_3,-1,1,-1,1,21059,-1,2.206171e-05,0.99995816,1.9789457e-05
2508,These,0,1,0,5,These results provide evidence that adoptive immunotherapy with Tim-3(+) T-bet(+) tumor-specific Th1 cells can be used to induce host cytotoxic responses that inhibit the development and growth of neoplastic cells.,15661898_7,-1,1,-1,1,2508,-1,1.9894629e-05,0.99997056,9.593094e-06
7690,tumor,16,17,118,123,"Tumors treated with the Toll-like receptor (TLR)7 agonist imiquimod before excision showed induction of E-selectin on tumor vessels, recruitment of CLA(+) CD8(+) T cells, and histological evidence of tumor regression.",18794336_2,-1,1,-1,1,7690,-1,2.2341943e-05,0.9999634,1.42248655e-05
22532,The,2,3,12,15,"BACKGROUND: The existence of Tc17 cells was recently shown in several types of infectious and autoimmune diseases, but their distribution and functions in uterine cervical cancer (UCC) have not been fully elucidated.",24523865_0,-1,1,-1,1,22532,-1,2.0359881e-05,0.999972,7.707853e-06
40202,the,15,16,85,88,"METHODS AND RESULTS: In advanced CTCL, CHOP chemotherapy has no survival benefit and the duration of response is significantly inferior to other canonical treatments.",32573814_3,-1,1,-1,1,40202,-1,2.2191412e-05,0.99996924,8.568787e-06
35083,to,14,15,102,104,"It is demonstrated that this biomimetic core-shell nanoplatform with oxygen generation can be partial to accumulate in tumor and downregulate the expression of hypoxia-inducible factor 1, which can further enhance the therapeutic effects of chemotherapy and reduce the expression of programmed death ligand 1 (PD-L1).",29882235_4,-1,1,-1,1,35083,-1,2.4176647e-05,0.9999653,1.0551937e-05
28593,FOXP3(hi,2,3,13,21,"Depletion of FOXP3(hi) Treg cells from tumor tissues, which would augment antitumor immunity, could thus be used as an effective treatment strategy for CRCs and other cancers, whereas strategies that locally increase the population of FOXP3(lo) non-Treg cells could be used to suppress or prevent tumor formation.",27111280_8,-1,1,-1,1,28593,-1,2.8668752e-05,0.9999491,2.2235514e-05
7746,the,6,7,27,30,"Similar to T(reg) cells in the peripheral blood of healthy individuals, tumor-infiltrating FOXP3(+)CD4 T cells, unlike FOXP3(-) T cells, were unable to produce IL-2 and IFN-gamma upon ex vivo stimulation, indicating that FOXP3 expression is a valid biological marker for human T(reg) cells even in the tumor microenvironment.",18820132_2,-1,1,-1,1,7746,-1,1.7184388e-05,0.99997306,9.7306665e-06
31278,that,3,4,21,25,We previously showed that polyclonal T cells can acquire antigen-specific targeting activity through arming with exosomal peptide-MHC (pMHC).,28096300_1,-1,1,-1,1,31278,-1,1.918933e-05,0.9999716,9.127531e-06
37969,than,21,22,117,121,"The expression of IFN and IL-2 in the CD4+CD25-FoxP3+ subset was significantly higher than in Treg cells, but lower than in the effector subset.",31630080_4,-1,1,-1,1,37969,-1,2.911147e-05,0.9999529,1.800098e-05
353,Stat6,7,8,55,60,These results suggest that pharmacologic inhibition of Stat6 signaling could potentiate anti-tumor immunity in vivo.,11086033_7,-1,1,-1,1,353,-1,2.7916518e-05,0.9999503,2.175775e-05
6813,to,29,30,222,224,More detailed investigations of the mechanisms underlying protective immunity in murine systems together with the characterization of the anti-tumor reactions of patients who achieved durable clinical benefits in response to immunotherapy uncovered several pathways that restrain the efficacy of GM-CSF-secreting tumor cell vaccines.,18364009_3,-1,1,-1,1,6813,-1,2.1838241e-05,0.99996924,8.901983e-06
38389,the,15,16,99,102,This review highlights the recent progress in the understanding of Tregs in different disorders of the respiratory system.,31827925_5,-1,1,-1,1,38389,-1,2.0323328e-05,0.9999689,1.0772218e-05
29223,the,4,5,23,26,"However, IL18 promoted the proliferation and invasion of pancreatic cancer cells, in vitro and in vivo, through the NF-B pathway.",27297583_5,-1,1,-1,1,29223,-1,1.8385965e-05,0.9999715,1.00738325e-05
30535,These,18,19,133,138,"Finally, IL-6 and PD-L1 blockade increased overall survival in KPC-Brca2 mice compared with isotype controls (p=0.0012).CONCLUSIONS: These preclinical results indicate that targeted inhibition of IL-6 may enhance the efficacy of anti-PD-L1 in PDAC.",27797936_10,-1,1,-1,1,30535,-1,2.2106306e-05,0.9999664,1.155542e-05
24370,Foxp3(+,15,16,93,100,Our results suggest that the dysfunction of DCs and the increase of IL-10-producing Breg and Foxp3(+) Treg might play important roles in HCC progression.,25066760_7,-1,1,-1,1,24370,-1,0.00023086733,0.9996171,0.00015194924
40227,to,6,7,36,38,"Tumor progression in the host leads to severe impairment of intrathymic T-cell differentiation/maturation, leading to the paralysis of cellular anti-tumor immunity.",32582141_0,-1,1,-1,1,40227,-1,2.3325934e-05,0.9999659,1.0724563e-05
14482,that,4,5,28,32,"Previously, we demonstrated that ANGPT2 augments the expression of various proangiogenic genes, the potent immunosuppressive cytokine, IL-10, and a chemokine for regulatory T cells (Tregs), CCL17 by TEMs in vitro.",21368233_3,-1,1,-1,1,14482,-1,1.753182e-05,0.99997354,8.929689e-06
3051,through,11,12,74,81,These studies are increasing our awareness of the many complex mechanisms through which TGF-beta signaling controls the pathogenesis of cancer.,16123803_6,-1,1,-1,1,3051,-1,2.485824e-05,0.9999622,1.2878956e-05
37145,to,10,11,71,73,CONCLUSION: IFN-I induces STAT3 activation to activate Gzmb expression to enhance CTL effector function to suppress tumor development.,31228946_12,-1,1,-1,1,37145,-1,2.1577189e-05,0.9999683,1.0087932e-05
9283,these,22,23,120,125,The objective of this study was to determine whether there is a similar tendency in mice as in human beings and whether these mice models may be used to find new therapeutic agents with antifibrotic properties but not cancer-promoting properties.,19318568_2,-1,1,-1,1,9283,-1,1.6923274e-05,0.9999747,8.3071545e-06
6241,T,9,10,66,67,Therapies that could possibly increase the suppressive ability of T regulatory cells were proven to improve that course of autoimmune diseases.,18092144_2,-1,1,-1,1,6241,-1,3.1678934e-05,0.99993217,3.6186757e-05
32894,that,5,6,30,34,This study tests a hypothesis that administration of curcumin down regulates Tregs in lung cancer (LC) patients.,28731226_3,-1,1,-1,1,32894,-1,1.8475157e-05,0.9999738,7.75714e-06
2992,this,23,24,152,156,"Formononetin, daidzein and equol also enhanced IL-4 gene promoter activity in EL4 cells transiently transfected with IL-4 gene promoter constructs, but this effect was impaired in EL4 cells transfected with an IL-4 promoter construct deleted of P4 site carrying nuclear factor of activated T cells (NF-AT) and activator protein-1 (AP-1) binding sites.",16108819_5,-1,1,-1,1,2992,-1,2.0268997e-05,0.9999708,8.9788955e-06
13294,Foxp3,0,1,0,5,Foxp3 expression in tumor antigen-specific CD8 T cells is restricted to the tumor microenvironment and influenced by cues in the tumor.,20857491_4,-1,1,-1,1,13294,-1,1.908153e-05,0.99996865,1.2265448e-05
16557,to,3,4,20,22,These results point to a more complex regulation of T(reg) cells in context of IL-2 administration.,22276195_8,-1,1,-1,1,16557,-1,2.2146183e-05,0.99996805,9.830337e-06
24895,tumor,23,24,174,179,"Under this complex scenario, galectins have emerged as promising molecular targets for cancer therapy responsible of creating immunosuppressive microenvironments at sites of tumor growth and metastasis.",25253145_1,-1,1,-1,1,24895,-1,2.013082e-05,0.99996996,9.928614e-06
39392,to,18,19,119,121,"CD4 T cell expression of IFN also differed in pre-treatment samples, indicating that predictors of response unrelated to exhaustion may be present in peripheral blood.",32210968_11,-1,1,-1,1,39392,-1,6.749977e-05,0.9999043,2.8234488e-05
35746,than,21,22,138,142,We further found that the IL-10 expression level and the STAT3 activation level were significantly higher in MYD88 L265P mutant lymphomas than in MYD88 WT lymphomas.,30253331_5,-1,1,-1,1,35746,-1,1.9743558e-05,0.9999678,1.24314e-05
22074,the,47,48,298,301,"The concentrations of Th17/Treg cell-associated cytokines were detected by enzyme-linked immunosorbent assay (ELISA).RESULTS: Under the same status of HPV16 DNA in vivo, the levels of Foxp3(+), transforming growth factor- (TGF-) and interleukin-10 (IL-10) were significantly higher than those of the control group (P < 0.01) while the levels of interleukin-17 (IL-17) and interleukin-21 (IL-21)were significantly lower than those of the control group (P < 0.05) .",24401583_5,-1,1,-1,1,22074,-1,1.941144e-05,0.99996805,1.2586581e-05
26880,these,2,3,12,17,"Altogether, these results suggest that STAT3 inhibitors may improve the outcome of chemotherapy by enhancing the type-1 interferon response of cancer cells.",26208907_9,-1,1,-1,1,26880,-1,2.3164639e-05,0.999967,9.874459e-06
23337,the,15,16,82,85,Recent work has implicated the TNF family members RANK and RANK-Ligand (RANKL) in the development of Aire-expressing mTECs.,24752296_5,-1,1,-1,1,23337,-1,1.9660678e-05,0.9999716,8.722384e-06
14886,TGF-1,11,12,74,80,Gastric cancer cells upregulated the production of TGF-1 and blockade of TGF-1 partly abrogated Tregs phenotype.,21528082_13,-1,1,-1,1,14886,-1,3.914384e-05,0.99991727,4.3524797e-05
4664,to,20,21,120,122,"Furthermore, such intervention of 2 of 4 other cervical cancer cell lines expressing HPV-16 E6 and HLA-A*2402 was found to induce IFN-gamma production by specific CTLs.",17096336_5,-1,1,-1,1,4664,-1,1.930265e-05,0.99997175,8.937622e-06
3618,Stat3,21,22,151,156,We induced rat peritoneal macrophages with rat breast cancer cell-conditioned medium and analyzed signal transducer and activators of transcription 3 (Stat3) activities of the cells.,16530087_2,-1,1,-1,1,3618,-1,2.108862e-05,0.99996567,1.323708e-05
23772,TFH,33,34,205,208,"FL-infiltrating T-cell populations that are thought to be fundamental to FL biology are follicular helper T-cells (TFH), follicular regulatory T-cells (TFR), a recently described population that regulates TFH activity, and regulatory T-cells (Treg).",24836297_1,-1,1,-1,1,23772,-1,2.5359566e-05,0.999959,1.5648178e-05
16808,tumor,30,31,174,179,"Deletion of IL-33/ST2 axis enhances cytotoxicity of NK cells, production of IFN- in these cells and systemic production of IFN-, IL-17 and TNF-, which leads to attenuated tumor growth.",22392053_9,-1,1,-1,1,16808,-1,2.1005762e-05,0.9999695,9.562293e-06
9828,generated,4,5,35,44,Antigen-specific T-cell lines were generated by ex vivo stimulation with Class-I and Class-II melanoma peptide pulsed dendritic cells in the presence of either IL-2 or IL-15 plus IL-21.,19501956_2,-1,1,-1,1,9828,-1,2.3235889e-05,0.9999615,1.5220676e-05
24576,the,12,13,78,81,"EVIDENCE SYNTHESIS: Overall, 34 publications, mostly retrospective, fulfilled the main inclusion criterion.",25151017_6,-1,1,-1,1,24576,-1,2.6478303e-05,0.99996245,1.1073372e-05
10787,the,6,7,45,48,"CD8(+) T-cell depletion completely abrogated the vaccine efficacy, and so protection required CD8(+) T cells.",19830696_4,-1,1,-1,1,10787,-1,2.5480074e-05,0.99996567,8.837369e-06
18852,therapeutic,5,6,33,44,"Given the increasing interest in therapeutic modulation of the IL-17 axis, it is crucial to better understand the cellular origins of IL-17 in various infection and diseases settings.",23052209_2,-1,1,-1,1,18852,-1,2.2234673e-05,0.9999685,9.232682e-06
2918,the,29,30,181,184,"However, TNF-alpha plus IFN- gamma was associated with the activation of NF-kappaB but not of AP-1/ERK1/2 for the induction of MDC and IP-10.CONCLUSIONS: IFN-gamma enhances LPS for the induction of MDC and IP-10 through up-regulation of TLR-4, and the signal pathways of NF-kappaB and AP-1/ERK1/2.",16094077_12,-1,1,-1,1,2918,-1,1.7504752e-05,0.99997234,1.017697e-05
30543,This,0,1,0,4,This study was carried out to investigate the effect of grape phenolic compounds on the regulation of cancer-mediated immune suppression.,27833081_1,-1,1,-1,1,30543,-1,1.8232338e-05,0.9999721,9.606036e-06
6389,that,16,17,91,95,"CONCLUSIONS: The HPV16 E6 and E7 synthetic long peptides vaccine is highly immunogenic, in that it increases the number and activity of HPV16-specific CD4(+) and CD8(+) T cells to a broad array of epitopes in all patients.",18172269_5,-1,1,-1,1,6389,-1,2.7591177e-05,0.99995506,1.7388613e-05
42386,the,29,30,138,141,"The presence or absence, in particular, of cytotoxic CD8+ cells in the vicinity of the main tumor mass, is able to predict, respectively, the success or failure of drug therapy.",34070750_4,-1,1,-1,1,42386,-1,2.0401762e-05,0.9999716,7.919041e-06
3145,tolerance,25,26,134,143,"Recently, it has been elucidated that regulatory T cells (Treg) play a critical role in maintaining not only self-tolerance, but also tolerance of tumor cells.",16210609_1,-1,1,-1,1,3145,-1,2.4878394e-05,0.99995923,1.5886424e-05
36426,TGF-,12,13,73,78,"Specifically, CD11b+CD103- DC predominate in PDA, express high IL-23 and TGF-, and induce FoxP3neg tumor-promoting IL-10+IL-17+IFN+regulatory CD4+ T cells.",30926808_2,-1,1,-1,1,36426,-1,4.826308e-05,0.9999294,2.2330469e-05
34599,These,0,1,0,5,These results suggest that Tr1 cells might be involved in the regulating immune responses in H. pylori infection and gastric cancer development.,29625086_7,-1,1,-1,1,34599,-1,2.1330594e-05,0.99996865,1.0000462e-05
19136,tumor,3,4,22,27,"In murine established tumor model, however, CCL2 blockade utilizing the specific siRNA or neutralizing mAb significantly inhibits Snail(+) tumor growth and metastasis following systemic induction of anti-tumor immune responses in host.",23143679_8,-1,1,-1,1,19136,-1,1.8794039e-05,0.99996996,1.1246358e-05
34213,that,24,25,150,154,"In sum, our study demonstrated that the relationship between the MUC16c level and Foxp3 expression in the local tumor environment was consistent with that of the serum CA125 level and circulating Treg proportion in the systemic environment.",29337110_10,-1,1,-1,1,34213,-1,2.3379065e-05,0.99996364,1.3029134e-05
12037,the,6,7,38,41,We found that the treatment increased the frequency of Treg cells more than 7-fold compared with pretreatment levels (P<0.0001).,20386464_2,-1,1,-1,1,12037,-1,1.6537606e-05,0.99997497,8.514722e-06
29990,this,14,15,72,76,"As little is known about their function in TDLNs of cancer patients, in this study, their frequency as well as their ability to produce interleukin (IL)-2, IL-10, or interferon (IFN)- were investigated in TDLNs of colorectal cancer (CRC) patients.",27619682_2,-1,1,-1,1,29990,-1,1.969374e-05,0.99997044,9.827782e-06
23937,STAT2,3,4,12,17,The role of STAT2 in mediating the antigrowth effects of type I interferon (IFN) is well-documented in vitro.,24895110_0,-1,1,-1,1,23937,-1,2.8274455e-05,0.9999589,1.28740985e-05
38135,T-ALL,16,17,97,102,"Using diagnostic samples from patients enrolled in the frontline Children's Oncology Group (COG) T-ALL clinical trial AALL1231, we demonstrated that one-third of primary T-ALLs were resistant to GCs when cells were cultured in the presence of IL-7, a cytokine that is critical for normal T cell function and that plays a well-established role in leukemogenesis.",31687977_1,-1,1,-1,1,38135,-1,7.71473e-05,0.99976665,0.0001562083
12096,taxol,10,11,59,64,"Two agents that target the tubulin cytoskeleton were used, taxol and colchicine, and a brief pretreatment with either increased antigen presentation by DCs independently of significant phenotypic change, cell death, or cytokine production.",20386470_3,-1,1,-1,1,12096,-1,5.8045924e-05,0.99991906,2.283769e-05
8868,generated,12,13,82,91,"With this cultivation strategy, TKTCs from peripheral blood mononuclear cells are generated within a short period of time using a pulse with a stimulating cell line followed by continuous growth in serum-free medium supplemented with a mixture of interleukin-2 and cyclosporin A. Expression and functional profiling did not allow a classification of TKTCs to any thus far defined subtype of T cells.",19240181_3,-1,1,-1,1,8868,-1,2.1530357e-05,0.9999651,1.3392237e-05
36539,this,1,2,3,7,"In this study, we analysed the localisation and regulation of IL-35 in the lung of patients with non-small cell lung cancer (NSCLC) to further elucidate the immune-escape of cancer cells in perioperative course of disease.",30956278_1,-1,1,-1,1,36539,-1,1.8892497e-05,0.9999709,1.01794585e-05
40328,These,2,3,14,19,SIGNIFICANCE: These findings provide new insight into pGSN-mediated immune cell dysfunction in ovarian cancer chemoresistance and demonstrate how this dysfunction can be exploited to enhance immunotherapy.,32641415_9,-1,1,-1,1,40328,-1,2.4180328e-05,0.9999651,1.07747455e-05
2991,gene,18,19,122,126,"Formononetin, daidzein and equol also enhanced IL-4 gene promoter activity in EL4 cells transiently transfected with IL-4 gene promoter constructs, but this effect was impaired in EL4 cells transfected with an IL-4 promoter construct deleted of P4 site carrying nuclear factor of activated T cells (NF-AT) and activator protein-1 (AP-1) binding sites.",16108819_5,-1,1,-1,1,2991,-1,2.3330806e-05,0.99995923,1.7390958e-05
38408,Thus,0,1,0,4,"Thus, STAT3-mediated immunosuppression is crucial for metastasis.",31848193_5,-1,1,-1,1,38408,-1,2.6718793e-05,0.99996126,1.2020121e-05
37334,TET,4,5,26,29,"Our findings also suggest TET activity as a biomarker for predicting the efficacy and patient response to anti-PD-1/PD-L1 therapy, and stimulating TET activity as an adjuvant immunotherapy of solid tumors.",31310587_8,-1,1,-1,1,37334,-1,2.8196475e-05,0.999959,1.2823787e-05
29548,tolerance,10,11,50,59,"Foxp3+ regulatory T cells (Tregs) maintain immune tolerance, prevent autoimmunity and modulate immune responses during infection and cancer.",27497235_0,-1,1,-1,1,29548,-1,3.3163476e-05,0.9999454,2.1373104e-05
42438,to,26,27,154,156,"Background: Increased IL-6 level, M2 macrophages and PD-1+CD8+ T cells in tumor microenvironments (TME) have been identified to correlate with resistance to checkpoint blockade immunotherapy, yet the mechanism remains poorly understood.",34093869_0,-1,1,-1,1,42438,-1,2.7922088e-05,0.9999609,1.1127525e-05
18934,to,24,25,167,169,These findings provide molecular insight into defective MHC-I expression in NB cells and provide the rational for T cell-based immunotherapy in NB variants refractory to conventional therapy.,23071666_8,-1,1,-1,1,18934,-1,3.3155917e-05,0.9999559,1.0901488e-05
30733,The,0,1,0,3,The myeloid-derived suppressor cells (MDSCs) and regulatory T cells (Tregs) in peripheral blood and spleen were determined by flow cytometry.,27926489_5,-1,1,-1,1,30733,-1,1.8373208e-05,0.9999697,1.1868722e-05
24602,their,15,16,92,97,"Myeloid-derived suppressor cells (MDSC) are elevated in most individuals with cancer, where their accumulation and suppressive activity are driven by inflammation.",25164013_2,-1,1,-1,1,24602,-1,2.2736556e-05,0.9999641,1.3180776e-05
25469,natural,36,37,230,237,"The constructed VELs had complexities of 10,500 and 8,000 individual members, generated as combinatorial M13 phage display and synthetic peptide libraries, respectively, with structural composition GWXPXDXPI, where X is any of 20 natural amino acids.",25483665_4,-1,1,-1,1,25469,-1,0.0119010005,0.9874795,0.000619478
37168,the,4,5,19,22,"Here, we evaluated the potential of Ch/-PGA NPs as vehicles for IFN- and their ability to modulate immune cells' phenotype.",31233057_4,-1,1,-1,1,37168,-1,1.7154121e-05,0.9999745,8.3816385e-06
42307,These,0,1,0,5,These findings provide a potential mechanism for controlling checkpoint blockade refractory tumors.,34011631_8,-1,1,-1,1,42307,-1,2.2022523e-05,0.9999685,9.475138e-06
16424,tumour,4,5,38,44,"The cytokine interleukin-17A supports tumour vascularization and growth, however, its role in lung cancer is unknown.",22186896_1,-1,1,-1,1,16424,-1,3.5248402e-05,0.99995184,1.2966123e-05
32376,the,8,9,47,50,"Therefore, we hypothesized that OSCC may favor the recruitment and retention of regulatory T (Treg) cells that express the CCL20 receptor, CCR6.",28600287_2,-1,1,-1,1,32376,-1,1.72983e-05,0.99997485,7.845176e-06
28613,The,0,1,0,3,"The fraction of T-regs among T cells was analysed by immunohistochemistry followed by automated image analysis in facial BCC, peritumoural skin and normal, buttock skin.",27117439_2,-1,1,-1,1,28613,-1,1.6152828e-05,0.99997556,8.3072255e-06
21232,that,4,5,21,25,It has been reported that dense intratumoral infiltration of Foxp3 (+)Tregs (Tregs) was an independent factor for poor prognosis of breast cancer (BC) patients.,24124553_0,-1,1,-1,1,21232,-1,1.8023818e-05,0.99997354,8.494628e-06
4875,tumor-induced,18,19,146,159,Curcumin could prevent tumor-induced thymic atrophy by restoring the activity of NF-kappaB. Further investigations suggest that neutralization of tumor-induced oxidative stress and restoration of NF-kappaB activity along with the reeducation of the TNF-alpha signaling pathway can be the mechanism behind curcumin-mediated thymic protection.,17210719_9,-1,1,-1,1,4875,-1,2.4639208e-05,0.9999639,1.1455247e-05
38283,Foxp3,16,17,88,93,"Upon TCR stimulation, the expression of TGF-beta was significantly higher in CD4+ CD25+ Foxp3+ TILs, while the expression of IL-10 was significantly higher in CD4+ CD25+ Foxp3- TILs.",31811667_7,-1,1,-1,1,38283,-1,2.9519515e-05,0.9999552,1.5250772e-05
24560,the,26,27,154,157,"Although several studies assessing the potential prognostic value of InfBMs in cancer have been published in the past decades, they have had no impact on the management of patients with urothelial bladder carcinoma (UBC).OBJECTIVE: To review and summarise the scientific literature on the prognostic value of tumour, serum, urine, and germline DNA InfBMs on UBC.EVIDENCE ACQUISITION: A systematic review of the literature was performed searching the Medline and Embase databases for original articles published between January 1975 and November 2013.",25151017_2,-1,1,-1,1,24560,-1,2.0628724e-05,0.9999713,8.074135e-06
23615,Thus,0,1,0,4,"Thus, tumor paracrine mechanisms establish a tumor endothelial death barrier, which has a critical role in establishing immune tolerance and determining the fate of tumors.",24793239_6,-1,1,-1,1,23615,-1,2.2899369e-05,0.9999659,1.1250699e-05
16845,Pokemon87,8,9,47,56,"The results suggest that Pokemon32, Pokemon61, Pokemon87, and Pokemon319 peptides are novel HLA-A(*)0201-restricted restricted CTL epitopes, and could be utilized in the cancer immunotherapy against a broad spectrum of tumors.",22405859_4,-1,1,-1,1,16845,-1,0.00012352814,0.9997062,0.00017027302
8679,to,14,15,75,77,"In conclusion, the hallmark of our panel of activated human Treg clones is to produce bioactive TGF-beta which has autocrine actions on Tregs and can have paracrine actions on other T cells.",19224638_8,-1,1,-1,1,8679,-1,1.842038e-05,0.99997234,9.283998e-06
16682,Foxp3,20,21,130,135,"Third, FTS induced an increase in antitumor cytotoxic T-cell reactivity in glioma cells by downregulating their own expression of Foxp3.",22323550_5,-1,1,-1,1,16682,-1,2.2306845e-05,0.9999658,1.1940882e-05
28395,that,34,35,177,181,"To verify the effect of tumor cells on the phenotype and function of CD4(+) Tregs, we established a coculture system using NSCLC cell line and healthy CD4(+) T cells and showed that SPC-A1 induced IL-10 and TGF-1 secretion by affecting the function of CD4(+) Tregs.",27000869_6,-1,1,-1,1,28395,-1,1.7333308e-05,0.9999738,8.849021e-06
19671,T(reg,7,8,29,34,"Here, we discuss the role of T(reg) cells in the pathogenesis of myasthenia gravis (MG) and review evidence indicating that a significant defect in T(reg) cell in vitro suppressive function exists in MG patients, without an alteration in circulating frequency.",23252899_2,-1,1,-1,1,19671,-1,2.0460251e-05,0.9999639,1.5715075e-05
37045,to,11,12,84,86,"We performed immunohistochemical analyses of whole tumor sections from 224 patients to assess the expression of BDCA2, CD3, CD4, CD8, Foxp3, granzyme B, IL-17, and CD34.",31201473_2,-1,1,-1,1,37045,-1,1.8521918e-05,0.99997246,9.044562e-06
380,tumor-bearing,16,17,111,124,"Administration of anti-(interleukin-12) (anti-IL-12) and anti-(interferon gamma) (anti-IFNgamma) antibodies in tumor-bearing animals showed down-regulation of the expression of CD40L on NK and T cells with simultaneous inhibition of cytotoxic acitivity of NK cells, cytokine release and the production of antitumor antibody.",11129327_6,-1,1,-1,1,380,-1,2.0367435e-05,0.99996996,9.691517e-06
41356,that,28,29,172,176,"Transcriptome and flow cytometry analyses revealed that EOMES does not only drive IL-10 expression, but rather controls a unique transcriptional signature in CD4+ T cells, that is enriched in genes typical for T regulatory type 1 (TR1) cells.",33526861_2,-1,1,-1,1,41356,-1,2.7399e-05,0.9999579,1.4690054e-05
25015,The,0,1,0,3,"The phenotypes, cytokine-release patterns, and suppressive ability of Tregs isolated from peripheral blood and tumor tissues were analyzed.",25268580_2,-1,1,-1,1,25015,-1,1.8404311e-05,0.9999713,1.0376533e-05
28787,to,25,26,164,166,"Transcription of IL17, which has been shown to have a regulatory function in human papillomavirus-associated tumours, was also elevated in equine sarcoids compared to spleen.",27160146_5,-1,1,-1,1,28787,-1,2.5329082e-05,0.9999635,1.1129868e-05
13068,that,3,4,12,16,It is clear that CD4(+) CD25(+) Foxp3(+) regulatory T (Treg) cells inhibit chronic inflammatory responses as well as adaptive immune responses.,20722759_0,-1,1,-1,1,13068,-1,2.0063595e-05,0.99997056,9.3276985e-06
43027,The,0,1,0,3,"The molecular mechanisms involved in these responses are being analyzed, but preliminary data suggest that methylation/demethylation mechanisms could also participate.",34680134_8,-1,1,-1,1,43027,-1,1.9178207e-05,0.9999727,8.094392e-06
27300,their,8,9,49,54,"Because the activities of mAbs are controlled by their Fc regions, the true effect of GITR signaling needs to be determined by examining its interaction with authentic ligand.",26423152_3,-1,1,-1,1,27300,-1,2.5659709e-05,0.9999633,1.1014884e-05
28001,that,19,20,126,130,"Our findings indicate that IL-6 causes a dysfunction in human DCs that activates cancer antigen-specific Th cells, suggesting that blocking the IL-6/STAT3 signaling pathway might be a promising strategy to improve cancer immunotherapy.",26759006_9,-1,1,-1,1,28001,-1,2.1390175e-05,0.9999703,8.334162e-06
14294,This,0,1,0,4,This study also supports our previous finding that IL-10 and IFN co-regulate IDO within the SLN.,21327637_18,-1,1,-1,1,14294,-1,2.2032418e-05,0.9999677,1.028868e-05
23988,the,43,44,284,287,BACKGROUND: Recent reports have revealed the therapeutic potential of cell-mediated immunity in neoplasms such as cutaneous squamous cell carcinoma (SCC).OBJECTIVES: To define the antigenic coexpression of regulatory T cells (Tregs) and plasmacytoid dendritic cells (pDCs) and assess the CD8(+) /Foxp3(+) CD25(+) cell ratio at peritumoral and intratumoral levels in order to investigate a correlation with the aggressiveness of SCC tumours.,24910265_0,-1,1,-1,1,23988,-1,1.6420558e-05,0.9999759,7.648534e-06
18368,to,18,19,99,101,"However, such data in patients with oral cancer is scarce and hence the current study was designed to elaborate the immunological balance between these two T cell subsets in oral cancer.",22956260_1,-1,1,-1,1,18368,-1,1.7537512e-05,0.9999739,8.607066e-06
34245,TGF-1,27,28,172,178,"Immunohistochemistry (IHC) as well as quantitative real-time reverse transcription- polymerase chain reaction (RT-PCR) was used to determine the expression levels of IL-6, TGF-1, IL-17, and FoxP3 in the prepared tissues.",29391307_3,-1,1,-1,1,34245,-1,3.536161e-05,0.9999274,3.7263097e-05
39689,the,27,28,168,171,"Our results first identify the significance of CD73+V1 Tregs in BC, and therapy targeting this subpopulation or blocking TDEs might have potential for BC treatment in the future.",32345959_8,-1,1,-1,1,39689,-1,2.6064601e-05,0.99996305,1.0921536e-05
22897,The,0,1,0,3,The complicated tumor-related Treg subsets and their functional mechanisms are not fully addressed yet.,24668348_1,-1,1,-1,1,22897,-1,2.2553171e-05,0.99996626,1.1229179e-05
31016,Thus,0,1,0,4,"Thus, our study revealed a novel IL-33-ST2-MyD88-STAT1 axis that restores mDC activation and maturation in established cancer and, thereby, the magnitude of antitumor immune responses, suggesting a potential use of rIL-33 as a new immunotherapy option to treat established cancer.",28011934_7,-1,1,-1,1,31016,-1,2.161811e-05,0.9999671,1.1239291e-05
15145,tumors,32,33,195,201,"Following treatment with rhIL-2, a dramatic increase in CD8 Foxp3+ T cell prevalence was observed in the circulation and tumor-draining lymph nodes (TD.LNs) of animals bearing IL-2 nonresponsive tumors, while no significant changes were observed in the circulation and TD.LNs of animals bearing IL-2 responsive tumors.",21638127_5,-1,1,-1,1,15145,-1,1.9699899e-05,0.99996746,1.2901322e-05
42422,HIF1,4,5,16,21,Loss of EGFR or HIF1 abrogates Th9 cell differentiation and suppresses their anti-tumor functions.,34075041_5,-1,1,-1,1,42422,-1,0.00010876977,0.99983764,5.358588e-05
43572,transcription factors,35,37,230,251,"The activation of T cells requires engagement of the T cell receptor/CD3 complex and co-stimulatory molecules, and results in the triggering of several signaling pathways which lead rapidly to the nuclear translocation of several transcription factors, such as nuclear factor (NF)-kappa B and NF-AT.",8605941_0,-1,1,-1,1,43572,-1,2.5008074e-05,0.99995196,2.3083996e-05
29856,tumor,15,16,94,99,This could be due to a disparity among patients in harboring multiple factors associated with tumor immunoediting and immune evasion mechanisms.,27603507_4,-1,1,-1,1,29856,-1,2.1968117e-05,0.9999689,9.16774e-06
21759,TGF-1,10,11,51,57,"The levels of intratumoral IL-12, IFN-, IL-10 and TGF-1 were evaluated.",24304581_6,-1,1,-1,1,21759,-1,3.2838525e-05,0.9999405,2.6600374e-05
36204,to,19,20,128,130,"Despite having favorable prognosis, patients with differentiated thyroid carcinoma (DTC) still suffer from reduced lifespan due to recurrences, metastasis, and dedifferentiation.",30711567_0,-1,1,-1,1,36204,-1,3.026071e-05,0.9999573,1.2453697e-05
6900,the,4,5,24,27,This study has provided the proof-of-principle for combining CpG and JSI-124 to enhance antitumor immune responses.,18392040_7,-1,1,-1,1,6900,-1,2.101984e-05,0.9999701,8.880903e-06
19480,to,39,40,276,278,"Priming (conditioning) of PC cells with AT-101 can significantly enhance the anti-tumor activity of EGFRBi armed ATC through increased IFN- induced activation of pS(727)-Stat1 and inhibition of pY(705)-Stat3 phosphorylation, and resulting in increased ratio of pro-apoptotic to anti-apoptotic proteins.",23185240_6,-1,1,-1,1,19480,-1,4.1953277e-05,0.9999225,3.5487043e-05
29199,Gfi1,7,8,49,53,These findings demonstrate the important role of Gfi1 in regulating the development and function of NKT1- and NKT2-type iNKT cell subsets.,27284976_7,-1,1,-1,1,29199,-1,0.00023161233,0.99899787,0.00077058026
9058,TRIAL,0,1,0,5,TRIAL REGISTRATION: ClinicalTrials.gov NCT00317759.,19270751_15,-1,1,-1,1,9058,-1,3.35296e-05,0.99994814,1.8309456e-05
34251,test,6,7,51,55,Statistical analysis included ANOVA and chi-square test.,29391307_4,-1,1,-1,1,34251,-1,4.4591365e-05,0.9999187,3.6651254e-05
16415,regulation,26,27,165,175,"Within these structures, there are proliferating CD4and CD8 T lymphocytes, as well as FoxP3CD4 lymphocytes, suggesting a complex interplay of lymphoid expansion and regulation within the dermal immunization microenvironment.",22130163_10,-1,1,-1,1,16415,-1,3.0378336e-05,0.9999287,4.094051e-05
30269,two-sided,4,5,27,36,All statistical tests were two-sided.,27707838_7,-1,1,-1,1,30269,-1,0.00020985231,0.9996501,0.00014000018
15695,the,11,12,69,72,"While there is evidence that specific T cell populations can promote the growth of established tumors, instances where T cell activity causes neoplasms to arise de novo are infrequent.",21881210_0,-1,1,-1,1,15695,-1,1.9119192e-05,0.999972,8.876126e-06
23416,tested,32,33,219,225,The present study was designed to investigate the correlation between apoptosis levels and Fas/FasL expression in CD8+T lymphocytes and Foxp3+T cells in patients with HCC.METHODS: CD8+T cells and CD3+Foxp3+T cells were tested from peripheral blood of HCC patients and normal controls and subjected to multicolor flow cytometry.,24761872_3,-1,1,-1,1,23416,-1,2.5643214e-05,0.9999573,1.6981941e-05
39161,than,39,40,209,213,"Moreover, we found that tumors from high-risk patients had higher relative abundance of T follicular helper cells, regulatory T cells, and M0 macrophages, and higher expression of PD-1, CTLA-4, LAG3, and CD47 than low-risk patients.",32028264_6,-1,1,-1,1,39161,-1,2.2408343e-05,0.99995935,1.8236506e-05
2823,the,7,8,39,42,"In this study, we further investigated the in vitro effect of IL-27 on CD8+ T cells of mouse spleen cells.",16034109_2,-1,1,-1,1,2823,-1,1.6845437e-05,0.9999747,8.476268e-06
43839,the,27,28,148,151,The adoptive transfer of tumor-draining lymph node (LN) T cells activated ex vivo with anti-CD3 and interleukin 2 (IL-2) mediates the regression of the poorly immunogenic murine melanoma D5.,9690455_0,-1,1,-1,1,43839,-1,2.0259624e-05,0.99996793,1.179169e-05
40855,these,10,11,73,78,This study supports the implementation of targeted strategies to augment these pathways for improved immunotherapeutic outcomes in patients with cancer.,33051240_7,-1,1,-1,1,40855,-1,1.778332e-05,0.99997187,1.0381915e-05
24642,the,1,2,6,9,"Using the diethylnitrosamine (DEN)-induced rat liver tumor model and in vitro cell experiments, the percentage of CD4(+)CD25(+)Treg/CD4(+) cells in the blood and the expressions of Foxp3(+), IL-10, TGF-, and cytotoxic T lymphocyte-associated antigen-4(CTLA-4) in spleen and liver tumors significantly decreased after LDR of the spleen in rats with liver cancer.",25168696_4,-1,1,-1,1,24642,-1,1.7820854e-05,0.9999727,9.531759e-06
37471,tumors,6,7,58,64,Histopathological and cytofluorimetric analyses of murine tumors and lymphoid tissues prompted analyses of patients' PC samples and follow-ups.,31366386_4,-1,1,-1,1,37471,-1,2.1905138e-05,0.99996173,1.631079e-05
27795,the,3,4,13,16,"In addition, the change of Treg immunosuppressive cytokine interleukin (IL)-10 was examined with IHC and real-time PCR.RESULTS: increased FoxP3+Tregs were observed in the adenomatous stroma/epithelium and the density in colorectal adenomas, which was similar to that in the CRCs, significantly increased as compared to normal tissues.",26724144_3,-1,1,-1,1,27795,-1,1.7176983e-05,0.99997497,7.915398e-06
15234,the,5,6,35,38,"CONCLUSION: Our study demonstrated the increased frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in NIP tumors, which might be influenced by CCL22.",21674673_6,-1,1,-1,1,15234,-1,1.6638802e-05,0.99997485,8.546595e-06
15237,tumors,19,20,106,112,"CONCLUSION: Our study demonstrated the increased frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in NIP tumors, which might be influenced by CCL22.",21674673_6,-1,1,-1,1,15237,-1,1.92243e-05,0.99996805,1.2695391e-05
4879,the,37,38,284,287,Curcumin could prevent tumor-induced thymic atrophy by restoring the activity of NF-kappaB. Further investigations suggest that neutralization of tumor-induced oxidative stress and restoration of NF-kappaB activity along with the reeducation of the TNF-alpha signaling pathway can be the mechanism behind curcumin-mediated thymic protection.,17210719_9,-1,1,-1,1,4879,-1,2.9356444e-05,0.9999584,1.2211587e-05
31461,to,30,31,210,212,This has provided impetus to identify other co-inhibitory receptors that could be exploited to enhance response rates of current immunotherapeutic agents and achieve responses to the cancers that are refectory to immunotherapy.,28258697_3,-1,1,-1,1,31461,-1,3.4690518e-05,0.9999492,1.6125545e-05
33836,terminally,20,21,118,128,"Although CD26neg T cells possess a regulatory phenotype, CD26int T cells are mainly naive and CD26high T cells appear terminally differentiated and exhausted.",29213079_2,-1,1,-1,1,33836,-1,4.0730098e-05,0.999899,6.0272152e-05
13043,treatment,1,2,7,16,"Before treatment, Treg levels were significantly higher in patients with melanoma when compared with data from 20 healthy subjects (P = 0.001; Mann-Whitney test).",20712892_5,-1,1,-1,1,13043,-1,2.3216677e-05,0.9999659,1.09228695e-05
23022,the,15,16,83,86,"The effects of MDPF on the growth of mouse S180 sarcoma, splenocyte proliferation, the activity of natural killer (NK) cells and cytotoxic T lymphocytes (CTLs), production and mRNA expression of cytokines from splenocytes, and serum antigen-specific antibody levels in tumor-bearing mice were measured.",24690776_5,-1,1,-1,1,23022,-1,1.8691593e-05,0.99997056,1.0796941e-05
28731,narrower,23,24,155,163,"Though isogenic, indolent and aggressive-stage cell lines had diverged phenotypically, the latter expressing multiple Th17 related cytokines, the former a narrower profile.",27144517_3,-1,1,-1,1,28731,-1,0.0004507551,0.99935895,0.00019027486
17603,The,0,1,0,3,The ratio of CD4+ICOS(hi) T cells to CD4+FoxP3+ T cells increased from 0.370.12 before vaccination to 2.30.72 (p=0.021) following vaccination.,22678162_7,-1,1,-1,1,17603,-1,1.7201917e-05,0.99997497,7.849997e-06
12744,to,27,28,183,185,Tumor-derived IL-4 induced the expression of type 2 cytokines and the transcription factor GATA-3 by responding CD8 T cells while reducing their CD8 coreceptor expression and ability to eliminate a secondary tumor challenge.,20562261_5,-1,1,-1,1,12744,-1,2.0291882e-05,0.99996805,1.161252e-05
7256,to,5,6,32,34,"Moreover, administration of P17 to mice immunized with peptide vaccines containing tumor or viral Ags enhanced anti-vaccine immune responses and improved protective immunogenicity against tumor growth or viral infection or replication.",18566377_4,-1,1,-1,1,7256,-1,2.114769e-05,0.99996865,1.0244922e-05
29177,the,7,8,42,45,"However, the impact of Gfi1-deficiency on the iNKT cell differentiation remains unclear.",27284976_1,-1,1,-1,1,29177,-1,1.9969211e-05,0.9999701,9.899627e-06
9805,the,17,18,108,111,"We speculate that iTreg cell development is driven by the need to maintain a noninflammatory environment in the gut, to suppress immune responses to environmental and food allergens, and to decrease chronic inflammation, whereas nTreg cells prevent autoimmunity and raise the activation threshold for all immune responses.",19464985_4,-1,1,-1,1,9805,-1,2.5644098e-05,0.99996316,1.1215616e-05
7535,this,4,5,27,31,"The likely explanation for this was the NS3/4A-mediated cleavage of mouse IPS-1, albeit less efficiently than human IPS-1.",18689426_9,-1,1,-1,1,7535,-1,2.3626277e-05,0.9999652,1.1160178e-05
23074,to,13,14,85,87,This peptide was also effective at inducing CD8+ T-cells that responded specifically to SIM2-expressing tumor cells.,24690990_4,-1,1,-1,1,23074,-1,2.8562366e-05,0.9999583,1.3179994e-05
13067,made,31,32,182,186,"Treg levels shifted in patients with melanoma treated with IFN-alpha 2b, although no firm conclusions regarding the role of Tregs as a marker of treatment response or outcome can be made at present.",20712892_10,-1,1,-1,1,13067,-1,3.0989595e-05,0.99995506,1.3946956e-05
27416,there,2,3,9,14,"However, there is an unmet need to identify the underlying mechanisms of cancer metastasis mediated by endogenous host galectin-3.",26442663_1,-1,1,-1,1,27416,-1,2.4997958e-05,0.9999652,9.785533e-06
27112,the,2,3,11,14,"Currently, the role of IFN- in autoimmune diseases is still controversial and needs further exploration.",26347149_1,-1,1,-1,1,27112,-1,2.0913672e-05,0.9999714,7.705709e-06
31361,the,4,5,20,23,AIM: To investigate the abundance and potential functions of LAP+CD4+ T cells in colorectal cancer (CRC).METHODS: Proportions of LAP+CD4+ T cells were examined in peripheral blood and tumor/paratumor tissues of CRC patients and healthy controls using flow cytometry.,28210081_0,-1,1,-1,1,31361,-1,1.5930575e-05,0.9999765,7.527144e-06
23391,STAT4,17,18,97,102,We further found that CPT enhanced perforin production of CD4+ T cells by up-regulating JAK2 and STAT4 phosphorylation.,24761844_6,-1,1,-1,1,23391,-1,2.9517014e-05,0.99994195,2.8479972e-05
22332,they,2,3,13,17,"Furthermore, they significantly inhibited the nuclear expression and translocation of nuclear factor of activated T cells (NF-AT)1.",24460246_7,-1,1,-1,1,22332,-1,2.2322387e-05,0.9999641,1.36062745e-05
5252,the,5,6,29,32,We provide evidence also for the latter by showing that c-MYC down-regulates genes of the NF-kappaB and interferon pathway in a dose-dependent fashion.,17419945_5,-1,1,-1,1,5252,-1,2.0982261e-05,0.9999697,9.300669e-06
18025,Treg,5,6,24,28,"In particular, CXCR3(+) Treg have been described as a subset specialized in the control of type I T-cell responses in vivo.",22798340_3,-1,1,-1,1,18025,-1,2.226932e-05,0.9999634,1.4358982e-05
3617,transcription,18,19,134,147,We induced rat peritoneal macrophages with rat breast cancer cell-conditioned medium and analyzed signal transducer and activators of transcription 3 (Stat3) activities of the cells.,16530087_2,-1,1,-1,1,3617,-1,2.6981896e-05,0.9999554,1.7578095e-05
6167,the,13,14,109,112,"These findings document the selective gammac-signaling cytokine-mediated activation of the mTORC1 pathway in the CTCL cells and suggest that the pathway represents a therapeutic target in CTCL and, possibly, other T-cell lymphomas.",18025151_8,-1,1,-1,1,6167,-1,1.8443012e-05,0.99996805,1.348864e-05
13265,transfer,3,4,22,30,CONCLUSIONS: Adoptive transfer of haplo-identical NK cells after lymphodepleting chemotherapy is associated with transient donor chimerism and may be limited by reconstituting recipient Treg cells.,20849361_13,-1,1,-1,1,13265,-1,3.0681877e-05,0.99994814,2.1138345e-05
758,this,8,9,51,55,"These observations place constraints on the use of this, and potentially other, HPV-derived CTL epitopes for the immunotherapy of cervical cancer.",11673561_9,-1,1,-1,1,758,-1,3.6266887e-05,0.999941,2.2792454e-05
6867,generate,26,27,121,129,"In this study, we tested the hypothesis that the combination of CpG (a DC activator) and JSI-124 (a STAT3 inhibitor) may generate synergistic antitumor effects compared to CpG or JSI-124 alone.",18392040_1,-1,1,-1,1,6867,-1,2.0198675e-05,0.99997044,9.316069e-06
18606,Tregs,6,7,30,35,CD4+CD25+ regulatory T cells (Tregs) play an essential role in the establishment and persistence of tumor immune suppression.,23000301_0,-1,1,-1,1,18606,-1,2.2162021e-05,0.9999658,1.2104184e-05
37801,thus,8,9,52,56,"However, TGF- also has tumor-suppressive activity; thus, dissecting cell type-specific molecular effects may inform therapeutic strategies targeting this cytokine.",31530731_2,-1,1,-1,1,37801,-1,2.6905636e-05,0.9999633,9.814431e-06
13299,Foxp3(+,2,3,15,22,"Interestingly, Foxp3(+) and Foxp3(-) CD8(+) T cells have similar IFN- production and antigen-specific degranulation after stimulation with RNEU(420-429) , the immunodominant HER-2/neu (neu) epitope in this model.",20857491_5,-1,1,-1,1,13299,-1,0.0001541298,0.9996847,0.0001611792
22736,Tregs,22,23,143,148,"Biomarkers relevant to the antitumor effects of IL-2 that may be altered by sorafenib including the percentages of natural T-regulatory cells (Tregs), myeloid-derived suppressor cells (MDSC), and STAT5 phosphorylation (pSTAT5) in T cells were evaluated.",24598448_1,-1,1,-1,1,22736,-1,2.2102593e-05,0.9999653,1.2533578e-05
28741,STAT5,15,16,92,97,"Th17 conversion of MAC-1 cells by IL-2 was blocked by pharmacological inhibition of JAK3 or STAT5, implicating IL2RG - JAK3 - STAT5 signaling in plasticity responses.",27144517_6,-1,1,-1,1,28741,-1,4.10114e-05,0.9999306,2.8356391e-05
43103,cell factors,11,13,59,71,"Moreover, EZH2 can regulate T cell fate by targeting non-T cell factors such as metabolism, cytokines, and myeloid-derived suppressor cells.",34737746_5,-1,1,-1,1,43103,-1,0.024509134,0.0017168226,0.97377396
15270,the,15,16,96,99,This study aimed to investigate whether Treg are accumulated in human gastric cancer tissue and the mechanism of Treg induction by gastric cancer cells.,21695703_1,-1,1,-1,1,15270,-1,1.7521834e-05,0.99997497,7.4809523e-06
4870,NF-kappaB,26,27,177,186,"In contrast, when degradation-defective IkappaBalpha (IkappaBalpha super-repressor) was introduced into T cells, the cells became more vulnerable, indicating that inhibition of NF-kappaB is the reason behind such tumor/TNF-alpha-mediated apoptosis.",17210719_8,-1,1,-1,1,4870,-1,3.5790526e-05,0.9999485,1.567058e-05
34899,Tregs,3,4,17,22,"The frequency of Tregs was significantly higher in MPEs compared to benign effusions; however, the level of TGF- and IL-10 in analyzed groups was comparable, and no correlation between concentrations of TGF- and IL-10 and percentage of Tregs was observed.",29785404_6,-1,1,-1,1,34899,-1,2.403102e-05,0.9999585,1.7438793e-05
29800,this,1,2,3,7,"In this study, we found that IRF4 expression was remarkably suppressed during the development of MDSCs in the tumor microenvironment.",27601624_4,-1,1,-1,1,29800,-1,1.8920424e-05,0.9999708,1.0278021e-05
43434,to,14,15,118,120,"Thus, our studies identify a novel endothelial-endogenous mechanism underlying VEGF-A-dependent desensitization of EC to proinflammatory stimuli.",36403190_9,-1,1,-1,1,43434,-1,2.9587742e-05,0.99995685,1.3582827e-05
42602,the,30,31,189,192,"OBJECTIVES: We aimed to pulsate lymphocytes of breast cancer patients and normal individuals, using Diospyros peregrina fruit preparation (DFP) to study the cancer-protective immunity, and the signal transduction processes involved with it.",34190692_2,-1,1,-1,1,42602,-1,1.8129382e-05,0.99997306,8.821596e-06
11773,tumor-draining,52,53,314,328,"We have performed an in-depth study of the local T-cell repertoire in a selected group of patients with cervical cancer, by systematic analyses of the proportion, breadth, and polarization of human papillomavirus (HPV) E6/E7-specific T cells within the total population of tumor-infiltrating lymphocytes (TIL) and tumor-draining lymph node cells (TDLNC).",20233872_1,-1,1,-1,1,11773,-1,7.9478625e-05,0.9998703,5.019241e-05
22811,the,7,8,32,35,"In this study, we have analyzed the in vitro immunomodulatory potential of a non-toxic neem leaf glycoprotein (NLGP) in reprogramming Stage III supraglottic laryngeal tumor cell lysate (SLTCL) induced M2 TAMs to their classical anti-tumor shape (M1).",24607970_1,-1,1,-1,1,22811,-1,1.7244365e-05,0.9999753,7.4391505e-06
26090,these,20,21,119,124,"CCL27 mRNA also displayed a higher expression level in tumor tissues compared with that in paratumor tissues; however, these levels were not significantly different (2.58  0.93 vs 2.30  0.78, P > 0.05).",25892871_6,-1,1,-1,1,26090,-1,1.973083e-05,0.99996865,1.1624395e-05
35556,Tregs,2,3,9,14,RESULTS: Tregs from non-relapse patients had increased expression of proliferation associated genes.,30131384_5,-1,1,-1,1,35556,-1,2.0776555e-05,0.99996805,1.1161424e-05
7918,Thus,0,1,0,4,"Thus, cytokines such as IFN-alpha and IL-2 have multiple and severe side effects.",18947877_2,-1,1,-1,1,7918,-1,3.0547097e-05,0.99995637,1.3053989e-05
30775,STAT1,5,6,24,29,"At the molecular level, STAT1 was hyper-phosphorylated in T cells lacking SHP2, which may account for the increased Th1 differentiation and IFN- secretion.",27935860_5,-1,1,-1,1,30775,-1,2.2346258e-05,0.9999572,2.0433283e-05
41140,genes,10,11,67,72,"In this study, we acquired and integrated differentially expressed genes of OSCC patients, including immune-related genes and transcription factors (TFs), from The Cancer Genome Atlas (TCGA) database.",33220636_2,-1,1,-1,1,41140,-1,3.2529442e-05,0.9999366,3.091361e-05
21848,The,0,1,0,3,The frequency and suppressing activity of Treg cells in general are high in different malignancies.,24354800_1,-1,1,-1,1,21848,-1,2.227471e-05,0.9999689,8.892477e-06
14553,to,10,11,73,75,CMFs from patients with inflammatory bowel diseases had reduced capacity to induce active Treg cells and increased capacity to transiently generate CD4+CD25+/- CD127+ T cells that express low levels of FoxP3.CONCLUSIONS: CMFs suppress the immune response in normal colon tissue and might therefore help maintain colonic mucosal tolerance.,21376048_7,-1,1,-1,1,14553,-1,2.0654075e-05,0.99996734,1.20150125e-05
38639,toward,17,18,120,126,"Despite expressing high levels of TGF1 receptors on their surface, IRISOE TNBC cells channeled TGF1/TRI/II signaling toward AKT, not SMAD, which activated stemness/EMT phenotypes.",31911557_3,-1,1,-1,1,38639,-1,3.0514335e-05,0.9999496,1.9884994e-05
2354,the,15,16,105,108,"Taken together, these observations demonstrate the functional expression of CD40 in epithelial tumors of the cervix and support the clinical exploitation of the CD40 pathway for the treatment of cervical cancer through its multiple effects on tumor cell growth, apoptosis, and immune recognition.",15611226_7,-1,1,-1,1,2354,-1,2.0084944e-05,0.99996877,1.1177963e-05
21597,The,0,1,0,3,The anti-GITR mAb was then combined with the intratumoral injection of the IFN--adenovirus vector.,24289533_4,-1,1,-1,1,21597,-1,1.7880917e-05,0.9999728,9.293445e-06
29080,the,16,17,88,91,"Here, we showed that suppressing mTOR signaling in in vitro-expanded V4  T cells via the mechanistic inhibitor rapamycin enhanced their cytotoxicity against multiple tumor cell lines, and these cells performed better tumor-suppressing effects upon adoptive therapy.",27256566_2,-1,1,-1,1,29080,-1,1.946876e-05,0.9999707,9.801848e-06
32112,to,33,34,192,194,"The CpG-HH2 complex significantly enhanced the production of IFN-, TNF- and IL-1, promoted the uptake of antigen and strengthened the activation of p38, Erk1/2 and NF-B in vitro, compared to CpG or HH2 alone.",28515346_3,-1,1,-1,1,32112,-1,2.1254986e-05,0.9999683,1.0493572e-05
29116,TLR1-TLR2,7,8,25,34,"A link between 4-1BB and TLR1-TLR2 signaling in CD8(+) T cells was highlighted by the suboptimal responses of 4-1BB(-/-) T cells to TLR1-TLR2 agonist, but their normal response to CD28 or OX40 costimulation.",27267778_4,-1,1,-1,1,29116,-1,4.3066597e-05,0.9999305,2.6370082e-05
21260,to,1,2,8,10,"Similar to intratumoral Treg infiltrates, CCL22 tumor secretion correlated with the prognosis of the molecular subtypes of breast carcinoma (P<0.0001).",24124553_6,-1,1,-1,1,21260,-1,2.2262237e-05,0.99996865,9.092942e-06
29493,Tregs,34,35,204,209,Several studies indicate that a correct combination of cluster of differentiation 8 and cluster of differentiation 4 T cells is key to fight tumor progression and that the presence of regulatory T cells (Tregs) infiltrating ovarian solid tumors (or present in ascites) is deleterious.,27420920_1,-1,1,-1,1,29493,-1,2.1197531e-05,0.9999671,1.1668493e-05
32400,the,11,12,56,59,This predominance of CCR6+ Treg cells was also found in the draining lymph nodes and tumor-infiltrating lymphocytes of OSCC patients with early or late clinical staging.,28600287_6,-1,1,-1,1,32400,-1,1.7584965e-05,0.99997234,1.0018387e-05
43800,The,0,1,0,3,The monoclonal immunoglobulin (Ig) (M-component) secreted by the tumour plasma cells in multiple myeloma (MM) has specific antigenic determinants (idiotypes; id) that can serve as tumour-specific antigens.,9531329_0,-1,1,-1,1,43800,-1,1.9893447e-05,0.9999703,9.781161e-06
17107,toxic,21,22,123,128,A detailed analysis of the balance between Tregs and Th17 cells seems necessary in order to design more effective and less toxic modes of immunotherapy myeloma which still is an uncurable malignancy.,22489248_7,-1,1,-1,1,17107,-1,0.00025959528,0.9996244,0.00011604207
3639,that,3,4,17,21,The data suggest that immunosuppressive activities of TAMs correlate with over-activated Stat3 signaling of the cells and disruption of Stat3 activity of TAMs can enhance rat immune response to breast cancer.,16530087_6,-1,1,-1,1,3639,-1,1.7144497e-05,0.99997497,7.9093015e-06
4330,This,0,1,0,4,This anti-rH2N immune response suppressed the growth of established H2N-positive NT2 breast cancer more efficiently than did the vector-targeted chemotherapy or Ad-sig-rH2N/ecdCD40L-infected dendritic cell vaccine alone.,16928818_13,-1,1,-1,1,4330,-1,2.0560128e-05,0.9999697,9.726144e-06
41739,the,16,17,93,96,"Single-cell RNA sequencing discovered a subtype of B cells positive for Erbin, one member of the leucine-rich repeat and PDZ domain (LAP) family, was involved in the lung metastases.",33707428_2,-1,1,-1,1,41739,-1,2.2658875e-05,0.9999653,1.2064615e-05
29895,the,36,37,187,190,The objective of this study was to observe the distribution of regulatory T cells (Tregs) in the development of tongue squamous cell carcinoma (SCC) and to determine the role of Tregs in the progression of tongue SCC.,27614428_0,-1,1,-1,1,29895,-1,1.7243307e-05,0.99997485,7.968674e-06
20615,tumour,17,18,97,103,The aim of this study was to investigate the level of IL-17-producing cells in the breast cancer tumour microenvironment and its prognostic role.,23738752_1,-1,1,-1,1,20615,-1,2.2480563e-05,0.9999651,1.2403715e-05
11130,that,4,5,32,36,"Real-time PCR analysis revealed that combination therapy led to an increase in IFN-gamma and tumor necrosis factor-alpha mRNA expression; however, levels of Foxp3 and transforming growth factor-beta within the remote tumor tissues were decreased.",19940990_6,-1,1,-1,1,11130,-1,1.676513e-05,0.99997497,8.28299e-06
10284,The,0,1,0,3,"The significant influence of the treatment on the frequency of immunosuppressive cells, the increase of vaccine-directed T cells upon treatment in a subset of patients together with the demonstration of a complete clinical response encourage further clinical investigation of the protamine-mRNA vaccine.",19609242_10,-1,1,-1,1,10284,-1,1.9103984e-05,0.9999716,9.26615e-06
15020,transduction,17,18,114,126,"This study evaluated relationships between plasma IL-6, IL-10, circulating MDSC subsets, and IFN--induced signal transduction in 40 patients with GI malignancies.",21604071_2,-1,1,-1,1,15020,-1,2.738683e-05,0.99995136,2.1262797e-05
28427,that,3,4,15,19,We report here that radiation induces rapid activation of the p65/p50 and p50/p50 NF-B complexes in human soft tissue sarcoma (STS) cells.,27014915_1,-1,1,-1,1,28427,-1,1.8114719e-05,0.9999727,9.206413e-06
20755,this,23,24,154,158,"Furthermore, CD4(+)foxp3(+) regulatory T cells (Tregs) were progressively decreased in both spleen and tumor tissues following mMSLN-VLP immunization and this was at least partly due to elevated levels of IL-6 production from activated plasmocytoid dendritic cell (pDC)-like cells following mMSLN-VLP immunization.",23874581_3,-1,1,-1,1,20755,-1,1.9264024e-05,0.9999703,1.0399885e-05
30620,the,41,42,247,250,"In addition to these findings, regulatory Tcells (Treg) showed enhanced function through cell-cell contact and increased secretion of typical soluble factors, interleukin (IL)-10 and transforming growth factor (TGF)-, in a cell line model using the MT-2 human polyclonal Tcells and its sublines exposed continuously to asbestos fibers.",27878235_2,-1,1,-1,1,30620,-1,1.8388444e-05,0.9999709,1.0708194e-05
1502,tumor,1,2,5,10,"Many tumor immunologists favor the hypothesis that optimal anti-tumor activity is mediated by type 1 CD4(+) and CD8(+) T cells, and that the production of type 2 CD4(+) T cells may be counterproductive for effective anti-tumor immunity.",14593499_0,-1,1,-1,1,1502,-1,1.9718038e-05,0.9999696,1.0677373e-05
42356,the,22,23,130,133,"The immune system is a fine modulator of the tumor biology supporting or inhibiting its progression, growth, invasion and conveys the pharmacological treatment effect.",34070750_0,-1,1,-1,1,42356,-1,2.9897788e-05,0.9999585,1.1625895e-05
23802,TFH,5,6,26,29,"Given that the balance of TFH and TFR populations likely dictate, in part, the biology of this disease, our data support the potential for targeting MSCs as a therapeutic strategy.",24836297_6,-1,1,-1,1,23802,-1,2.2038193e-05,0.9999627,1.5251091e-05
14809,Treg,8,9,47,51,"In patients treated with hormone therapy, high Treg were associated with a shorter survival in a multivariate analysis (OR 1.78, 95% CI 1.01 to 3.15, P = 0.040).",21521526_6,-1,1,-1,1,14809,-1,2.9527017e-05,0.99995184,1.8582026e-05
33598,The,0,1,0,3,The aim of this study is to explore their relevance to oncological features in non-muscle invasive bladder cancer (NMIBC).,29048388_1,-1,1,-1,1,33598,-1,1.9634466e-05,0.9999727,7.6251454e-06
35735,than,29,30,171,175,"Here, we demonstrated that, when incubated with autologous CD8+ T cells, the MYD88 L265P mutant lymphomas were more resistant to granzyme B- and perforin-mediated killing than MYD88 wild-type (WT) lymphomas.",30253331_3,-1,1,-1,1,35735,-1,1.8366205e-05,0.999969,1.265468e-05
13576,TGF-1,24,25,157,163,"The culture supernatant of ASCs isolated from breast cancer patients with pathological stage III induced upregulation of the mRNA expression levels of IL-4, TGF-1, IL-10, CCR4 and CD25 in PBLs.",20970781_4,-1,1,-1,1,13576,-1,4.6546633e-05,0.99991775,3.5711557e-05
26943,Th22,5,6,29,33,"Moreover, the frequencies of Th22 and Th17 cells were higher in stage III than in stage I+II of MM.",26255628_8,-1,1,-1,1,26943,-1,7.060053e-05,0.9998615,6.785211e-05
30214,this,1,2,3,7,"In this study, we investigated the potential role of Tr1 cells in DLBCL.",27704876_4,-1,1,-1,1,30214,-1,2.0206668e-05,0.9999684,1.1352125e-05
18673,tumor,12,13,62,67,"In this study, we used A20 B-cell lymphoma mice as aggressive tumor models to investigate the mechanism of the depletion of Tregs by low-dose cyclophosphamide (CY, 20 mg/kg).",23000689_3,-1,1,-1,1,18673,-1,2.0264173e-05,0.9999684,1.1291649e-05
10497,FOXP3,39,40,241,246,"In summary, our findings show that ovarian carcinoma cells are able to induce expression of FOXP3 and exhibit suppressive ability in activated nave T cells by producing soluble substances, and multiple cytokines involve in the induction of FOXP3 expression.",19673890_8,-1,1,-1,1,10497,-1,2.067587e-05,0.9999672,1.2052529e-05
27557,T-bet,0,1,0,5,"T-bet, GATA3, RORt, and Foxp3 signaling specific for Th1, Th2, Th17, and Treg were also analyzed by RT-PCR assay.",26475064_4,-1,1,-1,1,27557,-1,2.3839446e-05,0.99995124,2.4865296e-05
7372,NF-kappaB,12,13,73,82,These findings suggest that a cotreatment with TRAIL and an inhibitor of NF-kappaB signaling or a blocking anti-CD40 Ab could be of great interest in FL therapy.,18606651_7,-1,1,-1,1,7372,-1,4.0790703e-05,0.999944,1.5184005e-05
36892,Tregs,9,10,79,84,Helios+ Tregs possessed greater immunosuppressive capacity compared to Helios- Tregs.,31118027_8,-1,1,-1,1,36892,-1,2.037654e-05,0.9999629,1.667872e-05
3486,STAT5,0,1,0,5,STAT5 can also contribute to the transformed phenotype.,16375697_4,-1,1,-1,1,3486,-1,3.6548914e-05,0.999933,3.043359e-05
12379,that,30,31,199,203,"Significantly higher IL-17 levels were also observed in cases of patients with sinus tract (P = .03).CONCLUSIONS: We observed that chronic periapical lesions might experience a reagudization process that is correlated with an increased leukocyte infiltration, with the predominance of neutrophils attracted by a chemokine milieu, as well as the increased presence of IL-17.",20478453_9,-1,1,-1,1,12379,-1,1.938475e-05,0.99997115,9.513381e-06
34629,that,30,31,182,186,"BACKGROUND: It has been proposed that cancer establishment, maintenance, and recurrence may be attributed to a unique population of tumor cells termed cancer-initiating cells (CICs) that may include characteristics of putative cancer stem cell-like cells.",29699516_0,-1,1,-1,1,34629,-1,2.7550175e-05,0.99995947,1.3025365e-05
34551,the,10,11,71,74,In situ hybridization also confirmed abundant TGF1 mRNA expression in the lymphoid stroma.,29594353_6,-1,1,-1,1,34551,-1,1.7243396e-05,0.99997246,1.0273961e-05
28738,treatment,10,11,60,69,In indolent stage cells JAK3 expression was boosted by IL-2 treatment.,27144517_5,-1,1,-1,1,28738,-1,2.5303674e-05,0.9999622,1.2468898e-05
5713,FOXP3,6,7,44,49,"Furthermore, a positive correlation between FOXP3 expression with VEGF expression and IMD values was also detected, however, statistically that was non-significant.",17653902_7,-1,1,-1,1,5713,-1,1.930444e-05,0.999969,1.1691016e-05
7012,transcription factor,17,19,71,91,"Moreover, the activation of the nuclear factor kappa B (NF kappa B), a transcription factor activated by several cytokines released during inflammation and responsible for many of their proinflammatory effects, have been shown to promote the growth of the colon tumors in experimental models.",18473765_6,-1,1,-1,1,7012,-1,2.6463502e-05,0.9999535,1.9975543e-05
34436,The,0,1,0,3,The prolactin-inducible protein (PIP) is considered a valuable biomarker that is associated with both benign and malignant pathological conditions of the mammary gland.,29536339_0,-1,1,-1,1,34436,-1,1.7135579e-05,0.99997437,8.488043e-06
28617,Foxp3,9,10,55,60,Quantitative real-time PCR (qRT-PCR) was performed for Foxp3 and cytokines involved in T-reg attraction and T-cell activation.,27117439_3,-1,1,-1,1,28617,-1,2.2473889e-05,0.9999647,1.2859448e-05
29613,the,6,7,46,49,HPV 16-positive tumor cells exclusively carry the HPV 16 oncogenes E6 and E7.,27548034_2,-1,1,-1,1,29613,-1,1.800473e-05,0.9999716,1.0329067e-05
15841,tumor,24,25,123,128,"In addition, we found that the number of tumor-infiltrating Tregs was associated with cirrhosis background (P=0.011) and tumor differentiation (P=0.003), and was an independent prognostic factor for overall survival (HR=2.408, P=0.013) and disease-free survival (HR=2.204, P=0.041).",21935436_5,-1,1,-1,1,15841,-1,2.4971965e-05,0.99996245,1.2598579e-05
25944,there,3,4,8,13,"So far, there is a single connecting report that TGF- also may signal through CEAR.",25832000_3,-1,1,-1,1,25944,-1,2.9126986e-05,0.9999573,1.3594469e-05
43273,STAT1,12,13,77,82,Our data suggests that -arrestin 1 directly interacts with STAT1 to inhibit STAT1 phosphorylation to attenuate IFN- signaling.,35084016_5,-1,1,-1,1,43273,-1,2.2074928e-05,0.99995637,2.1609285e-05
39230,that,11,12,88,92,We investigated whether this tumor development is restricted by surveillance mechanisms that are exerted by IL-15-dependent cells.,32143838_1,-1,1,-1,1,39230,-1,1.8980632e-05,0.9999713,9.752891e-06
10770,tumor,14,15,93,98,"Though TGF-beta inhibition enhances antitumor immunity mediated by CD8(+) T cells in several tumor models, it is not always sufficient for rejection of tumors.",19830696_0,-1,1,-1,1,10770,-1,2.1158143e-05,0.99996877,1.0020205e-05
24658,relation,16,17,93,101,"The tumors became smaller than those in the non-radiated group, with both showing a parallel relation.",25168696_5,-1,1,-1,1,24658,-1,5.972587e-05,0.9998635,7.673095e-05
25363,The,0,1,0,3,"The Ki67 positive rates of CD4(+)T and CD8(+)T cells were 2.13  0.13% and 1.03  1.33%, and they were lower than in the blank group.",25446402_7,-1,1,-1,1,25363,-1,1.8656705e-05,0.9999715,9.870625e-06
38434,TGF-1,26,27,187,193,"BACKGROUND/AIM: We previously demonstrated that inflammatory cytokine interleukin-6 (IL-6) was produced during cancer progression, worked together with transforming growth factor-beta 1 (TGF-1), and induced the epithelial-mesenchymal transition (EMT) with chemo-resistance against gemcitabine (GR) at the invasion front of biliary tract cancers (BTCs).",31853779_0,-1,1,-1,1,38434,-1,3.436366e-05,0.9999448,2.083538e-05
26724,the,3,4,13,16,"In addition, the in vitro-induced CD8(+) Treg cells inhibited nave CD4(+) T-cell proliferation, which was partially mediated through TGF-1 and IFN-.",26166762_9,-1,1,-1,1,26724,-1,1.8850296e-05,0.999972,9.203422e-06
24098,to,14,15,95,97,"CONCLUSIONS: Overall, these data confirm that immunotherapy is a feasible therapeutic approach to recognize and target an aggressive cancer such as PDA.",24987872_8,-1,1,-1,1,24098,-1,2.0224132e-05,0.9999721,7.684454e-06
31890,GATA3,30,31,212,217,"Epithelial E-cadherin ablation activates the -catenin pathway, and we find that increasing -catenin signals in intestinal epithelial cells also boosts Treg cell frequencies through local accumulation of KLRG1+ GATA3+ Treg cells.",28437001_3,-1,1,-1,1,31890,-1,9.429006e-05,0.99983096,7.466957e-05
24293,the,5,6,19,22,"In Spp1(-/-) mice, the inhibition of lung metastases correlated with the expansion of granulocyte-oriented MDSCs.",25035397_6,-1,1,-1,1,24293,-1,1.8394494e-05,0.99997365,7.907564e-06
30837,this,1,2,3,7,"In this study, we report that activated (HLA-DR+) T cells with an effector memory (TEM) profile are enriched in such lesions.",27979840_2,-1,1,-1,1,30837,-1,1.9942592e-05,0.9999695,1.0579075e-05
26366,STAT3,8,9,53,58,"However, the underlying molecular mechanism by which STAT3 in CD8(+) T cells inhibits their accumulation in tumors remains to be defined.",26025380_2,-1,1,-1,1,26366,-1,2.5231007e-05,0.9999616,1.3174434e-05
2295,transfer,1,2,9,17,Adoptive transfer of E7-specific T-cell receptor transgenic CD8+ T cells combined with immunization resulted in induction of antigen-specific interferon gamma-secreting CD8+ T cells and rejection of HPV16 E7-expressing grafts.,15523090_4,-1,1,-1,1,2295,-1,2.5638425e-05,0.99995553,1.8834928e-05
5244,to,4,5,27,29,"In cells proliferating due to exogenous c-myc overexpression, the cell surface phenotype, the pattern of proliferation in single cell suspension, and the immunological characteristics of BL cells could be completely recapitulated.",17419945_3,-1,1,-1,1,5244,-1,3.303984e-05,0.9999573,9.6621225e-06
32278,that,17,18,135,139,"Given these divergent timescales, we addressed how cytokine-responsive cells translate brief cytokine exposure into phenotypic changes that persist over long timescales.",28575659_2,-1,1,-1,1,32278,-1,2.2536078e-05,0.9999672,1.0302538e-05
29943,the,15,16,122,125,"We hypothesize that tumors use epigenetic mechanisms to dysregulate CD1d-mediated antigen presentation, thereby impairing the ability of natural killer T (NKT) cells to recognize and destroy malignant cells.",27614429_2,-1,1,-1,1,29943,-1,1.7954357e-05,0.99997365,8.419268e-06
34923,the,8,9,54,57,Enhanced suppressive activity of Tregs is observed in the microenvironment of MPEs.,29785404_10,-1,1,-1,1,34923,-1,1.9001318e-05,0.9999733,7.732128e-06
23438,turnover,8,9,59,67,CONCLUSIONS: Fas/FasL interactions might lead to excessive turnover of CD8+T cells and reduce anti-tumor immune responses in patients with HCC.,24761872_9,-1,1,-1,1,23438,-1,2.5684538e-05,0.9999567,1.7575738e-05
38883,relocalization,10,11,74,88,These gene-activation events are further linked to clustering and nuclear relocalization of STAT1/2 within IFN-induced promyelocytic leukemia (PML) bodies.,31974171_4,-1,1,-1,1,38883,-1,3.2624524e-05,0.9999505,1.6858206e-05
39379,transcription factor,7,9,45,65,The results confirm the association of Eomes transcription factor with T cell exhaustion but levels of expression and the ratio with T-bet over Eomes did not differ between the patient groups.,32210968_9,-1,1,-1,1,39379,-1,2.2573777e-05,0.9999602,1.7205599e-05
18275,that,11,12,73,77,MDSCs and Tregs play an essential role in the immunosuppressive networks that contribute to tumor-immune evasion.,22891289_0,-1,1,-1,1,18275,-1,2.3657687e-05,0.99996436,1.20371815e-05
28400,The,0,1,0,3,The activity of DNA methyltransferases from CD4(+) T was decreased during this process.,27000869_7,-1,1,-1,1,28400,-1,2.0781961e-05,0.9999707,8.495445e-06
11147,T-regs,13,14,73,79,It has been reported that an increased population of regulatory T cells (T-regs) is one of the reasons for impaired anti-tumor immunity.,20002703_0,-1,1,-1,1,11147,-1,2.7603068e-05,0.99994445,2.7931801e-05
16654,to,4,5,49,51,CD4(+)CD25(-)CD127(low/-)Foxp3(-) T-cells failed to suppress PBMC proliferation and may be exhausted.,22322668_13,-1,1,-1,1,16654,-1,2.8902534e-05,0.99995863,1.24759545e-05
21585,the,4,5,25,28,Here we examined whether the suppression of regulatory T cells (Tregs) within tumors can enhance an antitumor immunity induced by an intratumoral IFN- gene transfer.,24289533_2,-1,1,-1,1,21585,-1,1.7688335e-05,0.99997497,7.3136384e-06
8943,Tregs,2,3,9,14,"However, Tregs also pose a major problem to anti-tumor immunity.",19254475_1,-1,1,-1,1,8943,-1,2.2234679e-05,0.99996686,1.08564145e-05
41874,TBK1-IRF3,9,10,74,83,"Despite priming equivalent antitumor T cell quantities, MDA5-orchestrated TBK1-IRF3 signaling, but not NFB-polarized TLR activation, culminates in polyfunctional and Th1-differentiated antitumor T cell phenotypes.",33767151_4,-1,1,-1,1,41874,-1,8.325328e-05,0.9998087,0.00010809765
16254,together,17,18,95,103,"Dickkopf-1 (DKK1), broadly expressed in myeloma cells but highly restricted in normal tissues, together with its functional roles as an osteoblast formation inhibitor, may be an ideal target for immunotherapy in myeloma.",22049519_0,-1,1,-1,1,16254,-1,5.408472e-05,0.9999294,1.6434298e-05
13244,to,38,39,199,201,"METHODS: Patients underwent a lymphodepleting preparative regimen: fludarabine 25 mg/m(2)  5 doses, cyclophosphamide 60 mg/kg  2 doses, and, in seven patients, 200 cGy total body irradiation (TBI) to increase host immune suppression.",20849361_2,-1,1,-1,1,13244,-1,2.3782393e-05,0.9999641,1.20498125e-05
24413,the,5,6,32,35,CONCLUSIONS: Our study revealed the potential application of APH complex as a novel immunomodulatory agent for vaccines against tumor refractory and growth.,25070035_10,-1,1,-1,1,24413,-1,1.8879133e-05,0.9999738,7.350185e-06
12569,this,1,2,3,7,"In this study, animals with Her2-expressing tumors were vaccinated by co-administration of GP96+ Her2/neu DNA vaccines.",20544406_3,-1,1,-1,1,12569,-1,1.907143e-05,0.99997044,1.0483672e-05
1430,than,27,28,186,190,These data were reproduced in additional experiments and confirmed that tumor irradiation prior to gene therapy resulted in complete tumor regression and specific tumor immunity in more than 50% of the mice.,12804139_6,-1,1,-1,1,1430,-1,2.6419331e-05,0.99995005,2.3547504e-05
28779,FOXP3,11,12,75,80,"Compared to healthy skin, sarcoids showed increased mRNA transcription for FOXP3 and the regulatory cytokine TGF.",27160146_4,-1,1,-1,1,28779,-1,2.4682253e-05,0.9999622,1.3131391e-05
2087,the,10,11,48,51,"Analysis of CD4+ T-helper (Th) immunity against the E2, E6, and E7 antigens of HPV16 in healthy women revealed strong proliferative E2- and E6-specific responses associated with prominent IFN-gamma and interleukin 5 secretion.",15289354_2,-1,1,-1,1,2087,-1,2.2815297e-05,0.9999633,1.3946193e-05
11174,tumors,14,15,67,73,The frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells in tumors was also evaluated by flow cytometry.,20002703_4,-1,1,-1,1,11174,-1,1.918488e-05,0.99997056,1.0287256e-05
38050,to,12,13,60,62,Colorectal cancer (CRC) is a common malignancy that has led to many cancer-related deaths.,31669380_1,-1,1,-1,1,38050,-1,2.8037071e-05,0.9999573,1.4634602e-05
30109,that,6,7,54,58,"Thus, immunosuppression-related signaling, especially that involving immune checkpoint and inflammation, has emerged as novel treatment targets for PAC.",27672267_2,-1,1,-1,1,30109,-1,3.600981e-05,0.9999417,2.2250113e-05
4104,the,2,3,15,18,Coinjection of the anti-IL-2 mAb with a plasmid carrying murine IL-2 cDNA significantly increased the serum IL-2 levels and induced a substantial increase in the division of CD8+ T and NK1.1(high) cells in vivo.,16785526_2,-1,1,-1,1,4104,-1,1.6550111e-05,0.9999745,8.982278e-06
4626,the,9,10,59,62,"However, the mechanisms of immunoregulation, in particular the allorecognition properties of Tregs, their effects on and interaction with other immune cells, and their sites of suppressive activity, are not well understood.",17084366_4,-1,1,-1,1,4626,-1,1.8160874e-05,0.99997294,8.953331e-06
27468,the,4,5,29,32,Recent studies have revealed the role of Treg cells in pathogenesis and progression of multiple malignant tumors.,26464657_2,-1,1,-1,1,27468,-1,1.8075896e-05,0.9999739,8.082584e-06
41527,thymoma,38,39,217,224,"Flow cytometry analysis of Th17 and Tregs in peripheral blood revealed that the percentages of Th17 in thymoma were lower than those in thymoma with MG, while the percentages of Tregs were higher than those in simple thymoma.",33636431_2,-1,1,-1,1,41527,-1,4.191519e-05,0.99992216,3.5913563e-05
21318,the,2,3,13,16,"We evaluated the phosphorylation of signal transducer and activator of transcription 5 (STAT5) in CD4(+) T cells, CD8(+) T cells, and TCR T cells in response to stimulation with IL-7 or IL-2 after HSCT by analyzing blood samples taken monthly 1 to 6 months after HSCT.",24140122_1,-1,1,-1,1,21318,-1,1.547867e-05,0.99997556,8.962572e-06
24967,two,21,22,123,126,"Depending on the cytokines they release and the immune responses they mediate, CD4(+) T cells are classically divided into two major cell populations: Th1 and Th2 cells.",25261206_1,-1,1,-1,1,24967,-1,5.7434292e-05,0.9998938,4.880613e-05
15610,tumor,10,11,63,68,CONCLUSIONS: The prevalence of IL-17-producing FOXP3(+) CD4(+) tumor infiltrating lymphocytes is increased in oral squamous cell carcinoma.,21837700_5,-1,1,-1,1,15610,-1,2.3041699e-05,0.99996614,1.0798798e-05
29042,the,15,16,80,83,"Bhlhe40 is highly expressed in stage 3 thymic iNKT cells and iNKT1 subsets, and the level of Bhlhe40 mRNA expression is correlated with Ifng mRNA expression in the resting state.",27226296_4,-1,1,-1,1,29042,-1,1.9200661e-05,0.9999716,9.128366e-06
14411,T,3,4,26,27,Foxp3(+)CD4(+) regulatory T (Treg) cells inhibit immune responses and temper inflammation.,21357259_0,-1,1,-1,1,14411,-1,2.179897e-05,0.99996126,1.6953092e-05
43499,the,2,3,6,9,"Thus, the stimulation of AP-1-mediated gene expression by IL-1 in EL4 cells is due to the promotion of Jun B protein accumulation that, in turn, facilitates Jun B heterodimerization with TPA-induced Fra-1 protein, thereby forming an active AP-1 complex.",7675040_8,-1,1,-1,1,43499,-1,1.6422764e-05,0.9999759,7.631725e-06
21959,TGF-,47,48,290,295,"Consistently, our in vivo study showed that ectopic expression of uncleavable tmTNF- mutant by 4T1 cells significantly promoted tumor progression and angiogenesis, accompanied with more accumulation of MDSCs and regulatory T cells in the tumor site, increased production of NO, IL-10, and TGF-, as well as poor lymphocyte infiltration.",24379122_5,-1,1,-1,1,21959,-1,3.990796e-05,0.9999391,2.1006907e-05
8613,the,22,23,167,170,"To identify immune cells and molecules associated with effective antitumor immune responses, reverse transcription-PCR arrays were performed using cells isolated from the vaccination site.",19223534_5,-1,1,-1,1,8613,-1,1.8809043e-05,0.9999727,8.460091e-06
1244,to,6,7,38,40,"Using a mammary tumor model syngeneic to BALB/c mice, we have characterized several tumor-derived factors.",12527946_0,-1,1,-1,1,1244,-1,2.456337e-05,0.99996245,1.2999393e-05
36549,the,16,17,92,95,"Immunohistochemistry, FACS analysis, real-time PCR, as well as western blot from samples of the control (CTR), peri-tumoural (PT) and the tumoural (TU) region of the lung derived from patients with NSCLC and 10 controls were performed.",30956278_3,-1,1,-1,1,36549,-1,2.0148656e-05,0.99996674,1.3136775e-05
17090,to,20,21,121,123,"In MM patients, Tregs seem to contribute to myeloma-related immune dysfunction and targeting them could, therefore, help to restore and enhance vital immune responses.",22489248_4,-1,1,-1,1,17090,-1,2.317603e-05,0.9999665,1.027396e-05
9182,This,0,1,0,4,"This response was as effective as a survivin full-length vaccine and was associated with an increased target cell lysis, increased presence of CD8(+) T-cells at the primary tumor site and enhanced production of proinflammatory cytokines by systemic CD8(+) T cells.",19291796_5,-1,1,-1,1,9182,-1,2.0332725e-05,0.99997044,9.238513e-06
3386,thereby,18,19,119,126,"Macrophages from wild-type BALB/c mice are polarized by interleukin-13 (IL-13) towards a tumor-promoting M2 phenotype, thereby inhibiting the generation of tumoricidal M1 macrophages.",16357187_2,-1,1,-1,1,3386,-1,2.0167692e-05,0.9999708,9.088219e-06
21854,FoxP3(+,15,16,66,73,We wanted to identify the role and regulation of CD4(+) CD25(+) FoxP3(+) Treg cells in B-cell acute lymphoblastic leukaemia (B-ALL).,24354800_2,-1,1,-1,1,21854,-1,0.00022505976,0.99948657,0.00028829594
5704,tumor,15,16,109,114,"We also analyzed whether FOXP3 gene expression correlated with other clinicopathological variables like age, tumor stage, histological grade and lymph node metastasis.",17653902_3,-1,1,-1,1,5704,-1,2.4346593e-05,0.99996066,1.498003e-05
27850,The,0,1,0,3,"The number and cell proliferative activity of FCAs, and the incidence and multiplicity of HCC were significantly greater in the IDO-WT than in the IDO-KO mice.",26727596_5,-1,1,-1,1,27850,-1,1.7698634e-05,0.9999715,1.0812695e-05
28019,the,7,8,41,44,"In stomach cancer, the mechanisms behind the accumulation of Tregs in tumor tissue has not been fully elucidated, and neither has Treg gene expression in situ.",26782287_2,-1,1,-1,1,28019,-1,1.9212363e-05,0.9999734,7.428531e-06
23159,that,3,4,24,28,"These findings indicate that EBV-induced IDO expression in MDMs is substantially mediated by IL-6- and TNF--dependent mechanisms via the p38/MAPK and NF-B pathways, suggesting that a possible role of EBV-mediated IDO expression in tumor stroma of NPC may be to create a microenvironment of suppressed T cell immune responses.",24696473_6,-1,1,-1,1,23159,-1,1.777789e-05,0.9999745,7.678584e-06
10009,to,13,14,94,96,"Existing therapies including corticosteroids and allergen immunotherapy act on Tregs, in part to increase IL-10 production, while vitamin D3 and long-acting beta-agonists enhance IL-10 Treg function.",19538496_7,-1,1,-1,1,10009,-1,2.3238366e-05,0.999966,1.0743483e-05
29724,the,26,27,162,165,"Moreover, the serum IL-10 level was significantly decreased, while the serum IL-17 level was significantly increased, resulting in declined IL-10/IL-17 ratio, in the remission group.",27584054_7,-1,1,-1,1,29724,-1,1.8042605e-05,0.9999721,9.879163e-06
7534,The,0,1,0,3,"The likely explanation for this was the NS3/4A-mediated cleavage of mouse IPS-1, albeit less efficiently than human IPS-1.",18689426_9,-1,1,-1,1,7534,-1,2.9379073e-05,0.9999603,1.0278188e-05
42983,treatment,7,8,55,64,CONCLUSIONS: These results suggest that anti-oestrogen treatment of ER+ breast cancer cells can alter cytokine production and immune cells in the area surrounding the cancer cells.,34602068_11,-1,1,-1,1,42983,-1,2.2681577e-05,0.9999645,1.2812978e-05
26738,the,15,16,87,90,"Although regulatory T cells (Tregs) play an integral role in immunologic tolerance and the maintenance of intestinal homeostasis, their involvement in canine gastrointestinal diseases, including idiopathic inflammatory bowel disease (IBD) and intestinal lymphoma, remains unclear.",26173451_0,-1,1,-1,1,26738,-1,1.9641053e-05,0.9999733,7.107598e-06
35416,the,6,7,26,29,Dendritic cells (DCs) are the most potent professional antigen presenting cells and inducers of T cell-mediated immunity.,30068989_0,-1,1,-1,1,35416,-1,2.1787167e-05,0.99996424,1.39401955e-05
27776,the,17,18,110,113,"Taken together, targeting HDAC5 weakens suppressive function and de-novo induction of Tregs, but also reduces the ability of CD8(+) T cells to produce IFN-.",26704363_9,-1,1,-1,1,27776,-1,1.811406e-05,0.99997437,7.539895e-06
35657,to,33,34,237,239,"Eighteen of 21 evaluable patients showed elevated antigen-specific T-cell activity by IFN ELISpot, and persistent cellular responses surpassing 100 spot-forming units (SFUs)/106 peripheral blood mononuclear cells (PBMCs) were noted out to 1 year.",30242022_4,-1,1,-1,1,35657,-1,4.179228e-05,0.9999323,2.5903972e-05
26145,tumor-specific,27,28,143,157,This deficiency is in part due to an incomplete understanding of how to best invoke dendritic cells (DC) that are crucial for the induction of tumor-specific CD8(+) T cells capable of mediating durable protective immunity.,25972487_1,-1,1,-1,1,26145,-1,2.7161152e-05,0.99996233,1.05108575e-05
6598,Foxp3,15,16,95,100,"In this study, we investigated the expression of forkhead/winged helix transcription factor 3 (Foxp3) in melanoma-invaded LNs and determined proportion and functionality of Treg cells among TIL extracted from these 10 metastatic melanoma LNs at different steps of their in vitro expansion.",18312383_2,-1,1,-1,1,6598,-1,1.756522e-05,0.9999714,1.10850615e-05
11344,Foxp3,6,7,15,20,"CD8+, CD4+ and Foxp3+ tumor-infiltrating lymphocytes, tryptase and chymase mast cells (MCs), CD34, number of microvessels and vascular endothelial growth factor were determined by immunohistochemistry.",20053697_2,-1,1,-1,1,11344,-1,3.6006673e-05,0.99994516,1.8868835e-05
21514,tumors,26,27,160,166,"To investigate whether TILs have any impact on the prognosis of angiosarcoma patients, 55 non-treated patients (40 patients at stage 1 with cutaneous localized tumors, 4 patients at stage 2 with lymph node metastases and 11 patients at stage 3 with distant metastases) with angiosarcoma were evaluated retrospectively by immunohistochemistry stained CD4, CD8, FOXP3 and Ki67.",24243586_1,-1,1,-1,1,21514,-1,3.691256e-05,0.9999229,4.02636e-05
27090,these,7,8,49,54,"However, the cytokine background associated with these disorders and whether it differs between ocular adnexal MZLs with (IgG4-associated MZL) and without (IgG4-negative MZL) numerous IgG4(+) plasma cells are unknown.",26311608_1,-1,1,-1,1,27090,-1,2.2858048e-05,0.99996614,1.0990918e-05
16521,the,23,24,172,175,The dysfunction of immune system such as decreased antigen presentation along with increased frequencies of suppressive cells and cytokines might facilitate progression of the disease and infectious complications limiting survival of MM patients.,22223085_6,-1,1,-1,1,16521,-1,2.3253295e-05,0.9999654,1.1354862e-05
25776,TGF-,9,10,51,56,"In addition, elevated level of growth factors like TGF- or EGF in microenvironment is related to the prostate cancer deterioration.",25618241_2,-1,1,-1,1,25776,-1,3.3242733e-05,0.99995005,1.66536e-05
15737,the,18,19,97,100,"Thus, our data indicate that a chronic increase in gut Th17 cell activity can be associated with the development of premalignant lesions of the gastroduodenal region.",21881210_6,-1,1,-1,1,15737,-1,1.7510387e-05,0.9999747,7.727908e-06
22755,to,9,10,64,66,The treatment-related toxicity was predictable and did not seem to be additive with this schedule of administration.,24598448_9,-1,1,-1,1,22755,-1,2.8411687e-05,0.99995995,1.1615184e-05
22096,the,9,10,66,69,Th17/Treg cell-associated cytokines may play an important role in the occurrence and development of cervical cancer.,24401583_8,-1,1,-1,1,22096,-1,2.0247255e-05,0.9999714,8.359117e-06
15254,Foxp3,6,7,41,46,In 16 cases intrahepatic distribution of Foxp3 by immuno-histochemistry was assessed.,21684822_6,-1,1,-1,1,15254,-1,2.0903803e-05,0.9999666,1.2525816e-05
37821,treatment,18,19,101,110,"Smad proteins were detected in the mitochondria of CD4+ T cells, where they were phosphorylated upon treatment with TGF-.",31530731_5,-1,1,-1,1,37821,-1,2.4402152e-05,0.9999627,1.2880337e-05
13217,to,11,12,72,74,caAkt expressing T cells (caAkt-T-cells) were also relatively resistant to suppression by and conversion into regulatory T cells (Tregs).,20842106_4,-1,1,-1,1,13217,-1,2.471304e-05,0.9999633,1.1968465e-05
15203,T,20,21,108,109,"BACKGROUND: The purpose of this study was to investigate the presence of CD4(+) CD25(+) FOXP3(+) regulatory T (Treg) cells both in peripheral blood and local tumors in patients with nasal inverted papilloma (NIP).METHODS: By using flow cytometry, the frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in both peripheral blood and tissues from 18 patients with NIP and 8 control subjects were determined.",21674673_0,-1,1,-1,1,15203,-1,2.1039337e-05,0.9999615,1.7503828e-05
28909,that,3,4,30,34,"Mechanism dissection revealed that infiltrating T cells might function through secreting the cytokine IL1, which increases the recruitment of T cells to bladder cancer and enhances the bladder cancer androgen receptor (AR) signaling that results in increased bladder cancer cell invasion via upregulation of hypoxia-inducible factor-1 (HIF1)/VEGFa expression.",27196763_4,-1,1,-1,1,28909,-1,1.6651493e-05,0.99997425,9.145217e-06
34462,transducer,15,16,105,115,This was associated with decreased phosphorylation of mitogen-activated protein kinase (MAPK) and signal transducer of activation of transcription (STAT) proteins in macrophages from PIP-/- mice.,29536339_5,-1,1,-1,1,34462,-1,2.6352061e-05,0.99995637,1.7266206e-05
33689,tumour-bearing,2,3,17,31,Splenocytes from tumour-bearing mice were co-cultured with tumour cells.,29112686_6,-1,1,-1,1,33689,-1,2.580461e-05,0.999962,1.220418e-05
20798,STAT-5,19,20,108,114,"Moreover, MO-MDSC and PMN-MDSCs diminish IL-2 levels, but only MO-MDSCs affect IL-2R (CD25) expression and STAT-5 signaling.",23878002_3,-1,1,-1,1,20798,-1,4.4379125e-05,0.9999217,3.3949087e-05
31555,Th17,0,1,0,4,Th17 and regulatory T (Treg) cells are integral in maintaining immune homeostasis and Th17-Treg imbalance is associated with inflammatory immunosuppression in cancer.,28290453_0,-1,1,-1,1,31555,-1,3.137878e-05,0.99995077,1.7804445e-05
32191,transcription factors,20,22,97,118,"In addition, HDAC11KO T cells had increased expression of Eomesodermin (Eomes) and TBX21 (Tbet), transcription factors previously shown to regulate inflammatory cytokine and effector molecule production.",28550044_4,-1,1,-1,1,32191,-1,3.074941e-05,0.99994755,2.1738113e-05
7463,the,11,12,68,71,Their frequency was profoundly diminished at the tumor stage and in the CTCL lymph node lesions with or without large cell transformation.,18684941_6,-1,1,-1,1,7463,-1,1.6813176e-05,0.99997187,1.1357708e-05
19069,the,3,4,29,32,"We subsequently investigated the effects of immunotherapy on circulating T(REG) combining an extensive phenotype examination, DNA methylation analysis and global transcriptome analysis.",23118856_1,-1,1,-1,1,19069,-1,1.6238513e-05,0.99997616,7.573708e-06
20341,to,27,28,148,150,"When cytokine ratios were examined, women with the highest ratios of Th1 cytokines to IL-5 levels were least likely to have ER(-) or TNBCs compared to ER(+) or LumA cancers, respectively.",23624818_7,-1,1,-1,1,20341,-1,2.1195357e-05,0.99996746,1.137408e-05
2307,to,25,26,158,160,"CONCLUSIONS: Antigen-specific CD8+ T cells can destroy epithelium expressing HPV16 E7 tumor antigen, but presentation of E7 antigen from skin is insufficient to reactivate memory CD8+ T cells induced by immunotherapy.",15523090_7,-1,1,-1,1,2307,-1,4.6349287e-05,0.99993956,1.41375e-05
39530,the,9,10,48,51,"The aim of the present study was to investigate the role and molecular mechanism of CC motif chemokine ligand11 (CCL11) in the regulation of Treg cells from patients with breast cancer (BC) and healthy individuals invitro, and from tumorbearing mice invivo.",32323817_1,-1,1,-1,1,39530,-1,1.5764928e-05,0.9999765,7.771898e-06
31243,c-Rel,77,78,392,397,"As stem cell factor (SCF) and FLT3 are important agents for hematopoietic stem cell expansion, and cytokines like interleukin (IL)-2, -7, and -15 are essential for T- and B- (and also NK) cell development and proliferation, the current study evaluated c-Rel expression in cord blood mononuclear cells and CD34+cells, as well as effects on B-, T-, and NK cells associated with alterations in c-Rel expression, using flow cytometry and PCR.",28090796_4,-1,1,-1,1,31243,-1,7.710033e-05,0.99985945,6.343776e-05
22523,the,18,19,102,105,"Coculture of CTCL cells with normal T lymphocytes consisting of both CD4(+) and CD8(+) populations or the CD4(+) subset alone, transfected with CD152 mRNA, inhibits proliferation of normal T cells in a CD152- and CD80-dependent manner.",24523507_4,-1,1,-1,1,22523,-1,2.3750532e-05,0.99996245,1.383868e-05
36707,types,18,19,105,110,OBJECTIVES: High levels of circulating interleukin-6 (IL-6) are associated with a poor prognosis in many types of cancer including non-small cell lung cancer (NSCLC).,31027698_0,-1,1,-1,1,36707,-1,5.012713e-05,0.99986684,8.3016384e-05
10799,to,12,13,77,79,"Though the abrogation of CD1d-restricted NKT cells, which have been reported to induce TGF-beta production by MDSC through an IL-13-IL-4R-STAT6 pathway, partially enhanced antitumor immunity regardless of vaccination, abrogation of the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway did not enhance vaccine efficacy.",19830696_6,-1,1,-1,1,10799,-1,2.4949808e-05,0.9999645,1.0579748e-05
36105,Therefore,0,1,0,9,"Therefore, many studies have been devoted to studying the roles of IL-32 in inflammationassociated cancers, including gastric, colon cancer, and hepatocellular carcinoma.",30638183_4,-1,1,-1,1,36105,-1,2.1217933e-05,0.9999659,1.2834361e-05
32775,the,3,4,19,22,"Therefore, without the use of mutations, PEGylation reduces the affinity for IL2R to a greater extent than for IL2R, the receptor complex predominant on CD8 T cells.",28678791_8,-1,1,-1,1,32775,-1,2.4052199e-05,0.99996686,9.048531e-06
34605,the,13,14,87,90,The fact that Tr1 cells could suppress inflammation and produce cytotoxic molecules at the same time has made them attractive potential candidates for future immunotherapies.,29625086_8,-1,1,-1,1,34605,-1,3.7619273e-05,0.9999428,1.9578962e-05
14233,The,0,1,0,3,The goal of this study is to examine the relationship between melanoma SLN tumor burden and the degree of SLN immune dysfunction as a model to study tumor-induced immune dysfunction.,21327637_2,-1,1,-1,1,14233,-1,1.916358e-05,0.9999727,8.116747e-06
27779,T,2,3,12,13,OBJECTIVES: T regulatory cells (Tregs) play a critical important role for the occurrence and development of human tumors.,26724144_0,-1,1,-1,1,27779,-1,2.7945074e-05,0.9999465,2.556902e-05
7477,This,2,3,8,12,METHOD: This study included 136 breast cancer patients operated in our department from 2003 to 2006.,18685848_1,-1,1,-1,1,7477,-1,2.1543785e-05,0.9999658,1.2670107e-05
7226,the,2,3,9,12,"However, the hybrids most inhibited the subcutaneous tumor growth in SCID mice compared with dendritic cells pulsed with other loading methods.",18563501_5,-1,1,-1,1,7226,-1,1.6764081e-05,0.99997246,1.0823807e-05
20084,therapeutic,35,36,267,278,"These findings suggest that IgG4 promoted by tumor-induced Th2-biased inflammation may restrict effector cell functions against tumors, providing a previously unexplored aspect of tumor-induced immune escape and a basis for biomarker development and patient-specific therapeutic approaches.",23454746_11,-1,1,-1,1,20084,-1,2.4937744e-05,0.99996257,1.2477336e-05
29706,the,33,34,202,205,"Serum levels of IL-10 and IL-17 were determined with ELISA, and expression of Foxp3 and RORt was assessed with quantitative real-time PCR.RESULTS: Treg and Th17 cell proportions in peripheral blood in the CLL patients were significantly higher than control.",27584054_2,-1,1,-1,1,29706,-1,1.7743681e-05,0.9999702,1.2073121e-05
40759,Egr2,1,2,8,12,Whether Egr2 and Egr3 directly regulate TGF-1 transcription in NK1.1- CD4+ NKG2D+ T cells remains elusive.,33011290_2,-1,1,-1,1,40759,-1,4.15137e-05,0.99992657,3.1885833e-05
12068,the,18,19,125,128,Our data suggest that approaches combining DC-mediated immunotherapy and depletion of Treg cells may be necessary to enhance the ability of vaccination therapy to elicit effective antitumor responses in cancer patients.,20386464_8,-1,1,-1,1,12068,-1,1.8828005e-05,0.99997413,7.0467454e-06
27799,the,24,25,167,170,"In addition, the change of Treg immunosuppressive cytokine interleukin (IL)-10 was examined with IHC and real-time PCR.RESULTS: increased FoxP3+Tregs were observed in the adenomatous stroma/epithelium and the density in colorectal adenomas, which was similar to that in the CRCs, significantly increased as compared to normal tissues.",26724144_3,-1,1,-1,1,27799,-1,1.622882e-05,0.99997413,9.651896e-06
15251,T-reg,6,7,34,39,Surface and intracellular (Foxp3) T-reg markers were evaluated by flow cytometry.,21684822_4,-1,1,-1,1,15251,-1,3.1447944e-05,0.9999199,4.8687416e-05
29209,therapeutic,7,8,40,51,We then investigated whether IL18 had a therapeutic effect for pancreatic cancer in vitro and in vivo and any underlying mechanisms.,27297583_2,-1,1,-1,1,29209,-1,2.1434e-05,0.9999676,1.0976961e-05
309,Stat5a,37,38,201,207,"Disruption of constitutive Jak3/Stat5 activation by AG-490 was demonstrated by inhibition of 1) tyrosine phosphorylation of Jak3, Stat5a (Tyr(694)), and Stat5b (Tyr(699)); 2) serine phosphorylation of Stat5a (Ser(726)) as determined by a novel phosphospecific Ab; and 3) Stat5a/b DNA binding to the Stat5-responsive beta-casein promoter.",11046040_5,-1,1,-1,1,309,-1,5.5103148e-05,0.9998944,5.056424e-05
33049,Tregs,12,13,67,72,"Here, we found that patients with GC showed a significantly higher Tregs infiltration in tumors, and CD45RA-CCR7- Treg subset constituted most tumor-infiltrating Tregs.",28817117_2,-1,1,-1,1,33049,-1,2.2788272e-05,0.9999635,1.3744758e-05
40148,therapeutic,29,30,185,196,"However, a major challenge in cancer immunotherapies remains the heterogeneity of the immunoregulatory capacities of cancers, and not all patients of a given cancer responds to current therapeutic strategies.",32573300_1,-1,1,-1,1,40148,-1,2.226888e-05,0.99996555,1.2129384e-05
42546,play,28,29,150,154,We suggested that the higher frequency of CD33+ pSTAT3+ MDSC and IL-17+ lymphocyte and the more frequent expression of IL-10 mRNA in PCa patients may play roles in tumor progression from BPH to PCa.,34184811_5,-1,1,-1,1,42546,-1,3.324633e-05,0.99995255,1.4164026e-05
10471,the,7,8,41,44,"However, more cells expressed FOXP3 when the supernatant of human epithelial ovarian carcinoma cell culture was added, yet not the supernatant of normal human ovarian surface epithelia cell culture.",19673890_5,-1,1,-1,1,10471,-1,2.2449372e-05,0.9999671,1.0472614e-05
1071,natural,7,8,43,50,"When expressed on cytotoxic T lymphocytes, natural killer cells, monocytes, and dendritic cells, they induce the apoptosis of many tumor cells, whereas their expression on tumor cells induces the apoptosis of killer cells.",11924906_5,-1,1,-1,1,1071,-1,9.090883e-05,0.99987805,3.105718e-05
14860,the,2,3,13,16,"Furthermore, the higher TGF-1 level correlated with the increased population of CD4(+)Foxp3(+) Tregs in advanced gastric cancer (r = 0.576, P < 0.05).",21528082_9,-1,1,-1,1,14860,-1,1.5669357e-05,0.9999745,9.78262e-06
39759,to,25,26,136,138,"After stratification of CRC patients, we found a significant difference in FoxP3, IL-10, IL-23, and IL-17A mRNA in early cases compared to IBD, and IL-23 alone in advanced CRC.",32390702_4,-1,1,-1,1,39759,-1,2.238431e-05,0.99996674,1.0885628e-05
13649,to,17,18,112,114,Marked induction of CXCR1 expression on Foxp3(+) CD4 Tregs by IL-6 followed by IL-8-mediated migration appeared to be responsible for enriched migration.,21048114_2,-1,1,-1,1,13649,-1,2.4724503e-05,0.9999635,1.1758107e-05
4902,that,2,3,9,13,We found that a cross-reactive FoxP3 antibody identified a subset of CD4(+) T cells in blood and lymph nodes of dogs.,17224188_5,-1,1,-1,1,4902,-1,1.8054092e-05,0.9999733,8.63709e-06
25169,that,9,10,49,53,"Using the C1498 AML mouse model, we demonstrated that leukemia development was associated with thymus atrophy, which was defined by abnormal organ weight and reduced cellularity.",25382729_2,-1,1,-1,1,25169,-1,1.7508788e-05,0.999974,8.445455e-06
30717,to,14,15,125,127,Further investigations are warranted to understand the exact mechanisms responsible for smoking-mediated immunopathology and to answer lingering questions over why cigarette smoking is always harmful rather than beneficial even though it exerts dual effects on immune responses.,27902485_7,-1,1,-1,1,30717,-1,2.0895915e-05,0.9999697,9.372239e-06
13232,to,8,9,58,60,"In conclusion, caAkt-transduced T cells showed resistance to several evasion strategies employed by tumors and may therefore enhance the antitumor activity of adoptively transferred T lymphocytes.",20842106_6,-1,1,-1,1,13232,-1,2.6555983e-05,0.9999621,1.1377567e-05
25451,to,7,8,49,51,The antigenic variability of tumor cells leading to dynamic changes in cancer epitope landscape along with escape from immune surveillance by down-regulating tumor antigen expression/presentation and immune tolerance are major obstacles for the design of effective vaccines.,25483665_0,-1,1,-1,1,25451,-1,1.9819294e-05,0.9999713,8.879449e-06
36807,FOXA1,15,16,92,97,"DISCUSSION: Collectively, our study is the first to investigate the suppressive function of FOXA1+ Tregs against T cells in lung cancer, and the results showed that FOXA1+ Tregs are markers of poor treatment responses in lung cancer patients.",31036318_14,-1,1,-1,1,36807,-1,4.3566502e-05,0.99990034,5.610724e-05
32820,gene,15,16,127,131,"PIM inhibition decreased cap-dependent protein translation, blocked JAK-STAT signaling, and markedly attenuated NFB-dependent gene expression.",28698206_6,-1,1,-1,1,32820,-1,5.1321367e-05,0.9999007,4.7959653e-05
31212,that,11,12,54,58,"In addition, c-Rel is a key regulator of apoptosis in that it influences the expression of anti-apoptotic genes such as Bcl-2 and Bcl-xL; conversely, inhibition of c-Rel increases cell apoptosis.",28090796_1,-1,1,-1,1,31212,-1,2.6101337e-05,0.9999571,1.6767211e-05
7853,tumor,14,15,65,70,"In mice gavaged with BaP + PC61, the number of tumor nodules and tumor volume decreased significantly with massive infiltrating cells and apoptosis of tumor cells.",18855977_9,-1,1,-1,1,7853,-1,2.1043854e-05,0.9999683,1.07189035e-05
17157,that,6,7,30,34,"In this study, we demonstrate that OX40 expression is regulated through a TCR and common gamma chain cytokine-dependent signaling cascade that requires JAK3-mediated activation of the downstream transcription factors STAT3 and STAT5.",22496812_4,-1,1,-1,1,17157,-1,1.5521522e-05,0.99997544,9.030505e-06
27371,their,15,16,104,109,"Collectively, these data indicate superior activation of Tregs in the tumor microenvironment, promoting their suppressive ability and selective proliferation at this site.",26433463_6,-1,1,-1,1,27371,-1,2.1899796e-05,0.99996674,1.1389289e-05
18193,to,14,15,101,103,"Serum levels of granulocyte colony-stimulating factor and interleukin-6, which both have been linked to MDSC induction, correlated positively with the frequency of CD14(+)HLA-DR(low/neg) cells.",22828446_7,-1,1,-1,1,18193,-1,4.062577e-05,0.9999379,2.1466052e-05
27334,These,0,1,0,5,These results suggest that GITR signaling has stimulatory effects on effector T cells and inhibitory effects through Treg cells.,26423152_10,-1,1,-1,1,27334,-1,1.9646479e-05,0.99997115,9.180369e-06
20343,to,11,12,68,70,"The strongest associations were in premenopausal women, who were up to 80 % less likely to have TNBC than LumA cancers (IL-12p40/IL-5, OR = 0.19, 95 % CI 0.07-0.56).",23624818_8,-1,1,-1,1,20343,-1,3.304022e-05,0.99995077,1.6195741e-05
18857,the,1,2,6,9,"While the diverse population of IL-17-producing T cells share many common characteristics, notable differences also exist.",23052209_3,-1,1,-1,1,18857,-1,2.021072e-05,0.99996877,1.1067509e-05
29687,the,7,8,40,43,OBJECTIVE: This study is to investigate the association between the Treg/Th17 cells and prognosis of chronic lymphocytic leukemia (CLL).METHODS: Totally 50 CLL patients and 20 Health controls were included in this study.,27584054_0,-1,1,-1,1,29687,-1,1.6616115e-05,0.99997604,7.3503425e-06
11137,the,30,31,206,209,"Real-time PCR analysis revealed that combination therapy led to an increase in IFN-gamma and tumor necrosis factor-alpha mRNA expression; however, levels of Foxp3 and transforming growth factor-beta within the remote tumor tissues were decreased.",19940990_6,-1,1,-1,1,11137,-1,1.51087515e-05,0.9999757,9.232025e-06
6557,the,9,10,51,54,ICOShigh Treg induce Tr1 or Th2 cells depending on the activation state of RC.,18292519_10,-1,1,-1,1,6557,-1,2.1886359e-05,0.9999691,9.026333e-06
31359,therapies,10,11,65,74,These findings will pave a way to developing novel combinatorial therapies with PD-1 blockade.,28096382_5,-1,1,-1,1,31359,-1,2.4656973e-05,0.99996364,1.1754766e-05
23489,Tregs,6,7,47,52,"Importantly, the frequency of CD45RA-Foxp3high Tregs positively correlate with tumor stage (P <0.0001) and nodal status (P <0.0001).CONCLUSIONS: CD45RA-Foxp3high Tregs increase in the peripheral circulation of HNSCC patients, and correlate with tumor stage and nodal status; suggesting a role in tumor progression which may be manipulated by future immunotherapy.",24761979_8,-1,1,-1,1,23489,-1,2.1385484e-05,0.9999608,1.785344e-05
3178,gene-3,28,29,181,187,"CD62L(high)CD4(+)CD25(+) Treg and CD62L(low)CD4(+)CD25(+) T cells, which possess effector T cell functions, had comparable expression of LFA-1, VLA-4, CTLA-4, lymphocyte activation gene-3, and glucocorticoid-induced TNFR.",16210609_6,-1,1,-1,1,3178,-1,0.00032247914,0.9992855,0.00039203046
26343,relationship,3,4,25,37,"A significantly negative relationship was found between Th cells (Th22, Th17, or Th1) and BCR-ABL (%) IS or the number of PB white blood cells.",26000313_8,-1,1,-1,1,26343,-1,3.880617e-05,0.99990904,5.214556e-05
20235,These,0,1,0,5,These findings suggest that the induction of immunosuppressive and immunomodulatory cells differs between KA and SCC.,23572151_9,-1,1,-1,1,20235,-1,1.9322206e-05,0.9999715,9.160021e-06
23162,the,18,19,134,137,"These findings indicate that EBV-induced IDO expression in MDMs is substantially mediated by IL-6- and TNF--dependent mechanisms via the p38/MAPK and NF-B pathways, suggesting that a possible role of EBV-mediated IDO expression in tumor stroma of NPC may be to create a microenvironment of suppressed T cell immune responses.",24696473_6,-1,1,-1,1,23162,-1,1.8513823e-05,0.9999721,9.413341e-06
15756,this,14,15,92,96,"Neutralizing IL-9 significantly inhibited tumor growth in the lymphoma model of murine, and this process was associated with down-regulation of Treg cells and MCs.",21898141_3,-1,1,-1,1,15756,-1,1.9487698e-05,0.9999702,1.0317848e-05
15771,targeting,7,8,29,38,"In vivo dendritic cells (DC) targeting is an attractive approach with potential advantages in vaccine efficacy, cost, and availability.",21934655_0,-1,1,-1,1,15771,-1,2.442557e-05,0.99996245,1.3079352e-05
41074,The,0,1,0,3,The results of the transplanted tumor model in mice showed that the tumor volume of the transplanted mice in the solanine group and the TGF inhibitor mice was reduced compared with the control group.,33204731_6,-1,1,-1,1,41074,-1,1.9276895e-05,0.99996984,1.0824564e-05
35982,Treg,3,4,27,31,Prevention of intratumoral Treg accumulation by inhibition of their migration to the tumor microenvironment is a promising therapeutic strategy.,30572845_1,-1,1,-1,1,35982,-1,2.8420749e-05,0.9999546,1.7042816e-05
25198,the,20,21,121,124,"Although cell death in these situations is considered sterile, various reports have implicated type I IFNs as drivers of the ensuing adaptive immune response to cell-associated Ags.",25385820_1,-1,1,-1,1,25198,-1,2.0231608e-05,0.9999707,9.133478e-06
27279,tumor,14,15,108,113,Adoptive transfer of Nr2f6-deficient T cells into tumor-bearing immunocompetent mice is sufficient to delay tumor outgrowth.,26387951_5,-1,1,-1,1,27279,-1,1.966199e-05,0.9999707,9.628686e-06
20117,the,28,29,168,171,"Our results suggest that IL-33 stimulated NF-B signaling and promoted the proliferation, activation and infiltration of CD8(+) T cells and NK cells, which resulted in the inhibition of pulmonary metastasis in B16 melanoma and LLC mice models.",23499895_6,-1,1,-1,1,20117,-1,1.8439665e-05,0.9999716,9.911196e-06
26361,to,4,5,21,23,"STAT3 has been shown to suppress CD8(+) T-cell antitumor functions in various cancer models, in part by restricting accumulation of CD8(+) T cells.",26025380_1,-1,1,-1,1,26361,-1,2.0011008e-05,0.99997056,9.38407e-06
32746,pleiotropic,21,22,129,140,Cytokines are potent immune modulating agents but are not ideal medicines in their natural form due to their short half-life and pleiotropic systemic effects.,28678791_0,-1,1,-1,1,32746,-1,0.00010208018,0.9998566,4.127304e-05
40901,targeting,18,19,121,130,"We discuss the importance of Th17 plasticity in autoimmunity and cancer and present current strategies and challenges in targeting pathogenic Th17 cells with cytokine-based approaches, considering human genetic variants associated with altered Th17 differentiation.",33064842_8,-1,1,-1,1,40901,-1,2.143378e-05,0.9999678,1.0730599e-05
25417,to,2,3,12,14,"In addition to conventional CD25FoxP3 Tregs, we identified a subset of CD25FoxP3 T cells that comprised up to 13% of CD4 TIL.",25480168_5,-1,1,-1,1,25417,-1,2.1931999e-05,0.9999676,1.0452125e-05
39552,the,5,6,26,29,The serum CCL11 level and the proportion of CD4+CD25+Foxp3+ Treg cells were significantly increased in patients with BC compared with healthy individuals.,32323817_5,-1,1,-1,1,39552,-1,1.8067065e-05,0.9999726,9.34287e-06
8036,trials,26,27,172,178,Lenalidomide (Revlimid; CC-5013) and pomalidomide (CC-4047) are IMiDs proprietary drugs having immunomodulatory properties that have both shown activity in cancer clinical trials; lenalidomide is approved in the United States for a subset of MDS patients and for treatment of patients with multiple myeloma when used in combination with dexamethasone.,19009291_0,-1,1,-1,1,8036,-1,3.3648696e-05,0.9999479,1.8497527e-05
16161,that,7,8,35,39,"Based on these results, we propose that loss of PML protein expression in gastric cancer cells contributes to increased IP-10 transcription via enhancement of STAT-1 activity, which, in turn, promotes lymphocyte trafficking within tumor regions.",22022583_9,-1,1,-1,1,16161,-1,1.8218028e-05,0.9999738,8.038781e-06
24879,TH-2,25,26,175,179,"Most interestingly, our results suggest that the nuclear factor-kappa B signaling pathway might be involved in the impairment of immunological responsiveness and the observed TH-2 deviation.",25242680_4,-1,1,-1,1,24879,-1,2.9917117e-05,0.9999515,1.8543638e-05
38009,nanogel,23,24,138,145,"Benefiting from those cases, the B16F10 tumor inhibition rate achieved 42.5% by this oral DNA vaccine, suggesting that this multi-faceted nanogel prepared by simple blending-by-blending method may provide a new strategy for oral DNA vaccine delivery.",31655203_5,-1,1,-1,1,38009,-1,6.269185e-05,0.99988484,5.2501175e-05
4766,the,5,6,39,42,"We demonstrated that immunization with the fusion protein vaccine caused significant inhibition of tumor growth with the delay time to tumor detection (tests vs. controls, 16 d vs. 9 d, p<0.01) and much smaller tumor size (p<0.01) in vivo.",17202676_4,-1,1,-1,1,4766,-1,1.6871973e-05,0.9999752,7.889761e-06
23766,to,9,10,70,72,"FL-infiltrating T-cell populations that are thought to be fundamental to FL biology are follicular helper T-cells (TFH), follicular regulatory T-cells (TFR), a recently described population that regulates TFH activity, and regulatory T-cells (Treg).",24836297_1,-1,1,-1,1,23766,-1,3.6099624e-05,0.9999455,1.831863e-05
19376,tumors,28,29,151,157,BACKGROUND: Cancer stem cells (CSCs) are proposed to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors.,23180012_0,-1,1,-1,1,19376,-1,2.3791292e-05,0.99996245,1.3801972e-05
20434,This,0,1,0,4,This study addresses the hypothesis that blocking RA receptor alpha (RAR) may enhance the efficacy of a tumour vaccine by inhibiting the induction of Treg cells.,23657628_4,-1,1,-1,1,20434,-1,2.0171807e-05,0.9999707,9.111206e-06
24144,that,6,7,24,28,"In this study, we found that blocking the STAT3 pathway in HCC cells dramatically inhibited murine HCC growth in vivo and prolonged survival of tumor-bearing mice.",25015826_2,-1,1,-1,1,24144,-1,1.7759017e-05,0.9999738,8.4645635e-06
37376,therapeutic,21,22,123,134,"Thus, in this proof-of-principle study, we highlight the antitumor effect of CRM aerosol delivery as a new and noninvasive therapeutic approach to locally modulate immunosurveillance at the tumor site in the lung.",31321243_5,-1,1,-1,1,37376,-1,2.3068947e-05,0.9999654,1.15436005e-05
31448,the,22,23,148,151,Immunotherapy is being increasingly recognized as a key therapeutic modality to treat cancer and represents one of the most exciting treatments for the disease.,28258697_0,-1,1,-1,1,31448,-1,2.2347604e-05,0.9999678,9.874863e-06
17106,to,15,16,89,91,A detailed analysis of the balance between Tregs and Th17 cells seems necessary in order to design more effective and less toxic modes of immunotherapy myeloma which still is an uncurable malignancy.,22489248_7,-1,1,-1,1,17106,-1,1.9855273e-05,0.99997115,9.033361e-06
41061,tumor,8,9,41,46,"Tumor volume of each group was recorded, tumor inhibition rate was calculated, and tumor metastasis was counted.",33204731_3,-1,1,-1,1,41061,-1,2.3137653e-05,0.9999629,1.3887869e-05
14673,than,14,15,78,82,"Development of ex-Tregs was more efficient in the mesenteric lymph node (mLN) than peripheral lymph node environment, correlating with a much greater level of IL-6 mRNA in mLN.",21389255_5,-1,1,-1,1,14673,-1,2.2140748e-05,0.9999629,1.4989439e-05
5447,IRF7,61,62,312,316,"Our results demonstrated the following: (1) CD4+ CD25+ Foxp3+ surround epithelial tumor aggregates; (2) Immature dendritic cells (DCs) were abundant in the tumor microenvironment; (3) BCC showed increased expression of IL-4, IL-10, and CCL22 and increased expression of interferon-associated genes (IFI27, IRF1, IRF7, and G1P2) and IL-12/23, gene indicating a Th2 dominant microenvironment.",17508019_2,-1,1,-1,1,5447,-1,4.480539e-05,0.99990416,5.1035437e-05
2095,to,11,12,66,68,"Of all HPV16+ cervical cancer patients, approximately half failed to mount a detectable immune response against the HPV16-derived peptides.",15289354_4,-1,1,-1,1,2095,-1,2.0893089e-05,0.99996793,1.1148741e-05
30538,the,29,30,213,216,"Finally, IL-6 and PD-L1 blockade increased overall survival in KPC-Brca2 mice compared with isotype controls (p=0.0012).CONCLUSIONS: These preclinical results indicate that targeted inhibition of IL-6 may enhance the efficacy of anti-PD-L1 in PDAC.",27797936_10,-1,1,-1,1,30538,-1,1.7579194e-05,0.9999751,7.38451e-06
16270,to,27,28,158,160,"We used DKK1-DNA vaccine in the murine MOPC-21 myeloma model, and the results clearly showed that active vaccination using the DKK1 vaccine not only was able to protect mice from developing myeloma, but it was also therapeutic against established myeloma.",22049519_3,-1,1,-1,1,16270,-1,2.1207083e-05,0.9999703,8.500321e-06
4897,FoxP3,7,8,49,54,"Therefore, we investigated whether expression of FoxP3, a transcription factor that is highly expressed in Tregs in humans and rodents could also be used to identify Tregs in dogs.",17224188_4,-1,1,-1,1,4897,-1,1.6249474e-05,0.9999738,1.00012385e-05
12181,TAAs,24,25,142,146,We herein tested whether these effects can translate into effective cancer immunotherapy when SA-4-1BBL was also used as a vehicle to deliver TAAs in vivo to dendritic cells (DCs) constitutively expressing the 4-1BB receptor.,20406989_3,-1,1,-1,1,12181,-1,2.7035774e-05,0.9999552,1.7760633e-05
40500,To,2,3,12,14,"OBJECTIVES: To investigate the effects of DHA on the proliferation and migration of melanoma in vivo and in vitro, and to explore its possible mechanism.",32859456_3,-1,1,-1,1,40500,-1,1.7675638e-05,0.9999732,9.1759575e-06
6385,the,20,21,146,149,The vaccine-induced responses were dominated by effector type CD4(+)CD25(+)Foxp3(-) type 1 cytokine IFN gamma-producing T cells but also included the expansion of T cells with a CD4(+)CD25(+)Foxp3(+) phenotype.,18172269_4,-1,1,-1,1,6385,-1,1.9950376e-05,0.99997056,9.503637e-06
4319,the,13,14,93,96,CCL-51 breast cancer nodules suppressed the growth of uninjected metastatic tumor nodules in the lung.,16928818_9,-1,1,-1,1,4319,-1,2.2544304e-05,0.99996495,1.24532335e-05
43407,tumors,20,21,144,150,"Overcoming vascular immunosuppression: lack of endothelial cell (EC) responsiveness to inflammatory stimuli in the proangiogenic environment of tumors, is essential for successful cancer immunotherapy.",36403190_0,-1,1,-1,1,43407,-1,2.202629e-05,0.9999689,9.128481e-06
22907,Tregs,12,13,93,98,"In hepatocellular carcinoma patients, here, we identified tumor-infiltrating human CD4CD69 Tregs which represent ~67.2 % of tumor-infiltrating CD4 T cells that is significantly higher than conventional CD4CD25Foxp3 Tregs.",24668348_3,-1,1,-1,1,22907,-1,1.9801726e-05,0.9999666,1.3550936e-05
34670,the,19,20,117,120,"Following treatment with IFN-, both CIC enriched and non-enriched TC-1 cells expressed similar levels of MHC-I, and the increased MHC-I expression on CICs resulted in greater CTL-mediated tumor lysis and improved tumor-free survival in mice.",29699516_10,-1,1,-1,1,34670,-1,1.7453633e-05,0.99997365,8.8828065e-06
43631,to,32,33,206,208,The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.,8662928_0,-1,1,-1,1,43631,-1,3.0451423e-05,0.999959,1.0507293e-05
34180,Treg,7,8,52,56,Our unpublished data indicated that the circulating Treg proportion might be related to the serum CA125 level.,29337110_4,-1,1,-1,1,34180,-1,4.038395e-05,0.9998815,7.814655e-05
14760,to,8,9,47,49,The first is the ability of IDO-expressing DCs to drive the differentiation of naive CD4(+) T cells toward a Foxp3+ (inducible Treg) phenotype.,21517755_4,-1,1,-1,1,14760,-1,1.7864108e-05,0.9999727,9.417261e-06
38577,Gene,22,23,156,160,"Runt-related transcription factor 3 (RUNX3)-associated immune pathways were investigated by the Kyoto Encyclopedia of Genes and Genomes, Gene Ontology, and Gene set enrichment analysis.",31898342_4,-1,1,-1,1,38577,-1,9.264481e-05,0.999833,7.431055e-05
38034,the,11,12,72,75,Inducible Treg ablation prolonged the survival of AML mice by promoting the antileukemic effects of CD8+ T cells.,31669202_5,-1,1,-1,1,38034,-1,1.743192e-05,0.99997437,8.159959e-06
27106,the,2,3,13,16,"Furthermore, the presence of a different inflammatory background in IgG4-negative MZLs suggests that IgG4-associated MZLs may have a different pathogenesis.",26311608_5,-1,1,-1,1,27106,-1,1.800931e-05,0.99997413,7.886623e-06
25743,this,1,2,3,7,"In this study, we aimed to investigate whether and how 14-3-3 is implicated in tumor inflammation modulation and immune recognition evasion.",25556369_2,-1,1,-1,1,25743,-1,1.8870878e-05,0.9999713,9.882801e-06
3258,to,7,8,54,56,Administration of Denileukin Diftitox does not appear to eliminate regulatory T lymphocytes or cause regression of metastatic melanoma.,16224276_8,-1,1,-1,1,3258,-1,2.6253629e-05,0.9999621,1.1658535e-05
4296,the,2,3,13,16,injection of the AdCDIRESE1A vector-directed chemotherapy on the immune response induced by i.t.,16928818_4,-1,1,-1,1,4296,-1,2.022221e-05,0.9999696,1.0191452e-05
42222,the,8,9,70,73,"However, tumstatin-treated U87MG cells showed significantly inhibited the effects of IL-17 overexpression.",33971545_11,-1,1,-1,1,42222,-1,1.9116267e-05,0.9999715,9.407896e-06
8311,the,1,2,3,6,"On the other hand, in cysts the Th2 activity is augmented.",19121066_9,-1,1,-1,1,8311,-1,3.923851e-05,0.99994206,1.8698138e-05
7275,to,18,19,122,124,These findings demonstrate that peptide inhibitors of TGF-beta may be a valuable tool to enhance vaccination efficacy and to break tolerance against pathogens or tumor Ags.,18566377_9,-1,1,-1,1,7275,-1,2.2695613e-05,0.9999689,8.428579e-06
26403,to,2,3,9,11,"In order to understand how tumor cells can escape immune surveillance mechanisms and thus develop antitumor therapies, it is critically important to investigate the mechanisms by which the immune system interacts with the tumor microenvironment.",26047948_0,-1,1,-1,1,26403,-1,1.8388744e-05,0.99997294,8.6598175e-06
21097,The,0,1,0,3,"The group with high FoxP3+ cells showed poor overall survival (OS, P < 0.001) and disease-free survival (DFS, P < 0.001), and high infiltration of IL-17-producing cells was also a predictor of poor OS (P = 0.024).",24007242_6,-1,1,-1,1,21097,-1,1.917488e-05,0.99997187,8.953192e-06
1710,the,10,11,44,47,"Despite the presence of these CD8+ T cells, the disease state persisted; therefore, a role for HPV-specific cytotoxic T cells (CTLs) in VIN resolution remains unproven.",14751153_11,-1,1,-1,1,1710,-1,1.9914973e-05,0.9999721,8.011475e-06
40096,the,13,14,84,87,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,1,-1,1,40096,-1,2.039263e-05,0.9999683,1.1308911e-05
37765,the,12,13,87,90,The OVA-specific IFN--producing CD8 T-cells were induced by administration of OVA and the anti-TLR4 mAb.,31515801_7,-1,1,-1,1,37765,-1,2.4142333e-05,0.9999641,1.1710151e-05
3995,the,14,15,68,71,"The efficacy of induction of Treg's by DCs depends on the nature of the DC maturation stimulus, with inflammatory cytokine-treated DCs (Cyt-DCs) being the most effective Treg inducers.",16763205_6,-1,1,-1,1,3995,-1,2.987335e-05,0.999959,1.11676145e-05
34325,released,4,5,31,39,IL33 is therefore continuously released during homeostatic turnover of the intestinal mucosa.,29463593_2,-1,1,-1,1,34325,-1,4.6800185e-05,0.99993527,1.7890648e-05
25443,T-helper,18,19,104,112,"In contrast, the more abundant CD25FoxP3 subset of CD4 TIL expressed low levels of PD-1 and produced T-helper 1 cytokines, yet conferred no prognostic benefit.",25480168_9,-1,1,-1,1,25443,-1,0.00031964196,0.99752766,0.0021527237
2448,STAT6-deficient,12,13,65,80,"After removal of primary tumor, MSC levels revert to baseline in STAT6-deficient mice, but remain elevated in BALB/c mice.",15634881_2,-1,1,-1,1,2448,-1,5.5564196e-05,0.9998915,5.2904263e-05
25415,TIL,6,7,37,40,"CD25 was expressed primarily by CD4 TIL, with negligible expression by CD8 TIL.",25480168_4,-1,1,-1,1,25415,-1,3.082318e-05,0.9999559,1.3317431e-05
20986,the,14,15,76,79,"Here, we investigated the effect of triptolide on regulatory T cells and on the level of IL-10, transforming growth factor-, and vascular endothelial growth factor in tumor-bearing mice.",23975869_2,-1,1,-1,1,20986,-1,1.6539507e-05,0.9999745,8.9309415e-06
24472,that,3,4,12,16,It is known that ganoderic acid Me can enhance IFN- expression and IDO is preferentially induced by IFN-.,25138378_1,-1,1,-1,1,24472,-1,2.0672796e-05,0.99997115,8.199062e-06
23041,the,26,27,177,180,MDPF also significantly promoted the production of IFN- and up-regulated the mRNA expression levels of IFN- and Th1 transcription factors T-bet and STAT-4 in splenocytes from the S180-bearing mice.,24690776_7,-1,1,-1,1,23041,-1,1.7450466e-05,0.99997246,1.0075245e-05
41899,TGF,17,18,85,89,"In this study, we examined five cancer immunity-related pathways (IFN, IFN, STAT3, TGF and TNF) in four large independent breast cancer cohorts (n = 6,381) and their associations with the prognosis of breast cancer subtypes.",33767579_2,-1,1,-1,1,41899,-1,3.4039665e-05,0.9999511,1.4850023e-05
28259,this,7,8,35,39,The role of the immune response in this phenomenon is yet unclear.,26899388_1,-1,1,-1,1,28259,-1,3.0098223e-05,0.9999596,1.0325554e-05
12196,the,3,4,24,27,Therapeutic efficacy of the vaccines was associated with increased CD4(+) T and CD8(+) T-cell effector and memory responses and higher intratumoral CD8(+) T effector/CD4(+)CD25(+)Foxp3(+) T regulatory cell ratio.,20406989_6,-1,1,-1,1,12196,-1,2.0497522e-05,0.9999709,8.556266e-06
41806,T,10,11,61,62,Killing activity of anti-GD2 Chimeric Antigen Receptor (CAR) T or natural killer (NK) cells against target NB cells was assessed through coculture experiments and quantified by FACS analysis.,33737337_2,-1,1,-1,1,41806,-1,2.1536389e-05,0.999962,1.6547709e-05
18990,This,0,1,0,4,"This work provides evidence that native preparations of the Euplotes raikovi pheromone Er-1 (a helical protein of 40 amino acids) specifically increases viability, DNA synthesis, proliferation, and the production of interferon-, tumor necrosis factor-, interleukin (IL)-1, IL-2, and IL-13 in human Jurkat T-cells.",23103669_1,-1,1,-1,1,18990,-1,2.0959043e-05,0.9999689,1.0173248e-05
12974,to,14,15,81,83,This approach is currently being tested in a clinical trial and could be applied to other trials of viral immunogene therapy.,20683443_6,-1,1,-1,1,12974,-1,2.5851958e-05,0.9999641,1.0073048e-05
35364,them,1,2,6,10,"Among them, CCL5, IL6 and IL8, or MIP2 in mouse, were consistently reduced by Notch1 depletion in several human and mouse melanoma cell lines.",30036609_5,-1,1,-1,1,35364,-1,2.6678845e-05,0.99995935,1.3956435e-05
15055,The,0,1,0,3,"The proportion of CD4(+)CD25(+) regulatory T cells, Foxp3 gene expression, levels of tumor growth factor- (TGF-) and immunoreactive fibronectin- (IFN-) in the periphery blood of 30 NSCLC patients and 30 healthy volunteers were compared.",21611754_1,-1,1,-1,1,15055,-1,1.6349728e-05,0.9999752,8.440658e-06
23169,play,10,11,50,54,IMPORTANCE: CD8(+) cytotoxic T lymphocytes (CTLs) play an important role in the control of viral infections and destroy tumor cells.,24696473_7,-1,1,-1,1,23169,-1,2.9175657e-05,0.99994946,2.133991e-05
32980,therapeutic,1,2,5,16,"More therapeutic options to treat this disease are needed, for the current standard of care is ineffective.",28775207_1,-1,1,-1,1,32980,-1,2.8628087e-05,0.9999583,1.3067279e-05
33535,Thus,0,1,0,4,"Thus, adoptive transfer of allogeneic T9IL-33 cells offers an attractive approach for separating GVL activity from GVHD.",29038366_4,-1,1,-1,1,33535,-1,2.577093e-05,0.9999635,1.06941225e-05
1801,to,15,16,96,98,"Moreover, multiple lines of evidence indicated that local release of IFN-gamma was not required to inhibit tumor formation.",14978132_5,-1,1,-1,1,1801,-1,2.3203484e-05,0.99996686,9.986396e-06
25629,time,7,8,42,46,Assessment of miR was performed with real time quantitative RT-PCR.,25544502_5,-1,1,-1,1,25629,-1,2.6135276e-05,0.9999585,1.5404601e-05
21498,TGF-1,27,28,172,178,Nanog targeting significantly reduced immunosuppressive cells (regulatory T cells and macrophages) and increased CD8(+) T effector cells in tumor bed in part by modulating TGF-1 production.,24227785_5,-1,1,-1,1,21498,-1,3.6041805e-05,0.9999343,2.965425e-05
14922,Foxp3-expressing,2,3,13,29,Coculture of Foxp3-expressing melanoma cells with naive CD4(+)CD25(-) T cells resulted in strong inhibition of T-cell proliferation.,21547596_5,-1,1,-1,1,14922,-1,2.3965613e-05,0.9999616,1.4386371e-05
36541,regulation,9,10,48,58,"In this study, we analysed the localisation and regulation of IL-35 in the lung of patients with non-small cell lung cancer (NSCLC) to further elucidate the immune-escape of cancer cells in perioperative course of disease.",30956278_1,-1,1,-1,1,36541,-1,2.2304705e-05,0.99996233,1.536884e-05
15476,tetramers,48,49,318,327,"EXPERIMENTAL DESIGN: CD8(+) T cells isolated from tumor, adjacent normal skin, and peripheral blood of 17 HLA-A2(+) patients with advanced-stage melanoma were analyzed for their antigen specificity and effector function against melanocyte differentiation antigens MART-1, gp100, and tyrosinase by using HLA-A2/peptide tetramers and functional assays.",21750202_1,-1,1,-1,1,15476,-1,3.987583e-05,0.99991,5.0113475e-05
7207,the,41,42,273,276,"To verify this hypothesis and develop the most effective dendritic cell vaccine against Ewing's sarcoma, we evaluated the antitumor efficacy of dendritic cell-Ewing's sarcoma hybrids and dendritic cells pulsed with other antigen-loading methods, including cell lysates and the characteristic EWS-FLI1 gene of Ewing's sarcoma, using an A673 cell line as a model.",18563501_1,-1,1,-1,1,7207,-1,2.3989143e-05,0.9999645,1.1531411e-05
4498,genes,27,28,181,186,"RESULTS: In vitro IL-2 treatment produced a rapid and dose-dependent increase in P-STAT5 within normal PBMC that correlated with the induction of transcript for the IL-2-responsive genes CIS, Pim-1, and SOCS1 (correlation coefficients 0.8628, 0.6667, and 0.7828, respectively).",17020993_6,-1,1,-1,1,4498,-1,2.6130136e-05,0.9999478,2.6074847e-05
1402,to,25,26,161,163,"We showed that generating the major histocompatibility complex (MHC) class I+/class II+/Ii- phenotype, within an established subcutaneous RM-9 tumor nodule, led to an effective immune response limiting tumor growth.",12804139_1,-1,1,-1,1,1402,-1,2.0245372e-05,0.99996996,9.760099e-06
15735,that,5,6,24,28,"Thus, our data indicate that a chronic increase in gut Th17 cell activity can be associated with the development of premalignant lesions of the gastroduodenal region.",21881210_6,-1,1,-1,1,15735,-1,1.7841052e-05,0.99997437,7.843138e-06
28325,the,6,7,55,58,T cell-restricted constitutively active IKK augmented the frequency of functional tumor-specific CD8(+) T cells and improved tumor control.,26903482_6,-1,1,-1,1,28325,-1,1.6648275e-05,0.9999757,7.64959e-06
22199,generate,36,37,232,240,"The data suggest that pretreatment of myeloma cells with JSI-124 and bortezomib can recover DC function through the up-regulation of HSP90 and the down-regulation of p-STAT3 and inhibitory cytokines, and that these DCs can potently generate myeloma-specific CTLs.",24407159_7,-1,1,-1,1,22199,-1,2.3491992e-05,0.9999615,1.49746e-05
11970,STAT5,9,10,65,70,"Exosomes inhibited the expression of JAK3 and phosphorylation of STAT5 in high doses in T-cells, but not JAK2, while EXO/IL-12 had much less attenuated reduction of the expression of p-STAT5.",20372811_6,-1,1,-1,1,11970,-1,3.160847e-05,0.9999409,2.753624e-05
24715,the,36,37,205,208,"In this model, mammary tumors in the involution group are sixfold larger than nulliparous group tumors, have decreased CD4(+) and CD8(+) T cell infiltrates and contain a greater number of macrophages with the ability to inhibit T cell activation.",25187059_6,-1,1,-1,1,24715,-1,2.7375861e-05,0.99995995,1.2672318e-05
25000,thereby,14,15,81,88,"Stimulation of these pathways was sufficient to block activation of NF-B in DC, thereby attenuating their ability to stimulate antigen-specific T-cell responses.",25261236_5,-1,1,-1,1,25000,-1,2.1483962e-05,0.99996984,8.705764e-06
24035,the,17,18,113,116,"Eradication of SA is, importantly, associated with significant clinical improvement, suggesting that SA promotes the disease activity, but the underlying mechanisms remain poorly characterized.",24957145_1,-1,1,-1,1,24035,-1,2.333947e-05,0.99996614,1.0491608e-05
20559,the,14,15,78,81,"Of note the effect of this cytokine, albeit not statistically significant, on the DCR subgroup led to a further 33.8% reduction in Foxp3+Treg cells.",23725550_10,-1,1,-1,1,20559,-1,1.7330622e-05,0.99997056,1.2081765e-05
23251,this,1,2,3,7,"In this study, the ILC2s related genes or molecules in PBMC from patients with gastric cancer were measured, and the potential correlation between them was analyzed.",24741632_3,-1,1,-1,1,23251,-1,2.0298263e-05,0.9999678,1.18989365e-05
7383,the,16,17,98,101,"Here, we show that tissue-produced inflammatory mediators prime maturing dendritic cells (DC) for the differential ability of attracting anti-inflammatory Treg cells.",18632653_1,-1,1,-1,1,7383,-1,2.0072779e-05,0.9999714,8.530638e-06
285,the,13,14,91,94,"Janus tyrosine kinase (Jak)3 and transcription factors Stat5a and Stat5b are essential for the proliferation of normal T cells and are constitutively hyperactivated in both HTLV-1-transformed human T cell lines and lymphocytes isolated from HTLV-1-infected patients; therefore, a critical role for the Jak3-Stat5 pathway in the progression of this disease has been postulated.",11046040_1,-1,1,-1,1,285,-1,1.8602195e-05,0.99997234,9.039249e-06
26605,the,28,29,190,193,Ex-vivo colon culture experiments indicated that IL-22 was able to induce Th1-like inflammation via signal transducer and activator of transcription factor-1 (STAT1) and CXCL10 induction in the presence of type I interferon (IFN).,26153763_3,-1,1,-1,1,26605,-1,1.9881993e-05,0.9999722,7.91786e-06
39305,transform,16,17,82,91,Tumor-associated macrophages (TAMs) in HGSOC make up a large part of the TMEs and transform between diverse phenotypes under different treatments.,32184777_3,-1,1,-1,1,39305,-1,2.065269e-05,0.99996316,1.6136353e-05
3397,tumor,21,22,134,139,"Although tumoricidal macrophages are a necessary component of immune surveillance in CD1(-/-) mice, they alone are not sufficient for tumor resistance because IL-4Ralpha(-/-) mice have M1 macrophages and retain high levels of myeloid suppressor cells after surgery; in addition, they are susceptible to 4T1 metastatic disease.",16357187_4,-1,1,-1,1,3397,-1,2.317185e-05,0.99996734,9.4907e-06
4101,that,3,4,13,17,Here we show that a widely used neutralizing anti-murine IL-2 mAb (S4B6) exhibits unexpected activities that enhance the treatment effects of IL-2 in vivo.,16785526_1,-1,1,-1,1,4101,-1,1.7698092e-05,0.9999734,8.930906e-06
15149,Foxp3,6,7,40,45,These findings suggest expansion of CD8 Foxp3+ T cell population in response to rhIL-2 treatment may serve as an early marker for tumor responsiveness to immunotherapy in an immune competent model.,21638127_6,-1,1,-1,1,15149,-1,2.9627065e-05,0.9999565,1.3917492e-05
24747,to,13,14,90,92,"Here, we prepared pancreatic cancer vaccine with PANC-1 cells via epigenetic modification to enhance the MHC-II expression.",25198660_2,-1,1,-1,1,24747,-1,1.9648085e-05,0.99997175,8.5878455e-06
18720,The,45,46,283,286,"CSC-enriched spheroid culture-derived cells (SDC) exhibited higher expression of ALDH, ICAM1 and of stem/progenitor cell markers on all 3 tumor cell lines investigated and lower MHC class I on the cervical cancer cell line as compared to their monolayer-derived cells (MDC).RESULTS: The expression of ICAM1 and MHCI was upregulated by IFN- treatment.",23001491_2,-1,1,-1,1,18720,-1,1.6942246e-05,0.99997354,9.542845e-06
12547,the,25,26,168,171,"Consistently, transfection of dominant-negative Eomes in Vgamma4 gammadelta T cells diminished the level of IFN-gamma secretion, indicating a critical role of Eomes in the effector function of these gammadelta T cells.",20525896_7,-1,1,-1,1,12547,-1,2.0109112e-05,0.9999715,8.3781615e-06
11135,Foxp3,24,25,157,162,"Real-time PCR analysis revealed that combination therapy led to an increase in IFN-gamma and tumor necrosis factor-alpha mRNA expression; however, levels of Foxp3 and transforming growth factor-beta within the remote tumor tissues were decreased.",19940990_6,-1,1,-1,1,11135,-1,2.0637252e-05,0.9999659,1.34599295e-05
21281,Foxp3,13,14,95,100,"Our study indicates that both CCL22 and TGF-1 are candidate chemoattractants for intratumoral Foxp3 (+)Tregs infiltration; however, unlike the later, CCL22 is an independent prognostic predictor of BC patients, and it therefore may have the potential to serve as a target for immunotherapeutic strategy of BC.",24124553_9,-1,1,-1,1,21281,-1,2.758084e-05,0.99995804,1.4328264e-05
18511,genes,20,21,131,136,"Specifically, we aimed to optimize the therapeutic efficacy of Flt3L/TK treatment in the RG2 model by overexpressing the following genes within the brain tumor microenvironment: 1) a TK mutant with enhanced cytotoxicity (SR39 mutant TK), 2) Flt3L-IgG fusion protein that has a longer half-life, 3) CD40L to stimulate DC maturation, 4) T helper cell type 1 polarizing dendritic cell cytokines interleukin-12 or C-X-C motif ligand 10 chemokine (CXCL)-10, 5) C-C motif ligand 2 chemokine (CCL2) or C-C motif ligand 3 chemokine (CCL3) to enhance dendritic cell recruitment into the tumor microenvironment, 6) T helper cell type 1 cytokines interferon- or interleukin-2 to enhance effector T-cell functions, and 7) IB or p65RHD (nuclear factor kappa-B [NF-B] inhibitors) to suppress the function of Foxp3+ Tregs and enhanced effector T-cell functions.",22996231_2,-1,1,-1,1,18511,-1,2.1461305e-05,0.9999666,1.1946701e-05
8693,the,56,57,375,378,"It is not known when immunosuppression occurs during tumor development but it likely involves cross-talk among tumor cells, tumor-associated macrophages and microglia (TAMs), and peripheral as well as tumor-infiltrating lymphocytes (TILs).RESULTS: We have performed a kinetic study of this immunomodulation, assessing the dynamics of immune infiltration and function, within the central nervous system (CNS) and peripherally.",19226468_1,-1,1,-1,1,8693,-1,1.7837323e-05,0.9999733,8.892363e-06
34495,the,14,15,100,103,A global transcriptome analysis of the immune microenvironment in 73 MM patients strongly supported the negative impact of IL-18-driven MDSCs on Tcell responses.,29551594_4,-1,1,-1,1,34495,-1,2.162238e-05,0.99996996,8.450867e-06
27929,to,14,15,87,89,Targeting of TGF and IL-10 reduced the ability of alveolar macrophages from IKTA mice to induce Foxp3 expression on T cells.,26756215_6,-1,1,-1,1,27929,-1,2.0199392e-05,0.9999697,1.0054158e-05
2147,themselves,6,7,33,43,"LP CD4(+)CD25(bright) T cells by themselves produced fewer amounts of IL-2, IFN-gamma, and IL-10.",15322172_5,-1,1,-1,1,2147,-1,3.733608e-05,0.99993753,2.5164845e-05
24886,the,1,2,7,10,"During the past decade, a better understanding of the cellular and molecular mechanisms underlying tumor immunity has provided the appropriate framework for the development of therapeutic strategies for cancer immunotherapy.",25253145_0,-1,1,-1,1,24886,-1,2.4196064e-05,0.9999652,1.0559555e-05
15580,forkhead,21,22,116,124,"BACKGROUND: T helper 17 (Th17) and regulatory T cells share plasticity in the expression of interleukin (IL)-17 and forkhead box P3 (FOXP3), but their mutual presence in human diseases is unclear.",21837700_0,-1,1,-1,1,15580,-1,3.868874e-05,0.9999454,1.591887e-05
11981,to,13,14,119,121,"Antitumor immune response and chemotherapy-induced immunomodulation in colon cancer patients represented the rationale to design new strategies, like GOLFIG chemoimmunotherapy (gemcitabine, oxaliplatin, 5-fluorouracil/folinic acid, granulocyte macrophage colony-stimulating factor, and aldesleukine), that resulted a safe and very active regimen.",20386463_0,-1,1,-1,1,11981,-1,2.4571458e-05,0.99996555,9.853035e-06
40897,to,28,29,194,196,"The goal of this review was to discuss how cytokines regulate intracellular networks, focusing on the regulation of lineage-specific transcription factors, chromatin remodelling and metabolism, to control human Th17 cell plasticity.",33064842_7,-1,1,-1,1,40897,-1,2.0613052e-05,0.9999703,9.098048e-06
30445,the,1,2,5,8,"With the agonistic ICOS-L protein (rICOS-L Ig), ICOS+ Foxp3+ cells were efficiently induced from naive CD4+ T cells under a stimulation with TGF- and CD3/CD28 mAbs.",27756099_4,-1,1,-1,1,30445,-1,2.258253e-05,0.99996734,1.00918305e-05
7417,the,19,20,104,107,"The current data, showing that the ability of mature DC to interact with Treg cells is predetermined at the stage of DC maturation, pave the way to preferentially target the regulatory versus proinflammatory T cells in autoimmunity and transplantation, as opposed to intracellular infections and cancer.",18632653_6,-1,1,-1,1,7417,-1,1.7922759e-05,0.99997175,1.0374955e-05
32475,the,13,14,74,77,"In summary, local IL-2 production results in efficacy and safety gains in the context of ACT.",28614908_7,-1,1,-1,1,32475,-1,2.1818389e-05,0.9999696,8.576335e-06
6793,to,12,13,85,87,"A comparative analysis of vaccination with irradiated, murine tumor cells engineered to express a large number of immunostimulatory molecules established the superior ability of granulocyte-macrophage colony-stimulating factor (GM-CSF) to evoke potent, specific, and long-lasting anti-tumor immunity.",18364009_0,-1,1,-1,1,6793,-1,2.3955326e-05,0.99996233,1.3753841e-05
10085,the,10,11,72,75,"Immune tolerance consistently blunts the generated immune response, and the largely solitary focus on CD8+ T cell immunity has proven ineffective in the absence of CD4+ T cell help.",19561540_1,-1,1,-1,1,10085,-1,2.3545854e-05,0.99996674,9.717131e-06
36391,to,6,7,26,28,"The aim of this study was to investigate the frequency of circulating CD4+CD25-Foxp3+ Treg cells and their role in NSCLC. Methods: The frequencies of Treg, T helper (Th)1, Th2, and Th17 cells in peripheral blood were separately measured in 36 NSCLC patients and 20 healthy controls (HCs) using flow cytometry.",30925076_2,-1,1,-1,1,36391,-1,1.779621e-05,0.99997365,8.586109e-06
31332,the,8,9,66,69,"Although immunotherapy by PD-1 blockade has dramatically improved the survival rate of cancer patients, further improvement in efficacy is required to reduce the fraction of less sensitive patients.",28096382_0,-1,1,-1,1,31332,-1,2.0600968e-05,0.9999715,7.945525e-06
39650,that,4,5,17,21,"First, we showed that T1 cells comprise the majority of CD3+ T cells in BC; next, we found that CD73+T1 cells were the predominant regulatory T-cell (Treg) population in BC, and that their prevalence in peripheral blood was also related to tumour burden.",32345959_2,-1,1,-1,1,39650,-1,1.6518547e-05,0.99997187,1.1572543e-05
2347,initiation factor,30,32,246,263,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,-1,1,-1,1,2347,-1,2.8961726e-05,0.9999485,2.2561913e-05
35119,the,28,29,196,199,"Disruption of EZH2 activity in Tregs, either pharmacologically or genetically, drove the acquisition of pro-inflammatory functions in TI-Tregs,remodeling the tumor microenvironment and enhancing the recruitment and function of CD8+ and CD4+ effector Tcells that eliminate tumors.",29898397_2,-1,1,-1,1,35119,-1,1.8634584e-05,0.9999734,7.933539e-06
8058,T,13,14,92,93,Both drugs inhibit IL-2-mediated generation of FOXP3 positive CTLA-4 positive CD25high CD4+ T regulatory cells from PBMCs by upto 50%.,19009291_5,-1,1,-1,1,8058,-1,4.091032e-05,0.9999119,4.7161866e-05
38799,the,33,34,170,173,"In summary, our data showed an association of IL21+ and IL26+ immune cell infiltration, increased ADC, and aggressive tumor disease, most likely due to the activation of the key cancer signaling pathways ERK1/2 and STAT3 and formation of tumor colonies.",31948053_7,-1,1,-1,1,38799,-1,1.7506409e-05,0.9999726,9.954543e-06
12759,These,0,1,0,5,These findings may explain the anomalies in the reported functional phenotype of type 2 polarized CD8 T cells.,20562261_8,-1,1,-1,1,12759,-1,2.200686e-05,0.9999685,9.459637e-06
36814,The,0,1,0,3,The inhibition of FOXA1+ Tregs represents a promising new strategy to enhance antitumor immunity.,31036318_15,-1,1,-1,1,36814,-1,1.8489503e-05,0.9999738,7.780361e-06
23155,the,31,32,172,175,"Moreover, the activation of IDO in response to EBV infection of MDMs suppressed the proliferation of T cells and impaired the cytotoxic activity of CD8(+) T cells, whereas the inhibition of IDO activity with 1-methyl-l-tryptophan (1-MT) did not affect T cell proliferation and function.",24696473_5,-1,1,-1,1,23155,-1,1.811862e-05,0.99997425,7.6450215e-06
9760,the,5,6,29,32,"In addition, Tregs inhibited the proliferation of TCR-stimulated (primed) CD4(+) T cells and nave CD8(+) T cells after TCR-mediated activation, however, Tregs with OX40 costimulation lost their suppressive function.",19455675_6,-1,1,-1,1,9760,-1,1.5780097e-05,0.9999758,8.475638e-06
17039,that,6,7,24,28,"In this report, we show that IL-22 stimulated production of vascular endothelial growth factor (VEGF) and the anti-apoptotic factor Bcl-X(L) in IL-22R-positive HPAFII human pancreatic cancer cells.",22471280_7,-1,1,-1,1,17039,-1,1.8431372e-05,0.99997187,9.683618e-06
14126,to,8,9,50,52,"RESULTS: The pathology advances with time leading to erosive dermatitis which is inflamed with a mixed infiltrate involving activated CD8+ T-cells, CD4+ T-cells including CD4+/CD25+/FoxP3+ Treg cells, mast cells and neutrophils.",21291541_5,-1,1,-1,1,14126,-1,2.0870993e-05,0.9999684,1.0711669e-05
20667,the,11,12,84,87,"Moreover, inhibitory cytokines IL-10 and transforming growth factor-1 increased in the gastric tissue, while there was a decrease in inflammatory interferon- (IFN-).",23777268_6,-1,1,-1,1,20667,-1,1.743396e-05,0.9999713,1.1342256e-05
5016,to,3,4,13,15,It also adds to our understanding of ATLL patients' severely immunocompromised state.,17278106_8,-1,1,-1,1,5016,-1,4.904013e-05,0.99992454,2.6376214e-05
42904,the,9,10,56,59,"Although Treg cell plasticity comes in various flavors, the major categories enclose the loss of Foxp3 expression, which is the master regulator of Treg cell lineage, giving rise to ""ex-Treg"" cells and the ""fragile"" Treg cells in which FOXP3 expression is retained but accompanied by the engagement of an inflammatory program and attenuation of the suppressive activity.",34539668_2,-1,1,-1,1,42904,-1,1.8355586e-05,0.99997246,9.198004e-06
19013,time-dependent,16,17,105,119,"Jurkat T-cell treatments with Er-1 induced the down-regulation of the IL-2R subunit by a reversible and time-dependent endocytosis, and increased the levels of phosphorylation of the extracellular signal-regulated kinases (ERK).",23103669_3,-1,1,-1,1,19013,-1,4.5910518e-05,0.9999207,3.337361e-05
4831,tumors,10,11,49,55,"Thymus is a major site of T-cell maturation, and tumors induce thymic atrophy to evade cellular immune response.",17210719_1,-1,1,-1,1,4831,-1,1.9577436e-05,0.9999707,9.736938e-06
13903,to,7,8,53,55,The presented analysis provides a practical approach to investigate the immunological environment of cancer patients.,21198537_10,-1,1,-1,1,13903,-1,2.0691212e-05,0.9999708,8.489882e-06
12923,transduction,1,2,10,22,Selective transduction of conventional and plasmacytoid DC subsets by CD40-Ad was observed in suspensions of human melanoma-draining SLN.,20664356_4,-1,1,-1,1,12923,-1,2.687609e-05,0.99995935,1.3794732e-05
12572,the,10,11,47,50,"Analyses of the immune response, 2weeks after the last immunization revealed decreased CD4+ CD25+ Foxp3+ naturally occurring regulatory T cells (Tregs) at the tumor site and increased IFN-/IL-4 level.",20544406_4,-1,1,-1,1,12572,-1,2.0435014e-05,0.9999703,9.198739e-06
7387,Treg-attracting,23,24,121,136,"Our data show that prostaglandin E(2) (PGE(2)), a factor overproduced in chronic inflammation and cancer, induces stable Treg-attracting properties in maturing DC, mediated by CCL22.",18632653_2,-1,1,-1,1,7387,-1,7.121235e-05,0.99987173,5.70194e-05
12983,the,30,31,177,180,"Given that local cell-mediated immunity (CMI) against the human papillomavirus type 16 E6 (HPV16 E6) protein is important for eradication of HPV16 E6-expressing cancer cells in the cervical mucosa, the HPV16 E6 protein may be a target for the mucosal immunotherapy of cervical cancer.",20706715_0,-1,1,-1,1,12983,-1,1.9402252e-05,0.99997056,1.0003208e-05
43282,STAT1,19,20,127,132,"While APLNR N112G, a constitutively active mutant receptor, increases intratumoral sensitivity to IFN- signaling by enhancing STAT1 phosphorylation upon IFN- exposure.",35084016_7,-1,1,-1,1,43282,-1,2.4203437e-05,0.99995136,2.4397199e-05
18294,the,14,15,88,91,"Suppression of iTreg differentiation from nave CD4(+) cells by gr-MDSC occurs early in the polarization process, requires inhibition of early T cell activation, and depends on ROS and IDO but does not require arginase 1, iNOS, NO, cystine/cysteine depletion, PD-1 and PD-L1 signaling, or COX-2.",22891289_5,-1,1,-1,1,18294,-1,2.349562e-05,0.9999653,1.1183416e-05
18082,tumor,7,8,38,43,Tregs in the draining lymph nodes and tumor were significantly suppressed by ACT.,22812187_6,-1,1,-1,1,18082,-1,2.265754e-05,0.9999646,1.2742362e-05
22445,these,7,8,49,54,"Unexpectedly, TCR activation was dispensable for these stages of functional differentiation.",24489097_5,-1,1,-1,1,22445,-1,2.7043203e-05,0.999962,1.0934875e-05
19947,These,0,1,0,5,These data indicate that Notch signaling controls human CD8(+) T cell priming and also influences effector T cell functions.,23380742_9,-1,1,-1,1,19947,-1,2.1536616e-05,0.99996877,9.74751e-06
36520,Treg,5,6,19,23,Regulatory Tcell (Treg) depletion enhanced their capacity to elicit strong CD4+ Tconv responses and ensuing antitumor protection.,30955881_2,-1,1,-1,1,36520,-1,2.6269625e-05,0.9999571,1.6695953e-05
16300,generation,15,16,86,96,"In the present study, we aimed to investigate the distribution, characterization, and generation of CD8+ Tcregs and Tc17 cells in NPC patients.",22051182_3,-1,1,-1,1,16300,-1,2.0853111e-05,0.99996006,1.9127516e-05
42720,tumors,4,5,25,31,BRCA1-mutated (BRCA1mut) tumors are thus Tcell inflamed at baseline.,34289354_2,-1,1,-1,1,42720,-1,1.9395993e-05,0.9999683,1.2258721e-05
5745,This,0,1,0,4,This review seeks to focus on the role of JAK tyrosine kinases and STAT transcription factors in mediating the lymphocyte life cycle and how they might be manipulated for therapeutic applications.,17659375_6,-1,1,-1,1,5745,-1,1.9828161e-05,0.9999714,8.743112e-06
41541,the,38,39,224,227,"Further, Th17 and Tregs levels were detected by immunohistochemical double staining of thymoma tissue; the number of positive Th17 cells in thymoma with MG was higher than that in simple thymoma, while positive Tregs showed the opposite results.",33636431_4,-1,1,-1,1,41541,-1,2.4553807e-05,0.9999651,1.0411441e-05
30156,TIL,17,18,120,123,Programmed death-1 (PD-1) is a coinhibitory receptor that downregulates the activity of tumor-infiltrating lymphocytes (TIL) in cancer and of virus-specific T cells in chronic infection.,27683557_0,-1,1,-1,1,30156,-1,2.7000176e-05,0.9999614,1.165966e-05
33332,that,25,26,173,177,These studies illuminate the interaction between tonic CAR signaling and the chosen expression platform and identify inhibitory properties of the 4-1BB costimulatory domain that have direct implications for rational CAR design.,28978471_5,-1,1,-1,1,33332,-1,2.0977268e-05,0.9999691,9.94944e-06
2193,the,25,26,129,132,"Compared with melanoma patients, healthy donors had higher basal levels of P-STAT1 (specific fluorescence [Fsp]; i.e., Fsp(PBS), the level of P-STAT1 in PBS-treated cells) in total PBMCs, natural killer (NK) cells, and T cells (mean Fsp(PBS) in total PBMCs: 5.5 in healthy donors versus 1.6 in patients, difference = 3.9, 95% confidence interval [CI] = 1.4 to 6.5, P =.004; mean Fsp(PBS) in NK cells: 4.6 in healthy donors versus 0.9 in patients, difference = 3.7, 95% CI = 1.7 to 5.7, P =.001; mean Fsp(PBS) in T cells: 6.8 in healthy donors versus 0.9 in patients, difference = 5.9, 95% CI = 2.5 to 9.3, P =.002).",15339971_7,-1,1,-1,1,2193,-1,1.9855424e-05,0.9999683,1.183841e-05
36609,tumor,2,3,25,30,Gastrointestinal stromal tumor (GIST) is driven by an activating mutation in the KIT proto-oncogene.,31000683_0,-1,1,-1,1,36609,-1,2.2426277e-05,0.9999591,1.8478799e-05
24705,To,0,1,0,2,"To determine the influence of the postpartum immune microenvironment on mammary tumor promotion, we developed an immune-competent model.",25187059_5,-1,1,-1,1,24705,-1,1.7203214e-05,0.99997413,8.712205e-06
8092,that,3,4,14,18,"Aged NZB mice that have developed a B-1 cell malignancy identified as IgM(+)CD5(+), have the most pronounced increase in Tregs.",19022624_4,-1,1,-1,1,8092,-1,2.1301235e-05,0.9999665,1.215771e-05
38727,STAT3,2,3,14,19,"Inhibition of STAT3 recovered the CXCL9-inhibited proliferation, activation, and secretion of anti-tumour cytokines of CD8+ T cells.",31913856_6,-1,1,-1,1,38727,-1,2.5665635e-05,0.9999567,1.7558415e-05
37484,tumors,1,2,15,21,"IL-30-silenced tumors developed in IL-30KO mice, IL-30-/-tumors, lacked vascular supply and displayed frequent apoptotic cancer cells entrapped by perforin+TRAIL+CD3+Tlymphocytes, most of which had a CD4+T phenotype, whereas IL-10+TGF+Foxp3+Tregs were lacking.",31366386_7,-1,1,-1,1,37484,-1,2.0596985e-05,0.9999678,1.1641802e-05
4888,to,19,20,118,120,Regulatory T cells (Treg) are a distinct group of T lymphocytes with immunosuppressive properties that serve normally to prevent harmful autoimmune responses.,17224188_0,-1,1,-1,1,4888,-1,2.790959e-05,0.99996245,9.639824e-06
23529,T-bet,17,18,102,107,"Therefore, we hypothesized that ICOS, and specifically ICOS-mediated PI3K signaling, was required for T-bet expression.",24778280_7,-1,1,-1,1,23529,-1,2.144966e-05,0.99996364,1.4888724e-05
9397,generally,6,7,37,46,Gliomas localized within the CNS are generally not rejected by the immune system despite being immunogenic.,19337997_0,-1,1,-1,1,9397,-1,3.159691e-05,0.99995077,1.7624308e-05
2344,initiation factor,21,23,171,188,"Moreover, we demonstrate that chemotherapeutic agents that suppress protein synthesis and reverse the CD40-mediated dissociation of the translational repressor eukaryotic initiation factor 4E-binding protein from the initiation factor eukaryotic initiation factor 4E, such as 5-fluorouracil, etoposide, and quercetin, dramatically increase the susceptibility of cervical carcinoma cells to CD40L-induced apoptosis.",15611226_6,-1,1,-1,1,2344,-1,2.7584707e-05,0.9999504,2.2024646e-05
26562,targeting,26,27,177,186,"In this review, we overview the updated understanding on the exhausted T cells in cancer and their potential regulatory mechanisms and discuss current therapeutic interventions targeting exhausted T cells in clinical trials.",26086965_3,-1,1,-1,1,26562,-1,2.0335314e-05,0.99996996,9.744251e-06
25984,trial,40,41,270,275,"The frequency, immunosuppressive phenotype, and activation status of Treg and natural killer (NK) cells were analyzed in the circulation and tumor microenvironment of cetuximab-treated patients with HNSCC enrolled in a novel neoadjuvant, single-agent cetuximab clinical trial.",25832655_2,-1,1,-1,1,25984,-1,2.5016156e-05,0.9999547,2.0282516e-05
35092,the,19,20,112,115,"Combined with immune checkpoints blockade therapy by programmed death 1 (PD-1) antibody, the dual inhibition of the PD-1/PD-L1 axis elicits significant immune response and presents a robust effect in lengthening tumor recurrent time and inhibiting tumor metastasis.",29882235_5,-1,1,-1,1,35092,-1,1.7429677e-05,0.99997354,9.027577e-06
39862,that,3,4,23,27,These findings suggest that HTLV-1 promotes the proliferation of infected T cells by hijacking the machinery of regulatory T cell differentiation.,32471947_8,-1,1,-1,1,39862,-1,1.732316e-05,0.9999757,7.0143583e-06
37697,these,21,22,149,154,"Further mechanistic research indicated that the IFN--induced expression and promoter activity of PD-L1 were suppressed by these two flavonoids, and these effects were mediated by STAT3 activity inhibition.",31437792_5,-1,1,-1,1,37697,-1,2.1224714e-05,0.9999678,1.0957864e-05
40877,Tfh,25,26,136,139,"While being able to shift phenotype within their lineage, Th17 cells can also acquire characteristics of Th1, Th2, T follicular helper (Tfh) or regulatory T cells.",33064842_3,-1,1,-1,1,40877,-1,2.9337642e-05,0.9999491,2.158396e-05
34815,the,20,21,132,135,CONCLUSIONS: These findings linked the anti-tumor properties of PE with the immune microenvironment to present a reliable basis for the future practical application of PE in cervical cancer as a novel and pharmacologically safe immunotherapy strategy.,29783020_7,-1,1,-1,1,34815,-1,2.0780664e-05,0.9999713,7.90327e-06
24880,that,6,7,29,33,"In summary, our data suggest that GEP might be a powerful tool for the prediction of immunosuppression and the monitoring of immune responses within immunotherapy trials.",25242680_5,-1,1,-1,1,24880,-1,1.8838135e-05,0.9999732,7.938698e-06
17209,to,7,8,46,48,"In contrast, moDCs require exogenous rhuIL-15 to phosphorylate STAT5 and attain stimulatory capacity comparable to LCs.",22510877_5,-1,1,-1,1,17209,-1,2.2807282e-05,0.99996567,1.1507486e-05
32299,The,0,1,0,3,The adenosine A2A receptor (A2AR) could protect cancerous tissues from immune clearance via inhibiting T cells response.,28592285_1,-1,1,-1,1,32299,-1,1.8230481e-05,0.9999722,9.511278e-06
2099,The,0,1,0,3,"The other half of the patients showed impaired HPV16-specific proliferative responses, which generally lacked both IFN-gamma and interleukin 5.",15289354_5,-1,1,-1,1,2099,-1,1.8826493e-05,0.99997115,1.0040529e-05
22571,to,32,33,194,196,"BACKGROUND: Human papillomavirus (HPV) infection has traditionally been regarded as a sexually transmitted disease (STD), but recent evidence implicates that an infected mother can transmit HPV to her newborn during pregnancy, at delivery, perinatal period or later.",24524328_0,-1,1,-1,1,22571,-1,2.1880636e-05,0.99996316,1.4917768e-05
7718,T,21,22,127,128,"In summary, we find that SCCs evade the immune response at least in part by down-regulating vascular E-selectin and recruiting T reg cells.",18794336_8,-1,1,-1,1,7718,-1,3.6176487e-05,0.9998361,0.00012775761
26095,this,11,12,58,62,"IL-22 promoted tumor growth in BALB/c nude mice; however, this effect was reversed by adding a STAT3 inhibitor.",25892871_8,-1,1,-1,1,26095,-1,2.2084969e-05,0.99996865,9.262457e-06
11467,tumor-bearing,15,16,76,89,"Here, we report that type 1 T helper cell-like effector cells that arose in tumor-bearing hosts progressively expressed programmed death 1 during tumor growth.",20118405_3,-1,1,-1,1,11467,-1,2.0203415e-05,0.99997056,9.201916e-06
34663,to,15,16,104,106,"Furthermore, cultured cytotoxic T lymphocytes (CTLs) from vaccinated mice demonstrated reduced capacity to lyse TC-1 cells enriched for CICs compared to non-enriched TC-1 cells.",29699516_9,-1,1,-1,1,34663,-1,1.9566802e-05,0.99996805,1.235596e-05
25700,the,16,17,100,103,"Collectively, irradiated k1106 cells induce the expression of IL-17 in Tregs, which interferes with the expression of p53 protein in k1106 cells and thereby represses irradiation-triggered apoptosis in k1106 cells.",25544504_10,-1,1,-1,1,25700,-1,1.8255023e-05,0.9999728,8.929887e-06
21316,relevant,31,32,203,211,Cytomegalovirus (CMV) reactivation may lead to CMV disease associated with high morbidity and mortality in patients after hematopoietic stem cell transplantation (HSCT); the identification of clinically relevant markers may aid in the identification of patients at increased risk for developing CMV-associated complications.,24140122_0,-1,1,-1,1,21316,-1,4.7452162e-05,0.99993145,2.1032183e-05
14522,tolerance,19,20,85,94,BACKGROUND & AIMS: Regulatory T (Treg) cells (CD4+ CD25high FoxP3+) regulate mucosal tolerance; their adoptive transfer prevents or reduces symptoms of colitis in mouse models of inflammatory bowel disease.,21376048_0,-1,1,-1,1,14522,-1,3.264998e-05,0.9999349,3.2446944e-05
12270,than,13,14,70,74,"To conclude, Tregs may play a more important role in conventional GCs than in Ly-rich GCs from the viewpoint of immunosuppression.",20422211_11,-1,1,-1,1,12270,-1,2.8168002e-05,0.9999558,1.6015274e-05
42291,tumors,18,19,139,145,"We show that induction of noncanonical NF-B signaling induces T cell-dependent immune responses, even in 2-microglobulin (2M)-deficient tumors, demonstrating that direct CD8 T cell recognition of tumor cell-expressed MHC class I is not required.",34011631_3,-1,1,-1,1,42291,-1,2.000278e-05,0.9999703,9.664626e-06
42039,the,9,10,62,65,"Finally, increased extracellular ADO is shown to downregulate the expression of NAP1L2, a nucleosome assembly protein we show to be important for DNA damage repair secondary to UVR.",33848530_7,-1,1,-1,1,42039,-1,1.7864395e-05,0.99997354,8.645217e-06
14534,to,39,40,230,232,"METHODS: Allogeneic cocultures of CD4+ T cells and CMFs, derived from normal mucosa of patients undergoing colectomy for colon cancer or inflamed colonic tissues from patients with ulcerative colitis or Crohn's disease, were used to assess activation of the Treg cells.",21376048_3,-1,1,-1,1,14534,-1,2.0480842e-05,0.9999713,8.231607e-06
15514,the,33,34,242,245,We compared the effect of intradermal versus intranodal administration of a DC vaccine on induction of immunologic responses in melanoma patients and examined whether concomitant administration of interleukin (IL)-2 increases the efficacy of the DC vaccine.,21771874_1,-1,1,-1,1,15514,-1,1.831505e-05,0.99997306,8.603103e-06
31681,this,1,2,3,7,"In this report, we found that memory CTLs need to be reactivated to exert effector functions.",28405920_3,-1,1,-1,1,31681,-1,2.3586643e-05,0.99996376,1.2638946e-05
16358,transplanted,4,5,26,38,"F344 rats, subcutaneously transplanted with F98 gliomas, were treated with SocL. There was a significant inhibition of intra-tumoral TGF-1 and T(reg) cell frequency as well as peripheral blood TGF-1 levels in SocL-treated animals compared to the controls.",22057676_4,-1,1,-1,1,16358,-1,2.7283666e-05,0.9999577,1.50474525e-05
22830,that,6,7,35,39,"Furthermore, our data also suggest that NLGP prevents M2 skewness of TAMs by downregulating phosphorylation of targeted STAT3.",24607970_3,-1,1,-1,1,22830,-1,1.9244024e-05,0.9999721,8.604203e-06
5708,FOXP3,1,2,13,18,Intratumoral FOXP3 expression was significantly higher in patients with stage III disease (TNM classification) compared to patients who had stage II disease (p=0.037).,17653902_5,-1,1,-1,1,5708,-1,2.287234e-05,0.9999627,1.4394565e-05
29741,they,11,12,56,60,"However, how MDSCs are induced and the cells from which they arise remains unknown.",27593937_2,-1,1,-1,1,29741,-1,2.6024565e-05,0.9999573,1.6686945e-05
30049,that,17,18,96,100,"Moreover, TSLP induced proliferation of CTCL cells both in vitro and in vivo These data suggest that periostin-mediated TSLP production by keratinocytes directly stimulates CTCL tumor cell growth in addition to inducing a Th2-dominant tumor environment in CTCL.",27634769_9,-1,1,-1,1,30049,-1,1.9026254e-05,0.9999726,8.347774e-06
18112,TGF-,2,3,6,11,"IL-6, TGF-, IL-17 and IL-10 were detected by enzyme-linked immunosorbent assay (ELISA).",22820395_3,-1,1,-1,1,18112,-1,4.2534375e-05,0.99993515,2.2357086e-05
17380,Tregs,9,10,66,71,"These observations provide strong evidence that endogenous CD4(+) Tregs have a negative impact on cancer therapy, and suggest that strategies reducing Treg levels may provide clinical benefit to cancer patients.",22555974_5,-1,1,-1,1,17380,-1,2.0049178e-05,0.9999689,1.1116318e-05
4313,The,0,1,0,3,The combination of i.t.,16928818_7,-1,1,-1,1,4313,-1,3.336078e-05,0.999951,1.5672937e-05
9769,the,5,6,42,45,"Interestingly, Tregs minimally suppressed the proliferation or the cytokine secretion of Ag-specific CD8(+) T cells after Ag-restimulation.",19455675_7,-1,1,-1,1,9769,-1,1.9064917e-05,0.99997115,9.820725e-06
21018,tumor-bearing,26,27,166,179,The results showed that triptolide significantly decreased the proportion of regulatory T cells and lowered the Foxp3 level in the spleen and axillary lymph nodes of tumor-bearing mice.,23975869_7,-1,1,-1,1,21018,-1,2.2195605e-05,0.99996746,1.0400112e-05
38255,the,4,5,15,18,"In this study, the composition and function of CD4+ CD25+ cells inside the microenvironment of triple-negative breast carcinoma (TNBC) were investigated.",31811667_3,-1,1,-1,1,38255,-1,1.5507596e-05,0.9999771,7.4237914e-06
35852,Thus,0,1,0,4,"Thus, stromal IL-33 is a potential target for future HNSCC immunotherapy.",30357458_12,-1,1,-1,1,35852,-1,3.256422e-05,0.99995327,1.4117174e-05
40774,TGF-1,27,28,156,162,"The ectopic expression of Egr2 or Egr3 resulted in the enhancement of TGF-1 expression, while knockdown of Egr2 or Egr3 led to the decreased expression of TGF-1 in NK1.1- CD4+ NKG2D+ T cells.",33011290_5,-1,1,-1,1,40774,-1,3.2699874e-05,0.999936,3.1348613e-05
40558,To,0,1,0,2,"To unravel the mechanism of anti-melanoma effect of GA, it has been delineated that GA inhibits pSTAT3 to evade anti-tumor suppressive function of Tregs and MDSCs.",32890791_6,-1,1,-1,1,40558,-1,1.8534894e-05,0.9999728,8.597803e-06
29851,Tregs,15,16,89,94,"Based on clinical results, we suggest that anecdotal reports on the association of human Tregs with poor prognosis are circumstantial rather than implying a cause-effect direction.",27603507_3,-1,1,-1,1,29851,-1,2.0533254e-05,0.9999664,1.3131446e-05
21606,tumors,19,20,133,139,The treatment with the antibody synergistically augmented the antitumor effect of IFN- gene therapy not only in the vector-injected tumors but also in the vector-uninjected tumors.,24289533_5,-1,1,-1,1,21606,-1,1.8357237e-05,0.99996984,1.1851757e-05
36505,their,19,20,120,125,Differentiation of proinflammatory CD4+ conventional Tcells (Tconv) is critical for productive antitumor responses yet their elicitation remains poorly understood.,30955881_0,-1,1,-1,1,36505,-1,3.1429394e-05,0.9999583,1.0236524e-05
3788,This,0,1,0,4,This effect is independent of both Stat1-activating cytokine IFN-gamma and Stat1-downstream effector molecule FasL because neither neutralization of IFN-gamma nor knocking out of FasL enhances or inhibits IL-12-mediated tumor regression.,16618773_3,-1,1,-1,1,3788,-1,1.9284407e-05,0.9999713,9.439404e-06
41179,to,7,8,47,49,"Quantitative PCR and western blot were applied to evaluate relevant mRNA and protein levels, respectively.",33268765_6,-1,1,-1,1,41179,-1,1.9928082e-05,0.99997115,8.969406e-06
23532,T-bet,10,11,59,64,We found that ICOS-mediated PI3K signaling is required for T-bet expression during an antitumor response elicited by anti-CTLA-4 therapy.,24778280_9,-1,1,-1,1,23532,-1,2.1065038e-05,0.9999654,1.3522918e-05
6580,to,25,26,152,154,"We describe within a few key elements that contribute to neoplastic development of ATL, in addition to interesting molecular drug targets that may lead to more effective therapeutic strategies.",18300056_4,-1,1,-1,1,6580,-1,2.2323742e-05,0.9999676,1.0142582e-05
14330,natural,9,10,72,79,"This pro-inflammatory milieu induced a chemotactic response in isolated natural killer (NK) cells, dendritic cells (DC) and anti-melanoma cytotoxic T cells (CTL).",21338484_4,-1,1,-1,1,14330,-1,7.0238304e-05,0.9999064,2.331863e-05
20649,transplanted,4,5,19,31,"Here, BM-MSCs were transplanted into the stomach of mice with a 44-week mouse-adapted H. pylori infection.",23777268_2,-1,1,-1,1,20649,-1,2.1059344e-05,0.999967,1.1913301e-05
40886,to,5,6,33,35,"How these signals are integrated to determine Th17 plasticity is not well defined, yet this is a crucial point of investigation as it represents a potential target to treat autoimmune and inflammatory diseases.",33064842_6,-1,1,-1,1,40886,-1,2.9297644e-05,0.999959,1.1701852e-05
6439,Tregs,9,10,39,44,"As a result, the frequency of Foxp3(+) Tregs in TILs was significantly higher than that in normal gastric mucosa (12.4% +/- 7.5% vs. 4.1% +/- 5.3%, p < 0.01).",18224687_6,-1,1,-1,1,6439,-1,2.1087775e-05,0.99996185,1.702166e-05
42415,the,14,15,63,66,"Moreover, amphiregulin (Areg), an EGFR ligand, is critical for the amplification of Th9 cells induced by TGF-1 and IL-4.",34075041_3,-1,1,-1,1,42415,-1,1.8182745e-05,0.999974,7.755396e-06
24432,the,7,8,43,46,"One common denominator of these stimuli is the activation of NF-B. Here, we show that human monocyte-derived, cytokine cocktail-matured DCs transfected with constitutively active mutants of IB kinases (caIKKs) by mRNA electroporation, further upregulated maturation markers, and secreted enhanced amounts of cytokines, including IL-12p70, which was produced for more than 48 h after transfection.",25100611_2,-1,1,-1,1,24432,-1,1.814115e-05,0.9999734,8.495008e-06
5264,their,30,31,150,155,"c-MYC acts at at least two different levels, the level of interferon induction as well as at the level of action of type I and type II interferons on their respective target promoters.",17419945_6,-1,1,-1,1,5264,-1,2.5296516e-05,0.9999635,1.1134092e-05
38951,type,3,4,15,19,RESULTS: Basal type BC contained a significantly higher density of CD66b+ TAN compared to the luminal type.,31991796_4,-1,1,-1,1,38951,-1,2.4685385e-05,0.9999536,2.170775e-05
24836,type,29,30,182,186,"Here, using a type II NKT-cell TCR transgenic mouse model, we demonstrated that CD1d-expressing hematopoietic cells, but not thymic epithelial cells, meditate efficient selection of type II NKT cells.",25236978_2,-1,1,-1,1,24836,-1,2.1854596e-05,0.99996257,1.5526104e-05
14722,tumor,31,32,147,152,"In tumor, spleen and blood, the number of cytotoxic CD8(+) T cells and CD57(+) natural killer cells and the levels of IL-10 increased, but that of tumor necrosis factor- (TNF-), IL-1 and IL-6 decreased.",21423208_5,-1,1,-1,1,14722,-1,0.0005892658,0.99926585,0.00014490906
34542,TGF1,7,8,39,44,The present study analyzes the in situ TGF1 expression in 23 cases of lymphocyte-rich gastric carcinomas (Ly-rich GCs) using immunohistochemistry and in situ hybridization.,29594353_3,-1,1,-1,1,34542,-1,2.0489057e-05,0.9999622,1.7321756e-05
42310,the,22,23,127,130,"BACKGROUND: Amplification of the MYCN oncogene is a molecular hallmark of aggressive neuroblastoma (NB), a childhood cancer of the sympathetic nervous system.",34016720_0,-1,1,-1,1,42310,-1,2.5440113e-05,0.9999583,1.6261685e-05
18317,the,5,6,37,40,"We observed that mcd-exosomes helped the maturation of dendritic cells, enhancing T cell proliferation induced by the treated dendritic cells.",22898052_2,-1,1,-1,1,18317,-1,2.27574e-05,0.9999678,9.438921e-06
9338,T,34,35,248,249,"Adoptive transfer of CD8(+) T cells of NFATc2((-/-)) mice induced transforming growth factor-beta(1) in the airways of recipient mice, thus supporting CD4(+)CD25(+)Foxp-3(+)glucocorticoid-induced tumor necrosis factor receptor (GITR)(+) regulatory T (T(reg)) cell survival.",19318584_4,-1,1,-1,1,9338,-1,2.6304793e-05,0.9999378,3.586511e-05
26069,transplanted,17,18,102,114,IL-22 alone or with a STAT3 inhibitor was injected into a BALB/c nude mouse model with subcutaneously transplanted RKO cells to study the effects of IL-22 on colon cancer growth.,25892871_3,-1,1,-1,1,26069,-1,4.227792e-05,0.99993575,2.196188e-05
21996,Foxp3,10,11,63,68,"METHODS: We assessed the expression of interleukin (IL)-17 and Foxp3 in the peripheral blood of endometrial carcinoma patients and healthy controls by flow cytometry to determine the relative numbers of Th17, Tc17 and Treg cells.",24388919_3,-1,1,-1,1,21996,-1,2.42795e-05,0.9999629,1.2744274e-05
15845,The,2,3,13,16,"CONCLUSIONS: The CCL20-CCR6 axis mediates the migration of circulating Tregs into tumor microenvironment, which in turn results in tumor progression and poor prognosis in HCC patients.",21935436_7,-1,1,-1,1,15845,-1,1.8001101e-05,0.99997413,7.9048905e-06
42832,transformation,8,9,52,66,Cholangiocarcinoma (CCA) results from the malignant transformation of cholangiocytes.,34495298_0,-1,1,-1,1,42832,-1,3.1323092e-05,0.99992836,4.031108e-05
38600,TIGIT,17,18,91,96,"RUNX3 was associated with a variety of immunomodulators, including LAG3, CTLA-4, PD-1, and TIGIT.",31898342_11,-1,1,-1,1,38600,-1,4.174011e-05,0.99992394,3.430139e-05
31788,to,10,11,56,58,"PEPvIII, a peptide sequence from EGFRvIII, was designed to represent a target of glioma and is presented by MHC I/II complexes.",28412740_2,-1,1,-1,1,31788,-1,2.2310189e-05,0.9999678,9.847421e-06
41721,the,24,25,179,182,"Although IRF-1 upregulated CXCR3 expression in HCC cells, it inhibited proliferation and exerted pro-apoptotic effects, which overcome proliferation partly mediated by activating the CXCL10/CXCR3 autocrine axis.",33689775_5,-1,1,-1,1,41721,-1,1.8567514e-05,0.99997354,7.939822e-06
26940,Th22,11,12,74,78,We also found that there was a significantly positive correlation between Th22 and Th17 cells in MM patients.,26255628_7,-1,1,-1,1,26940,-1,5.2240524e-05,0.9999223,2.551189e-05
22973,the,15,16,83,86,"Western blot analysis, EMSA and ChIP assay were employed to detect the activity of the NF-B and AP-1 signaling pathways.",24676671_3,-1,1,-1,1,22973,-1,1.8073582e-05,0.9999727,9.250982e-06
39592,these,1,2,4,9,"For these reasons, we aimed to further characterize the role of BRAF-V600E mutation in the modulation of PD-L1, a known immunoregulatory molecule, and galectin-1 (Gal-1), a potent immunoregulatory lectin involved in melanoma immune privilege.",32330348_3,-1,1,-1,1,39592,-1,2.2331104e-05,0.9999664,1.1253409e-05
6737,than,31,32,147,151,"In this study, we show that the frequency of AFP(46-55) CD4(+) T cells is significantly higher (p = 001) in patients with hepatocellular carcinoma than in healthy donors, suggesting that these cells are expanded in response to tumor Ag.",18354237_5,-1,1,-1,1,6737,-1,2.0120513e-05,0.999969,1.0839348e-05
20859,Therapeutic,0,1,0,11,"Therapeutic cancer vaccines show promise in preclinical studies, yet their clinical efficacy is limited.",23922012_0,-1,1,-1,1,20859,-1,2.570302e-05,0.99996185,1.2433425e-05
30148,the,15,16,85,88,"Thus, our study indicates that the high level of IL-35 in colorectal cancer promotes the production of IL-35 via STAT1 and STAT3, which suppresses T cell proliferation and may participate in tumor immunotolerance.",27682874_10,-1,1,-1,1,30148,-1,1.7722135e-05,0.9999739,8.352405e-06
21176,thymic,13,14,84,90,Involution was found to be associated with less proliferation and more apoptosis of thymic epithelial cells (TEC).,24051497_5,-1,1,-1,1,21176,-1,5.8764927e-05,0.9999074,3.3829732e-05
12455,the,17,18,93,96,The expression of IDO and forkhead box P3 (FoxP3) transcription factor was also increased in the presence of simvastatin.,20491794_7,-1,1,-1,1,12455,-1,2.2165459e-05,0.9999703,7.489812e-06
29249,the,3,4,26,29,"We therefore investigated the phenotypic and functional differences among in vitro activated CD8(+) T cells of three different sources, namely nave (NTeff), memory (MTeff) and tumor-infiltrating lymphocytes (TILeff) from human and mice, to better understand mechanisms behind potent effector functions and potential for overcoming current limitations.",27306834_1,-1,1,-1,1,29249,-1,1.4966306e-05,0.9999777,7.336236e-06
16202,T(reg,3,4,19,24,"By adding expanded T(reg), a higher capability for suppressing T(eff) could be shown in comparison with freshly isolated T(reg).",22041284_9,-1,1,-1,1,16202,-1,2.2770959e-05,0.99995494,2.2245931e-05
39937,The,0,1,0,3,"The systemic administration of DCs that pulse ALP and ovalbumin peptides strongly increased cytotoxic T lymphocyte (CTL) activity (by 9.5% compared to that in the control vaccine groups), the generation of CD107a-producing multifunctional T cells, and Th1-mediated humoral immunity, and caused a significant reduction (increased protection by 29% over that in control vaccine groups) in tumor growth.",32486094_7,-1,1,-1,1,39937,-1,1.7277594e-05,0.999974,8.664428e-06
13339,tumor-invaded,11,12,52,65,"CD8(+) FOXP3(+) CD25(+) T lymphocytes were found in tumor-invaded lymph nodes (TILN), s.c. metastases, and advanced primary lesions.",20861189_3,-1,1,-1,1,13339,-1,4.4175362e-05,0.9999279,2.798533e-05
28739,Th17,0,1,0,4,"Th17 conversion of MAC-1 cells by IL-2 was blocked by pharmacological inhibition of JAK3 or STAT5, implicating IL2RG - JAK3 - STAT5 signaling in plasticity responses.",27144517_6,-1,1,-1,1,28739,-1,3.1480427e-05,0.9999528,1.5778109e-05
16463,Tbet,22,23,138,142,"Since IL-12 is a classical promoter of type-1 immunity, the current study was undertaken to determine whether gene therapy using combined Tbet and IL-12 complementary DNA (cDNA) would yield improved antitumor efficacy based on the complementary/synergistic action of these biologic modifiers.",22215017_1,-1,1,-1,1,16463,-1,2.1328153e-05,0.9999639,1.475062e-05
43315,transformation,5,6,43,57,This model recapitulates the dysfunctional transformation of tumor infiltrating T-cells.,35177622_3,-1,1,-1,1,43315,-1,2.2934442e-05,0.9999486,2.8493747e-05
27066,Bcl-6,25,26,160,165,"TFH cells can be identified by a combination of markers, including the chemokine receptor CXCR5, costimulatory molecules ICOS and PD-1, transcription repressor Bcl-6, and cytokine IL-21.",26300592_1,-1,1,-1,1,27066,-1,0.00021615165,0.9992669,0.0005169202
26250,their,6,7,28,33,"RESULTS: Women with CIN and their controls had similar T-cell mediated immunity against HPV16 E2, E6 and E7 peptide pools.",25990808_4,-1,1,-1,1,26250,-1,3.140478e-05,0.9999541,1.44602645e-05
28198,the,9,10,51,54,"Finally, we report that inhibition of KRAS reduces the infiltration of Tregs in KRAS-driven lung tumorigenesis even before tumor formation.",26880715_6,-1,1,-1,1,28198,-1,1.674208e-05,0.9999753,7.889114e-06
14873,Tregs,31,32,176,181,"Moreover, using the purified CD4(+)CD25(-) T cells, we confirmed that the increased Tregs were mainly induced from the conversation of CD4(+)CD25(-) naive T cells, and induced Tregs were functional and able to suppress the proliferation of effector T cells.",21528082_11,-1,1,-1,1,14873,-1,2.0947748e-05,0.99996567,1.3360468e-05
42809,the,21,22,142,145,"Cbs heterozygous knockout mice, C57BL/6 mice, nude mice and non-obese diabetic severe combined immunodeficiency mice were used to investigate the in vivo functions of CBS.RESULTS: Downregulation of CBS was observed in HCC, and low expression of CBS predicted poor prognosis in HCC patients.",34413167_5,-1,1,-1,1,42809,-1,1.6645408e-05,0.9999759,7.4696386e-06
42277,to,13,14,90,92,"Thus, DNGR-1 blockade may improve antitumor immunity in tumor therapy settings associated to high Flt3L expression.",33980589_15,-1,1,-1,1,42277,-1,3.4902012e-05,0.9999523,1.2794993e-05
25136,the,8,9,37,40,"The focus of this study is to define the interaction between tumour and immune system, i.e. how immune tolerance starts and gradually leads to the induction of adaptive Treg cells in the tumour microenvironment.",25284464_2,-1,1,-1,1,25136,-1,1.7306747e-05,0.9999757,6.9835214e-06
38210,the,9,10,59,62,Chromatin immunoprecipitation (ChIP) was applied to detect the direct binding of p65 to miR-23a promoter.,31769216_6,-1,1,-1,1,38210,-1,1.64049e-05,0.9999757,7.933807e-06
28401,T,8,9,51,52,The activity of DNA methyltransferases from CD4(+) T was decreased during this process.,27000869_7,-1,1,-1,1,28401,-1,2.5960322e-05,0.99994624,2.7779684e-05
15663,transcription factor,13,15,71,91,Signal transducer and activator of transcription 3 (Stat3) is a potent transcription factor with diverse biological functions.,21864492_0,-1,1,-1,1,15663,-1,3.012781e-05,0.99994755,2.2348771e-05
36332,tumors,21,22,179,185,"When coadministered in immunocompetent models, the combination of niraparib and anti-PD-1 demonstrated synergistic antitumor activities in both BRCA-proficient and BRCA-deficient tumors.",30755715_4,-1,1,-1,1,36332,-1,1.8964678e-05,0.9999695,1.1610732e-05
25214,the,18,19,95,98,"Remarkably, this molecular pathway requires STING, but not TLR or NLR function, and results in the activation of IRF3 in a TBK1-dependent manner.",25385820_4,-1,1,-1,1,25214,-1,1.8182365e-05,0.9999721,9.731493e-06
37455,TAMs,39,40,258,262,"Treg cells suppressed CD8+ Tcell secretion of interferon- (IFN), which would otherwise block the activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated fatty acid synthesis in immunosuppressive (M2-like) tumor-associated macrophages (TAMs).",31350177_3,-1,1,-1,1,37455,-1,2.0933861e-05,0.9999683,1.0794106e-05
12859,that,4,5,25,29,We have previously shown that a treatment course with blocking anti-CTLA-4-mAb in murine allogeneic bone marrow chimeras induces an antileukemic response in close association with systemic autoimmunity.,20600326_2,-1,1,-1,1,12859,-1,2.0101754e-05,0.99997175,8.162421e-06
33502,the,26,27,145,148,"Here the authors show that TTP, encoded by Zfp36, degrades p28 to inhibit IL-27 production by macrophages and is thereby a negative regulator of the antitumour response.",29021521_9,-1,1,-1,1,33502,-1,1.8379898e-05,0.9999733,8.307191e-06
3463,T,11,12,80,81,CONCLUSIONS: AdCD40L gene therapy evokes Th1 cytokine responses and counteracts T regulatory cell development and/or function.,16361570_13,-1,1,-1,1,3463,-1,3.9497743e-05,0.9999094,5.109507e-05
22455,plays,2,3,16,21,Notch signaling plays a pivotal role in cell fate decision and lineage commitment of lymphocytes.,24489102_0,-1,1,-1,1,22455,-1,3.1477233e-05,0.9999534,1.517895e-05
21289,tumors,12,13,83,89,Over-expression of the proto-oncogene c-MYC is frequently observed in a variety of tumors and is a hallmark of Burkitts lymphoma.,24130880_0,-1,1,-1,1,21289,-1,2.3237786e-05,0.9999602,1.659669e-05
40549,triterpenoid,11,12,59,71,"In this study, we investigated the anti-cancer effect of a triterpenoid, glycyrrhizic acid (GA) on melanoma.",32890791_3,-1,1,-1,1,40549,-1,0.00024510303,0.99962556,0.00012935264
7208,gene,44,45,301,305,"To verify this hypothesis and develop the most effective dendritic cell vaccine against Ewing's sarcoma, we evaluated the antitumor efficacy of dendritic cell-Ewing's sarcoma hybrids and dendritic cells pulsed with other antigen-loading methods, including cell lysates and the characteristic EWS-FLI1 gene of Ewing's sarcoma, using an A673 cell line as a model.",18563501_1,-1,1,-1,1,7208,-1,4.582042e-05,0.9999229,3.1348234e-05
8123,these,12,13,80,85,"vFLIP activated NF-kappaB in mouse bone marrow-derived DCs in vitro and matured these DCs to a similar extent as lipopolysaccharide; costimulatory markers CD80, CD86, CD40, and ICAM-1 were upregulated and tumor necrosis factor alpha and interleukin-12 secreted.",19036811_2,-1,1,-1,1,8123,-1,2.1964814e-05,0.9999615,1.6484839e-05
30842,the,5,6,53,56,"Tumor-infiltrating lymphocytes coexpressed PD-1 with the inhibitory receptors TIM-3, CTLA-4, LAG-3, and TIGIT, but also displayed a recently activated, nonexhausted phenotype.",27979840_3,-1,1,-1,1,30842,-1,2.1486034e-05,0.99996614,1.2365897e-05
35315,through,23,24,142,149,Mucosa-associated lymphoid tissue 1 (Malt1) regulates immune cell function by mediating the activation of nuclear factor B (NF-B) signaling through both its adaptor and proteolytic function.,30025160_0,-1,1,-1,1,35315,-1,2.0591058e-05,0.9999671,1.23016625e-05
9945,their,14,15,83,88,"Patients with NSCLC have increased numbers of CD4(+)CD25(high) FOXP3(+) T(regs) in their peripheral blood and pleura effusion (PE), which express high levels of CTLA-4, GITR.",19538059_4,-1,1,-1,1,9945,-1,1.9416166e-05,0.9999702,1.0359199e-05
37775,LPS,2,3,18,21,Administration of LPS (at a dose that elicited levels of proinflammatory cytokines comparable to those by the anti-TLR4 mAb) plus OVA induced no or less-marked activation of OVA-specific T-cells and failed to suppress tumour growth in mice.,31515801_10,-1,1,-1,1,37775,-1,4.1536707e-05,0.9999304,2.8062987e-05
14504,the,46,47,248,251,"We now show that TEMs also express higher levels of IL-10 than TIE2(-) macrophages in tumors and that ANGPT2-stimulated release of IL-10 by TEMs suppresses T cell proliferation, increases the ratio of CD4(+) T cells to CD8(+) T cells, and promotes the expansion of CD4(+)CD25(high)FOXP3(+) Tregs.",21368233_4,-1,1,-1,1,14504,-1,1.7076285e-05,0.9999747,8.241251e-06
23333,the,13,14,94,97,"Thus, therapies to deplete Aire-expressing mTECs represent an attractive strategy to increase the pool of tumor-specific effector T cells.",24752296_4,-1,1,-1,1,23333,-1,1.6946437e-05,0.99997485,8.208958e-06
15447,the,5,6,32,35,"T cell progenitors originate in the bone marrow and, through a series of defined and coordinated developmental stages, enter the thymus, differentiate, undergo selection, and eventually mature into functional T cells.",21740230_3,-1,1,-1,1,15447,-1,2.1984682e-05,0.9999654,1.2600347e-05
4638,type,11,12,71,75,"About 50% of cervical cancers are associated with human papillomavirus type 16 (HPV-16), and since the HPV-16 E6 and E7 oncoproteins are constitutively expressed in the tumor cells, they are attractive targets for cytotoxic T lymphocyte (CTL)-mediated immunotherapy.",17096336_0,-1,1,-1,1,4638,-1,3.7045433e-05,0.99993885,2.4136543e-05
10493,FOXP3,16,17,92,97,"In summary, our findings show that ovarian carcinoma cells are able to induce expression of FOXP3 and exhibit suppressive ability in activated nave T cells by producing soluble substances, and multiple cytokines involve in the induction of FOXP3 expression.",19673890_8,-1,1,-1,1,10493,-1,1.889561e-05,0.9999697,1.14243185e-05
29847,Tregs,13,14,71,76,"Here, we provide a review of literature related to the contribution of Tregs in tumor dormancy or recurrence.",27603507_2,-1,1,-1,1,29847,-1,2.3273213e-05,0.9999653,1.1372071e-05
39669,that,7,8,61,65,"The microarray analysis and functional experiments indicated that breast tumour cell-derived exosomes (TDEs) could transmit lncRNA SNHG16, which upregulates CD73 expression, to V1 T cells.",32345959_5,-1,1,-1,1,39669,-1,1.7248065e-05,0.9999734,9.391527e-06
27798,FoxP3+Tregs,20,21,138,149,"In addition, the change of Treg immunosuppressive cytokine interleukin (IL)-10 was examined with IHC and real-time PCR.RESULTS: increased FoxP3+Tregs were observed in the adenomatous stroma/epithelium and the density in colorectal adenomas, which was similar to that in the CRCs, significantly increased as compared to normal tissues.",26724144_3,-1,1,-1,1,27798,-1,2.0067635e-05,0.9999678,1.2106357e-05
2327,Thus,0,1,0,4,"Thus, CD40 stimulation in cervical carcinoma cell lines expressing a TAP-dependent human papillomavirus 16 E6 Ag epitope resulted in their enhanced killing by specific CTLs.",15611226_4,-1,1,-1,1,2327,-1,2.3615305e-05,0.9999641,1.2310757e-05
21715,Tregs,4,5,27,32,"High intratumoral FoxP3(+) Tregs with high peritumoral IL-17(+) T cells showed a significantly lower survival rate compared with other groups (OS, P < 0.001 and DFS, P < 0.001).CONCLUSION: Our findings suggest that intrahepatic IL-17(+) T cells and FoxP3(+) Tregs may cooperate to promote the progression of HCC.",24303990_8,-1,1,-1,1,21715,-1,2.0371252e-05,0.99996376,1.5815778e-05
42003,that,6,7,35,39,"Taken together, our findings imply that considering the involvement of miR-124 in the regulation of PD-L1 through colorectal tumorigenesis and its remarkable antitumor effects, this miRNA could be regarded as the promising target for the development of therapeutic approaches for colorectal cancer.",33821473_10,-1,1,-1,1,42003,-1,1.9744211e-05,0.9999714,8.902766e-06
17767,tumor-node-metastasis,16,17,115,136,"Finally, intratumoral CD8(+)Foxp3(+) T lymphocytes were significantly increased with tumor progression in terms of tumor-node-metastasis (TNM) stage.",22729557_10,-1,1,-1,1,17767,-1,9.31923e-05,0.99985707,4.9677677e-05
9898,LPS-mediated,12,13,100,112,Blockade of CD27-CD70 or CD28-CD80/86 interactions by anti-CD70 or anti-CD80/86 antibodies restored LPS-mediated induction of IL-17 expression in CD4(+) T cells cocultured with lymphoma B cells.,19509224_2,-1,1,-1,1,9898,-1,4.0501647e-05,0.9999306,2.8917715e-05
13710,treatment,16,17,107,116,"Conversely, increased expression of PLZF/CD27 and CTLA4 was seen after treatment with no expression before treatment.",21061759_4,-1,1,-1,1,13710,-1,2.6483402e-05,0.9999614,1.216644e-05
27852,the,10,11,56,59,"The number and cell proliferative activity of FCAs, and the incidence and multiplicity of HCC were significantly greater in the IDO-WT than in the IDO-KO mice.",26727596_5,-1,1,-1,1,27852,-1,1.715343e-05,0.99997234,1.0482512e-05
18769,to,6,7,35,37,The potency of the therapy extends to support a bystander killing effect of antigen loss variants.,23008334_6,-1,1,-1,1,18769,-1,2.9763696e-05,0.999959,1.1263267e-05
3009,the,15,16,110,113,These results suggest that phyto-oestrogens and some of their metabolites may increase allergic responses via the enhancement of IL-4 production in T cells.,16108819_8,-1,1,-1,1,3009,-1,1.7866707e-05,0.99997413,8.025149e-06
37412,Release,0,1,0,7,Release of interleukin 1 (IL-1) from cancer-associated fibroblasts (CAF) induces CCL22 mRNA expression in oral cancer cells by activating transcription factor nuclear factor kappa B (NF-B).,31325403_8,-1,1,-1,1,37412,-1,2.2828008e-05,0.9999633,1.3937869e-05
16158,gene,26,27,179,183,"PML knockdown increased IFN--mediated Signal Transducer and Activator of Transcription-1 (STAT-1) binding to the IP-10 promoter, resulting in elevated transcription of the IP-10 gene.",22022583_7,-1,1,-1,1,16158,-1,2.4563795e-05,0.999956,1.9456316e-05
29494,tumors,39,40,238,244,Several studies indicate that a correct combination of cluster of differentiation 8 and cluster of differentiation 4 T cells is key to fight tumor progression and that the presence of regulatory T cells (Tregs) infiltrating ovarian solid tumors (or present in ascites) is deleterious.,27420920_1,-1,1,-1,1,29494,-1,2.1578835e-05,0.9999672,1.1199821e-05
2377,states,26,27,141,147,"Antioxidants, such as 2-mercaptoethanol (2-ME), or fetal calf serum could prevent the death of these cells but caused them to enter distinct states of differentiation.",15614042_3,-1,1,-1,1,2377,-1,3.7140602e-05,0.9999181,4.4717905e-05
7409,type,33,34,212,216,"In accordance with these observations, different DCs clinically used as cancer vaccines show different Treg-recruiting abilities, with PGE(2)-matured DC, but not type 1-polarized DC, generated in the presence of type I and type II IFNs, showing high Treg-attracting activity.",18632653_5,-1,1,-1,1,7409,-1,2.8095501e-05,0.9999553,1.6547125e-05
13225,that,33,34,210,214,"These characteristics provided a survival advantage to T cells cocultured with tumor cells in vitro; CD3/28-stimulated T cells expressing a chimeric antigen receptor (CAR) specific for disialoganglioside (GD2) that redirected their activity to the immunosuppressive, GD2-expressing neuroblastoma cell line, LAN-1, resisted tumor-induced apoptosis when co-expressing transgenic caAkt.",20842106_5,-1,1,-1,1,13225,-1,2.0613572e-05,0.999967,1.2415431e-05
25545,the,18,19,126,129,METHODS: We performed genome and exome sequencing and mapped shared chromosomal regions to identify genetic predisposition in the family.,25492914_3,-1,1,-1,1,25545,-1,1.9916117e-05,0.9999714,8.699271e-06
31652,TH,12,13,72,74,"Moreover, in iNKT cell-deficient APCMin/+ mice, expression of T-helper (TH) 1-associated genes, such as IFN- and Nos2, was increased in polyps, concomitantly with elevated frequencies of conventional CD4+ and CD8+ T cells in this tissue.",28401935_5,-1,1,-1,1,31652,-1,3.0214287e-05,0.9999498,1.9936077e-05
35694,Th,38,39,219,221,"PBMCs were stimulated with PMA and ionomycin in the presence of Berefeldin A as Golgi stop agent to detect intracellular cytokine production (IFN-, IL-17, and IL-4) from CD3+CD4+T cells population indicating T helper (Th) cells subsets by flowcytometry.",30246693_4,-1,1,-1,1,35694,-1,4.114539e-05,0.99992895,2.984503e-05
28084,Foxp3+CD4,6,7,39,48,The DC vaccine reduced accumulation of Foxp3+CD4+ regulatory T cells within the tumor microenvironment and prevented TGF- production from the tumor tissue.,26786094_6,-1,1,-1,1,28084,-1,0.00022859553,0.99874675,0.0010246875
8276,the,2,3,9,12,"However, the overall roles of T helper type 1 (Th1), Th2, and T-regulatory cell (Treg) responses and osteoclast regulatory factors in periapical cysts and granulomas have not been fully determined.",19121066_1,-1,1,-1,1,8276,-1,1.9547137e-05,0.9999715,8.932661e-06
34775,To,2,3,6,8,AIMS: To evaluate the roles of PE in the regulation of anti-tumor effects and the cellular immune response in the tumor microenvironment.,29783020_1,-1,1,-1,1,34775,-1,1.754542e-05,0.99997354,8.908807e-06
30639,Treg,23,24,155,159,The overall findings indicate that antitumor immunity in asbestos-exposed individuals may be reduced in Treg through changes in the function and volume of Treg.,27878235_6,-1,1,-1,1,30639,-1,2.8768553e-05,0.9999529,1.8294708e-05
41246,TGF,19,20,109,113,"Expression of SOX4 is regulated by the integrin v6 receptor on the surface of tumor cells, which activates TGF from a latent precursor.",33385331_3,-1,1,-1,1,41246,-1,4.272526e-05,0.9999411,1.6194334e-05
1263,tumor-bearers,12,13,66,79,"Interestingly, elevated levels of IL-11 were found in the sera of tumor-bearers, when compared to normal animals and even higher levels of IL-11 were detected in the tumor cystic fluid.",12527946_4,-1,1,-1,1,1263,-1,3.9869738e-05,0.99992883,3.125311e-05
36413,the,12,13,80,83,Conclusions: Elevated circulating CD4+CD25-Foxp3+ Treg cells may be involved in the pathogenesis of NSCLC.,30925076_8,-1,1,-1,1,36413,-1,2.226841e-05,0.9999684,9.270142e-06
10516,the,12,13,81,84,"Tumor and spleen CD4+CD25+Foxp3+ regulatory T lymphocytes, cytotoxic activity of the splenocytes, IFN-gamma and IL-4 secretion were assessed to describe the anti-tumor immune response.",19706340_3,-1,1,-1,1,10516,-1,2.1288573e-05,0.999967,1.1677976e-05
24076,the,9,10,46,49,"METHODS: The PDA cell lines were analyzed for the expression of MHC class I, II, and antigen-processing molecules by flow cytometry or polymerase chain reaction.",24987872_2,-1,1,-1,1,24076,-1,1.7570173e-05,0.9999739,8.578107e-06
3848,FOXP3,16,17,90,95,CD56+CD3- natural killer (NK) cells also expanded during IL-2 therapy but did not express FOXP3.,16645171_6,-1,1,-1,1,3848,-1,2.2912536e-05,0.9999647,1.2340586e-05
28460,tumor,8,9,63,68,"Consequently, combined BV6 and radiation completely suppressed tumor growth in vivo.",27014915_8,-1,1,-1,1,28460,-1,1.848902e-05,0.9999714,1.01006135e-05
18201,The,0,1,0,3,The mechanisms responsible for such accumulation remain to be elucidated.,22828446_10,-1,1,-1,1,18201,-1,1.989248e-05,0.9999713,8.830789e-06
22562,This,2,3,13,17,CONCLUSIONS: This study indicates that Tc17 cell infiltration in cervical cancers is associated with cancer progression accompanied by increased infiltrations of Th17 cells and regulatory T cells as well as promoted tumor vasculogenesis.,24523865_6,-1,1,-1,1,22562,-1,2.206173e-05,0.9999659,1.2042655e-05
35871,FoxP3,4,5,26,31,"RESULTS: The infiltrating FoxP3+ regulatory T cells (Tregs) in tumor tissues were associated with survival, while CD8+ tumor infiltrating lymphocytes (TILs) were not.",30359281_5,-1,1,-1,1,35871,-1,2.7497836e-05,0.99995565,1.6880736e-05
1590,the,6,7,37,40,Here we report the identification of the LAGE1 protein as a ligand for tumor-specific CD4(+) Treg cell clones generated from the tumor-infiltrating lymphocytes (TILs) of cancer patients.,14738769_2,-1,1,-1,1,1590,-1,1.6305514e-05,0.9999758,7.933861e-06
8839,the,9,10,43,46,"Thus, although the impact of TH17 cells on the evolution of EOC remains to be established, our data suggest that local IL-2 treatment in ovarian cancer may result in the conversion of tumor-associated Treg into TH17 cells, relieve Treg-mediated suppression, and contribute to enhance antitumor immunity.",19238008_6,-1,1,-1,1,8839,-1,1.7500377e-05,0.9999752,7.3251163e-06
1723,T-bet,25,26,133,138,"IL-27 is a novel IL-12 family member that plays a role in the early regulation of T helper cell 1 initiation, including induction of T-bet and IL-12 receptor beta 2 expression.",14871851_1,-1,1,-1,1,1723,-1,2.4479166e-05,0.99995804,1.7510378e-05
960,to,43,44,276,278,"We systematically investigated the impact of the relative maturation levels of dendritic cells (DCs) on their cell surface phenotype, expression of cytokines and chemokines/chemokine receptors (by DNA array and RNase protection analyses), biological activities, and abilities to induce tumor immunity.",11902830_0,-1,1,-1,1,960,-1,2.2107411e-05,0.9999677,1.0240927e-05
5484,the,12,13,71,74,IL-6 was able to suppress DC differentiation and G-CSF mainly acted on the suppressing allostimulatory capacity of DCs.,17545630_7,-1,1,-1,1,5484,-1,1.9531917e-05,0.99997175,8.69337e-06
12811,to,23,24,145,147,Results showed that H22/B7-1/B7-2/4-1BBL tumor vaccines probably protect the infiltrating lymphocytes from apoptosis and induce NF-B activation to improve T-cell-mediated antitumor response.,20563597_7,-1,1,-1,1,12811,-1,2.3401348e-05,0.9999665,1.0105092e-05
9963,Tregs,17,18,124,129,"These T-cells might prevent effective antitumor immune responses, and the increase in frequency of CD4(+)CD25(high)FOXP3(+) Tregs might play a role in the modulation of the immune response against NSCLC and could be important in the design of immunotherapeutic approaches.",19538059_7,-1,1,-1,1,9963,-1,2.1163221e-05,0.9999665,1.2378728e-05
23846,than,13,14,76,80,"RepSox-treated AML cells displayed higher CD34, CXCL12, and MYC mRNA levels than dimethyl sulfoxide-treated controls.",24855276_7,-1,1,-1,1,23846,-1,2.3951417e-05,0.99996126,1.4808312e-05
17330,These,0,1,0,5,These novel findings demonstrate that SCLC tumour cells can induce CD4(+) T-cell-mediated immunosuppression.,22532287_9,-1,1,-1,1,17330,-1,2.0949006e-05,0.99997044,8.600169e-06
10949,Treg,7,8,26,30,CD25+ FOXP3+CD4+ T cells (Treg) have been considered to play an important role in immune tolerance against several tumor antigens.,19902430_0,-1,1,-1,1,10949,-1,2.2553717e-05,0.99996567,1.1729527e-05
40636,three,46,47,321,326,"Furthermore, this combination therapy showed significant abscopal effect on the nonirradiated tumors in a concomitant model of mesothelioma through systemic activation of cytotoxic T cells and enhanced production of IFN- and granzyme B. Although local control was preserved with one fraction of nonablative irradiation, three fractions were required to generate the abscopal effect.",32948683_4,-1,1,-1,1,40636,-1,0.00029259836,0.99957615,0.00013125264
28069,The,0,1,0,3,"The impact of DC vaccine loaded with Hepa1-6 cell lysate on tumor progression, survival, and tumor-infiltrating lymphocytes and cytokines was examined.",26786094_3,-1,1,-1,1,28069,-1,1.8254897e-05,0.99997365,8.097657e-06
41289,the,2,3,9,12,"However, the influence of the tumor microenvironment (TME) on immune cells is not completely understood.",33419764_1,-1,1,-1,1,41289,-1,2.1019912e-05,0.9999715,7.455671e-06
24958,thereby,42,43,297,304,"These results demonstrate that nicotine suppresses acute colitis and colitis-associated tumorigenesis, and this effect may be associated with the activation of 7-nAChR. Furthermore, it is presumed that nicotine downregulates the expression of inflammatory mediators such as IL-6/Stat3 and TNF-, thereby reducing the colonic tumorigenesis associated with chronic colitis.",25258409_9,-1,1,-1,1,24958,-1,2.12373e-05,0.99996924,9.461871e-06
386,the,43,44,287,290,"Administration of anti-(interleukin-12) (anti-IL-12) and anti-(interferon gamma) (anti-IFNgamma) antibodies in tumor-bearing animals showed down-regulation of the expression of CD40L on NK and T cells with simultaneous inhibition of cytotoxic acitivity of NK cells, cytokine release and the production of antitumor antibody.",11129327_6,-1,1,-1,1,386,-1,1.9168541e-05,0.9999721,8.7239105e-06
39156,relative,11,12,66,74,"Moreover, we found that tumors from high-risk patients had higher relative abundance of T follicular helper cells, regulatory T cells, and M0 macrophages, and higher expression of PD-1, CTLA-4, LAG3, and CD47 than low-risk patients.",32028264_6,-1,1,-1,1,39156,-1,3.204287e-05,0.99994326,2.4687291e-05
40602,the,29,30,191,194,"Our results suggest that the EVs secreted by genetically modified tumor cells harboring TNFSF ligands can induce T cell proliferation, inhibit the transcription factor FoxP3, associated with the maintenance of Treg phenotype, and enhance antitumor activity mediated by immune cells.",32939048_5,-1,1,-1,1,40602,-1,1.8314304e-05,0.99997246,9.191971e-06
7569,the,32,33,173,176,"In 80 B-CLL patients, the frequency of Treg (CD4+CD25hi FOXP3+) cells was significantly higher in B-CLL patients when compared to healthy volunteers (HV) and increased with the progression of the disease (median: 8.24% in stage A, 11.24% in stage B and 12.57% in stage C according to the Binet classification).",18695923_3,-1,1,-1,1,7569,-1,1.8038545e-05,0.9999739,8.114993e-06
14945,tumor,40,41,274,279,These findings indicated that melanoma cells could have Foxp3-dependent Treg-like suppressive effects on T cells and suggested that the mimicking of Treg function by melanoma cells may represent a possible mechanism of tumor resistance to immune destruction in the melanoma tumor microenvironment.,21547596_8,-1,1,-1,1,14945,-1,1.9337102e-05,0.9999715,9.183059e-06
12932,their,14,15,128,133,Additional studies revealed that transduction and activation of monocyte-derived DCs with CD40-Ad-MART-1 significantly enhanced their priming efficiency of functional CD8(+) effector T cells with high avidity.,20664356_6,-1,1,-1,1,12932,-1,1.9758507e-05,0.9999713,8.970589e-06
26815,this,1,2,3,7,"In this review, we will first briefly depict the biochemistry of the cytokine, its receptor and the related signal transduction, before summarizing the regulation of IL-12 production and its biological functions.",26182974_7,-1,1,-1,1,26815,-1,2.6896914e-05,0.9999596,1.3568673e-05
942,the,2,3,6,9,"Thus, the data show that malignant CTCL cells themselves might contribute to the change in cytokine pattern accompanying progression of CTCL.",11807001_7,-1,1,-1,1,942,-1,1.8850862e-05,0.99997056,1.0552746e-05
11316,the,7,8,36,39,"Depletion of CD8+ T cells abrogated the effect of the combined IT, indicating a predominant role of these cells in driving the immune response.",20039320_6,-1,1,-1,1,11316,-1,2.608603e-05,0.99996364,1.0249131e-05
11932,the,13,14,93,96,CagA-overexpressing DC also exhibited a decline in the responses against LPS stimulation and the differentiation of CD4(+) T cells toward Th1 type cells compared to wild type DC.,20363211_4,-1,1,-1,1,11932,-1,1.809973e-05,0.99997354,8.35566e-06
3518,targets,16,17,117,124,The challenge for drug developers will be the exploitation of defined protein-protein or protein-DNA interactions as targets of inhibition.,16375697_10,-1,1,-1,1,3518,-1,3.0381863e-05,0.9999542,1.5363761e-05
18939,to,19,20,109,111,"The natural killer T (NKT) cell ligand, alpha-galactosylceramide (-GalCer), represents a potential adjuvant to boost immunotherapeutic vaccination strategies against poorly immunogenic cancers.",23090488_0,-1,1,-1,1,18939,-1,3.729326e-05,0.9999516,1.1055283e-05
36732,Treg,28,29,146,150,"Patients with high levels of IL-6 had significantly more Treg cells and elevated Programmed cell death protein-1 (PD-1) expression on CD4+, CD8+, Treg, and Th17 cells.",31027698_6,-1,1,-1,1,36732,-1,3.594822e-05,0.99993014,3.3845732e-05
29610,type,2,3,14,18,The high-risk type HPV 16 is associated with cervical carcinoma and head and neck squamous cell carcinoma.,27548034_1,-1,1,-1,1,29610,-1,2.651813e-05,0.99994624,2.7225937e-05
11716,the,1,2,3,6,"In the present study, we attempted to restore thymic function by BALB/c (H-2(d)) syngeneic (Syn), or B6 (H-2(b)) allogeneic (Allo) bone marrow transplantation (BMT) using intra-bone marrow-bone marrow transplantation (IBM-BMT) plus Syn-, Allo- or C3H (H-2(k)) 3rd-party fetal thymus transplantation (TT).",20229083_1,-1,1,-1,1,11716,-1,1.9505393e-05,0.9999709,9.575549e-06
42700,that,3,4,22,26,These results suggest that NFAT2 and miR-20a are crucial for regulating functional CD8+ T cells.,34237654_5,-1,1,-1,1,42700,-1,1.822649e-05,0.99997365,8.071135e-06
1436,the,16,17,103,106,Increasing the number of plasmid injections after tumor irradiation induced tumor regression in 70% of the mice.,12804139_7,-1,1,-1,1,1436,-1,2.5664409e-05,0.99995863,1.5743673e-05
372,tumor,4,5,32,37,The CD40-CD40L mediation during tumor regression was of interest.,11129327_3,-1,1,-1,1,372,-1,1.8681165e-05,0.9999714,9.9742965e-06
6379,the,24,25,113,116,"These responses were broad, involved both CD4(+) and CD8(+) T cells, and could be detected up to 12 months after the last vaccination.",18172269_3,-1,1,-1,1,6379,-1,2.3525554e-05,0.9999672,9.280436e-06
6351,that,7,8,52,56,"Further, immune cell depletion studies demonstrated that CpG-induced protective immunity was CD4+ T-cell dependent.",18157010_12,-1,1,-1,1,6351,-1,1.9034609e-05,0.99997187,9.115068e-06
22725,TGF--mediated,3,4,23,37,These findings confirm TGF--mediated effector Tm cell exhaustion as an important mechanism of immune suppression in B-cell NHL.,24569779_9,-1,1,-1,1,22725,-1,2.8956607e-05,0.9999443,2.6679258e-05
31469,to,32,33,180,182,"Tim-3 is a co-inhibitory receptor that is expressed on IFN-g-producing T cells, FoxP3+ Treg cells and innate immune cells (macrophages and dendritic cells) where it has been shown to suppress their responses upon interaction with their ligand(s).",28258697_4,-1,1,-1,1,31469,-1,2.0819782e-05,0.9999702,9.036627e-06
2121,this,27,28,183,187,"Therefore, our observations concerning the lack of functional HPV16-specific CD4+ T-cell immunity in patients with cervical cancer offer a possible explanation for the development of this disease.",15289354_8,-1,1,-1,1,2121,-1,1.8961506e-05,0.9999721,8.895864e-06
40857,Th,9,10,38,40,"Upon activation, nave CD4+ T helper (Th) cells differentiate into distinct Th effector cell lineages depending on the local cytokine environment.",33064842_0,-1,1,-1,1,40857,-1,3.445487e-05,0.9999443,2.1189833e-05
8266,to,26,27,164,166,"These results suggest that the loss of Smad3 increases susceptibility to colon cancer by at least two mechanisms: deficient T-regulatory cell function, which leads to excessive inflammation after a bacterial trigger; and increased expression of proinflammatory cytokines, enhanced nuclear factor-kappaB activation, and increased expression of both pro-oncogenic and anti-apoptotic proteins that result in increased cell proliferation/survival of epithelial cells in colonic tissues.",19119184_6,-1,1,-1,1,8266,-1,2.053898e-05,0.9999696,9.825507e-06
20544,Foxp3+Tregs,1,2,12,23,"Circulating Foxp3+Tregs were evaluated before and after temozolomide, and after IL-2.RESULTS: Among the 17 evaluable patients we observed 1 partial response (PR), 6 stable disease (SD) and 10 progressive disease (PD).",23725550_5,-1,1,-1,1,20544,-1,2.2775248e-05,0.99995923,1.7994329e-05
9142,time,3,4,14,18,"For the first time, we show that HER2-positive individuals with breast carcinomas have reduced numbers of circulating Th17 cells, which appear, in turn to have an inverse relationship with T(reg) frequency in MBC.",19277040_7,-1,1,-1,1,9142,-1,3.3714e-05,0.99993753,2.8707818e-05
3184,tumor-draining,4,5,22,36,The Treg generated in tumor-draining LNs possess the same functional properties as the Treg that arise naturally in the thymus but recognize tumor-associated Ag.,16210609_8,-1,1,-1,1,3184,-1,3.933057e-05,0.99994326,1.742722e-05
16940,the,4,5,23,26,TIM-3 was required for the negative effect of IL-12 on T cell function.,22426209_7,-1,1,-1,1,16940,-1,2.0733303e-05,0.99997175,7.47948e-06
8825,tumor,16,17,110,115,"Remarkably, analysis of EOC-associated conventional CD4CD25 T cell and Treg populations isolated ex vivo from tumor samples by cell sorting and cultured with tumor-associated CD3- cells in the presence of IL-2 revealed that EOC Treg stimulated under these conditions were rapidly converted into TH17 cells, down-regulated FOXP3 expression, and lost their suppressive capacity.",19238008_5,-1,1,-1,1,8825,-1,2.0182732e-05,0.99996865,1.1129224e-05
502,gene,5,6,25,29,"PTEN, a tumor suppressor gene, is essential for embryogenesis.",11371355_0,-1,1,-1,1,502,-1,7.6583514e-05,0.99980754,0.00011586935
27572,Th1,5,6,26,29,"The production of IFN by Th1 or Tc1 cells was sharply decreased and was accompanied by reduced T-bet mRNA, even when total T-cell numbers had recovered; the frequencies of Th17 and Treg cells and their specific transcription factors (RORt and Foxp3, respectively) were obviously increased.",26475064_7,-1,1,-1,1,27572,-1,6.824994e-05,0.9996784,0.00025342888
23606,tumor-rejecting,17,18,103,118,"In mice, genetic or pharmacologic suppression of FasL produced a substantial increase in the influx of tumor-rejecting CD8(+) over FoxP3(+) T cells.",24793239_4,-1,1,-1,1,23606,-1,7.225154e-05,0.99988997,3.7820457e-05
22179,the,12,13,79,82,DCs loaded with dying myeloma cells treated by JSI-124 and bortezomib produced the least amount of p-STAT3 compared to other treatments.,24407159_4,-1,1,-1,1,22179,-1,2.2083379e-05,0.9999653,1.2647058e-05
404,These,0,1,0,5,"These observations demonstrate that the expression of CD40L by the effector cells is regulated by IL-12 and IFNgamma, and could effectively modulate the NK-cell-mediated immune response during the regression of AK-5 tumor.",11129327_10,-1,1,-1,1,404,-1,1.8929793e-05,0.9999709,1.01576015e-05
20435,the,3,4,21,24,This study addresses the hypothesis that blocking RA receptor alpha (RAR) may enhance the efficacy of a tumour vaccine by inhibiting the induction of Treg cells.,23657628_4,-1,1,-1,1,20435,-1,1.855038e-05,0.99997354,7.939852e-06
41193,TAZ,2,3,13,16,Silencing of TAZ cancelled the effects of SKIL overexpression on malignant phenotypes and autophagy of NSCLC cells.,33268765_11,-1,1,-1,1,41193,-1,2.8846802e-05,0.9999578,1.3405583e-05
10184,this,8,9,43,47,"Thus, strategies that abrogate any part of this process should improve the outcome through activation of effector cells and prevention of tumor cell migration.",19567680_8,-1,1,-1,1,10184,-1,2.284786e-05,0.9999666,1.0538041e-05
12701,Treg,11,12,57,61,"In conclusion, the accumulation of Th17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.",20550524_8,-1,1,-1,1,12701,-1,2.1364895e-05,0.99996555,1.307645e-05
14983,AIRE,2,3,10,14,"Normally, AIRE drives low-level expression of huge numbers of peripheral tissue-specific antigens (TSAgs) in medullary thymic epithelial cells (mTECs), leading to the deletion of TSAg-reactive thymocytes maturing nearby.",21574164_1,-1,1,-1,1,14983,-1,0.00010904659,0.9998436,4.7339472e-05
20506,therapeutic,17,18,109,120,"Hypoxia, a common feature of solid tumors, has been associated with potentiated immunosuppression, decreased therapeutic response, malignant progression and local invasion.",23723999_1,-1,1,-1,1,20506,-1,5.4858094e-05,0.99992716,1.7964296e-05
38226,to,13,14,86,88,"Meanwhile, p65 functioned as a transcription repressor of miR-23a by directly binding to its promoter.",31769216_12,-1,1,-1,1,38226,-1,2.1169139e-05,0.9999685,1.0335972e-05
32444,these,2,3,10,15,"Together, these data suggest that CD70 expression is involved in promoting tumor aggressiveness and immunosuppression via tumor-associated macrophage recruitment/activation.",28612394_10,-1,1,-1,1,32444,-1,2.3154691e-05,0.9999666,1.0227759e-05
43107,The,0,1,0,3,The role of EZH2 in this process has not been fully addressed.,34737746_6,-1,1,-1,1,43107,-1,2.3612174e-05,0.999967,9.391584e-06
38640,SMAD,21,22,136,140,"Despite expressing high levels of TGF1 receptors on their surface, IRISOE TNBC cells channeled TGF1/TRI/II signaling toward AKT, not SMAD, which activated stemness/EMT phenotypes.",31911557_3,-1,1,-1,1,38640,-1,6.802113e-05,0.99990034,3.1667176e-05
18767,The,0,1,0,3,The potency of the therapy extends to support a bystander killing effect of antigen loss variants.,23008334_6,-1,1,-1,1,18767,-1,2.0090167e-05,0.9999722,7.6268943e-06
17351,treatment,41,42,246,255,"CD4(+)FoxP3(+) regulatory T cells (Tregs) have been shown to suppress T cell-mediated host immune responses against self- and nonself-antigens; however, the impact of CD4(+) Tregs on human antitumor immune responses and their influence on cancer treatment are unknown.",22555974_0,-1,1,-1,1,17351,-1,2.3627425e-05,0.999966,1.0320442e-05
32213,plays,1,2,13,18,Inflammation plays a critical role in the initiation of colorectal cancer but is also required to mediate antitumor immunity in established tumors.,28558303_0,-1,1,-1,1,32213,-1,3.412114e-05,0.999954,1.1868932e-05
24187,These,0,1,0,5,These mice developed lymphadenopathy and some organ infiltration by T cells but no splenomegaly and no detectable pathology.,25024217_4,-1,1,-1,1,24187,-1,2.3072289e-05,0.99996436,1.2535276e-05
14652,Tregs,6,7,45,50,"After adoptive transfer of HY-specific green Tregs (peripheral or thymic) to Rag2(-/-) B6 female mice bearing syngeneic HY-expressing MB49 tumors, a significant fraction rapidly lost expression of Foxp3.",21389255_1,-1,1,-1,1,14652,-1,2.5682522e-05,0.9999546,1.9705676e-05
19879,tested,8,9,51,57,"The interference efficiency of the TGF-1 gene was tested by real-time PCR and ELISA; the expression of Foxp3, IFN- and CD83 in CD4(+), CD8(+) or dendritic cells was examined via flow cytometry; and the tumorigenic ability of the cancer cells was investigated in the animal experiments.",23361571_3,-1,1,-1,1,19879,-1,2.0482332e-05,0.9999639,1.560867e-05
27736,Tregs,33,34,196,201,"The enhanced recruitment by CCL22 produced by EBVaGC cells, the decreased emigration due to CCR7 downregulation on the Treg surface, the higher proliferation rate, and the lower apoptosis rate of Tregs at tumour sites may promote the accumulation of Tregs in EBVaGC.",26673957_6,-1,1,-1,1,27736,-1,2.4455763e-05,0.9999609,1.4675899e-05
35197,tumor,12,13,58,63,Some mice were given an inhibitor of CXCL12 (AMD3100) and tumor growth was measured.,29909021_6,-1,1,-1,1,35197,-1,1.9371706e-05,0.99996936,1.1212477e-05
4877,the,28,29,226,229,Curcumin could prevent tumor-induced thymic atrophy by restoring the activity of NF-kappaB. Further investigations suggest that neutralization of tumor-induced oxidative stress and restoration of NF-kappaB activity along with the reeducation of the TNF-alpha signaling pathway can be the mechanism behind curcumin-mediated thymic protection.,17210719_9,-1,1,-1,1,4877,-1,1.9224912e-05,0.9999722,8.521913e-06
30656,This,0,1,0,4,This study investigated the immune modulation of Treg cells by ZA.METHODS: Flow cytometry was used to analyze the phenotypic and immunosuppressive characteristics of Treg cells treated with ZA.,27887569_5,-1,1,-1,1,30656,-1,2.018234e-05,0.9999702,9.605825e-06
25471,tumor,2,3,26,31,Statistically significant tumor growth inhibition was observed in BALB/c mice immunized with the VELs in both prophylactic and therapeutic settings.,25483665_5,-1,1,-1,1,25471,-1,2.0152718e-05,0.99996996,9.920436e-06
38527,TIL,6,7,54,57,"Strikingly, the tumors containing neoantigen-reactive TIL were classified as consensus molecular subtype 4 (CMS4), which is associated with TGF- pathway activation and worse clinical outcome.",31888734_7,-1,1,-1,1,38527,-1,2.2702727e-05,0.9999647,1.2534181e-05
20477,the,2,3,11,14,"We studied the effects of IL-22, an inducer of keratinocyte proliferation, on SCC proliferation in vitro.",23667456_3,-1,1,-1,1,20477,-1,1.8086626e-05,0.9999732,8.675856e-06
30796,The,0,1,0,3,The PDL1-PD1 (programmed death protein 1) signaling pathway promotes escape from immune surveillance in tumor cells.,27935862_2,-1,1,-1,1,30796,-1,1.9850526e-05,0.9999714,8.758542e-06
20256,tumor,21,22,135,140,"Consistently, enforced expression of SOCS-1 in CD8(+) Tcells phenocopied the miRNA-155 deficiency, whereas SOCS-1 silencing augmented tumor destruction.",23601686_5,-1,1,-1,1,20256,-1,1.9403184e-05,0.99997187,8.672256e-06
41328,that,18,19,139,143,We therefore developed synthetic promoters for regulation of gene expression under the control of inflammation and Hypoxia-induced signals that are associated with the tumor microenvironment (TME).,33514819_2,-1,1,-1,1,41328,-1,2.2217706e-05,0.99996805,9.707094e-06
43694,truncated,24,25,149,158,"These receptor functions required the presence of the box 3 motifs, as shown by the analysis of the mouse IL-10R constructs containing progressively truncated cytoplasmic domains.",8662928_10,-1,1,-1,1,43694,-1,3.5894176e-05,0.99993825,2.5878717e-05
33895,To,2,3,12,14,OBJECTIVES: To examine the expression and function of IL-25 in cutaneous T-cell lymphoma (CTCL).METHODS: Expression and location of IL-25 in lesional skin was investigated with immunohistochemistry.,29238954_2,-1,1,-1,1,33895,-1,1.8402638e-05,0.99997187,9.77614e-06
38937,two,11,12,62,65,"BACKGROUND: Urothelial bladder cancers (UBCs) are distinct in two main molecular subtypes, namely basal and luminal type.",31991796_0,-1,1,-1,1,38937,-1,3.4729626e-05,0.99994683,1.84686e-05
5818,the,24,25,171,174,Transwell inserts separating Treg from responders and neutralizing interleukin-10 (IL-10) or transforming growth factor-beta1 (TGF-beta1) antibodies were used to evaluate the mechanisms used by Treg to suppress responder cell proliferation.,17671115_4,-1,1,-1,1,5818,-1,1.7358474e-05,0.99997413,8.52709e-06
17994,to,16,17,106,108,"Moreover, WISP-1 was expressed in vivo following intradermal challenge with B16F10 cells and was inferred to be expressed at the tumor periphery.",22777646_8,-1,1,-1,1,17994,-1,2.5428075e-05,0.9999627,1.1894133e-05
35904,TGF-,6,7,36,41,"The excretion of intra-tumor IL-10, TGF- was notably lower but higher IFN- excretion in this combination immunotherapy.",30359281_12,-1,1,-1,1,35904,-1,3.240113e-05,0.9999516,1.5966618e-05
7148,the,4,5,25,28,"Despite the evidence for the role of inflammation in cancer initiation, promotion, and progression, the precise mechanism by which the inflammation within tumor is orchestrated by inflammatory cells remains to be determined.",18524989_0,-1,1,-1,1,7148,-1,1.8759501e-05,0.9999732,8.115621e-06
7913,sclerosis,27,28,164,173,"For decades cytokines such as type I interferons and IL-2 have been used in immunotherapy against cancer, viral hepatitis, and autoimmune diseases such as multiple sclerosis.",18947877_0,-1,1,-1,1,7913,-1,9.1477385e-05,0.9998729,3.56346e-05
592,the,18,19,98,101,"These phenomena are triggered or enhanced by infection with HHV8 that, in turn, is reactivated by the same cytokines.",11423257_2,-1,1,-1,1,592,-1,3.3816927e-05,0.99995124,1.4912739e-05
33996,to,16,17,105,107,Tumor-specific CD8 T cells often fail to elicit effective antitumor immune responses due to an inability to expand into a substantial effector population and persist long-term in vivo.,29271784_0,-1,1,-1,1,33996,-1,2.3953717e-05,0.99996376,1.2337432e-05
43204,the,10,11,59,62,"We propose that strategic targeting of this axis can boost the immunostimulatory effects of RT and radiosensitizing effects of IOs, thereby promoting the efficacy of combination therapy of RT and IOs.",34830176_6,-1,1,-1,1,43204,-1,1.8893383e-05,0.9999739,7.257283e-06
39172,to,4,5,32,34,Colorectal cancer is considered to be one of the major causes of morbidity and mortality all over the world.,32061875_0,-1,1,-1,1,39172,-1,3.71421e-05,0.999948,1.4884558e-05
36478,the,9,10,50,53,"In our study, we review publications available in the PUMED database concerning acute leukemia, with a particular emphasis on child's leukemias.",30944830_3,-1,1,-1,1,36478,-1,1.9562e-05,0.99997056,9.885839e-06
8677,the,3,4,15,18,"In conclusion, the hallmark of our panel of activated human Treg clones is to produce bioactive TGF-beta which has autocrine actions on Tregs and can have paracrine actions on other T cells.",19224638_8,-1,1,-1,1,8677,-1,1.8832478e-05,0.9999733,7.818006e-06
37875,to,14,15,87,89,BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is often accompanied by resistance to immunotherapies despite the presence of tumor-infiltrating lymphocytes.,31539182_0,-1,1,-1,1,37875,-1,3.1786905e-05,0.9999548,1.3442695e-05
19840,FoxP3,18,19,99,104,"Here, the percentage of Treg and Th17 cells, and the expression of transcription factors RORt and FoxP3 were studied by flow cytometry, real-time PCR, and Western blotting, respectively.",23335103_1,-1,1,-1,1,19840,-1,2.3433184e-05,0.9999622,1.4309479e-05
31327,to,10,11,77,79,"Taken together, our investigation reveals that assigning antigen specificity to nonspecific polyclonal CD8+25+ Tregs for enhanced immune suppression can be achieved through exosomal pMHC arming.",28096300_9,-1,1,-1,1,31327,-1,2.2171325e-05,0.9999678,1.0062389e-05
39036,the,7,8,52,55,"Consistent with their cytokine production profiles, the Raptor KO  T cells lost their anti-tumor function both in vitro and in vivo, whereas both Raptor and Rictor KO mice were resistant to imiquimod (IMQ)-induced psoriasis-like skin pathogenesis.",32001780_6,-1,1,-1,1,39036,-1,1.6599095e-05,0.99997544,7.906221e-06
41780,the,21,22,128,131,"ChIP assay verified that LINC00152 recruits EZH2 to the promoters of CXCL9 and CXCL10, thus the silencing of LINC00152 promoted the production of CXCL9 and CXCL10.",33709190_6,-1,1,-1,1,41780,-1,1.7170738e-05,0.9999747,8.086708e-06
29364,that,5,6,27,31,"Thus, the data demonstrate that binding of antigen-specific dextramers to ASTs specifically results in activation of NFAT, that the NFAT activation correlates with a downstream functional response and that the response can be heterogeneous.",27327144_12,-1,1,-1,1,29364,-1,1.6651966e-05,0.99997413,9.241709e-06
35614,the,7,8,49,52,"Furthermore, we investigated the relationship of the NLRP3 inflammasome with Th cells in MM.",30211233_2,-1,1,-1,1,35614,-1,1.6513575e-05,0.9999714,1.205666e-05
26677,tumor,22,23,120,125,"Taken together, S100A8 appears to play a crucial role in the activation of the TLR4/MD-2 pathway and the promotion of a tumor growth-enhancing immune microenvironment.",26165843_11,-1,1,-1,1,26677,-1,1.9735755e-05,0.9999702,1.00612515e-05
27904,to,5,6,37,39,Nuclear Factor (NF)-B is positioned to provide the interface between COPD and carcinogenesis through regulation of chronic inflammation in the lungs.,26756215_0,-1,1,-1,1,27904,-1,2.0013993e-05,0.9999709,9.084104e-06
2764,to,19,20,144,146,"Lastly, such ATV displayed a diminished responsiveness in their expression of IFN-gamma-regulated genes, including those mechanistically linked to Fas-mediated death (i.e., Fas and caspase-1).",15899830_4,-1,1,-1,1,2764,-1,2.5803838e-05,0.9999598,1.4383601e-05
15362,the,19,20,109,112,"This suppression was mediated by interleukin (IL)-10 released from CD4(+) CD25(+) T cells, by which impaired the induction of cytotoxic T lymphocytes (CTL) able to kill Ag-expressing tumor cells.",21710495_3,-1,1,-1,1,15362,-1,2.0731914e-05,0.99997056,8.658435e-06
25216,TBK1-dependent,24,25,123,137,"Remarkably, this molecular pathway requires STING, but not TLR or NLR function, and results in the activation of IRF3 in a TBK1-dependent manner.",25385820_4,-1,1,-1,1,25216,-1,4.4583725e-05,0.9998789,7.6572316e-05
19288,pET-15b,6,7,35,42,YB-1 was expressed and purified by pET-15b prokaryotic expression system.,23169344_4,-1,1,-1,1,19288,-1,4.5267618e-05,0.99993575,1.8944516e-05
26903,Gfi1,21,22,133,137,"Mechanistic investigations revealed that CCL5 activates CCR3, a highly expressed chemokine receptor on CD4 T cells, and also boosts Gfi1 expression to promote the differentiation of Th2 cells, which enhance the prometastatic activity of tumor-associated myeloid cells.",26249173_3,-1,1,-1,1,26903,-1,0.005764211,0.9597005,0.034535307
32869,Relapse,0,1,0,7,Relapse of AML was not prognosticated by Treg counts at onset of treatment or after the first cycle of immunotherapy.,28721449_5,-1,1,-1,1,32869,-1,5.0032024e-05,0.9999256,2.4384035e-05
7225,the,33,34,232,235,"By in vivo experiment in SCID mice, all dendritic cell-based strategies induced specific immune responses to Ewing's sarcoma after mice-human immune system reconstitution by inoculating human peripheral blood mononuclear cells into the peritoneal cavity of SCID mice.",18563501_4,-1,1,-1,1,7225,-1,1.9530977e-05,0.9999713,9.178364e-06
40118,the,40,41,234,237,"METHODS: We employed TC-1 carcinoma (expressing HPV16 E6 and E7 and devoid of PDL1 expression) in a syngeneic mouse model in monotherapy and combination therapy studies to analyze antitumor effects and changes in immune cell types in the spleen and the TME.RESULTS: As a monotherapy, the PDS0101 vaccine generated HPV-specific T cells and antitumor activity in mice bearing HPV-expressing mEER oropharyngeal and TC-1 lung carcinomas.",32554612_5,-1,1,-1,1,40118,-1,1.9099147e-05,0.9999702,1.0748794e-05
27914,Tregs,8,9,55,60,"Depletion of alveolar macrophages in IKTA mice reduced Tregs, increased lung CD8+ lymphocytes, and reduced tumor numbers following treatment with the carcinogen urethane.",26756215_4,-1,1,-1,1,27914,-1,2.3973067e-05,0.99996066,1.5397392e-05
38317,Foxp3-,16,17,88,94,"Together, these data demonstrated that the CD4+ CD25+ TILs were composed of distinctive Foxp3- and Foxp3+ cells, with the former representing the major subset.",31811667_11,-1,1,-1,1,38317,-1,4.3520628e-05,0.99992645,3.006002e-05
3700,the,4,5,21,24,"Further, we examined the role of CD4(+) and/or CD8(+) cells by depleting the cells in vivo and measuring CTL activity in vitro.",16585215_3,-1,1,-1,1,3700,-1,1.7148379e-05,0.9999745,8.315111e-06
28341,to,3,4,17,19,This study aimed to inhibit lung cancer (LC) growth in a mouse model by using an LC-specific vaccination.,26910585_1,-1,1,-1,1,28341,-1,1.7926131e-05,0.9999739,8.19892e-06
16855,the,22,23,122,125,"Increment of CD25(high+) FOXP3+ natural Tregs has been reported in patients with hepatocellular carcinoma (HCC); however, the involvement of other type of Tregs remain elusive.",22419479_1,-1,1,-1,1,16855,-1,2.0927375e-05,0.9999713,7.7847935e-06
38022,the,11,12,66,69,"Here, we studied the distribution and characteristics of Tregs in the LHME, investigated the effects of Treg ablation on leukemia progression, explored the mechanisms leading to Treg accumulation, and studied whether blocking Treg migration to the LHME delayed leukemia progression in MLL-AF9-induced mouse acute myeloid leukemia (AML) models using wildtype (WT) and Foxp3DTR/GFP mice.",31669202_3,-1,1,-1,1,38022,-1,1.8634124e-05,0.99996877,1.2599932e-05
22161,the,24,25,143,146,The chronic inflammation present in the thymus of MG patients could provide an explanation for the escape of thymic T cells from regulation in the MG thymus.,24405842_12,-1,1,-1,1,22161,-1,1.9800582e-05,0.9999709,9.337305e-06
4946,naive,19,20,126,131,"After adoptive transfer to naive recipients, CD11b(+)Gr-1(+) MSCs freshly isolated from spleens of tumor-bearing mice but not naive mice were able to inhibit NK cell cytotoxicity.",17244679_2,-1,1,-1,1,4946,-1,4.9362545e-05,0.99992776,2.2888713e-05
36930,The,0,1,0,3,"The spatiotemporal distribution of cytokines orchestrates immune responses in vivo, yet the underlying mechanisms remain to be explored.",31160756_0,-1,1,-1,1,36930,-1,1.9361896e-05,0.9999732,7.440483e-06
40099,TGFRII,25,26,164,171,"Bintrafusp alfa (M7824) is a first-in-class bifunctional fusion protein composed of the extracellular domains of the transforming growth factor- receptor type II (TGFRII) fused to a human IgG1 monoclonal antibody blocking programmed cell death protein-1 ligand (PDL1), designed both as a checkpoint inhibitor and to bring the TGFRII 'trap' to the tumor microenvironment (TME).",32554612_3,-1,1,-1,1,40099,-1,4.076311e-05,0.99992156,3.7680595e-05
20896,tumor,6,7,44,49,"This study demonstrates that local low-dose tumor irradiation influences the intratumoral immune population induced by SFVeE6,7 immunization by a strong increase in the ratio of antitumoral to immune suppressive cells, thus changing the intratumoral immune balance in favor of antitumor activity.",23922012_10,-1,1,-1,1,20896,-1,2.2810143e-05,0.9999682,8.975422e-06
18492,their,11,12,67,72,Compensation among BATF factors is based on the shared capacity of their leucine zipper domains to interact with non-AP1 factors such as IRF4 and IRF8 to mediate cooperative gene activation.,22992524_4,-1,1,-1,1,18492,-1,2.2969985e-05,0.9999665,1.05227155e-05
17455,FOXP3(-,28,29,149,156,"Collectively, these results show that in humans, a large proportion of CD4(+) memory T cells express intermediate levels of CD25, and this CD25(INT) FOXP3(-) subset is a functionally distinct memory population that is uniquely affected by IL-2.",22585674_5,-1,1,-1,1,17455,-1,3.312251e-05,0.9999443,2.2545537e-05
38212,tumor,1,2,10,15,Xenograft tumor models were developed to investigate the functions of p65 and miR-23a in vivo.,31769216_7,-1,1,-1,1,38212,-1,1.8453498e-05,0.99997103,1.0562529e-05
26341,Th22,10,11,73,77,"In addition, there existed a significantly positive relationship between Th22 and Th17 cells in PB or BM.",26000313_7,-1,1,-1,1,26341,-1,4.332439e-05,0.99993527,2.13495e-05
22697,T,12,13,95,96,"However, the underlying mechanism responsible for TGF--mediated inhibition of effector memory T (Tm) cells is largely unknown.",24569779_1,-1,1,-1,1,22697,-1,2.2873362e-05,0.99995685,2.030352e-05
18661,that,4,5,30,34,There is substantial evidence that CD4(+)CD25(+) regulatory T cells (Tregs) play a key role in the control of immune evasion.,23000689_1,-1,1,-1,1,18661,-1,1.8686444e-05,0.9999716,9.740273e-06
35907,to,6,7,53,55,Such combination immunotherapy was further confirmed to synergize with anti-PD-1 monotherapy to improve tumor growth inhibition and cure rates.,30359281_13,-1,1,-1,1,35907,-1,1.9647357e-05,0.999972,8.348279e-06
31498,the,23,24,133,136,"In order to address this question, we first used mRNA sequencing to compare the immunophenotype of the TNBC cell line MDA-MB-231 and the luminal breast cancer cell line MCF7 after both were cocultured with activated human T cells.",28264810_2,-1,1,-1,1,31498,-1,1.8398088e-05,0.9999726,9.031944e-06
5465,This,0,1,0,4,This study analyzed the soluble factors released by pancreatic cancer cells responsible for inhibiting DC differentiation and activation.,17545630_1,-1,1,-1,1,5465,-1,2.104184e-05,0.999969,9.948243e-06
15217,The,0,1,0,3,The suppressive capacity of Treg cells was estimated by WST-8 and enzyme-linked immunosorbent assay (ELISA; interferon-gamma [IFN-] and interleukin-4 [IL-4]) analysis.,21674673_2,-1,1,-1,1,15217,-1,1.7150744e-05,0.9999739,8.902593e-06
41196,the,4,5,33,36,Inhibition of autophagy reversed the effects of SKIL/TAZ overexpression on the STING pathway.,33268765_12,-1,1,-1,1,41196,-1,1.9889261e-05,0.99997246,7.672097e-06
34541,the,4,5,27,30,The present study analyzes the in situ TGF1 expression in 23 cases of lymphocyte-rich gastric carcinomas (Ly-rich GCs) using immunohistochemistry and in situ hybridization.,29594353_3,-1,1,-1,1,34541,-1,1.6505383e-05,0.9999758,7.675423e-06
41429,the,18,19,108,111,"In this study, we used a murine model of melanoma to discover that Tet2 inactivation significantly enhances the antitumor activity of TILs with an efficacy comparable to immune checkpoint inhibition imposed by anti-PD-L1 treatment.",33589517_2,-1,1,-1,1,41429,-1,1.806092e-05,0.9999747,7.2460716e-06
33319,through,9,10,79,86,"This mechanism was amplified in a non-self-inactivating gammaretroviral vector through positive feedback on the long terminal repeat (LTR) promoter, further enhancing CAR expression and tonic signaling.",28978471_3,-1,1,-1,1,33319,-1,2.0179767e-05,0.9999695,1.0334148e-05
30008,The,0,1,0,3,The percentage of CD127dim/- cells and also the MFI of FoxP3 expression was significantly lower in CD4+CD25-FoxP3+ in comparison with CD4+CD25+FoxP3+ population.,27619682_6,-1,1,-1,1,30008,-1,1.8058387e-05,0.9999727,9.205878e-06
2465,the,30,31,195,198,"Immunity in STAT6-deficient mice requires the activation of NO-producing M1 macrophages that are tumoricidal, the reduction in MSC levels to baseline after surgical removal of primary tumor, and the activation of tumor-specific T cells.",15634881_6,-1,1,-1,1,2465,-1,1.9588537e-05,0.99997103,9.402861e-06
39888,Treg,11,12,48,52,"The frequency of CD3+, CD4+ and CD4+CD25+FOXP3+ Treg was assessed by flow cytometry in 43 ALL patients versus 42 controls.",32480291_3,-1,1,-1,1,39888,-1,2.0611877e-05,0.9999629,1.6517548e-05
4741,to,25,26,204,206,SSX-1-specific polyclonal populations isolated from these cultures recognized peptides located in three distinct regions of the protein containing clusters of sequences with significant predicted binding to frequently expressed MHC class II alleles.,17186289_6,-1,1,-1,1,4741,-1,2.5216548e-05,0.9999615,1.3271291e-05
10715,to,11,12,71,73,Twenty-four patients with CTCL and 14 patients with GVHD were included to assess the relative numbers of regulatory T cells (Treg) and any change in the serum cytokine profile during 6 months of ECP therapy.,19773201_2,-1,1,-1,1,10715,-1,1.8638772e-05,0.99997306,8.3257e-06
36762,FOXA1,2,3,10,15,"Recently, FOXA1+ Tregs were reported as a novel subset of Tregs that control autoimmune diseases.",31036318_2,-1,1,-1,1,36762,-1,7.486449e-05,0.9998,0.0001251798
19175,T,25,26,149,150,The vaccine efficacy was correlated with increased percentages of CD8(+) T cells expressing IFN- as well as potent killing responses of both CD8(+) T and NK cells in the absence of detectable antibodies to ssDNA as a sign of autoimmunity.,23144888_5,-1,1,-1,1,19175,-1,3.3606593e-05,0.99990904,5.7290144e-05
24218,to,24,25,158,160,"Cancer cells may escape from host immune responses through active suppression of the immune response, but the detailed mechanisms in colorectal cancer remain to be elucidated.",25034363_0,-1,1,-1,1,24218,-1,2.957908e-05,0.99995685,1.3591948e-05
36896,This,26,27,199,203,"Further analysis indicates soluble GITR was negatively correlated with quantitative MG score and promoted Helios expression and enhanced function of Tregs independently of membrane GITRL.CONCLUSION: This work demonstrates abnormal changes in Helios+ Tregs and soluble GITR in MG, as well as direct regulation of Helios by GITR in the context of Tregs.",31118027_9,-1,1,-1,1,36896,-1,2.3154478e-05,0.99996495,1.18857015e-05
6528,Transwell,0,1,0,9,Transwell inserts separating Treg from RC were used to evaluate suppression mechanisms used by Treg.,18292519_4,-1,1,-1,1,6528,-1,3.0786847e-05,0.9999485,2.0663558e-05
20077,tumoricidal,8,9,57,68,"Additionally, IgG4 significantly impaired the potency of tumoricidal IgG1 in a human melanoma xenograft mouse model.",23454746_9,-1,1,-1,1,20077,-1,3.9127e-05,0.99994385,1.699657e-05
12699,the,3,4,15,18,"In conclusion, the accumulation of Th17 cells as well as Treg in the tumor microenvironment of gastric cancer occurred in early disease and then the infiltration of Th17 cells gradually decreased according to the disease progression, in contrast to increased Treg.",20550524_8,-1,1,-1,1,12699,-1,1.6728067e-05,0.9999752,8.016613e-06
892,The,0,1,0,3,"The induction of IL-8 by 15-d-PGJ(2) did not occur through the nuclear receptor PPAR-gamma, as synthetic PPAR-gamma agonists did not mimic the IL-8-inducing effects of 15-d-PGJ(2).",11801678_9,-1,1,-1,1,892,-1,1.7885068e-05,0.99997413,8.041859e-06
17431,that,24,25,136,140,"However, this study reports that the majority of resting human memory CD4(+) FOXP3(-) T cells expresses intermediate levels of CD25 and that CD25 expression can be used to delineate a functionally distinct memory subpopulation.",22585674_1,-1,1,-1,1,17431,-1,1.9378527e-05,0.99996865,1.1972136e-05
39601,to,5,6,37,39,"Surprisingly, melanoma cells exposed to vemurafenib expressed higher levels of Gal-1.",32330348_5,-1,1,-1,1,39601,-1,2.7183925e-05,0.99995935,1.3442973e-05
2123,the,8,9,42,45,"It is well known that immune responses in the intestine remain in a state of controlled inflammation, suggesting that not only active suppression by regulatory T cells plays an important role in the normal intestinal homeostasis, but also its dysregulation leads to the development of inflammatory bowel disease.",15322172_0,-1,1,-1,1,2123,-1,2.0550466e-05,0.9999689,1.05478985e-05
16824,the,12,13,78,81,"Therefore, the related peptide epitopes derived from Pokemon is essential for the development of specific immunotherapy of malignant tumors.",22405859_1,-1,1,-1,1,16824,-1,1.9499974e-05,0.99997234,8.137905e-06
38440,the,2,3,9,12,"However, the significance of cytokine-induced T cell accumulation at the tumor microenvironment in biliary tract cancer (BTC) is not well understood.",31853779_1,-1,1,-1,1,38440,-1,2.0064976e-05,0.9999726,7.3938077e-06
13331,terminal,37,38,230,238,"Such early effectors, if present, should be characterized by a specific phenotype, distinct from that expressed at later stages of the antigen-induced differentiation program, by short-lived effector cells, memory precursors, and terminal effectors.",20861189_1,-1,1,-1,1,13331,-1,4.128135e-05,0.99991393,4.4746812e-05
9959,tumor,22,23,137,142,"Our data suggest that in NSCLC patients, there is an increase of CD4(+)CD25(high)FOXP3(+) regulatory T-cells in the peripheral blood and tumor microenvironment.",19538059_6,-1,1,-1,1,9959,-1,2.0726404e-05,0.9999689,1.0441849e-05
33425,T,3,4,20,21,"Tumor-specific CD4+ T helper 9 (TH9) cells, so-called because of their production of the cytokine interleukin-9 (IL-9), are a powerful effector T cell subset for cancer immunotherapy.",29018172_0,-1,1,-1,1,33425,-1,4.0229894e-05,0.9999217,3.8052043e-05
22372,TGF-1,6,7,33,39,"Overall, our results explain how TGF-1 can participate in CD103 expression on locally TCR-engaged Ag-specific CD8 T cells, thus contributing to antitumor CTL responses and cancer cell destruction.",24477908_5,-1,1,-1,1,22372,-1,2.8568737e-05,0.9999486,2.2797887e-05
34613,the,25,26,182,185,"Increasing evidence indicates that Wnt/-catenin signaling, one of the best-characterized cancer drivers, promotes cancer progression by regulating the tumor-immune cycle in most of the nodes, including dendritic cells, T cells, and tumor cells.",29678298_1,-1,1,-1,1,34613,-1,2.64754e-05,0.9999491,2.4419585e-05
730,subunits,21,22,111,119,"This defect in presentation of HPV16 E6(29-38) correlated with low level expression of HLA class I, proteasome subunits low molecular mass protein 2 and 7, and the transporter proteins TAP1 and TAP2 in the cervical carcinoma cell lines.",11673561_5,-1,1,-1,1,730,-1,6.5847235e-05,0.99982905,0.00010505383
13360,FOXP3(+,2,3,7,14,"CD8(+) FOXP3(+) T cells produced IFN- on short in vitro activation, recognized autologous tumor by CD107a mobilization, and expressed Ki-67 on ex vivo analysis.",20861189_7,-1,1,-1,1,13360,-1,0.00038903506,0.9991258,0.0004852265
37261,These,0,1,0,5,These findings suggest that inhibitors must have dual FAD and CoREST targeting abilities to successfully initiate or prime macrophages toward an anti-tumor M1-like phenotype in triple-negative breast cancer.,31249575_5,-1,1,-1,1,37261,-1,1.9909385e-05,0.99997187,8.17095e-06
989,the,9,10,63,66,"Similarly, several natural defence mechanisms kill melanoma by the same pathways.",11905805_1,-1,1,-1,1,989,-1,3.8321425e-05,0.9999474,1.42091e-05
34026,The,0,1,0,3,The aim of this study is to investigate the role of Notch1 signaling upon immune suppression induced by melanoma cells.,29301578_1,-1,1,-1,1,34026,-1,1.9100711e-05,0.9999728,8.0382215e-06
18671,the,23,24,143,146,"Tregs can transfer cyclic adenosine monophosphate (cAMP) to effector T cells, suggesting an association between Tregs' immune-evasion role and the intracellular cAMP pathway.",23000689_2,-1,1,-1,1,18671,-1,1.8346347e-05,0.9999734,8.2926435e-06
19339,Foxp3(+,9,10,56,63,"In the current study, simultaneous CD200 expression and Foxp3(+) regulatory T cell levels were investigated in Iranian patients with AML by flow cytometry.",23179394_2,-1,1,-1,1,19339,-1,0.00011254245,0.9998029,8.4563755e-05
43136,TME,15,16,119,122,New approaches beyond PD-1/PD-L1 inhibition are required to target the immunologically diverse tumor microenvironment (TME) in high-grade serous ovarian cancer (HGSOC).,34799346_0,-1,1,-1,1,43136,-1,2.7884356e-05,0.9999591,1.2949288e-05
1453,gene,11,12,67,71,Ii protein was suppressed by the antisense effect of an Ii-reverse gene construct (Ii-RGC) in the same or another co-injected plasmid.,12827305_2,-1,1,-1,1,1453,-1,3.7616275e-05,0.99992895,3.3421467e-05
17742,the,10,11,67,70,The percentages of CD8(+)Foxp3(+) T lymphocytes were evaluated for the association with tumor stage.,22729557_5,-1,1,-1,1,17742,-1,2.1760365e-05,0.9999683,9.958565e-06
5480,the,25,26,147,150,"Addition of exogenous interleukin-6 (IL-6) and granulocyte colony-stimulating factor (G-CSF), which were present in high amounts in BxCM, mimicked the inhibitory effect of BxCM on DC differentiation and maturation.",17545630_6,-1,1,-1,1,5480,-1,2.5274006e-05,0.9999659,8.8263705e-06
30222,the,10,11,59,62,Further study showed that these Tr1 cells were enriched in the CD25low/-Foxp3-CD49b+LAG-3+ fraction and could be developed in vitro from naive CD45RA+ CD4+ T cells.,27704876_6,-1,1,-1,1,30222,-1,1.7181988e-05,0.9999726,1.0182351e-05
42929,the,26,27,176,179,"BACKGROUND: Oestrogen receptor-positive (ER+) breast cancer is commonly treated using endocrine therapies such as aromatase inhibitors which block synthesis of oestradiol, but the influence of this therapy on the immune composition of breast tumours has not been fully explored.",34602068_0,-1,1,-1,1,42929,-1,2.1900762e-05,0.99996996,8.093768e-06
25215,IRF3,21,22,113,117,"Remarkably, this molecular pathway requires STING, but not TLR or NLR function, and results in the activation of IRF3 in a TBK1-dependent manner.",25385820_4,-1,1,-1,1,25215,-1,2.1055392e-05,0.9999614,1.7605378e-05
23609,the,11,12,72,75,Pharmacologic inhibition of VEGF and PGE2 produced a marked increase in the influx of tumor-rejecting CD8(+) over FoxP3(+) T cells that was dependent on attenuation of FasL expression and led to CD8-dependent tumor growth suppression.,24793239_5,-1,1,-1,1,23609,-1,1.5869777e-05,0.99997604,8.096682e-06
15319,to,20,21,129,131,"Foxp3(+) regulatory T cells play a pivotal role in maintaining immune homeostasis and, importantly, preventing immune reactivity to self-antigens; however, their suppressive activity can compromise an effective antitumor immune response, and high frequencies of regulatory T cells in peripheral blood have been reported in both hematologic and solid cancers.",21708889_2,-1,1,-1,1,15319,-1,6.8789035e-05,0.999912,1.9171395e-05
34132,Treg,21,22,93,97,We aimed to investigate whether IL-17-producing CD4+ T cells (Th17) and CD4+ Foxp3+ T cells (Treg) are involved in the early stages of CCA genesis and can be targeted for suppression by melatonin.,29331794_2,-1,1,-1,1,34132,-1,2.1041398e-05,0.9999671,1.1840845e-05
16684,TGF--associated,4,5,30,46,This downregulation induced a TGF--associated mechanism in glioma cells altering the tumor microenvironment and causing reduced resistance of the tumor to the immune system.,22323550_6,-1,1,-1,1,16684,-1,2.8006021e-05,0.99995255,1.9484902e-05
20052,Th2-biased,1,2,6,16,"Since Th2-biased inflammation is a hallmark of tumor microenvironments, we investigated the presence and functional implications of IgG4 in malignant melanoma.",23454746_2,-1,1,-1,1,20052,-1,6.525512e-05,0.9998703,6.445177e-05
41068,TGF,6,7,35,39,"The expression levels of Foxp3 and TGF in transplanted tumor tissues were detected by quantitative fluorescence PCR.RESULTS: Compared with healthy people, Treg cells and IL-2, IL-10, and TGF contents in peripheral blood of liver cancer patients were increased.",33204731_5,-1,1,-1,1,41068,-1,2.8460574e-05,0.99995196,1.963198e-05
19550,tacrolimus,34,35,231,241,RESULTS: The role of mTOR in regulating the differentiation and function of alloreactive Tc cells in vitro was explored by stimulating OTI-Tc cells with ovalbumin-transgenic antigen-presenting cells in the presence of rapamycin or tacrolimus.,23222894_4,-1,1,-1,1,19550,-1,5.7724505e-05,0.99993014,1.2108417e-05
20280,that,12,13,94,98,"In vitro assays using co-culture of immunized splenocytes and exosome-loaded DCs demonstrated that CIITA- Exo enhanced splenocyte proliferation and IFN- production of CD4+T cells, while inhibiting IL-10 secretion.",23621273_5,-1,1,-1,1,20280,-1,2.0280637e-05,0.9999708,8.980197e-06
12755,the,14,15,100,103,The results demonstrate that endogenous IFN-gamma counteracts the induction of type 2 cytokines and the downregulation of both CD8 coreceptor levels and the anti-tumor response in CD8 T cells exposed to IL-4 during activation in vivo.,20562261_7,-1,1,-1,1,12755,-1,1.7437997e-05,0.99997485,7.743298e-06
3974,cells,16,17,90,95,We find that human myeloid dendritic cells (DCs) are superior to other antigen presenting cells for the maintenance of FOXP3(+) Treg's in culture.,16763205_2,-1,-1,2,2,3974,-1,4.360846e-05,4.3291093e-05,0.9999131
11089,regulatory T cells,8,11,84,102,"Pancreatitis-specific IL-10 responses were mediated by IL-10(+)IFN-gamma(-)FoxP3(+) regulatory T cells, which were expanded in the blood, bone marrow, and pancreatitis lesions and possessed the potential to suppress the proliferation of autologous conventional T cells in an antigen-specific manner.",19931255_9,-1,-1,2,2,11089,-1,2.8522107e-05,3.900663e-05,0.9999325
36454,T cells,15,17,92,99,Positive vimentin expression was associated with the infiltration of a lower number of CD8+ T cells and a higher number of FoxP3+ cells and poor patient prognosis (P=0.03).,30927618_5,-1,-1,2,2,36454,-1,3.114697e-05,3.619489e-05,0.99993265
17279,cell,35,36,179,183,"But CD4(+) T cells also decreased in spleen cells of tumor-bearing mice by alone 5-FU treated, splenic NK cell and CTL activity also degraded, while CD4(+) T cells and splenic NK cell and CTL activity significantly increased by BLTA treated.",22522606_11,-1,-1,2,2,17279,-1,4.1400264e-05,4.368467e-05,0.999915
31501,T cells,37,39,222,229,"In order to address this question, we first used mRNA sequencing to compare the immunophenotype of the TNBC cell line MDA-MB-231 and the luminal breast cancer cell line MCF7 after both were cocultured with activated human T cells.",28264810_2,-1,-1,2,2,31501,-1,3.226174e-05,4.1576e-05,0.9999261
33968,cells,28,29,164,169,HLA-DQA1-positive cells in the liver sinusoid were positive for CD68 (macrophages or Kupffer cells); those in the lymphocytic infiltrates were positive for CD20 (B cells) or CD3 (T cells).,29248968_4,-1,-1,2,2,33968,-1,4.4074965e-05,3.9245224e-05,0.9999167
27095,regulatory T-cell,13,15,68,85,"In this study, we identified the mRNA expression pattern of Th2 and regulatory T-cell (Treg) cytokines in IgG4-RD and in IgG4-associated MZL and IgG4-negative MZL using real-time polymerase chain reaction analysis.",26311608_2,-1,-1,2,2,27095,-1,7.9557125e-05,0.00013576362,0.99978465
17817,T cells,11,13,84,91,"In summary, direct ex vivo high-resolution molecular characterization of individual T cells provides key insights into the processes shaping the functional properties of tumor-specific and virus-specific T cells.",22735807_9,-1,-1,2,2,17817,-1,2.9976094e-05,4.1410192e-05,0.9999287
829,cells,24,25,130,135,"We evaluated regulation of the MHC class II transactivator (CIITA), the key intermediate that controls class II expression, in MG cells and tested whether MG cells could process native Ag.",11746775_2,-1,-1,2,2,829,-1,3.6370126e-05,4.2059117e-05,0.99992156
29040,cells,9,10,51,56,"Bhlhe40 is highly expressed in stage 3 thymic iNKT cells and iNKT1 subsets, and the level of Bhlhe40 mRNA expression is correlated with Ifng mRNA expression in the resting state.",27226296_4,-1,-1,2,2,29040,-1,3.6407666e-05,4.3149415e-05,0.9999205
3076,cells,8,9,70,75,"Both immature and spontaneously matured bone marrow-derived dendritic cells (SM-DC) were capable of inducing tumor cell apoptosis, with SM-DCs serving as comparatively better killers.",16166326_4,-1,-1,2,2,3076,-1,3.8231618e-05,4.2228196e-05,0.99991953
30995,T cell-dependent,14,16,79,95,We show that exogenous IL-33 can induce robust antitumor effect through a CD8+ T cell-dependent mechanism.,28011934_1,-1,-1,2,2,30995,-1,3.768966e-05,5.484655e-05,0.9999075
39680,T cells,39,41,222,229,"Regarding the mechanism, SNHG16 served as a ceRNA by sponging miR-16-5p, which led to the derepression of its target gene SMAD5 and resulted in potentiation of the TGF-1/SMAD5 pathway to upregulate CD73 expression in V1 T cells.",32345959_6,-1,-1,2,2,39680,-1,2.9887644e-05,4.2911444e-05,0.99992716
7229,cells,16,17,103,108,"However, the hybrids most inhibited the subcutaneous tumor growth in SCID mice compared with dendritic cells pulsed with other loading methods.",18563501_5,-1,-1,2,2,7229,-1,4.6434314e-05,4.6436882e-05,0.999907
19150,cells,11,12,69,74,CCL2 would be an attractive target for treatment to eliminate cancer cells via amelioration of tumor metastasis and immunosuppression.,23143679_10,-1,-1,2,2,19150,-1,3.5564106e-05,4.3426615e-05,0.9999211
14697,IL-32,4,5,25,31,The inhibitory effect of IL-32 on tumor growth was associated with the inhibition of constitutive activated nuclear transcription factor-B (NF-B) and of signal transducer and activator of transcription 3 (STAT3).,21423208_3,-1,-1,2,2,14697,-1,0.001089103,0.00053251896,0.9983784
43380,T cells,14,16,106,113,"TGF--expressing B cells in the melanoma tumor microenvironment assembled in clusters and interacted with T cells via lymphoid recruitment (SELL, CXCL13, CCL4, CD74) signals and with Tregs via CD47:SIRP-, and FOXP3-promoting Galectin-9:CD44.",35909944_3,-1,-1,2,2,43380,-1,3.302306e-05,4.0790444e-05,0.9999262
15194,Th2 cells,5,7,30,39,"Our findings show that memory Th2 cells can induce potent antitumor immunity through IL-4-induced activation of NK cells, suggesting potential applications in cellular therapy for cancer patients.",21646476_6,-1,-1,2,2,15194,-1,4.1043608e-05,8.547959e-05,0.9998735
42192,cell,16,17,99,103,"Human IL17 cDNA was then inserted into the pEGFPN1 plasmid and transfected into the glioma U87MG cell line, and tumstatin was used to block the effect of the IL-17 overexpression.",33971545_3,-1,-1,2,2,42192,-1,3.7859172e-05,5.031527e-05,0.9999118
19467,cells,35,36,215,220,"The effects of AT-101 on cytotoxicity, early apoptosis, and Granzyme B (GrzB) and IFN- signaling pathways were evaluated during EGFR bispecific antibody armed ATC (aATC)-mediated killing of L3.6pl and MiaPaCa-2 PC cells pre-sensitized with AT-101.",23185240_3,-1,-1,2,2,19467,-1,3.3852248e-05,4.3857475e-05,0.9999223
2662,cells,15,16,106,111,"These cells were anergic toward T-cell receptor stimulation and, when cocultured with activated CD4+CD25- cells, potently suppressed their proliferation and cytokine secretion.",15781662_9,-1,-1,2,2,2662,-1,3.700833e-05,4.5858764e-05,0.99991715
22723,T cells,25,27,160,167,"Clinically, intratumoral CD70-expressing T cells are prevalent in follicular B-cell lymphoma (FL) biopsy specimens, and increased numbers of intratumoral CD70+ T cells correlate with an inferior patient outcome.",24569779_8,-1,-1,2,2,22723,-1,3.0792125e-05,3.7228925e-05,0.99993205
13442,cell,12,13,68,72,"In this study, we performed gene expression profiling of purified B cell and non-B cell compartments obtained from FL and reactive lymph nodes.",20944673_2,-1,-1,2,2,13442,-1,3.7212598e-05,4.888584e-05,0.99991393
19345,lymphocyte,24,25,156,166,We also assessed the effect of CD200-CD200R blockade on Th1 and T-reg cytokine production and T cell proliferation in autologous AML- and monocyte-DC mixed lymphocyte reactions (MLRs).,23179394_3,-1,-1,2,2,19345,-1,5.123781e-05,4.9633596e-05,0.99989915
706,T cells,13,15,74,81,"Taken together, these findings may explain why Ag-experienced, CD45RO(+), T cells found in the tumor milieu are functionally suppressed.",11509600_10,-1,-1,2,2,706,-1,3.1316365e-05,3.879229e-05,0.9999299
7963,lymphocyte-rich,7,8,38,53,"Regardless of EBV positivity, TILs in lymphocyte-rich GCs predominantly expressed CXCR3, while its ligand CXCL9 was abundantly expressed by stromal cells and a portion of cancer cells.",18980207_3,-1,-1,2,2,7963,-1,6.784061e-05,0.00014393956,0.9997882
5937,cell-associated,10,11,70,85,We demonstrated that infection of melanoma cells and fibroblasts with cell-associated varicella-zoster virus (VZV) and infection of a T cell line with cell-free VZV resulted in an induction of IL-8 secretion in vitro.,17909856_1,-1,-1,2,2,5937,-1,9.037742e-05,0.00022182279,0.9996879
23578,T cells,14,16,85,92,"Therefore, by repressing autocrine IL-2 production, Ikaros ensures that naive CD8(+) T cells remain dependent on licensing by APCs and CD4(+) T cells, and it may therefore act as a cell-intrinsic safeguard against inappropriate CTL differentiation and immunopathology.",24778448_7,-1,-1,2,2,23578,-1,3.1391373e-05,3.811456e-05,0.9999305
24358,CD80,34,35,197,201,"4weeks following DEN treatment, no significant differences in CD80 and CD86 expression were found on DCs from HCC rats and normal rats but 12 and 16weeks following DEN treatment, the expression of CD80, CD86 and MHCII on DCs of HCC rats was significantly decreased.",25066760_3,-1,-1,2,2,24358,-1,6.4571956e-05,7.616399e-05,0.9998592
12487,cells,33,34,206,211,"In this study, we report that the plasma concentration of the chemokine CCL22 is abnormally high in HTLV-1-infected subjects and that the concentration is strongly correlated with the frequency of FoxP3(+) cells, which express the CCL22 receptor CCR4.",20525891_4,-1,-1,2,2,12487,-1,3.7803526e-05,4.6068242e-05,0.9999162
38059,lymphocytes,10,11,58,69,"In the tumor-associated lymph nodes (LNs) and circulating lymphocytes, however, granzyme B-expressing Treg cells were only scarcely found.",31669380_4,-1,-1,2,2,38059,-1,3.6239722e-05,4.1627653e-05,0.99992216
30881,Treg cells,13,15,95,105,"Furthermore, CCL5 was directly trans-activated by cancer-FOXP3 and promoted the recruitment of Treg cells from peripheral blood to the tumor site in vitro and in vivo.",27991933_6,-1,-1,2,2,30881,-1,4.458314e-05,5.522968e-05,0.9999002
26043,T cells,9,11,54,61,"IL-6 also contributes to IL-10 production from CD4(+) T cells in aged mice, causing attenuated responses of CD8(+) T cells.",25850032_5,-1,-1,2,2,26043,-1,2.9246989e-05,3.613464e-05,0.9999347
41552,T cells,10,12,52,59,The results of coculture of thymoma cells and CD4 + T cells showed that thymoma cells could promote the differentiation of Th17 cells and inhibit the Tregs.,33636431_7,-1,-1,2,2,41552,-1,3.278959e-05,3.5868296e-05,0.99993134
16676,T cells,18,20,92,99,"Second, FTS induced an increase in regulatory T cells in mouse splenocytes, in which Foxp3+ T cells did not interfere with the tumor growth inhibitory effects of FTS.",22323550_4,-1,-1,2,2,16676,-1,3.062058e-05,3.9290986e-05,0.99993
15924,cells,8,9,35,40,"Depletion of CD8(+) T cells and NK cells reversed the inhibition of tumor growth in an MC-38-cea2-bearing mice, indicating that CD8(+) T cells and NK cells are responsible for anti-tumor immunity by vaccine with a mixture of TAT-CEA fusion protein and poly(I:C).",21945963_9,-1,-1,2,2,15924,-1,3.4720728e-05,4.111021e-05,0.9999242
20527,cells,7,8,47,52,"BACKGROUND: In cancer immunotherapy, dendritic cells (DCs) play a fundamental role in the dialog between innate and adaptive immune response, but several immunosuppressive mechanisms remain to be overcome.",23725550_0,-1,-1,2,2,20527,-1,3.9470287e-05,4.467007e-05,0.99991584
19580,cells,6,7,35,40,It is presently unknown whether MM cells express IDO1 and whether IDO1 activity correlates with immune system impairment.,23232072_2,-1,-1,2,2,19580,-1,4.016877e-05,4.800851e-05,0.9999118
14948,cells,8,9,53,58,Conversion of conventional T cells into T regulatory cells (Tregs) has been proposed as a potential mechanism for Treg expansion in cancer.,21570917_0,-1,-1,2,2,14948,-1,3.6453515e-05,3.9558596e-05,0.99992394
831,cells,29,30,158,163,"We evaluated regulation of the MHC class II transactivator (CIITA), the key intermediate that controls class II expression, in MG cells and tested whether MG cells could process native Ag.",11746775_2,-1,-1,2,2,831,-1,3.640213e-05,4.268233e-05,0.99992096
6132,cells,16,17,106,111,"Thus, JunB is a critical regulator of intrinsic mast cell functions including cross-talk with endothelial cells.",17982078_8,-1,-1,2,2,6132,-1,3.278164e-05,4.369017e-05,0.99992347
35525,T cells,7,9,44,51,Cytolytic and noncytolytic activity of CD8+ T cells evaluated in direct and indirect contact co-culture with A549 cells in response to Notch signaling inhibition by measuring of lactate dehydrogenase release and cytokines production.,30086535_5,-1,-1,2,2,35525,-1,2.8516955e-05,3.548082e-05,0.999936
14184,Cells,0,1,0,5,Cells isolated from Eca tissue were analyzed by flow cytometry.,21314287_5,-1,-1,2,2,14184,-1,3.177345e-05,4.4839504e-05,0.99992335
35591,cell,9,10,63,67,"After co-culture of peripheral blood cells with bladder cancer cell lines, the induction of regulatory T cell (Treg) was higher in T24 whose IL-6 and IL-8 levels were higher.",30199269_2,-1,-1,2,2,35591,-1,3.441845e-05,4.9983024e-05,0.9999156
6640,cells,15,16,101,106,"More importantly, in mice bearing Neuro2a/pc micrometastases, a single sc injection of Neuro2a/IL-21 cells significantly increased the mean tumor-free survival of treated animals (43 vs. 22 days) and cured 14% of them.",18324400_5,-1,-1,2,2,6640,-1,5.687813e-05,4.3864704e-05,0.99989927
26693,T cells,14,16,126,133,The immunohistochemistry of tumor-infiltrating lymphocytes revealed a significant correlation between the intratumoral CD8(+) T cells and the forkhead box p3 (Foxp3)(+) cells in the intraepithelial and stromal areas of advanced OC tissues.,26166762_4,-1,-1,2,2,26693,-1,3.2600008e-05,3.8318314e-05,0.9999292
40466,cells,8,9,74,79,Emerging evidence indicates Batf3-dependent conventional type 1 dendritic cells (cDC1s) rarely found within the tumor myeloid compartment are crucial for effector T cell recruitment to the tumor microenvironment.,32848036_1,-1,-1,2,2,40466,-1,3.7201975e-05,3.963847e-05,0.9999231
6622,T cells,11,13,70,77,"In conclusion, our work suggests that CD4+CD25(high) Foxp3 expressing T cells are not expanded during in vitro amplification of TIL obtained from melanoma-invaded LNs.",18312383_6,-1,-1,2,2,6622,-1,3.0825475e-05,3.808388e-05,0.9999311
13676,T cells,20,22,116,123,"In the presence of tremelimumab, frequencies of IL-2-secreting CD4(+) T cells and IFN--secreting CD4(+) and CD8(+) T cells were increased in response to polyclonal activation and tumor antigens.",21056008_4,-1,-1,2,2,13676,-1,3.0829095e-05,3.6050664e-05,0.9999331
36983,Cells,0,1,0,5,"Cells received 4 hours of PMA/Ionomycin stimulation, in vitro.",31182685_3,-1,-1,2,2,36983,-1,3.362531e-05,5.5573542e-05,0.99991083
21881,cells,15,16,79,84,"After chemotherapy using the MCP841 protocol, the frequency of CD4(+) CD25(+) cells was gradually enhanced with the reduction of FoxP3, interleukin-10 positivity corresponded with disease presentation, indicating reduced immunosuppression.",24354800_9,-1,-1,2,2,21881,-1,4.1443298e-05,4.312398e-05,0.99991536
34990,cell,9,10,46,50,"Here, we use human tumor explant cultures and cell culture models to show that the (ds) RNA Sendai Virus (SeV), poly-I:C, and rintatolimod (poly-I:C12U) all activate the TLR3 pathway involving TRAF3 and IRF3, and induce IFN, ISG-60, and CXCL10 to promote CTL chemotaxis to ex vivo-treated tumors.",29853604_2,-1,-1,2,2,34990,-1,4.2395754e-05,6.808828e-05,0.9998895
14728,IL-32,7,8,44,50,We also found that forced overexpression of IL-32 inhibited colon cancer cell (SW620 and HCT116) growth accompanied with the inhibition of activated NF-B and STAT3 in vitro.,21423208_6,-1,-1,2,2,14728,-1,0.0011566273,0.00092191336,0.9979214
29094,T cells,23,25,156,163,The inhibition of STAT5 pathways via siRNA interference or a specific inhibitor eliminated the up-regulation of NKG2D and TNF- in rapamycin-treated V4  T cells.,27256566_5,-1,-1,2,2,29094,-1,2.900579e-05,4.0523664e-05,0.9999305
17056,cell-mediated,21,22,106,119,"Strikingly, we show for the first time that IL-22 can fully protect cancer cells from natural killer (NK) cell-mediated cytotoxicity by stimulating tumour production of IL-10 and transforming growth factor (TGF)-1.",22471280_10,-1,-1,2,2,17056,-1,4.713413e-05,7.615516e-05,0.99987674
35588,cells,15,16,83,88,IL-6 and IL-8 levels showed a significant correlation with NLR in blood and Foxp3+ cells around the tumor.,30199269_1,-1,-1,2,2,35588,-1,3.509947e-05,4.3405103e-05,0.99992156
33720,cell,5,6,33,37,"RESULTS: STAT3-blocked whole HCC cell lysates inhibited tumor growth and tumorigenesis, and prolonged the survival of tumor-bearing mice.",29115974_2,-1,-1,2,2,33720,-1,3.694871e-05,4.454422e-05,0.99991846
12655,T cells,2,4,9,16,Foxp3(+) T cells have been associated previously with impaired immunity in malignancies.,20547850_9,-1,-1,2,2,12655,-1,2.8941326e-05,3.9554634e-05,0.99993145
26229,cell-mediated immunity,3,5,27,49,BACKGROUND: Virus-specific cell-mediated immunity (CMI) plays a role in the outcome of genital HPV infections.,25990808_0,-1,-1,2,2,26229,-1,0.012012071,0.0008042115,0.9871837
18619,lymphocytes,17,18,100,111,An increase in the number of Tregs has been detected in the peripheral blood and tumor infiltrating lymphocytes of patients with hepatocellular carcinoma.,23000301_2,-1,-1,2,2,18619,-1,4.3806882e-05,5.038574e-05,0.9999057
39837,T cell,16,18,72,78,Human T cell leukemia virus type 1 (HTLV-1) is the etiologic agent of a T cell neoplasm and several inflammatory diseases.,32471947_0,-1,-1,2,2,39837,-1,3.5965928e-05,5.148561e-05,0.9999125
38383,cells,26,27,113,118,"Maintenance of immune tolerance is achieved via modulation of effector CD4+ T helper 1, 2 or 17 (Th1, Th2, Th17) cells by Tregs.",31827925_4,-1,-1,2,2,38383,-1,4.237057e-05,4.0597773e-05,0.99991703
8820,lymphocytes,17,18,129,140,"TH17 cells were also detected ex vivo, but at lower proportions than in cultured tumor-infiltrating lymphocytes/tumor-associated lymphocytes, and were confined to the CD4+CD25- fraction.",19238008_4,-1,-1,2,2,8820,-1,4.4880988e-05,4.0682353e-05,0.9999144
16057,T cell,6,8,37,43,"Notch1 pathway activation is seen in T cell acute lymphoblastic leukaemia (T-ALL) due to the high frequency of Notch1 mutations affecting approximately 60% of patients, causing ligand-independent signalling and/or prolonging Notch1 half-life.",21984373_1,-1,-1,2,2,16057,-1,3.9987204e-05,4.9496753e-05,0.9999106
24088,cells,1,2,12,17,"CIITA-tumor cells were rejected in 80% to 100% of injected mice, which also developed long-lasting immune memory.",24987872_6,-1,-1,2,2,24088,-1,3.797246e-05,4.7348025e-05,0.99991465
19227,T cells,1,3,4,11,CD4 T cells from MM patients secreted abnormal level of IL-10 compared to healthy donors (P=0.01) in proliferation assays without CD8 Treg cells.,23152910_10,-1,-1,2,2,19227,-1,2.744878e-05,3.434732e-05,0.99993825
42401,cells,8,9,46,51,Interleukin 9 (IL-9)-producing helper T (Th9) cells are essential for inducing anti-tumor immunity and inflammation in allergic and autoimmune diseases.,34075041_0,-1,-1,2,2,42401,-1,3.950941e-05,4.0967792e-05,0.99991953
9701,cells,24,25,153,158,"Vaccination with 4-1BBL activated dendritic cells and enhanced antigen uptake, generated CD8(+) T-cell effector/memory responses, and endowed T effector cells refractory to suppression by CD4(+)CD25(+)FoxP3(+) T regulatory cells.",19435920_4,-1,-1,2,2,9701,-1,3.7972113e-05,4.0177598e-05,0.9999218
34280,Regulatory T cells,0,3,0,18,Regulatory T cells (Tregs) characterized by the transcription factor forkhead box P3 (FoxP3) are crucial for maintaining immune tolerance and preventing autoimmunity.,29455107_0,-1,-1,2,2,34280,-1,3.7779573e-05,6.848105e-05,0.99989367
2984,T cells,41,43,249,256,"In this study we investigated whether formononetin, a phyto-oestrogen, and its metabolites, daidzein and equol, affect production of interleukin-4 (IL-4), a pro-inflammatory cytokine closely associated with allergic immune response, in primary CD4+ T cells and EL4 T lymphoma cells.",16108819_3,-1,-1,2,2,2984,-1,2.9034782e-05,3.8080532e-05,0.9999329
29639,cells,14,15,91,96,"But some vaccinated volunteers showed up to 0.1% HPV-specific, IFN- or perforin-secreting cells.",27548034_9,-1,-1,2,2,29639,-1,3.8471095e-05,4.516381e-05,0.9999163
21735,regulatory T cells,17,20,77,95,"However, among the immune cells recruited by SLC to tumors, the CD25+ Foxp3+ regulatory T cells (Tregs) compromise the anti-tumor effects.",24304581_1,-1,-1,2,2,21735,-1,3.627396e-05,4.2449537e-05,0.9999213
36184,T cells,4,6,26,33,"Interestingly, AML V9V2 T cells presented significantly higher Tim-3 expression than healthy V9V2 T cells.",30708194_8,-1,-1,2,2,36184,-1,2.788696e-05,3.697305e-05,0.99993515
20222,cells,26,27,155,160,"The purpose of this study was to investigate the involvement of immunosuppressive cells, such as Tregs and CD163+ macrophages, as well as immunomodulatory cells (i.e. IL-27-producing cells) in keratoacanthoma (KA) and invasive squamous cell carcinoma (SCC).",23572151_3,-1,-1,2,2,20222,-1,4.7727004e-05,4.0099316e-05,0.99991226
16572,cell,28,29,166,170,"Herein, we report the Tregs-targeting and immune-promoting effect of a class I specific HDAC inhibitor, entinostat, in combination with either IL-2 in a murine renal cell carcinoma (RENCA) model or a survivin-based vaccine therapy (SurVaxM) in a castration resistant prostate cancer (CR Myc-CaP) model.",22303460_2,-1,-1,2,2,16572,-1,4.95307e-05,6.8588866e-05,0.99988186
33701,T cells,8,10,44,51,Antibody-mediated depletion of CD4+ or CD8+ T cells abrogated the antitumour effects.,29112686_11,-1,-1,2,2,33701,-1,2.8030034e-05,3.6852092e-05,0.99993515
33797,cells,3,4,23,28,"Macrophages, dendritic cells and other innate immune cells are involved in inflammation and host defense against infection.",29180626_0,-1,-1,2,2,33797,-1,4.0982854e-05,4.28272e-05,0.9999162
8790,regulatory T cells,23,26,122,140,"Epithelial ovarian cancer (EOC) is a highly inflammatory malignancy, characterized by the presence, at the tumor site, of regulatory T cells (Treg) that suppress antitumor immunity.",19238008_0,-1,-1,2,2,8790,-1,3.2973694e-05,4.434278e-05,0.99992263
1175,T cells,16,18,99,106,"A mechanism for the compromised immune response is suggested by the observation that CnA beta(-/-) T cells are defective in stimulation-induced NFATc1, NFATc2, and NFATc3 activation.",12091710_7,-1,-1,2,2,1175,-1,2.8067458e-05,4.1567542e-05,0.9999304
19131,cells,7,8,64,69,CCL2 and LCN2 cooperatively generate immunoregulatory dendritic cells (DCreg) having suppressive activity accompanied by lowered expression of costimulatory molecules such as HLA-DR but increased expression of immunosuppressive molecules such as PD-L1 in human PBMCs.,23143679_6,-1,-1,2,2,19131,-1,3.679418e-05,4.246089e-05,0.9999207
3091,cell-mediated,22,23,168,181,"Because NO-treated tumor cells displayed a preferential loss of survivin protein expression via a proteasome-dependent pathway, enhanced tumor sensitivity to dendritic cell-mediated killing may be associated with the accelerated turnover of this critical antiapoptotic gene product.",16166326_7,-1,-1,2,2,3091,-1,5.6105695e-05,7.773505e-05,0.9998661
19992,suppressor cells,29,31,190,206,"Using multi-parameter fluorescence-activated cell sorting analysis, we quantified the cumulative frequency of regulatory T cells (Treg), exhausted CD4(+) helper T cells, and myeloid-derived suppressor cells (MDSC) to gain concurrent views on the overall level of immune dysfunction in these inoperable patients.",23423978_2,-1,-1,2,2,19992,-1,3.416715e-05,3.2948003e-05,0.9999329
15175,Th2 cells,14,16,88,97,"In this study, we investigated the cellular and molecular mechanisms employed by memory Th2 cells in sustaining tumor immunity by using a mouse model system wherein ovalbumin (OVA) is used as a specific tumor antigen.",21646476_2,-1,-1,2,2,15175,-1,5.328593e-05,0.00012524481,0.9998215
37192,T cell proliferation,6,9,53,73,"Concomitantly, these phenotypic alterations enhanced T cell proliferation.",31233057_8,-1,-1,2,2,37192,-1,3.5873923e-05,4.276934e-05,0.9999213
24476,cells,9,10,78,83,"After co-culturing with IDO expressing or control vector-transfected 2LL-EGFP cells, T cell apoptosis was determined and the proportion of the regulatory T cells (Tregs) and CD8+ T cell subset was measured.",25138378_4,-1,-1,2,2,24476,-1,3.665148e-05,4.0439085e-05,0.999923
13776,regulatory T-cell,6,8,29,46,"IL-10 and TGF- mRNA levels, regulatory T-cell (Treg) counts, and frequencies of IL-10/TGF- producing mononuclear cell subsets were determined in pB from 46 patients with mRCC before receiving sorafenib treatment.",21150720_3,-1,-1,2,2,13776,-1,8.031079e-05,0.00014953577,0.9997701
33692,cells,7,8,59,64,The IFN-positive and granzyme B-positive CD8+ splenocyte cells were quantified by flow cytometry.,29112686_7,-1,-1,2,2,33692,-1,3.627694e-05,4.616053e-05,0.9999176
12801,B7-1,7,10,48,52,"Mice inoculated with H22 tumor cells expressing B7-1, B7-2 and 4-1BBL developed a strong cytotoxic T lymphocyte response and long-term immunity against wild-type tumor, suggesting a synergistic effect between the B7 and 4-1BBL costimulatory pathways.",20563597_6,-1,-1,2,2,12801,-1,5.91834e-05,9.480336e-05,0.999846
41877,T cell,24,26,196,202,"Despite priming equivalent antitumor T cell quantities, MDA5-orchestrated TBK1-IRF3 signaling, but not NFB-polarized TLR activation, culminates in polyfunctional and Th1-differentiated antitumor T cell phenotypes.",33767151_4,-1,-1,2,2,41877,-1,3.6979916e-05,4.336373e-05,0.99991965
2534,NKT cells,10,12,46,55,Group E mice were transplanted with 1 x 10(6) NKT cells from HBV-immunized donors.,15688366_6,-1,-1,2,2,2534,-1,0.00014411245,0.0008104157,0.99904543
30680,Treg cells,17,19,116,126,"Co-culture with Treg cells significantly increased the migration rate of breast cancer cells, while pretreatment of Treg cells with ZA attenuated this effect.",27887569_11,-1,-1,2,2,30680,-1,3.3725875e-05,5.614231e-05,0.9999101
15211,Treg cells,54,56,290,300,"BACKGROUND: The purpose of this study was to investigate the presence of CD4(+) CD25(+) FOXP3(+) regulatory T (Treg) cells both in peripheral blood and local tumors in patients with nasal inverted papilloma (NIP).METHODS: By using flow cytometry, the frequencies of CD4(+) CD25(+) FOXP3(+) Treg cells in both peripheral blood and tissues from 18 patients with NIP and 8 control subjects were determined.",21674673_0,-1,-1,2,2,15211,-1,6.97377e-05,0.00012301709,0.9998073
26482,cells,2,3,11,16,"Id2-kd N2a cells grew aggressively in immune-compromised hosts, thereby establishing the immunogenicity of these cells.",26079374_4,-1,-1,2,2,26482,-1,3.6502657e-05,3.9975068e-05,0.9999236
36857,cell,10,11,47,51,"Our results suggest that HeLa, SiHa, and C-33A cell lines down-regulate the activation of transcription factors characteristic of M1 macrophages (STAT1, NF-B-p65) and induce the secretion of factors that favor tumor growth.",31099286_5,-1,-1,2,2,36857,-1,4.590384e-05,5.0029797e-05,0.99990404
20104,cells,16,17,95,100,Treatment with recombinant IL-33 could also increase the cytotoxicity of CD8(+) T cells and NK cells in vitro.,23499895_3,-1,-1,2,2,20104,-1,3.4029486e-05,4.3068492e-05,0.999923
4600,cell,22,23,151,155,"Together, our data reveal the contribution of distinct elements and factors in the constitutive and IFNgamma-inducible expression of CIITA in melanoma cell lines of the skin.",17067677_7,-1,-1,2,2,4600,-1,3.5816975e-05,6.85804e-05,0.9998957
31397,CTLA-4,21,22,115,121,"In contrast to LAP-CD4+ T cells, LAP+CD4+ T cells showed lower Foxp3 expression but significantly higher levels of CTLA-4, CCR4 and CCR5 (P < 0.01).",28210081_8,-1,-1,2,2,31397,-1,4.7181125e-05,5.5964676e-05,0.99989676
8125,CD80,23,24,155,159,"vFLIP activated NF-kappaB in mouse bone marrow-derived DCs in vitro and matured these DCs to a similar extent as lipopolysaccharide; costimulatory markers CD80, CD86, CD40, and ICAM-1 were upregulated and tumor necrosis factor alpha and interleukin-12 secreted.",19036811_2,-1,-1,2,2,8125,-1,7.09374e-05,8.156354e-05,0.99984753
12532,T cells,19,21,106,113,We also found that these effects were exerted by the activated (CD44(high)) portion of Vgamma4 gammadelta T cells.,20525896_4,-1,-1,2,2,12532,-1,2.9410094e-05,3.829056e-05,0.9999323
6247,cells,9,10,42,47,Activation and expansion of T helper (Th) cells followed by regulation of activation are essential to the generation of immune responses while limiting concomitant autoreactivity.,18156498_0,-1,-1,2,2,6247,-1,3.808727e-05,4.4644057e-05,0.99991715
34030,cells,19,20,113,118,The aim of this study is to investigate the role of Notch1 signaling upon immune suppression induced by melanoma cells.,29301578_1,-1,-1,2,2,34030,-1,3.731617e-05,5.304876e-05,0.99990964
24208,cell,20,21,145,149,Tumor-infiltrating A20-deleted CD8 T cells had enhanced production of IFN and TNF and reduced expression of the inhibitory receptor programmed cell death 1.,25024217_8,-1,-1,2,2,24208,-1,5.281133e-05,4.7630954e-05,0.9998995
5072,subsets,8,9,50,57,Patients with AML can be classified into distinct subsets according to their chemokine responsiveness and chemokine release profile.,17339182_11,-1,-1,2,2,5072,-1,4.8790575e-05,5.7633453e-05,0.99989355
566,T cells,9,11,45,52,"Thus, activation of T cells by IL-15 renders T cells resistant to suppression by TGFbeta1-producing tumor cells and rTGFbeta1.",11418694_9,-1,-1,2,2,566,-1,3.0942385e-05,3.8444283e-05,0.9999305
43566,T cells,3,5,18,25,"The activation of T cells requires engagement of the T cell receptor/CD3 complex and co-stimulatory molecules, and results in the triggering of several signaling pathways which lead rapidly to the nuclear translocation of several transcription factors, such as nuclear factor (NF)-kappa B and NF-AT.",8605941_0,-1,-1,2,2,43566,-1,3.2379805e-05,4.6888585e-05,0.9999207
17802,T cells,52,54,327,334,"Here we found that natural peptide vaccination induced tumor-reactive CD8 T cells with frequent coexpression of both memory/homing-associated genes (CD27, IL7R, EOMES, CXCR3, and CCR5) and effector-related genes (IFNG, KLRD1, PRF1, and GZMB), comparable with protective Epstein-Barr virus-specific and cytomegalovirus-specific T cells.",22735807_5,-1,-1,2,2,17802,-1,3.0491909e-05,3.998438e-05,0.99992955
8113,cell,31,32,175,179,"These results indicate that while high levels of Tregs found in NZB mice might suppress a more severe autoimmune disease, they may also contribute to the development of the B cell malignancy.",19022624_7,-1,-1,2,2,8113,-1,4.324589e-05,5.357151e-05,0.9999032
9615,CTL,16,17,127,130,"Important qualitative differences were observed between the two cell-based vaccines, as TS/A-CIITA-vaccinated mice developed a CTL response containing a large proportion of anti-gp70 AH1 epitope-specific cells, completely absent in TS/A-vaccinated mice, and a mixed T(h)1/T(h)2 type of response as opposed to a T(h)2 type of response in TS/A-vaccinated mice.",19395374_4,-1,-1,2,2,9615,-1,3.5627025e-05,5.1359944e-05,0.999913
31372,T cells,5,7,22,29,LAP-CD4+ and LAP+CD4+ T cells were isolated using a magnetic cell-sorting system and cell purity was analyzed by flow cytometry.,28210081_2,-1,-1,2,2,31372,-1,2.7107146e-05,3.4392164e-05,0.9999385
6891,cells,46,47,304,309,"Correlating with these findings, the combination therapy resulted in significantly higher intra-tumoral levels of several proinflammatory, TH1-related cytokines (including IL-12, IFN-gamma, TNF-alpha and IL-2), increases in intra-tumoral CD8+ and CD4+ T cells expressing activation/memory markers and NK cells and increases in activated DCs in the tumors and regional lymph nodes (LNs).",18392040_5,-1,-1,2,2,6891,-1,3.9167906e-05,4.2057593e-05,0.9999187
42958,cells,21,22,143,148,"Using flow cytometry and immunohistochemistry, we examined the immune cell infiltrate into tumours created by injecting SSM3 ER+ breast cancer cells into wild-type, immunocompetent 129/SvEv mice.",34602068_6,-1,-1,2,2,42958,-1,3.940263e-05,3.9966562e-05,0.9999206
29244,T cells,17,19,119,126,"Despite of the potential implications for cancer immunotherapy, conventional approaches using in vitro expanded CD8(+) T cells have suboptimal outcomes, mostly due to loss of functionality from cellular exhaustion.",27306834_0,-1,-1,2,2,29244,-1,2.9513216e-05,3.505289e-05,0.9999354
32171,lymphocytes,10,11,75,86,"In conclusion, ipilimumab administration results in elevations of effector lymphocytes and pro-inflammatory mediators in the gut lamina propria.",28548891_6,-1,-1,2,2,32171,-1,3.8580023e-05,5.185859e-05,0.9999095
32007,suppressor cells,1,3,16,32,Myeloidderived suppressor cells (MDSCs) have received a great deal of attention for their role in creating an immunosuppressive microenvironment in cancerbearing hosts.,28487978_1,-1,-1,2,2,32007,-1,3.988316e-05,3.9852668e-05,0.99992025
15996,regulatory T-cell,20,22,148,165,"These include: promoting proliferation, protecting cells from activation-induced cell death, supporting IFN- production, and suppressing inducible regulatory T-cell differentiation.",21972292_3,-1,-1,2,2,15996,-1,3.3887674e-05,5.4522923e-05,0.99991167
24968,cell,23,24,133,137,"Depending on the cytokines they release and the immune responses they mediate, CD4(+) T cells are classically divided into two major cell populations: Th1 and Th2 cells.",25261206_1,-1,-1,2,2,24968,-1,3.6031284e-05,4.216061e-05,0.9999218
41300,Th1 cells,34,36,198,207,"Here, we showed that the TME, via a TGF-dependent mechanism, increased alternative splicing events and induced the expression of an alternative isoform of the IRF1 transcription factor (IRF17) in Th1 cells.",33419764_3,-1,-1,2,2,41300,-1,5.848754e-05,0.00016398873,0.9997775
26019,T cells,11,13,64,71,"Here we focus on the impact of this inflammatory environment on T cells, and demonstrate that in contrast to successful tumour elimination in young mice, replenishment of tumour-specific CD4(+) T cells fails to induce tumour regression in aged hosts.",25850032_1,-1,-1,2,2,26019,-1,3.162195e-05,3.913401e-05,0.9999293
964,CD80,15,16,104,108,"Mature DCs expressed significantly heightened levels of their antigen-presenting machinery (e.g., CD54, CD80, CD86) and numerous cytokines and chemokines/chemokine receptors (i.e., Flt-3L, G-CSF, IL-1alpha and -1beta, IL-6, IL-12, CCL-2, -3, -4, -5, -17, and -22, MIP-2, and CCR7) and were significantly better at inducing effector T cell responses in vitro.",11902830_1,-1,-1,2,2,964,-1,7.1200244e-05,8.789568e-05,0.999841
21855,Treg cells,17,19,75,85,We wanted to identify the role and regulation of CD4(+) CD25(+) FoxP3(+) Treg cells in B-cell acute lymphoblastic leukaemia (B-ALL).,24354800_2,-1,-1,2,2,21855,-1,3.1973774e-05,4.7249534e-05,0.99992085
34980,cells,33,34,177,182,"Presence of cytotoxic CD8+ T cells (CTL) in tumor microenvironments (TME) is critical for the effectiveness of immune therapies and patients' outcome, whereas regulatory T(reg) cells promote cancer progression.",29853604_0,-1,-1,2,2,34980,-1,4.0814823e-05,4.1078685e-05,0.9999181
40165,cells,13,14,82,87,RESULTS: We found that both the phenotypic and functional maturation of dendritic cells was suppressed by the conditioned medium.,32573300_5,-1,-1,2,2,40165,-1,3.4233144e-05,4.7791455e-05,0.999918
21857,cells,13,14,72,77,"These diagnosed patients demonstrated a lower number of CD4(+) CD25(+) cells co-expressing a higher level of FoxP3, interleukin-10, transforming growth factor- and CD152/CTLA-4 than the normal population.",24354800_4,-1,-1,2,2,21857,-1,3.503254e-05,4.0177143e-05,0.9999248
19916,cells,7,8,40,45,"CONCLUSION: TGF-1, expressed in cancer cells, might be a potential therapeutic target for cancer treatment.",23361571_9,-1,-1,2,2,19916,-1,3.4948756e-05,5.7152723e-05,0.999908
37172,cells,19,20,108,113,"Here, we evaluated the potential of Ch/-PGA NPs as vehicles for IFN- and their ability to modulate immune cells' phenotype.",31233057_4,-1,-1,2,2,37172,-1,3.600588e-05,4.7580867e-05,0.99991643
15856,cells,14,15,136,141,"The ligand-activated transcription factor peroxisome proliferator-activated receptor (PPAR)- is highly expressed in colonic epithelial cells; however, the role of PPAR ligands, such as fatty acids, in mucosal inflammation and malignant transformation has not been clarified.",21940900_0,-1,-1,2,2,15856,-1,3.2090484e-05,5.3238018e-05,0.99991465
13734,lymphocytes,12,13,68,79,"Herein we demonstrate that effector/memory CD4(+) T helper-1 (Th-1) lymphocytes, in addition to polarizing type-1 antitumor immune responses, impair tumor-induced CD4(+)CD25(+)FoxP3(+) regulatory T lymphocyte (Treg) immunosuppressive function in vitro and in vivo.",21123824_1,-1,-1,2,2,13734,-1,3.550442e-05,4.062388e-05,0.9999238
30725,cell,3,4,15,19,"METHODS: 769-p cell lines were treated with sunitinib, celecoxib, or in combination at different concentrations respectively.",27926489_1,-1,-1,2,2,30725,-1,3.456879e-05,5.2348863e-05,0.9999131
1977,T cells,27,29,160,167,"Patients showed persistent IL-10 cytokine expression by the nonadherent fraction of PBMC when challenged with E6 and tat-E6, and, in contrast to controls, both T cells and non-T cells from patients expressed IL-10.",15138179_6,-1,-1,2,2,1977,-1,2.9909124e-05,3.780312e-05,0.9999323
37080,CTLs,9,10,52,56,"However, IFN-I function in cytotoxic T lymphocytes (CTLs) in the tumor microenvironment is largely unknown.",31228946_1,-1,-1,2,2,37080,-1,3.529804e-05,4.277467e-05,0.9999219
24580,cells,1,2,13,18,"Inflammatory cells, costimulatory molecules in tumour cells, and serum cytokines showed prognostic significance, mainly in univariable analyses.",25151017_8,-1,-1,2,2,24580,-1,4.192645e-05,4.2746775e-05,0.99991524
30851,cells,24,25,151,156,"We also identified a subset of CD8+PD-1+FOXP3+ T lymphocytes at the earliest phase of functional differentiation after priming, termed ""early effector cells"" (EEC), which also exhibited an activated nonexhausted phenotype, but was less differentiated and associated with coexpression of multiple inhibitory receptors.",27979840_4,-1,-1,2,2,30851,-1,3.5397617e-05,4.1891835e-05,0.99992275
29111,T cells,22,24,149,156,"We compared microarray gene analysis data between TLR1-TLR2-stimulated and unstimulated T-cell receptor transgenic ""pmel"" and MyD88(-/-) pmel CD8(+) T cells and identified changes in the expression of several TNF family members.",27267778_2,-1,-1,2,2,29111,-1,3.313936e-05,4.3249085e-05,0.9999236
31800,cells,25,26,147,152,"Here, we show that PEPvIII could be loaded by DCs and presented to T lymphocytes, especially PEPvIII-specific CTLs, to precisely kill U87-EGFRvIII cells.",28412740_4,-1,-1,2,2,31800,-1,3.74742e-05,4.2248776e-05,0.99992037
31742,cells,12,13,68,73,CXCR5+CD8+ T cells also enhanced the IgG expression by autologous B cells.,28412245_4,-1,-1,2,2,31742,-1,3.7897848e-05,4.4893186e-05,0.99991715
26375,cells,19,20,118,123,"Here, we show that STAT3 signaling in CD8(+) T cells inhibits chemokine CXCL10 production by tumor-associated myeloid cells by reducing IFN expression by T cells.",26025380_3,-1,-1,2,2,26375,-1,3.555974e-05,4.0226736e-05,0.9999243
25520,Treg cell,14,16,105,114,"Accordingly, pDCs cocultured with cervical/vulvar neoplastic keratinocytes have the capacity to induce a Treg cell differentiation from nave CD4(+) T cells, which is in agreement with the development of a tolerogenic response.",25492101_6,-1,-1,2,2,25520,-1,3.4109522e-05,5.412061e-05,0.9999118
35418,cells,12,13,74,79,Dendritic cells (DCs) are the most potent professional antigen presenting cells and inducers of T cell-mediated immunity.,30068989_0,-1,-1,2,2,35418,-1,4.1250096e-05,4.409922e-05,0.99991465
20985,regulatory T cells,9,12,50,68,"Here, we investigated the effect of triptolide on regulatory T cells and on the level of IL-10, transforming growth factor-, and vascular endothelial growth factor in tumor-bearing mice.",23975869_2,-1,-1,2,2,20985,-1,3.4599216e-05,7.0907256e-05,0.9998945
24848,T cells,7,9,51,58,The impaired IL-4 production by SAP-deficient 24 T cells was associated with reduced IFN regulatory factor 4 and GATA-3 induction following TCR stimulation.,25236978_5,-1,-1,2,2,24848,-1,2.6217613e-05,3.9845996e-05,0.99993396
28580,Treg cell,21,23,139,148,"Indeed, CRCs with abundant infiltration of FOXP3(lo) T cells showed significantly better prognosis than those with predominantly FOXP3(hi) Treg cell infiltration.",27111280_5,-1,-1,2,2,28580,-1,3.450992e-05,5.4300068e-05,0.99991107
40122,T cells,55,57,327,334,"METHODS: We employed TC-1 carcinoma (expressing HPV16 E6 and E7 and devoid of PDL1 expression) in a syngeneic mouse model in monotherapy and combination therapy studies to analyze antitumor effects and changes in immune cell types in the spleen and the TME.RESULTS: As a monotherapy, the PDS0101 vaccine generated HPV-specific T cells and antitumor activity in mice bearing HPV-expressing mEER oropharyngeal and TC-1 lung carcinomas.",32554612_5,-1,-1,2,2,40122,-1,3.8472317e-05,4.106339e-05,0.9999205
35537,T cells,14,16,86,93,This process was accompanied by increased expression of FasL and perforin within CD8+ T cells.,30086535_10,-1,-1,2,2,35537,-1,2.9502646e-05,3.9429724e-05,0.999931
40732,cells,18,19,129,134,Curcumin restored DC functions in xenogeneic nude mouse model implanted with high IL-6-producing human clear cell ovarian cancer cells.,33006786_5,-1,-1,2,2,40732,-1,3.492207e-05,4.7450874e-05,0.9999176
22663,cells,8,9,48,53,c-MET is expressed at high levels on nurse-like cells and at significantly higher levels than normal on monocytes from patients.,24561793_3,-1,-1,2,2,22663,-1,4.0272404e-05,4.342591e-05,0.9999163
31766,T cells,7,9,48,55,We further found that TCR-stimulated CXCR5+CD8+ T cells demonstrated higher granzyme B production and induced more specific lysis of autologous tumor cells than CXCR5-CD8+ T cells.,28412245_9,-1,-1,2,2,31766,-1,2.9949575e-05,3.5664532e-05,0.99993443
22471,T cells,19,21,94,101,"In this study, we show that Notch receptors (mRNA and protein) are expressed in peripheral  T cells.",24489102_3,-1,-1,2,2,22471,-1,3.0509662e-05,4.0517996e-05,0.99992895
25349,lymphocytes,5,6,35,46,"The number of infiltrating CD8(+)T lymphocytes and their IFN- production in positive B7-H4 expression cervical cancers was significantly lower than in negative B7-H4 cases (P<0.01, P<0.05), but there was no significant difference between cases positive and negative for B7-H4 with respect to infiltrating FOXP3(+)T and CD4(+)T cells or TGF-1 production.",25446402_5,-1,-1,2,2,25349,-1,3.7772224e-05,3.9791194e-05,0.9999224
8133,T cells,30,32,151,158,"When we coexpressed vFLIP in a lentivector with ovalbumin (Ova), we found an increased immune response to Ova; up to 10 times more Ova-specific CD8(+) T cells secreting gamma interferon were detected in the spleens of vFLIP_Ova-immunized mice than in the spleens of mice immunized with GFP_Ova.",19036811_4,-1,-1,2,2,8133,-1,3.0960946e-05,3.767234e-05,0.99993134
31786,PEPvIII,0,1,0,7,"PEPvIII, a peptide sequence from EGFRvIII, was designed to represent a target of glioma and is presented by MHC I/II complexes.",28412740_2,-1,-1,2,2,31786,-1,4.5727716e-05,0.99990225,5.2067884e-05
27363,CTLA4,25,26,135,140,"We did however find that unlike Tconvs, the majority of intra-tumoral Tregs express the activation markers CD69, CD25, ICOS, CD103 and CTLA4 and are significantly more proliferative than Tconvs.",26433463_4,-1,-1,2,2,27363,-1,6.56965e-05,6.259734e-05,0.99987173
19750,cells,17,18,99,104,A higher frequency of regulatory T cells (Tregs) has been observed in peripheral blood mononuclear cells (PBMC) of patients with different types of solid tumors and hematological malignancies as compared to healthy donors.,23319273_0,-1,-1,2,2,19750,-1,3.1594725e-05,3.909592e-05,0.9999293
11314,T cells,15,17,86,93,"In mice receiving vaccine+anti-CD4 mAb, which developed systemic immunity to NB, CD4+ T cells counts completely recovered in 90 days.",20039320_5,-1,-1,2,2,11314,-1,3.505138e-05,4.0254763e-05,0.99992466
22676,T-cell proliferation,9,11,87,107,"Furthermore nurse-like cells and chronic lymphocytic monocytes significantly inhibited T-cell proliferation, prevented by anti-transforming growth factor beta and interleukin-10 antibodies and indoleamine 2,3-dioxygenase inhibitors, and supported CD4(+)CD25(high+)/FOXP3(+) T regulatory cell expansion.",24561793_7,-1,-1,2,2,22676,-1,3.0475177e-05,3.751812e-05,0.99993193
15971,Treg cells,15,17,87,97,"In conclusion, GP reduced the proportion of Treg cells and Foxp3 lowered expression in Treg cells, and up-regulated Th1/Th2 cytokine ratio in serum in the tumor bearing mice, which might partially cause the inhibition of tumor growth.",21963624_7,-1,-1,2,2,15971,-1,3.4537734e-05,6.708275e-05,0.9998983
12213,Lymphocyte-rich,0,1,0,15,Lymphocyte-rich gastric carcinomas (Ly-rich GCs) are characterized by the formation of lymphoid stroma.,20422211_0,-1,-1,2,2,12213,-1,6.9230424e-05,0.00016009844,0.9997707
23917,cells,27,28,183,188,"Intravaginal imiquimod deposition induced upregulation of CXCL9 and CXCL10 mRNA expression in the genital tract, which are produced in response to IFN receptor signaling and attract cells expressing their ligand, CXCR3.",24893628_4,-1,-1,2,2,23917,-1,3.8884773e-05,4.466447e-05,0.99991643
16555,cells,10,11,55,60,This finding could be confirmed in nave murine T(reg) cells after IL-2 administration.,22276195_7,-1,-1,2,2,16555,-1,3.840592e-05,4.6106758e-05,0.9999155
76,T cells,13,15,87,94,Activation of the transcription factor nuclear factor-kappaB (NFkappaB) is impaired in T cells from patients with renal cell carcinomas (RCCs).,10491412_0,-1,-1,2,2,76,-1,3.0333533e-05,4.441328e-05,0.99992526
13255,cell,2,3,8,12,Mean NK cell dose was 2.16  10(7)cells/kg.,20849361_7,-1,-1,2,2,13255,-1,3.0017007e-05,4.6903453e-05,0.9999231
251,cell,14,15,81,85,"Investigations in our laboratory have focused on CD40, a critical regulator of B cell survival and differentiation, and its ligand, CD154 (CD40L).",11042507_1,-1,-1,2,2,251,-1,4.5617744e-05,4.990154e-05,0.9999044
13914,Treg cells,35,37,191,201,"Here, we demonstrated that PTX not only decreased the percentage of CD4+Foxp3+ regulatory T (Treg) cells both in vitro and in vivo but also impaired cell viability and cytokine production of Treg cells rather than CD4+Foxp3- effector T (Teff) cells.",21223350_2,-1,-1,2,2,13914,-1,5.7555117e-05,8.617491e-05,0.99985623
2790,cells,16,17,138,143,Paracrine production of IL-4 in vaccine sites promoted the accumulation and maturation of IL-12p70-secreting tumor-infiltrating dendritic cells (TIDCs).,15905564_3,-1,-1,2,2,2790,-1,4.6253852e-05,4.0198538e-05,0.9999136
10435,cells,42,43,261,266,"Whereas, LMP1 up-regulates anti-apoptotic proteins to support viral replication, it also potentiates apoptosis, suggesting that a viral protein contributes to the survival of the virus, and it also elicit host defense leading to the destruction of the infected cells.",19664329_1,-1,-1,2,2,10435,-1,3.5962956e-05,5.881565e-05,0.9999052
7888,cells,22,23,128,133,"Functional analysis demonstrated that CD4(+) cells in the tumor tended to produce more IL-10 but less IFN-gamma, whereas CD8(+) cells showed impaired capacity for the production of both IFN-gamma and perforin.",18941744_4,-1,-1,2,2,7888,-1,4.0809202e-05,4.0648778e-05,0.9999186
24514,CD8+ T cell,25,29,156,167,"These results suggest that GA-Me contributing to IDO helps to create a tolerogenic milieu in lung tumors by directly inducing T cell apoptosis, restraining CD8+ T cell activation, and enhancing Treg-mediated immunosuppression.",25138378_12,-1,-1,2,2,24514,-1,9.012525e-05,8.1666265e-05,0.9998282
770,T cell activation,10,13,54,71,Tumor cell supernatant (TSN) from AML cells inhibited T cell activation and Th1 cytokine production and also prevented activated T cells from entering the cell cycle.,11698483_2,-1,-1,2,2,770,-1,3.6614525e-05,4.022013e-05,0.9999232
31610,cell,3,4,22,26,Results from reporter cell lines suggested that acrolein acts via the aryl-hydrocarbon receptor which could be inhibited by resveratrol and 3'-methoxy-4'-nitroflavone Acrolein- stimulation of human PBMCs increased Foxp3+ expression by T cells which could be antagonized by resveratrol.,28332605_5,-1,-1,2,2,31610,-1,3.111423e-05,6.3792046e-05,0.9999051
4404,CD40L-expressed,6,7,39,54,The proliferation rate of parental and CD40L-expressed OVHM cells were not different.,16965650_9,-1,-1,2,2,4404,-1,0.00048734358,0.0018018003,0.9977108
3255,lymphocytes,6,7,38,49,"Furthermore, the increased numbers of lymphocytes in patients resulting from treatment with IL-2 were not susceptible to Denileukin Diftitox.",16224276_7,-1,-1,2,2,3255,-1,3.3441753e-05,5.5438144e-05,0.99991107
42934,lymphocytes,6,7,51,62,Previous findings suggest that tumour infiltrating lymphocytes and immune-related gene expression may be altered by treatment with aromatase inhibitors.,34602068_1,-1,-1,2,2,42934,-1,3.7426184e-05,5.0314142e-05,0.99991226
32568,T cells,6,8,37,44,"Consistent with exhaustion, Blimp-1+ T cells upregulate multiple inhibitory receptors including PD-1 and TIGIT.",28629373_9,-1,-1,2,2,32568,-1,2.811451e-05,3.718559e-05,0.9999347
3270,cell,30,31,177,181,"In this study, we show that similar to IFN-gamma-/- mice, JNK1-/- mice are highly susceptible to tumor development after inoculation of both melanoma cell line B16 and lymphoma cell line EL-4.",16237070_2,-1,-1,2,2,3270,-1,3.7633137e-05,5.5412176e-05,0.9999069
15233,cells,22,23,147,152,Phytohemagglutinin (PHA)-induced proliferation and cytokine production of CD4(+) CD25(-) T cells were suppressed equally well by CD4(+) CD25(high) cells from both patients with NIP and controls.,21674673_5,-1,-1,2,2,15233,-1,3.7725455e-05,4.021913e-05,0.99992216
9076,cells,37,38,213,218,"However, accumulated evidence highlights the functional plasticity of DC, which are shown to also be able to display a tolerogenic function eliciting the differentiation of T suppressor (Ts) and regulatory (Treg) cells.",19275918_2,-1,-1,2,2,9076,-1,3.8199312e-05,4.270713e-05,0.9999192
9897,cells,43,44,240,245,"We found that, in the absence of lymphoma B cells, treatment with IL-1beta/IL-6 or lipopolysaccharide (LPS) enhanced IL-17 expression in CD4(+) T cells and this enhancement was attenuated when CD4(+) T cells were cocultured with lymphoma B cells.",19509224_1,-1,-1,2,2,9897,-1,3.7054684e-05,4.2311367e-05,0.9999206
34085,T cell,2,4,12,18,The initial T cell response consists of predominantly CD8+ cytotoxic T cells and a smaller expansion of CD4+ cells.,29311309_2,-1,-1,2,2,34085,-1,3.4167733e-05,3.979828e-05,0.999926
43149,cells,21,22,90,95,"In syngeneic mouse models, B7-H3 (Cd276) knockout (KO) in tumor cells, but not in stromal cells, suppressed tumor progression, with a reduced number of M2 macrophages and an increased number of IFN+CD8+ T cells.",34799346_3,-1,-1,2,2,43149,-1,3.4485693e-05,3.964663e-05,0.99992585
7968,cells,9,10,56,61,"CXCL9(+) stromal cells were judged to include dendritic cells, because they partly co-expressed fascin, DC-sign, CD83, DC-lamp or HLA-DR.",18980207_4,-1,-1,2,2,7968,-1,3.288281e-05,4.2693755e-05,0.9999244
28868,T cells,24,26,142,149,"We show that FoxP3hiCD45RA-CD4+ Treg cells [activated Treg (aTreg) cells] are the predominant cell population among tumor-infiltrating FoxP3+ T cells, and that high aTreg cell-infiltrating content is associated with reduced survival in patients with head and neck squamous cell carcinoma (HNSCC).",27177223_1,-1,-1,2,2,28868,-1,3.2638785e-05,3.4931683e-05,0.9999324
5047,subsets,2,3,14,21,"These patient subsets did not differ in chemokine receptor expression, but, compared to CD34- AML cells, CD34+ cells showed higher expression of several receptors.",17339182_5,-1,-1,2,2,5047,-1,4.0530434e-05,5.1730665e-05,0.99990773
22499,cells,4,5,24,29,"CD80 expression in CTCL cells is strictly dependent on the expression of both members of the STAT5 family, STAT5a and STAT5b, as well as their joint ability to transcriptionally activate the CD80 gene.",24523507_1,-1,-1,2,2,22499,-1,4.8748658e-05,5.215946e-05,0.999899
22800,Treg cells,19,21,124,134,"CONCLUSIONS: Immunization of KPC mice with Listeria monocytogenes engineered to express Kras(G12D), along with depletion of Treg cells, reduces progression of early stage, but not late-stage, PanINs.",24607504_9,-1,-1,2,2,22800,-1,4.2733172e-05,5.8874673e-05,0.9998983
1792,T cells,12,14,86,93,"Interestingly, mice lacking the major IFN-gamma-inducing cytokines IL-12 and IL-18 or T cells, B cells, and the majority of NK cells that are potential sources of IFN-gamma nevertheless inhibited tumor development.",14978132_4,-1,-1,2,2,1792,-1,3.4245415e-05,4.6279718e-05,0.99991953
28702,cells,15,16,98,103,"GIFT4 treatment led to JAK1, JAK2 and JAK3-mediated hyper-phosphorylation of STAT5 in primary CLL cells, which is essential for GIFT4-triggered conversion of CLL cells.",27118475_7,-1,-1,2,2,28702,-1,3.5846868e-05,4.577453e-05,0.99991834
9931,regulatory T-cells,5,7,41,59,We have studied CD4(+)CD25(high)FOXP3(+) regulatory T-cells (T(regs)) from 51 patients with non-small-cell lung cancer (NSCLC) and 33 healthy donors.,19538059_0,-1,-1,2,2,9931,-1,3.5355763e-05,5.0936538e-05,0.9999137
4570,Cell,0,1,0,4,Cell lines established from tumor tissue of cutaneous melanoma biopsies often display constitutive and IFNgamma-inducible expression of MHC class II molecules.,17067677_0,-1,-1,2,2,4570,-1,3.7488717e-05,5.7257643e-05,0.9999052
14845,T cells,22,24,137,144,"The gastric cancer microenvironment was modeled by establishing the co-culture of gastric cancer cell line, MGC-803, with sorting CD4(+) T cells.",21528082_3,-1,-1,2,2,14845,-1,2.9524103e-05,3.7223148e-05,0.99993324
18845,cells,10,11,35,40,"While CD4+ TCR+ T helper (Th) 17 cells are the best-described cellular source of IL-17, many innate-like T cells are in fact potent producers of IL-17.",23052209_1,-1,-1,2,2,18845,-1,3.842014e-05,3.9292856e-05,0.9999223
6770,cells,31,32,215,220,"Key mechanisms induced by these DNA vaccines include efficient suppression of angiogenesis in the tumor vasculature and marked activation of cytotoxic T cells, natural killer cells, and antigen-presenting dendritic cells.",18363997_3,-1,-1,2,2,6770,-1,4.106452e-05,4.2259133e-05,0.99991655
33910,cells,6,7,42,47,IL-25 enhanced IL-13 production from MyLa cells via phosphorylation of signal transducer and activator of transcription 6.,29238954_10,-1,-1,2,2,33910,-1,3.2357628e-05,5.122145e-05,0.99991643
22260,cell,7,8,29,33,"Among NK1.1(+) cells, the NK cell population was predominant in number and was the only population displaying elevated granzyme B levels and increased degranulation, although not increased proliferation.",24446520_2,-1,-1,2,2,22260,-1,3.4212706e-05,4.4282766e-05,0.99992156
36199,T cells,12,14,86,93,"Together, these results demonstrated that IL-21 could significantly expand the V9V2 T cells, but its efficacy was limited since it also increased the expression of checkpoint molecule Tim-3.",30708194_11,-1,-1,2,2,36199,-1,2.709538e-05,4.1339677e-05,0.9999316
25353,B7-H4,22,23,161,166,"The number of infiltrating CD8(+)T lymphocytes and their IFN- production in positive B7-H4 expression cervical cancers was significantly lower than in negative B7-H4 cases (P<0.01, P<0.05), but there was no significant difference between cases positive and negative for B7-H4 with respect to infiltrating FOXP3(+)T and CD4(+)T cells or TGF-1 production.",25446402_5,-1,-1,2,2,25353,-1,6.244239e-05,7.4260446e-05,0.99986327
15993,cells,7,8,51,56,"These include: promoting proliferation, protecting cells from activation-induced cell death, supporting IFN- production, and suppressing inducible regulatory T-cell differentiation.",21972292_3,-1,-1,2,2,15993,-1,3.1986405e-05,4.3416792e-05,0.99992466
23055,T cell activation,28,31,169,186,"Here, we sought to determine whether peptide vaccines designed harbor both class I as well as class II restricted antigenic motifs could concurrently induce CD4 and CD8 T cell activation against autologous tumor antigens.",24690990_0,-1,-1,2,2,23055,-1,3.518173e-05,4.4691224e-05,0.9999201
14938,T cells,13,15,105,112,These findings indicated that melanoma cells could have Foxp3-dependent Treg-like suppressive effects on T cells and suggested that the mimicking of Treg function by melanoma cells may represent a possible mechanism of tumor resistance to immune destruction in the melanoma tumor microenvironment.,21547596_8,-1,-1,2,2,14938,-1,3.3665747e-05,4.583972e-05,0.9999205
9569,T cells,5,7,31,38,"Compared with primary FOXP3(-) T cells in the same microenvironment, these primary FOXP3(+) T cells expressed minimal levels of effector cytokines, negligible amount of cytotoxic molecule granzyme B, and levels of suppressive molecules interleukin-10 and PD-1.",19383912_4,-1,-1,2,2,9569,-1,2.8891047e-05,3.701213e-05,0.9999341
23603,Treg cells,52,54,299,309,"Tumor-derived vascular endothelial growth factor A (VEGF-A), interleukin 10 (IL-10) and prostaglandin E2 (PGE2) cooperatively induced FasL expression in endothelial cells, which acquired the ability to kill effector CD8(+) T cells but not Treg cells because of higher levels of c-FLIP expression in Treg cells.",24793239_3,-1,-1,2,2,23603,-1,3.286959e-05,6.4248714e-05,0.99990284
39280,Treg cells,23,25,169,179,"Diphtheria toxin-induced Treg cell ablation restrained gastric cancer progression in H. felis/MNU-treated DEREG (Foxp3-DTR) mice, clarifying the tumor-promoting role of Treg cells.",32156780_8,-1,-1,2,2,39280,-1,3.507172e-05,5.529529e-05,0.99990964
19700,cell,13,14,87,91,The transcription factor interferon regulatory factor-8 (IRF-8) is crucial for myeloid cell development and immune response and also acts as a tumor suppressor gene.,23308054_0,-1,-1,2,2,19700,-1,3.566534e-05,4.5475626e-05,0.9999188
1309,cells,32,33,171,176,"To understand the regulation function and mechanism of IL-16 on target cells, we used a 130 a.a. recombinant IL-16 to study its effects on the growth of Jurkat T leukemia cells in vitro.",12528894_3,-1,-1,2,2,1309,-1,3.5267574e-05,4.6121764e-05,0.9999186
11592,cells,16,17,97,102,"The ability of antiestrogen to induce transforming growth factor beta (TGFbeta) in breast cancer cells may be relevant to the emergence of resistance, not only at the level of cell autonomous effects of TGFbeta on cancer progression but also at the level of its effects on the host immune system.",20145137_1,-1,-1,2,2,11592,-1,3.5028115e-05,5.479144e-05,0.9999101
10948,T cells,4,6,17,24,CD25+ FOXP3+CD4+ T cells (Treg) have been considered to play an important role in immune tolerance against several tumor antigens.,19902430_0,-1,-1,2,2,10948,-1,2.7449863e-05,3.681618e-05,0.99993575
29411,cells,26,27,155,160,"In addition, most studies' report on that FoxP3 expression in all abovementioned cells is related to their status of activation since nave (non-activated cells) were found poorly FoxP3 expressing.",27339600_7,-1,-1,2,2,29411,-1,3.434277e-05,4.6193378e-05,0.9999194
23194,cells,17,18,117,122,"Previous studies reported leukemic cells from acute myeloid leukemia (AML) patients can differentiate into dendritic cells (DCs), which had some immunoregulatory dysfunctions to effectively stimulate autologous CTLs' anti-leukemia immune response.",24713261_0,-1,-1,2,2,23194,-1,3.2771535e-05,4.2225813e-05,0.999925
19301,cells,26,27,142,147,"Importantly, the survival rate of mice treated with YB-1 immunization combined with Treg depletion was 80% when challenged by 1  10(4) AGN2a cells, significantly higher than that of mice immunized with YB-1 alone (P < 0.01).",23169344_6,-1,-1,2,2,19301,-1,3.8084778e-05,4.249324e-05,0.9999194
43128,Tcell,26,29,182,188,"Our analyses reveal a gastritis characterized by severe mucosal injury, interferon gamma (IFN-)-producing gastric epithelial cells, and mixed inflammation that includes CD8 and CD4 Tcell infiltrates with reduced expression of granzyme B and FOXP3, respectively.",34755133_5,-1,-1,2,2,43128,-1,2.8676255e-05,3.7123493e-05,0.9999342
214,cells,28,29,159,164,"Then, with a focus on CML, the IRF4 level was determined in sorted cell subpopulations from CML patients and healthy volunteers and in in vitro-stimulated CML cells.",11013272_2,-1,-1,2,2,214,-1,3.5476067e-05,4.3285952e-05,0.9999212
17285,CTL,20,21,101,104,BLTA in combination with 5-FU could also enhance the ratio of CD4(+) T cells and splenic NK cell and CTL activity.,22522606_12,-1,-1,2,2,17285,-1,4.0740626e-05,4.305539e-05,0.9999162
30097,T cells,40,42,232,239,"Coculture of Tr1 cells with proinflammatory CD4+ T cells resulted in TGF--dependent reduction of interferon gamma (IFN-) and IL-10-dependent reduction of tumor necrosis factor alpha (TNF-), while coculture of Tr1 cells with CD8+ T cells resulted in lower tumor-specific cytotoxicity.",27644153_8,-1,-1,2,2,30097,-1,2.9910007e-05,3.598187e-05,0.9999341
39433,Treg cells,47,49,308,318,"In both healthy controls and pituitary adenoma patients, TIM-3+ Treg cells presented significantly higher levels of TGF- and IL-10 co-producing cells than TIM-3- Treg cells but compared to healthy controls, patients with nonfunctioning pituitary adenomas showed significantly higher levels of TIM-3+ FOXP3+ Treg cells.",32279926_7,-1,-1,2,2,39433,-1,3.0166675e-05,5.0167037e-05,0.99991965
41660,T cells,8,10,40,47,We isolated HLA-DR-CD33+ MDSCs and CD3+ T cells from BC patients' peripheral blood and healthy donors through MACS and immunophenotyped by flow cytometry.,33679700_3,-1,-1,2,2,41660,-1,3.2056127e-05,3.6406334e-05,0.9999316
8434,cells,17,18,117,122,"In vitro analysis revealed that a low concentration of 0.01 microg/ml basiliximab reduced almost all of CD4+CD25high cells, but less of the CD4+ CD25low cells, and augmented IFN-gamma production of activated PBMCs.",19148493_6,-1,-1,2,2,8434,-1,3.6908426e-05,4.1587784e-05,0.99992144
18605,regulatory T cells,2,5,10,28,CD4+CD25+ regulatory T cells (Tregs) play an essential role in the establishment and persistence of tumor immune suppression.,23000301_0,-1,-1,2,2,18605,-1,3.363608e-05,5.011809e-05,0.9999163
5325,cells,14,15,87,92,"Furthermore, a significantly reduced proportion of CD4+CD25+FoxP3+ regulatory T (Treg) cells was detected by flow cytometry in spleen lymphocytes from tumor-bearing mice treated with CTX.",17440723_4,-1,-1,2,2,5325,-1,3.5275974e-05,3.8572278e-05,0.9999261
22660,lymphocytic,15,16,98,109,We evaluated the expression of c-MET on nurse-like cells and monocytes from patients with chronic lymphocytic leukemia and searched for phenotypic/functional features supposed to be influenced by the hepatocyte growth factor/c-MET interaction.,24561793_2,-1,-1,2,2,22660,-1,7.616732e-05,9.902584e-05,0.9998248
17430,T cells,16,18,86,93,"However, this study reports that the majority of resting human memory CD4(+) FOXP3(-) T cells expresses intermediate levels of CD25 and that CD25 expression can be used to delineate a functionally distinct memory subpopulation.",22585674_1,-1,-1,2,2,17430,-1,2.7099717e-05,3.381326e-05,0.9999391
17261,cells,1,2,7,12,"Spleen cells of tumor-bearing mice had high CD4(+)CD25(+)regulatory T cell (CD4(+)CD25(+)T(reg)) ratio and high mRNA and proteins expression of Foxp3 and TIM-3, but in the BLTA and 5-FU group, CD4(+)CD25(+)T(reg) ratio degraded, with down regulation mRNA and proteins expression of Foxp3 and TIM-3.",22522606_10,-1,-1,2,2,17261,-1,3.6413767e-05,4.059732e-05,0.999923
39657,regulatory T-cell,28,30,135,152,"First, we showed that T1 cells comprise the majority of CD3+ T cells in BC; next, we found that CD73+T1 cells were the predominant regulatory T-cell (Treg) population in BC, and that their prevalence in peripheral blood was also related to tumour burden.",32345959_2,-1,-1,2,2,39657,-1,3.6173093e-05,4.6162208e-05,0.99991775
1147,cellular,12,13,81,89,"In T cells, calcineurin-NFAT signaling represents a critical event for mediating cellular activation and the immune response.",12091710_1,-1,-1,2,2,1147,-1,3.7444228e-05,4.691223e-05,0.9999156
2023,CD40 ligand,27,29,181,192,"In vitro generation of DC was achieved using a cytokine cocktail containing tumor necrosis factor alpha, granulocyte macrophage-colony stimulating factor, c-kit ligand, and soluble CD40 ligand; yet, addition of the HDAC inhibitor (Hdi) trichostatin A enhanced DC differentiation with retention of the fusion transcripts.",15197237_3,-1,-1,2,2,2023,-1,0.0013138355,0.00015515173,0.9985311
36914,cells,27,28,181,186,"Since 1998, when Itch was first discovered, hundreds of publications have described mechanisms through which Itch controls various biologic activities in both immune and non-immune cells.",31126634_2,-1,-1,2,2,36914,-1,3.648341e-05,5.3383283e-05,0.9999101
28517,Tcells,21,24,159,166,"We report that necroptotic cancer cells release damage-associated molecular patterns and promote maturation of dendritic cells, the cross-priming of cytotoxic Tcells, and the production of IFN- in response to tumor antigen stimulation.",27050509_3,-1,-1,2,2,28517,-1,3.1489966e-05,3.5958965e-05,0.9999325
30012,cells,4,5,26,31,"Moreover, CD4+CD25-FoxP3+ cells contained higher percentages of IL-2- and IFN--producing cells than CD4+CD25+FoxP3+ subpopulation.",27619682_7,-1,-1,2,2,30012,-1,3.179578e-05,4.1192226e-05,0.9999269
17938,cells,24,25,200,205,Prophylactic administration of breast cancer cells transfected with Stat3Y705F (Stat3Y705F-breast cancer cells) inhibited primary tumor growth compared with administration of empty vector-transfected cells in both models.,22753933_4,-1,-1,2,2,17938,-1,3.5813282e-05,4.384915e-05,0.99992037
3563,T cells,21,23,128,135,"Sezary syndrome (SS) is a leukemic variant of CTCL that presents with erythroderma, lymphadenopathies and presence of malignant T cells in peripheral blood.",16457762_1,-1,-1,2,2,3563,-1,6.206055e-05,3.7294452e-05,0.9999006
22456,cell,7,8,40,44,Notch signaling plays a pivotal role in cell fate decision and lineage commitment of lymphocytes.,24489102_0,-1,-1,2,2,22456,-1,4.0712748e-05,5.13423e-05,0.99990785
16850,Regulatory T cells,0,3,0,18,Regulatory T cells (Tregs) play pivotal role in cancer-induced immunoediting.,22419479_0,-1,-1,2,2,16850,-1,3.2411685e-05,5.2776642e-05,0.99991477
10677,T cells,23,25,160,167,Adoptive T cell immunotherapy using autologous lymphocytes is a viable treatment for patients with cancer and requires participation of Ag-specific CD4 and CD8 T cells.,19762283_0,-1,-1,2,2,10677,-1,3.179836e-05,3.53732e-05,0.99993277
15969,Treg cells,8,10,44,54,"In conclusion, GP reduced the proportion of Treg cells and Foxp3 lowered expression in Treg cells, and up-regulated Th1/Th2 cytokine ratio in serum in the tumor bearing mice, which might partially cause the inhibition of tumor growth.",21963624_7,-1,-1,2,2,15969,-1,3.4994282e-05,6.359275e-05,0.9999013
3295,T cells,24,26,153,160,"Taken together, our results demonstrate that JNK1 plays an important role in tumor immune surveillance through regulating the effector functions of CD8+ T cells.",16237070_7,-1,-1,2,2,3295,-1,2.8230475e-05,3.598855e-05,0.99993575
28642,cells,17,18,84,89,"METHODS: The expression and activation of NF-B, Akt and IDO1 by MyD88(+) EOC SKOV3 cells was determined using western blot; the TLR4/MD-2 complex on SKOV3 cells and the phenotype of T lymphocytes were determined using flow cytometry; IDO activity was evaluated by measuring L-kynurenine; Immunesuppressive cytokines were detected using ELISA; T-cell proliferation to mitogen stimulation was assessed by MTT assay; the cytotoxicity of lymphocytes and NK cells was measured using LDH-cytotoxicity assay.",27118139_3,-1,-1,2,2,28642,-1,3.3282344e-05,4.171743e-05,0.999925
30450,T cells,21,23,108,115,"With the agonistic ICOS-L protein (rICOS-L Ig), ICOS+ Foxp3+ cells were efficiently induced from naive CD4+ T cells under a stimulation with TGF- and CD3/CD28 mAbs.",27756099_4,-1,-1,2,2,30450,-1,3.0519812e-05,3.5065532e-05,0.99993443
21370,cells,26,27,152,157,"Compared with IL-2-CIK cells, the percentage of CD3CD56 cells was significantly increased in IL-15-CIK cells, but the expression of regulatory T (Treg) cells and IL-35 was significantly decreased in IL-15-CIK cells.",24145357_2,-1,-1,2,2,21370,-1,4.0551455e-05,4.150891e-05,0.999918
13722,TH1 cells,12,14,57,66,Further study of this pathway from NK to NK-T to TH7 and TH1 cells both with and without accessory or dendritic cells will improve understanding of contact sensitizers as topical immunomodulators.,21061759_8,-1,-1,2,2,13722,-1,0.000106694875,0.0002471153,0.9996462
23349,T cells,22,24,160,167,"Furthermore, we demonstrate that RANKL blockade can rescue melanoma-specific T cells from thymic deletion and that persistence of these tumor-specific effector T cells promoted increased host survival in response to tumor challenge.",24752296_7,-1,-1,2,2,23349,-1,3.0795087e-05,3.5487068e-05,0.9999337
3417,CD40L,0,1,0,5,CD40L stimulation of dendritic cells induces interleukin-12 expression that drives Th1 type of immune responses with activation of cytotoxic T cells.,16361570_1,-1,-1,2,2,3417,-1,5.005973e-05,6.0096598e-05,0.99988985
26211,regulatory T-cells,42,44,251,269,"We found that DCs exposed to butyrate express the immunosuppressive enzymes indoleamine 2,3-dioxygenase 1 (IDO1) and aldehyde dehydrogenase 1A2 (Aldh1A2), promote conversion of naive T-cells into immunosuppressive forkhead box P3(+) (FoxP3(+)) Tregs (regulatory T-cells) and suppress conversion of naive T-cells into pro-inflammatory interferon (IFN)--producing cells.",25984582_4,-1,-1,2,2,26211,-1,4.2157317e-05,6.0614784e-05,0.9998971
8436,cells,26,27,153,158,"In vitro analysis revealed that a low concentration of 0.01 microg/ml basiliximab reduced almost all of CD4+CD25high cells, but less of the CD4+ CD25low cells, and augmented IFN-gamma production of activated PBMCs.",19148493_6,-1,-1,2,2,8436,-1,3.762715e-05,4.195291e-05,0.99992037
6449,cells,10,11,51,56,"Furthermore, the frequency of CCL17(+) or CCL22(+) cells among CD14(+) cells within tumors was significantly higher than that of normal gastric mucosa, and there was a significant correlation between the frequency of CCL17(+) or CCL22(+) cells and Foxp3(+) Tregs in TILs.",18224687_8,-1,-1,2,2,6449,-1,4.976722e-05,4.5099863e-05,0.9999051
36173,cell,23,24,124,128,"In this study, we examined the proliferative response of V9V2 T cells to IL-21, a cytokine previously shown to promote NK cell and CD8 T cell cytotoxicity.",30708194_3,-1,-1,2,2,36173,-1,3.6990386e-05,5.2061536e-05,0.99991095
39107,T cells,33,35,195,202,"Distinct from its action on CD4+ T cells, IL35 signaling in gp130+CD8+ T cells activated the transcription factor STAT3, which antagonized intratumoral infiltration and effector function of CD8+ T cells via suppression of CXCR3, CCR5, and IFN expression.",32024640_3,-1,-1,2,2,39107,-1,2.9599101e-05,3.5059544e-05,0.9999354
15564,cells,3,4,16,21,ESO tetramer(+) cells were mostly effector memory cells at advanced stages of differentiation and were not detected in circulating CD25(+)FOXP3(+)Treg.,21829534_5,-1,-1,2,2,15564,-1,3.8428876e-05,4.0938234e-05,0.9999207
29666,T lymphocytes,17,19,93,106,Killer cell lectin-like receptor subfamily G member 1 (KLRG1) has been found on human memory T lymphocytes.,27557510_0,-1,-1,2,2,29666,-1,2.7300353e-05,3.868306e-05,0.99993396
42414,cells,23,24,112,117,"Here, we identify that Epidermal Growth Factor Receptor (EGFR) is essential for IL-9 induction in helper T (Th) cells.",34075041_2,-1,-1,2,2,42414,-1,3.9196726e-05,4.2811436e-05,0.999918
14361,T cells,4,6,18,25,Foxp3(+) IL-17(+) T cells in cancer tissue were examined by flow cytometry.,21352252_3,-1,-1,2,2,14361,-1,2.7926799e-05,3.7043737e-05,0.99993503
39160,CTLA-4,33,34,186,192,"Moreover, we found that tumors from high-risk patients had higher relative abundance of T follicular helper cells, regulatory T cells, and M0 macrophages, and higher expression of PD-1, CTLA-4, LAG3, and CD47 than low-risk patients.",32028264_6,-1,-1,2,2,39160,-1,5.2770938e-05,5.169373e-05,0.99989545
17777,cells,6,7,42,47,"Yet, large differences between individual cells may have important functional consequences.",22735807_1,-1,-1,2,2,17777,-1,3.2738746e-05,4.9549526e-05,0.9999176
3247,cell,12,13,72,76,"Thirteen patients (12 with metastatic melanoma, 1 with metastatic renal cell carcinoma) were treated at one of the two Food and Drug Administration-approved doses of Denileukin Diftitox (seven patients at 9 microg/kg, six patients at 18 microg/kg).",16224276_3,-1,-1,2,2,3247,-1,5.5379234e-05,9.634529e-05,0.99984825
35287,cells,12,13,72,77,The functional role of CTLA-4 expressed by Tregs and FoxO3 in dendritic cells (DC) was studied in vitro and in vivo by siRNA-silencing experiments.,29991500_5,-1,-1,2,2,35287,-1,3.420165e-05,4.5186105e-05,0.9999206
23407,cells,8,9,51,56,"However, the relationship between apoptosis, CD8+T cells and Foxp3+T cells in HCC patients is still unclear.",24761872_2,-1,-1,2,2,23407,-1,3.5968136e-05,4.067728e-05,0.99992335
1845,cells,5,6,30,35,"Thus, survivin enables cancer cells not only to suppress immune cell attack by inhibiting Fas-mediated apoptotic signaling, but to attack immune cells by induction of FasL.",15004200_10,-1,-1,2,2,1845,-1,3.4193352e-05,4.3663327e-05,0.99992216
22828,cytotoxic T cell,61,64,371,387,"Data generated from this study support that NLGP is effective in preventing the SLTCL induced generation (CD68(+)CD206(+)IL-10(high) to CD68(+)CD206(-)IL-10(low) TAMs) and functions (NO(low) to NO(high), MHC-I(low) to MHC-I(high), CD80(low) to CD80(high)) of pro-tumorous M2 macrophages, which in turn associated with sustained anti-tumor effector functions by promoting cytotoxic T cell activities and suppressing regulatory T cells.",24607970_2,-1,-1,2,2,22828,-1,4.5947472e-05,4.7860904e-05,0.9999062
36519,Tcell,1,4,11,17,Regulatory Tcell (Treg) depletion enhanced their capacity to elicit strong CD4+ Tconv responses and ensuing antitumor protection.,30955881_2,-1,-1,2,2,36519,-1,3.2866184e-05,4.2968073e-05,0.9999242
41987,cell,21,22,138,142,"Further investigation showed that transfection of HT29 and SW480 cells with miR-124 mimics significantly reduced PD-L1 mRNA, protein, and cell surface expression, and inhibited Tregs in coculture models via modulating interleukin[IL]-10, IL-2, tumor necrosis factor , transforming growth factor beta, and interferon gamma expression levels.",33821473_5,-1,-1,2,2,41987,-1,4.3990967e-05,5.772504e-05,0.9998983
12765,T-cell activation,7,9,52,69,OBJECTIVES: Costimulatory signals are essential for T-cell activation and hence play a very important role in antitumor immunity.,20563597_0,-1,-1,2,2,12765,-1,3.9445284e-05,5.747855e-05,0.9999031
19693,cell-intrinsic,8,9,53,67,These findings indicate a clinically relevant T(reg) cell-intrinsic defect in immune regulation in MG that may reveal a novel therapeutic target.,23252899_5,-1,-1,2,2,19693,-1,6.0319635e-05,9.0637586e-05,0.9998491
3732,cell-mediated,8,9,52,65,These data suggest that a novel CD1d-restricted NKT cell-mediated mechanism for tumor immunosuppression is active in the K7M2 osteosarcoma model and that NKT cells can regulate immunosurveillance through more than one pathway.,16585215_8,-1,-1,2,2,3732,-1,3.5951725e-05,5.1647843e-05,0.9999124
38764,Treg cells,6,8,36,46,"Our findings underscore the role of Treg cells, IL-2, and Blimp-1 in controlling the differentiation of cytotoxic CD4+ Tcells and offer a pathway to enhancement of anti-tumor activity through their manipulation.",31924474_5,-1,-1,2,2,38764,-1,5.8810114e-05,0.00010818114,0.999833
21863,Treg cells,0,2,0,10,Treg cells from patients showed a higher suppressive capability on CD4(+) CD25(-) responder T (Tresp) cells than normal.,24354800_5,-1,-1,2,2,21863,-1,3.9515122e-05,6.2171115e-05,0.9998982
1871,cells,20,21,143,148,In vitro treatment with recombinant IL-22 or overexpression of IL-22 promotes cell growth and survival in human hepatocellular carcinoma HepG2 cells.,15122762_5,-1,-1,2,2,1871,-1,3.5260546e-05,4.9772363e-05,0.9999149
32708,T cell,12,14,75,81,"Our study investigates the effects of tolerogenic GC-treated DCs on NK and T cell anti-tumor responses in OT-1/Rag-/- mice, expressing a transgenic TCR in CD8+ T cells.",28675711_1,-1,-1,2,2,32708,-1,3.4171477e-05,4.3606273e-05,0.99992216
40481,T cells,14,16,111,118,We found that TLR/CD40-mediated expansion and antitumor efficacy of adoptively transferred tumor-specific CD8+ T cells were abrogated in Batf3-/- mice.,32848036_4,-1,-1,2,2,40481,-1,3.093268e-05,3.485611e-05,0.9999343
33148,cells,5,6,15,20,"Thus, TIM-4+ B cells are enriched for IFN--producing proinflammatory Be1 cells that enhance immune responsiveness and can be specifically targeted with anti-TIM-4.",28848066_12,-1,-1,2,2,33148,-1,3.555558e-05,4.662434e-05,0.99991786
28668,cells,25,26,164,169,"BACKGROUND: Chronic lymphocytic leukemia (CLL) remains incurable with standard therapy, and is characterized by excessive expansion of monoclonal abnormal mature B cells and more regulatory immune properties of T cell compartment.",27118475_0,-1,-1,2,2,28668,-1,3.6534682e-05,4.3313164e-05,0.99992025
33626,cell,12,13,84,88,TAM count was significantly correlated with Treg count and with IL6-positive cancer cell count.,29048388_6,-1,-1,2,2,33626,-1,3.809973e-05,4.666047e-05,0.99991524
18374,cell,18,19,100,104,METHODS AND RESULTS: We analyzed various T cell subsets in the peripheral blood of 45 oral squamous cell carcinoma (OSCC) patients and 40 healthy volunteers.,22956260_2,-1,-1,2,2,18374,-1,4.3056094e-05,6.0513838e-05,0.9998964
39509,T cells,14,16,81,88,"In CDDO-Me-treated mice, both the absolute number and proportion of splenic CD4+ T cells were reduced, while the proportion of CD8+ T cells was significantly increased in both tumors and spleen.",32300202_6,-1,-1,2,2,39509,-1,3.0478588e-05,3.5323224e-05,0.9999342
12834,cells,22,23,127,132,"We found that Th17 but not Treg cells were differently represented in the two lymphomas and correlated with the amount of mast cells (MCs) and granulocytes, which preferentially occurred in the cellular milieu of AITL cases.",20595635_2,-1,-1,2,2,12834,-1,4.2545173e-05,3.93411e-05,0.9999181
19586,T cells,26,28,165,172,IDO1-driven tryptophan breakdown was correlated with the release of hepatocyte growth factor (HGF) and with the frequency of Treg cells and NY-ESO-1-specific CD8(+) T cells.,23232072_4,-1,-1,2,2,19586,-1,2.9258272e-05,3.4730547e-05,0.9999361
42118,T cell-mediated,12,14,74,89,These dual functions of TNAX101A may be advantageous for the treatment of T cell-mediated inflammatory diseases through both downregulation of effector T cell function and upregulation of Treg cell function.,33900821_4,-1,-1,2,2,42118,-1,3.3543136e-05,5.3467404e-05,0.999913
4057,regulatory T cells,10,13,69,87,Studies in cancer patients have suggested that breast tumors recruit regulatory T cells (Tregs) into the tumor microenvironment.,16785502_0,-1,-1,2,2,4057,-1,3.8054804e-05,4.976079e-05,0.99991226
33212,cells,12,13,80,85,Emerging evidence suggests a role for micro-environmental factors such as CD25+ cells modulating response to PD-1 inhibition.,28940183_1,-1,-1,2,2,33212,-1,3.8424834e-05,4.208551e-05,0.99991953
19419,cells,4,5,35,40,CD4(+)CD25(+)Foxp3(+) T regulatory cells (Tregs) and CD1d-restricted invariant natural killer T (iNKT) cells are two cell types that are known to regulate immune reactions.,23182710_0,-1,-1,2,2,19419,-1,3.516679e-05,4.029559e-05,0.99992454
22292,T cell,2,4,15,21,"IL-6 regulates T cell differentiation, activation and resistance against apoptosis and thereby controls the balance between pro-inflammatory T cell subsets such as Th1 or Th17 cells and immunosuppressive regulatory T cells.",24447345_1,-1,-1,2,2,22292,-1,3.6040823e-05,4.1559833e-05,0.9999224
39875,subsets,11,12,59,66,Regulatory T cells (Tregs) is one of the immunosuppressive subsets of CD4+ T cells characterized by transcription factor forkhead box protein P3 (FOXP3) expression which are involved in tumor development and progression.,32480291_0,-1,-1,2,2,39875,-1,4.801279e-05,4.8235193e-05,0.9999037
14413,cells,7,8,35,40,Foxp3(+)CD4(+) regulatory T (Treg) cells inhibit immune responses and temper inflammation.,21357259_0,-1,-1,2,2,14413,-1,3.392765e-05,3.8059326e-05,0.999928
20381,T cell,13,15,105,111,These results therefore indicate that NF-B activity mediates immune surveillance and promotes antitumor T cell responses in both murine and human lung cancer.,23635779_6,-1,-1,2,2,20381,-1,4.880585e-05,4.9997037e-05,0.9999013
287,T cell,27,29,198,204,"Janus tyrosine kinase (Jak)3 and transcription factors Stat5a and Stat5b are essential for the proliferation of normal T cells and are constitutively hyperactivated in both HTLV-1-transformed human T cell lines and lymphocytes isolated from HTLV-1-infected patients; therefore, a critical role for the Jak3-Stat5 pathway in the progression of this disease has been postulated.",11046040_1,-1,-1,2,2,287,-1,3.1926982e-05,4.6000463e-05,0.99992204
4013,T cell activation,11,14,74,91,"CTL-associated antigen 4 (CTLA4) blockade releases inhibitory controls on T cell activation and proliferation, inducing antitumor immunity in both preclinical and early clinical trials.",16778987_0,-1,-1,2,2,4013,-1,4.142397e-05,4.4278433e-05,0.9999143
36442,cell,8,9,48,52,"Here, we examined the association of programmed cell death ligand 1 (PD-L1) expression with epithelial-mesenchymal transition (EMT)-associated markers in pancreatic ductal adenocarcinoma (PDA) within the context of the tumor microenvironment.",30927618_1,-1,-1,2,2,36442,-1,0.00015078385,7.010944e-05,0.99977916
3135,cells,9,10,51,56,"In conclusion, tumor expansion can stimulate T reg cells via a specific DC subset.",16186184_5,-1,-1,2,2,3135,-1,5.0817045e-05,4.090502e-05,0.9999083
43217,T cell activation,11,14,83,100,"Importantly, we demonstrate that AX-0085 reverses the IFN--mediated repression of T cell activation in vitro and enhances the anti-tumor activity of anti-PD-1 antibody in vivo when used in combination.",35011581_2,-1,-1,2,2,43217,-1,3.7953312e-05,5.0048715e-05,0.999912
16163,cells,16,17,89,94,"Based on these results, we propose that loss of PML protein expression in gastric cancer cells contributes to increased IP-10 transcription via enhancement of STAT-1 activity, which, in turn, promotes lymphocyte trafficking within tumor regions.",22022583_9,-1,-1,2,2,16163,-1,3.3572276e-05,4.5342822e-05,0.9999211
23430,cells,15,16,84,89,"RESULTS: The frequency of CD8+T cells binding annexin V and Fas expression in CD8+T cells, were all higher in HCC patients than normal controls and the proportion of apoptotic CD8+T cells correlated with their Fas expression.",24761872_7,-1,-1,2,2,23430,-1,3.6211695e-05,4.0837484e-05,0.9999229
32074,T cells,6,8,46,53,"Compared to interleukin 10-nonexpressing CD8+ T cells, interleukin 10 receptor-expressing CD8+ T cells secreted significantly elevated interferon gamma levels.",28488547_7,-1,-1,2,2,32074,-1,2.7386506e-05,3.5048455e-05,0.99993753
12334,Regulatory T cells,0,3,0,18,"Regulatory T cells, characterized by FOX-P3 and TGF-beta mRNA level, were decreased in OTRs.",20463594_12,-1,-1,2,2,12334,-1,3.2570704e-05,4.8768637e-05,0.9999187
36679,T cells,8,10,40,47,RESULTS: We found more infiltrated CD4+ T cells in human PCa lesions than in the adjacent noncancerous tissues after Doc treatment.,31018021_11,-1,-1,2,2,36679,-1,3.032327e-05,3.7521346e-05,0.99993217
43772,cells,16,17,81,86,"gamma IFN, in fact, induces endothelial cells to acquire the same features of KS cells, including the spindle morphology and the pattern of cell marker expression.",9446657_8,-1,-1,2,2,43772,-1,3.5556743e-05,4.634856e-05,0.9999181
36142,cell,12,13,66,70,"In this work, we report that cell lysates generated from melanoma cell lines markedly induce XBP1s and certain members of the UPR such as the chaperone BiP in bone marrow derived DCs (BMDCs).",30687308_2,-1,-1,2,2,36142,-1,3.7923928e-05,6.464454e-05,0.9998975
39884,Treg cells,9,11,53,63,"Our current study aimed to evaluate the frequency of Treg cells, cytokine secretion and the expression of microRNAs (miRNAs) in pediatric acute lymphoblastic leukemia (ALL) patients.",32480291_2,-1,-1,2,2,39884,-1,3.5474415e-05,6.213047e-05,0.99990237
20501,Regulatory T cell,0,3,0,17,Regulatory T cell (Treg)-mediated immunosuppression represents one of the crucial tumor immune evasion mechanisms and is a main obstacle for successful tumor immunotherapy.,23723999_0,-1,-1,2,2,20501,-1,3.63531e-05,5.820927e-05,0.99990547
6502,T cells,9,11,51,58,"In addition, full transcriptome analysis of CD8(+) T cells displayed changes in several transcripts associated with increased cell cycle progression, cellular motility, and immune activation.",18286285_7,-1,-1,2,2,6502,-1,2.8882445e-05,3.7317357e-05,0.99993384
3418,cells,4,5,31,36,CD40L stimulation of dendritic cells induces interleukin-12 expression that drives Th1 type of immune responses with activation of cytotoxic T cells.,16361570_1,-1,-1,2,2,3418,-1,3.650847e-05,4.5802404e-05,0.99991775
24298,regulatory T cells,3,6,16,34,"Moreover, fewer regulatory T cells accumulated at the metastatic site in Spp1(-/-) mice.",25035397_8,-1,-1,2,2,24298,-1,3.357641e-05,4.3217442e-05,0.9999231
286,T cells,17,19,119,126,"Janus tyrosine kinase (Jak)3 and transcription factors Stat5a and Stat5b are essential for the proliferation of normal T cells and are constitutively hyperactivated in both HTLV-1-transformed human T cell lines and lymphocytes isolated from HTLV-1-infected patients; therefore, a critical role for the Jak3-Stat5 pathway in the progression of this disease has been postulated.",11046040_1,-1,-1,2,2,286,-1,3.094009e-05,4.12329e-05,0.99992776
20103,T cells,12,14,80,87,Treatment with recombinant IL-33 could also increase the cytotoxicity of CD8(+) T cells and NK cells in vitro.,23499895_3,-1,-1,2,2,20103,-1,2.7524105e-05,3.6635665e-05,0.99993587
23895,T cell-based,15,17,87,99,"Therefore, these data provide evidence for the use of the EWS/FLI-l peptide epitope in T cell-based immunotherapeutic concepts against Ewing's sarcoma cell in vitro and in vivo.",24861249_4,-1,-1,2,2,23895,-1,4.3805947e-05,8.1161124e-05,0.99987495
33714,cells,7,8,40,45,"METHODS: Hepatocellular carcinoma (HCC) cells, H22 and Hepa1-6, were modified by blocking the STAT3 signaling pathway with a STAT3 decoy oligodeoxynucleotide, and the immunogenicity and possibility of using these cell lysates as a vaccine were evaluated.",29115974_1,-1,-1,2,2,33714,-1,4.034475e-05,4.6202444e-05,0.99991345
5322,lymphocytes,18,19,119,130,"CTX treatment potentiated the antitumor effects of the DC vaccine, and increased the proportion of IFN-gamma secreting lymphocytes in spleens.",17440723_3,-1,-1,2,2,5322,-1,3.6787238e-05,4.5142096e-05,0.999918
7133,cells,17,18,149,154,"Tumor-specific Treg cells require ligand-specific activation and cell-to-cell contact to exert their suppressive activity on tumor-specific effector cells (CD8+ cytotoxic T lymphocytes and CD4+ Th cells), which includes decreased cytotoxity, proliferation, and Th1 cytokine secrection.",18512029_2,-1,-1,2,2,7133,-1,3.2820903e-05,3.9929342e-05,0.9999273
11083,T cells,0,2,0,7,T cells from pancreatic cancer patients responded to pancreatic cancer-associated but not pancreatitis-associated antigens with IFN-gamma secretion.,19931255_8,-1,-1,2,2,11083,-1,2.5329535e-05,4.0052095e-05,0.9999347
17217,CTLs,25,26,180,184,"LCs therefore provide a more potent costimulatory cytokine milieu for T-cell activation than do moDCs, thus accounting for their superior stimulation of MHC-restricted Ag-specific CTLs without need for exogenous cytokines.",22510877_6,-1,-1,2,2,17217,-1,3.5930167e-05,4.22163e-05,0.9999219
34066,T cell proliferation,8,11,54,74,"It could also enhance B16 cell-mediated inhibition of T cell proliferation and activation, and upregulate PD-1 expression on CD4+ and CD8+ T cells.",29301578_9,-1,-1,2,2,34066,-1,3.17875e-05,3.950514e-05,0.9999287
9839,cells,34,35,205,210,"IL15/IL21 cultures result in a cell population with a lower proportion of CD4(+)CD25(high)FoxP3(+) regulatory cells and higher number of CD8(+) and CD56(+) cells, and consequently render a higher yield of cells with a greater cytolytic activity and IFN-gamma production against melanoma cell lines.",19501956_4,-1,-1,2,2,9839,-1,3.3881257e-05,4.1666113e-05,0.9999244
26419,CCR5,0,1,0,4,"CCR5 blockade also suppresses interleukin (IL)-6 induction, which in turn deactivates signal transducer and activator of transcription 3 (Stat3) in tumors.",26047948_3,-1,-1,2,2,26419,-1,0.00023933018,0.0003783402,0.99938226
6607,Treg cells,16,18,107,117,We found that metastatic melanoma LNs expressed very heterogeneous levels of Foxp3 and that CD4+CD25(high) Treg cells extracted from these LNs were detectable at each step of the in vitro culture of TIL but decreasing during the culture.,18312383_3,-1,-1,2,2,6607,-1,3.703358e-05,4.644033e-05,0.99991643
25647,cells,49,50,270,275,"The results showed that NPC cell line C666-1 and surgically removed NPC tissue expressed miR-21, which was upregulated by the presence of the Toll-like receptor 3 ligand, Poly I: C. Exposure to miR-21 increased the expression of NFI-A and interleukin (IL)-10 in naive B cells.",25544502_8,-1,-1,2,2,25647,-1,3.6927428e-05,4.9593426e-05,0.99991345
43212,cells,30,31,167,172,"In this study, we describe a novel kinase inhibitor AX-0085 which can suppress the induction of PD-L1 expression by Interferon- (IFN-) in lung adenocarcinoma (LUAD) cells.",35011581_0,-1,-1,2,2,43212,-1,3.866699e-05,4.7167865e-05,0.99991417
42866,cell,6,7,34,38,"Effect of CXCL10 on breast cancer cell proliferation and invasion was examined in vitro, and expression of CXCL10 and its relationship with immune cell infiltration was assessed in breast cancer samples.",34504204_2,-1,-1,2,2,42866,-1,3.7560603e-05,4.6053847e-05,0.99991643
8428,lymphocytes,19,20,120,131,"During in vivo studies, basiliximab was administered intravenously on day 1, followed by AIT using autologous activated lymphocytes on day 8, and the treatment cycle was repeated.",19148493_4,-1,-1,2,2,8428,-1,3.7993766e-05,4.609328e-05,0.99991584
5170,T helper cells,7,10,45,59,"Unexpectedly, antigen presentation to CD4(+) T helper cells was reduced owing to potentiation of regulatory T-cell function by NPC-LMP1 transfectants, which produce increased levels of interleukin-10, rendering CD4(+) T cells hyporesponsive.",17372611_3,-1,-1,2,2,5170,-1,0.0005569828,0.006453246,0.9929898
22378,cell,28,29,180,184,"Overall, our results explain how TGF-1 can participate in CD103 expression on locally TCR-engaged Ag-specific CD8 T cells, thus contributing to antitumor CTL responses and cancer cell destruction.",24477908_5,-1,-1,2,2,22378,-1,3.704541e-05,4.3804463e-05,0.9999192
22667,T-cell proliferation,6,8,50,70,"Indoleamine 2,3-dioxygenase, an enzyme modulating T-cell proliferation and induced on normal monocytes after hepatocyte growth factor treatment, was detected together with interleukin-10 on nurse-like cells, and on freshly-prepared patients' monocytes.",24561793_5,-1,-1,2,2,22667,-1,3.219558e-05,4.2295193e-05,0.9999255
35171,T cells,10,12,81,88,This molecular circuit underlies the co-expression of co-inhibitory receptors in T cells and identifies regulators of T cell function with the potential to control autoimmunity and tumour immunity.,29899446_6,-1,-1,2,2,35171,-1,3.3209762e-05,4.4704437e-05,0.99992204
7070,regulatory T cells,15,18,79,97,Both CD3+CD8+ T cells and CD4+CD25+ T cells were expanded without induction of regulatory T cells.,18480841_7,-1,-1,2,2,7070,-1,4.090849e-05,4.9019316e-05,0.9999101
41151,CTLA4,14,15,81,86,"A 7 immune-related genes prognostic model for OSCC was obtained, including CGB8, CTLA4, TNFRSF19, CCL26, NRG1, TPM2 and PLAU, which was further proved to be an independent prognostic indicator after adjusting for other clinical factors.",33220636_4,-1,-1,2,2,41151,-1,7.696328e-05,8.20679e-05,0.99984086
34440,gland,24,25,162,167,The prolactin-inducible protein (PIP) is considered a valuable biomarker that is associated with both benign and malignant pathological conditions of the mammary gland.,29536339_0,-1,-1,2,2,34440,-1,0.00015981856,0.00037899014,0.99946123
5338,cells,31,32,185,190,"Indoleamine 2, 3-dioxygenase (IDO), a key enzyme that catalyses the initial and rate-limiting step in the degradation of the tryptophan, is simultaneously expressed in murine dendritic cells and macrophages stimulated with interferon-gamma (IFN-gamma).",17466914_0,-1,-1,2,2,5338,-1,3.2258482e-05,4.6199726e-05,0.99992144
33456,T cells,14,16,73,80,"Furthermore, forced expression of Foxo1 or a deficiency in Foxp1 in CD4+ T cells markedly increased the production of IL-9, whereas a deficiency in Foxo1 inhibited the ability of IL-7 to enhance the differentiation and antitumor activity of TH9 cells.",29018172_5,-1,-1,2,2,33456,-1,2.964256e-05,3.9228802e-05,0.9999311
9956,regulatory T-cells,15,17,90,108,"Our data suggest that in NSCLC patients, there is an increase of CD4(+)CD25(high)FOXP3(+) regulatory T-cells in the peripheral blood and tumor microenvironment.",19538059_6,-1,-1,2,2,9956,-1,9.039269e-05,0.00017785403,0.99973184
12780,cell,36,37,170,174,"This study investigated the role of B7 and 4-1BBL in the amplification of tumor immunity by transduction of the B7-1, B7-2 and 4-1BBL into mouse hepatocellular carcinoma cell line H22.METHODS: The tumorigenicity of H22 variants expressing either B7-1, B7-2 (H22/B7-1/B7-2) or 4-1BBL was compared with an H22 variant expressing B7-1, B7-2 and 4-1BBL (H22/B7-1/B7-2/4-1BBL).",20563597_2,-1,-1,2,2,12780,-1,3.7948863e-05,5.4805336e-05,0.99990726
28896,T cells,13,15,92,99,"The tumor microenvironment impacts tumor progression and individual cells, including CD4(+) T cells, which have been detected in bladder cancer tissues.",27196763_0,-1,-1,2,2,28896,-1,3.0957173e-05,3.8450366e-05,0.9999305
13489,cells,11,12,69,74,The effect of Foxp3+IL-17+ T cells on induction of cancer-initiating cells was examined; the latter's Akt and MAPK activities and colony formation were examined afterward.,20952660_6,-1,-1,2,2,13489,-1,3.5794e-05,4.3671378e-05,0.9999206
10461,T cells,12,14,82,89,"In the present study, we collected high-purity human CD4(+)CD25(-)CD45RA(+) nave T cells by microbead cell separation.",19673890_3,-1,-1,2,2,10461,-1,3.1233987e-05,3.490596e-05,0.99993384
28176,cell-intrinsic,9,10,43,57,"Similar to other oncogenes, KRAS acts in a cell-intrinsic manner to affect tumor growth or survival.",26880715_1,-1,-1,2,2,28176,-1,7.1690374e-05,0.000112605645,0.99981576
32398,CCR6,3,4,21,25,This predominance of CCR6+ Treg cells was also found in the draining lymph nodes and tumor-infiltrating lymphocytes of OSCC patients with early or late clinical staging.,28600287_6,-1,-1,2,2,32398,-1,0.00016624505,0.0001810862,0.9996526
41188,cells,8,9,58,63,Silencing of SKIL inhibited malignant phenotypes of NSCLC cells and promoted T cell infiltration.,33268765_9,-1,-1,2,2,41188,-1,3.8655646e-05,4.106659e-05,0.99992025
38838,cytotoxic T cells,10,13,69,86,"Major barriers persist, however, including insufficient induction of cytotoxic T cells and exhaustion of tumor-infiltrating lymphocytes.",31969386_1,-1,-1,2,2,38838,-1,4.4174332e-05,4.354542e-05,0.99991226
16390,cellular,7,8,47,55,"However, remarkably little is understood about cellular and molecular changes induced by these adjuvants in the vaccine microenvironment.",22130163_2,-1,-1,2,2,16390,-1,4.9656537e-05,6.2157575e-05,0.9998882
17112,cells,28,29,155,160,"Human MutS homologue 2 (hMSH2), a crucial element of the highly conserved DNA mismatch repair system, maintains genetic stability in the nucleus of normal cells.",22493490_0,-1,-1,2,2,17112,-1,3.904324e-05,5.4396955e-05,0.99990654
19324,regulatory T cells,3,6,16,34,The presence of regulatory T cells (Treg cells) in human uterine cancer is crucial for maintaining immunological homeostasis.,23178746_1,-1,-1,2,2,19324,-1,3.4339944e-05,3.9980263e-05,0.99992573
1105,CTLs,18,19,125,129,We have determined whether this immune evasion strategy can be manipulated to shield tumor-specific cytotoxic T lymphocytes (CTLs) from the inhibitory effects of tumor-derived TGF-beta.,11964281_2,-1,-1,2,2,1105,-1,3.8472823e-05,4.3107986e-05,0.99991834
34731,T-cell subset,9,11,46,59,"However, this early-induced CD8+ CD25+ CD127- T-cell subset is certainly distinct from the IFN+ CD8+ T-effector cells.",29768737_3,-1,-1,2,2,34731,-1,0.00080380164,0.02051282,0.97868335
21104,cells,10,11,72,77,Multivariate analysis revealed that the presence of intratumoral FoxP3+ cells was an independent prognostic indicator for poor DFS (P < 0.01).,24007242_7,-1,-1,2,2,21104,-1,4.0237308e-05,4.5409375e-05,0.9999143
6970,subset,10,11,79,85,"Interestingly, these IL-10-secreting cells derived from the CD25(high)TIRC7(-) subset, both in vitro and in vivo, in response to tumoral Ags.",18424726_5,-1,-1,2,2,6970,-1,4.0901115e-05,4.514609e-05,0.99991393
36697,cells,7,8,43,48,In vivo mouse model with xenografted 22RV1 cells and CD4+ T cells also confirmed the in vitro results.,31018021_16,-1,-1,2,2,36697,-1,3.7294532e-05,3.9953236e-05,0.99992275
21611,cells,9,10,64,69,"Immunostaining showed that the anti-GITR mAb decreased Foxp3(+) cells infiltrating in the tumors, while the intratumoral IFN- gene transfer increased CD4(+) and CD8(+) T cells in the tumors.",24289533_6,-1,-1,2,2,21611,-1,3.5770736e-05,3.7618844e-05,0.99992657
36565,cell,5,6,34,38,CONCLUSIONS: Induced IL-35+Foxp3+ cell numbers in the TU region of the lung of patients with NSCLC associated with ARG1 mRNA expression and with TTF-1+PD-L1+ cells.,30956278_8,-1,-1,2,2,36565,-1,5.370813e-05,4.1470295e-05,0.99990475
20017,suppressor cell,22,24,167,182,These clinical findings encourage efforts to restore T-cell function in patients with advanced stage disease by highlighting combined approaches to deplete endogenous suppressor cell populations that can also expand effector T-cell populations.,23423978_6,-1,-1,2,2,20017,-1,3.765713e-05,4.185704e-05,0.9999205
22918,T cell,7,9,52,58,"More importantly, they significantly suppressed CD4 T cell response via mTGF-1 in vitro.",24668348_5,-1,-1,2,2,22918,-1,3.101833e-05,4.275854e-05,0.9999262
6953,T lymphocyte activation,22,25,124,147,"Our experiments indicate that TIRC7, T cell immune response cDNA 7, a novel membrane molecule involved in the regulation of T lymphocyte activation, identifies two Treg subsets (CD25(low)TIRC7(+) and CD25(high)TIRC7(-)) that are characterized by the expression of Foxp3 and a suppressive activity in vitro and in vivo.",18424726_2,-1,-1,2,2,6953,-1,3.925195e-05,4.8333015e-05,0.9999125
29220,cells,42,43,269,274,Recombinant IL18 alone had no antitumor effect in the syngeneic mice with orthotopically transplanted tumors and promoted tumors in immunocompromised mice; it also facilitated immune responses in vitro and in vivo by augmenting the activity of cytotoxic T cells and NK cells in peripheral blood and lymph nodes.,27297583_4,-1,-1,2,2,29220,-1,3.736742e-05,3.869326e-05,0.99992394
29642,cellular,16,17,113,121,"In conclusion, our data suggest that vaccinated volunteers are superior to nonvaccinated donors for HPV-specific cellular cancer immunotherapy.",27548034_10,-1,-1,2,2,29642,-1,5.1541556e-05,4.943471e-05,0.999899
40153,cell,23,24,138,142,"To address this issue and to facilitate the development of new pharmacological compounds, we here describe an in vitro model of dendritic cell suppression by cancer cells.",32573300_2,-1,-1,2,2,40153,-1,4.4514898e-05,4.9845625e-05,0.9999057
33824,CD8+ T lymphocytes,0,4,0,18,"CD8+ T lymphocytes mediate potent immune responses against tumor, but the role of human CD4+ T cell subsets in cancer immunotherapy remains ill-defined.",29213079_0,-1,-1,2,2,33824,-1,8.469642e-05,9.9235695e-05,0.999816
8100,cells,22,23,129,134,Ex vivo treatment of splenocytes from NZB mice with IFN-alpha resulted in a decrease in the frequency of Tregs and malignant B-1 cells.,19022624_5,-1,-1,2,2,8100,-1,3.9833714e-05,5.032784e-05,0.9999099
26616,T cells,48,50,234,241,"To evaluate a potential synergy between IL-22 and type I IFN in aGVHD, we transplanted recipient mice, either wild-type (WT) or type I IFN receptor deficient (IFNAR(-/-)), with bone marrow cells and WT or IL-22 deficient (IL-22(-/-)) T cells.",26153763_4,-1,-1,2,2,26616,-1,2.9247849e-05,3.525684e-05,0.9999355
32049,T cell-mediated,11,13,62,77,Interleukin 10 is a cytokine with controversial roles in CD8+ T cell-mediated anti-tumor immunity.,28488547_2,-1,-1,2,2,32049,-1,3.199831e-05,5.5479642e-05,0.9999126
36624,T cells,5,7,25,32,GM-CSF is produced by  T cells via macrophage IL-1.,31000683_5,-1,-1,2,2,36624,-1,2.6745367e-05,3.9354596e-05,0.99993396
5147,cells,29,30,167,172,Sequence variation in the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) oncogene structure may affect antigen-presenting cell (APC) function of infected B cells and immune escape by EBV-specific T cells and thus contribute to the development of malignancy.,17372611_0,-1,-1,2,2,5147,-1,3.7833186e-05,4.5683213e-05,0.99991655
42846,cells,25,26,109,114,"The protective effect of PBC was relying on type 1 and type 2 T cell responses and, to a lesser extent, on B cells.",34495298_6,-1,-1,2,2,42846,-1,4.1099873e-05,4.579848e-05,0.9999131
26309,cells,32,33,210,215,"Taken together, the direct CD40-CD40L interaction of breast tumor cells and activated T cells increases TGF- production and the differentiation of Th17 cells, which promotes the proliferation of breast cancer cells.",25992978_5,-1,-1,2,2,26309,-1,3.7085072e-05,4.3693813e-05,0.9999192
38833,antigen receptor,23,25,124,140,"Given the antitumor properties of Tc22 cells, it may be prudent to polarize T cells to the Tc22 lineage when using chimeric antigen receptor (CAR)-T or T-cell receptor (TCR) transduction-based immunotherapies.",31964625_6,-1,-1,2,2,38833,-1,0.0001978626,8.238275e-05,0.9997198
722,cells,20,21,133,138,We generated HLA-A*0201-restricted CTL clones against HPV16 E6(29-38) that recognized HPV16 E6 Ags transfected into B lymphoblastoid cells.,11673561_3,-1,-1,2,2,722,-1,3.154048e-05,4.6620567e-05,0.9999218
40910,cells,2,3,13,18,"Regulatory B cells (Bregs) and CD4+ regulatory T cells (Tregs) are subgroups of immunoregulatory cells involved in modulating autoimmunity, inflammation, and transplantation reactions.",33083479_1,-1,-1,2,2,40910,-1,3.7690585e-05,4.1668423e-05,0.9999206
34614,cells,30,31,213,218,"Increasing evidence indicates that Wnt/-catenin signaling, one of the best-characterized cancer drivers, promotes cancer progression by regulating the tumor-immune cycle in most of the nodes, including dendritic cells, T cells, and tumor cells.",29678298_1,-1,-1,2,2,34614,-1,3.891059e-05,4.0917217e-05,0.99992025
26164,T cell,35,37,208,214,Delivery of DNA vaccines encoding XBP1 and tumor Ag to skin DC resulted in increased IFN- production by plasmacytoid DC (pDC) from skin/tumor draining lymph nodes and the cross-priming of Ag-specific CD8(+) T cell responses associated with therapeutic benefit.,25972487_3,-1,-1,2,2,26164,-1,4.8264323e-05,4.997194e-05,0.9999018
33094,cell,6,7,34,38,"Such subsets likely explain why B cell depletion can either ameliorate or exacerbate inflammatory diseases; however, these cells remain poorly understood because of the absence of specific markers.",28848066_1,-1,-1,2,2,33094,-1,4.1576674e-05,4.8592854e-05,0.99990976
11320,T cells,5,7,18,25,"In addition, CD8+ T cells from cured mice coinjected with Neuro2a/parental cells (pc) in NOD-SCID mice completely inhibited tumor growth.",20039320_7,-1,-1,2,2,11320,-1,2.9258621e-05,3.520352e-05,0.9999356
27116,T cells,10,12,54,61,"In this study, whether IFN- can induce CD4(+)CD25(-) T cells into CD4(+)CD25(+) Tregs in MG in vitro was investigated systematically.",26347149_2,-1,-1,2,2,27116,-1,2.9018767e-05,3.4716086e-05,0.99993634
39121,T-cell activation,12,14,76,93,We also demonstrated that B cell-specific deletion of IL35 facilitated CD8+ T-cell activation independently of effector or regulatory CD4+ T cells and was sufficient to phenocopy therapeutic anti-IL35 blockade in overcoming resistance to anti-PD-1 immunotherapy.,32024640_6,-1,-1,2,2,39121,-1,3.1547672e-05,4.759256e-05,0.99992085
29251,T cells,14,16,100,107,"We therefore investigated the phenotypic and functional differences among in vitro activated CD8(+) T cells of three different sources, namely nave (NTeff), memory (MTeff) and tumor-infiltrating lymphocytes (TILeff) from human and mice, to better understand mechanisms behind potent effector functions and potential for overcoming current limitations.",27306834_1,-1,-1,2,2,29251,-1,3.2220003e-05,3.6348116e-05,0.99993145
28049,T cells,13,15,86,93,CONCLUSION: We demonstrate strong proliferation among regulatory CD4+ FOXP3+ CD25high T cells in the gastric cancer mucosa.,26782287_6,-1,-1,2,2,28049,-1,2.812346e-05,3.471575e-05,0.9999372
854,cells,28,29,156,161,"We also demonstrate for the first time that MG cells can process native Ag for presentation to CD4(+) MHC class II-restricted Th1 cells, indicating that MG cells can serve as nonprofessional APC.",11746775_6,-1,-1,2,2,854,-1,3.653414e-05,3.8964045e-05,0.99992454
11354,lymphocytes,8,9,30,41,"Tryptase MCs, CD8+ and Foxp3+ lymphocytes had significantly increased in the interleukin 2 (IL-2) treated group.",20053697_6,-1,-1,2,2,11354,-1,3.2397948e-05,4.3780066e-05,0.9999238
43106,suppressor cells,21,23,123,139,"Moreover, EZH2 can regulate T cell fate by targeting non-T cell factors such as metabolism, cytokines, and myeloid-derived suppressor cells.",34737746_5,-1,-1,2,2,43106,-1,3.5087553e-05,3.6986254e-05,0.999928
42062,cell,16,17,82,86,"However, the expression patterns and roles of TFT cells in TME of diffuse large B cell lymphoma (DLBCL) remain to be established.",33864956_2,-1,-1,2,2,42062,-1,3.9949427e-05,4.7855123e-05,0.99991226
12082,cells,1,2,10,15,Dendritic cells (DCs) play a major role in the generation of the adaptive immune response owing to their capacity for antigen presentation leading to T lymphocyte activation and differentiation and there is compelling evidence for their contribution to the antitumoral immune response.,20386470_2,-1,-1,2,2,12082,-1,3.256015e-05,4.30856e-05,0.9999244
20450,cells,15,16,102,107,"In addition, RARi significantly suppressed TGF- and IL-10 and enhanced IL-12 production by dendritic cells (DC) in response to killed tumour cells or TLR agonists.",23657628_6,-1,-1,2,2,20450,-1,4.3919084e-05,4.4318454e-05,0.9999118
4020,T cells,25,27,145,152,We examined the mechanisms of action of anti-CTLA4 and a GM-CSF-transduced tumor cell vaccine (Gvax) and their impact on the balance of effector T cells (Teffs) and Tregs in an in vivo model of B16/BL6 melanoma.,16778987_1,-1,-1,2,2,4020,-1,2.9769684e-05,3.5991172e-05,0.9999342
22623,cells,14,15,96,101,"However, repeated injections of -GalCer result in long-term unresponsiveness or anergy of iNKT cells, severely limiting its efficacy in tumor eradication.",24532578_2,-1,-1,2,2,22623,-1,3.5579076e-05,4.88234e-05,0.9999156
10469,cells,3,4,14,19,"However, more cells expressed FOXP3 when the supernatant of human epithelial ovarian carcinoma cell culture was added, yet not the supernatant of normal human ovarian surface epithelia cell culture.",19673890_5,-1,-1,2,2,10469,-1,3.2489173e-05,4.6049292e-05,0.99992144
39602,cells,6,7,40,45,"In coculture experiments, A375 melanoma cells pretreated with vemurafenib induced apoptosis of interacting Jurkat T cells, whereas genetic inhibition of Gal-1 in these cells restored the viability of cocultured T lymphocytes, indicating that Gal-1 contributes to tumor immune escape.",32330348_6,-1,-1,2,2,39602,-1,3.4474862e-05,4.3918597e-05,0.9999217
27297,T cells,11,13,67,74,"GITR-deficient T cells, however, also proliferate more than normal T cells, and this effect is unexplained.",26423152_2,-1,-1,2,2,27297,-1,3.1186522e-05,3.927995e-05,0.9999294
25206,cells,8,9,40,45,"In this article, we show that dendritic cells (DCs) can uptake and sense nuclear DNA-associated entities released by dying cells to induce type I IFN.",25385820_3,-1,-1,2,2,25206,-1,3.683777e-05,4.389609e-05,0.9999193
17298,T lymphocytes,3,5,10,23,"As CD4(+) T lymphocytes coordinate and regulate immunity, a better understanding of interactions between SCLC tumour cells and CD4(+) T cells may lead to effective molecular immunotherapy.",22532287_4,-1,-1,2,2,17298,-1,3.086964e-05,3.8627517e-05,0.9999305
33142,cells,10,11,64,69,Anti-TIM-4 downregulated T-bet and IFN- expression by TIM-4+ B cells and indirectly increased IL-10 expression by TIM-1+ B cells.,28848066_11,-1,-1,2,2,33142,-1,3.597543e-05,5.0572195e-05,0.99991345
35753,T cell-mediated,18,20,123,138,Blocking either STAT3 or IL-10 could significantly increase the susceptibility of MYD88 L265P mutant lymphomas toward CD8+ T cell-mediated cytotoxicity.,30253331_7,-1,-1,2,2,35753,-1,3.8639973e-05,5.741899e-05,0.9999039
17491,cells,20,21,145,150,"Applying this triple combination also uniformly suppressed the production of CCL22/MDC, a chemokine associated with infiltration of T regulatory cells (T(reg)).",22593190_6,-1,-1,2,2,17491,-1,3.714047e-05,4.0511775e-05,0.9999223
43865,T cells,14,16,79,86,The levels of p56lck and p59fyn were lower in tumor-draining than in normal LN T cells and production of tyrosine-phosphorylated substrates was markedly depressed following anti-CD3 stimulation.,9690455_4,-1,-1,2,2,43865,-1,2.9419378e-05,3.9219907e-05,0.99993134
8714,regulatory T cells,5,8,25,43,"The percentage of FoxP3+ regulatory T cells (Tregs) increased by day 26, with elevated frequencies throughout the duration of the study.",19226468_6,-1,-1,2,2,8714,-1,3.4876968e-05,5.3432264e-05,0.99991167
19556,cells,12,13,80,85,"For future investigations, an in vivo model was established whereby DsRedOTI-Tc cells adoptively transferred into B6 mice bearing either a ovalbumin-transgenic mouse skin transplant or OVA-B16F10 tumor could be traced by fluorescence-activated cell sorting analysis as effector or memory Tc cells in transplant and tumor tissues.",23222894_6,-1,-1,2,2,19556,-1,4.0407554e-05,4.032209e-05,0.9999193
43497,cells,18,19,117,122,"Although IL-1 dramatically increases Jun B accumulation, it does not enhance TPA-induced Fra-1 protein levels in EL4 cells.",7675040_7,-1,-1,2,2,43497,-1,3.4050096e-05,5.062503e-05,0.99991524
10538,B7-DC,18,19,101,106,"The negative signal provided by interactions of programmed death-1 (PD-1) and its ligands, B7-H1 and B7-DC, has been suggested to play an important role in tumor evasion from host immunity.",19724910_0,-1,-1,2,2,10538,-1,0.0001368595,0.00015667587,0.99970645
40616,regulatory T cells,12,15,56,74,"In this study, we found that the upregulation of Foxp3+ regulatory T cells (Tregs) in the mesothelioma tumor microenvironment after nonablative oligofractionated irradiation significantly limited the success of irradiation.",32948683_2,-1,-1,2,2,40616,-1,3.6751575e-05,5.3819178e-05,0.9999094
34508,cells,6,7,44,49,"As myeloid cells and conventional dendritic cells (cDCs) are derived from the same progenitors, we postulated that myelopoiesis might impact cDC development.",29593283_2,-1,-1,2,2,34508,-1,3.7283942e-05,4.0698185e-05,0.99992204
3182,cells,15,16,105,110,"Thus, only CD62L expression could distinguish regulatory CD4(+)CD25(+) cells from effector CD4(+)CD25(+) cells in draining LNs as a surface marker.",16210609_7,-1,-1,2,2,3182,-1,3.971925e-05,3.855284e-05,0.9999218
5175,T cells,33,35,218,225,"Unexpectedly, antigen presentation to CD4(+) T helper cells was reduced owing to potentiation of regulatory T-cell function by NPC-LMP1 transfectants, which produce increased levels of interleukin-10, rendering CD4(+) T cells hyporesponsive.",17372611_3,-1,-1,2,2,5175,-1,3.1140262e-05,3.5272373e-05,0.9999336
16827,cytotoxic T lymphocyte,9,12,67,89,"In this study, we predicted and identified HLA-A(*)0201-restricted cytotoxic T lymphocyte (CTL) epitopes derived from Pokemon with computer-based epitope prediction, peptide-binding assay and testing of the induced CTLs toward different kinds of carcinoma cells.",22405859_2,-1,-1,2,2,16827,-1,4.009679e-05,4.574706e-05,0.99991417
21406,lymphocyte,40,41,244,254,"These reductions in T cell response could not be explained by a concurrent decrease in memory T cells whose absolute numbers were relatively unaffected by radical therapy (27,975 vs. 25,661/10(5) PBMC) despite a significant decrease in overall lymphocyte counts (1.74 vs. 0.69  10(9)/L).",24146146_5,-1,-1,2,2,21406,-1,4.24983e-05,4.5783258e-05,0.99991167
39991,CD8+ T cell,2,6,13,24,CONCLUSIONS: CD8+ T cell infiltration in advanced-stage tumor was systematically inhibited by Th17 cells via IL-17A/STAT3/CXCR3 axis.,32503584_13,-1,-1,2,2,39991,-1,5.8332098e-05,6.2683466e-05,0.999879
10241,cells,18,19,109,114,"They are essential for tumor rejection in various mouse models, but clinical trials in humans involving iNKT cells have been less successful, partly due to their rarity in humans compared with mice.",19585513_1,-1,-1,2,2,10241,-1,3.1655058e-05,4.3418993e-05,0.9999249
28652,cells,74,75,454,459,"METHODS: The expression and activation of NF-B, Akt and IDO1 by MyD88(+) EOC SKOV3 cells was determined using western blot; the TLR4/MD-2 complex on SKOV3 cells and the phenotype of T lymphocytes were determined using flow cytometry; IDO activity was evaluated by measuring L-kynurenine; Immunesuppressive cytokines were detected using ELISA; T-cell proliferation to mitogen stimulation was assessed by MTT assay; the cytotoxicity of lymphocytes and NK cells was measured using LDH-cytotoxicity assay.",27118139_3,-1,-1,2,2,28652,-1,3.3776665e-05,4.1892068e-05,0.9999244
18355,T-cell proliferation,97,99,684,704,"INTRODUCTION: In this study we describe a patient with a prolonged myasthenic crisis refractory to conventional immunomodulatory therapy who was treated with GM-CSF (granulocyte macrophage colony-stimulating factor, sargramostim).METHODS: T-regulatory cell (Treg) suppressive function and Foxp3 expression were evaluated before and after treatment with GM-CSF.RESULTS: Treatment with GM-CSF was associated with clinical improvement, expansion in the circulating numbers of Foxp3(+) cells, increase in Foxp3 expression levels in Tregs, early improvement in Treg suppressive capacity for AChR--induced T-cell proliferation, and subsequent enhancement in Treg suppression of polyclonal T-cell proliferation.",22907239_0,-1,-1,2,2,18355,-1,3.383031e-05,4.6481025e-05,0.99991965
13723,cells,21,22,112,117,Further study of this pathway from NK to NK-T to TH7 and TH1 cells both with and without accessory or dendritic cells will improve understanding of contact sensitizers as topical immunomodulators.,21061759_8,-1,-1,2,2,13723,-1,3.928164e-05,4.2581338e-05,0.9999181
3195,T cells,9,11,66,73,Blocking experiments revealed that ligation of CTLA-4 on effector T cells by CD86 on Treg plays a pivotal role in regulating CD4(+) effector T cells.,16210609_10,-1,-1,2,2,3195,-1,3.030751e-05,3.4879373e-05,0.9999348
4861,T cells,1,3,5,12,"When T cells were overexpressed with NF-kappaB, the cells became resistant to tumor-induced apoptosis.",17210719_7,-1,-1,2,2,4861,-1,2.9600471e-05,4.2249674e-05,0.99992824
42918,Treg cell,11,13,83,92,"Treg cell plasticity possess a tremendous therapeutic potential either by inducing Treg cell de-stabilization to promote anti-tumor immunity, or re-enforcing Treg cell stability to attenuate chronic inflammation.",34539668_3,-1,-1,2,2,42918,-1,3.3297503e-05,6.224632e-05,0.9999045
36091,cells,13,14,72,77,Interleukin-32 (IL-32) was originally identified in natural killer (NK) cells activated by IL-2 in 1992.,30638183_0,-1,-1,2,2,36091,-1,3.6911853e-05,4.588855e-05,0.99991715
31880,Treg cells,30,32,209,219,"Here using genetically modified mouse models we show that ablation of E-cadherin, a process associated with epithelial to mesenchymal transition and tumour progression, promotes the accumulation of intestinal Treg cells by the specific accumulation of the KLRG1+ GATA3+ Treg subset.",28437001_2,-1,-1,2,2,31880,-1,3.514242e-05,6.205198e-05,0.9999027
22353,CTL,33,34,205,208,"The interaction of integrin E(CD103)7, often expressed on tumor-infiltrating T lymphocytes, with its cognate ligand, the epithelial cell marker E-cadherin on tumor cells, plays a major role in antitumor CTL responses.",24477908_0,-1,-1,2,2,22353,-1,3.603756e-05,4.258611e-05,0.99992144
32730,cells,18,19,106,111,"In contrast, the peptide and GC-treated DCs in OT-1 mice increased the numbers of immature Mac-1+CD27- NK cells as well as Foxp3+ and IL-10 secreting CD8+OT-1 cells with suppressive properties.",28675711_6,-1,-1,2,2,32730,-1,3.9981904e-05,4.1899755e-05,0.9999181
16239,cells,27,28,180,185,"Interestingly, miR-135b suppressed T-helper (Th) 2 master regulators STAT6 and GATA3, and miR-135b blockade attenuated IL-17 production and paracrine inflammatory response by ALCL cells, indicating that miR-135b-mediated Th2 suppression may lead to the skewing to ALCL immunophenotype overlapping with Th17 cells.",22042699_6,-1,-1,2,2,16239,-1,6.155195e-05,4.513702e-05,0.9998933
13250,cell,15,16,72,76,"Subcutaneous IL-2 (10 MU) was given three times/week  6 doses after NK cell infusion to promote expansion, defined as detection of 100 donor-derived NK cells/L blood 14 days after infusion, based on molecular chimerism and flow cytometry.",20849361_4,-1,-1,2,2,13250,-1,3.2247317e-05,4.3431806e-05,0.9999243
37936,cells,10,11,71,76,Immature dendritic cells (Im-DCs) cocultured with JQ1-pretreated Cal27 cells exhibited significant upregulation of mature markers on their surface and an increase in the secretion of cytokines.,31600692_5,-1,-1,2,2,37936,-1,3.5225836e-05,4.1030562e-05,0.9999237
10002,T cells,11,13,64,71,"Together with studies of patients and in vitro studies of human T cells, these investigations are defining potential interventions to enhance Treg function in the airway in asthma.",19538496_6,-1,-1,2,2,10002,-1,3.26429e-05,4.3224532e-05,0.99992406
4166,T cells,38,40,223,230,"In addition, their functional activity resembled that of Treg, as evidenced by a poor proliferative capacity; suppression of proliferation of CD25- CD4 or CD8T cells and inhibition of interferon-gamma release by CD25- CD4+ T cells.",16799337_5,-1,-1,2,2,4166,-1,3.0411342e-05,3.557576e-05,0.9999341
27630,T cells,14,16,87,94,"In the present study, we found significantly higher levels of IL-17F-expressing CD4(+) T cells in CLL versus healthy peripheral blood mononuclear cells following in vitro stimulation in the presence of Th17-promoting cytokines.",26478573_6,-1,-1,2,2,27630,-1,3.0615392e-05,3.518565e-05,0.9999342
32280,cell,3,4,20,24,We studied melanoma cell responses to transient exposure to the cytokine interferon  (IFN) by combining a systems-scale analysis of gene expression dynamics with computational modeling and experiments.,28575659_3,-1,-1,2,2,32280,-1,3.5544315e-05,5.4529643e-05,0.99991
19179,T cells,5,7,29,36,"Antibody depletion of CD8(+) T cells one day before vaccination completely abrogated therapeutic efficacy, whereas depletion of CD4(+) T cells had no effect.",23144888_6,-1,-1,2,2,19179,-1,2.951253e-05,3.440415e-05,0.999936
19590,T cells,30,32,184,191,RESULTS: KYN was increased in 75% of patients with symptomatic MM and correlated with the expansion of CD4(+)CD25(+)FoxP3(+) Treg cells and the contraction of NY-ESO-1-specific CD8(+) T cells.,23232072_5,-1,-1,2,2,19590,-1,3.174486e-05,3.4384007e-05,0.99993396
29288,Tcells,13,16,77,84,"A deficiency of SIRT1 induced by either conditional deletion in mouse CD4(+) Tcells or the use of small interfering RNA (siRNA) in mouse or human Tcells increased IL-9 production, whereas ectopic SIRT1 expression inhibited it.",27317260_3,-1,-1,2,2,29288,-1,3.0981708e-05,4.062217e-05,0.99992836
28857,cells,7,8,27,32,FoxP3+ regulatory T (Treg) cells have diverse functions in the suppression of antitumor immunity.,27177223_0,-1,-1,2,2,28857,-1,3.4719113e-05,4.0855542e-05,0.9999244
42381,cells,12,13,58,63,"The presence or absence, in particular, of cytotoxic CD8+ cells in the vicinity of the main tumor mass, is able to predict, respectively, the success or failure of drug therapy.",34070750_4,-1,-1,2,2,42381,-1,4.0132123e-05,4.232915e-05,0.9999175
37968,Treg cells,16,18,95,105,"The expression of IFN and IL-2 in the CD4+CD25-FoxP3+ subset was significantly higher than in Treg cells, but lower than in the effector subset.",31630080_4,-1,-1,2,2,37968,-1,3.6299483e-05,6.2702355e-05,0.99990094
40463,T cells,8,10,49,56,In vivo expansion of adoptively transferred CD8+ T cells is a critical determinant of successful adoptive T cell therapy.,32848036_0,-1,-1,2,2,40463,-1,3.1947337e-05,3.616405e-05,0.99993193
34445,T cells,14,16,90,97,"Studies with PIP-deficient (PIP-/-) mice demonstrated significantly lower numbers of CD4+ T cells in their secondary lymphoid organs, impaired Th1 response, and impaired nitric oxide (NO) production.",29536339_2,-1,-1,2,2,34445,-1,3.018039e-05,3.7165766e-05,0.99993265
33065,T cells,14,16,123,130,"These tumor-associated CD45RA-CCR7- Treg subset exerted superior immunosuppressive properties to effectively suppress CD8+ T cells' anti-tumor function including CD8+ T-cell IFN- and granzyme B (GrB) production as well as CD8+ T-cell proliferation in vitro, and also contributed to the growth and progression of human gastric tumors in vivo, via IL-10 secretion and cell-cell contact mechanisms.",28817117_5,-1,-1,2,2,33065,-1,3.0380019e-05,3.4117813e-05,0.9999355
4510,cells,1,2,3,8,"NK cells were noticeably absent in the posttreatment sample, a finding that was consistent for all patients examined.",17020993_10,-1,-1,2,2,4510,-1,2.8752296e-05,4.28903e-05,0.99992836
6066,cells,14,15,72,77,"Moreover, the dual APL did not inhibit the secretion of IFN-gamma by LN cells from CD8(-/-) mice immunized with Torpedo acetylcholine receptor.",17956982_5,-1,-1,2,2,6066,-1,3.612092e-05,4.366545e-05,0.99992025
33735,cells,7,8,41,46,"In addition, the maturation of dendritic cells (DCs) was enhanced, which promoted the generation of immunological memory against HCC.",29115974_4,-1,-1,2,2,33735,-1,3.8078724e-05,4.4140048e-05,0.99991786
13557,cells,8,9,66,71,Immunomodulatory function of bone marrow derived mesenchymal stem cells in cancer has recently been investigated.,20970781_0,-1,-1,2,2,13557,-1,4.5660814e-05,4.0875595e-05,0.99991345
814,lymphocytes,19,20,105,116,"Malignant gliomas (MGs), lethal human central nervous system (CNS) neoplasms, contain tumor infiltrating lymphocytes (TIL).",11746775_0,-1,-1,2,2,814,-1,4.937657e-05,5.4469117e-05,0.99989617
41122,cells,2,3,11,16,CD103+CD8+ cells co-express CD49a and CD69 and display a molecular profile characterized by the expression of PD-1 and CD39.,33205076_4,-1,-1,2,2,41122,-1,3.772645e-05,3.9411734e-05,0.9999229
22235,cells,12,13,86,91,"Furthermore, this combination markedly decreased the number of splenic CD11b(+)Gr1(+) cells, and increased their expression levels of MHC II and CD80.",24416401_8,-1,-1,2,2,22235,-1,3.7785485e-05,4.170511e-05,0.9999205
23216,CTLs,27,28,190,194,"Hence, this study identified A20 as a negative regulator for controlling AML-DC maturation and immunostimulatory potency, as A20 down-regulation resulted in AML-DCs with enhanced autologous CTLs immune capacity through the NF-B pathway.",24713261_7,-1,-1,2,2,23216,-1,3.874693e-05,4.9195587e-05,0.999912
26543,cells,15,16,117,122,Blockade of selected molecular mechanisms that are known to promote Treg expansion identified IDO-positive dendritic cells as the primary mediator of post-IL-12 pTreg expansion.,26085681_6,-1,-1,2,2,26543,-1,3.5070367e-05,4.3210868e-05,0.9999217
34564,cells,9,10,57,62,"Our data revealed abundant expression of TGF1 in immune cells with contact to Treg cells in lymphoid stroma, which is consistent with the notion that TGF1 is one of the immunosuppressive factors in cancer stroma.",29594353_10,-1,-1,2,2,34564,-1,3.92023e-05,4.169789e-05,0.99991906
35656,cells,26,27,208,213,"Eighteen of 21 evaluable patients showed elevated antigen-specific T-cell activity by IFN ELISpot, and persistent cellular responses surpassing 100 spot-forming units (SFUs)/106 peripheral blood mononuclear cells (PBMCs) were noted out to 1 year.",30242022_4,-1,-1,2,2,35656,-1,3.6980015e-05,4.162826e-05,0.99992144
14936,cells,5,6,39,44,These findings indicated that melanoma cells could have Foxp3-dependent Treg-like suppressive effects on T cells and suggested that the mimicking of Treg function by melanoma cells may represent a possible mechanism of tumor resistance to immune destruction in the melanoma tumor microenvironment.,21547596_8,-1,-1,2,2,14936,-1,3.5461122e-05,4.8039743e-05,0.99991655
42543,lymphocyte,15,16,72,82,We suggested that the higher frequency of CD33+ pSTAT3+ MDSC and IL-17+ lymphocyte and the more frequent expression of IL-10 mRNA in PCa patients may play roles in tumor progression from BPH to PCa.,34184811_5,-1,-1,2,2,42543,-1,4.4417677e-05,5.233078e-05,0.9999032
14254,cells,29,30,165,170,"By using quantitative real-time PCR, gene expressions of cytokines (IL-4, IL-10, IFN, TGF, GM-CSF) and the surrogates of immunosuppressive regulatory and effector cells (IDO-expressing DCs and Foxp3-expressing T-regs, respectively) were measured and correlated against the SLN tumor burden (MART1) and against each other.",21327637_6,-1,-1,2,2,14254,-1,3.472964e-05,4.0961502e-05,0.9999243
11813,cytotoxic T lymphocytes,2,5,7,30,CD8(+) cytotoxic T lymphocytes (CTLs) are involved in antigen-specific tumor destruction and CD4(+) T cells are essential for helping this CD8(+) T cell-dependent tumor eradication.,20305684_1,-1,-1,2,2,11813,-1,3.3464832e-05,3.8855218e-05,0.99992764
32596,T cell-driven,14,16,84,97,"Our work has shown that absence of OX40 and CD30 costimulatory signals prevents CD4 T cell-driven autoimmunity in Foxp3-deficient mice, suggesting a novel way to block these side effects.",28646041_1,-1,-1,2,2,32596,-1,4.157072e-05,8.879007e-05,0.9998696
32249,cells,22,23,148,153,The tumor-infiltrating IL-10+ CD19loCD27hi plasmablasts were found to be gut-homing due to their higher expression of 47 while peripheral blood B cells did not show the same characteristic.,28558303_5,-1,-1,2,2,32249,-1,3.7887854e-05,4.637427e-05,0.9999157
31728,cells,18,19,102,107,"In this study, we demonstrated that CXCR5+CD8+ T cells were very rare in peripheral blood mononuclear cells from healthy and colorectal cancer individuals, but were significantly enriched in resected tumors and tumor-associated lymph nodes.",28412245_2,-1,-1,2,2,31728,-1,3.4597164e-05,4.070163e-05,0.9999248
10717,regulatory T cells,17,20,105,123,Twenty-four patients with CTCL and 14 patients with GVHD were included to assess the relative numbers of regulatory T cells (Treg) and any change in the serum cytokine profile during 6 months of ECP therapy.,19773201_2,-1,-1,2,2,10717,-1,4.1454143e-05,3.994819e-05,0.9999186
33372,cells,4,5,33,38,"The peripheral blood mononuclear cells were subjected to FACScan analysis after labeling with anti-CD4, -CD25, - Foxp3, -CD49b and -LAG3 antibodies.",28982868_3,-1,-1,2,2,33372,-1,3.4664885e-05,3.999473e-05,0.99992526
29426,T cells,31,33,181,188,"BACKGROUND: Regulatory T cells (Tregs), particularly the CD4(+)CD25(+)Foxp3(+) Tregs, down regulate immunity and promote tumor cell growth by directly suppressing CD8(+) and CD4(+) T cells.",27389040_0,-1,-1,2,2,29426,-1,2.888797e-05,3.5854482e-05,0.99993527
17502,cells,16,17,125,130,"These effects relied on the increased propensity of tumor-associated cells (mostly fibroblasts and infiltrating inflammatory cells) to hyperactivate NF-B and produce T(eff)-attracting chemokines in response to treatment, resulting in an enhanced ability of the treated tumors to attract T(eff) cells and reduced ability to attract T(reg) cells.",22593190_8,-1,-1,2,2,17502,-1,5.7993973e-05,4.0811756e-05,0.9999012
40498,T cell,14,16,92,98,"Recently studies have demonstrated that DHA also regulates tumor cell growth, angiogenesis, T cell differentiation and generation.",32859456_1,-1,-1,2,2,40498,-1,3.724057e-05,4.508022e-05,0.99991775
36561,cells,24,25,125,130,"Furthermore, in the CTR region of the lung of patients with NSCLC, CD68+ macrophages were induced and correlated with IL-35+ cells.",30956278_6,-1,-1,2,2,36561,-1,5.7024656e-05,4.10186e-05,0.999902
42014,cell,10,11,72,76,UVR and immunosuppression are major risk factors for cutaneous squamous cell carcinoma (cSCC).,33848530_0,-1,-1,2,2,42014,-1,4.7349797e-05,7.222949e-05,0.99988043
38834,T-cell receptor (TCR,27,31,152,172,"Given the antitumor properties of Tc22 cells, it may be prudent to polarize T cells to the Tc22 lineage when using chimeric antigen receptor (CAR)-T or T-cell receptor (TCR) transduction-based immunotherapies.",31964625_6,-1,-1,2,2,38834,-1,0.0017760205,0.037253466,0.9609706
38502,T cell,7,9,66,72,"Therefore, we investigated whether autologous neoantigen-specific T cell responses could also be observed in patients diagnosed with mismatch repair-proficient colorectal cancers.",31888734_2,-1,-1,2,2,38502,-1,4.215466e-05,5.5019642e-05,0.9999027
23433,cells,32,33,182,187,"RESULTS: The frequency of CD8+T cells binding annexin V and Fas expression in CD8+T cells, were all higher in HCC patients than normal controls and the proportion of apoptotic CD8+T cells correlated with their Fas expression.",24761872_7,-1,-1,2,2,23433,-1,3.6185545e-05,4.0387065e-05,0.99992335
22936,T cell,4,6,25,31,These Treg cells inhibit T cell response via membrane-bound TGF-.,24668348_10,-1,-1,2,2,22936,-1,3.261667e-05,4.5035522e-05,0.9999223
18293,cells,8,9,55,60,"Suppression of iTreg differentiation from nave CD4(+) cells by gr-MDSC occurs early in the polarization process, requires inhibition of early T cell activation, and depends on ROS and IDO but does not require arginase 1, iNOS, NO, cystine/cysteine depletion, PD-1 and PD-L1 signaling, or COX-2.",22891289_5,-1,-1,2,2,18293,-1,3.804108e-05,4.054309e-05,0.99992144
2878,cells,15,16,88,93,"In this study we examined the signal mechanisms for inducting these 2 chemokines in RT4 cells by lipopolysaccharide (LPS), IFN-gamma and TNF-alpha.",16094077_1,-1,-1,2,2,2878,-1,3.5167497e-05,4.594302e-05,0.99991894
3654,cell,12,13,87,91,Expression profiles of 80 cytokines were determined in the supernatant of mesothelioma cell lines and the original patient's pleural effusion.,16540497_2,-1,-1,2,2,3654,-1,3.8960512e-05,7.190915e-05,0.99988914
16143,cell,15,16,126,130,The extent of T-cell migration toward culture supernatants obtained from interferon-gamma (IFN--stimulated gastric carcinoma cell lines was additionally affected by expression of PML in vitro.,22022583_4,-1,-1,2,2,16143,-1,3.217344e-05,5.481945e-05,0.999913
12054,Treg cells,35,37,187,197,"Also, in vitro studies showed that coculture of mature DCs, autologous T cells and IL-2 leads to an increase in the number of Treg cells whereas IL-21 does not stimulate the induction of Treg cells.",20386464_5,-1,-1,2,2,12054,-1,3.7285885e-05,6.0252707e-05,0.9999025
26553,T cells,2,4,20,27,"Restoring exhausted T cells represents an inspiring strategy for cancer treatment, which has yielded promising results and become a significant breakthrough in the cancer immunotherapy.",26086965_2,-1,-1,2,2,26553,-1,3.0870855e-05,3.8422226e-05,0.99993074
32724,cell,17,18,114,118,We observed that immunization with CpG and peptide-treated DCs protected against tumor growth by activation of NK cell response.,28675711_4,-1,-1,2,2,32724,-1,4.0717183e-05,4.730155e-05,0.9999119
13205,T-cell proliferation,9,11,49,69,"The Akt/protein kinase B plays a central role in T-cell proliferation, function, and survival and we hypothesized that expression of constitutively active Akt (caAkt) in T cells could provide resistance to many of these tumor-associated inhibitory mechanisms.",20842106_2,-1,-1,2,2,13205,-1,3.5002773e-05,4.6088975e-05,0.9999188
23815,cellular,2,3,9,17,"In vitro cellular engineering may require increasing the ""stemness"" or immunogenicity of tumor cells and activating or restoring cancer-impaired immune-effector and antigen-presenting cells.",24855276_2,-1,-1,2,2,23815,-1,3.9332335e-05,4.6950987e-05,0.9999137
11437,cell,16,17,105,109,"Finally, we observed large amounts of biologically active IL-1alpha or IL-1beta secreted by two melanoma cell lines that did not express MITF-M, suggesting an autocrine MITF-M downregulation.",20099279_4,-1,-1,2,2,11437,-1,3.6651894e-05,6.738094e-05,0.99989605
23666,cells,33,34,180,185,"Notably, IL-22 binding protein (IL-22 BP) was associated with NKs and a significant decrease was seen at the tumor site in mice adoptively transferred with Tregs or depleted of NK cells.",24797894_6,-1,-1,2,2,23666,-1,3.4439126e-05,4.53504e-05,0.99992025
43152,T cells,41,43,204,211,"In syngeneic mouse models, B7-H3 (Cd276) knockout (KO) in tumor cells, but not in stromal cells, suppressed tumor progression, with a reduced number of M2 macrophages and an increased number of IFN+CD8+ T cells.",34799346_3,-1,-1,2,2,43152,-1,3.373615e-05,3.4673438e-05,0.9999316
42219,cells,10,11,70,75,"Moreover, the pEGFPN1IL17U87MG cells grew more rapidly than other cells.",33971545_10,-1,-1,2,2,42219,-1,3.6636426e-05,4.5082616e-05,0.99991834
5462,cell,2,3,19,23,"Although dendritic cell (DC) function is impaired in pancreatic cancer patients, the underlying mechanisms are unknown.",17545630_0,-1,-1,2,2,5462,-1,4.181126e-05,4.8474725e-05,0.99990964
7382,cells,11,12,83,88,"Here, we show that tissue-produced inflammatory mediators prime maturing dendritic cells (DC) for the differential ability of attracting anti-inflammatory Treg cells.",18632653_1,-1,-1,2,2,7382,-1,3.5263314e-05,4.009098e-05,0.99992466
20037,regulatory T cells,27,30,157,175,"The effects on GVHD following myeloablative conditioning were independent of CD8(+) T cells and dependent on CD4(+) T cells, and specifically donor FoxP3(+) regulatory T cells (Treg).",23430112_5,-1,-1,2,2,20037,-1,3.3307228e-05,3.6290487e-05,0.9999305
16501,T cells,27,29,139,146,"METHODS: This study aimed to characterise the frequency of T regulatory cells (Tregs), dendritic cells (DCs) as well as sub-populations of T cells bearing regulatory properties like CD4(+)GITR(+), CD4(+)CD62L(+), CD3(+)TCR(+) along with the concentrations of IL-10, TGF, IL-6 in 66 patients with MM.",22223085_1,-1,-1,2,2,16501,-1,2.9667826e-05,3.3197346e-05,0.9999372
14129,Treg cells,30,32,189,199,"RESULTS: The pathology advances with time leading to erosive dermatitis which is inflamed with a mixed infiltrate involving activated CD8+ T-cells, CD4+ T-cells including CD4+/CD25+/FoxP3+ Treg cells, mast cells and neutrophils.",21291541_5,-1,-1,2,2,14129,-1,4.625445e-05,5.5950808e-05,0.99989784
6510,cell,17,18,103,107,CONCLUSIONS: IL-21 was biologically active at all dose levels administered with evidence of in vivo NK cell and CD8(+) T cell activation.,18286285_9,-1,-1,2,2,6510,-1,3.72672e-05,4.641797e-05,0.9999163
43526,cell,16,17,68,72,We have also shown that infection of promonocytic (U937) and T (H9) cell lines with HIV stimulates IL-10 secretion.,8037735_3,-1,-1,2,2,43526,-1,3.7617232e-05,5.28032e-05,0.9999095
26006,cells,16,17,93,98,"In ex vivo assays, ipilimumab targeted CTLA-4(+) Treg and restored cytolytic functions of NK cells mediating ADCC.",25832655_7,-1,-1,2,2,26006,-1,3.317175e-05,4.192526e-05,0.9999249
816,cells,10,11,62,67,"Although MHC class II molecules are frequently detected on MG cells, suggesting that they may be capable of antigen (Ag) presentation to CD4(+) T cells, deficiencies in CD4(+) T-cell activation are associated with these nonimmunogenic tumors.",11746775_1,-1,-1,2,2,816,-1,3.729262e-05,4.065342e-05,0.99992204
31807,T cell activation,30,33,197,214,"In addition to inhibiting proliferation and inducing the apoptosis of U87-EGFRvIII cells, miR-326 also reduced the expression of TGF-1 in the tumour environment, resulting in improved efficacy of T cell activation and killing via suppressing the SMO/Gli2 axis, which at least partially reversed the immunosuppressive environment.",28412740_5,-1,-1,2,2,31807,-1,4.0598974e-05,4.806208e-05,0.9999113
19464,T cells,23,25,147,154,"In this study, we investigated the immunomodulatory effects of pan-Bcl-2 inhibitor AT-101 on pancreatic cancer (PC) cell cytotoxicity by activated T cells (ATC).",23185240_2,-1,-1,2,2,19464,-1,2.9246154e-05,3.6951886e-05,0.99993384
9410,T cells,19,21,126,133,We report here that syngeneic GL261 gliomas growing either intracranially or subcutaneously in mice are infiltrated by DC and T cells.,19337997_3,-1,-1,2,2,9410,-1,3.5575624e-05,3.797544e-05,0.99992645
36301,T cells,15,17,89,96,"In addition, under Th9 polarizing condition, TNF- activated STAT5 and NF-B pathways in T cells in a TNFR2-dependent manner.",30717817_8,-1,-1,2,2,36301,-1,2.9887486e-05,4.5249555e-05,0.9999248
28612,cell,17,18,88,92,"Regulatory T cells (T-regs) contribute to tumour immune escape, but their role in basal cell carcinoma (BCC) is not understood.",27117439_1,-1,-1,2,2,28612,-1,4.669638e-05,5.6550005e-05,0.99989676
37694,T cells,30,32,189,196,"Both baicalein and baicalin enhanced the cytotoxicity of T cells to eliminate tumor cells, which was abrogated after HCC cells were transfected with a PD-L1 overexpression plasmid or after T cells were pretreated with an anti-PD-1 blocking antibody.",31437792_4,-1,-1,2,2,37694,-1,3.1538126e-05,3.8313454e-05,0.99993014
12790,CTL,24,25,123,126,The study next investigated whether the combination of B7-1/B7-2 and 4-1BBL cell injection induced cytotoxic T lymphocyte (CTL) response and IL-2/IFN- secretion.,20563597_3,-1,-1,2,2,12790,-1,3.7667392e-05,4.307667e-05,0.9999193
8867,cells,10,11,72,77,"With this cultivation strategy, TKTCs from peripheral blood mononuclear cells are generated within a short period of time using a pulse with a stimulating cell line followed by continuous growth in serum-free medium supplemented with a mixture of interleukin-2 and cyclosporin A. Expression and functional profiling did not allow a classification of TKTCs to any thus far defined subtype of T cells.",19240181_3,-1,-1,2,2,8867,-1,3.4516277e-05,4.383357e-05,0.99992156
1634,cell,32,33,199,203,"A profound inhibition of proliferation, lower level of IFN-gamma and higher level of IL-10 gene expression were observed when CD8+ T cells were co-cultured with supernatants from 3 ovarian carcinoma cell lines.",14741732_3,-1,-1,2,2,1634,-1,3.456131e-05,4.9356928e-05,0.9999161
19371,cells,4,5,24,29,BACKGROUND: Cancer stem cells (CSCs) are proposed to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors.,23180012_0,-1,-1,2,2,19371,-1,4.2489846e-05,3.9023314e-05,0.9999186
22516,cells,15,16,99,104,"Although depletion of CD80 expression does not affect the proliferation rate and viability of CTCL cells, induced expression of the cell-inhibitory receptor of CD80, CD152 (CTLA-4), impairs growth of the cells.",24523507_3,-1,-1,2,2,22516,-1,4.8302125e-05,4.5205386e-05,0.99990654
17276,cell,20,21,106,110,"But CD4(+) T cells also decreased in spleen cells of tumor-bearing mice by alone 5-FU treated, splenic NK cell and CTL activity also degraded, while CD4(+) T cells and splenic NK cell and CTL activity significantly increased by BLTA treated.",22522606_11,-1,-1,2,2,17276,-1,4.115454e-05,4.3127406e-05,0.9999157
29766,cell,8,9,60,64,"Additionally, a negative association between CD11b+ myeloid cell densities and overall survival was observed.",27593937_8,-1,-1,2,2,29766,-1,3.995991e-05,4.4836917e-05,0.99991524
10053,T cells,5,7,33,40,"Compared with CD25(-) gammadelta T cells, TGF-beta induced CD25(+) gammadelta T cells not only expressed Foxp3, but also had increased TGF-beta and GITR expression.",19539651_6,-1,-1,2,2,10053,-1,2.9940078e-05,3.61978e-05,0.99993384
4400,cells,42,43,301,306,The production of IFN-gamma secreted by the spleen cells from CD40L/OVHM and OVHM cell-inoculated mice co-cultured with 20 Gy-irridiated OVHM cells were measured with enzyme-linked immunosorbent assay (ELISA).RESULTS: Expression of CD40L in OVHM/CD40L cells was significantly higher than that in OVHM cells (P<0.05).,16965650_7,-1,-1,2,2,4400,-1,4.1116e-05,4.2591088e-05,0.9999163
6102,T cells,28,30,178,185,"Recent work identified JunB, a member of the AP-1 transcription factor family, as critical regulator of basal and induced expression of inflammatory mediators in fibroblasts and T cells.",17982078_2,-1,-1,2,2,6102,-1,3.1898e-05,4.544216e-05,0.99992263
15721,T cells,22,24,135,142,"Furthermore, we found that Smad4 deficiency attenuated TGF--mediated in vitro polarization of FoxP3+CD4+ T cells, but not IL-17A+CD4+ T cells, suggesting that the epithelial lesions may have arisen as a consequence of unchecked Th17 cell activity.",21881210_3,-1,-1,2,2,15721,-1,3.1468197e-05,3.7121692e-05,0.99993145
9890,cells,10,11,44,49,"We found that, in the absence of lymphoma B cells, treatment with IL-1beta/IL-6 or lipopolysaccharide (LPS) enhanced IL-17 expression in CD4(+) T cells and this enhancement was attenuated when CD4(+) T cells were cocultured with lymphoma B cells.",19509224_1,-1,-1,2,2,9890,-1,3.690971e-05,4.204313e-05,0.99992096
257,CD154,16,17,88,93,"We have established that in some cases of CLL the malignant cells express both CD40 and CD154, and on the basis of those observations, proposed a model for CLL tumor growth due to CD40-CD154 interactions within and among the malignant cells, and for the occurrence of autoimmune syndromes in some cases of CLL.",11042507_2,-1,-1,2,2,257,-1,0.00035965897,0.00013900461,0.9995012
5776,cell,15,16,88,92,"In cocultures of activated T cells and Hodgkin cell lines, RNAi-mediated blockade of RS cell Gal1 increased T cell viability and restored the Th1/Th2 balance.",17670934_3,-1,-1,2,2,5776,-1,4.4291195e-05,4.3186534e-05,0.9999125
16056,cell,12,13,92,96,Tumour cells often express deregulated profiles of chemokine receptors that regulate cancer cell migration and proliferation.,21984373_0,-1,-1,2,2,16056,-1,4.181099e-05,4.7442358e-05,0.9999107
41575,lymphocytes,21,22,117,128,Outcomes for triple negative breast cancer (TNBC) are poor and may be improved by increasing CD8+ tumor infiltrating lymphocytes (TIL) to augment antitumor immunity.,33647370_0,-1,-1,2,2,41575,-1,4.37716e-05,4.463249e-05,0.99991167
32934,lymphocyte,3,4,14,24,BTLA (B-and-T lymphocyte associated) expression on transferred CD8+ TILs was associated with better clinical outcome.,28754817_1,-1,-1,2,2,32934,-1,4.751188e-05,5.45333e-05,0.99989784
30279,cells,45,46,253,258,RESULTS: We found that DDRD breast tumors were associated with CD4+ and CD8+ lymphocytic infiltration (Fisher's exact test P < .001) and that DDRD cells expressed the chemokines CXCL10 and CCL5 3.5- to 11.9-fold more than DNA damage response-proficient cells (P < .01).,27707838_8,-1,-1,2,2,30279,-1,3.681935e-05,4.0378494e-05,0.99992275
34150,cells,7,8,32,37,Accumulation of CD4+ and IL-17+ cells and intense staining of the Foxp3+ marker were consistent with their protein levels.,29331794_7,-1,-1,2,2,34150,-1,3.9306666e-05,3.887549e-05,0.9999218
28448,cell,33,34,230,234,"Inhibition of caspases, RIP1, or RIP3 blocks radiation/TNF-induced cell death, whereas inhibition of RIP1 blocks TNF-induced caspase activation, suggesting that caspases and RIP1 act sequentially to mediate the non-compensatory cell death pathways.",27014915_5,-1,-1,2,2,28448,-1,5.662659e-05,5.501397e-05,0.9998883
23908,T cells,11,13,87,94,RESULTS: Imiquimod induced cervicovaginal accumulation of activated E7-specific CD8(+) T cells elicited by CRT/E7 vaccination.,24893628_2,-1,-1,2,2,23908,-1,3.1133288e-05,3.7008598e-05,0.99993193
29761,cells,2,3,15,20,"CD11b+ myeloid cells, which resembled T-MDSCs both phenotypically and functionally, were primarily in the peritumoral stroma and a positive association with TAFs in vivo.",27593937_7,-1,-1,2,2,29761,-1,5.275706e-05,4.492571e-05,0.99990225
3107,regulatory T cells,9,12,60,78,Our experiments indicate that the accumulation of CD4+CD25+ regulatory T cells (T reg cells) expressing FoxP3 and exhibiting immunosuppressive function originates from the proliferation of naturally occurring CD25+ T cells and requires signaling through transforming growth factor (TGF)-beta receptor II.,16186184_1,-1,-1,2,2,3107,-1,2.9342578e-05,3.7423684e-05,0.99993324
25825,T cells,17,19,102,109,"Deletion of -catenin in DCs or blocking IL-10 after clonal expansion similarly led to reduced CD8(+) T cells, suggesting that -catenin in DCs plays a positive role in CD8(+) T-cell maintenance postclonal expansion through IL-10.",25730849_4,-1,-1,2,2,25825,-1,3.0149175e-05,3.824342e-05,0.9999316
10233,cells,5,6,21,26,Invariant NKT (iNKT) cells recognize lipid antigens presented by CD1d and respond rapidly by killing tumor cells and release cytokines that activate and regulate adaptive immune responses.,19585513_0,-1,-1,2,2,10233,-1,3.6787365e-05,4.2653217e-05,0.9999205
26493,T cells,11,13,76,83,"Mechanistically, immune cell depletion studies demonstrated that while CD8+ T cells are critical for antitumor immunity, CD4+ T cells are also required to induce a sustained long-lasting helper effect.",26079374_6,-1,-1,2,2,26493,-1,3.113051e-05,3.4737404e-05,0.9999342
4643,cytotoxic T lymphocyte,38,41,214,236,"About 50% of cervical cancers are associated with human papillomavirus type 16 (HPV-16), and since the HPV-16 E6 and E7 oncoproteins are constitutively expressed in the tumor cells, they are attractive targets for cytotoxic T lymphocyte (CTL)-mediated immunotherapy.",17096336_0,-1,-1,2,2,4643,-1,3.8287133e-05,4.9318496e-05,0.9999124
1817,cells,19,20,137,142,"Survivin, a member of the inhibitor-of-apoptosis family overexpressed by cancer cells, inhibits Fas-mediated apoptosis induced by immune cells.",15004200_1,-1,-1,2,2,1817,-1,4.0162126e-05,4.850801e-05,0.9999113
10798,NKT cells,5,7,41,50,"Though the abrogation of CD1d-restricted NKT cells, which have been reported to induce TGF-beta production by MDSC through an IL-13-IL-4R-STAT6 pathway, partially enhanced antitumor immunity regardless of vaccination, abrogation of the NKT cell-IL-13-IL-4R-STAT-6 immunoregulatory pathway did not enhance vaccine efficacy.",19830696_6,-1,-1,2,2,10798,-1,7.743602e-05,0.00017968564,0.9997428
5952,cells,2,3,12,17,"In melanoma cells, the JNK/SAPK pathway was shown to be important for the IL-8 secretion during the VZV replication, whereas in the T cell line, not only the JNK/SAPK but also the p38/MAPK pathways were required for IL-8 secretion.",17909856_4,-1,-1,2,2,5952,-1,3.2693348e-05,5.4389682e-05,0.999913
14171,regulatory T cells,13,16,78,96,"Recent studies indicate that some cytokines, such as interleukin (IL)-17, and regulatory T cells are involved in the development of cancer.",21314287_1,-1,-1,2,2,14171,-1,3.635254e-05,6.21501e-05,0.99990153
33980,regulatory T cell,7,10,44,61,"The immune regulatory molecules FOXP3 mRNA (regulatory T cell, T reg) and programmed cell death ligand-1 (PD-L1) mRNA were significantly increased in the HCV-high group.",29248968_7,-1,-1,2,2,33980,-1,3.851104e-05,4.3195352e-05,0.99991834
43520,cells,18,19,123,128,"In the present study we demonstrate that IL-10 is expressed and produced spontaneously in the peripheral blood mononuclear cells (PBMCs) of all HIV-1 infected individuals tested, 3 of 19 cases of HIV-negative lymphoma and none of five healthy controls.",8037735_1,-1,-1,2,2,43520,-1,3.418686e-05,3.9812934e-05,0.999926
31552,CD4+ T cell,15,19,92,103,CONCLUSION: Our data indicate that oxygen availability can function as a local modulator of CD4+ T cell responses and thus influences tumour immune surveillance in inflammation-associated colon cancer.,28278498_8,-1,-1,2,2,31552,-1,9.1734844e-05,9.455949e-05,0.99981374
10515,regulatory T lymphocytes,5,8,33,57,"Tumor and spleen CD4+CD25+Foxp3+ regulatory T lymphocytes, cytotoxic activity of the splenocytes, IFN-gamma and IL-4 secretion were assessed to describe the anti-tumor immune response.",19706340_3,-1,-1,2,2,10515,-1,4.6900244e-05,9.268792e-05,0.9998604
16351,cells,7,8,56,61,Development of neo-adjuvant strategies targeting T(reg) cells is therefore imperative.,22057676_1,-1,-1,2,2,16351,-1,4.05538e-05,4.7437487e-05,0.999912
40017,cells,12,13,72,77,Bach2 is highly expressed in rTreg cells but is down-regulated in aTreg cells and during inflammation.,32515782_4,-1,-1,2,2,40017,-1,3.4552653e-05,4.240482e-05,0.999923
15190,cells,21,22,107,112,"Interleukin 4 (IL-4) produced by memory Th2 cells in vivo was critical for the antitumor effects of the NK cells, which IL-4 directly stimulated to induce their perforin- and granzyme-B-dependent cytotoxic activity.",21646476_5,-1,-1,2,2,15190,-1,3.3715718e-05,4.2585274e-05,0.9999237
29376,cells,7,8,37,42,"During the last decade, B regulatory cells are appreciated to have a central role in preventing autoimmunity and maintaining self-tolerance.",27339600_0,-1,-1,2,2,29376,-1,3.2903714e-05,4.4055912e-05,0.999923
8694,cells,3,4,26,31,PDGF-driven murine glioma cells were injected into the white matter of 13 mice.,19226468_2,-1,-1,2,2,8694,-1,3.5423483e-05,4.378319e-05,0.99992085
41615,glandular,17,18,87,96,"Warthin tumour (WT) is a benign tumour of the salivary gland that proliferates in both glandular epithelial and lymphoid tissue components, and rarely exhibits cystic changes.",33647861_0,-1,-1,2,2,41615,-1,0.00066047575,0.0058237636,0.99351573
26720,Treg cells,13,15,60,70,"Compared with the CD8(+) T cells cultured alone, the CD8(+) Treg cells induced in vitro by coculture with SK-OV-3/A2780 showed increased CTLA-4 and Foxp3 expression and decreased CD28 expression.",26166762_8,-1,-1,2,2,26720,-1,2.822241e-05,4.132721e-05,0.9999304
1216,T cells,33,35,183,190,"Because STAT6 is a downstream effector of the IL-4R, and IL-13 binds to the type 2 IL-4R, IL-13 has been proposed as an inhibitor that blocks differentiation of tumor-specific CD8(+) T cells.",12421960_1,-1,-1,2,2,1216,-1,2.9889707e-05,3.9730236e-05,0.9999304
6059,cells,12,13,60,65,"The dual APL inhibited the proliferation of lymph node (LN) cells of the Torpedo acetylcholine receptor-immunized WT C57BL/6 mice, whereas the inhibition was abrogated in CD8(-/-) knockout mice.",17956982_4,-1,-1,2,2,6059,-1,4.1963984e-05,4.1681433e-05,0.9999163
29072,cells,21,22,151,156,"Recent studies have demonstrated pivotal roles of mTOR-mediated metabolism in the maturation, differentiation, and effector function of diverse immune cells, including DCs, NK cells, CD4+ T cell subsets, and CD8+ T cells, but the role of mTOR signaling in  T cells is barely known.",27256566_1,-1,-1,2,2,29072,-1,3.8050304e-05,4.0206385e-05,0.9999218
25277,regulatory T cells,3,6,12,30,"The idea of regulatory T cells (Tregs) lost its popularity during the 1980s and 1990s, since immunologists failed to elucidate how the innate regulation of immunological reactions worked.",25427312_0,-1,-1,2,2,25277,-1,3.405023e-05,5.3393545e-05,0.9999125
30284,cells,1,2,5,10,DDRD cells demonstrated increased cytosolic DNA and constitutive activation of the viral response cGAS/STING/TBK1/IRF3 pathway.,27707838_10,-1,-1,2,2,30284,-1,3.2083062e-05,4.7100708e-05,0.99992085
34621,regulatory T cells,30,33,185,203,"Specifically, abnormal Wnt/-catenin signaling directly alters a number of regulators critical for the antitumor activities of T cells, especially effector T cells, T helper cells, and regulatory T cells.",29678298_2,-1,-1,2,2,34621,-1,3.559848e-05,4.2158692e-05,0.99992216
5893,cells,1,2,10,15,"Dendritic cells (DCs), as specialized APCs, play a key role in the induction of anti-tumor immunity.",17895399_0,-1,-1,2,2,5893,-1,3.9746188e-05,4.234484e-05,0.999918
32843,cells,15,16,92,97,Regulatory T cells (Tregs) have been proposed to dampen functions of anti-neoplastic immune cells and thus promote cancer progression.,28721449_0,-1,-1,2,2,32843,-1,3.5847523e-05,4.173296e-05,0.9999224
17048,T cell,10,12,65,71,We show further that IL-22 activation of HPAFII cells diminished T cell production of interferon (IFN)- through the action of IL-10.,22471280_9,-1,-1,2,2,17048,-1,3.0487427e-05,4.1969135e-05,0.9999275
9032,CTL,28,29,189,192,"Patients received two infusions of a single tumor-reactive antigen-specific CTL clone expanded to 10(10)/m(2); the first infusion was given without fludarabine conditioning, and the second CTL infusion was given after a course of fludarabine (25 mg/m(2)/dayx5 days).",19270751_6,-1,-1,2,2,9032,-1,3.5562614e-05,4.610157e-05,0.99991834
22643,cells,4,5,30,35,"Moreover, TSC1-deficient iNKT cells display enhanced antitumor immunity in a melanoma lung metastasis model.",24532578_7,-1,-1,2,2,22643,-1,3.4953973e-05,4.046685e-05,0.99992466
16500,cells,18,19,97,102,"METHODS: This study aimed to characterise the frequency of T regulatory cells (Tregs), dendritic cells (DCs) as well as sub-populations of T cells bearing regulatory properties like CD4(+)GITR(+), CD4(+)CD62L(+), CD3(+)TCR(+) along with the concentrations of IL-10, TGF, IL-6 in 66 patients with MM.",22223085_1,-1,-1,2,2,16500,-1,3.5611716e-05,3.864491e-05,0.99992573
13307,T cells,12,14,68,75,"Adoptive transfer studies, using RNEU((420-429)) -specific effector T cells into neu-N mice (a model that results in immune tolerance to neu), confirm that CD8(+) Foxp3(+) T cells are present in tumors only if there is an existing pool of tumor-rejecting effector T cells.",20857491_6,-1,-1,2,2,13307,-1,3.0667765e-05,3.3940876e-05,0.9999354
35203,cells,13,14,67,72,RESULTS: C57BL/6 mice coinjected with KPC cells (or LLC or B16-F10 cells) and p50-/- PSCs developed smaller tumors than mice given injections of the cancer cells along with control PSCs.,29909021_8,-1,-1,2,2,35203,-1,4.7797494e-05,4.321571e-05,0.9999089
29786,suppressor cells,1,3,16,32,Myeloid-derived suppressor cells (MDSCs) are immature cells that do not differentiate into mature myeloid cells.,27601624_0,-1,-1,2,2,29786,-1,4.930895e-05,4.1082523e-05,0.9999095
5471,cell-derived,5,6,36,48,Both CD34+ hematopoietic progenitor cell-derived and CD14+ monocyte-derived immature DCs and mature DCs (mDCs) were inhibited by BxCM.,17545630_3,-1,-1,2,2,5471,-1,0.00013303409,0.00016575839,0.9997012
18907,subset,28,29,132,138,"Herein, we show that not only NF-kB p65, but also the Interferon Regulatory Factor 1 (IRF1) and certain APM components are low in a subset of NB cell lines with aggressive features.",23071666_2,-1,-1,2,2,18907,-1,4.2030773e-05,4.6722398e-05,0.9999112
34529,lymphocytes,13,14,90,101,"Although cancer tissue generally shows limited immune responses, some cancers abound with lymphocytes, which generally show favorable prognosis.",29594353_0,-1,-1,2,2,34529,-1,4.4549553e-05,5.1585917e-05,0.9999038
39404,cells,5,6,20,25,T regulatory (Treg) cells are generally considered a tumor-promoting immune cell type in malignant cancers with currently unclear roles in pituitary adenoma patients.,32279926_2,-1,-1,2,2,39404,-1,3.903733e-05,4.2786425e-05,0.9999182
14443,Treg cells,19,21,95,105,"Myeloid APCs, IL-2, and TGF- are essential for their induction from memory CCR6(+) T cells or Treg cells.",21357259_7,-1,-1,2,2,14443,-1,4.933104e-05,9.682785e-05,0.99985385
34619,T cells,22,24,156,163,"Specifically, abnormal Wnt/-catenin signaling directly alters a number of regulators critical for the antitumor activities of T cells, especially effector T cells, T helper cells, and regulatory T cells.",29678298_2,-1,-1,2,2,34619,-1,3.3336877e-05,3.4318004e-05,0.9999323
25385,B7-H4,3,4,10,15,"In vitro, B7-H4 inhibits the proliferation of CD4(+)T and CD8(+)T but promotes the proliferation of Tregs and the secretion of IL-10 and TGF-1.",25446402_12,-1,-1,2,2,25385,-1,5.272479e-05,6.8589245e-05,0.99987876
12499,cells,7,8,31,36,"Finally, we show that FoxP3(+) cells inhibit the proliferation of ex vivo, autologous leukemic clones from patients with ATLL.",20525891_6,-1,-1,2,2,12499,-1,3.8796486e-05,4.0569783e-05,0.9999207
39621,subset,10,11,75,81,Evidence for WNT/-catenin signaling-mediated immune evasion is found in a subset of cancers including melanoma.,32332858_2,-1,-1,2,2,39621,-1,4.658582e-05,5.037594e-05,0.99990296
9573,T cells,16,18,92,99,"Compared with primary FOXP3(-) T cells in the same microenvironment, these primary FOXP3(+) T cells expressed minimal levels of effector cytokines, negligible amount of cytotoxic molecule granzyme B, and levels of suppressive molecules interleukin-10 and PD-1.",19383912_4,-1,-1,2,2,9573,-1,2.9354538e-05,3.7071815e-05,0.9999336
41741,cells,4,5,20,25,"Erbin deletion in B cells suppressed lung metastasis of CRC in vivo. And, deletion of Erbin in B cells enhanced the killing effects of CD8+ T cells on tumor cells.",33707428_3,-1,-1,2,2,41741,-1,4.3754113e-05,4.753451e-05,0.9999087
4386,CD40L,14,15,93,98,"Immunofluorescent technique and flow cytometry were used to evaluate the expression of CD40, CD40L, MHC-I, MHC-II, CD80, CD86.",16965650_3,-1,-1,2,2,4386,-1,4.608871e-05,5.979728e-05,0.999894
17008,cells,24,25,141,146,Interleukin (IL)-22 is a cytokine involved in inflammatory and wound healing processes that is secreted primarily by T helper type 17 (Th17) cells.,22471280_0,-1,-1,2,2,17008,-1,5.3369633e-05,4.2454885e-05,0.99990416
19715,cell,6,7,47,51,"These events correlated with reduced dendritic cell and T cell infiltration, accumulation of myeloid-derived suppressor cells and a chemokine/chemokine receptor expression profile within the tumor microenvironment supporting tumor growth, angiogenesis, and metastasis.",23308054_3,-1,-1,2,2,19715,-1,3.6510195e-05,4.900429e-05,0.9999145
21379,cells,11,12,66,71,These data suggest that IL-15 may improve the cytotoxicity of CIK cells against leukemia cells by upregulating CD3CD56 cells and downregulating Treg cells and IL-35.,24145357_4,-1,-1,2,2,21379,-1,3.616438e-05,4.0930754e-05,0.999923
40354,cell,3,4,16,20,"SCCOHT and OCCC cell lines have shown sensitivity to the reversible LSD1 inhibitor SP-2577 (Seclidemstat), suggesting that SWI/SNF-deficient ovarian cancers are dependent on LSD1 activity.",32649682_5,-1,-1,2,2,40354,-1,3.5633802e-05,5.367327e-05,0.9999107
5758,cells,33,34,204,209,Classical Hodgkin lymphomas (cHLs) contain small numbers of neoplastic Reed-Sternberg (RS) cells within an extensive inflammatory infiltrate that includes abundant T helper (Th)-2 and T regulatory (Treg) cells.,17670934_0,-1,-1,2,2,5758,-1,4.447205e-05,4.2032592e-05,0.99991345
5638,T cells,16,18,103,110,"The CD45RA+/CCR7+ phenotype of HPV antigen-reactive T cells may serve as an indicator of dysfunctional T cells, despite effective interferon-gamma production in response to HPV antigens.",17589293_6,-1,-1,2,2,5638,-1,3.0052299e-05,3.9091883e-05,0.99993086
39974,T cells,11,13,50,57,CXCR3 (the receptor of CXCL10) expression on CD8+ T cells was lower in the peripheral blood of advanced-stage patients.,32503584_7,-1,-1,2,2,39974,-1,2.8496579e-05,3.7884416e-05,0.9999336
13417,cells,23,24,112,117,"In the lymph nodes of tumor-bearing animals, in contrast to the spleen, total amount of CD8(+) cells and CD4(+) cells were increased but both of these compartments harbored high numbers of CD4(+) CD25(hi) Treg cells.",20883319_6,-1,-1,2,2,13417,-1,4.4137007e-05,4.0222403e-05,0.9999157
39957,CD8+ T cell,7,11,38,49,"In the present study, we investigated CD8+ T cell infiltration in CRC tissues and the role of chemokine-chemokine receptor signaling in regulation of T cell recruitment.",32503584_2,-1,-1,2,2,39957,-1,6.5519656e-05,7.344498e-05,0.999861
876,T lymphocytes,14,16,78,91,"IL-8, a cytokine with both chemotactic and angiogenic effects, is produced by T lymphocytes following activation.",11801678_4,-1,-1,2,2,876,-1,2.9239478e-05,5.257292e-05,0.9999182
30135,cells,8,9,58,63,"IL-35 inhibited the proliferation of CD4+CD25- T effector cells in vitro in a dose-dependent manner, and its suppression was partially reversed by applying IL-35-neutralizing antibodies.",27682874_5,-1,-1,2,2,30135,-1,3.5023044e-05,4.505019e-05,0.9999199
22565,regulatory T cells,25,28,177,195,CONCLUSIONS: This study indicates that Tc17 cell infiltration in cervical cancers is associated with cancer progression accompanied by increased infiltrations of Th17 cells and regulatory T cells as well as promoted tumor vasculogenesis.,24523865_6,-1,-1,2,2,22565,-1,3.9320566e-05,3.9106435e-05,0.99992156
18579,T cells,5,7,13,20,"FoxP3*, CD8* T cells correlated positively with progression-free interval and survival.",22996369_9,-1,-1,2,2,18579,-1,2.7457998e-05,3.4377004e-05,0.99993825
3041,T cells,16,18,121,128,"While autoimmunity and inflammation are the principal phenotypes associated with the abrogation of TGF-beta signaling in T cells in mice, emerging evidence now also directly links Smad-dependent TGF-beta signaling in T cells to the suppression of epithelial neoplasia.",16123803_4,-1,-1,2,2,3041,-1,3.089078e-05,4.3451833e-05,0.9999256
26429,CCR5,0,1,0,4,"CCR5 blockade also induces suppressor of cytokine signaling 3 (SOCS3) upregulations, and anti-CCR5 antibody fails to suppress expression of phospho-Stat3 (p-Stat3), matrix metallopeptidase 9 (MMP9), and IL-6 in cells transfected with SOCS3 short-interfering RNA (SiRNA).",26047948_5,-1,-1,2,2,26429,-1,0.00022191113,0.00020504586,0.99957305
392,CD40L,0,1,0,5,"CD40L expression modulated the immune response exerted by NK cells, in part by the activation of nuclear factor kB (NF-kB).",11129327_8,-1,-1,2,2,392,-1,3.52865e-05,5.0324037e-05,0.9999144
10368,T cell,41,43,209,215,"Finally, the optimal construct, tFE67(Co), was generated by including tpa signal sequence, Flt3L, fusion of E6 and E7, and codon optimization, which induces 23 and 25 times stronger E6- and E7-specific CD8(+) T cell responses than those of initial E67 fusion construct.",19651174_4,-1,-1,2,2,10368,-1,3.8119502e-05,4.944782e-05,0.9999124
23345,T cells,10,12,77,84,"Furthermore, we demonstrate that RANKL blockade can rescue melanoma-specific T cells from thymic deletion and that persistence of these tumor-specific effector T cells promoted increased host survival in response to tumor challenge.",24752296_7,-1,-1,2,2,23345,-1,3.053082e-05,3.5933226e-05,0.9999336
36921,cell,17,18,106,110,"In this review, we explore recent discoveries that advance our understanding of how Itch regulates immune cell biology, and the extent to which these clarify how Itch prevents autoimmune disease.",31126634_5,-1,-1,2,2,36921,-1,3.9813178e-05,5.5802717e-05,0.9999044
20461,Treg cells,15,17,110,120,This protective effect was associated with significant reduction in tumour-infiltrating FoxP3(+) and IL-10(+) Treg cells and a corresponding increase in tumour-infiltrating CD4(+) and CD8(+) T cells that secreted IFN-.,23657628_8,-1,-1,2,2,20461,-1,3.1119125e-05,4.2821215e-05,0.9999261
29408,cells,14,15,81,86,"In addition, most studies' report on that FoxP3 expression in all abovementioned cells is related to their status of activation since nave (non-activated cells) were found poorly FoxP3 expressing.",27339600_7,-1,-1,2,2,29408,-1,3.503532e-05,4.8392427e-05,0.99991655
36940,cells,25,26,144,149,We showed here that the spatial distribution of interleukin-4 (IL4) in invariant natural killer T (iNKT) cells regulated crosstalk between iNKT cells and dendritic cells (DCs) and controlled iNKT cell-mediated T-helper type 1 (Th1) responses.,31160756_1,-1,-1,2,2,36940,-1,4.2247004e-05,4.0285282e-05,0.9999175
14407,T cells,3,5,15,22,This subset of T cells may be a novel therapeutic target in the treatment of CRC.,21352252_10,-1,-1,2,2,14407,-1,3.4468336e-05,4.526243e-05,0.99992025
7758,cells,7,8,46,51,"Accordingly, we enumerated FOXP3(+)CD4 T(reg) cells in intratumoral and peritumoral sections of metastatic melanoma tumors and found a significant increase in proportion of FOXP3(+)CD4 T(reg) cells in the intratumoral compared with peritumoral areas.",18820132_3,-1,-1,2,2,7758,-1,4.4315093e-05,4.1535837e-05,0.99991417
28515,cells,15,16,121,126,"We report that necroptotic cancer cells release damage-associated molecular patterns and promote maturation of dendritic cells, the cross-priming of cytotoxic Tcells, and the production of IFN- in response to tumor antigen stimulation.",27050509_3,-1,-1,2,2,28515,-1,3.3661247e-05,4.2183794e-05,0.9999242
29651,cells,9,10,58,63,"In this study, healthy human peripheral blood mononuclear cells (PBMCs) derived DCs were co-cultured with BCC pumc-91 and adriamycin-resistant pumc-91/ADM.",27556503_2,-1,-1,2,2,29651,-1,3.426619e-05,3.855732e-05,0.9999273
11816,T cells,17,19,100,107,CD8(+) cytotoxic T lymphocytes (CTLs) are involved in antigen-specific tumor destruction and CD4(+) T cells are essential for helping this CD8(+) T cell-dependent tumor eradication.,20305684_1,-1,-1,2,2,11816,-1,3.127239e-05,3.6297133e-05,0.9999324
11496,lymphocyte,16,17,93,103,"In a basic study of immunotolerance, injection of an endogenous superantigen, i.e. the minor lymphocyte stimulatory (Mls)-1(a), into specific TCR Vbeta8.1-Tg mice enabled generation of anergic CD25(-) iTreg, the immunosuppressive function of which was maintained by IL-10 production via p38-MAPK activation.",20127675_1,-1,-1,2,2,11496,-1,6.904613e-05,5.5471664e-05,0.99987555
14489,regulatory T cells,25,28,162,180,"Previously, we demonstrated that ANGPT2 augments the expression of various proangiogenic genes, the potent immunosuppressive cytokine, IL-10, and a chemokine for regulatory T cells (Tregs), CCL17 by TEMs in vitro.",21368233_3,-1,-1,2,2,14489,-1,3.697529e-05,5.311129e-05,0.9999099
12722,T cells,37,39,196,203,"It has not been established, however, whether IL-4 can induce comprehensive type 2 cytokine expression by CD8 T cells in vivo, nor whether the effects of IL-4 on type 2 cytokine production by CD8 T cells can be inhibited by IFN-gamma.",20562261_2,-1,-1,2,2,12722,-1,2.7857308e-05,3.747252e-05,0.9999347
20790,subsets,14,15,79,86,"Here, employing an in vitro coculture system, we demonstrate that splenic MDSC subsets suppress antigen-driven CD8(+) T-cell proliferation, but differ in their dependency on IFN-, STAT-1, IRF-1, and NO to do so.",23878002_2,-1,-1,2,2,20790,-1,4.0677976e-05,4.846369e-05,0.99991083
17562,cells,9,10,58,63,"In vivo, a substantially increased infiltration of immune cells was observed in mesenchymal GBMs, while immune infiltrates were rare in proneural GBMs.",22676416_4,-1,-1,2,2,17562,-1,4.851068e-05,4.8115126e-05,0.9999033
27566,T cells,6,8,34,41,RESULTS: Reconstitution of CD4(+) T cells was delayed more than that of CD8(+) T cells in T-cell restoration after SLTBI.,26475064_6,-1,-1,2,2,27566,-1,3.1391788e-05,3.4473516e-05,0.9999342
16867,T cell proliferation,9,12,64,84,"Their gene profiles, frequency and suppressor functions against T cell proliferation were compared among the subjects.",22419479_5,-1,-1,2,2,16867,-1,3.52551e-05,4.2214233e-05,0.9999225
40382,cell,11,12,80,84,"Here, we show that murine fibrosarcoma-conditioned medium promoted total spleen cell proliferation but inhibited T cell responses to mitogenic and allo-antigen-mediated stimulation.",32661685_1,-1,-1,2,2,40382,-1,3.6800233e-05,4.4760538e-05,0.99991834
37911,cell,10,11,52,56,This regulation of HDAC6 for murine and human TH 17 cell is highly conserved.,31539182_6,-1,-1,2,2,37911,-1,3.9156792e-05,5.3215055e-05,0.9999076
10619,T cells,29,31,248,255,The secreted mp28 prevented the IL-27-mediated signal transduction and activator of transcription 1 phosphorylation and subsequently inhibited the IL-27-mediated intercellular adhesion molecule-1 induction and interferon-gamma production in CD4(+) T cells.,19740343_4,-1,-1,2,2,10619,-1,3.063768e-05,3.9918996e-05,0.9999294
18541,cytotoxic T lymphocyte,11,14,82,104,Anti-tumor immunity and tumor specific effector T-cell functions were assessed by cytotoxic T lymphocyte assay and intracellular IFN- staining.,22996231_3,-1,-1,2,2,18541,-1,3.8220696e-05,4.834776e-05,0.99991333
30700,cells,35,36,187,192,"Adaptive immune cells affected by smoking mainly include T helper cells (Th1/Th2/Th17), CD4+CD25+ regulatory T cells, CD8+ T cells, B cells and memory T/B lymphocytes while innate immune cells impacted by smoking are mostly DCs, macrophages and NK cells.",27902485_2,-1,-1,2,2,30700,-1,4.728096e-05,4.023439e-05,0.9999124
30809,cells,12,13,75,80,Our study revealed that IL-17A promoted PDL1 expression in human and mouse cells.,27935862_5,-1,-1,2,2,30809,-1,3.509788e-05,5.2580286e-05,0.9999124
15902,cell,14,15,84,88,The positive charge of this peptide allows protein antigen fused with it to improve cell penetration.,21945963_3,-1,-1,2,2,15902,-1,3.973124e-05,6.0851005e-05,0.9998994
11785,T cells,28,30,141,148,HPV-specific CD4+ and CD8+ T-cell responses were detected in TIL and TDLNC and their relative contribution varied between <1% and 66% of all T cells.,20233872_3,-1,-1,2,2,11785,-1,3.0198215e-05,3.9029153e-05,0.99993086
16200,T cells,11,13,71,78,Canine T(reg) have the potential to suppress proliferation of effector T cells (T(eff)).,22041284_8,-1,-1,2,2,16200,-1,3.1055224e-05,3.549965e-05,0.99993336
34000,T cells,21,23,145,152,"Using an adoptive transfer model of cancer immunotherapy, we demonstrate that constitutive eomesodermin (Eomes) expression in tumor-specific CD8 T cells improves tumor rejection and survival.",29271784_1,-1,-1,2,2,34000,-1,3.0042222e-05,3.687448e-05,0.9999331
42973,cells,5,6,37,42,"PBMC migration towards breast cancer cells can be reduced by treatment with the non-steroidal anti-inflammatory drugs, aspirin and celecoxib.",34602068_9,-1,-1,2,2,42973,-1,3.390415e-05,4.916896e-05,0.99991703
28394,T cells,30,32,158,165,"To verify the effect of tumor cells on the phenotype and function of CD4(+) Tregs, we established a coculture system using NSCLC cell line and healthy CD4(+) T cells and showed that SPC-A1 induced IL-10 and TGF-1 secretion by affecting the function of CD4(+) Tregs.",27000869_6,-1,-1,2,2,28394,-1,3.3212942e-05,3.6679325e-05,0.99993
24286,suppressor cells,1,3,16,32,Myeloid-derived suppressor cells (MDSC) expanded with tumor progression at both primary and lung metastatic sites.,25035397_4,-1,-1,2,2,24286,-1,4.4319335e-05,4.307778e-05,0.9999126
13215,T cells,2,4,17,24,caAkt expressing T cells (caAkt-T-cells) were also relatively resistant to suppression by and conversion into regulatory T cells (Tregs).,20842106_4,-1,-1,2,2,13215,-1,3.0548545e-05,3.5265868e-05,0.9999342
43168,B7-H3,2,3,6,11,"Thus, B7-H3 expression in tumor cells contributes to CCL2-CCR2-M2 macrophage axis-mediated immunosuppression and tumor progression.",34799346_7,-1,-1,2,2,43168,-1,0.00016832518,0.00010681253,0.9997249
5604,T cells,48,50,296,303,"To monitor the differences in T-cell recognition, 2 approaches of tetramer-guided technology were employed: (i) the in situ localization of major histocompatibility complex class I peptide complexes in the tumor lesions and (ii) the ex vivo sorting of HLA-A*0201-restricted and HPV16 E6-reactive T cells.",17589293_1,-1,-1,2,2,5604,-1,3.252097e-05,3.953356e-05,0.9999279
5137,cells,9,10,67,72,"These results indicate that TGF-beta secreted by ovarian carcinoma cells owns vital function in the process of converting peripheral CD4(+)CD25(-) T cells into CD4(+)CD25(+) regulatory T cells, which may provide one immunotherapeutic target for ovarian cancer.",17353088_4,-1,-1,2,2,5137,-1,3.372002e-05,4.282363e-05,0.99992347
35193,Cytotoxic T cells,0,3,0,17,"Cytotoxic T cells were depleted from C57BL/6 mice by administration of antibodies against CD8 (anti-CD8), and growth of tumors from KPC cells, with or without control or p50-/- PSCs, was measured.",29909021_5,-1,-1,2,2,35193,-1,4.016115e-05,4.595602e-05,0.9999138
12266,cells,18,19,107,112,CCL22 was not detected in conventional GCs and only sparsely detected in dendritic cells but not in cancer cells in Ly-rich GCs.,20422211_10,-1,-1,2,2,12266,-1,3.6813308e-05,4.3380733e-05,0.9999198
33963,cells,1,2,18,23,HLA-DQA1-positive cells in the liver sinusoid were positive for CD68 (macrophages or Kupffer cells); those in the lymphocytic infiltrates were positive for CD20 (B cells) or CD3 (T cells).,29248968_4,-1,-1,2,2,33963,-1,3.8468635e-05,3.9406634e-05,0.99992204
35773,cell,12,13,82,86,Subsequent study revealed that BCC-derived IL-35 inhibited conventional T (Tconv) cell proliferation and further induced suppressed Tconv cells into IL-35-producing induced regulatory T (iTr35) cells.,30321288_4,-1,-1,2,2,35773,-1,4.2357726e-05,4.3407064e-05,0.9999143
22851,T cells,7,9,35,42,We found that double-negative (DN) T cells were significantly more abundant in thyroid cancer than in thyroid autoimmunity.,24623740_5,-1,-1,2,2,22851,-1,2.9241135e-05,4.1709605e-05,0.9999291
17718,cell,37,38,249,253,"These results suggest that HBx-mIL-12 can not only induce cell cycle arrest and apoptosis in HCC cells, but also effectively shift the tumor microenvironment from pro-oncogenic to antitumor through recruitment of immune cells and inhibiting stromal cell growth, such as vascular endothelial cells.",22710287_6,-1,-1,2,2,17718,-1,5.1632083e-05,4.644949e-05,0.9999019
10628,cytotoxic T-lymphocyte,7,9,52,74,Forced production of mp28 suppressed the allogeneic cytotoxic T-lymphocyte induction and subsequently retarded the graft rejection.,19740343_8,-1,-1,2,2,10628,-1,4.285591e-05,4.794945e-05,0.99990916
9875,T cells,22,24,111,118,"At tumor site, impaired STAT activation in T cells did not correlate with frequency of CD4(+) CD25(+) Foxp3(+) T cells.",19509154_7,-1,-1,2,2,9875,-1,3.1209045e-05,3.6488324e-05,0.9999323
77,cell,19,20,120,124,Activation of the transcription factor nuclear factor-kappaB (NFkappaB) is impaired in T cells from patients with renal cell carcinomas (RCCs).,10491412_0,-1,-1,2,2,77,-1,4.3768003e-05,5.6275116e-05,0.9999
1600,Treg cells,11,13,87,97,Phenotypic and functional analyses demonstrated that they were antigen-specific CD4(+) Treg cells expressing CD25 and GITR molecules and possessing suppressive activity on the proliferative response of naive CD4(+) T cells to anti-CD3 antibody stimulation.,14738769_3,-1,-1,2,2,1600,-1,3.1699205e-05,4.9682483e-05,0.9999186
36179,T cells,1,3,7,14,"V9V2 T cells from AML patients exhibited lower expression of IL-21R, and required higher levels of IL-21 for expansion.",30708194_6,-1,-1,2,2,36179,-1,2.8340066e-05,4.088371e-05,0.99993074
27336,T cells,11,13,78,85,These results suggest that GITR signaling has stimulatory effects on effector T cells and inhibitory effects through Treg cells.,26423152_10,-1,-1,2,2,27336,-1,3.0899795e-05,3.4124798e-05,0.99993503
11339,cells,10,11,68,73,"The purpose of this study was to investigate immunological effector cells and angiogenesis in malignant pleural mesothelioma (MPM) patients, who underwent multimodality treatments.",20053697_0,-1,-1,2,2,11339,-1,4.1014035e-05,4.6127e-05,0.99991286
18173,suppressor cells,1,3,16,32,Myeloid-derived suppressor cells (MDSCs) have emerged as a heterogeneic immunoregulatory population that can expand in response to inflammatory signals.,22828446_0,-1,-1,2,2,18173,-1,3.3729168e-05,3.8572998e-05,0.99992764
29871,precursors,16,17,92,102,"As a result, NOTCH1 target genes indispensable for Tcell differentiation were silenced and precursors were reprogrammed into innate cells with Tcell marks including intracellular CD3 and Tcell rearrangements.",27612641_3,-1,-1,2,2,29871,-1,4.3690776e-05,4.9322316e-05,0.9999069
1274,T cells,24,26,151,158,"Pretreatment of normal macrophages with IL-11 resulted in no decrease in NO production, nor an impaired production of IFN-gamma was observed in normal T cells upon pretreatment with IL-11.",12527946_6,-1,-1,2,2,1274,-1,3.139527e-05,4.282553e-05,0.99992585
12370,cells,4,5,19,24,The number of mast cells was significantly higher in granulomas than in cystic lesions (P = .02).,20478453_7,-1,-1,2,2,12370,-1,3.660635e-05,4.2141248e-05,0.9999212
37955,cells,29,30,195,200,We aimed to investigate the frequency of these cells and their ability to produce cytokines in tumor-draining lymph nodes from patients with breast cancer (BC).MATERIALS AND METHODS: Mononuclear cells from lymph nodes of 20 patients with BC were activated and stained for appropriate markers.,31630080_1,-1,-1,2,2,37955,-1,3.508066e-05,4.1693653e-05,0.9999232
28311,T cells,4,6,22,29,"During cancer growth, T cells show reduced NF-B activity, which is required for tumor rejection.",26903482_2,-1,-1,2,2,28311,-1,2.8671915e-05,4.4288536e-05,0.9999269
29999,Cells,0,1,0,5,"Cells were stimulated in vitro and stained with CD25, CD4, FoxP3, IFN-, IL-10, and IL-2 or isotype matched antibodies and subjected to flow cytometry.",27619682_4,-1,-1,2,2,29999,-1,3.0559342e-05,4.5153014e-05,0.9999243
9951,cells,16,17,110,115,"These cells were anergic toward T-cell receptor stimulation and, when cocultured with activated CD4(+)CD25(-) cells, potently suppressed their proliferation and cytokine secretion.",19538059_5,-1,-1,2,2,9951,-1,3.7709087e-05,4.213136e-05,0.99992025
12796,B7-1,20,23,106,110,"RESULTS: Syngeneic BALB/c mice injected with H22/B7-1/B7-2/4-1BBL cells that expressed elevated levels of B7-1, B7-2 and 4-1BBL showed a tumor development frequency of 50% compared with 100% in mice injected with the H22 parental line, H22/neo, H22/B7-1/B7-2 and H22/4-1BBL.",20563597_5,-1,-1,2,2,12796,-1,9.460212e-05,0.00015398039,0.9997514
57,CTL,25,26,169,172,"We show here that gene gun-mediated skin transfection of plasmid vector encoding the nontransforming, amino-terminal half of E6 resulted in the induction of E6-specific CTL activity and tumor rejection in a murine model.",10419051_3,-1,-1,2,2,57,-1,4.4895736e-05,4.777499e-05,0.99990726
17424,cells,27,28,138,143,Surface expression of the IL-2 receptor -chain (CD25) has been used to discriminate between CD4(+) CD25(HI) FOXP3(+) regulatory T (Treg) cells and CD4(+) CD25(NEG) FOXP3(-) non-Treg cells.,22585674_0,-1,-1,2,2,17424,-1,3.884745e-05,3.787795e-05,0.9999232
7875,cells,23,24,110,115,"In contrast to the increasing number of CD4(+) T cells, CD8(+), CD3(-)CD56(+), CD3(+)CD56(+), and gammadeltaT cells were all found to be under-represented in tumor infiltrating lymphocytes.",18941744_2,-1,-1,2,2,7875,-1,3.803617e-05,3.7914306e-05,0.99992406
19667,cells,2,3,7,12,T(reg) cells maintain immune homeostasis and self-tolerance and play an important role in the prevention of autoimmune disease.,23252899_1,-1,-1,2,2,19667,-1,4.097441e-05,4.670022e-05,0.99991226
12960,suppressor cells,14,16,95,111,"Possible mechanisms included: (i) decreases in immunosuppressive cells such as myeloid-derived suppressor cells (MDSC), T-regulatory cells (T-regs), and B-cells, (ii) stimulation of memory cells by intratumoral antigen release leading to efficient cross-priming, (iii) alteration of the tumor microenvironment with production of ""danger signals"" and immunostimulatory cytokines, and (iv) augmented trafficking of T-cells into the tumors.",20683443_5,-1,-1,2,2,12960,-1,3.5102323e-05,3.6767728e-05,0.99992824
20012,T cells,54,56,297,304,"In testing this hypothesis, we showed that combined regimens to deplete Tregs, MDSC, and PD-1(+) T cells in patients with advanced HCC restored production of granzyme B by CD8(+) T cells, reaching levels observed in normal controls and also modestly increased the number of IFN- producing CD4(+) T cells.",23423978_5,-1,-1,2,2,20012,-1,2.8926648e-05,3.767008e-05,0.99993336
11685,cells,6,7,40,45,METHODS: CT26.WT murine colon carcinoma cells were injected intraportally in Balb/c mice after median laparotomy using a standardized injection technique.,20205946_3,-1,-1,2,2,11685,-1,3.5357833e-05,4.4782977e-05,0.9999198
20473,T cell,2,4,14,20,We determined T cell polarization in TSCC and SCC by intracellular cytokine staining of T cell crawl outs from human skin explants.,23667456_2,-1,-1,2,2,20473,-1,3.6476875e-05,4.2709566e-05,0.99992085
17595,T cells,6,8,40,47,ELISpot analysis of CD4+ICOS(hi) sorted T cells demonstrated that following vaccination the cytokines produced by Mam-A-specific T cells switched from IL-10 (7821 spm pre-vaccination to 3214 spm 5months post-vaccine p<0.001) to IFN- (126 spm pre-vaccination to 12431 spm 5months post-vaccine p<0.001).,22678162_6,-1,-1,2,2,17595,-1,2.881913e-05,3.5624867e-05,0.9999355
1380,CTL,20,21,136,139,"AT-1 CTL lysed peptide-pulsed CMS8 cells at a nanomolar concentration, and the peptide strongly stimulated IFN-gamma production in AT-1 CTL.",12707369_2,-1,-1,2,2,1380,-1,4.312768e-05,4.0489365e-05,0.9999163
3306,T cells,20,22,104,111,"Here, we studied the impact of IL-2 administration on the frequency and function of human CD4+ CD25(hi) T cells in immune intact patients with melanoma or renal cancer.",16304057_3,-1,-1,2,2,3306,-1,3.016499e-05,3.9175844e-05,0.9999306
2858,T cell-depleted,13,15,79,94,"However, IL-27 still augmented the generation of CTL from T-bet-deficient CD4+ T cell-depleted spleen cells stimulated by allogeneic spleen cells with increased granzyme B expression.",16034109_8,-1,-1,2,2,2858,-1,4.303059e-05,5.6067212e-05,0.99990094
35503,T cells,52,54,309,316,"Neoadjuvant chemotherapy seemed to result in a relocation of Th1-committed CD4+ T cells from blood, presumably to the tumour, indicated by shifts in the methylation patterns, whereas no such shifts were seen for lineages corresponding to IL13, IL17A and FOXP3.CONCLUSION: Increased lineage commitment in CD4+ T cells, as determined by demethylation in predictive CpG sites, is associated with lower post-cystectomy tumour stage, complete response to neoadjuvant chemotherapy and overall better outcome, suggesting epigenetic profiling of CD4+ T cell lineages as a useful readout for clinical staging.",30075815_13,-1,-1,2,2,35503,-1,3.094519e-05,3.5553083e-05,0.9999335
4816,T cell,17,19,97,103,"Depletion of Treg from peripheral blood mononuclear cells (PBMC) of CRC patients unmasked CD4(+) T cell responses, as observed by IFNgamma release, to the tumor associated antigen 5T4, whereas no effect was observed in a healthy age-matched control group.",17205133_5,-1,-1,2,2,4816,-1,3.8384187e-05,4.273857e-05,0.9999188
9896,T cells,36,38,200,207,"We found that, in the absence of lymphoma B cells, treatment with IL-1beta/IL-6 or lipopolysaccharide (LPS) enhanced IL-17 expression in CD4(+) T cells and this enhancement was attenuated when CD4(+) T cells were cocultured with lymphoma B cells.",19509224_1,-1,-1,2,2,9896,-1,3.0482393e-05,3.6378835e-05,0.9999331
23412,lymphocytes,17,18,120,131,The present study was designed to investigate the correlation between apoptosis levels and Fas/FasL expression in CD8+T lymphocytes and Foxp3+T cells in patients with HCC.METHODS: CD8+T cells and CD3+Foxp3+T cells were tested from peripheral blood of HCC patients and normal controls and subjected to multicolor flow cytometry.,24761872_3,-1,-1,2,2,23412,-1,3.6091416e-05,4.1619045e-05,0.9999223
24158,T cell,12,14,60,66,"NK cells were shown to be necessary and sufficient in NK or T cell depletion experiments, or by adoptively transferring NK cells.",25015826_5,-1,-1,2,2,24158,-1,3.3643104e-05,4.1494117e-05,0.9999249
23244,Th2 cell,17,19,93,101,"Newly identified nuocytes or group 2 innate lymphoid cells (ILC2s) play an important role in Th2 cell mediated immunity such as protective immune responses to helminth parasites, allergic asthma, and chronic rhinosinusitis.",24741632_0,-1,-1,2,2,23244,-1,9.3563795e-05,0.0003070722,0.9995994
40383,T cell,15,17,113,119,"Here, we show that murine fibrosarcoma-conditioned medium promoted total spleen cell proliferation but inhibited T cell responses to mitogenic and allo-antigen-mediated stimulation.",32661685_1,-1,-1,2,2,40383,-1,3.330487e-05,4.121539e-05,0.9999255
37691,cells,20,21,121,126,"Both baicalein and baicalin enhanced the cytotoxicity of T cells to eliminate tumor cells, which was abrogated after HCC cells were transfected with a PD-L1 overexpression plasmid or after T cells were pretreated with an anti-PD-1 blocking antibody.",31437792_4,-1,-1,2,2,37691,-1,3.3966797e-05,4.252852e-05,0.99992347
6157,cell,7,8,57,61,Rapamycin inhibited mTORC1 signaling and suppressed CTCL cell proliferation but showed little effect on their apoptotic rate when used as a single agent.,18025151_5,-1,-1,2,2,6157,-1,5.20141e-05,4.920545e-05,0.9998988
20266,cell,16,17,95,99,"METHODS: In this study, we established an MHC class II molecule-expressing murine colon cancer cell line (CT26-CIITA) by transduction of the CIITA gene.",23621273_1,-1,-1,2,2,20266,-1,3.502452e-05,5.5332694e-05,0.99990964
13580,cells,10,11,67,72,"In addition, the percentage of CD4+CD25(high)Foxp3(+) T regulatory cells was increased in vitro.",20970781_5,-1,-1,2,2,13580,-1,3.1113643e-05,4.168952e-05,0.99992716
16967,cells,37,38,213,218,"Previously, we showed that the prophylactic delivery of IL-15 to Rag2(-/-)(c)(-/-) mice (mature T, B, and NK cell negative) afforded protection against a lethal HSV-2 challenge and metastasis of B16/F10 melanoma cells.",22447977_2,-1,-1,2,2,16967,-1,3.28148e-05,4.3612785e-05,0.9999236
11387,cells,45,46,253,258,"Since members of this family of cytokines are known to exhibit their effects on diverse immune cells, we have examined the effects of IL-21 on CLL patient derived regulatory T cell (Treg) induction, expansion and the inhibitory effect on natural killer cells in vitro.",20081380_3,-1,-1,2,2,11387,-1,3.431635e-05,4.258224e-05,0.9999231
43404,cell,7,8,59,63,"Overcoming vascular immunosuppression: lack of endothelial cell (EC) responsiveness to inflammatory stimuli in the proangiogenic environment of tumors, is essential for successful cancer immunotherapy.",36403190_0,-1,-1,2,2,43404,-1,3.6921432e-05,4.7765305e-05,0.99991524
12038,Treg cells,9,11,55,65,We found that the treatment increased the frequency of Treg cells more than 7-fold compared with pretreatment levels (P<0.0001).,20386464_2,-1,-1,2,2,12038,-1,4.079265e-05,8.299587e-05,0.99987626
23630,cells,14,15,74,79,"To determine the role of Tregs in CRC development and their effects on NK cells, we created novel transgenic Rag-Apc mice that lack T cells and develop spontaneous intestinal tumors, and we adoptively transferred Tregs or transiently depleted NK cells during initial stages of tumorigenesis.",24797894_1,-1,-1,2,2,23630,-1,3.4065954e-05,4.197803e-05,0.99992394
41171,cell,5,6,32,36,"SKIL expression levels in NSCLC cell line, clinical sample, and adjacent normal tissue were measured by quantitative PCR, western blot, or immunohistochemistry.",33268765_2,-1,-1,2,2,41171,-1,3.8358685e-05,5.7102512e-05,0.9999045
37429,cells,5,6,20,25,"Regulatory T (Treg) cells are crucial for immune homeostasis, but they also contribute to tumor immune evasion by promoting a suppressive tumor microenvironment (TME).",31350177_0,-1,-1,2,2,37429,-1,3.577892e-05,4.434393e-05,0.9999199
27523,cell,25,26,173,177,"In a xenograft mouse model, MFE significantly enhanced anti-cancer activity combined with 5-fluorouracil and markedly promoted splenocyte proliferation, natural killer (NK) cell activity, cytotoxic T lymphocyte (CTL) activity and IFN- production.",26473845_7,-1,-1,2,2,27523,-1,4.3275762e-05,4.395135e-05,0.99991274
36258,T cells,16,18,111,118,"Overall, this study suggests that B cell-mediated IL-10 production can exert complex effects toward autologous T cells.",30711567_13,-1,-1,2,2,36258,-1,2.7775015e-05,3.974817e-05,0.9999325
34735,T cells,6,8,24,31,"These CD8+ CD25+ CD127- T cells express other FOXP3- CD8+ Treg cell signature markers, and can selectively suppress autoreactive HLA-E+ TFH cells as well as tumor-induced CD4+ Treg cells.",29768737_4,-1,-1,2,2,34735,-1,3.194526e-05,3.3402794e-05,0.9999347
41195,cells,16,17,109,114,Silencing of TAZ cancelled the effects of SKIL overexpression on malignant phenotypes and autophagy of NSCLC cells.,33268765_11,-1,-1,2,2,41195,-1,3.9603106e-05,4.7767047e-05,0.9999126
22524,subset,21,22,113,119,"Coculture of CTCL cells with normal T lymphocytes consisting of both CD4(+) and CD8(+) populations or the CD4(+) subset alone, transfected with CD152 mRNA, inhibits proliferation of normal T cells in a CD152- and CD80-dependent manner.",24523507_4,-1,-1,2,2,22524,-1,4.387659e-05,4.4468066e-05,0.99991167
294,T cell,16,18,115,121,We recently reported that tyrphostin AG-490 selectively blocked IL-2 activation of Jak3/Stat5 and growth of murine T cell lines.,11046040_2,-1,-1,2,2,294,-1,3.1490064e-05,5.195771e-05,0.99991655
10280,suppressor cells,29,31,183,199,"During treatment the frequency of Foxp3+/CD4+ regulatory T cells was significantly decreased upon mRNA vaccination in peripheral blood of the patients in the KLH arm, whereas myeloid suppressor cells (CD11b+HLA-DR lo monocytes) were reduced in the patients not receiving KLH.",19609242_6,-1,-1,2,2,10280,-1,3.22163e-05,3.7890488e-05,0.9999299
1821,cells,4,5,27,32,"Mechanisms by which cancer cells express FasL, including involvement of survivin, are unclear.",15004200_3,-1,-1,2,2,1821,-1,3.417852e-05,5.870654e-05,0.999907
21531,T cells,6,8,36,43,"To evaluate whether CD8(+) effector T cells are activated or differentiated, flow cytometric analysis of peripheral blood mononuclear cells (PBMC) was performed.",24243586_7,-1,-1,2,2,21531,-1,2.6310427e-05,3.2397522e-05,0.99994123
42581,cell,31,32,188,192,"CD70 was overexpressed in primary SOX11+ MCL and it was associated with an immune unbalance of the tumor microenvironment characterized by increased number of effector regulatory t (Treg) cell infiltration, higher proliferation, and aggressive clinical course.",34189576_7,-1,-1,2,2,42581,-1,4.1253843e-05,4.389887e-05,0.9999149
39954,CD8+ T cell,5,9,34,45,"However, the mechanism underlying CD8+ T cell infiltration in colorectal tumor tissues is not fully understood.",32503584_1,-1,-1,2,2,39954,-1,7.4758085e-05,8.363554e-05,0.9998416
41054,Treg cells,5,7,23,33,"METHODS: The levels of Treg cells and IL-2, IL-10, and TGF in the blood of patients with liver cancer were detected by flow cytometry and ELISA, respectively.",33204731_1,-1,-1,2,2,41054,-1,3.8964525e-05,7.570064e-05,0.9998853
6942,regulatory T cells,3,6,22,40,Natural CD25(+)CD4(+) regulatory T cells (Treg) are essential for self-tolerance and for the control of T cell-mediated immune pathologies.,18424726_0,-1,-1,2,2,6942,-1,2.9644338e-05,3.8445356e-05,0.9999318
20992,cells,18,19,105,110,"Fifty male C57BL/6 mice were randomly grouped as follows: normal control group, model group with B16-F10 cells implanted, and three treatment groups with cyclophosphamide, triptolide-high dose, triptolide-low dose.",23975869_3,-1,-1,2,2,20992,-1,4.1728083e-05,4.6893336e-05,0.9999114
17277,CTL,22,23,115,118,"But CD4(+) T cells also decreased in spleen cells of tumor-bearing mice by alone 5-FU treated, splenic NK cell and CTL activity also degraded, while CD4(+) T cells and splenic NK cell and CTL activity significantly increased by BLTA treated.",22522606_11,-1,-1,2,2,17277,-1,4.3008895e-05,4.1607167e-05,0.99991536
11852,T-cell proliferation,40,42,213,233,"Curcumin, in turn, prevented this loss of T cells, expanded central memory T cell (T(CM))/effector memory T cell (T(EM)) populations, reversed the type 2 immune bias and attenuated the tumor-induced inhibition of T-cell proliferation in tumor-bearing hosts.",20305684_7,-1,-1,2,2,11852,-1,3.4378132e-05,3.8572056e-05,0.99992704
42768,cellular,26,27,202,210,"EOC-associated ascites allow studies on lymphocyte phenotype modulation in the tumor environment, where inflammatory profile contrasts with the presence of immunosuppressive elements and development of cellular self-regulating mechanisms.",34359872_8,-1,-1,2,2,42768,-1,3.7363818e-05,4.4500477e-05,0.9999182
5389,cells,10,11,51,56,"Of 25 significantly altered genes in T cells and B cells from melanoma patients, 17 are interferon (IFN)-stimulated genes.",17488182_3,-1,-1,2,2,5389,-1,3.5434135e-05,4.7337366e-05,0.99991727
39426,Treg cells,11,13,64,74,"In both healthy controls and pituitary adenoma patients, TIM-3+ Treg cells presented significantly higher levels of TGF- and IL-10 co-producing cells than TIM-3- Treg cells but compared to healthy controls, patients with nonfunctioning pituitary adenomas showed significantly higher levels of TIM-3+ FOXP3+ Treg cells.",32279926_7,-1,-1,2,2,39426,-1,3.482353e-05,6.8648376e-05,0.9998965
31663,CTLs,5,6,32,36,Memory cytotoxic T lymphocytes (CTLs) are able to provide protections to the host against repeated insults from intracellular pathogens.,28405920_0,-1,-1,2,2,31663,-1,3.8988917e-05,4.4938883e-05,0.9999161
39968,CD8+ T cell,11,15,66,77,"RESULTS: Compared with tumor tissues of early-stage CRC patients, CD8+ T cell density was lower in advanced-stage tumor tissues.",32503584_5,-1,-1,2,2,39968,-1,7.039933e-05,6.976565e-05,0.9998598
16338,CD4+ T cell,19,23,108,119,"Interestingly, both subsets expressed a high level of interferon  in TILs, and the Tcregs suppressed nave CD4+ T cell proliferation by a cell contact-dependent mechanism in vitro.",22051182_9,-1,-1,2,2,16338,-1,6.205578e-05,7.222409e-05,0.99986565
38997,cell,16,17,92,96,"Meanwhile, TGFBR2-edited CAR T cells had better in vivo tumor elimination efficacy, both in cell line-derived xenograft and patient-derived xenograft solid tumor models, whether administered locally or systemically.",31999649_3,-1,-1,2,2,38997,-1,3.7542966e-05,5.8846916e-05,0.99990356
12671,lymphocytes,32,33,176,187,"In the present study, we investigated the distribution of Th17 cells in relation to regulatory T cells (Treg) in the tumor-infiltrating lymphocytes (TILs), regional lymph node lymphocytes, and peripheral blood lymphocytes of gastric cancer patients.",20550524_1,-1,-1,2,2,12671,-1,4.8345675e-05,4.4136817e-05,0.9999075
2219,subsets,14,15,86,93,CONCLUSION: This flow cytometry method can be used to monitor STAT1 activation within subsets of immune cells from patients undergoing IFN alpha immunotherapy.,15339971_10,-1,-1,2,2,2219,-1,4.631382e-05,5.27511e-05,0.9999008
15949,Treg cells,10,12,53,63,This study aimed to investigate the effects of GP on Treg cells and Th1/Th2 cytokines in H22 hepatocarcinoma tumor-bearing mice.,21963624_2,-1,-1,2,2,15949,-1,3.7665293e-05,6.072476e-05,0.99990165
32827,cells,24,25,168,173,"In coculture experiments, T cells incubated with SEL24-B489-treated RS cells exhibited higher expression of activation markers than T cells coincubated with control RS cells.",28698206_9,-1,-1,2,2,32827,-1,3.642647e-05,4.1763353e-05,0.9999218
16993,cells,62,63,436,441,"This IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) bone marrow cells occurred independently of the IL-15/IL-2R and Jak/STAT pathways and instead required IL-15R signaling as well as activation of JNK and NF-B. Importantly, we also showed that the trans presentation of IL-15 by IL-15R boosts IL-15-mediated IFN- production by NK cells but reduces IL-15-mediated RANTES production by Rag2(-/-)(c)(-/-) myeloid bone marrow cells.",22447977_5,-1,-1,2,2,16993,-1,3.7888585e-05,4.136538e-05,0.9999207
23459,cell,54,55,343,347,"METHODS: Using multicolor flow cytometry, the frequency of three Treg subsets, separated on the basis of CD45RA and Foxp3, from the peripheral circulation of newly-presenting HNSCC patients (19 oral cavity squamous cell carcinoma, 20 hypopharyngeal squamous cell carcinoma, 18 nasopharyngeal squamous cell carcinoma, 19 oropharyngeal squamous cell carcinoma, and 36 laryngeal squamous cell carcinoma) were assessed with regard to 31 healthy donors and clinicopathological features.",24761979_2,-1,-1,2,2,23459,-1,5.066034e-05,7.016769e-05,0.9998791
18,CTL,7,8,32,35,The action of T helper cells in CTL priming is mediated by CD40-CD40 ligand interactions.,10395322_2,-1,-1,2,2,18,-1,4.0826384e-05,4.671047e-05,0.9999124
14309,cells,16,17,108,113,"RESULTS: Here we characterise the effects of conditioned media from reovirus-infected, dying human melanoma cells (reoTCM), in the absence of live virus, to address the immune bystander potential of reovirus therapy.",21338484_1,-1,-1,2,2,14309,-1,3.6539084e-05,5.0406867e-05,0.999913
35491,T cells,13,15,106,113,"Patients with complete response to neoadjuvant chemotherapy displayed significant hypomethylation in CD4+ T cells for all four investigated loci, most prominently in IFNG p<0.0001.",30075815_12,-1,-1,2,2,35491,-1,3.0100215e-05,3.9487615e-05,0.9999304
